data_2h35_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2h35 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 2' ' ' LEU . 29.8 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 7.8 mp 55.94 163.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.399 -0.813 . . . . 0.0 109.846 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.517 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 176.24 -47.8 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.021 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 3' ' ' SER . 54.2 Cg_exo -50.44 -170.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.473 2.115 . . . . 0.0 112.603 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -60.31 -16.17 32.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 109.667 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 5' ' ' ALA . 22.2 m-20 -39.51 -29.09 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.379 -0.826 . . . . 0.0 109.67 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 10' ' ' VAL . 4.6 ptpt -83.22 -49.99 8.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 7' ' ' LYS . 52.5 m -43.82 -32.77 1.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.474 -0.766 . . . . 0.0 109.751 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.85 -30.27 50.89 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.571 ' N ' ' O ' ' A' ' 7' ' ' LYS . 51.2 t -76.8 -51.57 18.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -57.64 -36.75 72.27 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.812 -1.155 . . . . 0.0 108.262 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.81 -58.25 8.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.13 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.99 -34.4 63.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 108.935 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -17.52 61.75 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.96 -44.6 18.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -70.1 -37.39 75.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -1.164 . . . . 0.0 108.51 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 t -60.16 -67.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 59.32 -136.81 50.59 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.28 29.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.487 -1.008 . . . . 0.0 110.485 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.593 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.9 m-70 -129.7 13.14 5.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 108.579 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.0 -52.36 11.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.584 -0.697 . . . . 0.0 109.811 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.01 -14.53 10.68 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.31 -56.48 3.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -1.188 . . . . 0.0 109.72 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 20' ' ' HIS . 14.1 m-85 -59.86 -24.83 64.54 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 109.247 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.03 -33.77 84.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.93 -39.0 57.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.584 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.563 ' C ' ' HG1' ' A' ' 108' ' ' THR . 13.2 tt0 -67.51 -20.0 65.38 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.361 -0.837 . . . . 0.0 109.552 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.43 61.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.078 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -75.98 -59.32 2.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -56.49 -12.55 1.78 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.282 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -65.21 -58.29 6.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.939 . . . . 0.0 109.835 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -84.52 -32.91 23.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 110.354 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 20.1 m-85 -63.54 -36.01 82.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.006 -1.058 . . . . 0.0 110.121 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.562 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 3.8 pp -46.92 -40.54 14.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.84 -1.163 . . . . 0.0 109.534 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.564 ' O ' ' C ' ' A' ' 36' ' ' PHE . 1.4 p -76.56 -23.58 53.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.022 -1.049 . . . . 0.0 108.792 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.564 ' C ' ' O ' ' A' ' 35' ' ' SER . 0.3 OUTLIER 21.44 66.0 0.3 Allowed Pre-proline 0 N--CA 1.501 2.103 0 CA-C-O 121.155 0.502 . . . . 0.0 111.291 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.44 -62.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.46 2.107 . . . . 0.0 112.076 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.479 ' CG2' ' CD2' ' D' ' 97' ' ' HIS . 1.2 p -91.15 -57.52 2.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.546 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -44.12 -22.94 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -0.795 . . . . 0.0 110.333 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.3 ttmt -49.06 -45.17 42.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.087 -1.008 . . . . 0.0 109.569 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.423 ' CB ' ' O ' ' D' ' 94' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.59 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.645 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.258 0 CA-C-O 120.983 0.42 . . . . 0.0 110.669 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.477 ' C ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -154.35 31.1 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.581 -1.324 . . . . 0.0 110.553 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 46' ' ' PHE . 35.6 m-20 42.26 88.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -0.798 . . . . 0.0 110.242 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.474 ' CD2' ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.44 -13.06 57.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 109.035 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 50' ' ' HIS . 32.8 p -78.02 165.73 23.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.559 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.675 ' N ' ' HD1' ' A' ' 50' ' ' HIS . 0.3 OUTLIER -57.81 -162.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.319 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.7 34.49 10.49 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 54' ' ' GLN . 30.2 t -139.06 82.29 1.89 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.357 -1.084 . . . . 0.0 109.259 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.68 -10.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.414 -0.804 . . . . 0.0 109.806 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 52' ' ' SER . 11.7 mt-30 -74.81 -35.23 62.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.123 -0.986 . . . . 0.0 109.676 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.66 -48.51 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.52 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' CD ' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -69.18 -25.5 64.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.416 -0.802 . . . . 0.0 109.046 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.91 -21.68 78.93 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.8 t-80 -82.43 -39.9 21.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -1.129 . . . . 0.0 109.847 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.92 -51.65 44.21 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -51.17 -22.66 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -1.022 . . . . 0.0 110.101 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.76 -29.72 56.23 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.056 -1.027 . . . . 0.0 109.255 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.8 -49.0 19.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.57 -22.71 64.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.406 -0.809 . . . . 0.0 109.191 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -78.25 -30.68 48.76 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.1 -1.0 . . . . 0.0 108.778 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.76 53.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.388 -0.82 . . . . 0.0 108.969 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.57 -40.58 72.15 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.153 -0.967 . . . . 0.0 108.757 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 m -68.81 -56.78 6.93 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 46.6 t30 -55.38 -24.17 28.35 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -80.24 -46.93 15.41 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.408 HG23 ' HZ3' ' A' ' 11' ' ' LYS . 36.0 t -64.41 -22.93 32.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.43 -17.04 64.56 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.616 ' O ' ' N ' ' A' ' 74' ' ' ASP . 4.2 m-70 -141.9 -61.25 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.434 -0.791 . . . . 0.0 109.435 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.1 p 44.72 12.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.721 0.772 . . . . 0.0 109.64 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 72' ' ' HIS . 44.5 t0 -134.21 10.45 3.83 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 2.0 m-20 -178.53 28.02 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.733 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.701 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 6.5 ptt? -78.46 -23.36 0.41 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 111.67 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.3 Cg_exo -54.36 -18.82 15.45 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.617 1.545 . . . . 0.0 112.132 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -93.43 -38.08 11.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.421 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.45 -40.18 64.38 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 108.956 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.8 mt -87.65 11.34 15.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.7 t -65.32 -26.85 68.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.713 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.98 -49.03 66.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.726 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mt -47.69 -46.96 29.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 109.022 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.7 t -62.78 -28.55 70.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.626 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -79.96 -28.14 39.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 109.588 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 90' ' ' LYS . 3.7 tt -83.22 -32.29 26.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 109.87 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -92.04 -22.0 20.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.219 -0.926 . . . . 0.0 110.218 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.07 -48.01 4.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.112 -0.992 . . . . 0.0 110.123 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -93.44 21.93 5.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.13 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.545 ' C ' ' H ' ' A' ' 92' ' ' ARG . 28.6 ttmt -172.11 147.07 2.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.022 -1.049 . . . . 0.0 110.006 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER 71.31 -20.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.522 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.545 ' H ' ' C ' ' A' ' 90' ' ' LYS . 70.4 mtt85 43.12 27.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 109.741 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 91' ' ' LEU . 12.2 p -46.98 165.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.725 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 96' ' ' VAL . 6.1 p-10 -109.7 101.18 45.6 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.493 -0.754 . . . . 0.0 109.28 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.72 -10.85 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.407 2.072 . . . . 0.0 112.331 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 94' ' ' ASP . 52.6 t -50.98 -18.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 100' ' ' LEU . 3.1 m120 -79.22 -24.38 43.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.316 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -44.33 -35.75 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -67.98 -23.78 65.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.873 . . . . 0.0 109.579 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 97' ' ' ASN . 8.8 mp -84.18 -62.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.638 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.47 -23.87 27.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.8 p -67.86 -50.4 56.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 109.727 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -78.02 -26.42 48.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.741 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 96.7 m -50.8 -50.45 56.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 109.629 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.26 -38.88 55.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.892 . . . . 0.0 109.765 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.88 -36.18 64.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.531 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.13 -27.67 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.069 -1.019 . . . . 0.0 109.852 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.563 ' HG1' ' C ' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -81.07 -45.19 16.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.123 -0.986 . . . . 0.0 109.842 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.506 ' N ' ' CG2' ' A' ' 108' ' ' THR . 15.6 mt -66.89 -20.67 65.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.926 . . . . 0.0 109.057 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 112' ' ' HIS . . . -51.66 -43.01 62.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.427 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.76 -3.62 0.12 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 109.193 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.545 ' H ' ' C ' ' A' ' 110' ' ' ALA . 79.7 m-70 -143.24 -85.59 0.15 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -0.888 . . . . 0.0 109.277 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.594 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -139.79 100.14 7.44 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.28 -98.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.646 2.231 . . . . 0.0 112.791 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.667 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -72.12 -56.58 5.34 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.557 -0.715 . . . . 0.0 110.064 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.667 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 17.5 mt-10 116.62 -6.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.485 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 4.9 t80 79.53 33.3 0.21 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.297 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.722 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -108.94 125.07 32.44 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.021 -1.049 . . . . 0.0 108.199 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.91 21.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.216 1.944 . . . . 0.0 112.801 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.722 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -149.44 -32.52 0.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.906 -1.121 . . . . 0.0 110.398 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.53 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 9.5 p -55.04 -48.79 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 110.404 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.53 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 4.4 t-160 -47.76 -36.2 11.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.45 -19.48 33.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.424 -0.797 . . . . 0.0 110.135 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 121' ' ' VAL . 92.3 p -61.64 -62.42 1.82 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.087 -1.008 . . . . 0.0 110.647 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.43 -19.95 62.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.059 -1.026 . . . . 0.0 109.595 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.3 -40.77 17.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.094 -1.004 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.23 -40.41 12.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.122 -0.987 . . . . 0.0 109.868 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.472 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 40.3 t80 -50.48 -20.84 1.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.898 -1.126 . . . . 0.0 108.717 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 133' ' ' SER . 23.6 mt -68.97 -17.88 63.99 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 134' ' ' THR . . . -57.59 -36.78 72.17 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 80.0 p -81.49 -26.82 34.89 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.27 -0.894 . . . . 0.0 108.596 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.42 -26.72 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.416 -0.802 . . . . 0.0 109.077 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 129' ' ' LEU . 1.9 t -82.68 -31.53 28.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.123 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 25.8 m -72.98 -36.77 67.16 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.31 -0.869 . . . . 0.0 109.553 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.61 -21.8 15.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.128 -0.983 . . . . 0.0 108.895 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -16.72 59.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.045 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.1 t -143.04 38.51 1.44 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.946 . . . . 0.0 109.6 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 2.6 p80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.647 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -130.3 172.03 12.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.381 -0.824 . . . . 0.0 109.352 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.425 ' O ' ' N ' ' B' ' 6' ' ' GLU . 7.7 p -90.51 141.59 27.39 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 109.301 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.429 ' O ' ' OG ' ' B' ' 9' ' ' SER . 87.8 Cg_exo -40.63 -23.92 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.509 2.139 . . . . 0.0 112.376 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' B' ' 4' ' ' THR . 73.1 mm-40 -78.87 -54.67 5.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.831 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -74.85 -23.1 58.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.503 ' O ' ' OG1' ' B' ' 12' ' ' THR . 2.1 tttm -84.29 -32.2 24.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.339 -0.851 . . . . 0.0 109.234 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' B' ' 5' ' ' PRO . 8.9 m -63.67 -23.36 67.34 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.733 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.8 -57.59 3.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.075 -1.016 . . . . 0.0 110.113 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.67 -24.35 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 70.1 m -83.98 -35.37 23.98 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.27 0.557 . . . . 0.0 109.74 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.28 -27.4 61.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.391 -0.818 . . . . 0.0 109.663 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.18 -18.73 10.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 109.339 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . 0.62 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.5 OUTLIER -50.95 -50.95 56.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.119 -0.988 . . . . 0.0 109.038 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.68 -51.02 60.5 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 7.7 mtmt -53.91 -25.91 22.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.359 -1.083 . . . . 0.0 109.093 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.41 124.31 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 109.74 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' B' ' 21' ' ' ASP . 1.8 m120 -81.86 68.31 8.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 108.94 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -45.98 -14.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.405 -0.809 . . . . 0.0 109.81 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' B' ' 19' ' ' ASN . 60.3 t0 -58.02 -18.04 21.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.839 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' B' ' 25' ' ' GLY . 35.1 mt-10 -155.79 -33.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.757 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.9 t -45.98 -23.91 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.249 -0.907 . . . . 0.0 109.702 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.54 -24.69 72.08 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -82.38 -33.03 26.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -74.74 -25.02 58.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -1.195 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.31 94.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.94 . . . . 0.0 109.559 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.41 -50.14 16.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.32 -28.2 8.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.1 -47.45 11.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.137 . . . . 0.0 109.35 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 tp -47.46 -31.55 4.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 109.435 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' B' ' 36' ' ' PRO . 14.4 mt -71.19 -46.1 62.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.23 -55.53 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.324 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.6 -22.93 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.563 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -150.4 76.9 8.29 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 109.492 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . 0.503 ' N ' ' O ' ' B' ' 32' ' ' LEU . 77.5 Cg_endo -82.93 -7.68 11.22 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.813 2.342 . . . . 0.0 112.385 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . 0.507 ' C ' ' H ' ' B' ' 39' ' ' GLN . 21.0 p-90 -63.93 -19.86 65.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 109.508 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 7.8 p -72.63 37.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' B' ' 37' ' ' TRP . 17.2 tt0 -80.71 10.53 4.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.447 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -89.16 -37.56 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.98 . . . . 0.0 109.556 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . 0.526 ' C ' ' H ' ' B' ' 43' ' ' GLU . 88.5 m-85 -89.68 -43.29 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 109.566 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.16 14.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 109.367 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' B' ' 41' ' ' PHE . 19.0 pt-20 -66.9 -13.88 62.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.418 ' C ' ' N ' ' B' ' 46' ' ' GLY . 49.9 m -77.63 -42.55 34.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.697 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.54 ' O ' ' N ' ' B' ' 47' ' ' ASP . 39.9 m-85 -47.5 -20.11 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' B' ' 44' ' ' SER . . . 59.14 -79.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' B' ' 45' ' ' PHE . 32.1 t0 -46.7 106.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -1.152 . . . . 0.0 109.555 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tp -163.08 21.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.262 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -52.53 -42.7 64.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 109.658 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.4 p -145.35 152.06 49.2 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.882 . . . . 0.0 109.211 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -40.25 -35.23 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.557 2.171 . . . . 0.0 112.325 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.75 -27.02 63.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.563 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -66.77 -19.97 65.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.2 -51.23 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.557 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 7.4 mmt -66.77 -22.0 66.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.52 -11.12 78.34 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' B' ' 59' ' ' LYS . 20.3 t-20 -71.6 136.28 83.44 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.264 -1.139 . . . . 0.0 109.335 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.11 -35.21 3.2 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.376 2.051 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.515 ' N ' ' OD1' ' B' ' 57' ' ' ASN . 41.0 mttm -63.91 -47.74 79.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.915 . . . . 0.0 109.856 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 96.3 t -46.9 -35.4 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -0.977 . . . . 0.0 109.625 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -49.91 52.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.347 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.78 -32.53 59.96 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.226 -0.921 . . . . 0.0 109.668 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -69.71 -23.92 63.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.329 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.78 -37.76 92.57 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -65.85 -25.71 67.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -1.099 . . . . 0.0 109.325 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -74.73 -49.0 22.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.93 -60.7 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.337 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.87 -21.16 65.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 109.097 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.76 -52.56 14.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.07 -35.21 33.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -1.134 . . . . 0.0 109.59 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -66.8 -49.81 64.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' SER . . . . . 0.62 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.1 t -56.83 -30.85 64.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.45 -0.781 . . . . 0.0 109.415 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -59.67 -40.33 87.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.323 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.86 -60.1 8.61 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.467 ' H ' HD13 ' B' ' 75' ' ' LEU . 4.6 mp -50.48 -26.42 5.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.335 -1.097 . . . . 0.0 109.31 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.68 -2.53 58.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.959 . . . . 0.0 109.484 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.517 ' CE1' ' OD2' ' B' ' 79' ' ' ASP . 71.1 t60 -171.07 62.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -0.912 . . . . 0.0 109.582 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 25.4 mt -70.3 2.19 4.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.178 -0.951 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.517 ' OD2' ' CE1' ' B' ' 77' ' ' HIS . 54.9 m-20 -55.79 -26.72 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.418 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 15.6 t-20 -170.62 112.0 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.6 mt -80.19 -58.18 3.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -47.23 -24.08 0.66 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -63.66 -51.47 53.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.481 ' C ' ' H ' ' B' ' 86' ' ' ALA . 0.7 OUTLIER -85.59 -39.56 17.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -1.158 . . . . 0.0 109.346 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.437 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.7 m-85 -70.54 10.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.614 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -67.84 -33.65 75.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -82.09 -53.34 6.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 109.432 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.464 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 35.8 mt -51.76 -49.72 62.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 0.0 109.29 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' B' ' 85' ' ' PHE . 7.3 m -59.74 -50.49 73.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.28 -38.77 92.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.869 . . . . 0.0 109.384 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 5.1 tt -74.53 -32.48 62.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.35 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' B' ' 97' ' ' HIS . 15.1 m80 -84.93 -20.3 30.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.108 -0.995 . . . . 0.0 109.644 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 46.6 t -83.74 -59.86 2.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.83 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -86.68 -34.78 19.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.12 -0.988 . . . . 0.0 111.531 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -79.73 -51.77 8.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.857 -1.152 . . . . 0.0 110.563 -178.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.33 -32.57 10.41 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.038 . . . . 0.0 110.244 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.569 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 11.3 t-160 54.07 54.07 10.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.967 . . . . 0.0 109.505 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.31 125.74 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 0.0 109.141 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -49.31 145.86 6.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.08 -11.86 31.22 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.612 2.208 . . . . 0.0 112.158 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -93.66 60.29 2.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -148.87 -46.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.526 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.0 OUTLIER -51.35 -47.43 62.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.65 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -48.31 -19.97 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' B' ' 103' ' ' PHE . 17.1 mt -88.54 -57.73 2.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.603 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -47.93 -20.9 0.36 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.526 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' B' ' 105' ' ' LEU . . . -81.71 -33.23 28.06 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -83.49 -17.45 41.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -1.115 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 78.6 t -83.18 -56.61 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 tt -48.71 -53.2 19.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.847 . . . . 0.0 109.476 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 89.7 t -46.99 -40.85 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.612 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.66 -33.93 76.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.518 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 19.1 t -66.28 -29.29 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.333 -0.855 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 118' ' ' PHE . 8.9 mt -81.68 -52.94 6.65 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.08 -24.4 17.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.465 ' HD1' ' C ' ' B' ' 116' ' ' HIS . 0.6 OUTLIER -84.82 -62.63 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 109.579 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -68.58 -17.56 64.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.756 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' B' ' 17' ' ' LYS . 72.4 m-85 -144.3 57.79 1.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -70.49 -23.05 77.87 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -72.62 10.78 0.76 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.252 -1.146 . . . . 0.0 109.509 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' B' ' 123' ' ' THR . 81.2 mm-40 -135.28 -0.34 2.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.39 -0.818 . . . . 0.0 109.642 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.542 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.81 33.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 109.339 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.52 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.0 OUTLIER -50.24 148.16 6.58 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.502 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.2 Cg_exo -46.73 -53.06 6.64 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.428 2.085 . . . . 0.0 113.159 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 26.4 Cg_endo -62.61 -21.83 73.32 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.024 1.816 . . . . 0.0 112.338 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 75.2 t -81.58 -25.63 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.506 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' B' ' 123' ' ' THR . 5.5 mp0 -83.21 -59.81 2.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.12 -0.988 . . . . 0.0 109.492 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.88 -38.26 7.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.58 29.72 0.86 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 0.0 109.574 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' B' ' 127' ' ' GLN . 17.2 t80 -124.24 -22.4 4.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.448 -0.783 . . . . 0.0 109.701 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -83.95 -63.84 1.27 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.123 -0.986 . . . . 0.0 110.061 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -49.76 -21.63 1.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 0.0 109.952 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.48 -68.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.972 . . . . 0.0 109.858 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.37 -19.95 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.793 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.94 -28.68 17.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.941 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.36 -36.45 89.23 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.48 -47.92 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -1.117 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.18 -43.25 31.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 109.354 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -80.02 -38.36 32.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 0.0 109.451 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' B' ' 142' ' ' ALA . . . -51.34 -48.35 62.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.393 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 36.2 mt -75.63 11.04 1.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' B' ' 140' ' ' ALA . . . -132.42 -4.62 3.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 109.43 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.16 -27.49 64.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.92 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.86 -16.44 36.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -62.17 -61.5 2.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.303 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.467 ' ND1' ' N ' ' B' ' 146' ' ' HIS . 2.0 m-70 . . . . . 0 C--N 1.302 -1.495 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' C' ' 2' ' ' LEU . 29.8 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' C' ' 2' ' ' LEU . 7.8 mp 56.03 163.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.35 -0.844 . . . . 0.0 109.738 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.499 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 176.24 -47.92 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.998 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' C' ' 3' ' ' SER . 54.3 Cg_exo -50.31 -170.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.573 2.182 . . . . 0.0 112.579 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -60.24 -16.24 31.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.733 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' C' ' 5' ' ' ALA . 22.1 m-20 -39.45 -29.18 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.448 -0.782 . . . . 0.0 109.696 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' C' ' 10' ' ' VAL . 4.5 ptpt -83.18 -50.0 8.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.369 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.408 ' C ' ' O ' ' C' ' 7' ' ' LYS . 53.3 m -43.86 -32.7 1.14 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 109.733 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.85 -30.29 50.87 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' C' ' 7' ' ' LYS . 51.2 t -76.77 -51.54 18.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' C' ' 7' ' ' LYS . 0.1 OUTLIER -57.63 -36.72 72.19 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.767 -1.173 . . . . 0.0 108.285 179.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.74 -58.23 8.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 109.215 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.05 -34.38 63.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 108.877 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -17.49 61.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.355 -0.841 . . . . 0.0 108.886 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.94 -44.68 18.51 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -70.12 -37.34 75.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.085 -1.244 . . . . 0.0 108.465 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.22 -67.41 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.603 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 59.24 -136.78 50.71 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.29 28.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.543 -0.975 . . . . 0.0 110.474 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.603 ' H ' ' C ' ' C' ' 18' ' ' GLY . 96.9 m-70 -129.63 13.18 5.92 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.05 -52.39 11.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.643 -0.661 . . . . 0.0 109.75 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.07 -14.45 10.95 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.36 -56.47 3.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -1.166 . . . . 0.0 109.691 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.558 ' CD2' ' O ' ' C' ' 20' ' ' HIS . 14.0 m-85 -59.85 -24.88 64.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.86 . . . . 0.0 109.285 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.91 -33.83 85.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.74 -39.12 57.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -1.193 . . . . 0.0 109.661 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . 0.562 ' C ' ' HG1' ' C' ' 108' ' ' THR . 13.2 tt0 -67.45 -20.11 65.45 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.336 -0.853 . . . . 0.0 109.457 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.07 -25.37 61.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.106 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -76.04 -59.36 2.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 109.405 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -56.45 -12.54 1.75 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 109.354 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.536 ' O ' ' NE ' ' C' ' 31' ' ' ARG . 0.0 OUTLIER -65.2 -58.35 6.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -84.51 -32.83 23.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.092 -1.005 . . . . 0.0 110.312 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 20.2 m-85 -63.55 -35.97 82.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.938 -1.101 . . . . 0.0 110.198 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.564 ' O ' ' CZ ' ' C' ' 36' ' ' PHE . 3.8 pp -46.97 -40.51 14.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.901 -1.124 . . . . 0.0 109.504 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.573 ' O ' ' C ' ' C' ' 36' ' ' PHE . 1.4 p -76.5 -23.66 53.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.931 -1.106 . . . . 0.0 108.875 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.573 ' C ' ' O ' ' C' ' 35' ' ' SER . 0.3 OUTLIER 21.56 65.96 0.3 Allowed Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 121.151 0.5 . . . . 0.0 111.211 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.39 -61.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.407 2.072 . . . . 0.0 112.147 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' THR . . . . . 0.494 ' CG2' ' CD2' ' B' ' 97' ' ' HIS . 1.1 p -91.18 -57.41 2.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.215 -0.928 . . . . 0.0 109.613 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -44.21 -22.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.47 -0.769 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' C' ' 38' ' ' THR . 26.2 ttmt -49.03 -45.13 42.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.957 -1.089 . . . . 0.0 109.596 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.599 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.649 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.274 0 CA-C-O 120.937 0.399 . . . . 0.0 110.686 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.468 ' C ' ' CD1' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -154.4 31.13 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.679 -1.263 . . . . 0.0 110.529 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' C' ' 46' ' ' PHE . 35.8 m-20 42.3 88.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.408 -0.808 . . . . 0.0 110.271 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.495 ' CD2' ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -65.33 -13.09 57.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.114 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.427 ' O ' ' O ' ' C' ' 50' ' ' HIS . 32.6 p -78.11 165.71 23.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.583 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.678 ' HD1' ' N ' ' C' ' 50' ' ' HIS . 0.3 OUTLIER -57.83 -162.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.361 -0.837 . . . . 0.0 109.283 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.82 34.44 10.94 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.55 ' O ' ' N ' ' C' ' 54' ' ' GLN . 30.4 t -139.06 82.25 1.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.286 -1.126 . . . . 0.0 109.218 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.69 -10.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.808 . . . . 0.0 109.847 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' C' ' 52' ' ' SER . 11.7 mt-30 -74.85 -35.25 62.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.3 t -65.67 -48.45 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.54 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.512 ' CD ' ' H ' ' C' ' 56' ' ' LYS . 0.0 OUTLIER -69.18 -25.51 64.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 0.0 109.12 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.91 -21.65 78.97 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.9 t-80 -82.59 -39.79 21.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -1.082 . . . . 0.0 109.798 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.04 -51.56 45.42 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -51.19 -22.67 2.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.445 -1.032 . . . . 0.0 110.153 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.73 -29.7 56.29 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.15 -0.969 . . . . 0.0 109.24 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.81 -49.0 19.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 108.726 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.58 -22.84 64.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.308 -0.87 . . . . 0.0 109.189 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -78.17 -30.69 49.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.134 -0.979 . . . . 0.0 108.832 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.64 -48.66 53.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.86 . . . . 0.0 108.996 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.57 -40.62 72.22 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.203 -0.936 . . . . 0.0 108.749 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 15.3 m -68.72 -56.84 6.8 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' C' ' 72' ' ' HIS . 46.6 t30 -55.42 -24.08 28.46 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -80.24 -47.01 15.28 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 36.2 t -64.35 -22.97 32.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.46 -17.06 64.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.611 ' O ' ' N ' ' C' ' 74' ' ' ASP . 4.3 m-70 -141.88 -61.31 0.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 109.422 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.2 p 44.78 12.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.728 0.775 . . . . 0.0 109.61 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' C' ' 72' ' ' HIS . 44.5 t0 -134.22 10.44 3.83 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 2.0 m-20 -178.59 28.03 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.762 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 6.5 ptt? -78.52 -23.33 0.41 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.413 -0.805 . . . . 0.0 111.703 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.0 Cg_exo -54.33 -18.83 15.38 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.565 1.51 . . . . 0.0 112.185 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -93.42 -38.06 11.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.17 64.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 108.897 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.62 11.27 15.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.349 -0.845 . . . . 0.0 108.755 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 14.8 t -65.33 -26.82 68.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 109.715 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.92 -49.04 66.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 109.741 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mt -47.76 -46.96 30.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.026 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 9.7 t -62.76 -28.52 70.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.64 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.94 -28.1 39.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 109.601 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' C' ' 90' ' ' LYS . 3.7 tt -83.25 -32.35 26.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.827 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -92.12 -21.94 20.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.13 -0.982 . . . . 0.0 110.122 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.03 -48.1 3.99 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.183 -0.948 . . . . 0.0 110.113 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -93.42 21.94 5.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 110.138 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' C' ' 92' ' ' ARG . 28.7 ttmt -172.15 147.13 2.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.932 -1.105 . . . . 0.0 110.067 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' C' ' 93' ' ' VAL . 1.0 OUTLIER 71.29 -20.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.386 -0.821 . . . . 0.0 109.536 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' C' ' 90' ' ' LYS . 70.4 mtt85 43.04 27.36 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 0.0 109.7 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' C' ' 91' ' ' LEU . 12.2 p -47.08 165.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' C' ' 96' ' ' VAL . 6.1 p-10 -109.74 101.29 46.11 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.69 -11.01 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.383 2.055 . . . . 0.0 112.274 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 94' ' ' ASP . 51.1 t -50.74 -18.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' C' ' 100' ' ' LEU . 3.1 m120 -79.18 -24.38 43.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.309 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -44.31 -35.8 2.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.338 -0.851 . . . . 0.0 109.745 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -68.0 -23.72 65.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.484 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' C' ' 100' ' ' LEU . 8.8 mp -84.22 -62.08 1.65 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.52 -23.78 28.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 109.653 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 13.7 p -67.93 -50.33 56.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.762 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -78.05 -26.42 48.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.716 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 96.4 m -50.81 -50.47 56.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.669 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.23 -38.81 54.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 109.811 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.94 -36.21 64.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.478 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.06 -27.68 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.987 -1.071 . . . . 0.0 109.927 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.562 ' HG1' ' C ' ' C' ' 27' ' ' GLU . 0.6 OUTLIER -81.15 -45.1 16.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.831 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.498 ' N ' ' CG2' ' C' ' 108' ' ' THR . 15.5 mt -67.04 -20.52 65.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.089 -1.007 . . . . 0.0 109.068 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' C' ' 112' ' ' HIS . . . -51.78 -42.95 62.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.418 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.76 -3.67 0.12 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 109.212 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . 0.549 ' H ' ' C ' ' C' ' 110' ' ' ALA . 79.8 m-70 -143.23 -85.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.38 -0.825 . . . . 0.0 109.249 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.588 ' CD2' ' O ' ' C' ' 113' ' ' LEU . 0.0 OUTLIER -139.88 100.04 7.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.26 -98.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.564 2.176 . . . . 0.0 112.807 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.676 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -72.22 -56.46 5.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.576 -0.702 . . . . 0.0 110.037 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.676 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 17.5 mt-10 116.56 -6.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 4.9 t80 79.56 33.28 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.318 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.714 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -108.92 125.11 32.36 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.93 21.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.239 1.959 . . . . 0.0 112.79 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.714 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -149.47 -32.59 0.21 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.901 -1.124 . . . . 0.0 110.336 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 9.6 p -54.86 -48.91 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.058 -1.026 . . . . 0.0 110.413 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.534 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 4.4 t-160 -47.78 -36.17 11.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.44 -19.45 33.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 110.149 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' C' ' 128' ' ' PHE . 92.5 p -61.64 -62.41 1.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 110.686 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.37 -20.03 62.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.997 -1.065 . . . . 0.0 109.619 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.28 -40.72 17.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.105 -0.997 . . . . 0.0 109.548 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.2 -40.42 12.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 109.845 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.475 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 40.4 t80 -50.51 -20.81 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.869 -1.145 . . . . 0.0 108.7 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' C' ' 133' ' ' SER . 23.4 mt -68.98 -17.95 64.0 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' C' ' 134' ' ' THR . . . -57.56 -36.79 72.13 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 79.6 p -81.48 -26.84 34.89 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.37 -26.84 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 109.108 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.54 ' N ' ' O ' ' C' ' 129' ' ' LEU . 1.9 t -82.51 -31.55 29.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.214 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 26.0 m -73.06 -36.71 66.94 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.373 -0.829 . . . . 0.0 109.486 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.61 -21.74 15.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.137 -0.977 . . . . 0.0 108.933 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -16.81 59.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.435 -0.791 . . . . 0.0 108.914 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 14.2 t -143.08 38.43 1.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.541 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 2.6 p80 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.631 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -130.32 171.95 12.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.306 -0.872 . . . . 0.0 109.382 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.416 ' O ' ' N ' ' D' ' 6' ' ' GLU . 7.6 p -90.54 141.63 27.37 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.262 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . 0.435 ' O ' ' OG ' ' D' ' 9' ' ' SER . 86.7 Cg_exo -40.59 -24.05 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.507 2.138 . . . . 0.0 112.398 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' D' ' 4' ' ' THR . 73.3 mm-40 -78.73 -54.79 5.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.932 . . . . 0.0 109.824 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -74.75 -23.13 58.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 109.614 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.514 ' O ' ' OG1' ' D' ' 12' ' ' THR . 2.2 tttm -84.29 -32.17 24.51 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.372 -0.83 . . . . 0.0 109.34 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' D' ' 5' ' ' PRO . 8.9 m -63.77 -23.31 67.31 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.677 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.82 -57.52 3.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.963 . . . . 0.0 110.125 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.68 -24.37 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 70.6 m -84.07 -35.24 23.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.773 -0.579 . . . . 0.0 109.717 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.33 -27.33 61.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.622 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.25 -18.75 11.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.33 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . 0.613 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.5 OUTLIER -50.98 -50.88 57.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.008 . . . . 0.0 109.062 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.73 -50.98 60.84 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.484 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 7.7 mtmt -53.9 -25.85 22.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.407 -1.054 . . . . 0.0 109.175 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.2 t -91.49 124.36 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 0.0 109.698 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' D' ' 21' ' ' ASP . 1.8 m120 -81.89 68.26 8.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.874 . . . . 0.0 108.925 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 69.0 t -45.96 -14.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 109.812 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' D' ' 19' ' ' ASN . 60.4 t0 -58.01 -18.1 21.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.764 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' D' ' 25' ' ' GLY . 35.1 mt-10 -155.78 -33.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.059 -1.025 . . . . 0.0 109.758 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -46.07 -23.89 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.644 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.57 -24.66 72.09 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -82.45 -32.96 26.61 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -74.78 -24.97 58.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -1.218 . . . . 0.0 109.548 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.25 -40.25 93.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.45 -50.03 17.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.38 -28.2 9.07 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.05 -47.57 11.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -1.117 . . . . 0.0 109.276 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 tp -47.34 -31.61 4.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' D' ' 36' ' ' PRO . 14.4 mt -71.16 -46.16 62.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.441 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.12 -55.58 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.373 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.69 -22.86 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.886 . . . . 0.0 109.501 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -150.48 76.94 8.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . 0.517 ' N ' ' O ' ' D' ' 32' ' ' LEU . 77.8 Cg_endo -82.89 -7.75 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.878 2.385 . . . . 0.0 112.351 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . 0.523 ' C ' ' H ' ' D' ' 39' ' ' GLN . 20.9 p-90 -63.85 -20.0 65.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 7.9 p -72.6 37.44 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.396 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' D' ' 37' ' ' TRP . 17.2 tt0 -80.73 10.54 4.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -89.13 -37.66 14.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.534 ' C ' ' H ' ' D' ' 43' ' ' GLU . 88.4 m-85 -89.65 -43.32 10.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 109.574 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.09 14.73 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.379 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' D' ' 41' ' ' PHE . 19.0 pt-20 -66.89 -13.87 62.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.085 -1.009 . . . . 0.0 109.492 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.417 ' O ' ' N ' ' D' ' 46' ' ' GLY . 49.8 m -77.75 -42.5 33.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' D' ' 47' ' ' ASP . 39.9 m-85 -47.53 -20.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.461 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 59.09 -79.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' D' ' 45' ' ' PHE . 32.1 t0 -46.83 106.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -1.174 . . . . 0.0 109.553 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -163.08 21.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 0.0 109.269 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -52.61 -42.58 64.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 109.708 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' THR . . . . . 0.432 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.4 p -145.4 152.08 49.04 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.319 -0.863 . . . . 0.0 109.265 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -40.28 -35.16 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.421 2.081 . . . . 0.0 112.365 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.74 -27.1 63.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.588 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -66.76 -19.94 65.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 t -74.13 -51.35 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.463 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 7.4 mmt -66.73 -22.03 66.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.56 -11.07 78.35 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' D' ' 59' ' ' LYS . 20.1 t-20 -71.73 136.33 83.07 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.169 -1.195 . . . . 0.0 109.266 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.07 -35.26 3.19 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.431 2.087 . . . . 0.0 112.374 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' D' ' 57' ' ' ASN . 40.9 mttm -63.95 -47.78 79.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 97.6 t -46.76 -35.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 109.795 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -49.9 52.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 109.355 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.76 -32.65 60.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -69.58 -24.0 63.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.8 -37.66 92.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -65.94 -25.63 67.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -1.143 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -74.71 -49.07 22.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 0.0 109.435 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.82 -60.76 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.312 -0.867 . . . . 0.0 109.362 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.85 -21.16 65.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.124 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.78 -52.43 15.15 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.02 -35.3 33.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 109.571 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -66.81 -49.83 64.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 109.446 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' SER . . . . . 0.613 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 8.1 t -56.75 -30.94 64.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.413 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -59.62 -40.36 87.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.324 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.75 -60.23 8.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.465 ' H ' HD13 ' D' ' 75' ' ' LEU . 4.6 mp -50.38 -26.56 5.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -1.125 . . . . 0.0 109.347 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.61 -2.57 58.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.149 -0.97 . . . . 0.0 109.435 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.516 ' CE1' ' OD2' ' D' ' 79' ' ' ASP . 71.3 t60 -171.01 62.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.547 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 25.1 mt -70.21 2.16 4.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.516 ' OD2' ' CE1' ' D' ' 77' ' ' HIS . 55.0 m-20 -55.92 -26.6 48.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 15.6 t-20 -170.6 111.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.428 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 14.5 mt -80.2 -58.11 3.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 109.507 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -47.31 -24.1 0.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -63.61 -51.51 53.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.472 ' C ' ' H ' ' D' ' 86' ' ' ALA . 0.7 OUTLIER -85.48 -39.65 17.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -1.14 . . . . 0.0 109.426 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.443 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.5 m-85 -70.53 10.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 109.532 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -67.75 -33.8 75.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.328 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -82.1 -53.21 6.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.456 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 35.6 mt -51.91 -49.69 62.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.252 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' D' ' 85' ' ' PHE . 7.2 m -59.69 -50.42 73.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.423 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.34 -38.84 92.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.392 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 5.1 tt -74.35 -32.56 62.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' D' ' 97' ' ' HIS . 15.2 m80 -84.91 -20.3 30.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.083 -1.011 . . . . 0.0 109.615 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 46.5 t -83.76 -59.92 2.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 0.0 110.844 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 41' ' ' THR . 37.4 m-20 -86.6 -34.76 19.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.065 -1.022 . . . . 0.0 111.565 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -79.82 -51.67 8.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.772 -1.205 . . . . 0.0 110.619 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.31 -32.73 10.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.064 . . . . 0.0 110.258 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.56 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 11.3 t-160 54.3 54.12 9.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 109.348 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.39 125.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.947 . . . . 0.0 109.156 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -49.33 145.88 7.01 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 109.322 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.11 -11.82 31.1 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.559 2.173 . . . . 0.0 112.098 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -93.71 60.36 2.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -148.83 -46.99 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 109.573 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 1.0 OUTLIER -51.34 -47.43 62.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.671 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -48.35 -19.89 0.35 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.437 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . 0.411 ' N ' ' C ' ' D' ' 103' ' ' PHE . 17.3 mt -88.69 -57.63 2.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.565 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -47.93 -20.94 0.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.528 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -81.72 -33.2 28.1 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -83.42 -17.51 41.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -1.191 . . . . 0.0 109.59 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 78.7 t -83.14 -56.66 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 tt -48.67 -53.17 19.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.456 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -47.03 -40.83 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.942 . . . . 0.0 109.631 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.74 -33.86 76.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.9 . . . . 0.0 109.521 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 t -66.3 -29.31 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' D' ' 118' ' ' PHE . 8.9 mt -81.61 -53.04 6.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.02 -24.41 16.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.508 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.456 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.6 OUTLIER -84.81 -62.58 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.606 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -68.59 -17.63 64.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.87 . . . . 0.0 109.664 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' D' ' 114' ' ' LEU . 72.2 m-85 -144.22 57.82 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 109.488 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -70.5 -23.06 77.87 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -72.61 10.81 0.75 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -1.151 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' D' ' 123' ' ' THR . 81.2 mm-40 -135.32 -0.26 2.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 0.0 109.762 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.529 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -73.77 33.54 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.517 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.0 OUTLIER -50.2 148.23 6.43 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.464 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.5 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.3 Cg_exo -46.85 -52.98 6.82 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.425 2.083 . . . . 0.0 113.119 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 26.1 Cg_endo -62.56 -21.99 73.48 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.115 1.877 . . . . 0.0 112.329 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.59 -25.52 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.141 -0.974 . . . . 0.0 109.513 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' D' ' 123' ' ' THR . 5.4 mp0 -83.41 -59.66 2.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.508 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.87 -38.2 7.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.543 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.59 29.54 0.88 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.489 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' D' ' 127' ' ' GLN . 17.1 t80 -124.14 -22.4 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.707 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -83.99 -63.7 1.3 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.951 . . . . 0.0 110.099 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -49.75 -21.64 1.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 109.978 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.45 -68.29 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.063 -1.023 . . . . 0.0 109.851 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.28 -19.95 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.844 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.03 -28.63 17.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.109 -0.994 . . . . 0.0 109.39 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.44 -36.4 88.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.47 -47.93 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -1.165 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.14 -43.21 31.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.894 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -80.2 -38.24 31.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.38 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' D' ' 142' ' ' ALA . . . -51.38 -48.43 62.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.346 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 36.0 mt -75.53 10.97 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.381 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' D' ' 140' ' ' ALA . . . -132.4 -4.66 3.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.365 -0.834 . . . . 0.0 109.441 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.11 -27.46 64.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.91 -16.38 36.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -62.19 -61.61 2.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.255 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.481 ' N ' ' ND1' ' D' ' 146' ' ' HIS . 2.0 m-70 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.519 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 2' ' ' LEU . 21.8 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 7.3 mp 55.12 166.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.76 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.568 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 176.14 -45.22 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.851 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 3' ' ' SER . 42.3 Cg_exo -55.36 -153.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.616 2.21 . . . . 0.0 112.864 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -78.61 -15.26 58.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.474 -0.766 . . . . 0.0 110.003 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 5' ' ' ALA . 16.4 m-20 -38.78 -29.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.379 -0.826 . . . . 0.0 109.735 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . 2.0 ptpm? -83.39 -41.79 17.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.187 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.481 ' N ' ' O ' ' A' ' 5' ' ' ALA . 45.9 m -51.35 -29.82 16.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.312 -0.868 . . . . 0.0 109.083 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.72 -36.87 42.74 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.99 -49.05 52.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -52.99 -46.02 68.11 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.02 -58.06 10.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.498 -0.751 . . . . 0.0 109.36 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.19 -35.96 60.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.406 -0.808 . . . . 0.0 109.129 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -17.14 62.29 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.256 -0.902 . . . . 0.0 109.302 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.08 22.6 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -73.01 -35.89 66.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -1.115 . . . . 0.0 108.744 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.02 -64.56 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 43.63 -122.35 3.93 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.31 22.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.403 -1.057 . . . . 0.0 110.345 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.568 ' H ' ' C ' ' A' ' 18' ' ' GLY . 78.2 m-70 -128.81 26.16 5.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -91.86 -63.1 1.29 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.621 -0.675 . . . . 0.0 109.9 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.7 -14.27 0.22 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 21' ' ' ALA . 10.4 mt-10 -84.72 -56.19 3.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -1.129 . . . . 0.0 109.814 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 20' ' ' HIS . 4.7 m-30 -60.24 -16.57 34.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.31 -34.14 30.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.07 39.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -1.2 . . . . 0.0 110.033 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.02 -19.73 64.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 109.662 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.72 -19.76 60.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 109.714 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.7 mt -78.73 -49.48 13.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 109.997 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' OE1' ' ND1' ' A' ' 50' ' ' HIS . 10.1 pt-20 -72.3 -33.25 67.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.091 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.575 ' NH1' ' SG ' ' A' ' 104' ' ' CYS . 45.8 ttt-85 -54.87 -44.58 74.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.927 . . . . 0.0 110.618 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.0 ptt? -84.13 -45.35 13.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.889 -1.132 . . . . 0.0 110.153 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.459 ' CD1' ' OG1' ' A' ' 39' ' ' THR . 1.1 m-85 -49.23 -41.42 37.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 109.825 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.04 -38.75 61.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.982 -1.074 . . . . 0.0 109.586 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.424 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 15.7 m -75.52 7.43 3.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.015 -1.053 . . . . 0.0 109.29 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.93 ' CZ ' ' OE1' ' B' ' 131' ' ' GLN . 77.0 m-85 -156.13 71.9 5.13 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.39 -19.86 0.77 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.727 2.285 . . . . 0.0 112.265 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 p -59.23 -22.79 61.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.459 ' OG1' ' CD1' ' A' ' 33' ' ' PHE . 70.5 p -89.48 -42.87 11.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.539 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -52.16 -38.97 59.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.562 ' CD2' ' O ' ' A' ' 45' ' ' HIS . 26.9 p-80 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.29 0.567 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.523 ' O ' ' C ' ' A' ' 47' ' ' ASP . 5.3 t80 -120.15 27.8 8.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.666 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 46' ' ' PHE . 1.6 p30 28.2 72.86 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.853 -0.529 . . . . 0.0 110.819 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 48' ' ' LEU . 2.2 mm? -64.83 -7.77 12.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.129 -0.982 . . . . 0.0 109.316 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 t -49.25 152.15 1.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.537 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.532 ' ND1' ' OE1' ' A' ' 30' ' ' GLU . 83.2 t60 -76.04 152.84 36.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.78 18.72 59.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 53' ' ' ALA . 2.0 t -68.0 -99.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.246 -1.15 . . . . 0.0 109.311 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.526 ' N ' ' OG ' ' A' ' 52' ' ' SER . . . 174.0 -78.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.506 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -44.85 -17.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.395 -0.816 . . . . 0.0 109.589 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ALA . 3.5 t -76.72 -27.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.214 -0.929 . . . . 0.0 109.433 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -66.02 -26.99 67.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 0.0 109.458 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.47 -42.18 42.01 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.459 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 15.1 t-80 -63.08 -27.98 69.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -1.203 . . . . 0.0 109.688 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.59 -47.31 90.25 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 32.6 mttp -56.08 -23.8 36.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -1.134 . . . . 0.0 109.754 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -72.54 -42.52 64.64 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.304 -0.872 . . . . 0.0 109.05 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.4 t -68.92 -47.69 74.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.517 -0.739 . . . . 0.0 109.2 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.91 -30.0 67.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.311 -0.868 . . . . 0.0 109.531 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.3 t70 -69.22 -41.88 76.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.122 -0.986 . . . . 0.0 108.821 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.38 -47.94 79.98 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.03 -47.14 87.81 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -62.22 -47.31 85.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 108.948 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -63.38 -26.71 68.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 108.682 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.14 -46.71 11.64 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.99 -22.43 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.25 -21.67 66.3 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.586 ' O ' ' N ' ' A' ' 74' ' ' ASP . 13.2 m80 -144.18 -50.59 0.3 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.9 p 44.87 14.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 121.792 0.806 . . . . 0.0 109.489 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 72' ' ' HIS . 14.6 t70 -128.62 9.56 5.99 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -173.74 27.12 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.046 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.3 ptt? -78.36 -24.92 0.45 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.415 -0.803 . . . . 0.0 111.594 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 76' ' ' MET . 43.7 Cg_exo -55.56 -20.62 27.72 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.766 1.644 . . . . 0.0 112.538 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.491 HD21 ' C ' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -94.06 -28.75 15.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.868 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.54 -48.05 20.64 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.142 -0.974 . . . . 0.0 109.178 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.13 6.89 8.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.15 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -59.4 -15.74 18.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.635 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.83 -48.7 11.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 109.74 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 86' ' ' LEU . 4.7 mt -47.19 -48.35 23.83 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 88.3 p -50.18 -24.82 3.04 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.093 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 82' ' ' ALA . 15.0 t70 -74.45 -25.5 59.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.158 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 90' ' ' LYS . 6.9 tp -81.82 -34.29 30.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.299 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -90.44 -21.78 21.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.21 -68.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.907 . . . . 0.0 109.675 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -88.4 -77.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.91 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 86' ' ' LEU . 19.3 mttm -59.31 171.18 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.868 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 93' ' ' VAL . 4.0 tp 56.79 56.95 5.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 109.682 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -66.05 9.75 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.953 . . . . 0.0 109.315 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.56 ' H ' ' C ' ' A' ' 91' ' ' LEU . 12.4 p -46.4 165.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.664 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.551 ' CG ' ' OD1' ' D' ' 99' ' ' ASP . 5.3 m-20 -84.34 116.96 67.47 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.299 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 97' ' ' ASN . 84.4 Cg_exo -44.28 -10.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.297 1.998 . . . . 0.0 112.357 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.841 HG22 ' OD2' ' D' ' 99' ' ' ASP . 98.2 t -53.88 -10.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 109.56 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 95' ' ' PRO . 2.7 m-80 -79.24 -24.9 42.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -53.16 -43.71 67.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.576 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 99' ' ' LYS . 7.5 mtmp? -69.32 -25.41 64.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.683 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 25.3 mt -81.67 -46.69 13.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.707 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -69.68 -20.76 63.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.694 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.7 p -78.75 -59.07 2.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 109.746 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.458 ' NE2' ' HH ' ' B' ' 35' ' ' TYR . 8.6 m170 -63.29 -26.72 68.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.806 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.575 ' SG ' ' NH1' ' A' ' 31' ' ' ARG . 35.0 m -65.08 -52.26 56.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 109.818 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -24.62 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.749 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.75 -34.85 60.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.083 -1.011 . . . . 0.0 109.926 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.1 t -83.33 -24.65 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.058 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -70.98 -63.64 1.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.137 -0.977 . . . . 0.0 110.458 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 113' ' ' LEU . 2.3 pp -64.04 -18.68 64.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.847 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.35 -33.29 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 0.0 109.709 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.79 -56.15 25.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.371 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -66.52 -68.28 0.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.115 -0.991 . . . . 0.0 108.422 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 114' ' ' PRO . 3.1 pp -116.67 111.44 41.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 113' ' ' LEU . 89.2 Cg_exo -41.58 -177.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.571 2.18 . . . . 0.0 113.167 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.64 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -45.45 -52.48 10.1 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.64 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 19.4 mt-10 124.98 -1.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 61.21 31.47 19.51 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.194 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.776 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -103.82 120.47 51.26 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.48 23.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.007 1.805 . . . . 0.0 112.663 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.776 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -152.51 -32.53 0.13 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.965 -1.084 . . . . 0.0 110.514 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.5 ' H ' ' HG1' ' A' ' 118' ' ' THR . 14.4 p -47.86 -48.26 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.957 -1.09 . . . . 0.0 110.081 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.491 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -63.76 -39.01 93.23 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 109.365 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.29 -19.78 33.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 120' ' ' ALA . 7.6 p -58.44 -62.07 2.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 110.018 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.507 ' N ' ' OG ' ' A' ' 124' ' ' SER . 5.0 mt -68.57 -19.58 64.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 109.329 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -73.74 -52.18 14.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.747 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HG3' ' H ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -86.29 -44.4 12.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 109.971 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.47 ' H ' ' HG3' ' A' ' 127' ' ' LYS . 39.5 t80 -47.43 -20.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.988 -1.07 . . . . 0.0 108.992 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 133' ' ' SER . 12.0 mt -71.88 -17.99 62.08 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.32 -33.56 73.8 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.404 ' HG ' ' N ' ' A' ' 132' ' ' VAL . 89.2 p -82.72 -29.88 29.5 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.408 -0.808 . . . . 0.0 108.834 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.404 ' N ' ' HG ' ' A' ' 131' ' ' SER . 8.1 t -85.23 -29.73 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 109.134 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 129' ' ' LEU . 18.0 m -82.79 -22.64 34.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 0.0 108.936 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 138' ' ' SER . 42.1 m -80.72 -39.93 26.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.332 -0.855 . . . . 0.0 109.223 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.05 -26.5 27.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.211 -0.931 . . . . 0.0 108.899 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.02 -31.92 73.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -0.788 . . . . 0.0 108.96 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.0 m -156.81 53.63 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 134' ' ' THR . 9.1 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.497 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 43.9 m80 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.1 OUTLIER -142.74 164.53 29.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 109.362 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.83 159.43 68.83 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.827 . . . . 0.0 109.348 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.74 -18.64 65.3 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.632 2.221 . . . . 0.0 112.003 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.5 -34.25 23.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.5 -61.76 1.76 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 109.591 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -47.01 -26.74 1.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.91 . . . . 0.0 109.609 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.0 t -57.11 -23.39 46.73 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.59 -57.69 3.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.917 -1.115 . . . . 0.0 110.102 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.4 -24.58 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 48.1 m -82.09 -36.92 27.09 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.396 0.617 . . . . 0.0 109.759 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.5 -34.65 70.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.597 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.7 OUTLIER -50.49 -34.56 25.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 109.157 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -45.74 -17.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.372 -0.83 . . . . 0.0 109.66 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.25 -49.41 7.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.45 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 0.1 OUTLIER -71.95 -30.28 65.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.2 . . . . 0.0 109.396 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.5 t -53.46 114.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 109.649 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' B' ' 21' ' ' ASP . 36.3 m-80 -79.53 66.04 4.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 108.946 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' B' ' 22' ' ' GLU . 72.1 t -43.72 -26.13 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.471 -0.768 . . . . 0.0 109.852 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' B' ' 19' ' ' ASN . 18.0 t70 -65.51 5.13 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' B' ' 20' ' ' VAL . 37.5 mt-10 -154.03 -51.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.976 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 88.0 t -49.63 -53.3 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.76 -40.46 25.95 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.63 -37.14 61.94 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.05 -35.77 61.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -1.144 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.83 68.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.507 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 tp -84.94 -52.06 6.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.533 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.76 -28.49 70.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -79.22 -28.21 42.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -1.173 . . . . 0.0 109.477 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 44.6 tp -48.08 -39.79 21.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.546 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.461 ' CD2' ' OG1' ' B' ' 38' ' ' THR . 21.1 mt -81.08 -23.01 38.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 71.5 t -66.23 -61.68 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.979 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.461 HG13 ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -78.44 -22.63 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 110.047 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.458 ' HH ' ' NE2' ' A' ' 103' ' ' HIS . 72.2 m-85 -134.57 77.03 59.77 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.067 -1.02 . . . . 0.0 109.926 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -84.2 27.89 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.014 2.476 . . . . 0.0 112.277 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -81.04 -20.13 42.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 109.89 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.57 ' C ' ' H ' ' B' ' 40' ' ' ARG . 6.1 p -47.7 -29.25 2.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.67 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 52.0 6.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' B' ' 38' ' ' THR . 42.6 ttm180 -110.21 -39.96 4.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 109.207 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 47.69 19.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' B' ' 44' ' ' SER . 77.2 m-85 54.53 55.18 8.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 109.388 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -46.3 -16.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.341 -0.849 . . . . 0.0 109.583 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.515 ' N ' ' O ' ' B' ' 42' ' ' PHE . 20.0 m -57.64 -54.68 44.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.432 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -70.12 3.75 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 109.235 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' B' ' 44' ' ' SER . . . 45.16 -149.45 1.24 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 56.52 73.11 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -1.132 . . . . 0.0 109.669 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 89.8 mt -137.42 29.72 2.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.85 . . . . 0.0 109.384 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 41.5 t -72.49 -38.0 68.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -0.922 . . . . 0.0 109.541 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' THR . . . . . 0.404 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.3 p -146.16 151.91 45.72 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -40.93 -35.34 1.66 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.384 2.056 . . . . 0.0 112.38 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.99 -32.14 73.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 109.554 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -66.2 -24.0 66.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.565 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.33 -60.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -91.91 25.48 2.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.966 . . . . 0.0 109.629 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.2 -52.44 2.05 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.84 157.0 90.78 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 109.437 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' B' ' 62' ' ' ALA . 65.8 Cg_endo -74.96 -44.59 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.709 2.273 . . . . 0.0 112.322 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -45.95 -35.32 4.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.727 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 38.0 t -76.12 -41.57 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -79.18 -24.85 42.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.868 . . . . 0.0 109.545 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' B' ' 58' ' ' PRO . . . -76.55 -51.14 12.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.616 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -51.28 -23.95 4.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.86 -45.63 95.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -50.74 -44.7 58.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -1.113 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -57.82 -51.52 69.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.51 -0.744 . . . . 0.0 109.434 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.88 -51.14 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.291 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.77 -45.35 94.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.256 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.76 -45.83 31.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.15 92.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -1.14 . . . . 0.0 109.614 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -57.59 -28.86 63.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 11.6 m -77.16 -33.62 56.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.476 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.38 -34.24 33.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.463 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.24 -60.0 7.25 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.48 HD11 ' H ' ' B' ' 75' ' ' LEU . 4.8 mp -55.03 -27.5 45.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -1.104 . . . . 0.0 109.45 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -2.14 36.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -171.26 63.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.49 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.99 -18.06 62.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -48.8 -26.05 2.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.445 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.34 65.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.276 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 pp -55.69 -40.92 73.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.627 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -50.35 -23.92 2.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.0 -42.88 7.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.7 OUTLIER -68.26 -42.92 78.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.148 -1.207 . . . . 0.0 109.629 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' B' ' 84' ' ' THR . 35.7 m-85 -67.3 -0.39 3.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -0.838 . . . . 0.0 109.459 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.46 -53.92 20.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.945 . . . . 0.0 109.383 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.5 p -61.6 -58.76 6.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' B' ' 92' ' ' HIS . 50.3 mt -51.21 -49.84 60.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.206 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' SER . . . . . 0.516 ' O ' ' N ' ' B' ' 93' ' ' CYS . 7.2 m -57.16 -46.24 82.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.249 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.502 ' CA ' ' HZ2' ' B' ' 144' ' ' LYS . 31.0 tt0 -62.21 -46.53 88.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.486 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 3.9 tt -72.62 -27.24 62.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 109.361 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' B' ' 88' ' ' LEU . 18.7 m80 -90.47 -20.29 22.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.978 . . . . 0.0 109.663 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' B' ' 89' ' ' SER . 26.6 t -83.17 -59.23 2.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 110.699 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.65 -40.51 15.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.988 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.1 OUTLIER -73.01 -51.96 16.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.945 -1.097 . . . . 0.0 110.642 -178.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.57 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 30.8 mt -95.79 -36.89 10.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.91 -1.119 . . . . 0.0 109.96 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 38.6 p-80 43.71 30.78 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -52.32 153.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 0.0 109.215 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 0.827 ' OD2' HG22 ' C' ' 96' ' ' VAL . 1.6 m-20 -71.24 143.05 87.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 109.589 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -41.22 -43.87 5.38 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.608 2.206 . . . . 0.0 112.46 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -72.01 54.46 0.28 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.449 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -150.98 -31.17 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 109.969 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.52 -41.68 54.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.072 -1.017 . . . . 0.0 109.931 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . 0.424 ' O ' ' ND2' ' B' ' 108' ' ' ASN . 73.8 ttt180 -79.59 -19.98 48.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 110.071 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' B' ' 105' ' ' LEU . 4.3 mm? -50.56 -60.86 2.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.137 -0.977 . . . . 0.0 109.793 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 pp -81.7 -22.39 37.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.012 -1.055 . . . . 0.0 109.721 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.35 -36.57 37.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' B' ' 104' ' ' ARG . 14.2 p30 -85.55 -34.81 21.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -1.158 . . . . 0.0 109.648 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 74.3 t -51.35 -48.0 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 109.465 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 tp -51.92 -54.0 34.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 109.49 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 25.2 t -46.42 -38.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.414 ' O ' ' ND1' ' B' ' 116' ' ' HIS . 13.2 m -79.2 -56.31 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 85.6 t -47.99 -24.52 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.552 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 14.2 mt -77.29 -43.54 32.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.26 -19.37 63.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.414 ' ND1' ' O ' ' B' ' 112' ' ' CYS . 4.3 m80 -78.29 -62.82 1.56 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.696 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -70.93 -17.43 62.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 0.0 109.845 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.45 ' CZ ' ' O ' ' B' ' 17' ' ' LYS . 63.1 m-85 -144.94 58.17 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.665 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -79.67 -17.92 74.31 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -65.05 4.99 0.39 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -1.079 . . . . 0.0 109.694 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' B' ' 119' ' ' GLY . 46.8 mm-40 -135.12 9.55 3.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -77.67 32.61 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.132 -0.98 . . . . 0.0 109.287 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.474 ' H ' ' C ' ' B' ' 121' ' ' GLU . 36.8 p -46.85 148.69 1.75 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.867 . . . . 0.0 109.51 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.466 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.1 Cg_exo -45.16 -57.03 2.31 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.542 2.161 . . . . 0.0 112.918 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 14.3 Cg_endo -56.86 -36.12 98.7 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.064 1.843 . . . . 0.0 111.995 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 63.0 t -76.39 -20.33 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.75 -44.98 26.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.329 -0.857 . . . . 0.0 109.494 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.32 84.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.942 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.51 29.28 0.89 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.606 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.99 -33.89 4.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.0 109.375 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . 0.93 ' OE1' ' CZ ' ' A' ' 36' ' ' PHE . 19.4 tt0 -83.95 -63.6 1.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 109.878 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -48.05 -21.88 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.844 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 71.3 t -71.75 -67.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.726 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' B' ' 137' ' ' VAL . 2.2 t -67.2 -40.29 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.637 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.75 -21.78 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.497 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.15 -22.11 63.84 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 134' ' ' VAL . 88.8 t -74.14 -30.94 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -1.178 . . . . 0.0 109.536 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.37 71.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -81.43 -21.2 39.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.592 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.14 -60.52 2.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.653 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.0 mt -57.92 -17.75 18.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.547 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' B' ' 144' ' ' LYS . . . -100.6 -6.91 24.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.895 . . . . 0.0 109.532 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -59.05 -4.71 0.53 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.467 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.532 ' C ' ' HD1' ' B' ' 146' ' ' HIS . 21.6 mmtp -92.13 -30.85 15.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -71.3 14.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.0 109.325 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.532 ' HD1' ' C ' ' B' ' 144' ' ' LYS . 28.1 p-80 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' C' ' 2' ' ' LEU . 21.8 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' C' ' 2' ' ' LEU . 7.4 mp 55.12 166.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 109.727 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.563 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 176.06 -45.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.877 . . . . 0.0 109.859 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' C' ' 3' ' ' SER . 42.6 Cg_exo -55.31 -153.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.633 2.222 . . . . 0.0 112.843 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -78.65 -15.27 58.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.416 -0.802 . . . . 0.0 110.018 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' C' ' 5' ' ' ALA . 15.9 m-20 -38.67 -29.16 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.829 . . . . 0.0 109.759 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' C' ' 5' ' ' ALA . 2.0 ptpm? -83.37 -41.83 17.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.192 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.481 ' N ' ' O ' ' C' ' 5' ' ' ALA . 45.8 m -51.25 -29.96 16.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.889 . . . . 0.0 109.057 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.71 -36.79 42.9 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.99 -49.06 52.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -53.04 -45.98 68.28 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.06 -58.12 9.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.475 -0.766 . . . . 0.0 109.31 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.13 -35.89 60.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.456 -0.777 . . . . 0.0 109.215 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -17.24 62.29 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 109.258 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.03 22.79 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -73.12 -35.73 66.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -1.118 . . . . 0.0 108.772 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.16 -64.52 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.581 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 43.68 -122.42 4.01 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.29 22.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -1.096 . . . . 0.0 110.347 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' C' ' 18' ' ' GLY . 78.4 m-70 -128.87 26.25 5.55 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.91 -63.15 1.28 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.599 -0.688 . . . . 0.0 109.837 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.67 -14.29 0.22 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' C' ' 21' ' ' ALA . 10.4 mt-10 -84.64 -56.37 3.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.801 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.438 ' CE2' ' O ' ' C' ' 20' ' ' HIS . 4.7 m-30 -60.16 -16.64 34.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.848 . . . . 0.0 109.516 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.13 -34.19 30.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.14 -32.03 38.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -1.184 . . . . 0.0 109.984 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.97 -19.9 64.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.623 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.59 60.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.734 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 5.7 mt -78.86 -49.5 12.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.949 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.521 ' OE1' ' ND1' ' C' ' 50' ' ' HIS . 10.1 pt-20 -72.24 -33.28 67.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.925 . . . . 0.0 110.13 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.567 ' NH1' ' SG ' ' C' ' 104' ' ' CYS . 45.8 ttt-85 -54.82 -44.63 74.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 110.596 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -84.09 -45.46 13.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.887 -1.133 . . . . 0.0 110.114 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . 0.46 ' CD1' ' OG1' ' C' ' 39' ' ' THR . 1.1 m-85 -49.21 -41.41 37.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.171 -0.956 . . . . 0.0 109.83 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.04 -38.74 61.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.019 -1.051 . . . . 0.0 109.594 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.427 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 15.6 m -75.51 7.48 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 109.326 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.93 ' CZ ' ' OE1' ' D' ' 131' ' ' GLN . 76.7 m-85 -156.19 72.05 5.09 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.338 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -46.5 -19.84 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.732 2.288 . . . . 0.0 112.203 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 19.9 p -59.22 -22.83 61.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.53 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.46 ' OG1' ' CD1' ' C' ' 33' ' ' PHE . 70.4 p -89.49 -42.91 11.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.963 . . . . 0.0 109.482 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -52.01 -39.13 59.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 109.608 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.568 ' O ' ' CD2' ' C' ' 45' ' ' HIS . 27.0 p-80 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.291 0.567 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.533 ' O ' ' C ' ' C' ' 47' ' ' ASP . 5.2 t80 -120.05 27.72 8.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 0.0 109.679 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.533 ' C ' ' O ' ' C' ' 46' ' ' PHE . 1.6 p30 28.35 72.67 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.087 0.47 . . . . 0.0 110.844 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' C' ' 48' ' ' LEU . 2.2 mm? -64.74 -7.8 12.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.147 -0.97 . . . . 0.0 109.364 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 33.7 t -49.25 152.13 1.27 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.521 ' ND1' ' OE1' ' C' ' 30' ' ' GLU . 83.2 t60 -76.0 152.82 36.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.449 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.88 18.6 59.93 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' C' ' 53' ' ' ALA . 2.0 t -67.93 -99.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -1.151 . . . . 0.0 109.309 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.517 ' N ' ' OG ' ' C' ' 52' ' ' SER . . . 174.06 -78.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.567 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -44.78 -17.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.466 -0.771 . . . . 0.0 109.709 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' C' ' 53' ' ' ALA . 3.5 t -76.68 -27.48 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.192 -0.943 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -66.04 -27.0 67.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.281 -0.887 . . . . 0.0 109.467 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.46 -42.28 41.72 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.461 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 14.9 t-80 -62.97 -28.2 69.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -1.158 . . . . 0.0 109.63 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.52 -47.26 90.7 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 32.7 mttp -56.1 -23.89 36.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -1.083 . . . . 0.0 109.671 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -72.42 -42.5 65.04 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.314 -0.866 . . . . 0.0 109.055 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.0 t -68.95 -47.67 74.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.501 -0.749 . . . . 0.0 109.229 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.92 -30.06 67.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 2.3 t70 -69.2 -41.79 76.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.0 108.886 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.45 -47.95 79.71 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.408 -0.807 . . . . 0.0 108.854 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.01 -47.15 87.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.219 -0.926 . . . . 0.0 108.654 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -62.13 -47.33 85.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.185 -0.947 . . . . 0.0 109.027 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -63.49 -26.63 68.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 108.647 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.588 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.16 -46.64 11.7 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.04 -22.46 30.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.26 -21.63 66.29 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' C' ' 74' ' ' ASP . 13.3 m80 -144.18 -50.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.8 p 44.99 13.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.659 0.742 . . . . 0.0 109.407 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' C' ' 72' ' ' HIS . 14.6 t70 -128.57 9.52 6.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -173.71 27.14 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.099 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.709 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.3 ptt? -78.37 -24.85 0.45 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.519 -0.738 . . . . 0.0 111.605 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' C' ' 76' ' ' MET . 44.0 Cg_exo -55.64 -20.57 28.08 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.748 1.632 . . . . 0.0 112.504 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.486 HD21 ' C ' ' C' ' 78' ' ' ASN . 0.1 OUTLIER -94.05 -28.82 15.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 109.867 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 -47.97 21.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.116 -0.99 . . . . 0.0 109.259 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.25 6.9 8.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -59.28 -15.82 18.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.668 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.86 -48.61 11.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.112 -0.993 . . . . 0.0 109.775 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' C' ' 86' ' ' LEU . 4.6 mt -47.2 -48.34 23.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 108.748 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 88.1 p -50.2 -24.76 3.03 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.458 -0.777 . . . . 0.0 109.079 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' C' ' 82' ' ' ALA . 14.9 t70 -74.44 -25.54 59.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.191 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' C' ' 90' ' ' LYS . 6.9 tp -81.75 -34.4 30.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.311 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -90.38 -21.75 21.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.24 -68.51 0.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.779 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -88.41 -77.16 0.37 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.89 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' C' ' 86' ' ' LEU . 19.2 mttm -59.28 171.14 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.889 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.579 ' C ' ' H ' ' C' ' 93' ' ' VAL . 4.0 tp 56.91 56.84 5.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.396 -0.815 . . . . 0.0 109.726 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -66.08 9.81 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 109.279 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.579 ' H ' ' C ' ' C' ' 91' ' ' LEU . 12.2 p -46.38 165.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.605 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' C' ' 96' ' ' VAL . 5.3 m-20 -84.27 117.02 67.66 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.915 . . . . 0.0 109.258 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' C' ' 97' ' ' ASN . 85.4 Cg_exo -44.41 -10.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.318 2.012 . . . . 0.0 112.318 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . 0.827 HG22 ' OD2' ' B' ' 99' ' ' ASP . 98.8 t -53.91 -10.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.111 -0.993 . . . . 0.0 109.543 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' C' ' 95' ' ' PRO . 2.7 m-80 -79.17 -24.97 42.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -53.14 -43.71 67.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.918 . . . . 0.0 109.55 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.437 ' CB ' ' NZ ' ' C' ' 99' ' ' LYS . 7.6 mtmp? -69.41 -25.27 64.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.643 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 25.4 mt -81.68 -46.8 13.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 109.661 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -69.54 -20.88 63.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.735 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 32.8 p -78.68 -59.11 2.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 109.791 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . 0.449 ' NE2' ' HH ' ' D' ' 35' ' ' TYR . 8.5 m170 -63.16 -26.73 68.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.871 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.567 ' SG ' ' NH1' ' C' ' 31' ' ' ARG . 34.5 m -65.17 -52.25 56.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.766 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.03 -24.68 0.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.721 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.78 -34.88 60.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -0.98 . . . . 0.0 109.855 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 71.2 t -83.26 -24.82 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.045 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -70.8 -63.7 1.05 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.129 -0.982 . . . . 0.0 110.561 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' C' ' 113' ' ' LEU . 2.4 pp -64.02 -18.68 64.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 109.823 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.35 -33.36 63.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.712 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.65 -56.22 25.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -66.58 -68.31 0.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.0 108.385 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' C' ' 114' ' ' PRO . 3.1 pp -116.56 111.46 41.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' C' ' 113' ' ' LEU . 89.9 Cg_exo -41.59 -177.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.507 2.138 . . . . 0.0 113.204 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.645 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -45.57 -52.42 10.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.479 -0.763 . . . . 0.0 109.038 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.645 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 19.4 mt-10 125.0 -1.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 61.28 31.33 19.4 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.262 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.775 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -103.88 120.54 50.95 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.53 23.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.049 1.833 . . . . 0.0 112.649 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.775 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -152.47 -32.5 0.14 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.864 -1.147 . . . . 0.0 110.568 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.489 ' N ' ' OG1' ' C' ' 118' ' ' THR . 14.4 p -47.93 -48.23 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 110.1 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.487 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 0.3 OUTLIER -63.74 -38.89 92.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.439 -0.788 . . . . 0.0 109.416 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.4 -19.75 33.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.885 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.608 ' N ' ' O ' ' C' ' 120' ' ' ALA . 7.6 p -58.36 -62.1 2.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 0.0 110.015 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.519 ' N ' ' OG ' ' C' ' 124' ' ' SER . 5.1 mt -68.54 -19.64 64.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 109.31 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -73.83 -52.21 13.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.701 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.472 ' HG3' ' H ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -86.26 -44.41 12.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.023 . . . . 0.0 109.936 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.472 ' H ' ' HG3' ' C' ' 127' ' ' LYS . 39.7 t80 -47.32 -20.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.045 -1.035 . . . . 0.0 108.921 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' C' ' 133' ' ' SER . 12.0 mt -71.75 -18.0 62.16 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.28 -33.67 73.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' SER . . . . . 0.401 ' HG ' ' N ' ' C' ' 132' ' ' VAL . 89.3 p -82.7 -29.96 29.52 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . 0.401 ' N ' ' HG ' ' C' ' 131' ' ' SER . 8.1 t -85.18 -29.72 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.157 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.488 ' N ' ' O ' ' C' ' 129' ' ' LEU . 17.8 m -82.79 -22.69 34.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.302 -0.873 . . . . 0.0 108.96 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' THR . . . . . 0.463 ' O ' ' N ' ' C' ' 138' ' ' SER . 41.9 m -80.67 -39.99 26.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 0.0 109.225 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.08 -26.45 27.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.266 -0.897 . . . . 0.0 108.846 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -31.95 73.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.413 -0.804 . . . . 0.0 108.978 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 7.1 m -156.74 53.65 0.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.413 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 138' ' ' SER . . . . . 0.463 ' N ' ' O ' ' C' ' 134' ' ' THR . 9.0 p . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 44.0 m80 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.563 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.1 OUTLIER -142.72 164.54 29.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.368 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.89 159.48 68.57 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.265 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.82 -18.65 65.64 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.72 2.28 . . . . 0.0 111.946 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -84.58 -34.14 23.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.53 -61.75 1.76 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.628 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.507 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -46.99 -26.76 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.609 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.1 t -57.04 -23.5 46.98 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.153 -0.967 . . . . 0.0 110.194 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.62 -57.65 3.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.019 -1.051 . . . . 0.0 110.115 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.35 -24.59 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 48.8 m -82.11 -36.92 27.04 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.309 0.575 . . . . 0.0 109.704 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.54 -34.65 70.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.7 OUTLIER -50.54 -34.48 25.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.14 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -45.78 -17.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.375 -0.828 . . . . 0.0 109.637 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.27 -49.37 7.48 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.454 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 0.1 OUTLIER -72.0 -30.23 65.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.094 -1.239 . . . . 0.0 109.445 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.47 114.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.7 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' D' ' 20' ' ' VAL . 36.4 m-80 -79.56 65.99 4.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 108.937 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' D' ' 22' ' ' GLU . 72.5 t -43.69 -26.18 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.451 -0.781 . . . . 0.0 109.79 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' D' ' 19' ' ' ASN . 18.0 t70 -65.45 5.13 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.527 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' D' ' 20' ' ' VAL . 37.5 mt-10 -154.06 -51.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 0.0 109.484 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 88.0 t -49.71 -53.35 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 109.547 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.67 -40.56 25.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.55 -37.2 62.22 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.09 -35.7 61.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -1.123 . . . . 0.0 109.555 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.51 -28.71 68.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 tp -85.04 -51.97 6.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.78 -28.41 70.02 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -79.4 -28.11 41.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -1.117 . . . . 0.0 109.49 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 44.3 tp -48.09 -39.91 21.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.475 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . 0.452 ' CD2' ' OG1' ' D' ' 38' ' ' THR . 21.2 mt -81.03 -23.03 38.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.291 -0.88 . . . . 0.0 109.695 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.18 -61.81 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.142 -0.974 . . . . 0.0 109.918 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' C' ' 122' ' ' HIS . 0.0 OUTLIER -78.42 -22.54 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 0.0 110.112 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . 0.449 ' HH ' ' NE2' ' C' ' 103' ' ' HIS . 72.3 m-85 -134.6 76.99 59.74 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.109 -0.994 . . . . 0.0 109.925 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.18 27.88 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.028 2.486 . . . . 0.0 112.339 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -81.1 -20.04 42.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -0.953 . . . . 0.0 109.853 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.573 ' C ' ' H ' ' D' ' 40' ' ' ARG . 6.0 p -47.81 -29.16 2.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 109.66 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 51.91 6.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . 0.573 ' H ' ' C ' ' D' ' 38' ' ' THR . 42.5 ttm180 -110.13 -39.92 4.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 47.73 19.72 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.621 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.514 ' O ' ' N ' ' D' ' 44' ' ' SER . 77.3 m-85 54.73 55.01 8.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.359 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -46.2 -16.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 109.636 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.514 ' N ' ' O ' ' D' ' 42' ' ' PHE . 20.2 m -57.69 -54.68 44.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -70.07 3.74 2.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.219 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' D' ' 44' ' ' SER . . . 45.05 -149.34 1.19 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 56.51 73.16 0.46 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.319 -1.106 . . . . 0.0 109.641 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 90.3 mt -137.5 29.69 2.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.858 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 41.5 t -72.46 -38.01 68.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.499 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -146.11 151.95 45.98 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.295 -0.878 . . . . 0.0 109.173 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -41.12 -35.23 1.82 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.404 2.07 . . . . 0.0 112.308 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.91 -32.28 73.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.11 -23.88 66.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.681 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.45 -60.73 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -91.97 25.59 2.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.33 -52.36 2.04 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.81 156.87 90.98 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.224 -1.162 . . . . 0.0 109.43 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.97 -44.49 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.645 2.23 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -45.98 -35.33 4.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 0.0 109.66 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -76.15 -41.58 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -79.17 -24.93 42.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.36 -0.837 . . . . 0.0 109.474 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.48 -51.26 12.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.53 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -51.27 -23.94 4.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 109.47 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.93 -45.59 95.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -50.83 -44.63 59.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.374 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -57.81 -51.55 69.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.41 -0.806 . . . . 0.0 109.477 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.83 -51.15 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.314 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.77 -45.33 94.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.24 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.81 -45.79 31.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.24 92.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -1.103 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -57.42 -29.07 63.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 11.6 m -77.0 -33.68 57.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 109.496 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.45 -34.26 34.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.367 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.16 -60.08 7.19 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.467 ' H ' HD11 ' D' ' 75' ' ' LEU . 4.8 mp -55.11 -27.44 45.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -1.14 . . . . 0.0 109.381 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -2.16 36.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -171.23 63.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.91 -18.06 62.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.442 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -48.84 -25.97 2.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.37 65.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.283 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' D' ' 82' ' ' LYS . 2.5 pp -55.65 -40.98 72.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . 0.408 ' H ' ' HG ' ' D' ' 81' ' ' LEU . 39.5 mttp -50.44 -23.77 2.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.055 -1.028 . . . . 0.0 109.438 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.18 -42.89 7.78 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.7 OUTLIER -68.18 -42.89 79.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.022 -1.281 . . . . 0.0 109.635 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' D' ' 84' ' ' THR . 35.4 m-85 -67.39 -0.27 3.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.498 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.52 -54.01 20.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.3 p -61.57 -58.66 7.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.366 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' D' ' 92' ' ' HIS . 49.1 mt -51.27 -49.88 60.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.256 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' SER . . . . . 0.536 ' O ' ' N ' ' D' ' 93' ' ' CYS . 7.2 m -57.12 -46.22 82.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 109.233 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.501 ' CA ' ' HZ2' ' D' ' 144' ' ' LYS . 30.9 tt0 -62.28 -46.58 88.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.419 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 3.9 tt -72.45 -27.27 62.21 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.135 -0.978 . . . . 0.0 109.461 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.459 ' N ' ' O ' ' D' ' 88' ' ' LEU . 19.0 m80 -90.52 -20.24 22.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.06 -1.025 . . . . 0.0 109.621 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . 0.536 ' N ' ' O ' ' D' ' 89' ' ' SER . 26.0 t -83.27 -59.27 2.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 110.563 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -86.6 -40.53 15.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.04 -1.037 . . . . 0.0 111.326 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.1 OUTLIER -72.99 -52.0 16.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.965 -1.084 . . . . 0.0 110.602 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.56 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 30.9 mt -95.74 -36.89 11.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.934 -1.104 . . . . 0.0 109.96 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 38.5 p-80 43.58 30.9 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.373 -0.829 . . . . 0.0 110.078 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -52.38 153.27 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.074 -1.016 . . . . 0.0 109.19 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . 0.841 ' OD2' HG22 ' A' ' 96' ' ' VAL . 1.6 m-20 -71.22 143.01 87.76 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 109.589 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -41.26 -43.83 5.48 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.573 2.182 . . . . 0.0 112.417 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -71.98 54.42 0.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -150.93 -31.18 0.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 109.961 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.48 -41.7 54.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.993 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . 0.426 ' O ' ' ND2' ' D' ' 108' ' ' ASN . 73.9 ttt180 -79.49 -20.1 48.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 110.094 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' D' ' 105' ' ' LEU . 4.3 mm? -50.58 -60.84 2.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 109.737 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 pp -81.68 -22.43 37.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.056 -1.028 . . . . 0.0 109.766 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.28 -36.55 37.09 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' D' ' 104' ' ' ARG . 14.2 p30 -85.6 -34.8 21.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -1.149 . . . . 0.0 109.675 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 74.6 t -51.3 -48.0 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 109.462 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.94 -54.1 33.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.368 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 25.1 t -46.29 -38.14 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 109.533 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . 0.422 ' O ' ' ND1' ' D' ' 116' ' ' HIS . 13.3 m -79.1 -56.35 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.56 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 86.8 t -47.93 -24.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.945 . . . . 0.0 109.479 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 14.2 mt -77.19 -43.65 32.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.389 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.52 63.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.407 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' D' ' 112' ' ' CYS . 4.4 m80 -78.18 -62.87 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 0.0 109.771 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -70.75 -17.56 62.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.869 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 63.5 m-85 -144.86 58.12 1.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 0.0 109.74 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -79.7 -17.93 74.23 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -65.03 4.92 0.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -1.083 . . . . 0.0 109.656 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' D' ' 119' ' ' GLY . 46.7 mm-40 -135.04 9.46 3.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.722 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.556 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -77.58 32.62 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.14 -0.975 . . . . 0.0 109.297 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.481 ' H ' ' C ' ' D' ' 121' ' ' GLU . 37.2 p -46.88 148.68 1.77 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.34 -0.85 . . . . 0.0 109.546 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.2 Cg_exo -45.28 -56.91 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.538 2.159 . . . . 0.0 112.887 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 14.3 Cg_endo -56.9 -36.16 98.86 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.16 1.907 . . . . 0.0 111.969 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 63.3 t -76.4 -20.34 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.71 -45.05 25.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 0.0 109.481 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.34 83.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 109.57 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.5 29.29 0.89 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.634 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.02 -33.88 4.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . 0.93 ' OE1' ' CZ ' ' C' ' 36' ' ' PHE . 19.4 tt0 -83.98 -63.48 1.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -48.12 -21.84 0.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.838 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 70.8 t -71.73 -67.25 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.151 -0.968 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -67.3 -40.14 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.82 -21.85 0.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.14 -22.02 64.06 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 89.5 t -74.12 -31.0 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -1.155 . . . . 0.0 109.562 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.36 71.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.53 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -81.34 -21.29 39.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.587 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.13 -60.46 2.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.658 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.1 mt -57.99 -17.69 18.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.514 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' D' ' 144' ' ' LYS . . . -100.66 -6.9 24.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.863 . . . . 0.0 109.603 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -59.03 -4.75 0.53 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.473 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.546 ' C ' ' HD1' ' D' ' 146' ' ' HIS . 21.5 mmtp -92.0 -31.03 15.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.579 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -71.32 14.2 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.001 . . . . 0.0 109.36 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.546 ' HD1' ' C ' ' D' ' 144' ' ' LYS . 28.0 p-80 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.07 -176.64 3.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.306 -0.871 . . . . 0.0 109.609 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.545 ' O ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -117.34 170.88 5.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.0 109.236 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 3' ' ' SER . 88.7 Cg_exo -41.39 -117.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 123.132 2.554 . . . . 0.0 113.304 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -43.99 -27.63 0.39 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.966 -1.084 . . . . 0.0 110.263 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 5' ' ' ALA . 29.9 m-20 -44.1 -35.07 2.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.973 . . . . 0.0 109.192 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -83.26 -34.02 25.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.267 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 m -59.22 -33.33 70.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.264 -0.897 . . . . 0.0 109.148 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -75.02 -32.64 61.66 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -76.03 -51.4 20.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -56.96 -33.98 67.59 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.18 -59.62 5.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.446 -0.784 . . . . 0.0 109.459 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' A' ' 17' ' ' VAL . . . -53.21 -34.44 57.05 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.425 -0.797 . . . . 0.0 109.141 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -17.62 61.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.22 -44.69 9.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -70.19 -38.15 75.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -1.123 . . . . 0.0 108.901 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 96.1 t -61.38 -64.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 53.93 -130.52 43.56 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.23 26.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.457 -1.025 . . . . 0.0 110.438 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.565 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.0 m-70 -130.56 23.85 5.09 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.81 -59.58 2.19 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.612 -0.68 . . . . 0.0 109.698 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -14.21 0.22 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 9.7 mt-10 -88.14 -56.63 3.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -1.141 . . . . 0.0 109.739 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.8 m-30 -57.46 -39.49 76.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.034 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.54 -22.95 53.63 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.51 -57.88 2.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -1.11 . . . . 0.0 109.735 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' OE1' ' NE2' ' A' ' 112' ' ' HIS . 72.4 mt-10 -50.26 -19.9 0.92 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.362 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.58 63.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.367 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 30' ' ' GLU . 9.1 mt -73.13 -56.42 5.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 29' ' ' LEU . 56.3 mt-10 -43.87 -37.19 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.691 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -48.76 78.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.945 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.1 ttp -83.99 -42.82 15.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.63 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.596 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 26.1 m-85 -64.28 -32.57 74.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 0.0 110.301 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mt -45.68 -43.02 12.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.971 -1.081 . . . . 0.0 109.727 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 36' ' ' PHE . 14.9 m -86.65 -15.76 38.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.328 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER 19.14 64.48 0.24 Allowed Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.976 -0.453 . . . . 0.0 111.319 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.52 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 85.4 Cg_endo -93.63 -62.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.623 2.215 . . . . 0.0 112.552 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.628 HG21 ' O ' ' D' ' 97' ' ' HIS . 3.5 p -91.43 -18.6 23.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 109.738 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 p -81.72 -23.03 36.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.968 . . . . 0.0 110.149 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -68.27 -34.93 77.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.063 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.508 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.441 ' CD2' ' O ' ' A' ' 45' ' ' HIS . 42.0 p-80 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.509 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -155.91 28.53 0.37 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.727 -1.233 . . . . 0.0 110.395 178.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 46' ' ' PHE . 7.3 m-20 33.31 81.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.635 -0.666 . . . . 0.0 110.33 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.613 ' CD2' ' H ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -60.13 -21.27 61.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.442 -0.786 . . . . 0.0 109.335 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 t -47.54 149.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.67 ' HD1' ' H ' ' A' ' 51' ' ' GLY . 2.0 t60 -74.77 151.06 39.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.67 ' H ' ' HD1' ' A' ' 50' ' ' HIS . . . 82.16 4.74 90.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' A' ' 53' ' ' ALA . 12.1 p -77.42 -19.77 55.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -1.143 . . . . 0.0 109.477 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 75.77 -16.95 0.55 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.37 -0.831 . . . . 0.0 109.869 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' A' ' 52' ' ' SER . 45.2 mt-30 -86.14 -21.43 27.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.121 -0.987 . . . . 0.0 109.954 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.1 -28.29 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 0.0 109.834 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -77.98 -30.41 50.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.123 -0.986 . . . . 0.0 108.989 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . . . -66.61 -26.46 72.91 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.448 ' CD2' ' C ' ' A' ' 58' ' ' HIS . 7.4 t60 -75.46 -34.78 60.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.131 -1.217 . . . . 0.0 109.636 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.34 -51.08 44.34 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -51.66 -23.46 4.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -1.065 . . . . 0.0 109.968 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -74.51 -42.38 59.02 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.125 -0.984 . . . . 0.0 109.082 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -72.5 -45.24 59.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.467 -0.77 . . . . 0.0 108.986 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.85 -27.59 65.97 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.291 -0.881 . . . . 0.0 109.188 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.39 -34.06 67.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 108.727 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.87 -52.15 46.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.318 -0.864 . . . . 0.0 108.933 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.17 -42.77 91.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 0.0 108.653 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -69.35 -50.19 48.56 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 108.745 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -58.98 -24.78 63.01 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.95 -45.6 12.99 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -63.77 -22.99 32.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.407 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -60.38 -22.78 63.7 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.61 ' O ' ' N ' ' A' ' 74' ' ' ASP . 40.2 m80 -147.22 -51.78 0.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.875 . . . . 0.0 109.532 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.4 p 44.49 13.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.758 0.79 . . . . 0.0 109.479 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' A' ' 72' ' ' HIS . 17.8 t70 -133.07 9.78 4.15 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -175.43 27.43 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.981 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 13.8 ptt? -78.66 -22.48 0.38 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.431 -0.793 . . . . 0.0 111.909 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.8 Cg_exo -53.48 -20.78 16.69 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.548 1.499 . . . . 0.0 112.33 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.17 -35.41 12.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.678 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.04 -47.55 61.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.306 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.5 mt -77.5 5.75 8.37 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.075 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.1 p -54.73 -24.64 23.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.291 -0.88 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -73.93 -55.21 6.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 109.557 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.464 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 4.6 mt -47.7 -48.13 29.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.808 . . . . 0.0 108.929 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 136' ' ' LEU . 28.8 t -59.21 -22.65 61.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.549 -0.719 . . . . 0.0 109.398 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 89' ' ' HIS . 16.5 t70 -81.89 -46.52 13.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.3 -26.74 65.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 11.4 m80 -81.47 -21.65 38.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.724 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.521 ' C ' ' H ' ' A' ' 90' ' ' LYS . . . -119.05 -55.46 2.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.294 -0.879 . . . . 0.0 109.746 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 85' ' ' ASP . 13.2 t-80 -71.41 17.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 109.751 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.643 ' C ' ' H ' ' A' ' 92' ' ' ARG . 9.8 ttmm -166.5 149.02 6.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 109.781 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.7 mt 61.81 -12.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 109.86 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.028 ' HD2' ' HG2' ' D' ' 40' ' ' ARG . 45.6 mmt-85 45.14 16.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 109.714 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 91' ' ' LEU . 12.1 p -57.68 131.02 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 1.08 ' OD1' ' NH1' ' D' ' 40' ' ' ARG . 0.8 OUTLIER -75.3 147.03 82.3 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.29 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.536 ' C ' ' H ' ' A' ' 97' ' ' ASN . 58.1 Cg_endo -72.57 -23.9 19.38 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.543 2.162 . . . . 0.0 112.126 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.8 t -49.06 -10.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.77 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 95' ' ' PRO . 12.0 m-20 -79.05 -24.88 43.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.534 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -54.28 -30.04 49.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.425 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 92.4 mttt -54.33 -26.62 30.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.489 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 100' ' ' LEU . 8.1 mp -84.06 -57.37 3.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.3 tp -50.89 -27.35 7.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -66.09 -58.52 5.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.616 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -63.57 -26.45 68.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.882 . . . . 0.0 109.67 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 73.6 m -58.2 -55.97 28.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 109.596 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mt -47.82 -37.98 14.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 106' ' ' LEU . 7.7 mp -71.13 -41.89 69.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.05 -24.95 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 109.348 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 m -80.76 -63.28 1.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.447 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 113' ' ' LEU . 33.8 mt -46.98 -28.29 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.25 90.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 110.017 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.68 64.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.097 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' A' ' 27' ' ' GLU . 28.1 m170 -93.19 -80.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.073 -1.017 . . . . 0.0 109.721 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.49 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -107.94 102.74 47.07 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -43.8 173.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.546 2.164 . . . . 0.0 113.563 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -87.32 -35.44 18.42 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.782 0.801 . . . . 0.0 109.422 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 13.1 mt-10 81.29 1.35 1.63 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 1.209 ' CD1' ' NH2' ' B' ' 30' ' ' ARG . 11.2 m-85 58.49 40.91 23.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.806 -0.559 . . . . 0.0 111.282 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.752 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -88.12 118.7 69.89 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 120.756 -1.215 . . . . 0.0 108.001 178.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.523 ' HA ' HG23 ' B' ' 33' ' ' VAL . 54.1 Cg_exo -49.05 18.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.319 2.012 . . . . 0.0 112.644 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.752 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -140.08 -39.21 0.45 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.111 -0.993 . . . . 0.0 110.053 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 4.2 p -51.68 -48.35 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.102 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.576 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 2.8 m-70 -62.75 -54.37 40.21 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.412 -0.805 . . . . 0.0 109.334 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.92 -19.61 60.87 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.253 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 1.1 p -60.77 -61.6 2.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 110.271 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.539 ' N ' ' OG ' ' A' ' 124' ' ' SER . 6.4 mt -80.64 -21.05 41.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.113 -0.992 . . . . 0.0 110.073 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -78.51 -40.69 34.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 110.109 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.29 -41.29 11.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.949 -1.094 . . . . 0.0 110.13 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.493 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 32.3 t80 -50.56 -20.51 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.8 -1.188 . . . . 0.0 108.839 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 133' ' ' SER . 11.9 mt -72.59 -17.74 61.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.13 76.83 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.2 p -79.39 -36.19 39.57 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.339 -0.851 . . . . 0.0 108.82 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.09 -27.23 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.183 -0.948 . . . . 0.0 108.67 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 129' ' ' LEU . 97.2 p -78.17 -45.99 21.7 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.474 -0.766 . . . . 0.0 109.204 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.429 ' N ' ' HG ' ' A' ' 133' ' ' SER . 95.2 m -67.81 -23.01 65.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.223 -0.923 . . . . 0.0 108.654 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.85 -29.9 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.433 ' O ' ' OG ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -72.51 -34.6 67.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.09 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 138' ' ' SER . 81.0 p -92.21 -29.73 16.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 137' ' ' THR . 3.5 t . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.521 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' B' ' 2' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -140.81 145.25 36.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.342 -0.849 . . . . 0.0 109.034 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 7.8 p -69.65 148.75 96.84 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.543 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -42.65 -24.85 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.598 2.199 . . . . 0.0 112.236 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -80.82 -53.03 6.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.92 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -60.28 -36.08 77.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.182 -0.948 . . . . 0.0 109.98 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.528 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -84.08 -31.57 25.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 109.922 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.07 -23.56 8.02 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.148 -0.97 . . . . 0.0 110.458 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.4 -58.04 3.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.942 -1.099 . . . . 0.0 110.272 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.53 -24.53 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.528 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.9 m -78.38 -40.35 36.49 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.338 0.589 . . . . 0.0 109.711 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.36 -26.14 68.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.339 -0.851 . . . . 0.0 109.488 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.53 -26.81 68.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.38 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.77 -17.7 64.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.42 -62.9 3.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.428 ' H ' ' HD2' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -78.71 7.1 7.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.099 -1.236 . . . . 0.0 110.815 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -75.65 121.32 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.826 -1.171 . . . . 0.0 109.186 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.43 85.1 6.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.402 -0.811 . . . . 0.0 109.224 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 36.0 t -55.96 -20.36 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 109.573 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 1.0 OUTLIER -57.36 -55.78 30.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 43.1 mt-10 -98.89 -44.29 6.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.58 -23.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.882 . . . . 0.0 109.658 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.18 -43.07 11.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.98 -25.86 61.33 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -79.44 -25.45 41.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.198 -1.177 . . . . 0.0 109.662 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.64 -23.22 39.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 109.619 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 tp -85.02 -57.26 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 0.0 109.503 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.03 -19.82 32.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 1.209 ' NH2' ' CD1' ' A' ' 117' ' ' PHE . 47.0 mtt180 -79.37 -27.34 41.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -1.188 . . . . 0.0 109.377 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 39.7 tp -65.58 -24.77 67.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.879 . . . . 0.0 109.585 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 41.2 mt -78.01 -53.8 7.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.085 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.565 ' CG1' ' H ' ' B' ' 34' ' ' VAL . 7.9 p -71.07 -60.73 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 110.039 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.565 ' H ' ' CG1' ' B' ' 33' ' ' VAL . 95.3 t -46.28 -30.5 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.958 -1.089 . . . . 0.0 109.549 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.9 91.2 1.58 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.391 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.71 30.48 0.52 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.733 2.289 . . . . 0.0 112.427 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -57.17 -28.66 62.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.488 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.616 ' HG1' ' H ' ' B' ' 39' ' ' GLN . 30.5 p -56.19 -77.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.892 . . . . 0.0 109.419 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . 0.616 ' H ' ' HG1' ' B' ' 38' ' ' THR . 14.8 tt0 50.62 46.12 26.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.554 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 1.034 ' NH1' ' OD1' ' C' ' 94' ' ' ASP . 68.9 mtm180 -148.01 -49.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.151 -0.968 . . . . 0.0 109.55 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . 0.517 ' C ' ' H ' ' B' ' 43' ' ' GLU . 1.3 p90 -96.72 -21.4 17.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.759 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -48.81 -11.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.98 . . . . 0.0 109.625 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.517 ' H ' ' C ' ' B' ' 41' ' ' PHE . 31.3 mt-10 -80.31 -20.3 44.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.171 -0.956 . . . . 0.0 109.475 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.474 ' O ' ' N ' ' B' ' 46' ' ' GLY . 11.2 t -58.25 -51.8 68.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.62 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' B' ' 47' ' ' ASP . 57.0 m-85 -47.92 -16.14 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.533 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 61.35 -77.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' B' ' 45' ' ' PHE . 0.9 OUTLIER -46.77 113.45 0.66 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -1.132 . . . . 0.0 109.605 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' B' ' 49' ' ' SER . 0.8 OUTLIER -161.15 22.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.009 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' B' ' 48' ' ' LEU . 17.9 m -45.13 -39.66 6.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 109.563 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -145.67 151.94 47.62 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.323 -0.861 . . . . 0.0 108.995 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -44.64 -21.84 0.53 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.295 1.996 . . . . 0.0 112.154 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.78 -29.21 27.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.657 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.547 ' O ' ' ND2' ' B' ' 57' ' ' ASN . . . -55.57 -26.94 46.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 109.535 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.51 -62.01 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.574 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 14.9 mmt -53.7 -16.97 1.89 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.541 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.25 -4.19 61.24 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' B' ' 53' ' ' ALA . 3.8 m120 -72.22 142.69 85.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.192 -1.181 . . . . 0.0 109.376 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.5 -52.1 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.509 2.14 . . . . 0.0 112.21 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -51.56 -48.11 63.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -0.86 . . . . 0.0 109.586 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.46 -27.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.529 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -79.16 -53.57 6.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.54 -59.04 3.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -49.06 -23.92 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.69 -37.62 92.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -71.7 -35.32 70.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.544 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -49.42 -44.87 45.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.179 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 54.4 t -73.57 -61.84 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.183 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tt -50.43 -23.24 2.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.092 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.35 -56.99 11.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.88 97.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -1.132 . . . . 0.0 109.439 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.82 -21.78 0.7 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 109.289 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p -87.89 -34.93 18.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.621 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -46.44 -34.36 4.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.59 -58.93 6.01 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.438 ' H ' HD13 ' B' ' 75' ' ' LEU . 4.6 mp -62.87 -23.3 67.25 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -1.092 . . . . 0.0 109.277 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.49 2.4 54.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.44 ' C ' ' H ' ' B' ' 79' ' ' ASP . 55.9 t60 -170.99 65.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.78 13.22 0.67 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' B' ' 77' ' ' HIS . 34.7 t70 -76.36 -27.65 56.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.563 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -170.98 106.4 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 109.512 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 mt -80.33 -44.01 20.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.409 ' CD ' ' N ' ' B' ' 82' ' ' LYS . 1.5 mptp? -49.41 -25.87 2.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.383 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.17 -53.71 3.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 3.9 p -65.9 -37.64 86.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.199 -1.177 . . . . 0.0 109.616 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -90.84 23.95 2.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.619 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.26 -41.55 40.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.392 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 21.1 p -72.69 -51.01 21.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.408 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -56.79 -48.85 76.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.33 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 28.1 t -61.57 -44.06 97.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.34 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -64.41 -23.75 67.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.377 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 7.4 tp -85.1 -68.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -49.59 -30.01 8.04 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.272 -0.893 . . . . 0.0 110.083 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . 0.584 ' SG ' ' CD1' ' B' ' 145' ' ' TYR . 38.0 t -83.98 -55.66 4.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 111.548 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.541 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 0.6 OUTLIER -86.26 -29.13 23.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.915 -1.116 . . . . 0.0 112.205 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -90.32 -52.06 5.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.639 -1.288 . . . . 0.0 110.981 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' B' ' 96' ' ' LEU . 3.7 mm? -97.59 -22.79 16.31 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.753 -1.217 . . . . 0.0 110.208 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.574 ' O ' HG21 ' C' ' 38' ' ' THR . 81.9 m-70 51.03 37.62 18.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.004 -1.06 . . . . 0.0 109.424 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . 0.415 ' O ' ' OH ' ' B' ' 145' ' ' TYR . 44.4 t -55.04 138.75 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 0.0 109.362 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' B' ' 101' ' ' GLU . 0.8 OUTLIER -49.94 151.28 3.42 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.73 30.57 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.575 2.183 . . . . 0.0 112.022 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' B' ' 99' ' ' ASP . 29.4 mt-10 -143.47 75.86 1.49 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.304 -0.873 . . . . 0.0 109.384 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -168.2 -40.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.454 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -52.52 -45.7 66.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . 0.429 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 55.4 ttp180 -66.34 -42.32 88.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.46 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' B' ' 105' ' ' LEU . 10.0 mp -54.37 -57.48 11.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' B' ' 106' ' ' LEU . 7.5 tt -52.15 -49.02 64.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.97 -22.41 54.96 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 27.4 m120 -80.76 -15.35 56.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.042 -1.269 . . . . 0.0 109.737 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 64.1 t -85.23 -44.78 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 109.609 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 tt -47.87 -54.33 12.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.599 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -45.57 -32.64 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.884 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.525 ' O ' ' ND1' ' B' ' 116' ' ' HIS . 45.6 m -77.3 -36.87 53.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 109.754 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 18.2 t -57.97 -46.36 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.739 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' B' ' 118' ' ' PHE . 19.0 mt -66.8 -30.54 70.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.697 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.458 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -61.08 -29.44 69.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.614 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' B' ' 112' ' ' CYS . 68.7 m80 -84.82 -62.89 1.44 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.708 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.518 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 6.6 t-160 -65.44 -18.45 65.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 40.5 m-85 -144.37 55.48 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 109.491 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.531 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -68.74 -21.32 74.85 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.06 -35.21 59.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.146 . . . . 0.0 109.421 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.0 mm-40 -75.31 3.05 9.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.439 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.552 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -72.33 35.43 0.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.555 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.527 ' H ' ' C ' ' B' ' 121' ' ' GLU . 4.8 p -47.12 147.4 2.47 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.369 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.483 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.2 Cg_exo -48.48 -51.28 10.53 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.31 2.007 . . . . 0.0 113.231 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 41.8 Cg_endo -67.99 -0.92 6.12 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.055 1.836 . . . . 0.0 112.754 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 40.3 t -99.08 -12.57 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.36 -60.19 2.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 109.496 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.51 ' O ' ' NZ ' ' B' ' 132' ' ' LYS . . . -67.07 -25.71 66.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.95 . . . . 0.0 109.264 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.45 18.19 2.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 109.651 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -107.89 -61.3 1.59 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.652 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -46.31 -48.28 18.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 109.742 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.828 ' HG2' ' OXT' ' D' ' 146' ' ' HIS . 33.1 mtmm -52.69 -21.89 4.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.781 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.34 -67.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.0 109.699 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' B' ' 137' ' ' VAL . 30.9 m -73.33 -15.88 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 109.909 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.918 ' HB1' ' CG ' ' D' ' 146' ' ' HIS . . . -47.47 -28.86 2.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.469 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.29 -22.8 58.22 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 134' ' ' VAL . 82.3 t -82.1 -27.04 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -1.136 . . . . 0.0 109.538 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.98 82.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.596 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . 1.07 ' ND2' ' ND2' ' D' ' 139' ' ' ASN . 23.9 m120 -79.63 -25.93 41.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.917 . . . . 0.0 109.754 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.47 -49.15 78.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.0 109.726 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 21.8 mt -82.64 16.41 2.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 109.668 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.77 -0.77 1.88 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.22 -0.925 . . . . 0.0 109.697 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -80.36 -28.31 38.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -70.91 -16.6 62.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.439 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.584 ' CD1' ' SG ' ' B' ' 93' ' ' CYS . 13.9 m-85 -64.67 -28.83 69.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.361 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.891 ' CG ' ' HB1' ' D' ' 135' ' ' ALA . 20.9 m-70 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.447 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.13 -176.71 3.16 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.278 -0.889 . . . . 0.0 109.536 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.545 ' O ' ' O ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER -117.22 170.84 5.53 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.539 -0.726 . . . . 0.0 109.191 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' C' ' 3' ' ' SER . 89.1 Cg_exo -41.37 -117.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.126 2.551 . . . . 0.0 113.275 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -43.92 -27.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 110.272 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' C' ' 5' ' ' ALA . 29.7 m-20 -44.16 -34.95 2.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.1 -1.0 . . . . 0.0 109.25 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -83.33 -33.95 25.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.319 -0.863 . . . . 0.0 109.307 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 55.1 m -59.29 -33.41 71.04 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.227 -0.921 . . . . 0.0 109.028 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -74.95 -32.65 61.78 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -76.05 -51.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -57.0 -34.01 67.72 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.2 -59.67 5.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.521 -0.737 . . . . 0.0 109.314 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.2 -34.43 56.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.383 -0.823 . . . . 0.0 109.109 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -17.64 61.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.308 -0.87 . . . . 0.0 109.263 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.17 -44.75 9.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -70.06 -38.29 75.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.168 -1.195 . . . . 0.0 108.89 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.35 -64.93 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.582 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 53.94 -130.56 43.67 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.15 26.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.42 -1.047 . . . . 0.0 110.453 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.582 ' H ' ' C ' ' C' ' 18' ' ' GLY . 93.2 m-70 -130.59 24.07 5.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.95 -59.52 2.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.627 -0.67 . . . . 0.0 109.735 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -14.31 0.23 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' C' ' 21' ' ' ALA . 9.7 mt-10 -88.05 -56.6 3.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.139 . . . . 0.0 109.74 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.8 m-30 -57.4 -39.54 76.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.066 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.53 -23.05 53.83 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.4 -57.99 2.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.286 -1.126 . . . . 0.0 109.774 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . 0.526 ' OE1' ' NE2' ' C' ' 112' ' ' HIS . 72.7 mt-10 -50.18 -19.88 0.88 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.29 -21.64 63.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.494 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 9.1 mt -73.12 -56.49 5.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -43.79 -37.15 2.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.827 . . . . 0.0 109.773 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -48.71 78.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 61.0 ttp -83.97 -42.87 15.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . 0.594 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 26.2 m-85 -64.17 -32.71 74.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.908 . . . . 0.0 110.239 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' C' ' 33' ' ' PHE . 5.7 mt -45.66 -43.07 12.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.966 -1.083 . . . . 0.0 109.658 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.57 ' O ' ' C ' ' C' ' 36' ' ' PHE . 14.9 m -86.66 -15.67 38.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -0.9 . . . . 0.0 109.367 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.594 ' CD2' ' O ' ' C' ' 33' ' ' PHE . 0.2 OUTLIER 19.17 64.46 0.24 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.917 -0.489 . . . . 0.0 111.354 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . 0.436 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 85.4 Cg_endo -93.68 -62.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.571 2.181 . . . . 0.0 112.551 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' THR . . . . . 0.574 HG21 ' O ' ' B' ' 97' ' ' HIS . 3.4 p -91.45 -18.48 24.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 109.754 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -81.72 -23.08 36.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.15 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -68.25 -34.96 77.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.087 -1.008 . . . . 0.0 109.67 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 -179.876 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.428 ' O ' ' CD2' ' C' ' 45' ' ' HIS . 42.1 p-80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.776 0.322 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.503 ' O ' ' C ' ' C' ' 47' ' ' ASP . 0.7 OUTLIER -155.86 28.54 0.37 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.76 -1.212 . . . . 0.0 110.406 178.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' C' ' 46' ' ' PHE . 7.3 m-20 33.41 81.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.663 -0.648 . . . . 0.0 110.295 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.596 ' CD2' ' H ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -60.06 -21.35 61.33 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.462 -0.774 . . . . 0.0 109.356 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 20.9 t -47.54 149.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.614 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.673 ' ND1' ' H ' ' C' ' 51' ' ' GLY . 2.0 t60 -74.81 151.08 39.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . 0.673 ' H ' ' ND1' ' C' ' 50' ' ' HIS . . . 82.26 4.64 90.13 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' C' ' 53' ' ' ALA . 12.0 p -77.42 -19.81 55.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -1.11 . . . . 0.0 109.482 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 75.8 -16.99 0.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.367 -0.833 . . . . 0.0 109.888 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' C' ' 52' ' ' SER . 45.1 mt-30 -86.1 -21.56 27.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.903 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 18.6 t -83.93 -28.42 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.062 -1.024 . . . . 0.0 109.901 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -77.96 -30.37 50.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.013 -1.055 . . . . 0.0 108.961 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . 0.532 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -66.68 -26.44 72.97 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.453 ' C ' ' CD2' ' C' ' 58' ' ' HIS . 7.4 t60 -75.41 -34.77 61.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.122 -1.222 . . . . 0.0 109.671 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.1 44.32 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -51.66 -23.42 4.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -1.077 . . . . 0.0 109.887 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' C' ' 57' ' ' GLY . 0.8 OUTLIER -74.54 -42.4 58.9 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.157 -0.965 . . . . 0.0 109.103 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -72.54 -45.23 59.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 108.98 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.85 -27.66 66.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.279 -0.888 . . . . 0.0 109.156 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -72.3 -34.01 67.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 108.866 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.86 -52.1 47.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.01 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mt -59.15 -42.8 91.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.912 . . . . 0.0 108.634 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -69.42 -50.13 48.65 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.282 -0.886 . . . . 0.0 108.695 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -59.01 -24.86 63.17 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.86 -45.64 13.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -63.65 -23.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' C' ' 72' ' ' HIS . . . -60.21 -22.86 63.5 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' C' ' 74' ' ' ASP . 40.3 m80 -147.24 -51.87 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.357 -0.839 . . . . 0.0 109.56 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.3 p 44.42 13.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.856 0.836 . . . . 0.0 109.539 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' C' ' 72' ' ' HIS . 17.8 t70 -133.12 9.76 4.13 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -175.4 27.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.897 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.689 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 13.8 ptt? -78.64 -22.62 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.478 -0.764 . . . . 0.0 111.865 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.6 Cg_exo -53.46 -20.69 16.36 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.586 1.524 . . . . 0.0 112.276 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.21 -35.42 12.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 109.738 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.03 -47.58 61.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 0.0 109.32 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -77.45 5.69 8.38 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.112 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 64.4 p -54.74 -24.67 23.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -73.95 -55.15 6.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.579 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.47 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 4.7 mt -47.75 -48.07 30.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.385 -0.822 . . . . 0.0 108.821 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' C' ' 136' ' ' LEU . 28.8 t -59.32 -22.63 61.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.49 -0.756 . . . . 0.0 109.315 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' C' ' 89' ' ' HIS . 16.5 t70 -81.9 -46.53 13.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.24 -26.82 65.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 11.4 m80 -81.34 -21.74 38.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.166 -0.959 . . . . 0.0 109.783 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.524 ' C ' ' H ' ' C' ' 90' ' ' LYS . . . -118.98 -55.51 2.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.313 -0.867 . . . . 0.0 109.773 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' C' ' 85' ' ' ASP . 13.2 t-80 -71.26 17.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.813 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.617 ' C ' ' H ' ' C' ' 92' ' ' ARG . 9.8 ttmm -166.53 149.02 6.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -0.998 . . . . 0.0 109.728 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.7 mt 61.79 -12.47 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.893 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . 0.991 ' HD2' ' HG2' ' B' ' 40' ' ' ARG . 45.7 mmt-85 45.05 16.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.73 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' C' ' 91' ' ' LEU . 12.0 p -57.73 130.97 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 1.034 ' OD1' ' NH1' ' B' ' 40' ' ' ARG . 0.8 OUTLIER -75.31 146.99 82.24 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' C' ' 97' ' ' ASN . 58.0 Cg_endo -72.63 -23.82 19.27 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.436 2.091 . . . . 0.0 112.153 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -48.95 -10.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.796 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' C' ' 95' ' ' PRO . 12.1 m-20 -79.21 -24.73 42.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 109.518 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' C' ' 99' ' ' LYS . 0.6 OUTLIER -54.27 -30.1 49.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 109.497 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.419 ' N ' ' CD1' ' C' ' 98' ' ' PHE . 92.3 mttt -54.25 -26.61 29.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.461 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' C' ' 100' ' ' LEU . 8.1 mp -84.18 -57.31 3.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 7.2 tp -50.93 -27.3 7.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 109.534 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 6.1 m -66.23 -58.55 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 0.0 109.551 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -63.39 -26.61 68.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.68 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 73.4 m -58.15 -55.94 28.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.627 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mt -47.86 -37.98 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 109.541 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.523 ' N ' ' CD1' ' C' ' 106' ' ' LEU . 7.7 mp -71.09 -41.99 69.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.99 -24.93 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.376 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 22.5 m -80.85 -63.2 1.46 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.442 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' C' ' 113' ' ' LEU . 34.4 mt -46.97 -28.35 1.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.18 90.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 110.044 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.69 63.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.386 -0.821 . . . . 0.0 110.027 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' C' ' 27' ' ' GLU . 28.1 m170 -93.16 -80.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.107 -0.995 . . . . 0.0 109.697 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.489 ' CD2' ' O ' ' C' ' 113' ' ' LEU . 0.1 OUTLIER -107.83 102.7 46.58 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -43.8 173.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.626 2.217 . . . . 0.0 113.504 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -87.19 -35.43 18.58 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.684 0.754 . . . . 0.0 109.482 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 13.2 mt-10 81.34 1.28 1.62 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 1.194 ' CD1' ' NH2' ' D' ' 30' ' ' ARG . 11.1 m-85 58.55 40.8 23.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.895 -0.503 . . . . 0.0 111.255 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.754 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -88.05 118.69 69.91 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.703 -1.248 . . . . 0.0 108.068 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . 0.512 ' HA ' HG23 ' D' ' 33' ' ' VAL . 54.0 Cg_exo -49.05 18.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.293 1.995 . . . . 0.0 112.662 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.754 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -139.99 -39.23 0.45 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.077 -1.015 . . . . 0.0 110.057 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 4.2 p -51.8 -48.33 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.103 -0.998 . . . . 0.0 109.952 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.573 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 2.9 m-70 -62.91 -54.32 40.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.399 -0.813 . . . . 0.0 109.259 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.81 -19.69 60.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.307 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 1.1 p -60.79 -61.5 2.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.345 -0.847 . . . . 0.0 110.303 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.535 ' N ' ' OG ' ' C' ' 124' ' ' SER . 6.4 mt -80.72 -21.04 41.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.089 -1.007 . . . . 0.0 110.05 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -78.51 -40.67 34.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 110.092 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.494 ' HG3' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.29 -41.3 11.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.987 -1.07 . . . . 0.0 110.097 -179.508 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.494 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 31.9 t80 -50.51 -20.59 1.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.8 -1.187 . . . . 0.0 108.841 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' C' ' 133' ' ' SER . 11.9 mt -72.53 -17.79 61.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.46 -38.1 76.85 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 60.8 p -79.46 -36.24 39.11 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.318 -0.864 . . . . 0.0 108.749 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.02 -27.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.218 -0.927 . . . . 0.0 108.638 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.587 ' N ' ' O ' ' C' ' 129' ' ' LEU . 96.8 p -78.32 -45.96 21.32 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.384 -0.822 . . . . 0.0 109.159 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' THR . . . . . 0.426 ' N ' ' HG ' ' C' ' 133' ' ' SER . 94.8 m -67.78 -22.99 65.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.258 -0.902 . . . . 0.0 108.705 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.77 -30.04 7.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' C' ' 84' ' ' SER . 0.5 OUTLIER -72.46 -34.6 67.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.393 -0.817 . . . . 0.0 109.056 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 137' ' ' THR . . . . . 0.44 ' O ' ' O ' ' C' ' 138' ' ' SER . 81.1 p -92.32 -29.56 16.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.573 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 138' ' ' SER . . . . . 0.44 ' O ' ' O ' ' C' ' 137' ' ' THR . 3.5 t . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . 0.405 ' C ' ' HD1' ' D' ' 2' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.519 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -140.84 145.18 35.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.164 -0.96 . . . . 0.0 109.059 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 7.9 p -69.6 148.83 96.95 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.531 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -42.8 -24.78 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.503 2.136 . . . . 0.0 112.229 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -80.79 -53.07 6.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.919 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -60.21 -36.07 76.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 109.989 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.515 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -84.06 -31.52 25.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 110.026 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.08 -23.49 7.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -0.959 . . . . 0.0 110.441 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.5 -58.02 3.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.935 -1.103 . . . . 0.0 110.222 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.55 -24.44 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 25.9 m -78.45 -40.32 36.0 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.317 0.58 . . . . 0.0 109.674 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -26.21 68.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.51 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -26.84 68.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.329 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.77 -17.7 64.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.509 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.38 -62.87 3.66 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.494 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.418 ' H ' ' HD2' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -78.79 7.16 7.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.285 . . . . 0.0 110.849 -178.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -75.73 121.39 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.742 -1.224 . . . . 0.0 109.138 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -81.42 85.21 6.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.212 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 36.5 t -55.97 -20.39 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.608 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' D' ' 22' ' ' GLU . 1.0 OUTLIER -57.32 -55.81 29.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.366 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' D' ' 21' ' ' ASP . 43.1 mt-10 -98.9 -44.31 6.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.66 -23.89 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.619 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.24 -43.11 10.93 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.87 -25.93 61.44 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -79.36 -25.56 42.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.213 -1.169 . . . . 0.0 109.674 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.61 -23.17 39.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 109.675 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 tp -85.03 -57.29 3.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 109.479 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.93 -19.92 31.71 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . 1.194 ' NH2' ' CD1' ' C' ' 117' ' ' PHE . 47.2 mtt180 -79.29 -27.28 42.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -1.176 . . . . 0.0 109.421 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 39.4 tp -65.68 -24.71 67.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 41.8 mt -78.19 -53.67 7.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.056 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . 0.572 ' CG1' ' H ' ' D' ' 34' ' ' VAL . 7.9 p -71.16 -60.6 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.125 -0.985 . . . . 0.0 110.05 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . 0.572 ' H ' ' CG1' ' D' ' 33' ' ' VAL . 94.9 t -46.41 -30.41 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.952 -1.093 . . . . 0.0 109.557 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.96 91.25 1.57 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 109.348 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -84.74 30.47 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.731 2.287 . . . . 0.0 112.409 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 -57.16 -28.75 63.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.608 ' HG1' ' H ' ' D' ' 39' ' ' GLN . 30.5 p -56.07 -77.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.379 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . 0.608 ' H ' ' HG1' ' D' ' 38' ' ' THR . 14.7 tt0 50.6 46.09 26.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 109.577 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . 1.08 ' NH1' ' OD1' ' A' ' 94' ' ' ASP . 69.3 mtm180 -147.97 -49.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' D' ' 43' ' ' GLU . 1.3 p90 -96.76 -21.24 17.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -48.86 -11.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.565 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' D' ' 41' ' ' PHE . 31.3 mt-10 -80.31 -20.3 44.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.471 ' O ' ' N ' ' D' ' 46' ' ' GLY . 11.3 t -58.2 -51.94 67.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.581 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' D' ' 47' ' ' ASP . 56.8 m-85 -47.75 -16.27 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.515 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 61.38 -77.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' D' ' 45' ' ' PHE . 0.9 OUTLIER -46.74 113.49 0.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -1.133 . . . . 0.0 109.607 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' D' ' 49' ' ' SER . 0.8 OUTLIER -161.22 22.18 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 108.971 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' D' ' 48' ' ' LEU . 17.8 m -45.06 -39.77 6.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 109.585 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -145.53 151.94 48.16 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.855 . . . . 0.0 109.056 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -44.61 -21.85 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.241 1.96 . . . . 0.0 112.16 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -83.81 -29.18 27.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 109.594 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . 0.54 ' O ' ' ND2' ' D' ' 57' ' ' ASN . . . -55.52 -26.94 45.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.655 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.51 -62.04 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.577 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 14.9 mmt -53.62 -17.0 1.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.556 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.27 -4.16 61.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' D' ' 53' ' ' ALA . 3.8 m120 -72.27 142.79 85.0 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.321 -1.105 . . . . 0.0 109.313 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.55 -52.11 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.515 2.144 . . . . 0.0 112.152 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -51.66 -47.96 63.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.624 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 95.5 t -47.51 -27.47 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -79.14 -53.52 6.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.68 -59.03 3.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.567 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -49.0 -24.03 1.36 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.933 . . . . 0.0 109.587 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.59 -37.66 92.71 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' D' ' 69' ' ' GLY . 27.8 mttp -71.67 -35.42 70.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -1.197 . . . . 0.0 109.519 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -49.35 -44.82 44.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 109.235 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 54.3 t -73.66 -61.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -0.869 . . . . 0.0 109.212 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tt -50.44 -23.35 2.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.155 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' D' ' 65' ' ' LYS . . . -66.23 -57.08 11.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.81 97.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.203 -1.174 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.89 -21.73 0.71 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.314 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p -88.05 -34.86 17.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.57 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -46.35 -34.49 4.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.893 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.52 -58.91 6.05 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.436 ' H ' HD13 ' D' ' 75' ' ' LEU . 4.5 mp -62.76 -23.48 67.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.175 -1.191 . . . . 0.0 109.26 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.35 2.32 54.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 109.454 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.453 ' C ' ' H ' ' D' ' 79' ' ' ASP . 55.9 t60 -170.95 65.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.79 13.3 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.304 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' D' ' 77' ' ' HIS . 34.7 t70 -76.46 -27.64 56.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -170.93 106.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.22 -44.09 20.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . 0.405 ' N ' ' CD ' ' D' ' 82' ' ' LYS . 1.5 mptp? -49.36 -25.89 2.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.469 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.18 -53.79 3.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' THR . . . . . . . . . . . . . 3.8 p -65.83 -37.63 86.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -1.144 . . . . 0.0 109.596 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -90.9 24.02 2.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.665 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.29 -41.58 40.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.337 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 21.2 p -72.79 -50.83 21.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 109.491 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.82 -48.94 76.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.352 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 27.7 t -61.48 -44.03 97.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.44 -23.75 67.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 7.4 tp -85.12 -68.78 0.7 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.842 . . . . 0.0 109.421 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -49.52 -30.14 7.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . 0.587 ' SG ' ' CD1' ' D' ' 145' ' ' TYR . 38.0 t -83.88 -55.55 4.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 111.633 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.543 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 0.6 OUTLIER -86.39 -29.07 23.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.957 -1.09 . . . . 0.0 112.161 -177.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -90.34 -52.07 5.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.619 -1.301 . . . . 0.0 111.043 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.5 ' N ' ' CD2' ' D' ' 96' ' ' LEU . 3.7 mm? -97.53 -22.85 16.3 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.787 -1.196 . . . . 0.0 110.241 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.628 ' O ' HG21 ' A' ' 38' ' ' THR . 81.9 m-70 51.07 37.59 18.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.019 -1.05 . . . . 0.0 109.473 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . 0.418 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 44.5 t -55.04 138.78 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.345 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' D' ' 101' ' ' GLU . 0.8 OUTLIER -49.93 151.24 3.43 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.7 30.6 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.568 2.179 . . . . 0.0 112.086 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' D' ' 99' ' ' ASP . 29.4 mt-10 -143.46 75.88 1.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 109.349 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -168.27 -40.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -52.54 -45.79 66.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 55.3 ttp180 -66.16 -42.39 89.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' D' ' 105' ' ' LEU . 10.1 mp -54.45 -57.43 11.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.442 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.433 ' C ' ' CD2' ' D' ' 106' ' ' LEU . 7.5 tt -52.13 -49.02 64.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.17 -0.956 . . . . 0.0 109.467 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -59.0 -22.37 55.01 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 27.4 m120 -80.66 -15.56 56.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.107 -1.231 . . . . 0.0 109.786 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 63.5 t -85.08 -44.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 109.65 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 tt -47.98 -54.24 13.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -45.5 -32.69 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.955 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . 0.516 ' O ' ' ND1' ' D' ' 116' ' ' HIS . 46.3 m -77.3 -36.86 53.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.76 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.94 -46.45 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.767 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 19.0 mt -66.77 -30.42 70.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.794 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.458 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -61.22 -29.42 69.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.97 . . . . 0.0 109.575 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' D' ' 112' ' ' CYS . 68.8 m80 -84.74 -63.0 1.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.071 -1.018 . . . . 0.0 109.685 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 6.6 t-160 -65.38 -18.4 65.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 109.581 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 40.6 m-85 -144.45 55.44 1.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.529 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -68.62 -21.42 74.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -76.03 -35.19 59.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -1.118 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' D' ' 123' ' ' THR . 59.0 mm-40 -75.33 3.04 9.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.537 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -72.24 35.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.334 -0.854 . . . . 0.0 109.545 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.532 ' H ' ' C ' ' D' ' 121' ' ' GLU . 4.8 p -47.15 147.35 2.53 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.955 . . . . 0.0 109.393 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.477 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.2 Cg_exo -48.38 -51.29 10.45 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.366 2.044 . . . . 0.0 113.202 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 41.6 Cg_endo -68.0 -1.0 6.22 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.06 1.84 . . . . 0.0 112.748 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.09 -12.52 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.174 -0.954 . . . . 0.0 109.607 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.25 -60.23 2.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 109.507 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 0.518 ' O ' ' NZ ' ' D' ' 132' ' ' LYS . . . -67.05 -25.79 66.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.37 18.06 2.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.356 -0.84 . . . . 0.0 109.621 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -107.83 -61.39 1.58 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.341 -0.85 . . . . 0.0 109.617 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -46.4 -48.17 18.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.957 . . . . 0.0 109.724 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . 0.777 ' HG2' ' OXT' ' B' ' 146' ' ' HIS . 33.0 mtmm -52.65 -21.87 4.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.863 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 25.7 t -74.39 -67.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -0.949 . . . . 0.0 109.661 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' D' ' 137' ' ' VAL . 31.4 m -73.5 -15.77 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.883 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.891 ' HB1' ' CG ' ' B' ' 146' ' ' HIS . . . -47.34 -29.0 2.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.23 -22.82 58.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' D' ' 134' ' ' VAL . 81.0 t -82.18 -26.95 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -1.133 . . . . 0.0 109.547 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.84 -47.96 83.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.93 . . . . 0.0 109.615 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . 1.07 ' ND2' ' ND2' ' B' ' 139' ' ' ASN . 23.7 m120 -79.62 -26.02 41.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.65 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.2 78.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.676 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 21.9 mt -82.68 16.41 2.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.651 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.75 -0.85 1.88 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.213 -0.929 . . . . 0.0 109.729 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -80.27 -28.24 38.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.778 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -70.91 -16.62 62.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.985 . . . . 0.0 109.465 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . 0.587 ' CD1' ' SG ' ' D' ' 93' ' ' CYS . 13.9 m-85 -64.66 -28.82 69.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.383 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.918 ' CG ' ' HB1' ' B' ' 135' ' ' ALA . 20.9 m-70 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.428 ' CG2' ' OG ' ' A' ' 131' ' ' SER . 16.8 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.0 mt -136.9 -161.01 1.11 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 0.0 109.354 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.453 ' N ' ' OD2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -133.15 174.43 4.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.332 -0.855 . . . . 0.0 109.285 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.23 -70.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.629 2.219 . . . . 0.0 112.689 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.451 ' O ' ' ND2' ' A' ' 9' ' ' ASN . . . -48.54 -44.14 36.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.109 -0.995 . . . . 0.0 109.903 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 1.3 m-20 -42.36 -35.76 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 10' ' ' VAL . 69.6 mttt -83.32 -56.43 3.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.32 -0.862 . . . . 0.0 109.524 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 94.5 m -45.43 -35.58 3.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 109.865 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 5' ' ' ALA . 9.0 m-20 -74.69 -33.49 62.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.01 -1.057 . . . . 0.0 108.15 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' A' ' 7' ' ' LYS . 75.4 t -76.22 -49.37 25.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.45 -40.08 64.93 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.89 -61.64 2.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.516 -0.74 . . . . 0.0 109.462 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.6 -38.5 66.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.381 -0.824 . . . . 0.0 109.137 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.47 -17.44 62.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.24 -0.912 . . . . 0.0 109.008 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.58 -46.62 7.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -68.69 -36.76 78.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -1.163 . . . . 0.0 108.842 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.5 t -62.0 -66.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 61.85 -141.08 47.3 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.17 39.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.493 -1.004 . . . . 0.0 110.355 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.541 ' H ' ' C ' ' A' ' 18' ' ' GLY . 87.6 m-70 -142.94 20.34 1.96 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.63 -61.28 1.92 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.652 -0.655 . . . . 0.0 109.583 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.65 -13.91 0.19 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 21' ' ' ALA . 10.2 mm-40 -84.99 -56.33 3.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -1.102 . . . . 0.0 109.613 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.8 m-30 -61.69 -30.88 71.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 109.254 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.44 74.88 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.48 -40.41 57.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -1.198 . . . . 0.0 109.669 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -56.96 -20.75 25.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.325 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.57 72.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.88 . . . . 0.0 109.483 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.41 -61.17 2.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.63 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.01 -12.66 12.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.631 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.518 ' NH2' ' CB ' ' B' ' 127' ' ' GLN . 6.2 tpm_? -74.35 -53.34 9.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -84.18 -28.74 27.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.918 . . . . 0.0 110.084 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -46.37 -37.77 7.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 110.042 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -96.61 -36.92 10.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 110.268 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.8 m -44.43 -25.88 0.29 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 110.028 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.551 ' CG ' ' O ' ' A' ' 35' ' ' SER . 50.9 m-85 -162.46 139.11 5.97 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.169 -0.957 . . . . 0.0 109.287 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 40' ' ' LYS . 55.9 Cg_endo -71.98 -34.02 9.02 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.596 2.197 . . . . 0.0 111.984 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.963 ' HA ' ' HB3' ' D' ' 97' ' ' HIS . 76.6 p -47.51 -18.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 109.509 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' A' ' 40' ' ' LYS . 25.7 p -84.85 -27.99 26.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 109.446 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.451 ' N ' ' HG1' ' A' ' 39' ' ' THR . 82.7 mttt -71.43 -25.3 62.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.676 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.535 ' HB ' ' ND1' ' D' ' 97' ' ' HIS . 15.1 t . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.169 -0.957 . . . . 0.0 109.529 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.566 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 14.9 p80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.13 0.491 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -144.95 25.45 1.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.49 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' A' ' 49' ' ' SER . 2.4 m-20 43.97 84.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.463 -0.773 . . . . 0.0 109.791 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.528 ' H ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -51.82 -11.36 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 47' ' ' ASP . 28.3 p -49.01 158.48 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -77.47 148.24 35.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.455 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.24 16.92 78.94 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 54' ' ' GLN . 54.6 p -74.42 -17.06 60.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -1.154 . . . . 0.0 109.485 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 67.41 -39.54 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.338 -0.851 . . . . 0.0 109.641 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.562 ' H ' ' C ' ' A' ' 52' ' ' SER . 56.6 mt-30 -65.87 -42.11 90.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.45 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.4 -44.67 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.298 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -39.4 67.0 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.15 -26.58 72.5 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.435 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 4.5 t-80 -68.15 -43.29 78.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -1.218 . . . . 0.0 109.317 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.75 -46.07 24.66 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -48.52 -23.66 1.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -1.047 . . . . 0.0 109.268 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -75.41 -38.94 59.56 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.283 -0.886 . . . . 0.0 108.672 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.49 -48.95 44.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.29 -32.86 74.74 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 109.083 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 68' ' ' ASN . 5.8 t0 -63.74 -36.49 84.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.238 -0.914 . . . . 0.0 108.626 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.55 -52.77 34.86 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.01 -41.01 91.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.4 m -71.87 -50.2 31.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 64' ' ' ASP . 49.4 t30 -60.16 -24.3 64.62 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -82.29 -46.69 13.31 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.11 -22.97 32.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.4 -14.92 63.34 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.606 ' O ' ' N ' ' A' ' 74' ' ' ASP . 35.5 m-70 -138.36 -62.97 0.56 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.517 -0.739 . . . . 0.0 109.287 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 72' ' ' HIS . 13.1 p 44.28 14.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.928 0.87 . . . . 0.0 109.37 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 72' ' ' HIS . 39.8 t0 -138.14 11.61 2.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.419 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 1.0 OUTLIER 174.92 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.246 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.685 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 14.3 ptt? -78.74 -22.68 0.39 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 111.981 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 76' ' ' MET . 59.5 Cg_exo -52.01 -19.67 9.02 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.705 1.603 . . . . 0.0 112.51 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.44 ' O ' ' OG ' ' A' ' 81' ' ' SER . 13.2 m120 -94.12 -35.76 12.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 109.764 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.96 -38.4 69.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.963 . . . . 0.0 109.285 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.79 11.49 15.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.392 -0.818 . . . . 0.0 109.049 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 68.3 p -68.08 -15.92 63.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 109.763 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -72.69 -55.8 6.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.031 . . . . 0.0 109.878 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 86' ' ' LEU . 6.1 mt -44.88 -47.26 11.15 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 62.6 m -46.79 -33.05 4.1 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' ALA . 1.5 m-20 -82.11 -17.32 46.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.188 -0.945 . . . . 0.0 109.558 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 83' ' ' LEU . 8.6 tp -74.06 -53.44 9.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.1 -1.0 . . . . 0.0 110.261 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.435 ' CE1' ' O ' ' A' ' 83' ' ' LEU . 6.0 p-80 -92.2 -21.66 20.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.975 -1.078 . . . . 0.0 110.643 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' CG ' ' A' ' 89' ' ' HIS . . . -97.27 -0.61 46.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.9 -1.125 . . . . 0.0 110.404 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 88' ' ' ALA . 70.9 m80 -154.91 42.94 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.787 -1.195 . . . . 0.0 110.256 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -172.39 -63.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.967 . . . . 0.0 109.329 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.1 mt -90.59 -23.79 20.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 53.99 53.3 11.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.665 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.437 ' CG1' ' H ' ' A' ' 94' ' ' ASP . 2.3 t -79.87 -136.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 109.447 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 96' ' ' VAL . 5.2 t70 -172.3 137.11 0.89 Allowed Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 109.234 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 98' ' ' PHE . 85.6 Cg_exo -41.86 -10.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.544 2.163 . . . . 0.0 112.639 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 94' ' ' ASP . 60.1 t -43.75 -28.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 109.955 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.19 -24.95 42.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 95' ' ' PRO . 38.4 t80 -44.96 -32.47 1.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.913 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.49 -27.22 27.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.007 . . . . 0.0 109.898 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.16 -62.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.036 -1.04 . . . . 0.0 110.024 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.7 tp -55.74 -20.96 16.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 109.878 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.552 ' HG ' ' H ' ' A' ' 103' ' ' HIS . 16.8 p -78.44 -50.37 11.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.051 -1.031 . . . . 0.0 109.843 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.552 ' H ' ' HG ' ' A' ' 102' ' ' SER . 34.2 m170 -76.4 -26.6 55.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -0.952 . . . . 0.0 109.808 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 55.6 m -58.81 -50.92 72.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.777 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.35 -35.88 13.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 109.63 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.538 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 3.7 mm? -69.99 -59.17 3.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.079 -1.013 . . . . 0.0 109.895 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.8 t -50.08 -36.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.478 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.463 ' H ' ' HG1' ' A' ' 108' ' ' THR . 4.9 p -70.56 -63.11 1.16 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.264 -0.897 . . . . 0.0 109.375 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' LEU . 17.5 mt -50.47 -31.42 15.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 -47.13 50.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.224 -0.923 . . . . 0.0 109.609 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.24 -41.35 22.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.89 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -80.1 -72.08 0.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.115 -0.991 . . . . 0.0 109.986 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -113.87 91.51 22.19 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 109.076 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 113' ' ' LEU . 84.7 Cg_exo -46.22 -175.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.329 2.019 . . . . 0.0 112.84 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.494 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.29 -42.21 13.94 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.636 0.732 . . . . 0.0 109.406 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER 85.0 3.66 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.897 ' CZ ' ' CE1' ' B' ' 116' ' ' HIS . 8.0 m-85 65.12 36.6 7.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.791 -0.568 . . . . 0.0 111.279 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.716 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -91.16 121.51 67.68 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.798 -1.189 . . . . 0.0 108.197 178.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.95 22.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.14 1.893 . . . . 0.0 112.656 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.716 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -151.23 -33.56 0.15 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.772 -1.205 . . . . 0.0 110.785 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 11.4 p -46.63 -47.84 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.932 -1.105 . . . . 0.0 110.061 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.532 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -72.78 -33.51 66.34 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.555 -0.716 . . . . 0.0 109.349 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.06 -19.81 36.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 110.023 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 120' ' ' ALA . 10.2 p -65.95 -62.47 1.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.202 -0.936 . . . . 0.0 110.84 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.513 ' N ' ' OG ' ' A' ' 124' ' ' SER . 9.3 mt -70.18 -19.42 63.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.07 -1.019 . . . . 0.0 109.789 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -78.93 -45.43 20.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.046 -1.034 . . . . 0.0 110.219 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -88.23 -43.24 11.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.988 -1.07 . . . . 0.0 110.14 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.455 ' H ' ' HG3' ' A' ' 127' ' ' LYS . 70.2 t80 -50.17 -21.02 1.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.957 -1.089 . . . . 0.0 109.271 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.4 mt -69.73 -17.7 63.47 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.25 -33.51 72.4 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.492 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 5.1 t -83.08 -30.41 28.0 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.417 -0.802 . . . . 0.0 108.992 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.5 t -85.41 -27.63 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 109.078 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 129' ' ' LEU . 77.9 p -83.75 -25.97 30.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.119 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.9 m -78.09 -36.94 47.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.213 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.3 m -76.57 -21.86 15.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.266 -0.896 . . . . 0.0 108.883 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.48 -37.87 68.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.451 -0.781 . . . . 0.0 108.985 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.5 p -89.14 -1.38 58.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.594 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.428 -179.889 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . 0.415 ' O ' ' CG ' ' B' ' 2' ' ' HIS . 12.3 t-80 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.684 ' H ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -106.29 162.45 13.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.433 -0.792 . . . . 0.0 109.261 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.434 ' O ' ' N ' ' B' ' 7' ' ' GLU . 0.7 OUTLIER -84.61 150.93 57.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 109.109 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.456 ' O ' ' OG ' ' B' ' 9' ' ' SER . 80.2 Cg_exo -42.01 -30.73 1.32 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.434 2.089 . . . . 0.0 112.026 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.36 -21.84 25.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.925 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 4' ' ' THR . 44.5 tt0 -77.11 -63.09 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.174 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.48 ' O ' ' OG1' ' B' ' 12' ' ' THR . 10.4 pttt -67.53 -25.73 65.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.963 . . . . 0.0 110.175 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' B' ' 5' ' ' PRO . 0.4 OUTLIER -43.8 -24.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 110.134 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.18 -56.23 3.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.087 -1.008 . . . . 0.0 109.751 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.04 -24.74 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.7 m -68.35 -39.12 81.98 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.351 0.596 . . . . 0.0 109.805 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.4 -31.23 57.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.847 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.3 -21.86 6.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.341 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . 0.519 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.2 OUTLIER -56.31 -38.27 71.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 109.234 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.21 -40.26 61.48 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -26.19 66.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -1.143 . . . . 0.0 109.178 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.16 121.0 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 109.666 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' B' ' 21' ' ' ASP . 59.6 t30 -80.04 71.83 6.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.0 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 82.8 t -45.89 -15.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 109.779 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 19' ' ' ASN . 34.8 m-20 -69.22 -4.09 16.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.624 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' B' ' 25' ' ' GLY . 47.9 mt-10 -155.79 -46.9 0.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.156 -0.965 . . . . 0.0 109.574 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -47.11 -23.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 109.723 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.95 -31.15 40.28 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -73.55 -39.52 49.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -70.24 -38.86 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 0.0 109.486 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.07 -30.25 61.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.556 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tp -81.47 -58.04 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.482 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.71 85.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -55.93 -39.35 71.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -1.126 . . . . 0.0 109.62 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.61 -35.98 4.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -81.19 -29.91 34.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 109.752 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.03 -64.48 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.425 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.97 -22.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.224 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -149.62 81.92 6.97 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.92 . . . . 0.0 109.562 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.95 9.85 3.15 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.562 2.175 . . . . 0.0 112.23 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' B' ' 38' ' ' THR . 0.4 OUTLIER -80.96 -19.96 42.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 109.694 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.554 ' N ' ' CD1' ' B' ' 37' ' ' TRP . 7.2 m -87.95 57.94 4.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.479 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -117.61 23.82 11.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.41 -0.807 . . . . 0.0 109.332 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -87.34 -39.76 15.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.958 . . . . 0.0 109.554 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -100.01 34.82 2.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 109.463 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' CE1' ' B' ' 45' ' ' PHE . 0.9 OUTLIER -143.32 15.04 1.84 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.222 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.49 -14.09 61.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.408 ' C ' ' N ' ' B' ' 46' ' ' GLY . 5.3 m -69.14 -46.92 66.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.477 ' CE1' ' CD2' ' B' ' 42' ' ' PHE . 80.1 m-85 -50.17 -16.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 45' ' ' PHE . . . 51.3 179.61 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 38.0 t0 55.86 71.28 0.56 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -1.178 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 27.9 mt -131.21 35.05 3.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 109.379 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m -51.89 -49.29 63.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.27 160.17 46.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 108.837 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.4 -17.32 4.14 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.079 1.853 . . . . 0.0 111.972 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.418 ' C ' ' N ' ' B' ' 54' ' ' VAL . 19.6 t70 -83.26 -51.56 7.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.556 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.95 -20.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.431 -0.793 . . . . 0.0 109.471 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.418 ' N ' ' C ' ' B' ' 52' ' ' ASP . 57.8 t -73.01 -57.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mtt -59.98 -16.73 32.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.53 -26.62 71.29 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -78.79 132.22 65.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.152 -1.205 . . . . 0.0 109.327 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.02 -30.89 4.09 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.341 2.028 . . . . 0.0 112.34 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -70.41 -30.13 66.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.85 -40.68 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.516 ' NZ ' ' CB ' ' B' ' 61' ' ' LYS . 8.1 mtmp? -65.45 -37.43 86.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 109.68 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.96 -51.04 67.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -55.82 -23.79 32.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.01 -48.94 65.33 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -52.29 -25.03 8.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -1.188 . . . . 0.0 109.587 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -61.94 1.7 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 109.491 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 t -52.18 -39.33 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 8.0 tt -70.16 -37.41 75.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.903 . . . . 0.0 109.343 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.89 -44.08 61.25 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.53 71.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 109.787 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . 0.418 ' O ' ' CD2' ' B' ' 75' ' ' LEU . 1.3 m-85 -66.3 -29.1 69.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' SER . . . . . 0.519 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.8 t -66.21 -33.77 76.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.515 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.17 -16.76 56.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.173 -0.954 . . . . 0.0 109.159 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.67 -19.76 63.15 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' B' ' 75' ' ' LEU . 1.5 pt? -137.78 -28.44 0.89 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -1.181 . . . . 0.0 109.952 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.1 19.02 0.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 109.586 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -171.55 70.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 70.5 mt -80.85 0.72 33.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.975 . . . . 0.0 109.492 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -54.04 -38.33 65.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.441 HD21 ' C ' ' B' ' 80' ' ' ASN . 0.3 OUTLIER -172.09 73.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.361 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.74 -41.73 43.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.628 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -50.82 -27.2 6.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.096 -1.002 . . . . 0.0 109.41 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' B' ' 86' ' ' ALA . . . -83.19 -57.54 2.48 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.6 OUTLIER -47.86 -39.71 19.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -1.164 . . . . 0.0 109.557 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.434 ' N ' ' CG2' ' B' ' 84' ' ' THR . 25.1 m-85 -69.83 -11.96 61.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.382 -0.824 . . . . 0.0 109.429 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' B' ' 83' ' ' GLY . . . -54.57 -43.72 72.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.438 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 11.4 p -64.38 -59.24 4.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.5 mt -54.97 -35.39 64.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' B' ' 141' ' ' LEU . 5.2 t -72.76 -46.43 53.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.337 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.54 -24.54 67.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.42 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.19 -68.36 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.557 ' O ' ' N ' ' B' ' 97' ' ' HIS . 75.1 m80 -54.35 -25.83 26.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 110.491 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.89 -60.66 2.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.013 -1.054 . . . . 0.0 111.501 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.561 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 11.8 m-20 -86.99 -39.75 15.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.92 -1.112 . . . . 0.0 111.701 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -83.17 -10.15 58.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.078 . . . . 0.0 111.07 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.502 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 0.2 OUTLIER -137.9 -43.78 0.52 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.886 -1.134 . . . . 0.0 110.068 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.91 ' HB3' ' HA ' ' C' ' 38' ' ' THR . 4.1 m80 72.95 58.57 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.246 -0.909 . . . . 0.0 109.575 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . 0.431 ' O ' ' OH ' ' B' ' 145' ' ' TYR . 79.1 t -82.64 114.21 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.09 -1.006 . . . . 0.0 109.434 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.74 154.45 2.37 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.27 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.402 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 47.2 Cg_endo -70.09 -164.3 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.573 2.182 . . . . 0.0 112.149 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 53.31 51.97 14.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' B' ' 100' ' ' PRO . 31.0 m120 -158.25 -36.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.24 -37.57 85.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -72.94 -26.39 61.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 tt -65.62 -55.49 17.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 tt -50.37 -47.0 56.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.24 -47.88 72.07 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.51 -50.29 65.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -1.161 . . . . 0.0 109.607 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 80.5 t -53.76 -38.5 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.17 -0.956 . . . . 0.0 109.524 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.96 -33.91 76.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.405 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.9 -26.24 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 60.7 m -79.27 -61.04 2.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.731 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.9 t -46.25 -30.0 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 31.9 mt -79.84 -31.45 40.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.601 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -82.26 -20.38 37.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.897 ' CE1' ' CZ ' ' A' ' 117' ' ' PHE . 11.0 t-80 -74.95 -55.73 5.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.531 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -74.46 -17.73 60.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.625 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -146.53 58.96 1.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.436 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -74.83 -21.92 77.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -72.89 -33.73 66.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -1.153 . . . . 0.0 109.433 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' B' ' 123' ' ' THR . 57.7 mm-40 -81.46 -4.52 56.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.8 34.33 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.36 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.519 ' H ' ' C ' ' B' ' 121' ' ' GLU . 28.7 p -48.4 148.45 3.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 109.096 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.3 Cg_exo -45.28 -52.85 6.04 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.196 1.931 . . . . 0.0 112.779 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 36.4 Cg_endo -65.68 13.67 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.053 1.835 . . . . 0.0 112.324 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' B' ' 124' ' ' PRO . 90.2 t -124.87 -21.42 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . 0.518 ' CB ' ' NH2' ' A' ' 31' ' ' ARG . 18.2 tm0? -83.15 -42.9 16.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.468 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -62.01 -44.21 97.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.587 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.75 -7.17 25.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.692 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -92.43 -30.12 15.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 109.603 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . 0.518 ' CG ' HE22 ' B' ' 127' ' ' GLN . 15.6 mm100 -81.45 -38.33 26.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.592 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -68.14 -49.43 61.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 109.646 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 2.6 p -58.47 -48.22 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.898 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.567 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 88.8 t -73.38 -34.57 43.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.842 ' CB ' ' O ' ' D' ' 146' ' ' HIS . . . -47.41 -22.28 0.42 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.35 -22.03 61.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' B' ' 134' ' ' VAL . 85.9 t -77.84 -26.09 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -1.154 . . . . 0.0 109.541 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.08 -46.58 61.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -74.69 -21.17 59.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.36 -59.63 3.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.524 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.433 ' O ' ' OG ' ' B' ' 89' ' ' SER . 13.4 mt -58.58 -24.9 61.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.23 22.36 4.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -77.25 -31.93 55.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.588 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.1 OUTLIER -79.55 -27.3 41.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.321 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' B' ' 98' ' ' VAL . 24.4 m-85 -65.99 3.68 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.799 ' O ' ' CB ' ' D' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . 0.427 ' CG2' ' OG ' ' C' ' 131' ' ' SER . 16.9 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 25.3 mt -136.96 -161.06 1.12 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.317 -0.865 . . . . 0.0 109.364 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.46 ' N ' ' OD2' ' C' ' 6' ' ' ASP . 0.3 OUTLIER -133.22 174.44 4.7 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.848 . . . . 0.0 109.199 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.22 -70.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.65 2.233 . . . . 0.0 112.638 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.45 ' O ' ' ND2' ' C' ' 9' ' ' ASN . . . -48.62 -44.12 36.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.161 -0.962 . . . . 0.0 109.88 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' C' ' 6' ' ' ASP . 1.3 m-20 -42.33 -35.77 1.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.88 . . . . 0.0 109.44 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' C' ' 10' ' ' VAL . 69.5 mttt -83.32 -56.42 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.827 . . . . 0.0 109.571 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 94.9 m -45.45 -35.62 3.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.406 -0.809 . . . . 0.0 109.906 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' C' ' 5' ' ' ALA . 8.9 m-20 -74.51 -33.5 62.82 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 7' ' ' LYS . 76.2 t -76.37 -49.25 25.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.52 -40.04 65.14 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.95 -61.63 2.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.473 -0.767 . . . . 0.0 109.408 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.51 66.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.842 . . . . 0.0 109.145 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -17.52 62.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 108.959 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.54 -46.71 7.8 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -68.63 -36.79 79.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -1.138 . . . . 0.0 108.828 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.0 t -61.96 -66.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 61.93 -141.15 47.27 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.07 39.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.476 -1.014 . . . . 0.0 110.36 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.551 ' H ' ' C ' ' C' ' 18' ' ' GLY . 87.6 m-70 -142.96 20.43 1.96 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.72 -61.15 1.95 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.635 -0.666 . . . . 0.0 109.649 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -13.9 0.2 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' C' ' 21' ' ' ALA . 10.3 mm-40 -85.02 -56.3 3.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -1.172 . . . . 0.0 109.544 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 1.8 m-30 -61.75 -30.91 71.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.852 . . . . 0.0 109.186 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.26 -29.5 75.02 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.54 -40.29 57.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -1.179 . . . . 0.0 109.676 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -56.9 -20.83 25.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.342 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -31.58 72.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.905 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.34 -61.3 2.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.57 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.97 -12.7 12.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.93 . . . . 0.0 109.563 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.508 ' NH2' ' CB ' ' D' ' 127' ' ' GLN . 6.2 tpm_? -74.34 -53.27 10.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.133 -0.979 . . . . 0.0 109.818 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -84.22 -28.72 27.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.943 . . . . 0.0 110.101 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -46.37 -37.8 8.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.119 -0.988 . . . . 0.0 110.022 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -96.57 -36.95 10.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.204 -0.935 . . . . 0.0 110.3 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.7 m -44.4 -25.91 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' C' ' 35' ' ' SER . 51.1 m-85 -162.44 139.11 5.99 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.114 -0.992 . . . . 0.0 109.286 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' C' ' 40' ' ' LYS . 56.0 Cg_endo -71.96 -34.15 8.89 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.647 2.231 . . . . 0.0 111.986 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' THR . . . . . 0.91 ' HA ' ' HB3' ' B' ' 97' ' ' HIS . 76.7 p -47.42 -18.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.437 ' N ' ' O ' ' C' ' 37' ' ' PRO . 25.8 p -84.9 -28.04 26.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' C' ' 37' ' ' PRO . 82.7 mttt -71.42 -25.3 62.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.908 . . . . 0.0 109.702 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.465 ' HB ' ' ND1' ' B' ' 97' ' ' HIS . 15.1 t . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 109.466 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.564 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 14.8 p80 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.013 0.435 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -144.95 25.56 1.42 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.14 -0.975 . . . . 0.0 109.582 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' C' ' 49' ' ' SER . 2.4 m-20 44.0 84.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.507 -0.746 . . . . 0.0 109.817 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.531 ' H ' ' CD1' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -51.81 -11.41 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.375 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.474 ' H ' ' C ' ' C' ' 47' ' ' ASP . 28.1 p -48.94 158.52 0.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.627 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -77.52 148.34 35.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.21 16.9 79.01 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.565 ' C ' ' H ' ' C' ' 54' ' ' GLN . 55.2 p -74.43 -17.03 60.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -1.167 . . . . 0.0 109.475 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . 67.35 -39.46 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.373 -0.829 . . . . 0.0 109.629 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.565 ' H ' ' C ' ' C' ' 52' ' ' SER . 56.6 mt-30 -65.95 -42.07 90.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 109.409 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.39 -44.74 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.178 -0.951 . . . . 0.0 109.274 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -39.39 67.13 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.16 -26.55 72.51 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.442 ' ND1' ' C ' ' C' ' 58' ' ' HIS . 4.4 t-80 -68.25 -43.24 78.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -1.202 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.83 -46.06 25.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -48.48 -23.62 1.02 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.377 -1.072 . . . . 0.0 109.272 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -75.45 -38.92 59.38 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.264 -0.898 . . . . 0.0 108.659 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.44 -49.04 44.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.2 -32.93 74.87 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.358 -0.839 . . . . 0.0 109.077 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' C' ' 68' ' ' ASN . 5.9 t0 -63.71 -36.43 83.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.171 -0.956 . . . . 0.0 108.637 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.68 -52.61 35.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.13 -40.98 91.66 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.2 m -71.85 -50.29 30.79 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' C' ' 64' ' ' ASP . 49.5 t30 -60.17 -24.16 64.52 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -82.28 -46.84 13.12 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.02 -22.92 32.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.41 -15.01 63.4 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.611 ' O ' ' N ' ' C' ' 74' ' ' ASP . 35.2 m-70 -138.3 -62.97 0.56 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.502 -0.749 . . . . 0.0 109.356 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.1 p 44.24 14.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.937 0.875 . . . . 0.0 109.399 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' C' ' 72' ' ' HIS . 39.7 t0 -138.19 11.57 2.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 1.0 OUTLIER 174.95 29.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.683 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 14.3 ptt? -78.67 -22.77 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 111.898 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' C' ' 76' ' ' MET . 60.3 Cg_exo -52.05 -19.66 9.13 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.652 1.568 . . . . 0.0 112.521 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.436 ' O ' ' OG ' ' C' ' 81' ' ' SER . 13.2 m120 -94.02 -35.78 12.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.789 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.95 -38.39 69.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.078 -1.013 . . . . 0.0 109.317 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.81 11.46 15.46 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.423 -0.798 . . . . 0.0 109.047 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 68.4 p -68.05 -15.87 63.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.755 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -72.69 -55.84 6.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.886 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' C' ' 86' ' ' LEU . 6.1 mt -44.84 -47.26 11.03 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' C' ' 88' ' ' ALA . 62.4 m -46.87 -32.96 4.11 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' C' ' 82' ' ' ALA . 1.5 m-20 -82.16 -17.21 47.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.615 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' C' ' 83' ' ' LEU . 8.6 tp -74.11 -53.42 9.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 0.0 110.346 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . 0.437 ' CE1' ' O ' ' C' ' 83' ' ' LEU . 6.0 p-80 -92.18 -21.68 20.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.889 -1.132 . . . . 0.0 110.655 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.442 ' O ' ' CG ' ' C' ' 89' ' ' HIS . . . -97.24 -0.63 46.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.864 -1.148 . . . . 0.0 110.4 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' C' ' 88' ' ' ALA . 70.7 m80 -154.93 42.95 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 110.227 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -172.39 -63.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 109.326 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 46.4 mt -90.66 -23.72 20.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 109.323 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 53.95 53.33 11.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 0.0 109.639 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.437 ' CG1' ' H ' ' C' ' 94' ' ' ASP . 2.3 t -79.9 -136.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 0.0 109.466 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' C' ' 96' ' ' VAL . 5.2 t70 -172.23 137.11 0.9 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.183 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' C' ' 98' ' ' PHE . 86.2 Cg_exo -41.75 -11.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.616 2.211 . . . . 0.0 112.627 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' C' ' 94' ' ' ASP . 59.1 t -43.65 -28.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.2 -24.96 42.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.542 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' C' ' 95' ' ' PRO . 38.4 t80 -44.98 -32.47 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 109.953 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.41 -27.23 27.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 0.0 109.977 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 mt -84.19 -62.25 1.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.993 -1.067 . . . . 0.0 109.94 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 36.9 tp -55.79 -20.91 16.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.914 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' SER . . . . . 0.56 ' HG ' ' H ' ' C' ' 103' ' ' HIS . 17.0 p -78.42 -50.38 11.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 109.903 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . 0.56 ' H ' ' HG ' ' C' ' 102' ' ' SER . 34.3 m170 -76.38 -26.58 55.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.836 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 55.7 m -58.66 -51.02 71.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.768 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.36 -35.88 13.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 109.618 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' C' ' 106' ' ' LEU . 3.7 mm? -70.02 -59.16 3.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.146 -0.971 . . . . 0.0 109.863 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 47.9 t -50.2 -36.77 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.962 . . . . 0.0 109.449 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.483 ' H ' ' HG1' ' C' ' 108' ' ' THR . 5.0 p -70.57 -63.09 1.16 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.224 -0.923 . . . . 0.0 109.417 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' C' ' 113' ' ' LEU . 17.6 mt -50.47 -31.55 15.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.334 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.51 -47.19 48.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.945 . . . . 0.0 109.631 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.32 -41.31 22.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.837 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -80.08 -72.13 0.42 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 110.003 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -113.86 91.56 22.31 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' C' ' 113' ' ' LEU . 84.5 Cg_exo -46.17 -175.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.447 2.098 . . . . 0.0 112.825 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.3 -42.21 13.92 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.555 -0.716 . . . . 0.0 109.393 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 0.0 OUTLIER 85.02 3.56 0.65 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 0.904 ' CZ ' ' CE1' ' D' ' 116' ' ' HIS . 8.1 m-85 65.1 36.74 7.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.798 -0.564 . . . . 0.0 111.225 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.718 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -91.06 121.59 67.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.719 -1.238 . . . . 0.0 108.179 178.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.15 22.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.11 1.874 . . . . 0.0 112.57 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.718 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -151.17 -33.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.963 -1.086 . . . . 0.0 110.84 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 11.5 p -46.63 -47.86 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.013 -1.055 . . . . 0.0 110.005 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.536 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 0.3 OUTLIER -72.79 -33.5 66.31 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.51 -0.744 . . . . 0.0 109.307 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.11 -19.75 36.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.826 . . . . 0.0 110.059 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.6 ' N ' ' O ' ' C' ' 120' ' ' ALA . 10.2 p -66.04 -62.47 1.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.947 . . . . 0.0 110.783 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.524 ' N ' ' OG ' ' C' ' 124' ' ' SER . 9.4 mt -70.14 -19.4 63.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.047 -1.033 . . . . 0.0 109.885 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.92 -45.34 20.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.01 -1.056 . . . . 0.0 110.306 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -88.31 -43.19 11.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.0 110.18 -179.401 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.455 ' H ' ' HG3' ' C' ' 127' ' ' LYS . 70.1 t80 -50.23 -21.03 1.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.911 -1.118 . . . . 0.0 109.316 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.6 mt -69.59 -17.77 63.57 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.21 -33.56 72.42 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' SER . . . . . 0.501 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 5.1 t -83.06 -30.41 28.04 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.349 -0.844 . . . . 0.0 108.988 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 72.7 t -85.41 -27.67 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.072 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.518 ' N ' ' O ' ' C' ' 129' ' ' LEU . 76.9 p -83.65 -26.01 30.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.817 . . . . 0.0 109.152 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 47.5 m -78.11 -36.91 47.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.343 -0.848 . . . . 0.0 109.183 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 33.4 m -76.49 -21.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.267 -0.895 . . . . 0.0 108.888 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -37.79 68.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 109.013 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 58.2 p -89.29 -1.23 57.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.693 ' H ' ' CD1' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -106.38 162.49 13.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.469 -0.77 . . . . 0.0 109.28 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.438 ' O ' ' N ' ' D' ' 7' ' ' GLU . 0.7 OUTLIER -84.69 151.01 57.67 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 109.06 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . 0.454 ' O ' ' OG ' ' D' ' 9' ' ' SER . 79.1 Cg_exo -42.09 -30.62 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.33 2.02 . . . . 0.0 112.103 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.41 -21.82 25.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.891 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' D' ' 4' ' ' THR . 44.6 tt0 -77.12 -63.02 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.126 -0.984 . . . . 0.0 110.164 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.473 ' O ' ' OG1' ' D' ' 12' ' ' THR . 10.4 pttt -67.64 -25.71 65.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.163 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' D' ' 5' ' ' PRO . 0.4 OUTLIER -43.73 -24.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.23 -56.21 3.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.094 -1.004 . . . . 0.0 109.75 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.06 -24.78 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 25.4 m -68.26 -39.23 82.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.357 0.599 . . . . 0.0 109.844 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.18 -31.36 58.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.923 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -21.77 6.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 0.0 109.31 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . 0.517 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.2 OUTLIER -56.34 -38.37 71.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.983 . . . . 0.0 109.151 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.23 -40.2 61.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -26.07 66.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -1.096 . . . . 0.0 109.198 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.11 121.06 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.607 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' D' ' 21' ' ' ASP . 59.6 t30 -80.12 71.75 6.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.278 -0.889 . . . . 0.0 109.023 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 80.1 t -45.82 -15.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 0.0 109.793 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' D' ' 19' ' ' ASN . 35.2 m-20 -69.28 -4.02 16.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' D' ' 25' ' ' GLY . 47.9 mt-10 -155.8 -46.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -47.06 -23.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.683 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.86 -31.22 40.44 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -73.54 -39.48 49.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -70.21 -38.86 75.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -1.146 . . . . 0.0 109.56 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.04 -30.24 61.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tp -81.46 -58.09 3.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.973 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.7 85.07 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -55.98 -39.4 71.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -1.142 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.59 -35.99 4.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.602 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 mt -81.22 -29.82 34.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.787 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 66.8 t -66.01 -64.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 109.497 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -22.6 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 109.232 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -149.6 81.8 7.03 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.618 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.05 9.98 3.13 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.552 2.168 . . . . 0.0 112.173 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . 0.568 ' CD1' ' N ' ' D' ' 38' ' ' THR . 0.4 OUTLIER -80.97 -20.02 42.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.568 ' N ' ' CD1' ' D' ' 37' ' ' TRP . 7.3 m -88.0 58.08 4.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 109.472 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -117.66 23.72 11.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.431 -0.793 . . . . 0.0 109.324 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -87.31 -39.72 15.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 109.552 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -100.01 34.75 2.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.223 -0.923 . . . . 0.0 109.432 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.487 ' CD2' ' CE1' ' D' ' 45' ' ' PHE . 0.9 OUTLIER -143.3 15.12 1.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 109.222 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.47 -14.15 61.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.583 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' D' ' 46' ' ' GLY . 5.3 m -69.04 -46.9 66.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . 0.487 ' CE1' ' CD2' ' D' ' 42' ' ' PHE . 80.0 m-85 -50.23 -16.16 0.3 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' D' ' 44' ' ' SER . . . 51.26 179.58 0.04 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 55.95 71.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -1.153 . . . . 0.0 109.481 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 27.6 mt -131.26 35.11 3.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 109.391 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 13.4 m -51.92 -49.37 63.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.937 . . . . 0.0 109.49 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.21 160.22 46.55 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.327 -0.858 . . . . 0.0 108.832 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.42 -17.3 4.18 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.112 1.874 . . . . 0.0 111.946 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . 0.416 ' C ' ' N ' ' D' ' 54' ' ' VAL . 19.5 t70 -83.26 -51.51 7.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.345 -0.847 . . . . 0.0 109.593 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.07 -19.84 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 109.437 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' D' ' 52' ' ' ASP . 58.5 t -73.2 -57.86 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mtt -60.07 -16.65 33.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 0.0 109.41 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.5 -26.72 71.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -78.74 132.27 65.16 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.226 -1.161 . . . . 0.0 109.321 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.98 -31.02 4.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.365 2.043 . . . . 0.0 112.299 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -70.38 -30.11 66.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.616 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.83 -40.64 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 109.602 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . 0.512 ' NZ ' ' CB ' ' D' ' 61' ' ' LYS . 8.1 mtmp? -65.53 -37.43 86.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.681 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.94 -51.06 67.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -55.7 -23.94 31.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.073 -1.017 . . . . 0.0 109.455 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.03 -48.87 65.98 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -52.4 -24.9 8.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -1.233 . . . . 0.0 109.522 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.48 -62.0 1.67 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.259 -0.9 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 t -52.17 -39.33 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 8.0 tt -70.09 -37.46 75.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.326 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.85 -44.14 61.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.43 71.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -1.155 . . . . 0.0 109.803 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . 0.413 ' O ' ' CD2' ' D' ' 75' ' ' LEU . 1.3 m-85 -66.29 -29.14 69.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.077 -1.015 . . . . 0.0 109.537 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' SER . . . . . 0.517 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 8.8 t -66.36 -33.57 76.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.31 -16.7 55.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.14 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.62 -19.86 63.17 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.565 ' N ' ' CD2' ' D' ' 75' ' ' LEU . 1.5 pt? -137.66 -28.44 0.9 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.21 -1.17 . . . . 0.0 109.931 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.05 19.0 0.75 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.095 -1.003 . . . . 0.0 109.607 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -171.58 70.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.87 0.66 34.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.425 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -53.99 -38.41 65.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 109.32 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.447 ' C ' HD21 ' D' ' 80' ' ' ASN . 0.3 OUTLIER -172.03 73.18 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.371 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.72 -41.62 44.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -50.93 -27.12 6.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.08 -1.013 . . . . 0.0 109.426 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' D' ' 86' ' ' ALA . . . -83.22 -57.63 2.46 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.6 OUTLIER -47.64 -39.83 18.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -1.159 . . . . 0.0 109.584 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.427 ' N ' ' CG2' ' D' ' 84' ' ' THR . 25.1 m-85 -69.78 -12.09 61.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.326 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' D' ' 83' ' ' GLY . . . -54.49 -43.69 72.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.154 -0.966 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 11.3 p -64.42 -59.22 4.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 109.384 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.7 mt -54.92 -35.51 64.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.304 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' D' ' 141' ' ' LEU . 5.2 t -72.73 -46.46 53.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.907 . . . . 0.0 109.314 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.52 -24.47 67.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.872 . . . . 0.0 109.452 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.31 -68.2 0.71 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.556 ' O ' ' N ' ' D' ' 97' ' ' HIS . 75.1 m80 -54.57 -25.67 27.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 110.493 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.92 -60.61 2.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.017 -1.052 . . . . 0.0 111.594 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.553 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 11.9 m-20 -87.07 -39.64 15.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.996 -1.065 . . . . 0.0 111.693 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -83.17 -10.2 58.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.913 -1.117 . . . . 0.0 111.11 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.511 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 0.2 OUTLIER -137.89 -43.85 0.53 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.869 -1.144 . . . . 0.0 109.971 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.963 ' HB3' ' HA ' ' A' ' 38' ' ' THR . 4.1 m80 73.11 58.5 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.87 . . . . 0.0 109.509 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . 0.44 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 79.3 t -82.66 114.21 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 109.421 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.76 154.45 2.38 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.264 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.1 -164.4 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.61 2.206 . . . . 0.0 112.153 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 53.32 52.03 14.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.485 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -158.28 -36.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.34 -37.55 86.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -72.88 -26.43 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 tt -65.6 -55.58 16.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.357 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 tt -50.41 -46.98 56.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.919 . . . . 0.0 109.356 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.15 -47.93 71.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.43 -50.28 65.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -1.157 . . . . 0.0 109.616 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 80.5 t -53.85 -38.53 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 109.498 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.96 -33.87 76.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.423 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.95 -26.11 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.552 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 60.7 m -79.31 -61.0 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 109.738 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 4.9 t -46.34 -29.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 109.815 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 32.1 mt -79.76 -31.56 40.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -82.12 -20.47 37.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.897 . . . . 0.0 109.494 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.904 ' CE1' ' CZ ' ' C' ' 117' ' ' PHE . 11.0 t-80 -75.0 -55.72 5.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.176 -0.952 . . . . 0.0 109.471 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -74.53 -17.75 60.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.544 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -146.54 59.01 1.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -74.81 -22.0 77.66 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -72.87 -33.73 66.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -1.197 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' D' ' 123' ' ' THR . 57.4 mm-40 -81.38 -4.63 56.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.361 -0.837 . . . . 0.0 109.522 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.82 34.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.285 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.521 ' H ' ' C ' ' D' ' 121' ' ' GLU . 28.3 p -48.32 148.3 3.36 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.108 -0.995 . . . . 0.0 109.083 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.494 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.3 Cg_exo -45.1 -52.91 5.85 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.228 1.952 . . . . 0.0 112.812 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 36.4 Cg_endo -65.65 13.57 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.013 1.809 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' D' ' 124' ' ' PRO . 90.8 t -124.84 -21.34 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.299 -0.876 . . . . 0.0 109.605 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . 0.516 HE22 ' CG ' ' D' ' 131' ' ' GLN . 18.2 tm0? -83.18 -42.96 16.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 0.468 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -61.91 -44.35 96.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.67 -7.15 24.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.683 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -92.43 -30.01 15.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 109.706 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . 0.516 ' CG ' HE22 ' D' ' 127' ' ' GLN . 15.6 mm100 -81.62 -38.2 26.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -68.21 -49.33 61.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 109.691 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 2.6 p -58.49 -48.18 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.865 . . . . 0.0 109.966 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.569 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 88.5 t -73.44 -34.45 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.347 -0.846 . . . . 0.0 109.796 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.799 ' CB ' ' O ' ' B' ' 146' ' ' HIS . . . -47.45 -22.29 0.43 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.37 -22.01 61.31 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' D' ' 134' ' ' VAL . 85.8 t -77.83 -26.07 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -1.138 . . . . 0.0 109.537 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.14 -46.6 61.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.214 -0.929 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -74.71 -21.08 59.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.497 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.32 -59.71 3.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.553 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . 0.437 ' O ' ' OG ' ' D' ' 89' ' ' SER . 13.5 mt -58.52 -24.93 61.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.927 . . . . 0.0 109.438 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.24 22.45 4.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 109.39 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -77.34 -31.85 54.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.634 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.1 OUTLIER -79.55 -27.35 41.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.398 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . 0.44 ' OH ' ' O ' ' D' ' 98' ' ' VAL . 24.4 m-85 -65.88 3.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.842 ' O ' ' CB ' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.439 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.7 mp -108.21 -165.39 1.04 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.311 -0.868 . . . . 0.0 109.2 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.469 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 178.98 -49.53 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.936 . . . . 0.0 109.992 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' ASP . 73.9 Cg_exo -47.23 171.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.384 2.056 . . . . 0.0 112.448 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -45.8 -16.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.766 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' PRO . 3.1 p30 -39.55 -33.35 0.17 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 10' ' ' VAL . 9.6 ptpt -83.14 -46.59 12.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.338 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 m -45.44 -31.07 1.56 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.314 -0.866 . . . . 0.0 109.424 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -78.23 -36.94 46.42 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 7' ' ' LYS . 71.5 t -70.5 -49.52 52.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -51.07 -47.32 61.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.404 -0.81 . . . . 0.0 108.847 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -55.92 27.57 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.43 -0.794 . . . . 0.0 109.304 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.23 70.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.251 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -17.41 61.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.223 -0.923 . . . . 0.0 108.933 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.63 -44.17 16.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 41.6 mmtt -70.2 -43.25 71.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -1.17 . . . . 0.0 108.637 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.27 -63.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 44.2 -125.39 5.78 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 22.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.416 -1.05 . . . . 0.0 110.438 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.598 ' H ' ' C ' ' A' ' 18' ' ' GLY . 78.9 m-70 -129.11 25.99 5.5 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -91.51 -64.38 1.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.694 -0.629 . . . . 0.0 109.746 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.28 -14.37 0.17 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' ALA . 2.2 mm-40 -84.03 -56.47 3.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -1.052 . . . . 0.0 109.672 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.2 m-30 -60.67 -35.56 76.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 109.187 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.86 -22.88 68.84 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.51 -41.76 31.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -1.163 . . . . 0.0 109.715 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.42 -19.82 62.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 108.92 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.432 ' CB ' ' SG ' ' A' ' 104' ' ' CYS . . . -72.85 -21.88 60.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.371 -0.831 . . . . 0.0 109.132 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.1 mt -72.45 -53.68 11.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.349 -0.845 . . . . 0.0 109.712 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.13 -27.05 69.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.489 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.711 HH22 ' HG ' ' A' ' 35' ' ' SER . 0.9 OUTLIER -63.89 -30.68 71.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.547 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 39.6 ttp -70.75 -57.93 4.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.482 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -49.19 -33.68 12.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.45 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' HB3' ' B' ' 128' ' ' ALA . 11.7 mt -73.5 -51.55 16.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.852 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.711 ' HG ' HH22 ' A' ' 31' ' ' ARG . 52.4 m -67.76 -17.87 64.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.949 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CZ ' ' NH2' ' B' ' 104' ' ' ARG . 29.4 m-85 -152.62 109.52 2.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.052 -1.03 . . . . 0.0 109.499 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' THR . 72.4 Cg_endo -80.53 -27.21 3.49 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.331 2.02 . . . . 0.0 112.092 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' D' ' 97' ' ' HIS . 21.1 p -47.45 -18.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 109.447 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' PRO . 55.9 p -81.6 -22.74 37.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -64.71 -39.61 93.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 109.642 -179.77 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.465 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.592 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -151.0 68.01 0.93 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' SER . 1.5 m-20 -48.35 -18.3 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 109.631 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.592 ' CD1' ' O ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER 46.4 21.33 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.24 -0.912 . . . . 0.0 109.638 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.526 ' C ' ' HD1' ' A' ' 50' ' ' HIS . 5.2 m -75.31 18.68 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -0.94 . . . . 0.0 109.404 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.526 ' HD1' ' C ' ' A' ' 49' ' ' SER . 2.5 m80 57.51 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.615 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.03 10.5 83.83 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 54' ' ' GLN . 3.2 p -54.48 -12.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -1.104 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 71.0 -16.79 0.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.381 -0.825 . . . . 0.0 109.736 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.522 ' H ' ' C ' ' A' ' 52' ' ' SER . 5.1 pt20 -81.65 -28.87 33.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.2 t -73.52 -38.44 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.61 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.509 ' CD ' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.63 -22.83 46.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.083 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . . . -81.13 -23.89 58.36 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.47 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.7 t-80 -78.47 -38.57 40.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -1.171 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.72 -48.95 49.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 53.7 mttm -51.61 -23.45 4.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -1.121 . . . . 0.0 109.948 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 57' ' ' GLY . 0.5 OUTLIER -72.18 -42.46 65.83 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.127 -0.983 . . . . 0.0 109.024 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 t -69.85 -48.44 63.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.486 -0.758 . . . . 0.0 108.977 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.47 -28.57 69.31 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.384 -0.822 . . . . 0.0 109.275 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 30.4 m-20 -70.23 -36.49 74.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 0.0 108.872 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.68 47.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.402 -0.811 . . . . 0.0 108.964 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.01 -42.12 84.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.261 -0.899 . . . . 0.0 108.674 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' ALA . 25.8 m -67.59 -51.6 48.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.362 -0.836 . . . . 0.0 108.881 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.518 HD22 ' CB ' ' A' ' 79' ' ' ALA . 9.4 t30 -60.49 -29.31 68.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 108.781 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -82.98 -46.49 12.83 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.19 -22.4 29.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -66.1 -24.21 66.65 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.205 0.526 . . . . 0.0 109.711 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.584 ' O ' ' N ' ' A' ' 74' ' ' ASP . 11.8 m80 -137.27 -47.8 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.0 p 45.06 13.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.665 0.745 . . . . 0.0 109.378 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 72' ' ' HIS . 26.2 t70 -135.76 11.37 3.41 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -173.72 28.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.043 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.704 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -77.96 -24.91 0.46 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 0.0 111.399 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 76' ' ' MET . 41.8 Cg_exo -56.52 -24.61 54.2 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.791 1.661 . . . . 0.0 112.324 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -89.38 -29.19 19.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.932 . . . . 0.0 109.65 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' CB ' HD22 ' A' ' 68' ' ' ASN . . . -77.05 -43.2 35.4 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.127 -0.983 . . . . 0.0 109.127 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.5 8.7 13.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.432 -0.792 . . . . 0.0 108.952 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 77' ' ' PRO . 5.5 m -63.52 -23.18 67.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 109.562 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -76.35 -55.3 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.614 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.62 -46.81 19.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 135' ' ' VAL . 5.0 m -56.8 -25.43 55.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.435 -0.79 . . . . 0.0 109.246 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' ALA . 11.6 t70 -81.02 -35.02 32.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.382 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tt -72.06 -26.95 62.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 109.198 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 90' ' ' LYS . 68.4 m80 -82.67 -31.49 28.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 109.472 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.14 -42.65 15.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.495 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -78.13 -18.84 55.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.535 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' HIS . 46.7 mttm -146.08 179.81 7.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 93' ' ' VAL . 12.6 mt 59.09 58.4 3.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -53.84 -6.88 0.1 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 109.336 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.531 ' H ' ' C ' ' A' ' 91' ' ' LEU . 11.5 p -54.59 137.94 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.49 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.741 ' HB2' ' OD2' ' D' ' 99' ' ' ASP . 0.7 OUTLIER -77.27 157.92 80.11 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.086 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASN . 9.9 Cg_endo -54.72 -10.47 2.53 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.721 2.281 . . . . 0.0 111.882 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.638 HG23 ' CG ' ' D' ' 99' ' ' ASP . 85.3 t -42.98 -22.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 109.775 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 95' ' ' PRO . 3.1 m120 -79.07 -41.26 29.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.205 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 95' ' ' PRO . 31.7 t80 -48.62 -25.72 1.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.165 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -70.62 -30.32 66.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.208 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.6 mt -84.08 -61.34 1.84 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 0.0 109.642 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.49 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 4.6 tt -49.23 -23.51 1.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.671 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.8 m -72.81 -44.05 61.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.059 -1.025 . . . . 0.0 109.759 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.509 ' CD2' ' OD1' ' B' ' 108' ' ' ASN . 41.3 t-80 -80.55 -26.63 37.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.783 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.655 ' SG ' ' N ' ' A' ' 105' ' ' LEU . 11.2 p -58.04 -48.14 80.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.717 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.655 ' N ' ' SG ' ' A' ' 104' ' ' CYS . 2.5 mt -46.31 -39.14 9.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 3.7 mm? -68.8 -30.28 68.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.607 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 104' ' ' CYS . 86.0 t -75.12 -51.5 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 110' ' ' ALA . 27.8 m -60.05 -59.66 5.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 114' ' ' PRO . 12.3 mt -46.37 -18.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.457 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -69.66 -42.55 74.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.258 -0.902 . . . . 0.0 110.406 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.19 -3.67 43.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.132 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -129.73 -81.72 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 109.693 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -119.17 82.15 22.17 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 113' ' ' LEU . 53.6 Cg_exo -48.76 -169.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.51 2.14 . . . . 0.0 112.524 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.67 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -51.0 -56.21 13.61 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.556 -0.715 . . . . 0.0 109.302 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.67 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 3.0 mm-40 122.63 -8.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.497 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 5.6 t80 80.34 34.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 122.01 -0.431 . . . . 0.0 111.199 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -113.43 120.22 40.24 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.25 16.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.331 2.021 . . . . 0.0 112.87 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -140.98 -34.61 0.5 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.016 -1.052 . . . . 0.0 110.106 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 9.4 p -51.79 -47.28 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.14 -0.975 . . . . 0.0 109.994 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.514 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -60.19 -39.9 88.16 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.331 -0.856 . . . . 0.0 109.283 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.39 -19.99 32.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.824 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.543 ' HG ' ' H ' ' A' ' 125' ' ' LEU . 24.2 p -61.83 -62.39 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 110.3 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.543 ' H ' ' HG ' ' A' ' 124' ' ' SER . 1.3 mt -68.2 -19.53 64.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.172 -0.955 . . . . 0.0 109.513 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.05 -45.54 13.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.974 . . . . 0.0 109.854 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -87.19 -41.48 13.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.155 -0.965 . . . . 0.0 109.883 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 37.1 t80 -50.14 -20.84 1.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.966 -1.084 . . . . 0.0 108.854 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 133' ' ' SER . 19.4 mt -70.56 -17.91 62.92 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -59.7 -31.64 69.77 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.469 ' H ' ' HG ' ' A' ' 131' ' ' SER . 0.8 OUTLIER -81.72 -34.05 30.75 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.362 -0.836 . . . . 0.0 108.902 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.0 t -83.8 -29.21 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.336 -0.852 . . . . 0.0 108.91 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 129' ' ' LEU . 23.3 t -80.3 -25.44 39.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.403 -0.811 . . . . 0.0 109.132 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 m -75.37 -39.67 58.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.264 -0.897 . . . . 0.0 109.215 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 84' ' ' SER . 28.9 m -75.04 -22.09 16.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.255 -0.903 . . . . 0.0 108.965 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.91 -35.13 72.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 109.02 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 83.6 m -87.21 -29.85 21.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.561 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.47 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 1.5 t60 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.248 0.546 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.663 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -138.46 -162.94 1.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.331 -0.856 . . . . 0.0 109.071 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.54 153.32 61.58 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 108.866 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.92 -26.32 66.86 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.491 2.127 . . . . 0.0 112.197 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.2 -27.86 22.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.973 . . . . 0.0 109.793 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -84.14 -48.1 10.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.023 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.466 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.8 OUTLIER -68.78 -43.42 75.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.55 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -56.58 -23.58 41.57 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 110.059 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.54 -57.61 3.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.021 -1.05 . . . . 0.0 110.044 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.95 -24.33 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 47.1 m -80.88 -36.97 30.59 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.687 -0.633 . . . . 0.0 109.779 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 -22.38 63.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.927 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 16' ' ' GLY . 1.7 mt -59.82 -28.05 67.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.0 109.335 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . 0.608 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.5 OUTLIER -47.57 -17.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.933 . . . . 0.0 109.178 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -76.88 -36.15 37.31 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.445 ' O ' ' CE2' ' B' ' 118' ' ' PHE . 3.3 mmtt -89.33 -35.82 15.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -1.148 . . . . 0.0 109.281 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.1 t -47.92 114.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.659 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' B' ' 21' ' ' ASP . 83.6 m-20 -77.86 65.82 3.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.327 -0.858 . . . . 0.0 108.933 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -44.6 -17.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.385 -0.822 . . . . 0.0 109.682 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' B' ' 19' ' ' ASN . 13.3 m-20 -78.8 6.76 8.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.232 -0.917 . . . . 0.0 109.539 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' B' ' 19' ' ' ASN . 58.2 mt-10 -155.65 -46.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.538 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' B' ' 27' ' ' ALA . 85.8 t -47.74 -42.24 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.621 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.81 -43.33 96.62 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.9 -39.08 25.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -76.25 -25.82 55.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -1.175 . . . . 0.0 109.561 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' B' ' 23' ' ' VAL . . . -75.54 -34.1 60.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.937 . . . . 0.0 109.515 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tp -82.91 -52.35 6.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.451 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.68 -26.68 17.31 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -77.86 -31.44 51.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.131 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 32.6 tp -49.04 -34.56 13.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.355 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.9 mt -80.39 -22.03 41.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -82.51 -64.22 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.627 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.01 -22.9 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.888 . . . . 0.0 109.659 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -152.16 88.47 4.1 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 109.465 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.94 12.98 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.543 2.162 . . . . 0.0 112.227 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . 0.592 ' CZ2' ' ND2' ' B' ' 102' ' ' ASN . 0.7 OUTLIER -71.91 -19.92 61.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.525 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.444 ' N ' ' CD1' ' B' ' 37' ' ' TRP . 1.3 p -84.14 50.99 1.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.977 . . . . 0.0 109.27 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 38.5 tt0 -92.14 31.23 1.3 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -87.88 -42.84 12.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.674 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -93.18 14.32 18.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 109.578 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' B' ' 43' ' ' GLU . 1.6 p90 -68.21 -34.19 75.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.608 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.543 ' N ' ' CD1' ' B' ' 42' ' ' PHE . 12.0 pt-20 -53.28 -17.4 1.75 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.607 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 60.9 m -85.55 -34.73 21.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.583 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 47' ' ' ASP . 10.0 m-85 -51.04 -20.92 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.96 12.42 0.15 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' B' ' 45' ' ' PHE . 15.1 m-20 -160.64 110.52 1.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.151 . . . . 0.0 109.448 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tp -158.67 20.6 0.22 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.255 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.1 m -46.78 -41.1 14.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 109.646 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' THR . . . . . 0.428 ' OG1' ' OD1' ' B' ' 52' ' ' ASP . 4.7 p -146.6 150.33 39.79 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.851 . . . . 0.0 109.216 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -41.15 -43.65 5.19 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.444 2.096 . . . . 0.0 112.354 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.428 ' OD1' ' OG1' ' B' ' 50' ' ' THR . 1.7 p-10 -64.13 -31.01 72.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.534 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.92 -19.86 20.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.93 . . . . 0.0 109.42 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.43 -61.32 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -0.901 . . . . 0.0 109.573 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' B' ' 55' ' ' MET . 5.5 mmt -70.98 -0.51 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.77 31.08 7.17 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -143.09 137.06 14.51 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.26 -1.141 . . . . 0.0 109.31 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.11 -30.88 5.27 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.489 2.126 . . . . 0.0 112.26 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -21.1 59.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 109.777 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 69.8 t -75.82 -41.52 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.523 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -78.31 -25.26 46.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.57 71.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.62 -23.82 67.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.32 -50.31 22.17 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -49.51 -30.92 9.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.173 -1.192 . . . . 0.0 109.534 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -65.45 -53.74 38.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.583 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 28.2 t -58.96 -36.94 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.57 -48.37 72.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.97 -41.05 10.31 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.05 -43.45 91.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.608 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.4 -47.31 86.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' SER . . . . . 0.608 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 19.2 m -62.44 -42.03 99.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 109.622 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -48.37 -34.79 11.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.416 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.68 -60.48 6.91 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.443 HD11 ' H ' ' B' ' 75' ' ' LEU . 4.6 mp -54.04 -22.09 9.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.248 -1.148 . . . . 0.0 109.35 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.16 2.68 56.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -170.27 66.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.68 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.27 15.27 2.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.34 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.85 -23.21 60.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.46 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 37.1 t-20 -167.2 108.09 0.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 0.0 109.593 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mt -80.35 -51.53 8.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -67.12 -23.97 65.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.812 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -78.7 -39.11 22.2 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.9 t -85.1 -47.43 10.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.153 -1.204 . . . . 0.0 109.715 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.557 ' N ' ' CG2' ' B' ' 84' ' ' THR . 40.5 m-85 -84.67 26.92 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.539 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.32 72.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 109.633 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 50.9 p -75.81 -53.82 7.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.752 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -48.13 -43.05 30.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' B' ' 140' ' ' ALA . 2.9 m -66.89 -48.35 68.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.849 . . . . 0.0 109.668 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -67.39 -22.64 65.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 109.734 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.71 -68.37 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.078 -1.013 . . . . 0.0 109.566 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.576 ' NE2' ' O ' ' B' ' 141' ' ' LEU . 1.1 p-80 -54.38 -20.67 7.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.974 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . 0.429 ' N ' ' ND1' ' B' ' 92' ' ' HIS . 41.4 t -83.51 -59.6 2.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 110.858 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.31 -56.44 3.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.067 -1.021 . . . . 0.0 111.379 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -57.71 -51.74 68.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 110.579 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.614 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 12.1 mt -97.32 -64.52 1.03 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.002 -1.062 . . . . 0.0 109.95 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.717 ' HB2' ' HB ' ' C' ' 38' ' ' THR . 0.0 OUTLIER 91.2 25.12 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.308 0.575 . . . . 0.0 109.865 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 17.5 t -46.74 140.86 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.103 -0.998 . . . . 0.0 109.493 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 0.667 ' OD2' ' HB2' ' C' ' 94' ' ' ASP . 96.0 m-20 -54.0 149.41 18.05 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.363 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.9 36.46 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.478 2.119 . . . . 0.0 112.143 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -145.07 45.57 1.34 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.179 -0.95 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.592 ' ND2' ' CZ2' ' B' ' 37' ' ' TRP . 4.4 m120 -143.74 5.96 1.39 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.1 m-85 -89.74 -69.68 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 109.454 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . 0.574 ' NH2' ' CZ ' ' A' ' 36' ' ' PHE . 43.9 ttt180 -54.94 -20.88 9.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.54 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 tp -75.31 -31.13 60.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tt -68.19 -55.39 12.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.63 -20.55 39.41 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . 0.509 ' OD1' ' CD2' ' A' ' 103' ' ' HIS . 61.8 t30 -60.09 -34.78 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -1.159 . . . . 0.0 109.684 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.53 -24.12 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 109.593 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.73 -36.4 82.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 109.501 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.447 ' CG1' ' CD1' ' B' ' 130' ' ' TYR . 4.4 m -74.91 -26.04 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.239 -0.913 . . . . 0.0 109.662 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.469 ' SG ' ' CE1' ' A' ' 122' ' ' HIS . 17.0 t -66.79 -63.4 1.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 109.612 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 t -49.14 -21.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 109.539 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.9 -57.03 4.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.66 -27.32 49.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.836 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.494 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.71 -60.25 2.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.052 -1.03 . . . . 0.0 109.443 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -62.3 -17.49 58.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.692 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.445 ' CE2' ' O ' ' B' ' 17' ' ' LYS . 65.5 m-85 -150.05 60.5 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 109.703 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 121' ' ' GLU . . . -66.52 -45.26 86.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -47.39 -19.86 0.19 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -1.172 . . . . 0.0 109.289 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' B' ' 119' ' ' GLY . 70.1 mm-40 -94.77 -26.82 16.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.642 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.478 ' CD1' ' C ' ' B' ' 122' ' ' PHE . 0.7 OUTLIER -48.54 120.82 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.355 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.431 ' HG1' ' CG2' ' B' ' 126' ' ' VAL . 9.6 p -149.15 149.31 29.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 108.896 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.438 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 2.5 Cg_endo -46.15 -58.1 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.327 2.018 . . . . 0.0 113.177 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 19.5 Cg_endo -59.76 -11.1 13.53 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.174 1.916 . . . . 0.0 112.51 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.431 ' CG2' ' HG1' ' B' ' 123' ' ' THR . 53.5 t -94.81 -53.12 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 109.907 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . 0.515 ' O ' ' NE2' ' B' ' 131' ' ' GLN . 41.1 mm-40 -61.34 -59.88 4.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 109.489 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 34' ' ' LEU . . . -51.16 -37.43 46.27 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.484 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.24 18.53 2.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.447 ' CD1' ' CG1' ' B' ' 111' ' ' VAL . 15.2 t80 -109.56 -61.71 1.6 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.229 -0.92 . . . . 0.0 109.688 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . 0.596 ' H ' ' NE2' ' B' ' 131' ' ' GLN . 4.1 mp0 -48.43 -24.09 1.15 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.0 -1.063 . . . . 0.0 109.726 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.439 ' HG3' ' CD2' ' D' ' 146' ' ' HIS . 35.8 ttpt -85.73 -37.38 19.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 0.0 110.169 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 0.4 OUTLIER -60.76 -44.36 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.859 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.477 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 7.0 m -83.56 -16.97 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 0.0 109.935 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.96 -25.15 1.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 0.0 109.404 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.95 -23.9 56.48 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' B' ' 134' ' ' VAL . 42.7 t -79.6 -31.78 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -1.164 . . . . 0.0 109.429 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.54 -50.79 57.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' B' ' 142' ' ' ALA . 57.3 t30 -67.07 -32.31 73.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.427 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . 0.425 ' O ' ' OG ' ' B' ' 89' ' ' SER . . . -48.7 -42.27 34.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.291 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.576 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 38.4 mt -84.17 18.37 2.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.376 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 139' ' ' ASN . . . -128.39 -31.08 2.32 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.536 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -46.37 -41.87 14.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 109.285 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' B' ' 146' ' ' HIS . 35.7 mmtt -75.46 -54.43 7.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.037 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.497 ' O ' ' CG ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -57.43 -6.19 0.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.545 -0.722 . . . . 0.0 109.241 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.474 ' H ' ' C ' ' B' ' 144' ' ' LYS . 11.8 m-70 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.79 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 7.7 mp -108.21 -165.41 1.04 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.359 -0.838 . . . . 0.0 109.269 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.478 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 179.02 -49.6 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.018 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' C' ' 6' ' ' ASP . 74.3 Cg_exo -47.17 170.88 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.398 2.065 . . . . 0.0 112.521 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.73 -16.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 109.828 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' C' ' 4' ' ' PRO . 3.1 p30 -39.61 -33.35 0.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.765 . . . . 0.0 109.799 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' C' ' 10' ' ' VAL . 9.6 ptpt -83.1 -46.57 12.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.893 . . . . 0.0 109.431 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.407 ' C ' ' O ' ' C' ' 7' ' ' LYS . 49.6 m -45.48 -31.12 1.62 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.419 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -78.23 -36.81 46.6 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' C' ' 7' ' ' LYS . 71.8 t -70.49 -49.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -51.07 -47.33 61.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.45 -56.02 26.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.405 -0.81 . . . . 0.0 109.294 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.65 -37.3 70.58 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.285 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -17.48 61.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.156 -0.965 . . . . 0.0 108.907 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.6 -44.09 17.04 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt -70.22 -43.29 70.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -1.119 . . . . 0.0 108.56 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.22 -63.89 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.606 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 44.24 -125.44 5.84 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.41 22.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.349 -1.089 . . . . 0.0 110.449 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.606 ' H ' ' C ' ' C' ' 18' ' ' GLY . 78.9 m-70 -129.08 26.07 5.5 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.52 -64.37 1.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.68 -0.638 . . . . 0.0 109.811 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.37 -14.28 0.18 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 21' ' ' ALA . 2.1 mm-40 -84.01 -56.52 3.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -1.055 . . . . 0.0 109.671 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -60.53 -35.7 76.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.165 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.84 -22.92 68.83 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.51 -41.71 31.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -1.121 . . . . 0.0 109.683 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.51 -19.79 62.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 108.947 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.428 ' CB ' ' SG ' ' C' ' 104' ' ' CYS . . . -72.89 -21.84 60.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.109 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 11.2 mt -72.57 -53.57 11.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 109.635 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.19 -27.01 69.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.484 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.692 HH22 ' HG ' ' C' ' 35' ' ' SER . 0.9 OUTLIER -63.81 -30.81 71.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 39.5 ttp -70.79 -57.98 4.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.405 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 0.3 OUTLIER -49.2 -33.63 12.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.468 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' D' ' 128' ' ' ALA . 11.8 mt -73.44 -51.57 16.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 109.856 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.692 ' HG ' HH22 ' C' ' 31' ' ' ARG . 53.3 m -67.92 -17.73 64.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.938 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.568 ' CZ ' ' NH2' ' D' ' 104' ' ' ARG . 29.2 m-85 -152.64 109.51 2.74 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.972 . . . . 0.0 109.546 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' C' ' 39' ' ' THR . 72.1 Cg_endo -80.43 -27.29 3.53 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.388 2.058 . . . . 0.0 112.16 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' THR . . . . . 0.717 ' HB ' ' HB2' ' B' ' 97' ' ' HIS . 22.0 p -47.37 -18.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.863 . . . . 0.0 109.581 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.438 ' N ' ' O ' ' C' ' 37' ' ' PRO . 55.9 p -81.56 -22.74 37.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' C' ' 37' ' ' PRO . 1.8 tpmt? -64.68 -39.59 93.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.878 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 0.0 109.616 -179.684 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.476 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' C' ' 48' ' ' LEU . 0.3 OUTLIER -150.99 68.1 0.93 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' C' ' 49' ' ' SER . 1.5 m-20 -48.42 -18.31 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.07 -1.019 . . . . 0.0 109.613 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.582 ' CD1' ' O ' ' C' ' 46' ' ' PHE . 0.9 OUTLIER 46.56 21.19 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.211 -0.93 . . . . 0.0 109.536 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.53 ' C ' ' HD1' ' C' ' 50' ' ' HIS . 5.2 m -75.31 18.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.53 ' HD1' ' C ' ' C' ' 49' ' ' SER . 2.4 m80 57.53 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 109.661 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.02 10.5 83.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.514 ' C ' ' H ' ' C' ' 54' ' ' GLN . 3.2 p -54.43 -12.71 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 71.13 -16.87 0.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.382 -0.824 . . . . 0.0 109.729 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' C' ' 52' ' ' SER . 5.1 pt20 -81.57 -28.85 33.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.959 . . . . 0.0 109.684 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 22.4 t -73.54 -38.43 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.525 ' CD ' ' H ' ' C' ' 56' ' ' LYS . 0.0 OUTLIER -78.71 -22.75 46.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.395 -0.816 . . . . 0.0 109.011 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . 0.495 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -81.2 -23.81 58.35 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.471 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.7 t-80 -78.6 -38.45 39.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -1.147 . . . . 0.0 109.506 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.79 -48.85 49.73 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.41 ' O ' ' CG ' ' C' ' 64' ' ' ASP . 53.7 mttm -51.8 -23.28 4.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.36 -1.082 . . . . 0.0 109.924 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' C' ' 57' ' ' GLY . 0.5 OUTLIER -72.26 -42.39 65.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.116 -0.99 . . . . 0.0 109.054 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t -69.82 -48.51 63.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.46 -28.59 69.32 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . 0.41 ' CG ' ' O ' ' C' ' 60' ' ' LYS . 30.2 m-20 -70.23 -36.4 74.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 108.926 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.95 -52.74 47.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.476 -0.765 . . . . 0.0 108.968 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' C' ' 70' ' ' VAL . 11.3 mt -58.03 -42.16 84.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 108.665 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.48 ' O ' ' N ' ' C' ' 71' ' ' ALA . 26.1 m -67.54 -51.55 49.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.245 -0.91 . . . . 0.0 108.998 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.529 HD22 ' CB ' ' C' ' 79' ' ' ALA . 9.4 t30 -60.46 -29.34 68.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 108.744 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -82.95 -46.54 12.8 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' C' ' 66' ' ' LEU . 48.6 t -67.16 -22.38 29.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -66.07 -24.26 66.68 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.658 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' C' ' 74' ' ' ASP . 11.8 m80 -137.27 -47.86 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.754 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' C' ' 69' ' ' ALA . 10.9 p 45.09 13.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.802 0.81 . . . . 0.0 109.411 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' C' ' 72' ' ' HIS . 26.3 t70 -135.71 11.46 3.42 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -173.77 28.26 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.007 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.712 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -77.94 -25.02 0.46 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.489 -0.757 . . . . 0.0 111.414 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' C' ' 76' ' ' MET . 41.9 Cg_exo -56.37 -24.7 53.3 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.851 1.701 . . . . 0.0 112.363 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -89.39 -29.21 19.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . 0.529 ' CB ' HD22 ' C' ' 68' ' ' ASN . . . -77.0 -43.2 35.69 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.143 -0.973 . . . . 0.0 109.068 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.5 8.7 13.19 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.358 -0.839 . . . . 0.0 108.962 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.6 m -63.43 -23.39 67.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.551 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -76.24 -55.33 5.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.629 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.59 -46.8 19.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.818 . . . . 0.0 108.861 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' C' ' 135' ' ' VAL . 5.0 m -56.91 -25.33 57.08 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.404 -0.81 . . . . 0.0 109.25 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' C' ' 82' ' ' ALA . 11.6 t70 -81.02 -35.06 32.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.91 -27.04 62.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.25 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . 0.439 ' O ' ' O ' ' C' ' 90' ' ' LYS . 68.2 m80 -82.74 -31.36 28.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.17 -42.64 15.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -78.16 -18.79 55.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.854 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' C' ' 87' ' ' HIS . 46.8 mttm -146.06 179.81 7.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.898 . . . . 0.0 109.511 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' C' ' 93' ' ' VAL . 12.5 mt 59.08 58.54 3.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.456 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -53.99 -6.82 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.248 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' C' ' 91' ' ' LEU . 11.5 p -54.64 137.89 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.667 ' HB2' ' OD2' ' B' ' 99' ' ' ASP . 0.7 OUTLIER -77.24 157.89 80.23 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.086 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' C' ' 97' ' ' ASN . 10.0 Cg_endo -54.74 -10.34 2.46 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.627 2.218 . . . . 0.0 111.953 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . 0.598 HG23 ' CG ' ' B' ' 99' ' ' ASP . 85.4 t -43.09 -22.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -0.819 . . . . 0.0 109.743 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' C' ' 95' ' ' PRO . 3.1 m120 -79.15 -41.16 29.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.959 . . . . 0.0 109.206 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' C' ' 95' ' ' PRO . 31.9 t80 -48.59 -25.68 1.85 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 109.249 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -70.65 -30.37 66.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.18 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' C' ' 97' ' ' ASN . 20.4 mt -84.07 -61.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 109.63 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 4.6 tt -49.15 -23.55 1.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.744 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 34.5 m -72.87 -43.91 61.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.798 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . 0.514 ' CD2' ' OD1' ' D' ' 108' ' ' ASN . 41.3 t-80 -80.58 -26.69 37.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 109.732 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.655 ' SG ' ' N ' ' C' ' 105' ' ' LEU . 11.1 p -57.98 -48.09 81.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.768 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.655 ' N ' ' SG ' ' C' ' 104' ' ' CYS . 2.5 mt -46.46 -39.12 10.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.393 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.546 ' N ' ' CD2' ' C' ' 106' ' ' LEU . 3.7 mm? -68.72 -30.37 68.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.603 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.04 -51.43 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.459 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.464 ' O ' ' N ' ' C' ' 110' ' ' ALA . 27.1 m -60.12 -59.63 5.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.244 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' C' ' 114' ' ' PRO . 12.4 mt -46.29 -18.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' C' ' 108' ' ' THR . . . -69.66 -42.56 74.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.0 110.368 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.15 -3.63 43.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.0 110.17 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -129.72 -81.83 0.56 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 109.622 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.4 OUTLIER -119.17 82.2 22.28 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 53.3 Cg_exo -48.79 -169.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.427 2.085 . . . . 0.0 112.604 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.658 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -50.89 -56.27 13.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.491 -0.756 . . . . 0.0 109.289 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.658 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 3.0 mm-40 122.66 -8.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 0.503 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 5.6 t80 80.26 34.95 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.935 -0.478 . . . . 0.0 111.212 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.739 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -113.45 120.26 40.13 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -48.3 16.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.242 1.961 . . . . 0.0 112.992 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -140.93 -34.73 0.49 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.049 -1.032 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.519 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 9.4 p -51.75 -47.18 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.519 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 0.1 OUTLIER -60.34 -39.81 88.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.26 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.44 -20.03 32.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.344 -0.847 . . . . 0.0 109.785 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.548 ' HG ' ' H ' ' C' ' 125' ' ' LEU . 24.3 p -61.83 -62.42 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 110.283 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.548 ' H ' ' HG ' ' C' ' 124' ' ' SER . 1.3 mt -68.14 -19.51 64.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 0.0 109.544 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -83.13 -45.46 13.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 109.841 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.422 ' HG3' ' H ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -87.31 -41.36 13.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.974 . . . . 0.0 109.84 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.462 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 37.1 t80 -50.22 -20.83 1.13 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.879 -1.138 . . . . 0.0 108.81 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' C' ' 133' ' ' SER . 19.2 mt -70.57 -17.92 62.91 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -59.64 -31.69 69.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' SER . . . . . 0.435 ' H ' ' HG ' ' C' ' 131' ' ' SER . 0.8 OUTLIER -81.79 -33.94 30.59 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.429 -0.795 . . . . 0.0 108.933 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 26.4 t -83.85 -29.16 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.334 -0.854 . . . . 0.0 108.927 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.536 ' N ' ' O ' ' C' ' 129' ' ' LEU . 23.3 t -80.37 -25.39 39.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.393 -0.817 . . . . 0.0 109.109 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 44.9 m -75.35 -39.69 59.04 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . 0.416 ' O ' ' OG ' ' C' ' 84' ' ' SER . 28.8 m -75.07 -22.12 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 108.887 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.95 -35.03 72.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.041 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 82.3 m -87.38 -29.79 21.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 109.434 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 1.5 t60 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.314 0.578 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.662 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -138.39 -162.92 1.37 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.331 -0.856 . . . . 0.0 109.068 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.53 153.2 61.52 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 108.939 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.71 -26.39 68.49 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.498 2.132 . . . . 0.0 112.3 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.15 -27.86 22.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.862 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -84.07 -48.06 10.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.095 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.455 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.8 OUTLIER -68.84 -43.39 75.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.149 -0.969 . . . . 0.0 109.52 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -56.65 -23.58 42.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.173 -0.955 . . . . 0.0 110.026 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.57 -57.63 3.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.98 -1.075 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.02 -24.32 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 46.1 m -80.89 -36.96 30.54 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.723 -0.611 . . . . 0.0 109.782 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.81 -22.3 63.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.941 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' D' ' 16' ' ' GLY . 1.8 mt -59.85 -28.1 67.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.11 -0.994 . . . . 0.0 109.379 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . 0.622 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.5 OUTLIER -47.53 -17.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.198 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -76.83 -36.13 37.68 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.454 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 3.2 mmtt -89.36 -35.8 15.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -1.196 . . . . 0.0 109.298 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -47.94 114.95 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.32 -0.863 . . . . 0.0 109.668 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' D' ' 21' ' ' ASP . 83.5 m-20 -77.91 65.78 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 0.0 108.85 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 71.5 t -44.55 -17.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' D' ' 19' ' ' ASN . 13.4 m-20 -78.84 6.74 8.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' D' ' 19' ' ' ASN . 58.1 mt-10 -155.58 -46.94 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' D' ' 27' ' ' ALA . 85.9 t -47.8 -42.22 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.629 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.76 -43.42 96.46 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.85 -39.18 25.21 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -76.21 -25.78 55.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -1.151 . . . . 0.0 109.557 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' D' ' 23' ' ' VAL . . . -75.6 -34.02 60.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.477 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tp -82.96 -52.38 6.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.426 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.66 -26.71 17.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -77.91 -31.34 51.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 0.0 109.447 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 32.5 tp -48.99 -34.61 13.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.352 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 29.1 mt -80.44 -21.97 41.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 23.8 t -82.54 -64.27 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.05 -22.86 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 109.639 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -152.17 88.57 4.08 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.479 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.89 12.84 2.51 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.621 2.214 . . . . 0.0 112.251 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . 0.601 ' CZ2' ' ND2' ' D' ' 102' ' ' ASN . 0.7 OUTLIER -71.8 -20.01 61.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 109.546 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.448 ' N ' ' CD1' ' D' ' 37' ' ' TRP . 1.3 p -84.09 51.06 1.97 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 109.273 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . 0.434 ' O ' ' CD1' ' D' ' 42' ' ' PHE . 38.6 tt0 -92.2 31.15 1.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.252 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -87.85 -42.92 12.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.589 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -93.1 14.3 18.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 109.551 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' D' ' 43' ' ' GLU . 1.6 p90 -68.28 -34.13 75.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.595 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . 0.54 ' N ' ' CD1' ' D' ' 42' ' ' PHE . 11.9 pt-20 -53.31 -17.4 1.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.543 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 60.8 m -85.56 -34.7 21.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 109.59 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' D' ' 47' ' ' ASP . 10.1 m-85 -51.08 -20.95 1.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.358 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.98 12.44 0.15 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' D' ' 45' ' ' PHE . 15.1 m-20 -160.63 110.51 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -1.102 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tp -158.72 20.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.294 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 58.7 m -46.91 -41.03 15.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.642 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' D' ' 52' ' ' ASP . 4.8 p -146.57 150.37 40.02 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.359 -0.838 . . . . 0.0 109.217 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -41.16 -43.65 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.467 2.111 . . . . 0.0 112.382 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . 0.423 ' OD1' ' OG1' ' D' ' 50' ' ' THR . 1.7 p-10 -64.11 -31.09 72.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.152 -0.968 . . . . 0.0 109.447 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -56.94 -19.88 20.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 48.3 t -71.36 -61.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.571 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' D' ' 55' ' ' MET . 5.5 mmt -70.99 -0.48 9.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 0.0 109.443 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.72 30.92 7.32 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -142.94 137.02 14.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.211 -1.17 . . . . 0.0 109.385 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.04 -30.77 5.45 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.516 2.144 . . . . 0.0 112.336 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -21.07 59.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 109.739 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.92 -41.46 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.476 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -78.35 -25.35 46.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.57 71.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -62.61 -23.83 67.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.549 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.36 -50.23 22.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -49.57 -30.84 9.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -1.147 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -65.5 -53.68 38.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.899 . . . . 0.0 109.591 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 28.2 t -59.03 -36.92 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.413 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.51 -48.43 72.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 109.345 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.94 -41.08 10.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.28 91.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.167 . . . . 0.0 109.64 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -61.5 -47.27 86.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.612 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' SER . . . . . 0.622 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 19.4 m -62.56 -41.97 99.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.349 -0.844 . . . . 0.0 109.531 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -48.31 -34.85 11.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.44 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.71 -60.42 6.98 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.442 ' H ' HD11 ' D' ' 75' ' ' LEU . 4.6 mp -54.04 -22.1 9.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.157 . . . . 0.0 109.32 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.06 2.51 56.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.942 . . . . 0.0 109.626 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -170.19 66.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.26 15.25 2.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.348 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.82 -23.22 60.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 37.1 t-20 -167.2 108.11 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.582 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mt -80.31 -51.67 8.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 109.373 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -67.01 -24.13 65.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.707 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -78.6 -39.11 22.58 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.9 t -85.1 -47.44 10.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.15 -1.206 . . . . 0.0 109.696 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' D' ' 84' ' ' THR . 40.4 m-85 -84.72 27.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.486 -0.759 . . . . 0.0 109.519 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.28 -31.41 72.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.359 -0.838 . . . . 0.0 109.626 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 51.1 p -75.77 -53.84 7.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.715 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -48.12 -42.98 30.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' D' ' 140' ' ' ALA . 3.0 m -67.0 -48.33 68.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.574 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -67.35 -22.66 65.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.761 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.73 -68.36 0.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.124 -0.985 . . . . 0.0 109.567 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.577 ' NE2' ' O ' ' D' ' 141' ' ' LEU . 1.1 p-80 -54.44 -20.67 7.99 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.172 -0.955 . . . . 0.0 109.939 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . 0.426 ' N ' ' ND1' ' D' ' 92' ' ' HIS . 41.3 t -83.53 -59.57 2.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 110.818 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.36 -56.41 3.45 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.072 -1.018 . . . . 0.0 111.396 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -57.69 -51.73 68.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.095 -1.003 . . . . 0.0 110.599 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.615 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 12.2 mt -97.42 -64.32 1.05 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.081 -1.012 . . . . 0.0 109.94 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.766 ' HB2' ' HB ' ' A' ' 38' ' ' THR . 0.0 OUTLIER 91.03 25.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.297 0.57 . . . . 0.0 109.868 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 17.5 t -46.73 140.79 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.5 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . 0.741 ' OD2' ' HB2' ' A' ' 94' ' ' ASP . 96.0 m-20 -53.94 149.41 17.68 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.399 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.84 36.45 0.4 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.6 2.2 . . . . 0.0 112.119 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -145.12 45.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . 0.601 ' ND2' ' CZ2' ' D' ' 37' ' ' TRP . 4.4 m120 -143.8 5.95 1.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -0.843 . . . . 0.0 109.556 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 1.1 m-85 -89.73 -69.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 109.516 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . 0.568 ' NH2' ' CZ ' ' C' ' 36' ' ' PHE . 44.1 ttt180 -55.08 -20.88 10.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 tp -75.19 -31.14 60.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tt -68.29 -55.33 12.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.7 -20.45 39.5 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . 0.514 ' OD1' ' CD2' ' C' ' 103' ' ' HIS . 61.7 t30 -60.18 -34.78 74.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -1.094 . . . . 0.0 109.636 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 6.8 t -86.47 -24.15 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 109.599 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.64 -36.42 82.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 109.553 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . 0.438 ' CG1' ' CD1' ' D' ' 130' ' ' TYR . 4.4 m -74.99 -25.92 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.248 -0.908 . . . . 0.0 109.665 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . 0.47 ' SG ' ' CE1' ' C' ' 122' ' ' HIS . 16.9 t -66.84 -63.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.148 -0.97 . . . . 0.0 109.584 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 t -49.16 -21.59 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.506 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.91 -57.01 4.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.4 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -55.62 -27.37 49.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.892 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.489 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.75 -60.07 2.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.5 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -62.39 -17.55 59.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.611 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 65.7 m-85 -150.0 60.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.987 . . . . 0.0 109.675 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' D' ' 121' ' ' GLU . . . -66.53 -45.33 86.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -47.29 -19.88 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -1.181 . . . . 0.0 109.31 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' D' ' 119' ' ' GLY . 70.1 mm-40 -94.76 -26.78 16.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.652 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.475 ' CD1' ' C ' ' D' ' 122' ' ' PHE . 0.7 OUTLIER -48.67 120.86 4.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.348 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.421 ' HG1' ' CG2' ' D' ' 126' ' ' VAL . 9.7 p -149.12 149.32 29.4 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.009 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.427 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 2.5 Cg_endo -46.21 -58.01 1.9 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.366 2.044 . . . . 0.0 113.168 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 19.3 Cg_endo -59.84 -11.12 13.8 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.168 1.912 . . . . 0.0 112.474 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . 0.421 ' CG2' ' HG1' ' D' ' 123' ' ' THR . 53.6 t -94.8 -53.19 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.034 -1.041 . . . . 0.0 109.821 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . 0.517 ' O ' ' NE2' ' D' ' 131' ' ' GLN . 41.0 mm-40 -61.37 -59.73 4.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.503 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' C' ' 34' ' ' LEU . . . -51.3 -37.39 47.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.18 18.48 2.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.694 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . 0.438 ' CD1' ' CG1' ' D' ' 111' ' ' VAL . 15.1 t80 -109.5 -61.73 1.59 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -0.908 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . 0.602 ' NE2' ' H ' ' D' ' 131' ' ' GLN . 4.1 mp0 -48.46 -24.16 1.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.003 -1.061 . . . . 0.0 109.662 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -85.69 -37.38 19.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -0.888 . . . . 0.0 110.21 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 0.4 OUTLIER -60.88 -44.21 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.067 -1.021 . . . . 0.0 109.821 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.496 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 7.0 m -83.6 -16.94 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.2 -0.938 . . . . 0.0 109.877 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.99 -25.13 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.07 -1.019 . . . . 0.0 109.432 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.97 -23.94 56.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' D' ' 134' ' ' VAL . 42.4 t -79.49 -31.78 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -1.105 . . . . 0.0 109.522 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.57 -50.78 56.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.396 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' D' ' 142' ' ' ALA . 57.3 t30 -67.07 -32.27 73.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . 0.417 ' O ' ' OG ' ' D' ' 89' ' ' SER . . . -48.68 -42.42 34.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.95 . . . . 0.0 109.237 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . 0.577 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 38.3 mt -84.12 18.44 2.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.392 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' D' ' 139' ' ' ASN . . . -128.45 -31.03 2.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.163 -0.961 . . . . 0.0 109.556 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -46.33 -41.92 14.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 109.285 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.476 ' C ' ' H ' ' D' ' 146' ' ' HIS . 35.7 mmtt -75.41 -54.39 7.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.419 -0.801 . . . . 0.0 109.127 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . 0.467 ' O ' ' CG ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -57.42 -6.21 0.42 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.501 -0.75 . . . . 0.0 109.234 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.476 ' H ' ' C ' ' D' ' 144' ' ' LYS . 11.6 m-70 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.759 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 73.9 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.2 mt -144.7 178.82 7.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.995 . . . . 0.0 109.723 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.73 167.11 26.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.434 -0.791 . . . . 0.0 109.069 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.15 -43.72 2.98 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.599 2.199 . . . . 0.0 112.563 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.29 -19.35 33.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.977 -1.077 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -47.85 -37.14 13.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -43.59 19.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.869 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.0 m -51.15 -37.53 46.79 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.123 -0.986 . . . . 0.0 109.558 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -74.93 -31.96 61.64 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.36 -51.27 30.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -49.98 -47.44 52.81 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.9 -61.28 2.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.458 -0.776 . . . . 0.0 109.537 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.06 68.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.424 -0.797 . . . . 0.0 109.058 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -17.16 64.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.425 -0.797 . . . . 0.0 108.955 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.34 -44.96 15.69 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.2 mmmt -70.66 -40.66 72.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -1.166 . . . . 0.0 108.802 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.27 -64.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 46.1 -127.34 9.36 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 23.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -1.102 . . . . 0.0 110.569 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.612 ' H ' ' C ' ' A' ' 18' ' ' GLY . 86.0 m-70 -130.07 25.77 5.22 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -90.24 -63.8 1.23 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.693 -0.629 . . . . 0.0 109.754 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.77 -14.3 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.0 mm-40 -83.28 -56.51 3.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -1.076 . . . . 0.0 109.559 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.625 ' CD1' ' CD2' ' A' ' 112' ' ' HIS . 3.6 m-30 -62.07 -32.24 72.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.462 -0.773 . . . . 0.0 109.274 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.19 -23.4 77.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.08 -44.38 22.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -1.09 . . . . 0.0 109.587 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -61.1 -26.24 67.52 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -26.78 68.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.1 mt -72.51 -58.4 3.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.471 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -52.16 -38.91 59.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.866 ' HG3' HE22 ' B' ' 127' ' ' GLN . 0.9 OUTLIER -68.21 -50.58 53.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.299 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.469 ' C ' ' SD ' ' A' ' 32' ' ' MET . 15.2 tmm? -62.4 -29.15 70.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.351 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.69 -58.73 6.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 110.026 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' PHE . 2.4 pp -73.89 -39.62 63.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.2 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.524 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 50.8 m -46.71 -16.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.081 -1.012 . . . . 0.0 109.825 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 35' ' ' SER . 15.2 m-85 -159.37 89.64 1.99 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 0.0 109.362 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 40' ' ' LYS . 52.5 Cg_exo -52.77 -20.07 12.07 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.457 2.105 . . . . 0.0 112.095 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 p -49.08 -18.91 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.403 ' N ' ' C ' ' A' ' 37' ' ' PRO . 30.3 p -84.17 -22.92 30.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' PRO . 29.9 ttmt -55.5 -47.01 76.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.567 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.715 HG21 ' O ' ' D' ' 94' ' ' ASP . 5.1 t . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.8 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.598 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.19 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -145.53 31.24 1.09 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.506 -1.371 . . . . 0.0 110.078 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 49' ' ' SER . 1.1 m-20 52.84 91.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.872 . . . . 0.0 109.614 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.19 1.87 0.43 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.373 -0.83 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 47' ' ' ASP . 9.2 m -62.48 140.95 58.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.514 ' N ' ' HD1' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -63.72 140.34 58.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.448 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.21 12.13 81.23 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 54' ' ' GLN . 2.2 t -59.31 -20.58 55.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -1.174 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 72.61 -24.33 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -0.782 . . . . 0.0 109.61 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 52' ' ' SER . 33.5 mt-30 -80.31 -24.32 40.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.569 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.8 t -75.85 -35.14 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.17 -34.67 42.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.946 . . . . 0.0 108.901 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.19 -24.52 76.3 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.513 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 5.9 t-80 -68.15 -43.87 77.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.317 -1.108 . . . . 0.0 109.316 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.8 -46.97 25.19 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 48.5 mttm -54.6 -23.19 15.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.512 -0.993 . . . . 0.0 109.644 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -36.85 58.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.199 -0.938 . . . . 0.0 108.902 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -73.73 -47.39 44.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.64 -29.09 67.51 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.312 -0.868 . . . . 0.0 109.342 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 25.6 m-20 -66.79 -47.23 72.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.096 -1.002 . . . . 0.0 108.75 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -49.46 76.11 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mt -55.37 -46.03 76.5 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 71' ' ' ALA . 27.6 m -64.97 -55.55 18.43 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.301 -0.874 . . . . 0.0 108.749 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -55.9 -29.3 59.78 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.73 -48.12 12.06 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.17 -22.5 31.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -68.94 -16.48 63.76 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 74' ' ' ASP . 34.2 m170 -145.1 -56.9 0.33 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.306 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.4 p 44.94 13.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.665 0.745 . . . . 0.0 109.576 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 72' ' ' HIS . 99.2 m-20 -123.69 8.41 8.86 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -175.92 28.69 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.147 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 5.2 ptt? -78.09 -24.64 0.45 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 111.676 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 76' ' ' MET . 53.2 Cg_exo -54.83 -23.66 34.93 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.759 1.639 . . . . 0.0 112.195 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -93.32 -37.24 12.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.88 75.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.149 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.5 mt -81.74 8.79 9.15 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.325 -0.86 . . . . 0.0 109.048 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.0 t -56.11 -41.05 74.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.845 . . . . 0.0 109.618 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -56.22 -57.33 12.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.576 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mt -46.31 -46.69 18.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.376 -0.827 . . . . 0.0 108.819 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 135' ' ' VAL . 3.8 m -59.96 -29.64 68.56 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.476 -0.765 . . . . 0.0 109.289 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 89' ' ' HIS . 76.0 m-20 -81.52 -38.93 25.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 0.0 109.339 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 tt -59.18 -36.04 74.62 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.334 -0.853 . . . . 0.0 109.46 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -92.12 -23.07 19.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.949 . . . . 0.0 109.69 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.52 -9.49 29.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.238 -0.914 . . . . 0.0 109.922 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 85' ' ' ASP . 42.9 m80 -143.93 47.93 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -0.97 . . . . 0.0 109.698 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.13 -69.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 109.319 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 93' ' ' VAL . 11.7 mt -88.76 -23.84 22.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 51.65 10.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.565 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 91' ' ' LEU . 14.8 p -52.62 144.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.492 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 151.68 86.12 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.31 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 97' ' ' ASN . 47.6 Cg_endo -70.12 -20.98 32.45 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.558 2.172 . . . . 0.0 112.123 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.429 ' CG1' ' OD1' ' D' ' 99' ' ' ASP . 93.2 t -45.84 -15.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 109.756 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 95' ' ' PRO . 3.4 m120 -79.25 -24.88 42.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 109.577 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.495 ' CD1' ' C ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -69.1 -31.14 69.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.364 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -58.56 -29.94 66.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.512 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 17.6 mt -83.91 -62.18 1.63 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.581 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.1 tt -45.65 -24.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.597 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.7 t -65.22 -57.26 8.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.928 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -73.74 -26.5 60.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.981 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 9.5 m -70.32 -23.45 62.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.099 -1.001 . . . . 0.0 110.157 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.56 -22.87 40.37 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.937 -1.102 . . . . 0.0 108.926 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.99 -18.78 33.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.852 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.0 t -77.5 -50.33 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.411 ' HG1' ' H ' ' A' ' 109' ' ' LEU . 43.4 p -52.56 -51.91 57.46 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.161 -0.962 . . . . 0.0 109.678 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 113' ' ' LEU . 7.9 mt -43.74 -26.36 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.465 -0.772 . . . . 0.0 109.759 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -71.92 -25.65 61.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.924 . . . . 0.0 110.486 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.47 -3.79 54.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.106 -0.996 . . . . 0.0 110.902 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.625 ' CD2' ' CD1' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -150.15 -69.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.782 -1.199 . . . . 0.0 109.669 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -118.29 81.24 16.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.47 ' N ' ' O ' ' A' ' 109' ' ' LEU . 51.2 Cg_exo -49.32 -170.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.44 2.094 . . . . 0.0 112.589 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.649 ' O ' ' CG ' ' A' ' 116' ' ' GLU . . . -48.65 -55.63 10.75 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.649 ' CG ' ' O ' ' A' ' 115' ' ' ALA . 2.8 mm-40 130.5 0.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.1 t80 66.3 30.37 9.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.842 -0.536 . . . . 0.0 111.138 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.706 ' O ' ' N ' ' A' ' 120' ' ' ALA . 2.1 p -103.79 128.12 27.97 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 120.996 -1.065 . . . . 0.0 108.249 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.64 23.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.102 1.868 . . . . 0.0 112.923 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.706 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -157.03 -32.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 0.0 110.669 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.628 ' H ' ' HG1' ' A' ' 118' ' ' THR . 12.9 p -49.84 -47.24 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.13 -0.981 . . . . 0.0 110.299 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.509 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 2.4 t60 -61.74 -38.56 88.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.771 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.41 -20.12 34.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 109.95 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -62.36 1.52 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.95 . . . . 0.0 110.245 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.11 -19.81 66.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.071 -1.018 . . . . 0.0 109.467 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.17 -49.27 37.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.15 -42.1 11.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 109.635 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.517 ' N ' ' CD ' ' A' ' 127' ' ' LYS . 32.0 t80 -50.0 -22.92 1.75 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 109.255 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.453 ' C ' ' CD1' ' A' ' 129' ' ' LEU . 1.2 pp -76.37 -22.08 55.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.14 -38.1 75.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.6 m -67.92 -26.8 66.16 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.55 -37.67 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.8 t -80.06 -18.0 51.22 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.298 -0.876 . . . . 0.0 108.738 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.8 m -83.28 -42.44 17.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.468 -0.77 . . . . 0.0 109.208 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.415 ' O ' ' OG ' ' A' ' 84' ' ' SER . 27.3 m -70.06 -21.97 24.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.24 -0.913 . . . . 0.0 108.756 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.46 -31.8 72.22 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.1 m -153.27 57.1 0.77 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.689 ' H ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -107.63 -159.13 0.68 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.496 -0.752 . . . . 0.0 109.361 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 9.9 p -103.57 134.4 19.77 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.394 -0.816 . . . . 0.0 109.29 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.45 ' O ' ' OG ' ' B' ' 9' ' ' SER . 75.7 Cg_exo -42.1 -22.79 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.438 2.092 . . . . 0.0 112.467 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -76.62 -55.6 5.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 110.065 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -68.16 -60.45 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.961 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.52 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -48.74 -30.14 5.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 5' ' ' PRO . 2.9 m -62.05 -23.61 66.58 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.979 -1.075 . . . . 0.0 110.032 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.05 -57.68 3.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.886 -1.134 . . . . 0.0 109.958 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.55 -24.95 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 56.6 m -83.39 -37.36 23.4 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.453 0.644 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.19 -29.92 71.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.369 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.7 OUTLIER -52.16 -32.46 36.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.119 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . 0.643 ' HE1' ' HG ' ' B' ' 72' ' ' SER . 0.2 OUTLIER -47.15 -17.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.509 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.34 -52.02 5.81 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.48 -29.41 65.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -1.179 . . . . 0.0 109.263 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -48.72 114.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 22' ' ' GLU . 18.3 m120 -82.56 69.41 9.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 108.953 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.465 ' C ' ' H ' ' B' ' 22' ' ' GLU . 78.3 t -43.88 -29.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 0.0 109.72 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -64.69 1.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' B' ' 20' ' ' VAL . 33.0 mt-10 -155.89 -46.11 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 109.424 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -48.52 -53.96 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.41 -48.52 48.14 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.34 -46.35 79.09 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.44 -39.96 95.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.27 -1.136 . . . . 0.0 109.394 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.74 88.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.179 -0.95 . . . . 0.0 109.364 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -82.2 -51.22 8.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.309 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.91 -35.08 62.53 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -79.37 -30.65 42.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -1.158 . . . . 0.0 109.495 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 60.6 tp -49.42 -39.03 31.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.379 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.53 -23.45 56.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.583 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.79 -61.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.188 -0.945 . . . . 0.0 109.413 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.36 -23.82 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -136.73 76.09 48.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.64 11.49 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.725 2.283 . . . . 0.0 112.335 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -80.62 -19.71 44.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 109.341 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 42.0 p -79.77 40.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 109.36 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -92.16 12.84 20.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 0.0 109.55 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -87.86 -34.49 18.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' B' ' 42' ' ' PHE . 29.9 m-85 -95.79 32.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' B' ' 41' ' ' PHE . 57.5 m-85 -141.36 26.32 1.98 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.94 -25.08 37.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.516 ' C ' ' H ' ' B' ' 46' ' ' GLY . 66.8 m -82.13 -38.17 25.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.602 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -56.0 -5.41 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' B' ' 44' ' ' SER . . . 48.57 -167.67 0.16 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' B' ' 48' ' ' LEU . 18.9 t70 60.19 -150.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -1.149 . . . . 0.0 109.536 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.504 ' H ' ' CG ' ' B' ' 47' ' ' ASP . 24.2 mt 60.57 34.33 20.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 109.53 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.3 m -80.49 -22.52 40.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.41 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' THR . . . . . 0.502 ' O ' ' N ' ' B' ' 53' ' ' ALA . 21.4 p -146.11 149.02 37.24 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.279 -0.888 . . . . 0.0 109.166 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -36.75 -45.07 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.644 2.23 . . . . 0.0 112.591 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.88 -26.93 61.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 109.544 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -57.78 -19.64 29.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.05 -63.36 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.135 -0.978 . . . . 0.0 109.633 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' MET . . . . . 0.542 ' SD ' ' N ' ' B' ' 55' ' ' MET . 2.3 mpp? -79.69 14.81 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.05 -49.01 4.41 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . 0.471 HD21 ' N ' ' B' ' 57' ' ' ASN . 1.0 OUTLIER -77.82 149.61 77.54 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.227 -1.16 . . . . 0.0 109.46 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.36 -51.94 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.671 2.247 . . . . 0.0 112.176 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.403 ' CG ' ' N ' ' B' ' 60' ' ' VAL . 54.2 pttt -46.92 -40.75 14.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.56 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' B' ' 59' ' ' LYS . 87.1 t -54.21 -44.85 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' B' ' 61' ' ' LYS . 7.0 mtmp? -77.39 -43.0 34.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.222 -0.924 . . . . 0.0 109.438 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.17 -33.12 18.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -67.67 -24.4 65.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.68 -30.25 74.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -68.15 -41.23 81.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.121 . . . . 0.0 109.318 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -64.08 -50.89 66.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.779 . . . . 0.0 109.36 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -61.78 -23.91 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.251 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tt -78.11 -29.8 49.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.475 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.22 -57.13 14.33 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.54 -22.03 63.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -74.46 -30.34 61.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.63 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' SER . . . . . 0.643 ' HG ' ' HE1' ' B' ' 15' ' ' TRP . 4.4 m -89.11 -20.48 24.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 109.762 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -46.15 -30.79 2.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 109.621 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.29 -59.24 7.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.441 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.75 -17.73 10.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 109.667 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -97.38 32.9 2.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.977 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.549 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 9.5 m-70 -176.67 -49.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.161 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' B' ' 77' ' ' HIS . 29.8 mt 39.64 35.3 0.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.637 -0.665 . . . . 0.0 109.614 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -138.62 -31.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.651 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 7.5 p-10 -151.91 72.71 1.03 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.171 -0.956 . . . . 0.0 109.363 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.546 ' O ' ' CZ ' ' B' ' 85' ' ' PHE . 9.6 mp -60.4 -27.08 67.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.912 . . . . 0.0 109.461 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -80.62 -61.48 1.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.77 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.32 -23.9 43.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -62.4 -51.91 65.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.166 -1.196 . . . . 0.0 109.537 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.546 ' CZ ' ' O ' ' B' ' 81' ' ' LEU . 2.2 p90 -133.18 51.93 2.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.639 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.97 -29.47 4.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -0.994 . . . . 0.0 109.287 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.647 ' HG1' ' N ' ' B' ' 88' ' ' LEU . 17.8 p -60.5 -58.5 8.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.326 -0.859 . . . . 0.0 109.392 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.647 ' N ' ' HG1' ' B' ' 87' ' ' THR . 90.7 mt -48.56 -37.43 17.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.026 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -69.06 -34.84 75.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.913 . . . . 0.0 109.002 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -82.91 -39.01 22.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 109.419 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.07 -25.31 64.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 109.397 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' B' ' 97' ' ' HIS . 6.8 m80 -90.98 -21.81 21.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.181 -0.95 . . . . 0.0 109.567 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.58 -59.05 2.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 111.059 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.626 ' O ' HG21 ' C' ' 41' ' ' THR . 1.3 m-20 -87.21 -57.0 3.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.976 -1.077 . . . . 0.0 112.009 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . 0.484 ' CD ' ' N ' ' B' ' 95' ' ' LYS . 12.1 mptt -62.81 -52.16 64.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.122 -0.986 . . . . 0.0 111.195 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.608 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -95.43 -38.2 10.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.973 -1.079 . . . . 0.0 109.837 -178.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 25.3 p80 45.52 33.06 1.25 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.206 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 52.0 t -50.13 132.4 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.949 -1.094 . . . . 0.0 109.139 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 4.2 m-20 -51.15 151.24 5.02 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.266 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.03 -170.35 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.439 2.093 . . . . 0.0 112.026 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' D' ' 101' ' ' GLU . 69.1 mm-40 53.24 69.95 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.47 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.467 ' ND2' ' CD1' ' B' ' 103' ' ' PHE . 3.9 p-10 -171.24 -39.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.49 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . 0.467 ' CD1' ' ND2' ' B' ' 102' ' ' ASN . 12.9 m-85 -50.34 -34.51 24.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -76.13 -43.94 40.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.613 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' B' ' 105' ' ' LEU . 9.9 mp -49.32 -51.81 31.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 tt -51.69 -37.17 49.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.852 . . . . 0.0 109.353 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.98 -20.57 59.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -65.36 -34.26 77.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 109.561 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.86 -31.67 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 7.7 tp -51.67 -52.09 50.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.517 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.564 ' CG2' ' CE1' ' B' ' 130' ' ' TYR . 42.6 t -51.18 -42.86 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.596 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -60.06 -39.56 86.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.164 -0.96 . . . . 0.0 109.618 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.55 -55.03 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.606 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.03 -31.75 71.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.495 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -64.9 -27.8 69.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.403 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.568 ' HD1' ' C ' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.79 -61.28 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.227 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.42 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 8.3 m-70 -63.3 -18.28 63.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 58.8 m-85 -148.44 59.53 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -71.95 -14.8 76.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -79.48 -20.29 47.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.271 -1.135 . . . . 0.0 109.528 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' B' ' 123' ' ' THR . 29.1 mm-40 -95.48 -2.49 48.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.953 . . . . 0.0 109.77 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -73.78 33.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 0.0 109.606 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.508 ' H ' ' C ' ' B' ' 121' ' ' GLU . 22.0 p -49.22 148.41 4.4 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.364 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.443 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 2.3 Cg_endo -46.83 -57.51 2.25 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.448 2.099 . . . . 0.0 113.002 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 17.8 Cg_endo -59.49 -42.36 48.86 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.093 1.862 . . . . 0.0 112.233 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 98.9 t -65.11 -20.76 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.458 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . 0.866 HE22 ' HG3' ' A' ' 31' ' ' ARG . 37.0 tt0 -83.31 -48.99 9.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.552 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.66 -30.06 67.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.14 19.17 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.144 -0.972 . . . . 0.0 109.672 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.564 ' CE1' ' CG2' ' B' ' 111' ' ' VAL . 47.4 t80 -107.95 -61.4 1.58 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.283 -0.886 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -55.28 -23.26 22.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.947 . . . . 0.0 109.57 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -83.04 -21.8 33.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.647 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 76.8 t -81.13 -68.31 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 109.696 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 22.4 m -53.76 -25.04 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.848 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.56 -29.78 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.461 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.4 -29.28 56.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 96.4 t -76.42 -38.14 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -1.169 . . . . 0.0 109.4 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.96 79.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.42 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . 1.616 HD22 ' CD2' ' D' ' 146' ' ' HIS . 1.8 m120 -79.67 -22.96 42.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.85 -60.52 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.601 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.74 -25.26 66.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.331 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 -16.35 27.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.472 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -51.33 -33.38 29.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 109.361 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -73.34 -27.15 61.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' B' ' 92' ' ' HIS . 16.2 m-85 -71.94 -46.18 58.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.5 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 1.616 ' CD2' HD22 ' D' ' 139' ' ' ASN . 43.5 p-80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.942 -1.027 . . . . 0.0 109.548 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 73.2 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 78.0 mt -144.72 178.84 7.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 109.772 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.77 167.17 25.85 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.05 -43.81 3.0 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.668 2.245 . . . . 0.0 112.62 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.3 -19.35 33.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.999 -1.063 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -47.84 -37.24 13.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.735 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -43.61 19.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.953 . . . . 0.0 109.886 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 37.3 m -51.14 -37.5 46.53 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.184 -0.947 . . . . 0.0 109.562 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -74.94 -31.92 61.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.46 -51.13 30.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -50.15 -47.3 54.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.87 -61.35 2.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.479 -0.763 . . . . 0.0 109.573 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.48 -40.21 68.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.278 -0.889 . . . . 0.0 109.039 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -17.1 64.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.309 -0.869 . . . . 0.0 108.959 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.36 -44.84 15.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -70.68 -40.68 72.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -1.153 . . . . 0.0 108.841 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -60.28 -64.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 46.0 -127.27 9.15 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 23.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.465 -1.02 . . . . 0.0 110.544 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.611 ' H ' ' C ' ' C' ' 18' ' ' GLY . 85.9 m-70 -130.05 25.77 5.23 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -90.19 -63.88 1.21 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.74 -14.34 0.23 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.0 mm-40 -83.28 -56.42 3.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -1.044 . . . . 0.0 109.53 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.622 ' CE1' ' CD2' ' C' ' 112' ' ' HIS . 3.6 m-30 -62.11 -32.31 72.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.416 -0.802 . . . . 0.0 109.179 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.18 -23.46 77.23 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.93 -44.38 22.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.212 -1.169 . . . . 0.0 109.662 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.24 -26.08 67.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.31 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.37 -26.86 68.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 14.1 mt -72.44 -58.37 3.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.523 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -52.23 -38.82 59.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.57 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.854 ' HG3' HE22 ' D' ' 127' ' ' GLN . 0.9 OUTLIER -68.21 -50.67 52.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.224 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' MET . . . . . 0.482 ' C ' ' SD ' ' C' ' 32' ' ' MET . 15.2 tmm? -62.39 -29.07 70.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.953 . . . . 0.0 109.392 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -62.78 -58.69 6.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.953 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' C' ' 36' ' ' PHE . 2.4 pp -74.0 -39.57 63.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 110.144 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.528 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 50.5 m -46.81 -16.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.059 -1.026 . . . . 0.0 109.815 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' C' ' 35' ' ' SER . 15.2 m-85 -159.37 89.74 1.99 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.332 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.73 -20.18 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.519 2.146 . . . . 0.0 112.082 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 19.3 p -49.01 -18.96 0.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 30.2 p -84.12 -22.98 30.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.471 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -55.5 -46.97 76.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.576 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.626 HG21 ' O ' ' B' ' 94' ' ' ASP . 5.2 t . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.36 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.573 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.201 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -145.72 31.21 1.07 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.503 -1.373 . . . . 0.0 110.046 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' C' ' 49' ' ' SER . 1.1 m-20 52.88 91.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.633 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.07 1.74 0.41 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 109.58 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.496 ' H ' ' C ' ' C' ' 47' ' ' ASP . 9.3 m -62.46 140.97 58.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.443 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.514 ' HD1' ' N ' ' C' ' 50' ' ' HIS . 0.1 OUTLIER -63.64 140.32 58.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.938 . . . . 0.0 109.541 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.15 12.16 81.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.54 ' C ' ' H ' ' C' ' 54' ' ' GLN . 2.3 t -59.22 -20.68 56.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -1.205 . . . . 0.0 109.326 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 72.62 -24.29 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.629 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.54 ' H ' ' C ' ' C' ' 52' ' ' SER . 33.5 mt-30 -80.41 -24.17 39.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 16.8 t -75.96 -35.09 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.19 -34.61 42.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.871 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.23 -24.41 76.45 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.507 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 5.8 t-80 -68.19 -43.93 76.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -1.061 . . . . 0.0 109.277 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.77 -46.88 24.98 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' C' ' 64' ' ' ASP . 48.3 mttm -54.77 -23.12 16.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -1.027 . . . . 0.0 109.57 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.27 -36.91 58.21 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.178 -0.951 . . . . 0.0 108.9 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -73.77 -47.35 44.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.56 -29.09 67.56 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.428 -0.795 . . . . 0.0 109.416 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' C' ' 60' ' ' LYS . 25.8 m-20 -66.74 -47.23 72.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 108.697 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -62.08 -49.31 76.46 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mt -55.36 -46.11 76.46 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.514 ' O ' ' N ' ' C' ' 71' ' ' ALA . 27.4 m -65.03 -55.5 18.56 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -55.86 -29.37 59.8 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.72 -48.12 12.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.14 -22.55 31.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -68.9 -16.5 63.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.58 ' O ' ' N ' ' C' ' 74' ' ' ASP . 34.2 m170 -145.17 -56.82 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 0.0 109.217 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.5 p 44.85 13.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.744 0.783 . . . . 0.0 109.56 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' C' ' 72' ' ' HIS . 99.3 m-20 -123.63 8.35 8.89 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -175.84 28.73 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.178 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 5.2 ptt? -78.13 -24.55 0.45 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.765 . . . . 0.0 111.664 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.9 Cg_exo -54.8 -23.73 35.01 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.74 1.627 . . . . 0.0 112.197 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -93.26 -37.19 12.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.587 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.75 75.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.929 . . . . 0.0 109.203 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 mt -81.88 8.85 9.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 0.0 108.939 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 27.9 t -56.24 -40.95 74.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.882 . . . . 0.0 109.589 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -56.31 -57.33 12.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.536 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mt -46.25 -46.68 17.96 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' C' ' 135' ' ' VAL . 3.9 m -59.99 -29.56 68.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.564 -0.71 . . . . 0.0 109.285 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' C' ' 89' ' ' HIS . 75.9 m-20 -81.63 -38.88 25.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.324 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 tt -59.14 -36.11 74.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.375 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -92.16 -23.04 19.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.684 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.52 -9.39 29.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.215 -0.928 . . . . 0.0 109.887 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' C' ' 85' ' ' ASP . 43.2 m80 -144.03 47.94 1.41 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.056 -1.027 . . . . 0.0 109.776 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.19 -69.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' C' ' 93' ' ' VAL . 11.6 mt -88.77 -23.8 22.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 109.51 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 51.67 10.06 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.494 ' H ' ' C ' ' C' ' 91' ' ' LEU . 14.9 p -52.69 144.52 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.1 151.71 86.13 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.313 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' C' ' 97' ' ' ASN . 47.7 Cg_endo -70.11 -21.0 32.45 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.546 2.164 . . . . 0.0 112.136 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 90.6 t -45.75 -15.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.769 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' C' ' 95' ' ' PRO . 3.3 m120 -79.21 -24.89 42.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.595 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' C' ' 98' ' ' PHE . 0.1 OUTLIER -68.99 -31.27 69.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 109.435 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -58.51 -29.9 66.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.6 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.506 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 17.7 mt -83.92 -62.14 1.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.584 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 7.1 tt -45.65 -24.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.616 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.7 t -65.33 -57.24 8.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.865 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -73.78 -26.43 60.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 109.998 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 9.6 m -70.41 -23.34 62.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 110.17 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -22.7 40.15 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.943 -1.098 . . . . 0.0 108.936 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -85.12 -18.77 33.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.912 . . . . 0.0 109.702 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 74.1 t -77.51 -50.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.965 . . . . 0.0 109.742 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.407 ' HG1' ' H ' ' C' ' 109' ' ' LEU . 43.5 p -52.46 -52.04 56.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.251 -0.906 . . . . 0.0 109.666 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' C' ' 114' ' ' PRO . 7.9 mt -43.61 -26.41 0.23 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.723 . . . . 0.0 109.756 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.9 -25.66 62.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 110.477 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.45 -3.88 54.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.053 -1.029 . . . . 0.0 110.835 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . 0.622 ' CD2' ' CE1' ' C' ' 24' ' ' TYR . 0.2 OUTLIER -150.11 -69.22 0.19 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.73 -1.231 . . . . 0.0 109.639 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' C' ' 109' ' ' LEU . 0.4 OUTLIER -118.22 81.27 16.59 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . 0.48 ' N ' ' O ' ' C' ' 109' ' ' LEU . 51.4 Cg_exo -49.24 -170.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.462 2.108 . . . . 0.0 112.567 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.638 ' O ' ' CG ' ' C' ' 116' ' ' GLU . . . -48.7 -55.62 10.87 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.638 ' CG ' ' O ' ' C' ' 115' ' ' ALA . 2.8 mm-40 130.46 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 13.0 t80 66.37 30.38 8.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.717 -0.614 . . . . 0.0 111.08 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.7 ' O ' ' N ' ' C' ' 120' ' ' ALA . 2.1 p -103.83 128.04 28.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 108.287 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.59 23.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.217 1.945 . . . . 0.0 112.907 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.7 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -157.01 -32.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.746 -1.221 . . . . 0.0 110.675 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.63 ' H ' ' HG1' ' C' ' 118' ' ' THR . 12.9 p -49.86 -47.31 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.035 . . . . 0.0 110.236 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.512 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 2.4 t60 -61.72 -38.5 88.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.85 . . . . 0.0 109.778 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.37 -20.19 34.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.995 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -62.29 1.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.14 -19.87 66.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 109.411 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.12 -49.31 37.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.958 . . . . 0.0 109.66 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.18 -42.03 11.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 109.632 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.515 ' N ' ' CD ' ' C' ' 127' ' ' LYS . 32.1 t80 -49.97 -22.88 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 109.364 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' C' ' 129' ' ' LEU . 1.2 pp -76.43 -22.03 55.18 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.15 -38.11 75.97 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 33.8 m -67.88 -26.82 66.2 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 5.7 t -85.61 -37.61 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.358 -0.839 . . . . 0.0 108.879 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 14.9 t -79.97 -18.09 51.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.318 -0.864 . . . . 0.0 108.778 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 42.6 m -83.24 -42.46 17.18 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.452 -0.78 . . . . 0.0 109.238 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . 0.435 ' O ' ' OG ' ' C' ' 84' ' ' SER . 27.4 m -70.13 -21.93 24.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.245 -0.909 . . . . 0.0 108.694 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.4 -31.91 72.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.448 -0.783 . . . . 0.0 108.941 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 7.2 m -153.19 57.1 0.77 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.296 -0.877 . . . . 0.0 109.47 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 25.5 t . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.935 . . . . 0.0 109.518 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.696 ' H ' ' CD1' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -107.64 -159.17 0.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.506 -0.747 . . . . 0.0 109.35 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.401 ' O ' ' N ' ' D' ' 6' ' ' GLU . 9.9 p -103.56 134.36 19.79 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.435 -0.791 . . . . 0.0 109.34 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . 0.453 ' O ' ' OG ' ' D' ' 9' ' ' SER . 75.7 Cg_exo -42.08 -22.73 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.397 2.065 . . . . 0.0 112.495 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' D' ' 4' ' ' THR . 79.3 mt-10 -76.71 -55.63 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 110.043 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -68.14 -60.39 2.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.033 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.522 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -48.68 -30.16 5.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.846 . . . . 0.0 110.198 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' D' ' 5' ' ' PRO . 2.8 m -62.08 -23.63 66.62 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.041 -1.037 . . . . 0.0 110.083 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.97 -57.59 3.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.014 -1.054 . . . . 0.0 110.035 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.6 -25.02 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.522 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 56.9 m -83.48 -37.26 23.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.22 -29.93 71.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.346 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.7 OUTLIER -52.08 -32.54 35.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.092 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . 0.638 ' HE1' ' HG ' ' D' ' 72' ' ' SER . 0.2 OUTLIER -47.14 -17.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.31 -52.01 5.83 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.421 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.1 OUTLIER -70.47 -29.32 65.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.202 -1.175 . . . . 0.0 109.322 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -48.84 114.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.55 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' D' ' 22' ' ' GLU . 18.4 m120 -82.67 69.49 9.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 108.941 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . 0.486 ' C ' ' H ' ' D' ' 22' ' ' GLU . 78.7 t -43.81 -29.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 109.713 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -64.63 1.87 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.617 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' D' ' 20' ' ' VAL . 33.0 mt-10 -155.88 -46.18 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.393 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -48.54 -53.93 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.4 -48.51 48.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.4 -46.36 78.59 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -62.36 -40.07 95.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -1.153 . . . . 0.0 109.314 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -37.79 88.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.364 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -82.1 -51.35 8.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.275 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.91 -35.09 62.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -79.4 -30.58 42.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -1.14 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 60.1 tp -49.52 -38.95 32.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 109.368 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.57 -23.42 56.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.595 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.7 -61.62 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.21 -0.931 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.32 -23.81 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.77 76.06 48.09 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 109.258 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.64 11.42 2.72 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.769 2.312 . . . . 0.0 112.358 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -80.54 -19.75 45.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.36 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 42.1 p -79.71 40.07 0.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -92.07 12.86 20.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -87.88 -34.44 18.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.591 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' D' ' 42' ' ' PHE . 29.4 m-85 -95.81 32.37 1.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 0.0 109.546 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.434 ' CD1' ' C ' ' D' ' 41' ' ' PHE . 56.5 m-85 -141.38 26.36 1.98 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 109.454 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -80.94 -25.07 37.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.51 ' C ' ' H ' ' D' ' 46' ' ' GLY . 67.1 m -82.15 -38.31 24.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.922 . . . . 0.0 109.483 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -55.93 -5.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' D' ' 44' ' ' SER . . . 48.53 -167.77 0.15 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' D' ' 48' ' ' LEU . 18.9 t70 60.26 -150.21 0.42 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -1.154 . . . . 0.0 109.559 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . 0.502 ' H ' ' CG ' ' D' ' 47' ' ' ASP . 23.5 mt 60.46 34.39 20.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.562 -0.711 . . . . 0.0 109.656 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.2 m -80.47 -22.54 40.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' THR . . . . . 0.495 ' O ' ' N ' ' D' ' 53' ' ' ALA . 21.1 p -146.05 149.07 37.58 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 109.157 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -36.85 -45.06 1.19 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.593 2.195 . . . . 0.0 112.595 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.73 -27.04 61.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 109.6 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -57.81 -19.59 29.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.589 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.99 -63.45 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 109.63 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' D' ' 55' ' ' MET . 2.3 mpp? -79.71 14.86 1.53 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.436 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.98 -49.06 4.41 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . 0.472 HD21 ' N ' ' D' ' 57' ' ' ASN . 1.0 OUTLIER -77.78 149.63 77.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.276 -1.132 . . . . 0.0 109.47 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.33 -52.03 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.642 2.228 . . . . 0.0 112.148 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -46.88 -40.71 14.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.336 -0.853 . . . . 0.0 109.58 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 86.6 t -54.22 -44.83 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.397 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' D' ' 61' ' ' LYS . 7.0 mtmp? -77.4 -43.06 33.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.11 -33.15 17.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -67.55 -24.49 65.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.584 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.57 -30.31 74.79 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -68.16 -41.21 81.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.33 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -64.08 -50.95 66.34 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.338 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 25.4 t -61.74 -23.84 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.201 -0.937 . . . . 0.0 109.331 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -78.17 -29.78 48.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.32 -57.09 14.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.48 -22.03 63.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -1.135 . . . . 0.0 109.517 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -74.53 -30.23 61.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.607 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' SER . . . . . 0.638 ' HG ' ' HE1' ' D' ' 15' ' ' TRP . 4.5 m -89.21 -20.49 24.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.688 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -46.15 -30.73 2.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.692 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.41 -59.17 6.99 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.424 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -56.74 -17.82 10.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -1.153 . . . . 0.0 109.628 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . 0.558 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -97.36 33.04 2.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 109.993 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 9.5 m-70 -176.81 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.143 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' D' ' 77' ' ' HIS . 29.9 mt 39.61 35.38 0.19 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.644 -0.66 . . . . 0.0 109.621 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -138.73 -31.4 0.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.788 . . . . 0.0 109.631 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' D' ' 80' ' ' ASN . 7.4 p-10 -151.95 72.85 1.03 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.296 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . 0.537 ' O ' ' CZ ' ' D' ' 85' ' ' PHE . 9.5 mp -60.36 -27.15 67.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -80.6 -61.5 1.95 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.776 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.33 -23.79 42.75 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' D' ' 81' ' ' LEU . 0.8 OUTLIER -62.34 -51.91 65.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 109.554 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.537 ' CZ ' ' O ' ' D' ' 81' ' ' LEU . 2.2 p90 -133.2 51.83 2.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 109.651 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.01 -29.31 4.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.322 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' THR . . . . . 0.647 ' HG1' ' N ' ' D' ' 88' ' ' LEU . 17.8 p -60.59 -58.55 8.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.325 -0.859 . . . . 0.0 109.319 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.647 ' N ' ' HG1' ' D' ' 87' ' ' THR . 90.8 mt -48.47 -37.47 17.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.008 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -69.05 -34.95 76.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.034 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -82.87 -39.07 22.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -0.825 . . . . 0.0 109.4 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.05 -25.3 64.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.401 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' D' ' 97' ' ' HIS . 7.0 m80 -91.0 -21.74 21.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.625 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.56 -59.01 2.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 111.162 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.715 ' O ' HG21 ' A' ' 41' ' ' THR . 1.3 m-20 -87.28 -57.0 3.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.014 -1.054 . . . . 0.0 111.934 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' D' ' 95' ' ' LYS . 12.0 mptt -62.66 -52.25 64.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.131 -0.98 . . . . 0.0 111.263 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.606 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -95.41 -38.19 10.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.892 -1.13 . . . . 0.0 109.764 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.606 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 25.4 p80 45.36 33.26 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 52.5 t -50.12 132.37 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.041 -1.037 . . . . 0.0 109.14 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' D' ' 102' ' ' ASN . 4.2 m-20 -51.19 151.2 5.12 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.293 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.98 -170.32 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.464 2.109 . . . . 0.0 112.026 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' B' ' 101' ' ' GLU . 69.2 mm-40 53.14 70.04 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . 0.472 ' ND2' ' CD1' ' D' ' 103' ' ' PHE . 4.0 p-10 -171.23 -39.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -0.897 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' ND2' ' D' ' 102' ' ' ASN . 12.8 m-85 -50.25 -34.55 23.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -76.12 -43.99 40.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.559 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' D' ' 105' ' ' LEU . 9.9 mp -49.35 -51.85 31.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.441 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 tt -51.66 -37.21 49.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.137 -0.977 . . . . 0.0 109.303 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.93 -20.62 59.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -65.25 -34.36 78.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -1.179 . . . . 0.0 109.616 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.82 -31.71 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 7.6 tp -51.64 -52.12 50.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.559 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . 0.553 ' CG2' ' CE1' ' D' ' 130' ' ' TYR . 42.9 t -51.15 -42.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.577 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -60.18 -39.52 86.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.594 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.53 -55.0 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 109.681 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.96 -31.81 71.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -64.87 -27.83 69.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.469 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.563 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.79 -61.25 1.83 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 109.25 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . 0.417 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 8.3 m-70 -63.24 -18.42 63.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.525 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 58.9 m-85 -148.41 59.53 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 109.386 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -72.03 -14.74 76.24 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -79.45 -20.34 47.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.455 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' D' ' 123' ' ' THR . 29.2 mm-40 -95.4 -2.5 48.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.768 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.91 34.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.536 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.519 ' H ' ' C ' ' D' ' 121' ' ' GLU . 21.7 p -49.25 148.37 4.5 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.391 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.441 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 2.3 Cg_endo -46.71 -57.56 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.463 2.109 . . . . 0.0 113.03 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 17.7 Cg_endo -59.51 -42.38 48.48 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.12 1.88 . . . . 0.0 112.236 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 98.7 t -64.93 -20.95 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.917 . . . . 0.0 109.547 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . 0.854 HE22 ' HG3' ' C' ' 31' ' ' ARG . 37.0 tt0 -83.28 -48.91 9.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.576 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.72 -30.0 67.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.528 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.14 19.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.653 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . 0.553 ' CE1' ' CG2' ' D' ' 111' ' ' VAL . 47.1 t80 -107.92 -61.31 1.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.3 -0.875 . . . . 0.0 109.68 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -55.29 -23.25 22.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -83.06 -21.83 33.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.933 . . . . 0.0 109.653 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.09 -68.27 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.945 . . . . 0.0 109.721 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 22.3 m -53.83 -25.06 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.28 -0.888 . . . . 0.0 109.869 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.56 -29.79 7.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -0.949 . . . . 0.0 109.438 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.33 -29.31 56.38 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.4 -38.15 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 0.0 109.432 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.88 79.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . 1.616 HD22 ' CD2' ' B' ' 146' ' ' HIS . 1.8 m120 -79.68 -22.99 42.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.952 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.72 -60.64 2.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.628 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.83 -25.21 66.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.266 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 -16.41 27.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 109.422 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -51.23 -33.47 28.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 18.8 mmtm -73.32 -27.17 61.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . 0.432 ' OH ' ' O ' ' D' ' 92' ' ' HIS . 16.2 m-85 -71.85 -46.28 58.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.455 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 1.616 ' CD2' HD22 ' B' ' 139' ' ' ASN . 43.7 p-80 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.483 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 1' ' ' VAL . 9.9 mt 54.48 170.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 0.0 109.638 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.465 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 176.32 -53.64 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.0 . . . . 0.0 110.317 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 6' ' ' ASP . 59.0 Cg_endo -73.97 -165.22 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.397 2.064 . . . . 0.0 112.777 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 8' ' ' THR . . . -43.93 -15.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.434 -0.792 . . . . 0.0 110.114 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' PRO . 53.5 m-20 -38.72 -37.22 0.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.806 . . . . 0.0 109.76 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -30.77 26.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.881 . . . . 0.0 109.685 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 5' ' ' ALA . 40.9 m -52.02 -37.48 53.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.173 -0.954 . . . . 0.0 109.213 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -73.87 -33.36 64.03 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.76 -52.29 26.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.94 -45.59 51.36 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.09 -61.76 2.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.579 -0.701 . . . . 0.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.35 63.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.3 -0.875 . . . . 0.0 109.242 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.453 ' HE1' ' HG1' ' A' ' 67' ' ' THR . 0.2 OUTLIER -75.55 -17.38 60.09 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.31 -0.869 . . . . 0.0 109.062 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.06 -43.32 14.0 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -70.36 -39.96 74.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 108.828 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.5 t -60.03 -65.4 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.587 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 57.29 -135.75 51.33 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 28.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.998 . . . . 0.0 110.48 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.587 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.9 m-70 -131.93 24.36 4.62 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.24 -62.76 1.42 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.624 -0.672 . . . . 0.0 109.727 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.41 -14.5 0.19 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' ALA . 1.3 mm-40 -84.15 -56.16 3.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -1.061 . . . . 0.0 109.433 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.641 ' CD1' ' CD2' ' A' ' 112' ' ' HIS . 3.1 m-30 -59.95 -37.09 78.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.374 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.73 -24.24 69.6 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.35 -45.05 20.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.629 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.01 -21.21 61.02 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.399 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.31 -21.53 62.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.693 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 mt -78.04 -51.54 10.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.505 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.34 -12.67 61.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.837 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.565 ' NH2' ' SG ' ' A' ' 104' ' ' CYS . 0.9 OUTLIER -76.48 -40.37 50.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 110.276 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.0 ptt? -84.16 -35.56 23.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 109.963 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -45.99 -41.72 12.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 109.665 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.78 ' CD1' ' HB3' ' B' ' 128' ' ' ALA . 2.2 pp -84.63 -35.89 22.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.067 -1.021 . . . . 0.0 109.82 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.4 p -85.33 1.45 48.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.538 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' MET . 67.0 m-85 -159.17 68.13 3.2 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 39' ' ' THR . 72.1 Cg_exo -47.75 -34.34 21.14 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.821 2.347 . . . . 0.0 112.279 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 1.347 ' CG2' ' HD1' ' D' ' 97' ' ' HIS . 2.2 p -47.05 -18.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.927 . . . . 0.0 109.591 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' PRO . 81.4 p -84.5 -31.33 24.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 0.0 109.709 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -68.6 -26.44 65.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 109.685 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.857 HG23 ' CD2' ' D' ' 97' ' ' HIS . 5.3 t . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.259 -0.9 . . . . 0.0 109.87 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 26.6 p80 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 120.867 0.365 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.433 ' O ' ' OG ' ' A' ' 52' ' ' SER . 2.8 p90 -135.86 26.85 3.31 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.001 -1.062 . . . . 0.0 109.687 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 49' ' ' SER . 55.2 m-20 44.44 83.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.485 -0.759 . . . . 0.0 109.529 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.01 -8.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 109.5 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 47' ' ' ASP . 35.0 p -68.36 169.45 10.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 0.0 109.469 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -78.96 164.3 24.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.863 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.04 17.31 71.66 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 54' ' ' GLN . 3.0 t -77.52 -28.62 52.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -1.156 . . . . 0.0 109.487 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 73.28 -31.66 0.23 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.602 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 52' ' ' SER . 38.0 mt-30 -80.51 -22.56 40.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -83.46 -35.93 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -81.42 -32.93 32.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.198 -0.939 . . . . 0.0 108.615 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.66 -21.96 78.85 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.409 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 10.1 t-80 -70.51 -29.97 66.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -1.055 . . . . 0.0 109.24 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.76 -51.45 57.95 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -48.36 -23.82 1.04 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -1.136 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -71.39 -51.12 25.8 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.179 -0.951 . . . . 0.0 108.608 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.7 t -60.85 -47.7 92.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.76 89.42 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.348 -0.845 . . . . 0.0 108.923 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 68' ' ' ASN . 14.3 t0 -60.06 -39.07 84.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -65.01 -52.33 56.69 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' VAL . 15.5 mt -57.59 -43.91 84.97 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.453 ' HG1' ' HE1' ' A' ' 14' ' ' TRP . 19.0 m -69.34 -51.25 38.81 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' ASP . 60.7 t30 -61.64 -26.14 67.81 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.17 -46.59 10.94 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' LEU . 20.8 t -65.2 -22.67 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -64.09 -21.62 66.6 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' ' 74' ' ' ASP . 42.4 m80 -146.44 -51.94 0.23 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.4 p 44.74 13.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.687 0.756 . . . . 0.0 109.407 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 72' ' ' HIS . 29.2 m-20 -127.04 9.5 6.83 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -173.68 27.3 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.046 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.689 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 4.8 ptt? -78.33 -24.2 0.43 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.44 -0.788 . . . . 0.0 111.668 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.8 Cg_exo -53.02 -27.73 37.26 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.634 1.556 . . . . 0.0 112.506 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.46 HD21 ' N ' ' A' ' 78' ' ' ASN . 1.4 m-80 -94.3 -24.79 17.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.74 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.79 -46.38 21.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.0 109.223 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.7 mt -82.05 9.3 8.7 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 108.981 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 77' ' ' PRO . 4.5 m -65.69 -22.41 66.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 109.512 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -82.01 -59.64 2.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.135 -0.978 . . . . 0.0 109.694 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.51 ' CD1' ' C ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -50.8 -26.2 5.39 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.2 m -67.5 -33.4 75.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' ALA . 4.3 t70 -78.26 -30.07 48.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 108.806 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.502 ' CD1' ' C ' ' A' ' 86' ' ' LEU . 2.1 tm? -54.31 -49.55 69.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.509 -0.744 . . . . 0.0 109.388 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -92.24 -21.78 20.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.008 . . . . 0.0 110.375 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.93 -2.62 55.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.042 -1.036 . . . . 0.0 110.293 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -128.56 -77.06 0.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.194 -0.941 . . . . 0.0 109.771 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -46.66 -78.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.761 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' A' ' 91' ' ' LEU . 8.2 mp -71.06 -39.05 72.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.106 -0.996 . . . . 0.0 109.647 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 61.84 59.28 1.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 109.42 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 94' ' ' ASP . 90.3 t -85.21 166.59 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 109.614 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 96' ' ' VAL . 3.8 m-20 -99.33 120.05 58.92 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.381 -0.824 . . . . 0.0 109.217 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 98' ' ' PHE . 83.3 Cg_exo -44.11 -10.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.225 1.95 . . . . 0.0 112.432 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 94' ' ' ASP . 96.1 t -45.55 -23.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 95' ' ' PRO . 73.3 m-20 -79.3 -24.84 42.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 109.57 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' OG ' ' A' ' 102' ' ' SER . 20.4 t80 -46.53 -35.05 5.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -64.61 -33.27 75.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.0 mt -84.06 -43.75 14.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.523 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -54.38 -52.04 62.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.537 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 98' ' ' PHE . 15.7 m -59.63 -33.52 71.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.555 ' HD1' ' N ' ' A' ' 103' ' ' HIS . 0.7 OUTLIER -80.65 -26.65 37.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.095 -1.003 . . . . 0.0 110.096 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.565 ' SG ' ' NH2' ' A' ' 31' ' ' ARG . 72.0 m -63.95 -58.36 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.246 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.43 -34.51 4.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.935 . . . . 0.0 110.093 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.8 mt -70.75 -28.2 64.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 110.176 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -83.04 -38.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.979 -1.076 . . . . 0.0 109.582 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 110' ' ' ALA . 19.1 p -70.58 -58.9 3.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.2 -0.938 . . . . 0.0 109.649 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 113' ' ' LEU . 9.5 mt -43.12 -26.28 0.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.765 . . . . 0.0 109.587 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -67.36 -22.64 65.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 110.589 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.37 -48.02 12.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.025 . . . . 0.0 111.006 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.641 ' CD2' ' CD1' ' A' ' 24' ' ' TYR . 1.1 p-80 -100.76 -58.87 1.8 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.025 -1.047 . . . . 0.0 111.037 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.522 ' H ' ' CD2' ' A' ' 112' ' ' HIS . 0.9 OUTLIER -112.44 93.35 22.53 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 109.284 -178.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 113' ' ' LEU . 76.7 Cg_exo -47.0 -174.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.364 2.042 . . . . 0.0 112.685 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.648 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -61.56 -55.35 31.77 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.648 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 27.8 mt-10 119.92 1.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.506 ' O ' ' CD2' ' A' ' 117' ' ' PHE . 38.3 t80 59.62 31.63 21.04 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.298 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.794 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.3 p -104.4 120.8 49.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.985 -1.072 . . . . 0.0 108.14 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.1 23.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.09 1.86 . . . . 0.0 112.72 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.794 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -154.43 -29.96 0.11 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.853 -1.155 . . . . 0.0 110.676 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.513 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 13.7 p -51.16 -50.16 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.996 -1.065 . . . . 0.0 110.274 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.513 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 3.1 t-160 -61.31 -53.41 57.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.868 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.83 61.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 120' ' ' ALA . 20.5 m -63.72 -62.51 1.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.164 -0.96 . . . . 0.0 110.277 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.47 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 1.2 mt -64.4 -16.85 63.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.352 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.07 -49.18 9.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 110.902 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.62 -59.03 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.818 -1.176 . . . . 0.0 111.264 -178.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.454 ' N ' ' HD2' ' A' ' 127' ' ' LYS . 21.4 m-85 -47.98 -21.23 0.41 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.717 -1.239 . . . . 0.0 109.752 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -72.1 -31.03 65.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 134' ' ' THR . . . -49.2 -33.18 11.9 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.467 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 43.2 t -60.36 -37.02 79.39 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 t -77.06 -48.72 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.406 ' CB ' ' CE1' ' A' ' 98' ' ' PHE . 13.5 t -66.48 -22.72 66.19 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.278 -0.889 . . . . 0.0 108.635 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 130' ' ' ALA . 11.2 m -64.06 -31.75 73.06 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.411 -0.806 . . . . 0.0 108.827 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.62 -37.26 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 109.14 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.59 -35.29 75.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.299 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 134' ' ' THR . 34.9 p -67.9 -33.75 75.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.21 0.529 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mt -87.8 161.05 17.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.561 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.19 138.18 19.47 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.371 -0.83 . . . . 0.0 108.826 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -40.02 -54.19 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.524 2.149 . . . . 0.0 112.637 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -72.01 -21.84 61.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 110.02 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -76.62 -63.12 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 109.902 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.466 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -66.58 -29.59 69.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.068 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.6 t -47.5 -23.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 110.101 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.66 -56.85 3.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 109.992 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.13 -24.64 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.9 m -73.52 -40.28 64.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.746 -0.596 . . . . 0.0 109.607 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.42 -31.23 71.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.409 -0.807 . . . . 0.0 109.447 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.8 OUTLIER -50.7 -31.47 16.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 0.0 109.155 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . 0.415 ' CE2' ' OG ' ' B' ' 72' ' ' SER . 1.5 t90 -47.57 -17.82 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.382 -0.824 . . . . 0.0 109.537 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.97 -51.1 5.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' B' ' 17' ' ' LYS . 0.1 OUTLIER -71.23 -29.56 65.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.169 -1.194 . . . . 0.0 109.33 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -49.42 114.79 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.925 . . . . 0.0 109.581 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' B' ' 22' ' ' GLU . 95.3 m-20 -78.39 67.65 4.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.01 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' B' ' 22' ' ' GLU . 68.8 t -44.32 -29.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.831 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.14 7.43 0.57 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' B' ' 20' ' ' VAL . 38.5 mt-10 -155.23 -49.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -48.59 -60.72 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.89 -39.22 17.69 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.09 -43.73 89.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.419 ' O ' ' CG ' ' B' ' 30' ' ' ARG . 57.0 mt-10 -79.47 -40.39 29.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.291 -1.123 . . . . 0.0 109.546 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 -34.32 8.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -82.6 -56.67 3.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.73 -44.83 80.35 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' B' ' 26' ' ' GLU . 0.0 OUTLIER -53.89 -36.48 62.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -1.123 . . . . 0.0 109.26 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -55.95 -47.63 77.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 0.0 109.412 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.02 -22.73 67.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.65 -64.72 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 109.358 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -67.64 -22.79 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -139.46 80.97 21.13 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.86 -16.04 9.09 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.668 2.245 . . . . 0.0 112.515 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -51.02 -19.91 1.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.075 -1.016 . . . . 0.0 109.416 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 3.6 p -85.54 55.51 3.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.215 -0.928 . . . . 0.0 109.147 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -109.77 41.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.435 -0.791 . . . . 0.0 109.255 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 mmt-85 -104.03 -49.29 3.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.0 109.479 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' B' ' 41' ' ' PHE . 27.7 m-85 -91.86 30.04 1.46 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.585 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' B' ' 44' ' ' SER . 9.4 p90 -92.55 -12.97 30.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -46.07 -13.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.909 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.544 ' N ' ' O ' ' B' ' 42' ' ' PHE . 23.8 p -124.3 23.49 8.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.245 -0.909 . . . . 0.0 109.583 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.34 -14.2 21.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 0.0 109.322 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.54 -116.76 2.21 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -144.26 105.23 4.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -1.11 . . . . 0.0 109.557 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.94 30.57 1.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.14 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.5 p -44.0 -32.37 1.13 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.817 . . . . 0.0 109.859 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 17.8 p -146.61 148.31 33.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 109.334 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -40.16 -50.2 3.57 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.517 2.145 . . . . 0.0 112.177 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.21 -35.09 76.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.83 -19.77 4.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.507 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.18 -63.95 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 12.2 mmt -63.05 -7.58 5.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.38 -10.24 64.06 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -78.37 141.98 62.22 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.173 -1.192 . . . . 0.0 109.378 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -74.3 -57.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.59 2.193 . . . . 0.0 112.214 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' B' ' 63' ' ' HIS . 45.6 mtpt -51.98 -48.49 64.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.556 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' B' ' 59' ' ' LYS . 74.3 t -45.8 -39.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.0 109.289 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -79.35 -52.4 8.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.85 . . . . 0.0 109.321 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.36 -59.18 3.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.805 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . 0.538 ' N ' ' O ' ' B' ' 59' ' ' LYS . 1.7 t60 -48.29 -24.85 1.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.41 -36.73 91.99 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -69.29 -25.14 64.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -1.125 . . . . 0.0 109.479 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -73.13 -35.35 66.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.559 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 39.6 t -75.75 -28.3 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.21 -34.94 68.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.302 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.51 -45.12 37.44 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.83 91.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -1.209 . . . . 0.0 109.65 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -57.29 -41.07 79.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 109.579 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' SER . . . . . 0.415 ' OG ' ' CE2' ' B' ' 15' ' ' TRP . 5.7 t -76.63 -37.75 55.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.653 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -47.5 -37.57 12.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.535 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -60.4 7.6 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.456 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -55.82 -30.04 60.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.248 -1.148 . . . . 0.0 109.401 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.09 5.4 29.82 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.201 -0.937 . . . . 0.0 109.65 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.522 ' NE2' ' OD1' ' B' ' 80' ' ' ASN . 7.5 t60 -170.93 67.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 109.525 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.93 17.96 1.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -79.63 -29.23 40.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.452 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.522 ' OD1' ' NE2' ' B' ' 77' ' ' HIS . 4.3 p-10 -163.21 95.82 0.86 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.235 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.4 ' H ' HD13 ' B' ' 81' ' ' LEU . 5.0 mp -80.28 -58.91 2.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.204 -0.935 . . . . 0.0 109.64 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -57.46 -23.83 52.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.075 -1.016 . . . . 0.0 109.568 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.06 -54.41 3.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.0 t -61.38 -47.58 85.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -1.157 . . . . 0.0 109.614 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.557 ' N ' ' CG2' ' B' ' 84' ' ' THR . 54.4 m-85 -76.7 22.04 0.19 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.351 -0.843 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.46 -26.8 44.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 75.3 p -78.85 -59.1 2.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.754 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.4 mt -48.63 -45.05 37.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.955 . . . . 0.0 109.288 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 53.9 p -64.72 -52.71 55.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.267 -0.896 . . . . 0.0 109.269 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -61.27 -22.7 65.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 tp -86.9 -68.71 0.73 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.417 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.509 ' O ' ' N ' ' B' ' 97' ' ' HIS . 48.8 m80 -51.01 -26.54 6.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.094 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . 0.407 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 27.5 t -83.73 -55.93 3.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 111.303 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.529 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 27.4 t0 -86.24 -32.2 21.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.001 -1.062 . . . . 0.0 111.945 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -89.36 -51.76 5.39 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.689 -1.257 . . . . 0.0 111.132 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.63 -27.03 15.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.852 -1.155 . . . . 0.0 110.43 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 1.275 ' HD1' ' CG2' ' C' ' 38' ' ' THR . 83.0 m-70 51.67 29.57 5.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.038 -1.039 . . . . 0.0 109.61 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 40.0 t -47.14 130.2 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.968 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.38 152.46 32.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.28 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.88 -164.09 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.553 2.169 . . . . 0.0 112.165 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.26 60.72 2.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.877 . . . . 0.0 109.578 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.515 ' C ' HD21 ' B' ' 102' ' ' ASN . 0.1 OUTLIER -171.3 -41.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.457 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -46.21 -40.55 11.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 109.714 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -80.07 -19.92 46.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.554 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' B' ' 102' ' ' ASN . 12.3 tp -70.47 -59.77 2.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 109.639 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -49.84 -46.22 51.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 109.354 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.06 -20.44 58.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . 0.454 ' O ' ' SG ' ' B' ' 112' ' ' CYS . 18.4 t30 -80.53 -25.2 38.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -1.105 . . . . 0.0 109.577 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 74.2 t -86.19 -43.09 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 109.683 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tt -48.26 -33.05 8.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.464 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -83.05 -26.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.532 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' B' ' 108' ' ' ASN . 72.4 m -69.1 -24.79 64.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.538 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 42.4 t -76.34 -34.89 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' B' ' 118' ' ' PHE . 9.5 mt -69.83 -40.16 76.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 109.413 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -54.4 -28.92 46.93 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 109.438 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.524 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.74 -62.41 1.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.106 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -63.36 -17.75 62.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.551 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' B' ' 114' ' ' LEU . 93.3 m-85 -149.72 60.4 1.0 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 109.402 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.535 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -69.22 -24.72 75.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -64.75 -29.67 70.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -1.153 . . . . 0.0 109.346 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' B' ' 123' ' ' THR . 78.3 mm-40 -87.81 5.71 38.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 109.736 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.543 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.64 33.09 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 109.422 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.523 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.4 p -52.41 149.13 10.88 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.353 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.501 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.1 Cg_exo -45.41 -53.66 5.23 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.452 2.101 . . . . 0.0 112.988 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 24.6 Cg_endo -62.16 -29.65 81.04 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.05 1.834 . . . . 0.0 112.223 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.81 -28.15 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 109.423 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -83.15 -53.89 5.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.78 ' HB3' ' CD1' ' A' ' 34' ' ' LEU . . . -63.25 -26.49 68.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.576 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.51 -2.33 53.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.114 -0.991 . . . . 0.0 109.807 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' B' ' 132' ' ' LYS . 41.8 t80 -92.49 -61.52 1.58 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.717 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -45.25 -23.32 0.17 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 109.931 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' B' ' 130' ' ' TYR . 51.1 mtmt -85.46 -34.6 21.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.217 -0.927 . . . . 0.0 110.322 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 0.6 OUTLIER -68.61 -44.15 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.075 . . . . 0.0 109.676 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.501 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 6.1 m -79.64 -20.91 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' D' ' 146' ' ' HIS . . . -50.51 -32.41 18.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -0.974 . . . . 0.0 109.364 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.63 -26.56 56.36 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.42 -32.96 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -1.148 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.44 90.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.67 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.89 -21.05 47.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.766 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.01 -58.86 6.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.663 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 48.4 mt -61.48 -31.88 71.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 109.497 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.06 25.15 4.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.251 -0.905 . . . . 0.0 109.599 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -80.0 -16.13 55.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.712 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' B' ' 146' ' ' HIS . 13.2 mptt -98.34 -26.72 14.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 0.0 109.613 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -54.38 -6.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.11 -0.994 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.522 ' H ' ' C ' ' B' ' 144' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.428 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' C' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' C' ' 1' ' ' VAL . 9.9 mt 54.47 170.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.353 -0.842 . . . . 0.0 109.621 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.473 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 176.31 -53.58 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.322 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' C' ' 6' ' ' ASP . 59.0 Cg_endo -74.05 -165.15 0.24 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.373 2.048 . . . . 0.0 112.776 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' C' ' 8' ' ' THR . . . -44.0 -15.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.497 -0.752 . . . . 0.0 110.129 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' C' ' 4' ' ' PRO . 53.1 m-20 -38.82 -37.11 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 109.779 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -30.94 26.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.666 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.518 ' N ' ' O ' ' C' ' 5' ' ' ALA . 41.7 m -51.87 -37.52 52.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.068 -1.02 . . . . 0.0 109.283 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -73.87 -33.39 64.05 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -71.69 -52.38 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.87 -45.61 50.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.02 -61.9 2.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.629 -0.669 . . . . 0.0 109.883 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.57 -33.37 63.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.295 -0.878 . . . . 0.0 109.246 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . 0.46 ' HE1' ' HG1' ' C' ' 67' ' ' THR . 0.2 OUTLIER -75.59 -17.38 60.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.285 -0.884 . . . . 0.0 109.029 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.0 -43.24 14.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -70.41 -39.83 74.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -1.199 . . . . 0.0 108.856 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.2 -65.39 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.6 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 57.27 -135.74 51.33 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 28.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.439 -1.036 . . . . 0.0 110.453 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.6 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.7 m-70 -131.92 24.27 4.62 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.19 -62.9 1.39 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.603 -0.686 . . . . 0.0 109.651 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.2 -14.7 0.17 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 21' ' ' ALA . 1.3 mm-40 -84.11 -56.11 3.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.461 -1.023 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.638 ' CD1' ' CD2' ' C' ' 112' ' ' HIS . 3.1 m-30 -60.05 -36.96 78.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.387 -0.821 . . . . 0.0 109.391 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.77 -24.27 69.7 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.31 -45.0 20.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 109.681 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.03 -21.28 61.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.25 -21.48 62.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.671 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 12.4 mt -78.08 -51.59 10.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.1 -12.9 61.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.825 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.557 ' NH2' ' SG ' ' C' ' 104' ' ' CYS . 0.9 OUTLIER -76.4 -40.48 50.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.137 -0.977 . . . . 0.0 110.25 -179.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' MET . . . . . 0.542 ' O ' ' N ' ' C' ' 36' ' ' PHE . 3.0 ptt? -84.04 -35.61 23.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.98 -1.075 . . . . 0.0 109.982 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' C' ' 33' ' ' PHE . 0.0 OUTLIER -45.87 -41.77 11.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.947 . . . . 0.0 109.719 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.775 HD13 ' HB3' ' D' ' 128' ' ' ALA . 2.3 pp -84.59 -35.93 22.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.962 . . . . 0.0 109.937 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.3 p -85.25 1.43 48.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' C' ' 32' ' ' MET . 67.3 m-85 -159.1 68.1 3.23 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' C' ' 39' ' ' THR . 69.3 Cg_exo -47.73 -34.29 20.9 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.8 2.334 . . . . 0.0 112.308 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' THR . . . . . 1.275 ' CG2' ' HD1' ' B' ' 97' ' ' HIS . 2.1 p -47.09 -18.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 109.568 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.441 ' N ' ' O ' ' C' ' 37' ' ' PRO . 81.6 p -84.52 -31.25 24.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.756 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -68.66 -26.43 65.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.951 . . . . 0.0 109.609 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.785 HG23 ' CD2' ' B' ' 97' ' ' HIS . 5.4 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.862 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.53 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 26.7 p80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.838 0.352 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.427 ' O ' ' OG ' ' C' ' 52' ' ' SER . 2.8 p90 -135.91 26.93 3.29 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.047 -1.033 . . . . 0.0 109.611 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' C' ' 49' ' ' SER . 55.6 m-20 44.41 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.393 -0.817 . . . . 0.0 109.568 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.98 -8.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.474 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.531 ' H ' ' C ' ' C' ' 47' ' ' ASP . 35.6 p -68.39 169.48 10.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -78.98 164.3 24.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.525 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.05 17.27 71.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.528 ' C ' ' H ' ' C' ' 54' ' ' GLN . 3.0 t -77.53 -28.54 52.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -1.128 . . . . 0.0 109.516 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 73.18 -31.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.606 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' C' ' 52' ' ' SER . 38.1 mt-30 -80.52 -22.67 40.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 0.0 109.389 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -83.38 -36.09 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.423 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -81.36 -32.89 32.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.138 -0.976 . . . . 0.0 108.674 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.6 -22.01 78.86 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.406 ' ND1' ' C ' ' C' ' 58' ' ' HIS . 10.0 t-80 -70.44 -30.02 66.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -1.134 . . . . 0.0 109.254 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -51.47 57.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -48.29 -23.86 1.02 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 0.0 109.775 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -71.44 -51.08 25.81 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.257 -0.902 . . . . 0.0 108.577 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 25.6 t -60.78 -47.78 91.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.02 -38.71 89.12 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -59.97 -39.29 85.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 108.489 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -64.89 -52.39 56.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' C' ' 70' ' ' VAL . 15.6 mt -57.58 -43.99 85.01 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.46 ' HG1' ' HE1' ' C' ' 14' ' ' TRP . 19.3 m -69.18 -51.36 38.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.285 -0.885 . . . . 0.0 108.702 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -61.53 -26.12 67.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.208 -0.932 . . . . 0.0 108.521 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -85.12 -46.61 10.96 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' C' ' 66' ' ' LEU . 20.8 t -65.11 -22.8 32.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -64.0 -21.69 66.61 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' C' ' 74' ' ' ASP . 42.5 m80 -146.45 -51.89 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.878 . . . . 0.0 109.473 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.4 p 44.71 13.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.74 0.781 . . . . 0.0 109.406 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' C' ' 72' ' ' HIS . 29.2 m-20 -127.03 9.57 6.85 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -173.75 27.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.121 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 4.8 ptt? -78.3 -24.16 0.43 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.514 -0.741 . . . . 0.0 111.679 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.0 Cg_exo -52.97 -27.96 37.81 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.626 1.551 . . . . 0.0 112.398 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.453 HD21 ' N ' ' C' ' 78' ' ' ASN . 1.4 m-80 -94.09 -24.8 17.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.826 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 -46.41 21.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.094 -1.003 . . . . 0.0 109.203 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 9.8 mt -82.03 9.26 8.73 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.42 -0.8 . . . . 0.0 109.024 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' C' ' 77' ' ' PRO . 4.5 m -65.59 -22.44 66.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -82.06 -59.67 2.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.623 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.51 ' C ' ' CD1' ' C' ' 83' ' ' LEU . 0.4 OUTLIER -50.85 -26.09 5.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -67.59 -33.27 74.67 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' C' ' 82' ' ' ALA . 4.2 t70 -78.41 -29.93 47.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 108.79 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.501 ' C ' ' CD1' ' C' ' 86' ' ' LEU . 2.1 tm? -54.48 -49.46 70.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.501 -0.75 . . . . 0.0 109.338 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -92.31 -21.67 20.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.407 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.9 -2.72 55.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.086 -1.009 . . . . 0.0 110.345 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -128.61 -77.01 0.56 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.953 . . . . 0.0 109.847 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -46.64 -78.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.981 . . . . 0.0 109.817 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.521 ' CD1' ' N ' ' C' ' 91' ' ' LEU . 8.2 mp -70.98 -39.17 72.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.569 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 61.86 59.35 1.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.389 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' C' ' 94' ' ' ASP . 90.6 t -85.16 166.6 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 109.669 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' C' ' 96' ' ' VAL . 3.8 m-20 -99.32 120.02 59.02 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.35 -0.843 . . . . 0.0 109.28 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' C' ' 98' ' ' PHE . 82.8 Cg_exo -44.12 -10.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.276 1.984 . . . . 0.0 112.394 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' C' ' 94' ' ' ASP . 95.7 t -45.63 -23.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.346 -0.846 . . . . 0.0 109.659 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' C' ' 95' ' ' PRO . 73.4 m-20 -79.24 -24.82 42.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.598 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' C' ' 102' ' ' SER . 20.5 t80 -46.51 -35.06 5.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.65 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' C' ' 99' ' ' LYS . 0.3 OUTLIER -64.55 -33.31 75.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.428 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 8.9 mt -84.05 -43.86 14.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.477 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -54.32 -52.09 62.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' C' ' 98' ' ' PHE . 15.6 m -59.52 -33.57 71.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 109.934 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . 0.555 ' HD1' ' N ' ' C' ' 103' ' ' HIS . 0.7 OUTLIER -80.71 -26.56 37.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 110.068 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.557 ' SG ' ' NH2' ' C' ' 31' ' ' ARG . 71.8 m -63.9 -58.45 6.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.33 -34.58 4.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.153 -0.967 . . . . 0.0 110.094 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -70.71 -28.3 64.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.044 -1.035 . . . . 0.0 110.176 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.95 -38.22 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 109.579 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.42 ' O ' ' N ' ' C' ' 110' ' ' ALA . 19.2 p -70.67 -58.88 3.19 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.187 -0.945 . . . . 0.0 109.599 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' C' ' 113' ' ' LEU . 9.5 mt -43.18 -26.28 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' C' ' 108' ' ' THR . . . -67.29 -22.62 65.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 110.641 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.34 -47.99 12.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.074 -1.016 . . . . 0.0 111.017 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . 0.638 ' CD2' ' CD1' ' C' ' 24' ' ' TYR . 1.1 p-80 -100.85 -58.81 1.82 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.98 -1.075 . . . . 0.0 111.034 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.518 ' H ' ' CD2' ' C' ' 112' ' ' HIS . 0.9 OUTLIER -112.4 93.43 22.72 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.272 -178.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' C' ' 113' ' ' LEU . 78.0 Cg_exo -47.15 -174.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.355 2.037 . . . . 0.0 112.643 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.657 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -61.65 -55.42 30.79 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.657 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 27.7 mt-10 120.0 1.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' C' ' 117' ' ' PHE . 38.4 t80 59.69 31.7 21.03 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.225 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.781 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.3 p -104.46 120.73 49.62 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.01 23.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.164 1.909 . . . . 0.0 112.679 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.781 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -154.41 -29.95 0.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.945 -1.097 . . . . 0.0 110.701 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 13.7 p -51.14 -50.17 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.95 -1.094 . . . . 0.0 110.302 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.511 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 3.1 t-160 -61.34 -53.3 58.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 109.887 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.79 -19.88 61.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.949 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.573 ' N ' ' O ' ' C' ' 120' ' ' ALA . 20.6 m -63.67 -62.56 1.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 110.254 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' C' ' 129' ' ' LEU . 1.2 mt -64.37 -16.91 63.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.348 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -84.08 -49.04 9.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.89 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.73 -59.04 2.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.879 -1.138 . . . . 0.0 111.302 -178.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.464 ' N ' ' HD2' ' C' ' 127' ' ' LYS . 21.4 m-85 -47.92 -21.31 0.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.82 -1.175 . . . . 0.0 109.811 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' C' ' 125' ' ' LEU . 0.1 OUTLIER -71.99 -31.02 65.84 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' C' ' 134' ' ' THR . . . -49.28 -33.14 12.27 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' SER . . . . . 0.465 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 42.3 t -60.3 -37.07 79.4 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 6.5 t -77.02 -48.73 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.402 ' CB ' ' CE1' ' C' ' 98' ' ' PHE . 13.5 t -66.47 -22.78 66.2 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' THR . . . . . 0.52 ' N ' ' O ' ' C' ' 130' ' ' ALA . 11.2 m -64.08 -31.56 72.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.324 -0.86 . . . . 0.0 108.86 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.75 -37.21 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.134 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.72 -35.21 75.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.277 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 137' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' C' ' 134' ' ' THR . 35.1 p -68.06 -33.6 74.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.371 -0.83 . . . . 0.0 109.492 179.893 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.234 0.54 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mt -87.84 161.07 17.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.31 138.22 19.48 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -40.02 -54.19 2.19 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.526 2.151 . . . . 0.0 112.601 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.04 -21.74 61.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -76.69 -63.1 1.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 109.824 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.475 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -66.66 -29.6 69.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 109.936 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -47.52 -23.63 0.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.959 . . . . 0.0 110.048 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.74 -56.89 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.074 -1.016 . . . . 0.0 109.936 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.19 -24.51 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 26.0 m -73.55 -40.36 64.03 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.379 0.609 . . . . 0.0 109.591 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.37 -31.24 71.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.8 OUTLIER -50.7 -31.47 16.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.154 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . 0.416 ' CE2' ' OG ' ' D' ' 72' ' ' SER . 1.5 t90 -47.44 -18.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.491 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.91 -51.08 6.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.424 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.1 OUTLIER -71.25 -29.6 65.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -1.218 . . . . 0.0 109.335 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -49.26 114.76 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' D' ' 22' ' ' GLU . 95.4 m-20 -78.45 67.6 4.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.321 -0.862 . . . . 0.0 109.074 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' D' ' 22' ' ' GLU . 69.0 t -44.34 -29.1 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.73 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.08 7.39 0.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.557 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' D' ' 20' ' ' VAL . 38.7 mt-10 -155.29 -49.36 0.08 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.0 t -48.69 -60.74 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.92 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.87 -39.15 17.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.1 -43.8 89.29 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' D' ' 30' ' ' ARG . 57.0 mt-10 -79.51 -40.34 29.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -1.169 . . . . 0.0 109.487 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 -34.26 8.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -82.58 -56.75 3.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.307 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.67 -44.78 79.72 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' D' ' 26' ' ' GLU . 0.0 OUTLIER -53.95 -36.44 62.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -1.123 . . . . 0.0 109.31 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -56.01 -47.57 77.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.37 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 mt -65.06 -22.74 67.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.595 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 74.7 t -81.63 -64.68 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -67.67 -22.79 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.501 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -139.41 80.86 21.58 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.77 -16.17 9.14 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.726 2.284 . . . . 0.0 112.437 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -51.04 -19.77 1.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 109.516 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 3.7 p -85.56 55.56 3.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 109.231 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -109.81 41.27 1.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.258 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 57.5 mmt-85 -103.91 -49.34 3.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.82 . . . . 0.0 109.477 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -91.82 29.98 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.585 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' D' ' 44' ' ' SER . 9.4 p90 -92.63 -12.98 30.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -45.92 -14.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.338 -0.851 . . . . 0.0 109.971 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.543 ' N ' ' O ' ' D' ' 42' ' ' PHE . 23.4 p -124.26 23.47 8.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.87 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.4 -14.06 21.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.253 -0.904 . . . . 0.0 109.267 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.43 -116.86 2.25 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -144.3 105.34 4.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.355 -1.085 . . . . 0.0 109.535 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 mt -90.94 30.5 1.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.042 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.8 p -43.91 -32.47 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 109.925 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 17.9 p -146.52 148.4 33.81 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 109.389 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -40.37 -49.96 3.8 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.378 2.052 . . . . 0.0 112.232 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -61.29 -35.06 76.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.92 -19.69 4.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.23 -63.9 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -0.929 . . . . 0.0 109.542 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 12.2 mmt -63.07 -7.59 5.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.5 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.35 -10.25 64.12 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -78.43 141.92 61.89 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.228 -1.16 . . . . 0.0 109.325 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.26 -57.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.492 2.128 . . . . 0.0 112.242 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' D' ' 63' ' ' HIS . 45.7 mtpt -52.02 -48.4 64.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.619 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 73.9 t -45.86 -39.7 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 109.251 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -79.44 -52.34 8.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.315 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.29 -59.26 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.812 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . 0.546 ' N ' ' O ' ' D' ' 59' ' ' LYS . 1.7 t60 -48.25 -24.87 1.31 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.646 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.32 -36.83 92.23 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -69.33 -25.18 64.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -1.12 . . . . 0.0 109.416 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -73.08 -35.32 66.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.575 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 39.8 t -75.72 -28.39 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.454 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.15 -34.92 68.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.33 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.53 -45.14 37.57 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.89 91.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -1.129 . . . . 0.0 109.656 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -57.21 -41.14 78.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.626 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' SER . . . . . 0.416 ' OG ' ' CE2' ' D' ' 15' ' ' TRP . 5.7 t -76.64 -37.8 55.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.655 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -47.32 -37.79 11.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.928 . . . . 0.0 109.517 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.17 -60.31 7.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.45 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -55.95 -29.95 60.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.348 -1.089 . . . . 0.0 109.365 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.05 5.32 30.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.597 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.524 ' NE2' ' OD1' ' D' ' 80' ' ' ASN . 7.5 t60 -170.9 67.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.556 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.94 17.93 1.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.935 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -79.59 -29.22 41.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.524 ' OD1' ' NE2' ' D' ' 77' ' ' HIS . 4.3 p-10 -163.28 95.83 0.85 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.284 -0.885 . . . . 0.0 109.198 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . 0.41 HD13 ' H ' ' D' ' 81' ' ' LEU . 5.0 mp -80.33 -58.85 2.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.58 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -57.61 -23.78 52.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.008 . . . . 0.0 109.46 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.98 -54.4 3.22 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.0 t -61.31 -47.55 85.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -1.166 . . . . 0.0 109.652 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' D' ' 84' ' ' THR . 54.7 m-85 -76.76 22.03 0.19 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.424 -0.797 . . . . 0.0 109.476 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.42 -26.87 44.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.898 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 76.0 p -78.81 -59.23 2.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.3 mt -48.48 -45.06 36.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.319 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 54.0 p -64.74 -52.8 55.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.229 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -61.21 -22.66 64.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.481 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 8.8 tp -87.0 -68.66 0.73 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.433 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' D' ' 97' ' ' HIS . 49.0 m80 -51.0 -26.57 6.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 110.08 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . 0.413 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 27.4 t -83.71 -55.87 4.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.187 -0.945 . . . . 0.0 111.361 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 27.4 t0 -86.27 -32.11 21.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.038 -1.039 . . . . 0.0 111.928 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -89.48 -51.83 5.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.696 -1.253 . . . . 0.0 111.055 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.55 -27.02 15.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.871 -1.143 . . . . 0.0 110.45 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 1.347 ' HD1' ' CG2' ' A' ' 38' ' ' THR . 82.8 m-70 51.68 29.55 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.052 -1.03 . . . . 0.0 109.581 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . 0.422 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 39.8 t -47.18 130.27 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.111 -0.993 . . . . 0.0 109.488 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.31 152.45 31.9 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.344 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.96 -164.09 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.494 2.13 . . . . 0.0 112.206 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.19 60.83 2.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.568 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . 0.515 ' C ' HD21 ' D' ' 102' ' ' ASN . 0.1 OUTLIER -171.27 -41.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.957 . . . . 0.0 109.457 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -46.21 -40.47 11.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.731 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -80.04 -19.99 46.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 0.0 109.577 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' D' ' 102' ' ' ASN . 12.2 tp -70.54 -59.76 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.613 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -49.77 -46.33 50.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.33 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.08 -20.39 57.99 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . 0.449 ' O ' ' SG ' ' D' ' 112' ' ' CYS . 18.3 t30 -80.57 -25.1 38.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -1.165 . . . . 0.0 109.672 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 73.9 t -86.28 -43.09 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.659 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tt -48.08 -33.22 7.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.54 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -82.9 -26.16 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' D' ' 108' ' ' ASN . 72.0 m -69.05 -24.84 64.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.177 -0.952 . . . . 0.0 109.496 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.34 -34.8 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' D' ' 118' ' ' PHE . 9.4 mt -69.82 -40.14 76.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.472 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -54.47 -29.0 48.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.318 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.532 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -84.64 -62.42 1.55 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 109.113 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -63.4 -17.67 62.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 109.639 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' D' ' 114' ' ' LEU . 93.1 m-85 -149.65 60.29 1.01 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.462 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.534 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -69.28 -24.62 75.95 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -64.76 -29.67 70.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -1.154 . . . . 0.0 109.351 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' D' ' 123' ' ' THR . 78.3 mm-40 -87.83 5.76 38.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.862 . . . . 0.0 109.764 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.67 33.12 0.08 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.416 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.525 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.4 p -52.45 149.16 10.94 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.833 . . . . 0.0 109.367 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.498 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.1 Cg_exo -45.52 -53.6 5.35 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.452 2.101 . . . . 0.0 112.907 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 24.3 Cg_endo -62.22 -29.65 80.68 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.063 1.842 . . . . 0.0 112.211 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.72 -28.16 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.185 -0.947 . . . . 0.0 109.537 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -83.18 -53.92 5.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 109.508 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 0.775 ' HB3' HD13 ' C' ' 34' ' ' LEU . . . -63.19 -26.5 68.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.622 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.54 -2.3 53.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 109.823 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' D' ' 132' ' ' LYS . 41.8 t80 -92.42 -61.7 1.55 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.968 . . . . 0.0 109.646 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -45.23 -23.32 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 109.94 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' D' ' 130' ' ' TYR . 51.0 mtmt -85.46 -34.54 21.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.147 -0.971 . . . . 0.0 110.344 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 0.6 OUTLIER -68.59 -44.22 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.995 -1.066 . . . . 0.0 109.649 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.486 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 6.1 m -79.6 -20.98 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' B' ' 146' ' ' HIS . . . -50.41 -32.46 17.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.096 -1.002 . . . . 0.0 109.336 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.59 -26.66 56.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.32 -32.96 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -1.133 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.43 90.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.9 . . . . 0.0 109.626 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.98 -21.06 47.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.664 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.01 -58.92 6.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.42 -31.89 71.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.07 25.2 4.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.289 -0.882 . . . . 0.0 109.549 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -80.0 -16.11 55.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.131 -0.981 . . . . 0.0 109.733 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.518 ' C ' ' H ' ' D' ' 146' ' ' HIS . 13.2 mptt -98.42 -26.64 14.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 109.571 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' D' ' 98' ' ' VAL . 12.1 m-85 -54.43 -6.85 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.336 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.54 ' HB2' ' HB3' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.44 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.0 tp -170.95 164.65 7.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 0.0 109.864 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.569 ' HG ' ' N ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -84.83 165.75 35.68 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.348 -0.845 . . . . 0.0 109.51 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.569 ' N ' ' HG ' ' A' ' 3' ' ' SER . 57.1 Cg_endo -73.64 -77.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.773 2.315 . . . . 0.0 112.655 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -45.22 -30.01 1.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 109.964 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 5' ' ' ALA . 26.2 t0 -43.77 -23.04 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.246 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -83.34 -60.61 2.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.372 -0.83 . . . . 0.0 109.324 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.5 m -44.45 -35.97 2.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.535 -0.728 . . . . 0.0 109.9 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.422 ' C ' ' OG ' ' A' ' 124' ' ' SER . 2.5 m-20 -74.49 -30.02 61.65 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 7' ' ' LYS . 76.6 t -76.31 -53.52 15.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -52.62 -38.28 59.9 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.081 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.04 -63.76 1.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.47 -0.769 . . . . 0.0 109.144 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.7 76.27 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -17.23 62.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 109.03 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -79.02 -46.25 8.43 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -69.17 -38.27 78.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 108.982 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.9 t -61.07 -64.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.579 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 54.43 -132.59 46.55 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.87 26.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -1.073 . . . . 0.0 110.522 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.579 ' H ' ' C ' ' A' ' 18' ' ' GLY . 92.7 m-70 -129.94 22.29 5.36 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -86.7 -60.0 2.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.65 -0.656 . . . . 0.0 109.598 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.4 -14.28 0.18 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 21' ' ' ALA . 7.3 mm-40 -86.85 -56.52 3.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.425 -1.044 . . . . 0.0 109.781 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.8 m-30 -60.67 -37.55 81.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.15 -22.88 71.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.09 -51.43 8.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.144 -1.209 . . . . 0.0 109.839 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.59 -19.8 28.29 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.325 -0.859 . . . . 0.0 109.372 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.2 -23.74 62.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.269 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.5 mt -70.33 -56.15 7.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.303 -0.873 . . . . 0.0 109.459 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.03 -12.62 8.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.404 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -76.29 -61.1 2.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -19.45 65.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.49 -53.15 61.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 0.0 109.715 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.959 HD13 ' HB3' ' B' ' 128' ' ' ALA . 2.2 pp -88.01 -41.87 12.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.941 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.7 t -58.9 -2.27 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.663 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' A' ' 35' ' ' SER . 64.9 m-85 -160.24 81.85 2.27 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 109.418 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -49.17 -27.03 11.85 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.725 2.284 . . . . 0.0 112.316 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.5 p -49.04 -21.42 0.69 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -0.991 . . . . 0.0 109.388 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.9 p -90.36 -27.07 19.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -55.09 -47.51 74.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.636 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.914 HG23 ' CD2' ' D' ' 97' ' ' HIS . 13.1 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.457 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 25.2 p80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.041 0.448 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.465 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -164.73 29.63 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.029 -1.045 . . . . 0.0 110.371 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 46' ' ' PHE . 5.9 m-20 41.04 88.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.533 -0.729 . . . . 0.0 110.113 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.597 ' H ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -61.43 -19.53 62.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.505 -0.747 . . . . 0.0 109.15 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -47.3 121.49 3.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.64 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -65.25 107.86 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.91 -6.58 4.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 54' ' ' GLN . 2.0 t -75.02 -0.23 18.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.39 -1.065 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 71.1 -14.94 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 109.589 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 52' ' ' SER . 54.6 mt-30 -86.09 -28.9 23.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.506 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -82.96 -39.1 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -81.98 -25.56 34.66 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.73 -25.56 64.72 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.526 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 5.8 t-80 -72.75 -42.38 64.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -1.183 . . . . 0.0 109.613 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.96 -46.44 32.46 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.705 ' HZ2' ' HZ3' ' A' ' 61' ' ' LYS . 6.4 mtmm -53.08 -22.66 6.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -1.081 . . . . 0.0 109.912 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.705 ' HZ3' ' HZ2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -73.99 -48.66 28.76 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.037 -1.039 . . . . 0.0 108.599 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -67.85 -45.99 83.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.05 -35.28 80.12 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.488 -0.757 . . . . 0.0 109.398 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 11.7 t70 -65.17 -48.4 73.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.122 -0.986 . . . . 0.0 108.676 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -59.47 -50.68 73.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.47 -49.77 66.75 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -61.8 -54.52 41.12 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.901 . . . . 0.0 108.883 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -60.44 -20.89 61.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 108.777 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.2 -48.08 9.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.38 -22.84 27.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.97 -33.61 68.31 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.601 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.7 m170 -97.2 -66.58 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.441 -0.787 . . . . 0.0 109.557 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 72' ' ' HIS . 13.1 p 44.89 14.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.883 0.849 . . . . 0.0 109.156 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 72' ' ' HIS . 91.6 m-20 -140.49 13.31 2.35 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -175.27 31.85 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.544 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -64.01 -46.46 80.67 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 110.062 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 76' ' ' MET . 81.5 Cg_exo -44.15 -40.78 12.65 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.471 2.114 . . . . 0.0 112.563 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -94.32 -17.21 22.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 109.975 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.8 -58.11 3.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.162 -0.961 . . . . 0.0 109.302 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.401 ' C ' ' N ' ' A' ' 82' ' ' ALA . 11.0 mt -77.69 11.21 2.21 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.367 -0.833 . . . . 0.0 109.045 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.67 -16.21 0.61 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.563 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -80.91 -57.8 3.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.7 mt -44.88 -43.94 9.23 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.91 -27.33 18.21 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.501 -0.749 . . . . 0.0 109.056 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 82' ' ' ALA . 34.4 t70 -76.26 -21.44 56.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.935 . . . . 0.0 109.291 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 90' ' ' LYS . 3.3 tp -82.99 -34.64 26.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -92.42 -21.72 20.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.519 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.33 -98.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.918 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -86.36 -76.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.0 ttmm -45.31 124.51 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 109.765 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.2 mt 54.04 57.73 5.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.307 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.974 ' NE ' ' HG2' ' D' ' 40' ' ' ARG . 85.2 mtm-85 -49.81 -38.91 36.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.614 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.4 t 47.22 -101.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.441 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 0.3 OUTLIER 171.33 137.36 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 109.176 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.24 -16.78 19.5 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.371 2.047 . . . . 0.0 112.014 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.66 -9.47 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.701 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 98' ' ' PHE . 29.6 p30 -78.91 -24.79 43.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.117 -0.989 . . . . 0.0 109.34 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.532 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.7 OUTLIER -50.1 -47.19 54.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.313 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.24 -22.66 66.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.908 . . . . 0.0 109.609 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 42.7 mt -84.01 -62.03 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.651 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.46 -25.82 11.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.081 -1.012 . . . . 0.0 109.708 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 t -69.97 -59.18 3.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.87 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.766 ' ND1' ' OD1' ' B' ' 108' ' ' ASN . 43.2 m170 -63.26 -26.67 68.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.621 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 67.4 m -67.9 -48.25 66.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 109.567 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.88 -41.21 32.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.406 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 106' ' ' LEU . 9.4 mp -68.17 -50.78 52.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 109.522 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.583 ' CG1' HE22 ' B' ' 127' ' ' GLN . 70.4 t -53.99 -51.42 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 110' ' ' ALA . 40.2 m -59.82 -58.47 8.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 113' ' ' LEU . 4.6 mt -45.98 -19.95 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.875 . . . . 0.0 109.643 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -72.29 -35.47 68.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 110.135 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 1.279 ' HB3' ' CE2' ' B' ' 122' ' ' PHE . . . -75.04 -3.78 34.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.031 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.6 -82.3 0.31 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -106.82 94.4 10.42 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.8 175.87 9.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.093 1.862 . . . . 0.0 112.935 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -47.78 -44.84 28.82 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.438 0.637 . . . . 0.0 109.814 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 6.9 mt-10 87.1 5.65 0.31 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 t80 68.38 36.42 3.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.871 -0.518 . . . . 0.0 111.51 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.713 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -96.96 121.65 58.68 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.807 -1.183 . . . . 0.0 108.224 178.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.95 20.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.15 1.9 . . . . 0.0 112.765 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -145.43 -37.66 0.27 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.934 -1.104 . . . . 0.0 110.264 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.648 ' H ' ' HG1' ' A' ' 118' ' ' THR . 7.8 p -46.91 -44.76 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.069 -1.019 . . . . 0.0 110.126 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.507 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 4.8 m-70 -56.7 -50.0 73.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.81 -19.58 34.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.786 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 120' ' ' ALA . 15.5 t -54.82 -58.18 8.59 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.205 -0.934 . . . . 0.0 110.597 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.43 -19.73 30.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.199 -0.938 . . . . 0.0 110.156 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -83.25 -40.36 19.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.887 -1.133 . . . . 0.0 110.18 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' CD ' ' C ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -87.09 -47.21 9.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.005 -1.06 . . . . 0.0 109.63 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -48.63 -21.59 0.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.96 -1.088 . . . . 0.0 109.212 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.622 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.6 mt -69.73 -17.87 63.48 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.457 ' O ' ' OG1' ' A' ' 134' ' ' THR . . . -61.05 -29.97 70.04 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.3 p -82.78 -35.93 26.08 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.419 -0.801 . . . . 0.0 108.973 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.19 -27.34 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.234 -0.916 . . . . 0.0 108.897 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 129' ' ' LEU . 57.4 p -84.17 -24.91 29.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.427 -0.795 . . . . 0.0 109.052 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 18.7 m -78.16 -34.92 49.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.158 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.4 t -78.34 -26.4 14.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.156 -0.965 . . . . 0.0 108.577 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -33.67 76.41 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.3 m -85.26 -15.19 44.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.574 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.608 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -121.42 -175.15 3.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.557 -0.714 . . . . 0.0 109.196 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -79.57 152.76 75.71 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 109.016 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.83 -28.55 75.87 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.526 2.151 . . . . 0.0 112.01 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -86.7 -21.92 26.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.485 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.57 -63.11 1.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.723 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -57.21 -40.4 77.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.791 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.7 t -45.54 -23.71 0.26 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 110.038 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.44 -57.07 3.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.148 -0.97 . . . . 0.0 109.792 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.22 -24.55 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 8.4 m -71.18 -44.45 65.44 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.676 -0.64 . . . . 0.0 109.446 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.41 74.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.358 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.425 ' O ' ' CG2' ' B' ' 18' ' ' VAL . 0.7 OUTLIER -49.27 -21.06 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.193 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -17.3 60.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.5 -57.48 7.34 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.654 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.547 ' HE2' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -86.59 12.5 10.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.979 -1.307 . . . . 0.0 110.929 -178.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' B' ' 14' ' ' LEU . 2.2 t -79.49 114.93 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.839 -1.163 . . . . 0.0 109.007 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.48 82.73 3.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.518 ' C ' ' H ' ' B' ' 22' ' ' GLU . 72.1 t -54.94 -18.21 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 5.0 m-20 -66.21 6.3 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.712 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.518 ' H ' ' C ' ' B' ' 20' ' ' VAL . 35.1 mt-10 -156.01 -52.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 95.3 t -47.57 -35.66 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.705 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.52 -57.55 4.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.5 -50.78 55.65 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.19 -45.98 90.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -1.138 . . . . 0.0 109.602 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.1 -35.22 34.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -84.96 -58.03 2.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 109.654 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.22 -37.45 72.91 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -69.74 -38.48 76.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -1.212 . . . . 0.0 109.734 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 40.6 tp -52.99 -24.22 8.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.074 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' B' ' 36' ' ' PRO . 15.7 mt -75.54 -54.39 7.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.037 -1.04 . . . . 0.0 110.893 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.41 HG23 ' H ' ' B' ' 34' ' ' VAL . 2.2 m -52.72 -49.02 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.712 -1.242 . . . . 0.0 109.764 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.41 ' H ' HG23 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -70.76 -22.72 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 109.126 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -149.43 74.94 9.63 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . 0.48 ' N ' ' O ' ' B' ' 32' ' ' LEU . 72.3 Cg_endo -81.54 -22.87 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.788 2.326 . . . . 0.0 112.219 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -48.98 -19.92 0.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.908 . . . . 0.0 109.47 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.488 ' C ' ' H ' ' B' ' 40' ' ' ARG . 33.5 p -80.35 9.9 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -71.8 12.26 0.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.318 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 0.93 ' HG2' ' NE ' ' C' ' 92' ' ' ARG . 97.4 mtt180 -80.29 -19.77 45.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.52 26.27 4.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.306 -0.871 . . . . 0.0 109.129 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.507 ' CE1' ' CD2' ' B' ' 45' ' ' PHE . 33.4 t80 -148.77 11.73 0.86 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.89 -22.13 40.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.889 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 27.4 p -84.61 7.13 21.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' B' ' 42' ' ' PHE . 3.7 m-85 -81.44 -16.44 52.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.94 -175.37 45.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -83.14 103.84 12.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -1.088 . . . . 0.0 109.578 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' B' ' 48' ' ' LEU . 10.2 mp -88.17 29.73 0.93 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.199 -0.938 . . . . 0.0 109.147 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.1 m -44.88 -35.88 3.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.838 . . . . 0.0 109.789 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 5.5 p -146.43 148.83 35.54 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.61 -36.35 4.71 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.565 2.177 . . . . 0.0 112.501 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.68 -33.58 72.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.743 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.88 63.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.609 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.97 -59.69 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.963 . . . . 0.0 109.525 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' MET . . . . . 0.495 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -87.45 10.54 17.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.37 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.91 -31.22 32.89 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -81.94 147.96 59.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 109.434 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.63 -57.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.544 2.163 . . . . 0.0 112.427 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.03 -33.36 4.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.777 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 70.8 t -61.03 -57.92 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.459 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -64.96 -33.6 76.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.56 -53.65 44.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.589 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -53.3 -24.01 10.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.187 -0.946 . . . . 0.0 109.538 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.08 -23.88 73.08 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.88 -44.08 81.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -1.158 . . . . 0.0 109.164 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -55.35 -47.29 75.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.416 -0.802 . . . . 0.0 109.351 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 25.4 t -58.14 -47.01 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.321 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.42 -35.02 74.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 109.276 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.83 -53.18 46.05 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.11 63.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -1.201 . . . . 0.0 109.616 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -55.85 -31.16 62.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.398 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 33.2 t -76.56 -31.45 57.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.421 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -50.28 -40.02 47.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.368 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.89 -59.95 8.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.455 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -58.16 -26.92 63.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -1.166 . . . . 0.0 109.387 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.05 2.51 46.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.481 ' C ' ' H ' ' B' ' 79' ' ' ASP . 66.0 t60 -170.89 65.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.731 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 80.0 mt -75.85 19.58 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.955 . . . . 0.0 109.432 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' B' ' 77' ' ' HIS . 8.9 m-20 -79.6 -29.49 41.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' B' ' 80' ' ' ASN . 5.4 p30 -173.32 107.09 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' B' ' 81' ' ' LEU . 8.3 mp -80.28 -58.77 2.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.476 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' B' ' 82' ' ' LYS . 0.0 OUTLIER -46.5 -24.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.5 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.71 -50.24 9.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.7 t -82.35 -47.37 12.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -1.133 . . . . 0.0 109.366 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.552 ' N ' ' CG2' ' B' ' 84' ' ' THR . 27.6 m-85 -65.03 1.36 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.732 . . . . 0.0 109.482 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.9 -34.93 66.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.514 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -74.34 -57.55 3.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mp -49.3 -45.0 44.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -63.95 -52.15 61.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.67 -22.83 64.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 6.5 tt -85.51 -62.81 1.44 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' B' ' 97' ' ' HIS . 75.2 m80 -61.34 -20.14 62.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 110.13 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 51.7 t -83.51 -60.63 2.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.022 -1.049 . . . . 0.0 110.571 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.43 -28.32 22.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.047 -1.033 . . . . 0.0 110.994 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -83.99 -51.91 6.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.064 . . . . 0.0 110.686 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 11.7 mt -107.0 -21.29 13.05 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.08 -1.012 . . . . 0.0 109.966 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.876 ' CD2' HG23 ' C' ' 41' ' ' THR . 33.0 p80 43.02 37.46 1.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.346 -0.846 . . . . 0.0 109.971 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.0 130.89 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.195 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -46.94 147.35 2.31 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.39 -16.93 44.1 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.508 2.139 . . . . 0.0 112.086 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' B' ' 101' ' ' GLU . 58.7 mp0 -81.25 55.22 2.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.317 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.441 ' ND2' ' C ' ' B' ' 101' ' ' GLU . 9.8 m-80 -156.1 -37.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -64.16 -38.67 91.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.116 -0.99 . . . . 0.0 109.529 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -69.72 -28.18 65.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.677 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 16.1 mt -71.61 -52.76 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tt -52.17 -47.81 65.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.353 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.73 -20.4 70.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . 0.766 ' OD1' ' ND1' ' A' ' 103' ' ' HIS . 0.4 OUTLIER -83.27 -19.11 36.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -1.177 . . . . 0.0 109.743 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 72.8 t -80.34 -44.56 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.093 -1.004 . . . . 0.0 109.561 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 10.7 mt -47.38 -31.92 4.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.99 -33.47 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.429 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 11.9 m -79.15 -54.51 5.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.48 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 14.0 t -49.52 -46.01 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.426 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.05 -22.83 64.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.855 . . . . 0.0 109.345 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.455 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -80.73 -24.29 38.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.478 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.47 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.77 -61.59 1.75 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 109.346 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.413 ' C ' ' CG ' ' B' ' 118' ' ' PHE . 55.3 m80 -60.25 -17.7 43.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.651 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.413 ' CG ' ' C ' ' B' ' 117' ' ' HIS . 19.2 m-85 -150.29 58.56 0.96 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.585 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -68.64 -28.6 73.05 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -68.99 6.37 0.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.412 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.511 ' C ' ' H ' ' B' ' 123' ' ' THR . 17.8 mm-40 -126.0 -1.2 7.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.448 -0.782 . . . . 0.0 109.438 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 1.279 ' CE2' ' HB3' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -72.75 35.37 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.552 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.511 ' H ' ' C ' ' B' ' 121' ' ' GLU . 13.2 p -50.85 146.64 9.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.3 Cg_exo -48.29 -51.39 10.21 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.382 2.055 . . . . 0.0 113.04 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 39.9 Cg_endo -67.57 -27.67 38.8 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.063 1.842 . . . . 0.0 112.496 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.412 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 55.5 t -77.39 -24.14 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.494 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . 0.583 HE22 ' CG1' ' A' ' 107' ' ' VAL . 9.1 tt0 -83.28 -54.55 4.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.959 ' HB3' HD13 ' A' ' 34' ' ' LEU . . . -49.19 -44.07 42.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.488 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.37 13.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.884 . . . . 0.0 109.597 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' B' ' 128' ' ' ALA . 32.0 t80 -97.95 -59.89 1.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . 0.408 ' OE1' ' CZ ' ' A' ' 36' ' ' PHE . 38.2 tt0 -47.45 -30.53 3.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -66.15 -46.62 76.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 109.753 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.73 -55.55 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.109 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.95 -36.76 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -0.942 . . . . 0.0 110.02 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -50.16 -24.57 2.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.486 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.99 -31.41 55.6 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.2 t -82.78 -29.89 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.18 -1.188 . . . . 0.0 109.523 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.77 77.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.471 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . 1.169 ' OD1' ' CE1' ' D' ' 146' ' ' HIS . 4.2 m120 -71.33 -27.75 63.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.514 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.36 -60.38 2.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.92 -16.14 2.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.26 -3.07 13.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.368 -0.832 . . . . 0.0 109.516 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 139' ' ' ASN . 21.9 t-80 -64.27 -33.28 75.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.505 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -82.45 -29.74 30.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.561 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -51.37 -20.98 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 1.222 ' CE1' ' OD1' ' D' ' 139' ' ' ASN . 43.0 m80 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.477 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 14.0 tp -170.86 164.68 7.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.113 -0.992 . . . . 0.0 109.869 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.577 ' HG ' ' N ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER -84.76 165.88 35.11 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.496 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.577 ' N ' ' HG ' ' C' ' 3' ' ' SER . 56.9 Cg_endo -73.72 -77.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.79 2.327 . . . . 0.0 112.591 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -45.17 -30.1 1.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 109.953 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' C' ' 5' ' ' ALA . 26.3 t0 -43.62 -23.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.323 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' C' ' 10' ' ' VAL . 0.0 OUTLIER -83.39 -60.51 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.385 -0.822 . . . . 0.0 109.33 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.402 ' C ' ' O ' ' C' ' 7' ' ' LYS . 45.6 m -44.43 -36.0 2.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 109.805 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . 0.424 ' C ' ' OG ' ' C' ' 124' ' ' SER . 2.5 m-20 -74.46 -30.12 61.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' C' ' 7' ' ' LYS . 76.8 t -76.27 -53.49 15.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' C' ' 7' ' ' LYS . 0.0 OUTLIER -52.78 -38.17 60.69 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.03 -63.72 1.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.203 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.77 76.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.396 -0.815 . . . . 0.0 108.818 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -17.22 62.53 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.049 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' C' ' 11' ' ' LYS . . . -79.07 -46.24 8.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -69.21 -38.25 78.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 0.0 108.922 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.11 -65.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 54.42 -132.49 46.48 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.9 26.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.481 -1.011 . . . . 0.0 110.49 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.598 ' H ' ' C ' ' C' ' 18' ' ' GLY . 92.7 m-70 -129.89 22.25 5.38 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -86.72 -60.09 2.08 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.681 -0.637 . . . . 0.0 109.512 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.33 -14.27 0.17 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' C' ' 21' ' ' ALA . 7.3 mm-40 -86.84 -56.57 3.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -1.087 . . . . 0.0 109.795 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.8 m-30 -60.73 -37.51 81.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -22.89 71.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.2 -51.33 8.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -1.199 . . . . 0.0 109.841 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.58 -19.89 28.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.17 -23.76 62.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.286 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 26.8 mt -70.28 -56.12 7.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 109.444 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.06 -12.63 8.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -76.3 -61.18 2.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.894 . . . . 0.0 109.726 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -19.44 65.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.607 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.49 -53.27 60.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.639 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.925 HD13 ' HB3' ' D' ' 128' ' ' ALA . 2.2 pp -87.87 -41.99 12.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 0.0 109.919 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.8 t -58.89 -2.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.096 -1.002 . . . . 0.0 109.637 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' C' ' 35' ' ' SER . 64.9 m-85 -160.07 81.78 2.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.468 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -49.17 -26.93 11.71 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.696 2.264 . . . . 0.0 112.302 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 5.2 p -49.1 -21.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.363 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.3 p -90.28 -27.17 19.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.55 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -55.11 -47.43 74.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.608 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.876 HG23 ' CD2' ' B' ' 97' ' ' HIS . 13.0 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 0.0 109.398 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.451 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 25.0 p80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.056 0.455 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.47 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -164.74 29.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.981 -1.074 . . . . 0.0 110.301 179.206 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' C' ' 46' ' ' PHE . 5.9 m-20 41.0 88.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.554 -0.716 . . . . 0.0 110.119 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.589 ' H ' ' CD1' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -61.44 -19.58 62.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.448 -0.782 . . . . 0.0 109.239 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -47.25 121.51 3.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.632 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.15 107.87 1.69 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 109.369 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.87 -6.54 4.44 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.517 ' C ' ' H ' ' C' ' 54' ' ' GLN . 2.0 t -75.07 -0.12 17.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -1.042 . . . . 0.0 109.427 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 71.02 -14.87 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.845 . . . . 0.0 109.63 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' C' ' 52' ' ' SER . 54.8 mt-30 -86.07 -29.04 23.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -82.85 -39.11 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.955 . . . . 0.0 109.328 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -82.0 -25.62 34.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 108.542 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.73 -25.56 64.7 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.532 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 5.7 t-80 -72.79 -42.38 63.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -1.179 . . . . 0.0 109.631 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.93 -46.5 32.28 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.703 ' HZ2' ' HZ3' ' C' ' 61' ' ' LYS . 6.4 mtmm -53.04 -22.61 6.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.997 . . . . 0.0 109.911 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . 0.703 ' HZ3' ' HZ2' ' C' ' 60' ' ' LYS . 0.3 OUTLIER -74.01 -48.76 28.02 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.115 -0.991 . . . . 0.0 108.502 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -67.75 -46.05 83.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.92 -35.42 80.56 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.454 -0.778 . . . . 0.0 109.355 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 11.6 t70 -65.19 -48.36 73.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.946 . . . . 0.0 108.654 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -59.53 -50.64 73.14 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.44 -49.85 66.5 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -61.67 -54.62 40.29 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.205 -0.934 . . . . 0.0 108.897 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -60.31 -21.03 61.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 108.756 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.2 -48.1 9.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -68.32 -22.83 27.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.62 68.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.596 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.7 m170 -97.26 -66.47 0.9 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.428 -0.795 . . . . 0.0 109.556 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' C' ' 72' ' ' HIS . 13.1 p 44.78 14.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.978 0.894 . . . . 0.0 109.214 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' C' ' 72' ' ' HIS . 91.2 m-20 -140.57 13.37 2.33 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -175.23 31.81 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.537 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -63.9 -46.47 81.34 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 110.099 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' C' ' 76' ' ' MET . 81.6 Cg_exo -44.21 -40.72 12.81 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.468 2.112 . . . . 0.0 112.607 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -94.25 -17.31 22.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.985 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.8 -57.95 3.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 109.309 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . 0.403 ' C ' ' N ' ' C' ' 82' ' ' ALA . 11.0 mt -77.79 11.22 2.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.06 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.68 -16.24 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.513 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -80.89 -57.69 3.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.669 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' C' ' 82' ' ' ALA . 3.8 mt -44.95 -43.96 9.43 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.85 -27.33 17.86 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' C' ' 82' ' ' ALA . 34.4 t70 -76.32 -21.55 56.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.283 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' C' ' 90' ' ' LYS . 3.3 tp -82.9 -34.56 26.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.281 -0.887 . . . . 0.0 109.47 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -92.47 -21.75 19.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 109.495 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.28 -98.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.901 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -86.26 -76.41 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.853 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' C' ' 86' ' ' LEU . 6.9 ttmm -45.27 124.54 4.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.799 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 16.1 mt 53.97 57.7 5.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.846 . . . . 0.0 109.345 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . 0.93 ' NE ' ' HG2' ' B' ' 40' ' ' ARG . 85.3 mtm-85 -49.87 -38.77 36.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.822 . . . . 0.0 109.649 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 58.3 t 47.14 -101.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 109.335 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.439 ' O ' ' ND2' ' C' ' 97' ' ' ASN . 0.3 OUTLIER 171.42 137.39 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.134 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.28 -16.75 19.44 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.366 2.044 . . . . 0.0 112.036 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.66 -9.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.86 . . . . 0.0 109.671 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' C' ' 98' ' ' PHE . 29.7 p30 -78.94 -24.78 43.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 109.29 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . 0.523 ' N ' ' OD1' ' C' ' 97' ' ' ASN . 0.7 OUTLIER -50.18 -47.14 54.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.292 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.21 -22.7 66.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.594 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.492 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 43.5 mt -84.04 -62.04 1.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.585 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.37 -25.81 10.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 109.725 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -70.02 -59.16 3.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.18 -0.95 . . . . 0.0 109.805 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . 0.77 ' ND1' ' OD1' ' D' ' 108' ' ' ASN . 43.4 m170 -63.37 -26.58 68.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.644 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 67.9 m -67.99 -48.17 66.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.89 -41.24 32.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.962 . . . . 0.0 109.362 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' C' ' 106' ' ' LEU . 9.4 mp -68.1 -50.74 52.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 109.568 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . 0.584 ' CG1' HE22 ' D' ' 127' ' ' GLN . 70.0 t -54.06 -51.3 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.356 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.452 ' O ' ' N ' ' C' ' 110' ' ' ALA . 39.9 m -59.91 -58.46 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' C' ' 113' ' ' LEU . 4.5 mt -45.99 -19.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.374 -0.829 . . . . 0.0 109.592 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' C' ' 108' ' ' THR . . . -72.36 -35.38 68.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.147 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . 1.298 ' HB3' ' CE2' ' D' ' 122' ' ' PHE . . . -75.15 -3.67 34.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 110.012 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.72 -82.23 0.3 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 109.386 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' C' ' 109' ' ' LEU . 0.3 OUTLIER -106.91 94.47 10.67 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 175.9 9.67 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.169 1.913 . . . . 0.0 112.903 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -47.82 -44.84 29.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.641 -0.662 . . . . 0.0 109.85 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 6.9 mt-10 87.06 5.81 0.31 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 t80 68.27 36.46 3.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.826 -0.546 . . . . 0.0 111.523 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.718 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -96.93 121.63 58.79 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.796 -1.19 . . . . 0.0 108.226 178.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -51.02 20.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.104 1.869 . . . . 0.0 112.826 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.718 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -145.37 -37.72 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.897 -1.127 . . . . 0.0 110.258 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.657 ' H ' ' HG1' ' C' ' 118' ' ' THR . 7.8 p -46.88 -44.77 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.156 -0.965 . . . . 0.0 110.172 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.508 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 4.7 m-70 -56.68 -49.9 73.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.412 -0.805 . . . . 0.0 109.78 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.87 -19.57 34.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.771 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.536 ' N ' ' O ' ' C' ' 120' ' ' ALA . 15.3 t -54.78 -58.33 7.97 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 110.606 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 mt -85.22 -19.71 31.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.147 -0.971 . . . . 0.0 110.227 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -83.33 -40.29 19.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.898 -1.126 . . . . 0.0 110.202 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.472 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -87.17 -47.17 9.09 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.863 -1.148 . . . . 0.0 109.649 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -48.71 -21.55 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.018 -1.052 . . . . 0.0 109.22 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.613 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.7 mt -69.69 -17.9 63.51 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' C' ' 134' ' ' THR . . . -61.09 -29.96 70.07 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 53.2 p -82.73 -35.86 26.28 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.475 -0.766 . . . . 0.0 109.033 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.34 -27.32 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -0.946 . . . . 0.0 108.793 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.613 ' N ' ' O ' ' C' ' 129' ' ' LEU . 56.8 p -84.08 -24.9 30.18 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.455 -0.778 . . . . 0.0 109.162 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 18.8 m -78.04 -35.1 50.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 109.146 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 96.6 t -78.16 -26.41 14.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.226 -0.921 . . . . 0.0 108.641 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.83 -33.59 76.21 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 76.0 m -85.29 -15.17 44.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.446 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.577 179.978 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -121.35 -175.04 2.98 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.443 -0.786 . . . . 0.0 109.2 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -79.77 152.79 75.2 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.344 -0.847 . . . . 0.0 109.045 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.83 -28.42 75.78 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.528 2.152 . . . . 0.0 112.024 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -86.85 -21.87 26.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.61 -63.02 1.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.733 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.51 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -57.27 -40.42 77.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 109.742 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.7 t -45.58 -23.61 0.25 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 110.08 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -81.44 -57.19 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.074 -1.016 . . . . 0.0 109.795 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.13 -24.49 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 8.4 m -71.17 -44.59 65.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.7 -0.625 . . . . 0.0 109.391 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.46 74.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.424 ' O ' ' CG2' ' D' ' 18' ' ' VAL . 0.7 OUTLIER -49.31 -21.06 0.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.839 . . . . 0.0 109.148 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -17.3 60.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 109.632 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.41 -57.51 7.38 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.665 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.548 ' H ' ' HE2' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -86.68 12.62 10.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.007 -1.29 . . . . 0.0 110.922 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' D' ' 14' ' ' LEU . 2.2 t -79.65 115.03 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.822 -1.174 . . . . 0.0 108.959 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -76.53 82.72 3.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 109.488 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' D' ' 22' ' ' GLU . 71.1 t -54.8 -18.39 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' D' ' 21' ' ' ASP . 5.1 m-20 -66.15 6.3 0.42 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.89 . . . . 0.0 109.632 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' D' ' 20' ' ' VAL . 35.3 mt-10 -155.95 -52.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 95.7 t -47.53 -35.74 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.693 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.48 -57.57 4.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.51 -50.79 55.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.19 -45.94 91.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -1.119 . . . . 0.0 109.541 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.21 -35.23 35.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.621 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -84.97 -58.03 2.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.176 -0.952 . . . . 0.0 109.613 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.23 -37.48 73.06 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -69.73 -38.44 76.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -1.209 . . . . 0.0 109.775 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 40.7 tp -53.0 -24.18 8.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 110.149 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' D' ' 36' ' ' PRO . 15.8 mt -75.48 -54.5 6.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.01 -1.057 . . . . 0.0 110.882 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . 0.405 HG23 ' H ' ' D' ' 34' ' ' VAL . 2.3 m -52.73 -48.95 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.743 -1.223 . . . . 0.0 109.769 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . 0.405 ' H ' HG23 ' D' ' 33' ' ' VAL . 0.0 OUTLIER -70.78 -22.69 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.077 -1.015 . . . . 0.0 109.158 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -149.42 74.87 9.64 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . 0.49 ' N ' ' O ' ' D' ' 32' ' ' LEU . 72.4 Cg_endo -81.49 -22.92 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.84 2.36 . . . . 0.0 112.244 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -48.91 -20.0 0.45 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.478 ' C ' ' H ' ' D' ' 40' ' ' ARG . 33.5 p -80.29 9.86 5.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.905 . . . . 0.0 109.563 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -71.8 12.26 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 109.388 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . 0.974 ' HG2' ' NE ' ' A' ' 92' ' ' ARG . 97.4 mtt180 -80.26 -19.8 45.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 109.409 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.55 26.27 4.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.172 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.515 ' CE1' ' CD2' ' D' ' 45' ' ' PHE . 33.3 t80 -148.78 11.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.406 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.95 -22.09 39.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 27.2 p -84.65 7.01 21.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . 0.515 ' CD2' ' CE1' ' D' ' 42' ' ' PHE . 3.6 m-85 -81.38 -16.42 52.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.18 -0.95 . . . . 0.0 109.442 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.03 -175.32 45.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -83.13 103.86 12.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -1.123 . . . . 0.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' D' ' 48' ' ' LEU . 10.2 mp -88.27 29.75 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.849 . . . . 0.0 109.116 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.9 m -44.84 -35.85 2.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.379 -0.826 . . . . 0.0 109.807 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -146.47 148.73 35.09 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -42.57 -36.39 4.68 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.546 2.164 . . . . 0.0 112.444 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.68 -33.52 72.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.12 -0.987 . . . . 0.0 109.706 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.29 -19.7 63.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.406 -0.809 . . . . 0.0 109.561 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 62.6 t -61.08 -59.68 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -87.43 10.55 17.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.87 -31.22 33.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -81.92 147.92 59.48 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.155 -1.203 . . . . 0.0 109.426 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.56 -57.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.57 2.18 . . . . 0.0 112.542 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -33.38 4.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 109.775 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.05 -57.92 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.977 . . . . 0.0 109.434 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -65.01 -33.53 76.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.251 -0.906 . . . . 0.0 109.618 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.56 -53.71 43.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.56 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -53.27 -24.01 10.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.571 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.12 -23.7 73.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.96 -44.08 81.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -1.107 . . . . 0.0 109.192 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -55.4 -47.14 76.35 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.384 -0.822 . . . . 0.0 109.388 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.23 -46.94 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.31 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.48 -34.98 74.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.268 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.93 -53.16 46.43 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.11 63.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -1.193 . . . . 0.0 109.523 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -55.87 -31.08 62.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.449 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 33.1 t -76.58 -31.47 57.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -50.23 -40.06 46.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.88 -59.96 8.39 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.441 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.6 mp -58.19 -26.89 63.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -1.132 . . . . 0.0 109.358 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.02 2.41 46.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.617 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.467 ' C ' ' H ' ' D' ' 79' ' ' ASP . 66.2 t60 -170.84 66.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.928 . . . . 0.0 109.654 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.83 19.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.407 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' D' ' 77' ' ' HIS . 8.8 m-20 -79.61 -29.47 41.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.529 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.42 ' O ' ' OD1' ' D' ' 80' ' ' ASN . 5.5 p30 -173.3 107.0 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' D' ' 81' ' ' LEU . 8.3 mp -80.21 -58.77 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.915 . . . . 0.0 109.494 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . 0.412 ' HD2' ' H ' ' D' ' 82' ' ' LYS . 0.0 OUTLIER -46.45 -24.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.582 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.73 -50.21 9.52 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.7 t -82.34 -47.3 12.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -1.173 . . . . 0.0 109.409 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.545 ' N ' ' CG2' ' D' ' 84' ' ' THR . 27.9 m-85 -65.08 1.35 0.99 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.55 -0.719 . . . . 0.0 109.504 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.85 -35.05 66.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.188 -0.945 . . . . 0.0 109.388 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 29.9 p -74.37 -57.54 3.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.426 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mp -49.37 -44.95 45.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -63.89 -52.2 61.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.474 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.68 -22.8 64.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 6.5 tt -85.65 -62.6 1.49 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.694 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' D' ' 97' ' ' HIS . 75.1 m80 -61.43 -20.17 62.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 110.079 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 51.6 t -83.51 -60.71 2.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.582 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.36 -28.32 22.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.991 -1.068 . . . . 0.0 111.026 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -83.88 -52.04 6.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.0 -1.062 . . . . 0.0 110.742 -178.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.589 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 11.6 mt -106.87 -21.31 13.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.024 -1.047 . . . . 0.0 110.05 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.914 ' CD2' HG23 ' A' ' 41' ' ' THR . 33.1 p80 43.03 37.47 1.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.842 . . . . 0.0 109.931 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.09 130.92 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.167 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -46.94 147.36 2.31 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.33 -16.94 44.39 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.495 2.13 . . . . 0.0 112.119 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' D' ' 101' ' ' GLU . 58.7 mp0 -81.3 55.27 2.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.344 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . 0.437 ' ND2' ' C ' ' D' ' 101' ' ' GLU . 10.0 m-80 -156.19 -37.67 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.982 . . . . 0.0 109.688 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -64.12 -38.76 92.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -69.68 -28.1 65.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.66 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.71 -52.76 16.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tt -52.2 -47.75 65.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.405 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.71 -20.45 70.22 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . 0.77 ' OD1' ' ND1' ' C' ' 103' ' ' HIS . 0.4 OUTLIER -83.24 -19.12 36.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -1.167 . . . . 0.0 109.753 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 73.0 t -80.31 -44.54 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.616 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 mt -47.37 -32.0 4.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.423 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 10.5 t -58.86 -33.64 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 11.8 m -79.06 -54.54 5.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 14.0 t -49.47 -46.04 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.406 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.0 -22.92 64.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.463 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -80.62 -24.37 39.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.471 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.73 -61.65 1.74 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.359 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . 0.416 ' C ' ' CG ' ' D' ' 118' ' ' PHE . 55.2 m80 -60.18 -17.73 43.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.416 ' CG ' ' C ' ' D' ' 117' ' ' HIS . 19.0 m-85 -150.27 58.57 0.96 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.88 . . . . 0.0 109.633 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -68.6 -28.65 73.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -68.92 6.35 0.92 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -1.108 . . . . 0.0 109.41 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' D' ' 123' ' ' THR . 17.7 mm-40 -126.0 -1.22 7.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.436 -0.79 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 1.298 ' CE2' ' HB3' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -72.67 35.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.849 . . . . 0.0 109.517 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.513 ' H ' ' C ' ' D' ' 121' ' ' GLU . 13.1 p -50.82 146.58 9.85 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.427 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.482 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.3 Cg_exo -48.22 -51.44 10.08 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.315 2.01 . . . . 0.0 113.057 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 39.4 Cg_endo -67.63 -27.7 38.39 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.013 1.809 . . . . 0.0 112.436 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . 0.413 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 55.6 t -77.3 -24.1 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.143 -0.973 . . . . 0.0 109.523 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . 0.584 HE22 ' CG1' ' C' ' 107' ' ' VAL . 9.1 tt0 -83.34 -54.52 4.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 0.925 ' HB3' HD13 ' C' ' 34' ' ' LEU . . . -49.14 -44.1 42.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.497 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.39 13.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.573 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' D' ' 128' ' ' ALA . 32.0 t80 -97.89 -59.89 1.67 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.64 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . 0.402 ' OE1' ' CZ ' ' C' ' 36' ' ' PHE . 38.2 tt0 -47.46 -30.49 3.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -66.05 -46.72 76.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.774 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 38.4 t -59.77 -55.55 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 110.043 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.91 -36.85 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.991 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -50.0 -24.64 2.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.511 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.96 -31.43 55.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -82.69 -30.06 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -1.166 . . . . 0.0 109.495 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.64 77.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.91 . . . . 0.0 109.46 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . 1.222 ' OD1' ' CE1' ' B' ' 146' ' ' HIS . 4.2 m120 -71.35 -27.89 63.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.414 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.23 -60.42 2.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.428 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.96 -16.13 2.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.348 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.2 -3.04 13.96 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.309 -0.869 . . . . 0.0 109.569 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' D' ' 139' ' ' ASN . 22.0 t-80 -64.22 -33.28 75.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.867 . . . . 0.0 109.581 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -82.42 -29.76 30.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -51.33 -21.05 1.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 1.169 ' CE1' ' OD1' ' B' ' 139' ' ' ASN . 43.0 m80 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.475 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.475 ' CB ' ' O ' ' A' ' 1' ' ' VAL . 7.1 tp 73.73 170.63 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.564 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.461 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 174.42 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.937 . . . . 0.0 110.106 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 3' ' ' SER . 95.5 Cg_exo -41.41 168.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.597 2.198 . . . . 0.0 112.902 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -50.76 -16.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.444 -0.785 . . . . 0.0 109.994 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 5' ' ' ALA . 2.8 p30 -39.78 -28.33 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.382 -0.824 . . . . 0.0 109.819 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.726 ' HZ3' ' HZ3' ' A' ' 11' ' ' LYS . 5.9 ptmm? -83.27 -52.38 6.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.414 ' H ' ' CG ' ' A' ' 7' ' ' LYS . 48.9 m -47.93 -26.75 1.84 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 108.928 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -79.99 -39.34 30.23 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' LYS . 21.2 t -69.43 -47.01 75.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.726 ' HZ3' ' HZ3' ' A' ' 7' ' ' LYS . 2.4 mptm? -50.22 -48.5 54.41 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.58 -63.1 1.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.502 0.667 . . . . 0.0 109.303 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.75 -41.75 56.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -0.817 . . . . 0.0 109.112 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.95 -17.4 64.43 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.377 -0.827 . . . . 0.0 109.047 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -79.62 -47.5 7.26 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -68.39 -36.74 79.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -1.121 . . . . 0.0 108.766 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.96 -66.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.575 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 63.44 -141.44 45.87 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.13 37.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.462 -1.022 . . . . 0.0 110.177 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.575 ' H ' ' C ' ' A' ' 18' ' ' GLY . 89.5 m-70 -140.2 24.61 2.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.3 -48.78 7.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.664 -0.647 . . . . 0.0 109.961 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.38 -14.71 28.23 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' O ' ' OE1' ' A' ' 27' ' ' GLU . 12.6 mt-10 -85.68 -56.28 3.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.9 m-30 -55.18 -27.11 43.42 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.369 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.05 -24.45 76.5 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.69 -36.3 28.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -1.123 . . . . 0.0 109.625 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 23' ' ' GLU . 1.4 mp0 -70.4 -19.88 62.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.96 . . . . 0.0 109.296 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.65 -19.73 60.76 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.277 -0.889 . . . . 0.0 109.072 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.86 -58.14 3.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 109.712 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -51.01 -43.68 60.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 109.655 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -56.25 -30.57 62.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 109.642 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 38.6 ttp -84.24 -57.16 3.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.906 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.438 ' CZ ' ' CZ ' ' A' ' 46' ' ' PHE . 25.7 m-85 -47.66 -36.94 11.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.978 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.588 HD11 ' CB ' ' B' ' 128' ' ' ALA . 3.5 pp -84.48 -25.74 28.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.925 -1.11 . . . . 0.0 109.809 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 28.1 t -60.93 -21.97 63.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 109.534 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 1.025 ' HZ ' ' OE1' ' B' ' 131' ' ' GLN . 66.6 m-85 -156.2 128.76 4.15 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.965 . . . . 0.0 109.2 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.59 -20.23 15.92 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.348 2.032 . . . . 0.0 111.986 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.6 p -62.67 -18.77 62.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 109.572 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.4 p -80.99 -35.55 31.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.779 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -67.59 -36.5 81.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.963 . . . . 0.0 109.662 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.404 HG22 ' CD2' ' D' ' 97' ' ' HIS . 15.2 t . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.209 -0.932 . . . . 0.0 109.844 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.066 0.46 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.479 ' C ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -165.44 26.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.071 -1.018 . . . . 0.0 110.385 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.604 ' C ' ' H ' ' A' ' 49' ' ' SER . 22.3 m-20 41.63 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.534 -0.729 . . . . 0.0 110.249 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.791 ' H ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -56.5 0.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.604 ' H ' ' C ' ' A' ' 47' ' ' ASP . 2.8 t -46.56 132.18 10.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.96 . . . . 0.0 109.668 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.526 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 11.3 t-80 -76.23 144.15 40.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.413 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.526 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 73.2 10.15 77.92 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.474 ' OG ' ' N ' ' A' ' 53' ' ' ALA . 88.7 p -68.98 -100.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -1.184 . . . . 0.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.474 ' N ' ' OG ' ' A' ' 52' ' ' SER . . . -178.39 -31.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.377 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -81.23 -17.71 48.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.926 . . . . 0.0 109.087 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.48 -33.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 109.682 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -70.81 -28.34 64.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.076 -1.015 . . . . 0.0 109.262 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' O ' ' CE ' ' A' ' 61' ' ' LYS . . . -69.71 -48.1 44.59 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.538 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.6 OUTLIER -54.2 -35.56 62.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -1.11 . . . . 0.0 109.392 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.29 -58.69 10.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -51.65 -24.03 5.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -1.174 . . . . 0.0 109.593 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' CE ' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -77.35 -23.47 50.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.332 -0.855 . . . . 0.0 108.896 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.36 -52.91 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 108.712 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.488 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -66.27 -24.21 66.53 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.421 -0.8 . . . . 0.0 109.574 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.14 -33.0 33.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' A' ' 68' ' ' ASN . . . -82.63 -34.32 27.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.489 ' O ' ' CD1' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -81.63 -23.03 37.25 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.98 -1.075 . . . . 0.0 108.116 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 63' ' ' ALA . 18.5 m -78.05 -43.87 28.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.052 -1.03 . . . . 0.0 108.704 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 69' ' ' ALA . 1.6 p-10 -58.15 -21.91 48.93 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.61 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -78.78 -47.47 16.68 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.62 -22.37 30.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.01 -17.67 63.28 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.419 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.563 ' O ' ' N ' ' A' ' 74' ' ' ASP . 38.3 m80 -143.81 -53.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.343 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.3 p 45.03 15.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.776 0.798 . . . . 0.0 109.286 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 72' ' ' HIS . 89.8 m-20 -131.73 9.64 4.63 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -174.33 27.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.358 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.694 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.3 ptt? -78.56 -24.41 0.43 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.519 -0.738 . . . . 0.0 111.804 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.2 Cg_exo -53.19 -29.49 46.55 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.79 1.66 . . . . 0.0 112.573 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.428 ' O ' ' OG ' ' A' ' 81' ' ' SER . 8.5 t-20 -94.1 -11.29 30.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 109.828 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.22 -58.23 3.04 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.107 -0.995 . . . . 0.0 109.258 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.35 13.94 2.69 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 2.5 p -59.22 -15.8 17.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.785 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.4 -53.61 6.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.0 109.912 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.443 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 3.5 mt -44.79 -42.3 7.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.0 108.901 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.4 p -54.56 -29.21 50.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.545 -0.722 . . . . 0.0 109.517 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' ALA . 49.4 t0 -82.53 -16.92 46.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.334 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 tt -81.04 -62.23 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.956 -1.09 . . . . 0.0 111.249 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.4 p-80 -77.0 -21.53 54.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.886 -1.133 . . . . 0.0 111.163 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.74 23.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.778 -1.201 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 90' ' ' LYS . 15.4 t-80 -99.78 -74.81 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.171 -0.956 . . . . 0.0 110.132 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 89' ' ' HIS . 17.8 mtpp -52.0 -101.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 109.986 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.468 ' H ' ' CD1' ' A' ' 91' ' ' LEU . 10.0 mp -45.12 -31.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 58.17 41.91 22.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.495 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' HIS . 5.9 t -66.84 168.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 109.353 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' VAL . 1.1 p-10 -123.46 152.09 64.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.336 -0.852 . . . . 0.0 109.333 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -41.6 -14.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.681 2.254 . . . . 0.0 112.558 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.867 HG13 ' HB3' ' D' ' 99' ' ' ASP . 46.9 t -59.29 -28.29 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 0.0 109.877 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.666 HD21 ' N ' ' A' ' 97' ' ' ASN . 0.6 OUTLIER -79.5 -24.8 42.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.95 . . . . 0.0 109.7 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -65.65 -41.95 91.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -47.28 -30.21 2.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.558 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 3.7 mm? -84.11 -60.04 2.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.5 tt -53.34 -20.78 4.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 109.76 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -77.65 -59.06 2.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.818 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.832 ' HE2' ' HH ' ' B' ' 35' ' ' TYR . 32.1 m170 -64.55 -26.57 68.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 109.915 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 95.4 m -61.06 -58.01 10.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.895 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.92 -30.88 1.91 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 109.576 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.5 mt -75.06 -52.18 11.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.593 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.3 -24.76 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 109.445 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.6 m -73.61 -63.32 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.672 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 113' ' ' LEU . 18.9 mt -53.77 -33.57 56.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.386 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.41 -42.17 9.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.324 -0.86 . . . . 0.0 109.742 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.47 -56.04 4.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.436 -0.79 . . . . 0.0 109.943 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -68.28 -67.51 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.545 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -111.85 93.46 20.8 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 113' ' ' LEU . 99.1 Cg_exo -43.39 178.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.478 2.119 . . . . 0.0 113.068 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.57 -38.26 17.33 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.611 0.72 . . . . 0.0 109.281 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 4.7 mt-10 77.85 1.3 2.85 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 61.91 38.46 14.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.74 -0.6 . . . . 0.0 111.24 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.73 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -87.59 120.9 71.23 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 120.633 -1.292 . . . . 0.0 108.21 178.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.35 19.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.26 1.973 . . . . 0.0 112.889 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.73 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -150.74 -33.3 0.16 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.715 -1.24 . . . . 0.0 110.984 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 10.7 p -45.43 -48.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.013 -1.055 . . . . 0.0 109.934 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.536 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 20.3 m-70 -71.19 -43.73 66.84 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.444 -0.785 . . . . 0.0 108.952 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.86 -20.2 64.27 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.33 -0.856 . . . . 0.0 109.107 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 120' ' ' ALA . 12.2 p -66.33 -62.75 1.31 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.506 ' N ' ' OG ' ' A' ' 124' ' ' SER . 5.5 mt -70.31 -25.1 63.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.151 -0.968 . . . . 0.0 109.719 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.36 -45.52 46.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.058 -1.026 . . . . 0.0 109.813 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.37 -50.54 5.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.106 -0.996 . . . . 0.0 110.113 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' A' ' 124' ' ' SER . 28.5 t80 -48.43 -22.27 0.68 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.049 -1.032 . . . . 0.0 109.485 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 133' ' ' SER . 6.4 mt -74.57 -22.6 58.9 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.45 -32.36 72.34 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.0 t -80.09 -35.49 36.86 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.391 -0.818 . . . . 0.0 109.012 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.54 -30.62 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 129' ' ' LEU . 42.2 t -76.19 -26.27 56.0 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.422 -0.799 . . . . 0.0 108.853 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 138' ' ' SER . 19.3 m -66.89 -28.72 68.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.327 -0.858 . . . . 0.0 109.021 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.12 -47.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.091 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.25 -38.15 73.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.013 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.3 p -93.71 -15.8 24.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 134' ' ' THR . 23.3 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.898 . . . . 0.0 109.518 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . 0.406 ' C ' ' HD1' ' B' ' 2' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.234 0.54 . . . . 0.0 109.665 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mt -92.5 -170.94 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.185 -0.947 . . . . 0.0 109.254 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.409 ' O ' ' N ' ' B' ' 6' ' ' GLU . 2.9 p -111.06 129.78 23.64 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.377 -0.827 . . . . 0.0 108.97 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.78 -25.02 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.392 2.061 . . . . 0.0 112.401 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' B' ' 4' ' ' THR . 48.6 mt-10 -86.62 -48.58 8.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 0.0 109.894 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.77 -34.39 39.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.853 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -64.97 -34.95 79.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.014 . . . . 0.0 109.425 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -69.04 -23.62 64.09 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 109.374 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.52 -55.0 4.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.215 -0.928 . . . . 0.0 110.238 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.7 -26.45 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 34.2 m -84.64 -54.25 4.85 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.363 0.601 . . . . 0.0 109.893 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -45.0 -31.18 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.451 -0.781 . . . . 0.0 109.859 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -24.64 63.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.226 -0.921 . . . . 0.0 109.623 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . 0.629 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 2.1 t90 -48.3 -27.49 2.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.17 -52.33 7.88 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.488 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 1.1 mppt? -64.39 -15.59 60.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -1.121 . . . . 0.0 109.084 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.23 114.96 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.356 -0.84 . . . . 0.0 109.67 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' B' ' 22' ' ' GLU . 2.4 m-80 -81.3 77.41 8.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.318 -0.864 . . . . 0.0 108.794 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' B' ' 19' ' ' ASN . 76.8 t -43.14 -21.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 109.966 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 19' ' ' ASN . 0.8 OUTLIER -83.86 11.71 7.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.59 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' B' ' 19' ' ' ASN . 36.6 mt-10 -156.15 -55.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.492 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 75.1 t -47.86 -36.37 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -57.71 9.45 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.82 -35.84 40.14 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -75.18 -26.97 59.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -1.139 . . . . 0.0 109.575 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.21 -48.1 65.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 40.3 mt -82.96 -30.58 28.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.895 . . . . 0.0 109.498 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.03 -59.19 10.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 0.584 ' NH2' ' SD ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -57.45 -40.84 79.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -1.133 . . . . 0.0 109.376 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' B' ' 30' ' ' ARG . 2.3 tt -43.79 -38.3 3.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.291 -0.88 . . . . 0.0 109.464 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.96 -21.83 43.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' B' ' 30' ' ' ARG . 15.6 t -86.09 -64.0 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.156 -0.965 . . . . 0.0 109.532 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.18 -22.93 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.832 ' HH ' ' HE2' ' A' ' 103' ' ' HIS . 48.5 m-85 -150.05 78.75 7.91 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 109.479 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' B' ' 38' ' ' THR . 16.6 Cg_exo -65.38 -28.22 54.75 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.042 2.494 . . . . 0.0 112.584 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . 0.54 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 0.5 OUTLIER -46.56 -20.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.022 . . . . 0.0 109.708 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.54 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 17.3 m -96.16 61.47 2.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.168 -0.957 . . . . 0.0 109.411 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.13 24.38 6.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.363 -0.835 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -84.44 -25.79 28.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -101.06 34.63 2.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.84 . . . . 0.0 109.494 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -135.9 17.46 3.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.331 -0.855 . . . . 0.0 109.425 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' B' ' 44' ' ' SER . 0.0 OUTLIER -84.98 -30.76 23.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.515 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 39.4 t -83.11 -10.81 58.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.514 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -73.82 1.02 11.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.89 178.73 0.18 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 48.77 89.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -1.108 . . . . 0.0 109.408 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 tp -158.8 19.35 0.2 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.46 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -53.16 -39.14 63.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' THR . . . . . 0.421 ' O ' ' N ' ' B' ' 52' ' ' ASP . 1.3 p -145.65 153.7 51.26 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.408 -0.808 . . . . 0.0 109.009 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -43.61 -19.36 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.265 1.977 . . . . 0.0 112.241 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.6 OUTLIER -81.48 -44.29 17.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.36 -20.0 0.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.315 -0.866 . . . . 0.0 109.398 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.03 -63.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.529 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' MET . . . . . 0.584 ' SD ' ' NH2' ' B' ' 30' ' ' ARG . 11.4 mmt -52.32 -22.02 4.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.605 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.23 -15.81 70.93 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . 0.566 ' ND2' ' H ' ' B' ' 60' ' ' VAL . 0.3 OUTLIER -73.46 136.39 78.22 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.225 -1.162 . . . . 0.0 109.294 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.34 -53.36 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.339 2.026 . . . . 0.0 112.381 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.475 ' N ' ' ND2' ' B' ' 57' ' ' ASN . 17.2 mtpp -52.49 -48.99 65.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.531 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.566 ' H ' ' ND2' ' B' ' 57' ' ' ASN . 99.2 t -49.6 -37.58 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 51.0 mtpt -79.16 -33.94 43.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.83 -29.08 35.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.583 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -69.1 -23.79 64.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.568 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.32 -38.02 91.11 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 30.8 mmtm -60.93 -32.11 71.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -1.181 . . . . 0.0 109.351 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.78 -61.34 2.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.88 -24.51 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.83 -42.53 60.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.226 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.77 -39.8 17.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.71 -38.22 67.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -61.84 -32.8 73.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.146 -0.971 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' SER . . . . . 0.629 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 13.4 m -88.5 -31.9 18.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 109.532 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . 0.491 ' CG ' ' HG1' ' B' ' 84' ' ' THR . 43.0 t0 -49.52 -42.49 43.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 109.473 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.12 -60.06 8.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.455 ' H ' HD12 ' B' ' 75' ' ' LEU . 5.0 mp -57.03 -26.44 60.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -1.127 . . . . 0.0 109.389 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.2 -0.35 48.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.958 . . . . 0.0 109.488 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.478 ' C ' ' H ' ' B' ' 79' ' ' ASP . 75.9 t60 -171.2 64.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.534 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 54.3 mt -72.36 12.15 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' B' ' 77' ' ' HIS . 2.8 m-20 -71.83 -20.79 61.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.434 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -171.6 109.74 0.28 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -79.69 -58.54 3.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -47.63 -24.01 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.97 -61.85 4.09 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.6 t -66.62 -47.09 73.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -1.177 . . . . 0.0 109.355 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.548 ' N ' ' CG2' ' B' ' 84' ' ' THR . 69.0 m-85 -70.88 15.14 0.11 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.558 -0.714 . . . . 0.0 109.526 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -69.4 -38.88 78.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 109.573 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.434 ' HG1' ' H ' ' B' ' 88' ' ' LEU . 17.8 p -83.62 -51.69 7.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.639 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.434 ' H ' ' HG1' ' B' ' 87' ' ' THR . 26.5 mt -53.04 -24.87 10.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.478 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 99.5 p -81.92 -40.61 22.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.505 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -81.43 -22.59 38.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.622 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 4.2 tt -82.29 -48.39 11.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.061 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.537 ' NE2' ' O ' ' B' ' 141' ' ' LEU . 1.9 p-80 -75.18 -22.28 58.15 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.918 -1.114 . . . . 0.0 110.22 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . 0.461 ' SG ' ' CE1' ' B' ' 145' ' ' TYR . 51.2 t -83.73 -60.25 2.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.132 -0.98 . . . . 0.0 111.356 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 12.8 t70 -86.8 -27.4 23.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.983 -1.073 . . . . 0.0 111.784 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . 0.53 ' O ' ' CE1' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -84.56 -49.99 8.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.704 -1.248 . . . . 0.0 110.655 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.48 ' CD1' ' N ' ' B' ' 96' ' ' LEU . 8.3 mp -86.52 -34.64 19.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.793 -1.192 . . . . 0.0 109.931 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' B' ' 94' ' ' ASP . 3.3 m80 71.77 36.92 1.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 109.545 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.85 134.84 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 0.799 ' HB3' HG13 ' C' ' 96' ' ' VAL . 3.7 m-20 -81.72 151.68 68.28 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.405 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.519 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 65.3 Cg_exo -47.23 -173.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.39 2.06 . . . . 0.0 112.358 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 57.62 53.2 7.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.52 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' B' ' 100' ' ' PRO . 69.3 m-80 -159.31 -34.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.6 m-85 -73.75 -54.55 7.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.333 -0.854 . . . . 0.0 109.585 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -57.1 -22.35 39.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.713 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 tt -76.77 -41.62 44.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -0.969 . . . . 0.0 109.517 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 tt -68.58 -56.59 7.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.231 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.45 -20.24 2.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -85.62 -55.61 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -1.116 . . . . 0.0 109.984 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.12 -24.8 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.055 -1.028 . . . . 0.0 109.49 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.41 -59.18 5.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.255 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.92 -39.94 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.229 -0.919 . . . . 0.0 109.677 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.423 ' O ' ' CE1' ' B' ' 116' ' ' HIS . 76.3 m -48.87 -43.77 39.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.591 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 70.4 t -55.99 -53.42 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.353 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' B' ' 114' ' ' LEU . 9.3 mp -49.81 -41.99 45.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 119' ' ' GLY . . . -47.88 -41.54 24.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.78 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.673 ' HD1' ' N ' ' B' ' 116' ' ' HIS . 0.4 OUTLIER -68.87 -52.16 32.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.612 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' B' ' 118' ' ' PHE . 74.9 m80 -69.24 -17.55 63.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.713 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 63.8 m-85 -156.84 64.34 0.52 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.955 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 115' ' ' ALA . . . -76.25 -21.36 75.81 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -72.85 -29.22 63.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -1.128 . . . . 0.0 109.362 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 123' ' ' THR . 63.4 mm-40 -78.53 -15.49 58.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.271 -0.893 . . . . 0.0 109.554 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -69.82 59.66 0.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.472 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 11.7 p -59.04 150.98 58.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.94 . . . . 0.0 108.917 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.434 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.3 Cg_exo -44.15 -58.15 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.446 2.097 . . . . 0.0 112.716 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 27.5 Cg_endo -61.89 -46.52 13.24 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.161 1.907 . . . . 0.0 112.027 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.472 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 40.6 t -66.86 -18.2 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -83.14 -26.29 31.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.588 ' CB ' HD11 ' A' ' 34' ' ' LEU . . . -68.8 -32.1 71.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.37 26.38 0.92 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.935 . . . . 0.0 109.648 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.647 ' CG ' ' N ' ' B' ' 131' ' ' GLN . 5.8 p90 -74.53 -52.31 12.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.14 -0.975 . . . . 0.0 109.791 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . 1.025 ' OE1' ' HZ ' ' A' ' 36' ' ' PHE . 36.5 tt0 -86.06 -38.93 17.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.162 -0.961 . . . . 0.0 109.999 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 1.009 ' HG3' ' O ' ' D' ' 146' ' ' HIS . 32.1 ttpt -50.9 -34.56 28.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.233 -0.917 . . . . 0.0 110.959 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . 0.672 ' CG1' ' H ' ' B' ' 134' ' ' VAL . 7.1 p -65.27 -63.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.844 -1.16 . . . . 0.0 109.891 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.672 ' H ' ' CG1' ' B' ' 133' ' ' VAL . 1.8 m -73.77 -14.82 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.361 -0.837 . . . . 0.0 109.75 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . -45.78 -23.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.55 -26.41 46.84 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' B' ' 134' ' ' VAL . 74.9 t -80.05 -21.28 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -1.104 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.86 -51.11 71.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.555 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.69 -22.52 53.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.34 -45.94 88.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.537 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 19.9 mt -84.01 15.57 3.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.544 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.62 -1.5 2.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 109.505 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . 0.433 ' O ' ' CD2' ' B' ' 143' ' ' HIS . 21.9 t-160 -79.87 -26.57 40.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.518 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.517 ' C ' ' HD1' ' B' ' 146' ' ' HIS . 12.3 mptt -73.26 -11.39 60.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.379 -0.826 . . . . 0.0 109.342 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.461 ' CE1' ' SG ' ' B' ' 93' ' ' CYS . 15.6 m-85 -72.84 7.19 2.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.301 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 1.021 ' O ' ' HG3' ' D' ' 132' ' ' LYS . 7.5 p-80 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.453 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' C' ' 2' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . 0.473 ' CB ' ' O ' ' C' ' 1' ' ' VAL . 7.1 tp 73.63 170.67 0.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 109.545 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.471 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 174.45 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.166 -0.959 . . . . 0.0 110.041 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' C' ' 3' ' ' SER . 96.6 Cg_exo -41.4 168.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.683 2.255 . . . . 0.0 112.837 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -50.77 -16.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.436 -0.79 . . . . 0.0 110.003 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' C' ' 5' ' ' ALA . 2.8 p30 -39.7 -28.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.746 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.724 ' HZ3' ' HZ3' ' C' ' 11' ' ' LYS . 5.9 ptmm? -83.2 -52.31 6.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.514 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.417 ' N ' ' CG ' ' C' ' 7' ' ' LYS . 49.2 m -47.93 -26.76 1.85 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 108.954 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -80.01 -39.43 29.96 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' C' ' 7' ' ' LYS . 21.4 t -69.35 -47.01 75.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . 0.724 ' HZ3' ' HZ3' ' C' ' 7' ' ' LYS . 2.4 mptm? -50.12 -48.57 53.49 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' C' ' 15' ' ' GLY . . . -52.65 -63.13 1.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.628 -0.67 . . . . 0.0 109.316 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.57 -41.82 54.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.2 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -17.34 64.37 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.412 -0.805 . . . . 0.0 109.05 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' C' ' 12' ' ' ALA . . . -79.71 -47.38 7.29 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -68.41 -36.71 79.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -1.113 . . . . 0.0 108.85 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.99 -66.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 63.39 -141.4 45.89 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 37.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.519 -0.989 . . . . 0.0 110.157 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.584 ' H ' ' C ' ' C' ' 18' ' ' GLY . 89.4 m-70 -140.27 24.5 2.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.36 -48.73 7.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.561 -0.712 . . . . 0.0 109.927 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.3 -14.74 27.82 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' C' ' 27' ' ' GLU . 12.6 mt-10 -85.64 -56.32 3.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -1.156 . . . . 0.0 109.653 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.0 m-30 -55.4 -26.86 44.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 109.288 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.18 -24.41 76.62 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.73 -36.33 28.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -1.165 . . . . 0.0 109.627 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' C' ' 23' ' ' GLU . 1.4 mp0 -70.27 -20.03 63.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.5 -19.88 60.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.038 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.74 -58.19 3.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.353 -0.842 . . . . 0.0 109.735 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -50.94 -43.77 60.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 109.685 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -56.3 -30.46 62.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.651 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 38.5 ttp -84.27 -57.22 3.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.815 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . 0.434 ' CZ ' ' CZ ' ' C' ' 46' ' ' PHE . 25.8 m-85 -47.7 -36.86 11.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.998 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.588 HD11 ' CB ' ' D' ' 128' ' ' ALA . 3.4 pp -84.49 -25.76 28.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.994 -1.067 . . . . 0.0 109.808 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 28.1 t -60.88 -22.06 63.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 109.472 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 1.047 ' HZ ' ' OE1' ' D' ' 131' ' ' GLN . 66.7 m-85 -156.18 128.69 4.13 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.21 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.58 -20.17 16.01 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.292 1.995 . . . . 0.0 112.08 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 68.2 p -62.62 -18.92 63.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 76.8 p -80.88 -35.61 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.0 109.756 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -67.61 -36.45 80.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 109.7 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.778 -179.708 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.121 0.486 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -165.44 26.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 110.346 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' C' ' 49' ' ' SER . 22.5 m-20 41.74 88.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.701 . . . . 0.0 110.25 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.813 ' H ' ' CD1' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -56.52 0.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.385 -0.822 . . . . 0.0 109.538 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.614 ' H ' ' C ' ' C' ' 47' ' ' ASP . 2.8 t -46.58 132.1 10.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.163 -0.961 . . . . 0.0 109.681 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.518 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 11.4 t-80 -76.16 144.12 40.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.388 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . 0.518 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 73.26 10.14 78.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' C' ' 53' ' ' ALA . 88.5 p -68.88 -100.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -1.147 . . . . 0.0 109.392 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.524 ' N ' ' OG ' ' C' ' 52' ' ' SER . . . -178.41 -31.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.41 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -81.26 -17.58 48.94 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.264 -0.897 . . . . 0.0 109.171 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.57 -33.99 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.626 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -70.78 -28.27 64.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.314 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . 0.427 ' O ' ' CE ' ' C' ' 61' ' ' LYS . . . -69.82 -48.18 43.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.6 OUTLIER -54.01 -35.63 62.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -1.155 . . . . 0.0 109.366 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.43 -58.59 10.92 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -51.7 -23.95 5.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -1.099 . . . . 0.0 109.625 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' C' ' 57' ' ' GLY . 0.0 OUTLIER -77.39 -23.46 50.7 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 108.911 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.43 -52.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.488 ' O ' ' OG1' ' C' ' 67' ' ' THR . . . -66.26 -24.23 66.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.32 -0.862 . . . . 0.0 109.581 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.02 -32.97 33.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.99 . . . . 0.0 109.821 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' C' ' 68' ' ' ASN . . . -82.68 -34.33 27.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.122 -0.986 . . . . 0.0 109.549 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.494 ' O ' ' CD1' ' C' ' 66' ' ' LEU . 0.1 OUTLIER -81.51 -23.05 37.57 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' C' ' 63' ' ' ALA . 18.3 m -78.05 -43.86 28.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.068 -1.02 . . . . 0.0 108.711 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' C' ' 69' ' ' ALA . 1.6 p-10 -58.15 -21.86 48.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.611 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -78.79 -47.53 16.53 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.55 -22.42 30.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.0 -17.66 63.29 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.438 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.567 ' O ' ' N ' ' C' ' 74' ' ' ASP . 38.3 m80 -143.87 -53.45 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 0.0 109.291 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.2 p 45.04 15.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.799 0.809 . . . . 0.0 109.283 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' C' ' 72' ' ' HIS . 89.8 m-20 -131.76 9.66 4.62 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -174.28 27.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.265 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.3 ptt? -78.57 -24.37 0.43 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.472 -0.767 . . . . 0.0 111.783 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.0 Cg_exo -53.24 -29.47 46.94 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.79 1.66 . . . . 0.0 112.571 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.438 ' O ' ' OG ' ' C' ' 81' ' ' SER . 8.5 t-20 -94.15 -11.16 31.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 109.828 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.27 -58.16 3.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.153 -0.967 . . . . 0.0 109.281 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.34 13.87 2.72 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 108.796 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 2.5 p -59.15 -15.84 16.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 109.809 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.51 -53.58 6.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.0 109.831 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.444 ' O ' ' CE1' ' C' ' 87' ' ' HIS . 3.5 mt -44.73 -42.24 7.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.389 -0.819 . . . . 0.0 108.928 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 66.7 p -54.69 -29.17 52.18 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.552 -0.717 . . . . 0.0 109.446 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' C' ' 82' ' ' ALA . 49.2 t0 -82.55 -16.93 46.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.396 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.8 tt -81.0 -62.32 1.7 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.918 -1.113 . . . . 0.0 111.241 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.4 p-80 -76.95 -21.47 54.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.86 -1.15 . . . . 0.0 111.16 -178.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.91 -29.78 23.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.77 -1.206 . . . . 0.0 110.207 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' C' ' 90' ' ' LYS . 15.5 t-80 -99.79 -74.85 0.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 110.139 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' C' ' 89' ' ' HIS . 17.8 mtpp -51.96 -101.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.967 . . . . 0.0 109.985 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.465 ' H ' ' CD1' ' C' ' 91' ' ' LEU . 10.0 mp -45.17 -31.77 1.58 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.827 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 58.16 41.93 22.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.503 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' C' ' 87' ' ' HIS . 5.9 t -66.95 168.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.372 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' C' ' 96' ' ' VAL . 1.1 p-10 -123.51 152.14 64.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.34 -0.85 . . . . 0.0 109.272 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -41.73 -14.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.666 2.244 . . . . 0.0 112.584 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . 0.799 HG13 ' HB3' ' B' ' 99' ' ' ASP . 46.7 t -59.24 -28.33 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 109.934 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.656 HD21 ' N ' ' C' ' 97' ' ' ASN . 0.6 OUTLIER -79.45 -24.91 42.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.664 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -65.62 -42.03 91.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.584 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -47.22 -30.26 2.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' C' ' 100' ' ' LEU . 3.7 mm? -84.07 -60.04 2.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.593 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.5 tt -53.25 -20.9 4.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.736 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -77.6 -59.08 2.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 109.763 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . 0.808 ' HE2' ' HH ' ' D' ' 35' ' ' TYR . 32.1 m170 -64.61 -26.6 68.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.837 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 95.2 m -61.0 -58.02 10.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 0.0 109.869 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.94 -30.9 1.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.5 mt -74.97 -52.29 11.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.155 -0.966 . . . . 0.0 109.616 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.29 -24.69 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.493 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 24.7 m -73.71 -63.25 1.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' C' ' 113' ' ' LEU . 18.9 mt -53.77 -33.68 56.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.372 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.3 -42.28 9.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.74 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.37 -56.0 4.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -68.28 -67.5 0.46 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.608 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -111.87 93.52 21.1 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' C' ' 113' ' ' LEU . 98.5 Cg_exo -43.44 178.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.406 2.071 . . . . 0.0 113.105 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.59 -38.25 17.31 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.666 0.746 . . . . 0.0 109.312 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 4.8 mt-10 77.87 1.24 2.84 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 61.88 38.5 14.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.793 -0.567 . . . . 0.0 111.268 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.735 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.7 OUTLIER -87.59 120.95 71.24 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.73 -1.231 . . . . 0.0 108.197 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.43 19.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.285 1.99 . . . . 0.0 112.816 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -150.74 -33.22 0.16 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.726 -1.234 . . . . 0.0 110.962 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.539 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 10.8 p -45.57 -48.09 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.876 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.539 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 20.2 m-70 -71.18 -43.81 66.73 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.451 -0.78 . . . . 0.0 108.917 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.74 -20.23 64.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.329 -0.857 . . . . 0.0 109.15 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.57 ' N ' ' O ' ' C' ' 120' ' ' ALA . 12.1 p -66.38 -62.72 1.32 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.21 -0.931 . . . . 0.0 110.215 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.513 ' N ' ' OG ' ' C' ' 124' ' ' SER . 5.6 mt -70.23 -25.1 63.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.166 -0.959 . . . . 0.0 109.736 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -74.47 -45.39 46.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.087 -1.008 . . . . 0.0 109.784 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.45 -50.47 5.93 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.044 -1.035 . . . . 0.0 110.127 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.451 ' CD2' ' CD2' ' C' ' 2' ' ' LEU . 28.5 t80 -48.44 -22.35 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.912 -1.118 . . . . 0.0 109.453 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' C' ' 133' ' ' SER . 6.4 mt -74.55 -22.57 58.94 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.42 -32.31 72.26 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 13.8 t -80.16 -35.44 36.52 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.382 -0.824 . . . . 0.0 109.095 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 22.4 t -83.51 -30.71 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.149 -0.969 . . . . 0.0 108.57 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.564 ' N ' ' O ' ' C' ' 129' ' ' LEU . 42.1 t -76.25 -26.17 55.74 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.434 -0.792 . . . . 0.0 108.873 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' THR . . . . . 0.53 ' O ' ' N ' ' C' ' 138' ' ' SER . 19.5 m -66.85 -28.76 68.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.278 -0.889 . . . . 0.0 109.091 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.09 -47.52 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.11 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.19 -38.05 73.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.112 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 70.4 p -93.83 -15.76 24.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 138' ' ' SER . . . . . 0.53 ' N ' ' O ' ' C' ' 134' ' ' THR . 23.3 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.885 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . 0.405 ' HD1' ' C ' ' D' ' 2' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.251 0.548 . . . . 0.0 109.641 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mt -92.65 -170.89 2.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 109.193 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.403 ' O ' ' N ' ' D' ' 6' ' ' GLU . 2.9 p -111.14 129.8 23.64 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.828 . . . . 0.0 108.938 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -40.82 -24.95 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.305 2.003 . . . . 0.0 112.439 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' D' ' 4' ' ' THR . 48.6 mt-10 -86.67 -48.63 8.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.858 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -79.61 -34.41 40.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.94 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.506 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -65.04 -34.86 79.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -0.964 . . . . 0.0 109.362 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 27.1 t -69.1 -23.6 64.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.11 -0.994 . . . . 0.0 109.335 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.55 -54.96 4.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.903 . . . . 0.0 110.189 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.71 -26.47 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.004 -1.06 . . . . 0.0 108.277 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 34.2 m -84.61 -54.31 4.81 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.395 0.616 . . . . 0.0 109.859 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -45.04 -31.09 1.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 0.0 109.898 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -24.68 63.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.625 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . 0.628 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 2.1 t90 -48.27 -27.51 2.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.14 -52.37 7.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.505 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 1.1 mppt? -64.44 -15.59 60.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.356 -1.085 . . . . 0.0 109.047 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.2 114.84 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.671 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' D' ' 22' ' ' GLU . 2.4 m-80 -81.21 77.35 8.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 108.855 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' D' ' 19' ' ' ASN . 76.5 t -43.11 -21.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.439 -0.788 . . . . 0.0 109.926 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' D' ' 19' ' ' ASN . 0.8 OUTLIER -83.84 11.72 7.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.658 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' D' ' 19' ' ' ASN . 36.6 mt-10 -156.13 -55.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 109.477 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -48.03 -36.23 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.534 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.79 -57.67 9.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.77 -35.87 39.81 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.21 -26.87 59.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.21 -48.12 65.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.948 . . . . 0.0 109.516 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 40.9 mt -83.09 -30.49 27.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.452 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.08 -59.11 10.62 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . 0.583 ' NH2' ' SD ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -57.53 -40.78 79.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -1.085 . . . . 0.0 109.346 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' D' ' 30' ' ' ARG . 2.3 tt -43.81 -38.31 3.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -79.94 -21.79 43.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' D' ' 30' ' ' ARG . 15.6 t -86.11 -63.98 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -22.88 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 109.297 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . 0.808 ' HH ' ' HE2' ' C' ' 103' ' ' HIS . 48.5 m-85 -150.13 78.79 7.84 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 109.501 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' D' ' 38' ' ' THR . 16.6 Cg_exo -65.5 -28.12 53.83 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.988 2.459 . . . . 0.0 112.621 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . 0.538 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 0.5 OUTLIER -46.63 -19.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.81 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.538 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 17.5 m -96.16 61.37 2.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.219 -0.926 . . . . 0.0 109.375 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.02 24.3 6.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 109.557 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -84.35 -25.86 28.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.119 -0.988 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -100.97 34.53 2.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -135.92 17.51 3.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 109.431 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' D' ' 44' ' ' SER . 0.0 OUTLIER -85.05 -30.67 23.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.418 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.508 ' H ' ' CD ' ' D' ' 43' ' ' GLU . 39.3 t -83.13 -10.78 58.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.491 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -73.91 1.12 11.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.315 -0.866 . . . . 0.0 109.435 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.9 178.7 0.18 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 48.78 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.157 . . . . 0.0 109.441 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 tp -158.91 19.49 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.355 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -53.28 -39.06 63.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' THR . . . . . 0.428 ' O ' ' N ' ' D' ' 52' ' ' ASP . 1.2 p -145.66 153.7 51.2 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.844 . . . . 0.0 109.053 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.64 -19.37 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.276 1.984 . . . . 0.0 112.168 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' D' ' 52' ' ' ASP . 0.6 OUTLIER -81.39 -44.54 17.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.23 -19.92 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . 0.412 ' N ' ' C ' ' D' ' 52' ' ' ASP . 97.5 t -66.2 -63.16 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' MET . . . . . 0.583 ' SD ' ' NH2' ' D' ' 30' ' ' ARG . 11.4 mmt -52.25 -22.08 4.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.581 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.18 -15.92 70.77 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' D' ' 60' ' ' VAL . 0.3 OUTLIER -73.38 136.46 78.44 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.294 -1.121 . . . . 0.0 109.269 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.38 -53.41 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.343 2.028 . . . . 0.0 112.33 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . 0.468 ' N ' ' ND2' ' D' ' 57' ' ' ASN . 17.3 mtpp -52.42 -48.99 65.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . 0.565 ' H ' ' ND2' ' D' ' 57' ' ' ASN . 99.5 t -49.73 -37.47 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . 0.523 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 50.9 mtpt -79.15 -33.91 43.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.502 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.84 -29.05 35.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 109.619 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -69.09 -23.81 64.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.57 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.27 -38.0 91.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 30.8 mmtm -60.96 -32.1 71.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -1.15 . . . . 0.0 109.264 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.8 -61.44 2.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 109.419 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.94 -24.42 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.8 -42.55 60.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.184 -0.947 . . . . 0.0 109.275 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.79 -39.76 17.7 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.73 -38.25 67.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 0.0 109.475 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -61.93 -32.64 73.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' SER . . . . . 0.628 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 13.6 m -88.53 -31.89 18.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . 0.498 ' CG ' ' HG1' ' D' ' 84' ' ' THR . 43.0 t0 -49.54 -42.35 43.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.89 . . . . 0.0 109.515 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.2 -60.07 8.52 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.479 HD12 ' H ' ' D' ' 75' ' ' LEU . 5.0 mp -57.02 -26.43 60.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -1.101 . . . . 0.0 109.406 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.18 -0.42 49.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.462 ' C ' ' H ' ' D' ' 79' ' ' ASP . 76.0 t60 -171.07 64.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.536 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 53.9 mt -72.34 12.21 0.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' D' ' 77' ' ' HIS . 2.8 m-20 -71.88 -20.76 61.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.428 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -171.62 109.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.414 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -79.78 -58.48 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -47.68 -23.99 0.82 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.95 -61.93 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.5 t -66.56 -47.14 73.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -1.154 . . . . 0.0 109.425 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 68.8 m-85 -70.85 15.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.495 -0.753 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -69.5 -38.74 77.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.625 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' THR . . . . . 0.444 ' HG1' ' H ' ' D' ' 88' ' ' LEU . 17.9 p -83.72 -51.75 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.605 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.444 ' H ' ' HG1' ' D' ' 87' ' ' THR . 26.1 mt -52.92 -24.93 10.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.564 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 99.1 p -81.88 -40.66 22.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.234 -0.916 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -81.42 -22.59 38.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.609 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 4.2 tt -82.17 -48.51 11.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 110.089 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.532 ' NE2' ' O ' ' D' ' 141' ' ' LEU . 1.9 p-80 -75.11 -22.26 58.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.915 -1.116 . . . . 0.0 110.19 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' D' ' 145' ' ' TYR . 51.2 t -83.76 -60.17 2.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.142 -0.974 . . . . 0.0 111.358 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 12.8 t70 -86.82 -27.38 23.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.074 -1.016 . . . . 0.0 111.835 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . 0.531 ' O ' ' CE1' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -84.65 -49.94 8.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.727 -1.233 . . . . 0.0 110.613 -178.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.485 ' C ' ' CG ' ' D' ' 97' ' ' HIS . 8.3 mp -86.55 -34.61 19.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.823 -1.173 . . . . 0.0 109.905 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' D' ' 94' ' ' ASP . 3.3 m80 71.72 36.98 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.89 . . . . 0.0 109.612 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.91 134.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.194 -0.942 . . . . 0.0 109.314 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . 0.867 ' HB3' HG13 ' A' ' 96' ' ' VAL . 3.8 m-20 -81.76 151.63 68.1 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.356 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . 0.508 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 66.7 Cg_exo -47.25 -173.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.433 2.088 . . . . 0.0 112.277 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 57.67 53.09 7.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.521 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' D' ' 100' ' ' PRO . 69.3 m-80 -159.23 -34.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.515 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.84 -54.56 7.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -57.08 -22.37 38.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 tt -76.7 -41.7 44.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.509 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 tt -68.54 -56.64 7.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.203 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.4 -20.18 2.28 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -85.68 -55.65 3.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -1.139 . . . . 0.0 109.978 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.07 -24.78 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.078 -1.014 . . . . 0.0 109.613 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.45 -59.12 5.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.284 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 t -59.01 -39.92 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.595 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . 0.421 ' O ' ' CE1' ' D' ' 116' ' ' HIS . 76.2 m -48.88 -43.7 39.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 109.622 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 70.0 t -55.97 -53.43 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.412 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . 0.465 ' H ' ' CD1' ' D' ' 114' ' ' LEU . 9.3 mp -49.88 -41.92 46.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' D' ' 119' ' ' GLY . . . -47.9 -41.54 24.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.735 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.668 ' HD1' ' N ' ' D' ' 116' ' ' HIS . 0.4 OUTLIER -68.84 -52.32 31.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.537 -179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 74.9 m80 -69.1 -17.65 63.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.738 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 64.0 m-85 -156.82 64.45 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.522 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' D' ' 115' ' ' ALA . . . -76.4 -21.26 75.7 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -72.78 -29.3 63.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.157 . . . . 0.0 109.375 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' D' ' 123' ' ' THR . 63.3 mm-40 -78.56 -15.46 58.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -69.84 59.77 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.321 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.466 ' OG1' ' CG2' ' D' ' 126' ' ' VAL . 12.0 p -59.05 150.95 59.09 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 108.916 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.3 Cg_exo -44.09 -58.12 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.414 2.076 . . . . 0.0 112.755 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 27.6 Cg_endo -61.9 -46.62 12.88 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.117 1.878 . . . . 0.0 112.033 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . 0.466 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 40.3 t -66.68 -18.33 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.695 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -83.13 -26.4 31.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.114 -0.992 . . . . 0.0 109.703 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 0.588 ' CB ' HD11 ' C' ' 34' ' ' LEU . . . -68.73 -32.08 71.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.051 -1.03 . . . . 0.0 109.572 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.37 26.45 0.91 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . 0.644 ' CG ' ' N ' ' D' ' 131' ' ' GLN . 5.8 p90 -74.6 -52.19 12.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.813 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . 1.047 ' OE1' ' HZ ' ' C' ' 36' ' ' PHE . 36.6 tt0 -86.03 -38.98 17.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.146 -0.972 . . . . 0.0 110.023 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . 1.021 ' HG3' ' O ' ' B' ' 146' ' ' HIS . 32.1 ttpt -50.9 -34.55 28.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 110.981 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . 0.678 ' CG1' ' H ' ' D' ' 134' ' ' VAL . 7.1 p -65.18 -64.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.865 -1.147 . . . . 0.0 109.87 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.678 ' H ' ' CG1' ' D' ' 133' ' ' VAL . 1.8 m -73.83 -14.65 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.409 -0.807 . . . . 0.0 109.826 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' D' ' 131' ' ' GLN . . . -45.87 -23.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.099 -1.001 . . . . 0.0 109.662 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -82.6 -26.36 46.82 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' D' ' 134' ' ' VAL . 75.0 t -80.04 -21.36 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -1.159 . . . . 0.0 109.441 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.8 -51.06 71.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 109.659 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.78 -22.42 53.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.0 88.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 20.2 mt -84.03 15.65 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.587 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.69 -1.42 2.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.304 -0.872 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . 0.432 ' CD2' ' O ' ' D' ' 143' ' ' HIS . 21.8 t-160 -79.98 -26.53 39.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.47 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.525 ' C ' ' HD1' ' D' ' 146' ' ' HIS . 12.3 mptt -73.28 -11.35 60.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . 0.458 ' CE1' ' SG ' ' D' ' 93' ' ' CYS . 15.8 m-85 -72.84 7.11 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.942 . . . . 0.0 109.24 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 1.009 ' O ' ' HG3' ' B' ' 132' ' ' LYS . 7.6 p-80 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 3.0 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 3' ' ' SER . 3.3 tp 75.68 174.32 0.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.335 -0.853 . . . . 0.0 109.537 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.623 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 164.56 -38.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 110.516 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 3' ' ' SER . 76.4 Cg_exo -49.62 -173.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.327 2.018 . . . . 0.0 112.966 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -75.81 -15.86 60.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 0.0 110.073 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' A' ' 127' ' ' LYS . 4.9 p30 -39.03 -38.29 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.301 -0.875 . . . . 0.0 109.554 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 12.9 mtmm -57.41 -58.41 8.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 108.958 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 m -51.51 -31.83 25.33 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 108.989 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -76.61 -34.71 58.36 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.73 -49.91 37.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.16 -42.31 63.3 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.66 -60.78 3.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.409 -0.807 . . . . 0.0 109.389 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.62 -34.11 57.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.113 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -17.69 61.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.379 -0.826 . . . . 0.0 109.077 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.44 -45.11 10.07 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -68.72 -39.8 80.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -1.134 . . . . 0.0 108.859 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -60.92 -65.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.603 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 58.06 -136.73 50.63 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.06 27.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.474 -1.016 . . . . 0.0 110.329 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.603 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.7 m-70 -131.44 27.1 4.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -90.96 -63.83 1.21 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.695 -0.628 . . . . 0.0 109.917 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.98 -14.47 0.13 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.4 mt-10 -85.06 -56.33 3.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -1.056 . . . . 0.0 109.633 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.8 m-30 -57.95 -43.93 86.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.328 -0.858 . . . . 0.0 109.111 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.03 -22.88 56.33 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.05 -33.91 59.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -1.129 . . . . 0.0 109.689 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' OE2' ' NE2' ' A' ' 112' ' ' HIS . 47.2 mt-10 -69.17 -20.18 64.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.282 -0.886 . . . . 0.0 109.687 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -19.68 59.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.344 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.7 mt -72.14 -48.11 46.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 109.6 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.46 -24.79 63.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.211 -0.93 . . . . 0.0 109.503 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.918 HH11 ' HG2' ' B' ' 127' ' ' GLN . 50.2 ttm-85 -76.1 -21.16 56.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.206 -0.934 . . . . 0.0 109.345 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 54.0 ttp -82.24 -50.7 8.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.467 ' CD2' ' OG1' ' A' ' 39' ' ' THR . 9.4 m-85 -52.59 -44.34 65.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.701 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.679 ' HB3' ' HB1' ' B' ' 128' ' ' ALA . 6.5 mt -67.59 -58.7 4.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.975 . . . . 0.0 109.682 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.671 ' HA ' ' OE1' ' B' ' 131' ' ' GLN . 40.2 m -48.47 -34.03 10.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.905 . . . . 0.0 109.755 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 35' ' ' SER . 3.0 m-85 -146.73 90.46 5.5 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.232 -0.918 . . . . 0.0 109.397 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 39' ' ' THR . 48.4 Cg_exo -53.51 -19.32 13.32 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.72 2.28 . . . . 0.0 112.149 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 37' ' ' PRO . 12.9 p -42.64 -18.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.405 -0.809 . . . . 0.0 110.092 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 37' ' ' PRO . 46.7 p -75.42 -22.29 57.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.928 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -46.55 -44.92 18.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.912 . . . . 0.0 109.853 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.417 HG22 ' CD2' ' D' ' 97' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.658 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.477 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.594 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -146.1 66.36 1.2 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' A' ' 49' ' ' SER . 17.0 m-20 -41.05 -18.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.265 -0.897 . . . . 0.0 110.214 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 46' ' ' PHE . 1.1 mt 51.94 9.8 0.1 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.603 ' HG ' ' N ' ' A' ' 50' ' ' HIS . 10.7 t -67.18 155.87 37.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.38 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.614 ' HD1' ' N ' ' A' ' 51' ' ' GLY . 11.4 t-80 -65.24 139.84 58.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.542 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.614 ' N ' ' HD1' ' A' ' 50' ' ' HIS . . . 54.52 30.62 50.63 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.9 t -63.24 -98.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -1.15 . . . . 0.0 109.376 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 172.56 -39.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.862 . . . . 0.0 109.487 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -74.77 -20.1 59.94 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.275 -0.891 . . . . 0.0 109.44 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -84.72 -41.09 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -78.95 -26.48 43.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.862 . . . . 0.0 109.054 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.416 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . . . -80.55 -21.94 63.23 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.565 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -79.02 -39.31 34.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -1.125 . . . . 0.0 109.558 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.79 -47.67 30.69 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 51.2 mttp -52.45 -23.78 6.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 0.0 109.804 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.416 ' NZ ' ' O ' ' A' ' 57' ' ' GLY . 1.7 mmpp? -72.08 -42.49 66.11 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.149 -0.969 . . . . 0.0 109.034 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 t -70.69 -48.24 59.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.52 -30.5 70.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.286 -0.884 . . . . 0.0 109.071 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.9 t0 -68.4 -32.59 72.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.927 . . . . 0.0 108.738 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.46 -49.42 59.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.407 -0.808 . . . . 0.0 108.983 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.61 -39.93 93.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.274 -0.891 . . . . 0.0 108.817 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -70.69 -49.77 43.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.264 -0.898 . . . . 0.0 108.612 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -58.39 -21.03 48.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.47 -46.83 12.03 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -63.59 -22.83 31.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -59.34 -25.97 64.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 74' ' ' ASP . 40.5 m80 -147.14 -48.4 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.855 . . . . 0.0 109.402 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.4 p 44.99 13.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.752 0.787 . . . . 0.0 109.47 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 72' ' ' HIS . 37.3 m-20 -135.52 10.75 3.45 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 3.9 m-20 -174.94 26.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 15.0 ptt? -78.53 -22.59 0.39 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 111.706 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 76' ' ' MET . 49.7 Cg_exo -55.05 -17.93 15.85 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.506 1.471 . . . . 0.0 112.221 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.407 HD21 ' N ' ' A' ' 78' ' ' ASN . 1.6 m-80 -94.14 -46.81 6.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.272 -0.893 . . . . 0.0 109.387 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.02 -42.3 99.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.825 . . . . 0.0 109.15 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.76 9.16 8.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.489 -0.757 . . . . 0.0 108.996 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -57.33 -25.55 59.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.375 -0.828 . . . . 0.0 109.637 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -56.4 -57.99 9.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.119 -0.988 . . . . 0.0 109.463 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.477 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 6.6 mt -45.31 -50.45 11.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 135' ' ' VAL . 3.4 m -49.25 -38.45 26.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 82' ' ' ALA . 27.9 t70 -82.52 -17.29 45.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.839 . . . . 0.0 109.865 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -70.7 -51.9 24.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.58 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 14.3 p-80 -92.16 -21.92 20.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.89 -1.131 . . . . 0.0 110.689 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.64 -51.32 69.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.852 -1.155 . . . . 0.0 109.907 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -155.69 63.78 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.94 . . . . 0.0 109.906 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -163.06 0.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.865 . . . . 0.0 109.29 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.6 tp -171.78 -31.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 51.76 47.74 24.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.46 136.97 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.484 ' OD2' ' CE1' ' D' ' 97' ' ' HIS . 22.5 m-20 -58.33 128.41 82.39 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 97' ' ' ASN . 73.0 Cg_endo -77.09 -18.62 14.3 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.302 2.002 . . . . 0.0 112.056 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -46.75 -14.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.499 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 95' ' ' PRO . 20.7 m-80 -79.04 -24.6 43.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.506 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -52.98 -50.59 63.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.527 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' O ' ' CE1' ' A' ' 103' ' ' HIS . 47.0 mttp -56.61 -25.98 54.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.71 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.5 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.8 mt -84.2 -34.81 23.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 109.492 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.3 tp -74.86 -29.14 60.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 109.717 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -73.33 -39.13 65.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.963 . . . . 0.0 109.718 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.712 ' CB ' HD22 ' B' ' 108' ' ' ASN . 7.1 m170 -80.73 -26.85 37.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.649 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 33.5 m -64.26 -53.79 43.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.168 -0.958 . . . . 0.0 109.755 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -46.7 -28.67 1.57 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.937 . . . . 0.0 109.601 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.92 -31.53 35.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 109.955 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.7 t -82.64 -26.59 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 109.649 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.63 ' HG1' ' H ' ' A' ' 109' ' ' LEU . 5.1 p -74.41 -62.07 1.65 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 109.567 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.63 ' H ' ' HG1' ' A' ' 108' ' ' THR . 17.7 mt -46.06 -35.31 4.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 0.0 109.416 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.77 -40.75 66.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.952 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' B' ' 122' ' ' PHE . . . -73.3 -40.9 64.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.702 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.531 ' NE2' ' OE2' ' A' ' 27' ' ' GLU . 64.5 m-70 -89.67 -78.77 0.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.545 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -107.7 113.49 61.34 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.511 ' O ' ' O ' ' A' ' 113' ' ' LEU . 77.8 Cg_exo -45.93 -173.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.235 1.957 . . . . 0.0 112.282 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.642 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -69.25 -53.2 21.06 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.473 -0.767 . . . . 0.0 109.078 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.642 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 26.0 mt-10 125.65 -0.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.502 ' O ' ' CD2' ' A' ' 117' ' ' PHE . 56.6 t80 58.04 33.56 23.31 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.408 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.795 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -106.59 117.22 57.5 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.14 20.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.146 1.898 . . . . 0.0 112.708 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.795 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -146.42 -34.07 0.3 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 0.0 110.211 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 14.0 p -47.71 -47.04 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 109.926 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.484 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -67.85 -33.64 75.15 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.4 -0.813 . . . . 0.0 109.287 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.32 -20.24 32.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.696 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.5 m -69.06 -62.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.12 -19.71 64.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.0 -1.062 . . . . 0.0 109.1 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.15 -46.79 13.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.71 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -89.84 -39.06 13.32 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.792 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.499 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 27.8 t80 -47.86 -20.66 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.915 -1.116 . . . . 0.0 108.666 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' N ' ' C ' ' A' ' 127' ' ' LYS . 29.1 mt -70.73 -19.64 62.72 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -55.08 -38.38 68.01 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.487 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 5.4 t -77.92 -29.72 50.17 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.32 -39.11 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -68.08 -20.97 64.99 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.192 -0.943 . . . . 0.0 109.04 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 138' ' ' SER . 94.9 m -69.11 -39.53 78.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.505 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -76.51 -31.12 19.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.264 -0.897 . . . . 0.0 109.433 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.511 ' O ' ' NE2' ' A' ' 87' ' ' HIS . 0.5 OUTLIER -84.74 -23.84 29.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.868 . . . . 0.0 109.18 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.5 m -100.25 -15.57 18.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.371 -0.83 . . . . 0.0 109.453 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 134' ' ' THR . 1.8 t . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.5 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -133.82 -171.96 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.449 -0.782 . . . . 0.0 109.317 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.419 ' O ' ' N ' ' B' ' 6' ' ' GLU . 12.6 p -90.0 134.86 30.96 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.25 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -41.61 -22.88 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.421 2.081 . . . . 0.0 112.357 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' B' ' 4' ' ' THR . 9.6 mp0 -79.28 -52.25 8.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.953 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.03 -60.58 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.692 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.46 ' O ' ' OG1' ' B' ' 12' ' ' THR . 5.0 ttpp -49.74 -51.75 36.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.823 . . . . 0.0 109.976 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -43.57 -23.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.63 -0.669 . . . . 0.0 110.235 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -82.94 -56.17 3.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.057 -1.027 . . . . 0.0 109.826 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.78 -24.56 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 10.9 m -71.61 -42.79 67.24 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.441 0.638 . . . . 0.0 109.544 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.59 67.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.05 -27.45 8.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.965 . . . . 0.0 109.445 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . 0.562 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.4 OUTLIER -52.37 -17.7 1.3 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.184 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.63 -41.77 28.43 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -28.75 35.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -1.22 . . . . 0.0 109.231 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 78.0 t -58.47 114.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.844 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' B' ' 21' ' ' ASP . 7.9 t-20 -81.76 67.08 7.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.237 -0.915 . . . . 0.0 108.726 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' B' ' 19' ' ' ASN . 84.4 t -42.75 -20.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.475 -0.766 . . . . 0.0 109.792 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' B' ' 19' ' ' ASN . 78.5 m-20 -75.55 2.72 10.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' B' ' 19' ' ' ASN . 33.9 mt-10 -155.57 -47.94 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -47.09 -33.06 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.507 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.72 -55.58 19.25 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.44 -36.75 93.01 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -76.09 -47.32 24.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -1.162 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.25 -33.84 59.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.15 -57.81 3.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.875 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.81 -45.06 55.67 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -50.33 -36.39 31.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -1.119 . . . . 0.0 109.489 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 42.9 tp -49.46 -38.9 31.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.351 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -81.1 -21.83 39.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 109.538 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 t -77.86 -64.32 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 0.0 109.703 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -22.76 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.604 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -141.33 81.34 15.64 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.272 -0.892 . . . . 0.0 109.404 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.75 7.47 4.84 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.687 2.258 . . . . 0.0 112.475 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . 0.404 ' C ' ' H ' ' B' ' 39' ' ' GLN . 1.5 p-90 -66.01 -19.79 65.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.097 -1.002 . . . . 0.0 109.476 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 82.3 p -76.89 41.78 0.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . 0.427 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 35.1 tt0 -84.1 26.41 0.75 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.89 . . . . 0.0 109.372 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.13 -49.2 4.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.347 -0.845 . . . . 0.0 109.582 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -88.22 3.35 49.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' B' ' 39' ' ' GLN . 8.0 p90 -52.49 -30.12 28.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.675 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -49.16 -24.89 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.606 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 39.1 t -95.36 -9.02 34.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 0.0 109.536 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' B' ' 42' ' ' PHE . 16.1 m-85 -87.03 21.82 2.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 109.497 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -98.99 2.44 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' B' ' 47' ' ' ASP . 27.2 p-10 -156.86 112.66 2.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -1.125 . . . . 0.0 109.606 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' B' ' 48' ' ' LEU . 9.4 mp -80.01 24.54 0.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.15 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' SER . . . . . 0.437 ' H ' ' C ' ' B' ' 47' ' ' ASP . 29.2 t -43.09 -29.97 0.4 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.385 -0.822 . . . . 0.0 109.686 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' THR . . . . . 0.415 ' O ' ' N ' ' B' ' 53' ' ' ALA . 73.1 p -148.74 139.02 13.15 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 109.16 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -39.35 -36.12 0.88 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.442 2.095 . . . . 0.0 112.411 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.29 -33.77 61.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.847 . . . . 0.0 109.624 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -48.86 -19.81 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.563 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.56 -64.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.606 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' B' ' 55' ' ' MET . 1.9 mpt? -80.26 4.22 18.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.983 . . . . 0.0 109.467 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.02 -26.84 47.56 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' B' ' 53' ' ' ALA . 67.3 m-80 -84.79 141.84 38.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.095 -1.238 . . . . 0.0 109.423 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.05 -40.01 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.612 2.208 . . . . 0.0 112.245 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -47.39 78.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.549 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 89.9 t -50.79 -41.01 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.895 . . . . 0.0 109.58 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -79.09 -42.44 26.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.741 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.55 -30.27 71.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . 0.49 ' O ' ' ND1' ' B' ' 63' ' ' HIS . 1.3 t-80 -66.21 -23.88 66.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.542 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.62 -46.69 74.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.51 ' HZ3' ' C ' ' B' ' 21' ' ' ASP . 8.3 mtpp -54.49 -29.42 50.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.576 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.85 -32.79 63.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.925 . . . . 0.0 109.579 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 t -81.32 -30.75 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.46 -44.61 57.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 109.39 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.95 -44.87 19.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.12 -45.75 86.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -1.175 . . . . 0.0 109.621 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -57.43 -51.29 70.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.625 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' SER . . . . . 0.562 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.9 t -57.54 -43.05 84.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -0.824 . . . . 0.0 109.644 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -48.38 -29.99 4.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.986 . . . . 0.0 109.445 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.43 -60.25 5.61 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.463 ' H ' HD13 ' B' ' 75' ' ' LEU . 4.9 mp -54.95 -23.69 20.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -1.113 . . . . 0.0 109.264 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.51 9.41 43.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.523 ' CE1' ' OD1' ' B' ' 80' ' ' ASN . 9.5 t-80 -170.77 70.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.958 . . . . 0.0 109.739 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.14 -7.75 58.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.185 -0.947 . . . . 0.0 109.387 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.63 -26.73 5.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.433 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.523 ' OD1' ' CE1' ' B' ' 77' ' ' HIS . 8.6 p-10 -172.33 41.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.289 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.536 ' CD2' ' N ' ' B' ' 81' ' ' LEU . 1.6 pt? -46.63 -18.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.36 -0.837 . . . . 0.0 109.849 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' B' ' 80' ' ' ASN . 59.6 mttm -79.93 -32.32 40.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.06 -1.025 . . . . 0.0 109.638 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.26 -23.01 55.9 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.7 OUTLIER -70.78 -42.99 69.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.102 -1.234 . . . . 0.0 109.733 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.483 ' N ' ' CG2' ' B' ' 84' ' ' THR . 30.9 m-85 -84.81 25.96 0.88 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.6 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.51 -26.94 55.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.264 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.48 ' HG1' ' N ' ' B' ' 88' ' ' LEU . 81.2 p -79.69 -54.89 5.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.311 -0.868 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.48 ' N ' ' HG1' ' B' ' 87' ' ' THR . 17.1 mt -47.97 -43.12 29.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.163 -0.961 . . . . 0.0 109.266 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' SER . . . . . 0.514 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 1.5 m -64.72 -38.89 92.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.192 -0.942 . . . . 0.0 109.555 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -82.1 -22.6 36.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.5 tt -90.29 -39.22 12.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.977 . . . . 0.0 109.744 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' B' ' 97' ' ' HIS . 4.0 m80 -77.75 -29.92 51.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.02 -1.05 . . . . 0.0 110.176 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' B' ' 94' ' ' ASP . 13.2 p -83.51 -48.62 10.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.048 -1.032 . . . . 0.0 110.81 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.639 ' N ' ' SG ' ' B' ' 93' ' ' CYS . 23.6 m-20 -87.33 -34.38 18.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.904 -1.123 . . . . 0.0 111.523 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -89.01 -51.84 5.4 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.815 -1.178 . . . . 0.0 111.01 -178.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 12.9 mt -98.3 -17.79 18.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.95 -1.094 . . . . 0.0 110.314 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 31.0 p80 42.6 33.8 0.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.396 -0.815 . . . . 0.0 110.204 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 68.0 t -58.25 127.44 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.158 -0.964 . . . . 0.0 109.031 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' B' ' 99' ' ' ASP . 4.6 p-10 -45.61 148.33 1.3 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 109.494 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' B' ' 102' ' ' ASN . 59.8 Cg_endo -72.99 -40.09 1.94 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.61 2.207 . . . . 0.0 112.342 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -67.76 52.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.486 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' B' ' 100' ' ' PRO . 56.0 t-20 -140.68 -49.7 0.44 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.274 -0.891 . . . . 0.0 109.644 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -46.23 -24.22 0.44 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.832 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -74.54 -20.01 60.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' B' ' 108' ' ' ASN . 43.1 mt -80.65 -59.55 2.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.548 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 8.2 tt -46.94 -35.13 6.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.523 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.27 -26.4 74.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . 0.712 HD22 ' CB ' ' A' ' 103' ' ' HIS . 32.1 t-20 -85.52 -19.24 31.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -1.172 . . . . 0.0 109.778 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 77.4 t -84.15 -24.69 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.596 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 tt -71.73 -60.0 2.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.52 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 t -51.39 -29.02 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 14.5 t -65.3 -41.35 94.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.183 -0.948 . . . . 0.0 109.571 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.06 -45.94 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.584 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.74 -26.55 68.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.634 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.493 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -68.12 -34.43 76.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.492 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.96 -62.85 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 109.398 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.614 ' ND1' ' CZ ' ' B' ' 118' ' ' PHE . 12.4 t-80 -55.82 -19.68 12.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 109.74 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.614 ' CZ ' ' ND1' ' B' ' 117' ' ' HIS . 67.5 m-85 -151.6 60.8 0.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -72.63 -16.93 77.78 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -69.41 -30.03 67.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.481 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -94.01 13.54 22.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.915 . . . . 0.0 109.822 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.578 ' CD2' ' HB3' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -81.43 33.31 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.46 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 13.1 p -47.73 130.11 11.2 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.5 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 45.5 Cg_exo -43.38 -51.9 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.194 1.929 . . . . 0.0 113.029 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 18.9 Cg_endo -58.84 -33.97 98.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.823 1.682 . . . . 0.0 111.883 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 49.7 t -82.41 -9.98 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 0.0 109.579 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . 0.918 ' HG2' HH11 ' A' ' 31' ' ' ARG . 13.9 tp60 -75.85 -59.78 2.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.679 ' HB1' ' HB3' ' A' ' 34' ' ' LEU . . . -61.08 -34.04 74.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.451 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.19 11.77 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 109.545 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' B' ' 128' ' ' ALA . 6.3 t80 -105.0 -55.25 2.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 109.704 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . 0.671 ' OE1' ' HA ' ' A' ' 35' ' ' SER . 6.5 pt20 -45.82 -44.2 13.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.928 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -57.14 -50.04 74.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.979 . . . . 0.0 109.997 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.92 -46.95 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.133 -0.98 . . . . 0.0 109.984 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.39 -33.78 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.919 . . . . 0.0 110.197 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . -47.89 -27.26 2.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.975 -1.078 . . . . 0.0 109.394 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.77 -25.67 73.02 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.35 -49.25 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -1.125 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.62 -42.79 35.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -78.22 -23.47 47.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.41 3.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.86 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.53 -14.15 0.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.879 . . . . 0.0 109.368 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' B' ' 144' ' ' LYS . . . -93.95 4.67 53.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.362 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . 0.515 ' O ' ' CG ' ' B' ' 143' ' ' HIS . 11.0 t-160 -68.47 7.8 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.335 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' B' ' 142' ' ' ALA . 39.7 mmtt -139.25 -41.31 0.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.352 -0.842 . . . . 0.0 109.498 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.513 ' CE1' ' OXT' ' B' ' 146' ' ' HIS . 0.0 OUTLIER -56.19 -12.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 109.491 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.513 ' OXT' ' CE1' ' B' ' 145' ' ' TYR . 15.7 m-70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.711 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' C' ' 2' ' ' LEU . 2.9 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' C' ' 3' ' ' SER . 3.3 tp 75.68 174.4 0.24 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -0.849 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.618 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 164.45 -38.1 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.363 -0.835 . . . . 0.0 110.46 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' C' ' 3' ' ' SER . 77.3 Cg_exo -49.6 -173.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.305 2.003 . . . . 0.0 112.972 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.484 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -75.75 -15.84 60.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.405 -0.81 . . . . 0.0 110.147 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' C' ' 127' ' ' LYS . 4.8 p30 -39.11 -38.21 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.554 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.477 ' N ' ' OD1' ' C' ' 6' ' ' ASP . 12.9 mtmm -57.43 -58.37 8.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 108.932 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.8 m -51.57 -31.84 26.08 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 108.942 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -76.62 -34.75 58.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 51.7 t -72.62 -49.97 37.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.03 -42.46 63.08 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.62 -60.78 3.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.361 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.73 -33.98 57.4 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.378 -0.826 . . . . 0.0 109.162 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -17.73 61.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.081 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.35 -45.13 10.18 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -68.82 -39.74 79.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.227 -1.161 . . . . 0.0 108.849 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.86 -65.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 58.12 -136.69 50.69 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.12 27.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.464 -1.021 . . . . 0.0 110.302 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.618 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.6 m-70 -131.5 27.16 4.73 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.02 -63.88 1.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.611 -0.68 . . . . 0.0 109.869 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.91 -14.38 0.12 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.5 mt-10 -85.1 -56.34 3.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -1.055 . . . . 0.0 109.683 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.9 m-30 -58.03 -43.83 86.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.125 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.08 -22.83 56.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.07 -33.97 59.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.165 . . . . 0.0 109.69 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . 0.525 ' OE2' ' NE2' ' C' ' 112' ' ' HIS . 47.1 mt-10 -69.01 -20.27 64.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.716 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.61 -19.73 59.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.27 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -72.1 -48.07 46.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.349 -0.845 . . . . 0.0 109.681 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.54 -24.68 63.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.899 HH11 ' HG2' ' D' ' 127' ' ' GLN . 50.3 ttm-85 -76.15 -21.23 56.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 54.1 ttp -82.12 -50.65 8.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . 0.46 ' CD2' ' OG1' ' C' ' 39' ' ' THR . 9.4 m-85 -52.72 -44.29 66.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.699 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.677 ' HB3' ' HB1' ' D' ' 128' ' ' ALA . 6.5 mt -67.51 -58.83 4.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.663 ' HA ' ' OE1' ' D' ' 131' ' ' GLN . 40.9 m -48.34 -34.08 10.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.802 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -146.67 90.42 5.53 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.94 . . . . 0.0 109.356 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' C' ' 39' ' ' THR . 48.2 Cg_exo -53.48 -19.33 13.21 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.745 2.297 . . . . 0.0 112.172 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' THR . . . . . 0.406 ' O ' ' CG2' ' C' ' 41' ' ' THR . 12.8 p -42.65 -18.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.43 -0.794 . . . . 0.0 110.117 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.561 ' N ' ' O ' ' C' ' 37' ' ' PRO . 45.6 p -75.44 -22.22 57.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 110.09 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -46.59 -44.96 18.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' C' ' 38' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.491 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -146.16 66.34 1.2 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' C' ' 49' ' ' SER . 17.0 m-20 -40.99 -18.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.274 -0.892 . . . . 0.0 110.299 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.578 ' N ' ' O ' ' C' ' 46' ' ' PHE . 1.1 mt 52.03 9.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.069 -1.02 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.591 ' HG ' ' N ' ' C' ' 50' ' ' HIS . 10.7 t -67.09 155.85 37.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.615 ' HD1' ' N ' ' C' ' 51' ' ' GLY . 11.3 t-80 -65.34 139.84 58.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . 0.615 ' N ' ' HD1' ' C' ' 50' ' ' HIS . . . 54.57 30.66 51.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 37.1 t -63.27 -98.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -1.122 . . . . 0.0 109.396 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . 172.56 -39.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.545 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -74.68 -20.22 59.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.41 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.0 t -84.63 -41.02 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -79.03 -26.4 43.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 109.083 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . 0.431 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -80.67 -21.79 63.23 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.577 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.3 OUTLIER -79.05 -39.28 34.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -1.132 . . . . 0.0 109.575 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.87 -47.66 31.18 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 51.3 mttp -52.45 -23.79 6.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -1.083 . . . . 0.0 109.696 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' C' ' 57' ' ' GLY . 1.7 mmpp? -72.11 -42.53 65.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.171 -0.955 . . . . 0.0 109.042 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 t -70.58 -48.31 59.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.453 -0.78 . . . . 0.0 108.969 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.55 -30.41 70.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.242 -0.911 . . . . 0.0 109.11 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 8.0 t0 -68.46 -32.54 72.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 108.693 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.56 -49.36 60.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.473 -0.767 . . . . 0.0 108.954 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.56 -40.05 93.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 108.744 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -70.67 -49.82 43.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -58.38 -20.96 48.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.51 -46.83 12.0 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -63.44 -23.0 32.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' C' ' 72' ' ' HIS . . . -59.3 -26.1 64.7 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' C' ' 74' ' ' ASP . 40.5 m80 -147.08 -48.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.424 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.4 p 45.06 12.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.783 0.802 . . . . 0.0 109.525 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' C' ' 72' ' ' HIS . 37.4 m-20 -135.45 10.68 3.47 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 3.9 m-20 -174.96 26.68 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.686 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 15.1 ptt? -78.63 -22.54 0.39 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.403 -0.811 . . . . 0.0 111.705 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' C' ' 76' ' ' MET . 49.7 Cg_exo -54.98 -18.02 15.73 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.547 1.498 . . . . 0.0 112.208 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -94.12 -46.77 6.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.96 . . . . 0.0 109.381 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.96 -42.36 99.03 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.294 -0.878 . . . . 0.0 109.183 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.76 9.22 8.28 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 108.994 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -57.48 -25.45 59.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 109.608 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -56.49 -58.02 9.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.377 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.478 ' O ' ' CE1' ' C' ' 87' ' ' HIS . 6.5 mt -45.17 -50.5 11.36 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' C' ' 135' ' ' VAL . 3.4 m -49.29 -38.36 27.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' C' ' 82' ' ' ALA . 27.9 t70 -82.51 -17.44 45.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 109.782 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -70.69 -51.83 25.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.567 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . 0.52 ' NE2' ' O ' ' C' ' 136' ' ' LEU . 14.3 p-80 -92.2 -21.8 20.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.965 -1.084 . . . . 0.0 110.754 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' C' ' 84' ' ' SER . . . -60.67 -51.37 69.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.838 -1.164 . . . . 0.0 109.881 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -155.66 63.9 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.88 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -163.16 1.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.259 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 60.5 tp -171.77 -32.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.299 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 51.7 47.82 24.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.626 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.62 136.88 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.407 ' OD2' ' CE1' ' B' ' 97' ' ' HIS . 22.3 m-20 -58.25 128.36 81.98 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.269 -0.894 . . . . 0.0 109.507 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' C' ' 97' ' ' ASN . 74.3 Cg_endo -77.01 -18.57 14.48 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.336 2.024 . . . . 0.0 112.194 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -46.72 -15.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 109.569 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' C' ' 95' ' ' PRO . 20.7 m-80 -78.97 -24.5 43.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.99 -50.65 63.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.4 ' O ' ' CE1' ' C' ' 103' ' ' HIS . 46.9 mttp -56.61 -25.96 54.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.73 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 9.8 mt -84.24 -34.62 23.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 109.592 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 8.3 tp -74.99 -29.09 60.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 109.714 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 66.6 m -73.36 -39.13 65.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.668 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . 0.707 ' CB ' HD22 ' D' ' 108' ' ' ASN . 7.2 m170 -80.77 -26.81 37.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.299 -0.876 . . . . 0.0 109.644 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 33.0 m -64.32 -53.69 44.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.739 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -46.79 -28.59 1.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.968 . . . . 0.0 109.63 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 15.8 mt -80.94 -31.52 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 109.941 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 87.9 t -82.59 -26.66 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.03 -1.044 . . . . 0.0 109.683 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.615 ' HG1' ' H ' ' C' ' 109' ' ' LEU . 5.2 p -74.41 -62.06 1.65 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.189 -0.944 . . . . 0.0 109.585 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.615 ' H ' ' HG1' ' C' ' 108' ' ' THR . 17.5 mt -46.06 -35.22 4.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.87 -40.74 66.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.931 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . 0.588 ' HB3' ' CD2' ' D' ' 122' ' ' PHE . . . -73.37 -40.83 64.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.661 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . 0.525 ' NE2' ' OE2' ' C' ' 27' ' ' GLU . 64.7 m-70 -89.67 -78.77 0.35 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.571 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.4 OUTLIER -107.75 113.53 61.23 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' C' ' 113' ' ' LEU . 78.9 Cg_exo -45.99 -173.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.198 1.932 . . . . 0.0 112.292 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.65 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -69.46 -52.98 21.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 109.098 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.65 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 26.1 mt-10 125.48 -0.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' C' ' 117' ' ' PHE . 56.8 t80 58.02 33.52 23.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.344 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.784 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -106.51 117.3 57.39 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.3 20.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.134 1.889 . . . . 0.0 112.689 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.784 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -146.39 -34.11 0.3 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.026 -1.046 . . . . 0.0 110.232 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 14.0 p -47.71 -47.05 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 109.871 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.471 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 0.0 OUTLIER -67.94 -33.55 74.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.813 . . . . 0.0 109.259 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.27 -20.35 32.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.905 . . . . 0.0 109.713 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.542 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.5 m -68.99 -62.84 1.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.11 -19.69 64.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.951 -1.093 . . . . 0.0 109.076 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.18 -46.75 13.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.679 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -89.85 -39.02 13.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.007 . . . . 0.0 109.836 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.493 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 27.6 t80 -47.82 -20.74 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.966 -1.083 . . . . 0.0 108.629 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.431 ' N ' ' C ' ' C' ' 127' ' ' LYS . 29.5 mt -70.66 -19.66 62.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -55.09 -38.37 68.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' SER . . . . . 0.495 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 5.4 t -77.9 -29.74 50.3 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.28 -39.21 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.352 -0.842 . . . . 0.0 108.787 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -67.96 -21.03 65.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.922 . . . . 0.0 109.063 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' C' ' 138' ' ' SER . 93.7 m -69.15 -39.46 78.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.845 . . . . 0.0 109.46 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' C' ' 84' ' ' SER . 1.0 OUTLIER -76.62 -31.01 19.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.297 -0.877 . . . . 0.0 109.41 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' C' ' 87' ' ' HIS . 0.5 OUTLIER -84.76 -23.89 29.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.889 . . . . 0.0 109.13 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 43.0 m -100.23 -15.57 18.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.319 -0.863 . . . . 0.0 109.443 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 138' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' C' ' 134' ' ' THR . 1.8 t . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -133.79 -171.87 2.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.292 -179.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.417 ' O ' ' N ' ' D' ' 6' ' ' GLU . 12.6 p -90.06 134.88 30.83 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.88 . . . . 0.0 109.322 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -41.61 -22.94 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.423 2.082 . . . . 0.0 112.365 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . 0.421 ' N ' ' CD ' ' D' ' 6' ' ' GLU . 9.6 mp0 -79.16 -52.37 8.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -62.99 -60.56 3.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 109.754 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.458 ' O ' ' OG1' ' D' ' 12' ' ' THR . 5.0 ttpp -49.71 -51.87 35.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.94 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -43.51 -23.69 0.08 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.61 -0.681 . . . . 0.0 110.285 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.01 -56.14 3.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.027 -1.045 . . . . 0.0 109.763 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.75 -24.63 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 10.5 m -71.5 -42.83 67.53 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.455 0.645 . . . . 0.0 109.594 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.4 -27.63 68.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.746 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.94 -27.53 7.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . 0.559 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.4 OUTLIER -52.35 -17.82 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 109.155 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.47 -41.92 28.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.99 -28.73 35.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -1.204 . . . . 0.0 109.219 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 78.4 t -58.45 114.91 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.804 . . . . 0.0 109.886 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' D' ' 21' ' ' ASP . 7.9 t-20 -81.84 67.07 7.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.262 -0.899 . . . . 0.0 108.737 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' D' ' 19' ' ' ASN . 84.3 t -42.72 -20.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.467 -0.77 . . . . 0.0 109.835 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' D' ' 19' ' ' ASN . 78.5 m-20 -75.68 2.82 10.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.88 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' D' ' 19' ' ' ASN . 33.9 mt-10 -155.6 -47.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 53.1 t -47.1 -33.08 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 109.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.74 -55.61 19.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.47 -36.63 92.85 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -76.23 -47.21 24.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -1.119 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.27 -33.86 59.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.394 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.18 -57.77 3.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.958 . . . . 0.0 109.385 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.81 -45.03 55.69 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -50.37 -36.43 32.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -1.096 . . . . 0.0 109.486 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 42.9 tp -49.41 -38.85 30.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.354 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.13 -21.94 39.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 t -77.81 -64.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -0.99 . . . . 0.0 109.705 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -22.88 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.639 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -141.26 81.36 15.73 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.325 -0.86 . . . . 0.0 109.396 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.8 7.47 4.85 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.703 2.269 . . . . 0.0 112.449 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . 0.417 ' C ' ' H ' ' D' ' 39' ' ' GLN . 1.5 p-90 -65.97 -19.86 66.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.512 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 82.4 p -76.83 41.74 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . 0.421 ' O ' ' CD1' ' D' ' 42' ' ' PHE . 35.1 tt0 -84.03 26.34 0.74 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.383 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.11 -49.19 4.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.905 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -88.16 3.37 49.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' D' ' 39' ' ' GLN . 7.8 p90 -52.63 -30.14 29.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.601 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -49.11 -24.89 1.81 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.649 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 39.2 t -95.38 -8.99 34.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.537 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -87.05 21.88 2.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -99.13 2.45 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' D' ' 47' ' ' ASP . 27.2 p-10 -156.8 112.7 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' D' ' 48' ' ' LEU . 9.4 mp -80.04 24.57 0.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.172 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.43 ' H ' ' C ' ' D' ' 47' ' ' ASP . 29.1 t -43.09 -30.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.428 -0.795 . . . . 0.0 109.624 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' THR . . . . . 0.431 ' O ' ' N ' ' D' ' 53' ' ' ALA . 73.1 p -148.77 138.95 13.09 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 109.154 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -39.36 -36.1 0.88 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.458 2.105 . . . . 0.0 112.415 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.2 -33.86 61.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.16 -0.962 . . . . 0.0 109.652 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -48.92 -19.78 0.43 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 93.9 t -67.45 -64.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.733 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' D' ' 55' ' ' MET . 1.9 mpt? -80.17 4.14 18.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 109.496 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.08 -26.74 47.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' D' ' 53' ' ' ALA . 67.2 m-80 -84.84 141.83 38.56 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 0.0 109.489 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.1 -39.91 1.49 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.497 2.132 . . . . 0.0 112.254 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.92 -47.38 77.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.48 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 89.4 t -50.83 -40.94 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -79.19 -42.41 26.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.624 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.53 -30.23 71.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.621 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . 0.488 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 1.3 t-80 -66.26 -23.85 66.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.561 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.7 -46.65 73.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . 0.512 ' HZ3' ' C ' ' D' ' 21' ' ' ASP . 8.2 mtpp -54.41 -29.54 49.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -1.192 . . . . 0.0 109.556 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.75 -32.86 64.05 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 109.625 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 34.7 t -81.23 -30.78 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.54 -44.54 57.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.339 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.92 -44.84 18.87 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.61 87.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -1.137 . . . . 0.0 109.621 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -57.46 -51.3 69.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 109.594 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' SER . . . . . 0.559 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 9.0 t -57.54 -43.03 84.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.699 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -48.36 -30.13 4.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.42 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.32 -60.21 5.69 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.468 ' H ' HD13 ' D' ' 75' ' ' LEU . 4.9 mp -55.07 -23.64 21.28 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.223 -1.163 . . . . 0.0 109.239 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.54 9.48 43.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.622 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.527 ' CE1' ' OD1' ' D' ' 80' ' ' ASN . 9.5 t-80 -170.84 70.01 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 109.787 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 91.0 mt -85.98 -7.83 58.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.58 -26.74 5.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.527 ' OD1' ' CE1' ' D' ' 77' ' ' HIS . 8.5 p-10 -172.3 41.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 109.233 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' D' ' 81' ' ' LEU . 1.5 pt? -46.66 -18.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.884 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' D' ' 80' ' ' ASN . 59.5 mttm -80.02 -32.29 39.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.106 -0.996 . . . . 0.0 109.609 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.26 -23.04 55.79 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.7 OUTLIER -70.78 -43.05 69.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.039 -1.271 . . . . 0.0 109.676 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.485 ' N ' ' CG2' ' D' ' 84' ' ' THR . 30.8 m-85 -84.81 26.01 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.57 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.56 -26.93 56.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.918 . . . . 0.0 109.274 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' THR . . . . . 0.474 ' HG1' ' N ' ' D' ' 88' ' ' LEU . 81.3 p -79.67 -54.99 5.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.474 ' N ' ' HG1' ' D' ' 87' ' ' THR . 17.0 mt -47.86 -43.16 28.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.358 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' SER . . . . . 0.523 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 1.5 m -64.81 -38.81 92.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 109.513 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -82.09 -22.6 36.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.676 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' D' ' 87' ' ' THR . 7.5 tt -90.24 -39.29 12.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 109.753 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' D' ' 97' ' ' HIS . 4.0 m80 -77.64 -29.92 51.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.054 -1.028 . . . . 0.0 110.234 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' D' ' 94' ' ' ASP . 13.1 p -83.51 -48.59 10.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.129 -0.982 . . . . 0.0 110.807 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.638 ' N ' ' SG ' ' D' ' 93' ' ' CYS . 23.9 m-20 -87.31 -34.42 18.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.91 -1.119 . . . . 0.0 111.493 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -89.03 -51.8 5.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.807 -1.183 . . . . 0.0 111.006 -178.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.582 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 12.9 mt -98.29 -17.79 18.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.942 -1.099 . . . . 0.0 110.26 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 31.0 p80 42.39 34.03 0.48 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.301 -0.874 . . . . 0.0 110.213 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 67.7 t -58.32 127.27 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 109.093 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' D' ' 99' ' ' ASP . 4.7 p-10 -45.4 148.41 1.18 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.563 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' D' ' 102' ' ' ASN . 59.3 Cg_endo -73.13 -40.05 1.89 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.614 2.209 . . . . 0.0 112.316 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -67.69 52.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.482 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' D' ' 100' ' ' PRO . 56.1 t-20 -140.75 -49.61 0.44 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -46.27 -24.24 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 109.764 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -74.61 -19.95 60.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' D' ' 108' ' ' ASN . 43.5 mt -80.7 -59.59 2.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.963 . . . . 0.0 109.453 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 8.2 tt -46.91 -35.17 6.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.23 -26.43 74.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . 0.707 HD22 ' CB ' ' C' ' 103' ' ' HIS . 32.1 t-20 -85.49 -19.26 31.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -1.163 . . . . 0.0 109.794 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 77.4 t -84.05 -24.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -71.82 -59.99 2.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.465 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 11.6 t -51.3 -29.12 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.592 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 14.6 t -65.36 -41.24 94.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.22 -45.9 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.542 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.71 -26.56 68.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.643 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.501 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -68.17 -34.29 76.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 109.524 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.454 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -85.06 -62.84 1.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 0.0 109.388 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . 0.615 ' ND1' ' CZ ' ' D' ' 118' ' ' PHE . 12.3 t-80 -55.75 -19.76 12.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 109.748 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.615 ' CZ ' ' ND1' ' D' ' 117' ' ' HIS . 67.6 m-85 -151.62 60.83 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.539 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -72.54 -17.05 77.68 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -69.36 -30.06 67.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.144 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -94.0 13.58 22.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.807 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.588 ' CD2' ' HB3' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -81.46 33.26 0.35 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.663 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.46 ' OG1' ' CG2' ' D' ' 126' ' ' VAL . 13.3 p -47.67 130.07 11.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.312 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.513 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 45.6 Cg_exo -43.43 -51.88 5.57 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.134 1.89 . . . . 0.0 113.037 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 18.8 Cg_endo -58.78 -33.92 98.71 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.791 1.661 . . . . 0.0 111.955 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 49.1 t -82.37 -10.06 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.535 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . 0.899 ' HG2' HH11 ' C' ' 31' ' ' ARG . 14.0 tp60 -75.94 -59.75 2.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 109.423 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 0.677 ' HB1' ' HB3' ' C' ' 34' ' ' LEU . . . -61.12 -33.99 74.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.26 11.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' D' ' 128' ' ' ALA . 6.3 t80 -104.88 -55.34 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.299 -0.876 . . . . 0.0 109.738 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . 0.663 ' OE1' ' HA ' ' C' ' 35' ' ' SER . 6.5 pt20 -45.87 -44.12 14.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.88 . . . . 0.0 109.899 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -57.17 -50.11 73.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.991 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.84 -46.93 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.024 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.36 -33.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.113 -0.992 . . . . 0.0 110.203 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.89 -27.32 2.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.968 -1.082 . . . . 0.0 109.404 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.69 -25.67 72.93 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.34 -49.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -1.151 . . . . 0.0 109.441 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.65 -42.81 35.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.435 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -78.21 -23.43 47.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.464 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.01 -60.4 3.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.51 -14.14 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' D' ' 144' ' ' LYS . . . -94.01 4.75 53.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.91 . . . . 0.0 109.386 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' D' ' 143' ' ' HIS . 11.0 t-160 -68.52 7.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 109.342 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' D' ' 142' ' ' ALA . 39.7 mmtt -139.32 -41.28 0.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.367 -0.833 . . . . 0.0 109.466 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . 0.521 ' CE1' ' OXT' ' D' ' 146' ' ' HIS . 0.0 OUTLIER -56.26 -12.04 1.43 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.406 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.521 ' OXT' ' CE1' ' D' ' 145' ' ' TYR . 15.5 m-70 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.742 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.42 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 48.9 mt -125.32 -162.32 1.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.354 -0.841 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.496 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 177.12 -48.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.865 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 3' ' ' SER . 68.3 Cg_exo -49.18 174.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.391 2.061 . . . . 0.0 112.437 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -56.98 -16.56 7.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.614 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.472 ' C ' ' O ' ' A' ' 5' ' ' ALA . 14.8 t70 -39.92 -31.67 0.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 109.524 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 5' ' ' ALA . 9.3 mtmp? -73.34 -55.97 5.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.407 -0.808 . . . . 0.0 109.216 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 m -47.53 -28.63 2.33 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.139 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -78.33 -38.58 41.83 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 7' ' ' LYS . 40.9 t -70.8 -48.91 54.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -51.58 -44.66 62.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 108.839 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.81 -58.55 7.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.818 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.83 62.73 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.47 -17.4 58.07 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.201 -0.937 . . . . 0.0 108.914 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.35 -38.77 44.85 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -84.4 -40.86 17.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.381 -1.07 . . . . 0.0 109.32 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.573 ' O ' ' C ' ' A' ' 18' ' ' GLY . 93.7 t -66.69 -45.93 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 109.709 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.573 ' C ' ' O ' ' A' ' 17' ' ' VAL . . . -25.1 137.81 0.01 OUTLIER Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 18' ' ' GLY . . . 74.26 -29.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.43 -1.041 . . . . 0.0 109.331 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 17' ' ' VAL . 38.0 m-70 -110.76 16.79 21.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.39 -60.8 2.08 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.008 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.46 -14.84 0.39 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.0 mt-10 -85.47 -56.35 3.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -1.177 . . . . 0.0 109.758 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.4 m-30 -60.69 -35.2 75.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.0 109.398 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.37 -23.01 73.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.74 -47.03 14.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -1.154 . . . . 0.0 109.64 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -63.57 -19.87 65.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 109.327 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.03 -27.6 63.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.44 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.4 -53.68 15.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.907 . . . . 0.0 109.57 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.16 -29.37 69.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.251 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.38 -30.34 67.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.299 -0.876 . . . . 0.0 109.224 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 47.9 ttp -72.83 -52.7 13.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.186 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.38 -32.04 10.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.239 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.528 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.6 mt -78.42 -39.76 37.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -0.903 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.524 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 15.0 m -51.67 -29.67 18.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 35' ' ' SER . 57.1 m-85 -160.85 130.39 3.28 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.248 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.27 -19.89 14.89 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.317 2.011 . . . . 0.0 112.158 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' D' ' 97' ' ' HIS . 22.3 p -46.53 -46.0 18.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.785 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -45.39 -22.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 109.93 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.5 ttmt -51.81 -42.46 62.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.169 -0.957 . . . . 0.0 110.113 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 1.337 HG23 ' CD2' ' D' ' 97' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 0.0 109.757 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.531 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 4.2 p80 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.098 0.475 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -157.71 28.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 110.074 179.409 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 49' ' ' SER . 73.9 m-20 43.67 89.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.478 -0.764 . . . . 0.0 110.345 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.803 ' H ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.6 1.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.356 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 47' ' ' ASP . 5.0 m -84.77 157.0 21.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.15 -0.968 . . . . 0.0 109.769 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.604 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 40.2 t-80 -76.44 170.58 16.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.396 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.604 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 76.18 -21.88 2.14 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 54' ' ' GLN . 4.7 p -55.95 -18.7 9.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -1.098 . . . . 0.0 109.374 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 72.82 -23.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.814 . . . . 0.0 109.732 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 52' ' ' SER . 24.1 mt-30 -84.83 -17.94 36.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 0.0 109.565 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.09 -32.64 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.576 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -72.92 -29.39 63.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 0.0 109.211 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.98 66.09 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.495 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.2 t-80 -60.71 -30.72 70.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.126 -1.22 . . . . 0.0 110.076 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.79 -31.38 79.58 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 59.2 mttp -68.89 -23.01 64.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -1.115 . . . . 0.0 110.253 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -69.49 -58.19 4.28 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.883 -1.136 . . . . 0.0 108.748 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.52 -41.52 64.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.6 -0.688 . . . . 0.0 109.599 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.53 -43.86 46.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.158 -0.964 . . . . 0.0 109.237 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 34.9 t0 -68.85 -33.85 74.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.149 -0.97 . . . . 0.0 108.639 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . -66.87 -49.14 66.62 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -53.06 -47.06 68.74 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.282 -0.886 . . . . 0.0 108.627 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.2 m -57.01 -56.57 20.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 108.755 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.534 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 28.5 t30 -58.86 -21.09 56.36 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.08 -47.38 10.24 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.4 t -68.44 -22.74 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.43 75.58 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.609 ' O ' ' N ' ' A' ' 74' ' ' ASP . 5.5 m-70 -115.87 -60.57 1.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.493 -0.754 . . . . 0.0 109.509 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.486 ' CG1' ' O ' ' A' ' 72' ' ' HIS . 13.3 p 45.09 12.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.726 0.774 . . . . 0.0 109.549 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 72' ' ' HIS . 28.8 m-20 -138.34 11.11 2.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -177.3 27.79 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.697 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 3.0 ptt? -78.51 -23.81 0.42 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 111.69 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 76' ' ' MET . 53.2 Cg_exo -54.47 -19.62 18.19 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.559 1.506 . . . . 0.0 112.193 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -93.16 -40.68 10.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.323 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.76 -43.45 65.76 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.308 -0.87 . . . . 0.0 109.014 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.35 10.37 12.86 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 84' ' ' SER . 7.7 t -51.84 -47.68 64.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -46.13 -58.07 3.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 109.726 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.8 mt -45.24 -44.29 11.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 108.827 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 81' ' ' SER . 6.9 p -55.18 -30.05 59.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.467 -0.77 . . . . 0.0 108.978 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 89' ' ' HIS . 1.6 m-20 -82.08 -49.65 9.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.837 . . . . 0.0 109.263 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 tp -51.03 -30.02 14.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 109.25 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -92.89 -21.79 19.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -0.843 . . . . 0.0 110.371 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.72 20.82 5.52 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.113 -0.992 . . . . 0.0 110.322 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.666 ' N ' ' O ' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -140.51 -78.27 0.3 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 109.78 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 92' ' ' ARG . 16.9 mttp -67.36 -119.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 109.816 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.455 ' H ' ' CD1' ' A' ' 91' ' ' LEU . 10.3 mp -44.58 -19.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.82 . . . . 0.0 109.774 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 90' ' ' LYS . 49.7 ttt180 57.21 45.95 19.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.302 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.7 t -48.43 133.15 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.647 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -91.58 126.06 55.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.273 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -43.84 -10.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.374 2.05 . . . . 0.0 112.377 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 1.256 HG13 ' CG ' ' D' ' 99' ' ' ASP . 25.1 t -56.39 -31.79 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.088 -1.008 . . . . 0.0 109.648 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -79.57 -38.14 34.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 0.0 109.662 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -46.06 -30.29 1.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.27 -28.02 69.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.89 . . . . 0.0 109.646 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.49 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 11.4 mt -84.29 -34.3 23.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.803 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 tp -64.14 -61.15 2.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.98 . . . . 0.0 109.741 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 t -47.76 -34.76 8.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.759 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -80.84 -26.66 36.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.826 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 97.7 m -76.35 -38.06 56.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.49 -52.04 67.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.118 -0.989 . . . . 0.0 109.716 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.7 mt -60.19 -32.35 71.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.4 t -63.65 -59.62 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 0.0 109.19 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.7 p -54.76 -53.55 53.68 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.244 -0.91 . . . . 0.0 109.276 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 114' ' ' PRO . 7.7 mt -45.41 -26.71 0.58 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.266 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.26 81.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 0.0 109.979 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.612 ' HB2' ' CE2' ' B' ' 122' ' ' PHE . . . -78.99 -3.54 45.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 109.931 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -134.51 -80.09 0.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 109.7 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -118.4 82.53 19.16 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.438 ' N ' ' O ' ' A' ' 109' ' ' LEU . 51.3 Cg_exo -49.61 -169.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.454 2.102 . . . . 0.0 112.432 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.656 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -52.85 -55.72 21.08 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.656 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 46.3 mt-10 123.24 -5.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 7.6 t80 73.24 30.97 1.48 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.732 -0.605 . . . . 0.0 111.116 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.8 p -104.54 126.25 31.89 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 108.38 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.603 ' HB3' ' HB3' ' B' ' 51' ' ' PRO . 54.2 Cg_exo -49.73 22.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.353 2.036 . . . . 0.0 112.897 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -153.3 -32.94 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.83 -1.169 . . . . 0.0 110.645 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.513 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 9.6 p -52.8 -49.5 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.982 -1.074 . . . . 0.0 110.154 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.513 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 4.7 t-160 -59.47 -37.46 78.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 109.218 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.08 -19.41 34.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -0.839 . . . . 0.0 109.487 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 120' ' ' ALA . 23.3 p -64.18 -62.1 1.83 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 110.848 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.488 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.6 mt -68.46 -19.76 64.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.982 -1.074 . . . . 0.0 109.757 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.66 -46.62 12.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 109.36 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -80.44 -46.23 16.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -0.964 . . . . 0.0 109.278 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 26.8 t80 -49.93 -21.79 1.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.93 . . . . 0.0 108.969 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 mt -73.96 -21.76 59.9 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -57.88 -31.83 67.1 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.4 ' HG ' ' N ' ' A' ' 132' ' ' VAL . 90.0 p -79.83 -33.61 40.11 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.378 -0.826 . . . . 0.0 108.954 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.4 ' N ' ' HG ' ' A' ' 131' ' ' SER . 42.8 t -82.24 -35.52 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 108.636 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 47.4 t -72.23 -28.62 63.28 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.436 -0.79 . . . . 0.0 109.172 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 32.2 m -66.51 -34.34 77.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.171 -0.956 . . . . 0.0 109.082 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 97.5 t -77.38 -40.43 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.29 -0.881 . . . . 0.0 108.998 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.79 -27.28 68.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 108.955 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.3 m -86.24 -26.47 25.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 109.455 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.45 -179.93 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.95 155.81 43.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 109.356 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -54.51 152.71 11.65 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 108.914 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.07 -18.57 44.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.463 2.109 . . . . 0.0 112.06 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -87.13 -37.86 16.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.628 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -84.0 -23.22 31.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 109.891 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.52 ' O ' ' OG1' ' B' ' 12' ' ' THR . 7.9 tttm -84.12 -55.12 4.37 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.148 -0.97 . . . . 0.0 109.095 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.8 t -48.03 -23.52 0.83 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.125 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.15 -59.68 2.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.966 -1.084 . . . . 0.0 109.894 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.03 -24.44 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 4.2 m -74.79 -51.93 12.8 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.405 0.622 . . . . 0.0 109.649 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.36 -24.88 47.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.571 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.65 -28.26 67.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.344 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.83 -17.06 62.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.415 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.28 -63.77 3.13 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.596 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -70.68 -11.72 61.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.033 -1.274 . . . . 0.0 110.809 -178.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -70.73 121.35 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.833 -1.167 . . . . 0.0 109.348 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' B' ' 21' ' ' ASP . 0.9 OUTLIER -77.15 73.26 3.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.247 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 75.5 t -52.89 -6.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.64 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' B' ' 19' ' ' ASN . 9.8 p30 -67.88 -20.73 65.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.914 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 9.2 pt-20 -150.11 -32.49 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.897 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.16 -28.27 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.667 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.1 -41.26 99.81 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.11 -55.04 17.83 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.422 ' O ' ' NH1' ' B' ' 30' ' ' ARG . 58.2 mt-10 -49.87 -26.99 4.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -1.141 . . . . 0.0 109.367 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.24 -32.62 22.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.06 -36.41 21.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.6 -40.58 90.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' B' ' 26' ' ' GLU . 0.0 OUTLIER -62.85 -21.88 66.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -1.17 . . . . 0.0 109.426 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.98 -28.38 65.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.965 . . . . 0.0 109.539 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' B' ' 36' ' ' PRO . 27.7 mt -81.24 -53.89 5.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.995 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' B' ' 34' ' ' VAL . 6.2 p -56.18 -43.21 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.0 109.607 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.477 ' N ' ' CG1' ' B' ' 33' ' ' VAL . 57.8 t -79.53 -22.92 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 109.364 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -153.04 75.52 6.69 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.327 -0.858 . . . . 0.0 109.127 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . 0.47 ' N ' ' O ' ' B' ' 32' ' ' LEU . 92.1 Cg_endo -83.69 3.79 7.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.971 2.448 . . . . 0.0 112.562 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -57.42 -19.82 26.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 109.547 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.415 ' H ' ' HG1' ' B' ' 38' ' ' THR . 6.2 p -79.96 5.44 13.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -48.28 -22.74 0.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.912 . . . . 0.0 109.531 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -62.36 -38.81 90.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.39 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . 0.433 ' O ' ' CG ' ' B' ' 42' ' ' PHE . 80.7 m-85 -88.01 27.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.433 ' CG ' ' O ' ' B' ' 41' ' ' PHE . 75.2 m-85 -154.82 32.93 0.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.9 . . . . 0.0 109.518 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.33 -27.84 52.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 67.6 m -76.28 -29.7 57.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.526 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' B' ' 47' ' ' ASP . 3.8 m-85 -48.68 -22.71 0.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.319 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' B' ' 47' ' ' ASP . . . 68.04 -53.16 0.4 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 45' ' ' PHE . 51.2 m-20 -60.35 -151.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -1.144 . . . . 0.0 109.552 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt 58.82 17.91 5.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.492 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 30.2 p -69.45 -28.34 66.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.36 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' THR . . . . . 0.523 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.4 p -145.24 151.31 47.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 109.021 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.603 ' HB3' ' HB3' ' A' ' 119' ' ' PRO . 81.0 Cg_exo -38.27 -32.51 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.619 2.213 . . . . 0.0 112.574 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.19 -24.14 40.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.721 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -68.89 -19.57 64.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.893 . . . . 0.0 109.727 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 t -65.24 -64.03 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 109.571 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 25.5 mtm -95.38 29.33 2.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.12 -58.58 0.66 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -69.4 150.26 97.1 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.293 -1.122 . . . . 0.0 109.478 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' B' ' 60' ' ' VAL . 69.2 Cg_endo -75.05 -56.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.609 2.206 . . . . 0.0 112.395 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -18.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 109.743 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' B' ' 58' ' ' PRO . 91.4 t -81.66 -44.96 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.426 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -79.01 -27.1 43.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.16 -20.93 63.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 109.64 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -72.3 -23.94 61.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -0.99 . . . . 0.0 109.406 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.04 -25.99 74.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.97 -42.82 76.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 109.063 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -64.34 -41.49 96.74 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 109.557 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 29.0 t -65.27 -62.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.296 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tt -54.32 -40.2 67.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.194 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.52 -53.85 38.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.1 -44.38 42.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.097 . . . . 0.0 109.632 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -63.31 -45.89 89.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' SER . . . . . 0.424 ' HG ' ' N ' ' B' ' 73' ' ' ASP . 98.6 p -61.07 -34.83 75.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 0.0 109.563 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . 0.424 ' N ' ' HG ' ' B' ' 72' ' ' SER . 13.6 t70 -53.98 -39.63 66.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -0.961 . . . . 0.0 109.431 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.24 -60.14 8.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.453 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -53.73 -30.07 42.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.173 -1.193 . . . . 0.0 109.168 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.21 4.32 46.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.32 -0.863 . . . . 0.0 109.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -170.22 67.48 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 109.675 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.96 12.78 2.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.237 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.0 -29.75 68.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 24.9 t-20 -164.02 111.32 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 109.56 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.528 ' CD1' ' N ' ' B' ' 81' ' ' LEU . 7.5 mp -80.29 -56.07 4.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.478 ' NZ ' ' CD2' ' B' ' 143' ' ' HIS . 77.0 tttt -62.31 -24.12 67.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.608 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -75.07 -51.11 7.86 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.7 t -73.41 -46.29 49.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -1.133 . . . . 0.0 109.475 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.542 ' N ' ' CG2' ' B' ' 84' ' ' THR . 54.4 m-85 -84.29 26.13 0.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.445 -0.785 . . . . 0.0 109.575 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.11 -28.05 67.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.469 ' O ' ' N ' ' B' ' 91' ' ' LEU . 82.0 p -77.22 -58.14 3.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.83 . . . . 0.0 109.607 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.24 -41.6 18.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -68.71 -37.62 79.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.907 . . . . 0.0 109.58 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -82.67 -28.14 30.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 109.499 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' B' ' 87' ' ' THR . 10.3 tt -75.5 -69.05 0.51 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.232 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' B' ' 97' ' ' HIS . 70.8 m80 -50.1 -23.85 2.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.183 -0.948 . . . . 0.0 109.735 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 38.8 t -83.92 -56.23 3.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.92 . . . . 0.0 111.066 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.538 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 73.4 m-20 -86.17 -24.49 26.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.967 -1.083 . . . . 0.0 111.856 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . 0.469 ' CD ' ' N ' ' B' ' 95' ' ' LYS . 10.7 mptt -94.25 -51.73 4.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.678 -1.264 . . . . 0.0 110.676 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -27.69 13.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.049 -1.032 . . . . 0.0 109.934 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 1.239 ' CD2' HG23 ' C' ' 41' ' ' THR . 21.4 m-70 57.71 53.71 6.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 109.716 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.37 124.29 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.151 -0.968 . . . . 0.0 109.295 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 1.296 ' OD2' HG13 ' C' ' 96' ' ' VAL . 68.7 m-20 -47.99 149.27 2.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.389 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.32 62.93 5.31 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.554 2.169 . . . . 0.0 112.046 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -172.09 73.92 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.434 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.95 -27.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.86 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 0.1 OUTLIER -56.28 -20.53 19.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.002 -1.061 . . . . 0.0 109.689 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -86.15 -41.13 14.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.428 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 tp -48.97 -40.18 29.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.319 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.28 -47.59 64.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.272 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.46 -20.09 54.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -81.72 -55.74 4.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -1.164 . . . . 0.0 110.164 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 p -61.92 -24.15 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.078 -1.013 . . . . 0.0 109.682 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.57 -58.06 9.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.401 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 69.5 t -46.64 -26.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 109.772 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.49 -32.66 74.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 109.63 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.48 -31.57 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.965 . . . . 0.0 109.497 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.14 -29.4 60.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.158 -0.964 . . . . 0.0 109.497 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.424 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -74.97 -32.23 61.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.572 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.477 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.85 -56.98 3.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.224 -0.923 . . . . 0.0 109.404 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' B' ' 118' ' ' PHE . 13.7 m170 -56.83 -17.78 10.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.621 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.408 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 72.1 m-85 -154.48 60.59 0.69 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -70.97 -26.24 74.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' B' ' 120' ' ' LYS . 11.8 mptt -70.0 9.86 0.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -1.168 . . . . 0.0 109.289 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.503 ' H ' ' C ' ' B' ' 119' ' ' GLY . 68.7 mm-40 -136.64 2.53 2.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.828 . . . . 0.0 109.387 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.612 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -72.91 39.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.502 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.538 ' C ' HE22 ' B' ' 127' ' ' GLN . 0.8 OUTLIER -52.46 149.08 11.09 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 109.331 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.486 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.3 Cg_exo -47.62 -52.38 8.14 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.46 2.107 . . . . 0.0 113.246 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 35.8 Cg_endo -65.35 -3.88 8.35 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.087 1.858 . . . . 0.0 112.708 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 56.8 t -96.81 -22.09 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.044 -1.035 . . . . 0.0 109.724 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . 0.538 HE22 ' C ' ' B' ' 123' ' ' THR . 1.8 mp0 -83.27 -59.95 2.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.029 -1.044 . . . . 0.0 109.715 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -54.03 -35.02 61.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.991 . . . . 0.0 109.408 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.89 26.48 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.69 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -118.82 -61.47 1.64 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.304 -0.873 . . . . 0.0 109.654 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -52.81 -23.42 6.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.636 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -71.58 -39.02 70.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.112 -0.992 . . . . 0.0 109.731 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.71 -55.85 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 109.799 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' B' ' 137' ' ' VAL . 11.4 m -69.78 -28.57 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 110.041 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.57 -25.89 1.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 109.354 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.79 -24.6 57.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' B' ' 134' ' ' VAL . 74.8 t -79.42 -37.6 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -1.1 . . . . 0.0 109.345 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.81 79.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.433 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . 0.445 HD22 HD22 ' D' ' 139' ' ' ASN . 65.1 t30 -72.1 -44.03 63.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.36 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.3 -40.82 49.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 109.341 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 36.5 mt -81.94 12.79 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.338 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 139' ' ' ASN . . . -139.78 1.63 1.91 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 109.81 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . 0.478 ' CD2' ' NZ ' ' B' ' 82' ' ' LYS . 10.4 t60 -79.37 -34.05 42.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.51 ' C ' ' HD1' ' B' ' 146' ' ' HIS . 5.0 tptp -67.41 -25.44 65.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.409 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -64.03 -14.14 52.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.526 ' CG ' ' OXT' ' B' ' 146' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.503 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . 0.417 ' CD1' ' CD2' ' C' ' 128' ' ' PHE . 48.9 mt -125.35 -162.29 1.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.824 . . . . 0.0 109.435 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.502 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 177.1 -48.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.954 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' C' ' 3' ' ' SER . 67.4 Cg_exo -49.21 174.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.381 2.054 . . . . 0.0 112.477 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -56.92 -16.54 7.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.639 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' C' ' 5' ' ' ALA . 14.9 t70 -40.0 -31.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 109.525 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' C' ' 5' ' ' ALA . 9.3 mtmp? -73.41 -55.91 5.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.211 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 44.6 m -47.51 -28.63 2.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.381 -0.824 . . . . 0.0 109.211 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -78.3 -38.6 42.09 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' C' ' 7' ' ' LYS . 40.7 t -70.86 -48.83 54.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -51.63 -44.62 63.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.404 -0.81 . . . . 0.0 108.853 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.86 -58.58 7.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.447 -0.783 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.55 -31.93 62.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.309 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.42 -17.37 58.18 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.155 -0.966 . . . . 0.0 109.004 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.33 -38.84 44.84 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -84.26 -40.9 17.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -1.067 . . . . 0.0 109.355 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.566 ' O ' ' C ' ' C' ' 18' ' ' GLY . 93.5 t -66.71 -46.0 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.821 . . . . 0.0 109.687 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' C' ' 17' ' ' VAL . . . -25.08 137.73 0.01 OUTLIER Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' C' ' 18' ' ' GLY . . . 74.45 -29.39 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.517 -0.99 . . . . 0.0 109.237 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.54 ' H ' ' C ' ' C' ' 18' ' ' GLY . 37.6 m-70 -110.56 16.82 21.27 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.32 -60.86 2.06 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.957 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.53 -14.7 0.39 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.0 mt-10 -85.52 -56.4 3.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -1.148 . . . . 0.0 109.728 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.4 m-30 -60.71 -35.2 75.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.445 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.39 -22.9 73.31 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.79 -47.09 14.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -1.165 . . . . 0.0 109.598 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -63.66 -19.77 65.16 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.298 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.64 63.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 109.509 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.39 -53.7 15.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.13 -29.37 69.73 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 109.226 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.37 -30.4 67.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.259 -0.901 . . . . 0.0 109.197 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 47.8 ttp -72.81 -52.72 13.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -0.838 . . . . 0.0 109.191 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.36 -31.96 10.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.888 . . . . 0.0 109.293 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.54 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.5 mt -78.46 -39.77 37.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.3 -0.875 . . . . 0.0 109.421 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.521 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 15.0 m -51.75 -29.55 19.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' C' ' 35' ' ' SER . 57.3 m-85 -160.89 130.34 3.25 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.273 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -76.24 -19.92 14.93 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.375 2.05 . . . . 0.0 112.203 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' B' ' 97' ' ' HIS . 22.4 p -46.53 -46.01 18.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.705 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -45.46 -22.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 109.868 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' C' ' 38' ' ' THR . 26.6 ttmt -51.83 -42.42 62.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.137 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 1.239 HG23 ' CD2' ' B' ' 97' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 109.789 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.511 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 4.1 p80 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.042 0.449 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -157.77 28.38 0.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.117 -0.99 . . . . 0.0 110.077 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' C' ' 49' ' ' SER . 73.9 m-20 43.61 89.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.548 -0.72 . . . . 0.0 110.376 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.806 ' H ' ' CD1' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -60.69 1.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 0.0 109.26 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.56 ' H ' ' C ' ' C' ' 47' ' ' ASP . 5.0 m -84.83 157.03 21.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.955 . . . . 0.0 109.734 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.612 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 40.4 t-80 -76.45 170.56 16.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.446 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . 0.612 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 76.26 -22.08 2.13 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.516 ' C ' ' H ' ' C' ' 54' ' ' GLN . 4.7 p -55.85 -18.68 9.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -1.105 . . . . 0.0 109.368 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 72.82 -23.3 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 109.669 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.516 ' H ' ' C ' ' C' ' 52' ' ' SER . 24.1 mt-30 -84.76 -17.96 36.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.568 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.02 -32.62 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 109.639 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -72.98 -29.39 63.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.166 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.82 -45.0 66.48 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.496 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.2 t-80 -60.66 -30.74 70.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.245 . . . . 0.0 110.071 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.87 -31.29 79.22 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 59.2 mttp -68.93 -23.02 64.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -1.106 . . . . 0.0 110.213 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' C' ' 65' ' ' ALA . 0.0 OUTLIER -69.41 -58.17 4.33 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.982 -1.074 . . . . 0.0 108.755 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 13.3 t -55.59 -41.47 64.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.605 -0.684 . . . . 0.0 109.578 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.6 -43.81 46.24 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.102 -0.999 . . . . 0.0 109.195 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 35.0 t0 -68.99 -33.84 74.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 108.563 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' C' ' 61' ' ' LYS . . . -66.94 -49.01 66.83 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -53.05 -47.08 68.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.1 m -57.06 -56.59 19.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.9 . . . . 0.0 108.701 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . 0.535 ' O ' ' CD2' ' C' ' 72' ' ' HIS . 28.5 t30 -58.82 -21.1 55.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 108.57 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.09 -47.42 10.2 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.36 -22.72 27.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.95 -33.32 75.31 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' C' ' 74' ' ' ASP . 5.6 m-70 -115.96 -60.47 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.534 -0.729 . . . . 0.0 109.527 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' C' ' 72' ' ' HIS . 13.2 p 45.02 12.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.744 0.783 . . . . 0.0 109.583 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' C' ' 72' ' ' HIS . 28.9 m-20 -138.33 11.18 2.78 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -177.36 27.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.696 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 3.0 ptt? -78.54 -23.91 0.42 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.837 . . . . 0.0 111.642 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' C' ' 76' ' ' MET . 53.1 Cg_exo -54.4 -19.72 18.18 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.582 1.521 . . . . 0.0 112.207 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -93.01 -40.75 10.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.178 -0.951 . . . . 0.0 109.435 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.82 -43.45 65.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.261 -0.899 . . . . 0.0 108.948 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -85.29 10.32 12.88 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' C' ' 84' ' ' SER . 7.6 t -51.87 -47.65 64.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.324 -0.86 . . . . 0.0 109.683 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -46.09 -58.15 3.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 109.707 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' C' ' 82' ' ' ALA . 3.8 mt -45.18 -44.33 10.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 0.0 108.785 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' C' ' 81' ' ' SER . 6.9 p -55.19 -30.03 59.1 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.68 ' O ' ' N ' ' C' ' 89' ' ' HIS . 1.6 m-20 -82.15 -49.53 10.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.198 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.19 -29.95 15.53 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.095 -1.003 . . . . 0.0 109.173 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -92.82 -21.92 19.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.833 . . . . 0.0 110.336 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.72 20.87 5.52 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.076 -1.015 . . . . 0.0 110.398 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' C' ' 85' ' ' ASP . 0.7 OUTLIER -140.57 -78.26 0.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.078 -1.013 . . . . 0.0 109.806 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' C' ' 92' ' ' ARG . 16.9 mttp -67.38 -119.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.843 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.454 ' H ' ' CD1' ' C' ' 91' ' ' LEU . 10.3 mp -44.5 -19.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 109.802 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' C' ' 90' ' ' LYS . 49.7 ttt180 57.28 45.92 19.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.928 . . . . 0.0 109.304 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 4.7 t -48.48 133.21 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 109.599 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' C' ' 96' ' ' VAL . 0.6 OUTLIER -91.55 126.03 55.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.281 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.81 -11.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.268 1.979 . . . . 0.0 112.396 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . 1.296 HG13 ' OD2' ' B' ' 99' ' ' ASP . 24.8 t -56.22 -31.89 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 109.693 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -79.44 -38.16 35.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.662 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -46.12 -30.25 1.85 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 109.62 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.3 -27.97 69.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.942 . . . . 0.0 109.637 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 11.2 mt -84.22 -34.34 23.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 109.84 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tp -64.22 -61.03 2.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 109.806 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 24.4 t -47.7 -34.73 8.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 109.836 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -80.96 -26.59 36.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.735 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 97.9 m -76.35 -38.1 56.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 109.953 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -52.19 66.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 109.681 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 36.8 mt -60.14 -32.28 70.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.947 . . . . 0.0 110.006 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 34.3 t -63.72 -59.56 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 109.264 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 41.3 p -54.77 -53.59 53.1 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.229 -0.92 . . . . 0.0 109.224 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' C' ' 114' ' ' PRO . 7.7 mt -45.29 -26.74 0.55 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.459 -0.775 . . . . 0.0 109.299 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.26 81.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.304 -0.872 . . . . 0.0 110.039 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . 0.623 ' HB2' ' CE2' ' D' ' 122' ' ' PHE . . . -78.94 -3.6 45.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -134.44 -80.06 0.45 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.232 -0.917 . . . . 0.0 109.713 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -118.41 82.6 19.31 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' C' ' 113' ' ' LEU . 51.3 Cg_exo -49.78 -169.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.402 2.068 . . . . 0.0 112.402 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.662 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -52.85 -55.71 21.1 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.662 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 46.4 mt-10 123.24 -5.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 0.414 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 7.6 t80 73.21 30.97 1.49 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.803 -0.561 . . . . 0.0 111.033 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.75 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.8 p -104.48 126.26 31.9 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.07 -1.019 . . . . 0.0 108.439 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . 0.602 ' HB3' ' HB3' ' D' ' 51' ' ' PRO . 53.9 Cg_exo -49.74 22.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.407 2.071 . . . . 0.0 112.901 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.75 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -153.37 -32.98 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.777 -1.202 . . . . 0.0 110.553 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 9.7 p -52.76 -49.47 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.057 -1.027 . . . . 0.0 110.18 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.514 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 4.7 t-160 -59.48 -37.5 78.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 0.0 109.176 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.12 -19.43 34.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.411 -0.806 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.523 ' N ' ' O ' ' C' ' 120' ' ' ALA . 23.1 p -64.12 -62.12 1.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 110.844 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.488 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.6 mt -68.49 -19.72 64.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.016 -1.053 . . . . 0.0 109.761 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.67 -46.64 12.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.99 -1.069 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.473 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -80.38 -46.37 16.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.155 -0.966 . . . . 0.0 109.277 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 26.9 t80 -49.88 -21.68 1.24 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.016 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.3 mt -73.98 -21.82 59.85 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -57.93 -31.76 67.13 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 131' ' ' SER . . . . . 0.406 ' HG ' ' N ' ' C' ' 132' ' ' VAL . 90.0 p -79.86 -33.65 39.91 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.341 -0.85 . . . . 0.0 108.925 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . 0.406 ' N ' ' HG ' ' C' ' 131' ' ' SER . 42.6 t -82.27 -35.51 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 108.578 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.465 ' N ' ' O ' ' C' ' 129' ' ' LEU . 47.5 t -72.18 -28.61 63.33 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.408 -0.808 . . . . 0.0 109.237 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 134' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 32.3 m -66.55 -34.31 77.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.954 . . . . 0.0 109.108 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.32 -40.45 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.316 -0.865 . . . . 0.0 109.08 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.7 -27.42 68.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 108.945 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 61.7 m -86.2 -26.46 25.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.923 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.92 155.78 43.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.436 -0.79 . . . . 0.0 109.306 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -54.48 152.76 11.45 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 108.878 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.01 -18.63 44.1 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.477 2.118 . . . . 0.0 112.068 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -87.11 -37.92 16.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.914 . . . . 0.0 109.622 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -84.1 -23.15 30.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.836 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' D' ' 12' ' ' THR . 7.9 tttm -84.12 -55.19 4.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.229 -0.919 . . . . 0.0 109.102 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -48.04 -23.49 0.83 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.09 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.16 -59.64 2.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.891 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.01 -24.47 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 4.2 m -74.81 -51.9 12.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.698 -0.626 . . . . 0.0 109.65 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.31 -24.92 46.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.64 -28.28 67.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.78 -17.04 62.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -0.952 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.25 -63.73 3.15 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.585 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.426 ' H ' ' HD2' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -70.77 -11.74 61.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.036 -1.273 . . . . 0.0 110.778 -178.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -70.66 121.27 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.856 -1.152 . . . . 0.0 109.343 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' D' ' 21' ' ' ASP . 0.9 OUTLIER -77.12 73.4 3.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.226 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 76.1 t -53.05 -6.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.556 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' D' ' 19' ' ' ASN . 9.8 p30 -67.92 -20.69 65.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.936 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.505 ' N ' ' OD1' ' D' ' 21' ' ' ASP . 9.3 pt-20 -150.27 -32.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.067 -1.02 . . . . 0.0 109.884 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.22 -28.36 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 109.626 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.03 -41.41 99.86 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.06 -55.07 17.89 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . 0.416 ' O ' ' NH1' ' D' ' 30' ' ' ARG . 58.3 mt-10 -49.79 -27.03 4.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -1.155 . . . . 0.0 109.432 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.31 -32.55 22.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.06 -36.35 21.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.63 -40.66 90.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . 0.416 ' NH1' ' O ' ' D' ' 26' ' ' GLU . 0.0 OUTLIER -62.93 -21.7 66.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -1.12 . . . . 0.0 109.467 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tt -70.07 -28.32 65.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.152 -0.968 . . . . 0.0 109.523 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' D' ' 36' ' ' PRO . 27.7 mt -81.32 -53.86 5.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.925 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' D' ' 34' ' ' VAL . 6.2 p -56.21 -43.18 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.003 . . . . 0.0 109.628 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . 0.481 ' N ' ' CG1' ' D' ' 33' ' ' VAL . 57.8 t -79.56 -22.83 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -153.11 75.5 6.65 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.848 . . . . 0.0 109.126 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' D' ' 32' ' ' LEU . 92.6 Cg_endo -83.6 3.69 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.935 2.423 . . . . 0.0 112.553 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -57.39 -19.87 26.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.485 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.495 ' H ' ' HG1' ' D' ' 38' ' ' THR . 6.0 p -80.0 5.41 14.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 109.414 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -48.17 -22.76 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.593 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -62.34 -38.84 91.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.366 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' D' ' 42' ' ' PHE . 80.2 m-85 -87.95 27.87 1.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.429 ' CG ' ' O ' ' D' ' 41' ' ' PHE . 75.1 m-85 -154.8 32.85 0.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.524 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.37 -27.7 52.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 109.538 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 67.5 m -76.34 -29.67 57.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 109.476 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' D' ' 47' ' ' ASP . 3.8 m-85 -48.7 -22.71 0.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' D' ' 47' ' ' ASP . . . 68.02 -53.11 0.39 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' D' ' 45' ' ' PHE . 51.6 m-20 -60.38 -151.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -1.123 . . . . 0.0 109.485 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt 58.73 17.97 5.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 30.4 p -69.46 -28.38 66.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.923 . . . . 0.0 109.309 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' THR . . . . . 0.526 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.5 p -145.32 151.24 47.21 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.071 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . 0.602 ' HB3' ' HB3' ' C' ' 119' ' ' PRO . 80.8 Cg_exo -38.12 -32.6 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.598 2.199 . . . . 0.0 112.599 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.19 -24.04 40.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.737 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -69.03 -19.45 64.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.671 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 18.4 t -65.31 -63.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.618 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 25.5 mtm -95.41 29.43 2.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.12 -58.58 0.66 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -69.36 150.25 97.15 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.224 -1.162 . . . . 0.0 109.608 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.463 ' O ' ' N ' ' D' ' 60' ' ' VAL . 68.4 Cg_endo -75.01 -56.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.639 2.226 . . . . 0.0 112.331 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -18.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' D' ' 58' ' ' PRO . 91.2 t -81.66 -44.98 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.421 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -79.04 -27.12 43.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.9 63.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.75 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -72.27 -24.02 61.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.408 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.01 -25.98 74.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' D' ' 65' ' ' LYS . 0.3 OUTLIER -55.99 -42.86 77.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.207 -1.172 . . . . 0.0 109.044 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -64.34 -41.46 96.76 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.589 -0.694 . . . . 0.0 109.561 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 28.7 t -65.19 -62.93 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.288 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tt -54.35 -40.15 67.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.205 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.55 -53.87 38.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.16 -44.38 42.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -1.122 . . . . 0.0 109.54 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.33 -45.82 89.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 72' ' ' SER . . . . . 0.424 ' HG ' ' N ' ' D' ' 73' ' ' ASP . 98.4 p -61.08 -34.89 75.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.459 -0.776 . . . . 0.0 109.526 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . 0.424 ' N ' ' HG ' ' D' ' 72' ' ' SER . 13.6 t70 -54.02 -39.66 66.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.14 -60.16 8.4 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.471 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.9 mp -53.75 -30.06 42.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.324 -1.103 . . . . 0.0 109.193 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.13 4.31 45.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -170.35 67.45 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.669 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt -78.9 12.73 2.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.246 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.0 -29.76 68.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 24.8 t-20 -164.0 111.29 1.12 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.636 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' D' ' 81' ' ' LEU . 7.5 mp -80.26 -56.11 4.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . 0.478 ' NZ ' ' CD2' ' D' ' 143' ' ' HIS . 77.2 tttt -62.42 -24.06 67.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -75.04 -51.06 7.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.7 t -73.43 -46.31 49.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 0.0 109.498 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.538 ' N ' ' CG2' ' D' ' 84' ' ' THR . 54.5 m-85 -84.28 26.11 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.583 -0.698 . . . . 0.0 109.624 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.08 -28.08 67.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 0.0 109.422 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 87' ' ' THR . . . . . 0.464 ' O ' ' N ' ' D' ' 91' ' ' LEU . 82.6 p -77.13 -58.17 3.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.646 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.26 -41.57 18.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -68.67 -37.67 79.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.527 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -82.73 -28.15 30.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 0.0 109.378 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' D' ' 87' ' ' THR . 10.3 tt -75.58 -68.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.234 -0.917 . . . . 0.0 109.238 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.583 ' O ' ' N ' ' D' ' 97' ' ' HIS . 71.0 m80 -50.08 -23.87 2.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.757 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 38.8 t -83.94 -56.21 3.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 111.03 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.538 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 73.3 m-20 -86.21 -24.6 26.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.074 -1.016 . . . . 0.0 111.749 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' D' ' 95' ' ' LYS . 10.7 mptt -94.21 -51.63 4.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.638 -1.289 . . . . 0.0 110.742 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.96 -27.73 13.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 0.0 109.907 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 1.337 ' CD2' HG23 ' A' ' 41' ' ' THR . 21.4 m-70 57.77 53.67 6.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.33 124.26 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.134 -0.979 . . . . 0.0 109.261 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . 1.256 ' CG ' HG13 ' A' ' 96' ' ' VAL . 68.7 m-20 -47.93 149.29 2.44 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.123 -0.986 . . . . 0.0 109.426 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.3 62.91 5.29 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.532 2.155 . . . . 0.0 112.082 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -172.05 73.84 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.85 -27.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.867 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 0.1 OUTLIER -56.38 -20.37 19.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.094 -1.004 . . . . 0.0 109.633 -179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -86.28 -41.04 14.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.056 -1.028 . . . . 0.0 109.36 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 tp -48.99 -40.14 29.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.386 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.35 -47.56 63.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.295 -0.878 . . . . 0.0 109.315 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.39 -19.98 54.28 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -81.79 -55.82 4.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -1.196 . . . . 0.0 110.01 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.96 -24.09 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.032 -1.042 . . . . 0.0 109.682 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.62 -57.97 9.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.0 109.42 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 70.0 t -46.67 -26.06 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.772 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.45 -32.65 74.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.112 -0.993 . . . . 0.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.51 -31.56 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.534 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 12.4 mt -75.04 -29.5 60.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.504 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.42 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -74.93 -32.29 61.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.937 . . . . 0.0 109.483 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.466 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.89 -56.99 3.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 0.0 109.359 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . 0.409 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 13.7 m170 -56.81 -17.73 10.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 109.569 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.409 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 72.2 m-85 -154.54 60.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 109.64 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -71.04 -26.22 74.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . 0.494 ' CD ' ' N ' ' D' ' 120' ' ' LYS . 11.9 mptt -70.03 9.95 0.49 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -1.102 . . . . 0.0 109.343 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' D' ' 119' ' ' GLY . 68.8 mm-40 -136.71 2.54 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.39 -0.819 . . . . 0.0 109.45 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.623 ' CE2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -72.94 39.05 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.56 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.526 ' C ' HE22 ' D' ' 127' ' ' GLN . 0.8 OUTLIER -52.42 149.06 10.98 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.289 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -47.72 -52.38 8.19 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.449 2.099 . . . . 0.0 113.229 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 36.0 Cg_endo -65.27 -3.92 8.31 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.11 1.873 . . . . 0.0 112.7 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.85 -22.04 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.05 -1.032 . . . . 0.0 109.699 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . 0.526 HE22 ' C ' ' D' ' 123' ' ' THR . 1.8 mp0 -83.27 -60.0 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 0.0 109.687 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -53.93 -35.11 61.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.9 26.46 0.99 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.679 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -118.8 -61.37 1.66 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.366 -0.834 . . . . 0.0 109.684 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -52.83 -23.46 7.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.625 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -71.49 -39.2 71.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.747 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 74.6 t -62.71 -55.77 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.088 -1.008 . . . . 0.0 109.816 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' D' ' 137' ' ' VAL . 11.4 m -69.75 -28.56 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -0.853 . . . . 0.0 110.036 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.55 -25.96 1.29 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.99 -1.069 . . . . 0.0 109.383 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.78 -24.52 58.07 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' D' ' 134' ' ' VAL . 75.4 t -79.36 -37.65 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -1.126 . . . . 0.0 109.343 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.78 79.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . 0.445 HD22 HD22 ' B' ' 139' ' ' ASN . 65.0 t30 -72.05 -44.08 63.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.24 -40.94 49.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 37.1 mt -81.95 12.9 3.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.272 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.91 1.63 1.88 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.284 -0.885 . . . . 0.0 109.711 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . 0.478 ' CD2' ' NZ ' ' D' ' 82' ' ' LYS . 10.4 t60 -79.32 -34.09 42.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.512 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 5.0 tptp -67.42 -25.5 65.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.381 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -63.99 -14.16 51.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.92 . . . . 0.0 109.529 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.526 ' CG ' ' OXT' ' D' ' 146' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.551 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.498 ' CG1' ' OG ' ' A' ' 131' ' ' SER . 96.6 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.337 0.589 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.606 ' CD1' ' HZ1' ' A' ' 127' ' ' LYS . 1.1 mp 59.06 163.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.359 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 174.77 -44.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.92 . . . . 0.0 110.033 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 3' ' ' SER . 52.9 Cg_exo -53.7 172.85 0.22 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.691 2.261 . . . . 0.0 113.105 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.598 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -46.9 -14.6 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 4' ' ' PRO . 3.0 p30 -38.59 -22.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.445 -0.785 . . . . 0.0 110.121 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 5' ' ' ALA . 38.0 mttt -80.42 -56.78 3.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.115 -0.991 . . . . 0.0 109.407 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 m -46.82 -28.65 1.62 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.511 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -78.35 -38.07 42.89 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 7' ' ' LYS . 25.4 t -71.61 -49.28 47.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -50.99 -44.23 60.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.21 -61.21 2.77 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.97 -35.38 69.09 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -0.756 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -77.01 -17.16 59.03 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.204 -0.935 . . . . 0.0 108.888 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.57 -38.23 44.45 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -84.46 -35.21 23.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.402 -1.058 . . . . 0.0 109.495 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.546 ' O ' ' C ' ' A' ' 18' ' ' GLY . 42.6 t -73.64 -36.91 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 109.674 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.589 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . -30.58 143.72 0.01 OUTLIER Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 71.07 -31.96 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -1.043 . . . . 0.0 109.113 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.589 ' H ' ' C ' ' A' ' 18' ' ' GLY . 49.8 m-70 -107.94 17.13 22.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.49 -36.05 20.79 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.879 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.3 -14.44 64.14 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -87.99 -56.14 3.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -1.113 . . . . 0.0 109.876 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.4 m-30 -58.42 -35.38 71.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.365 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.73 -23.06 64.89 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.38 -49.91 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -1.188 . . . . 0.0 109.696 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -56.62 -19.76 17.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.83 -21.25 60.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 109.597 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.0 mt -82.61 -54.31 5.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -64.43 -34.04 77.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.553 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.489 ' CG ' HH11 ' A' ' 31' ' ' ARG . 0.5 OUTLIER -66.4 -38.57 87.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 109.631 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 32' ' ' MET . 15.1 tmm? -75.13 -31.97 61.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.313 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -54.14 -49.93 68.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.78 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' A' ' 36' ' ' PHE . 1.3 pp -81.27 -43.61 18.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 m -62.95 4.48 0.17 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.617 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.542 ' H ' ' C ' ' A' ' 34' ' ' LEU . 2.5 t80 -162.74 93.76 1.2 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.222 -0.923 . . . . 0.0 109.165 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.76 -23.38 6.95 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.495 2.13 . . . . 0.0 112.404 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.533 ' OG1' ' CE2' ' A' ' 36' ' ' PHE . 9.5 p -54.65 -28.57 48.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 109.283 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -89.98 -22.8 21.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 109.547 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -46.12 -31.1 2.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 1.218 HG23 ' CG ' ' D' ' 97' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.555 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.23 0 CA-C-O 120.589 0.233 . . . . 0.0 111.177 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.06 35.21 2.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.832 -1.168 . . . . 0.0 109.917 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 49' ' ' SER . 14.5 m-20 52.79 91.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 109.53 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.03 -1.65 0.33 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 47' ' ' ASP . 92.8 p -54.31 126.74 24.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.915 . . . . 0.0 109.463 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -57.25 136.01 56.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.472 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.41 70.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.538 ' C ' ' H ' ' A' ' 54' ' ' GLN . 4.5 t -64.04 -14.56 55.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -1.141 . . . . 0.0 109.457 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 70.88 -18.82 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.622 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.538 ' H ' ' C ' ' A' ' 52' ' ' SER . 32.9 mt-30 -85.67 -18.09 34.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 109.376 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.64 -36.12 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -75.92 -33.47 59.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 108.96 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.72 -25.19 74.11 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.498 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.3 t-80 -71.49 -43.29 66.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -1.117 . . . . 0.0 109.392 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -49.38 -48.17 34.28 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 86.4 mttt -52.71 -22.62 5.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.995 . . . . 0.0 110.005 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.85 -40.91 60.73 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.146 -0.971 . . . . 0.0 108.792 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -73.05 -47.28 48.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.88 -32.59 74.19 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 26.1 t0 -71.93 -32.46 67.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.081 -1.012 . . . . 0.0 108.599 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -68.19 -52.57 32.87 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 70' ' ' VAL . 4.5 mt -51.01 -41.38 59.75 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.246 -0.909 . . . . 0.0 108.97 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 71' ' ' ALA . 16.3 m -68.26 -57.81 5.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.182 -0.949 . . . . 0.0 108.728 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -59.76 -23.84 63.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 108.758 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.08 -46.93 10.68 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' LEU . 41.5 t -68.56 -22.93 27.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -67.75 -36.13 79.97 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' A' ' 74' ' ' ASP . 84.8 m-70 -102.78 -65.61 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.491 -0.756 . . . . 0.0 109.465 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' A' ' 72' ' ' HIS . 12.6 p 44.83 14.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.863 0.839 . . . . 0.0 109.437 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 72' ' ' HIS . 71.0 m-20 -137.18 11.89 3.05 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.23 31.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.205 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.686 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 8.1 ptt? -78.32 -22.89 0.4 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.929 . . . . 0.0 111.937 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.4 Cg_exo -53.27 -22.4 20.15 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.558 1.506 . . . . 0.0 112.335 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -92.98 -40.52 10.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.05 84.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 109.175 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.6 mt -83.93 9.48 12.11 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.451 -0.781 . . . . 0.0 108.918 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -58.43 -50.39 73.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 109.53 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 83' ' ' LEU . . . -50.11 -58.52 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.579 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 82' ' ' ALA . 4.5 mt -46.02 -46.2 16.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 108.894 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -64.89 -32.11 73.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.541 -0.724 . . . . 0.0 109.404 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -75.5 -23.84 56.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.99 -34.16 26.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 109.518 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -92.14 -21.88 20.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.927 . . . . 0.0 109.524 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.34 -84.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.732 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -78.54 -70.42 0.49 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.85 . . . . 0.0 109.918 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.632 ' C ' ' H ' ' A' ' 92' ' ' ARG . 25.5 ttmt -46.31 137.97 5.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.988 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.1 mt 66.19 -20.43 0.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.652 -0.655 . . . . 0.0 109.754 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.632 ' H ' ' C ' ' A' ' 90' ' ' LYS . 65.5 mtt180 38.9 27.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.41 -0.806 . . . . 0.0 109.685 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.565 ' CG2' ' ND2' ' A' ' 97' ' ' ASN . 7.5 p -45.45 141.19 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.872 . . . . 0.0 109.669 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.3 149.55 86.89 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 109.376 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.524 ' C ' ' H ' ' A' ' 97' ' ' ASN . 59.8 Cg_endo -73.56 -22.25 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.526 2.151 . . . . 0.0 112.271 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.5 -3.63 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 109.609 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.565 ' ND2' ' CG2' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -79.36 -41.93 26.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.928 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -51.25 -48.73 62.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 109.433 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -48.28 -30.61 4.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.498 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 18.7 mt -84.24 -62.03 1.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tp -49.89 -20.94 1.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.728 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 t -69.34 -59.11 3.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.454 ' ND1' ' OD1' ' B' ' 108' ' ' ASN . 32.1 m170 -68.43 -26.61 65.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.882 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 50.4 m -62.93 -45.48 92.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 109.927 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.482 ' O ' ' OG1' ' A' ' 108' ' ' THR . 1.0 OUTLIER -55.97 -55.39 33.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.95 . . . . 0.0 109.429 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 4.1 mm? -47.83 -29.15 3.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.613 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.5 t -83.41 -24.63 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 105' ' ' LEU . 27.9 p -71.46 -63.39 1.13 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.986 -1.071 . . . . 0.0 110.345 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -64.67 -26.22 68.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 109.636 -179.511 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.4 -37.39 25.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.16 -56.24 4.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 110.07 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -71.38 -67.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.808 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 114' ' ' PRO . 2.1 tm? -110.7 98.52 37.86 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 66.6 Cg_exo -49.17 -170.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.277 1.984 . . . . 0.0 112.296 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.652 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -73.04 -55.33 6.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 108.827 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.652 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 18.3 mt-10 118.69 -8.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 5.3 t80 77.14 33.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.881 -0.512 . . . . 0.0 111.146 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.4 OUTLIER -101.62 116.0 64.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.04 20.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.982 1.788 . . . . 0.0 112.468 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -144.83 -29.47 0.46 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.159 -0.963 . . . . 0.0 110.431 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 10.6 p -49.34 -50.77 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.139 -0.975 . . . . 0.0 109.967 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.529 ' H ' ' ND1' ' A' ' 122' ' ' HIS . 3.0 m80 -60.87 -34.67 74.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.121 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.18 -20.19 32.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.386 -0.821 . . . . 0.0 109.707 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.3 m -64.84 -62.12 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.541 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.88 -19.8 62.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.145 -0.972 . . . . 0.0 109.972 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.43 -44.47 19.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.033 . . . . 0.0 110.114 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.606 ' HZ1' ' CD1' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -89.04 -41.49 12.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.985 -1.072 . . . . 0.0 109.954 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 41.4 t80 -50.48 -20.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.878 -1.138 . . . . 0.0 108.907 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.596 ' O ' ' N ' ' A' ' 133' ' ' SER . 18.1 mt -71.42 -17.67 62.38 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.04 -31.69 71.32 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.498 ' OG ' ' CG1' ' A' ' 1' ' ' VAL . 4.0 t -83.53 -33.08 25.56 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.379 -0.826 . . . . 0.0 108.911 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.4 t -85.17 -26.63 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 108.907 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 129' ' ' LEU . 33.0 t -84.02 -25.52 29.85 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 108.873 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 33.5 m -77.62 -39.06 46.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.15 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.18 -27.04 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.262 -0.898 . . . . 0.0 108.69 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -29.98 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 137' ' ' THR . 93.5 m -112.52 24.02 12.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.409 -0.807 . . . . 0.0 109.437 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.666 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.671 ' H ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -92.04 155.58 18.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 0.0 109.328 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.14 153.9 84.03 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.013 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.02 -15.91 36.09 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.655 2.237 . . . . 0.0 112.313 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -85.28 -42.75 14.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.71 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.16 -22.56 30.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.917 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -79.23 -40.41 30.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.184 -0.947 . . . . 0.0 109.315 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 9.0 t -61.63 -23.64 66.18 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.815 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.11 -55.49 4.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 110.121 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.17 -24.72 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.078 -1.014 . . . . 0.0 108.414 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -82.21 -37.03 26.65 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.385 0.612 . . . . 0.0 109.617 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.46 96.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.528 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 17' ' ' LYS . 0.8 OUTLIER -61.82 -35.1 77.24 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.471 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -48.07 -21.52 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 109.046 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' B' ' 14' ' ' LEU . . . -86.5 -32.63 15.5 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' B' ' 14' ' ' LEU . 1.0 OUTLIER -78.02 -31.42 50.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -1.151 . . . . 0.0 109.087 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' B' ' 20' ' ' VAL . 69.7 t -54.09 114.88 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.551 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' B' ' 21' ' ' ASP . 3.1 m120 -71.41 64.06 0.4 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 109.168 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' B' ' 18' ' ' VAL . 42.1 t -45.68 -16.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.516 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' B' ' 19' ' ' ASN . 21.8 t70 -77.1 5.46 8.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.454 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -154.17 -43.84 0.09 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -0.87 . . . . 0.0 109.467 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -55.16 -24.9 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.507 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.41 -42.52 93.8 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.72 -35.92 54.18 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -73.44 -36.49 65.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 109.376 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.45 -52.94 62.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.47 -51.57 66.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 109.2 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.75 -40.65 95.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' B' ' 33' ' ' VAL . 16.7 mmt85 -58.13 -44.36 87.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -1.13 . . . . 0.0 109.524 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 35' ' ' TYR . 34.0 tp -46.83 -32.53 3.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.319 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 mt -81.18 -21.84 39.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' B' ' 30' ' ' ARG . 21.2 t -87.12 -64.29 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 109.549 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -49.57 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.874 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.417 ' O ' ' O ' ' B' ' 31' ' ' LEU . 0.1 OUTLIER -118.53 85.68 27.03 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.365 -0.834 . . . . 0.0 109.45 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -84.26 34.47 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.702 2.268 . . . . 0.0 112.315 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . 0.434 ' CD1' ' N ' ' B' ' 38' ' ' THR . 1.9 p-90 -81.04 -29.74 34.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.13 -0.981 . . . . 0.0 109.602 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.434 ' N ' ' CD1' ' B' ' 37' ' ' TRP . 65.1 p -60.62 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.433 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 48.95 45.2 22.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.471 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 0.497 ' HA ' ' NH1' ' C' ' 92' ' ' ARG . 19.2 ptt180 -137.82 -39.18 0.56 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.249 -0.907 . . . . 0.0 109.367 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -100.41 -25.47 14.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 109.44 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -74.48 6.11 4.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.424 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.14 -23.28 51.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 20.3 p -59.62 -40.31 87.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.507 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -51.63 -17.61 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.69 55.12 11.65 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -159.55 79.33 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -1.162 . . . . 0.0 109.394 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 36.6 mt -131.56 14.63 4.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 109.421 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.8 m -46.91 -41.75 16.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.221 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 5.9 p -146.64 148.68 34.41 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.438 -0.789 . . . . 0.0 108.896 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -41.07 -39.52 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.37 2.047 . . . . 0.0 112.292 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.403 ' C ' ' N ' ' B' ' 54' ' ' VAL . 1.0 OUTLIER -67.04 -40.43 87.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 109.643 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.14 -19.84 0.31 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.385 -0.822 . . . . 0.0 109.552 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.403 ' N ' ' C ' ' B' ' 52' ' ' ASP . 83.5 t -67.56 -64.01 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 10.4 mtt -86.12 -6.1 59.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 109.601 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.13 -35.6 88.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -81.24 148.36 63.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.205 -1.173 . . . . 0.0 109.418 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.13 -51.7 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.548 2.165 . . . . 0.0 112.287 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.421 ' HG3' ' H ' ' B' ' 60' ' ' VAL . 0.0 OUTLIER -47.3 -39.4 14.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 109.758 -179.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.421 ' H ' ' HG3' ' B' ' 59' ' ' LYS . 61.2 t -61.68 -45.47 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -75.17 -24.84 57.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.43 -43.05 70.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.574 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -64.1 -23.9 67.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.685 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.29 75.84 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.5 ' NZ ' ' OD1' ' B' ' 21' ' ' ASP . 19.3 mtpt -67.13 -25.02 65.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -1.15 . . . . 0.0 109.619 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -72.02 -28.75 63.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.583 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.11 -48.79 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.54 -16.92 42.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.31 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.14 -48.64 45.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.51 90.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -1.157 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -47.31 -41.2 18.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 0.0 109.559 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 14.0 m -49.42 -44.3 45.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 109.48 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -67.78 -16.72 64.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.06 -26.54 69.25 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.466 HD23 ' H ' ' B' ' 75' ' ' LEU . 2.0 pt? -136.08 -18.6 1.55 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.236 -1.155 . . . . 0.0 110.153 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -82.24 1.44 36.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.061 -1.024 . . . . 0.0 109.731 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 59.4 m-70 -163.06 67.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 109.549 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.09 4.85 3.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.49 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.02 -37.21 79.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.487 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 14.1 t-20 -171.45 99.43 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.492 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.04 -57.25 3.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.536 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -47.12 -24.02 0.6 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.558 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -66.43 -54.91 20.58 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.551 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.8 t -75.5 -47.32 27.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 0.0 109.488 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.551 ' N ' ' CG2' ' B' ' 84' ' ' THR . 53.3 m-85 -62.73 -1.18 0.78 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.5 -0.75 . . . . 0.0 109.381 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -59.22 -35.85 74.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.453 ' O ' ' N ' ' B' ' 91' ' ' LEU . 21.5 p -83.28 -47.96 10.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.932 . . . . 0.0 109.531 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 40.5 mt -55.42 -43.12 75.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -67.41 -51.3 53.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.53 -22.41 64.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.868 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.6 tt -81.42 -60.11 2.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.77 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.469 ' O ' ' N ' ' B' ' 97' ' ' HIS . 66.5 m80 -61.78 -22.42 65.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.288 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 39.4 t -83.1 -60.58 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 110.729 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.538 ' O ' ' CE1' ' B' ' 97' ' ' HIS . 5.1 m-20 -87.23 -27.74 22.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.137 -0.977 . . . . 0.0 111.149 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.2 OUTLIER -87.68 -16.68 33.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.889 -1.132 . . . . 0.0 110.646 -178.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.498 ' C ' ' ND1' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -138.37 -39.26 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.942 -1.099 . . . . 0.0 109.929 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 1.181 ' CG ' HG23 ' C' ' 41' ' ' THR . 4.9 m80 64.87 58.78 0.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.101 -1.0 . . . . 0.0 109.754 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.7 132.63 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.081 -1.012 . . . . 0.0 109.335 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.44 152.55 2.22 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.359 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.04 -29.84 17.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.66 2.24 . . . . 0.0 112.187 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.33 53.68 0.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -149.35 -38.95 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.586 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.69 -29.78 70.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.545 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . 0.402 ' NH1' ' CB ' ' B' ' 104' ' ' ARG . 31.4 mtm105 -77.82 -20.03 53.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 109.678 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.73 -50.04 9.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 tt -52.04 -49.04 64.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.5 -20.39 63.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . 0.483 ' O ' ' SG ' ' B' ' 112' ' ' CYS . 0.2 OUTLIER -81.76 -19.43 41.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -1.135 . . . . 0.0 109.658 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 92.6 t -86.36 -53.01 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.242 -0.911 . . . . 0.0 109.675 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' B' ' 113' ' ' VAL . 2.8 tt -45.98 -60.2 2.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.336 -0.853 . . . . 0.0 109.717 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 61.5 t -46.68 -33.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.934 . . . . 0.0 109.748 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' B' ' 108' ' ' ASN . 60.2 m -79.21 -23.94 43.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.657 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 110' ' ' LEU . 98.2 t -75.0 -21.34 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.569 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.523 ' CD1' ' CZ ' ' B' ' 130' ' ' TYR . 21.5 mt -79.06 -48.59 14.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 109.49 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.27 -23.1 3.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.507 ' ND1' ' HD1' ' B' ' 117' ' ' HIS . 6.5 t-80 -83.81 -57.75 3.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.571 ' HD1' ' N ' ' B' ' 117' ' ' HIS . 0.3 OUTLIER -72.4 -17.78 61.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.524 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' B' ' 114' ' ' LEU . 95.1 m-85 -141.64 56.53 1.51 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -73.16 -24.94 74.61 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.2 9.32 1.02 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -1.132 . . . . 0.0 109.624 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.1 mm-40 -142.68 8.78 1.75 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.541 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -78.68 34.19 0.22 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.971 . . . . 0.0 109.442 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.436 ' H ' ' C ' ' B' ' 121' ' ' GLU . 69.2 p -48.67 148.47 3.62 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.265 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.499 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.4 Cg_exo -44.09 -55.82 2.88 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.544 2.163 . . . . 0.0 112.983 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 12.4 Cg_endo -56.22 -23.23 44.29 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.188 1.925 . . . . 0.0 112.22 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 76.5 t -82.87 -23.31 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 109.559 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -83.18 -59.67 2.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.25 -36.85 14.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.903 . . . . 0.0 109.842 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.6 -5.22 56.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.131 -0.98 . . . . 0.0 110.065 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.523 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 0.1 OUTLIER -92.58 -40.72 10.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.006 . . . . 0.0 109.47 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -83.97 -23.05 31.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 109.633 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -71.14 -42.36 69.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 110.141 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . 0.677 ' CG1' ' H ' ' B' ' 134' ' ' VAL . 6.3 p -71.96 -66.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.112 -0.992 . . . . 0.0 110.327 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.677 ' H ' ' CG1' ' B' ' 133' ' ' VAL . 33.1 m -43.32 -19.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.949 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' B' ' 133' ' ' VAL . . . -59.55 -28.11 66.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.267 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.85 -30.85 58.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.41 -36.31 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -1.156 . . . . 0.0 109.451 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.42 -40.11 89.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . 0.964 HD22 HD22 ' D' ' 139' ' ' ASN . 53.7 t30 -75.88 -25.98 56.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.67 -48.98 74.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.2 -4.24 28.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.393 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' B' ' 145' ' ' TYR . . . -102.36 -39.51 7.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 0.0 109.545 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -45.32 -40.26 7.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 109.784 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.26 27.33 1.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.113 -0.992 . . . . 0.0 109.559 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.576 ' O ' ' CG ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -140.43 1.27 1.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.515 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.461 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . 0.499 ' CG1' ' OG ' ' C' ' 131' ' ' SER . 97.6 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . 0.62 ' CD1' ' HZ1' ' C' ' 127' ' ' LYS . 1.1 mp 58.91 163.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 174.82 -44.9 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 110.005 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' C' ' 3' ' ' SER . 52.9 Cg_exo -53.55 172.86 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.702 2.268 . . . . 0.0 113.14 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -47.02 -14.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.637 -0.664 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' C' ' 4' ' ' PRO . 3.0 p30 -38.68 -22.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.391 -0.818 . . . . 0.0 110.146 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' C' ' 5' ' ' ALA . 37.9 mttt -80.51 -56.77 3.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.109 -0.994 . . . . 0.0 109.378 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 54.5 m -46.82 -28.62 1.61 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.349 -0.844 . . . . 0.0 109.504 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -78.42 -38.07 42.29 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' C' ' 7' ' ' LYS . 25.4 t -71.58 -49.16 48.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -51.15 -44.16 61.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 108.621 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.22 -61.13 2.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.458 -0.776 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.09 -35.33 69.27 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.41 -0.806 . . . . 0.0 109.333 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -77.09 -17.12 58.93 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.188 -0.945 . . . . 0.0 108.877 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.49 -38.41 44.54 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -84.37 -35.21 23.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.294 -1.121 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.538 ' O ' ' C ' ' C' ' 18' ' ' GLY . 42.6 t -73.58 -36.94 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.813 . . . . 0.0 109.684 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.587 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . -30.63 143.72 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' C' ' 18' ' ' GLY . . . 71.09 -31.92 0.24 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.409 -1.053 . . . . 0.0 109.121 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.587 ' H ' ' C ' ' C' ' 18' ' ' GLY . 49.7 m-70 -107.92 17.2 22.72 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.63 -35.98 20.63 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.847 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.38 -14.44 64.34 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -87.87 -56.13 3.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.3 -1.118 . . . . 0.0 109.97 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 1.4 m-30 -58.52 -35.33 72.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.374 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.65 -23.02 64.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.42 -49.91 8.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.225 -1.162 . . . . 0.0 109.759 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.53 -19.85 17.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.659 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.75 -21.31 61.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 109.542 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 11.1 mt -82.53 -54.3 5.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.877 . . . . 0.0 109.653 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -33.95 77.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.564 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.499 ' CG ' HH11 ' C' ' 31' ' ' ARG . 0.5 OUTLIER -66.48 -38.55 87.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.647 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' C' ' 32' ' ' MET . 15.1 tmm? -75.09 -32.0 61.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 109.32 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -54.11 -49.87 68.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.843 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' C' ' 36' ' ' PHE . 1.3 pp -81.3 -43.71 18.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.165 -0.96 . . . . 0.0 110.024 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -62.92 4.47 0.17 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 0.0 109.582 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.553 ' H ' ' C ' ' C' ' 34' ' ' LEU . 2.5 t80 -162.74 93.75 1.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.16 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -79.81 -23.29 6.96 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.496 2.131 . . . . 0.0 112.405 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' THR . . . . . 0.53 ' OG1' ' CE2' ' C' ' 36' ' ' PHE . 9.1 p -54.77 -28.49 49.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.0 109.253 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 8.6 p -90.12 -22.65 21.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 109.515 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -46.23 -31.13 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.576 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 1.181 HG23 ' CG ' ' B' ' 97' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.552 ' C ' ' ND1' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 120.572 0.225 . . . . 0.0 111.174 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.07 35.09 2.57 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.83 -1.169 . . . . 0.0 109.924 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.505 ' C ' ' H ' ' C' ' 49' ' ' SER . 14.4 m-20 52.97 91.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.1 -1.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.39 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.505 ' H ' ' C ' ' C' ' 47' ' ' ASP . 92.4 p -54.38 126.81 24.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -57.29 136.03 56.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.47 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.79 15.41 70.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.55 ' C ' ' H ' ' C' ' 54' ' ' GLN . 4.4 t -64.08 -14.46 54.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.164 . . . . 0.0 109.468 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 70.82 -18.86 0.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.833 . . . . 0.0 109.659 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.55 ' H ' ' C ' ' C' ' 52' ' ' SER . 32.9 mt-30 -85.69 -18.11 34.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.08 -1.012 . . . . 0.0 109.367 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.65 -36.01 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -76.04 -33.51 59.62 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.257 -0.902 . . . . 0.0 108.895 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.66 -25.17 74.04 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.489 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.3 t-80 -71.46 -43.26 66.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -1.151 . . . . 0.0 109.417 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -49.5 -48.1 35.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 86.5 mttt -52.79 -22.51 5.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -1.002 . . . . 0.0 109.965 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -40.91 60.66 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.158 -0.964 . . . . 0.0 108.772 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -73.04 -47.24 48.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.86 -32.6 74.21 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.442 -0.786 . . . . 0.0 109.152 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 26.4 t0 -71.88 -32.46 67.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.045 . . . . 0.0 108.61 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -68.22 -52.47 33.74 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' C' ' 70' ' ' VAL . 4.5 mt -51.06 -41.36 59.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 108.926 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.433 ' O ' ' N ' ' C' ' 71' ' ' ALA . 16.3 m -68.27 -57.82 5.37 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.947 . . . . 0.0 108.739 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -59.81 -23.79 63.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 108.701 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.11 -46.92 10.68 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' C' ' 66' ' ' LEU . 41.6 t -68.53 -22.93 27.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -67.71 -36.18 80.15 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' C' ' 74' ' ' ASP . 84.9 m-70 -102.79 -65.5 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' C' ' 72' ' ' HIS . 12.6 p 44.8 14.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.791 0.805 . . . . 0.0 109.39 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' C' ' 72' ' ' HIS . 71.2 m-20 -137.12 11.93 3.06 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.22 31.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.153 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 8.2 ptt? -78.32 -22.82 0.4 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 111.987 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.6 Cg_exo -53.24 -22.47 20.16 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.556 1.504 . . . . 0.0 112.361 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -92.95 -40.44 10.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.483 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.11 83.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.9 . . . . 0.0 109.137 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 28.9 mt -83.79 9.34 12.13 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 108.932 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -58.27 -50.52 73.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.575 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' C' ' 83' ' ' LEU . . . -50.04 -58.57 5.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.569 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' C' ' 82' ' ' ALA . 4.5 mt -46.07 -46.15 16.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' C' ' 88' ' ' ALA . 5.8 p -64.94 -32.11 73.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.535 -0.728 . . . . 0.0 109.391 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' C' ' 82' ' ' ALA . 31.9 t70 -75.43 -23.85 57.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tt -83.01 -34.25 26.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.858 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -91.97 -21.97 20.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' C' ' 84' ' ' SER . . . -69.32 -84.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.713 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -78.45 -70.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.893 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.636 ' C ' ' H ' ' C' ' 92' ' ' ARG . 25.5 ttmt -46.3 137.99 5.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 110.013 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.1 mt 66.23 -20.41 0.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.711 -0.618 . . . . 0.0 109.759 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . 0.636 ' H ' ' C ' ' C' ' 90' ' ' LYS . 65.3 mtt180 38.8 27.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.539 -0.726 . . . . 0.0 109.676 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.576 ' CG2' ' ND2' ' C' ' 97' ' ' ASN . 7.5 p -45.47 141.2 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.828 . . . . 0.0 109.681 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -74.31 149.51 86.86 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.894 . . . . 0.0 109.371 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' C' ' 97' ' ' ASN . 59.5 Cg_endo -73.61 -22.2 18.39 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.435 2.09 . . . . 0.0 112.204 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.56 -3.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.576 ' ND2' ' CG2' ' C' ' 93' ' ' VAL . 0.7 OUTLIER -79.24 -41.92 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 109.998 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -51.29 -48.7 62.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 109.41 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -48.34 -30.57 5.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.176 -0.952 . . . . 0.0 109.434 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.502 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 18.6 mt -84.21 -62.09 1.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 109.622 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tp -49.88 -20.92 0.99 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.725 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 10.2 t -69.29 -59.14 3.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.939 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . 0.463 ' ND1' ' OD1' ' D' ' 108' ' ' ASN . 32.1 m170 -68.42 -26.61 65.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.821 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 50.9 m -63.03 -45.36 92.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.887 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.484 ' O ' ' OG1' ' C' ' 108' ' ' THR . 1.0 OUTLIER -56.0 -55.41 33.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.987 . . . . 0.0 109.456 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' C' ' 106' ' ' LEU . 4.1 mm? -47.79 -29.18 2.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.135 -0.978 . . . . 0.0 109.591 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.36 -24.79 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 0.0 110.113 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' C' ' 105' ' ' LEU . 28.0 p -71.45 -63.34 1.14 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.026 -1.046 . . . . 0.0 110.352 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' C' ' 113' ' ' LEU . 0.1 OUTLIER -64.64 -26.29 68.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.056 -1.027 . . . . 0.0 109.636 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.35 -37.43 24.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.107 -0.995 . . . . 0.0 109.707 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.18 -56.17 4.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 110.075 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -71.45 -67.51 0.52 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.821 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' C' ' 114' ' ' PRO . 2.1 tm? -110.68 98.49 37.66 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' C' ' 113' ' ' LEU . 65.7 Cg_exo -49.18 -170.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.269 1.98 . . . . 0.0 112.304 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.654 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -72.99 -55.22 6.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 108.866 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.654 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 18.3 mt-10 118.58 -8.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 0.464 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 5.3 t80 77.13 33.74 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.937 -0.477 . . . . 0.0 111.139 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.4 OUTLIER -101.62 116.08 64.02 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.1 20.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.935 1.757 . . . . 0.0 112.482 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -144.81 -29.37 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.038 -1.039 . . . . 0.0 110.423 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 10.5 p -49.39 -50.8 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.06 -1.025 . . . . 0.0 109.899 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.55 ' H ' ' ND1' ' C' ' 122' ' ' HIS . 2.9 m80 -60.81 -34.76 75.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.119 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.18 -20.06 33.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.765 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.522 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.4 m -64.93 -62.08 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 110.518 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.94 -19.69 62.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.187 -0.945 . . . . 0.0 109.949 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.48 -44.52 19.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.068 -1.02 . . . . 0.0 110.109 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.62 ' HZ1' ' CD1' ' C' ' 2' ' ' LEU . 0.0 OUTLIER -89.07 -41.37 12.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.004 -1.06 . . . . 0.0 109.977 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 41.7 t80 -50.52 -20.91 1.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.99 -1.069 . . . . 0.0 108.899 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' C' ' 133' ' ' SER . 18.2 mt -71.42 -17.66 62.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.411 ' O ' ' OG1' ' C' ' 134' ' ' THR . . . -61.0 -31.6 71.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 131' ' ' SER . . . . . 0.499 ' OG ' ' CG1' ' C' ' 1' ' ' VAL . 4.0 t -83.59 -33.05 25.46 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.289 -0.882 . . . . 0.0 108.918 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.18 -26.66 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.0 108.922 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.594 ' N ' ' O ' ' C' ' 129' ' ' LEU . 33.0 t -84.01 -25.45 29.93 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.383 -0.823 . . . . 0.0 108.969 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 134' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 33.2 m -77.69 -38.93 46.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 109.189 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 34.8 m -73.39 -26.85 22.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.3 -0.875 . . . . 0.0 108.677 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.81 -30.03 70.6 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 137' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' C' ' 137' ' ' THR . 93.5 m -112.45 24.07 12.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.413 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 -179.983 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.67 ' H ' ' CD1' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -92.11 155.61 17.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.16 153.95 83.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 108.933 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.01 -15.96 36.31 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.616 2.21 . . . . 0.0 112.263 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.3 -42.77 14.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.682 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.17 -22.53 30.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.886 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -79.25 -40.5 30.46 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.124 -0.985 . . . . 0.0 109.245 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -61.58 -23.64 66.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 109.821 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.1 -55.43 4.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.065 -1.022 . . . . 0.0 110.144 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.26 -24.62 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.01 -1.056 . . . . 0.0 108.418 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -82.18 -37.14 26.56 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.752 -0.593 . . . . 0.0 109.591 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.5 96.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -0.848 . . . . 0.0 109.456 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' D' ' 17' ' ' LYS . 0.8 OUTLIER -61.81 -35.12 77.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.43 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -47.95 -21.63 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.138 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . 0.414 ' N ' ' C ' ' D' ' 14' ' ' LEU . . . -86.52 -32.52 15.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' D' ' 14' ' ' LEU . 1.0 OUTLIER -77.97 -31.46 50.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -1.123 . . . . 0.0 109.101 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -54.23 114.98 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.535 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' D' ' 21' ' ' ASP . 3.1 m120 -71.45 64.15 0.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.133 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 42.1 t -45.74 -16.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' D' ' 19' ' ' ASN . 21.4 t70 -77.32 5.67 8.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.937 . . . . 0.0 109.312 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' D' ' 19' ' ' ASN . 81.2 mt-10 -154.31 -43.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.352 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 78.7 t -55.03 -25.07 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 109.474 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.43 -42.55 93.74 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.67 -35.88 54.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -73.43 -36.52 65.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -1.138 . . . . 0.0 109.399 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.39 -53.05 61.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.179 -0.95 . . . . 0.0 109.417 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.42 -51.55 67.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.271 -0.893 . . . . 0.0 109.271 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.6 -40.77 95.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' D' ' 33' ' ' VAL . 16.6 mmt85 -58.1 -44.38 87.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' D' ' 35' ' ' TYR . 33.6 tp -46.86 -32.44 3.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 109.247 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 mt -81.24 -21.87 39.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.893 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' D' ' 30' ' ' ARG . 21.2 t -87.13 -64.2 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -49.53 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.925 . . . . 0.0 109.841 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' D' ' 31' ' ' LEU . 0.1 OUTLIER -118.48 85.71 26.8 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.282 -0.886 . . . . 0.0 109.425 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.18 34.44 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.787 2.324 . . . . 0.0 112.356 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . 0.442 ' CD1' ' N ' ' D' ' 38' ' ' THR . 1.9 p-90 -81.09 -29.79 34.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.442 ' N ' ' CD1' ' D' ' 37' ' ' TRP . 65.5 p -60.58 -96.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.937 . . . . 0.0 109.325 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 49.12 45.06 23.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.478 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . 0.585 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 19.1 ptt180 -137.76 -39.24 0.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.855 . . . . 0.0 109.357 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -100.38 -25.4 14.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -74.49 6.04 4.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.14 -23.19 51.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.554 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 20.4 p -59.61 -40.43 87.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.438 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -51.49 -17.73 0.89 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.77 55.14 11.77 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -159.55 79.19 0.72 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -1.087 . . . . 0.0 109.422 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 35.9 mt -131.46 14.57 5.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.427 -0.795 . . . . 0.0 109.383 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 24.4 m -46.85 -41.75 16.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.211 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 6.1 p -146.73 148.67 34.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -41.16 -39.4 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.305 2.003 . . . . 0.0 112.333 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . 0.404 ' C ' ' N ' ' D' ' 54' ' ' VAL . 1.0 OUTLIER -67.04 -40.47 87.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.703 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.14 -19.83 0.31 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 109.523 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 52' ' ' ASP . 83.2 t -67.52 -64.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 109.681 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 10.4 mtt -86.21 -6.12 59.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.527 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.69 87.99 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -81.28 148.35 63.01 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.188 -1.183 . . . . 0.0 109.424 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.14 -51.71 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.559 2.173 . . . . 0.0 112.213 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . 0.412 ' HG3' ' H ' ' D' ' 60' ' ' VAL . 0.0 OUTLIER -47.3 -39.32 14.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.709 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . 0.412 ' H ' ' HG3' ' D' ' 59' ' ' LYS . 61.9 t -61.79 -45.4 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.118 -0.989 . . . . 0.0 109.289 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -75.25 -24.76 57.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 109.294 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.51 -42.98 70.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.605 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -64.04 -24.02 67.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.709 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.58 -33.24 76.07 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . 0.504 ' NZ ' ' OD1' ' D' ' 21' ' ' ASP . 19.4 mtpt -67.28 -24.87 65.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -1.216 . . . . 0.0 109.642 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -71.95 -28.88 63.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.628 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.1 -48.76 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.5 -16.91 41.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.376 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.11 -48.71 45.24 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.89 -46.61 89.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -1.181 . . . . 0.0 109.852 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' D' ' 74' ' ' GLY . 1.1 m-85 -47.25 -41.19 18.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 109.588 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 14.0 m -49.51 -44.21 46.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.459 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -67.85 -16.65 64.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.221 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' D' ' 71' ' ' PHE . . . -63.01 -26.61 69.27 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.472 HD23 ' H ' ' D' ' 75' ' ' LEU . 2.0 pt? -136.09 -18.54 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.271 -1.134 . . . . 0.0 110.176 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -82.25 1.49 36.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.997 -1.065 . . . . 0.0 109.746 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 59.8 m-70 -163.06 67.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.16 4.89 3.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.411 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' D' ' 77' ' ' HIS . 1.1 m-20 -60.13 -37.14 79.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 14.1 t-20 -171.42 99.39 0.19 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.532 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -80.18 -57.2 3.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -47.19 -23.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 0.0 109.524 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -66.37 -54.88 20.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.8 t -75.54 -47.45 26.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -1.18 . . . . 0.0 109.384 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.556 ' N ' ' CG2' ' D' ' 84' ' ' THR . 53.4 m-85 -62.53 -1.26 0.76 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.541 -0.724 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -59.2 -35.79 74.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 87' ' ' THR . . . . . 0.483 ' O ' ' N ' ' D' ' 91' ' ' LEU . 21.3 p -83.39 -47.93 10.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt -55.53 -43.0 75.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -67.36 -51.41 52.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.437 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.38 -22.55 64.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.482 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' D' ' 87' ' ' THR . 7.5 tt -81.36 -60.21 2.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.227 -0.921 . . . . 0.0 109.727 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.457 ' O ' ' N ' ' D' ' 97' ' ' HIS . 66.5 m80 -61.64 -22.51 65.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.225 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 39.4 t -83.09 -60.61 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 110.768 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.539 ' O ' ' CE1' ' D' ' 97' ' ' HIS . 5.1 m-20 -87.18 -27.7 22.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.122 -0.986 . . . . 0.0 111.098 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.2 OUTLIER -87.71 -16.73 33.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.851 -1.156 . . . . 0.0 110.644 -178.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.501 ' C ' ' ND1' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -138.38 -39.33 0.53 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.963 -1.086 . . . . 0.0 109.831 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 1.218 ' CG ' HG23 ' A' ' 41' ' ' THR . 5.0 m80 64.83 58.81 0.94 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 109.778 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.62 132.62 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.1 -1.0 . . . . 0.0 109.363 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.39 152.5 2.2 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.399 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.02 -29.76 17.43 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.536 2.157 . . . . 0.0 112.195 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.45 53.82 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -149.31 -39.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.58 -29.77 70.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.575 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . 0.411 ' NH1' ' CB ' ' D' ' 104' ' ' ARG . 31.4 mtm105 -77.87 -20.05 53.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.599 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 13.6 mt -82.64 -50.14 9.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.9 tt -51.97 -49.1 63.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.361 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.49 -20.3 63.39 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . 0.487 ' O ' ' SG ' ' D' ' 112' ' ' CYS . 0.2 OUTLIER -81.86 -19.45 40.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -1.195 . . . . 0.0 109.613 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 92.4 t -86.36 -52.95 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -0.984 . . . . 0.0 109.721 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' D' ' 113' ' ' VAL . 2.8 tt -45.96 -60.13 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 0.0 109.787 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 61.3 t -46.68 -33.26 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.812 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' D' ' 108' ' ' ASN . 60.4 m -79.23 -23.95 43.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' D' ' 110' ' ' LEU . 98.7 t -74.94 -21.34 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.591 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . 0.519 ' CD1' ' CZ ' ' D' ' 130' ' ' TYR . 21.4 mt -78.98 -48.7 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 109.494 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.12 -23.31 3.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.443 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.516 ' ND1' ' HD1' ' D' ' 117' ' ' HIS . 6.5 t-80 -83.72 -57.81 3.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . 0.58 ' N ' ' HD1' ' D' ' 117' ' ' HIS . 0.3 OUTLIER -72.4 -17.75 61.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 109.511 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' D' ' 114' ' ' LEU . 95.2 m-85 -141.7 56.66 1.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -73.28 -24.85 74.52 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.31 9.46 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -1.098 . . . . 0.0 109.577 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' D' ' 123' ' ' THR . 58.9 mm-40 -142.75 8.84 1.73 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.541 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -78.67 34.15 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.434 ' H ' ' C ' ' D' ' 121' ' ' GLU . 69.6 p -48.59 148.46 3.54 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.206 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.495 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.5 Cg_exo -44.15 -55.76 2.94 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.565 2.177 . . . . 0.0 112.97 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 12.6 Cg_endo -56.21 -23.35 44.85 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.249 1.966 . . . . 0.0 112.208 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 75.5 t -82.8 -23.3 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.569 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -83.28 -59.6 2.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.73 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.2 -36.87 14.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.62 -5.11 56.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 0.0 110.042 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . 0.519 ' CZ ' ' CD1' ' D' ' 114' ' ' LEU . 0.1 OUTLIER -92.65 -40.74 10.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.025 -1.047 . . . . 0.0 109.474 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -84.0 -22.99 31.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.685 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -71.11 -42.4 69.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.113 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . 0.683 ' CG1' ' H ' ' D' ' 134' ' ' VAL . 6.4 p -71.97 -66.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -0.983 . . . . 0.0 110.349 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.683 ' H ' ' CG1' ' D' ' 133' ' ' VAL . 33.1 m -43.43 -19.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 0.0 109.941 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' D' ' 133' ' ' VAL . . . -59.62 -27.97 66.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.384 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.9 -30.94 58.66 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.31 -36.39 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -1.139 . . . . 0.0 109.418 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.37 -40.17 89.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . 0.964 HD22 HD22 ' B' ' 139' ' ' ASN . 53.7 t30 -75.88 -25.97 56.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.439 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.64 -49.04 74.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.419 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.16 -4.29 28.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.127 -0.983 . . . . 0.0 109.36 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' D' ' 145' ' ' TYR . . . -102.37 -39.42 7.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.417 -0.802 . . . . 0.0 109.515 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -45.39 -40.25 7.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 109.733 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.26 27.29 1.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.564 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . 0.57 ' O ' ' CG ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -140.46 1.21 1.74 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.412 ' HB3' ' CB ' ' B' ' 135' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 10.8 mp 53.21 176.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.158 -0.963 . . . . 0.0 109.553 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.506 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 174.59 -47.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 110.066 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' ASP . 71.1 Cg_exo -47.24 169.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.571 2.18 . . . . 0.0 112.744 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -45.35 -15.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.407 -0.808 . . . . 0.0 110.123 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' PRO . 25.0 t70 -38.78 -40.49 0.62 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 109.928 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -67.97 -45.74 73.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.131 -0.981 . . . . 0.0 109.224 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 5' ' ' ALA . 36.0 m -52.98 -31.1 38.82 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 108.782 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -78.07 -36.06 48.73 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.2 t -69.74 -49.05 61.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.79 -47.47 64.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -49.2 -60.79 2.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.613 -0.679 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.42 ' O ' ' CG2' ' A' ' 17' ' ' VAL . . . -50.86 -39.06 52.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.311 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -17.26 61.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.436 -0.79 . . . . 0.0 109.217 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -81.62 -45.68 7.19 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.67 -34.8 72.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -1.162 . . . . 0.0 108.674 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 70.4 t -61.97 -66.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 64.55 -143.61 47.22 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 48.37 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.584 -0.951 . . . . 0.0 109.978 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 18' ' ' GLY . 80.7 m-70 -151.81 19.53 0.7 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.42 -65.19 1.04 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.715 -0.616 . . . . 0.0 109.794 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.58 -14.77 0.24 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' ALA . 2.1 mm-40 -83.07 -56.46 3.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -1.19 . . . . 0.0 109.726 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.8 m-30 -55.95 -35.3 66.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.852 . . . . 0.0 109.13 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.11 -22.76 60.97 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.58 -38.28 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -1.168 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.73 -19.69 63.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.684 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.44 -22.41 51.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.117 -0.989 . . . . 0.0 109.708 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.463 ' CD1' ' HD1' ' A' ' 58' ' ' HIS . 7.6 mt -76.42 -43.97 37.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -65.68 -12.82 56.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.2 -0.937 . . . . 0.0 109.695 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -58.98 2.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptm -62.31 -25.61 67.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.476 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 48' ' ' LEU . 1.3 t80 -58.65 -55.99 27.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 0.0 109.653 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.699 HD11 ' HB3' ' B' ' 128' ' ' ALA . 2.3 pp -82.41 -42.46 18.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.126 -0.984 . . . . 0.0 110.227 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.527 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 12.6 t -59.65 -9.3 2.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.02 -1.05 . . . . 0.0 109.687 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 1.003 ' CZ ' ' NE2' ' B' ' 131' ' ' GLN . 79.3 m-85 -155.35 81.71 3.99 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.155 -0.966 . . . . 0.0 109.503 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 39' ' ' THR . 52.6 Cg_exo -52.5 -24.92 23.51 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.704 2.269 . . . . 0.0 112.273 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.402 HG22 ' HB2' ' D' ' 97' ' ' HIS . 9.0 p -46.88 -19.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 37' ' ' PRO . 51.2 p -82.89 -26.2 31.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.656 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 37' ' ' PRO . 26.6 ttpt -79.3 -53.66 6.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.181 -0.95 . . . . 0.0 109.658 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.563 -179.942 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.569 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 22.4 p80 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.489 0.661 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.543 ' O ' ' C ' ' A' ' 47' ' ' ASP . 3.9 t80 -104.38 31.57 4.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.561 -0.712 . . . . 0.0 109.736 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 46' ' ' PHE . 15.0 m-20 28.63 67.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.884 -0.51 . . . . 0.0 110.533 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.528 ' O ' ' CE2' ' A' ' 33' ' ' PHE . 87.3 mt -85.16 22.33 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.428 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 50' ' ' HIS . 19.3 m -76.65 26.67 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.358 -0.839 . . . . 0.0 109.418 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' A' ' 48' ' ' LEU . 54.6 t60 58.08 158.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 0.0 109.57 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.65 17.92 5.02 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.1 t -80.25 -17.76 51.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -1.111 . . . . 0.0 109.512 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 55' ' ' VAL . . . 68.6 -58.52 0.48 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 109.798 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 52' ' ' SER . 0.6 OUTLIER -43.76 -20.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.775 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 53' ' ' ALA . 89.8 t -77.55 -27.17 15.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.136 -0.977 . . . . 0.0 109.28 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.9 ptmt -63.7 -27.2 69.05 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.266 -0.896 . . . . 0.0 109.327 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.84 -27.62 68.81 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.463 ' HD1' ' CD1' ' A' ' 29' ' ' LEU . 54.0 t-80 -84.17 -30.65 25.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -1.17 . . . . 0.0 110.096 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.01 -49.47 55.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -60.1 -23.64 63.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -1.106 . . . . 0.0 110.082 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -34.04 65.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.087 -1.008 . . . . 0.0 109.135 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.29 -52.92 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.41 -0.806 . . . . 0.0 108.944 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.96 -28.44 69.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.297 -0.877 . . . . 0.0 109.166 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.26 -41.42 81.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.199 -0.938 . . . . 0.0 108.89 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.54 80.44 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.34 -46.17 87.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -63.24 -48.77 76.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.256 -0.902 . . . . 0.0 108.976 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.66 -22.56 66.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 108.835 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.21 -47.68 9.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -66.84 -22.56 29.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.98 -14.68 62.44 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 74' ' ' ASP . 21.5 m80 -141.87 -57.44 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.808 . . . . 0.0 109.648 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 69' ' ' ALA . 8.2 p 46.14 15.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 122.1 0.953 . . . . 0.0 108.76 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 72' ' ' HIS . 22.0 m-20 -136.36 12.41 3.26 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.9 30.39 0.06 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.554 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 1.2 mtm -66.54 -44.82 56.88 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.611 -0.681 . . . . 0.0 110.073 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 76' ' ' MET . 95.7 Cg_exo -42.12 -43.02 7.39 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.356 2.038 . . . . 0.0 112.727 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.23 -19.01 21.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 109.97 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.12 -58.44 3.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 109.165 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.5 mt -83.14 16.9 2.19 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -61.59 -21.98 64.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.473 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -74.8 -57.97 3.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.538 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.1 mt -44.75 -39.66 5.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' ALA . 26.5 t -54.48 -34.45 61.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 82' ' ' ALA . 4.0 m-20 -66.02 -24.39 66.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.144 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.46 ' CD1' ' NZ ' ' A' ' 90' ' ' LYS . 7.3 tp -80.45 -38.6 29.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.882 . . . . 0.0 109.176 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -92.28 -21.65 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.688 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 84' ' ' SER . . . -76.43 -39.02 54.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.244 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' LYS . 50.3 t-80 -146.58 -83.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 110.167 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.46 ' NZ ' ' CD1' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -43.88 105.98 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tp 63.61 59.14 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 109.293 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.637 HH12 ' HE1' ' D' ' 42' ' ' PHE . 10.6 ptp180 -60.64 -22.71 64.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.629 ' CG2' ' H ' ' A' ' 94' ' ' ASP . 12.8 p 42.1 -176.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.671 -0.643 . . . . 0.0 110.122 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.629 ' H ' ' CG2' ' A' ' 93' ' ' VAL . 50.7 m-20 -80.88 120.7 79.61 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.961 -1.087 . . . . 0.0 109.488 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.586 ' C ' ' H ' ' A' ' 97' ' ' ASN . 73.5 Cg_endo -78.67 -37.78 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.282 1.988 . . . . 0.0 112.183 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -55.38 -0.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.703 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.586 ' H ' ' C ' ' A' ' 95' ' ' PRO . 4.8 m120 -79.03 -24.77 43.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.695 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 95' ' ' PRO . 26.8 m-85 -49.3 -17.59 0.27 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.419 ' N ' ' C ' ' A' ' 97' ' ' ASN . 92.0 mttt -81.99 -28.23 32.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.888 . . . . 0.0 109.44 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 13.5 mt -84.11 -39.02 20.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.95 -40.12 79.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.379 -0.825 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -66.14 -59.25 3.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.781 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -62.22 -26.57 68.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.736 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 57.9 m -74.06 -34.84 64.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.961 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -84.25 -34.66 23.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.04 -1.037 . . . . 0.0 109.11 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.02 -44.02 97.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.421 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.58 -24.87 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.869 . . . . 0.0 109.213 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 104' ' ' CYS . 54.5 m -64.62 -59.33 4.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 113' ' ' LEU . 59.0 mt -46.12 -37.9 7.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.86 -37.96 6.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.798 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.15 -55.91 4.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.812 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -74.81 -66.59 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 109.899 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -108.9 98.44 29.79 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 88.7 Cg_exo -44.08 179.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.404 2.069 . . . . 0.0 113.095 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 117' ' ' PHE . . . -86.94 -34.64 19.27 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.599 0.714 . . . . 0.0 109.613 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 72.9 -0.51 3.34 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 1.492 ' CZ ' ' NE2' ' B' ' 116' ' ' HIS . 26.3 m-85 61.07 41.82 13.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.897 -0.502 . . . . 0.0 111.641 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.732 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -95.07 114.31 63.41 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.762 -1.211 . . . . 0.0 107.887 178.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.677 ' HA ' ' CG1' ' B' ' 33' ' ' VAL . 51.5 Cg_exo -49.77 18.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.087 1.858 . . . . 0.0 112.715 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -142.13 -23.39 0.69 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.048 -1.032 . . . . 0.0 110.579 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' A' ' 122' ' ' HIS . 13.3 p -59.25 -58.04 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.027 -1.046 . . . . 0.0 110.179 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.621 ' H ' ' CG1' ' A' ' 121' ' ' VAL . 1.7 m-70 -71.29 -32.02 68.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 108.934 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.38 -20.41 60.08 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.435 -0.791 . . . . 0.0 108.939 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 128' ' ' PHE . 3.1 m -73.42 -63.42 1.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 110.038 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mt -63.44 -28.17 69.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.85 -1.156 . . . . 0.0 109.382 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.752 ' OD1' ' CD2' ' B' ' 35' ' ' TYR . 8.7 t0 -69.67 -47.91 61.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.117 -0.99 . . . . 0.0 109.473 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.44 -40.83 11.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.099 -1.001 . . . . 0.0 109.931 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 124' ' ' SER . 72.7 t80 -48.45 -20.91 0.47 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.994 -1.066 . . . . 0.0 109.098 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 133' ' ' SER . 12.1 mt -71.43 -26.27 62.67 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -55.07 -30.57 59.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.1 t -81.17 -33.43 33.09 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.1 -28.62 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.31 -0.869 . . . . 0.0 108.828 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 129' ' ' LEU . 18.3 p -80.52 -23.27 40.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.398 -0.814 . . . . 0.0 109.096 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.431 ' N ' ' HG ' ' A' ' 133' ' ' SER . 29.3 m -75.35 -39.88 58.86 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.31 -0.869 . . . . 0.0 109.163 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.67 -29.72 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.187 -0.945 . . . . 0.0 108.794 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -33.96 77.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.384 -0.823 . . . . 0.0 108.927 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 62.8 m -96.12 -21.46 17.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 109.517 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.415 ' H ' HD13 ' B' ' 3' ' ' LEU . 0.2 OUTLIER -146.36 169.13 19.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 109.232 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.4 p -67.26 152.01 96.56 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.92 -27.5 25.6 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.533 2.155 . . . . 0.0 112.033 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -57.7 -45.24 85.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.233 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.31 -49.23 15.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -0.887 . . . . 0.0 109.374 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.495 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.5 OUTLIER -50.52 -54.18 24.34 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.28 -0.887 . . . . 0.0 109.531 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -43.52 -24.14 0.1 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.745 -0.597 . . . . 0.0 110.267 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.3 -56.57 3.69 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.016 -1.052 . . . . 0.0 109.725 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.8 -24.61 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 16.5 m -72.19 -47.42 50.82 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.539 0.685 . . . . 0.0 109.431 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.13 -31.89 70.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.371 -0.831 . . . . 0.0 109.589 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.08 -33.2 11.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.112 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -23.78 1.34 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.82 -61.79 3.9 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.451 ' CD ' ' N ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -58.33 -30.07 66.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -1.126 . . . . 0.0 109.224 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 49.2 t -54.11 114.71 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.558 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' B' ' 20' ' ' VAL . 45.0 m-80 -83.7 70.63 10.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 108.942 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' B' ' 22' ' ' GLU . 73.8 t -43.65 -26.6 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.425 -0.797 . . . . 0.0 109.658 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' B' ' 19' ' ' ASN . 1.2 p30 -58.41 -5.67 0.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.63 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.468 ' H ' ' C ' ' B' ' 20' ' ' VAL . 54.3 mt-10 -154.92 -42.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.533 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 81.5 t -49.68 -24.49 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.46 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.11 -55.53 3.49 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.78 -31.06 66.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.78 -26.67 57.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -1.162 . . . . 0.0 109.44 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.92 -52.58 64.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.366 -0.834 . . . . 0.0 109.625 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' B' ' 28' ' ' LEU . 3.7 mm? -64.49 -56.81 11.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.977 . . . . 0.0 109.394 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.26 -48.8 46.45 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 0.975 ' NH2' ' CD1' ' A' ' 117' ' ' PHE . 28.2 mmt180 -56.54 -47.71 78.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -1.152 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.26 -34.76 15.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 39.9 mt -80.69 -21.55 41.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.677 ' CG1' ' HA ' ' A' ' 119' ' ' PRO . 88.2 t -86.97 -64.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 0.0 109.726 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.504 HG12 ' HB3' ' A' ' 122' ' ' HIS . 2.8 t -52.04 -45.21 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 110.003 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.752 ' CD2' ' OD1' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -160.35 102.64 1.37 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.1 -1.0 . . . . 0.0 109.591 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.14 69.8 6.9 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.526 2.15 . . . . 0.0 112.149 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' B' ' 37' ' ' TRP . 0.0 OUTLIER -79.6 -19.53 49.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.399 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' B' ' 39' ' ' GLN . 28.4 p -48.05 -69.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.945 . . . . 0.0 109.621 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . 0.497 ' N ' ' OG1' ' B' ' 38' ' ' THR . 19.6 tt0 51.36 46.17 26.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.254 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -153.22 -58.67 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -84.7 8.34 17.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.487 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.596 ' HE1' HH12 ' C' ' 92' ' ' ARG . 29.0 p90 -58.07 -35.42 71.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -80.4 -21.63 42.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 109.382 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.407 ' C ' ' H ' ' B' ' 46' ' ' GLY . 16.5 m -58.5 -50.24 74.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 109.563 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.98 -8.83 1.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.517 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' B' ' 44' ' ' SER . . . 64.02 -94.51 0.15 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -45.2 122.46 3.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.331 -1.1 . . . . 0.0 109.747 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -153.5 15.15 0.51 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.24 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.0 t -46.77 -39.07 11.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.625 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 8.1 p -144.63 152.24 52.3 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.492 -0.755 . . . . 0.0 108.965 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -44.92 -45.12 14.26 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.064 1.843 . . . . 0.0 112.143 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 53' ' ' ALA . 1.7 p30 -59.07 -39.79 83.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.527 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' B' ' 52' ' ' ASP . . . -52.25 -19.82 2.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' B' ' 56' ' ' GLY . 99.3 t -66.11 -63.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.492 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 39.6 mtm -73.63 9.77 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.511 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' B' ' 54' ' ' VAL . . . -88.21 -13.79 63.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -90.79 148.59 38.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.174 -1.192 . . . . 0.0 109.355 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.19 -19.6 17.29 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.619 2.213 . . . . 0.0 112.098 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.75 -28.25 33.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.632 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -78.36 -40.34 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.681 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -79.08 -28.54 43.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.1 -48.71 19.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.694 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . 0.449 ' O ' ' ND1' ' B' ' 63' ' ' HIS . 3.1 t-80 -48.21 -23.87 1.0 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.41 -54.91 13.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -46.78 -34.62 5.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -1.154 . . . . 0.0 109.609 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -75.81 -37.62 58.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.318 -0.864 . . . . 0.0 109.669 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 33.6 t -71.73 -46.6 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.79 -32.56 67.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 109.253 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.81 -53.7 42.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.61 -48.85 66.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.397 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.49 -36.17 73.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.316 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 29.8 p -80.09 -24.23 40.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.479 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -51.87 -42.49 62.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.411 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.06 -60.25 8.3 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.434 ' H ' HD13 ' B' ' 75' ' ' LEU . 4.7 mp -58.26 -30.76 66.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.248 -1.148 . . . . 0.0 109.32 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.78 -3.01 58.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.595 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.505 ' C ' ' H ' ' B' ' 79' ' ' ASP . 10.3 t-80 -168.0 61.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.629 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mt -73.37 14.38 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.141 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' B' ' 77' ' ' HIS . 30.1 t70 -69.07 -32.19 71.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.496 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' B' ' 79' ' ' ASP . 9.8 m120 -163.23 104.2 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 109.461 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 37.6 mt -80.28 -58.8 2.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.378 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -48.6 -24.23 1.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.415 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.03 -62.15 3.46 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.7 t -62.82 -47.18 84.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -1.223 . . . . 0.0 109.437 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.5 m-85 -66.84 0.91 2.13 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.491 -0.756 . . . . 0.0 109.447 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -59.86 -47.36 86.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.405 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 4.9 p -72.68 -53.6 11.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.376 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 24.7 mt -49.87 -46.49 51.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' SER . . . . . 0.631 ' HG ' ' N ' ' B' ' 90' ' ' GLU . 85.9 p -56.37 -46.67 79.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.347 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.631 ' N ' ' HG ' ' B' ' 89' ' ' SER . 34.8 tt0 -64.73 -40.6 95.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.301 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.31 -44.58 87.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.374 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' B' ' 97' ' ' HIS . 76.0 m80 -73.38 -24.25 60.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 110.247 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.72 -60.91 1.97 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.028 -1.045 . . . . 0.0 111.24 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.1 -57.1 3.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.861 -1.15 . . . . 0.0 111.671 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -66.15 -9.92 36.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 111.515 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.563 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 1.0 OUTLIER -143.11 -33.89 0.44 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.741 -1.224 . . . . 0.0 109.987 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 33.2 p-80 43.62 25.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' B' ' 96' ' ' LEU . 24.9 t -53.73 138.96 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.089 -1.007 . . . . 0.0 109.104 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 7.4 m-20 -46.43 149.43 1.38 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.443 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.19 -17.47 45.17 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.575 2.184 . . . . 0.0 112.217 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -89.76 47.05 1.42 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' B' ' 99' ' ' ASP . 2.9 m120 -137.29 -3.44 1.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -0.886 . . . . 0.0 109.794 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -97.68 -60.46 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.432 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -50.92 -19.97 1.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.691 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' B' ' 105' ' ' LEU . 7.9 mp -77.9 -52.84 8.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.621 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 5.0 tt -54.6 -52.17 63.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 109.341 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.56 -22.02 7.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -85.65 -53.69 5.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -1.184 . . . . 0.0 109.69 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 91.9 t -46.66 -30.28 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.808 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 113' ' ' VAL . 5.2 tp -62.07 -55.32 30.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.597 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 90.3 t -46.75 -26.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 109.784 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 34.6 t -74.75 -26.22 59.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 109.643 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' B' ' 110' ' ' LEU . 39.3 t -83.45 -25.32 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.022 . . . . 0.0 109.525 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.6 -25.6 33.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.467 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -75.69 -19.58 59.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.705 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 1.492 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.3 OUTLIER -83.42 -52.48 6.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.165 -0.96 . . . . 0.0 109.458 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.487 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 61.0 m170 -73.32 -17.62 61.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.452 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.487 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 11.1 m-85 -149.41 55.78 0.98 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.857 . . . . 0.0 109.39 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -61.6 -14.78 44.46 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.62 -20.94 27.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -1.122 . . . . 0.0 109.512 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.4 mm-40 -83.85 -7.37 59.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -73.54 33.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.572 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.514 ' H ' ' C ' ' B' ' 121' ' ' GLU . 77.8 p -47.51 148.38 2.47 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 0.0 109.374 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.4 Cg_exo -44.64 -56.13 2.83 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.505 2.137 . . . . 0.0 112.941 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 19.8 Cg_endo -60.5 -35.28 91.03 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.162 1.908 . . . . 0.0 112.104 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.435 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 78.2 t -72.02 -17.34 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 109.581 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -83.42 -59.75 2.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 109.75 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.699 ' HB3' HD11 ' A' ' 34' ' ' LEU . . . -53.74 -33.38 55.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.58 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.44 27.5 0.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -125.09 -38.27 2.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.317 -0.864 . . . . 0.0 109.606 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . 1.003 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 46.0 tt0 -67.56 -23.94 65.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.898 . . . . 0.0 109.822 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -84.5 -36.42 22.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 109.716 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.68 -49.34 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.968 . . . . 0.0 109.786 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.5 m -79.5 -23.82 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.895 . . . . 0.0 109.768 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.4 -27.94 11.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 109.456 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.16 -23.05 61.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.3 t -79.07 -27.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.46 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.98 -42.8 56.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . 0.532 ' OD1' ' OD1' ' D' ' 139' ' ' ASN . 37.8 t30 -76.83 -21.22 55.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.57 -60.34 2.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 17.1 mt -55.21 -22.33 17.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.459 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.25 -17.99 24.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.882 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -46.3 -46.55 18.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.511 ' C ' ' H ' ' B' ' 146' ' ' HIS . 5.7 tppt? -77.08 -57.56 3.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.472 ' CD1' ' C ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -51.53 -10.61 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.533 -0.729 . . . . 0.0 109.23 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.511 ' H ' ' C ' ' B' ' 144' ' ' LYS . 11.6 m-70 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.735 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' C' ' 2' ' ' LEU . 1.3 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' C' ' 2' ' ' LEU . 10.8 mp 53.17 176.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 109.541 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.513 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 174.56 -47.79 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 0.0 109.976 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' C' ' 6' ' ' ASP . 71.8 Cg_exo -47.16 169.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.549 2.166 . . . . 0.0 112.759 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.47 -15.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.43 -0.794 . . . . 0.0 110.126 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' C' ' 4' ' ' PRO . 25.1 t70 -38.8 -40.53 0.63 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 109.888 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -67.93 -45.68 73.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.113 -0.992 . . . . 0.0 109.299 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.418 ' N ' ' O ' ' C' ' 5' ' ' ALA . 37.4 m -52.99 -31.06 38.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -78.08 -35.98 48.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.67 -49.1 61.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.82 -47.45 64.31 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' C' ' 15' ' ' GLY . . . -49.17 -60.77 2.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.585 -0.697 . . . . 0.0 109.569 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' C' ' 17' ' ' VAL . . . -50.94 -38.96 53.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.322 -0.861 . . . . 0.0 109.319 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -17.31 61.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.207 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' C' ' 12' ' ' ALA . . . -81.57 -45.68 7.22 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.63 -34.92 72.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -1.165 . . . . 0.0 108.696 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' C' ' 13' ' ' ALA . 70.2 t -61.94 -66.91 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 64.51 -143.62 47.26 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.42 48.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.443 -1.034 . . . . 0.0 110.0 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' C' ' 18' ' ' GLY . 80.7 m-70 -151.73 19.64 0.7 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.45 -65.24 1.03 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.66 -0.65 . . . . 0.0 109.769 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.65 -14.58 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' C' ' 21' ' ' ALA . 2.1 mm-40 -83.19 -56.46 3.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -1.168 . . . . 0.0 109.673 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.8 m-30 -55.95 -35.29 66.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.41 -0.806 . . . . 0.0 109.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.06 -22.83 60.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.52 -38.32 29.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -1.118 . . . . 0.0 109.795 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.61 -19.71 63.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.72 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.52 -22.39 51.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 109.683 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.464 ' CD1' ' HD1' ' C' ' 58' ' ' HIS . 7.5 mt -76.38 -43.99 38.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 109.706 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -65.7 -12.81 56.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.699 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -59.01 2.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptm -62.26 -25.67 67.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . 0.525 ' CE2' ' O ' ' C' ' 48' ' ' LEU . 1.3 t80 -58.56 -56.09 26.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 109.621 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.714 HD11 ' HB3' ' D' ' 128' ' ' ALA . 2.3 pp -82.34 -42.51 18.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 110.234 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 12.6 t -59.69 -9.21 2.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.01 . . . . 0.0 109.659 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 1.01 ' CZ ' ' NE2' ' D' ' 131' ' ' GLN . 79.5 m-85 -155.33 81.66 4.01 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.582 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' C' ' 39' ' ' THR . 52.6 Cg_exo -52.48 -24.96 23.56 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.689 2.259 . . . . 0.0 112.245 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' THR . . . . . 0.402 HG22 ' HB2' ' B' ' 97' ' ' HIS . 8.7 p -46.78 -19.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.877 . . . . 0.0 109.517 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.445 ' N ' ' O ' ' C' ' 37' ' ' PRO . 51.5 p -82.89 -26.15 31.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 109.676 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' C' ' 37' ' ' PRO . 26.6 ttpt -79.37 -53.62 6.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.653 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.907 . . . . 0.0 109.576 -179.929 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.571 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 22.0 p80 . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 121.495 0.664 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.544 ' O ' ' C ' ' C' ' 47' ' ' ASP . 3.9 t80 -104.31 31.46 4.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.756 . . . . 0.0 109.705 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' C' ' 46' ' ' PHE . 15.1 m-20 28.69 67.71 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.817 -0.552 . . . . 0.0 110.524 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.525 ' O ' ' CE2' ' C' ' 33' ' ' PHE . 87.2 mt -85.15 22.25 1.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.978 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.434 ' O ' ' O ' ' C' ' 50' ' ' HIS . 19.3 m -76.61 26.6 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' C' ' 48' ' ' LEU . 54.9 t60 58.07 158.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.842 . . . . 0.0 109.557 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.72 17.91 5.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' C' ' 47' ' ' ASP . 9.0 t -80.33 -17.73 51.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -1.152 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' C' ' 55' ' ' VAL . . . 68.62 -58.54 0.48 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.688 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' C' ' 53' ' ' ALA . 0.7 OUTLIER -43.74 -20.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.401 -0.812 . . . . 0.0 109.818 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' C' ' 53' ' ' ALA . 89.1 t -77.41 -27.33 15.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.277 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' C' ' 53' ' ' ALA . 5.9 ptmt -63.6 -27.18 69.06 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.293 -0.879 . . . . 0.0 109.395 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.86 -27.63 68.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.464 ' HD1' ' CD1' ' C' ' 29' ' ' LEU . 53.9 t-80 -84.15 -30.66 25.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -1.17 . . . . 0.0 110.103 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.06 -49.41 55.73 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -60.1 -23.66 64.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -1.146 . . . . 0.0 110.068 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.32 -33.96 65.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.192 -0.942 . . . . 0.0 109.146 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.41 -52.83 21.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.434 -0.791 . . . . 0.0 108.991 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.47 69.86 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.324 -0.86 . . . . 0.0 109.186 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -68.3 -41.38 81.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 108.848 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.07 -42.47 80.38 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.4 -46.2 87.5 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -63.24 -48.68 77.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.206 -0.934 . . . . 0.0 109.029 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.72 -22.55 66.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 108.829 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -85.22 -47.69 9.85 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.83 -22.69 29.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -14.57 62.42 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.555 ' O ' ' N ' ' C' ' 74' ' ' ASP . 21.5 m80 -141.92 -57.45 0.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.796 . . . . 0.0 109.65 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' C' ' 69' ' ' ALA . 8.2 p 46.16 15.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 122.067 0.937 . . . . 0.0 108.718 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' C' ' 72' ' ' HIS . 21.9 m-20 -136.39 12.53 3.25 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.96 30.52 0.06 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.557 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 1.2 mtm -66.63 -44.69 55.38 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.658 -0.651 . . . . 0.0 110.098 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' C' ' 76' ' ' MET . 95.5 Cg_exo -42.24 -43.03 7.67 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.431 2.087 . . . . 0.0 112.601 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.15 -18.97 21.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.001 . . . . 0.0 110.025 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 -58.5 3.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.034 -1.041 . . . . 0.0 109.081 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 18.7 mt -83.14 16.91 2.19 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' C' ' 77' ' ' PRO . 0.5 OUTLIER -61.67 -21.93 64.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.848 . . . . 0.0 109.363 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -74.79 -57.97 3.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' C' ' 82' ' ' ALA . 3.1 mt -44.74 -39.74 5.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' SER . . . . . 0.524 ' O ' ' N ' ' C' ' 88' ' ' ALA . 26.5 t -54.51 -34.45 61.68 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' C' ' 82' ' ' ALA . 4.0 m-20 -66.09 -24.28 66.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.136 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.454 ' CD1' ' NZ ' ' C' ' 90' ' ' LYS . 7.3 tp -80.52 -38.52 29.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.327 -0.858 . . . . 0.0 109.203 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -92.32 -21.64 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.723 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' C' ' 84' ' ' SER . . . -76.49 -38.95 54.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' C' ' 90' ' ' LYS . 50.1 t-80 -146.6 -83.43 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.101 -0.999 . . . . 0.0 110.114 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.454 ' NZ ' ' CD1' ' C' ' 86' ' ' LEU . 0.9 OUTLIER -43.85 105.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 109.67 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tp 63.61 59.22 1.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.343 -0.848 . . . . 0.0 109.29 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . 0.596 HH12 ' HE1' ' B' ' 42' ' ' PHE . 10.6 ptp180 -60.74 -22.63 64.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.578 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.644 ' CG2' ' H ' ' C' ' 94' ' ' ASP . 12.7 p 42.08 -176.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.642 -0.661 . . . . 0.0 110.084 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.644 ' H ' ' CG2' ' C' ' 93' ' ' VAL . 50.7 m-20 -80.85 120.68 79.6 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.969 -1.082 . . . . 0.0 109.459 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.604 ' C ' ' H ' ' C' ' 97' ' ' ASN . 73.5 Cg_endo -78.61 -37.86 0.6 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.359 2.039 . . . . 0.0 112.124 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -55.36 -0.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.707 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' C' ' 95' ' ' PRO . 4.8 m120 -79.03 -24.85 43.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.065 -1.022 . . . . 0.0 109.693 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' C' ' 95' ' ' PRO . 26.9 m-85 -49.27 -17.64 0.27 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.421 ' N ' ' C ' ' C' ' 97' ' ' ASN . 91.9 mttt -81.99 -28.22 32.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.377 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 13.5 mt -84.1 -39.04 19.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.384 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.97 -40.08 79.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -66.28 -59.18 3.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.986 . . . . 0.0 109.772 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -62.15 -26.59 68.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 109.809 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 57.8 m -74.12 -34.8 64.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.487 ' C ' ' CD1' ' C' ' 105' ' ' LEU . 0.0 OUTLIER -84.2 -34.67 23.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.11 -0.994 . . . . 0.0 109.182 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 20.0 mt -62.99 -44.09 96.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.455 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.47 -24.92 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' C' ' 104' ' ' CYS . 54.8 m -64.6 -59.33 4.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.564 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' C' ' 113' ' ' LEU . 59.1 mt -46.21 -37.84 7.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.601 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.8 -38.05 6.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.849 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.04 -55.95 4.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.861 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -74.82 -66.59 0.73 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 109.895 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -108.9 98.45 29.84 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.481 -0.762 . . . . 0.0 108.96 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' C' ' 113' ' ' LEU . 89.8 Cg_exo -44.02 179.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.45 2.1 . . . . 0.0 113.036 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -86.94 -34.76 19.23 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.594 0.711 . . . . 0.0 109.584 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 72.97 -0.53 3.35 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 1.493 ' CZ ' ' NE2' ' D' ' 116' ' ' HIS . 26.6 m-85 61.05 41.79 13.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.884 -0.51 . . . . 0.0 111.624 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.3 OUTLIER -95.01 114.22 63.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.773 -1.204 . . . . 0.0 107.922 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . 0.674 ' HA ' ' CG1' ' D' ' 33' ' ' VAL . 51.8 Cg_exo -49.68 18.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.224 1.949 . . . . 0.0 112.678 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -142.1 -23.41 0.69 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 110.599 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.61 ' CG1' ' H ' ' C' ' 122' ' ' HIS . 13.4 p -59.27 -57.99 8.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.003 -1.06 . . . . 0.0 110.206 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.61 ' H ' ' CG1' ' C' ' 121' ' ' VAL . 1.7 m-70 -71.23 -32.19 68.47 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 108.879 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.5 60.14 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.398 -0.814 . . . . 0.0 108.968 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.534 ' O ' ' N ' ' C' ' 128' ' ' PHE . 3.1 m -73.44 -63.37 1.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.247 -0.908 . . . . 0.0 109.979 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mt -63.55 -28.09 69.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.978 -1.077 . . . . 0.0 109.339 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . 0.744 ' OD1' ' CD2' ' D' ' 35' ' ' TYR . 8.7 t0 -69.63 -47.99 61.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.113 -0.992 . . . . 0.0 109.527 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.32 -40.82 11.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.064 -1.022 . . . . 0.0 109.938 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' C' ' 124' ' ' SER . 72.8 t80 -48.64 -20.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.954 -1.091 . . . . 0.0 109.043 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' C' ' 133' ' ' SER . 12.1 mt -71.48 -26.33 62.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -55.0 -30.58 59.72 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 4.2 t -81.17 -33.36 33.13 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.449 -0.782 . . . . 0.0 108.897 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 55.5 t -85.15 -28.61 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.354 -0.841 . . . . 0.0 108.817 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.547 ' N ' ' O ' ' C' ' 129' ' ' LEU . 18.6 p -80.61 -23.17 39.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.515 -0.741 . . . . 0.0 109.009 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 134' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 29.5 m -75.34 -40.0 58.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 109.15 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.55 -29.75 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.915 . . . . 0.0 108.783 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -34.01 77.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.4 -0.812 . . . . 0.0 108.885 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 63.0 m -96.13 -21.42 17.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.508 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 -179.933 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.401 ' H ' HD13 ' D' ' 3' ' ' LEU . 0.2 OUTLIER -146.33 169.13 19.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 109.257 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 3.4 p -67.27 152.04 96.53 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.01 -27.54 25.17 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.562 2.175 . . . . 0.0 111.947 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -57.63 -45.21 85.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.34 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.22 -49.38 15.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.349 -0.844 . . . . 0.0 109.359 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.493 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.5 OUTLIER -50.4 -54.22 23.42 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.312 -0.868 . . . . 0.0 109.582 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -43.56 -24.06 0.1 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.72 -0.612 . . . . 0.0 110.278 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.36 -56.54 3.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.061 -1.024 . . . . 0.0 109.677 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.84 -24.63 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 16.3 m -72.25 -47.29 51.38 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.432 0.634 . . . . 0.0 109.462 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.19 -31.91 70.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.546 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.05 -33.13 10.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.22 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -49.1 -23.86 1.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 109.427 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.69 -61.87 3.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.454 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -58.32 -30.02 66.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.203 -1.175 . . . . 0.0 109.259 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 49.8 t -54.14 114.67 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.887 . . . . 0.0 109.598 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' D' ' 21' ' ' ASP . 45.1 m-80 -83.74 70.6 10.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 108.89 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' D' ' 22' ' ' GLU . 73.5 t -43.46 -26.76 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.416 -0.802 . . . . 0.0 109.691 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' D' ' 19' ' ' ASN . 1.2 p30 -58.37 -5.66 0.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.644 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' D' ' 20' ' ' VAL . 54.3 mt-10 -155.0 -42.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 81.4 t -49.76 -24.44 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -0.942 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.13 -55.53 3.49 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.84 -31.06 67.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.79 -26.57 57.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -1.187 . . . . 0.0 109.444 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.11 -52.56 64.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' D' ' 28' ' ' LEU . 3.7 mm? -64.52 -56.75 12.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.128 -0.983 . . . . 0.0 109.384 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.33 -48.75 47.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . 0.961 ' NH2' ' CD1' ' C' ' 117' ' ' PHE . 28.3 mmt180 -56.61 -47.63 79.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.334 -1.097 . . . . 0.0 109.517 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.29 -34.81 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.568 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 40.1 mt -80.67 -21.52 41.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . 0.674 ' CG1' ' HA ' ' C' ' 119' ' ' PRO . 88.3 t -87.01 -64.07 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.915 . . . . 0.0 109.744 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' C' ' 122' ' ' HIS . 2.8 t -52.06 -45.19 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 110.007 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . 0.744 ' CD2' ' OD1' ' C' ' 126' ' ' ASP . 0.2 OUTLIER -160.42 102.53 1.36 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.105 -0.997 . . . . 0.0 109.614 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.04 69.92 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.491 2.127 . . . . 0.0 112.076 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -19.66 48.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.422 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' D' ' 39' ' ' GLN . 28.5 p -48.04 -69.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.59 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . 0.494 ' N ' ' OG1' ' D' ' 38' ' ' THR . 19.5 tt0 51.39 46.13 26.94 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.139 -0.976 . . . . 0.0 109.304 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -153.26 -58.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.355 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -84.66 8.25 17.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.637 ' HE1' HH12 ' A' ' 92' ' ' ARG . 29.1 p90 -57.97 -35.49 71.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' D' ' 42' ' ' PHE . 19.7 pt-20 -80.35 -21.64 42.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.841 . . . . 0.0 109.398 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.422 ' C ' ' H ' ' D' ' 46' ' ' GLY . 16.6 m -58.5 -50.26 74.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.482 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.01 -8.81 1.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.43 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' D' ' 44' ' ' SER . . . 64.01 -94.57 0.15 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -45.11 122.47 3.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -1.108 . . . . 0.0 109.779 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -153.57 15.2 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.235 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.0 t -46.76 -39.15 11.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.603 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 8.0 p -144.64 152.23 52.22 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.416 -0.802 . . . . 0.0 108.902 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -44.9 -45.13 14.18 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.072 1.848 . . . . 0.0 112.151 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' D' ' 53' ' ' ALA . 1.7 p30 -59.12 -39.67 83.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.606 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . 0.414 ' N ' ' OD1' ' D' ' 52' ' ' ASP . . . -52.32 -19.82 2.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.416 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' D' ' 56' ' ' GLY . 99.3 t -66.02 -64.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 39.6 mtm -73.56 9.67 1.32 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' D' ' 54' ' ' VAL . . . -88.15 -13.75 63.51 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.76 148.47 38.47 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.18 -1.188 . . . . 0.0 109.369 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.15 -19.54 17.43 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.58 2.187 . . . . 0.0 112.154 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.76 -28.28 33.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.654 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.31 -40.32 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 0.0 109.697 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -79.13 -28.55 42.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.649 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.11 -48.73 19.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.735 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . 0.426 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 3.1 t-80 -48.13 -23.88 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.691 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.44 -54.98 13.47 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -46.69 -34.65 5.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -1.132 . . . . 0.0 109.582 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -75.9 -37.64 58.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.351 -0.843 . . . . 0.0 109.558 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 34.1 t -71.73 -46.63 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.411 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.75 -32.56 67.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 0.0 109.279 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.81 -53.65 42.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.68 -48.79 66.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 109.364 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.63 -36.03 73.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.237 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 30.1 p -80.19 -24.2 40.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.468 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -51.92 -42.6 62.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.0 -60.12 8.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.453 ' H ' HD13 ' D' ' 75' ' ' LEU . 4.7 mp -58.38 -30.79 67.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -1.123 . . . . 0.0 109.238 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.68 -3.15 58.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 109.543 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.5 ' C ' ' H ' ' D' ' 79' ' ' ASP . 10.2 t-80 -167.96 61.81 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.666 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mt -73.42 14.43 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -0.971 . . . . 0.0 109.145 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' D' ' 77' ' ' HIS . 30.2 t70 -68.99 -32.32 71.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.482 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' D' ' 79' ' ' ASP . 9.8 m120 -163.19 104.14 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.337 -0.852 . . . . 0.0 109.45 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 37.3 mt -80.24 -58.8 2.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.409 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -48.59 -24.14 1.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.444 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.09 -62.21 3.42 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.7 t -62.76 -47.18 84.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.166 . . . . 0.0 109.452 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.4 m-85 -66.94 0.96 2.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.521 -0.737 . . . . 0.0 109.486 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -59.73 -47.42 85.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.966 . . . . 0.0 109.466 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 5.1 p -72.64 -53.63 11.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 0.0 109.42 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 24.7 mt -49.87 -46.52 51.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.432 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 89' ' ' SER . . . . . 0.634 ' HG ' ' N ' ' D' ' 90' ' ' GLU . 85.5 p -56.3 -46.7 79.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.419 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.634 ' N ' ' HG ' ' D' ' 89' ' ' SER . 34.8 tt0 -64.69 -40.6 95.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.327 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.25 -44.7 87.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 109.338 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' D' ' 97' ' ' HIS . 76.0 m80 -73.39 -24.24 60.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 110.207 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.71 -60.94 1.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 0.0 111.245 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -88.05 -57.12 3.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.884 -1.135 . . . . 0.0 111.691 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -66.23 -9.83 36.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.319 -0.863 . . . . 0.0 111.494 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.559 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 1.0 OUTLIER -143.13 -33.89 0.43 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.771 -1.206 . . . . 0.0 110.028 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 33.2 p-80 43.62 25.51 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.264 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' D' ' 96' ' ' LEU . 24.9 t -53.7 139.09 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.065 -1.022 . . . . 0.0 109.045 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' D' ' 102' ' ' ASN . 7.4 m-20 -46.54 149.41 1.42 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.509 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.19 -17.43 45.18 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.584 2.189 . . . . 0.0 112.263 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -89.74 46.94 1.41 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 109.668 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' D' ' 99' ' ' ASP . 2.9 m120 -137.29 -3.42 1.95 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 109.811 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -97.73 -60.41 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.118 -0.989 . . . . 0.0 109.435 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -51.05 -19.93 1.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 109.588 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' D' ' 105' ' ' LEU . 7.9 mp -77.98 -52.87 8.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.0 tt -54.48 -52.19 62.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.58 -22.0 7.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -85.64 -53.7 5.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -1.19 . . . . 0.0 109.723 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 92.9 t -46.66 -30.27 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 109.88 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.99 -55.39 29.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.644 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 90.2 t -46.71 -26.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.774 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 34.4 t -74.63 -26.31 59.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.893 . . . . 0.0 109.704 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.48 -25.28 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.6 -25.6 33.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.742 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -75.72 -19.48 59.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.673 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 1.493 ' NE2' ' CZ ' ' C' ' 117' ' ' PHE . 0.3 OUTLIER -83.52 -52.44 6.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . 0.493 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 61.0 m170 -73.29 -17.62 61.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 11.2 m-85 -149.39 55.73 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -61.47 -14.81 43.62 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.7 -20.89 27.07 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.213 -1.169 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.528 ' C ' ' H ' ' D' ' 123' ' ' THR . 59.4 mm-40 -83.87 -7.34 59.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.683 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.71 33.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 109.527 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.528 ' H ' ' C ' ' D' ' 121' ' ' GLU . 77.4 p -47.55 148.42 2.49 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.434 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.3 Cg_exo -44.63 -56.15 2.81 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.491 2.127 . . . . 0.0 112.956 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 19.8 Cg_endo -60.46 -35.26 91.34 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.187 1.924 . . . . 0.0 112.078 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . 0.428 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 78.5 t -72.09 -17.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -83.33 -59.78 2.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 109.789 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 0.714 ' HB3' HD11 ' C' ' 34' ' ' LEU . . . -53.69 -33.43 55.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.624 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.48 27.64 0.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.541 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -125.2 -38.22 2.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.411 -0.805 . . . . 0.0 109.512 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . 1.01 ' NE2' ' CZ ' ' C' ' 36' ' ' PHE . 45.9 tt0 -67.51 -23.97 65.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 109.835 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -84.46 -36.49 22.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 109.679 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.65 -49.39 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.787 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 4.5 m -79.43 -23.87 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 109.783 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.4 -27.84 11.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.106 -0.996 . . . . 0.0 109.463 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.28 -23.1 61.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 93.9 t -78.93 -27.65 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -1.173 . . . . 0.0 109.55 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.92 -42.84 56.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.933 . . . . 0.0 109.446 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . 0.532 ' OD1' ' OD1' ' B' ' 139' ' ' ASN . 37.8 t30 -76.8 -21.17 55.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.578 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.67 -60.29 2.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 0.0 109.54 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 17.1 mt -55.24 -22.26 17.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.429 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.32 -17.88 24.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -46.34 -46.51 18.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.51 ' C ' ' H ' ' D' ' 146' ' ' HIS . 5.7 tppt? -77.2 -57.43 3.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . 0.484 ' CD1' ' C ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -51.58 -10.59 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.519 -0.738 . . . . 0.0 109.193 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.51 ' H ' ' C ' ' D' ' 144' ' ' LYS . 11.4 m-70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.666 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.7 mt -138.96 -174.21 3.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.248 -0.907 . . . . 0.0 109.412 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.488 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 175.9 -49.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 3' ' ' SER . 71.9 Cg_exo -47.01 173.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.507 2.138 . . . . 0.0 112.568 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -65.11 -16.33 63.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 5' ' ' ALA . 1.2 m-20 -39.71 -40.62 0.96 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 109.595 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' CB ' ' HZ1' ' A' ' 7' ' ' LYS . 8.3 mtmp? -60.51 -59.29 5.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.206 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 m -50.26 -28.68 8.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.198 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 5' ' ' ALA . 55.5 m-80 -80.09 -35.32 37.09 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.81 -44.57 45.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.74 -39.63 89.39 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.414 -0.803 . . . . 0.0 108.86 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.78 46.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.153 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.97 -35.43 64.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.445 -0.784 . . . . 0.0 109.073 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.54 -17.51 61.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.051 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.47 -46.34 8.96 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -68.9 -37.47 78.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.198 -1.177 . . . . 0.0 108.766 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.2 t -61.17 -65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.596 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 59.59 -137.54 49.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.23 29.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.471 -1.017 . . . . 0.0 110.296 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.596 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.1 m-70 -131.82 23.35 4.62 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -87.3 -61.48 1.71 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.613 -0.68 . . . . 0.0 109.639 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.34 -14.62 0.35 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 21' ' ' ALA . 3.7 mm-40 -84.08 -56.45 3.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -1.111 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.1 m-30 -59.61 -33.17 71.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.396 -0.815 . . . . 0.0 109.322 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.33 -22.96 76.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.73 -43.54 20.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -1.176 . . . . 0.0 109.752 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.86 -19.91 65.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 -20.0 59.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.911 . . . . 0.0 109.366 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.6 mt -73.0 -46.04 54.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.588 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -61.98 -17.73 58.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 109.604 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.0 mmt-85 -81.18 -31.9 33.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 0.0 109.598 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -73.02 -37.63 66.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 109.525 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -62.95 -60.0 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.3 mt -59.32 -48.88 79.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.655 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' B' ' 131' ' ' GLN . 40.3 t -46.04 -27.4 0.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.923 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CD1' ' O ' ' A' ' 35' ' ' SER . 47.7 m-85 -154.18 123.88 3.25 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.026 -1.046 . . . . 0.0 109.55 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 40' ' ' LYS . 73.3 Cg_endo -77.9 -19.52 12.41 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.412 2.075 . . . . 0.0 112.159 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.2 p -43.9 -19.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 109.889 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 37' ' ' PRO . 3.4 p -90.27 -22.83 21.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.174 -0.954 . . . . 0.0 109.575 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 37' ' ' PRO . 27.8 ttmt -50.16 -18.74 0.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 109.954 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.863 -179.614 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.528 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.583 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -156.17 71.19 0.71 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -46.41 -13.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.453 -0.779 . . . . 0.0 111.203 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 9.5 mt 59.0 -5.43 0.06 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.772 -1.205 . . . . 0.0 109.608 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.614 ' H ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -46.79 124.88 6.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 109.552 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -53.3 138.96 31.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.46 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.27 27.81 65.93 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.451 ' OG ' ' CB ' ' A' ' 49' ' ' SER . 3.2 m -60.9 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.273 -1.134 . . . . 0.0 109.31 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' VAL . . . 167.8 -64.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.424 -0.797 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -45.61 -17.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.47 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' ALA . 61.3 t -73.93 -29.98 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 109.791 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -70.96 -26.49 63.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.71 -22.92 68.38 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.4 OUTLIER -79.2 -39.89 32.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.171 -1.194 . . . . 0.0 109.549 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.27 -49.96 54.23 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 49.8 mttp -51.98 -23.87 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -1.104 . . . . 0.0 110.0 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -72.41 -45.11 61.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.19 -0.944 . . . . 0.0 109.107 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.3 t -67.62 -46.14 83.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.475 -0.765 . . . . 0.0 109.261 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.79 -31.0 68.68 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.2 -0.937 . . . . 0.0 109.313 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.4 t70 -69.39 -34.57 74.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.973 . . . . 0.0 108.752 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.85 -51.37 62.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.32 -0.863 . . . . 0.0 108.96 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.8 mt -56.34 -46.29 80.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 108.82 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -62.68 -51.57 66.69 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.274 -0.891 . . . . 0.0 108.871 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -59.67 -22.74 62.35 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.56 -46.98 11.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.65 -22.91 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.7 -16.95 64.59 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' A' ' 74' ' ' ASP . 15.8 m80 -143.88 -60.16 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.402 -0.811 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 69' ' ' ALA . 12.7 p 44.66 14.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.751 0.786 . . . . 0.0 109.286 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 72' ' ' HIS . 13.7 m-20 -131.22 11.44 5.0 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.8 p-10 -177.82 31.79 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.944 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.696 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -77.99 -24.21 0.44 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.398 -0.814 . . . . 0.0 111.709 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 76' ' ' MET . 75.6 Cg_exo -50.21 -33.92 37.8 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.71 1.607 . . . . 0.0 112.239 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -94.29 -16.04 23.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 0.0 109.503 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.65 -57.96 3.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 109.087 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.18 10.23 2.55 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.405 -0.809 . . . . 0.0 108.946 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 77' ' ' PRO . 1.4 m -61.09 -28.73 69.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.396 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -63.9 -50.58 68.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.543 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.526 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 4.5 mt -47.22 -47.34 24.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 108.785 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.7 t -55.31 -25.9 37.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.426 -0.796 . . . . 0.0 109.299 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 89' ' ' HIS . 1.9 m-20 -78.45 -53.05 7.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.25 -28.65 65.1 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.327 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 8.4 m80 -92.6 -21.76 19.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.046 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.14 -2.39 14.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.133 -0.979 . . . . 0.0 110.354 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 85' ' ' ASP . 78.1 m80 -142.59 36.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.983 -1.073 . . . . 0.0 110.176 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -171.55 -77.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 0.0 109.723 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.49 -37.34 68.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.09 -1.006 . . . . 0.0 109.346 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.649 ' HG2' ' NH1' ' D' ' 40' ' ' ARG . 28.1 ttm180 55.63 52.4 11.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.122 -0.987 . . . . 0.0 109.492 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.562 ' O ' ' NH2' ' D' ' 40' ' ' ARG . 0.3 OUTLIER -78.7 -173.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.154 -0.966 . . . . 0.0 109.44 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 96' ' ' VAL . 1.8 m-20 -123.91 113.65 28.35 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.482 -0.761 . . . . 0.0 109.139 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 98' ' ' PHE . 84.3 Cg_exo -43.34 -14.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.265 1.976 . . . . 0.0 112.378 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 94' ' ' ASP . 94.9 t -48.07 -25.65 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.595 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -79.38 -24.86 42.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.621 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' A' ' 95' ' ' PRO . 28.5 t80 -46.38 -40.76 12.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 109.623 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -59.42 -25.18 64.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.591 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.1 mt -84.01 -61.32 1.85 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.576 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tp -47.95 -41.08 24.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.2 t -61.99 -42.31 99.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.669 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -80.91 -26.51 36.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.762 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 79.9 m -58.38 -56.86 16.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.603 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.6 mt -47.01 -37.14 8.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.365 -0.834 . . . . 0.0 109.568 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.09 -30.93 68.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.866 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.9 t -82.97 -24.81 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.2 m -81.82 -62.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.61 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 113' ' ' LEU . 12.5 mt -46.26 -39.94 10.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.311 -0.868 . . . . 0.0 109.64 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.5 -42.49 7.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.818 . . . . 0.0 109.927 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.04 -44.37 69.37 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.312 -0.868 . . . . 0.0 109.483 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -91.52 -77.24 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.561 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 109' ' ' LEU . 1.9 tt -96.88 119.59 63.28 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.49 165.38 32.58 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.242 1.962 . . . . 0.0 112.821 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.5 ' C ' ' H ' ' A' ' 117' ' ' PHE . . . -87.81 -28.5 21.61 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.53 0.681 . . . . 0.0 109.68 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.542 ' O ' ' CG ' ' A' ' 117' ' ' PHE . 83.8 mt-10 57.09 10.62 0.84 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' A' ' 116' ' ' GLU . 27.7 p90 40.6 32.5 0.15 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.339 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 120' ' ' ALA . 3.2 p -56.02 134.39 74.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -49.51 18.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.401 2.068 . . . . 0.0 113.251 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -157.37 -20.2 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.595 -1.316 . . . . 0.0 111.555 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.64 -63.13 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.543 -1.348 . . . . 0.0 110.055 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.616 ' CD2' HG22 ' B' ' 34' ' ' VAL . 0.0 OUTLIER -50.5 -31.14 14.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 108.977 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.65 -19.94 32.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.341 -0.85 . . . . 0.0 109.777 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 20.4 p -64.89 -62.33 1.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.201 -0.937 . . . . 0.0 110.599 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.507 ' N ' ' OG ' ' A' ' 124' ' ' SER . 2.0 mt -72.91 -19.78 61.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.119 -0.988 . . . . 0.0 110.051 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -81.45 -43.51 18.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 109.896 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -87.28 -47.59 8.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 109.86 -179.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 31.2 t80 -48.73 -21.5 0.63 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.122 -0.986 . . . . 0.0 109.47 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 133' ' ' SER . 18.7 mt -73.75 -21.06 60.32 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.15 -32.96 68.67 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.67 -30.42 46.19 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.404 -0.81 . . . . 0.0 108.869 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.06 -30.18 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 108.85 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 129' ' ' LEU . 78.8 p -79.09 -25.08 43.08 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.392 -0.817 . . . . 0.0 108.968 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 53.6 m -70.68 -37.57 73.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.299 -0.875 . . . . 0.0 109.244 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.52 -22.04 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.307 -0.871 . . . . 0.0 108.955 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -33.83 40.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.356 -0.84 . . . . 0.0 109.149 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 71.4 p -91.34 -1.46 57.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.48 -179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . 0.579 ' O ' ' CG ' ' B' ' 2' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.314 0.578 . . . . 0.0 109.603 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.594 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -122.17 -174.11 2.82 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.344 -0.847 . . . . 0.0 109.286 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.498 ' O ' ' N ' ' B' ' 6' ' ' GLU . 9.6 p -104.77 143.67 27.17 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.471 -0.768 . . . . 0.0 109.129 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -39.33 -22.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.561 2.174 . . . . 0.0 112.349 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' B' ' 4' ' ' THR . 25.1 mt-10 -75.5 -57.05 4.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.903 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -80.75 -22.93 39.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 109.798 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.493 ' O ' ' OG1' ' B' ' 12' ' ' THR . 2.5 tttm -79.77 -31.99 40.94 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.222 -0.924 . . . . 0.0 109.281 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t -63.92 -23.36 67.32 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.686 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.08 -57.68 3.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.074 -1.016 . . . . 0.0 110.062 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.12 -24.44 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 73.9 m -84.06 -35.47 23.76 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.364 0.602 . . . . 0.0 109.588 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -64.25 -60.05 3.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.812 . . . . 0.0 109.751 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -43.59 -18.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.51 -0.744 . . . . 0.0 110.139 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . 0.537 ' N ' ' O ' ' B' ' 13' ' ' ALA . 25.9 t90 -75.45 -33.39 60.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 0.0 109.499 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 13' ' ' ALA . . . -67.28 -52.54 30.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.618 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -56.22 -36.41 68.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.364 -1.08 . . . . 0.0 109.236 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 6.6 t -57.32 117.35 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.421 -0.8 . . . . 0.0 109.695 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' B' ' 21' ' ' ASP . 60.9 t30 -87.96 81.08 7.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.343 -0.848 . . . . 0.0 108.964 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.412 ' C ' ' N ' ' B' ' 22' ' ' GLU . 91.2 t -44.41 -17.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 109.781 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' B' ' 19' ' ' ASN . 22.2 t70 -51.12 -15.35 0.33 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.674 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.412 ' N ' ' C ' ' B' ' 20' ' ' VAL . 33.7 mt-10 -156.17 -37.55 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.619 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -47.44 -54.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.617 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.32 -33.33 70.27 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.62 -49.63 74.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' B' ' 28' ' ' LEU . 90.6 mt-10 -73.08 -44.27 60.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.0 109.501 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.52 -22.23 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' B' ' 26' ' ' GLU . 0.2 OUTLIER -82.78 -57.97 3.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.292 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.6 -43.74 59.37 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -50.17 -33.57 19.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -1.137 . . . . 0.0 109.43 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 42.0 tp -52.27 -36.94 54.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 24.4 mt -81.26 -42.57 20.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 109.844 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -56.74 -54.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 0.0 109.427 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.616 HG22 ' CD2' ' A' ' 122' ' ' HIS . 21.6 t -68.41 -23.0 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.525 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -160.8 87.1 1.76 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 109.382 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.22 18.59 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.666 2.244 . . . . 0.0 112.22 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . 0.545 ' C ' ' H ' ' B' ' 39' ' ' GLN . 1.3 p-90 -69.8 -19.95 63.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.476 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.494 ' C ' ' H ' ' B' ' 40' ' ' ARG . 75.8 p -69.83 35.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.857 . . . . 0.0 109.531 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' B' ' 37' ' ' TRP . 12.1 tt0 -73.27 14.78 0.28 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 0.625 ' NH1' ' HG2' ' C' ' 92' ' ' ARG . 64.7 mtt-85 -98.03 -48.95 4.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.384 -0.823 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -91.09 2.73 56.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 109.516 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' B' ' 39' ' ' GLN . 1.4 p90 -67.83 -4.34 12.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.58 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -46.86 -37.16 8.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 60.8 m -67.09 -43.46 82.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 109.436 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' B' ' 47' ' ' ASP . 2.6 m-85 -84.4 27.3 0.71 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 109.23 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.01 87.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' B' ' 45' ' ' PHE . 18.6 t0 -174.2 47.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.333 -1.098 . . . . 0.0 109.227 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' B' ' 48' ' ' LEU . 9.5 mp -88.77 27.91 1.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 109.575 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -46.95 -37.67 9.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 109.321 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' THR . . . . . 0.401 ' O ' ' N ' ' B' ' 53' ' ' ALA . 5.6 p -146.98 148.89 33.98 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.45 -0.781 . . . . 0.0 109.012 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.13 -42.51 2.22 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.518 2.145 . . . . 0.0 112.516 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.406 ' C ' ' N ' ' B' ' 54' ' ' VAL . 7.6 p-10 -77.37 -29.62 53.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.0 109.746 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -47.98 -19.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.619 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.406 ' N ' ' C ' ' B' ' 52' ' ' ASP . 68.2 t -63.87 -61.45 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.656 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -81.5 4.41 21.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.535 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.37 1.33 84.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -87.32 150.23 48.73 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.236 -1.156 . . . . 0.0 109.304 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.73 -28.33 9.77 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.598 2.199 . . . . 0.0 112.377 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' B' ' 60' ' ' VAL . 0.0 OUTLIER -84.42 -39.34 19.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.933 . . . . 0.0 109.846 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' B' ' 59' ' ' LYS . 53.9 t -52.43 -42.67 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.468 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -78.97 -26.86 43.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.108 -0.995 . . . . 0.0 109.484 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.73 -58.06 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.487 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . 0.464 ' O ' ' ND1' ' B' ' 63' ' ' HIS . 1.6 t-80 -48.1 -23.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.191 -0.943 . . . . 0.0 109.545 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.23 -47.47 90.83 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -62.29 -35.57 79.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.182 . . . . 0.0 109.441 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -60.58 -44.34 96.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.27 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 36.6 t -71.26 -58.83 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.22 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.2 tt -48.78 -44.6 39.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.277 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.05 -47.06 41.62 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.57 32.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -1.156 . . . . 0.0 109.475 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -53.05 -22.8 6.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.247 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.46 -41.01 22.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.445 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.39 -27.65 1.76 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.42 -60.16 5.27 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.465 HD11 ' H ' ' B' ' 75' ' ' LEU . 4.7 mp -56.23 -17.98 9.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -1.121 . . . . 0.0 109.302 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.52 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -80.53 -26.25 38.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.695 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' B' ' 79' ' ' ASP . 39.5 m80 -157.23 59.99 0.51 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.76 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 23.3 mt -56.41 -4.7 0.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 109.295 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' B' ' 77' ' ' HIS . 7.5 m-20 -51.82 -26.48 9.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.723 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.558 ' N ' ' ND2' ' B' ' 80' ' ' ASN . 0.0 OUTLIER -165.98 95.01 0.58 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.626 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -80.27 -58.75 2.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.36 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.645 ' HZ2' ' CG ' ' B' ' 143' ' ' HIS . 16.6 ttmm -47.44 -23.94 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 109.573 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.64 -49.29 11.18 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 1.3 t -73.9 -45.58 49.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -1.165 . . . . 0.0 109.647 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.531 ' N ' ' CG2' ' B' ' 84' ' ' THR . 48.4 m-85 -64.63 4.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.365 -0.834 . . . . 0.0 109.572 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -64.08 -34.02 77.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.944 . . . . 0.0 109.475 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.422 ' H ' ' HG1' ' B' ' 87' ' ' THR . 10.2 p -77.25 -53.06 8.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.606 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 9.4 mp -51.25 -49.21 61.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.321 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 3.5 m -53.33 -49.37 67.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.362 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.53 -22.7 66.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.359 -0.838 . . . . 0.0 109.369 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.95 -57.87 3.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 0.0 109.667 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' B' ' 97' ' ' HIS . 45.2 m80 -68.64 -20.25 64.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 110.31 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 53.7 t -83.8 -60.92 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.03 . . . . 0.0 110.747 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -87.75 -56.08 3.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.023 . . . . 0.0 111.246 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -51.7 68.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.893 . . . . 0.0 110.759 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.679 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -98.47 -59.71 1.69 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.012 -1.055 . . . . 0.0 109.893 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.679 ' ND1' ' O ' ' B' ' 96' ' ' LEU . 0.0 OUTLIER 83.94 20.66 0.16 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.773 -0.579 . . . . 0.0 109.77 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 68.5 t -48.35 140.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.048 -1.032 . . . . 0.0 109.292 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -56.93 150.61 37.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.273 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.49 -7.76 21.9 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.539 2.159 . . . . 0.0 112.15 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.52 60.89 2.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 109.542 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.96 -34.69 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.14 -14.05 52.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.504 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . 0.412 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 90.1 mtt-85 -86.25 -20.04 29.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.95 . . . . 0.0 109.778 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 37.2 mt -82.68 -53.61 5.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.792 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 tt -50.82 -46.32 59.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.79 -28.81 63.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 21.9 m120 -85.56 -20.78 29.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -1.173 . . . . 0.0 109.628 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 81.0 t -81.14 -28.86 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.56 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.94 -58.8 3.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.231 -0.918 . . . . 0.0 109.607 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 3.8 m -52.26 -26.07 8.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.296 -0.877 . . . . 0.0 109.929 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 t -70.43 -34.81 72.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 49.6 t -71.61 -22.48 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 109.56 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.423 ' CD1' ' OH ' ' B' ' 130' ' ' TYR . 14.6 mt -80.93 -47.11 14.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.488 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.484 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -51.96 -19.98 2.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 109.442 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.402 ' HE2' ' CB ' ' A' ' 115' ' ' ALA . 62.6 m80 -84.93 -63.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.544 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.79 -17.77 64.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.579 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -143.22 52.23 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.334 -0.854 . . . . 0.0 109.429 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -68.68 -13.01 65.28 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -77.99 -29.92 49.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -1.136 . . . . 0.0 109.395 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -94.29 14.48 20.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.569 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -84.0 34.01 0.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.902 . . . . 0.0 109.533 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -48.11 148.78 2.86 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.268 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.499 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 4.9 Cg_exo -45.73 -53.41 5.66 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.397 2.065 . . . . 0.0 113.007 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 28.1 Cg_endo -63.09 -29.13 74.52 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.031 1.821 . . . . 0.0 112.228 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 63.2 t -74.13 -13.73 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.51 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -83.47 -59.74 2.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 109.575 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.19 -32.69 64.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.405 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.82 26.24 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.423 ' OH ' ' CD1' ' B' ' 114' ' ' LEU . 1.3 t80 -131.19 -34.28 1.44 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -0.846 . . . . 0.0 109.246 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 35' ' ' SER . 12.3 mt-30 -76.64 -63.44 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.736 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -47.29 -21.95 0.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.554 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.14 -64.95 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.02 -26.83 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.81 -29.95 8.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.01 -32.52 69.61 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.06 -37.35 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -1.148 . . . . 0.0 109.362 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.32 -33.36 75.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.427 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . 0.557 HD22 HD22 ' D' ' 139' ' ' ASN . 65.3 t30 -72.57 -36.55 68.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.85 -48.49 74.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.364 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.409 ' CD2' ' HD1' ' B' ' 92' ' ' HIS . 17.0 mt -60.27 -30.1 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.97 0.55 49.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 109.7 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . 0.645 ' CG ' ' HZ2' ' B' ' 82' ' ' LYS . 72.0 t60 -67.2 -27.9 67.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.18 -0.95 . . . . 0.0 109.608 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -89.4 -23.04 22.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -55.34 -5.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.525 ' H ' ' C ' ' B' ' 144' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.515 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . 0.451 ' H1 ' ' H ' ' C' ' 2' ' ' LEU . 4.8 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . 0.451 ' H ' ' H1 ' ' C' ' 1' ' ' VAL . 14.6 mt -139.02 -174.23 3.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.311 -0.868 . . . . 0.0 109.34 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.478 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 175.94 -49.25 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 109.945 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' C' ' 3' ' ' SER . 72.1 Cg_exo -46.99 173.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.421 2.081 . . . . 0.0 112.641 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -65.12 -16.26 63.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.812 . . . . 0.0 109.64 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.457 ' C ' ' O ' ' C' ' 5' ' ' ALA . 1.2 m-20 -39.67 -40.63 0.94 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 0.0 109.647 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.419 ' CB ' ' HZ1' ' C' ' 7' ' ' LYS . 8.3 mtmp? -60.51 -59.33 5.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 109.216 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 48.8 m -50.26 -28.63 8.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 109.156 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' C' ' 5' ' ' ALA . 55.6 m-80 -80.16 -35.3 36.75 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.86 -44.54 45.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.69 -39.74 89.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.408 -0.807 . . . . 0.0 108.84 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.87 -52.87 46.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.865 . . . . 0.0 109.154 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.95 -35.43 64.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.365 -0.834 . . . . 0.0 109.056 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -17.46 61.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.314 -0.866 . . . . 0.0 109.007 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.52 -46.35 8.9 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -68.93 -37.43 78.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 108.772 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.14 -65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 59.67 -137.6 49.64 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 29.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.5 -1.0 . . . . 0.0 110.363 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.611 ' H ' ' C ' ' C' ' 18' ' ' GLY . 93.0 m-70 -131.73 23.33 4.65 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -87.3 -61.55 1.7 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.672 -0.643 . . . . 0.0 109.573 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.41 -14.49 0.35 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' C' ' 21' ' ' ALA . 3.7 mm-40 -84.14 -56.48 3.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -1.076 . . . . 0.0 109.484 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.1 m-30 -59.59 -33.16 71.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.396 -0.815 . . . . 0.0 109.332 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.32 -22.95 76.49 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.7 -43.58 20.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.184 -1.186 . . . . 0.0 109.689 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.75 -20.05 65.88 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.4 -19.98 59.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.03 -45.94 54.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.652 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -61.89 -17.86 58.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.677 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 36.2 mmt-85 -81.17 -31.82 33.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.552 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -73.06 -37.6 66.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.605 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' C' ' 33' ' ' PHE . 0.7 OUTLIER -63.06 -59.94 4.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.25 -48.93 79.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.0 109.63 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.52 ' OG ' ' NE2' ' D' ' 131' ' ' GLN . 40.4 t -46.02 -27.43 0.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.922 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' C' ' 35' ' ' SER . 47.3 m-85 -154.13 123.79 3.25 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 0.0 109.476 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' C' ' 40' ' ' LYS . 73.2 Cg_endo -77.8 -19.47 12.59 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.425 2.083 . . . . 0.0 112.272 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 21.2 p -43.91 -19.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 109.851 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.515 ' N ' ' O ' ' C' ' 37' ' ' PRO . 3.5 p -90.18 -22.89 21.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' C' ' 37' ' ' PRO . 27.9 ttmt -50.16 -18.7 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 109.922 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 109.835 -179.655 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.51 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.582 ' O ' ' HG ' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -156.15 71.08 0.71 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' C' ' 49' ' ' SER . 0.9 OUTLIER -46.34 -13.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.602 -0.687 . . . . 0.0 111.242 -178.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' C' ' 46' ' ' PHE . 9.6 mt 58.93 -5.34 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.787 -1.196 . . . . 0.0 109.664 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.626 ' H ' ' C ' ' C' ' 47' ' ' ASP . 0.0 OUTLIER -46.88 124.95 6.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.0 109.544 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -53.38 138.99 31.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.25 27.82 65.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.456 ' O ' ' CB ' ' C' ' 53' ' ' ALA . 3.2 m -60.89 -97.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -1.141 . . . . 0.0 109.336 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' C' ' 55' ' ' VAL . . . 167.83 -64.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.459 -0.776 . . . . 0.0 109.175 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -45.56 -17.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.541 -0.724 . . . . 0.0 109.534 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' C' ' 53' ' ' ALA . 61.6 t -73.86 -30.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.284 -0.885 . . . . 0.0 109.758 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -70.96 -26.46 63.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.85 -22.81 68.25 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.4 OUTLIER -79.22 -39.9 32.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.298 -1.119 . . . . 0.0 109.603 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.15 -50.02 53.54 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 49.7 mttp -52.06 -23.73 5.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -1.149 . . . . 0.0 109.966 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -72.55 -45.15 60.65 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.117 -0.99 . . . . 0.0 109.072 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.59 -46.12 83.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.531 -0.731 . . . . 0.0 109.277 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.86 -30.94 68.53 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.222 -0.923 . . . . 0.0 109.346 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 2.4 t70 -69.44 -34.49 74.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 108.83 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.84 -51.38 62.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 108.918 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 mt -56.28 -46.47 79.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.241 -0.912 . . . . 0.0 108.739 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -62.61 -51.66 66.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.328 -0.857 . . . . 0.0 108.81 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.6 -22.75 62.25 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.58 -47.06 10.94 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.64 -22.88 31.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.75 -16.91 64.58 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.597 ' O ' ' N ' ' C' ' 74' ' ' ASP . 15.8 m80 -143.88 -60.07 0.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.515 -0.741 . . . . 0.0 109.388 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' C' ' 69' ' ' ALA . 12.8 p 44.63 14.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.817 0.818 . . . . 0.0 109.376 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' C' ' 72' ' ' HIS . 13.7 m-20 -131.23 11.41 4.99 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 1.8 p-10 -177.77 31.76 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.962 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.694 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -77.98 -24.23 0.44 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.458 -0.776 . . . . 0.0 111.655 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' C' ' 76' ' ' MET . 75.3 Cg_exo -50.3 -33.82 38.19 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.689 1.593 . . . . 0.0 112.279 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -94.34 -16.05 23.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' C' ' 81' ' ' SER . . . -79.53 -58.04 3.39 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.123 -0.986 . . . . 0.0 109.139 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 mt -77.16 10.18 2.58 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.395 -0.815 . . . . 0.0 108.962 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' C' ' 77' ' ' PRO . 1.5 m -61.0 -28.81 69.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.389 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -63.85 -50.68 67.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.509 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 4.5 mt -47.27 -47.29 25.1 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 20.7 t -55.36 -25.8 37.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.498 -0.751 . . . . 0.0 109.247 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' C' ' 89' ' ' HIS . 1.9 m-20 -78.55 -53.01 7.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.935 . . . . 0.0 109.463 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.2 -28.76 65.11 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.302 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 8.3 m80 -92.58 -21.66 19.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 110.048 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.21 -2.28 14.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.234 -0.916 . . . . 0.0 110.414 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' C' ' 85' ' ' ASP . 78.0 m80 -142.6 36.08 1.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.984 -1.073 . . . . 0.0 110.096 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -171.57 -77.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.04 -1.037 . . . . 0.0 109.72 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.52 -37.34 68.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 109.327 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . 0.625 ' HG2' ' NH1' ' B' ' 40' ' ' ARG . 28.1 ttm180 55.64 52.38 11.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.575 ' O ' ' NH2' ' B' ' 40' ' ' ARG . 0.3 OUTLIER -78.68 -173.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.45 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' C' ' 96' ' ' VAL . 1.8 m-20 -123.8 113.67 28.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.464 -0.773 . . . . 0.0 109.169 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' C' ' 98' ' ' PHE . 84.8 Cg_exo -43.43 -14.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.216 1.944 . . . . 0.0 112.406 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' C' ' 94' ' ' ASP . 94.2 t -48.05 -25.66 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 109.551 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -79.44 -24.8 42.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.644 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . 0.42 ' N ' ' O ' ' C' ' 95' ' ' PRO . 28.5 t80 -46.43 -40.79 12.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 109.55 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -59.5 -24.93 64.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 20.2 mt -84.13 -61.26 1.86 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.628 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tp -48.01 -41.02 24.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 9.2 t -61.96 -42.3 98.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.715 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -80.94 -26.59 36.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.676 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 79.8 m -58.31 -56.86 16.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 0.0 109.625 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -47.07 -37.06 8.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.526 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.19 -31.01 68.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.782 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.89 -24.88 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.586 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 28.1 m -81.78 -62.95 1.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.596 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' C' ' 113' ' ' LEU . 12.5 mt -46.26 -39.9 10.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.895 . . . . 0.0 109.581 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.62 -42.33 7.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.958 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.1 -44.45 69.01 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.507 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -91.41 -77.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.63 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' C' ' 109' ' ' LEU . 1.9 tt -96.82 119.44 63.64 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.41 165.34 32.76 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.287 1.991 . . . . 0.0 112.821 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -87.79 -28.57 21.6 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.565 0.698 . . . . 0.0 109.647 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' C' ' 117' ' ' PHE . 83.8 mt-10 57.07 10.63 0.84 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' C' ' 116' ' ' GLU . 27.8 p90 40.58 32.51 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.314 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.703 ' O ' ' N ' ' C' ' 120' ' ' ALA . 3.2 p -56.03 134.35 74.06 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.44 18.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.387 2.058 . . . . 0.0 113.293 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.703 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -157.44 -20.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.623 -1.298 . . . . 0.0 111.543 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.65 -63.01 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.513 -1.367 . . . . 0.0 110.106 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.626 ' CD2' HG22 ' D' ' 34' ' ' VAL . 0.0 OUTLIER -50.71 -31.02 15.29 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.28 -0.888 . . . . 0.0 108.868 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.65 -20.03 31.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.742 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 20.4 p -64.8 -62.33 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.671 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.505 ' N ' ' OG ' ' C' ' 124' ' ' SER . 2.0 mt -72.98 -19.68 61.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.1 -1.0 . . . . 0.0 110.081 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -81.48 -43.42 18.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.029 -1.044 . . . . 0.0 109.948 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -87.33 -47.64 8.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.873 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 31.1 t80 -48.68 -21.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.447 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' C' ' 133' ' ' SER . 18.8 mt -73.62 -21.23 60.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.05 -32.96 68.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.71 -30.43 45.95 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.07 -30.25 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.845 . . . . 0.0 108.764 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.46 ' N ' ' O ' ' C' ' 129' ' ' LEU . 79.1 p -79.03 -25.1 43.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.347 -0.846 . . . . 0.0 108.968 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 53.5 m -70.69 -37.54 73.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.284 -0.885 . . . . 0.0 109.215 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.9 p -79.59 -22.0 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 108.871 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.65 -33.9 40.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.39 -0.818 . . . . 0.0 109.144 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 69.8 p -91.23 -1.54 57.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 109.58 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . 0.581 ' O ' ' CG ' ' D' ' 2' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.394 0.616 . . . . 0.0 109.634 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -122.25 -174.11 2.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.278 -0.889 . . . . 0.0 109.258 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.498 ' O ' ' N ' ' D' ' 6' ' ' GLU . 9.7 p -104.75 143.73 27.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 109.122 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -39.26 -22.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.637 2.224 . . . . 0.0 112.296 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' D' ' 4' ' ' THR . 25.2 mt-10 -75.55 -56.92 4.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.937 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -80.82 -22.82 39.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.944 . . . . 0.0 109.861 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' D' ' 12' ' ' THR . 2.5 tttm -79.8 -31.97 40.75 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.254 -0.904 . . . . 0.0 109.296 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 11.2 t -63.84 -23.45 67.36 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.718 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.07 -57.66 3.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.057 -1.027 . . . . 0.0 110.086 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.1 -24.42 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 75.1 m -84.13 -35.5 23.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.327 0.584 . . . . 0.0 109.547 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -64.29 -59.95 3.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.441 -0.787 . . . . 0.0 109.71 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -43.72 -18.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 0.0 110.117 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . 0.53 ' N ' ' O ' ' D' ' 13' ' ' ALA . 25.6 t90 -75.39 -33.37 61.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.917 -1.114 . . . . 0.0 109.532 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.31 -52.57 30.55 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.62 ' H ' ' CD ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -56.25 -36.37 68.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.326 -1.102 . . . . 0.0 109.189 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 6.6 t -57.45 117.38 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.819 . . . . 0.0 109.676 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' D' ' 21' ' ' ASP . 61.0 t30 -88.03 81.12 7.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 108.912 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' D' ' 22' ' ' GLU . 92.0 t -44.47 -17.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 0.0 109.846 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' D' ' 19' ' ' ASN . 22.2 t70 -51.15 -15.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' D' ' 20' ' ' VAL . 33.6 mt-10 -156.12 -37.67 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 77.2 t -47.38 -53.97 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 109.703 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.35 -33.28 70.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.67 -49.66 74.23 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' D' ' 28' ' ' LEU . 90.5 mt-10 -73.06 -44.27 60.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -1.171 . . . . 0.0 109.505 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.51 -22.28 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.618 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' D' ' 26' ' ' GLU . 0.2 OUTLIER -82.65 -58.01 3.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.288 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.64 -43.68 59.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -50.13 -33.61 19.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -1.134 . . . . 0.0 109.482 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 42.1 tp -52.3 -36.93 54.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.935 . . . . 0.0 109.494 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.17 -42.69 20.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -56.72 -54.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.155 -0.965 . . . . 0.0 109.432 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . 0.626 HG22 ' CD2' ' C' ' 122' ' ' HIS . 21.6 t -68.41 -23.05 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.525 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -160.8 86.99 1.77 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -83.0 18.36 1.5 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.74 2.293 . . . . 0.0 112.281 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . 0.561 ' C ' ' H ' ' D' ' 39' ' ' GLN . 1.3 p-90 -69.68 -19.98 63.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.464 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.497 ' C ' ' H ' ' D' ' 40' ' ' ARG . 75.8 p -69.92 35.63 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.175 -0.953 . . . . 0.0 109.568 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . 0.561 ' H ' ' C ' ' D' ' 37' ' ' TRP . 12.1 tt0 -73.23 14.77 0.28 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.322 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . 0.649 ' NH1' ' HG2' ' A' ' 92' ' ' ARG . 64.7 mtt-85 -98.03 -48.9 4.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.483 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -91.17 2.73 56.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.983 . . . . 0.0 109.531 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' D' ' 39' ' ' GLN . 1.4 p90 -67.87 -4.33 12.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.619 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -46.81 -37.17 8.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 109.657 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 60.5 m -67.13 -43.39 82.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' D' ' 47' ' ' ASP . 2.6 m-85 -84.34 27.3 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.248 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.97 87.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' D' ' 45' ' ' PHE . 18.7 t0 -174.2 47.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -1.101 . . . . 0.0 109.252 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' D' ' 48' ' ' LEU . 9.5 mp -88.78 27.92 1.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 109.564 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -46.94 -37.67 9.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.297 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' THR . . . . . 0.41 ' O ' ' N ' ' D' ' 53' ' ' ALA . 5.6 p -147.07 148.8 33.46 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.034 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -39.04 -42.54 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.552 2.168 . . . . 0.0 112.447 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . 0.404 ' C ' ' N ' ' D' ' 54' ' ' VAL . 7.6 p-10 -77.39 -29.62 53.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 0.0 109.728 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -48.04 -19.64 0.27 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 109.572 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 52' ' ' ASP . 67.1 t -63.93 -61.43 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.608 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -81.52 4.4 21.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.505 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.4 1.34 84.14 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -87.39 150.21 48.53 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.222 -1.163 . . . . 0.0 109.348 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.79 -28.26 9.72 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.576 2.184 . . . . 0.0 112.314 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' D' ' 60' ' ' VAL . 0.0 OUTLIER -84.41 -39.32 19.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 109.848 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . 0.405 ' H ' ' HG2' ' D' ' 59' ' ' LYS . 53.8 t -52.38 -42.75 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.024 . . . . 0.0 109.428 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -79.01 -26.8 43.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.933 . . . . 0.0 109.458 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.76 -58.01 3.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.55 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . 0.5 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 1.6 t-80 -48.14 -23.9 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.561 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.3 -47.37 91.25 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -62.24 -35.67 79.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -1.203 . . . . 0.0 109.475 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -60.56 -44.39 96.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.837 . . . . 0.0 109.248 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 36.3 t -71.21 -58.77 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.25 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.2 tt -48.88 -44.54 40.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.275 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.03 -47.06 41.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.96 -55.63 32.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -1.199 . . . . 0.0 109.393 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -53.0 -22.85 6.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.321 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.33 -41.1 22.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -0.834 . . . . 0.0 109.565 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.34 -27.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.408 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.41 -60.16 5.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.463 ' H ' HD11 ' D' ' 75' ' ' LEU . 4.7 mp -56.25 -17.93 8.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -1.119 . . . . 0.0 109.342 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -80.6 -26.13 38.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.237 -0.914 . . . . 0.0 109.701 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' D' ' 79' ' ' ASP . 39.5 m80 -157.36 60.01 0.5 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.688 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 23.2 mt -56.36 -4.8 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.045 -1.034 . . . . 0.0 109.309 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' D' ' 77' ' ' HIS . 7.5 m-20 -51.8 -26.47 9.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.714 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.556 ' N ' ' ND2' ' D' ' 80' ' ' ASN . 0.0 OUTLIER -166.04 94.96 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -80.26 -58.71 3.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . 0.643 ' HZ2' ' CG ' ' D' ' 143' ' ' HIS . 16.6 ttmm -47.44 -23.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.915 . . . . 0.0 109.567 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.81 -49.12 10.81 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.522 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 1.3 t -73.93 -45.67 49.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -1.207 . . . . 0.0 109.599 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.522 ' N ' ' CG2' ' D' ' 84' ' ' THR . 48.5 m-85 -64.66 4.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.398 -0.813 . . . . 0.0 109.613 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -64.1 -33.94 76.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.507 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 87' ' ' THR . . . . . 0.438 ' H ' ' HG1' ' D' ' 87' ' ' THR . 10.4 p -77.31 -53.09 8.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 9.4 mp -51.17 -49.31 61.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 3.5 m -53.3 -49.37 67.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.339 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -62.55 -22.72 66.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.335 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.86 -57.99 3.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.316 -0.865 . . . . 0.0 109.617 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.574 ' O ' ' N ' ' D' ' 97' ' ' HIS . 45.2 m80 -68.54 -20.35 64.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.844 . . . . 0.0 110.337 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 53.6 t -83.72 -60.94 1.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 110.781 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -87.78 -56.07 3.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -0.982 . . . . 0.0 111.283 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -51.66 68.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.794 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.665 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -98.47 -59.61 1.71 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.983 -1.073 . . . . 0.0 109.956 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.665 ' ND1' ' O ' ' D' ' 96' ' ' LEU . 0.0 OUTLIER 83.77 20.79 0.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.812 -0.555 . . . . 0.0 109.761 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 67.3 t -48.43 140.63 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 109.231 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -57.02 150.64 38.54 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.285 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.44 -7.78 21.97 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.524 2.149 . . . . 0.0 112.208 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.56 60.83 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 109.503 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 -34.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.602 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -64.09 -14.02 51.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.969 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 89.9 mtt-85 -86.31 -19.97 29.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.769 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 37.3 mt -82.74 -53.56 5.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.821 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 tt -50.79 -46.41 59.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 109.485 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.74 -28.86 63.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 21.9 m120 -85.57 -20.71 29.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -1.215 . . . . 0.0 109.606 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.25 -28.69 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 8.8 tp -68.11 -58.7 4.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.627 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 3.8 m -52.31 -26.16 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.179 -0.951 . . . . 0.0 109.819 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 18.4 t -70.31 -34.78 73.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.743 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 49.8 t -71.7 -22.33 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.947 . . . . 0.0 109.6 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . 0.42 ' CD1' ' OH ' ' D' ' 130' ' ' TYR . 14.6 mt -81.03 -47.11 14.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -51.96 -19.93 2.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.473 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.408 ' HE2' ' CB ' ' C' ' 115' ' ' ALA . 62.6 m80 -84.95 -62.99 1.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.9 -17.67 64.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.92 . . . . 0.0 109.575 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -143.22 52.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.555 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -68.72 -12.92 65.24 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -78.06 -29.9 49.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -1.134 . . . . 0.0 109.394 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -94.27 14.5 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.892 . . . . 0.0 109.569 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -83.96 34.04 0.5 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.0 109.597 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -48.17 148.84 2.88 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 109.228 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.498 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.1 Cg_exo -45.88 -53.31 5.86 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.395 2.063 . . . . 0.0 112.923 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 28.3 Cg_endo -63.12 -29.04 74.12 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.004 1.803 . . . . 0.0 112.297 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 63.0 t -74.23 -13.64 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.496 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -83.52 -59.76 2.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.24 -32.56 64.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.374 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.92 26.3 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.857 . . . . 0.0 109.471 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . 0.42 ' OH ' ' CD1' ' D' ' 114' ' ' LEU . 1.3 t80 -131.27 -34.24 1.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.409 -0.807 . . . . 0.0 109.291 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . 0.52 ' NE2' ' OG ' ' C' ' 35' ' ' SER . 12.3 mt-30 -76.64 -63.5 1.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.646 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -47.34 -21.86 0.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 109.569 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.22 -64.91 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.546 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.06 -26.79 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.9 -29.9 9.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.41 69.49 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.11 -37.32 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.396 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.34 -33.42 75.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.375 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . 0.557 HD22 HD22 ' B' ' 139' ' ' ASN . 65.3 t30 -72.55 -36.46 68.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.92 -48.46 74.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 mt -60.16 -30.19 69.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.92 0.56 49.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 109.681 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . 0.643 ' CG ' ' HZ2' ' D' ' 82' ' ' LYS . 72.3 t60 -67.12 -27.97 67.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.527 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.9 OUTLIER -89.54 -22.85 22.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.955 . . . . 0.0 109.593 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -55.44 -5.4 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.527 ' H ' ' C ' ' D' ' 144' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.428 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.5 tp -172.34 163.4 5.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 109.857 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.474 ' OG ' ' OD2' ' A' ' 6' ' ' ASP . 0.8 OUTLIER -75.74 -176.92 0.63 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.368 -0.832 . . . . 0.0 109.058 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 58.4 Cg_endo -86.87 -68.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.664 2.243 . . . . 0.0 112.716 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -47.54 -40.44 18.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.054 -1.029 . . . . 0.0 109.485 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.474 ' OD2' ' OG ' ' A' ' 3' ' ' SER . 63.9 m-20 -43.55 -29.46 0.48 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.86 . . . . 0.0 109.02 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 10' ' ' VAL . 58.4 mttt -83.08 -53.72 5.59 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' LYS . 35.9 m -44.65 -38.51 4.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.448 -0.782 . . . . 0.0 109.282 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -72.46 -29.69 63.9 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.575 ' N ' ' O ' ' A' ' 7' ' ' LYS . 54.1 t -75.12 -55.0 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -51.65 -39.11 57.52 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.23 179.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.18 -63.12 1.37 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.322 -0.861 . . . . 0.0 109.296 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.68 -38.61 67.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.388 -0.82 . . . . 0.0 108.892 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.94 -17.58 63.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.466 -0.772 . . . . 0.0 108.981 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.14 -44.98 16.61 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.427 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 39.1 mmtt -68.23 -41.4 81.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -1.137 . . . . 0.0 108.859 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.28 -64.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 50.0 -127.87 25.1 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.47 24.68 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.474 -1.015 . . . . 0.0 110.381 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.577 ' H ' ' C ' ' A' ' 18' ' ' GLY . 87.4 m-70 -130.38 28.49 4.95 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -93.36 -61.31 1.59 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.671 -0.643 . . . . 0.0 109.778 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.27 -14.3 0.16 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.6 mt-10 -86.54 -56.29 3.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -1.117 . . . . 0.0 109.761 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.1 m-30 -59.79 -32.36 70.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 109.59 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.04 -22.92 76.13 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.92 -41.86 18.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -1.17 . . . . 0.0 109.959 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -65.93 -19.88 66.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.294 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.77 -20.4 60.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.436 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.52 -51.11 15.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.739 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.66 -22.43 65.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.164 -0.96 . . . . 0.0 109.584 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.973 HH21 ' HB2' ' B' ' 127' ' ' GLN . 2.3 tpt180 -73.37 -20.75 60.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.311 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 46.1 ttp -78.36 -53.64 7.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.862 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -48.36 -24.2 1.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.351 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 1.052 ' HB3' ' HB3' ' B' ' 128' ' ' ALA . 10.5 mt -82.32 -46.2 13.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.978 . . . . 0.0 109.579 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 46.0 m -69.21 -20.78 63.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 35' ' ' SER . 95.5 m-85 -158.4 79.23 3.14 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.988 . . . . 0.0 109.737 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.31 -26.42 15.67 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.659 2.239 . . . . 0.0 112.07 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.433 ' O ' ' CG2' ' A' ' 41' ' ' THR . 12.6 p -49.45 -18.24 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.918 . . . . 0.0 109.477 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.6 p -79.01 -22.34 45.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -46.01 -42.91 13.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 38' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.461 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 15.9 p80 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.662 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -149.81 69.32 1.02 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.548 ' C ' ' O ' ' A' ' 46' ' ' PHE . 1.1 m-20 -24.38 -37.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.855 -0.528 . . . . 0.0 111.203 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.662 ' N ' ' O ' ' A' ' 46' ' ' PHE . 4.3 mt 53.58 7.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.072 -1.017 . . . . 0.0 109.373 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 47' ' ' ASP . 4.9 m -64.34 5.7 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.528 ' H ' ' C ' ' A' ' 48' ' ' LEU . 37.8 t60 61.32 125.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.5 14.14 66.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.5 t -77.86 -103.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.164 -1.198 . . . . 0.0 109.41 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.91 -29.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 0.0 109.496 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -80.03 -17.98 51.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.199 -0.938 . . . . 0.0 109.169 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -84.52 -40.14 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.295 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -77.3 -32.37 55.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.16 -21.82 75.02 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.477 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 7.8 t-80 -75.65 -37.54 59.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.314 -1.11 . . . . 0.0 109.781 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.12 -48.5 46.39 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -51.77 -23.13 4.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -1.05 . . . . 0.0 109.979 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.39 -39.84 64.79 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.218 -0.926 . . . . 0.0 109.184 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.37 -33.6 19.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.457 -0.777 . . . . 0.0 108.935 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.16 -32.9 44.4 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.389 -0.82 . . . . 0.0 109.415 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -70.39 -33.37 71.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 108.861 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.13 19.02 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.429 -0.794 . . . . 0.0 108.898 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.23 -38.24 70.8 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.254 -0.904 . . . . 0.0 108.717 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -71.5 -50.29 32.88 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.196 -0.94 . . . . 0.0 108.608 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -59.78 -21.15 60.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.202 -0.936 . . . . 0.0 108.496 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.07 -47.35 13.66 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.94 -22.85 31.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.72 -15.1 63.41 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 74' ' ' ASP . 36.8 m80 -139.5 -63.01 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.479 -0.763 . . . . 0.0 109.423 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 69' ' ' ALA . 12.3 p 43.92 13.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.752 0.787 . . . . 0.0 109.65 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.612 ' N ' ' O ' ' A' ' 72' ' ' HIS . 16.2 m-20 -134.25 10.39 3.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 20.3 t0 -177.02 28.35 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.148 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.7 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 11.4 ptt? -78.81 -22.45 0.38 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 111.805 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 76' ' ' MET . 71.8 Cg_exo -49.02 -29.0 14.69 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.473 1.449 . . . . 0.0 112.424 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -94.23 -24.41 17.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 0.0 109.653 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.29 -53.58 8.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 0.0 109.143 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 mt -78.02 9.06 3.95 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.441 -0.787 . . . . 0.0 108.98 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 84' ' ' SER . 11.1 t -66.06 -41.5 90.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.412 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -52.46 -52.87 51.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.465 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 82' ' ' ALA . 4.9 mt -44.89 -45.05 10.11 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 9.9 p -55.75 -39.87 71.76 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' ALA . 25.7 t70 -67.58 -17.95 64.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.147 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 tt -82.85 -43.46 16.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.333 -0.855 . . . . 0.0 109.378 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -92.45 -21.27 20.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.952 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 84' ' ' SER . . . -60.63 -87.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.106 -0.996 . . . . 0.0 110.741 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 90' ' ' LYS . 44.9 t-80 -96.62 -46.3 6.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.245 -0.909 . . . . 0.0 111.02 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 89' ' ' HIS . 35.9 mttm -41.22 -94.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.22 -0.925 . . . . 0.0 110.324 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mp -67.54 -34.97 78.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.012 -1.055 . . . . 0.0 109.623 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.394 ' NH2' ' HE ' ' D' ' 40' ' ' ARG . 45.5 ttp85 60.89 58.2 2.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.607 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 t -84.33 161.64 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 109.373 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.45 151.43 50.78 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.21 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' ASN . 58.4 Cg_endo -73.08 -18.8 23.6 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.55 2.167 . . . . 0.0 112.195 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.498 HG23 ' CB ' ' D' ' 99' ' ' ASP . 24.4 t -47.22 -20.04 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.743 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.646 HD21 ' N ' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -79.15 -24.73 43.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.709 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -46.66 -32.57 3.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 109.659 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.498 ' O ' ' ND1' ' A' ' 103' ' ' HIS . 55.8 mttm -83.89 -36.78 23.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 0.0 109.814 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.538 ' CD1' ' N ' ' A' ' 100' ' ' LEU . 7.2 mp -66.37 -61.93 1.74 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.131 -0.981 . . . . 0.0 109.516 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.97 -47.4 52.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.239 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.8 t -61.9 -38.85 89.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.603 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' LYS . 22.9 m80 -77.37 -27.73 52.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.935 . . . . 0.0 109.609 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 70.8 m -64.74 -46.93 80.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.728 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.25 -48.64 65.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.435 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 106' ' ' LEU . 9.6 mp -61.54 -59.1 5.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.713 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.04 -34.3 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.237 -0.914 . . . . 0.0 109.386 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.8 m -75.77 -60.87 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.392 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 113' ' ' LEU . 13.1 mt -46.11 -41.44 12.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.91 -28.58 0.68 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 110.182 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.89 -56.38 4.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 109.768 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -85.77 -65.13 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.466 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -95.92 106.89 30.89 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.2 171.17 9.48 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.718 1.612 . . . . 0.0 112.3 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 117' ' ' PHE . . . -87.22 -34.37 19.0 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.487 0.66 . . . . 0.0 109.88 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 117' ' ' PHE . 23.2 mt-10 55.63 9.96 0.46 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 115' ' ' ALA . 29.3 p90 40.63 32.34 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.54 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 120' ' ' ALA . 4.9 p -60.88 145.55 88.59 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.41 29.56 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 121.946 1.764 . . . . 0.0 111.773 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 118' ' ' THR . . . -162.61 -23.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.12 -0.988 . . . . 0.0 111.06 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.446 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.6 t -59.86 -62.62 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.794 -1.191 . . . . 0.0 109.799 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -27.12 67.68 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.126 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.54 -20.09 32.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 120' ' ' ALA . 95.5 p -67.19 -62.0 1.64 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 110.8 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.6 mt -80.23 -19.88 45.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.925 -1.109 . . . . 0.0 110.81 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.69 -42.68 27.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.663 -1.273 . . . . 0.0 110.241 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.467 ' CD ' ' C ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -90.04 -45.0 9.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.958 -1.089 . . . . 0.0 110.126 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -47.31 -21.55 0.3 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.01 -1.056 . . . . 0.0 109.454 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 127' ' ' LYS . 15.8 mt -69.63 -17.68 63.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.98 -38.19 78.58 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.5 p -78.68 -25.92 44.88 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.362 -0.836 . . . . 0.0 108.747 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.1 t -84.99 -40.54 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.234 -0.916 . . . . 0.0 108.598 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.8 t -68.84 -28.76 67.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.397 -0.814 . . . . 0.0 109.297 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 51.6 m -64.65 -40.0 94.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.138 -0.976 . . . . 0.0 108.985 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 p -82.68 -21.89 9.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.26 -0.9 . . . . 0.0 108.584 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.82 -28.26 44.4 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 138' ' ' SER . 49.1 m -68.14 -23.34 64.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.846 . . . . 0.0 109.405 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . 1.538 ' HE2' ' CD2' ' D' ' 146' ' ' HIS . 6.2 p80 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.23 0.538 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.642 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -141.87 -162.63 1.43 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.26 -0.9 . . . . 0.0 109.149 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.449 ' H ' ' HG1' ' B' ' 4' ' ' THR . 7.6 p -93.77 131.08 32.9 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.0 109.237 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.45 -23.77 0.32 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.365 2.043 . . . . 0.0 112.308 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -81.46 -53.02 6.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.968 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 5.5 mp0 -61.3 -55.58 30.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.662 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.507 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -57.04 -35.44 69.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.869 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -58.67 -23.81 60.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 110.047 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.61 -56.45 3.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.094 -1.004 . . . . 0.0 109.712 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.07 -25.15 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 75.9 m -78.7 -35.26 45.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -60.38 -61.52 2.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.425 -0.797 . . . . 0.0 109.328 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -43.62 -18.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.672 -0.642 . . . . 0.0 109.765 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' B' ' 13' ' ' ALA . 22.1 t-105 -78.09 -17.96 56.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.972 . . . . 0.0 109.646 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.09 -42.61 7.49 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.593 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -68.75 -31.95 71.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -1.093 . . . . 0.0 109.214 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 4.8 t -52.33 119.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -0.819 . . . . 0.0 109.692 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' B' ' 21' ' ' ASP . 54.9 m-20 -86.98 82.86 7.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.035 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' B' ' 22' ' ' GLU . 94.7 t -44.14 -20.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.816 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' B' ' 19' ' ' ASN . 12.6 m-20 -51.72 -8.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.73 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' B' ' 20' ' ' VAL . 34.8 mt-10 -155.53 -49.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.5 t -46.08 -26.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 109.779 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.09 -31.18 32.4 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -82.47 -25.67 49.96 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.73 -29.94 25.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.697 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.55 -23.45 63.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.949 . . . . 0.0 109.807 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.67 -58.16 3.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 109.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.19 -29.35 68.36 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -68.37 -29.44 68.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -1.114 . . . . 0.0 109.745 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp -51.62 -39.7 58.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.244 -0.91 . . . . 0.0 109.652 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 mt -78.12 -21.85 49.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.825 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 45.7 t -71.83 -47.96 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.875 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -63.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.019 -1.051 . . . . 0.0 109.787 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -119.42 97.09 50.16 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.396 -0.815 . . . . 0.0 109.754 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' B' ' 38' ' ' THR . 90.6 Cg_endo -85.59 10.52 3.67 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.717 2.278 . . . . 0.0 111.888 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -45.21 -19.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 109.694 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.671 ' C ' ' H ' ' B' ' 40' ' ' ARG . 11.0 p -46.96 -34.36 5.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.616 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 61.06 -13.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 1.372 ' HE ' ' NH2' ' C' ' 92' ' ' ARG . 79.8 mtt180 -88.94 -25.63 21.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.955 . . . . 0.0 108.946 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 53.79 6.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.415 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.624 ' CD2' ' CE1' ' B' ' 45' ' ' PHE . 3.0 m-85 48.11 30.08 2.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 109.163 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -48.41 -20.19 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 32.5 p -74.39 -14.66 60.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.952 . . . . 0.0 109.409 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.624 ' CE1' ' CD2' ' B' ' 42' ' ' PHE . 17.5 m-85 -85.53 -2.3 58.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.364 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.08 -101.9 0.21 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' B' ' 49' ' ' SER . 1.9 p-10 -178.24 111.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -1.115 . . . . 0.0 109.525 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 mp -81.3 28.18 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 108.687 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' SER . . . . . 0.454 ' H ' ' C ' ' B' ' 47' ' ' ASP . 12.2 t -43.97 -29.66 0.61 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.733 . . . . 0.0 110.25 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 13.8 p -140.22 146.93 48.09 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.014 -1.054 . . . . 0.0 109.728 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -40.13 -49.65 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.652 2.235 . . . . 0.0 112.293 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -69.47 -27.95 65.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 109.954 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.5 -19.43 37.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.067 -1.021 . . . . 0.0 109.545 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.05 -59.88 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 109.624 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 11.4 mtm -95.96 20.04 10.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.35 -17.23 50.85 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -86.54 149.99 50.18 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.181 -1.188 . . . . 0.0 109.443 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.13 -45.59 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.678 2.252 . . . . 0.0 112.341 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' B' ' 63' ' ' HIS . 50.1 mtpt -54.17 -51.91 62.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -52.67 -42.51 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.54 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -79.13 -25.98 42.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.595 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.55 -59.04 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.644 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' B' ' 59' ' ' LYS . 13.5 t-80 -49.28 -23.94 1.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 109.595 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.68 -28.51 73.08 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -65.97 -32.27 73.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -1.135 . . . . 0.0 109.187 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -70.32 -60.09 2.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 0.0 109.511 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 28.3 t -46.33 -29.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 109.42 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -77.75 -34.86 52.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.287 -0.883 . . . . 0.0 109.369 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.66 -46.66 93.25 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.8 -44.57 82.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -1.175 . . . . 0.0 109.6 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -60.35 -53.52 56.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.457 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' SER . . . . . 0.507 ' OG ' ' NE1' ' B' ' 15' ' ' TRP . 62.5 m -51.94 -27.42 13.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . 0.437 ' CG ' ' HG1' ' B' ' 84' ' ' THR . 10.5 t0 -49.74 -34.44 19.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.24 -59.85 6.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.445 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.2 mp -59.09 -17.93 30.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.374 -1.074 . . . . 0.0 109.398 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -84.89 -16.61 40.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 31.0 m80 -160.11 64.23 0.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.915 . . . . 0.0 109.607 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.74 4.17 0.44 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.399 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' B' ' 77' ' ' HIS . 59.1 m-20 -75.54 -22.93 56.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -0.875 . . . . 0.0 109.404 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -157.31 103.44 1.98 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.88 . . . . 0.0 109.378 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' B' ' 81' ' ' LEU . 3.6 mm? -80.2 -58.78 2.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.416 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 1.275 ' NZ ' ' NZ ' ' D' ' 82' ' ' LYS . 83.5 mttt -55.25 -24.0 25.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.24 -60.23 7.84 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.0 t -69.43 -46.28 67.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 0.0 109.36 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.552 ' N ' ' CG2' ' B' ' 84' ' ' THR . 46.9 m-85 -70.34 16.81 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.547 -0.721 . . . . 0.0 109.613 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -73.75 -38.97 64.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 11.3 p -80.44 -46.18 16.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.524 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 42.8 mt -56.11 -54.84 40.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.242 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -50.15 -29.8 9.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.221 -0.924 . . . . 0.0 109.007 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.63 -63.01 1.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.116 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 tt -49.65 -23.44 1.72 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 109.078 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' B' ' 88' ' ' LEU . 7.8 m80 -76.17 -54.27 7.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 24.3 t -82.59 -19.42 38.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.003 . . . . 0.0 109.868 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.538 ' C ' ' HE2' ' B' ' 97' ' ' HIS . 1.4 m-20 -86.27 -25.02 25.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.088 -1.008 . . . . 0.0 111.026 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . 0.511 ' CA ' ' HE2' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -125.8 -51.96 1.57 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.843 -1.161 . . . . 0.0 110.796 -179.24 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.519 ' CD1' ' N ' ' B' ' 96' ' ' LEU . 8.0 mp -70.1 -58.12 4.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.974 -1.079 . . . . 0.0 110.096 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.582 ' CD2' ' N ' ' B' ' 97' ' ' HIS . 1.0 OUTLIER 72.18 19.84 4.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.326 -0.859 . . . . 0.0 109.584 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -57.86 132.11 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.138 -0.976 . . . . 0.0 109.199 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' B' ' 100' ' ' PRO . 0.7 OUTLIER -64.64 152.54 89.6 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.362 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.51 ' C ' HD21 ' B' ' 102' ' ' ASN . 74.1 Cg_exo -45.65 -175.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.43 2.087 . . . . 0.0 112.408 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 55.35 76.89 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.51 HD21 ' C ' ' B' ' 100' ' ' PRO . 0.8 OUTLIER -173.52 -56.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . 0.431 ' H ' ' CG ' ' B' ' 102' ' ' ASN . 1.8 p90 -58.34 -19.65 36.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -80.15 -44.59 19.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -0.925 . . . . 0.0 109.533 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.3 -48.85 79.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 5.2 tt -56.43 -54.43 45.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.357 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.06 -31.74 62.05 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -66.78 -53.49 32.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -1.216 . . . . 0.0 109.684 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.54 -47.53 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.475 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 tp -49.01 -26.75 2.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.86 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.0 t -70.78 -38.83 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.092 -1.005 . . . . 0.0 109.937 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 t -76.79 -22.93 52.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.001 . . . . 0.0 109.932 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 97.1 t -68.74 -24.32 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.891 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' B' ' 116' ' ' HIS . 48.7 mt -82.58 -54.33 5.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.103 -0.998 . . . . 0.0 109.678 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.476 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.64 -19.88 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.63 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.49 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.82 -62.87 1.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -0.963 . . . . 0.0 109.427 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -62.34 -17.81 59.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.438 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -151.41 61.5 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.495 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -70.8 -19.53 76.86 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.54 -30.82 70.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -1.161 . . . . 0.0 109.372 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' B' ' 123' ' ' THR . 30.9 mt-10 -90.48 14.3 13.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.465 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.524 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.4 OUTLIER -70.78 35.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.0 109.596 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.546 ' H ' ' C ' ' B' ' 121' ' ' GLU . 30.4 p -59.79 144.59 85.44 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.161 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.744 ' HA ' HH22 ' A' ' 31' ' ' ARG . 31.7 Cg_exo -44.82 -43.44 14.98 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.464 2.109 . . . . 0.0 113.408 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' B' ' 124' ' ' PRO . 3.0 Cg_exo -75.17 20.19 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.447 2.098 . . . . 0.0 112.175 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 79.6 t -125.06 -29.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . 0.973 ' HB2' HH21 ' A' ' 31' ' ' ARG . 86.6 mm-40 -83.15 -59.7 2.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.99 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 1.052 ' HB3' ' HB3' ' A' ' 34' ' ' LEU . . . -56.64 -42.66 79.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.06 11.07 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.536 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.505 ' H ' ' C ' ' B' ' 128' ' ' ALA . 4.9 t80 -105.2 -61.31 1.5 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.317 -0.864 . . . . 0.0 109.567 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . 0.529 ' CD ' ' H ' ' B' ' 131' ' ' GLN . 3.8 mp0 -50.02 -38.39 37.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -0.949 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 1.112 ' HD3' ' O ' ' D' ' 146' ' ' HIS . 18.7 ttpp -64.68 -28.58 69.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.771 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.45 -67.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.733 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.4 m -61.3 -24.66 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.74 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.25 -29.32 5.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.6 -29.1 56.1 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.93 -34.28 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -1.133 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.71 -48.18 63.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.469 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . 0.457 ' C ' HD21 ' B' ' 139' ' ' ASN . 0.2 OUTLIER -77.76 -29.62 51.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.495 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.25 82.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.409 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.24 13.21 1.96 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.47 4.53 1.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' B' ' 139' ' ' ASN . 12.3 t-80 -79.39 -26.29 42.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.203 -0.935 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.547 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.8 OUTLIER -81.95 -1.38 47.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.521 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -66.07 7.64 0.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 109.27 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 1.504 ' CD2' ' HE2' ' D' ' 2' ' ' HIS . 4.7 m-70 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.461 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 9.5 tp -172.41 163.46 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 109.777 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.8 OUTLIER -75.79 -177.06 0.65 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.016 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 58.4 Cg_endo -86.84 -68.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.606 2.204 . . . . 0.0 112.711 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -47.62 -40.31 19.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 109.542 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.464 ' OD2' ' OG ' ' C' ' 3' ' ' SER . 63.9 m-20 -43.6 -29.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 0.0 109.039 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' C' ' 10' ' ' VAL . 58.4 mttt -83.05 -53.78 5.55 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.414 ' C ' ' O ' ' C' ' 7' ' ' LYS . 35.4 m -44.7 -38.52 4.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.488 -0.757 . . . . 0.0 109.227 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -72.38 -29.7 64.01 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' C' ' 7' ' ' LYS . 54.2 t -75.13 -55.07 12.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' C' ' 11' ' ' LYS . 0.1 OUTLIER -51.53 -39.25 57.34 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.649 -1.221 . . . . 0.0 108.229 179.109 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.05 -63.18 1.35 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 109.321 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.64 67.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.388 -0.82 . . . . 0.0 108.836 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.91 -17.64 63.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.469 -0.769 . . . . 0.0 108.988 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.04 -45.09 16.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . 0.43 ' H ' ' HG2' ' C' ' 16' ' ' LYS . 39.2 mmtt -68.15 -41.48 81.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 108.862 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -60.16 -64.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.581 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 49.93 -127.9 24.86 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.39 24.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.388 -1.066 . . . . 0.0 110.426 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' C' ' 18' ' ' GLY . 87.4 m-70 -130.45 28.41 4.94 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -93.2 -61.24 1.61 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.642 -0.661 . . . . 0.0 109.849 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.41 -14.27 0.18 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.6 mt-10 -86.56 -56.27 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -1.056 . . . . 0.0 109.764 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 4.1 m-30 -59.78 -32.44 70.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 0.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.9 -23.02 75.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.89 -41.8 18.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -1.213 . . . . 0.0 109.974 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' C' ' 27' ' ' GLU . 0.1 OUTLIER -66.03 -19.84 65.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.261 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.77 -20.35 60.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.48 -51.23 15.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 109.672 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.59 -22.35 65.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.947 HH21 ' HB2' ' D' ' 127' ' ' GLN . 2.3 tpt180 -73.38 -20.87 60.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 46.0 ttp -78.19 -53.76 6.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.333 -0.854 . . . . 0.0 109.57 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 0.0 OUTLIER -48.3 -24.25 1.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.397 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 1.025 ' HB3' ' HB3' ' D' ' 128' ' ' ALA . 10.6 mt -82.27 -46.11 14.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.656 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 45.8 m -69.27 -20.72 63.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.854 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' C' ' 35' ' ' SER . 95.5 m-85 -158.42 79.11 3.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.033 -1.042 . . . . 0.0 109.758 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' C' ' 39' ' ' THR . 51.8 Cg_exo -50.19 -26.43 15.22 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.612 2.208 . . . . 0.0 112.049 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' C' ' 41' ' ' THR . 12.6 p -49.44 -18.33 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.405 ' N ' ' C ' ' C' ' 37' ' ' PRO . 53.9 p -78.91 -22.32 46.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.722 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -46.11 -42.84 14.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.913 . . . . 0.0 109.776 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' C' ' 38' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.459 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 15.9 p80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.667 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -149.76 69.28 1.02 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' C' ' 46' ' ' PHE . 1.1 m-20 -24.35 -37.74 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.925 -0.484 . . . . 0.0 111.183 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.667 ' N ' ' O ' ' C' ' 46' ' ' PHE . 4.3 mt 53.7 7.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.06 -1.025 . . . . 0.0 109.344 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.509 ' H ' ' C ' ' C' ' 47' ' ' ASP . 5.0 m -64.32 5.69 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.601 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.531 ' H ' ' C ' ' C' ' 48' ' ' LEU . 38.1 t60 61.42 125.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.311 -0.868 . . . . 0.0 109.501 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.46 14.24 66.32 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 13.5 t -77.81 -103.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -1.159 . . . . 0.0 109.48 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.96 -29.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.439 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -80.04 -17.97 51.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.265 -0.897 . . . . 0.0 109.157 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -84.35 -40.25 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -77.37 -32.37 54.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -0.924 . . . . 0.0 109.082 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.14 -21.8 75.13 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.463 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 7.8 t-80 -75.7 -37.46 59.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -1.103 . . . . 0.0 109.721 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.22 -48.49 47.05 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -51.7 -23.15 4.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -1.079 . . . . 0.0 110.063 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -39.83 64.68 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.109 -0.994 . . . . 0.0 109.218 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.29 -33.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.11 -32.95 44.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.378 -0.826 . . . . 0.0 109.462 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -70.33 -33.41 71.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.077 -1.014 . . . . 0.0 108.841 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.03 -53.14 18.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.412 -0.805 . . . . 0.0 108.843 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.29 -38.23 70.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 108.642 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -71.54 -50.28 32.78 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.83 -21.02 60.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.21 -47.37 13.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.84 -23.02 31.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.52 -15.21 63.46 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.62 ' O ' ' N ' ' C' ' 74' ' ' ASP . 36.8 m80 -139.42 -63.17 0.52 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.379 -0.825 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' C' ' 69' ' ' ALA . 12.3 p 43.97 13.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.813 0.816 . . . . 0.0 109.634 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.62 ' N ' ' O ' ' C' ' 72' ' ' HIS . 16.2 m-20 -134.25 10.39 3.81 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.431 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 20.2 t0 -176.95 28.29 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.037 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 11.4 ptt? -78.87 -22.44 0.38 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 111.745 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 72.7 Cg_exo -49.02 -29.03 14.75 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.569 1.513 . . . . 0.0 112.4 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -94.3 -24.29 17.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.709 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.36 -53.49 8.1 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.179 -0.951 . . . . 0.0 109.191 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 15.0 mt -78.05 9.13 3.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.43 -0.794 . . . . 0.0 109.022 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' C' ' 84' ' ' SER . 11.1 t -66.1 -41.59 90.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -52.3 -53.01 49.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.486 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' C' ' 82' ' ' ALA . 4.9 mt -44.83 -45.0 9.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' C' ' 88' ' ' ALA . 10.0 p -55.85 -39.77 71.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' C' ' 82' ' ' ALA . 25.8 t70 -67.64 -17.9 64.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 tt -82.81 -43.45 16.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.35 -0.844 . . . . 0.0 109.469 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -92.42 -21.23 20.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 109.979 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' C' ' 84' ' ' SER . . . -60.73 -87.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 110.729 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . 0.459 ' O ' ' O ' ' C' ' 90' ' ' LYS . 45.1 t-80 -96.61 -46.21 6.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 111.043 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' C' ' 89' ' ' HIS . 35.9 mttm -41.33 -94.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.145 -0.972 . . . . 0.0 110.346 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.55 -34.95 78.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.017 . . . . 0.0 109.65 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . 1.372 ' NH2' ' HE ' ' B' ' 40' ' ' ARG . 45.6 ttp85 60.87 58.19 2.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 109.602 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 t -84.29 161.56 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 109.451 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.38 151.37 50.85 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.957 . . . . 0.0 109.342 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' C' ' 97' ' ' ASN . 58.6 Cg_endo -72.99 -18.86 23.8 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.524 2.149 . . . . 0.0 112.234 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . 0.441 HG23 ' CB ' ' B' ' 99' ' ' ASP . 24.5 t -47.21 -19.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.733 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.646 HD21 ' N ' ' C' ' 97' ' ' ASN . 0.8 OUTLIER -79.12 -24.86 43.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.732 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . 0.411 ' N ' ' O ' ' C' ' 95' ' ' PRO . 4.8 m-85 -46.63 -32.53 3.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 109.686 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.504 ' O ' ' ND1' ' C' ' 103' ' ' HIS . 55.7 mttm -83.94 -36.78 23.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 109.781 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' C' ' 100' ' ' LEU . 7.2 mp -66.35 -62.02 1.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.491 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.94 -47.39 52.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 42.7 t -61.95 -38.76 89.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.634 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' C' ' 99' ' ' LYS . 22.9 m80 -77.4 -27.59 52.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.621 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 70.8 m -64.8 -46.99 79.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.728 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.24 -48.6 65.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.454 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' C' ' 106' ' ' LEU . 9.5 mp -61.51 -59.22 5.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.94 -34.25 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 16.8 m -75.77 -60.87 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 13.0 mt -46.11 -41.44 12.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 0.0 109.676 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.83 -28.74 0.68 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.153 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.83 -56.35 4.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.132 -0.98 . . . . 0.0 109.722 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -85.83 -65.08 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.472 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 109' ' ' LEU . 0.1 OUTLIER -95.94 106.86 30.72 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.21 171.23 9.38 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.73 1.62 . . . . 0.0 112.352 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -87.28 -34.34 18.94 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.441 0.639 . . . . 0.0 109.87 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' C' ' 117' ' ' PHE . 23.2 mt-10 55.66 9.87 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' C' ' 115' ' ' ALA . 29.2 p90 40.63 32.42 0.15 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.522 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.523 ' C ' ' H ' ' C' ' 120' ' ' ALA . 5.0 p -60.96 145.66 88.75 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.47 29.51 0.13 Allowed 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.957 1.771 . . . . 0.0 111.734 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' C' ' 118' ' ' THR . . . -162.62 -23.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.174 -0.954 . . . . 0.0 111.072 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.453 ' O ' ' OG ' ' C' ' 124' ' ' SER . 2.6 t -59.94 -62.55 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.829 -1.17 . . . . 0.0 109.818 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -27.2 67.78 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.426 -0.797 . . . . 0.0 109.087 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.04 32.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.645 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.476 ' N ' ' O ' ' C' ' 120' ' ' ALA . 95.7 p -67.25 -61.94 1.67 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 110.828 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 9.7 mt -80.15 -19.97 45.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.065 -1.022 . . . . 0.0 110.844 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.73 -42.49 28.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.759 -1.213 . . . . 0.0 110.332 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.469 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -90.15 -44.88 9.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.999 -1.063 . . . . 0.0 110.17 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.403 ' CB ' ' O ' ' C' ' 124' ' ' SER . 71.2 t80 -47.3 -21.53 0.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.029 -1.044 . . . . 0.0 109.564 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.8 mt -69.66 -17.67 63.52 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.97 -38.25 78.66 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 60.5 p -78.66 -25.89 44.98 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.31 -0.869 . . . . 0.0 108.756 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -85.05 -40.48 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.409 ' N ' ' O ' ' C' ' 129' ' ' LEU . 2.7 t -68.85 -28.85 67.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.453 -0.779 . . . . 0.0 109.239 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 51.5 m -64.63 -39.99 94.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 109.015 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 p -82.62 -21.9 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.83 -28.36 44.36 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 137' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' C' ' 138' ' ' SER . 49.8 m -68.15 -23.34 64.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 109.392 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 138' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' C' ' 137' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . 1.504 ' HE2' ' CD2' ' B' ' 146' ' ' HIS . 6.2 p80 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.253 0.549 . . . . 0.0 109.756 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.631 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -141.96 -162.64 1.43 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.276 -0.89 . . . . 0.0 109.183 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.491 ' H ' ' HG1' ' D' ' 4' ' ' THR . 7.6 p -93.74 131.04 33.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 109.263 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.45 -23.68 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.329 2.019 . . . . 0.0 112.402 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -81.57 -53.02 6.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.816 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' D' ' 7' ' ' GLU . 5.5 mp0 -61.34 -55.52 30.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.502 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -57.17 -35.42 69.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.806 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -58.71 -23.73 60.15 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 109.992 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.54 -56.61 3.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.978 -1.076 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -25.13 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 73.6 m -78.66 -35.24 45.55 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -60.5 -61.41 2.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.252 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -43.73 -18.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 109.759 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' D' ' 13' ' ' ALA . 22.1 t-105 -78.03 -18.04 56.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.148 -0.97 . . . . 0.0 109.646 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.97 -42.72 7.49 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.589 ' H ' ' CD ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -68.66 -31.97 71.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -1.12 . . . . 0.0 109.2 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 4.7 t -52.4 119.89 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.655 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' D' ' 21' ' ' ASP . 55.8 m-20 -86.99 82.85 7.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 108.98 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . 0.521 ' C ' ' H ' ' D' ' 22' ' ' GLU . 91.6 t -43.99 -20.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 109.789 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' D' ' 19' ' ' ASN . 12.7 m-20 -51.62 -8.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.802 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' D' ' 20' ' ' VAL . 34.8 mt-10 -155.48 -49.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 109.629 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 74.1 t -46.11 -26.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.788 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.05 -31.18 32.53 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -82.56 -25.65 49.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -84.67 -29.99 25.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -1.144 . . . . 0.0 109.682 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.47 -23.49 63.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.812 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.68 -58.25 3.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.477 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.21 -29.27 68.25 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -68.43 -29.43 68.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.681 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp -51.61 -39.75 58.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.635 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.04 -21.88 50.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.878 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.85 -47.93 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.869 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -63.35 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 0.0 109.788 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -119.42 97.01 50.16 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 0.0 109.814 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' D' ' 38' ' ' THR . 90.9 Cg_endo -85.57 10.56 3.65 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.659 2.239 . . . . 0.0 111.906 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -45.24 -19.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 0.0 109.732 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.684 ' C ' ' H ' ' D' ' 40' ' ' ARG . 10.9 p -46.95 -34.37 5.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 109.637 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 61.09 -13.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.38 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . 1.394 ' HE ' ' NH2' ' A' ' 92' ' ' ARG . 79.9 mtt180 -89.01 -25.55 21.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 108.971 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 53.68 6.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 109.429 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.613 ' CD2' ' CE1' ' D' ' 45' ' ' PHE . 3.0 m-85 48.03 30.14 1.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.174 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -48.34 -20.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 109.72 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 33.1 p -74.46 -14.66 60.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.973 . . . . 0.0 109.392 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . 0.613 ' CE1' ' CD2' ' D' ' 42' ' ' PHE . 17.4 m-85 -85.42 -2.38 58.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.08 -101.88 0.21 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' D' ' 49' ' ' SER . 1.9 p-10 -178.2 111.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.509 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 mp -81.27 28.1 0.39 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 108.753 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.455 ' H ' ' C ' ' D' ' 47' ' ' ASP . 12.0 t -43.86 -29.72 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.638 -0.664 . . . . 0.0 110.3 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 14.0 p -140.16 146.9 48.14 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.089 -1.007 . . . . 0.0 109.693 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -40.14 -49.61 3.71 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.676 2.251 . . . . 0.0 112.255 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -69.5 -27.98 65.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.91 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.48 -19.4 36.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.605 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.06 -59.97 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.584 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 11.4 mtm -95.87 20.14 10.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 109.458 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.44 -17.24 50.48 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -86.59 150.0 50.08 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.229 -1.159 . . . . 0.0 109.395 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.18 -45.58 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.579 2.186 . . . . 0.0 112.236 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' D' ' 63' ' ' HIS . 50.1 mtpt -54.12 -51.96 62.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 59.9 t -52.64 -42.55 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -79.0 -26.13 43.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.569 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.45 -59.07 2.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.657 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . 0.472 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 13.5 t-80 -49.37 -23.88 1.66 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.558 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.74 -28.51 73.06 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -65.92 -32.3 73.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -1.172 . . . . 0.0 109.21 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -70.29 -60.11 2.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 109.501 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 27.6 t -46.41 -29.68 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.375 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -77.71 -34.88 52.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.372 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.68 -46.69 93.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.57 81.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.59 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -60.43 -53.51 56.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -0.887 . . . . 0.0 109.375 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 72' ' ' SER . . . . . 0.501 ' OG ' ' NE1' ' D' ' 15' ' ' TRP . 63.2 m -51.96 -27.41 13.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.455 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' D' ' 84' ' ' THR . 10.6 t0 -49.71 -34.49 18.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.95 . . . . 0.0 109.391 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.26 -59.91 6.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.453 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.2 mp -59.03 -17.97 30.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -1.151 . . . . 0.0 109.427 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . 0.53 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -84.9 -16.61 40.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 31.1 m80 -160.1 64.16 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.74 4.19 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.414 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' D' ' 77' ' ' HIS . 59.5 m-20 -75.41 -22.98 56.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.92 . . . . 0.0 109.421 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -157.3 103.47 1.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.354 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' D' ' 81' ' ' LEU . 3.6 mm? -80.23 -58.79 2.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.945 . . . . 0.0 109.427 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . 1.275 ' NZ ' ' NZ ' ' B' ' 82' ' ' LYS . 83.5 mttt -55.3 -23.9 25.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.577 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.23 -60.26 7.8 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.0 t -69.44 -46.23 67.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.151 -1.205 . . . . 0.0 109.378 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.555 ' N ' ' CG2' ' D' ' 84' ' ' THR . 46.8 m-85 -70.35 16.85 0.07 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.523 -0.736 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -73.85 -38.8 64.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.453 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 11.0 p -80.62 -46.14 16.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.414 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.515 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 42.3 mt -56.07 -54.86 39.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 109.287 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -50.19 -29.73 9.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.944 . . . . 0.0 109.037 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' D' ' 94' ' ' ASP . 42.4 tt0 -82.6 -63.03 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.128 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 tt -49.73 -23.42 1.78 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 109.046 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' D' ' 88' ' ' LEU . 7.9 m80 -76.13 -54.33 6.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.181 -0.949 . . . . 0.0 109.486 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 24.1 t -82.57 -19.42 38.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.161 -0.962 . . . . 0.0 109.916 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.544 ' C ' ' HE2' ' D' ' 97' ' ' HIS . 1.4 m-20 -86.23 -24.96 25.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.082 -1.011 . . . . 0.0 111.086 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . 0.514 ' CA ' ' HE2' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -125.83 -52.04 1.57 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.829 -1.169 . . . . 0.0 110.725 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' D' ' 96' ' ' LEU . 8.0 mp -70.16 -58.1 4.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.894 -1.129 . . . . 0.0 110.053 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.562 ' N ' ' CD2' ' D' ' 97' ' ' HIS . 1.0 OUTLIER 72.12 19.88 4.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.583 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.69 132.07 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.101 -0.999 . . . . 0.0 109.221 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . 0.498 ' CB ' HG23 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -64.6 152.6 89.31 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 109.309 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . 0.512 ' C ' HD21 ' D' ' 102' ' ' ASN . 74.3 Cg_exo -45.72 -175.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.504 2.136 . . . . 0.0 112.402 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 55.4 76.82 0.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . 0.512 HD21 ' C ' ' D' ' 100' ' ' PRO . 0.8 OUTLIER -173.56 -56.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.859 . . . . 0.0 109.372 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . 0.429 ' H ' ' CG ' ' D' ' 102' ' ' ASN . 1.9 p90 -58.42 -19.55 37.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -80.23 -44.45 19.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.39 -48.88 79.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.382 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.2 tt -56.41 -54.5 44.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.298 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.04 -31.7 61.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -66.82 -53.47 32.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -1.194 . . . . 0.0 109.686 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 79.3 t -49.44 -47.5 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tp -49.13 -26.66 2.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 109.823 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.77 -38.82 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.09 -1.006 . . . . 0.0 109.998 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 22.8 t -76.77 -22.99 52.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.898 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.7 -24.34 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.948 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' D' ' 116' ' ' HIS . 48.6 mt -82.58 -54.4 5.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.14 -0.975 . . . . 0.0 109.668 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.487 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.62 -19.94 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 109.647 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.465 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.71 -62.89 1.44 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.429 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -62.36 -17.78 59.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.865 . . . . 0.0 109.436 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -151.38 61.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -70.82 -19.49 76.86 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.58 -30.74 70.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -1.165 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' D' ' 123' ' ' THR . 30.9 mt-10 -90.57 14.36 13.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.4 OUTLIER -70.77 35.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.523 ' H ' ' C ' ' D' ' 121' ' ' GLU . 30.4 p -59.75 144.64 85.16 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.158 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.724 ' HA ' HH22 ' C' ' 31' ' ' ARG . 31.5 Cg_exo -44.85 -43.39 15.09 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.439 2.093 . . . . 0.0 113.517 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' D' ' 124' ' ' PRO . 3.1 Cg_exo -75.16 20.12 0.48 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.437 2.091 . . . . 0.0 112.174 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 79.5 t -125.02 -29.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.341 -0.85 . . . . 0.0 109.602 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . 0.947 ' HB2' HH21 ' C' ' 31' ' ' ARG . 86.5 mm-40 -83.17 -59.78 2.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.446 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 1.025 ' HB3' ' HB3' ' C' ' 34' ' ' LEU . . . -56.68 -42.57 79.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.964 . . . . 0.0 109.363 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.05 11.05 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . 0.5 ' H ' ' C ' ' D' ' 128' ' ' ALA . 4.9 t80 -105.22 -61.3 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . 0.524 ' CD ' ' H ' ' D' ' 131' ' ' GLN . 3.8 mp0 -50.05 -38.45 37.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 109.388 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . 1.079 ' HD3' ' O ' ' B' ' 146' ' ' HIS . 18.7 ttpp -64.54 -28.61 69.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.77 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 79.3 t -71.49 -67.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.708 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 2.4 m -61.23 -24.58 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.807 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.34 -29.29 5.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 0.0 109.287 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.63 -29.08 56.08 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 66.1 t -72.9 -34.15 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -1.116 . . . . 0.0 109.514 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.81 -48.13 64.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.506 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . 0.458 ' C ' HD21 ' D' ' 139' ' ' ASN . 0.2 OUTLIER -77.75 -29.55 51.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.589 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.14 83.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.411 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 30.9 mt -79.24 13.14 1.99 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.362 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.47 4.56 1.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.631 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' D' ' 139' ' ' ASN . 12.3 t-80 -79.34 -26.26 42.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.167 -0.958 . . . . 0.0 109.459 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.549 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.8 OUTLIER -82.04 -1.4 48.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.479 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -65.91 7.6 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 1.538 ' CD2' ' HE2' ' B' ' 2' ' ' HIS . 4.7 m-70 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.472 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.485 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 36.4 mt -121.29 -171.74 2.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.829 . . . . 0.0 109.561 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -97.75 -179.08 0.81 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 109.296 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 26.0 Cg_exo -60.87 -68.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.605 2.203 . . . . 0.0 112.291 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.452 ' O ' ' ND2' ' A' ' 9' ' ' ASN . . . -52.39 -36.12 53.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.797 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.63 ' CB ' ' HZ3' ' A' ' 127' ' ' LYS . 3.3 m-20 -44.18 -33.7 1.62 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -83.41 -60.12 2.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.621 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.8 m -46.97 -29.74 2.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.419 -0.8 . . . . 0.0 109.979 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 5' ' ' ALA . 22.9 m-20 -77.33 -36.83 53.51 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.024 -1.048 . . . . 0.0 108.279 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -76.14 -47.97 29.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -53.17 -38.54 62.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.52 -62.99 1.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.411 -0.806 . . . . 0.0 109.357 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.27 67.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.421 -0.799 . . . . 0.0 109.204 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -17.31 61.52 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 108.967 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.59 -40.07 59.76 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -84.75 -49.79 8.16 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.503 -0.998 . . . . 0.0 109.327 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 20' ' ' HIS . 70.4 t -59.96 -35.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.56 -0.712 . . . . 0.0 109.675 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.629 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . -31.53 144.8 0.02 OUTLIER Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 69.12 -32.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -1.07 . . . . 0.0 108.896 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.629 ' H ' ' C ' ' A' ' 18' ' ' GLY . 1.2 m80 -104.88 13.94 30.34 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.55 -48.69 9.99 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.939 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.46 -14.62 42.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -89.1 -56.62 3.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -1.095 . . . . 0.0 109.702 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.639 ' CZ ' ' CE1' ' A' ' 112' ' ' HIS . 2.9 m-30 -58.98 -33.14 70.34 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 109.176 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.82 -33.06 76.49 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.04 -50.8 10.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -1.174 . . . . 0.0 109.721 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -52.4 -19.8 2.4 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.55 -25.54 65.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 33.5 mt -72.27 -58.02 3.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.671 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.71 -14.29 30.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.524 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 1.052 ' NH1' ' CG ' ' B' ' 127' ' ' GLN . 1.8 tpm_? -75.45 -38.98 59.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 109.357 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.512 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -80.02 -48.5 13.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.218 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 32' ' ' MET . 37.1 t80 -43.72 -19.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.396 -0.815 . . . . 0.0 109.831 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.821 ' HB3' ' HB1' ' B' ' 128' ' ' ALA . 11.0 mt -79.88 -60.2 2.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.136 -0.978 . . . . 0.0 109.701 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.704 ' OG ' ' OE1' ' B' ' 131' ' ' GLN . 29.6 m -81.39 -31.37 33.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 109.676 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -113.63 95.04 35.22 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.411 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.12 -20.1 8.9 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.447 2.098 . . . . 0.0 112.228 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 40' ' ' LYS . 71.1 p -47.64 -42.1 23.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 109.274 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 38' ' ' THR . 12.6 p -44.03 -22.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.83 . . . . 0.0 109.854 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' THR . 30.6 ttpt -70.87 -19.11 62.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.638 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 1.109 HG23 ' CD2' ' D' ' 97' ' ' HIS . 8.7 t . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.542 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.586 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.231 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.514 ' C ' ' H ' ' A' ' 48' ' ' LEU . 2.1 p90 -142.54 44.91 1.62 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.532 -1.355 . . . . 0.0 110.11 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.12 -35.32 0.3 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 110.453 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER 61.86 55.85 2.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.043 . . . . 0.0 109.0 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 48.1 m -165.39 157.06 14.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 0.0 109.541 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.491 ' C ' ' H ' ' A' ' 52' ' ' SER . 2.7 m-70 -59.6 160.94 6.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.877 . . . . 0.0 109.385 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.73 -18.14 1.92 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.555 ' C ' ' H ' ' A' ' 54' ' ' GLN . 29.5 p -48.78 -25.94 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -1.145 . . . . 0.0 109.322 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 67.05 -40.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.835 . . . . 0.0 109.688 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.555 ' H ' ' C ' ' A' ' 52' ' ' SER . 20.5 mt-30 -69.76 -23.73 63.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.304 -0.873 . . . . 0.0 109.304 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -69.61 -40.57 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.97 . . . . 0.0 109.129 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -65.73 -54.38 28.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.241 -0.912 . . . . 0.0 108.62 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.19 -36.09 21.1 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.493 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.1 t-80 -60.5 -36.57 78.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.315 . . . . 0.0 109.895 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.42 -29.28 38.27 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 56.8 mttm -65.18 -23.57 67.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -1.162 . . . . 0.0 110.263 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.16 -58.13 4.47 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.962 -1.086 . . . . 0.0 108.656 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.3 t -56.46 -44.76 81.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.655 -0.653 . . . . 0.0 109.315 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.51 74.46 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.298 -0.876 . . . . 0.0 109.225 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.9 t70 -66.03 -37.98 87.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -67.56 -53.33 29.22 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 70' ' ' VAL . 1.1 mt -58.53 -42.34 87.54 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 71' ' ' ALA . 15.5 m -69.68 -51.58 33.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.273 -0.892 . . . . 0.0 108.696 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -62.23 -25.97 68.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.08 -46.38 11.21 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 66' ' ' LEU . 38.1 t -66.7 -22.75 30.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -69.51 -36.37 76.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.589 ' O ' ' N ' ' A' ' 74' ' ' ASP . 26.1 m80 -103.29 -66.74 0.92 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.615 -0.678 . . . . 0.0 109.424 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.478 ' CG1' ' O ' ' A' ' 72' ' ' HIS . 14.9 p 44.37 14.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.953 0.882 . . . . 0.0 109.287 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 72' ' ' HIS . 5.5 m-20 -137.96 12.02 2.87 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.72 31.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 3.5 ptt? -78.29 -23.67 0.42 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.334 -0.854 . . . . 0.0 111.842 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.8 Cg_exo -53.58 -19.46 13.94 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.665 1.576 . . . . 0.0 112.477 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -94.19 -40.43 10.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.68 -48.9 67.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.918 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.61 6.04 6.53 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.446 -0.784 . . . . 0.0 109.198 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.1 t -54.53 -19.56 6.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 109.614 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -83.12 -58.53 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 109.916 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.8 mt -45.34 -44.58 11.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -0.847 . . . . 0.0 109.082 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.515 ' HG ' ' C ' ' A' ' 136' ' ' LEU . 23.3 t -60.06 -18.93 50.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.519 -0.738 . . . . 0.0 109.56 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 89' ' ' HIS . 36.8 t70 -81.06 -50.94 9.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.913 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.6 tt -64.16 -26.79 68.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.97 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.74 -21.78 26.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 110.328 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.56 -11.03 11.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 0.0 110.154 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.564 ' N ' ' O ' ' A' ' 85' ' ' ASP . 42.7 t60 -106.64 -74.6 0.65 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 109.919 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' ARG . 79.8 mttt -63.84 -110.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.058 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 mt -44.48 -17.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.017 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.568 ' CG ' HH21 ' D' ' 40' ' ' ARG . 31.8 ttm-85 46.75 41.56 10.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.142 -0.974 . . . . 0.0 109.481 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.9 t -45.94 144.8 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.867 . . . . 0.0 109.701 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 10.6 m-20 -80.52 150.2 69.77 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.65 -19.48 21.34 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.437 2.091 . . . . 0.0 112.229 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.35 -7.75 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.666 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 94' ' ' ASP . 12.7 m120 -79.74 -36.26 37.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.478 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -46.33 -41.58 13.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.879 -1.138 . . . . 0.0 109.536 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.49 ' NZ ' ' CB ' ' A' ' 99' ' ' LYS . 8.0 mtmp? -51.38 -28.24 12.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.963 . . . . 0.0 109.291 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.467 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 15.4 mt -84.29 -61.95 1.68 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.682 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tp -49.78 -23.62 1.93 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.878 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -73.38 -49.45 27.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -80.62 -26.37 37.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 0.0 109.923 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 65.7 m -65.06 -60.29 3.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.158 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -57.45 -22.44 43.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 109.825 -179.401 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.18 -31.42 38.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.802 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.1 t -83.38 -24.94 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 110.051 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 1.5 t -79.68 -47.72 14.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.0 109.959 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.541 ' O ' ' NE2' ' A' ' 112' ' ' HIS . 0.8 OUTLIER -69.72 -18.59 63.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.752 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.92 -22.22 46.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 110.257 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.4 -56.24 24.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 110.182 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.707 ' CG ' ' H ' ' A' ' 113' ' ' LEU . 9.4 p80 -72.48 -61.93 1.63 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.098 -1.001 . . . . 0.0 109.469 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.707 ' H ' ' CG ' ' A' ' 112' ' ' HIS . 0.0 OUTLIER -119.73 121.43 29.84 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.3 175.7 7.38 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.422 2.081 . . . . 0.0 112.99 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.654 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -45.36 -54.96 6.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.632 -0.668 . . . . 0.0 109.346 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.654 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 26.1 mt-10 122.9 -2.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.468 ' CG ' ' C ' ' A' ' 116' ' ' GLU . 1.8 m-85 72.22 32.88 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.714 -0.616 . . . . 0.0 111.278 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.772 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.3 p -97.59 121.27 58.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.895 -1.128 . . . . 0.0 108.16 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.62 24.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.934 1.756 . . . . 0.0 112.502 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -150.38 -32.41 0.18 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.981 -1.074 . . . . 0.0 110.401 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.635 ' H ' ' HG1' ' A' ' 118' ' ' THR . 12.0 p -53.92 -50.04 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.04 -1.037 . . . . 0.0 110.329 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 23.2 m-70 -54.84 -44.98 74.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.36 -20.05 32.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 110.375 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 120' ' ' ALA . 94.0 p -52.19 -52.97 48.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.945 . . . . 0.0 110.545 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.5 mt -84.11 -19.34 34.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.0 109.975 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.71 -51.83 9.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.296 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.63 ' HZ3' ' CB ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -78.63 -43.06 27.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.978 -1.076 . . . . 0.0 110.151 -179.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.485 ' CD2' ' CD1' ' A' ' 2' ' ' LEU . 33.9 t80 -50.59 -21.39 1.52 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.858 -1.151 . . . . 0.0 108.929 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 133' ' ' SER . 17.4 mt -73.78 -18.26 60.99 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -60.14 -35.48 75.37 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 97.5 p -80.78 -27.02 36.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -84.73 -30.13 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 129' ' ' LEU . 51.6 m -79.17 -40.83 29.89 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 53.2 m -69.3 -26.4 64.71 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.4 t -81.49 -30.28 10.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.515 ' C ' ' HG ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -71.09 -23.34 62.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.365 -0.834 . . . . 0.0 109.052 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 138' ' ' SER . 37.8 p -87.29 -18.39 30.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 0.0 109.568 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' THR . 21.6 m . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.449 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 82.0 t60 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.169 0.509 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.623 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -135.99 179.64 6.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 0.0 109.006 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 7' ' ' GLU . 7.3 p -76.15 132.55 73.4 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.104 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -41.28 -24.71 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.343 2.029 . . . . 0.0 112.457 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.2 -21.76 25.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.876 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' B' ' 4' ' ' THR . 32.2 tt0 -80.45 -63.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.959 . . . . 0.0 109.932 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' B' ' 12' ' ' THR . 24.2 pttt -62.25 -31.69 72.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 110.051 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.2 t -44.57 -23.35 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.0 110.406 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -81.59 -57.35 3.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.945 -1.097 . . . . 0.0 110.102 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.74 -24.62 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.094 -1.003 . . . . 0.0 108.318 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 12.5 m -71.95 -42.07 67.01 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.339 0.59 . . . . 0.0 109.88 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.75 -30.46 69.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.344 -0.848 . . . . 0.0 109.802 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -50.28 -18.83 0.67 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.97 . . . . 0.0 109.349 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -53.08 -51.48 61.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.15 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.09 -32.41 35.32 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -46.7 13.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -1.084 . . . . 0.0 109.177 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.99 114.85 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.732 . . . . 0.0 109.853 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' B' ' 21' ' ' ASP . 19.1 m120 -79.41 71.58 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 108.748 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -46.98 -11.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.851 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' B' ' 19' ' ' ASN . 16.5 m-20 -73.45 -5.5 40.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 109.821 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -156.26 -40.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.119 -0.988 . . . . 0.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 78.0 t -46.5 -55.42 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.883 . . . . 0.0 109.64 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.76 -29.83 50.71 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.51 -30.05 69.27 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.92 -31.41 59.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.221 -1.164 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.17 -54.28 48.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.514 ' CD2' ' N ' ' B' ' 28' ' ' LEU . 3.8 mm? -61.87 -40.1 94.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.273 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.92 -42.91 76.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -72.69 -37.08 67.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -1.122 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 tp -50.07 -31.7 13.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.265 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.28 -22.47 38.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.04 -64.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.627 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -22.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.422 -0.799 . . . . 0.0 109.663 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -140.25 79.17 21.94 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 109.559 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' B' ' 39' ' ' GLN . 79.3 Cg_endo -83.48 -12.45 8.99 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.888 2.392 . . . . 0.0 112.369 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . 0.53 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 3.4 p-90 -48.57 -33.99 10.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.523 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.53 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 3.2 m -78.95 2.65 19.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . 0.444 ' O ' ' OE1' ' B' ' 39' ' ' GLN . 1.4 tm0? -65.53 -19.08 65.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -68.59 -40.84 80.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.751 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -93.04 -18.96 22.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.956 . . . . 0.0 109.749 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.555 ' CE1' ' CE1' ' B' ' 45' ' ' PHE . 1.3 t80 -89.87 28.71 1.3 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -84.48 -13.97 50.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.614 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -80.2 -7.51 59.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.619 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.555 ' CE1' ' CE1' ' B' ' 42' ' ' PHE . 33.7 m-85 -83.65 -3.53 57.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.511 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.99 -172.77 25.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' B' ' 47' ' ' ASP . 2.0 p-10 -84.79 98.37 10.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -1.153 . . . . 0.0 109.42 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.511 ' N ' ' CD1' ' B' ' 48' ' ' LEU . 7.2 mp -88.0 30.8 0.82 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 108.972 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -45.05 -30.87 1.15 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 109.934 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -142.37 138.15 16.24 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -41.28 -28.4 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.406 2.071 . . . . 0.0 112.279 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.95 -39.79 49.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.93 -19.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.86 . . . . 0.0 109.603 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.1 -63.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.651 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -51.39 -20.0 1.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 109.741 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.07 -31.63 38.31 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.16 132.83 95.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -1.191 . . . . 0.0 109.357 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.31 -50.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.46 2.107 . . . . 0.0 112.551 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.04 -34.98 72.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.987 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -55.23 -49.88 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.033 -1.042 . . . . 0.0 109.217 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.473 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 26.2 mtmt -73.63 -29.33 62.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.289 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.92 -46.34 68.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -54.34 -25.28 23.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.553 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -32.35 83.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 0.4 OUTLIER -62.75 -36.91 84.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -1.198 . . . . 0.0 109.308 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -75.74 -35.05 60.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.354 -0.841 . . . . 0.0 109.417 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.03 -63.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.334 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tt -53.61 -32.94 53.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 108.91 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.83 -57.1 20.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.32 79.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -1.137 . . . . 0.0 109.447 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -67.2 -35.09 78.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.484 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 61.7 p -73.82 -35.69 64.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.409 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.49 -21.29 0.53 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.347 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.17 -60.08 4.66 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.47 ' H ' HD13 ' B' ' 75' ' ' LEU . 5.1 mp -53.47 -28.9 33.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -1.133 . . . . 0.0 109.254 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.75 3.49 41.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.495 ' C ' ' H ' ' B' ' 79' ' ' ASP . 23.5 t-80 -170.43 61.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.632 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 59.1 mt -73.72 15.16 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 109.327 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' B' ' 77' ' ' HIS . 16.8 t70 -76.43 -36.05 58.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.873 . . . . 0.0 109.513 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -161.55 100.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.377 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 33.7 mt -79.31 -50.19 11.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.362 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.438 ' HZ2' ' CG ' ' B' ' 143' ' ' HIS . 24.6 mmtp -48.41 -23.95 1.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.11 -63.31 3.69 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.3 t -63.9 -48.07 78.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -1.13 . . . . 0.0 109.493 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.555 ' N ' ' CG2' ' B' ' 84' ' ' THR . 46.9 m-85 -63.64 -8.5 10.21 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.538 -0.726 . . . . 0.0 109.348 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.32 -34.75 34.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 109.366 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 28.4 p -83.99 -50.99 7.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.09 -55.54 31.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.174 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' SER . . . . . 0.491 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 1.5 m -51.51 -39.02 56.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.365 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' B' ' 94' ' ' ASP . 29.0 tt0 -74.25 -54.58 7.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 tt -62.46 -29.36 70.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.718 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' B' ' 97' ' ' HIS . 1.3 m80 -79.32 -48.41 14.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 110.001 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 89' ' ' SER . 6.5 m -82.91 -31.08 27.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.032 . . . . 0.0 110.386 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' B' ' 90' ' ' GLU . 6.4 t70 -86.75 -43.47 12.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.084 -1.01 . . . . 0.0 110.937 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -52.33 5.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 110.733 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.648 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 4.1 mm? -82.85 -43.49 16.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.868 -1.145 . . . . 0.0 109.528 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 1.069 ' CD2' HG23 ' C' ' 41' ' ' THR . 0.0 OUTLIER 74.85 19.77 2.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 109.637 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' B' ' 97' ' ' HIS . 8.8 t -45.18 122.1 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 109.449 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 0.509 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 15.4 m-20 -69.05 151.34 97.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' B' ' 99' ' ' ASP . 74.5 Cg_exo -42.84 178.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.626 2.217 . . . . 0.0 112.369 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 57.58 64.75 1.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.839 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' B' ' 99' ' ' ASP . 73.2 m-20 -161.92 -52.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -0.86 . . . . 0.0 109.308 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -67.01 -26.01 66.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 39.5 ttt-85 -78.61 -25.7 45.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.515 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.89 -45.65 49.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.641 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 tt -49.48 -45.99 47.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.415 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.42 -48.82 64.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 30.1 m120 -50.25 -44.27 53.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -1.153 . . . . 0.0 109.737 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.95 -35.4 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.748 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tp -63.35 -38.8 92.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 109.669 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 66.3 t -51.34 -30.52 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.95 . . . . 0.0 109.693 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.26 -59.26 2.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.621 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 t -46.14 -28.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.816 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 mt -82.51 -53.23 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.593 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.464 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -65.31 -19.44 65.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.696 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -62.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 109.655 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -77.16 -48.36 17.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.892 . . . . 0.0 109.803 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.8 30.13 1.64 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.714 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -54.94 -27.82 46.04 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -64.55 7.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -1.111 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' B' ' 119' ' ' GLY . 61.1 mm-40 -133.12 6.82 3.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.41 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.556 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.3 34.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.52 ' H ' ' C ' ' B' ' 121' ' ' GLU . 2.9 p -45.02 148.99 0.91 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.463 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.5 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.4 Cg_exo -44.33 -54.07 4.3 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.449 2.099 . . . . 0.0 112.769 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 21.1 Cg_endo -61.37 -48.16 10.28 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.057 1.838 . . . . 0.0 111.975 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.511 ' CG2' ' HG1' ' B' ' 123' ' ' THR . 73.9 t -55.6 -13.03 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . 1.052 ' CG ' ' NH1' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -82.45 -59.94 2.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.606 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.821 ' HB1' ' HB3' ' A' ' 34' ' ' LEU . . . -66.46 -26.53 67.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.928 . . . . 0.0 109.504 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.76 26.38 0.83 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.499 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.46 -61.25 1.42 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.382 -0.824 . . . . 0.0 109.368 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . 0.704 ' OE1' ' OG ' ' A' ' 35' ' ' SER . 26.0 mp0 -53.62 -36.36 61.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.632 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -69.44 -25.11 63.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 109.567 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 63.6 t -77.35 -43.59 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.512 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.65 -17.05 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.628 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.39 -28.93 70.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.31 -36.57 59.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 77.5 t -75.17 -36.49 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -1.092 . . . . 0.0 109.444 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.25 -38.92 55.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.915 . . . . 0.0 109.468 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' B' ' 143' ' ' HIS . 9.9 m120 -85.18 -21.31 29.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.731 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.62 -55.52 33.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.114 -0.991 . . . . 0.0 109.478 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 41.5 mt -61.64 -24.68 66.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' B' ' 145' ' ' TYR . . . -100.27 1.71 41.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.403 -0.811 . . . . 0.0 109.412 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 139' ' ' ASN . 71.2 t60 -80.8 -1.78 44.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.0 109.466 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' B' ' 146' ' ' HIS . 5.4 tppt? -120.73 -31.9 4.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.822 . . . . 0.0 109.889 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' B' ' 142' ' ' ALA . 0.1 OUTLIER -49.29 -10.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 109.933 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.523 ' H ' ' C ' ' B' ' 144' ' ' LYS . 4.9 m-70 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.662 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . 0.482 ' CD1' ' CD2' ' C' ' 128' ' ' PHE . 36.5 mt -121.2 -171.78 2.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.376 -0.827 . . . . 0.0 109.605 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.47 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.8 OUTLIER -97.75 -178.97 0.79 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.409 -0.807 . . . . 0.0 109.277 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 26.0 Cg_exo -60.97 -68.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.51 2.14 . . . . 0.0 112.329 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.464 ' O ' ' ND2' ' C' ' 9' ' ' ASN . . . -52.33 -36.17 52.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.794 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.614 ' CB ' ' HZ3' ' C' ' 127' ' ' LYS . 3.3 m-20 -44.2 -33.67 1.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 109.444 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -83.38 -60.13 2.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.841 . . . . 0.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.2 m -46.92 -29.75 2.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.355 -0.841 . . . . 0.0 109.94 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' C' ' 5' ' ' ALA . 23.1 m-20 -77.5 -36.69 52.37 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.985 -1.072 . . . . 0.0 108.233 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.19 -47.85 29.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -53.18 -38.58 62.93 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.49 -63.05 1.44 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.443 -0.785 . . . . 0.0 109.36 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.22 67.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.851 . . . . 0.0 109.286 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.98 -17.24 61.48 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.417 -0.802 . . . . 0.0 108.892 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.69 -39.98 59.39 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -84.73 -49.77 8.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.521 -0.988 . . . . 0.0 109.333 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' C' ' 18' ' ' GLY . 71.1 t -60.06 -34.99 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.504 -0.747 . . . . 0.0 109.639 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.623 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . -31.56 144.79 0.02 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . 69.16 -32.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -1.101 . . . . 0.0 108.874 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.623 ' H ' ' C ' ' C' ' 18' ' ' GLY . 1.2 m80 -104.96 13.83 30.38 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.52 -48.8 9.89 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.82 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -14.72 42.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -89.07 -56.6 3.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -1.137 . . . . 0.0 109.706 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.636 ' CZ ' ' CE1' ' C' ' 112' ' ' HIS . 2.9 m-30 -59.01 -33.13 70.38 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.424 -0.798 . . . . 0.0 109.191 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.73 -33.19 76.64 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.89 -50.83 10.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.168 -1.195 . . . . 0.0 109.828 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -52.4 -19.76 2.38 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.61 -25.53 65.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 33.2 mt -72.15 -58.09 3.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.744 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -61.57 -14.42 29.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.086 -1.009 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 1.063 ' NH1' ' CG ' ' D' ' 127' ' ' GLN . 1.9 tpm_? -75.41 -39.05 59.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.344 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' MET . . . . . 0.502 ' O ' ' N ' ' C' ' 34' ' ' LEU . 0.0 OUTLIER -79.98 -48.51 13.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.193 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' C' ' 32' ' ' MET . 36.6 t80 -43.78 -19.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.338 -0.851 . . . . 0.0 109.782 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.828 ' HB3' ' HB1' ' D' ' 128' ' ' ALA . 10.9 mt -79.85 -60.23 2.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.755 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.711 ' OG ' ' OE1' ' D' ' 131' ' ' GLN . 30.0 m -81.27 -31.48 33.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.891 . . . . 0.0 109.698 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -113.57 95.0 34.86 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.439 -0.788 . . . . 0.0 109.424 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.18 -20.01 8.88 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.435 2.09 . . . . 0.0 112.224 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' THR . . . . . 0.459 ' O ' ' N ' ' C' ' 40' ' ' LYS . 70.7 p -47.69 -42.07 24.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 109.253 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.405 ' C ' ' O ' ' C' ' 38' ' ' THR . 12.9 p -44.1 -22.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.813 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' C' ' 38' ' ' THR . 30.5 ttpt -70.94 -19.18 62.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.61 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 1.069 HG23 ' CD2' ' B' ' 97' ' ' HIS . 8.5 t . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.593 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.282 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.524 ' C ' ' H ' ' C' ' 48' ' ' LEU . 2.1 p90 -142.48 44.89 1.63 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.444 -1.41 . . . . 0.0 110.095 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.05 -35.22 0.3 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 110.448 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' C' ' 46' ' ' PHE . 1.0 OUTLIER 61.72 55.84 2.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.02 -1.05 . . . . 0.0 109.097 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' C' ' 48' ' ' LEU . 48.0 m -165.35 157.01 14.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.992 -1.067 . . . . 0.0 109.534 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.498 ' C ' ' H ' ' C' ' 52' ' ' SER . 2.7 m-70 -59.48 160.87 6.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.375 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.71 -18.14 1.91 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.555 ' C ' ' H ' ' C' ' 54' ' ' GLN . 30.6 p -48.66 -25.9 2.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -1.158 . . . . 0.0 109.395 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . 66.97 -40.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.748 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.555 ' H ' ' C ' ' C' ' 52' ' ' SER . 20.4 mt-30 -69.73 -23.79 63.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.295 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.64 -40.51 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.915 . . . . 0.0 109.133 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -65.7 -54.42 27.69 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.307 -0.87 . . . . 0.0 108.656 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.17 -36.12 21.08 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.488 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.1 t-80 -60.54 -36.5 78.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.957 -1.319 . . . . 0.0 109.874 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.36 -29.33 37.91 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 56.8 mttm -65.07 -23.67 67.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -1.207 . . . . 0.0 110.268 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.18 -58.18 4.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.999 -1.063 . . . . 0.0 108.591 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 72.8 t -56.49 -44.71 81.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.579 -0.7 . . . . 0.0 109.299 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.93 -41.6 74.38 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.24 -0.912 . . . . 0.0 109.21 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 7.9 t70 -65.88 -38.1 87.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.13 -0.981 . . . . 0.0 108.493 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -67.5 -53.43 28.7 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' C' ' 70' ' ' VAL . 1.0 OUTLIER -58.49 -42.25 87.14 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.431 ' O ' ' N ' ' C' ' 71' ' ' ALA . 15.7 m -69.64 -51.67 32.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.888 . . . . 0.0 108.731 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -62.22 -25.95 68.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 108.537 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.11 -46.4 11.17 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' C' ' 66' ' ' LEU . 38.2 t -66.56 -22.85 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -69.56 -36.3 76.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.587 ' O ' ' N ' ' C' ' 74' ' ' ASP . 26.1 m80 -103.32 -66.69 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.609 -0.682 . . . . 0.0 109.443 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' C' ' 72' ' ' HIS . 14.8 p 44.42 14.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.954 0.883 . . . . 0.0 109.323 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' C' ' 72' ' ' HIS . 5.5 m-20 -137.99 12.07 2.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.78 31.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.139 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 3.5 ptt? -78.27 -23.66 0.42 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 111.849 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.8 Cg_exo -53.6 -19.35 13.76 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.705 1.604 . . . . 0.0 112.5 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -94.25 -40.44 9.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.08 -1.012 . . . . 0.0 109.741 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.73 -48.88 67.81 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.248 -0.908 . . . . 0.0 109.36 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.58 6.03 6.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 109.298 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 34.1 t -54.48 -19.59 6.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 109.602 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -83.16 -58.52 2.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 109.891 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' C' ' 82' ' ' ALA . 3.8 mt -45.32 -44.69 11.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.424 -0.797 . . . . 0.0 109.068 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' SER . . . . . 0.52 ' HG ' ' C ' ' C' ' 136' ' ' LEU . 23.3 t -59.96 -18.93 49.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -0.775 . . . . 0.0 109.536 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' C' ' 89' ' ' HIS . 36.7 t70 -81.11 -50.9 9.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.95 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 4.6 tt -64.15 -26.71 68.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.89 . . . . 0.0 110.068 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.79 -21.78 26.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.312 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.47 -11.26 11.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.141 -0.975 . . . . 0.0 110.172 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . 0.56 ' N ' ' O ' ' C' ' 85' ' ' ASP . 42.4 t60 -106.51 -74.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.958 . . . . 0.0 109.996 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' C' ' 92' ' ' ARG . 79.7 mttt -63.74 -110.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 110.077 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 14.1 mt -44.45 -17.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.346 -0.846 . . . . 0.0 110.009 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' C' ' 90' ' ' LYS . 31.8 ttm-85 46.84 41.47 10.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.138 -0.977 . . . . 0.0 109.492 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 70.1 t -45.91 144.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.694 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' C' ' 97' ' ' ASN . 10.7 m-20 -80.68 150.29 69.43 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.71 -19.49 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.384 2.056 . . . . 0.0 112.22 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.31 -7.71 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.357 -0.84 . . . . 0.0 109.752 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' C' ' 94' ' ' ASP . 12.8 m120 -79.71 -36.25 37.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.475 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -46.35 -41.56 13.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.896 -1.127 . . . . 0.0 109.569 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.48 ' CB ' ' NZ ' ' C' ' 99' ' ' LYS . 8.0 mtmp? -51.39 -28.25 12.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.238 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.468 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 15.4 mt -84.31 -61.8 1.72 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.719 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tp -49.92 -23.65 2.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.796 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -73.28 -49.47 27.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.906 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -80.68 -26.41 37.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.862 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 65.3 m -64.95 -60.37 3.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.167 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' C' ' 105' ' ' LEU . 0.9 OUTLIER -57.51 -22.38 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 109.827 -179.402 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.08 -31.47 39.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.879 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 57.0 t -83.32 -24.91 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.042 -1.036 . . . . 0.0 110.094 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' C' ' 109' ' ' LEU . 1.5 t -79.79 -47.68 14.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.06 -1.025 . . . . 0.0 109.919 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.55 ' N ' ' CG2' ' C' ' 108' ' ' THR . 0.8 OUTLIER -69.77 -18.51 63.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 109.762 -179.583 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.95 -22.2 46.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 110.287 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.51 -56.16 25.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -0.995 . . . . 0.0 110.162 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . 0.708 ' CG ' ' H ' ' C' ' 113' ' ' LEU . 9.4 p80 -72.42 -61.85 1.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.016 . . . . 0.0 109.563 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.708 ' H ' ' CG ' ' C' ' 112' ' ' HIS . 0.0 OUTLIER -119.81 121.46 29.76 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.37 175.61 7.56 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.476 2.117 . . . . 0.0 112.932 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.649 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -45.22 -55.08 6.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.604 -0.685 . . . . 0.0 109.374 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.649 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 26.0 mt-10 122.98 -2.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 0.472 ' CG ' ' C ' ' C' ' 116' ' ' GLU . 1.8 m-85 72.23 32.86 1.64 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.708 -0.62 . . . . 0.0 111.259 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.772 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.3 p -97.54 121.26 58.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.927 -1.108 . . . . 0.0 108.231 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.55 24.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.059 1.839 . . . . 0.0 112.531 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -150.46 -32.31 0.18 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.928 -1.108 . . . . 0.0 110.46 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.62 ' H ' ' HG1' ' C' ' 118' ' ' THR . 11.9 p -54.03 -50.11 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 110.292 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.523 ' CE1' ' CB ' ' C' ' 115' ' ' ALA . 23.1 m-70 -54.71 -45.07 73.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.577 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.37 -20.02 32.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 110.267 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.549 ' N ' ' O ' ' C' ' 120' ' ' ALA . 93.6 p -52.22 -52.93 49.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.931 . . . . 0.0 110.615 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 5.5 mt -84.11 -19.24 34.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.081 -1.012 . . . . 0.0 110.047 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.76 -51.82 9.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.092 . . . . 0.0 110.333 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.614 ' HZ3' ' CB ' ' C' ' 6' ' ' ASP . 0.0 OUTLIER -78.68 -43.02 26.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.057 -1.027 . . . . 0.0 110.188 -179.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.482 ' CD2' ' CD1' ' C' ' 2' ' ' LEU . 33.7 t80 -50.5 -21.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 0.0 108.992 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' C' ' 133' ' ' SER . 17.4 mt -73.77 -18.26 60.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -60.14 -35.48 75.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 97.3 p -80.74 -27.09 36.94 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -84.71 -30.06 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.492 ' N ' ' O ' ' C' ' 129' ' ' LEU . 50.3 m -79.31 -40.78 29.54 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 53.3 m -69.31 -26.35 64.68 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.289 -0.882 . . . . 0.0 108.644 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 23.6 t -81.56 -30.19 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . 0.52 ' C ' ' HG ' ' C' ' 84' ' ' SER . 1.0 OUTLIER -71.26 -23.21 61.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.0 109.071 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 137' ' ' THR . . . . . 0.433 ' O ' ' O ' ' C' ' 138' ' ' SER . 38.3 p -87.28 -18.43 30.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.21 -0.931 . . . . 0.0 109.552 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 138' ' ' SER . . . . . 0.433 ' O ' ' O ' ' C' ' 137' ' ' THR . 21.7 m . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.433 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 82.1 t60 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.17 0.51 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.63 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -135.94 179.73 6.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 108.982 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.466 ' O ' ' N ' ' D' ' 7' ' ' GLU . 7.3 p -76.16 132.42 73.61 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.153 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -41.19 -24.75 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.369 2.046 . . . . 0.0 112.446 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.14 -21.84 25.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.927 . . . . 0.0 109.874 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' D' ' 4' ' ' THR . 32.2 tt0 -80.36 -63.09 1.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.097 -1.002 . . . . 0.0 109.938 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.491 ' O ' ' OG1' ' D' ' 12' ' ' THR . 24.1 pttt -62.38 -31.63 72.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.008 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.2 t -44.55 -23.44 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -81.57 -57.34 3.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.019 -1.051 . . . . 0.0 110.11 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.76 -24.64 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.055 -1.028 . . . . 0.0 108.256 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 12.6 m -71.91 -42.15 67.06 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.347 0.594 . . . . 0.0 109.852 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.77 -30.38 69.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.868 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -50.32 -18.79 0.67 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.95 . . . . 0.0 109.33 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -53.18 -51.39 62.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 0.0 109.158 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.09 -32.47 35.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 -46.68 14.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -1.098 . . . . 0.0 109.214 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 69.6 t -59.02 114.91 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.546 -0.721 . . . . 0.0 109.842 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' D' ' 21' ' ' ASP . 19.0 m120 -79.43 71.58 6.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 108.742 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 57.2 t -46.99 -11.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.89 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' D' ' 19' ' ' ASN . 16.5 m-20 -73.51 -5.35 39.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 109.847 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -156.31 -40.35 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 109.577 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -46.4 -55.54 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.0 109.66 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.72 -29.85 50.42 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.53 -29.93 69.34 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.94 -31.46 59.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -1.11 . . . . 0.0 109.467 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.11 -54.32 48.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . 0.496 ' N ' ' CD2' ' D' ' 28' ' ' LEU . 3.8 mm? -61.9 -40.06 94.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.935 . . . . 0.0 109.26 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.98 -42.78 76.31 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 60.2 mmt-85 -72.74 -36.97 67.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -1.098 . . . . 0.0 109.481 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 65.2 tp -50.12 -31.72 14.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.32 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.18 -22.59 38.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.625 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.97 -64.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.578 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -64.11 -22.69 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -0.828 . . . . 0.0 109.644 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -140.31 79.22 21.56 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -83.49 -12.42 8.98 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.865 2.377 . . . . 0.0 112.36 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . 0.524 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 3.3 p-90 -48.62 -33.95 10.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.586 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.524 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 3.2 m -78.96 2.59 19.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.509 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' D' ' 39' ' ' GLN . 1.4 tm0? -65.48 -19.08 65.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . 1.568 HH21 ' CG ' ' A' ' 92' ' ' ARG . 32.9 mtp85 -68.49 -40.94 80.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.746 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -93.03 -18.98 22.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' D' ' 45' ' ' PHE . 1.3 t80 -89.86 28.56 1.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 109.44 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -84.39 -13.99 50.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.351 -0.843 . . . . 0.0 109.608 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -80.12 -7.59 58.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.602 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' D' ' 42' ' ' PHE . 33.5 m-85 -83.68 -3.44 57.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.483 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.03 -172.78 25.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' D' ' 47' ' ' ASP . 1.9 p-10 -84.81 98.39 10.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.125 . . . . 0.0 109.339 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' D' ' 48' ' ' LEU . 7.2 mp -88.0 30.85 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 108.956 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -45.0 -30.96 1.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 109.89 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 6.7 p -142.35 138.2 16.29 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -41.2 -28.45 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.423 2.082 . . . . 0.0 112.362 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . 0.4 ' C ' ' N ' ' D' ' 54' ' ' VAL . 12.0 t70 -76.96 -39.81 49.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.0 109.578 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.8 -19.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.355 -0.84 . . . . 0.0 109.653 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . 0.4 ' N ' ' C ' ' D' ' 52' ' ' ASP . 45.8 t -67.06 -63.87 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.656 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -51.48 -19.92 1.63 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.757 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.0 -31.75 38.23 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.18 132.74 95.19 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.232 -1.157 . . . . 0.0 109.318 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.26 -50.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.447 2.098 . . . . 0.0 112.523 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.05 -34.93 72.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.967 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -55.34 -49.88 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.032 . . . . 0.0 109.193 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . 0.486 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 26.2 mtmt -73.6 -29.34 62.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.169 -0.957 . . . . 0.0 109.277 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.31 68.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.449 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -54.39 -25.36 24.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.25 83.1 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 0.4 OUTLIER -62.88 -36.79 84.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.183 -1.186 . . . . 0.0 109.274 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -75.76 -35.1 60.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 109.344 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.03 -63.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.285 -0.885 . . . . 0.0 109.324 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tt -53.75 -32.81 53.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 108.898 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.93 -56.98 21.07 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.81 -42.25 79.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -1.085 . . . . 0.0 109.455 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . 0.405 ' O ' ' CD1' ' D' ' 71' ' ' PHE . 3.0 t80 -67.24 -35.12 78.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 62.2 p -73.78 -35.61 64.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.63 -21.16 0.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.908 . . . . 0.0 109.361 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.13 -60.12 4.65 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.486 ' H ' HD13 ' D' ' 75' ' ' LEU . 5.1 mp -53.46 -28.9 32.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -1.161 . . . . 0.0 109.25 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.78 3.5 41.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.486 ' C ' ' H ' ' D' ' 79' ' ' ASP . 23.5 t-80 -170.41 61.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.692 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 59.2 mt -73.69 15.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.257 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' D' ' 77' ' ' HIS . 16.8 t70 -76.38 -36.02 58.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.216 -0.927 . . . . 0.0 109.522 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -161.61 100.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 109.401 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 33.2 mt -79.21 -50.23 11.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . 0.437 ' HZ2' ' CG ' ' D' ' 143' ' ' HIS . 24.6 mmtp -48.41 -23.92 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.08 -63.27 3.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.3 t -63.94 -48.11 77.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -1.14 . . . . 0.0 109.397 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' D' ' 84' ' ' THR . 46.6 m-85 -63.61 -8.5 10.11 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.435 -0.79 . . . . 0.0 109.374 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.25 -34.86 34.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.394 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 27.9 p -83.96 -50.97 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 0.0 109.535 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' D' ' 92' ' ' HIS . 35.8 mt -56.11 -55.56 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 109.161 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 89' ' ' SER . . . . . 0.495 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 1.5 m -51.55 -38.91 56.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.323 -0.861 . . . . 0.0 109.44 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' D' ' 94' ' ' ASP . 29.1 tt0 -74.24 -54.64 7.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -62.49 -29.3 70.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.687 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' D' ' 97' ' ' HIS . 1.3 m80 -79.31 -48.35 14.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.97 . . . . 0.0 110.043 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' D' ' 89' ' ' SER . 6.6 m -82.97 -31.14 27.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.028 -1.045 . . . . 0.0 110.301 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' D' ' 90' ' ' GLU . 6.4 t70 -86.66 -43.52 12.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.065 -1.022 . . . . 0.0 110.901 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -52.25 5.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 0.0 110.732 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.63 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 4.1 mm? -82.98 -43.48 16.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.0 109.486 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 1.109 ' CD2' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER 74.81 19.77 2.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.427 -0.796 . . . . 0.0 109.727 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' D' ' 97' ' ' HIS . 8.6 t -45.11 122.24 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 109.471 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . 0.512 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 15.6 m-20 -69.18 151.46 97.05 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.41 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' D' ' 99' ' ' ASP . 75.7 Cg_exo -42.9 178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.631 2.22 . . . . 0.0 112.414 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 57.52 64.76 1.5 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 109.569 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' D' ' 99' ' ' ASP . 73.1 m-20 -161.92 -52.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.41 -0.806 . . . . 0.0 109.263 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -66.96 -25.96 66.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . 0.417 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 39.3 ttt-85 -78.53 -25.76 45.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.91 -45.7 49.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.915 . . . . 0.0 109.605 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 tt -49.39 -46.07 46.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.4 -48.83 64.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 30.1 m120 -50.22 -44.26 53.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -1.172 . . . . 0.0 109.739 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.04 -35.27 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.757 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tp -63.41 -38.8 92.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.662 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 66.8 t -51.37 -30.52 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.676 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.22 -59.38 2.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.615 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 29.3 t -46.17 -27.91 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.833 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 17.0 mt -82.66 -53.12 6.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.527 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.454 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -65.38 -19.43 65.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.639 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.08 -62.84 1.25 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.689 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -77.26 -48.3 17.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.823 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -92.8 30.21 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.751 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -55.05 -27.73 46.51 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -64.65 7.09 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -1.136 . . . . 0.0 109.598 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' D' ' 119' ' ' GLY . 61.0 mm-40 -133.14 6.87 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 109.434 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.538 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -73.32 34.8 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.427 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.528 ' HG1' ' CG2' ' D' ' 126' ' ' VAL . 2.9 p -44.87 148.96 0.88 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.339 -0.85 . . . . 0.0 109.504 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.492 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -44.36 -54.04 4.34 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.437 2.091 . . . . 0.0 112.78 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 21.2 Cg_endo -61.35 -48.25 10.11 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.934 1.756 . . . . 0.0 112.0 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . 0.528 ' CG2' ' HG1' ' D' ' 123' ' ' THR . 72.8 t -55.48 -13.02 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -0.839 . . . . 0.0 109.518 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . 1.063 ' CG ' ' NH1' ' C' ' 31' ' ' ARG . 0.7 OUTLIER -82.47 -59.87 2.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.646 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 0.828 ' HB1' ' HB3' ' C' ' 34' ' ' LEU . . . -66.56 -26.52 67.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.435 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.78 26.44 0.83 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.47 -61.36 1.41 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.295 -0.878 . . . . 0.0 109.303 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . 0.711 ' OE1' ' OG ' ' C' ' 35' ' ' SER . 26.1 mp0 -53.56 -36.37 61.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.671 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -69.47 -25.13 63.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 64.4 t -77.27 -43.66 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.581 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.61 -17.1 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.36 -28.95 70.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.541 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -36.43 59.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 76.4 t -75.24 -36.47 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -1.153 . . . . 0.0 109.456 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.22 -38.91 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' D' ' 143' ' ' HIS . 9.9 m120 -85.21 -21.3 29.18 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.21 -0.931 . . . . 0.0 109.758 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.69 -55.52 33.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.514 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.52 -24.77 66.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.277 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' D' ' 145' ' ' TYR . . . -100.29 1.79 42.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 109.378 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . 0.527 ' N ' ' O ' ' D' ' 139' ' ' ASN . 71.2 t60 -80.91 -1.68 44.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.453 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' D' ' 146' ' ' HIS . 5.4 tppt? -120.75 -32.04 4.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' D' ' 142' ' ' ALA . 0.1 OUTLIER -49.12 -10.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.233 -0.917 . . . . 0.0 109.888 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' D' ' 144' ' ' LYS . 4.9 m-70 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.656 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.4 tp -171.74 145.51 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 109.634 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.6 168.29 20.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 109.319 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 5' ' ' ALA . 55.7 Cg_endo -73.13 -61.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.618 2.212 . . . . 0.0 112.666 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 4' ' ' PRO . . . -45.26 -38.27 5.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.934 . . . . 0.0 109.673 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 5' ' ' ALA . 4.8 m-20 -44.52 -28.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 108.977 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 10' ' ' VAL . 76.8 mttt -83.06 -60.33 2.19 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.437 -0.789 . . . . 0.0 109.093 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.1 m -46.37 -31.61 2.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.471 -0.768 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -76.72 -35.85 57.55 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 7' ' ' LYS . 4.4 t -73.58 -50.25 31.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -49.15 -42.79 40.75 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.4 -63.57 1.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.257 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.37 -39.05 69.63 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 109.178 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.43 ' NE1' ' OG1' ' A' ' 67' ' ' THR . 0.1 OUTLIER -71.31 -17.19 62.47 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.044 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.26 -46.23 7.66 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -70.67 -34.61 72.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.146 . . . . 0.0 108.742 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.1 t -63.02 -66.03 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 60.84 -140.82 48.08 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 20' ' ' HIS . . . -66.7 49.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.434 -1.039 . . . . 0.0 110.194 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.444 ' N ' ' O ' ' A' ' 18' ' ' GLY . 80.0 m-70 -153.75 19.64 0.53 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -83.8 -62.87 1.46 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.701 -0.624 . . . . 0.0 109.781 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.2 -14.45 0.16 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 21' ' ' ALA . 3.4 mm-40 -86.71 -56.47 3.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -1.132 . . . . 0.0 109.744 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.9 m-30 -55.38 -52.23 64.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 109.159 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.14 -22.79 14.58 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.67 -45.4 52.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -1.129 . . . . 0.0 109.702 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.518 ' OE1' ' NE2' ' A' ' 112' ' ' HIS . 94.9 mt-10 -65.69 -19.83 66.05 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.509 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.58 -24.5 60.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.381 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.3 mt -65.81 -41.23 92.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.735 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -75.68 -12.54 60.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.09 -1.006 . . . . 0.0 109.739 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -78.93 -47.36 16.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 0.0 110.155 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptm -65.74 -26.35 67.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.007 -1.058 . . . . 0.0 109.683 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.37 -36.45 82.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.101 -0.999 . . . . 0.0 109.436 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.703 ' HB3' ' HB1' ' B' ' 128' ' ' ALA . 12.1 mt -85.66 -44.88 12.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.708 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 40.2 t -51.5 -19.61 1.52 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.824 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' A' ' 35' ' ' SER . 60.1 m-85 -160.92 90.23 1.61 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.001 . . . . 0.0 109.733 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 39' ' ' THR . 52.4 Cg_exo -50.28 -26.15 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.594 2.196 . . . . 0.0 112.158 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.407 HG21 ' CB ' ' D' ' 97' ' ' HIS . 10.8 p -47.54 -18.51 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 37' ' ' PRO . 22.1 p -76.47 -22.89 53.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.273 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -74.22 -31.74 62.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.88 . . . . 0.0 109.84 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 1.247 ' CG2' ' CE1' ' D' ' 97' ' ' HIS . 14.3 t . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.333 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.546 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 21.7 p80 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.558 0.694 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.714 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -166.63 75.49 0.18 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.621 ' C ' ' O ' ' A' ' 46' ' ' PHE . 20.8 m-20 -8.8 -54.67 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.028 -0.42 . . . . 0.0 111.522 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.714 ' N ' ' O ' ' A' ' 46' ' ' PHE . 5.7 mt 56.71 4.81 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.244 -0.91 . . . . 0.0 109.386 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 47' ' ' ASP . 33.3 t -73.24 19.0 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.242 -0.911 . . . . 0.0 109.362 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.522 ' H ' ' C ' ' A' ' 48' ' ' LEU . 6.6 t-80 58.86 156.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.06 15.33 1.46 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.7 t -72.59 -21.27 61.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 109.403 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 55' ' ' VAL . . . 67.5 -50.62 0.5 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.709 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.494 HE22 ' CG ' ' A' ' 47' ' ' ASP . 15.8 pt20 -45.37 -17.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.684 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 53' ' ' ALA . 77.9 t -73.84 -32.85 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.83 -24.82 67.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.641 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.15 -51.1 40.94 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 24.7 t-80 -67.82 -27.81 67.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.13 -1.217 . . . . 0.0 110.282 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.22 -31.05 79.39 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 16.9 mtpp -71.79 -23.63 61.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -1.157 . . . . 0.0 110.146 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -66.8 -58.1 5.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.124 -0.985 . . . . 0.0 108.644 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.8 t -55.2 -48.94 75.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.544 -0.723 . . . . 0.0 109.238 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -64.23 -42.57 96.5 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.23 -0.919 . . . . 0.0 108.959 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.5 t70 -72.02 -25.63 61.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.806 . . . . 0.0 109.056 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . -80.65 -44.74 18.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.475 ' O ' ' CD1' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -76.57 -27.35 55.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.568 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 63' ' ' ALA . 52.8 m -75.92 -44.62 39.37 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -57.41 -20.81 32.32 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.24 -45.88 12.42 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.0 t -59.62 -22.63 23.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -65.39 -15.25 62.39 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.568 ' O ' ' N ' ' A' ' 74' ' ' ASP . 31.6 m80 -153.04 -51.75 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.403 -0.811 . . . . 0.0 109.353 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.631 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.9 p 44.56 15.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.977 0.894 . . . . 0.0 109.32 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 72' ' ' HIS . 95.9 m-20 -134.3 10.57 3.81 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 31.1 t70 -175.23 27.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.14 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.1 ptt? -78.59 -24.19 0.43 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.47 -0.769 . . . . 0.0 111.829 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.3 Cg_exo -52.9 -19.8 11.91 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.701 1.601 . . . . 0.0 112.634 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.448 ' ND2' ' N ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -94.21 -33.12 13.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.114 -0.991 . . . . 0.0 109.822 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.448 ' N ' ' ND2' ' A' ' 78' ' ' ASN . . . -74.6 -40.79 61.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.27 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.64 12.12 13.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.024 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 66.5 p -70.6 -16.21 62.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.655 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -82.07 -51.71 7.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.4 mt -44.89 -43.0 8.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.382 -0.824 . . . . 0.0 109.043 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.1 p -57.14 -22.07 37.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -72.54 -32.75 66.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.686 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 90' ' ' LYS . 7.0 tt -81.4 -29.18 34.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.417 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -89.9 -28.42 19.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 109.529 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 90' ' ' LYS . . . -83.9 -80.41 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.665 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 89' ' ' HIS . 30.4 t-80 -61.09 2.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.841 . . . . 0.0 109.61 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 88' ' ' ALA . 6.1 mtmm -156.15 152.29 27.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.289 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.647 ' C ' ' H ' ' A' ' 93' ' ' VAL . 10.9 mp 56.95 63.89 1.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 108.983 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.272 ' HB3' ' NH1' ' D' ' 40' ' ' ARG . 8.4 ptp180 -62.77 14.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.578 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.647 ' H ' ' C ' ' A' ' 91' ' ' LEU . 73.7 t -41.43 121.69 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -0.812 . . . . 0.0 109.631 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.11 147.81 2.29 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' A' ' 97' ' ' ASN . 37.9 Cg_endo -68.23 -10.66 29.63 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.486 2.124 . . . . 0.0 112.069 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.25 -1.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.716 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 95' ' ' PRO . 5.0 m120 -74.66 -42.34 58.65 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.084 -1.01 . . . . 0.0 109.808 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 2.2 m-85 -46.38 -42.05 14.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 0.0 109.275 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -58.1 -32.91 68.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.244 -0.91 . . . . 0.0 109.316 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 97' ' ' ASN . 11.1 mt -84.08 -62.28 1.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -50.22 -41.84 50.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 0.0 109.291 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 98' ' ' PHE . 39.4 m -63.26 -51.03 67.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -66.1 -26.82 67.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.513 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 96.6 m -63.51 -50.59 69.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.75 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.31 -43.02 22.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 106' ' ' LEU . 8.6 mp -64.17 -59.24 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.423 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.563 ' CG1' ' NE2' ' B' ' 127' ' ' GLN . 76.7 t -56.48 -30.99 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -75.7 -63.03 1.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.459 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 113' ' ' LEU . 13.1 mt -51.34 -30.65 19.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.0 109.495 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -47.43 -42.29 22.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.885 . . . . 0.0 109.679 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.11 -49.25 11.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.829 . . . . 0.0 109.787 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 27' ' ' GLU . 11.4 m170 -76.24 -69.98 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 109.868 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -110.96 97.05 32.57 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 109.054 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 113' ' ' LEU . 71.2 Cg_exo -47.31 -174.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.372 2.048 . . . . 0.0 112.879 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.67 -35.09 19.53 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.664 0.745 . . . . 0.0 109.574 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 3.8 mt-10 78.4 0.86 2.63 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.942 ' HD1' ' NH2' ' B' ' 30' ' ' ARG . 21.7 t80 65.3 37.56 6.32 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.639 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.749 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -93.97 115.07 64.69 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.82 -1.175 . . . . 0.0 107.953 178.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.737 ' HA ' HG13 ' B' ' 33' ' ' VAL . 50.4 Cg_exo -50.36 21.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.021 1.814 . . . . 0.0 112.553 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.749 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -147.07 -21.7 0.4 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.003 -1.061 . . . . 0.0 110.961 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.627 ' CG1' ' H ' ' A' ' 122' ' ' HIS . 10.5 p -58.13 -58.75 5.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.976 -1.078 . . . . 0.0 110.48 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.657 ' CD2' ' SG ' ' B' ' 112' ' ' CYS . 1.1 m-70 -71.03 -24.89 62.45 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.3 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.08 -20.74 32.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 128' ' ' PHE . 62.7 p -77.41 -63.19 1.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.248 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.46 -19.84 57.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.057 -1.027 . . . . 0.0 109.102 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.548 ' OD2' ' OH ' ' B' ' 35' ' ' TYR . 7.4 t70 -77.77 -51.18 10.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.482 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.28 -41.82 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.845 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 124' ' ' SER . 29.8 t80 -50.23 -22.88 1.92 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 109.037 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.0 mt -73.99 -24.76 59.64 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -56.77 -31.87 65.05 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 89.6 p -73.97 -32.56 63.51 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.37 -29.79 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 129' ' ' LEU . 9.9 p -81.92 -25.26 35.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.843 . . . . 0.0 108.913 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 36.8 m -74.91 -40.13 61.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.305 -0.872 . . . . 0.0 109.102 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.13 -21.79 17.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 108.782 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.75 -35.96 72.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.472 -0.767 . . . . 0.0 109.103 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 138' ' ' SER . 57.8 p -88.13 -2.3 58.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' THR . 28.3 m . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 109.471 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.671 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -136.41 -163.11 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 109.265 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.412 ' O ' ' N ' ' B' ' 6' ' ' GLU . 11.9 p -88.98 130.64 43.87 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.19 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.445 ' O ' ' OG ' ' B' ' 9' ' ' SER . 86.4 Cg_exo -42.05 -23.04 0.23 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.362 2.041 . . . . 0.0 112.271 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' B' ' 4' ' ' THR . 51.9 mt-10 -80.11 -54.26 5.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.812 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.42 -41.09 85.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.746 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.474 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.3 OUTLIER -68.54 -35.1 76.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.5 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 5' ' ' PRO . 4.9 m -60.68 -23.58 64.95 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.885 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.49 -57.58 3.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.11 -0.994 . . . . 0.0 109.809 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.76 -24.39 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 85.6 m -83.85 -35.2 24.37 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.345 0.593 . . . . 0.0 109.606 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.05 -29.27 67.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.386 -0.821 . . . . 0.0 109.791 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.1 -21.07 0.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.244 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . 0.402 ' HE1' ' HB2' ' B' ' 72' ' ' SER . 0.8 OUTLIER -53.54 -17.88 2.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.175 -0.953 . . . . 0.0 109.084 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.8 -33.31 46.97 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -89.82 -41.46 11.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -1.178 . . . . 0.0 109.361 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -57.22 114.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 109.833 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' B' ' 21' ' ' ASP . 7.4 m120 -84.3 68.41 10.18 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -43.88 -18.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.392 -0.817 . . . . 0.0 109.73 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' B' ' 19' ' ' ASN . 1.1 m-20 -62.39 -10.79 12.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.709 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -154.42 -35.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -0.995 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 72.3 t -48.74 -34.89 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.3 -25.9 68.87 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.97 -36.3 25.37 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -67.67 -30.7 70.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -1.114 . . . . 0.0 109.472 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.68 -54.53 45.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' B' ' 28' ' ' LEU . 9.9 mp -64.3 -55.76 19.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.399 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.03 -41.32 29.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . 0.942 ' NH2' ' HD1' ' A' ' 117' ' ' PHE . 73.5 mtt-85 -80.01 -34.64 38.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -1.144 . . . . 0.0 109.499 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 tp -47.11 -37.21 9.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 109.499 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' B' ' 36' ' ' PRO . 15.0 mt -81.32 -39.29 25.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.817 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.737 HG13 ' HA ' ' A' ' 119' ' ' PRO . 72.4 t -58.13 -61.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.12 -0.988 . . . . 0.0 109.442 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.636 HG13 ' HB3' ' A' ' 122' ' ' HIS . 1.7 t -68.69 -22.56 26.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.83 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.548 ' OH ' ' OD2' ' A' ' 126' ' ' ASP . 64.0 m-85 -146.75 76.47 11.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.776 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . 0.423 ' N ' ' O ' ' B' ' 32' ' ' LEU . 72.1 Cg_endo -82.95 28.98 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.95 2.433 . . . . 0.0 112.382 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -81.08 -19.85 42.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.167 -0.958 . . . . 0.0 109.654 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' B' ' 39' ' ' GLN . 44.8 p -78.39 -104.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.523 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . 0.506 ' N ' ' OG1' ' B' ' 38' ' ' THR . 13.9 mt-30 54.94 10.65 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.654 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 1.301 ' NH1' ' HB3' ' C' ' 92' ' ' ARG . 15.9 mmt180 -88.55 -58.98 2.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -71.44 -8.19 52.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.75 28.16 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.361 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.66 -27.3 65.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 93.9 p -84.15 -27.19 28.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 109.465 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -49.65 -24.39 2.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.331 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.87 173.05 0.19 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.97 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -1.142 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 12.6 mt -138.92 19.68 2.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -58.93 -33.9 71.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.61 154.34 69.06 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.49 -24.26 74.15 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.212 1.941 . . . . 0.0 111.756 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.2 -21.02 29.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 109.608 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.96 -19.95 65.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 109.736 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.44 ' C ' ' H ' ' B' ' 56' ' ' GLY . 4.4 t -67.05 -64.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.94 . . . . 0.0 109.473 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.09 8.13 1.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' B' ' 54' ' ' VAL . . . -74.57 -29.99 60.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -84.42 147.72 50.57 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.195 -1.179 . . . . 0.0 109.34 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.72 -7.08 19.66 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.564 2.176 . . . . 0.0 112.175 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -85.77 -28.45 24.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.162 -0.961 . . . . 0.0 109.659 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.31 -53.0 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.174 -0.954 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -57.8 -26.38 61.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.0 -46.5 43.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -61.87 -23.82 66.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.376 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.06 -19.97 77.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -69.52 -37.31 77.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -1.197 . . . . 0.0 109.124 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -68.06 -40.78 82.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.337 -0.852 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.14 -59.15 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.285 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.8 tt -58.56 -52.66 64.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.001 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.08 -45.02 26.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.45 96.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -1.129 . . . . 0.0 109.386 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . 0.526 ' O ' ' CD1' ' B' ' 71' ' ' PHE . 2.5 t80 -69.63 -27.3 64.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.378 -0.826 . . . . 0.0 109.332 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' SER . . . . . 0.402 ' HB2' ' HE1' ' B' ' 15' ' ' TRP . 88.1 p -76.77 -27.91 55.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.938 . . . . 0.0 109.557 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' B' ' 77' ' ' HIS . 10.6 t70 -47.34 -37.08 10.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.584 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.05 -60.63 6.6 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.446 HD11 ' H ' ' B' ' 75' ' ' LEU . 4.7 mp -56.71 -24.67 50.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -1.217 . . . . 0.0 109.176 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.542 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -93.91 -11.06 31.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.314 -0.866 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 80.3 m-70 -161.31 65.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 109.648 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.69 10.27 0.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 0.0 109.04 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' B' ' 77' ' ' HIS . 2.8 p30 -64.42 -30.24 71.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.286 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' B' ' 79' ' ' ASP . 34.5 t-20 -171.05 105.13 0.23 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.371 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.21 -58.79 2.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -48.24 -23.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.447 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -68.72 -54.77 13.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.9 t -75.19 -47.17 29.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -1.18 . . . . 0.0 109.427 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' B' ' 84' ' ' THR . 48.8 m-85 -62.72 -5.42 2.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.428 -0.795 . . . . 0.0 109.459 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.7 -34.59 62.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.329 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' THR . . . . . 0.55 ' HG1' ' H ' ' B' ' 88' ' ' LEU . 37.3 p -79.82 -51.15 9.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.393 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.55 ' H ' ' HG1' ' B' ' 87' ' ' THR . 27.8 mt -59.69 -42.08 92.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.88 . . . . 0.0 109.333 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' B' ' 140' ' ' ALA . 5.1 m -65.08 -42.46 94.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -73.04 -40.19 65.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 4.6 tt -66.97 -34.98 78.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' B' ' 97' ' ' HIS . 60.1 m80 -84.35 -20.29 32.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.004 -1.06 . . . . 0.0 109.703 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 39.3 t -84.02 -60.04 2.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.915 . . . . 0.0 110.987 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -86.91 -29.86 21.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.991 -1.068 . . . . 0.0 111.601 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -85.8 -51.81 6.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.695 -1.253 . . . . 0.0 110.69 -178.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.613 ' C ' ' CG ' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -102.77 -24.21 13.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.021 -1.049 . . . . 0.0 109.853 -179.269 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 1.198 ' CE1' HG23 ' C' ' 41' ' ' THR . 0.5 OUTLIER 44.64 47.23 8.62 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.146 -0.971 . . . . 0.0 109.822 179.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -60.73 121.48 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -0.995 . . . . 0.0 108.987 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' B' ' 100' ' ' PRO . 13.9 m-20 -59.08 143.99 83.41 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 0.0 109.236 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' B' ' 99' ' ' ASP . 76.1 Cg_exo -45.85 -174.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.356 2.038 . . . . 0.0 112.317 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 57.45 76.58 0.31 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.448 ' C ' ' N ' ' B' ' 104' ' ' ARG . 40.5 t-20 -171.57 -67.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.41 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -49.05 -15.78 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.93 . . . . 0.0 109.319 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . 0.448 ' N ' ' C ' ' B' ' 102' ' ' ASN . 10.3 mmt180 -76.27 -31.06 58.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 mt -77.83 -52.03 9.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 5.4 tt -51.03 -49.16 61.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.155 -0.966 . . . . 0.0 109.308 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.78 -21.32 65.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -85.62 -27.76 25.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -1.18 . . . . 0.0 109.731 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.15 -47.48 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 109.647 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 16.1 mt -48.39 -39.74 23.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 65.2 t -51.08 -36.41 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.657 ' SG ' ' CD2' ' A' ' 122' ' ' HIS . 14.4 t -78.19 -22.99 47.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.554 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.17 -27.2 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.603 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 28.6 mt -81.36 -22.39 38.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.972 . . . . 0.0 109.502 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' B' ' 119' ' ' GLY . . . -83.48 -37.0 23.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.468 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 9.1 t-80 -68.97 -49.04 61.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.496 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 0.3 OUTLIER -74.32 -17.68 60.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.475 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 6.1 m-85 -152.38 61.94 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.439 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.54 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -62.08 -25.52 66.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -74.1 -31.03 62.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -1.139 . . . . 0.0 109.544 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -82.25 11.73 5.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.321 -0.862 . . . . 0.0 109.626 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.553 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -85.0 35.05 0.56 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.557 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 63.4 p -54.53 147.31 30.04 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.373 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.499 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 4.0 Cg_exo -45.13 -54.53 4.22 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.541 2.16 . . . . 0.0 113.173 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 18.4 Cg_endo -59.41 -11.56 14.05 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.119 1.88 . . . . 0.0 112.236 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 72.5 t -97.72 -20.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.222 -0.924 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . 0.563 ' NE2' ' CG1' ' A' ' 107' ' ' VAL . 5.4 tp-100 -83.37 -59.99 2.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.159 -0.963 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.703 ' HB1' ' HB3' ' A' ' 34' ' ' LEU . . . -61.67 -34.81 76.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.21 -0.931 . . . . 0.0 109.623 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.02 23.93 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' B' ' 128' ' ' ALA . 23.4 t80 -118.9 -59.17 1.89 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.837 . . . . 0.0 109.68 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -47.07 -23.33 0.47 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.861 . . . . 0.0 109.955 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -82.52 -38.28 24.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 109.892 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.6 -41.04 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.885 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' B' ' 136' ' ' GLY . 1.6 m -81.97 -40.72 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.77 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 1.06 ' O ' ' CD2' ' D' ' 146' ' ' HIS . . . -47.51 -20.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.008 . . . . 0.0 109.523 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . 0.6 ' N ' ' HE2' ' D' ' 146' ' ' HIS . . . -75.63 -41.63 28.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.21 -21.96 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -1.13 . . . . 0.0 109.483 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.55 -44.36 80.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.463 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . 0.804 HD22 ' HB2' ' D' ' 146' ' ' HIS . 0.9 OUTLIER -79.71 -35.35 39.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . 0.403 ' O ' ' OG ' ' B' ' 89' ' ' SER . . . -49.2 -43.95 42.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.905 . . . . 0.0 109.53 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.1 17.79 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.415 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' B' ' 146' ' ' HIS . . . -141.07 8.18 2.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -67.03 -38.19 85.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.307 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.32 -13.42 62.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' B' ' 145' ' ' TYR . 23.1 p90 -160.55 55.36 0.32 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 1.035 ' CD2' ' O ' ' D' ' 135' ' ' ALA . 2.2 p-80 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 12.4 tp -171.71 145.52 1.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.953 . . . . 0.0 109.661 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.59 168.39 20.17 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.309 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' C' ' 5' ' ' ALA . 55.7 Cg_endo -73.22 -61.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.656 2.237 . . . . 0.0 112.662 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.2 -38.26 5.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.145 -0.972 . . . . 0.0 109.717 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' C' ' 5' ' ' ALA . 4.8 m-20 -44.63 -28.23 0.58 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.05 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' C' ' 10' ' ' VAL . 77.0 mttt -83.19 -60.24 2.21 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.443 -0.786 . . . . 0.0 109.033 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 46.1 m -46.46 -31.56 2.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.519 -0.738 . . . . 0.0 109.639 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -76.73 -35.93 57.48 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' C' ' 7' ' ' LYS . 4.5 t -73.53 -50.24 31.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -49.08 -42.98 40.61 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.32 -63.59 1.14 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.494 -0.754 . . . . 0.0 109.3 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.33 -39.12 69.59 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.428 -0.795 . . . . 0.0 109.191 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . 0.428 ' NE1' ' OG1' ' C' ' 67' ' ' THR . 0.1 OUTLIER -71.21 -17.31 62.52 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.285 -0.885 . . . . 0.0 109.088 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.19 -46.18 7.73 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -70.6 -34.78 72.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -1.156 . . . . 0.0 108.806 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.8 -66.19 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 60.9 -140.83 48.09 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.405 ' O ' ' CG ' ' C' ' 20' ' ' HIS . . . -66.63 49.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.458 -1.025 . . . . 0.0 110.169 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' C' ' 18' ' ' GLY . 79.7 m-70 -153.79 19.66 0.52 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -83.87 -62.83 1.47 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.693 -0.63 . . . . 0.0 109.743 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.25 -14.37 0.16 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 21' ' ' ALA . 3.4 mm-40 -86.75 -56.5 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 109.703 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.8 m-30 -55.27 -52.35 63.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.175 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.05 -22.88 14.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.57 -45.42 53.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 109.762 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . 0.512 ' OE1' ' NE2' ' C' ' 112' ' ' HIS . 94.9 mt-10 -65.65 -19.87 66.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.482 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.49 60.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.905 . . . . 0.0 109.377 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 21.4 mt -65.88 -41.2 91.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.711 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -75.64 -12.55 60.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.858 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -78.94 -47.34 16.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.154 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptm -65.76 -26.24 67.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 0.0 109.733 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.41 -36.52 83.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 0.0 109.373 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.7 ' HB3' ' HB1' ' D' ' 128' ' ' ALA . 12.1 mt -85.66 -44.88 12.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.678 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 40.3 t -51.51 -19.63 1.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.852 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' C' ' 35' ' ' SER . 59.9 m-85 -160.92 90.4 1.61 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 0.0 109.65 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' C' ' 39' ' ' THR . 52.2 Cg_exo -50.4 -26.17 15.52 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.488 2.125 . . . . 0.0 112.137 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 10.8 p -47.32 -18.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.439 ' N ' ' O ' ' C' ' 37' ' ' PRO . 21.8 p -76.6 -22.76 53.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.238 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -74.29 -31.77 62.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.777 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 1.198 HG23 ' CE1' ' B' ' 97' ' ' HIS . 14.2 t . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 109.354 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.534 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 21.6 p80 . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.542 0.687 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.705 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.9 OUTLIER -166.6 75.47 0.18 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.609 ' C ' ' O ' ' C' ' 46' ' ' PHE . 20.7 m-20 -8.76 -54.69 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 120.985 0.422 . . . . 0.0 111.493 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.705 ' N ' ' O ' ' C' ' 46' ' ' PHE . 5.7 mt 56.71 4.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.503 ' H ' ' C ' ' C' ' 47' ' ' ASP . 33.4 t -73.34 19.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 109.348 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.523 ' H ' ' C ' ' C' ' 48' ' ' LEU . 6.6 t-80 58.81 156.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.42 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.06 15.23 1.43 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.487 ' O ' ' N ' ' C' ' 54' ' ' GLN . 10.7 t -72.49 -21.33 61.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -1.127 . . . . 0.0 109.422 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' C' ' 55' ' ' VAL . . . 67.54 -50.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.463 -0.773 . . . . 0.0 109.717 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.491 HE22 ' CG ' ' C' ' 47' ' ' ASP . 15.8 pt20 -45.39 -17.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.667 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' C' ' 53' ' ' ALA . 77.4 t -73.87 -32.94 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.75 -24.77 67.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.673 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.16 -51.07 41.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 24.9 t-80 -67.8 -27.92 67.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -1.202 . . . . 0.0 110.221 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.13 -31.05 79.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.419 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 16.9 mtpp -71.92 -23.48 61.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -1.152 . . . . 0.0 110.118 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' C' ' 65' ' ' ALA . 0.4 OUTLIER -66.91 -58.15 5.56 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.044 -1.035 . . . . 0.0 108.574 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -55.08 -48.98 75.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.536 -0.728 . . . . 0.0 109.245 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.459 ' O ' ' OG1' ' C' ' 67' ' ' THR . . . -64.33 -42.55 96.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.299 -0.875 . . . . 0.0 108.854 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 7.4 t70 -72.0 -25.69 61.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.065 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' C' ' 61' ' ' LYS . . . -80.61 -44.75 18.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.375 -0.828 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' C' ' 66' ' ' LEU . 0.1 OUTLIER -76.5 -27.38 56.01 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' C' ' 63' ' ' ALA . 52.0 m -75.89 -44.66 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -57.45 -20.72 32.34 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.33 -45.68 12.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 6.0 t -59.75 -22.57 24.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.521 ' O ' ' CD2' ' C' ' 72' ' ' HIS . . . -65.48 -15.17 62.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.092 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' C' ' 74' ' ' ASP . 32.0 m80 -153.03 -51.87 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.434 -0.791 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.1 p 44.59 15.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.85 0.833 . . . . 0.0 109.214 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' C' ' 72' ' ' HIS . 95.8 m-20 -134.36 10.43 3.78 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' C' ' 78' ' ' ASN . 31.2 t70 -175.1 27.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.248 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.693 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.1 ptt? -78.52 -24.29 0.43 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.433 -0.792 . . . . 0.0 111.839 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.4 Cg_exo -52.81 -19.79 11.62 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.711 1.607 . . . . 0.0 112.629 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.452 ' ND2' ' N ' ' C' ' 79' ' ' ALA . 0.8 OUTLIER -94.25 -33.09 13.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.823 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . 0.452 ' N ' ' ND2' ' C' ' 78' ' ' ASN . . . -74.6 -40.81 61.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.62 12.13 13.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 108.983 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 66.3 p -70.63 -16.19 62.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.632 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -82.1 -51.59 7.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.16 -0.963 . . . . 0.0 109.719 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 mt -45.2 -42.82 9.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.804 . . . . 0.0 109.028 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 29.7 p -57.1 -22.15 37.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.493 -0.755 . . . . 0.0 109.574 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' C' ' 82' ' ' ALA . 0.8 OUTLIER -72.6 -32.7 66.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.94 . . . . 0.0 109.592 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' C' ' 90' ' ' LYS . 7.0 tt -81.37 -29.13 34.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 109.516 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -89.87 -28.47 19.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.58 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' C' ' 90' ' ' LYS . . . -83.84 -80.44 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' C' ' 89' ' ' HIS . 30.6 t-80 -61.2 2.49 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.57 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' C' ' 88' ' ' ALA . 6.1 mtmm -156.07 152.38 27.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.281 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.649 ' C ' ' H ' ' C' ' 93' ' ' VAL . 10.9 mp 56.97 63.81 1.82 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -0.865 . . . . 0.0 109.033 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . 1.301 ' HB3' ' NH1' ' B' ' 40' ' ' ARG . 8.4 ptp180 -62.73 14.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.47 -0.769 . . . . 0.0 109.501 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.649 ' H ' ' C ' ' C' ' 91' ' ' LEU . 74.1 t -41.38 121.66 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.384 -0.823 . . . . 0.0 109.64 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.06 147.87 2.2 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.465 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' C' ' 97' ' ' ASN . 38.0 Cg_endo -68.25 -10.7 29.74 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.512 2.141 . . . . 0.0 112.126 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.27 -1.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.58 ' H ' ' C ' ' C' ' 95' ' ' PRO . 5.1 m120 -74.69 -42.27 58.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.857 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . 0.428 ' O ' ' OG ' ' C' ' 102' ' ' SER . 2.2 m-85 -46.37 -42.1 14.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 0.0 109.337 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -57.95 -33.07 68.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.302 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' C' ' 97' ' ' ASN . 11.1 mt -84.09 -62.12 1.64 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -50.35 -41.91 52.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.199 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 102' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' C' ' 98' ' ' PHE . 39.0 m -63.17 -51.01 68.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.528 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -66.1 -26.76 67.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.544 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.55 -50.5 69.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.753 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.38 -43.02 23.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -0.931 . . . . 0.0 109.384 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.487 ' N ' ' CD1' ' C' ' 106' ' ' LEU . 8.6 mp -64.15 -59.39 4.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.356 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . 0.554 ' CG1' ' NE2' ' D' ' 127' ' ' GLN . 77.0 t -56.33 -30.93 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.379 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 26.6 m -75.75 -63.09 1.38 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.318 -0.864 . . . . 0.0 109.388 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 113' ' ' LEU . 13.1 mt -51.32 -30.66 19.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 109.486 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' D' ' 115' ' ' ALA . . . -47.42 -42.29 21.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.717 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.12 -49.21 11.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.422 -0.799 . . . . 0.0 109.763 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . 0.512 ' NE2' ' OE1' ' C' ' 27' ' ' GLU . 11.4 m170 -76.3 -70.0 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.871 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -110.88 97.07 32.27 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.433 -0.792 . . . . 0.0 109.132 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' C' ' 113' ' ' LEU . 73.0 Cg_exo -47.46 -174.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.399 2.066 . . . . 0.0 112.883 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.59 -35.18 19.6 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.696 0.76 . . . . 0.0 109.517 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 3.8 mt-10 78.45 0.84 2.61 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 0.934 ' HD1' HH21 ' D' ' 30' ' ' ARG . 22.0 t80 65.27 37.64 6.33 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.602 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.764 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -94.01 115.15 64.81 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.749 -1.22 . . . . 0.0 107.907 178.184 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . 0.737 ' HA ' HG13 ' D' ' 33' ' ' VAL . 50.5 Cg_exo -50.38 21.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.974 1.782 . . . . 0.0 112.571 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -147.08 -21.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.039 . . . . 0.0 110.966 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' C' ' 122' ' ' HIS . 10.4 p -58.23 -58.76 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.95 -1.094 . . . . 0.0 110.385 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.649 ' CD2' ' SG ' ' D' ' 112' ' ' CYS . 1.1 m-70 -70.98 -24.97 62.51 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.266 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.1 -20.68 32.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.508 ' N ' ' O ' ' C' ' 120' ' ' ALA . 62.5 p -77.38 -63.15 1.44 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.267 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.5 -19.95 58.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.075 -1.016 . . . . 0.0 109.084 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . 0.543 ' OD2' ' OH ' ' D' ' 35' ' ' TYR . 7.4 t70 -77.71 -51.21 10.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.455 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.26 -41.75 11.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.817 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' C' ' 124' ' ' SER . 29.8 t80 -50.25 -22.94 1.96 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.985 -1.072 . . . . 0.0 108.991 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' C' ' 133' ' ' SER . 14.9 mt -74.05 -24.69 59.56 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -56.67 -31.99 64.97 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 89.4 p -73.99 -32.42 63.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.48 -29.74 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.47 ' N ' ' O ' ' C' ' 129' ' ' LEU . 9.8 p -81.86 -25.33 35.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.329 -0.857 . . . . 0.0 108.881 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 134' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 36.8 m -74.96 -40.08 60.95 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.361 -0.837 . . . . 0.0 109.1 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.08 -21.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.344 -0.847 . . . . 0.0 108.779 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.77 -35.99 72.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.434 -0.792 . . . . 0.0 109.072 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 137' ' ' THR . . . . . 0.434 ' O ' ' O ' ' C' ' 138' ' ' SER . 57.5 p -88.04 -2.44 58.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 109.571 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 138' ' ' SER . . . . . 0.434 ' O ' ' O ' ' C' ' 137' ' ' THR . 28.3 m . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 109.555 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.653 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -136.45 -163.14 1.36 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 109.254 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.403 ' O ' ' N ' ' D' ' 6' ' ' GLU . 11.9 p -89.02 130.64 43.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.132 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . 0.447 ' O ' ' OG ' ' D' ' 9' ' ' SER . 86.9 Cg_exo -42.05 -23.06 0.23 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.292 1.995 . . . . 0.0 112.24 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' D' ' 4' ' ' THR . 51.9 mt-10 -80.05 -54.34 5.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.925 . . . . 0.0 109.877 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.39 -40.98 85.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.946 . . . . 0.0 109.87 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.479 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.3 OUTLIER -68.64 -35.08 76.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.473 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 9' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' D' ' 5' ' ' PRO . 4.9 m -60.66 -23.64 64.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 109.879 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.38 -57.64 3.39 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.067 -1.02 . . . . 0.0 109.859 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.69 -24.41 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 82.0 m -83.9 -35.1 24.35 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.349 0.595 . . . . 0.0 109.695 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.11 -29.37 67.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.83 . . . . 0.0 109.668 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.1 -20.98 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.312 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -53.61 -17.93 2.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 109.067 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.7 -33.35 47.3 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -89.72 -41.63 11.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -1.178 . . . . 0.0 109.35 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -57.17 114.83 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.847 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' D' ' 21' ' ' ASP . 7.4 m120 -84.1 68.41 10.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.296 -0.877 . . . . 0.0 108.686 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' D' ' 19' ' ' ASN . 72.3 t -43.94 -18.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 109.673 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' D' ' 19' ' ' ASN . 1.1 m-20 -62.39 -10.77 12.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.764 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -154.37 -35.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 109.517 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 72.8 t -48.72 -34.97 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.17 -25.99 68.8 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.04 -36.22 25.37 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -67.66 -30.67 70.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -1.125 . . . . 0.0 109.487 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.43 46.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' D' ' 28' ' ' LEU . 10.0 mp -64.32 -55.71 19.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.377 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.1 -41.35 29.86 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . 0.934 HH21 ' HD1' ' C' ' 117' ' ' PHE . 73.3 mtt-85 -80.0 -34.57 38.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -1.117 . . . . 0.0 109.502 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 tp -47.19 -37.11 9.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' D' ' 36' ' ' PRO . 14.7 mt -81.31 -39.24 25.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.923 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . 0.737 HG13 ' HA ' ' C' ' 119' ' ' PRO . 73.1 t -58.11 -61.48 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.385 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . 0.641 HG13 ' HB3' ' C' ' 122' ' ' HIS . 1.7 t -68.69 -22.55 26.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.397 -0.814 . . . . 0.0 109.828 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . 0.543 ' OH ' ' OD2' ' C' ' 126' ' ' ASP . 63.9 m-85 -146.77 76.43 11.65 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.153 -0.967 . . . . 0.0 109.767 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' D' ' 32' ' ' LEU . 72.2 Cg_endo -82.86 28.9 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.912 2.408 . . . . 0.0 112.323 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -80.95 -20.0 42.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.095 -1.003 . . . . 0.0 109.717 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' D' ' 39' ' ' GLN . 44.8 p -78.37 -103.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.554 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . 0.524 ' N ' ' OG1' ' D' ' 38' ' ' THR . 13.9 mt-30 55.03 10.67 0.42 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.645 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . 1.272 ' NH1' ' HB3' ' A' ' 92' ' ' ARG . 15.8 mmt180 -88.7 -58.86 2.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -71.45 -8.28 52.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -87.72 28.22 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.7 -27.31 65.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.462 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 94.0 p -84.11 -27.22 28.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -49.55 -24.43 2.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.299 -0.876 . . . . 0.0 109.241 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.82 173.11 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.89 91.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -1.091 . . . . 0.0 109.572 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 12.6 mt -139.01 19.71 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 109.31 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -58.85 -34.02 71.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.15 -0.969 . . . . 0.0 109.434 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.6 154.23 68.97 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.32 -24.34 73.94 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.253 1.969 . . . . 0.0 111.765 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.22 -21.0 29.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.608 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.98 -19.9 65.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 109.735 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' D' ' 56' ' ' GLY . 4.4 t -67.07 -64.03 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 0.0 109.465 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.05 8.13 1.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.537 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' D' ' 54' ' ' VAL . . . -74.68 -29.83 60.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -84.42 147.65 50.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.212 -1.169 . . . . 0.0 109.377 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.65 -7.14 19.79 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.584 2.19 . . . . 0.0 112.193 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -85.69 -28.56 24.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.666 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 83.9 t -70.24 -52.95 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -57.82 -26.42 61.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.89 -46.68 43.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -61.72 -23.84 66.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.887 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.07 -20.0 77.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -69.51 -37.3 77.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 109.084 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -68.13 -40.69 82.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.444 -0.785 . . . . 0.0 109.498 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 41.9 t -61.29 -59.1 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.203 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 4.8 tt -58.59 -52.61 64.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 108.983 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.15 -44.98 27.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.46 96.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -1.128 . . . . 0.0 109.379 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' D' ' 71' ' ' PHE . 2.5 t80 -69.59 -27.22 64.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.853 . . . . 0.0 109.336 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 88.5 p -76.93 -27.85 55.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' D' ' 77' ' ' HIS . 10.6 t70 -47.42 -37.11 10.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.09 -60.6 6.62 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.449 ' H ' HD11 ' D' ' 75' ' ' LEU . 4.7 mp -56.61 -24.79 50.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -1.159 . . . . 0.0 109.156 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . 0.544 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -93.86 -11.11 31.86 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 109.583 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 80.0 m-70 -161.19 65.15 0.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.59 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.73 10.29 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.082 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' D' ' 77' ' ' HIS . 2.8 p30 -64.35 -30.23 71.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.378 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 34.5 t-20 -171.09 105.08 0.23 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.14 -58.87 2.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -48.23 -23.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.0 109.449 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . 0.436 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -68.73 -54.82 13.23 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.54 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.9 t -75.2 -47.17 29.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -1.164 . . . . 0.0 109.417 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.54 ' N ' ' CG2' ' D' ' 84' ' ' THR . 48.6 m-85 -62.7 -5.41 2.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.67 62.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.273 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 87' ' ' THR . . . . . 0.548 ' HG1' ' H ' ' D' ' 88' ' ' LEU . 37.1 p -79.75 -51.22 9.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.379 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.548 ' H ' ' HG1' ' D' ' 87' ' ' THR . 27.1 mt -59.68 -42.07 92.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 89' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' D' ' 140' ' ' ALA . 5.1 m -65.09 -42.41 94.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -73.1 -40.15 65.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 4.6 tt -67.02 -35.03 79.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.607 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.561 ' O ' ' N ' ' D' ' 97' ' ' HIS . 60.0 m80 -84.28 -20.28 32.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.926 -1.109 . . . . 0.0 109.722 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 39.4 t -84.01 -60.07 2.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 111.01 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -86.96 -29.8 21.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.001 -1.062 . . . . 0.0 111.59 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -85.77 -51.92 6.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.772 -1.205 . . . . 0.0 110.649 -178.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.607 ' C ' ' CG ' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -102.75 -24.12 13.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.06 -1.025 . . . . 0.0 109.856 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 1.247 ' CE1' ' CG2' ' A' ' 41' ' ' THR . 0.5 OUTLIER 44.64 47.08 8.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.104 -0.998 . . . . 0.0 109.892 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 t -60.6 121.51 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.119 -0.988 . . . . 0.0 109.033 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' D' ' 100' ' ' PRO . 13.9 m-20 -59.09 143.97 83.47 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.225 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' D' ' 99' ' ' ASP . 75.4 Cg_exo -45.85 -174.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.423 2.082 . . . . 0.0 112.342 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 57.44 76.61 0.31 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' D' ' 104' ' ' ARG . 40.5 t-20 -171.6 -67.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.432 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -49.0 -15.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' D' ' 102' ' ' ASN . 10.3 mmt180 -76.2 -31.15 58.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.336 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 mt -77.78 -51.99 9.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.859 . . . . 0.0 109.645 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.4 tt -51.09 -49.18 61.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.107 -0.996 . . . . 0.0 109.23 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.77 -21.24 65.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -85.75 -27.64 25.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -1.162 . . . . 0.0 109.715 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.15 -47.48 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.646 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 16.2 mt -48.48 -39.7 23.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 109.503 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 65.4 t -51.11 -36.45 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . 0.649 ' SG ' ' CD2' ' C' ' 122' ' ' HIS . 14.4 t -78.09 -23.02 48.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -79.14 -27.18 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.644 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 29.0 mt -81.47 -22.31 38.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.903 . . . . 0.0 109.507 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' D' ' 119' ' ' GLY . . . -83.45 -36.93 23.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 109.635 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.456 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 9.2 t-80 -68.96 -49.08 61.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . 0.502 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 0.3 OUTLIER -74.32 -17.7 60.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.486 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 6.2 m-85 -152.37 62.07 0.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -62.07 -25.55 66.38 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -74.16 -31.0 62.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.535 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -82.27 11.75 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -84.98 34.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.961 . . . . 0.0 109.536 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 65.1 p -54.42 147.34 28.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.503 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.9 Cg_exo -45.11 -54.58 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.411 2.074 . . . . 0.0 113.16 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 18.3 Cg_endo -59.39 -11.5 13.81 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.113 1.875 . . . . 0.0 112.298 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 72.1 t -97.86 -20.44 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 109.59 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . 0.554 ' NE2' ' CG1' ' C' ' 107' ' ' VAL . 5.4 tp-100 -83.34 -60.1 2.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 109.859 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 0.7 ' HB1' ' HB3' ' C' ' 34' ' ' LEU . . . -61.67 -34.78 76.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.96 23.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . 0.441 ' H ' ' C ' ' D' ' 128' ' ' ALA . 23.5 t80 -118.96 -59.19 1.88 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.44 -0.788 . . . . 0.0 109.591 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -47.03 -23.35 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.983 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -82.56 -38.22 24.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -0.972 . . . . 0.0 109.932 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 45.2 t -61.59 -41.05 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -0.95 . . . . 0.0 109.881 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' D' ' 136' ' ' GLY . 1.6 m -82.04 -40.71 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.98 . . . . 0.0 109.771 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 1.035 ' O ' ' CD2' ' B' ' 146' ' ' HIS . . . -47.5 -20.99 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.119 -0.988 . . . . 0.0 109.58 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . 0.592 ' N ' ' HE2' ' B' ' 146' ' ' HIS . . . -75.63 -41.51 29.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.31 -21.86 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -1.128 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.63 -44.29 81.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . 0.824 HD22 ' HB2' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -79.67 -35.4 39.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.539 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . 0.4 ' O ' ' OG ' ' D' ' 89' ' ' SER . . . -49.23 -43.94 43.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.496 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 40.2 mt -84.07 17.72 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' D' ' 146' ' ' HIS . . . -140.99 8.15 2.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.264 -0.898 . . . . 0.0 109.467 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -67.02 -38.13 85.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.888 . . . . 0.0 109.31 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.38 -13.47 62.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.862 . . . . 0.0 109.355 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' D' ' 145' ' ' TYR . 23.2 p90 -160.51 55.4 0.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 1.06 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 2.2 p-80 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.416 ' C ' ' OG ' ' A' ' 3' ' ' SER . 14.7 mt -139.09 -178.34 5.3 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.375 -0.828 . . . . 0.0 109.18 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.453 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 178.77 -50.9 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.993 . . . . 0.0 110.065 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 6' ' ' ASP . 83.0 Cg_exo -43.63 155.64 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.43 2.087 . . . . 0.0 112.538 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -46.21 -16.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 109.803 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' PRO . 12.5 t70 -39.45 -44.86 1.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 109.816 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 8' ' ' THR . 6.5 ptmt -58.01 -50.41 73.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.125 -0.985 . . . . 0.0 108.992 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.415 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 22.7 m -54.73 -31.41 58.3 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 108.652 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -77.23 -34.84 55.87 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.85 -51.81 41.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -47.78 46.96 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.47 -61.14 2.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.645 -0.659 . . . . 0.0 109.458 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.27 -41.91 51.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.403 -0.811 . . . . 0.0 109.066 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -17.54 64.93 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.4 -0.813 . . . . 0.0 109.178 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -78.18 -45.48 10.11 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -68.62 -39.59 80.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -1.174 . . . . 0.0 108.763 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.88 -64.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 54.76 -132.77 47.83 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.73 27.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -1.063 . . . . 0.0 110.376 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.584 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.8 m-70 -131.83 25.2 4.67 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.232 -0.918 . . . . 0.0 108.538 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -89.41 -59.55 2.18 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.566 -0.709 . . . . 0.0 109.789 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.71 -13.89 0.2 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.6 mt-10 -87.58 -56.48 3.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 109.912 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.526 ' CD1' ' ND1' ' A' ' 112' ' ' HIS . 3.0 m-30 -60.11 -29.22 68.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.5 87.19 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.16 -39.13 29.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -1.165 . . . . 0.0 109.75 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -63.88 -25.54 68.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.261 -0.899 . . . . 0.0 109.318 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.35 -23.06 66.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.572 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.401 ' CD1' ' CG ' ' A' ' 58' ' ' HIS . 10.7 mt -76.65 -58.49 3.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.55 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -62.39 -12.42 21.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.446 ' HE ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -69.65 -49.92 49.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 110.329 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.6 ptt? -84.11 -36.45 22.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.046 -1.034 . . . . 0.0 110.404 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -43.78 -23.84 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.171 -0.955 . . . . 0.0 110.107 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 1.523 HD12 ' CB ' ' B' ' 128' ' ' ALA . 2.3 pp -92.16 -28.8 16.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.125 -0.984 . . . . 0.0 109.951 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 81.2 p -89.21 -18.44 27.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.087 -1.008 . . . . 0.0 110.022 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 35' ' ' SER . 84.7 m-85 -157.95 75.82 3.81 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.104 -0.997 . . . . 0.0 109.719 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.34 -19.98 60.77 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.889 2.393 . . . . 0.0 112.247 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.4 p -48.61 -18.78 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.943 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.459 ' HG1' ' N ' ' A' ' 40' ' ' LYS . 38.1 p -85.92 -52.98 5.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.957 . . . . 0.0 109.803 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 41' ' ' THR . 0.5 OUTLIER -80.01 -17.57 52.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 109.644 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 40' ' ' LYS . 10.7 t . . . . . 0 N--CA 1.494 1.771 0 O-C-N 121.453 -0.78 . . . . 0.0 109.894 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -139.35 63.78 1.49 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 49' ' ' SER . 33.7 m-20 -37.94 -22.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 46' ' ' PHE . 1.2 mt 52.6 6.33 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.218 -0.926 . . . . 0.0 109.583 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 47' ' ' ASP . 34.5 t -81.3 153.3 27.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 28.3 m170 -47.79 128.64 13.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.53 22.04 13.45 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 54' ' ' GLN . 36.9 m -95.03 66.02 2.95 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -1.155 . . . . 0.0 108.964 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -37.85 -25.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.818 -0.551 . . . . 0.0 110.237 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' A' ' 52' ' ' SER . 14.1 mt-30 -60.8 -46.22 91.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.9 t -55.99 -47.62 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.087 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -66.55 -54.19 26.45 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.515 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . . . -53.12 -26.77 29.07 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.504 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.8 t-80 -69.85 -33.48 72.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.985 -1.303 . . . . 0.0 109.798 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.6 -48.61 83.68 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 51.3 mttp -51.0 -23.82 3.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -1.057 . . . . 0.0 109.811 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' A' ' 57' ' ' GLY . 0.5 OUTLIER -71.43 -50.68 29.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.208 -0.933 . . . . 0.0 108.891 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.63 -43.61 90.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.603 -0.686 . . . . 0.0 109.327 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.04 -28.88 64.7 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.234 -0.916 . . . . 0.0 109.432 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 15.1 t70 -72.26 -40.12 67.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 108.782 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.33 82.03 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.372 -0.83 . . . . 0.0 108.875 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.15 -40.31 95.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -70.62 -51.03 30.87 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -59.39 -22.96 62.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.58 -47.31 11.42 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.08 -22.63 31.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.44 -15.09 63.43 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.596 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.1 m80 -143.78 -59.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.509 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.5 p 44.57 13.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.713 0.768 . . . . 0.0 109.492 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' A' ' 72' ' ' HIS . 12.8 t70 -133.38 9.66 4.04 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 2.1 m-20 -179.58 27.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.942 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.683 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 17.7 ptt? -78.74 -22.75 0.39 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 112.006 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 76' ' ' MET . 52.3 Cg_exo -52.63 -22.01 15.99 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.578 1.519 . . . . 0.0 112.592 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.13 -24.03 17.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.728 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.47 -54.29 6.92 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.151 -0.968 . . . . 0.0 109.183 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 7.0 mp -77.15 8.89 3.46 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.433 -0.792 . . . . 0.0 109.046 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.6 t -65.18 -15.83 62.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 109.886 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.79 -46.08 14.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 0.0 109.854 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 82' ' ' ALA . 4.2 mt -46.43 -45.93 18.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.314 -0.866 . . . . 0.0 108.94 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 135' ' ' VAL . 37.6 m -54.04 -29.15 42.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.552 -0.717 . . . . 0.0 109.45 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' ALA . 25.9 t0 -65.68 -33.93 77.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 109.499 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 90' ' ' LYS . 3.0 tt -82.99 -63.65 1.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -50.09 -21.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 109.954 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.76 -48.11 5.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.168 -0.957 . . . . 0.0 109.955 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.42 ' HD1' ' HZ1' ' A' ' 90' ' ' LYS . 7.8 t-80 -76.73 -70.95 0.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 86' ' ' LEU . 30.1 mttm -86.43 140.65 29.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.808 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.419 ' CD1' ' N ' ' A' ' 91' ' ' LEU . 10.6 mp 53.88 57.91 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.07 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.585 ' HD3' ' CD ' ' D' ' 40' ' ' ARG . 72.5 ttt180 -47.89 -47.58 31.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.829 . . . . 0.0 109.288 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.597 ' CG1' ' H ' ' A' ' 94' ' ' ASP . 62.1 t 49.67 179.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.353 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.597 ' H ' ' CG1' ' A' ' 93' ' ' VAL . 34.7 m-20 -133.09 151.87 78.64 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.151 -0.968 . . . . 0.0 109.12 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 98' ' ' PHE . 82.3 Cg_exo -39.28 -19.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.571 2.181 . . . . 0.0 112.282 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 1.31 HG22 ' CB ' ' D' ' 99' ' ' ASP . 64.6 t -47.07 -32.91 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.697 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.452 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 1.5 m120 -79.23 -25.15 42.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 95' ' ' PRO . 77.4 t80 -67.88 -56.38 9.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.83 -28.8 2.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 109.545 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 17.0 mt -84.04 -52.37 6.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.7 tp -47.2 -39.75 14.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.948 . . . . 0.0 109.76 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.2 p -65.04 -59.22 4.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -52.97 -26.79 16.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.811 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 60.4 m -66.46 -58.44 5.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -45.98 -22.99 0.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 109.91 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 4.1 mm? -82.19 -32.33 29.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.029 -1.044 . . . . 0.0 109.808 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.92 -27.5 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.686 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.625 ' HG1' ' H ' ' A' ' 109' ' ' LEU . 6.8 p -69.01 -60.45 2.35 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.156 -0.965 . . . . 0.0 109.549 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.625 ' H ' ' HG1' ' A' ' 108' ' ' THR . 37.1 mt -55.88 -42.1 75.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 109.291 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.31 11.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.798 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.27 -55.79 4.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 109.901 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.526 ' ND1' ' CD1' ' A' ' 24' ' ' TYR . 22.3 m170 -59.59 -62.66 1.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.083 -1.011 . . . . 0.0 109.128 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.54 ' O ' ' O ' ' A' ' 114' ' ' PRO . 2.4 pp -137.69 118.94 10.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.54 ' O ' ' O ' ' A' ' 113' ' ' LEU . 88.2 Cg_exo -40.78 -178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.551 2.167 . . . . 0.0 113.292 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.647 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -57.42 -55.19 37.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.43 -0.794 . . . . 0.0 109.157 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.647 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 4.8 mm-40 120.48 -2.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.2 t80 64.52 52.19 1.83 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.962 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -133.04 111.5 13.17 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.679 ' HA ' HG11 ' B' ' 33' ' ' VAL . 76.7 Cg_exo -47.48 10.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.139 1.893 . . . . 0.0 112.582 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -132.65 -19.37 2.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.289 -0.882 . . . . 0.0 110.197 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 11.6 p -60.36 -55.4 24.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.154 -0.966 . . . . 0.0 110.299 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.984 ' HB3' HG11 ' B' ' 34' ' ' VAL . 6.4 m170 -71.93 -33.35 68.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 0.0 108.947 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.99 -20.16 49.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.2 m -64.86 -62.71 1.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 110.003 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.54 -19.56 65.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.191 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.91 -50.11 11.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.718 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -85.55 -43.19 13.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.114 -0.991 . . . . 0.0 109.857 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.449 ' H ' ' HG3' ' A' ' 127' ' ' LYS . 53.6 t80 -49.44 -21.0 0.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.962 -1.086 . . . . 0.0 108.668 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.622 ' O ' ' N ' ' A' ' 133' ' ' SER . 12.8 mt -71.94 -17.48 62.08 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.98 -31.65 72.02 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.4 p -83.29 -34.02 25.83 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.418 -0.801 . . . . 0.0 108.86 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.31 -28.01 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 108.654 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 129' ' ' LEU . 36.8 m -80.08 -28.85 39.05 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.495 -0.753 . . . . 0.0 109.236 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 41.9 m -71.31 -33.59 69.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.245 -0.909 . . . . 0.0 109.044 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.432 ' O ' ' OG ' ' A' ' 84' ' ' SER . 30.0 t -79.93 -28.19 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -35.81 73.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.468 -0.77 . . . . 0.0 109.106 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.9 t -101.86 -14.57 17.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 0.0 109.588 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.329 -179.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.265 0.555 . . . . 0.0 109.826 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.92 179.06 9.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.422 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.437 ' OG1' ' OE2' ' B' ' 7' ' ' GLU . 2.2 p -73.39 151.64 89.79 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.413 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.54 -28.61 21.28 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.558 2.172 . . . . 0.0 112.049 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -78.73 -41.23 31.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.573 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.437 ' OE2' ' OG1' ' B' ' 4' ' ' THR . 46.2 mt-10 -64.77 -46.08 83.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.559 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.48 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -72.63 -37.44 68.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 109.624 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.403 ' C ' ' O ' ' B' ' 8' ' ' LYS . 3.3 t -45.63 -23.62 0.26 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.688 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.32 -56.51 3.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 109.949 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -65.21 -24.62 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 5.8 m -77.53 -45.73 24.52 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.398 0.618 . . . . 0.0 109.53 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.21 -34.54 72.3 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.396 -0.815 . . . . 0.0 109.573 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.43 ' C ' ' N ' ' B' ' 16' ' ' GLY . 0.8 OUTLIER -51.8 -32.12 30.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.922 . . . . 0.0 109.122 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -48.68 -17.99 0.22 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.343 -0.848 . . . . 0.0 109.267 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' B' ' 14' ' ' LEU . . . -76.78 -56.7 4.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.416 ' N ' ' CD ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -64.78 -27.48 68.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -1.203 . . . . 0.0 109.15 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.9 114.69 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' B' ' 21' ' ' ASP . 25.4 m-80 -80.42 69.15 6.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.231 -0.918 . . . . 0.0 109.048 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 74.2 t -44.32 -21.32 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.419 -0.801 . . . . 0.0 109.651 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' B' ' 19' ' ' ASN . 68.1 m-20 -74.08 3.87 6.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' B' ' 19' ' ' ASN . 35.1 mt-10 -153.01 -41.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.177 -0.952 . . . . 0.0 109.313 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.54 -46.63 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.288 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.32 -42.94 64.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.88 -44.02 63.75 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -68.01 -25.06 65.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.27 -49.44 66.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.551 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' B' ' 28' ' ' LEU . 9.4 mp -79.12 -54.51 5.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.45 -33.4 8.3 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -82.08 -39.33 23.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -1.119 . . . . 0.0 109.337 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -49.2 -35.79 18.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 27.3 mt -79.88 -31.95 40.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 109.56 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 119' ' ' PRO . 61.7 t -66.43 -64.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.423 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.984 HG11 ' HB3' ' A' ' 122' ' ' HIS . 1.3 t -64.43 -22.74 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.355 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -146.17 80.73 10.05 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.342 -0.849 . . . . 0.0 109.382 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.36 -5.6 14.33 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.672 2.248 . . . . 0.0 112.439 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . 0.535 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 1.3 p-90 -58.86 -24.43 62.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.535 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 3.1 m -95.91 38.22 1.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.39 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -90.98 9.52 30.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 109.624 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 1.674 ' CD ' ' HD3' ' C' ' 92' ' ' ARG . 55.1 ttt85 -81.56 -29.83 33.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' B' ' 42' ' ' PHE . 66.2 m-85 -90.91 30.08 1.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.948 . . . . 0.0 109.405 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' B' ' 41' ' ' PHE . 70.5 m-85 -145.66 22.61 1.45 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.48 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -78.93 -16.51 56.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.255 -0.903 . . . . 0.0 109.51 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.464 ' C ' ' H ' ' B' ' 46' ' ' GLY . 27.8 p -67.47 -43.23 81.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.598 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' B' ' 47' ' ' ASP . 88.4 m-85 -48.89 -14.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.506 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' B' ' 44' ' ' SER . . . 66.89 -65.42 0.19 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' B' ' 45' ' ' PHE . 4.6 m-20 -46.18 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -1.163 . . . . 0.0 109.576 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 tp -159.47 22.62 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 12.9 p -70.45 -33.83 71.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.533 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' THR . . . . . 0.442 ' O ' ' N ' ' B' ' 53' ' ' ALA . 3.4 p -145.7 151.52 46.5 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 0.0 109.111 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -39.96 -42.09 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.373 2.049 . . . . 0.0 112.238 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.2 -31.05 72.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -61.93 -19.79 63.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.475 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 78.6 t -67.96 -63.83 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.657 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 22.4 ptp -83.18 4.49 26.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.723 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.88 -17.23 70.64 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -82.19 138.18 45.67 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.0 109.024 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.18 -12.88 30.7 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.247 1.964 . . . . 0.0 112.14 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -80.17 -57.47 3.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.332 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 43.0 t -48.02 -31.58 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.341 -0.85 . . . . 0.0 109.56 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -78.99 -32.94 45.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.508 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.62 -45.79 16.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.69 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' B' ' 63' ' ' HIS . 0.9 OUTLIER -62.72 -23.64 67.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.22 -0.925 . . . . 0.0 109.671 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.57 -36.34 83.15 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -60.15 -25.46 65.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -1.2 . . . . 0.0 109.58 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.69 -50.17 39.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.317 -0.865 . . . . 0.0 109.62 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.72 -36.73 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 5.6 tt -71.58 -48.03 51.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.288 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.46 -44.91 16.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.62 -51.85 56.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -1.131 . . . . 0.0 109.44 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -49.5 -35.29 19.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.403 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -76.01 -24.49 55.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.4 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -52.37 -43.58 64.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.86 -60.12 8.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.46 ' H ' HD13 ' B' ' 75' ' ' LEU . 4.2 mp -57.98 -28.08 64.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.117 . . . . 0.0 109.277 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -80.45 -9.28 59.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.29 -0.881 . . . . 0.0 109.556 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.546 ' C ' ' H ' ' B' ' 79' ' ' ASP . 57.2 m80 -160.27 65.94 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.389 -0.819 . . . . 0.0 109.539 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mt -68.4 11.62 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' B' ' 77' ' ' HIS . 81.5 m-20 -72.4 -31.07 65.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.124 -0.985 . . . . 0.0 109.553 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 16.4 t-20 -171.02 108.89 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.464 ' CD1' ' N ' ' B' ' 81' ' ' LEU . 9.5 mp -80.26 -54.75 5.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.5 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' B' ' 82' ' ' LYS . 0.6 OUTLIER -49.92 -24.0 2.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.486 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -73.12 -52.44 8.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.1 t -76.48 -47.58 22.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -1.189 . . . . 0.0 109.528 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.547 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.2 m-85 -66.04 4.76 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.461 -0.775 . . . . 0.0 109.566 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -63.73 -33.4 75.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.423 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.1 p -79.36 -51.3 9.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.418 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' B' ' 92' ' ' HIS . 8.7 mp -53.33 -51.17 63.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.345 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' SER . . . . . 0.409 ' HG ' ' N ' ' B' ' 90' ' ' GLU . 36.4 p -54.7 -45.4 73.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.927 . . . . 0.0 109.632 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.428 ' O ' ' OD2' ' B' ' 94' ' ' ASP . 32.9 tt0 -66.3 -41.58 89.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.663 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.53 -20.14 40.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.599 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' B' ' 88' ' ' LEU . 1.5 m80 -87.65 -41.21 13.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 110.239 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -82.99 -39.64 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.048 -1.032 . . . . 0.0 110.795 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' B' ' 90' ' ' GLU . 12.1 m-20 -86.18 -36.38 19.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.921 -1.112 . . . . 0.0 111.181 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -52.18 5.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.928 -1.108 . . . . 0.0 110.594 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.583 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 10.0 mp -86.29 -31.81 21.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.92 -1.112 . . . . 0.0 109.68 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 13.5 p80 41.89 29.39 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.382 -0.824 . . . . 0.0 109.858 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.09 124.65 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.178 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 1.267 ' CB ' HG22 ' C' ' 96' ' ' VAL . 0.4 OUTLIER -47.67 154.24 0.94 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.09 -160.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.628 2.219 . . . . 0.0 111.959 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.447 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 29.6 mm-40 57.64 26.3 12.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' B' ' 101' ' ' GLU . 39.1 m-20 -137.53 -32.76 0.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.35 -0.844 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.48 -37.01 85.65 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.497 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -70.14 -23.74 63.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.589 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' B' ' 105' ' ' LEU . 7.8 mp -79.74 -17.68 52.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.48 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' B' ' 106' ' ' LEU . 2.6 tm? -78.92 -46.72 17.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.318 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.99 -20.46 77.67 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -70.52 -55.66 8.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.083 -1.245 . . . . 0.0 109.797 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -53.72 -24.06 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.634 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.44 -50.85 65.91 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.472 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.563 ' CG2' ' CE1' ' B' ' 130' ' ' TYR . 46.7 t -49.44 -45.21 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.716 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 56.5 m -51.55 -35.92 42.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.631 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.91 -28.58 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 41.6 mt -72.73 -40.68 65.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.21 -20.85 59.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 109.297 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.569 ' ND1' ' HD1' ' B' ' 117' ' ' HIS . 3.0 t-80 -84.75 -54.62 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.301 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.569 ' HD1' ' ND1' ' B' ' 116' ' ' HIS . 0.5 OUTLIER -70.97 -17.54 62.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 0.0 109.671 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.41 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 68.3 m-85 -152.71 62.3 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.573 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.542 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -58.86 -26.99 61.3 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -68.37 -34.97 77.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -82.78 14.23 3.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.638 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.551 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -82.91 36.32 0.5 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.627 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.413 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 7.4 p -46.42 154.15 0.67 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.454 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.582 ' O ' HD11 ' A' ' 34' ' ' LEU . 24.5 Cg_exo -55.49 -44.81 44.85 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.358 2.039 . . . . 0.0 113.749 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' B' ' 124' ' ' PRO . 67.1 Cg_endo -78.17 -8.16 16.35 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.021 1.814 . . . . 0.0 112.615 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.413 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 10.6 t -83.76 -31.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 109.198 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -83.26 -59.73 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 109.629 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 1.523 ' CB ' HD12 ' A' ' 34' ' ' LEU . . . -48.49 -41.96 31.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.18 -36.46 83.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.831 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.563 ' CE1' ' CG2' ' B' ' 111' ' ' VAL . 30.0 t80 -61.23 -60.9 3.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.067 -1.021 . . . . 0.0 109.402 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -47.77 -25.81 1.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.873 . . . . 0.0 109.563 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' B' ' 132' ' ' LYS . 5.0 ttpm? -85.53 -31.52 22.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 109.739 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.49 -65.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.54 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 5.9 m -55.48 -15.67 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.597 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.648 ' CB ' ' OXT' ' D' ' 146' ' ' HIS . . . -56.22 -33.73 65.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.341 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.83 -30.52 57.62 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.15 -32.86 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.428 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.94 76.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.332 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -78.73 -21.26 48.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.299 -0.875 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.64 -60.73 2.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.942 . . . . 0.0 109.676 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 63.9 mt -54.22 -20.32 6.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.135 -0.978 . . . . 0.0 109.256 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.98 -4.6 58.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 109.116 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' B' ' 146' ' ' HIS . 71.4 t60 -49.45 -39.08 31.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.498 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -86.94 -55.15 3.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.133 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -52.8 -10.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.514 -0.741 . . . . 0.0 109.36 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.62 ' OXT' ' CB ' ' D' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.469 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . 0.429 ' C ' ' OG ' ' C' ' 3' ' ' SER . 14.6 mt -139.05 -178.3 5.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.361 -0.837 . . . . 0.0 109.218 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 178.76 -50.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' C' ' 6' ' ' ASP . 83.1 Cg_exo -43.64 155.71 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.309 2.006 . . . . 0.0 112.576 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -46.27 -16.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.841 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' C' ' 4' ' ' PRO . 12.5 t70 -39.43 -44.91 1.43 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.39 -0.819 . . . . 0.0 109.792 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' C' ' 8' ' ' THR . 6.5 ptmt -57.95 -50.48 73.23 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.117 -0.989 . . . . 0.0 109.01 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.411 ' N ' ' CG ' ' C' ' 7' ' ' LYS . 22.6 m -54.67 -31.51 57.85 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 108.61 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -77.16 -34.85 56.38 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.79 -51.82 41.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.37 -47.74 47.33 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' C' ' 15' ' ' GLY . . . -52.45 -61.18 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.494 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.18 -42.0 50.44 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.392 -0.817 . . . . 0.0 109.06 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -17.57 64.93 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.437 -0.789 . . . . 0.0 109.156 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' C' ' 12' ' ' ALA . . . -78.2 -45.38 10.17 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 39.6 mmtt -68.72 -39.54 80.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 108.798 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.86 -65.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.594 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 54.78 -132.82 47.94 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.75 27.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.456 -1.026 . . . . 0.0 110.383 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.594 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.7 m-70 -131.77 25.12 4.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -89.32 -59.6 2.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.679 -0.638 . . . . 0.0 109.827 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.73 -13.85 0.2 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.5 mt-10 -87.59 -56.45 3.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.39 -1.065 . . . . 0.0 109.897 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.526 ' CD1' ' ND1' ' C' ' 112' ' ' HIS . 3.0 m-30 -60.18 -29.15 68.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.06 -34.49 86.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.12 -39.13 30.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -1.159 . . . . 0.0 109.754 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.94 -25.55 68.19 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 109.271 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.4 -22.95 66.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.594 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 10.7 mt -76.65 -58.47 3.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.566 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -62.38 -12.57 22.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 109.923 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.434 ' HE ' ' HA ' ' C' ' 31' ' ' ARG . 0.3 OUTLIER -69.64 -49.79 50.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 110.327 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' MET . . . . . 0.432 ' O ' ' N ' ' C' ' 34' ' ' LEU . 2.6 ptt? -84.22 -36.53 22.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.136 -0.977 . . . . 0.0 110.335 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' C' ' 32' ' ' MET . 13.9 t80 -43.63 -23.93 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 110.175 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 1.478 HD12 ' CB ' ' D' ' 128' ' ' ALA . 2.3 pp -92.05 -28.85 16.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.001 -1.062 . . . . 0.0 110.03 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.516 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 81.5 p -89.25 -18.45 27.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 0.0 109.928 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.516 ' CG ' ' O ' ' C' ' 35' ' ' SER . 85.0 m-85 -157.89 75.78 3.84 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.127 -0.983 . . . . 0.0 109.797 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' C' ' 39' ' ' THR . 26.2 Cg_exo -60.36 -19.99 60.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.906 2.404 . . . . 0.0 112.166 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 24.4 p -48.63 -18.76 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 109.926 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.455 ' HG1' ' N ' ' C' ' 40' ' ' LYS . 38.0 p -85.93 -53.07 5.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.712 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' C' ' 41' ' ' THR . 0.5 OUTLIER -79.93 -17.56 52.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.666 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.483 ' C ' ' O ' ' C' ' 40' ' ' LYS . 10.9 t . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.484 -0.76 . . . . 0.0 109.992 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -139.26 63.69 1.49 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.551 ' C ' ' H ' ' C' ' 49' ' ' SER . 33.9 m-20 -37.9 -22.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.365 -0.834 . . . . 0.0 110.226 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' C' ' 46' ' ' PHE . 1.2 mt 52.64 6.34 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.127 -0.983 . . . . 0.0 109.608 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.551 ' H ' ' C ' ' C' ' 47' ' ' ASP . 34.6 t -81.3 153.32 27.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.95 . . . . 0.0 109.351 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' C' ' 50' ' ' HIS . 28.6 m170 -47.92 128.71 13.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.372 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.48 22.06 13.48 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.554 ' O ' ' N ' ' C' ' 54' ' ' GLN . 37.9 m -95.15 66.15 2.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -1.124 . . . . 0.0 108.936 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' C' ' 52' ' ' SER . . . -37.92 -25.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.809 -0.557 . . . . 0.0 110.264 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' C' ' 52' ' ' SER . 14.2 mt-30 -60.64 -46.28 90.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 109.529 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.05 -47.51 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.976 . . . . 0.0 109.128 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -66.52 -54.22 26.25 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . 0.523 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -53.21 -26.64 29.33 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.499 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 6.8 t-80 -69.92 -33.55 72.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.08 -1.247 . . . . 0.0 109.736 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.48 -48.68 82.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 51.4 mttp -51.07 -23.81 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -1.095 . . . . 0.0 109.705 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' C' ' 57' ' ' GLY . 0.5 OUTLIER -71.49 -50.5 30.86 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 108.966 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.72 -43.61 89.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.601 -0.687 . . . . 0.0 109.303 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.12 -28.71 64.5 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.306 -0.872 . . . . 0.0 109.44 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 15.1 t70 -72.35 -40.09 67.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.034 . . . . 0.0 108.753 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.57 -47.38 81.75 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.01 -40.29 95.15 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -70.63 -51.01 30.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.264 -0.898 . . . . 0.0 108.604 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -59.35 -23.03 62.18 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.56 -47.27 11.48 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.96 -22.79 32.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.47 -14.99 63.38 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.602 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.2 m80 -143.75 -59.56 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.581 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.5 p 44.68 13.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.711 0.767 . . . . 0.0 109.507 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' C' ' 72' ' ' HIS . 12.8 t70 -133.37 9.58 4.04 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 2.1 m-20 -179.43 27.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.883 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 17.7 ptt? -78.82 -22.69 0.39 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.365 -0.834 . . . . 0.0 112.004 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.1 Cg_exo -52.54 -22.07 15.79 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.63 1.553 . . . . 0.0 112.522 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.16 -24.08 17.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.643 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 -54.27 6.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.15 -0.968 . . . . 0.0 109.142 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . 0.43 ' CD1' ' N ' ' C' ' 80' ' ' LEU . 7.0 mp -77.21 8.94 3.46 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.384 -0.823 . . . . 0.0 109.058 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t -65.21 -15.82 62.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.843 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.75 -46.13 14.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.183 -0.948 . . . . 0.0 109.846 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' C' ' 82' ' ' ALA . 4.1 mt -46.26 -46.0 17.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.835 . . . . 0.0 109.044 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' C' ' 135' ' ' VAL . 37.6 m -54.02 -29.13 42.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.547 -0.721 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' C' ' 82' ' ' ALA . 25.9 t0 -65.81 -33.85 76.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.109 -0.994 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' C' ' 90' ' ' LYS . 3.0 tt -83.02 -63.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -49.97 -22.02 1.41 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.877 . . . . 0.0 110.028 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.69 -48.14 5.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 110.007 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . 0.433 ' HD1' ' HZ1' ' C' ' 90' ' ' LYS . 7.8 t-80 -76.72 -71.05 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.956 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' C' ' 86' ' ' LEU . 30.1 mttm -86.29 140.58 29.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.736 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' C' ' 91' ' ' LEU . 10.6 mp 54.0 57.82 5.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.021 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . 1.674 ' HD3' ' CD ' ' B' ' 40' ' ' ARG . 72.5 ttt180 -47.86 -47.52 31.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 0.0 109.374 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.591 ' CG1' ' H ' ' C' ' 94' ' ' ASP . 61.9 t 49.67 179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.314 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . 0.591 ' H ' ' CG1' ' C' ' 93' ' ' VAL . 34.8 m-20 -133.12 151.81 78.49 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.266 -0.896 . . . . 0.0 109.119 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' C' ' 98' ' ' PHE . 81.7 Cg_exo -39.19 -19.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.612 2.208 . . . . 0.0 112.302 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . 1.267 HG22 ' CB ' ' B' ' 99' ' ' ASP . 63.9 t -46.98 -32.92 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.74 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' C' ' 97' ' ' ASN . 1.5 m120 -79.31 -25.07 42.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.942 . . . . 0.0 109.507 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' C' ' 95' ' ' PRO . 77.2 t80 -67.95 -56.37 9.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.8 -28.83 2.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 17.0 mt -83.98 -52.36 6.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.165 -0.959 . . . . 0.0 109.565 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 58.0 tp -47.27 -39.55 14.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.777 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 99.3 p -65.13 -59.25 4.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -53.01 -26.72 16.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.83 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 60.4 m -66.42 -58.48 5.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 109.825 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -45.93 -23.13 0.26 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' C' ' 106' ' ' LEU . 4.1 mm? -82.12 -32.34 30.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.046 -1.034 . . . . 0.0 109.819 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 38.4 t -82.86 -27.61 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.173 -0.954 . . . . 0.0 109.689 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.624 ' HG1' ' H ' ' C' ' 109' ' ' LEU . 6.8 p -68.92 -60.52 2.31 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.184 -0.948 . . . . 0.0 109.572 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.624 ' H ' ' HG1' ' C' ' 108' ' ' THR . 36.7 mt -55.79 -42.08 75.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.346 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.33 11.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.773 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.24 -55.79 4.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.941 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . 0.526 ' ND1' ' CD1' ' C' ' 24' ' ' TYR . 22.6 m170 -59.67 -62.64 1.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.983 -1.073 . . . . 0.0 109.062 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.55 ' O ' ' O ' ' C' ' 114' ' ' PRO . 2.4 pp -137.71 118.91 10.63 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . 0.55 ' O ' ' O ' ' C' ' 113' ' ' LEU . 89.4 Cg_exo -40.74 -178.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.561 2.174 . . . . 0.0 113.318 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.649 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -57.46 -55.07 39.52 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.422 -0.799 . . . . 0.0 109.164 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.649 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 4.8 mm-40 120.32 -2.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 20.0 t80 64.34 52.32 1.91 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.161 0.505 . . . . 0.0 110.989 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.0 OUTLIER -133.13 111.5 13.07 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . 0.665 ' HA ' HG11 ' D' ' 33' ' ' VAL . 78.1 Cg_exo -47.41 10.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.171 1.914 . . . . 0.0 112.561 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -132.72 -19.4 2.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.882 . . . . 0.0 110.279 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.541 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 11.7 p -60.42 -55.33 25.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.119 -0.988 . . . . 0.0 110.302 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 1.003 ' HB3' HG11 ' D' ' 34' ' ' VAL . 6.4 m170 -72.05 -33.25 67.82 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.129 -0.982 . . . . 0.0 108.883 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.08 -20.18 49.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.485 -0.759 . . . . 0.0 109.137 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.581 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.1 m -64.86 -62.7 1.41 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.351 -0.843 . . . . 0.0 109.998 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.55 -19.5 65.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 109.203 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.99 -50.09 11.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.75 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -85.66 -43.12 13.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.117 -0.989 . . . . 0.0 109.795 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.456 ' H ' ' HG3' ' C' ' 127' ' ' LYS . 53.5 t80 -49.45 -20.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.898 -1.126 . . . . 0.0 108.672 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' C' ' 133' ' ' SER . 12.8 mt -71.9 -17.62 62.09 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.9 -31.72 72.04 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 57.0 p -83.22 -34.01 25.98 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.325 -0.859 . . . . 0.0 108.947 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -85.31 -27.96 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 108.655 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.626 ' N ' ' O ' ' C' ' 129' ' ' LEU . 37.2 m -80.14 -28.92 38.83 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.408 -0.808 . . . . 0.0 109.159 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 134' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 41.8 m -71.24 -33.67 70.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 109.035 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' C' ' 84' ' ' SER . 30.0 t -79.9 -28.13 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.26 -0.9 . . . . 0.0 108.623 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.63 -35.76 73.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.037 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 14.9 t -101.93 -14.55 17.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.83 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.146 -0.971 . . . . 0.0 109.401 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.325 0.583 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.05 179.04 9.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.365 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.421 ' OG1' ' OE2' ' D' ' 7' ' ' GLU . 2.2 p -73.36 151.57 89.84 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.46 -28.54 21.77 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.552 2.168 . . . . 0.0 112.107 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -78.83 -41.25 30.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.939 . . . . 0.0 109.534 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . 0.421 ' OE2' ' OG1' ' D' ' 4' ' ' THR . 46.2 mt-10 -64.76 -46.03 83.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.481 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -72.63 -37.53 68.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.605 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 3.4 t -45.52 -23.7 0.25 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.788 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.23 -56.51 3.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.147 -0.971 . . . . 0.0 109.999 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 6.7 p -65.24 -24.62 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 5.8 m -77.51 -45.66 24.83 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.395 0.616 . . . . 0.0 109.575 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.45 72.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.385 -0.822 . . . . 0.0 109.592 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.43 ' C ' ' N ' ' D' ' 16' ' ' GLY . 0.8 OUTLIER -51.9 -32.12 31.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.072 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -48.66 -17.96 0.22 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.275 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' D' ' 14' ' ' LEU . . . -76.8 -56.81 3.99 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.432 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -64.77 -27.39 68.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 109.217 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.91 114.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' D' ' 21' ' ' ASP . 25.3 m-80 -80.45 69.15 6.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.009 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -44.39 -21.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.748 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' D' ' 19' ' ' ASN . 68.0 m-20 -74.16 3.92 6.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.489 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' D' ' 19' ' ' ASN . 35.1 mt-10 -153.0 -41.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.316 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.52 -46.59 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.36 -42.9 65.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.87 -44.05 63.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.1 -24.94 65.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -1.163 . . . . 0.0 109.528 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.32 -49.46 67.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . 0.484 ' CD1' ' N ' ' D' ' 28' ' ' LEU . 9.4 mp -79.12 -54.38 6.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.57 -33.38 8.68 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -81.99 -39.33 23.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -1.142 . . . . 0.0 109.419 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -49.27 -35.76 18.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 27.0 mt -79.9 -31.83 40.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.618 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' C' ' 119' ' ' PRO . 61.6 t -66.51 -64.41 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 109.38 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . 1.003 HG11 ' HB3' ' C' ' 122' ' ' HIS . 1.3 t -64.47 -22.64 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -146.21 80.85 9.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.397 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.45 -5.56 14.23 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.692 2.261 . . . . 0.0 112.386 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . 0.546 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 1.3 p-90 -58.87 -24.37 62.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.965 . . . . 0.0 109.51 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.546 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 3.0 m -96.01 38.29 1.19 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -91.16 9.63 30.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 109.496 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . 1.585 ' CD ' ' HD3' ' A' ' 92' ' ' ARG . 55.0 ttt85 -81.6 -29.82 33.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.543 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' D' ' 42' ' ' PHE . 66.1 m-85 -90.9 30.12 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 109.384 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' D' ' 41' ' ' PHE . 70.4 m-85 -145.66 22.65 1.45 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 109.381 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -79.11 -16.45 56.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.407 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.468 ' O ' ' N ' ' D' ' 46' ' ' GLY . 27.6 p -67.48 -43.32 81.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' D' ' 47' ' ' ASP . 88.3 m-85 -48.73 -14.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 66.9 -65.38 0.19 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' D' ' 45' ' ' PHE . 4.6 m-20 -46.18 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -1.16 . . . . 0.0 109.555 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 tp -159.46 22.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 12.8 p -70.54 -33.8 71.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 50' ' ' THR . . . . . 0.427 ' O ' ' N ' ' D' ' 53' ' ' ALA . 3.4 p -145.64 151.56 46.82 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.325 -0.859 . . . . 0.0 109.031 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -39.97 -42.01 3.12 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.302 2.001 . . . . 0.0 112.256 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.32 -31.01 72.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.488 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -61.92 -19.81 63.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.98 -63.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 109.615 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 22.4 ptp -83.2 4.5 26.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.364 -0.835 . . . . 0.0 109.648 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.92 -17.25 70.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -82.1 138.05 46.03 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.276 -1.132 . . . . 0.0 109.071 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.11 -12.84 30.81 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.232 1.955 . . . . 0.0 112.162 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -80.15 -57.45 3.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -48.0 -31.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -79.03 -32.81 45.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.76 -45.64 16.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.679 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . 0.493 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 0.9 OUTLIER -62.79 -23.67 67.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.722 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.49 -36.32 83.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -60.17 -25.44 65.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.108 -1.23 . . . . 0.0 109.591 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.71 -50.13 39.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.81 -36.67 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.35 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.6 tt -71.56 -48.09 50.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.42 -44.95 16.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.55 -51.94 56.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -1.102 . . . . 0.0 109.414 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -49.53 -35.32 19.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.269 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -75.98 -24.49 55.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -52.3 -43.64 64.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.381 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.84 -60.13 8.57 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.454 ' H ' HD13 ' D' ' 75' ' ' LEU . 4.2 mp -57.98 -27.99 63.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -1.118 . . . . 0.0 109.317 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -80.62 -9.24 59.79 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.214 -0.929 . . . . 0.0 109.427 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.547 ' C ' ' H ' ' D' ' 79' ' ' ASP . 56.8 m80 -160.34 66.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.42 11.58 0.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.309 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' D' ' 77' ' ' HIS . 81.4 m-20 -72.38 -30.97 65.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.614 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 16.5 t-20 -171.07 108.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.605 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' D' ' 81' ' ' LEU . 9.5 mp -80.31 -54.68 5.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.502 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' D' ' 82' ' ' LYS . 0.6 OUTLIER -49.97 -24.03 2.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.421 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . 0.44 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -73.15 -52.37 8.94 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.1 t -76.51 -47.63 22.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -1.179 . . . . 0.0 109.484 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.1 m-85 -66.0 4.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.783 . . . . 0.0 109.505 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -63.63 -33.49 75.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.0 p -79.27 -51.43 9.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.411 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' D' ' 92' ' ' HIS . 8.7 mp -53.24 -51.19 63.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.352 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 89' ' ' SER . . . . . 0.406 ' HG ' ' N ' ' D' ' 90' ' ' GLU . 34.8 p -54.57 -45.47 73.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.69 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.432 ' O ' ' OD2' ' D' ' 94' ' ' ASP . 32.9 tt0 -66.24 -41.64 89.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.155 -0.966 . . . . 0.0 109.624 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.43 -20.2 40.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.643 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.581 ' N ' ' O ' ' D' ' 88' ' ' LEU . 1.5 m80 -87.62 -41.16 13.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 110.267 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 35.6 t -83.11 -39.57 20.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.043 -1.035 . . . . 0.0 110.739 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' D' ' 90' ' ' GLU . 12.2 m-20 -86.27 -36.41 19.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.009 -1.057 . . . . 0.0 111.093 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -52.26 5.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.9 -1.125 . . . . 0.0 110.531 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.571 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 10.0 mp -86.28 -31.89 21.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.912 -1.117 . . . . 0.0 109.603 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 13.5 p80 42.04 29.32 0.13 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.426 -0.796 . . . . 0.0 109.818 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.16 124.61 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.862 . . . . 0.0 109.168 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . 1.31 ' CB ' HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -47.55 154.21 0.92 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.18 -160.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.651 2.234 . . . . 0.0 112.001 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . 0.446 ' O ' ' OD1' ' D' ' 102' ' ' ASN . 29.8 mm-40 57.64 26.31 12.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.872 . . . . 0.0 109.499 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' D' ' 101' ' ' GLU . 39.1 m-20 -137.47 -32.88 0.75 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.369 -0.832 . . . . 0.0 109.341 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.39 -37.13 86.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -70.14 -23.6 63.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.987 . . . . 0.0 109.548 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' D' ' 105' ' ' LEU . 7.8 mp -79.85 -17.7 52.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 0.0 109.463 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.486 ' C ' ' CD1' ' D' ' 106' ' ' LEU . 2.6 tm? -78.87 -46.76 17.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.302 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.02 -20.41 77.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -70.45 -55.7 8.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -1.216 . . . . 0.0 109.787 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -53.66 -24.05 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.962 . . . . 0.0 109.71 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.48 -50.8 66.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.913 . . . . 0.0 109.501 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . 0.556 ' CG2' ' CE1' ' D' ' 130' ' ' TYR . 46.9 t -49.53 -45.19 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 56.4 m -51.6 -35.84 43.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.61 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.96 -28.59 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 41.6 mt -72.74 -40.73 65.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.353 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.0 59.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 109.259 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.572 ' ND1' ' HD1' ' D' ' 117' ' ' HIS . 3.0 t-80 -84.58 -54.69 4.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.322 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . 0.572 ' HD1' ' ND1' ' D' ' 116' ' ' HIS . 0.5 OUTLIER -70.97 -17.45 62.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.704 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.402 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 68.3 m-85 -152.75 62.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.601 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -58.84 -27.0 61.26 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -68.42 -34.95 76.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -1.225 . . . . 0.0 109.559 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.84 14.35 3.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.624 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.558 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -83.01 36.4 0.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.418 ' HG1' ' CG2' ' D' ' 126' ' ' VAL . 7.4 p -46.45 154.14 0.68 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.115 -0.991 . . . . 0.0 109.445 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.585 ' O ' HD11 ' C' ' 34' ' ' LEU . 24.4 Cg_exo -55.4 -44.89 44.3 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.334 2.022 . . . . 0.0 113.786 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' D' ' 124' ' ' PRO . 67.1 Cg_endo -78.21 -8.06 16.28 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.994 1.796 . . . . 0.0 112.598 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . 0.418 ' CG2' ' HG1' ' D' ' 123' ' ' THR . 10.6 t -83.79 -31.04 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 109.276 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.28 -59.67 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 109.637 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 1.478 ' CB ' HD12 ' C' ' 34' ' ' LEU . . . -48.55 -41.97 31.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 0.0 109.42 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.55 83.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.89 . . . . 0.0 109.881 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . 0.556 ' CE1' ' CG2' ' D' ' 111' ' ' VAL . 29.7 t80 -61.11 -60.87 3.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.0 109.398 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -47.83 -25.8 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.584 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . 0.441 ' NZ ' ' CB ' ' D' ' 132' ' ' LYS . 5.0 ttpm? -85.5 -31.56 22.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.728 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.39 -65.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.527 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 5.9 m -55.53 -15.64 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.639 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.62 ' CB ' ' OXT' ' B' ' 146' ' ' HIS . . . -56.22 -33.68 65.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.929 . . . . 0.0 109.335 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.9 -30.52 57.5 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.14 -32.85 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -1.117 . . . . 0.0 109.433 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.97 76.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.345 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -78.7 -21.11 48.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 109.428 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.77 -60.63 2.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 63.6 mt -54.33 -20.25 6.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.315 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.01 -4.57 58.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 109.126 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' D' ' 146' ' ' HIS . 71.4 t60 -49.48 -39.13 32.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.484 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 0.8 OUTLIER -86.83 -55.13 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.944 . . . . 0.0 109.217 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -52.82 -10.41 0.16 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.56 -0.713 . . . . 0.0 109.387 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.648 ' OXT' ' CB ' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.484 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.527 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 3.9 mm? -95.01 -169.27 1.96 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.697 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.45 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -116.24 179.54 0.78 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.504 -0.747 . . . . 0.0 109.228 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 21.7 Cg_exo -62.81 -69.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.722 2.281 . . . . 0.0 112.752 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -83.09 -16.63 46.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.897 . . . . 0.0 110.391 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 5' ' ' ALA . 7.8 t70 -40.1 -41.17 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.215 -0.928 . . . . 0.0 109.778 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 10' ' ' VAL . 68.8 mttt -69.44 -55.97 8.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.872 . . . . 0.0 109.639 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.0 m -45.03 -30.78 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 109.674 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -78.48 -36.4 45.24 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 7' ' ' LYS . 48.9 t -72.09 -48.84 47.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -53.05 -44.39 67.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 108.78 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.74 -57.4 12.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.434 -0.791 . . . . 0.0 109.32 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.2 68.67 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.431 -0.793 . . . . 0.0 109.27 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.92 -17.22 60.6 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.248 -0.908 . . . . 0.0 108.936 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.76 -42.0 22.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -71.43 -42.12 68.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -1.178 . . . . 0.0 108.84 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.71 -63.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.576 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 47.73 -127.2 14.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.3 24.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.457 -1.025 . . . . 0.0 110.446 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.576 ' H ' ' C ' ' A' ' 18' ' ' GLY . 88.3 m-70 -128.84 22.13 5.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.887 . . . . 0.0 108.609 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 23' ' ' GLU . . . -88.73 -55.93 3.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.577 -0.702 . . . . 0.0 109.443 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.49 -14.43 0.61 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 21' ' ' ALA . 12.7 mm-40 -87.49 -56.52 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.396 -1.061 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.9 m-30 -60.87 -22.84 64.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 0.0 109.246 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.19 -23.54 63.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.93 -40.04 22.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -1.132 . . . . 0.0 109.619 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -69.43 -19.62 63.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.819 . . . . 0.0 109.25 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.3 -20.44 57.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 0.0 109.641 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.3 mt -78.15 -46.9 19.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.786 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.02 -38.13 75.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 109.738 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.4 mtt85 -63.18 -39.13 93.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.54 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 51.0 ttp -64.6 -50.44 67.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.203 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 1.8 t80 -44.07 -33.87 1.6 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.427 -0.796 . . . . 0.0 109.697 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.807 ' HB3' ' HB1' ' B' ' 128' ' ' ALA . 10.3 mt -84.95 -40.02 17.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.76 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.543 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 74.4 m -53.42 -38.4 63.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 109.665 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 35' ' ' SER . 30.5 m-85 -164.29 87.11 1.14 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 39' ' ' THR . 76.5 Cg_exo -48.18 -19.98 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.612 2.208 . . . . 0.0 112.141 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.79 ' HB ' ' HB3' ' D' ' 97' ' ' HIS . 9.1 p -46.82 -18.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.88 . . . . 0.0 109.738 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' PRO . 53.2 p -80.89 -63.11 1.48 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.13 -0.981 . . . . 0.0 109.989 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 41' ' ' THR . 8.6 mmpt? -59.09 -18.57 36.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.94 . . . . 0.0 109.955 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 40' ' ' LYS . 5.8 t . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.143 -0.973 . . . . 0.0 109.835 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.622 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 121.473 0.654 . . . . 0.0 109.612 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.771 ' O ' ' N ' ' A' ' 48' ' ' LEU . 3.3 m-85 -82.89 14.2 3.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.315 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 49' ' ' SER . 4.7 m-20 60.42 -51.35 0.09 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.771 ' N ' ' O ' ' A' ' 46' ' ' PHE . 19.5 mt 41.59 20.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.677 -0.639 . . . . 0.0 109.961 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 47' ' ' ASP . 6.2 m -93.35 42.33 1.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.493 ' CG ' ' C ' ' A' ' 49' ' ' SER . 0.7 OUTLIER 71.88 129.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.434 -0.792 . . . . 0.0 109.351 -179.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.54 29.33 73.22 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 53' ' ' ALA . 8.1 p -52.36 -36.68 54.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -1.064 . . . . 0.0 109.54 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 73.27 -64.45 0.4 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 53' ' ' ALA . 18.9 mt-30 -43.59 -35.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 109.48 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.32 -28.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 110.017 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 2.5 ptpt -61.53 -38.89 89.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 0.0 109.453 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' N ' ' CG ' ' A' ' 56' ' ' LYS . . . -52.43 -35.83 45.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 8.7 t-80 -76.6 -27.91 55.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.167 . . . . 0.0 109.913 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.59 -37.26 94.17 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 46.6 mtpt -62.68 -24.34 67.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -1.186 . . . . 0.0 110.268 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.447 ' HD2' ' H ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -65.01 -58.7 5.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.041 -1.037 . . . . 0.0 109.356 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.5 t -54.0 -43.83 59.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.469 -0.77 . . . . 0.0 109.289 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.78 -46.88 62.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 0.0 108.924 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 62.4 m-20 -64.48 -34.4 78.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 108.661 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . -67.13 -50.36 61.64 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -55.69 -44.62 77.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 71' ' ' ALA . 19.3 m -65.5 -54.21 31.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.258 -0.901 . . . . 0.0 108.786 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -55.86 -27.35 51.27 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.12 -47.68 13.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.32 -22.74 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -70.28 -13.01 61.98 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' A' ' 74' ' ' ASP . 34.0 m170 -136.3 -67.17 0.52 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.457 -0.777 . . . . 0.0 109.251 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 72' ' ' HIS . 13.2 p 44.77 14.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.952 0.882 . . . . 0.0 109.439 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 72' ' ' HIS . 35.0 m-20 -139.24 12.57 2.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 1.1 m-20 172.79 30.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.692 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 6.9 ptt? -78.31 -22.82 0.4 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 111.928 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.6 Cg_exo -53.84 -20.75 18.41 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.577 1.518 . . . . 0.0 112.387 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.44 ' O ' ' OG ' ' A' ' 81' ' ' SER . 17.6 t-20 -94.11 -35.54 12.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 109.844 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.03 -46.89 61.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.097 -1.002 . . . . 0.0 109.257 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.8 mt -80.3 8.27 7.8 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 109.024 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 44.2 p -56.05 -21.92 24.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.907 . . . . 0.0 109.731 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -70.8 -53.79 14.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.788 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' ALA . 6.0 mt -44.78 -47.1 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -50.2 -39.61 44.62 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 82' ' ' ALA . 28.8 t70 -82.82 -17.33 44.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.817 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 86' ' ' LEU . 3.3 tm? -71.41 -58.19 3.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -83.11 -21.72 33.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.102 . . . . 0.0 110.736 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.04 -79.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.888 -1.132 . . . . 0.0 109.788 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -59.53 5.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.811 . . . . 0.0 109.475 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 86' ' ' LEU . 41.2 mttm -88.02 135.7 33.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 93' ' ' VAL . 14.9 mt 61.16 66.43 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.833 . . . . 0.0 109.153 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 1.448 ' NE ' ' HB2' ' D' ' 40' ' ' ARG . 39.1 ttt-85 -66.33 18.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.504 -0.748 . . . . 0.0 109.347 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.632 ' H ' ' C ' ' A' ' 91' ' ' LEU . 11.9 p -42.61 129.52 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.895 . . . . 0.0 109.767 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.85 148.74 75.45 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.28 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ASN . 37.5 Cg_endo -67.56 -10.9 30.28 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.476 2.117 . . . . 0.0 112.046 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 95' ' ' PRO . 47.7 t -44.55 -19.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.715 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' PRO . 17.8 m120 -79.16 -24.77 43.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.545 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.534 ' CG ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -53.71 -45.01 70.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.372 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.534 ' N ' ' CG ' ' A' ' 98' ' ' PHE . 65.2 mttm -49.28 -41.02 36.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.501 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 12.4 mt -71.55 -43.24 66.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.892 . . . . 0.0 109.403 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 tt -57.99 -57.09 14.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.317 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.5 p -61.86 -34.9 76.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.857 . . . . 0.0 109.687 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 103' ' ' HIS . 22.8 t-160 -77.68 -26.69 50.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.462 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 55.6 m -69.68 -41.52 75.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 0.0 109.686 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mt -52.35 -50.17 62.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.36 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 3.8 mm? -58.83 -59.12 5.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.1 t -51.71 -49.68 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.197 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 110' ' ' ALA . 17.6 m -62.15 -60.27 3.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.394 -0.816 . . . . 0.0 109.3 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 113' ' ' LEU . 24.9 mt -47.13 -18.92 0.1 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 109.522 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -73.41 -36.24 65.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.01 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.13 -3.18 24.87 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.708 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -141.28 -83.9 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 0.0 109.908 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -106.06 83.37 1.07 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.085 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.32 -174.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.148 1.899 . . . . 0.0 112.356 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.65 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -46.19 -55.43 7.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.557 -0.715 . . . . 0.0 109.26 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.65 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 31.7 mt-10 118.87 -7.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 4.8 t80 79.08 34.48 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.969 -0.457 . . . . 0.0 111.2 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.722 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -109.47 122.7 38.67 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.476 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.39 18.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.32 2.013 . . . . 0.0 112.925 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.722 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -146.34 -33.17 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.886 -1.134 . . . . 0.0 110.404 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.549 ' H ' ' HG1' ' A' ' 118' ' ' THR . 7.2 p -51.68 -47.26 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.111 -0.993 . . . . 0.0 110.117 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.517 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 2.0 t-160 -59.8 -37.27 78.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.955 . . . . 0.0 109.365 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.19 -19.71 33.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.711 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 14.8 p -64.86 -62.5 1.53 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 110.625 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.497 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.6 mt -72.24 -19.77 61.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 0.0 109.978 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -82.38 -44.46 16.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.974 -1.079 . . . . 0.0 109.594 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -84.88 -41.02 16.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 109.52 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 27.8 t80 -51.72 -21.1 2.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.897 -1.127 . . . . 0.0 108.446 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 133' ' ' SER . 20.2 mt -76.6 -26.55 55.13 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -54.52 -33.46 59.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.404 ' OG ' ' CD2' ' A' ' 2' ' ' LEU . 1.6 m -77.65 -41.74 37.25 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.05 -33.13 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.224 -0.923 . . . . 0.0 108.578 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 129' ' ' LEU . 31.3 m -77.12 -42.21 38.9 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.399 -0.813 . . . . 0.0 109.172 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 92.3 m -70.39 -26.07 63.53 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.214 -0.929 . . . . 0.0 108.557 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.4 t -77.14 -37.78 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.06 -38.48 86.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 108.834 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 m -90.39 -14.6 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 -179.945 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 8.5 t60 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.547 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -127.76 177.82 6.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.391 -0.818 . . . . 0.0 109.186 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.445 ' OG1' ' OE2' ' B' ' 7' ' ' GLU . 0.6 OUTLIER -68.65 125.32 91.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 108.983 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.44 ' O ' ' OG ' ' B' ' 9' ' ' SER . 83.1 Cg_exo -42.07 -35.55 3.32 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.349 2.032 . . . . 0.0 112.537 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' B' ' 6' ' ' GLU . 14.3 mp0 -76.16 -23.89 54.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 109.7 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 0.2 OUTLIER -84.17 -39.53 19.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 109.767 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.49 ' O ' ' OG1' ' B' ' 12' ' ' THR . 22.9 pttt -83.87 -39.18 20.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 110.114 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' B' ' 8' ' ' LYS . 19.5 m -43.9 -23.33 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.865 . . . . 0.0 110.192 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -82.25 -57.06 3.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.139 -0.976 . . . . 0.0 109.997 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.09 -24.63 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 5.1 m -75.02 -45.71 39.9 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.367 0.603 . . . . 0.0 109.565 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.52 94.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.53 -0.731 . . . . 0.0 109.626 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.5 OUTLIER -48.0 -34.47 9.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -45.84 -17.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.847 . . . . 0.0 109.413 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -76.56 -43.06 20.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -79.76 -30.55 40.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -1.191 . . . . 0.0 109.254 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -47.82 114.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.552 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' B' ' 22' ' ' GLU . 5.8 m-20 -77.84 66.13 3.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.198 -0.939 . . . . 0.0 108.998 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.466 ' C ' ' H ' ' B' ' 22' ' ' GLU . 73.8 t -43.81 -26.87 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 109.754 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.76 7.21 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.504 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' B' ' 20' ' ' VAL . 36.6 mt-10 -155.24 -50.25 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.563 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 69.3 t -47.03 -33.75 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.627 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.57 -50.72 59.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.39 -36.87 78.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -73.74 -38.64 64.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -1.133 . . . . 0.0 109.449 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.85 -34.05 72.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.405 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -84.99 -34.53 22.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.53 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.36 -50.36 60.16 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -58.21 -30.55 66.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -1.204 . . . . 0.0 109.425 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -50.44 -39.21 46.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.469 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -81.01 -21.97 39.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.69 -64.13 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.724 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.47 HG13 ' CD2' ' A' ' 122' ' ' HIS . 2.3 t -64.46 -22.94 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.876 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -139.71 78.61 25.5 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.271 -0.893 . . . . 0.0 109.392 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' B' ' 39' ' ' GLN . 74.7 Cg_endo -82.82 -17.87 6.84 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.817 2.345 . . . . 0.0 112.381 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . 0.536 ' O ' ' NH2' ' C' ' 92' ' ' ARG . 5.2 p-90 -49.64 -19.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.5 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.403 ' O ' ' N ' ' B' ' 41' ' ' PHE . 1.4 p -92.15 -11.34 35.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.241 -0.912 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' B' ' 36' ' ' PRO . 1.5 tm0? -45.05 -34.24 2.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.711 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 1.368 ' HB2' ' NE ' ' C' ' 92' ' ' ARG . 37.6 mtp85 -61.08 -26.03 67.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.478 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' B' ' 38' ' ' THR . 32.1 t80 -100.88 30.64 3.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.315 -0.866 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -146.25 31.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 109.327 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -79.75 -14.04 59.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.402 ' O ' ' N ' ' B' ' 46' ' ' GLY . 28.5 t -65.47 -43.85 89.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.538 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' B' ' 47' ' ' ASP . 44.8 m-85 -48.87 -18.58 0.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 48' ' ' LEU . . . 65.77 -66.56 0.12 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 45' ' ' PHE . 79.6 m-20 -54.05 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -1.136 . . . . 0.0 109.674 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 46' ' ' GLY . 0.8 OUTLIER -164.47 21.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.115 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 56.0 m -57.97 -41.1 82.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.413 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' THR . . . . . 0.431 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.3 p -146.25 152.4 46.56 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.424 -0.797 . . . . 0.0 109.045 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -40.63 -30.04 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.402 2.068 . . . . 0.0 112.345 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -75.05 -29.2 60.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.641 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -63.9 -20.5 65.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 109.557 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.55 -24.01 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' MET . . . . . 0.413 ' O ' ' OD1' ' B' ' 57' ' ' ASN . 16.3 mmt -90.01 -6.2 55.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 109.611 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.587 ' O ' ' CB ' ' B' ' 57' ' ' ASN . . . -47.93 -35.83 13.43 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . 0.71 ' N ' ' CD ' ' B' ' 58' ' ' PRO . 21.0 m-20 91.7 23.56 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 122.245 -0.562 . . . . 0.0 111.623 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' B' ' 57' ' ' ASN . 77.4 Cg_endo -81.34 -157.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.965 1.776 . . . . 0.0 112.125 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -47.66 -24.39 0.91 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.71 -50.05 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.566 -0.709 . . . . 0.0 109.294 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -32.49 42.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.363 -0.836 . . . . 0.0 109.637 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.72 74.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 109.565 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -59.42 -26.3 65.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.589 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.56 -19.4 74.64 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -76.04 -24.98 55.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 109.122 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -74.29 -59.29 2.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 109.568 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 40.4 t -47.0 -34.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 109.473 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.33 -42.75 96.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -0.914 . . . . 0.0 109.16 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.73 -49.82 52.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.75 -33.44 66.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -1.127 . . . . 0.0 109.51 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -76.25 -37.66 57.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -80.49 -28.13 37.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.341 -0.849 . . . . 0.0 109.436 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -51.17 -38.89 54.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.21 -60.13 7.99 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.462 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -56.83 -18.65 13.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -1.106 . . . . 0.0 109.407 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -83.22 -19.31 36.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 71.5 m-70 -159.42 62.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.11 -0.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 109.315 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' B' ' 77' ' ' HIS . 45.7 t0 -57.62 -25.87 60.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 9.1 p-10 -170.58 105.85 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.2 mp -79.98 -57.26 3.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.469 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -45.79 -24.06 0.34 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -0.973 . . . . 0.0 109.61 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.76 -63.21 2.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.0 t -61.01 -47.49 86.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -1.168 . . . . 0.0 109.516 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.547 ' N ' ' CG2' ' B' ' 84' ' ' THR . 64.2 m-85 -67.86 4.77 1.04 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.747 . . . . 0.0 109.597 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.82 -46.57 78.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.544 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -75.12 -52.59 10.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.526 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 55.6 mt -50.73 -47.36 59.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' SER . . . . . 0.495 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 14.7 m -57.52 -36.26 71.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.356 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.87 -22.28 43.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.91 -18.06 26.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.972 . . . . 0.0 109.815 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' B' ' 88' ' ' LEU . 9.9 m80 -87.89 -60.76 1.88 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.916 -1.115 . . . . 0.0 110.484 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . 0.636 ' HG ' ' H ' ' B' ' 94' ' ' ASP . 12.8 p -83.82 -59.77 2.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.955 -1.091 . . . . 0.0 111.469 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.636 ' H ' ' HG ' ' B' ' 93' ' ' CYS . 14.2 m-20 -59.2 -26.76 65.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.071 -1.018 . . . . 0.0 111.724 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 3.1 tppp? -107.51 -51.97 2.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.737 -1.227 . . . . 0.0 110.795 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.447 ' C ' ' CD2' ' B' ' 97' ' ' HIS . 5.7 mp -87.19 -30.48 20.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.926 -1.109 . . . . 0.0 109.931 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.734 ' HB3' ' CG2' ' C' ' 38' ' ' THR . 9.6 m-70 66.47 49.16 1.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.117 -0.989 . . . . 0.0 110.013 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 33.1 t -96.62 114.18 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.198 -0.939 . . . . 0.0 109.031 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' B' ' 100' ' ' PRO . 0.9 OUTLIER -62.59 153.66 76.84 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.605 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' B' ' 99' ' ' ASP . 51.0 Cg_exo -51.98 -156.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.442 2.095 . . . . 0.0 112.452 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 52.95 46.74 26.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.522 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' B' ' 100' ' ' PRO . 35.3 m120 -158.08 -35.74 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.526 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.0 -39.22 93.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.152 -0.968 . . . . 0.0 109.526 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -65.47 -31.24 72.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 109.658 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' B' ' 105' ' ' LEU . 9.8 mp -62.35 -57.95 9.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.118 -0.989 . . . . 0.0 109.462 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 tt -48.23 -22.75 0.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.928 . . . . 0.0 109.605 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' B' ' 109' ' ' VAL . . . -79.29 -45.35 8.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -46.61 -16.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -1.122 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' B' ' 107' ' ' GLY . 97.6 t -85.15 -62.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.41 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 14.6 mt -47.41 -26.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.92 -47.65 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.792 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 20.2 p -79.28 -41.32 28.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.018 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 77.7 t -47.4 -41.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.747 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' B' ' 118' ' ' PHE . 46.1 mt -79.47 -40.49 29.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 109.526 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.438 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.14 -30.41 2.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.513 ' HD1' ' C ' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.64 -56.98 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.265 -0.897 . . . . 0.0 109.288 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . 0.411 ' C ' ' CG ' ' B' ' 118' ' ' PHE . 85.7 m-70 -63.53 -17.72 63.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 0.0 109.57 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' B' ' 114' ' ' LEU . 65.2 m-85 -153.29 62.35 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.938 . . . . 0.0 109.543 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' B' ' 122' ' ' PHE . . . -68.92 -50.48 34.78 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -47.86 -31.05 4.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 109.38 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -82.7 -19.07 38.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' B' ' 119' ' ' GLY . 6.3 t80 -76.09 66.61 2.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.29 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -79.14 149.8 73.53 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.276 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.493 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.5 Cg_exo -45.36 -53.58 5.3 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.466 2.111 . . . . 0.0 112.968 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 26.0 Cg_endo -62.45 1.11 1.08 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.01 1.806 . . . . 0.0 112.192 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' B' ' 124' ' ' PRO . 87.9 t -112.45 -8.23 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.316 -0.865 . . . . 0.0 109.306 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.3 -53.97 5.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.517 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.807 ' HB1' ' HB3' ' A' ' 34' ' ' LEU . . . -54.69 -33.81 61.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.886 . . . . 0.0 109.537 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.2 2.6 17.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.675 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.17 -29.6 13.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.218 -0.926 . . . . 0.0 109.374 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -84.4 -23.3 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 109.916 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . 0.723 ' HG3' ' HB3' ' D' ' 146' ' ' HIS . 14.4 ttmt -85.56 -36.08 20.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.13 -0.981 . . . . 0.0 110.121 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' B' ' 134' ' ' VAL . 11.8 p -65.38 -58.91 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.081 -1.012 . . . . 0.0 110.037 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.621 ' H ' ' CG1' ' B' ' 133' ' ' VAL . 11.3 t -62.1 -33.43 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.02 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -45.89 -21.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 0.0 109.684 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 134' ' ' VAL . . . -82.7 -26.83 44.59 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' B' ' 134' ' ' VAL . 97.7 t -78.88 -21.2 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -1.133 . . . . 0.0 109.585 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.02 -38.37 32.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.629 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.8 -21.09 30.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.785 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.21 -48.46 70.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.115 -0.991 . . . . 0.0 109.713 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -58.26 -22.04 50.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.574 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' B' ' 145' ' ' TYR . . . -89.71 26.1 1.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . 0.584 ' CD2' ' HZ1' ' B' ' 144' ' ' LYS . 10.2 t60 -80.53 -6.98 59.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.962 . . . . 0.0 109.13 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.584 ' HZ1' ' CD2' ' B' ' 143' ' ' HIS . 11.6 mptt -122.14 -27.84 4.47 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.52 -0.737 . . . . 0.0 109.696 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 142' ' ' ALA . 0.1 OUTLIER -50.26 -7.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -0.993 . . . . 0.0 110.034 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.707 ' HB3' ' HG3' ' D' ' 132' ' ' LYS . 12.0 m-70 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.736 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.289 0.566 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' C' ' 2' ' ' LEU . 3.9 mm? -94.95 -169.37 1.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.213 -0.929 . . . . 0.0 109.691 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.452 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.1 OUTLIER -116.13 179.55 0.78 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.491 -0.756 . . . . 0.0 109.233 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 21.8 Cg_exo -62.85 -69.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.69 2.26 . . . . 0.0 112.781 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -83.13 -16.69 45.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.931 . . . . 0.0 110.308 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' C' ' 5' ' ' ALA . 7.8 t70 -40.05 -41.18 1.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.955 . . . . 0.0 109.773 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' C' ' 10' ' ' VAL . 68.7 mttt -69.45 -56.04 8.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 53.5 m -45.04 -30.75 1.12 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.32 -0.863 . . . . 0.0 109.707 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -78.39 -36.41 45.92 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' C' ' 7' ' ' LYS . 49.2 t -72.01 -48.93 47.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -53.02 -44.45 67.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 108.783 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.77 -57.34 12.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.361 -0.837 . . . . 0.0 109.338 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -36.27 68.85 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.377 -0.827 . . . . 0.0 109.24 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.79 -17.2 60.66 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.278 -0.889 . . . . 0.0 109.029 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.83 -41.98 21.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -71.43 -42.08 68.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -1.153 . . . . 0.0 108.837 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.71 -63.79 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.576 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 47.8 -127.32 14.62 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 24.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.414 -1.05 . . . . 0.0 110.447 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.576 ' H ' ' C ' ' C' ' 18' ' ' GLY . 88.3 m-70 -128.85 22.05 5.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.905 . . . . 0.0 108.612 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' C' ' 23' ' ' GLU . . . -88.75 -55.85 3.53 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.585 -0.697 . . . . 0.0 109.464 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.59 -14.4 0.64 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' C' ' 21' ' ' ALA . 12.8 mm-40 -87.48 -56.56 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -1.079 . . . . 0.0 109.714 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.9 m-30 -60.78 -22.9 64.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.2 -23.49 63.22 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.96 -40.1 22.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -1.128 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -69.35 -19.59 63.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.284 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -20.39 57.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.684 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mt -78.3 -46.84 19.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 109.752 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -58.04 -38.1 75.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.74 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -63.2 -39.19 93.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 109.526 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 50.9 ttp -64.52 -50.54 66.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.196 -0.94 . . . . 0.0 109.176 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . 0.469 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 1.8 t80 -43.95 -33.99 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.682 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.811 ' HB3' ' HB1' ' D' ' 128' ' ' ALA . 10.4 mt -85.0 -39.87 17.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.793 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 74.5 m -53.44 -38.44 63.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.96 . . . . 0.0 109.749 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' C' ' 35' ' ' SER . 30.8 m-85 -164.22 87.12 1.15 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.877 . . . . 0.0 109.521 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' C' ' 39' ' ' THR . 76.6 Cg_exo -48.21 -19.92 2.0 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.551 2.167 . . . . 0.0 112.135 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' THR . . . . . 0.734 ' CG2' ' HB3' ' B' ' 97' ' ' HIS . 9.0 p -46.84 -18.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.889 . . . . 0.0 109.757 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.444 ' N ' ' O ' ' C' ' 37' ' ' PRO . 53.2 p -80.91 -63.1 1.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.981 . . . . 0.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' C' ' 41' ' ' THR . 8.6 mmpt? -59.05 -18.59 36.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.165 -0.96 . . . . 0.0 109.935 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.403 ' C ' ' O ' ' C' ' 40' ' ' LYS . 5.8 t . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.144 -0.972 . . . . 0.0 109.828 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.626 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.488 0.661 . . . . 0.0 109.648 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.778 ' O ' ' N ' ' C' ' 48' ' ' LEU . 3.3 m-85 -82.87 14.33 3.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.399 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' C' ' 49' ' ' SER . 4.6 m-20 60.39 -51.33 0.09 Allowed 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.778 ' N ' ' O ' ' C' ' 46' ' ' PHE . 19.4 mt 41.53 20.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.661 -0.649 . . . . 0.0 110.004 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.538 ' N ' ' O ' ' C' ' 47' ' ' ASP . 6.2 m -93.35 42.27 1.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . 0.49 ' CG ' ' C ' ' C' ' 49' ' ' SER . 0.7 OUTLIER 71.98 129.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.516 -0.74 . . . . 0.0 109.295 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.42 29.4 73.24 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' C' ' 53' ' ' ALA . 8.1 p -52.34 -36.7 54.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -1.111 . . . . 0.0 109.595 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 73.26 -64.41 0.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.862 . . . . 0.0 109.549 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' C' ' 53' ' ' ALA . 18.9 mt-30 -43.57 -35.78 1.85 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.0 109.482 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -55.35 -28.15 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.433 -0.792 . . . . 0.0 109.986 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' C' ' 57' ' ' GLY . 2.5 ptpt -61.47 -38.97 89.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.031 -1.043 . . . . 0.0 109.461 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . 0.434 ' N ' ' CG ' ' C' ' 56' ' ' LYS . . . -52.41 -35.75 44.73 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 8.7 t-80 -76.65 -27.84 55.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -1.165 . . . . 0.0 109.922 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.61 -37.27 94.18 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -62.64 -24.3 67.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -1.153 . . . . 0.0 110.362 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' C' ' 65' ' ' ALA . 0.2 OUTLIER -65.04 -58.78 5.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.011 -1.056 . . . . 0.0 109.319 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.6 t -54.02 -43.85 60.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.434 -0.791 . . . . 0.0 109.246 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.7 -46.9 62.26 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 108.921 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -64.44 -34.51 78.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 108.655 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' C' ' 61' ' ' LYS . . . -67.06 -50.31 62.26 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -55.75 -44.6 77.77 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 108.704 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.421 ' O ' ' N ' ' C' ' 71' ' ' ALA . 19.2 m -65.43 -54.22 31.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -0.847 . . . . 0.0 108.794 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -55.9 -27.39 51.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.02 -47.78 13.13 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.26 -22.69 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -70.36 -13.04 61.98 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' C' ' 74' ' ' ASP . 34.0 m170 -136.31 -67.12 0.52 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.548 -0.72 . . . . 0.0 109.206 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' C' ' 72' ' ' HIS . 13.2 p 44.64 14.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.946 0.879 . . . . 0.0 109.37 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' C' ' 72' ' ' HIS . 35.2 m-20 -139.26 12.52 2.59 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 1.1 m-20 172.72 30.92 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.688 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 6.9 ptt? -78.29 -22.87 0.4 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.174 -0.954 . . . . 0.0 111.889 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.4 Cg_exo -53.82 -20.69 18.17 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.596 1.531 . . . . 0.0 112.405 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.439 ' O ' ' OG ' ' C' ' 81' ' ' SER . 17.7 t-20 -94.15 -35.55 12.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.825 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.04 -46.91 61.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.157 -0.965 . . . . 0.0 109.303 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 11.7 mt -80.21 8.17 7.9 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.387 -0.821 . . . . 0.0 109.047 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 45.0 p -56.01 -21.87 23.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 109.797 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -70.88 -53.82 13.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.746 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' C' ' 82' ' ' ALA . 6.0 mt -44.82 -46.93 10.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -50.24 -39.62 45.24 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' C' ' 82' ' ' ALA . 28.7 t70 -82.79 -17.39 44.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.807 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.482 ' C ' ' CD1' ' C' ' 86' ' ' LEU . 3.3 tm? -71.4 -58.16 3.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 110.426 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -83.12 -21.79 33.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.956 -1.09 . . . . 0.0 110.697 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.11 -79.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 109.72 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.18 -59.53 5.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.491 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' C' ' 86' ' ' LEU . 41.2 mttm -87.99 135.77 33.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.637 ' C ' ' H ' ' C' ' 93' ' ' VAL . 14.9 mt 61.09 66.44 0.89 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.141 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . 1.368 ' NE ' ' HB2' ' B' ' 40' ' ' ARG . 38.9 ttt-85 -66.34 18.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.637 ' H ' ' C ' ' C' ' 91' ' ' LEU . 11.8 p -42.57 129.55 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 109.709 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.86 148.81 75.36 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.213 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' C' ' 97' ' ' ASN . 37.6 Cg_endo -67.57 -10.95 30.46 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.48 2.12 . . . . 0.0 112.059 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -44.56 -19.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.358 -0.839 . . . . 0.0 109.669 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' C' ' 95' ' ' PRO . 17.7 m120 -79.1 -24.71 43.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.653 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . 0.541 ' CG ' ' N ' ' C' ' 99' ' ' LYS . 0.1 OUTLIER -53.75 -44.96 70.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.426 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.541 ' N ' ' CG ' ' C' ' 98' ' ' PHE . 65.3 mttm -49.33 -41.05 37.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.5 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 12.4 mt -71.61 -43.16 66.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 tt -58.0 -57.03 14.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.341 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 84.3 p -61.87 -34.95 76.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 109.69 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . 0.421 ' O ' ' CD2' ' C' ' 103' ' ' HIS . 22.8 t-160 -77.65 -26.62 50.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 55.3 m -69.84 -41.45 74.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 0.0 109.64 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mt -52.33 -50.19 62.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.962 . . . . 0.0 109.324 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' C' ' 106' ' ' LEU . 3.8 mm? -58.87 -59.11 5.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.635 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -51.73 -49.64 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.197 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.44 ' O ' ' N ' ' C' ' 110' ' ' ALA . 17.6 m -62.06 -60.35 3.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.29 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' C' ' 113' ' ' LEU . 25.5 mt -47.18 -18.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.872 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' C' ' 108' ' ' THR . . . -73.46 -36.14 65.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 110.069 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.11 -3.27 25.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.747 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -141.2 -83.95 0.21 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 109.904 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' C' ' 109' ' ' LEU . 0.3 OUTLIER -106.0 83.35 1.05 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.068 -179.629 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.28 -174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.087 1.858 . . . . 0.0 112.399 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.653 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -46.18 -55.51 6.99 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.558 -0.714 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.653 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 31.7 mt-10 118.93 -6.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 0.489 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 4.8 t80 79.01 34.54 0.21 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.968 -0.458 . . . . 0.0 111.228 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.732 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -109.52 122.7 38.63 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.04 . . . . 0.0 108.271 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.36 18.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.3 2.0 . . . . 0.0 112.915 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -146.32 -33.22 0.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.89 -1.131 . . . . 0.0 110.403 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.536 ' H ' ' HG1' ' C' ' 118' ' ' THR . 7.2 p -51.66 -47.13 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 110.177 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.52 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 2.0 t-160 -59.8 -37.32 78.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.357 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.25 -19.72 33.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.646 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 14.8 p -64.79 -62.54 1.5 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 110.593 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.517 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.6 mt -72.34 -19.73 61.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.11 -0.993 . . . . 0.0 109.932 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.26 -44.5 16.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.981 -1.075 . . . . 0.0 109.64 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -84.94 -41.03 16.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.13 -0.981 . . . . 0.0 109.567 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.492 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 28.0 t80 -51.67 -21.01 2.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.937 -1.102 . . . . 0.0 108.559 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' C' ' 133' ' ' SER . 20.3 mt -76.66 -26.5 54.89 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -54.55 -33.41 60.09 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 131' ' ' SER . . . . . 0.401 ' O ' ' CG2' ' C' ' 135' ' ' VAL . 1.6 m -77.57 -41.87 37.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 4.9 t -75.03 -33.14 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 133' ' ' SER . . . . . 0.513 ' N ' ' O ' ' C' ' 129' ' ' LEU . 31.5 m -77.11 -42.21 38.96 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.485 -0.759 . . . . 0.0 109.146 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 92.2 m -70.26 -26.1 63.66 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.174 -0.954 . . . . 0.0 108.569 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' C' ' 131' ' ' SER . 8.6 t -77.17 -37.84 26.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.17 -38.45 86.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 108.846 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 24.9 m -90.34 -14.57 32.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.239 -0.913 . . . . 0.0 109.477 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.461 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 t60 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -127.74 177.74 6.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.343 -0.848 . . . . 0.0 109.138 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.436 ' OG1' ' OE2' ' D' ' 7' ' ' GLU . 0.6 OUTLIER -68.65 125.3 91.64 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.044 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . 0.435 ' O ' ' OG ' ' D' ' 9' ' ' SER . 82.7 Cg_exo -42.11 -35.47 3.32 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.325 2.017 . . . . 0.0 112.488 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . 0.453 ' N ' ' CD ' ' D' ' 6' ' ' GLU . 14.2 mp0 -76.2 -23.93 54.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 109.731 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' D' ' 7' ' ' GLU . 0.2 OUTLIER -84.09 -39.6 19.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.797 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.486 ' O ' ' OG1' ' D' ' 12' ' ' THR . 22.9 pttt -83.78 -39.27 20.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.0 110.074 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 9' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 19.7 m -43.78 -23.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 110.163 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -82.25 -57.05 3.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.114 -0.991 . . . . 0.0 109.979 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.08 -24.73 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 5.0 m -74.9 -45.83 40.06 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.387 0.613 . . . . 0.0 109.597 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.51 94.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.427 -0.796 . . . . 0.0 109.688 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.5 OUTLIER -48.06 -34.49 9.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.368 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -45.77 -17.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.827 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -76.44 -43.11 20.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -79.72 -30.6 40.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.127 -1.219 . . . . 0.0 109.247 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -47.86 114.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 109.569 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' D' ' 22' ' ' GLU . 5.8 m-20 -77.87 66.04 3.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 108.988 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . 0.466 ' C ' ' H ' ' D' ' 22' ' ' GLU . 73.7 t -43.66 -26.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.446 -0.784 . . . . 0.0 109.786 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.72 7.22 0.92 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' D' ' 20' ' ' VAL . 36.6 mt-10 -155.28 -50.25 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.567 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 69.7 t -46.98 -33.86 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.47 -50.78 59.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.35 -36.81 79.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -73.68 -38.76 64.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -1.158 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.82 -34.07 72.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 109.436 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -84.94 -34.56 22.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.45 -50.2 60.81 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -58.22 -30.6 66.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -1.117 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -50.41 -39.17 46.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.967 . . . . 0.0 109.499 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 mt -81.03 -22.0 39.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.163 -0.961 . . . . 0.0 109.597 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 21.1 t -82.7 -64.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.772 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . 0.477 HG13 ' CD2' ' C' ' 122' ' ' HIS . 2.3 t -64.57 -22.9 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.875 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -139.77 78.63 25.16 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.285 -0.884 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' D' ' 39' ' ' GLN . 76.6 Cg_endo -82.81 -17.81 6.9 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.814 2.342 . . . . 0.0 112.417 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . 0.57 ' O ' ' NH2' ' A' ' 92' ' ' ARG . 5.2 p-90 -49.7 -19.89 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.435 ' O ' ' N ' ' D' ' 41' ' ' PHE . 1.4 p -92.1 -11.39 35.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.264 -0.897 . . . . 0.0 109.332 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' D' ' 36' ' ' PRO . 1.5 tm0? -45.03 -34.17 2.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.337 -0.852 . . . . 0.0 109.736 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . 1.448 ' HB2' ' NE ' ' A' ' 92' ' ' ARG . 37.7 mtp85 -61.12 -26.08 67.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.441 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' D' ' 38' ' ' THR . 32.3 t80 -100.85 30.75 3.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -0.865 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -146.26 31.24 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 109.343 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.75 -14.08 58.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.406 ' C ' ' N ' ' D' ' 46' ' ' GLY . 28.5 t -65.52 -43.79 88.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.541 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . 0.501 ' O ' ' N ' ' D' ' 47' ' ' ASP . 44.5 m-85 -48.99 -18.49 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.425 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' D' ' 48' ' ' LEU . . . 65.82 -66.58 0.12 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' D' ' 45' ' ' PHE . 79.6 m-20 -54.07 86.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -1.123 . . . . 0.0 109.632 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' D' ' 46' ' ' GLY . 0.8 OUTLIER -164.46 21.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.167 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.0 m -57.98 -41.04 82.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.419 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 50' ' ' THR . . . . . 0.434 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.3 p -146.28 152.29 46.16 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.0 109.092 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -40.49 -30.12 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.449 2.1 . . . . 0.0 112.361 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -75.13 -29.14 60.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.615 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -63.93 -20.39 65.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.63 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.58 -24.04 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 55' ' ' MET . . . . . 0.418 ' O ' ' OD1' ' D' ' 57' ' ' ASN . 16.3 mmt -90.0 -6.14 55.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.605 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.602 ' O ' ' CB ' ' D' ' 57' ' ' ASN . . . -47.94 -35.82 13.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . 0.725 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 21.3 m-20 91.7 23.55 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 122.137 -0.625 . . . . 0.0 111.568 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' D' ' 57' ' ' ASN . 75.3 Cg_endo -81.36 -157.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.948 1.765 . . . . 0.0 112.122 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -47.61 -24.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 58' ' ' PRO . 54.7 t -51.56 -50.18 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.494 -0.754 . . . . 0.0 109.279 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -32.62 43.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.38 -0.825 . . . . 0.0 109.631 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.02 -49.74 74.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.979 . . . . 0.0 109.532 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -59.42 -26.28 65.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 109.557 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.47 -19.46 74.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -76.09 -24.91 55.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -1.176 . . . . 0.0 109.082 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -74.36 -59.18 2.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.84 . . . . 0.0 109.564 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -47.15 -34.16 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.465 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.47 -42.61 95.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.142 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.71 -49.92 51.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.7 -33.5 66.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -1.144 . . . . 0.0 109.52 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -76.2 -37.66 57.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -80.42 -28.28 37.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 109.385 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -51.11 -38.86 54.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.915 . . . . 0.0 109.415 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.22 -60.15 7.96 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.482 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.9 mp -56.87 -18.63 13.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -1.131 . . . . 0.0 109.345 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -83.22 -19.32 36.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.883 . . . . 0.0 109.615 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 72.0 m-70 -159.37 62.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.689 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.1 -0.43 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.945 . . . . 0.0 109.409 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' D' ' 77' ' ' HIS . 45.8 t0 -57.66 -25.85 60.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.503 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' D' ' 80' ' ' ASN . 9.0 p-10 -170.64 105.9 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 10.2 mp -79.97 -57.3 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -45.83 -23.97 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 109.566 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.82 -63.27 2.75 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.0 t -61.02 -47.46 86.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -1.181 . . . . 0.0 109.557 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 64.4 m-85 -67.82 4.68 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.574 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.68 -46.68 77.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.544 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -75.08 -52.46 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.522 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 55.6 mt -50.74 -47.46 59.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 89' ' ' SER . . . . . 0.504 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 14.7 m -57.5 -36.19 71.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -79.88 -22.25 43.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.98 -18.01 26.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.766 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' D' ' 88' ' ' LEU . 10.0 m80 -87.88 -60.67 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.96 -1.088 . . . . 0.0 110.486 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . 0.649 ' HG ' ' H ' ' D' ' 94' ' ' ASP . 12.5 p -83.94 -59.78 2.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.969 -1.082 . . . . 0.0 111.438 -178.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.649 ' H ' ' HG ' ' D' ' 93' ' ' CYS . 14.2 m-20 -59.14 -26.76 65.02 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.095 -1.003 . . . . 0.0 111.709 -177.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . 0.526 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 3.2 tppp? -107.55 -51.93 2.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.658 -1.276 . . . . 0.0 110.796 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.451 ' C ' ' CD2' ' D' ' 97' ' ' HIS . 5.7 mp -87.22 -30.55 20.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.915 -1.115 . . . . 0.0 109.918 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.79 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 9.6 m-70 66.47 49.19 1.41 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.16 -0.962 . . . . 0.0 110.039 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 33.0 t -96.63 114.2 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.27 -0.894 . . . . 0.0 108.987 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' D' ' 100' ' ' PRO . 0.9 OUTLIER -62.65 153.59 77.63 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.553 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' D' ' 99' ' ' ASP . 50.6 Cg_exo -51.86 -156.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.504 2.136 . . . . 0.0 112.409 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 52.93 46.66 26.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.578 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' D' ' 100' ' ' PRO . 35.3 m120 -158.03 -35.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -65.0 -39.16 93.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.494 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -65.55 -31.2 72.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 109.666 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' D' ' 105' ' ' LEU . 9.8 mp -62.4 -57.98 9.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.437 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 tt -48.2 -22.73 0.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.627 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' D' ' 109' ' ' VAL . . . -79.3 -45.51 8.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -46.53 -16.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -1.176 . . . . 0.0 109.623 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' D' ' 107' ' ' GLY . 98.2 t -85.07 -62.62 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.503 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 14.7 mt -47.39 -26.18 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.661 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 70.8 t -68.96 -47.52 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.084 -1.01 . . . . 0.0 109.906 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 20.0 p -79.41 -41.22 28.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.138 -0.976 . . . . 0.0 110.037 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 78.2 t -47.57 -41.07 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.721 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' D' ' 118' ' ' PHE . 46.6 mt -79.52 -40.37 29.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.567 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.429 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.2 -30.38 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.399 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.525 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -84.75 -56.96 3.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 109.235 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 85.8 m-70 -63.48 -17.66 62.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.574 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' D' ' 114' ' ' LEU . 65.6 m-85 -153.33 62.32 0.76 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 109.544 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' D' ' 122' ' ' PHE . . . -68.84 -50.51 35.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -47.95 -30.93 4.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.191 . . . . 0.0 109.404 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -82.81 -18.98 38.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.557 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' D' ' 119' ' ' GLY . 6.3 t80 -76.17 66.6 2.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.129 -0.982 . . . . 0.0 109.293 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -79.1 149.68 73.51 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.288 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -45.3 -53.6 5.24 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.488 2.125 . . . . 0.0 112.972 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 25.7 Cg_endo -62.52 1.18 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.012 1.808 . . . . 0.0 112.21 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . 0.404 ' H ' ' C ' ' D' ' 124' ' ' PRO . 86.9 t -112.44 -8.31 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.21 -54.08 5.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 109.556 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 0.811 ' HB1' ' HB3' ' C' ' 34' ' ' LEU . . . -54.62 -33.84 61.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.14 2.52 17.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.21 -29.5 13.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 109.444 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -84.34 -23.49 30.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 109.901 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . 0.707 ' HG3' ' HB3' ' B' ' 146' ' ' HIS . 14.4 ttmt -85.46 -36.06 20.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.141 -0.974 . . . . 0.0 110.183 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . 0.62 ' CG1' ' H ' ' D' ' 134' ' ' VAL . 11.9 p -65.44 -58.78 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.094 -1.004 . . . . 0.0 110.041 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.62 ' H ' ' CG1' ' D' ' 133' ' ' VAL . 11.5 t -62.23 -33.38 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 0.0 109.959 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -45.92 -21.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 0.0 109.743 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -82.79 -26.75 44.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' D' ' 134' ' ' VAL . 97.5 t -78.89 -21.15 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -1.148 . . . . 0.0 109.644 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.11 -38.3 31.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 109.644 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.66 -21.21 30.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.755 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.26 -48.44 70.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 0.0 109.697 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.15 -22.08 49.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . 0.533 ' O ' ' CD1' ' D' ' 145' ' ' TYR . . . -89.65 26.07 1.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 0.0 109.568 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . 0.577 ' CD2' ' HZ1' ' D' ' 144' ' ' LYS . 10.0 t60 -80.53 -6.91 58.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.108 -0.995 . . . . 0.0 109.128 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.577 ' HZ1' ' CD2' ' D' ' 143' ' ' HIS . 11.6 mptt -122.15 -27.96 4.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.457 -0.777 . . . . 0.0 109.671 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' D' ' 142' ' ' ALA . 0.1 OUTLIER -50.21 -7.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 110.066 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.723 ' HB3' ' HG3' ' B' ' 132' ' ' LYS . 12.0 m-70 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.669 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.28 -169.92 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -0.907 . . . . 0.0 109.903 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.51 ' N ' ' OD2' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -100.01 -179.2 0.78 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.35 -0.844 . . . . 0.0 109.566 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 23.0 Cg_exo -62.83 -58.51 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.893 2.395 . . . . 0.0 113.049 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -78.65 -16.44 57.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.03 -1.044 . . . . 0.0 110.204 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 3' ' ' SER . 33.5 m-20 -39.79 -30.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 0.0 109.72 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.592 ' H ' ' CD ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -83.7 -39.47 20.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.531 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' ALA . 37.2 m -44.82 -42.87 8.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.461 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.24 -25.33 62.44 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.578 ' N ' ' O ' ' A' ' 7' ' ' LYS . 53.2 t -78.82 -55.19 10.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -53.48 -37.19 62.47 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.459 -1.296 . . . . 0.0 107.875 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.78 -63.18 1.22 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.238 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.409 ' O ' ' CG2' ' A' ' 17' ' ' VAL . . . -60.24 -36.17 77.15 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -0.843 . . . . 0.0 108.768 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -17.51 62.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 109.088 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -78.79 -46.43 8.54 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.14 -36.62 74.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -1.098 . . . . 0.0 108.817 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 95.4 t -60.65 -65.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 58.71 -134.9 52.32 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.41 27.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.429 -1.042 . . . . 0.0 110.437 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.577 ' H ' ' C ' ' A' ' 18' ' ' GLY . 92.4 m-70 -131.58 25.68 4.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.199 -0.938 . . . . 0.0 108.481 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.57 -61.66 1.66 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.613 -0.679 . . . . 0.0 109.754 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.68 -14.38 0.23 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 1.2 mm-40 -84.33 -56.33 3.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -1.091 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.605 ' CE1' ' CG ' ' A' ' 112' ' ' HIS . 2.8 m-30 -60.64 -27.78 68.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.458 -0.776 . . . . 0.0 109.172 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.82 -22.92 75.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.2 18.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -1.138 . . . . 0.0 109.795 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -64.29 -19.88 65.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 109.511 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.11 -19.68 60.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 109.313 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.43 -54.1 6.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 109.6 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.26 -37.6 64.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.447 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -43.87 98.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 53.5 ttp -67.26 -49.92 62.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.425 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -51.54 -46.32 63.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.632 ' HB3' ' HB3' ' B' ' 128' ' ' ALA . 12.8 mt -64.09 -60.21 3.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 109.793 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 18.8 p -55.46 -18.98 8.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.646 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 35' ' ' SER . 79.6 m-85 -156.05 113.36 2.13 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 39' ' ' THR . 73.0 Cg_endo -79.56 -20.14 9.62 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.32 2.013 . . . . 0.0 111.945 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.0 p -47.12 -18.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.373 -0.829 . . . . 0.0 109.735 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 37' ' ' PRO . 42.6 p -74.68 -22.72 58.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 109.876 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -70.13 -20.05 63.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.0 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.818 -179.69 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.574 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 15.1 p80 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 120.984 0.421 . . . . 0.0 111.297 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 47' ' ' ASP . 4.9 p90 -145.42 23.2 1.47 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.891 -1.131 . . . . 0.0 109.526 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 49' ' ' SER . 57.2 m-20 42.52 84.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.551 -0.718 . . . . 0.0 109.829 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.474 ' H ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -50.22 -11.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 47' ' ' ASP . 14.7 m -58.88 147.36 34.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.383 -0.823 . . . . 0.0 109.491 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -64.54 148.46 50.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.596 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.03 83.81 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 54' ' ' GLN . 5.4 p -69.07 -23.72 64.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -1.221 . . . . 0.0 109.337 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' LYS . . . 67.57 -56.15 0.46 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.837 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 52' ' ' SER . 43.1 mt-30 -43.89 -22.44 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.356 -0.84 . . . . 0.0 109.812 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 53' ' ' ALA . 41.0 t -74.35 -26.74 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.32 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.7 ptmt -65.7 -27.41 68.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.87 . . . . 0.0 109.552 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.08 -50.44 40.12 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -53.85 -32.42 52.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -1.156 . . . . 0.0 109.476 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.22 -47.27 91.92 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -58.35 -23.43 56.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -1.081 . . . . 0.0 109.592 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.29 -39.49 62.9 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.228 -0.92 . . . . 0.0 108.88 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.7 -49.07 48.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.97 71.17 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.299 -0.876 . . . . 0.0 109.052 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -67.18 -38.73 85.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.299 -0.876 . . . . 0.0 108.759 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -64.07 -52.1 60.96 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -57.24 -44.6 83.98 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.243 -0.91 . . . . 0.0 108.731 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.4 m -68.74 -50.65 48.97 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -60.36 -24.28 64.95 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.96 -45.64 12.0 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.65 -23.38 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.66 -18.7 64.23 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.7 m80 -144.08 -58.89 0.39 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.404 -0.81 . . . . 0.0 109.339 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.3 p 44.19 13.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 121.879 0.847 . . . . 0.0 109.561 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.612 ' N ' ' O ' ' A' ' 72' ' ' HIS . 46.0 t0 -133.8 11.08 3.99 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 179.03 29.39 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.973 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.695 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 17.4 ptt? -78.62 -22.61 0.39 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.426 -0.796 . . . . 0.0 111.805 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.695 ' CD ' ' N ' ' A' ' 76' ' ' MET . 52.4 Cg_exo -54.12 -22.27 24.84 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.497 1.465 . . . . 0.0 112.347 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.429 ' O ' ' OG ' ' A' ' 81' ' ' SER . 9.4 m120 -94.16 -33.86 13.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.8 59.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.146 -0.971 . . . . 0.0 109.353 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.36 8.5 7.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.372 -0.83 . . . . 0.0 109.123 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 37.0 p -55.89 -17.11 5.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.929 . . . . 0.0 109.666 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.09 -55.97 4.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.448 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 3.5 mt -45.4 -44.02 11.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 108.935 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 136' ' ' LEU . 29.7 t -57.23 -22.63 42.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.503 -0.748 . . . . 0.0 109.448 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.538 ' OD1' ' CE1' ' A' ' 89' ' ' HIS . 23.1 t70 -82.01 -58.3 3.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.854 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.63 -27.45 17.17 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.757 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.448 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 38.6 m80 -91.84 -21.76 20.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.858 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.47 -11.35 15.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.214 -0.929 . . . . 0.0 109.902 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.538 ' CE1' ' OD1' ' A' ' 85' ' ' ASP . 14.4 m80 -113.94 -77.81 0.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 89' ' ' HIS . 9.9 mptt -45.79 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.481 ' C ' ' N ' ' A' ' 93' ' ' VAL . 19.6 mt -65.69 -17.33 64.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.838 . . . . 0.0 110.16 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.518 ' NH1' ' OE2' ' D' ' 43' ' ' GLU . 25.0 ttm180 48.93 15.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 109.003 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.481 ' N ' ' C ' ' A' ' 91' ' ' LEU . 10.8 p -46.01 156.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.0 109.878 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.23 153.03 37.98 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.39 -0.818 . . . . 0.0 109.046 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 98' ' ' PHE . 32.7 Cg_endo -65.79 -10.64 27.48 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.539 2.159 . . . . 0.0 111.954 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 95' ' ' PRO . 83.4 t -44.05 -29.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.343 -0.848 . . . . 0.0 109.767 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -79.32 -32.92 43.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.577 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -50.18 -34.9 24.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.347 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -49.99 -34.91 22.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.8 mt -82.12 -50.52 8.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.1 tp -45.77 -20.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.627 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' LEU . 93.3 p -73.3 -59.33 2.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 109.945 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.796 ' CG ' HD22 ' B' ' 108' ' ' ASN . 40.7 m80 -71.81 -26.48 62.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.922 . . . . 0.0 109.769 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 62.4 m -58.11 -42.23 85.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.89 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.64 -22.74 62.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.186 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.546 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 3.7 mm? -79.01 -35.96 41.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.0 -1.062 . . . . 0.0 110.137 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.3 t -62.89 -39.46 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.058 -1.026 . . . . 0.0 109.499 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.486 ' OG1' ' N ' ' A' ' 109' ' ' LEU . 12.2 p -65.23 -62.97 1.22 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.176 -0.952 . . . . 0.0 109.644 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.486 ' N ' ' OG1' ' A' ' 108' ' ' THR . 14.7 mt -48.2 -22.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.35 -36.47 83.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 109.896 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.16 -42.59 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.158 -0.964 . . . . 0.0 109.893 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.605 ' CG ' ' CE1' ' A' ' 24' ' ' TYR . 93.3 m-70 -81.8 -75.36 0.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.011 . . . . 0.0 109.519 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.479 ' O ' ' CG ' ' A' ' 113' ' ' LEU . 1.5 pp -137.14 94.44 12.48 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.19 -171.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.248 1.965 . . . . 0.0 112.931 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -47.23 -38.55 12.44 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.52 0.676 . . . . 0.0 109.539 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 6.7 mt-10 85.37 9.52 0.33 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.805 ' CE1' ' NE2' ' B' ' 116' ' ' HIS . 6.9 m-85 65.04 34.86 8.48 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.83 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.713 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -94.42 121.3 63.76 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.745 -1.222 . . . . 0.0 107.971 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -51.31 23.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.039 1.826 . . . . 0.0 112.914 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -154.97 -30.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.778 -1.201 . . . . 0.0 110.851 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.543 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 11.8 p -47.83 -50.38 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.086 -1.008 . . . . 0.0 110.375 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.543 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 2.4 t-80 -65.38 -43.5 90.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.453 -0.779 . . . . 0.0 109.999 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' B' ' 34' ' ' VAL . . . -79.07 -19.36 51.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.243 -0.911 . . . . 0.0 109.921 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 120' ' ' ALA . 64.3 m -72.45 -63.95 1.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 111.08 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.01 -18.25 64.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.947 -1.096 . . . . 0.0 109.48 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.26 -49.41 10.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.961 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.83 -57.77 2.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.906 -1.122 . . . . 0.0 111.441 -178.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' A' ' 124' ' ' SER . 21.9 m-85 -46.55 -21.53 0.19 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.776 -1.202 . . . . 0.0 110.239 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' A' ' 129' ' ' LEU . 0.7 OUTLIER -66.58 -18.87 65.6 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 134' ' ' THR . . . -55.96 -33.21 64.55 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.489 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 7.9 t -66.77 -36.73 83.11 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.217 -0.927 . . . . 0.0 108.762 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.34 -40.0 24.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.8 t -73.41 -37.8 65.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.324 -0.86 . . . . 0.0 108.905 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 130' ' ' ALA . 88.9 m -71.55 -31.08 66.62 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.234 -0.916 . . . . 0.0 108.555 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.44 -36.58 67.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' A' ' 84' ' ' SER . 3.3 mp -56.71 -32.93 65.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 109.008 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.9 m -89.34 -27.25 20.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.59 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.528 -179.927 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 19.0 m170 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.617 ' H ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -86.47 178.11 7.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.188 -0.945 . . . . 0.0 109.25 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.415 ' O ' ' N ' ' B' ' 6' ' ' GLU . 7.5 p -92.09 145.42 30.81 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 109.368 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -39.96 -26.03 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.544 2.162 . . . . 0.0 112.17 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' B' ' 4' ' ' THR . 39.4 mt-10 -81.69 -51.91 7.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.565 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' B' ' 7' ' ' GLU . 0.7 OUTLIER -75.38 -22.6 57.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.913 . . . . 0.0 109.504 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.491 ' O ' ' OG1' ' B' ' 12' ' ' THR . 6.7 tttm -78.47 -37.1 44.21 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.33 -0.856 . . . . 0.0 109.121 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -63.12 -23.31 67.38 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.12 -57.64 3.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.148 -0.97 . . . . 0.0 110.166 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.46 -24.92 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.055 . . . . 0.0 108.574 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 96.4 m -78.26 -31.58 49.17 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.749 -0.594 . . . . 0.0 109.823 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -67.23 -63.79 0.99 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.767 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' B' ' 14' ' ' LEU . 10.6 mp -45.83 -19.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.388 -0.82 . . . . 0.0 109.901 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' TRP . . . . . 0.463 ' N ' ' O ' ' B' ' 13' ' ' ALA . 4.0 t90 -78.78 -40.82 32.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.064 -1.023 . . . . 0.0 108.82 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.43 -24.07 59.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -79.87 -32.65 40.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -1.014 . . . . 0.0 109.286 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -62.6 132.08 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.318 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' B' ' 21' ' ' ASP . 71.8 m-20 -81.26 78.28 8.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.246 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -49.82 -10.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' B' ' 19' ' ' ASN . 21.4 m-20 -55.31 -29.95 59.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.895 . . . . 0.0 109.729 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' B' ' 25' ' ' GLY . 18.3 pt-20 -152.5 -32.16 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.96 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' B' ' 22' ' ' GLU . 92.8 t -44.71 -26.32 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 109.638 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.51 -26.27 47.57 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.52 ' CA ' ' HZ1' ' B' ' 65' ' ' LYS . . . -66.85 -45.12 86.62 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.415 ' OE2' ' N ' ' B' ' 26' ' ' GLU . 1.2 mp0 -63.91 -47.75 79.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -1.144 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.41 -30.8 42.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.161 -0.962 . . . . 0.0 109.372 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.2 -54.27 5.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.37 -35.23 91.78 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -67.01 -32.38 73.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.12 . . . . 0.0 109.466 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 tp -47.24 -41.31 18.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 109.638 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.68 -23.91 39.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 109.712 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.17 -64.03 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.983 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 2.5 t -46.76 -43.9 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.322 -0.861 . . . . 0.0 109.373 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -171.79 130.0 0.69 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.336 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.59 62.32 7.71 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.302 2.002 . . . . 0.0 112.088 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' TRP . . . . . 0.493 ' CD1' ' N ' ' B' ' 37' ' ' TRP . 0.0 OUTLIER -57.65 -43.75 85.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.151 -0.968 . . . . 0.0 109.276 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.533 ' OG1' ' N ' ' B' ' 39' ' ' GLN . 1.7 p -49.78 -64.42 0.81 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.902 . . . . 0.0 109.373 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . 0.533 ' N ' ' OG1' ' B' ' 38' ' ' THR . 31.8 tt0 48.16 43.94 18.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.483 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 -163.44 -36.67 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.554 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -119.28 16.11 13.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 109.193 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' B' ' 43' ' ' GLU . 30.7 p90 -87.54 -35.15 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.534 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.489 ' OE2' ' NH1' ' C' ' 92' ' ' ARG . 12.1 pt-20 -81.98 -13.92 56.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.683 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 86.4 p -57.68 -29.05 64.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.6 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -85.23 19.23 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.514 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.62 1.87 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' B' ' 48' ' ' LEU . 35.7 t0 49.79 -145.96 0.41 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -1.196 . . . . 0.0 109.488 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.542 ' H ' ' CG ' ' B' ' 47' ' ' ASP . 2.4 tp 82.73 24.29 0.16 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.787 -0.571 . . . . 0.0 109.64 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -57.59 -35.16 70.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.935 . . . . 0.0 109.202 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' THR . . . . . 0.605 ' HG1' ' H ' ' B' ' 52' ' ' ASP . 1.2 p -146.93 153.64 46.09 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 108.923 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.44 -22.74 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.258 1.972 . . . . 0.0 112.257 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.605 ' H ' ' HG1' ' B' ' 50' ' ' THR . 26.2 t70 -85.13 -38.58 18.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.92 -19.52 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.34 -0.85 . . . . 0.0 109.53 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' B' ' 52' ' ' ASP . 14.4 t -60.63 -59.34 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 17.2 ptp -90.33 14.13 13.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.895 . . . . 0.0 109.572 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.85 -18.98 58.77 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -89.08 146.95 37.45 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.133 -1.216 . . . . 0.0 109.486 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.87 -20.44 17.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.565 2.177 . . . . 0.0 112.388 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.61 -32.37 25.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 109.796 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -60.65 -41.15 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.969 . . . . 0.0 109.654 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.536 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 11.9 ptpt -79.03 -35.87 42.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -0.989 . . . . 0.0 109.38 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.25 69.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.87 -24.05 60.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.91 . . . . 0.0 109.594 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.72 -19.08 80.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -68.5 -32.2 72.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -1.139 . . . . 0.0 109.323 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -75.95 -34.46 59.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.631 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.9 -62.87 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tt -50.21 -29.01 8.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.934 . . . . 0.0 109.315 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.73 -38.93 96.74 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.47 93.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -1.135 . . . . 0.0 109.822 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -46.98 -30.25 2.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.772 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' SER . . . . . 0.445 ' O ' ' N ' ' B' ' 76' ' ' ALA . 3.9 p -57.56 -49.7 75.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -60.38 -16.91 39.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.399 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.17 -31.04 79.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' B' ' 75' ' ' LEU . 1.4 pt? -136.58 -22.38 1.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.268 -1.136 . . . . 0.0 110.031 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -77.59 5.11 9.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.03 -1.044 . . . . 0.0 109.733 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 46.5 m-70 -161.03 66.22 0.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 87.1 mt -72.96 10.82 0.8 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.498 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' B' ' 77' ' ' HIS . 13.7 t70 -66.74 -45.68 77.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.422 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -162.21 96.2 0.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.805 . . . . 0.0 109.414 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 24.7 mt -76.16 -58.79 3.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.579 ' NZ ' ' CD2' ' B' ' 143' ' ' HIS . 11.0 ttmm -54.72 -23.94 19.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.486 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.13 -47.54 9.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.8 t -78.25 -48.28 16.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -1.158 . . . . 0.0 109.628 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' PHE . . . . . 0.563 ' N ' ' CG2' ' B' ' 84' ' ' THR . 27.9 m-85 -59.62 -1.71 0.28 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.5 -0.75 . . . . 0.0 109.425 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -56.3 -35.25 67.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.371 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 34.8 p -73.09 -57.77 3.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 32.5 mt -56.43 -29.5 61.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.312 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 69.6 m -81.14 -32.56 33.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -82.6 -22.28 34.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.869 . . . . 0.0 109.546 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 tt -78.78 -68.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.759 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' B' ' 97' ' ' HIS . 0.4 OUTLIER -55.31 -20.12 10.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.075 -179.198 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' CYS . . . . . 0.532 ' N ' ' ND1' ' B' ' 92' ' ' HIS . 36.4 t -83.53 -60.68 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 110.642 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' B' ' 94' ' ' ASP . 0.8 OUTLIER -87.78 -25.75 23.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.084 -1.01 . . . . 0.0 111.446 -178.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.96 -52.24 5.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.717 -1.239 . . . . 0.0 110.96 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.607 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 2.3 mm? -112.56 -11.63 13.56 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.941 -1.1 . . . . 0.0 109.828 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 49.2 p-80 41.84 41.51 1.87 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.351 -0.843 . . . . 0.0 109.761 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 59.6 t -51.41 132.32 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -0.819 . . . . 0.0 109.457 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.07 153.0 90.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.171 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.47 -164.76 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.544 2.162 . . . . 0.0 112.229 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 56.91 48.38 15.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -0.936 . . . . 0.0 109.36 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -160.62 -33.53 0.05 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.315 -0.865 . . . . 0.0 109.46 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -63.42 -60.94 2.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.37 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -57.53 -20.3 30.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.357 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 tt -77.34 -49.79 14.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.383 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tt -49.38 -46.3 47.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.274 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.35 -45.82 95.45 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' ASN . . . . . 0.796 HD22 ' CG ' ' A' ' 103' ' ' HIS . 11.8 t-20 -53.8 -34.7 59.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.151 -1.205 . . . . 0.0 109.565 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' VAL . . . . . 0.481 ' O ' ' SG ' ' B' ' 112' ' ' CYS . 89.7 t -80.28 -24.06 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 34.6 tp -78.06 -32.37 50.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.29 -49.59 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 109.754 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' B' ' 109' ' ' VAL . 18.7 p -53.08 -37.21 61.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.692 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' VAL . . . . . 0.468 ' N ' ' SG ' ' B' ' 112' ' ' CYS . 96.5 t -60.64 -21.37 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.661 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' B' ' 130' ' ' TYR . 23.6 mt -77.63 -57.02 4.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' ALA . . . . . 0.462 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.1 -19.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.372 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' HIS . . . . . 0.805 ' NE2' ' CE1' ' A' ' 117' ' ' PHE . 1.5 t-80 -79.33 -56.78 4.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -69.24 -17.72 63.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 109.71 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -151.22 60.96 0.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 0.0 109.588 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -77.76 -23.23 67.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.53 8.71 4.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -1.1 . . . . 0.0 109.447 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' B' ' 123' ' ' THR . 20.4 mm-40 -134.63 12.88 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.18 43.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.0 109.119 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.417 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.0 OUTLIER -48.64 151.1 2.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.147 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.485 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.0 Cg_exo -45.98 -52.32 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.281 1.987 . . . . 0.0 113.029 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 46.8 Cg_endo -68.34 15.24 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.173 1.916 . . . . 0.0 112.973 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 53.2 t -108.53 -42.69 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.988 -1.07 . . . . 0.0 109.878 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' GLN . . . . . 0.544 ' CD ' ' H ' ' B' ' 127' ' ' GLN . 0.0 OUTLIER -70.7 -59.87 2.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.086 -1.009 . . . . 0.0 109.798 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 34' ' ' LEU . . . -49.48 -34.79 17.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.099 -1.001 . . . . 0.0 109.358 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.34 27.75 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.29 -0.881 . . . . 0.0 109.641 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' TYR . . . . . 0.516 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 1.6 t80 -126.69 -34.68 2.39 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.356 -0.84 . . . . 0.0 109.637 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -71.22 -62.86 1.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.743 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -48.7 -21.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.774 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 33.8 t -69.13 -65.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.741 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 9.2 m -74.15 -16.38 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.607 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.463 ' HB2' ' HD2' ' D' ' 146' ' ' HIS . . . -49.41 -30.26 7.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.331 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.59 -26.3 70.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.79 -39.81 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -1.11 . . . . 0.0 109.367 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.88 95.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . 0.873 ' ND2' ' CE1' ' D' ' 146' ' ' HIS . 1.2 m-20 -73.72 -44.14 57.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.422 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.09 -37.68 47.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.331 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.529 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 18.1 mt -82.35 11.27 5.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' B' ' 144' ' ' LYS . . . -123.7 -30.97 3.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.382 -0.823 . . . . 0.0 109.514 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . 0.579 ' CD2' ' NZ ' ' B' ' 82' ' ' LYS . 1.5 m80 -49.68 -13.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.355 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 144' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' B' ' 142' ' ' ALA . 3.2 tptp -77.88 -43.07 31.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.21 -0.931 . . . . 0.0 109.511 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -50.1 -25.25 3.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 146' ' ' HIS . . . . . 0.837 ' CE1' ' ND2' ' D' ' 139' ' ' ASN . 25.8 m170 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.495 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.36 -169.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.897 . . . . 0.0 109.862 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 3' ' ' SER . . . . . 0.529 ' H ' ' CG ' ' C' ' 6' ' ' ASP . 0.1 OUTLIER -99.93 -179.11 0.77 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.404 -0.81 . . . . 0.0 109.644 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 4' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 22.8 Cg_exo -62.92 -58.46 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.908 2.405 . . . . 0.0 113.091 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 5' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -78.7 -16.4 57.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.1 -1.0 . . . . 0.0 110.215 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' C' ' 3' ' ' SER . 33.5 m-20 -39.86 -30.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 7' ' ' LYS . . . . . 0.588 ' CD ' ' H ' ' C' ' 7' ' ' LYS . 0.0 OUTLIER -83.65 -39.52 20.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.493 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.45 ' N ' ' O ' ' C' ' 5' ' ' ALA . 36.4 m -44.85 -42.87 8.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.369 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.23 -25.37 62.47 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' C' ' 7' ' ' LYS . 52.9 t -78.83 -55.24 10.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' C' ' 15' ' ' GLY . 0.0 OUTLIER -53.41 -37.18 62.27 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.526 -1.27 . . . . 0.0 107.89 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.79 -63.16 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.332 -0.855 . . . . 0.0 109.241 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . 0.406 ' O ' ' CG2' ' C' ' 17' ' ' VAL . . . -60.29 -36.2 77.31 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -17.49 62.37 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 109.067 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' C' ' 11' ' ' LYS . . . -78.86 -46.42 8.48 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.04 -36.65 75.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -1.118 . . . . 0.0 108.869 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' C' ' 13' ' ' ALA . 94.9 t -60.65 -66.02 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.588 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 58.77 -134.78 52.36 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.55 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -1.025 . . . . 0.0 110.427 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' HIS . . . . . 0.588 ' H ' ' C ' ' C' ' 18' ' ' GLY . 92.2 m-70 -131.59 25.72 4.74 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.65 -61.55 1.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.61 -0.681 . . . . 0.0 109.755 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.7 -14.42 0.23 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 21' ' ' ALA . 1.2 mm-40 -84.28 -56.4 3.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -1.059 . . . . 0.0 109.526 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' TYR . . . . . 0.606 ' CE1' ' CG ' ' C' ' 112' ' ' HIS . 2.8 m-30 -60.6 -27.83 68.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 109.176 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.75 -22.94 75.66 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.72 -41.98 18.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.249 -1.147 . . . . 0.0 109.832 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -64.37 -19.99 65.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.405 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.05 -19.71 60.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.347 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.41 -53.98 6.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.688 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.31 -37.64 65.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -43.84 98.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 53.4 ttp -67.29 -49.96 62.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.407 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -51.49 -46.32 63.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' D' ' 128' ' ' ALA . 12.8 mt -64.08 -60.22 3.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.927 . . . . 0.0 109.865 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 18.7 p -55.36 -19.05 7.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' C' ' 35' ' ' SER . 79.6 m-85 -156.16 113.27 2.11 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.578 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' C' ' 39' ' ' THR . 73.0 Cg_endo -79.47 -20.12 9.74 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.259 1.973 . . . . 0.0 111.982 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 40.9 p -47.17 -18.41 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 109.65 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.443 ' N ' ' O ' ' C' ' 37' ' ' PRO . 42.4 p -74.71 -22.79 58.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 109.854 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -69.96 -20.15 63.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 110.082 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.075 -1.016 . . . . 0.0 109.83 -179.688 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' HIS . . . . . 0.573 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 15.1 p80 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 120.909 0.385 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' PHE . . . . . 0.415 ' O ' ' C ' ' C' ' 47' ' ' ASP . 5.0 p90 -145.36 23.2 1.48 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.9 -1.125 . . . . 0.0 109.541 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' C' ' 49' ' ' SER . 56.9 m-20 42.51 84.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.533 -0.73 . . . . 0.0 109.772 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.471 ' H ' ' CD1' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -50.27 -11.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.421 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.504 ' H ' ' C ' ' C' ' 47' ' ' ASP . 14.7 m -58.97 147.38 34.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -64.57 148.37 50.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.63 -4.15 83.65 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' SER . . . . . 0.494 ' O ' ' N ' ' C' ' 54' ' ' GLN . 5.4 p -69.03 -23.66 64.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 109.328 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' C' ' 55' ' ' VAL . . . 67.5 -56.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.795 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' C' ' 52' ' ' SER . 43.0 mt-30 -43.95 -22.5 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.372 -0.83 . . . . 0.0 109.798 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 53' ' ' ALA . 40.9 t -74.23 -26.72 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.323 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' C' ' 53' ' ' ALA . 5.7 ptmt -65.75 -27.41 68.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.18 -50.51 39.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -53.73 -32.44 52.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -1.136 . . . . 0.0 109.567 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.23 -47.3 91.76 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -58.2 -23.46 55.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.385 -1.068 . . . . 0.0 109.694 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.26 -39.44 63.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.229 -0.919 . . . . 0.0 108.927 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.76 -49.05 48.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.48 -30.02 71.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.315 -0.866 . . . . 0.0 109.017 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -67.14 -38.66 85.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.898 . . . . 0.0 108.819 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -64.09 -52.13 60.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -57.08 -44.71 83.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.227 -0.92 . . . . 0.0 108.764 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 17.5 m -68.74 -50.61 49.28 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.294 -0.879 . . . . 0.0 108.703 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -60.38 -24.27 64.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.95 -45.64 12.0 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.56 -23.48 33.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -18.74 64.27 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' HIS . . . . . 0.614 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.7 m80 -144.06 -58.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.446 -0.783 . . . . 0.0 109.337 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.3 p 44.28 13.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.796 0.808 . . . . 0.0 109.475 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' C' ' 72' ' ' HIS . 46.0 t0 -133.86 11.11 3.97 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 179.0 29.25 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.003 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 17.4 ptt? -78.57 -22.63 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 111.796 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.4 Cg_exo -54.0 -22.36 24.45 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.559 1.506 . . . . 0.0 112.334 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' ASN . . . . . 0.434 ' O ' ' OG ' ' C' ' 81' ' ' SER . 9.4 m120 -94.2 -33.86 13.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.13 -0.981 . . . . 0.0 109.775 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.29 -46.74 60.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -0.948 . . . . 0.0 109.427 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 12.9 mt -80.39 8.43 7.62 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 109.07 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 38.5 p -55.78 -17.14 5.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.742 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.16 -55.89 4.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 109.752 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.486 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 3.5 mt -45.41 -43.97 11.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 108.967 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' C' ' 136' ' ' LEU . 29.7 t -57.32 -22.55 42.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 109.44 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' C' ' 89' ' ' HIS . 23.0 t70 -82.01 -58.37 3.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.14 -0.975 . . . . 0.0 109.926 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.49 -27.42 16.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 109.77 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 38.8 m80 -91.97 -21.7 20.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.795 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.41 -11.41 15.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 109.914 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' C' ' 85' ' ' ASP . 14.3 m80 -113.94 -77.86 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.034 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' C' ' 89' ' ' HIS . 9.9 mptt -45.78 -97.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.868 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' C' ' 93' ' ' VAL . 19.6 mt -65.67 -17.32 64.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 110.178 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 92' ' ' ARG . . . . . 0.489 ' NH1' ' OE2' ' B' ' 43' ' ' GLU . 25.1 ttm180 48.86 15.34 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 0.0 108.938 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' C' ' 91' ' ' LEU . 10.8 p -46.05 156.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 0.0 109.886 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.21 153.0 37.99 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.079 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' C' ' 98' ' ' PHE . 32.7 Cg_endo -65.87 -10.58 27.37 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.535 2.157 . . . . 0.0 111.947 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 84.0 t -44.01 -29.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.852 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -79.42 -32.86 42.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.621 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 98' ' ' PHE . . . . . 0.448 ' N ' ' O ' ' C' ' 95' ' ' PRO . 0.0 OUTLIER -50.18 -34.91 24.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.345 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.413 ' O ' ' OG ' ' C' ' 102' ' ' SER . 65.6 mttm -50.02 -34.91 22.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.484 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 9.9 mt -82.11 -50.53 8.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 53.2 tp -45.75 -20.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 0.0 109.64 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 102' ' ' SER . . . . . 0.445 ' N ' ' O ' ' C' ' 100' ' ' LEU . 93.1 p -73.4 -59.15 2.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.932 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 103' ' ' HIS . . . . . 0.808 ' CG ' HD22 ' D' ' 108' ' ' ASN . 40.7 m80 -71.92 -26.52 62.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 104' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 62.1 m -58.07 -42.13 84.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.042 -1.036 . . . . 0.0 109.942 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.68 -22.85 62.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.123 -0.986 . . . . 0.0 110.123 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' C' ' 106' ' ' LEU . 3.7 mm? -79.01 -35.98 41.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.021 -1.049 . . . . 0.0 110.146 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.8 -39.47 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.054 -1.029 . . . . 0.0 109.536 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' C' ' 109' ' ' LEU . 12.5 p -65.31 -62.86 1.28 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.171 -0.956 . . . . 0.0 109.639 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 109' ' ' LEU . . . . . 0.492 ' N ' ' OG1' ' C' ' 108' ' ' THR . 14.8 mt -48.3 -22.42 0.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.355 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.5 83.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.932 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.54 20.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.961 . . . . 0.0 109.863 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 112' ' ' HIS . . . . . 0.606 ' CG ' ' CE1' ' C' ' 24' ' ' TYR . 93.3 m-70 -81.78 -75.43 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -0.991 . . . . 0.0 109.54 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.482 ' O ' ' CG ' ' C' ' 113' ' ' LEU . 1.5 pp -137.05 94.42 12.62 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.2 -171.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.26 1.973 . . . . 0.0 112.899 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 115' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -47.3 -38.53 12.79 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.622 0.725 . . . . 0.0 109.598 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 116' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 6.7 mt-10 85.34 9.57 0.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 117' ' ' PHE . . . . . 0.812 ' CE1' ' NE2' ' D' ' 116' ' ' HIS . 6.9 m-85 65.11 34.93 8.28 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.779 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 118' ' ' THR . . . . . 0.727 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -94.58 121.33 63.43 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.783 -1.198 . . . . 0.0 107.942 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -51.35 23.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.124 1.883 . . . . 0.0 112.849 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 120' ' ' ALA . . . . . 0.727 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -155.06 -30.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.742 -1.223 . . . . 0.0 110.773 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 121' ' ' VAL . . . . . 0.55 ' HB ' ' OG1' ' C' ' 118' ' ' THR . 11.9 p -47.8 -50.35 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 122' ' ' HIS . . . . . 0.532 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 2.4 t-80 -65.41 -43.56 90.17 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.41 -0.806 . . . . 0.0 109.976 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 123' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' D' ' 34' ' ' VAL . . . -79.06 -19.38 51.5 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 109.914 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 124' ' ' SER . . . . . 0.58 ' N ' ' O ' ' C' ' 120' ' ' ALA . 63.7 m -72.42 -63.85 1.07 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 111.128 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.05 -18.18 64.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.06 -1.025 . . . . 0.0 109.562 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.24 -49.55 9.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.899 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 127' ' ' LYS . . . . . 0.434 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -90.86 -57.64 2.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.903 -1.123 . . . . 0.0 111.476 -178.187 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 128' ' ' PHE . . . . . 0.466 ' CD2' ' HA ' ' C' ' 124' ' ' SER . 21.9 m-85 -46.57 -21.53 0.19 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.731 -1.231 . . . . 0.0 110.189 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 129' ' ' LEU . . . . . 0.502 ' CD1' ' C ' ' C' ' 129' ' ' LEU . 0.7 OUTLIER -66.6 -18.86 65.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' C' ' 134' ' ' THR . . . -56.01 -33.18 64.64 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 131' ' ' SER . . . . . 0.483 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 7.9 t -66.67 -36.83 83.47 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.168 -0.958 . . . . 0.0 108.767 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.3 -39.98 24.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 34.9 t -73.52 -37.66 65.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.466 -0.771 . . . . 0.0 108.95 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 134' ' ' THR . . . . . 0.505 ' N ' ' O ' ' C' ' 130' ' ' ALA . 88.8 m -71.62 -31.1 66.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.35 -36.58 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . 0.459 ' O ' ' CB ' ' C' ' 84' ' ' SER . 3.2 mp -56.73 -32.85 65.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.361 -0.837 . . . . 0.0 108.998 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 51.4 m -89.36 -27.46 20.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.477 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.977 . . . . 0.0 109.501 -179.853 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 18.9 m170 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 3' ' ' LEU . . . . . 0.602 ' H ' ' CD1' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -86.4 178.15 7.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 109.338 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.412 ' O ' ' N ' ' D' ' 6' ' ' GLU . 7.3 p -92.2 145.54 30.95 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 109.285 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -40.09 -25.96 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.534 2.156 . . . . 0.0 112.177 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 6' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' D' ' 4' ' ' THR . 39.5 mt-10 -81.72 -51.91 7.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' D' ' 7' ' ' GLU . 0.7 OUTLIER -75.3 -22.75 57.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.47 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 8' ' ' LYS . . . . . 0.497 ' O ' ' OG1' ' D' ' 12' ' ' THR . 6.7 tttm -78.39 -37.17 44.73 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.299 -0.876 . . . . 0.0 109.131 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 37.5 t -63.07 -23.28 67.37 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.23 -57.5 3.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.962 . . . . 0.0 110.082 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.52 -24.88 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.977 -1.077 . . . . 0.0 108.54 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 12' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 96.7 m -78.35 -31.59 48.64 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.729 -0.607 . . . . 0.0 109.724 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -67.25 -63.82 0.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.747 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' D' ' 14' ' ' LEU . 10.6 mp -45.79 -19.29 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.377 -0.827 . . . . 0.0 109.898 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 15' ' ' TRP . . . . . 0.472 ' N ' ' O ' ' D' ' 13' ' ' ALA . 4.1 t90 -78.95 -40.8 30.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.986 -1.071 . . . . 0.0 108.751 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.31 -24.19 59.57 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -79.77 -32.71 40.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.456 -1.026 . . . . 0.0 109.353 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -62.62 132.13 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.4 -0.812 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 19' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' D' ' 21' ' ' ASP . 71.7 m-20 -81.21 78.17 8.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.291 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 78.4 t -49.78 -10.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.498 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' D' ' 19' ' ' ASN . 21.4 m-20 -55.33 -29.89 59.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 22' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' D' ' 25' ' ' GLY . 18.3 pt-20 -152.57 -32.15 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.095 -1.003 . . . . 0.0 110.045 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' D' ' 22' ' ' GLU . 93.0 t -44.72 -26.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.113 -0.992 . . . . 0.0 109.597 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.5 -26.31 47.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 25' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -66.71 -45.22 86.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 26' ' ' GLU . . . . . 0.423 ' OE2' ' N ' ' D' ' 26' ' ' GLU . 1.2 mp0 -63.9 -47.82 79.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -1.125 . . . . 0.0 109.318 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.3 -30.86 41.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.339 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.22 -54.32 5.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.24 -35.29 91.88 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -66.98 -32.36 73.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -1.091 . . . . 0.0 109.495 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 64.5 tp -47.35 -41.24 19.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.599 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 mt -80.73 -23.88 39.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.699 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.09 -64.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.474 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 34' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' C' ' 123' ' ' ALA . 2.4 t -46.65 -43.89 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -171.88 130.05 0.68 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 109.304 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.51 62.17 7.63 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.366 2.044 . . . . 0.0 112.126 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 37' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' D' ' 37' ' ' TRP . 0.0 OUTLIER -57.6 -43.72 84.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.143 -0.973 . . . . 0.0 109.272 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 38' ' ' THR . . . . . 0.553 ' OG1' ' N ' ' D' ' 39' ' ' GLN . 1.8 p -49.86 -64.41 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.371 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 39' ' ' GLN . . . . . 0.553 ' N ' ' OG1' ' D' ' 38' ' ' THR . 31.9 tt0 48.09 44.09 18.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 109.429 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -163.55 -36.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -119.3 16.14 13.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.309 -0.869 . . . . 0.0 109.216 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 42' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' D' ' 43' ' ' GLU . 30.8 p90 -87.61 -35.07 18.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.542 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 43' ' ' GLU . . . . . 0.518 ' OE2' ' NH1' ' A' ' 92' ' ' ARG . 12.1 pt-20 -81.97 -13.89 56.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.696 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 86.2 p -57.63 -29.09 64.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.607 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -85.27 19.24 2.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.44 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.63 1.87 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 47' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' D' ' 48' ' ' LEU . 35.7 t0 49.98 -146.01 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -1.186 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 48' ' ' LEU . . . . . 0.531 ' CB ' ' O ' ' D' ' 47' ' ' ASP . 2.4 tp 82.77 24.19 0.16 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.807 -0.558 . . . . 0.0 109.622 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -57.56 -35.12 69.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.273 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 50' ' ' THR . . . . . 0.602 ' HG1' ' H ' ' D' ' 52' ' ' ASP . 1.2 p -146.93 153.69 46.13 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 108.887 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -42.47 -22.7 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.249 1.966 . . . . 0.0 112.251 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . 0.602 ' H ' ' HG1' ' D' ' 50' ' ' THR . 26.1 t70 -85.15 -38.6 18.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.562 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.82 -19.58 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.362 -0.836 . . . . 0.0 109.573 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 t -60.66 -59.45 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.514 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 17.1 ptp -90.25 14.19 13.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.0 109.493 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.03 -18.91 58.61 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -89.07 146.99 37.55 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 109.443 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.76 -20.56 17.34 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.609 2.206 . . . . 0.0 112.4 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.55 -32.39 25.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 109.785 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 67.0 t -60.72 -41.18 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.672 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 61' ' ' LYS . . . . . 0.535 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 12.0 ptpt -78.94 -35.79 42.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.34 -30.12 69.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.93 -24.08 60.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.71 -19.12 80.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 65' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 0.3 OUTLIER -68.44 -32.32 72.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -1.128 . . . . 0.0 109.326 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -75.78 -34.55 60.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.313 -0.867 . . . . 0.0 109.738 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.85 -62.94 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.469 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tt -50.14 -29.07 8.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.373 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.02 96.84 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.56 93.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -1.165 . . . . 0.0 109.804 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -47.0 -30.29 2.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.173 -0.954 . . . . 0.0 109.634 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 72' ' ' SER . . . . . 0.416 ' O ' ' N ' ' D' ' 76' ' ' ALA . 3.8 p -57.6 -49.68 75.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.461 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -60.32 -17.01 39.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.09 79.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' D' ' 75' ' ' LEU . 1.4 pt? -136.62 -22.34 1.27 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.317 -1.108 . . . . 0.0 109.973 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 76' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -77.61 5.09 9.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.072 -1.017 . . . . 0.0 109.679 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 77' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 46.8 m-70 -160.99 66.27 0.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.531 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.08 11.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.533 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' D' ' 77' ' ' HIS . 13.7 t70 -66.73 -45.72 77.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.399 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -162.21 96.19 0.97 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.787 . . . . 0.0 109.417 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 24.9 mt -76.19 -58.77 3.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 82' ' ' LYS . . . . . 0.584 ' NZ ' ' CD2' ' D' ' 143' ' ' HIS . 11.0 ttmm -54.76 -23.87 19.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.534 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.14 -47.51 9.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.8 t -78.28 -48.21 16.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -1.193 . . . . 0.0 109.67 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' D' ' 84' ' ' THR . 27.9 m-85 -59.72 -1.76 0.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 109.387 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 86' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -56.21 -35.24 67.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.158 -0.964 . . . . 0.0 109.423 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 34.5 p -73.2 -57.6 3.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 31.9 mt -56.49 -29.49 61.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.31 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 69.2 m -81.12 -32.64 33.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.439 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -82.62 -22.41 34.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.862 . . . . 0.0 109.482 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 tt -78.69 -68.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.853 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 92' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' D' ' 97' ' ' HIS . 0.4 OUTLIER -55.17 -20.28 10.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 0.0 110.092 -179.304 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 93' ' ' CYS . . . . . 0.526 ' N ' ' ND1' ' D' ' 92' ' ' HIS . 36.4 t -83.45 -60.66 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.1 -1.0 . . . . 0.0 110.706 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 94' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' D' ' 94' ' ' ASP . 0.8 OUTLIER -87.78 -25.64 23.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.087 -1.008 . . . . 0.0 111.45 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.02 -52.28 5.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.84 -1.163 . . . . 0.0 110.895 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 96' ' ' LEU . . . . . 0.609 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 2.3 mm? -112.5 -11.67 13.58 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.995 -1.065 . . . . 0.0 109.857 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 97' ' ' HIS . . . . . 0.609 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 49.3 p-80 41.89 41.48 1.89 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.31 -0.869 . . . . 0.0 109.786 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.42 132.32 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 0.0 109.472 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.01 152.96 90.0 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.245 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.54 -164.81 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.595 2.197 . . . . 0.0 112.162 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 57.01 48.34 15.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.32 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -160.61 -33.61 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -63.3 -60.91 2.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.445 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -57.63 -20.24 31.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 109.333 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 tt -77.37 -49.72 14.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.355 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tt -49.41 -46.29 47.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.859 . . . . 0.0 109.316 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.36 -45.78 95.53 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 108' ' ' ASN . . . . . 0.808 HD22 ' CG ' ' C' ' 103' ' ' HIS . 11.8 t-20 -53.76 -34.7 59.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -1.176 . . . . 0.0 109.583 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 109' ' ' VAL . . . . . 0.487 ' O ' ' SG ' ' D' ' 112' ' ' CYS . 90.7 t -80.25 -24.12 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 34.2 tp -78.05 -32.43 50.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 109.412 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 94.3 t -65.15 -49.77 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.685 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 112' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' D' ' 109' ' ' VAL . 18.6 p -52.95 -37.23 60.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.939 . . . . 0.0 109.747 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 113' ' ' VAL . . . . . 0.462 ' N ' ' SG ' ' D' ' 112' ' ' CYS . 96.5 t -60.66 -21.38 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.675 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 114' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' D' ' 130' ' ' TYR . 23.6 mt -77.64 -57.07 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 109.571 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.03 -19.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.088 -1.007 . . . . 0.0 109.386 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 116' ' ' HIS . . . . . 0.812 ' NE2' ' CE1' ' C' ' 117' ' ' PHE . 1.5 t-80 -79.45 -56.69 4.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.147 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -69.27 -17.61 63.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.683 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -151.31 60.98 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 119' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -77.78 -23.32 67.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.41 8.63 4.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.363 -1.08 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' D' ' 123' ' ' THR . 20.3 mm-40 -134.57 12.81 3.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.404 -0.81 . . . . 0.0 109.52 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.15 43.86 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.116 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.437 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.0 OUTLIER -48.61 151.1 2.15 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 109.161 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.483 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.0 Cg_exo -46.0 -52.3 7.25 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.307 2.005 . . . . 0.0 113.034 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 125' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 46.7 Cg_endo -68.29 15.16 0.16 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.157 1.905 . . . . 0.0 113.091 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 53.1 t -108.4 -42.76 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.056 -1.027 . . . . 0.0 109.914 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 127' ' ' GLN . . . . . 0.548 ' H ' ' CD ' ' D' ' 127' ' ' GLN . 0.0 OUTLIER -70.66 -60.01 2.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.997 -1.064 . . . . 0.0 109.734 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 128' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' C' ' 34' ' ' LEU . . . -49.37 -34.77 16.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.11 -0.993 . . . . 0.0 109.461 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.39 27.76 1.04 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.306 -0.871 . . . . 0.0 109.686 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 130' ' ' TYR . . . . . 0.516 ' CZ ' ' CD1' ' D' ' 114' ' ' LEU . 1.6 t80 -126.65 -34.73 2.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.345 -0.847 . . . . 0.0 109.592 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -71.32 -62.86 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.642 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -48.77 -21.7 0.67 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 109.709 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 34.2 t -69.17 -65.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.715 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' D' ' 137' ' ' VAL . 9.0 m -74.22 -16.44 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -0.92 . . . . 0.0 109.569 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.41 ' HB2' ' HD2' ' B' ' 146' ' ' HIS . . . -49.32 -30.28 7.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.372 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.68 -26.22 70.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 137' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' D' ' 134' ' ' VAL . 89.1 t -68.84 -39.75 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -1.132 . . . . 0.0 109.336 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.01 94.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 139' ' ' ASN . . . . . 0.837 ' ND2' ' CE1' ' B' ' 146' ' ' HIS . 1.2 m-20 -73.7 -44.03 57.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.13 -37.67 47.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.926 . . . . 0.0 109.351 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 141' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 18.0 mt -82.31 11.2 5.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' D' ' 144' ' ' LYS . . . -123.66 -30.94 3.53 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.414 -0.804 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 143' ' ' HIS . . . . . 0.584 ' CD2' ' NZ ' ' D' ' 82' ' ' LYS . 1.5 m80 -49.69 -13.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.401 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 144' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' D' ' 142' ' ' ALA . 3.2 tptp -77.76 -43.0 32.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.25 -25.24 3.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.263 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 146' ' ' HIS . . . . . 0.873 ' CE1' ' ND2' ' B' ' 139' ' ' ASN . 25.9 m170 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.449 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 2' ' ' LEU . 29.8 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 7.8 mp 55.94 163.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.399 -0.813 . . . . 0.0 109.846 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.517 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 176.24 -47.8 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.021 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 3' ' ' SER . 54.2 Cg_exo -50.44 -170.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.473 2.115 . . . . 0.0 112.603 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -60.31 -16.17 32.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 109.667 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 5' ' ' ALA . 22.2 m-20 -39.51 -29.09 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.379 -0.826 . . . . 0.0 109.67 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 10' ' ' VAL . 4.6 ptpt -83.22 -49.99 8.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 7' ' ' LYS . 52.5 m -43.82 -32.77 1.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.474 -0.766 . . . . 0.0 109.751 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.85 -30.27 50.89 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.571 ' N ' ' O ' ' A' ' 7' ' ' LYS . 51.2 t -76.8 -51.57 18.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -57.64 -36.75 72.27 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.812 -1.155 . . . . 0.0 108.262 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.81 -58.25 8.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.13 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.99 -34.4 63.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 108.935 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -17.52 61.75 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.96 -44.6 18.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -70.1 -37.39 75.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -1.164 . . . . 0.0 108.51 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 t -60.16 -67.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 59.32 -136.81 50.59 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.28 29.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.487 -1.008 . . . . 0.0 110.485 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.593 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.9 m-70 -129.7 13.14 5.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 108.579 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.0 -52.36 11.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.584 -0.697 . . . . 0.0 109.811 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.01 -14.53 10.68 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.31 -56.48 3.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -1.188 . . . . 0.0 109.72 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 20' ' ' HIS . 14.1 m-85 -59.86 -24.83 64.54 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 109.247 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.03 -33.77 84.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.93 -39.0 57.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.584 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.563 ' C ' ' HG1' ' A' ' 108' ' ' THR . 13.2 tt0 -67.51 -20.0 65.38 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.361 -0.837 . . . . 0.0 109.552 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.43 61.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.078 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -75.98 -59.32 2.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -56.49 -12.55 1.78 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.282 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -65.21 -58.29 6.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.939 . . . . 0.0 109.835 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -84.52 -32.91 23.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 110.354 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 20.1 m-85 -63.54 -36.01 82.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.006 -1.058 . . . . 0.0 110.121 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.562 ' O ' ' CZ ' ' A' ' 36' ' ' PHE . 3.8 pp -46.92 -40.54 14.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.84 -1.163 . . . . 0.0 109.534 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.564 ' O ' ' C ' ' A' ' 36' ' ' PHE . 1.4 p -76.56 -23.58 53.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.022 -1.049 . . . . 0.0 108.792 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.564 ' C ' ' O ' ' A' ' 35' ' ' SER . 0.3 OUTLIER 21.44 66.0 0.3 Allowed Pre-proline 0 N--CA 1.501 2.103 0 CA-C-O 121.155 0.502 . . . . 0.0 111.291 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.44 -62.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.46 2.107 . . . . 0.0 112.076 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.479 ' CG2' ' CD2' ' D' ' 97' ' ' HIS . 1.2 p -91.15 -57.52 2.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.546 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -44.12 -22.94 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -0.795 . . . . 0.0 110.333 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.3 ttmt -49.06 -45.17 42.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.087 -1.008 . . . . 0.0 109.569 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.423 ' CB ' ' O ' ' D' ' 94' ' ' ASP . 0.6 OUTLIER -80.02 -18.96 48.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.59 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -77.06 -35.54 56.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.8 t80 55.04 79.9 0.32 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 109.298 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.708 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 72.1 Cg_exo -46.16 -27.99 5.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.654 2.236 . . . . 0.0 112.496 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.708 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 90.87 35.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 O-C-N 122.019 -0.426 . . . . 0.0 110.669 179.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.477 ' C ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -154.35 31.1 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.581 -1.324 . . . . 0.0 110.553 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 46' ' ' PHE . 35.6 m-20 42.26 88.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -0.798 . . . . 0.0 110.242 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.474 ' CD2' ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.44 -13.06 57.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 109.035 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 50' ' ' HIS . 32.8 p -78.02 165.73 23.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.559 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.675 ' N ' ' HD1' ' A' ' 50' ' ' HIS . 0.3 OUTLIER -57.81 -162.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.319 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.7 34.49 10.49 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 54' ' ' GLN . 30.2 t -139.06 82.29 1.89 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.357 -1.084 . . . . 0.0 109.259 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.68 -10.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.414 -0.804 . . . . 0.0 109.806 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 52' ' ' SER . 11.7 mt-30 -74.81 -35.23 62.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.123 -0.986 . . . . 0.0 109.676 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.66 -48.51 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.52 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' CD ' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -69.18 -25.5 64.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.416 -0.802 . . . . 0.0 109.046 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.91 -21.68 78.93 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.8 t-80 -82.43 -39.9 21.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -1.129 . . . . 0.0 109.847 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.92 -51.65 44.21 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -51.17 -22.66 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -1.022 . . . . 0.0 110.101 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.76 -29.72 56.23 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.056 -1.027 . . . . 0.0 109.255 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.8 -49.0 19.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.57 -22.71 64.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.406 -0.809 . . . . 0.0 109.191 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -78.25 -30.68 48.76 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.1 -1.0 . . . . 0.0 108.778 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.76 53.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.388 -0.82 . . . . 0.0 108.969 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.57 -40.58 72.15 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.153 -0.967 . . . . 0.0 108.757 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 m -68.81 -56.78 6.93 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 46.6 t30 -55.38 -24.17 28.35 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -80.24 -46.93 15.41 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.408 HG23 ' HZ3' ' A' ' 11' ' ' LYS . 36.0 t -64.41 -22.93 32.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.43 -17.04 64.56 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.616 ' O ' ' N ' ' A' ' 74' ' ' ASP . 4.2 m-70 -141.9 -61.25 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.434 -0.791 . . . . 0.0 109.435 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.1 p 44.72 12.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.721 0.772 . . . . 0.0 109.64 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 72' ' ' HIS . 44.5 t0 -134.21 10.45 3.83 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 2.0 m-20 -178.53 28.02 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.733 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.701 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 6.5 ptt? -78.46 -23.36 0.41 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 111.67 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.3 Cg_exo -54.36 -18.82 15.45 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.617 1.545 . . . . 0.0 112.132 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -93.43 -38.08 11.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.421 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.45 -40.18 64.38 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 108.956 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.8 mt -87.65 11.34 15.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.7 t -65.32 -26.85 68.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.713 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.98 -49.03 66.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.726 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mt -47.69 -46.96 29.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 109.022 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.7 t -62.78 -28.55 70.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.626 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -79.96 -28.14 39.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 109.588 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 90' ' ' LYS . 3.7 tt -83.22 -32.29 26.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 109.87 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -92.04 -22.0 20.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.219 -0.926 . . . . 0.0 110.218 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.07 -48.01 4.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.112 -0.992 . . . . 0.0 110.123 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -93.44 21.93 5.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.13 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.545 ' C ' ' H ' ' A' ' 92' ' ' ARG . 28.6 ttmt -172.11 147.07 2.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.022 -1.049 . . . . 0.0 110.006 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER 71.31 -20.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.522 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.545 ' H ' ' C ' ' A' ' 90' ' ' LYS . 70.4 mtt85 43.12 27.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 109.741 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 91' ' ' LEU . 12.2 p -46.98 165.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.725 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 96' ' ' VAL . 6.1 p-10 -109.7 101.18 45.6 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.493 -0.754 . . . . 0.0 109.28 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.72 -10.85 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.407 2.072 . . . . 0.0 112.331 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 94' ' ' ASP . 52.6 t -50.98 -18.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 100' ' ' LEU . 3.1 m120 -79.22 -24.38 43.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.316 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -44.33 -35.75 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -67.98 -23.78 65.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.873 . . . . 0.0 109.579 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 97' ' ' ASN . 8.8 mp -84.18 -62.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.638 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.47 -23.87 27.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.8 p -67.86 -50.4 56.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 109.727 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -78.02 -26.42 48.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.741 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 96.7 m -50.8 -50.45 56.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 109.629 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.26 -38.88 55.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.892 . . . . 0.0 109.765 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.88 -36.18 64.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.531 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.13 -27.67 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.069 -1.019 . . . . 0.0 109.852 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.563 ' HG1' ' C ' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -81.07 -45.19 16.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.123 -0.986 . . . . 0.0 109.842 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.506 ' N ' ' CG2' ' A' ' 108' ' ' THR . 15.6 mt -66.89 -20.67 65.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.926 . . . . 0.0 109.057 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' A' ' 112' ' ' HIS . . . -51.66 -43.01 62.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.427 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.76 -3.62 0.12 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 109.193 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.545 ' H ' ' C ' ' A' ' 110' ' ' ALA . 79.7 m-70 -143.24 -85.59 0.15 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -0.888 . . . . 0.0 109.277 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.594 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -139.79 100.14 7.44 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.28 -98.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.646 2.231 . . . . 0.0 112.791 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.667 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -72.12 -56.58 5.34 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.557 -0.715 . . . . 0.0 110.064 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.667 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 17.5 mt-10 116.62 -6.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.485 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 4.9 t80 79.53 33.3 0.21 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.297 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.722 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -108.94 125.07 32.44 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.021 -1.049 . . . . 0.0 108.199 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.91 21.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.216 1.944 . . . . 0.0 112.801 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.722 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -149.44 -32.52 0.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.906 -1.121 . . . . 0.0 110.398 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.53 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 9.5 p -55.04 -48.79 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 110.404 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.53 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 4.4 t-160 -47.76 -36.2 11.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.45 -19.48 33.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.424 -0.797 . . . . 0.0 110.135 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 121' ' ' VAL . 92.3 p -61.64 -62.42 1.82 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.087 -1.008 . . . . 0.0 110.647 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.43 -19.95 62.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.059 -1.026 . . . . 0.0 109.595 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.3 -40.77 17.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.094 -1.004 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.23 -40.41 12.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.122 -0.987 . . . . 0.0 109.868 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.472 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 40.3 t80 -50.48 -20.84 1.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.898 -1.126 . . . . 0.0 108.717 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 133' ' ' SER . 23.6 mt -68.97 -17.88 63.99 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 134' ' ' THR . . . -57.59 -36.78 72.17 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 80.0 p -81.49 -26.82 34.89 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.27 -0.894 . . . . 0.0 108.596 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.42 -26.72 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.416 -0.802 . . . . 0.0 109.077 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 129' ' ' LEU . 1.9 t -82.68 -31.53 28.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.123 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 25.8 m -72.98 -36.77 67.16 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.31 -0.869 . . . . 0.0 109.553 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.61 -21.8 15.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.128 -0.983 . . . . 0.0 108.895 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -16.72 59.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.045 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.1 t -143.04 38.51 1.44 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.946 . . . . 0.0 109.6 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -48.46 132.24 16.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -75.45 -9.97 59.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 0.0 109.337 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.406 ' O ' ' O ' ' A' ' 141' ' ' ARG . 35.5 t80 56.95 90.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 140' ' ' TYR . 35.6 mtp85 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.571 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.443 ' C ' ' CD2' ' B' ' 2' ' ' HIS . 5.3 p . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.443 ' CD2' ' C ' ' B' ' 1' ' ' VAL . 2.6 p80 173.87 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.782 . . . . 0.0 109.14 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.647 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -130.3 172.03 12.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.381 -0.824 . . . . 0.0 109.352 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.425 ' O ' ' N ' ' B' ' 6' ' ' GLU . 7.7 p -90.51 141.59 27.39 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 109.301 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.429 ' O ' ' OG ' ' B' ' 9' ' ' SER . 87.8 Cg_exo -40.63 -23.92 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.509 2.139 . . . . 0.0 112.376 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' B' ' 4' ' ' THR . 73.1 mm-40 -78.87 -54.67 5.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.831 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -74.85 -23.1 58.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.503 ' O ' ' OG1' ' B' ' 12' ' ' THR . 2.1 tttm -84.29 -32.2 24.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.339 -0.851 . . . . 0.0 109.234 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' B' ' 5' ' ' PRO . 8.9 m -63.67 -23.36 67.34 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.733 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.8 -57.59 3.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.075 -1.016 . . . . 0.0 110.113 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.67 -24.35 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 70.1 m -83.98 -35.37 23.98 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.27 0.557 . . . . 0.0 109.74 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.28 -27.4 61.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.391 -0.818 . . . . 0.0 109.663 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.18 -18.73 10.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 109.339 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . 0.62 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.5 OUTLIER -50.95 -50.95 56.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.119 -0.988 . . . . 0.0 109.038 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.68 -51.02 60.5 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 7.7 mtmt -53.91 -25.91 22.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.359 -1.083 . . . . 0.0 109.093 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.41 124.31 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 109.74 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' B' ' 21' ' ' ASP . 1.8 m120 -81.86 68.31 8.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 108.94 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -45.98 -14.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.405 -0.809 . . . . 0.0 109.81 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' B' ' 19' ' ' ASN . 60.3 t0 -58.02 -18.04 21.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.839 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' B' ' 25' ' ' GLY . 35.1 mt-10 -155.79 -33.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.757 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.9 t -45.98 -23.91 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.249 -0.907 . . . . 0.0 109.702 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.54 -24.69 72.08 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -82.38 -33.03 26.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -74.74 -25.02 58.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -1.195 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.31 94.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.94 . . . . 0.0 109.559 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.41 -50.14 16.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.32 -28.2 8.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.1 -47.45 11.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.137 . . . . 0.0 109.35 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 tp -47.46 -31.55 4.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 109.435 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' B' ' 36' ' ' PRO . 14.4 mt -71.19 -46.1 62.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.23 -55.53 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.324 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.6 -22.93 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.563 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -150.4 76.9 8.29 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 109.492 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . 0.503 ' N ' ' O ' ' B' ' 32' ' ' LEU . 77.5 Cg_endo -82.93 -7.68 11.22 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.813 2.342 . . . . 0.0 112.385 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . 0.507 ' C ' ' H ' ' B' ' 39' ' ' GLN . 21.0 p-90 -63.93 -19.86 65.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 109.508 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 7.8 p -72.63 37.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . 0.507 ' H ' ' C ' ' B' ' 37' ' ' TRP . 17.2 tt0 -80.71 10.53 4.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.447 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -89.16 -37.56 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.98 . . . . 0.0 109.556 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . 0.526 ' C ' ' H ' ' B' ' 43' ' ' GLU . 88.5 m-85 -89.68 -43.29 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 109.566 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.16 14.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 109.367 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' B' ' 41' ' ' PHE . 19.0 pt-20 -66.9 -13.88 62.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.418 ' C ' ' N ' ' B' ' 46' ' ' GLY . 49.9 m -77.63 -42.55 34.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.697 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.54 ' O ' ' N ' ' B' ' 47' ' ' ASP . 39.9 m-85 -47.5 -20.11 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' B' ' 44' ' ' SER . . . 59.14 -79.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' B' ' 45' ' ' PHE . 32.1 t0 -46.7 106.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -1.152 . . . . 0.0 109.555 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tp -163.08 21.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.262 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -52.53 -42.7 64.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 109.658 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.4 p -145.35 152.06 49.2 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.882 . . . . 0.0 109.211 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -40.25 -35.23 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.557 2.171 . . . . 0.0 112.325 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.75 -27.02 63.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.563 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -66.77 -19.97 65.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.2 -51.23 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.557 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 7.4 mmt -66.77 -22.0 66.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.52 -11.12 78.34 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' B' ' 59' ' ' LYS . 20.3 t-20 -71.6 136.28 83.44 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.264 -1.139 . . . . 0.0 109.335 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.11 -35.21 3.2 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.376 2.051 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.515 ' N ' ' OD1' ' B' ' 57' ' ' ASN . 41.0 mttm -63.91 -47.74 79.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.915 . . . . 0.0 109.856 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 96.3 t -46.9 -35.4 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -0.977 . . . . 0.0 109.625 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -49.91 52.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.347 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.78 -32.53 59.96 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.226 -0.921 . . . . 0.0 109.668 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 0.559 ' HE2' ' CHA' ' B' ' 147' ' ' HEC . 37.1 t-80 -69.71 -23.92 63.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.329 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.78 -37.76 92.57 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -65.85 -25.71 67.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -1.099 . . . . 0.0 109.325 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -74.73 -49.0 22.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.93 -60.7 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.337 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.87 -21.16 65.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 109.097 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.76 -52.56 14.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.07 -35.21 33.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -1.134 . . . . 0.0 109.59 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -66.8 -49.81 64.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.62 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.1 t -56.83 -30.85 64.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.45 -0.781 . . . . 0.0 109.415 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -59.67 -40.33 87.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.323 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.86 -60.1 8.61 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.467 ' H ' HD13 ' B' ' 75' ' ' LEU . 4.6 mp -50.48 -26.42 5.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.335 -1.097 . . . . 0.0 109.31 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.68 -2.53 58.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.959 . . . . 0.0 109.484 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.517 ' CE1' ' OD2' ' B' ' 79' ' ' ASP . 71.1 t60 -171.07 62.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -0.912 . . . . 0.0 109.582 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 25.4 mt -70.3 2.19 4.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.178 -0.951 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.517 ' OD2' ' CE1' ' B' ' 77' ' ' HIS . 54.9 m-20 -55.79 -26.72 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.418 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 15.6 t-20 -170.62 112.0 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.6 mt -80.19 -58.18 3.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -47.23 -24.08 0.66 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -63.66 -51.47 53.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.481 ' C ' ' H ' ' B' ' 86' ' ' ALA . 0.7 OUTLIER -85.59 -39.56 17.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -1.158 . . . . 0.0 109.346 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.437 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.7 m-85 -70.54 10.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.614 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -67.84 -33.65 75.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -82.09 -53.34 6.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 109.432 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.464 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 35.8 mt -51.76 -49.72 62.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 0.0 109.29 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' B' ' 85' ' ' PHE . 7.3 m -59.74 -50.49 73.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.28 -38.77 92.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.869 . . . . 0.0 109.384 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 5.1 tt -74.53 -32.48 62.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.35 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' B' ' 97' ' ' HIS . 15.1 m80 -84.93 -20.3 30.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.108 -0.995 . . . . 0.0 109.644 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 46.6 t -83.74 -59.86 2.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.83 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -86.68 -34.78 19.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.12 -0.988 . . . . 0.0 111.531 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -79.73 -51.77 8.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.857 -1.152 . . . . 0.0 110.563 -178.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.33 -32.57 10.41 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.038 . . . . 0.0 110.244 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.569 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 11.3 t-160 54.07 54.07 10.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.967 . . . . 0.0 109.505 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.31 125.74 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 0.0 109.141 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -49.31 145.86 6.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.08 -11.86 31.22 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.612 2.208 . . . . 0.0 112.158 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -93.66 60.29 2.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -148.87 -46.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.526 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.0 OUTLIER -51.35 -47.43 62.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.65 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -48.31 -19.97 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' B' ' 103' ' ' PHE . 17.1 mt -88.54 -57.73 2.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.603 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -47.93 -20.9 0.36 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.526 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' B' ' 105' ' ' LEU . . . -81.71 -33.23 28.06 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -83.49 -17.45 41.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -1.115 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 78.6 t -83.18 -56.61 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 tt -48.71 -53.2 19.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.847 . . . . 0.0 109.476 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 89.7 t -46.99 -40.85 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.612 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.66 -33.93 76.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.518 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 19.1 t -66.28 -29.29 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.333 -0.855 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 118' ' ' PHE . 8.9 mt -81.68 -52.94 6.65 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.08 -24.4 17.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.465 ' HD1' ' C ' ' B' ' 116' ' ' HIS . 0.6 OUTLIER -84.82 -62.63 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 109.579 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -68.58 -17.56 64.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.756 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' B' ' 17' ' ' LYS . 72.4 m-85 -144.3 57.79 1.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -70.49 -23.05 77.87 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -72.62 10.78 0.76 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.252 -1.146 . . . . 0.0 109.509 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' B' ' 123' ' ' THR . 81.2 mm-40 -135.28 -0.34 2.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.39 -0.818 . . . . 0.0 109.642 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.542 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.81 33.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 109.339 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.52 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.0 OUTLIER -50.24 148.16 6.58 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.502 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.2 Cg_exo -46.73 -53.06 6.64 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.428 2.085 . . . . 0.0 113.159 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 26.4 Cg_endo -62.61 -21.83 73.32 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.024 1.816 . . . . 0.0 112.338 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 75.2 t -81.58 -25.63 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.506 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' B' ' 123' ' ' THR . 5.5 mp0 -83.21 -59.81 2.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.12 -0.988 . . . . 0.0 109.492 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.88 -38.26 7.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.58 29.72 0.86 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 0.0 109.574 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' B' ' 127' ' ' GLN . 17.2 t80 -124.24 -22.4 4.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.448 -0.783 . . . . 0.0 109.701 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -83.95 -63.84 1.27 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.123 -0.986 . . . . 0.0 110.061 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -49.76 -21.63 1.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 0.0 109.952 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.48 -68.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.972 . . . . 0.0 109.858 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.37 -19.95 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.793 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.94 -28.68 17.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.941 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.36 -36.45 89.23 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.48 -47.92 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -1.117 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.18 -43.25 31.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 109.354 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -80.02 -38.36 32.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 0.0 109.451 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' B' ' 142' ' ' ALA . . . -51.34 -48.35 62.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.393 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 36.2 mt -75.63 11.04 1.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' B' ' 140' ' ' ALA . . . -132.42 -4.62 3.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 109.43 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.16 -27.49 64.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.92 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.86 -16.44 36.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -62.17 -61.5 2.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.303 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.467 ' ND1' ' N ' ' B' ' 146' ' ' HIS . 2.0 m-70 . . . . . 0 C--N 1.302 -1.495 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' C' ' 2' ' ' LEU . 29.8 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' C' ' 2' ' ' LEU . 7.8 mp 56.03 163.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.35 -0.844 . . . . 0.0 109.738 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.499 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 176.24 -47.92 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.998 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' C' ' 3' ' ' SER . 54.3 Cg_exo -50.31 -170.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.573 2.182 . . . . 0.0 112.579 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -60.24 -16.24 31.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.733 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' C' ' 5' ' ' ALA . 22.1 m-20 -39.45 -29.18 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.448 -0.782 . . . . 0.0 109.696 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' C' ' 10' ' ' VAL . 4.5 ptpt -83.18 -50.0 8.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.369 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.408 ' C ' ' O ' ' C' ' 7' ' ' LYS . 53.3 m -43.86 -32.7 1.14 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 109.733 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.85 -30.29 50.87 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' C' ' 7' ' ' LYS . 51.2 t -76.77 -51.54 18.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' C' ' 7' ' ' LYS . 0.1 OUTLIER -57.63 -36.72 72.19 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.767 -1.173 . . . . 0.0 108.285 179.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.74 -58.23 8.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 109.215 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.05 -34.38 63.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 108.877 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -17.49 61.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.355 -0.841 . . . . 0.0 108.886 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.94 -44.68 18.51 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -70.12 -37.34 75.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.085 -1.244 . . . . 0.0 108.465 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 t -60.22 -67.41 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.603 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 59.24 -136.78 50.71 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.29 28.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.543 -0.975 . . . . 0.0 110.474 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.603 ' H ' ' C ' ' C' ' 18' ' ' GLY . 96.9 m-70 -129.63 13.18 5.92 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.05 -52.39 11.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.643 -0.661 . . . . 0.0 109.75 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.07 -14.45 10.95 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.36 -56.47 3.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -1.166 . . . . 0.0 109.691 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.558 ' CD2' ' O ' ' C' ' 20' ' ' HIS . 14.0 m-85 -59.85 -24.88 64.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.86 . . . . 0.0 109.285 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.91 -33.83 85.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.74 -39.12 57.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -1.193 . . . . 0.0 109.661 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . 0.562 ' C ' ' HG1' ' C' ' 108' ' ' THR . 13.2 tt0 -67.45 -20.11 65.45 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.336 -0.853 . . . . 0.0 109.457 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.07 -25.37 61.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.106 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -76.04 -59.36 2.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 109.405 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -56.45 -12.54 1.75 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 109.354 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.536 ' O ' ' NE ' ' C' ' 31' ' ' ARG . 0.0 OUTLIER -65.2 -58.35 6.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -84.51 -32.83 23.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.092 -1.005 . . . . 0.0 110.312 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 20.2 m-85 -63.55 -35.97 82.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.938 -1.101 . . . . 0.0 110.198 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.564 ' O ' ' CZ ' ' C' ' 36' ' ' PHE . 3.8 pp -46.97 -40.51 14.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.901 -1.124 . . . . 0.0 109.504 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.573 ' O ' ' C ' ' C' ' 36' ' ' PHE . 1.4 p -76.5 -23.66 53.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.931 -1.106 . . . . 0.0 108.875 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.573 ' C ' ' O ' ' C' ' 35' ' ' SER . 0.3 OUTLIER 21.56 65.96 0.3 Allowed Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 121.151 0.5 . . . . 0.0 111.211 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.39 -61.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.407 2.072 . . . . 0.0 112.147 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' THR . . . . . 0.494 ' CG2' ' CD2' ' B' ' 97' ' ' HIS . 1.1 p -91.18 -57.41 2.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.215 -0.928 . . . . 0.0 109.613 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -44.21 -22.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.47 -0.769 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' C' ' 38' ' ' THR . 26.2 ttmt -49.03 -45.13 42.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.957 -1.089 . . . . 0.0 109.596 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.0 -19.01 48.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.599 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -77.09 -35.52 56.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.639 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . . . . . . . . . 39.8 t80 55.08 79.88 0.32 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.251 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.702 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 72.0 Cg_exo -46.11 -28.01 5.0 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.649 2.233 . . . . 0.0 112.489 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.702 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 0.0 OUTLIER 90.89 35.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 O-C-N 122.055 -0.403 . . . . 0.0 110.686 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.468 ' C ' ' CD1' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -154.4 31.13 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.679 -1.263 . . . . 0.0 110.529 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' C' ' 46' ' ' PHE . 35.8 m-20 42.3 88.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.408 -0.808 . . . . 0.0 110.271 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.495 ' CD2' ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -65.33 -13.09 57.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.114 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.427 ' O ' ' O ' ' C' ' 50' ' ' HIS . 32.6 p -78.11 165.71 23.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.583 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.678 ' HD1' ' N ' ' C' ' 50' ' ' HIS . 0.3 OUTLIER -57.83 -162.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.361 -0.837 . . . . 0.0 109.283 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.82 34.44 10.94 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.55 ' O ' ' N ' ' C' ' 54' ' ' GLN . 30.4 t -139.06 82.25 1.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.286 -1.126 . . . . 0.0 109.218 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.69 -10.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.808 . . . . 0.0 109.847 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' C' ' 52' ' ' SER . 11.7 mt-30 -74.85 -35.25 62.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.3 t -65.67 -48.45 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.54 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.512 ' CD ' ' H ' ' C' ' 56' ' ' LYS . 0.0 OUTLIER -69.18 -25.51 64.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 0.0 109.12 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.91 -21.65 78.97 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.9 t-80 -82.59 -39.79 21.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -1.082 . . . . 0.0 109.798 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.04 -51.56 45.42 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -51.19 -22.67 2.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.445 -1.032 . . . . 0.0 110.153 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.73 -29.7 56.29 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.15 -0.969 . . . . 0.0 109.24 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.81 -49.0 19.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 108.726 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.58 -22.84 64.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.308 -0.87 . . . . 0.0 109.189 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -78.17 -30.69 49.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.134 -0.979 . . . . 0.0 108.832 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.64 -48.66 53.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.86 . . . . 0.0 108.996 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.57 -40.62 72.22 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.203 -0.936 . . . . 0.0 108.749 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 15.3 m -68.72 -56.84 6.8 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' C' ' 72' ' ' HIS . 46.6 t30 -55.42 -24.08 28.46 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -80.24 -47.01 15.28 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 36.2 t -64.35 -22.97 32.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.46 -17.06 64.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.611 ' O ' ' N ' ' C' ' 74' ' ' ASP . 4.3 m-70 -141.88 -61.31 0.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 109.422 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.2 p 44.78 12.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.728 0.775 . . . . 0.0 109.61 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' C' ' 72' ' ' HIS . 44.5 t0 -134.22 10.44 3.83 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 2.0 m-20 -178.59 28.03 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.762 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 6.5 ptt? -78.52 -23.33 0.41 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.413 -0.805 . . . . 0.0 111.703 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.0 Cg_exo -54.33 -18.83 15.38 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.565 1.51 . . . . 0.0 112.185 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -93.42 -38.06 11.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.17 64.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 108.897 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.62 11.27 15.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.349 -0.845 . . . . 0.0 108.755 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 14.8 t -65.33 -26.82 68.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 109.715 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.92 -49.04 66.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 109.741 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mt -47.76 -46.96 30.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.026 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 9.7 t -62.76 -28.52 70.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.64 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.94 -28.1 39.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 109.601 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' C' ' 90' ' ' LYS . 3.7 tt -83.25 -32.35 26.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.827 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -92.12 -21.94 20.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.13 -0.982 . . . . 0.0 110.122 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.03 -48.1 3.99 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.183 -0.948 . . . . 0.0 110.113 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -93.42 21.94 5.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 110.138 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' C' ' 92' ' ' ARG . 28.7 ttmt -172.15 147.13 2.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.932 -1.105 . . . . 0.0 110.067 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' C' ' 93' ' ' VAL . 1.0 OUTLIER 71.29 -20.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.386 -0.821 . . . . 0.0 109.536 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' C' ' 90' ' ' LYS . 70.4 mtt85 43.04 27.36 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 0.0 109.7 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' C' ' 91' ' ' LEU . 12.2 p -47.08 165.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' C' ' 96' ' ' VAL . 6.1 p-10 -109.74 101.29 46.11 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.69 -11.01 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.383 2.055 . . . . 0.0 112.274 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 94' ' ' ASP . 51.1 t -50.74 -18.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' C' ' 100' ' ' LEU . 3.1 m120 -79.18 -24.38 43.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.309 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -44.31 -35.8 2.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.338 -0.851 . . . . 0.0 109.745 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -68.0 -23.72 65.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.484 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' C' ' 100' ' ' LEU . 8.8 mp -84.22 -62.08 1.65 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.52 -23.78 28.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 109.653 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 13.7 p -67.93 -50.33 56.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.762 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -78.05 -26.42 48.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.716 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 96.4 m -50.81 -50.47 56.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.669 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.23 -38.81 54.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 109.811 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.94 -36.21 64.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.478 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.06 -27.68 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.987 -1.071 . . . . 0.0 109.927 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.562 ' HG1' ' C ' ' C' ' 27' ' ' GLU . 0.6 OUTLIER -81.15 -45.1 16.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.831 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.498 ' N ' ' CG2' ' C' ' 108' ' ' THR . 15.5 mt -67.04 -20.52 65.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.089 -1.007 . . . . 0.0 109.068 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' C' ' 112' ' ' HIS . . . -51.78 -42.95 62.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.418 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.76 -3.67 0.12 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 109.212 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . 0.549 ' H ' ' C ' ' C' ' 110' ' ' ALA . 79.8 m-70 -143.23 -85.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.38 -0.825 . . . . 0.0 109.249 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.588 ' CD2' ' O ' ' C' ' 113' ' ' LEU . 0.0 OUTLIER -139.88 100.04 7.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.26 -98.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.564 2.176 . . . . 0.0 112.807 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.676 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -72.22 -56.46 5.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.576 -0.702 . . . . 0.0 110.037 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.676 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 17.5 mt-10 116.56 -6.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 4.9 t80 79.56 33.28 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.318 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.714 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -108.92 125.11 32.36 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.93 21.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.239 1.959 . . . . 0.0 112.79 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.714 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -149.47 -32.59 0.21 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.901 -1.124 . . . . 0.0 110.336 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 9.6 p -54.86 -48.91 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.058 -1.026 . . . . 0.0 110.413 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.534 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 4.4 t-160 -47.78 -36.17 11.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.44 -19.45 33.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 110.149 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' C' ' 128' ' ' PHE . 92.5 p -61.64 -62.41 1.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 110.686 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.37 -20.03 62.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.997 -1.065 . . . . 0.0 109.619 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.28 -40.72 17.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.105 -0.997 . . . . 0.0 109.548 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.2 -40.42 12.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 109.845 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.475 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 40.4 t80 -50.51 -20.81 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.869 -1.145 . . . . 0.0 108.7 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' C' ' 133' ' ' SER . 23.4 mt -68.98 -17.95 64.0 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' C' ' 134' ' ' THR . . . -57.56 -36.79 72.13 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 79.6 p -81.48 -26.84 34.89 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.37 -26.84 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 109.108 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.54 ' N ' ' O ' ' C' ' 129' ' ' LEU . 1.9 t -82.51 -31.55 29.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.214 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 26.0 m -73.06 -36.71 66.94 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.373 -0.829 . . . . 0.0 109.486 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.61 -21.74 15.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.137 -0.977 . . . . 0.0 108.933 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -16.81 59.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.435 -0.791 . . . . 0.0 108.914 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 14.2 t -143.08 38.43 1.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 17.2 m -48.35 132.19 16.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.541 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -75.33 -10.11 59.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.387 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.407 ' O ' ' O ' ' C' ' 141' ' ' ARG . 35.4 t80 56.99 91.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.444 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' C' ' 140' ' ' TYR . 35.7 mtp85 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.438 ' C ' ' CD2' ' D' ' 2' ' ' HIS . 5.2 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.438 ' CD2' ' C ' ' D' ' 1' ' ' VAL . 2.6 p80 173.8 93.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 109.127 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.631 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -130.32 171.95 12.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.306 -0.872 . . . . 0.0 109.382 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.416 ' O ' ' N ' ' D' ' 6' ' ' GLU . 7.6 p -90.54 141.63 27.37 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.262 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . 0.435 ' O ' ' OG ' ' D' ' 9' ' ' SER . 86.7 Cg_exo -40.59 -24.05 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.507 2.138 . . . . 0.0 112.398 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' D' ' 4' ' ' THR . 73.3 mm-40 -78.73 -54.79 5.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.932 . . . . 0.0 109.824 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -74.75 -23.13 58.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 109.614 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.514 ' O ' ' OG1' ' D' ' 12' ' ' THR . 2.2 tttm -84.29 -32.17 24.51 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.372 -0.83 . . . . 0.0 109.34 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' D' ' 5' ' ' PRO . 8.9 m -63.77 -23.31 67.31 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.677 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.82 -57.52 3.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.963 . . . . 0.0 110.125 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 1.7 p -62.68 -24.37 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 70.6 m -84.07 -35.24 23.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.773 -0.579 . . . . 0.0 109.717 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.33 -27.33 61.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.622 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.25 -18.75 11.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.33 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . 0.613 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.5 OUTLIER -50.98 -50.88 57.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.008 . . . . 0.0 109.062 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.73 -50.98 60.84 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.484 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 7.7 mtmt -53.9 -25.85 22.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.407 -1.054 . . . . 0.0 109.175 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.2 t -91.49 124.36 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 0.0 109.698 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' D' ' 21' ' ' ASP . 1.8 m120 -81.89 68.26 8.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.874 . . . . 0.0 108.925 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 69.0 t -45.96 -14.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 109.812 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' D' ' 19' ' ' ASN . 60.4 t0 -58.01 -18.1 21.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.764 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' D' ' 25' ' ' GLY . 35.1 mt-10 -155.78 -33.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.059 -1.025 . . . . 0.0 109.758 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -46.07 -23.89 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.644 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.57 -24.66 72.09 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -82.45 -32.96 26.61 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -74.78 -24.97 58.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -1.218 . . . . 0.0 109.548 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.25 -40.25 93.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.45 -50.03 17.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.38 -28.2 9.07 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.05 -47.57 11.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -1.117 . . . . 0.0 109.276 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 tp -47.34 -31.61 4.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' D' ' 36' ' ' PRO . 14.4 mt -71.16 -46.16 62.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.441 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.12 -55.58 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.373 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.69 -22.86 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.886 . . . . 0.0 109.501 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -150.48 76.94 8.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . 0.517 ' N ' ' O ' ' D' ' 32' ' ' LEU . 77.8 Cg_endo -82.89 -7.75 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.878 2.385 . . . . 0.0 112.351 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . 0.523 ' C ' ' H ' ' D' ' 39' ' ' GLN . 20.9 p-90 -63.85 -20.0 65.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 7.9 p -72.6 37.44 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.396 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' D' ' 37' ' ' TRP . 17.2 tt0 -80.73 10.54 4.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -89.13 -37.66 14.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.534 ' C ' ' H ' ' D' ' 43' ' ' GLU . 88.4 m-85 -89.65 -43.32 10.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 109.574 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.09 14.73 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.379 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' D' ' 41' ' ' PHE . 19.0 pt-20 -66.89 -13.87 62.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.085 -1.009 . . . . 0.0 109.492 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.417 ' O ' ' N ' ' D' ' 46' ' ' GLY . 49.8 m -77.75 -42.5 33.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' D' ' 47' ' ' ASP . 39.9 m-85 -47.53 -20.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.461 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 59.09 -79.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' D' ' 45' ' ' PHE . 32.1 t0 -46.83 106.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -1.174 . . . . 0.0 109.553 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -163.08 21.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 0.0 109.269 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -52.61 -42.58 64.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 109.708 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' THR . . . . . 0.432 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.4 p -145.4 152.08 49.04 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.319 -0.863 . . . . 0.0 109.265 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -40.28 -35.16 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.421 2.081 . . . . 0.0 112.365 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.74 -27.1 63.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.588 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -66.76 -19.94 65.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 t -74.13 -51.35 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.463 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 7.4 mmt -66.73 -22.03 66.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.56 -11.07 78.35 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' D' ' 59' ' ' LYS . 20.1 t-20 -71.73 136.33 83.07 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.169 -1.195 . . . . 0.0 109.266 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.07 -35.26 3.19 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.431 2.087 . . . . 0.0 112.374 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' D' ' 57' ' ' ASN . 40.9 mttm -63.95 -47.78 79.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 97.6 t -46.76 -35.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 109.795 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -49.9 52.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 109.355 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.76 -32.65 60.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 0.549 ' HE2' ' CHA' ' D' ' 147' ' ' HEC . 36.9 t-80 -69.58 -24.0 63.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.8 -37.66 92.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -65.94 -25.63 67.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -1.143 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -74.71 -49.07 22.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 0.0 109.435 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.82 -60.76 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.312 -0.867 . . . . 0.0 109.362 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.85 -21.16 65.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.124 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.78 -52.43 15.15 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.02 -35.3 33.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 109.571 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -66.81 -49.83 64.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 109.446 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' SER . . . . . 0.613 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 8.1 t -56.75 -30.94 64.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.413 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -59.62 -40.36 87.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.324 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.75 -60.23 8.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.465 ' H ' HD13 ' D' ' 75' ' ' LEU . 4.6 mp -50.38 -26.56 5.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -1.125 . . . . 0.0 109.347 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.61 -2.57 58.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.149 -0.97 . . . . 0.0 109.435 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.516 ' CE1' ' OD2' ' D' ' 79' ' ' ASP . 71.3 t60 -171.01 62.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.547 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 25.1 mt -70.21 2.16 4.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.516 ' OD2' ' CE1' ' D' ' 77' ' ' HIS . 55.0 m-20 -55.92 -26.6 48.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 15.6 t-20 -170.6 111.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.428 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 14.5 mt -80.2 -58.11 3.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 109.507 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -47.31 -24.1 0.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -63.61 -51.51 53.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.472 ' C ' ' H ' ' D' ' 86' ' ' ALA . 0.7 OUTLIER -85.48 -39.65 17.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -1.14 . . . . 0.0 109.426 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.443 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.5 m-85 -70.53 10.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 109.532 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -67.75 -33.8 75.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.328 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -82.1 -53.21 6.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.456 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 35.6 mt -51.91 -49.69 62.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.252 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' D' ' 85' ' ' PHE . 7.2 m -59.69 -50.42 73.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.423 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.34 -38.84 92.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.392 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 5.1 tt -74.35 -32.56 62.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' D' ' 97' ' ' HIS . 15.2 m80 -84.91 -20.3 30.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.083 -1.011 . . . . 0.0 109.615 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 46.5 t -83.76 -59.92 2.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 0.0 110.844 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 41' ' ' THR . 37.4 m-20 -86.6 -34.76 19.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.065 -1.022 . . . . 0.0 111.565 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -79.82 -51.67 8.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.772 -1.205 . . . . 0.0 110.619 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.31 -32.73 10.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.064 . . . . 0.0 110.258 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.56 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 11.3 t-160 54.3 54.12 9.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 109.348 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.39 125.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.947 . . . . 0.0 109.156 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -49.33 145.88 7.01 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 109.322 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.11 -11.82 31.1 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.559 2.173 . . . . 0.0 112.098 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -93.71 60.36 2.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -148.83 -46.99 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 109.573 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 1.0 OUTLIER -51.34 -47.43 62.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.671 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -48.35 -19.89 0.35 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.437 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . 0.411 ' N ' ' C ' ' D' ' 103' ' ' PHE . 17.3 mt -88.69 -57.63 2.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.565 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -47.93 -20.94 0.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.528 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -81.72 -33.2 28.1 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -83.42 -17.51 41.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -1.191 . . . . 0.0 109.59 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 78.7 t -83.14 -56.66 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 tt -48.67 -53.17 19.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.456 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -47.03 -40.83 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.942 . . . . 0.0 109.631 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.74 -33.86 76.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.9 . . . . 0.0 109.521 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 t -66.3 -29.31 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' D' ' 118' ' ' PHE . 8.9 mt -81.61 -53.04 6.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.02 -24.41 16.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.508 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.456 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.6 OUTLIER -84.81 -62.58 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.606 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -68.59 -17.63 64.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.87 . . . . 0.0 109.664 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' D' ' 114' ' ' LEU . 72.2 m-85 -144.22 57.82 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 109.488 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -70.5 -23.06 77.87 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -72.61 10.81 0.75 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -1.151 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' D' ' 123' ' ' THR . 81.2 mm-40 -135.32 -0.26 2.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 0.0 109.762 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.529 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -73.77 33.54 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.517 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.0 OUTLIER -50.2 148.23 6.43 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.464 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.5 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.3 Cg_exo -46.85 -52.98 6.82 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.425 2.083 . . . . 0.0 113.119 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 26.1 Cg_endo -62.56 -21.99 73.48 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.115 1.877 . . . . 0.0 112.329 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.59 -25.52 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.141 -0.974 . . . . 0.0 109.513 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' D' ' 123' ' ' THR . 5.4 mp0 -83.41 -59.66 2.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.508 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.87 -38.2 7.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.543 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.59 29.54 0.88 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.489 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' D' ' 127' ' ' GLN . 17.1 t80 -124.14 -22.4 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.707 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -83.99 -63.7 1.3 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.951 . . . . 0.0 110.099 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -49.75 -21.64 1.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 109.978 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.45 -68.29 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.063 -1.023 . . . . 0.0 109.851 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.28 -19.95 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.844 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.03 -28.63 17.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.109 -0.994 . . . . 0.0 109.39 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.44 -36.4 88.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.47 -47.93 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -1.165 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.14 -43.21 31.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.894 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -80.2 -38.24 31.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.38 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' D' ' 142' ' ' ALA . . . -51.38 -48.43 62.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.346 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 36.0 mt -75.53 10.97 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.381 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' D' ' 140' ' ' ALA . . . -132.4 -4.66 3.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.365 -0.834 . . . . 0.0 109.441 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.11 -27.46 64.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.91 -16.38 36.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -62.19 -61.61 2.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.255 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.481 ' N ' ' ND1' ' D' ' 146' ' ' HIS . 2.0 m-70 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.519 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 0.559 ' CHA' ' HE2' ' B' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 0.549 ' CHA' ' HE2' ' D' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 2' ' ' LEU . 21.8 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 7.3 mp 55.12 166.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.76 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.568 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 176.14 -45.22 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.851 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 3' ' ' SER . 42.3 Cg_exo -55.36 -153.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.616 2.21 . . . . 0.0 112.864 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -78.61 -15.26 58.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.474 -0.766 . . . . 0.0 110.003 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 5' ' ' ALA . 16.4 m-20 -38.78 -29.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.379 -0.826 . . . . 0.0 109.735 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . 2.0 ptpm? -83.39 -41.79 17.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.187 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.481 ' N ' ' O ' ' A' ' 5' ' ' ALA . 45.9 m -51.35 -29.82 16.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.312 -0.868 . . . . 0.0 109.083 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.72 -36.87 42.74 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.99 -49.05 52.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -52.99 -46.02 68.11 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.02 -58.06 10.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.498 -0.751 . . . . 0.0 109.36 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.19 -35.96 60.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.406 -0.808 . . . . 0.0 109.129 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -17.14 62.29 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.256 -0.902 . . . . 0.0 109.302 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.08 22.6 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -73.01 -35.89 66.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -1.115 . . . . 0.0 108.744 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.02 -64.56 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 43.63 -122.35 3.93 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.31 22.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.403 -1.057 . . . . 0.0 110.345 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.568 ' H ' ' C ' ' A' ' 18' ' ' GLY . 78.2 m-70 -128.81 26.16 5.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -91.86 -63.1 1.29 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.621 -0.675 . . . . 0.0 109.9 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.7 -14.27 0.22 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 21' ' ' ALA . 10.4 mt-10 -84.72 -56.19 3.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -1.129 . . . . 0.0 109.814 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 20' ' ' HIS . 4.7 m-30 -60.24 -16.57 34.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.31 -34.14 30.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.07 39.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -1.2 . . . . 0.0 110.033 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.02 -19.73 64.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 109.662 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.72 -19.76 60.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 109.714 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.7 mt -78.73 -49.48 13.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 109.997 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' OE1' ' ND1' ' A' ' 50' ' ' HIS . 10.1 pt-20 -72.3 -33.25 67.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.091 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.575 ' NH1' ' SG ' ' A' ' 104' ' ' CYS . 45.8 ttt-85 -54.87 -44.58 74.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.927 . . . . 0.0 110.618 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.583 ' HE1' ' CBC' ' A' ' 142' ' ' HEC . 12.0 ptt? -84.13 -45.35 13.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.889 -1.132 . . . . 0.0 110.153 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.459 ' CD1' ' OG1' ' A' ' 39' ' ' THR . 1.1 m-85 -49.23 -41.42 37.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 109.825 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.04 -38.75 61.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.982 -1.074 . . . . 0.0 109.586 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.424 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 15.7 m -75.52 7.43 3.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.015 -1.053 . . . . 0.0 109.29 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.93 ' CZ ' ' OE1' ' B' ' 131' ' ' GLN . 77.0 m-85 -156.13 71.9 5.13 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.39 -19.86 0.77 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.727 2.285 . . . . 0.0 112.265 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 p -59.23 -22.79 61.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.459 ' OG1' ' CD1' ' A' ' 33' ' ' PHE . 70.5 p -89.48 -42.87 11.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.539 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -52.16 -38.97 59.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.57 ' C ' ' H ' ' A' ' 43' ' ' PHE . 2.7 t -68.43 -18.59 64.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -61.42 4.13 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 109.605 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.57 ' H ' ' C ' ' A' ' 41' ' ' THR . 42.1 m-85 54.17 65.79 4.96 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.584 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 74.4 Cg_endo -78.55 -12.6 15.22 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.856 2.371 . . . . 0.0 112.379 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 44' ' ' PRO . 26.9 p-80 40.48 29.42 0.06 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.405 -0.809 . . . . 0.0 109.588 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.523 ' O ' ' C ' ' A' ' 47' ' ' ASP . 5.3 t80 -120.15 27.8 8.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.666 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 46' ' ' PHE . 1.6 p30 28.2 72.86 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.853 -0.529 . . . . 0.0 110.819 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 48' ' ' LEU . 2.2 mm? -64.83 -7.77 12.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.129 -0.982 . . . . 0.0 109.316 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 t -49.25 152.15 1.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.537 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.532 ' ND1' ' OE1' ' A' ' 30' ' ' GLU . 83.2 t60 -76.04 152.84 36.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.78 18.72 59.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 53' ' ' ALA . 2.0 t -68.0 -99.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.246 -1.15 . . . . 0.0 109.311 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.526 ' N ' ' OG ' ' A' ' 52' ' ' SER . . . 174.0 -78.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.506 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -44.85 -17.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.395 -0.816 . . . . 0.0 109.589 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ALA . 3.5 t -76.72 -27.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.214 -0.929 . . . . 0.0 109.433 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -66.02 -26.99 67.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 0.0 109.458 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.47 -42.18 42.01 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.459 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 15.1 t-80 -63.08 -27.98 69.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -1.203 . . . . 0.0 109.688 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.59 -47.31 90.25 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 32.6 mttp -56.08 -23.8 36.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -1.134 . . . . 0.0 109.754 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.577 ' HB3' HMA1 ' A' ' 142' ' ' HEC . 10.0 mmpt? -72.54 -42.52 64.64 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.304 -0.872 . . . . 0.0 109.05 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.4 t -68.92 -47.69 74.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.517 -0.739 . . . . 0.0 109.2 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.91 -30.0 67.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.311 -0.868 . . . . 0.0 109.531 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.3 t70 -69.22 -41.88 76.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.122 -0.986 . . . . 0.0 108.821 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.38 -47.94 79.98 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.03 -47.14 87.81 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -62.22 -47.31 85.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 108.948 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -63.38 -26.71 68.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 108.682 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.14 -46.71 11.64 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.99 -22.43 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.25 -21.67 66.3 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.586 ' O ' ' N ' ' A' ' 74' ' ' ASP . 13.2 m80 -144.18 -50.59 0.3 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.9 p 44.87 14.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 121.792 0.806 . . . . 0.0 109.489 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 72' ' ' HIS . 14.6 t70 -128.62 9.56 5.99 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -173.74 27.12 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.046 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.3 ptt? -78.36 -24.92 0.45 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.415 -0.803 . . . . 0.0 111.594 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 76' ' ' MET . 43.7 Cg_exo -55.56 -20.62 27.72 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.766 1.644 . . . . 0.0 112.538 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.491 HD21 ' C ' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -94.06 -28.75 15.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.868 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.54 -48.05 20.64 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.142 -0.974 . . . . 0.0 109.178 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.13 6.89 8.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.15 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -59.4 -15.74 18.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.635 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.83 -48.7 11.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 109.74 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 86' ' ' LEU . 4.7 mt -47.19 -48.35 23.83 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 88.3 p -50.18 -24.82 3.04 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.093 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 82' ' ' ALA . 15.0 t70 -74.45 -25.5 59.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.158 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.466 HD22 ' CBD' ' A' ' 142' ' ' HEC . 6.9 tp -81.82 -34.29 30.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.299 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -90.44 -21.78 21.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.21 -68.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.907 . . . . 0.0 109.675 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -88.4 -77.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.91 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 86' ' ' LEU . 19.3 mttm -59.31 171.18 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.868 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.56 ' C ' ' H ' ' A' ' 93' ' ' VAL . 4.0 tp 56.79 56.95 5.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 109.682 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -66.05 9.75 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.953 . . . . 0.0 109.315 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.56 ' H ' ' C ' ' A' ' 91' ' ' LEU . 12.4 p -46.4 165.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.664 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.551 ' CG ' ' OD1' ' D' ' 99' ' ' ASP . 5.3 m-20 -84.34 116.96 67.47 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.299 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 97' ' ' ASN . 84.4 Cg_exo -44.28 -10.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.297 1.998 . . . . 0.0 112.357 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.841 HG22 ' OD2' ' D' ' 99' ' ' ASP . 98.2 t -53.88 -10.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 109.56 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 95' ' ' PRO . 2.7 m-80 -79.24 -24.9 42.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -53.16 -43.71 67.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.576 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 99' ' ' LYS . 7.5 mtmp? -69.32 -25.41 64.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.683 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 25.3 mt -81.67 -46.69 13.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.707 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.947 ' CD2' HBB3 ' A' ' 142' ' ' HEC . 6.3 tt -69.68 -20.76 63.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.694 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.7 p -78.75 -59.07 2.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 109.746 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.458 ' NE2' ' HH ' ' B' ' 35' ' ' TYR . 8.6 m170 -63.29 -26.72 68.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.806 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.575 ' SG ' ' NH1' ' A' ' 31' ' ' ARG . 35.0 m -65.08 -52.26 56.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 109.818 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -24.62 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.749 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.75 -34.85 60.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.083 -1.011 . . . . 0.0 109.926 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.1 t -83.33 -24.65 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.058 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -70.98 -63.64 1.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.137 -0.977 . . . . 0.0 110.458 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 113' ' ' LEU . 2.3 pp -64.04 -18.68 64.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.847 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.35 -33.29 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 0.0 109.709 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.79 -56.15 25.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.371 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -66.52 -68.28 0.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.115 -0.991 . . . . 0.0 108.422 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 114' ' ' PRO . 3.1 pp -116.67 111.44 41.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 113' ' ' LEU . 89.2 Cg_exo -41.58 -177.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.571 2.18 . . . . 0.0 113.167 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.64 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -45.45 -52.48 10.1 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.64 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 19.4 mt-10 124.98 -1.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 61.21 31.47 19.51 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.194 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.776 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -103.82 120.47 51.26 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.48 23.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.007 1.805 . . . . 0.0 112.663 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.776 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -152.51 -32.53 0.13 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.965 -1.084 . . . . 0.0 110.514 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.5 ' H ' ' HG1' ' A' ' 118' ' ' THR . 14.4 p -47.86 -48.26 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.957 -1.09 . . . . 0.0 110.081 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.491 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -63.76 -39.01 93.23 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 109.365 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.29 -19.78 33.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 120' ' ' ALA . 7.6 p -58.44 -62.07 2.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 110.018 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.507 ' N ' ' OG ' ' A' ' 124' ' ' SER . 5.0 mt -68.57 -19.58 64.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 109.329 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -73.74 -52.18 14.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.747 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HG3' ' H ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -86.29 -44.4 12.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 109.971 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.47 ' H ' ' HG3' ' A' ' 127' ' ' LYS . 39.5 t80 -47.43 -20.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.988 -1.07 . . . . 0.0 108.992 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.596 HD23 HBB1 ' A' ' 142' ' ' HEC . 12.0 mt -71.88 -17.99 62.08 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.32 -33.56 73.8 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.404 ' HG ' ' N ' ' A' ' 132' ' ' VAL . 89.2 p -82.72 -29.88 29.5 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.408 -0.808 . . . . 0.0 108.834 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.404 ' N ' ' HG ' ' A' ' 131' ' ' SER . 8.1 t -85.23 -29.73 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 109.134 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 129' ' ' LEU . 18.0 m -82.79 -22.64 34.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 0.0 108.936 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 138' ' ' SER . 42.1 m -80.72 -39.93 26.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.332 -0.855 . . . . 0.0 109.223 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.05 -26.5 27.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.211 -0.931 . . . . 0.0 108.899 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.02 -31.92 73.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -0.788 . . . . 0.0 108.96 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.0 m -156.81 53.63 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 134' ' ' THR . 9.1 p -58.8 115.09 2.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.497 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 140' ' ' TYR . 14.5 pttm -73.07 -25.85 61.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.917 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.517 ' CG ' ' O ' ' A' ' 139' ' ' LYS . 64.1 m-85 -159.74 154.12 23.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.387 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' C' ' 141' ' ' ARG . 22.4 mtm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.535 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.701 ' H2 ' ' HB2' ' D' ' 146' ' ' HIS . 6.8 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.331 0.586 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' B' ' 1' ' ' VAL . 43.9 m80 -159.07 102.58 1.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.297 -0.877 . . . . 0.0 109.163 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.1 OUTLIER -142.74 164.53 29.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 109.362 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.83 159.43 68.83 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.827 . . . . 0.0 109.348 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.74 -18.64 65.3 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.632 2.221 . . . . 0.0 112.003 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.5 -34.25 23.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.5 -61.76 1.76 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 109.591 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -47.01 -26.74 1.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.91 . . . . 0.0 109.609 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.0 t -57.11 -23.39 46.73 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.59 -57.69 3.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.917 -1.115 . . . . 0.0 110.102 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.4 -24.58 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 48.1 m -82.09 -36.92 27.09 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.396 0.617 . . . . 0.0 109.759 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.5 -34.65 70.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.597 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.7 OUTLIER -50.49 -34.56 25.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 109.157 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -45.74 -17.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.372 -0.83 . . . . 0.0 109.66 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.25 -49.41 7.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.45 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 0.1 OUTLIER -71.95 -30.28 65.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.2 . . . . 0.0 109.396 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.5 t -53.46 114.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 109.649 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' B' ' 21' ' ' ASP . 36.3 m-80 -79.53 66.04 4.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 108.946 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' B' ' 22' ' ' GLU . 72.1 t -43.72 -26.13 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.471 -0.768 . . . . 0.0 109.852 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' B' ' 19' ' ' ASN . 18.0 t70 -65.51 5.13 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' B' ' 20' ' ' VAL . 37.5 mt-10 -154.03 -51.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.976 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 88.0 t -49.63 -53.3 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.76 -40.46 25.95 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.63 -37.14 61.94 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.05 -35.77 61.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -1.144 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.83 68.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.507 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 tp -84.94 -52.06 6.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.533 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.76 -28.49 70.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -79.22 -28.21 42.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -1.173 . . . . 0.0 109.477 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 44.6 tp -48.08 -39.79 21.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.546 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.461 ' CD2' ' OG1' ' B' ' 38' ' ' THR . 21.1 mt -81.08 -23.01 38.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 71.5 t -66.23 -61.68 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.979 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.461 HG13 ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -78.44 -22.63 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 110.047 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.458 ' HH ' ' NE2' ' A' ' 103' ' ' HIS . 72.2 m-85 -134.57 77.03 59.77 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.067 -1.02 . . . . 0.0 109.926 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -84.2 27.89 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.014 2.476 . . . . 0.0 112.277 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -81.04 -20.13 42.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 109.89 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.57 ' C ' ' H ' ' B' ' 40' ' ' ARG . 6.1 p -47.7 -29.25 2.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.67 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 52.0 6.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' B' ' 38' ' ' THR . 42.6 ttm180 -110.21 -39.96 4.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 109.207 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 47.69 19.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 1.164 ' CZ ' HBC3 ' B' ' 147' ' ' HEC . 77.2 m-85 54.53 55.18 8.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 109.388 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -46.3 -16.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.341 -0.849 . . . . 0.0 109.583 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.515 ' N ' ' O ' ' B' ' 42' ' ' PHE . 20.0 m -57.64 -54.68 44.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.432 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -70.12 3.75 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 109.235 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' B' ' 44' ' ' SER . . . 45.16 -149.45 1.24 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 56.52 73.11 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -1.132 . . . . 0.0 109.669 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 89.8 mt -137.42 29.72 2.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.85 . . . . 0.0 109.384 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 41.5 t -72.49 -38.0 68.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -0.922 . . . . 0.0 109.541 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' THR . . . . . 0.404 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.3 p -146.16 151.91 45.72 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -40.93 -35.34 1.66 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.384 2.056 . . . . 0.0 112.38 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.99 -32.14 73.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 109.554 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -66.2 -24.0 66.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.565 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.33 -60.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -91.91 25.48 2.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.966 . . . . 0.0 109.629 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.2 -52.44 2.05 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.84 157.0 90.78 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 109.437 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' B' ' 62' ' ' ALA . 65.8 Cg_endo -74.96 -44.59 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.709 2.273 . . . . 0.0 112.322 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -45.95 -35.32 4.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.727 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 38.0 t -76.12 -41.57 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -79.18 -24.85 42.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.868 . . . . 0.0 109.545 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' B' ' 58' ' ' PRO . . . -76.55 -51.14 12.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.616 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 1.076 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 45.7 t-80 -51.28 -23.95 4.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.86 -45.63 95.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -50.74 -44.7 58.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -1.113 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . 0.417 ' O ' HMA3 ' B' ' 147' ' ' HEC . 49.5 mmtt -57.82 -51.52 69.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.51 -0.744 . . . . 0.0 109.434 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.848 HG11 ' C2B' ' B' ' 147' ' ' HEC . 53.7 t -57.88 -51.14 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.291 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.77 -45.35 94.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.256 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.76 -45.83 31.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.15 92.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -1.14 . . . . 0.0 109.614 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -57.59 -28.86 63.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 11.6 m -77.16 -33.62 56.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.476 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.38 -34.24 33.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.463 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.24 -60.0 7.25 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.48 HD11 ' H ' ' B' ' 75' ' ' LEU . 4.8 mp -55.03 -27.5 45.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -1.104 . . . . 0.0 109.45 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -2.14 36.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -171.26 63.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.49 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.99 -18.06 62.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -48.8 -26.05 2.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.445 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.34 65.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.276 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 pp -55.69 -40.92 73.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.627 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -50.35 -23.92 2.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.473 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.0 -42.88 7.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.7 OUTLIER -68.26 -42.92 78.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.148 -1.207 . . . . 0.0 109.629 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' B' ' 84' ' ' THR . 35.7 m-85 -67.3 -0.39 3.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -0.838 . . . . 0.0 109.459 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.46 -53.92 20.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.945 . . . . 0.0 109.383 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.5 p -61.6 -58.76 6.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' B' ' 92' ' ' HIS . 50.3 mt -51.21 -49.84 60.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.206 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' SER . . . . . 0.516 ' O ' ' N ' ' B' ' 93' ' ' CYS . 7.2 m -57.16 -46.24 82.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.249 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.502 ' CA ' ' HZ2' ' B' ' 144' ' ' LYS . 31.0 tt0 -62.21 -46.53 88.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.486 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 3.9 tt -72.62 -27.24 62.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 109.361 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' B' ' 88' ' ' LEU . 18.7 m80 -90.47 -20.29 22.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.978 . . . . 0.0 109.663 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' B' ' 89' ' ' SER . 26.6 t -83.17 -59.23 2.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 110.699 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.65 -40.51 15.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.988 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.1 OUTLIER -73.01 -51.96 16.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.945 -1.097 . . . . 0.0 110.642 -178.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.57 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 30.8 mt -95.79 -36.89 10.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.91 -1.119 . . . . 0.0 109.96 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 38.6 p-80 43.71 30.78 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -52.32 153.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 0.0 109.215 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 0.827 ' OD2' HG22 ' C' ' 96' ' ' VAL . 1.6 m-20 -71.24 143.05 87.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 109.589 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -41.22 -43.87 5.38 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.608 2.206 . . . . 0.0 112.46 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -72.01 54.46 0.28 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.449 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.6 ' O ' HMC1 ' B' ' 147' ' ' HEC . 9.5 m120 -150.98 -31.17 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 109.969 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . 0.484 ' O ' HBB2 ' B' ' 147' ' ' HEC . 21.6 m-85 -75.52 -41.68 54.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.072 -1.017 . . . . 0.0 109.931 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . 0.424 ' O ' ' ND2' ' B' ' 108' ' ' ASN . 73.8 ttt180 -79.59 -19.98 48.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 110.071 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' B' ' 105' ' ' LEU . 4.3 mm? -50.56 -60.86 2.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.137 -0.977 . . . . 0.0 109.793 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 1.192 ' CD2' ' HHC' ' B' ' 147' ' ' HEC . 1.9 pp -81.7 -22.39 37.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.012 -1.055 . . . . 0.0 109.721 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.35 -36.57 37.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' B' ' 104' ' ' ARG . 14.2 p30 -85.55 -34.81 21.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -1.158 . . . . 0.0 109.648 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 74.3 t -51.35 -48.0 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 109.465 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 tp -51.92 -54.0 34.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 109.49 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 25.2 t -46.42 -38.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.414 ' O ' ' ND1' ' B' ' 116' ' ' HIS . 13.2 m -79.2 -56.31 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 85.6 t -47.99 -24.52 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.552 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 14.2 mt -77.29 -43.54 32.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.26 -19.37 63.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.414 ' ND1' ' O ' ' B' ' 112' ' ' CYS . 4.3 m80 -78.29 -62.82 1.56 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.696 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -70.93 -17.43 62.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 0.0 109.845 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.45 ' CZ ' ' O ' ' B' ' 17' ' ' LYS . 63.1 m-85 -144.94 58.17 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.665 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -79.67 -17.92 74.31 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -65.05 4.99 0.39 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -1.079 . . . . 0.0 109.694 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' B' ' 119' ' ' GLY . 46.8 mm-40 -135.12 9.55 3.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -77.67 32.61 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.132 -0.98 . . . . 0.0 109.287 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.474 ' H ' ' C ' ' B' ' 121' ' ' GLU . 36.8 p -46.85 148.69 1.75 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.867 . . . . 0.0 109.51 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.466 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.1 Cg_exo -45.16 -57.03 2.31 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.542 2.161 . . . . 0.0 112.918 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 14.3 Cg_endo -56.86 -36.12 98.7 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.064 1.843 . . . . 0.0 111.995 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 63.0 t -76.39 -20.33 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.75 -44.98 26.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.329 -0.857 . . . . 0.0 109.494 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.32 84.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.942 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.51 29.28 0.89 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.606 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.99 -33.89 4.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.0 109.375 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . 0.93 ' OE1' ' CZ ' ' A' ' 36' ' ' PHE . 19.4 tt0 -83.95 -63.6 1.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 109.878 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -48.05 -21.88 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.844 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 71.3 t -71.75 -67.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.726 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' B' ' 137' ' ' VAL . 2.2 t -67.2 -40.29 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.637 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.75 -21.78 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.497 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.15 -22.11 63.84 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 134' ' ' VAL . 88.8 t -74.14 -30.94 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -1.178 . . . . 0.0 109.536 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.37 71.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -81.43 -21.2 39.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.592 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.14 -60.52 2.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.653 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.0 mt -57.92 -17.75 18.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.547 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' B' ' 144' ' ' LYS . . . -100.6 -6.91 24.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.895 . . . . 0.0 109.532 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -59.05 -4.71 0.53 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.467 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.532 ' C ' ' HD1' ' B' ' 146' ' ' HIS . 21.6 mmtp -92.13 -30.85 15.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -71.3 14.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.0 109.325 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.705 ' HB2' ' H2 ' ' D' ' 1' ' ' VAL . 28.1 p-80 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' C' ' 2' ' ' LEU . 21.8 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' C' ' 2' ' ' LEU . 7.4 mp 55.12 166.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 109.727 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.563 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 176.06 -45.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.877 . . . . 0.0 109.859 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' C' ' 3' ' ' SER . 42.6 Cg_exo -55.31 -153.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.633 2.222 . . . . 0.0 112.843 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -78.65 -15.27 58.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.416 -0.802 . . . . 0.0 110.018 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' C' ' 5' ' ' ALA . 15.9 m-20 -38.67 -29.16 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.829 . . . . 0.0 109.759 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' C' ' 5' ' ' ALA . 2.0 ptpm? -83.37 -41.83 17.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.192 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.481 ' N ' ' O ' ' C' ' 5' ' ' ALA . 45.8 m -51.25 -29.96 16.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.889 . . . . 0.0 109.057 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.71 -36.79 42.9 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -70.99 -49.06 52.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -53.04 -45.98 68.28 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.06 -58.12 9.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.475 -0.766 . . . . 0.0 109.31 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.13 -35.89 60.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.456 -0.777 . . . . 0.0 109.215 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -17.24 62.29 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 109.258 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.03 22.79 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -73.12 -35.73 66.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -1.118 . . . . 0.0 108.772 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 57.7 t -62.16 -64.52 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.581 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 43.68 -122.42 4.01 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.29 22.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -1.096 . . . . 0.0 110.347 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' C' ' 18' ' ' GLY . 78.4 m-70 -128.87 26.25 5.55 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.91 -63.15 1.28 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.599 -0.688 . . . . 0.0 109.837 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.67 -14.29 0.22 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' C' ' 21' ' ' ALA . 10.4 mt-10 -84.64 -56.37 3.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.801 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.438 ' CE2' ' O ' ' C' ' 20' ' ' HIS . 4.7 m-30 -60.16 -16.64 34.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.848 . . . . 0.0 109.516 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.13 -34.19 30.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.14 -32.03 38.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -1.184 . . . . 0.0 109.984 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.97 -19.9 64.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.623 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.59 60.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.734 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 5.7 mt -78.86 -49.5 12.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.949 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.521 ' OE1' ' ND1' ' C' ' 50' ' ' HIS . 10.1 pt-20 -72.24 -33.28 67.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.925 . . . . 0.0 110.13 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.567 ' NH1' ' SG ' ' C' ' 104' ' ' CYS . 45.8 ttt-85 -54.82 -44.63 74.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 110.596 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.588 ' HE1' ' CBC' ' C' ' 142' ' ' HEC . 12.1 ptt? -84.09 -45.46 13.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.887 -1.133 . . . . 0.0 110.114 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.46 ' CD1' ' OG1' ' C' ' 39' ' ' THR . 1.1 m-85 -49.21 -41.41 37.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.171 -0.956 . . . . 0.0 109.83 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.04 -38.74 61.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.019 -1.051 . . . . 0.0 109.594 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.427 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 15.6 m -75.51 7.48 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 109.326 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.93 ' CZ ' ' OE1' ' D' ' 131' ' ' GLN . 76.7 m-85 -156.19 72.05 5.09 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.338 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -46.5 -19.84 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.732 2.288 . . . . 0.0 112.203 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 19.9 p -59.22 -22.83 61.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.53 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.46 ' OG1' ' CD1' ' C' ' 33' ' ' PHE . 70.4 p -89.49 -42.91 11.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.963 . . . . 0.0 109.482 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -52.01 -39.13 59.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 109.608 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.558 ' C ' ' H ' ' C' ' 43' ' ' PHE . 2.7 t -68.27 -18.7 64.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -61.47 4.15 0.1 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 0.0 109.568 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.558 ' H ' ' C ' ' C' ' 41' ' ' THR . 42.0 m-85 54.28 65.69 5.0 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.486 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.577 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 74.5 Cg_endo -78.59 -12.47 15.21 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.71 2.273 . . . . 0.0 112.424 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.577 ' ND1' ' O ' ' C' ' 44' ' ' PRO . 27.0 p-80 40.44 29.36 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 109.564 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.533 ' O ' ' C ' ' C' ' 47' ' ' ASP . 5.2 t80 -120.05 27.72 8.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 0.0 109.679 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.533 ' C ' ' O ' ' C' ' 46' ' ' PHE . 1.6 p30 28.35 72.67 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.087 0.47 . . . . 0.0 110.844 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' C' ' 48' ' ' LEU . 2.2 mm? -64.74 -7.8 12.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.147 -0.97 . . . . 0.0 109.364 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 33.7 t -49.25 152.13 1.27 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.521 ' ND1' ' OE1' ' C' ' 30' ' ' GLU . 83.2 t60 -76.0 152.82 36.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.449 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.88 18.6 59.93 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' C' ' 53' ' ' ALA . 2.0 t -67.93 -99.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -1.151 . . . . 0.0 109.309 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.517 ' N ' ' OG ' ' C' ' 52' ' ' SER . . . 174.06 -78.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.567 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -44.78 -17.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.466 -0.771 . . . . 0.0 109.709 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' C' ' 53' ' ' ALA . 3.5 t -76.68 -27.48 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.192 -0.943 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -66.04 -27.0 67.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.281 -0.887 . . . . 0.0 109.467 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.46 -42.28 41.72 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.461 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 14.9 t-80 -62.97 -28.2 69.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -1.158 . . . . 0.0 109.63 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.52 -47.26 90.7 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 32.7 mttp -56.1 -23.89 36.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -1.083 . . . . 0.0 109.671 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.582 ' HB3' HMA1 ' C' ' 142' ' ' HEC . 10.0 mmpt? -72.42 -42.5 65.04 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.314 -0.866 . . . . 0.0 109.055 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.0 t -68.95 -47.67 74.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.501 -0.749 . . . . 0.0 109.229 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.92 -30.06 67.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 2.3 t70 -69.2 -41.79 76.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.0 108.886 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.45 -47.95 79.71 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.408 -0.807 . . . . 0.0 108.854 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.01 -47.15 87.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.219 -0.926 . . . . 0.0 108.654 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -62.13 -47.33 85.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.185 -0.947 . . . . 0.0 109.027 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -63.49 -26.63 68.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 108.647 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.588 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.16 -46.64 11.7 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.04 -22.46 30.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.26 -21.63 66.29 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' C' ' 74' ' ' ASP . 13.3 m80 -144.18 -50.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.8 p 44.99 13.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.659 0.742 . . . . 0.0 109.407 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' C' ' 72' ' ' HIS . 14.6 t70 -128.57 9.52 6.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -173.71 27.14 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.099 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.709 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.3 ptt? -78.37 -24.85 0.45 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.519 -0.738 . . . . 0.0 111.605 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' C' ' 76' ' ' MET . 44.0 Cg_exo -55.64 -20.57 28.08 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.748 1.632 . . . . 0.0 112.504 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.486 HD21 ' C ' ' C' ' 78' ' ' ASN . 0.1 OUTLIER -94.05 -28.82 15.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 109.867 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 -47.97 21.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.116 -0.99 . . . . 0.0 109.259 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.25 6.9 8.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -59.28 -15.82 18.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.668 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.86 -48.61 11.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.112 -0.993 . . . . 0.0 109.775 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' C' ' 86' ' ' LEU . 4.6 mt -47.2 -48.34 23.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 108.748 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 88.1 p -50.2 -24.76 3.03 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.458 -0.777 . . . . 0.0 109.079 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' C' ' 82' ' ' ALA . 14.9 t70 -74.44 -25.54 59.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.191 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.47 HD22 ' CBD' ' C' ' 142' ' ' HEC . 6.9 tp -81.75 -34.4 30.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.311 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -90.38 -21.75 21.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.24 -68.51 0.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.779 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -88.41 -77.16 0.37 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.89 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' C' ' 86' ' ' LEU . 19.2 mttm -59.28 171.14 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.889 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.579 ' C ' ' H ' ' C' ' 93' ' ' VAL . 4.0 tp 56.91 56.84 5.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.396 -0.815 . . . . 0.0 109.726 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -66.08 9.81 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 109.279 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.579 ' H ' ' C ' ' C' ' 91' ' ' LEU . 12.2 p -46.38 165.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.605 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' C' ' 96' ' ' VAL . 5.3 m-20 -84.27 117.02 67.66 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.915 . . . . 0.0 109.258 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' C' ' 97' ' ' ASN . 85.4 Cg_exo -44.41 -10.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.318 2.012 . . . . 0.0 112.318 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . 0.827 HG22 ' OD2' ' B' ' 99' ' ' ASP . 98.8 t -53.91 -10.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.111 -0.993 . . . . 0.0 109.543 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' C' ' 95' ' ' PRO . 2.7 m-80 -79.17 -24.97 42.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -53.14 -43.71 67.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.918 . . . . 0.0 109.55 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.437 ' CB ' ' NZ ' ' C' ' 99' ' ' LYS . 7.6 mtmp? -69.41 -25.27 64.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.643 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 25.4 mt -81.68 -46.8 13.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 109.661 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.946 ' CD2' HBB3 ' C' ' 142' ' ' HEC . 6.3 tt -69.54 -20.88 63.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.735 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 32.8 p -78.68 -59.11 2.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 109.791 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.449 ' NE2' ' HH ' ' D' ' 35' ' ' TYR . 8.5 m170 -63.16 -26.73 68.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.871 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.567 ' SG ' ' NH1' ' C' ' 31' ' ' ARG . 34.5 m -65.17 -52.25 56.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.766 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.03 -24.68 0.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.721 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.78 -34.88 60.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -0.98 . . . . 0.0 109.855 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 71.2 t -83.26 -24.82 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.045 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -70.8 -63.7 1.05 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.129 -0.982 . . . . 0.0 110.561 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' C' ' 113' ' ' LEU . 2.4 pp -64.02 -18.68 64.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 109.823 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.35 -33.36 63.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.712 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.65 -56.22 25.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -66.58 -68.31 0.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.0 108.385 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' C' ' 114' ' ' PRO . 3.1 pp -116.56 111.46 41.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' C' ' 113' ' ' LEU . 89.9 Cg_exo -41.59 -177.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.507 2.138 . . . . 0.0 113.204 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.645 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -45.57 -52.42 10.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.479 -0.763 . . . . 0.0 109.038 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.645 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 19.4 mt-10 125.0 -1.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 61.28 31.33 19.4 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.262 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.775 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -103.88 120.54 50.95 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.53 23.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.049 1.833 . . . . 0.0 112.649 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.775 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -152.47 -32.5 0.14 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.864 -1.147 . . . . 0.0 110.568 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.489 ' N ' ' OG1' ' C' ' 118' ' ' THR . 14.4 p -47.93 -48.23 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 110.1 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.487 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 0.3 OUTLIER -63.74 -38.89 92.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.439 -0.788 . . . . 0.0 109.416 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.4 -19.75 33.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.885 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.608 ' N ' ' O ' ' C' ' 120' ' ' ALA . 7.6 p -58.36 -62.1 2.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 0.0 110.015 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.519 ' N ' ' OG ' ' C' ' 124' ' ' SER . 5.1 mt -68.54 -19.64 64.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 109.31 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -73.83 -52.21 13.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.701 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.472 ' HG3' ' H ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -86.26 -44.41 12.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.023 . . . . 0.0 109.936 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.472 ' H ' ' HG3' ' C' ' 127' ' ' LYS . 39.7 t80 -47.32 -20.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.045 -1.035 . . . . 0.0 108.921 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.593 HD23 HBB1 ' C' ' 142' ' ' HEC . 12.0 mt -71.75 -18.0 62.16 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.28 -33.67 73.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' SER . . . . . 0.401 ' HG ' ' N ' ' C' ' 132' ' ' VAL . 89.3 p -82.7 -29.96 29.52 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . 0.401 ' N ' ' HG ' ' C' ' 131' ' ' SER . 8.1 t -85.18 -29.72 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.157 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.488 ' N ' ' O ' ' C' ' 129' ' ' LEU . 17.8 m -82.79 -22.69 34.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.302 -0.873 . . . . 0.0 108.96 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' THR . . . . . 0.463 ' O ' ' N ' ' C' ' 138' ' ' SER . 41.9 m -80.67 -39.99 26.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 0.0 109.225 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 26.8 m -71.08 -26.45 27.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.266 -0.897 . . . . 0.0 108.846 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -31.95 73.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.413 -0.804 . . . . 0.0 108.978 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 7.1 m -156.74 53.65 0.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.413 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' SER . . . . . 0.463 ' N ' ' O ' ' C' ' 134' ' ' THR . 9.0 p -58.74 115.02 2.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' C' ' 140' ' ' TYR . 14.5 pttm -73.06 -25.78 61.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.474 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.513 ' CG ' ' O ' ' C' ' 139' ' ' LYS . 64.4 m-85 -159.76 154.16 23.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 109.419 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 141' ' ' ARG . 22.3 mtm180 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.705 ' H2 ' ' HB2' ' B' ' 146' ' ' HIS . 6.7 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.313 0.578 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' D' ' 1' ' ' VAL . 44.0 m80 -159.08 102.52 1.63 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.349 -0.844 . . . . 0.0 109.152 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.563 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.1 OUTLIER -142.72 164.54 29.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.368 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.89 159.48 68.57 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.265 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.82 -18.65 65.64 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.72 2.28 . . . . 0.0 111.946 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -84.58 -34.14 23.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.53 -61.75 1.76 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.628 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.507 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -46.99 -26.76 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.609 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.1 t -57.04 -23.5 46.98 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.153 -0.967 . . . . 0.0 110.194 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.62 -57.65 3.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.019 -1.051 . . . . 0.0 110.115 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.35 -24.59 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 48.8 m -82.11 -36.92 27.04 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.309 0.575 . . . . 0.0 109.704 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.54 -34.65 70.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.7 OUTLIER -50.54 -34.48 25.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.14 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -45.78 -17.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.375 -0.828 . . . . 0.0 109.637 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.27 -49.37 7.48 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.454 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 0.1 OUTLIER -72.0 -30.23 65.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.094 -1.239 . . . . 0.0 109.445 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.47 114.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.7 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' D' ' 20' ' ' VAL . 36.4 m-80 -79.56 65.99 4.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 108.937 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' D' ' 22' ' ' GLU . 72.5 t -43.69 -26.18 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.451 -0.781 . . . . 0.0 109.79 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' D' ' 19' ' ' ASN . 18.0 t70 -65.45 5.13 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.527 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' D' ' 20' ' ' VAL . 37.5 mt-10 -154.06 -51.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 0.0 109.484 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 88.0 t -49.71 -53.35 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 109.547 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.67 -40.56 25.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.55 -37.2 62.22 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.09 -35.7 61.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -1.123 . . . . 0.0 109.555 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.51 -28.71 68.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 tp -85.04 -51.97 6.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.78 -28.41 70.02 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -79.4 -28.11 41.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -1.117 . . . . 0.0 109.49 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 44.3 tp -48.09 -39.91 21.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.475 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . 0.452 ' CD2' ' OG1' ' D' ' 38' ' ' THR . 21.2 mt -81.03 -23.03 38.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.291 -0.88 . . . . 0.0 109.695 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.18 -61.81 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.142 -0.974 . . . . 0.0 109.918 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' C' ' 122' ' ' HIS . 0.0 OUTLIER -78.42 -22.54 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 0.0 110.112 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . 0.449 ' HH ' ' NE2' ' C' ' 103' ' ' HIS . 72.3 m-85 -134.6 76.99 59.74 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.109 -0.994 . . . . 0.0 109.925 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.18 27.88 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.028 2.486 . . . . 0.0 112.339 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -81.1 -20.04 42.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -0.953 . . . . 0.0 109.853 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.573 ' C ' ' H ' ' D' ' 40' ' ' ARG . 6.0 p -47.81 -29.16 2.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 109.66 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 51.91 6.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . 0.573 ' H ' ' C ' ' D' ' 38' ' ' THR . 42.5 ttm180 -110.13 -39.92 4.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 47.73 19.72 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.621 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 1.164 ' CE2' HMD2 ' D' ' 147' ' ' HEC . 77.3 m-85 54.73 55.01 8.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.359 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -46.2 -16.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 109.636 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.514 ' N ' ' O ' ' D' ' 42' ' ' PHE . 20.2 m -57.69 -54.68 44.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -70.07 3.74 2.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.219 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' D' ' 44' ' ' SER . . . 45.05 -149.34 1.19 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 56.51 73.16 0.46 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.319 -1.106 . . . . 0.0 109.641 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 90.3 mt -137.5 29.69 2.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.858 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 41.5 t -72.46 -38.01 68.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.499 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -146.11 151.95 45.98 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.295 -0.878 . . . . 0.0 109.173 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -41.12 -35.23 1.82 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.404 2.07 . . . . 0.0 112.308 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.91 -32.28 73.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.11 -23.88 66.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.681 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.45 -60.73 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -91.97 25.59 2.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.33 -52.36 2.04 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.81 156.87 90.98 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.224 -1.162 . . . . 0.0 109.43 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.97 -44.49 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.645 2.23 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -45.98 -35.33 4.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 0.0 109.66 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -76.15 -41.58 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -79.17 -24.93 42.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.36 -0.837 . . . . 0.0 109.474 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.48 -51.26 12.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.53 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 1.08 ' CE1' ' CHA' ' D' ' 147' ' ' HEC . 45.7 t-80 -51.27 -23.94 4.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 109.47 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.93 -45.59 95.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -50.83 -44.63 59.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.374 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . 0.417 ' O ' HMA3 ' D' ' 147' ' ' HEC . 49.5 mmtt -57.81 -51.55 69.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.41 -0.806 . . . . 0.0 109.477 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.843 HG11 ' C2B' ' D' ' 147' ' ' HEC . 53.9 t -57.83 -51.15 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.314 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.77 -45.33 94.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.24 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.81 -45.79 31.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.24 92.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -1.103 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -57.42 -29.07 63.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 11.6 m -77.0 -33.68 57.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 109.496 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.45 -34.26 34.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.367 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.16 -60.08 7.19 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.467 ' H ' HD11 ' D' ' 75' ' ' LEU . 4.8 mp -55.11 -27.44 45.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -1.14 . . . . 0.0 109.381 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -2.16 36.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -171.23 63.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.91 -18.06 62.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.442 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -48.84 -25.97 2.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.37 65.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.283 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' D' ' 82' ' ' LYS . 2.5 pp -55.65 -40.98 72.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . 0.408 ' H ' ' HG ' ' D' ' 81' ' ' LEU . 39.5 mttp -50.44 -23.77 2.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.055 -1.028 . . . . 0.0 109.438 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.18 -42.89 7.78 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.7 OUTLIER -68.18 -42.89 79.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.022 -1.281 . . . . 0.0 109.635 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' D' ' 84' ' ' THR . 35.4 m-85 -67.39 -0.27 3.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.498 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.52 -54.01 20.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.3 p -61.57 -58.66 7.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.366 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' D' ' 92' ' ' HIS . 49.1 mt -51.27 -49.88 60.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.256 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' SER . . . . . 0.536 ' O ' ' N ' ' D' ' 93' ' ' CYS . 7.2 m -57.12 -46.22 82.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 109.233 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.501 ' CA ' ' HZ2' ' D' ' 144' ' ' LYS . 30.9 tt0 -62.28 -46.58 88.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.419 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 3.9 tt -72.45 -27.27 62.21 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.135 -0.978 . . . . 0.0 109.461 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.459 ' N ' ' O ' ' D' ' 88' ' ' LEU . 19.0 m80 -90.52 -20.24 22.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.06 -1.025 . . . . 0.0 109.621 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . 0.536 ' N ' ' O ' ' D' ' 89' ' ' SER . 26.0 t -83.27 -59.27 2.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 110.563 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -86.6 -40.53 15.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.04 -1.037 . . . . 0.0 111.326 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.1 OUTLIER -72.99 -52.0 16.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.965 -1.084 . . . . 0.0 110.602 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.56 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 30.9 mt -95.74 -36.89 11.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.934 -1.104 . . . . 0.0 109.96 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 38.5 p-80 43.58 30.9 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.373 -0.829 . . . . 0.0 110.078 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -52.38 153.27 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.074 -1.016 . . . . 0.0 109.19 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . 0.841 ' OD2' HG22 ' A' ' 96' ' ' VAL . 1.6 m-20 -71.22 143.01 87.76 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 109.589 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -41.26 -43.83 5.48 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.573 2.182 . . . . 0.0 112.417 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -71.98 54.42 0.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.601 ' O ' HMC1 ' D' ' 147' ' ' HEC . 9.4 m120 -150.93 -31.18 0.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 109.961 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . 0.496 ' O ' HBB2 ' D' ' 147' ' ' HEC . 21.6 m-85 -75.48 -41.7 54.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.993 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . 0.426 ' O ' ' ND2' ' D' ' 108' ' ' ASN . 73.9 ttt180 -79.49 -20.1 48.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 110.094 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' D' ' 105' ' ' LEU . 4.3 mm? -50.58 -60.84 2.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 109.737 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 1.214 ' CD2' ' HHC' ' D' ' 147' ' ' HEC . 1.9 pp -81.68 -22.43 37.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.056 -1.028 . . . . 0.0 109.766 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.28 -36.55 37.09 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' D' ' 104' ' ' ARG . 14.2 p30 -85.6 -34.8 21.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -1.149 . . . . 0.0 109.675 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 74.6 t -51.3 -48.0 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 109.462 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.94 -54.1 33.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.368 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 25.1 t -46.29 -38.14 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 109.533 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . 0.422 ' O ' ' ND1' ' D' ' 116' ' ' HIS . 13.3 m -79.1 -56.35 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.56 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 86.8 t -47.93 -24.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.945 . . . . 0.0 109.479 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 14.2 mt -77.19 -43.65 32.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.389 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.52 63.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.407 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' D' ' 112' ' ' CYS . 4.4 m80 -78.18 -62.87 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 0.0 109.771 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -70.75 -17.56 62.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.869 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 63.5 m-85 -144.86 58.12 1.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 0.0 109.74 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -79.7 -17.93 74.23 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -65.03 4.92 0.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -1.083 . . . . 0.0 109.656 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' D' ' 119' ' ' GLY . 46.7 mm-40 -135.04 9.46 3.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.722 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.556 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -77.58 32.62 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.14 -0.975 . . . . 0.0 109.297 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.481 ' H ' ' C ' ' D' ' 121' ' ' GLU . 37.2 p -46.88 148.68 1.77 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.34 -0.85 . . . . 0.0 109.546 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.462 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.2 Cg_exo -45.28 -56.91 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.538 2.159 . . . . 0.0 112.887 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 14.3 Cg_endo -56.9 -36.16 98.86 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.16 1.907 . . . . 0.0 111.969 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 63.3 t -76.4 -20.34 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.71 -45.05 25.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 0.0 109.481 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.34 83.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 109.57 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.5 29.29 0.89 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.634 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.02 -33.88 4.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . 0.93 ' OE1' ' CZ ' ' C' ' 36' ' ' PHE . 19.4 tt0 -83.98 -63.48 1.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -48.12 -21.84 0.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.838 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 70.8 t -71.73 -67.25 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.151 -0.968 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -67.3 -40.14 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.82 -21.85 0.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.14 -22.02 64.06 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 89.5 t -74.12 -31.0 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -1.155 . . . . 0.0 109.562 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.36 71.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.53 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -81.34 -21.29 39.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.587 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.13 -60.46 2.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.658 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.1 mt -57.99 -17.69 18.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.514 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' D' ' 144' ' ' LYS . . . -100.66 -6.9 24.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.863 . . . . 0.0 109.603 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -59.03 -4.75 0.53 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.473 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.546 ' C ' ' HD1' ' D' ' 146' ' ' HIS . 21.5 mmtp -92.0 -31.03 15.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.579 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -71.32 14.2 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.001 . . . . 0.0 109.36 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.701 ' HB2' ' H2 ' ' B' ' 1' ' ' VAL . 28.0 p-80 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.947 HBB3 ' CD2' ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 1.192 ' HHC' ' CD2' ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 0.946 HBB3 ' CD2' ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.214 ' HHC' ' CD2' ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.07 -176.64 3.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.306 -0.871 . . . . 0.0 109.609 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.545 ' O ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -117.34 170.88 5.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.0 109.236 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 3' ' ' SER . 88.7 Cg_exo -41.39 -117.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 123.132 2.554 . . . . 0.0 113.304 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -43.99 -27.63 0.39 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.966 -1.084 . . . . 0.0 110.263 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 5' ' ' ALA . 29.9 m-20 -44.1 -35.07 2.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.973 . . . . 0.0 109.192 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -83.26 -34.02 25.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.267 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 m -59.22 -33.33 70.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.264 -0.897 . . . . 0.0 109.148 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -75.02 -32.64 61.66 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -76.03 -51.4 20.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -56.96 -33.98 67.59 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.18 -59.62 5.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.446 -0.784 . . . . 0.0 109.459 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' A' ' 17' ' ' VAL . . . -53.21 -34.44 57.05 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.425 -0.797 . . . . 0.0 109.141 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -17.62 61.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.22 -44.69 9.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -70.19 -38.15 75.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -1.123 . . . . 0.0 108.901 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 96.1 t -61.38 -64.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 53.93 -130.52 43.56 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.23 26.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.457 -1.025 . . . . 0.0 110.438 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.565 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.0 m-70 -130.56 23.85 5.09 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.81 -59.58 2.19 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.612 -0.68 . . . . 0.0 109.698 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -14.21 0.22 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 9.7 mt-10 -88.14 -56.63 3.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -1.141 . . . . 0.0 109.739 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.8 m-30 -57.46 -39.49 76.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.034 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.54 -22.95 53.63 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.51 -57.88 2.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -1.11 . . . . 0.0 109.735 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' OE1' ' NE2' ' A' ' 112' ' ' HIS . 72.4 mt-10 -50.26 -19.9 0.92 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.362 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.58 63.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.367 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 30' ' ' GLU . 9.1 mt -73.13 -56.42 5.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 29' ' ' LEU . 56.3 mt-10 -43.87 -37.19 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.691 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -48.76 78.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.945 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.639 ' HE2' HBC1 ' A' ' 142' ' ' HEC . 61.1 ttp -83.99 -42.82 15.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.63 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.596 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 26.1 m-85 -64.28 -32.57 74.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 0.0 110.301 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mt -45.68 -43.02 12.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.971 -1.081 . . . . 0.0 109.727 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 36' ' ' PHE . 14.9 m -86.65 -15.76 38.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.328 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER 19.14 64.48 0.24 Allowed Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.976 -0.453 . . . . 0.0 111.319 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.52 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 85.4 Cg_endo -93.63 -62.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.623 2.215 . . . . 0.0 112.552 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.628 HG21 ' O ' ' D' ' 97' ' ' HIS . 3.5 p -91.43 -18.6 23.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 109.738 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 p -81.72 -23.03 36.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.968 . . . . 0.0 110.149 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -68.27 -34.93 77.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.063 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 t -49.82 -36.92 28.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.508 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 43' ' ' PHE . 60.7 m-85 -90.87 15.56 11.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 109.192 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 42' ' ' TYR . 20.2 m-85 60.02 142.6 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.467 -0.771 . . . . 0.0 109.536 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 59.7 Cg_endo -73.4 -42.74 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.446 2.097 . . . . 0.0 111.938 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 42.0 p-80 43.27 31.95 0.43 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.616 -0.677 . . . . 0.0 111.078 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.509 ' O ' ' C ' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -155.91 28.53 0.37 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.727 -1.233 . . . . 0.0 110.395 178.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 46' ' ' PHE . 7.3 m-20 33.31 81.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.635 -0.666 . . . . 0.0 110.33 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.613 ' CD2' ' H ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -60.13 -21.27 61.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.442 -0.786 . . . . 0.0 109.335 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 t -47.54 149.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.67 ' HD1' ' H ' ' A' ' 51' ' ' GLY . 2.0 t60 -74.77 151.06 39.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.67 ' H ' ' HD1' ' A' ' 50' ' ' HIS . . . 82.16 4.74 90.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' A' ' 53' ' ' ALA . 12.1 p -77.42 -19.77 55.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -1.143 . . . . 0.0 109.477 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 75.77 -16.95 0.55 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.37 -0.831 . . . . 0.0 109.869 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' A' ' 52' ' ' SER . 45.2 mt-30 -86.14 -21.43 27.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.121 -0.987 . . . . 0.0 109.954 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.8 t -84.1 -28.29 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 0.0 109.834 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -77.98 -30.41 50.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.123 -0.986 . . . . 0.0 108.989 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.531 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . . . -66.61 -26.46 72.91 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.448 ' CD2' ' C ' ' A' ' 58' ' ' HIS . 7.4 t60 -75.46 -34.78 60.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.131 -1.217 . . . . 0.0 109.636 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.34 -51.08 44.34 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -51.66 -23.46 4.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -1.065 . . . . 0.0 109.968 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -74.51 -42.38 59.02 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.125 -0.984 . . . . 0.0 109.082 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -72.5 -45.24 59.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.467 -0.77 . . . . 0.0 108.986 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.85 -27.59 65.97 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.291 -0.881 . . . . 0.0 109.188 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.39 -34.06 67.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 108.727 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.414 ' CB ' HMB3 ' A' ' 142' ' ' HEC . . . -66.87 -52.15 46.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.318 -0.864 . . . . 0.0 108.933 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.17 -42.77 91.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 0.0 108.653 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -69.35 -50.19 48.56 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 108.745 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -58.98 -24.78 63.01 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.95 -45.6 12.99 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -63.77 -22.99 32.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.407 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -60.38 -22.78 63.7 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.61 ' O ' ' N ' ' A' ' 74' ' ' ASP . 40.2 m80 -147.22 -51.78 0.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.875 . . . . 0.0 109.532 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.4 p 44.49 13.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.758 0.79 . . . . 0.0 109.479 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' A' ' 72' ' ' HIS . 17.8 t70 -133.07 9.78 4.15 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -175.43 27.43 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.981 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 13.8 ptt? -78.66 -22.48 0.38 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.431 -0.793 . . . . 0.0 111.909 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.8 Cg_exo -53.48 -20.78 16.69 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.548 1.499 . . . . 0.0 112.33 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.17 -35.41 12.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.678 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.04 -47.55 61.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.306 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.5 mt -77.5 5.75 8.37 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.075 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.1 p -54.73 -24.64 23.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.291 -0.88 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -73.93 -55.21 6.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 109.557 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.464 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 4.6 mt -47.7 -48.13 29.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.808 . . . . 0.0 108.929 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 136' ' ' LEU . 28.8 t -59.21 -22.65 61.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.549 -0.719 . . . . 0.0 109.398 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 89' ' ' HIS . 16.5 t70 -81.89 -46.52 13.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.3 -26.74 65.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 11.4 m80 -81.47 -21.65 38.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.724 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.521 ' C ' ' H ' ' A' ' 90' ' ' LYS . . . -119.05 -55.46 2.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.294 -0.879 . . . . 0.0 109.746 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 85' ' ' ASP . 13.2 t-80 -71.41 17.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 109.751 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.643 ' C ' ' H ' ' A' ' 92' ' ' ARG . 9.8 ttmm -166.5 149.02 6.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 109.781 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.7 mt 61.81 -12.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 109.86 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.028 ' HD2' ' HG2' ' D' ' 40' ' ' ARG . 45.6 mmt-85 45.14 16.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 109.714 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 91' ' ' LEU . 12.1 p -57.68 131.02 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 1.08 ' OD1' ' NH1' ' D' ' 40' ' ' ARG . 0.8 OUTLIER -75.3 147.03 82.3 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.29 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.536 ' C ' ' H ' ' A' ' 97' ' ' ASN . 58.1 Cg_endo -72.57 -23.9 19.38 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.543 2.162 . . . . 0.0 112.126 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.8 t -49.06 -10.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.77 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 95' ' ' PRO . 12.0 m-20 -79.05 -24.88 43.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.534 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -54.28 -30.04 49.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.425 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 92.4 mttt -54.33 -26.62 30.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.489 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 100' ' ' LEU . 8.1 mp -84.06 -57.37 3.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.659 HD21 HBB3 ' A' ' 142' ' ' HEC . 7.3 tp -50.89 -27.35 7.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -66.09 -58.52 5.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.616 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -63.57 -26.45 68.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.882 . . . . 0.0 109.67 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 73.6 m -58.2 -55.97 28.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 109.596 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mt -47.82 -37.98 14.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 106' ' ' LEU . 7.7 mp -71.13 -41.89 69.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.05 -24.95 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 109.348 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 m -80.76 -63.28 1.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.447 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 113' ' ' LEU . 33.8 mt -46.98 -28.29 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.25 90.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 110.017 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.68 64.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.097 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' A' ' 27' ' ' GLU . 28.1 m170 -93.19 -80.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.073 -1.017 . . . . 0.0 109.721 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.49 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -107.94 102.74 47.07 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -43.8 173.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.546 2.164 . . . . 0.0 113.563 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -87.32 -35.44 18.42 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.782 0.801 . . . . 0.0 109.422 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 13.1 mt-10 81.29 1.35 1.63 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 1.209 ' CD1' ' NH2' ' B' ' 30' ' ' ARG . 11.2 m-85 58.49 40.91 23.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.806 -0.559 . . . . 0.0 111.282 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.752 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -88.12 118.7 69.89 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 120.756 -1.215 . . . . 0.0 108.001 178.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.523 ' HA ' HG23 ' B' ' 33' ' ' VAL . 54.1 Cg_exo -49.05 18.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.319 2.012 . . . . 0.0 112.644 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.752 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -140.08 -39.21 0.45 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.111 -0.993 . . . . 0.0 110.053 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 4.2 p -51.68 -48.35 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.102 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.576 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 2.8 m-70 -62.75 -54.37 40.21 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.412 -0.805 . . . . 0.0 109.334 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.92 -19.61 60.87 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.253 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 1.1 p -60.77 -61.6 2.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 110.271 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.539 ' N ' ' OG ' ' A' ' 124' ' ' SER . 6.4 mt -80.64 -21.05 41.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.113 -0.992 . . . . 0.0 110.073 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -78.51 -40.69 34.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 110.109 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.493 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.29 -41.29 11.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.949 -1.094 . . . . 0.0 110.13 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.493 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 32.3 t80 -50.56 -20.51 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.8 -1.188 . . . . 0.0 108.839 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.629 HD22 HBB1 ' A' ' 142' ' ' HEC . 11.9 mt -72.59 -17.74 61.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.13 76.83 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.2 p -79.39 -36.19 39.57 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.339 -0.851 . . . . 0.0 108.82 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.09 -27.23 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.183 -0.948 . . . . 0.0 108.67 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 129' ' ' LEU . 97.2 p -78.17 -45.99 21.7 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.474 -0.766 . . . . 0.0 109.204 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.429 ' N ' ' HG ' ' A' ' 133' ' ' SER . 95.2 m -67.81 -23.01 65.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.223 -0.923 . . . . 0.0 108.654 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.85 -29.9 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.433 ' O ' ' OG ' ' A' ' 84' ' ' SER . 0.5 OUTLIER -72.51 -34.6 67.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.09 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 138' ' ' SER . 81.0 p -92.21 -29.73 16.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 137' ' ' THR . 3.5 t 61.96 132.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.521 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -170.53 109.43 0.35 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.494 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 49.55 74.94 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.899 . . . . 0.0 109.397 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.7 ptp85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.472 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.305 0.574 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' B' ' 2' ' ' HIS . 0.3 OUTLIER -171.75 93.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -140.81 145.25 36.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.342 -0.849 . . . . 0.0 109.034 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 7.8 p -69.65 148.75 96.84 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.543 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -42.65 -24.85 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.598 2.199 . . . . 0.0 112.236 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -80.82 -53.03 6.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.92 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -60.28 -36.08 77.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.182 -0.948 . . . . 0.0 109.98 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.528 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -84.08 -31.57 25.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 109.922 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.07 -23.56 8.02 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.148 -0.97 . . . . 0.0 110.458 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.4 -58.04 3.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.942 -1.099 . . . . 0.0 110.272 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.53 -24.53 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.528 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.9 m -78.38 -40.35 36.49 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.338 0.589 . . . . 0.0 109.711 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.36 -26.14 68.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.339 -0.851 . . . . 0.0 109.488 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.53 -26.81 68.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.38 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.77 -17.7 64.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.42 -62.9 3.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.428 ' H ' ' HD2' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -78.71 7.1 7.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.099 -1.236 . . . . 0.0 110.815 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -75.65 121.32 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.826 -1.171 . . . . 0.0 109.186 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.43 85.1 6.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.402 -0.811 . . . . 0.0 109.224 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 36.0 t -55.96 -20.36 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 109.573 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 1.0 OUTLIER -57.36 -55.78 30.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 43.1 mt-10 -98.89 -44.29 6.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.58 -23.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.882 . . . . 0.0 109.658 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.18 -43.07 11.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.98 -25.86 61.33 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -79.44 -25.45 41.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.198 -1.177 . . . . 0.0 109.662 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.64 -23.22 39.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 109.619 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 tp -85.02 -57.26 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 0.0 109.503 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.03 -19.82 32.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 1.209 ' NH2' ' CD1' ' A' ' 117' ' ' PHE . 47.0 mtt180 -79.37 -27.34 41.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -1.188 . . . . 0.0 109.377 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . 0.579 ' CD2' HMC3 ' B' ' 147' ' ' HEC . 39.7 tp -65.58 -24.77 67.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.879 . . . . 0.0 109.585 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 41.2 mt -78.01 -53.8 7.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.085 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.565 ' CG1' ' H ' ' B' ' 34' ' ' VAL . 7.9 p -71.07 -60.73 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 110.039 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.565 ' H ' ' CG1' ' B' ' 33' ' ' VAL . 95.3 t -46.28 -30.5 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.958 -1.089 . . . . 0.0 109.549 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.9 91.2 1.58 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.391 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.71 30.48 0.52 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.733 2.289 . . . . 0.0 112.427 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -57.17 -28.66 62.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.488 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.689 HG23 HBC1 ' B' ' 147' ' ' HEC . 30.5 p -56.19 -77.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.892 . . . . 0.0 109.419 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . 0.616 ' H ' ' HG1' ' B' ' 38' ' ' THR . 14.8 tt0 50.62 46.12 26.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.554 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 1.034 ' NH1' ' OD1' ' C' ' 94' ' ' ASP . 68.9 mtm180 -148.01 -49.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.151 -0.968 . . . . 0.0 109.55 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . 0.517 ' C ' ' H ' ' B' ' 43' ' ' GLU . 1.3 p90 -96.72 -21.4 17.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.759 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -48.81 -11.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.98 . . . . 0.0 109.625 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.517 ' H ' ' C ' ' B' ' 41' ' ' PHE . 31.3 mt-10 -80.31 -20.3 44.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.171 -0.956 . . . . 0.0 109.475 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.474 ' O ' ' N ' ' B' ' 46' ' ' GLY . 11.2 t -58.25 -51.8 68.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.62 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' B' ' 47' ' ' ASP . 57.0 m-85 -47.92 -16.14 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.533 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 61.35 -77.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' B' ' 45' ' ' PHE . 0.9 OUTLIER -46.77 113.45 0.66 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -1.132 . . . . 0.0 109.605 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' B' ' 49' ' ' SER . 0.8 OUTLIER -161.15 22.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.009 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' B' ' 48' ' ' LEU . 17.9 m -45.13 -39.66 6.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 109.563 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -145.67 151.94 47.62 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.323 -0.861 . . . . 0.0 108.995 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -44.64 -21.84 0.53 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.295 1.996 . . . . 0.0 112.154 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.78 -29.21 27.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.657 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.547 ' O ' ' ND2' ' B' ' 57' ' ' ASN . . . -55.57 -26.94 46.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 109.535 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.51 -62.01 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.574 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 14.9 mmt -53.7 -16.97 1.89 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.541 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.25 -4.19 61.24 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' B' ' 53' ' ' ALA . 3.8 m120 -72.22 142.69 85.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.192 -1.181 . . . . 0.0 109.376 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.5 -52.1 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.509 2.14 . . . . 0.0 112.21 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -51.56 -48.11 63.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -0.86 . . . . 0.0 109.586 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.46 -27.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.529 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -79.16 -53.57 6.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.54 -59.04 3.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 0.908 ' HE1' ' CHA' ' B' ' 147' ' ' HEC . 1.2 t60 -49.06 -23.92 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.69 -37.62 92.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -71.7 -35.32 70.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.544 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . 0.76 ' O ' HMA3 ' B' ' 147' ' ' HEC . 41.4 mttm -49.42 -44.87 45.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.179 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.939 HG21 ' C1B' ' B' ' 147' ' ' HEC . 54.4 t -73.57 -61.84 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.183 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tt -50.43 -23.24 2.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.092 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.35 -56.99 11.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.88 97.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -1.132 . . . . 0.0 109.439 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.82 -21.78 0.7 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 109.289 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p -87.89 -34.93 18.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.621 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -46.44 -34.36 4.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.59 -58.93 6.01 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.438 ' H ' HD13 ' B' ' 75' ' ' LEU . 4.6 mp -62.87 -23.3 67.25 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -1.092 . . . . 0.0 109.277 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.49 2.4 54.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.44 ' C ' ' H ' ' B' ' 79' ' ' ASP . 55.9 t60 -170.99 65.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.78 13.22 0.67 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' B' ' 77' ' ' HIS . 34.7 t70 -76.36 -27.65 56.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.563 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -170.98 106.4 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 109.512 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 mt -80.33 -44.01 20.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.409 ' CD ' ' N ' ' B' ' 82' ' ' LYS . 1.5 mptp? -49.41 -25.87 2.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.383 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.17 -53.71 3.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 3.9 p -65.9 -37.64 86.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.199 -1.177 . . . . 0.0 109.616 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -90.84 23.95 2.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.619 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.26 -41.55 40.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.392 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 21.1 p -72.69 -51.01 21.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.408 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -56.79 -48.85 76.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.33 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 28.1 t -61.57 -44.06 97.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.34 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -64.41 -23.75 67.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.377 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 7.4 tp -85.1 -68.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -49.59 -30.01 8.04 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.272 -0.893 . . . . 0.0 110.083 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . 0.584 ' SG ' ' CD1' ' B' ' 145' ' ' TYR . 38.0 t -83.98 -55.66 4.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 111.548 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.541 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 0.6 OUTLIER -86.26 -29.13 23.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.915 -1.116 . . . . 0.0 112.205 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -90.32 -52.06 5.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.639 -1.288 . . . . 0.0 110.981 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' B' ' 96' ' ' LEU . 3.7 mm? -97.59 -22.79 16.31 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.753 -1.217 . . . . 0.0 110.208 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.574 ' O ' HG21 ' C' ' 38' ' ' THR . 81.9 m-70 51.03 37.62 18.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.004 -1.06 . . . . 0.0 109.424 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . 0.415 ' O ' ' OH ' ' B' ' 145' ' ' TYR . 44.4 t -55.04 138.75 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 0.0 109.362 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' B' ' 101' ' ' GLU . 0.8 OUTLIER -49.94 151.28 3.42 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.73 30.57 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.575 2.183 . . . . 0.0 112.022 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' B' ' 99' ' ' ASP . 29.4 mt-10 -143.47 75.86 1.49 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.304 -0.873 . . . . 0.0 109.384 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -168.2 -40.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.454 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . 0.411 ' HA ' HBB2 ' B' ' 147' ' ' HEC . 24.0 m-85 -52.52 -45.7 66.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.5 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . 0.429 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 55.4 ttp180 -66.34 -42.32 88.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.46 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' B' ' 105' ' ' LEU . 10.0 mp -54.37 -57.48 11.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.892 HD12 ' CAB' ' B' ' 147' ' ' HEC . 7.5 tt -52.15 -49.02 64.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.97 -22.41 54.96 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 27.4 m120 -80.76 -15.35 56.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.042 -1.269 . . . . 0.0 109.737 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 64.1 t -85.23 -44.78 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 109.609 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 tt -47.87 -54.33 12.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.599 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -45.57 -32.64 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.884 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.525 ' O ' ' ND1' ' B' ' 116' ' ' HIS . 45.6 m -77.3 -36.87 53.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 109.754 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 18.2 t -57.97 -46.36 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.739 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' B' ' 118' ' ' PHE . 19.0 mt -66.8 -30.54 70.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.697 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.458 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -61.08 -29.44 69.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.614 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' B' ' 112' ' ' CYS . 68.7 m80 -84.82 -62.89 1.44 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.708 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.518 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 6.6 t-160 -65.44 -18.45 65.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 40.5 m-85 -144.37 55.48 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 109.491 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.531 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -68.74 -21.32 74.85 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.06 -35.21 59.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.146 . . . . 0.0 109.421 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.0 mm-40 -75.31 3.05 9.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.439 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.552 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -72.33 35.43 0.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.555 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.527 ' H ' ' C ' ' B' ' 121' ' ' GLU . 4.8 p -47.12 147.4 2.47 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.369 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.483 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.2 Cg_exo -48.48 -51.28 10.53 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.31 2.007 . . . . 0.0 113.231 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 41.8 Cg_endo -67.99 -0.92 6.12 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.055 1.836 . . . . 0.0 112.754 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 40.3 t -99.08 -12.57 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 109.598 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.36 -60.19 2.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 109.496 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.51 ' O ' ' NZ ' ' B' ' 132' ' ' LYS . . . -67.07 -25.71 66.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.95 . . . . 0.0 109.264 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.45 18.19 2.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 109.651 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -107.89 -61.3 1.59 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.652 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -46.31 -48.28 18.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 109.742 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.828 ' HG2' ' OXT' ' D' ' 146' ' ' HIS . 33.1 mtmm -52.69 -21.89 4.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.781 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.34 -67.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.0 109.699 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' B' ' 137' ' ' VAL . 30.9 m -73.33 -15.88 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 109.909 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.918 ' HB1' ' CG ' ' D' ' 146' ' ' HIS . . . -47.47 -28.86 2.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.469 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.29 -22.8 58.22 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 134' ' ' VAL . 82.3 t -82.1 -27.04 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -1.136 . . . . 0.0 109.538 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.98 82.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.596 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 1.07 ' ND2' ' ND2' ' D' ' 139' ' ' ASN . 23.9 m120 -79.63 -25.93 41.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.917 . . . . 0.0 109.754 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.47 -49.15 78.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.0 109.726 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 21.8 mt -82.64 16.41 2.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 109.668 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.77 -0.77 1.88 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.22 -0.925 . . . . 0.0 109.697 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -80.36 -28.31 38.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -70.91 -16.6 62.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.439 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.584 ' CD1' ' SG ' ' B' ' 93' ' ' CYS . 13.9 m-85 -64.67 -28.83 69.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.361 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.891 ' CG ' ' HB1' ' D' ' 135' ' ' ALA . 20.9 m-70 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.447 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.13 -176.71 3.16 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.278 -0.889 . . . . 0.0 109.536 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.545 ' O ' ' O ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER -117.22 170.84 5.53 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.539 -0.726 . . . . 0.0 109.191 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' C' ' 3' ' ' SER . 89.1 Cg_exo -41.37 -117.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.126 2.551 . . . . 0.0 113.275 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -43.92 -27.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 110.272 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' C' ' 5' ' ' ALA . 29.7 m-20 -44.16 -34.95 2.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.1 -1.0 . . . . 0.0 109.25 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -83.33 -33.95 25.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.319 -0.863 . . . . 0.0 109.307 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 55.1 m -59.29 -33.41 71.04 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.227 -0.921 . . . . 0.0 109.028 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -74.95 -32.65 61.78 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 53.6 t -76.05 -51.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -57.0 -34.01 67.72 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.2 -59.67 5.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.521 -0.737 . . . . 0.0 109.314 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.2 -34.43 56.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.383 -0.823 . . . . 0.0 109.109 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -17.64 61.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.308 -0.87 . . . . 0.0 109.263 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.17 -44.75 9.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -70.06 -38.29 75.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.168 -1.195 . . . . 0.0 108.89 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.35 -64.93 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.582 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 53.94 -130.56 43.67 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.15 26.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.42 -1.047 . . . . 0.0 110.453 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.582 ' H ' ' C ' ' C' ' 18' ' ' GLY . 93.2 m-70 -130.59 24.07 5.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.95 -59.52 2.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.627 -0.67 . . . . 0.0 109.735 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -14.31 0.23 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' C' ' 21' ' ' ALA . 9.7 mt-10 -88.05 -56.6 3.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.139 . . . . 0.0 109.74 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.8 m-30 -57.4 -39.54 76.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.066 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.53 -23.05 53.83 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.4 -57.99 2.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.286 -1.126 . . . . 0.0 109.774 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . 0.526 ' OE1' ' NE2' ' C' ' 112' ' ' HIS . 72.7 mt-10 -50.18 -19.88 0.88 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.29 -21.64 63.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.494 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 9.1 mt -73.12 -56.49 5.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -43.79 -37.15 2.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.827 . . . . 0.0 109.773 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -48.71 78.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.645 ' HE2' HBC1 ' C' ' 142' ' ' HEC . 61.0 ttp -83.97 -42.87 15.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.594 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 26.2 m-85 -64.17 -32.71 74.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.908 . . . . 0.0 110.239 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' C' ' 33' ' ' PHE . 5.7 mt -45.66 -43.07 12.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.966 -1.083 . . . . 0.0 109.658 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.57 ' O ' ' C ' ' C' ' 36' ' ' PHE . 14.9 m -86.66 -15.67 38.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -0.9 . . . . 0.0 109.367 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.594 ' CD2' ' O ' ' C' ' 33' ' ' PHE . 0.2 OUTLIER 19.17 64.46 0.24 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.917 -0.489 . . . . 0.0 111.354 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . 0.436 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 85.4 Cg_endo -93.68 -62.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.571 2.181 . . . . 0.0 112.551 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' THR . . . . . 0.574 HG21 ' O ' ' B' ' 97' ' ' HIS . 3.4 p -91.45 -18.48 24.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 109.754 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -81.72 -23.08 36.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.15 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -68.25 -34.96 77.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.087 -1.008 . . . . 0.0 109.67 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 13.9 t -49.97 -36.85 29.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' C' ' 43' ' ' PHE . 60.6 m-85 -90.79 15.5 11.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.236 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' C' ' 42' ' ' TYR . 20.3 m-85 59.94 142.55 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.444 -0.785 . . . . 0.0 109.574 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.562 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 59.8 Cg_endo -73.33 -42.71 0.85 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.487 2.125 . . . . 0.0 111.976 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.562 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 42.1 p-80 43.23 31.86 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.625 -0.672 . . . . 0.0 111.106 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.503 ' O ' ' C ' ' C' ' 47' ' ' ASP . 0.7 OUTLIER -155.86 28.54 0.37 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.76 -1.212 . . . . 0.0 110.406 178.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' C' ' 46' ' ' PHE . 7.3 m-20 33.41 81.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.663 -0.648 . . . . 0.0 110.295 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.596 ' CD2' ' H ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -60.06 -21.35 61.33 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.462 -0.774 . . . . 0.0 109.356 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 20.9 t -47.54 149.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.614 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.673 ' ND1' ' H ' ' C' ' 51' ' ' GLY . 2.0 t60 -74.81 151.08 39.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . 0.673 ' H ' ' ND1' ' C' ' 50' ' ' HIS . . . 82.26 4.64 90.13 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' C' ' 53' ' ' ALA . 12.0 p -77.42 -19.81 55.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -1.11 . . . . 0.0 109.482 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 75.8 -16.99 0.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.367 -0.833 . . . . 0.0 109.888 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' C' ' 52' ' ' SER . 45.1 mt-30 -86.1 -21.56 27.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.903 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 18.6 t -83.93 -28.42 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.062 -1.024 . . . . 0.0 109.901 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -77.96 -30.37 50.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.013 -1.055 . . . . 0.0 108.961 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . 0.532 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -66.68 -26.44 72.97 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.453 ' C ' ' CD2' ' C' ' 58' ' ' HIS . 7.4 t60 -75.41 -34.77 61.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.122 -1.222 . . . . 0.0 109.671 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.1 44.32 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -51.66 -23.42 4.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -1.077 . . . . 0.0 109.887 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' C' ' 57' ' ' GLY . 0.8 OUTLIER -74.54 -42.4 58.9 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.157 -0.965 . . . . 0.0 109.103 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -72.54 -45.23 59.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 108.98 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.85 -27.66 66.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.279 -0.888 . . . . 0.0 109.156 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -72.3 -34.01 67.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 108.866 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . 0.424 ' CB ' HMB3 ' C' ' 142' ' ' HEC . . . -66.86 -52.1 47.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.01 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mt -59.15 -42.8 91.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.912 . . . . 0.0 108.634 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -69.42 -50.13 48.65 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.282 -0.886 . . . . 0.0 108.695 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -59.01 -24.86 63.17 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.86 -45.64 13.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -63.65 -23.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' C' ' 72' ' ' HIS . . . -60.21 -22.86 63.5 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' C' ' 74' ' ' ASP . 40.3 m80 -147.24 -51.87 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.357 -0.839 . . . . 0.0 109.56 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.3 p 44.42 13.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.856 0.836 . . . . 0.0 109.539 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' C' ' 72' ' ' HIS . 17.8 t70 -133.12 9.76 4.13 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -175.4 27.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.897 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.689 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 13.8 ptt? -78.64 -22.62 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.478 -0.764 . . . . 0.0 111.865 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.6 Cg_exo -53.46 -20.69 16.36 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.586 1.524 . . . . 0.0 112.276 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.21 -35.42 12.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 109.738 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.03 -47.58 61.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 0.0 109.32 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -77.45 5.69 8.38 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.112 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 64.4 p -54.74 -24.67 23.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -73.95 -55.15 6.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.579 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.47 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 4.7 mt -47.75 -48.07 30.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.385 -0.822 . . . . 0.0 108.821 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' C' ' 136' ' ' LEU . 28.8 t -59.32 -22.63 61.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.49 -0.756 . . . . 0.0 109.315 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' C' ' 89' ' ' HIS . 16.5 t70 -81.9 -46.53 13.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.24 -26.82 65.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 11.4 m80 -81.34 -21.74 38.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.166 -0.959 . . . . 0.0 109.783 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.524 ' C ' ' H ' ' C' ' 90' ' ' LYS . . . -118.98 -55.51 2.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.313 -0.867 . . . . 0.0 109.773 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' C' ' 85' ' ' ASP . 13.2 t-80 -71.26 17.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.813 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.617 ' C ' ' H ' ' C' ' 92' ' ' ARG . 9.8 ttmm -166.53 149.02 6.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -0.998 . . . . 0.0 109.728 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.7 mt 61.79 -12.47 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.893 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . 0.991 ' HD2' ' HG2' ' B' ' 40' ' ' ARG . 45.7 mmt-85 45.05 16.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.73 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' C' ' 91' ' ' LEU . 12.0 p -57.73 130.97 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 1.034 ' OD1' ' NH1' ' B' ' 40' ' ' ARG . 0.8 OUTLIER -75.31 146.99 82.24 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' C' ' 97' ' ' ASN . 58.0 Cg_endo -72.63 -23.82 19.27 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.436 2.091 . . . . 0.0 112.153 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 t -48.95 -10.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.796 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' C' ' 95' ' ' PRO . 12.1 m-20 -79.21 -24.73 42.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 109.518 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' C' ' 99' ' ' LYS . 0.6 OUTLIER -54.27 -30.1 49.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 109.497 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.419 ' N ' ' CD1' ' C' ' 98' ' ' PHE . 92.3 mttt -54.25 -26.61 29.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.461 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' C' ' 100' ' ' LEU . 8.1 mp -84.18 -57.31 3.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.645 HD21 HBB3 ' C' ' 142' ' ' HEC . 7.2 tp -50.93 -27.3 7.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 109.534 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 6.1 m -66.23 -58.55 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 0.0 109.551 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -63.39 -26.61 68.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.68 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 73.4 m -58.15 -55.94 28.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.627 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mt -47.86 -37.98 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 109.541 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.523 ' N ' ' CD1' ' C' ' 106' ' ' LEU . 7.7 mp -71.09 -41.99 69.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.99 -24.93 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.376 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 22.5 m -80.85 -63.2 1.46 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.442 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' C' ' 113' ' ' LEU . 34.4 mt -46.97 -28.35 1.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.18 90.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 110.044 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.69 63.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.386 -0.821 . . . . 0.0 110.027 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' C' ' 27' ' ' GLU . 28.1 m170 -93.16 -80.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.107 -0.995 . . . . 0.0 109.697 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.489 ' CD2' ' O ' ' C' ' 113' ' ' LEU . 0.1 OUTLIER -107.83 102.7 46.58 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -43.8 173.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.626 2.217 . . . . 0.0 113.504 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -87.19 -35.43 18.58 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.684 0.754 . . . . 0.0 109.482 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 13.2 mt-10 81.34 1.28 1.62 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 1.194 ' CD1' ' NH2' ' D' ' 30' ' ' ARG . 11.1 m-85 58.55 40.8 23.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.895 -0.503 . . . . 0.0 111.255 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.754 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -88.05 118.69 69.91 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.703 -1.248 . . . . 0.0 108.068 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . 0.512 ' HA ' HG23 ' D' ' 33' ' ' VAL . 54.0 Cg_exo -49.05 18.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.293 1.995 . . . . 0.0 112.662 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.754 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -139.99 -39.23 0.45 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.077 -1.015 . . . . 0.0 110.057 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 4.2 p -51.8 -48.33 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.103 -0.998 . . . . 0.0 109.952 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.573 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 2.9 m-70 -62.91 -54.32 40.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.399 -0.813 . . . . 0.0 109.259 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.81 -19.69 60.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.307 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 1.1 p -60.79 -61.5 2.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.345 -0.847 . . . . 0.0 110.303 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.535 ' N ' ' OG ' ' C' ' 124' ' ' SER . 6.4 mt -80.72 -21.04 41.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.089 -1.007 . . . . 0.0 110.05 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -78.51 -40.67 34.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 110.092 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.494 ' HG3' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.29 -41.3 11.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.987 -1.07 . . . . 0.0 110.097 -179.508 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.494 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 31.9 t80 -50.51 -20.59 1.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.8 -1.187 . . . . 0.0 108.841 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.625 HD22 HBB1 ' C' ' 142' ' ' HEC . 11.9 mt -72.53 -17.79 61.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.46 -38.1 76.85 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 60.8 p -79.46 -36.24 39.11 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.318 -0.864 . . . . 0.0 108.749 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.02 -27.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.218 -0.927 . . . . 0.0 108.638 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.587 ' N ' ' O ' ' C' ' 129' ' ' LEU . 96.8 p -78.32 -45.96 21.32 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.384 -0.822 . . . . 0.0 109.159 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' THR . . . . . 0.426 ' N ' ' HG ' ' C' ' 133' ' ' SER . 94.8 m -67.78 -22.99 65.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.258 -0.902 . . . . 0.0 108.705 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.77 -30.04 7.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' C' ' 84' ' ' SER . 0.5 OUTLIER -72.46 -34.6 67.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.393 -0.817 . . . . 0.0 109.056 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' THR . . . . . 0.44 ' O ' ' O ' ' C' ' 138' ' ' SER . 81.1 p -92.32 -29.56 16.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.573 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' SER . . . . . 0.44 ' O ' ' O ' ' C' ' 137' ' ' THR . 3.5 t 61.91 132.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -170.54 109.41 0.35 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 49.55 74.93 0.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.428 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 2.7 ptp85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.463 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.324 0.583 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.405 ' C ' ' HD1' ' D' ' 2' ' ' HIS . 0.3 OUTLIER -171.72 93.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.449 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.519 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -140.84 145.18 35.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.164 -0.96 . . . . 0.0 109.059 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 7.9 p -69.6 148.83 96.95 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.531 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -42.8 -24.78 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.503 2.136 . . . . 0.0 112.229 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -80.79 -53.07 6.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.919 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -60.21 -36.07 76.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 109.989 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.515 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -84.06 -31.52 25.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 110.026 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.08 -23.49 7.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -0.959 . . . . 0.0 110.441 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.5 -58.02 3.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.935 -1.103 . . . . 0.0 110.222 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.55 -24.44 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 25.9 m -78.45 -40.32 36.0 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.317 0.58 . . . . 0.0 109.674 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -26.21 68.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.51 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -26.84 68.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.329 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.77 -17.7 64.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.509 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.38 -62.87 3.66 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.494 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.418 ' H ' ' HD2' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -78.79 7.16 7.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.285 . . . . 0.0 110.849 -178.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -75.73 121.39 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.742 -1.224 . . . . 0.0 109.138 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -81.42 85.21 6.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.212 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 36.5 t -55.97 -20.39 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.608 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' D' ' 22' ' ' GLU . 1.0 OUTLIER -57.32 -55.81 29.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.366 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' D' ' 21' ' ' ASP . 43.1 mt-10 -98.9 -44.31 6.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.66 -23.89 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.619 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.24 -43.11 10.93 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.87 -25.93 61.44 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -79.36 -25.56 42.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.213 -1.169 . . . . 0.0 109.674 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.61 -23.17 39.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 109.675 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 tp -85.03 -57.29 3.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 109.479 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.93 -19.92 31.71 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . 1.194 ' NH2' ' CD1' ' C' ' 117' ' ' PHE . 47.2 mtt180 -79.29 -27.28 42.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -1.176 . . . . 0.0 109.421 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . 0.574 ' CD2' HMC3 ' D' ' 147' ' ' HEC . 39.4 tp -65.68 -24.71 67.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 109.522 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 41.8 mt -78.19 -53.67 7.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.056 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . 0.572 ' CG1' ' H ' ' D' ' 34' ' ' VAL . 7.9 p -71.16 -60.6 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.125 -0.985 . . . . 0.0 110.05 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . 0.572 ' H ' ' CG1' ' D' ' 33' ' ' VAL . 94.9 t -46.41 -30.41 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.952 -1.093 . . . . 0.0 109.557 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.96 91.25 1.57 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 109.348 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -84.74 30.47 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.731 2.287 . . . . 0.0 112.409 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 -57.16 -28.75 63.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.696 HG23 HBC1 ' D' ' 147' ' ' HEC . 30.5 p -56.07 -77.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.379 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . 0.608 ' H ' ' HG1' ' D' ' 38' ' ' THR . 14.7 tt0 50.6 46.09 26.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 109.577 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . 1.08 ' NH1' ' OD1' ' A' ' 94' ' ' ASP . 69.3 mtm180 -147.97 -49.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' D' ' 43' ' ' GLU . 1.3 p90 -96.76 -21.24 17.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -48.86 -11.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.565 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' D' ' 41' ' ' PHE . 31.3 mt-10 -80.31 -20.3 44.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.471 ' O ' ' N ' ' D' ' 46' ' ' GLY . 11.3 t -58.2 -51.94 67.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.581 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' D' ' 47' ' ' ASP . 56.8 m-85 -47.75 -16.27 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.515 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 61.38 -77.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' D' ' 45' ' ' PHE . 0.9 OUTLIER -46.74 113.49 0.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -1.133 . . . . 0.0 109.607 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' D' ' 49' ' ' SER . 0.8 OUTLIER -161.22 22.18 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 108.971 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' D' ' 48' ' ' LEU . 17.8 m -45.06 -39.77 6.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 109.585 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -145.53 151.94 48.16 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.855 . . . . 0.0 109.056 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -44.61 -21.85 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.241 1.96 . . . . 0.0 112.16 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -83.81 -29.18 27.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 109.594 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . 0.54 ' O ' ' ND2' ' D' ' 57' ' ' ASN . . . -55.52 -26.94 45.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.655 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.51 -62.04 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.577 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 14.9 mmt -53.62 -17.0 1.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.556 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.27 -4.16 61.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' D' ' 53' ' ' ALA . 3.8 m120 -72.27 142.79 85.0 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.321 -1.105 . . . . 0.0 109.313 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.55 -52.11 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.515 2.144 . . . . 0.0 112.152 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -51.66 -47.96 63.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.624 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 95.5 t -47.51 -27.47 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -79.14 -53.52 6.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.68 -59.03 3.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.567 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 0.911 ' HE1' ' CHA' ' D' ' 147' ' ' HEC . 1.2 t60 -49.0 -24.03 1.36 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.933 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.59 -37.66 92.71 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' D' ' 69' ' ' GLY . 27.8 mttp -71.67 -35.42 70.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -1.197 . . . . 0.0 109.519 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . 0.765 ' O ' HMA3 ' D' ' 147' ' ' HEC . 41.4 mttm -49.35 -44.82 44.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 109.235 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.938 HG21 ' C1B' ' D' ' 147' ' ' HEC . 54.3 t -73.66 -61.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -0.869 . . . . 0.0 109.212 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tt -50.44 -23.35 2.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.155 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' D' ' 65' ' ' LYS . . . -66.23 -57.08 11.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.81 97.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.203 -1.174 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.89 -21.73 0.71 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.314 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p -88.05 -34.86 17.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.57 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -46.35 -34.49 4.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.893 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.52 -58.91 6.05 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.436 ' H ' HD13 ' D' ' 75' ' ' LEU . 4.5 mp -62.76 -23.48 67.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.175 -1.191 . . . . 0.0 109.26 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.35 2.32 54.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 109.454 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.453 ' C ' ' H ' ' D' ' 79' ' ' ASP . 55.9 t60 -170.95 65.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.79 13.3 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.304 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' D' ' 77' ' ' HIS . 34.7 t70 -76.46 -27.64 56.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -170.93 106.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.22 -44.09 20.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . 0.405 ' N ' ' CD ' ' D' ' 82' ' ' LYS . 1.5 mptp? -49.36 -25.89 2.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.469 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.18 -53.79 3.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' THR . . . . . . . . . . . . . 3.8 p -65.83 -37.63 86.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -1.144 . . . . 0.0 109.596 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -90.9 24.02 2.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.665 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.29 -41.58 40.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.337 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 21.2 p -72.79 -50.83 21.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 109.491 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.82 -48.94 76.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.352 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 27.7 t -61.48 -44.03 97.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.44 -23.75 67.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 7.4 tp -85.12 -68.78 0.7 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.842 . . . . 0.0 109.421 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -49.52 -30.14 7.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . 0.587 ' SG ' ' CD1' ' D' ' 145' ' ' TYR . 38.0 t -83.88 -55.55 4.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 111.633 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.543 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 0.6 OUTLIER -86.39 -29.07 23.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.957 -1.09 . . . . 0.0 112.161 -177.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -90.34 -52.07 5.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.619 -1.301 . . . . 0.0 111.043 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.5 ' N ' ' CD2' ' D' ' 96' ' ' LEU . 3.7 mm? -97.53 -22.85 16.3 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.787 -1.196 . . . . 0.0 110.241 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.628 ' O ' HG21 ' A' ' 38' ' ' THR . 81.9 m-70 51.07 37.59 18.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.019 -1.05 . . . . 0.0 109.473 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . 0.418 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 44.5 t -55.04 138.78 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.345 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' D' ' 101' ' ' GLU . 0.8 OUTLIER -49.93 151.24 3.43 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.7 30.6 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.568 2.179 . . . . 0.0 112.086 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' D' ' 99' ' ' ASP . 29.4 mt-10 -143.46 75.88 1.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 109.349 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -168.27 -40.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . 0.404 ' HA ' HBB2 ' D' ' 147' ' ' HEC . 24.0 m-85 -52.54 -45.79 66.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.482 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 55.3 ttp180 -66.16 -42.39 89.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' D' ' 105' ' ' LEU . 10.1 mp -54.45 -57.43 11.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.442 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.897 HD12 ' CAB' ' D' ' 147' ' ' HEC . 7.5 tt -52.13 -49.02 64.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.17 -0.956 . . . . 0.0 109.467 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -59.0 -22.37 55.01 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 27.4 m120 -80.66 -15.56 56.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.107 -1.231 . . . . 0.0 109.786 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 63.5 t -85.08 -44.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 109.65 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 tt -47.98 -54.24 13.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -45.5 -32.69 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.955 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . 0.516 ' O ' ' ND1' ' D' ' 116' ' ' HIS . 46.3 m -77.3 -36.86 53.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.76 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.94 -46.45 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.767 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 19.0 mt -66.77 -30.42 70.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.794 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.458 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -61.22 -29.42 69.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.97 . . . . 0.0 109.575 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' D' ' 112' ' ' CYS . 68.8 m80 -84.74 -63.0 1.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.071 -1.018 . . . . 0.0 109.685 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 6.6 t-160 -65.38 -18.4 65.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 109.581 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 40.6 m-85 -144.45 55.44 1.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.529 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -68.62 -21.42 74.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -76.03 -35.19 59.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -1.118 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' D' ' 123' ' ' THR . 59.0 mm-40 -75.33 3.04 9.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.537 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -72.24 35.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.334 -0.854 . . . . 0.0 109.545 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.532 ' H ' ' C ' ' D' ' 121' ' ' GLU . 4.8 p -47.15 147.35 2.53 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.955 . . . . 0.0 109.393 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.477 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.2 Cg_exo -48.38 -51.29 10.45 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.366 2.044 . . . . 0.0 113.202 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 41.6 Cg_endo -68.0 -1.0 6.22 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.06 1.84 . . . . 0.0 112.748 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.09 -12.52 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.174 -0.954 . . . . 0.0 109.607 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.25 -60.23 2.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 109.507 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 0.518 ' O ' ' NZ ' ' D' ' 132' ' ' LYS . . . -67.05 -25.79 66.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.37 18.06 2.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.356 -0.84 . . . . 0.0 109.621 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -107.83 -61.39 1.58 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.341 -0.85 . . . . 0.0 109.617 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -46.4 -48.17 18.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.957 . . . . 0.0 109.724 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . 0.777 ' HG2' ' OXT' ' B' ' 146' ' ' HIS . 33.0 mtmm -52.65 -21.87 4.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.863 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 25.7 t -74.39 -67.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -0.949 . . . . 0.0 109.661 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' D' ' 137' ' ' VAL . 31.4 m -73.5 -15.77 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.883 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.891 ' HB1' ' CG ' ' B' ' 146' ' ' HIS . . . -47.34 -29.0 2.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.23 -22.82 58.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' D' ' 134' ' ' VAL . 81.0 t -82.18 -26.95 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -1.133 . . . . 0.0 109.547 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.84 -47.96 83.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.93 . . . . 0.0 109.615 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 1.07 ' ND2' ' ND2' ' B' ' 139' ' ' ASN . 23.7 m120 -79.62 -26.02 41.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.65 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.2 78.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.676 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 21.9 mt -82.68 16.41 2.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.651 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.75 -0.85 1.88 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.213 -0.929 . . . . 0.0 109.729 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -80.27 -28.24 38.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.778 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -70.91 -16.62 62.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.985 . . . . 0.0 109.465 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . 0.587 ' CD1' ' SG ' ' D' ' 93' ' ' CYS . 13.9 m-85 -64.66 -28.82 69.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.383 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.918 ' CG ' ' HB1' ' B' ' 135' ' ' ALA . 20.9 m-70 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.659 HBB3 HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 0.939 ' C1B' HG21 ' B' ' 67' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 0.645 HBC1 ' HE2' ' C' ' 32' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 0.938 ' C1B' HG21 ' D' ' 67' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.428 ' CG2' ' OG ' ' A' ' 131' ' ' SER . 16.8 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.0 mt -136.9 -161.01 1.11 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 0.0 109.354 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.453 ' N ' ' OD2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -133.15 174.43 4.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.332 -0.855 . . . . 0.0 109.285 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.23 -70.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.629 2.219 . . . . 0.0 112.689 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.451 ' O ' ' ND2' ' A' ' 9' ' ' ASN . . . -48.54 -44.14 36.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.109 -0.995 . . . . 0.0 109.903 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 1.3 m-20 -42.36 -35.76 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 10' ' ' VAL . 69.6 mttt -83.32 -56.43 3.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.32 -0.862 . . . . 0.0 109.524 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 94.5 m -45.43 -35.58 3.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 109.865 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 5' ' ' ALA . 9.0 m-20 -74.69 -33.49 62.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.01 -1.057 . . . . 0.0 108.15 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' A' ' 7' ' ' LYS . 75.4 t -76.22 -49.37 25.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.45 -40.08 64.93 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.89 -61.64 2.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.516 -0.74 . . . . 0.0 109.462 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.6 -38.5 66.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.381 -0.824 . . . . 0.0 109.137 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.47 -17.44 62.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.24 -0.912 . . . . 0.0 109.008 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.58 -46.62 7.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -68.69 -36.76 78.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -1.163 . . . . 0.0 108.842 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.5 t -62.0 -66.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 61.85 -141.08 47.3 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.17 39.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.493 -1.004 . . . . 0.0 110.355 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.541 ' H ' ' C ' ' A' ' 18' ' ' GLY . 87.6 m-70 -142.94 20.34 1.96 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.63 -61.28 1.92 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.652 -0.655 . . . . 0.0 109.583 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.65 -13.91 0.19 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 21' ' ' ALA . 10.2 mm-40 -84.99 -56.33 3.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -1.102 . . . . 0.0 109.613 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.8 m-30 -61.69 -30.88 71.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 109.254 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.44 74.88 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.48 -40.41 57.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -1.198 . . . . 0.0 109.669 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -56.96 -20.75 25.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.325 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.57 72.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.88 . . . . 0.0 109.483 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.41 -61.17 2.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.63 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.01 -12.66 12.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.631 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.518 ' NH2' ' CB ' ' B' ' 127' ' ' GLN . 6.2 tpm_? -74.35 -53.34 9.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.891 ' HE2' ' CBC' ' A' ' 142' ' ' HEC . 1.2 ptt? -84.18 -28.74 27.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.918 . . . . 0.0 110.084 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -46.37 -37.77 7.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 110.042 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -96.61 -36.92 10.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 110.268 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.8 m -44.43 -25.88 0.29 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 110.028 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.551 ' CG ' ' O ' ' A' ' 35' ' ' SER . 50.9 m-85 -162.46 139.11 5.97 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.169 -0.957 . . . . 0.0 109.287 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 40' ' ' LYS . 55.9 Cg_endo -71.98 -34.02 9.02 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.596 2.197 . . . . 0.0 111.984 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.963 ' HA ' ' HB3' ' D' ' 97' ' ' HIS . 76.6 p -47.51 -18.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 109.509 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' A' ' 40' ' ' LYS . 25.7 p -84.85 -27.99 26.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 109.446 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.451 ' N ' ' HG1' ' A' ' 39' ' ' THR . 82.7 mttt -71.43 -25.3 62.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.676 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.535 ' HB ' ' ND1' ' D' ' 97' ' ' HIS . 15.1 t -49.4 -38.89 30.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.169 -0.957 . . . . 0.0 109.529 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 43' ' ' PHE . 98.0 m-85 -71.29 -1.09 11.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.95 . . . . 0.0 109.406 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.514 ' O ' ' O ' ' A' ' 42' ' ' TYR . 84.9 m-85 58.26 141.71 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 0.0 109.728 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.7 ' O ' ' CD2' ' A' ' 46' ' ' PHE . 64.3 Cg_endo -75.04 -41.49 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.58 2.186 . . . . 0.0 112.048 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.662 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 14.9 p80 50.53 27.94 3.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.527 -0.733 . . . . 0.0 110.641 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.7 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 2.6 p90 -144.95 25.45 1.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.49 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' A' ' 49' ' ' SER . 2.4 m-20 43.97 84.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.463 -0.773 . . . . 0.0 109.791 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.528 ' H ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -51.82 -11.36 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 47' ' ' ASP . 28.3 p -49.01 158.48 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -77.47 148.24 35.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.455 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.24 16.92 78.94 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 54' ' ' GLN . 54.6 p -74.42 -17.06 60.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -1.154 . . . . 0.0 109.485 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 67.41 -39.54 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.338 -0.851 . . . . 0.0 109.641 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.562 ' H ' ' C ' ' A' ' 52' ' ' SER . 56.6 mt-30 -65.87 -42.11 90.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.45 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.4 -44.67 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.298 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -39.4 67.0 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.15 -26.58 72.5 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.435 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 4.5 t-80 -68.15 -43.29 78.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -1.218 . . . . 0.0 109.317 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.75 -46.07 24.66 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -48.52 -23.66 1.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -1.047 . . . . 0.0 109.268 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -75.41 -38.94 59.56 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.283 -0.886 . . . . 0.0 108.672 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.49 -48.95 44.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.29 -32.86 74.74 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 109.083 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 68' ' ' ASN . 5.8 t0 -63.74 -36.49 84.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.238 -0.914 . . . . 0.0 108.626 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.55 -52.77 34.86 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.01 -41.01 91.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.4 m -71.87 -50.2 31.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 64' ' ' ASP . 49.4 t30 -60.16 -24.3 64.62 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -82.29 -46.69 13.31 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.11 -22.97 32.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.4 -14.92 63.34 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.606 ' O ' ' N ' ' A' ' 74' ' ' ASP . 35.5 m-70 -138.36 -62.97 0.56 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.517 -0.739 . . . . 0.0 109.287 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 72' ' ' HIS . 13.1 p 44.28 14.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.928 0.87 . . . . 0.0 109.37 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 72' ' ' HIS . 39.8 t0 -138.14 11.61 2.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.419 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 1.0 OUTLIER 174.92 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.246 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.685 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 14.3 ptt? -78.74 -22.68 0.39 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 111.981 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 76' ' ' MET . 59.5 Cg_exo -52.01 -19.67 9.02 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.705 1.603 . . . . 0.0 112.51 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.44 ' O ' ' OG ' ' A' ' 81' ' ' SER . 13.2 m120 -94.12 -35.76 12.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 109.764 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.96 -38.4 69.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.963 . . . . 0.0 109.285 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.79 11.49 15.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.392 -0.818 . . . . 0.0 109.049 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 68.3 p -68.08 -15.92 63.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 109.763 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -72.69 -55.8 6.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.031 . . . . 0.0 109.878 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 86' ' ' LEU . 6.1 mt -44.88 -47.26 11.15 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 62.6 m -46.79 -33.05 4.1 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' ALA . 1.5 m-20 -82.11 -17.32 46.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.188 -0.945 . . . . 0.0 109.558 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.576 HD23 ' CBD' ' A' ' 142' ' ' HEC . 8.6 tp -74.06 -53.44 9.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.1 -1.0 . . . . 0.0 110.261 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.435 ' CE1' ' O ' ' A' ' 83' ' ' LEU . 6.0 p-80 -92.2 -21.66 20.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.975 -1.078 . . . . 0.0 110.643 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' CG ' ' A' ' 89' ' ' HIS . . . -97.27 -0.61 46.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.9 -1.125 . . . . 0.0 110.404 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 88' ' ' ALA . 70.9 m80 -154.91 42.94 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.787 -1.195 . . . . 0.0 110.256 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -172.39 -63.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.967 . . . . 0.0 109.329 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.1 mt -90.59 -23.79 20.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 53.99 53.3 11.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.665 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.437 ' CG1' ' H ' ' A' ' 94' ' ' ASP . 2.3 t -79.87 -136.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 109.447 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 96' ' ' VAL . 5.2 t70 -172.3 137.11 0.89 Allowed Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 109.234 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 98' ' ' PHE . 85.6 Cg_exo -41.86 -10.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.544 2.163 . . . . 0.0 112.639 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 94' ' ' ASP . 60.1 t -43.75 -28.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 109.955 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.19 -24.95 42.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 95' ' ' PRO . 38.4 t80 -44.96 -32.47 1.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.913 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.49 -27.22 27.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.007 . . . . 0.0 109.898 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.16 -62.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.036 -1.04 . . . . 0.0 110.024 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 1.043 HD21 ' HHC' ' A' ' 142' ' ' HEC . 36.7 tp -55.74 -20.96 16.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 109.878 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.552 ' HG ' ' H ' ' A' ' 103' ' ' HIS . 16.8 p -78.44 -50.37 11.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.051 -1.031 . . . . 0.0 109.843 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.552 ' H ' ' HG ' ' A' ' 102' ' ' SER . 34.2 m170 -76.4 -26.6 55.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -0.952 . . . . 0.0 109.808 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 55.6 m -58.81 -50.92 72.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.777 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.35 -35.88 13.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 109.63 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.538 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 3.7 mm? -69.99 -59.17 3.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.079 -1.013 . . . . 0.0 109.895 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.8 t -50.08 -36.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.478 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.463 ' H ' ' HG1' ' A' ' 108' ' ' THR . 4.9 p -70.56 -63.11 1.16 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.264 -0.897 . . . . 0.0 109.375 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' LEU . 17.5 mt -50.47 -31.42 15.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 -47.13 50.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.224 -0.923 . . . . 0.0 109.609 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.24 -41.35 22.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.89 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -80.1 -72.08 0.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.115 -0.991 . . . . 0.0 109.986 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -113.87 91.51 22.19 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 109.076 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 113' ' ' LEU . 84.7 Cg_exo -46.22 -175.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.329 2.019 . . . . 0.0 112.84 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.494 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.29 -42.21 13.94 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.636 0.732 . . . . 0.0 109.406 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER 85.0 3.66 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.897 ' CZ ' ' CE1' ' B' ' 116' ' ' HIS . 8.0 m-85 65.12 36.6 7.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.791 -0.568 . . . . 0.0 111.279 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.716 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -91.16 121.51 67.68 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.798 -1.189 . . . . 0.0 108.197 178.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.95 22.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.14 1.893 . . . . 0.0 112.656 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.716 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -151.23 -33.56 0.15 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.772 -1.205 . . . . 0.0 110.785 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 11.4 p -46.63 -47.84 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.932 -1.105 . . . . 0.0 110.061 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.532 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -72.78 -33.51 66.34 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.555 -0.716 . . . . 0.0 109.349 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.06 -19.81 36.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 110.023 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 120' ' ' ALA . 10.2 p -65.95 -62.47 1.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.202 -0.936 . . . . 0.0 110.84 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.513 ' N ' ' OG ' ' A' ' 124' ' ' SER . 9.3 mt -70.18 -19.42 63.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.07 -1.019 . . . . 0.0 109.789 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -78.93 -45.43 20.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.046 -1.034 . . . . 0.0 110.219 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -88.23 -43.24 11.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.988 -1.07 . . . . 0.0 110.14 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.455 ' H ' ' HG3' ' A' ' 127' ' ' LYS . 70.2 t80 -50.17 -21.02 1.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.957 -1.089 . . . . 0.0 109.271 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.4 mt -69.73 -17.7 63.47 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.25 -33.51 72.4 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.492 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 5.1 t -83.08 -30.41 28.0 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.417 -0.802 . . . . 0.0 108.992 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.5 t -85.41 -27.63 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 109.078 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 129' ' ' LEU . 77.9 p -83.75 -25.97 30.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.119 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.9 m -78.09 -36.94 47.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.213 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.3 m -76.57 -21.86 15.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.266 -0.896 . . . . 0.0 108.883 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.48 -37.87 68.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.451 -0.781 . . . . 0.0 108.985 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.5 p -89.14 -1.38 58.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.594 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t -61.93 103.06 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.428 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -81.3 76.46 8.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.441 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -158.58 108.06 2.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.501 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' B' ' 2' ' ' HIS . 8.5 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.467 ' N ' ' CG1' ' B' ' 1' ' ' VAL . 12.3 t-80 -169.85 49.63 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.684 ' H ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -106.29 162.45 13.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.433 -0.792 . . . . 0.0 109.261 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.434 ' O ' ' N ' ' B' ' 7' ' ' GLU . 0.7 OUTLIER -84.61 150.93 57.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 109.109 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.456 ' O ' ' OG ' ' B' ' 9' ' ' SER . 80.2 Cg_exo -42.01 -30.73 1.32 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.434 2.089 . . . . 0.0 112.026 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.36 -21.84 25.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.925 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 4' ' ' THR . 44.5 tt0 -77.11 -63.09 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.174 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.48 ' O ' ' OG1' ' B' ' 12' ' ' THR . 10.4 pttt -67.53 -25.73 65.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.963 . . . . 0.0 110.175 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' B' ' 5' ' ' PRO . 0.4 OUTLIER -43.8 -24.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 110.134 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.18 -56.23 3.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.087 -1.008 . . . . 0.0 109.751 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.04 -24.74 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.7 m -68.35 -39.12 81.98 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.351 0.596 . . . . 0.0 109.805 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.4 -31.23 57.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.847 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.3 -21.86 6.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.341 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . 0.519 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.2 OUTLIER -56.31 -38.27 71.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 109.234 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.21 -40.26 61.48 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -26.19 66.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -1.143 . . . . 0.0 109.178 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.16 121.0 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 109.666 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' B' ' 21' ' ' ASP . 59.6 t30 -80.04 71.83 6.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.0 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 82.8 t -45.89 -15.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 109.779 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 19' ' ' ASN . 34.8 m-20 -69.22 -4.09 16.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.624 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' B' ' 25' ' ' GLY . 47.9 mt-10 -155.79 -46.9 0.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.156 -0.965 . . . . 0.0 109.574 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -47.11 -23.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 109.723 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.95 -31.15 40.28 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -73.55 -39.52 49.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -70.24 -38.86 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 0.0 109.486 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.07 -30.25 61.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.556 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tp -81.47 -58.04 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.482 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.71 85.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -55.93 -39.35 71.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -1.126 . . . . 0.0 109.62 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.61 -35.98 4.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -81.19 -29.91 34.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 109.752 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.03 -64.48 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.425 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.97 -22.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.224 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -149.62 81.92 6.97 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.92 . . . . 0.0 109.562 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.95 9.85 3.15 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.562 2.175 . . . . 0.0 112.23 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' B' ' 38' ' ' THR . 0.4 OUTLIER -80.96 -19.96 42.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 109.694 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.554 ' N ' ' CD1' ' B' ' 37' ' ' TRP . 7.2 m -87.95 57.94 4.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.479 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -117.61 23.82 11.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.41 -0.807 . . . . 0.0 109.332 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -87.34 -39.76 15.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.958 . . . . 0.0 109.554 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -100.01 34.82 2.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 109.463 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.527 ' CE1' HMD2 ' B' ' 147' ' ' HEC . 0.9 OUTLIER -143.32 15.04 1.84 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.222 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.49 -14.09 61.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.408 ' C ' ' N ' ' B' ' 46' ' ' GLY . 5.3 m -69.14 -46.92 66.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.477 ' CE1' ' CD2' ' B' ' 42' ' ' PHE . 80.1 m-85 -50.17 -16.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 45' ' ' PHE . . . 51.3 179.61 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 38.0 t0 55.86 71.28 0.56 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -1.178 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 27.9 mt -131.21 35.05 3.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 109.379 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m -51.89 -49.29 63.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.27 160.17 46.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 108.837 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.4 -17.32 4.14 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.079 1.853 . . . . 0.0 111.972 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.418 ' C ' ' N ' ' B' ' 54' ' ' VAL . 19.6 t70 -83.26 -51.56 7.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.556 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.95 -20.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.431 -0.793 . . . . 0.0 109.471 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.418 ' N ' ' C ' ' B' ' 52' ' ' ASP . 57.8 t -73.01 -57.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mtt -59.98 -16.73 32.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.53 -26.62 71.29 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -78.79 132.22 65.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.152 -1.205 . . . . 0.0 109.327 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.02 -30.89 4.09 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.341 2.028 . . . . 0.0 112.34 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -70.41 -30.13 66.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.85 -40.68 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.516 ' NZ ' ' CB ' ' B' ' 61' ' ' LYS . 8.1 mtmp? -65.45 -37.43 86.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 109.68 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.96 -51.04 67.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 0.672 ' HE2' ' C4D' ' B' ' 147' ' ' HEC . 41.0 t60 -55.82 -23.79 32.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.01 -48.94 65.33 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -52.29 -25.03 8.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -1.188 . . . . 0.0 109.587 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . 0.494 ' HB3' HBA2 ' B' ' 147' ' ' HEC . 0.3 OUTLIER -74.47 -61.94 1.7 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 109.491 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.772 HG13 ' C2B' ' B' ' 147' ' ' HEC . 35.0 t -52.18 -39.33 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 8.0 tt -70.16 -37.41 75.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.903 . . . . 0.0 109.343 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.89 -44.08 61.25 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.53 71.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 109.787 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.418 ' O ' ' CD2' ' B' ' 75' ' ' LEU . 1.3 m-85 -66.3 -29.1 69.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.519 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.8 t -66.21 -33.77 76.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.515 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.17 -16.76 56.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.173 -0.954 . . . . 0.0 109.159 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.67 -19.76 63.15 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' B' ' 75' ' ' LEU . 1.5 pt? -137.78 -28.44 0.89 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -1.181 . . . . 0.0 109.952 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.1 19.02 0.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 109.586 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -171.55 70.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 70.5 mt -80.85 0.72 33.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.975 . . . . 0.0 109.492 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -54.04 -38.33 65.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.441 HD21 ' C ' ' B' ' 80' ' ' ASN . 0.3 OUTLIER -172.09 73.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.361 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.74 -41.73 43.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.628 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -50.82 -27.2 6.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.096 -1.002 . . . . 0.0 109.41 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' B' ' 86' ' ' ALA . . . -83.19 -57.54 2.48 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.6 OUTLIER -47.86 -39.71 19.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -1.164 . . . . 0.0 109.557 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.434 ' N ' ' CG2' ' B' ' 84' ' ' THR . 25.1 m-85 -69.83 -11.96 61.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.382 -0.824 . . . . 0.0 109.429 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' B' ' 83' ' ' GLY . . . -54.57 -43.72 72.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.438 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 11.4 p -64.38 -59.24 4.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.5 mt -54.97 -35.39 64.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' B' ' 141' ' ' LEU . 5.2 t -72.76 -46.43 53.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.337 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.54 -24.54 67.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.42 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.19 -68.36 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.557 ' O ' ' N ' ' B' ' 97' ' ' HIS . 75.1 m80 -54.35 -25.83 26.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 110.491 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.89 -60.66 2.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.013 -1.054 . . . . 0.0 111.501 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.561 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 11.8 m-20 -86.99 -39.75 15.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.92 -1.112 . . . . 0.0 111.701 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -83.17 -10.15 58.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.078 . . . . 0.0 111.07 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.502 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 0.2 OUTLIER -137.9 -43.78 0.52 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.886 -1.134 . . . . 0.0 110.068 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.91 ' HB3' ' HA ' ' C' ' 38' ' ' THR . 4.1 m80 72.95 58.57 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.246 -0.909 . . . . 0.0 109.575 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . 0.431 ' O ' ' OH ' ' B' ' 145' ' ' TYR . 79.1 t -82.64 114.21 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.09 -1.006 . . . . 0.0 109.434 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.74 154.45 2.37 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.27 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.402 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 47.2 Cg_endo -70.09 -164.3 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.573 2.182 . . . . 0.0 112.149 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 53.31 51.97 14.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' B' ' 100' ' ' PRO . 31.0 m120 -158.25 -36.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.24 -37.57 85.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -72.94 -26.39 61.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 tt -65.62 -55.49 17.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.967 HD11 ' CHC' ' B' ' 147' ' ' HEC . 7.9 tt -50.37 -47.0 56.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.24 -47.88 72.07 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.51 -50.29 65.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -1.161 . . . . 0.0 109.607 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 80.5 t -53.76 -38.5 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.17 -0.956 . . . . 0.0 109.524 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.96 -33.91 76.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.405 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.9 -26.24 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 60.7 m -79.27 -61.04 2.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.731 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 4.9 t -46.25 -30.0 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 31.9 mt -79.84 -31.45 40.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.601 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -82.26 -20.38 37.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.897 ' CE1' ' CZ ' ' A' ' 117' ' ' PHE . 11.0 t-80 -74.95 -55.73 5.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.531 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -74.46 -17.73 60.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.625 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -146.53 58.96 1.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.436 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -74.83 -21.92 77.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -72.89 -33.73 66.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -1.153 . . . . 0.0 109.433 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' B' ' 123' ' ' THR . 57.7 mm-40 -81.46 -4.52 56.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.8 34.33 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.36 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.519 ' H ' ' C ' ' B' ' 121' ' ' GLU . 28.7 p -48.4 148.45 3.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 109.096 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.3 Cg_exo -45.28 -52.85 6.04 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.196 1.931 . . . . 0.0 112.779 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 36.4 Cg_endo -65.68 13.67 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.053 1.835 . . . . 0.0 112.324 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' B' ' 124' ' ' PRO . 90.2 t -124.87 -21.42 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . 0.518 ' CB ' ' NH2' ' A' ' 31' ' ' ARG . 18.2 tm0? -83.15 -42.9 16.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.468 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -62.01 -44.21 97.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.587 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.75 -7.17 25.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.692 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -92.43 -30.12 15.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 109.603 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . 0.518 ' CG ' HE22 ' B' ' 127' ' ' GLN . 15.6 mm100 -81.45 -38.33 26.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.592 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -68.14 -49.43 61.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 109.646 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 2.6 p -58.47 -48.22 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.898 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.567 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 88.8 t -73.38 -34.57 43.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.842 ' CB ' ' O ' ' D' ' 146' ' ' HIS . . . -47.41 -22.28 0.42 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.35 -22.03 61.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' B' ' 134' ' ' VAL . 85.9 t -77.84 -26.09 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -1.154 . . . . 0.0 109.541 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.08 -46.58 61.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -74.69 -21.17 59.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.36 -59.63 3.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.524 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.433 ' O ' ' OG ' ' B' ' 89' ' ' SER . 13.4 mt -58.58 -24.9 61.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.23 22.36 4.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -77.25 -31.93 55.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.588 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.1 OUTLIER -79.55 -27.3 41.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.321 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' B' ' 98' ' ' VAL . 24.4 m-85 -65.99 3.68 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.799 ' O ' ' CB ' ' D' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.427 ' CG2' ' OG ' ' C' ' 131' ' ' SER . 16.9 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 25.3 mt -136.96 -161.06 1.12 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.317 -0.865 . . . . 0.0 109.364 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.46 ' N ' ' OD2' ' C' ' 6' ' ' ASP . 0.3 OUTLIER -133.22 174.44 4.7 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.848 . . . . 0.0 109.199 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.22 -70.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.65 2.233 . . . . 0.0 112.638 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.45 ' O ' ' ND2' ' C' ' 9' ' ' ASN . . . -48.62 -44.12 36.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.161 -0.962 . . . . 0.0 109.88 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' C' ' 6' ' ' ASP . 1.3 m-20 -42.33 -35.77 1.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.88 . . . . 0.0 109.44 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' C' ' 10' ' ' VAL . 69.5 mttt -83.32 -56.42 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.827 . . . . 0.0 109.571 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 94.9 m -45.45 -35.62 3.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.406 -0.809 . . . . 0.0 109.906 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' C' ' 5' ' ' ALA . 8.9 m-20 -74.51 -33.5 62.82 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 7' ' ' LYS . 76.2 t -76.37 -49.25 25.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.52 -40.04 65.14 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.95 -61.63 2.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.473 -0.767 . . . . 0.0 109.408 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.51 66.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.842 . . . . 0.0 109.145 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -17.52 62.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 108.959 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.54 -46.71 7.8 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -68.63 -36.79 79.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -1.138 . . . . 0.0 108.828 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 71.0 t -61.96 -66.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 61.93 -141.15 47.27 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.07 39.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.476 -1.014 . . . . 0.0 110.36 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.551 ' H ' ' C ' ' C' ' 18' ' ' GLY . 87.6 m-70 -142.96 20.43 1.96 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.72 -61.15 1.95 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.635 -0.666 . . . . 0.0 109.649 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -13.9 0.2 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' C' ' 21' ' ' ALA . 10.3 mm-40 -85.02 -56.3 3.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -1.172 . . . . 0.0 109.544 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 1.8 m-30 -61.75 -30.91 71.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.852 . . . . 0.0 109.186 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.26 -29.5 75.02 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.54 -40.29 57.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -1.179 . . . . 0.0 109.676 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -56.9 -20.83 25.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.342 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -31.58 72.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.905 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.34 -61.3 2.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.57 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.97 -12.7 12.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.93 . . . . 0.0 109.563 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.508 ' NH2' ' CB ' ' D' ' 127' ' ' GLN . 6.2 tpm_? -74.34 -53.27 10.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.133 -0.979 . . . . 0.0 109.818 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.904 ' HE2' ' CBC' ' C' ' 142' ' ' HEC . 1.2 ptt? -84.22 -28.72 27.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.943 . . . . 0.0 110.101 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -46.37 -37.8 8.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.119 -0.988 . . . . 0.0 110.022 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -96.57 -36.95 10.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.204 -0.935 . . . . 0.0 110.3 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.7 m -44.4 -25.91 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' C' ' 35' ' ' SER . 51.1 m-85 -162.44 139.11 5.99 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.114 -0.992 . . . . 0.0 109.286 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' C' ' 40' ' ' LYS . 56.0 Cg_endo -71.96 -34.15 8.89 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.647 2.231 . . . . 0.0 111.986 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' THR . . . . . 0.91 ' HA ' ' HB3' ' B' ' 97' ' ' HIS . 76.7 p -47.42 -18.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.437 ' N ' ' O ' ' C' ' 37' ' ' PRO . 25.8 p -84.9 -28.04 26.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' C' ' 43' ' ' PHE . 82.7 mttt -71.42 -25.3 62.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.908 . . . . 0.0 109.702 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.491 ' O ' ' CD2' ' C' ' 43' ' ' PHE . 15.1 t -49.38 -38.91 30.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.504 ' O ' ' O ' ' C' ' 43' ' ' PHE . 98.0 m-85 -71.34 -1.05 11.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 109.351 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.504 ' O ' ' O ' ' C' ' 42' ' ' TYR . 85.0 m-85 58.26 141.64 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.647 -0.658 . . . . 0.0 109.693 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.692 ' O ' ' CD2' ' C' ' 46' ' ' PHE . 64.0 Cg_endo -74.99 -41.45 0.66 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.468 2.112 . . . . 0.0 112.073 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.66 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 14.8 p80 50.65 27.81 3.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.536 -0.728 . . . . 0.0 110.582 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.692 ' CD2' ' O ' ' C' ' 44' ' ' PRO . 2.6 p90 -144.95 25.56 1.42 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.14 -0.975 . . . . 0.0 109.582 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' C' ' 49' ' ' SER . 2.4 m-20 44.0 84.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.507 -0.746 . . . . 0.0 109.817 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.531 ' H ' ' CD1' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -51.81 -11.41 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.375 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.474 ' H ' ' C ' ' C' ' 47' ' ' ASP . 28.1 p -48.94 158.52 0.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.627 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -77.52 148.34 35.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.21 16.9 79.01 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.565 ' C ' ' H ' ' C' ' 54' ' ' GLN . 55.2 p -74.43 -17.03 60.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -1.167 . . . . 0.0 109.475 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . 67.35 -39.46 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.373 -0.829 . . . . 0.0 109.629 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.565 ' H ' ' C ' ' C' ' 52' ' ' SER . 56.6 mt-30 -65.95 -42.07 90.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 109.409 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.39 -44.74 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.178 -0.951 . . . . 0.0 109.274 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -39.39 67.13 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.16 -26.55 72.51 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.442 ' ND1' ' C ' ' C' ' 58' ' ' HIS . 4.4 t-80 -68.25 -43.24 78.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -1.202 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.83 -46.06 25.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -48.48 -23.62 1.02 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.377 -1.072 . . . . 0.0 109.272 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -75.45 -38.92 59.38 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.264 -0.898 . . . . 0.0 108.659 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.44 -49.04 44.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.2 -32.93 74.87 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.358 -0.839 . . . . 0.0 109.077 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' C' ' 68' ' ' ASN . 5.9 t0 -63.71 -36.43 83.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.171 -0.956 . . . . 0.0 108.637 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.68 -52.61 35.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.13 -40.98 91.66 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.2 m -71.85 -50.29 30.79 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' C' ' 64' ' ' ASP . 49.5 t30 -60.17 -24.16 64.52 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -82.28 -46.84 13.12 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.02 -22.92 32.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.41 -15.01 63.4 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.611 ' O ' ' N ' ' C' ' 74' ' ' ASP . 35.2 m-70 -138.3 -62.97 0.56 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.502 -0.749 . . . . 0.0 109.356 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.1 p 44.24 14.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.937 0.875 . . . . 0.0 109.399 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' C' ' 72' ' ' HIS . 39.7 t0 -138.19 11.57 2.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 1.0 OUTLIER 174.95 29.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.683 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 14.3 ptt? -78.67 -22.77 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 111.898 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' C' ' 76' ' ' MET . 60.3 Cg_exo -52.05 -19.66 9.13 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.652 1.568 . . . . 0.0 112.521 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.436 ' O ' ' OG ' ' C' ' 81' ' ' SER . 13.2 m120 -94.02 -35.78 12.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.789 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.95 -38.39 69.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.078 -1.013 . . . . 0.0 109.317 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.81 11.46 15.46 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.423 -0.798 . . . . 0.0 109.047 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 68.4 p -68.05 -15.87 63.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.755 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -72.69 -55.84 6.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.886 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' C' ' 86' ' ' LEU . 6.1 mt -44.84 -47.26 11.03 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' C' ' 88' ' ' ALA . 62.4 m -46.87 -32.96 4.11 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' C' ' 82' ' ' ALA . 1.5 m-20 -82.16 -17.21 47.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.615 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.584 HD23 ' CBD' ' C' ' 142' ' ' HEC . 8.6 tp -74.11 -53.42 9.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 0.0 110.346 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . 0.437 ' CE1' ' O ' ' C' ' 83' ' ' LEU . 6.0 p-80 -92.18 -21.68 20.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.889 -1.132 . . . . 0.0 110.655 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.442 ' O ' ' CG ' ' C' ' 89' ' ' HIS . . . -97.24 -0.63 46.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.864 -1.148 . . . . 0.0 110.4 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' C' ' 88' ' ' ALA . 70.7 m80 -154.93 42.95 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 110.227 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -172.39 -63.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 109.326 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 46.4 mt -90.66 -23.72 20.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 109.323 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 53.95 53.33 11.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 0.0 109.639 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.437 ' CG1' ' H ' ' C' ' 94' ' ' ASP . 2.3 t -79.9 -136.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 0.0 109.466 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' C' ' 96' ' ' VAL . 5.2 t70 -172.23 137.11 0.9 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.183 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' C' ' 98' ' ' PHE . 86.2 Cg_exo -41.75 -11.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.616 2.211 . . . . 0.0 112.627 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' C' ' 94' ' ' ASP . 59.1 t -43.65 -28.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.2 -24.96 42.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.542 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' C' ' 95' ' ' PRO . 38.4 t80 -44.98 -32.47 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 109.953 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.41 -27.23 27.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 0.0 109.977 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 mt -84.19 -62.25 1.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.993 -1.067 . . . . 0.0 109.94 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 1.046 HD21 ' HHC' ' C' ' 142' ' ' HEC . 36.9 tp -55.79 -20.91 16.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.914 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' SER . . . . . 0.56 ' HG ' ' H ' ' C' ' 103' ' ' HIS . 17.0 p -78.42 -50.38 11.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 109.903 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.56 ' H ' ' HG ' ' C' ' 102' ' ' SER . 34.3 m170 -76.38 -26.58 55.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.836 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 55.7 m -58.66 -51.02 71.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.768 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.36 -35.88 13.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 109.618 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' C' ' 106' ' ' LEU . 3.7 mm? -70.02 -59.16 3.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.146 -0.971 . . . . 0.0 109.863 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 47.9 t -50.2 -36.77 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.962 . . . . 0.0 109.449 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.483 ' H ' ' HG1' ' C' ' 108' ' ' THR . 5.0 p -70.57 -63.09 1.16 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.224 -0.923 . . . . 0.0 109.417 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' C' ' 113' ' ' LEU . 17.6 mt -50.47 -31.55 15.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.334 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.51 -47.19 48.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.945 . . . . 0.0 109.631 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.32 -41.31 22.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.837 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -80.08 -72.13 0.42 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 110.003 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -113.86 91.56 22.31 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' C' ' 113' ' ' LEU . 84.5 Cg_exo -46.17 -175.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.447 2.098 . . . . 0.0 112.825 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.3 -42.21 13.92 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.555 -0.716 . . . . 0.0 109.393 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 0.0 OUTLIER 85.02 3.56 0.65 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 0.904 ' CZ ' ' CE1' ' D' ' 116' ' ' HIS . 8.1 m-85 65.1 36.74 7.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.798 -0.564 . . . . 0.0 111.225 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.718 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -91.06 121.59 67.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.719 -1.238 . . . . 0.0 108.179 178.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.15 22.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.11 1.874 . . . . 0.0 112.57 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.718 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -151.17 -33.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.963 -1.086 . . . . 0.0 110.84 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 11.5 p -46.63 -47.86 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.013 -1.055 . . . . 0.0 110.005 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.536 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 0.3 OUTLIER -72.79 -33.5 66.31 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.51 -0.744 . . . . 0.0 109.307 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.11 -19.75 36.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.826 . . . . 0.0 110.059 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.6 ' N ' ' O ' ' C' ' 120' ' ' ALA . 10.2 p -66.04 -62.47 1.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.947 . . . . 0.0 110.783 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.524 ' N ' ' OG ' ' C' ' 124' ' ' SER . 9.4 mt -70.14 -19.4 63.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.047 -1.033 . . . . 0.0 109.885 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.92 -45.34 20.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.01 -1.056 . . . . 0.0 110.306 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -88.31 -43.19 11.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.0 110.18 -179.401 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.455 ' H ' ' HG3' ' C' ' 127' ' ' LYS . 70.1 t80 -50.23 -21.03 1.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.911 -1.118 . . . . 0.0 109.316 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.6 mt -69.59 -17.77 63.57 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.21 -33.56 72.42 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' SER . . . . . 0.501 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 5.1 t -83.06 -30.41 28.04 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.349 -0.844 . . . . 0.0 108.988 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 72.7 t -85.41 -27.67 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.072 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.518 ' N ' ' O ' ' C' ' 129' ' ' LEU . 76.9 p -83.65 -26.01 30.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.817 . . . . 0.0 109.152 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 47.5 m -78.11 -36.91 47.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.343 -0.848 . . . . 0.0 109.183 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 33.4 m -76.49 -21.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.267 -0.895 . . . . 0.0 108.888 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -37.79 68.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 109.013 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 58.2 p -89.29 -1.23 57.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t -61.91 102.98 0.31 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -81.2 76.33 8.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -158.51 108.08 2.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.897 . . . . 0.0 109.448 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.449 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' D' ' 2' ' ' HIS . 8.4 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.434 0.635 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.46 ' N ' ' CG1' ' D' ' 1' ' ' VAL . 12.3 t-80 -169.88 49.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.108 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.693 ' H ' ' CD1' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -106.38 162.49 13.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.469 -0.77 . . . . 0.0 109.28 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.438 ' O ' ' N ' ' D' ' 7' ' ' GLU . 0.7 OUTLIER -84.69 151.01 57.67 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 109.06 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . 0.454 ' O ' ' OG ' ' D' ' 9' ' ' SER . 79.1 Cg_exo -42.09 -30.62 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.33 2.02 . . . . 0.0 112.103 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.41 -21.82 25.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.891 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' D' ' 4' ' ' THR . 44.6 tt0 -77.12 -63.02 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.126 -0.984 . . . . 0.0 110.164 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.473 ' O ' ' OG1' ' D' ' 12' ' ' THR . 10.4 pttt -67.64 -25.71 65.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.163 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' D' ' 5' ' ' PRO . 0.4 OUTLIER -43.73 -24.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.23 -56.21 3.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.094 -1.004 . . . . 0.0 109.75 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.06 -24.78 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 25.4 m -68.26 -39.23 82.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.357 0.599 . . . . 0.0 109.844 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.18 -31.36 58.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.923 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -21.77 6.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 0.0 109.31 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . 0.517 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.2 OUTLIER -56.34 -38.37 71.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.983 . . . . 0.0 109.151 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.23 -40.2 61.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -26.07 66.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -1.096 . . . . 0.0 109.198 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.11 121.06 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.607 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' D' ' 21' ' ' ASP . 59.6 t30 -80.12 71.75 6.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.278 -0.889 . . . . 0.0 109.023 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 80.1 t -45.82 -15.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 0.0 109.793 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' D' ' 19' ' ' ASN . 35.2 m-20 -69.28 -4.02 16.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' D' ' 25' ' ' GLY . 47.9 mt-10 -155.8 -46.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -47.06 -23.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.683 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.86 -31.22 40.44 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -73.54 -39.48 49.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -70.21 -38.86 75.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -1.146 . . . . 0.0 109.56 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.04 -30.24 61.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tp -81.46 -58.09 3.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.973 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.7 85.07 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -55.98 -39.4 71.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -1.142 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.59 -35.99 4.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.602 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 mt -81.22 -29.82 34.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.787 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 66.8 t -66.01 -64.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 109.497 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -22.6 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 109.232 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -149.6 81.8 7.03 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.618 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.05 9.98 3.13 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.552 2.168 . . . . 0.0 112.173 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . 0.568 ' CD1' ' N ' ' D' ' 38' ' ' THR . 0.4 OUTLIER -80.97 -20.02 42.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.568 ' N ' ' CD1' ' D' ' 37' ' ' TRP . 7.3 m -88.0 58.08 4.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 109.472 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -117.66 23.72 11.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.431 -0.793 . . . . 0.0 109.324 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -87.31 -39.72 15.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 109.552 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -100.01 34.75 2.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.223 -0.923 . . . . 0.0 109.432 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 0.529 ' CE1' HMD2 ' D' ' 147' ' ' HEC . 0.9 OUTLIER -143.3 15.12 1.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 109.222 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.47 -14.15 61.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.583 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' D' ' 46' ' ' GLY . 5.3 m -69.04 -46.9 66.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . 0.487 ' CE1' ' CD2' ' D' ' 42' ' ' PHE . 80.0 m-85 -50.23 -16.16 0.3 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' D' ' 44' ' ' SER . . . 51.26 179.58 0.04 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 55.95 71.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -1.153 . . . . 0.0 109.481 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 27.6 mt -131.26 35.11 3.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 109.391 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 13.4 m -51.92 -49.37 63.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.937 . . . . 0.0 109.49 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.21 160.22 46.55 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.327 -0.858 . . . . 0.0 108.832 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.42 -17.3 4.18 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.112 1.874 . . . . 0.0 111.946 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . 0.416 ' C ' ' N ' ' D' ' 54' ' ' VAL . 19.5 t70 -83.26 -51.51 7.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.345 -0.847 . . . . 0.0 109.593 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.07 -19.84 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 109.437 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' D' ' 52' ' ' ASP . 58.5 t -73.2 -57.86 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mtt -60.07 -16.65 33.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 0.0 109.41 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.5 -26.72 71.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -78.74 132.27 65.16 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.226 -1.161 . . . . 0.0 109.321 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.98 -31.02 4.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.365 2.043 . . . . 0.0 112.299 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -70.38 -30.11 66.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.616 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.83 -40.64 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 109.602 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . 0.512 ' NZ ' ' CB ' ' D' ' 61' ' ' LYS . 8.1 mtmp? -65.53 -37.43 86.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.681 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.94 -51.06 67.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 0.667 ' HE2' ' C4D' ' D' ' 147' ' ' HEC . 41.0 t60 -55.7 -23.94 31.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.073 -1.017 . . . . 0.0 109.455 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.03 -48.87 65.98 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -52.4 -24.9 8.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -1.233 . . . . 0.0 109.522 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . 0.491 ' HB3' HBA2 ' D' ' 147' ' ' HEC . 0.3 OUTLIER -74.48 -62.0 1.67 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.259 -0.9 . . . . 0.0 109.501 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.766 HG13 ' C2B' ' D' ' 147' ' ' HEC . 35.3 t -52.17 -39.33 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 8.0 tt -70.09 -37.46 75.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.326 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.85 -44.14 61.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.43 71.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -1.155 . . . . 0.0 109.803 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . 0.413 ' O ' ' CD2' ' D' ' 75' ' ' LEU . 1.3 m-85 -66.29 -29.14 69.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.077 -1.015 . . . . 0.0 109.537 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' SER . . . . . 0.517 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 8.8 t -66.36 -33.57 76.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.31 -16.7 55.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.14 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.62 -19.86 63.17 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.565 ' N ' ' CD2' ' D' ' 75' ' ' LEU . 1.5 pt? -137.66 -28.44 0.9 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.21 -1.17 . . . . 0.0 109.931 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.05 19.0 0.75 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.095 -1.003 . . . . 0.0 109.607 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -171.58 70.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 70.4 mt -80.87 0.66 34.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.425 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -53.99 -38.41 65.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 109.32 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.447 ' C ' HD21 ' D' ' 80' ' ' ASN . 0.3 OUTLIER -172.03 73.18 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.371 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.72 -41.62 44.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -50.93 -27.12 6.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.08 -1.013 . . . . 0.0 109.426 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' D' ' 86' ' ' ALA . . . -83.22 -57.63 2.46 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.6 OUTLIER -47.64 -39.83 18.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -1.159 . . . . 0.0 109.584 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.427 ' N ' ' CG2' ' D' ' 84' ' ' THR . 25.1 m-85 -69.78 -12.09 61.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.326 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' D' ' 83' ' ' GLY . . . -54.49 -43.69 72.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.154 -0.966 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 11.3 p -64.42 -59.22 4.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 109.384 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.7 mt -54.92 -35.51 64.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.304 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' D' ' 141' ' ' LEU . 5.2 t -72.73 -46.46 53.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.907 . . . . 0.0 109.314 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.52 -24.47 67.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.872 . . . . 0.0 109.452 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.31 -68.2 0.71 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.556 ' O ' ' N ' ' D' ' 97' ' ' HIS . 75.1 m80 -54.57 -25.67 27.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 110.493 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.92 -60.61 2.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.017 -1.052 . . . . 0.0 111.594 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.553 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 11.9 m-20 -87.07 -39.64 15.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.996 -1.065 . . . . 0.0 111.693 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -83.17 -10.2 58.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.913 -1.117 . . . . 0.0 111.11 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.511 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 0.2 OUTLIER -137.89 -43.85 0.53 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.869 -1.144 . . . . 0.0 109.971 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.963 ' HB3' ' HA ' ' A' ' 38' ' ' THR . 4.1 m80 73.11 58.5 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.87 . . . . 0.0 109.509 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . 0.44 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 79.3 t -82.66 114.21 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 109.421 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.76 154.45 2.38 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.264 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.1 -164.4 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.61 2.206 . . . . 0.0 112.153 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 53.32 52.03 14.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.485 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -158.28 -36.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.34 -37.55 86.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -72.88 -26.43 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 tt -65.6 -55.58 16.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.357 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.957 HD11 ' CHC' ' D' ' 147' ' ' HEC . 7.9 tt -50.41 -46.98 56.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.919 . . . . 0.0 109.356 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.15 -47.93 71.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.43 -50.28 65.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -1.157 . . . . 0.0 109.616 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 80.5 t -53.85 -38.53 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 109.498 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.96 -33.87 76.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.423 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.95 -26.11 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.552 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 60.7 m -79.31 -61.0 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 109.738 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 4.9 t -46.34 -29.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 109.815 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 32.1 mt -79.76 -31.56 40.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -82.12 -20.47 37.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.897 . . . . 0.0 109.494 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.904 ' CE1' ' CZ ' ' C' ' 117' ' ' PHE . 11.0 t-80 -75.0 -55.72 5.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.176 -0.952 . . . . 0.0 109.471 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -74.53 -17.75 60.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.544 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -146.54 59.01 1.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -74.81 -22.0 77.66 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -72.87 -33.73 66.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -1.197 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' D' ' 123' ' ' THR . 57.4 mm-40 -81.38 -4.63 56.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.361 -0.837 . . . . 0.0 109.522 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.82 34.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.285 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.521 ' H ' ' C ' ' D' ' 121' ' ' GLU . 28.3 p -48.32 148.3 3.36 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.108 -0.995 . . . . 0.0 109.083 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.494 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.3 Cg_exo -45.1 -52.91 5.85 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.228 1.952 . . . . 0.0 112.812 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 36.4 Cg_endo -65.65 13.57 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.013 1.809 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' D' ' 124' ' ' PRO . 90.8 t -124.84 -21.34 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.299 -0.876 . . . . 0.0 109.605 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . 0.516 HE22 ' CG ' ' D' ' 131' ' ' GLN . 18.2 tm0? -83.18 -42.96 16.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 0.468 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -61.91 -44.35 96.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.67 -7.15 24.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.683 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -92.43 -30.01 15.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 109.706 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . 0.516 ' CG ' HE22 ' D' ' 127' ' ' GLN . 15.6 mm100 -81.62 -38.2 26.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -68.21 -49.33 61.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 109.691 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 2.6 p -58.49 -48.18 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.865 . . . . 0.0 109.966 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.569 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 88.5 t -73.44 -34.45 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.347 -0.846 . . . . 0.0 109.796 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.799 ' CB ' ' O ' ' B' ' 146' ' ' HIS . . . -47.45 -22.29 0.43 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.37 -22.01 61.31 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' D' ' 134' ' ' VAL . 85.8 t -77.83 -26.07 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -1.138 . . . . 0.0 109.537 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.14 -46.6 61.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.214 -0.929 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -74.71 -21.08 59.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.497 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.32 -59.71 3.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.553 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.437 ' O ' ' OG ' ' D' ' 89' ' ' SER . 13.5 mt -58.52 -24.93 61.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.927 . . . . 0.0 109.438 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.24 22.45 4.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 109.39 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -77.34 -31.85 54.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.634 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.1 OUTLIER -79.55 -27.35 41.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.398 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . 0.44 ' OH ' ' O ' ' D' ' 98' ' ' VAL . 24.4 m-85 -65.88 3.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.842 ' O ' ' CB ' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.439 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 1.043 ' HHC' HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 0.967 ' CHC' HD11 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 1.046 ' HHC' HD21 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 0.957 ' CHC' HD11 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.7 mp -108.21 -165.39 1.04 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.311 -0.868 . . . . 0.0 109.2 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.469 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 178.98 -49.53 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.936 . . . . 0.0 109.992 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' ASP . 73.9 Cg_exo -47.23 171.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.384 2.056 . . . . 0.0 112.448 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -45.8 -16.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.766 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' PRO . 3.1 p30 -39.55 -33.35 0.17 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 10' ' ' VAL . 9.6 ptpt -83.14 -46.59 12.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.338 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 m -45.44 -31.07 1.56 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.314 -0.866 . . . . 0.0 109.424 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -78.23 -36.94 46.42 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 7' ' ' LYS . 71.5 t -70.5 -49.52 52.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -51.07 -47.32 61.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.404 -0.81 . . . . 0.0 108.847 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -55.92 27.57 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.43 -0.794 . . . . 0.0 109.304 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.23 70.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.251 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -17.41 61.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.223 -0.923 . . . . 0.0 108.933 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.63 -44.17 16.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 41.6 mmtt -70.2 -43.25 71.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -1.17 . . . . 0.0 108.637 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.27 -63.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 44.2 -125.39 5.78 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 22.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.416 -1.05 . . . . 0.0 110.438 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.598 ' H ' ' C ' ' A' ' 18' ' ' GLY . 78.9 m-70 -129.11 25.99 5.5 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -91.51 -64.38 1.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.694 -0.629 . . . . 0.0 109.746 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.28 -14.37 0.17 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' ALA . 2.2 mm-40 -84.03 -56.47 3.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -1.052 . . . . 0.0 109.672 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.2 m-30 -60.67 -35.56 76.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 109.187 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.86 -22.88 68.84 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.51 -41.76 31.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -1.163 . . . . 0.0 109.715 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.42 -19.82 62.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 108.92 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.432 ' CB ' ' SG ' ' A' ' 104' ' ' CYS . . . -72.85 -21.88 60.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.371 -0.831 . . . . 0.0 109.132 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.1 mt -72.45 -53.68 11.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.349 -0.845 . . . . 0.0 109.712 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.13 -27.05 69.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.489 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.711 HH22 ' HG ' ' A' ' 35' ' ' SER . 0.9 OUTLIER -63.89 -30.68 71.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.547 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.964 ' HE2' ' CBC' ' A' ' 142' ' ' HEC . 39.6 ttp -70.75 -57.93 4.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.482 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -49.19 -33.68 12.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.45 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.474 ' HB3' ' HB3' ' B' ' 128' ' ' ALA . 11.7 mt -73.5 -51.55 16.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.852 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.711 ' HG ' HH22 ' A' ' 31' ' ' ARG . 52.4 m -67.76 -17.87 64.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.949 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CZ ' ' NH2' ' B' ' 104' ' ' ARG . 29.4 m-85 -152.62 109.52 2.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.052 -1.03 . . . . 0.0 109.499 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' THR . 72.4 Cg_endo -80.53 -27.21 3.49 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.331 2.02 . . . . 0.0 112.092 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' D' ' 97' ' ' HIS . 21.1 p -47.45 -18.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 109.447 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' PRO . 55.9 p -81.6 -22.74 37.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -64.71 -39.61 93.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -46.79 -37.16 8.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 109.642 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.575 ' HE2' ' CE1' ' D' ' 97' ' ' HIS . 3.9 m-85 -65.36 -58.54 5.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 109.111 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.505 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 81.7 t80 48.33 67.6 4.34 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.52 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.75 -34.38 0.29 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.919 2.413 . . . . 0.0 112.145 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.465 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -174.29 73.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.412 -0.805 . . . . 0.0 109.149 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.592 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -151.0 68.01 0.93 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' SER . 1.5 m-20 -48.35 -18.3 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 109.631 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.592 ' CD1' ' O ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER 46.4 21.33 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.24 -0.912 . . . . 0.0 109.638 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.526 ' C ' ' HD1' ' A' ' 50' ' ' HIS . 5.2 m -75.31 18.68 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -0.94 . . . . 0.0 109.404 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.526 ' HD1' ' C ' ' A' ' 49' ' ' SER . 2.5 m80 57.51 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.615 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.03 10.5 83.83 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 54' ' ' GLN . 3.2 p -54.48 -12.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -1.104 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 71.0 -16.79 0.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.381 -0.825 . . . . 0.0 109.736 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.522 ' H ' ' C ' ' A' ' 52' ' ' SER . 5.1 pt20 -81.65 -28.87 33.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.2 t -73.52 -38.44 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.61 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.509 ' CD ' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.63 -22.83 46.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.083 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . . . -81.13 -23.89 58.36 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.47 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.7 t-80 -78.47 -38.57 40.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -1.171 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.72 -48.95 49.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 53.7 mttm -51.61 -23.45 4.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -1.121 . . . . 0.0 109.948 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.535 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 0.5 OUTLIER -72.18 -42.46 65.83 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.127 -0.983 . . . . 0.0 109.024 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 t -69.85 -48.44 63.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.486 -0.758 . . . . 0.0 108.977 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.47 -28.57 69.31 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.384 -0.822 . . . . 0.0 109.275 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 30.4 m-20 -70.23 -36.49 74.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 0.0 108.872 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.68 47.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.402 -0.811 . . . . 0.0 108.964 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.3 mt -58.01 -42.12 84.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.261 -0.899 . . . . 0.0 108.674 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' ALA . 25.8 m -67.59 -51.6 48.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.362 -0.836 . . . . 0.0 108.881 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.518 HD22 ' CB ' ' A' ' 79' ' ' ALA . 9.4 t30 -60.49 -29.31 68.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 108.781 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -82.98 -46.49 12.83 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.19 -22.4 29.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -66.1 -24.21 66.65 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.205 0.526 . . . . 0.0 109.711 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.584 ' O ' ' N ' ' A' ' 74' ' ' ASP . 11.8 m80 -137.27 -47.8 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.0 p 45.06 13.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.665 0.745 . . . . 0.0 109.378 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 72' ' ' HIS . 26.2 t70 -135.76 11.37 3.41 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -173.72 28.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.043 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.704 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -77.96 -24.91 0.46 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 0.0 111.399 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 76' ' ' MET . 41.8 Cg_exo -56.52 -24.61 54.2 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.791 1.661 . . . . 0.0 112.324 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -89.38 -29.19 19.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.932 . . . . 0.0 109.65 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' CB ' HD22 ' A' ' 68' ' ' ASN . . . -77.05 -43.2 35.4 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.127 -0.983 . . . . 0.0 109.127 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.5 8.7 13.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.432 -0.792 . . . . 0.0 108.952 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 77' ' ' PRO . 5.5 m -63.52 -23.18 67.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 109.562 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -76.35 -55.3 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.614 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.62 -46.81 19.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 135' ' ' VAL . 5.0 m -56.8 -25.43 55.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.435 -0.79 . . . . 0.0 109.246 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' ALA . 11.6 t70 -81.02 -35.02 32.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.382 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tt -72.06 -26.95 62.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 109.198 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 90' ' ' LYS . 68.4 m80 -82.67 -31.49 28.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 109.472 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.14 -42.65 15.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.495 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -78.13 -18.84 55.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.535 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' HIS . 46.7 mttm -146.08 179.81 7.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 93' ' ' VAL . 12.6 mt 59.09 58.4 3.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -53.84 -6.88 0.1 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 109.336 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.531 ' H ' ' C ' ' A' ' 91' ' ' LEU . 11.5 p -54.59 137.94 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.49 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.741 ' HB2' ' OD2' ' D' ' 99' ' ' ASP . 0.7 OUTLIER -77.27 157.92 80.11 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.086 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASN . 9.9 Cg_endo -54.72 -10.47 2.53 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.721 2.281 . . . . 0.0 111.882 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.638 HG23 ' CG ' ' D' ' 99' ' ' ASP . 85.3 t -42.98 -22.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 109.775 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 95' ' ' PRO . 3.1 m120 -79.07 -41.26 29.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.205 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 95' ' ' PRO . 31.7 t80 -48.62 -25.72 1.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.165 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -70.62 -30.32 66.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.208 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.6 mt -84.08 -61.34 1.84 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 0.0 109.642 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.893 HD23 HBB3 ' A' ' 142' ' ' HEC . 4.6 tt -49.23 -23.51 1.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.671 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.8 m -72.81 -44.05 61.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.059 -1.025 . . . . 0.0 109.759 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.509 ' CD2' ' OD1' ' B' ' 108' ' ' ASN . 41.3 t-80 -80.55 -26.63 37.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.783 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.655 ' SG ' ' N ' ' A' ' 105' ' ' LEU . 11.2 p -58.04 -48.14 80.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.717 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.655 ' N ' ' SG ' ' A' ' 104' ' ' CYS . 2.5 mt -46.31 -39.14 9.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 3.7 mm? -68.8 -30.28 68.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.607 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 104' ' ' CYS . 86.0 t -75.12 -51.5 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 110' ' ' ALA . 27.8 m -60.05 -59.66 5.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 114' ' ' PRO . 12.3 mt -46.37 -18.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.457 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -69.66 -42.55 74.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.258 -0.902 . . . . 0.0 110.406 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.19 -3.67 43.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.132 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -129.73 -81.72 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 109.693 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -119.17 82.15 22.17 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 113' ' ' LEU . 53.6 Cg_exo -48.76 -169.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.51 2.14 . . . . 0.0 112.524 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.67 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -51.0 -56.21 13.61 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.556 -0.715 . . . . 0.0 109.302 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.67 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 3.0 mm-40 122.63 -8.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.497 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 5.6 t80 80.34 34.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 122.01 -0.431 . . . . 0.0 111.199 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -113.43 120.22 40.24 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.25 16.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.331 2.021 . . . . 0.0 112.87 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -140.98 -34.61 0.5 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.016 -1.052 . . . . 0.0 110.106 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 9.4 p -51.79 -47.28 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.14 -0.975 . . . . 0.0 109.994 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.514 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -60.19 -39.9 88.16 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.331 -0.856 . . . . 0.0 109.283 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.39 -19.99 32.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.824 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.543 ' HG ' ' H ' ' A' ' 125' ' ' LEU . 24.2 p -61.83 -62.39 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 110.3 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.543 ' H ' ' HG ' ' A' ' 124' ' ' SER . 1.3 mt -68.2 -19.53 64.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.172 -0.955 . . . . 0.0 109.513 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.05 -45.54 13.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.974 . . . . 0.0 109.854 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -87.19 -41.48 13.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.155 -0.965 . . . . 0.0 109.883 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 37.1 t80 -50.14 -20.84 1.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.966 -1.084 . . . . 0.0 108.854 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 133' ' ' SER . 19.4 mt -70.56 -17.91 62.92 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -59.7 -31.64 69.77 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.469 ' H ' ' HG ' ' A' ' 131' ' ' SER . 0.8 OUTLIER -81.72 -34.05 30.75 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.362 -0.836 . . . . 0.0 108.902 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.0 t -83.8 -29.21 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.336 -0.852 . . . . 0.0 108.91 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 129' ' ' LEU . 23.3 t -80.3 -25.44 39.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.403 -0.811 . . . . 0.0 109.132 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 m -75.37 -39.67 58.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.264 -0.897 . . . . 0.0 109.215 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 84' ' ' SER . 28.9 m -75.04 -22.09 16.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.255 -0.903 . . . . 0.0 108.965 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.91 -35.13 72.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 109.02 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 83.6 m -87.21 -29.85 21.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.561 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 68.5 m 50.41 -166.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -60.86 156.45 17.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' A' ' 140' ' ' TYR . 78.1 t80 -82.11 40.9 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.451 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.432 ' CG2' ' N ' ' B' ' 2' ' ' HIS . 10.0 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.432 ' N ' ' CG2' ' B' ' 1' ' ' VAL . 1.5 t60 -140.37 123.42 16.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.165 -0.959 . . . . 0.0 109.688 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.663 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -138.46 -162.94 1.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.331 -0.856 . . . . 0.0 109.071 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.54 153.32 61.58 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 108.866 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.92 -26.32 66.86 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.491 2.127 . . . . 0.0 112.197 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.2 -27.86 22.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.973 . . . . 0.0 109.793 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -84.14 -48.1 10.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.023 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.466 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.8 OUTLIER -68.78 -43.42 75.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.55 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -56.58 -23.58 41.57 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 110.059 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.54 -57.61 3.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.021 -1.05 . . . . 0.0 110.044 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.95 -24.33 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 47.1 m -80.88 -36.97 30.59 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.687 -0.633 . . . . 0.0 109.779 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 -22.38 63.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.927 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 16' ' ' GLY . 1.7 mt -59.82 -28.05 67.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.0 109.335 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . 0.608 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.5 OUTLIER -47.57 -17.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.933 . . . . 0.0 109.178 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -76.88 -36.15 37.31 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.445 ' O ' ' CE2' ' B' ' 118' ' ' PHE . 3.3 mmtt -89.33 -35.82 15.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -1.148 . . . . 0.0 109.281 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.1 t -47.92 114.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.659 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' B' ' 21' ' ' ASP . 83.6 m-20 -77.86 65.82 3.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.327 -0.858 . . . . 0.0 108.933 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -44.6 -17.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.385 -0.822 . . . . 0.0 109.682 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' B' ' 19' ' ' ASN . 13.3 m-20 -78.8 6.76 8.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.232 -0.917 . . . . 0.0 109.539 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' B' ' 19' ' ' ASN . 58.2 mt-10 -155.65 -46.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.538 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' B' ' 27' ' ' ALA . 85.8 t -47.74 -42.24 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.621 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.81 -43.33 96.62 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.9 -39.08 25.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -76.25 -25.82 55.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -1.175 . . . . 0.0 109.561 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' B' ' 23' ' ' VAL . . . -75.54 -34.1 60.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.937 . . . . 0.0 109.515 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tp -82.91 -52.35 6.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.451 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.68 -26.68 17.31 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -77.86 -31.44 51.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.131 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . 0.575 ' CD2' HMC2 ' B' ' 147' ' ' HEC . 32.6 tp -49.04 -34.56 13.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.355 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.9 mt -80.39 -22.03 41.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -82.51 -64.22 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.627 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.01 -22.9 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.888 . . . . 0.0 109.659 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -152.16 88.47 4.1 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 109.465 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.94 12.98 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.543 2.162 . . . . 0.0 112.227 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . 0.592 ' CZ2' ' ND2' ' B' ' 102' ' ' ASN . 0.7 OUTLIER -71.91 -19.92 61.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.525 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.444 ' N ' ' CD1' ' B' ' 37' ' ' TRP . 1.3 p -84.14 50.99 1.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.977 . . . . 0.0 109.27 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 38.5 tt0 -92.14 31.23 1.3 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -87.88 -42.84 12.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.674 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -93.18 14.32 18.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 109.578 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' B' ' 43' ' ' GLU . 1.6 p90 -68.21 -34.19 75.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.608 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.543 ' N ' ' CD1' ' B' ' 42' ' ' PHE . 12.0 pt-20 -53.28 -17.4 1.75 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.607 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 60.9 m -85.55 -34.73 21.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.583 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 47' ' ' ASP . 10.0 m-85 -51.04 -20.92 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.96 12.42 0.15 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' B' ' 45' ' ' PHE . 15.1 m-20 -160.64 110.52 1.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.151 . . . . 0.0 109.448 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tp -158.67 20.6 0.22 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.255 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.1 m -46.78 -41.1 14.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 109.646 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' THR . . . . . 0.428 ' OG1' ' OD1' ' B' ' 52' ' ' ASP . 4.7 p -146.6 150.33 39.79 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.851 . . . . 0.0 109.216 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -41.15 -43.65 5.19 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.444 2.096 . . . . 0.0 112.354 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.428 ' OD1' ' OG1' ' B' ' 50' ' ' THR . 1.7 p-10 -64.13 -31.01 72.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.534 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.92 -19.86 20.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.93 . . . . 0.0 109.42 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.43 -61.32 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -0.901 . . . . 0.0 109.573 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' B' ' 55' ' ' MET . 5.5 mmt -70.98 -0.51 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.77 31.08 7.17 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -143.09 137.06 14.51 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.26 -1.141 . . . . 0.0 109.31 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.11 -30.88 5.27 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.489 2.126 . . . . 0.0 112.26 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -21.1 59.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 109.777 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 69.8 t -75.82 -41.52 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.523 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -78.31 -25.26 46.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.57 71.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 0.932 ' CE1' ' O1A' ' B' ' 147' ' ' HEC . 72.6 t60 -62.62 -23.82 67.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.32 -50.31 22.17 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -49.51 -30.92 9.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.173 -1.192 . . . . 0.0 109.534 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . 0.441 ' HB3' HBA1 ' B' ' 147' ' ' HEC . 67.7 mmtt -65.45 -53.74 38.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.583 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.977 HG13 ' C2B' ' B' ' 147' ' ' HEC . 28.2 t -58.96 -36.94 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.57 -48.37 72.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.97 -41.05 10.31 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.05 -43.45 91.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.608 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.501 ' CE2' ' HAB' ' B' ' 147' ' ' HEC . 29.0 m-85 -61.4 -47.31 86.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.608 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 19.2 m -62.44 -42.03 99.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 109.622 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -48.37 -34.79 11.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.416 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.68 -60.48 6.91 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.443 HD11 ' H ' ' B' ' 75' ' ' LEU . 4.6 mp -54.04 -22.09 9.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.248 -1.148 . . . . 0.0 109.35 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.16 2.68 56.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -170.27 66.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.68 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.27 15.27 2.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.34 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.85 -23.21 60.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.46 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 37.1 t-20 -167.2 108.09 0.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 0.0 109.593 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mt -80.35 -51.53 8.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -67.12 -23.97 65.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.812 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -78.7 -39.11 22.2 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.9 t -85.1 -47.43 10.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.153 -1.204 . . . . 0.0 109.715 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.557 ' N ' ' CG2' ' B' ' 84' ' ' THR . 40.5 m-85 -84.67 26.92 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.539 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.32 72.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 109.633 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 50.9 p -75.81 -53.82 7.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.752 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -48.13 -43.05 30.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' B' ' 140' ' ' ALA . 2.9 m -66.89 -48.35 68.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.849 . . . . 0.0 109.668 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -67.39 -22.64 65.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 109.734 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.71 -68.37 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.078 -1.013 . . . . 0.0 109.566 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.576 ' NE2' ' O ' ' B' ' 141' ' ' LEU . 1.1 p-80 -54.38 -20.67 7.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.974 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . 0.429 ' N ' ' ND1' ' B' ' 92' ' ' HIS . 41.4 t -83.51 -59.6 2.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 110.858 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.31 -56.44 3.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.067 -1.021 . . . . 0.0 111.379 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -57.71 -51.74 68.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 110.579 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.614 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 12.1 mt -97.32 -64.52 1.03 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.002 -1.062 . . . . 0.0 109.95 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.717 ' HB2' ' HB ' ' C' ' 38' ' ' THR . 0.0 OUTLIER 91.2 25.12 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.308 0.575 . . . . 0.0 109.865 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 17.5 t -46.74 140.86 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.103 -0.998 . . . . 0.0 109.493 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 0.667 ' OD2' ' HB2' ' C' ' 94' ' ' ASP . 96.0 m-20 -54.0 149.41 18.05 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.363 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.9 36.46 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.478 2.119 . . . . 0.0 112.143 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -145.07 45.57 1.34 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.179 -0.95 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.592 ' ND2' ' CZ2' ' B' ' 37' ' ' TRP . 4.4 m120 -143.74 5.96 1.39 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.1 m-85 -89.74 -69.68 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 109.454 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . 0.574 ' NH2' ' CZ ' ' A' ' 36' ' ' PHE . 43.9 ttt180 -54.94 -20.88 9.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.54 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 tp -75.31 -31.13 60.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 1.001 ' CD1' ' CHC' ' B' ' 147' ' ' HEC . 8.8 tt -68.19 -55.39 12.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.63 -20.55 39.41 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . 0.509 ' OD1' ' CD2' ' A' ' 103' ' ' HIS . 61.8 t30 -60.09 -34.78 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -1.159 . . . . 0.0 109.684 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.53 -24.12 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 109.593 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.73 -36.4 82.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 109.501 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.447 ' CG1' ' CD1' ' B' ' 130' ' ' TYR . 4.4 m -74.91 -26.04 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.239 -0.913 . . . . 0.0 109.662 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.469 ' SG ' ' CE1' ' A' ' 122' ' ' HIS . 17.0 t -66.79 -63.4 1.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 109.612 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 t -49.14 -21.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 109.539 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.9 -57.03 4.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.66 -27.32 49.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.836 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.494 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.71 -60.25 2.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.052 -1.03 . . . . 0.0 109.443 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -62.3 -17.49 58.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.692 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.445 ' CE2' ' O ' ' B' ' 17' ' ' LYS . 65.5 m-85 -150.05 60.5 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 109.703 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 121' ' ' GLU . . . -66.52 -45.26 86.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -47.39 -19.86 0.19 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -1.172 . . . . 0.0 109.289 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' B' ' 119' ' ' GLY . 70.1 mm-40 -94.77 -26.82 16.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.642 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.478 ' CD1' ' C ' ' B' ' 122' ' ' PHE . 0.7 OUTLIER -48.54 120.82 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.355 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.431 ' HG1' ' CG2' ' B' ' 126' ' ' VAL . 9.6 p -149.15 149.31 29.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 108.896 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.438 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 2.5 Cg_endo -46.15 -58.1 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.327 2.018 . . . . 0.0 113.177 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 19.5 Cg_endo -59.76 -11.1 13.53 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.174 1.916 . . . . 0.0 112.51 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.431 ' CG2' ' HG1' ' B' ' 123' ' ' THR . 53.5 t -94.81 -53.12 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 109.907 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . 0.515 ' O ' ' NE2' ' B' ' 131' ' ' GLN . 41.1 mm-40 -61.34 -59.88 4.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 109.489 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 34' ' ' LEU . . . -51.16 -37.43 46.27 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.484 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.24 18.53 2.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.447 ' CD1' ' CG1' ' B' ' 111' ' ' VAL . 15.2 t80 -109.56 -61.71 1.6 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.229 -0.92 . . . . 0.0 109.688 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . 0.596 ' H ' ' NE2' ' B' ' 131' ' ' GLN . 4.1 mp0 -48.43 -24.09 1.15 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.0 -1.063 . . . . 0.0 109.726 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.439 ' HG3' ' CD2' ' D' ' 146' ' ' HIS . 35.8 ttpt -85.73 -37.38 19.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 0.0 110.169 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 0.4 OUTLIER -60.76 -44.36 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.859 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.477 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 7.0 m -83.56 -16.97 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 0.0 109.935 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.96 -25.15 1.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 0.0 109.404 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.95 -23.9 56.48 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' B' ' 134' ' ' VAL . 42.7 t -79.6 -31.78 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -1.164 . . . . 0.0 109.429 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.54 -50.79 57.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.417 ' O ' ' N ' ' B' ' 142' ' ' ALA . 57.3 t30 -67.07 -32.31 73.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.427 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . 0.425 ' O ' ' OG ' ' B' ' 89' ' ' SER . . . -48.7 -42.27 34.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.291 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.576 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 38.4 mt -84.17 18.37 2.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.376 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 139' ' ' ASN . . . -128.39 -31.08 2.32 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.536 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -46.37 -41.87 14.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 109.285 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' B' ' 146' ' ' HIS . 35.7 mmtt -75.46 -54.43 7.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.037 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.497 ' O ' ' CG ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -57.43 -6.19 0.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.545 -0.722 . . . . 0.0 109.241 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.474 ' H ' ' C ' ' B' ' 144' ' ' LYS . 11.8 m-70 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.79 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 7.7 mp -108.21 -165.41 1.04 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.359 -0.838 . . . . 0.0 109.269 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.478 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 179.02 -49.6 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.018 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' C' ' 6' ' ' ASP . 74.3 Cg_exo -47.17 170.88 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.398 2.065 . . . . 0.0 112.521 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.73 -16.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 109.828 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' C' ' 4' ' ' PRO . 3.1 p30 -39.61 -33.35 0.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.765 . . . . 0.0 109.799 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' C' ' 10' ' ' VAL . 9.6 ptpt -83.1 -46.57 12.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.893 . . . . 0.0 109.431 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.407 ' C ' ' O ' ' C' ' 7' ' ' LYS . 49.6 m -45.48 -31.12 1.62 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.419 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -78.23 -36.81 46.6 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' C' ' 7' ' ' LYS . 71.8 t -70.49 -49.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -51.07 -47.33 61.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.45 -56.02 26.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.405 -0.81 . . . . 0.0 109.294 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.65 -37.3 70.58 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.285 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -17.48 61.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.156 -0.965 . . . . 0.0 108.907 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.6 -44.09 17.04 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt -70.22 -43.29 70.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -1.119 . . . . 0.0 108.56 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.22 -63.89 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.606 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 44.24 -125.44 5.84 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.41 22.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.349 -1.089 . . . . 0.0 110.449 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.606 ' H ' ' C ' ' C' ' 18' ' ' GLY . 78.9 m-70 -129.08 26.07 5.5 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.52 -64.37 1.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.68 -0.638 . . . . 0.0 109.811 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.37 -14.28 0.18 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 21' ' ' ALA . 2.1 mm-40 -84.01 -56.52 3.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -1.055 . . . . 0.0 109.671 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -60.53 -35.7 76.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.165 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.84 -22.92 68.83 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.51 -41.71 31.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -1.121 . . . . 0.0 109.683 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.51 -19.79 62.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 108.947 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.428 ' CB ' ' SG ' ' C' ' 104' ' ' CYS . . . -72.89 -21.84 60.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.109 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 11.2 mt -72.57 -53.57 11.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 109.635 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.19 -27.01 69.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.484 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.692 HH22 ' HG ' ' C' ' 35' ' ' SER . 0.9 OUTLIER -63.81 -30.81 71.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.967 ' HE2' ' CBC' ' C' ' 142' ' ' HEC . 39.5 ttp -70.79 -57.98 4.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.405 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 0.3 OUTLIER -49.2 -33.63 12.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.468 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' D' ' 128' ' ' ALA . 11.8 mt -73.44 -51.57 16.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 109.856 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.692 ' HG ' HH22 ' C' ' 31' ' ' ARG . 53.3 m -67.92 -17.73 64.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.938 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.568 ' CZ ' ' NH2' ' D' ' 104' ' ' ARG . 29.2 m-85 -152.64 109.51 2.74 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.972 . . . . 0.0 109.546 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' C' ' 39' ' ' THR . 72.1 Cg_endo -80.43 -27.29 3.53 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.388 2.058 . . . . 0.0 112.16 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' THR . . . . . 0.717 ' HB ' ' HB2' ' B' ' 97' ' ' HIS . 22.0 p -47.37 -18.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.863 . . . . 0.0 109.581 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.438 ' N ' ' O ' ' C' ' 37' ' ' PRO . 55.9 p -81.56 -22.74 37.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' C' ' 37' ' ' PRO . 1.8 tpmt? -64.68 -39.59 93.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.878 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -46.83 -37.26 8.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 0.0 109.616 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.535 ' HE2' ' CE1' ' B' ' 97' ' ' HIS . 3.9 m-85 -65.32 -58.49 5.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.96 . . . . 0.0 109.148 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.502 ' CD2' ' O ' ' C' ' 43' ' ' PHE . 81.5 t80 48.37 67.51 4.43 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.544 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.73 -34.28 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.937 2.425 . . . . 0.0 112.175 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.476 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER -174.29 73.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 109.145 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' C' ' 48' ' ' LEU . 0.3 OUTLIER -150.99 68.1 0.93 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' C' ' 49' ' ' SER . 1.5 m-20 -48.42 -18.31 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.07 -1.019 . . . . 0.0 109.613 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.582 ' CD1' ' O ' ' C' ' 46' ' ' PHE . 0.9 OUTLIER 46.56 21.19 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.211 -0.93 . . . . 0.0 109.536 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.53 ' C ' ' HD1' ' C' ' 50' ' ' HIS . 5.2 m -75.31 18.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.53 ' HD1' ' C ' ' C' ' 49' ' ' SER . 2.4 m80 57.53 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 109.661 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.02 10.5 83.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.514 ' C ' ' H ' ' C' ' 54' ' ' GLN . 3.2 p -54.43 -12.71 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 71.13 -16.87 0.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.382 -0.824 . . . . 0.0 109.729 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' C' ' 52' ' ' SER . 5.1 pt20 -81.57 -28.85 33.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.959 . . . . 0.0 109.684 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 22.4 t -73.54 -38.43 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.525 ' CD ' ' H ' ' C' ' 56' ' ' LYS . 0.0 OUTLIER -78.71 -22.75 46.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.395 -0.816 . . . . 0.0 109.011 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . 0.495 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -81.2 -23.81 58.35 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.471 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.7 t-80 -78.6 -38.45 39.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -1.147 . . . . 0.0 109.506 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.79 -48.85 49.73 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.41 ' O ' ' CG ' ' C' ' 64' ' ' ASP . 53.7 mttm -51.8 -23.28 4.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.36 -1.082 . . . . 0.0 109.924 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.539 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 0.5 OUTLIER -72.26 -42.39 65.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.116 -0.99 . . . . 0.0 109.054 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t -69.82 -48.51 63.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.46 -28.59 69.32 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . 0.41 ' CG ' ' O ' ' C' ' 60' ' ' LYS . 30.2 m-20 -70.23 -36.4 74.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 108.926 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.95 -52.74 47.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.476 -0.765 . . . . 0.0 108.968 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' C' ' 70' ' ' VAL . 11.3 mt -58.03 -42.16 84.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 108.665 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.48 ' O ' ' N ' ' C' ' 71' ' ' ALA . 26.1 m -67.54 -51.55 49.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.245 -0.91 . . . . 0.0 108.998 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.529 HD22 ' CB ' ' C' ' 79' ' ' ALA . 9.4 t30 -60.46 -29.34 68.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 108.744 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -82.95 -46.54 12.8 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' C' ' 66' ' ' LEU . 48.6 t -67.16 -22.38 29.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -66.07 -24.26 66.68 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.658 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' C' ' 74' ' ' ASP . 11.8 m80 -137.27 -47.86 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.754 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' C' ' 69' ' ' ALA . 10.9 p 45.09 13.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.802 0.81 . . . . 0.0 109.411 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' C' ' 72' ' ' HIS . 26.3 t70 -135.71 11.46 3.42 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -173.77 28.26 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.007 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.712 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -77.94 -25.02 0.46 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.489 -0.757 . . . . 0.0 111.414 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' C' ' 76' ' ' MET . 41.9 Cg_exo -56.37 -24.7 53.3 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.851 1.701 . . . . 0.0 112.363 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -89.39 -29.21 19.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . 0.529 ' CB ' HD22 ' C' ' 68' ' ' ASN . . . -77.0 -43.2 35.69 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.143 -0.973 . . . . 0.0 109.068 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.5 8.7 13.19 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.358 -0.839 . . . . 0.0 108.962 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.6 m -63.43 -23.39 67.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.551 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -76.24 -55.33 5.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.629 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.59 -46.8 19.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.818 . . . . 0.0 108.861 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' C' ' 135' ' ' VAL . 5.0 m -56.91 -25.33 57.08 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.404 -0.81 . . . . 0.0 109.25 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' C' ' 82' ' ' ALA . 11.6 t70 -81.02 -35.06 32.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.91 -27.04 62.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.25 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . 0.439 ' O ' ' O ' ' C' ' 90' ' ' LYS . 68.2 m80 -82.74 -31.36 28.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.17 -42.64 15.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -78.16 -18.79 55.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.854 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' C' ' 87' ' ' HIS . 46.8 mttm -146.06 179.81 7.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.898 . . . . 0.0 109.511 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' C' ' 93' ' ' VAL . 12.5 mt 59.08 58.54 3.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.456 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -53.99 -6.82 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.248 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' C' ' 91' ' ' LEU . 11.5 p -54.64 137.89 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.667 ' HB2' ' OD2' ' B' ' 99' ' ' ASP . 0.7 OUTLIER -77.24 157.89 80.23 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.086 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' C' ' 97' ' ' ASN . 10.0 Cg_endo -54.74 -10.34 2.46 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.627 2.218 . . . . 0.0 111.953 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . 0.598 HG23 ' CG ' ' B' ' 99' ' ' ASP . 85.4 t -43.09 -22.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -0.819 . . . . 0.0 109.743 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' C' ' 95' ' ' PRO . 3.1 m120 -79.15 -41.16 29.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.959 . . . . 0.0 109.206 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' C' ' 95' ' ' PRO . 31.9 t80 -48.59 -25.68 1.85 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 109.249 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -70.65 -30.37 66.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.18 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' C' ' 97' ' ' ASN . 20.4 mt -84.07 -61.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 109.63 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.903 HD23 HBB3 ' C' ' 142' ' ' HEC . 4.6 tt -49.15 -23.55 1.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.744 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 34.5 m -72.87 -43.91 61.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.798 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.514 ' CD2' ' OD1' ' D' ' 108' ' ' ASN . 41.3 t-80 -80.58 -26.69 37.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 109.732 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.655 ' SG ' ' N ' ' C' ' 105' ' ' LEU . 11.1 p -57.98 -48.09 81.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.768 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.655 ' N ' ' SG ' ' C' ' 104' ' ' CYS . 2.5 mt -46.46 -39.12 10.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.393 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.546 ' N ' ' CD2' ' C' ' 106' ' ' LEU . 3.7 mm? -68.72 -30.37 68.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.603 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.04 -51.43 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.459 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.464 ' O ' ' N ' ' C' ' 110' ' ' ALA . 27.1 m -60.12 -59.63 5.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.244 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' C' ' 114' ' ' PRO . 12.4 mt -46.29 -18.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' C' ' 108' ' ' THR . . . -69.66 -42.56 74.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.0 110.368 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.15 -3.63 43.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.0 110.17 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -129.72 -81.83 0.56 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 109.622 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.4 OUTLIER -119.17 82.2 22.28 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 53.3 Cg_exo -48.79 -169.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.427 2.085 . . . . 0.0 112.604 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.658 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -50.89 -56.27 13.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.491 -0.756 . . . . 0.0 109.289 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.658 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 3.0 mm-40 122.66 -8.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 0.503 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 5.6 t80 80.26 34.95 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.935 -0.478 . . . . 0.0 111.212 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.739 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -113.45 120.26 40.13 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -48.3 16.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.242 1.961 . . . . 0.0 112.992 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -140.93 -34.73 0.49 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.049 -1.032 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.519 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 9.4 p -51.75 -47.18 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.519 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 0.1 OUTLIER -60.34 -39.81 88.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.26 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.44 -20.03 32.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.344 -0.847 . . . . 0.0 109.785 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.548 ' HG ' ' H ' ' C' ' 125' ' ' LEU . 24.3 p -61.83 -62.42 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 110.283 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.548 ' H ' ' HG ' ' C' ' 124' ' ' SER . 1.3 mt -68.14 -19.51 64.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 0.0 109.544 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -83.13 -45.46 13.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 109.841 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.422 ' HG3' ' H ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -87.31 -41.36 13.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.974 . . . . 0.0 109.84 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.462 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 37.1 t80 -50.22 -20.83 1.13 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.879 -1.138 . . . . 0.0 108.81 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' C' ' 133' ' ' SER . 19.2 mt -70.57 -17.92 62.91 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -59.64 -31.69 69.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' SER . . . . . 0.435 ' H ' ' HG ' ' C' ' 131' ' ' SER . 0.8 OUTLIER -81.79 -33.94 30.59 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.429 -0.795 . . . . 0.0 108.933 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 26.4 t -83.85 -29.16 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.334 -0.854 . . . . 0.0 108.927 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.536 ' N ' ' O ' ' C' ' 129' ' ' LEU . 23.3 t -80.37 -25.39 39.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.393 -0.817 . . . . 0.0 109.109 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 44.9 m -75.35 -39.69 59.04 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . 0.416 ' O ' ' OG ' ' C' ' 84' ' ' SER . 28.8 m -75.07 -22.12 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 108.887 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.95 -35.03 72.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.041 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 82.3 m -87.38 -29.79 21.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 68.7 m 50.37 -166.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 109.434 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -60.84 156.41 17.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.902 . . . . 0.0 109.52 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' C' ' 140' ' ' TYR . 78.3 t80 -82.05 40.84 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.457 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.504 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.43 ' CG2' ' N ' ' D' ' 2' ' ' HIS . 9.9 p . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.43 ' N ' ' CG2' ' D' ' 1' ' ' VAL . 1.5 t60 -140.48 123.31 16.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.26 -0.9 . . . . 0.0 109.572 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.662 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -138.39 -162.92 1.37 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.331 -0.856 . . . . 0.0 109.068 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.53 153.2 61.52 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 108.939 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.71 -26.39 68.49 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.498 2.132 . . . . 0.0 112.3 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.15 -27.86 22.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.862 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -84.07 -48.06 10.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.095 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.455 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.8 OUTLIER -68.84 -43.39 75.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.149 -0.969 . . . . 0.0 109.52 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -56.65 -23.58 42.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.173 -0.955 . . . . 0.0 110.026 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.57 -57.63 3.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.98 -1.075 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.02 -24.32 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 46.1 m -80.89 -36.96 30.54 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.723 -0.611 . . . . 0.0 109.782 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.81 -22.3 63.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.941 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' D' ' 16' ' ' GLY . 1.8 mt -59.85 -28.1 67.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.11 -0.994 . . . . 0.0 109.379 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . 0.622 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.5 OUTLIER -47.53 -17.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.198 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -76.83 -36.13 37.68 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.454 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 3.2 mmtt -89.36 -35.8 15.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -1.196 . . . . 0.0 109.298 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -47.94 114.95 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.32 -0.863 . . . . 0.0 109.668 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' D' ' 21' ' ' ASP . 83.5 m-20 -77.91 65.78 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 0.0 108.85 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 71.5 t -44.55 -17.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' D' ' 19' ' ' ASN . 13.4 m-20 -78.84 6.74 8.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' D' ' 19' ' ' ASN . 58.1 mt-10 -155.58 -46.94 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' D' ' 27' ' ' ALA . 85.9 t -47.8 -42.22 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.629 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.76 -43.42 96.46 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.85 -39.18 25.21 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -76.21 -25.78 55.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -1.151 . . . . 0.0 109.557 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' D' ' 23' ' ' VAL . . . -75.6 -34.02 60.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.477 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tp -82.96 -52.38 6.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.426 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.66 -26.71 17.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -77.91 -31.34 51.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 0.0 109.447 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . 0.559 ' CD2' HMC2 ' D' ' 147' ' ' HEC . 32.5 tp -48.99 -34.61 13.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.352 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 29.1 mt -80.44 -21.97 41.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 23.8 t -82.54 -64.27 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.05 -22.86 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 109.639 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -152.17 88.57 4.08 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.479 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.89 12.84 2.51 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.621 2.214 . . . . 0.0 112.251 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . 0.601 ' CZ2' ' ND2' ' D' ' 102' ' ' ASN . 0.7 OUTLIER -71.8 -20.01 61.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 109.546 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.448 ' N ' ' CD1' ' D' ' 37' ' ' TRP . 1.3 p -84.09 51.06 1.97 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 109.273 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . 0.434 ' O ' ' CD1' ' D' ' 42' ' ' PHE . 38.6 tt0 -92.2 31.15 1.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.252 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -87.85 -42.92 12.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.589 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -93.1 14.3 18.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 109.551 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' D' ' 43' ' ' GLU . 1.6 p90 -68.28 -34.13 75.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.595 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . 0.54 ' N ' ' CD1' ' D' ' 42' ' ' PHE . 11.9 pt-20 -53.31 -17.4 1.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.543 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 60.8 m -85.56 -34.7 21.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 109.59 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' D' ' 47' ' ' ASP . 10.1 m-85 -51.08 -20.95 1.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.358 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.98 12.44 0.15 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' D' ' 45' ' ' PHE . 15.1 m-20 -160.63 110.51 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -1.102 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tp -158.72 20.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.294 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 58.7 m -46.91 -41.03 15.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.642 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' D' ' 52' ' ' ASP . 4.8 p -146.57 150.37 40.02 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.359 -0.838 . . . . 0.0 109.217 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -41.16 -43.65 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.467 2.111 . . . . 0.0 112.382 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . 0.423 ' OD1' ' OG1' ' D' ' 50' ' ' THR . 1.7 p-10 -64.11 -31.09 72.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.152 -0.968 . . . . 0.0 109.447 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -56.94 -19.88 20.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 48.3 t -71.36 -61.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.571 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' D' ' 55' ' ' MET . 5.5 mmt -70.99 -0.48 9.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 0.0 109.443 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.72 30.92 7.32 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -142.94 137.02 14.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.211 -1.17 . . . . 0.0 109.385 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.04 -30.77 5.45 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.516 2.144 . . . . 0.0 112.336 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -21.07 59.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 109.739 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.92 -41.46 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.476 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -78.35 -25.35 46.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.57 71.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 0.924 ' CE1' ' O1A' ' D' ' 147' ' ' HEC . 72.7 t60 -62.61 -23.83 67.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.549 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.36 -50.23 22.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -49.57 -30.84 9.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -1.147 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . 0.437 ' HB3' HBA1 ' D' ' 147' ' ' HEC . 67.8 mmtt -65.5 -53.68 38.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.899 . . . . 0.0 109.591 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.972 HG13 ' C2B' ' D' ' 147' ' ' HEC . 28.2 t -59.03 -36.92 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.413 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.51 -48.43 72.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 109.345 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.94 -41.08 10.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.28 91.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.167 . . . . 0.0 109.64 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . 0.499 ' CE2' ' HAB' ' D' ' 147' ' ' HEC . 28.8 m-85 -61.5 -47.27 86.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.612 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' SER . . . . . 0.622 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 19.4 m -62.56 -41.97 99.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.349 -0.844 . . . . 0.0 109.531 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -48.31 -34.85 11.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.44 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.71 -60.42 6.98 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.442 ' H ' HD11 ' D' ' 75' ' ' LEU . 4.6 mp -54.04 -22.1 9.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.157 . . . . 0.0 109.32 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.06 2.51 56.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.942 . . . . 0.0 109.626 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -170.19 66.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.26 15.25 2.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.348 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.82 -23.22 60.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 37.1 t-20 -167.2 108.11 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.582 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mt -80.31 -51.67 8.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 109.373 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -67.01 -24.13 65.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.707 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -78.6 -39.11 22.58 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.9 t -85.1 -47.44 10.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.15 -1.206 . . . . 0.0 109.696 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' D' ' 84' ' ' THR . 40.4 m-85 -84.72 27.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.486 -0.759 . . . . 0.0 109.519 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.28 -31.41 72.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.359 -0.838 . . . . 0.0 109.626 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 51.1 p -75.77 -53.84 7.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.715 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -48.12 -42.98 30.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' D' ' 140' ' ' ALA . 3.0 m -67.0 -48.33 68.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.574 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -67.35 -22.66 65.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.761 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.73 -68.36 0.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.124 -0.985 . . . . 0.0 109.567 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.577 ' NE2' ' O ' ' D' ' 141' ' ' LEU . 1.1 p-80 -54.44 -20.67 7.99 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.172 -0.955 . . . . 0.0 109.939 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . 0.426 ' N ' ' ND1' ' D' ' 92' ' ' HIS . 41.3 t -83.53 -59.57 2.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 110.818 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.36 -56.41 3.45 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.072 -1.018 . . . . 0.0 111.396 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -57.69 -51.73 68.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.095 -1.003 . . . . 0.0 110.599 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.615 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 12.2 mt -97.42 -64.32 1.05 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.081 -1.012 . . . . 0.0 109.94 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.766 ' HB2' ' HB ' ' A' ' 38' ' ' THR . 0.0 OUTLIER 91.03 25.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.297 0.57 . . . . 0.0 109.868 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 17.5 t -46.73 140.79 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.5 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . 0.741 ' OD2' ' HB2' ' A' ' 94' ' ' ASP . 96.0 m-20 -53.94 149.41 17.68 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.399 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.84 36.45 0.4 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.6 2.2 . . . . 0.0 112.119 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -145.12 45.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.601 ' ND2' ' CZ2' ' D' ' 37' ' ' TRP . 4.4 m120 -143.8 5.95 1.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -0.843 . . . . 0.0 109.556 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 1.1 m-85 -89.73 -69.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 109.516 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . 0.568 ' NH2' ' CZ ' ' C' ' 36' ' ' PHE . 44.1 ttt180 -55.08 -20.88 10.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 tp -75.19 -31.14 60.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 1.013 ' CD1' ' CHC' ' D' ' 147' ' ' HEC . 8.8 tt -68.29 -55.33 12.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.7 -20.45 39.5 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . 0.514 ' OD1' ' CD2' ' C' ' 103' ' ' HIS . 61.7 t30 -60.18 -34.78 74.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -1.094 . . . . 0.0 109.636 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 6.8 t -86.47 -24.15 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 109.599 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.64 -36.42 82.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 109.553 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . 0.438 ' CG1' ' CD1' ' D' ' 130' ' ' TYR . 4.4 m -74.99 -25.92 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.248 -0.908 . . . . 0.0 109.665 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . 0.47 ' SG ' ' CE1' ' C' ' 122' ' ' HIS . 16.9 t -66.84 -63.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.148 -0.97 . . . . 0.0 109.584 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 10.6 t -49.16 -21.59 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.506 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.91 -57.01 4.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.4 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -55.62 -27.37 49.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.892 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.489 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.75 -60.07 2.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.5 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -62.39 -17.55 59.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.611 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 65.7 m-85 -150.0 60.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.987 . . . . 0.0 109.675 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' D' ' 121' ' ' GLU . . . -66.53 -45.33 86.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -47.29 -19.88 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -1.181 . . . . 0.0 109.31 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' D' ' 119' ' ' GLY . 70.1 mm-40 -94.76 -26.78 16.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.652 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.475 ' CD1' ' C ' ' D' ' 122' ' ' PHE . 0.7 OUTLIER -48.67 120.86 4.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.348 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.421 ' HG1' ' CG2' ' D' ' 126' ' ' VAL . 9.7 p -149.12 149.32 29.4 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.009 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.427 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 2.5 Cg_endo -46.21 -58.01 1.9 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.366 2.044 . . . . 0.0 113.168 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 19.3 Cg_endo -59.84 -11.12 13.8 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.168 1.912 . . . . 0.0 112.474 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . 0.421 ' CG2' ' HG1' ' D' ' 123' ' ' THR . 53.6 t -94.8 -53.19 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.034 -1.041 . . . . 0.0 109.821 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . 0.517 ' O ' ' NE2' ' D' ' 131' ' ' GLN . 41.0 mm-40 -61.37 -59.73 4.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.503 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' C' ' 34' ' ' LEU . . . -51.3 -37.39 47.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.18 18.48 2.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.694 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . 0.438 ' CD1' ' CG1' ' D' ' 111' ' ' VAL . 15.1 t80 -109.5 -61.73 1.59 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -0.908 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . 0.602 ' NE2' ' H ' ' D' ' 131' ' ' GLN . 4.1 mp0 -48.46 -24.16 1.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.003 -1.061 . . . . 0.0 109.662 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -85.69 -37.38 19.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -0.888 . . . . 0.0 110.21 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 0.4 OUTLIER -60.88 -44.21 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.067 -1.021 . . . . 0.0 109.821 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.496 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 7.0 m -83.6 -16.94 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.2 -0.938 . . . . 0.0 109.877 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.99 -25.13 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.07 -1.019 . . . . 0.0 109.432 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.97 -23.94 56.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' D' ' 134' ' ' VAL . 42.4 t -79.49 -31.78 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -1.105 . . . . 0.0 109.522 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.57 -50.78 56.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.396 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' D' ' 142' ' ' ALA . 57.3 t30 -67.07 -32.27 73.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . 0.417 ' O ' ' OG ' ' D' ' 89' ' ' SER . . . -48.68 -42.42 34.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.95 . . . . 0.0 109.237 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.577 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 38.3 mt -84.12 18.44 2.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.392 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' D' ' 139' ' ' ASN . . . -128.45 -31.03 2.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.163 -0.961 . . . . 0.0 109.556 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -46.33 -41.92 14.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 109.285 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.476 ' C ' ' H ' ' D' ' 146' ' ' HIS . 35.7 mmtt -75.41 -54.39 7.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.419 -0.801 . . . . 0.0 109.127 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . 0.467 ' O ' ' CG ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -57.42 -6.21 0.42 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.501 -0.75 . . . . 0.0 109.234 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.476 ' H ' ' C ' ' D' ' 144' ' ' LYS . 11.6 m-70 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.759 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.964 ' CBC' ' HE2' ' A' ' 32' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 1.001 ' CHC' ' CD1' ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 0.967 ' CBC' ' HE2' ' C' ' 32' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.013 ' CHC' ' CD1' ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 73.9 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.2 mt -144.7 178.82 7.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.995 . . . . 0.0 109.723 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.73 167.11 26.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.434 -0.791 . . . . 0.0 109.069 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.15 -43.72 2.98 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.599 2.199 . . . . 0.0 112.563 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.29 -19.35 33.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.977 -1.077 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -47.85 -37.14 13.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -43.59 19.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.869 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.0 m -51.15 -37.53 46.79 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.123 -0.986 . . . . 0.0 109.558 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -74.93 -31.96 61.64 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.36 -51.27 30.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -49.98 -47.44 52.81 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.9 -61.28 2.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.458 -0.776 . . . . 0.0 109.537 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.06 68.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.424 -0.797 . . . . 0.0 109.058 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -17.16 64.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.425 -0.797 . . . . 0.0 108.955 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.34 -44.96 15.69 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.2 mmmt -70.66 -40.66 72.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -1.166 . . . . 0.0 108.802 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.27 -64.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 46.1 -127.34 9.36 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 23.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -1.102 . . . . 0.0 110.569 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.612 ' H ' ' C ' ' A' ' 18' ' ' GLY . 86.0 m-70 -130.07 25.77 5.22 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -90.24 -63.8 1.23 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.693 -0.629 . . . . 0.0 109.754 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.77 -14.3 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.0 mm-40 -83.28 -56.51 3.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -1.076 . . . . 0.0 109.559 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.625 ' CD1' ' CD2' ' A' ' 112' ' ' HIS . 3.6 m-30 -62.07 -32.24 72.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.462 -0.773 . . . . 0.0 109.274 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.19 -23.4 77.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.08 -44.38 22.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -1.09 . . . . 0.0 109.587 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -61.1 -26.24 67.52 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -26.78 68.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.1 mt -72.51 -58.4 3.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.471 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -52.16 -38.91 59.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.866 ' HG3' HE22 ' B' ' 127' ' ' GLN . 0.9 OUTLIER -68.21 -50.58 53.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.299 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.469 ' C ' ' SD ' ' A' ' 32' ' ' MET . 15.2 tmm? -62.4 -29.15 70.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.351 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.69 -58.73 6.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 110.026 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' PHE . 2.4 pp -73.89 -39.62 63.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.2 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.524 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 50.8 m -46.71 -16.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.081 -1.012 . . . . 0.0 109.825 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 35' ' ' SER . 15.2 m-85 -159.37 89.64 1.99 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 0.0 109.362 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 40' ' ' LYS . 52.5 Cg_exo -52.77 -20.07 12.07 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.457 2.105 . . . . 0.0 112.095 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 p -49.08 -18.91 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.403 ' N ' ' C ' ' A' ' 37' ' ' PRO . 30.3 p -84.17 -22.92 30.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' PRO . 29.9 ttmt -55.5 -47.01 76.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.567 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.715 HG21 ' O ' ' D' ' 94' ' ' ASP . 5.1 t -72.4 -18.85 61.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.8 . . . . 0.0 109.417 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 37.2 t80 -75.96 -15.64 60.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.587 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 41' ' ' THR . 21.2 m-85 55.66 87.07 0.15 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.661 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 45.4 Cg_exo -51.92 -38.83 69.39 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.436 2.09 . . . . 0.0 111.76 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.661 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 94.35 34.46 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 178.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.467 ' CZ ' ' CB ' ' A' ' 44' ' ' PRO . 2.2 p90 -145.53 31.24 1.09 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.506 -1.371 . . . . 0.0 110.078 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 49' ' ' SER . 1.1 m-20 52.84 91.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.872 . . . . 0.0 109.614 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.19 1.87 0.43 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.373 -0.83 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 47' ' ' ASP . 9.2 m -62.48 140.95 58.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.514 ' N ' ' HD1' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -63.72 140.34 58.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.448 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.21 12.13 81.23 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 54' ' ' GLN . 2.2 t -59.31 -20.58 55.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -1.174 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 72.61 -24.33 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -0.782 . . . . 0.0 109.61 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.531 ' H ' ' C ' ' A' ' 52' ' ' SER . 33.5 mt-30 -80.31 -24.32 40.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.569 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.8 t -75.85 -35.14 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.17 -34.67 42.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.946 . . . . 0.0 108.901 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.19 -24.52 76.3 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.513 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 5.9 t-80 -68.15 -43.87 77.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.317 -1.108 . . . . 0.0 109.316 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.8 -46.97 25.19 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 48.5 mttm -54.6 -23.19 15.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.512 -0.993 . . . . 0.0 109.644 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -36.85 58.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.199 -0.938 . . . . 0.0 108.902 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -73.73 -47.39 44.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.64 -29.09 67.51 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.312 -0.868 . . . . 0.0 109.342 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 25.6 m-20 -66.79 -47.23 72.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.096 -1.002 . . . . 0.0 108.75 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -49.46 76.11 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mt -55.37 -46.03 76.5 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 71' ' ' ALA . 27.6 m -64.97 -55.55 18.43 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.301 -0.874 . . . . 0.0 108.749 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -55.9 -29.3 59.78 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.73 -48.12 12.06 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.17 -22.5 31.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -68.94 -16.48 63.76 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 74' ' ' ASP . 34.2 m170 -145.1 -56.9 0.33 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.306 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.4 p 44.94 13.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.665 0.745 . . . . 0.0 109.576 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 72' ' ' HIS . 99.2 m-20 -123.69 8.41 8.86 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -175.92 28.69 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.147 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 5.2 ptt? -78.09 -24.64 0.45 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 111.676 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 76' ' ' MET . 53.2 Cg_exo -54.83 -23.66 34.93 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.759 1.639 . . . . 0.0 112.195 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -93.32 -37.24 12.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.88 75.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.149 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.5 mt -81.74 8.79 9.15 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.325 -0.86 . . . . 0.0 109.048 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.0 t -56.11 -41.05 74.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.845 . . . . 0.0 109.618 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -56.22 -57.33 12.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.576 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mt -46.31 -46.69 18.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.376 -0.827 . . . . 0.0 108.819 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 135' ' ' VAL . 3.8 m -59.96 -29.64 68.56 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.476 -0.765 . . . . 0.0 109.289 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 89' ' ' HIS . 76.0 m-20 -81.52 -38.93 25.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 0.0 109.339 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 tt -59.18 -36.04 74.62 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.334 -0.853 . . . . 0.0 109.46 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -92.12 -23.07 19.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.949 . . . . 0.0 109.69 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.52 -9.49 29.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.238 -0.914 . . . . 0.0 109.922 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 85' ' ' ASP . 42.9 m80 -143.93 47.93 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -0.97 . . . . 0.0 109.698 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.13 -69.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 109.319 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 93' ' ' VAL . 11.7 mt -88.76 -23.84 22.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 51.65 10.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.565 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 91' ' ' LEU . 14.8 p -52.62 144.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.492 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 151.68 86.12 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.31 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 97' ' ' ASN . 47.6 Cg_endo -70.12 -20.98 32.45 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.558 2.172 . . . . 0.0 112.123 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.429 ' CG1' ' OD1' ' D' ' 99' ' ' ASP . 93.2 t -45.84 -15.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 109.756 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 95' ' ' PRO . 3.4 m120 -79.25 -24.88 42.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 109.577 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.495 ' CD1' ' C ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -69.1 -31.14 69.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.364 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -58.56 -29.94 66.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.512 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 17.6 mt -83.91 -62.18 1.63 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.581 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.1 tt -45.65 -24.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.597 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.7 t -65.22 -57.26 8.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.928 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -73.74 -26.5 60.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.981 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 9.5 m -70.32 -23.45 62.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.099 -1.001 . . . . 0.0 110.157 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.56 -22.87 40.37 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.937 -1.102 . . . . 0.0 108.926 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.99 -18.78 33.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.852 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.0 t -77.5 -50.33 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.411 ' HG1' ' H ' ' A' ' 109' ' ' LEU . 43.4 p -52.56 -51.91 57.46 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.161 -0.962 . . . . 0.0 109.678 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 113' ' ' LEU . 7.9 mt -43.74 -26.36 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.465 -0.772 . . . . 0.0 109.759 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -71.92 -25.65 61.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.924 . . . . 0.0 110.486 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.47 -3.79 54.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.106 -0.996 . . . . 0.0 110.902 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.625 ' CD2' ' CD1' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -150.15 -69.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.782 -1.199 . . . . 0.0 109.669 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -118.29 81.24 16.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.47 ' N ' ' O ' ' A' ' 109' ' ' LEU . 51.2 Cg_exo -49.32 -170.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.44 2.094 . . . . 0.0 112.589 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.649 ' O ' ' CG ' ' A' ' 116' ' ' GLU . . . -48.65 -55.63 10.75 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.649 ' CG ' ' O ' ' A' ' 115' ' ' ALA . 2.8 mm-40 130.5 0.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.1 t80 66.3 30.37 9.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.842 -0.536 . . . . 0.0 111.138 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.706 ' O ' ' N ' ' A' ' 120' ' ' ALA . 2.1 p -103.79 128.12 27.97 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 120.996 -1.065 . . . . 0.0 108.249 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.64 23.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.102 1.868 . . . . 0.0 112.923 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.706 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -157.03 -32.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 0.0 110.669 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.628 ' H ' ' HG1' ' A' ' 118' ' ' THR . 12.9 p -49.84 -47.24 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.13 -0.981 . . . . 0.0 110.299 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.509 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 2.4 t60 -61.74 -38.56 88.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.771 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.41 -20.12 34.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 109.95 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -62.36 1.52 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.95 . . . . 0.0 110.245 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.11 -19.81 66.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.071 -1.018 . . . . 0.0 109.467 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.17 -49.27 37.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.15 -42.1 11.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 109.635 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.517 ' N ' ' CD ' ' A' ' 127' ' ' LYS . 32.0 t80 -50.0 -22.92 1.75 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 109.255 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.453 ' C ' ' CD1' ' A' ' 129' ' ' LEU . 1.2 pp -76.37 -22.08 55.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.14 -38.1 75.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.6 m -67.92 -26.8 66.16 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.55 -37.67 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.8 t -80.06 -18.0 51.22 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.298 -0.876 . . . . 0.0 108.738 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.8 m -83.28 -42.44 17.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.468 -0.77 . . . . 0.0 109.208 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.415 ' O ' ' OG ' ' A' ' 84' ' ' SER . 27.3 m -70.06 -21.97 24.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.24 -0.913 . . . . 0.0 108.756 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.46 -31.8 72.22 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.1 m -153.27 57.1 0.77 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.7 t -63.56 -57.47 10.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 51.69 -122.93 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.404 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -152.8 50.21 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 109.463 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.441 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.526 ' O ' ' NZ ' ' B' ' 132' ' ' LYS . 7.6 p . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 52.31 47.91 23.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.094 -1.004 . . . . 0.0 108.949 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.689 ' H ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -107.63 -159.13 0.68 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.496 -0.752 . . . . 0.0 109.361 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 9.9 p -103.57 134.4 19.77 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.394 -0.816 . . . . 0.0 109.29 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.45 ' O ' ' OG ' ' B' ' 9' ' ' SER . 75.7 Cg_exo -42.1 -22.79 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.438 2.092 . . . . 0.0 112.467 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -76.62 -55.6 5.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 110.065 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -68.16 -60.45 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.961 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.52 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -48.74 -30.14 5.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 5' ' ' PRO . 2.9 m -62.05 -23.61 66.58 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.979 -1.075 . . . . 0.0 110.032 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.05 -57.68 3.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.886 -1.134 . . . . 0.0 109.958 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.55 -24.95 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 56.6 m -83.39 -37.36 23.4 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.453 0.644 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.19 -29.92 71.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.369 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.7 OUTLIER -52.16 -32.46 36.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.119 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . 0.643 ' HE1' ' HG ' ' B' ' 72' ' ' SER . 0.2 OUTLIER -47.15 -17.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.509 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.34 -52.02 5.81 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.48 -29.41 65.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -1.179 . . . . 0.0 109.263 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -48.72 114.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 22' ' ' GLU . 18.3 m120 -82.56 69.41 9.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 108.953 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.465 ' C ' ' H ' ' B' ' 22' ' ' GLU . 78.3 t -43.88 -29.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 0.0 109.72 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -64.69 1.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' B' ' 20' ' ' VAL . 33.0 mt-10 -155.89 -46.11 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 109.424 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -48.52 -53.96 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.41 -48.52 48.14 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.34 -46.35 79.09 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.44 -39.96 95.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.27 -1.136 . . . . 0.0 109.394 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.74 88.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.179 -0.95 . . . . 0.0 109.364 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -82.2 -51.22 8.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.309 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.91 -35.08 62.53 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -79.37 -30.65 42.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -1.158 . . . . 0.0 109.495 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . 0.532 HD22 HMC2 ' B' ' 147' ' ' HEC . 60.6 tp -49.42 -39.03 31.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.379 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.53 -23.45 56.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.583 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.79 -61.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.188 -0.945 . . . . 0.0 109.413 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.36 -23.82 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -136.73 76.09 48.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.64 11.49 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.725 2.283 . . . . 0.0 112.335 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -80.62 -19.71 44.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 109.341 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.654 ' HB ' HBC2 ' B' ' 147' ' ' HEC . 42.0 p -79.77 40.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 109.36 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -92.16 12.84 20.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 0.0 109.55 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -87.86 -34.49 18.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' B' ' 42' ' ' PHE . 29.9 m-85 -95.79 32.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.441 ' HE1' HBC2 ' B' ' 147' ' ' HEC . 57.5 m-85 -141.36 26.32 1.98 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.94 -25.08 37.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.516 ' C ' ' H ' ' B' ' 46' ' ' GLY . 66.8 m -82.13 -38.17 25.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.602 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -56.0 -5.41 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' B' ' 44' ' ' SER . . . 48.57 -167.67 0.16 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' B' ' 48' ' ' LEU . 18.9 t70 60.19 -150.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -1.149 . . . . 0.0 109.536 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.504 ' H ' ' CG ' ' B' ' 47' ' ' ASP . 24.2 mt 60.57 34.33 20.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 109.53 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.3 m -80.49 -22.52 40.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.41 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' THR . . . . . 0.502 ' O ' ' N ' ' B' ' 53' ' ' ALA . 21.4 p -146.11 149.02 37.24 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.279 -0.888 . . . . 0.0 109.166 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -36.75 -45.07 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.644 2.23 . . . . 0.0 112.591 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.88 -26.93 61.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 109.544 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -57.78 -19.64 29.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.05 -63.36 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.135 -0.978 . . . . 0.0 109.633 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' MET . . . . . 0.542 ' SD ' ' N ' ' B' ' 55' ' ' MET . 2.3 mpp? -79.69 14.81 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.05 -49.01 4.41 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . 0.471 HD21 ' N ' ' B' ' 57' ' ' ASN . 1.0 OUTLIER -77.82 149.61 77.54 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.227 -1.16 . . . . 0.0 109.46 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.36 -51.94 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.671 2.247 . . . . 0.0 112.176 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.403 ' CG ' ' N ' ' B' ' 60' ' ' VAL . 54.2 pttt -46.92 -40.75 14.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.56 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' B' ' 59' ' ' LYS . 87.1 t -54.21 -44.85 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' B' ' 61' ' ' LYS . 7.0 mtmp? -77.39 -43.0 34.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.222 -0.924 . . . . 0.0 109.438 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.17 -33.12 18.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 0.732 ' HE2' ' C4D' ' B' ' 147' ' ' HEC . 5.8 t60 -67.67 -24.4 65.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.68 -30.25 74.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -68.15 -41.23 81.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.121 . . . . 0.0 109.318 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -64.08 -50.89 66.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.779 . . . . 0.0 109.36 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.776 HG21 ' C4A' ' B' ' 147' ' ' HEC . 25.3 t -61.78 -23.91 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.251 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tt -78.11 -29.8 49.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.475 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.22 -57.13 14.33 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.54 -22.03 63.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -74.46 -30.34 61.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.63 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.643 ' HG ' ' HE1' ' B' ' 15' ' ' TRP . 4.4 m -89.11 -20.48 24.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 109.762 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -46.15 -30.79 2.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 109.621 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.29 -59.24 7.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.441 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.75 -17.73 10.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 109.667 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -97.38 32.9 2.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.977 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.549 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 9.5 m-70 -176.67 -49.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.161 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' B' ' 77' ' ' HIS . 29.8 mt 39.64 35.3 0.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.637 -0.665 . . . . 0.0 109.614 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -138.62 -31.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.651 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 7.5 p-10 -151.91 72.71 1.03 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.171 -0.956 . . . . 0.0 109.363 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.546 ' O ' ' CZ ' ' B' ' 85' ' ' PHE . 9.6 mp -60.4 -27.08 67.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.912 . . . . 0.0 109.461 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -80.62 -61.48 1.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.77 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.32 -23.9 43.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -62.4 -51.91 65.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.166 -1.196 . . . . 0.0 109.537 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.546 ' CZ ' ' O ' ' B' ' 81' ' ' LEU . 2.2 p90 -133.18 51.93 2.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.639 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.97 -29.47 4.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -0.994 . . . . 0.0 109.287 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.647 ' HG1' ' N ' ' B' ' 88' ' ' LEU . 17.8 p -60.5 -58.5 8.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.326 -0.859 . . . . 0.0 109.392 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.647 ' N ' ' HG1' ' B' ' 87' ' ' THR . 90.7 mt -48.56 -37.43 17.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.026 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -69.06 -34.84 75.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.913 . . . . 0.0 109.002 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -82.91 -39.01 22.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 109.419 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.07 -25.31 64.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 109.397 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' B' ' 97' ' ' HIS . 6.8 m80 -90.98 -21.81 21.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.181 -0.95 . . . . 0.0 109.567 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.58 -59.05 2.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 111.059 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.626 ' O ' HG21 ' C' ' 41' ' ' THR . 1.3 m-20 -87.21 -57.0 3.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.976 -1.077 . . . . 0.0 112.009 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.484 ' CD ' ' N ' ' B' ' 95' ' ' LYS . 12.1 mptt -62.81 -52.16 64.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.122 -0.986 . . . . 0.0 111.195 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.608 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -95.43 -38.2 10.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.973 -1.079 . . . . 0.0 109.837 -178.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 25.3 p80 45.52 33.06 1.25 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.206 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 52.0 t -50.13 132.4 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.949 -1.094 . . . . 0.0 109.139 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 4.2 m-20 -51.15 151.24 5.02 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.266 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.03 -170.35 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.439 2.093 . . . . 0.0 112.026 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' D' ' 101' ' ' GLU . 69.1 mm-40 53.24 69.95 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.47 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.467 ' ND2' ' CD1' ' B' ' 103' ' ' PHE . 3.9 p-10 -171.24 -39.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.49 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . 0.467 ' CD1' ' ND2' ' B' ' 102' ' ' ASN . 12.9 m-85 -50.34 -34.51 24.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -76.13 -43.94 40.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.613 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' B' ' 105' ' ' LEU . 9.9 mp -49.32 -51.81 31.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 1.019 HD11 ' CHC' ' B' ' 147' ' ' HEC . 6.5 tt -51.69 -37.17 49.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.852 . . . . 0.0 109.353 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.98 -20.57 59.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -65.36 -34.26 77.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 109.561 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.86 -31.67 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 7.7 tp -51.67 -52.09 50.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.517 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.564 ' CG2' ' CE1' ' B' ' 130' ' ' TYR . 42.6 t -51.18 -42.86 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.596 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -60.06 -39.56 86.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.164 -0.96 . . . . 0.0 109.618 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.55 -55.03 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.606 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.03 -31.75 71.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.495 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -64.9 -27.8 69.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.403 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.568 ' HD1' ' C ' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.79 -61.28 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.227 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.42 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 8.3 m-70 -63.3 -18.28 63.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 58.8 m-85 -148.44 59.53 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -71.95 -14.8 76.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -79.48 -20.29 47.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.271 -1.135 . . . . 0.0 109.528 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' B' ' 123' ' ' THR . 29.1 mm-40 -95.48 -2.49 48.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.953 . . . . 0.0 109.77 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -73.78 33.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 0.0 109.606 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.508 ' H ' ' C ' ' B' ' 121' ' ' GLU . 22.0 p -49.22 148.41 4.4 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.364 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.443 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 2.3 Cg_endo -46.83 -57.51 2.25 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.448 2.099 . . . . 0.0 113.002 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 17.8 Cg_endo -59.49 -42.36 48.86 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.093 1.862 . . . . 0.0 112.233 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 98.9 t -65.11 -20.76 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.458 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . 0.866 HE22 ' HG3' ' A' ' 31' ' ' ARG . 37.0 tt0 -83.31 -48.99 9.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.552 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.66 -30.06 67.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.14 19.17 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.144 -0.972 . . . . 0.0 109.672 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.564 ' CE1' ' CG2' ' B' ' 111' ' ' VAL . 47.4 t80 -107.95 -61.4 1.58 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.283 -0.886 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -55.28 -23.26 22.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.947 . . . . 0.0 109.57 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' B' ' 1' ' ' VAL . 22.7 ttpp -83.04 -21.8 33.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.647 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 76.8 t -81.13 -68.31 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 109.696 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 22.4 m -53.76 -25.04 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.848 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.56 -29.78 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.461 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.4 -29.28 56.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 96.4 t -76.42 -38.14 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -1.169 . . . . 0.0 109.4 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.96 79.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.42 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 1.616 HD22 ' CD2' ' D' ' 146' ' ' HIS . 1.8 m120 -79.67 -22.96 42.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.85 -60.52 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.601 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.74 -25.26 66.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.331 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 -16.35 27.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.472 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -51.33 -33.38 29.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 109.361 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -73.34 -27.15 61.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' B' ' 92' ' ' HIS . 16.2 m-85 -71.94 -46.18 58.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.5 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 1.616 ' CD2' HD22 ' D' ' 139' ' ' ASN . 43.5 p-80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.942 -1.027 . . . . 0.0 109.548 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 73.2 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 78.0 mt -144.72 178.84 7.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 109.772 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.77 167.17 25.85 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.05 -43.81 3.0 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.668 2.245 . . . . 0.0 112.62 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.3 -19.35 33.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.999 -1.063 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -47.84 -37.24 13.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.735 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -43.61 19.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.953 . . . . 0.0 109.886 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 37.3 m -51.14 -37.5 46.53 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.184 -0.947 . . . . 0.0 109.562 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -74.94 -31.92 61.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.46 -51.13 30.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -50.15 -47.3 54.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.87 -61.35 2.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.479 -0.763 . . . . 0.0 109.573 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.48 -40.21 68.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.278 -0.889 . . . . 0.0 109.039 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -17.1 64.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.309 -0.869 . . . . 0.0 108.959 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.36 -44.84 15.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -70.68 -40.68 72.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -1.153 . . . . 0.0 108.841 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -60.28 -64.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 46.0 -127.27 9.15 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 23.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.465 -1.02 . . . . 0.0 110.544 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.611 ' H ' ' C ' ' C' ' 18' ' ' GLY . 85.9 m-70 -130.05 25.77 5.23 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -90.19 -63.88 1.21 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.74 -14.34 0.23 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.0 mm-40 -83.28 -56.42 3.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -1.044 . . . . 0.0 109.53 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.622 ' CE1' ' CD2' ' C' ' 112' ' ' HIS . 3.6 m-30 -62.11 -32.31 72.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.416 -0.802 . . . . 0.0 109.179 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.18 -23.46 77.23 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.93 -44.38 22.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.212 -1.169 . . . . 0.0 109.662 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.24 -26.08 67.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.31 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.37 -26.86 68.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 14.1 mt -72.44 -58.37 3.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.523 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -52.23 -38.82 59.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.57 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.854 ' HG3' HE22 ' D' ' 127' ' ' GLN . 0.9 OUTLIER -68.21 -50.67 52.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.224 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.482 ' C ' ' SD ' ' C' ' 32' ' ' MET . 15.2 tmm? -62.39 -29.07 70.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.953 . . . . 0.0 109.392 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -62.78 -58.69 6.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.953 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' C' ' 36' ' ' PHE . 2.4 pp -74.0 -39.57 63.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 110.144 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.528 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 50.5 m -46.81 -16.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.059 -1.026 . . . . 0.0 109.815 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' C' ' 35' ' ' SER . 15.2 m-85 -159.37 89.74 1.99 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.332 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.73 -20.18 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.519 2.146 . . . . 0.0 112.082 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 19.3 p -49.01 -18.96 0.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 30.2 p -84.12 -22.98 30.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.471 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -55.5 -46.97 76.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.576 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.626 HG21 ' O ' ' B' ' 94' ' ' ASP . 5.2 t -72.4 -18.92 61.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.36 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' C' ' 42' ' ' TYR . 37.3 t80 -75.93 -15.66 60.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 109.622 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' C' ' 41' ' ' THR . 21.2 m-85 55.67 87.08 0.15 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.66 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 46.0 Cg_exo -51.91 -38.85 69.27 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.425 2.083 . . . . 0.0 111.784 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.66 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 0.0 OUTLIER 94.28 34.62 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 178.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.48 ' CZ ' ' CB ' ' C' ' 44' ' ' PRO . 2.1 p90 -145.72 31.21 1.07 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.503 -1.373 . . . . 0.0 110.046 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' C' ' 49' ' ' SER . 1.1 m-20 52.88 91.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.633 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.07 1.74 0.41 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 109.58 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.496 ' H ' ' C ' ' C' ' 47' ' ' ASP . 9.3 m -62.46 140.97 58.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.443 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.514 ' HD1' ' N ' ' C' ' 50' ' ' HIS . 0.1 OUTLIER -63.64 140.32 58.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.938 . . . . 0.0 109.541 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.15 12.16 81.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.54 ' C ' ' H ' ' C' ' 54' ' ' GLN . 2.3 t -59.22 -20.68 56.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -1.205 . . . . 0.0 109.326 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 72.62 -24.29 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.629 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.54 ' H ' ' C ' ' C' ' 52' ' ' SER . 33.5 mt-30 -80.41 -24.17 39.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 16.8 t -75.96 -35.09 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.19 -34.61 42.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.871 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.23 -24.41 76.45 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.507 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 5.8 t-80 -68.19 -43.93 76.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -1.061 . . . . 0.0 109.277 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.77 -46.88 24.98 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' C' ' 64' ' ' ASP . 48.3 mttm -54.77 -23.12 16.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -1.027 . . . . 0.0 109.57 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.27 -36.91 58.21 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.178 -0.951 . . . . 0.0 108.9 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -73.77 -47.35 44.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.56 -29.09 67.56 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.428 -0.795 . . . . 0.0 109.416 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' C' ' 60' ' ' LYS . 25.8 m-20 -66.74 -47.23 72.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 108.697 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -62.08 -49.31 76.46 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mt -55.36 -46.11 76.46 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.514 ' O ' ' N ' ' C' ' 71' ' ' ALA . 27.4 m -65.03 -55.5 18.56 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -55.86 -29.37 59.8 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.72 -48.12 12.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.14 -22.55 31.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -68.9 -16.5 63.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.58 ' O ' ' N ' ' C' ' 74' ' ' ASP . 34.2 m170 -145.17 -56.82 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 0.0 109.217 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.5 p 44.85 13.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.744 0.783 . . . . 0.0 109.56 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' C' ' 72' ' ' HIS . 99.3 m-20 -123.63 8.35 8.89 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -175.84 28.73 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.178 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 5.2 ptt? -78.13 -24.55 0.45 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.765 . . . . 0.0 111.664 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.9 Cg_exo -54.8 -23.73 35.01 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.74 1.627 . . . . 0.0 112.197 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -93.26 -37.19 12.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.587 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.75 75.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.929 . . . . 0.0 109.203 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 mt -81.88 8.85 9.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 0.0 108.939 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 27.9 t -56.24 -40.95 74.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.882 . . . . 0.0 109.589 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -56.31 -57.33 12.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.536 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mt -46.25 -46.68 17.96 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' C' ' 135' ' ' VAL . 3.9 m -59.99 -29.56 68.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.564 -0.71 . . . . 0.0 109.285 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' C' ' 89' ' ' HIS . 75.9 m-20 -81.63 -38.88 25.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.324 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 tt -59.14 -36.11 74.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.375 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -92.16 -23.04 19.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.684 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.52 -9.39 29.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.215 -0.928 . . . . 0.0 109.887 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' C' ' 85' ' ' ASP . 43.2 m80 -144.03 47.94 1.41 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.056 -1.027 . . . . 0.0 109.776 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.19 -69.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' C' ' 93' ' ' VAL . 11.6 mt -88.77 -23.8 22.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 109.51 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 51.67 10.06 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.494 ' H ' ' C ' ' C' ' 91' ' ' LEU . 14.9 p -52.69 144.52 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.1 151.71 86.13 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.313 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' C' ' 97' ' ' ASN . 47.7 Cg_endo -70.11 -21.0 32.45 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.546 2.164 . . . . 0.0 112.136 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 90.6 t -45.75 -15.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.769 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' C' ' 95' ' ' PRO . 3.3 m120 -79.21 -24.89 42.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.595 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' C' ' 98' ' ' PHE . 0.1 OUTLIER -68.99 -31.27 69.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 109.435 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -58.51 -29.9 66.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.6 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.506 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 17.7 mt -83.92 -62.14 1.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.584 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 7.1 tt -45.65 -24.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.616 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.7 t -65.33 -57.24 8.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.865 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -73.78 -26.43 60.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 109.998 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 9.6 m -70.41 -23.34 62.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 110.17 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -22.7 40.15 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.943 -1.098 . . . . 0.0 108.936 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -85.12 -18.77 33.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.912 . . . . 0.0 109.702 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 74.1 t -77.51 -50.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.965 . . . . 0.0 109.742 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.407 ' HG1' ' H ' ' C' ' 109' ' ' LEU . 43.5 p -52.46 -52.04 56.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.251 -0.906 . . . . 0.0 109.666 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' C' ' 114' ' ' PRO . 7.9 mt -43.61 -26.41 0.23 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.723 . . . . 0.0 109.756 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.9 -25.66 62.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 110.477 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.45 -3.88 54.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.053 -1.029 . . . . 0.0 110.835 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . 0.622 ' CD2' ' CE1' ' C' ' 24' ' ' TYR . 0.2 OUTLIER -150.11 -69.22 0.19 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.73 -1.231 . . . . 0.0 109.639 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' C' ' 109' ' ' LEU . 0.4 OUTLIER -118.22 81.27 16.59 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . 0.48 ' N ' ' O ' ' C' ' 109' ' ' LEU . 51.4 Cg_exo -49.24 -170.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.462 2.108 . . . . 0.0 112.567 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.638 ' O ' ' CG ' ' C' ' 116' ' ' GLU . . . -48.7 -55.62 10.87 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.638 ' CG ' ' O ' ' C' ' 115' ' ' ALA . 2.8 mm-40 130.46 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 13.0 t80 66.37 30.38 8.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.717 -0.614 . . . . 0.0 111.08 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.7 ' O ' ' N ' ' C' ' 120' ' ' ALA . 2.1 p -103.83 128.04 28.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 108.287 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.59 23.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.217 1.945 . . . . 0.0 112.907 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.7 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -157.01 -32.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.746 -1.221 . . . . 0.0 110.675 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.63 ' H ' ' HG1' ' C' ' 118' ' ' THR . 12.9 p -49.86 -47.31 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.035 . . . . 0.0 110.236 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.512 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 2.4 t60 -61.72 -38.5 88.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.85 . . . . 0.0 109.778 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.37 -20.19 34.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.995 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -62.29 1.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.14 -19.87 66.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 109.411 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.12 -49.31 37.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.958 . . . . 0.0 109.66 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.18 -42.03 11.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 109.632 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.515 ' N ' ' CD ' ' C' ' 127' ' ' LYS . 32.1 t80 -49.97 -22.88 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 109.364 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' C' ' 129' ' ' LEU . 1.2 pp -76.43 -22.03 55.18 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.15 -38.11 75.97 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 33.8 m -67.88 -26.82 66.2 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 5.7 t -85.61 -37.61 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.358 -0.839 . . . . 0.0 108.879 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 14.9 t -79.97 -18.09 51.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.318 -0.864 . . . . 0.0 108.778 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 42.6 m -83.24 -42.46 17.18 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.452 -0.78 . . . . 0.0 109.238 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . 0.435 ' O ' ' OG ' ' C' ' 84' ' ' SER . 27.4 m -70.13 -21.93 24.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.245 -0.909 . . . . 0.0 108.694 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.4 -31.91 72.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.448 -0.783 . . . . 0.0 108.941 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 7.2 m -153.19 57.1 0.77 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.296 -0.877 . . . . 0.0 109.47 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 25.5 t -63.52 -57.44 10.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.935 . . . . 0.0 109.518 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 51.58 -122.9 2.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.405 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -152.83 50.29 0.74 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.956 . . . . 0.0 109.367 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.493 179.943 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.527 ' O ' ' NZ ' ' D' ' 132' ' ' LYS . 7.6 p . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 52.31 47.95 23.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 108.964 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.696 ' H ' ' CD1' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -107.64 -159.17 0.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.506 -0.747 . . . . 0.0 109.35 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.401 ' O ' ' N ' ' D' ' 6' ' ' GLU . 9.9 p -103.56 134.36 19.79 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.435 -0.791 . . . . 0.0 109.34 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . 0.453 ' O ' ' OG ' ' D' ' 9' ' ' SER . 75.7 Cg_exo -42.08 -22.73 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.397 2.065 . . . . 0.0 112.495 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' D' ' 4' ' ' THR . 79.3 mt-10 -76.71 -55.63 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 110.043 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -68.14 -60.39 2.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.033 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.522 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -48.68 -30.16 5.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.846 . . . . 0.0 110.198 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' D' ' 5' ' ' PRO . 2.8 m -62.08 -23.63 66.62 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.041 -1.037 . . . . 0.0 110.083 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.97 -57.59 3.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.014 -1.054 . . . . 0.0 110.035 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.6 -25.02 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.522 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 56.9 m -83.48 -37.26 23.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.22 -29.93 71.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.346 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.7 OUTLIER -52.08 -32.54 35.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.092 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . 0.638 ' HE1' ' HG ' ' D' ' 72' ' ' SER . 0.2 OUTLIER -47.14 -17.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.31 -52.01 5.83 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.421 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.1 OUTLIER -70.47 -29.32 65.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.202 -1.175 . . . . 0.0 109.322 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -48.84 114.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.55 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' D' ' 22' ' ' GLU . 18.4 m120 -82.67 69.49 9.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 108.941 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . 0.486 ' C ' ' H ' ' D' ' 22' ' ' GLU . 78.7 t -43.81 -29.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 109.713 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -64.63 1.87 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.617 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' D' ' 20' ' ' VAL . 33.0 mt-10 -155.88 -46.18 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.393 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -48.54 -53.93 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.4 -48.51 48.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.4 -46.36 78.59 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -62.36 -40.07 95.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -1.153 . . . . 0.0 109.314 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -37.79 88.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.364 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -82.1 -51.35 8.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.275 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.91 -35.09 62.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -79.4 -30.58 42.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -1.14 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . 0.521 HD22 HMC2 ' D' ' 147' ' ' HEC . 60.1 tp -49.52 -38.95 32.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 109.368 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.57 -23.42 56.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.595 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.7 -61.62 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.21 -0.931 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.32 -23.81 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.77 76.06 48.09 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 109.258 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.64 11.42 2.72 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.769 2.312 . . . . 0.0 112.358 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -80.54 -19.75 45.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.36 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.635 ' HB ' HBC2 ' D' ' 147' ' ' HEC . 42.1 p -79.71 40.07 0.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -92.07 12.86 20.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -87.88 -34.44 18.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.591 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' D' ' 42' ' ' PHE . 29.4 m-85 -95.81 32.37 1.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 0.0 109.546 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 0.434 ' CD1' ' C ' ' D' ' 41' ' ' PHE . 56.5 m-85 -141.38 26.36 1.98 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 109.454 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -80.94 -25.07 37.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.51 ' C ' ' H ' ' D' ' 46' ' ' GLY . 67.1 m -82.15 -38.31 24.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.922 . . . . 0.0 109.483 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -55.93 -5.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' D' ' 44' ' ' SER . . . 48.53 -167.77 0.15 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' D' ' 48' ' ' LEU . 18.9 t70 60.26 -150.21 0.42 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -1.154 . . . . 0.0 109.559 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . 0.502 ' H ' ' CG ' ' D' ' 47' ' ' ASP . 23.5 mt 60.46 34.39 20.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.562 -0.711 . . . . 0.0 109.656 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.2 m -80.47 -22.54 40.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' THR . . . . . 0.495 ' O ' ' N ' ' D' ' 53' ' ' ALA . 21.1 p -146.05 149.07 37.58 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 109.157 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -36.85 -45.06 1.19 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.593 2.195 . . . . 0.0 112.595 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.73 -27.04 61.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 109.6 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -57.81 -19.59 29.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.589 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.99 -63.45 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 109.63 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' D' ' 55' ' ' MET . 2.3 mpp? -79.71 14.86 1.53 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.436 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.98 -49.06 4.41 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . 0.472 HD21 ' N ' ' D' ' 57' ' ' ASN . 1.0 OUTLIER -77.78 149.63 77.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.276 -1.132 . . . . 0.0 109.47 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.33 -52.03 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.642 2.228 . . . . 0.0 112.148 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -46.88 -40.71 14.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.336 -0.853 . . . . 0.0 109.58 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 86.6 t -54.22 -44.83 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.397 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' D' ' 61' ' ' LYS . 7.0 mtmp? -77.4 -43.06 33.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.11 -33.15 17.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 0.724 ' HE2' ' C4D' ' D' ' 147' ' ' HEC . 5.8 t60 -67.55 -24.49 65.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.584 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.57 -30.31 74.79 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -68.16 -41.21 81.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.33 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -64.08 -50.95 66.34 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.338 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.776 HG21 ' C4A' ' D' ' 147' ' ' HEC . 25.4 t -61.74 -23.84 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.201 -0.937 . . . . 0.0 109.331 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -78.17 -29.78 48.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.32 -57.09 14.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.48 -22.03 63.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -1.135 . . . . 0.0 109.517 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -74.53 -30.23 61.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.607 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' SER . . . . . 0.638 ' HG ' ' HE1' ' D' ' 15' ' ' TRP . 4.5 m -89.21 -20.49 24.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.688 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -46.15 -30.73 2.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.692 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.41 -59.17 6.99 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.424 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -56.74 -17.82 10.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -1.153 . . . . 0.0 109.628 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . 0.558 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -97.36 33.04 2.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 109.993 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 9.5 m-70 -176.81 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.143 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' D' ' 77' ' ' HIS . 29.9 mt 39.61 35.38 0.19 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.644 -0.66 . . . . 0.0 109.621 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -138.73 -31.4 0.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.788 . . . . 0.0 109.631 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' D' ' 80' ' ' ASN . 7.4 p-10 -151.95 72.85 1.03 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.296 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . 0.537 ' O ' ' CZ ' ' D' ' 85' ' ' PHE . 9.5 mp -60.36 -27.15 67.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -80.6 -61.5 1.95 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.776 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.33 -23.79 42.75 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' D' ' 81' ' ' LEU . 0.8 OUTLIER -62.34 -51.91 65.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 109.554 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.537 ' CZ ' ' O ' ' D' ' 81' ' ' LEU . 2.2 p90 -133.2 51.83 2.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 109.651 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.01 -29.31 4.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.322 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' THR . . . . . 0.647 ' HG1' ' N ' ' D' ' 88' ' ' LEU . 17.8 p -60.59 -58.55 8.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.325 -0.859 . . . . 0.0 109.319 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.647 ' N ' ' HG1' ' D' ' 87' ' ' THR . 90.8 mt -48.47 -37.47 17.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.008 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -69.05 -34.95 76.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.034 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -82.87 -39.07 22.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -0.825 . . . . 0.0 109.4 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.05 -25.3 64.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.401 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' D' ' 97' ' ' HIS . 7.0 m80 -91.0 -21.74 21.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.625 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.56 -59.01 2.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 111.162 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.715 ' O ' HG21 ' A' ' 41' ' ' THR . 1.3 m-20 -87.28 -57.0 3.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.014 -1.054 . . . . 0.0 111.934 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' D' ' 95' ' ' LYS . 12.0 mptt -62.66 -52.25 64.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.131 -0.98 . . . . 0.0 111.263 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.606 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -95.41 -38.19 10.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.892 -1.13 . . . . 0.0 109.764 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.606 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 25.4 p80 45.36 33.26 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 52.5 t -50.12 132.37 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.041 -1.037 . . . . 0.0 109.14 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' D' ' 102' ' ' ASN . 4.2 m-20 -51.19 151.2 5.12 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.293 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.98 -170.32 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.464 2.109 . . . . 0.0 112.026 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' B' ' 101' ' ' GLU . 69.2 mm-40 53.14 70.04 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.472 ' ND2' ' CD1' ' D' ' 103' ' ' PHE . 4.0 p-10 -171.23 -39.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -0.897 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' ND2' ' D' ' 102' ' ' ASN . 12.8 m-85 -50.25 -34.55 23.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -76.12 -43.99 40.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.559 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' D' ' 105' ' ' LEU . 9.9 mp -49.35 -51.85 31.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.441 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 1.005 HD11 ' CHC' ' D' ' 147' ' ' HEC . 6.5 tt -51.66 -37.21 49.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.137 -0.977 . . . . 0.0 109.303 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.93 -20.62 59.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -65.25 -34.36 78.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -1.179 . . . . 0.0 109.616 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.82 -31.71 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 7.6 tp -51.64 -52.12 50.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.559 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . 0.553 ' CG2' ' CE1' ' D' ' 130' ' ' TYR . 42.9 t -51.15 -42.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.577 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -60.18 -39.52 86.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.594 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.53 -55.0 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 109.681 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.96 -31.81 71.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -64.87 -27.83 69.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.469 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.563 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.79 -61.25 1.83 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 109.25 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . 0.417 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 8.3 m-70 -63.24 -18.42 63.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.525 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 58.9 m-85 -148.41 59.53 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 109.386 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -72.03 -14.74 76.24 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -79.45 -20.34 47.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.455 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' D' ' 123' ' ' THR . 29.2 mm-40 -95.4 -2.5 48.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.768 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.91 34.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.536 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.519 ' H ' ' C ' ' D' ' 121' ' ' GLU . 21.7 p -49.25 148.37 4.5 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.391 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.441 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 2.3 Cg_endo -46.71 -57.56 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.463 2.109 . . . . 0.0 113.03 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 17.7 Cg_endo -59.51 -42.38 48.48 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.12 1.88 . . . . 0.0 112.236 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 98.7 t -64.93 -20.95 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.917 . . . . 0.0 109.547 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . 0.854 HE22 ' HG3' ' C' ' 31' ' ' ARG . 37.0 tt0 -83.28 -48.91 9.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.576 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.72 -30.0 67.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.528 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.14 19.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.653 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . 0.553 ' CE1' ' CG2' ' D' ' 111' ' ' VAL . 47.1 t80 -107.92 -61.31 1.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.3 -0.875 . . . . 0.0 109.68 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -55.29 -23.25 22.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' D' ' 1' ' ' VAL . 22.7 ttpp -83.06 -21.83 33.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.933 . . . . 0.0 109.653 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.09 -68.27 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.945 . . . . 0.0 109.721 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 22.3 m -53.83 -25.06 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.28 -0.888 . . . . 0.0 109.869 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.56 -29.79 7.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -0.949 . . . . 0.0 109.438 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.33 -29.31 56.38 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.4 -38.15 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 0.0 109.432 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.88 79.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 1.616 HD22 ' CD2' ' B' ' 146' ' ' HIS . 1.8 m120 -79.68 -22.99 42.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.952 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.72 -60.64 2.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.628 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.83 -25.21 66.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.266 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 -16.41 27.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 109.422 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -51.23 -33.47 28.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 18.8 mmtm -73.32 -27.17 61.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . 0.432 ' OH ' ' O ' ' D' ' 92' ' ' HIS . 16.2 m-85 -71.85 -46.28 58.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.455 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 1.616 ' CD2' HD22 ' B' ' 139' ' ' ASN . 43.7 p-80 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.483 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 1.019 ' CHC' HD11 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.005 ' CHC' HD11 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 1' ' ' VAL . 9.9 mt 54.48 170.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 0.0 109.638 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.465 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 176.32 -53.64 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.0 . . . . 0.0 110.317 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 6' ' ' ASP . 59.0 Cg_endo -73.97 -165.22 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.397 2.064 . . . . 0.0 112.777 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 8' ' ' THR . . . -43.93 -15.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.434 -0.792 . . . . 0.0 110.114 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' PRO . 53.5 m-20 -38.72 -37.22 0.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.806 . . . . 0.0 109.76 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -30.77 26.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.881 . . . . 0.0 109.685 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 5' ' ' ALA . 40.9 m -52.02 -37.48 53.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.173 -0.954 . . . . 0.0 109.213 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -73.87 -33.36 64.03 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.76 -52.29 26.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.94 -45.59 51.36 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.09 -61.76 2.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.579 -0.701 . . . . 0.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.35 63.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.3 -0.875 . . . . 0.0 109.242 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.453 ' HE1' ' HG1' ' A' ' 67' ' ' THR . 0.2 OUTLIER -75.55 -17.38 60.09 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.31 -0.869 . . . . 0.0 109.062 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.06 -43.32 14.0 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -70.36 -39.96 74.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 108.828 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.5 t -60.03 -65.4 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.587 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 57.29 -135.75 51.33 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 28.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.998 . . . . 0.0 110.48 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.587 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.9 m-70 -131.93 24.36 4.62 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.24 -62.76 1.42 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.624 -0.672 . . . . 0.0 109.727 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.41 -14.5 0.19 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' ALA . 1.3 mm-40 -84.15 -56.16 3.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -1.061 . . . . 0.0 109.433 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.641 ' CD1' ' CD2' ' A' ' 112' ' ' HIS . 3.1 m-30 -59.95 -37.09 78.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.374 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.73 -24.24 69.6 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.35 -45.05 20.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.629 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.01 -21.21 61.02 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.399 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.31 -21.53 62.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.693 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 mt -78.04 -51.54 10.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.505 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.34 -12.67 61.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.837 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.565 ' NH2' ' SG ' ' A' ' 104' ' ' CYS . 0.9 OUTLIER -76.48 -40.37 50.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 110.276 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.0 ptt? -84.16 -35.56 23.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 109.963 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -45.99 -41.72 12.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 109.665 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.78 ' CD1' ' HB3' ' B' ' 128' ' ' ALA . 2.2 pp -84.63 -35.89 22.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.067 -1.021 . . . . 0.0 109.82 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.4 p -85.33 1.45 48.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.538 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' MET . 67.0 m-85 -159.17 68.13 3.2 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 39' ' ' THR . 72.1 Cg_exo -47.75 -34.34 21.14 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.821 2.347 . . . . 0.0 112.279 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 1.347 ' CG2' ' HD1' ' D' ' 97' ' ' HIS . 2.2 p -47.05 -18.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.927 . . . . 0.0 109.591 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' PRO . 81.4 p -84.5 -31.33 24.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 0.0 109.709 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -68.6 -26.44 65.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 109.685 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.857 HG23 ' CD2' ' D' ' 97' ' ' HIS . 5.3 t -90.94 -17.94 25.55 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.259 -0.9 . . . . 0.0 109.87 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.6 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 2.0 t80 -60.99 -65.71 0.65 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.095 -1.003 . . . . 0.0 109.09 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 42' ' ' TYR . 0.6 OUTLIER 166.06 78.87 0.01 OUTLIER Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.443 -0.785 . . . . 0.0 109.578 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.582 ' O ' ' CD2' ' A' ' 46' ' ' PHE . 75.8 Cg_endo -83.53 -42.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.626 2.217 . . . . 0.0 111.573 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 26.6 p80 44.5 31.93 0.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.579 -0.701 . . . . 0.0 110.903 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 2.8 p90 -135.86 26.85 3.31 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.001 -1.062 . . . . 0.0 109.687 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 49' ' ' SER . 55.2 m-20 44.44 83.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.485 -0.759 . . . . 0.0 109.529 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.01 -8.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 109.5 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 47' ' ' ASP . 35.0 p -68.36 169.45 10.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 0.0 109.469 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -78.96 164.3 24.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.863 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.04 17.31 71.66 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 54' ' ' GLN . 3.0 t -77.52 -28.62 52.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -1.156 . . . . 0.0 109.487 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 73.28 -31.66 0.23 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.602 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 52' ' ' SER . 38.0 mt-30 -80.51 -22.56 40.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -83.46 -35.93 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -81.42 -32.93 32.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.198 -0.939 . . . . 0.0 108.615 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.66 -21.96 78.85 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.409 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 10.1 t-80 -70.51 -29.97 66.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -1.055 . . . . 0.0 109.24 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.76 -51.45 57.95 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -48.36 -23.82 1.04 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -1.136 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 10.4 mmpt? -71.39 -51.12 25.8 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.179 -0.951 . . . . 0.0 108.608 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.7 t -60.85 -47.7 92.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.76 89.42 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.348 -0.845 . . . . 0.0 108.923 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 68' ' ' ASN . 14.3 t0 -60.06 -39.07 84.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -65.01 -52.33 56.69 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' VAL . 15.5 mt -57.59 -43.91 84.97 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.453 ' HG1' ' HE1' ' A' ' 14' ' ' TRP . 19.0 m -69.34 -51.25 38.81 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' ASP . 60.7 t30 -61.64 -26.14 67.81 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.17 -46.59 10.94 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' LEU . 20.8 t -65.2 -22.67 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -64.09 -21.62 66.6 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' ' 74' ' ' ASP . 42.4 m80 -146.44 -51.94 0.23 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.4 p 44.74 13.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.687 0.756 . . . . 0.0 109.407 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 72' ' ' HIS . 29.2 m-20 -127.04 9.5 6.83 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -173.68 27.3 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.046 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.689 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 4.8 ptt? -78.33 -24.2 0.43 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.44 -0.788 . . . . 0.0 111.668 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.8 Cg_exo -53.02 -27.73 37.26 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.634 1.556 . . . . 0.0 112.506 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.46 HD21 ' N ' ' A' ' 78' ' ' ASN . 1.4 m-80 -94.3 -24.79 17.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.74 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.79 -46.38 21.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.0 109.223 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.7 mt -82.05 9.3 8.7 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 108.981 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 77' ' ' PRO . 4.5 m -65.69 -22.41 66.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 109.512 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -82.01 -59.64 2.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.135 -0.978 . . . . 0.0 109.694 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.51 ' CD1' ' C ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -50.8 -26.2 5.39 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.2 m -67.5 -33.4 75.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' ALA . 4.3 t70 -78.26 -30.07 48.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 108.806 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.991 HD11 ' CBD' ' A' ' 142' ' ' HEC . 2.1 tm? -54.31 -49.55 69.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.509 -0.744 . . . . 0.0 109.388 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -92.24 -21.78 20.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.008 . . . . 0.0 110.375 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.93 -2.62 55.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.042 -1.036 . . . . 0.0 110.293 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -128.56 -77.06 0.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.194 -0.941 . . . . 0.0 109.771 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -46.66 -78.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.761 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' A' ' 91' ' ' LEU . 8.2 mp -71.06 -39.05 72.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.106 -0.996 . . . . 0.0 109.647 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 61.84 59.28 1.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 109.42 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 94' ' ' ASP . 90.3 t -85.21 166.59 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 109.614 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 96' ' ' VAL . 3.8 m-20 -99.33 120.05 58.92 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.381 -0.824 . . . . 0.0 109.217 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 98' ' ' PHE . 83.3 Cg_exo -44.11 -10.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.225 1.95 . . . . 0.0 112.432 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 94' ' ' ASP . 96.1 t -45.55 -23.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 95' ' ' PRO . 73.3 m-20 -79.3 -24.84 42.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 109.57 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' OG ' ' A' ' 102' ' ' SER . 20.4 t80 -46.53 -35.05 5.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -64.61 -33.27 75.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.0 mt -84.06 -43.75 14.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.523 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.991 HD11 ' HHC' ' A' ' 142' ' ' HEC . 4.8 tt -54.38 -52.04 62.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.537 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 98' ' ' PHE . 15.7 m -59.63 -33.52 71.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.555 ' HD1' ' N ' ' A' ' 103' ' ' HIS . 0.7 OUTLIER -80.65 -26.65 37.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.095 -1.003 . . . . 0.0 110.096 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.565 ' SG ' ' NH2' ' A' ' 31' ' ' ARG . 72.0 m -63.95 -58.36 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.246 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.43 -34.51 4.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.935 . . . . 0.0 110.093 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.8 mt -70.75 -28.2 64.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 110.176 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -83.04 -38.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.979 -1.076 . . . . 0.0 109.582 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 110' ' ' ALA . 19.1 p -70.58 -58.9 3.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.2 -0.938 . . . . 0.0 109.649 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 113' ' ' LEU . 9.5 mt -43.12 -26.28 0.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.765 . . . . 0.0 109.587 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -67.36 -22.64 65.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 110.589 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.37 -48.02 12.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.025 . . . . 0.0 111.006 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.641 ' CD2' ' CD1' ' A' ' 24' ' ' TYR . 1.1 p-80 -100.76 -58.87 1.8 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.025 -1.047 . . . . 0.0 111.037 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.522 ' H ' ' CD2' ' A' ' 112' ' ' HIS . 0.9 OUTLIER -112.44 93.35 22.53 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 109.284 -178.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 113' ' ' LEU . 76.7 Cg_exo -47.0 -174.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.364 2.042 . . . . 0.0 112.685 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.648 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -61.56 -55.35 31.77 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.648 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 27.8 mt-10 119.92 1.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.506 ' O ' ' CD2' ' A' ' 117' ' ' PHE . 38.3 t80 59.62 31.63 21.04 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.298 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.794 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.3 p -104.4 120.8 49.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.985 -1.072 . . . . 0.0 108.14 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.1 23.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.09 1.86 . . . . 0.0 112.72 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.794 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -154.43 -29.96 0.11 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.853 -1.155 . . . . 0.0 110.676 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.513 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 13.7 p -51.16 -50.16 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.996 -1.065 . . . . 0.0 110.274 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.513 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 3.1 t-160 -61.31 -53.41 57.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.868 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.72 -19.83 61.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 120' ' ' ALA . 20.5 m -63.72 -62.51 1.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.164 -0.96 . . . . 0.0 110.277 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.47 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 1.2 mt -64.4 -16.85 63.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.352 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.07 -49.18 9.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 110.902 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.62 -59.03 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.818 -1.176 . . . . 0.0 111.264 -178.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.454 ' N ' ' HD2' ' A' ' 127' ' ' LYS . 21.4 m-85 -47.98 -21.23 0.41 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.717 -1.239 . . . . 0.0 109.752 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.56 HD11 HBB1 ' A' ' 142' ' ' HEC . 0.1 OUTLIER -72.1 -31.03 65.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 134' ' ' THR . . . -49.2 -33.18 11.9 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.467 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 43.2 t -60.36 -37.02 79.39 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 t -77.06 -48.72 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.406 ' CB ' ' CE1' ' A' ' 98' ' ' PHE . 13.5 t -66.48 -22.72 66.19 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.278 -0.889 . . . . 0.0 108.635 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 130' ' ' ALA . 11.2 m -64.06 -31.75 73.06 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.411 -0.806 . . . . 0.0 108.827 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.62 -37.26 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 109.14 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.59 -35.29 75.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.299 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 134' ' ' THR . 34.9 p -67.9 -33.75 75.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 t 46.69 89.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 1.224 ' NZ ' ' NZ ' ' C' ' 139' ' ' LYS . 42.0 mtpt -65.55 -123.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 109.471 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -55.13 89.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.483 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 139' ' ' LYS . 75.9 mtt-85 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.479 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.43 HG11 ' H ' ' B' ' 2' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.43 ' H ' HG11 ' B' ' 1' ' ' VAL . 19.1 m-70 45.0 52.75 8.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 109.813 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mt -87.8 161.05 17.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.561 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.19 138.18 19.47 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.371 -0.83 . . . . 0.0 108.826 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -40.02 -54.19 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.524 2.149 . . . . 0.0 112.637 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -72.01 -21.84 61.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 110.02 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -76.62 -63.12 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 109.902 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.466 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -66.58 -29.59 69.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.068 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.6 t -47.5 -23.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 110.101 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.66 -56.85 3.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 109.992 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.13 -24.64 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.9 m -73.52 -40.28 64.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.746 -0.596 . . . . 0.0 109.607 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.42 -31.23 71.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.409 -0.807 . . . . 0.0 109.447 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.8 OUTLIER -50.7 -31.47 16.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 0.0 109.155 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . 0.415 ' CE2' ' OG ' ' B' ' 72' ' ' SER . 1.5 t90 -47.57 -17.82 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.382 -0.824 . . . . 0.0 109.537 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.97 -51.1 5.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' B' ' 17' ' ' LYS . 0.1 OUTLIER -71.23 -29.56 65.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.169 -1.194 . . . . 0.0 109.33 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -49.42 114.79 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.925 . . . . 0.0 109.581 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' B' ' 22' ' ' GLU . 95.3 m-20 -78.39 67.65 4.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.01 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' B' ' 22' ' ' GLU . 68.8 t -44.32 -29.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.831 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.14 7.43 0.57 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' B' ' 20' ' ' VAL . 38.5 mt-10 -155.23 -49.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -48.59 -60.72 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.89 -39.22 17.69 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.09 -43.73 89.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.419 ' O ' ' CG ' ' B' ' 30' ' ' ARG . 57.0 mt-10 -79.47 -40.39 29.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.291 -1.123 . . . . 0.0 109.546 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 -34.32 8.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -82.6 -56.67 3.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.73 -44.83 80.35 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' B' ' 26' ' ' GLU . 0.0 OUTLIER -53.89 -36.48 62.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -1.123 . . . . 0.0 109.26 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -55.95 -47.63 77.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 0.0 109.412 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.02 -22.73 67.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.65 -64.72 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 109.358 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -67.64 -22.79 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -139.46 80.97 21.13 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.86 -16.04 9.09 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.668 2.245 . . . . 0.0 112.515 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -51.02 -19.91 1.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.075 -1.016 . . . . 0.0 109.416 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.417 ' HB ' HBC1 ' B' ' 147' ' ' HEC . 3.6 p -85.54 55.51 3.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.215 -0.928 . . . . 0.0 109.147 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -109.77 41.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.435 -0.791 . . . . 0.0 109.255 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 mmt-85 -104.03 -49.29 3.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.0 109.479 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' B' ' 41' ' ' PHE . 27.7 m-85 -91.86 30.04 1.46 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.585 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' B' ' 44' ' ' SER . 9.4 p90 -92.55 -12.97 30.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -46.07 -13.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.909 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.544 ' N ' ' O ' ' B' ' 42' ' ' PHE . 23.8 p -124.3 23.49 8.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.245 -0.909 . . . . 0.0 109.583 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.34 -14.2 21.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 0.0 109.322 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.54 -116.76 2.21 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -144.26 105.23 4.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -1.11 . . . . 0.0 109.557 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.94 30.57 1.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.14 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.5 p -44.0 -32.37 1.13 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.817 . . . . 0.0 109.859 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 17.8 p -146.61 148.31 33.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 109.334 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -40.16 -50.2 3.57 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.517 2.145 . . . . 0.0 112.177 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.21 -35.09 76.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.83 -19.77 4.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.507 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.18 -63.95 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 12.2 mmt -63.05 -7.58 5.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.38 -10.24 64.06 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -78.37 141.98 62.22 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.173 -1.192 . . . . 0.0 109.378 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -74.3 -57.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.59 2.193 . . . . 0.0 112.214 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' B' ' 63' ' ' HIS . 45.6 mtpt -51.98 -48.49 64.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.556 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' B' ' 59' ' ' LYS . 74.3 t -45.8 -39.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.0 109.289 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -79.35 -52.4 8.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.85 . . . . 0.0 109.321 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.36 -59.18 3.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.805 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 0.538 ' N ' ' O ' ' B' ' 59' ' ' LYS . 1.7 t60 -48.29 -24.85 1.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.41 -36.73 91.99 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -69.29 -25.14 64.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -1.125 . . . . 0.0 109.479 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -73.13 -35.35 66.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.559 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.47 HG13 ' C2B' ' B' ' 147' ' ' HEC . 39.6 t -75.75 -28.3 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.21 -34.94 68.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.302 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.51 -45.12 37.44 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.83 91.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -1.209 . . . . 0.0 109.65 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -57.29 -41.07 79.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 109.579 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.415 ' OG ' ' CE2' ' B' ' 15' ' ' TRP . 5.7 t -76.63 -37.75 55.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.653 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -47.5 -37.57 12.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.535 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -60.4 7.6 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.456 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -55.82 -30.04 60.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.248 -1.148 . . . . 0.0 109.401 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.09 5.4 29.82 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.201 -0.937 . . . . 0.0 109.65 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.522 ' NE2' ' OD1' ' B' ' 80' ' ' ASN . 7.5 t60 -170.93 67.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 109.525 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.93 17.96 1.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -79.63 -29.23 40.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.452 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.522 ' OD1' ' NE2' ' B' ' 77' ' ' HIS . 4.3 p-10 -163.21 95.82 0.86 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.235 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.4 ' H ' HD13 ' B' ' 81' ' ' LEU . 5.0 mp -80.28 -58.91 2.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.204 -0.935 . . . . 0.0 109.64 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -57.46 -23.83 52.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.075 -1.016 . . . . 0.0 109.568 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.06 -54.41 3.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.0 t -61.38 -47.58 85.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -1.157 . . . . 0.0 109.614 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.557 ' N ' ' CG2' ' B' ' 84' ' ' THR . 54.4 m-85 -76.7 22.04 0.19 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.351 -0.843 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.46 -26.8 44.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 75.3 p -78.85 -59.1 2.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.754 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.4 mt -48.63 -45.05 37.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.955 . . . . 0.0 109.288 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 53.9 p -64.72 -52.71 55.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.267 -0.896 . . . . 0.0 109.269 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -61.27 -22.7 65.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 tp -86.9 -68.71 0.73 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.417 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.509 ' O ' ' N ' ' B' ' 97' ' ' HIS . 48.8 m80 -51.01 -26.54 6.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.094 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . 0.407 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 27.5 t -83.73 -55.93 3.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 111.303 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.529 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 27.4 t0 -86.24 -32.2 21.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.001 -1.062 . . . . 0.0 111.945 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -89.36 -51.76 5.39 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.689 -1.257 . . . . 0.0 111.132 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.63 -27.03 15.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.852 -1.155 . . . . 0.0 110.43 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 1.275 ' HD1' ' CG2' ' C' ' 38' ' ' THR . 83.0 m-70 51.67 29.57 5.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.038 -1.039 . . . . 0.0 109.61 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 40.0 t -47.14 130.2 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.968 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.38 152.46 32.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.28 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.88 -164.09 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.553 2.169 . . . . 0.0 112.165 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.26 60.72 2.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.877 . . . . 0.0 109.578 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.515 ' C ' HD21 ' B' ' 102' ' ' ASN . 0.1 OUTLIER -171.3 -41.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.457 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -46.21 -40.55 11.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 109.714 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -80.07 -19.92 46.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.554 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' B' ' 102' ' ' ASN . 12.3 tp -70.47 -59.77 2.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 109.639 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.815 HD13 ' CHC' ' B' ' 147' ' ' HEC . 7.0 tt -49.84 -46.22 51.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 109.354 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.06 -20.44 58.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . 0.454 ' O ' ' SG ' ' B' ' 112' ' ' CYS . 18.4 t30 -80.53 -25.2 38.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -1.105 . . . . 0.0 109.577 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 74.2 t -86.19 -43.09 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 109.683 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tt -48.26 -33.05 8.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.464 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -83.05 -26.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.532 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' B' ' 108' ' ' ASN . 72.4 m -69.1 -24.79 64.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.538 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 42.4 t -76.34 -34.89 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' B' ' 118' ' ' PHE . 9.5 mt -69.83 -40.16 76.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 109.413 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -54.4 -28.92 46.93 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 109.438 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.524 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.74 -62.41 1.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.106 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -63.36 -17.75 62.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.551 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' B' ' 114' ' ' LEU . 93.3 m-85 -149.72 60.4 1.0 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 109.402 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.535 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -69.22 -24.72 75.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -64.75 -29.67 70.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -1.153 . . . . 0.0 109.346 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' B' ' 123' ' ' THR . 78.3 mm-40 -87.81 5.71 38.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 109.736 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.543 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.64 33.09 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 109.422 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.523 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.4 p -52.41 149.13 10.88 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.353 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.501 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.1 Cg_exo -45.41 -53.66 5.23 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.452 2.101 . . . . 0.0 112.988 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 24.6 Cg_endo -62.16 -29.65 81.04 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.05 1.834 . . . . 0.0 112.223 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 45.7 t -68.81 -28.15 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 109.423 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -83.15 -53.89 5.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.78 ' HB3' ' CD1' ' A' ' 34' ' ' LEU . . . -63.25 -26.49 68.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.576 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.51 -2.33 53.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.114 -0.991 . . . . 0.0 109.807 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' B' ' 132' ' ' LYS . 41.8 t80 -92.49 -61.52 1.58 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.717 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -45.25 -23.32 0.17 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 109.931 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' B' ' 130' ' ' TYR . 51.1 mtmt -85.46 -34.6 21.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.217 -0.927 . . . . 0.0 110.322 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 0.6 OUTLIER -68.61 -44.15 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.075 . . . . 0.0 109.676 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.501 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 6.1 m -79.64 -20.91 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' D' ' 146' ' ' HIS . . . -50.51 -32.41 18.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -0.974 . . . . 0.0 109.364 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.63 -26.56 56.36 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.42 -32.96 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -1.148 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.44 90.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.67 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.89 -21.05 47.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.766 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.01 -58.86 6.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.663 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 48.4 mt -61.48 -31.88 71.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 109.497 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.06 25.15 4.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.251 -0.905 . . . . 0.0 109.599 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -80.0 -16.13 55.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.712 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' B' ' 146' ' ' HIS . 13.2 mptt -98.34 -26.72 14.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 0.0 109.613 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -54.38 -6.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.11 -0.994 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.522 ' H ' ' C ' ' B' ' 144' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.428 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' C' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' C' ' 1' ' ' VAL . 9.9 mt 54.47 170.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.353 -0.842 . . . . 0.0 109.621 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.473 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 176.31 -53.58 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.322 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' C' ' 6' ' ' ASP . 59.0 Cg_endo -74.05 -165.15 0.24 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.373 2.048 . . . . 0.0 112.776 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' C' ' 8' ' ' THR . . . -44.0 -15.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.497 -0.752 . . . . 0.0 110.129 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' C' ' 4' ' ' PRO . 53.1 m-20 -38.82 -37.11 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 109.779 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -30.94 26.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.666 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.518 ' N ' ' O ' ' C' ' 5' ' ' ALA . 41.7 m -51.87 -37.52 52.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.068 -1.02 . . . . 0.0 109.283 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -73.87 -33.39 64.05 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -71.69 -52.38 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.87 -45.61 50.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.02 -61.9 2.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.629 -0.669 . . . . 0.0 109.883 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.57 -33.37 63.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.295 -0.878 . . . . 0.0 109.246 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . 0.46 ' HE1' ' HG1' ' C' ' 67' ' ' THR . 0.2 OUTLIER -75.59 -17.38 60.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.285 -0.884 . . . . 0.0 109.029 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.0 -43.24 14.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -70.41 -39.83 74.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -1.199 . . . . 0.0 108.856 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.2 -65.39 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.6 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 57.27 -135.74 51.33 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 28.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.439 -1.036 . . . . 0.0 110.453 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.6 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.7 m-70 -131.92 24.27 4.62 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.19 -62.9 1.39 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.603 -0.686 . . . . 0.0 109.651 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.2 -14.7 0.17 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 21' ' ' ALA . 1.3 mm-40 -84.11 -56.11 3.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.461 -1.023 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.638 ' CD1' ' CD2' ' C' ' 112' ' ' HIS . 3.1 m-30 -60.05 -36.96 78.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.387 -0.821 . . . . 0.0 109.391 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.77 -24.27 69.7 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.31 -45.0 20.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 109.681 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.03 -21.28 61.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.25 -21.48 62.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.671 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 12.4 mt -78.08 -51.59 10.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.1 -12.9 61.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.825 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.557 ' NH2' ' SG ' ' C' ' 104' ' ' CYS . 0.9 OUTLIER -76.4 -40.48 50.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.137 -0.977 . . . . 0.0 110.25 -179.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.542 ' O ' ' N ' ' C' ' 36' ' ' PHE . 3.0 ptt? -84.04 -35.61 23.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.98 -1.075 . . . . 0.0 109.982 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' C' ' 33' ' ' PHE . 0.0 OUTLIER -45.87 -41.77 11.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.947 . . . . 0.0 109.719 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.775 HD13 ' HB3' ' D' ' 128' ' ' ALA . 2.3 pp -84.59 -35.93 22.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.962 . . . . 0.0 109.937 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.3 p -85.25 1.43 48.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' C' ' 32' ' ' MET . 67.3 m-85 -159.1 68.1 3.23 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' C' ' 39' ' ' THR . 69.3 Cg_exo -47.73 -34.29 20.9 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.8 2.334 . . . . 0.0 112.308 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' THR . . . . . 1.275 ' CG2' ' HD1' ' B' ' 97' ' ' HIS . 2.1 p -47.09 -18.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 109.568 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.441 ' N ' ' O ' ' C' ' 37' ' ' PRO . 81.6 p -84.52 -31.25 24.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.756 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -68.66 -26.43 65.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.951 . . . . 0.0 109.609 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.785 HG23 ' CD2' ' B' ' 97' ' ' HIS . 5.4 t -90.89 -17.99 25.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.862 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.595 ' O ' ' CD2' ' C' ' 43' ' ' PHE . 2.0 t80 -60.96 -65.64 0.66 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.157 -0.964 . . . . 0.0 109.154 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' C' ' 42' ' ' TYR . 0.6 OUTLIER 165.97 78.98 0.01 OUTLIER Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.817 . . . . 0.0 109.584 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.58 ' O ' ' CD2' ' C' ' 46' ' ' PHE . 76.3 Cg_endo -83.63 -41.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.577 2.185 . . . . 0.0 111.593 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.576 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 26.7 p80 44.51 31.98 0.68 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.564 -0.71 . . . . 0.0 110.858 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' C' ' 44' ' ' PRO . 2.8 p90 -135.91 26.93 3.29 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.047 -1.033 . . . . 0.0 109.611 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' C' ' 49' ' ' SER . 55.6 m-20 44.41 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.393 -0.817 . . . . 0.0 109.568 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.98 -8.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.474 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.531 ' H ' ' C ' ' C' ' 47' ' ' ASP . 35.6 p -68.39 169.48 10.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -78.98 164.3 24.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.525 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.05 17.27 71.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.528 ' C ' ' H ' ' C' ' 54' ' ' GLN . 3.0 t -77.53 -28.54 52.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -1.128 . . . . 0.0 109.516 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 73.18 -31.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.606 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' C' ' 52' ' ' SER . 38.1 mt-30 -80.52 -22.67 40.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 0.0 109.389 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -83.38 -36.09 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.423 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -81.36 -32.89 32.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.138 -0.976 . . . . 0.0 108.674 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.6 -22.01 78.86 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.406 ' ND1' ' C ' ' C' ' 58' ' ' HIS . 10.0 t-80 -70.44 -30.02 66.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -1.134 . . . . 0.0 109.254 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -51.47 57.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -48.29 -23.86 1.02 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 0.0 109.775 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.583 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 10.4 mmpt? -71.44 -51.08 25.81 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.257 -0.902 . . . . 0.0 108.577 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 25.6 t -60.78 -47.78 91.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.02 -38.71 89.12 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -59.97 -39.29 85.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 108.489 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -64.89 -52.39 56.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' C' ' 70' ' ' VAL . 15.6 mt -57.58 -43.99 85.01 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.46 ' HG1' ' HE1' ' C' ' 14' ' ' TRP . 19.3 m -69.18 -51.36 38.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.285 -0.885 . . . . 0.0 108.702 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -61.53 -26.12 67.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.208 -0.932 . . . . 0.0 108.521 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -85.12 -46.61 10.96 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' C' ' 66' ' ' LEU . 20.8 t -65.11 -22.8 32.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -64.0 -21.69 66.61 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' C' ' 74' ' ' ASP . 42.5 m80 -146.45 -51.89 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.878 . . . . 0.0 109.473 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.4 p 44.71 13.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.74 0.781 . . . . 0.0 109.406 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' C' ' 72' ' ' HIS . 29.2 m-20 -127.03 9.57 6.85 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -173.75 27.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.121 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 4.8 ptt? -78.3 -24.16 0.43 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.514 -0.741 . . . . 0.0 111.679 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.0 Cg_exo -52.97 -27.96 37.81 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.626 1.551 . . . . 0.0 112.398 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.453 HD21 ' N ' ' C' ' 78' ' ' ASN . 1.4 m-80 -94.09 -24.8 17.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.826 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 -46.41 21.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.094 -1.003 . . . . 0.0 109.203 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 9.8 mt -82.03 9.26 8.73 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.42 -0.8 . . . . 0.0 109.024 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' C' ' 77' ' ' PRO . 4.5 m -65.59 -22.44 66.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -82.06 -59.67 2.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.623 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.51 ' C ' ' CD1' ' C' ' 83' ' ' LEU . 0.4 OUTLIER -50.85 -26.09 5.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -67.59 -33.27 74.67 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' C' ' 82' ' ' ALA . 4.2 t70 -78.41 -29.93 47.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 108.79 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 1.007 HD11 ' CBD' ' C' ' 142' ' ' HEC . 2.1 tm? -54.48 -49.46 70.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.501 -0.75 . . . . 0.0 109.338 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -92.31 -21.67 20.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.407 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.9 -2.72 55.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.086 -1.009 . . . . 0.0 110.345 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -128.61 -77.01 0.56 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.953 . . . . 0.0 109.847 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -46.64 -78.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.981 . . . . 0.0 109.817 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.521 ' CD1' ' N ' ' C' ' 91' ' ' LEU . 8.2 mp -70.98 -39.17 72.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.569 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 61.86 59.35 1.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.389 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' C' ' 94' ' ' ASP . 90.6 t -85.16 166.6 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 109.669 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' C' ' 96' ' ' VAL . 3.8 m-20 -99.32 120.02 59.02 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.35 -0.843 . . . . 0.0 109.28 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' C' ' 98' ' ' PHE . 82.8 Cg_exo -44.12 -10.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.276 1.984 . . . . 0.0 112.394 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' C' ' 94' ' ' ASP . 95.7 t -45.63 -23.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.346 -0.846 . . . . 0.0 109.659 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' C' ' 95' ' ' PRO . 73.4 m-20 -79.24 -24.82 42.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.598 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' C' ' 102' ' ' SER . 20.5 t80 -46.51 -35.06 5.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.65 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' C' ' 99' ' ' LYS . 0.3 OUTLIER -64.55 -33.31 75.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.428 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 8.9 mt -84.05 -43.86 14.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.477 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.964 ' CD1' ' HHC' ' C' ' 142' ' ' HEC . 4.8 tt -54.32 -52.09 62.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' C' ' 98' ' ' PHE . 15.6 m -59.52 -33.57 71.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 109.934 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.555 ' HD1' ' N ' ' C' ' 103' ' ' HIS . 0.7 OUTLIER -80.71 -26.56 37.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 110.068 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.557 ' SG ' ' NH2' ' C' ' 31' ' ' ARG . 71.8 m -63.9 -58.45 6.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.33 -34.58 4.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.153 -0.967 . . . . 0.0 110.094 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -70.71 -28.3 64.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.044 -1.035 . . . . 0.0 110.176 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.95 -38.22 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 109.579 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.42 ' O ' ' N ' ' C' ' 110' ' ' ALA . 19.2 p -70.67 -58.88 3.19 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.187 -0.945 . . . . 0.0 109.599 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' C' ' 113' ' ' LEU . 9.5 mt -43.18 -26.28 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' C' ' 108' ' ' THR . . . -67.29 -22.62 65.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 110.641 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.34 -47.99 12.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.074 -1.016 . . . . 0.0 111.017 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . 0.638 ' CD2' ' CD1' ' C' ' 24' ' ' TYR . 1.1 p-80 -100.85 -58.81 1.82 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.98 -1.075 . . . . 0.0 111.034 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.518 ' H ' ' CD2' ' C' ' 112' ' ' HIS . 0.9 OUTLIER -112.4 93.43 22.72 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.272 -178.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' C' ' 113' ' ' LEU . 78.0 Cg_exo -47.15 -174.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.355 2.037 . . . . 0.0 112.643 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.657 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -61.65 -55.42 30.79 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.657 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 27.7 mt-10 120.0 1.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' C' ' 117' ' ' PHE . 38.4 t80 59.69 31.7 21.03 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.225 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.781 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.3 p -104.46 120.73 49.62 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.01 23.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.164 1.909 . . . . 0.0 112.679 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.781 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -154.41 -29.95 0.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.945 -1.097 . . . . 0.0 110.701 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 13.7 p -51.14 -50.17 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.95 -1.094 . . . . 0.0 110.302 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.511 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 3.1 t-160 -61.34 -53.3 58.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 109.887 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.79 -19.88 61.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.949 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.573 ' N ' ' O ' ' C' ' 120' ' ' ALA . 20.6 m -63.67 -62.56 1.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 110.254 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' C' ' 129' ' ' LEU . 1.2 mt -64.37 -16.91 63.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.348 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -84.08 -49.04 9.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.89 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.73 -59.04 2.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.879 -1.138 . . . . 0.0 111.302 -178.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.464 ' N ' ' HD2' ' C' ' 127' ' ' LYS . 21.4 m-85 -47.92 -21.31 0.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.82 -1.175 . . . . 0.0 109.811 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.559 HD11 HBB1 ' C' ' 142' ' ' HEC . 0.1 OUTLIER -71.99 -31.02 65.84 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' C' ' 134' ' ' THR . . . -49.28 -33.14 12.27 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' SER . . . . . 0.465 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 42.3 t -60.3 -37.07 79.4 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 6.5 t -77.02 -48.73 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.402 ' CB ' ' CE1' ' C' ' 98' ' ' PHE . 13.5 t -66.47 -22.78 66.2 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' THR . . . . . 0.52 ' N ' ' O ' ' C' ' 130' ' ' ALA . 11.2 m -64.08 -31.56 72.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.324 -0.86 . . . . 0.0 108.86 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.75 -37.21 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.134 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.72 -35.21 75.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.277 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' C' ' 134' ' ' THR . 35.1 p -68.06 -33.6 74.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 11.7 t 46.72 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.371 -0.83 . . . . 0.0 109.492 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . 1.224 ' NZ ' ' NZ ' ' A' ' 139' ' ' LYS . 41.9 mtpt -65.53 -123.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -55.19 89.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.468 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' C' ' 139' ' ' LYS . 76.1 mtt-85 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.413 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.432 HG11 ' H ' ' D' ' 2' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.432 ' H ' HG11 ' D' ' 1' ' ' VAL . 19.1 m-70 45.04 52.75 8.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 109.84 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mt -87.84 161.07 17.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.31 138.22 19.48 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -40.02 -54.19 2.19 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.526 2.151 . . . . 0.0 112.601 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.04 -21.74 61.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -76.69 -63.1 1.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 109.824 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.475 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -66.66 -29.6 69.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 109.936 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -47.52 -23.63 0.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.959 . . . . 0.0 110.048 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.74 -56.89 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.074 -1.016 . . . . 0.0 109.936 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.19 -24.51 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 26.0 m -73.55 -40.36 64.03 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.379 0.609 . . . . 0.0 109.591 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.37 -31.24 71.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.8 OUTLIER -50.7 -31.47 16.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.154 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . 0.416 ' CE2' ' OG ' ' D' ' 72' ' ' SER . 1.5 t90 -47.44 -18.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.491 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.91 -51.08 6.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.424 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.1 OUTLIER -71.25 -29.6 65.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -1.218 . . . . 0.0 109.335 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -49.26 114.76 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' D' ' 22' ' ' GLU . 95.4 m-20 -78.45 67.6 4.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.321 -0.862 . . . . 0.0 109.074 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' D' ' 22' ' ' GLU . 69.0 t -44.34 -29.1 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.73 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.08 7.39 0.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.557 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' D' ' 20' ' ' VAL . 38.7 mt-10 -155.29 -49.36 0.08 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.0 t -48.69 -60.74 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.92 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.87 -39.15 17.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.1 -43.8 89.29 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' D' ' 30' ' ' ARG . 57.0 mt-10 -79.51 -40.34 29.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -1.169 . . . . 0.0 109.487 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 -34.26 8.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -82.58 -56.75 3.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.307 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.67 -44.78 79.72 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' D' ' 26' ' ' GLU . 0.0 OUTLIER -53.95 -36.44 62.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -1.123 . . . . 0.0 109.31 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -56.01 -47.57 77.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.37 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 mt -65.06 -22.74 67.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.595 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 74.7 t -81.63 -64.68 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.434 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -67.67 -22.79 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.501 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -139.41 80.86 21.58 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.77 -16.17 9.14 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.726 2.284 . . . . 0.0 112.437 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -51.04 -19.77 1.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 109.516 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.41 ' HB ' HBC1 ' D' ' 147' ' ' HEC . 3.7 p -85.56 55.56 3.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 109.231 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -109.81 41.27 1.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.258 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 57.5 mmt-85 -103.91 -49.34 3.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.82 . . . . 0.0 109.477 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -91.82 29.98 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.585 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' D' ' 44' ' ' SER . 9.4 p90 -92.63 -12.98 30.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -45.92 -14.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.338 -0.851 . . . . 0.0 109.971 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.543 ' N ' ' O ' ' D' ' 42' ' ' PHE . 23.4 p -124.26 23.47 8.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.87 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.4 -14.06 21.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.253 -0.904 . . . . 0.0 109.267 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.43 -116.86 2.25 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -144.3 105.34 4.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.355 -1.085 . . . . 0.0 109.535 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 mt -90.94 30.5 1.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.042 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.8 p -43.91 -32.47 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 109.925 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 17.9 p -146.52 148.4 33.81 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 109.389 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -40.37 -49.96 3.8 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.378 2.052 . . . . 0.0 112.232 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -61.29 -35.06 76.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.92 -19.69 4.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.23 -63.9 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -0.929 . . . . 0.0 109.542 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 12.2 mmt -63.07 -7.59 5.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.5 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.35 -10.25 64.12 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -78.43 141.92 61.89 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.228 -1.16 . . . . 0.0 109.325 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.26 -57.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.492 2.128 . . . . 0.0 112.242 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' D' ' 63' ' ' HIS . 45.7 mtpt -52.02 -48.4 64.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.619 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 73.9 t -45.86 -39.7 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 109.251 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -79.44 -52.34 8.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.315 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.29 -59.26 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.812 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 0.546 ' N ' ' O ' ' D' ' 59' ' ' LYS . 1.7 t60 -48.25 -24.87 1.31 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.646 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.32 -36.83 92.23 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -69.33 -25.18 64.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -1.12 . . . . 0.0 109.416 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -73.08 -35.32 66.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.575 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.462 HG13 ' C2B' ' D' ' 147' ' ' HEC . 39.8 t -75.72 -28.39 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.454 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.15 -34.92 68.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.33 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.53 -45.14 37.57 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.89 91.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -1.129 . . . . 0.0 109.656 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -57.21 -41.14 78.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.626 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' SER . . . . . 0.416 ' OG ' ' CE2' ' D' ' 15' ' ' TRP . 5.7 t -76.64 -37.8 55.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.655 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -47.32 -37.79 11.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.928 . . . . 0.0 109.517 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.17 -60.31 7.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.45 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -55.95 -29.95 60.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.348 -1.089 . . . . 0.0 109.365 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.05 5.32 30.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.597 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.524 ' NE2' ' OD1' ' D' ' 80' ' ' ASN . 7.5 t60 -170.9 67.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.556 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.94 17.93 1.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.935 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -79.59 -29.22 41.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.524 ' OD1' ' NE2' ' D' ' 77' ' ' HIS . 4.3 p-10 -163.28 95.83 0.85 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.284 -0.885 . . . . 0.0 109.198 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . 0.41 HD13 ' H ' ' D' ' 81' ' ' LEU . 5.0 mp -80.33 -58.85 2.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.58 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -57.61 -23.78 52.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.008 . . . . 0.0 109.46 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.98 -54.4 3.22 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.0 t -61.31 -47.55 85.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -1.166 . . . . 0.0 109.652 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' D' ' 84' ' ' THR . 54.7 m-85 -76.76 22.03 0.19 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.424 -0.797 . . . . 0.0 109.476 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.42 -26.87 44.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.898 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 76.0 p -78.81 -59.23 2.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.3 mt -48.48 -45.06 36.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.319 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 54.0 p -64.74 -52.8 55.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.229 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -61.21 -22.66 64.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.481 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 8.8 tp -87.0 -68.66 0.73 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.433 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' D' ' 97' ' ' HIS . 49.0 m80 -51.0 -26.57 6.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 110.08 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . 0.413 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 27.4 t -83.71 -55.87 4.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.187 -0.945 . . . . 0.0 111.361 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 27.4 t0 -86.27 -32.11 21.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.038 -1.039 . . . . 0.0 111.928 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -89.48 -51.83 5.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.696 -1.253 . . . . 0.0 111.055 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.55 -27.02 15.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.871 -1.143 . . . . 0.0 110.45 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 1.347 ' HD1' ' CG2' ' A' ' 38' ' ' THR . 82.8 m-70 51.68 29.55 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.052 -1.03 . . . . 0.0 109.581 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . 0.422 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 39.8 t -47.18 130.27 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.111 -0.993 . . . . 0.0 109.488 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.31 152.45 31.9 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.344 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.96 -164.09 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.494 2.13 . . . . 0.0 112.206 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.19 60.83 2.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.568 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.515 ' C ' HD21 ' D' ' 102' ' ' ASN . 0.1 OUTLIER -171.27 -41.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.957 . . . . 0.0 109.457 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -46.21 -40.47 11.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.731 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -80.04 -19.99 46.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 0.0 109.577 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' D' ' 102' ' ' ASN . 12.2 tp -70.54 -59.76 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.613 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.821 HD13 ' CHC' ' D' ' 147' ' ' HEC . 7.0 tt -49.77 -46.33 50.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.33 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.08 -20.39 57.99 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . 0.449 ' O ' ' SG ' ' D' ' 112' ' ' CYS . 18.3 t30 -80.57 -25.1 38.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -1.165 . . . . 0.0 109.672 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 73.9 t -86.28 -43.09 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.659 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tt -48.08 -33.22 7.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.54 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -82.9 -26.16 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' D' ' 108' ' ' ASN . 72.0 m -69.05 -24.84 64.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.177 -0.952 . . . . 0.0 109.496 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.34 -34.8 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' D' ' 118' ' ' PHE . 9.4 mt -69.82 -40.14 76.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.472 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -54.47 -29.0 48.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.318 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.532 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -84.64 -62.42 1.55 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 109.113 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -63.4 -17.67 62.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 109.639 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' D' ' 114' ' ' LEU . 93.1 m-85 -149.65 60.29 1.01 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.462 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.534 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -69.28 -24.62 75.95 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -64.76 -29.67 70.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -1.154 . . . . 0.0 109.351 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' D' ' 123' ' ' THR . 78.3 mm-40 -87.83 5.76 38.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.862 . . . . 0.0 109.764 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.67 33.12 0.08 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.416 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.525 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.4 p -52.45 149.16 10.94 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.833 . . . . 0.0 109.367 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.498 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.1 Cg_exo -45.52 -53.6 5.35 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.452 2.101 . . . . 0.0 112.907 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 24.3 Cg_endo -62.22 -29.65 80.68 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.063 1.842 . . . . 0.0 112.211 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.72 -28.16 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.185 -0.947 . . . . 0.0 109.537 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -83.18 -53.92 5.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 109.508 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 0.775 ' HB3' HD13 ' C' ' 34' ' ' LEU . . . -63.19 -26.5 68.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.622 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.54 -2.3 53.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 109.823 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' D' ' 132' ' ' LYS . 41.8 t80 -92.42 -61.7 1.55 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.968 . . . . 0.0 109.646 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -45.23 -23.32 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 109.94 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' D' ' 130' ' ' TYR . 51.0 mtmt -85.46 -34.54 21.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.147 -0.971 . . . . 0.0 110.344 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 0.6 OUTLIER -68.59 -44.22 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.995 -1.066 . . . . 0.0 109.649 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.486 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 6.1 m -79.6 -20.98 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' B' ' 146' ' ' HIS . . . -50.41 -32.46 17.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.096 -1.002 . . . . 0.0 109.336 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.59 -26.66 56.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.32 -32.96 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -1.133 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.43 90.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.9 . . . . 0.0 109.626 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.98 -21.06 47.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.664 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.01 -58.92 6.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.42 -31.89 71.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.07 25.2 4.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.289 -0.882 . . . . 0.0 109.549 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -80.0 -16.11 55.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.131 -0.981 . . . . 0.0 109.733 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.518 ' C ' ' H ' ' D' ' 146' ' ' HIS . 13.2 mptt -98.42 -26.64 14.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 109.571 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' D' ' 98' ' ' VAL . 12.1 m-85 -54.43 -6.85 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.336 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.54 ' HB2' ' HB3' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.44 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.991 ' CBD' HD11 ' A' ' 86' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 0.815 ' CHC' HD13 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 1.007 ' CBD' HD11 ' C' ' 86' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 0.821 ' CHC' HD13 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.0 tp -170.95 164.65 7.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 0.0 109.864 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.569 ' HG ' ' N ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -84.83 165.75 35.68 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.348 -0.845 . . . . 0.0 109.51 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.569 ' N ' ' HG ' ' A' ' 3' ' ' SER . 57.1 Cg_endo -73.64 -77.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.773 2.315 . . . . 0.0 112.655 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -45.22 -30.01 1.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 109.964 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 5' ' ' ALA . 26.2 t0 -43.77 -23.04 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.246 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -83.34 -60.61 2.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.372 -0.83 . . . . 0.0 109.324 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.5 m -44.45 -35.97 2.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.535 -0.728 . . . . 0.0 109.9 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.422 ' C ' ' OG ' ' A' ' 124' ' ' SER . 2.5 m-20 -74.49 -30.02 61.65 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 7' ' ' LYS . 76.6 t -76.31 -53.52 15.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -52.62 -38.28 59.9 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.081 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.04 -63.76 1.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.47 -0.769 . . . . 0.0 109.144 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.7 76.27 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -17.23 62.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 109.03 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -79.02 -46.25 8.43 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -69.17 -38.27 78.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 108.982 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.9 t -61.07 -64.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.579 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 54.43 -132.59 46.55 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.87 26.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -1.073 . . . . 0.0 110.522 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.579 ' H ' ' C ' ' A' ' 18' ' ' GLY . 92.7 m-70 -129.94 22.29 5.36 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -86.7 -60.0 2.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.65 -0.656 . . . . 0.0 109.598 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.4 -14.28 0.18 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 21' ' ' ALA . 7.3 mm-40 -86.85 -56.52 3.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.425 -1.044 . . . . 0.0 109.781 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.8 m-30 -60.67 -37.55 81.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.15 -22.88 71.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.09 -51.43 8.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.144 -1.209 . . . . 0.0 109.839 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.59 -19.8 28.29 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.325 -0.859 . . . . 0.0 109.372 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.2 -23.74 62.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.269 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.5 mt -70.33 -56.15 7.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.303 -0.873 . . . . 0.0 109.459 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.03 -12.62 8.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.404 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -76.29 -61.1 2.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.486 ' HE3' ' CBC' ' A' ' 142' ' ' HEC . 0.0 OUTLIER -66.53 -19.45 65.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.49 -53.15 61.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 0.0 109.715 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.959 HD13 ' HB3' ' B' ' 128' ' ' ALA . 2.2 pp -88.01 -41.87 12.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.941 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.7 t -58.9 -2.27 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.663 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' A' ' 35' ' ' SER . 64.9 m-85 -160.24 81.85 2.27 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 109.418 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -49.17 -27.03 11.85 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.725 2.284 . . . . 0.0 112.316 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.5 p -49.04 -21.42 0.69 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -0.991 . . . . 0.0 109.388 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.9 p -90.36 -27.07 19.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -55.09 -47.51 74.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.636 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.914 HG23 ' CD2' ' D' ' 97' ' ' HIS . 13.1 t -49.22 -24.57 1.81 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 43' ' ' PHE . 16.0 t80 -73.95 4.06 5.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.432 ' O ' ' O ' ' A' ' 42' ' ' TYR . 7.0 m-85 61.56 144.53 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.805 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 60.0 Cg_endo -73.65 -42.69 0.78 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.385 2.057 . . . . 0.0 111.928 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.548 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 25.2 p80 40.74 31.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.67 -0.643 . . . . 0.0 110.62 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.465 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -164.73 29.63 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.029 -1.045 . . . . 0.0 110.371 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 46' ' ' PHE . 5.9 m-20 41.04 88.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.533 -0.729 . . . . 0.0 110.113 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.597 ' H ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -61.43 -19.53 62.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.505 -0.747 . . . . 0.0 109.15 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -47.3 121.49 3.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.64 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -65.25 107.86 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.91 -6.58 4.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 54' ' ' GLN . 2.0 t -75.02 -0.23 18.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.39 -1.065 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 71.1 -14.94 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 109.589 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 52' ' ' SER . 54.6 mt-30 -86.09 -28.9 23.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.506 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -82.96 -39.1 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -81.98 -25.56 34.66 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.73 -25.56 64.72 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.526 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 5.8 t-80 -72.75 -42.38 64.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -1.183 . . . . 0.0 109.613 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.96 -46.44 32.46 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.705 ' HZ2' ' HZ3' ' A' ' 61' ' ' LYS . 6.4 mtmm -53.08 -22.66 6.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -1.081 . . . . 0.0 109.912 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.705 ' HZ3' ' HZ2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -73.99 -48.66 28.76 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.037 -1.039 . . . . 0.0 108.599 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -67.85 -45.99 83.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.05 -35.28 80.12 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.488 -0.757 . . . . 0.0 109.398 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 11.7 t70 -65.17 -48.4 73.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.122 -0.986 . . . . 0.0 108.676 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.513 ' HB2' HMA2 ' A' ' 142' ' ' HEC . . . -59.47 -50.68 73.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.47 -49.77 66.75 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -61.8 -54.52 41.12 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.901 . . . . 0.0 108.883 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -60.44 -20.89 61.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 108.777 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.2 -48.08 9.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.38 -22.84 27.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.97 -33.61 68.31 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.601 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.7 m170 -97.2 -66.58 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.441 -0.787 . . . . 0.0 109.557 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 72' ' ' HIS . 13.1 p 44.89 14.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.883 0.849 . . . . 0.0 109.156 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 72' ' ' HIS . 91.6 m-20 -140.49 13.31 2.35 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -175.27 31.85 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.544 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -64.01 -46.46 80.67 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 110.062 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 76' ' ' MET . 81.5 Cg_exo -44.15 -40.78 12.65 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.471 2.114 . . . . 0.0 112.563 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -94.32 -17.21 22.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 109.975 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.8 -58.11 3.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.162 -0.961 . . . . 0.0 109.302 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' C ' ' N ' ' A' ' 82' ' ' ALA . 11.0 mt -77.69 11.21 2.21 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.367 -0.833 . . . . 0.0 109.045 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.67 -16.21 0.61 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.563 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -80.91 -57.8 3.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.7 mt -44.88 -43.94 9.23 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.91 -27.33 18.21 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.501 -0.749 . . . . 0.0 109.056 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 82' ' ' ALA . 34.4 t70 -76.26 -21.44 56.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.935 . . . . 0.0 109.291 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.502 HD22 ' CBD' ' A' ' 142' ' ' HEC . 3.3 tp -82.99 -34.64 26.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -92.42 -21.72 20.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.519 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.33 -98.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.918 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -86.36 -76.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.0 ttmm -45.31 124.51 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 109.765 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.2 mt 54.04 57.73 5.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.307 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.974 ' NE ' ' HG2' ' D' ' 40' ' ' ARG . 85.2 mtm-85 -49.81 -38.91 36.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.614 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.4 t 47.22 -101.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.441 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 0.3 OUTLIER 171.33 137.36 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 109.176 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.24 -16.78 19.5 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.371 2.047 . . . . 0.0 112.014 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.66 -9.47 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.701 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 98' ' ' PHE . 29.6 p30 -78.91 -24.79 43.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.117 -0.989 . . . . 0.0 109.34 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.532 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.7 OUTLIER -50.1 -47.19 54.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.313 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.24 -22.66 66.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.908 . . . . 0.0 109.609 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 42.7 mt -84.01 -62.03 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.651 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.649 HD21 ' HHC' ' A' ' 142' ' ' HEC . 4.7 tp -52.46 -25.82 11.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.081 -1.012 . . . . 0.0 109.708 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 t -69.97 -59.18 3.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.87 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.766 ' ND1' ' OD1' ' B' ' 108' ' ' ASN . 43.2 m170 -63.26 -26.67 68.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.621 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 67.4 m -67.9 -48.25 66.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 109.567 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.88 -41.21 32.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.406 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 106' ' ' LEU . 9.4 mp -68.17 -50.78 52.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 109.522 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.583 ' CG1' HE22 ' B' ' 127' ' ' GLN . 70.4 t -53.99 -51.42 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 110' ' ' ALA . 40.2 m -59.82 -58.47 8.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 113' ' ' LEU . 4.6 mt -45.98 -19.95 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.875 . . . . 0.0 109.643 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -72.29 -35.47 68.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 110.135 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 1.279 ' HB3' ' CE2' ' B' ' 122' ' ' PHE . . . -75.04 -3.78 34.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.031 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.6 -82.3 0.31 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -106.82 94.4 10.42 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.8 175.87 9.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.093 1.862 . . . . 0.0 112.935 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -47.78 -44.84 28.82 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.438 0.637 . . . . 0.0 109.814 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 6.9 mt-10 87.1 5.65 0.31 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 t80 68.38 36.42 3.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.871 -0.518 . . . . 0.0 111.51 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.713 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -96.96 121.65 58.68 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.807 -1.183 . . . . 0.0 108.224 178.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.95 20.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.15 1.9 . . . . 0.0 112.765 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -145.43 -37.66 0.27 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.934 -1.104 . . . . 0.0 110.264 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.648 ' H ' ' HG1' ' A' ' 118' ' ' THR . 7.8 p -46.91 -44.76 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.069 -1.019 . . . . 0.0 110.126 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.507 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 4.8 m-70 -56.7 -50.0 73.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.81 -19.58 34.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.786 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 120' ' ' ALA . 15.5 t -54.82 -58.18 8.59 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.205 -0.934 . . . . 0.0 110.597 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.43 -19.73 30.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.199 -0.938 . . . . 0.0 110.156 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -83.25 -40.36 19.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.887 -1.133 . . . . 0.0 110.18 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.475 ' CD ' ' C ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -87.09 -47.21 9.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.005 -1.06 . . . . 0.0 109.63 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -48.63 -21.59 0.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.96 -1.088 . . . . 0.0 109.212 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.622 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.6 mt -69.73 -17.87 63.48 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.457 ' O ' ' OG1' ' A' ' 134' ' ' THR . . . -61.05 -29.97 70.04 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.3 p -82.78 -35.93 26.08 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.419 -0.801 . . . . 0.0 108.973 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.19 -27.34 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.234 -0.916 . . . . 0.0 108.897 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 129' ' ' LEU . 57.4 p -84.17 -24.91 29.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.427 -0.795 . . . . 0.0 109.052 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 18.7 m -78.16 -34.92 49.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.158 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.4 t -78.34 -26.4 14.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.156 -0.965 . . . . 0.0 108.577 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -33.67 76.41 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.3 m -85.26 -15.19 44.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.2 t 60.19 160.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.574 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -80.34 -33.35 37.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -72.7 93.11 1.61 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.495 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.534 -179.943 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.536 ' H2 ' ' C ' ' B' ' 132' ' ' LYS . 7.1 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 51.71 58.9 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.139 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.608 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -121.42 -175.15 3.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.557 -0.714 . . . . 0.0 109.196 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -79.57 152.76 75.71 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 109.016 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.83 -28.55 75.87 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.526 2.151 . . . . 0.0 112.01 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -86.7 -21.92 26.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.485 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.57 -63.11 1.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.723 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -57.21 -40.4 77.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.791 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.7 t -45.54 -23.71 0.26 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 110.038 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.44 -57.07 3.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.148 -0.97 . . . . 0.0 109.792 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.22 -24.55 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 8.4 m -71.18 -44.45 65.44 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.676 -0.64 . . . . 0.0 109.446 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.41 74.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.358 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.425 ' O ' ' CG2' ' B' ' 18' ' ' VAL . 0.7 OUTLIER -49.27 -21.06 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.193 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -17.3 60.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.5 -57.48 7.34 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.654 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.547 ' HE2' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -86.59 12.5 10.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.979 -1.307 . . . . 0.0 110.929 -178.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' B' ' 14' ' ' LEU . 2.2 t -79.49 114.93 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.839 -1.163 . . . . 0.0 109.007 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.48 82.73 3.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.518 ' C ' ' H ' ' B' ' 22' ' ' GLU . 72.1 t -54.94 -18.21 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 5.0 m-20 -66.21 6.3 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.712 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.518 ' H ' ' C ' ' B' ' 20' ' ' VAL . 35.1 mt-10 -156.01 -52.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 95.3 t -47.57 -35.66 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.705 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.52 -57.55 4.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.5 -50.78 55.65 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.19 -45.98 90.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -1.138 . . . . 0.0 109.602 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.1 -35.22 34.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.688 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -84.96 -58.03 2.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 109.654 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.22 -37.45 72.91 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -69.74 -38.48 76.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -1.212 . . . . 0.0 109.734 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 40.6 tp -52.99 -24.22 8.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.074 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' B' ' 36' ' ' PRO . 15.7 mt -75.54 -54.39 7.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.037 -1.04 . . . . 0.0 110.893 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.41 HG23 ' H ' ' B' ' 34' ' ' VAL . 2.2 m -52.72 -49.02 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.712 -1.242 . . . . 0.0 109.764 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.41 ' H ' HG23 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -70.76 -22.72 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 109.126 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -149.43 74.94 9.63 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . 0.48 ' N ' ' O ' ' B' ' 32' ' ' LEU . 72.3 Cg_endo -81.54 -22.87 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.788 2.326 . . . . 0.0 112.219 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -48.98 -19.92 0.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.908 . . . . 0.0 109.47 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.488 ' C ' ' H ' ' B' ' 40' ' ' ARG . 33.5 p -80.35 9.9 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -71.8 12.26 0.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.318 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.93 ' HG2' ' NE ' ' C' ' 92' ' ' ARG . 97.4 mtt180 -80.29 -19.77 45.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.52 26.27 4.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.306 -0.871 . . . . 0.0 109.129 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.507 ' CE1' ' CD2' ' B' ' 45' ' ' PHE . 33.4 t80 -148.77 11.73 0.86 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.89 -22.13 40.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.889 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 27.4 p -84.61 7.13 21.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' B' ' 42' ' ' PHE . 3.7 m-85 -81.44 -16.44 52.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.94 -175.37 45.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -83.14 103.84 12.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -1.088 . . . . 0.0 109.578 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' B' ' 48' ' ' LEU . 10.2 mp -88.17 29.73 0.93 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.199 -0.938 . . . . 0.0 109.147 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.1 m -44.88 -35.88 3.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.838 . . . . 0.0 109.789 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 5.5 p -146.43 148.83 35.54 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.61 -36.35 4.71 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.565 2.177 . . . . 0.0 112.501 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.68 -33.58 72.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.743 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.88 63.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.609 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.97 -59.69 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.963 . . . . 0.0 109.525 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' MET . . . . . 0.495 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -87.45 10.54 17.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.37 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.91 -31.22 32.89 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -81.94 147.96 59.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 109.434 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.63 -57.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.544 2.163 . . . . 0.0 112.427 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.03 -33.36 4.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.777 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 70.8 t -61.03 -57.92 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.459 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -64.96 -33.6 76.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.56 -53.65 44.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.589 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -53.3 -24.01 10.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.187 -0.946 . . . . 0.0 109.538 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.08 -23.88 73.08 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.88 -44.08 81.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -1.158 . . . . 0.0 109.164 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -55.35 -47.29 75.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.416 -0.802 . . . . 0.0 109.351 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.537 HG23 ' C4A' ' B' ' 147' ' ' HEC . 25.4 t -58.14 -47.01 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.42 -35.02 74.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 109.276 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.83 -53.18 46.05 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.11 63.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -1.201 . . . . 0.0 109.616 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -55.85 -31.16 62.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.398 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 33.2 t -76.56 -31.45 57.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.421 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -50.28 -40.02 47.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.368 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.89 -59.95 8.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.455 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -58.16 -26.92 63.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -1.166 . . . . 0.0 109.387 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.05 2.51 46.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.481 ' C ' ' H ' ' B' ' 79' ' ' ASP . 66.0 t60 -170.89 65.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.731 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 80.0 mt -75.85 19.58 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.955 . . . . 0.0 109.432 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' B' ' 77' ' ' HIS . 8.9 m-20 -79.6 -29.49 41.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' B' ' 80' ' ' ASN . 5.4 p30 -173.32 107.09 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' B' ' 81' ' ' LEU . 8.3 mp -80.28 -58.77 2.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.476 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' B' ' 82' ' ' LYS . 0.0 OUTLIER -46.5 -24.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.5 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.71 -50.24 9.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.7 t -82.35 -47.37 12.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -1.133 . . . . 0.0 109.366 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.552 ' N ' ' CG2' ' B' ' 84' ' ' THR . 27.6 m-85 -65.03 1.36 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.732 . . . . 0.0 109.482 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.9 -34.93 66.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.514 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -74.34 -57.55 3.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mp -49.3 -45.0 44.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -63.95 -52.15 61.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.67 -22.83 64.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 6.5 tt -85.51 -62.81 1.44 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' B' ' 97' ' ' HIS . 75.2 m80 -61.34 -20.14 62.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 110.13 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 51.7 t -83.51 -60.63 2.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.022 -1.049 . . . . 0.0 110.571 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.43 -28.32 22.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.047 -1.033 . . . . 0.0 110.994 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -83.99 -51.91 6.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.064 . . . . 0.0 110.686 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 11.7 mt -107.0 -21.29 13.05 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.08 -1.012 . . . . 0.0 109.966 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.876 ' CD2' HG23 ' C' ' 41' ' ' THR . 33.0 p80 43.02 37.46 1.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.346 -0.846 . . . . 0.0 109.971 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.0 130.89 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.195 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -46.94 147.35 2.31 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.39 -16.93 44.1 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.508 2.139 . . . . 0.0 112.086 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' B' ' 101' ' ' GLU . 58.7 mp0 -81.25 55.22 2.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.317 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.441 ' ND2' ' C ' ' B' ' 101' ' ' GLU . 9.8 m-80 -156.1 -37.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -64.16 -38.67 91.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.116 -0.99 . . . . 0.0 109.529 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -69.72 -28.18 65.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.677 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 16.1 mt -71.61 -52.76 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.656 HD12 ' CHC' ' B' ' 147' ' ' HEC . 6.7 tt -52.17 -47.81 65.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.353 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.73 -20.4 70.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . 0.766 ' OD1' ' ND1' ' A' ' 103' ' ' HIS . 0.4 OUTLIER -83.27 -19.11 36.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -1.177 . . . . 0.0 109.743 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 72.8 t -80.34 -44.56 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.093 -1.004 . . . . 0.0 109.561 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 10.7 mt -47.38 -31.92 4.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.99 -33.47 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.429 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 11.9 m -79.15 -54.51 5.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.48 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 14.0 t -49.52 -46.01 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.426 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.05 -22.83 64.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.855 . . . . 0.0 109.345 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.455 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -80.73 -24.29 38.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.478 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.47 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.77 -61.59 1.75 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 109.346 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.413 ' C ' ' CG ' ' B' ' 118' ' ' PHE . 55.3 m80 -60.25 -17.7 43.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.651 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.413 ' CG ' ' C ' ' B' ' 117' ' ' HIS . 19.2 m-85 -150.29 58.56 0.96 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.585 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -68.64 -28.6 73.05 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -68.99 6.37 0.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.412 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.511 ' C ' ' H ' ' B' ' 123' ' ' THR . 17.8 mm-40 -126.0 -1.2 7.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.448 -0.782 . . . . 0.0 109.438 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 1.279 ' CE2' ' HB3' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -72.75 35.37 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.552 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.511 ' H ' ' C ' ' B' ' 121' ' ' GLU . 13.2 p -50.85 146.64 9.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.3 Cg_exo -48.29 -51.39 10.21 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.382 2.055 . . . . 0.0 113.04 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 39.9 Cg_endo -67.57 -27.67 38.8 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.063 1.842 . . . . 0.0 112.496 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.412 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 55.5 t -77.39 -24.14 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.494 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . 0.583 HE22 ' CG1' ' A' ' 107' ' ' VAL . 9.1 tt0 -83.28 -54.55 4.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.959 ' HB3' HD13 ' A' ' 34' ' ' LEU . . . -49.19 -44.07 42.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.488 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.37 13.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.884 . . . . 0.0 109.597 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' B' ' 128' ' ' ALA . 32.0 t80 -97.95 -59.89 1.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . 0.408 ' OE1' ' CZ ' ' A' ' 36' ' ' PHE . 38.2 tt0 -47.45 -30.53 3.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.536 ' C ' ' H2 ' ' B' ' 1' ' ' VAL . 8.7 mtpm? -66.15 -46.62 76.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 109.753 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.73 -55.55 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.109 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.95 -36.76 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -0.942 . . . . 0.0 110.02 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -50.16 -24.57 2.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.486 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.99 -31.41 55.6 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.2 t -82.78 -29.89 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.18 -1.188 . . . . 0.0 109.523 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.77 77.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.471 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 1.169 ' OD1' ' CE1' ' D' ' 146' ' ' HIS . 4.2 m120 -71.33 -27.75 63.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.514 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.36 -60.38 2.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.92 -16.14 2.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.26 -3.07 13.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.368 -0.832 . . . . 0.0 109.516 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 139' ' ' ASN . 21.9 t-80 -64.27 -33.28 75.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.505 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -82.45 -29.74 30.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.561 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -51.37 -20.98 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 1.222 ' CE1' ' OD1' ' D' ' 139' ' ' ASN . 43.0 m80 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.477 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 14.0 tp -170.86 164.68 7.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.113 -0.992 . . . . 0.0 109.869 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.577 ' HG ' ' N ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER -84.76 165.88 35.11 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.496 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.577 ' N ' ' HG ' ' C' ' 3' ' ' SER . 56.9 Cg_endo -73.72 -77.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.79 2.327 . . . . 0.0 112.591 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -45.17 -30.1 1.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 109.953 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' C' ' 5' ' ' ALA . 26.3 t0 -43.62 -23.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.323 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' C' ' 10' ' ' VAL . 0.0 OUTLIER -83.39 -60.51 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.385 -0.822 . . . . 0.0 109.33 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.402 ' C ' ' O ' ' C' ' 7' ' ' LYS . 45.6 m -44.43 -36.0 2.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 109.805 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . 0.424 ' C ' ' OG ' ' C' ' 124' ' ' SER . 2.5 m-20 -74.46 -30.12 61.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' C' ' 7' ' ' LYS . 76.8 t -76.27 -53.49 15.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' C' ' 7' ' ' LYS . 0.0 OUTLIER -52.78 -38.17 60.69 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.03 -63.72 1.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.203 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.77 76.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.396 -0.815 . . . . 0.0 108.818 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -17.22 62.53 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.049 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' C' ' 11' ' ' LYS . . . -79.07 -46.24 8.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -69.21 -38.25 78.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 0.0 108.922 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.11 -65.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 54.42 -132.49 46.48 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.9 26.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.481 -1.011 . . . . 0.0 110.49 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.598 ' H ' ' C ' ' C' ' 18' ' ' GLY . 92.7 m-70 -129.89 22.25 5.38 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -86.72 -60.09 2.08 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.681 -0.637 . . . . 0.0 109.512 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.33 -14.27 0.17 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' C' ' 21' ' ' ALA . 7.3 mm-40 -86.84 -56.57 3.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -1.087 . . . . 0.0 109.795 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.8 m-30 -60.73 -37.51 81.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -22.89 71.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.2 -51.33 8.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -1.199 . . . . 0.0 109.841 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.58 -19.89 28.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.17 -23.76 62.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.286 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 26.8 mt -70.28 -56.12 7.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 109.444 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.06 -12.63 8.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -76.3 -61.18 2.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.894 . . . . 0.0 109.726 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.487 ' HE3' ' CBC' ' C' ' 142' ' ' HEC . 0.0 OUTLIER -66.42 -19.44 65.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.607 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.49 -53.27 60.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.639 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.925 HD13 ' HB3' ' D' ' 128' ' ' ALA . 2.2 pp -87.87 -41.99 12.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 0.0 109.919 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.8 t -58.89 -2.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.096 -1.002 . . . . 0.0 109.637 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' C' ' 35' ' ' SER . 64.9 m-85 -160.07 81.78 2.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.468 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -49.17 -26.93 11.71 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.696 2.264 . . . . 0.0 112.302 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 5.2 p -49.1 -21.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.363 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.3 p -90.28 -27.17 19.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.55 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -55.11 -47.43 74.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.608 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.876 HG23 ' CD2' ' B' ' 97' ' ' HIS . 13.0 t -49.36 -24.5 1.94 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 0.0 109.398 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' C' ' 43' ' ' PHE . 15.8 t80 -73.84 3.94 5.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.215 -0.928 . . . . 0.0 109.343 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' C' ' 42' ' ' TYR . 7.0 m-85 61.59 144.52 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.472 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.536 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 60.2 Cg_endo -73.64 -42.68 0.79 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.468 2.112 . . . . 0.0 111.97 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 25.0 p80 40.75 31.98 0.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.685 -0.634 . . . . 0.0 110.625 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.47 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -164.74 29.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.981 -1.074 . . . . 0.0 110.301 179.206 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' C' ' 46' ' ' PHE . 5.9 m-20 41.0 88.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.554 -0.716 . . . . 0.0 110.119 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.589 ' H ' ' CD1' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -61.44 -19.58 62.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.448 -0.782 . . . . 0.0 109.239 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -47.25 121.51 3.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.632 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.15 107.87 1.69 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 109.369 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.87 -6.54 4.44 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.517 ' C ' ' H ' ' C' ' 54' ' ' GLN . 2.0 t -75.07 -0.12 17.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -1.042 . . . . 0.0 109.427 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 71.02 -14.87 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.845 . . . . 0.0 109.63 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' C' ' 52' ' ' SER . 54.8 mt-30 -86.07 -29.04 23.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -82.85 -39.11 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.955 . . . . 0.0 109.328 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -82.0 -25.62 34.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 108.542 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.73 -25.56 64.7 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.532 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 5.7 t-80 -72.79 -42.38 63.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -1.179 . . . . 0.0 109.631 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.93 -46.5 32.28 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.703 ' HZ2' ' HZ3' ' C' ' 61' ' ' LYS . 6.4 mtmm -53.04 -22.61 6.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.997 . . . . 0.0 109.911 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.703 ' HZ3' ' HZ2' ' C' ' 60' ' ' LYS . 0.3 OUTLIER -74.01 -48.76 28.02 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.115 -0.991 . . . . 0.0 108.502 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -67.75 -46.05 83.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.92 -35.42 80.56 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.454 -0.778 . . . . 0.0 109.355 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 11.6 t70 -65.19 -48.36 73.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.946 . . . . 0.0 108.654 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . 0.527 ' HB2' HMA2 ' C' ' 142' ' ' HEC . . . -59.53 -50.64 73.14 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.44 -49.85 66.5 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -61.67 -54.62 40.29 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.205 -0.934 . . . . 0.0 108.897 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -60.31 -21.03 61.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 108.756 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.2 -48.1 9.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -68.32 -22.83 27.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.62 68.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.596 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.7 m170 -97.26 -66.47 0.9 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.428 -0.795 . . . . 0.0 109.556 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' C' ' 72' ' ' HIS . 13.1 p 44.78 14.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.978 0.894 . . . . 0.0 109.214 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' C' ' 72' ' ' HIS . 91.2 m-20 -140.57 13.37 2.33 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -175.23 31.81 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.537 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -63.9 -46.47 81.34 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 110.099 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' C' ' 76' ' ' MET . 81.6 Cg_exo -44.21 -40.72 12.81 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.468 2.112 . . . . 0.0 112.607 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -94.25 -17.31 22.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.985 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.8 -57.95 3.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 109.309 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . 0.403 ' C ' ' N ' ' C' ' 82' ' ' ALA . 11.0 mt -77.79 11.22 2.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.06 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.68 -16.24 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.513 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -80.89 -57.69 3.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.669 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' C' ' 82' ' ' ALA . 3.8 mt -44.95 -43.96 9.43 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.85 -27.33 17.86 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' C' ' 82' ' ' ALA . 34.4 t70 -76.32 -21.55 56.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.283 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.498 HD22 ' CBD' ' C' ' 142' ' ' HEC . 3.3 tp -82.9 -34.56 26.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.281 -0.887 . . . . 0.0 109.47 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -92.47 -21.75 19.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 109.495 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.28 -98.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.901 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -86.26 -76.41 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.853 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' C' ' 86' ' ' LEU . 6.9 ttmm -45.27 124.54 4.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.799 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 16.1 mt 53.97 57.7 5.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.846 . . . . 0.0 109.345 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . 0.93 ' NE ' ' HG2' ' B' ' 40' ' ' ARG . 85.3 mtm-85 -49.87 -38.77 36.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.822 . . . . 0.0 109.649 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 58.3 t 47.14 -101.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 109.335 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.439 ' O ' ' ND2' ' C' ' 97' ' ' ASN . 0.3 OUTLIER 171.42 137.39 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.134 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.28 -16.75 19.44 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.366 2.044 . . . . 0.0 112.036 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.66 -9.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.86 . . . . 0.0 109.671 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' C' ' 98' ' ' PHE . 29.7 p30 -78.94 -24.78 43.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 109.29 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . 0.523 ' N ' ' OD1' ' C' ' 97' ' ' ASN . 0.7 OUTLIER -50.18 -47.14 54.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.292 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.21 -22.7 66.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.594 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.492 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 43.5 mt -84.04 -62.04 1.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.585 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.642 HD21 ' HHC' ' C' ' 142' ' ' HEC . 4.7 tp -52.37 -25.81 10.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 109.725 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -70.02 -59.16 3.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.18 -0.95 . . . . 0.0 109.805 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.77 ' ND1' ' OD1' ' D' ' 108' ' ' ASN . 43.4 m170 -63.37 -26.58 68.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.644 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 67.9 m -67.99 -48.17 66.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.89 -41.24 32.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.962 . . . . 0.0 109.362 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' C' ' 106' ' ' LEU . 9.4 mp -68.1 -50.74 52.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 109.568 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . 0.584 ' CG1' HE22 ' D' ' 127' ' ' GLN . 70.0 t -54.06 -51.3 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.356 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.452 ' O ' ' N ' ' C' ' 110' ' ' ALA . 39.9 m -59.91 -58.46 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' C' ' 113' ' ' LEU . 4.5 mt -45.99 -19.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.374 -0.829 . . . . 0.0 109.592 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' C' ' 108' ' ' THR . . . -72.36 -35.38 68.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.147 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . 1.298 ' HB3' ' CE2' ' D' ' 122' ' ' PHE . . . -75.15 -3.67 34.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 110.012 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.72 -82.23 0.3 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 109.386 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' C' ' 109' ' ' LEU . 0.3 OUTLIER -106.91 94.47 10.67 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 175.9 9.67 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.169 1.913 . . . . 0.0 112.903 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -47.82 -44.84 29.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.641 -0.662 . . . . 0.0 109.85 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 6.9 mt-10 87.06 5.81 0.31 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 t80 68.27 36.46 3.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.826 -0.546 . . . . 0.0 111.523 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.718 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -96.93 121.63 58.79 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.796 -1.19 . . . . 0.0 108.226 178.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -51.02 20.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.104 1.869 . . . . 0.0 112.826 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.718 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -145.37 -37.72 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.897 -1.127 . . . . 0.0 110.258 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.657 ' H ' ' HG1' ' C' ' 118' ' ' THR . 7.8 p -46.88 -44.77 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.156 -0.965 . . . . 0.0 110.172 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.508 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 4.7 m-70 -56.68 -49.9 73.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.412 -0.805 . . . . 0.0 109.78 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.87 -19.57 34.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.771 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.536 ' N ' ' O ' ' C' ' 120' ' ' ALA . 15.3 t -54.78 -58.33 7.97 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 110.606 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 mt -85.22 -19.71 31.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.147 -0.971 . . . . 0.0 110.227 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -83.33 -40.29 19.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.898 -1.126 . . . . 0.0 110.202 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.472 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -87.17 -47.17 9.09 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.863 -1.148 . . . . 0.0 109.649 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -48.71 -21.55 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.018 -1.052 . . . . 0.0 109.22 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.613 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.7 mt -69.69 -17.9 63.51 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' C' ' 134' ' ' THR . . . -61.09 -29.96 70.07 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 53.2 p -82.73 -35.86 26.28 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.475 -0.766 . . . . 0.0 109.033 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.34 -27.32 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -0.946 . . . . 0.0 108.793 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.613 ' N ' ' O ' ' C' ' 129' ' ' LEU . 56.8 p -84.08 -24.9 30.18 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.455 -0.778 . . . . 0.0 109.162 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 18.8 m -78.04 -35.1 50.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 109.146 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 96.6 t -78.16 -26.41 14.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.226 -0.921 . . . . 0.0 108.641 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.83 -33.59 76.21 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 76.0 m -85.29 -15.17 44.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.446 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 4.2 t 60.23 160.85 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.577 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -80.35 -33.45 37.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -72.6 93.22 1.58 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.44 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.456 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.534 ' H2 ' ' C ' ' D' ' 132' ' ' LYS . 7.2 p . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 51.77 58.77 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.169 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -121.35 -175.04 2.98 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.443 -0.786 . . . . 0.0 109.2 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -79.77 152.79 75.2 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.344 -0.847 . . . . 0.0 109.045 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.83 -28.42 75.78 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.528 2.152 . . . . 0.0 112.024 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -86.85 -21.87 26.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.61 -63.02 1.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.733 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.51 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -57.27 -40.42 77.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 109.742 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.7 t -45.58 -23.61 0.25 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 110.08 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -81.44 -57.19 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.074 -1.016 . . . . 0.0 109.795 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.13 -24.49 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 8.4 m -71.17 -44.59 65.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.7 -0.625 . . . . 0.0 109.391 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.46 74.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.424 ' O ' ' CG2' ' D' ' 18' ' ' VAL . 0.7 OUTLIER -49.31 -21.06 0.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.839 . . . . 0.0 109.148 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -17.3 60.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 109.632 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.41 -57.51 7.38 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.665 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.548 ' H ' ' HE2' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -86.68 12.62 10.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.007 -1.29 . . . . 0.0 110.922 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' D' ' 14' ' ' LEU . 2.2 t -79.65 115.03 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.822 -1.174 . . . . 0.0 108.959 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -76.53 82.72 3.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 109.488 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' D' ' 22' ' ' GLU . 71.1 t -54.8 -18.39 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' D' ' 21' ' ' ASP . 5.1 m-20 -66.15 6.3 0.42 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.89 . . . . 0.0 109.632 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' D' ' 20' ' ' VAL . 35.3 mt-10 -155.95 -52.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 95.7 t -47.53 -35.74 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.693 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.48 -57.57 4.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.51 -50.79 55.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.19 -45.94 91.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -1.119 . . . . 0.0 109.541 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.21 -35.23 35.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.621 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -84.97 -58.03 2.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.176 -0.952 . . . . 0.0 109.613 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.23 -37.48 73.06 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -69.73 -38.44 76.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -1.209 . . . . 0.0 109.775 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 40.7 tp -53.0 -24.18 8.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 110.149 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' D' ' 36' ' ' PRO . 15.8 mt -75.48 -54.5 6.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.01 -1.057 . . . . 0.0 110.882 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . 0.405 HG23 ' H ' ' D' ' 34' ' ' VAL . 2.3 m -52.73 -48.95 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.743 -1.223 . . . . 0.0 109.769 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . 0.405 ' H ' HG23 ' D' ' 33' ' ' VAL . 0.0 OUTLIER -70.78 -22.69 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.077 -1.015 . . . . 0.0 109.158 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -149.42 74.87 9.64 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . 0.49 ' N ' ' O ' ' D' ' 32' ' ' LEU . 72.4 Cg_endo -81.49 -22.92 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.84 2.36 . . . . 0.0 112.244 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -48.91 -20.0 0.45 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.478 ' C ' ' H ' ' D' ' 40' ' ' ARG . 33.5 p -80.29 9.86 5.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.905 . . . . 0.0 109.563 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -71.8 12.26 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 109.388 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . 0.974 ' HG2' ' NE ' ' A' ' 92' ' ' ARG . 97.4 mtt180 -80.26 -19.8 45.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 109.409 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.55 26.27 4.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.172 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 0.515 ' CE1' ' CD2' ' D' ' 45' ' ' PHE . 33.3 t80 -148.78 11.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.406 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.95 -22.09 39.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 27.2 p -84.65 7.01 21.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . 0.515 ' CD2' ' CE1' ' D' ' 42' ' ' PHE . 3.6 m-85 -81.38 -16.42 52.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.18 -0.95 . . . . 0.0 109.442 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.03 -175.32 45.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -83.13 103.86 12.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -1.123 . . . . 0.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' D' ' 48' ' ' LEU . 10.2 mp -88.27 29.75 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.849 . . . . 0.0 109.116 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.9 m -44.84 -35.85 2.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.379 -0.826 . . . . 0.0 109.807 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -146.47 148.73 35.09 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -42.57 -36.39 4.68 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.546 2.164 . . . . 0.0 112.444 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.68 -33.52 72.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.12 -0.987 . . . . 0.0 109.706 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.29 -19.7 63.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.406 -0.809 . . . . 0.0 109.561 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 62.6 t -61.08 -59.68 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -87.43 10.55 17.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.87 -31.22 33.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -81.92 147.92 59.48 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.155 -1.203 . . . . 0.0 109.426 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.56 -57.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.57 2.18 . . . . 0.0 112.542 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -33.38 4.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 109.775 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.05 -57.92 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.977 . . . . 0.0 109.434 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -65.01 -33.53 76.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.251 -0.906 . . . . 0.0 109.618 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.56 -53.71 43.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.56 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -53.27 -24.01 10.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.571 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.12 -23.7 73.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.96 -44.08 81.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -1.107 . . . . 0.0 109.192 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -55.4 -47.14 76.35 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.384 -0.822 . . . . 0.0 109.388 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.544 HG23 ' C4A' ' D' ' 147' ' ' HEC . 25.3 t -58.23 -46.94 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.31 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.48 -34.98 74.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.268 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.93 -53.16 46.43 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.11 63.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -1.193 . . . . 0.0 109.523 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -55.87 -31.08 62.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.449 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 33.1 t -76.58 -31.47 57.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -50.23 -40.06 46.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.88 -59.96 8.39 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.441 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.6 mp -58.19 -26.89 63.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -1.132 . . . . 0.0 109.358 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.02 2.41 46.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.617 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.467 ' C ' ' H ' ' D' ' 79' ' ' ASP . 66.2 t60 -170.84 66.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.928 . . . . 0.0 109.654 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.83 19.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.407 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' D' ' 77' ' ' HIS . 8.8 m-20 -79.61 -29.47 41.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.529 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.42 ' O ' ' OD1' ' D' ' 80' ' ' ASN . 5.5 p30 -173.3 107.0 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' D' ' 81' ' ' LEU . 8.3 mp -80.21 -58.77 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.915 . . . . 0.0 109.494 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . 0.412 ' HD2' ' H ' ' D' ' 82' ' ' LYS . 0.0 OUTLIER -46.45 -24.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.582 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.73 -50.21 9.52 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.7 t -82.34 -47.3 12.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -1.173 . . . . 0.0 109.409 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.545 ' N ' ' CG2' ' D' ' 84' ' ' THR . 27.9 m-85 -65.08 1.35 0.99 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.55 -0.719 . . . . 0.0 109.504 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.85 -35.05 66.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.188 -0.945 . . . . 0.0 109.388 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 29.9 p -74.37 -57.54 3.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.426 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mp -49.37 -44.95 45.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -63.89 -52.2 61.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.474 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.68 -22.8 64.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 6.5 tt -85.65 -62.6 1.49 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.694 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' D' ' 97' ' ' HIS . 75.1 m80 -61.43 -20.17 62.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 110.079 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 51.6 t -83.51 -60.71 2.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.582 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.36 -28.32 22.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.991 -1.068 . . . . 0.0 111.026 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -83.88 -52.04 6.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.0 -1.062 . . . . 0.0 110.742 -178.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.589 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 11.6 mt -106.87 -21.31 13.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.024 -1.047 . . . . 0.0 110.05 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.914 ' CD2' HG23 ' A' ' 41' ' ' THR . 33.1 p80 43.03 37.47 1.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.842 . . . . 0.0 109.931 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.09 130.92 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.167 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -46.94 147.36 2.31 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.33 -16.94 44.39 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.495 2.13 . . . . 0.0 112.119 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' D' ' 101' ' ' GLU . 58.7 mp0 -81.3 55.27 2.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.344 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.437 ' ND2' ' C ' ' D' ' 101' ' ' GLU . 10.0 m-80 -156.19 -37.67 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.982 . . . . 0.0 109.688 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -64.12 -38.76 92.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -69.68 -28.1 65.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.66 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.71 -52.76 16.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.655 HD12 ' CHC' ' D' ' 147' ' ' HEC . 6.7 tt -52.2 -47.75 65.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.405 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.71 -20.45 70.22 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . 0.77 ' OD1' ' ND1' ' C' ' 103' ' ' HIS . 0.4 OUTLIER -83.24 -19.12 36.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -1.167 . . . . 0.0 109.753 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 73.0 t -80.31 -44.54 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.616 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 mt -47.37 -32.0 4.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.423 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 10.5 t -58.86 -33.64 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 11.8 m -79.06 -54.54 5.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 14.0 t -49.47 -46.04 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.406 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.0 -22.92 64.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.463 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -80.62 -24.37 39.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.471 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.73 -61.65 1.74 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.359 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . 0.416 ' C ' ' CG ' ' D' ' 118' ' ' PHE . 55.2 m80 -60.18 -17.73 43.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.416 ' CG ' ' C ' ' D' ' 117' ' ' HIS . 19.0 m-85 -150.27 58.57 0.96 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.88 . . . . 0.0 109.633 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -68.6 -28.65 73.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -68.92 6.35 0.92 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -1.108 . . . . 0.0 109.41 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' D' ' 123' ' ' THR . 17.7 mm-40 -126.0 -1.22 7.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.436 -0.79 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 1.298 ' CE2' ' HB3' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -72.67 35.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.849 . . . . 0.0 109.517 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.513 ' H ' ' C ' ' D' ' 121' ' ' GLU . 13.1 p -50.82 146.58 9.85 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.427 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.482 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.3 Cg_exo -48.22 -51.44 10.08 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.315 2.01 . . . . 0.0 113.057 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 39.4 Cg_endo -67.63 -27.7 38.39 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.013 1.809 . . . . 0.0 112.436 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . 0.413 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 55.6 t -77.3 -24.1 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.143 -0.973 . . . . 0.0 109.523 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . 0.584 HE22 ' CG1' ' C' ' 107' ' ' VAL . 9.1 tt0 -83.34 -54.52 4.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 0.925 ' HB3' HD13 ' C' ' 34' ' ' LEU . . . -49.14 -44.1 42.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.497 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.39 13.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.573 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . 0.473 ' H ' ' C ' ' D' ' 128' ' ' ALA . 32.0 t80 -97.89 -59.89 1.67 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.64 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . 0.402 ' OE1' ' CZ ' ' C' ' 36' ' ' PHE . 38.2 tt0 -47.46 -30.49 3.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . 0.534 ' C ' ' H2 ' ' D' ' 1' ' ' VAL . 8.7 mtpm? -66.05 -46.72 76.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.774 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 38.4 t -59.77 -55.55 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 110.043 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.91 -36.85 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.991 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -50.0 -24.64 2.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.511 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.96 -31.43 55.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -82.69 -30.06 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -1.166 . . . . 0.0 109.495 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.64 77.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.91 . . . . 0.0 109.46 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 1.222 ' OD1' ' CE1' ' B' ' 146' ' ' HIS . 4.2 m120 -71.35 -27.89 63.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.414 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.23 -60.42 2.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.428 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.96 -16.13 2.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.348 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.2 -3.04 13.96 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.309 -0.869 . . . . 0.0 109.569 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' D' ' 139' ' ' ASN . 22.0 t-80 -64.22 -33.28 75.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.867 . . . . 0.0 109.581 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -82.42 -29.76 30.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -51.33 -21.05 1.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 1.169 ' CE1' ' OD1' ' B' ' 139' ' ' ASN . 43.0 m80 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.649 ' HHC' HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 0.656 ' CHC' HD12 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 0.642 ' HHC' HD21 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 0.655 ' CHC' HD12 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.475 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.475 ' CB ' ' O ' ' A' ' 1' ' ' VAL . 7.1 tp 73.73 170.63 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.564 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.461 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 174.42 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.937 . . . . 0.0 110.106 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 3' ' ' SER . 95.5 Cg_exo -41.41 168.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.597 2.198 . . . . 0.0 112.902 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -50.76 -16.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.444 -0.785 . . . . 0.0 109.994 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 5' ' ' ALA . 2.8 p30 -39.78 -28.33 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.382 -0.824 . . . . 0.0 109.819 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.726 ' HZ3' ' HZ3' ' A' ' 11' ' ' LYS . 5.9 ptmm? -83.27 -52.38 6.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.414 ' H ' ' CG ' ' A' ' 7' ' ' LYS . 48.9 m -47.93 -26.75 1.84 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 108.928 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -79.99 -39.34 30.23 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 7' ' ' LYS . 21.2 t -69.43 -47.01 75.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.726 ' HZ3' ' HZ3' ' A' ' 7' ' ' LYS . 2.4 mptm? -50.22 -48.5 54.41 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.58 -63.1 1.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.502 0.667 . . . . 0.0 109.303 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.75 -41.75 56.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -0.817 . . . . 0.0 109.112 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.95 -17.4 64.43 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.377 -0.827 . . . . 0.0 109.047 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -79.62 -47.5 7.26 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -68.39 -36.74 79.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -1.121 . . . . 0.0 108.766 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.96 -66.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.575 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 63.44 -141.44 45.87 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.13 37.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.462 -1.022 . . . . 0.0 110.177 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.575 ' H ' ' C ' ' A' ' 18' ' ' GLY . 89.5 m-70 -140.2 24.61 2.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.3 -48.78 7.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.664 -0.647 . . . . 0.0 109.961 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.38 -14.71 28.23 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' O ' ' OE1' ' A' ' 27' ' ' GLU . 12.6 mt-10 -85.68 -56.28 3.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.9 m-30 -55.18 -27.11 43.42 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.369 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.05 -24.45 76.5 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.69 -36.3 28.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -1.123 . . . . 0.0 109.625 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 23' ' ' GLU . 1.4 mp0 -70.4 -19.88 62.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.96 . . . . 0.0 109.296 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.65 -19.73 60.76 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.277 -0.889 . . . . 0.0 109.072 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.86 -58.14 3.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 109.712 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -51.01 -43.68 60.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 109.655 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -56.25 -30.57 62.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 109.642 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.406 ' HE2' HBC3 ' A' ' 142' ' ' HEC . 38.6 ttp -84.24 -57.16 3.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.906 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.438 ' CZ ' ' CZ ' ' A' ' 46' ' ' PHE . 25.7 m-85 -47.66 -36.94 11.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.978 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.588 HD11 ' CB ' ' B' ' 128' ' ' ALA . 3.5 pp -84.48 -25.74 28.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.925 -1.11 . . . . 0.0 109.809 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 28.1 t -60.93 -21.97 63.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 109.534 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 1.025 ' HZ ' ' OE1' ' B' ' 131' ' ' GLN . 66.6 m-85 -156.2 128.76 4.15 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.965 . . . . 0.0 109.2 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.59 -20.23 15.92 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.348 2.032 . . . . 0.0 111.986 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.6 p -62.67 -18.77 62.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 109.572 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.4 p -80.99 -35.55 31.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.779 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -67.59 -36.5 81.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.963 . . . . 0.0 109.662 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.404 HG22 ' CD2' ' D' ' 97' ' ' HIS . 15.2 t -84.77 -18.18 35.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.209 -0.932 . . . . 0.0 109.844 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -64.27 -66.91 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.169 -0.957 . . . . 0.0 109.449 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.539 ' CD2' ' ND1' ' A' ' 45' ' ' HIS . 35.9 t80 -175.27 85.26 0.31 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.449 -0.782 . . . . 0.0 109.814 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 70.2 Cg_endo -80.64 -43.06 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.404 2.069 . . . . 0.0 111.814 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.539 ' ND1' ' CD2' ' A' ' 43' ' ' PHE . 45.3 p-80 38.27 33.05 0.05 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.606 -0.683 . . . . 0.0 110.645 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.479 ' C ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -165.44 26.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.071 -1.018 . . . . 0.0 110.385 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.604 ' C ' ' H ' ' A' ' 49' ' ' SER . 22.3 m-20 41.63 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.534 -0.729 . . . . 0.0 110.249 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.791 ' H ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -56.5 0.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.604 ' H ' ' C ' ' A' ' 47' ' ' ASP . 2.8 t -46.56 132.18 10.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.96 . . . . 0.0 109.668 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.526 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 11.3 t-80 -76.23 144.15 40.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.413 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.526 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 73.2 10.15 77.92 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.474 ' OG ' ' N ' ' A' ' 53' ' ' ALA . 88.7 p -68.98 -100.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -1.184 . . . . 0.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.474 ' N ' ' OG ' ' A' ' 52' ' ' SER . . . -178.39 -31.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.377 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -81.23 -17.71 48.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.926 . . . . 0.0 109.087 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.48 -33.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 109.682 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -70.81 -28.34 64.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.076 -1.015 . . . . 0.0 109.262 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' O ' ' CE ' ' A' ' 61' ' ' LYS . . . -69.71 -48.1 44.59 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.538 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.6 OUTLIER -54.2 -35.56 62.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -1.11 . . . . 0.0 109.392 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.29 -58.69 10.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -51.65 -24.03 5.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -1.174 . . . . 0.0 109.593 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.478 ' O ' ' CMA' ' A' ' 142' ' ' HEC . 0.0 OUTLIER -77.35 -23.47 50.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.332 -0.855 . . . . 0.0 108.896 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.36 -52.91 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 108.712 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.488 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -66.27 -24.21 66.53 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.421 -0.8 . . . . 0.0 109.574 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.14 -33.0 33.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.773 ' CB ' HMA2 ' A' ' 142' ' ' HEC . . . -82.63 -34.32 27.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.489 ' O ' ' CD1' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -81.63 -23.03 37.25 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.98 -1.075 . . . . 0.0 108.116 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 63' ' ' ALA . 18.5 m -78.05 -43.87 28.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.052 -1.03 . . . . 0.0 108.704 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 69' ' ' ALA . 1.6 p-10 -58.15 -21.91 48.93 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.61 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -78.78 -47.47 16.68 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.62 -22.37 30.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.01 -17.67 63.28 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.419 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.563 ' O ' ' N ' ' A' ' 74' ' ' ASP . 38.3 m80 -143.81 -53.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.343 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.3 p 45.03 15.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.776 0.798 . . . . 0.0 109.286 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 72' ' ' HIS . 89.8 m-20 -131.73 9.64 4.63 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -174.33 27.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.358 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.694 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.3 ptt? -78.56 -24.41 0.43 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.519 -0.738 . . . . 0.0 111.804 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.2 Cg_exo -53.19 -29.49 46.55 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.79 1.66 . . . . 0.0 112.573 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.428 ' O ' ' OG ' ' A' ' 81' ' ' SER . 8.5 t-20 -94.1 -11.29 30.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 109.828 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.22 -58.23 3.04 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.107 -0.995 . . . . 0.0 109.258 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.35 13.94 2.69 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 2.5 p -59.22 -15.8 17.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.785 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.4 -53.61 6.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.0 109.912 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.51 HD22 HBA1 ' A' ' 142' ' ' HEC . 3.5 mt -44.79 -42.3 7.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.0 108.901 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.4 p -54.56 -29.21 50.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.545 -0.722 . . . . 0.0 109.517 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' ALA . 49.4 t0 -82.53 -16.92 46.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.334 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 tt -81.04 -62.23 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.956 -1.09 . . . . 0.0 111.249 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.4 p-80 -77.0 -21.53 54.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.886 -1.133 . . . . 0.0 111.163 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.74 23.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.778 -1.201 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 90' ' ' LYS . 15.4 t-80 -99.78 -74.81 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.171 -0.956 . . . . 0.0 110.132 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 89' ' ' HIS . 17.8 mtpp -52.0 -101.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 109.986 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.468 ' H ' ' CD1' ' A' ' 91' ' ' LEU . 10.0 mp -45.12 -31.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 58.17 41.91 22.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.495 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' HIS . 5.9 t -66.84 168.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 109.353 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' VAL . 1.1 p-10 -123.46 152.09 64.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.336 -0.852 . . . . 0.0 109.333 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -41.6 -14.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.681 2.254 . . . . 0.0 112.558 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.867 HG13 ' HB3' ' D' ' 99' ' ' ASP . 46.9 t -59.29 -28.29 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 0.0 109.877 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.666 HD21 ' N ' ' A' ' 97' ' ' ASN . 0.6 OUTLIER -79.5 -24.8 42.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.95 . . . . 0.0 109.7 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -65.65 -41.95 91.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -47.28 -30.21 2.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.558 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 100' ' ' LEU . 3.7 mm? -84.11 -60.04 2.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.707 ' CD2' HBB3 ' A' ' 142' ' ' HEC . 6.5 tt -53.34 -20.78 4.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 109.76 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -77.65 -59.06 2.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.818 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.832 ' HE2' ' HH ' ' B' ' 35' ' ' TYR . 32.1 m170 -64.55 -26.57 68.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 109.915 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 95.4 m -61.06 -58.01 10.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.895 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.92 -30.88 1.91 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 109.576 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.5 mt -75.06 -52.18 11.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.593 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.3 -24.76 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 109.445 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.6 m -73.61 -63.32 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.672 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 113' ' ' LEU . 18.9 mt -53.77 -33.57 56.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.386 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.41 -42.17 9.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.324 -0.86 . . . . 0.0 109.742 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.47 -56.04 4.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.436 -0.79 . . . . 0.0 109.943 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -68.28 -67.51 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.545 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -111.85 93.46 20.8 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 113' ' ' LEU . 99.1 Cg_exo -43.39 178.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.478 2.119 . . . . 0.0 113.068 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.57 -38.26 17.33 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.611 0.72 . . . . 0.0 109.281 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 4.7 mt-10 77.85 1.3 2.85 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 61.91 38.46 14.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.74 -0.6 . . . . 0.0 111.24 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.73 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -87.59 120.9 71.23 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 120.633 -1.292 . . . . 0.0 108.21 178.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.35 19.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.26 1.973 . . . . 0.0 112.889 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.73 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -150.74 -33.3 0.16 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.715 -1.24 . . . . 0.0 110.984 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 10.7 p -45.43 -48.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.013 -1.055 . . . . 0.0 109.934 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.536 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 20.3 m-70 -71.19 -43.73 66.84 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.444 -0.785 . . . . 0.0 108.952 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.86 -20.2 64.27 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.33 -0.856 . . . . 0.0 109.107 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 120' ' ' ALA . 12.2 p -66.33 -62.75 1.31 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.506 ' N ' ' OG ' ' A' ' 124' ' ' SER . 5.5 mt -70.31 -25.1 63.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.151 -0.968 . . . . 0.0 109.719 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.36 -45.52 46.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.058 -1.026 . . . . 0.0 109.813 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.37 -50.54 5.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.106 -0.996 . . . . 0.0 110.113 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' A' ' 124' ' ' SER . 28.5 t80 -48.43 -22.27 0.68 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.049 -1.032 . . . . 0.0 109.485 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.623 HD22 HBB1 ' A' ' 142' ' ' HEC . 6.4 mt -74.57 -22.6 58.9 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.45 -32.36 72.34 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.0 t -80.09 -35.49 36.86 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.391 -0.818 . . . . 0.0 109.012 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.54 -30.62 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 129' ' ' LEU . 42.2 t -76.19 -26.27 56.0 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.422 -0.799 . . . . 0.0 108.853 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 138' ' ' SER . 19.3 m -66.89 -28.72 68.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.327 -0.858 . . . . 0.0 109.021 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.12 -47.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.091 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.25 -38.15 73.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.013 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.3 p -93.71 -15.8 24.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.663 ' HG ' ' H ' ' A' ' 139' ' ' LYS . 23.3 t 52.3 -144.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.898 . . . . 0.0 109.518 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.663 ' H ' ' HG ' ' A' ' 138' ' ' SER . 53.0 tttp -170.87 -6.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -152.65 108.3 3.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 109.4 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.429 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.406 ' C ' ' HD1' ' B' ' 2' ' ' HIS . 0.5 OUTLIER -99.13 77.2 2.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.387 -0.82 . . . . 0.0 109.665 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mt -92.5 -170.94 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.185 -0.947 . . . . 0.0 109.254 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.409 ' O ' ' N ' ' B' ' 6' ' ' GLU . 2.9 p -111.06 129.78 23.64 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.377 -0.827 . . . . 0.0 108.97 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.78 -25.02 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.392 2.061 . . . . 0.0 112.401 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' B' ' 4' ' ' THR . 48.6 mt-10 -86.62 -48.58 8.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 0.0 109.894 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.77 -34.39 39.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.853 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -64.97 -34.95 79.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.014 . . . . 0.0 109.425 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -69.04 -23.62 64.09 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 109.374 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.52 -55.0 4.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.215 -0.928 . . . . 0.0 110.238 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.7 -26.45 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 34.2 m -84.64 -54.25 4.85 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.363 0.601 . . . . 0.0 109.893 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -45.0 -31.18 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.451 -0.781 . . . . 0.0 109.859 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -24.64 63.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.226 -0.921 . . . . 0.0 109.623 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . 0.629 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 2.1 t90 -48.3 -27.49 2.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.17 -52.33 7.88 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.488 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 1.1 mppt? -64.39 -15.59 60.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -1.121 . . . . 0.0 109.084 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.23 114.96 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.356 -0.84 . . . . 0.0 109.67 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' B' ' 22' ' ' GLU . 2.4 m-80 -81.3 77.41 8.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.318 -0.864 . . . . 0.0 108.794 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' B' ' 19' ' ' ASN . 76.8 t -43.14 -21.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 109.966 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 19' ' ' ASN . 0.8 OUTLIER -83.86 11.71 7.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.59 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' B' ' 19' ' ' ASN . 36.6 mt-10 -156.15 -55.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.492 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 75.1 t -47.86 -36.37 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -57.71 9.45 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.82 -35.84 40.14 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -75.18 -26.97 59.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -1.139 . . . . 0.0 109.575 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.21 -48.1 65.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 40.3 mt -82.96 -30.58 28.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.895 . . . . 0.0 109.498 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.03 -59.19 10.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.584 ' NH2' ' SD ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -57.45 -40.84 79.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -1.133 . . . . 0.0 109.376 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' B' ' 30' ' ' ARG . 2.3 tt -43.79 -38.3 3.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.291 -0.88 . . . . 0.0 109.464 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.96 -21.83 43.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' B' ' 30' ' ' ARG . 15.6 t -86.09 -64.0 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.156 -0.965 . . . . 0.0 109.532 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.18 -22.93 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.832 ' HH ' ' HE2' ' A' ' 103' ' ' HIS . 48.5 m-85 -150.05 78.75 7.91 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 109.479 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' B' ' 38' ' ' THR . 16.6 Cg_exo -65.38 -28.22 54.75 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.042 2.494 . . . . 0.0 112.584 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . 0.54 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 0.5 OUTLIER -46.56 -20.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.022 . . . . 0.0 109.708 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.608 HG23 HBC2 ' B' ' 147' ' ' HEC . 17.3 m -96.16 61.47 2.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.168 -0.957 . . . . 0.0 109.411 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.13 24.38 6.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.363 -0.835 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -84.44 -25.79 28.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -101.06 34.63 2.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.84 . . . . 0.0 109.494 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.49 ' HE1' ' CBC' ' B' ' 147' ' ' HEC . 64.7 m-85 -135.9 17.46 3.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.331 -0.855 . . . . 0.0 109.425 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' B' ' 44' ' ' SER . 0.0 OUTLIER -84.98 -30.76 23.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.515 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 39.4 t -83.11 -10.81 58.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.514 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -73.82 1.02 11.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.89 178.73 0.18 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 48.77 89.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -1.108 . . . . 0.0 109.408 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 tp -158.8 19.35 0.2 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.46 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -53.16 -39.14 63.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' THR . . . . . 0.421 ' O ' ' N ' ' B' ' 52' ' ' ASP . 1.3 p -145.65 153.7 51.26 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.408 -0.808 . . . . 0.0 109.009 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -43.61 -19.36 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.265 1.977 . . . . 0.0 112.241 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.6 OUTLIER -81.48 -44.29 17.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.36 -20.0 0.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.315 -0.866 . . . . 0.0 109.398 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.03 -63.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.529 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' MET . . . . . 0.584 ' SD ' ' NH2' ' B' ' 30' ' ' ARG . 11.4 mmt -52.32 -22.02 4.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.605 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.23 -15.81 70.93 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . 0.566 ' ND2' ' H ' ' B' ' 60' ' ' VAL . 0.3 OUTLIER -73.46 136.39 78.22 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.225 -1.162 . . . . 0.0 109.294 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.34 -53.36 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.339 2.026 . . . . 0.0 112.381 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.475 ' N ' ' ND2' ' B' ' 57' ' ' ASN . 17.2 mtpp -52.49 -48.99 65.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.531 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.566 ' H ' ' ND2' ' B' ' 57' ' ' ASN . 99.2 t -49.6 -37.58 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 51.0 mtpt -79.16 -33.94 43.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.83 -29.08 35.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.583 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 0.923 ' HE1' ' CHA' ' B' ' 147' ' ' HEC . 1.8 t60 -69.1 -23.79 64.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.568 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.32 -38.02 91.11 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 30.8 mmtm -60.93 -32.11 71.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -1.181 . . . . 0.0 109.351 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . 0.482 ' O ' HMA3 ' B' ' 147' ' ' HEC . 37.0 mmtt -65.78 -61.34 2.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 1.165 HG21 ' CHB' ' B' ' 147' ' ' HEC . 43.8 t -56.88 -24.51 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.83 -42.53 60.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.226 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.77 -39.8 17.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.71 -38.22 67.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -61.84 -32.8 73.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.146 -0.971 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.629 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 13.4 m -88.5 -31.9 18.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 109.532 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.491 ' CG ' ' HG1' ' B' ' 84' ' ' THR . 43.0 t0 -49.52 -42.49 43.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 109.473 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.12 -60.06 8.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.455 ' H ' HD12 ' B' ' 75' ' ' LEU . 5.0 mp -57.03 -26.44 60.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -1.127 . . . . 0.0 109.389 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.2 -0.35 48.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.958 . . . . 0.0 109.488 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.478 ' C ' ' H ' ' B' ' 79' ' ' ASP . 75.9 t60 -171.2 64.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.534 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 54.3 mt -72.36 12.15 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' B' ' 77' ' ' HIS . 2.8 m-20 -71.83 -20.79 61.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.434 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -171.6 109.74 0.28 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -79.69 -58.54 3.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -47.63 -24.01 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.97 -61.85 4.09 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.6 t -66.62 -47.09 73.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -1.177 . . . . 0.0 109.355 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.548 ' N ' ' CG2' ' B' ' 84' ' ' THR . 69.0 m-85 -70.88 15.14 0.11 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.558 -0.714 . . . . 0.0 109.526 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -69.4 -38.88 78.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 109.573 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.434 ' HG1' ' H ' ' B' ' 88' ' ' LEU . 17.8 p -83.62 -51.69 7.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.639 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.434 ' H ' ' HG1' ' B' ' 87' ' ' THR . 26.5 mt -53.04 -24.87 10.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.478 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 99.5 p -81.92 -40.61 22.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.505 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -81.43 -22.59 38.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.622 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 4.2 tt -82.29 -48.39 11.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.061 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.537 ' NE2' ' O ' ' B' ' 141' ' ' LEU . 1.9 p-80 -75.18 -22.28 58.15 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.918 -1.114 . . . . 0.0 110.22 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . 0.461 ' SG ' ' CE1' ' B' ' 145' ' ' TYR . 51.2 t -83.73 -60.25 2.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.132 -0.98 . . . . 0.0 111.356 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 12.8 t70 -86.8 -27.4 23.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.983 -1.073 . . . . 0.0 111.784 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.53 ' O ' ' CE1' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -84.56 -49.99 8.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.704 -1.248 . . . . 0.0 110.655 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.48 ' CD1' ' N ' ' B' ' 96' ' ' LEU . 8.3 mp -86.52 -34.64 19.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.793 -1.192 . . . . 0.0 109.931 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' B' ' 94' ' ' ASP . 3.3 m80 71.77 36.92 1.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 109.545 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.85 134.84 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 0.799 ' HB3' HG13 ' C' ' 96' ' ' VAL . 3.7 m-20 -81.72 151.68 68.28 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.405 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.519 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 65.3 Cg_exo -47.23 -173.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.39 2.06 . . . . 0.0 112.358 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 57.62 53.2 7.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.52 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' B' ' 100' ' ' PRO . 69.3 m-80 -159.31 -34.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.6 m-85 -73.75 -54.55 7.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.333 -0.854 . . . . 0.0 109.585 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -57.1 -22.35 39.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.713 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 tt -76.77 -41.62 44.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -0.969 . . . . 0.0 109.517 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 1.157 HD11 ' CHC' ' B' ' 147' ' ' HEC . 4.9 tt -68.58 -56.59 7.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.231 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.45 -20.24 2.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -85.62 -55.61 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -1.116 . . . . 0.0 109.984 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.12 -24.8 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.055 -1.028 . . . . 0.0 109.49 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.41 -59.18 5.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.255 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.92 -39.94 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.229 -0.919 . . . . 0.0 109.677 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.423 ' O ' ' CE1' ' B' ' 116' ' ' HIS . 76.3 m -48.87 -43.77 39.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.591 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 70.4 t -55.99 -53.42 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.353 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' B' ' 114' ' ' LEU . 9.3 mp -49.81 -41.99 45.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 119' ' ' GLY . . . -47.88 -41.54 24.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.78 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.673 ' HD1' ' N ' ' B' ' 116' ' ' HIS . 0.4 OUTLIER -68.87 -52.16 32.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.612 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' B' ' 118' ' ' PHE . 74.9 m80 -69.24 -17.55 63.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.713 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 63.8 m-85 -156.84 64.34 0.52 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.955 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 115' ' ' ALA . . . -76.25 -21.36 75.81 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -72.85 -29.22 63.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -1.128 . . . . 0.0 109.362 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 123' ' ' THR . 63.4 mm-40 -78.53 -15.49 58.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.271 -0.893 . . . . 0.0 109.554 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -69.82 59.66 0.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.472 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 11.7 p -59.04 150.98 58.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.94 . . . . 0.0 108.917 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.434 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.3 Cg_exo -44.15 -58.15 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.446 2.097 . . . . 0.0 112.716 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 27.5 Cg_endo -61.89 -46.52 13.24 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.161 1.907 . . . . 0.0 112.027 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.472 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 40.6 t -66.86 -18.2 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -83.14 -26.29 31.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.588 ' CB ' HD11 ' A' ' 34' ' ' LEU . . . -68.8 -32.1 71.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.37 26.38 0.92 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.935 . . . . 0.0 109.648 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.647 ' CG ' ' N ' ' B' ' 131' ' ' GLN . 5.8 p90 -74.53 -52.31 12.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.14 -0.975 . . . . 0.0 109.791 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . 1.025 ' OE1' ' HZ ' ' A' ' 36' ' ' PHE . 36.5 tt0 -86.06 -38.93 17.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.162 -0.961 . . . . 0.0 109.999 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 1.009 ' HG3' ' O ' ' D' ' 146' ' ' HIS . 32.1 ttpt -50.9 -34.56 28.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.233 -0.917 . . . . 0.0 110.959 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . 0.672 ' CG1' ' H ' ' B' ' 134' ' ' VAL . 7.1 p -65.27 -63.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.844 -1.16 . . . . 0.0 109.891 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.672 ' H ' ' CG1' ' B' ' 133' ' ' VAL . 1.8 m -73.77 -14.82 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.361 -0.837 . . . . 0.0 109.75 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . -45.78 -23.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.55 -26.41 46.84 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' B' ' 134' ' ' VAL . 74.9 t -80.05 -21.28 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -1.104 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.86 -51.11 71.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.555 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.69 -22.52 53.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.34 -45.94 88.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.537 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 19.9 mt -84.01 15.57 3.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.544 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.62 -1.5 2.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 109.505 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . 0.433 ' O ' ' CD2' ' B' ' 143' ' ' HIS . 21.9 t-160 -79.87 -26.57 40.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.518 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.517 ' C ' ' HD1' ' B' ' 146' ' ' HIS . 12.3 mptt -73.26 -11.39 60.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.379 -0.826 . . . . 0.0 109.342 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.461 ' CE1' ' SG ' ' B' ' 93' ' ' CYS . 15.6 m-85 -72.84 7.19 2.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.301 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 1.021 ' O ' ' HG3' ' D' ' 132' ' ' LYS . 7.5 p-80 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.453 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' C' ' 2' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . 0.473 ' CB ' ' O ' ' C' ' 1' ' ' VAL . 7.1 tp 73.63 170.67 0.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 109.545 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.471 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 174.45 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.166 -0.959 . . . . 0.0 110.041 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' C' ' 3' ' ' SER . 96.6 Cg_exo -41.4 168.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.683 2.255 . . . . 0.0 112.837 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -50.77 -16.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.436 -0.79 . . . . 0.0 110.003 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' C' ' 5' ' ' ALA . 2.8 p30 -39.7 -28.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.746 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.724 ' HZ3' ' HZ3' ' C' ' 11' ' ' LYS . 5.9 ptmm? -83.2 -52.31 6.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.514 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.417 ' N ' ' CG ' ' C' ' 7' ' ' LYS . 49.2 m -47.93 -26.76 1.85 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 108.954 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -80.01 -39.43 29.96 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' C' ' 7' ' ' LYS . 21.4 t -69.35 -47.01 75.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . 0.724 ' HZ3' ' HZ3' ' C' ' 7' ' ' LYS . 2.4 mptm? -50.12 -48.57 53.49 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' C' ' 15' ' ' GLY . . . -52.65 -63.13 1.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.628 -0.67 . . . . 0.0 109.316 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.57 -41.82 54.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.2 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -17.34 64.37 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.412 -0.805 . . . . 0.0 109.05 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' C' ' 12' ' ' ALA . . . -79.71 -47.38 7.29 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -68.41 -36.71 79.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -1.113 . . . . 0.0 108.85 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.99 -66.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 63.39 -141.4 45.89 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 37.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.519 -0.989 . . . . 0.0 110.157 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.584 ' H ' ' C ' ' C' ' 18' ' ' GLY . 89.4 m-70 -140.27 24.5 2.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.36 -48.73 7.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.561 -0.712 . . . . 0.0 109.927 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.3 -14.74 27.82 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' C' ' 27' ' ' GLU . 12.6 mt-10 -85.64 -56.32 3.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -1.156 . . . . 0.0 109.653 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.0 m-30 -55.4 -26.86 44.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 109.288 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.18 -24.41 76.62 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.73 -36.33 28.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -1.165 . . . . 0.0 109.627 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' C' ' 23' ' ' GLU . 1.4 mp0 -70.27 -20.03 63.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.5 -19.88 60.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.038 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.74 -58.19 3.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.353 -0.842 . . . . 0.0 109.735 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -50.94 -43.77 60.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 109.685 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -56.3 -30.46 62.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.651 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.404 ' HE2' HBC3 ' C' ' 142' ' ' HEC . 38.5 ttp -84.27 -57.22 3.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.815 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.434 ' CZ ' ' CZ ' ' C' ' 46' ' ' PHE . 25.8 m-85 -47.7 -36.86 11.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.998 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.588 HD11 ' CB ' ' D' ' 128' ' ' ALA . 3.4 pp -84.49 -25.76 28.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.994 -1.067 . . . . 0.0 109.808 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 28.1 t -60.88 -22.06 63.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 109.472 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 1.047 ' HZ ' ' OE1' ' D' ' 131' ' ' GLN . 66.7 m-85 -156.18 128.69 4.13 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.21 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.58 -20.17 16.01 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.292 1.995 . . . . 0.0 112.08 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 68.2 p -62.62 -18.92 63.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 76.8 p -80.88 -35.61 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.0 109.756 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -67.61 -36.45 80.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 109.7 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -84.85 -18.15 35.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.778 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -64.25 -66.91 0.48 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.112 -0.992 . . . . 0.0 109.531 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.539 ' CD2' ' ND1' ' C' ' 45' ' ' HIS . 35.7 t80 -175.3 85.26 0.31 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.843 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.514 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 69.2 Cg_endo -80.77 -42.94 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.325 2.016 . . . . 0.0 111.802 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.539 ' ND1' ' CD2' ' C' ' 43' ' ' PHE . 45.2 p-80 38.25 33.04 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.627 -0.67 . . . . 0.0 110.686 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -165.44 26.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 110.346 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' C' ' 49' ' ' SER . 22.5 m-20 41.74 88.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.701 . . . . 0.0 110.25 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.813 ' H ' ' CD1' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -56.52 0.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.385 -0.822 . . . . 0.0 109.538 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.614 ' H ' ' C ' ' C' ' 47' ' ' ASP . 2.8 t -46.58 132.1 10.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.163 -0.961 . . . . 0.0 109.681 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.518 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 11.4 t-80 -76.16 144.12 40.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.388 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . 0.518 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 73.26 10.14 78.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' C' ' 53' ' ' ALA . 88.5 p -68.88 -100.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -1.147 . . . . 0.0 109.392 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.524 ' N ' ' OG ' ' C' ' 52' ' ' SER . . . -178.41 -31.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.41 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -81.26 -17.58 48.94 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.264 -0.897 . . . . 0.0 109.171 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.57 -33.99 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.626 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -70.78 -28.27 64.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.314 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . 0.427 ' O ' ' CE ' ' C' ' 61' ' ' LYS . . . -69.82 -48.18 43.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.6 OUTLIER -54.01 -35.63 62.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -1.155 . . . . 0.0 109.366 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.43 -58.59 10.92 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -51.7 -23.95 5.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -1.099 . . . . 0.0 109.625 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.488 ' O ' ' CMA' ' C' ' 142' ' ' HEC . 0.0 OUTLIER -77.39 -23.46 50.7 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 108.911 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.43 -52.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.488 ' O ' ' OG1' ' C' ' 67' ' ' THR . . . -66.26 -24.23 66.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.32 -0.862 . . . . 0.0 109.581 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.02 -32.97 33.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.99 . . . . 0.0 109.821 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . 0.772 ' CB ' HMA2 ' C' ' 142' ' ' HEC . . . -82.68 -34.33 27.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.122 -0.986 . . . . 0.0 109.549 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.494 ' O ' ' CD1' ' C' ' 66' ' ' LEU . 0.1 OUTLIER -81.51 -23.05 37.57 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' C' ' 63' ' ' ALA . 18.3 m -78.05 -43.86 28.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.068 -1.02 . . . . 0.0 108.711 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' C' ' 69' ' ' ALA . 1.6 p-10 -58.15 -21.86 48.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.611 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -78.79 -47.53 16.53 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.55 -22.42 30.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.0 -17.66 63.29 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.438 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.567 ' O ' ' N ' ' C' ' 74' ' ' ASP . 38.3 m80 -143.87 -53.45 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 0.0 109.291 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.2 p 45.04 15.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.799 0.809 . . . . 0.0 109.283 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' C' ' 72' ' ' HIS . 89.8 m-20 -131.76 9.66 4.62 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -174.28 27.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.265 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.3 ptt? -78.57 -24.37 0.43 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.472 -0.767 . . . . 0.0 111.783 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.0 Cg_exo -53.24 -29.47 46.94 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.79 1.66 . . . . 0.0 112.571 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.438 ' O ' ' OG ' ' C' ' 81' ' ' SER . 8.5 t-20 -94.15 -11.16 31.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 109.828 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.27 -58.16 3.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.153 -0.967 . . . . 0.0 109.281 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 mt -81.34 13.87 2.72 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 108.796 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 2.5 p -59.15 -15.84 16.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 109.809 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.51 -53.58 6.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.0 109.831 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.504 HD22 HBA1 ' C' ' 142' ' ' HEC . 3.5 mt -44.73 -42.24 7.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.389 -0.819 . . . . 0.0 108.928 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 66.7 p -54.69 -29.17 52.18 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.552 -0.717 . . . . 0.0 109.446 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' C' ' 82' ' ' ALA . 49.2 t0 -82.55 -16.93 46.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.396 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.8 tt -81.0 -62.32 1.7 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.918 -1.113 . . . . 0.0 111.241 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.4 p-80 -76.95 -21.47 54.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.86 -1.15 . . . . 0.0 111.16 -178.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.91 -29.78 23.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.77 -1.206 . . . . 0.0 110.207 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' C' ' 90' ' ' LYS . 15.5 t-80 -99.79 -74.85 0.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 110.139 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' C' ' 89' ' ' HIS . 17.8 mtpp -51.96 -101.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.967 . . . . 0.0 109.985 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.465 ' H ' ' CD1' ' C' ' 91' ' ' LEU . 10.0 mp -45.17 -31.77 1.58 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.827 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 58.16 41.93 22.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.503 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' C' ' 87' ' ' HIS . 5.9 t -66.95 168.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.372 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' C' ' 96' ' ' VAL . 1.1 p-10 -123.51 152.14 64.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.34 -0.85 . . . . 0.0 109.272 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -41.73 -14.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.666 2.244 . . . . 0.0 112.584 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . 0.799 HG13 ' HB3' ' B' ' 99' ' ' ASP . 46.7 t -59.24 -28.33 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 109.934 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.656 HD21 ' N ' ' C' ' 97' ' ' ASN . 0.6 OUTLIER -79.45 -24.91 42.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.664 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -65.62 -42.03 91.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.584 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -47.22 -30.26 2.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' C' ' 100' ' ' LEU . 3.7 mm? -84.07 -60.04 2.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.593 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.71 ' CD2' HBB3 ' C' ' 142' ' ' HEC . 6.5 tt -53.25 -20.9 4.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.736 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -77.6 -59.08 2.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 109.763 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.808 ' HE2' ' HH ' ' D' ' 35' ' ' TYR . 32.1 m170 -64.61 -26.6 68.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.837 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 95.2 m -61.0 -58.02 10.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 0.0 109.869 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.94 -30.9 1.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.5 mt -74.97 -52.29 11.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.155 -0.966 . . . . 0.0 109.616 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.29 -24.69 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.493 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 24.7 m -73.71 -63.25 1.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' C' ' 113' ' ' LEU . 18.9 mt -53.77 -33.68 56.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.372 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.3 -42.28 9.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.74 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.37 -56.0 4.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -68.28 -67.5 0.46 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.608 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -111.87 93.52 21.1 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' C' ' 113' ' ' LEU . 98.5 Cg_exo -43.44 178.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.406 2.071 . . . . 0.0 113.105 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.59 -38.25 17.31 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.666 0.746 . . . . 0.0 109.312 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 4.8 mt-10 77.87 1.24 2.84 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 61.88 38.5 14.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.793 -0.567 . . . . 0.0 111.268 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.735 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.7 OUTLIER -87.59 120.95 71.24 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.73 -1.231 . . . . 0.0 108.197 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.43 19.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.285 1.99 . . . . 0.0 112.816 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -150.74 -33.22 0.16 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.726 -1.234 . . . . 0.0 110.962 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.539 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 10.8 p -45.57 -48.09 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.876 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.539 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 20.2 m-70 -71.18 -43.81 66.73 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.451 -0.78 . . . . 0.0 108.917 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.74 -20.23 64.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.329 -0.857 . . . . 0.0 109.15 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.57 ' N ' ' O ' ' C' ' 120' ' ' ALA . 12.1 p -66.38 -62.72 1.32 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.21 -0.931 . . . . 0.0 110.215 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.513 ' N ' ' OG ' ' C' ' 124' ' ' SER . 5.6 mt -70.23 -25.1 63.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.166 -0.959 . . . . 0.0 109.736 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -74.47 -45.39 46.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.087 -1.008 . . . . 0.0 109.784 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.45 -50.47 5.93 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.044 -1.035 . . . . 0.0 110.127 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.451 ' CD2' ' CD2' ' C' ' 2' ' ' LEU . 28.5 t80 -48.44 -22.35 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.912 -1.118 . . . . 0.0 109.453 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.615 HD22 HBB1 ' C' ' 142' ' ' HEC . 6.4 mt -74.55 -22.57 58.94 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.42 -32.31 72.26 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 13.8 t -80.16 -35.44 36.52 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.382 -0.824 . . . . 0.0 109.095 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 22.4 t -83.51 -30.71 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.149 -0.969 . . . . 0.0 108.57 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.564 ' N ' ' O ' ' C' ' 129' ' ' LEU . 42.1 t -76.25 -26.17 55.74 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.434 -0.792 . . . . 0.0 108.873 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' THR . . . . . 0.53 ' O ' ' N ' ' C' ' 138' ' ' SER . 19.5 m -66.85 -28.76 68.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.278 -0.889 . . . . 0.0 109.091 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.09 -47.52 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.11 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.19 -38.05 73.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.112 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 70.4 p -93.83 -15.76 24.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' SER . . . . . 0.647 ' HG ' ' H ' ' C' ' 139' ' ' LYS . 23.3 t 52.29 -144.51 0.61 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.885 . . . . 0.0 109.476 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . 0.647 ' H ' ' HG ' ' C' ' 138' ' ' SER . 53.0 tttp -170.79 -6.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.409 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -152.67 108.24 3.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 0.0 109.431 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.513 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.405 ' HD1' ' C ' ' D' ' 2' ' ' HIS . 0.5 OUTLIER -99.17 77.3 2.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.245 -0.91 . . . . 0.0 109.641 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mt -92.65 -170.89 2.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 109.193 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.403 ' O ' ' N ' ' D' ' 6' ' ' GLU . 2.9 p -111.14 129.8 23.64 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.828 . . . . 0.0 108.938 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -40.82 -24.95 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.305 2.003 . . . . 0.0 112.439 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' D' ' 4' ' ' THR . 48.6 mt-10 -86.67 -48.63 8.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.858 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -79.61 -34.41 40.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.94 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.506 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -65.04 -34.86 79.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -0.964 . . . . 0.0 109.362 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 27.1 t -69.1 -23.6 64.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.11 -0.994 . . . . 0.0 109.335 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.55 -54.96 4.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.903 . . . . 0.0 110.189 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.71 -26.47 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.004 -1.06 . . . . 0.0 108.277 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 34.2 m -84.61 -54.31 4.81 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.395 0.616 . . . . 0.0 109.859 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -45.04 -31.09 1.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 0.0 109.898 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -24.68 63.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.625 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . 0.628 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 2.1 t90 -48.27 -27.51 2.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.14 -52.37 7.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.505 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 1.1 mppt? -64.44 -15.59 60.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.356 -1.085 . . . . 0.0 109.047 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.2 114.84 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.671 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' D' ' 22' ' ' GLU . 2.4 m-80 -81.21 77.35 8.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 108.855 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' D' ' 19' ' ' ASN . 76.5 t -43.11 -21.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.439 -0.788 . . . . 0.0 109.926 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' D' ' 19' ' ' ASN . 0.8 OUTLIER -83.84 11.72 7.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.658 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' D' ' 19' ' ' ASN . 36.6 mt-10 -156.13 -55.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 109.477 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -48.03 -36.23 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.534 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.79 -57.67 9.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.77 -35.87 39.81 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.21 -26.87 59.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.21 -48.12 65.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.948 . . . . 0.0 109.516 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 40.9 mt -83.09 -30.49 27.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.452 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.08 -59.11 10.62 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . 0.583 ' NH2' ' SD ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -57.53 -40.78 79.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -1.085 . . . . 0.0 109.346 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' D' ' 30' ' ' ARG . 2.3 tt -43.81 -38.31 3.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -79.94 -21.79 43.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' D' ' 30' ' ' ARG . 15.6 t -86.11 -63.98 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.25 -22.88 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 109.297 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . 0.808 ' HH ' ' HE2' ' C' ' 103' ' ' HIS . 48.5 m-85 -150.13 78.79 7.84 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 109.501 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' D' ' 38' ' ' THR . 16.6 Cg_exo -65.5 -28.12 53.83 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.988 2.459 . . . . 0.0 112.621 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . 0.538 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 0.5 OUTLIER -46.63 -19.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.81 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.614 HG23 HBC2 ' D' ' 147' ' ' HEC . 17.5 m -96.16 61.37 2.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.219 -0.926 . . . . 0.0 109.375 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.02 24.3 6.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 109.557 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -84.35 -25.86 28.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.119 -0.988 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -100.97 34.53 2.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 0.479 ' HE1' ' CBC' ' D' ' 147' ' ' HEC . 64.5 m-85 -135.92 17.51 3.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 109.431 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' D' ' 44' ' ' SER . 0.0 OUTLIER -85.05 -30.67 23.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.418 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.508 ' H ' ' CD ' ' D' ' 43' ' ' GLU . 39.3 t -83.13 -10.78 58.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.491 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -73.91 1.12 11.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.315 -0.866 . . . . 0.0 109.435 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.9 178.7 0.18 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 48.78 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.157 . . . . 0.0 109.441 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 tp -158.91 19.49 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.355 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -53.28 -39.06 63.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' THR . . . . . 0.428 ' O ' ' N ' ' D' ' 52' ' ' ASP . 1.2 p -145.66 153.7 51.2 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.844 . . . . 0.0 109.053 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.64 -19.37 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.276 1.984 . . . . 0.0 112.168 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' D' ' 52' ' ' ASP . 0.6 OUTLIER -81.39 -44.54 17.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.23 -19.92 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . 0.412 ' N ' ' C ' ' D' ' 52' ' ' ASP . 97.5 t -66.2 -63.16 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' MET . . . . . 0.583 ' SD ' ' NH2' ' D' ' 30' ' ' ARG . 11.4 mmt -52.25 -22.08 4.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.581 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.18 -15.92 70.77 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' D' ' 60' ' ' VAL . 0.3 OUTLIER -73.38 136.46 78.44 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.294 -1.121 . . . . 0.0 109.269 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.38 -53.41 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.343 2.028 . . . . 0.0 112.33 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . 0.468 ' N ' ' ND2' ' D' ' 57' ' ' ASN . 17.3 mtpp -52.42 -48.99 65.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . 0.565 ' H ' ' ND2' ' D' ' 57' ' ' ASN . 99.5 t -49.73 -37.47 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . 0.523 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 50.9 mtpt -79.15 -33.91 43.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.502 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.84 -29.05 35.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 109.619 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 0.949 ' HE1' ' CHA' ' D' ' 147' ' ' HEC . 1.8 t60 -69.09 -23.81 64.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.57 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.27 -38.0 91.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 30.8 mmtm -60.96 -32.1 71.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -1.15 . . . . 0.0 109.264 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . 0.484 ' O ' HMA3 ' D' ' 147' ' ' HEC . 37.0 mmtt -65.8 -61.44 2.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 109.419 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 1.193 HG21 ' CHB' ' D' ' 147' ' ' HEC . 43.8 t -56.94 -24.42 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.8 -42.55 60.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.184 -0.947 . . . . 0.0 109.275 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.79 -39.76 17.7 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.73 -38.25 67.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 0.0 109.475 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -61.93 -32.64 73.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' SER . . . . . 0.628 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 13.6 m -88.53 -31.89 18.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . 0.498 ' CG ' ' HG1' ' D' ' 84' ' ' THR . 43.0 t0 -49.54 -42.35 43.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.89 . . . . 0.0 109.515 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.2 -60.07 8.52 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.479 HD12 ' H ' ' D' ' 75' ' ' LEU . 5.0 mp -57.02 -26.43 60.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -1.101 . . . . 0.0 109.406 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.18 -0.42 49.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.462 ' C ' ' H ' ' D' ' 79' ' ' ASP . 76.0 t60 -171.07 64.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.536 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 53.9 mt -72.34 12.21 0.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' D' ' 77' ' ' HIS . 2.8 m-20 -71.88 -20.76 61.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.428 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -171.62 109.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.414 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -79.78 -58.48 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -47.68 -23.99 0.82 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.95 -61.93 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.5 t -66.56 -47.14 73.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -1.154 . . . . 0.0 109.425 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 68.8 m-85 -70.85 15.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.495 -0.753 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -69.5 -38.74 77.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.625 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' THR . . . . . 0.444 ' HG1' ' H ' ' D' ' 88' ' ' LEU . 17.9 p -83.72 -51.75 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.605 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.444 ' H ' ' HG1' ' D' ' 87' ' ' THR . 26.1 mt -52.92 -24.93 10.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.564 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 99.1 p -81.88 -40.66 22.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.234 -0.916 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -81.42 -22.59 38.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.609 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 4.2 tt -82.17 -48.51 11.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 110.089 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.532 ' NE2' ' O ' ' D' ' 141' ' ' LEU . 1.9 p-80 -75.11 -22.26 58.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.915 -1.116 . . . . 0.0 110.19 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . 0.458 ' SG ' ' CE1' ' D' ' 145' ' ' TYR . 51.2 t -83.76 -60.17 2.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.142 -0.974 . . . . 0.0 111.358 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 12.8 t70 -86.82 -27.38 23.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.074 -1.016 . . . . 0.0 111.835 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . 0.531 ' O ' ' CE1' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -84.65 -49.94 8.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.727 -1.233 . . . . 0.0 110.613 -178.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.485 ' C ' ' CG ' ' D' ' 97' ' ' HIS . 8.3 mp -86.55 -34.61 19.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.823 -1.173 . . . . 0.0 109.905 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' D' ' 94' ' ' ASP . 3.3 m80 71.72 36.98 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.89 . . . . 0.0 109.612 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.91 134.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.194 -0.942 . . . . 0.0 109.314 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . 0.867 ' HB3' HG13 ' A' ' 96' ' ' VAL . 3.8 m-20 -81.76 151.63 68.1 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.356 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . 0.508 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 66.7 Cg_exo -47.25 -173.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.433 2.088 . . . . 0.0 112.277 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 57.67 53.09 7.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.521 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' D' ' 100' ' ' PRO . 69.3 m-80 -159.23 -34.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.515 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.84 -54.56 7.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -57.08 -22.37 38.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 tt -76.7 -41.7 44.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.509 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 1.166 ' CD1' ' CHC' ' D' ' 147' ' ' HEC . 4.9 tt -68.54 -56.64 7.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.203 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.4 -20.18 2.28 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -85.68 -55.65 3.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -1.139 . . . . 0.0 109.978 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.07 -24.78 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.078 -1.014 . . . . 0.0 109.613 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.45 -59.12 5.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.284 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 t -59.01 -39.92 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.595 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . 0.421 ' O ' ' CE1' ' D' ' 116' ' ' HIS . 76.2 m -48.88 -43.7 39.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 109.622 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 70.0 t -55.97 -53.43 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.412 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . 0.465 ' H ' ' CD1' ' D' ' 114' ' ' LEU . 9.3 mp -49.88 -41.92 46.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' D' ' 119' ' ' GLY . . . -47.9 -41.54 24.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.735 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.668 ' HD1' ' N ' ' D' ' 116' ' ' HIS . 0.4 OUTLIER -68.84 -52.32 31.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.537 -179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 74.9 m80 -69.1 -17.65 63.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.738 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 64.0 m-85 -156.82 64.45 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.522 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' D' ' 115' ' ' ALA . . . -76.4 -21.26 75.7 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -72.78 -29.3 63.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.157 . . . . 0.0 109.375 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' D' ' 123' ' ' THR . 63.3 mm-40 -78.56 -15.46 58.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -69.84 59.77 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.321 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.466 ' OG1' ' CG2' ' D' ' 126' ' ' VAL . 12.0 p -59.05 150.95 59.09 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 108.916 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.3 Cg_exo -44.09 -58.12 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.414 2.076 . . . . 0.0 112.755 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 27.6 Cg_endo -61.9 -46.62 12.88 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.117 1.878 . . . . 0.0 112.033 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . 0.466 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 40.3 t -66.68 -18.33 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.695 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -83.13 -26.4 31.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.114 -0.992 . . . . 0.0 109.703 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 0.588 ' CB ' HD11 ' C' ' 34' ' ' LEU . . . -68.73 -32.08 71.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.051 -1.03 . . . . 0.0 109.572 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.37 26.45 0.91 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . 0.644 ' CG ' ' N ' ' D' ' 131' ' ' GLN . 5.8 p90 -74.6 -52.19 12.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.813 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . 1.047 ' OE1' ' HZ ' ' C' ' 36' ' ' PHE . 36.6 tt0 -86.03 -38.98 17.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.146 -0.972 . . . . 0.0 110.023 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . 1.021 ' HG3' ' O ' ' B' ' 146' ' ' HIS . 32.1 ttpt -50.9 -34.55 28.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 110.981 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . 0.678 ' CG1' ' H ' ' D' ' 134' ' ' VAL . 7.1 p -65.18 -64.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.865 -1.147 . . . . 0.0 109.87 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.678 ' H ' ' CG1' ' D' ' 133' ' ' VAL . 1.8 m -73.83 -14.65 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.409 -0.807 . . . . 0.0 109.826 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' D' ' 131' ' ' GLN . . . -45.87 -23.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.099 -1.001 . . . . 0.0 109.662 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -82.6 -26.36 46.82 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' D' ' 134' ' ' VAL . 75.0 t -80.04 -21.36 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -1.159 . . . . 0.0 109.441 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.8 -51.06 71.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 109.659 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.78 -22.42 53.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.0 88.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 20.2 mt -84.03 15.65 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.587 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.69 -1.42 2.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.304 -0.872 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . 0.432 ' CD2' ' O ' ' D' ' 143' ' ' HIS . 21.8 t-160 -79.98 -26.53 39.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.47 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.525 ' C ' ' HD1' ' D' ' 146' ' ' HIS . 12.3 mptt -73.28 -11.35 60.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . 0.458 ' CE1' ' SG ' ' D' ' 93' ' ' CYS . 15.8 m-85 -72.84 7.11 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.942 . . . . 0.0 109.24 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 1.009 ' O ' ' HG3' ' B' ' 132' ' ' LYS . 7.6 p-80 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.773 HMA2 ' CB ' ' A' ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 1.165 ' CHB' HG21 ' B' ' 67' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 0.772 HMA2 ' CB ' ' C' ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.193 ' CHB' HG21 ' D' ' 67' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 3.0 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 3' ' ' SER . 3.3 tp 75.68 174.32 0.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.335 -0.853 . . . . 0.0 109.537 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.623 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 164.56 -38.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 110.516 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 3' ' ' SER . 76.4 Cg_exo -49.62 -173.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.327 2.018 . . . . 0.0 112.966 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -75.81 -15.86 60.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 0.0 110.073 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' A' ' 127' ' ' LYS . 4.9 p30 -39.03 -38.29 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.301 -0.875 . . . . 0.0 109.554 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 12.9 mtmm -57.41 -58.41 8.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 108.958 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 m -51.51 -31.83 25.33 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 108.989 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -76.61 -34.71 58.36 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.8 t -72.73 -49.91 37.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.16 -42.31 63.3 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.66 -60.78 3.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.409 -0.807 . . . . 0.0 109.389 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.62 -34.11 57.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.113 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -17.69 61.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.379 -0.826 . . . . 0.0 109.077 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.44 -45.11 10.07 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -68.72 -39.8 80.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -1.134 . . . . 0.0 108.859 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.1 t -60.92 -65.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.603 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 58.06 -136.73 50.63 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.06 27.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.474 -1.016 . . . . 0.0 110.329 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.603 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.7 m-70 -131.44 27.1 4.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -90.96 -63.83 1.21 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.695 -0.628 . . . . 0.0 109.917 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.98 -14.47 0.13 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.4 mt-10 -85.06 -56.33 3.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -1.056 . . . . 0.0 109.633 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.8 m-30 -57.95 -43.93 86.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.328 -0.858 . . . . 0.0 109.111 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.03 -22.88 56.33 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.05 -33.91 59.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -1.129 . . . . 0.0 109.689 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' OE2' ' NE2' ' A' ' 112' ' ' HIS . 47.2 mt-10 -69.17 -20.18 64.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.282 -0.886 . . . . 0.0 109.687 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -19.68 59.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.344 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.7 mt -72.14 -48.11 46.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 109.6 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.46 -24.79 63.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.211 -0.93 . . . . 0.0 109.503 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.918 HH11 ' HG2' ' B' ' 127' ' ' GLN . 50.2 ttm-85 -76.1 -21.16 56.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.206 -0.934 . . . . 0.0 109.345 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.924 ' HE3' ' CBC' ' A' ' 142' ' ' HEC . 54.0 ttp -82.24 -50.7 8.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.467 ' CD2' ' OG1' ' A' ' 39' ' ' THR . 9.4 m-85 -52.59 -44.34 65.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.701 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.679 ' HB3' ' HB1' ' B' ' 128' ' ' ALA . 6.5 mt -67.59 -58.7 4.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.975 . . . . 0.0 109.682 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.671 ' HA ' ' OE1' ' B' ' 131' ' ' GLN . 40.2 m -48.47 -34.03 10.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.905 . . . . 0.0 109.755 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 35' ' ' SER . 3.0 m-85 -146.73 90.46 5.5 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.232 -0.918 . . . . 0.0 109.397 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 39' ' ' THR . 48.4 Cg_exo -53.51 -19.32 13.32 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.72 2.28 . . . . 0.0 112.149 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 37' ' ' PRO . 12.9 p -42.64 -18.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.405 -0.809 . . . . 0.0 110.092 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 37' ' ' PRO . 46.7 p -75.42 -22.29 57.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.928 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.537 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 1.8 mptm? -46.55 -44.92 18.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.912 . . . . 0.0 109.853 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.417 HG22 ' CD2' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -62.52 -18.33 61.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.658 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 39' ' ' THR . 55.8 m-85 -108.78 42.74 1.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 109.166 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.664 ' O ' ' CG ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -123.67 47.92 1.96 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.52 -0.737 . . . . 0.0 110.327 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 43' ' ' PHE . 31.9 Cg_endo -65.34 -3.53 7.71 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.469 2.113 . . . . 0.0 111.904 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.477 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -169.14 59.31 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.594 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -146.1 66.36 1.2 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' A' ' 49' ' ' SER . 17.0 m-20 -41.05 -18.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.265 -0.897 . . . . 0.0 110.214 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 46' ' ' PHE . 1.1 mt 51.94 9.8 0.1 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.603 ' HG ' ' N ' ' A' ' 50' ' ' HIS . 10.7 t -67.18 155.87 37.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.38 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.614 ' HD1' ' N ' ' A' ' 51' ' ' GLY . 11.4 t-80 -65.24 139.84 58.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.542 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.614 ' N ' ' HD1' ' A' ' 50' ' ' HIS . . . 54.52 30.62 50.63 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.9 t -63.24 -98.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -1.15 . . . . 0.0 109.376 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 172.56 -39.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.862 . . . . 0.0 109.487 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -74.77 -20.1 59.94 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.275 -0.891 . . . . 0.0 109.44 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -84.72 -41.09 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -78.95 -26.48 43.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.862 . . . . 0.0 109.054 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.416 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . . . -80.55 -21.94 63.23 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.565 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -79.02 -39.31 34.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -1.125 . . . . 0.0 109.558 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.79 -47.67 30.69 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 51.2 mttp -52.45 -23.78 6.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 0.0 109.804 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.639 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 1.7 mmpp? -72.08 -42.49 66.11 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.149 -0.969 . . . . 0.0 109.034 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 t -70.69 -48.24 59.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.52 -30.5 70.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.286 -0.884 . . . . 0.0 109.071 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.9 t0 -68.4 -32.59 72.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.927 . . . . 0.0 108.738 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.451 ' CB ' HMB3 ' A' ' 142' ' ' HEC . . . -68.46 -49.42 59.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.407 -0.808 . . . . 0.0 108.983 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.61 -39.93 93.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.274 -0.891 . . . . 0.0 108.817 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -70.69 -49.77 43.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.264 -0.898 . . . . 0.0 108.612 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -58.39 -21.03 48.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.47 -46.83 12.03 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -63.59 -22.83 31.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -59.34 -25.97 64.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 74' ' ' ASP . 40.5 m80 -147.14 -48.4 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.855 . . . . 0.0 109.402 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.4 p 44.99 13.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.752 0.787 . . . . 0.0 109.47 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 72' ' ' HIS . 37.3 m-20 -135.52 10.75 3.45 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 3.9 m-20 -174.94 26.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 15.0 ptt? -78.53 -22.59 0.39 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 111.706 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 76' ' ' MET . 49.7 Cg_exo -55.05 -17.93 15.85 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.506 1.471 . . . . 0.0 112.221 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.407 HD21 ' N ' ' A' ' 78' ' ' ASN . 1.6 m-80 -94.14 -46.81 6.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.272 -0.893 . . . . 0.0 109.387 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.02 -42.3 99.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.825 . . . . 0.0 109.15 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.76 9.16 8.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.489 -0.757 . . . . 0.0 108.996 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -57.33 -25.55 59.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.375 -0.828 . . . . 0.0 109.637 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -56.4 -57.99 9.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.119 -0.988 . . . . 0.0 109.463 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.477 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 6.6 mt -45.31 -50.45 11.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 135' ' ' VAL . 3.4 m -49.25 -38.45 26.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 82' ' ' ALA . 27.9 t70 -82.52 -17.29 45.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.839 . . . . 0.0 109.865 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -70.7 -51.9 24.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.58 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 14.3 p-80 -92.16 -21.92 20.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.89 -1.131 . . . . 0.0 110.689 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.64 -51.32 69.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.852 -1.155 . . . . 0.0 109.907 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -155.69 63.78 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.94 . . . . 0.0 109.906 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -163.06 0.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.865 . . . . 0.0 109.29 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.6 tp -171.78 -31.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 51.76 47.74 24.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.46 136.97 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.484 ' OD2' ' CE1' ' D' ' 97' ' ' HIS . 22.5 m-20 -58.33 128.41 82.39 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 97' ' ' ASN . 73.0 Cg_endo -77.09 -18.62 14.3 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.302 2.002 . . . . 0.0 112.056 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -46.75 -14.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.499 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 95' ' ' PRO . 20.7 m-80 -79.04 -24.6 43.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.506 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -52.98 -50.59 63.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.527 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' O ' ' CE1' ' A' ' 103' ' ' HIS . 47.0 mttp -56.61 -25.98 54.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.71 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.5 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.8 mt -84.2 -34.81 23.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 109.492 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.501 HD21 ' CHC' ' A' ' 142' ' ' HEC . 8.3 tp -74.86 -29.14 60.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 109.717 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -73.33 -39.13 65.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.963 . . . . 0.0 109.718 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.712 ' CB ' HD22 ' B' ' 108' ' ' ASN . 7.1 m170 -80.73 -26.85 37.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.649 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 33.5 m -64.26 -53.79 43.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.168 -0.958 . . . . 0.0 109.755 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -46.7 -28.67 1.57 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.937 . . . . 0.0 109.601 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.92 -31.53 35.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 109.955 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.7 t -82.64 -26.59 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 109.649 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.63 ' HG1' ' H ' ' A' ' 109' ' ' LEU . 5.1 p -74.41 -62.07 1.65 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 109.567 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.63 ' H ' ' HG1' ' A' ' 108' ' ' THR . 17.7 mt -46.06 -35.31 4.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 0.0 109.416 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.77 -40.75 66.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.952 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' B' ' 122' ' ' PHE . . . -73.3 -40.9 64.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.702 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.531 ' NE2' ' OE2' ' A' ' 27' ' ' GLU . 64.5 m-70 -89.67 -78.77 0.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.545 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -107.7 113.49 61.34 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.511 ' O ' ' O ' ' A' ' 113' ' ' LEU . 77.8 Cg_exo -45.93 -173.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.235 1.957 . . . . 0.0 112.282 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.642 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -69.25 -53.2 21.06 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.473 -0.767 . . . . 0.0 109.078 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.642 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 26.0 mt-10 125.65 -0.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.502 ' O ' ' CD2' ' A' ' 117' ' ' PHE . 56.6 t80 58.04 33.56 23.31 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.408 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.795 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -106.59 117.22 57.5 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.14 20.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.146 1.898 . . . . 0.0 112.708 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.795 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -146.42 -34.07 0.3 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 0.0 110.211 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 14.0 p -47.71 -47.04 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 109.926 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.484 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -67.85 -33.64 75.15 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.4 -0.813 . . . . 0.0 109.287 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.32 -20.24 32.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.696 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.5 m -69.06 -62.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.12 -19.71 64.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.0 -1.062 . . . . 0.0 109.1 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.15 -46.79 13.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.71 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -89.84 -39.06 13.32 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.792 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.499 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 27.8 t80 -47.86 -20.66 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.915 -1.116 . . . . 0.0 108.666 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' N ' ' C ' ' A' ' 127' ' ' LYS . 29.1 mt -70.73 -19.64 62.72 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -55.08 -38.38 68.01 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.487 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 5.4 t -77.92 -29.72 50.17 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.32 -39.11 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -68.08 -20.97 64.99 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.192 -0.943 . . . . 0.0 109.04 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 138' ' ' SER . 94.9 m -69.11 -39.53 78.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.505 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -76.51 -31.12 19.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.264 -0.897 . . . . 0.0 109.433 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.511 ' O ' ' NE2' ' A' ' 87' ' ' HIS . 0.5 OUTLIER -84.74 -23.84 29.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.868 . . . . 0.0 109.18 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.5 m -100.25 -15.57 18.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.371 -0.83 . . . . 0.0 109.453 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 134' ' ' THR . 1.8 t -63.61 140.35 58.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.5 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -84.96 -131.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -71.27 -111.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.47 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.7 ' CG2' ' H ' ' B' ' 2' ' ' HIS . 7.7 p . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.7 ' H ' ' CG2' ' B' ' 1' ' ' VAL . 20.6 t-80 51.3 88.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.897 -1.127 . . . . 0.0 109.057 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -133.82 -171.96 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.449 -0.782 . . . . 0.0 109.317 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.419 ' O ' ' N ' ' B' ' 6' ' ' GLU . 12.6 p -90.0 134.86 30.96 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.25 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -41.61 -22.88 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.421 2.081 . . . . 0.0 112.357 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' B' ' 4' ' ' THR . 9.6 mp0 -79.28 -52.25 8.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.953 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.03 -60.58 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.692 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.46 ' O ' ' OG1' ' B' ' 12' ' ' THR . 5.0 ttpp -49.74 -51.75 36.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.823 . . . . 0.0 109.976 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -43.57 -23.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.63 -0.669 . . . . 0.0 110.235 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -82.94 -56.17 3.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.057 -1.027 . . . . 0.0 109.826 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.78 -24.56 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 10.9 m -71.61 -42.79 67.24 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.441 0.638 . . . . 0.0 109.544 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.59 67.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.05 -27.45 8.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.965 . . . . 0.0 109.445 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . 0.562 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.4 OUTLIER -52.37 -17.7 1.3 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.184 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.63 -41.77 28.43 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -28.75 35.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -1.22 . . . . 0.0 109.231 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 78.0 t -58.47 114.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.844 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' B' ' 21' ' ' ASP . 7.9 t-20 -81.76 67.08 7.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.237 -0.915 . . . . 0.0 108.726 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' B' ' 19' ' ' ASN . 84.4 t -42.75 -20.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.475 -0.766 . . . . 0.0 109.792 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' B' ' 19' ' ' ASN . 78.5 m-20 -75.55 2.72 10.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' B' ' 19' ' ' ASN . 33.9 mt-10 -155.57 -47.94 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -47.09 -33.06 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.507 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.72 -55.58 19.25 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.44 -36.75 93.01 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -76.09 -47.32 24.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -1.162 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.25 -33.84 59.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.15 -57.81 3.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.875 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.81 -45.06 55.67 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -50.33 -36.39 31.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -1.119 . . . . 0.0 109.489 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . 0.745 ' CD2' HBC1 ' B' ' 147' ' ' HEC . 42.9 tp -49.46 -38.9 31.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -81.1 -21.83 39.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 109.538 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 t -77.86 -64.32 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 0.0 109.703 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -22.76 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.604 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -141.33 81.34 15.64 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.272 -0.892 . . . . 0.0 109.404 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.75 7.47 4.84 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.687 2.258 . . . . 0.0 112.475 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . 0.404 ' C ' ' H ' ' B' ' 39' ' ' GLN . 1.5 p-90 -66.01 -19.79 65.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.097 -1.002 . . . . 0.0 109.476 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 82.3 p -76.89 41.78 0.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . 0.427 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 35.1 tt0 -84.1 26.41 0.75 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.89 . . . . 0.0 109.372 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.13 -49.2 4.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.347 -0.845 . . . . 0.0 109.582 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -88.22 3.35 49.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' B' ' 39' ' ' GLN . 8.0 p90 -52.49 -30.12 28.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.675 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -49.16 -24.89 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.606 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 39.1 t -95.36 -9.02 34.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 0.0 109.536 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' B' ' 42' ' ' PHE . 16.1 m-85 -87.03 21.82 2.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 109.497 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -98.99 2.44 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' B' ' 47' ' ' ASP . 27.2 p-10 -156.86 112.66 2.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -1.125 . . . . 0.0 109.606 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' B' ' 48' ' ' LEU . 9.4 mp -80.01 24.54 0.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.15 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.437 ' H ' ' C ' ' B' ' 47' ' ' ASP . 29.2 t -43.09 -29.97 0.4 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.385 -0.822 . . . . 0.0 109.686 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' THR . . . . . 0.415 ' O ' ' N ' ' B' ' 53' ' ' ALA . 73.1 p -148.74 139.02 13.15 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 109.16 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -39.35 -36.12 0.88 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.442 2.095 . . . . 0.0 112.411 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.29 -33.77 61.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.847 . . . . 0.0 109.624 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -48.86 -19.81 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.563 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.56 -64.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.606 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' B' ' 55' ' ' MET . 1.9 mpt? -80.26 4.22 18.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.983 . . . . 0.0 109.467 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.02 -26.84 47.56 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' B' ' 53' ' ' ALA . 67.3 m-80 -84.79 141.84 38.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.095 -1.238 . . . . 0.0 109.423 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.05 -40.01 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.612 2.208 . . . . 0.0 112.245 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -47.39 78.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.549 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 89.9 t -50.79 -41.01 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.895 . . . . 0.0 109.58 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -79.09 -42.44 26.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.741 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.55 -30.27 71.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 0.65 ' HE2' HAD2 ' B' ' 147' ' ' HEC . 1.3 t-80 -66.21 -23.88 66.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.542 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.62 -46.69 74.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.51 ' HZ3' ' C ' ' B' ' 21' ' ' ASP . 8.3 mtpp -54.49 -29.42 50.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.576 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.85 -32.79 63.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.925 . . . . 0.0 109.579 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.778 HG21 ' C4A' ' B' ' 147' ' ' HEC . 34.8 t -81.32 -30.75 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.46 -44.61 57.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 109.39 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.95 -44.87 19.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.12 -45.75 86.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -1.175 . . . . 0.0 109.621 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.47 ' CE2' HMB2 ' B' ' 147' ' ' HEC . 14.0 m-85 -57.43 -51.29 70.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.625 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.562 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.9 t -57.54 -43.05 84.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -0.824 . . . . 0.0 109.644 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -48.38 -29.99 4.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.986 . . . . 0.0 109.445 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.43 -60.25 5.61 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.463 ' H ' HD13 ' B' ' 75' ' ' LEU . 4.9 mp -54.95 -23.69 20.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -1.113 . . . . 0.0 109.264 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.51 9.41 43.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.523 ' CE1' ' OD1' ' B' ' 80' ' ' ASN . 9.5 t-80 -170.77 70.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.958 . . . . 0.0 109.739 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.14 -7.75 58.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.185 -0.947 . . . . 0.0 109.387 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.63 -26.73 5.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.433 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.523 ' OD1' ' CE1' ' B' ' 77' ' ' HIS . 8.6 p-10 -172.33 41.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.289 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.536 ' CD2' ' N ' ' B' ' 81' ' ' LEU . 1.6 pt? -46.63 -18.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.36 -0.837 . . . . 0.0 109.849 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' B' ' 80' ' ' ASN . 59.6 mttm -79.93 -32.32 40.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.06 -1.025 . . . . 0.0 109.638 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.26 -23.01 55.9 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.7 OUTLIER -70.78 -42.99 69.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.102 -1.234 . . . . 0.0 109.733 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.483 ' N ' ' CG2' ' B' ' 84' ' ' THR . 30.9 m-85 -84.81 25.96 0.88 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.6 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.51 -26.94 55.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.264 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.48 ' HG1' ' N ' ' B' ' 88' ' ' LEU . 81.2 p -79.69 -54.89 5.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.311 -0.868 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.48 ' N ' ' HG1' ' B' ' 87' ' ' THR . 17.1 mt -47.97 -43.12 29.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.163 -0.961 . . . . 0.0 109.266 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' SER . . . . . 0.514 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 1.5 m -64.72 -38.89 92.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.192 -0.942 . . . . 0.0 109.555 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -82.1 -22.6 36.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.5 tt -90.29 -39.22 12.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.977 . . . . 0.0 109.744 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' B' ' 97' ' ' HIS . 4.0 m80 -77.75 -29.92 51.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.02 -1.05 . . . . 0.0 110.176 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' B' ' 94' ' ' ASP . 13.2 p -83.51 -48.62 10.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.048 -1.032 . . . . 0.0 110.81 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.639 ' N ' ' SG ' ' B' ' 93' ' ' CYS . 23.6 m-20 -87.33 -34.38 18.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.904 -1.123 . . . . 0.0 111.523 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -89.01 -51.84 5.4 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.815 -1.178 . . . . 0.0 111.01 -178.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 12.9 mt -98.3 -17.79 18.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.95 -1.094 . . . . 0.0 110.314 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 31.0 p80 42.6 33.8 0.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.396 -0.815 . . . . 0.0 110.204 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 68.0 t -58.25 127.44 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.158 -0.964 . . . . 0.0 109.031 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' B' ' 99' ' ' ASP . 4.6 p-10 -45.61 148.33 1.3 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 109.494 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' B' ' 102' ' ' ASN . 59.8 Cg_endo -72.99 -40.09 1.94 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.61 2.207 . . . . 0.0 112.342 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -67.76 52.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.486 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' B' ' 100' ' ' PRO . 56.0 t-20 -140.68 -49.7 0.44 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.274 -0.891 . . . . 0.0 109.644 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -46.23 -24.22 0.44 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.832 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -74.54 -20.01 60.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' B' ' 108' ' ' ASN . 43.1 mt -80.65 -59.55 2.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.548 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.925 HD21 ' CAB' ' B' ' 147' ' ' HEC . 8.2 tt -46.94 -35.13 6.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.523 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.27 -26.4 74.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . 0.712 HD22 ' CB ' ' A' ' 103' ' ' HIS . 32.1 t-20 -85.52 -19.24 31.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -1.172 . . . . 0.0 109.778 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 77.4 t -84.15 -24.69 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.596 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 tt -71.73 -60.0 2.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.52 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 11.7 t -51.39 -29.02 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 14.5 t -65.3 -41.35 94.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.183 -0.948 . . . . 0.0 109.571 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.06 -45.94 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.584 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.74 -26.55 68.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.634 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.493 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -68.12 -34.43 76.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.492 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.96 -62.85 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 109.398 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.614 ' ND1' ' CZ ' ' B' ' 118' ' ' PHE . 12.4 t-80 -55.82 -19.68 12.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 109.74 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.614 ' CZ ' ' ND1' ' B' ' 117' ' ' HIS . 67.5 m-85 -151.6 60.8 0.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -72.63 -16.93 77.78 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -69.41 -30.03 67.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.481 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -94.01 13.54 22.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.915 . . . . 0.0 109.822 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.578 ' CD2' ' HB3' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -81.43 33.31 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.46 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 13.1 p -47.73 130.11 11.2 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.5 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 45.5 Cg_exo -43.38 -51.9 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.194 1.929 . . . . 0.0 113.029 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 18.9 Cg_endo -58.84 -33.97 98.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.823 1.682 . . . . 0.0 111.883 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 49.7 t -82.41 -9.98 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 0.0 109.579 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . 0.918 ' HG2' HH11 ' A' ' 31' ' ' ARG . 13.9 tp60 -75.85 -59.78 2.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.679 ' HB1' ' HB3' ' A' ' 34' ' ' LEU . . . -61.08 -34.04 74.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.451 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.19 11.77 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 109.545 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' B' ' 128' ' ' ALA . 6.3 t80 -105.0 -55.25 2.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 109.704 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . 0.671 ' OE1' ' HA ' ' A' ' 35' ' ' SER . 6.5 pt20 -45.82 -44.2 13.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.928 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' B' ' 1' ' ' VAL . 21.0 mtmm -57.14 -50.04 74.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.979 . . . . 0.0 109.997 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.92 -46.95 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.133 -0.98 . . . . 0.0 109.984 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.39 -33.78 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.919 . . . . 0.0 110.197 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . -47.89 -27.26 2.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.975 -1.078 . . . . 0.0 109.394 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.77 -25.67 73.02 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.35 -49.25 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -1.125 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.62 -42.79 35.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -78.22 -23.47 47.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.41 3.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.86 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.53 -14.15 0.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.879 . . . . 0.0 109.368 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' B' ' 144' ' ' LYS . . . -93.95 4.67 53.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.362 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . 0.515 ' O ' ' CG ' ' B' ' 143' ' ' HIS . 11.0 t-160 -68.47 7.8 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.335 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' B' ' 142' ' ' ALA . 39.7 mmtt -139.25 -41.31 0.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.352 -0.842 . . . . 0.0 109.498 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.513 ' CE1' ' OXT' ' B' ' 146' ' ' HIS . 0.0 OUTLIER -56.19 -12.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 109.491 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.513 ' OXT' ' CE1' ' B' ' 145' ' ' TYR . 15.7 m-70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.711 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' C' ' 2' ' ' LEU . 2.9 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' C' ' 3' ' ' SER . 3.3 tp 75.68 174.4 0.24 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -0.849 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.618 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 164.45 -38.1 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.363 -0.835 . . . . 0.0 110.46 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' C' ' 3' ' ' SER . 77.3 Cg_exo -49.6 -173.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.305 2.003 . . . . 0.0 112.972 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.484 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -75.75 -15.84 60.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.405 -0.81 . . . . 0.0 110.147 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' C' ' 127' ' ' LYS . 4.8 p30 -39.11 -38.21 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.554 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.477 ' N ' ' OD1' ' C' ' 6' ' ' ASP . 12.9 mtmm -57.43 -58.37 8.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 108.932 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.8 m -51.57 -31.84 26.08 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 108.942 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -76.62 -34.75 58.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 51.7 t -72.62 -49.97 37.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.03 -42.46 63.08 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.62 -60.78 3.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.361 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.73 -33.98 57.4 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.378 -0.826 . . . . 0.0 109.162 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -17.73 61.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.081 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.35 -45.13 10.18 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -68.82 -39.74 79.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.227 -1.161 . . . . 0.0 108.849 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -60.86 -65.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 58.12 -136.69 50.69 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.12 27.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.464 -1.021 . . . . 0.0 110.302 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.618 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.6 m-70 -131.5 27.16 4.73 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.02 -63.88 1.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.611 -0.68 . . . . 0.0 109.869 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.91 -14.38 0.12 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.5 mt-10 -85.1 -56.34 3.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -1.055 . . . . 0.0 109.683 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.9 m-30 -58.03 -43.83 86.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.125 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.08 -22.83 56.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.07 -33.97 59.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.165 . . . . 0.0 109.69 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . 0.525 ' OE2' ' NE2' ' C' ' 112' ' ' HIS . 47.1 mt-10 -69.01 -20.27 64.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.716 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.61 -19.73 59.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.27 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -72.1 -48.07 46.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.349 -0.845 . . . . 0.0 109.681 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.54 -24.68 63.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.899 HH11 ' HG2' ' D' ' 127' ' ' GLN . 50.3 ttm-85 -76.15 -21.23 56.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.915 ' HE3' ' CBC' ' C' ' 142' ' ' HEC . 54.1 ttp -82.12 -50.65 8.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.49 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.46 ' CD2' ' OG1' ' C' ' 39' ' ' THR . 9.4 m-85 -52.72 -44.29 66.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.699 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.677 ' HB3' ' HB1' ' D' ' 128' ' ' ALA . 6.5 mt -67.51 -58.83 4.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.663 ' HA ' ' OE1' ' D' ' 131' ' ' GLN . 40.9 m -48.34 -34.08 10.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.802 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -146.67 90.42 5.53 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.94 . . . . 0.0 109.356 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' C' ' 39' ' ' THR . 48.2 Cg_exo -53.48 -19.33 13.21 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.745 2.297 . . . . 0.0 112.172 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' THR . . . . . 0.406 ' O ' ' CG2' ' C' ' 41' ' ' THR . 12.8 p -42.65 -18.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.43 -0.794 . . . . 0.0 110.117 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.561 ' N ' ' O ' ' C' ' 37' ' ' PRO . 45.6 p -75.44 -22.22 57.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 110.09 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' C' ' 43' ' ' PHE . 1.8 mptm? -46.59 -44.96 18.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' C' ' 38' ' ' THR . 0.0 OUTLIER -62.46 -18.37 61.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' C' ' 39' ' ' THR . 55.6 m-85 -108.81 42.85 1.33 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 109.135 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.656 ' O ' ' CG ' ' C' ' 43' ' ' PHE . 0.1 OUTLIER -123.79 47.94 2.01 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.475 -0.766 . . . . 0.0 110.343 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' C' ' 43' ' ' PHE . 31.8 Cg_endo -65.32 -3.56 7.74 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.459 2.106 . . . . 0.0 111.868 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.491 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER -169.11 59.3 0.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.879 . . . . 0.0 109.304 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -146.16 66.34 1.2 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' C' ' 49' ' ' SER . 17.0 m-20 -40.99 -18.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.274 -0.892 . . . . 0.0 110.299 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.578 ' N ' ' O ' ' C' ' 46' ' ' PHE . 1.1 mt 52.03 9.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.069 -1.02 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.591 ' HG ' ' N ' ' C' ' 50' ' ' HIS . 10.7 t -67.09 155.85 37.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.615 ' HD1' ' N ' ' C' ' 51' ' ' GLY . 11.3 t-80 -65.34 139.84 58.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . 0.615 ' N ' ' HD1' ' C' ' 50' ' ' HIS . . . 54.57 30.66 51.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 37.1 t -63.27 -98.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -1.122 . . . . 0.0 109.396 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . 172.56 -39.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.545 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -74.68 -20.22 59.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.41 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.0 t -84.63 -41.02 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -79.03 -26.4 43.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 109.083 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . 0.431 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -80.67 -21.79 63.23 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.577 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.3 OUTLIER -79.05 -39.28 34.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -1.132 . . . . 0.0 109.575 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.87 -47.66 31.18 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 51.3 mttp -52.45 -23.79 6.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -1.083 . . . . 0.0 109.696 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.632 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 1.7 mmpp? -72.11 -42.53 65.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.171 -0.955 . . . . 0.0 109.042 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 t -70.58 -48.31 59.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.453 -0.78 . . . . 0.0 108.969 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.55 -30.41 70.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.242 -0.911 . . . . 0.0 109.11 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 8.0 t0 -68.46 -32.54 72.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 108.693 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . 0.447 ' CB ' HMB3 ' C' ' 142' ' ' HEC . . . -68.56 -49.36 60.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.473 -0.767 . . . . 0.0 108.954 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.56 -40.05 93.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 108.744 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -70.67 -49.82 43.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -58.38 -20.96 48.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.51 -46.83 12.0 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -63.44 -23.0 32.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' C' ' 72' ' ' HIS . . . -59.3 -26.1 64.7 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' C' ' 74' ' ' ASP . 40.5 m80 -147.08 -48.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.424 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.4 p 45.06 12.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.783 0.802 . . . . 0.0 109.525 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' C' ' 72' ' ' HIS . 37.4 m-20 -135.45 10.68 3.47 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 3.9 m-20 -174.96 26.68 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.686 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 15.1 ptt? -78.63 -22.54 0.39 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.403 -0.811 . . . . 0.0 111.705 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' C' ' 76' ' ' MET . 49.7 Cg_exo -54.98 -18.02 15.73 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.547 1.498 . . . . 0.0 112.208 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -94.12 -46.77 6.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.96 . . . . 0.0 109.381 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.96 -42.36 99.03 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.294 -0.878 . . . . 0.0 109.183 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.76 9.22 8.28 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 108.994 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -57.48 -25.45 59.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 109.608 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -56.49 -58.02 9.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.377 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.478 ' O ' ' CE1' ' C' ' 87' ' ' HIS . 6.5 mt -45.17 -50.5 11.36 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' C' ' 135' ' ' VAL . 3.4 m -49.29 -38.36 27.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' C' ' 82' ' ' ALA . 27.9 t70 -82.51 -17.44 45.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 109.782 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -70.69 -51.83 25.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.567 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . 0.52 ' NE2' ' O ' ' C' ' 136' ' ' LEU . 14.3 p-80 -92.2 -21.8 20.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.965 -1.084 . . . . 0.0 110.754 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' C' ' 84' ' ' SER . . . -60.67 -51.37 69.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.838 -1.164 . . . . 0.0 109.881 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -155.66 63.9 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.88 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -163.16 1.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.259 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 60.5 tp -171.77 -32.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.299 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 51.7 47.82 24.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.626 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.62 136.88 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.407 ' OD2' ' CE1' ' B' ' 97' ' ' HIS . 22.3 m-20 -58.25 128.36 81.98 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.269 -0.894 . . . . 0.0 109.507 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' C' ' 97' ' ' ASN . 74.3 Cg_endo -77.01 -18.57 14.48 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.336 2.024 . . . . 0.0 112.194 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -46.72 -15.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 109.569 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' C' ' 95' ' ' PRO . 20.7 m-80 -78.97 -24.5 43.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.99 -50.65 63.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.4 ' O ' ' CE1' ' C' ' 103' ' ' HIS . 46.9 mttp -56.61 -25.96 54.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.73 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 9.8 mt -84.24 -34.62 23.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 109.592 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.501 HD21 ' CHC' ' C' ' 142' ' ' HEC . 8.3 tp -74.99 -29.09 60.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 109.714 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 66.6 m -73.36 -39.13 65.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.668 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.707 ' CB ' HD22 ' D' ' 108' ' ' ASN . 7.2 m170 -80.77 -26.81 37.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.299 -0.876 . . . . 0.0 109.644 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 33.0 m -64.32 -53.69 44.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.739 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -46.79 -28.59 1.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.968 . . . . 0.0 109.63 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 15.8 mt -80.94 -31.52 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 109.941 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 87.9 t -82.59 -26.66 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.03 -1.044 . . . . 0.0 109.683 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.615 ' HG1' ' H ' ' C' ' 109' ' ' LEU . 5.2 p -74.41 -62.06 1.65 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.189 -0.944 . . . . 0.0 109.585 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.615 ' H ' ' HG1' ' C' ' 108' ' ' THR . 17.5 mt -46.06 -35.22 4.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.87 -40.74 66.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.931 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . 0.588 ' HB3' ' CD2' ' D' ' 122' ' ' PHE . . . -73.37 -40.83 64.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.661 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . 0.525 ' NE2' ' OE2' ' C' ' 27' ' ' GLU . 64.7 m-70 -89.67 -78.77 0.35 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.571 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.4 OUTLIER -107.75 113.53 61.23 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' C' ' 113' ' ' LEU . 78.9 Cg_exo -45.99 -173.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.198 1.932 . . . . 0.0 112.292 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.65 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -69.46 -52.98 21.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 109.098 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.65 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 26.1 mt-10 125.48 -0.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' C' ' 117' ' ' PHE . 56.8 t80 58.02 33.52 23.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.344 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.784 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -106.51 117.3 57.39 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.3 20.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.134 1.889 . . . . 0.0 112.689 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.784 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -146.39 -34.11 0.3 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.026 -1.046 . . . . 0.0 110.232 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 14.0 p -47.71 -47.05 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 109.871 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.471 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 0.0 OUTLIER -67.94 -33.55 74.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.813 . . . . 0.0 109.259 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.27 -20.35 32.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.905 . . . . 0.0 109.713 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.542 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.5 m -68.99 -62.84 1.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.11 -19.69 64.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.951 -1.093 . . . . 0.0 109.076 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.18 -46.75 13.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.679 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -89.85 -39.02 13.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.007 . . . . 0.0 109.836 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.493 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 27.6 t80 -47.82 -20.74 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.966 -1.083 . . . . 0.0 108.629 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.431 ' N ' ' C ' ' C' ' 127' ' ' LYS . 29.5 mt -70.66 -19.66 62.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -55.09 -38.37 68.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' SER . . . . . 0.495 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 5.4 t -77.9 -29.74 50.3 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.28 -39.21 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.352 -0.842 . . . . 0.0 108.787 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -67.96 -21.03 65.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.922 . . . . 0.0 109.063 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' C' ' 138' ' ' SER . 93.7 m -69.15 -39.46 78.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.845 . . . . 0.0 109.46 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' C' ' 84' ' ' SER . 1.0 OUTLIER -76.62 -31.01 19.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.297 -0.877 . . . . 0.0 109.41 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' C' ' 87' ' ' HIS . 0.5 OUTLIER -84.76 -23.89 29.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.889 . . . . 0.0 109.13 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 43.0 m -100.23 -15.57 18.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.319 -0.863 . . . . 0.0 109.443 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' C' ' 134' ' ' THR . 1.8 t -63.62 140.32 58.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -84.97 -131.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -71.33 -111.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.426 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.486 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.69 ' CG2' ' H ' ' D' ' 2' ' ' HIS . 7.6 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.69 ' H ' ' CG2' ' D' ' 1' ' ' VAL . 20.2 t-80 51.29 88.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.098 -1.001 . . . . 0.0 109.082 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -133.79 -171.87 2.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.292 -179.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.417 ' O ' ' N ' ' D' ' 6' ' ' GLU . 12.6 p -90.06 134.88 30.83 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.88 . . . . 0.0 109.322 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -41.61 -22.94 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.423 2.082 . . . . 0.0 112.365 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . 0.421 ' N ' ' CD ' ' D' ' 6' ' ' GLU . 9.6 mp0 -79.16 -52.37 8.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -62.99 -60.56 3.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 109.754 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.458 ' O ' ' OG1' ' D' ' 12' ' ' THR . 5.0 ttpp -49.71 -51.87 35.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.94 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -43.51 -23.69 0.08 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.61 -0.681 . . . . 0.0 110.285 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.01 -56.14 3.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.027 -1.045 . . . . 0.0 109.763 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.75 -24.63 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 10.5 m -71.5 -42.83 67.53 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.455 0.645 . . . . 0.0 109.594 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.4 -27.63 68.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.746 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.94 -27.53 7.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . 0.559 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.4 OUTLIER -52.35 -17.82 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 109.155 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.47 -41.92 28.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.99 -28.73 35.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -1.204 . . . . 0.0 109.219 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 78.4 t -58.45 114.91 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.804 . . . . 0.0 109.886 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' D' ' 21' ' ' ASP . 7.9 t-20 -81.84 67.07 7.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.262 -0.899 . . . . 0.0 108.737 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' D' ' 19' ' ' ASN . 84.3 t -42.72 -20.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.467 -0.77 . . . . 0.0 109.835 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' D' ' 19' ' ' ASN . 78.5 m-20 -75.68 2.82 10.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.88 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' D' ' 19' ' ' ASN . 33.9 mt-10 -155.6 -47.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 53.1 t -47.1 -33.08 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 109.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.74 -55.61 19.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.47 -36.63 92.85 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -76.23 -47.21 24.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -1.119 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.27 -33.86 59.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.394 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.18 -57.77 3.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.958 . . . . 0.0 109.385 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.81 -45.03 55.69 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -50.37 -36.43 32.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -1.096 . . . . 0.0 109.486 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . 0.754 ' CD2' HBC1 ' D' ' 147' ' ' HEC . 42.9 tp -49.41 -38.85 30.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.354 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.13 -21.94 39.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 t -77.81 -64.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -0.99 . . . . 0.0 109.705 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -22.88 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.639 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -141.26 81.36 15.73 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.325 -0.86 . . . . 0.0 109.396 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.8 7.47 4.85 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.703 2.269 . . . . 0.0 112.449 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . 0.417 ' C ' ' H ' ' D' ' 39' ' ' GLN . 1.5 p-90 -65.97 -19.86 66.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.512 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 82.4 p -76.83 41.74 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . 0.421 ' O ' ' CD1' ' D' ' 42' ' ' PHE . 35.1 tt0 -84.03 26.34 0.74 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.383 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.11 -49.19 4.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.905 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -88.16 3.37 49.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' D' ' 39' ' ' GLN . 7.8 p90 -52.63 -30.14 29.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.601 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -49.11 -24.89 1.81 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.649 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 39.2 t -95.38 -8.99 34.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.537 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -87.05 21.88 2.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -99.13 2.45 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' D' ' 47' ' ' ASP . 27.2 p-10 -156.8 112.7 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' D' ' 48' ' ' LEU . 9.4 mp -80.04 24.57 0.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.172 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.43 ' H ' ' C ' ' D' ' 47' ' ' ASP . 29.1 t -43.09 -30.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.428 -0.795 . . . . 0.0 109.624 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' THR . . . . . 0.431 ' O ' ' N ' ' D' ' 53' ' ' ALA . 73.1 p -148.77 138.95 13.09 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 109.154 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -39.36 -36.1 0.88 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.458 2.105 . . . . 0.0 112.415 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.2 -33.86 61.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.16 -0.962 . . . . 0.0 109.652 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -48.92 -19.78 0.43 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 93.9 t -67.45 -64.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.733 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' D' ' 55' ' ' MET . 1.9 mpt? -80.17 4.14 18.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 109.496 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.08 -26.74 47.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' D' ' 53' ' ' ALA . 67.2 m-80 -84.84 141.83 38.56 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 0.0 109.489 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.1 -39.91 1.49 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.497 2.132 . . . . 0.0 112.254 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.92 -47.38 77.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.48 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 89.4 t -50.83 -40.94 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -79.19 -42.41 26.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.624 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.53 -30.23 71.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.621 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 0.639 ' HE2' HAD2 ' D' ' 147' ' ' HEC . 1.3 t-80 -66.26 -23.85 66.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.561 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.7 -46.65 73.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . 0.512 ' HZ3' ' C ' ' D' ' 21' ' ' ASP . 8.2 mtpp -54.41 -29.54 49.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -1.192 . . . . 0.0 109.556 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.75 -32.86 64.05 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 109.625 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.768 HG21 ' C4A' ' D' ' 147' ' ' HEC . 34.7 t -81.23 -30.78 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.54 -44.54 57.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.339 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.92 -44.84 18.87 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.61 87.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -1.137 . . . . 0.0 109.621 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . 0.472 ' CE2' HMB2 ' D' ' 147' ' ' HEC . 13.9 m-85 -57.46 -51.3 69.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 109.594 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' SER . . . . . 0.559 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 9.0 t -57.54 -43.03 84.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.699 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -48.36 -30.13 4.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.42 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.32 -60.21 5.69 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.468 ' H ' HD13 ' D' ' 75' ' ' LEU . 4.9 mp -55.07 -23.64 21.28 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.223 -1.163 . . . . 0.0 109.239 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.54 9.48 43.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.622 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.527 ' CE1' ' OD1' ' D' ' 80' ' ' ASN . 9.5 t-80 -170.84 70.01 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 109.787 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 91.0 mt -85.98 -7.83 58.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.58 -26.74 5.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.527 ' OD1' ' CE1' ' D' ' 77' ' ' HIS . 8.5 p-10 -172.3 41.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 109.233 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' D' ' 81' ' ' LEU . 1.5 pt? -46.66 -18.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.884 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' D' ' 80' ' ' ASN . 59.5 mttm -80.02 -32.29 39.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.106 -0.996 . . . . 0.0 109.609 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.26 -23.04 55.79 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.7 OUTLIER -70.78 -43.05 69.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.039 -1.271 . . . . 0.0 109.676 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.485 ' N ' ' CG2' ' D' ' 84' ' ' THR . 30.8 m-85 -84.81 26.01 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.57 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.56 -26.93 56.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.918 . . . . 0.0 109.274 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' THR . . . . . 0.474 ' HG1' ' N ' ' D' ' 88' ' ' LEU . 81.3 p -79.67 -54.99 5.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.474 ' N ' ' HG1' ' D' ' 87' ' ' THR . 17.0 mt -47.86 -43.16 28.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.358 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' SER . . . . . 0.523 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 1.5 m -64.81 -38.81 92.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 109.513 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -82.09 -22.6 36.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.676 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' D' ' 87' ' ' THR . 7.5 tt -90.24 -39.29 12.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 109.753 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' D' ' 97' ' ' HIS . 4.0 m80 -77.64 -29.92 51.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.054 -1.028 . . . . 0.0 110.234 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' D' ' 94' ' ' ASP . 13.1 p -83.51 -48.59 10.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.129 -0.982 . . . . 0.0 110.807 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.638 ' N ' ' SG ' ' D' ' 93' ' ' CYS . 23.9 m-20 -87.31 -34.42 18.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.91 -1.119 . . . . 0.0 111.493 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -89.03 -51.8 5.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.807 -1.183 . . . . 0.0 111.006 -178.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.582 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 12.9 mt -98.29 -17.79 18.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.942 -1.099 . . . . 0.0 110.26 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 31.0 p80 42.39 34.03 0.48 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.301 -0.874 . . . . 0.0 110.213 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 67.7 t -58.32 127.27 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 109.093 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' D' ' 99' ' ' ASP . 4.7 p-10 -45.4 148.41 1.18 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.563 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' D' ' 102' ' ' ASN . 59.3 Cg_endo -73.13 -40.05 1.89 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.614 2.209 . . . . 0.0 112.316 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -67.69 52.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.482 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' D' ' 100' ' ' PRO . 56.1 t-20 -140.75 -49.61 0.44 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -46.27 -24.24 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 109.764 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -74.61 -19.95 60.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' D' ' 108' ' ' ASN . 43.5 mt -80.7 -59.59 2.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.963 . . . . 0.0 109.453 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.933 HD21 ' CAB' ' D' ' 147' ' ' HEC . 8.2 tt -46.91 -35.17 6.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.23 -26.43 74.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . 0.707 HD22 ' CB ' ' C' ' 103' ' ' HIS . 32.1 t-20 -85.49 -19.26 31.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -1.163 . . . . 0.0 109.794 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 77.4 t -84.05 -24.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -71.82 -59.99 2.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.465 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 11.6 t -51.3 -29.12 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.592 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 14.6 t -65.36 -41.24 94.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.22 -45.9 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.542 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.71 -26.56 68.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.643 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.501 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -68.17 -34.29 76.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 109.524 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.454 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -85.06 -62.84 1.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 0.0 109.388 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . 0.615 ' ND1' ' CZ ' ' D' ' 118' ' ' PHE . 12.3 t-80 -55.75 -19.76 12.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 109.748 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.615 ' CZ ' ' ND1' ' D' ' 117' ' ' HIS . 67.6 m-85 -151.62 60.83 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.539 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -72.54 -17.05 77.68 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -69.36 -30.06 67.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.144 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -94.0 13.58 22.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.807 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.588 ' CD2' ' HB3' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -81.46 33.26 0.35 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.663 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.46 ' OG1' ' CG2' ' D' ' 126' ' ' VAL . 13.3 p -47.67 130.07 11.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.312 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.513 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 45.6 Cg_exo -43.43 -51.88 5.57 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.134 1.89 . . . . 0.0 113.037 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 18.8 Cg_endo -58.78 -33.92 98.71 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.791 1.661 . . . . 0.0 111.955 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 49.1 t -82.37 -10.06 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.535 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . 0.899 ' HG2' HH11 ' C' ' 31' ' ' ARG . 14.0 tp60 -75.94 -59.75 2.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 109.423 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 0.677 ' HB1' ' HB3' ' C' ' 34' ' ' LEU . . . -61.12 -33.99 74.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.26 11.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' D' ' 128' ' ' ALA . 6.3 t80 -104.88 -55.34 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.299 -0.876 . . . . 0.0 109.738 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . 0.663 ' OE1' ' HA ' ' C' ' 35' ' ' SER . 6.5 pt20 -45.87 -44.12 14.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.88 . . . . 0.0 109.899 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' D' ' 1' ' ' VAL . 21.1 mtmm -57.17 -50.11 73.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.991 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.84 -46.93 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.024 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.36 -33.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.113 -0.992 . . . . 0.0 110.203 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.89 -27.32 2.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.968 -1.082 . . . . 0.0 109.404 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.69 -25.67 72.93 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.34 -49.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -1.151 . . . . 0.0 109.441 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.65 -42.81 35.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.435 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -78.21 -23.43 47.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.464 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.01 -60.4 3.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.51 -14.14 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' D' ' 144' ' ' LYS . . . -94.01 4.75 53.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.91 . . . . 0.0 109.386 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' D' ' 143' ' ' HIS . 11.0 t-160 -68.52 7.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 109.342 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' D' ' 142' ' ' ALA . 39.7 mmtt -139.32 -41.28 0.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.367 -0.833 . . . . 0.0 109.466 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . 0.521 ' CE1' ' OXT' ' D' ' 146' ' ' HIS . 0.0 OUTLIER -56.26 -12.04 1.43 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.406 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.521 ' OXT' ' CE1' ' D' ' 145' ' ' TYR . 15.5 m-70 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.742 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.924 ' CBC' ' HE3' ' A' ' 32' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 0.925 ' CAB' HD21 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 0.915 ' CBC' ' HE3' ' C' ' 32' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 0.933 ' CAB' HD21 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.42 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 48.9 mt -125.32 -162.32 1.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.354 -0.841 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.496 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 177.12 -48.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.865 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 3' ' ' SER . 68.3 Cg_exo -49.18 174.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.391 2.061 . . . . 0.0 112.437 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -56.98 -16.56 7.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.614 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.472 ' C ' ' O ' ' A' ' 5' ' ' ALA . 14.8 t70 -39.92 -31.67 0.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 109.524 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 5' ' ' ALA . 9.3 mtmp? -73.34 -55.97 5.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.407 -0.808 . . . . 0.0 109.216 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 m -47.53 -28.63 2.33 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.139 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -78.33 -38.58 41.83 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 7' ' ' LYS . 40.9 t -70.8 -48.91 54.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -51.58 -44.66 62.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 108.839 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.81 -58.55 7.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.818 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.83 62.73 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.47 -17.4 58.07 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.201 -0.937 . . . . 0.0 108.914 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.35 -38.77 44.85 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -84.4 -40.86 17.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.381 -1.07 . . . . 0.0 109.32 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.573 ' O ' ' C ' ' A' ' 18' ' ' GLY . 93.7 t -66.69 -45.93 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 109.709 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.573 ' C ' ' O ' ' A' ' 17' ' ' VAL . . . -25.1 137.81 0.01 OUTLIER Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 18' ' ' GLY . . . 74.26 -29.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.43 -1.041 . . . . 0.0 109.331 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 17' ' ' VAL . 38.0 m-70 -110.76 16.79 21.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.39 -60.8 2.08 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.008 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.46 -14.84 0.39 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.0 mt-10 -85.47 -56.35 3.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -1.177 . . . . 0.0 109.758 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.4 m-30 -60.69 -35.2 75.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.0 109.398 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.37 -23.01 73.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.74 -47.03 14.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -1.154 . . . . 0.0 109.64 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -63.57 -19.87 65.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 109.327 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.03 -27.6 63.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.44 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.4 -53.68 15.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.907 . . . . 0.0 109.57 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.16 -29.37 69.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.251 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.38 -30.34 67.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.299 -0.876 . . . . 0.0 109.224 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.564 ' HE3' ' CBC' ' A' ' 142' ' ' HEC . 47.9 ttp -72.83 -52.7 13.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.186 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.38 -32.04 10.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.239 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.528 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.6 mt -78.42 -39.76 37.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -0.903 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.524 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 15.0 m -51.67 -29.67 18.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 35' ' ' SER . 57.1 m-85 -160.85 130.39 3.28 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.248 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.27 -19.89 14.89 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.317 2.011 . . . . 0.0 112.158 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' D' ' 97' ' ' HIS . 22.3 p -46.53 -46.0 18.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.785 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -45.39 -22.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 109.93 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.5 ttmt -51.81 -42.46 62.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.169 -0.957 . . . . 0.0 110.113 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 1.337 HG23 ' CD2' ' D' ' 97' ' ' HIS . 0.7 OUTLIER -75.63 -18.86 59.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 0.0 109.757 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.402 ' O ' ' CB ' ' A' ' 43' ' ' PHE . 58.5 t80 -55.88 -5.48 0.17 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 41' ' ' THR . 0.1 OUTLIER 70.4 67.38 0.41 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.283 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 54.2 Cg_exo -48.71 -42.06 37.11 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.641 2.227 . . . . 0.0 111.821 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 4.2 p80 40.7 33.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.735 -0.603 . . . . 0.0 110.413 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -157.71 28.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 110.074 179.409 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 49' ' ' SER . 73.9 m-20 43.67 89.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.478 -0.764 . . . . 0.0 110.345 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.803 ' H ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.6 1.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.356 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 47' ' ' ASP . 5.0 m -84.77 157.0 21.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.15 -0.968 . . . . 0.0 109.769 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.604 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 40.2 t-80 -76.44 170.58 16.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.396 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.604 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 76.18 -21.88 2.14 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 54' ' ' GLN . 4.7 p -55.95 -18.7 9.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -1.098 . . . . 0.0 109.374 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 72.82 -23.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.814 . . . . 0.0 109.732 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 52' ' ' SER . 24.1 mt-30 -84.83 -17.94 36.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 0.0 109.565 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.09 -32.64 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.576 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -72.92 -29.39 63.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 0.0 109.211 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.98 66.09 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.495 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.2 t-80 -60.71 -30.72 70.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.126 -1.22 . . . . 0.0 110.076 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.79 -31.38 79.58 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 59.2 mttp -68.89 -23.01 64.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -1.115 . . . . 0.0 110.253 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.721 ' HG2' ' CAA' ' A' ' 142' ' ' HEC . 0.0 OUTLIER -69.49 -58.19 4.28 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.883 -1.136 . . . . 0.0 108.748 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.52 -41.52 64.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.6 -0.688 . . . . 0.0 109.599 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.53 -43.86 46.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.158 -0.964 . . . . 0.0 109.237 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 34.9 t0 -68.85 -33.85 74.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.149 -0.97 . . . . 0.0 108.639 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.58 ' HB1' HMA2 ' A' ' 142' ' ' HEC . . . -66.87 -49.14 66.62 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -53.06 -47.06 68.74 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.282 -0.886 . . . . 0.0 108.627 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.2 m -57.01 -56.57 20.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 108.755 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.534 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 28.5 t30 -58.86 -21.09 56.36 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.08 -47.38 10.24 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.4 t -68.44 -22.74 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.43 75.58 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.609 ' O ' ' N ' ' A' ' 74' ' ' ASP . 5.5 m-70 -115.87 -60.57 1.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.493 -0.754 . . . . 0.0 109.509 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.486 ' CG1' ' O ' ' A' ' 72' ' ' HIS . 13.3 p 45.09 12.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.726 0.774 . . . . 0.0 109.549 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 72' ' ' HIS . 28.8 m-20 -138.34 11.11 2.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -177.3 27.79 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.697 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 3.0 ptt? -78.51 -23.81 0.42 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 111.69 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 76' ' ' MET . 53.2 Cg_exo -54.47 -19.62 18.19 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.559 1.506 . . . . 0.0 112.193 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -93.16 -40.68 10.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.323 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.76 -43.45 65.76 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.308 -0.87 . . . . 0.0 109.014 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.35 10.37 12.86 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 84' ' ' SER . 7.7 t -51.84 -47.68 64.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -46.13 -58.07 3.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 109.726 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.8 mt -45.24 -44.29 11.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 108.827 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 81' ' ' SER . 6.9 p -55.18 -30.05 59.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.467 -0.77 . . . . 0.0 108.978 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 89' ' ' HIS . 1.6 m-20 -82.08 -49.65 9.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.837 . . . . 0.0 109.263 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 tp -51.03 -30.02 14.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 109.25 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -92.89 -21.79 19.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -0.843 . . . . 0.0 110.371 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.72 20.82 5.52 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.113 -0.992 . . . . 0.0 110.322 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.666 ' N ' ' O ' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -140.51 -78.27 0.3 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 109.78 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 92' ' ' ARG . 16.9 mttp -67.36 -119.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 109.816 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.455 ' H ' ' CD1' ' A' ' 91' ' ' LEU . 10.3 mp -44.58 -19.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.82 . . . . 0.0 109.774 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 90' ' ' LYS . 49.7 ttt180 57.21 45.95 19.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.302 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.7 t -48.43 133.15 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.647 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -91.58 126.06 55.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.273 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -43.84 -10.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.374 2.05 . . . . 0.0 112.377 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 1.256 HG13 ' CG ' ' D' ' 99' ' ' ASP . 25.1 t -56.39 -31.79 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.088 -1.008 . . . . 0.0 109.648 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -79.57 -38.14 34.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 0.0 109.662 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -46.06 -30.29 1.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.27 -28.02 69.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.89 . . . . 0.0 109.646 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.49 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 11.4 mt -84.29 -34.3 23.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.803 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.539 HD22 ' CHC' ' A' ' 142' ' ' HEC . 5.5 tp -64.14 -61.15 2.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.98 . . . . 0.0 109.741 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 t -47.76 -34.76 8.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.759 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -80.84 -26.66 36.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.826 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 97.7 m -76.35 -38.06 56.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.49 -52.04 67.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.118 -0.989 . . . . 0.0 109.716 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.7 mt -60.19 -32.35 71.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.4 t -63.65 -59.62 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 0.0 109.19 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.7 p -54.76 -53.55 53.68 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.244 -0.91 . . . . 0.0 109.276 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 114' ' ' PRO . 7.7 mt -45.41 -26.71 0.58 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.266 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.26 81.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 0.0 109.979 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.612 ' HB2' ' CE2' ' B' ' 122' ' ' PHE . . . -78.99 -3.54 45.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 109.931 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -134.51 -80.09 0.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 109.7 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -118.4 82.53 19.16 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' N ' ' O ' ' A' ' 109' ' ' LEU . 51.3 Cg_exo -49.61 -169.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.454 2.102 . . . . 0.0 112.432 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.656 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -52.85 -55.72 21.08 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.656 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 46.3 mt-10 123.24 -5.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 7.6 t80 73.24 30.97 1.48 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.732 -0.605 . . . . 0.0 111.116 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.8 p -104.54 126.25 31.89 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 108.38 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.603 ' HB3' ' HB3' ' B' ' 51' ' ' PRO . 54.2 Cg_exo -49.73 22.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.353 2.036 . . . . 0.0 112.897 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -153.3 -32.94 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.83 -1.169 . . . . 0.0 110.645 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.513 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 9.6 p -52.8 -49.5 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.982 -1.074 . . . . 0.0 110.154 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.513 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 4.7 t-160 -59.47 -37.46 78.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 109.218 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.08 -19.41 34.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -0.839 . . . . 0.0 109.487 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 120' ' ' ALA . 23.3 p -64.18 -62.1 1.83 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 110.848 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.488 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.6 mt -68.46 -19.76 64.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.982 -1.074 . . . . 0.0 109.757 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.66 -46.62 12.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 109.36 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -80.44 -46.23 16.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -0.964 . . . . 0.0 109.278 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 26.8 t80 -49.93 -21.79 1.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.93 . . . . 0.0 108.969 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.1 mt -73.96 -21.76 59.9 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -57.88 -31.83 67.1 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.4 ' HG ' ' N ' ' A' ' 132' ' ' VAL . 90.0 p -79.83 -33.61 40.11 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.378 -0.826 . . . . 0.0 108.954 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.4 ' N ' ' HG ' ' A' ' 131' ' ' SER . 42.8 t -82.24 -35.52 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 108.636 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 47.4 t -72.23 -28.62 63.28 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.436 -0.79 . . . . 0.0 109.172 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 32.2 m -66.51 -34.34 77.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.171 -0.956 . . . . 0.0 109.082 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 97.5 t -77.38 -40.43 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.29 -0.881 . . . . 0.0 108.998 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.79 -27.28 68.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 108.955 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.3 m -86.24 -26.47 25.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 109.455 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.9 m -54.35 136.36 43.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.45 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -85.3 -165.32 1.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -56.85 -72.93 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.485 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.684 179.852 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' B' ' 2' ' ' HIS . 7.2 p . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.486 ' N ' ' CG1' ' B' ' 1' ' ' VAL . 21.3 t-160 -172.8 71.34 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 109.177 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.95 155.81 43.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 109.356 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -54.51 152.71 11.65 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 108.914 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.07 -18.57 44.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.463 2.109 . . . . 0.0 112.06 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -87.13 -37.86 16.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.628 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -84.0 -23.22 31.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 109.891 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.52 ' O ' ' OG1' ' B' ' 12' ' ' THR . 7.9 tttm -84.12 -55.12 4.37 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.148 -0.97 . . . . 0.0 109.095 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.8 t -48.03 -23.52 0.83 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.125 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.15 -59.68 2.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.966 -1.084 . . . . 0.0 109.894 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.03 -24.44 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 4.2 m -74.79 -51.93 12.8 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.405 0.622 . . . . 0.0 109.649 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.36 -24.88 47.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.571 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.65 -28.26 67.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.344 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.83 -17.06 62.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.415 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.28 -63.77 3.13 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.596 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -70.68 -11.72 61.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.033 -1.274 . . . . 0.0 110.809 -178.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -70.73 121.35 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.833 -1.167 . . . . 0.0 109.348 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' B' ' 21' ' ' ASP . 0.9 OUTLIER -77.15 73.26 3.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.247 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 75.5 t -52.89 -6.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.64 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' B' ' 19' ' ' ASN . 9.8 p30 -67.88 -20.73 65.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.914 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 9.2 pt-20 -150.11 -32.49 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.897 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.16 -28.27 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.667 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.1 -41.26 99.81 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.11 -55.04 17.83 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.422 ' O ' ' NH1' ' B' ' 30' ' ' ARG . 58.2 mt-10 -49.87 -26.99 4.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -1.141 . . . . 0.0 109.367 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.24 -32.62 22.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.06 -36.41 21.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.6 -40.58 90.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' B' ' 26' ' ' GLU . 0.0 OUTLIER -62.85 -21.88 66.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -1.17 . . . . 0.0 109.426 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.98 -28.38 65.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.965 . . . . 0.0 109.539 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' B' ' 36' ' ' PRO . 27.7 mt -81.24 -53.89 5.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.995 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' B' ' 34' ' ' VAL . 6.2 p -56.18 -43.21 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.0 109.607 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.477 ' N ' ' CG1' ' B' ' 33' ' ' VAL . 57.8 t -79.53 -22.92 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 109.364 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -153.04 75.52 6.69 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.327 -0.858 . . . . 0.0 109.127 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . 0.47 ' N ' ' O ' ' B' ' 32' ' ' LEU . 92.1 Cg_endo -83.69 3.79 7.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.971 2.448 . . . . 0.0 112.562 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -57.42 -19.82 26.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 109.547 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.415 ' H ' ' HG1' ' B' ' 38' ' ' THR . 6.2 p -79.96 5.44 13.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -48.28 -22.74 0.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.912 . . . . 0.0 109.531 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -62.36 -38.81 90.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.39 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . 0.433 ' O ' ' CG ' ' B' ' 42' ' ' PHE . 80.7 m-85 -88.01 27.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.993 ' HE2' HBC3 ' B' ' 147' ' ' HEC . 75.2 m-85 -154.82 32.93 0.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.9 . . . . 0.0 109.518 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.33 -27.84 52.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 67.6 m -76.28 -29.7 57.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.526 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' B' ' 47' ' ' ASP . 3.8 m-85 -48.68 -22.71 0.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.319 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' B' ' 47' ' ' ASP . . . 68.04 -53.16 0.4 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 45' ' ' PHE . 51.2 m-20 -60.35 -151.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -1.144 . . . . 0.0 109.552 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt 58.82 17.91 5.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.492 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 30.2 p -69.45 -28.34 66.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.36 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' THR . . . . . 0.523 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.4 p -145.24 151.31 47.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 109.021 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.603 ' HB3' ' HB3' ' A' ' 119' ' ' PRO . 81.0 Cg_exo -38.27 -32.51 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.619 2.213 . . . . 0.0 112.574 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.19 -24.14 40.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.721 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -68.89 -19.57 64.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.893 . . . . 0.0 109.727 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 t -65.24 -64.03 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 109.571 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 25.5 mtm -95.38 29.33 2.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.12 -58.58 0.66 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -69.4 150.26 97.1 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.293 -1.122 . . . . 0.0 109.478 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' B' ' 60' ' ' VAL . 69.2 Cg_endo -75.05 -56.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.609 2.206 . . . . 0.0 112.395 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -18.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 109.743 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' B' ' 58' ' ' PRO . 91.4 t -81.66 -44.96 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.426 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -79.01 -27.1 43.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.16 -20.93 63.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 109.64 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 0.697 ' HE2' HAD2 ' B' ' 147' ' ' HEC . 59.4 t-80 -72.3 -23.94 61.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -0.99 . . . . 0.0 109.406 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.04 -25.99 74.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.97 -42.82 76.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 109.063 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . 0.427 ' HD3' ' CAA' ' B' ' 147' ' ' HEC . 91.9 mttt -64.34 -41.49 96.74 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 109.557 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.669 HG23 ' C1B' ' B' ' 147' ' ' HEC . 29.0 t -65.27 -62.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.296 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tt -54.32 -40.2 67.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.194 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.52 -53.85 38.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.1 -44.38 42.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.097 . . . . 0.0 109.632 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -63.31 -45.89 89.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.424 ' HG ' ' N ' ' B' ' 73' ' ' ASP . 98.6 p -61.07 -34.83 75.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 0.0 109.563 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.424 ' N ' ' HG ' ' B' ' 72' ' ' SER . 13.6 t70 -53.98 -39.63 66.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -0.961 . . . . 0.0 109.431 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.24 -60.14 8.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.453 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -53.73 -30.07 42.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.173 -1.193 . . . . 0.0 109.168 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.21 4.32 46.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.32 -0.863 . . . . 0.0 109.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -170.22 67.48 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 109.675 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.96 12.78 2.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.237 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.0 -29.75 68.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 24.9 t-20 -164.02 111.32 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 109.56 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.528 ' CD1' ' N ' ' B' ' 81' ' ' LEU . 7.5 mp -80.29 -56.07 4.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.478 ' NZ ' ' CD2' ' B' ' 143' ' ' HIS . 77.0 tttt -62.31 -24.12 67.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.608 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -75.07 -51.11 7.86 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.7 t -73.41 -46.29 49.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -1.133 . . . . 0.0 109.475 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.542 ' N ' ' CG2' ' B' ' 84' ' ' THR . 54.4 m-85 -84.29 26.13 0.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.445 -0.785 . . . . 0.0 109.575 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.11 -28.05 67.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.469 ' O ' ' N ' ' B' ' 91' ' ' LEU . 82.0 p -77.22 -58.14 3.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.83 . . . . 0.0 109.607 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.24 -41.6 18.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -68.71 -37.62 79.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.907 . . . . 0.0 109.58 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -82.67 -28.14 30.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 109.499 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' B' ' 87' ' ' THR . 10.3 tt -75.5 -69.05 0.51 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.232 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' B' ' 97' ' ' HIS . 70.8 m80 -50.1 -23.85 2.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.183 -0.948 . . . . 0.0 109.735 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 38.8 t -83.92 -56.23 3.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.92 . . . . 0.0 111.066 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.538 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 73.4 m-20 -86.17 -24.49 26.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.967 -1.083 . . . . 0.0 111.856 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.469 ' CD ' ' N ' ' B' ' 95' ' ' LYS . 10.7 mptt -94.25 -51.73 4.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.678 -1.264 . . . . 0.0 110.676 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -27.69 13.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.049 -1.032 . . . . 0.0 109.934 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 1.239 ' CD2' HG23 ' C' ' 41' ' ' THR . 21.4 m-70 57.71 53.71 6.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 109.716 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.37 124.29 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.151 -0.968 . . . . 0.0 109.295 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 1.296 ' OD2' HG13 ' C' ' 96' ' ' VAL . 68.7 m-20 -47.99 149.27 2.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.389 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.32 62.93 5.31 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.554 2.169 . . . . 0.0 112.046 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -172.09 73.92 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.434 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.95 -27.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.86 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 0.1 OUTLIER -56.28 -20.53 19.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.002 -1.061 . . . . 0.0 109.689 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -86.15 -41.13 14.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.428 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 tp -48.97 -40.18 29.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.319 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.547 HD11 ' CAB' ' B' ' 147' ' ' HEC . 5.7 tt -69.28 -47.59 64.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.272 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.46 -20.09 54.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -81.72 -55.74 4.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -1.164 . . . . 0.0 110.164 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 p -61.92 -24.15 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.078 -1.013 . . . . 0.0 109.682 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.57 -58.06 9.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.401 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 69.5 t -46.64 -26.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 109.772 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.49 -32.66 74.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 109.63 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.48 -31.57 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.965 . . . . 0.0 109.497 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.14 -29.4 60.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.158 -0.964 . . . . 0.0 109.497 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.424 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -74.97 -32.23 61.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.572 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.477 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.85 -56.98 3.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.224 -0.923 . . . . 0.0 109.404 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' B' ' 118' ' ' PHE . 13.7 m170 -56.83 -17.78 10.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.621 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.408 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 72.1 m-85 -154.48 60.59 0.69 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -70.97 -26.24 74.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' B' ' 120' ' ' LYS . 11.8 mptt -70.0 9.86 0.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -1.168 . . . . 0.0 109.289 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.503 ' H ' ' C ' ' B' ' 119' ' ' GLY . 68.7 mm-40 -136.64 2.53 2.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.828 . . . . 0.0 109.387 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.612 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -72.91 39.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.502 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.538 ' C ' HE22 ' B' ' 127' ' ' GLN . 0.8 OUTLIER -52.46 149.08 11.09 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 109.331 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.486 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.3 Cg_exo -47.62 -52.38 8.14 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.46 2.107 . . . . 0.0 113.246 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 35.8 Cg_endo -65.35 -3.88 8.35 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.087 1.858 . . . . 0.0 112.708 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 56.8 t -96.81 -22.09 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.044 -1.035 . . . . 0.0 109.724 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . 0.538 HE22 ' C ' ' B' ' 123' ' ' THR . 1.8 mp0 -83.27 -59.95 2.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.029 -1.044 . . . . 0.0 109.715 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -54.03 -35.02 61.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.991 . . . . 0.0 109.408 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.89 26.48 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.69 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -118.82 -61.47 1.64 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.304 -0.873 . . . . 0.0 109.654 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -52.81 -23.42 6.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.636 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -71.58 -39.02 70.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.112 -0.992 . . . . 0.0 109.731 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.71 -55.85 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 109.799 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' B' ' 137' ' ' VAL . 11.4 m -69.78 -28.57 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 110.041 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.57 -25.89 1.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 109.354 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.79 -24.6 57.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' B' ' 134' ' ' VAL . 74.8 t -79.42 -37.6 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -1.1 . . . . 0.0 109.345 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.81 79.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.433 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.445 HD22 HD22 ' D' ' 139' ' ' ASN . 65.1 t30 -72.1 -44.03 63.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.36 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.3 -40.82 49.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 109.341 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 36.5 mt -81.94 12.79 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.338 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 139' ' ' ASN . . . -139.78 1.63 1.91 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 109.81 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . 0.478 ' CD2' ' NZ ' ' B' ' 82' ' ' LYS . 10.4 t60 -79.37 -34.05 42.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.51 ' C ' ' HD1' ' B' ' 146' ' ' HIS . 5.0 tptp -67.41 -25.44 65.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.409 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -64.03 -14.14 52.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.526 ' CG ' ' OXT' ' B' ' 146' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.503 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . 0.417 ' CD1' ' CD2' ' C' ' 128' ' ' PHE . 48.9 mt -125.35 -162.29 1.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.824 . . . . 0.0 109.435 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.502 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 177.1 -48.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.954 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' C' ' 3' ' ' SER . 67.4 Cg_exo -49.21 174.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.381 2.054 . . . . 0.0 112.477 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -56.92 -16.54 7.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.639 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' C' ' 5' ' ' ALA . 14.9 t70 -40.0 -31.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 109.525 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' C' ' 5' ' ' ALA . 9.3 mtmp? -73.41 -55.91 5.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.211 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 44.6 m -47.51 -28.63 2.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.381 -0.824 . . . . 0.0 109.211 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -78.3 -38.6 42.09 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' C' ' 7' ' ' LYS . 40.7 t -70.86 -48.83 54.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -51.63 -44.62 63.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.404 -0.81 . . . . 0.0 108.853 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.86 -58.58 7.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.447 -0.783 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.55 -31.93 62.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.309 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.42 -17.37 58.18 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.155 -0.966 . . . . 0.0 109.004 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.33 -38.84 44.84 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -84.26 -40.9 17.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -1.067 . . . . 0.0 109.355 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.566 ' O ' ' C ' ' C' ' 18' ' ' GLY . 93.5 t -66.71 -46.0 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.821 . . . . 0.0 109.687 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' C' ' 17' ' ' VAL . . . -25.08 137.73 0.01 OUTLIER Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' C' ' 18' ' ' GLY . . . 74.45 -29.39 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.517 -0.99 . . . . 0.0 109.237 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.54 ' H ' ' C ' ' C' ' 18' ' ' GLY . 37.6 m-70 -110.56 16.82 21.27 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.32 -60.86 2.06 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.957 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.53 -14.7 0.39 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.0 mt-10 -85.52 -56.4 3.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -1.148 . . . . 0.0 109.728 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.4 m-30 -60.71 -35.2 75.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.445 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.39 -22.9 73.31 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.79 -47.09 14.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -1.165 . . . . 0.0 109.598 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -63.66 -19.77 65.16 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.298 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.64 63.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 109.509 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.39 -53.7 15.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.13 -29.37 69.73 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 109.226 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.37 -30.4 67.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.259 -0.901 . . . . 0.0 109.197 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.557 ' HE3' ' CBC' ' C' ' 142' ' ' HEC . 47.8 ttp -72.81 -52.72 13.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -0.838 . . . . 0.0 109.191 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.36 -31.96 10.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.888 . . . . 0.0 109.293 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.54 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.5 mt -78.46 -39.77 37.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.3 -0.875 . . . . 0.0 109.421 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.521 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 15.0 m -51.75 -29.55 19.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' C' ' 35' ' ' SER . 57.3 m-85 -160.89 130.34 3.25 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.273 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -76.24 -19.92 14.93 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.375 2.05 . . . . 0.0 112.203 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' B' ' 97' ' ' HIS . 22.4 p -46.53 -46.01 18.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.705 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -45.46 -22.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 109.868 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' C' ' 38' ' ' THR . 26.6 ttmt -51.83 -42.42 62.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.137 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 1.239 HG23 ' CD2' ' B' ' 97' ' ' HIS . 0.7 OUTLIER -75.63 -18.85 59.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 109.789 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.431 ' O ' ' CB ' ' C' ' 43' ' ' PHE . 58.6 t80 -55.87 -5.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.986 . . . . 0.0 109.531 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.52 ' H ' ' C ' ' C' ' 41' ' ' THR . 0.2 OUTLIER 70.43 67.35 0.41 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.92 . . . . 0.0 109.325 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.541 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 54.4 Cg_exo -48.79 -41.89 37.88 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.696 2.264 . . . . 0.0 111.778 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.541 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 4.1 p80 40.5 33.69 0.2 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.765 -0.585 . . . . 0.0 110.4 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -157.77 28.38 0.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.117 -0.99 . . . . 0.0 110.077 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' C' ' 49' ' ' SER . 73.9 m-20 43.61 89.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.548 -0.72 . . . . 0.0 110.376 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.806 ' H ' ' CD1' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -60.69 1.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 0.0 109.26 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.56 ' H ' ' C ' ' C' ' 47' ' ' ASP . 5.0 m -84.83 157.03 21.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.955 . . . . 0.0 109.734 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.612 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 40.4 t-80 -76.45 170.56 16.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.446 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . 0.612 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 76.26 -22.08 2.13 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.516 ' C ' ' H ' ' C' ' 54' ' ' GLN . 4.7 p -55.85 -18.68 9.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -1.105 . . . . 0.0 109.368 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 72.82 -23.3 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 109.669 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.516 ' H ' ' C ' ' C' ' 52' ' ' SER . 24.1 mt-30 -84.76 -17.96 36.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.568 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 44.2 t -84.02 -32.62 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 109.639 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -72.98 -29.39 63.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.166 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.82 -45.0 66.48 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.496 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.2 t-80 -60.66 -30.74 70.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.245 . . . . 0.0 110.071 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.87 -31.29 79.22 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 59.2 mttp -68.93 -23.02 64.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -1.106 . . . . 0.0 110.213 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.709 ' HG2' ' CAA' ' C' ' 142' ' ' HEC . 0.0 OUTLIER -69.41 -58.17 4.33 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.982 -1.074 . . . . 0.0 108.755 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 13.3 t -55.59 -41.47 64.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.605 -0.684 . . . . 0.0 109.578 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.6 -43.81 46.24 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.102 -0.999 . . . . 0.0 109.195 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 35.0 t0 -68.99 -33.84 74.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 108.563 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . 0.587 ' HB1' HMA2 ' C' ' 142' ' ' HEC . . . -66.94 -49.01 66.83 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -53.05 -47.08 68.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.1 m -57.06 -56.59 19.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.9 . . . . 0.0 108.701 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . 0.535 ' O ' ' CD2' ' C' ' 72' ' ' HIS . 28.5 t30 -58.82 -21.1 55.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 108.57 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.09 -47.42 10.2 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.36 -22.72 27.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.95 -33.32 75.31 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' C' ' 74' ' ' ASP . 5.6 m-70 -115.96 -60.47 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.534 -0.729 . . . . 0.0 109.527 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' C' ' 72' ' ' HIS . 13.2 p 45.02 12.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.744 0.783 . . . . 0.0 109.583 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' C' ' 72' ' ' HIS . 28.9 m-20 -138.33 11.18 2.78 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -177.36 27.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.696 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 3.0 ptt? -78.54 -23.91 0.42 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.837 . . . . 0.0 111.642 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' C' ' 76' ' ' MET . 53.1 Cg_exo -54.4 -19.72 18.18 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.582 1.521 . . . . 0.0 112.207 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -93.01 -40.75 10.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.178 -0.951 . . . . 0.0 109.435 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.82 -43.45 65.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.261 -0.899 . . . . 0.0 108.948 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -85.29 10.32 12.88 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' C' ' 84' ' ' SER . 7.6 t -51.87 -47.65 64.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.324 -0.86 . . . . 0.0 109.683 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -46.09 -58.15 3.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 109.707 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' C' ' 82' ' ' ALA . 3.8 mt -45.18 -44.33 10.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 0.0 108.785 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' C' ' 81' ' ' SER . 6.9 p -55.19 -30.03 59.1 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.68 ' O ' ' N ' ' C' ' 89' ' ' HIS . 1.6 m-20 -82.15 -49.53 10.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.198 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.19 -29.95 15.53 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.095 -1.003 . . . . 0.0 109.173 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -92.82 -21.92 19.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.833 . . . . 0.0 110.336 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.72 20.87 5.52 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.076 -1.015 . . . . 0.0 110.398 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' C' ' 85' ' ' ASP . 0.7 OUTLIER -140.57 -78.26 0.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.078 -1.013 . . . . 0.0 109.806 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' C' ' 92' ' ' ARG . 16.9 mttp -67.38 -119.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.843 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.454 ' H ' ' CD1' ' C' ' 91' ' ' LEU . 10.3 mp -44.5 -19.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 109.802 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' C' ' 90' ' ' LYS . 49.7 ttt180 57.28 45.92 19.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.928 . . . . 0.0 109.304 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 4.7 t -48.48 133.21 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 109.599 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' C' ' 96' ' ' VAL . 0.6 OUTLIER -91.55 126.03 55.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.281 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.81 -11.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.268 1.979 . . . . 0.0 112.396 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . 1.296 HG13 ' OD2' ' B' ' 99' ' ' ASP . 24.8 t -56.22 -31.89 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 109.693 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -79.44 -38.16 35.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.662 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -46.12 -30.25 1.85 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 109.62 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.3 -27.97 69.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.942 . . . . 0.0 109.637 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 11.2 mt -84.22 -34.34 23.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 109.84 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.544 HD22 ' CHC' ' C' ' 142' ' ' HEC . 5.4 tp -64.22 -61.03 2.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 109.806 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 24.4 t -47.7 -34.73 8.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 109.836 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -80.96 -26.59 36.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.735 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 97.9 m -76.35 -38.1 56.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 109.953 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -52.19 66.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 109.681 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 36.8 mt -60.14 -32.28 70.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.947 . . . . 0.0 110.006 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 34.3 t -63.72 -59.56 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 109.264 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 41.3 p -54.77 -53.59 53.1 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.229 -0.92 . . . . 0.0 109.224 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' C' ' 114' ' ' PRO . 7.7 mt -45.29 -26.74 0.55 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.459 -0.775 . . . . 0.0 109.299 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.44 -39.26 81.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.304 -0.872 . . . . 0.0 110.039 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . 0.623 ' HB2' ' CE2' ' D' ' 122' ' ' PHE . . . -78.94 -3.6 45.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -134.44 -80.06 0.45 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.232 -0.917 . . . . 0.0 109.713 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -118.41 82.6 19.31 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' C' ' 113' ' ' LEU . 51.3 Cg_exo -49.78 -169.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.402 2.068 . . . . 0.0 112.402 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.662 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -52.85 -55.71 21.1 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.662 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 46.4 mt-10 123.24 -5.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 0.414 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 7.6 t80 73.21 30.97 1.49 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.803 -0.561 . . . . 0.0 111.033 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.75 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.8 p -104.48 126.26 31.9 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.07 -1.019 . . . . 0.0 108.439 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . 0.602 ' HB3' ' HB3' ' D' ' 51' ' ' PRO . 53.9 Cg_exo -49.74 22.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.407 2.071 . . . . 0.0 112.901 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.75 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -153.37 -32.98 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.777 -1.202 . . . . 0.0 110.553 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 9.7 p -52.76 -49.47 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.057 -1.027 . . . . 0.0 110.18 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.514 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 4.7 t-160 -59.48 -37.5 78.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 0.0 109.176 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.12 -19.43 34.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.411 -0.806 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.523 ' N ' ' O ' ' C' ' 120' ' ' ALA . 23.1 p -64.12 -62.12 1.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 110.844 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.488 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.6 mt -68.49 -19.72 64.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.016 -1.053 . . . . 0.0 109.761 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.67 -46.64 12.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.99 -1.069 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.473 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -80.38 -46.37 16.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.155 -0.966 . . . . 0.0 109.277 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 26.9 t80 -49.88 -21.68 1.24 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.016 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.3 mt -73.98 -21.82 59.85 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -57.93 -31.76 67.13 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 131' ' ' SER . . . . . 0.406 ' HG ' ' N ' ' C' ' 132' ' ' VAL . 90.0 p -79.86 -33.65 39.91 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.341 -0.85 . . . . 0.0 108.925 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . 0.406 ' N ' ' HG ' ' C' ' 131' ' ' SER . 42.6 t -82.27 -35.51 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 108.578 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.465 ' N ' ' O ' ' C' ' 129' ' ' LEU . 47.5 t -72.18 -28.61 63.33 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.408 -0.808 . . . . 0.0 109.237 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 134' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 32.3 m -66.55 -34.31 77.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.954 . . . . 0.0 109.108 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.32 -40.45 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.316 -0.865 . . . . 0.0 109.08 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.7 -27.42 68.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 108.945 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 61.7 m -86.2 -26.46 25.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 41.1 m -54.37 136.38 43.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -85.28 -165.33 1.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.867 . . . . 0.0 109.556 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' C' ' 141' ' ' ARG . 89.3 t80 -56.77 -72.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.514 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' C' ' 140' ' ' TYR . 92.1 mtt180 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.618 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' D' ' 2' ' ' HIS . 7.4 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.486 ' N ' ' CG1' ' D' ' 1' ' ' VAL . 21.3 t-160 -172.74 71.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.92 155.78 43.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.436 -0.79 . . . . 0.0 109.306 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -54.48 152.76 11.45 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 108.878 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.01 -18.63 44.1 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.477 2.118 . . . . 0.0 112.068 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -87.11 -37.92 16.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.914 . . . . 0.0 109.622 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -84.1 -23.15 30.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.836 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' D' ' 12' ' ' THR . 7.9 tttm -84.12 -55.19 4.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.229 -0.919 . . . . 0.0 109.102 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -48.04 -23.49 0.83 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.09 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.16 -59.64 2.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.891 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.01 -24.47 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 4.2 m -74.81 -51.9 12.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.698 -0.626 . . . . 0.0 109.65 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.31 -24.92 46.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.64 -28.28 67.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.78 -17.04 62.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -0.952 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.25 -63.73 3.15 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.585 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.426 ' H ' ' HD2' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -70.77 -11.74 61.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.036 -1.273 . . . . 0.0 110.778 -178.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -70.66 121.27 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.856 -1.152 . . . . 0.0 109.343 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' D' ' 21' ' ' ASP . 0.9 OUTLIER -77.12 73.4 3.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.226 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 76.1 t -53.05 -6.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.556 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' D' ' 19' ' ' ASN . 9.8 p30 -67.92 -20.69 65.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.936 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.505 ' N ' ' OD1' ' D' ' 21' ' ' ASP . 9.3 pt-20 -150.27 -32.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.067 -1.02 . . . . 0.0 109.884 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.22 -28.36 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 109.626 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.03 -41.41 99.86 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.06 -55.07 17.89 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . 0.416 ' O ' ' NH1' ' D' ' 30' ' ' ARG . 58.3 mt-10 -49.79 -27.03 4.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -1.155 . . . . 0.0 109.432 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.31 -32.55 22.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.06 -36.35 21.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.63 -40.66 90.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . 0.416 ' NH1' ' O ' ' D' ' 26' ' ' GLU . 0.0 OUTLIER -62.93 -21.7 66.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -1.12 . . . . 0.0 109.467 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tt -70.07 -28.32 65.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.152 -0.968 . . . . 0.0 109.523 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' D' ' 36' ' ' PRO . 27.7 mt -81.32 -53.86 5.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.925 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' D' ' 34' ' ' VAL . 6.2 p -56.21 -43.18 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.003 . . . . 0.0 109.628 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . 0.481 ' N ' ' CG1' ' D' ' 33' ' ' VAL . 57.8 t -79.56 -22.83 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -153.11 75.5 6.65 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.848 . . . . 0.0 109.126 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' D' ' 32' ' ' LEU . 92.6 Cg_endo -83.6 3.69 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.935 2.423 . . . . 0.0 112.553 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -57.39 -19.87 26.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.485 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.495 ' H ' ' HG1' ' D' ' 38' ' ' THR . 6.0 p -80.0 5.41 14.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 109.414 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -48.17 -22.76 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.593 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -62.34 -38.84 91.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.366 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' D' ' 42' ' ' PHE . 80.2 m-85 -87.95 27.87 1.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 1.013 ' HE2' HBC3 ' D' ' 147' ' ' HEC . 75.1 m-85 -154.8 32.85 0.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.524 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.37 -27.7 52.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 109.538 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 67.5 m -76.34 -29.67 57.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 109.476 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' D' ' 47' ' ' ASP . 3.8 m-85 -48.7 -22.71 0.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' D' ' 47' ' ' ASP . . . 68.02 -53.11 0.39 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' D' ' 45' ' ' PHE . 51.6 m-20 -60.38 -151.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -1.123 . . . . 0.0 109.485 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt 58.73 17.97 5.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 30.4 p -69.46 -28.38 66.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.923 . . . . 0.0 109.309 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' THR . . . . . 0.526 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.5 p -145.32 151.24 47.21 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.071 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . 0.602 ' HB3' ' HB3' ' C' ' 119' ' ' PRO . 80.8 Cg_exo -38.12 -32.6 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.598 2.199 . . . . 0.0 112.599 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.19 -24.04 40.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.737 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -69.03 -19.45 64.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.671 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 18.4 t -65.31 -63.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.618 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 25.5 mtm -95.41 29.43 2.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.12 -58.58 0.66 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -69.36 150.25 97.15 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.224 -1.162 . . . . 0.0 109.608 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.463 ' O ' ' N ' ' D' ' 60' ' ' VAL . 68.4 Cg_endo -75.01 -56.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.639 2.226 . . . . 0.0 112.331 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -18.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' D' ' 58' ' ' PRO . 91.2 t -81.66 -44.98 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.421 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -79.04 -27.12 43.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.9 63.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.75 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 0.692 ' HE2' HAD2 ' D' ' 147' ' ' HEC . 59.5 t-80 -72.27 -24.02 61.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.408 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.01 -25.98 74.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' D' ' 65' ' ' LYS . 0.3 OUTLIER -55.99 -42.86 77.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.207 -1.172 . . . . 0.0 109.044 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . 0.428 ' HD3' ' CAA' ' D' ' 147' ' ' HEC . 91.9 mttt -64.34 -41.46 96.76 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.589 -0.694 . . . . 0.0 109.561 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.676 HG23 ' C1B' ' D' ' 147' ' ' HEC . 28.7 t -65.19 -62.93 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.288 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 tt -54.35 -40.15 67.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.205 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.55 -53.87 38.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.16 -44.38 42.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -1.122 . . . . 0.0 109.54 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.33 -45.82 89.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' SER . . . . . 0.424 ' HG ' ' N ' ' D' ' 73' ' ' ASP . 98.4 p -61.08 -34.89 75.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.459 -0.776 . . . . 0.0 109.526 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . 0.424 ' N ' ' HG ' ' D' ' 72' ' ' SER . 13.6 t70 -54.02 -39.66 66.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.14 -60.16 8.4 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.471 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.9 mp -53.75 -30.06 42.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.324 -1.103 . . . . 0.0 109.193 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.13 4.31 45.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -170.35 67.45 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.669 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt -78.9 12.73 2.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.246 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.0 -29.76 68.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 24.8 t-20 -164.0 111.29 1.12 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.636 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' D' ' 81' ' ' LEU . 7.5 mp -80.26 -56.11 4.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . 0.478 ' NZ ' ' CD2' ' D' ' 143' ' ' HIS . 77.2 tttt -62.42 -24.06 67.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -75.04 -51.06 7.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.7 t -73.43 -46.31 49.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 0.0 109.498 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.538 ' N ' ' CG2' ' D' ' 84' ' ' THR . 54.5 m-85 -84.28 26.11 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.583 -0.698 . . . . 0.0 109.624 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.08 -28.08 67.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 0.0 109.422 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 87' ' ' THR . . . . . 0.464 ' O ' ' N ' ' D' ' 91' ' ' LEU . 82.6 p -77.13 -58.17 3.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.646 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.26 -41.57 18.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -68.67 -37.67 79.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.527 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -82.73 -28.15 30.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 0.0 109.378 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' D' ' 87' ' ' THR . 10.3 tt -75.58 -68.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.234 -0.917 . . . . 0.0 109.238 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.583 ' O ' ' N ' ' D' ' 97' ' ' HIS . 71.0 m80 -50.08 -23.87 2.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.757 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 38.8 t -83.94 -56.21 3.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 111.03 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.538 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 73.3 m-20 -86.21 -24.6 26.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.074 -1.016 . . . . 0.0 111.749 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' D' ' 95' ' ' LYS . 10.7 mptt -94.21 -51.63 4.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.638 -1.289 . . . . 0.0 110.742 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.96 -27.73 13.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 0.0 109.907 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 1.337 ' CD2' HG23 ' A' ' 41' ' ' THR . 21.4 m-70 57.77 53.67 6.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.33 124.26 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.134 -0.979 . . . . 0.0 109.261 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . 1.256 ' CG ' HG13 ' A' ' 96' ' ' VAL . 68.7 m-20 -47.93 149.29 2.44 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.123 -0.986 . . . . 0.0 109.426 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.3 62.91 5.29 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.532 2.155 . . . . 0.0 112.082 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -172.05 73.84 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.85 -27.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.867 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 0.1 OUTLIER -56.38 -20.37 19.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.094 -1.004 . . . . 0.0 109.633 -179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -86.28 -41.04 14.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.056 -1.028 . . . . 0.0 109.36 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 tp -48.99 -40.14 29.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.386 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.555 HD11 ' CAB' ' D' ' 147' ' ' HEC . 5.7 tt -69.35 -47.56 63.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.295 -0.878 . . . . 0.0 109.315 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.39 -19.98 54.28 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -81.79 -55.82 4.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -1.196 . . . . 0.0 110.01 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.96 -24.09 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.032 -1.042 . . . . 0.0 109.682 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.62 -57.97 9.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.0 109.42 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 70.0 t -46.67 -26.06 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.772 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.45 -32.65 74.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.112 -0.993 . . . . 0.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.51 -31.56 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.534 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 12.4 mt -75.04 -29.5 60.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.504 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.42 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -74.93 -32.29 61.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.937 . . . . 0.0 109.483 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.466 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.89 -56.99 3.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 0.0 109.359 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . 0.409 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 13.7 m170 -56.81 -17.73 10.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 109.569 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.409 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 72.2 m-85 -154.54 60.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 109.64 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -71.04 -26.22 74.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . 0.494 ' CD ' ' N ' ' D' ' 120' ' ' LYS . 11.9 mptt -70.03 9.95 0.49 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -1.102 . . . . 0.0 109.343 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' D' ' 119' ' ' GLY . 68.8 mm-40 -136.71 2.54 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.39 -0.819 . . . . 0.0 109.45 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.623 ' CE2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -72.94 39.05 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.56 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.526 ' C ' HE22 ' D' ' 127' ' ' GLN . 0.8 OUTLIER -52.42 149.06 10.98 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.289 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -47.72 -52.38 8.19 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.449 2.099 . . . . 0.0 113.229 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 36.0 Cg_endo -65.27 -3.92 8.31 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.11 1.873 . . . . 0.0 112.7 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.85 -22.04 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.05 -1.032 . . . . 0.0 109.699 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . 0.526 HE22 ' C ' ' D' ' 123' ' ' THR . 1.8 mp0 -83.27 -60.0 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 0.0 109.687 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -53.93 -35.11 61.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.9 26.46 0.99 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.679 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -118.8 -61.37 1.66 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.366 -0.834 . . . . 0.0 109.684 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -52.83 -23.46 7.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.625 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -71.49 -39.2 71.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.747 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 74.6 t -62.71 -55.77 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.088 -1.008 . . . . 0.0 109.816 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' D' ' 137' ' ' VAL . 11.4 m -69.75 -28.56 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -0.853 . . . . 0.0 110.036 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.55 -25.96 1.29 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.99 -1.069 . . . . 0.0 109.383 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.78 -24.52 58.07 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' D' ' 134' ' ' VAL . 75.4 t -79.36 -37.65 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -1.126 . . . . 0.0 109.343 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.78 79.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.445 HD22 HD22 ' B' ' 139' ' ' ASN . 65.0 t30 -72.05 -44.08 63.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.24 -40.94 49.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 37.1 mt -81.95 12.9 3.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.272 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.91 1.63 1.88 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.284 -0.885 . . . . 0.0 109.711 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . 0.478 ' CD2' ' NZ ' ' D' ' 82' ' ' LYS . 10.4 t60 -79.32 -34.09 42.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.512 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 5.0 tptp -67.42 -25.5 65.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.381 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -63.99 -14.16 51.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.92 . . . . 0.0 109.529 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.526 ' CG ' ' OXT' ' D' ' 146' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.551 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.721 ' CAA' ' HG2' ' A' ' 61' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 0.993 HBC3 ' HE2' ' B' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 0.709 ' CAA' ' HG2' ' C' ' 61' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.013 HBC3 ' HE2' ' D' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.498 ' CG1' ' OG ' ' A' ' 131' ' ' SER . 96.6 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.337 0.589 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.606 ' CD1' ' HZ1' ' A' ' 127' ' ' LYS . 1.1 mp 59.06 163.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.359 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 174.77 -44.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.92 . . . . 0.0 110.033 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 3' ' ' SER . 52.9 Cg_exo -53.7 172.85 0.22 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.691 2.261 . . . . 0.0 113.105 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.598 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -46.9 -14.6 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 4' ' ' PRO . 3.0 p30 -38.59 -22.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.445 -0.785 . . . . 0.0 110.121 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 5' ' ' ALA . 38.0 mttt -80.42 -56.78 3.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.115 -0.991 . . . . 0.0 109.407 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 m -46.82 -28.65 1.62 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.511 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -78.35 -38.07 42.89 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 7' ' ' LYS . 25.4 t -71.61 -49.28 47.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -50.99 -44.23 60.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.21 -61.21 2.77 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.97 -35.38 69.09 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -0.756 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -77.01 -17.16 59.03 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.204 -0.935 . . . . 0.0 108.888 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.57 -38.23 44.45 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -84.46 -35.21 23.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.402 -1.058 . . . . 0.0 109.495 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.546 ' O ' ' C ' ' A' ' 18' ' ' GLY . 42.6 t -73.64 -36.91 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 109.674 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.589 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . -30.58 143.72 0.01 OUTLIER Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 71.07 -31.96 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -1.043 . . . . 0.0 109.113 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.589 ' H ' ' C ' ' A' ' 18' ' ' GLY . 49.8 m-70 -107.94 17.13 22.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.49 -36.05 20.79 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.879 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.3 -14.44 64.14 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -87.99 -56.14 3.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -1.113 . . . . 0.0 109.876 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.4 m-30 -58.42 -35.38 71.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.365 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.73 -23.06 64.89 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.38 -49.91 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -1.188 . . . . 0.0 109.696 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -56.62 -19.76 17.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.83 -21.25 60.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 109.597 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.0 mt -82.61 -54.31 5.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -64.43 -34.04 77.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.553 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.489 ' CG ' HH11 ' A' ' 31' ' ' ARG . 0.5 OUTLIER -66.4 -38.57 87.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 109.631 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 32' ' ' MET . 15.1 tmm? -75.13 -31.97 61.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.313 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -54.14 -49.93 68.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.78 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' A' ' 36' ' ' PHE . 1.3 pp -81.27 -43.61 18.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 m -62.95 4.48 0.17 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.617 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.542 ' H ' ' C ' ' A' ' 34' ' ' LEU . 2.5 t80 -162.74 93.76 1.2 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.222 -0.923 . . . . 0.0 109.165 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.76 -23.38 6.95 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.495 2.13 . . . . 0.0 112.404 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.533 ' OG1' ' CE2' ' A' ' 36' ' ' PHE . 9.5 p -54.65 -28.57 48.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 109.283 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 42' ' ' TYR . 8.8 p -89.98 -22.8 21.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 109.547 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -46.12 -31.1 2.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 1.218 HG23 ' CG ' ' D' ' 97' ' ' HIS . 0.6 OUTLIER -77.96 -18.93 55.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 39' ' ' THR . 33.7 t80 -60.38 -22.56 63.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.575 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.6 t80 53.73 83.83 0.22 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.408 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.713 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 76.3 Cg_exo -47.25 -41.2 27.98 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.611 2.207 . . . . 0.0 112.2 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.713 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 97.69 33.79 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 120.589 0.233 . . . . 0.0 111.177 179.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.563 ' CZ ' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -137.06 35.21 2.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.832 -1.168 . . . . 0.0 109.917 178.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 49' ' ' SER . 14.5 m-20 52.79 91.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 109.53 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.03 -1.65 0.33 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 47' ' ' ASP . 92.8 p -54.31 126.74 24.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.915 . . . . 0.0 109.463 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -57.25 136.01 56.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.472 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.41 70.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.538 ' C ' ' H ' ' A' ' 54' ' ' GLN . 4.5 t -64.04 -14.56 55.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -1.141 . . . . 0.0 109.457 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 70.88 -18.82 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.622 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.538 ' H ' ' C ' ' A' ' 52' ' ' SER . 32.9 mt-30 -85.67 -18.09 34.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 109.376 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.64 -36.12 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -75.92 -33.47 59.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 108.96 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.72 -25.19 74.11 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.498 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.3 t-80 -71.49 -43.29 66.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -1.117 . . . . 0.0 109.392 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -49.38 -48.17 34.28 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 86.4 mttt -52.71 -22.62 5.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.995 . . . . 0.0 110.005 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.85 -40.91 60.73 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.146 -0.971 . . . . 0.0 108.792 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -73.05 -47.28 48.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.88 -32.59 74.19 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 26.1 t0 -71.93 -32.46 67.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.081 -1.012 . . . . 0.0 108.599 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -68.19 -52.57 32.87 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 70' ' ' VAL . 4.5 mt -51.01 -41.38 59.75 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.246 -0.909 . . . . 0.0 108.97 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 71' ' ' ALA . 16.3 m -68.26 -57.81 5.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.182 -0.949 . . . . 0.0 108.728 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -59.76 -23.84 63.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 108.758 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.08 -46.93 10.68 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' LEU . 41.5 t -68.56 -22.93 27.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -67.75 -36.13 79.97 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' A' ' 74' ' ' ASP . 84.8 m-70 -102.78 -65.61 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.491 -0.756 . . . . 0.0 109.465 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' A' ' 72' ' ' HIS . 12.6 p 44.83 14.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.863 0.839 . . . . 0.0 109.437 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 72' ' ' HIS . 71.0 m-20 -137.18 11.89 3.05 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.23 31.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.205 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.686 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 8.1 ptt? -78.32 -22.89 0.4 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.929 . . . . 0.0 111.937 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.4 Cg_exo -53.27 -22.4 20.15 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.558 1.506 . . . . 0.0 112.335 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -92.98 -40.52 10.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.05 84.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 109.175 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.6 mt -83.93 9.48 12.11 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.451 -0.781 . . . . 0.0 108.918 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -58.43 -50.39 73.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 109.53 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 83' ' ' LEU . . . -50.11 -58.52 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.579 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.51 HD22 HBA1 ' A' ' 142' ' ' HEC . 4.5 mt -46.02 -46.2 16.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 108.894 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 p -64.89 -32.11 73.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.541 -0.724 . . . . 0.0 109.404 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -75.5 -23.84 56.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.672 HD22 HBD2 ' A' ' 142' ' ' HEC . 5.7 tt -82.99 -34.16 26.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 109.518 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.435 ' HE2' ' C1D' ' A' ' 142' ' ' HEC . 47.1 m80 -92.14 -21.88 20.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.927 . . . . 0.0 109.524 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.34 -84.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.732 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -78.54 -70.42 0.49 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.85 . . . . 0.0 109.918 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.632 ' C ' ' H ' ' A' ' 92' ' ' ARG . 25.5 ttmt -46.31 137.97 5.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.988 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.1 mt 66.19 -20.43 0.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.652 -0.655 . . . . 0.0 109.754 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.361 ' NH2' HBD2 ' D' ' 147' ' ' HEC . 65.5 mtt180 38.9 27.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.41 -0.806 . . . . 0.0 109.685 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.565 ' CG2' ' ND2' ' A' ' 97' ' ' ASN . 7.5 p -45.45 141.19 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.872 . . . . 0.0 109.669 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.3 149.55 86.89 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 109.376 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.524 ' C ' ' H ' ' A' ' 97' ' ' ASN . 59.8 Cg_endo -73.56 -22.25 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.526 2.151 . . . . 0.0 112.271 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.5 -3.63 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 109.609 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.565 ' ND2' ' CG2' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -79.36 -41.93 26.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.928 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -51.25 -48.73 62.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 109.433 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -48.28 -30.61 4.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.498 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 18.7 mt -84.24 -62.03 1.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.41 HD22 ' CHC' ' A' ' 142' ' ' HEC . 4.9 tp -49.89 -20.94 1.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.728 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 t -69.34 -59.11 3.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.454 ' ND1' ' OD1' ' B' ' 108' ' ' ASN . 32.1 m170 -68.43 -26.61 65.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.882 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 50.4 m -62.93 -45.48 92.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 109.927 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.482 ' O ' ' OG1' ' A' ' 108' ' ' THR . 1.0 OUTLIER -55.97 -55.39 33.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.95 . . . . 0.0 109.429 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 4.1 mm? -47.83 -29.15 3.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.613 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.5 t -83.41 -24.63 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 105' ' ' LEU . 27.9 p -71.46 -63.39 1.13 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.986 -1.071 . . . . 0.0 110.345 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -64.67 -26.22 68.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 109.636 -179.511 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.4 -37.39 25.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.16 -56.24 4.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 110.07 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -71.38 -67.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.808 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 114' ' ' PRO . 2.1 tm? -110.7 98.52 37.86 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 66.6 Cg_exo -49.17 -170.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.277 1.984 . . . . 0.0 112.296 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.652 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -73.04 -55.33 6.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 108.827 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.652 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 18.3 mt-10 118.69 -8.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 5.3 t80 77.14 33.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.881 -0.512 . . . . 0.0 111.146 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.4 OUTLIER -101.62 116.0 64.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.04 20.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.982 1.788 . . . . 0.0 112.468 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -144.83 -29.47 0.46 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.159 -0.963 . . . . 0.0 110.431 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 10.6 p -49.34 -50.77 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.139 -0.975 . . . . 0.0 109.967 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.529 ' H ' ' ND1' ' A' ' 122' ' ' HIS . 3.0 m80 -60.87 -34.67 74.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.121 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.18 -20.19 32.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.386 -0.821 . . . . 0.0 109.707 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.3 m -64.84 -62.12 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.541 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.88 -19.8 62.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.145 -0.972 . . . . 0.0 109.972 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.43 -44.47 19.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.033 . . . . 0.0 110.114 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.606 ' HZ1' ' CD1' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -89.04 -41.49 12.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.985 -1.072 . . . . 0.0 109.954 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 41.4 t80 -50.48 -20.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.878 -1.138 . . . . 0.0 108.907 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.596 ' O ' ' N ' ' A' ' 133' ' ' SER . 18.1 mt -71.42 -17.67 62.38 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.04 -31.69 71.32 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.498 ' OG ' ' CG1' ' A' ' 1' ' ' VAL . 4.0 t -83.53 -33.08 25.56 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.379 -0.826 . . . . 0.0 108.911 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.4 t -85.17 -26.63 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 108.907 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 129' ' ' LEU . 33.0 t -84.02 -25.52 29.85 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 108.873 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 33.5 m -77.62 -39.06 46.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.15 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.18 -27.04 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.262 -0.898 . . . . 0.0 108.69 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -29.98 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 137' ' ' THR . 93.5 m -112.52 24.02 12.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.409 -0.807 . . . . 0.0 109.437 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.6 t -46.91 -65.41 0.57 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.666 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.494 ' NZ ' ' CB ' ' A' ' 139' ' ' LYS . 8.4 mtmp? 52.38 -106.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.907 . . . . 0.0 109.525 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -150.81 -55.53 0.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.399 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.419 -179.979 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.603 ' H2 ' ' CB ' ' B' ' 133' ' ' VAL . 8.1 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 49.62 42.11 22.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.087 -1.008 . . . . 0.0 109.332 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.671 ' H ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -92.04 155.58 18.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 0.0 109.328 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.14 153.9 84.03 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.013 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.02 -15.91 36.09 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.655 2.237 . . . . 0.0 112.313 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -85.28 -42.75 14.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.71 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.16 -22.56 30.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.917 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -79.23 -40.41 30.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.184 -0.947 . . . . 0.0 109.315 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 9.0 t -61.63 -23.64 66.18 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.815 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.11 -55.49 4.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 110.121 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.17 -24.72 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.078 -1.014 . . . . 0.0 108.414 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -82.21 -37.03 26.65 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.385 0.612 . . . . 0.0 109.617 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.46 96.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.528 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 17' ' ' LYS . 0.8 OUTLIER -61.82 -35.1 77.24 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.471 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -48.07 -21.52 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 109.046 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' B' ' 14' ' ' LEU . . . -86.5 -32.63 15.5 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' B' ' 14' ' ' LEU . 1.0 OUTLIER -78.02 -31.42 50.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -1.151 . . . . 0.0 109.087 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' B' ' 20' ' ' VAL . 69.7 t -54.09 114.88 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.551 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' B' ' 21' ' ' ASP . 3.1 m120 -71.41 64.06 0.4 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 109.168 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' B' ' 18' ' ' VAL . 42.1 t -45.68 -16.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.516 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' B' ' 19' ' ' ASN . 21.8 t70 -77.1 5.46 8.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.454 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -154.17 -43.84 0.09 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -0.87 . . . . 0.0 109.467 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -55.16 -24.9 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.507 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.41 -42.52 93.8 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.72 -35.92 54.18 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -73.44 -36.49 65.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 109.376 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.45 -52.94 62.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.47 -51.57 66.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 109.2 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.75 -40.65 95.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' B' ' 33' ' ' VAL . 16.7 mmt85 -58.13 -44.36 87.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -1.13 . . . . 0.0 109.524 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 35' ' ' TYR . 34.0 tp -46.83 -32.53 3.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.319 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 mt -81.18 -21.84 39.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' B' ' 30' ' ' ARG . 21.2 t -87.12 -64.29 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 109.549 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -49.57 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.874 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.417 ' O ' ' O ' ' B' ' 31' ' ' LEU . 0.1 OUTLIER -118.53 85.68 27.03 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.365 -0.834 . . . . 0.0 109.45 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -84.26 34.47 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.702 2.268 . . . . 0.0 112.315 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . 0.434 ' CD1' ' N ' ' B' ' 38' ' ' THR . 1.9 p-90 -81.04 -29.74 34.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.13 -0.981 . . . . 0.0 109.602 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.434 ' N ' ' CD1' ' B' ' 37' ' ' TRP . 65.1 p -60.62 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.433 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 48.95 45.2 22.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.471 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.497 ' HA ' ' NH1' ' C' ' 92' ' ' ARG . 19.2 ptt180 -137.82 -39.18 0.56 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.249 -0.907 . . . . 0.0 109.367 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . 0.653 ' CE2' HMD3 ' B' ' 147' ' ' HEC . 38.0 t80 -100.41 -25.47 14.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 1.209 ' CZ ' ' CBC' ' B' ' 147' ' ' HEC . 62.8 m-85 -74.48 6.11 4.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.14 -23.28 51.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 20.3 p -59.62 -40.31 87.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.507 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -51.63 -17.61 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.69 55.12 11.65 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -159.55 79.33 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -1.162 . . . . 0.0 109.394 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 36.6 mt -131.56 14.63 4.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 109.421 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.8 m -46.91 -41.75 16.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.221 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 5.9 p -146.64 148.68 34.41 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.438 -0.789 . . . . 0.0 108.896 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -41.07 -39.52 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.37 2.047 . . . . 0.0 112.292 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.403 ' C ' ' N ' ' B' ' 54' ' ' VAL . 1.0 OUTLIER -67.04 -40.43 87.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 109.643 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.14 -19.84 0.31 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.385 -0.822 . . . . 0.0 109.552 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.403 ' N ' ' C ' ' B' ' 52' ' ' ASP . 83.5 t -67.56 -64.01 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 10.4 mtt -86.12 -6.1 59.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 109.601 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.13 -35.6 88.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -81.24 148.36 63.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.205 -1.173 . . . . 0.0 109.418 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.13 -51.7 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.548 2.165 . . . . 0.0 112.287 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.421 ' HG3' ' H ' ' B' ' 60' ' ' VAL . 0.0 OUTLIER -47.3 -39.4 14.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 109.758 -179.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.421 ' H ' ' HG3' ' B' ' 59' ' ' LYS . 61.2 t -61.68 -45.47 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -75.17 -24.84 57.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.43 -43.05 70.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.574 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 1.18 ' HE2' ' C4D' ' B' ' 147' ' ' HEC . 55.2 t60 -64.1 -23.9 67.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.685 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.29 75.84 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.5 ' NZ ' ' OD1' ' B' ' 21' ' ' ASP . 19.3 mtpt -67.13 -25.02 65.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -1.15 . . . . 0.0 109.619 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . 0.82 ' O ' HMA3 ' B' ' 147' ' ' HEC . 66.8 mttm -72.02 -28.75 63.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.583 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 1.033 HG21 ' CHB' ' B' ' 147' ' ' HEC . 41.6 t -80.11 -48.79 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.54 -16.92 42.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.31 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.14 -48.64 45.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.51 90.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -1.157 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -47.31 -41.2 18.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 0.0 109.559 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 14.0 m -49.42 -44.3 45.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 109.48 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -67.78 -16.72 64.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.06 -26.54 69.25 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.466 HD23 ' H ' ' B' ' 75' ' ' LEU . 2.0 pt? -136.08 -18.6 1.55 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.236 -1.155 . . . . 0.0 110.153 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -82.24 1.44 36.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.061 -1.024 . . . . 0.0 109.731 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 59.4 m-70 -163.06 67.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 109.549 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.09 4.85 3.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.49 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.02 -37.21 79.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.487 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 14.1 t-20 -171.45 99.43 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.492 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.04 -57.25 3.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.536 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -47.12 -24.02 0.6 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.558 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -66.43 -54.91 20.58 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.551 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.8 t -75.5 -47.32 27.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 0.0 109.488 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.551 ' N ' ' CG2' ' B' ' 84' ' ' THR . 53.3 m-85 -62.73 -1.18 0.78 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.5 -0.75 . . . . 0.0 109.381 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -59.22 -35.85 74.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.453 ' O ' ' N ' ' B' ' 91' ' ' LEU . 21.5 p -83.28 -47.96 10.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.932 . . . . 0.0 109.531 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 40.5 mt -55.42 -43.12 75.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -67.41 -51.3 53.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.53 -22.41 64.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.868 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.6 tt -81.42 -60.11 2.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.77 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.469 ' O ' ' N ' ' B' ' 97' ' ' HIS . 66.5 m80 -61.78 -22.42 65.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.288 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 39.4 t -83.1 -60.58 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 110.729 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.538 ' O ' ' CE1' ' B' ' 97' ' ' HIS . 5.1 m-20 -87.23 -27.74 22.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.137 -0.977 . . . . 0.0 111.149 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.2 OUTLIER -87.68 -16.68 33.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.889 -1.132 . . . . 0.0 110.646 -178.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.498 ' C ' ' ND1' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -138.37 -39.26 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.942 -1.099 . . . . 0.0 109.929 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 1.181 ' CG ' HG23 ' C' ' 41' ' ' THR . 4.9 m80 64.87 58.78 0.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.101 -1.0 . . . . 0.0 109.754 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.7 132.63 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.081 -1.012 . . . . 0.0 109.335 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.44 152.55 2.22 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.359 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.04 -29.84 17.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.66 2.24 . . . . 0.0 112.187 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.33 53.68 0.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.768 ' OD1' ' CMC' ' B' ' 147' ' ' HEC . 31.4 t-20 -149.35 -38.95 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.586 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.69 -29.78 70.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.545 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . 0.402 ' NH1' ' CB ' ' B' ' 104' ' ' ARG . 31.4 mtm105 -77.82 -20.03 53.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 109.678 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.73 -50.04 9.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 1.058 ' CD1' ' CHC' ' B' ' 147' ' ' HEC . 6.0 tt -52.04 -49.04 64.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.39 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.5 -20.39 63.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . 0.483 ' O ' ' SG ' ' B' ' 112' ' ' CYS . 0.2 OUTLIER -81.76 -19.43 41.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -1.135 . . . . 0.0 109.658 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 92.6 t -86.36 -53.01 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.242 -0.911 . . . . 0.0 109.675 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' B' ' 113' ' ' VAL . 2.8 tt -45.98 -60.2 2.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.336 -0.853 . . . . 0.0 109.717 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 61.5 t -46.68 -33.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.934 . . . . 0.0 109.748 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' B' ' 108' ' ' ASN . 60.2 m -79.21 -23.94 43.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.657 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 110' ' ' LEU . 98.2 t -75.0 -21.34 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.569 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.523 ' CD1' ' CZ ' ' B' ' 130' ' ' TYR . 21.5 mt -79.06 -48.59 14.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 109.49 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.27 -23.1 3.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.507 ' ND1' ' HD1' ' B' ' 117' ' ' HIS . 6.5 t-80 -83.81 -57.75 3.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.571 ' HD1' ' N ' ' B' ' 117' ' ' HIS . 0.3 OUTLIER -72.4 -17.78 61.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.524 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' B' ' 114' ' ' LEU . 95.1 m-85 -141.64 56.53 1.51 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -73.16 -24.94 74.61 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.2 9.32 1.02 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -1.132 . . . . 0.0 109.624 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.1 mm-40 -142.68 8.78 1.75 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.541 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -78.68 34.19 0.22 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.971 . . . . 0.0 109.442 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.436 ' H ' ' C ' ' B' ' 121' ' ' GLU . 69.2 p -48.67 148.47 3.62 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.265 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.499 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.4 Cg_exo -44.09 -55.82 2.88 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.544 2.163 . . . . 0.0 112.983 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 12.4 Cg_endo -56.22 -23.23 44.29 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.188 1.925 . . . . 0.0 112.22 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 76.5 t -82.87 -23.31 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 109.559 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -83.18 -59.67 2.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.25 -36.85 14.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.903 . . . . 0.0 109.842 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.6 -5.22 56.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.131 -0.98 . . . . 0.0 110.065 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.523 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 0.1 OUTLIER -92.58 -40.72 10.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.006 . . . . 0.0 109.47 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -83.97 -23.05 31.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 109.633 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -71.14 -42.36 69.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 110.141 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . 0.677 ' CG1' ' H ' ' B' ' 134' ' ' VAL . 6.3 p -71.96 -66.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.112 -0.992 . . . . 0.0 110.327 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.677 ' H ' ' CG1' ' B' ' 133' ' ' VAL . 33.1 m -43.32 -19.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.949 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' B' ' 133' ' ' VAL . . . -59.55 -28.11 66.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.267 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.85 -30.85 58.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.41 -36.31 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -1.156 . . . . 0.0 109.451 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.42 -40.11 89.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.964 HD22 HD22 ' D' ' 139' ' ' ASN . 53.7 t30 -75.88 -25.98 56.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.67 -48.98 74.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.2 -4.24 28.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.393 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' B' ' 145' ' ' TYR . . . -102.36 -39.51 7.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 0.0 109.545 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -45.32 -40.26 7.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 109.784 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.26 27.33 1.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.113 -0.992 . . . . 0.0 109.559 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.576 ' O ' ' CG ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -140.43 1.27 1.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.515 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.461 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.499 ' CG1' ' OG ' ' C' ' 131' ' ' SER . 97.6 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . 0.62 ' CD1' ' HZ1' ' C' ' 127' ' ' LYS . 1.1 mp 58.91 163.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 174.82 -44.9 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 110.005 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' C' ' 3' ' ' SER . 52.9 Cg_exo -53.55 172.86 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.702 2.268 . . . . 0.0 113.14 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -47.02 -14.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.637 -0.664 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' C' ' 4' ' ' PRO . 3.0 p30 -38.68 -22.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.391 -0.818 . . . . 0.0 110.146 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' C' ' 5' ' ' ALA . 37.9 mttt -80.51 -56.77 3.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.109 -0.994 . . . . 0.0 109.378 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 54.5 m -46.82 -28.62 1.61 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.349 -0.844 . . . . 0.0 109.504 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -78.42 -38.07 42.29 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' C' ' 7' ' ' LYS . 25.4 t -71.58 -49.16 48.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -51.15 -44.16 61.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 108.621 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.22 -61.13 2.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.458 -0.776 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.09 -35.33 69.27 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.41 -0.806 . . . . 0.0 109.333 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -77.09 -17.12 58.93 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.188 -0.945 . . . . 0.0 108.877 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.49 -38.41 44.54 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -84.37 -35.21 23.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.294 -1.121 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.538 ' O ' ' C ' ' C' ' 18' ' ' GLY . 42.6 t -73.58 -36.94 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.813 . . . . 0.0 109.684 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.587 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . -30.63 143.72 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' C' ' 18' ' ' GLY . . . 71.09 -31.92 0.24 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.409 -1.053 . . . . 0.0 109.121 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.587 ' H ' ' C ' ' C' ' 18' ' ' GLY . 49.7 m-70 -107.92 17.2 22.72 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.63 -35.98 20.63 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.847 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.38 -14.44 64.34 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -87.87 -56.13 3.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.3 -1.118 . . . . 0.0 109.97 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 1.4 m-30 -58.52 -35.33 72.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.374 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.65 -23.02 64.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.42 -49.91 8.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.225 -1.162 . . . . 0.0 109.759 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.53 -19.85 17.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.659 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.75 -21.31 61.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 109.542 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 11.1 mt -82.53 -54.3 5.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.877 . . . . 0.0 109.653 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -33.95 77.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.564 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.499 ' CG ' HH11 ' C' ' 31' ' ' ARG . 0.5 OUTLIER -66.48 -38.55 87.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.647 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 1.504 ' HE3' ' CAB' ' C' ' 142' ' ' HEC . 15.1 tmm? -75.09 -32.0 61.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 109.32 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.641 ' HE1' ' C4D' ' C' ' 142' ' ' HEC . 74.5 t80 -54.11 -49.87 68.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.843 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' C' ' 36' ' ' PHE . 1.3 pp -81.3 -43.71 18.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.165 -0.96 . . . . 0.0 110.024 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -62.92 4.47 0.17 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 0.0 109.582 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.976 ' HB3' ' CMC' ' C' ' 142' ' ' HEC . 2.5 t80 -162.74 93.75 1.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.16 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -79.81 -23.29 6.96 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.496 2.131 . . . . 0.0 112.405 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' THR . . . . . 0.53 ' OG1' ' CE2' ' C' ' 36' ' ' PHE . 9.1 p -54.77 -28.49 49.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.0 109.253 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.896 ' HB ' ' CHC' ' C' ' 142' ' ' HEC . 8.6 p -90.12 -22.65 21.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 109.515 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.948 ' O ' ' C3D' ' C' ' 142' ' ' HEC . 29.3 ttpt -46.23 -31.13 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.576 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 1.181 HG23 ' CG ' ' B' ' 97' ' ' HIS . 0.5 OUTLIER -77.9 -18.96 55.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' C' ' 39' ' ' THR . 33.6 t80 -60.26 -22.67 63.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.641 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.514 ' HA ' HBA2 ' C' ' 142' ' ' HEC . 49.6 t80 53.69 83.88 0.22 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.388 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.72 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 76.0 Cg_exo -47.33 -41.11 28.6 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.529 2.153 . . . . 0.0 112.202 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 1.074 ' N ' ' CMA' ' C' ' 142' ' ' HEC . 0.0 OUTLIER 97.71 33.74 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.267 -0.271 . . . . 0.0 111.174 179.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.976 ' CD1' HMA1 ' C' ' 142' ' ' HEC . 0.1 OUTLIER -137.07 35.09 2.57 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.83 -1.169 . . . . 0.0 109.924 178.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.505 ' C ' ' H ' ' C' ' 49' ' ' SER . 14.4 m-20 52.97 91.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 1.483 HD11 ' CHA' ' C' ' 142' ' ' HEC . 11.3 mt -60.1 -1.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.39 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.505 ' H ' ' C ' ' C' ' 47' ' ' ASP . 92.4 p -54.38 126.81 24.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -57.29 136.03 56.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.47 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.79 15.41 70.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.55 ' C ' ' H ' ' C' ' 54' ' ' GLN . 4.4 t -64.08 -14.46 54.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.164 . . . . 0.0 109.468 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 70.82 -18.86 0.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.833 . . . . 0.0 109.659 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.55 ' H ' ' C ' ' C' ' 52' ' ' SER . 32.9 mt-30 -85.69 -18.11 34.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.08 -1.012 . . . . 0.0 109.367 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.65 -36.01 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -76.04 -33.51 59.62 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.257 -0.902 . . . . 0.0 108.895 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.66 -25.17 74.04 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.489 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.3 t-80 -71.46 -43.26 66.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -1.151 . . . . 0.0 109.417 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -49.5 -48.1 35.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 86.5 mttt -52.79 -22.51 5.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -1.002 . . . . 0.0 109.965 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -40.91 60.66 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.158 -0.964 . . . . 0.0 108.772 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 1.2 t -73.04 -47.24 48.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.86 -32.6 74.21 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.442 -0.786 . . . . 0.0 109.152 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 26.4 t0 -71.88 -32.46 67.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.045 . . . . 0.0 108.61 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -68.22 -52.47 33.74 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' C' ' 70' ' ' VAL . 4.5 mt -51.06 -41.36 59.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 108.926 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.433 ' O ' ' N ' ' C' ' 71' ' ' ALA . 16.3 m -68.27 -57.82 5.37 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.947 . . . . 0.0 108.739 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -59.81 -23.79 63.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 108.701 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.11 -46.92 10.68 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' C' ' 66' ' ' LEU . 41.6 t -68.53 -22.93 27.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -67.71 -36.18 80.15 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' C' ' 74' ' ' ASP . 84.9 m-70 -102.79 -65.5 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' C' ' 72' ' ' HIS . 12.6 p 44.8 14.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.791 0.805 . . . . 0.0 109.39 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' C' ' 72' ' ' HIS . 71.2 m-20 -137.12 11.93 3.06 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.22 31.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.153 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 8.2 ptt? -78.32 -22.82 0.4 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 111.987 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.6 Cg_exo -53.24 -22.47 20.16 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.556 1.504 . . . . 0.0 112.361 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -92.95 -40.44 10.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.483 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.11 83.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.9 . . . . 0.0 109.137 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 28.9 mt -83.79 9.34 12.13 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 108.932 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -58.27 -50.52 73.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.575 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' C' ' 83' ' ' LEU . . . -50.04 -58.57 5.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.569 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' C' ' 82' ' ' ALA . 4.5 mt -46.07 -46.15 16.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' C' ' 88' ' ' ALA . 5.8 p -64.94 -32.11 73.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.535 -0.728 . . . . 0.0 109.391 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' C' ' 82' ' ' ALA . 31.9 t70 -75.43 -23.85 57.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tt -83.01 -34.25 26.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.858 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -91.97 -21.97 20.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' C' ' 84' ' ' SER . . . -69.32 -84.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.713 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -78.45 -70.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.893 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.636 ' C ' ' H ' ' C' ' 92' ' ' ARG . 25.5 ttmt -46.3 137.99 5.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 110.013 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.1 mt 66.23 -20.41 0.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.711 -0.618 . . . . 0.0 109.759 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . 0.636 ' H ' ' C ' ' C' ' 90' ' ' LYS . 65.3 mtt180 38.8 27.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.539 -0.726 . . . . 0.0 109.676 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.576 ' CG2' ' ND2' ' C' ' 97' ' ' ASN . 7.5 p -45.47 141.2 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.828 . . . . 0.0 109.681 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -74.31 149.51 86.86 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.894 . . . . 0.0 109.371 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' C' ' 97' ' ' ASN . 59.5 Cg_endo -73.61 -22.2 18.39 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.435 2.09 . . . . 0.0 112.204 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.56 -3.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.576 ' ND2' ' CG2' ' C' ' 93' ' ' VAL . 0.7 OUTLIER -79.24 -41.92 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 109.998 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -51.29 -48.7 62.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 109.41 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -48.34 -30.57 5.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.176 -0.952 . . . . 0.0 109.434 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.502 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 18.6 mt -84.21 -62.09 1.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 109.622 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tp -49.88 -20.92 0.99 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.725 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 10.2 t -69.29 -59.14 3.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.939 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.463 ' ND1' ' OD1' ' D' ' 108' ' ' ASN . 32.1 m170 -68.42 -26.61 65.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.821 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 50.9 m -63.03 -45.36 92.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.887 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.484 ' O ' ' OG1' ' C' ' 108' ' ' THR . 1.0 OUTLIER -56.0 -55.41 33.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.987 . . . . 0.0 109.456 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' C' ' 106' ' ' LEU . 4.1 mm? -47.79 -29.18 2.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.135 -0.978 . . . . 0.0 109.591 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.36 -24.79 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 0.0 110.113 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' C' ' 105' ' ' LEU . 28.0 p -71.45 -63.34 1.14 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.026 -1.046 . . . . 0.0 110.352 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' C' ' 113' ' ' LEU . 0.1 OUTLIER -64.64 -26.29 68.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.056 -1.027 . . . . 0.0 109.636 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.35 -37.43 24.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.107 -0.995 . . . . 0.0 109.707 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.18 -56.17 4.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 110.075 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -71.45 -67.51 0.52 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.821 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' C' ' 114' ' ' PRO . 2.1 tm? -110.68 98.49 37.66 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' C' ' 113' ' ' LEU . 65.7 Cg_exo -49.18 -170.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.269 1.98 . . . . 0.0 112.304 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.654 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -72.99 -55.22 6.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 108.866 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.654 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 18.3 mt-10 118.58 -8.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 0.464 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 5.3 t80 77.13 33.74 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.937 -0.477 . . . . 0.0 111.139 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.4 OUTLIER -101.62 116.08 64.02 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.1 20.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.935 1.757 . . . . 0.0 112.482 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -144.81 -29.37 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.038 -1.039 . . . . 0.0 110.423 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 10.5 p -49.39 -50.8 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.06 -1.025 . . . . 0.0 109.899 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.55 ' H ' ' ND1' ' C' ' 122' ' ' HIS . 2.9 m80 -60.81 -34.76 75.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.119 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.18 -20.06 33.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.765 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.522 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.4 m -64.93 -62.08 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 110.518 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.94 -19.69 62.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.187 -0.945 . . . . 0.0 109.949 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.48 -44.52 19.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.068 -1.02 . . . . 0.0 110.109 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.62 ' HZ1' ' CD1' ' C' ' 2' ' ' LEU . 0.0 OUTLIER -89.07 -41.37 12.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.004 -1.06 . . . . 0.0 109.977 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 41.7 t80 -50.52 -20.91 1.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.99 -1.069 . . . . 0.0 108.899 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' C' ' 133' ' ' SER . 18.2 mt -71.42 -17.66 62.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.411 ' O ' ' OG1' ' C' ' 134' ' ' THR . . . -61.0 -31.6 71.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 131' ' ' SER . . . . . 0.499 ' OG ' ' CG1' ' C' ' 1' ' ' VAL . 4.0 t -83.59 -33.05 25.46 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.289 -0.882 . . . . 0.0 108.918 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.18 -26.66 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.0 108.922 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.594 ' N ' ' O ' ' C' ' 129' ' ' LEU . 33.0 t -84.01 -25.45 29.93 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.383 -0.823 . . . . 0.0 108.969 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 134' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 33.2 m -77.69 -38.93 46.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 109.189 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 34.8 m -73.39 -26.85 22.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.3 -0.875 . . . . 0.0 108.677 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.81 -30.03 70.6 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 137' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' C' ' 137' ' ' THR . 93.5 m -112.45 24.07 12.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.413 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 3.6 t -46.91 -65.43 0.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . 0.494 ' CB ' ' NZ ' ' C' ' 139' ' ' LYS . 8.4 mtmp? 52.39 -106.19 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.129 -0.982 . . . . 0.0 109.563 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -150.82 -55.53 0.15 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.415 179.94 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.596 ' H2 ' ' CB ' ' D' ' 133' ' ' VAL . 8.2 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 49.78 42.04 23.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.288 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.67 ' H ' ' CD1' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -92.11 155.61 17.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.16 153.95 83.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 108.933 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.01 -15.96 36.31 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.616 2.21 . . . . 0.0 112.263 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.3 -42.77 14.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.682 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.17 -22.53 30.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.886 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -79.25 -40.5 30.46 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.124 -0.985 . . . . 0.0 109.245 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -61.58 -23.64 66.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 109.821 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.1 -55.43 4.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.065 -1.022 . . . . 0.0 110.144 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.26 -24.62 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.01 -1.056 . . . . 0.0 108.418 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -82.18 -37.14 26.56 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.752 -0.593 . . . . 0.0 109.591 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.5 96.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -0.848 . . . . 0.0 109.456 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' D' ' 17' ' ' LYS . 0.8 OUTLIER -61.81 -35.12 77.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.43 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -47.95 -21.63 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.138 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . 0.414 ' N ' ' C ' ' D' ' 14' ' ' LEU . . . -86.52 -32.52 15.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' D' ' 14' ' ' LEU . 1.0 OUTLIER -77.97 -31.46 50.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -1.123 . . . . 0.0 109.101 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -54.23 114.98 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.535 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' D' ' 21' ' ' ASP . 3.1 m120 -71.45 64.15 0.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.133 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 42.1 t -45.74 -16.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' D' ' 19' ' ' ASN . 21.4 t70 -77.32 5.67 8.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.937 . . . . 0.0 109.312 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' D' ' 19' ' ' ASN . 81.2 mt-10 -154.31 -43.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.352 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 78.7 t -55.03 -25.07 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 109.474 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.43 -42.55 93.74 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.67 -35.88 54.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -73.43 -36.52 65.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -1.138 . . . . 0.0 109.399 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.39 -53.05 61.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.179 -0.95 . . . . 0.0 109.417 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.42 -51.55 67.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.271 -0.893 . . . . 0.0 109.271 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.6 -40.77 95.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' D' ' 33' ' ' VAL . 16.6 mmt85 -58.1 -44.38 87.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . 0.535 ' HG ' ' HAB' ' D' ' 147' ' ' HEC . 33.6 tp -46.86 -32.44 3.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 109.247 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 mt -81.24 -21.87 39.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.893 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' D' ' 30' ' ' ARG . 21.2 t -87.13 -64.2 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -49.53 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.925 . . . . 0.0 109.841 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' D' ' 31' ' ' LEU . 0.1 OUTLIER -118.48 85.71 26.8 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.282 -0.886 . . . . 0.0 109.425 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . 0.808 ' O ' ' C2C' ' D' ' 147' ' ' HEC . 89.7 Cg_endo -84.18 34.44 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.787 2.324 . . . . 0.0 112.356 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . 0.573 ' CG ' HMC1 ' D' ' 147' ' ' HEC . 1.9 p-90 -81.09 -29.79 34.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 1.352 ' C ' ' C1C' ' D' ' 147' ' ' HEC . 65.5 p -60.58 -96.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.937 . . . . 0.0 109.325 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . 1.439 ' H ' ' C4B' ' D' ' 147' ' ' HEC . 78.7 mm-40 49.12 45.06 23.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.478 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . 0.585 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 19.1 ptt180 -137.76 -39.24 0.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.855 . . . . 0.0 109.357 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -100.38 -25.4 14.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 1.578 ' CB ' HMA1 ' D' ' 147' ' ' HEC . 61.9 m-85 -74.49 6.04 4.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.467 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.14 -23.19 51.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.554 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 20.4 p -59.61 -40.43 87.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.438 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -51.49 -17.73 0.89 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.77 55.14 11.77 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -159.55 79.19 0.72 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -1.087 . . . . 0.0 109.422 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . 0.576 HD23 ' C3A' ' D' ' 147' ' ' HEC . 35.9 mt -131.46 14.57 5.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.427 -0.795 . . . . 0.0 109.383 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 24.4 m -46.85 -41.75 16.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.211 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 6.1 p -146.73 148.67 34.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -41.16 -39.4 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.305 2.003 . . . . 0.0 112.333 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . 0.404 ' C ' ' N ' ' D' ' 54' ' ' VAL . 1.0 OUTLIER -67.04 -40.47 87.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.703 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.14 -19.83 0.31 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 109.523 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 52' ' ' ASP . 83.2 t -67.52 -64.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 109.681 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 10.4 mtt -86.21 -6.12 59.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.527 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.69 87.99 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -81.28 148.35 63.01 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.188 -1.183 . . . . 0.0 109.424 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.14 -51.71 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.559 2.173 . . . . 0.0 112.213 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . 0.412 ' HG3' ' H ' ' D' ' 60' ' ' VAL . 0.0 OUTLIER -47.3 -39.32 14.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.709 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . 0.412 ' H ' ' HG3' ' D' ' 59' ' ' LYS . 61.9 t -61.79 -45.4 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.118 -0.989 . . . . 0.0 109.289 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -75.25 -24.76 57.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 109.294 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.51 -42.98 70.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.605 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -64.04 -24.02 67.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.709 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.58 -33.24 76.07 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . 0.504 ' NZ ' ' OD1' ' D' ' 21' ' ' ASP . 19.4 mtpt -67.28 -24.87 65.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -1.216 . . . . 0.0 109.642 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -71.95 -28.88 63.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.628 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.1 -48.76 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.5 -16.91 41.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.376 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.11 -48.71 45.24 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.89 -46.61 89.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -1.181 . . . . 0.0 109.852 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' D' ' 74' ' ' GLY . 1.1 m-85 -47.25 -41.19 18.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 109.588 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 14.0 m -49.51 -44.21 46.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.459 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -67.85 -16.65 64.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.221 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' D' ' 71' ' ' PHE . . . -63.01 -26.61 69.27 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.472 HD23 ' H ' ' D' ' 75' ' ' LEU . 2.0 pt? -136.09 -18.54 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.271 -1.134 . . . . 0.0 110.176 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -82.25 1.49 36.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.997 -1.065 . . . . 0.0 109.746 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 59.8 m-70 -163.06 67.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.16 4.89 3.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.411 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' D' ' 77' ' ' HIS . 1.1 m-20 -60.13 -37.14 79.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 14.1 t-20 -171.42 99.39 0.19 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.532 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -80.18 -57.2 3.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -47.19 -23.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 0.0 109.524 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -66.37 -54.88 20.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.8 t -75.54 -47.45 26.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -1.18 . . . . 0.0 109.384 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.556 ' N ' ' CG2' ' D' ' 84' ' ' THR . 53.4 m-85 -62.53 -1.26 0.76 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.541 -0.724 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -59.2 -35.79 74.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 87' ' ' THR . . . . . 0.483 ' O ' ' N ' ' D' ' 91' ' ' LEU . 21.3 p -83.39 -47.93 10.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt -55.53 -43.0 75.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -67.36 -51.41 52.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.437 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.38 -22.55 64.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.482 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' D' ' 87' ' ' THR . 7.5 tt -81.36 -60.21 2.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.227 -0.921 . . . . 0.0 109.727 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.457 ' O ' ' N ' ' D' ' 97' ' ' HIS . 66.5 m80 -61.64 -22.51 65.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.225 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 39.4 t -83.09 -60.61 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 110.768 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.539 ' O ' ' CE1' ' D' ' 97' ' ' HIS . 5.1 m-20 -87.18 -27.7 22.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.122 -0.986 . . . . 0.0 111.098 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.2 OUTLIER -87.71 -16.73 33.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.851 -1.156 . . . . 0.0 110.644 -178.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.501 ' C ' ' ND1' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -138.38 -39.33 0.53 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.963 -1.086 . . . . 0.0 109.831 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 1.218 ' CG ' HG23 ' A' ' 41' ' ' THR . 5.0 m80 64.83 58.81 0.94 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 109.778 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.62 132.62 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.1 -1.0 . . . . 0.0 109.363 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.39 152.5 2.2 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.399 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.02 -29.76 17.43 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.536 2.157 . . . . 0.0 112.195 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.45 53.82 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -149.31 -39.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.58 -29.77 70.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.575 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . 0.411 ' NH1' ' CB ' ' D' ' 104' ' ' ARG . 31.4 mtm105 -77.87 -20.05 53.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.599 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 13.6 mt -82.64 -50.14 9.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.9 tt -51.97 -49.1 63.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.361 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.49 -20.3 63.39 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . 0.487 ' O ' ' SG ' ' D' ' 112' ' ' CYS . 0.2 OUTLIER -81.86 -19.45 40.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -1.195 . . . . 0.0 109.613 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 92.4 t -86.36 -52.95 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -0.984 . . . . 0.0 109.721 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' D' ' 113' ' ' VAL . 2.8 tt -45.96 -60.13 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 0.0 109.787 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 61.3 t -46.68 -33.26 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.812 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' D' ' 108' ' ' ASN . 60.4 m -79.23 -23.95 43.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' D' ' 110' ' ' LEU . 98.7 t -74.94 -21.34 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.591 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . 0.519 ' CD1' ' CZ ' ' D' ' 130' ' ' TYR . 21.4 mt -78.98 -48.7 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 109.494 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.12 -23.31 3.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.443 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.516 ' ND1' ' HD1' ' D' ' 117' ' ' HIS . 6.5 t-80 -83.72 -57.81 3.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . 0.58 ' N ' ' HD1' ' D' ' 117' ' ' HIS . 0.3 OUTLIER -72.4 -17.75 61.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 109.511 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' D' ' 114' ' ' LEU . 95.2 m-85 -141.7 56.66 1.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -73.28 -24.85 74.52 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.31 9.46 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -1.098 . . . . 0.0 109.577 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' D' ' 123' ' ' THR . 58.9 mm-40 -142.75 8.84 1.73 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.541 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -78.67 34.15 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.434 ' H ' ' C ' ' D' ' 121' ' ' GLU . 69.6 p -48.59 148.46 3.54 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.206 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.495 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.5 Cg_exo -44.15 -55.76 2.94 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.565 2.177 . . . . 0.0 112.97 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 12.6 Cg_endo -56.21 -23.35 44.85 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.249 1.966 . . . . 0.0 112.208 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 75.5 t -82.8 -23.3 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.569 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -83.28 -59.6 2.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.73 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.2 -36.87 14.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.62 -5.11 56.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 0.0 110.042 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . 0.519 ' CZ ' ' CD1' ' D' ' 114' ' ' LEU . 0.1 OUTLIER -92.65 -40.74 10.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.025 -1.047 . . . . 0.0 109.474 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -84.0 -22.99 31.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.685 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -71.11 -42.4 69.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.113 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . 0.683 ' CG1' ' H ' ' D' ' 134' ' ' VAL . 6.4 p -71.97 -66.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -0.983 . . . . 0.0 110.349 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.683 ' H ' ' CG1' ' D' ' 133' ' ' VAL . 33.1 m -43.43 -19.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 0.0 109.941 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' D' ' 133' ' ' VAL . . . -59.62 -27.97 66.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.384 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.9 -30.94 58.66 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.31 -36.39 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -1.139 . . . . 0.0 109.418 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.37 -40.17 89.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.964 HD22 HD22 ' B' ' 139' ' ' ASN . 53.7 t30 -75.88 -25.97 56.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.439 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.64 -49.04 74.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.419 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.16 -4.29 28.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.127 -0.983 . . . . 0.0 109.36 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' D' ' 145' ' ' TYR . . . -102.37 -39.42 7.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.417 -0.802 . . . . 0.0 109.515 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -45.39 -40.25 7.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 109.733 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.26 27.29 1.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.564 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . 0.57 ' O ' ' CG ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -140.46 1.21 1.74 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.412 ' HB3' ' CB ' ' B' ' 135' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.672 HBD2 HD22 ' A' ' 86' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 1.209 ' CBC' ' CZ ' ' B' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 1.504 ' CAB' ' HE3' ' C' ' 32' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.578 HMA1 ' CB ' ' D' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 10.8 mp 53.21 176.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.158 -0.963 . . . . 0.0 109.553 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.506 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 174.59 -47.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 110.066 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' ASP . 71.1 Cg_exo -47.24 169.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.571 2.18 . . . . 0.0 112.744 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -45.35 -15.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.407 -0.808 . . . . 0.0 110.123 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' PRO . 25.0 t70 -38.78 -40.49 0.62 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 109.928 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -67.97 -45.74 73.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.131 -0.981 . . . . 0.0 109.224 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 5' ' ' ALA . 36.0 m -52.98 -31.1 38.82 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 108.782 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -78.07 -36.06 48.73 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.2 t -69.74 -49.05 61.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.79 -47.47 64.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -49.2 -60.79 2.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.613 -0.679 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.42 ' O ' ' CG2' ' A' ' 17' ' ' VAL . . . -50.86 -39.06 52.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.311 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -17.26 61.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.436 -0.79 . . . . 0.0 109.217 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -81.62 -45.68 7.19 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.67 -34.8 72.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -1.162 . . . . 0.0 108.674 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 70.4 t -61.97 -66.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 64.55 -143.61 47.22 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 48.37 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.584 -0.951 . . . . 0.0 109.978 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 18' ' ' GLY . 80.7 m-70 -151.81 19.53 0.7 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.42 -65.19 1.04 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.715 -0.616 . . . . 0.0 109.794 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.58 -14.77 0.24 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' ALA . 2.1 mm-40 -83.07 -56.46 3.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -1.19 . . . . 0.0 109.726 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.8 m-30 -55.95 -35.3 66.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.852 . . . . 0.0 109.13 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.11 -22.76 60.97 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.58 -38.28 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -1.168 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.73 -19.69 63.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.684 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.44 -22.41 51.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.117 -0.989 . . . . 0.0 109.708 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.463 ' CD1' ' HD1' ' A' ' 58' ' ' HIS . 7.6 mt -76.42 -43.97 37.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -65.68 -12.82 56.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.2 -0.937 . . . . 0.0 109.695 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -58.98 2.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.651 ' HE1' HBC2 ' A' ' 142' ' ' HEC . 2.0 ptm -62.31 -25.61 67.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.476 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 48' ' ' LEU . 1.3 t80 -58.65 -55.99 27.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 0.0 109.653 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.699 HD11 ' HB3' ' B' ' 128' ' ' ALA . 2.3 pp -82.41 -42.46 18.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.126 -0.984 . . . . 0.0 110.227 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.527 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 12.6 t -59.65 -9.3 2.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.02 -1.05 . . . . 0.0 109.687 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 1.003 ' CZ ' ' NE2' ' B' ' 131' ' ' GLN . 79.3 m-85 -155.35 81.71 3.99 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.155 -0.966 . . . . 0.0 109.503 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 39' ' ' THR . 52.6 Cg_exo -52.5 -24.92 23.51 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.704 2.269 . . . . 0.0 112.273 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.402 HG22 ' HB2' ' D' ' 97' ' ' HIS . 9.0 p -46.88 -19.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 37' ' ' PRO . 51.2 p -82.89 -26.2 31.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.656 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 42' ' ' TYR . 26.6 ttpt -79.3 -53.66 6.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.181 -0.95 . . . . 0.0 109.658 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t -46.97 -18.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.563 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.473 ' O ' ' CG ' ' A' ' 42' ' ' TYR . 82.0 t80 -78.8 3.15 17.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 49.24 66.51 5.6 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 65.8 Cg_endo -76.91 -1.62 11.79 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.679 2.252 . . . . 0.0 112.524 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.569 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 22.4 p80 41.47 24.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 109.502 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.543 ' O ' ' C ' ' A' ' 47' ' ' ASP . 3.9 t80 -104.38 31.57 4.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.561 -0.712 . . . . 0.0 109.736 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 46' ' ' PHE . 15.0 m-20 28.63 67.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.884 -0.51 . . . . 0.0 110.533 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.528 ' O ' ' CE2' ' A' ' 33' ' ' PHE . 87.3 mt -85.16 22.33 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.428 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 50' ' ' HIS . 19.3 m -76.65 26.67 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.358 -0.839 . . . . 0.0 109.418 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' A' ' 48' ' ' LEU . 54.6 t60 58.08 158.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 0.0 109.57 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.65 17.92 5.02 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.1 t -80.25 -17.76 51.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -1.111 . . . . 0.0 109.512 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 55' ' ' VAL . . . 68.6 -58.52 0.48 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 109.798 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 52' ' ' SER . 0.6 OUTLIER -43.76 -20.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.775 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 53' ' ' ALA . 89.8 t -77.55 -27.17 15.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.136 -0.977 . . . . 0.0 109.28 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.9 ptmt -63.7 -27.2 69.05 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.266 -0.896 . . . . 0.0 109.327 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.84 -27.62 68.81 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.463 ' HD1' ' CD1' ' A' ' 29' ' ' LEU . 54.0 t-80 -84.17 -30.65 25.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -1.17 . . . . 0.0 110.096 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.01 -49.47 55.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -60.1 -23.64 63.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -1.106 . . . . 0.0 110.082 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.531 ' O ' HMA2 ' A' ' 142' ' ' HEC . 0.3 OUTLIER -73.29 -34.04 65.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.087 -1.008 . . . . 0.0 109.135 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.29 -52.92 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.41 -0.806 . . . . 0.0 108.944 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.96 -28.44 69.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.297 -0.877 . . . . 0.0 109.166 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.26 -41.42 81.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.199 -0.938 . . . . 0.0 108.89 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.54 80.44 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.34 -46.17 87.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -63.24 -48.77 76.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.256 -0.902 . . . . 0.0 108.976 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.66 -22.56 66.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 108.835 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.21 -47.68 9.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -66.84 -22.56 29.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.98 -14.68 62.44 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 74' ' ' ASP . 21.5 m80 -141.87 -57.44 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.808 . . . . 0.0 109.648 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 69' ' ' ALA . 8.2 p 46.14 15.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 122.1 0.953 . . . . 0.0 108.76 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 72' ' ' HIS . 22.0 m-20 -136.36 12.41 3.26 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.9 30.39 0.06 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.554 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 1.2 mtm -66.54 -44.82 56.88 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.611 -0.681 . . . . 0.0 110.073 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 76' ' ' MET . 95.7 Cg_exo -42.12 -43.02 7.39 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.356 2.038 . . . . 0.0 112.727 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.23 -19.01 21.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 109.97 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.12 -58.44 3.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 109.165 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.5 mt -83.14 16.9 2.19 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -61.59 -21.98 64.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.473 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -74.8 -57.97 3.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.538 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.1 mt -44.75 -39.66 5.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' ALA . 26.5 t -54.48 -34.45 61.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 82' ' ' ALA . 4.0 m-20 -66.02 -24.39 66.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.144 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.584 HD22 ' CBD' ' A' ' 142' ' ' HEC . 7.3 tp -80.45 -38.6 29.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.882 . . . . 0.0 109.176 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -92.28 -21.65 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.688 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 84' ' ' SER . . . -76.43 -39.02 54.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.244 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' LYS . 50.3 t-80 -146.58 -83.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 110.167 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.46 ' NZ ' ' CD1' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -43.88 105.98 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tp 63.61 59.14 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 109.293 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.637 HH12 ' HE1' ' D' ' 42' ' ' PHE . 10.6 ptp180 -60.64 -22.71 64.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.629 ' CG2' ' H ' ' A' ' 94' ' ' ASP . 12.8 p 42.1 -176.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.671 -0.643 . . . . 0.0 110.122 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.629 ' H ' ' CG2' ' A' ' 93' ' ' VAL . 50.7 m-20 -80.88 120.7 79.61 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.961 -1.087 . . . . 0.0 109.488 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.586 ' C ' ' H ' ' A' ' 97' ' ' ASN . 73.5 Cg_endo -78.67 -37.78 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.282 1.988 . . . . 0.0 112.183 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -55.38 -0.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.703 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.586 ' H ' ' C ' ' A' ' 95' ' ' PRO . 4.8 m120 -79.03 -24.77 43.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.695 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 95' ' ' PRO . 26.8 m-85 -49.3 -17.59 0.27 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.419 ' N ' ' C ' ' A' ' 97' ' ' ASN . 92.0 mttt -81.99 -28.23 32.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.888 . . . . 0.0 109.44 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 13.5 mt -84.11 -39.02 20.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.841 ' CD1' ' CHC' ' A' ' 142' ' ' HEC . 2.0 tt -57.95 -40.12 79.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.379 -0.825 . . . . 0.0 109.456 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -66.14 -59.25 3.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.781 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -62.22 -26.57 68.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.736 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 57.9 m -74.06 -34.84 64.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.961 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -84.25 -34.66 23.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.04 -1.037 . . . . 0.0 109.11 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.02 -44.02 97.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.421 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.58 -24.87 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.869 . . . . 0.0 109.213 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 104' ' ' CYS . 54.5 m -64.62 -59.33 4.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 113' ' ' LEU . 59.0 mt -46.12 -37.9 7.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.86 -37.96 6.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.798 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.15 -55.91 4.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.812 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -74.81 -66.59 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 109.899 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -108.9 98.44 29.79 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 88.7 Cg_exo -44.08 179.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.404 2.069 . . . . 0.0 113.095 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 117' ' ' PHE . . . -86.94 -34.64 19.27 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.599 0.714 . . . . 0.0 109.613 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 72.9 -0.51 3.34 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 1.492 ' CZ ' ' NE2' ' B' ' 116' ' ' HIS . 26.3 m-85 61.07 41.82 13.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.897 -0.502 . . . . 0.0 111.641 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.732 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -95.07 114.31 63.41 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.762 -1.211 . . . . 0.0 107.887 178.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.677 ' HA ' ' CG1' ' B' ' 33' ' ' VAL . 51.5 Cg_exo -49.77 18.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.087 1.858 . . . . 0.0 112.715 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -142.13 -23.39 0.69 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.048 -1.032 . . . . 0.0 110.579 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' A' ' 122' ' ' HIS . 13.3 p -59.25 -58.04 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.027 -1.046 . . . . 0.0 110.179 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.621 ' H ' ' CG1' ' A' ' 121' ' ' VAL . 1.7 m-70 -71.29 -32.02 68.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 108.934 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.38 -20.41 60.08 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.435 -0.791 . . . . 0.0 108.939 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 128' ' ' PHE . 3.1 m -73.42 -63.42 1.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 110.038 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mt -63.44 -28.17 69.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.85 -1.156 . . . . 0.0 109.382 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.752 ' OD1' ' CD2' ' B' ' 35' ' ' TYR . 8.7 t0 -69.67 -47.91 61.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.117 -0.99 . . . . 0.0 109.473 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.44 -40.83 11.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.099 -1.001 . . . . 0.0 109.931 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 124' ' ' SER . 72.7 t80 -48.45 -20.91 0.47 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.994 -1.066 . . . . 0.0 109.098 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.725 ' CD2' HBB1 ' A' ' 142' ' ' HEC . 12.1 mt -71.43 -26.27 62.67 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -55.07 -30.57 59.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.1 t -81.17 -33.43 33.09 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.1 -28.62 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.31 -0.869 . . . . 0.0 108.828 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 129' ' ' LEU . 18.3 p -80.52 -23.27 40.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.398 -0.814 . . . . 0.0 109.096 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.431 ' N ' ' HG ' ' A' ' 133' ' ' SER . 29.3 m -75.35 -39.88 58.86 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.31 -0.869 . . . . 0.0 109.163 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.67 -29.72 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.187 -0.945 . . . . 0.0 108.794 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -33.96 77.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.384 -0.823 . . . . 0.0 108.927 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 62.8 m -96.12 -21.46 17.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.3 t -51.09 121.16 5.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 109.517 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.46 ' NZ ' ' CB ' ' A' ' 139' ' ' LYS . 6.9 mtpm? -84.3 48.54 1.51 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -48.43 104.21 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.43 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.5 mtt85 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.53 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.718 ' CG2' ' H ' ' B' ' 2' ' ' HIS . 9.2 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.718 ' H ' ' CG2' ' B' ' 1' ' ' VAL . 2.0 t-80 56.05 83.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.375 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.415 ' H ' HD13 ' B' ' 3' ' ' LEU . 0.2 OUTLIER -146.36 169.13 19.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 109.232 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.4 p -67.26 152.01 96.56 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.92 -27.5 25.6 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.533 2.155 . . . . 0.0 112.033 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -57.7 -45.24 85.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.233 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.31 -49.23 15.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -0.887 . . . . 0.0 109.374 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.495 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.5 OUTLIER -50.52 -54.18 24.34 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.28 -0.887 . . . . 0.0 109.531 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -43.52 -24.14 0.1 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.745 -0.597 . . . . 0.0 110.267 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.3 -56.57 3.69 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.016 -1.052 . . . . 0.0 109.725 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.8 -24.61 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 16.5 m -72.19 -47.42 50.82 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.539 0.685 . . . . 0.0 109.431 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.13 -31.89 70.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.371 -0.831 . . . . 0.0 109.589 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.08 -33.2 11.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.112 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -23.78 1.34 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.82 -61.79 3.9 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.451 ' CD ' ' N ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -58.33 -30.07 66.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -1.126 . . . . 0.0 109.224 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 49.2 t -54.11 114.71 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.558 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' B' ' 20' ' ' VAL . 45.0 m-80 -83.7 70.63 10.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 108.942 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' B' ' 22' ' ' GLU . 73.8 t -43.65 -26.6 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.425 -0.797 . . . . 0.0 109.658 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' B' ' 19' ' ' ASN . 1.2 p30 -58.41 -5.67 0.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.63 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.468 ' H ' ' C ' ' B' ' 20' ' ' VAL . 54.3 mt-10 -154.92 -42.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.533 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 81.5 t -49.68 -24.49 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.46 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.11 -55.53 3.49 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.78 -31.06 66.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.78 -26.67 57.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -1.162 . . . . 0.0 109.44 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.92 -52.58 64.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.366 -0.834 . . . . 0.0 109.625 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' B' ' 28' ' ' LEU . 3.7 mm? -64.49 -56.81 11.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.977 . . . . 0.0 109.394 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.26 -48.8 46.45 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.975 ' NH2' ' CD1' ' A' ' 117' ' ' PHE . 28.2 mmt180 -56.54 -47.71 78.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -1.152 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.26 -34.76 15.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 39.9 mt -80.69 -21.55 41.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.677 ' CG1' ' HA ' ' A' ' 119' ' ' PRO . 88.2 t -86.97 -64.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 0.0 109.726 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.504 HG12 ' HB3' ' A' ' 122' ' ' HIS . 2.8 t -52.04 -45.21 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 110.003 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.752 ' CD2' ' OD1' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -160.35 102.64 1.37 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.1 -1.0 . . . . 0.0 109.591 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.14 69.8 6.9 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.526 2.15 . . . . 0.0 112.149 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' B' ' 37' ' ' TRP . 0.0 OUTLIER -79.6 -19.53 49.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.399 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' B' ' 39' ' ' GLN . 28.4 p -48.05 -69.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.945 . . . . 0.0 109.621 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . 0.497 ' N ' ' OG1' ' B' ' 38' ' ' THR . 19.6 tt0 51.36 46.17 26.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.254 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -153.22 -58.67 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -84.7 8.34 17.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.487 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.596 ' HE1' HH12 ' C' ' 92' ' ' ARG . 29.0 p90 -58.07 -35.42 71.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -80.4 -21.63 42.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 109.382 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.407 ' C ' ' H ' ' B' ' 46' ' ' GLY . 16.5 m -58.5 -50.24 74.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 109.563 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.98 -8.83 1.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.517 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' B' ' 44' ' ' SER . . . 64.02 -94.51 0.15 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -45.2 122.46 3.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.331 -1.1 . . . . 0.0 109.747 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -153.5 15.15 0.51 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.24 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.0 t -46.77 -39.07 11.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.625 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 8.1 p -144.63 152.24 52.3 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.492 -0.755 . . . . 0.0 108.965 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -44.92 -45.12 14.26 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.064 1.843 . . . . 0.0 112.143 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 53' ' ' ALA . 1.7 p30 -59.07 -39.79 83.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.527 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' B' ' 52' ' ' ASP . . . -52.25 -19.82 2.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' B' ' 56' ' ' GLY . 99.3 t -66.11 -63.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.492 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 39.6 mtm -73.63 9.77 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.511 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' B' ' 54' ' ' VAL . . . -88.21 -13.79 63.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -90.79 148.59 38.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.174 -1.192 . . . . 0.0 109.355 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.19 -19.6 17.29 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.619 2.213 . . . . 0.0 112.098 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.75 -28.25 33.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.632 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -78.36 -40.34 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.681 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -79.08 -28.54 43.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.1 -48.71 19.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.694 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 1.043 ' HE2' ' C4D' ' B' ' 147' ' ' HEC . 3.1 t-80 -48.21 -23.87 1.0 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.41 -54.91 13.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -46.78 -34.62 5.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -1.154 . . . . 0.0 109.609 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . 0.925 ' HD3' ' O2A' ' B' ' 147' ' ' HEC . 86.8 mttt -75.81 -37.62 58.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.318 -0.864 . . . . 0.0 109.669 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.688 HG22 ' CHB' ' B' ' 147' ' ' HEC . 33.6 t -71.73 -46.6 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.79 -32.56 67.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 109.253 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.81 -53.7 42.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.61 -48.85 66.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.397 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.49 -36.17 73.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.316 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 29.8 p -80.09 -24.23 40.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.479 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -51.87 -42.49 62.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.411 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.06 -60.25 8.3 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.434 ' H ' HD13 ' B' ' 75' ' ' LEU . 4.7 mp -58.26 -30.76 66.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.248 -1.148 . . . . 0.0 109.32 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.78 -3.01 58.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.595 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.505 ' C ' ' H ' ' B' ' 79' ' ' ASP . 10.3 t-80 -168.0 61.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.629 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mt -73.37 14.38 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.141 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' B' ' 77' ' ' HIS . 30.1 t70 -69.07 -32.19 71.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.496 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' B' ' 79' ' ' ASP . 9.8 m120 -163.23 104.2 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 109.461 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 37.6 mt -80.28 -58.8 2.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.378 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -48.6 -24.23 1.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.415 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.03 -62.15 3.46 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.7 t -62.82 -47.18 84.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -1.223 . . . . 0.0 109.437 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.5 m-85 -66.84 0.91 2.13 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.491 -0.756 . . . . 0.0 109.447 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -59.86 -47.36 86.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.405 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 4.9 p -72.68 -53.6 11.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.376 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 24.7 mt -49.87 -46.49 51.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' SER . . . . . 0.631 ' HG ' ' N ' ' B' ' 90' ' ' GLU . 85.9 p -56.37 -46.67 79.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.347 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.631 ' N ' ' HG ' ' B' ' 89' ' ' SER . 34.8 tt0 -64.73 -40.6 95.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.301 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.31 -44.58 87.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.374 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' B' ' 97' ' ' HIS . 76.0 m80 -73.38 -24.25 60.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 110.247 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.72 -60.91 1.97 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.028 -1.045 . . . . 0.0 111.24 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.1 -57.1 3.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.861 -1.15 . . . . 0.0 111.671 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -66.15 -9.92 36.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 111.515 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.563 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 1.0 OUTLIER -143.11 -33.89 0.44 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.741 -1.224 . . . . 0.0 109.987 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 33.2 p-80 43.62 25.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' B' ' 96' ' ' LEU . 24.9 t -53.73 138.96 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.089 -1.007 . . . . 0.0 109.104 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 7.4 m-20 -46.43 149.43 1.38 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.443 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.19 -17.47 45.17 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.575 2.184 . . . . 0.0 112.217 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -89.76 47.05 1.42 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.461 ' O ' HMC1 ' B' ' 147' ' ' HEC . 2.9 m120 -137.29 -3.44 1.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -0.886 . . . . 0.0 109.794 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . 0.403 ' HA ' HBB3 ' B' ' 147' ' ' HEC . 2.4 m-85 -97.68 -60.46 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.432 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -50.92 -19.97 1.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.691 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' B' ' 105' ' ' LEU . 7.9 mp -77.9 -52.84 8.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.621 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.936 HD11 ' CHC' ' B' ' 147' ' ' HEC . 5.0 tt -54.6 -52.17 63.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 109.341 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.56 -22.02 7.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -85.65 -53.69 5.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -1.184 . . . . 0.0 109.69 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 91.9 t -46.66 -30.28 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.808 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 113' ' ' VAL . 5.2 tp -62.07 -55.32 30.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.597 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 90.3 t -46.75 -26.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 109.784 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 34.6 t -74.75 -26.22 59.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 109.643 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' B' ' 110' ' ' LEU . 39.3 t -83.45 -25.32 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.022 . . . . 0.0 109.525 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.6 -25.6 33.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.467 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -75.69 -19.58 59.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.705 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 1.492 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.3 OUTLIER -83.42 -52.48 6.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.165 -0.96 . . . . 0.0 109.458 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.487 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 61.0 m170 -73.32 -17.62 61.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.452 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.487 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 11.1 m-85 -149.41 55.78 0.98 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.857 . . . . 0.0 109.39 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -61.6 -14.78 44.46 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.62 -20.94 27.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -1.122 . . . . 0.0 109.512 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.4 mm-40 -83.85 -7.37 59.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -73.54 33.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.572 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.514 ' H ' ' C ' ' B' ' 121' ' ' GLU . 77.8 p -47.51 148.38 2.47 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 0.0 109.374 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.4 Cg_exo -44.64 -56.13 2.83 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.505 2.137 . . . . 0.0 112.941 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 19.8 Cg_endo -60.5 -35.28 91.03 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.162 1.908 . . . . 0.0 112.104 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.435 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 78.2 t -72.02 -17.34 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 109.581 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -83.42 -59.75 2.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 109.75 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.699 ' HB3' HD11 ' A' ' 34' ' ' LEU . . . -53.74 -33.38 55.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.58 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.44 27.5 0.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -125.09 -38.27 2.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.317 -0.864 . . . . 0.0 109.606 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . 1.003 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 46.0 tt0 -67.56 -23.94 65.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.898 . . . . 0.0 109.822 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' B' ' 1' ' ' VAL . 35.4 mtmt -84.5 -36.42 22.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 109.716 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.68 -49.34 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.968 . . . . 0.0 109.786 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.5 m -79.5 -23.82 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.895 . . . . 0.0 109.768 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.4 -27.94 11.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 109.456 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.16 -23.05 61.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.3 t -79.07 -27.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.46 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.98 -42.8 56.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.532 ' OD1' ' OD1' ' D' ' 139' ' ' ASN . 37.8 t30 -76.83 -21.22 55.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.57 -60.34 2.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 17.1 mt -55.21 -22.33 17.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.459 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.25 -17.99 24.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.882 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -46.3 -46.55 18.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.511 ' C ' ' H ' ' B' ' 146' ' ' HIS . 5.7 tppt? -77.08 -57.56 3.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.472 ' CD1' ' C ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -51.53 -10.61 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.533 -0.729 . . . . 0.0 109.23 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.511 ' H ' ' C ' ' B' ' 144' ' ' LYS . 11.6 m-70 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.735 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' C' ' 2' ' ' LEU . 1.3 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' C' ' 2' ' ' LEU . 10.8 mp 53.17 176.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 109.541 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.513 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 174.56 -47.79 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 0.0 109.976 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' C' ' 6' ' ' ASP . 71.8 Cg_exo -47.16 169.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.549 2.166 . . . . 0.0 112.759 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.47 -15.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.43 -0.794 . . . . 0.0 110.126 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' C' ' 4' ' ' PRO . 25.1 t70 -38.8 -40.53 0.63 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 109.888 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -67.93 -45.68 73.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.113 -0.992 . . . . 0.0 109.299 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.418 ' N ' ' O ' ' C' ' 5' ' ' ALA . 37.4 m -52.99 -31.06 38.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -78.08 -35.98 48.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.67 -49.1 61.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.82 -47.45 64.31 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' C' ' 15' ' ' GLY . . . -49.17 -60.77 2.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.585 -0.697 . . . . 0.0 109.569 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' C' ' 17' ' ' VAL . . . -50.94 -38.96 53.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.322 -0.861 . . . . 0.0 109.319 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -17.31 61.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.207 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' C' ' 12' ' ' ALA . . . -81.57 -45.68 7.22 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.63 -34.92 72.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -1.165 . . . . 0.0 108.696 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' C' ' 13' ' ' ALA . 70.2 t -61.94 -66.91 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 64.51 -143.62 47.26 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.42 48.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.443 -1.034 . . . . 0.0 110.0 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' C' ' 18' ' ' GLY . 80.7 m-70 -151.73 19.64 0.7 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.45 -65.24 1.03 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.66 -0.65 . . . . 0.0 109.769 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.65 -14.58 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' C' ' 21' ' ' ALA . 2.1 mm-40 -83.19 -56.46 3.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -1.168 . . . . 0.0 109.673 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.8 m-30 -55.95 -35.29 66.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.41 -0.806 . . . . 0.0 109.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.06 -22.83 60.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.52 -38.32 29.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -1.118 . . . . 0.0 109.795 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.61 -19.71 63.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.72 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.52 -22.39 51.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 109.683 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.464 ' CD1' ' HD1' ' C' ' 58' ' ' HIS . 7.5 mt -76.38 -43.99 38.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 109.706 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -65.7 -12.81 56.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.699 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -59.01 2.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.661 ' HE1' HBC2 ' C' ' 142' ' ' HEC . 2.0 ptm -62.26 -25.67 67.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.525 ' CE2' ' O ' ' C' ' 48' ' ' LEU . 1.3 t80 -58.56 -56.09 26.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 109.621 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.714 HD11 ' HB3' ' D' ' 128' ' ' ALA . 2.3 pp -82.34 -42.51 18.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 110.234 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 12.6 t -59.69 -9.21 2.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.01 . . . . 0.0 109.659 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 1.01 ' CZ ' ' NE2' ' D' ' 131' ' ' GLN . 79.5 m-85 -155.33 81.66 4.01 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.582 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' C' ' 39' ' ' THR . 52.6 Cg_exo -52.48 -24.96 23.56 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.689 2.259 . . . . 0.0 112.245 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' THR . . . . . 0.402 HG22 ' HB2' ' B' ' 97' ' ' HIS . 8.7 p -46.78 -19.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.877 . . . . 0.0 109.517 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.445 ' N ' ' O ' ' C' ' 37' ' ' PRO . 51.5 p -82.89 -26.15 31.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 109.676 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' C' ' 42' ' ' TYR . 26.6 ttpt -79.37 -53.62 6.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.653 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t -47.06 -18.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.907 . . . . 0.0 109.576 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.469 ' O ' ' CG ' ' C' ' 42' ' ' TYR . 82.4 t80 -78.79 3.21 17.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.481 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' C' ' 40' ' ' LYS . 22.7 m-85 49.16 66.62 5.46 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.345 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.554 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 64.8 Cg_endo -77.02 -1.56 11.74 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.808 2.338 . . . . 0.0 112.389 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.571 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 22.0 p80 41.43 24.63 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.34 -0.85 . . . . 0.0 109.516 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.544 ' O ' ' C ' ' C' ' 47' ' ' ASP . 3.9 t80 -104.31 31.46 4.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.756 . . . . 0.0 109.705 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' C' ' 46' ' ' PHE . 15.1 m-20 28.69 67.71 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.817 -0.552 . . . . 0.0 110.524 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.525 ' O ' ' CE2' ' C' ' 33' ' ' PHE . 87.2 mt -85.15 22.25 1.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.978 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.434 ' O ' ' O ' ' C' ' 50' ' ' HIS . 19.3 m -76.61 26.6 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' C' ' 48' ' ' LEU . 54.9 t60 58.07 158.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.842 . . . . 0.0 109.557 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.72 17.91 5.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' C' ' 47' ' ' ASP . 9.0 t -80.33 -17.73 51.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -1.152 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' C' ' 55' ' ' VAL . . . 68.62 -58.54 0.48 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.688 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' C' ' 53' ' ' ALA . 0.7 OUTLIER -43.74 -20.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.401 -0.812 . . . . 0.0 109.818 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' C' ' 53' ' ' ALA . 89.1 t -77.41 -27.33 15.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.277 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' C' ' 53' ' ' ALA . 5.9 ptmt -63.6 -27.18 69.06 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.293 -0.879 . . . . 0.0 109.395 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.86 -27.63 68.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.464 ' HD1' ' CD1' ' C' ' 29' ' ' LEU . 53.9 t-80 -84.15 -30.66 25.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -1.17 . . . . 0.0 110.103 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.06 -49.41 55.73 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -60.1 -23.66 64.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -1.146 . . . . 0.0 110.068 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.532 ' O ' HMA2 ' C' ' 142' ' ' HEC . 0.3 OUTLIER -73.32 -33.96 65.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.192 -0.942 . . . . 0.0 109.146 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.41 -52.83 21.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.434 -0.791 . . . . 0.0 108.991 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.47 69.86 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.324 -0.86 . . . . 0.0 109.186 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -68.3 -41.38 81.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 108.848 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.07 -42.47 80.38 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.4 -46.2 87.5 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -63.24 -48.68 77.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.206 -0.934 . . . . 0.0 109.029 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -62.72 -22.55 66.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 108.829 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -85.22 -47.69 9.85 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.83 -22.69 29.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -14.57 62.42 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.555 ' O ' ' N ' ' C' ' 74' ' ' ASP . 21.5 m80 -141.92 -57.45 0.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.796 . . . . 0.0 109.65 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' C' ' 69' ' ' ALA . 8.2 p 46.16 15.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 122.067 0.937 . . . . 0.0 108.718 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' C' ' 72' ' ' HIS . 21.9 m-20 -136.39 12.53 3.25 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.96 30.52 0.06 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.557 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 1.2 mtm -66.63 -44.69 55.38 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.658 -0.651 . . . . 0.0 110.098 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' C' ' 76' ' ' MET . 95.5 Cg_exo -42.24 -43.03 7.67 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.431 2.087 . . . . 0.0 112.601 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.15 -18.97 21.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.001 . . . . 0.0 110.025 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 -58.5 3.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.034 -1.041 . . . . 0.0 109.081 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 18.7 mt -83.14 16.91 2.19 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' C' ' 77' ' ' PRO . 0.5 OUTLIER -61.67 -21.93 64.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.848 . . . . 0.0 109.363 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -74.79 -57.97 3.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' C' ' 82' ' ' ALA . 3.1 mt -44.74 -39.74 5.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' SER . . . . . 0.524 ' O ' ' N ' ' C' ' 88' ' ' ALA . 26.5 t -54.51 -34.45 61.68 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' C' ' 82' ' ' ALA . 4.0 m-20 -66.09 -24.28 66.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.136 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.585 HD22 ' CBD' ' C' ' 142' ' ' HEC . 7.3 tp -80.52 -38.52 29.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.327 -0.858 . . . . 0.0 109.203 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -92.32 -21.64 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.723 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' C' ' 84' ' ' SER . . . -76.49 -38.95 54.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' C' ' 90' ' ' LYS . 50.1 t-80 -146.6 -83.43 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.101 -0.999 . . . . 0.0 110.114 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.454 ' NZ ' ' CD1' ' C' ' 86' ' ' LEU . 0.9 OUTLIER -43.85 105.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 109.67 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tp 63.61 59.22 1.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.343 -0.848 . . . . 0.0 109.29 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . 0.596 HH12 ' HE1' ' B' ' 42' ' ' PHE . 10.6 ptp180 -60.74 -22.63 64.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.578 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.644 ' CG2' ' H ' ' C' ' 94' ' ' ASP . 12.7 p 42.08 -176.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.642 -0.661 . . . . 0.0 110.084 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.644 ' H ' ' CG2' ' C' ' 93' ' ' VAL . 50.7 m-20 -80.85 120.68 79.6 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.969 -1.082 . . . . 0.0 109.459 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.604 ' C ' ' H ' ' C' ' 97' ' ' ASN . 73.5 Cg_endo -78.61 -37.86 0.6 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.359 2.039 . . . . 0.0 112.124 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 6.2 t -55.36 -0.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.707 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' C' ' 95' ' ' PRO . 4.8 m120 -79.03 -24.85 43.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.065 -1.022 . . . . 0.0 109.693 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' C' ' 95' ' ' PRO . 26.9 m-85 -49.27 -17.64 0.27 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.421 ' N ' ' C ' ' C' ' 97' ' ' ASN . 91.9 mttt -81.99 -28.22 32.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.377 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 13.5 mt -84.1 -39.04 19.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.384 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.843 ' CD1' ' CHC' ' C' ' 142' ' ' HEC . 2.0 tt -57.97 -40.08 79.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -66.28 -59.18 3.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.986 . . . . 0.0 109.772 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -62.15 -26.59 68.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 109.809 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 57.8 m -74.12 -34.8 64.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.487 ' C ' ' CD1' ' C' ' 105' ' ' LEU . 0.0 OUTLIER -84.2 -34.67 23.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.11 -0.994 . . . . 0.0 109.182 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 20.0 mt -62.99 -44.09 96.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.455 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.47 -24.92 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' C' ' 104' ' ' CYS . 54.8 m -64.6 -59.33 4.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.564 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' C' ' 113' ' ' LEU . 59.1 mt -46.21 -37.84 7.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.601 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.8 -38.05 6.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.849 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.04 -55.95 4.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.861 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -74.82 -66.59 0.73 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 109.895 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -108.9 98.45 29.84 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.481 -0.762 . . . . 0.0 108.96 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' C' ' 113' ' ' LEU . 89.8 Cg_exo -44.02 179.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.45 2.1 . . . . 0.0 113.036 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -86.94 -34.76 19.23 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.594 0.711 . . . . 0.0 109.584 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 72.97 -0.53 3.35 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 1.493 ' CZ ' ' NE2' ' D' ' 116' ' ' HIS . 26.6 m-85 61.05 41.79 13.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.884 -0.51 . . . . 0.0 111.624 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.3 OUTLIER -95.01 114.22 63.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.773 -1.204 . . . . 0.0 107.922 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . 0.674 ' HA ' ' CG1' ' D' ' 33' ' ' VAL . 51.8 Cg_exo -49.68 18.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.224 1.949 . . . . 0.0 112.678 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -142.1 -23.41 0.69 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 110.599 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.61 ' CG1' ' H ' ' C' ' 122' ' ' HIS . 13.4 p -59.27 -57.99 8.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.003 -1.06 . . . . 0.0 110.206 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.61 ' H ' ' CG1' ' C' ' 121' ' ' VAL . 1.7 m-70 -71.23 -32.19 68.47 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 108.879 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.5 60.14 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.398 -0.814 . . . . 0.0 108.968 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.534 ' O ' ' N ' ' C' ' 128' ' ' PHE . 3.1 m -73.44 -63.37 1.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.247 -0.908 . . . . 0.0 109.979 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mt -63.55 -28.09 69.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.978 -1.077 . . . . 0.0 109.339 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . 0.744 ' OD1' ' CD2' ' D' ' 35' ' ' TYR . 8.7 t0 -69.63 -47.99 61.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.113 -0.992 . . . . 0.0 109.527 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.32 -40.82 11.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.064 -1.022 . . . . 0.0 109.938 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' C' ' 124' ' ' SER . 72.8 t80 -48.64 -20.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.954 -1.091 . . . . 0.0 109.043 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.72 ' CD2' HBB1 ' C' ' 142' ' ' HEC . 12.1 mt -71.48 -26.33 62.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -55.0 -30.58 59.72 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 4.2 t -81.17 -33.36 33.13 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.449 -0.782 . . . . 0.0 108.897 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 55.5 t -85.15 -28.61 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.354 -0.841 . . . . 0.0 108.817 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.547 ' N ' ' O ' ' C' ' 129' ' ' LEU . 18.6 p -80.61 -23.17 39.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.515 -0.741 . . . . 0.0 109.009 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 134' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 29.5 m -75.34 -40.0 58.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 109.15 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.55 -29.75 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.915 . . . . 0.0 108.783 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -34.01 77.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.4 -0.812 . . . . 0.0 108.885 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 63.0 m -96.13 -21.42 17.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.508 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 44.0 t -51.17 121.1 5.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . 0.463 ' CB ' ' NZ ' ' C' ' 139' ' ' LYS . 6.9 mtpm? -84.2 48.49 1.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.519 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -48.39 104.19 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.463 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 50.5 mtt85 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.465 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.687 ' CG2' ' H ' ' D' ' 2' ' ' HIS . 9.0 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.687 ' H ' ' CG2' ' D' ' 1' ' ' VAL . 2.0 t-80 55.94 83.89 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.383 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.401 ' H ' HD13 ' D' ' 3' ' ' LEU . 0.2 OUTLIER -146.33 169.13 19.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 109.257 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 3.4 p -67.27 152.04 96.53 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.01 -27.54 25.17 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.562 2.175 . . . . 0.0 111.947 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -57.63 -45.21 85.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.34 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.22 -49.38 15.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.349 -0.844 . . . . 0.0 109.359 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.493 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.5 OUTLIER -50.4 -54.22 23.42 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.312 -0.868 . . . . 0.0 109.582 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -43.56 -24.06 0.1 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.72 -0.612 . . . . 0.0 110.278 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.36 -56.54 3.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.061 -1.024 . . . . 0.0 109.677 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.84 -24.63 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 16.3 m -72.25 -47.29 51.38 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.432 0.634 . . . . 0.0 109.462 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.19 -31.91 70.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.546 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.05 -33.13 10.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.22 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -49.1 -23.86 1.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 109.427 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.69 -61.87 3.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.454 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -58.32 -30.02 66.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.203 -1.175 . . . . 0.0 109.259 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 49.8 t -54.14 114.67 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.887 . . . . 0.0 109.598 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' D' ' 21' ' ' ASP . 45.1 m-80 -83.74 70.6 10.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 108.89 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' D' ' 22' ' ' GLU . 73.5 t -43.46 -26.76 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.416 -0.802 . . . . 0.0 109.691 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' D' ' 19' ' ' ASN . 1.2 p30 -58.37 -5.66 0.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.644 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' D' ' 20' ' ' VAL . 54.3 mt-10 -155.0 -42.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 81.4 t -49.76 -24.44 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -0.942 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.13 -55.53 3.49 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.84 -31.06 67.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.79 -26.57 57.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -1.187 . . . . 0.0 109.444 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.11 -52.56 64.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' D' ' 28' ' ' LEU . 3.7 mm? -64.52 -56.75 12.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.128 -0.983 . . . . 0.0 109.384 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.33 -48.75 47.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . 0.961 ' NH2' ' CD1' ' C' ' 117' ' ' PHE . 28.3 mmt180 -56.61 -47.63 79.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.334 -1.097 . . . . 0.0 109.517 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.29 -34.81 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.568 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 40.1 mt -80.67 -21.52 41.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . 0.674 ' CG1' ' HA ' ' C' ' 119' ' ' PRO . 88.3 t -87.01 -64.07 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.915 . . . . 0.0 109.744 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' C' ' 122' ' ' HIS . 2.8 t -52.06 -45.19 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 110.007 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . 0.744 ' CD2' ' OD1' ' C' ' 126' ' ' ASP . 0.2 OUTLIER -160.42 102.53 1.36 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.105 -0.997 . . . . 0.0 109.614 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.04 69.92 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.491 2.127 . . . . 0.0 112.076 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -19.66 48.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.422 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' D' ' 39' ' ' GLN . 28.5 p -48.04 -69.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.59 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . 0.494 ' N ' ' OG1' ' D' ' 38' ' ' THR . 19.5 tt0 51.39 46.13 26.94 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.139 -0.976 . . . . 0.0 109.304 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -153.26 -58.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.355 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -84.66 8.25 17.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 0.637 ' HE1' HH12 ' A' ' 92' ' ' ARG . 29.1 p90 -57.97 -35.49 71.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' D' ' 42' ' ' PHE . 19.7 pt-20 -80.35 -21.64 42.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.841 . . . . 0.0 109.398 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.422 ' C ' ' H ' ' D' ' 46' ' ' GLY . 16.6 m -58.5 -50.26 74.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.482 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.01 -8.81 1.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.43 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' D' ' 44' ' ' SER . . . 64.01 -94.57 0.15 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -45.11 122.47 3.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -1.108 . . . . 0.0 109.779 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -153.57 15.2 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.235 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.0 t -46.76 -39.15 11.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.603 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 8.0 p -144.64 152.23 52.22 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.416 -0.802 . . . . 0.0 108.902 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -44.9 -45.13 14.18 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.072 1.848 . . . . 0.0 112.151 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' D' ' 53' ' ' ALA . 1.7 p30 -59.12 -39.67 83.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.606 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . 0.414 ' N ' ' OD1' ' D' ' 52' ' ' ASP . . . -52.32 -19.82 2.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.416 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' D' ' 56' ' ' GLY . 99.3 t -66.02 -64.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 39.6 mtm -73.56 9.67 1.32 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' D' ' 54' ' ' VAL . . . -88.15 -13.75 63.51 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.76 148.47 38.47 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.18 -1.188 . . . . 0.0 109.369 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.15 -19.54 17.43 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.58 2.187 . . . . 0.0 112.154 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.76 -28.28 33.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.654 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.31 -40.32 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 0.0 109.697 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -79.13 -28.55 42.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.649 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.11 -48.73 19.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.735 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 1.041 ' HE2' ' C4D' ' D' ' 147' ' ' HEC . 3.1 t-80 -48.13 -23.88 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.691 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.44 -54.98 13.47 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -46.69 -34.65 5.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -1.132 . . . . 0.0 109.582 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . 0.919 ' HD3' ' O2A' ' D' ' 147' ' ' HEC . 86.7 mttt -75.9 -37.64 58.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.351 -0.843 . . . . 0.0 109.558 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.686 HG22 ' CHB' ' D' ' 147' ' ' HEC . 34.1 t -71.73 -46.63 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.411 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.75 -32.56 67.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 0.0 109.279 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.81 -53.65 42.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.68 -48.79 66.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 109.364 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.63 -36.03 73.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.237 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 30.1 p -80.19 -24.2 40.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.468 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -51.92 -42.6 62.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.0 -60.12 8.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.453 ' H ' HD13 ' D' ' 75' ' ' LEU . 4.7 mp -58.38 -30.79 67.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -1.123 . . . . 0.0 109.238 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.68 -3.15 58.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 109.543 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.5 ' C ' ' H ' ' D' ' 79' ' ' ASP . 10.2 t-80 -167.96 61.81 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.666 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mt -73.42 14.43 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -0.971 . . . . 0.0 109.145 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' D' ' 77' ' ' HIS . 30.2 t70 -68.99 -32.32 71.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.482 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' D' ' 79' ' ' ASP . 9.8 m120 -163.19 104.14 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.337 -0.852 . . . . 0.0 109.45 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 37.3 mt -80.24 -58.8 2.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.409 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -48.59 -24.14 1.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.444 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.09 -62.21 3.42 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.7 t -62.76 -47.18 84.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.166 . . . . 0.0 109.452 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.4 m-85 -66.94 0.96 2.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.521 -0.737 . . . . 0.0 109.486 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -59.73 -47.42 85.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.966 . . . . 0.0 109.466 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 5.1 p -72.64 -53.63 11.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 0.0 109.42 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 24.7 mt -49.87 -46.52 51.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.432 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 89' ' ' SER . . . . . 0.634 ' HG ' ' N ' ' D' ' 90' ' ' GLU . 85.5 p -56.3 -46.7 79.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.419 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.634 ' N ' ' HG ' ' D' ' 89' ' ' SER . 34.8 tt0 -64.69 -40.6 95.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.327 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.25 -44.7 87.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 109.338 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' D' ' 97' ' ' HIS . 76.0 m80 -73.39 -24.24 60.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 110.207 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.71 -60.94 1.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 0.0 111.245 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -88.05 -57.12 3.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.884 -1.135 . . . . 0.0 111.691 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -66.23 -9.83 36.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.319 -0.863 . . . . 0.0 111.494 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.559 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 1.0 OUTLIER -143.13 -33.89 0.43 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.771 -1.206 . . . . 0.0 110.028 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 33.2 p-80 43.62 25.51 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.264 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' D' ' 96' ' ' LEU . 24.9 t -53.7 139.09 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.065 -1.022 . . . . 0.0 109.045 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' D' ' 102' ' ' ASN . 7.4 m-20 -46.54 149.41 1.42 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.509 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.19 -17.43 45.18 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.584 2.189 . . . . 0.0 112.263 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -89.74 46.94 1.41 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 109.668 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.461 ' O ' HMC1 ' D' ' 147' ' ' HEC . 2.9 m120 -137.29 -3.42 1.95 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 109.811 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . 0.4 ' HA ' HBB3 ' D' ' 147' ' ' HEC . 2.4 m-85 -97.73 -60.41 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.118 -0.989 . . . . 0.0 109.435 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -51.05 -19.93 1.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 109.588 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' D' ' 105' ' ' LEU . 7.9 mp -77.98 -52.87 8.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.934 HD11 ' CHC' ' D' ' 147' ' ' HEC . 5.0 tt -54.48 -52.19 62.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.58 -22.0 7.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -85.64 -53.7 5.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -1.19 . . . . 0.0 109.723 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 92.9 t -46.66 -30.27 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 109.88 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.99 -55.39 29.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.644 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 90.2 t -46.71 -26.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.774 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 34.4 t -74.63 -26.31 59.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.893 . . . . 0.0 109.704 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.48 -25.28 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.6 -25.6 33.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.742 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -75.72 -19.48 59.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.673 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 1.493 ' NE2' ' CZ ' ' C' ' 117' ' ' PHE . 0.3 OUTLIER -83.52 -52.44 6.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . 0.493 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 61.0 m170 -73.29 -17.62 61.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 11.2 m-85 -149.39 55.73 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -61.47 -14.81 43.62 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.7 -20.89 27.07 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.213 -1.169 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.528 ' C ' ' H ' ' D' ' 123' ' ' THR . 59.4 mm-40 -83.87 -7.34 59.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.683 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.71 33.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 109.527 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.528 ' H ' ' C ' ' D' ' 121' ' ' GLU . 77.4 p -47.55 148.42 2.49 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.434 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.469 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.3 Cg_exo -44.63 -56.15 2.81 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.491 2.127 . . . . 0.0 112.956 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 19.8 Cg_endo -60.46 -35.26 91.34 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.187 1.924 . . . . 0.0 112.078 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . 0.428 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 78.5 t -72.09 -17.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -83.33 -59.78 2.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 109.789 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 0.714 ' HB3' HD11 ' C' ' 34' ' ' LEU . . . -53.69 -33.43 55.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.624 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.48 27.64 0.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.541 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -125.2 -38.22 2.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.411 -0.805 . . . . 0.0 109.512 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . 1.01 ' NE2' ' CZ ' ' C' ' 36' ' ' PHE . 45.9 tt0 -67.51 -23.97 65.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 109.835 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' D' ' 1' ' ' VAL . 35.4 mtmt -84.46 -36.49 22.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 109.679 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.65 -49.39 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.787 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 4.5 m -79.43 -23.87 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 109.783 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.4 -27.84 11.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.106 -0.996 . . . . 0.0 109.463 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.28 -23.1 61.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 93.9 t -78.93 -27.65 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -1.173 . . . . 0.0 109.55 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.92 -42.84 56.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.933 . . . . 0.0 109.446 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.532 ' OD1' ' OD1' ' B' ' 139' ' ' ASN . 37.8 t30 -76.8 -21.17 55.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.578 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.67 -60.29 2.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 0.0 109.54 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 17.1 mt -55.24 -22.26 17.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.429 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.32 -17.88 24.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -46.34 -46.51 18.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.51 ' C ' ' H ' ' D' ' 146' ' ' HIS . 5.7 tppt? -77.2 -57.43 3.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . 0.484 ' CD1' ' C ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -51.58 -10.59 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.519 -0.738 . . . . 0.0 109.193 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.51 ' H ' ' C ' ' D' ' 144' ' ' LYS . 11.4 m-70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.666 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.841 ' CHC' ' CD1' ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 1.043 ' C4D' ' HE2' ' B' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 0.843 ' CHC' ' CD1' ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.041 ' C4D' ' HE2' ' D' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.7 mt -138.96 -174.21 3.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.248 -0.907 . . . . 0.0 109.412 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.488 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 175.9 -49.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 3' ' ' SER . 71.9 Cg_exo -47.01 173.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.507 2.138 . . . . 0.0 112.568 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -65.11 -16.33 63.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 5' ' ' ALA . 1.2 m-20 -39.71 -40.62 0.96 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 109.595 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' CB ' ' HZ1' ' A' ' 7' ' ' LYS . 8.3 mtmp? -60.51 -59.29 5.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.206 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 m -50.26 -28.68 8.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.198 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 5' ' ' ALA . 55.5 m-80 -80.09 -35.32 37.09 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.81 -44.57 45.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.74 -39.63 89.39 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.414 -0.803 . . . . 0.0 108.86 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.78 46.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.153 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.97 -35.43 64.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.445 -0.784 . . . . 0.0 109.073 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.54 -17.51 61.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.051 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.47 -46.34 8.96 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -68.9 -37.47 78.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.198 -1.177 . . . . 0.0 108.766 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.2 t -61.17 -65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.596 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 59.59 -137.54 49.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.23 29.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.471 -1.017 . . . . 0.0 110.296 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.596 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.1 m-70 -131.82 23.35 4.62 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -87.3 -61.48 1.71 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.613 -0.68 . . . . 0.0 109.639 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.34 -14.62 0.35 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 21' ' ' ALA . 3.7 mm-40 -84.08 -56.45 3.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -1.111 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.1 m-30 -59.61 -33.17 71.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.396 -0.815 . . . . 0.0 109.322 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.33 -22.96 76.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.73 -43.54 20.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -1.176 . . . . 0.0 109.752 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.86 -19.91 65.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 -20.0 59.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.911 . . . . 0.0 109.366 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.6 mt -73.0 -46.04 54.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.588 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -61.98 -17.73 58.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 109.604 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.0 mmt-85 -81.18 -31.9 33.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 0.0 109.598 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -73.02 -37.63 66.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 109.525 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -62.95 -60.0 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.3 mt -59.32 -48.88 79.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.655 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' B' ' 131' ' ' GLN . 40.3 t -46.04 -27.4 0.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.923 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CD1' ' O ' ' A' ' 35' ' ' SER . 47.7 m-85 -154.18 123.88 3.25 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.026 -1.046 . . . . 0.0 109.55 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 40' ' ' LYS . 73.3 Cg_endo -77.9 -19.52 12.41 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.412 2.075 . . . . 0.0 112.159 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.2 p -43.9 -19.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 109.889 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 37' ' ' PRO . 3.4 p -90.27 -22.83 21.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.174 -0.954 . . . . 0.0 109.575 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 37' ' ' PRO . 27.8 ttmt -50.16 -18.74 0.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 109.954 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t -105.61 -18.4 14.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.863 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.52 38.13 1.57 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.348 -0.845 . . . . 0.0 109.168 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.688 ' O ' ' CG ' ' A' ' 43' ' ' PHE . 6.2 p90 -115.14 81.15 7.69 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.463 -0.773 . . . . 0.0 109.975 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.34 -6.28 15.48 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.372 2.048 . . . . 0.0 111.873 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.528 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.3 OUTLIER -165.61 50.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.583 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -156.17 71.19 0.71 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -46.41 -13.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.453 -0.779 . . . . 0.0 111.203 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 9.5 mt 59.0 -5.43 0.06 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.772 -1.205 . . . . 0.0 109.608 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.614 ' H ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -46.79 124.88 6.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 109.552 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -53.3 138.96 31.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.46 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.27 27.81 65.93 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.451 ' OG ' ' CB ' ' A' ' 49' ' ' SER . 3.2 m -60.9 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.273 -1.134 . . . . 0.0 109.31 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' VAL . . . 167.8 -64.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.424 -0.797 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -45.61 -17.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.47 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' ALA . 61.3 t -73.93 -29.98 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 109.791 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -70.96 -26.49 63.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.71 -22.92 68.38 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.4 OUTLIER -79.2 -39.89 32.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.171 -1.194 . . . . 0.0 109.549 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.27 -49.96 54.23 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 49.8 mttp -51.98 -23.87 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -1.104 . . . . 0.0 110.0 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.654 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 10.1 mmpt? -72.41 -45.11 61.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.19 -0.944 . . . . 0.0 109.107 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.3 t -67.62 -46.14 83.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.475 -0.765 . . . . 0.0 109.261 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.79 -31.0 68.68 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.2 -0.937 . . . . 0.0 109.313 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.4 t70 -69.39 -34.57 74.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.973 . . . . 0.0 108.752 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.85 -51.37 62.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.32 -0.863 . . . . 0.0 108.96 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.8 mt -56.34 -46.29 80.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 108.82 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -62.68 -51.57 66.69 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.274 -0.891 . . . . 0.0 108.871 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -59.67 -22.74 62.35 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.56 -46.98 11.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.65 -22.91 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.7 -16.95 64.59 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' A' ' 74' ' ' ASP . 15.8 m80 -143.88 -60.16 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.402 -0.811 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 69' ' ' ALA . 12.7 p 44.66 14.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.751 0.786 . . . . 0.0 109.286 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 72' ' ' HIS . 13.7 m-20 -131.22 11.44 5.0 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.8 p-10 -177.82 31.79 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.944 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.696 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -77.99 -24.21 0.44 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.398 -0.814 . . . . 0.0 111.709 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 76' ' ' MET . 75.6 Cg_exo -50.21 -33.92 37.8 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.71 1.607 . . . . 0.0 112.239 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -94.29 -16.04 23.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 0.0 109.503 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.65 -57.96 3.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 109.087 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.18 10.23 2.55 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.405 -0.809 . . . . 0.0 108.946 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 77' ' ' PRO . 1.4 m -61.09 -28.73 69.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.396 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -63.9 -50.58 68.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.543 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.526 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 4.5 mt -47.22 -47.34 24.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 108.785 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.7 t -55.31 -25.9 37.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.426 -0.796 . . . . 0.0 109.299 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 89' ' ' HIS . 1.9 m-20 -78.45 -53.05 7.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.486 HD12 ' O1D' ' A' ' 142' ' ' HEC . 5.2 tt -58.25 -28.65 65.1 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.327 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 8.4 m80 -92.6 -21.76 19.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.046 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.14 -2.39 14.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.133 -0.979 . . . . 0.0 110.354 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 85' ' ' ASP . 78.1 m80 -142.59 36.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.983 -1.073 . . . . 0.0 110.176 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -171.55 -77.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 0.0 109.723 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.49 -37.34 68.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.09 -1.006 . . . . 0.0 109.346 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.649 ' HG2' ' NH1' ' D' ' 40' ' ' ARG . 28.1 ttm180 55.63 52.4 11.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.122 -0.987 . . . . 0.0 109.492 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.562 ' O ' ' NH2' ' D' ' 40' ' ' ARG . 0.3 OUTLIER -78.7 -173.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.154 -0.966 . . . . 0.0 109.44 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 96' ' ' VAL . 1.8 m-20 -123.91 113.65 28.35 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.482 -0.761 . . . . 0.0 109.139 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 98' ' ' PHE . 84.3 Cg_exo -43.34 -14.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.265 1.976 . . . . 0.0 112.378 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 94' ' ' ASP . 94.9 t -48.07 -25.65 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.595 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -79.38 -24.86 42.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.621 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' A' ' 95' ' ' PRO . 28.5 t80 -46.38 -40.76 12.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 109.623 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -59.42 -25.18 64.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.591 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.1 mt -84.01 -61.32 1.85 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.576 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.819 HD22 HBB3 ' A' ' 142' ' ' HEC . 6.3 tp -47.95 -41.08 24.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.655 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.2 t -61.99 -42.31 99.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.669 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -80.91 -26.51 36.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.762 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 79.9 m -58.38 -56.86 16.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.603 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.6 mt -47.01 -37.14 8.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.365 -0.834 . . . . 0.0 109.568 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.09 -30.93 68.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.866 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.9 t -82.97 -24.81 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.2 m -81.82 -62.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.61 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 113' ' ' LEU . 12.5 mt -46.26 -39.94 10.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.311 -0.868 . . . . 0.0 109.64 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.5 -42.49 7.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.818 . . . . 0.0 109.927 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.04 -44.37 69.37 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.312 -0.868 . . . . 0.0 109.483 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -91.52 -77.24 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.561 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 109' ' ' LEU . 1.9 tt -96.88 119.59 63.28 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.49 165.38 32.58 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.242 1.962 . . . . 0.0 112.821 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.5 ' C ' ' H ' ' A' ' 117' ' ' PHE . . . -87.81 -28.5 21.61 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.53 0.681 . . . . 0.0 109.68 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.542 ' O ' ' CG ' ' A' ' 117' ' ' PHE . 83.8 mt-10 57.09 10.62 0.84 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' A' ' 116' ' ' GLU . 27.7 p90 40.6 32.5 0.15 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.339 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 120' ' ' ALA . 3.2 p -56.02 134.39 74.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -49.51 18.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.401 2.068 . . . . 0.0 113.251 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -157.37 -20.2 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.595 -1.316 . . . . 0.0 111.555 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.64 -63.13 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.543 -1.348 . . . . 0.0 110.055 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.616 ' CD2' HG22 ' B' ' 34' ' ' VAL . 0.0 OUTLIER -50.5 -31.14 14.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 108.977 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.65 -19.94 32.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.341 -0.85 . . . . 0.0 109.777 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 20.4 p -64.89 -62.33 1.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.201 -0.937 . . . . 0.0 110.599 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.507 ' N ' ' OG ' ' A' ' 124' ' ' SER . 2.0 mt -72.91 -19.78 61.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.119 -0.988 . . . . 0.0 110.051 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -81.45 -43.51 18.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 109.896 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -87.28 -47.59 8.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 109.86 -179.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 31.2 t80 -48.73 -21.5 0.63 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.122 -0.986 . . . . 0.0 109.47 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 133' ' ' SER . 18.7 mt -73.75 -21.06 60.32 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.15 -32.96 68.67 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.67 -30.42 46.19 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.404 -0.81 . . . . 0.0 108.869 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.06 -30.18 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 108.85 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 129' ' ' LEU . 78.8 p -79.09 -25.08 43.08 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.392 -0.817 . . . . 0.0 108.968 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 53.6 m -70.68 -37.57 73.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.299 -0.875 . . . . 0.0 109.244 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.52 -22.04 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.307 -0.871 . . . . 0.0 108.955 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -33.83 40.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.356 -0.84 . . . . 0.0 109.149 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 139' ' ' LYS . 71.4 p -91.34 -1.46 57.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 78.3 p -48.09 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.48 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 137' ' ' THR . 44.4 mttp -65.25 -19.29 65.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.554 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -162.14 -24.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.565 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.47 179.961 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' B' ' 2' ' ' HIS . 7.9 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.579 ' O ' ' CG ' ' B' ' 2' ' ' HIS . 0.4 OUTLIER -167.01 56.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -0.957 . . . . 0.0 109.603 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.594 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -122.17 -174.11 2.82 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.344 -0.847 . . . . 0.0 109.286 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.498 ' O ' ' N ' ' B' ' 6' ' ' GLU . 9.6 p -104.77 143.67 27.17 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.471 -0.768 . . . . 0.0 109.129 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -39.33 -22.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.561 2.174 . . . . 0.0 112.349 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' B' ' 4' ' ' THR . 25.1 mt-10 -75.5 -57.05 4.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.903 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -80.75 -22.93 39.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 109.798 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.493 ' O ' ' OG1' ' B' ' 12' ' ' THR . 2.5 tttm -79.77 -31.99 40.94 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.222 -0.924 . . . . 0.0 109.281 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t -63.92 -23.36 67.32 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.686 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.08 -57.68 3.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.074 -1.016 . . . . 0.0 110.062 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.12 -24.44 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 73.9 m -84.06 -35.47 23.76 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.364 0.602 . . . . 0.0 109.588 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -64.25 -60.05 3.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.812 . . . . 0.0 109.751 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -43.59 -18.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.51 -0.744 . . . . 0.0 110.139 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . 0.537 ' N ' ' O ' ' B' ' 13' ' ' ALA . 25.9 t90 -75.45 -33.39 60.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 0.0 109.499 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 13' ' ' ALA . . . -67.28 -52.54 30.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.618 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -56.22 -36.41 68.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.364 -1.08 . . . . 0.0 109.236 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 6.6 t -57.32 117.35 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.421 -0.8 . . . . 0.0 109.695 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' B' ' 21' ' ' ASP . 60.9 t30 -87.96 81.08 7.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.343 -0.848 . . . . 0.0 108.964 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.412 ' C ' ' N ' ' B' ' 22' ' ' GLU . 91.2 t -44.41 -17.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 109.781 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' B' ' 19' ' ' ASN . 22.2 t70 -51.12 -15.35 0.33 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.674 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.412 ' N ' ' C ' ' B' ' 20' ' ' VAL . 33.7 mt-10 -156.17 -37.55 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.619 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -47.44 -54.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.617 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.32 -33.33 70.27 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.62 -49.63 74.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' B' ' 28' ' ' LEU . 90.6 mt-10 -73.08 -44.27 60.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.0 109.501 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.52 -22.23 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' B' ' 26' ' ' GLU . 0.2 OUTLIER -82.78 -57.97 3.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.292 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.6 -43.74 59.37 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -50.17 -33.57 19.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -1.137 . . . . 0.0 109.43 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . 0.486 HD23 HMC3 ' B' ' 147' ' ' HEC . 42.0 tp -52.27 -36.94 54.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 24.4 mt -81.26 -42.57 20.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 109.844 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -56.74 -54.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 0.0 109.427 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.616 HG22 ' CD2' ' A' ' 122' ' ' HIS . 21.6 t -68.41 -23.0 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.525 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -160.8 87.1 1.76 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 109.382 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.22 18.59 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.666 2.244 . . . . 0.0 112.22 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . 0.545 ' C ' ' H ' ' B' ' 39' ' ' GLN . 1.3 p-90 -69.8 -19.95 63.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.476 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.494 ' C ' ' H ' ' B' ' 40' ' ' ARG . 75.8 p -69.83 35.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.857 . . . . 0.0 109.531 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' B' ' 37' ' ' TRP . 12.1 tt0 -73.27 14.78 0.28 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.625 ' NH1' ' HG2' ' C' ' 92' ' ' ARG . 64.7 mtt-85 -98.03 -48.95 4.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.384 -0.823 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -91.09 2.73 56.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 109.516 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' B' ' 39' ' ' GLN . 1.4 p90 -67.83 -4.34 12.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.58 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -46.86 -37.16 8.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 60.8 m -67.09 -43.46 82.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 109.436 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' B' ' 47' ' ' ASP . 2.6 m-85 -84.4 27.3 0.71 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 109.23 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.01 87.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' B' ' 45' ' ' PHE . 18.6 t0 -174.2 47.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.333 -1.098 . . . . 0.0 109.227 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' B' ' 48' ' ' LEU . 9.5 mp -88.77 27.91 1.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 109.575 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -46.95 -37.67 9.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 109.321 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' THR . . . . . 0.401 ' O ' ' N ' ' B' ' 53' ' ' ALA . 5.6 p -146.98 148.89 33.98 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.45 -0.781 . . . . 0.0 109.012 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.13 -42.51 2.22 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.518 2.145 . . . . 0.0 112.516 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.406 ' C ' ' N ' ' B' ' 54' ' ' VAL . 7.6 p-10 -77.37 -29.62 53.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.0 109.746 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -47.98 -19.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.619 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.406 ' N ' ' C ' ' B' ' 52' ' ' ASP . 68.2 t -63.87 -61.45 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.656 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -81.5 4.41 21.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.535 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.37 1.33 84.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -87.32 150.23 48.73 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.236 -1.156 . . . . 0.0 109.304 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.73 -28.33 9.77 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.598 2.199 . . . . 0.0 112.377 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' B' ' 60' ' ' VAL . 0.0 OUTLIER -84.42 -39.34 19.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.933 . . . . 0.0 109.846 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' B' ' 59' ' ' LYS . 53.9 t -52.43 -42.67 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.468 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -78.97 -26.86 43.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.108 -0.995 . . . . 0.0 109.484 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.73 -58.06 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.487 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 1.065 ' HE2' ' C4D' ' B' ' 147' ' ' HEC . 1.6 t-80 -48.1 -23.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.191 -0.943 . . . . 0.0 109.545 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.23 -47.47 90.83 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -62.29 -35.57 79.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.182 . . . . 0.0 109.441 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . 0.742 ' HD3' ' CGA' ' B' ' 147' ' ' HEC . 53.2 mttm -60.58 -44.34 96.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.27 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.859 HG22 ' CHB' ' B' ' 147' ' ' HEC . 36.6 t -71.26 -58.83 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.22 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.2 tt -48.78 -44.6 39.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.277 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.05 -47.06 41.62 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.57 32.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -1.156 . . . . 0.0 109.475 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -53.05 -22.8 6.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.247 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.46 -41.01 22.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.445 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.39 -27.65 1.76 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.42 -60.16 5.27 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.465 HD11 ' H ' ' B' ' 75' ' ' LEU . 4.7 mp -56.23 -17.98 9.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -1.121 . . . . 0.0 109.302 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.52 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -80.53 -26.25 38.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.695 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' B' ' 79' ' ' ASP . 39.5 m80 -157.23 59.99 0.51 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.76 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 23.3 mt -56.41 -4.7 0.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 109.295 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' B' ' 77' ' ' HIS . 7.5 m-20 -51.82 -26.48 9.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.723 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.558 ' N ' ' ND2' ' B' ' 80' ' ' ASN . 0.0 OUTLIER -165.98 95.01 0.58 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.626 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -80.27 -58.75 2.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.36 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.645 ' HZ2' ' CG ' ' B' ' 143' ' ' HIS . 16.6 ttmm -47.44 -23.94 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 109.573 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.64 -49.29 11.18 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 1.3 t -73.9 -45.58 49.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -1.165 . . . . 0.0 109.647 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.531 ' N ' ' CG2' ' B' ' 84' ' ' THR . 48.4 m-85 -64.63 4.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.365 -0.834 . . . . 0.0 109.572 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -64.08 -34.02 77.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.944 . . . . 0.0 109.475 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.422 ' H ' ' HG1' ' B' ' 87' ' ' THR . 10.2 p -77.25 -53.06 8.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.606 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 9.4 mp -51.25 -49.21 61.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.321 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 3.5 m -53.33 -49.37 67.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.362 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.53 -22.7 66.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.359 -0.838 . . . . 0.0 109.369 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.95 -57.87 3.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 0.0 109.667 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' B' ' 97' ' ' HIS . 45.2 m80 -68.64 -20.25 64.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 110.31 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 53.7 t -83.8 -60.92 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.03 . . . . 0.0 110.747 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -87.75 -56.08 3.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.023 . . . . 0.0 111.246 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -51.7 68.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.893 . . . . 0.0 110.759 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.679 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -98.47 -59.71 1.69 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.012 -1.055 . . . . 0.0 109.893 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.679 ' ND1' ' O ' ' B' ' 96' ' ' LEU . 0.0 OUTLIER 83.94 20.66 0.16 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.773 -0.579 . . . . 0.0 109.77 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 68.5 t -48.35 140.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.048 -1.032 . . . . 0.0 109.292 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -56.93 150.61 37.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.273 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.49 -7.76 21.9 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.539 2.159 . . . . 0.0 112.15 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.52 60.89 2.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 109.542 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.414 ' ND2' ' CMC' ' B' ' 147' ' ' HEC . 0.3 OUTLIER -156.96 -34.69 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.14 -14.05 52.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.504 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . 0.412 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 90.1 mtt-85 -86.25 -20.04 29.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.95 . . . . 0.0 109.778 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 37.2 mt -82.68 -53.61 5.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.792 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.716 HD11 ' CHC' ' B' ' 147' ' ' HEC . 4.1 tt -50.82 -46.32 59.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.79 -28.81 63.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 21.9 m120 -85.56 -20.78 29.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -1.173 . . . . 0.0 109.628 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 81.0 t -81.14 -28.86 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.56 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.94 -58.8 3.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.231 -0.918 . . . . 0.0 109.607 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 3.8 m -52.26 -26.07 8.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.296 -0.877 . . . . 0.0 109.929 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 t -70.43 -34.81 72.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 49.6 t -71.61 -22.48 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 109.56 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.423 ' CD1' ' OH ' ' B' ' 130' ' ' TYR . 14.6 mt -80.93 -47.11 14.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.488 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.484 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -51.96 -19.98 2.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 109.442 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.402 ' HE2' ' CB ' ' A' ' 115' ' ' ALA . 62.6 m80 -84.93 -63.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.544 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.79 -17.77 64.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.579 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -143.22 52.23 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.334 -0.854 . . . . 0.0 109.429 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -68.68 -13.01 65.28 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -77.99 -29.92 49.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -1.136 . . . . 0.0 109.395 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -94.29 14.48 20.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.569 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -84.0 34.01 0.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.902 . . . . 0.0 109.533 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -48.11 148.78 2.86 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.268 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.499 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 4.9 Cg_exo -45.73 -53.41 5.66 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.397 2.065 . . . . 0.0 113.007 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 28.1 Cg_endo -63.09 -29.13 74.52 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.031 1.821 . . . . 0.0 112.228 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 63.2 t -74.13 -13.73 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.51 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -83.47 -59.74 2.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 109.575 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.19 -32.69 64.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.405 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.82 26.24 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.423 ' OH ' ' CD1' ' B' ' 114' ' ' LEU . 1.3 t80 -131.19 -34.28 1.44 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -0.846 . . . . 0.0 109.246 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 35' ' ' SER . 12.3 mt-30 -76.64 -63.44 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.736 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -47.29 -21.95 0.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.554 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.14 -64.95 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.02 -26.83 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.81 -29.95 8.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.01 -32.52 69.61 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.06 -37.35 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -1.148 . . . . 0.0 109.362 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.32 -33.36 75.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.427 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.557 HD22 HD22 ' D' ' 139' ' ' ASN . 65.3 t30 -72.57 -36.55 68.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.85 -48.49 74.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.364 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.409 ' CD2' ' HD1' ' B' ' 92' ' ' HIS . 17.0 mt -60.27 -30.1 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.97 0.55 49.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 109.7 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . 0.645 ' CG ' ' HZ2' ' B' ' 82' ' ' LYS . 72.0 t60 -67.2 -27.9 67.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.18 -0.95 . . . . 0.0 109.608 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -89.4 -23.04 22.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -55.34 -5.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.525 ' H ' ' C ' ' B' ' 144' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.515 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.451 ' H1 ' ' H ' ' C' ' 2' ' ' LEU . 4.8 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . 0.451 ' H ' ' H1 ' ' C' ' 1' ' ' VAL . 14.6 mt -139.02 -174.23 3.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.311 -0.868 . . . . 0.0 109.34 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.478 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 175.94 -49.25 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 109.945 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' C' ' 3' ' ' SER . 72.1 Cg_exo -46.99 173.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.421 2.081 . . . . 0.0 112.641 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -65.12 -16.26 63.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.812 . . . . 0.0 109.64 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.457 ' C ' ' O ' ' C' ' 5' ' ' ALA . 1.2 m-20 -39.67 -40.63 0.94 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 0.0 109.647 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.419 ' CB ' ' HZ1' ' C' ' 7' ' ' LYS . 8.3 mtmp? -60.51 -59.33 5.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 109.216 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 48.8 m -50.26 -28.63 8.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 109.156 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' C' ' 5' ' ' ALA . 55.6 m-80 -80.16 -35.3 36.75 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.86 -44.54 45.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.69 -39.74 89.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.408 -0.807 . . . . 0.0 108.84 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.87 -52.87 46.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.865 . . . . 0.0 109.154 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.95 -35.43 64.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.365 -0.834 . . . . 0.0 109.056 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -17.46 61.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.314 -0.866 . . . . 0.0 109.007 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.52 -46.35 8.9 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -68.93 -37.43 78.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 108.772 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.14 -65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 59.67 -137.6 49.64 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 29.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.5 -1.0 . . . . 0.0 110.363 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.611 ' H ' ' C ' ' C' ' 18' ' ' GLY . 93.0 m-70 -131.73 23.33 4.65 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -87.3 -61.55 1.7 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.672 -0.643 . . . . 0.0 109.573 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.41 -14.49 0.35 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' C' ' 21' ' ' ALA . 3.7 mm-40 -84.14 -56.48 3.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -1.076 . . . . 0.0 109.484 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.1 m-30 -59.59 -33.16 71.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.396 -0.815 . . . . 0.0 109.332 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.32 -22.95 76.49 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.7 -43.58 20.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.184 -1.186 . . . . 0.0 109.689 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.75 -20.05 65.88 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.4 -19.98 59.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.03 -45.94 54.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.652 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -61.89 -17.86 58.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.677 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 36.2 mmt-85 -81.17 -31.82 33.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.552 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -73.06 -37.6 66.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.605 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' C' ' 33' ' ' PHE . 0.7 OUTLIER -63.06 -59.94 4.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -59.25 -48.93 79.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.0 109.63 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.52 ' OG ' ' NE2' ' D' ' 131' ' ' GLN . 40.4 t -46.02 -27.43 0.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.922 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' C' ' 35' ' ' SER . 47.3 m-85 -154.13 123.79 3.25 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 0.0 109.476 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' C' ' 40' ' ' LYS . 73.2 Cg_endo -77.8 -19.47 12.59 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.425 2.083 . . . . 0.0 112.272 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 21.2 p -43.91 -19.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 109.851 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.515 ' N ' ' O ' ' C' ' 37' ' ' PRO . 3.5 p -90.18 -22.89 21.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' C' ' 37' ' ' PRO . 27.9 ttmt -50.16 -18.7 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 109.922 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 9.1 t -105.65 -18.45 14.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 109.835 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.4 38.12 1.56 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.695 ' O ' ' CG ' ' C' ' 43' ' ' PHE . 6.3 p90 -115.07 81.18 7.56 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.33 -6.24 15.47 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.398 2.065 . . . . 0.0 111.917 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.51 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.3 OUTLIER -165.69 50.91 0.09 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.387 -0.82 . . . . 0.0 108.941 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.582 ' O ' ' HG ' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -156.15 71.08 0.71 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.626 ' C ' ' H ' ' C' ' 49' ' ' SER . 0.9 OUTLIER -46.34 -13.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.602 -0.687 . . . . 0.0 111.242 -178.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' C' ' 46' ' ' PHE . 9.6 mt 58.93 -5.34 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.787 -1.196 . . . . 0.0 109.664 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.626 ' H ' ' C ' ' C' ' 47' ' ' ASP . 0.0 OUTLIER -46.88 124.95 6.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.0 109.544 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -53.38 138.99 31.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.25 27.82 65.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.456 ' O ' ' CB ' ' C' ' 53' ' ' ALA . 3.2 m -60.89 -97.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -1.141 . . . . 0.0 109.336 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' C' ' 55' ' ' VAL . . . 167.83 -64.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.459 -0.776 . . . . 0.0 109.175 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -45.56 -17.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.541 -0.724 . . . . 0.0 109.534 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' C' ' 53' ' ' ALA . 61.6 t -73.86 -30.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.284 -0.885 . . . . 0.0 109.758 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -70.96 -26.46 63.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.85 -22.81 68.25 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.4 OUTLIER -79.22 -39.9 32.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.298 -1.119 . . . . 0.0 109.603 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.15 -50.02 53.54 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 49.7 mttp -52.06 -23.73 5.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -1.149 . . . . 0.0 109.966 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.639 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 10.2 mmpt? -72.55 -45.15 60.65 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.117 -0.99 . . . . 0.0 109.072 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.59 -46.12 83.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.531 -0.731 . . . . 0.0 109.277 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.86 -30.94 68.53 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.222 -0.923 . . . . 0.0 109.346 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 2.4 t70 -69.44 -34.49 74.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 108.83 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.84 -51.38 62.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 108.918 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 mt -56.28 -46.47 79.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.241 -0.912 . . . . 0.0 108.739 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -62.61 -51.66 66.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.328 -0.857 . . . . 0.0 108.81 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.6 -22.75 62.25 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.58 -47.06 10.94 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.64 -22.88 31.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.75 -16.91 64.58 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.597 ' O ' ' N ' ' C' ' 74' ' ' ASP . 15.8 m80 -143.88 -60.07 0.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.515 -0.741 . . . . 0.0 109.388 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' C' ' 69' ' ' ALA . 12.8 p 44.63 14.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.817 0.818 . . . . 0.0 109.376 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' C' ' 72' ' ' HIS . 13.7 m-20 -131.23 11.41 4.99 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 1.8 p-10 -177.77 31.76 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.962 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.694 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -77.98 -24.23 0.44 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.458 -0.776 . . . . 0.0 111.655 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' C' ' 76' ' ' MET . 75.3 Cg_exo -50.3 -33.82 38.19 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.689 1.593 . . . . 0.0 112.279 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -94.34 -16.05 23.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' C' ' 81' ' ' SER . . . -79.53 -58.04 3.39 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.123 -0.986 . . . . 0.0 109.139 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 mt -77.16 10.18 2.58 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.395 -0.815 . . . . 0.0 108.962 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' C' ' 77' ' ' PRO . 1.5 m -61.0 -28.81 69.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.389 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -63.85 -50.68 67.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.509 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 4.5 mt -47.27 -47.29 25.1 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 20.7 t -55.36 -25.8 37.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.498 -0.751 . . . . 0.0 109.247 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' C' ' 89' ' ' HIS . 1.9 m-20 -78.55 -53.01 7.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.935 . . . . 0.0 109.463 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.499 HD12 ' O1D' ' C' ' 142' ' ' HEC . 5.2 tt -58.2 -28.76 65.11 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.302 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 8.3 m80 -92.58 -21.66 19.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 110.048 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.21 -2.28 14.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.234 -0.916 . . . . 0.0 110.414 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' C' ' 85' ' ' ASP . 78.0 m80 -142.6 36.08 1.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.984 -1.073 . . . . 0.0 110.096 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -171.57 -77.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.04 -1.037 . . . . 0.0 109.72 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.52 -37.34 68.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 109.327 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . 0.625 ' HG2' ' NH1' ' B' ' 40' ' ' ARG . 28.1 ttm180 55.64 52.38 11.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.575 ' O ' ' NH2' ' B' ' 40' ' ' ARG . 0.3 OUTLIER -78.68 -173.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.45 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' C' ' 96' ' ' VAL . 1.8 m-20 -123.8 113.67 28.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.464 -0.773 . . . . 0.0 109.169 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' C' ' 98' ' ' PHE . 84.8 Cg_exo -43.43 -14.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.216 1.944 . . . . 0.0 112.406 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' C' ' 94' ' ' ASP . 94.2 t -48.05 -25.66 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 109.551 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -79.44 -24.8 42.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.644 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . 0.42 ' N ' ' O ' ' C' ' 95' ' ' PRO . 28.5 t80 -46.43 -40.79 12.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 109.55 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -59.5 -24.93 64.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 20.2 mt -84.13 -61.26 1.86 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.628 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.818 HD22 HBB3 ' C' ' 142' ' ' HEC . 6.3 tp -48.01 -41.02 24.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 9.2 t -61.96 -42.3 98.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.715 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -80.94 -26.59 36.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.676 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 79.8 m -58.31 -56.86 16.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 0.0 109.625 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -47.07 -37.06 8.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.526 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.19 -31.01 68.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.782 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.89 -24.88 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.586 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 28.1 m -81.78 -62.95 1.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.596 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' C' ' 113' ' ' LEU . 12.5 mt -46.26 -39.9 10.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.895 . . . . 0.0 109.581 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.62 -42.33 7.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.958 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.1 -44.45 69.01 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.507 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -91.41 -77.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.63 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' C' ' 109' ' ' LEU . 1.9 tt -96.82 119.44 63.64 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.41 165.34 32.76 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.287 1.991 . . . . 0.0 112.821 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -87.79 -28.57 21.6 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.565 0.698 . . . . 0.0 109.647 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' C' ' 117' ' ' PHE . 83.8 mt-10 57.07 10.63 0.84 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' C' ' 116' ' ' GLU . 27.8 p90 40.58 32.51 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.314 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.703 ' O ' ' N ' ' C' ' 120' ' ' ALA . 3.2 p -56.03 134.35 74.06 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.44 18.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.387 2.058 . . . . 0.0 113.293 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.703 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -157.44 -20.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.623 -1.298 . . . . 0.0 111.543 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.65 -63.01 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.513 -1.367 . . . . 0.0 110.106 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.626 ' CD2' HG22 ' D' ' 34' ' ' VAL . 0.0 OUTLIER -50.71 -31.02 15.29 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.28 -0.888 . . . . 0.0 108.868 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.65 -20.03 31.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.742 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 20.4 p -64.8 -62.33 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.671 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.505 ' N ' ' OG ' ' C' ' 124' ' ' SER . 2.0 mt -72.98 -19.68 61.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.1 -1.0 . . . . 0.0 110.081 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -81.48 -43.42 18.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.029 -1.044 . . . . 0.0 109.948 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -87.33 -47.64 8.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.873 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 31.1 t80 -48.68 -21.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.447 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' C' ' 133' ' ' SER . 18.8 mt -73.62 -21.23 60.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.05 -32.96 68.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.71 -30.43 45.95 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.07 -30.25 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.845 . . . . 0.0 108.764 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.46 ' N ' ' O ' ' C' ' 129' ' ' LEU . 79.1 p -79.03 -25.1 43.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.347 -0.846 . . . . 0.0 108.968 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 53.5 m -70.69 -37.54 73.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.284 -0.885 . . . . 0.0 109.215 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.9 p -79.59 -22.0 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 108.871 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.65 -33.9 40.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.39 -0.818 . . . . 0.0 109.144 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 137' ' ' THR . . . . . 0.446 ' O ' ' N ' ' C' ' 139' ' ' LYS . 69.8 p -91.23 -1.54 57.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 109.58 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 78.4 p -48.07 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' C' ' 137' ' ' THR . 44.4 mttp -65.29 -19.22 65.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -162.2 -24.48 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.438 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' D' ' 2' ' ' HIS . 7.9 p . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.581 ' O ' ' CG ' ' D' ' 2' ' ' HIS . 0.4 OUTLIER -166.99 56.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.155 -0.966 . . . . 0.0 109.634 179.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -122.25 -174.11 2.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.278 -0.889 . . . . 0.0 109.258 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.498 ' O ' ' N ' ' D' ' 6' ' ' GLU . 9.7 p -104.75 143.73 27.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 109.122 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -39.26 -22.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.637 2.224 . . . . 0.0 112.296 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' D' ' 4' ' ' THR . 25.2 mt-10 -75.55 -56.92 4.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.937 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -80.82 -22.82 39.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.944 . . . . 0.0 109.861 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' D' ' 12' ' ' THR . 2.5 tttm -79.8 -31.97 40.75 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.254 -0.904 . . . . 0.0 109.296 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 11.2 t -63.84 -23.45 67.36 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.718 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.07 -57.66 3.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.057 -1.027 . . . . 0.0 110.086 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.1 -24.42 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 75.1 m -84.13 -35.5 23.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.327 0.584 . . . . 0.0 109.547 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -64.29 -59.95 3.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.441 -0.787 . . . . 0.0 109.71 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -43.72 -18.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 0.0 110.117 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . 0.53 ' N ' ' O ' ' D' ' 13' ' ' ALA . 25.6 t90 -75.39 -33.37 61.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.917 -1.114 . . . . 0.0 109.532 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.31 -52.57 30.55 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.62 ' H ' ' CD ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -56.25 -36.37 68.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.326 -1.102 . . . . 0.0 109.189 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 6.6 t -57.45 117.38 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.819 . . . . 0.0 109.676 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' D' ' 21' ' ' ASP . 61.0 t30 -88.03 81.12 7.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 108.912 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' D' ' 22' ' ' GLU . 92.0 t -44.47 -17.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 0.0 109.846 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' D' ' 19' ' ' ASN . 22.2 t70 -51.15 -15.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' D' ' 20' ' ' VAL . 33.6 mt-10 -156.12 -37.67 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 77.2 t -47.38 -53.97 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 109.703 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.35 -33.28 70.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.67 -49.66 74.23 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' D' ' 28' ' ' LEU . 90.5 mt-10 -73.06 -44.27 60.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -1.171 . . . . 0.0 109.505 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.51 -22.28 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.618 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' D' ' 26' ' ' GLU . 0.2 OUTLIER -82.65 -58.01 3.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.288 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.64 -43.68 59.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -50.13 -33.61 19.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -1.134 . . . . 0.0 109.482 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . 0.504 HD23 HMC3 ' D' ' 147' ' ' HEC . 42.1 tp -52.3 -36.93 54.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.935 . . . . 0.0 109.494 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.17 -42.69 20.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -56.72 -54.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.155 -0.965 . . . . 0.0 109.432 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . 0.626 HG22 ' CD2' ' C' ' 122' ' ' HIS . 21.6 t -68.41 -23.05 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.525 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -160.8 86.99 1.77 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -83.0 18.36 1.5 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.74 2.293 . . . . 0.0 112.281 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . 0.561 ' C ' ' H ' ' D' ' 39' ' ' GLN . 1.3 p-90 -69.68 -19.98 63.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.464 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.497 ' C ' ' H ' ' D' ' 40' ' ' ARG . 75.8 p -69.92 35.63 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.175 -0.953 . . . . 0.0 109.568 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . 0.561 ' H ' ' C ' ' D' ' 37' ' ' TRP . 12.1 tt0 -73.23 14.77 0.28 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.322 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . 0.649 ' NH1' ' HG2' ' A' ' 92' ' ' ARG . 64.7 mtt-85 -98.03 -48.9 4.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.483 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -91.17 2.73 56.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.983 . . . . 0.0 109.531 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' D' ' 39' ' ' GLN . 1.4 p90 -67.87 -4.33 12.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.619 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -46.81 -37.17 8.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 109.657 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 60.5 m -67.13 -43.39 82.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' D' ' 47' ' ' ASP . 2.6 m-85 -84.34 27.3 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.248 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.97 87.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' D' ' 45' ' ' PHE . 18.7 t0 -174.2 47.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -1.101 . . . . 0.0 109.252 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' D' ' 48' ' ' LEU . 9.5 mp -88.78 27.92 1.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 109.564 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -46.94 -37.67 9.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.297 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' THR . . . . . 0.41 ' O ' ' N ' ' D' ' 53' ' ' ALA . 5.6 p -147.07 148.8 33.46 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.034 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -39.04 -42.54 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.552 2.168 . . . . 0.0 112.447 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . 0.404 ' C ' ' N ' ' D' ' 54' ' ' VAL . 7.6 p-10 -77.39 -29.62 53.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 0.0 109.728 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -48.04 -19.64 0.27 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 109.572 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 52' ' ' ASP . 67.1 t -63.93 -61.43 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.608 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -81.52 4.4 21.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.505 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.4 1.34 84.14 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -87.39 150.21 48.53 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.222 -1.163 . . . . 0.0 109.348 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.79 -28.26 9.72 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.576 2.184 . . . . 0.0 112.314 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' D' ' 60' ' ' VAL . 0.0 OUTLIER -84.41 -39.32 19.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 109.848 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . 0.405 ' H ' ' HG2' ' D' ' 59' ' ' LYS . 53.8 t -52.38 -42.75 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.024 . . . . 0.0 109.428 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -79.01 -26.8 43.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.933 . . . . 0.0 109.458 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.76 -58.01 3.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.55 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 1.073 ' HE2' ' C4D' ' D' ' 147' ' ' HEC . 1.6 t-80 -48.14 -23.9 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.561 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.3 -47.37 91.25 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -62.24 -35.67 79.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -1.203 . . . . 0.0 109.475 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . 0.747 ' HD3' ' CGA' ' D' ' 147' ' ' HEC . 53.0 mttm -60.56 -44.39 96.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.837 . . . . 0.0 109.248 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.857 HG22 ' CHB' ' D' ' 147' ' ' HEC . 36.3 t -71.21 -58.77 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.25 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.2 tt -48.88 -44.54 40.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.275 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.03 -47.06 41.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.96 -55.63 32.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -1.199 . . . . 0.0 109.393 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -53.0 -22.85 6.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.321 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.33 -41.1 22.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -0.834 . . . . 0.0 109.565 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.34 -27.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.408 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.41 -60.16 5.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.463 ' H ' HD11 ' D' ' 75' ' ' LEU . 4.7 mp -56.25 -17.93 8.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -1.119 . . . . 0.0 109.342 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -80.6 -26.13 38.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.237 -0.914 . . . . 0.0 109.701 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' D' ' 79' ' ' ASP . 39.5 m80 -157.36 60.01 0.5 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.688 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 23.2 mt -56.36 -4.8 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.045 -1.034 . . . . 0.0 109.309 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' D' ' 77' ' ' HIS . 7.5 m-20 -51.8 -26.47 9.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.714 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.556 ' N ' ' ND2' ' D' ' 80' ' ' ASN . 0.0 OUTLIER -166.04 94.96 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -80.26 -58.71 3.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . 0.643 ' HZ2' ' CG ' ' D' ' 143' ' ' HIS . 16.6 ttmm -47.44 -23.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.915 . . . . 0.0 109.567 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.81 -49.12 10.81 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.522 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 1.3 t -73.93 -45.67 49.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -1.207 . . . . 0.0 109.599 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.522 ' N ' ' CG2' ' D' ' 84' ' ' THR . 48.5 m-85 -64.66 4.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.398 -0.813 . . . . 0.0 109.613 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -64.1 -33.94 76.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.507 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 87' ' ' THR . . . . . 0.438 ' H ' ' HG1' ' D' ' 87' ' ' THR . 10.4 p -77.31 -53.09 8.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 9.4 mp -51.17 -49.31 61.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 3.5 m -53.3 -49.37 67.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.339 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -62.55 -22.72 66.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.335 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.86 -57.99 3.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.316 -0.865 . . . . 0.0 109.617 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.574 ' O ' ' N ' ' D' ' 97' ' ' HIS . 45.2 m80 -68.54 -20.35 64.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.844 . . . . 0.0 110.337 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 53.6 t -83.72 -60.94 1.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 110.781 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -87.78 -56.07 3.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -0.982 . . . . 0.0 111.283 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -51.66 68.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.794 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.665 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -98.47 -59.61 1.71 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.983 -1.073 . . . . 0.0 109.956 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.665 ' ND1' ' O ' ' D' ' 96' ' ' LEU . 0.0 OUTLIER 83.77 20.79 0.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.812 -0.555 . . . . 0.0 109.761 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 67.3 t -48.43 140.63 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 109.231 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -57.02 150.64 38.54 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.285 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.44 -7.78 21.97 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.524 2.149 . . . . 0.0 112.208 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.56 60.83 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 109.503 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.406 ' ND2' ' CMC' ' D' ' 147' ' ' HEC . 0.3 OUTLIER -156.86 -34.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.602 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -64.09 -14.02 51.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.969 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 89.9 mtt-85 -86.31 -19.97 29.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.769 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 37.3 mt -82.74 -53.56 5.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.821 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.721 HD11 ' CHC' ' D' ' 147' ' ' HEC . 4.1 tt -50.79 -46.41 59.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 109.485 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.74 -28.86 63.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 21.9 m120 -85.57 -20.71 29.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -1.215 . . . . 0.0 109.606 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.25 -28.69 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 8.8 tp -68.11 -58.7 4.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.627 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 3.8 m -52.31 -26.16 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.179 -0.951 . . . . 0.0 109.819 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 18.4 t -70.31 -34.78 73.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.743 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 49.8 t -71.7 -22.33 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.947 . . . . 0.0 109.6 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . 0.42 ' CD1' ' OH ' ' D' ' 130' ' ' TYR . 14.6 mt -81.03 -47.11 14.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -51.96 -19.93 2.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.473 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.408 ' HE2' ' CB ' ' C' ' 115' ' ' ALA . 62.6 m80 -84.95 -62.99 1.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.9 -17.67 64.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.92 . . . . 0.0 109.575 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -143.22 52.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.555 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -68.72 -12.92 65.24 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -78.06 -29.9 49.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -1.134 . . . . 0.0 109.394 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -94.27 14.5 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.892 . . . . 0.0 109.569 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -83.96 34.04 0.5 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.0 109.597 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 1.2 p -48.17 148.84 2.88 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 109.228 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.498 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.1 Cg_exo -45.88 -53.31 5.86 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.395 2.063 . . . . 0.0 112.923 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 28.3 Cg_endo -63.12 -29.04 74.12 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.004 1.803 . . . . 0.0 112.297 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 63.0 t -74.23 -13.64 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.496 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -83.52 -59.76 2.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.24 -32.56 64.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.374 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.92 26.3 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.857 . . . . 0.0 109.471 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . 0.42 ' OH ' ' CD1' ' D' ' 114' ' ' LEU . 1.3 t80 -131.27 -34.24 1.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.409 -0.807 . . . . 0.0 109.291 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . 0.52 ' NE2' ' OG ' ' C' ' 35' ' ' SER . 12.3 mt-30 -76.64 -63.5 1.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.646 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -47.34 -21.86 0.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 109.569 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.22 -64.91 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.546 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.06 -26.79 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.9 -29.9 9.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.41 69.49 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.11 -37.32 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.396 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.34 -33.42 75.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.375 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.557 HD22 HD22 ' B' ' 139' ' ' ASN . 65.3 t30 -72.55 -36.46 68.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.92 -48.46 74.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 mt -60.16 -30.19 69.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.92 0.56 49.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 109.681 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . 0.643 ' CG ' ' HZ2' ' D' ' 82' ' ' LYS . 72.3 t60 -67.12 -27.97 67.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.527 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.9 OUTLIER -89.54 -22.85 22.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.955 . . . . 0.0 109.593 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -55.44 -5.4 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.527 ' H ' ' C ' ' D' ' 144' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.428 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.819 HBB3 HD22 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 1.065 ' C4D' ' HE2' ' B' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 0.818 HBB3 HD22 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.073 ' C4D' ' HE2' ' D' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.5 tp -172.34 163.4 5.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 109.857 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.474 ' OG ' ' OD2' ' A' ' 6' ' ' ASP . 0.8 OUTLIER -75.74 -176.92 0.63 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.368 -0.832 . . . . 0.0 109.058 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 58.4 Cg_endo -86.87 -68.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.664 2.243 . . . . 0.0 112.716 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -47.54 -40.44 18.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.054 -1.029 . . . . 0.0 109.485 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.474 ' OD2' ' OG ' ' A' ' 3' ' ' SER . 63.9 m-20 -43.55 -29.46 0.48 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.86 . . . . 0.0 109.02 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 10' ' ' VAL . 58.4 mttt -83.08 -53.72 5.59 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' LYS . 35.9 m -44.65 -38.51 4.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.448 -0.782 . . . . 0.0 109.282 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -72.46 -29.69 63.9 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.575 ' N ' ' O ' ' A' ' 7' ' ' LYS . 54.1 t -75.12 -55.0 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -51.65 -39.11 57.52 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.23 179.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.18 -63.12 1.37 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.322 -0.861 . . . . 0.0 109.296 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.68 -38.61 67.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.388 -0.82 . . . . 0.0 108.892 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.94 -17.58 63.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.466 -0.772 . . . . 0.0 108.981 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.14 -44.98 16.61 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.427 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 39.1 mmtt -68.23 -41.4 81.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -1.137 . . . . 0.0 108.859 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.28 -64.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 50.0 -127.87 25.1 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.47 24.68 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.474 -1.015 . . . . 0.0 110.381 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.577 ' H ' ' C ' ' A' ' 18' ' ' GLY . 87.4 m-70 -130.38 28.49 4.95 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -93.36 -61.31 1.59 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.671 -0.643 . . . . 0.0 109.778 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.27 -14.3 0.16 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.6 mt-10 -86.54 -56.29 3.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -1.117 . . . . 0.0 109.761 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.1 m-30 -59.79 -32.36 70.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 109.59 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.04 -22.92 76.13 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.92 -41.86 18.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -1.17 . . . . 0.0 109.959 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -65.93 -19.88 66.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.294 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.77 -20.4 60.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.436 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.52 -51.11 15.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.739 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.66 -22.43 65.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.164 -0.96 . . . . 0.0 109.584 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.973 HH21 ' HB2' ' B' ' 127' ' ' GLN . 2.3 tpt180 -73.37 -20.75 60.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.311 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.611 ' HE2' ' CBC' ' A' ' 142' ' ' HEC . 46.1 ttp -78.36 -53.64 7.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.862 . . . . 0.0 109.525 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -48.36 -24.2 1.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.351 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 1.052 ' HB3' ' HB3' ' B' ' 128' ' ' ALA . 10.5 mt -82.32 -46.2 13.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.978 . . . . 0.0 109.579 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 46.0 m -69.21 -20.78 63.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 35' ' ' SER . 95.5 m-85 -158.4 79.23 3.14 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.988 . . . . 0.0 109.737 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.31 -26.42 15.67 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.659 2.239 . . . . 0.0 112.07 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.433 ' O ' ' CG2' ' A' ' 41' ' ' THR . 12.6 p -49.45 -18.24 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.918 . . . . 0.0 109.477 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.6 p -79.01 -22.34 45.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -46.01 -42.91 13.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.482 ' C ' ' H ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -62.42 -35.76 80.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.461 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -76.79 22.46 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.173 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 41' ' ' THR . 39.1 m-85 -146.03 59.75 5.8 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 -0.75 8.01 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.669 2.246 . . . . 0.0 111.942 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 15.9 p80 -141.79 56.95 1.5 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.165 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.662 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -149.81 69.32 1.02 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.548 ' C ' ' O ' ' A' ' 46' ' ' PHE . 1.1 m-20 -24.38 -37.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.855 -0.528 . . . . 0.0 111.203 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.662 ' N ' ' O ' ' A' ' 46' ' ' PHE . 4.3 mt 53.58 7.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.072 -1.017 . . . . 0.0 109.373 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 47' ' ' ASP . 4.9 m -64.34 5.7 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.528 ' H ' ' C ' ' A' ' 48' ' ' LEU . 37.8 t60 61.32 125.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.5 14.14 66.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.5 t -77.86 -103.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.164 -1.198 . . . . 0.0 109.41 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.91 -29.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 0.0 109.496 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -80.03 -17.98 51.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.199 -0.938 . . . . 0.0 109.169 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -84.52 -40.14 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.295 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -77.3 -32.37 55.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.16 -21.82 75.02 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.477 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 7.8 t-80 -75.65 -37.54 59.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.314 -1.11 . . . . 0.0 109.781 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.12 -48.5 46.39 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -51.77 -23.13 4.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -1.05 . . . . 0.0 109.979 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.39 -39.84 64.79 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.218 -0.926 . . . . 0.0 109.184 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.37 -33.6 19.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.457 -0.777 . . . . 0.0 108.935 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.16 -32.9 44.4 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.389 -0.82 . . . . 0.0 109.415 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -70.39 -33.37 71.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 108.861 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.13 19.02 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.429 -0.794 . . . . 0.0 108.898 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.23 -38.24 70.8 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.254 -0.904 . . . . 0.0 108.717 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -71.5 -50.29 32.88 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.196 -0.94 . . . . 0.0 108.608 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -59.78 -21.15 60.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.202 -0.936 . . . . 0.0 108.496 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.07 -47.35 13.66 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.94 -22.85 31.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.72 -15.1 63.41 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 74' ' ' ASP . 36.8 m80 -139.5 -63.01 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.479 -0.763 . . . . 0.0 109.423 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 69' ' ' ALA . 12.3 p 43.92 13.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.752 0.787 . . . . 0.0 109.65 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.612 ' N ' ' O ' ' A' ' 72' ' ' HIS . 16.2 m-20 -134.25 10.39 3.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 20.3 t0 -177.02 28.35 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.148 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.7 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 11.4 ptt? -78.81 -22.45 0.38 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 111.805 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 76' ' ' MET . 71.8 Cg_exo -49.02 -29.0 14.69 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.473 1.449 . . . . 0.0 112.424 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -94.23 -24.41 17.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 0.0 109.653 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.29 -53.58 8.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 0.0 109.143 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 mt -78.02 9.06 3.95 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.441 -0.787 . . . . 0.0 108.98 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 84' ' ' SER . 11.1 t -66.06 -41.5 90.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.412 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -52.46 -52.87 51.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.465 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 82' ' ' ALA . 4.9 mt -44.89 -45.05 10.11 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 9.9 p -55.75 -39.87 71.76 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' ALA . 25.7 t70 -67.58 -17.95 64.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.147 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.434 ' CD1' HBD1 ' A' ' 142' ' ' HEC . 1.2 tt -82.85 -43.46 16.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.333 -0.855 . . . . 0.0 109.378 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -92.45 -21.27 20.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.952 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 84' ' ' SER . . . -60.63 -87.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.106 -0.996 . . . . 0.0 110.741 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 90' ' ' LYS . 44.9 t-80 -96.62 -46.3 6.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.245 -0.909 . . . . 0.0 111.02 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 89' ' ' HIS . 35.9 mttm -41.22 -94.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.22 -0.925 . . . . 0.0 110.324 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mp -67.54 -34.97 78.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.012 -1.055 . . . . 0.0 109.623 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.394 ' NH2' ' HE ' ' D' ' 40' ' ' ARG . 45.5 ttp85 60.89 58.2 2.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.607 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 t -84.33 161.64 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 109.373 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.45 151.43 50.78 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.21 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' ASN . 58.4 Cg_endo -73.08 -18.8 23.6 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.55 2.167 . . . . 0.0 112.195 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.498 HG23 ' CB ' ' D' ' 99' ' ' ASP . 24.4 t -47.22 -20.04 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.743 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.646 HD21 ' N ' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -79.15 -24.73 43.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.709 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -46.66 -32.57 3.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 109.659 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.498 ' O ' ' ND1' ' A' ' 103' ' ' HIS . 55.8 mttm -83.89 -36.78 23.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 0.0 109.814 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.538 ' CD1' ' N ' ' A' ' 100' ' ' LEU . 7.2 mp -66.37 -61.93 1.74 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.131 -0.981 . . . . 0.0 109.516 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 1.315 HD22 ' CBB' ' A' ' 142' ' ' HEC . 6.4 tt -49.97 -47.4 52.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.239 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.8 t -61.9 -38.85 89.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.603 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' LYS . 22.9 m80 -77.37 -27.73 52.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.935 . . . . 0.0 109.609 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 70.8 m -64.74 -46.93 80.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.728 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.25 -48.64 65.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.435 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 106' ' ' LEU . 9.6 mp -61.54 -59.1 5.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.713 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.04 -34.3 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.237 -0.914 . . . . 0.0 109.386 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.8 m -75.77 -60.87 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.392 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 113' ' ' LEU . 13.1 mt -46.11 -41.44 12.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.91 -28.58 0.68 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 110.182 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.89 -56.38 4.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 109.768 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -85.77 -65.13 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.466 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -95.92 106.89 30.89 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.2 171.17 9.48 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.718 1.612 . . . . 0.0 112.3 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' A' ' 117' ' ' PHE . . . -87.22 -34.37 19.0 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.487 0.66 . . . . 0.0 109.88 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 117' ' ' PHE . 23.2 mt-10 55.63 9.96 0.46 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 115' ' ' ALA . 29.3 p90 40.63 32.34 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.54 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 120' ' ' ALA . 4.9 p -60.88 145.55 88.59 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.41 29.56 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 121.946 1.764 . . . . 0.0 111.773 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 118' ' ' THR . . . -162.61 -23.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.12 -0.988 . . . . 0.0 111.06 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.446 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.6 t -59.86 -62.62 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.794 -1.191 . . . . 0.0 109.799 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -27.12 67.68 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.126 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.54 -20.09 32.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 120' ' ' ALA . 95.5 p -67.19 -62.0 1.64 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 110.8 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.6 mt -80.23 -19.88 45.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.925 -1.109 . . . . 0.0 110.81 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.69 -42.68 27.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.663 -1.273 . . . . 0.0 110.241 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.467 ' CD ' ' C ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -90.04 -45.0 9.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.958 -1.089 . . . . 0.0 110.126 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -47.31 -21.55 0.3 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.01 -1.056 . . . . 0.0 109.454 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 127' ' ' LYS . 15.8 mt -69.63 -17.68 63.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.98 -38.19 78.58 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.5 p -78.68 -25.92 44.88 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.362 -0.836 . . . . 0.0 108.747 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.1 t -84.99 -40.54 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.234 -0.916 . . . . 0.0 108.598 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.8 t -68.84 -28.76 67.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.397 -0.814 . . . . 0.0 109.297 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 51.6 m -64.65 -40.0 94.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.138 -0.976 . . . . 0.0 108.985 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 p -82.68 -21.89 9.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.26 -0.9 . . . . 0.0 108.584 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.82 -28.26 44.4 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 138' ' ' SER . 49.1 m -68.14 -23.34 64.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.846 . . . . 0.0 109.405 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.7 OUTLIER 73.15 110.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -62.75 -98.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.405 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 47.45 76.25 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.534 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.724 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' B' ' 2' ' ' HIS . 2.9 p . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 1.538 ' HE2' ' CD2' ' D' ' 146' ' ' HIS . 6.2 p80 -172.81 112.42 0.24 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.919 -1.113 . . . . 0.0 109.818 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.642 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -141.87 -162.63 1.43 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.26 -0.9 . . . . 0.0 109.149 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.449 ' H ' ' HG1' ' B' ' 4' ' ' THR . 7.6 p -93.77 131.08 32.9 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.0 109.237 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.45 -23.77 0.32 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.365 2.043 . . . . 0.0 112.308 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -81.46 -53.02 6.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.968 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 5.5 mp0 -61.3 -55.58 30.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.662 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.507 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -57.04 -35.44 69.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.869 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -58.67 -23.81 60.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 110.047 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.61 -56.45 3.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.094 -1.004 . . . . 0.0 109.712 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.07 -25.15 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 75.9 m -78.7 -35.26 45.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -60.38 -61.52 2.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.425 -0.797 . . . . 0.0 109.328 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -43.62 -18.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.672 -0.642 . . . . 0.0 109.765 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' B' ' 13' ' ' ALA . 22.1 t-105 -78.09 -17.96 56.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.972 . . . . 0.0 109.646 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.09 -42.61 7.49 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.593 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -68.75 -31.95 71.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -1.093 . . . . 0.0 109.214 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 4.8 t -52.33 119.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -0.819 . . . . 0.0 109.692 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' B' ' 21' ' ' ASP . 54.9 m-20 -86.98 82.86 7.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.035 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' B' ' 22' ' ' GLU . 94.7 t -44.14 -20.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.816 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' B' ' 19' ' ' ASN . 12.6 m-20 -51.72 -8.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.73 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' B' ' 20' ' ' VAL . 34.8 mt-10 -155.53 -49.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.5 t -46.08 -26.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 109.779 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.09 -31.18 32.4 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -82.47 -25.67 49.96 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.73 -29.94 25.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.697 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.55 -23.45 63.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.949 . . . . 0.0 109.807 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.67 -58.16 3.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 109.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.19 -29.35 68.36 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -68.37 -29.44 68.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -1.114 . . . . 0.0 109.745 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp -51.62 -39.7 58.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.244 -0.91 . . . . 0.0 109.652 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 mt -78.12 -21.85 49.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.825 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 45.7 t -71.83 -47.96 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.875 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -63.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.019 -1.051 . . . . 0.0 109.787 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -119.42 97.09 50.16 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.396 -0.815 . . . . 0.0 109.754 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' B' ' 38' ' ' THR . 90.6 Cg_endo -85.59 10.52 3.67 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.717 2.278 . . . . 0.0 111.888 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -45.21 -19.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 109.694 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.671 ' C ' ' H ' ' B' ' 40' ' ' ARG . 11.0 p -46.96 -34.36 5.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.616 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 61.06 -13.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 1.372 ' HE ' ' NH2' ' C' ' 92' ' ' ARG . 79.8 mtt180 -88.94 -25.63 21.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.955 . . . . 0.0 108.946 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 53.79 6.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.415 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.624 ' CD2' ' CE1' ' B' ' 45' ' ' PHE . 3.0 m-85 48.11 30.08 2.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 109.163 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -48.41 -20.19 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 32.5 p -74.39 -14.66 60.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.952 . . . . 0.0 109.409 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.624 ' CE1' ' CD2' ' B' ' 42' ' ' PHE . 17.5 m-85 -85.53 -2.3 58.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.364 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.08 -101.9 0.21 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' B' ' 49' ' ' SER . 1.9 p-10 -178.24 111.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -1.115 . . . . 0.0 109.525 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 mp -81.3 28.18 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 108.687 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.454 ' H ' ' C ' ' B' ' 47' ' ' ASP . 12.2 t -43.97 -29.66 0.61 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.733 . . . . 0.0 110.25 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 13.8 p -140.22 146.93 48.09 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.014 -1.054 . . . . 0.0 109.728 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -40.13 -49.65 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.652 2.235 . . . . 0.0 112.293 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -69.47 -27.95 65.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 109.954 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.5 -19.43 37.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.067 -1.021 . . . . 0.0 109.545 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.05 -59.88 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 109.624 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 11.4 mtm -95.96 20.04 10.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.35 -17.23 50.85 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -86.54 149.99 50.18 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.181 -1.188 . . . . 0.0 109.443 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.13 -45.59 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.678 2.252 . . . . 0.0 112.341 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' B' ' 63' ' ' HIS . 50.1 mtpt -54.17 -51.91 62.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -52.67 -42.51 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.54 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -79.13 -25.98 42.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.595 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.55 -59.04 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.644 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' B' ' 59' ' ' LYS . 13.5 t-80 -49.28 -23.94 1.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 109.595 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.68 -28.51 73.08 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -65.97 -32.27 73.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -1.135 . . . . 0.0 109.187 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -70.32 -60.09 2.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 0.0 109.511 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 28.3 t -46.33 -29.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 109.42 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -77.75 -34.86 52.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.287 -0.883 . . . . 0.0 109.369 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.66 -46.66 93.25 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.8 -44.57 82.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -1.175 . . . . 0.0 109.6 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -60.35 -53.52 56.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.457 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.507 ' OG ' ' NE1' ' B' ' 15' ' ' TRP . 62.5 m -51.94 -27.42 13.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.437 ' CG ' ' HG1' ' B' ' 84' ' ' THR . 10.5 t0 -49.74 -34.44 19.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.24 -59.85 6.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.445 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.2 mp -59.09 -17.93 30.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.374 -1.074 . . . . 0.0 109.398 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -84.89 -16.61 40.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 31.0 m80 -160.11 64.23 0.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.915 . . . . 0.0 109.607 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.74 4.17 0.44 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.399 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' B' ' 77' ' ' HIS . 59.1 m-20 -75.54 -22.93 56.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -0.875 . . . . 0.0 109.404 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -157.31 103.44 1.98 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.88 . . . . 0.0 109.378 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' B' ' 81' ' ' LEU . 3.6 mm? -80.2 -58.78 2.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.416 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 1.275 ' NZ ' ' NZ ' ' D' ' 82' ' ' LYS . 83.5 mttt -55.25 -24.0 25.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.24 -60.23 7.84 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.0 t -69.43 -46.28 67.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 0.0 109.36 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.552 ' N ' ' CG2' ' B' ' 84' ' ' THR . 46.9 m-85 -70.34 16.81 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.547 -0.721 . . . . 0.0 109.613 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -73.75 -38.97 64.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 11.3 p -80.44 -46.18 16.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.524 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 42.8 mt -56.11 -54.84 40.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.242 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -50.15 -29.8 9.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.221 -0.924 . . . . 0.0 109.007 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.63 -63.01 1.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.116 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 tt -49.65 -23.44 1.72 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 109.078 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' B' ' 88' ' ' LEU . 7.8 m80 -76.17 -54.27 7.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 24.3 t -82.59 -19.42 38.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.003 . . . . 0.0 109.868 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.538 ' C ' ' HE2' ' B' ' 97' ' ' HIS . 1.4 m-20 -86.27 -25.02 25.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.088 -1.008 . . . . 0.0 111.026 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.511 ' CA ' ' HE2' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -125.8 -51.96 1.57 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.843 -1.161 . . . . 0.0 110.796 -179.24 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.519 ' CD1' ' N ' ' B' ' 96' ' ' LEU . 8.0 mp -70.1 -58.12 4.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.974 -1.079 . . . . 0.0 110.096 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.582 ' CD2' ' N ' ' B' ' 97' ' ' HIS . 1.0 OUTLIER 72.18 19.84 4.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.326 -0.859 . . . . 0.0 109.584 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -57.86 132.11 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.138 -0.976 . . . . 0.0 109.199 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' B' ' 100' ' ' PRO . 0.7 OUTLIER -64.64 152.54 89.6 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.362 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.51 ' C ' HD21 ' B' ' 102' ' ' ASN . 74.1 Cg_exo -45.65 -175.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.43 2.087 . . . . 0.0 112.408 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 55.35 76.89 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.51 HD21 ' C ' ' B' ' 100' ' ' PRO . 0.8 OUTLIER -173.52 -56.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . 0.431 ' H ' ' CG ' ' B' ' 102' ' ' ASN . 1.8 p90 -58.34 -19.65 36.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -80.15 -44.59 19.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -0.925 . . . . 0.0 109.533 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.3 -48.85 79.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 5.2 tt -56.43 -54.43 45.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.357 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.06 -31.74 62.05 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -66.78 -53.49 32.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -1.216 . . . . 0.0 109.684 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.54 -47.53 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.475 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 tp -49.01 -26.75 2.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.86 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.0 t -70.78 -38.83 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.092 -1.005 . . . . 0.0 109.937 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 t -76.79 -22.93 52.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.001 . . . . 0.0 109.932 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 97.1 t -68.74 -24.32 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.891 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' B' ' 116' ' ' HIS . 48.7 mt -82.58 -54.33 5.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.103 -0.998 . . . . 0.0 109.678 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.476 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.64 -19.88 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.63 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.49 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.82 -62.87 1.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -0.963 . . . . 0.0 109.427 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -62.34 -17.81 59.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.438 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -151.41 61.5 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.495 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -70.8 -19.53 76.86 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.54 -30.82 70.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -1.161 . . . . 0.0 109.372 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' B' ' 123' ' ' THR . 30.9 mt-10 -90.48 14.3 13.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.465 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.524 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.4 OUTLIER -70.78 35.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.0 109.596 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.546 ' H ' ' C ' ' B' ' 121' ' ' GLU . 30.4 p -59.79 144.59 85.44 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.161 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.744 ' HA ' HH22 ' A' ' 31' ' ' ARG . 31.7 Cg_exo -44.82 -43.44 14.98 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.464 2.109 . . . . 0.0 113.408 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' B' ' 124' ' ' PRO . 3.0 Cg_exo -75.17 20.19 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.447 2.098 . . . . 0.0 112.175 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 79.6 t -125.06 -29.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . 0.973 ' HB2' HH21 ' A' ' 31' ' ' ARG . 86.6 mm-40 -83.15 -59.7 2.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.99 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 1.052 ' HB3' ' HB3' ' A' ' 34' ' ' LEU . . . -56.64 -42.66 79.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.06 11.07 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.536 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.505 ' H ' ' C ' ' B' ' 128' ' ' ALA . 4.9 t80 -105.2 -61.31 1.5 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.317 -0.864 . . . . 0.0 109.567 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . 0.529 ' CD ' ' H ' ' B' ' 131' ' ' GLN . 3.8 mp0 -50.02 -38.39 37.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -0.949 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 1.112 ' HD3' ' O ' ' D' ' 146' ' ' HIS . 18.7 ttpp -64.68 -28.58 69.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.771 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 79.4 t -71.45 -67.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.733 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.4 m -61.3 -24.66 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.74 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.25 -29.32 5.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.6 -29.1 56.1 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.93 -34.28 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -1.133 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.71 -48.18 63.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.469 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.457 ' C ' HD21 ' B' ' 139' ' ' ASN . 0.2 OUTLIER -77.76 -29.62 51.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.495 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.25 82.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.409 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.24 13.21 1.96 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.47 4.53 1.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' B' ' 139' ' ' ASN . 12.3 t-80 -79.39 -26.29 42.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.203 -0.935 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.547 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.8 OUTLIER -81.95 -1.38 47.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.521 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -66.07 7.64 0.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 109.27 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 1.504 ' CD2' ' HE2' ' D' ' 2' ' ' HIS . 4.7 m-70 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.461 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 9.5 tp -172.41 163.46 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 109.777 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.8 OUTLIER -75.79 -177.06 0.65 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.016 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 58.4 Cg_endo -86.84 -68.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.606 2.204 . . . . 0.0 112.711 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -47.62 -40.31 19.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 109.542 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.464 ' OD2' ' OG ' ' C' ' 3' ' ' SER . 63.9 m-20 -43.6 -29.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 0.0 109.039 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' C' ' 10' ' ' VAL . 58.4 mttt -83.05 -53.78 5.55 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.414 ' C ' ' O ' ' C' ' 7' ' ' LYS . 35.4 m -44.7 -38.52 4.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.488 -0.757 . . . . 0.0 109.227 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -72.38 -29.7 64.01 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' C' ' 7' ' ' LYS . 54.2 t -75.13 -55.07 12.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' C' ' 11' ' ' LYS . 0.1 OUTLIER -51.53 -39.25 57.34 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.649 -1.221 . . . . 0.0 108.229 179.109 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.05 -63.18 1.35 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 109.321 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.64 67.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.388 -0.82 . . . . 0.0 108.836 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.91 -17.64 63.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.469 -0.769 . . . . 0.0 108.988 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.04 -45.09 16.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . 0.43 ' H ' ' HG2' ' C' ' 16' ' ' LYS . 39.2 mmtt -68.15 -41.48 81.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 108.862 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -60.16 -64.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.581 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 49.93 -127.9 24.86 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.39 24.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.388 -1.066 . . . . 0.0 110.426 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' C' ' 18' ' ' GLY . 87.4 m-70 -130.45 28.41 4.94 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -93.2 -61.24 1.61 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.642 -0.661 . . . . 0.0 109.849 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.41 -14.27 0.18 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.6 mt-10 -86.56 -56.27 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -1.056 . . . . 0.0 109.764 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 4.1 m-30 -59.78 -32.44 70.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 0.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.9 -23.02 75.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.89 -41.8 18.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -1.213 . . . . 0.0 109.974 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' C' ' 27' ' ' GLU . 0.1 OUTLIER -66.03 -19.84 65.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.261 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.77 -20.35 60.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.48 -51.23 15.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 109.672 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.59 -22.35 65.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.947 HH21 ' HB2' ' D' ' 127' ' ' GLN . 2.3 tpt180 -73.38 -20.87 60.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.619 ' HE2' ' CBC' ' C' ' 142' ' ' HEC . 46.0 ttp -78.19 -53.76 6.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.333 -0.854 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 0.0 OUTLIER -48.3 -24.25 1.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.397 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 1.025 ' HB3' ' HB3' ' D' ' 128' ' ' ALA . 10.6 mt -82.27 -46.11 14.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.656 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 45.8 m -69.27 -20.72 63.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.854 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' C' ' 35' ' ' SER . 95.5 m-85 -158.42 79.11 3.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.033 -1.042 . . . . 0.0 109.758 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' C' ' 39' ' ' THR . 51.8 Cg_exo -50.19 -26.43 15.22 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.612 2.208 . . . . 0.0 112.049 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' C' ' 41' ' ' THR . 12.6 p -49.44 -18.33 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.405 ' N ' ' C ' ' C' ' 37' ' ' PRO . 53.9 p -78.91 -22.32 46.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.722 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -46.11 -42.84 14.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.913 . . . . 0.0 109.776 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.493 ' C ' ' H ' ' C' ' 43' ' ' PHE . 0.0 OUTLIER -62.47 -35.74 80.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.459 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -76.74 22.31 0.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.145 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.493 ' H ' ' C ' ' C' ' 41' ' ' THR . 39.3 m-85 -145.95 59.73 5.84 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.54 -0.7 7.95 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.648 2.232 . . . . 0.0 111.914 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 15.9 p80 -141.82 56.93 1.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.787 . . . . 0.0 109.138 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.667 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -149.76 69.28 1.02 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' C' ' 46' ' ' PHE . 1.1 m-20 -24.35 -37.74 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.925 -0.484 . . . . 0.0 111.183 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.667 ' N ' ' O ' ' C' ' 46' ' ' PHE . 4.3 mt 53.7 7.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.06 -1.025 . . . . 0.0 109.344 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.509 ' H ' ' C ' ' C' ' 47' ' ' ASP . 5.0 m -64.32 5.69 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.601 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.531 ' H ' ' C ' ' C' ' 48' ' ' LEU . 38.1 t60 61.42 125.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.311 -0.868 . . . . 0.0 109.501 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.46 14.24 66.32 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 13.5 t -77.81 -103.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -1.159 . . . . 0.0 109.48 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.96 -29.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.439 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -80.04 -17.97 51.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.265 -0.897 . . . . 0.0 109.157 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -84.35 -40.25 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -77.37 -32.37 54.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -0.924 . . . . 0.0 109.082 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.14 -21.8 75.13 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.463 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 7.8 t-80 -75.7 -37.46 59.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -1.103 . . . . 0.0 109.721 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.22 -48.49 47.05 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -51.7 -23.15 4.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -1.079 . . . . 0.0 110.063 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -39.83 64.68 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.109 -0.994 . . . . 0.0 109.218 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.29 -33.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.11 -32.95 44.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.378 -0.826 . . . . 0.0 109.462 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -70.33 -33.41 71.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.077 -1.014 . . . . 0.0 108.841 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.03 -53.14 18.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.412 -0.805 . . . . 0.0 108.843 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.29 -38.23 70.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 108.642 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -71.54 -50.28 32.78 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.83 -21.02 60.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.21 -47.37 13.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.84 -23.02 31.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.52 -15.21 63.46 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.62 ' O ' ' N ' ' C' ' 74' ' ' ASP . 36.8 m80 -139.42 -63.17 0.52 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.379 -0.825 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' C' ' 69' ' ' ALA . 12.3 p 43.97 13.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.813 0.816 . . . . 0.0 109.634 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.62 ' N ' ' O ' ' C' ' 72' ' ' HIS . 16.2 m-20 -134.25 10.39 3.81 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.431 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 20.2 t0 -176.95 28.29 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.037 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 11.4 ptt? -78.87 -22.44 0.38 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 111.745 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 72.7 Cg_exo -49.02 -29.03 14.75 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.569 1.513 . . . . 0.0 112.4 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -94.3 -24.29 17.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.709 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.36 -53.49 8.1 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.179 -0.951 . . . . 0.0 109.191 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 15.0 mt -78.05 9.13 3.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.43 -0.794 . . . . 0.0 109.022 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' C' ' 84' ' ' SER . 11.1 t -66.1 -41.59 90.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -52.3 -53.01 49.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.486 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' C' ' 82' ' ' ALA . 4.9 mt -44.83 -45.0 9.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' C' ' 88' ' ' ALA . 10.0 p -55.85 -39.77 71.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' C' ' 82' ' ' ALA . 25.8 t70 -67.64 -17.9 64.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.425 ' CD1' HBD1 ' C' ' 142' ' ' HEC . 1.2 tt -82.81 -43.45 16.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.35 -0.844 . . . . 0.0 109.469 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -92.42 -21.23 20.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 109.979 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' C' ' 84' ' ' SER . . . -60.73 -87.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 110.729 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . 0.459 ' O ' ' O ' ' C' ' 90' ' ' LYS . 45.1 t-80 -96.61 -46.21 6.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 111.043 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' C' ' 89' ' ' HIS . 35.9 mttm -41.33 -94.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.145 -0.972 . . . . 0.0 110.346 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.55 -34.95 78.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.017 . . . . 0.0 109.65 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . 1.372 ' NH2' ' HE ' ' B' ' 40' ' ' ARG . 45.6 ttp85 60.87 58.19 2.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 109.602 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 t -84.29 161.56 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 109.451 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.38 151.37 50.85 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.957 . . . . 0.0 109.342 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' C' ' 97' ' ' ASN . 58.6 Cg_endo -72.99 -18.86 23.8 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.524 2.149 . . . . 0.0 112.234 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . 0.441 HG23 ' CB ' ' B' ' 99' ' ' ASP . 24.5 t -47.21 -19.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.733 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.646 HD21 ' N ' ' C' ' 97' ' ' ASN . 0.8 OUTLIER -79.12 -24.86 43.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.732 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . 0.411 ' N ' ' O ' ' C' ' 95' ' ' PRO . 4.8 m-85 -46.63 -32.53 3.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 109.686 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.504 ' O ' ' ND1' ' C' ' 103' ' ' HIS . 55.7 mttm -83.94 -36.78 23.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 109.781 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' C' ' 100' ' ' LEU . 7.2 mp -66.35 -62.02 1.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.491 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 1.325 HD22 ' CBB' ' C' ' 142' ' ' HEC . 6.4 tt -49.94 -47.39 52.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 42.7 t -61.95 -38.76 89.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.634 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' C' ' 99' ' ' LYS . 22.9 m80 -77.4 -27.59 52.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.621 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 70.8 m -64.8 -46.99 79.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.728 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.24 -48.6 65.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.454 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' C' ' 106' ' ' LEU . 9.5 mp -61.51 -59.22 5.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.94 -34.25 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 16.8 m -75.77 -60.87 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 13.0 mt -46.11 -41.44 12.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 0.0 109.676 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.83 -28.74 0.68 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.153 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.83 -56.35 4.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.132 -0.98 . . . . 0.0 109.722 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -85.83 -65.08 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.472 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 109' ' ' LEU . 0.1 OUTLIER -95.94 106.86 30.72 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.21 171.23 9.38 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.73 1.62 . . . . 0.0 112.352 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -87.28 -34.34 18.94 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.441 0.639 . . . . 0.0 109.87 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' C' ' 117' ' ' PHE . 23.2 mt-10 55.66 9.87 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' C' ' 115' ' ' ALA . 29.2 p90 40.63 32.42 0.15 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.522 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.523 ' C ' ' H ' ' C' ' 120' ' ' ALA . 5.0 p -60.96 145.66 88.75 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.47 29.51 0.13 Allowed 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.957 1.771 . . . . 0.0 111.734 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' C' ' 118' ' ' THR . . . -162.62 -23.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.174 -0.954 . . . . 0.0 111.072 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.453 ' O ' ' OG ' ' C' ' 124' ' ' SER . 2.6 t -59.94 -62.55 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.829 -1.17 . . . . 0.0 109.818 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -27.2 67.78 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.426 -0.797 . . . . 0.0 109.087 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.04 32.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.645 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.476 ' N ' ' O ' ' C' ' 120' ' ' ALA . 95.7 p -67.25 -61.94 1.67 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 110.828 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 9.7 mt -80.15 -19.97 45.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.065 -1.022 . . . . 0.0 110.844 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.73 -42.49 28.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.759 -1.213 . . . . 0.0 110.332 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.469 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -90.15 -44.88 9.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.999 -1.063 . . . . 0.0 110.17 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.403 ' CB ' ' O ' ' C' ' 124' ' ' SER . 71.2 t80 -47.3 -21.53 0.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.029 -1.044 . . . . 0.0 109.564 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.8 mt -69.66 -17.67 63.52 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.97 -38.25 78.66 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 60.5 p -78.66 -25.89 44.98 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.31 -0.869 . . . . 0.0 108.756 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -85.05 -40.48 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.409 ' N ' ' O ' ' C' ' 129' ' ' LEU . 2.7 t -68.85 -28.85 67.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.453 -0.779 . . . . 0.0 109.239 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 51.5 m -64.63 -39.99 94.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 109.015 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 p -82.62 -21.9 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 tp -78.83 -28.36 44.36 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 137' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' C' ' 138' ' ' SER . 49.8 m -68.15 -23.34 64.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 109.392 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 138' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' C' ' 137' ' ' THR . 0.7 OUTLIER 73.25 110.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -62.87 -98.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' C' ' 141' ' ' ARG . 64.5 m-85 47.3 76.29 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.613 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' C' ' 140' ' ' TYR . 74.2 mtt-85 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.664 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.502 ' CG1' ' N ' ' D' ' 2' ' ' HIS . 2.9 p . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 1.504 ' HE2' ' CD2' ' B' ' 146' ' ' HIS . 6.2 p80 -172.91 112.53 0.23 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.895 -1.128 . . . . 0.0 109.756 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.631 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -141.96 -162.64 1.43 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.276 -0.89 . . . . 0.0 109.183 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.491 ' H ' ' HG1' ' D' ' 4' ' ' THR . 7.6 p -93.74 131.04 33.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 109.263 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.45 -23.68 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.329 2.019 . . . . 0.0 112.402 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -81.57 -53.02 6.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.816 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' D' ' 7' ' ' GLU . 5.5 mp0 -61.34 -55.52 30.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.502 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -57.17 -35.42 69.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.806 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -58.71 -23.73 60.15 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 109.992 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.54 -56.61 3.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.978 -1.076 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -25.13 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 73.6 m -78.66 -35.24 45.55 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -60.5 -61.41 2.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.252 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -43.73 -18.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 109.759 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' D' ' 13' ' ' ALA . 22.1 t-105 -78.03 -18.04 56.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.148 -0.97 . . . . 0.0 109.646 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.97 -42.72 7.49 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.589 ' H ' ' CD ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -68.66 -31.97 71.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -1.12 . . . . 0.0 109.2 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 4.7 t -52.4 119.89 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.655 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' D' ' 21' ' ' ASP . 55.8 m-20 -86.99 82.85 7.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 108.98 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . 0.521 ' C ' ' H ' ' D' ' 22' ' ' GLU . 91.6 t -43.99 -20.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 109.789 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' D' ' 19' ' ' ASN . 12.7 m-20 -51.62 -8.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.802 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' D' ' 20' ' ' VAL . 34.8 mt-10 -155.48 -49.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 109.629 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 74.1 t -46.11 -26.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.788 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.05 -31.18 32.53 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -82.56 -25.65 49.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -84.67 -29.99 25.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -1.144 . . . . 0.0 109.682 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.47 -23.49 63.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.812 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.68 -58.25 3.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.477 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.21 -29.27 68.25 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -68.43 -29.43 68.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.681 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . 0.723 ' CD2' HMC3 ' B' ' 147' ' ' HEC . 35.7 tp -51.61 -39.75 58.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.635 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . 1.304 ' O ' HMB3 ' D' ' 147' ' ' HEC . 16.8 mt -78.04 -21.88 50.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.878 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.85 -47.93 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.869 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -63.35 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 0.0 109.788 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -119.42 97.01 50.16 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 0.0 109.814 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' D' ' 38' ' ' THR . 90.9 Cg_endo -85.57 10.56 3.65 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.659 2.239 . . . . 0.0 111.906 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -45.24 -19.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 0.0 109.732 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.684 ' C ' ' H ' ' D' ' 40' ' ' ARG . 10.9 p -46.95 -34.37 5.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 109.637 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 61.09 -13.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.38 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . 1.394 ' HE ' ' NH2' ' A' ' 92' ' ' ARG . 79.9 mtt180 -89.01 -25.55 21.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 108.971 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.602 ' HE1' ' NB ' ' D' ' 147' ' ' HEC . 3.4 m-85 53.68 6.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 109.429 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 0.848 ' HZ ' ' HHD' ' B' ' 147' ' ' HEC . 3.0 m-85 48.03 30.14 1.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.174 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -48.34 -20.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 109.72 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 33.1 p -74.46 -14.66 60.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.973 . . . . 0.0 109.392 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . 0.613 ' CE1' ' CD2' ' D' ' 42' ' ' PHE . 17.4 m-85 -85.42 -2.38 58.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.08 -101.88 0.21 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' D' ' 49' ' ' SER . 1.9 p-10 -178.2 111.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.509 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 mp -81.27 28.1 0.39 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 108.753 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.455 ' H ' ' C ' ' D' ' 47' ' ' ASP . 12.0 t -43.86 -29.72 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.638 -0.664 . . . . 0.0 110.3 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 14.0 p -140.16 146.9 48.14 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.089 -1.007 . . . . 0.0 109.693 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -40.14 -49.61 3.71 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.676 2.251 . . . . 0.0 112.255 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -69.5 -27.98 65.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.91 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.48 -19.4 36.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.605 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.06 -59.97 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.584 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 11.4 mtm -95.87 20.14 10.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 109.458 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.44 -17.24 50.48 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -86.59 150.0 50.08 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.229 -1.159 . . . . 0.0 109.395 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.18 -45.58 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.579 2.186 . . . . 0.0 112.236 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' D' ' 63' ' ' HIS . 50.1 mtpt -54.12 -51.96 62.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 59.9 t -52.64 -42.55 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -79.0 -26.13 43.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.569 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.45 -59.07 2.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.657 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 0.919 ' HE2' HAD2 ' B' ' 147' ' ' HEC . 13.5 t-80 -49.37 -23.88 1.66 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.558 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.74 -28.51 73.06 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -65.92 -32.3 73.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -1.172 . . . . 0.0 109.21 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . 0.637 ' HB3' HBA2 ' B' ' 147' ' ' HEC . 45.9 mmtt -70.29 -60.11 2.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.825 HG12 ' C2B' ' B' ' 147' ' ' HEC . 27.6 t -46.41 -29.68 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.375 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -77.71 -34.88 52.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.372 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.68 -46.69 93.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.57 81.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.59 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -60.43 -53.51 56.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -0.887 . . . . 0.0 109.375 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' SER . . . . . 0.501 ' OG ' ' NE1' ' D' ' 15' ' ' TRP . 63.2 m -51.96 -27.41 13.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.455 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' D' ' 84' ' ' THR . 10.6 t0 -49.71 -34.49 18.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.95 . . . . 0.0 109.391 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.26 -59.91 6.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.453 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.2 mp -59.03 -17.97 30.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -1.151 . . . . 0.0 109.427 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . 0.53 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -84.9 -16.61 40.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 31.1 m80 -160.1 64.16 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.74 4.19 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.414 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' D' ' 77' ' ' HIS . 59.5 m-20 -75.41 -22.98 56.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.92 . . . . 0.0 109.421 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -157.3 103.47 1.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.354 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' D' ' 81' ' ' LEU . 3.6 mm? -80.23 -58.79 2.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.945 . . . . 0.0 109.427 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . 1.275 ' NZ ' ' NZ ' ' B' ' 82' ' ' LYS . 83.5 mttt -55.3 -23.9 25.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.577 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.23 -60.26 7.8 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.0 t -69.44 -46.23 67.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.151 -1.205 . . . . 0.0 109.378 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.555 ' N ' ' CG2' ' D' ' 84' ' ' THR . 46.8 m-85 -70.35 16.85 0.07 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.523 -0.736 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -73.85 -38.8 64.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.453 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 11.0 p -80.62 -46.14 16.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.414 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.515 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 42.3 mt -56.07 -54.86 39.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 109.287 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -50.19 -29.73 9.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.944 . . . . 0.0 109.037 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' D' ' 94' ' ' ASP . 42.4 tt0 -82.6 -63.03 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.128 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 tt -49.73 -23.42 1.78 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 109.046 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' D' ' 88' ' ' LEU . 7.9 m80 -76.13 -54.33 6.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.181 -0.949 . . . . 0.0 109.486 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 24.1 t -82.57 -19.42 38.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.161 -0.962 . . . . 0.0 109.916 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.544 ' C ' ' HE2' ' D' ' 97' ' ' HIS . 1.4 m-20 -86.23 -24.96 25.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.082 -1.011 . . . . 0.0 111.086 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . 0.514 ' CA ' ' HE2' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -125.83 -52.04 1.57 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.829 -1.169 . . . . 0.0 110.725 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' D' ' 96' ' ' LEU . 8.0 mp -70.16 -58.1 4.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.894 -1.129 . . . . 0.0 110.053 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.562 ' N ' ' CD2' ' D' ' 97' ' ' HIS . 1.0 OUTLIER 72.12 19.88 4.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.583 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.69 132.07 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.101 -0.999 . . . . 0.0 109.221 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . 0.498 ' CB ' HG23 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -64.6 152.6 89.31 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 109.309 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . 0.512 ' C ' HD21 ' D' ' 102' ' ' ASN . 74.3 Cg_exo -45.72 -175.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.504 2.136 . . . . 0.0 112.402 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 55.4 76.82 0.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.512 HD21 ' C ' ' D' ' 100' ' ' PRO . 0.8 OUTLIER -173.56 -56.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.859 . . . . 0.0 109.372 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . 0.518 ' O ' HBB2 ' B' ' 147' ' ' HEC . 1.9 p90 -58.42 -19.55 37.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.0 109.515 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -80.23 -44.45 19.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.39 -48.88 79.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.382 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 1.352 ' CD1' ' CHC' ' B' ' 147' ' ' HEC . 5.2 tt -56.41 -54.5 44.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.298 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.04 -31.7 61.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -66.82 -53.47 32.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -1.194 . . . . 0.0 109.686 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 79.3 t -49.44 -47.5 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tp -49.13 -26.66 2.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 109.823 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.77 -38.82 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.09 -1.006 . . . . 0.0 109.998 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 22.8 t -76.77 -22.99 52.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.898 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.7 -24.34 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.948 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' D' ' 116' ' ' HIS . 48.6 mt -82.58 -54.4 5.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.14 -0.975 . . . . 0.0 109.668 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.487 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.62 -19.94 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 109.647 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.465 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.71 -62.89 1.44 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.429 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -62.36 -17.78 59.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.865 . . . . 0.0 109.436 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -151.38 61.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -70.82 -19.49 76.86 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.58 -30.74 70.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -1.165 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' D' ' 123' ' ' THR . 30.9 mt-10 -90.57 14.36 13.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.4 OUTLIER -70.77 35.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.523 ' H ' ' C ' ' D' ' 121' ' ' GLU . 30.4 p -59.75 144.64 85.16 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.158 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.724 ' HA ' HH22 ' C' ' 31' ' ' ARG . 31.5 Cg_exo -44.85 -43.39 15.09 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.439 2.093 . . . . 0.0 113.517 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' D' ' 124' ' ' PRO . 3.1 Cg_exo -75.16 20.12 0.48 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.437 2.091 . . . . 0.0 112.174 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 79.5 t -125.02 -29.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.341 -0.85 . . . . 0.0 109.602 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . 0.947 ' HB2' HH21 ' C' ' 31' ' ' ARG . 86.5 mm-40 -83.17 -59.78 2.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.446 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 1.025 ' HB3' ' HB3' ' C' ' 34' ' ' LEU . . . -56.68 -42.57 79.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.964 . . . . 0.0 109.363 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.05 11.05 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . 0.5 ' H ' ' C ' ' D' ' 128' ' ' ALA . 4.9 t80 -105.22 -61.3 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . 0.524 ' CD ' ' H ' ' D' ' 131' ' ' GLN . 3.8 mp0 -50.05 -38.45 37.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 109.388 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . 1.079 ' HD3' ' O ' ' B' ' 146' ' ' HIS . 18.7 ttpp -64.54 -28.61 69.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.77 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 79.3 t -71.49 -67.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.708 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 2.4 m -61.23 -24.58 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.807 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.34 -29.29 5.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 0.0 109.287 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.63 -29.08 56.08 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 66.1 t -72.9 -34.15 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -1.116 . . . . 0.0 109.514 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.81 -48.13 64.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.506 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.458 ' C ' HD21 ' D' ' 139' ' ' ASN . 0.2 OUTLIER -77.75 -29.55 51.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.589 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.14 83.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.411 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 30.9 mt -79.24 13.14 1.99 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.362 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.47 4.56 1.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.631 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' D' ' 139' ' ' ASN . 12.3 t-80 -79.34 -26.26 42.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.167 -0.958 . . . . 0.0 109.459 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.549 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.8 OUTLIER -82.04 -1.4 48.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.479 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -65.91 7.6 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 1.538 ' CD2' ' HE2' ' B' ' 2' ' ' HIS . 4.7 m-70 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.472 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 1.315 ' CBB' HD22 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 1.352 ' CHC' ' CD1' ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 1.325 ' CBB' HD22 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.304 HMB3 ' O ' ' D' ' 32' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.485 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 36.4 mt -121.29 -171.74 2.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.829 . . . . 0.0 109.561 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -97.75 -179.08 0.81 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 109.296 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 26.0 Cg_exo -60.87 -68.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.605 2.203 . . . . 0.0 112.291 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.452 ' O ' ' ND2' ' A' ' 9' ' ' ASN . . . -52.39 -36.12 53.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.797 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.63 ' CB ' ' HZ3' ' A' ' 127' ' ' LYS . 3.3 m-20 -44.18 -33.7 1.62 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -83.41 -60.12 2.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.621 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.8 m -46.97 -29.74 2.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.419 -0.8 . . . . 0.0 109.979 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 5' ' ' ALA . 22.9 m-20 -77.33 -36.83 53.51 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.024 -1.048 . . . . 0.0 108.279 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -76.14 -47.97 29.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -53.17 -38.54 62.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.52 -62.99 1.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.411 -0.806 . . . . 0.0 109.357 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.27 67.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.421 -0.799 . . . . 0.0 109.204 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -17.31 61.52 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 108.967 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.59 -40.07 59.76 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -84.75 -49.79 8.16 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.503 -0.998 . . . . 0.0 109.327 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 20' ' ' HIS . 70.4 t -59.96 -35.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.56 -0.712 . . . . 0.0 109.675 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.629 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . -31.53 144.8 0.02 OUTLIER Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 69.12 -32.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -1.07 . . . . 0.0 108.896 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.629 ' H ' ' C ' ' A' ' 18' ' ' GLY . 1.2 m80 -104.88 13.94 30.34 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.55 -48.69 9.99 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.939 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.46 -14.62 42.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -89.1 -56.62 3.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -1.095 . . . . 0.0 109.702 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.639 ' CZ ' ' CE1' ' A' ' 112' ' ' HIS . 2.9 m-30 -58.98 -33.14 70.34 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 109.176 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.82 -33.06 76.49 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.04 -50.8 10.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -1.174 . . . . 0.0 109.721 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -52.4 -19.8 2.4 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.55 -25.54 65.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 33.5 mt -72.27 -58.02 3.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.671 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.71 -14.29 30.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.524 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 1.052 ' NH1' ' CG ' ' B' ' 127' ' ' GLN . 1.8 tpm_? -75.45 -38.98 59.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 109.357 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.512 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -80.02 -48.5 13.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.218 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 32' ' ' MET . 37.1 t80 -43.72 -19.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.396 -0.815 . . . . 0.0 109.831 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.821 ' HB3' ' HB1' ' B' ' 128' ' ' ALA . 11.0 mt -79.88 -60.2 2.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.136 -0.978 . . . . 0.0 109.701 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.704 ' OG ' ' OE1' ' B' ' 131' ' ' GLN . 29.6 m -81.39 -31.37 33.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 109.676 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -113.63 95.04 35.22 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.411 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.12 -20.1 8.9 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.447 2.098 . . . . 0.0 112.228 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 40' ' ' LYS . 71.1 p -47.64 -42.1 23.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 109.274 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 38' ' ' THR . 12.6 p -44.03 -22.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.83 . . . . 0.0 109.854 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' THR . 30.6 ttpt -70.87 -19.11 62.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.638 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 1.109 HG23 ' CD2' ' D' ' 97' ' ' HIS . 8.7 t -80.37 -20.63 43.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.542 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -85.0 -14.78 46.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 53.4 83.1 0.23 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.674 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 46.0 Cg_exo -52.0 -41.23 65.16 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.582 2.188 . . . . 0.0 111.874 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.674 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 96.15 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 178.189 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.514 ' C ' ' H ' ' A' ' 48' ' ' LEU . 2.1 p90 -142.54 44.91 1.62 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.532 -1.355 . . . . 0.0 110.11 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.12 -35.32 0.3 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 110.453 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER 61.86 55.85 2.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.043 . . . . 0.0 109.0 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 48.1 m -165.39 157.06 14.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 0.0 109.541 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.491 ' C ' ' H ' ' A' ' 52' ' ' SER . 2.7 m-70 -59.6 160.94 6.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.877 . . . . 0.0 109.385 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.73 -18.14 1.92 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.555 ' C ' ' H ' ' A' ' 54' ' ' GLN . 29.5 p -48.78 -25.94 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -1.145 . . . . 0.0 109.322 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 67.05 -40.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.835 . . . . 0.0 109.688 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.555 ' H ' ' C ' ' A' ' 52' ' ' SER . 20.5 mt-30 -69.76 -23.73 63.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.304 -0.873 . . . . 0.0 109.304 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -69.61 -40.57 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.97 . . . . 0.0 109.129 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -65.73 -54.38 28.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.241 -0.912 . . . . 0.0 108.62 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.19 -36.09 21.1 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.493 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.1 t-80 -60.5 -36.57 78.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.315 . . . . 0.0 109.895 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.42 -29.28 38.27 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 56.8 mttm -65.18 -23.57 67.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -1.162 . . . . 0.0 110.263 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 0.5 OUTLIER -69.16 -58.13 4.47 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.962 -1.086 . . . . 0.0 108.656 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.3 t -56.46 -44.76 81.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.655 -0.653 . . . . 0.0 109.315 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.51 74.46 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.298 -0.876 . . . . 0.0 109.225 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.9 t70 -66.03 -37.98 87.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.775 ' HB3' HMA2 ' A' ' 142' ' ' HEC . . . -67.56 -53.33 29.22 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 70' ' ' VAL . 1.1 mt -58.53 -42.34 87.54 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 71' ' ' ALA . 15.5 m -69.68 -51.58 33.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.273 -0.892 . . . . 0.0 108.696 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -62.23 -25.97 68.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.08 -46.38 11.21 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 66' ' ' LEU . 38.1 t -66.7 -22.75 30.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -69.51 -36.37 76.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.589 ' O ' ' N ' ' A' ' 74' ' ' ASP . 26.1 m80 -103.29 -66.74 0.92 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.615 -0.678 . . . . 0.0 109.424 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.478 ' CG1' ' O ' ' A' ' 72' ' ' HIS . 14.9 p 44.37 14.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.953 0.882 . . . . 0.0 109.287 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 72' ' ' HIS . 5.5 m-20 -137.96 12.02 2.87 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.72 31.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 3.5 ptt? -78.29 -23.67 0.42 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.334 -0.854 . . . . 0.0 111.842 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.8 Cg_exo -53.58 -19.46 13.94 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.665 1.576 . . . . 0.0 112.477 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -94.19 -40.43 10.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.68 -48.9 67.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.918 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.61 6.04 6.53 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.446 -0.784 . . . . 0.0 109.198 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.1 t -54.53 -19.56 6.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 109.614 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -83.12 -58.53 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 109.916 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.46 ' CD2' HBA1 ' A' ' 142' ' ' HEC . 3.8 mt -45.34 -44.58 11.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -0.847 . . . . 0.0 109.082 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.515 ' HG ' ' C ' ' A' ' 136' ' ' LEU . 23.3 t -60.06 -18.93 50.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.519 -0.738 . . . . 0.0 109.56 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 89' ' ' HIS . 36.8 t70 -81.06 -50.94 9.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.913 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.442 ' CD1' HBD2 ' A' ' 142' ' ' HEC . 4.6 tt -64.16 -26.79 68.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.97 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.74 -21.78 26.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 110.328 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.56 -11.03 11.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 0.0 110.154 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.564 ' N ' ' O ' ' A' ' 85' ' ' ASP . 42.7 t60 -106.64 -74.6 0.65 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 109.919 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' ARG . 79.8 mttt -63.84 -110.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.058 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 mt -44.48 -17.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.017 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.568 ' CG ' HH21 ' D' ' 40' ' ' ARG . 31.8 ttm-85 46.75 41.56 10.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.142 -0.974 . . . . 0.0 109.481 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.9 t -45.94 144.8 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.867 . . . . 0.0 109.701 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 10.6 m-20 -80.52 150.2 69.77 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.65 -19.48 21.34 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.437 2.091 . . . . 0.0 112.229 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.35 -7.75 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.666 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 94' ' ' ASP . 12.7 m120 -79.74 -36.26 37.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.478 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -46.33 -41.58 13.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.879 -1.138 . . . . 0.0 109.536 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.49 ' NZ ' ' CB ' ' A' ' 99' ' ' LYS . 8.0 mtmp? -51.38 -28.24 12.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.963 . . . . 0.0 109.291 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.467 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 15.4 mt -84.29 -61.95 1.68 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.682 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.712 HD23 ' CHC' ' A' ' 142' ' ' HEC . 5.4 tp -49.78 -23.62 1.93 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.878 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -73.38 -49.45 27.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -80.62 -26.37 37.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 0.0 109.923 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 65.7 m -65.06 -60.29 3.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.158 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -57.45 -22.44 43.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 109.825 -179.401 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.18 -31.42 38.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.802 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.1 t -83.38 -24.94 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 110.051 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 1.5 t -79.68 -47.72 14.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.0 109.959 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.541 ' O ' ' NE2' ' A' ' 112' ' ' HIS . 0.8 OUTLIER -69.72 -18.59 63.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.752 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.92 -22.22 46.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 110.257 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.4 -56.24 24.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 110.182 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.707 ' CG ' ' H ' ' A' ' 113' ' ' LEU . 9.4 p80 -72.48 -61.93 1.63 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.098 -1.001 . . . . 0.0 109.469 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.707 ' H ' ' CG ' ' A' ' 112' ' ' HIS . 0.0 OUTLIER -119.73 121.43 29.84 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.3 175.7 7.38 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.422 2.081 . . . . 0.0 112.99 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.654 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -45.36 -54.96 6.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.632 -0.668 . . . . 0.0 109.346 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.654 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 26.1 mt-10 122.9 -2.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.468 ' CG ' ' C ' ' A' ' 116' ' ' GLU . 1.8 m-85 72.22 32.88 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.714 -0.616 . . . . 0.0 111.278 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.772 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.3 p -97.59 121.27 58.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.895 -1.128 . . . . 0.0 108.16 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.62 24.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.934 1.756 . . . . 0.0 112.502 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -150.38 -32.41 0.18 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.981 -1.074 . . . . 0.0 110.401 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.635 ' H ' ' HG1' ' A' ' 118' ' ' THR . 12.0 p -53.92 -50.04 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.04 -1.037 . . . . 0.0 110.329 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 23.2 m-70 -54.84 -44.98 74.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.36 -20.05 32.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 110.375 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 120' ' ' ALA . 94.0 p -52.19 -52.97 48.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.945 . . . . 0.0 110.545 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.5 mt -84.11 -19.34 34.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.0 109.975 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.71 -51.83 9.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.296 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.63 ' HZ3' ' CB ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -78.63 -43.06 27.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.978 -1.076 . . . . 0.0 110.151 -179.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.485 ' CD2' ' CD1' ' A' ' 2' ' ' LEU . 33.9 t80 -50.59 -21.39 1.52 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.858 -1.151 . . . . 0.0 108.929 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 133' ' ' SER . 17.4 mt -73.78 -18.26 60.99 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -60.14 -35.48 75.37 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 97.5 p -80.78 -27.02 36.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -84.73 -30.13 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 129' ' ' LEU . 51.6 m -79.17 -40.83 29.89 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 53.2 m -69.3 -26.4 64.71 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.4 t -81.49 -30.28 10.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.515 ' C ' ' HG ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -71.09 -23.34 62.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.365 -0.834 . . . . 0.0 109.052 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 138' ' ' SER . 37.8 p -87.29 -18.39 30.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 0.0 109.568 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' THR . 21.6 m 51.65 98.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.449 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -62.03 -160.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.947 . . . . 0.0 109.58 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -76.8 -44.91 30.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.452 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.626 ' CG1' ' H ' ' B' ' 2' ' ' HIS . 13.1 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.626 ' H ' ' CG1' ' B' ' 1' ' ' VAL . 82.0 t60 47.76 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.009 -1.057 . . . . 0.0 109.767 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.623 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -135.99 179.64 6.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 0.0 109.006 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 7' ' ' GLU . 7.3 p -76.15 132.55 73.4 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.104 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -41.28 -24.71 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.343 2.029 . . . . 0.0 112.457 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.2 -21.76 25.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.876 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' B' ' 4' ' ' THR . 32.2 tt0 -80.45 -63.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.959 . . . . 0.0 109.932 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' B' ' 12' ' ' THR . 24.2 pttt -62.25 -31.69 72.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 110.051 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.2 t -44.57 -23.35 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.0 110.406 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -81.59 -57.35 3.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.945 -1.097 . . . . 0.0 110.102 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.74 -24.62 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.094 -1.003 . . . . 0.0 108.318 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 12.5 m -71.95 -42.07 67.01 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.339 0.59 . . . . 0.0 109.88 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.75 -30.46 69.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.344 -0.848 . . . . 0.0 109.802 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -50.28 -18.83 0.67 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.97 . . . . 0.0 109.349 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -53.08 -51.48 61.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.15 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.09 -32.41 35.32 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -46.7 13.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -1.084 . . . . 0.0 109.177 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.99 114.85 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.732 . . . . 0.0 109.853 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' B' ' 21' ' ' ASP . 19.1 m120 -79.41 71.58 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 108.748 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -46.98 -11.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.851 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' B' ' 19' ' ' ASN . 16.5 m-20 -73.45 -5.5 40.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 109.821 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -156.26 -40.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.119 -0.988 . . . . 0.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 78.0 t -46.5 -55.42 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.883 . . . . 0.0 109.64 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.76 -29.83 50.71 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.51 -30.05 69.27 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.92 -31.41 59.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.221 -1.164 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.17 -54.28 48.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.514 ' CD2' ' N ' ' B' ' 28' ' ' LEU . 3.8 mm? -61.87 -40.1 94.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.273 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.92 -42.91 76.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -72.69 -37.08 67.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -1.122 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 tp -50.07 -31.7 13.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.265 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.28 -22.47 38.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.04 -64.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.627 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -22.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.422 -0.799 . . . . 0.0 109.663 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -140.25 79.17 21.94 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 109.559 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' B' ' 39' ' ' GLN . 79.3 Cg_endo -83.48 -12.45 8.99 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.888 2.392 . . . . 0.0 112.369 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . 0.53 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 3.4 p-90 -48.57 -33.99 10.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.523 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.53 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 3.2 m -78.95 2.65 19.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . 0.444 ' O ' ' OE1' ' B' ' 39' ' ' GLN . 1.4 tm0? -65.53 -19.08 65.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -68.59 -40.84 80.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.751 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -93.04 -18.96 22.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.956 . . . . 0.0 109.749 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.555 ' CE1' ' CE1' ' B' ' 45' ' ' PHE . 1.3 t80 -89.87 28.71 1.3 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -84.48 -13.97 50.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.614 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -80.2 -7.51 59.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.619 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.896 ' CZ ' HMD2 ' B' ' 147' ' ' HEC . 33.7 m-85 -83.65 -3.53 57.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.511 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.99 -172.77 25.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' B' ' 47' ' ' ASP . 2.0 p-10 -84.79 98.37 10.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -1.153 . . . . 0.0 109.42 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.511 ' N ' ' CD1' ' B' ' 48' ' ' LEU . 7.2 mp -88.0 30.8 0.82 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 108.972 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -45.05 -30.87 1.15 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 109.934 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -142.37 138.15 16.24 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -41.28 -28.4 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.406 2.071 . . . . 0.0 112.279 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.95 -39.79 49.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.93 -19.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.86 . . . . 0.0 109.603 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.1 -63.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.651 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -51.39 -20.0 1.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 109.741 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.07 -31.63 38.31 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.16 132.83 95.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -1.191 . . . . 0.0 109.357 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.31 -50.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.46 2.107 . . . . 0.0 112.551 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.04 -34.98 72.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.987 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -55.23 -49.88 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.033 -1.042 . . . . 0.0 109.217 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.473 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 26.2 mtmt -73.63 -29.33 62.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.289 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.92 -46.34 68.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 1.389 ' HE2' ' C4D' ' B' ' 147' ' ' HEC . 2.5 t60 -54.34 -25.28 23.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.553 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -32.35 83.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 0.4 OUTLIER -62.75 -36.91 84.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -1.198 . . . . 0.0 109.308 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . 0.539 ' O ' HMA3 ' B' ' 147' ' ' HEC . 49.3 mttp -75.74 -35.05 60.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.354 -0.841 . . . . 0.0 109.417 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.706 HG21 ' CHB' ' B' ' 147' ' ' HEC . 47.8 t -69.03 -63.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.334 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tt -53.61 -32.94 53.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 108.91 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.83 -57.1 20.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.32 79.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -1.137 . . . . 0.0 109.447 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -67.2 -35.09 78.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.484 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 61.7 p -73.82 -35.69 64.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.409 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.49 -21.29 0.53 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.347 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.17 -60.08 4.66 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.47 ' H ' HD13 ' B' ' 75' ' ' LEU . 5.1 mp -53.47 -28.9 33.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -1.133 . . . . 0.0 109.254 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.75 3.49 41.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.495 ' C ' ' H ' ' B' ' 79' ' ' ASP . 23.5 t-80 -170.43 61.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.632 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 59.1 mt -73.72 15.16 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 109.327 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' B' ' 77' ' ' HIS . 16.8 t70 -76.43 -36.05 58.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.873 . . . . 0.0 109.513 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -161.55 100.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.377 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 33.7 mt -79.31 -50.19 11.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.362 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.438 ' HZ2' ' CG ' ' B' ' 143' ' ' HIS . 24.6 mmtp -48.41 -23.95 1.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.11 -63.31 3.69 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.3 t -63.9 -48.07 78.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -1.13 . . . . 0.0 109.493 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.555 ' N ' ' CG2' ' B' ' 84' ' ' THR . 46.9 m-85 -63.64 -8.5 10.21 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.538 -0.726 . . . . 0.0 109.348 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.32 -34.75 34.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 109.366 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 28.4 p -83.99 -50.99 7.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.09 -55.54 31.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.174 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' SER . . . . . 0.491 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 1.5 m -51.51 -39.02 56.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.365 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' B' ' 94' ' ' ASP . 29.0 tt0 -74.25 -54.58 7.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 tt -62.46 -29.36 70.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.718 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' B' ' 97' ' ' HIS . 1.3 m80 -79.32 -48.41 14.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 110.001 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' B' ' 89' ' ' SER . 6.5 m -82.91 -31.08 27.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.032 . . . . 0.0 110.386 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' B' ' 90' ' ' GLU . 6.4 t70 -86.75 -43.47 12.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.084 -1.01 . . . . 0.0 110.937 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -52.33 5.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 110.733 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.648 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 4.1 mm? -82.85 -43.49 16.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.868 -1.145 . . . . 0.0 109.528 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 1.069 ' CD2' HG23 ' C' ' 41' ' ' THR . 0.0 OUTLIER 74.85 19.77 2.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 109.637 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' B' ' 97' ' ' HIS . 8.8 t -45.18 122.1 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 109.449 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 0.509 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 15.4 m-20 -69.05 151.34 97.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' B' ' 99' ' ' ASP . 74.5 Cg_exo -42.84 178.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.626 2.217 . . . . 0.0 112.369 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 57.58 64.75 1.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.839 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' B' ' 99' ' ' ASP . 73.2 m-20 -161.92 -52.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -0.86 . . . . 0.0 109.308 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . 0.683 ' O ' HBB2 ' B' ' 147' ' ' HEC . 4.2 p90 -67.01 -26.01 66.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 39.5 ttt-85 -78.61 -25.7 45.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.515 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.89 -45.65 49.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.641 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.946 HD13 ' C3B' ' B' ' 147' ' ' HEC . 4.6 tt -49.48 -45.99 47.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.415 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.42 -48.82 64.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 30.1 m120 -50.25 -44.27 53.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -1.153 . . . . 0.0 109.737 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.95 -35.4 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.748 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tp -63.35 -38.8 92.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 109.669 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 66.3 t -51.34 -30.52 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.95 . . . . 0.0 109.693 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.26 -59.26 2.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.621 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 t -46.14 -28.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.816 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 mt -82.51 -53.23 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.593 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.464 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -65.31 -19.44 65.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.696 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -62.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 109.655 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -77.16 -48.36 17.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.892 . . . . 0.0 109.803 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.8 30.13 1.64 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.714 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -54.94 -27.82 46.04 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -64.55 7.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -1.111 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' B' ' 119' ' ' GLY . 61.1 mm-40 -133.12 6.82 3.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.41 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.556 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.3 34.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.52 ' H ' ' C ' ' B' ' 121' ' ' GLU . 2.9 p -45.02 148.99 0.91 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.463 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.5 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.4 Cg_exo -44.33 -54.07 4.3 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.449 2.099 . . . . 0.0 112.769 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 21.1 Cg_endo -61.37 -48.16 10.28 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.057 1.838 . . . . 0.0 111.975 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.511 ' CG2' ' HG1' ' B' ' 123' ' ' THR . 73.9 t -55.6 -13.03 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . 1.052 ' CG ' ' NH1' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -82.45 -59.94 2.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.606 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.821 ' HB1' ' HB3' ' A' ' 34' ' ' LEU . . . -66.46 -26.53 67.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.928 . . . . 0.0 109.504 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.76 26.38 0.83 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.499 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.46 -61.25 1.42 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.382 -0.824 . . . . 0.0 109.368 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . 0.704 ' OE1' ' OG ' ' A' ' 35' ' ' SER . 26.0 mp0 -53.62 -36.36 61.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.632 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -69.44 -25.11 63.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 109.567 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 63.6 t -77.35 -43.59 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.512 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.65 -17.05 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.628 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.39 -28.93 70.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.31 -36.57 59.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 77.5 t -75.17 -36.49 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -1.092 . . . . 0.0 109.444 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.25 -38.92 55.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.915 . . . . 0.0 109.468 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' B' ' 143' ' ' HIS . 9.9 m120 -85.18 -21.31 29.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.731 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.62 -55.52 33.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.114 -0.991 . . . . 0.0 109.478 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 41.5 mt -61.64 -24.68 66.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' B' ' 145' ' ' TYR . . . -100.27 1.71 41.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.403 -0.811 . . . . 0.0 109.412 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 139' ' ' ASN . 71.2 t60 -80.8 -1.78 44.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.0 109.466 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' B' ' 146' ' ' HIS . 5.4 tppt? -120.73 -31.9 4.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.822 . . . . 0.0 109.889 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' B' ' 142' ' ' ALA . 0.1 OUTLIER -49.29 -10.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 109.933 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.523 ' H ' ' C ' ' B' ' 144' ' ' LYS . 4.9 m-70 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.662 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . 0.482 ' CD1' ' CD2' ' C' ' 128' ' ' PHE . 36.5 mt -121.2 -171.78 2.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.376 -0.827 . . . . 0.0 109.605 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.47 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.8 OUTLIER -97.75 -178.97 0.79 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.409 -0.807 . . . . 0.0 109.277 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 26.0 Cg_exo -60.97 -68.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.51 2.14 . . . . 0.0 112.329 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.464 ' O ' ' ND2' ' C' ' 9' ' ' ASN . . . -52.33 -36.17 52.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.794 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.614 ' CB ' ' HZ3' ' C' ' 127' ' ' LYS . 3.3 m-20 -44.2 -33.67 1.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 109.444 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -83.38 -60.13 2.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.841 . . . . 0.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.2 m -46.92 -29.75 2.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.355 -0.841 . . . . 0.0 109.94 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' C' ' 5' ' ' ALA . 23.1 m-20 -77.5 -36.69 52.37 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.985 -1.072 . . . . 0.0 108.233 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.19 -47.85 29.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -53.18 -38.58 62.93 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.49 -63.05 1.44 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.443 -0.785 . . . . 0.0 109.36 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.22 67.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.851 . . . . 0.0 109.286 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.98 -17.24 61.48 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.417 -0.802 . . . . 0.0 108.892 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.69 -39.98 59.39 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -84.73 -49.77 8.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.521 -0.988 . . . . 0.0 109.333 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' C' ' 18' ' ' GLY . 71.1 t -60.06 -34.99 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.504 -0.747 . . . . 0.0 109.639 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.623 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . -31.56 144.79 0.02 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . 69.16 -32.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -1.101 . . . . 0.0 108.874 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.623 ' H ' ' C ' ' C' ' 18' ' ' GLY . 1.2 m80 -104.96 13.83 30.38 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.52 -48.8 9.89 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.82 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -14.72 42.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -89.07 -56.6 3.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -1.137 . . . . 0.0 109.706 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.636 ' CZ ' ' CE1' ' C' ' 112' ' ' HIS . 2.9 m-30 -59.01 -33.13 70.38 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.424 -0.798 . . . . 0.0 109.191 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.73 -33.19 76.64 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.89 -50.83 10.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.168 -1.195 . . . . 0.0 109.828 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -52.4 -19.76 2.38 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.61 -25.53 65.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 33.2 mt -72.15 -58.09 3.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.744 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -61.57 -14.42 29.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.086 -1.009 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 1.063 ' NH1' ' CG ' ' D' ' 127' ' ' GLN . 1.9 tpm_? -75.41 -39.05 59.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.344 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.502 ' O ' ' N ' ' C' ' 34' ' ' LEU . 0.0 OUTLIER -79.98 -48.51 13.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.193 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' C' ' 32' ' ' MET . 36.6 t80 -43.78 -19.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.338 -0.851 . . . . 0.0 109.782 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.828 ' HB3' ' HB1' ' D' ' 128' ' ' ALA . 10.9 mt -79.85 -60.23 2.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.755 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.711 ' OG ' ' OE1' ' D' ' 131' ' ' GLN . 30.0 m -81.27 -31.48 33.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.891 . . . . 0.0 109.698 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -113.57 95.0 34.86 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.439 -0.788 . . . . 0.0 109.424 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.18 -20.01 8.88 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.435 2.09 . . . . 0.0 112.224 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' THR . . . . . 0.459 ' O ' ' N ' ' C' ' 40' ' ' LYS . 70.7 p -47.69 -42.07 24.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 109.253 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.405 ' C ' ' O ' ' C' ' 38' ' ' THR . 12.9 p -44.1 -22.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.813 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' C' ' 38' ' ' THR . 30.5 ttpt -70.94 -19.18 62.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.61 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 1.069 HG23 ' CD2' ' B' ' 97' ' ' HIS . 8.5 t -80.28 -20.58 44.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -84.99 -14.93 45.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.361 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 53.45 83.06 0.23 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.669 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 46.2 Cg_exo -52.04 -41.16 65.89 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.552 2.168 . . . . 0.0 111.866 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.669 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 0.0 OUTLIER 96.1 35.8 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.524 ' C ' ' H ' ' C' ' 48' ' ' LEU . 2.1 p90 -142.48 44.89 1.63 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.444 -1.41 . . . . 0.0 110.095 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.05 -35.22 0.3 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 110.448 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' C' ' 46' ' ' PHE . 1.0 OUTLIER 61.72 55.84 2.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.02 -1.05 . . . . 0.0 109.097 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' C' ' 48' ' ' LEU . 48.0 m -165.35 157.01 14.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.992 -1.067 . . . . 0.0 109.534 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.498 ' C ' ' H ' ' C' ' 52' ' ' SER . 2.7 m-70 -59.48 160.87 6.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.375 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.71 -18.14 1.91 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.555 ' C ' ' H ' ' C' ' 54' ' ' GLN . 30.6 p -48.66 -25.9 2.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -1.158 . . . . 0.0 109.395 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . 66.97 -40.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.748 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.555 ' H ' ' C ' ' C' ' 52' ' ' SER . 20.4 mt-30 -69.73 -23.79 63.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.295 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.64 -40.51 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.915 . . . . 0.0 109.133 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -65.7 -54.42 27.69 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.307 -0.87 . . . . 0.0 108.656 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.17 -36.12 21.08 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.488 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.1 t-80 -60.54 -36.5 78.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.957 -1.319 . . . . 0.0 109.874 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.36 -29.33 37.91 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 56.8 mttm -65.07 -23.67 67.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -1.207 . . . . 0.0 110.268 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.53 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 0.5 OUTLIER -69.18 -58.18 4.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.999 -1.063 . . . . 0.0 108.591 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 72.8 t -56.49 -44.71 81.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.579 -0.7 . . . . 0.0 109.299 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.93 -41.6 74.38 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.24 -0.912 . . . . 0.0 109.21 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 7.9 t70 -65.88 -38.1 87.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.13 -0.981 . . . . 0.0 108.493 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . 0.763 ' HB3' HMA2 ' C' ' 142' ' ' HEC . . . -67.5 -53.43 28.7 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' C' ' 70' ' ' VAL . 1.0 OUTLIER -58.49 -42.25 87.14 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.431 ' O ' ' N ' ' C' ' 71' ' ' ALA . 15.7 m -69.64 -51.67 32.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.888 . . . . 0.0 108.731 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -62.22 -25.95 68.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 108.537 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.11 -46.4 11.17 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' C' ' 66' ' ' LEU . 38.2 t -66.56 -22.85 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -69.56 -36.3 76.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.587 ' O ' ' N ' ' C' ' 74' ' ' ASP . 26.1 m80 -103.32 -66.69 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.609 -0.682 . . . . 0.0 109.443 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' C' ' 72' ' ' HIS . 14.8 p 44.42 14.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.954 0.883 . . . . 0.0 109.323 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' C' ' 72' ' ' HIS . 5.5 m-20 -137.99 12.07 2.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.78 31.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.139 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 3.5 ptt? -78.27 -23.66 0.42 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 111.849 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.8 Cg_exo -53.6 -19.35 13.76 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.705 1.604 . . . . 0.0 112.5 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -94.25 -40.44 9.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.08 -1.012 . . . . 0.0 109.741 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.73 -48.88 67.81 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.248 -0.908 . . . . 0.0 109.36 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.58 6.03 6.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 109.298 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 34.1 t -54.48 -19.59 6.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 109.602 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -83.16 -58.52 2.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 109.891 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.461 ' CD2' HBA1 ' C' ' 142' ' ' HEC . 3.8 mt -45.32 -44.69 11.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.424 -0.797 . . . . 0.0 109.068 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' SER . . . . . 0.52 ' HG ' ' C ' ' C' ' 136' ' ' LEU . 23.3 t -59.96 -18.93 49.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -0.775 . . . . 0.0 109.536 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' C' ' 89' ' ' HIS . 36.7 t70 -81.11 -50.9 9.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.95 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.435 ' CD1' HBD2 ' C' ' 142' ' ' HEC . 4.6 tt -64.15 -26.71 68.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.89 . . . . 0.0 110.068 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.79 -21.78 26.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.312 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.47 -11.26 11.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.141 -0.975 . . . . 0.0 110.172 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . 0.56 ' N ' ' O ' ' C' ' 85' ' ' ASP . 42.4 t60 -106.51 -74.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.958 . . . . 0.0 109.996 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' C' ' 92' ' ' ARG . 79.7 mttt -63.74 -110.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 110.077 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 14.1 mt -44.45 -17.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.346 -0.846 . . . . 0.0 110.009 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' C' ' 90' ' ' LYS . 31.8 ttm-85 46.84 41.47 10.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.138 -0.977 . . . . 0.0 109.492 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 70.1 t -45.91 144.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.694 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' C' ' 97' ' ' ASN . 10.7 m-20 -80.68 150.29 69.43 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.71 -19.49 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.384 2.056 . . . . 0.0 112.22 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.31 -7.71 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.357 -0.84 . . . . 0.0 109.752 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' C' ' 94' ' ' ASP . 12.8 m120 -79.71 -36.25 37.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.475 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -46.35 -41.56 13.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.896 -1.127 . . . . 0.0 109.569 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.48 ' CB ' ' NZ ' ' C' ' 99' ' ' LYS . 8.0 mtmp? -51.39 -28.25 12.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.238 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.468 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 15.4 mt -84.31 -61.8 1.72 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.719 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.714 HD23 ' CHC' ' C' ' 142' ' ' HEC . 5.4 tp -49.92 -23.65 2.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.796 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -73.28 -49.47 27.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.906 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -80.68 -26.41 37.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.862 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 65.3 m -64.95 -60.37 3.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.167 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' C' ' 105' ' ' LEU . 0.9 OUTLIER -57.51 -22.38 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 109.827 -179.402 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.08 -31.47 39.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.879 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 57.0 t -83.32 -24.91 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.042 -1.036 . . . . 0.0 110.094 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' C' ' 109' ' ' LEU . 1.5 t -79.79 -47.68 14.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.06 -1.025 . . . . 0.0 109.919 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.55 ' N ' ' CG2' ' C' ' 108' ' ' THR . 0.8 OUTLIER -69.77 -18.51 63.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 109.762 -179.583 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.95 -22.2 46.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 110.287 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.51 -56.16 25.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -0.995 . . . . 0.0 110.162 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . 0.708 ' CG ' ' H ' ' C' ' 113' ' ' LEU . 9.4 p80 -72.42 -61.85 1.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.016 . . . . 0.0 109.563 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.708 ' H ' ' CG ' ' C' ' 112' ' ' HIS . 0.0 OUTLIER -119.81 121.46 29.76 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.37 175.61 7.56 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.476 2.117 . . . . 0.0 112.932 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.649 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -45.22 -55.08 6.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.604 -0.685 . . . . 0.0 109.374 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.649 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 26.0 mt-10 122.98 -2.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 0.472 ' CG ' ' C ' ' C' ' 116' ' ' GLU . 1.8 m-85 72.23 32.86 1.64 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.708 -0.62 . . . . 0.0 111.259 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.772 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.3 p -97.54 121.26 58.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.927 -1.108 . . . . 0.0 108.231 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.55 24.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.059 1.839 . . . . 0.0 112.531 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -150.46 -32.31 0.18 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.928 -1.108 . . . . 0.0 110.46 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.62 ' H ' ' HG1' ' C' ' 118' ' ' THR . 11.9 p -54.03 -50.11 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 110.292 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.523 ' CE1' ' CB ' ' C' ' 115' ' ' ALA . 23.1 m-70 -54.71 -45.07 73.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.577 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.37 -20.02 32.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 110.267 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.549 ' N ' ' O ' ' C' ' 120' ' ' ALA . 93.6 p -52.22 -52.93 49.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.931 . . . . 0.0 110.615 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 5.5 mt -84.11 -19.24 34.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.081 -1.012 . . . . 0.0 110.047 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.76 -51.82 9.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.092 . . . . 0.0 110.333 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.614 ' HZ3' ' CB ' ' C' ' 6' ' ' ASP . 0.0 OUTLIER -78.68 -43.02 26.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.057 -1.027 . . . . 0.0 110.188 -179.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.482 ' CD2' ' CD1' ' C' ' 2' ' ' LEU . 33.7 t80 -50.5 -21.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 0.0 108.992 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.52 ' CD2' HBB1 ' C' ' 142' ' ' HEC . 17.4 mt -73.77 -18.26 60.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -60.14 -35.48 75.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 97.3 p -80.74 -27.09 36.94 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -84.71 -30.06 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.492 ' N ' ' O ' ' C' ' 129' ' ' LEU . 50.3 m -79.31 -40.78 29.54 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 53.3 m -69.31 -26.35 64.68 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.289 -0.882 . . . . 0.0 108.644 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 23.6 t -81.56 -30.19 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.52 ' C ' ' HG ' ' C' ' 84' ' ' SER . 1.0 OUTLIER -71.26 -23.21 61.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.0 109.071 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 137' ' ' THR . . . . . 0.433 ' O ' ' O ' ' C' ' 138' ' ' SER . 38.3 p -87.28 -18.43 30.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.21 -0.931 . . . . 0.0 109.552 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 138' ' ' SER . . . . . 0.433 ' O ' ' O ' ' C' ' 137' ' ' THR . 21.7 m 51.72 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.433 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -61.92 -160.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.928 . . . . 0.0 109.548 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -76.75 -45.0 30.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.571 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.507 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.632 ' CG1' ' H ' ' D' ' 2' ' ' HIS . 13.0 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.632 ' H ' ' CG1' ' D' ' 1' ' ' VAL . 82.1 t60 47.72 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.987 -1.071 . . . . 0.0 109.724 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.63 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -135.94 179.73 6.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 108.982 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.466 ' O ' ' N ' ' D' ' 7' ' ' GLU . 7.3 p -76.16 132.42 73.61 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.153 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -41.19 -24.75 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.369 2.046 . . . . 0.0 112.446 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.14 -21.84 25.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.927 . . . . 0.0 109.874 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' D' ' 4' ' ' THR . 32.2 tt0 -80.36 -63.09 1.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.097 -1.002 . . . . 0.0 109.938 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.491 ' O ' ' OG1' ' D' ' 12' ' ' THR . 24.1 pttt -62.38 -31.63 72.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.008 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.2 t -44.55 -23.44 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -81.57 -57.34 3.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.019 -1.051 . . . . 0.0 110.11 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.76 -24.64 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.055 -1.028 . . . . 0.0 108.256 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 12.6 m -71.91 -42.15 67.06 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.347 0.594 . . . . 0.0 109.852 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.77 -30.38 69.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.868 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -50.32 -18.79 0.67 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.95 . . . . 0.0 109.33 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -53.18 -51.39 62.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 0.0 109.158 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.09 -32.47 35.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 -46.68 14.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -1.098 . . . . 0.0 109.214 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 69.6 t -59.02 114.91 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.546 -0.721 . . . . 0.0 109.842 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' D' ' 21' ' ' ASP . 19.0 m120 -79.43 71.58 6.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 108.742 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 57.2 t -46.99 -11.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.89 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' D' ' 19' ' ' ASN . 16.5 m-20 -73.51 -5.35 39.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 109.847 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -156.31 -40.35 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 109.577 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -46.4 -55.54 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.0 109.66 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.72 -29.85 50.42 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.53 -29.93 69.34 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.94 -31.46 59.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -1.11 . . . . 0.0 109.467 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.11 -54.32 48.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . 0.496 ' N ' ' CD2' ' D' ' 28' ' ' LEU . 3.8 mm? -61.9 -40.06 94.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.935 . . . . 0.0 109.26 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.98 -42.78 76.31 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 60.2 mmt-85 -72.74 -36.97 67.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -1.098 . . . . 0.0 109.481 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 65.2 tp -50.12 -31.72 14.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.32 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.18 -22.59 38.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.625 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.97 -64.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.578 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -64.11 -22.69 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -0.828 . . . . 0.0 109.644 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -140.31 79.22 21.56 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -83.49 -12.42 8.98 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.865 2.377 . . . . 0.0 112.36 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . 0.524 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 3.3 p-90 -48.62 -33.95 10.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.586 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.524 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 3.2 m -78.96 2.59 19.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.509 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' D' ' 39' ' ' GLN . 1.4 tm0? -65.48 -19.08 65.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . 1.568 HH21 ' CG ' ' A' ' 92' ' ' ARG . 32.9 mtp85 -68.49 -40.94 80.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.746 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -93.03 -18.98 22.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' D' ' 45' ' ' PHE . 1.3 t80 -89.86 28.56 1.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 109.44 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -84.39 -13.99 50.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.351 -0.843 . . . . 0.0 109.608 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -80.12 -7.59 58.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.602 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . 0.9 ' CZ ' HMD2 ' D' ' 147' ' ' HEC . 33.5 m-85 -83.68 -3.44 57.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.483 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.03 -172.78 25.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' D' ' 47' ' ' ASP . 1.9 p-10 -84.81 98.39 10.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.125 . . . . 0.0 109.339 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' D' ' 48' ' ' LEU . 7.2 mp -88.0 30.85 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 108.956 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -45.0 -30.96 1.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 109.89 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 6.7 p -142.35 138.2 16.29 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -41.2 -28.45 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.423 2.082 . . . . 0.0 112.362 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . 0.4 ' C ' ' N ' ' D' ' 54' ' ' VAL . 12.0 t70 -76.96 -39.81 49.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.0 109.578 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.8 -19.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.355 -0.84 . . . . 0.0 109.653 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . 0.4 ' N ' ' C ' ' D' ' 52' ' ' ASP . 45.8 t -67.06 -63.87 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.656 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -51.48 -19.92 1.63 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.757 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.0 -31.75 38.23 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.18 132.74 95.19 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.232 -1.157 . . . . 0.0 109.318 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.26 -50.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.447 2.098 . . . . 0.0 112.523 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.05 -34.93 72.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.967 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -55.34 -49.88 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.032 . . . . 0.0 109.193 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . 0.486 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 26.2 mtmt -73.6 -29.34 62.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.169 -0.957 . . . . 0.0 109.277 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.31 68.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.449 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 1.412 ' HE2' ' C4D' ' D' ' 147' ' ' HEC . 2.5 t60 -54.39 -25.36 24.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.25 83.1 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 0.4 OUTLIER -62.88 -36.79 84.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.183 -1.186 . . . . 0.0 109.274 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . 0.534 ' O ' HMA3 ' D' ' 147' ' ' HEC . 49.3 mttp -75.76 -35.1 60.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 109.344 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.696 HG21 ' CHB' ' D' ' 147' ' ' HEC . 47.7 t -69.03 -63.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.285 -0.885 . . . . 0.0 109.324 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tt -53.75 -32.81 53.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 108.898 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.93 -56.98 21.07 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.81 -42.25 79.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -1.085 . . . . 0.0 109.455 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . 0.405 ' O ' ' CD1' ' D' ' 71' ' ' PHE . 3.0 t80 -67.24 -35.12 78.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 62.2 p -73.78 -35.61 64.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.63 -21.16 0.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.908 . . . . 0.0 109.361 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.13 -60.12 4.65 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.486 ' H ' HD13 ' D' ' 75' ' ' LEU . 5.1 mp -53.46 -28.9 32.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -1.161 . . . . 0.0 109.25 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.78 3.5 41.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.486 ' C ' ' H ' ' D' ' 79' ' ' ASP . 23.5 t-80 -170.41 61.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.692 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 59.2 mt -73.69 15.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.257 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' D' ' 77' ' ' HIS . 16.8 t70 -76.38 -36.02 58.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.216 -0.927 . . . . 0.0 109.522 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -161.61 100.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 109.401 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 33.2 mt -79.21 -50.23 11.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . 0.437 ' HZ2' ' CG ' ' D' ' 143' ' ' HIS . 24.6 mmtp -48.41 -23.92 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.08 -63.27 3.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.3 t -63.94 -48.11 77.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -1.14 . . . . 0.0 109.397 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' D' ' 84' ' ' THR . 46.6 m-85 -63.61 -8.5 10.11 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.435 -0.79 . . . . 0.0 109.374 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.25 -34.86 34.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.394 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 27.9 p -83.96 -50.97 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 0.0 109.535 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' D' ' 92' ' ' HIS . 35.8 mt -56.11 -55.56 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 109.161 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 89' ' ' SER . . . . . 0.495 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 1.5 m -51.55 -38.91 56.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.323 -0.861 . . . . 0.0 109.44 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' D' ' 94' ' ' ASP . 29.1 tt0 -74.24 -54.64 7.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -62.49 -29.3 70.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.687 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' D' ' 97' ' ' HIS . 1.3 m80 -79.31 -48.35 14.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.97 . . . . 0.0 110.043 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' D' ' 89' ' ' SER . 6.6 m -82.97 -31.14 27.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.028 -1.045 . . . . 0.0 110.301 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' D' ' 90' ' ' GLU . 6.4 t70 -86.66 -43.52 12.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.065 -1.022 . . . . 0.0 110.901 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -52.25 5.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 0.0 110.732 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.63 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 4.1 mm? -82.98 -43.48 16.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.0 109.486 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 1.109 ' CD2' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER 74.81 19.77 2.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.427 -0.796 . . . . 0.0 109.727 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' D' ' 97' ' ' HIS . 8.6 t -45.11 122.24 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 109.471 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . 0.512 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 15.6 m-20 -69.18 151.46 97.05 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.41 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' D' ' 99' ' ' ASP . 75.7 Cg_exo -42.9 178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.631 2.22 . . . . 0.0 112.414 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 57.52 64.76 1.5 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 109.569 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' D' ' 99' ' ' ASP . 73.1 m-20 -161.92 -52.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.41 -0.806 . . . . 0.0 109.263 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . 0.696 ' O ' HBB2 ' D' ' 147' ' ' HEC . 4.2 p90 -66.96 -25.96 66.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . 0.417 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 39.3 ttt-85 -78.53 -25.76 45.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.91 -45.7 49.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.915 . . . . 0.0 109.605 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.952 HD13 ' C3B' ' D' ' 147' ' ' HEC . 4.6 tt -49.39 -46.07 46.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.4 -48.83 64.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 30.1 m120 -50.22 -44.26 53.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -1.172 . . . . 0.0 109.739 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.04 -35.27 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.757 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tp -63.41 -38.8 92.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.662 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 66.8 t -51.37 -30.52 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.676 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.22 -59.38 2.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.615 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 29.3 t -46.17 -27.91 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.833 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 17.0 mt -82.66 -53.12 6.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.527 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.454 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -65.38 -19.43 65.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.639 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.08 -62.84 1.25 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.689 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -77.26 -48.3 17.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.823 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -92.8 30.21 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.751 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -55.05 -27.73 46.51 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -64.65 7.09 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -1.136 . . . . 0.0 109.598 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' D' ' 119' ' ' GLY . 61.0 mm-40 -133.14 6.87 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 109.434 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.538 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -73.32 34.8 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.427 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.528 ' HG1' ' CG2' ' D' ' 126' ' ' VAL . 2.9 p -44.87 148.96 0.88 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.339 -0.85 . . . . 0.0 109.504 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.492 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -44.36 -54.04 4.34 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.437 2.091 . . . . 0.0 112.78 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 21.2 Cg_endo -61.35 -48.25 10.11 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.934 1.756 . . . . 0.0 112.0 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . 0.528 ' CG2' ' HG1' ' D' ' 123' ' ' THR . 72.8 t -55.48 -13.02 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -0.839 . . . . 0.0 109.518 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . 1.063 ' CG ' ' NH1' ' C' ' 31' ' ' ARG . 0.7 OUTLIER -82.47 -59.87 2.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.646 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 0.828 ' HB1' ' HB3' ' C' ' 34' ' ' LEU . . . -66.56 -26.52 67.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.435 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.78 26.44 0.83 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.47 -61.36 1.41 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.295 -0.878 . . . . 0.0 109.303 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . 0.711 ' OE1' ' OG ' ' C' ' 35' ' ' SER . 26.1 mp0 -53.56 -36.37 61.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.671 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -69.47 -25.13 63.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 64.4 t -77.27 -43.66 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.581 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.61 -17.1 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.36 -28.95 70.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.541 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -36.43 59.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 76.4 t -75.24 -36.47 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -1.153 . . . . 0.0 109.456 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.22 -38.91 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' D' ' 143' ' ' HIS . 9.9 m120 -85.21 -21.3 29.18 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.21 -0.931 . . . . 0.0 109.758 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.69 -55.52 33.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.514 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.52 -24.77 66.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.277 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' D' ' 145' ' ' TYR . . . -100.29 1.79 42.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 109.378 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . 0.527 ' N ' ' O ' ' D' ' 139' ' ' ASN . 71.2 t60 -80.91 -1.68 44.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.453 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' D' ' 146' ' ' HIS . 5.4 tppt? -120.75 -32.04 4.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' D' ' 142' ' ' ALA . 0.1 OUTLIER -49.12 -10.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.233 -0.917 . . . . 0.0 109.888 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' D' ' 144' ' ' LYS . 4.9 m-70 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.656 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.775 HMA2 ' HB3' ' A' ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 1.389 ' C4D' ' HE2' ' B' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 0.763 HMA2 ' HB3' ' C' ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.412 ' C4D' ' HE2' ' D' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.4 tp -171.74 145.51 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 109.634 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.6 168.29 20.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 109.319 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 5' ' ' ALA . 55.7 Cg_endo -73.13 -61.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.618 2.212 . . . . 0.0 112.666 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 4' ' ' PRO . . . -45.26 -38.27 5.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.934 . . . . 0.0 109.673 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 5' ' ' ALA . 4.8 m-20 -44.52 -28.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 108.977 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 10' ' ' VAL . 76.8 mttt -83.06 -60.33 2.19 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.437 -0.789 . . . . 0.0 109.093 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.1 m -46.37 -31.61 2.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.471 -0.768 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -76.72 -35.85 57.55 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 7' ' ' LYS . 4.4 t -73.58 -50.25 31.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -49.15 -42.79 40.75 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.4 -63.57 1.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.257 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.37 -39.05 69.63 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 109.178 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.43 ' NE1' ' OG1' ' A' ' 67' ' ' THR . 0.1 OUTLIER -71.31 -17.19 62.47 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.044 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.26 -46.23 7.66 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -70.67 -34.61 72.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.146 . . . . 0.0 108.742 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.1 t -63.02 -66.03 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 60.84 -140.82 48.08 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 20' ' ' HIS . . . -66.7 49.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.434 -1.039 . . . . 0.0 110.194 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.444 ' N ' ' O ' ' A' ' 18' ' ' GLY . 80.0 m-70 -153.75 19.64 0.53 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -83.8 -62.87 1.46 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.701 -0.624 . . . . 0.0 109.781 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.2 -14.45 0.16 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 21' ' ' ALA . 3.4 mm-40 -86.71 -56.47 3.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -1.132 . . . . 0.0 109.744 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.9 m-30 -55.38 -52.23 64.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 109.159 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.14 -22.79 14.58 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.67 -45.4 52.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -1.129 . . . . 0.0 109.702 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.518 ' OE1' ' NE2' ' A' ' 112' ' ' HIS . 94.9 mt-10 -65.69 -19.83 66.05 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.509 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.58 -24.5 60.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.381 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.3 mt -65.81 -41.23 92.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.735 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -75.68 -12.54 60.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.09 -1.006 . . . . 0.0 109.739 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -78.93 -47.36 16.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 0.0 110.155 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.901 ' HE3' HBC1 ' A' ' 142' ' ' HEC . 1.1 ptm -65.74 -26.35 67.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.007 -1.058 . . . . 0.0 109.683 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.37 -36.45 82.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.101 -0.999 . . . . 0.0 109.436 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.703 ' HB3' ' HB1' ' B' ' 128' ' ' ALA . 12.1 mt -85.66 -44.88 12.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.708 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 40.2 t -51.5 -19.61 1.52 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.824 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' A' ' 35' ' ' SER . 60.1 m-85 -160.92 90.23 1.61 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.001 . . . . 0.0 109.733 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 39' ' ' THR . 52.4 Cg_exo -50.28 -26.15 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.594 2.196 . . . . 0.0 112.158 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.407 HG21 ' CB ' ' D' ' 97' ' ' HIS . 10.8 p -47.54 -18.51 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 37' ' ' PRO . 22.1 p -76.47 -22.89 53.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.273 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 43' ' ' PHE . 28.8 ttmt -74.22 -31.74 62.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.88 . . . . 0.0 109.84 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 1.247 ' CG2' ' CE1' ' D' ' 97' ' ' HIS . 14.3 t -47.13 -25.74 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.333 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.474 ' C ' ' CG ' ' A' ' 43' ' ' PHE . 97.5 m-85 -87.86 30.95 0.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.474 ' CG ' ' C ' ' A' ' 42' ' ' TYR . 0.9 OUTLIER 70.26 149.55 0.12 Allowed Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.16 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 46' ' ' PHE . 40.0 Cg_endo -68.73 -42.92 4.17 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.058 1.838 . . . . 0.0 112.337 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.546 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 21.7 p80 34.38 34.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.549 -0.72 . . . . 0.0 109.248 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.714 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -166.63 75.49 0.18 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.621 ' C ' ' O ' ' A' ' 46' ' ' PHE . 20.8 m-20 -8.8 -54.67 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.028 -0.42 . . . . 0.0 111.522 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.714 ' N ' ' O ' ' A' ' 46' ' ' PHE . 5.7 mt 56.71 4.81 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.244 -0.91 . . . . 0.0 109.386 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 47' ' ' ASP . 33.3 t -73.24 19.0 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.242 -0.911 . . . . 0.0 109.362 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.522 ' H ' ' C ' ' A' ' 48' ' ' LEU . 6.6 t-80 58.86 156.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.06 15.33 1.46 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.7 t -72.59 -21.27 61.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 109.403 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 55' ' ' VAL . . . 67.5 -50.62 0.5 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.709 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.494 HE22 ' CG ' ' A' ' 47' ' ' ASP . 15.8 pt20 -45.37 -17.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.684 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 53' ' ' ALA . 77.9 t -73.84 -32.85 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.83 -24.82 67.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.641 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.15 -51.1 40.94 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 24.7 t-80 -67.82 -27.81 67.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.13 -1.217 . . . . 0.0 110.282 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.22 -31.05 79.39 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 16.9 mtpp -71.79 -23.63 61.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -1.157 . . . . 0.0 110.146 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.809 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 0.4 OUTLIER -66.8 -58.1 5.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.124 -0.985 . . . . 0.0 108.644 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.8 t -55.2 -48.94 75.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.544 -0.723 . . . . 0.0 109.238 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -64.23 -42.57 96.5 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.23 -0.919 . . . . 0.0 108.959 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.5 t70 -72.02 -25.63 61.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.806 . . . . 0.0 109.056 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 1.006 ' HB3' HMA2 ' A' ' 142' ' ' HEC . . . -80.65 -44.74 18.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.475 ' O ' ' CD1' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -76.57 -27.35 55.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.568 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 63' ' ' ALA . 52.8 m -75.92 -44.62 39.37 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -57.41 -20.81 32.32 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.24 -45.88 12.42 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.0 t -59.62 -22.63 23.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -65.39 -15.25 62.39 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.568 ' O ' ' N ' ' A' ' 74' ' ' ASP . 31.6 m80 -153.04 -51.75 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.403 -0.811 . . . . 0.0 109.353 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.631 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.9 p 44.56 15.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.977 0.894 . . . . 0.0 109.32 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 72' ' ' HIS . 95.9 m-20 -134.3 10.57 3.81 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 31.1 t70 -175.23 27.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.14 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.1 ptt? -78.59 -24.19 0.43 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.47 -0.769 . . . . 0.0 111.829 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.3 Cg_exo -52.9 -19.8 11.91 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.701 1.601 . . . . 0.0 112.634 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.448 ' ND2' ' N ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -94.21 -33.12 13.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.114 -0.991 . . . . 0.0 109.822 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.448 ' N ' ' ND2' ' A' ' 78' ' ' ASN . . . -74.6 -40.79 61.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.27 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.64 12.12 13.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.024 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 66.5 p -70.6 -16.21 62.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.655 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -82.07 -51.71 7.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.4 mt -44.89 -43.0 8.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.382 -0.824 . . . . 0.0 109.043 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.1 p -57.14 -22.07 37.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -72.54 -32.75 66.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.686 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 90' ' ' LYS . 7.0 tt -81.4 -29.18 34.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.417 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -89.9 -28.42 19.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 109.529 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 90' ' ' LYS . . . -83.9 -80.41 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.665 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 89' ' ' HIS . 30.4 t-80 -61.09 2.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.841 . . . . 0.0 109.61 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 88' ' ' ALA . 6.1 mtmm -156.15 152.29 27.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.289 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.647 ' C ' ' H ' ' A' ' 93' ' ' VAL . 10.9 mp 56.95 63.89 1.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 108.983 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.272 ' HB3' ' NH1' ' D' ' 40' ' ' ARG . 8.4 ptp180 -62.77 14.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.578 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.647 ' H ' ' C ' ' A' ' 91' ' ' LEU . 73.7 t -41.43 121.69 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -0.812 . . . . 0.0 109.631 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.11 147.81 2.29 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.571 ' C ' ' H ' ' A' ' 97' ' ' ASN . 37.9 Cg_endo -68.23 -10.66 29.63 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.486 2.124 . . . . 0.0 112.069 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.25 -1.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.716 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.996 ' HB3' HMC2 ' A' ' 142' ' ' HEC . 5.0 m120 -74.66 -42.34 58.65 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.084 -1.01 . . . . 0.0 109.808 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 2.2 m-85 -46.38 -42.05 14.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 0.0 109.275 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -58.1 -32.91 68.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.244 -0.91 . . . . 0.0 109.316 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 97' ' ' ASN . 11.1 mt -84.08 -62.28 1.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 1.055 HD22 HBB3 ' A' ' 142' ' ' HEC . 6.3 tt -50.22 -41.84 50.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 0.0 109.291 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 98' ' ' PHE . 39.4 m -63.26 -51.03 67.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -66.1 -26.82 67.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.513 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 96.6 m -63.51 -50.59 69.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.75 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.31 -43.02 22.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 106' ' ' LEU . 8.6 mp -64.17 -59.24 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.423 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.563 ' CG1' ' NE2' ' B' ' 127' ' ' GLN . 76.7 t -56.48 -30.99 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -75.7 -63.03 1.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.459 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 113' ' ' LEU . 13.1 mt -51.34 -30.65 19.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.0 109.495 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -47.43 -42.29 22.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.885 . . . . 0.0 109.679 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.11 -49.25 11.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.829 . . . . 0.0 109.787 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 27' ' ' GLU . 11.4 m170 -76.24 -69.98 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 109.868 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -110.96 97.05 32.57 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 109.054 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 113' ' ' LEU . 71.2 Cg_exo -47.31 -174.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.372 2.048 . . . . 0.0 112.879 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.67 -35.09 19.53 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.664 0.745 . . . . 0.0 109.574 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 3.8 mt-10 78.4 0.86 2.63 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.942 ' HD1' ' NH2' ' B' ' 30' ' ' ARG . 21.7 t80 65.3 37.56 6.32 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.639 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.749 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -93.97 115.07 64.69 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.82 -1.175 . . . . 0.0 107.953 178.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.737 ' HA ' HG13 ' B' ' 33' ' ' VAL . 50.4 Cg_exo -50.36 21.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.021 1.814 . . . . 0.0 112.553 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.749 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -147.07 -21.7 0.4 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.003 -1.061 . . . . 0.0 110.961 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.627 ' CG1' ' H ' ' A' ' 122' ' ' HIS . 10.5 p -58.13 -58.75 5.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.976 -1.078 . . . . 0.0 110.48 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.657 ' CD2' ' SG ' ' B' ' 112' ' ' CYS . 1.1 m-70 -71.03 -24.89 62.45 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.3 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.08 -20.74 32.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 128' ' ' PHE . 62.7 p -77.41 -63.19 1.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.248 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.46 -19.84 57.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.057 -1.027 . . . . 0.0 109.102 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.548 ' OD2' ' OH ' ' B' ' 35' ' ' TYR . 7.4 t70 -77.77 -51.18 10.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.482 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.28 -41.82 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.845 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 124' ' ' SER . 29.8 t80 -50.23 -22.88 1.92 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 109.037 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.0 mt -73.99 -24.76 59.64 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -56.77 -31.87 65.05 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 89.6 p -73.97 -32.56 63.51 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.37 -29.79 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 129' ' ' LEU . 9.9 p -81.92 -25.26 35.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.843 . . . . 0.0 108.913 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 36.8 m -74.91 -40.13 61.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.305 -0.872 . . . . 0.0 109.102 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.13 -21.79 17.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 108.782 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.75 -35.96 72.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.472 -0.767 . . . . 0.0 109.103 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 138' ' ' SER . 57.8 p -88.13 -2.3 58.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' THR . 28.3 m 51.79 98.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 109.471 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 138' ' ' SER . 5.9 mtpm? -55.11 -170.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.537 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -61.34 -67.76 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.811 HH12 HH12 ' C' ' 141' ' ' ARG . 43.3 mtp180 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.479 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.643 ' CG2' ' H ' ' B' ' 2' ' ' HIS . 8.2 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.643 ' H ' ' CG2' ' B' ' 1' ' ' VAL . 86.7 m-70 52.13 98.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 109.34 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.671 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -136.41 -163.11 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 109.265 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.412 ' O ' ' N ' ' B' ' 6' ' ' GLU . 11.9 p -88.98 130.64 43.87 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.19 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.445 ' O ' ' OG ' ' B' ' 9' ' ' SER . 86.4 Cg_exo -42.05 -23.04 0.23 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.362 2.041 . . . . 0.0 112.271 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' B' ' 4' ' ' THR . 51.9 mt-10 -80.11 -54.26 5.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.812 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.42 -41.09 85.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.746 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.474 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.3 OUTLIER -68.54 -35.1 76.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.5 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 5' ' ' PRO . 4.9 m -60.68 -23.58 64.95 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.885 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.49 -57.58 3.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.11 -0.994 . . . . 0.0 109.809 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.76 -24.39 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 85.6 m -83.85 -35.2 24.37 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.345 0.593 . . . . 0.0 109.606 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.05 -29.27 67.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.386 -0.821 . . . . 0.0 109.791 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.1 -21.07 0.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.244 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . 0.402 ' HE1' ' HB2' ' B' ' 72' ' ' SER . 0.8 OUTLIER -53.54 -17.88 2.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.175 -0.953 . . . . 0.0 109.084 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.8 -33.31 46.97 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -89.82 -41.46 11.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -1.178 . . . . 0.0 109.361 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -57.22 114.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 109.833 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' B' ' 21' ' ' ASP . 7.4 m120 -84.3 68.41 10.18 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -43.88 -18.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.392 -0.817 . . . . 0.0 109.73 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' B' ' 19' ' ' ASN . 1.1 m-20 -62.39 -10.79 12.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.709 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -154.42 -35.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -0.995 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 72.3 t -48.74 -34.89 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.3 -25.9 68.87 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.97 -36.3 25.37 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -67.67 -30.7 70.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -1.114 . . . . 0.0 109.472 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.68 -54.53 45.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' B' ' 28' ' ' LEU . 9.9 mp -64.3 -55.76 19.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.399 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.03 -41.32 29.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.942 ' NH2' ' HD1' ' A' ' 117' ' ' PHE . 73.5 mtt-85 -80.01 -34.64 38.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -1.144 . . . . 0.0 109.499 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 tp -47.11 -37.21 9.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 109.499 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' B' ' 36' ' ' PRO . 15.0 mt -81.32 -39.29 25.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.817 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.737 HG13 ' HA ' ' A' ' 119' ' ' PRO . 72.4 t -58.13 -61.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.12 -0.988 . . . . 0.0 109.442 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.636 HG13 ' HB3' ' A' ' 122' ' ' HIS . 1.7 t -68.69 -22.56 26.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.83 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.548 ' OH ' ' OD2' ' A' ' 126' ' ' ASP . 64.0 m-85 -146.75 76.47 11.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.776 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . 0.423 ' N ' ' O ' ' B' ' 32' ' ' LEU . 72.1 Cg_endo -82.95 28.98 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.95 2.433 . . . . 0.0 112.382 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -81.08 -19.85 42.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.167 -0.958 . . . . 0.0 109.654 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' B' ' 39' ' ' GLN . 44.8 p -78.39 -104.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.523 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . 0.506 ' N ' ' OG1' ' B' ' 38' ' ' THR . 13.9 mt-30 54.94 10.65 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.654 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 1.301 ' NH1' ' HB3' ' C' ' 92' ' ' ARG . 15.9 mmt180 -88.55 -58.98 2.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -71.44 -8.19 52.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 1.418 ' CZ ' ' CBC' ' B' ' 147' ' ' HEC . 50.4 m-85 -87.75 28.16 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.361 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.66 -27.3 65.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 93.9 p -84.15 -27.19 28.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 109.465 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -49.65 -24.39 2.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.331 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.87 173.05 0.19 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.97 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -1.142 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 12.6 mt -138.92 19.68 2.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -58.93 -33.9 71.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.61 154.34 69.06 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.49 -24.26 74.15 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.212 1.941 . . . . 0.0 111.756 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.2 -21.02 29.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 109.608 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.96 -19.95 65.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 109.736 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.44 ' C ' ' H ' ' B' ' 56' ' ' GLY . 4.4 t -67.05 -64.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.94 . . . . 0.0 109.473 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.09 8.13 1.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' B' ' 54' ' ' VAL . . . -74.57 -29.99 60.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -84.42 147.72 50.57 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.195 -1.179 . . . . 0.0 109.34 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.72 -7.08 19.66 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.564 2.176 . . . . 0.0 112.175 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -85.77 -28.45 24.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.162 -0.961 . . . . 0.0 109.659 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 83.5 t -70.31 -53.0 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.174 -0.954 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -57.8 -26.38 61.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.0 -46.5 43.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 0.746 ' HE2' HAD2 ' B' ' 147' ' ' HEC . 58.0 t-80 -61.87 -23.82 66.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.376 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.06 -19.97 77.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -69.52 -37.31 77.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -1.197 . . . . 0.0 109.124 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . 0.59 ' CB ' HBA2 ' B' ' 147' ' ' HEC . 62.1 mmtt -68.06 -40.78 82.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.337 -0.852 . . . . 0.0 109.539 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.554 HG13 ' C2B' ' B' ' 147' ' ' HEC . 42.1 t -61.14 -59.15 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.285 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.8 tt -58.56 -52.66 64.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.001 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.08 -45.02 26.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.45 96.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -1.129 . . . . 0.0 109.386 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.526 ' O ' ' CD1' ' B' ' 71' ' ' PHE . 2.5 t80 -69.63 -27.3 64.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.378 -0.826 . . . . 0.0 109.332 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.402 ' HB2' ' HE1' ' B' ' 15' ' ' TRP . 88.1 p -76.77 -27.91 55.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.938 . . . . 0.0 109.557 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' B' ' 77' ' ' HIS . 10.6 t70 -47.34 -37.08 10.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.584 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.05 -60.63 6.6 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.446 HD11 ' H ' ' B' ' 75' ' ' LEU . 4.7 mp -56.71 -24.67 50.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -1.217 . . . . 0.0 109.176 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.542 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -93.91 -11.06 31.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.314 -0.866 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 80.3 m-70 -161.31 65.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 109.648 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.69 10.27 0.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 0.0 109.04 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' B' ' 77' ' ' HIS . 2.8 p30 -64.42 -30.24 71.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.286 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' B' ' 79' ' ' ASP . 34.5 t-20 -171.05 105.13 0.23 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.371 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.21 -58.79 2.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -48.24 -23.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.447 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -68.72 -54.77 13.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.9 t -75.19 -47.17 29.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -1.18 . . . . 0.0 109.427 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' B' ' 84' ' ' THR . 48.8 m-85 -62.72 -5.42 2.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.428 -0.795 . . . . 0.0 109.459 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.7 -34.59 62.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.329 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.55 ' HG1' ' H ' ' B' ' 88' ' ' LEU . 37.3 p -79.82 -51.15 9.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.393 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.55 ' H ' ' HG1' ' B' ' 87' ' ' THR . 27.8 mt -59.69 -42.08 92.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.88 . . . . 0.0 109.333 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' B' ' 140' ' ' ALA . 5.1 m -65.08 -42.46 94.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -73.04 -40.19 65.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 4.6 tt -66.97 -34.98 78.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' B' ' 97' ' ' HIS . 60.1 m80 -84.35 -20.29 32.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.004 -1.06 . . . . 0.0 109.703 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 39.3 t -84.02 -60.04 2.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.915 . . . . 0.0 110.987 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -86.91 -29.86 21.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.991 -1.068 . . . . 0.0 111.601 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -85.8 -51.81 6.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.695 -1.253 . . . . 0.0 110.69 -178.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.613 ' C ' ' CG ' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -102.77 -24.21 13.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.021 -1.049 . . . . 0.0 109.853 -179.269 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 1.198 ' CE1' HG23 ' C' ' 41' ' ' THR . 0.5 OUTLIER 44.64 47.23 8.62 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.146 -0.971 . . . . 0.0 109.822 179.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -60.73 121.48 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -0.995 . . . . 0.0 108.987 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' B' ' 100' ' ' PRO . 13.9 m-20 -59.08 143.99 83.41 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 0.0 109.236 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' B' ' 99' ' ' ASP . 76.1 Cg_exo -45.85 -174.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.356 2.038 . . . . 0.0 112.317 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 57.45 76.58 0.31 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.448 ' C ' ' N ' ' B' ' 104' ' ' ARG . 40.5 t-20 -171.57 -67.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.41 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -49.05 -15.78 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.93 . . . . 0.0 109.319 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . 0.448 ' N ' ' C ' ' B' ' 102' ' ' ASN . 10.3 mmt180 -76.27 -31.06 58.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 mt -77.83 -52.03 9.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.893 HD11 ' CHC' ' B' ' 147' ' ' HEC . 5.4 tt -51.03 -49.16 61.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.155 -0.966 . . . . 0.0 109.308 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.78 -21.32 65.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -85.62 -27.76 25.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -1.18 . . . . 0.0 109.731 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.15 -47.48 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 109.647 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 16.1 mt -48.39 -39.74 23.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 65.2 t -51.08 -36.41 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.657 ' SG ' ' CD2' ' A' ' 122' ' ' HIS . 14.4 t -78.19 -22.99 47.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.554 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.17 -27.2 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.603 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 28.6 mt -81.36 -22.39 38.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.972 . . . . 0.0 109.502 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' B' ' 119' ' ' GLY . . . -83.48 -37.0 23.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.468 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 9.1 t-80 -68.97 -49.04 61.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.496 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 0.3 OUTLIER -74.32 -17.68 60.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.475 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 6.1 m-85 -152.38 61.94 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.439 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.54 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -62.08 -25.52 66.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -74.1 -31.03 62.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -1.139 . . . . 0.0 109.544 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -82.25 11.73 5.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.321 -0.862 . . . . 0.0 109.626 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.553 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -85.0 35.05 0.56 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.557 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 63.4 p -54.53 147.31 30.04 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.373 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.499 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 4.0 Cg_exo -45.13 -54.53 4.22 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.541 2.16 . . . . 0.0 113.173 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 18.4 Cg_endo -59.41 -11.56 14.05 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.119 1.88 . . . . 0.0 112.236 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 72.5 t -97.72 -20.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.222 -0.924 . . . . 0.0 109.626 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . 0.563 ' NE2' ' CG1' ' A' ' 107' ' ' VAL . 5.4 tp-100 -83.37 -59.99 2.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.159 -0.963 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.703 ' HB1' ' HB3' ' A' ' 34' ' ' LEU . . . -61.67 -34.81 76.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.21 -0.931 . . . . 0.0 109.623 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.02 23.93 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' B' ' 128' ' ' ALA . 23.4 t80 -118.9 -59.17 1.89 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.837 . . . . 0.0 109.68 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -47.07 -23.33 0.47 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.861 . . . . 0.0 109.955 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -82.52 -38.28 24.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 109.892 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.6 -41.04 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.885 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' B' ' 136' ' ' GLY . 1.6 m -81.97 -40.72 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.77 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 1.06 ' O ' ' CD2' ' D' ' 146' ' ' HIS . . . -47.51 -20.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.008 . . . . 0.0 109.523 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . 0.6 ' N ' ' HE2' ' D' ' 146' ' ' HIS . . . -75.63 -41.63 28.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.21 -21.96 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -1.13 . . . . 0.0 109.483 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.55 -44.36 80.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.463 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.804 HD22 ' HB2' ' D' ' 146' ' ' HIS . 0.9 OUTLIER -79.71 -35.35 39.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . 0.403 ' O ' ' OG ' ' B' ' 89' ' ' SER . . . -49.2 -43.95 42.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.905 . . . . 0.0 109.53 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.1 17.79 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.415 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' B' ' 146' ' ' HIS . . . -141.07 8.18 2.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -67.03 -38.19 85.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.307 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.32 -13.42 62.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' B' ' 145' ' ' TYR . 23.1 p90 -160.55 55.36 0.32 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 1.035 ' CD2' ' O ' ' D' ' 135' ' ' ALA . 2.2 p-80 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 12.4 tp -171.71 145.52 1.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.953 . . . . 0.0 109.661 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.59 168.39 20.17 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.309 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' C' ' 5' ' ' ALA . 55.7 Cg_endo -73.22 -61.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.656 2.237 . . . . 0.0 112.662 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.2 -38.26 5.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.145 -0.972 . . . . 0.0 109.717 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' C' ' 5' ' ' ALA . 4.8 m-20 -44.63 -28.23 0.58 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.05 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' C' ' 10' ' ' VAL . 77.0 mttt -83.19 -60.24 2.21 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.443 -0.786 . . . . 0.0 109.033 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 46.1 m -46.46 -31.56 2.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.519 -0.738 . . . . 0.0 109.639 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -76.73 -35.93 57.48 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' C' ' 7' ' ' LYS . 4.5 t -73.53 -50.24 31.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -49.08 -42.98 40.61 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.32 -63.59 1.14 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.494 -0.754 . . . . 0.0 109.3 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.33 -39.12 69.59 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.428 -0.795 . . . . 0.0 109.191 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . 0.428 ' NE1' ' OG1' ' C' ' 67' ' ' THR . 0.1 OUTLIER -71.21 -17.31 62.52 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.285 -0.885 . . . . 0.0 109.088 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.19 -46.18 7.73 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -70.6 -34.78 72.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -1.156 . . . . 0.0 108.806 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 69.0 t -62.8 -66.19 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 60.9 -140.83 48.09 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.405 ' O ' ' CG ' ' C' ' 20' ' ' HIS . . . -66.63 49.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.458 -1.025 . . . . 0.0 110.169 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' C' ' 18' ' ' GLY . 79.7 m-70 -153.79 19.66 0.52 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -83.87 -62.83 1.47 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.693 -0.63 . . . . 0.0 109.743 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.25 -14.37 0.16 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 21' ' ' ALA . 3.4 mm-40 -86.75 -56.5 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 109.703 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.8 m-30 -55.27 -52.35 63.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.175 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.05 -22.88 14.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.57 -45.42 53.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 109.762 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . 0.512 ' OE1' ' NE2' ' C' ' 112' ' ' HIS . 94.9 mt-10 -65.65 -19.87 66.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.482 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.49 60.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.905 . . . . 0.0 109.377 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 21.4 mt -65.88 -41.2 91.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.711 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -75.64 -12.55 60.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.858 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -78.94 -47.34 16.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.154 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.902 ' HE3' HBC1 ' C' ' 142' ' ' HEC . 1.1 ptm -65.76 -26.24 67.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 0.0 109.733 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.41 -36.52 83.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 0.0 109.373 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.7 ' HB3' ' HB1' ' D' ' 128' ' ' ALA . 12.1 mt -85.66 -44.88 12.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.678 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 40.3 t -51.51 -19.63 1.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.852 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' C' ' 35' ' ' SER . 59.9 m-85 -160.92 90.4 1.61 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 0.0 109.65 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' C' ' 39' ' ' THR . 52.2 Cg_exo -50.4 -26.17 15.52 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.488 2.125 . . . . 0.0 112.137 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 10.8 p -47.32 -18.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.439 ' N ' ' O ' ' C' ' 37' ' ' PRO . 21.8 p -76.6 -22.76 53.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.238 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' C' ' 43' ' ' PHE . 28.8 ttmt -74.29 -31.77 62.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.777 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 1.198 HG23 ' CE1' ' B' ' 97' ' ' HIS . 14.2 t -47.03 -25.75 0.89 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 109.354 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.474 ' C ' ' CG ' ' C' ' 43' ' ' PHE . 97.4 m-85 -87.92 31.02 0.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.474 ' CG ' ' C ' ' C' ' 42' ' ' TYR . 0.9 OUTLIER 70.2 149.64 0.12 Allowed Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.531 ' O ' ' C ' ' C' ' 45' ' ' HIS . 39.9 Cg_endo -68.86 -42.88 3.99 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.036 1.824 . . . . 0.0 112.261 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.534 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 21.6 p80 34.42 34.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.586 -0.696 . . . . 0.0 109.244 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.705 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.9 OUTLIER -166.6 75.47 0.18 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.609 ' C ' ' O ' ' C' ' 46' ' ' PHE . 20.7 m-20 -8.76 -54.69 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 120.985 0.422 . . . . 0.0 111.493 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.705 ' N ' ' O ' ' C' ' 46' ' ' PHE . 5.7 mt 56.71 4.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.503 ' H ' ' C ' ' C' ' 47' ' ' ASP . 33.4 t -73.34 19.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 109.348 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.523 ' H ' ' C ' ' C' ' 48' ' ' LEU . 6.6 t-80 58.81 156.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.42 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.06 15.23 1.43 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.487 ' O ' ' N ' ' C' ' 54' ' ' GLN . 10.7 t -72.49 -21.33 61.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -1.127 . . . . 0.0 109.422 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' C' ' 55' ' ' VAL . . . 67.54 -50.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.463 -0.773 . . . . 0.0 109.717 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.491 HE22 ' CG ' ' C' ' 47' ' ' ASP . 15.8 pt20 -45.39 -17.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.667 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' C' ' 53' ' ' ALA . 77.4 t -73.87 -32.94 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.75 -24.77 67.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.673 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.16 -51.07 41.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 24.9 t-80 -67.8 -27.92 67.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -1.202 . . . . 0.0 110.221 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.13 -31.05 79.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.419 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 16.9 mtpp -71.92 -23.48 61.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -1.152 . . . . 0.0 110.118 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.81 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 0.4 OUTLIER -66.91 -58.15 5.56 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.044 -1.035 . . . . 0.0 108.574 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -55.08 -48.98 75.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.536 -0.728 . . . . 0.0 109.245 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.459 ' O ' ' OG1' ' C' ' 67' ' ' THR . . . -64.33 -42.55 96.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.299 -0.875 . . . . 0.0 108.854 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 7.4 t70 -72.0 -25.69 61.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.065 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . 1.002 ' HB3' HMA2 ' C' ' 142' ' ' HEC . . . -80.61 -44.75 18.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.375 -0.828 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' C' ' 66' ' ' LEU . 0.1 OUTLIER -76.5 -27.38 56.01 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' C' ' 63' ' ' ALA . 52.0 m -75.89 -44.66 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -57.45 -20.72 32.34 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.33 -45.68 12.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 6.0 t -59.75 -22.57 24.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.521 ' O ' ' CD2' ' C' ' 72' ' ' HIS . . . -65.48 -15.17 62.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.092 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' C' ' 74' ' ' ASP . 32.0 m80 -153.03 -51.87 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.434 -0.791 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.1 p 44.59 15.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.85 0.833 . . . . 0.0 109.214 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' C' ' 72' ' ' HIS . 95.8 m-20 -134.36 10.43 3.78 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' C' ' 78' ' ' ASN . 31.2 t70 -175.1 27.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.248 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.693 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.1 ptt? -78.52 -24.29 0.43 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.433 -0.792 . . . . 0.0 111.839 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.4 Cg_exo -52.81 -19.79 11.62 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.711 1.607 . . . . 0.0 112.629 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.452 ' ND2' ' N ' ' C' ' 79' ' ' ALA . 0.8 OUTLIER -94.25 -33.09 13.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.823 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . 0.452 ' N ' ' ND2' ' C' ' 78' ' ' ASN . . . -74.6 -40.81 61.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.62 12.13 13.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 108.983 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 66.3 p -70.63 -16.19 62.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.632 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -82.1 -51.59 7.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.16 -0.963 . . . . 0.0 109.719 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 mt -45.2 -42.82 9.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.804 . . . . 0.0 109.028 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 29.7 p -57.1 -22.15 37.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.493 -0.755 . . . . 0.0 109.574 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' C' ' 82' ' ' ALA . 0.8 OUTLIER -72.6 -32.7 66.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.94 . . . . 0.0 109.592 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' C' ' 90' ' ' LYS . 7.0 tt -81.37 -29.13 34.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 109.516 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -89.87 -28.47 19.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.58 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.543 ' C ' ' H ' ' C' ' 90' ' ' LYS . . . -83.84 -80.44 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' C' ' 89' ' ' HIS . 30.6 t-80 -61.2 2.49 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.57 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' C' ' 88' ' ' ALA . 6.1 mtmm -156.07 152.38 27.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.281 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.649 ' C ' ' H ' ' C' ' 93' ' ' VAL . 10.9 mp 56.97 63.81 1.82 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -0.865 . . . . 0.0 109.033 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . 1.301 ' HB3' ' NH1' ' B' ' 40' ' ' ARG . 8.4 ptp180 -62.73 14.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.47 -0.769 . . . . 0.0 109.501 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.649 ' H ' ' C ' ' C' ' 91' ' ' LEU . 74.1 t -41.38 121.66 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.384 -0.823 . . . . 0.0 109.64 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.06 147.87 2.2 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.465 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' C' ' 97' ' ' ASN . 38.0 Cg_endo -68.25 -10.7 29.74 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.512 2.141 . . . . 0.0 112.126 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.27 -1.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 1.002 ' HB3' HMC2 ' C' ' 142' ' ' HEC . 5.1 m120 -74.69 -42.27 58.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.857 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . 0.428 ' O ' ' OG ' ' C' ' 102' ' ' SER . 2.2 m-85 -46.37 -42.1 14.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 0.0 109.337 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -57.95 -33.07 68.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.302 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' C' ' 97' ' ' ASN . 11.1 mt -84.09 -62.12 1.64 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 1.012 HD22 HBB3 ' C' ' 142' ' ' HEC . 6.3 tt -50.35 -41.91 52.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.199 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' C' ' 98' ' ' PHE . 39.0 m -63.17 -51.01 68.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.528 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -66.1 -26.76 67.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.544 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.55 -50.5 69.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.753 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.38 -43.02 23.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -0.931 . . . . 0.0 109.384 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.487 ' N ' ' CD1' ' C' ' 106' ' ' LEU . 8.6 mp -64.15 -59.39 4.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.356 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . 0.554 ' CG1' ' NE2' ' D' ' 127' ' ' GLN . 77.0 t -56.33 -30.93 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.379 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 26.6 m -75.75 -63.09 1.38 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.318 -0.864 . . . . 0.0 109.388 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 113' ' ' LEU . 13.1 mt -51.32 -30.66 19.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 109.486 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' D' ' 115' ' ' ALA . . . -47.42 -42.29 21.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.717 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.12 -49.21 11.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.422 -0.799 . . . . 0.0 109.763 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . 0.512 ' NE2' ' OE1' ' C' ' 27' ' ' GLU . 11.4 m170 -76.3 -70.0 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.871 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -110.88 97.07 32.27 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.433 -0.792 . . . . 0.0 109.132 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' C' ' 113' ' ' LEU . 73.0 Cg_exo -47.46 -174.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.399 2.066 . . . . 0.0 112.883 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.59 -35.18 19.6 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.696 0.76 . . . . 0.0 109.517 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 3.8 mt-10 78.45 0.84 2.61 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 0.934 ' HD1' HH21 ' D' ' 30' ' ' ARG . 22.0 t80 65.27 37.64 6.33 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.602 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.764 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -94.01 115.15 64.81 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.749 -1.22 . . . . 0.0 107.907 178.184 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . 0.737 ' HA ' HG13 ' D' ' 33' ' ' VAL . 50.5 Cg_exo -50.38 21.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.974 1.782 . . . . 0.0 112.571 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -147.08 -21.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.039 . . . . 0.0 110.966 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' C' ' 122' ' ' HIS . 10.4 p -58.23 -58.76 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.95 -1.094 . . . . 0.0 110.385 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.649 ' CD2' ' SG ' ' D' ' 112' ' ' CYS . 1.1 m-70 -70.98 -24.97 62.51 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.266 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.1 -20.68 32.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.508 ' N ' ' O ' ' C' ' 120' ' ' ALA . 62.5 p -77.38 -63.15 1.44 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.267 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.5 -19.95 58.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.075 -1.016 . . . . 0.0 109.084 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . 0.543 ' OD2' ' OH ' ' D' ' 35' ' ' TYR . 7.4 t70 -77.71 -51.21 10.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.455 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.26 -41.75 11.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.817 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' C' ' 124' ' ' SER . 29.8 t80 -50.25 -22.94 1.96 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.985 -1.072 . . . . 0.0 108.991 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.487 ' CD2' HBB1 ' C' ' 142' ' ' HEC . 14.9 mt -74.05 -24.69 59.56 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -56.67 -31.99 64.97 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 89.4 p -73.99 -32.42 63.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.48 -29.74 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.47 ' N ' ' O ' ' C' ' 129' ' ' LEU . 9.8 p -81.86 -25.33 35.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.329 -0.857 . . . . 0.0 108.881 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 134' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 36.8 m -74.96 -40.08 60.95 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.361 -0.837 . . . . 0.0 109.1 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.08 -21.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.344 -0.847 . . . . 0.0 108.779 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.77 -35.99 72.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.434 -0.792 . . . . 0.0 109.072 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 137' ' ' THR . . . . . 0.434 ' O ' ' O ' ' C' ' 138' ' ' SER . 57.5 p -88.04 -2.44 58.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 109.571 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 138' ' ' SER . . . . . 0.434 ' O ' ' O ' ' C' ' 137' ' ' THR . 28.3 m 51.89 98.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 109.555 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' C' ' 138' ' ' SER . 5.9 mtpm? -55.04 -170.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 109.532 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -61.42 -67.75 0.38 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.435 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . 0.811 HH12 HH12 ' A' ' 141' ' ' ARG . 43.4 mtp180 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.441 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.648 ' CG2' ' H ' ' D' ' 2' ' ' HIS . 8.3 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.648 ' H ' ' CG2' ' D' ' 1' ' ' VAL . 86.8 m-70 52.03 98.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.384 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.653 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -136.45 -163.14 1.36 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 109.254 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.403 ' O ' ' N ' ' D' ' 6' ' ' GLU . 11.9 p -89.02 130.64 43.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.132 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . 0.447 ' O ' ' OG ' ' D' ' 9' ' ' SER . 86.9 Cg_exo -42.05 -23.06 0.23 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.292 1.995 . . . . 0.0 112.24 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' D' ' 4' ' ' THR . 51.9 mt-10 -80.05 -54.34 5.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.925 . . . . 0.0 109.877 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.39 -40.98 85.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.946 . . . . 0.0 109.87 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.479 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.3 OUTLIER -68.64 -35.08 76.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.473 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 9' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' D' ' 5' ' ' PRO . 4.9 m -60.66 -23.64 64.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 109.879 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.38 -57.64 3.39 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.067 -1.02 . . . . 0.0 109.859 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.69 -24.41 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 82.0 m -83.9 -35.1 24.35 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.349 0.595 . . . . 0.0 109.695 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.11 -29.37 67.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.83 . . . . 0.0 109.668 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.1 -20.98 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.312 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -53.61 -17.93 2.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 109.067 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.7 -33.35 47.3 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -89.72 -41.63 11.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -1.178 . . . . 0.0 109.35 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -57.17 114.83 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.847 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' D' ' 21' ' ' ASP . 7.4 m120 -84.1 68.41 10.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.296 -0.877 . . . . 0.0 108.686 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' D' ' 19' ' ' ASN . 72.3 t -43.94 -18.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 109.673 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' D' ' 19' ' ' ASN . 1.1 m-20 -62.39 -10.77 12.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.764 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -154.37 -35.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 109.517 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 72.8 t -48.72 -34.97 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.17 -25.99 68.8 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.04 -36.22 25.37 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -67.66 -30.67 70.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -1.125 . . . . 0.0 109.487 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.43 46.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' D' ' 28' ' ' LEU . 10.0 mp -64.32 -55.71 19.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.377 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.1 -41.35 29.86 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . 0.934 HH21 ' HD1' ' C' ' 117' ' ' PHE . 73.3 mtt-85 -80.0 -34.57 38.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -1.117 . . . . 0.0 109.502 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 tp -47.19 -37.11 9.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' D' ' 36' ' ' PRO . 14.7 mt -81.31 -39.24 25.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.923 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . 0.737 HG13 ' HA ' ' C' ' 119' ' ' PRO . 73.1 t -58.11 -61.48 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.385 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . 0.641 HG13 ' HB3' ' C' ' 122' ' ' HIS . 1.7 t -68.69 -22.55 26.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.397 -0.814 . . . . 0.0 109.828 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . 0.543 ' OH ' ' OD2' ' C' ' 126' ' ' ASP . 63.9 m-85 -146.77 76.43 11.65 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.153 -0.967 . . . . 0.0 109.767 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' D' ' 32' ' ' LEU . 72.2 Cg_endo -82.86 28.9 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.912 2.408 . . . . 0.0 112.323 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -80.95 -20.0 42.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.095 -1.003 . . . . 0.0 109.717 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' D' ' 39' ' ' GLN . 44.8 p -78.37 -103.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.554 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . 0.524 ' N ' ' OG1' ' D' ' 38' ' ' THR . 13.9 mt-30 55.03 10.67 0.42 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.645 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . 1.272 ' NH1' ' HB3' ' A' ' 92' ' ' ARG . 15.8 mmt180 -88.7 -58.86 2.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -71.45 -8.28 52.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 1.399 ' CZ ' ' CBC' ' D' ' 147' ' ' HEC . 49.4 m-85 -87.72 28.22 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.7 -27.31 65.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.462 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 94.0 p -84.11 -27.22 28.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -49.55 -24.43 2.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.299 -0.876 . . . . 0.0 109.241 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.82 173.11 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.89 91.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -1.091 . . . . 0.0 109.572 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 12.6 mt -139.01 19.71 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 109.31 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -58.85 -34.02 71.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.15 -0.969 . . . . 0.0 109.434 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.6 154.23 68.97 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.32 -24.34 73.94 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.253 1.969 . . . . 0.0 111.765 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.22 -21.0 29.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.608 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.98 -19.9 65.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 109.735 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' D' ' 56' ' ' GLY . 4.4 t -67.07 -64.03 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 0.0 109.465 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.05 8.13 1.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.537 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' D' ' 54' ' ' VAL . . . -74.68 -29.83 60.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -84.42 147.65 50.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.212 -1.169 . . . . 0.0 109.377 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.65 -7.14 19.79 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.584 2.19 . . . . 0.0 112.193 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -85.69 -28.56 24.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.666 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 83.9 t -70.24 -52.95 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -57.82 -26.42 61.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.89 -46.68 43.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 0.735 ' HE2' HAD2 ' D' ' 147' ' ' HEC . 58.2 t-80 -61.72 -23.84 66.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.887 . . . . 0.0 109.443 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.07 -20.0 77.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -69.51 -37.3 77.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 109.084 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . 0.593 ' CB ' HBA2 ' D' ' 147' ' ' HEC . 62.1 mmtt -68.13 -40.69 82.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.444 -0.785 . . . . 0.0 109.498 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.557 HG13 ' C2B' ' D' ' 147' ' ' HEC . 41.9 t -61.29 -59.1 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.203 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 4.8 tt -58.59 -52.61 64.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 108.983 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.15 -44.98 27.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.46 96.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -1.128 . . . . 0.0 109.379 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' D' ' 71' ' ' PHE . 2.5 t80 -69.59 -27.22 64.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.853 . . . . 0.0 109.336 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 88.5 p -76.93 -27.85 55.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' D' ' 77' ' ' HIS . 10.6 t70 -47.42 -37.11 10.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.09 -60.6 6.62 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.449 ' H ' HD11 ' D' ' 75' ' ' LEU . 4.7 mp -56.61 -24.79 50.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -1.159 . . . . 0.0 109.156 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . 0.544 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -93.86 -11.11 31.86 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 109.583 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 80.0 m-70 -161.19 65.15 0.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.59 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.73 10.29 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.082 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' D' ' 77' ' ' HIS . 2.8 p30 -64.35 -30.23 71.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.378 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 34.5 t-20 -171.09 105.08 0.23 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.14 -58.87 2.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -48.23 -23.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.0 109.449 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . 0.436 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -68.73 -54.82 13.23 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.54 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.9 t -75.2 -47.17 29.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -1.164 . . . . 0.0 109.417 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.54 ' N ' ' CG2' ' D' ' 84' ' ' THR . 48.6 m-85 -62.7 -5.41 2.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.67 62.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.273 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 87' ' ' THR . . . . . 0.548 ' HG1' ' H ' ' D' ' 88' ' ' LEU . 37.1 p -79.75 -51.22 9.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.379 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.548 ' H ' ' HG1' ' D' ' 87' ' ' THR . 27.1 mt -59.68 -42.07 92.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 89' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' D' ' 140' ' ' ALA . 5.1 m -65.09 -42.41 94.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -73.1 -40.15 65.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 4.6 tt -67.02 -35.03 79.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.607 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.561 ' O ' ' N ' ' D' ' 97' ' ' HIS . 60.0 m80 -84.28 -20.28 32.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.926 -1.109 . . . . 0.0 109.722 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 39.4 t -84.01 -60.07 2.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 111.01 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -86.96 -29.8 21.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.001 -1.062 . . . . 0.0 111.59 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -85.77 -51.92 6.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.772 -1.205 . . . . 0.0 110.649 -178.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.607 ' C ' ' CG ' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -102.75 -24.12 13.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.06 -1.025 . . . . 0.0 109.856 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 1.247 ' CE1' ' CG2' ' A' ' 41' ' ' THR . 0.5 OUTLIER 44.64 47.08 8.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.104 -0.998 . . . . 0.0 109.892 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 t -60.6 121.51 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.119 -0.988 . . . . 0.0 109.033 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' D' ' 100' ' ' PRO . 13.9 m-20 -59.09 143.97 83.47 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.225 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' D' ' 99' ' ' ASP . 75.4 Cg_exo -45.85 -174.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.423 2.082 . . . . 0.0 112.342 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 57.44 76.61 0.31 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' D' ' 104' ' ' ARG . 40.5 t-20 -171.6 -67.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.432 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -49.0 -15.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' D' ' 102' ' ' ASN . 10.3 mmt180 -76.2 -31.15 58.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.336 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 mt -77.78 -51.99 9.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.859 . . . . 0.0 109.645 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.891 HD11 ' CHC' ' D' ' 147' ' ' HEC . 5.4 tt -51.09 -49.18 61.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.107 -0.996 . . . . 0.0 109.23 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.77 -21.24 65.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -85.75 -27.64 25.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -1.162 . . . . 0.0 109.715 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.15 -47.48 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.646 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 16.2 mt -48.48 -39.7 23.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 109.503 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 65.4 t -51.11 -36.45 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . 0.649 ' SG ' ' CD2' ' C' ' 122' ' ' HIS . 14.4 t -78.09 -23.02 48.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -79.14 -27.18 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.644 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 29.0 mt -81.47 -22.31 38.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.903 . . . . 0.0 109.507 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' D' ' 119' ' ' GLY . . . -83.45 -36.93 23.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 109.635 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.456 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 9.2 t-80 -68.96 -49.08 61.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . 0.502 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 0.3 OUTLIER -74.32 -17.7 60.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.486 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 6.2 m-85 -152.37 62.07 0.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -62.07 -25.55 66.38 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -74.16 -31.0 62.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.535 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -82.27 11.75 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -84.98 34.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.961 . . . . 0.0 109.536 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 65.1 p -54.42 147.34 28.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.503 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.9 Cg_exo -45.11 -54.58 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.411 2.074 . . . . 0.0 113.16 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 18.3 Cg_endo -59.39 -11.5 13.81 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.113 1.875 . . . . 0.0 112.298 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 72.1 t -97.86 -20.44 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 109.59 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . 0.554 ' NE2' ' CG1' ' C' ' 107' ' ' VAL . 5.4 tp-100 -83.34 -60.1 2.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 109.859 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 0.7 ' HB1' ' HB3' ' C' ' 34' ' ' LEU . . . -61.67 -34.78 76.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.96 23.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . 0.441 ' H ' ' C ' ' D' ' 128' ' ' ALA . 23.5 t80 -118.96 -59.19 1.88 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.44 -0.788 . . . . 0.0 109.591 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -47.03 -23.35 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.983 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -82.56 -38.22 24.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -0.972 . . . . 0.0 109.932 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 45.2 t -61.59 -41.05 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -0.95 . . . . 0.0 109.881 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' D' ' 136' ' ' GLY . 1.6 m -82.04 -40.71 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.98 . . . . 0.0 109.771 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 1.035 ' O ' ' CD2' ' B' ' 146' ' ' HIS . . . -47.5 -20.99 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.119 -0.988 . . . . 0.0 109.58 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . 0.592 ' N ' ' HE2' ' B' ' 146' ' ' HIS . . . -75.63 -41.51 29.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.31 -21.86 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -1.128 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.63 -44.29 81.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.824 HD22 ' HB2' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -79.67 -35.4 39.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.539 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . 0.4 ' O ' ' OG ' ' D' ' 89' ' ' SER . . . -49.23 -43.94 43.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.496 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 40.2 mt -84.07 17.72 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' D' ' 146' ' ' HIS . . . -140.99 8.15 2.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.264 -0.898 . . . . 0.0 109.467 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -67.02 -38.13 85.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.888 . . . . 0.0 109.31 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.38 -13.47 62.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.862 . . . . 0.0 109.355 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' D' ' 145' ' ' TYR . 23.2 p90 -160.51 55.4 0.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 1.06 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 2.2 p-80 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 1.055 HBB3 HD22 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 1.418 ' CBC' ' CZ ' ' B' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 1.012 HBB3 HD22 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.399 ' CBC' ' CZ ' ' D' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.416 ' C ' ' OG ' ' A' ' 3' ' ' SER . 14.7 mt -139.09 -178.34 5.3 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.375 -0.828 . . . . 0.0 109.18 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.453 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 178.77 -50.9 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.993 . . . . 0.0 110.065 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 6' ' ' ASP . 83.0 Cg_exo -43.63 155.64 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.43 2.087 . . . . 0.0 112.538 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -46.21 -16.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 109.803 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' PRO . 12.5 t70 -39.45 -44.86 1.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 109.816 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 8' ' ' THR . 6.5 ptmt -58.01 -50.41 73.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.125 -0.985 . . . . 0.0 108.992 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.415 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 22.7 m -54.73 -31.41 58.3 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 108.652 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -77.23 -34.84 55.87 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.85 -51.81 41.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -47.78 46.96 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.47 -61.14 2.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.645 -0.659 . . . . 0.0 109.458 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.27 -41.91 51.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.403 -0.811 . . . . 0.0 109.066 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -17.54 64.93 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.4 -0.813 . . . . 0.0 109.178 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -78.18 -45.48 10.11 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -68.62 -39.59 80.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -1.174 . . . . 0.0 108.763 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.88 -64.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 54.76 -132.77 47.83 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.73 27.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -1.063 . . . . 0.0 110.376 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.584 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.8 m-70 -131.83 25.2 4.67 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.232 -0.918 . . . . 0.0 108.538 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -89.41 -59.55 2.18 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.566 -0.709 . . . . 0.0 109.789 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.71 -13.89 0.2 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.6 mt-10 -87.58 -56.48 3.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 109.912 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.526 ' CD1' ' ND1' ' A' ' 112' ' ' HIS . 3.0 m-30 -60.11 -29.22 68.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.5 87.19 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.16 -39.13 29.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -1.165 . . . . 0.0 109.75 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -63.88 -25.54 68.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.261 -0.899 . . . . 0.0 109.318 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.35 -23.06 66.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.572 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.401 ' CD1' ' CG ' ' A' ' 58' ' ' HIS . 10.7 mt -76.65 -58.49 3.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.55 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -62.39 -12.42 21.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.446 ' HE ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -69.65 -49.92 49.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 110.329 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.6 ptt? -84.11 -36.45 22.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.046 -1.034 . . . . 0.0 110.404 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -43.78 -23.84 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.171 -0.955 . . . . 0.0 110.107 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 1.523 HD12 ' CB ' ' B' ' 128' ' ' ALA . 2.3 pp -92.16 -28.8 16.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.125 -0.984 . . . . 0.0 109.951 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 81.2 p -89.21 -18.44 27.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.087 -1.008 . . . . 0.0 110.022 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 35' ' ' SER . 84.7 m-85 -157.95 75.82 3.81 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.104 -0.997 . . . . 0.0 109.719 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.34 -19.98 60.77 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.889 2.393 . . . . 0.0 112.247 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.4 p -48.61 -18.78 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.943 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.459 ' HG1' ' N ' ' A' ' 40' ' ' LYS . 38.1 p -85.92 -52.98 5.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.957 . . . . 0.0 109.803 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 42' ' ' TYR . 0.5 OUTLIER -80.01 -17.57 52.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 109.644 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 40' ' ' LYS . 10.7 t -37.55 -28.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.453 -0.78 . . . . 0.0 109.894 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 40' ' ' LYS . 23.6 m-85 -51.31 -36.5 42.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.101 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.527 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 77.8 t80 45.54 56.6 15.49 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.44 -0.787 . . . . 0.0 110.099 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 43' ' ' PHE . 80.8 Cg_endo -79.6 -41.69 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.637 2.225 . . . . 0.0 111.901 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -176.58 56.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -139.35 63.78 1.49 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 49' ' ' SER . 33.7 m-20 -37.94 -22.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 46' ' ' PHE . 1.2 mt 52.6 6.33 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.218 -0.926 . . . . 0.0 109.583 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 47' ' ' ASP . 34.5 t -81.3 153.3 27.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 28.3 m170 -47.79 128.64 13.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.53 22.04 13.45 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 54' ' ' GLN . 36.9 m -95.03 66.02 2.95 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -1.155 . . . . 0.0 108.964 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -37.85 -25.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.818 -0.551 . . . . 0.0 110.237 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' A' ' 52' ' ' SER . 14.1 mt-30 -60.8 -46.22 91.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.9 t -55.99 -47.62 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.087 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -66.55 -54.19 26.45 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.515 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . . . -53.12 -26.77 29.07 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.504 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.8 t-80 -69.85 -33.48 72.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.985 -1.303 . . . . 0.0 109.798 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.6 -48.61 83.68 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 51.3 mttp -51.0 -23.82 3.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -1.057 . . . . 0.0 109.811 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.656 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 0.5 OUTLIER -71.43 -50.68 29.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.208 -0.933 . . . . 0.0 108.891 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.63 -43.61 90.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.603 -0.686 . . . . 0.0 109.327 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.04 -28.88 64.7 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.234 -0.916 . . . . 0.0 109.432 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 15.1 t70 -72.26 -40.12 67.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 108.782 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.33 82.03 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.372 -0.83 . . . . 0.0 108.875 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.15 -40.31 95.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -70.62 -51.03 30.87 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -59.39 -22.96 62.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.58 -47.31 11.42 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.08 -22.63 31.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.44 -15.09 63.43 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.596 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.1 m80 -143.78 -59.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.509 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.5 p 44.57 13.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.713 0.768 . . . . 0.0 109.492 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' A' ' 72' ' ' HIS . 12.8 t70 -133.38 9.66 4.04 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 2.1 m-20 -179.58 27.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.942 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.683 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 17.7 ptt? -78.74 -22.75 0.39 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 112.006 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 76' ' ' MET . 52.3 Cg_exo -52.63 -22.01 15.99 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.578 1.519 . . . . 0.0 112.592 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.13 -24.03 17.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.728 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.47 -54.29 6.92 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.151 -0.968 . . . . 0.0 109.183 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 80' ' ' LEU . 7.0 mp -77.15 8.89 3.46 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.433 -0.792 . . . . 0.0 109.046 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.6 t -65.18 -15.83 62.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 109.886 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.79 -46.08 14.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 0.0 109.854 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 82' ' ' ALA . 4.2 mt -46.43 -45.93 18.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.314 -0.866 . . . . 0.0 108.94 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 135' ' ' VAL . 37.6 m -54.04 -29.15 42.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.552 -0.717 . . . . 0.0 109.45 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' ALA . 25.9 t0 -65.68 -33.93 77.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 109.499 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.543 ' CD1' ' CBD' ' A' ' 142' ' ' HEC . 3.0 tt -82.99 -63.65 1.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -50.09 -21.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 109.954 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.76 -48.11 5.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.168 -0.957 . . . . 0.0 109.955 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.42 ' HD1' ' HZ1' ' A' ' 90' ' ' LYS . 7.8 t-80 -76.73 -70.95 0.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 86' ' ' LEU . 30.1 mttm -86.43 140.65 29.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.808 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.419 ' CD1' ' N ' ' A' ' 91' ' ' LEU . 10.6 mp 53.88 57.91 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.07 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.585 ' HD3' ' CD ' ' D' ' 40' ' ' ARG . 72.5 ttt180 -47.89 -47.58 31.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.829 . . . . 0.0 109.288 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.597 ' CG1' ' H ' ' A' ' 94' ' ' ASP . 62.1 t 49.67 179.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.353 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.597 ' H ' ' CG1' ' A' ' 93' ' ' VAL . 34.7 m-20 -133.09 151.87 78.64 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.151 -0.968 . . . . 0.0 109.12 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 98' ' ' PHE . 82.3 Cg_exo -39.28 -19.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.571 2.181 . . . . 0.0 112.282 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 1.31 HG22 ' CB ' ' D' ' 99' ' ' ASP . 64.6 t -47.07 -32.91 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.697 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.452 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 1.5 m120 -79.23 -25.15 42.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 95' ' ' PRO . 77.4 t80 -67.88 -56.38 9.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.83 -28.8 2.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 109.545 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 17.0 mt -84.04 -52.37 6.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.79 HD22 ' CHC' ' A' ' 142' ' ' HEC . 57.7 tp -47.2 -39.75 14.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.948 . . . . 0.0 109.76 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.2 p -65.04 -59.22 4.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -52.97 -26.79 16.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.811 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 60.4 m -66.46 -58.44 5.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -45.98 -22.99 0.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 109.91 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 4.1 mm? -82.19 -32.33 29.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.029 -1.044 . . . . 0.0 109.808 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.92 -27.5 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.686 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.625 ' HG1' ' H ' ' A' ' 109' ' ' LEU . 6.8 p -69.01 -60.45 2.35 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.156 -0.965 . . . . 0.0 109.549 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.625 ' H ' ' HG1' ' A' ' 108' ' ' THR . 37.1 mt -55.88 -42.1 75.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 109.291 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.31 11.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.798 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.27 -55.79 4.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 109.901 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.526 ' ND1' ' CD1' ' A' ' 24' ' ' TYR . 22.3 m170 -59.59 -62.66 1.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.083 -1.011 . . . . 0.0 109.128 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.54 ' O ' ' O ' ' A' ' 114' ' ' PRO . 2.4 pp -137.69 118.94 10.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.54 ' O ' ' O ' ' A' ' 113' ' ' LEU . 88.2 Cg_exo -40.78 -178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.551 2.167 . . . . 0.0 113.292 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.647 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -57.42 -55.19 37.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.43 -0.794 . . . . 0.0 109.157 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.647 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 4.8 mm-40 120.48 -2.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.2 t80 64.52 52.19 1.83 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.962 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -133.04 111.5 13.17 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.679 ' HA ' HG11 ' B' ' 33' ' ' VAL . 76.7 Cg_exo -47.48 10.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.139 1.893 . . . . 0.0 112.582 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -132.65 -19.37 2.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.289 -0.882 . . . . 0.0 110.197 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 11.6 p -60.36 -55.4 24.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.154 -0.966 . . . . 0.0 110.299 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.984 ' HB3' HG11 ' B' ' 34' ' ' VAL . 6.4 m170 -71.93 -33.35 68.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 0.0 108.947 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.99 -20.16 49.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.2 m -64.86 -62.71 1.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 110.003 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.54 -19.56 65.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.191 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.91 -50.11 11.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.718 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -85.55 -43.19 13.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.114 -0.991 . . . . 0.0 109.857 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.449 ' H ' ' HG3' ' A' ' 127' ' ' LYS . 53.6 t80 -49.44 -21.0 0.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.962 -1.086 . . . . 0.0 108.668 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.686 HD21 HBB1 ' A' ' 142' ' ' HEC . 12.8 mt -71.94 -17.48 62.08 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.98 -31.65 72.02 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.4 p -83.29 -34.02 25.83 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.418 -0.801 . . . . 0.0 108.86 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.31 -28.01 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 108.654 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 129' ' ' LEU . 36.8 m -80.08 -28.85 39.05 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.495 -0.753 . . . . 0.0 109.236 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 41.9 m -71.31 -33.59 69.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.245 -0.909 . . . . 0.0 109.044 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.432 ' O ' ' OG ' ' A' ' 84' ' ' SER . 30.0 t -79.93 -28.19 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -35.81 73.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.468 -0.77 . . . . 0.0 109.106 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.9 t -101.86 -14.57 17.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 0.0 109.588 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.424 ' HG ' ' H ' ' A' ' 139' ' ' LYS . 8.5 t 55.73 -173.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.329 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 141' ' ' ARG . 56.5 mttp -49.61 -59.86 3.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.561 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.511 ' O ' ' CD2' ' A' ' 140' ' ' TYR . 67.9 t80 52.38 9.33 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.525 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.489 ' H ' ' C ' ' A' ' 139' ' ' LYS . 26.0 mtm180 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.475 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.682 ' CG1' ' H ' ' B' ' 2' ' ' HIS . 2.7 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . 0.682 ' H ' ' CG1' ' B' ' 1' ' ' VAL . 0.5 OUTLIER 53.89 105.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.121 -0.987 . . . . 0.0 109.826 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.92 179.06 9.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.422 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.437 ' OG1' ' OE2' ' B' ' 7' ' ' GLU . 2.2 p -73.39 151.64 89.79 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.413 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.54 -28.61 21.28 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.558 2.172 . . . . 0.0 112.049 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -78.73 -41.23 31.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.573 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.437 ' OE2' ' OG1' ' B' ' 4' ' ' THR . 46.2 mt-10 -64.77 -46.08 83.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.559 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.48 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -72.63 -37.44 68.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 109.624 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.403 ' C ' ' O ' ' B' ' 8' ' ' LYS . 3.3 t -45.63 -23.62 0.26 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.688 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.32 -56.51 3.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 109.949 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -65.21 -24.62 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 5.8 m -77.53 -45.73 24.52 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.398 0.618 . . . . 0.0 109.53 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.21 -34.54 72.3 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.396 -0.815 . . . . 0.0 109.573 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.43 ' C ' ' N ' ' B' ' 16' ' ' GLY . 0.8 OUTLIER -51.8 -32.12 30.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.922 . . . . 0.0 109.122 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -48.68 -17.99 0.22 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.343 -0.848 . . . . 0.0 109.267 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' B' ' 14' ' ' LEU . . . -76.78 -56.7 4.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.416 ' N ' ' CD ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -64.78 -27.48 68.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -1.203 . . . . 0.0 109.15 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.9 114.69 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' B' ' 21' ' ' ASP . 25.4 m-80 -80.42 69.15 6.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.231 -0.918 . . . . 0.0 109.048 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 74.2 t -44.32 -21.32 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.419 -0.801 . . . . 0.0 109.651 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' B' ' 19' ' ' ASN . 68.1 m-20 -74.08 3.87 6.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' B' ' 19' ' ' ASN . 35.1 mt-10 -153.01 -41.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.177 -0.952 . . . . 0.0 109.313 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.54 -46.63 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.288 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.32 -42.94 64.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.88 -44.02 63.75 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -68.01 -25.06 65.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.27 -49.44 66.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.551 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' B' ' 28' ' ' LEU . 9.4 mp -79.12 -54.51 5.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.45 -33.4 8.3 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -82.08 -39.33 23.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -1.119 . . . . 0.0 109.337 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -49.2 -35.79 18.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 27.3 mt -79.88 -31.95 40.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 109.56 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 119' ' ' PRO . 61.7 t -66.43 -64.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.423 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.984 HG11 ' HB3' ' A' ' 122' ' ' HIS . 1.3 t -64.43 -22.74 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.355 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -146.17 80.73 10.05 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.342 -0.849 . . . . 0.0 109.382 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.36 -5.6 14.33 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.672 2.248 . . . . 0.0 112.439 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . 0.535 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 1.3 p-90 -58.86 -24.43 62.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.535 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 3.1 m -95.91 38.22 1.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.39 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -90.98 9.52 30.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 109.624 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 1.674 ' CD ' ' HD3' ' C' ' 92' ' ' ARG . 55.1 ttt85 -81.56 -29.83 33.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' B' ' 42' ' ' PHE . 66.2 m-85 -90.91 30.08 1.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.948 . . . . 0.0 109.405 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 1.024 ' HE1' ' CBC' ' B' ' 147' ' ' HEC . 70.5 m-85 -145.66 22.61 1.45 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.48 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -78.93 -16.51 56.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.255 -0.903 . . . . 0.0 109.51 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.464 ' C ' ' H ' ' B' ' 46' ' ' GLY . 27.8 p -67.47 -43.23 81.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.598 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' B' ' 47' ' ' ASP . 88.4 m-85 -48.89 -14.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.506 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' B' ' 44' ' ' SER . . . 66.89 -65.42 0.19 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' B' ' 45' ' ' PHE . 4.6 m-20 -46.18 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -1.163 . . . . 0.0 109.576 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 tp -159.47 22.62 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 12.9 p -70.45 -33.83 71.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.533 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' THR . . . . . 0.442 ' O ' ' N ' ' B' ' 53' ' ' ALA . 3.4 p -145.7 151.52 46.5 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 0.0 109.111 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -39.96 -42.09 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.373 2.049 . . . . 0.0 112.238 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.2 -31.05 72.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -61.93 -19.79 63.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.475 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 78.6 t -67.96 -63.83 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.657 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 22.4 ptp -83.18 4.49 26.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.723 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.88 -17.23 70.64 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -82.19 138.18 45.67 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.0 109.024 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.18 -12.88 30.7 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.247 1.964 . . . . 0.0 112.14 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -80.17 -57.47 3.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.332 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 43.0 t -48.02 -31.58 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.341 -0.85 . . . . 0.0 109.56 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -78.99 -32.94 45.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.508 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.62 -45.79 16.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.69 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 1.092 ' HE2' ' CAD' ' B' ' 147' ' ' HEC . 0.9 OUTLIER -62.72 -23.64 67.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.22 -0.925 . . . . 0.0 109.671 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.57 -36.34 83.15 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -60.15 -25.46 65.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -1.2 . . . . 0.0 109.58 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.69 -50.17 39.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.317 -0.865 . . . . 0.0 109.62 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 1.024 HG23 ' CHB' ' B' ' 147' ' ' HEC . 42.3 t -57.72 -36.73 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 5.6 tt -71.58 -48.03 51.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.288 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.46 -44.91 16.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.62 -51.85 56.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -1.131 . . . . 0.0 109.44 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -49.5 -35.29 19.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.403 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -76.01 -24.49 55.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.4 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -52.37 -43.58 64.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.86 -60.12 8.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.46 ' H ' HD13 ' B' ' 75' ' ' LEU . 4.2 mp -57.98 -28.08 64.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.117 . . . . 0.0 109.277 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -80.45 -9.28 59.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.29 -0.881 . . . . 0.0 109.556 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.546 ' C ' ' H ' ' B' ' 79' ' ' ASP . 57.2 m80 -160.27 65.94 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.389 -0.819 . . . . 0.0 109.539 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mt -68.4 11.62 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' B' ' 77' ' ' HIS . 81.5 m-20 -72.4 -31.07 65.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.124 -0.985 . . . . 0.0 109.553 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 16.4 t-20 -171.02 108.89 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.464 ' CD1' ' N ' ' B' ' 81' ' ' LEU . 9.5 mp -80.26 -54.75 5.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.5 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.429 ' CD ' ' N ' ' B' ' 82' ' ' LYS . 0.6 OUTLIER -49.92 -24.0 2.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.486 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -73.12 -52.44 8.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.1 t -76.48 -47.58 22.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -1.189 . . . . 0.0 109.528 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.547 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.2 m-85 -66.04 4.76 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.461 -0.775 . . . . 0.0 109.566 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -63.73 -33.4 75.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.423 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.1 p -79.36 -51.3 9.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.418 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' B' ' 92' ' ' HIS . 8.7 mp -53.33 -51.17 63.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.345 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' SER . . . . . 0.409 ' HG ' ' N ' ' B' ' 90' ' ' GLU . 36.4 p -54.7 -45.4 73.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.927 . . . . 0.0 109.632 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.428 ' O ' ' OD2' ' B' ' 94' ' ' ASP . 32.9 tt0 -66.3 -41.58 89.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.663 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.53 -20.14 40.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.599 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' B' ' 88' ' ' LEU . 1.5 m80 -87.65 -41.21 13.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 110.239 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -82.99 -39.64 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.048 -1.032 . . . . 0.0 110.795 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' B' ' 90' ' ' GLU . 12.1 m-20 -86.18 -36.38 19.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.921 -1.112 . . . . 0.0 111.181 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -52.18 5.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.928 -1.108 . . . . 0.0 110.594 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.583 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 10.0 mp -86.29 -31.81 21.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.92 -1.112 . . . . 0.0 109.68 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 13.5 p80 41.89 29.39 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.382 -0.824 . . . . 0.0 109.858 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.09 124.65 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.178 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 1.267 ' CB ' HG22 ' C' ' 96' ' ' VAL . 0.4 OUTLIER -47.67 154.24 0.94 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.09 -160.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.628 2.219 . . . . 0.0 111.959 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.447 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 29.6 mm-40 57.64 26.3 12.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' B' ' 101' ' ' GLU . 39.1 m-20 -137.53 -32.76 0.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.35 -0.844 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.48 -37.01 85.65 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.497 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -70.14 -23.74 63.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.589 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' B' ' 105' ' ' LEU . 7.8 mp -79.74 -17.68 52.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.48 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 1.151 ' CG ' ' CAB' ' B' ' 147' ' ' HEC . 2.6 tm? -78.92 -46.72 17.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.318 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.99 -20.46 77.67 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -70.52 -55.66 8.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.083 -1.245 . . . . 0.0 109.797 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -53.72 -24.06 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.634 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.44 -50.85 65.91 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.472 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.563 ' CG2' ' CE1' ' B' ' 130' ' ' TYR . 46.7 t -49.44 -45.21 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.716 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 56.5 m -51.55 -35.92 42.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.631 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.91 -28.58 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 41.6 mt -72.73 -40.68 65.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.21 -20.85 59.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 109.297 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.569 ' ND1' ' HD1' ' B' ' 117' ' ' HIS . 3.0 t-80 -84.75 -54.62 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.301 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.569 ' HD1' ' ND1' ' B' ' 116' ' ' HIS . 0.5 OUTLIER -70.97 -17.54 62.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 0.0 109.671 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.41 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 68.3 m-85 -152.71 62.3 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.573 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.542 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -58.86 -26.99 61.3 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -68.37 -34.97 77.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -82.78 14.23 3.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.638 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.551 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -82.91 36.32 0.5 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.627 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.413 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 7.4 p -46.42 154.15 0.67 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.454 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.582 ' O ' HD11 ' A' ' 34' ' ' LEU . 24.5 Cg_exo -55.49 -44.81 44.85 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.358 2.039 . . . . 0.0 113.749 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' B' ' 124' ' ' PRO . 67.1 Cg_endo -78.17 -8.16 16.35 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.021 1.814 . . . . 0.0 112.615 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.413 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 10.6 t -83.76 -31.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 109.198 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -83.26 -59.73 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 109.629 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 1.523 ' CB ' HD12 ' A' ' 34' ' ' LEU . . . -48.49 -41.96 31.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.18 -36.46 83.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.831 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.563 ' CE1' ' CG2' ' B' ' 111' ' ' VAL . 30.0 t80 -61.23 -60.9 3.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.067 -1.021 . . . . 0.0 109.402 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -47.77 -25.81 1.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.873 . . . . 0.0 109.563 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' B' ' 132' ' ' LYS . 5.0 ttpm? -85.53 -31.52 22.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 109.739 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.49 -65.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.54 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 5.9 m -55.48 -15.67 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.597 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.648 ' CB ' ' OXT' ' D' ' 146' ' ' HIS . . . -56.22 -33.73 65.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.341 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.83 -30.52 57.62 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.15 -32.86 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.428 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.94 76.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.332 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -78.73 -21.26 48.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.299 -0.875 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.64 -60.73 2.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.942 . . . . 0.0 109.676 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 63.9 mt -54.22 -20.32 6.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.135 -0.978 . . . . 0.0 109.256 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.98 -4.6 58.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 109.116 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' B' ' 146' ' ' HIS . 71.4 t60 -49.45 -39.08 31.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.498 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -86.94 -55.15 3.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.133 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -52.8 -10.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.514 -0.741 . . . . 0.0 109.36 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.62 ' OXT' ' CB ' ' D' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.469 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . 0.429 ' C ' ' OG ' ' C' ' 3' ' ' SER . 14.6 mt -139.05 -178.3 5.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.361 -0.837 . . . . 0.0 109.218 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.451 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 178.76 -50.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' C' ' 6' ' ' ASP . 83.1 Cg_exo -43.64 155.71 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.309 2.006 . . . . 0.0 112.576 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -46.27 -16.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.841 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' C' ' 4' ' ' PRO . 12.5 t70 -39.43 -44.91 1.43 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.39 -0.819 . . . . 0.0 109.792 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' C' ' 8' ' ' THR . 6.5 ptmt -57.95 -50.48 73.23 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.117 -0.989 . . . . 0.0 109.01 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.411 ' N ' ' CG ' ' C' ' 7' ' ' LYS . 22.6 m -54.67 -31.51 57.85 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 108.61 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -77.16 -34.85 56.38 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.79 -51.82 41.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.37 -47.74 47.33 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' C' ' 15' ' ' GLY . . . -52.45 -61.18 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.494 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.18 -42.0 50.44 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.392 -0.817 . . . . 0.0 109.06 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -17.57 64.93 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.437 -0.789 . . . . 0.0 109.156 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' C' ' 12' ' ' ALA . . . -78.2 -45.38 10.17 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 39.6 mmtt -68.72 -39.54 80.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 108.798 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.86 -65.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.594 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 54.78 -132.82 47.94 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.75 27.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.456 -1.026 . . . . 0.0 110.383 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.594 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.7 m-70 -131.77 25.12 4.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -89.32 -59.6 2.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.679 -0.638 . . . . 0.0 109.827 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.73 -13.85 0.2 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.5 mt-10 -87.59 -56.45 3.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.39 -1.065 . . . . 0.0 109.897 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.526 ' CD1' ' ND1' ' C' ' 112' ' ' HIS . 3.0 m-30 -60.18 -29.15 68.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.06 -34.49 86.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.12 -39.13 30.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -1.159 . . . . 0.0 109.754 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.94 -25.55 68.19 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 109.271 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.4 -22.95 66.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.594 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 10.7 mt -76.65 -58.47 3.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.566 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -62.38 -12.57 22.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 109.923 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.434 ' HE ' ' HA ' ' C' ' 31' ' ' ARG . 0.3 OUTLIER -69.64 -49.79 50.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 110.327 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.432 ' O ' ' N ' ' C' ' 34' ' ' LEU . 2.6 ptt? -84.22 -36.53 22.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.136 -0.977 . . . . 0.0 110.335 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' C' ' 32' ' ' MET . 13.9 t80 -43.63 -23.93 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 110.175 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 1.478 HD12 ' CB ' ' D' ' 128' ' ' ALA . 2.3 pp -92.05 -28.85 16.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.001 -1.062 . . . . 0.0 110.03 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.516 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 81.5 p -89.25 -18.45 27.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 0.0 109.928 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.516 ' CG ' ' O ' ' C' ' 35' ' ' SER . 85.0 m-85 -157.89 75.78 3.84 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.127 -0.983 . . . . 0.0 109.797 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' C' ' 39' ' ' THR . 26.2 Cg_exo -60.36 -19.99 60.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.906 2.404 . . . . 0.0 112.166 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 24.4 p -48.63 -18.76 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 109.926 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.455 ' HG1' ' N ' ' C' ' 40' ' ' LYS . 38.0 p -85.93 -53.07 5.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.712 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' C' ' 42' ' ' TYR . 0.5 OUTLIER -79.93 -17.56 52.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.666 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.483 ' C ' ' O ' ' C' ' 40' ' ' LYS . 10.9 t -37.45 -28.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.484 -0.76 . . . . 0.0 109.992 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.544 ' N ' ' O ' ' C' ' 40' ' ' LYS . 23.6 m-85 -51.32 -36.54 43.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.018 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.53 ' CD2' ' O ' ' C' ' 43' ' ' PHE . 77.6 t80 45.56 56.6 15.51 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.461 -0.774 . . . . 0.0 110.076 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' C' ' 43' ' ' PHE . 82.5 Cg_endo -79.56 -41.62 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.551 2.167 . . . . 0.0 111.964 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER -176.52 56.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.568 -0.708 . . . . 0.0 109.117 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -139.26 63.69 1.49 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.551 ' C ' ' H ' ' C' ' 49' ' ' SER . 33.9 m-20 -37.9 -22.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.365 -0.834 . . . . 0.0 110.226 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' C' ' 46' ' ' PHE . 1.2 mt 52.64 6.34 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.127 -0.983 . . . . 0.0 109.608 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.551 ' H ' ' C ' ' C' ' 47' ' ' ASP . 34.6 t -81.3 153.32 27.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.95 . . . . 0.0 109.351 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' C' ' 50' ' ' HIS . 28.6 m170 -47.92 128.71 13.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.372 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.48 22.06 13.48 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.554 ' O ' ' N ' ' C' ' 54' ' ' GLN . 37.9 m -95.15 66.15 2.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -1.124 . . . . 0.0 108.936 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' C' ' 52' ' ' SER . . . -37.92 -25.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.809 -0.557 . . . . 0.0 110.264 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' C' ' 52' ' ' SER . 14.2 mt-30 -60.64 -46.28 90.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 109.529 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.05 -47.51 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.976 . . . . 0.0 109.128 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -66.52 -54.22 26.25 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . 0.523 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -53.21 -26.64 29.33 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.499 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 6.8 t-80 -69.92 -33.55 72.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.08 -1.247 . . . . 0.0 109.736 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.48 -48.68 82.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 51.4 mttp -51.07 -23.81 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -1.095 . . . . 0.0 109.705 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.668 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 0.5 OUTLIER -71.49 -50.5 30.86 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 108.966 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.72 -43.61 89.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.601 -0.687 . . . . 0.0 109.303 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.12 -28.71 64.5 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.306 -0.872 . . . . 0.0 109.44 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 15.1 t70 -72.35 -40.09 67.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.034 . . . . 0.0 108.753 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.57 -47.38 81.75 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.01 -40.29 95.15 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -70.63 -51.01 30.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.264 -0.898 . . . . 0.0 108.604 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -59.35 -23.03 62.18 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.56 -47.27 11.48 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.96 -22.79 32.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.47 -14.99 63.38 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.602 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.2 m80 -143.75 -59.56 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.581 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.5 p 44.68 13.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.711 0.767 . . . . 0.0 109.507 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' C' ' 72' ' ' HIS . 12.8 t70 -133.37 9.58 4.04 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 2.1 m-20 -179.43 27.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.883 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 17.7 ptt? -78.82 -22.69 0.39 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.365 -0.834 . . . . 0.0 112.004 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.1 Cg_exo -52.54 -22.07 15.79 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.63 1.553 . . . . 0.0 112.522 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.16 -24.08 17.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.643 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 -54.27 6.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.15 -0.968 . . . . 0.0 109.142 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . 0.43 ' CD1' ' N ' ' C' ' 80' ' ' LEU . 7.0 mp -77.21 8.94 3.46 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.384 -0.823 . . . . 0.0 109.058 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t -65.21 -15.82 62.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.843 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.75 -46.13 14.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.183 -0.948 . . . . 0.0 109.846 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' C' ' 82' ' ' ALA . 4.1 mt -46.26 -46.0 17.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.835 . . . . 0.0 109.044 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' C' ' 135' ' ' VAL . 37.6 m -54.02 -29.13 42.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.547 -0.721 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' C' ' 82' ' ' ALA . 25.9 t0 -65.81 -33.85 76.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.109 -0.994 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.539 HD12 HBD2 ' C' ' 142' ' ' HEC . 3.0 tt -83.02 -63.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -49.97 -22.02 1.41 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.877 . . . . 0.0 110.028 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.69 -48.14 5.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 110.007 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . 0.433 ' HD1' ' HZ1' ' C' ' 90' ' ' LYS . 7.8 t-80 -76.72 -71.05 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.956 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' C' ' 86' ' ' LEU . 30.1 mttm -86.29 140.58 29.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.736 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' C' ' 91' ' ' LEU . 10.6 mp 54.0 57.82 5.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.021 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . 1.674 ' HD3' ' CD ' ' B' ' 40' ' ' ARG . 72.5 ttt180 -47.86 -47.52 31.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 0.0 109.374 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.591 ' CG1' ' H ' ' C' ' 94' ' ' ASP . 61.9 t 49.67 179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.314 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . 0.591 ' H ' ' CG1' ' C' ' 93' ' ' VAL . 34.8 m-20 -133.12 151.81 78.49 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.266 -0.896 . . . . 0.0 109.119 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' C' ' 98' ' ' PHE . 81.7 Cg_exo -39.19 -19.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.612 2.208 . . . . 0.0 112.302 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . 1.267 HG22 ' CB ' ' B' ' 99' ' ' ASP . 63.9 t -46.98 -32.92 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.74 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' C' ' 97' ' ' ASN . 1.5 m120 -79.31 -25.07 42.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.942 . . . . 0.0 109.507 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' C' ' 95' ' ' PRO . 77.2 t80 -67.95 -56.37 9.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.8 -28.83 2.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 17.0 mt -83.98 -52.36 6.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.165 -0.959 . . . . 0.0 109.565 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.777 HD22 ' CHC' ' C' ' 142' ' ' HEC . 58.0 tp -47.27 -39.55 14.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.777 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 99.3 p -65.13 -59.25 4.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -53.01 -26.72 16.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.83 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 60.4 m -66.42 -58.48 5.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 109.825 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -45.93 -23.13 0.26 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' C' ' 106' ' ' LEU . 4.1 mm? -82.12 -32.34 30.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.046 -1.034 . . . . 0.0 109.819 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 38.4 t -82.86 -27.61 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.173 -0.954 . . . . 0.0 109.689 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.624 ' HG1' ' H ' ' C' ' 109' ' ' LEU . 6.8 p -68.92 -60.52 2.31 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.184 -0.948 . . . . 0.0 109.572 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.624 ' H ' ' HG1' ' C' ' 108' ' ' THR . 36.7 mt -55.79 -42.08 75.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.346 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.33 11.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.773 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.24 -55.79 4.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.941 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . 0.526 ' ND1' ' CD1' ' C' ' 24' ' ' TYR . 22.6 m170 -59.67 -62.64 1.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.983 -1.073 . . . . 0.0 109.062 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.55 ' O ' ' O ' ' C' ' 114' ' ' PRO . 2.4 pp -137.71 118.91 10.63 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . 0.55 ' O ' ' O ' ' C' ' 113' ' ' LEU . 89.4 Cg_exo -40.74 -178.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.561 2.174 . . . . 0.0 113.318 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.649 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -57.46 -55.07 39.52 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.422 -0.799 . . . . 0.0 109.164 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.649 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 4.8 mm-40 120.32 -2.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 20.0 t80 64.34 52.32 1.91 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.161 0.505 . . . . 0.0 110.989 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.0 OUTLIER -133.13 111.5 13.07 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . 0.665 ' HA ' HG11 ' D' ' 33' ' ' VAL . 78.1 Cg_exo -47.41 10.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.171 1.914 . . . . 0.0 112.561 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -132.72 -19.4 2.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.882 . . . . 0.0 110.279 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.541 ' CG1' ' N ' ' C' ' 122' ' ' HIS . 11.7 p -60.42 -55.33 25.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.119 -0.988 . . . . 0.0 110.302 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 1.003 ' HB3' HG11 ' D' ' 34' ' ' VAL . 6.4 m170 -72.05 -33.25 67.82 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.129 -0.982 . . . . 0.0 108.883 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.08 -20.18 49.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.485 -0.759 . . . . 0.0 109.137 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.581 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.1 m -64.86 -62.7 1.41 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.351 -0.843 . . . . 0.0 109.998 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.55 -19.5 65.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 109.203 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.99 -50.09 11.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.75 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -85.66 -43.12 13.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.117 -0.989 . . . . 0.0 109.795 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.456 ' H ' ' HG3' ' C' ' 127' ' ' LYS . 53.5 t80 -49.45 -20.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.898 -1.126 . . . . 0.0 108.672 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.689 HD21 HBB1 ' C' ' 142' ' ' HEC . 12.8 mt -71.9 -17.62 62.09 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.9 -31.72 72.04 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 57.0 p -83.22 -34.01 25.98 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.325 -0.859 . . . . 0.0 108.947 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -85.31 -27.96 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 108.655 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.626 ' N ' ' O ' ' C' ' 129' ' ' LEU . 37.2 m -80.14 -28.92 38.83 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.408 -0.808 . . . . 0.0 109.159 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 134' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 41.8 m -71.24 -33.67 70.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 109.035 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' C' ' 84' ' ' SER . 30.0 t -79.9 -28.13 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.26 -0.9 . . . . 0.0 108.623 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.63 -35.76 73.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.037 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 14.9 t -101.93 -14.55 17.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.83 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 138' ' ' SER . . . . . 0.412 ' HG ' ' H ' ' C' ' 139' ' ' LYS . 8.5 t 55.66 -173.39 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.146 -0.971 . . . . 0.0 109.401 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' C' ' 141' ' ' ARG . 56.5 mttp -49.6 -59.83 3.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.937 . . . . 0.0 109.56 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.509 ' CD2' ' O ' ' C' ' 140' ' ' TYR . 68.0 t80 52.35 9.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . 0.484 ' H ' ' C ' ' C' ' 139' ' ' LYS . 26.0 mtm180 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.923 -1.036 . . . . 0.0 109.464 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.703 ' CG1' ' H ' ' D' ' 2' ' ' HIS . 2.6 p . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . 0.703 ' H ' ' CG1' ' D' ' 1' ' ' VAL . 0.5 OUTLIER 53.87 106.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.085 -1.009 . . . . 0.0 109.782 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.05 179.04 9.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.365 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.421 ' OG1' ' OE2' ' D' ' 7' ' ' GLU . 2.2 p -73.36 151.57 89.84 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.46 -28.54 21.77 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.552 2.168 . . . . 0.0 112.107 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -78.83 -41.25 30.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.939 . . . . 0.0 109.534 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.421 ' OE2' ' OG1' ' D' ' 4' ' ' THR . 46.2 mt-10 -64.76 -46.03 83.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.481 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -72.63 -37.53 68.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.605 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 3.4 t -45.52 -23.7 0.25 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.788 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.23 -56.51 3.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.147 -0.971 . . . . 0.0 109.999 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 6.7 p -65.24 -24.62 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 5.8 m -77.51 -45.66 24.83 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.395 0.616 . . . . 0.0 109.575 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.45 72.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.385 -0.822 . . . . 0.0 109.592 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.43 ' C ' ' N ' ' D' ' 16' ' ' GLY . 0.8 OUTLIER -51.9 -32.12 31.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.072 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -48.66 -17.96 0.22 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.275 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' D' ' 14' ' ' LEU . . . -76.8 -56.81 3.99 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.432 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -64.77 -27.39 68.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 109.217 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.91 114.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' D' ' 21' ' ' ASP . 25.3 m-80 -80.45 69.15 6.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.009 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -44.39 -21.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.748 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' D' ' 19' ' ' ASN . 68.0 m-20 -74.16 3.92 6.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.489 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' D' ' 19' ' ' ASN . 35.1 mt-10 -153.0 -41.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.316 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.52 -46.59 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.36 -42.9 65.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.87 -44.05 63.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.1 -24.94 65.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -1.163 . . . . 0.0 109.528 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.32 -49.46 67.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . 0.484 ' CD1' ' N ' ' D' ' 28' ' ' LEU . 9.4 mp -79.12 -54.38 6.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.57 -33.38 8.68 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -81.99 -39.33 23.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -1.142 . . . . 0.0 109.419 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -49.27 -35.76 18.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 27.0 mt -79.9 -31.83 40.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.618 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' C' ' 119' ' ' PRO . 61.6 t -66.51 -64.41 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 109.38 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . 1.003 HG11 ' HB3' ' C' ' 122' ' ' HIS . 1.3 t -64.47 -22.64 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -146.21 80.85 9.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.397 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.45 -5.56 14.23 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.692 2.261 . . . . 0.0 112.386 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . 0.546 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 1.3 p-90 -58.87 -24.37 62.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.965 . . . . 0.0 109.51 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.546 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 3.0 m -96.01 38.29 1.19 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -91.16 9.63 30.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 109.496 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . 1.585 ' CD ' ' HD3' ' A' ' 92' ' ' ARG . 55.0 ttt85 -81.6 -29.82 33.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.543 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' D' ' 42' ' ' PHE . 66.1 m-85 -90.9 30.12 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 109.384 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 1.044 ' HE1' ' CBC' ' D' ' 147' ' ' HEC . 70.4 m-85 -145.66 22.65 1.45 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 109.381 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -79.11 -16.45 56.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.407 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.468 ' O ' ' N ' ' D' ' 46' ' ' GLY . 27.6 p -67.48 -43.32 81.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' D' ' 47' ' ' ASP . 88.3 m-85 -48.73 -14.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 66.9 -65.38 0.19 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' D' ' 45' ' ' PHE . 4.6 m-20 -46.18 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -1.16 . . . . 0.0 109.555 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 tp -159.46 22.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 12.8 p -70.54 -33.8 71.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 50' ' ' THR . . . . . 0.427 ' O ' ' N ' ' D' ' 53' ' ' ALA . 3.4 p -145.64 151.56 46.82 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.325 -0.859 . . . . 0.0 109.031 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -39.97 -42.01 3.12 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.302 2.001 . . . . 0.0 112.256 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.32 -31.01 72.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.488 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -61.92 -19.81 63.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.98 -63.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 109.615 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 22.4 ptp -83.2 4.5 26.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.364 -0.835 . . . . 0.0 109.648 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.92 -17.25 70.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -82.1 138.05 46.03 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.276 -1.132 . . . . 0.0 109.071 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.11 -12.84 30.81 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.232 1.955 . . . . 0.0 112.162 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -80.15 -57.45 3.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -48.0 -31.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -79.03 -32.81 45.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.76 -45.64 16.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.679 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 1.092 ' HE2' ' CAD' ' D' ' 147' ' ' HEC . 0.9 OUTLIER -62.79 -23.67 67.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.722 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.49 -36.32 83.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -60.17 -25.44 65.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.108 -1.23 . . . . 0.0 109.591 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.71 -50.13 39.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 1.016 HG23 ' CHB' ' D' ' 147' ' ' HEC . 42.3 t -57.81 -36.67 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.35 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.6 tt -71.56 -48.09 50.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.42 -44.95 16.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.55 -51.94 56.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -1.102 . . . . 0.0 109.414 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -49.53 -35.32 19.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.269 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -75.98 -24.49 55.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -52.3 -43.64 64.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.381 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.84 -60.13 8.57 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.454 ' H ' HD13 ' D' ' 75' ' ' LEU . 4.2 mp -57.98 -27.99 63.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -1.118 . . . . 0.0 109.317 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -80.62 -9.24 59.79 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.214 -0.929 . . . . 0.0 109.427 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.547 ' C ' ' H ' ' D' ' 79' ' ' ASP . 56.8 m80 -160.34 66.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.42 11.58 0.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.309 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' D' ' 77' ' ' HIS . 81.4 m-20 -72.38 -30.97 65.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.614 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 16.5 t-20 -171.07 108.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.605 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' D' ' 81' ' ' LEU . 9.5 mp -80.31 -54.68 5.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.502 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . 0.434 ' N ' ' CD ' ' D' ' 82' ' ' LYS . 0.6 OUTLIER -49.97 -24.03 2.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.421 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . 0.44 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -73.15 -52.37 8.94 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.1 t -76.51 -47.63 22.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -1.179 . . . . 0.0 109.484 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.1 m-85 -66.0 4.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.783 . . . . 0.0 109.505 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -63.63 -33.49 75.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.0 p -79.27 -51.43 9.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.411 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' D' ' 92' ' ' HIS . 8.7 mp -53.24 -51.19 63.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.352 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 89' ' ' SER . . . . . 0.406 ' HG ' ' N ' ' D' ' 90' ' ' GLU . 34.8 p -54.57 -45.47 73.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.69 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.432 ' O ' ' OD2' ' D' ' 94' ' ' ASP . 32.9 tt0 -66.24 -41.64 89.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.155 -0.966 . . . . 0.0 109.624 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.43 -20.2 40.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.643 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.581 ' N ' ' O ' ' D' ' 88' ' ' LEU . 1.5 m80 -87.62 -41.16 13.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 110.267 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 35.6 t -83.11 -39.57 20.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.043 -1.035 . . . . 0.0 110.739 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' D' ' 90' ' ' GLU . 12.2 m-20 -86.27 -36.41 19.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.009 -1.057 . . . . 0.0 111.093 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -52.26 5.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.9 -1.125 . . . . 0.0 110.531 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.571 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 10.0 mp -86.28 -31.89 21.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.912 -1.117 . . . . 0.0 109.603 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 13.5 p80 42.04 29.32 0.13 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.426 -0.796 . . . . 0.0 109.818 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.16 124.61 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.862 . . . . 0.0 109.168 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . 1.31 ' CB ' HG22 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -47.55 154.21 0.92 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.18 -160.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.651 2.234 . . . . 0.0 112.001 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . 0.446 ' O ' ' OD1' ' D' ' 102' ' ' ASN . 29.8 mm-40 57.64 26.31 12.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.872 . . . . 0.0 109.499 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' D' ' 101' ' ' GLU . 39.1 m-20 -137.47 -32.88 0.75 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.369 -0.832 . . . . 0.0 109.341 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.39 -37.13 86.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -70.14 -23.6 63.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.987 . . . . 0.0 109.548 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' D' ' 105' ' ' LEU . 7.8 mp -79.85 -17.7 52.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 0.0 109.463 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 1.158 ' CG ' ' CAB' ' D' ' 147' ' ' HEC . 2.6 tm? -78.87 -46.76 17.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.302 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.02 -20.41 77.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -70.45 -55.7 8.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -1.216 . . . . 0.0 109.787 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -53.66 -24.05 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.962 . . . . 0.0 109.71 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.48 -50.8 66.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.913 . . . . 0.0 109.501 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . 0.556 ' CG2' ' CE1' ' D' ' 130' ' ' TYR . 46.9 t -49.53 -45.19 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 56.4 m -51.6 -35.84 43.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.61 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.96 -28.59 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 41.6 mt -72.74 -40.73 65.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.353 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.0 59.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 109.259 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.572 ' ND1' ' HD1' ' D' ' 117' ' ' HIS . 3.0 t-80 -84.58 -54.69 4.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.322 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . 0.572 ' HD1' ' ND1' ' D' ' 116' ' ' HIS . 0.5 OUTLIER -70.97 -17.45 62.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.704 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.402 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 68.3 m-85 -152.75 62.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.601 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -58.84 -27.0 61.26 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -68.42 -34.95 76.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -1.225 . . . . 0.0 109.559 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.84 14.35 3.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.624 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.558 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -83.01 36.4 0.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.418 ' HG1' ' CG2' ' D' ' 126' ' ' VAL . 7.4 p -46.45 154.14 0.68 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.115 -0.991 . . . . 0.0 109.445 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.585 ' O ' HD11 ' C' ' 34' ' ' LEU . 24.4 Cg_exo -55.4 -44.89 44.3 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.334 2.022 . . . . 0.0 113.786 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' D' ' 124' ' ' PRO . 67.1 Cg_endo -78.21 -8.06 16.28 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.994 1.796 . . . . 0.0 112.598 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . 0.418 ' CG2' ' HG1' ' D' ' 123' ' ' THR . 10.6 t -83.79 -31.04 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 109.276 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.28 -59.67 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 109.637 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 1.478 ' CB ' HD12 ' C' ' 34' ' ' LEU . . . -48.55 -41.97 31.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 0.0 109.42 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.55 83.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.89 . . . . 0.0 109.881 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . 0.556 ' CE1' ' CG2' ' D' ' 111' ' ' VAL . 29.7 t80 -61.11 -60.87 3.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.0 109.398 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -47.83 -25.8 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.584 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . 0.441 ' NZ ' ' CB ' ' D' ' 132' ' ' LYS . 5.0 ttpm? -85.5 -31.56 22.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.728 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.39 -65.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.527 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 5.9 m -55.53 -15.64 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.639 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.62 ' CB ' ' OXT' ' B' ' 146' ' ' HIS . . . -56.22 -33.68 65.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.929 . . . . 0.0 109.335 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.9 -30.52 57.5 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.14 -32.85 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -1.117 . . . . 0.0 109.433 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.97 76.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.345 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -78.7 -21.11 48.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 109.428 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.77 -60.63 2.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 63.6 mt -54.33 -20.25 6.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.315 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.01 -4.57 58.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 109.126 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' D' ' 146' ' ' HIS . 71.4 t60 -49.48 -39.13 32.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.484 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 0.8 OUTLIER -86.83 -55.13 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.944 . . . . 0.0 109.217 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -52.82 -10.41 0.16 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.56 -0.713 . . . . 0.0 109.387 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.648 ' OXT' ' CB ' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.484 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.79 ' CHC' HD22 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 1.151 ' CAB' ' CG ' ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 0.777 ' CHC' HD22 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.158 ' CAB' ' CG ' ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.412 HG23 ' OH ' ' C' ' 140' ' ' TYR . 40.2 t . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.527 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 3.9 mm? -95.01 -169.27 1.96 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.697 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.45 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -116.24 179.54 0.78 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.504 -0.747 . . . . 0.0 109.228 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 21.7 Cg_exo -62.81 -69.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.722 2.281 . . . . 0.0 112.752 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -83.09 -16.63 46.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.897 . . . . 0.0 110.391 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 5' ' ' ALA . 7.8 t70 -40.1 -41.17 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.215 -0.928 . . . . 0.0 109.778 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 10' ' ' VAL . 68.8 mttt -69.44 -55.97 8.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.872 . . . . 0.0 109.639 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.0 m -45.03 -30.78 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 109.674 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -78.48 -36.4 45.24 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 7' ' ' LYS . 48.9 t -72.09 -48.84 47.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -53.05 -44.39 67.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 108.78 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.74 -57.4 12.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.434 -0.791 . . . . 0.0 109.32 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.2 68.67 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.431 -0.793 . . . . 0.0 109.27 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.92 -17.22 60.6 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.248 -0.908 . . . . 0.0 108.936 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.76 -42.0 22.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -71.43 -42.12 68.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -1.178 . . . . 0.0 108.84 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.71 -63.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.576 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 47.73 -127.2 14.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.3 24.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.457 -1.025 . . . . 0.0 110.446 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.576 ' H ' ' C ' ' A' ' 18' ' ' GLY . 88.3 m-70 -128.84 22.13 5.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.887 . . . . 0.0 108.609 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 23' ' ' GLU . . . -88.73 -55.93 3.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.577 -0.702 . . . . 0.0 109.443 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.49 -14.43 0.61 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 21' ' ' ALA . 12.7 mm-40 -87.49 -56.52 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.396 -1.061 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.9 m-30 -60.87 -22.84 64.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 0.0 109.246 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.19 -23.54 63.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.93 -40.04 22.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -1.132 . . . . 0.0 109.619 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -69.43 -19.62 63.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.819 . . . . 0.0 109.25 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.3 -20.44 57.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 0.0 109.641 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.3 mt -78.15 -46.9 19.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.786 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.02 -38.13 75.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 109.738 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.4 mtt85 -63.18 -39.13 93.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.54 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.832 ' HE1' HBC3 ' A' ' 142' ' ' HEC . 51.0 ttp -64.6 -50.44 67.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 1.8 t80 -44.07 -33.87 1.6 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.427 -0.796 . . . . 0.0 109.697 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.807 ' HB3' ' HB1' ' B' ' 128' ' ' ALA . 10.3 mt -84.95 -40.02 17.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.76 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.543 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 74.4 m -53.42 -38.4 63.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 109.665 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 35' ' ' SER . 30.5 m-85 -164.29 87.11 1.14 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 39' ' ' THR . 76.5 Cg_exo -48.18 -19.98 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.612 2.208 . . . . 0.0 112.141 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.79 ' HB ' ' HB3' ' D' ' 97' ' ' HIS . 9.1 p -46.82 -18.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.88 . . . . 0.0 109.738 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' PRO . 53.2 p -80.89 -63.11 1.48 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.13 -0.981 . . . . 0.0 109.989 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' TYR . 8.6 mmpt? -59.09 -18.57 36.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.94 . . . . 0.0 109.955 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 40' ' ' LYS . 5.8 t -44.37 -19.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.143 -0.973 . . . . 0.0 109.835 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 40' ' ' LYS . 38.6 m-85 -73.3 4.05 5.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.55 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 83.2 t80 47.57 74.18 0.86 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.179 -0.951 . . . . 0.0 109.471 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.685 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 69.8 Cg_endo -78.1 -14.9 14.87 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.742 2.295 . . . . 0.0 112.23 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.685 ' ND1' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 81.33 26.19 0.22 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.473 0.654 . . . . 0.0 109.612 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.771 ' O ' ' N ' ' A' ' 48' ' ' LEU . 3.3 m-85 -82.89 14.2 3.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.315 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 49' ' ' SER . 4.7 m-20 60.42 -51.35 0.09 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.771 ' N ' ' O ' ' A' ' 46' ' ' PHE . 19.5 mt 41.59 20.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.677 -0.639 . . . . 0.0 109.961 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 47' ' ' ASP . 6.2 m -93.35 42.33 1.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.493 ' CG ' ' C ' ' A' ' 49' ' ' SER . 0.7 OUTLIER 71.88 129.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.434 -0.792 . . . . 0.0 109.351 -179.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.54 29.33 73.22 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 53' ' ' ALA . 8.1 p -52.36 -36.68 54.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -1.064 . . . . 0.0 109.54 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 52' ' ' SER . . . 73.27 -64.45 0.4 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 53' ' ' ALA . 18.9 mt-30 -43.59 -35.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 109.48 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.32 -28.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 110.017 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 2.5 ptpt -61.53 -38.89 89.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 0.0 109.453 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' N ' ' CG ' ' A' ' 56' ' ' LYS . . . -52.43 -35.83 45.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 8.7 t-80 -76.6 -27.91 55.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.167 . . . . 0.0 109.913 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.59 -37.26 94.17 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 46.6 mtpt -62.68 -24.34 67.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -1.186 . . . . 0.0 110.268 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.901 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 0.2 OUTLIER -65.01 -58.7 5.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.041 -1.037 . . . . 0.0 109.356 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.5 t -54.0 -43.83 59.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.469 -0.77 . . . . 0.0 109.289 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.78 -46.88 62.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 0.0 108.924 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 62.4 m-20 -64.48 -34.4 78.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 108.661 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . -67.13 -50.36 61.64 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -55.69 -44.62 77.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 71' ' ' ALA . 19.3 m -65.5 -54.21 31.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.258 -0.901 . . . . 0.0 108.786 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -55.86 -27.35 51.27 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.12 -47.68 13.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.32 -22.74 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -70.28 -13.01 61.98 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' A' ' 74' ' ' ASP . 34.0 m170 -136.3 -67.17 0.52 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.457 -0.777 . . . . 0.0 109.251 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 72' ' ' HIS . 13.2 p 44.77 14.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.952 0.882 . . . . 0.0 109.439 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 72' ' ' HIS . 35.0 m-20 -139.24 12.57 2.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 1.1 m-20 172.79 30.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.692 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 6.9 ptt? -78.31 -22.82 0.4 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 111.928 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.6 Cg_exo -53.84 -20.75 18.41 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.577 1.518 . . . . 0.0 112.387 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.44 ' O ' ' OG ' ' A' ' 81' ' ' SER . 17.6 t-20 -94.11 -35.54 12.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 109.844 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.03 -46.89 61.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.097 -1.002 . . . . 0.0 109.257 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.8 mt -80.3 8.27 7.8 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 109.024 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 44.2 p -56.05 -21.92 24.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.907 . . . . 0.0 109.731 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -70.8 -53.79 14.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.788 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' ALA . 6.0 mt -44.78 -47.1 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -50.2 -39.61 44.62 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 82' ' ' ALA . 28.8 t70 -82.82 -17.33 44.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.817 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 86' ' ' LEU . 3.3 tm? -71.41 -58.19 3.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -83.11 -21.72 33.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.102 . . . . 0.0 110.736 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.04 -79.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.888 -1.132 . . . . 0.0 109.788 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -59.53 5.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.811 . . . . 0.0 109.475 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 86' ' ' LEU . 41.2 mttm -88.02 135.7 33.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 93' ' ' VAL . 14.9 mt 61.16 66.43 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.833 . . . . 0.0 109.153 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 1.448 ' NE ' ' HB2' ' D' ' 40' ' ' ARG . 39.1 ttt-85 -66.33 18.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.504 -0.748 . . . . 0.0 109.347 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.632 ' H ' ' C ' ' A' ' 91' ' ' LEU . 11.9 p -42.61 129.52 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.895 . . . . 0.0 109.767 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.85 148.74 75.45 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.28 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ASN . 37.5 Cg_endo -67.56 -10.9 30.28 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.476 2.117 . . . . 0.0 112.046 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 95' ' ' PRO . 47.7 t -44.55 -19.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.715 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' PRO . 17.8 m120 -79.16 -24.77 43.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.545 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.534 ' CG ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -53.71 -45.01 70.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.372 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.534 ' N ' ' CG ' ' A' ' 98' ' ' PHE . 65.2 mttm -49.28 -41.02 36.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.501 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 12.4 mt -71.55 -43.24 66.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.892 . . . . 0.0 109.403 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 1.085 ' CD1' ' CHC' ' A' ' 142' ' ' HEC . 3.5 tt -57.99 -57.09 14.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.317 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.5 p -61.86 -34.9 76.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.857 . . . . 0.0 109.687 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 103' ' ' HIS . 22.8 t-160 -77.68 -26.69 50.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.462 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 55.6 m -69.68 -41.52 75.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 0.0 109.686 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mt -52.35 -50.17 62.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.36 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 3.8 mm? -58.83 -59.12 5.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.1 t -51.71 -49.68 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.197 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 110' ' ' ALA . 17.6 m -62.15 -60.27 3.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.394 -0.816 . . . . 0.0 109.3 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 113' ' ' LEU . 24.9 mt -47.13 -18.92 0.1 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 109.522 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -73.41 -36.24 65.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.01 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.13 -3.18 24.87 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.708 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -141.28 -83.9 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 0.0 109.908 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -106.06 83.37 1.07 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.085 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.32 -174.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.148 1.899 . . . . 0.0 112.356 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.65 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -46.19 -55.43 7.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.557 -0.715 . . . . 0.0 109.26 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.65 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 31.7 mt-10 118.87 -7.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 4.8 t80 79.08 34.48 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.969 -0.457 . . . . 0.0 111.2 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.722 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -109.47 122.7 38.67 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.476 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.39 18.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.32 2.013 . . . . 0.0 112.925 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.722 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -146.34 -33.17 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.886 -1.134 . . . . 0.0 110.404 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.549 ' H ' ' HG1' ' A' ' 118' ' ' THR . 7.2 p -51.68 -47.26 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.111 -0.993 . . . . 0.0 110.117 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.517 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 2.0 t-160 -59.8 -37.27 78.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.955 . . . . 0.0 109.365 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.19 -19.71 33.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.711 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 14.8 p -64.86 -62.5 1.53 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 110.625 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.497 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.6 mt -72.24 -19.77 61.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 0.0 109.978 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -82.38 -44.46 16.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.974 -1.079 . . . . 0.0 109.594 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -84.88 -41.02 16.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 109.52 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 27.8 t80 -51.72 -21.1 2.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.897 -1.127 . . . . 0.0 108.446 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 133' ' ' SER . 20.2 mt -76.6 -26.55 55.13 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -54.52 -33.46 59.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.404 ' OG ' ' CD2' ' A' ' 2' ' ' LEU . 1.6 m -77.65 -41.74 37.25 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.05 -33.13 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.224 -0.923 . . . . 0.0 108.578 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 129' ' ' LEU . 31.3 m -77.12 -42.21 38.9 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.399 -0.813 . . . . 0.0 109.172 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 92.3 m -70.39 -26.07 63.53 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.214 -0.929 . . . . 0.0 108.557 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.4 t -77.14 -37.78 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.06 -38.48 86.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 108.834 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 m -90.39 -14.6 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 53.8 p 49.02 -150.6 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -150.92 -79.81 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 0.0 109.433 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.442 ' OH ' HG23 ' C' ' 1' ' ' VAL . 77.4 m-85 -74.51 -60.08 2.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.381 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.417 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.472 ' O ' ' CG1' ' B' ' 1' ' ' VAL . 14.4 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 8.5 t60 55.32 62.21 2.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.547 ' N ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -127.76 177.82 6.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.391 -0.818 . . . . 0.0 109.186 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.445 ' OG1' ' OE2' ' B' ' 7' ' ' GLU . 0.6 OUTLIER -68.65 125.32 91.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 108.983 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.44 ' O ' ' OG ' ' B' ' 9' ' ' SER . 83.1 Cg_exo -42.07 -35.55 3.32 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.349 2.032 . . . . 0.0 112.537 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' B' ' 6' ' ' GLU . 14.3 mp0 -76.16 -23.89 54.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 109.7 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 0.2 OUTLIER -84.17 -39.53 19.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 109.767 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.49 ' O ' ' OG1' ' B' ' 12' ' ' THR . 22.9 pttt -83.87 -39.18 20.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 110.114 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' B' ' 8' ' ' LYS . 19.5 m -43.9 -23.33 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.865 . . . . 0.0 110.192 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -82.25 -57.06 3.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.139 -0.976 . . . . 0.0 109.997 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.09 -24.63 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 5.1 m -75.02 -45.71 39.9 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.367 0.603 . . . . 0.0 109.565 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.52 94.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.53 -0.731 . . . . 0.0 109.626 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.5 OUTLIER -48.0 -34.47 9.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -45.84 -17.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.847 . . . . 0.0 109.413 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -76.56 -43.06 20.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -79.76 -30.55 40.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -1.191 . . . . 0.0 109.254 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -47.82 114.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.552 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' B' ' 22' ' ' GLU . 5.8 m-20 -77.84 66.13 3.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.198 -0.939 . . . . 0.0 108.998 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.466 ' C ' ' H ' ' B' ' 22' ' ' GLU . 73.8 t -43.81 -26.87 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 109.754 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.76 7.21 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.504 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' B' ' 20' ' ' VAL . 36.6 mt-10 -155.24 -50.25 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.563 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 69.3 t -47.03 -33.75 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.627 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.57 -50.72 59.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.39 -36.87 78.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -73.74 -38.64 64.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -1.133 . . . . 0.0 109.449 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.85 -34.05 72.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.405 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -84.99 -34.53 22.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.53 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.36 -50.36 60.16 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -58.21 -30.55 66.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -1.204 . . . . 0.0 109.425 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . 0.465 ' CD2' HBC1 ' B' ' 147' ' ' HEC . 9.3 tp -50.44 -39.21 46.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.469 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -81.01 -21.97 39.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.69 -64.13 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.724 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.47 HG13 ' CD2' ' A' ' 122' ' ' HIS . 2.3 t -64.46 -22.94 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.876 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -139.71 78.61 25.5 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.271 -0.893 . . . . 0.0 109.392 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' B' ' 39' ' ' GLN . 74.7 Cg_endo -82.82 -17.87 6.84 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.817 2.345 . . . . 0.0 112.381 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . 0.536 ' O ' ' NH2' ' C' ' 92' ' ' ARG . 5.2 p-90 -49.64 -19.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.5 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.403 ' O ' ' N ' ' B' ' 41' ' ' PHE . 1.4 p -92.15 -11.34 35.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.241 -0.912 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' B' ' 36' ' ' PRO . 1.5 tm0? -45.05 -34.24 2.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.711 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 1.368 ' HB2' ' NE ' ' C' ' 92' ' ' ARG . 37.6 mtp85 -61.08 -26.03 67.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.478 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' B' ' 38' ' ' THR . 32.1 t80 -100.88 30.64 3.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.315 -0.866 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -146.25 31.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 109.327 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -79.75 -14.04 59.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.402 ' O ' ' N ' ' B' ' 46' ' ' GLY . 28.5 t -65.47 -43.85 89.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.538 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' B' ' 47' ' ' ASP . 44.8 m-85 -48.87 -18.58 0.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 48' ' ' LEU . . . 65.77 -66.56 0.12 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 45' ' ' PHE . 79.6 m-20 -54.05 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -1.136 . . . . 0.0 109.674 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 46' ' ' GLY . 0.8 OUTLIER -164.47 21.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.115 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 56.0 m -57.97 -41.1 82.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.413 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' THR . . . . . 0.431 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.3 p -146.25 152.4 46.56 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.424 -0.797 . . . . 0.0 109.045 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -40.63 -30.04 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.402 2.068 . . . . 0.0 112.345 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -75.05 -29.2 60.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.641 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -63.9 -20.5 65.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 109.557 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.55 -24.01 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' MET . . . . . 0.413 ' O ' ' OD1' ' B' ' 57' ' ' ASN . 16.3 mmt -90.01 -6.2 55.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 109.611 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.587 ' O ' ' CB ' ' B' ' 57' ' ' ASN . . . -47.93 -35.83 13.43 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . 0.71 ' N ' ' CD ' ' B' ' 58' ' ' PRO . 21.0 m-20 91.7 23.56 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 122.245 -0.562 . . . . 0.0 111.623 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' B' ' 57' ' ' ASN . 77.4 Cg_endo -81.34 -157.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.965 1.776 . . . . 0.0 112.125 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -47.66 -24.39 0.91 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.71 -50.05 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.566 -0.709 . . . . 0.0 109.294 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -32.49 42.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.363 -0.836 . . . . 0.0 109.637 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.99 -49.72 74.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 109.565 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 1.174 ' NE2' HAD2 ' B' ' 147' ' ' HEC . 46.3 t-80 -59.42 -26.3 65.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.589 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.56 -19.4 74.64 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -76.04 -24.98 55.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 109.122 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -74.29 -59.29 2.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 109.568 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 1.52 HG13 ' C1B' ' B' ' 147' ' ' HEC . 40.4 t -47.0 -34.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 109.473 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.33 -42.75 96.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -0.914 . . . . 0.0 109.16 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.73 -49.82 52.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.75 -33.44 66.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -1.127 . . . . 0.0 109.51 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -76.25 -37.66 57.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -80.49 -28.13 37.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.341 -0.849 . . . . 0.0 109.436 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -51.17 -38.89 54.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.21 -60.13 7.99 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.462 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -56.83 -18.65 13.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -1.106 . . . . 0.0 109.407 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -83.22 -19.31 36.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 71.5 m-70 -159.42 62.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.11 -0.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 109.315 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' B' ' 77' ' ' HIS . 45.7 t0 -57.62 -25.87 60.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 9.1 p-10 -170.58 105.85 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 10.2 mp -79.98 -57.26 3.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.469 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -45.79 -24.06 0.34 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -0.973 . . . . 0.0 109.61 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.76 -63.21 2.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.0 t -61.01 -47.49 86.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -1.168 . . . . 0.0 109.516 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.547 ' N ' ' CG2' ' B' ' 84' ' ' THR . 64.2 m-85 -67.86 4.77 1.04 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.747 . . . . 0.0 109.597 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.82 -46.57 78.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.544 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -75.12 -52.59 10.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.526 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 55.6 mt -50.73 -47.36 59.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' SER . . . . . 0.495 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 14.7 m -57.52 -36.26 71.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.356 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.87 -22.28 43.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.91 -18.06 26.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.972 . . . . 0.0 109.815 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' B' ' 88' ' ' LEU . 9.9 m80 -87.89 -60.76 1.88 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.916 -1.115 . . . . 0.0 110.484 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . 0.636 ' HG ' ' H ' ' B' ' 94' ' ' ASP . 12.8 p -83.82 -59.77 2.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.955 -1.091 . . . . 0.0 111.469 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.636 ' H ' ' HG ' ' B' ' 93' ' ' CYS . 14.2 m-20 -59.2 -26.76 65.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.071 -1.018 . . . . 0.0 111.724 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 3.1 tppp? -107.51 -51.97 2.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.737 -1.227 . . . . 0.0 110.795 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.447 ' C ' ' CD2' ' B' ' 97' ' ' HIS . 5.7 mp -87.19 -30.48 20.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.926 -1.109 . . . . 0.0 109.931 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.734 ' HB3' ' CG2' ' C' ' 38' ' ' THR . 9.6 m-70 66.47 49.16 1.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.117 -0.989 . . . . 0.0 110.013 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 33.1 t -96.62 114.18 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.198 -0.939 . . . . 0.0 109.031 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' B' ' 100' ' ' PRO . 0.9 OUTLIER -62.59 153.66 76.84 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.605 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' B' ' 99' ' ' ASP . 51.0 Cg_exo -51.98 -156.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.442 2.095 . . . . 0.0 112.452 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 52.95 46.74 26.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.522 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' B' ' 100' ' ' PRO . 35.3 m120 -158.08 -35.74 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.526 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.0 -39.22 93.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.152 -0.968 . . . . 0.0 109.526 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -65.47 -31.24 72.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 109.658 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' B' ' 105' ' ' LEU . 9.8 mp -62.35 -57.95 9.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.118 -0.989 . . . . 0.0 109.462 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 1.543 HD23 ' CBB' ' B' ' 147' ' ' HEC . 6.4 tt -48.23 -22.75 0.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.928 . . . . 0.0 109.605 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' B' ' 109' ' ' VAL . . . -79.29 -45.35 8.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -46.61 -16.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -1.122 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' B' ' 107' ' ' GLY . 97.6 t -85.15 -62.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.41 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 14.6 mt -47.41 -26.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.92 -47.65 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.792 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 20.2 p -79.28 -41.32 28.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.018 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 77.7 t -47.4 -41.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.747 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' B' ' 118' ' ' PHE . 46.1 mt -79.47 -40.49 29.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 109.526 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.438 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.14 -30.41 2.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.513 ' HD1' ' C ' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.64 -56.98 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.265 -0.897 . . . . 0.0 109.288 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . 0.411 ' C ' ' CG ' ' B' ' 118' ' ' PHE . 85.7 m-70 -63.53 -17.72 63.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 0.0 109.57 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' B' ' 114' ' ' LEU . 65.2 m-85 -153.29 62.35 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.938 . . . . 0.0 109.543 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' B' ' 122' ' ' PHE . . . -68.92 -50.48 34.78 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -47.86 -31.05 4.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 109.38 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -82.7 -19.07 38.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' B' ' 119' ' ' GLY . 6.3 t80 -76.09 66.61 2.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.29 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -79.14 149.8 73.53 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.276 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.493 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.5 Cg_exo -45.36 -53.58 5.3 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.466 2.111 . . . . 0.0 112.968 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 26.0 Cg_endo -62.45 1.11 1.08 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.01 1.806 . . . . 0.0 112.192 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' B' ' 124' ' ' PRO . 87.9 t -112.45 -8.23 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.316 -0.865 . . . . 0.0 109.306 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.3 -53.97 5.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.517 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.807 ' HB1' ' HB3' ' A' ' 34' ' ' LEU . . . -54.69 -33.81 61.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.886 . . . . 0.0 109.537 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.2 2.6 17.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.675 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.17 -29.6 13.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.218 -0.926 . . . . 0.0 109.374 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -84.4 -23.3 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 109.916 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.723 ' HG3' ' HB3' ' D' ' 146' ' ' HIS . 14.4 ttmt -85.56 -36.08 20.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.13 -0.981 . . . . 0.0 110.121 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . 0.621 ' CG1' ' H ' ' B' ' 134' ' ' VAL . 11.8 p -65.38 -58.91 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.081 -1.012 . . . . 0.0 110.037 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.621 ' H ' ' CG1' ' B' ' 133' ' ' VAL . 11.3 t -62.1 -33.43 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.02 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -45.89 -21.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 0.0 109.684 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 134' ' ' VAL . . . -82.7 -26.83 44.59 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' B' ' 134' ' ' VAL . 97.7 t -78.88 -21.2 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -1.133 . . . . 0.0 109.585 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.02 -38.37 32.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.629 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.8 -21.09 30.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.785 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.21 -48.46 70.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.115 -0.991 . . . . 0.0 109.713 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -58.26 -22.04 50.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.574 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' B' ' 145' ' ' TYR . . . -89.71 26.1 1.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . 0.584 ' CD2' ' HZ1' ' B' ' 144' ' ' LYS . 10.2 t60 -80.53 -6.98 59.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.962 . . . . 0.0 109.13 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.584 ' HZ1' ' CD2' ' B' ' 143' ' ' HIS . 11.6 mptt -122.14 -27.84 4.47 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.52 -0.737 . . . . 0.0 109.696 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 142' ' ' ALA . 0.1 OUTLIER -50.26 -7.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -0.993 . . . . 0.0 110.034 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.707 ' HB3' ' HG3' ' D' ' 132' ' ' LYS . 12.0 m-70 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.736 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . 0.442 HG23 ' OH ' ' A' ' 140' ' ' TYR . 40.2 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.289 0.566 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' C' ' 2' ' ' LEU . 3.9 mm? -94.95 -169.37 1.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.213 -0.929 . . . . 0.0 109.691 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.452 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.1 OUTLIER -116.13 179.55 0.78 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.491 -0.756 . . . . 0.0 109.233 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 21.8 Cg_exo -62.85 -69.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.69 2.26 . . . . 0.0 112.781 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -83.13 -16.69 45.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.931 . . . . 0.0 110.308 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' C' ' 5' ' ' ALA . 7.8 t70 -40.05 -41.18 1.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.955 . . . . 0.0 109.773 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' C' ' 10' ' ' VAL . 68.7 mttt -69.45 -56.04 8.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 53.5 m -45.04 -30.75 1.12 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.32 -0.863 . . . . 0.0 109.707 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -78.39 -36.41 45.92 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' C' ' 7' ' ' LYS . 49.2 t -72.01 -48.93 47.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -53.02 -44.45 67.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 108.783 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.77 -57.34 12.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.361 -0.837 . . . . 0.0 109.338 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.45 -36.27 68.85 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.377 -0.827 . . . . 0.0 109.24 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.79 -17.2 60.66 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.278 -0.889 . . . . 0.0 109.029 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.83 -41.98 21.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -71.43 -42.08 68.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -1.153 . . . . 0.0 108.837 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.71 -63.79 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.576 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 47.8 -127.32 14.62 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 24.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.414 -1.05 . . . . 0.0 110.447 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.576 ' H ' ' C ' ' C' ' 18' ' ' GLY . 88.3 m-70 -128.85 22.05 5.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.905 . . . . 0.0 108.612 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' C' ' 23' ' ' GLU . . . -88.75 -55.85 3.53 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.585 -0.697 . . . . 0.0 109.464 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.59 -14.4 0.64 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' C' ' 21' ' ' ALA . 12.8 mm-40 -87.48 -56.56 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -1.079 . . . . 0.0 109.714 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.9 m-30 -60.78 -22.9 64.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.2 -23.49 63.22 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.96 -40.1 22.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -1.128 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -69.35 -19.59 63.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.284 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -20.39 57.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.684 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mt -78.3 -46.84 19.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 109.752 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -58.04 -38.1 75.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.74 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -63.2 -39.19 93.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 109.526 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.807 ' HE1' HBC3 ' C' ' 142' ' ' HEC . 50.9 ttp -64.52 -50.54 66.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.196 -0.94 . . . . 0.0 109.176 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . 0.469 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 1.8 t80 -43.95 -33.99 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.682 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.811 ' HB3' ' HB1' ' D' ' 128' ' ' ALA . 10.4 mt -85.0 -39.87 17.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.793 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 74.5 m -53.44 -38.44 63.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.96 . . . . 0.0 109.749 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' C' ' 35' ' ' SER . 30.8 m-85 -164.22 87.12 1.15 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.877 . . . . 0.0 109.521 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' C' ' 39' ' ' THR . 76.6 Cg_exo -48.21 -19.92 2.0 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.551 2.167 . . . . 0.0 112.135 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' THR . . . . . 0.734 ' CG2' ' HB3' ' B' ' 97' ' ' HIS . 9.0 p -46.84 -18.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.889 . . . . 0.0 109.757 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.444 ' N ' ' O ' ' C' ' 37' ' ' PRO . 53.2 p -80.91 -63.1 1.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.981 . . . . 0.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' C' ' 42' ' ' TYR . 8.6 mmpt? -59.05 -18.59 36.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.165 -0.96 . . . . 0.0 109.935 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.403 ' C ' ' O ' ' C' ' 40' ' ' LYS . 5.8 t -44.46 -19.11 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.144 -0.972 . . . . 0.0 109.828 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' C' ' 40' ' ' LYS . 38.5 m-85 -73.34 4.04 5.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 109.582 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' C' ' 43' ' ' PHE . 83.1 t80 47.58 74.16 0.86 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 109.452 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.688 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 70.5 Cg_endo -78.03 -14.87 15.01 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.772 2.314 . . . . 0.0 112.308 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.688 ' ND1' ' O ' ' C' ' 44' ' ' PRO . 0.0 OUTLIER 81.25 26.12 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.621 -0.675 . . . . 0.0 109.648 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.778 ' O ' ' N ' ' C' ' 48' ' ' LEU . 3.3 m-85 -82.87 14.33 3.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.399 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' C' ' 49' ' ' SER . 4.6 m-20 60.39 -51.33 0.09 Allowed 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.778 ' N ' ' O ' ' C' ' 46' ' ' PHE . 19.4 mt 41.53 20.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.661 -0.649 . . . . 0.0 110.004 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.538 ' N ' ' O ' ' C' ' 47' ' ' ASP . 6.2 m -93.35 42.27 1.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . 0.49 ' CG ' ' C ' ' C' ' 49' ' ' SER . 0.7 OUTLIER 71.98 129.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.516 -0.74 . . . . 0.0 109.295 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.42 29.4 73.24 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' C' ' 53' ' ' ALA . 8.1 p -52.34 -36.7 54.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -1.111 . . . . 0.0 109.595 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' C' ' 52' ' ' SER . . . 73.26 -64.41 0.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.862 . . . . 0.0 109.549 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' C' ' 53' ' ' ALA . 18.9 mt-30 -43.57 -35.78 1.85 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.0 109.482 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -55.35 -28.15 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.433 -0.792 . . . . 0.0 109.986 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' C' ' 57' ' ' GLY . 2.5 ptpt -61.47 -38.97 89.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.031 -1.043 . . . . 0.0 109.461 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . 0.434 ' N ' ' CG ' ' C' ' 56' ' ' LYS . . . -52.41 -35.75 44.73 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 8.7 t-80 -76.65 -27.84 55.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -1.165 . . . . 0.0 109.922 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.61 -37.27 94.18 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -62.64 -24.3 67.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -1.153 . . . . 0.0 110.362 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.904 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 0.2 OUTLIER -65.04 -58.78 5.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.011 -1.056 . . . . 0.0 109.319 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.402 HG12 HBB2 ' C' ' 142' ' ' HEC . 11.6 t -54.02 -43.85 60.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.434 -0.791 . . . . 0.0 109.246 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.7 -46.9 62.26 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 108.921 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -64.44 -34.51 78.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 108.655 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' C' ' 61' ' ' LYS . . . -67.06 -50.31 62.26 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -55.75 -44.6 77.77 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 108.704 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.421 ' O ' ' N ' ' C' ' 71' ' ' ALA . 19.2 m -65.43 -54.22 31.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -0.847 . . . . 0.0 108.794 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -55.9 -27.39 51.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.02 -47.78 13.13 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.26 -22.69 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -70.36 -13.04 61.98 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' C' ' 74' ' ' ASP . 34.0 m170 -136.31 -67.12 0.52 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.548 -0.72 . . . . 0.0 109.206 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' C' ' 72' ' ' HIS . 13.2 p 44.64 14.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.946 0.879 . . . . 0.0 109.37 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' C' ' 72' ' ' HIS . 35.2 m-20 -139.26 12.52 2.59 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 1.1 m-20 172.72 30.92 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.688 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 6.9 ptt? -78.29 -22.87 0.4 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.174 -0.954 . . . . 0.0 111.889 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.4 Cg_exo -53.82 -20.69 18.17 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.596 1.531 . . . . 0.0 112.405 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.439 ' O ' ' OG ' ' C' ' 81' ' ' SER . 17.7 t-20 -94.15 -35.55 12.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.825 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.04 -46.91 61.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.157 -0.965 . . . . 0.0 109.303 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 11.7 mt -80.21 8.17 7.9 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.387 -0.821 . . . . 0.0 109.047 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 45.0 p -56.01 -21.87 23.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 109.797 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -70.88 -53.82 13.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.746 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' C' ' 82' ' ' ALA . 6.0 mt -44.82 -46.93 10.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -50.24 -39.62 45.24 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' C' ' 82' ' ' ALA . 28.7 t70 -82.79 -17.39 44.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.807 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.482 ' C ' ' CD1' ' C' ' 86' ' ' LEU . 3.3 tm? -71.4 -58.16 3.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 110.426 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -83.12 -21.79 33.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.956 -1.09 . . . . 0.0 110.697 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.11 -79.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 109.72 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.18 -59.53 5.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.491 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' C' ' 86' ' ' LEU . 41.2 mttm -87.99 135.77 33.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.637 ' C ' ' H ' ' C' ' 93' ' ' VAL . 14.9 mt 61.09 66.44 0.89 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.141 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . 1.368 ' NE ' ' HB2' ' B' ' 40' ' ' ARG . 38.9 ttt-85 -66.34 18.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.637 ' H ' ' C ' ' C' ' 91' ' ' LEU . 11.8 p -42.57 129.55 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 109.709 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.86 148.81 75.36 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.213 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' C' ' 97' ' ' ASN . 37.6 Cg_endo -67.57 -10.95 30.46 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.48 2.12 . . . . 0.0 112.059 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -44.56 -19.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.358 -0.839 . . . . 0.0 109.669 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' C' ' 95' ' ' PRO . 17.7 m120 -79.1 -24.71 43.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.653 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . 0.541 ' CG ' ' N ' ' C' ' 99' ' ' LYS . 0.1 OUTLIER -53.75 -44.96 70.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.426 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.541 ' N ' ' CG ' ' C' ' 98' ' ' PHE . 65.3 mttm -49.33 -41.05 37.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.5 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 12.4 mt -71.61 -43.16 66.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 1.106 ' CD1' ' CHC' ' C' ' 142' ' ' HEC . 3.6 tt -58.0 -57.03 14.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.341 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 84.3 p -61.87 -34.95 76.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 109.69 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.421 ' O ' ' CD2' ' C' ' 103' ' ' HIS . 22.8 t-160 -77.65 -26.62 50.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 55.3 m -69.84 -41.45 74.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 0.0 109.64 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mt -52.33 -50.19 62.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.962 . . . . 0.0 109.324 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' C' ' 106' ' ' LEU . 3.8 mm? -58.87 -59.11 5.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.635 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -51.73 -49.64 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.197 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.44 ' O ' ' N ' ' C' ' 110' ' ' ALA . 17.6 m -62.06 -60.35 3.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.29 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' C' ' 113' ' ' LEU . 25.5 mt -47.18 -18.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.872 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' C' ' 108' ' ' THR . . . -73.46 -36.14 65.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 110.069 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.11 -3.27 25.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.747 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -141.2 -83.95 0.21 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 109.904 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' C' ' 109' ' ' LEU . 0.3 OUTLIER -106.0 83.35 1.05 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.068 -179.629 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.28 -174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.087 1.858 . . . . 0.0 112.399 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.653 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -46.18 -55.51 6.99 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.558 -0.714 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.653 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 31.7 mt-10 118.93 -6.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 0.489 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 4.8 t80 79.01 34.54 0.21 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.968 -0.458 . . . . 0.0 111.228 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.732 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -109.52 122.7 38.63 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.04 . . . . 0.0 108.271 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.36 18.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.3 2.0 . . . . 0.0 112.915 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -146.32 -33.22 0.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.89 -1.131 . . . . 0.0 110.403 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.536 ' H ' ' HG1' ' C' ' 118' ' ' THR . 7.2 p -51.66 -47.13 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 110.177 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.52 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 2.0 t-160 -59.8 -37.32 78.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.357 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.25 -19.72 33.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.646 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 14.8 p -64.79 -62.54 1.5 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 110.593 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.517 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.6 mt -72.34 -19.73 61.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.11 -0.993 . . . . 0.0 109.932 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.26 -44.5 16.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.981 -1.075 . . . . 0.0 109.64 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -84.94 -41.03 16.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.13 -0.981 . . . . 0.0 109.567 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.492 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 28.0 t80 -51.67 -21.01 2.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.937 -1.102 . . . . 0.0 108.559 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' C' ' 133' ' ' SER . 20.3 mt -76.66 -26.5 54.89 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -54.55 -33.41 60.09 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 131' ' ' SER . . . . . 0.401 ' O ' ' CG2' ' C' ' 135' ' ' VAL . 1.6 m -77.57 -41.87 37.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 4.9 t -75.03 -33.14 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 133' ' ' SER . . . . . 0.513 ' N ' ' O ' ' C' ' 129' ' ' LEU . 31.5 m -77.11 -42.21 38.96 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.485 -0.759 . . . . 0.0 109.146 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 92.2 m -70.26 -26.1 63.66 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.174 -0.954 . . . . 0.0 108.569 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' C' ' 131' ' ' SER . 8.6 t -77.17 -37.84 26.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.17 -38.45 86.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 108.846 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 24.9 m -90.34 -14.57 32.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.239 -0.913 . . . . 0.0 109.477 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 53.7 p 48.95 -150.56 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.461 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -150.94 -79.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 109.43 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.412 ' OH ' HG23 ' A' ' 1' ' ' VAL . 77.7 m-85 -74.43 -60.09 2.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.414 179.935 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' D' ' 1' ' ' VAL . 14.4 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 t60 55.29 62.27 2.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.935 . . . . 0.0 109.512 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -127.74 177.74 6.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.343 -0.848 . . . . 0.0 109.138 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.436 ' OG1' ' OE2' ' D' ' 7' ' ' GLU . 0.6 OUTLIER -68.65 125.3 91.64 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.044 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . 0.435 ' O ' ' OG ' ' D' ' 9' ' ' SER . 82.7 Cg_exo -42.11 -35.47 3.32 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.325 2.017 . . . . 0.0 112.488 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . 0.453 ' N ' ' CD ' ' D' ' 6' ' ' GLU . 14.2 mp0 -76.2 -23.93 54.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 109.731 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' D' ' 7' ' ' GLU . 0.2 OUTLIER -84.09 -39.6 19.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.797 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.486 ' O ' ' OG1' ' D' ' 12' ' ' THR . 22.9 pttt -83.78 -39.27 20.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.0 110.074 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 9' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 19.7 m -43.78 -23.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 110.163 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -82.25 -57.05 3.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.114 -0.991 . . . . 0.0 109.979 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.08 -24.73 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 5.0 m -74.9 -45.83 40.06 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.387 0.613 . . . . 0.0 109.597 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.51 94.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.427 -0.796 . . . . 0.0 109.688 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.5 OUTLIER -48.06 -34.49 9.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.368 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -45.77 -17.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.827 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -76.44 -43.11 20.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -79.72 -30.6 40.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.127 -1.219 . . . . 0.0 109.247 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -47.86 114.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 109.569 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' D' ' 22' ' ' GLU . 5.8 m-20 -77.87 66.04 3.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 108.988 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . 0.466 ' C ' ' H ' ' D' ' 22' ' ' GLU . 73.7 t -43.66 -26.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.446 -0.784 . . . . 0.0 109.786 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.72 7.22 0.92 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' D' ' 20' ' ' VAL . 36.6 mt-10 -155.28 -50.25 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.567 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 69.7 t -46.98 -33.86 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.47 -50.78 59.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.35 -36.81 79.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -73.68 -38.76 64.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -1.158 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.82 -34.07 72.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 109.436 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -84.94 -34.56 22.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.45 -50.2 60.81 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -58.22 -30.6 66.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -1.117 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . 0.458 ' CD2' HBC1 ' D' ' 147' ' ' HEC . 9.3 tp -50.41 -39.17 46.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.967 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 mt -81.03 -22.0 39.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.163 -0.961 . . . . 0.0 109.597 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 21.1 t -82.7 -64.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.772 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . 0.477 HG13 ' CD2' ' C' ' 122' ' ' HIS . 2.3 t -64.57 -22.9 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.875 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -139.77 78.63 25.16 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.285 -0.884 . . . . 0.0 109.399 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' D' ' 39' ' ' GLN . 76.6 Cg_endo -82.81 -17.81 6.9 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.814 2.342 . . . . 0.0 112.417 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . 0.57 ' O ' ' NH2' ' A' ' 92' ' ' ARG . 5.2 p-90 -49.7 -19.89 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 0.435 ' O ' ' N ' ' D' ' 41' ' ' PHE . 1.4 p -92.1 -11.39 35.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.264 -0.897 . . . . 0.0 109.332 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' D' ' 36' ' ' PRO . 1.5 tm0? -45.03 -34.17 2.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.337 -0.852 . . . . 0.0 109.736 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . 1.448 ' HB2' ' NE ' ' A' ' 92' ' ' ARG . 37.7 mtp85 -61.12 -26.08 67.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.441 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' D' ' 38' ' ' THR . 32.3 t80 -100.85 30.75 3.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -0.865 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -146.26 31.24 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 109.343 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.75 -14.08 58.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.406 ' C ' ' N ' ' D' ' 46' ' ' GLY . 28.5 t -65.52 -43.79 88.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.541 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . 0.501 ' O ' ' N ' ' D' ' 47' ' ' ASP . 44.5 m-85 -48.99 -18.49 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.425 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' D' ' 48' ' ' LEU . . . 65.82 -66.58 0.12 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' D' ' 45' ' ' PHE . 79.6 m-20 -54.07 86.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -1.123 . . . . 0.0 109.632 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' D' ' 46' ' ' GLY . 0.8 OUTLIER -164.46 21.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.167 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.0 m -57.98 -41.04 82.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.419 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 50' ' ' THR . . . . . 0.434 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.3 p -146.28 152.29 46.16 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.0 109.092 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -40.49 -30.12 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.449 2.1 . . . . 0.0 112.361 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -75.13 -29.14 60.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.615 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -63.93 -20.39 65.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.63 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.58 -24.04 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 55' ' ' MET . . . . . 0.418 ' O ' ' OD1' ' D' ' 57' ' ' ASN . 16.3 mmt -90.0 -6.14 55.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.605 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.602 ' O ' ' CB ' ' D' ' 57' ' ' ASN . . . -47.94 -35.82 13.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . 0.725 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 21.3 m-20 91.7 23.55 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 122.137 -0.625 . . . . 0.0 111.568 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' D' ' 57' ' ' ASN . 75.3 Cg_endo -81.36 -157.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.948 1.765 . . . . 0.0 112.122 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -47.61 -24.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 58' ' ' PRO . 54.7 t -51.56 -50.18 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.494 -0.754 . . . . 0.0 109.279 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.37 -32.62 43.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.38 -0.825 . . . . 0.0 109.631 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.02 -49.74 74.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.979 . . . . 0.0 109.532 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 1.191 ' NE2' HAD2 ' D' ' 147' ' ' HEC . 46.5 t-80 -59.42 -26.28 65.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 109.557 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.47 -19.46 74.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -76.09 -24.91 55.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -1.176 . . . . 0.0 109.082 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -74.36 -59.18 2.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.84 . . . . 0.0 109.564 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 1.551 HG13 ' C1B' ' D' ' 147' ' ' HEC . 40.5 t -47.15 -34.16 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.465 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.47 -42.61 95.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.142 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.71 -49.92 51.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.7 -33.5 66.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -1.144 . . . . 0.0 109.52 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -76.2 -37.66 57.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -80.42 -28.28 37.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 109.385 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -51.11 -38.86 54.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.915 . . . . 0.0 109.415 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.22 -60.15 7.96 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.482 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.9 mp -56.87 -18.63 13.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -1.131 . . . . 0.0 109.345 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -83.22 -19.32 36.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.883 . . . . 0.0 109.615 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 72.0 m-70 -159.37 62.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.689 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.1 -0.43 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.945 . . . . 0.0 109.409 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' D' ' 77' ' ' HIS . 45.8 t0 -57.66 -25.85 60.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.503 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' D' ' 80' ' ' ASN . 9.0 p-10 -170.64 105.9 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 10.2 mp -79.97 -57.3 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -45.83 -23.97 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 109.566 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.82 -63.27 2.75 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.0 t -61.02 -47.46 86.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -1.181 . . . . 0.0 109.557 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 64.4 m-85 -67.82 4.68 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.574 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.68 -46.68 77.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.544 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -75.08 -52.46 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.522 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 55.6 mt -50.74 -47.46 59.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 89' ' ' SER . . . . . 0.504 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 14.7 m -57.5 -36.19 71.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -79.88 -22.25 43.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.98 -18.01 26.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.766 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' D' ' 88' ' ' LEU . 10.0 m80 -87.88 -60.67 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.96 -1.088 . . . . 0.0 110.486 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . 0.649 ' HG ' ' H ' ' D' ' 94' ' ' ASP . 12.5 p -83.94 -59.78 2.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.969 -1.082 . . . . 0.0 111.438 -178.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.649 ' H ' ' HG ' ' D' ' 93' ' ' CYS . 14.2 m-20 -59.14 -26.76 65.02 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.095 -1.003 . . . . 0.0 111.709 -177.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . 0.526 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 3.2 tppp? -107.55 -51.93 2.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.658 -1.276 . . . . 0.0 110.796 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.451 ' C ' ' CD2' ' D' ' 97' ' ' HIS . 5.7 mp -87.22 -30.55 20.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.915 -1.115 . . . . 0.0 109.918 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.79 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 9.6 m-70 66.47 49.19 1.41 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.16 -0.962 . . . . 0.0 110.039 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 33.0 t -96.63 114.2 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.27 -0.894 . . . . 0.0 108.987 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' D' ' 100' ' ' PRO . 0.9 OUTLIER -62.65 153.59 77.63 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.553 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' D' ' 99' ' ' ASP . 50.6 Cg_exo -51.86 -156.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.504 2.136 . . . . 0.0 112.409 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 52.93 46.66 26.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.578 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' D' ' 100' ' ' PRO . 35.3 m120 -158.03 -35.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -65.0 -39.16 93.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.494 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -65.55 -31.2 72.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 109.666 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' D' ' 105' ' ' LEU . 9.8 mp -62.4 -57.98 9.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.437 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 1.537 ' CD2' HBB1 ' D' ' 147' ' ' HEC . 6.4 tt -48.2 -22.73 0.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.627 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' D' ' 109' ' ' VAL . . . -79.3 -45.51 8.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -46.53 -16.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -1.176 . . . . 0.0 109.623 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' D' ' 107' ' ' GLY . 98.2 t -85.07 -62.62 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.503 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 14.7 mt -47.39 -26.18 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.661 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 70.8 t -68.96 -47.52 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.084 -1.01 . . . . 0.0 109.906 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 20.0 p -79.41 -41.22 28.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.138 -0.976 . . . . 0.0 110.037 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 78.2 t -47.57 -41.07 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.721 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' D' ' 118' ' ' PHE . 46.6 mt -79.52 -40.37 29.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.567 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.429 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.2 -30.38 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.399 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.525 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -84.75 -56.96 3.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 109.235 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 85.8 m-70 -63.48 -17.66 62.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.574 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' D' ' 114' ' ' LEU . 65.6 m-85 -153.33 62.32 0.76 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 109.544 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' D' ' 122' ' ' PHE . . . -68.84 -50.51 35.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -47.95 -30.93 4.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.191 . . . . 0.0 109.404 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -82.81 -18.98 38.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.557 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' D' ' 119' ' ' GLY . 6.3 t80 -76.17 66.6 2.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.129 -0.982 . . . . 0.0 109.293 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -79.1 149.68 73.51 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.288 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -45.3 -53.6 5.24 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.488 2.125 . . . . 0.0 112.972 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 25.7 Cg_endo -62.52 1.18 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.012 1.808 . . . . 0.0 112.21 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . 0.404 ' H ' ' C ' ' D' ' 124' ' ' PRO . 86.9 t -112.44 -8.31 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.21 -54.08 5.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 109.556 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 0.811 ' HB1' ' HB3' ' C' ' 34' ' ' LEU . . . -54.62 -33.84 61.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.14 2.52 17.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.21 -29.5 13.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 109.444 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -84.34 -23.49 30.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 109.901 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . 0.707 ' HG3' ' HB3' ' B' ' 146' ' ' HIS . 14.4 ttmt -85.46 -36.06 20.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.141 -0.974 . . . . 0.0 110.183 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . 0.62 ' CG1' ' H ' ' D' ' 134' ' ' VAL . 11.9 p -65.44 -58.78 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.094 -1.004 . . . . 0.0 110.041 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.62 ' H ' ' CG1' ' D' ' 133' ' ' VAL . 11.5 t -62.23 -33.38 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 0.0 109.959 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -45.92 -21.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 0.0 109.743 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -82.79 -26.75 44.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' D' ' 134' ' ' VAL . 97.5 t -78.89 -21.15 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -1.148 . . . . 0.0 109.644 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.11 -38.3 31.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 109.644 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.66 -21.21 30.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.755 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.26 -48.44 70.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 0.0 109.697 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.15 -22.08 49.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . 0.533 ' O ' ' CD1' ' D' ' 145' ' ' TYR . . . -89.65 26.07 1.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 0.0 109.568 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . 0.577 ' CD2' ' HZ1' ' D' ' 144' ' ' LYS . 10.0 t60 -80.53 -6.91 58.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.108 -0.995 . . . . 0.0 109.128 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.577 ' HZ1' ' CD2' ' D' ' 143' ' ' HIS . 11.6 mptt -122.15 -27.96 4.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.457 -0.777 . . . . 0.0 109.671 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' D' ' 142' ' ' ALA . 0.1 OUTLIER -50.21 -7.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 110.066 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.723 ' HB3' ' HG3' ' B' ' 132' ' ' LYS . 12.0 m-70 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.669 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 1.085 ' CHC' ' CD1' ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 1.543 ' CBB' HD23 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 1.106 ' CHC' ' CD1' ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.551 ' C1B' HG13 ' D' ' 67' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.28 -169.92 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -0.907 . . . . 0.0 109.903 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.51 ' N ' ' OD2' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -100.01 -179.2 0.78 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.35 -0.844 . . . . 0.0 109.566 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 23.0 Cg_exo -62.83 -58.51 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.893 2.395 . . . . 0.0 113.049 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -78.65 -16.44 57.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.03 -1.044 . . . . 0.0 110.204 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 3' ' ' SER . 33.5 m-20 -39.79 -30.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 0.0 109.72 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.592 ' H ' ' CD ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -83.7 -39.47 20.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.531 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' ALA . 37.2 m -44.82 -42.87 8.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.461 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.24 -25.33 62.44 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.578 ' N ' ' O ' ' A' ' 7' ' ' LYS . 53.2 t -78.82 -55.19 10.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -53.48 -37.19 62.47 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.459 -1.296 . . . . 0.0 107.875 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.78 -63.18 1.22 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.238 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' O ' ' CG2' ' A' ' 17' ' ' VAL . . . -60.24 -36.17 77.15 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -0.843 . . . . 0.0 108.768 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -17.51 62.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 109.088 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -78.79 -46.43 8.54 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.14 -36.62 74.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -1.098 . . . . 0.0 108.817 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 13' ' ' ALA . 95.4 t -60.65 -65.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 58.71 -134.9 52.32 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.41 27.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.429 -1.042 . . . . 0.0 110.437 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.577 ' H ' ' C ' ' A' ' 18' ' ' GLY . 92.4 m-70 -131.58 25.68 4.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.199 -0.938 . . . . 0.0 108.481 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.57 -61.66 1.66 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.613 -0.679 . . . . 0.0 109.754 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.68 -14.38 0.23 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 1.2 mm-40 -84.33 -56.33 3.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -1.091 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.605 ' CE1' ' CG ' ' A' ' 112' ' ' HIS . 2.8 m-30 -60.64 -27.78 68.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.458 -0.776 . . . . 0.0 109.172 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.82 -22.92 75.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.2 18.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -1.138 . . . . 0.0 109.795 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -64.29 -19.88 65.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 109.511 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.11 -19.68 60.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 109.313 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.43 -54.1 6.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 109.6 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.26 -37.6 64.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.447 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -43.87 98.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.917 ' HE2' HBC3 ' A' ' 142' ' ' HEC . 53.5 ttp -67.26 -49.92 62.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.425 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -51.54 -46.32 63.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.632 ' HB3' ' HB3' ' B' ' 128' ' ' ALA . 12.8 mt -64.09 -60.21 3.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 109.793 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 18.8 p -55.46 -18.98 8.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.646 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 35' ' ' SER . 79.6 m-85 -156.05 113.36 2.13 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 39' ' ' THR . 73.0 Cg_endo -79.56 -20.14 9.62 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.32 2.013 . . . . 0.0 111.945 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.0 p -47.12 -18.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.373 -0.829 . . . . 0.0 109.735 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 37' ' ' PRO . 42.6 p -74.68 -22.72 58.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 109.876 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -70.13 -20.05 63.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.0 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t -73.69 -18.9 60.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.818 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -80.1 19.38 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.969 . . . . 0.0 109.576 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 51.5 94.04 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.996 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.665 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 71.5 Cg_endo -81.58 -34.56 0.51 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.653 2.236 . . . . 0.0 111.791 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.665 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 15.1 p80 51.56 30.65 6.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.744 -0.597 . . . . 0.0 111.297 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.605 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 4.9 p90 -145.42 23.2 1.47 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.891 -1.131 . . . . 0.0 109.526 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 49' ' ' SER . 57.2 m-20 42.52 84.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.551 -0.718 . . . . 0.0 109.829 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.474 ' H ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -50.22 -11.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 47' ' ' ASP . 14.7 m -58.88 147.36 34.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.383 -0.823 . . . . 0.0 109.491 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -64.54 148.46 50.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.596 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.03 83.81 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 54' ' ' GLN . 5.4 p -69.07 -23.72 64.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -1.221 . . . . 0.0 109.337 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' LYS . . . 67.57 -56.15 0.46 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.837 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 52' ' ' SER . 43.1 mt-30 -43.89 -22.44 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.356 -0.84 . . . . 0.0 109.812 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 53' ' ' ALA . 41.0 t -74.35 -26.74 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.32 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.7 ptmt -65.7 -27.41 68.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.87 . . . . 0.0 109.552 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.08 -50.44 40.12 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -53.85 -32.42 52.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -1.156 . . . . 0.0 109.476 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.22 -47.27 91.92 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -58.35 -23.43 56.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -1.081 . . . . 0.0 109.592 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.665 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 0.7 OUTLIER -74.29 -39.49 62.9 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.228 -0.92 . . . . 0.0 108.88 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.7 -49.07 48.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.97 71.17 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.299 -0.876 . . . . 0.0 109.052 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -67.18 -38.73 85.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.299 -0.876 . . . . 0.0 108.759 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.528 ' CB ' HMB3 ' A' ' 142' ' ' HEC . . . -64.07 -52.1 60.96 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -57.24 -44.6 83.98 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.243 -0.91 . . . . 0.0 108.731 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.4 m -68.74 -50.65 48.97 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -60.36 -24.28 64.95 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.96 -45.64 12.0 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.65 -23.38 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.66 -18.7 64.23 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.7 m80 -144.08 -58.89 0.39 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.404 -0.81 . . . . 0.0 109.339 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.3 p 44.19 13.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 121.879 0.847 . . . . 0.0 109.561 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.612 ' N ' ' O ' ' A' ' 72' ' ' HIS . 46.0 t0 -133.8 11.08 3.99 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 179.03 29.39 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.973 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.695 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 17.4 ptt? -78.62 -22.61 0.39 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.426 -0.796 . . . . 0.0 111.805 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.695 ' CD ' ' N ' ' A' ' 76' ' ' MET . 52.4 Cg_exo -54.12 -22.27 24.84 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.497 1.465 . . . . 0.0 112.347 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.429 ' O ' ' OG ' ' A' ' 81' ' ' SER . 9.4 m120 -94.16 -33.86 13.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.8 59.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.146 -0.971 . . . . 0.0 109.353 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.36 8.5 7.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.372 -0.83 . . . . 0.0 109.123 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 37.0 p -55.89 -17.11 5.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.929 . . . . 0.0 109.666 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.09 -55.97 4.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.448 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 3.5 mt -45.4 -44.02 11.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 108.935 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 136' ' ' LEU . 29.7 t -57.23 -22.63 42.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.503 -0.748 . . . . 0.0 109.448 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.538 ' OD1' ' CE1' ' A' ' 89' ' ' HIS . 23.1 t70 -82.01 -58.3 3.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.854 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.63 -27.45 17.17 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.757 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.448 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 38.6 m80 -91.84 -21.76 20.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.858 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.47 -11.35 15.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.214 -0.929 . . . . 0.0 109.902 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.538 ' CE1' ' OD1' ' A' ' 85' ' ' ASP . 14.4 m80 -113.94 -77.81 0.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 89' ' ' HIS . 9.9 mptt -45.79 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.481 ' C ' ' N ' ' A' ' 93' ' ' VAL . 19.6 mt -65.69 -17.33 64.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.838 . . . . 0.0 110.16 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.518 ' NH1' ' OE2' ' D' ' 43' ' ' GLU . 25.0 ttm180 48.93 15.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 109.003 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.481 ' N ' ' C ' ' A' ' 91' ' ' LEU . 10.8 p -46.01 156.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.0 109.878 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.23 153.03 37.98 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.39 -0.818 . . . . 0.0 109.046 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 98' ' ' PHE . 32.7 Cg_endo -65.79 -10.64 27.48 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.539 2.159 . . . . 0.0 111.954 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 95' ' ' PRO . 83.4 t -44.05 -29.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.343 -0.848 . . . . 0.0 109.767 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -79.32 -32.92 43.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.577 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -50.18 -34.9 24.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.347 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -49.99 -34.91 22.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.8 mt -82.12 -50.52 8.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.901 HD21 HBB3 ' A' ' 142' ' ' HEC . 53.1 tp -45.77 -20.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.627 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' LEU . 93.3 p -73.3 -59.33 2.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 109.945 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.796 ' CG ' HD22 ' B' ' 108' ' ' ASN . 40.7 m80 -71.81 -26.48 62.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.922 . . . . 0.0 109.769 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 62.4 m -58.11 -42.23 85.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.89 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.64 -22.74 62.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.186 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.546 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 3.7 mm? -79.01 -35.96 41.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.0 -1.062 . . . . 0.0 110.137 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.3 t -62.89 -39.46 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.058 -1.026 . . . . 0.0 109.499 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.486 ' OG1' ' N ' ' A' ' 109' ' ' LEU . 12.2 p -65.23 -62.97 1.22 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.176 -0.952 . . . . 0.0 109.644 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.486 ' N ' ' OG1' ' A' ' 108' ' ' THR . 14.7 mt -48.2 -22.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.35 -36.47 83.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 109.896 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.16 -42.59 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.158 -0.964 . . . . 0.0 109.893 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.605 ' CG ' ' CE1' ' A' ' 24' ' ' TYR . 93.3 m-70 -81.8 -75.36 0.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.011 . . . . 0.0 109.519 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.479 ' O ' ' CG ' ' A' ' 113' ' ' LEU . 1.5 pp -137.14 94.44 12.48 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.19 -171.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.248 1.965 . . . . 0.0 112.931 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -47.23 -38.55 12.44 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.52 0.676 . . . . 0.0 109.539 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 6.7 mt-10 85.37 9.52 0.33 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.805 ' CE1' ' NE2' ' B' ' 116' ' ' HIS . 6.9 m-85 65.04 34.86 8.48 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.83 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.713 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -94.42 121.3 63.76 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.745 -1.222 . . . . 0.0 107.971 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -51.31 23.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.039 1.826 . . . . 0.0 112.914 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -154.97 -30.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.778 -1.201 . . . . 0.0 110.851 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.543 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 11.8 p -47.83 -50.38 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.086 -1.008 . . . . 0.0 110.375 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.543 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 2.4 t-80 -65.38 -43.5 90.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.453 -0.779 . . . . 0.0 109.999 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' B' ' 34' ' ' VAL . . . -79.07 -19.36 51.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.243 -0.911 . . . . 0.0 109.921 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 120' ' ' ALA . 64.3 m -72.45 -63.95 1.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 111.08 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.01 -18.25 64.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.947 -1.096 . . . . 0.0 109.48 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.26 -49.41 10.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.961 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.83 -57.77 2.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.906 -1.122 . . . . 0.0 111.441 -178.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' A' ' 124' ' ' SER . 21.9 m-85 -46.55 -21.53 0.19 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.776 -1.202 . . . . 0.0 110.239 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' A' ' 129' ' ' LEU . 0.7 OUTLIER -66.58 -18.87 65.6 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 134' ' ' THR . . . -55.96 -33.21 64.55 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.489 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 7.9 t -66.77 -36.73 83.11 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.217 -0.927 . . . . 0.0 108.762 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.34 -40.0 24.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.8 t -73.41 -37.8 65.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.324 -0.86 . . . . 0.0 108.905 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 130' ' ' ALA . 88.9 m -71.55 -31.08 66.62 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.234 -0.916 . . . . 0.0 108.555 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.44 -36.58 67.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' A' ' 84' ' ' SER . 3.3 mp -56.71 -32.93 65.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 109.008 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.9 m -89.34 -27.25 20.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.59 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.2 p -66.59 132.09 47.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.528 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.459 ' C ' ' CG ' ' A' ' 140' ' ' TYR . 18.9 pttp -169.28 172.09 7.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.403 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.459 ' CG ' ' C ' ' A' ' 139' ' ' LYS . 28.1 m-85 -154.43 -44.49 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.534 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.439 ' CA ' ' HE ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.447 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.514 ' H3 ' ' CG ' ' B' ' 3' ' ' LEU . 13.2 p . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 19.0 m170 50.79 35.57 12.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.285 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.617 ' H ' ' CD1' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -86.47 178.11 7.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.188 -0.945 . . . . 0.0 109.25 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.415 ' O ' ' N ' ' B' ' 6' ' ' GLU . 7.5 p -92.09 145.42 30.81 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 109.368 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -39.96 -26.03 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.544 2.162 . . . . 0.0 112.17 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' B' ' 4' ' ' THR . 39.4 mt-10 -81.69 -51.91 7.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.565 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' B' ' 7' ' ' GLU . 0.7 OUTLIER -75.38 -22.6 57.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.913 . . . . 0.0 109.504 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.491 ' O ' ' OG1' ' B' ' 12' ' ' THR . 6.7 tttm -78.47 -37.1 44.21 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.33 -0.856 . . . . 0.0 109.121 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -63.12 -23.31 67.38 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.12 -57.64 3.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.148 -0.97 . . . . 0.0 110.166 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.46 -24.92 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.055 . . . . 0.0 108.574 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 96.4 m -78.26 -31.58 49.17 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.749 -0.594 . . . . 0.0 109.823 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -67.23 -63.79 0.99 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.767 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' B' ' 14' ' ' LEU . 10.6 mp -45.83 -19.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.388 -0.82 . . . . 0.0 109.901 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' TRP . . . . . 0.463 ' N ' ' O ' ' B' ' 13' ' ' ALA . 4.0 t90 -78.78 -40.82 32.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.064 -1.023 . . . . 0.0 108.82 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.43 -24.07 59.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -79.87 -32.65 40.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -1.014 . . . . 0.0 109.286 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -62.6 132.08 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.318 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' B' ' 21' ' ' ASP . 71.8 m-20 -81.26 78.28 8.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.246 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -49.82 -10.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' B' ' 19' ' ' ASN . 21.4 m-20 -55.31 -29.95 59.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.895 . . . . 0.0 109.729 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' B' ' 25' ' ' GLY . 18.3 pt-20 -152.5 -32.16 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.96 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' B' ' 22' ' ' GLU . 92.8 t -44.71 -26.32 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 109.638 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.51 -26.27 47.57 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.52 ' CA ' ' HZ1' ' B' ' 65' ' ' LYS . . . -66.85 -45.12 86.62 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.415 ' OE2' ' N ' ' B' ' 26' ' ' GLU . 1.2 mp0 -63.91 -47.75 79.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -1.144 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.41 -30.8 42.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.161 -0.962 . . . . 0.0 109.372 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.2 -54.27 5.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.37 -35.23 91.78 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -67.01 -32.38 73.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.12 . . . . 0.0 109.466 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 tp -47.24 -41.31 18.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 109.638 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.68 -23.91 39.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 109.712 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.17 -64.03 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.983 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 2.5 t -46.76 -43.9 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.322 -0.861 . . . . 0.0 109.373 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -171.79 130.0 0.69 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.336 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.59 62.32 7.71 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.302 2.002 . . . . 0.0 112.088 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' TRP . . . . . 0.493 ' CD1' ' N ' ' B' ' 37' ' ' TRP . 0.0 OUTLIER -57.65 -43.75 85.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.151 -0.968 . . . . 0.0 109.276 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 1.044 HG23 HBC3 ' B' ' 147' ' ' HEC . 1.7 p -49.78 -64.42 0.81 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.902 . . . . 0.0 109.373 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . 0.533 ' N ' ' OG1' ' B' ' 38' ' ' THR . 31.8 tt0 48.16 43.94 18.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.483 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 -163.44 -36.67 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.554 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -119.28 16.11 13.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 109.193 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' B' ' 43' ' ' GLU . 30.7 p90 -87.54 -35.15 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.534 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.489 ' OE2' ' NH1' ' C' ' 92' ' ' ARG . 12.1 pt-20 -81.98 -13.92 56.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.683 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 86.4 p -57.68 -29.05 64.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.6 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -85.23 19.23 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.514 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.62 1.87 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' B' ' 48' ' ' LEU . 35.7 t0 49.79 -145.96 0.41 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -1.196 . . . . 0.0 109.488 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.542 ' H ' ' CG ' ' B' ' 47' ' ' ASP . 2.4 tp 82.73 24.29 0.16 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.787 -0.571 . . . . 0.0 109.64 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -57.59 -35.16 70.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.935 . . . . 0.0 109.202 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' THR . . . . . 0.605 ' HG1' ' H ' ' B' ' 52' ' ' ASP . 1.2 p -146.93 153.64 46.09 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 108.923 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.44 -22.74 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.258 1.972 . . . . 0.0 112.257 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.605 ' H ' ' HG1' ' B' ' 50' ' ' THR . 26.2 t70 -85.13 -38.58 18.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.92 -19.52 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.34 -0.85 . . . . 0.0 109.53 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' B' ' 52' ' ' ASP . 14.4 t -60.63 -59.34 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 17.2 ptp -90.33 14.13 13.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.895 . . . . 0.0 109.572 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.85 -18.98 58.77 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -89.08 146.95 37.45 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.133 -1.216 . . . . 0.0 109.486 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.87 -20.44 17.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.565 2.177 . . . . 0.0 112.388 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.61 -32.37 25.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 109.796 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -60.65 -41.15 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.969 . . . . 0.0 109.654 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.536 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 11.9 ptpt -79.03 -35.87 42.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -0.989 . . . . 0.0 109.38 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.25 69.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' HIS . . . . . 0.907 ' HE2' ' CAD' ' B' ' 147' ' ' HEC . 0.8 OUTLIER -72.87 -24.05 60.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.91 . . . . 0.0 109.594 -179.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.72 -19.08 80.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -68.5 -32.2 72.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -1.139 . . . . 0.0 109.323 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -75.95 -34.46 59.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.631 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' VAL . . . . . 0.821 HG22 ' CHB' ' B' ' 147' ' ' HEC . 53.9 t -68.9 -62.87 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.5 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tt -50.21 -29.01 8.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.934 . . . . 0.0 109.315 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.73 -38.93 96.74 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.47 93.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -1.135 . . . . 0.0 109.822 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -46.98 -30.25 2.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.772 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.445 ' O ' ' N ' ' B' ' 76' ' ' ALA . 3.9 p -57.56 -49.7 75.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -60.38 -16.91 39.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.399 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.17 -31.04 79.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' B' ' 75' ' ' LEU . 1.4 pt? -136.58 -22.38 1.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.268 -1.136 . . . . 0.0 110.031 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -77.59 5.11 9.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.03 -1.044 . . . . 0.0 109.733 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 46.5 m-70 -161.03 66.22 0.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 87.1 mt -72.96 10.82 0.8 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.498 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' B' ' 77' ' ' HIS . 13.7 t70 -66.74 -45.68 77.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.422 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -162.21 96.2 0.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.805 . . . . 0.0 109.414 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 24.7 mt -76.16 -58.79 3.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.579 ' NZ ' ' CD2' ' B' ' 143' ' ' HIS . 11.0 ttmm -54.72 -23.94 19.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.486 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.13 -47.54 9.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.8 t -78.25 -48.28 16.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -1.158 . . . . 0.0 109.628 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' PHE . . . . . 0.563 ' N ' ' CG2' ' B' ' 84' ' ' THR . 27.9 m-85 -59.62 -1.71 0.28 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.5 -0.75 . . . . 0.0 109.425 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -56.3 -35.25 67.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.371 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 34.8 p -73.09 -57.77 3.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 32.5 mt -56.43 -29.5 61.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.312 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 69.6 m -81.14 -32.56 33.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -82.6 -22.28 34.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.869 . . . . 0.0 109.546 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 tt -78.78 -68.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.759 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' B' ' 97' ' ' HIS . 0.4 OUTLIER -55.31 -20.12 10.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.075 -179.198 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' CYS . . . . . 0.532 ' N ' ' ND1' ' B' ' 92' ' ' HIS . 36.4 t -83.53 -60.68 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 110.642 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' B' ' 94' ' ' ASP . 0.8 OUTLIER -87.78 -25.75 23.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.084 -1.01 . . . . 0.0 111.446 -178.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.96 -52.24 5.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.717 -1.239 . . . . 0.0 110.96 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.607 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 2.3 mm? -112.56 -11.63 13.56 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.941 -1.1 . . . . 0.0 109.828 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 49.2 p-80 41.84 41.51 1.87 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.351 -0.843 . . . . 0.0 109.761 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 59.6 t -51.41 132.32 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -0.819 . . . . 0.0 109.457 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.07 153.0 90.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.171 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.47 -164.76 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.544 2.162 . . . . 0.0 112.229 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 56.91 48.38 15.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -0.936 . . . . 0.0 109.36 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -160.62 -33.53 0.05 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.315 -0.865 . . . . 0.0 109.46 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -63.42 -60.94 2.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.37 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -57.53 -20.3 30.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.357 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 tt -77.34 -49.79 14.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.383 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.852 HD11 ' CHC' ' B' ' 147' ' ' HEC . 6.7 tt -49.38 -46.3 47.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.274 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.35 -45.82 95.45 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . 0.796 HD22 ' CG ' ' A' ' 103' ' ' HIS . 11.8 t-20 -53.8 -34.7 59.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.151 -1.205 . . . . 0.0 109.565 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' VAL . . . . . 0.481 ' O ' ' SG ' ' B' ' 112' ' ' CYS . 89.7 t -80.28 -24.06 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 34.6 tp -78.06 -32.37 50.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.29 -49.59 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 109.754 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' B' ' 109' ' ' VAL . 18.7 p -53.08 -37.21 61.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.692 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' VAL . . . . . 0.468 ' N ' ' SG ' ' B' ' 112' ' ' CYS . 96.5 t -60.64 -21.37 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.661 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' B' ' 130' ' ' TYR . 23.6 mt -77.63 -57.02 4.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' ALA . . . . . 0.462 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.1 -19.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.372 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' HIS . . . . . 0.805 ' NE2' ' CE1' ' A' ' 117' ' ' PHE . 1.5 t-80 -79.33 -56.78 4.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -69.24 -17.72 63.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 109.71 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -151.22 60.96 0.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 0.0 109.588 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -77.76 -23.23 67.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.53 8.71 4.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -1.1 . . . . 0.0 109.447 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' B' ' 123' ' ' THR . 20.4 mm-40 -134.63 12.88 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.18 43.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.0 109.119 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.417 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.0 OUTLIER -48.64 151.1 2.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.147 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.485 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.0 Cg_exo -45.98 -52.32 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.281 1.987 . . . . 0.0 113.029 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 46.8 Cg_endo -68.34 15.24 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.173 1.916 . . . . 0.0 112.973 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 53.2 t -108.53 -42.69 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.988 -1.07 . . . . 0.0 109.878 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' GLN . . . . . 0.544 ' CD ' ' H ' ' B' ' 127' ' ' GLN . 0.0 OUTLIER -70.7 -59.87 2.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.086 -1.009 . . . . 0.0 109.798 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 34' ' ' LEU . . . -49.48 -34.79 17.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.099 -1.001 . . . . 0.0 109.358 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.34 27.75 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.29 -0.881 . . . . 0.0 109.641 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' TYR . . . . . 0.516 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 1.6 t80 -126.69 -34.68 2.39 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.356 -0.84 . . . . 0.0 109.637 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -71.22 -62.86 1.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.743 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -48.7 -21.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.774 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . 0.411 HG11 ' H1 ' ' B' ' 1' ' ' VAL . 33.8 t -69.13 -65.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.741 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 9.2 m -74.15 -16.38 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.607 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.463 ' HB2' ' HD2' ' D' ' 146' ' ' HIS . . . -49.41 -30.26 7.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.331 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.59 -26.3 70.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.79 -39.81 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -1.11 . . . . 0.0 109.367 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.88 95.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.873 ' ND2' ' CE1' ' D' ' 146' ' ' HIS . 1.2 m-20 -73.72 -44.14 57.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.422 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.09 -37.68 47.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.331 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.529 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 18.1 mt -82.35 11.27 5.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' B' ' 144' ' ' LYS . . . -123.7 -30.97 3.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.382 -0.823 . . . . 0.0 109.514 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . 0.579 ' CD2' ' NZ ' ' B' ' 82' ' ' LYS . 1.5 m80 -49.68 -13.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.355 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' B' ' 142' ' ' ALA . 3.2 tptp -77.88 -43.07 31.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.21 -0.931 . . . . 0.0 109.511 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -50.1 -25.25 3.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' HIS . . . . . 0.837 ' CE1' ' ND2' ' D' ' 139' ' ' ASN . 25.8 m170 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.495 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.36 -169.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.897 . . . . 0.0 109.862 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' SER . . . . . 0.529 ' H ' ' CG ' ' C' ' 6' ' ' ASP . 0.1 OUTLIER -99.93 -179.11 0.77 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.404 -0.81 . . . . 0.0 109.644 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 22.8 Cg_exo -62.92 -58.46 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.908 2.405 . . . . 0.0 113.091 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -78.7 -16.4 57.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.1 -1.0 . . . . 0.0 110.215 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' C' ' 3' ' ' SER . 33.5 m-20 -39.86 -30.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' LYS . . . . . 0.588 ' CD ' ' H ' ' C' ' 7' ' ' LYS . 0.0 OUTLIER -83.65 -39.52 20.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.493 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.45 ' N ' ' O ' ' C' ' 5' ' ' ALA . 36.4 m -44.85 -42.87 8.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.369 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.23 -25.37 62.47 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' C' ' 7' ' ' LYS . 52.9 t -78.83 -55.24 10.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' C' ' 15' ' ' GLY . 0.0 OUTLIER -53.41 -37.18 62.27 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.526 -1.27 . . . . 0.0 107.89 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.79 -63.16 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.332 -0.855 . . . . 0.0 109.241 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . 0.406 ' O ' ' CG2' ' C' ' 17' ' ' VAL . . . -60.29 -36.2 77.31 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -17.49 62.37 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 109.067 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' C' ' 11' ' ' LYS . . . -78.86 -46.42 8.48 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.04 -36.65 75.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -1.118 . . . . 0.0 108.869 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' C' ' 13' ' ' ALA . 94.9 t -60.65 -66.02 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.588 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 58.77 -134.78 52.36 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.55 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -1.025 . . . . 0.0 110.427 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' HIS . . . . . 0.588 ' H ' ' C ' ' C' ' 18' ' ' GLY . 92.2 m-70 -131.59 25.72 4.74 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.65 -61.55 1.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.61 -0.681 . . . . 0.0 109.755 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.7 -14.42 0.23 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 21' ' ' ALA . 1.2 mm-40 -84.28 -56.4 3.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -1.059 . . . . 0.0 109.526 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . 0.606 ' CE1' ' CG ' ' C' ' 112' ' ' HIS . 2.8 m-30 -60.6 -27.83 68.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 109.176 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.75 -22.94 75.66 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.72 -41.98 18.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.249 -1.147 . . . . 0.0 109.832 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -64.37 -19.99 65.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.405 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.05 -19.71 60.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.347 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 12.8 mt -78.41 -53.98 6.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.688 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.31 -37.64 65.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -43.84 98.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' MET . . . . . 0.911 ' HE2' HBC3 ' C' ' 142' ' ' HEC . 53.4 ttp -67.29 -49.96 62.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.407 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -51.49 -46.32 63.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' D' ' 128' ' ' ALA . 12.8 mt -64.08 -60.22 3.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.927 . . . . 0.0 109.865 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 18.7 p -55.36 -19.05 7.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' C' ' 35' ' ' SER . 79.6 m-85 -156.16 113.27 2.11 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.578 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' C' ' 39' ' ' THR . 73.0 Cg_endo -79.47 -20.12 9.74 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.259 1.973 . . . . 0.0 111.982 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 40.9 p -47.17 -18.41 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 109.65 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.443 ' N ' ' O ' ' C' ' 37' ' ' PRO . 42.4 p -74.71 -22.79 58.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 109.854 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -69.96 -20.15 63.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 110.082 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.401 ' C ' ' H ' ' C' ' 43' ' ' PHE . 12.2 t -73.69 -18.85 60.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.075 -1.016 . . . . 0.0 109.83 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -80.2 19.48 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' C' ' 41' ' ' THR . 78.5 m-85 51.48 94.02 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.999 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.668 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 71.2 Cg_endo -81.59 -34.49 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.556 2.171 . . . . 0.0 111.763 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' HIS . . . . . 0.668 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 15.1 p80 51.67 30.51 6.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.279 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' PHE . . . . . 0.608 ' CD2' ' O ' ' C' ' 44' ' ' PRO . 5.0 p90 -145.36 23.2 1.48 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.9 -1.125 . . . . 0.0 109.541 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' C' ' 49' ' ' SER . 56.9 m-20 42.51 84.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.533 -0.73 . . . . 0.0 109.772 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.471 ' H ' ' CD1' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -50.27 -11.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.421 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.504 ' H ' ' C ' ' C' ' 47' ' ' ASP . 14.7 m -58.97 147.38 34.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -64.57 148.37 50.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.63 -4.15 83.65 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' SER . . . . . 0.494 ' O ' ' N ' ' C' ' 54' ' ' GLN . 5.4 p -69.03 -23.66 64.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 109.328 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' C' ' 55' ' ' VAL . . . 67.5 -56.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.795 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' C' ' 52' ' ' SER . 43.0 mt-30 -43.95 -22.5 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.372 -0.83 . . . . 0.0 109.798 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 53' ' ' ALA . 40.9 t -74.23 -26.72 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.323 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' C' ' 53' ' ' ALA . 5.7 ptmt -65.75 -27.41 68.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.18 -50.51 39.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -53.73 -32.44 52.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -1.136 . . . . 0.0 109.567 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.23 -47.3 91.76 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -58.2 -23.46 55.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.385 -1.068 . . . . 0.0 109.694 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' LYS . . . . . 0.65 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 0.7 OUTLIER -74.26 -39.44 63.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.229 -0.919 . . . . 0.0 108.927 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.76 -49.05 48.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.48 -30.02 71.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.315 -0.866 . . . . 0.0 109.017 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -67.14 -38.66 85.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.898 . . . . 0.0 108.819 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' ALA . . . . . 0.525 ' CB ' HMB3 ' C' ' 142' ' ' HEC . . . -64.09 -52.13 60.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -57.08 -44.71 83.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.227 -0.92 . . . . 0.0 108.764 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 17.5 m -68.74 -50.61 49.28 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.294 -0.879 . . . . 0.0 108.703 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -60.38 -24.27 64.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.95 -45.64 12.0 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.56 -23.48 33.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -18.74 64.27 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' HIS . . . . . 0.614 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.7 m80 -144.06 -58.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.446 -0.783 . . . . 0.0 109.337 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.3 p 44.28 13.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.796 0.808 . . . . 0.0 109.475 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' C' ' 72' ' ' HIS . 46.0 t0 -133.86 11.11 3.97 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 179.0 29.25 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.003 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 17.4 ptt? -78.57 -22.63 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 111.796 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.4 Cg_exo -54.0 -22.36 24.45 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.559 1.506 . . . . 0.0 112.334 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' ASN . . . . . 0.434 ' O ' ' OG ' ' C' ' 81' ' ' SER . 9.4 m120 -94.2 -33.86 13.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.13 -0.981 . . . . 0.0 109.775 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.29 -46.74 60.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -0.948 . . . . 0.0 109.427 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 12.9 mt -80.39 8.43 7.62 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 109.07 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 38.5 p -55.78 -17.14 5.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.742 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.16 -55.89 4.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 109.752 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.486 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 3.5 mt -45.41 -43.97 11.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 108.967 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' C' ' 136' ' ' LEU . 29.7 t -57.32 -22.55 42.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 109.44 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' C' ' 89' ' ' HIS . 23.0 t70 -82.01 -58.37 3.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.14 -0.975 . . . . 0.0 109.926 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.49 -27.42 16.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 109.77 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 38.8 m80 -91.97 -21.7 20.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.795 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.41 -11.41 15.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 109.914 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' C' ' 85' ' ' ASP . 14.3 m80 -113.94 -77.86 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.034 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' C' ' 89' ' ' HIS . 9.9 mptt -45.78 -97.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.868 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' C' ' 93' ' ' VAL . 19.6 mt -65.67 -17.32 64.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 110.178 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' ARG . . . . . 0.489 ' NH1' ' OE2' ' B' ' 43' ' ' GLU . 25.1 ttm180 48.86 15.34 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 0.0 108.938 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' C' ' 91' ' ' LEU . 10.8 p -46.05 156.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 0.0 109.886 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.21 153.0 37.99 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.079 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' C' ' 98' ' ' PHE . 32.7 Cg_endo -65.87 -10.58 27.37 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.535 2.157 . . . . 0.0 111.947 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 84.0 t -44.01 -29.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.852 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -79.42 -32.86 42.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.621 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' PHE . . . . . 0.448 ' N ' ' O ' ' C' ' 95' ' ' PRO . 0.0 OUTLIER -50.18 -34.91 24.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.345 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.413 ' O ' ' OG ' ' C' ' 102' ' ' SER . 65.6 mttm -50.02 -34.91 22.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.484 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 9.9 mt -82.11 -50.53 8.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.872 HD21 HBB3 ' C' ' 142' ' ' HEC . 53.2 tp -45.75 -20.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 0.0 109.64 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' SER . . . . . 0.445 ' N ' ' O ' ' C' ' 100' ' ' LEU . 93.1 p -73.4 -59.15 2.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.932 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.808 ' CG ' HD22 ' D' ' 108' ' ' ASN . 40.7 m80 -71.92 -26.52 62.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 104' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 62.1 m -58.07 -42.13 84.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.042 -1.036 . . . . 0.0 109.942 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.68 -22.85 62.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.123 -0.986 . . . . 0.0 110.123 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' C' ' 106' ' ' LEU . 3.7 mm? -79.01 -35.98 41.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.021 -1.049 . . . . 0.0 110.146 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 45.7 t -62.8 -39.47 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.054 -1.029 . . . . 0.0 109.536 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' C' ' 109' ' ' LEU . 12.5 p -65.31 -62.86 1.28 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.171 -0.956 . . . . 0.0 109.639 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 109' ' ' LEU . . . . . 0.492 ' N ' ' OG1' ' C' ' 108' ' ' THR . 14.8 mt -48.3 -22.42 0.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.355 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.5 83.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.932 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.54 20.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.961 . . . . 0.0 109.863 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 112' ' ' HIS . . . . . 0.606 ' CG ' ' CE1' ' C' ' 24' ' ' TYR . 93.3 m-70 -81.78 -75.43 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -0.991 . . . . 0.0 109.54 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.482 ' O ' ' CG ' ' C' ' 113' ' ' LEU . 1.5 pp -137.05 94.42 12.62 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.2 -171.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.26 1.973 . . . . 0.0 112.899 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 115' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -47.3 -38.53 12.79 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.622 0.725 . . . . 0.0 109.598 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 116' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 6.7 mt-10 85.34 9.57 0.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 117' ' ' PHE . . . . . 0.812 ' CE1' ' NE2' ' D' ' 116' ' ' HIS . 6.9 m-85 65.11 34.93 8.28 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.779 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 118' ' ' THR . . . . . 0.727 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -94.58 121.33 63.43 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.783 -1.198 . . . . 0.0 107.942 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -51.35 23.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.124 1.883 . . . . 0.0 112.849 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 120' ' ' ALA . . . . . 0.727 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -155.06 -30.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.742 -1.223 . . . . 0.0 110.773 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 121' ' ' VAL . . . . . 0.55 ' HB ' ' OG1' ' C' ' 118' ' ' THR . 11.9 p -47.8 -50.35 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 122' ' ' HIS . . . . . 0.532 ' N ' ' CG1' ' C' ' 121' ' ' VAL . 2.4 t-80 -65.41 -43.56 90.17 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.41 -0.806 . . . . 0.0 109.976 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 123' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' D' ' 34' ' ' VAL . . . -79.06 -19.38 51.5 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 109.914 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 124' ' ' SER . . . . . 0.58 ' N ' ' O ' ' C' ' 120' ' ' ALA . 63.7 m -72.42 -63.85 1.07 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 111.128 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.05 -18.18 64.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.06 -1.025 . . . . 0.0 109.562 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.24 -49.55 9.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.899 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . 0.434 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -90.86 -57.64 2.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.903 -1.123 . . . . 0.0 111.476 -178.187 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 128' ' ' PHE . . . . . 0.466 ' CD2' ' HA ' ' C' ' 124' ' ' SER . 21.9 m-85 -46.57 -21.53 0.19 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.731 -1.231 . . . . 0.0 110.189 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 129' ' ' LEU . . . . . 0.502 ' CD1' ' C ' ' C' ' 129' ' ' LEU . 0.7 OUTLIER -66.6 -18.86 65.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' C' ' 134' ' ' THR . . . -56.01 -33.18 64.64 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 131' ' ' SER . . . . . 0.483 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 7.9 t -66.67 -36.83 83.47 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.168 -0.958 . . . . 0.0 108.767 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.3 -39.98 24.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 34.9 t -73.52 -37.66 65.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.466 -0.771 . . . . 0.0 108.95 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 134' ' ' THR . . . . . 0.505 ' N ' ' O ' ' C' ' 130' ' ' ALA . 88.8 m -71.62 -31.1 66.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.35 -36.58 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.459 ' O ' ' CB ' ' C' ' 84' ' ' SER . 3.2 mp -56.73 -32.85 65.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.361 -0.837 . . . . 0.0 108.998 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 51.4 m -89.36 -27.46 20.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.477 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 25.1 p -66.47 132.03 47.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.977 . . . . 0.0 109.501 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . 0.46 ' C ' ' CG ' ' C' ' 140' ' ' TYR . 18.9 pttp -169.24 172.1 7.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.46 ' CG ' ' C ' ' C' ' 139' ' ' LYS . 27.8 m-85 -154.4 -44.54 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.971 . . . . 0.0 109.521 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 141' ' ' ARG . . . . . 0.433 ' CA ' ' HE ' ' C' ' 141' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.438 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 1' ' ' VAL . . . . . 0.499 ' H3 ' ' CG ' ' D' ' 3' ' ' LEU . 13.5 p . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 18.9 m170 50.84 35.5 12.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.32 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 3' ' ' LEU . . . . . 0.602 ' H ' ' CD1' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -86.4 178.15 7.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 109.338 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.412 ' O ' ' N ' ' D' ' 6' ' ' GLU . 7.3 p -92.2 145.54 30.95 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 109.285 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -40.09 -25.96 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.534 2.156 . . . . 0.0 112.177 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 6' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' D' ' 4' ' ' THR . 39.5 mt-10 -81.72 -51.91 7.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' D' ' 7' ' ' GLU . 0.7 OUTLIER -75.3 -22.75 57.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.47 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 8' ' ' LYS . . . . . 0.497 ' O ' ' OG1' ' D' ' 12' ' ' THR . 6.7 tttm -78.39 -37.17 44.73 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.299 -0.876 . . . . 0.0 109.131 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 37.5 t -63.07 -23.28 67.37 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.23 -57.5 3.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.962 . . . . 0.0 110.082 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.52 -24.88 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.977 -1.077 . . . . 0.0 108.54 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 12' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 96.7 m -78.35 -31.59 48.64 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.729 -0.607 . . . . 0.0 109.724 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -67.25 -63.82 0.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.747 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' D' ' 14' ' ' LEU . 10.6 mp -45.79 -19.29 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.377 -0.827 . . . . 0.0 109.898 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 15' ' ' TRP . . . . . 0.472 ' N ' ' O ' ' D' ' 13' ' ' ALA . 4.1 t90 -78.95 -40.8 30.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.986 -1.071 . . . . 0.0 108.751 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.31 -24.19 59.57 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -79.77 -32.71 40.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.456 -1.026 . . . . 0.0 109.353 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -62.62 132.13 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.4 -0.812 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 19' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' D' ' 21' ' ' ASP . 71.7 m-20 -81.21 78.17 8.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.291 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 78.4 t -49.78 -10.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.498 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' D' ' 19' ' ' ASN . 21.4 m-20 -55.33 -29.89 59.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 22' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' D' ' 25' ' ' GLY . 18.3 pt-20 -152.57 -32.15 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.095 -1.003 . . . . 0.0 110.045 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' D' ' 22' ' ' GLU . 93.0 t -44.72 -26.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.113 -0.992 . . . . 0.0 109.597 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.5 -26.31 47.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 25' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -66.71 -45.22 86.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 26' ' ' GLU . . . . . 0.423 ' OE2' ' N ' ' D' ' 26' ' ' GLU . 1.2 mp0 -63.9 -47.82 79.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -1.125 . . . . 0.0 109.318 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.3 -30.86 41.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.339 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.22 -54.32 5.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.24 -35.29 91.88 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -66.98 -32.36 73.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -1.091 . . . . 0.0 109.495 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 64.5 tp -47.35 -41.24 19.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.599 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 mt -80.73 -23.88 39.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.699 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.09 -64.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.474 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 34' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' C' ' 123' ' ' ALA . 2.4 t -46.65 -43.89 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -171.88 130.05 0.68 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 109.304 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.51 62.17 7.63 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.366 2.044 . . . . 0.0 112.126 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 37' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' D' ' 37' ' ' TRP . 0.0 OUTLIER -57.6 -43.72 84.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.143 -0.973 . . . . 0.0 109.272 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 38' ' ' THR . . . . . 1.095 HG23 HBC3 ' D' ' 147' ' ' HEC . 1.8 p -49.86 -64.41 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.371 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 39' ' ' GLN . . . . . 0.553 ' N ' ' OG1' ' D' ' 38' ' ' THR . 31.9 tt0 48.09 44.09 18.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 109.429 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -163.55 -36.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -119.3 16.14 13.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.309 -0.869 . . . . 0.0 109.216 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 42' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' D' ' 43' ' ' GLU . 30.8 p90 -87.61 -35.07 18.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.542 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . 0.518 ' OE2' ' NH1' ' A' ' 92' ' ' ARG . 12.1 pt-20 -81.97 -13.89 56.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.696 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 86.2 p -57.63 -29.09 64.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.607 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -85.27 19.24 2.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.44 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.63 1.87 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' D' ' 48' ' ' LEU . 35.7 t0 49.98 -146.01 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -1.186 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 48' ' ' LEU . . . . . 0.531 ' CB ' ' O ' ' D' ' 47' ' ' ASP . 2.4 tp 82.77 24.19 0.16 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.807 -0.558 . . . . 0.0 109.622 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -57.56 -35.12 69.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.273 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 50' ' ' THR . . . . . 0.602 ' HG1' ' H ' ' D' ' 52' ' ' ASP . 1.2 p -146.93 153.69 46.13 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 108.887 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -42.47 -22.7 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.249 1.966 . . . . 0.0 112.251 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . 0.602 ' H ' ' HG1' ' D' ' 50' ' ' THR . 26.1 t70 -85.15 -38.6 18.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.562 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.82 -19.58 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.362 -0.836 . . . . 0.0 109.573 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 t -60.66 -59.45 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.514 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 17.1 ptp -90.25 14.19 13.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.0 109.493 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.03 -18.91 58.61 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -89.07 146.99 37.55 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 109.443 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.76 -20.56 17.34 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.609 2.206 . . . . 0.0 112.4 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.55 -32.39 25.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 109.785 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 67.0 t -60.72 -41.18 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.672 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 61' ' ' LYS . . . . . 0.535 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 12.0 ptpt -78.94 -35.79 42.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.34 -30.12 69.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 63' ' ' HIS . . . . . 0.889 ' HE2' ' CAD' ' D' ' 147' ' ' HEC . 0.8 OUTLIER -72.93 -24.08 60.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.71 -19.12 80.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 65' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 0.3 OUTLIER -68.44 -32.32 72.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -1.128 . . . . 0.0 109.326 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -75.78 -34.55 60.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.313 -0.867 . . . . 0.0 109.738 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 67' ' ' VAL . . . . . 0.814 HG22 ' CHB' ' D' ' 147' ' ' HEC . 53.9 t -68.85 -62.94 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 tt -50.14 -29.07 8.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.373 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.02 96.84 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.56 93.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -1.165 . . . . 0.0 109.804 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -47.0 -30.29 2.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.173 -0.954 . . . . 0.0 109.634 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 72' ' ' SER . . . . . 0.416 ' O ' ' N ' ' D' ' 76' ' ' ALA . 3.8 p -57.6 -49.68 75.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.461 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -60.32 -17.01 39.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.09 79.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' D' ' 75' ' ' LEU . 1.4 pt? -136.62 -22.34 1.27 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.317 -1.108 . . . . 0.0 109.973 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 76' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -77.61 5.09 9.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.072 -1.017 . . . . 0.0 109.679 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 77' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 46.8 m-70 -160.99 66.27 0.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.531 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.08 11.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.533 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' D' ' 77' ' ' HIS . 13.7 t70 -66.73 -45.72 77.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.399 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -162.21 96.19 0.97 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.787 . . . . 0.0 109.417 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 24.9 mt -76.19 -58.77 3.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 82' ' ' LYS . . . . . 0.584 ' NZ ' ' CD2' ' D' ' 143' ' ' HIS . 11.0 ttmm -54.76 -23.87 19.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.534 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.14 -47.51 9.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.8 t -78.28 -48.21 16.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -1.193 . . . . 0.0 109.67 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' D' ' 84' ' ' THR . 27.9 m-85 -59.72 -1.76 0.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 109.387 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 86' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -56.21 -35.24 67.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.158 -0.964 . . . . 0.0 109.423 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 34.5 p -73.2 -57.6 3.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 31.9 mt -56.49 -29.49 61.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.31 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 69.2 m -81.12 -32.64 33.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.439 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -82.62 -22.41 34.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.862 . . . . 0.0 109.482 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 tt -78.69 -68.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.853 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 92' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' D' ' 97' ' ' HIS . 0.4 OUTLIER -55.17 -20.28 10.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 0.0 110.092 -179.304 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 93' ' ' CYS . . . . . 0.526 ' N ' ' ND1' ' D' ' 92' ' ' HIS . 36.4 t -83.45 -60.66 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.1 -1.0 . . . . 0.0 110.706 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' D' ' 94' ' ' ASP . 0.8 OUTLIER -87.78 -25.64 23.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.087 -1.008 . . . . 0.0 111.45 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.02 -52.28 5.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.84 -1.163 . . . . 0.0 110.895 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 96' ' ' LEU . . . . . 0.609 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 2.3 mm? -112.5 -11.67 13.58 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.995 -1.065 . . . . 0.0 109.857 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 97' ' ' HIS . . . . . 0.609 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 49.3 p-80 41.89 41.48 1.89 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.31 -0.869 . . . . 0.0 109.786 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.42 132.32 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 0.0 109.472 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.01 152.96 90.0 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.245 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.54 -164.81 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.595 2.197 . . . . 0.0 112.162 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 57.01 48.34 15.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.32 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -160.61 -33.61 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -63.3 -60.91 2.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.445 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -57.63 -20.24 31.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 109.333 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 tt -77.37 -49.72 14.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.355 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.857 HD11 ' CHC' ' D' ' 147' ' ' HEC . 6.7 tt -49.41 -46.29 47.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.859 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.36 -45.78 95.53 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 108' ' ' ASN . . . . . 0.808 HD22 ' CG ' ' C' ' 103' ' ' HIS . 11.8 t-20 -53.76 -34.7 59.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -1.176 . . . . 0.0 109.583 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 109' ' ' VAL . . . . . 0.487 ' O ' ' SG ' ' D' ' 112' ' ' CYS . 90.7 t -80.25 -24.12 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 34.2 tp -78.05 -32.43 50.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 109.412 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 94.3 t -65.15 -49.77 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.685 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 112' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' D' ' 109' ' ' VAL . 18.6 p -52.95 -37.23 60.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.939 . . . . 0.0 109.747 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 113' ' ' VAL . . . . . 0.462 ' N ' ' SG ' ' D' ' 112' ' ' CYS . 96.5 t -60.66 -21.38 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.675 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 114' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' D' ' 130' ' ' TYR . 23.6 mt -77.64 -57.07 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 109.571 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.03 -19.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.088 -1.007 . . . . 0.0 109.386 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 116' ' ' HIS . . . . . 0.812 ' NE2' ' CE1' ' C' ' 117' ' ' PHE . 1.5 t-80 -79.45 -56.69 4.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.147 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -69.27 -17.61 63.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.683 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -151.31 60.98 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 119' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -77.78 -23.32 67.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.41 8.63 4.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.363 -1.08 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' D' ' 123' ' ' THR . 20.3 mm-40 -134.57 12.81 3.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.404 -0.81 . . . . 0.0 109.52 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.15 43.86 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.116 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.437 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.0 OUTLIER -48.61 151.1 2.15 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 109.161 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.483 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.0 Cg_exo -46.0 -52.3 7.25 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.307 2.005 . . . . 0.0 113.034 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 125' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 46.7 Cg_endo -68.29 15.16 0.16 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.157 1.905 . . . . 0.0 113.091 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 53.1 t -108.4 -42.76 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.056 -1.027 . . . . 0.0 109.914 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 127' ' ' GLN . . . . . 0.548 ' H ' ' CD ' ' D' ' 127' ' ' GLN . 0.0 OUTLIER -70.66 -60.01 2.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.997 -1.064 . . . . 0.0 109.734 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 128' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' C' ' 34' ' ' LEU . . . -49.37 -34.77 16.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.11 -0.993 . . . . 0.0 109.461 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.39 27.76 1.04 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.306 -0.871 . . . . 0.0 109.686 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 130' ' ' TYR . . . . . 0.516 ' CZ ' ' CD1' ' D' ' 114' ' ' LEU . 1.6 t80 -126.65 -34.73 2.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.345 -0.847 . . . . 0.0 109.592 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -71.32 -62.86 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.642 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -48.77 -21.7 0.67 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 109.709 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 133' ' ' VAL . . . . . 0.403 HG11 ' H1 ' ' D' ' 1' ' ' VAL . 34.2 t -69.17 -65.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.715 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' D' ' 137' ' ' VAL . 9.0 m -74.22 -16.44 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -0.92 . . . . 0.0 109.569 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.41 ' HB2' ' HD2' ' B' ' 146' ' ' HIS . . . -49.32 -30.28 7.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.372 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.68 -26.22 70.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 137' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' D' ' 134' ' ' VAL . 89.1 t -68.84 -39.75 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -1.132 . . . . 0.0 109.336 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.01 94.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.837 ' ND2' ' CE1' ' B' ' 146' ' ' HIS . 1.2 m-20 -73.7 -44.03 57.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.13 -37.67 47.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.926 . . . . 0.0 109.351 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 18.0 mt -82.31 11.2 5.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' D' ' 144' ' ' LYS . . . -123.66 -30.94 3.53 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.414 -0.804 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 143' ' ' HIS . . . . . 0.584 ' CD2' ' NZ ' ' D' ' 82' ' ' LYS . 1.5 m80 -49.69 -13.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.401 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 144' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' D' ' 142' ' ' ALA . 3.2 tptp -77.76 -43.0 32.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.25 -25.24 3.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.263 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 146' ' ' HIS . . . . . 0.873 ' CE1' ' ND2' ' B' ' 139' ' ' ASN . 25.9 m170 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.449 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' HEC . . . . . 0.917 HBC3 ' HE2' ' A' ' 32' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' HEC . . . . . 1.044 HBC3 HG23 ' B' ' 38' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 142' ' ' HEC . . . . . 0.911 HBC3 ' HE2' ' C' ' 32' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 147' ' ' HEC . . . . . 1.095 HBC3 HG23 ' D' ' 38' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 2' ' ' LEU . 29.8 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 7.8 mp 55.94 163.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.399 -0.813 . . . . 0.0 109.846 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.517 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 176.24 -47.8 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.021 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 3' ' ' SER . 54.2 Cg_exo -50.44 -170.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.473 2.115 . . . . 0.0 112.603 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -60.31 -16.17 32.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 109.667 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 5' ' ' ALA . 22.2 m-20 -39.51 -29.09 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.379 -0.826 . . . . 0.0 109.67 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 10' ' ' VAL . 4.6 ptpt -83.22 -49.99 8.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 7' ' ' LYS . 52.5 m -43.82 -32.77 1.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.474 -0.766 . . . . 0.0 109.751 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.85 -30.27 50.89 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.571 ' N ' ' O ' ' A' ' 7' ' ' LYS . 51.2 t -76.8 -51.57 18.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HZ1' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -57.64 -36.75 72.27 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.812 -1.155 . . . . 0.0 108.262 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.81 -58.25 8.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.13 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.99 -34.4 63.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 108.935 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -17.52 61.75 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.96 -44.6 18.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -70.1 -37.39 75.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -1.164 . . . . 0.0 108.51 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.574 ' CG1' ' HB2' ' A' ' 21' ' ' ALA . 4.2 t -60.16 -67.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 59.32 -136.81 50.59 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.28 29.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.487 -1.008 . . . . 0.0 110.485 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.565 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.9 m-70 -129.7 13.14 5.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 108.579 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.574 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . . . -75.0 -52.36 11.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.584 -0.697 . . . . 0.0 109.811 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.01 -14.53 10.68 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.31 -56.48 3.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -1.188 . . . . 0.0 109.72 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 20' ' ' HIS . 14.1 m-85 -59.86 -24.83 64.54 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 109.247 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.03 -33.77 84.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.93 -39.0 57.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.584 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.436 ' CG ' ' OG1' ' A' ' 108' ' ' THR . 13.2 tt0 -67.51 -20.0 65.38 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.361 -0.837 . . . . 0.0 109.552 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.43 61.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.078 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -75.98 -59.32 2.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -56.49 -12.55 1.78 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.282 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -65.21 -58.29 6.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.939 . . . . 0.0 109.835 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -84.52 -32.91 23.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 110.354 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 20.1 m-85 -63.54 -36.01 82.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.006 -1.058 . . . . 0.0 110.121 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 35' ' ' SER . 3.8 pp -46.92 -40.54 14.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.84 -1.163 . . . . 0.0 109.534 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.663 ' N ' HD12 ' A' ' 34' ' ' LEU . 1.4 p -76.56 -23.58 53.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.022 -1.049 . . . . 0.0 108.792 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.564 ' C ' ' O ' ' A' ' 35' ' ' SER . 0.3 OUTLIER 21.44 66.0 0.3 Allowed Pre-proline 0 N--CA 1.501 2.103 0 CA-C-O 121.155 0.502 . . . . 0.0 111.291 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.44 -62.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.46 2.107 . . . . 0.0 112.076 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.558 ' O ' HG22 ' A' ' 41' ' ' THR . 1.2 p -91.15 -57.52 2.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.546 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 39' ' ' THR . 3.0 p -44.12 -22.94 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -0.795 . . . . 0.0 110.333 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.3 ttmt -49.06 -45.17 42.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.087 -1.008 . . . . 0.0 109.569 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 38' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.59 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.645 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.258 0 CA-C-O 120.983 0.42 . . . . 0.0 110.669 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.477 ' C ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -154.35 31.1 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.581 -1.324 . . . . 0.0 110.553 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 46' ' ' PHE . 35.6 m-20 42.26 88.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -0.798 . . . . 0.0 110.242 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.44 -13.06 57.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 109.035 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 50' ' ' HIS . 32.8 p -78.02 165.73 23.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.559 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.564 ' N ' ' ND1' ' A' ' 50' ' ' HIS . 0.3 OUTLIER -57.81 -162.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.319 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.7 34.49 10.49 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 54' ' ' GLN . 30.2 t -139.06 82.29 1.89 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.357 -1.084 . . . . 0.0 109.259 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.68 -10.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.414 -0.804 . . . . 0.0 109.806 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 52' ' ' SER . 11.7 mt-30 -74.81 -35.23 62.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.123 -0.986 . . . . 0.0 109.676 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.66 -48.51 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.52 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.579 ' CD ' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -69.18 -25.5 64.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.416 -0.802 . . . . 0.0 109.046 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.91 -21.68 78.93 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.8 t-80 -82.43 -39.9 21.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -1.129 . . . . 0.0 109.847 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.92 -51.65 44.21 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -51.17 -22.66 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -1.022 . . . . 0.0 110.101 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.76 -29.72 56.23 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.056 -1.027 . . . . 0.0 109.255 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -79.8 -49.0 19.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.519 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -68.57 -22.71 64.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.406 -0.809 . . . . 0.0 109.191 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -78.25 -30.68 48.76 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.1 -1.0 . . . . 0.0 108.778 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.76 53.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.388 -0.82 . . . . 0.0 108.969 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.57 -40.58 72.15 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.153 -0.967 . . . . 0.0 108.757 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 m -68.81 -56.78 6.93 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 46.6 t30 -55.38 -24.17 28.35 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -80.24 -46.93 15.41 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.586 HG13 ' HZ1' ' A' ' 11' ' ' LYS . 36.0 t -64.41 -22.93 32.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.43 -17.04 64.56 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.616 ' O ' ' N ' ' A' ' 74' ' ' ASP . 4.2 m-70 -141.9 -61.25 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.434 -0.791 . . . . 0.0 109.435 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.1 p 44.72 12.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.721 0.772 . . . . 0.0 109.64 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 72' ' ' HIS . 44.5 t0 -134.21 10.45 3.83 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 2.0 m-20 -178.53 28.02 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.733 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.701 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 6.5 ptt? -78.46 -23.36 0.41 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 111.67 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.3 Cg_exo -54.36 -18.82 15.45 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.617 1.545 . . . . 0.0 112.132 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -93.43 -38.08 11.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.421 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.45 -40.18 64.38 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 108.956 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.8 mt -87.65 11.34 15.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.7 t -65.32 -26.85 68.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.713 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.98 -49.03 66.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.726 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.439 ' N ' HD23 ' A' ' 83' ' ' LEU . 4.1 mt -47.69 -46.96 29.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 109.022 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 9.7 t -62.78 -28.55 70.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.626 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -79.96 -28.14 39.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 109.588 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 90' ' ' LYS . 3.7 tt -83.22 -32.29 26.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 109.87 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -92.04 -22.0 20.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.219 -0.926 . . . . 0.0 110.218 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -104.07 -48.01 4.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.112 -0.992 . . . . 0.0 110.123 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -93.44 21.93 5.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.13 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.504 ' C ' ' H ' ' A' ' 92' ' ' ARG . 28.6 ttmt -172.11 147.07 2.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.022 -1.049 . . . . 0.0 110.006 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER 71.31 -20.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.522 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.504 ' H ' ' C ' ' A' ' 90' ' ' LYS . 70.4 mtt85 43.12 27.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 109.741 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.534 HG22 ' N ' ' A' ' 94' ' ' ASP . 12.2 p -46.98 165.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.725 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.534 ' N ' HG22 ' A' ' 93' ' ' VAL . 6.1 p-10 -109.7 101.18 45.6 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.493 -0.754 . . . . 0.0 109.28 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.72 -10.85 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.407 2.072 . . . . 0.0 112.331 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 94' ' ' ASP . 52.6 t -50.98 -18.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 100' ' ' LEU . 3.1 m120 -79.22 -24.38 43.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.316 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -44.33 -35.75 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -67.98 -23.78 65.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.873 . . . . 0.0 109.579 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 100' ' ' LEU . 8.8 mp -84.18 -62.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.638 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.47 -23.87 27.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.8 p -67.86 -50.4 56.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 109.727 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -78.02 -26.42 48.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.741 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 96.7 m -50.8 -50.45 56.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 109.629 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.26 -38.88 55.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.892 . . . . 0.0 109.765 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.88 -36.18 64.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.531 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.13 -27.67 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.069 -1.019 . . . . 0.0 109.852 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -81.07 -45.19 16.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.123 -0.986 . . . . 0.0 109.842 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.506 ' N ' ' CG2' ' A' ' 108' ' ' THR . 15.6 mt -66.89 -20.67 65.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.926 . . . . 0.0 109.057 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 112' ' ' HIS . . . -51.66 -43.01 62.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.427 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.76 -3.62 0.12 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 109.193 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.512 ' H ' ' C ' ' A' ' 110' ' ' ALA . 80.9 m80 -143.24 -85.59 0.15 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -0.888 . . . . 0.0 109.277 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.82 HD23 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -139.79 100.14 7.44 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.28 -98.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.646 2.231 . . . . 0.0 112.791 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.797 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -72.12 -56.58 5.34 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.557 -0.715 . . . . 0.0 110.064 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.667 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 17.5 mt-10 116.62 -6.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.485 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 4.9 t80 79.53 33.3 0.21 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.297 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.722 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -108.94 125.07 32.44 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.021 -1.049 . . . . 0.0 108.199 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.91 21.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.216 1.944 . . . . 0.0 112.801 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.722 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -149.44 -32.52 0.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.906 -1.121 . . . . 0.0 110.398 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.797 HG21 ' O ' ' A' ' 115' ' ' ALA . 9.5 p -55.04 -48.79 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 110.404 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.625 ' N ' HG13 ' A' ' 121' ' ' VAL . 4.4 t-160 -47.76 -36.2 11.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.45 -19.48 33.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.424 -0.797 . . . . 0.0 110.135 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 92.3 p -61.64 -62.42 1.82 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.087 -1.008 . . . . 0.0 110.647 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.43 -19.95 62.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.059 -1.026 . . . . 0.0 109.595 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.3 -40.77 17.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.094 -1.004 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.23 -40.41 12.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.122 -0.987 . . . . 0.0 109.868 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.461 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 40.3 t80 -50.48 -20.84 1.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.898 -1.126 . . . . 0.0 108.717 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 133' ' ' SER . 23.6 mt -68.97 -17.88 63.99 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.78 72.17 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 80.0 p -81.49 -26.82 34.89 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.27 -0.894 . . . . 0.0 108.596 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.42 -26.72 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.416 -0.802 . . . . 0.0 109.077 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 129' ' ' LEU . 1.9 t -82.68 -31.53 28.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.123 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.8 m -72.98 -36.77 67.16 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.31 -0.869 . . . . 0.0 109.553 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.61 -21.8 15.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.128 -0.983 . . . . 0.0 108.895 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -16.72 59.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.045 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 133' ' ' SER . 14.1 t -143.04 38.51 1.44 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.946 . . . . 0.0 109.6 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 2.6 p80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 1.025 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -130.3 172.03 12.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.381 -0.824 . . . . 0.0 109.352 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.425 ' O ' ' N ' ' B' ' 6' ' ' GLU . 7.7 p -90.51 141.59 27.39 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 109.301 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -40.63 -23.92 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.509 2.139 . . . . 0.0 112.376 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' B' ' 4' ' ' THR . 73.1 mm-40 -78.87 -54.67 5.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.831 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -74.85 -23.1 58.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.716 ' HB2' HD13 ' B' ' 3' ' ' LEU . 2.1 tttm -84.29 -32.2 24.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.339 -0.851 . . . . 0.0 109.234 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.9 m -63.67 -23.36 67.34 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.733 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.8 -57.59 3.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.075 -1.016 . . . . 0.0 110.113 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.474 HG23 ' CD2' ' B' ' 130' ' ' TYR . 1.7 p -62.67 -24.35 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 70.1 m -83.98 -35.37 23.98 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.27 0.557 . . . . 0.0 109.74 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.28 -27.4 61.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.391 -0.818 . . . . 0.0 109.663 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.18 -18.73 10.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 109.339 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' TRP . . . . . 0.665 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.5 OUTLIER -50.95 -50.95 56.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.119 -0.988 . . . . 0.0 109.038 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.68 -51.02 60.5 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 7.7 mtmt -53.91 -25.91 22.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.359 -1.083 . . . . 0.0 109.093 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.41 124.31 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 109.74 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' B' ' 21' ' ' ASP . 25.8 m-20 -81.86 68.31 8.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 108.94 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.403 HG22 HD13 ' B' ' 68' ' ' LEU . 70.0 t -45.98 -14.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.405 -0.809 . . . . 0.0 109.81 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' B' ' 19' ' ' ASN . 60.3 t0 -58.02 -18.04 21.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.839 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' B' ' 25' ' ' GLY . 35.1 mt-10 -155.79 -33.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.757 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.9 t -45.98 -23.91 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.249 -0.907 . . . . 0.0 109.702 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.54 -24.69 72.08 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -82.38 -33.03 26.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -74.74 -25.02 58.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -1.195 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.31 94.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.94 . . . . 0.0 109.559 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.41 -50.14 16.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.32 -28.2 8.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.1 -47.45 11.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.137 . . . . 0.0 109.35 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 tp -47.46 -31.55 4.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 109.435 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' B' ' 36' ' ' PRO . 14.4 mt -71.19 -46.1 62.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.23 -55.53 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.324 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.6 -22.93 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.563 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -150.4 76.9 8.29 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 109.492 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.503 ' N ' ' O ' ' B' ' 32' ' ' LEU . 77.5 Cg_endo -82.93 -7.68 11.22 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.813 2.342 . . . . 0.0 112.385 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.471 ' C ' ' H ' ' B' ' 39' ' ' GLN . 21.0 p-90 -63.93 -19.86 65.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 109.508 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 7.8 p -72.63 37.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' B' ' 37' ' ' TRP . 17.2 tt0 -80.71 10.53 4.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.447 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -89.16 -37.56 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.98 . . . . 0.0 109.556 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' PHE . . . . . 0.471 ' C ' ' H ' ' B' ' 43' ' ' GLU . 88.5 m-85 -89.68 -43.29 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 109.566 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.16 14.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 109.367 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' B' ' 41' ' ' PHE . 19.0 pt-20 -66.9 -13.88 62.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.418 ' C ' ' N ' ' B' ' 46' ' ' GLY . 49.9 m -77.63 -42.55 34.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.697 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.54 ' O ' ' N ' ' B' ' 47' ' ' ASP . 39.9 m-85 -47.5 -20.11 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' B' ' 44' ' ' SER . . . 59.14 -79.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' B' ' 45' ' ' PHE . 32.1 t0 -46.7 106.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -1.152 . . . . 0.0 109.555 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tp -163.08 21.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.262 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -52.53 -42.7 64.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 109.658 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.4 p -145.35 152.06 49.2 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.882 . . . . 0.0 109.211 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -40.25 -35.23 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.557 2.171 . . . . 0.0 112.325 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.75 -27.02 63.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.563 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -66.77 -19.97 65.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.2 -51.23 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.557 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 7.4 mmt -66.77 -22.0 66.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.52 -11.12 78.34 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' B' ' 59' ' ' LYS . 20.3 t-20 -71.6 136.28 83.44 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.264 -1.139 . . . . 0.0 109.335 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.11 -35.21 3.2 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.376 2.051 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.515 ' N ' ' OD1' ' B' ' 57' ' ' ASN . 41.0 mttm -63.91 -47.74 79.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.915 . . . . 0.0 109.856 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 96.3 t -46.9 -35.4 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -0.977 . . . . 0.0 109.625 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -49.91 52.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.347 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.78 -32.53 59.96 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.226 -0.921 . . . . 0.0 109.668 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -69.71 -23.92 63.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.329 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.78 -37.76 92.57 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -65.85 -25.71 67.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -1.099 . . . . 0.0 109.325 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -74.73 -49.0 22.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.93 -60.7 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.337 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.645 HD23 ' O ' ' B' ' 68' ' ' LEU . 1.3 tt -62.87 -21.16 65.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 109.097 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.76 -52.56 14.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.07 -35.21 33.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -1.134 . . . . 0.0 109.59 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' B' ' 137' ' ' VAL . 22.7 m-85 -66.8 -49.81 64.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' SER . . . . . 0.665 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.1 t -56.83 -30.85 64.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.45 -0.781 . . . . 0.0 109.415 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -59.67 -40.33 87.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.323 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.86 -60.1 8.61 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.585 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -50.48 -26.42 5.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.335 -1.097 . . . . 0.0 109.31 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.68 -2.53 58.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.959 . . . . 0.0 109.484 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.517 ' CE1' ' OD2' ' B' ' 79' ' ' ASP . 71.1 t60 -171.07 62.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -0.912 . . . . 0.0 109.582 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 25.4 mt -70.3 2.19 4.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.178 -0.951 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.517 ' OD2' ' CE1' ' B' ' 77' ' ' HIS . 54.9 m-20 -55.79 -26.72 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.418 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 15.6 t-20 -170.62 112.0 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.6 mt -80.19 -58.18 3.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -47.23 -24.08 0.66 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -63.66 -51.47 53.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.452 ' C ' ' H ' ' B' ' 86' ' ' ALA . 0.7 OUTLIER -85.59 -39.56 17.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -1.158 . . . . 0.0 109.346 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.437 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.7 m-85 -70.54 10.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.614 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -67.84 -33.65 75.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -82.09 -53.34 6.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 109.432 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.464 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 35.8 mt -51.76 -49.72 62.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 0.0 109.29 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 7.3 m -59.74 -50.49 73.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.377 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.28 -38.77 92.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.869 . . . . 0.0 109.384 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 5.1 tt -74.53 -32.48 62.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.35 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' B' ' 97' ' ' HIS . 15.1 m80 -84.93 -20.3 30.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.108 -0.995 . . . . 0.0 109.644 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 46.6 t -83.74 -59.86 2.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.83 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -86.68 -34.78 19.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.12 -0.988 . . . . 0.0 111.531 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -79.73 -51.77 8.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.857 -1.152 . . . . 0.0 110.563 -178.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.33 -32.57 10.41 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.038 . . . . 0.0 110.244 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.569 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 11.3 t-160 54.07 54.07 10.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.967 . . . . 0.0 109.505 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.31 125.74 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 0.0 109.141 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -49.31 145.86 6.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.08 -11.86 31.22 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.612 2.208 . . . . 0.0 112.158 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -93.66 60.29 2.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -148.87 -46.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.526 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.0 OUTLIER -51.35 -47.43 62.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.65 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -48.31 -19.97 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' B' ' 103' ' ' PHE . 17.1 mt -88.54 -57.73 2.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.603 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -47.93 -20.9 0.36 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.526 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' GLY . . . . . 0.413 ' O ' HG23 ' B' ' 111' ' ' VAL . . . -81.71 -33.23 28.06 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -83.49 -17.45 41.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -1.115 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 78.6 t -83.18 -56.61 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.496 HD23 ' O ' ' B' ' 110' ' ' LEU . 2.0 tt -48.71 -53.2 19.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.847 . . . . 0.0 109.476 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 107' ' ' GLY . 89.7 t -46.99 -40.85 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.612 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.66 -33.93 76.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.518 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 19.1 t -66.28 -29.29 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.333 -0.855 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 118' ' ' PHE . 8.9 mt -81.68 -52.94 6.65 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.478 ' C ' ' HB1' ' A' ' 110' ' ' ALA . . . -54.08 -24.4 17.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.469 ' N ' ' HB1' ' A' ' 110' ' ' ALA . 0.6 OUTLIER -84.82 -62.63 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 109.579 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -68.58 -17.56 64.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.756 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' B' ' 17' ' ' LYS . 72.4 m-85 -144.3 57.79 1.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -70.49 -23.05 77.87 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -72.62 10.78 0.76 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.252 -1.146 . . . . 0.0 109.509 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' B' ' 123' ' ' THR . 81.2 mm-40 -135.28 -0.34 2.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.39 -0.818 . . . . 0.0 109.642 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.542 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.81 33.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 109.339 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.488 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.0 OUTLIER -50.24 148.16 6.58 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.519 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.2 Cg_exo -46.73 -53.06 6.64 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.428 2.085 . . . . 0.0 113.159 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 26.4 Cg_endo -62.61 -21.83 73.32 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.024 1.816 . . . . 0.0 112.338 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.453 HG23 ' OG1' ' B' ' 123' ' ' THR . 75.2 t -81.58 -25.63 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.506 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' B' ' 123' ' ' THR . 5.5 mp0 -83.21 -59.81 2.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.12 -0.988 . . . . 0.0 109.492 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -45.88 -38.26 7.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.58 29.72 0.86 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 0.0 109.574 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.474 ' CD2' HG23 ' B' ' 11' ' ' VAL . 17.2 t80 -124.24 -22.4 4.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.448 -0.783 . . . . 0.0 109.701 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -83.95 -63.84 1.27 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.123 -0.986 . . . . 0.0 110.061 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -49.76 -21.63 1.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 0.0 109.952 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' VAL . . . . . 0.568 HG22 HD21 ' B' ' 3' ' ' LEU . 2.2 t -72.48 -68.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.972 . . . . 0.0 109.858 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.37 -19.95 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.793 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.94 -28.68 17.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.941 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.36 -36.45 89.23 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' B' ' 71' ' ' PHE . 99.4 t -63.48 -47.92 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -1.117 . . . . 0.0 109.468 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.18 -43.25 31.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 109.354 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -80.02 -38.36 32.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 0.0 109.451 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.34 -48.35 62.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 36.2 mt -75.63 11.04 1.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.42 -4.62 3.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 109.43 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.16 -27.49 64.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.92 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.86 -16.44 36.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -62.17 -61.5 2.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.303 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.467 ' ND1' ' N ' ' B' ' 146' ' ' HIS . 2.0 m-70 . . . . . 0 C--N 1.302 -1.495 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' C' ' 2' ' ' LEU . 29.8 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' C' ' 2' ' ' LEU . 7.8 mp 56.03 163.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.35 -0.844 . . . . 0.0 109.738 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 176.24 -47.92 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.998 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' C' ' 3' ' ' SER . 54.3 Cg_exo -50.31 -170.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.573 2.182 . . . . 0.0 112.579 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -60.24 -16.24 31.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.733 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' C' ' 5' ' ' ALA . 22.1 m-20 -39.45 -29.18 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.448 -0.782 . . . . 0.0 109.696 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' C' ' 10' ' ' VAL . 4.5 ptpt -83.18 -50.0 8.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.369 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.408 ' C ' ' O ' ' C' ' 7' ' ' LYS . 53.3 m -43.86 -32.7 1.14 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 109.733 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.85 -30.29 50.87 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' C' ' 7' ' ' LYS . 51.2 t -76.77 -51.54 18.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 11' ' ' LYS . . . . . 0.541 ' NZ ' HG13 ' C' ' 70' ' ' VAL . 0.1 OUTLIER -57.63 -36.72 72.19 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.767 -1.173 . . . . 0.0 108.285 179.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.74 -58.23 8.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 109.215 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.05 -34.38 63.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 108.877 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -17.49 61.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.355 -0.841 . . . . 0.0 108.886 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.94 -44.68 18.51 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.41 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 17.9 mmtp -70.12 -37.34 75.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.085 -1.244 . . . . 0.0 108.465 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' C' ' 21' ' ' ALA . 4.1 t -60.22 -67.41 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.575 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 59.24 -136.78 50.71 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.29 28.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.543 -0.975 . . . . 0.0 110.474 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.575 ' H ' ' C ' ' C' ' 18' ' ' GLY . 96.9 m-70 -129.63 13.18 5.92 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.568 ' HB2' ' CG1' ' C' ' 17' ' ' VAL . . . -75.05 -52.39 11.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.643 -0.661 . . . . 0.0 109.75 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.07 -14.45 10.95 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.36 -56.47 3.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -1.166 . . . . 0.0 109.691 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.558 ' CD2' ' O ' ' C' ' 20' ' ' HIS . 14.0 m-85 -59.85 -24.88 64.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.86 . . . . 0.0 109.285 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.91 -33.83 85.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.74 -39.12 57.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -1.193 . . . . 0.0 109.661 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' GLU . . . . . 0.431 ' CG ' ' OG1' ' C' ' 108' ' ' THR . 13.2 tt0 -67.45 -20.11 65.45 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.336 -0.853 . . . . 0.0 109.457 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.07 -25.37 61.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.106 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -76.04 -59.36 2.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 109.405 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -56.45 -12.54 1.75 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 109.354 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.536 ' O ' ' NE ' ' C' ' 31' ' ' ARG . 0.0 OUTLIER -65.2 -58.35 6.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -84.51 -32.83 23.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.092 -1.005 . . . . 0.0 110.312 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 20.2 m-85 -63.55 -35.97 82.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.938 -1.101 . . . . 0.0 110.198 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.683 HD12 ' N ' ' C' ' 35' ' ' SER . 3.8 pp -46.97 -40.51 14.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.901 -1.124 . . . . 0.0 109.504 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.683 ' N ' HD12 ' C' ' 34' ' ' LEU . 1.4 p -76.5 -23.66 53.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.931 -1.106 . . . . 0.0 108.875 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.573 ' C ' ' O ' ' C' ' 35' ' ' SER . 0.3 OUTLIER 21.56 65.96 0.3 Allowed Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 121.151 0.5 . . . . 0.0 111.211 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.39 -61.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.407 2.072 . . . . 0.0 112.147 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.545 ' O ' HG22 ' C' ' 41' ' ' THR . 1.1 p -91.18 -57.41 2.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.215 -0.928 . . . . 0.0 109.613 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.477 HG23 ' H ' ' C' ' 39' ' ' THR . 3.0 p -44.21 -22.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.47 -0.769 . . . . 0.0 110.31 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' C' ' 38' ' ' THR . 26.2 ttmt -49.03 -45.13 42.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.957 -1.089 . . . . 0.0 109.596 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.545 HG22 ' O ' ' C' ' 38' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.599 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.649 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.274 0 CA-C-O 120.937 0.399 . . . . 0.0 110.686 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.468 ' C ' ' CD1' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -154.4 31.13 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.679 -1.263 . . . . 0.0 110.529 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' C' ' 46' ' ' PHE . 35.8 m-20 42.3 88.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.408 -0.808 . . . . 0.0 110.271 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.596 HD23 ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -65.33 -13.09 57.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.114 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.427 ' O ' ' O ' ' C' ' 50' ' ' HIS . 32.6 p -78.11 165.71 23.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.583 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 50' ' ' HIS . . . . . 0.568 ' N ' ' ND1' ' C' ' 50' ' ' HIS . 0.3 OUTLIER -57.83 -162.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.361 -0.837 . . . . 0.0 109.283 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.82 34.44 10.94 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.55 ' O ' ' N ' ' C' ' 54' ' ' GLN . 30.4 t -139.06 82.25 1.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.286 -1.126 . . . . 0.0 109.218 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.69 -10.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.808 . . . . 0.0 109.847 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' C' ' 52' ' ' SER . 11.7 mt-30 -74.85 -35.25 62.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.3 t -65.67 -48.45 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.54 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.577 ' CD ' ' H ' ' C' ' 56' ' ' LYS . 0.0 OUTLIER -69.18 -25.51 64.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 0.0 109.12 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.91 -21.65 78.97 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.9 t-80 -82.59 -39.79 21.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -1.082 . . . . 0.0 109.798 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.04 -51.56 45.42 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -51.19 -22.67 2.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.445 -1.032 . . . . 0.0 110.153 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.73 -29.7 56.29 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.15 -0.969 . . . . 0.0 109.24 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.488 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -79.81 -49.0 19.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 108.726 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -68.58 -22.84 64.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.308 -0.87 . . . . 0.0 109.189 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -78.17 -30.69 49.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.134 -0.979 . . . . 0.0 108.832 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.64 -48.66 53.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.86 . . . . 0.0 108.996 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.57 -40.62 72.22 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.203 -0.936 . . . . 0.0 108.749 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 15.3 m -68.72 -56.84 6.8 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' C' ' 72' ' ' HIS . 46.6 t30 -55.42 -24.08 28.46 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -80.24 -47.01 15.28 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.541 HG13 ' NZ ' ' C' ' 11' ' ' LYS . 36.2 t -64.35 -22.97 32.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.46 -17.06 64.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.611 ' O ' ' N ' ' C' ' 74' ' ' ASP . 4.3 m-70 -141.88 -61.31 0.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 109.422 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.554 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.2 p 44.78 12.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.728 0.775 . . . . 0.0 109.61 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' C' ' 72' ' ' HIS . 44.5 t0 -134.22 10.44 3.83 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 2.0 m-20 -178.59 28.03 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.762 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 6.5 ptt? -78.52 -23.33 0.41 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.413 -0.805 . . . . 0.0 111.703 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.0 Cg_exo -54.33 -18.83 15.38 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.565 1.51 . . . . 0.0 112.185 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -93.42 -38.06 11.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.17 64.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 108.897 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.62 11.27 15.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.349 -0.845 . . . . 0.0 108.755 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 14.8 t -65.33 -26.82 68.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 109.715 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.92 -49.04 66.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 109.741 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.439 ' N ' HD23 ' C' ' 83' ' ' LEU . 4.1 mt -47.76 -46.96 30.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.026 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.563 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 9.7 t -62.76 -28.52 70.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.64 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.94 -28.1 39.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 109.601 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' C' ' 90' ' ' LYS . 3.7 tt -83.25 -32.35 26.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.827 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 87' ' ' HIS . . . . . 0.413 ' CE1' HD22 ' C' ' 86' ' ' LEU . 67.0 m80 -92.12 -21.94 20.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.13 -0.982 . . . . 0.0 110.122 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -104.03 -48.1 3.99 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.183 -0.948 . . . . 0.0 110.113 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -93.42 21.94 5.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 110.138 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.506 ' C ' ' H ' ' C' ' 92' ' ' ARG . 28.7 ttmt -172.15 147.13 2.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.932 -1.105 . . . . 0.0 110.067 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' C' ' 93' ' ' VAL . 1.0 OUTLIER 71.29 -20.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.386 -0.821 . . . . 0.0 109.536 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 92' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' C' ' 90' ' ' LYS . 70.4 mtt85 43.04 27.36 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 0.0 109.7 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.539 HG22 ' N ' ' C' ' 94' ' ' ASP . 12.2 p -47.08 165.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.539 ' N ' HG22 ' C' ' 93' ' ' VAL . 6.1 p-10 -109.74 101.29 46.11 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.69 -11.01 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.383 2.055 . . . . 0.0 112.274 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 94' ' ' ASP . 51.1 t -50.74 -18.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' C' ' 100' ' ' LEU . 3.1 m120 -79.18 -24.38 43.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.309 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -44.31 -35.8 2.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.338 -0.851 . . . . 0.0 109.745 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -68.0 -23.72 65.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.484 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.583 ' N ' HD12 ' C' ' 100' ' ' LEU . 8.8 mp -84.22 -62.08 1.65 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.52 -23.78 28.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 109.653 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 13.7 p -67.93 -50.33 56.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.762 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -78.05 -26.42 48.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.716 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 96.4 m -50.81 -50.47 56.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.669 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.23 -38.81 54.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 109.811 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.94 -36.21 64.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.478 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.06 -27.68 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.987 -1.071 . . . . 0.0 109.927 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.498 ' CG2' ' N ' ' C' ' 109' ' ' LEU . 0.6 OUTLIER -81.15 -45.1 16.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.831 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.498 ' N ' ' CG2' ' C' ' 108' ' ' THR . 15.5 mt -67.04 -20.52 65.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.089 -1.007 . . . . 0.0 109.068 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' C' ' 112' ' ' HIS . . . -51.78 -42.95 62.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.418 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.76 -3.67 0.12 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 109.212 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 112' ' ' HIS . . . . . 0.522 ' H ' ' C ' ' C' ' 110' ' ' ALA . 81.0 m80 -143.23 -85.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.38 -0.825 . . . . 0.0 109.249 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.833 ' O ' HD23 ' C' ' 113' ' ' LEU . 0.0 OUTLIER -139.88 100.04 7.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.26 -98.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.564 2.176 . . . . 0.0 112.807 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.808 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -72.22 -56.46 5.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.576 -0.702 . . . . 0.0 110.037 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.676 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 17.5 mt-10 116.56 -6.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 4.9 t80 79.56 33.28 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.318 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.714 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -108.92 125.11 32.36 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.93 21.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.239 1.959 . . . . 0.0 112.79 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.714 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -149.47 -32.59 0.21 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.901 -1.124 . . . . 0.0 110.336 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.808 HG21 ' O ' ' C' ' 115' ' ' ALA . 9.6 p -54.86 -48.91 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.058 -1.026 . . . . 0.0 110.413 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.632 ' N ' HG13 ' C' ' 121' ' ' VAL . 4.4 t-160 -47.78 -36.17 11.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.44 -19.45 33.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 110.149 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' C' ' 128' ' ' PHE . 92.5 p -61.64 -62.41 1.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 110.686 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.37 -20.03 62.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.997 -1.065 . . . . 0.0 109.619 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.28 -40.72 17.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.105 -0.997 . . . . 0.0 109.548 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.2 -40.42 12.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 109.845 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.465 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 40.4 t80 -50.51 -20.81 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.869 -1.145 . . . . 0.0 108.7 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' C' ' 133' ' ' SER . 23.4 mt -68.98 -17.95 64.0 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.79 72.13 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 79.6 p -81.48 -26.84 34.89 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.37 -26.84 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 109.108 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.54 ' N ' ' O ' ' C' ' 129' ' ' LEU . 1.9 t -82.51 -31.55 29.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.214 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 26.0 m -73.06 -36.71 66.94 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.373 -0.829 . . . . 0.0 109.486 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.61 -21.74 15.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.137 -0.977 . . . . 0.0 108.933 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -16.81 59.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.435 -0.791 . . . . 0.0 108.914 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 137' ' ' THR . . . . . 0.455 HG22 ' O ' ' C' ' 133' ' ' SER . 14.2 t -143.08 38.43 1.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.541 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 2.6 p80 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 1.054 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -130.32 171.95 12.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.306 -0.872 . . . . 0.0 109.382 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.416 ' O ' ' N ' ' D' ' 6' ' ' GLU . 7.6 p -90.54 141.63 27.37 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.262 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -40.59 -24.05 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.507 2.138 . . . . 0.0 112.398 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 6' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' D' ' 4' ' ' THR . 73.3 mm-40 -78.73 -54.79 5.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.932 . . . . 0.0 109.824 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -74.75 -23.13 58.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 109.614 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.726 ' HB2' HD13 ' D' ' 3' ' ' LEU . 2.2 tttm -84.29 -32.17 24.51 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.372 -0.83 . . . . 0.0 109.34 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 m -63.77 -23.31 67.31 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.677 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.82 -57.52 3.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.963 . . . . 0.0 110.125 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.477 HG23 ' CD2' ' D' ' 130' ' ' TYR . 1.7 p -62.68 -24.37 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 70.6 m -84.07 -35.24 23.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.773 -0.579 . . . . 0.0 109.717 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.33 -27.33 61.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.622 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.25 -18.75 11.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.33 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 15' ' ' TRP . . . . . 0.655 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.5 OUTLIER -50.98 -50.88 57.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.008 . . . . 0.0 109.062 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.73 -50.98 60.84 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.484 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 7.7 mtmt -53.9 -25.85 22.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.407 -1.054 . . . . 0.0 109.175 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.2 t -91.49 124.36 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 0.0 109.698 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' D' ' 21' ' ' ASP . 25.7 m-20 -81.89 68.26 8.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.874 . . . . 0.0 108.925 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.416 ' O ' HG12 ' D' ' 20' ' ' VAL . 69.0 t -45.96 -14.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 109.812 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' D' ' 19' ' ' ASN . 60.4 t0 -58.01 -18.1 21.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.764 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -155.78 -33.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.059 -1.025 . . . . 0.0 109.758 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -46.07 -23.89 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.644 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.57 -24.66 72.09 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.45 -32.96 26.61 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -74.78 -24.97 58.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -1.218 . . . . 0.0 109.548 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.25 -40.25 93.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.45 -50.03 17.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.38 -28.2 9.07 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.05 -47.57 11.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -1.117 . . . . 0.0 109.276 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 tp -47.34 -31.61 4.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 32' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' D' ' 36' ' ' PRO . 14.4 mt -71.16 -46.16 62.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.441 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.12 -55.58 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.373 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.409 ' H ' HG23 ' D' ' 34' ' ' VAL . 2.7 t -67.69 -22.86 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.886 . . . . 0.0 109.501 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -150.48 76.94 8.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' PRO . . . . . 0.517 ' N ' ' O ' ' D' ' 32' ' ' LEU . 77.8 Cg_endo -82.89 -7.75 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.878 2.385 . . . . 0.0 112.351 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 37' ' ' TRP . . . . . 0.474 ' C ' ' H ' ' D' ' 39' ' ' GLN . 20.9 p-90 -63.85 -20.0 65.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 7.9 p -72.6 37.44 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.396 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' D' ' 37' ' ' TRP . 17.2 tt0 -80.73 10.54 4.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -89.13 -37.66 14.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.49 ' C ' ' H ' ' D' ' 43' ' ' GLU . 88.4 m-85 -89.65 -43.32 10.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 109.574 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.09 14.73 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.379 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 43' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' D' ' 41' ' ' PHE . 19.0 pt-20 -66.89 -13.87 62.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.085 -1.009 . . . . 0.0 109.492 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 44' ' ' SER . . . . . 0.417 ' O ' ' N ' ' D' ' 46' ' ' GLY . 49.8 m -77.75 -42.5 33.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' D' ' 47' ' ' ASP . 39.9 m-85 -47.53 -20.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.461 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 59.09 -79.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' D' ' 45' ' ' PHE . 32.1 t0 -46.83 106.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -1.174 . . . . 0.0 109.553 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -163.08 21.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 0.0 109.269 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -52.61 -42.58 64.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 109.708 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' THR . . . . . 0.432 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.4 p -145.4 152.08 49.04 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.319 -0.863 . . . . 0.0 109.265 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -40.28 -35.16 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.421 2.081 . . . . 0.0 112.365 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.74 -27.1 63.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.588 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -66.76 -19.94 65.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 t -74.13 -51.35 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.463 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 7.4 mmt -66.73 -22.03 66.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.56 -11.07 78.35 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 57' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' D' ' 59' ' ' LYS . 20.1 t-20 -71.73 136.33 83.07 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.169 -1.195 . . . . 0.0 109.266 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.07 -35.26 3.19 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.431 2.087 . . . . 0.0 112.374 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' D' ' 57' ' ' ASN . 40.9 mttm -63.95 -47.78 79.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 97.6 t -46.76 -35.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 109.795 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -49.9 52.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 109.355 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.76 -32.65 60.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -69.58 -24.0 63.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.8 -37.66 92.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -65.94 -25.63 67.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -1.143 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -74.71 -49.07 22.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 0.0 109.435 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.82 -60.76 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.312 -0.867 . . . . 0.0 109.362 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.642 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.3 tt -62.85 -21.16 65.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.124 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.78 -52.43 15.15 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.02 -35.3 33.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 109.571 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 71' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' D' ' 137' ' ' VAL . 22.7 m-85 -66.81 -49.83 64.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 109.446 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 72' ' ' SER . . . . . 0.655 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 8.1 t -56.75 -30.94 64.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.413 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -59.62 -40.36 87.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.324 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.75 -60.23 8.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.579 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.6 mp -50.38 -26.56 5.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -1.125 . . . . 0.0 109.347 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.61 -2.57 58.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.149 -0.97 . . . . 0.0 109.435 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.516 ' CE1' ' OD2' ' D' ' 79' ' ' ASP . 71.3 t60 -171.01 62.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.547 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 25.1 mt -70.21 2.16 4.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.516 ' OD2' ' CE1' ' D' ' 77' ' ' HIS . 55.0 m-20 -55.92 -26.6 48.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 80' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 15.6 t-20 -170.6 111.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.428 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 14.5 mt -80.2 -58.11 3.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 109.507 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -47.31 -24.1 0.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 83' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -63.61 -51.51 53.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.448 ' C ' ' H ' ' D' ' 86' ' ' ALA . 0.7 OUTLIER -85.48 -39.65 17.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -1.14 . . . . 0.0 109.426 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.443 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.5 m-85 -70.53 10.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 109.532 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 86' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -67.75 -33.8 75.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.328 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -82.1 -53.21 6.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.456 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 35.6 mt -51.91 -49.69 62.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.252 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 7.2 m -59.69 -50.42 73.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.423 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.34 -38.84 92.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.392 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 5.1 tt -74.35 -32.56 62.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' D' ' 97' ' ' HIS . 15.2 m80 -84.91 -20.3 30.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.083 -1.011 . . . . 0.0 109.615 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 46.5 t -83.76 -59.92 2.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 0.0 110.844 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 41' ' ' THR . 37.4 m-20 -86.6 -34.76 19.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.065 -1.022 . . . . 0.0 111.565 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 95' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -79.82 -51.67 8.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.772 -1.205 . . . . 0.0 110.619 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.31 -32.73 10.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.064 . . . . 0.0 110.258 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.56 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 11.3 t-160 54.3 54.12 9.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 109.348 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.39 125.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.947 . . . . 0.0 109.156 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -49.33 145.88 7.01 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 109.322 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.11 -11.82 31.1 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.559 2.173 . . . . 0.0 112.098 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -93.71 60.36 2.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -148.83 -46.99 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 109.573 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 103' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 1.0 OUTLIER -51.34 -47.43 62.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.671 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -48.35 -19.89 0.35 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.437 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 105' ' ' LEU . . . . . 0.411 ' N ' ' C ' ' D' ' 103' ' ' PHE . 17.3 mt -88.69 -57.63 2.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.565 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -47.93 -20.94 0.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.528 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 107' ' ' GLY . . . . . 0.407 ' O ' HG23 ' D' ' 111' ' ' VAL . . . -81.72 -33.2 28.1 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -83.42 -17.51 41.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -1.191 . . . . 0.0 109.59 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 78.7 t -83.14 -56.66 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 110' ' ' LEU . . . . . 0.495 ' O ' HD23 ' D' ' 110' ' ' LEU . 2.0 tt -48.67 -53.17 19.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.456 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 111' ' ' VAL . . . . . 0.407 HG23 ' O ' ' D' ' 107' ' ' GLY . 88.6 t -47.03 -40.83 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.942 . . . . 0.0 109.631 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.74 -33.86 76.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.9 . . . . 0.0 109.521 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 t -66.3 -29.31 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 114' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' D' ' 118' ' ' PHE . 8.9 mt -81.61 -53.04 6.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.478 ' C ' ' HB1' ' C' ' 110' ' ' ALA . . . -54.02 -24.41 16.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.508 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.468 ' N ' ' HB1' ' C' ' 110' ' ' ALA . 0.6 OUTLIER -84.81 -62.58 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.606 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -68.59 -17.63 64.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.87 . . . . 0.0 109.664 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.484 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 72.2 m-85 -144.22 57.82 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 109.488 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -70.5 -23.06 77.87 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -72.61 10.81 0.75 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -1.151 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' D' ' 123' ' ' THR . 81.2 mm-40 -135.32 -0.26 2.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 0.0 109.762 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.529 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -73.77 33.54 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.486 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.0 OUTLIER -50.2 148.23 6.43 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.464 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.515 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.3 Cg_exo -46.85 -52.98 6.82 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.425 2.083 . . . . 0.0 113.119 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 26.1 Cg_endo -62.56 -21.99 73.48 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.115 1.877 . . . . 0.0 112.329 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.459 HG23 ' OG1' ' D' ' 123' ' ' THR . 75.8 t -81.59 -25.52 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.141 -0.974 . . . . 0.0 109.513 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 127' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' D' ' 123' ' ' THR . 5.4 mp0 -83.41 -59.66 2.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.508 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -45.87 -38.2 7.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.543 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.59 29.54 0.88 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.489 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.477 ' CD2' HG23 ' D' ' 11' ' ' VAL . 17.1 t80 -124.14 -22.4 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.707 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -83.99 -63.7 1.3 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.951 . . . . 0.0 110.099 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -49.75 -21.64 1.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 109.978 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 133' ' ' VAL . . . . . 0.588 HG22 HD21 ' D' ' 3' ' ' LEU . 2.2 t -72.45 -68.29 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.063 -1.023 . . . . 0.0 109.851 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.28 -19.95 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.844 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.03 -28.63 17.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.109 -0.994 . . . . 0.0 109.39 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.44 -36.4 88.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 137' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' D' ' 71' ' ' PHE . 99.4 t -63.47 -47.93 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -1.165 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.14 -43.21 31.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.894 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -80.2 -38.24 31.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.38 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.38 -48.43 62.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.346 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 36.0 mt -75.53 10.97 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.381 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.4 -4.66 3.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.365 -0.834 . . . . 0.0 109.441 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.11 -27.46 64.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.91 -16.38 36.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -62.19 -61.61 2.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.255 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.481 ' N ' ' ND1' ' D' ' 146' ' ' HIS . 2.0 m-70 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.519 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 2' ' ' LEU . 21.8 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.3 mp 55.12 166.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.76 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.568 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 176.14 -45.22 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.851 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 3' ' ' SER . 42.3 Cg_exo -55.36 -153.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.616 2.21 . . . . 0.0 112.864 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -78.61 -15.26 58.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.474 -0.766 . . . . 0.0 110.003 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 5' ' ' ALA . 16.4 m-20 -38.78 -29.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.379 -0.826 . . . . 0.0 109.735 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . 2.0 ptpm? -83.39 -41.79 17.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.187 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.481 ' N ' ' O ' ' A' ' 5' ' ' ALA . 45.9 m -51.35 -29.82 16.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.312 -0.868 . . . . 0.0 109.083 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.72 -36.87 42.74 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.486 HG21 ' CD2' ' A' ' 128' ' ' PHE . 53.7 t -70.99 -49.05 52.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -52.99 -46.02 68.11 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.02 -58.06 10.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.498 -0.751 . . . . 0.0 109.36 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.834 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -53.19 -35.96 60.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.406 -0.808 . . . . 0.0 109.129 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -17.14 62.29 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.256 -0.902 . . . . 0.0 109.302 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.08 22.6 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 12.9 mmmt -73.01 -35.89 66.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -1.115 . . . . 0.0 108.744 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 13' ' ' ALA . 57.9 t -62.02 -64.56 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 43.63 -122.35 3.93 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.31 22.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.403 -1.057 . . . . 0.0 110.345 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.545 ' H ' ' C ' ' A' ' 18' ' ' GLY . 78.2 m-70 -128.81 26.16 5.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' A' ' 63' ' ' ALA . . . -91.86 -63.1 1.29 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.621 -0.675 . . . . 0.0 109.9 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.7 -14.27 0.22 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 21' ' ' ALA . 10.4 mt-10 -84.72 -56.19 3.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -1.129 . . . . 0.0 109.814 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 20' ' ' HIS . 4.7 m-30 -60.24 -16.57 34.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.31 -34.14 30.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.07 39.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -1.2 . . . . 0.0 110.033 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.02 -19.73 64.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 109.662 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.72 -19.76 60.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 109.714 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.619 HD11 ' ND1' ' A' ' 58' ' ' HIS . 5.7 mt -78.73 -49.48 13.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 109.997 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' OE1' ' ND1' ' A' ' 50' ' ' HIS . 10.1 pt-20 -72.3 -33.25 67.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.091 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.575 ' NH1' ' SG ' ' A' ' 104' ' ' CYS . 45.8 ttt-85 -54.87 -44.58 74.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.927 . . . . 0.0 110.618 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.0 ptt? -84.13 -45.35 13.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.889 -1.132 . . . . 0.0 110.153 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -49.23 -41.42 37.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 109.825 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 34' ' ' LEU . 2.5 pp -75.04 -38.75 61.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.982 -1.074 . . . . 0.0 109.586 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.43 ' N ' HD12 ' A' ' 34' ' ' LEU . 15.7 m -75.52 7.43 3.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.015 -1.053 . . . . 0.0 109.29 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 1.08 ' CZ ' ' NE2' ' B' ' 131' ' ' GLN . 77.0 m-85 -156.13 71.9 5.13 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.39 -19.86 0.77 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.727 2.285 . . . . 0.0 112.265 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 p -59.23 -22.79 61.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 p -89.48 -42.87 11.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -52.16 -38.97 59.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.441 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 11.6 p80 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.29 0.567 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.523 ' O ' ' C ' ' A' ' 47' ' ' ASP . 5.3 t80 -120.15 27.8 8.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.666 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 46' ' ' PHE . 1.6 p30 28.2 72.86 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.853 -0.529 . . . . 0.0 110.819 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 48' ' ' LEU . 2.2 mm? -64.83 -7.77 12.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.129 -0.982 . . . . 0.0 109.316 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 t -49.25 152.15 1.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.537 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.532 ' ND1' ' OE1' ' A' ' 30' ' ' GLU . 83.2 t60 -76.04 152.84 36.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.78 18.72 59.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.0 t -68.0 -99.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.246 -1.15 . . . . 0.0 109.311 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 174.0 -78.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.506 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -44.85 -17.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.395 -0.816 . . . . 0.0 109.589 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ALA . 3.5 t -76.72 -27.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.214 -0.929 . . . . 0.0 109.433 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.9 ptmt -66.02 -26.99 67.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 0.0 109.458 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.47 -42.18 42.01 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.619 ' ND1' HD11 ' A' ' 29' ' ' LEU . 15.1 t-80 -63.08 -27.98 69.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -1.203 . . . . 0.0 109.688 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.59 -47.31 90.25 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 32.6 mttp -56.08 -23.8 36.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -1.134 . . . . 0.0 109.754 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -72.54 -42.52 64.64 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.304 -0.872 . . . . 0.0 109.05 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.4 t -68.92 -47.69 74.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.517 -0.739 . . . . 0.0 109.2 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -69.91 -30.0 67.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.311 -0.868 . . . . 0.0 109.531 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.3 t70 -69.22 -41.88 76.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.122 -0.986 . . . . 0.0 108.821 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.38 -47.94 79.98 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 70' ' ' VAL . 4.8 mt -61.03 -47.14 87.81 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -62.22 -47.31 85.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 108.948 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -63.38 -26.71 68.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 108.682 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.14 -46.71 11.64 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 66' ' ' LEU . 78.4 t -65.99 -22.43 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.25 -21.67 66.3 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.586 ' O ' ' N ' ' A' ' 74' ' ' ASP . 13.2 m80 -144.18 -50.59 0.3 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.9 p 44.87 14.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 121.792 0.806 . . . . 0.0 109.489 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 72' ' ' HIS . 14.6 t70 -128.62 9.56 5.99 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -173.74 27.12 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.046 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.3 ptt? -78.36 -24.92 0.45 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.415 -0.803 . . . . 0.0 111.594 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 76' ' ' MET . 43.7 Cg_exo -55.56 -20.62 27.72 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.766 1.644 . . . . 0.0 112.538 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.52 HD22 ' C ' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -94.06 -28.75 15.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.868 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.54 -48.05 20.64 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.142 -0.974 . . . . 0.0 109.178 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 80' ' ' LEU . 6.9 mp -79.13 6.89 8.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.15 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -59.4 -15.74 18.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.635 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.83 -48.7 11.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 109.74 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 83' ' ' LEU . 4.7 mt -47.19 -48.35 23.83 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 88.3 p -50.18 -24.82 3.04 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.093 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 82' ' ' ALA . 15.0 t70 -74.45 -25.5 59.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.158 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 90' ' ' LYS . 6.9 tp -81.82 -34.29 30.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.299 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -90.44 -21.78 21.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -71.21 -68.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.907 . . . . 0.0 109.675 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -88.4 -77.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.91 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 86' ' ' LEU . 19.3 mttm -59.31 171.18 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.868 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.528 ' C ' ' H ' ' A' ' 93' ' ' VAL . 4.0 tp 56.79 56.95 5.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 109.682 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -66.05 9.75 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.953 . . . . 0.0 109.315 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 94' ' ' ASP . 12.4 p -46.4 165.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.664 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.551 ' CG ' ' OD1' ' D' ' 99' ' ' ASP . 5.3 m-20 -84.34 116.96 67.47 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.299 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 97' ' ' ASN . 84.4 Cg_exo -44.28 -10.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.297 1.998 . . . . 0.0 112.357 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.723 ' CG2' ' OD2' ' D' ' 99' ' ' ASP . 98.2 t -53.88 -10.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 109.56 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 95' ' ' PRO . 2.7 m-80 -79.24 -24.9 42.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -53.16 -43.71 67.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.576 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 99' ' ' LYS . 7.5 mtmp? -69.32 -25.41 64.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.683 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 25.3 mt -81.67 -46.69 13.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.707 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -69.68 -20.76 63.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.694 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.7 p -78.75 -59.07 2.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 109.746 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -63.29 -26.72 68.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.806 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.575 ' SG ' ' NH1' ' A' ' 31' ' ' ARG . 35.0 m -65.08 -52.26 56.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 109.818 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -24.62 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.749 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.75 -34.85 60.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.083 -1.011 . . . . 0.0 109.926 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' HE ' ' A' ' 31' ' ' ARG . 71.1 t -83.33 -24.65 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.058 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -70.98 -63.64 1.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.137 -0.977 . . . . 0.0 110.458 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 113' ' ' LEU . 2.3 pp -64.04 -18.68 64.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.847 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.35 -33.29 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 0.0 109.709 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.79 -56.15 25.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.371 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -66.52 -68.28 0.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.115 -0.991 . . . . 0.0 108.422 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.1 pp -116.67 111.44 41.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.637 ' O ' HD12 ' A' ' 113' ' ' LEU . 89.2 Cg_exo -41.58 -177.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.571 2.18 . . . . 0.0 113.167 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.702 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -45.45 -52.48 10.1 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.64 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 19.4 mt-10 124.98 -1.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 61.21 31.47 19.51 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.194 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.776 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -103.82 120.47 51.26 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.48 23.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.007 1.805 . . . . 0.0 112.663 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.776 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -152.51 -32.53 0.13 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.965 -1.084 . . . . 0.0 110.514 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.702 HG21 ' O ' ' A' ' 115' ' ' ALA . 14.4 p -47.86 -48.26 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.957 -1.09 . . . . 0.0 110.081 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.64 ' N ' HG13 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -63.76 -39.01 93.23 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 109.365 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.29 -19.78 33.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 120' ' ' ALA . 7.6 p -58.44 -62.07 2.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 110.018 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.507 ' N ' ' OG ' ' A' ' 124' ' ' SER . 5.0 mt -68.57 -19.58 64.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 109.329 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -73.74 -52.18 14.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.747 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.463 ' CD ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -86.29 -44.4 12.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 109.971 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' CD2' HG21 ' A' ' 10' ' ' VAL . 39.5 t80 -47.43 -20.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.988 -1.07 . . . . 0.0 108.992 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 133' ' ' SER . 12.0 mt -71.88 -17.99 62.08 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.32 -33.56 73.8 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 135' ' ' VAL . 89.2 p -82.72 -29.88 29.5 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.408 -0.808 . . . . 0.0 108.834 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 t -85.23 -29.73 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 109.134 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 129' ' ' LEU . 18.0 m -82.79 -22.64 34.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 0.0 108.936 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 138' ' ' SER . 42.1 m -80.72 -39.93 26.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.332 -0.855 . . . . 0.0 109.223 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 131' ' ' SER . 26.8 m -71.05 -26.5 27.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.211 -0.931 . . . . 0.0 108.899 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.02 -31.92 73.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -0.788 . . . . 0.0 108.96 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.0 m -156.81 53.63 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 134' ' ' THR . 9.1 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.497 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 43.9 m80 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.913 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.1 OUTLIER -142.74 164.53 29.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 109.362 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.83 159.43 68.83 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.827 . . . . 0.0 109.348 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.74 -18.64 65.3 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.632 2.221 . . . . 0.0 112.003 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.5 -34.25 23.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.5 -61.76 1.76 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 109.591 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.696 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -47.01 -26.74 1.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.91 . . . . 0.0 109.609 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.0 t -57.11 -23.39 46.73 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.59 -57.69 3.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.917 -1.115 . . . . 0.0 110.102 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.4 -24.58 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 48.1 m -82.09 -36.92 27.09 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.396 0.617 . . . . 0.0 109.759 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.5 -34.65 70.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.597 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.7 OUTLIER -50.49 -34.56 25.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 109.157 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -45.74 -17.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.372 -0.83 . . . . 0.0 109.66 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.25 -49.41 7.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.45 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 0.1 OUTLIER -71.95 -30.28 65.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.2 . . . . 0.0 109.396 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.434 HG22 ' CD2' ' B' ' 114' ' ' LEU . 77.5 t -53.46 114.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 109.649 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' B' ' 21' ' ' ASP . 36.3 m-80 -79.53 66.04 4.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 108.946 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' B' ' 22' ' ' GLU . 72.1 t -43.72 -26.13 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.471 -0.768 . . . . 0.0 109.852 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' B' ' 19' ' ' ASN . 18.0 t70 -65.51 5.13 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' B' ' 20' ' ' VAL . 37.5 mt-10 -154.03 -51.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.976 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 88.0 t -49.63 -53.3 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.76 -40.46 25.95 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.63 -37.14 61.94 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.05 -35.77 61.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -1.144 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.83 68.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.507 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 tp -84.94 -52.06 6.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.533 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.76 -28.49 70.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -79.22 -28.21 42.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -1.173 . . . . 0.0 109.477 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' LEU . . . . . 0.421 HD13 ' HB3' ' B' ' 106' ' ' LEU . 44.6 tp -48.08 -39.79 21.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.546 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.461 ' CD2' ' OG1' ' B' ' 38' ' ' THR . 21.1 mt -81.08 -23.01 38.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 71.5 t -66.23 -61.68 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.979 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -78.44 -22.63 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 110.047 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -134.57 77.03 59.77 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.067 -1.02 . . . . 0.0 109.926 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -84.2 27.89 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.014 2.476 . . . . 0.0 112.277 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -81.04 -20.13 42.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 109.89 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.532 ' C ' ' H ' ' B' ' 40' ' ' ARG . 6.1 p -47.7 -29.25 2.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.67 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 52.0 6.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' B' ' 38' ' ' THR . 42.6 ttm180 -110.21 -39.96 4.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 109.207 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 47.69 19.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' B' ' 44' ' ' SER . 77.2 m-85 54.53 55.18 8.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 109.388 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -46.3 -16.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.341 -0.849 . . . . 0.0 109.583 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.515 ' N ' ' O ' ' B' ' 42' ' ' PHE . 20.0 m -57.64 -54.68 44.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.432 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -70.12 3.75 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 109.235 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.16 -149.45 1.24 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 56.52 73.11 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -1.132 . . . . 0.0 109.669 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 89.8 mt -137.42 29.72 2.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.85 . . . . 0.0 109.384 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 41.5 t -72.49 -38.0 68.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -0.922 . . . . 0.0 109.541 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -146.16 151.91 45.72 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -40.93 -35.34 1.66 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.384 2.056 . . . . 0.0 112.38 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.99 -32.14 73.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 109.554 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.2 -24.0 66.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.565 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.33 -60.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -91.91 25.48 2.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.966 . . . . 0.0 109.629 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.2 -52.44 2.05 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.84 157.0 90.78 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 109.437 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' B' ' 62' ' ' ALA . 65.8 Cg_endo -74.96 -44.59 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.709 2.273 . . . . 0.0 112.322 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -45.95 -35.32 4.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.727 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 38.0 t -76.12 -41.57 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -79.18 -24.85 42.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.868 . . . . 0.0 109.545 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' B' ' 58' ' ' PRO . . . -76.55 -51.14 12.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.616 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -51.28 -23.95 4.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.86 -45.63 95.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -50.74 -44.7 58.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -1.113 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -57.82 -51.52 69.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.51 -0.744 . . . . 0.0 109.434 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.88 -51.14 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.291 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.77 -45.35 94.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.256 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.76 -45.83 31.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.15 92.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -1.14 . . . . 0.0 109.614 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -57.59 -28.86 63.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 11.6 m -77.16 -33.62 56.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.476 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.38 -34.24 33.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.463 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.24 -60.0 7.25 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.59 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.8 mp -55.03 -27.5 45.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -1.104 . . . . 0.0 109.45 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -2.14 36.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -171.26 63.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.49 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.99 -18.06 62.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -48.8 -26.05 2.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.445 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -171.34 65.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.276 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.437 HD12 ' N ' ' B' ' 82' ' ' LYS . 2.5 pp -55.69 -40.92 73.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.627 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.437 ' N ' HD12 ' B' ' 81' ' ' LEU . 39.5 mttp -50.35 -23.92 2.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.473 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.0 -42.88 7.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.7 OUTLIER -68.26 -42.92 78.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.148 -1.207 . . . . 0.0 109.629 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' B' ' 84' ' ' THR . 35.7 m-85 -67.3 -0.39 3.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -0.838 . . . . 0.0 109.459 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.46 -53.92 20.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.945 . . . . 0.0 109.383 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.5 p -61.6 -58.76 6.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' B' ' 92' ' ' HIS . 50.3 mt -51.21 -49.84 60.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.206 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' SER . . . . . 0.516 ' O ' ' N ' ' B' ' 93' ' ' CYS . 7.2 m -57.16 -46.24 82.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.249 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.536 ' HA ' ' HZ2' ' B' ' 144' ' ' LYS . 31.0 tt0 -62.21 -46.53 88.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.486 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 3.9 tt -72.62 -27.24 62.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 109.361 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' B' ' 88' ' ' LEU . 18.7 m80 -90.47 -20.29 22.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.978 . . . . 0.0 109.663 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' B' ' 89' ' ' SER . 26.6 t -83.17 -59.23 2.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 110.699 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.65 -40.51 15.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.988 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.1 OUTLIER -73.01 -51.96 16.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.945 -1.097 . . . . 0.0 110.642 -178.475 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.57 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 30.8 mt -95.79 -36.89 10.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.91 -1.119 . . . . 0.0 109.96 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 38.6 p-80 43.71 30.78 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.427 ' H ' HG23 ' B' ' 98' ' ' VAL . 3.4 t -52.32 153.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 0.0 109.215 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' ASP . . . . . 0.681 ' OD2' ' CG2' ' C' ' 96' ' ' VAL . 1.6 m-20 -71.24 143.05 87.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 109.589 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -41.22 -43.87 5.38 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.608 2.206 . . . . 0.0 112.46 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -72.01 54.46 0.28 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.449 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -150.98 -31.17 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 109.969 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.52 -41.68 54.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.072 -1.017 . . . . 0.0 109.931 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.424 ' O ' ' ND2' ' B' ' 108' ' ' ASN . 73.8 ttt180 -79.59 -19.98 48.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 110.071 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.443 ' N ' HD22 ' B' ' 105' ' ' LEU . 4.3 mm? -50.56 -60.86 2.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.137 -0.977 . . . . 0.0 109.793 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.421 ' HB3' HD13 ' B' ' 31' ' ' LEU . 1.9 pp -81.7 -22.39 37.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.012 -1.055 . . . . 0.0 109.721 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.35 -36.57 37.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' B' ' 104' ' ' ARG . 14.2 p30 -85.55 -34.81 21.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -1.158 . . . . 0.0 109.648 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 74.3 t -51.35 -48.0 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 109.465 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 tp -51.92 -54.0 34.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 109.49 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 25.2 t -46.42 -38.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.414 ' O ' ' ND1' ' B' ' 116' ' ' HIS . 13.2 m -79.2 -56.31 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 85.6 t -47.99 -24.52 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.552 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.434 ' CD2' HG22 ' B' ' 18' ' ' VAL . 14.2 mt -77.29 -43.54 32.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.26 -19.37 63.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.417 ' HD1' ' N ' ' B' ' 116' ' ' HIS . 4.3 m80 -78.29 -62.82 1.56 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.696 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -70.93 -17.43 62.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 0.0 109.845 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.45 ' CZ ' ' O ' ' B' ' 17' ' ' LYS . 63.1 m-85 -144.94 58.17 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.665 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -79.67 -17.92 74.31 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -65.05 4.99 0.39 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -1.079 . . . . 0.0 109.694 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' B' ' 119' ' ' GLY . 46.8 mm-40 -135.12 9.55 3.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -77.67 32.61 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.132 -0.98 . . . . 0.0 109.287 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.429 ' H ' ' C ' ' B' ' 121' ' ' GLU . 36.8 p -46.85 148.69 1.75 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.867 . . . . 0.0 109.51 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.48 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.1 Cg_exo -45.16 -57.03 2.31 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.542 2.161 . . . . 0.0 112.918 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 14.3 Cg_endo -56.86 -36.12 98.7 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.064 1.843 . . . . 0.0 111.995 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.408 HG23 ' OG1' ' B' ' 123' ' ' THR . 63.0 t -76.39 -20.33 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.75 -44.98 26.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.329 -0.857 . . . . 0.0 109.494 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.32 84.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.942 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.51 29.28 0.89 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.606 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.99 -33.89 4.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.0 109.375 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 1.08 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 38.1 tt0 -83.95 -63.6 1.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 109.878 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -48.05 -21.88 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.844 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' VAL . . . . . 0.479 HG22 HD21 ' B' ' 3' ' ' LEU . 71.3 t -71.75 -67.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.726 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.401 ' H ' HG23 ' B' ' 134' ' ' VAL . 2.2 t -67.2 -40.29 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.637 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.75 -21.78 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.497 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.15 -22.11 63.84 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.8 t -74.14 -30.94 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -1.178 . . . . 0.0 109.536 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.37 71.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -81.43 -21.2 39.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.592 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.14 -60.52 2.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.653 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.0 mt -57.92 -17.75 18.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.547 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' B' ' 144' ' ' LYS . . . -100.6 -6.91 24.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.895 . . . . 0.0 109.532 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -59.05 -4.71 0.53 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.467 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.536 ' HZ2' ' HA ' ' B' ' 90' ' ' GLU . 21.6 mmtp -92.13 -30.85 15.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -71.3 14.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.0 109.325 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' B' ' 144' ' ' LYS . 28.1 p-80 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' C' ' 2' ' ' LEU . 21.8 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.499 ' N ' HD12 ' C' ' 2' ' ' LEU . 7.4 mp 55.12 166.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 109.727 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.563 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 176.06 -45.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.877 . . . . 0.0 109.859 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' C' ' 3' ' ' SER . 42.6 Cg_exo -55.31 -153.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.633 2.222 . . . . 0.0 112.843 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -78.65 -15.27 58.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.416 -0.802 . . . . 0.0 110.018 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' C' ' 5' ' ' ALA . 15.9 m-20 -38.67 -29.16 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.829 . . . . 0.0 109.759 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' C' ' 5' ' ' ALA . 2.0 ptpm? -83.37 -41.83 17.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.192 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.481 ' N ' ' O ' ' C' ' 5' ' ' ALA . 45.8 m -51.25 -29.96 16.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.889 . . . . 0.0 109.057 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.71 -36.79 42.9 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.483 HG21 ' CD2' ' C' ' 128' ' ' PHE . 53.8 t -70.99 -49.06 52.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -53.04 -45.98 68.28 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.06 -58.12 9.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.475 -0.766 . . . . 0.0 109.31 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.823 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -53.13 -35.89 60.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.456 -0.777 . . . . 0.0 109.215 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -17.24 62.29 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 109.258 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.03 22.79 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -73.12 -35.73 66.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -1.118 . . . . 0.0 108.772 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.823 HG23 ' O ' ' C' ' 13' ' ' ALA . 57.7 t -62.16 -64.52 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 43.68 -122.42 4.01 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.29 22.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -1.096 . . . . 0.0 110.347 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.543 ' H ' ' C ' ' C' ' 18' ' ' GLY . 78.4 m-70 -128.87 26.25 5.55 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' C' ' 63' ' ' ALA . . . -91.91 -63.15 1.28 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.599 -0.688 . . . . 0.0 109.837 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.67 -14.29 0.22 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' C' ' 21' ' ' ALA . 10.4 mt-10 -84.64 -56.37 3.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.801 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.438 ' CE2' ' O ' ' C' ' 20' ' ' HIS . 4.7 m-30 -60.16 -16.64 34.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.848 . . . . 0.0 109.516 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.13 -34.19 30.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.14 -32.03 38.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -1.184 . . . . 0.0 109.984 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.97 -19.9 64.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.623 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.59 60.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.734 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.619 HD11 ' ND1' ' C' ' 58' ' ' HIS . 5.7 mt -78.86 -49.5 12.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.949 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.521 ' OE1' ' ND1' ' C' ' 50' ' ' HIS . 10.1 pt-20 -72.24 -33.28 67.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.925 . . . . 0.0 110.13 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.567 ' NH1' ' SG ' ' C' ' 104' ' ' CYS . 45.8 ttt-85 -54.82 -44.63 74.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 110.596 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 32' ' ' MET . . . . . 0.409 ' H ' ' HG2' ' C' ' 32' ' ' MET . 12.1 ptt? -84.09 -45.46 13.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.887 -1.133 . . . . 0.0 110.114 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -49.21 -41.41 37.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.171 -0.956 . . . . 0.0 109.83 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.564 HD12 ' C ' ' C' ' 34' ' ' LEU . 2.5 pp -75.04 -38.74 61.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.019 -1.051 . . . . 0.0 109.594 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.432 ' N ' HD12 ' C' ' 34' ' ' LEU . 15.6 m -75.51 7.48 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 109.326 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 1.071 ' CZ ' ' NE2' ' D' ' 131' ' ' GLN . 76.7 m-85 -156.19 72.05 5.09 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.338 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -46.5 -19.84 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.732 2.288 . . . . 0.0 112.203 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 19.9 p -59.22 -22.83 61.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.53 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 70.4 p -89.49 -42.91 11.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.963 . . . . 0.0 109.482 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -52.01 -39.13 59.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 109.608 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.404 HG22 ' H ' ' C' ' 41' ' ' THR . 2.7 t . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 11.6 p80 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.291 0.567 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.533 ' O ' ' C ' ' C' ' 47' ' ' ASP . 5.2 t80 -120.05 27.72 8.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 0.0 109.679 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.533 ' C ' ' O ' ' C' ' 46' ' ' PHE . 1.6 p30 28.35 72.67 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.087 0.47 . . . . 0.0 110.844 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' C' ' 48' ' ' LEU . 2.2 mm? -64.74 -7.8 12.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.147 -0.97 . . . . 0.0 109.364 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 33.7 t -49.25 152.13 1.27 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' HIS . . . . . 0.521 ' ND1' ' OE1' ' C' ' 30' ' ' GLU . 83.2 t60 -76.0 152.82 36.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.449 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.88 18.6 59.93 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' C' ' 53' ' ' ALA . 2.0 t -67.93 -99.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -1.151 . . . . 0.0 109.309 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.517 ' N ' ' OG ' ' C' ' 52' ' ' SER . . . 174.06 -78.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.567 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -44.78 -17.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.466 -0.771 . . . . 0.0 109.709 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' C' ' 53' ' ' ALA . 3.5 t -76.68 -27.48 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.192 -0.943 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -66.04 -27.0 67.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.281 -0.887 . . . . 0.0 109.467 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.46 -42.28 41.72 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.619 ' ND1' HD11 ' C' ' 29' ' ' LEU . 14.9 t-80 -62.97 -28.2 69.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -1.158 . . . . 0.0 109.63 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.52 -47.26 90.7 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 32.7 mttp -56.1 -23.89 36.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -1.083 . . . . 0.0 109.671 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -72.42 -42.5 65.04 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.314 -0.866 . . . . 0.0 109.055 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.0 t -68.95 -47.67 74.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.501 -0.749 . . . . 0.0 109.229 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -69.92 -30.06 67.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 2.3 t70 -69.2 -41.79 76.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.0 108.886 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.45 -47.95 79.71 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.408 -0.807 . . . . 0.0 108.854 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.424 ' O ' HG23 ' C' ' 70' ' ' VAL . 4.8 mt -61.01 -47.15 87.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.219 -0.926 . . . . 0.0 108.654 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' C' ' 71' ' ' ALA . 20.9 m -62.13 -47.33 85.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.185 -0.947 . . . . 0.0 109.027 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -63.49 -26.63 68.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 108.647 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.588 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.16 -46.64 11.7 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.424 HG23 ' O ' ' C' ' 66' ' ' LEU . 78.2 t -66.04 -22.46 30.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' C' ' 67' ' ' THR . . . -66.26 -21.63 66.29 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' C' ' 74' ' ' ASP . 13.3 m80 -144.18 -50.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.8 p 44.99 13.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.659 0.742 . . . . 0.0 109.407 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' C' ' 72' ' ' HIS . 14.6 t70 -128.57 9.52 6.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -173.71 27.14 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.099 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.709 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.3 ptt? -78.37 -24.85 0.45 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.519 -0.738 . . . . 0.0 111.605 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' C' ' 76' ' ' MET . 44.0 Cg_exo -55.64 -20.57 28.08 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.748 1.632 . . . . 0.0 112.504 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.514 HD22 ' C ' ' C' ' 78' ' ' ASN . 0.1 OUTLIER -94.05 -28.82 15.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 109.867 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 -47.97 21.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.116 -0.99 . . . . 0.0 109.259 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 80' ' ' LEU . . . . . 0.588 ' N ' HD12 ' C' ' 80' ' ' LEU . 6.9 mp -79.25 6.9 8.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -59.28 -15.82 18.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.668 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.86 -48.61 11.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.112 -0.993 . . . . 0.0 109.775 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.436 ' N ' HD23 ' C' ' 83' ' ' LEU . 4.6 mt -47.2 -48.34 23.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 108.748 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 88.1 p -50.2 -24.76 3.03 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.458 -0.777 . . . . 0.0 109.079 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' C' ' 82' ' ' ALA . 14.9 t70 -74.44 -25.54 59.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.191 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' C' ' 90' ' ' LYS . 6.9 tp -81.75 -34.4 30.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.311 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -90.38 -21.75 21.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -71.24 -68.51 0.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.779 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -88.41 -77.16 0.37 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.89 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' C' ' 86' ' ' LEU . 19.2 mttm -59.28 171.14 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.889 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' C' ' 93' ' ' VAL . 4.0 tp 56.91 56.84 5.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.396 -0.815 . . . . 0.0 109.726 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -66.08 9.81 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 109.279 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.534 ' H ' ' C ' ' C' ' 91' ' ' LEU . 12.2 p -46.38 165.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.605 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' C' ' 96' ' ' VAL . 5.3 m-20 -84.27 117.02 67.66 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.915 . . . . 0.0 109.258 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.412 ' C ' ' N ' ' C' ' 97' ' ' ASN . 85.4 Cg_exo -44.41 -10.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.318 2.012 . . . . 0.0 112.318 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.681 ' CG2' ' OD2' ' B' ' 99' ' ' ASP . 98.8 t -53.91 -10.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.111 -0.993 . . . . 0.0 109.543 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.412 ' N ' ' C ' ' C' ' 95' ' ' PRO . 2.7 m-80 -79.17 -24.97 42.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -53.14 -43.71 67.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.918 . . . . 0.0 109.55 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.437 ' CB ' ' NZ ' ' C' ' 99' ' ' LYS . 7.6 mtmp? -69.41 -25.27 64.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.643 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 25.4 mt -81.68 -46.8 13.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 109.661 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -69.54 -20.88 63.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.735 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 32.8 p -78.68 -59.11 2.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 109.791 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -63.16 -26.73 68.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.871 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.567 ' SG ' ' NH1' ' C' ' 31' ' ' ARG . 34.5 m -65.17 -52.25 56.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.766 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.03 -24.68 0.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.721 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.78 -34.88 60.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -0.98 . . . . 0.0 109.855 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 107' ' ' VAL . . . . . 0.495 HG11 ' HE ' ' C' ' 31' ' ' ARG . 71.2 t -83.26 -24.82 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.045 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -70.8 -63.7 1.05 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.129 -0.982 . . . . 0.0 110.561 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' C' ' 113' ' ' LEU . 2.4 pp -64.02 -18.68 64.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 109.823 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.35 -33.36 63.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.712 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.65 -56.22 25.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -66.58 -68.31 0.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.0 108.385 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.668 ' O ' HD12 ' C' ' 113' ' ' LEU . 3.1 pp -116.56 111.46 41.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 114' ' ' PRO . . . . . 0.627 ' O ' HD12 ' C' ' 113' ' ' LEU . 89.9 Cg_exo -41.59 -177.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.507 2.138 . . . . 0.0 113.204 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.713 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -45.57 -52.42 10.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.479 -0.763 . . . . 0.0 109.038 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.645 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 19.4 mt-10 125.0 -1.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 61.28 31.33 19.4 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.262 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.775 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -103.88 120.54 50.95 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.53 23.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.049 1.833 . . . . 0.0 112.649 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.775 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -152.47 -32.5 0.14 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.864 -1.147 . . . . 0.0 110.568 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.713 HG21 ' O ' ' C' ' 115' ' ' ALA . 14.4 p -47.93 -48.23 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 110.1 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.643 ' N ' HG13 ' C' ' 121' ' ' VAL . 0.6 OUTLIER -63.74 -38.89 92.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.439 -0.788 . . . . 0.0 109.416 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.4 -19.75 33.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.885 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.608 ' N ' ' O ' ' C' ' 120' ' ' ALA . 7.6 p -58.36 -62.1 2.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 0.0 110.015 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.519 ' N ' ' OG ' ' C' ' 124' ' ' SER . 5.1 mt -68.54 -19.64 64.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 109.31 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -73.83 -52.21 13.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.701 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.459 ' CD ' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -86.26 -44.41 12.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.023 . . . . 0.0 109.936 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.483 ' CD2' HG21 ' C' ' 10' ' ' VAL . 39.7 t80 -47.32 -20.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.045 -1.035 . . . . 0.0 108.921 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' C' ' 133' ' ' SER . 12.0 mt -71.75 -18.0 62.16 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.28 -33.67 73.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.424 ' O ' HG13 ' C' ' 135' ' ' VAL . 89.3 p -82.7 -29.96 29.52 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 t -85.18 -29.72 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.157 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.488 ' N ' ' O ' ' C' ' 129' ' ' LEU . 17.8 m -82.79 -22.69 34.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.302 -0.873 . . . . 0.0 108.96 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 134' ' ' THR . . . . . 0.463 ' O ' ' N ' ' C' ' 138' ' ' SER . 41.9 m -80.67 -39.99 26.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 0.0 109.225 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.424 HG13 ' O ' ' C' ' 131' ' ' SER . 26.8 m -71.08 -26.45 27.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.266 -0.897 . . . . 0.0 108.846 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -31.95 73.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.413 -0.804 . . . . 0.0 108.978 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 7.1 m -156.74 53.65 0.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.413 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 138' ' ' SER . . . . . 0.463 ' N ' ' O ' ' C' ' 134' ' ' THR . 9.0 p . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 44.0 m80 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.931 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.1 OUTLIER -142.72 164.54 29.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.368 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.89 159.48 68.57 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.265 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.82 -18.65 65.64 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.72 2.28 . . . . 0.0 111.946 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -84.58 -34.14 23.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.53 -61.75 1.76 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.628 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.697 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -46.99 -26.76 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.609 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.1 t -57.04 -23.5 46.98 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.153 -0.967 . . . . 0.0 110.194 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.62 -57.65 3.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.019 -1.051 . . . . 0.0 110.115 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.35 -24.59 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 48.8 m -82.11 -36.92 27.04 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.309 0.575 . . . . 0.0 109.704 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.54 -34.65 70.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.7 OUTLIER -50.54 -34.48 25.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.14 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -45.78 -17.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.375 -0.828 . . . . 0.0 109.637 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.27 -49.37 7.48 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.454 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 0.1 OUTLIER -72.0 -30.23 65.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.094 -1.239 . . . . 0.0 109.445 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.442 HG22 ' CD2' ' D' ' 114' ' ' LEU . 77.4 t -53.47 114.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.7 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' D' ' 20' ' ' VAL . 36.4 m-80 -79.56 65.99 4.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 108.937 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' D' ' 22' ' ' GLU . 72.5 t -43.69 -26.18 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.451 -0.781 . . . . 0.0 109.79 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' D' ' 19' ' ' ASN . 18.0 t70 -65.45 5.13 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.527 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' D' ' 20' ' ' VAL . 37.5 mt-10 -154.06 -51.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 0.0 109.484 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 88.0 t -49.71 -53.35 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 109.547 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.67 -40.56 25.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.55 -37.2 62.22 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.09 -35.7 61.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -1.123 . . . . 0.0 109.555 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.51 -28.71 68.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 tp -85.04 -51.97 6.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.78 -28.41 70.02 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -79.4 -28.11 41.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -1.117 . . . . 0.0 109.49 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' D' ' 106' ' ' LEU . 44.3 tp -48.09 -39.91 21.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 32' ' ' LEU . . . . . 0.452 ' CD2' ' OG1' ' D' ' 38' ' ' THR . 21.2 mt -81.03 -23.03 38.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.291 -0.88 . . . . 0.0 109.695 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.18 -61.81 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.142 -0.974 . . . . 0.0 109.918 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' C' ' 122' ' ' HIS . 0.0 OUTLIER -78.42 -22.54 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 0.0 110.112 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -134.6 76.99 59.74 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.109 -0.994 . . . . 0.0 109.925 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.18 27.88 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.028 2.486 . . . . 0.0 112.339 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -81.1 -20.04 42.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -0.953 . . . . 0.0 109.853 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.527 ' C ' ' H ' ' D' ' 40' ' ' ARG . 6.0 p -47.81 -29.16 2.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 109.66 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 51.91 6.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' ARG . . . . . 0.527 ' H ' ' C ' ' D' ' 38' ' ' THR . 42.5 ttm180 -110.13 -39.92 4.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 47.73 19.72 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.621 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.514 ' O ' ' N ' ' D' ' 44' ' ' SER . 77.3 m-85 54.73 55.01 8.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.359 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -46.2 -16.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 109.636 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 44' ' ' SER . . . . . 0.514 ' N ' ' O ' ' D' ' 42' ' ' PHE . 20.2 m -57.69 -54.68 44.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -70.07 3.74 2.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.219 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.05 -149.34 1.19 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 56.51 73.16 0.46 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.319 -1.106 . . . . 0.0 109.641 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 90.3 mt -137.5 29.69 2.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.858 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 41.5 t -72.46 -38.01 68.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.499 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -146.11 151.95 45.98 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.295 -0.878 . . . . 0.0 109.173 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -41.12 -35.23 1.82 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.404 2.07 . . . . 0.0 112.308 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.91 -32.28 73.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.11 -23.88 66.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.681 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.45 -60.73 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -91.97 25.59 2.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.33 -52.36 2.04 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.81 156.87 90.98 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.224 -1.162 . . . . 0.0 109.43 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.97 -44.49 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.645 2.23 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -45.98 -35.33 4.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 0.0 109.66 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -76.15 -41.58 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -79.17 -24.93 42.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.36 -0.837 . . . . 0.0 109.474 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.48 -51.26 12.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.53 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -51.27 -23.94 4.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 109.47 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.93 -45.59 95.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -50.83 -44.63 59.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.374 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -57.81 -51.55 69.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.41 -0.806 . . . . 0.0 109.477 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.83 -51.15 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.314 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.77 -45.33 94.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.24 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.81 -45.79 31.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.24 92.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -1.103 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -57.42 -29.07 63.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 11.6 m -77.0 -33.68 57.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 109.496 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.45 -34.26 34.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.367 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.16 -60.08 7.19 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.57 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.8 mp -55.11 -27.44 45.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -1.14 . . . . 0.0 109.381 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -2.16 36.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -171.23 63.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.91 -18.06 62.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.442 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -48.84 -25.97 2.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -171.37 65.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.283 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 81' ' ' LEU . . . . . 0.439 HD12 ' N ' ' D' ' 82' ' ' LYS . 2.5 pp -55.65 -40.98 72.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 82' ' ' LYS . . . . . 0.439 ' N ' HD12 ' D' ' 81' ' ' LEU . 39.5 mttp -50.44 -23.77 2.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.055 -1.028 . . . . 0.0 109.438 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.18 -42.89 7.78 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.7 OUTLIER -68.18 -42.89 79.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.022 -1.281 . . . . 0.0 109.635 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' D' ' 84' ' ' THR . 35.4 m-85 -67.39 -0.27 3.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.498 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.52 -54.01 20.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.3 p -61.57 -58.66 7.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.366 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' D' ' 92' ' ' HIS . 49.1 mt -51.27 -49.88 60.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.256 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 89' ' ' SER . . . . . 0.536 ' O ' ' N ' ' D' ' 93' ' ' CYS . 7.2 m -57.12 -46.22 82.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 109.233 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.548 ' HA ' ' HZ2' ' D' ' 144' ' ' LYS . 30.9 tt0 -62.28 -46.58 88.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.419 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 3.9 tt -72.45 -27.27 62.21 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.135 -0.978 . . . . 0.0 109.461 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.459 ' N ' ' O ' ' D' ' 88' ' ' LEU . 19.0 m80 -90.52 -20.24 22.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.06 -1.025 . . . . 0.0 109.621 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 93' ' ' CYS . . . . . 0.536 ' N ' ' O ' ' D' ' 89' ' ' SER . 26.0 t -83.27 -59.27 2.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 110.563 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -86.6 -40.53 15.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.04 -1.037 . . . . 0.0 111.326 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 95' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.1 OUTLIER -72.99 -52.0 16.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.965 -1.084 . . . . 0.0 110.602 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.56 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 30.9 mt -95.74 -36.89 11.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.934 -1.104 . . . . 0.0 109.96 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 38.5 p-80 43.58 30.9 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.373 -0.829 . . . . 0.0 110.078 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 98' ' ' VAL . . . . . 0.463 HG23 ' H ' ' D' ' 98' ' ' VAL . 3.4 t -52.38 153.27 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.074 -1.016 . . . . 0.0 109.19 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 99' ' ' ASP . . . . . 0.723 ' OD2' ' CG2' ' A' ' 96' ' ' VAL . 1.6 m-20 -71.22 143.01 87.76 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 109.589 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -41.26 -43.83 5.48 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.573 2.182 . . . . 0.0 112.417 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -71.98 54.42 0.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -150.93 -31.18 0.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 109.961 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.48 -41.7 54.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.993 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 104' ' ' ARG . . . . . 0.426 ' O ' ' ND2' ' D' ' 108' ' ' ASN . 73.9 ttt180 -79.49 -20.1 48.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 110.094 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 105' ' ' LEU . . . . . 0.44 ' N ' HD22 ' D' ' 105' ' ' LEU . 4.3 mm? -50.58 -60.84 2.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 109.737 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.424 ' HB3' HD13 ' D' ' 31' ' ' LEU . 1.9 pp -81.68 -22.43 37.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.056 -1.028 . . . . 0.0 109.766 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.28 -36.55 37.09 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 108' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' D' ' 104' ' ' ARG . 14.2 p30 -85.6 -34.8 21.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -1.149 . . . . 0.0 109.675 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 74.6 t -51.3 -48.0 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 109.462 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.94 -54.1 33.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.368 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 25.1 t -46.29 -38.14 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 109.533 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 112' ' ' CYS . . . . . 0.422 ' O ' ' ND1' ' D' ' 116' ' ' HIS . 13.3 m -79.1 -56.35 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.56 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 86.8 t -47.93 -24.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.945 . . . . 0.0 109.479 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 114' ' ' LEU . . . . . 0.442 ' CD2' HG22 ' D' ' 18' ' ' VAL . 14.2 mt -77.19 -43.65 32.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.389 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.52 63.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.407 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' D' ' 112' ' ' CYS . 4.4 m80 -78.18 -62.87 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 0.0 109.771 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -70.75 -17.56 62.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.869 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 63.5 m-85 -144.86 58.12 1.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 0.0 109.74 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -79.7 -17.93 74.23 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -65.03 4.92 0.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -1.083 . . . . 0.0 109.656 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' D' ' 119' ' ' GLY . 46.7 mm-40 -135.04 9.46 3.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.722 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.556 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -77.58 32.62 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.14 -0.975 . . . . 0.0 109.297 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.442 ' H ' ' C ' ' D' ' 121' ' ' GLU . 37.2 p -46.88 148.68 1.77 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.34 -0.85 . . . . 0.0 109.546 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.472 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.2 Cg_exo -45.28 -56.91 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.538 2.159 . . . . 0.0 112.887 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 14.3 Cg_endo -56.9 -36.16 98.86 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.16 1.907 . . . . 0.0 111.969 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.417 HG23 ' OG1' ' D' ' 123' ' ' THR . 63.3 t -76.4 -20.34 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.71 -45.05 25.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 0.0 109.481 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.34 83.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 109.57 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.5 29.29 0.89 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.634 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.02 -33.88 4.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 1.071 ' NE2' ' CZ ' ' C' ' 36' ' ' PHE . 38.1 tt0 -83.98 -63.48 1.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -48.12 -21.84 0.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.838 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 133' ' ' VAL . . . . . 0.48 HG22 HD21 ' D' ' 3' ' ' LEU . 70.8 t -71.73 -67.25 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.151 -0.968 . . . . 0.0 109.71 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.414 ' H ' HG23 ' D' ' 134' ' ' VAL . 2.2 t -67.3 -40.14 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.82 -21.85 0.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.14 -22.02 64.06 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 89.5 t -74.12 -31.0 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -1.155 . . . . 0.0 109.562 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.36 71.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.53 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -81.34 -21.29 39.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.587 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.13 -60.46 2.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.658 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.1 mt -57.99 -17.69 18.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.514 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 142' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' D' ' 144' ' ' LYS . . . -100.66 -6.9 24.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.863 . . . . 0.0 109.603 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -59.03 -4.75 0.53 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.473 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.548 ' HZ2' ' HA ' ' D' ' 90' ' ' GLU . 21.5 mmtp -92.0 -31.03 15.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.579 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -71.32 14.2 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.001 . . . . 0.0 109.36 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' D' ' 144' ' ' LYS . 28.0 p-80 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.515 HD11 ' HA ' ' A' ' 128' ' ' PHE . 4.3 mm? -105.07 -176.64 3.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.306 -0.871 . . . . 0.0 109.609 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.545 ' O ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -117.34 170.88 5.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.0 109.236 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 3' ' ' SER . 88.7 Cg_exo -41.39 -117.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 123.132 2.554 . . . . 0.0 113.304 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -43.99 -27.63 0.39 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.966 -1.084 . . . . 0.0 110.263 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 10' ' ' VAL . 29.9 m-20 -44.1 -35.07 2.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.973 . . . . 0.0 109.192 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -83.26 -34.02 25.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.267 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 m -59.22 -33.33 70.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.264 -0.897 . . . . 0.0 109.148 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -75.02 -32.64 61.66 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 6' ' ' ASP . 54.3 t -76.03 -51.4 20.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HE2' HG13 ' A' ' 70' ' ' VAL . 1.1 mptm? -56.96 -33.98 67.59 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.18 -59.62 5.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.446 -0.784 . . . . 0.0 109.459 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -53.21 -34.44 57.05 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.425 -0.797 . . . . 0.0 109.141 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -17.62 61.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.22 -44.69 9.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -70.19 -38.15 75.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -1.123 . . . . 0.0 108.901 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 13' ' ' ALA . 96.1 t -61.38 -64.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 53.93 -130.52 43.56 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.23 26.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.457 -1.025 . . . . 0.0 110.438 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.534 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.0 m-70 -130.56 23.85 5.09 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.81 -59.58 2.19 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.612 -0.68 . . . . 0.0 109.698 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -14.21 0.22 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 9.7 mt-10 -88.14 -56.63 3.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -1.141 . . . . 0.0 109.739 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.8 m-30 -57.46 -39.49 76.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.034 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.54 -22.95 53.63 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.51 -57.88 2.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -1.11 . . . . 0.0 109.735 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' OE1' ' NE2' ' A' ' 112' ' ' HIS . 72.4 mt-10 -50.26 -19.9 0.92 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.362 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.58 63.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.367 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.612 HD21 ' CE1' ' A' ' 58' ' ' HIS . 9.1 mt -73.13 -56.42 5.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 29' ' ' LEU . 56.3 mt-10 -43.87 -37.19 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.691 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -48.76 78.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.945 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.1 ttp -83.99 -42.82 15.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.63 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.596 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 26.1 m-85 -64.28 -32.57 74.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 0.0 110.301 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mt -45.68 -43.02 12.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.971 -1.081 . . . . 0.0 109.727 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 36' ' ' PHE . 14.9 m -86.65 -15.76 38.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.328 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER 19.14 64.48 0.24 Allowed Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.976 -0.453 . . . . 0.0 111.319 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.52 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 85.4 Cg_endo -93.63 -62.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.623 2.215 . . . . 0.0 112.552 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.741 ' O ' HG22 ' A' ' 41' ' ' THR . 3.5 p -91.43 -18.6 23.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 109.738 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 p -81.72 -23.03 36.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.968 . . . . 0.0 110.149 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -68.27 -34.93 77.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.063 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 38' ' ' THR . 14.1 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.508 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 21.9 p80 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.516 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -155.91 28.53 0.37 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.727 -1.233 . . . . 0.0 110.395 178.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 46' ' ' PHE . 7.3 m-20 33.31 81.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.635 -0.666 . . . . 0.0 110.33 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.862 HD23 ' H ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -60.13 -21.27 61.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.442 -0.786 . . . . 0.0 109.335 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 t -47.54 149.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.59 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 2.0 t60 -74.77 151.06 39.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.59 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 82.16 4.74 90.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.667 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 12.1 p -77.42 -19.77 55.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -1.143 . . . . 0.0 109.477 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 75.77 -16.95 0.55 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.37 -0.831 . . . . 0.0 109.869 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -86.14 -21.43 27.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.121 -0.987 . . . . 0.0 109.954 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.516 HG22 ' CE2' ' A' ' 46' ' ' PHE . 18.8 t -84.1 -28.29 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 0.0 109.834 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -77.98 -30.41 50.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.123 -0.986 . . . . 0.0 108.989 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.512 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . . . -66.61 -26.46 72.91 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.612 ' CE1' HD21 ' A' ' 29' ' ' LEU . 8.3 t-80 -75.46 -34.78 60.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.131 -1.217 . . . . 0.0 109.636 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.34 -51.08 44.34 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -51.66 -23.46 4.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -1.065 . . . . 0.0 109.968 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -74.51 -42.38 59.02 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.125 -0.984 . . . . 0.0 109.082 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -72.5 -45.24 59.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.467 -0.77 . . . . 0.0 108.986 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.85 -27.59 65.97 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.291 -0.881 . . . . 0.0 109.188 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.39 -34.06 67.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 108.727 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.87 -52.15 46.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.318 -0.864 . . . . 0.0 108.933 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 128' ' ' PHE . 9.1 mt -59.17 -42.77 91.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 0.0 108.653 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -69.35 -50.19 48.56 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 108.745 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -58.98 -24.78 63.01 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.95 -45.6 12.99 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' HE2' ' A' ' 11' ' ' LYS . 4.9 t -63.77 -22.99 32.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.38 -22.78 63.7 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.61 ' O ' ' N ' ' A' ' 74' ' ' ASP . 90.6 m-70 -147.22 -51.78 0.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.875 . . . . 0.0 109.532 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.4 p 44.49 13.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.758 0.79 . . . . 0.0 109.479 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' A' ' 72' ' ' HIS . 17.8 t70 -133.07 9.78 4.15 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 34.1 t70 -175.43 27.43 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.981 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 13.8 ptt? -78.66 -22.48 0.38 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.431 -0.793 . . . . 0.0 111.909 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.8 Cg_exo -53.48 -20.78 16.69 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.548 1.499 . . . . 0.0 112.33 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -94.17 -35.41 12.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.678 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.04 -47.55 61.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.306 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.5 mt -77.5 5.75 8.37 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.075 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.1 p -54.73 -24.64 23.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.291 -0.88 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -73.93 -55.21 6.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 109.557 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.464 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 4.6 mt -47.7 -48.13 29.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.808 . . . . 0.0 108.929 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -59.21 -22.65 61.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.549 -0.719 . . . . 0.0 109.398 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 89' ' ' HIS . 16.5 t70 -81.89 -46.52 13.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.3 -26.74 65.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 11.4 m80 -81.47 -21.65 38.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.724 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 90' ' ' LYS . . . -119.05 -55.46 2.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.294 -0.879 . . . . 0.0 109.746 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 85' ' ' ASP . 13.2 t-80 -71.41 17.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 109.751 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.599 ' C ' ' H ' ' A' ' 92' ' ' ARG . 9.8 ttmm -166.5 149.02 6.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 109.781 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.7 mt 61.81 -12.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 109.86 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.038 ' HD2' ' HG2' ' D' ' 40' ' ' ARG . 45.6 mmt-85 45.14 16.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 109.714 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 91' ' ' LEU . 12.1 p -57.68 131.02 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 1.08 ' OD1' ' NH1' ' D' ' 40' ' ' ARG . 0.8 OUTLIER -75.3 147.03 82.3 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.29 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 97' ' ' ASN . 58.1 Cg_endo -72.57 -23.9 19.38 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.543 2.162 . . . . 0.0 112.126 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.8 t -49.06 -10.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.77 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 95' ' ' PRO . 12.0 m-20 -79.05 -24.88 43.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.534 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -54.28 -30.04 49.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.425 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 92.4 mttt -54.33 -26.62 30.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.489 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.674 HD12 ' N ' ' A' ' 100' ' ' LEU . 8.1 mp -84.06 -57.37 3.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.3 tp -50.89 -27.35 7.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -66.09 -58.52 5.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.616 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -63.57 -26.45 68.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.882 . . . . 0.0 109.67 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 73.6 m -58.2 -55.97 28.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 109.596 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mt -47.82 -37.98 14.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 106' ' ' LEU . 7.7 mp -71.13 -41.89 69.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.05 -24.95 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 109.348 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 m -80.76 -63.28 1.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.447 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 113' ' ' LEU . 33.8 mt -46.98 -28.29 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.25 90.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 110.017 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.68 64.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.097 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' A' ' 27' ' ' GLU . 28.1 m170 -93.19 -80.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.073 -1.017 . . . . 0.0 109.721 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -107.94 102.74 47.07 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -43.8 173.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.546 2.164 . . . . 0.0 113.563 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -87.32 -35.44 18.42 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.782 0.801 . . . . 0.0 109.422 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 13.1 mt-10 81.29 1.35 1.63 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 1.209 ' CD1' ' NH2' ' B' ' 30' ' ' ARG . 11.2 m-85 58.49 40.91 23.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.806 -0.559 . . . . 0.0 111.282 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.752 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -88.12 118.7 69.89 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 120.756 -1.215 . . . . 0.0 108.001 178.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.596 ' HA ' HG21 ' B' ' 33' ' ' VAL . 54.1 Cg_exo -49.05 18.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.319 2.012 . . . . 0.0 112.644 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.752 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -140.08 -39.21 0.45 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.111 -0.993 . . . . 0.0 110.053 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 4.2 p -51.68 -48.35 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.102 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.576 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 2.8 m-70 -62.75 -54.37 40.21 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.412 -0.805 . . . . 0.0 109.334 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.92 -19.61 60.87 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.253 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 1.1 p -60.77 -61.6 2.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 110.271 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.539 ' N ' ' OG ' ' A' ' 124' ' ' SER . 6.4 mt -80.64 -21.05 41.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.113 -0.992 . . . . 0.0 110.073 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -78.51 -40.69 34.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 110.109 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.29 -41.29 11.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.949 -1.094 . . . . 0.0 110.13 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.515 ' HA ' HD11 ' A' ' 2' ' ' LEU . 32.3 t80 -50.56 -20.51 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.8 -1.188 . . . . 0.0 108.839 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 133' ' ' SER . 11.9 mt -72.59 -17.74 61.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.13 76.83 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.2 p -79.39 -36.19 39.57 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.339 -0.851 . . . . 0.0 108.82 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.09 -27.23 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.183 -0.948 . . . . 0.0 108.67 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 129' ' ' LEU . 97.2 p -78.17 -45.99 21.7 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.474 -0.766 . . . . 0.0 109.204 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 95.2 m -67.81 -23.01 65.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.223 -0.923 . . . . 0.0 108.654 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.85 -29.9 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -34.6 67.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.09 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 138' ' ' SER . 81.0 p -92.21 -29.73 16.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 137' ' ' THR . 3.5 t . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.521 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' B' ' 2' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.842 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -140.81 145.25 36.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.342 -0.849 . . . . 0.0 109.034 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 7.8 p -69.65 148.75 96.84 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.543 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -42.65 -24.85 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.598 2.199 . . . . 0.0 112.236 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -80.82 -53.03 6.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.92 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -60.28 -36.08 77.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.182 -0.948 . . . . 0.0 109.98 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.508 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -84.08 -31.57 25.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 109.922 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.07 -23.56 8.02 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.148 -0.97 . . . . 0.0 110.458 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.4 -58.04 3.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.942 -1.099 . . . . 0.0 110.272 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.46 HG23 ' CD2' ' B' ' 130' ' ' TYR . 7.6 p -65.53 -24.53 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.9 m -78.38 -40.35 36.49 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.338 0.589 . . . . 0.0 109.711 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.36 -26.14 68.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.339 -0.851 . . . . 0.0 109.488 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.722 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.9 OUTLIER -62.53 -26.81 68.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.38 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.77 -17.7 64.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.42 -62.9 3.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.62 ' HD3' HD23 ' B' ' 14' ' ' LEU . 0.0 OUTLIER -78.71 7.1 7.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.099 -1.236 . . . . 0.0 110.815 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.722 HG23 ' O ' ' B' ' 14' ' ' LEU . 2.3 t -75.65 121.32 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.826 -1.171 . . . . 0.0 109.186 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.43 85.1 6.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.402 -0.811 . . . . 0.0 109.224 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 36.0 t -55.96 -20.36 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 109.573 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 1.0 OUTLIER -57.36 -55.78 30.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 43.1 mt-10 -98.89 -44.29 6.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.58 -23.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.882 . . . . 0.0 109.658 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.18 -43.07 11.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.98 -25.86 61.33 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -79.44 -25.45 41.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.198 -1.177 . . . . 0.0 109.662 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.64 -23.22 39.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 109.619 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 tp -85.02 -57.26 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 0.0 109.503 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.03 -19.82 32.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 1.209 ' NH2' ' CD1' ' A' ' 117' ' ' PHE . 47.0 mtt180 -79.37 -27.34 41.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -1.188 . . . . 0.0 109.377 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 39.7 tp -65.58 -24.77 67.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.879 . . . . 0.0 109.585 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 41.2 mt -78.01 -53.8 7.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.085 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.742 HG13 ' H ' ' B' ' 34' ' ' VAL . 7.9 p -71.07 -60.73 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 110.039 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.742 ' H ' HG13 ' B' ' 33' ' ' VAL . 95.3 t -46.28 -30.5 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.958 -1.089 . . . . 0.0 109.549 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.9 91.2 1.58 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.391 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.71 30.48 0.52 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.733 2.289 . . . . 0.0 112.427 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -57.17 -28.66 62.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.488 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' B' ' 39' ' ' GLN . 30.5 p -56.19 -77.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.892 . . . . 0.0 109.419 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLN . . . . . 0.534 ' N ' ' OG1' ' B' ' 38' ' ' THR . 14.8 tt0 50.62 46.12 26.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.554 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 1.034 ' NH1' ' OD1' ' C' ' 94' ' ' ASP . 68.9 mtm180 -148.01 -49.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.151 -0.968 . . . . 0.0 109.55 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' B' ' 43' ' ' GLU . 1.3 p90 -96.72 -21.4 17.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.759 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -48.81 -11.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.98 . . . . 0.0 109.625 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' B' ' 41' ' ' PHE . 31.3 mt-10 -80.31 -20.3 44.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.171 -0.956 . . . . 0.0 109.475 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.474 ' O ' ' N ' ' B' ' 46' ' ' GLY . 11.2 t -58.25 -51.8 68.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.62 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' B' ' 47' ' ' ASP . 57.0 m-85 -47.92 -16.14 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.533 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 61.35 -77.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' B' ' 45' ' ' PHE . 0.9 OUTLIER -46.77 113.45 0.66 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -1.132 . . . . 0.0 109.605 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' B' ' 49' ' ' SER . 0.8 OUTLIER -161.15 22.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.009 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' B' ' 48' ' ' LEU . 17.9 m -45.13 -39.66 6.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 109.563 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -145.67 151.94 47.62 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.323 -0.861 . . . . 0.0 108.995 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -44.64 -21.84 0.53 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.295 1.996 . . . . 0.0 112.154 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.78 -29.21 27.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.657 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.57 -26.94 46.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 109.535 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.51 -62.01 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.574 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 14.9 mmt -53.7 -16.97 1.89 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.541 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.25 -4.19 61.24 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.444 HD21 ' HB3' ' B' ' 45' ' ' PHE . 65.4 m-20 -72.22 142.69 85.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.192 -1.181 . . . . 0.0 109.376 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.5 -52.1 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.509 2.14 . . . . 0.0 112.21 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -51.56 -48.11 63.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -0.86 . . . . 0.0 109.586 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.46 -27.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.529 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -79.16 -53.57 6.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.54 -59.04 3.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -49.06 -23.92 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.69 -37.62 92.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -71.7 -35.32 70.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.544 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -49.42 -44.87 45.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.179 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 54.4 t -73.57 -61.84 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.183 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.716 HD23 ' O ' ' B' ' 68' ' ' LEU . 1.8 tt -50.43 -23.24 2.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.092 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.35 -56.99 11.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.88 97.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -1.132 . . . . 0.0 109.439 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' PHE . . . . . 0.55 ' CZ ' HG11 ' B' ' 134' ' ' VAL . 0.1 OUTLIER -48.82 -21.78 0.7 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 109.289 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p -87.89 -34.93 18.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.621 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -46.44 -34.36 4.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.59 -58.93 6.01 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.528 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -62.87 -23.3 67.25 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -1.092 . . . . 0.0 109.277 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.49 2.4 54.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.408 ' C ' ' H ' ' B' ' 79' ' ' ASP . 55.9 t60 -170.99 65.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.78 13.22 0.67 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' B' ' 77' ' ' HIS . 34.7 t70 -76.36 -27.65 56.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.563 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -170.98 106.4 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 109.512 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 mt -80.33 -44.01 20.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.436 ' CD ' ' H ' ' B' ' 82' ' ' LYS . 1.5 mptp? -49.41 -25.87 2.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.383 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.17 -53.71 3.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 3.9 p -65.9 -37.64 86.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.199 -1.177 . . . . 0.0 109.616 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -90.84 23.95 2.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.619 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.26 -41.55 40.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.392 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 21.1 p -72.69 -51.01 21.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.408 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -56.79 -48.85 76.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.33 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 28.1 t -61.57 -44.06 97.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.34 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -64.41 -23.75 67.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.377 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 7.4 tp -85.1 -68.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -49.59 -30.01 8.04 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.272 -0.893 . . . . 0.0 110.083 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' CYS . . . . . 0.571 ' SG ' ' CD1' ' B' ' 145' ' ' TYR . 38.0 t -83.98 -55.66 4.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 111.548 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.541 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 0.6 OUTLIER -86.26 -29.13 23.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.915 -1.116 . . . . 0.0 112.205 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 95' ' ' LYS . . . . . 0.45 ' C ' HD22 ' B' ' 96' ' ' LEU . 5.6 mptp? -90.32 -52.06 5.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.639 -1.288 . . . . 0.0 110.981 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.537 HD22 ' N ' ' B' ' 96' ' ' LEU . 3.7 mm? -97.59 -22.79 16.31 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.753 -1.217 . . . . 0.0 110.208 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.604 ' O ' HG22 ' C' ' 38' ' ' THR . 81.9 m-70 51.03 37.62 18.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.004 -1.06 . . . . 0.0 109.424 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.04 138.75 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 0.0 109.362 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.94 151.28 3.42 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.73 30.57 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.575 2.183 . . . . 0.0 112.022 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -143.47 75.86 1.49 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.304 -0.873 . . . . 0.0 109.384 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -168.2 -40.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.454 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -52.52 -45.7 66.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.429 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 55.4 ttp180 -66.34 -42.32 88.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.46 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.606 HD12 ' N ' ' B' ' 105' ' ' LEU . 10.0 mp -54.37 -57.48 11.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.692 HD23 ' C ' ' B' ' 106' ' ' LEU . 7.5 tt -52.15 -49.02 64.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.97 -22.41 54.96 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 27.4 m120 -80.76 -15.35 56.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.042 -1.269 . . . . 0.0 109.737 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 64.1 t -85.23 -44.78 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 109.609 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.523 HD23 ' O ' ' B' ' 110' ' ' LEU . 1.7 tt -47.87 -54.33 12.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.599 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.433 ' H ' HG23 ' B' ' 111' ' ' VAL . 3.5 t -45.57 -32.64 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.884 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.525 ' O ' ' ND1' ' B' ' 116' ' ' HIS . 45.6 m -77.3 -36.87 53.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 109.754 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 18.2 t -57.97 -46.36 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.739 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' B' ' 118' ' ' PHE . 19.0 mt -66.8 -30.54 70.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.697 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.458 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -61.08 -29.44 69.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.614 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' B' ' 112' ' ' CYS . 68.7 m80 -84.82 -62.89 1.44 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.708 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.518 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 1.0 OUTLIER -65.44 -18.45 65.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 40.5 m-85 -144.37 55.48 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 109.491 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.531 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -68.74 -21.32 74.85 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.06 -35.21 59.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.146 . . . . 0.0 109.421 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.482 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.0 mm-40 -75.31 3.05 9.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.439 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.552 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -72.33 35.43 0.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.555 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.557 ' OG1' HG23 ' B' ' 126' ' ' VAL . 4.8 p -47.12 147.4 2.47 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.369 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.2 Cg_exo -48.48 -51.28 10.53 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.31 2.007 . . . . 0.0 113.231 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 41.8 Cg_endo -67.99 -0.92 6.12 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.055 1.836 . . . . 0.0 112.754 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.557 HG23 ' OG1' ' B' ' 123' ' ' THR . 40.3 t -99.08 -12.57 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 109.598 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.36 -60.19 2.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 109.496 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.51 ' O ' ' NZ ' ' B' ' 132' ' ' LYS . . . -67.07 -25.71 66.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.95 . . . . 0.0 109.264 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.45 18.19 2.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 109.651 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.46 ' CD2' HG23 ' B' ' 11' ' ' VAL . 6.1 t80 -107.89 -61.3 1.59 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.652 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.415 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 53.6 tt0 -46.31 -48.28 18.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 109.742 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.821 ' HG2' ' OXT' ' D' ' 146' ' ' HIS . 33.1 mtmm -52.69 -21.89 4.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.781 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.34 -67.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.0 109.699 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.55 HG11 ' CZ ' ' B' ' 71' ' ' PHE . 30.9 m -73.33 -15.88 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 109.909 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.906 ' HB1' ' CG ' ' D' ' 146' ' ' HIS . . . -47.47 -28.86 2.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.469 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.29 -22.8 58.22 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 134' ' ' VAL . 82.3 t -82.1 -27.04 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -1.136 . . . . 0.0 109.538 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.98 82.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.596 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' ASN . . . . . 0.783 ' OD1' ' OD1' ' D' ' 139' ' ' ASN . 64.4 m-80 -79.63 -25.93 41.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.917 . . . . 0.0 109.754 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.47 -49.15 78.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.0 109.726 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 21.8 mt -82.64 16.41 2.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 109.668 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.77 -0.77 1.88 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.22 -0.925 . . . . 0.0 109.697 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -80.36 -28.31 38.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -70.91 -16.6 62.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.439 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.571 ' CD1' ' SG ' ' B' ' 93' ' ' CYS . 13.9 m-85 -64.67 -28.83 69.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.361 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.867 ' CG ' ' HB1' ' D' ' 135' ' ' ALA . 20.9 m-70 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.447 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' C' ' 128' ' ' PHE . 4.3 mm? -105.13 -176.71 3.16 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.278 -0.889 . . . . 0.0 109.536 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.545 ' O ' ' O ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER -117.22 170.84 5.53 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.539 -0.726 . . . . 0.0 109.191 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' C' ' 3' ' ' SER . 89.1 Cg_exo -41.37 -117.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.126 2.551 . . . . 0.0 113.275 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -43.92 -27.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 110.272 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.505 ' O ' HG23 ' C' ' 10' ' ' VAL . 29.7 m-20 -44.16 -34.95 2.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.1 -1.0 . . . . 0.0 109.25 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -83.33 -33.95 25.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.319 -0.863 . . . . 0.0 109.307 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 55.1 m -59.29 -33.41 71.04 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.227 -0.921 . . . . 0.0 109.028 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 9' ' ' ASN . . . . . 0.401 ' CG ' ' HB1' ' C' ' 120' ' ' ALA . 6.5 m120 -74.95 -32.65 61.78 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.505 HG23 ' O ' ' C' ' 6' ' ' ASP . 53.6 t -76.05 -51.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 11' ' ' LYS . . . . . 0.507 ' HE2' HG13 ' C' ' 70' ' ' VAL . 1.1 mptm? -57.0 -34.01 67.72 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.2 -59.67 5.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.521 -0.737 . . . . 0.0 109.314 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.768 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -53.2 -34.43 56.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.383 -0.823 . . . . 0.0 109.109 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -17.64 61.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.308 -0.87 . . . . 0.0 109.263 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.17 -44.75 9.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -70.06 -38.29 75.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.168 -1.195 . . . . 0.0 108.89 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.768 HG23 ' O ' ' C' ' 13' ' ' ALA . 95.6 t -61.35 -64.93 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.552 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 53.94 -130.56 43.67 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.15 26.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.42 -1.047 . . . . 0.0 110.453 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.552 ' H ' ' C ' ' C' ' 18' ' ' GLY . 93.2 m-70 -130.59 24.07 5.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.95 -59.52 2.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.627 -0.67 . . . . 0.0 109.735 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -14.31 0.23 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' C' ' 21' ' ' ALA . 9.7 mt-10 -88.05 -56.6 3.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.139 . . . . 0.0 109.74 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.8 m-30 -57.4 -39.54 76.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.066 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.53 -23.05 53.83 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.4 -57.99 2.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.286 -1.126 . . . . 0.0 109.774 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' GLU . . . . . 0.526 ' OE1' ' NE2' ' C' ' 112' ' ' HIS . 72.7 mt-10 -50.18 -19.88 0.88 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.29 -21.64 63.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.494 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.615 HD21 ' CE1' ' C' ' 58' ' ' HIS . 9.1 mt -73.12 -56.49 5.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.571 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -43.79 -37.15 2.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.827 . . . . 0.0 109.773 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -48.71 78.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 61.0 ttp -83.97 -42.87 15.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' PHE . . . . . 0.594 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 26.2 m-85 -64.17 -32.71 74.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.908 . . . . 0.0 110.239 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' C' ' 33' ' ' PHE . 5.7 mt -45.66 -43.07 12.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.966 -1.083 . . . . 0.0 109.658 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.57 ' O ' ' C ' ' C' ' 36' ' ' PHE . 14.9 m -86.66 -15.67 38.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -0.9 . . . . 0.0 109.367 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.594 ' CD2' ' O ' ' C' ' 33' ' ' PHE . 0.2 OUTLIER 19.17 64.46 0.24 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.917 -0.489 . . . . 0.0 111.354 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.436 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 85.4 Cg_endo -93.68 -62.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.571 2.181 . . . . 0.0 112.551 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.719 ' O ' HG22 ' C' ' 41' ' ' THR . 3.4 p -91.45 -18.48 24.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 109.754 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -81.72 -23.08 36.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.15 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -68.25 -34.96 77.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.087 -1.008 . . . . 0.0 109.67 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.719 HG22 ' O ' ' C' ' 38' ' ' THR . 13.9 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 22.0 p80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.776 0.322 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' C' ' 55' ' ' VAL . 0.7 OUTLIER -155.86 28.54 0.37 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.76 -1.212 . . . . 0.0 110.406 178.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' C' ' 46' ' ' PHE . 7.3 m-20 33.41 81.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.663 -0.648 . . . . 0.0 110.295 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.862 HD23 ' H ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -60.06 -21.35 61.33 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.462 -0.774 . . . . 0.0 109.356 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 20.9 t -47.54 149.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.614 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 2.0 t60 -74.81 151.08 39.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' GLY . . . . . 0.584 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 82.26 4.64 90.13 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.667 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 12.0 p -77.42 -19.81 55.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -1.11 . . . . 0.0 109.482 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 75.8 -16.99 0.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.367 -0.833 . . . . 0.0 109.888 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -86.1 -21.56 27.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.903 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.511 HG22 ' CE2' ' C' ' 46' ' ' PHE . 18.6 t -83.93 -28.42 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.062 -1.024 . . . . 0.0 109.901 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -77.96 -30.37 50.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.013 -1.055 . . . . 0.0 108.961 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' GLY . . . . . 0.512 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -66.68 -26.44 72.97 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.615 ' CE1' HD21 ' C' ' 29' ' ' LEU . 8.2 t-80 -75.41 -34.77 61.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.122 -1.222 . . . . 0.0 109.671 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.1 44.32 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -51.66 -23.42 4.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -1.077 . . . . 0.0 109.887 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' C' ' 57' ' ' GLY . 0.8 OUTLIER -74.54 -42.4 58.9 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.157 -0.965 . . . . 0.0 109.103 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -72.54 -45.23 59.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 108.98 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.85 -27.66 66.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.279 -0.888 . . . . 0.0 109.156 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -72.3 -34.01 67.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 108.866 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.86 -52.1 47.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.01 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' C' ' 128' ' ' PHE . 9.2 mt -59.15 -42.8 91.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.912 . . . . 0.0 108.634 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -69.42 -50.13 48.65 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.282 -0.886 . . . . 0.0 108.695 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -59.01 -24.86 63.17 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.86 -45.64 13.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.507 HG13 ' HE2' ' C' ' 11' ' ' LYS . 4.9 t -63.65 -23.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.21 -22.86 63.5 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' C' ' 74' ' ' ASP . 90.8 m-70 -147.24 -51.87 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.357 -0.839 . . . . 0.0 109.56 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.3 p 44.42 13.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.856 0.836 . . . . 0.0 109.539 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' C' ' 72' ' ' HIS . 17.8 t70 -133.12 9.76 4.13 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.434 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 34.1 t70 -175.4 27.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.897 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.689 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 13.8 ptt? -78.64 -22.62 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.478 -0.764 . . . . 0.0 111.865 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.6 Cg_exo -53.46 -20.69 16.36 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.586 1.524 . . . . 0.0 112.276 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -94.21 -35.42 12.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 109.738 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.03 -47.58 61.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 0.0 109.32 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -77.45 5.69 8.38 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.112 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 64.4 p -54.74 -24.67 23.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -73.95 -55.15 6.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.579 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.47 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 4.7 mt -47.75 -48.07 30.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.385 -0.822 . . . . 0.0 108.821 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -59.32 -22.63 61.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.49 -0.756 . . . . 0.0 109.315 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' C' ' 89' ' ' HIS . 16.5 t70 -81.9 -46.53 13.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.24 -26.82 65.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 87' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 11.4 m80 -81.34 -21.74 38.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.166 -0.959 . . . . 0.0 109.783 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' C' ' 90' ' ' LYS . . . -118.98 -55.51 2.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.313 -0.867 . . . . 0.0 109.773 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 89' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' C' ' 85' ' ' ASP . 13.2 t-80 -71.26 17.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.813 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.618 ' C ' ' H ' ' C' ' 92' ' ' ARG . 9.8 ttmm -166.53 149.02 6.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -0.998 . . . . 0.0 109.728 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.7 mt 61.79 -12.47 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.893 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 92' ' ' ARG . . . . . 1.005 ' HD2' ' HG2' ' B' ' 40' ' ' ARG . 45.7 mmt-85 45.05 16.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.73 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' C' ' 91' ' ' LEU . 12.0 p -57.73 130.97 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 1.034 ' OD1' ' NH1' ' B' ' 40' ' ' ARG . 0.8 OUTLIER -75.31 146.99 82.24 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' C' ' 97' ' ' ASN . 58.0 Cg_endo -72.63 -23.82 19.27 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.436 2.091 . . . . 0.0 112.153 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.458 ' H ' HG23 ' C' ' 96' ' ' VAL . 5.6 t -48.95 -10.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.796 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' C' ' 95' ' ' PRO . 12.1 m-20 -79.21 -24.73 42.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 109.518 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 98' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' C' ' 99' ' ' LYS . 0.6 OUTLIER -54.27 -30.1 49.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 109.497 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.419 ' N ' ' CD1' ' C' ' 98' ' ' PHE . 92.3 mttt -54.25 -26.61 29.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.461 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.67 ' N ' HD12 ' C' ' 100' ' ' LEU . 8.1 mp -84.18 -57.31 3.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 7.2 tp -50.93 -27.3 7.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 109.534 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 6.1 m -66.23 -58.55 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 0.0 109.551 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -63.39 -26.61 68.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.68 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 73.4 m -58.15 -55.94 28.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.627 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mt -47.86 -37.98 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 109.541 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.571 ' N ' HD12 ' C' ' 106' ' ' LEU . 7.7 mp -71.09 -41.99 69.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.99 -24.93 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.376 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 22.5 m -80.85 -63.2 1.46 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.442 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' C' ' 113' ' ' LEU . 34.4 mt -46.97 -28.35 1.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.18 90.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 110.044 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.69 63.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.386 -0.821 . . . . 0.0 110.027 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 112' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' C' ' 27' ' ' GLU . 28.1 m170 -93.16 -80.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.107 -0.995 . . . . 0.0 109.697 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.853 ' O ' HD23 ' C' ' 113' ' ' LEU . 0.1 OUTLIER -107.83 102.7 46.58 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -43.8 173.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.626 2.217 . . . . 0.0 113.504 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -87.19 -35.43 18.58 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.684 0.754 . . . . 0.0 109.482 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 13.2 mt-10 81.34 1.28 1.62 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 1.194 ' CD1' ' NH2' ' D' ' 30' ' ' ARG . 11.1 m-85 58.55 40.8 23.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.895 -0.503 . . . . 0.0 111.255 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.754 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -88.05 118.69 69.91 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.703 -1.248 . . . . 0.0 108.068 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 119' ' ' PRO . . . . . 0.603 ' HA ' HG21 ' D' ' 33' ' ' VAL . 54.0 Cg_exo -49.05 18.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.293 1.995 . . . . 0.0 112.662 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.754 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -139.99 -39.23 0.45 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.077 -1.015 . . . . 0.0 110.057 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.575 HG13 ' N ' ' C' ' 122' ' ' HIS . 4.2 p -51.8 -48.33 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.103 -0.998 . . . . 0.0 109.952 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.575 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.9 m-70 -62.91 -54.32 40.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.399 -0.813 . . . . 0.0 109.259 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.81 -19.69 60.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.307 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 1.1 p -60.79 -61.5 2.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.345 -0.847 . . . . 0.0 110.303 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.535 ' N ' ' OG ' ' C' ' 124' ' ' SER . 6.4 mt -80.72 -21.04 41.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.089 -1.007 . . . . 0.0 110.05 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -78.51 -40.67 34.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 110.092 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.29 -41.3 11.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.987 -1.07 . . . . 0.0 110.097 -179.508 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.527 ' HA ' HD11 ' C' ' 2' ' ' LEU . 31.9 t80 -50.51 -20.59 1.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.8 -1.187 . . . . 0.0 108.841 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' C' ' 133' ' ' SER . 11.9 mt -72.53 -17.79 61.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.46 -38.1 76.85 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 60.8 p -79.46 -36.24 39.11 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.318 -0.864 . . . . 0.0 108.749 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.02 -27.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.218 -0.927 . . . . 0.0 108.638 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.587 ' N ' ' O ' ' C' ' 129' ' ' LEU . 96.8 p -78.32 -45.96 21.32 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.384 -0.822 . . . . 0.0 109.159 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 94.8 m -67.78 -22.99 65.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.258 -0.902 . . . . 0.0 108.705 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.77 -30.04 7.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -34.6 67.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.393 -0.817 . . . . 0.0 109.056 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 137' ' ' THR . . . . . 0.44 ' O ' ' O ' ' C' ' 138' ' ' SER . 81.1 p -92.32 -29.56 16.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.573 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 138' ' ' SER . . . . . 0.44 ' O ' ' O ' ' C' ' 137' ' ' THR . 3.5 t . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.832 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -140.84 145.18 35.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.164 -0.96 . . . . 0.0 109.059 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 7.9 p -69.6 148.83 96.95 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.531 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -42.8 -24.78 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.503 2.136 . . . . 0.0 112.229 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -80.79 -53.07 6.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.919 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -60.21 -36.07 76.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 109.989 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.531 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -84.06 -31.52 25.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 110.026 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.08 -23.49 7.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -0.959 . . . . 0.0 110.441 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.5 -58.02 3.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.935 -1.103 . . . . 0.0 110.222 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' D' ' 130' ' ' TYR . 7.7 p -65.55 -24.44 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 25.9 m -78.45 -40.32 36.0 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.317 0.58 . . . . 0.0 109.674 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -26.21 68.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.51 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.73 ' O ' HG23 ' D' ' 18' ' ' VAL . 0.9 OUTLIER -62.52 -26.84 68.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.329 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.77 -17.7 64.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.509 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.38 -62.87 3.66 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.494 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.627 ' HD3' HD23 ' D' ' 14' ' ' LEU . 0.0 OUTLIER -78.79 7.16 7.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.285 . . . . 0.0 110.849 -178.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.73 HG23 ' O ' ' D' ' 14' ' ' LEU . 2.3 t -75.73 121.39 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.742 -1.224 . . . . 0.0 109.138 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 19' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -81.42 85.21 6.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.212 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 36.5 t -55.97 -20.39 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.608 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' D' ' 22' ' ' GLU . 1.0 OUTLIER -57.32 -55.81 29.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.366 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' D' ' 21' ' ' ASP . 43.1 mt-10 -98.9 -44.31 6.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.66 -23.89 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.619 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.24 -43.11 10.93 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.87 -25.93 61.44 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -79.36 -25.56 42.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.213 -1.169 . . . . 0.0 109.674 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.61 -23.17 39.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 109.675 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 tp -85.03 -57.29 3.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 109.479 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.93 -19.92 31.71 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' ARG . . . . . 1.194 ' NH2' ' CD1' ' C' ' 117' ' ' PHE . 47.2 mtt180 -79.29 -27.28 42.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -1.176 . . . . 0.0 109.421 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 39.4 tp -65.68 -24.71 67.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 41.8 mt -78.19 -53.67 7.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.056 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' VAL . . . . . 0.732 HG13 ' H ' ' D' ' 34' ' ' VAL . 7.9 p -71.16 -60.6 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.125 -0.985 . . . . 0.0 110.05 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.732 ' H ' HG13 ' D' ' 33' ' ' VAL . 94.9 t -46.41 -30.41 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.952 -1.093 . . . . 0.0 109.557 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.96 91.25 1.57 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 109.348 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -84.74 30.47 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.731 2.287 . . . . 0.0 112.409 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 -57.16 -28.75 63.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' D' ' 39' ' ' GLN . 30.5 p -56.07 -77.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.379 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 39' ' ' GLN . . . . . 0.542 ' N ' ' OG1' ' D' ' 38' ' ' THR . 14.7 tt0 50.6 46.09 26.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 109.577 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 40' ' ' ARG . . . . . 1.08 ' NH1' ' OD1' ' A' ' 94' ' ' ASP . 69.3 mtm180 -147.97 -49.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' D' ' 43' ' ' GLU . 1.3 p90 -96.76 -21.24 17.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -48.86 -11.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.565 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' D' ' 41' ' ' PHE . 31.3 mt-10 -80.31 -20.3 44.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 44' ' ' SER . . . . . 0.471 ' O ' ' N ' ' D' ' 46' ' ' GLY . 11.3 t -58.2 -51.94 67.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.581 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' D' ' 47' ' ' ASP . 56.8 m-85 -47.75 -16.27 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.515 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 61.38 -77.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' D' ' 45' ' ' PHE . 0.9 OUTLIER -46.74 113.49 0.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -1.133 . . . . 0.0 109.607 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 48' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' D' ' 49' ' ' SER . 0.8 OUTLIER -161.22 22.18 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 108.971 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' D' ' 48' ' ' LEU . 17.8 m -45.06 -39.77 6.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 109.585 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -145.53 151.94 48.16 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.855 . . . . 0.0 109.056 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -44.61 -21.85 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.241 1.96 . . . . 0.0 112.16 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -83.81 -29.18 27.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 109.594 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.94 45.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.655 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.51 -62.04 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.577 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 14.9 mmt -53.62 -17.0 1.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.556 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.27 -4.16 61.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 57' ' ' ASN . . . . . 0.433 HD21 ' HB3' ' D' ' 45' ' ' PHE . 64.8 m-20 -72.27 142.79 85.0 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.321 -1.105 . . . . 0.0 109.313 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.55 -52.11 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.515 2.144 . . . . 0.0 112.152 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -51.66 -47.96 63.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.624 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 95.5 t -47.51 -27.47 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -79.14 -53.52 6.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.68 -59.03 3.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.567 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -49.0 -24.03 1.36 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.933 . . . . 0.0 109.587 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.59 -37.66 92.71 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 65' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' D' ' 69' ' ' GLY . 27.8 mttp -71.67 -35.42 70.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -1.197 . . . . 0.0 109.519 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -49.35 -44.82 44.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 109.235 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 54.3 t -73.66 -61.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -0.869 . . . . 0.0 109.212 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.72 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.8 tt -50.44 -23.35 2.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.155 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 69' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' D' ' 65' ' ' LYS . . . -66.23 -57.08 11.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.81 97.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.203 -1.174 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 71' ' ' PHE . . . . . 0.552 ' CZ ' HG11 ' D' ' 134' ' ' VAL . 0.1 OUTLIER -48.89 -21.73 0.71 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.314 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p -88.05 -34.86 17.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.57 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -46.35 -34.49 4.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.893 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.52 -58.91 6.05 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.531 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.5 mp -62.76 -23.48 67.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.175 -1.191 . . . . 0.0 109.26 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.35 2.32 54.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 109.454 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' D' ' 79' ' ' ASP . 55.9 t60 -170.95 65.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.79 13.3 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.304 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' D' ' 77' ' ' HIS . 34.7 t70 -76.46 -27.64 56.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -170.93 106.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.22 -44.09 20.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 82' ' ' LYS . . . . . 0.431 ' CD ' ' H ' ' D' ' 82' ' ' LYS . 1.5 mptp? -49.36 -25.89 2.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.469 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.18 -53.79 3.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 84' ' ' THR . . . . . . . . . . . . . 3.8 p -65.83 -37.63 86.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -1.144 . . . . 0.0 109.596 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 85' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -90.9 24.02 2.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.665 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.29 -41.58 40.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.337 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 21.2 p -72.79 -50.83 21.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 109.491 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.82 -48.94 76.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.352 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 27.7 t -61.48 -44.03 97.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.44 -23.75 67.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 7.4 tp -85.12 -68.78 0.7 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.842 . . . . 0.0 109.421 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -49.52 -30.14 7.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 93' ' ' CYS . . . . . 0.587 ' SG ' ' CD1' ' D' ' 145' ' ' TYR . 38.0 t -83.88 -55.55 4.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 111.633 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.543 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 0.6 OUTLIER -86.39 -29.07 23.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.957 -1.09 . . . . 0.0 112.161 -177.399 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 95' ' ' LYS . . . . . 0.447 ' C ' HD22 ' D' ' 96' ' ' LEU . 5.6 mptp? -90.34 -52.07 5.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.619 -1.301 . . . . 0.0 111.043 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.531 ' N ' HD22 ' D' ' 96' ' ' LEU . 3.7 mm? -97.53 -22.85 16.3 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.787 -1.196 . . . . 0.0 110.241 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.668 ' O ' HG22 ' A' ' 38' ' ' THR . 81.9 m-70 51.07 37.59 18.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.019 -1.05 . . . . 0.0 109.473 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 44.5 t -55.04 138.78 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.345 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.93 151.24 3.43 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.7 30.6 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.568 2.179 . . . . 0.0 112.086 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -143.46 75.88 1.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 109.349 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -168.27 -40.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -52.54 -45.79 66.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 104' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 55.3 ttp180 -66.16 -42.39 89.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 105' ' ' LEU . . . . . 0.594 ' N ' HD12 ' D' ' 105' ' ' LEU . 10.1 mp -54.45 -57.43 11.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.442 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.691 HD23 ' C ' ' D' ' 106' ' ' LEU . 7.5 tt -52.13 -49.02 64.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.17 -0.956 . . . . 0.0 109.467 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -59.0 -22.37 55.01 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 108' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 27.4 m120 -80.66 -15.56 56.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.107 -1.231 . . . . 0.0 109.786 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 63.5 t -85.08 -44.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 109.65 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 110' ' ' LEU . . . . . 0.517 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.7 tt -47.98 -54.24 13.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 111' ' ' VAL . . . . . 0.452 HG23 ' H ' ' D' ' 111' ' ' VAL . 3.4 t -45.5 -32.69 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.955 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 112' ' ' CYS . . . . . 0.52 ' O ' ' ND1' ' D' ' 116' ' ' HIS . 46.3 m -77.3 -36.86 53.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.76 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.94 -46.45 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.767 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 19.0 mt -66.77 -30.42 70.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.794 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.458 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -61.22 -29.42 69.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.97 . . . . 0.0 109.575 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' D' ' 112' ' ' CYS . 68.8 m80 -84.74 -63.0 1.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.071 -1.018 . . . . 0.0 109.685 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 117' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 1.0 OUTLIER -65.38 -18.4 65.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 109.581 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 40.6 m-85 -144.45 55.44 1.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.529 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -68.62 -21.42 74.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -76.03 -35.19 59.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -1.118 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' D' ' 123' ' ' THR . 59.0 mm-40 -75.33 3.04 9.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.537 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -72.24 35.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.334 -0.854 . . . . 0.0 109.545 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.549 ' OG1' HG23 ' D' ' 126' ' ' VAL . 4.8 p -47.15 147.35 2.53 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.955 . . . . 0.0 109.393 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.499 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.2 Cg_exo -48.38 -51.29 10.45 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.366 2.044 . . . . 0.0 113.202 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 41.6 Cg_endo -68.0 -1.0 6.22 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.06 1.84 . . . . 0.0 112.748 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.549 HG23 ' OG1' ' D' ' 123' ' ' THR . 40.0 t -99.09 -12.52 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.174 -0.954 . . . . 0.0 109.607 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.25 -60.23 2.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 109.507 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.518 ' O ' ' NZ ' ' D' ' 132' ' ' LYS . . . -67.05 -25.79 66.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.37 18.06 2.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.356 -0.84 . . . . 0.0 109.621 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.45 ' CD2' HG23 ' D' ' 11' ' ' VAL . 6.2 t80 -107.83 -61.39 1.58 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.341 -0.85 . . . . 0.0 109.617 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 53.6 tt0 -46.4 -48.17 18.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.957 . . . . 0.0 109.724 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 132' ' ' LYS . . . . . 0.775 ' HG2' ' OXT' ' B' ' 146' ' ' HIS . 33.0 mtmm -52.65 -21.87 4.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.863 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 25.7 t -74.39 -67.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -0.949 . . . . 0.0 109.661 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.552 HG11 ' CZ ' ' D' ' 71' ' ' PHE . 31.4 m -73.5 -15.77 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.883 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.867 ' HB1' ' CG ' ' B' ' 146' ' ' HIS . . . -47.34 -29.0 2.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.23 -22.82 58.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 137' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' D' ' 134' ' ' VAL . 81.0 t -82.18 -26.95 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -1.133 . . . . 0.0 109.547 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.84 -47.96 83.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.93 . . . . 0.0 109.615 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 139' ' ' ASN . . . . . 0.783 ' OD1' ' OD1' ' B' ' 139' ' ' ASN . 64.2 m-80 -79.62 -26.02 41.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.65 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.2 78.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.676 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 21.9 mt -82.68 16.41 2.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.651 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.75 -0.85 1.88 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.213 -0.929 . . . . 0.0 109.729 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -80.27 -28.24 38.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.778 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -70.91 -16.62 62.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.985 . . . . 0.0 109.465 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 145' ' ' TYR . . . . . 0.587 ' CD1' ' SG ' ' D' ' 93' ' ' CYS . 13.9 m-85 -64.66 -28.82 69.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.383 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.906 ' CG ' ' HB1' ' B' ' 135' ' ' ALA . 20.9 m-70 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.428 ' CG2' ' OG ' ' A' ' 131' ' ' SER . 16.8 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.438 HD13 ' CD1' ' A' ' 128' ' ' PHE . 25.0 mt -136.9 -161.01 1.11 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 0.0 109.354 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.453 ' N ' ' OD2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -133.15 174.43 4.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.332 -0.855 . . . . 0.0 109.285 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.23 -70.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.629 2.219 . . . . 0.0 112.689 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -48.54 -44.14 36.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.109 -0.995 . . . . 0.0 109.903 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 10' ' ' VAL . 1.3 m-20 -42.36 -35.76 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 10' ' ' VAL . 69.6 mttt -83.32 -56.43 3.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.32 -0.862 . . . . 0.0 109.524 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 94.5 m -45.43 -35.58 3.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 109.865 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.69 -33.49 62.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.01 -1.057 . . . . 0.0 108.15 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 6' ' ' ASP . 75.4 t -76.22 -49.37 25.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.45 -40.08 64.93 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.89 -61.64 2.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.516 -0.74 . . . . 0.0 109.462 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.64 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.6 -38.5 66.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.381 -0.824 . . . . 0.0 109.137 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.47 -17.44 62.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.24 -0.912 . . . . 0.0 109.008 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.58 -46.62 7.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -68.69 -36.76 78.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -1.163 . . . . 0.0 108.842 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 13' ' ' ALA . 70.5 t -62.0 -66.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 61.85 -141.08 47.3 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.17 39.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.493 -1.004 . . . . 0.0 110.355 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' GLY . 87.6 m-70 -142.94 20.34 1.96 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.63 -61.28 1.92 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.652 -0.655 . . . . 0.0 109.583 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.65 -13.91 0.19 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 21' ' ' ALA . 10.2 mm-40 -84.99 -56.33 3.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -1.102 . . . . 0.0 109.613 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.8 m-30 -61.69 -30.88 71.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 109.254 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.44 74.88 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -75.48 -40.41 57.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -1.198 . . . . 0.0 109.669 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -56.96 -20.75 25.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.325 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.57 72.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.88 . . . . 0.0 109.483 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.865 HD11 ' CG ' ' A' ' 58' ' ' HIS . 78.4 mt -64.41 -61.17 2.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.63 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.01 -12.66 12.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.631 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.518 ' NH2' ' CB ' ' B' ' 127' ' ' GLN . 6.2 tpm_? -74.35 -53.34 9.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -84.18 -28.74 27.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.918 . . . . 0.0 110.084 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -46.37 -37.77 7.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 110.042 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.747 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -96.61 -36.92 10.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 110.268 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.8 m -44.43 -25.88 0.29 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 110.028 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.551 ' CG ' ' O ' ' A' ' 35' ' ' SER . 50.9 m-85 -162.46 139.11 5.97 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.169 -0.957 . . . . 0.0 109.287 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 40' ' ' LYS . 55.9 Cg_endo -71.98 -34.02 9.02 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.596 2.197 . . . . 0.0 111.984 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.965 ' HA ' ' HB3' ' D' ' 97' ' ' HIS . 76.6 p -47.51 -18.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 109.509 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 37' ' ' PRO . 25.7 p -84.85 -27.99 26.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 109.446 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 37' ' ' PRO . 82.7 mttt -71.43 -25.3 62.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.676 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 38' ' ' THR . 15.1 t . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.169 -0.957 . . . . 0.0 109.529 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.566 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 14.9 p80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.13 0.491 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -144.95 25.45 1.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.49 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.453 ' C ' ' N ' ' A' ' 49' ' ' SER . 2.4 m-20 43.97 84.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.463 -0.773 . . . . 0.0 109.791 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.675 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -51.82 -11.36 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.453 ' N ' ' C ' ' A' ' 47' ' ' ASP . 28.3 p -49.01 158.48 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -77.47 148.24 35.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.455 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.24 16.92 78.94 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 54.6 p -74.42 -17.06 60.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -1.154 . . . . 0.0 109.485 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.41 -39.54 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.338 -0.851 . . . . 0.0 109.641 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 52' ' ' SER . 56.6 mt-30 -65.87 -42.11 90.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.45 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.551 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 93.5 t -66.4 -44.67 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.298 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -39.4 67.0 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.15 -26.58 72.5 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.865 ' CG ' HD11 ' A' ' 29' ' ' LEU . 4.5 t-80 -68.15 -43.29 78.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -1.218 . . . . 0.0 109.317 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.75 -46.07 24.66 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -48.52 -23.66 1.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -1.047 . . . . 0.0 109.268 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -75.41 -38.94 59.56 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.283 -0.886 . . . . 0.0 108.672 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.49 -48.95 44.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.29 -32.86 74.74 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 109.083 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 68' ' ' ASN . 5.8 t0 -63.74 -36.49 84.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.238 -0.914 . . . . 0.0 108.626 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.55 -52.77 34.86 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.01 -41.01 91.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.4 m -71.87 -50.2 31.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' ASP . 49.4 t30 -60.16 -24.3 64.62 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.616 ' HB1' ' SD ' ' A' ' 76' ' ' MET . . . -82.29 -46.69 13.31 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.11 -22.97 32.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.4 -14.92 63.34 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.606 ' O ' ' N ' ' A' ' 74' ' ' ASP . 35.5 m-70 -138.36 -62.97 0.56 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.517 -0.739 . . . . 0.0 109.287 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 73' ' ' VAL . 13.1 p 44.28 14.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.928 0.87 . . . . 0.0 109.37 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 72' ' ' HIS . 39.8 t0 -138.14 11.61 2.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.432 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.0 OUTLIER 174.92 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.246 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.685 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 14.3 ptt? -78.74 -22.68 0.39 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 111.981 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 76' ' ' MET . 59.5 Cg_exo -52.01 -19.67 9.02 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.705 1.603 . . . . 0.0 112.51 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -94.12 -35.76 12.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 109.764 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.96 -38.4 69.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.963 . . . . 0.0 109.285 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.79 11.49 15.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.392 -0.818 . . . . 0.0 109.049 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.3 p -68.08 -15.92 63.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 109.763 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -72.69 -55.8 6.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.031 . . . . 0.0 109.878 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 86' ' ' LEU . 6.1 mt -44.88 -47.26 11.15 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.81 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 62.6 m -46.79 -33.05 4.1 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' ALA . 1.5 m-20 -82.11 -17.32 46.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.188 -0.945 . . . . 0.0 109.558 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 83' ' ' LEU . 8.6 tp -74.06 -53.44 9.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.1 -1.0 . . . . 0.0 110.261 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.435 ' CE1' ' O ' ' A' ' 83' ' ' LEU . 6.0 p-80 -92.2 -21.66 20.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.975 -1.078 . . . . 0.0 110.643 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -97.27 -0.61 46.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.9 -1.125 . . . . 0.0 110.404 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 88' ' ' ALA . 70.9 m80 -154.91 42.94 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.787 -1.195 . . . . 0.0 110.256 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -172.39 -63.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.967 . . . . 0.0 109.329 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.1 mt -90.59 -23.79 20.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 53.99 53.3 11.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.665 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 94' ' ' ASP . 2.3 t -79.87 -136.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 109.447 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 96' ' ' VAL . 5.2 t70 -172.3 137.11 0.89 Allowed Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 109.234 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 98' ' ' PHE . 85.6 Cg_exo -41.86 -10.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.544 2.163 . . . . 0.0 112.639 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 94' ' ' ASP . 60.1 t -43.75 -28.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 109.955 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -79.19 -24.95 42.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 95' ' ' PRO . 38.4 t80 -44.96 -32.47 1.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.913 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.49 -27.22 27.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.007 . . . . 0.0 109.898 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.16 -62.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.036 -1.04 . . . . 0.0 110.024 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.7 tp -55.74 -20.96 16.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 109.878 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.8 p -78.44 -50.37 11.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.051 -1.031 . . . . 0.0 109.843 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -76.4 -26.6 55.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -0.952 . . . . 0.0 109.808 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 55.6 m -58.81 -50.92 72.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.777 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.35 -35.88 13.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 109.63 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.792 HD12 ' CE1' ' A' ' 122' ' ' HIS . 3.7 mm? -69.99 -59.17 3.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.079 -1.013 . . . . 0.0 109.895 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.8 t -50.08 -36.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.478 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 p -70.56 -63.11 1.16 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.264 -0.897 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' LEU . 17.5 mt -50.47 -31.42 15.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 -47.13 50.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.224 -0.923 . . . . 0.0 109.609 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.24 -41.35 22.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.89 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -80.1 -72.08 0.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.115 -0.991 . . . . 0.0 109.986 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -113.87 91.51 22.19 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 109.076 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 113' ' ' LEU . 84.7 Cg_exo -46.22 -175.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.329 2.019 . . . . 0.0 112.84 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.494 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.29 -42.21 13.94 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.636 0.732 . . . . 0.0 109.406 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER 85.0 3.66 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.897 ' CZ ' ' CE1' ' B' ' 116' ' ' HIS . 8.0 m-85 65.12 36.6 7.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.791 -0.568 . . . . 0.0 111.279 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.716 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -91.16 121.51 67.68 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.798 -1.189 . . . . 0.0 108.197 178.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.95 22.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.14 1.893 . . . . 0.0 112.656 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.716 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -151.23 -33.56 0.15 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.772 -1.205 . . . . 0.0 110.785 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.668 HG13 ' N ' ' A' ' 122' ' ' HIS . 11.4 p -46.63 -47.84 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.932 -1.105 . . . . 0.0 110.061 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.792 ' CE1' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -72.78 -33.51 66.34 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.555 -0.716 . . . . 0.0 109.349 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.06 -19.81 36.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 110.023 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 120' ' ' ALA . 10.2 p -65.95 -62.47 1.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.202 -0.936 . . . . 0.0 110.84 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.513 ' N ' ' OG ' ' A' ' 124' ' ' SER . 9.3 mt -70.18 -19.42 63.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.07 -1.019 . . . . 0.0 109.789 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -78.93 -45.43 20.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.046 -1.034 . . . . 0.0 110.219 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.445 ' CD ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -88.23 -43.24 11.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.988 -1.07 . . . . 0.0 110.14 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 10' ' ' VAL . 70.2 t80 -50.17 -21.02 1.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.957 -1.089 . . . . 0.0 109.271 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.4 mt -69.73 -17.7 63.47 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.25 -33.51 72.4 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.492 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 5.1 t -83.08 -30.41 28.0 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.417 -0.802 . . . . 0.0 108.992 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.5 t -85.41 -27.63 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 109.078 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 129' ' ' LEU . 77.9 p -83.75 -25.97 30.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.119 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.9 m -78.09 -36.94 47.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.213 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 131' ' ' SER . 33.3 m -76.57 -21.86 15.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.266 -0.896 . . . . 0.0 108.883 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.48 -37.87 68.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.451 -0.781 . . . . 0.0 108.985 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.5 p -89.14 -1.38 58.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.594 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.428 -179.889 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' HIS . . . . . 0.415 ' O ' ' CG ' ' B' ' 2' ' ' HIS . 12.3 t-80 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 1.046 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -106.29 162.45 13.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.433 -0.792 . . . . 0.0 109.261 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.434 ' O ' ' N ' ' B' ' 7' ' ' GLU . 0.7 OUTLIER -84.61 150.93 57.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 109.109 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.01 -30.73 1.32 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.434 2.089 . . . . 0.0 112.026 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.36 -21.84 25.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.925 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 4' ' ' THR . 44.5 tt0 -77.11 -63.09 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.174 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.506 ' HB3' HD22 ' B' ' 3' ' ' LEU . 10.4 pttt -67.53 -25.73 65.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.963 . . . . 0.0 110.175 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -43.8 -24.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 110.134 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.18 -56.23 3.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.087 -1.008 . . . . 0.0 109.751 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.404 ' H ' HG12 ' B' ' 11' ' ' VAL . 0.9 OUTLIER -71.04 -24.74 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.7 m -68.35 -39.12 81.98 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.351 0.596 . . . . 0.0 109.805 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.4 -31.23 57.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.847 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.3 -21.86 6.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.341 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' TRP . . . . . 0.557 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.2 OUTLIER -56.31 -38.27 71.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 109.234 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.21 -40.26 61.48 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -26.19 66.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -1.143 . . . . 0.0 109.178 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.16 121.0 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 109.666 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' B' ' 21' ' ' ASP . 10.2 t-20 -80.04 71.83 6.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.0 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 82.8 t -45.89 -15.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 109.779 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 19' ' ' ASN . 34.8 m-20 -69.22 -4.09 16.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.624 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' B' ' 25' ' ' GLY . 47.9 mt-10 -155.79 -46.9 0.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.156 -0.965 . . . . 0.0 109.574 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -47.11 -23.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 109.723 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.95 -31.15 40.28 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -73.55 -39.52 49.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -70.24 -38.86 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 0.0 109.486 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.07 -30.25 61.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.556 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tp -81.47 -58.04 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.482 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.71 85.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -55.93 -39.35 71.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -1.126 . . . . 0.0 109.62 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.61 -35.98 4.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -81.19 -29.91 34.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 109.752 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.03 -64.48 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.425 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 34' ' ' VAL . 0.0 OUTLIER -63.97 -22.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.224 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -149.62 81.92 6.97 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.92 . . . . 0.0 109.562 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.95 9.85 3.15 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.562 2.175 . . . . 0.0 112.23 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' B' ' 38' ' ' THR . 0.4 OUTLIER -80.96 -19.96 42.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 109.694 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.554 ' N ' ' CD1' ' B' ' 37' ' ' TRP . 7.2 m -87.95 57.94 4.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.479 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -117.61 23.82 11.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.41 -0.807 . . . . 0.0 109.332 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -87.34 -39.76 15.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.958 . . . . 0.0 109.554 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -100.01 34.82 2.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 109.463 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' CE1' ' B' ' 45' ' ' PHE . 0.9 OUTLIER -143.32 15.04 1.84 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.222 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.49 -14.09 61.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.408 ' C ' ' N ' ' B' ' 46' ' ' GLY . 5.3 m -69.14 -46.92 66.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.477 ' CE1' ' CD2' ' B' ' 42' ' ' PHE . 80.1 m-85 -50.17 -16.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 45' ' ' PHE . . . 51.3 179.61 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 38.0 t0 55.86 71.28 0.56 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -1.178 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 27.9 mt -131.21 35.05 3.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 109.379 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m -51.89 -49.29 63.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.27 160.17 46.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 108.837 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.4 -17.32 4.14 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.079 1.853 . . . . 0.0 111.972 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.418 ' C ' ' N ' ' B' ' 54' ' ' VAL . 19.6 t70 -83.26 -51.56 7.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.556 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.95 -20.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.431 -0.793 . . . . 0.0 109.471 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.418 ' N ' ' C ' ' B' ' 52' ' ' ASP . 57.8 t -73.01 -57.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mtt -59.98 -16.73 32.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.53 -26.62 71.29 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -78.79 132.22 65.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.152 -1.205 . . . . 0.0 109.327 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.02 -30.89 4.09 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.341 2.028 . . . . 0.0 112.34 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -70.41 -30.13 66.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.85 -40.68 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.516 ' NZ ' ' CB ' ' B' ' 61' ' ' LYS . 8.1 mtmp? -65.45 -37.43 86.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 109.68 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.96 -51.04 67.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -55.82 -23.79 32.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.01 -48.94 65.33 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -52.29 -25.03 8.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -1.188 . . . . 0.0 109.587 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -61.94 1.7 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 109.491 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 t -52.18 -39.33 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.684 HD23 ' O ' ' B' ' 68' ' ' LEU . 8.0 tt -70.16 -37.41 75.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.903 . . . . 0.0 109.343 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.89 -44.08 61.25 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.53 71.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 109.787 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' PHE . . . . . 0.418 ' O ' ' CD2' ' B' ' 75' ' ' LEU . 1.3 m-85 -66.3 -29.1 69.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' SER . . . . . 0.557 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.8 t -66.21 -33.77 76.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.515 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.17 -16.76 56.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.173 -0.954 . . . . 0.0 109.159 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.67 -19.76 63.15 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.838 ' N ' HD23 ' B' ' 75' ' ' LEU . 1.5 pt? -137.78 -28.44 0.89 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -1.181 . . . . 0.0 109.952 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' B' ' 72' ' ' SER . . . -80.1 19.02 0.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 109.586 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -171.55 70.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.465 HD21 ' HA ' ' B' ' 75' ' ' LEU . 70.5 mt -80.85 0.72 33.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.975 . . . . 0.0 109.492 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -54.04 -38.33 65.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -172.09 73.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.361 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.448 HD12 ' N ' ' B' ' 82' ' ' LYS . 2.2 pp -76.74 -41.73 43.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.628 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.448 ' N ' HD12 ' B' ' 81' ' ' LEU . 53.1 mttp -50.82 -27.2 6.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.096 -1.002 . . . . 0.0 109.41 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' B' ' 86' ' ' ALA . . . -83.19 -57.54 2.48 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.6 OUTLIER -47.86 -39.71 19.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -1.164 . . . . 0.0 109.557 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.459 ' CZ ' HG13 ' B' ' 137' ' ' VAL . 25.1 m-85 -69.83 -11.96 61.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.382 -0.824 . . . . 0.0 109.429 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' B' ' 83' ' ' GLY . . . -54.57 -43.72 72.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.438 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 11.4 p -64.38 -59.24 4.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' B' ' 88' ' ' LEU . 19.5 mt -54.97 -35.39 64.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.349 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -72.76 -46.43 53.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.337 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.54 -24.54 67.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.42 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.19 -68.36 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.557 ' O ' ' N ' ' B' ' 97' ' ' HIS . 75.1 m80 -54.35 -25.83 26.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 110.491 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.89 -60.66 2.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.013 -1.054 . . . . 0.0 111.501 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.561 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 11.8 m-20 -86.99 -39.75 15.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.92 -1.112 . . . . 0.0 111.701 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -83.17 -10.15 58.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.078 . . . . 0.0 111.07 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.519 ' O ' HD13 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -137.9 -43.78 0.52 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.886 -1.134 . . . . 0.0 110.068 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.92 ' HB3' ' HA ' ' C' ' 38' ' ' THR . 4.1 m80 72.95 58.57 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.246 -0.909 . . . . 0.0 109.575 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 79.1 t -82.64 114.21 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.09 -1.006 . . . . 0.0 109.434 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.74 154.45 2.37 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.27 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.402 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 47.2 Cg_endo -70.09 -164.3 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.573 2.182 . . . . 0.0 112.149 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 53.31 51.97 14.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' B' ' 100' ' ' PRO . 31.0 m120 -158.25 -36.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.24 -37.57 85.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -72.94 -26.39 61.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.483 ' O ' HD23 ' B' ' 105' ' ' LEU . 1.3 tt -65.62 -55.49 17.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.402 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 tt -50.37 -47.0 56.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.24 -47.88 72.07 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.51 -50.29 65.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -1.161 . . . . 0.0 109.607 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 80.5 t -53.76 -38.5 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.17 -0.956 . . . . 0.0 109.524 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.96 -33.91 76.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.405 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.9 -26.24 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 60.7 m -79.27 -61.04 2.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.731 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' VAL . . . . . 0.407 HG23 ' H ' ' B' ' 113' ' ' VAL . 4.9 t -46.25 -30.0 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 31.9 mt -79.84 -31.45 40.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.601 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -82.26 -20.38 37.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.897 ' CE1' ' CZ ' ' A' ' 117' ' ' PHE . 11.0 t-80 -74.95 -55.73 5.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.531 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -74.46 -17.73 60.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.625 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -146.53 58.96 1.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.436 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -74.83 -21.92 77.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -72.89 -33.73 66.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -1.153 . . . . 0.0 109.433 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' B' ' 123' ' ' THR . 57.7 mm-40 -81.46 -4.52 56.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.8 34.33 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.36 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.468 ' H ' ' C ' ' B' ' 121' ' ' GLU . 28.7 p -48.4 148.45 3.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 109.096 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.507 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.3 Cg_exo -45.28 -52.85 6.04 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.196 1.931 . . . . 0.0 112.779 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 36.4 Cg_endo -65.68 13.67 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.053 1.835 . . . . 0.0 112.324 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.461 HG23 ' OG1' ' B' ' 123' ' ' THR . 90.2 t -124.87 -21.42 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' GLN . . . . . 0.549 HE22 ' CG ' ' B' ' 131' ' ' GLN . 18.2 tm0? -83.15 -42.9 16.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.747 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -62.01 -44.21 97.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.587 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.75 -7.17 25.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.692 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -92.43 -30.12 15.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 109.603 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.549 ' CG ' HE22 ' B' ' 127' ' ' GLN . 15.6 mm100 -81.45 -38.33 26.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.592 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -68.14 -49.43 61.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 109.646 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 2.6 p -58.47 -48.22 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.898 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.567 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 88.8 t -73.38 -34.57 43.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.842 ' CB ' ' O ' ' D' ' 146' ' ' HIS . . . -47.41 -22.28 0.42 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.35 -22.03 61.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.459 HG13 ' CZ ' ' B' ' 85' ' ' PHE . 85.9 t -77.84 -26.09 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -1.154 . . . . 0.0 109.541 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.08 -46.58 61.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -74.69 -21.17 59.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.36 -59.63 3.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.524 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -58.58 -24.9 61.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.23 22.36 4.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -77.25 -31.93 55.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.588 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.449 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 0.1 OUTLIER -79.55 -27.3 41.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.321 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -65.99 3.68 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.799 ' O ' ' CB ' ' D' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.427 ' CG2' ' OG ' ' C' ' 131' ' ' SER . 16.9 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.436 HD13 ' CD1' ' C' ' 128' ' ' PHE . 25.3 mt -136.96 -161.06 1.12 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.317 -0.865 . . . . 0.0 109.364 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.46 ' N ' ' OD2' ' C' ' 6' ' ' ASP . 0.3 OUTLIER -133.22 174.44 4.7 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.848 . . . . 0.0 109.199 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.22 -70.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.65 2.233 . . . . 0.0 112.638 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -48.62 -44.12 36.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.161 -0.962 . . . . 0.0 109.88 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.563 ' O ' HG23 ' C' ' 10' ' ' VAL . 1.3 m-20 -42.33 -35.77 1.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.88 . . . . 0.0 109.44 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' C' ' 10' ' ' VAL . 69.5 mttt -83.32 -56.42 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.827 . . . . 0.0 109.571 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 94.9 m -45.45 -35.62 3.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.406 -0.809 . . . . 0.0 109.906 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.51 -33.5 62.82 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.563 HG23 ' O ' ' C' ' 6' ' ' ASP . 76.2 t -76.37 -49.25 25.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.52 -40.04 65.14 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.95 -61.63 2.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.473 -0.767 . . . . 0.0 109.408 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.644 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.59 -38.51 66.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.842 . . . . 0.0 109.145 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -17.52 62.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 108.959 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.54 -46.71 7.8 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -68.63 -36.79 79.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -1.138 . . . . 0.0 108.828 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.644 HG23 ' O ' ' C' ' 13' ' ' ALA . 71.0 t -61.96 -66.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 61.93 -141.15 47.27 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.07 39.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.476 -1.014 . . . . 0.0 110.36 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' C' ' 18' ' ' GLY . 87.6 m-70 -142.96 20.43 1.96 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.72 -61.15 1.95 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.635 -0.666 . . . . 0.0 109.649 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -13.9 0.2 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' C' ' 21' ' ' ALA . 10.3 mm-40 -85.02 -56.3 3.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -1.172 . . . . 0.0 109.544 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 1.8 m-30 -61.75 -30.91 71.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.852 . . . . 0.0 109.186 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.26 -29.5 75.02 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' C' ' 55' ' ' VAL . . . -75.54 -40.29 57.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -1.179 . . . . 0.0 109.676 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -56.9 -20.83 25.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.342 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -31.58 72.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.905 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.86 HD11 ' CG ' ' C' ' 58' ' ' HIS . 78.4 mt -64.34 -61.3 2.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.57 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.97 -12.7 12.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.93 . . . . 0.0 109.563 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.508 ' NH2' ' CB ' ' D' ' 127' ' ' GLN . 6.2 tpm_? -74.34 -53.27 10.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.133 -0.979 . . . . 0.0 109.818 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -84.22 -28.72 27.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.943 . . . . 0.0 110.101 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -46.37 -37.8 8.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.119 -0.988 . . . . 0.0 110.022 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.76 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -96.57 -36.95 10.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.204 -0.935 . . . . 0.0 110.3 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.7 m -44.4 -25.91 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' C' ' 35' ' ' SER . 51.1 m-85 -162.44 139.11 5.99 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.114 -0.992 . . . . 0.0 109.286 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' C' ' 40' ' ' LYS . 56.0 Cg_endo -71.96 -34.15 8.89 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.647 2.231 . . . . 0.0 111.986 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.92 ' HA ' ' HB3' ' B' ' 97' ' ' HIS . 76.7 p -47.42 -18.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.437 ' N ' ' O ' ' C' ' 37' ' ' PRO . 25.8 p -84.9 -28.04 26.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' C' ' 37' ' ' PRO . 82.7 mttt -71.42 -25.3 62.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.908 . . . . 0.0 109.702 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.653 HG22 ' O ' ' C' ' 38' ' ' THR . 15.1 t . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 109.466 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.564 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 14.8 p80 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.013 0.435 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -144.95 25.56 1.42 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.14 -0.975 . . . . 0.0 109.582 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.445 ' C ' ' N ' ' C' ' 49' ' ' SER . 2.4 m-20 44.0 84.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.507 -0.746 . . . . 0.0 109.817 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.672 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -51.81 -11.41 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.375 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.445 ' N ' ' C ' ' C' ' 47' ' ' ASP . 28.1 p -48.94 158.52 0.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.627 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -77.52 148.34 35.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.21 16.9 79.01 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 55.2 p -74.43 -17.03 60.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -1.167 . . . . 0.0 109.475 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 67.35 -39.46 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.373 -0.829 . . . . 0.0 109.629 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.529 ' H ' ' C ' ' C' ' 52' ' ' SER . 56.6 mt-30 -65.95 -42.07 90.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 109.409 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.557 ' O ' ' HB1' ' C' ' 26' ' ' ALA . 93.4 t -66.39 -44.74 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.178 -0.951 . . . . 0.0 109.274 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -39.39 67.13 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.16 -26.55 72.51 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.86 ' CG ' HD11 ' C' ' 29' ' ' LEU . 4.4 t-80 -68.25 -43.24 78.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -1.202 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.83 -46.06 25.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -48.48 -23.62 1.02 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.377 -1.072 . . . . 0.0 109.272 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -75.45 -38.92 59.38 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.264 -0.898 . . . . 0.0 108.659 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.44 -49.04 44.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.2 -32.93 74.87 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.358 -0.839 . . . . 0.0 109.077 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' C' ' 68' ' ' ASN . 5.9 t0 -63.71 -36.43 83.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.171 -0.956 . . . . 0.0 108.637 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.68 -52.61 35.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.13 -40.98 91.66 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.2 m -71.85 -50.29 30.79 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' C' ' 64' ' ' ASP . 49.5 t30 -60.17 -24.16 64.52 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.614 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -82.28 -46.84 13.12 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.02 -22.92 32.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.41 -15.01 63.4 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.611 ' O ' ' N ' ' C' ' 74' ' ' ASP . 35.2 m-70 -138.3 -62.97 0.56 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.502 -0.749 . . . . 0.0 109.356 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.572 HG22 ' O ' ' C' ' 73' ' ' VAL . 13.1 p 44.24 14.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.937 0.875 . . . . 0.0 109.399 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' C' ' 72' ' ' HIS . 39.7 t0 -138.19 11.57 2.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 1.0 OUTLIER 174.95 29.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.683 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 14.3 ptt? -78.67 -22.77 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 111.898 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' C' ' 76' ' ' MET . 60.3 Cg_exo -52.05 -19.66 9.13 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.652 1.568 . . . . 0.0 112.521 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -94.02 -35.78 12.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.789 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.95 -38.39 69.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.078 -1.013 . . . . 0.0 109.317 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.81 11.46 15.46 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.423 -0.798 . . . . 0.0 109.047 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 68.4 p -68.05 -15.87 63.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.755 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -72.69 -55.84 6.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.886 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' C' ' 86' ' ' LEU . 6.1 mt -44.84 -47.26 11.03 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.794 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 62.4 m -46.87 -32.96 4.11 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' C' ' 82' ' ' ALA . 1.5 m-20 -82.16 -17.21 47.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.615 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' C' ' 83' ' ' LEU . 8.6 tp -74.11 -53.42 9.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 0.0 110.346 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 87' ' ' HIS . . . . . 0.437 ' CE1' ' O ' ' C' ' 83' ' ' LEU . 6.0 p-80 -92.18 -21.68 20.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.889 -1.132 . . . . 0.0 110.655 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -97.24 -0.63 46.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.864 -1.148 . . . . 0.0 110.4 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 89' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' C' ' 88' ' ' ALA . 70.7 m80 -154.93 42.95 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 110.227 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -172.39 -63.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 109.326 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 46.4 mt -90.66 -23.72 20.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 109.323 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 53.95 53.33 11.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 0.0 109.639 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.512 HG12 ' H ' ' C' ' 94' ' ' ASP . 2.3 t -79.9 -136.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 0.0 109.466 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' C' ' 96' ' ' VAL . 5.2 t70 -172.23 137.11 0.9 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.183 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' C' ' 98' ' ' PHE . 86.2 Cg_exo -41.75 -11.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.616 2.211 . . . . 0.0 112.627 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' C' ' 94' ' ' ASP . 59.1 t -43.65 -28.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -79.2 -24.96 42.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.542 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 98' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' C' ' 95' ' ' PRO . 38.4 t80 -44.98 -32.47 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 109.953 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.41 -27.23 27.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 0.0 109.977 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 mt -84.19 -62.25 1.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.993 -1.067 . . . . 0.0 109.94 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 36.9 tp -55.79 -20.91 16.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.914 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 17.0 p -78.42 -50.38 11.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 109.903 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -76.38 -26.58 55.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.836 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 55.7 m -58.66 -51.02 71.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.768 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.36 -35.88 13.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 109.618 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.786 HD12 ' CE1' ' C' ' 122' ' ' HIS . 3.7 mm? -70.02 -59.16 3.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.146 -0.971 . . . . 0.0 109.863 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 47.9 t -50.2 -36.77 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.962 . . . . 0.0 109.449 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 5.0 p -70.57 -63.09 1.16 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.224 -0.923 . . . . 0.0 109.417 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' C' ' 113' ' ' LEU . 17.6 mt -50.47 -31.55 15.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.334 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.51 -47.19 48.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.945 . . . . 0.0 109.631 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.32 -41.31 22.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.837 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -80.08 -72.13 0.42 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 110.003 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -113.86 91.56 22.31 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' C' ' 113' ' ' LEU . 84.5 Cg_exo -46.17 -175.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.447 2.098 . . . . 0.0 112.825 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.3 -42.21 13.92 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.555 -0.716 . . . . 0.0 109.393 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 0.0 OUTLIER 85.02 3.56 0.65 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.904 ' CZ ' ' CE1' ' D' ' 116' ' ' HIS . 8.1 m-85 65.1 36.74 7.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.798 -0.564 . . . . 0.0 111.225 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.718 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -91.06 121.59 67.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.719 -1.238 . . . . 0.0 108.179 178.427 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.15 22.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.11 1.874 . . . . 0.0 112.57 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.718 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -151.17 -33.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.963 -1.086 . . . . 0.0 110.84 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.649 HG13 ' N ' ' C' ' 122' ' ' HIS . 11.5 p -46.63 -47.86 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.013 -1.055 . . . . 0.0 110.005 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.786 ' CE1' HD12 ' C' ' 106' ' ' LEU . 0.3 OUTLIER -72.79 -33.5 66.31 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.51 -0.744 . . . . 0.0 109.307 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.11 -19.75 36.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.826 . . . . 0.0 110.059 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.6 ' N ' ' O ' ' C' ' 120' ' ' ALA . 10.2 p -66.04 -62.47 1.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.947 . . . . 0.0 110.783 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.524 ' N ' ' OG ' ' C' ' 124' ' ' SER . 9.4 mt -70.14 -19.4 63.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.047 -1.033 . . . . 0.0 109.885 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.92 -45.34 20.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.01 -1.056 . . . . 0.0 110.306 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.451 ' CD ' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -88.31 -43.19 11.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.0 110.18 -179.401 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.46 ' CD1' HG21 ' C' ' 10' ' ' VAL . 70.1 t80 -50.23 -21.03 1.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.911 -1.118 . . . . 0.0 109.316 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.6 mt -69.59 -17.77 63.57 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.21 -33.56 72.42 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.501 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 5.1 t -83.06 -30.41 28.04 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.349 -0.844 . . . . 0.0 108.988 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 72.7 t -85.41 -27.67 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.072 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.518 ' N ' ' O ' ' C' ' 129' ' ' LEU . 76.9 p -83.65 -26.01 30.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.817 . . . . 0.0 109.152 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 47.5 m -78.11 -36.91 47.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.343 -0.848 . . . . 0.0 109.183 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.458 HG13 ' O ' ' C' ' 131' ' ' SER . 33.4 m -76.49 -21.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.267 -0.895 . . . . 0.0 108.888 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -37.79 68.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 109.013 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 58.2 p -89.29 -1.23 57.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 1.147 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -106.38 162.49 13.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.469 -0.77 . . . . 0.0 109.28 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.438 ' O ' ' N ' ' D' ' 7' ' ' GLU . 0.7 OUTLIER -84.69 151.01 57.67 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 109.06 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -42.09 -30.62 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.33 2.02 . . . . 0.0 112.103 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.41 -21.82 25.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.891 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 7' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' D' ' 4' ' ' THR . 44.6 tt0 -77.12 -63.02 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.126 -0.984 . . . . 0.0 110.164 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.496 ' HB3' HD22 ' D' ' 3' ' ' LEU . 10.4 pttt -67.64 -25.71 65.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.163 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 9' ' ' SER . . . . . 0.409 ' C ' ' O ' ' D' ' 8' ' ' LYS . 0.4 OUTLIER -43.73 -24.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.23 -56.21 3.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.094 -1.004 . . . . 0.0 109.75 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.435 ' H ' HG12 ' D' ' 11' ' ' VAL . 0.9 OUTLIER -71.06 -24.78 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 25.4 m -68.26 -39.23 82.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.357 0.599 . . . . 0.0 109.844 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.18 -31.36 58.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.923 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -21.77 6.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 0.0 109.31 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 15' ' ' TRP . . . . . 0.551 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.2 OUTLIER -56.34 -38.37 71.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.983 . . . . 0.0 109.151 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.23 -40.2 61.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -26.07 66.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -1.096 . . . . 0.0 109.198 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.11 121.06 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.607 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' D' ' 21' ' ' ASP . 59.6 t30 -80.12 71.75 6.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.278 -0.889 . . . . 0.0 109.023 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 80.1 t -45.82 -15.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 0.0 109.793 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' D' ' 19' ' ' ASN . 35.2 m-20 -69.28 -4.02 16.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' D' ' 25' ' ' GLY . 47.9 mt-10 -155.8 -46.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -47.06 -23.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.683 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.86 -31.22 40.44 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -73.54 -39.48 49.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -70.21 -38.86 75.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -1.146 . . . . 0.0 109.56 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.04 -30.24 61.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tp -81.46 -58.09 3.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.973 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.7 85.07 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -55.98 -39.4 71.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -1.142 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.59 -35.99 4.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.602 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 mt -81.22 -29.82 34.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.787 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 66.8 t -66.01 -64.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 109.497 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.419 HG23 ' H ' ' D' ' 34' ' ' VAL . 0.0 OUTLIER -64.06 -22.6 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 109.232 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -149.6 81.8 7.03 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.618 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.05 9.98 3.13 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.552 2.168 . . . . 0.0 112.173 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' TRP . . . . . 0.568 ' CD1' ' N ' ' D' ' 38' ' ' THR . 0.4 OUTLIER -80.97 -20.02 42.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.568 ' N ' ' CD1' ' D' ' 37' ' ' TRP . 7.3 m -88.0 58.08 4.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 109.472 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -117.66 23.72 11.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.431 -0.793 . . . . 0.0 109.324 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -87.31 -39.72 15.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 109.552 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -100.01 34.75 2.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.223 -0.923 . . . . 0.0 109.432 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.487 ' CD2' ' CE1' ' D' ' 45' ' ' PHE . 0.9 OUTLIER -143.3 15.12 1.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 109.222 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 43' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' D' ' 43' ' ' GLU . 7.2 pt-20 -72.47 -14.15 61.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.583 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' D' ' 46' ' ' GLY . 5.3 m -69.04 -46.9 66.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.487 ' CE1' ' CD2' ' D' ' 42' ' ' PHE . 80.0 m-85 -50.23 -16.16 0.3 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' D' ' 44' ' ' SER . . . 51.26 179.58 0.04 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 55.95 71.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -1.153 . . . . 0.0 109.481 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 27.6 mt -131.26 35.11 3.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 109.391 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 13.4 m -51.92 -49.37 63.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.937 . . . . 0.0 109.49 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.21 160.22 46.55 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.327 -0.858 . . . . 0.0 108.832 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.42 -17.3 4.18 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.112 1.874 . . . . 0.0 111.946 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 52' ' ' ASP . . . . . 0.416 ' C ' ' N ' ' D' ' 54' ' ' VAL . 19.5 t70 -83.26 -51.51 7.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.345 -0.847 . . . . 0.0 109.593 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.07 -19.84 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 109.437 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' D' ' 52' ' ' ASP . 58.5 t -73.2 -57.86 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mtt -60.07 -16.65 33.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 0.0 109.41 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.5 -26.72 71.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -78.74 132.27 65.16 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.226 -1.161 . . . . 0.0 109.321 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.98 -31.02 4.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.365 2.043 . . . . 0.0 112.299 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -70.38 -30.11 66.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.616 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.83 -40.64 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 109.602 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 61' ' ' LYS . . . . . 0.512 ' NZ ' ' CB ' ' D' ' 61' ' ' LYS . 8.1 mtmp? -65.53 -37.43 86.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.681 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.94 -51.06 67.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -55.7 -23.94 31.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.073 -1.017 . . . . 0.0 109.455 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.03 -48.87 65.98 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -52.4 -24.9 8.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -1.233 . . . . 0.0 109.522 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.48 -62.0 1.67 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.259 -0.9 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 t -52.17 -39.33 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.686 ' O ' HD23 ' D' ' 68' ' ' LEU . 8.0 tt -70.09 -37.46 75.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.326 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.85 -44.14 61.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.43 71.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -1.155 . . . . 0.0 109.803 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 71' ' ' PHE . . . . . 0.413 ' O ' ' CD2' ' D' ' 75' ' ' LEU . 1.3 m-85 -66.29 -29.14 69.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.077 -1.015 . . . . 0.0 109.537 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 72' ' ' SER . . . . . 0.551 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 8.8 t -66.36 -33.57 76.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.31 -16.7 55.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.14 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.62 -19.86 63.17 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.859 HD23 ' H ' ' D' ' 75' ' ' LEU . 1.5 pt? -137.66 -28.44 0.9 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.21 -1.17 . . . . 0.0 109.931 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 76' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' D' ' 72' ' ' SER . . . -80.05 19.0 0.75 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.095 -1.003 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -171.58 70.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 78' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' D' ' 75' ' ' LEU . 70.4 mt -80.87 0.66 34.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.425 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -53.99 -38.41 65.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 109.32 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -172.03 73.18 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.371 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 81' ' ' LEU . . . . . 0.446 HD12 ' N ' ' D' ' 82' ' ' LYS . 2.2 pp -76.72 -41.62 44.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 82' ' ' LYS . . . . . 0.446 ' N ' HD12 ' D' ' 81' ' ' LEU . 53.1 mttp -50.93 -27.12 6.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.08 -1.013 . . . . 0.0 109.426 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 83' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' D' ' 86' ' ' ALA . . . -83.22 -57.63 2.46 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.6 OUTLIER -47.64 -39.83 18.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -1.159 . . . . 0.0 109.584 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.459 ' CZ ' HG13 ' D' ' 137' ' ' VAL . 25.1 m-85 -69.78 -12.09 61.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.326 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 86' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' D' ' 83' ' ' GLY . . . -54.49 -43.69 72.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.154 -0.966 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 11.3 p -64.42 -59.22 4.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 109.384 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.7 mt -54.92 -35.51 64.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.304 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -72.73 -46.46 53.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.907 . . . . 0.0 109.314 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.52 -24.47 67.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.872 . . . . 0.0 109.452 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.31 -68.2 0.71 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.556 ' O ' ' N ' ' D' ' 97' ' ' HIS . 75.1 m80 -54.57 -25.67 27.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 110.493 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.92 -60.61 2.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.017 -1.052 . . . . 0.0 111.594 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.553 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 11.9 m-20 -87.07 -39.64 15.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.996 -1.065 . . . . 0.0 111.693 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -83.17 -10.2 58.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.913 -1.117 . . . . 0.0 111.11 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.529 ' O ' HD13 ' D' ' 96' ' ' LEU . 0.2 OUTLIER -137.89 -43.85 0.53 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.869 -1.144 . . . . 0.0 109.971 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.965 ' HB3' ' HA ' ' A' ' 38' ' ' THR . 4.1 m80 73.11 58.5 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.87 . . . . 0.0 109.509 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 98' ' ' VAL . . . . . 0.401 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 79.3 t -82.66 114.21 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 109.421 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.76 154.45 2.38 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.264 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.1 -164.4 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.61 2.206 . . . . 0.0 112.153 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 53.32 52.03 14.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.485 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -158.28 -36.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.34 -37.55 86.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -72.88 -26.43 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 105' ' ' LEU . . . . . 0.483 ' O ' HD23 ' D' ' 105' ' ' LEU . 1.3 tt -65.6 -55.58 16.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.357 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 tt -50.41 -46.98 56.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.919 . . . . 0.0 109.356 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.15 -47.93 71.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.43 -50.28 65.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -1.157 . . . . 0.0 109.616 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 80.5 t -53.85 -38.53 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 109.498 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.96 -33.87 76.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.423 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.95 -26.11 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.552 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 60.7 m -79.31 -61.0 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 109.738 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 113' ' ' VAL . . . . . 0.431 ' H ' HG23 ' D' ' 113' ' ' VAL . 4.9 t -46.34 -29.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 109.815 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 32.1 mt -79.76 -31.56 40.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -82.12 -20.47 37.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.897 . . . . 0.0 109.494 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.904 ' CE1' ' CZ ' ' C' ' 117' ' ' PHE . 11.0 t-80 -75.0 -55.72 5.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.176 -0.952 . . . . 0.0 109.471 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -74.53 -17.75 60.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.544 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -146.54 59.01 1.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -74.81 -22.0 77.66 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -72.87 -33.73 66.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -1.197 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' D' ' 123' ' ' THR . 57.4 mm-40 -81.38 -4.63 56.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.361 -0.837 . . . . 0.0 109.522 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.82 34.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.285 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.487 ' H ' ' C ' ' D' ' 121' ' ' GLU . 28.3 p -48.32 148.3 3.36 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.108 -0.995 . . . . 0.0 109.083 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.513 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.3 Cg_exo -45.1 -52.91 5.85 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.228 1.952 . . . . 0.0 112.812 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 36.4 Cg_endo -65.65 13.57 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.013 1.809 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.458 HG23 ' OG1' ' D' ' 123' ' ' THR . 90.8 t -124.84 -21.34 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.299 -0.876 . . . . 0.0 109.605 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 127' ' ' GLN . . . . . 0.549 HE22 ' CG ' ' D' ' 131' ' ' GLN . 18.2 tm0? -83.18 -42.96 16.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.76 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -61.91 -44.35 96.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.67 -7.15 24.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.683 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -92.43 -30.01 15.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 109.706 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 0.549 ' CG ' HE22 ' D' ' 127' ' ' GLN . 15.6 mm100 -81.62 -38.2 26.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -68.21 -49.33 61.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 109.691 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 133' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 2.6 p -58.49 -48.18 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.865 . . . . 0.0 109.966 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.569 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 88.5 t -73.44 -34.45 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.347 -0.846 . . . . 0.0 109.796 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.799 ' CB ' ' O ' ' B' ' 146' ' ' HIS . . . -47.45 -22.29 0.43 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.37 -22.01 61.31 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 137' ' ' VAL . . . . . 0.459 HG13 ' CZ ' ' D' ' 85' ' ' PHE . 85.8 t -77.83 -26.07 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -1.138 . . . . 0.0 109.537 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.14 -46.6 61.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.214 -0.929 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -74.71 -21.08 59.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.497 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.32 -59.71 3.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.553 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.52 -24.93 61.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.927 . . . . 0.0 109.438 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.24 22.45 4.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 109.39 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -77.34 -31.85 54.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.634 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.1 OUTLIER -79.55 -27.35 41.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.398 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 145' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' D' ' 98' ' ' VAL . 24.4 m-85 -65.88 3.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.842 ' O ' ' CB ' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.439 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.486 ' C ' HD12 ' A' ' 2' ' ' LEU . 3.7 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.572 HD13 ' OG ' ' A' ' 131' ' ' SER . 7.7 mp -108.21 -165.39 1.04 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.311 -0.868 . . . . 0.0 109.2 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.515 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 178.98 -49.53 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.936 . . . . 0.0 109.992 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' ASP . 73.9 Cg_exo -47.23 171.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.384 2.056 . . . . 0.0 112.448 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -45.8 -16.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.766 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' PRO . 3.1 p30 -39.55 -33.35 0.17 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 10' ' ' VAL . 9.6 ptpt -83.14 -46.59 12.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.338 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 m -45.44 -31.07 1.56 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.314 -0.866 . . . . 0.0 109.424 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -78.23 -36.94 46.42 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 7' ' ' LYS . 71.5 t -70.5 -49.52 52.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -51.07 -47.32 61.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.404 -0.81 . . . . 0.0 108.847 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -55.92 27.57 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.43 -0.794 . . . . 0.0 109.304 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.716 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -56.74 -37.23 70.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.251 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -17.41 61.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.223 -0.923 . . . . 0.0 108.933 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.63 -44.17 16.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 41.6 mmtt -70.2 -43.25 71.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -1.17 . . . . 0.0 108.637 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 13' ' ' ALA . 59.1 t -59.27 -63.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 44.2 -125.39 5.78 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 22.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.416 -1.05 . . . . 0.0 110.438 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.568 ' H ' ' C ' ' A' ' 18' ' ' GLY . 78.9 m-70 -129.11 25.99 5.5 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -91.51 -64.38 1.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.694 -0.629 . . . . 0.0 109.746 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.28 -14.37 0.17 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' ALA . 2.2 mm-40 -84.03 -56.47 3.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -1.052 . . . . 0.0 109.672 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.2 m-30 -60.67 -35.56 76.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 109.187 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.86 -22.88 68.84 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.51 -41.76 31.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -1.163 . . . . 0.0 109.715 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.42 -19.82 62.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 108.92 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.92 ' HB1' ' SG ' ' A' ' 104' ' ' CYS . . . -72.85 -21.88 60.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.371 -0.831 . . . . 0.0 109.132 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.1 mt -72.45 -53.68 11.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.349 -0.845 . . . . 0.0 109.712 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.13 -27.05 69.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.489 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 31' ' ' ARG . 0.9 OUTLIER -63.89 -30.68 71.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.547 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 39.6 ttp -70.75 -57.93 4.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.482 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -49.19 -33.68 12.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.45 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 11.7 mt -73.5 -51.55 16.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.852 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 52.4 m -67.76 -17.87 64.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.949 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CZ ' ' NH2' ' B' ' 104' ' ' ARG . 29.4 m-85 -152.62 109.52 2.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.052 -1.03 . . . . 0.0 109.499 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' THR . 72.4 Cg_endo -80.53 -27.21 3.49 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.331 2.02 . . . . 0.0 112.092 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.786 ' HB ' ' HB2' ' D' ' 97' ' ' HIS . 21.1 p -47.45 -18.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 109.447 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' PRO . 55.9 p -81.6 -22.74 37.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HZ1' HD21 ' A' ' 48' ' ' LEU . 1.8 tpmt? -64.71 -39.61 93.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 38' ' ' THR . 8.8 t . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 109.642 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.465 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.592 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -151.0 68.01 0.93 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' SER . 1.5 m-20 -48.35 -18.3 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 109.631 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.592 ' CD1' ' O ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER 46.4 21.33 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.24 -0.912 . . . . 0.0 109.638 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 50' ' ' HIS . 5.2 m -75.31 18.68 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -0.94 . . . . 0.0 109.404 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.492 ' N ' ' ND1' ' A' ' 50' ' ' HIS . 2.5 m80 57.51 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.615 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.03 10.5 83.83 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 3.2 p -54.48 -12.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -1.104 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 71.0 -16.79 0.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.381 -0.825 . . . . 0.0 109.736 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 52' ' ' SER . 5.1 pt20 -81.65 -28.87 33.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.508 HG22 ' CE2' ' A' ' 46' ' ' PHE . 22.2 t -73.52 -38.44 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.61 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.585 ' CD ' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.63 -22.83 46.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.083 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.13 -23.89 58.36 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.47 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.7 t-80 -78.47 -38.57 40.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -1.171 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.72 -48.95 49.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 53.7 mttm -51.61 -23.45 4.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -1.121 . . . . 0.0 109.948 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.18 -42.46 65.83 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.127 -0.983 . . . . 0.0 109.024 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 t -69.85 -48.44 63.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.486 -0.758 . . . . 0.0 108.977 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.426 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -65.47 -28.57 69.31 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.384 -0.822 . . . . 0.0 109.275 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 30.4 m-20 -70.23 -36.49 74.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 0.0 108.872 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.68 47.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.402 -0.811 . . . . 0.0 108.964 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 70' ' ' VAL . 11.3 mt -58.01 -42.12 84.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.261 -0.899 . . . . 0.0 108.674 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' ALA . 25.8 m -67.59 -51.6 48.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.362 -0.836 . . . . 0.0 108.881 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.49 -29.31 68.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 108.781 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -82.98 -46.49 12.83 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 66' ' ' LEU . 48.4 t -67.19 -22.4 29.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -66.1 -24.21 66.65 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.205 0.526 . . . . 0.0 109.711 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.592 ' O ' HG12 ' A' ' 73' ' ' VAL . 11.8 m80 -137.27 -47.8 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 72' ' ' HIS . 11.0 p 45.06 13.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.665 0.745 . . . . 0.0 109.378 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 72' ' ' HIS . 26.2 t70 -135.76 11.37 3.41 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -173.72 28.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.043 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.704 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -77.96 -24.91 0.46 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 0.0 111.399 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 76' ' ' MET . 41.8 Cg_exo -56.52 -24.61 54.2 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.791 1.661 . . . . 0.0 112.324 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -89.38 -29.19 19.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.932 . . . . 0.0 109.65 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.05 -43.2 35.4 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.127 -0.983 . . . . 0.0 109.127 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 80' ' ' LEU . 6.4 mp -83.5 8.7 13.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.432 -0.792 . . . . 0.0 108.952 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.5 m -63.52 -23.18 67.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -76.35 -55.3 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.614 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 83' ' ' LEU . 4.5 mt -46.62 -46.81 19.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 m -56.8 -25.43 55.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.435 -0.79 . . . . 0.0 109.246 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' ALA . 11.6 t70 -81.02 -35.02 32.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.382 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tt -72.06 -26.95 62.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 109.198 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 90' ' ' LYS . 68.4 m80 -82.67 -31.49 28.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 109.472 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.14 -42.65 15.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.495 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -78.13 -18.84 55.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.535 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' HIS . 46.7 mttm -146.08 179.81 7.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 93' ' ' VAL . 12.6 mt 59.09 58.4 3.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -53.84 -6.88 0.1 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 109.336 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 91' ' ' LEU . 11.5 p -54.59 137.94 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.49 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.765 ' HB2' ' OD2' ' D' ' 99' ' ' ASP . 0.7 OUTLIER -77.27 157.92 80.11 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.086 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASN . 9.9 Cg_endo -54.72 -10.47 2.53 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.721 2.281 . . . . 0.0 111.882 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.518 HG21 ' CG ' ' D' ' 99' ' ' ASP . 85.3 t -42.98 -22.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 109.775 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 95' ' ' PRO . 3.1 m120 -79.07 -41.26 29.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.205 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 95' ' ' PRO . 31.7 t80 -48.62 -25.72 1.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.165 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -70.62 -30.32 66.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.208 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.551 HD13 ' CD1' ' A' ' 36' ' ' PHE . 20.6 mt -84.08 -61.34 1.84 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 0.0 109.642 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 4.6 tt -49.23 -23.51 1.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.671 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.8 m -72.81 -44.05 61.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.059 -1.025 . . . . 0.0 109.759 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.509 ' CD2' ' OD1' ' B' ' 108' ' ' ASN . 41.3 t-80 -80.55 -26.63 37.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.783 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.92 ' SG ' ' HB1' ' A' ' 28' ' ' ALA . 11.2 p -58.04 -48.14 80.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.717 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.655 ' N ' ' SG ' ' A' ' 104' ' ' CYS . 2.5 mt -46.31 -39.14 9.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 106' ' ' LEU . 3.7 mm? -68.8 -30.28 68.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.607 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.592 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 86.0 t -75.12 -51.5 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 110' ' ' ALA . 27.8 m -60.05 -59.66 5.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 114' ' ' PRO . 12.3 mt -46.37 -18.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.457 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -69.66 -42.55 74.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.258 -0.902 . . . . 0.0 110.406 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.19 -3.67 43.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.132 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -129.73 -81.72 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 109.693 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -119.17 82.15 22.17 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 113' ' ' LEU . 53.6 Cg_exo -48.76 -169.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.51 2.14 . . . . 0.0 112.524 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.827 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -51.0 -56.21 13.61 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.556 -0.715 . . . . 0.0 109.302 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.67 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 3.0 mm-40 122.63 -8.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.497 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 5.6 t80 80.34 34.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 122.01 -0.431 . . . . 0.0 111.199 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -113.43 120.22 40.24 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.25 16.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.331 2.021 . . . . 0.0 112.87 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -140.98 -34.61 0.5 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.016 -1.052 . . . . 0.0 110.106 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.827 HG21 ' O ' ' A' ' 115' ' ' ALA . 9.4 p -51.79 -47.28 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.14 -0.975 . . . . 0.0 109.994 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.616 ' N ' HG13 ' A' ' 121' ' ' VAL . 1.0 OUTLIER -60.19 -39.9 88.16 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.331 -0.856 . . . . 0.0 109.283 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.39 -19.99 32.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.824 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 120' ' ' ALA . 24.2 p -61.83 -62.39 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 110.3 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.505 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.3 mt -68.2 -19.53 64.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.172 -0.955 . . . . 0.0 109.513 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.05 -45.54 13.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.974 . . . . 0.0 109.854 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -87.19 -41.48 13.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.155 -0.965 . . . . 0.0 109.883 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 37.1 t80 -50.14 -20.84 1.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.966 -1.084 . . . . 0.0 108.854 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' SER . 19.4 mt -70.56 -17.91 62.92 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.7 -31.64 69.77 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.572 ' OG ' HD13 ' A' ' 2' ' ' LEU . 0.8 OUTLIER -81.72 -34.05 30.75 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.362 -0.836 . . . . 0.0 108.902 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.0 t -83.8 -29.21 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.336 -0.852 . . . . 0.0 108.91 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 129' ' ' LEU . 23.3 t -80.3 -25.44 39.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.403 -0.811 . . . . 0.0 109.132 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 m -75.37 -39.67 58.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.264 -0.897 . . . . 0.0 109.215 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.04 -22.09 16.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.255 -0.903 . . . . 0.0 108.965 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.91 -35.13 72.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 109.02 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 83.6 m -87.21 -29.85 21.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.561 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.47 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 1.5 t60 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.248 0.546 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.916 ' N ' HD12 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -138.46 -162.94 1.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.331 -0.856 . . . . 0.0 109.071 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.409 ' HG1' ' CD ' ' B' ' 7' ' ' GLU . 1.0 OUTLIER -84.54 153.32 61.58 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 108.866 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.92 -26.32 66.86 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.491 2.127 . . . . 0.0 112.197 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.2 -27.86 22.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.973 . . . . 0.0 109.793 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.409 ' CD ' ' HG1' ' B' ' 4' ' ' THR . 61.2 mt-10 -84.14 -48.1 10.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.023 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.694 ' HB2' HD13 ' B' ' 3' ' ' LEU . 0.8 OUTLIER -68.78 -43.42 75.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.55 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -56.58 -23.58 41.57 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 110.059 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.54 -57.61 3.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.021 -1.05 . . . . 0.0 110.044 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.95 -24.33 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 47.1 m -80.88 -36.97 30.59 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.687 -0.633 . . . . 0.0 109.779 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 -22.38 63.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.927 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 16' ' ' GLY . 1.7 mt -59.82 -28.05 67.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.0 109.335 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' TRP . . . . . 0.657 ' HE1' ' HG ' ' B' ' 72' ' ' SER . 0.5 OUTLIER -47.57 -17.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.933 . . . . 0.0 109.178 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -76.88 -36.15 37.31 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.445 ' O ' ' CE2' ' B' ' 118' ' ' PHE . 3.3 mmtt -89.33 -35.82 15.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -1.148 . . . . 0.0 109.281 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.1 t -47.92 114.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.659 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' B' ' 21' ' ' ASP . 83.6 m-20 -77.86 65.82 3.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.327 -0.858 . . . . 0.0 108.933 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -44.6 -17.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.385 -0.822 . . . . 0.0 109.682 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' B' ' 19' ' ' ASN . 13.3 m-20 -78.8 6.76 8.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.232 -0.917 . . . . 0.0 109.539 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' B' ' 19' ' ' ASN . 58.2 mt-10 -155.65 -46.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.538 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' B' ' 27' ' ' ALA . 85.8 t -47.74 -42.24 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.621 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.81 -43.33 96.62 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.9 -39.08 25.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -76.25 -25.82 55.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -1.175 . . . . 0.0 109.561 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' B' ' 23' ' ' VAL . . . -75.54 -34.1 60.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.937 . . . . 0.0 109.515 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tp -82.91 -52.35 6.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.451 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.68 -26.68 17.31 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -77.86 -31.44 51.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.131 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 32.6 tp -49.04 -34.56 13.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.355 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.9 mt -80.39 -22.03 41.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -82.51 -64.22 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.627 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.453 ' H ' HG23 ' B' ' 34' ' ' VAL . 3.0 t -61.01 -22.9 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.888 . . . . 0.0 109.659 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -152.16 88.47 4.1 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 109.465 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.94 12.98 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.543 2.162 . . . . 0.0 112.227 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.592 ' CZ2' ' ND2' ' B' ' 102' ' ' ASN . 0.7 OUTLIER -71.91 -19.92 61.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.525 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.591 HG23 ' NE1' ' B' ' 37' ' ' TRP . 1.3 p -84.14 50.99 1.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.977 . . . . 0.0 109.27 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 38.5 tt0 -92.14 31.23 1.3 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -87.88 -42.84 12.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.674 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -93.18 14.32 18.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 109.578 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' B' ' 43' ' ' GLU . 1.6 p90 -68.21 -34.19 75.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.608 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.543 ' N ' ' CD1' ' B' ' 42' ' ' PHE . 12.0 pt-20 -53.28 -17.4 1.75 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.607 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 60.9 m -85.55 -34.73 21.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.583 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 47' ' ' ASP . 10.0 m-85 -51.04 -20.92 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.96 12.42 0.15 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' B' ' 45' ' ' PHE . 15.1 m-20 -160.64 110.52 1.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.151 . . . . 0.0 109.448 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tp -158.67 20.6 0.22 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.255 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.1 m -46.78 -41.1 14.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 109.646 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' THR . . . . . 0.431 ' HG1' ' CG ' ' B' ' 52' ' ' ASP . 4.7 p -146.6 150.33 39.79 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.851 . . . . 0.0 109.216 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -41.15 -43.65 5.19 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.444 2.096 . . . . 0.0 112.354 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.431 ' CG ' ' HG1' ' B' ' 50' ' ' THR . 1.7 p-10 -64.13 -31.01 72.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.534 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.92 -19.86 20.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.93 . . . . 0.0 109.42 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.43 -61.32 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -0.901 . . . . 0.0 109.573 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' B' ' 55' ' ' MET . 5.5 mmt -70.98 -0.51 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.77 31.08 7.17 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -143.09 137.06 14.51 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.26 -1.141 . . . . 0.0 109.31 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.11 -30.88 5.27 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.489 2.126 . . . . 0.0 112.26 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -21.1 59.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 109.777 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 69.8 t -75.82 -41.52 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.523 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -78.31 -25.26 46.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.57 71.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.62 -23.82 67.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.32 -50.31 22.17 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -49.51 -30.92 9.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.173 -1.192 . . . . 0.0 109.534 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -65.45 -53.74 38.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.583 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 28.2 t -58.96 -36.94 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.43 HD23 ' C ' ' B' ' 68' ' ' LEU . 5.7 tt -65.57 -48.37 72.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.97 -41.05 10.31 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.05 -43.45 91.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.608 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.4 -47.31 86.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' SER . . . . . 0.657 ' HG ' ' HE1' ' B' ' 15' ' ' TRP . 19.2 m -62.44 -42.03 99.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 109.622 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -48.37 -34.79 11.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.416 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.68 -60.48 6.91 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -54.04 -22.09 9.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.248 -1.148 . . . . 0.0 109.35 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.16 2.68 56.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -170.27 66.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.68 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.27 15.27 2.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.34 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.85 -23.21 60.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.46 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 37.1 t-20 -167.2 108.09 0.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 0.0 109.593 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mt -80.35 -51.53 8.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.431 ' HZ2' ' HB2' ' B' ' 143' ' ' HIS . 52.4 mttm -67.12 -23.97 65.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.812 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -78.7 -39.11 22.2 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.9 t -85.1 -47.43 10.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.153 -1.204 . . . . 0.0 109.715 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.557 ' N ' ' CG2' ' B' ' 84' ' ' THR . 40.5 m-85 -84.67 26.92 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.539 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.32 72.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 109.633 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 50.9 p -75.81 -53.82 7.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.752 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -48.13 -43.05 30.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 2.9 m -66.89 -48.35 68.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.849 . . . . 0.0 109.668 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -67.39 -22.64 65.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 109.734 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.71 -68.37 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.078 -1.013 . . . . 0.0 109.566 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.576 ' NE2' ' O ' ' B' ' 141' ' ' LEU . 1.1 p-80 -54.38 -20.67 7.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.974 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' CYS . . . . . 0.429 ' N ' ' ND1' ' B' ' 92' ' ' HIS . 41.4 t -83.51 -59.6 2.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 110.858 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.31 -56.44 3.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.067 -1.021 . . . . 0.0 111.379 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -57.71 -51.74 68.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 110.579 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.572 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 12.1 mt -97.32 -64.52 1.03 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.002 -1.062 . . . . 0.0 109.95 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.723 ' HB2' ' HB ' ' C' ' 38' ' ' THR . 0.0 OUTLIER 91.2 25.12 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.308 0.575 . . . . 0.0 109.865 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 98' ' ' VAL . 17.5 t -46.74 140.86 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.103 -0.998 . . . . 0.0 109.493 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' ASP . . . . . 0.688 ' OD2' ' HB2' ' C' ' 94' ' ' ASP . 96.0 m-20 -54.0 149.41 18.05 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.363 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.9 36.46 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.478 2.119 . . . . 0.0 112.143 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -145.07 45.57 1.34 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.179 -0.95 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.592 ' ND2' ' CZ2' ' B' ' 37' ' ' TRP . 4.4 m120 -143.74 5.96 1.39 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.1 m-85 -89.74 -69.68 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 109.454 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.574 ' NH2' ' CZ ' ' A' ' 36' ' ' PHE . 43.9 ttt180 -54.94 -20.88 9.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.54 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 tp -75.31 -31.13 60.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tt -68.19 -55.39 12.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.63 -20.55 39.41 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ASN . . . . . 0.509 ' OD1' ' CD2' ' A' ' 103' ' ' HIS . 61.8 t30 -60.09 -34.78 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -1.159 . . . . 0.0 109.684 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.53 -24.12 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 109.593 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.73 -36.4 82.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 109.501 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.447 ' CG1' ' CD1' ' B' ' 130' ' ' TYR . 4.4 m -74.91 -26.04 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.239 -0.913 . . . . 0.0 109.662 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 17.0 t -66.79 -63.4 1.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 109.612 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' VAL . . . . . 0.433 ' H ' HG23 ' B' ' 113' ' ' VAL . 10.6 t -49.14 -21.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 109.539 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.9 -57.03 4.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.66 -27.32 49.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.836 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.494 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.71 -60.25 2.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.052 -1.03 . . . . 0.0 109.443 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -62.3 -17.49 58.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.692 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.445 ' CE2' ' O ' ' B' ' 17' ' ' LYS . 65.5 m-85 -150.05 60.5 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 109.703 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 121' ' ' GLU . . . -66.52 -45.26 86.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' B' ' 120' ' ' LYS . 28.6 mmtp -47.39 -19.86 0.19 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -1.172 . . . . 0.0 109.289 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' B' ' 119' ' ' GLY . 70.1 mm-40 -94.77 -26.82 16.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.642 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.478 ' CD1' ' C ' ' B' ' 122' ' ' PHE . 0.7 OUTLIER -48.54 120.82 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.355 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 9.6 p -149.15 149.31 29.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 108.896 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.448 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 2.5 Cg_endo -46.15 -58.1 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.327 2.018 . . . . 0.0 113.177 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 19.5 Cg_endo -59.76 -11.1 13.53 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.174 1.916 . . . . 0.0 112.51 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 53.5 t -94.81 -53.12 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 109.907 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -61.34 -59.88 4.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 109.489 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -51.16 -37.43 46.27 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.484 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.24 18.53 2.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.447 ' CD1' ' CG1' ' B' ' 111' ' ' VAL . 15.2 t80 -109.56 -61.71 1.6 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.229 -0.92 . . . . 0.0 109.688 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.523 ' CD ' ' H ' ' B' ' 131' ' ' GLN . 22.8 mp0 -48.43 -24.09 1.15 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.0 -1.063 . . . . 0.0 109.726 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.447 ' HG3' ' CD2' ' D' ' 146' ' ' HIS . 35.8 ttpt -85.73 -37.38 19.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 0.0 110.169 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 0.4 OUTLIER -60.76 -44.36 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.859 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.477 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 7.0 m -83.56 -16.97 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 0.0 109.935 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.96 -25.15 1.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 0.0 109.404 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.95 -23.9 56.48 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' B' ' 134' ' ' VAL . 42.7 t -79.6 -31.78 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -1.164 . . . . 0.0 109.429 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.54 -50.79 57.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -67.07 -32.31 73.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.427 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.7 -42.27 34.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.291 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.576 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 38.4 mt -84.17 18.37 2.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.376 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.39 -31.08 2.32 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.536 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' HIS . . . . . 0.431 ' HB2' ' HZ2' ' B' ' 82' ' ' LYS . 15.1 t-80 -46.37 -41.87 14.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 109.285 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' B' ' 146' ' ' HIS . 35.7 mmtt -75.46 -54.43 7.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.037 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.497 ' O ' ' CG ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -57.43 -6.19 0.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.545 -0.722 . . . . 0.0 109.241 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.446 ' H ' ' C ' ' B' ' 144' ' ' LYS . 11.8 m-70 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.79 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.48 ' C ' HD12 ' C' ' 2' ' ' LEU . 3.7 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.581 HD13 ' OG ' ' C' ' 131' ' ' SER . 7.7 mp -108.21 -165.41 1.04 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.359 -0.838 . . . . 0.0 109.269 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.516 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 179.02 -49.6 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.018 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' C' ' 6' ' ' ASP . 74.3 Cg_exo -47.17 170.88 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.398 2.065 . . . . 0.0 112.521 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.73 -16.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 109.828 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' C' ' 4' ' ' PRO . 3.1 p30 -39.61 -33.35 0.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.765 . . . . 0.0 109.799 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' C' ' 10' ' ' VAL . 9.6 ptpt -83.1 -46.57 12.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.893 . . . . 0.0 109.431 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.407 ' C ' ' O ' ' C' ' 7' ' ' LYS . 49.6 m -45.48 -31.12 1.62 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.419 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -78.23 -36.81 46.6 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' C' ' 7' ' ' LYS . 71.8 t -70.49 -49.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -51.07 -47.33 61.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.45 -56.02 26.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.405 -0.81 . . . . 0.0 109.294 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.696 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -56.65 -37.3 70.58 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.285 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -17.48 61.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.156 -0.965 . . . . 0.0 108.907 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.6 -44.09 17.04 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' C' ' 16' ' ' LYS . 41.7 mmtt -70.22 -43.29 70.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -1.119 . . . . 0.0 108.56 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.696 HG23 ' O ' ' C' ' 13' ' ' ALA . 59.8 t -59.22 -63.89 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.566 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 44.24 -125.44 5.84 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.41 22.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.349 -1.089 . . . . 0.0 110.449 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.566 ' H ' ' C ' ' C' ' 18' ' ' GLY . 78.9 m-70 -129.08 26.07 5.5 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.52 -64.37 1.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.68 -0.638 . . . . 0.0 109.811 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.37 -14.28 0.18 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 21' ' ' ALA . 2.1 mm-40 -84.01 -56.52 3.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -1.055 . . . . 0.0 109.671 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 24' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -60.53 -35.7 76.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.165 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.84 -22.92 68.83 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.51 -41.71 31.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -1.121 . . . . 0.0 109.683 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.51 -19.79 62.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 108.947 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.922 ' HB1' ' SG ' ' C' ' 104' ' ' CYS . . . -72.89 -21.84 60.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.109 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 11.2 mt -72.57 -53.57 11.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 109.635 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.19 -27.01 69.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.484 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -30.81 71.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 39.5 ttp -70.79 -57.98 4.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.405 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 0.3 OUTLIER -49.2 -33.63 12.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.468 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.453 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 11.8 mt -73.44 -51.57 16.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 109.856 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 53.3 m -67.92 -17.73 64.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.938 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.568 ' CZ ' ' NH2' ' D' ' 104' ' ' ARG . 29.2 m-85 -152.64 109.51 2.74 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.972 . . . . 0.0 109.546 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' C' ' 39' ' ' THR . 72.1 Cg_endo -80.43 -27.29 3.53 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.388 2.058 . . . . 0.0 112.16 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.753 ' O ' HG22 ' C' ' 41' ' ' THR . 22.0 p -47.37 -18.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.863 . . . . 0.0 109.581 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.438 ' N ' ' O ' ' C' ' 37' ' ' PRO . 55.9 p -81.56 -22.74 37.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.532 ' HZ1' HD21 ' C' ' 48' ' ' LEU . 1.8 tpmt? -64.68 -39.59 93.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.878 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.753 HG22 ' O ' ' C' ' 38' ' ' THR . 8.8 t . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 0.0 109.616 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.476 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' C' ' 48' ' ' LEU . 0.3 OUTLIER -150.99 68.1 0.93 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' C' ' 49' ' ' SER . 1.5 m-20 -48.42 -18.31 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.07 -1.019 . . . . 0.0 109.613 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.582 ' CD1' ' O ' ' C' ' 46' ' ' PHE . 0.9 OUTLIER 46.56 21.19 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.211 -0.93 . . . . 0.0 109.536 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.461 ' O ' ' O ' ' C' ' 50' ' ' HIS . 5.2 m -75.31 18.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' HIS . . . . . 0.496 ' N ' ' ND1' ' C' ' 50' ' ' HIS . 2.4 m80 57.53 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 109.661 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.02 10.5 83.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 3.2 p -54.43 -12.71 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 71.13 -16.87 0.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.382 -0.824 . . . . 0.0 109.729 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' C' ' 52' ' ' SER . 5.1 pt20 -81.57 -28.85 33.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.959 . . . . 0.0 109.684 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.514 HG22 ' CE2' ' C' ' 46' ' ' PHE . 22.4 t -73.54 -38.43 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.584 ' CD ' ' H ' ' C' ' 56' ' ' LYS . 0.0 OUTLIER -78.71 -22.75 46.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.395 -0.816 . . . . 0.0 109.011 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.2 -23.81 58.35 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.471 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.7 t-80 -78.6 -38.45 39.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -1.147 . . . . 0.0 109.506 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.79 -48.85 49.73 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.41 ' O ' ' CG ' ' C' ' 64' ' ' ASP . 53.7 mttm -51.8 -23.28 4.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.36 -1.082 . . . . 0.0 109.924 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.26 -42.39 65.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.116 -0.99 . . . . 0.0 109.054 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t -69.82 -48.51 63.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.455 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -65.46 -28.59 69.32 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 64' ' ' ASP . . . . . 0.41 ' CG ' ' O ' ' C' ' 60' ' ' LYS . 30.2 m-20 -70.23 -36.4 74.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 108.926 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.95 -52.74 47.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.476 -0.765 . . . . 0.0 108.968 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.415 ' O ' HG23 ' C' ' 70' ' ' VAL . 11.3 mt -58.03 -42.16 84.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 108.665 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.478 ' O ' ' N ' ' C' ' 71' ' ' ALA . 26.1 m -67.54 -51.55 49.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.245 -0.91 . . . . 0.0 108.998 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -60.46 -29.34 68.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 108.744 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -82.95 -46.54 12.8 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.415 HG23 ' O ' ' C' ' 66' ' ' LEU . 48.6 t -67.16 -22.38 29.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -66.07 -24.26 66.68 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.658 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.593 ' O ' HG12 ' C' ' 73' ' ' VAL . 11.8 m80 -137.27 -47.86 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.754 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.593 HG12 ' O ' ' C' ' 72' ' ' HIS . 10.9 p 45.09 13.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.802 0.81 . . . . 0.0 109.411 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' C' ' 72' ' ' HIS . 26.3 t70 -135.71 11.46 3.42 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -173.77 28.26 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.007 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.712 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -77.94 -25.02 0.46 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.489 -0.757 . . . . 0.0 111.414 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' C' ' 76' ' ' MET . 41.9 Cg_exo -56.37 -24.7 53.3 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.851 1.701 . . . . 0.0 112.363 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -89.39 -29.21 19.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.0 -43.2 35.69 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.143 -0.973 . . . . 0.0 109.068 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 80' ' ' LEU . . . . . 0.471 ' N ' HD12 ' C' ' 80' ' ' LEU . 6.4 mp -83.5 8.7 13.19 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.358 -0.839 . . . . 0.0 108.962 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.6 m -63.43 -23.39 67.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.551 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -76.24 -55.33 5.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.629 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.42 ' N ' HD23 ' C' ' 83' ' ' LEU . 4.5 mt -46.59 -46.8 19.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.818 . . . . 0.0 108.861 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 5.0 m -56.91 -25.33 57.08 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.404 -0.81 . . . . 0.0 109.25 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' C' ' 82' ' ' ALA . 11.6 t70 -81.02 -35.06 32.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.91 -27.04 62.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.25 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' HIS . . . . . 0.439 ' O ' ' O ' ' C' ' 90' ' ' LYS . 68.2 m80 -82.74 -31.36 28.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.17 -42.64 15.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -78.16 -18.79 55.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.854 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' C' ' 87' ' ' HIS . 46.8 mttm -146.06 179.81 7.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.898 . . . . 0.0 109.511 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' C' ' 93' ' ' VAL . 12.5 mt 59.08 58.54 3.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.456 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -53.99 -6.82 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.248 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' C' ' 91' ' ' LEU . 11.5 p -54.64 137.89 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.688 ' HB2' ' OD2' ' B' ' 99' ' ' ASP . 0.7 OUTLIER -77.24 157.89 80.23 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.086 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' C' ' 97' ' ' ASN . 10.0 Cg_endo -54.74 -10.34 2.46 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.627 2.218 . . . . 0.0 111.953 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.478 HG21 ' CG ' ' B' ' 99' ' ' ASP . 85.4 t -43.09 -22.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -0.819 . . . . 0.0 109.743 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' C' ' 95' ' ' PRO . 3.1 m120 -79.15 -41.16 29.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.959 . . . . 0.0 109.206 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 98' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' C' ' 95' ' ' PRO . 31.9 t80 -48.59 -25.68 1.85 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 109.249 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -70.65 -30.37 66.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.18 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.559 HD13 ' CD1' ' C' ' 36' ' ' PHE . 20.4 mt -84.07 -61.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 109.63 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 101' ' ' LEU . . . . . 0.471 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 4.6 tt -49.15 -23.55 1.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.744 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 34.5 m -72.87 -43.91 61.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.798 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 103' ' ' HIS . . . . . 0.514 ' CD2' ' OD1' ' D' ' 108' ' ' ASN . 41.3 t-80 -80.58 -26.69 37.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 109.732 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.922 ' SG ' ' HB1' ' C' ' 28' ' ' ALA . 11.1 p -57.98 -48.09 81.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.768 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.655 ' N ' ' SG ' ' C' ' 104' ' ' CYS . 2.5 mt -46.46 -39.12 10.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.393 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.613 HD12 ' CE1' ' C' ' 122' ' ' HIS . 3.7 mm? -68.72 -30.37 68.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.603 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 107' ' ' VAL . . . . . 0.597 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 85.7 t -75.04 -51.43 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.459 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.464 ' O ' ' N ' ' C' ' 110' ' ' ALA . 27.1 m -60.12 -59.63 5.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.244 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' C' ' 114' ' ' PRO . 12.4 mt -46.29 -18.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -69.66 -42.56 74.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.0 110.368 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.15 -3.63 43.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.0 110.17 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -129.72 -81.83 0.56 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 109.622 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.4 OUTLIER -119.17 82.2 22.28 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 114' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 53.3 Cg_exo -48.79 -169.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.427 2.085 . . . . 0.0 112.604 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.839 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -50.89 -56.27 13.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.491 -0.756 . . . . 0.0 109.289 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.658 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 3.0 mm-40 122.66 -8.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.503 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 5.6 t80 80.26 34.95 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.935 -0.478 . . . . 0.0 111.212 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.739 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -113.45 120.26 40.13 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -48.3 16.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.242 1.961 . . . . 0.0 112.992 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -140.93 -34.73 0.49 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.049 -1.032 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.839 HG21 ' O ' ' C' ' 115' ' ' ALA . 9.4 p -51.75 -47.18 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.613 ' CE1' HD12 ' C' ' 106' ' ' LEU . 1.0 OUTLIER -60.34 -39.81 88.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.26 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.44 -20.03 32.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.344 -0.847 . . . . 0.0 109.785 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.535 ' N ' ' O ' ' C' ' 120' ' ' ALA . 24.3 p -61.83 -62.42 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 110.283 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.5 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.3 mt -68.14 -19.51 64.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 0.0 109.544 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -83.13 -45.46 13.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 109.841 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.416 ' CG ' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -87.31 -41.36 13.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.974 . . . . 0.0 109.84 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.462 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 37.1 t80 -50.22 -20.83 1.13 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.879 -1.138 . . . . 0.0 108.81 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' C' ' 133' ' ' SER . 19.2 mt -70.57 -17.92 62.91 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.64 -31.69 69.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.581 ' OG ' HD13 ' C' ' 2' ' ' LEU . 0.8 OUTLIER -81.79 -33.94 30.59 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.429 -0.795 . . . . 0.0 108.933 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 26.4 t -83.85 -29.16 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.334 -0.854 . . . . 0.0 108.927 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.536 ' N ' ' O ' ' C' ' 129' ' ' LEU . 23.3 t -80.37 -25.39 39.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.393 -0.817 . . . . 0.0 109.109 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 44.9 m -75.35 -39.69 59.04 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 28.8 m -75.07 -22.12 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 108.887 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.95 -35.03 72.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.041 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 82.3 m -87.38 -29.79 21.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 109.434 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 1.5 t60 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.314 0.578 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.919 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -138.39 -162.92 1.37 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.331 -0.856 . . . . 0.0 109.068 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.53 153.2 61.52 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 108.939 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.71 -26.39 68.49 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.498 2.132 . . . . 0.0 112.3 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.15 -27.86 22.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.862 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -84.07 -48.06 10.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.095 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.705 ' HB2' HD13 ' D' ' 3' ' ' LEU . 0.8 OUTLIER -68.84 -43.39 75.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.149 -0.969 . . . . 0.0 109.52 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -56.65 -23.58 42.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.173 -0.955 . . . . 0.0 110.026 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.57 -57.63 3.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.98 -1.075 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.02 -24.32 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 46.1 m -80.89 -36.96 30.54 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.723 -0.611 . . . . 0.0 109.782 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.81 -22.3 63.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.941 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' D' ' 16' ' ' GLY . 1.8 mt -59.85 -28.1 67.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.11 -0.994 . . . . 0.0 109.379 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 15' ' ' TRP . . . . . 0.66 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.5 OUTLIER -47.53 -17.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.198 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 16' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -76.83 -36.13 37.68 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.454 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 3.2 mmtt -89.36 -35.8 15.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -1.196 . . . . 0.0 109.298 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -47.94 114.95 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.32 -0.863 . . . . 0.0 109.668 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' D' ' 21' ' ' ASP . 83.5 m-20 -77.91 65.78 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 0.0 108.85 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 71.5 t -44.55 -17.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' D' ' 19' ' ' ASN . 13.4 m-20 -78.84 6.74 8.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' D' ' 19' ' ' ASN . 58.1 mt-10 -155.58 -46.94 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' D' ' 27' ' ' ALA . 85.9 t -47.8 -42.22 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.629 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.76 -43.42 96.46 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.85 -39.18 25.21 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -76.21 -25.78 55.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -1.151 . . . . 0.0 109.557 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' D' ' 23' ' ' VAL . . . -75.6 -34.02 60.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.477 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tp -82.96 -52.38 6.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.426 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.66 -26.71 17.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -77.91 -31.34 51.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 0.0 109.447 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 32.5 tp -48.99 -34.61 13.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.352 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 29.1 mt -80.44 -21.97 41.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 23.8 t -82.54 -64.27 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.418 HG23 ' H ' ' D' ' 34' ' ' VAL . 3.0 t -61.05 -22.86 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 109.639 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -152.17 88.57 4.08 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.479 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.89 12.84 2.51 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.621 2.214 . . . . 0.0 112.251 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' TRP . . . . . 0.601 ' CZ2' ' ND2' ' D' ' 102' ' ' ASN . 0.7 OUTLIER -71.8 -20.01 61.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 109.546 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.592 HG23 ' NE1' ' D' ' 37' ' ' TRP . 1.3 p -84.09 51.06 1.97 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 109.273 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 39' ' ' GLN . . . . . 0.434 ' O ' ' CD1' ' D' ' 42' ' ' PHE . 38.6 tt0 -92.2 31.15 1.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.252 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -87.85 -42.92 12.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.589 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -93.1 14.3 18.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 109.551 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' D' ' 43' ' ' GLU . 1.6 p90 -68.28 -34.13 75.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.595 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 43' ' ' GLU . . . . . 0.54 ' N ' ' CD1' ' D' ' 42' ' ' PHE . 11.9 pt-20 -53.31 -17.4 1.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.543 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 60.8 m -85.56 -34.7 21.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 109.59 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' D' ' 47' ' ' ASP . 10.1 m-85 -51.08 -20.95 1.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.358 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.98 12.44 0.15 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' D' ' 45' ' ' PHE . 15.1 m-20 -160.63 110.51 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -1.102 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tp -158.72 20.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.294 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 58.7 m -46.91 -41.03 15.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.642 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 50' ' ' THR . . . . . 0.469 ' HG1' ' CG ' ' D' ' 52' ' ' ASP . 4.8 p -146.57 150.37 40.02 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.359 -0.838 . . . . 0.0 109.217 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -41.16 -43.65 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.467 2.111 . . . . 0.0 112.382 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 52' ' ' ASP . . . . . 0.469 ' CG ' ' HG1' ' D' ' 50' ' ' THR . 1.7 p-10 -64.11 -31.09 72.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.152 -0.968 . . . . 0.0 109.447 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -56.94 -19.88 20.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 48.3 t -71.36 -61.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.571 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' D' ' 55' ' ' MET . 5.5 mmt -70.99 -0.48 9.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 0.0 109.443 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.72 30.92 7.32 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -142.94 137.02 14.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.211 -1.17 . . . . 0.0 109.385 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.04 -30.77 5.45 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.516 2.144 . . . . 0.0 112.336 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -21.07 59.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 109.739 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.92 -41.46 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.476 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -78.35 -25.35 46.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.57 71.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -62.61 -23.83 67.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.549 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.36 -50.23 22.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -49.57 -30.84 9.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -1.147 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -65.5 -53.68 38.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.899 . . . . 0.0 109.591 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 28.2 t -59.03 -36.92 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.413 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.425 HD23 ' C ' ' D' ' 68' ' ' LEU . 5.7 tt -65.51 -48.43 72.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 109.345 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.94 -41.08 10.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.28 91.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.167 . . . . 0.0 109.64 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -61.5 -47.27 86.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.612 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 72' ' ' SER . . . . . 0.66 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 19.4 m -62.56 -41.97 99.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.349 -0.844 . . . . 0.0 109.531 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -48.31 -34.85 11.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.44 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.71 -60.42 6.98 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.556 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.6 mp -54.04 -22.1 9.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.157 . . . . 0.0 109.32 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.06 2.51 56.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.942 . . . . 0.0 109.626 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -170.19 66.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.26 15.25 2.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.348 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.82 -23.22 60.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 80' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 37.1 t-20 -167.2 108.11 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.582 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mt -80.31 -51.67 8.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 109.373 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 82' ' ' LYS . . . . . 0.43 ' HZ2' ' HB2' ' D' ' 143' ' ' HIS . 52.5 mttm -67.01 -24.13 65.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.707 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 83' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -78.6 -39.11 22.58 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.9 t -85.1 -47.44 10.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.15 -1.206 . . . . 0.0 109.696 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' D' ' 84' ' ' THR . 40.4 m-85 -84.72 27.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.486 -0.759 . . . . 0.0 109.519 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.28 -31.41 72.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.359 -0.838 . . . . 0.0 109.626 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 51.1 p -75.77 -53.84 7.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.715 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -48.12 -42.98 30.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 3.0 m -67.0 -48.33 68.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.574 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -67.35 -22.66 65.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.761 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.73 -68.36 0.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.124 -0.985 . . . . 0.0 109.567 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.577 ' NE2' ' O ' ' D' ' 141' ' ' LEU . 1.1 p-80 -54.44 -20.67 7.99 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.172 -0.955 . . . . 0.0 109.939 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 93' ' ' CYS . . . . . 0.426 ' N ' ' ND1' ' D' ' 92' ' ' HIS . 41.3 t -83.53 -59.57 2.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 110.818 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.36 -56.41 3.45 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.072 -1.018 . . . . 0.0 111.396 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -57.69 -51.73 68.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.095 -1.003 . . . . 0.0 110.599 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.568 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 12.2 mt -97.42 -64.32 1.05 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.081 -1.012 . . . . 0.0 109.94 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.786 ' HB2' ' HB ' ' A' ' 38' ' ' THR . 0.0 OUTLIER 91.03 25.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.297 0.57 . . . . 0.0 109.868 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 98' ' ' VAL . . . . . 0.431 HG23 ' H ' ' D' ' 98' ' ' VAL . 17.5 t -46.73 140.79 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.5 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 99' ' ' ASP . . . . . 0.765 ' OD2' ' HB2' ' A' ' 94' ' ' ASP . 96.0 m-20 -53.94 149.41 17.68 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.399 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.84 36.45 0.4 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.6 2.2 . . . . 0.0 112.119 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -145.12 45.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 102' ' ' ASN . . . . . 0.601 ' ND2' ' CZ2' ' D' ' 37' ' ' TRP . 4.4 m120 -143.8 5.95 1.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -0.843 . . . . 0.0 109.556 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 1.1 m-85 -89.73 -69.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 109.516 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 104' ' ' ARG . . . . . 0.568 ' NH2' ' CZ ' ' C' ' 36' ' ' PHE . 44.1 ttt180 -55.08 -20.88 10.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 tp -75.19 -31.14 60.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tt -68.29 -55.33 12.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.7 -20.45 39.5 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 108' ' ' ASN . . . . . 0.514 ' OD1' ' CD2' ' C' ' 103' ' ' HIS . 61.7 t30 -60.18 -34.78 74.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -1.094 . . . . 0.0 109.636 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 6.8 t -86.47 -24.15 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 109.599 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.64 -36.42 82.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 109.553 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 111' ' ' VAL . . . . . 0.438 ' CG1' ' CD1' ' D' ' 130' ' ' TYR . 4.4 m -74.99 -25.92 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.248 -0.908 . . . . 0.0 109.665 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 16.9 t -66.84 -63.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.148 -0.97 . . . . 0.0 109.584 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 113' ' ' VAL . . . . . 0.401 ' H ' HG23 ' D' ' 113' ' ' VAL . 10.6 t -49.16 -21.59 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.506 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.91 -57.01 4.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.4 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -55.62 -27.37 49.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.892 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.489 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.75 -60.07 2.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.5 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -62.39 -17.55 59.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.611 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 65.7 m-85 -150.0 60.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.987 . . . . 0.0 109.675 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' D' ' 121' ' ' GLU . . . -66.53 -45.33 86.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -47.29 -19.88 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -1.181 . . . . 0.0 109.31 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' D' ' 119' ' ' GLY . 70.1 mm-40 -94.76 -26.78 16.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.652 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.475 ' CD1' ' C ' ' D' ' 122' ' ' PHE . 0.7 OUTLIER -48.67 120.86 4.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.348 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 9.7 p -149.12 149.32 29.4 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.009 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.434 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 2.5 Cg_endo -46.21 -58.01 1.9 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.366 2.044 . . . . 0.0 113.168 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 19.3 Cg_endo -59.84 -11.12 13.8 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.168 1.912 . . . . 0.0 112.474 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 53.6 t -94.8 -53.19 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.034 -1.041 . . . . 0.0 109.821 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -61.37 -59.73 4.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.503 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -51.3 -37.39 47.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.18 18.48 2.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.694 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.438 ' CD1' ' CG1' ' D' ' 111' ' ' VAL . 15.1 t80 -109.5 -61.73 1.59 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -0.908 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 0.519 ' CD ' ' H ' ' D' ' 131' ' ' GLN . 22.8 mp0 -48.46 -24.16 1.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.003 -1.061 . . . . 0.0 109.662 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 132' ' ' LYS . . . . . 0.401 ' HG3' ' CD2' ' B' ' 146' ' ' HIS . 35.7 ttpt -85.69 -37.38 19.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -0.888 . . . . 0.0 110.21 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 133' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 0.4 OUTLIER -60.88 -44.21 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.067 -1.021 . . . . 0.0 109.821 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.496 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 7.0 m -83.6 -16.94 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.2 -0.938 . . . . 0.0 109.877 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.99 -25.13 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.07 -1.019 . . . . 0.0 109.432 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.97 -23.94 56.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 137' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' D' ' 134' ' ' VAL . 42.4 t -79.49 -31.78 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -1.105 . . . . 0.0 109.522 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.57 -50.78 56.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.396 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -67.07 -32.27 73.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.68 -42.42 34.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.95 . . . . 0.0 109.237 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 141' ' ' LEU . . . . . 0.577 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 38.3 mt -84.12 18.44 2.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.392 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.45 -31.03 2.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.163 -0.961 . . . . 0.0 109.556 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 143' ' ' HIS . . . . . 0.43 ' HB2' ' HZ2' ' D' ' 82' ' ' LYS . 15.1 t-80 -46.33 -41.92 14.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 109.285 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' D' ' 146' ' ' HIS . 35.7 mmtt -75.41 -54.39 7.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.419 -0.801 . . . . 0.0 109.127 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 145' ' ' TYR . . . . . 0.467 ' O ' ' CG ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -57.42 -6.21 0.42 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.501 -0.75 . . . . 0.0 109.234 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.447 ' CD2' ' HG3' ' B' ' 132' ' ' LYS . 11.6 m-70 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.759 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 1' ' ' VAL . 73.9 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.585 HD21 ' OG ' ' A' ' 131' ' ' SER . 78.2 mt -144.7 178.82 7.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.995 . . . . 0.0 109.723 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.73 167.11 26.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.434 -0.791 . . . . 0.0 109.069 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.15 -43.72 2.98 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.599 2.199 . . . . 0.0 112.563 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.29 -19.35 33.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.977 -1.077 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.783 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.7 t0 -47.85 -37.14 13.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.413 ' CD ' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -81.19 -43.59 19.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.869 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.0 m -51.15 -37.53 46.79 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.123 -0.986 . . . . 0.0 109.558 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -74.93 -31.96 61.64 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 6' ' ' ASP . 58.6 t -72.36 -51.27 30.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -49.98 -47.44 52.81 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.9 -61.28 2.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.458 -0.776 . . . . 0.0 109.537 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.64 -40.06 68.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.424 -0.797 . . . . 0.0 109.058 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -17.16 64.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.425 -0.797 . . . . 0.0 108.955 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.34 -44.96 15.69 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 12.2 mmmt -70.66 -40.66 72.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -1.166 . . . . 0.0 108.802 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' ALA . 61.9 t -60.27 -64.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 46.1 -127.34 9.36 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 23.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -1.102 . . . . 0.0 110.569 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' A' ' 18' ' ' GLY . 86.0 m-70 -130.07 25.77 5.22 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -90.24 -63.8 1.23 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.693 -0.629 . . . . 0.0 109.754 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.77 -14.3 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.0 mm-40 -83.28 -56.51 3.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -1.076 . . . . 0.0 109.559 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.664 ' CD1' ' CE1' ' A' ' 112' ' ' HIS . 3.6 m-30 -62.07 -32.24 72.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.462 -0.773 . . . . 0.0 109.274 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.19 -23.4 77.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.08 -44.38 22.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -1.09 . . . . 0.0 109.587 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -61.1 -26.24 67.52 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -26.78 68.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.526 HD11 ' ND1' ' A' ' 58' ' ' HIS . 14.1 mt -72.51 -58.4 3.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.471 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -52.16 -38.91 59.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.61 ' HG3' ' OE1' ' B' ' 127' ' ' GLN . 0.9 OUTLIER -68.21 -50.58 53.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.299 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.469 ' C ' ' SD ' ' A' ' 32' ' ' MET . 15.2 tmm? -62.4 -29.15 70.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.351 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.69 -58.73 6.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 110.026 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.4 pp -73.89 -39.62 63.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.2 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.524 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 50.8 m -46.71 -16.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.081 -1.012 . . . . 0.0 109.825 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 35' ' ' SER . 15.2 m-85 -159.37 89.64 1.99 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 0.0 109.362 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 40' ' ' LYS . 52.5 Cg_exo -52.77 -20.07 12.07 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.457 2.105 . . . . 0.0 112.095 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 p -49.08 -18.91 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.403 ' N ' ' C ' ' A' ' 37' ' ' PRO . 30.3 p -84.17 -22.92 30.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' PRO . 29.9 ttmt -55.5 -47.01 76.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.567 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.667 HG21 ' O ' ' D' ' 94' ' ' ASP . 5.1 t . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.8 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.598 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.19 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -145.53 31.24 1.09 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.506 -1.371 . . . . 0.0 110.078 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 49' ' ' SER . 1.1 m-20 52.84 91.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.872 . . . . 0.0 109.614 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.19 1.87 0.43 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.373 -0.83 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 47' ' ' ASP . 9.2 m -62.48 140.95 58.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.421 ' ND1' ' O ' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -63.72 140.34 58.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.448 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.21 12.13 81.23 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.631 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 2.2 t -59.31 -20.58 55.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -1.174 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 72.61 -24.33 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -0.782 . . . . 0.0 109.61 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 52' ' ' SER . 33.5 mt-30 -80.31 -24.32 40.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.569 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.8 t -75.85 -35.14 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 56' ' ' LYS . 14.1 ptpt -79.17 -34.67 42.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.946 . . . . 0.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.19 -24.52 76.3 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.526 ' ND1' HD11 ' A' ' 29' ' ' LEU . 5.9 t-80 -68.15 -43.87 77.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.317 -1.108 . . . . 0.0 109.316 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.8 -46.97 25.19 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 48.5 mttm -54.6 -23.19 15.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.512 -0.993 . . . . 0.0 109.644 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -36.85 58.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.199 -0.938 . . . . 0.0 108.902 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -73.73 -47.39 44.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.499 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -68.64 -29.09 67.51 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.312 -0.868 . . . . 0.0 109.342 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 25.6 m-20 -66.79 -47.23 72.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.096 -1.002 . . . . 0.0 108.75 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -49.46 76.11 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.3 mt -55.37 -46.03 76.5 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 71' ' ' ALA . 27.6 m -64.97 -55.55 18.43 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.301 -0.874 . . . . 0.0 108.749 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -55.9 -29.3 59.78 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.73 -48.12 12.06 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 66' ' ' LEU . 54.9 t -65.17 -22.5 31.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -68.94 -16.48 63.76 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 74' ' ' ASP . 63.2 m-70 -145.1 -56.9 0.33 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.306 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.4 p 44.94 13.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.665 0.745 . . . . 0.0 109.576 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 72' ' ' HIS . 99.2 m-20 -123.69 8.41 8.86 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -175.92 28.69 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.147 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 5.2 ptt? -78.09 -24.64 0.45 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 111.676 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 76' ' ' MET . 53.2 Cg_exo -54.83 -23.66 34.93 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.759 1.639 . . . . 0.0 112.195 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -93.32 -37.24 12.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.88 75.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.149 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.5 mt -81.74 8.79 9.15 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.325 -0.86 . . . . 0.0 109.048 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.0 t -56.11 -41.05 74.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.845 . . . . 0.0 109.618 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -56.22 -57.33 12.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.576 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.46 ' N ' HD23 ' A' ' 83' ' ' LEU . 4.2 mt -46.31 -46.69 18.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.376 -0.827 . . . . 0.0 108.819 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -59.96 -29.64 68.56 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.476 -0.765 . . . . 0.0 109.289 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 89' ' ' HIS . 76.0 m-20 -81.52 -38.93 25.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 0.0 109.339 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 87' ' ' HIS . 4.1 tt -59.18 -36.04 74.62 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.334 -0.853 . . . . 0.0 109.46 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.434 ' CE1' HD22 ' A' ' 86' ' ' LEU . 51.1 m80 -92.12 -23.07 19.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.949 . . . . 0.0 109.69 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.52 -9.49 29.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.238 -0.914 . . . . 0.0 109.922 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 85' ' ' ASP . 42.9 m80 -143.93 47.93 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -0.97 . . . . 0.0 109.698 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.13 -69.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 109.319 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.453 ' C ' ' N ' ' A' ' 93' ' ' VAL . 11.7 mt -88.76 -23.84 22.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 51.65 10.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.565 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.453 ' N ' ' C ' ' A' ' 91' ' ' LEU . 14.8 p -52.62 144.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.492 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 151.68 86.12 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.31 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 97' ' ' ASN . 47.6 Cg_endo -70.12 -20.98 32.45 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.558 2.172 . . . . 0.0 112.123 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.546 HG11 ' OD1' ' D' ' 99' ' ' ASP . 93.2 t -45.84 -15.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 109.756 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 95' ' ' PRO . 3.4 m120 -79.25 -24.88 42.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 109.577 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.495 ' CD1' ' C ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -69.1 -31.14 69.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.364 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -58.56 -29.94 66.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.504 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 17.6 mt -83.91 -62.18 1.63 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.581 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.1 tt -45.65 -24.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.597 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.7 t -65.22 -57.26 8.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.928 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -73.74 -26.5 60.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.981 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 9.5 m -70.32 -23.45 62.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.099 -1.001 . . . . 0.0 110.157 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.725 HD12 ' O ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -80.56 -22.87 40.37 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.937 -1.102 . . . . 0.0 108.926 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.99 -18.78 33.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.852 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.0 t -77.5 -50.33 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 110' ' ' ALA . 43.4 p -52.56 -51.91 57.46 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.161 -0.962 . . . . 0.0 109.678 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 113' ' ' LEU . 7.9 mt -43.74 -26.36 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.465 -0.772 . . . . 0.0 109.759 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -71.92 -25.65 61.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.924 . . . . 0.0 110.486 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.47 -3.79 54.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.106 -0.996 . . . . 0.0 110.902 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.664 ' CE1' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -150.15 -69.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.782 -1.199 . . . . 0.0 109.669 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -118.29 81.24 16.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.47 ' N ' ' O ' ' A' ' 109' ' ' LEU . 51.2 Cg_exo -49.32 -170.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.44 2.094 . . . . 0.0 112.589 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.729 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -48.65 -55.63 10.75 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.649 ' CG ' ' O ' ' A' ' 115' ' ' ALA . 2.8 mm-40 130.5 0.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.1 t80 66.3 30.37 9.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.842 -0.536 . . . . 0.0 111.138 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.706 ' O ' ' N ' ' A' ' 120' ' ' ALA . 2.1 p -103.79 128.12 27.97 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 120.996 -1.065 . . . . 0.0 108.249 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.64 23.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.102 1.868 . . . . 0.0 112.923 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.706 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -157.03 -32.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 0.0 110.669 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.729 HG21 ' O ' ' A' ' 115' ' ' ALA . 12.9 p -49.84 -47.24 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.13 -0.981 . . . . 0.0 110.299 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.656 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.4 t60 -61.74 -38.56 88.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.771 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.41 -20.12 34.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 109.95 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -66.28 -62.36 1.52 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.95 . . . . 0.0 110.245 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.568 HD22 HD21 ' A' ' 105' ' ' LEU . 1.4 mt -65.11 -19.81 66.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.071 -1.018 . . . . 0.0 109.467 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.17 -49.27 37.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.15 -42.1 11.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 109.635 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.574 ' CD2' HG21 ' A' ' 10' ' ' VAL . 32.0 t80 -50.0 -22.92 1.75 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 109.255 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.665 HD12 ' C ' ' A' ' 129' ' ' LEU . 1.2 pp -76.37 -22.08 55.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.14 -38.1 75.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.585 ' OG ' HD21 ' A' ' 2' ' ' LEU . 34.6 m -67.92 -26.8 66.16 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.469 ' O ' HD13 ' A' ' 136' ' ' LEU . 5.6 t -85.55 -37.67 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.8 t -80.06 -18.0 51.22 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.298 -0.876 . . . . 0.0 108.738 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 41.8 m -83.28 -42.44 17.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.468 -0.77 . . . . 0.0 109.208 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 131' ' ' SER . 27.3 m -70.06 -21.97 24.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.24 -0.913 . . . . 0.0 108.756 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 132' ' ' VAL . 0.9 OUTLIER -67.46 -31.8 72.22 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.1 m -153.27 57.1 0.77 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 1.078 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -107.63 -159.13 0.68 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.496 -0.752 . . . . 0.0 109.361 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 9.9 p -103.57 134.4 19.77 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.394 -0.816 . . . . 0.0 109.29 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -42.1 -22.79 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.438 2.092 . . . . 0.0 112.467 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -76.62 -55.6 5.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 110.065 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -68.16 -60.45 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.961 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.775 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -48.74 -30.14 5.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 2.9 m -62.05 -23.61 66.58 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.979 -1.075 . . . . 0.0 110.032 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.05 -57.68 3.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.886 -1.134 . . . . 0.0 109.958 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.55 -24.95 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 56.6 m -83.39 -37.36 23.4 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.453 0.644 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' B' ' 9' ' ' SER . . . -63.19 -29.92 71.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.369 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.7 OUTLIER -52.16 -32.46 36.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.119 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 15' ' ' TRP . . . . . 0.539 ' HE1' ' HG ' ' B' ' 72' ' ' SER . 0.2 OUTLIER -47.15 -17.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.509 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.34 -52.02 5.81 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' B' ' 17' ' ' LYS . 0.1 OUTLIER -70.48 -29.41 65.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -1.179 . . . . 0.0 109.263 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -48.72 114.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 22' ' ' GLU . 18.3 m120 -82.56 69.41 9.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 108.953 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' B' ' 22' ' ' GLU . 78.3 t -43.88 -29.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 0.0 109.72 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -64.69 1.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' B' ' 20' ' ' VAL . 33.0 mt-10 -155.89 -46.11 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 109.424 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -48.52 -53.96 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.41 -48.52 48.14 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.34 -46.35 79.09 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.44 -39.96 95.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.27 -1.136 . . . . 0.0 109.394 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.74 88.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.179 -0.95 . . . . 0.0 109.364 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -82.2 -51.22 8.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.309 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.91 -35.08 62.53 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -79.37 -30.65 42.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -1.158 . . . . 0.0 109.495 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 60.6 tp -49.42 -39.03 31.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.379 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.53 -23.45 56.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.583 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.79 -61.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.188 -0.945 . . . . 0.0 109.413 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.403 ' H ' HG23 ' B' ' 34' ' ' VAL . 3.2 t -69.36 -23.82 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -136.73 76.09 48.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.64 11.49 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.725 2.283 . . . . 0.0 112.335 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.468 ' CE2' HG23 ' B' ' 38' ' ' THR . 51.3 p-90 -80.62 -19.71 44.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 109.341 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.468 HG23 ' CE2' ' B' ' 37' ' ' TRP . 42.0 p -79.77 40.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 109.36 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -92.16 12.84 20.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 0.0 109.55 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -87.86 -34.49 18.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' B' ' 42' ' ' PHE . 29.9 m-85 -95.79 32.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' B' ' 41' ' ' PHE . 57.5 m-85 -141.36 26.32 1.98 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.94 -25.08 37.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.483 ' C ' ' H ' ' B' ' 46' ' ' GLY . 66.8 m -82.13 -38.17 25.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.602 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -56.0 -5.41 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' B' ' 44' ' ' SER . . . 48.57 -167.67 0.16 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' B' ' 48' ' ' LEU . 18.9 t70 60.19 -150.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -1.149 . . . . 0.0 109.536 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.473 ' H ' ' CG ' ' B' ' 47' ' ' ASP . 24.2 mt 60.57 34.33 20.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 109.53 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.3 m -80.49 -22.52 40.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.41 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' THR . . . . . 0.502 ' O ' ' N ' ' B' ' 53' ' ' ALA . 21.4 p -146.11 149.02 37.24 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.279 -0.888 . . . . 0.0 109.166 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -36.75 -45.07 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.644 2.23 . . . . 0.0 112.591 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.88 -26.93 61.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 109.544 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -57.78 -19.64 29.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.05 -63.36 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.135 -0.978 . . . . 0.0 109.633 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' MET . . . . . 0.542 ' SD ' ' N ' ' B' ' 55' ' ' MET . 2.3 mpp? -79.69 14.81 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.05 -49.01 4.41 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.46 HD21 ' HE2' ' B' ' 59' ' ' LYS . 3.8 m-20 -77.82 149.61 77.54 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.227 -1.16 . . . . 0.0 109.46 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.36 -51.94 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.671 2.247 . . . . 0.0 112.176 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.46 ' HE2' HD21 ' B' ' 57' ' ' ASN . 54.2 pttt -46.92 -40.75 14.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.56 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' B' ' 59' ' ' LYS . 87.1 t -54.21 -44.85 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' B' ' 61' ' ' LYS . 7.0 mtmp? -77.39 -43.0 34.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.222 -0.924 . . . . 0.0 109.438 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.17 -33.12 18.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -67.67 -24.4 65.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.68 -30.25 74.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -68.15 -41.23 81.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.121 . . . . 0.0 109.318 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -64.08 -50.89 66.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.779 . . . . 0.0 109.36 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -61.78 -23.91 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.251 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tt -78.11 -29.8 49.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.475 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.22 -57.13 14.33 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.54 -22.03 63.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -74.46 -30.34 61.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.63 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' SER . . . . . 0.539 ' HG ' ' HE1' ' B' ' 15' ' ' TRP . 4.4 m -89.11 -20.48 24.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 109.762 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -46.15 -30.79 2.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 109.621 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.29 -59.24 7.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.558 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.75 -17.73 10.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 109.667 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -97.38 32.9 2.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.977 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.549 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 9.5 m-70 -176.67 -49.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.161 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' B' ' 77' ' ' HIS . 29.8 mt 39.64 35.3 0.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.637 -0.665 . . . . 0.0 109.614 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -138.62 -31.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.651 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 7.5 p-10 -151.91 72.71 1.03 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.171 -0.956 . . . . 0.0 109.363 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.552 HD12 ' N ' ' B' ' 81' ' ' LEU . 9.6 mp -60.4 -27.08 67.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.912 . . . . 0.0 109.461 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -80.62 -61.48 1.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.77 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.32 -23.9 43.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.432 HG23 ' O ' ' B' ' 80' ' ' ASN . 0.8 OUTLIER -62.4 -51.91 65.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.166 -1.196 . . . . 0.0 109.537 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.546 ' CZ ' ' O ' ' B' ' 81' ' ' LEU . 2.2 p90 -133.18 51.93 2.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.639 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.97 -29.47 4.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -0.994 . . . . 0.0 109.287 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' B' ' 88' ' ' LEU . 17.8 p -60.5 -58.5 8.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.326 -0.859 . . . . 0.0 109.392 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.404 ' N ' ' OG1' ' B' ' 87' ' ' THR . 90.7 mt -48.56 -37.43 17.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.026 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -69.06 -34.84 75.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.913 . . . . 0.0 109.002 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -82.91 -39.01 22.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 109.419 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.07 -25.31 64.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 109.397 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' B' ' 97' ' ' HIS . 6.8 m80 -90.98 -21.81 21.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.181 -0.95 . . . . 0.0 109.567 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.58 -59.05 2.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 111.059 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.592 ' O ' HG21 ' C' ' 41' ' ' THR . 1.3 m-20 -87.21 -57.0 3.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.976 -1.077 . . . . 0.0 112.009 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' LYS . . . . . 0.484 ' CD ' ' N ' ' B' ' 95' ' ' LYS . 12.1 mptt -62.81 -52.16 64.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.122 -0.986 . . . . 0.0 111.195 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.608 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -95.43 -38.2 10.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.973 -1.079 . . . . 0.0 109.837 -178.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 25.3 p80 45.52 33.06 1.25 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.206 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.587 HG23 HD12 ' B' ' 96' ' ' LEU . 52.0 t -50.13 132.4 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.949 -1.094 . . . . 0.0 109.139 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' ASP . . . . . 0.507 ' OD1' HG11 ' C' ' 96' ' ' VAL . 4.2 m-20 -51.15 151.24 5.02 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.266 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.03 -170.35 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.439 2.093 . . . . 0.0 112.026 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' D' ' 101' ' ' GLU . 69.1 mm-40 53.24 69.95 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.47 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.467 ' ND2' ' CD1' ' B' ' 103' ' ' PHE . 3.9 p-10 -171.24 -39.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.49 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.467 ' CD1' ' ND2' ' B' ' 102' ' ' ASN . 12.9 m-85 -50.34 -34.51 24.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -76.13 -43.94 40.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.613 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.521 HD12 ' N ' ' B' ' 105' ' ' LEU . 9.9 mp -49.32 -51.81 31.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 tt -51.69 -37.17 49.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.852 . . . . 0.0 109.353 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.98 -20.57 59.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -65.36 -34.26 77.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 109.561 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.86 -31.67 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 7.7 tp -51.67 -52.09 50.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.517 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.564 ' CG2' ' CE1' ' B' ' 130' ' ' TYR . 42.6 t -51.18 -42.86 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.596 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -60.06 -39.56 86.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.164 -0.96 . . . . 0.0 109.618 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.55 -55.03 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.606 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.03 -31.75 71.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.495 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -64.9 -27.8 69.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.403 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.463 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.79 -61.28 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.227 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.42 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 8.3 m-70 -63.3 -18.28 63.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 58.8 m-85 -148.44 59.53 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -71.95 -14.8 76.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -79.48 -20.29 47.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.271 -1.135 . . . . 0.0 109.528 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' B' ' 123' ' ' THR . 29.1 mm-40 -95.48 -2.49 48.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.953 . . . . 0.0 109.77 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -73.78 33.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 0.0 109.606 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.468 ' H ' ' C ' ' B' ' 121' ' ' GLU . 22.0 p -49.22 148.41 4.4 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.364 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.454 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 2.3 Cg_endo -46.83 -57.51 2.25 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.448 2.099 . . . . 0.0 113.002 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 17.8 Cg_endo -59.49 -42.36 48.86 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.093 1.862 . . . . 0.0 112.233 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 98.9 t -65.11 -20.76 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.458 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' GLN . . . . . 0.61 ' OE1' ' HG3' ' A' ' 31' ' ' ARG . 17.7 tt0 -83.31 -48.99 9.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.552 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.658 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -58.66 -30.06 67.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.437 ' O ' HG23 ' B' ' 133' ' ' VAL . . . -82.14 19.17 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.144 -0.972 . . . . 0.0 109.672 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.564 ' CE1' ' CG2' ' B' ' 111' ' ' VAL . 47.4 t80 -107.95 -61.4 1.58 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.283 -0.886 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 5.9 tp-100 -55.28 -23.26 22.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.947 . . . . 0.0 109.57 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -83.04 -21.8 33.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.647 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' VAL . . . . . 0.437 HG23 ' O ' ' B' ' 129' ' ' ALA . 76.8 t -81.13 -68.31 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 109.696 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 22.4 m -53.76 -25.04 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.848 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -49.56 -29.78 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.461 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.4 -29.28 56.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 96.4 t -76.42 -38.14 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -1.169 . . . . 0.0 109.4 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.96 79.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.42 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' ASN . . . . . 1.117 ' OD1' ' ND1' ' D' ' 146' ' ' HIS . 18.9 m-20 -79.67 -22.96 42.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.85 -60.52 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.601 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.74 -25.26 66.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.331 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 -16.35 27.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.472 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -51.33 -33.38 29.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 109.361 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -73.34 -27.15 61.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -71.94 -46.18 58.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.5 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 1.123 ' ND1' ' OD1' ' D' ' 139' ' ' ASN . 29.4 p80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.942 -1.027 . . . . 0.0 109.548 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.488 ' O ' HG12 ' C' ' 1' ' ' VAL . 73.2 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.571 HD21 ' OG ' ' C' ' 131' ' ' SER . 78.0 mt -144.72 178.84 7.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 109.772 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.77 167.17 25.85 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.05 -43.81 3.0 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.668 2.245 . . . . 0.0 112.62 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.3 -19.35 33.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.999 -1.063 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.771 ' O ' HG23 ' C' ' 10' ' ' VAL . 24.5 t0 -47.84 -37.24 13.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.735 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -43.61 19.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.953 . . . . 0.0 109.886 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 37.3 m -51.14 -37.5 46.53 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.184 -0.947 . . . . 0.0 109.562 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -74.94 -31.92 61.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.771 HG23 ' O ' ' C' ' 6' ' ' ASP . 58.5 t -72.46 -51.13 30.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -50.15 -47.3 54.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.87 -61.35 2.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.479 -0.763 . . . . 0.0 109.573 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.644 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.48 -40.21 68.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.278 -0.889 . . . . 0.0 109.039 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -17.1 64.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.309 -0.869 . . . . 0.0 108.959 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.36 -44.84 15.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -70.68 -40.68 72.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -1.153 . . . . 0.0 108.841 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.644 HG23 ' O ' ' C' ' 13' ' ' ALA . 61.7 t -60.28 -64.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 46.0 -127.27 9.15 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 23.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.465 -1.02 . . . . 0.0 110.544 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' C' ' 18' ' ' GLY . 85.9 m-70 -130.05 25.77 5.23 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -90.19 -63.88 1.21 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.74 -14.34 0.23 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.0 mm-40 -83.28 -56.42 3.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -1.044 . . . . 0.0 109.53 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.659 ' CD1' ' CE1' ' C' ' 112' ' ' HIS . 3.6 m-30 -62.11 -32.31 72.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.416 -0.802 . . . . 0.0 109.179 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.18 -23.46 77.23 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.93 -44.38 22.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.212 -1.169 . . . . 0.0 109.662 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.24 -26.08 67.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.31 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.37 -26.86 68.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.534 HD11 ' ND1' ' C' ' 58' ' ' HIS . 14.1 mt -72.44 -58.37 3.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.523 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -52.23 -38.82 59.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.57 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.607 ' HG3' ' OE1' ' D' ' 127' ' ' GLN . 0.9 OUTLIER -68.21 -50.67 52.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.224 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 32' ' ' MET . . . . . 0.482 ' C ' ' SD ' ' C' ' 32' ' ' MET . 15.2 tmm? -62.39 -29.07 70.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.953 . . . . 0.0 109.392 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -62.78 -58.69 6.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.953 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.4 pp -74.0 -39.57 63.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 110.144 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.528 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 50.5 m -46.81 -16.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.059 -1.026 . . . . 0.0 109.815 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' C' ' 35' ' ' SER . 15.2 m-85 -159.37 89.74 1.99 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.332 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.73 -20.18 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.519 2.146 . . . . 0.0 112.082 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 19.3 p -49.01 -18.96 0.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 30.2 p -84.12 -22.98 30.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.471 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -55.5 -46.97 76.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.576 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.592 HG21 ' O ' ' B' ' 94' ' ' ASP . 5.2 t . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.36 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.573 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.201 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -145.72 31.21 1.07 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.503 -1.373 . . . . 0.0 110.046 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' C' ' 47' ' ' ASP . 1.1 m-20 52.88 91.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.633 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.07 1.74 0.41 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 109.58 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.465 ' H ' ' C ' ' C' ' 47' ' ' ASP . 9.3 m -62.46 140.97 58.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.443 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 50' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' C' ' 50' ' ' HIS . 0.1 OUTLIER -63.64 140.32 58.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.938 . . . . 0.0 109.541 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.15 12.16 81.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 2.3 t -59.22 -20.68 56.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -1.205 . . . . 0.0 109.326 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 72.62 -24.29 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.629 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' C' ' 52' ' ' SER . 33.5 mt-30 -80.41 -24.17 39.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 16.8 t -75.96 -35.09 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.19 -34.61 42.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.871 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.23 -24.41 76.45 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.534 ' ND1' HD11 ' C' ' 29' ' ' LEU . 5.8 t-80 -68.19 -43.93 76.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -1.061 . . . . 0.0 109.277 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.77 -46.88 24.98 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' C' ' 64' ' ' ASP . 48.3 mttm -54.77 -23.12 16.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -1.027 . . . . 0.0 109.57 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.27 -36.91 58.21 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.178 -0.951 . . . . 0.0 108.9 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.467 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -73.77 -47.35 44.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.503 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -68.56 -29.09 67.56 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.428 -0.795 . . . . 0.0 109.416 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 64' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' C' ' 60' ' ' LYS . 25.8 m-20 -66.74 -47.23 72.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 108.697 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 65' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -62.08 -49.31 76.46 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.434 ' O ' HG23 ' C' ' 70' ' ' VAL . 1.3 mt -55.36 -46.11 76.46 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.514 ' O ' ' N ' ' C' ' 71' ' ' ALA . 27.4 m -65.03 -55.5 18.56 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -55.86 -29.37 59.8 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.72 -48.12 12.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 66' ' ' LEU . 54.9 t -65.14 -22.55 31.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -68.9 -16.5 63.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.58 ' O ' ' N ' ' C' ' 74' ' ' ASP . 62.7 m-70 -145.17 -56.82 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 0.0 109.217 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.5 p 44.85 13.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.744 0.783 . . . . 0.0 109.56 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' C' ' 72' ' ' HIS . 99.3 m-20 -123.63 8.35 8.89 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -175.84 28.73 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.178 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 5.2 ptt? -78.13 -24.55 0.45 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.765 . . . . 0.0 111.664 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.9 Cg_exo -54.8 -23.73 35.01 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.74 1.627 . . . . 0.0 112.197 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -93.26 -37.19 12.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.587 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.75 75.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.929 . . . . 0.0 109.203 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 mt -81.88 8.85 9.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 0.0 108.939 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 27.9 t -56.24 -40.95 74.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.882 . . . . 0.0 109.589 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -56.31 -57.33 12.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.536 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.457 ' N ' HD23 ' C' ' 83' ' ' LEU . 4.2 mt -46.25 -46.68 17.96 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 3.9 m -59.99 -29.56 68.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.564 -0.71 . . . . 0.0 109.285 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' C' ' 89' ' ' HIS . 75.9 m-20 -81.63 -38.88 25.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.324 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' C' ' 87' ' ' HIS . 4.1 tt -59.14 -36.11 74.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.375 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 87' ' ' HIS . . . . . 0.432 ' CE1' HD22 ' C' ' 86' ' ' LEU . 52.1 m80 -92.16 -23.04 19.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.684 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.52 -9.39 29.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.215 -0.928 . . . . 0.0 109.887 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' C' ' 85' ' ' ASP . 43.2 m80 -144.03 47.94 1.41 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.056 -1.027 . . . . 0.0 109.776 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.19 -69.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' C' ' 93' ' ' VAL . 11.6 mt -88.77 -23.8 22.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 109.51 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 51.67 10.06 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.466 ' H ' ' C ' ' C' ' 91' ' ' LEU . 14.9 p -52.69 144.52 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.1 151.71 86.13 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.313 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' C' ' 97' ' ' ASN . 47.7 Cg_endo -70.11 -21.0 32.45 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.546 2.164 . . . . 0.0 112.136 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.507 HG11 ' OD1' ' B' ' 99' ' ' ASP . 90.6 t -45.75 -15.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.769 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' C' ' 95' ' ' PRO . 3.3 m120 -79.21 -24.89 42.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.595 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 98' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' C' ' 98' ' ' PHE . 0.1 OUTLIER -68.99 -31.27 69.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 109.435 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -58.51 -29.9 66.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.6 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.471 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 17.7 mt -83.92 -62.14 1.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.584 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 7.1 tt -45.65 -24.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.616 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.7 t -65.33 -57.24 8.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.865 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -73.78 -26.43 60.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 109.998 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 9.6 m -70.41 -23.34 62.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 110.17 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.714 ' O ' HD12 ' C' ' 105' ' ' LEU . 0.1 OUTLIER -80.69 -22.7 40.15 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.943 -1.098 . . . . 0.0 108.936 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -85.12 -18.77 33.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.912 . . . . 0.0 109.702 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 107' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 74.1 t -77.51 -50.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.965 . . . . 0.0 109.742 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 43.5 p -52.46 -52.04 56.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.251 -0.906 . . . . 0.0 109.666 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' C' ' 114' ' ' PRO . 7.9 mt -43.61 -26.41 0.23 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.723 . . . . 0.0 109.756 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -71.9 -25.66 62.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 110.477 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.45 -3.88 54.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.053 -1.029 . . . . 0.0 110.835 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 112' ' ' HIS . . . . . 0.659 ' CE1' ' CD1' ' C' ' 24' ' ' TYR . 0.2 OUTLIER -150.11 -69.22 0.19 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.73 -1.231 . . . . 0.0 109.639 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' C' ' 109' ' ' LEU . 0.4 OUTLIER -118.22 81.27 16.59 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 114' ' ' PRO . . . . . 0.48 ' N ' ' O ' ' C' ' 109' ' ' LEU . 51.4 Cg_exo -49.24 -170.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.462 2.108 . . . . 0.0 112.567 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.738 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -48.7 -55.62 10.87 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.638 ' CG ' ' O ' ' C' ' 115' ' ' ALA . 2.8 mm-40 130.46 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 13.0 t80 66.37 30.38 8.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.717 -0.614 . . . . 0.0 111.08 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.7 ' O ' ' N ' ' C' ' 120' ' ' ALA . 2.1 p -103.83 128.04 28.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 108.287 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.59 23.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.217 1.945 . . . . 0.0 112.907 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.7 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -157.01 -32.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.746 -1.221 . . . . 0.0 110.675 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.738 HG21 ' O ' ' C' ' 115' ' ' ALA . 12.9 p -49.86 -47.31 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.035 . . . . 0.0 110.236 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.641 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.4 t60 -61.72 -38.5 88.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.85 . . . . 0.0 109.778 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.37 -20.19 34.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.995 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -62.29 1.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.576 HD22 HD21 ' C' ' 105' ' ' LEU . 1.4 mt -65.14 -19.87 66.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 109.411 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.12 -49.31 37.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.958 . . . . 0.0 109.66 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.18 -42.03 11.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 109.632 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.573 ' CD2' HG21 ' C' ' 10' ' ' VAL . 32.1 t80 -49.97 -22.88 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 109.364 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.665 HD12 ' C ' ' C' ' 129' ' ' LEU . 1.2 pp -76.43 -22.03 55.18 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.15 -38.11 75.97 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.571 ' OG ' HD21 ' C' ' 2' ' ' LEU . 33.8 m -67.88 -26.82 66.2 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 132' ' ' VAL . . . . . 0.449 ' O ' HD13 ' C' ' 136' ' ' LEU . 5.7 t -85.61 -37.61 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.358 -0.839 . . . . 0.0 108.879 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 14.9 t -79.97 -18.09 51.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.318 -0.864 . . . . 0.0 108.778 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 42.6 m -83.24 -42.46 17.18 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.452 -0.78 . . . . 0.0 109.238 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.461 HG13 ' O ' ' C' ' 131' ' ' SER . 27.4 m -70.13 -21.93 24.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.245 -0.909 . . . . 0.0 108.694 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 136' ' ' LEU . . . . . 0.449 HD13 ' O ' ' C' ' 132' ' ' VAL . 0.9 OUTLIER -67.4 -31.91 72.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.448 -0.783 . . . . 0.0 108.941 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 7.2 m -153.19 57.1 0.77 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.296 -0.877 . . . . 0.0 109.47 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 25.5 t . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.935 . . . . 0.0 109.518 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 1.05 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -107.64 -159.17 0.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.506 -0.747 . . . . 0.0 109.35 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.401 ' O ' ' N ' ' D' ' 6' ' ' GLU . 9.9 p -103.56 134.36 19.79 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.435 -0.791 . . . . 0.0 109.34 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -42.08 -22.73 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.397 2.065 . . . . 0.0 112.495 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 6' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' D' ' 4' ' ' THR . 79.3 mt-10 -76.71 -55.63 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 110.043 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -68.14 -60.39 2.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.033 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.786 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -48.68 -30.16 5.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.846 . . . . 0.0 110.198 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 9' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 2.8 m -62.08 -23.63 66.62 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.041 -1.037 . . . . 0.0 110.083 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.97 -57.59 3.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.014 -1.054 . . . . 0.0 110.035 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.6 -25.02 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 56.9 m -83.48 -37.26 23.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' D' ' 9' ' ' SER . . . -63.22 -29.93 71.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.346 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.7 OUTLIER -52.08 -32.54 35.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.092 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 15' ' ' TRP . . . . . 0.533 ' HE1' ' HG ' ' D' ' 72' ' ' SER . 0.2 OUTLIER -47.14 -17.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 16' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.31 -52.01 5.83 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.421 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.1 OUTLIER -70.47 -29.32 65.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.202 -1.175 . . . . 0.0 109.322 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -48.84 114.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.55 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' D' ' 22' ' ' GLU . 18.4 m120 -82.67 69.49 9.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 108.941 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' D' ' 22' ' ' GLU . 78.7 t -43.81 -29.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 109.713 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -64.63 1.87 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.617 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' D' ' 20' ' ' VAL . 33.0 mt-10 -155.88 -46.18 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.393 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -48.54 -53.93 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.4 -48.51 48.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.4 -46.36 78.59 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -62.36 -40.07 95.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -1.153 . . . . 0.0 109.314 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -37.79 88.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.364 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -82.1 -51.35 8.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.275 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.91 -35.09 62.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -79.4 -30.58 42.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -1.14 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 60.1 tp -49.52 -38.95 32.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 109.368 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.57 -23.42 56.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.595 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.7 -61.62 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.21 -0.931 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.32 -23.81 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.77 76.06 48.09 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 109.258 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.64 11.42 2.72 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.769 2.312 . . . . 0.0 112.358 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' TRP . . . . . 0.477 ' CE2' HG23 ' D' ' 38' ' ' THR . 50.7 p-90 -80.54 -19.75 45.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.36 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.477 HG23 ' CE2' ' D' ' 37' ' ' TRP . 42.1 p -79.71 40.07 0.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -92.07 12.86 20.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -87.88 -34.44 18.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.591 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' D' ' 42' ' ' PHE . 29.4 m-85 -95.81 32.37 1.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 0.0 109.546 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.434 ' CD1' ' C ' ' D' ' 41' ' ' PHE . 56.5 m-85 -141.38 26.36 1.98 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 109.454 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -80.94 -25.07 37.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 44' ' ' SER . . . . . 0.472 ' C ' ' H ' ' D' ' 46' ' ' GLY . 67.1 m -82.15 -38.31 24.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.922 . . . . 0.0 109.483 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -55.93 -5.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' D' ' 44' ' ' SER . . . 48.53 -167.77 0.15 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' D' ' 48' ' ' LEU . 18.9 t70 60.26 -150.21 0.42 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -1.154 . . . . 0.0 109.559 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 48' ' ' LEU . . . . . 0.455 ' H ' ' CG ' ' D' ' 47' ' ' ASP . 23.5 mt 60.46 34.39 20.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.562 -0.711 . . . . 0.0 109.656 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.2 m -80.47 -22.54 40.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 50' ' ' THR . . . . . 0.495 ' O ' ' N ' ' D' ' 53' ' ' ALA . 21.1 p -146.05 149.07 37.58 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 109.157 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -36.85 -45.06 1.19 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.593 2.195 . . . . 0.0 112.595 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.73 -27.04 61.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 109.6 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -57.81 -19.59 29.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.589 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.99 -63.45 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 109.63 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' D' ' 55' ' ' MET . 2.3 mpp? -79.71 14.86 1.53 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.436 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.98 -49.06 4.41 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' ASN . . . . . 0.456 HD21 ' HE2' ' D' ' 59' ' ' LYS . 3.8 m-20 -77.78 149.63 77.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.276 -1.132 . . . . 0.0 109.47 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.33 -52.03 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.642 2.228 . . . . 0.0 112.148 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' LYS . . . . . 0.456 ' HE2' HD21 ' D' ' 57' ' ' ASN . 54.2 pttt -46.88 -40.71 14.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.336 -0.853 . . . . 0.0 109.58 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 86.6 t -54.22 -44.83 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.397 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 61' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' D' ' 61' ' ' LYS . 7.0 mtmp? -77.4 -43.06 33.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.11 -33.15 17.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -67.55 -24.49 65.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.584 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.57 -30.31 74.79 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -68.16 -41.21 81.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.33 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -64.08 -50.95 66.34 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.338 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 25.4 t -61.74 -23.84 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.201 -0.937 . . . . 0.0 109.331 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -78.17 -29.78 48.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.32 -57.09 14.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.48 -22.03 63.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -1.135 . . . . 0.0 109.517 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -74.53 -30.23 61.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.607 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' SER . . . . . 0.533 ' HG ' ' HE1' ' D' ' 15' ' ' TRP . 4.5 m -89.21 -20.49 24.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.688 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -46.15 -30.73 2.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.692 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.41 -59.17 6.99 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.538 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -56.74 -17.82 10.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -1.153 . . . . 0.0 109.628 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 76' ' ' ALA . . . . . 0.558 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -97.36 33.04 2.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 109.993 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 2.3 m80 -176.81 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.143 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 78' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' D' ' 77' ' ' HIS . 29.9 mt 39.61 35.38 0.19 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.644 -0.66 . . . . 0.0 109.621 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -138.73 -31.4 0.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.788 . . . . 0.0 109.631 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 80' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' D' ' 80' ' ' ASN . 7.4 p-10 -151.95 72.85 1.03 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.296 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 81' ' ' LEU . . . . . 0.57 HD12 ' N ' ' D' ' 81' ' ' LEU . 9.5 mp -60.36 -27.15 67.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -80.6 -61.5 1.95 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.776 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.33 -23.79 42.75 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.426 HG23 ' O ' ' D' ' 80' ' ' ASN . 0.8 OUTLIER -62.34 -51.91 65.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 109.554 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.537 ' CZ ' ' O ' ' D' ' 81' ' ' LEU . 2.2 p90 -133.2 51.83 2.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 109.651 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.01 -29.31 4.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.322 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 87' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' D' ' 88' ' ' LEU . 17.8 p -60.59 -58.55 8.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.325 -0.859 . . . . 0.0 109.319 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.415 ' N ' ' OG1' ' D' ' 87' ' ' THR . 90.8 mt -48.47 -37.47 17.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.008 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -69.05 -34.95 76.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.034 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -82.87 -39.07 22.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -0.825 . . . . 0.0 109.4 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.05 -25.3 64.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.401 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' D' ' 97' ' ' HIS . 7.0 m80 -91.0 -21.74 21.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.625 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.56 -59.01 2.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 111.162 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.667 ' O ' HG21 ' A' ' 41' ' ' THR . 1.3 m-20 -87.28 -57.0 3.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.014 -1.054 . . . . 0.0 111.934 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 95' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' D' ' 95' ' ' LYS . 12.0 mptt -62.66 -52.25 64.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.131 -0.98 . . . . 0.0 111.263 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.606 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -95.41 -38.19 10.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.892 -1.13 . . . . 0.0 109.764 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.606 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 25.4 p80 45.36 33.26 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 98' ' ' VAL . . . . . 0.59 HG23 HD12 ' D' ' 96' ' ' LEU . 52.5 t -50.12 132.37 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.041 -1.037 . . . . 0.0 109.14 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 99' ' ' ASP . . . . . 0.546 ' OD1' HG11 ' A' ' 96' ' ' VAL . 4.2 m-20 -51.19 151.2 5.12 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.293 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.98 -170.32 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.464 2.109 . . . . 0.0 112.026 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' B' ' 101' ' ' GLU . 69.2 mm-40 53.14 70.04 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 102' ' ' ASN . . . . . 0.472 ' ND2' ' CD1' ' D' ' 103' ' ' PHE . 4.0 p-10 -171.23 -39.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -0.897 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' ND2' ' D' ' 102' ' ' ASN . 12.8 m-85 -50.25 -34.55 23.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -76.12 -43.99 40.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.559 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 105' ' ' LEU . . . . . 0.52 ' N ' HD12 ' D' ' 105' ' ' LEU . 9.9 mp -49.35 -51.85 31.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.441 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 tt -51.66 -37.21 49.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.137 -0.977 . . . . 0.0 109.303 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.93 -20.62 59.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -65.25 -34.36 78.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -1.179 . . . . 0.0 109.616 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.82 -31.71 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 7.6 tp -51.64 -52.12 50.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.559 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 111' ' ' VAL . . . . . 0.553 ' CG2' ' CE1' ' D' ' 130' ' ' TYR . 42.9 t -51.15 -42.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.577 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -60.18 -39.52 86.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.594 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.53 -55.0 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 109.681 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.96 -31.81 71.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -64.87 -27.83 69.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.469 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.48 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.79 -61.25 1.83 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 109.25 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 117' ' ' HIS . . . . . 0.417 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 8.3 m-70 -63.24 -18.42 63.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.525 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 58.9 m-85 -148.41 59.53 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 109.386 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -72.03 -14.74 76.24 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -79.45 -20.34 47.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.455 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.482 ' C ' ' H ' ' D' ' 123' ' ' THR . 29.2 mm-40 -95.4 -2.5 48.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.768 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.91 34.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.536 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.482 ' H ' ' C ' ' D' ' 121' ' ' GLU . 21.7 p -49.25 148.37 4.5 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.391 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.451 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 2.3 Cg_endo -46.71 -57.56 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.463 2.109 . . . . 0.0 113.03 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 17.7 Cg_endo -59.51 -42.38 48.48 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.12 1.88 . . . . 0.0 112.236 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 98.7 t -64.93 -20.95 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.917 . . . . 0.0 109.547 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 127' ' ' GLN . . . . . 0.607 ' OE1' ' HG3' ' C' ' 31' ' ' ARG . 17.7 tt0 -83.28 -48.91 9.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.576 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.658 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -58.72 -30.0 67.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.432 ' O ' HG23 ' D' ' 133' ' ' VAL . . . -82.14 19.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.653 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.553 ' CE1' ' CG2' ' D' ' 111' ' ' VAL . 47.1 t80 -107.92 -61.31 1.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.3 -0.875 . . . . 0.0 109.68 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 5.9 tp-100 -55.29 -23.25 22.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -83.06 -21.83 33.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.933 . . . . 0.0 109.653 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 133' ' ' VAL . . . . . 0.432 HG23 ' O ' ' D' ' 129' ' ' ALA . 77.6 t -81.09 -68.27 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.945 . . . . 0.0 109.721 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 22.3 m -53.83 -25.06 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.28 -0.888 . . . . 0.0 109.869 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -49.56 -29.79 7.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -0.949 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.33 -29.31 56.38 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.4 -38.15 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 0.0 109.432 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.88 79.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 139' ' ' ASN . . . . . 1.123 ' OD1' ' ND1' ' B' ' 146' ' ' HIS . 19.1 m-20 -79.68 -22.99 42.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.952 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.72 -60.64 2.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.628 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.83 -25.21 66.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.266 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 -16.41 27.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 109.422 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -51.23 -33.47 28.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 18.8 mmtm -73.32 -27.17 61.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 145' ' ' TYR . . . . . 0.412 ' OH ' ' O ' ' D' ' 92' ' ' HIS . 16.2 m-85 -71.85 -46.28 58.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.455 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 1.117 ' ND1' ' OD1' ' B' ' 139' ' ' ASN . 29.3 p80 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.483 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 1' ' ' VAL . 9.9 mt 54.48 170.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 0.0 109.638 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.488 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 176.32 -53.64 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.0 . . . . 0.0 110.317 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 6' ' ' ASP . 59.0 Cg_endo -73.97 -165.22 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.397 2.064 . . . . 0.0 112.777 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 8' ' ' THR . . . -43.93 -15.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.434 -0.792 . . . . 0.0 110.114 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' PRO . 53.5 m-20 -38.72 -37.22 0.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.806 . . . . 0.0 109.76 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -30.77 26.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.881 . . . . 0.0 109.685 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 5' ' ' ALA . 40.9 m -52.02 -37.48 53.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.173 -0.954 . . . . 0.0 109.213 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -73.87 -33.36 64.03 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.76 -52.29 26.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.94 -45.59 51.36 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.09 -61.76 2.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.579 -0.701 . . . . 0.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -55.65 -33.35 63.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.3 -0.875 . . . . 0.0 109.242 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.55 -17.38 60.09 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.31 -0.869 . . . . 0.0 109.062 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.06 -43.32 14.0 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -70.36 -39.96 74.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 108.828 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 13' ' ' ALA . 89.5 t -60.03 -65.4 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 57.29 -135.75 51.33 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 28.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.998 . . . . 0.0 110.48 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.556 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.9 m-70 -131.93 24.36 4.62 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.24 -62.76 1.42 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.624 -0.672 . . . . 0.0 109.727 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.41 -14.5 0.19 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' ALA . 1.3 mm-40 -84.15 -56.16 3.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -1.061 . . . . 0.0 109.433 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.641 ' CD1' ' CD2' ' A' ' 112' ' ' HIS . 3.1 m-30 -59.95 -37.09 78.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.374 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.73 -24.24 69.6 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.35 -45.05 20.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.629 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.01 -21.21 61.02 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.399 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.31 -21.53 62.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.693 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.617 HD11 ' ND1' ' A' ' 58' ' ' HIS . 12.5 mt -78.04 -51.54 10.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.505 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.34 -12.67 61.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.837 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.565 ' NH2' ' SG ' ' A' ' 104' ' ' CYS . 0.9 OUTLIER -76.48 -40.37 50.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 110.276 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.0 ptt? -84.16 -35.56 23.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 109.963 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -45.99 -41.72 12.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 109.665 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.885 ' CD1' ' HB2' ' B' ' 128' ' ' ALA . 2.2 pp -84.63 -35.89 22.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.067 -1.021 . . . . 0.0 109.82 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.4 p -85.33 1.45 48.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.538 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' MET . 67.0 m-85 -159.17 68.13 3.2 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 39' ' ' THR . 72.1 Cg_exo -47.75 -34.34 21.14 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.821 2.347 . . . . 0.0 112.279 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 1.318 HG22 ' ND1' ' D' ' 97' ' ' HIS . 2.2 p -47.05 -18.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.927 . . . . 0.0 109.591 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' PRO . 81.4 p -84.5 -31.33 24.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 0.0 109.709 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -68.6 -26.44 65.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 109.685 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.909 HG21 ' CD2' ' D' ' 97' ' ' HIS . 5.3 t . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.259 -0.9 . . . . 0.0 109.87 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 26.6 p80 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 120.867 0.365 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -135.86 26.85 3.31 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.001 -1.062 . . . . 0.0 109.687 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 49' ' ' SER . 55.2 m-20 44.44 83.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.485 -0.759 . . . . 0.0 109.529 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.565 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -52.01 -8.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 109.5 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 47' ' ' ASP . 35.0 p -68.36 169.45 10.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 0.0 109.469 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -78.96 164.3 24.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.863 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.04 17.31 71.66 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.632 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 3.0 t -77.52 -28.62 52.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -1.156 . . . . 0.0 109.487 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 73.28 -31.66 0.23 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.602 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 52' ' ' SER . 38.0 mt-30 -80.51 -22.56 40.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -83.46 -35.93 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -81.42 -32.93 32.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.198 -0.939 . . . . 0.0 108.615 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.66 -21.96 78.85 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.617 ' ND1' HD11 ' A' ' 29' ' ' LEU . 10.1 t-80 -70.51 -29.97 66.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -1.055 . . . . 0.0 109.24 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.76 -51.45 57.95 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -48.36 -23.82 1.04 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -1.136 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -71.39 -51.12 25.8 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.179 -0.951 . . . . 0.0 108.608 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.7 t -60.85 -47.7 92.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.76 89.42 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.348 -0.845 . . . . 0.0 108.923 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -60.06 -39.07 84.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -65.01 -52.33 56.69 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.5 mt -57.59 -43.91 84.97 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 71' ' ' ALA . 19.0 m -69.34 -51.25 38.81 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -61.64 -26.14 67.81 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.17 -46.59 10.94 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.8 t -65.2 -22.67 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -64.09 -21.62 66.6 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' ' 74' ' ' ASP . 95.4 m-70 -146.44 -51.94 0.23 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.4 p 44.74 13.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.687 0.756 . . . . 0.0 109.407 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 72' ' ' HIS . 29.2 m-20 -127.04 9.5 6.83 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.411 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 49.8 t0 -173.68 27.3 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.046 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.689 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 4.8 ptt? -78.33 -24.2 0.43 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.44 -0.788 . . . . 0.0 111.668 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.8 Cg_exo -53.02 -27.73 37.26 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.634 1.556 . . . . 0.0 112.506 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -94.3 -24.79 17.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.74 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.79 -46.38 21.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.0 109.223 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.427 ' CD1' HG13 ' A' ' 132' ' ' VAL . 9.7 mt -82.05 9.3 8.7 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 108.981 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.5 m -65.69 -22.41 66.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 109.512 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -82.01 -59.64 2.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.135 -0.978 . . . . 0.0 109.694 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -50.8 -26.2 5.39 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 73.2 m -67.5 -33.4 75.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' ALA . 4.3 t70 -78.26 -30.07 48.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 108.806 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.781 ' C ' HD13 ' A' ' 86' ' ' LEU . 2.1 tm? -54.31 -49.55 69.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.509 -0.744 . . . . 0.0 109.388 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.466 ' N ' HD13 ' A' ' 86' ' ' LEU . 8.2 p-80 -92.24 -21.78 20.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.008 . . . . 0.0 110.375 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -92.93 -2.62 55.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.042 -1.036 . . . . 0.0 110.293 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -128.56 -77.06 0.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.194 -0.941 . . . . 0.0 109.771 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -46.66 -78.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.761 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.2 mp -71.06 -39.05 72.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.106 -0.996 . . . . 0.0 109.647 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 61.84 59.28 1.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 109.42 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 94' ' ' ASP . 90.3 t -85.21 166.59 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 109.614 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.624 ' N ' HG12 ' A' ' 93' ' ' VAL . 3.8 m-20 -99.33 120.05 58.92 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.381 -0.824 . . . . 0.0 109.217 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' PHE . 83.3 Cg_exo -44.11 -10.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.225 1.95 . . . . 0.0 112.432 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 94' ' ' ASP . 96.1 t -45.55 -23.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 95' ' ' PRO . 73.3 m-20 -79.3 -24.84 42.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 109.57 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' OG ' ' A' ' 102' ' ' SER . 20.4 t80 -46.53 -35.05 5.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -64.61 -33.27 75.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.485 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.0 mt -84.06 -43.75 14.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.523 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.423 ' O ' HD23 ' A' ' 101' ' ' LEU . 4.8 tt -54.38 -52.04 62.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.537 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 98' ' ' PHE . 15.7 m -59.63 -33.52 71.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 103' ' ' HIS . 0.7 OUTLIER -80.65 -26.65 37.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.095 -1.003 . . . . 0.0 110.096 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.565 ' SG ' ' NH2' ' A' ' 31' ' ' ARG . 72.0 m -63.95 -58.36 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.246 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.43 -34.51 4.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.935 . . . . 0.0 110.093 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.8 mt -70.75 -28.2 64.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 110.176 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -83.04 -38.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.979 -1.076 . . . . 0.0 109.582 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 110' ' ' ALA . 19.1 p -70.58 -58.9 3.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.2 -0.938 . . . . 0.0 109.649 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 113' ' ' LEU . 9.5 mt -43.12 -26.28 0.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.765 . . . . 0.0 109.587 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -67.36 -22.64 65.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 110.589 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.37 -48.02 12.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.025 . . . . 0.0 111.006 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.641 ' CD2' ' CD1' ' A' ' 24' ' ' TYR . 1.1 p-80 -100.76 -58.87 1.8 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.025 -1.047 . . . . 0.0 111.037 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.538 ' C ' HD13 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -112.44 93.35 22.53 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 109.284 -178.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 113' ' ' LEU . 76.7 Cg_exo -47.0 -174.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.364 2.042 . . . . 0.0 112.685 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.795 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -61.56 -55.35 31.77 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.648 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 27.8 mt-10 119.92 1.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.506 ' O ' ' CD2' ' A' ' 117' ' ' PHE . 38.3 t80 59.62 31.63 21.04 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.298 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.794 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.3 p -104.4 120.8 49.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.985 -1.072 . . . . 0.0 108.14 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.1 23.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.09 1.86 . . . . 0.0 112.72 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.794 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -154.43 -29.96 0.11 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.853 -1.155 . . . . 0.0 110.676 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.795 HG21 ' O ' ' A' ' 115' ' ' ALA . 13.7 p -51.16 -50.16 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.996 -1.065 . . . . 0.0 110.274 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.667 ' N ' HG13 ' A' ' 121' ' ' VAL . 3.1 t-160 -61.31 -53.41 57.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.868 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' B' ' 34' ' ' VAL . . . -72.72 -19.83 61.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 120' ' ' ALA . 20.5 m -63.72 -62.51 1.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.164 -0.96 . . . . 0.0 110.277 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 1.2 mt -64.4 -16.85 63.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.352 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.07 -49.18 9.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 110.902 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.62 -59.03 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.818 -1.176 . . . . 0.0 111.264 -178.385 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.48 ' N ' ' HD2' ' A' ' 127' ' ' LYS . 21.4 m-85 -47.98 -21.23 0.41 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.717 -1.239 . . . . 0.0 109.752 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.918 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -72.1 -31.03 65.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 134' ' ' THR . . . -49.2 -33.18 11.9 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.467 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 43.2 t -60.36 -37.02 79.39 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 80' ' ' LEU . 6.3 t -77.06 -48.72 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.406 ' CB ' ' CE1' ' A' ' 98' ' ' PHE . 13.5 t -66.48 -22.72 66.19 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.278 -0.889 . . . . 0.0 108.635 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 130' ' ' ALA . 11.2 m -64.06 -31.75 73.06 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.411 -0.806 . . . . 0.0 108.827 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.62 -37.26 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 109.14 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 83' ' ' LEU . 5.6 mp -60.59 -35.29 75.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.299 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 134' ' ' THR . 34.9 p -67.9 -33.75 75.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.21 0.529 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.717 HD13 ' HB3' ' B' ' 8' ' ' LYS . 1.9 mt -87.8 161.05 17.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.561 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.19 138.18 19.47 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.371 -0.83 . . . . 0.0 108.826 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -40.02 -54.19 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.524 2.149 . . . . 0.0 112.637 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -72.01 -21.84 61.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 110.02 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -76.62 -63.12 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 109.902 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.717 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -66.58 -29.59 69.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.068 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.6 t -47.5 -23.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 110.101 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.66 -56.85 3.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 109.992 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.428 ' H ' HG12 ' B' ' 11' ' ' VAL . 0.8 OUTLIER -68.13 -24.64 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.9 m -73.52 -40.28 64.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.746 -0.596 . . . . 0.0 109.607 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.42 -31.23 71.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.409 -0.807 . . . . 0.0 109.447 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.8 OUTLIER -50.7 -31.47 16.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 0.0 109.155 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -47.57 -17.82 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.382 -0.824 . . . . 0.0 109.537 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.97 -51.1 5.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.45 ' H ' ' HG2' ' B' ' 17' ' ' LYS . 0.1 OUTLIER -71.23 -29.56 65.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.169 -1.194 . . . . 0.0 109.33 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -49.42 114.79 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.925 . . . . 0.0 109.581 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' B' ' 22' ' ' GLU . 95.3 m-20 -78.39 67.65 4.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.01 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' B' ' 22' ' ' GLU . 68.8 t -44.32 -29.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.831 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.14 7.43 0.57 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' B' ' 20' ' ' VAL . 38.5 mt-10 -155.23 -49.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -48.59 -60.72 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.89 -39.22 17.69 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.09 -43.73 89.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.419 ' O ' ' CG ' ' B' ' 30' ' ' ARG . 57.0 mt-10 -79.47 -40.39 29.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.291 -1.123 . . . . 0.0 109.546 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 -34.32 8.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -82.6 -56.67 3.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.73 -44.83 80.35 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.571 HH21 HG11 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -53.89 -36.48 62.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -1.123 . . . . 0.0 109.26 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -55.95 -47.63 77.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 0.0 109.412 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.02 -22.73 67.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.571 HG11 HH21 ' B' ' 30' ' ' ARG . 74.8 t -81.65 -64.72 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 109.358 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 123' ' ' ALA . 2.2 t -67.64 -22.79 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.465 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.428 ' CG ' HD21 ' B' ' 105' ' ' LEU . 83.5 m-85 -139.46 80.97 21.13 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.428 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.86 -16.04 9.09 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.668 2.245 . . . . 0.0 112.515 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -51.02 -19.91 1.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.075 -1.016 . . . . 0.0 109.416 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 3.6 p -85.54 55.51 3.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.215 -0.928 . . . . 0.0 109.147 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -109.77 41.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.435 -0.791 . . . . 0.0 109.255 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 mmt-85 -104.03 -49.29 3.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.0 109.479 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' B' ' 41' ' ' PHE . 27.7 m-85 -91.86 30.04 1.46 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.585 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' B' ' 44' ' ' SER . 9.4 p90 -92.55 -12.97 30.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -46.07 -13.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.909 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.544 ' N ' ' O ' ' B' ' 42' ' ' PHE . 23.8 p -124.3 23.49 8.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.245 -0.909 . . . . 0.0 109.583 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.34 -14.2 21.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 0.0 109.322 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.54 -116.76 2.21 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -144.26 105.23 4.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -1.11 . . . . 0.0 109.557 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.94 30.57 1.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.14 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.5 p -44.0 -32.37 1.13 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.817 . . . . 0.0 109.859 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 17.8 p -146.61 148.31 33.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -40.16 -50.2 3.57 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.517 2.145 . . . . 0.0 112.177 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.21 -35.09 76.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' B' ' 50' ' ' THR . . . -53.83 -19.77 4.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.507 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.18 -63.95 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 12.2 mmt -63.05 -7.58 5.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.38 -10.24 64.06 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -78.37 141.98 62.22 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.173 -1.192 . . . . 0.0 109.378 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -74.3 -57.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.59 2.193 . . . . 0.0 112.214 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' B' ' 63' ' ' HIS . 45.6 mtpt -51.98 -48.49 64.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.556 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' B' ' 59' ' ' LYS . 74.3 t -45.8 -39.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.0 109.289 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -79.35 -52.4 8.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.85 . . . . 0.0 109.321 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.36 -59.18 3.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.805 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' HIS . . . . . 0.538 ' N ' ' O ' ' B' ' 59' ' ' LYS . 1.7 t60 -48.29 -24.85 1.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.41 -36.73 91.99 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -69.29 -25.14 64.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -1.125 . . . . 0.0 109.479 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -73.13 -35.35 66.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.559 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 39.6 t -75.75 -28.3 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.21 -34.94 68.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.302 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.51 -45.12 37.44 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.83 91.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -1.209 . . . . 0.0 109.65 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' PHE . . . . . 0.421 ' CE2' HD21 ' B' ' 110' ' ' LEU . 25.5 t80 -57.29 -41.07 79.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 109.579 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.7 t -76.63 -37.75 55.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.653 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -47.5 -37.57 12.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.535 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -60.4 7.6 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.569 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -55.82 -30.04 60.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.248 -1.148 . . . . 0.0 109.401 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.09 5.4 29.82 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.201 -0.937 . . . . 0.0 109.65 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.522 ' NE2' ' OD1' ' B' ' 80' ' ' ASN . 7.5 t60 -170.93 67.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 109.525 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.93 17.96 1.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -79.63 -29.23 40.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.452 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.522 ' OD1' ' NE2' ' B' ' 77' ' ' HIS . 4.3 p-10 -163.21 95.82 0.86 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.235 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.493 HD12 ' H ' ' B' ' 81' ' ' LEU . 5.0 mp -80.28 -58.91 2.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.204 -0.935 . . . . 0.0 109.64 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -57.46 -23.83 52.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.075 -1.016 . . . . 0.0 109.568 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.06 -54.41 3.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.0 t -61.38 -47.58 85.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -1.157 . . . . 0.0 109.614 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.557 ' N ' ' CG2' ' B' ' 84' ' ' THR . 54.4 m-85 -76.7 22.04 0.19 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.351 -0.843 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.46 -26.8 44.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 75.3 p -78.85 -59.1 2.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.754 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.4 mt -48.63 -45.05 37.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.955 . . . . 0.0 109.288 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 53.9 p -64.72 -52.71 55.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.267 -0.896 . . . . 0.0 109.269 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -61.27 -22.7 65.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 tp -86.9 -68.71 0.73 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.417 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.509 ' O ' ' N ' ' B' ' 97' ' ' HIS . 48.8 m80 -51.01 -26.54 6.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.094 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' CYS . . . . . 0.407 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 27.5 t -83.73 -55.93 3.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 111.303 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.529 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 27.4 t0 -86.24 -32.2 21.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.001 -1.062 . . . . 0.0 111.945 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -89.36 -51.76 5.39 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.689 -1.257 . . . . 0.0 111.132 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.63 -27.03 15.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.852 -1.155 . . . . 0.0 110.43 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 1.24 ' ND1' HG22 ' C' ' 38' ' ' THR . 83.0 m-70 51.67 29.57 5.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.038 -1.039 . . . . 0.0 109.61 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.401 ' O ' ' OH ' ' B' ' 145' ' ' TYR . 40.0 t -47.14 130.2 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.968 . . . . 0.0 109.503 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.38 152.46 32.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.28 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.88 -164.09 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.553 2.169 . . . . 0.0 112.165 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.26 60.72 2.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.877 . . . . 0.0 109.578 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' B' ' 105' ' ' LEU . 33.2 t-20 -171.3 -41.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -46.21 -40.55 11.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 109.714 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -80.07 -19.92 46.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.554 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' B' ' 102' ' ' ASN . 12.3 tp -70.47 -59.77 2.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 109.639 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -49.84 -46.22 51.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 109.354 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.06 -20.44 58.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -80.53 -25.2 38.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -1.105 . . . . 0.0 109.577 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 74.2 t -86.19 -43.09 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 109.683 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.421 HD21 ' CE2' ' B' ' 71' ' ' PHE . 6.3 tt -48.26 -33.05 8.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.464 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -83.05 -26.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.532 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.4 m -69.1 -24.79 64.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.538 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 42.4 t -76.34 -34.89 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' B' ' 118' ' ' PHE . 9.5 mt -69.83 -40.16 76.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 109.413 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -54.4 -28.92 46.93 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 109.438 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.525 ' HD1' ' C ' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.74 -62.41 1.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.106 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -63.36 -17.75 62.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.551 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' B' ' 114' ' ' LEU . 93.3 m-85 -149.72 60.4 1.0 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 109.402 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.535 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -69.22 -24.72 75.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -64.75 -29.67 70.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -1.153 . . . . 0.0 109.346 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.489 ' C ' ' H ' ' B' ' 123' ' ' THR . 78.3 mm-40 -87.81 5.71 38.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 109.736 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.543 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.64 33.09 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 109.422 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.489 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.4 p -52.41 149.13 10.88 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.353 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.516 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.1 Cg_exo -45.41 -53.66 5.23 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.452 2.101 . . . . 0.0 112.988 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 24.6 Cg_endo -62.16 -29.65 81.04 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.05 1.834 . . . . 0.0 112.223 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.441 HG23 ' OG1' ' B' ' 123' ' ' THR . 45.7 t -68.81 -28.15 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 109.423 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -83.15 -53.89 5.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.885 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -63.25 -26.49 68.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.576 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.51 -2.33 53.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.114 -0.991 . . . . 0.0 109.807 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' B' ' 132' ' ' LYS . 41.8 t80 -92.49 -61.52 1.58 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.717 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 1.5 tm0? -45.25 -23.32 0.17 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 109.931 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' B' ' 130' ' ' TYR . 51.1 mtmt -85.46 -34.6 21.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.217 -0.927 . . . . 0.0 110.322 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 0.6 OUTLIER -68.61 -44.15 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.075 . . . . 0.0 109.676 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.501 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 6.1 m -79.64 -20.91 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -50.51 -32.41 18.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -0.974 . . . . 0.0 109.364 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.63 -26.56 56.36 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.42 -32.96 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -1.148 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.44 90.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.67 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.89 -21.05 47.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.766 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.01 -58.86 6.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.663 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 48.4 mt -61.48 -31.88 71.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 109.497 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.06 25.15 4.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.251 -0.905 . . . . 0.0 109.599 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -80.0 -16.13 55.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.712 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 13.2 mptt -98.34 -26.72 14.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 0.0 109.613 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' B' ' 98' ' ' VAL . 12.3 m-85 -54.38 -6.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.11 -0.994 . . . . 0.0 109.425 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' B' ' 144' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.428 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' C' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' C' ' 1' ' ' VAL . 9.9 mt 54.47 170.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.353 -0.842 . . . . 0.0 109.621 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.49 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 176.31 -53.58 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.322 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' C' ' 6' ' ' ASP . 59.0 Cg_endo -74.05 -165.15 0.24 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.373 2.048 . . . . 0.0 112.776 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' C' ' 8' ' ' THR . . . -44.0 -15.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.497 -0.752 . . . . 0.0 110.129 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' C' ' 4' ' ' PRO . 53.1 m-20 -38.82 -37.11 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 109.779 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' C' ' 8' ' ' THR . 0.0 OUTLIER -83.8 -30.94 26.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.666 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.518 ' N ' ' O ' ' C' ' 5' ' ' ALA . 41.7 m -51.87 -37.52 52.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.068 -1.02 . . . . 0.0 109.283 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -73.87 -33.39 64.05 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -71.69 -52.38 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.87 -45.61 50.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.02 -61.9 2.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.629 -0.669 . . . . 0.0 109.883 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.661 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -55.57 -33.37 63.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.295 -0.878 . . . . 0.0 109.246 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -17.38 60.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.285 -0.884 . . . . 0.0 109.029 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.0 -43.24 14.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -70.41 -39.83 74.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -1.199 . . . . 0.0 108.856 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.661 HG23 ' O ' ' C' ' 13' ' ' ALA . 88.3 t -60.2 -65.39 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 57.27 -135.74 51.33 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 28.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.439 -1.036 . . . . 0.0 110.453 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.7 m-70 -131.92 24.27 4.62 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.19 -62.9 1.39 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.603 -0.686 . . . . 0.0 109.651 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.2 -14.7 0.17 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 21' ' ' ALA . 1.3 mm-40 -84.11 -56.11 3.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.461 -1.023 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.638 ' CD1' ' CD2' ' C' ' 112' ' ' HIS . 3.1 m-30 -60.05 -36.96 78.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.387 -0.821 . . . . 0.0 109.391 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.77 -24.27 69.7 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.31 -45.0 20.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 109.681 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.03 -21.28 61.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.25 -21.48 62.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.671 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.626 HD11 ' ND1' ' C' ' 58' ' ' HIS . 12.4 mt -78.08 -51.59 10.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.1 -12.9 61.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.825 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.557 ' NH2' ' SG ' ' C' ' 104' ' ' CYS . 0.9 OUTLIER -76.4 -40.48 50.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.137 -0.977 . . . . 0.0 110.25 -179.448 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 32' ' ' MET . . . . . 0.542 ' O ' ' N ' ' C' ' 36' ' ' PHE . 3.0 ptt? -84.04 -35.61 23.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.98 -1.075 . . . . 0.0 109.982 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 33' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' C' ' 33' ' ' PHE . 0.0 OUTLIER -45.87 -41.77 11.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.947 . . . . 0.0 109.719 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.883 ' CD1' ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -84.59 -35.93 22.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.962 . . . . 0.0 109.937 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.3 p -85.25 1.43 48.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' C' ' 32' ' ' MET . 67.3 m-85 -159.1 68.1 3.23 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' C' ' 39' ' ' THR . 69.3 Cg_exo -47.73 -34.29 20.9 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.8 2.334 . . . . 0.0 112.308 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 38' ' ' THR . . . . . 1.24 HG22 ' ND1' ' B' ' 97' ' ' HIS . 2.1 p -47.09 -18.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 109.568 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.441 ' N ' ' O ' ' C' ' 37' ' ' PRO . 81.6 p -84.52 -31.25 24.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.756 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -68.66 -26.43 65.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.951 . . . . 0.0 109.609 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.832 HG21 ' CD2' ' B' ' 97' ' ' HIS . 5.4 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.862 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.53 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 26.7 p80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.838 0.352 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.422 ' O ' ' OG ' ' C' ' 52' ' ' SER . 2.8 p90 -135.91 26.93 3.29 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.047 -1.033 . . . . 0.0 109.611 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' C' ' 49' ' ' SER . 55.6 m-20 44.41 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.393 -0.817 . . . . 0.0 109.568 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.566 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.6 OUTLIER -51.98 -8.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.474 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.495 ' H ' ' C ' ' C' ' 47' ' ' ASP . 35.6 p -68.39 169.48 10.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -78.98 164.3 24.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.525 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.05 17.27 71.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.615 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 3.0 t -77.53 -28.54 52.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -1.128 . . . . 0.0 109.516 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 73.18 -31.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.606 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' C' ' 52' ' ' SER . 38.1 mt-30 -80.52 -22.67 40.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 0.0 109.389 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -83.38 -36.09 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.423 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -81.36 -32.89 32.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.138 -0.976 . . . . 0.0 108.674 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.6 -22.01 78.86 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.626 ' ND1' HD11 ' C' ' 29' ' ' LEU . 10.0 t-80 -70.44 -30.02 66.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -1.134 . . . . 0.0 109.254 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -51.47 57.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -48.29 -23.86 1.02 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 0.0 109.775 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -71.44 -51.08 25.81 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.257 -0.902 . . . . 0.0 108.577 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 25.6 t -60.78 -47.78 91.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.02 -38.71 89.12 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -59.97 -39.29 85.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 108.489 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -64.89 -52.39 56.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.58 -43.99 85.01 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.415 ' O ' ' N ' ' C' ' 71' ' ' ALA . 19.3 m -69.18 -51.36 38.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.285 -0.885 . . . . 0.0 108.702 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -61.53 -26.12 67.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.208 -0.932 . . . . 0.0 108.521 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -85.12 -46.61 10.96 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 20.8 t -65.11 -22.8 32.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -64.0 -21.69 66.61 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' C' ' 74' ' ' ASP . 95.4 m-70 -146.45 -51.89 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.878 . . . . 0.0 109.473 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.4 p 44.71 13.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.74 0.781 . . . . 0.0 109.406 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' C' ' 72' ' ' HIS . 29.2 m-20 -127.03 9.57 6.85 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.413 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 49.7 t0 -173.75 27.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.121 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 4.8 ptt? -78.3 -24.16 0.43 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.514 -0.741 . . . . 0.0 111.679 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.0 Cg_exo -52.97 -27.96 37.81 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.626 1.551 . . . . 0.0 112.398 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -94.09 -24.8 17.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.826 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 -46.41 21.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.094 -1.003 . . . . 0.0 109.203 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 80' ' ' LEU . . . . . 0.416 ' CD1' HG13 ' C' ' 132' ' ' VAL . 9.8 mt -82.03 9.26 8.73 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.42 -0.8 . . . . 0.0 109.024 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 4.5 m -65.59 -22.44 66.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.572 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -82.06 -59.67 2.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.623 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.723 HD12 ' O ' ' C' ' 83' ' ' LEU . 0.4 OUTLIER -50.85 -26.09 5.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 73.3 m -67.59 -33.27 74.67 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' C' ' 82' ' ' ALA . 4.2 t70 -78.41 -29.93 47.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 108.79 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.777 ' C ' HD13 ' C' ' 86' ' ' LEU . 2.1 tm? -54.48 -49.46 70.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.501 -0.75 . . . . 0.0 109.338 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 87' ' ' HIS . . . . . 0.461 ' N ' HD13 ' C' ' 86' ' ' LEU . 8.2 p-80 -92.31 -21.67 20.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.407 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -92.9 -2.72 55.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.086 -1.009 . . . . 0.0 110.345 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -128.61 -77.01 0.56 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.953 . . . . 0.0 109.847 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -46.64 -78.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.981 . . . . 0.0 109.817 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.602 HD12 ' N ' ' C' ' 91' ' ' LEU . 8.2 mp -70.98 -39.17 72.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.569 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 61.86 59.35 1.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.389 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.63 HG12 ' N ' ' C' ' 94' ' ' ASP . 90.6 t -85.16 166.6 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 109.669 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.63 ' N ' HG12 ' C' ' 93' ' ' VAL . 3.8 m-20 -99.32 120.02 59.02 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.35 -0.843 . . . . 0.0 109.28 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' C' ' 98' ' ' PHE . 82.8 Cg_exo -44.12 -10.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.276 1.984 . . . . 0.0 112.394 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' C' ' 94' ' ' ASP . 95.7 t -45.63 -23.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.346 -0.846 . . . . 0.0 109.659 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' C' ' 95' ' ' PRO . 73.4 m-20 -79.24 -24.82 42.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.598 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 98' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' C' ' 102' ' ' SER . 20.5 t80 -46.51 -35.06 5.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.65 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' C' ' 99' ' ' LYS . 0.3 OUTLIER -64.55 -33.31 75.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.428 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 8.9 mt -84.05 -43.86 14.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.477 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 101' ' ' LEU . . . . . 0.433 HD23 ' C ' ' C' ' 101' ' ' LEU . 4.8 tt -54.32 -52.09 62.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 102' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' C' ' 98' ' ' PHE . 15.6 m -59.52 -33.57 71.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 109.934 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 103' ' ' HIS . . . . . 0.507 ' ND1' ' N ' ' C' ' 103' ' ' HIS . 0.7 OUTLIER -80.71 -26.56 37.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 110.068 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.557 ' SG ' ' NH2' ' C' ' 31' ' ' ARG . 71.8 m -63.9 -58.45 6.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.33 -34.58 4.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.153 -0.967 . . . . 0.0 110.094 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -70.71 -28.3 64.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.044 -1.035 . . . . 0.0 110.176 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.95 -38.22 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 109.579 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.42 ' O ' ' N ' ' C' ' 110' ' ' ALA . 19.2 p -70.67 -58.88 3.19 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.187 -0.945 . . . . 0.0 109.599 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' C' ' 113' ' ' LEU . 9.5 mt -43.18 -26.28 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' C' ' 108' ' ' THR . . . -67.29 -22.62 65.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 110.641 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.34 -47.99 12.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.074 -1.016 . . . . 0.0 111.017 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 112' ' ' HIS . . . . . 0.638 ' CD2' ' CD1' ' C' ' 24' ' ' TYR . 1.1 p-80 -100.85 -58.81 1.82 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.98 -1.075 . . . . 0.0 111.034 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.548 ' C ' HD13 ' C' ' 113' ' ' LEU . 0.9 OUTLIER -112.4 93.43 22.72 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.272 -178.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 114' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' C' ' 113' ' ' LEU . 78.0 Cg_exo -47.15 -174.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.355 2.037 . . . . 0.0 112.643 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.781 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -61.65 -55.42 30.79 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.657 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 27.7 mt-10 120.0 1.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' C' ' 117' ' ' PHE . 38.4 t80 59.69 31.7 21.03 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.225 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.781 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.3 p -104.46 120.73 49.62 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.01 23.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.164 1.909 . . . . 0.0 112.679 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.781 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -154.41 -29.95 0.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.945 -1.097 . . . . 0.0 110.701 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.781 HG21 ' O ' ' C' ' 115' ' ' ALA . 13.7 p -51.14 -50.17 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.95 -1.094 . . . . 0.0 110.302 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.675 ' N ' HG13 ' C' ' 121' ' ' VAL . 3.1 t-160 -61.34 -53.3 58.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 109.887 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 123' ' ' ALA . . . . . 0.516 ' HB2' ' HA ' ' D' ' 34' ' ' VAL . . . -72.79 -19.88 61.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.949 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.573 ' N ' ' O ' ' C' ' 120' ' ' ALA . 20.6 m -63.67 -62.56 1.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 110.254 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' C' ' 129' ' ' LEU . 1.2 mt -64.37 -16.91 63.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.348 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -84.08 -49.04 9.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.89 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.73 -59.04 2.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.879 -1.138 . . . . 0.0 111.302 -178.395 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.487 ' N ' ' HD2' ' C' ' 127' ' ' LYS . 21.4 m-85 -47.92 -21.31 0.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.82 -1.175 . . . . 0.0 109.811 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.898 ' O ' HD12 ' C' ' 129' ' ' LEU . 0.1 OUTLIER -71.99 -31.02 65.84 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' C' ' 134' ' ' THR . . . -49.28 -33.14 12.27 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.465 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 42.3 t -60.3 -37.07 79.4 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 132' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' C' ' 80' ' ' LEU . 6.5 t -77.02 -48.73 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.402 ' CB ' ' CE1' ' C' ' 98' ' ' PHE . 13.5 t -66.47 -22.78 66.2 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 134' ' ' THR . . . . . 0.52 ' N ' ' O ' ' C' ' 130' ' ' ALA . 11.2 m -64.08 -31.56 72.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.324 -0.86 . . . . 0.0 108.86 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.75 -37.21 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.134 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 136' ' ' LEU . . . . . 0.467 HD11 HD11 ' C' ' 83' ' ' LEU . 5.6 mp -60.72 -35.21 75.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.277 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 137' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' C' ' 134' ' ' THR . 35.1 p -68.06 -33.6 74.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.371 -0.83 . . . . 0.0 109.492 179.893 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.234 0.54 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' D' ' 8' ' ' LYS . 1.9 mt -87.84 161.07 17.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.31 138.22 19.48 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -40.02 -54.19 2.19 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.526 2.151 . . . . 0.0 112.601 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.04 -21.74 61.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -76.69 -63.1 1.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 109.824 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.716 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -66.66 -29.6 69.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 109.936 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -47.52 -23.63 0.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.959 . . . . 0.0 110.048 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.74 -56.89 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.074 -1.016 . . . . 0.0 109.936 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.4 ' H ' HG12 ' D' ' 11' ' ' VAL . 0.8 OUTLIER -68.19 -24.51 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 26.0 m -73.55 -40.36 64.03 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.379 0.609 . . . . 0.0 109.591 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.37 -31.24 71.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.8 OUTLIER -50.7 -31.47 16.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.154 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -47.44 -18.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.491 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.91 -51.08 6.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.424 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.1 OUTLIER -71.25 -29.6 65.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -1.218 . . . . 0.0 109.335 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -49.26 114.76 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' D' ' 22' ' ' GLU . 95.4 m-20 -78.45 67.6 4.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.321 -0.862 . . . . 0.0 109.074 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' D' ' 22' ' ' GLU . 69.0 t -44.34 -29.1 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.73 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.08 7.39 0.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.557 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' D' ' 20' ' ' VAL . 38.7 mt-10 -155.29 -49.36 0.08 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.0 t -48.69 -60.74 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.92 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.87 -39.15 17.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.1 -43.8 89.29 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' D' ' 30' ' ' ARG . 57.0 mt-10 -79.51 -40.34 29.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -1.169 . . . . 0.0 109.487 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 -34.26 8.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -82.58 -56.75 3.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.307 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.67 -44.78 79.72 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 30' ' ' ARG . . . . . 0.58 HH21 HG11 ' D' ' 33' ' ' VAL . 0.0 OUTLIER -53.95 -36.44 62.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -1.123 . . . . 0.0 109.31 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -56.01 -47.57 77.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.37 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 mt -65.06 -22.74 67.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.595 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' VAL . . . . . 0.58 HG11 HH21 ' D' ' 30' ' ' ARG . 74.7 t -81.63 -64.68 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.434 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' C' ' 123' ' ' ALA . 2.2 t -67.67 -22.79 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.501 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 35' ' ' TYR . . . . . 0.425 ' CG ' HD21 ' D' ' 105' ' ' LEU . 83.5 m-85 -139.41 80.86 21.58 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.77 -16.17 9.14 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.726 2.284 . . . . 0.0 112.437 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -51.04 -19.77 1.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 109.516 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 3.7 p -85.56 55.56 3.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 109.231 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -109.81 41.27 1.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.258 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 57.5 mmt-85 -103.91 -49.34 3.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.82 . . . . 0.0 109.477 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -91.82 29.98 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.585 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' D' ' 44' ' ' SER . 9.4 p90 -92.63 -12.98 30.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -45.92 -14.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.338 -0.851 . . . . 0.0 109.971 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 44' ' ' SER . . . . . 0.543 ' N ' ' O ' ' D' ' 42' ' ' PHE . 23.4 p -124.26 23.47 8.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.87 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.4 -14.06 21.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.253 -0.904 . . . . 0.0 109.267 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.43 -116.86 2.25 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -144.3 105.34 4.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.355 -1.085 . . . . 0.0 109.535 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 mt -90.94 30.5 1.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.042 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.8 p -43.91 -32.47 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 109.925 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 17.9 p -146.52 148.4 33.81 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 109.389 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -40.37 -49.96 3.8 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.378 2.052 . . . . 0.0 112.232 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -61.29 -35.06 76.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.92 -19.69 4.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.23 -63.9 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -0.929 . . . . 0.0 109.542 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 12.2 mmt -63.07 -7.59 5.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.5 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.35 -10.25 64.12 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -78.43 141.92 61.89 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.228 -1.16 . . . . 0.0 109.325 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.26 -57.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.492 2.128 . . . . 0.0 112.242 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' D' ' 63' ' ' HIS . 45.7 mtpt -52.02 -48.4 64.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.619 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 73.9 t -45.86 -39.7 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 109.251 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -79.44 -52.34 8.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.315 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.29 -59.26 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.812 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' D' ' 59' ' ' LYS . 1.7 t60 -48.25 -24.87 1.31 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.646 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.32 -36.83 92.23 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -69.33 -25.18 64.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -1.12 . . . . 0.0 109.416 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -73.08 -35.32 66.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.575 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 39.8 t -75.72 -28.39 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.454 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.15 -34.92 68.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.33 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.53 -45.14 37.57 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.89 91.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -1.129 . . . . 0.0 109.656 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 71' ' ' PHE . . . . . 0.421 ' CE2' HD21 ' D' ' 110' ' ' LEU . 25.6 t80 -57.21 -41.14 78.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.626 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 5.7 t -76.64 -37.8 55.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.655 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -47.32 -37.79 11.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.928 . . . . 0.0 109.517 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.17 -60.31 7.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.559 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -55.95 -29.95 60.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.348 -1.089 . . . . 0.0 109.365 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.05 5.32 30.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.597 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.524 ' NE2' ' OD1' ' D' ' 80' ' ' ASN . 7.5 t60 -170.9 67.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.556 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.94 17.93 1.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.935 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -79.59 -29.22 41.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 80' ' ' ASN . . . . . 0.524 ' OD1' ' NE2' ' D' ' 77' ' ' HIS . 4.3 p-10 -163.28 95.83 0.85 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.284 -0.885 . . . . 0.0 109.198 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 81' ' ' LEU . . . . . 0.509 HD12 ' H ' ' D' ' 81' ' ' LEU . 5.0 mp -80.33 -58.85 2.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.58 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -57.61 -23.78 52.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.008 . . . . 0.0 109.46 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 83' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' D' ' 86' ' ' ALA . . . -82.98 -54.4 3.22 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.0 t -61.31 -47.55 85.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -1.166 . . . . 0.0 109.652 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' D' ' 84' ' ' THR . 54.7 m-85 -76.76 22.03 0.19 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.424 -0.797 . . . . 0.0 109.476 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 86' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.42 -26.87 44.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.898 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 76.0 p -78.81 -59.23 2.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.3 mt -48.48 -45.06 36.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.319 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 54.0 p -64.74 -52.8 55.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.229 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -61.21 -22.66 64.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.481 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 8.8 tp -87.0 -68.66 0.73 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.433 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' D' ' 97' ' ' HIS . 49.0 m80 -51.0 -26.57 6.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 110.08 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 93' ' ' CYS . . . . . 0.413 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 27.4 t -83.71 -55.87 4.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.187 -0.945 . . . . 0.0 111.361 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 27.4 t0 -86.27 -32.11 21.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.038 -1.039 . . . . 0.0 111.928 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -89.48 -51.83 5.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.696 -1.253 . . . . 0.0 111.055 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.55 -27.02 15.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.871 -1.143 . . . . 0.0 110.45 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 1.318 ' ND1' HG22 ' A' ' 38' ' ' THR . 82.8 m-70 51.68 29.55 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.052 -1.03 . . . . 0.0 109.581 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 98' ' ' VAL . . . . . 0.449 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 39.8 t -47.18 130.27 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.111 -0.993 . . . . 0.0 109.488 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.31 152.45 31.9 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.344 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.96 -164.09 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.494 2.13 . . . . 0.0 112.206 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.19 60.83 2.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.568 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 102' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' D' ' 105' ' ' LEU . 33.3 t-20 -171.27 -41.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.957 . . . . 0.0 109.457 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -46.21 -40.47 11.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.731 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -80.04 -19.99 46.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 0.0 109.577 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 105' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' D' ' 102' ' ' ASN . 12.2 tp -70.54 -59.76 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.613 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -49.77 -46.33 50.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.33 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.08 -20.39 57.99 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -80.57 -25.1 38.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -1.165 . . . . 0.0 109.672 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 73.9 t -86.28 -43.09 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.659 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 110' ' ' LEU . . . . . 0.421 HD21 ' CE2' ' D' ' 71' ' ' PHE . 6.3 tt -48.08 -33.22 7.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.54 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 111' ' ' VAL . . . . . 0.416 ' H ' HG12 ' D' ' 111' ' ' VAL . 4.3 p -82.9 -26.16 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 72.0 m -69.05 -24.84 64.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.177 -0.952 . . . . 0.0 109.496 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.34 -34.8 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 114' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' D' ' 118' ' ' PHE . 9.4 mt -69.82 -40.14 76.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.472 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -54.47 -29.0 48.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.318 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.532 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -84.64 -62.42 1.55 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 109.113 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -63.4 -17.67 62.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 109.639 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' D' ' 114' ' ' LEU . 93.1 m-85 -149.65 60.29 1.01 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.462 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.534 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -69.28 -24.62 75.95 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -64.76 -29.67 70.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -1.154 . . . . 0.0 109.351 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' D' ' 123' ' ' THR . 78.3 mm-40 -87.83 5.76 38.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.862 . . . . 0.0 109.764 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.67 33.12 0.08 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.416 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.496 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.4 p -52.45 149.16 10.94 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.833 . . . . 0.0 109.367 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.1 Cg_exo -45.52 -53.6 5.35 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.452 2.101 . . . . 0.0 112.907 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 24.3 Cg_endo -62.22 -29.65 80.68 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.063 1.842 . . . . 0.0 112.211 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.447 HG23 ' OG1' ' D' ' 123' ' ' THR . 46.2 t -68.72 -28.16 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.185 -0.947 . . . . 0.0 109.537 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -83.18 -53.92 5.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 109.508 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.883 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -63.19 -26.5 68.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.622 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.54 -2.3 53.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 109.823 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' D' ' 132' ' ' LYS . 41.8 t80 -92.42 -61.7 1.55 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.968 . . . . 0.0 109.646 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 1.5 tm0? -45.23 -23.32 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 109.94 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 132' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' D' ' 130' ' ' TYR . 51.0 mtmt -85.46 -34.54 21.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.147 -0.971 . . . . 0.0 110.344 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 133' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 0.6 OUTLIER -68.59 -44.22 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.995 -1.066 . . . . 0.0 109.649 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.486 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 6.1 m -79.6 -20.98 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -50.41 -32.46 17.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.096 -1.002 . . . . 0.0 109.336 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.59 -26.66 56.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.32 -32.96 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -1.133 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.43 90.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.9 . . . . 0.0 109.626 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.98 -21.06 47.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.664 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.01 -58.92 6.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.42 -31.89 71.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.07 25.2 4.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.289 -0.882 . . . . 0.0 109.549 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -80.0 -16.11 55.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.131 -0.981 . . . . 0.0 109.733 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 13.2 mptt -98.42 -26.64 14.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 109.571 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 145' ' ' TYR . . . . . 0.449 ' OH ' ' O ' ' D' ' 98' ' ' VAL . 12.1 m-85 -54.43 -6.85 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.336 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' D' ' 144' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.44 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.535 HD21 ' OD2' ' A' ' 6' ' ' ASP . 14.0 tp -170.95 164.65 7.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 0.0 109.864 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.83 165.75 35.68 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.348 -0.845 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.64 -77.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.773 2.315 . . . . 0.0 112.655 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -45.22 -30.01 1.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 109.964 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.775 ' O ' HG23 ' A' ' 10' ' ' VAL . 26.2 t0 -43.77 -23.04 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.246 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -83.34 -60.61 2.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.372 -0.83 . . . . 0.0 109.324 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.5 m -44.45 -35.97 2.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.535 -0.728 . . . . 0.0 109.9 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.422 ' C ' ' OG ' ' A' ' 124' ' ' SER . 2.5 m-20 -74.49 -30.02 61.65 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 6' ' ' ASP . 76.6 t -76.31 -53.52 15.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -52.62 -38.28 59.9 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.081 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.04 -63.76 1.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.47 -0.769 . . . . 0.0 109.144 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.745 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -58.56 -37.7 76.27 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -17.23 62.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 109.03 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -79.02 -46.25 8.43 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 13.2 mmmt -69.17 -38.27 78.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 108.982 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 13' ' ' ALA . 98.9 t -61.07 -64.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 54.43 -132.59 46.55 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.87 26.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -1.073 . . . . 0.0 110.522 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.547 ' H ' ' C ' ' A' ' 18' ' ' GLY . 92.7 m-70 -129.94 22.29 5.36 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -86.7 -60.0 2.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.65 -0.656 . . . . 0.0 109.598 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.4 -14.28 0.18 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 21' ' ' ALA . 7.3 mm-40 -86.85 -56.52 3.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.425 -1.044 . . . . 0.0 109.781 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.8 m-30 -60.67 -37.55 81.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.15 -22.88 71.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -82.09 -51.43 8.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.144 -1.209 . . . . 0.0 109.839 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.59 -19.8 28.29 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.325 -0.859 . . . . 0.0 109.372 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.2 -23.74 62.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.269 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.534 HD11 ' ND1' ' A' ' 58' ' ' HIS . 26.5 mt -70.33 -56.15 7.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.303 -0.873 . . . . 0.0 109.459 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.03 -12.62 8.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.404 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -76.29 -61.1 2.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -19.45 65.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.49 -53.15 61.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 0.0 109.715 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.039 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.2 pp -88.01 -41.87 12.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.941 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.7 t -58.9 -2.27 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.663 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' A' ' 35' ' ' SER . 64.9 m-85 -160.24 81.85 2.27 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 109.418 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -49.17 -27.03 11.85 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.725 2.284 . . . . 0.0 112.316 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 41' ' ' THR . 5.5 p -49.04 -21.42 0.69 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -0.991 . . . . 0.0 109.388 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.9 p -90.36 -27.07 19.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -55.09 -47.51 74.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.636 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 1.108 HG21 ' CD2' ' D' ' 97' ' ' HIS . 13.1 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.457 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 25.2 p80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.041 0.448 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.465 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -164.73 29.63 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.029 -1.045 . . . . 0.0 110.371 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 46' ' ' PHE . 5.9 m-20 41.04 88.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.533 -0.729 . . . . 0.0 110.113 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.676 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -61.43 -19.53 62.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.505 -0.747 . . . . 0.0 109.15 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -47.3 121.49 3.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.64 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -65.25 107.86 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.91 -6.58 4.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.604 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 2.0 t -75.02 -0.23 18.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.39 -1.065 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 71.1 -14.94 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 109.589 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' A' ' 52' ' ' SER . 54.6 mt-30 -86.09 -28.9 23.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.506 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.598 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 4.2 t -82.96 -39.1 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -81.98 -25.56 34.66 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.508 ' HA2' ' HZ2' ' A' ' 60' ' ' LYS . . . -76.73 -25.56 64.72 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.534 ' ND1' HD11 ' A' ' 29' ' ' LEU . 5.8 t-80 -72.75 -42.38 64.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -1.183 . . . . 0.0 109.613 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.96 -46.44 32.46 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HZ2' ' HA2' ' A' ' 57' ' ' GLY . 6.4 mtmm -53.08 -22.66 6.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -1.081 . . . . 0.0 109.912 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HZ1' ' HZ1' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -73.99 -48.66 28.76 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.037 -1.039 . . . . 0.0 108.599 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -67.85 -45.99 83.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.467 ' N ' HG12 ' A' ' 62' ' ' VAL . . . -66.05 -35.28 80.12 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.488 -0.757 . . . . 0.0 109.398 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 11.7 t70 -65.17 -48.4 73.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.122 -0.986 . . . . 0.0 108.676 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -59.47 -50.68 73.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.47 -49.77 66.75 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -61.8 -54.52 41.12 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.901 . . . . 0.0 108.883 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -60.44 -20.89 61.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 108.777 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.2 -48.08 9.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.38 -22.84 27.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.97 -33.61 68.31 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.601 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.7 m170 -97.2 -66.58 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.441 -0.787 . . . . 0.0 109.557 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.1 p 44.89 14.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.883 0.849 . . . . 0.0 109.156 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 72' ' ' HIS . 91.6 m-20 -140.49 13.31 2.35 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -175.27 31.85 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.544 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -64.01 -46.46 80.67 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 110.062 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 76' ' ' MET . 81.5 Cg_exo -44.15 -40.78 12.65 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.471 2.114 . . . . 0.0 112.563 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -94.32 -17.21 22.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 109.975 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.8 -58.11 3.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.162 -0.961 . . . . 0.0 109.302 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.401 ' C ' ' N ' ' A' ' 82' ' ' ALA . 11.0 mt -77.69 11.21 2.21 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.367 -0.833 . . . . 0.0 109.045 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.67 -16.21 0.61 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.563 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -80.91 -57.8 3.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.45 ' N ' HD23 ' A' ' 83' ' ' LEU . 3.7 mt -44.88 -43.94 9.23 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.91 -27.33 18.21 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.501 -0.749 . . . . 0.0 109.056 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' ALA . 34.4 t70 -76.26 -21.44 56.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.935 . . . . 0.0 109.291 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 90' ' ' LYS . 3.3 tp -82.99 -34.64 26.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -92.42 -21.72 20.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.519 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.33 -98.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.918 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -86.36 -76.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.0 ttmm -45.31 124.51 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 109.765 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 93' ' ' VAL . 16.2 mt 54.04 57.73 5.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.307 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.967 ' NE ' ' HG2' ' D' ' 40' ' ' ARG . 85.2 mtm-85 -49.81 -38.91 36.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.614 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 94' ' ' ASP . 59.4 t 47.22 -101.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.487 ' N ' HG12 ' A' ' 93' ' ' VAL . 0.3 OUTLIER 171.33 137.36 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 109.176 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.24 -16.78 19.5 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.371 2.047 . . . . 0.0 112.014 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 96' ' ' VAL . 61.5 t -60.66 -9.47 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.701 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 98' ' ' PHE . 29.6 p30 -78.91 -24.79 43.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.117 -0.989 . . . . 0.0 109.34 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.532 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.7 OUTLIER -50.1 -47.19 54.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.313 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.24 -22.66 66.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.908 . . . . 0.0 109.609 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.459 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 42.7 mt -84.01 -62.03 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.651 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.46 -25.82 11.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.081 -1.012 . . . . 0.0 109.708 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 t -69.97 -59.18 3.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.87 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.766 ' ND1' ' OD1' ' B' ' 108' ' ' ASN . 43.2 m170 -63.26 -26.67 68.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.621 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 67.4 m -67.9 -48.25 66.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 109.567 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.88 -41.21 32.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.406 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 106' ' ' LEU . 9.4 mp -68.17 -50.78 52.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 109.522 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.606 ' CG1' HE22 ' B' ' 127' ' ' GLN . 70.4 t -53.99 -51.42 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 110' ' ' ALA . 40.2 m -59.82 -58.47 8.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 113' ' ' LEU . 4.6 mt -45.98 -19.95 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.875 . . . . 0.0 109.643 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -72.29 -35.47 68.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 110.135 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 1.313 ' HB2' ' CE2' ' B' ' 122' ' ' PHE . . . -75.04 -3.78 34.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.031 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.6 -82.3 0.31 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -106.82 94.4 10.42 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.8 175.87 9.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.093 1.862 . . . . 0.0 112.935 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -47.78 -44.84 28.82 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.438 0.637 . . . . 0.0 109.814 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 6.9 mt-10 87.1 5.65 0.31 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 t80 68.38 36.42 3.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.871 -0.518 . . . . 0.0 111.51 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.713 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -96.96 121.65 58.68 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.807 -1.183 . . . . 0.0 108.224 178.419 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.95 20.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.15 1.9 . . . . 0.0 112.765 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -145.43 -37.66 0.27 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.934 -1.104 . . . . 0.0 110.264 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.616 HG13 ' N ' ' A' ' 122' ' ' HIS . 7.8 p -46.91 -44.76 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.069 -1.019 . . . . 0.0 110.126 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.616 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.3 m80 -56.7 -50.0 73.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.81 -19.58 34.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.786 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 120' ' ' ALA . 15.5 t -54.82 -58.18 8.59 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.205 -0.934 . . . . 0.0 110.597 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.43 -19.73 30.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.199 -0.938 . . . . 0.0 110.156 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -83.25 -40.36 19.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.887 -1.133 . . . . 0.0 110.18 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' CD ' ' C ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -87.09 -47.21 9.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.005 -1.06 . . . . 0.0 109.63 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.51 ' CD1' HG21 ' A' ' 10' ' ' VAL . 70.9 t80 -48.63 -21.59 0.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.96 -1.088 . . . . 0.0 109.212 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.622 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.6 mt -69.73 -17.87 63.48 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.05 -29.97 70.04 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.48 ' HB3' HD13 ' A' ' 2' ' ' LEU . 53.3 p -82.78 -35.93 26.08 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.419 -0.801 . . . . 0.0 108.973 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.19 -27.34 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.234 -0.916 . . . . 0.0 108.897 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 129' ' ' LEU . 57.4 p -84.17 -24.91 29.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.427 -0.795 . . . . 0.0 109.052 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.7 m -78.16 -34.92 49.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.158 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.4 t -78.34 -26.4 14.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.156 -0.965 . . . . 0.0 108.577 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -33.67 76.41 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.3 m -85.26 -15.19 44.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.574 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 1.02 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -121.42 -175.15 3.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.557 -0.714 . . . . 0.0 109.196 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -79.57 152.76 75.71 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 109.016 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.83 -28.55 75.87 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.526 2.151 . . . . 0.0 112.01 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -86.7 -21.92 26.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.485 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.57 -63.11 1.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.723 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.711 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -57.21 -40.4 77.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.791 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.7 t -45.54 -23.71 0.26 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 110.038 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.44 -57.07 3.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.148 -0.97 . . . . 0.0 109.792 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.407 ' H ' HG12 ' B' ' 11' ' ' VAL . 0.8 OUTLIER -67.22 -24.55 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 8.4 m -71.18 -44.45 65.44 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.676 -0.64 . . . . 0.0 109.446 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.41 74.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.358 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.807 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -49.27 -21.06 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.193 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -17.3 60.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.5 -57.48 7.34 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.654 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.576 ' HE2' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -86.59 12.5 10.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.979 -1.307 . . . . 0.0 110.929 -178.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.807 HG23 ' O ' ' B' ' 14' ' ' LEU . 2.2 t -79.49 114.93 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.839 -1.163 . . . . 0.0 109.007 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.48 82.73 3.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.48 ' C ' ' H ' ' B' ' 22' ' ' GLU . 72.1 t -54.94 -18.21 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 5.0 m-20 -66.21 6.3 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.712 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' B' ' 20' ' ' VAL . 35.1 mt-10 -156.01 -52.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' B' ' 27' ' ' ALA . 95.3 t -47.57 -35.66 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.705 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.52 -57.55 4.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.5 -50.78 55.65 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.19 -45.98 90.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -1.138 . . . . 0.0 109.602 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' B' ' 23' ' ' VAL . . . -51.1 -35.22 34.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.688 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -84.96 -58.03 2.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 109.654 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.22 -37.45 72.91 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.513 HH21 HG22 ' B' ' 113' ' ' VAL . 8.1 ttp180 -69.74 -38.48 76.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -1.212 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 40.6 tp -52.99 -24.22 8.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.074 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' B' ' 36' ' ' PRO . 15.7 mt -75.54 -54.39 7.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.037 -1.04 . . . . 0.0 110.893 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.41 HG22 ' H ' ' B' ' 33' ' ' VAL . 2.2 m -52.72 -49.02 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.712 -1.242 . . . . 0.0 109.764 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -70.76 -22.72 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 109.126 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -149.43 74.94 9.63 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.48 ' N ' ' O ' ' B' ' 32' ' ' LEU . 72.3 Cg_endo -81.54 -22.87 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.788 2.326 . . . . 0.0 112.219 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -48.98 -19.92 0.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.908 . . . . 0.0 109.47 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.465 ' C ' ' H ' ' B' ' 40' ' ' ARG . 33.5 p -80.35 9.9 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -71.8 12.26 0.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.318 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.921 ' HG2' ' NE ' ' C' ' 92' ' ' ARG . 97.4 mtt180 -80.29 -19.77 45.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.52 26.27 4.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.306 -0.871 . . . . 0.0 109.129 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.507 ' CE1' ' CD2' ' B' ' 45' ' ' PHE . 33.4 t80 -148.77 11.73 0.86 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.89 -22.13 40.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.889 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 27.4 p -84.61 7.13 21.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' B' ' 42' ' ' PHE . 3.7 m-85 -81.44 -16.44 52.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.94 -175.37 45.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ASP . . . . . 0.443 ' O ' ' HB1' ' B' ' 53' ' ' ALA . 3.6 p-10 -83.14 103.84 12.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -1.088 . . . . 0.0 109.578 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.579 ' N ' HD12 ' B' ' 48' ' ' LEU . 10.2 mp -88.17 29.73 0.93 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.199 -0.938 . . . . 0.0 109.147 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.1 m -44.88 -35.88 3.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.838 . . . . 0.0 109.789 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 5.5 p -146.43 148.83 35.54 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.61 -36.35 4.71 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.565 2.177 . . . . 0.0 112.501 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.68 -33.58 72.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.743 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' B' ' 47' ' ' ASP . . . -62.16 -19.88 63.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.609 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.97 -59.69 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.963 . . . . 0.0 109.525 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' MET . . . . . 0.495 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -87.45 10.54 17.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.37 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.91 -31.22 32.89 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -81.94 147.96 59.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 109.434 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.63 -57.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.544 2.163 . . . . 0.0 112.427 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.03 -33.36 4.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.777 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 70.8 t -61.03 -57.92 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.459 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -64.96 -33.6 76.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.56 -53.65 44.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.589 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -53.3 -24.01 10.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.187 -0.946 . . . . 0.0 109.538 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.08 -23.88 73.08 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.88 -44.08 81.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -1.158 . . . . 0.0 109.164 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -55.35 -47.29 75.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.416 -0.802 . . . . 0.0 109.351 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 25.4 t -58.14 -47.01 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.321 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.42 -35.02 74.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 109.276 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.83 -53.18 46.05 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.11 63.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -1.201 . . . . 0.0 109.616 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -55.85 -31.16 62.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.398 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 33.2 t -76.56 -31.45 57.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.421 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -50.28 -40.02 47.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.368 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.89 -59.95 8.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.551 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -58.16 -26.92 63.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -1.166 . . . . 0.0 109.387 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.05 2.51 46.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.443 ' C ' ' H ' ' B' ' 79' ' ' ASP . 66.0 t60 -170.89 65.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.731 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 80.0 mt -75.85 19.58 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.955 . . . . 0.0 109.432 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' B' ' 77' ' ' HIS . 8.9 m-20 -79.6 -29.49 41.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' B' ' 80' ' ' ASN . 0.6 OUTLIER -173.32 107.09 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.564 HD12 ' N ' ' B' ' 81' ' ' LEU . 8.3 mp -80.28 -58.77 2.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.476 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' B' ' 82' ' ' LYS . 0.0 OUTLIER -46.5 -24.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.5 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.71 -50.24 9.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.7 t -82.35 -47.37 12.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -1.133 . . . . 0.0 109.366 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.552 ' N ' ' CG2' ' B' ' 84' ' ' THR . 27.6 m-85 -65.03 1.36 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.732 . . . . 0.0 109.482 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.9 -34.93 66.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.514 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -74.34 -57.55 3.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.479 ' N ' HD12 ' B' ' 88' ' ' LEU . 9.0 mp -49.3 -45.0 44.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -63.95 -52.15 61.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.67 -22.83 64.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 6.5 tt -85.51 -62.81 1.44 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' B' ' 97' ' ' HIS . 75.2 m80 -61.34 -20.14 62.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 110.13 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 51.7 t -83.51 -60.63 2.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.022 -1.049 . . . . 0.0 110.571 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.43 -28.32 22.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.047 -1.033 . . . . 0.0 110.994 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -83.99 -51.91 6.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.064 . . . . 0.0 110.686 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 11.7 mt -107.0 -21.29 13.05 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.08 -1.012 . . . . 0.0 109.966 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 1.073 ' CD2' HG21 ' C' ' 41' ' ' THR . 33.0 p80 43.02 37.46 1.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.346 -0.846 . . . . 0.0 109.971 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.0 130.89 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.195 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -46.94 147.35 2.31 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.39 -16.93 44.1 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.508 2.139 . . . . 0.0 112.086 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' B' ' 101' ' ' GLU . 58.7 mp0 -81.25 55.22 2.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.317 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -156.1 -37.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -64.16 -38.67 91.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.116 -0.99 . . . . 0.0 109.529 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -69.72 -28.18 65.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.677 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 16.1 mt -71.61 -52.76 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tt -52.17 -47.81 65.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.353 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.73 -20.4 70.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ASN . . . . . 0.766 ' OD1' ' ND1' ' A' ' 103' ' ' HIS . 0.4 OUTLIER -83.27 -19.11 36.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -1.177 . . . . 0.0 109.743 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 72.8 t -80.34 -44.56 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.093 -1.004 . . . . 0.0 109.561 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 10.7 mt -47.38 -31.92 4.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.99 -33.47 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.429 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 11.9 m -79.15 -54.51 5.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.48 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' VAL . . . . . 0.513 HG22 HH21 ' B' ' 30' ' ' ARG . 14.0 t -49.52 -46.01 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.426 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.05 -22.83 64.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.855 . . . . 0.0 109.345 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.455 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -80.73 -24.29 38.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.478 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.47 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.77 -61.59 1.75 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 109.346 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.413 ' C ' ' CG ' ' B' ' 118' ' ' PHE . 55.3 m80 -60.25 -17.7 43.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.651 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.413 ' CG ' ' C ' ' B' ' 117' ' ' HIS . 19.2 m-85 -150.29 58.56 0.96 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.585 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -68.64 -28.6 73.05 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -68.99 6.37 0.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.412 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' B' ' 123' ' ' THR . 17.8 mm-40 -126.0 -1.2 7.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.448 -0.782 . . . . 0.0 109.438 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 1.313 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -72.75 35.37 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.552 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.504 ' OG1' HG23 ' B' ' 126' ' ' VAL . 13.2 p -50.85 146.64 9.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.51 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.3 Cg_exo -48.29 -51.39 10.21 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.382 2.055 . . . . 0.0 113.04 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 39.9 Cg_endo -67.57 -27.67 38.8 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.063 1.842 . . . . 0.0 112.496 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.504 HG23 ' OG1' ' B' ' 123' ' ' THR . 55.5 t -77.39 -24.14 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.494 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' GLN . . . . . 0.606 HE22 ' CG1' ' A' ' 107' ' ' VAL . 9.1 tt0 -83.28 -54.55 4.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 1.039 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -49.19 -44.07 42.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.488 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.37 13.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.884 . . . . 0.0 109.597 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' B' ' 128' ' ' ALA . 32.0 t80 -97.95 -59.89 1.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 38.2 tt0 -47.45 -30.53 3.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -66.15 -46.62 76.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 109.753 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.73 -55.55 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.109 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.442 HG22 ' H ' ' B' ' 134' ' ' VAL . 3.5 m -67.95 -36.76 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -0.942 . . . . 0.0 110.02 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -50.16 -24.57 2.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.486 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.99 -31.41 55.6 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.2 t -82.78 -29.89 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.18 -1.188 . . . . 0.0 109.523 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.77 77.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.471 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 139' ' ' ASN . . . . . 1.169 ' OD1' ' CE1' ' D' ' 146' ' ' HIS . 4.2 m120 -71.33 -27.75 63.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.514 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.36 -60.38 2.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.92 -16.14 2.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.26 -3.07 13.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.368 -0.832 . . . . 0.0 109.516 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 139' ' ' ASN . 21.9 t-80 -64.27 -33.28 75.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.505 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -82.45 -29.74 30.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.561 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -51.37 -20.98 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 1.222 ' CE1' ' OD1' ' D' ' 139' ' ' ASN . 43.0 m80 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.477 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.543 HD21 ' OD2' ' C' ' 6' ' ' ASP . 14.0 tp -170.86 164.68 7.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.113 -0.992 . . . . 0.0 109.869 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.76 165.88 35.11 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.496 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.72 -77.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.79 2.327 . . . . 0.0 112.591 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -45.17 -30.1 1.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 109.953 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.771 ' O ' HG23 ' C' ' 10' ' ' VAL . 26.3 t0 -43.62 -23.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.323 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' C' ' 10' ' ' VAL . 0.0 OUTLIER -83.39 -60.51 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.385 -0.822 . . . . 0.0 109.33 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.402 ' C ' ' O ' ' C' ' 7' ' ' LYS . 45.6 m -44.43 -36.0 2.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 109.805 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 9' ' ' ASN . . . . . 0.424 ' C ' ' OG ' ' C' ' 124' ' ' SER . 2.5 m-20 -74.46 -30.12 61.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.771 HG23 ' O ' ' C' ' 6' ' ' ASP . 76.8 t -76.27 -53.49 15.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 11' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' C' ' 7' ' ' LYS . 0.0 OUTLIER -52.78 -38.17 60.69 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.03 -63.72 1.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.203 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.729 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -58.55 -37.77 76.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.396 -0.815 . . . . 0.0 108.818 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -17.22 62.53 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.049 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 15' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' C' ' 11' ' ' LYS . . . -79.07 -46.24 8.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 13.3 mmmt -69.21 -38.25 78.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 0.0 108.922 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.729 HG23 ' O ' ' C' ' 13' ' ' ALA . 98.3 t -61.11 -65.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.567 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 54.42 -132.49 46.48 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.9 26.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.481 -1.011 . . . . 0.0 110.49 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.567 ' H ' ' C ' ' C' ' 18' ' ' GLY . 92.7 m-70 -129.89 22.25 5.38 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -86.72 -60.09 2.08 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.681 -0.637 . . . . 0.0 109.512 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.33 -14.27 0.17 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' C' ' 21' ' ' ALA . 7.3 mm-40 -86.84 -56.57 3.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -1.087 . . . . 0.0 109.795 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.8 m-30 -60.73 -37.51 81.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -22.89 71.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' C' ' 55' ' ' VAL . . . -82.2 -51.33 8.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -1.199 . . . . 0.0 109.841 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.58 -19.89 28.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.17 -23.76 62.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.286 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.539 HD11 ' ND1' ' C' ' 58' ' ' HIS . 26.8 mt -70.28 -56.12 7.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 109.444 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.06 -12.63 8.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -76.3 -61.18 2.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.894 . . . . 0.0 109.726 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -19.44 65.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.607 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.49 -53.27 60.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.639 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 1.061 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.2 pp -87.87 -41.99 12.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 0.0 109.919 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.8 t -58.89 -2.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.096 -1.002 . . . . 0.0 109.637 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' C' ' 35' ' ' SER . 64.9 m-85 -160.07 81.78 2.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.468 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -49.17 -26.93 11.71 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.696 2.264 . . . . 0.0 112.302 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.418 ' O ' HG22 ' C' ' 41' ' ' THR . 5.2 p -49.1 -21.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.363 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.3 p -90.28 -27.17 19.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.55 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -55.11 -47.43 74.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.608 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' THR . . . . . 1.073 HG21 ' CD2' ' B' ' 97' ' ' HIS . 13.0 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 0.0 109.398 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.451 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 25.0 p80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.056 0.455 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.47 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -164.74 29.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.981 -1.074 . . . . 0.0 110.301 179.206 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' C' ' 46' ' ' PHE . 5.9 m-20 41.0 88.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.554 -0.716 . . . . 0.0 110.119 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.675 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -61.44 -19.58 62.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.448 -0.782 . . . . 0.0 109.239 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -47.25 121.51 3.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.632 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.15 107.87 1.69 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 109.369 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.87 -6.54 4.44 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.597 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 2.0 t -75.07 -0.12 17.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -1.042 . . . . 0.0 109.427 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 71.02 -14.87 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.845 . . . . 0.0 109.63 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' C' ' 52' ' ' SER . 54.8 mt-30 -86.07 -29.04 23.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.611 ' O ' ' HB1' ' C' ' 26' ' ' ALA . 4.2 t -82.85 -39.11 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.955 . . . . 0.0 109.328 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -82.0 -25.62 34.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 108.542 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' GLY . . . . . 0.553 ' HA2' ' HZ2' ' C' ' 60' ' ' LYS . . . -76.73 -25.56 64.7 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.539 ' ND1' HD11 ' C' ' 29' ' ' LEU . 5.7 t-80 -72.79 -42.38 63.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -1.179 . . . . 0.0 109.631 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.93 -46.5 32.28 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.553 ' HZ2' ' HA2' ' C' ' 57' ' ' GLY . 6.4 mtmm -53.04 -22.61 6.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.997 . . . . 0.0 109.911 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 61' ' ' LYS . . . . . 0.438 ' HZ1' ' HZ1' ' C' ' 60' ' ' LYS . 0.3 OUTLIER -74.01 -48.76 28.02 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.115 -0.991 . . . . 0.0 108.502 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.445 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -67.75 -46.05 83.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.445 ' N ' HG12 ' C' ' 62' ' ' VAL . . . -65.92 -35.42 80.56 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.454 -0.778 . . . . 0.0 109.355 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 64' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 11.6 t70 -65.19 -48.36 73.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.946 . . . . 0.0 108.654 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 65' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -59.53 -50.64 73.14 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.44 -49.85 66.5 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -61.67 -54.62 40.29 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.205 -0.934 . . . . 0.0 108.897 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -60.31 -21.03 61.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 108.756 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.2 -48.1 9.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -68.32 -22.83 27.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.62 68.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.596 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.7 m170 -97.26 -66.47 0.9 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.428 -0.795 . . . . 0.0 109.556 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.532 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.1 p 44.78 14.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.978 0.894 . . . . 0.0 109.214 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' C' ' 72' ' ' HIS . 91.2 m-20 -140.57 13.37 2.33 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -175.23 31.81 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.537 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -63.9 -46.47 81.34 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 110.099 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' C' ' 76' ' ' MET . 81.6 Cg_exo -44.21 -40.72 12.81 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.468 2.112 . . . . 0.0 112.607 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -94.25 -17.31 22.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.985 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.8 -57.95 3.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 109.309 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 80' ' ' LEU . . . . . 0.403 ' C ' ' N ' ' C' ' 82' ' ' ALA . 11.0 mt -77.79 11.22 2.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.06 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.68 -16.24 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.513 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -80.89 -57.69 3.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.669 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.452 ' N ' HD23 ' C' ' 83' ' ' LEU . 3.8 mt -44.95 -43.96 9.43 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.85 -27.33 17.86 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' C' ' 82' ' ' ALA . 34.4 t70 -76.32 -21.55 56.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.283 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' C' ' 90' ' ' LYS . 3.3 tp -82.9 -34.56 26.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.281 -0.887 . . . . 0.0 109.47 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -92.47 -21.75 19.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 109.495 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.28 -98.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.901 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -86.26 -76.41 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.853 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' C' ' 86' ' ' LEU . 6.9 ttmm -45.27 124.54 4.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.799 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.441 ' O ' HG23 ' C' ' 93' ' ' VAL . 16.1 mt 53.97 57.7 5.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.846 . . . . 0.0 109.345 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 92' ' ' ARG . . . . . 0.921 ' NE ' ' HG2' ' B' ' 40' ' ' ARG . 85.3 mtm-85 -49.87 -38.77 36.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.822 . . . . 0.0 109.649 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.485 HG12 ' N ' ' C' ' 94' ' ' ASP . 58.3 t 47.14 -101.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 109.335 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.485 ' N ' HG12 ' C' ' 93' ' ' VAL . 0.3 OUTLIER 171.42 137.39 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.134 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.28 -16.75 19.44 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.366 2.044 . . . . 0.0 112.036 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.432 HG12 ' O ' ' C' ' 96' ' ' VAL . 60.9 t -60.66 -9.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.86 . . . . 0.0 109.671 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' C' ' 98' ' ' PHE . 29.7 p30 -78.94 -24.78 43.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 109.29 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 98' ' ' PHE . . . . . 0.523 ' N ' ' OD1' ' C' ' 97' ' ' ASN . 0.7 OUTLIER -50.18 -47.14 54.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.292 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.21 -22.7 66.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.594 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.489 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 43.5 mt -84.04 -62.04 1.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.585 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.37 -25.81 10.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 109.725 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -70.02 -59.16 3.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.18 -0.95 . . . . 0.0 109.805 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 103' ' ' HIS . . . . . 0.77 ' ND1' ' OD1' ' D' ' 108' ' ' ASN . 43.4 m170 -63.37 -26.58 68.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.644 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 67.9 m -67.99 -48.17 66.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.89 -41.24 32.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.962 . . . . 0.0 109.362 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.494 ' N ' HD12 ' C' ' 106' ' ' LEU . 9.4 mp -68.1 -50.74 52.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 109.568 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 107' ' ' VAL . . . . . 0.61 ' CG1' HE22 ' D' ' 127' ' ' GLN . 70.0 t -54.06 -51.3 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.356 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.452 ' O ' ' N ' ' C' ' 110' ' ' ALA . 39.9 m -59.91 -58.46 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' C' ' 113' ' ' LEU . 4.5 mt -45.99 -19.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.374 -0.829 . . . . 0.0 109.592 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -72.36 -35.38 68.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.147 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 111' ' ' ALA . . . . . 1.319 ' HB2' ' CE2' ' D' ' 122' ' ' PHE . . . -75.15 -3.67 34.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 110.012 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.72 -82.23 0.3 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 109.386 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' C' ' 113' ' ' LEU . 0.3 OUTLIER -106.91 94.47 10.67 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 175.9 9.67 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.169 1.913 . . . . 0.0 112.903 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -47.82 -44.84 29.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.641 -0.662 . . . . 0.0 109.85 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 6.9 mt-10 87.06 5.81 0.31 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 t80 68.27 36.46 3.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.826 -0.546 . . . . 0.0 111.523 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.718 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -96.93 121.63 58.79 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.796 -1.19 . . . . 0.0 108.226 178.4 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -51.02 20.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.104 1.869 . . . . 0.0 112.826 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.718 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -145.37 -37.72 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.897 -1.127 . . . . 0.0 110.258 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.618 HG13 ' N ' ' C' ' 122' ' ' HIS . 7.8 p -46.88 -44.77 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.156 -0.965 . . . . 0.0 110.172 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.618 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.2 m80 -56.68 -49.9 73.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.412 -0.805 . . . . 0.0 109.78 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.87 -19.57 34.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.771 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.536 ' N ' ' O ' ' C' ' 120' ' ' ALA . 15.3 t -54.78 -58.33 7.97 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 110.606 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 mt -85.22 -19.71 31.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.147 -0.971 . . . . 0.0 110.227 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -83.33 -40.29 19.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.898 -1.126 . . . . 0.0 110.202 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.472 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -87.17 -47.17 9.09 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.863 -1.148 . . . . 0.0 109.649 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.511 ' CD1' HG21 ' C' ' 10' ' ' VAL . 71.1 t80 -48.71 -21.55 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.018 -1.052 . . . . 0.0 109.22 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.613 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.7 mt -69.69 -17.9 63.51 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.09 -29.96 70.07 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.493 ' HB3' HD13 ' C' ' 2' ' ' LEU . 53.2 p -82.73 -35.86 26.28 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.475 -0.766 . . . . 0.0 109.033 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.34 -27.32 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -0.946 . . . . 0.0 108.793 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.613 ' N ' ' O ' ' C' ' 129' ' ' LEU . 56.8 p -84.08 -24.9 30.18 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.455 -0.778 . . . . 0.0 109.162 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 18.8 m -78.04 -35.1 50.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 109.146 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 96.6 t -78.16 -26.41 14.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.226 -0.921 . . . . 0.0 108.641 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.83 -33.59 76.21 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 76.0 m -85.29 -15.17 44.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.446 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.577 179.978 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 1.08 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -121.35 -175.04 2.98 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.443 -0.786 . . . . 0.0 109.2 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -79.77 152.79 75.2 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.344 -0.847 . . . . 0.0 109.045 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.83 -28.42 75.78 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.528 2.152 . . . . 0.0 112.024 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -86.85 -21.87 26.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.61 -63.02 1.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.733 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.731 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -57.27 -40.42 77.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 109.742 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.7 t -45.58 -23.61 0.25 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 110.08 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -81.44 -57.19 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.074 -1.016 . . . . 0.0 109.795 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.402 ' H ' HG12 ' D' ' 11' ' ' VAL . 0.9 OUTLIER -67.13 -24.49 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 8.4 m -71.17 -44.59 65.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.7 -0.625 . . . . 0.0 109.391 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.46 74.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.791 ' O ' HG23 ' D' ' 18' ' ' VAL . 0.7 OUTLIER -49.31 -21.06 0.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.839 . . . . 0.0 109.148 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -17.3 60.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 109.632 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.41 -57.51 7.38 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.665 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.584 ' H ' ' HE2' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -86.68 12.62 10.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.007 -1.29 . . . . 0.0 110.922 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.791 HG23 ' O ' ' D' ' 14' ' ' LEU . 2.2 t -79.65 115.03 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.822 -1.174 . . . . 0.0 108.959 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 19' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -76.53 82.72 3.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 109.488 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' D' ' 22' ' ' GLU . 71.1 t -54.8 -18.39 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' D' ' 21' ' ' ASP . 5.1 m-20 -66.15 6.3 0.42 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.89 . . . . 0.0 109.632 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' D' ' 20' ' ' VAL . 35.3 mt-10 -155.95 -52.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' D' ' 27' ' ' ALA . 95.7 t -47.53 -35.74 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.693 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.48 -57.57 4.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.51 -50.79 55.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.19 -45.94 91.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -1.119 . . . . 0.0 109.541 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' D' ' 23' ' ' VAL . . . -51.21 -35.23 35.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.621 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -84.97 -58.03 2.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.176 -0.952 . . . . 0.0 109.613 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.23 -37.48 73.06 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' ARG . . . . . 0.529 HH21 HG22 ' D' ' 113' ' ' VAL . 8.1 ttp180 -69.73 -38.44 76.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -1.209 . . . . 0.0 109.775 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 40.7 tp -53.0 -24.18 8.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 110.149 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 32' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' D' ' 36' ' ' PRO . 15.8 mt -75.48 -54.5 6.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.01 -1.057 . . . . 0.0 110.882 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 33' ' ' VAL . . . . . 0.43 HG22 ' H ' ' D' ' 33' ' ' VAL . 2.3 m -52.73 -48.95 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.743 -1.223 . . . . 0.0 109.769 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.469 HG22 ' O ' ' D' ' 30' ' ' ARG . 0.0 OUTLIER -70.78 -22.69 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.077 -1.015 . . . . 0.0 109.158 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -149.42 74.87 9.64 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' PRO . . . . . 0.49 ' N ' ' O ' ' D' ' 32' ' ' LEU . 72.4 Cg_endo -81.49 -22.92 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.84 2.36 . . . . 0.0 112.244 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -48.91 -20.0 0.45 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.456 ' C ' ' H ' ' D' ' 40' ' ' ARG . 33.5 p -80.29 9.86 5.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.905 . . . . 0.0 109.563 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -71.8 12.26 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 109.388 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' ARG . . . . . 0.967 ' HG2' ' NE ' ' A' ' 92' ' ' ARG . 97.4 mtt180 -80.26 -19.8 45.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 109.409 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.55 26.27 4.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.172 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.515 ' CE1' ' CD2' ' D' ' 45' ' ' PHE . 33.3 t80 -148.78 11.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.406 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.95 -22.09 39.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 27.2 p -84.65 7.01 21.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.515 ' CD2' ' CE1' ' D' ' 42' ' ' PHE . 3.6 m-85 -81.38 -16.42 52.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.18 -0.95 . . . . 0.0 109.442 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.03 -175.32 45.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.444 ' O ' ' HB1' ' D' ' 53' ' ' ALA . 3.6 p-10 -83.13 103.86 12.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -1.123 . . . . 0.0 109.531 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 48' ' ' LEU . . . . . 0.583 ' N ' HD12 ' D' ' 48' ' ' LEU . 10.2 mp -88.27 29.75 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.849 . . . . 0.0 109.116 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.9 m -44.84 -35.85 2.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.379 -0.826 . . . . 0.0 109.807 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -146.47 148.73 35.09 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -42.57 -36.39 4.68 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.546 2.164 . . . . 0.0 112.444 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.68 -33.52 72.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.12 -0.987 . . . . 0.0 109.706 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' D' ' 47' ' ' ASP . . . -62.29 -19.7 63.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.406 -0.809 . . . . 0.0 109.561 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 62.6 t -61.08 -59.68 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -87.43 10.55 17.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.87 -31.22 33.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -81.92 147.92 59.48 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.155 -1.203 . . . . 0.0 109.426 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.56 -57.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.57 2.18 . . . . 0.0 112.542 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -33.38 4.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 109.775 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.05 -57.92 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.977 . . . . 0.0 109.434 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -65.01 -33.53 76.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.251 -0.906 . . . . 0.0 109.618 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.56 -53.71 43.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.56 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -53.27 -24.01 10.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.571 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.12 -23.7 73.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.96 -44.08 81.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -1.107 . . . . 0.0 109.192 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -55.4 -47.14 76.35 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.384 -0.822 . . . . 0.0 109.388 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.23 -46.94 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.31 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.48 -34.98 74.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.268 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.93 -53.16 46.43 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.11 63.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -1.193 . . . . 0.0 109.523 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -55.87 -31.08 62.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.449 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 33.1 t -76.58 -31.47 57.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -50.23 -40.06 46.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.88 -59.96 8.39 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.544 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.6 mp -58.19 -26.89 63.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -1.132 . . . . 0.0 109.358 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.02 2.41 46.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.617 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.444 ' C ' ' H ' ' D' ' 79' ' ' ASP . 66.2 t60 -170.84 66.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.928 . . . . 0.0 109.654 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 78' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' D' ' 78' ' ' LEU . 79.7 mt -75.83 19.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.407 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' D' ' 77' ' ' HIS . 8.8 m-20 -79.61 -29.47 41.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.529 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 80' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' D' ' 80' ' ' ASN . 0.6 OUTLIER -173.3 107.0 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.467 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 81' ' ' LEU . . . . . 0.56 HD12 ' N ' ' D' ' 81' ' ' LEU . 8.3 mp -80.21 -58.77 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.915 . . . . 0.0 109.494 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 82' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' D' ' 82' ' ' LYS . 0.0 OUTLIER -46.45 -24.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.582 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.73 -50.21 9.52 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.7 t -82.34 -47.3 12.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -1.173 . . . . 0.0 109.409 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.545 ' N ' ' CG2' ' D' ' 84' ' ' THR . 27.9 m-85 -65.08 1.35 0.99 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.55 -0.719 . . . . 0.0 109.504 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 86' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.85 -35.05 66.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.188 -0.945 . . . . 0.0 109.388 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 29.9 p -74.37 -57.54 3.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.426 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.483 HD12 ' N ' ' D' ' 88' ' ' LEU . 9.0 mp -49.37 -44.95 45.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -63.89 -52.2 61.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.474 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.68 -22.8 64.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 6.5 tt -85.65 -62.6 1.49 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.694 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' D' ' 97' ' ' HIS . 75.1 m80 -61.43 -20.17 62.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 110.079 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 51.6 t -83.51 -60.71 2.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.582 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.36 -28.32 22.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.991 -1.068 . . . . 0.0 111.026 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 95' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -83.88 -52.04 6.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.0 -1.062 . . . . 0.0 110.742 -178.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.589 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 11.6 mt -106.87 -21.31 13.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.024 -1.047 . . . . 0.0 110.05 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 1.108 ' CD2' HG21 ' A' ' 41' ' ' THR . 33.1 p80 43.03 37.47 1.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.842 . . . . 0.0 109.931 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.09 130.92 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.167 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -46.94 147.36 2.31 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.33 -16.94 44.39 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.495 2.13 . . . . 0.0 112.119 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 101' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' D' ' 101' ' ' GLU . 58.7 mp0 -81.3 55.27 2.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.344 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -156.19 -37.67 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.982 . . . . 0.0 109.688 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -64.12 -38.76 92.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -69.68 -28.1 65.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.66 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.71 -52.76 16.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tt -52.2 -47.75 65.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.405 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.71 -20.45 70.22 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 108' ' ' ASN . . . . . 0.77 ' OD1' ' ND1' ' C' ' 103' ' ' HIS . 0.4 OUTLIER -83.24 -19.12 36.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -1.167 . . . . 0.0 109.753 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 73.0 t -80.31 -44.54 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.616 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 mt -47.37 -32.0 4.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.423 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 111' ' ' VAL . . . . . 0.426 ' H ' HG23 ' D' ' 111' ' ' VAL . 10.5 t -58.86 -33.64 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 11.8 m -79.06 -54.54 5.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 113' ' ' VAL . . . . . 0.529 HG22 HH21 ' D' ' 30' ' ' ARG . 14.0 t -49.47 -46.04 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.406 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.0 -22.92 64.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.463 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -80.62 -24.37 39.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.471 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.73 -61.65 1.74 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.359 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 117' ' ' HIS . . . . . 0.416 ' C ' ' CG ' ' D' ' 118' ' ' PHE . 55.2 m80 -60.18 -17.73 43.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.416 ' CG ' ' C ' ' D' ' 117' ' ' HIS . 19.0 m-85 -150.27 58.57 0.96 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.88 . . . . 0.0 109.633 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.463 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -68.6 -28.65 73.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -68.92 6.35 0.92 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -1.108 . . . . 0.0 109.41 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' D' ' 123' ' ' THR . 17.7 mm-40 -126.0 -1.22 7.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.436 -0.79 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 1.319 ' CE2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -72.67 35.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.849 . . . . 0.0 109.517 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.504 ' OG1' HG23 ' D' ' 126' ' ' VAL . 13.1 p -50.82 146.58 9.85 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.427 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.497 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.3 Cg_exo -48.22 -51.44 10.08 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.315 2.01 . . . . 0.0 113.057 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 39.4 Cg_endo -67.63 -27.7 38.39 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.013 1.809 . . . . 0.0 112.436 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.504 HG23 ' OG1' ' D' ' 123' ' ' THR . 55.6 t -77.3 -24.1 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.143 -0.973 . . . . 0.0 109.523 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 127' ' ' GLN . . . . . 0.61 HE22 ' CG1' ' C' ' 107' ' ' VAL . 9.1 tt0 -83.34 -54.52 4.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 1.061 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -49.14 -44.1 42.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.497 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.39 13.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.573 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.437 ' H ' ' C ' ' D' ' 128' ' ' ALA . 32.0 t80 -97.89 -59.89 1.67 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.64 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 38.2 tt0 -47.46 -30.49 3.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -66.05 -46.72 76.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.774 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 38.4 t -59.77 -55.55 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 110.043 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.4 HG22 ' H ' ' D' ' 134' ' ' VAL . 3.5 m -67.91 -36.85 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.991 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -50.0 -24.64 2.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.511 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.96 -31.43 55.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -82.69 -30.06 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -1.166 . . . . 0.0 109.495 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.64 77.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.91 . . . . 0.0 109.46 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 139' ' ' ASN . . . . . 1.222 ' OD1' ' CE1' ' B' ' 146' ' ' HIS . 4.2 m120 -71.35 -27.89 63.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.414 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.23 -60.42 2.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.428 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.96 -16.13 2.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.348 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.2 -3.04 13.96 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.309 -0.869 . . . . 0.0 109.569 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' D' ' 139' ' ' ASN . 22.0 t-80 -64.22 -33.28 75.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.867 . . . . 0.0 109.581 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -82.42 -29.76 30.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -51.33 -21.05 1.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 1.169 ' CE1' ' OD1' ' B' ' 139' ' ' ASN . 43.0 m80 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.475 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.568 HD11 ' HE3' ' A' ' 127' ' ' LYS . 7.1 tp 73.73 170.63 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.564 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.483 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 174.42 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.937 . . . . 0.0 110.106 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 3' ' ' SER . 95.5 Cg_exo -41.41 168.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.597 2.198 . . . . 0.0 112.902 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -50.76 -16.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.444 -0.785 . . . . 0.0 109.994 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 5' ' ' ALA . 2.8 p30 -39.78 -28.33 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.382 -0.824 . . . . 0.0 109.819 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 5' ' ' ALA . 5.9 ptmm? -83.27 -52.38 6.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.408 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 48.9 m -47.93 -26.75 1.84 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 108.928 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.433 ' CG ' ' HB1' ' A' ' 120' ' ' ALA . 10.0 m120 -79.99 -39.34 30.23 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.597 HG21 ' CG ' ' A' ' 128' ' ' PHE . 21.2 t -69.43 -47.01 75.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HZ2' ' HZ3' ' A' ' 7' ' ' LYS . 2.4 mptm? -50.22 -48.5 54.41 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.58 -63.1 1.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.502 0.667 . . . . 0.0 109.303 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -50.75 -41.75 56.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -0.817 . . . . 0.0 109.112 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.95 -17.4 64.43 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.377 -0.827 . . . . 0.0 109.047 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -79.62 -47.5 7.26 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -68.39 -36.74 79.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -1.121 . . . . 0.0 108.766 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 13' ' ' ALA . 69.4 t -60.96 -66.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 63.44 -141.44 45.87 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.13 37.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.462 -1.022 . . . . 0.0 110.177 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.551 ' H ' ' C ' ' A' ' 18' ' ' GLY . 89.5 m-70 -140.2 24.61 2.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . . . -88.3 -48.78 7.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.664 -0.647 . . . . 0.0 109.961 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.38 -14.71 28.23 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' O ' ' OE1' ' A' ' 27' ' ' GLU . 12.6 mt-10 -85.68 -56.28 3.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.9 m-30 -55.18 -27.11 43.42 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.369 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.05 -24.45 76.5 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.69 -36.3 28.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -1.123 . . . . 0.0 109.625 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 23' ' ' GLU . 1.4 mp0 -70.4 -19.88 62.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.96 . . . . 0.0 109.296 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.65 -19.73 60.76 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.277 -0.889 . . . . 0.0 109.072 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 58' ' ' HIS . 17.3 mt -77.86 -58.14 3.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 109.712 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -51.01 -43.68 60.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 109.655 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -56.25 -30.57 62.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 109.642 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 38.6 ttp -84.24 -57.16 3.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.906 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.438 ' CZ ' ' CZ ' ' A' ' 46' ' ' PHE . 25.7 m-85 -47.66 -36.94 11.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.978 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.844 HD13 ' HB2' ' B' ' 128' ' ' ALA . 3.5 pp -84.48 -25.74 28.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.925 -1.11 . . . . 0.0 109.809 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.533 ' N ' HD12 ' A' ' 34' ' ' LEU . 28.1 t -60.93 -21.97 63.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 109.534 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 1.174 ' HZ ' ' NE2' ' B' ' 131' ' ' GLN . 66.6 m-85 -156.2 128.76 4.15 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.965 . . . . 0.0 109.2 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.59 -20.23 15.92 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.348 2.032 . . . . 0.0 111.986 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.6 p -62.67 -18.77 62.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 109.572 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.4 p -80.99 -35.55 31.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.779 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -67.59 -36.5 81.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.963 . . . . 0.0 109.662 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.209 -0.932 . . . . 0.0 109.844 -179.73 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.066 0.46 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.479 ' C ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -165.44 26.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.071 -1.018 . . . . 0.0 110.385 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 49' ' ' SER . 22.3 m-20 41.63 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.534 -0.729 . . . . 0.0 110.249 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.015 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -56.5 0.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 47' ' ' ASP . 2.8 t -46.56 132.18 10.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.96 . . . . 0.0 109.668 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.526 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 11.3 t-80 -76.23 144.15 40.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.413 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.526 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 73.2 10.15 77.92 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.527 ' OG ' ' N ' ' A' ' 53' ' ' ALA . 88.7 p -68.98 -100.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -1.184 . . . . 0.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.527 ' N ' ' OG ' ' A' ' 52' ' ' SER . . . -178.39 -31.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.377 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -81.23 -17.71 48.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.926 . . . . 0.0 109.087 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.48 -33.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 109.682 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.408 ' HG2' ' H ' ' A' ' 56' ' ' LYS . 14.7 ptpt -70.81 -28.34 64.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.076 -1.015 . . . . 0.0 109.262 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' O ' ' CE ' ' A' ' 61' ' ' LYS . . . -69.71 -48.1 44.59 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.538 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.6 OUTLIER -54.2 -35.56 62.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -1.11 . . . . 0.0 109.392 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.29 -58.69 10.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -51.65 -24.03 5.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -1.174 . . . . 0.0 109.593 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' CE ' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -77.35 -23.47 50.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.332 -0.855 . . . . 0.0 108.896 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.36 -52.91 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 108.712 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -66.27 -24.21 66.53 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.421 -0.8 . . . . 0.0 109.574 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.14 -33.0 33.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' A' ' 68' ' ' ASN . . . -82.63 -34.32 27.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.912 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -81.63 -23.03 37.25 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.98 -1.075 . . . . 0.0 108.116 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 63' ' ' ALA . 18.5 m -78.05 -43.87 28.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.052 -1.03 . . . . 0.0 108.704 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.556 HD21 HD21 ' A' ' 80' ' ' LEU . 1.6 p-10 -58.15 -21.91 48.93 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.61 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -78.78 -47.47 16.68 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.62 -22.37 30.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.01 -17.67 63.28 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.419 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.566 ' O ' HG12 ' A' ' 73' ' ' VAL . 85.4 m-70 -143.81 -53.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.343 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.3 p 45.03 15.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.776 0.798 . . . . 0.0 109.286 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 72' ' ' HIS . 89.8 m-20 -131.73 9.64 4.63 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.403 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 22.4 t0 -174.33 27.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.358 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.694 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.3 ptt? -78.56 -24.41 0.43 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.519 -0.738 . . . . 0.0 111.804 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.2 Cg_exo -53.19 -29.49 46.55 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.79 1.66 . . . . 0.0 112.573 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.428 ' O ' ' OG ' ' A' ' 81' ' ' SER . 8.5 t-20 -94.1 -11.29 30.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 109.828 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.22 -58.23 3.04 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.107 -0.995 . . . . 0.0 109.258 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 68' ' ' ASN . 6.0 mt -81.35 13.94 2.69 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 2.5 p -59.22 -15.8 17.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.785 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.4 -53.61 6.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.0 109.912 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.448 ' N ' HD23 ' A' ' 83' ' ' LEU . 3.5 mt -44.79 -42.3 7.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.0 108.901 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.642 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 64.4 p -54.56 -29.21 50.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.545 -0.722 . . . . 0.0 109.517 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' ALA . 49.4 t0 -82.53 -16.92 46.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.334 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 tt -81.04 -62.23 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.956 -1.09 . . . . 0.0 111.249 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.4 p-80 -77.0 -21.53 54.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.886 -1.133 . . . . 0.0 111.163 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -85.94 -29.74 23.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.778 -1.201 . . . . 0.0 110.151 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 90' ' ' LYS . 15.4 t-80 -99.78 -74.81 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.171 -0.956 . . . . 0.0 110.132 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 89' ' ' HIS . 17.8 mtpp -52.0 -101.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 109.986 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.0 mp -45.12 -31.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 58.17 41.91 22.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.495 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' HIS . 5.9 t -66.84 168.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 109.353 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' VAL . 1.1 p-10 -123.46 152.09 64.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.336 -0.852 . . . . 0.0 109.333 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -41.6 -14.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.681 2.254 . . . . 0.0 112.558 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.937 HG11 ' HB3' ' D' ' 99' ' ' ASP . 46.9 t -59.29 -28.29 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 0.0 109.877 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.5 -24.8 42.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.95 . . . . 0.0 109.7 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -65.65 -41.95 91.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -47.28 -30.21 2.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.558 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 100' ' ' LEU . 3.7 mm? -84.11 -60.04 2.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.5 tt -53.34 -20.78 4.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 109.76 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -77.65 -59.06 2.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.818 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.799 ' NE2' ' OH ' ' B' ' 35' ' ' TYR . 32.1 m170 -64.55 -26.57 68.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 109.915 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 95.4 m -61.06 -58.01 10.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.895 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.92 -30.88 1.91 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 109.576 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.5 mt -75.06 -52.18 11.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.593 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.3 -24.76 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 109.445 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.6 m -73.61 -63.32 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.672 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 113' ' ' LEU . 18.9 mt -53.77 -33.57 56.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.386 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.41 -42.17 9.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.324 -0.86 . . . . 0.0 109.742 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.47 -56.04 4.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.436 -0.79 . . . . 0.0 109.943 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -68.28 -67.51 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.545 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -111.85 93.46 20.8 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 113' ' ' LEU . 99.1 Cg_exo -43.39 178.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.478 2.119 . . . . 0.0 113.068 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.57 -38.26 17.33 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.611 0.72 . . . . 0.0 109.281 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 4.7 mt-10 77.85 1.3 2.85 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 61.91 38.46 14.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.74 -0.6 . . . . 0.0 111.24 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.73 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -87.59 120.9 71.23 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 120.633 -1.292 . . . . 0.0 108.21 178.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.35 19.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.26 1.973 . . . . 0.0 112.889 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.73 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -150.74 -33.3 0.16 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.715 -1.24 . . . . 0.0 110.984 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.664 HG13 ' N ' ' A' ' 122' ' ' HIS . 10.7 p -45.43 -48.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.013 -1.055 . . . . 0.0 109.934 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.664 ' N ' HG13 ' A' ' 121' ' ' VAL . 20.3 m-70 -71.19 -43.73 66.84 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.444 -0.785 . . . . 0.0 108.952 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.86 -20.2 64.27 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.33 -0.856 . . . . 0.0 109.107 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 120' ' ' ALA . 12.2 p -66.33 -62.75 1.31 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.506 ' N ' ' OG ' ' A' ' 124' ' ' SER . 5.5 mt -70.31 -25.1 63.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.151 -0.968 . . . . 0.0 109.719 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.36 -45.52 46.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.058 -1.026 . . . . 0.0 109.813 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.568 ' HE3' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -90.37 -50.54 5.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.106 -0.996 . . . . 0.0 110.113 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CG ' HG21 ' A' ' 10' ' ' VAL . 28.5 t80 -48.43 -22.27 0.68 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.049 -1.032 . . . . 0.0 109.485 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 133' ' ' SER . 6.4 mt -74.57 -22.6 58.9 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.45 -32.36 72.34 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.434 ' HB2' HD13 ' A' ' 2' ' ' LEU . 14.0 t -80.09 -35.49 36.86 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.391 -0.818 . . . . 0.0 109.012 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.54 -30.62 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 129' ' ' LEU . 42.2 t -76.19 -26.27 56.0 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.422 -0.799 . . . . 0.0 108.853 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 138' ' ' SER . 19.3 m -66.89 -28.72 68.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.327 -0.858 . . . . 0.0 109.021 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.12 -47.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.091 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.25 -38.15 73.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.013 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.3 p -93.71 -15.8 24.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 134' ' ' THR . 23.3 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.898 . . . . 0.0 109.518 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.234 0.54 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mt -92.5 -170.94 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.185 -0.947 . . . . 0.0 109.254 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.409 ' O ' ' N ' ' B' ' 6' ' ' GLU . 2.9 p -111.06 129.78 23.64 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.377 -0.827 . . . . 0.0 108.97 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.78 -25.02 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.392 2.061 . . . . 0.0 112.401 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' B' ' 4' ' ' THR . 48.6 mt-10 -86.62 -48.58 8.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 0.0 109.894 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.77 -34.39 39.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.853 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -64.97 -34.95 79.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.014 . . . . 0.0 109.425 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 26.8 t -69.04 -23.62 64.09 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 109.374 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.52 -55.0 4.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.215 -0.928 . . . . 0.0 110.238 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.7 -26.45 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 34.2 m -84.64 -54.25 4.85 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.363 0.601 . . . . 0.0 109.893 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' B' ' 9' ' ' SER . . . -45.0 -31.18 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.451 -0.781 . . . . 0.0 109.859 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.494 HD23 ' HB2' ' B' ' 17' ' ' LYS . 0.6 OUTLIER -59.21 -24.64 63.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.226 -0.921 . . . . 0.0 109.623 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 15' ' ' TRP . . . . . 0.649 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 2.1 t90 -48.3 -27.49 2.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.17 -52.33 7.88 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.494 ' HB2' HD23 ' B' ' 14' ' ' LEU . 1.1 mppt? -64.39 -15.59 60.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -1.121 . . . . 0.0 109.084 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.23 114.96 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.356 -0.84 . . . . 0.0 109.67 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' B' ' 22' ' ' GLU . 5.1 m120 -81.3 77.41 8.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.318 -0.864 . . . . 0.0 108.794 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' B' ' 19' ' ' ASN . 76.8 t -43.14 -21.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 109.966 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 19' ' ' ASN . 0.8 OUTLIER -83.86 11.71 7.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.59 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' B' ' 19' ' ' ASN . 36.6 mt-10 -156.15 -55.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.492 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 75.1 t -47.86 -36.37 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -57.71 9.45 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.82 -35.84 40.14 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -75.18 -26.97 59.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -1.139 . . . . 0.0 109.575 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.21 -48.1 65.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 40.3 mt -82.96 -30.58 28.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.895 . . . . 0.0 109.498 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.03 -59.19 10.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.584 ' NH2' ' SD ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -57.45 -40.84 79.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -1.133 . . . . 0.0 109.376 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 31' ' ' LEU . . . . . 0.693 ' O ' HD23 ' B' ' 31' ' ' LEU . 2.3 tt -43.79 -38.3 3.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.291 -0.88 . . . . 0.0 109.464 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.96 -21.83 43.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' B' ' 30' ' ' ARG . 15.6 t -86.09 -64.0 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.156 -0.965 . . . . 0.0 109.532 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 30' ' ' ARG . 0.1 OUTLIER -62.18 -22.93 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.366 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.799 ' OH ' ' NE2' ' A' ' 103' ' ' HIS . 48.5 m-85 -150.05 78.75 7.91 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 109.479 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' B' ' 38' ' ' THR . 16.6 Cg_exo -65.38 -28.22 54.75 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.042 2.494 . . . . 0.0 112.584 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.533 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 0.5 OUTLIER -46.56 -20.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.022 . . . . 0.0 109.708 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.533 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 17.3 m -96.16 61.47 2.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.168 -0.957 . . . . 0.0 109.411 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.13 24.38 6.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.363 -0.835 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -84.44 -25.79 28.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -101.06 34.63 2.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.84 . . . . 0.0 109.494 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -135.9 17.46 3.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.331 -0.855 . . . . 0.0 109.425 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' B' ' 44' ' ' SER . 0.0 OUTLIER -84.98 -30.76 23.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.495 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 39.4 t -83.11 -10.81 58.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.514 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.44 ' O ' ' ND2' ' B' ' 57' ' ' ASN . 15.6 m-85 -73.82 1.02 11.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.89 178.73 0.18 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 48.77 89.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -1.108 . . . . 0.0 109.408 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 tp -158.8 19.35 0.2 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.46 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -53.16 -39.14 63.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' THR . . . . . 0.421 ' O ' ' N ' ' B' ' 52' ' ' ASP . 1.3 p -145.65 153.7 51.26 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.408 -0.808 . . . . 0.0 109.009 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -43.61 -19.36 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.265 1.977 . . . . 0.0 112.241 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.6 OUTLIER -81.48 -44.29 17.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.36 -20.0 0.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.315 -0.866 . . . . 0.0 109.398 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.03 -63.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.529 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' MET . . . . . 0.584 ' SD ' ' NH2' ' B' ' 30' ' ' ARG . 11.4 mmt -52.32 -22.02 4.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.605 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.23 -15.81 70.93 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' B' ' 45' ' ' PHE . 25.3 t-20 -73.46 136.39 78.22 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.225 -1.162 . . . . 0.0 109.294 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.34 -53.36 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.339 2.026 . . . . 0.0 112.381 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -52.49 -48.99 65.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.531 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 99.2 t -49.6 -37.58 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.318 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 51.0 mtpt -79.16 -33.94 43.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.83 -29.08 35.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.583 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -69.1 -23.79 64.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.568 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.32 -38.02 91.11 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 30.8 mmtm -60.93 -32.11 71.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -1.181 . . . . 0.0 109.351 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.78 -61.34 2.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.88 -24.51 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.83 -42.53 60.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.226 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.77 -39.8 17.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.71 -38.22 67.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -61.84 -32.8 73.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.146 -0.971 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' SER . . . . . 0.649 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 13.4 m -88.5 -31.9 18.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 109.532 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -49.52 -42.49 43.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 109.473 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.12 -60.06 8.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.612 ' H ' HD12 ' B' ' 75' ' ' LEU . 5.0 mp -57.03 -26.44 60.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -1.127 . . . . 0.0 109.389 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.2 -0.35 48.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.958 . . . . 0.0 109.488 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.441 ' C ' ' H ' ' B' ' 79' ' ' ASP . 75.9 t60 -171.2 64.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.534 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 54.3 mt -72.36 12.15 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' B' ' 77' ' ' HIS . 2.8 m-20 -71.83 -20.79 61.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.434 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -171.6 109.74 0.28 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -79.69 -58.54 3.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -47.63 -24.01 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.97 -61.85 4.09 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.6 t -66.62 -47.09 73.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -1.177 . . . . 0.0 109.355 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.548 ' N ' ' CG2' ' B' ' 84' ' ' THR . 69.0 m-85 -70.88 15.14 0.11 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.558 -0.714 . . . . 0.0 109.526 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -69.4 -38.88 78.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 109.573 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 17.8 p -83.62 -51.69 7.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.639 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 26.5 mt -53.04 -24.87 10.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.478 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 99.5 p -81.92 -40.61 22.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.505 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -81.43 -22.59 38.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.622 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 4.2 tt -82.29 -48.39 11.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.061 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.537 ' NE2' ' O ' ' B' ' 141' ' ' LEU . 1.9 p-80 -75.18 -22.28 58.15 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.918 -1.114 . . . . 0.0 110.22 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' CYS . . . . . 0.461 ' SG ' ' CE1' ' B' ' 145' ' ' TYR . 51.2 t -83.73 -60.25 2.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.132 -0.98 . . . . 0.0 111.356 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 12.8 t70 -86.8 -27.4 23.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.983 -1.073 . . . . 0.0 111.784 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' LYS . . . . . 0.53 ' O ' ' CE1' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -84.56 -49.99 8.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.704 -1.248 . . . . 0.0 110.655 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.521 ' N ' HD12 ' B' ' 96' ' ' LEU . 8.3 mp -86.52 -34.64 19.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.793 -1.192 . . . . 0.0 109.931 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' B' ' 94' ' ' ASP . 3.3 m80 71.77 36.92 1.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 109.545 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.85 134.84 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' ASP . . . . . 0.848 ' HB3' HG11 ' C' ' 96' ' ' VAL . 3.7 m-20 -81.72 151.68 68.28 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.405 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.519 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 65.3 Cg_exo -47.23 -173.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.39 2.06 . . . . 0.0 112.358 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 57.62 53.2 7.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.52 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' B' ' 100' ' ' PRO . 69.3 m-80 -159.31 -34.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.6 m-85 -73.75 -54.55 7.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.333 -0.854 . . . . 0.0 109.585 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -57.1 -22.35 39.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.713 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 tt -76.77 -41.62 44.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -0.969 . . . . 0.0 109.517 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.531 HD23 ' C ' ' B' ' 106' ' ' LEU . 4.9 tt -68.58 -56.59 7.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.231 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.45 -20.24 2.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -85.62 -55.61 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -1.116 . . . . 0.0 109.984 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.12 -24.8 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.055 -1.028 . . . . 0.0 109.49 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.503 HD23 ' C ' ' B' ' 110' ' ' LEU . 2.5 tt -57.41 -59.18 5.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.255 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.92 -39.94 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.229 -0.919 . . . . 0.0 109.677 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.423 ' O ' ' CE1' ' B' ' 116' ' ' HIS . 76.3 m -48.87 -43.77 39.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.591 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 70.4 t -55.99 -53.42 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.353 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.627 ' N ' HD12 ' B' ' 114' ' ' LEU . 9.3 mp -49.81 -41.99 45.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 119' ' ' GLY . . . -47.88 -41.54 24.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.78 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.65 ' N ' ' ND1' ' B' ' 116' ' ' HIS . 0.4 OUTLIER -68.87 -52.16 32.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.612 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' B' ' 118' ' ' PHE . 74.9 m80 -69.24 -17.55 63.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.713 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 63.8 m-85 -156.84 64.34 0.52 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.955 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 115' ' ' ALA . . . -76.25 -21.36 75.81 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -72.85 -29.22 63.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -1.128 . . . . 0.0 109.362 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 123' ' ' THR . 63.4 mm-40 -78.53 -15.49 58.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.271 -0.893 . . . . 0.0 109.554 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' B' ' 115' ' ' ALA . 3.8 m-85 -69.82 59.66 0.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.472 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 11.7 p -59.04 150.98 58.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.94 . . . . 0.0 108.917 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.444 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.3 Cg_exo -44.15 -58.15 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.446 2.097 . . . . 0.0 112.716 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 27.5 Cg_endo -61.89 -46.52 13.24 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.161 1.907 . . . . 0.0 112.027 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.472 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 40.6 t -66.86 -18.2 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' GLN . . . . . 0.497 ' OE1' HD11 ' A' ' 34' ' ' LEU . 14.1 tm0? -83.14 -26.29 31.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.844 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -68.8 -32.1 71.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.37 26.38 0.92 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.935 . . . . 0.0 109.648 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.647 ' CG ' ' N ' ' B' ' 131' ' ' GLN . 5.8 p90 -74.53 -52.31 12.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.14 -0.975 . . . . 0.0 109.791 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 1.174 ' NE2' ' HZ ' ' A' ' 36' ' ' PHE . 20.6 tt0 -86.06 -38.93 17.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.162 -0.961 . . . . 0.0 109.999 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.993 ' HG3' ' O ' ' D' ' 146' ' ' HIS . 32.1 ttpt -50.9 -34.56 28.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.233 -0.917 . . . . 0.0 110.959 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 133' ' ' VAL . . . . . 0.89 HG13 ' H ' ' B' ' 134' ' ' VAL . 7.1 p -65.27 -63.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.844 -1.16 . . . . 0.0 109.891 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.89 ' H ' HG13 ' B' ' 133' ' ' VAL . 1.8 m -73.77 -14.82 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.361 -0.837 . . . . 0.0 109.75 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . -45.78 -23.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.55 -26.41 46.84 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' B' ' 134' ' ' VAL . 74.9 t -80.05 -21.28 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -1.104 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.86 -51.11 71.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.555 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.69 -22.52 53.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.34 -45.94 88.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.537 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 19.9 mt -84.01 15.57 3.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.544 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.62 -1.5 2.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 109.505 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -79.87 -26.57 40.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.518 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -73.26 -11.39 60.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.379 -0.826 . . . . 0.0 109.342 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.461 ' CE1' ' SG ' ' B' ' 93' ' ' CYS . 15.6 m-85 -72.84 7.19 2.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.301 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 1.01 ' O ' ' HG3' ' D' ' 132' ' ' LYS . 7.5 p-80 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.453 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' C' ' 2' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.579 HD11 ' HE3' ' C' ' 127' ' ' LYS . 7.1 tp 73.63 170.67 0.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 109.545 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.492 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 174.45 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.166 -0.959 . . . . 0.0 110.041 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' C' ' 3' ' ' SER . 96.6 Cg_exo -41.4 168.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.683 2.255 . . . . 0.0 112.837 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -50.77 -16.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.436 -0.79 . . . . 0.0 110.003 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' C' ' 5' ' ' ALA . 2.8 p30 -39.7 -28.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.746 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' C' ' 5' ' ' ALA . 5.9 ptmm? -83.2 -52.31 6.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.514 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.417 ' N ' ' CG ' ' C' ' 7' ' ' LYS . 49.2 m -47.93 -26.76 1.85 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 108.954 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 9' ' ' ASN . . . . . 0.434 ' CG ' ' HB1' ' C' ' 120' ' ' ALA . 10.0 m120 -80.01 -39.43 29.96 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.603 HG21 ' CG ' ' C' ' 128' ' ' PHE . 21.4 t -69.35 -47.01 75.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 11' ' ' LYS . . . . . 0.408 ' HZ2' ' HZ3' ' C' ' 7' ' ' LYS . 2.4 mptm? -50.12 -48.57 53.49 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.65 -63.13 1.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.628 -0.67 . . . . 0.0 109.316 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.652 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -50.57 -41.82 54.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.2 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 14' ' ' TRP . . . . . 0.401 ' NE1' ' OG1' ' C' ' 67' ' ' THR . 0.1 OUTLIER -68.04 -17.34 64.37 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.412 -0.805 . . . . 0.0 109.05 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.71 -47.38 7.29 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -68.41 -36.71 79.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -1.113 . . . . 0.0 108.85 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.652 HG23 ' O ' ' C' ' 13' ' ' ALA . 69.5 t -60.99 -66.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 63.39 -141.4 45.89 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 37.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.519 -0.989 . . . . 0.0 110.157 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.548 ' H ' ' C ' ' C' ' 18' ' ' GLY . 89.4 m-70 -140.27 24.5 2.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.431 ' HB2' ' CG1' ' C' ' 17' ' ' VAL . . . -88.36 -48.73 7.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.561 -0.712 . . . . 0.0 109.927 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.3 -14.74 27.82 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' C' ' 27' ' ' GLU . 12.6 mt-10 -85.64 -56.32 3.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -1.156 . . . . 0.0 109.653 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.0 m-30 -55.4 -26.86 44.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 109.288 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.18 -24.41 76.62 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.73 -36.33 28.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -1.165 . . . . 0.0 109.627 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' C' ' 23' ' ' GLU . 1.4 mp0 -70.27 -20.03 63.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.5 -19.88 60.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.038 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' C' ' 58' ' ' HIS . 17.1 mt -77.74 -58.19 3.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.353 -0.842 . . . . 0.0 109.735 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -50.94 -43.77 60.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 109.685 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -56.3 -30.46 62.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.651 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 38.5 ttp -84.27 -57.22 3.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.815 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' PHE . . . . . 0.434 ' CZ ' ' CZ ' ' C' ' 46' ' ' PHE . 25.8 m-85 -47.7 -36.86 11.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.998 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.816 HD13 ' HB2' ' D' ' 128' ' ' ALA . 3.4 pp -84.49 -25.76 28.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.994 -1.067 . . . . 0.0 109.808 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.531 ' N ' HD12 ' C' ' 34' ' ' LEU . 28.1 t -60.88 -22.06 63.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 109.472 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 1.197 ' HZ ' ' NE2' ' D' ' 131' ' ' GLN . 66.7 m-85 -156.18 128.69 4.13 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.21 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.58 -20.17 16.01 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.292 1.995 . . . . 0.0 112.08 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 68.2 p -62.62 -18.92 63.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 76.8 p -80.88 -35.61 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.0 109.756 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -67.61 -36.45 80.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 109.7 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.778 -179.708 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.121 0.486 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -165.44 26.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 110.346 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' C' ' 49' ' ' SER . 22.5 m-20 41.74 88.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.701 . . . . 0.0 110.25 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 1.011 ' H ' HD13 ' C' ' 48' ' ' LEU . 0.0 OUTLIER -56.52 0.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.385 -0.822 . . . . 0.0 109.538 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.583 ' H ' ' C ' ' C' ' 47' ' ' ASP . 2.8 t -46.58 132.1 10.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.163 -0.961 . . . . 0.0 109.681 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' HIS . . . . . 0.518 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 11.4 t-80 -76.16 144.12 40.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.388 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' GLY . . . . . 0.518 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 73.26 10.14 78.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' C' ' 53' ' ' ALA . 88.5 p -68.88 -100.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -1.147 . . . . 0.0 109.392 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.524 ' N ' ' OG ' ' C' ' 52' ' ' SER . . . -178.41 -31.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.41 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -81.26 -17.58 48.94 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.264 -0.897 . . . . 0.0 109.171 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.57 -33.99 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.626 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -70.78 -28.27 64.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.314 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' GLY . . . . . 0.427 ' O ' ' CE ' ' C' ' 61' ' ' LYS . . . -69.82 -48.18 43.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.6 OUTLIER -54.01 -35.63 62.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -1.155 . . . . 0.0 109.366 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.43 -58.59 10.92 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -51.7 -23.95 5.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -1.099 . . . . 0.0 109.625 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' C' ' 57' ' ' GLY . 0.0 OUTLIER -77.39 -23.46 50.7 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 108.911 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.43 -52.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.26 -24.23 66.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.32 -0.862 . . . . 0.0 109.581 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.02 -32.97 33.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.99 . . . . 0.0 109.821 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' C' ' 68' ' ' ASN . . . -82.68 -34.33 27.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.122 -0.986 . . . . 0.0 109.549 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.911 ' O ' HD12 ' C' ' 66' ' ' LEU . 0.1 OUTLIER -81.51 -23.05 37.57 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.401 ' OG1' ' NE1' ' C' ' 14' ' ' TRP . 18.3 m -78.05 -43.86 28.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.068 -1.02 . . . . 0.0 108.711 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.555 HD21 HD21 ' C' ' 80' ' ' LEU . 1.6 p-10 -58.15 -21.86 48.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.611 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -78.79 -47.53 16.53 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.55 -22.42 30.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.0 -17.66 63.29 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.438 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.573 ' O ' HG12 ' C' ' 73' ' ' VAL . 85.6 m-70 -143.87 -53.45 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 0.0 109.291 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.2 p 45.04 15.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.799 0.809 . . . . 0.0 109.283 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' C' ' 72' ' ' HIS . 89.8 m-20 -131.76 9.66 4.62 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 22.3 t0 -174.28 27.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.265 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.3 ptt? -78.57 -24.37 0.43 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.472 -0.767 . . . . 0.0 111.783 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.0 Cg_exo -53.24 -29.47 46.94 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.79 1.66 . . . . 0.0 112.571 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.438 ' O ' ' OG ' ' C' ' 81' ' ' SER . 8.5 t-20 -94.15 -11.16 31.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 109.828 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.27 -58.16 3.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.153 -0.967 . . . . 0.0 109.281 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 80' ' ' LEU . . . . . 0.555 HD21 HD21 ' C' ' 68' ' ' ASN . 6.0 mt -81.34 13.87 2.72 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 108.796 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 81' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 2.5 p -59.15 -15.84 16.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 109.809 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.51 -53.58 6.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.0 109.831 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.444 ' O ' ' CE1' ' C' ' 87' ' ' HIS . 3.5 mt -44.73 -42.24 7.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.389 -0.819 . . . . 0.0 108.928 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.646 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 66.7 p -54.69 -29.17 52.18 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.552 -0.717 . . . . 0.0 109.446 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' C' ' 82' ' ' ALA . 49.2 t0 -82.55 -16.93 46.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.396 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.8 tt -81.0 -62.32 1.7 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.918 -1.113 . . . . 0.0 111.241 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 87' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.4 p-80 -76.95 -21.47 54.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.86 -1.15 . . . . 0.0 111.16 -178.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -85.91 -29.78 23.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.77 -1.206 . . . . 0.0 110.207 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 89' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' C' ' 90' ' ' LYS . 15.5 t-80 -99.79 -74.85 0.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 110.139 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' C' ' 89' ' ' HIS . 17.8 mtpp -51.96 -101.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.967 . . . . 0.0 109.985 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.611 HD12 ' N ' ' C' ' 91' ' ' LEU . 10.0 mp -45.17 -31.77 1.58 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.827 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 58.16 41.93 22.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.503 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' C' ' 87' ' ' HIS . 5.9 t -66.95 168.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.372 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' C' ' 96' ' ' VAL . 1.1 p-10 -123.51 152.14 64.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.34 -0.85 . . . . 0.0 109.272 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -41.73 -14.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.666 2.244 . . . . 0.0 112.584 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.848 HG11 ' HB3' ' B' ' 99' ' ' ASP . 46.7 t -59.24 -28.33 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 109.934 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.45 -24.91 42.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.664 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -65.62 -42.03 91.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.584 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -47.22 -30.26 2.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.592 ' N ' HD22 ' C' ' 100' ' ' LEU . 3.7 mm? -84.07 -60.04 2.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.593 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.5 tt -53.25 -20.9 4.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.736 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -77.6 -59.08 2.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 109.763 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 103' ' ' HIS . . . . . 0.787 ' NE2' ' OH ' ' D' ' 35' ' ' TYR . 32.1 m170 -64.61 -26.6 68.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.837 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 95.2 m -61.0 -58.02 10.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 0.0 109.869 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.94 -30.9 1.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.5 mt -74.97 -52.29 11.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.155 -0.966 . . . . 0.0 109.616 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.29 -24.69 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.493 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 24.7 m -73.71 -63.25 1.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' C' ' 113' ' ' LEU . 18.9 mt -53.77 -33.68 56.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.372 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.3 -42.28 9.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.74 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.37 -56.0 4.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -68.28 -67.5 0.46 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.608 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -111.87 93.52 21.1 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 114' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' C' ' 113' ' ' LEU . 98.5 Cg_exo -43.44 178.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.406 2.071 . . . . 0.0 113.105 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.59 -38.25 17.31 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.666 0.746 . . . . 0.0 109.312 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 4.8 mt-10 77.87 1.24 2.84 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 61.88 38.5 14.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.793 -0.567 . . . . 0.0 111.268 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.735 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.7 OUTLIER -87.59 120.95 71.24 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.73 -1.231 . . . . 0.0 108.197 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.43 19.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.285 1.99 . . . . 0.0 112.816 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -150.74 -33.22 0.16 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.726 -1.234 . . . . 0.0 110.962 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.646 HG13 ' N ' ' C' ' 122' ' ' HIS . 10.8 p -45.57 -48.09 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.876 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.646 ' N ' HG13 ' C' ' 121' ' ' VAL . 20.2 m-70 -71.18 -43.81 66.73 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.451 -0.78 . . . . 0.0 108.917 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.74 -20.23 64.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.329 -0.857 . . . . 0.0 109.15 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.57 ' N ' ' O ' ' C' ' 120' ' ' ALA . 12.1 p -66.38 -62.72 1.32 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.21 -0.931 . . . . 0.0 110.215 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.513 ' N ' ' OG ' ' C' ' 124' ' ' SER . 5.6 mt -70.23 -25.1 63.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.166 -0.959 . . . . 0.0 109.736 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -74.47 -45.39 46.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.087 -1.008 . . . . 0.0 109.784 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.579 ' HE3' HD11 ' C' ' 2' ' ' LEU . 0.0 OUTLIER -90.45 -50.47 5.93 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.044 -1.035 . . . . 0.0 110.127 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.603 ' CG ' HG21 ' C' ' 10' ' ' VAL . 28.5 t80 -48.44 -22.35 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.912 -1.118 . . . . 0.0 109.453 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' C' ' 133' ' ' SER . 6.4 mt -74.55 -22.57 58.94 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.42 -32.31 72.26 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.425 ' HB2' HD13 ' C' ' 2' ' ' LEU . 13.8 t -80.16 -35.44 36.52 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.382 -0.824 . . . . 0.0 109.095 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 22.4 t -83.51 -30.71 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.149 -0.969 . . . . 0.0 108.57 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.564 ' N ' ' O ' ' C' ' 129' ' ' LEU . 42.1 t -76.25 -26.17 55.74 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.434 -0.792 . . . . 0.0 108.873 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 134' ' ' THR . . . . . 0.53 ' O ' ' N ' ' C' ' 138' ' ' SER . 19.5 m -66.85 -28.76 68.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.278 -0.889 . . . . 0.0 109.091 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.09 -47.52 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.11 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.19 -38.05 73.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.112 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 70.4 p -93.83 -15.76 24.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 138' ' ' SER . . . . . 0.53 ' N ' ' O ' ' C' ' 134' ' ' THR . 23.3 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.885 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.251 0.548 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mt -92.65 -170.89 2.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 109.193 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.403 ' O ' ' N ' ' D' ' 6' ' ' GLU . 2.9 p -111.14 129.8 23.64 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.828 . . . . 0.0 108.938 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -40.82 -24.95 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.305 2.003 . . . . 0.0 112.439 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' D' ' 4' ' ' THR . 48.6 mt-10 -86.67 -48.63 8.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.858 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -79.61 -34.41 40.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.94 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.478 ' CD ' ' C ' ' D' ' 8' ' ' LYS . 0.0 OUTLIER -65.04 -34.86 79.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -0.964 . . . . 0.0 109.362 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 9' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 27.1 t -69.1 -23.6 64.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.11 -0.994 . . . . 0.0 109.335 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.55 -54.96 4.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.903 . . . . 0.0 110.189 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.71 -26.47 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.004 -1.06 . . . . 0.0 108.277 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 34.2 m -84.61 -54.31 4.81 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.395 0.616 . . . . 0.0 109.859 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' D' ' 9' ' ' SER . . . -45.04 -31.09 1.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 0.0 109.898 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.48 HD23 ' HB2' ' D' ' 17' ' ' LYS . 0.6 OUTLIER -59.22 -24.68 63.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.625 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 15' ' ' TRP . . . . . 0.65 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 2.1 t90 -48.27 -27.51 2.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.14 -52.37 7.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.505 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 1.1 mppt? -64.44 -15.59 60.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.356 -1.085 . . . . 0.0 109.047 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.2 114.84 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.671 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' D' ' 22' ' ' GLU . 5.1 m120 -81.21 77.35 8.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 108.855 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' D' ' 19' ' ' ASN . 76.5 t -43.11 -21.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.439 -0.788 . . . . 0.0 109.926 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' D' ' 19' ' ' ASN . 0.8 OUTLIER -83.84 11.72 7.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.658 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' D' ' 19' ' ' ASN . 36.6 mt-10 -156.13 -55.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 109.477 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -48.03 -36.23 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.534 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.79 -57.67 9.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.77 -35.87 39.81 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.21 -26.87 59.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.21 -48.12 65.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.948 . . . . 0.0 109.516 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 40.9 mt -83.09 -30.49 27.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.452 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.08 -59.11 10.62 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' ARG . . . . . 0.583 ' NH2' ' SD ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -57.53 -40.78 79.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -1.085 . . . . 0.0 109.346 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 31' ' ' LEU . . . . . 0.695 ' O ' HD23 ' D' ' 31' ' ' LEU . 2.3 tt -43.81 -38.31 3.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -79.94 -21.79 43.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' D' ' 30' ' ' ARG . 15.6 t -86.11 -63.98 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 30' ' ' ARG . 0.1 OUTLIER -62.25 -22.88 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 109.297 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 35' ' ' TYR . . . . . 0.787 ' OH ' ' NE2' ' C' ' 103' ' ' HIS . 48.5 m-85 -150.13 78.79 7.84 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 109.501 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 36' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' D' ' 38' ' ' THR . 16.6 Cg_exo -65.5 -28.12 53.83 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.988 2.459 . . . . 0.0 112.621 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 37' ' ' TRP . . . . . 0.538 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 0.5 OUTLIER -46.63 -19.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.81 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.538 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 17.5 m -96.16 61.37 2.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.219 -0.926 . . . . 0.0 109.375 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.02 24.3 6.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 109.557 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -84.35 -25.86 28.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.119 -0.988 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -100.97 34.53 2.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -135.92 17.51 3.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 109.431 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' D' ' 44' ' ' SER . 0.0 OUTLIER -85.05 -30.67 23.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.418 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 44' ' ' SER . . . . . 0.491 ' H ' ' CD ' ' D' ' 43' ' ' GLU . 39.3 t -83.13 -10.78 58.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.491 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.435 ' O ' ' ND2' ' D' ' 57' ' ' ASN . 15.6 m-85 -73.91 1.12 11.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.315 -0.866 . . . . 0.0 109.435 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.9 178.7 0.18 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 48.78 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.157 . . . . 0.0 109.441 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 tp -158.91 19.49 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.355 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -53.28 -39.06 63.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' THR . . . . . 0.428 ' O ' ' N ' ' D' ' 52' ' ' ASP . 1.2 p -145.66 153.7 51.2 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.844 . . . . 0.0 109.053 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.64 -19.37 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.276 1.984 . . . . 0.0 112.168 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 52' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' D' ' 52' ' ' ASP . 0.6 OUTLIER -81.39 -44.54 17.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.23 -19.92 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 54' ' ' VAL . . . . . 0.412 ' N ' ' C ' ' D' ' 52' ' ' ASP . 97.5 t -66.2 -63.16 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 55' ' ' MET . . . . . 0.583 ' SD ' ' NH2' ' D' ' 30' ' ' ARG . 11.4 mmt -52.25 -22.08 4.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.581 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.18 -15.92 70.77 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 57' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' D' ' 45' ' ' PHE . 25.3 t-20 -73.38 136.46 78.44 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.294 -1.121 . . . . 0.0 109.269 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.38 -53.41 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.343 2.028 . . . . 0.0 112.33 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -52.42 -48.99 65.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 99.5 t -49.73 -37.47 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 61' ' ' LYS . . . . . 0.523 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 50.9 mtpt -79.15 -33.91 43.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.502 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.84 -29.05 35.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 109.619 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -69.09 -23.81 64.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.57 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.27 -38.0 91.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 65' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 30.8 mmtm -60.96 -32.1 71.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -1.15 . . . . 0.0 109.264 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.8 -61.44 2.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 109.419 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.94 -24.42 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.8 -42.55 60.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.184 -0.947 . . . . 0.0 109.275 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.79 -39.76 17.7 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.73 -38.25 67.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 0.0 109.475 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -61.93 -32.64 73.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 72' ' ' SER . . . . . 0.65 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 13.6 m -88.53 -31.89 18.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -49.54 -42.35 43.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.89 . . . . 0.0 109.515 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.2 -60.07 8.52 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.631 HD12 ' H ' ' D' ' 75' ' ' LEU . 5.0 mp -57.02 -26.43 60.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -1.101 . . . . 0.0 109.406 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.18 -0.42 49.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.444 ' C ' ' H ' ' D' ' 79' ' ' ASP . 76.0 t60 -171.07 64.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.536 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 53.9 mt -72.34 12.21 0.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' D' ' 77' ' ' HIS . 2.8 m-20 -71.88 -20.76 61.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.428 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -171.62 109.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.414 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -79.78 -58.48 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -47.68 -23.99 0.82 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.95 -61.93 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.5 t -66.56 -47.14 73.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -1.154 . . . . 0.0 109.425 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 68.8 m-85 -70.85 15.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.495 -0.753 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 86' ' ' ALA . . . . . 0.491 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -69.5 -38.74 77.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.625 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 17.9 p -83.72 -51.75 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.605 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 26.1 mt -52.92 -24.93 10.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.564 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 99.1 p -81.88 -40.66 22.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.234 -0.916 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -81.42 -22.59 38.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.609 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 4.2 tt -82.17 -48.51 11.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 110.089 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.532 ' NE2' ' O ' ' D' ' 141' ' ' LEU . 1.9 p-80 -75.11 -22.26 58.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.915 -1.116 . . . . 0.0 110.19 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' CE1' ' D' ' 145' ' ' TYR . 51.2 t -83.76 -60.17 2.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.142 -0.974 . . . . 0.0 111.358 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 12.8 t70 -86.82 -27.38 23.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.074 -1.016 . . . . 0.0 111.835 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 95' ' ' LYS . . . . . 0.531 ' O ' ' CE1' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -84.65 -49.94 8.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.727 -1.233 . . . . 0.0 110.613 -178.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.521 HD12 ' N ' ' D' ' 96' ' ' LEU . 8.3 mp -86.55 -34.61 19.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.823 -1.173 . . . . 0.0 109.905 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' D' ' 94' ' ' ASP . 3.3 m80 71.72 36.98 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.89 . . . . 0.0 109.612 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.91 134.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.194 -0.942 . . . . 0.0 109.314 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 99' ' ' ASP . . . . . 0.937 ' HB3' HG11 ' A' ' 96' ' ' VAL . 3.8 m-20 -81.76 151.63 68.1 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.356 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 100' ' ' PRO . . . . . 0.508 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 66.7 Cg_exo -47.25 -173.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.433 2.088 . . . . 0.0 112.277 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 57.67 53.09 7.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.521 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 102' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' D' ' 100' ' ' PRO . 69.3 m-80 -159.23 -34.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.515 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.84 -54.56 7.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -57.08 -22.37 38.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 tt -76.7 -41.7 44.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.509 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.542 HD23 ' C ' ' D' ' 106' ' ' LEU . 4.9 tt -68.54 -56.64 7.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.203 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.4 -20.18 2.28 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -85.68 -55.65 3.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -1.139 . . . . 0.0 109.978 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.07 -24.78 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.078 -1.014 . . . . 0.0 109.613 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 110' ' ' LEU . . . . . 0.501 HD23 ' C ' ' D' ' 110' ' ' LEU . 2.5 tt -57.45 -59.12 5.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.284 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 t -59.01 -39.92 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.595 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 112' ' ' CYS . . . . . 0.421 ' O ' ' CE1' ' D' ' 116' ' ' HIS . 76.2 m -48.88 -43.7 39.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 109.622 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 70.0 t -55.97 -53.43 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.412 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 114' ' ' LEU . . . . . 0.637 HD12 ' N ' ' D' ' 114' ' ' LEU . 9.3 mp -49.88 -41.92 46.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' D' ' 119' ' ' GLY . . . -47.9 -41.54 24.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.735 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.661 ' N ' ' ND1' ' D' ' 116' ' ' HIS . 0.4 OUTLIER -68.84 -52.32 31.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.537 -179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 117' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 74.9 m80 -69.1 -17.65 63.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.738 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 64.0 m-85 -156.82 64.45 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.522 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' D' ' 115' ' ' ALA . . . -76.4 -21.26 75.7 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -72.78 -29.3 63.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.157 . . . . 0.0 109.375 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' D' ' 123' ' ' THR . 63.3 mm-40 -78.56 -15.46 58.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' D' ' 115' ' ' ALA . 3.8 m-85 -69.84 59.77 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.321 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.466 ' OG1' ' CG2' ' D' ' 126' ' ' VAL . 12.0 p -59.05 150.95 59.09 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 108.916 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.445 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.3 Cg_exo -44.09 -58.12 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.414 2.076 . . . . 0.0 112.755 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 27.6 Cg_endo -61.9 -46.62 12.88 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.117 1.878 . . . . 0.0 112.033 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.466 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 40.3 t -66.68 -18.33 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.695 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 127' ' ' GLN . . . . . 0.505 ' OE1' HD11 ' C' ' 34' ' ' LEU . 14.1 tm0? -83.13 -26.4 31.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.114 -0.992 . . . . 0.0 109.703 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.816 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -68.73 -32.08 71.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.051 -1.03 . . . . 0.0 109.572 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.37 26.45 0.91 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.644 ' CG ' ' N ' ' D' ' 131' ' ' GLN . 5.8 p90 -74.6 -52.19 12.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.813 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 1.197 ' NE2' ' HZ ' ' C' ' 36' ' ' PHE . 20.6 tt0 -86.03 -38.98 17.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.146 -0.972 . . . . 0.0 110.023 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 132' ' ' LYS . . . . . 1.01 ' HG3' ' O ' ' B' ' 146' ' ' HIS . 32.1 ttpt -50.9 -34.55 28.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 110.981 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 133' ' ' VAL . . . . . 0.889 HG13 ' H ' ' D' ' 134' ' ' VAL . 7.1 p -65.18 -64.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.865 -1.147 . . . . 0.0 109.87 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.889 ' H ' HG13 ' D' ' 133' ' ' VAL . 1.8 m -73.83 -14.65 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.409 -0.807 . . . . 0.0 109.826 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' D' ' 131' ' ' GLN . . . -45.87 -23.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.099 -1.001 . . . . 0.0 109.662 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 136' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -82.6 -26.36 46.82 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 137' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' D' ' 134' ' ' VAL . 75.0 t -80.04 -21.36 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -1.159 . . . . 0.0 109.441 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.8 -51.06 71.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 109.659 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.78 -22.42 53.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.0 88.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 141' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 20.2 mt -84.03 15.65 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.587 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.69 -1.42 2.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.304 -0.872 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -79.98 -26.53 39.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -73.28 -11.35 60.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 145' ' ' TYR . . . . . 0.448 ' CE1' ' SG ' ' D' ' 93' ' ' CYS . 15.8 m-85 -72.84 7.11 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.942 . . . . 0.0 109.24 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.993 ' O ' ' HG3' ' B' ' 132' ' ' LYS . 7.6 p-80 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 3.0 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 3' ' ' SER . 3.3 tp 75.68 174.32 0.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.335 -0.853 . . . . 0.0 109.537 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.623 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 164.56 -38.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 110.516 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 3' ' ' SER . 76.4 Cg_exo -49.62 -173.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.327 2.018 . . . . 0.0 112.966 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -75.81 -15.86 60.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 0.0 110.073 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' A' ' 127' ' ' LYS . 4.9 p30 -39.03 -38.29 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.301 -0.875 . . . . 0.0 109.554 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 12.9 mtmm -57.41 -58.41 8.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 108.958 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 m -51.51 -31.83 25.33 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 108.989 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -76.61 -34.71 58.36 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.625 HG21 ' CD2' ' A' ' 128' ' ' PHE . 51.8 t -72.73 -49.91 37.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HE2' HG13 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -52.16 -42.31 63.3 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.66 -60.78 3.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.409 -0.807 . . . . 0.0 109.389 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -53.62 -34.11 57.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.113 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -17.69 61.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.379 -0.826 . . . . 0.0 109.077 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.44 -45.11 10.07 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.41 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 13.1 mmmt -68.72 -39.8 80.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -1.134 . . . . 0.0 108.859 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 13' ' ' ALA . 89.1 t -60.92 -65.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 58.06 -136.73 50.63 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.06 27.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.474 -1.016 . . . . 0.0 110.329 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.563 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.7 m-70 -131.44 27.1 4.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -90.96 -63.83 1.21 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.695 -0.628 . . . . 0.0 109.917 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.98 -14.47 0.13 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.4 mt-10 -85.06 -56.33 3.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -1.056 . . . . 0.0 109.633 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.8 m-30 -57.95 -43.93 86.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.328 -0.858 . . . . 0.0 109.111 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.03 -22.88 56.33 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.05 -33.91 59.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -1.129 . . . . 0.0 109.689 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' OE2' ' NE2' ' A' ' 112' ' ' HIS . 47.2 mt-10 -69.17 -20.18 64.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.282 -0.886 . . . . 0.0 109.687 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -19.68 59.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.344 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.7 mt -72.14 -48.11 46.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 109.6 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.46 -24.79 63.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.211 -0.93 . . . . 0.0 109.503 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.927 HH11 ' HG2' ' B' ' 127' ' ' GLN . 50.2 ttm-85 -76.1 -21.16 56.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.206 -0.934 . . . . 0.0 109.345 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 54.0 ttp -82.24 -50.7 8.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CD2' ' OG1' ' A' ' 39' ' ' THR . 9.4 m-85 -52.59 -44.34 65.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.701 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.755 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 6.5 mt -67.59 -58.7 4.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.975 . . . . 0.0 109.682 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.676 ' HA ' ' OE1' ' B' ' 131' ' ' GLN . 40.2 m -48.47 -34.03 10.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.905 . . . . 0.0 109.755 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 35' ' ' SER . 3.0 m-85 -146.73 90.46 5.5 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.232 -0.918 . . . . 0.0 109.397 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 39' ' ' THR . 48.4 Cg_exo -53.51 -19.32 13.32 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.72 2.28 . . . . 0.0 112.149 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 37' ' ' PRO . 12.9 p -42.64 -18.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.405 -0.809 . . . . 0.0 110.092 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 37' ' ' PRO . 46.7 p -75.42 -22.29 57.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.928 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -46.55 -44.92 18.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.912 . . . . 0.0 109.853 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.475 HG21 ' CD2' ' D' ' 97' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.658 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.477 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.594 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -146.1 66.36 1.2 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 49' ' ' SER . 17.0 m-20 -41.05 -18.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.265 -0.897 . . . . 0.0 110.214 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 46' ' ' PHE . 1.1 mt 51.94 9.8 0.1 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 47' ' ' ASP . 10.7 t -67.18 155.87 37.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.38 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.506 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 11.4 t-80 -65.24 139.84 58.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.542 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.506 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 54.52 30.62 50.63 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.554 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 36.9 t -63.24 -98.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -1.15 . . . . 0.0 109.376 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 172.56 -39.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.862 . . . . 0.0 109.487 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -74.77 -20.1 59.94 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.275 -0.891 . . . . 0.0 109.44 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -84.72 -41.09 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -78.95 -26.48 43.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.862 . . . . 0.0 109.054 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.55 -21.94 63.23 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.565 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -79.02 -39.31 34.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -1.125 . . . . 0.0 109.558 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.79 -47.67 30.69 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 51.2 mttp -52.45 -23.78 6.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 0.0 109.804 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -72.08 -42.49 66.11 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.149 -0.969 . . . . 0.0 109.034 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 t -70.69 -48.24 59.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.52 -30.5 70.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.286 -0.884 . . . . 0.0 109.071 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.9 t0 -68.4 -32.59 72.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.927 . . . . 0.0 108.738 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.46 -49.42 59.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.407 -0.808 . . . . 0.0 108.983 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.61 -39.93 93.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.274 -0.891 . . . . 0.0 108.817 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -70.69 -49.77 43.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.264 -0.898 . . . . 0.0 108.612 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -58.39 -21.03 48.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.47 -46.83 12.03 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.415 HG13 ' HE2' ' A' ' 11' ' ' LYS . 3.9 t -63.59 -22.83 31.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.97 64.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 74' ' ' ASP . 93.2 m-70 -147.14 -48.4 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.855 . . . . 0.0 109.402 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.4 p 44.99 13.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.752 0.787 . . . . 0.0 109.47 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 72' ' ' HIS . 37.3 m-20 -135.52 10.75 3.45 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 3.9 m-20 -174.94 26.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 15.0 ptt? -78.53 -22.59 0.39 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 111.706 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 76' ' ' MET . 49.7 Cg_exo -55.05 -17.93 15.85 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.506 1.471 . . . . 0.0 112.221 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -94.14 -46.81 6.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.272 -0.893 . . . . 0.0 109.387 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.02 -42.3 99.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.825 . . . . 0.0 109.15 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.76 9.16 8.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.489 -0.757 . . . . 0.0 108.996 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -57.33 -25.55 59.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.375 -0.828 . . . . 0.0 109.637 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -56.4 -57.99 9.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.119 -0.988 . . . . 0.0 109.463 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.477 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 6.6 mt -45.31 -50.45 11.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 3.4 m -49.25 -38.45 26.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 82' ' ' ALA . 27.9 t70 -82.52 -17.29 45.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.839 . . . . 0.0 109.865 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -70.7 -51.9 24.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.58 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 14.3 p-80 -92.16 -21.92 20.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.89 -1.131 . . . . 0.0 110.689 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -60.64 -51.32 69.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.852 -1.155 . . . . 0.0 109.907 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -155.69 63.78 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.94 . . . . 0.0 109.906 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -163.06 0.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.865 . . . . 0.0 109.29 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.6 tp -171.78 -31.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 51.76 47.74 24.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.46 136.97 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.484 ' OD2' ' CE1' ' D' ' 97' ' ' HIS . 22.5 m-20 -58.33 128.41 82.39 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 97' ' ' ASN . 73.0 Cg_endo -77.09 -18.62 14.3 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.302 2.002 . . . . 0.0 112.056 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.443 ' H ' HG23 ' A' ' 96' ' ' VAL . 3.3 t -46.75 -14.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.499 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 95' ' ' PRO . 20.7 m-80 -79.04 -24.6 43.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.506 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -52.98 -50.59 63.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.527 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' O ' ' CE1' ' A' ' 103' ' ' HIS . 47.0 mttp -56.61 -25.98 54.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.71 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.8 mt -84.2 -34.81 23.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 109.492 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.3 tp -74.86 -29.14 60.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 109.717 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -73.33 -39.13 65.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.963 . . . . 0.0 109.718 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 99' ' ' LYS . 7.1 m170 -80.73 -26.85 37.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.649 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 33.5 m -64.26 -53.79 43.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.168 -0.958 . . . . 0.0 109.755 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -46.7 -28.67 1.57 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.937 . . . . 0.0 109.601 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.92 -31.53 35.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 109.955 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.7 t -82.64 -26.59 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 109.649 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 p -74.41 -62.07 1.65 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 109.567 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 113' ' ' LEU . 17.7 mt -46.06 -35.31 4.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 0.0 109.416 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.77 -40.75 66.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.952 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' B' ' 122' ' ' PHE . . . -73.3 -40.9 64.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.702 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.531 ' NE2' ' OE2' ' A' ' 27' ' ' GLU . 64.5 m-70 -89.67 -78.77 0.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.545 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -107.7 113.49 61.34 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.511 ' O ' ' O ' ' A' ' 113' ' ' LEU . 77.8 Cg_exo -45.93 -173.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.235 1.957 . . . . 0.0 112.282 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.642 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -69.25 -53.2 21.06 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.473 -0.767 . . . . 0.0 109.078 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.642 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 26.0 mt-10 125.65 -0.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.502 ' O ' ' CD2' ' A' ' 117' ' ' PHE . 56.6 t80 58.04 33.56 23.31 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.408 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.795 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -106.59 117.22 57.5 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.513 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.14 20.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.146 1.898 . . . . 0.0 112.708 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.795 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -146.42 -34.07 0.3 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 0.0 110.211 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 115' ' ' ALA . 14.0 p -47.71 -47.04 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 109.926 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.61 ' N ' HG13 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -67.85 -33.64 75.15 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.4 -0.813 . . . . 0.0 109.287 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.32 -20.24 32.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.696 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.5 m -69.06 -62.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.12 -19.71 64.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.0 -1.062 . . . . 0.0 109.1 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.15 -46.79 13.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.71 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -89.84 -39.06 13.32 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.792 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.625 ' CD2' HG21 ' A' ' 10' ' ' VAL . 27.8 t80 -47.86 -20.66 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.915 -1.116 . . . . 0.0 108.666 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' N ' ' C ' ' A' ' 127' ' ' LYS . 29.1 mt -70.73 -19.64 62.72 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -55.08 -38.38 68.01 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.502 ' HB2' HD13 ' A' ' 2' ' ' LEU . 5.4 t -77.92 -29.72 50.17 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 135' ' ' VAL . 22.0 t -80.32 -39.11 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -68.08 -20.97 64.99 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.192 -0.943 . . . . 0.0 109.04 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 138' ' ' SER . 94.9 m -69.11 -39.53 78.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.505 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 132' ' ' VAL . 1.0 OUTLIER -76.51 -31.12 19.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.264 -0.897 . . . . 0.0 109.433 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.511 ' O ' ' NE2' ' A' ' 87' ' ' HIS . 0.5 OUTLIER -84.74 -23.84 29.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.868 . . . . 0.0 109.18 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.5 m -100.25 -15.57 18.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.371 -0.83 . . . . 0.0 109.453 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 134' ' ' THR . 1.8 t . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.5 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.784 ' N ' HD12 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -133.82 -171.96 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.449 -0.782 . . . . 0.0 109.317 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.419 ' O ' ' N ' ' B' ' 6' ' ' GLU . 12.6 p -90.0 134.86 30.96 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.25 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -41.61 -22.88 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.421 2.081 . . . . 0.0 112.357 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' B' ' 4' ' ' THR . 9.6 mp0 -79.28 -52.25 8.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.953 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.03 -60.58 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.692 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.559 ' HG3' HD13 ' B' ' 3' ' ' LEU . 5.0 ttpp -49.74 -51.75 36.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.823 . . . . 0.0 109.976 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -43.57 -23.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.63 -0.669 . . . . 0.0 110.235 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -82.94 -56.17 3.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.057 -1.027 . . . . 0.0 109.826 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' B' ' 130' ' ' TYR . 1.2 p -68.78 -24.56 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 10.9 m -71.61 -42.79 67.24 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.441 0.638 . . . . 0.0 109.544 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.59 67.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.05 -27.45 8.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.965 . . . . 0.0 109.445 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' TRP . . . . . 0.605 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.4 OUTLIER -52.37 -17.7 1.3 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.184 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.63 -41.77 28.43 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -28.75 35.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -1.22 . . . . 0.0 109.231 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 78.0 t -58.47 114.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.844 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' B' ' 21' ' ' ASP . 7.9 t-20 -81.76 67.08 7.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.237 -0.915 . . . . 0.0 108.726 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' B' ' 19' ' ' ASN . 84.4 t -42.75 -20.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.475 -0.766 . . . . 0.0 109.792 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' B' ' 19' ' ' ASN . 78.5 m-20 -75.55 2.72 10.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' B' ' 19' ' ' ASN . 33.9 mt-10 -155.57 -47.94 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -47.09 -33.06 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.507 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.72 -55.58 19.25 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.44 -36.75 93.01 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -76.09 -47.32 24.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -1.162 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.25 -33.84 59.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.15 -57.81 3.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.875 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.81 -45.06 55.67 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -50.33 -36.39 31.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -1.119 . . . . 0.0 109.489 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 42.9 tp -49.46 -38.9 31.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.351 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -81.1 -21.83 39.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 109.538 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 t -77.86 -64.32 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 0.0 109.703 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.403 ' H ' HG23 ' B' ' 34' ' ' VAL . 0.2 OUTLIER -69.11 -22.76 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.604 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -141.33 81.34 15.64 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.272 -0.892 . . . . 0.0 109.404 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.75 7.47 4.84 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.687 2.258 . . . . 0.0 112.475 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.55 ' CD1' HG23 ' B' ' 38' ' ' THR . 1.5 p-90 -66.01 -19.79 65.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.097 -1.002 . . . . 0.0 109.476 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.55 HG23 ' CD1' ' B' ' 37' ' ' TRP . 82.3 p -76.89 41.78 0.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLN . . . . . 0.427 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 35.1 tt0 -84.1 26.41 0.75 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.89 . . . . 0.0 109.372 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.13 -49.2 4.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.347 -0.845 . . . . 0.0 109.582 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -88.22 3.35 49.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' B' ' 39' ' ' GLN . 8.0 p90 -52.49 -30.12 28.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.675 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -49.16 -24.89 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.606 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 39.1 t -95.36 -9.02 34.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 0.0 109.536 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' B' ' 42' ' ' PHE . 16.1 m-85 -87.03 21.82 2.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 109.497 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -98.99 2.44 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' B' ' 47' ' ' ASP . 27.2 p-10 -156.86 112.66 2.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -1.125 . . . . 0.0 109.606 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.524 ' N ' HD12 ' B' ' 48' ' ' LEU . 9.4 mp -80.01 24.54 0.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.15 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.425 ' C ' ' O ' ' B' ' 48' ' ' LEU . 29.2 t -43.09 -29.97 0.4 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.385 -0.822 . . . . 0.0 109.686 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' THR . . . . . 0.415 ' O ' ' N ' ' B' ' 53' ' ' ALA . 73.1 p -148.74 139.02 13.15 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 109.16 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -39.35 -36.12 0.88 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.442 2.095 . . . . 0.0 112.411 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.29 -33.77 61.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.847 . . . . 0.0 109.624 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -48.86 -19.81 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.563 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.56 -64.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.606 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' B' ' 55' ' ' MET . 1.9 mpt? -80.26 4.22 18.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.983 . . . . 0.0 109.467 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.02 -26.84 47.56 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' B' ' 53' ' ' ALA . 67.3 m-80 -84.79 141.84 38.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.095 -1.238 . . . . 0.0 109.423 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.05 -40.01 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.612 2.208 . . . . 0.0 112.245 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -47.39 78.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.549 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 89.9 t -50.79 -41.01 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.895 . . . . 0.0 109.58 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -79.09 -42.44 26.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.741 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.55 -30.27 71.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' HIS . . . . . 0.49 ' O ' ' ND1' ' B' ' 63' ' ' HIS . 1.3 t-80 -66.21 -23.88 66.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.542 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.62 -46.69 74.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.489 ' HZ3' ' C ' ' B' ' 21' ' ' ASP . 8.3 mtpp -54.49 -29.42 50.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.576 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.85 -32.79 63.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.925 . . . . 0.0 109.579 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 t -81.32 -30.75 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.46 -44.61 57.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 109.39 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.95 -44.87 19.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.12 -45.75 86.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -1.175 . . . . 0.0 109.621 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -57.43 -51.29 70.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.625 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' SER . . . . . 0.605 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.9 t -57.54 -43.05 84.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -0.824 . . . . 0.0 109.644 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -48.38 -29.99 4.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.986 . . . . 0.0 109.445 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.43 -60.25 5.61 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.601 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -54.95 -23.69 20.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -1.113 . . . . 0.0 109.264 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.51 9.41 43.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -170.77 70.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.958 . . . . 0.0 109.739 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.14 -7.75 58.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.185 -0.947 . . . . 0.0 109.387 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.63 -26.73 5.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.433 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 8.6 p-10 -172.33 41.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.289 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.702 HD23 ' N ' ' B' ' 81' ' ' LEU . 1.6 pt? -46.63 -18.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.36 -0.837 . . . . 0.0 109.849 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' B' ' 80' ' ' ASN . 59.6 mttm -79.93 -32.32 40.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.06 -1.025 . . . . 0.0 109.638 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.26 -23.01 55.9 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.7 OUTLIER -70.78 -42.99 69.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.102 -1.234 . . . . 0.0 109.733 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.483 ' N ' ' CG2' ' B' ' 84' ' ' THR . 30.9 m-85 -84.81 25.96 0.88 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.6 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.51 -26.94 55.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.264 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.447 ' O ' ' N ' ' B' ' 91' ' ' LEU . 81.2 p -79.69 -54.89 5.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.311 -0.868 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.1 mt -47.97 -43.12 29.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.163 -0.961 . . . . 0.0 109.266 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' SER . . . . . 0.514 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 1.5 m -64.72 -38.89 92.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.192 -0.942 . . . . 0.0 109.555 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.482 ' HA ' ' HG ' ' B' ' 93' ' ' CYS . 56.8 tt0 -82.1 -22.6 36.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.5 tt -90.29 -39.22 12.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.977 . . . . 0.0 109.744 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' B' ' 97' ' ' HIS . 4.0 m80 -77.75 -29.92 51.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.02 -1.05 . . . . 0.0 110.176 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' B' ' 94' ' ' ASP . 13.2 p -83.51 -48.62 10.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.048 -1.032 . . . . 0.0 110.81 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.639 ' N ' ' SG ' ' B' ' 93' ' ' CYS . 23.6 m-20 -87.33 -34.38 18.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.904 -1.123 . . . . 0.0 111.523 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -89.01 -51.84 5.4 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.815 -1.178 . . . . 0.0 111.01 -178.259 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 12.9 mt -98.3 -17.79 18.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.95 -1.094 . . . . 0.0 110.314 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 31.0 p80 42.6 33.8 0.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.396 -0.815 . . . . 0.0 110.204 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 68.0 t -58.25 127.44 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.158 -0.964 . . . . 0.0 109.031 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' B' ' 99' ' ' ASP . 4.6 p-10 -45.61 148.33 1.3 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 109.494 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' B' ' 102' ' ' ASN . 59.8 Cg_endo -72.99 -40.09 1.94 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.61 2.207 . . . . 0.0 112.342 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -67.76 52.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.486 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' B' ' 100' ' ' PRO . 56.0 t-20 -140.68 -49.7 0.44 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.274 -0.891 . . . . 0.0 109.644 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -46.23 -24.22 0.44 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.832 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -74.54 -20.01 60.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' B' ' 108' ' ' ASN . 43.1 mt -80.65 -59.55 2.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.548 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 8.2 tt -46.94 -35.13 6.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.523 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.27 -26.4 74.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ASN . . . . . 0.534 HD21 ' C ' ' B' ' 108' ' ' ASN . 0.1 OUTLIER -85.52 -19.24 31.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -1.172 . . . . 0.0 109.778 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 77.4 t -84.15 -24.69 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.596 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.453 HD23 ' O ' ' B' ' 110' ' ' LEU . 1.4 tt -71.73 -60.0 2.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.44 ' H ' HG23 ' B' ' 111' ' ' VAL . 11.7 t -51.39 -29.02 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 14.5 t -65.3 -41.35 94.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.183 -0.948 . . . . 0.0 109.571 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.06 -45.94 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.584 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.74 -26.55 68.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.634 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.493 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -68.12 -34.43 76.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.492 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.96 -62.85 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 109.398 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.614 ' ND1' ' CZ ' ' B' ' 118' ' ' PHE . 12.4 t-80 -55.82 -19.68 12.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 109.74 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.614 ' CZ ' ' ND1' ' B' ' 117' ' ' HIS . 67.5 m-85 -151.6 60.8 0.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -72.63 -16.93 77.78 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -69.41 -30.03 67.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.481 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -94.01 13.54 22.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.915 . . . . 0.0 109.822 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.585 ' CD2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -81.43 33.31 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.46 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 13.1 p -47.73 130.11 11.2 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.516 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 45.5 Cg_exo -43.38 -51.9 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.194 1.929 . . . . 0.0 113.029 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 18.9 Cg_endo -58.84 -33.97 98.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.823 1.682 . . . . 0.0 111.883 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 49.7 t -82.41 -9.98 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 0.0 109.579 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' GLN . . . . . 0.927 ' HG2' HH11 ' A' ' 31' ' ' ARG . 13.9 tp60 -75.85 -59.78 2.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -61.08 -34.04 74.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.451 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.19 11.77 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 109.545 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' B' ' 128' ' ' ALA . 6.3 t80 -105.0 -55.25 2.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 109.704 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.676 ' OE1' ' HA ' ' A' ' 35' ' ' SER . 6.5 pt20 -45.82 -44.2 13.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.928 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -57.14 -50.04 74.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.979 . . . . 0.0 109.997 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.92 -46.95 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.133 -0.98 . . . . 0.0 109.984 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.39 -33.78 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.919 . . . . 0.0 110.197 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.89 -27.26 2.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.975 -1.078 . . . . 0.0 109.394 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.77 -25.67 73.02 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.35 -49.25 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -1.125 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.62 -42.79 35.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -78.22 -23.47 47.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.41 3.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.86 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.53 -14.15 0.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.879 . . . . 0.0 109.368 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' B' ' 144' ' ' LYS . . . -93.95 4.67 53.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.362 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 143' ' ' HIS . . . . . 0.515 ' O ' ' CG ' ' B' ' 143' ' ' HIS . 11.0 t-160 -68.47 7.8 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.335 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' B' ' 142' ' ' ALA . 39.7 mmtt -139.25 -41.31 0.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.352 -0.842 . . . . 0.0 109.498 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.513 ' CE1' ' OXT' ' B' ' 146' ' ' HIS . 0.0 OUTLIER -56.19 -12.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 109.491 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.513 ' OXT' ' CE1' ' B' ' 145' ' ' TYR . 15.7 m-70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.711 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' C' ' 2' ' ' LEU . 2.9 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' C' ' 3' ' ' SER . 3.3 tp 75.68 174.4 0.24 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -0.849 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.618 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 164.45 -38.1 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.363 -0.835 . . . . 0.0 110.46 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' C' ' 3' ' ' SER . 77.3 Cg_exo -49.6 -173.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.305 2.003 . . . . 0.0 112.972 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.484 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -75.75 -15.84 60.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.405 -0.81 . . . . 0.0 110.147 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' C' ' 127' ' ' LYS . 4.8 p30 -39.11 -38.21 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.554 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.477 ' N ' ' OD1' ' C' ' 6' ' ' ASP . 12.9 mtmm -57.43 -58.37 8.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 108.932 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.8 m -51.57 -31.84 26.08 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 108.942 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -76.62 -34.75 58.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.631 HG21 ' CD2' ' C' ' 128' ' ' PHE . 51.7 t -72.62 -49.97 37.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 11' ' ' LYS . . . . . 0.433 ' HE2' HG13 ' C' ' 70' ' ' VAL . 0.6 OUTLIER -52.03 -42.46 63.08 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.62 -60.78 3.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.361 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.668 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -53.73 -33.98 57.4 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.378 -0.826 . . . . 0.0 109.162 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -17.73 61.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.081 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.35 -45.13 10.18 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -68.82 -39.74 79.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.227 -1.161 . . . . 0.0 108.849 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.668 HG23 ' O ' ' C' ' 13' ' ' ALA . 89.8 t -60.86 -65.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.59 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 58.12 -136.69 50.69 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.12 27.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.464 -1.021 . . . . 0.0 110.302 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.59 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.6 m-70 -131.5 27.16 4.73 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.02 -63.88 1.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.611 -0.68 . . . . 0.0 109.869 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.91 -14.38 0.12 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.5 mt-10 -85.1 -56.34 3.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -1.055 . . . . 0.0 109.683 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.9 m-30 -58.03 -43.83 86.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.125 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.08 -22.83 56.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.07 -33.97 59.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.165 . . . . 0.0 109.69 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' GLU . . . . . 0.525 ' OE2' ' NE2' ' C' ' 112' ' ' HIS . 47.1 mt-10 -69.01 -20.27 64.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.716 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.61 -19.73 59.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.27 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -72.1 -48.07 46.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.349 -0.845 . . . . 0.0 109.681 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.54 -24.68 63.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.91 HH11 ' HG2' ' D' ' 127' ' ' GLN . 50.3 ttm-85 -76.15 -21.23 56.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 54.1 ttp -82.12 -50.65 8.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' PHE . . . . . 0.441 ' CD2' ' OG1' ' C' ' 39' ' ' THR . 9.4 m-85 -52.72 -44.29 66.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.699 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.786 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 6.5 mt -67.51 -58.83 4.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.671 ' HA ' ' OE1' ' D' ' 131' ' ' GLN . 40.9 m -48.34 -34.08 10.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.802 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -146.67 90.42 5.53 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.94 . . . . 0.0 109.356 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' C' ' 39' ' ' THR . 48.2 Cg_exo -53.48 -19.33 13.21 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.745 2.297 . . . . 0.0 112.172 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.407 ' O ' HG22 ' C' ' 41' ' ' THR . 12.8 p -42.65 -18.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.43 -0.794 . . . . 0.0 110.117 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.561 ' N ' ' O ' ' C' ' 37' ' ' PRO . 45.6 p -75.44 -22.22 57.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 110.09 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -46.59 -44.96 18.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.431 HG21 ' CD2' ' B' ' 97' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.491 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -146.16 66.34 1.2 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' C' ' 49' ' ' SER . 17.0 m-20 -40.99 -18.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.274 -0.892 . . . . 0.0 110.299 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.578 ' N ' ' O ' ' C' ' 46' ' ' PHE . 1.1 mt 52.03 9.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.069 -1.02 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.474 ' H ' ' C ' ' C' ' 47' ' ' ASP . 10.7 t -67.09 155.85 37.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' HIS . . . . . 0.51 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 11.3 t-80 -65.34 139.84 58.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 51' ' ' GLY . . . . . 0.51 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 54.57 30.66 51.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' C' ' 53' ' ' ALA . 37.1 t -63.27 -98.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -1.122 . . . . 0.0 109.396 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' C' ' 52' ' ' SER . . . 172.56 -39.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.545 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -74.68 -20.22 59.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.41 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.0 t -84.63 -41.02 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -79.03 -26.4 43.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 109.083 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.67 -21.79 63.23 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.577 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.3 OUTLIER -79.05 -39.28 34.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -1.132 . . . . 0.0 109.575 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.87 -47.66 31.18 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 51.3 mttp -52.45 -23.79 6.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -1.083 . . . . 0.0 109.696 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -72.11 -42.53 65.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.171 -0.955 . . . . 0.0 109.042 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 t -70.58 -48.31 59.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.453 -0.78 . . . . 0.0 108.969 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.55 -30.41 70.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.242 -0.911 . . . . 0.0 109.11 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 8.0 t0 -68.46 -32.54 72.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 108.693 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.56 -49.36 60.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.473 -0.767 . . . . 0.0 108.954 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.56 -40.05 93.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 108.744 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -70.67 -49.82 43.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -58.38 -20.96 48.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.51 -46.83 12.0 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.433 HG13 ' HE2' ' C' ' 11' ' ' LYS . 3.9 t -63.44 -23.0 32.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.3 -26.1 64.7 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' C' ' 74' ' ' ASP . 93.2 m-70 -147.08 -48.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.424 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.4 p 45.06 12.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.783 0.802 . . . . 0.0 109.525 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' C' ' 72' ' ' HIS . 37.4 m-20 -135.45 10.68 3.47 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.414 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 3.9 m-20 -174.96 26.68 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.686 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 15.1 ptt? -78.63 -22.54 0.39 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.403 -0.811 . . . . 0.0 111.705 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' C' ' 76' ' ' MET . 49.7 Cg_exo -54.98 -18.02 15.73 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.547 1.498 . . . . 0.0 112.208 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -94.12 -46.77 6.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.96 . . . . 0.0 109.381 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.96 -42.36 99.03 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.294 -0.878 . . . . 0.0 109.183 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.76 9.22 8.28 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 108.994 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -57.48 -25.45 59.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 109.608 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -56.49 -58.02 9.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.377 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.478 ' O ' ' CE1' ' C' ' 87' ' ' HIS . 6.5 mt -45.17 -50.5 11.36 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 3.4 m -49.29 -38.36 27.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' C' ' 82' ' ' ALA . 27.9 t70 -82.51 -17.44 45.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 109.782 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -70.69 -51.83 25.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.567 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' HIS . . . . . 0.52 ' NE2' ' O ' ' C' ' 136' ' ' LEU . 14.3 p-80 -92.2 -21.8 20.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.965 -1.084 . . . . 0.0 110.754 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -60.67 -51.37 69.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.838 -1.164 . . . . 0.0 109.881 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -155.66 63.9 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.88 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.403 ' H ' ' H ' ' C' ' 91' ' ' LEU . 26.3 ttmt -163.16 1.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.259 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.403 ' H ' ' H ' ' C' ' 90' ' ' LYS . 60.5 tp -171.77 -32.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.299 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 51.7 47.82 24.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.626 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.62 136.88 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.407 ' OD2' ' CE1' ' B' ' 97' ' ' HIS . 22.3 m-20 -58.25 128.36 81.98 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.269 -0.894 . . . . 0.0 109.507 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' C' ' 97' ' ' ASN . 74.3 Cg_endo -77.01 -18.57 14.48 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.336 2.024 . . . . 0.0 112.194 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -46.72 -15.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 109.569 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' C' ' 95' ' ' PRO . 20.7 m-80 -78.97 -24.5 43.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.99 -50.65 63.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.4 ' O ' ' CE1' ' C' ' 103' ' ' HIS . 46.9 mttp -56.61 -25.96 54.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.73 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 9.8 mt -84.24 -34.62 23.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 109.592 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 8.3 tp -74.99 -29.09 60.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 109.714 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 66.6 m -73.36 -39.13 65.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.668 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 103' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' C' ' 99' ' ' LYS . 7.2 m170 -80.77 -26.81 37.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.299 -0.876 . . . . 0.0 109.644 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 33.0 m -64.32 -53.69 44.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.739 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -46.79 -28.59 1.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.968 . . . . 0.0 109.63 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 15.8 mt -80.94 -31.52 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 109.941 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 87.9 t -82.59 -26.66 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.03 -1.044 . . . . 0.0 109.683 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 5.2 p -74.41 -62.06 1.65 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.189 -0.944 . . . . 0.0 109.585 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 113' ' ' LEU . 17.5 mt -46.06 -35.22 4.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.87 -40.74 66.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.931 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 111' ' ' ALA . . . . . 0.595 ' HB2' ' CD2' ' D' ' 122' ' ' PHE . . . -73.37 -40.83 64.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.661 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 112' ' ' HIS . . . . . 0.525 ' NE2' ' OE2' ' C' ' 27' ' ' GLU . 64.7 m-70 -89.67 -78.77 0.35 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.571 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.4 OUTLIER -107.75 113.53 61.23 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 114' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' C' ' 113' ' ' LEU . 78.9 Cg_exo -45.99 -173.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.198 1.932 . . . . 0.0 112.292 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.65 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -69.46 -52.98 21.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 109.098 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.65 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 26.1 mt-10 125.48 -0.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' C' ' 117' ' ' PHE . 56.8 t80 58.02 33.52 23.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.344 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.784 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -106.51 117.3 57.39 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.3 20.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.134 1.889 . . . . 0.0 112.689 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.784 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -146.39 -34.11 0.3 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.026 -1.046 . . . . 0.0 110.232 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.617 HG13 ' N ' ' C' ' 122' ' ' HIS . 14.0 p -47.71 -47.05 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 109.871 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.617 ' N ' HG13 ' C' ' 121' ' ' VAL . 0.0 OUTLIER -67.94 -33.55 74.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.813 . . . . 0.0 109.259 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.27 -20.35 32.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.905 . . . . 0.0 109.713 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.542 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.5 m -68.99 -62.84 1.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.11 -19.69 64.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.951 -1.093 . . . . 0.0 109.076 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.18 -46.75 13.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.679 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -89.85 -39.02 13.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.007 . . . . 0.0 109.836 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.631 ' CD2' HG21 ' C' ' 10' ' ' VAL . 27.6 t80 -47.82 -20.74 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.966 -1.083 . . . . 0.0 108.629 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.431 ' N ' ' C ' ' C' ' 127' ' ' LYS . 29.5 mt -70.66 -19.66 62.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -55.09 -38.37 68.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.495 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 5.4 t -77.9 -29.74 50.3 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 132' ' ' VAL . . . . . 0.42 ' O ' HG22 ' C' ' 135' ' ' VAL . 22.0 t -80.28 -39.21 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.352 -0.842 . . . . 0.0 108.787 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -67.96 -21.03 65.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.922 . . . . 0.0 109.063 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 134' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' C' ' 138' ' ' SER . 93.7 m -69.15 -39.46 78.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.845 . . . . 0.0 109.46 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.452 ' H ' HG13 ' C' ' 135' ' ' VAL . 1.0 OUTLIER -76.62 -31.01 19.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.297 -0.877 . . . . 0.0 109.41 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 136' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' C' ' 87' ' ' HIS . 0.5 OUTLIER -84.76 -23.89 29.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.889 . . . . 0.0 109.13 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 43.0 m -100.23 -15.57 18.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.319 -0.863 . . . . 0.0 109.443 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 138' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' C' ' 134' ' ' THR . 1.8 t . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.79 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -133.79 -171.87 2.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.292 -179.473 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.417 ' O ' ' N ' ' D' ' 6' ' ' GLU . 12.6 p -90.06 134.88 30.83 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.88 . . . . 0.0 109.322 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -41.61 -22.94 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.423 2.082 . . . . 0.0 112.365 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 6' ' ' GLU . . . . . 0.421 ' N ' ' CD ' ' D' ' 6' ' ' GLU . 9.6 mp0 -79.16 -52.37 8.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -62.99 -60.56 3.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 109.754 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.574 ' HG3' HD13 ' D' ' 3' ' ' LEU . 5.0 ttpp -49.71 -51.87 35.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.94 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -43.51 -23.69 0.08 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.61 -0.681 . . . . 0.0 110.285 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.01 -56.14 3.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.027 -1.045 . . . . 0.0 109.763 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.46 HG23 ' CD2' ' D' ' 130' ' ' TYR . 1.2 p -68.75 -24.63 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 10.5 m -71.5 -42.83 67.53 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.455 0.645 . . . . 0.0 109.594 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.4 -27.63 68.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.746 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.94 -27.53 7.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 15' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.4 OUTLIER -52.35 -17.82 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 109.155 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.47 -41.92 28.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.99 -28.73 35.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -1.204 . . . . 0.0 109.219 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 78.4 t -58.45 114.91 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.804 . . . . 0.0 109.886 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' D' ' 21' ' ' ASP . 7.9 t-20 -81.84 67.07 7.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.262 -0.899 . . . . 0.0 108.737 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' D' ' 19' ' ' ASN . 84.3 t -42.72 -20.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.467 -0.77 . . . . 0.0 109.835 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.56 ' C ' ' HZ3' ' D' ' 65' ' ' LYS . 78.5 m-20 -75.68 2.82 10.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.88 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' D' ' 19' ' ' ASN . 33.9 mt-10 -155.6 -47.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 53.1 t -47.1 -33.08 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 109.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.74 -55.61 19.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.47 -36.63 92.85 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -76.23 -47.21 24.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -1.119 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.27 -33.86 59.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.394 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.18 -57.77 3.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.958 . . . . 0.0 109.385 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.81 -45.03 55.69 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -50.37 -36.43 32.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -1.096 . . . . 0.0 109.486 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 42.9 tp -49.41 -38.85 30.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.354 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.13 -21.94 39.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 t -77.81 -64.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -0.99 . . . . 0.0 109.705 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.427 HG23 ' H ' ' D' ' 34' ' ' VAL . 0.2 OUTLIER -68.92 -22.88 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.639 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -141.26 81.36 15.73 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.325 -0.86 . . . . 0.0 109.396 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.8 7.47 4.85 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.703 2.269 . . . . 0.0 112.449 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' TRP . . . . . 0.546 ' NE1' HG23 ' D' ' 38' ' ' THR . 1.5 p-90 -65.97 -19.86 66.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.512 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.546 HG23 ' NE1' ' D' ' 37' ' ' TRP . 82.4 p -76.83 41.74 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.413 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 39' ' ' GLN . . . . . 0.421 ' O ' ' CD1' ' D' ' 42' ' ' PHE . 35.1 tt0 -84.03 26.34 0.74 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.383 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.11 -49.19 4.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.905 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -88.16 3.37 49.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' D' ' 39' ' ' GLN . 7.8 p90 -52.63 -30.14 29.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.601 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -49.11 -24.89 1.81 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.649 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 39.2 t -95.38 -8.99 34.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.537 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -87.05 21.88 2.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -99.13 2.45 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' D' ' 47' ' ' ASP . 27.2 p-10 -156.8 112.7 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 48' ' ' LEU . . . . . 0.533 ' N ' HD12 ' D' ' 48' ' ' LEU . 9.4 mp -80.04 24.57 0.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.172 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' D' ' 48' ' ' LEU . 29.1 t -43.09 -30.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.428 -0.795 . . . . 0.0 109.624 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 50' ' ' THR . . . . . 0.431 ' O ' ' N ' ' D' ' 53' ' ' ALA . 73.1 p -148.77 138.95 13.09 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 109.154 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -39.36 -36.1 0.88 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.458 2.105 . . . . 0.0 112.415 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.2 -33.86 61.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.16 -0.962 . . . . 0.0 109.652 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -48.92 -19.78 0.43 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 93.9 t -67.45 -64.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.733 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' D' ' 55' ' ' MET . 1.9 mpt? -80.17 4.14 18.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 109.496 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.08 -26.74 47.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 57' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' D' ' 53' ' ' ALA . 67.2 m-80 -84.84 141.83 38.56 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 0.0 109.489 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.1 -39.91 1.49 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.497 2.132 . . . . 0.0 112.254 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.92 -47.38 77.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.48 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 89.4 t -50.83 -40.94 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -79.19 -42.41 26.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.624 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.53 -30.23 71.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.621 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' HIS . . . . . 0.488 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 1.3 t-80 -66.26 -23.85 66.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.561 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.7 -46.65 73.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 65' ' ' LYS . . . . . 0.56 ' HZ3' ' C ' ' D' ' 21' ' ' ASP . 8.2 mtpp -54.41 -29.54 49.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -1.192 . . . . 0.0 109.556 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.75 -32.86 64.05 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 109.625 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 34.7 t -81.23 -30.78 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.54 -44.54 57.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.339 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.92 -44.84 18.87 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.61 87.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -1.137 . . . . 0.0 109.621 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -57.46 -51.3 69.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 109.594 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 72' ' ' SER . . . . . 0.6 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 9.0 t -57.54 -43.03 84.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.699 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -48.36 -30.13 4.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.42 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.32 -60.21 5.69 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.594 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.9 mp -55.07 -23.64 21.28 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.223 -1.163 . . . . 0.0 109.239 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.54 9.48 43.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.622 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -170.84 70.01 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 109.787 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 91.0 mt -85.98 -7.83 58.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.58 -26.74 5.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 80' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' D' ' 80' ' ' ASN . 8.5 p-10 -172.3 41.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 109.233 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 81' ' ' LEU . . . . . 0.698 HD23 ' N ' ' D' ' 81' ' ' LEU . 1.5 pt? -46.66 -18.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.884 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 82' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' D' ' 80' ' ' ASN . 59.5 mttm -80.02 -32.29 39.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.106 -0.996 . . . . 0.0 109.609 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.26 -23.04 55.79 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.7 OUTLIER -70.78 -43.05 69.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.039 -1.271 . . . . 0.0 109.676 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.485 ' N ' ' CG2' ' D' ' 84' ' ' THR . 30.8 m-85 -84.81 26.01 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.57 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.56 -26.93 56.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.918 . . . . 0.0 109.274 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 87' ' ' THR . . . . . 0.457 ' O ' ' N ' ' D' ' 91' ' ' LEU . 81.3 p -79.67 -54.99 5.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -47.86 -43.16 28.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.358 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 89' ' ' SER . . . . . 0.523 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 1.5 m -64.81 -38.81 92.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 109.513 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.483 ' HA ' ' HG ' ' D' ' 93' ' ' CYS . 57.2 tt0 -82.09 -22.6 36.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.676 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' D' ' 87' ' ' THR . 7.5 tt -90.24 -39.29 12.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 109.753 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' D' ' 97' ' ' HIS . 4.0 m80 -77.64 -29.92 51.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.054 -1.028 . . . . 0.0 110.234 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 93' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' D' ' 94' ' ' ASP . 13.1 p -83.51 -48.59 10.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.129 -0.982 . . . . 0.0 110.807 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.638 ' N ' ' SG ' ' D' ' 93' ' ' CYS . 23.9 m-20 -87.31 -34.42 18.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.91 -1.119 . . . . 0.0 111.493 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 95' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -89.03 -51.8 5.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.807 -1.183 . . . . 0.0 111.006 -178.237 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.582 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 12.9 mt -98.29 -17.79 18.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.942 -1.099 . . . . 0.0 110.26 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 31.0 p80 42.39 34.03 0.48 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.301 -0.874 . . . . 0.0 110.213 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 67.7 t -58.32 127.27 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 109.093 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 99' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' D' ' 99' ' ' ASP . 4.7 p-10 -45.4 148.41 1.18 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.563 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 100' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' D' ' 102' ' ' ASN . 59.3 Cg_endo -73.13 -40.05 1.89 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.614 2.209 . . . . 0.0 112.316 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -67.69 52.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.482 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 102' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' D' ' 100' ' ' PRO . 56.1 t-20 -140.75 -49.61 0.44 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -46.27 -24.24 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 109.764 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -74.61 -19.95 60.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 105' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' D' ' 108' ' ' ASN . 43.5 mt -80.7 -59.59 2.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.963 . . . . 0.0 109.453 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 8.2 tt -46.91 -35.17 6.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.23 -26.43 74.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 108' ' ' ASN . . . . . 0.542 HD21 ' C ' ' D' ' 108' ' ' ASN . 0.1 OUTLIER -85.49 -19.26 31.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -1.163 . . . . 0.0 109.794 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 77.4 t -84.05 -24.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 110' ' ' LEU . . . . . 0.449 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.5 tt -71.82 -59.99 2.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.465 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 11.6 t -51.3 -29.12 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.592 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 14.6 t -65.36 -41.24 94.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.22 -45.9 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.542 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.71 -26.56 68.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.643 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.501 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -68.17 -34.29 76.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 109.524 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.454 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -85.06 -62.84 1.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 0.0 109.388 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 117' ' ' HIS . . . . . 0.615 ' ND1' ' CZ ' ' D' ' 118' ' ' PHE . 12.3 t-80 -55.75 -19.76 12.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 109.748 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.615 ' CZ ' ' ND1' ' D' ' 117' ' ' HIS . 67.6 m-85 -151.62 60.83 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.539 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -72.54 -17.05 77.68 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -69.36 -30.06 67.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.144 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -94.0 13.58 22.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.807 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -81.46 33.26 0.35 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.663 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.46 ' OG1' ' CG2' ' D' ' 126' ' ' VAL . 13.3 p -47.67 130.07 11.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.312 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.525 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 45.6 Cg_exo -43.43 -51.88 5.57 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.134 1.89 . . . . 0.0 113.037 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 18.8 Cg_endo -58.78 -33.92 98.71 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.791 1.661 . . . . 0.0 111.955 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 49.1 t -82.37 -10.06 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.535 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 127' ' ' GLN . . . . . 0.91 ' HG2' HH11 ' C' ' 31' ' ' ARG . 14.0 tp60 -75.94 -59.75 2.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 109.423 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.786 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -61.12 -33.99 74.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.26 11.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' D' ' 128' ' ' ALA . 6.3 t80 -104.88 -55.34 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.299 -0.876 . . . . 0.0 109.738 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 0.671 ' OE1' ' HA ' ' C' ' 35' ' ' SER . 6.5 pt20 -45.87 -44.12 14.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.88 . . . . 0.0 109.899 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -57.17 -50.11 73.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.991 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.84 -46.93 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.024 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.449 ' H ' HG22 ' D' ' 134' ' ' VAL . 15.6 m -83.36 -33.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.113 -0.992 . . . . 0.0 110.203 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.89 -27.32 2.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.968 -1.082 . . . . 0.0 109.404 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.69 -25.67 72.93 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.34 -49.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -1.151 . . . . 0.0 109.441 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.65 -42.81 35.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.435 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -78.21 -23.43 47.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.464 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.01 -60.4 3.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.51 -14.14 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 142' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' D' ' 144' ' ' LYS . . . -94.01 4.75 53.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.91 . . . . 0.0 109.386 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 143' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' D' ' 143' ' ' HIS . 11.0 t-160 -68.52 7.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 109.342 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' D' ' 142' ' ' ALA . 39.7 mmtt -139.32 -41.28 0.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.367 -0.833 . . . . 0.0 109.466 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 145' ' ' TYR . . . . . 0.521 ' CE1' ' OXT' ' D' ' 146' ' ' HIS . 0.0 OUTLIER -56.26 -12.04 1.43 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.406 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.521 ' OXT' ' CE1' ' D' ' 145' ' ' TYR . 15.5 m-70 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.742 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.42 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 48.9 mt -125.32 -162.32 1.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.354 -0.841 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 177.12 -48.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.865 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 3' ' ' SER . 68.3 Cg_exo -49.18 174.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.391 2.061 . . . . 0.0 112.437 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -56.98 -16.56 7.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.614 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.472 ' C ' ' O ' ' A' ' 5' ' ' ALA . 14.8 t70 -39.92 -31.67 0.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 109.524 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 5' ' ' ALA . 9.3 mtmp? -73.34 -55.97 5.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.407 -0.808 . . . . 0.0 109.216 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 m -47.53 -28.63 2.33 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.139 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -78.33 -38.58 41.83 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.514 HG21 ' CD2' ' A' ' 128' ' ' PHE . 40.9 t -70.8 -48.91 54.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -51.58 -44.66 62.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 108.839 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.81 -58.55 7.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.818 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -55.68 -31.83 62.73 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.47 -17.4 58.07 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.201 -0.937 . . . . 0.0 108.914 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.35 -38.77 44.85 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -84.4 -40.86 17.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.381 -1.07 . . . . 0.0 109.32 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.573 ' O ' ' C ' ' A' ' 18' ' ' GLY . 93.7 t -66.69 -45.93 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 109.709 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.632 ' O ' ' HB3' ' A' ' 19' ' ' ALA . . . -25.1 137.81 0.01 OUTLIER Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . 74.26 -29.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.43 -1.041 . . . . 0.0 109.331 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.511 ' H ' ' C ' ' A' ' 18' ' ' GLY . 38.0 m-70 -110.76 16.79 21.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HB1' ' HB1' ' A' ' 63' ' ' ALA . . . -82.39 -60.8 2.08 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.008 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.46 -14.84 0.39 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.0 mt-10 -85.47 -56.35 3.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -1.177 . . . . 0.0 109.758 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.4 m-30 -60.69 -35.2 75.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.0 109.398 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.37 -23.01 73.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.74 -47.03 14.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -1.154 . . . . 0.0 109.64 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -63.57 -19.87 65.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 109.327 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.03 -27.6 63.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.44 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.416 HD11 ' ND1' ' A' ' 58' ' ' HIS . 9.0 mt -70.4 -53.68 15.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.907 . . . . 0.0 109.57 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.16 -29.37 69.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.251 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.38 -30.34 67.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.299 -0.876 . . . . 0.0 109.224 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 47.9 ttp -72.83 -52.7 13.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.186 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.38 -32.04 10.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.239 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.6 mt -78.42 -39.76 37.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -0.903 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.524 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 15.0 m -51.67 -29.67 18.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 35' ' ' SER . 57.1 m-85 -160.85 130.39 3.28 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.248 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.27 -19.89 14.89 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.317 2.011 . . . . 0.0 112.158 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.672 ' O ' HG22 ' A' ' 41' ' ' THR . 22.3 p -46.53 -46.0 18.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.785 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -45.39 -22.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 109.93 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.5 ttmt -51.81 -42.46 62.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.169 -0.957 . . . . 0.0 110.113 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 1.615 HG21 ' CD2' ' D' ' 97' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 0.0 109.757 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.531 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 4.2 p80 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.098 0.475 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -157.71 28.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 110.074 179.409 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' SER . 73.9 m-20 43.67 89.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.478 -0.764 . . . . 0.0 110.345 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.024 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.6 1.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.356 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.512 ' N ' HD22 ' A' ' 48' ' ' LEU . 5.0 m -84.77 157.0 21.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.15 -0.968 . . . . 0.0 109.769 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.604 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 40.2 t-80 -76.44 170.58 16.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.396 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.604 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 76.18 -21.88 2.14 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.7 p -55.95 -18.7 9.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -1.098 . . . . 0.0 109.374 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 72.82 -23.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.814 . . . . 0.0 109.732 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 52' ' ' SER . 24.1 mt-30 -84.83 -17.94 36.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 0.0 109.565 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.52 HG23 ' OG ' ' A' ' 52' ' ' SER . 44.5 t -84.09 -32.64 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.576 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -72.92 -29.39 63.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 0.0 109.211 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.98 66.09 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.495 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.2 t-80 -60.71 -30.72 70.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.126 -1.22 . . . . 0.0 110.076 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.79 -31.38 79.58 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 59.2 mttp -68.89 -23.01 64.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -1.115 . . . . 0.0 110.253 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -69.49 -58.19 4.28 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.883 -1.136 . . . . 0.0 108.748 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.52 -41.52 64.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.6 -0.688 . . . . 0.0 109.599 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.571 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -75.53 -43.86 46.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.158 -0.964 . . . . 0.0 109.237 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 34.9 t0 -68.85 -33.85 74.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.149 -0.97 . . . . 0.0 108.639 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . -66.87 -49.14 66.62 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -53.06 -47.06 68.74 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.282 -0.886 . . . . 0.0 108.627 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.2 m -57.01 -56.57 20.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 108.755 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.534 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 28.5 t30 -58.86 -21.09 56.36 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.08 -47.38 10.24 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.4 t -68.44 -22.74 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.43 75.58 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.609 ' O ' ' N ' ' A' ' 74' ' ' ASP . 5.5 m-70 -115.87 -60.57 1.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.493 -0.754 . . . . 0.0 109.509 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.3 p 45.09 12.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.726 0.774 . . . . 0.0 109.549 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 72' ' ' HIS . 28.8 m-20 -138.34 11.11 2.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -177.3 27.79 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.697 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 3.0 ptt? -78.51 -23.81 0.42 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 111.69 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 76' ' ' MET . 53.2 Cg_exo -54.47 -19.62 18.19 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.559 1.506 . . . . 0.0 112.193 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -93.16 -40.68 10.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.323 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.76 -43.45 65.76 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.308 -0.87 . . . . 0.0 109.014 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.35 10.37 12.86 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.7 t -51.84 -47.68 64.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -46.13 -58.07 3.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 109.726 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.463 ' N ' HD23 ' A' ' 83' ' ' LEU . 3.8 mt -45.24 -44.29 11.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 108.827 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.9 p -55.18 -30.05 59.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.467 -0.77 . . . . 0.0 108.978 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 89' ' ' HIS . 1.6 m-20 -82.08 -49.65 9.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.837 . . . . 0.0 109.263 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 tp -51.03 -30.02 14.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 109.25 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -92.89 -21.79 19.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -0.843 . . . . 0.0 110.371 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.72 20.82 5.52 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.113 -0.992 . . . . 0.0 110.322 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.666 ' N ' ' O ' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -140.51 -78.27 0.3 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 109.78 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 92' ' ' ARG . 16.9 mttp -67.36 -119.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 109.816 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.3 mp -44.58 -19.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.82 . . . . 0.0 109.774 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 90' ' ' LYS . 49.7 ttt180 57.21 45.95 19.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.302 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.431 ' H ' HG23 ' A' ' 93' ' ' VAL . 4.7 t -48.43 133.15 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.647 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -91.58 126.06 55.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.273 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -43.84 -10.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.374 2.05 . . . . 0.0 112.377 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 1.265 HG11 ' CG ' ' D' ' 99' ' ' ASP . 25.1 t -56.39 -31.79 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.088 -1.008 . . . . 0.0 109.648 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -79.57 -38.14 34.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 0.0 109.662 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -46.06 -30.29 1.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.27 -28.02 69.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.89 . . . . 0.0 109.646 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 11.4 mt -84.29 -34.3 23.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.803 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 tp -64.14 -61.15 2.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.98 . . . . 0.0 109.741 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 t -47.76 -34.76 8.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.759 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 107' ' ' VAL . 12.3 t-80 -80.84 -26.66 36.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.826 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 97.7 m -76.35 -38.06 56.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.49 -52.04 67.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.118 -0.989 . . . . 0.0 109.716 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.7 mt -60.19 -32.35 71.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 34.4 t -63.65 -59.62 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 0.0 109.19 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.7 p -54.76 -53.55 53.68 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.244 -0.91 . . . . 0.0 109.276 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 114' ' ' PRO . 7.7 mt -45.41 -26.71 0.58 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.266 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -68.45 -39.26 81.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 0.0 109.979 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.659 ' HB2' ' CE2' ' B' ' 122' ' ' PHE . . . -78.99 -3.54 45.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 109.931 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -134.51 -80.09 0.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 109.7 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -118.4 82.53 19.16 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.438 ' N ' ' O ' ' A' ' 109' ' ' LEU . 51.3 Cg_exo -49.61 -169.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.454 2.102 . . . . 0.0 112.432 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.807 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -52.85 -55.72 21.08 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.656 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 46.3 mt-10 123.24 -5.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 7.6 t80 73.24 30.97 1.48 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.732 -0.605 . . . . 0.0 111.116 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.8 p -104.54 126.25 31.89 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 108.38 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.665 ' HB3' ' HB3' ' B' ' 51' ' ' PRO . 54.2 Cg_exo -49.73 22.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.353 2.036 . . . . 0.0 112.897 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -153.3 -32.94 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.83 -1.169 . . . . 0.0 110.645 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.807 HG21 ' O ' ' A' ' 115' ' ' ALA . 9.6 p -52.8 -49.5 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.982 -1.074 . . . . 0.0 110.154 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.643 ' N ' HG13 ' A' ' 121' ' ' VAL . 4.7 t-160 -59.47 -37.46 78.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 109.218 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.08 -19.41 34.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -0.839 . . . . 0.0 109.487 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 120' ' ' ALA . 23.3 p -64.18 -62.1 1.83 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 110.848 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.488 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.6 mt -68.46 -19.76 64.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.982 -1.074 . . . . 0.0 109.757 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.66 -46.62 12.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 109.36 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -80.44 -46.23 16.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -0.964 . . . . 0.0 109.278 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.514 ' CD2' HG21 ' A' ' 10' ' ' VAL . 26.8 t80 -49.93 -21.79 1.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.93 . . . . 0.0 108.969 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 129' ' ' LEU . 15.1 mt -73.96 -21.76 59.9 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -57.88 -31.83 67.1 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 90.0 p -79.83 -33.61 40.11 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.378 -0.826 . . . . 0.0 108.954 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.24 -35.52 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 108.636 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 47.4 t -72.23 -28.62 63.28 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.436 -0.79 . . . . 0.0 109.172 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 32.2 m -66.51 -34.34 77.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.171 -0.956 . . . . 0.0 109.082 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 97.5 t -77.38 -40.43 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.29 -0.881 . . . . 0.0 108.998 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.79 -27.28 68.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 108.955 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.3 m -86.24 -26.47 25.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 109.455 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.45 -179.93 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.525 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -127.95 155.81 43.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 109.356 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -54.51 152.71 11.65 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 108.914 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.07 -18.57 44.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.463 2.109 . . . . 0.0 112.06 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -87.13 -37.86 16.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.628 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -84.0 -23.22 31.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 109.891 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -84.12 -55.12 4.37 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.148 -0.97 . . . . 0.0 109.095 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.8 t -48.03 -23.52 0.83 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.125 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.15 -59.68 2.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.966 -1.084 . . . . 0.0 109.894 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.03 -24.44 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -74.79 -51.93 12.8 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.405 0.622 . . . . 0.0 109.649 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.36 -24.88 47.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.571 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.663 ' O ' HG23 ' B' ' 18' ' ' VAL . 1.2 mt -59.65 -28.26 67.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.344 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.83 -17.06 62.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.415 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.28 -63.77 3.13 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.596 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.5 ' HD3' HD23 ' B' ' 14' ' ' LEU . 0.0 OUTLIER -70.68 -11.72 61.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.033 -1.274 . . . . 0.0 110.809 -178.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.663 HG23 ' O ' ' B' ' 14' ' ' LEU . 12.9 t -70.73 121.35 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.833 -1.167 . . . . 0.0 109.348 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' B' ' 21' ' ' ASP . 4.1 m-20 -77.15 73.26 3.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.247 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.513 HG12 ' O ' ' B' ' 20' ' ' VAL . 75.5 t -52.89 -6.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.64 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 9.8 p30 -67.88 -20.73 65.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.914 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 9.2 pt-20 -150.11 -32.49 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.897 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.16 -28.27 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.667 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.1 -41.26 99.81 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.11 -55.04 17.83 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.422 ' O ' ' NH1' ' B' ' 30' ' ' ARG . 58.2 mt-10 -49.87 -26.99 4.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -1.141 . . . . 0.0 109.367 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.24 -32.62 22.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.06 -36.41 21.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.6 -40.58 90.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' B' ' 26' ' ' GLU . 0.0 OUTLIER -62.85 -21.88 66.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -1.17 . . . . 0.0 109.426 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.98 -28.38 65.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.965 . . . . 0.0 109.539 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' B' ' 36' ' ' PRO . 27.7 mt -81.24 -53.89 5.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.995 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.494 HG13 ' N ' ' B' ' 34' ' ' VAL . 6.2 p -56.18 -43.21 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.0 109.607 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.494 ' N ' HG13 ' B' ' 33' ' ' VAL . 57.8 t -79.53 -22.92 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 109.364 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -153.04 75.52 6.69 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.327 -0.858 . . . . 0.0 109.127 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.47 ' N ' ' O ' ' B' ' 32' ' ' LEU . 92.1 Cg_endo -83.69 3.79 7.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.971 2.448 . . . . 0.0 112.562 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.407 ' NE1' HG23 ' B' ' 38' ' ' THR . 3.1 p-90 -57.42 -19.82 26.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 109.547 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.407 HG23 ' NE1' ' B' ' 37' ' ' TRP . 6.2 p -79.96 5.44 13.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -48.28 -22.74 0.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.912 . . . . 0.0 109.531 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -62.36 -38.81 90.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.39 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' PHE . . . . . 0.433 ' O ' ' CG ' ' B' ' 42' ' ' PHE . 80.7 m-85 -88.01 27.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.433 ' CG ' ' O ' ' B' ' 41' ' ' PHE . 75.2 m-85 -154.82 32.93 0.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.9 . . . . 0.0 109.518 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.33 -27.84 52.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 67.6 m -76.28 -29.7 57.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.526 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' B' ' 47' ' ' ASP . 3.8 m-85 -48.68 -22.71 0.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.319 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' B' ' 47' ' ' ASP . . . 68.04 -53.16 0.4 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 45' ' ' PHE . 51.2 m-20 -60.35 -151.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -1.144 . . . . 0.0 109.552 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt 58.82 17.91 5.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.492 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 30.2 p -69.45 -28.34 66.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.36 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' THR . . . . . 0.523 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.4 p -145.24 151.31 47.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 109.021 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.665 ' HB3' ' HB3' ' A' ' 119' ' ' PRO . 81.0 Cg_exo -38.27 -32.51 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.619 2.213 . . . . 0.0 112.574 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.19 -24.14 40.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.721 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -68.89 -19.57 64.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.893 . . . . 0.0 109.727 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.45 ' O ' HG11 ' B' ' 60' ' ' VAL . 18.6 t -65.24 -64.03 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 109.571 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 25.5 mtm -95.38 29.33 2.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.12 -58.58 0.66 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -69.4 150.26 97.1 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.293 -1.122 . . . . 0.0 109.478 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' B' ' 60' ' ' VAL . 69.2 Cg_endo -75.05 -56.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.609 2.206 . . . . 0.0 112.395 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -18.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 109.743 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' B' ' 58' ' ' PRO . 91.4 t -81.66 -44.96 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.426 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -79.01 -27.1 43.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.16 -20.93 63.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 109.64 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -72.3 -23.94 61.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -0.99 . . . . 0.0 109.406 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.04 -25.99 74.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -55.97 -42.82 76.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 109.063 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -64.34 -41.49 96.74 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 109.557 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 29.0 t -65.27 -62.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.296 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.66 HD23 ' O ' ' B' ' 68' ' ' LEU . 2.4 tt -54.32 -40.2 67.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.194 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.52 -53.85 38.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.1 -44.38 42.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.097 . . . . 0.0 109.632 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -63.31 -45.89 89.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 98.6 p -61.07 -34.83 75.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 0.0 109.563 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -53.98 -39.63 66.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -0.961 . . . . 0.0 109.431 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.24 -60.14 8.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.589 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -53.73 -30.07 42.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.173 -1.193 . . . . 0.0 109.168 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.21 4.32 46.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.32 -0.863 . . . . 0.0 109.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -170.22 67.48 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 109.675 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.96 12.78 2.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.237 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.0 -29.75 68.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 24.9 t-20 -164.02 111.32 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 109.56 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.576 HD12 ' N ' ' B' ' 81' ' ' LEU . 7.5 mp -80.29 -56.07 4.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.524 ' HZ1' ' CE1' ' B' ' 143' ' ' HIS . 77.0 tttt -62.31 -24.12 67.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.608 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -75.07 -51.11 7.86 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.7 t -73.41 -46.29 49.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -1.133 . . . . 0.0 109.475 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.542 ' N ' ' CG2' ' B' ' 84' ' ' THR . 54.4 m-85 -84.29 26.13 0.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.445 -0.785 . . . . 0.0 109.575 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.11 -28.05 67.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.469 ' O ' ' N ' ' B' ' 91' ' ' LEU . 82.0 p -77.22 -58.14 3.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.83 . . . . 0.0 109.607 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.24 -41.6 18.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -68.71 -37.62 79.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.907 . . . . 0.0 109.58 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -82.67 -28.14 30.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 109.499 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' B' ' 87' ' ' THR . 10.3 tt -75.5 -69.05 0.51 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.232 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' B' ' 97' ' ' HIS . 70.8 m80 -50.1 -23.85 2.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.183 -0.948 . . . . 0.0 109.735 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 38.8 t -83.92 -56.23 3.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.92 . . . . 0.0 111.066 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.538 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 73.4 m-20 -86.17 -24.49 26.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.967 -1.083 . . . . 0.0 111.856 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 95' ' ' LYS . . . . . 0.469 ' CD ' ' N ' ' B' ' 95' ' ' LYS . 10.7 mptt -94.25 -51.73 4.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.678 -1.264 . . . . 0.0 110.676 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -27.69 13.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.049 -1.032 . . . . 0.0 109.934 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 1.58 ' CD2' HG21 ' C' ' 41' ' ' THR . 21.4 m-70 57.71 53.71 6.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 109.716 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.435 HG12 HD22 ' B' ' 102' ' ' ASN . 11.2 t -73.37 124.29 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.151 -0.968 . . . . 0.0 109.295 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 99' ' ' ASP . . . . . 1.291 ' OD2' HG11 ' C' ' 96' ' ' VAL . 68.7 m-20 -47.99 149.27 2.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.389 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.32 62.93 5.31 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.554 2.169 . . . . 0.0 112.046 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -172.09 73.92 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.434 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.435 HD22 HG12 ' B' ' 98' ' ' VAL . 2.3 p30 -178.95 -27.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.86 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 0.1 OUTLIER -56.28 -20.53 19.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.002 -1.061 . . . . 0.0 109.689 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -86.15 -41.13 14.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.428 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 tp -48.97 -40.18 29.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.319 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.28 -47.59 64.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.272 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.46 -20.09 54.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -81.72 -55.74 4.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -1.164 . . . . 0.0 110.164 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 p -61.92 -24.15 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.078 -1.013 . . . . 0.0 109.682 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.474 HD23 ' O ' ' B' ' 110' ' ' LEU . 1.6 tt -61.57 -58.06 9.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.401 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' B' ' 130' ' ' TYR . 69.5 t -46.64 -26.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 109.772 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.49 -32.66 74.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 109.63 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.48 -31.57 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.965 . . . . 0.0 109.497 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.14 -29.4 60.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.158 -0.964 . . . . 0.0 109.497 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.424 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -74.97 -32.23 61.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.572 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.479 ' HD1' ' C ' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.85 -56.98 3.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.224 -0.923 . . . . 0.0 109.404 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' B' ' 118' ' ' PHE . 13.7 m170 -56.83 -17.78 10.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.621 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.408 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 72.1 m-85 -154.48 60.59 0.69 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -70.97 -26.24 74.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 120' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' B' ' 120' ' ' LYS . 11.8 mptt -70.0 9.86 0.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -1.168 . . . . 0.0 109.289 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' B' ' 119' ' ' GLY . 68.7 mm-40 -136.64 2.53 2.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.828 . . . . 0.0 109.387 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.659 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -72.91 39.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.502 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.572 ' C ' HE22 ' B' ' 127' ' ' GLN . 0.8 OUTLIER -52.46 149.08 11.09 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 109.331 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.3 Cg_exo -47.62 -52.38 8.14 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.46 2.107 . . . . 0.0 113.246 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 35.8 Cg_endo -65.35 -3.88 8.35 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.087 1.858 . . . . 0.0 112.708 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.454 HG23 ' OG1' ' B' ' 123' ' ' THR . 56.8 t -96.81 -22.09 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.044 -1.035 . . . . 0.0 109.724 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 127' ' ' GLN . . . . . 0.572 HE22 ' C ' ' B' ' 123' ' ' THR . 1.8 mp0 -83.27 -59.95 2.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.029 -1.044 . . . . 0.0 109.715 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -54.03 -35.02 61.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.991 . . . . 0.0 109.408 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.89 26.48 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.69 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.414 ' CE1' HG22 ' B' ' 111' ' ' VAL . 32.7 t80 -118.82 -61.47 1.64 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.304 -0.873 . . . . 0.0 109.654 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 93.1 mt-30 -52.81 -23.42 6.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.636 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -71.58 -39.02 70.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.112 -0.992 . . . . 0.0 109.731 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.71 -55.85 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 109.799 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' B' ' 137' ' ' VAL . 11.4 m -69.78 -28.57 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 110.041 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -47.57 -25.89 1.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 109.354 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.79 -24.6 57.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' B' ' 134' ' ' VAL . 74.8 t -79.42 -37.6 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -1.1 . . . . 0.0 109.345 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.81 79.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.433 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -72.1 -44.03 63.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.36 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.3 -40.82 49.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 109.341 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 36.5 mt -81.94 12.79 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.338 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 142' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' B' ' 103' ' ' PHE . . . -139.78 1.63 1.91 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 109.81 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 143' ' ' HIS . . . . . 0.524 ' CE1' ' HZ1' ' B' ' 82' ' ' LYS . 56.8 t-80 -79.37 -34.05 42.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.51 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 5.0 tptp -67.41 -25.44 65.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.409 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -64.03 -14.14 52.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.526 ' CG ' ' OXT' ' B' ' 146' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.503 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.417 ' CD1' ' CD2' ' C' ' 128' ' ' PHE . 48.9 mt -125.35 -162.29 1.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.824 . . . . 0.0 109.435 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.502 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 177.1 -48.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.954 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' C' ' 3' ' ' SER . 67.4 Cg_exo -49.21 174.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.381 2.054 . . . . 0.0 112.477 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -56.92 -16.54 7.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.639 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' C' ' 5' ' ' ALA . 14.9 t70 -40.0 -31.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 109.525 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' C' ' 5' ' ' ALA . 9.3 mtmp? -73.41 -55.91 5.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.211 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 44.6 m -47.51 -28.63 2.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.381 -0.824 . . . . 0.0 109.211 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -78.3 -38.6 42.09 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.51 HG21 ' CD2' ' C' ' 128' ' ' PHE . 40.7 t -70.86 -48.83 54.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -51.63 -44.62 63.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.404 -0.81 . . . . 0.0 108.853 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.86 -58.58 7.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.447 -0.783 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.481 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -55.55 -31.93 62.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.309 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.42 -17.37 58.18 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.155 -0.966 . . . . 0.0 109.004 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.33 -38.84 44.84 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -84.26 -40.9 17.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -1.067 . . . . 0.0 109.355 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.566 ' O ' ' C ' ' C' ' 18' ' ' GLY . 93.5 t -66.71 -46.0 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.821 . . . . 0.0 109.687 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' C' ' 19' ' ' ALA . . . -25.08 137.73 0.01 OUTLIER Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 19' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' C' ' 18' ' ' GLY . . . 74.45 -29.39 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.517 -0.99 . . . . 0.0 109.237 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.513 ' H ' ' C ' ' C' ' 18' ' ' GLY . 37.6 m-70 -110.56 16.82 21.27 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.599 ' HB1' ' HB1' ' C' ' 63' ' ' ALA . . . -82.32 -60.86 2.06 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.957 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.53 -14.7 0.39 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.0 mt-10 -85.52 -56.4 3.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -1.148 . . . . 0.0 109.728 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.4 m-30 -60.71 -35.2 75.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.445 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.39 -22.9 73.31 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.79 -47.09 14.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -1.165 . . . . 0.0 109.598 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -63.66 -19.77 65.16 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.298 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.64 63.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 109.509 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.42 HD11 ' ND1' ' C' ' 58' ' ' HIS . 9.0 mt -70.39 -53.7 15.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.13 -29.37 69.73 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 109.226 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.37 -30.4 67.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.259 -0.901 . . . . 0.0 109.197 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 47.8 ttp -72.81 -52.72 13.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -0.838 . . . . 0.0 109.191 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.36 -31.96 10.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.888 . . . . 0.0 109.293 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.5 mt -78.46 -39.77 37.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.3 -0.875 . . . . 0.0 109.421 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.521 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 15.0 m -51.75 -29.55 19.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' C' ' 35' ' ' SER . 57.3 m-85 -160.89 130.34 3.25 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.273 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -76.24 -19.92 14.93 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.375 2.05 . . . . 0.0 112.203 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.68 ' O ' HG22 ' C' ' 41' ' ' THR . 22.4 p -46.53 -46.01 18.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.705 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -45.46 -22.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 109.868 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' C' ' 38' ' ' THR . 26.6 ttmt -51.83 -42.42 62.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.137 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 41' ' ' THR . . . . . 1.58 HG21 ' CD2' ' B' ' 97' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 109.789 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.511 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 4.1 p80 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.042 0.449 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -157.77 28.38 0.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.117 -0.99 . . . . 0.0 110.077 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' C' ' 49' ' ' SER . 73.9 m-20 43.61 89.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.548 -0.72 . . . . 0.0 110.376 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 1.002 ' H ' HD13 ' C' ' 48' ' ' LEU . 0.0 OUTLIER -60.69 1.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 0.0 109.26 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.517 ' H ' ' C ' ' C' ' 47' ' ' ASP . 5.0 m -84.83 157.03 21.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.955 . . . . 0.0 109.734 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 50' ' ' HIS . . . . . 0.612 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 40.4 t-80 -76.45 170.56 16.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.446 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 51' ' ' GLY . . . . . 0.612 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 76.26 -22.08 2.13 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 4.7 p -55.85 -18.68 9.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -1.105 . . . . 0.0 109.368 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 72.82 -23.3 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 109.669 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' C' ' 52' ' ' SER . 24.1 mt-30 -84.76 -17.96 36.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.568 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.519 HG23 ' OG ' ' C' ' 52' ' ' SER . 44.2 t -84.02 -32.62 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 109.639 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' C' ' 56' ' ' LYS . 13.7 ptpt -72.98 -29.39 63.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.166 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.82 -45.0 66.48 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.496 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.2 t-80 -60.66 -30.74 70.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.245 . . . . 0.0 110.071 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.87 -31.29 79.22 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 59.2 mttp -68.93 -23.02 64.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -1.106 . . . . 0.0 110.213 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 61' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' C' ' 65' ' ' ALA . 0.0 OUTLIER -69.41 -58.17 4.33 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.982 -1.074 . . . . 0.0 108.755 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 13.3 t -55.59 -41.47 64.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.605 -0.684 . . . . 0.0 109.578 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.599 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -75.6 -43.81 46.24 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.102 -0.999 . . . . 0.0 109.195 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 64' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 35.0 t0 -68.99 -33.84 74.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 108.563 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 65' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' C' ' 61' ' ' LYS . . . -66.94 -49.01 66.83 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -53.05 -47.08 68.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.1 m -57.06 -56.59 19.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.9 . . . . 0.0 108.701 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.535 ' O ' ' CD2' ' C' ' 72' ' ' HIS . 28.5 t30 -58.82 -21.1 55.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 108.57 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.09 -47.42 10.2 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.36 -22.72 27.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.95 -33.32 75.31 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' C' ' 74' ' ' ASP . 5.6 m-70 -115.96 -60.47 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.534 -0.729 . . . . 0.0 109.527 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.556 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.2 p 45.02 12.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.744 0.783 . . . . 0.0 109.583 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' C' ' 72' ' ' HIS . 28.9 m-20 -138.33 11.18 2.78 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -177.36 27.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.696 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 3.0 ptt? -78.54 -23.91 0.42 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.837 . . . . 0.0 111.642 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' C' ' 76' ' ' MET . 53.1 Cg_exo -54.4 -19.72 18.18 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.582 1.521 . . . . 0.0 112.207 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -93.01 -40.75 10.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.178 -0.951 . . . . 0.0 109.435 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.82 -43.45 65.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.261 -0.899 . . . . 0.0 108.948 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -85.29 10.32 12.88 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 7.6 t -51.87 -47.65 64.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.324 -0.86 . . . . 0.0 109.683 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -46.09 -58.15 3.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 109.707 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.46 ' N ' HD23 ' C' ' 83' ' ' LEU . 3.8 mt -45.18 -44.33 10.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 0.0 108.785 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.9 p -55.19 -30.03 59.1 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.68 ' O ' ' N ' ' C' ' 89' ' ' HIS . 1.6 m-20 -82.15 -49.53 10.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.198 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.19 -29.95 15.53 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.095 -1.003 . . . . 0.0 109.173 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -92.82 -21.92 19.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.833 . . . . 0.0 110.336 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.72 20.87 5.52 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.076 -1.015 . . . . 0.0 110.398 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 89' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' C' ' 85' ' ' ASP . 0.7 OUTLIER -140.57 -78.26 0.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.078 -1.013 . . . . 0.0 109.806 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' C' ' 92' ' ' ARG . 16.9 mttp -67.38 -119.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.843 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.585 HD12 ' N ' ' C' ' 91' ' ' LEU . 10.3 mp -44.5 -19.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 109.802 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 92' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' C' ' 90' ' ' LYS . 49.7 ttt180 57.28 45.92 19.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.928 . . . . 0.0 109.304 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.416 HG23 ' H ' ' C' ' 93' ' ' VAL . 4.7 t -48.48 133.21 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 109.599 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' C' ' 96' ' ' VAL . 0.6 OUTLIER -91.55 126.03 55.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.281 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.81 -11.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.268 1.979 . . . . 0.0 112.396 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 1.291 HG11 ' OD2' ' B' ' 99' ' ' ASP . 24.8 t -56.22 -31.89 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 109.693 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -79.44 -38.16 35.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.662 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -46.12 -30.25 1.85 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 109.62 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.3 -27.97 69.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.942 . . . . 0.0 109.637 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 11.2 mt -84.22 -34.34 23.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 109.84 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tp -64.22 -61.03 2.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 109.806 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 24.4 t -47.7 -34.73 8.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 109.836 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 103' ' ' HIS . . . . . 0.459 ' O ' HG23 ' C' ' 107' ' ' VAL . 12.3 t-80 -80.96 -26.59 36.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.735 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 97.9 m -76.35 -38.1 56.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 109.953 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -52.19 66.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 109.681 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' C' ' 106' ' ' LEU . 36.8 mt -60.14 -32.28 70.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.947 . . . . 0.0 110.006 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 107' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 34.3 t -63.72 -59.56 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 109.264 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 41.3 p -54.77 -53.59 53.1 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.229 -0.92 . . . . 0.0 109.224 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' C' ' 114' ' ' PRO . 7.7 mt -45.29 -26.74 0.55 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.459 -0.775 . . . . 0.0 109.299 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -68.44 -39.26 81.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.304 -0.872 . . . . 0.0 110.039 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 111' ' ' ALA . . . . . 0.657 ' HB2' ' CE2' ' D' ' 122' ' ' PHE . . . -78.94 -3.6 45.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -134.44 -80.06 0.45 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.232 -0.917 . . . . 0.0 109.713 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -118.41 82.6 19.31 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 114' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' C' ' 113' ' ' LEU . 51.3 Cg_exo -49.78 -169.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.402 2.068 . . . . 0.0 112.402 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.822 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -52.85 -55.71 21.1 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.662 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 46.4 mt-10 123.24 -5.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.414 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 7.6 t80 73.21 30.97 1.49 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.803 -0.561 . . . . 0.0 111.033 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.75 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.8 p -104.48 126.26 31.9 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.07 -1.019 . . . . 0.0 108.439 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 119' ' ' PRO . . . . . 0.657 ' HB3' ' HB3' ' D' ' 51' ' ' PRO . 53.9 Cg_exo -49.74 22.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.407 2.071 . . . . 0.0 112.901 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.75 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -153.37 -32.98 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.777 -1.202 . . . . 0.0 110.553 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.822 HG21 ' O ' ' C' ' 115' ' ' ALA . 9.7 p -52.76 -49.47 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.057 -1.027 . . . . 0.0 110.18 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.645 ' N ' HG13 ' C' ' 121' ' ' VAL . 4.7 t-160 -59.48 -37.5 78.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 0.0 109.176 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.12 -19.43 34.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.411 -0.806 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.523 ' N ' ' O ' ' C' ' 120' ' ' ALA . 23.1 p -64.12 -62.12 1.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 110.844 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.488 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.6 mt -68.49 -19.72 64.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.016 -1.053 . . . . 0.0 109.761 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.67 -46.64 12.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.99 -1.069 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.473 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -80.38 -46.37 16.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.155 -0.966 . . . . 0.0 109.277 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.51 ' CD2' HG21 ' C' ' 10' ' ' VAL . 26.9 t80 -49.88 -21.68 1.24 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.016 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' C' ' 129' ' ' LEU . 15.3 mt -73.98 -21.82 59.85 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -57.93 -31.76 67.13 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 90.0 p -79.86 -33.65 39.91 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.341 -0.85 . . . . 0.0 108.925 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 42.6 t -82.27 -35.51 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 108.578 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 47.5 t -72.18 -28.61 63.33 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.408 -0.808 . . . . 0.0 109.237 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 32.3 m -66.55 -34.31 77.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.954 . . . . 0.0 109.108 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.32 -40.45 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.316 -0.865 . . . . 0.0 109.08 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.7 -27.42 68.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 108.945 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 61.7 m -86.2 -26.46 25.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.923 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.51 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -127.92 155.78 43.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.436 -0.79 . . . . 0.0 109.306 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -54.48 152.76 11.45 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 108.878 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.01 -18.63 44.1 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.477 2.118 . . . . 0.0 112.068 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -87.11 -37.92 16.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.914 . . . . 0.0 109.622 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -84.1 -23.15 30.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.836 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -84.12 -55.19 4.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.229 -0.919 . . . . 0.0 109.102 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -48.04 -23.49 0.83 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.09 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.16 -59.64 2.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.891 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.01 -24.47 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -74.81 -51.9 12.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.698 -0.626 . . . . 0.0 109.65 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.31 -24.92 46.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.662 ' O ' HG23 ' D' ' 18' ' ' VAL . 1.2 mt -59.64 -28.28 67.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.78 -17.04 62.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -0.952 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.25 -63.73 3.15 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.585 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.503 ' HD3' HD23 ' D' ' 14' ' ' LEU . 0.0 OUTLIER -70.77 -11.74 61.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.036 -1.273 . . . . 0.0 110.778 -178.781 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.662 HG23 ' O ' ' D' ' 14' ' ' LEU . 12.9 t -70.66 121.27 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.856 -1.152 . . . . 0.0 109.343 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' D' ' 21' ' ' ASP . 4.1 m-20 -77.12 73.4 3.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.226 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.525 ' O ' HG12 ' D' ' 20' ' ' VAL . 76.1 t -53.05 -6.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.556 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' D' ' 19' ' ' ASN . 9.8 p30 -67.92 -20.69 65.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.936 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.505 ' N ' ' OD1' ' D' ' 21' ' ' ASP . 9.3 pt-20 -150.27 -32.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.067 -1.02 . . . . 0.0 109.884 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.22 -28.36 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 109.626 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.03 -41.41 99.86 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.06 -55.07 17.89 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 26' ' ' GLU . . . . . 0.416 ' O ' ' NH1' ' D' ' 30' ' ' ARG . 58.3 mt-10 -49.79 -27.03 4.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -1.155 . . . . 0.0 109.432 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.31 -32.55 22.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.06 -36.35 21.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.63 -40.66 90.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 30' ' ' ARG . . . . . 0.416 ' NH1' ' O ' ' D' ' 26' ' ' GLU . 0.0 OUTLIER -62.93 -21.7 66.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -1.12 . . . . 0.0 109.467 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tt -70.07 -28.32 65.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.152 -0.968 . . . . 0.0 109.523 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 32' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' D' ' 36' ' ' PRO . 27.7 mt -81.32 -53.86 5.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.925 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 33' ' ' VAL . . . . . 0.505 HG13 ' N ' ' D' ' 34' ' ' VAL . 6.2 p -56.21 -43.18 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.003 . . . . 0.0 109.628 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.505 ' N ' HG13 ' D' ' 33' ' ' VAL . 57.8 t -79.56 -22.83 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -153.11 75.5 6.65 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.848 . . . . 0.0 109.126 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' D' ' 32' ' ' LEU . 92.6 Cg_endo -83.6 3.69 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.935 2.423 . . . . 0.0 112.553 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -57.39 -19.87 26.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.485 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 6.0 p -80.0 5.41 14.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 109.414 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -48.17 -22.76 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.593 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -62.34 -38.84 91.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.366 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' D' ' 42' ' ' PHE . 80.2 m-85 -87.95 27.87 1.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.429 ' CG ' ' O ' ' D' ' 41' ' ' PHE . 75.1 m-85 -154.8 32.85 0.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.524 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.37 -27.7 52.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 109.538 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 67.5 m -76.34 -29.67 57.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 109.476 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' D' ' 47' ' ' ASP . 3.8 m-85 -48.7 -22.71 0.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' D' ' 47' ' ' ASP . . . 68.02 -53.11 0.39 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' D' ' 45' ' ' PHE . 51.6 m-20 -60.38 -151.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -1.123 . . . . 0.0 109.485 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt 58.73 17.97 5.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 30.4 p -69.46 -28.38 66.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.923 . . . . 0.0 109.309 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' THR . . . . . 0.526 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.5 p -145.32 151.24 47.21 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.071 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 51' ' ' PRO . . . . . 0.657 ' HB3' ' HB3' ' C' ' 119' ' ' PRO . 80.8 Cg_exo -38.12 -32.6 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.598 2.199 . . . . 0.0 112.599 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.19 -24.04 40.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.737 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -69.03 -19.45 64.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.671 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 54' ' ' VAL . . . . . 0.437 ' O ' HG11 ' D' ' 60' ' ' VAL . 18.4 t -65.31 -63.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.618 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 25.5 mtm -95.41 29.43 2.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.12 -58.58 0.66 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -69.36 150.25 97.15 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.224 -1.162 . . . . 0.0 109.608 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.463 ' O ' ' N ' ' D' ' 60' ' ' VAL . 68.4 Cg_endo -75.01 -56.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.639 2.226 . . . . 0.0 112.331 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -18.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 60' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' D' ' 58' ' ' PRO . 91.2 t -81.66 -44.98 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.421 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -79.04 -27.12 43.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.9 63.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.75 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -72.27 -24.02 61.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.408 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.01 -25.98 74.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.99 -42.86 77.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.207 -1.172 . . . . 0.0 109.044 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -64.34 -41.46 96.76 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.589 -0.694 . . . . 0.0 109.561 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 28.7 t -65.19 -62.93 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.288 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.676 ' O ' HD23 ' D' ' 68' ' ' LEU . 2.4 tt -54.35 -40.15 67.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.205 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.55 -53.87 38.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.16 -44.38 42.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -1.122 . . . . 0.0 109.54 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.33 -45.82 89.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 98.4 p -61.08 -34.89 75.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.459 -0.776 . . . . 0.0 109.526 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -54.02 -39.66 66.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.14 -60.16 8.4 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.605 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.9 mp -53.75 -30.06 42.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.324 -1.103 . . . . 0.0 109.193 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.13 4.31 45.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -170.35 67.45 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.669 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt -78.9 12.73 2.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.246 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.0 -29.76 68.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 80' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 24.8 t-20 -164.0 111.29 1.12 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.636 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 81' ' ' LEU . . . . . 0.563 HD12 ' N ' ' D' ' 81' ' ' LEU . 7.5 mp -80.26 -56.11 4.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 82' ' ' LYS . . . . . 0.415 ' HZ1' ' CE1' ' D' ' 143' ' ' HIS . 77.2 tttt -62.42 -24.06 67.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 83' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -75.04 -51.06 7.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.7 t -73.43 -46.31 49.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 0.0 109.498 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.538 ' N ' ' CG2' ' D' ' 84' ' ' THR . 54.5 m-85 -84.28 26.11 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.583 -0.698 . . . . 0.0 109.624 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.08 -28.08 67.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 0.0 109.422 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 87' ' ' THR . . . . . 0.464 ' O ' ' N ' ' D' ' 91' ' ' LEU . 82.6 p -77.13 -58.17 3.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.646 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.26 -41.57 18.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -68.67 -37.67 79.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.527 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -82.73 -28.15 30.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 0.0 109.378 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' D' ' 87' ' ' THR . 10.3 tt -75.58 -68.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.234 -0.917 . . . . 0.0 109.238 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.583 ' O ' ' N ' ' D' ' 97' ' ' HIS . 71.0 m80 -50.08 -23.87 2.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.757 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 38.8 t -83.94 -56.21 3.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 111.03 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.538 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 73.3 m-20 -86.21 -24.6 26.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.074 -1.016 . . . . 0.0 111.749 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 95' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' D' ' 95' ' ' LYS . 10.7 mptt -94.21 -51.63 4.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.638 -1.289 . . . . 0.0 110.742 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.96 -27.73 13.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 0.0 109.907 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 1.615 ' CD2' HG21 ' A' ' 41' ' ' THR . 21.4 m-70 57.77 53.67 6.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 98' ' ' VAL . . . . . 0.435 HG12 HD22 ' D' ' 102' ' ' ASN . 11.2 t -73.33 124.26 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.134 -0.979 . . . . 0.0 109.261 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 99' ' ' ASP . . . . . 1.265 ' CG ' HG11 ' A' ' 96' ' ' VAL . 68.7 m-20 -47.93 149.29 2.44 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.123 -0.986 . . . . 0.0 109.426 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.3 62.91 5.29 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.532 2.155 . . . . 0.0 112.082 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -172.05 73.84 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 102' ' ' ASN . . . . . 0.435 HD22 HG12 ' D' ' 98' ' ' VAL . 2.3 p30 -178.85 -27.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.867 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 103' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 0.1 OUTLIER -56.38 -20.37 19.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.094 -1.004 . . . . 0.0 109.633 -179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -86.28 -41.04 14.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.056 -1.028 . . . . 0.0 109.36 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 tp -48.99 -40.14 29.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.386 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.35 -47.56 63.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.295 -0.878 . . . . 0.0 109.315 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.39 -19.98 54.28 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -81.79 -55.82 4.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -1.196 . . . . 0.0 110.01 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.96 -24.09 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.032 -1.042 . . . . 0.0 109.682 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 110' ' ' LEU . . . . . 0.482 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.6 tt -61.62 -57.97 9.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 111' ' ' VAL . . . . . 0.408 HG22 ' CE1' ' D' ' 130' ' ' TYR . 70.0 t -46.67 -26.06 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.772 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.45 -32.65 74.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.112 -0.993 . . . . 0.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.51 -31.56 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.534 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 12.4 mt -75.04 -29.5 60.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.504 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.42 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -74.93 -32.29 61.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.937 . . . . 0.0 109.483 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.476 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.89 -56.99 3.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 0.0 109.359 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 117' ' ' HIS . . . . . 0.409 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 13.7 m170 -56.81 -17.73 10.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 109.569 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.409 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 72.2 m-85 -154.54 60.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 109.64 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -71.04 -26.22 74.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 120' ' ' LYS . . . . . 0.494 ' CD ' ' N ' ' D' ' 120' ' ' LYS . 11.9 mptt -70.03 9.95 0.49 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -1.102 . . . . 0.0 109.343 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' D' ' 119' ' ' GLY . 68.8 mm-40 -136.71 2.54 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.39 -0.819 . . . . 0.0 109.45 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.657 ' CE2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -72.94 39.05 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.56 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.563 ' C ' HE22 ' D' ' 127' ' ' GLN . 0.8 OUTLIER -52.42 149.06 10.98 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.289 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.507 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -47.72 -52.38 8.19 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.449 2.099 . . . . 0.0 113.229 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 36.0 Cg_endo -65.27 -3.92 8.31 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.11 1.873 . . . . 0.0 112.7 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.462 HG23 ' OG1' ' D' ' 123' ' ' THR . 55.7 t -96.85 -22.04 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.05 -1.032 . . . . 0.0 109.699 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 127' ' ' GLN . . . . . 0.563 HE22 ' C ' ' D' ' 123' ' ' THR . 1.8 mp0 -83.27 -60.0 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 0.0 109.687 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -53.93 -35.11 61.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.9 26.46 0.99 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.679 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.408 ' CE1' HG22 ' D' ' 111' ' ' VAL . 32.9 t80 -118.8 -61.37 1.66 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.366 -0.834 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 93.0 mt-30 -52.83 -23.46 7.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.625 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -71.49 -39.2 71.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.747 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 74.6 t -62.71 -55.77 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.088 -1.008 . . . . 0.0 109.816 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' D' ' 137' ' ' VAL . 11.4 m -69.75 -28.56 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -0.853 . . . . 0.0 110.036 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -47.55 -25.96 1.29 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.99 -1.069 . . . . 0.0 109.383 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.78 -24.52 58.07 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 137' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' D' ' 134' ' ' VAL . 75.4 t -79.36 -37.65 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -1.126 . . . . 0.0 109.343 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.78 79.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -72.05 -44.08 63.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.417 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.24 -40.94 49.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 37.1 mt -81.95 12.9 3.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.272 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 142' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' D' ' 103' ' ' PHE . . . -139.91 1.63 1.88 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.284 -0.885 . . . . 0.0 109.711 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 143' ' ' HIS . . . . . 0.415 ' CE1' ' HZ1' ' D' ' 82' ' ' LYS . 57.1 t-80 -79.32 -34.09 42.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.512 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 5.0 tptp -67.42 -25.5 65.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.381 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -63.99 -14.16 51.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.92 . . . . 0.0 109.529 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.526 ' CG ' ' OXT' ' D' ' 146' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.551 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.498 ' CG1' ' OG ' ' A' ' 131' ' ' SER . 96.6 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.337 0.589 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp 59.06 163.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.359 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 174.77 -44.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.92 . . . . 0.0 110.033 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 3' ' ' SER . 52.9 Cg_exo -53.7 172.85 0.22 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.691 2.261 . . . . 0.0 113.105 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.598 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -46.9 -14.6 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 4' ' ' PRO . 3.0 p30 -38.59 -22.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.445 -0.785 . . . . 0.0 110.121 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 5' ' ' ALA . 38.0 mttt -80.42 -56.78 3.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.115 -0.991 . . . . 0.0 109.407 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 m -46.82 -28.65 1.62 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.511 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -78.35 -38.07 42.89 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.439 HG21 ' CD2' ' A' ' 128' ' ' PHE . 25.4 t -71.61 -49.28 47.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -50.99 -44.23 60.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.21 -61.21 2.77 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.97 -35.38 69.09 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -0.756 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -77.01 -17.16 59.03 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.204 -0.935 . . . . 0.0 108.888 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.57 -38.23 44.45 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -84.46 -35.21 23.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.402 -1.058 . . . . 0.0 109.495 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 21' ' ' ALA . 42.6 t -73.64 -36.91 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 109.674 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 19' ' ' ALA . . . -30.58 143.72 0.01 OUTLIER Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . 71.07 -31.96 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -1.043 . . . . 0.0 109.113 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.557 ' H ' ' C ' ' A' ' 18' ' ' GLY . 49.8 m-70 -107.94 17.13 22.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 17' ' ' VAL . . . -85.49 -36.05 20.79 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.879 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.3 -14.44 64.14 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -87.99 -56.14 3.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -1.113 . . . . 0.0 109.876 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.4 m-30 -58.42 -35.38 71.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.365 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.73 -23.06 64.89 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.38 -49.91 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -1.188 . . . . 0.0 109.696 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -56.62 -19.76 17.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.83 -21.25 60.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 109.597 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.528 HD11 ' ND1' ' A' ' 58' ' ' HIS . 11.0 mt -82.61 -54.31 5.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -64.43 -34.04 77.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.553 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.502 ' CG ' HH11 ' A' ' 31' ' ' ARG . 0.5 OUTLIER -66.4 -38.57 87.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 109.631 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 32' ' ' MET . 15.1 tmm? -75.13 -31.97 61.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.313 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -54.14 -49.93 68.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.78 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 36' ' ' PHE . 1.3 pp -81.27 -43.61 18.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 m -62.95 4.48 0.17 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.617 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.533 ' CE2' ' OG1' ' A' ' 38' ' ' THR . 2.5 t80 -162.74 93.76 1.2 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.222 -0.923 . . . . 0.0 109.165 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.76 -23.38 6.95 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.495 2.13 . . . . 0.0 112.404 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.533 ' OG1' ' CE2' ' A' ' 36' ' ' PHE . 9.5 p -54.65 -28.57 48.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 109.283 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -89.98 -22.8 21.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 109.547 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -46.12 -31.1 2.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 1.281 HG21 ' CG ' ' D' ' 97' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.555 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.23 0 CA-C-O 120.589 0.233 . . . . 0.0 111.177 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.06 35.21 2.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.832 -1.168 . . . . 0.0 109.917 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 49' ' ' SER . 14.5 m-20 52.79 91.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 109.53 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.03 -1.65 0.33 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 47' ' ' ASP . 92.8 p -54.31 126.74 24.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.915 . . . . 0.0 109.463 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -57.25 136.01 56.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.472 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.41 70.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.597 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.5 t -64.04 -14.56 55.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -1.141 . . . . 0.0 109.457 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 70.88 -18.82 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.622 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 52' ' ' SER . 32.9 mt-30 -85.67 -18.09 34.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 109.376 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.64 -36.12 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -75.92 -33.47 59.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 108.96 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.72 -25.19 74.11 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.528 ' ND1' HD11 ' A' ' 29' ' ' LEU . 6.3 t-80 -71.49 -43.29 66.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -1.117 . . . . 0.0 109.392 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -49.38 -48.17 34.28 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 86.4 mttt -52.71 -22.62 5.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.995 . . . . 0.0 110.005 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.85 -40.91 60.73 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.146 -0.971 . . . . 0.0 108.792 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -73.05 -47.28 48.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.535 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -65.88 -32.59 74.19 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 26.1 t0 -71.93 -32.46 67.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.081 -1.012 . . . . 0.0 108.599 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -68.19 -52.57 32.87 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.01 -41.38 59.75 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.246 -0.909 . . . . 0.0 108.97 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 71' ' ' ALA . 16.3 m -68.26 -57.81 5.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.182 -0.949 . . . . 0.0 108.728 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -59.76 -23.84 63.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 108.758 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.08 -46.93 10.68 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.56 -22.93 27.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -67.75 -36.13 79.97 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' A' ' 74' ' ' ASP . 84.8 m-70 -102.78 -65.61 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.491 -0.756 . . . . 0.0 109.465 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 72' ' ' HIS . 12.6 p 44.83 14.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.863 0.839 . . . . 0.0 109.437 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 72' ' ' HIS . 71.0 m-20 -137.18 11.89 3.05 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.404 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 0.3 OUTLIER 172.23 31.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.205 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.686 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 8.1 ptt? -78.32 -22.89 0.4 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.929 . . . . 0.0 111.937 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.4 Cg_exo -53.27 -22.4 20.15 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.558 1.506 . . . . 0.0 112.335 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -92.98 -40.52 10.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.05 84.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 109.175 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.6 mt -83.93 9.48 12.11 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.451 -0.781 . . . . 0.0 108.918 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -58.43 -50.39 73.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 109.53 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 83' ' ' LEU . . . -50.11 -58.52 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.579 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.429 ' N ' HD23 ' A' ' 83' ' ' LEU . 4.5 mt -46.02 -46.2 16.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 108.894 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 5.7 p -64.89 -32.11 73.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.541 -0.724 . . . . 0.0 109.404 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -75.5 -23.84 56.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.99 -34.16 26.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 109.518 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -92.14 -21.88 20.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.927 . . . . 0.0 109.524 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -69.34 -84.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.732 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -78.54 -70.42 0.49 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.85 . . . . 0.0 109.918 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.593 ' C ' ' H ' ' A' ' 92' ' ' ARG . 25.5 ttmt -46.31 137.97 5.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.988 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.1 mt 66.19 -20.43 0.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.652 -0.655 . . . . 0.0 109.754 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.595 ' NH1' ' HA ' ' D' ' 40' ' ' ARG . 65.5 mtt180 38.9 27.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.41 -0.806 . . . . 0.0 109.685 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.565 ' CG2' ' ND2' ' A' ' 97' ' ' ASN . 7.5 p -45.45 141.19 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.872 . . . . 0.0 109.669 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.3 149.55 86.89 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 109.376 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 97' ' ' ASN . 59.8 Cg_endo -73.56 -22.25 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.526 2.151 . . . . 0.0 112.271 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 96' ' ' VAL . 21.9 t -56.5 -3.63 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 109.609 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.565 ' ND2' ' CG2' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -79.36 -41.93 26.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.928 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -51.25 -48.73 62.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 109.433 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -48.28 -30.61 4.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.487 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 18.7 mt -84.24 -62.03 1.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tp -49.89 -20.94 1.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.728 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 t -69.34 -59.11 3.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.454 ' ND1' ' OD1' ' B' ' 108' ' ' ASN . 32.1 m170 -68.43 -26.61 65.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.882 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 50.4 m -62.93 -45.48 92.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 109.927 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.97 -55.39 33.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.95 . . . . 0.0 109.429 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 4.1 mm? -47.83 -29.15 3.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.613 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.5 t -83.41 -24.63 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.409 ' OG1' HD23 ' A' ' 109' ' ' LEU . 27.9 p -71.46 -63.39 1.13 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.986 -1.071 . . . . 0.0 110.345 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -64.67 -26.22 68.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 109.636 -179.511 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 106' ' ' LEU . . . -49.4 -37.39 25.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.16 -56.24 4.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 110.07 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -71.38 -67.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.808 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.62 ' C ' HD13 ' A' ' 113' ' ' LEU . 2.1 tm? -110.7 98.52 37.86 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 66.6 Cg_exo -49.17 -170.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.277 1.984 . . . . 0.0 112.296 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.652 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -73.04 -55.33 6.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 108.827 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.652 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 18.3 mt-10 118.69 -8.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 5.3 t80 77.14 33.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.881 -0.512 . . . . 0.0 111.146 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.4 OUTLIER -101.62 116.0 64.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.448 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.04 20.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.982 1.788 . . . . 0.0 112.468 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -144.83 -29.47 0.46 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.159 -0.963 . . . . 0.0 110.431 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.668 HG13 ' N ' ' A' ' 122' ' ' HIS . 10.6 p -49.34 -50.77 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.139 -0.975 . . . . 0.0 109.967 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.668 ' N ' HG13 ' A' ' 121' ' ' VAL . 3.0 m80 -60.87 -34.67 74.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.121 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.18 -20.19 32.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.386 -0.821 . . . . 0.0 109.707 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.3 m -64.84 -62.12 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.541 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.88 -19.8 62.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.145 -0.972 . . . . 0.0 109.972 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.43 -44.47 19.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.033 . . . . 0.0 110.114 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.411 ' CD ' ' C ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -89.04 -41.49 12.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.985 -1.072 . . . . 0.0 109.954 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 10' ' ' VAL . 41.4 t80 -50.48 -20.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.878 -1.138 . . . . 0.0 108.907 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.596 ' O ' ' N ' ' A' ' 133' ' ' SER . 18.1 mt -71.42 -17.67 62.38 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.04 -31.69 71.32 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.498 ' OG ' ' CG1' ' A' ' 1' ' ' VAL . 4.0 t -83.53 -33.08 25.56 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.379 -0.826 . . . . 0.0 108.911 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.4 t -85.17 -26.63 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 108.907 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 129' ' ' LEU . 33.0 t -84.02 -25.52 29.85 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 108.873 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.5 m -77.62 -39.06 46.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.15 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 131' ' ' SER . 34.7 m -73.18 -27.04 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.262 -0.898 . . . . 0.0 108.69 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -29.98 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 137' ' ' THR . 93.5 m -112.52 24.02 12.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.409 -0.807 . . . . 0.0 109.437 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.666 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.988 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -92.04 155.58 18.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 0.0 109.328 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.14 153.9 84.03 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.013 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.02 -15.91 36.09 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.655 2.237 . . . . 0.0 112.313 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -85.28 -42.75 14.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.71 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.16 -22.56 30.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.917 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.603 ' HB2' HD13 ' B' ' 3' ' ' LEU . 7.7 tttm -79.23 -40.41 30.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.184 -0.947 . . . . 0.0 109.315 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 9.0 t -61.63 -23.64 66.18 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.815 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.11 -55.49 4.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 110.121 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.17 -24.72 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.078 -1.014 . . . . 0.0 108.414 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 50.9 m -82.21 -37.03 26.65 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.385 0.612 . . . . 0.0 109.617 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.46 96.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.528 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 17' ' ' LYS . 0.8 OUTLIER -61.82 -35.1 77.24 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.471 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -48.07 -21.52 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 109.046 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' B' ' 14' ' ' LEU . . . -86.5 -32.63 15.5 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' B' ' 14' ' ' LEU . 1.0 OUTLIER -78.02 -31.42 50.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -1.151 . . . . 0.0 109.087 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' B' ' 20' ' ' VAL . 69.7 t -54.09 114.88 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.551 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' B' ' 21' ' ' ASP . 3.1 m120 -71.41 64.06 0.4 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 109.168 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' B' ' 18' ' ' VAL . 42.1 t -45.68 -16.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.516 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' B' ' 19' ' ' ASN . 21.8 t70 -77.1 5.46 8.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.454 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -154.17 -43.84 0.09 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -0.87 . . . . 0.0 109.467 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -55.16 -24.9 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.507 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.41 -42.52 93.8 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.72 -35.92 54.18 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -73.44 -36.49 65.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 109.376 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.45 -52.94 62.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.47 -51.57 66.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 109.2 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.75 -40.65 95.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' B' ' 33' ' ' VAL . 16.7 mmt85 -58.13 -44.36 87.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -1.13 . . . . 0.0 109.524 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 35' ' ' TYR . 34.0 tp -46.83 -32.53 3.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.319 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 mt -81.18 -21.84 39.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' B' ' 30' ' ' ARG . 21.2 t -87.12 -64.29 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 109.549 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.432 ' H ' HG23 ' B' ' 34' ' ' VAL . 0.2 OUTLIER -60.05 -49.57 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.874 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.417 ' O ' ' O ' ' B' ' 31' ' ' LEU . 0.1 OUTLIER -118.53 85.68 27.03 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.365 -0.834 . . . . 0.0 109.45 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -84.26 34.47 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.702 2.268 . . . . 0.0 112.315 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.542 ' NE1' HG23 ' B' ' 38' ' ' THR . 1.9 p-90 -81.04 -29.74 34.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.13 -0.981 . . . . 0.0 109.602 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.542 HG23 ' NE1' ' B' ' 37' ' ' TRP . 65.1 p -60.62 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.433 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 48.95 45.2 22.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.471 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.507 ' HA ' ' NH1' ' C' ' 92' ' ' ARG . 19.2 ptt180 -137.82 -39.18 0.56 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.249 -0.907 . . . . 0.0 109.367 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -100.41 -25.47 14.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 109.44 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -74.48 6.11 4.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.424 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.14 -23.28 51.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 20.3 p -59.62 -40.31 87.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.507 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -51.63 -17.61 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.69 55.12 11.65 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -159.55 79.33 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -1.162 . . . . 0.0 109.394 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 36.6 mt -131.56 14.63 4.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 109.421 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.8 m -46.91 -41.75 16.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.221 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 5.9 p -146.64 148.68 34.41 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.438 -0.789 . . . . 0.0 108.896 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -41.07 -39.52 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.37 2.047 . . . . 0.0 112.292 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.403 ' C ' ' N ' ' B' ' 54' ' ' VAL . 1.0 OUTLIER -67.04 -40.43 87.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 109.643 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.14 -19.84 0.31 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.385 -0.822 . . . . 0.0 109.552 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.403 ' N ' ' C ' ' B' ' 52' ' ' ASP . 83.5 t -67.56 -64.01 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 10.4 mtt -86.12 -6.1 59.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 109.601 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.13 -35.6 88.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -81.24 148.36 63.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.205 -1.173 . . . . 0.0 109.418 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.13 -51.7 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.548 2.165 . . . . 0.0 112.287 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.3 -39.4 14.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 109.758 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.68 -45.47 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.435 ' HZ2' ' HB3' ' B' ' 61' ' ' LYS . 13.4 mtpp -75.17 -24.84 57.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.43 -43.05 70.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.574 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -64.1 -23.9 67.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.685 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.29 75.84 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.5 ' NZ ' ' OD1' ' B' ' 21' ' ' ASP . 19.3 mtpt -67.13 -25.02 65.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -1.15 . . . . 0.0 109.619 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -72.02 -28.75 63.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.583 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.11 -48.79 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.667 HD23 ' O ' ' B' ' 68' ' ' LEU . 1.3 tt -60.54 -16.92 42.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.31 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.14 -48.64 45.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.51 90.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -1.157 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -47.31 -41.2 18.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 0.0 109.559 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 14.0 m -49.42 -44.3 45.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 109.48 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -67.78 -16.72 64.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.06 -26.54 69.25 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.722 HD23 ' H ' ' B' ' 75' ' ' LEU . 2.0 pt? -136.08 -18.6 1.55 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.236 -1.155 . . . . 0.0 110.153 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -82.24 1.44 36.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.061 -1.024 . . . . 0.0 109.731 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 59.4 m-70 -163.06 67.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 109.549 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.09 4.85 3.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.49 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.02 -37.21 79.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.487 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 14.1 t-20 -171.45 99.43 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.492 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.04 -57.25 3.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.536 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -47.12 -24.02 0.6 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.558 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -66.43 -54.91 20.58 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.551 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.8 t -75.5 -47.32 27.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 0.0 109.488 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.551 ' N ' ' CG2' ' B' ' 84' ' ' THR . 53.3 m-85 -62.73 -1.18 0.78 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.5 -0.75 . . . . 0.0 109.381 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -59.22 -35.85 74.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' THR . . . . . 0.453 ' O ' ' N ' ' B' ' 91' ' ' LEU . 21.5 p -83.28 -47.96 10.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.932 . . . . 0.0 109.531 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' B' ' 85' ' ' PHE . 40.5 mt -55.42 -43.12 75.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -67.41 -51.3 53.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.53 -22.41 64.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.868 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.672 HD23 ' C ' ' B' ' 91' ' ' LEU . 7.6 tt -81.42 -60.11 2.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.77 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.584 ' N ' HD23 ' B' ' 91' ' ' LEU . 66.5 m80 -61.78 -22.42 65.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.288 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 93' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 39.4 t -83.1 -60.58 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 110.729 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.538 ' O ' ' CE1' ' B' ' 97' ' ' HIS . 5.1 m-20 -87.23 -27.74 22.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.137 -0.977 . . . . 0.0 111.149 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.2 OUTLIER -87.68 -16.68 33.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.889 -1.132 . . . . 0.0 110.646 -178.641 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.498 ' C ' ' ND1' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -138.37 -39.26 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.942 -1.099 . . . . 0.0 109.929 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 1.257 ' CG ' HG21 ' C' ' 41' ' ' THR . 4.9 m80 64.87 58.78 0.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.101 -1.0 . . . . 0.0 109.754 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.7 132.63 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.081 -1.012 . . . . 0.0 109.335 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.44 152.55 2.22 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.359 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.04 -29.84 17.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.66 2.24 . . . . 0.0 112.187 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.33 53.68 0.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -149.35 -38.95 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.586 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.69 -29.78 70.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.545 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.402 ' NH1' ' CB ' ' B' ' 104' ' ' ARG . 31.4 mtm105 -77.82 -20.03 53.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 109.678 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.73 -50.04 9.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 tt -52.04 -49.04 64.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.5 -20.39 63.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' ASN . . . . . 0.454 ' OD1' ' ND1' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -81.76 -19.43 41.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -1.135 . . . . 0.0 109.658 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 92.6 t -86.36 -53.01 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.242 -0.911 . . . . 0.0 109.675 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.512 HD23 ' C ' ' B' ' 110' ' ' LEU . 2.8 tt -45.98 -60.2 2.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.336 -0.853 . . . . 0.0 109.717 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 61.5 t -46.68 -33.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.934 . . . . 0.0 109.748 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.21 -23.94 43.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.657 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 110' ' ' LEU . 98.2 t -75.0 -21.34 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.569 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.523 ' CD1' ' CZ ' ' B' ' 130' ' ' TYR . 21.5 mt -79.06 -48.59 14.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 109.49 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.27 -23.1 3.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.498 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 6.5 t-80 -83.81 -57.75 3.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.59 ' HD1' ' N ' ' B' ' 117' ' ' HIS . 0.3 OUTLIER -72.4 -17.78 61.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.524 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' B' ' 114' ' ' LEU . 95.1 m-85 -141.64 56.53 1.51 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -73.16 -24.94 74.61 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.2 9.32 1.02 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -1.132 . . . . 0.0 109.624 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' B' ' 119' ' ' GLY . 59.1 mm-40 -142.68 8.78 1.75 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.541 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -78.68 34.19 0.22 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.971 . . . . 0.0 109.442 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.481 ' OG1' HG23 ' B' ' 126' ' ' VAL . 69.2 p -48.67 148.47 3.62 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.265 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.513 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.4 Cg_exo -44.09 -55.82 2.88 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.544 2.163 . . . . 0.0 112.983 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 12.4 Cg_endo -56.22 -23.23 44.29 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.188 1.925 . . . . 0.0 112.22 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.481 HG23 ' OG1' ' B' ' 123' ' ' THR . 76.5 t -82.87 -23.31 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 109.559 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -83.18 -59.67 2.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.25 -36.85 14.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.903 . . . . 0.0 109.842 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.6 -5.22 56.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.131 -0.98 . . . . 0.0 110.065 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.523 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 0.1 OUTLIER -92.58 -40.72 10.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.006 . . . . 0.0 109.47 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -83.97 -23.05 31.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 109.633 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -71.14 -42.36 69.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 110.141 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 133' ' ' VAL . . . . . 0.93 HG13 ' H ' ' B' ' 134' ' ' VAL . 6.3 p -71.96 -66.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.112 -0.992 . . . . 0.0 110.327 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.93 ' H ' HG13 ' B' ' 133' ' ' VAL . 33.1 m -43.32 -19.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.949 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' B' ' 133' ' ' VAL . . . -59.55 -28.11 66.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.267 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.85 -30.85 58.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.41 -36.31 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -1.156 . . . . 0.0 109.451 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.42 -40.11 89.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -75.88 -25.98 56.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.67 -48.98 74.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.2 -4.24 28.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.393 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 142' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' B' ' 145' ' ' TYR . . . -102.36 -39.51 7.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 0.0 109.545 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -45.32 -40.26 7.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 109.784 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.26 27.33 1.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.113 -0.992 . . . . 0.0 109.559 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.576 ' O ' ' CG ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -140.43 1.27 1.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.515 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.461 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.499 ' CG1' ' OG ' ' C' ' 131' ' ' SER . 97.6 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp 58.91 163.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 174.82 -44.9 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 110.005 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' C' ' 3' ' ' SER . 52.9 Cg_exo -53.55 172.86 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.702 2.268 . . . . 0.0 113.14 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -47.02 -14.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.637 -0.664 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' C' ' 4' ' ' PRO . 3.0 p30 -38.68 -22.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.391 -0.818 . . . . 0.0 110.146 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' C' ' 5' ' ' ALA . 37.9 mttt -80.51 -56.77 3.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.109 -0.994 . . . . 0.0 109.378 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 54.5 m -46.82 -28.62 1.61 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.349 -0.844 . . . . 0.0 109.504 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -78.42 -38.07 42.29 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.448 HG21 ' CD2' ' C' ' 128' ' ' PHE . 25.4 t -71.58 -49.16 48.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -51.15 -44.16 61.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 108.621 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.22 -61.13 2.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.458 -0.776 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.09 -35.33 69.27 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.41 -0.806 . . . . 0.0 109.333 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -77.09 -17.12 58.93 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.188 -0.945 . . . . 0.0 108.877 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.49 -38.41 44.54 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -84.37 -35.21 23.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.294 -1.121 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.559 HG12 ' HB2' ' C' ' 21' ' ' ALA . 42.6 t -73.58 -36.94 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.813 . . . . 0.0 109.684 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' C' ' 19' ' ' ALA . . . -30.63 143.72 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 19' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' C' ' 18' ' ' GLY . . . 71.09 -31.92 0.24 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.409 -1.053 . . . . 0.0 109.121 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' C' ' 18' ' ' GLY . 49.7 m-70 -107.92 17.2 22.72 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.559 ' HB2' HG12 ' C' ' 17' ' ' VAL . . . -85.63 -35.98 20.63 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.847 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.38 -14.44 64.34 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -87.87 -56.13 3.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.3 -1.118 . . . . 0.0 109.97 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 1.4 m-30 -58.52 -35.33 72.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.374 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.65 -23.02 64.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.42 -49.91 8.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.225 -1.162 . . . . 0.0 109.759 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.53 -19.85 17.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.659 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.75 -21.31 61.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 109.542 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.545 HD11 ' ND1' ' C' ' 58' ' ' HIS . 11.1 mt -82.53 -54.3 5.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.877 . . . . 0.0 109.653 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -33.95 77.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.564 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.508 ' CG ' HH11 ' C' ' 31' ' ' ARG . 0.5 OUTLIER -66.48 -38.55 87.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.647 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 32' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' C' ' 32' ' ' MET . 15.1 tmm? -75.09 -32.0 61.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 109.32 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -54.11 -49.87 68.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.843 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' C' ' 36' ' ' PHE . 1.3 pp -81.3 -43.71 18.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.165 -0.96 . . . . 0.0 110.024 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -62.92 4.47 0.17 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 0.0 109.582 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.53 ' CE2' ' OG1' ' C' ' 38' ' ' THR . 2.5 t80 -162.74 93.75 1.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.16 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -79.81 -23.29 6.96 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.496 2.131 . . . . 0.0 112.405 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.53 ' OG1' ' CE2' ' C' ' 36' ' ' PHE . 9.1 p -54.77 -28.49 49.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.0 109.253 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 8.6 p -90.12 -22.65 21.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 109.515 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -46.23 -31.13 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.576 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' THR . . . . . 1.257 HG21 ' CG ' ' B' ' 97' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.552 ' C ' ' ND1' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 120.572 0.225 . . . . 0.0 111.174 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.07 35.09 2.57 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.83 -1.169 . . . . 0.0 109.924 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' C' ' 49' ' ' SER . 14.4 m-20 52.97 91.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.1 -1.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.39 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.468 ' H ' ' C ' ' C' ' 47' ' ' ASP . 92.4 p -54.38 126.81 24.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -57.29 136.03 56.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.47 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.79 15.41 70.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 4.4 t -64.08 -14.46 54.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.164 . . . . 0.0 109.468 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 70.82 -18.86 0.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.833 . . . . 0.0 109.659 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' C' ' 52' ' ' SER . 32.9 mt-30 -85.69 -18.11 34.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.08 -1.012 . . . . 0.0 109.367 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.65 -36.01 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -76.04 -33.51 59.62 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.257 -0.902 . . . . 0.0 108.895 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.66 -25.17 74.04 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.545 ' ND1' HD11 ' C' ' 29' ' ' LEU . 6.3 t-80 -71.46 -43.26 66.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -1.151 . . . . 0.0 109.417 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -49.5 -48.1 35.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 86.5 mttt -52.79 -22.51 5.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -1.002 . . . . 0.0 109.965 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -40.91 60.66 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.158 -0.964 . . . . 0.0 108.772 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.48 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -73.04 -47.24 48.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.521 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -65.86 -32.6 74.21 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.442 -0.786 . . . . 0.0 109.152 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 64' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 26.4 t0 -71.88 -32.46 67.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.045 . . . . 0.0 108.61 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 65' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -68.22 -52.47 33.74 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.06 -41.36 59.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 108.926 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.433 ' O ' ' N ' ' C' ' 71' ' ' ALA . 16.3 m -68.27 -57.82 5.37 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.947 . . . . 0.0 108.739 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -59.81 -23.79 63.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 108.701 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.11 -46.92 10.68 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.53 -22.93 27.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -67.71 -36.18 80.15 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' C' ' 74' ' ' ASP . 84.9 m-70 -102.79 -65.5 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.558 HG12 ' O ' ' C' ' 72' ' ' HIS . 12.6 p 44.8 14.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.791 0.805 . . . . 0.0 109.39 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' C' ' 72' ' ' HIS . 71.2 m-20 -137.12 11.93 3.06 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.415 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 0.3 OUTLIER 172.22 31.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.153 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 8.2 ptt? -78.32 -22.82 0.4 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 111.987 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.6 Cg_exo -53.24 -22.47 20.16 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.556 1.504 . . . . 0.0 112.361 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -92.95 -40.44 10.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.483 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.11 83.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.9 . . . . 0.0 109.137 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 28.9 mt -83.79 9.34 12.13 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 108.932 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -58.27 -50.52 73.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.575 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' C' ' 83' ' ' LEU . . . -50.04 -58.57 5.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.569 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.418 ' N ' HD23 ' C' ' 83' ' ' LEU . 4.5 mt -46.07 -46.15 16.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 5.8 p -64.94 -32.11 73.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.535 -0.728 . . . . 0.0 109.391 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' C' ' 82' ' ' ALA . 31.9 t70 -75.43 -23.85 57.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tt -83.01 -34.25 26.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.858 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -91.97 -21.97 20.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -69.32 -84.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.713 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -78.45 -70.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.893 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' C' ' 92' ' ' ARG . 25.5 ttmt -46.3 137.99 5.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 110.013 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.1 mt 66.23 -20.41 0.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.711 -0.618 . . . . 0.0 109.759 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 92' ' ' ARG . . . . . 0.592 ' H ' ' C ' ' C' ' 90' ' ' LYS . 65.3 mtt180 38.8 27.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.539 -0.726 . . . . 0.0 109.676 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.576 ' CG2' ' ND2' ' C' ' 97' ' ' ASN . 7.5 p -45.47 141.2 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.828 . . . . 0.0 109.681 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -74.31 149.51 86.86 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.894 . . . . 0.0 109.371 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' C' ' 97' ' ' ASN . 59.5 Cg_endo -73.61 -22.2 18.39 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.435 2.09 . . . . 0.0 112.204 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.42 HG12 ' O ' ' C' ' 96' ' ' VAL . 21.9 t -56.56 -3.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.576 ' ND2' ' CG2' ' C' ' 93' ' ' VAL . 0.7 OUTLIER -79.24 -41.92 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 109.998 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -51.29 -48.7 62.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 109.41 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -48.34 -30.57 5.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.176 -0.952 . . . . 0.0 109.434 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.47 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 18.6 mt -84.21 -62.09 1.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 109.622 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tp -49.88 -20.92 0.99 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.725 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 10.2 t -69.29 -59.14 3.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.939 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 103' ' ' HIS . . . . . 0.463 ' ND1' ' OD1' ' D' ' 108' ' ' ASN . 32.1 m170 -68.42 -26.61 65.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.821 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 50.9 m -63.03 -45.36 92.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.887 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.0 -55.41 33.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.987 . . . . 0.0 109.456 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' C' ' 110' ' ' ALA . 4.1 mm? -47.79 -29.18 2.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.135 -0.978 . . . . 0.0 109.591 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.36 -24.79 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 0.0 110.113 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.407 ' OG1' HD23 ' C' ' 109' ' ' LEU . 28.0 p -71.45 -63.34 1.14 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.026 -1.046 . . . . 0.0 110.352 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.57 HD23 ' H ' ' C' ' 109' ' ' LEU . 0.1 OUTLIER -64.64 -26.29 68.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.056 -1.027 . . . . 0.0 109.636 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' C' ' 106' ' ' LEU . . . -49.35 -37.43 24.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.107 -0.995 . . . . 0.0 109.707 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.18 -56.17 4.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 110.075 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -71.45 -67.51 0.52 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.821 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.615 ' C ' HD13 ' C' ' 113' ' ' LEU . 2.1 tm? -110.68 98.49 37.66 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 114' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' C' ' 113' ' ' LEU . 65.7 Cg_exo -49.18 -170.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.269 1.98 . . . . 0.0 112.304 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.654 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -72.99 -55.22 6.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 108.866 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.654 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 18.3 mt-10 118.58 -8.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.464 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 5.3 t80 77.13 33.74 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.937 -0.477 . . . . 0.0 111.139 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.4 OUTLIER -101.62 116.08 64.02 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.477 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.1 20.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.935 1.757 . . . . 0.0 112.482 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -144.81 -29.37 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.038 -1.039 . . . . 0.0 110.423 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.669 HG13 ' N ' ' C' ' 122' ' ' HIS . 10.5 p -49.39 -50.8 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.06 -1.025 . . . . 0.0 109.899 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.669 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.9 m80 -60.81 -34.76 75.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.119 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.18 -20.06 33.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.765 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.522 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.4 m -64.93 -62.08 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 110.518 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.94 -19.69 62.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.187 -0.945 . . . . 0.0 109.949 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.48 -44.52 19.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.068 -1.02 . . . . 0.0 110.109 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.413 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -89.07 -41.37 12.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.004 -1.06 . . . . 0.0 109.977 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.448 ' CD2' HG21 ' C' ' 10' ' ' VAL . 41.7 t80 -50.52 -20.91 1.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.99 -1.069 . . . . 0.0 108.899 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' C' ' 133' ' ' SER . 18.2 mt -71.42 -17.66 62.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.411 ' O ' ' OG1' ' C' ' 134' ' ' THR . . . -61.0 -31.6 71.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.499 ' OG ' ' CG1' ' C' ' 1' ' ' VAL . 4.0 t -83.59 -33.05 25.46 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.289 -0.882 . . . . 0.0 108.918 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.18 -26.66 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.0 108.922 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.594 ' N ' ' O ' ' C' ' 129' ' ' LEU . 33.0 t -84.01 -25.45 29.93 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.383 -0.823 . . . . 0.0 108.969 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 134' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 33.2 m -77.69 -38.93 46.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 109.189 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.407 HG13 ' O ' ' C' ' 131' ' ' SER . 34.8 m -73.39 -26.85 22.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.3 -0.875 . . . . 0.0 108.677 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.81 -30.03 70.6 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 137' ' ' THR . . . . . 0.712 HG22 ' O ' ' C' ' 137' ' ' THR . 93.5 m -112.45 24.07 12.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.413 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 -179.983 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.976 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -92.11 155.61 17.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.442 ' H ' HG22 ' D' ' 4' ' ' THR . 0.2 OUTLIER -64.16 153.95 83.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 108.933 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.01 -15.96 36.31 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.616 2.21 . . . . 0.0 112.263 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.3 -42.77 14.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.682 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.17 -22.53 30.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.886 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.604 ' HB2' HD13 ' D' ' 3' ' ' LEU . 7.7 tttm -79.25 -40.5 30.46 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.124 -0.985 . . . . 0.0 109.245 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -61.58 -23.64 66.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 109.821 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.1 -55.43 4.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.065 -1.022 . . . . 0.0 110.144 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.26 -24.62 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.01 -1.056 . . . . 0.0 108.418 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 49.9 m -82.18 -37.14 26.56 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.752 -0.593 . . . . 0.0 109.591 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.5 96.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -0.848 . . . . 0.0 109.456 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' D' ' 17' ' ' LYS . 0.8 OUTLIER -61.81 -35.12 77.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.43 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -47.95 -21.63 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.138 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 16' ' ' GLY . . . . . 0.414 ' N ' ' C ' ' D' ' 14' ' ' LEU . . . -86.52 -32.52 15.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' D' ' 14' ' ' LEU . 1.0 OUTLIER -77.97 -31.46 50.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -1.123 . . . . 0.0 109.101 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -54.23 114.98 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.535 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' D' ' 21' ' ' ASP . 3.1 m120 -71.45 64.15 0.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.133 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 42.1 t -45.74 -16.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' D' ' 19' ' ' ASN . 21.4 t70 -77.32 5.67 8.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.937 . . . . 0.0 109.312 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' D' ' 19' ' ' ASN . 81.2 mt-10 -154.31 -43.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.352 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 78.7 t -55.03 -25.07 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 109.474 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.43 -42.55 93.74 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.67 -35.88 54.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -73.43 -36.52 65.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -1.138 . . . . 0.0 109.399 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.39 -53.05 61.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.179 -0.95 . . . . 0.0 109.417 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.42 -51.55 67.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.271 -0.893 . . . . 0.0 109.271 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.6 -40.77 95.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 30' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' D' ' 33' ' ' VAL . 16.6 mmt85 -58.1 -44.38 87.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 31' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' D' ' 35' ' ' TYR . 33.6 tp -46.86 -32.44 3.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 109.247 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 mt -81.24 -21.87 39.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.893 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' D' ' 30' ' ' ARG . 21.2 t -87.13 -64.2 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.417 HG23 ' H ' ' D' ' 34' ' ' VAL . 0.2 OUTLIER -60.16 -49.53 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.925 . . . . 0.0 109.841 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 35' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' D' ' 31' ' ' LEU . 0.1 OUTLIER -118.48 85.71 26.8 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.282 -0.886 . . . . 0.0 109.425 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.18 34.44 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.787 2.324 . . . . 0.0 112.356 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 37' ' ' TRP . . . . . 0.529 ' NE1' HG23 ' D' ' 38' ' ' THR . 1.9 p-90 -81.09 -29.79 34.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.529 HG23 ' NE1' ' D' ' 37' ' ' TRP . 65.5 p -60.58 -96.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.937 . . . . 0.0 109.325 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 49.12 45.06 23.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.478 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' ARG . . . . . 0.595 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 19.1 ptt180 -137.76 -39.24 0.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.855 . . . . 0.0 109.357 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -100.38 -25.4 14.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -74.49 6.04 4.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.14 -23.19 51.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.554 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 20.4 p -59.61 -40.43 87.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.438 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -51.49 -17.73 0.89 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.77 55.14 11.77 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -159.55 79.19 0.72 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -1.087 . . . . 0.0 109.422 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 35.9 mt -131.46 14.57 5.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.427 -0.795 . . . . 0.0 109.383 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 24.4 m -46.85 -41.75 16.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.211 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 6.1 p -146.73 148.67 34.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -41.16 -39.4 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.305 2.003 . . . . 0.0 112.333 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 52' ' ' ASP . . . . . 0.404 ' C ' ' N ' ' D' ' 54' ' ' VAL . 1.0 OUTLIER -67.04 -40.47 87.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.703 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.14 -19.83 0.31 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 109.523 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 54' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 52' ' ' ASP . 83.2 t -67.52 -64.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 109.681 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 10.4 mtt -86.21 -6.12 59.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.527 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.69 87.99 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -81.28 148.35 63.01 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.188 -1.183 . . . . 0.0 109.424 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.14 -51.71 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.559 2.173 . . . . 0.0 112.213 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.3 -39.32 14.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.709 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.79 -45.4 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.118 -0.989 . . . . 0.0 109.289 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -75.25 -24.76 57.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 109.294 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.51 -42.98 70.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.605 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -64.04 -24.02 67.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.709 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.58 -33.24 76.07 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 65' ' ' LYS . . . . . 0.509 ' NZ ' ' OD1' ' D' ' 21' ' ' ASP . 19.4 mtpt -67.28 -24.87 65.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -1.216 . . . . 0.0 109.642 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -71.95 -28.88 63.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.628 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.1 -48.76 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.655 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.3 tt -60.5 -16.91 41.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.376 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.11 -48.71 45.24 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.89 -46.61 89.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -1.181 . . . . 0.0 109.852 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 71' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' D' ' 74' ' ' GLY . 1.1 m-85 -47.25 -41.19 18.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 109.588 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 14.0 m -49.51 -44.21 46.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.459 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -67.85 -16.65 64.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.221 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 74' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' D' ' 71' ' ' PHE . . . -63.01 -26.61 69.27 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.735 HD23 ' H ' ' D' ' 75' ' ' LEU . 2.0 pt? -136.09 -18.54 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.271 -1.134 . . . . 0.0 110.176 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 76' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -82.25 1.49 36.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.997 -1.065 . . . . 0.0 109.746 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 59.8 m-70 -163.06 67.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.16 4.89 3.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.411 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.13 -37.14 79.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 80' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 14.1 t-20 -171.42 99.39 0.19 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.532 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -80.18 -57.2 3.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -47.19 -23.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 0.0 109.524 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 83' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -66.37 -54.88 20.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.8 t -75.54 -47.45 26.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -1.18 . . . . 0.0 109.384 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.556 ' N ' ' CG2' ' D' ' 84' ' ' THR . 53.4 m-85 -62.53 -1.26 0.76 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.541 -0.724 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 86' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -59.2 -35.79 74.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 87' ' ' THR . . . . . 0.483 ' O ' ' N ' ' D' ' 91' ' ' LEU . 21.3 p -83.39 -47.93 10.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.432 HD12 ' CD1' ' D' ' 85' ' ' PHE . 40.9 mt -55.53 -43.0 75.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -67.36 -51.41 52.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.437 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.38 -22.55 64.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.482 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.672 HD23 ' C ' ' D' ' 91' ' ' LEU . 7.5 tt -81.36 -60.21 2.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.227 -0.921 . . . . 0.0 109.727 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.591 ' N ' HD23 ' D' ' 91' ' ' LEU . 66.5 m80 -61.64 -22.51 65.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.225 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 93' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 39.4 t -83.09 -60.61 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 110.768 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.539 ' O ' ' CE1' ' D' ' 97' ' ' HIS . 5.1 m-20 -87.18 -27.7 22.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.122 -0.986 . . . . 0.0 111.098 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 95' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.2 OUTLIER -87.71 -16.73 33.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.851 -1.156 . . . . 0.0 110.644 -178.567 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.501 ' C ' ' ND1' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -138.38 -39.33 0.53 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.963 -1.086 . . . . 0.0 109.831 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 1.281 ' CG ' HG21 ' A' ' 41' ' ' THR . 5.0 m80 64.83 58.81 0.94 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 109.778 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.62 132.62 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.1 -1.0 . . . . 0.0 109.363 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.39 152.5 2.2 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.399 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.02 -29.76 17.43 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.536 2.157 . . . . 0.0 112.195 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.45 53.82 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -149.31 -39.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.58 -29.77 70.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.575 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 104' ' ' ARG . . . . . 0.411 ' NH1' ' CB ' ' D' ' 104' ' ' ARG . 31.4 mtm105 -77.87 -20.05 53.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.599 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 13.6 mt -82.64 -50.14 9.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.9 tt -51.97 -49.1 63.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.361 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.49 -20.3 63.39 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 108' ' ' ASN . . . . . 0.463 ' OD1' ' ND1' ' C' ' 103' ' ' HIS . 0.2 OUTLIER -81.86 -19.45 40.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -1.195 . . . . 0.0 109.613 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 92.4 t -86.36 -52.95 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -0.984 . . . . 0.0 109.721 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 110' ' ' LEU . . . . . 0.504 HD23 ' C ' ' D' ' 110' ' ' LEU . 2.8 tt -45.96 -60.13 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 0.0 109.787 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 61.3 t -46.68 -33.26 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.812 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.23 -23.95 43.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 113' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' D' ' 110' ' ' LEU . 98.7 t -74.94 -21.34 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.591 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 114' ' ' LEU . . . . . 0.519 ' CD1' ' CZ ' ' D' ' 130' ' ' TYR . 21.4 mt -78.98 -48.7 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 109.494 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.12 -23.31 3.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.443 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.484 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 6.5 t-80 -83.72 -57.81 3.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 117' ' ' HIS . . . . . 0.6 ' N ' ' HD1' ' D' ' 117' ' ' HIS . 0.3 OUTLIER -72.4 -17.75 61.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 109.511 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' D' ' 114' ' ' LEU . 95.2 m-85 -141.7 56.66 1.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.28 -24.85 74.52 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.31 9.46 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -1.098 . . . . 0.0 109.577 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -142.75 8.84 1.73 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.541 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -78.67 34.15 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.471 ' OG1' HG23 ' D' ' 126' ' ' VAL . 69.6 p -48.59 148.46 3.54 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.206 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.507 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.5 Cg_exo -44.15 -55.76 2.94 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.565 2.177 . . . . 0.0 112.97 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 12.6 Cg_endo -56.21 -23.35 44.85 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.249 1.966 . . . . 0.0 112.208 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.471 HG23 ' OG1' ' D' ' 123' ' ' THR . 75.5 t -82.8 -23.3 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.569 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -83.28 -59.6 2.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.73 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.2 -36.87 14.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.62 -5.11 56.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 0.0 110.042 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.519 ' CZ ' ' CD1' ' D' ' 114' ' ' LEU . 0.1 OUTLIER -92.65 -40.74 10.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.025 -1.047 . . . . 0.0 109.474 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -84.0 -22.99 31.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.685 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -71.11 -42.4 69.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.113 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 133' ' ' VAL . . . . . 0.965 HG13 ' H ' ' D' ' 134' ' ' VAL . 6.4 p -71.97 -66.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -0.983 . . . . 0.0 110.349 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.965 ' H ' HG13 ' D' ' 133' ' ' VAL . 33.1 m -43.43 -19.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 0.0 109.941 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' D' ' 133' ' ' VAL . . . -59.62 -27.97 66.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.384 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.9 -30.94 58.66 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.31 -36.39 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -1.139 . . . . 0.0 109.418 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.37 -40.17 89.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.88 -25.97 56.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.439 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.64 -49.04 74.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.419 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.16 -4.29 28.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.127 -0.983 . . . . 0.0 109.36 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 142' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' D' ' 145' ' ' TYR . . . -102.37 -39.42 7.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.417 -0.802 . . . . 0.0 109.515 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -45.39 -40.25 7.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 109.733 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.406 ' HB2' ' HZ2' ' D' ' 144' ' ' LYS . 0.0 OUTLIER -87.26 27.29 1.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.564 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 145' ' ' TYR . . . . . 0.57 ' O ' ' CG ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -140.46 1.21 1.74 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.408 ' HB3' ' CB ' ' B' ' 135' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 2' ' ' LEU . 10.8 mp 53.21 176.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.158 -0.963 . . . . 0.0 109.553 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.51 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 174.59 -47.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 110.066 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' ASP . 71.1 Cg_exo -47.24 169.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.571 2.18 . . . . 0.0 112.744 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -45.35 -15.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.407 -0.808 . . . . 0.0 110.123 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' PRO . 25.0 t70 -38.78 -40.49 0.62 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 109.928 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 7' ' ' LYS . 13.5 ptpt -67.97 -45.74 73.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.131 -0.981 . . . . 0.0 109.224 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 5' ' ' ALA . 36.0 m -52.98 -31.1 38.82 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 108.782 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -78.07 -36.06 48.73 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 128' ' ' PHE . 91.2 t -69.74 -49.05 61.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.79 -47.47 64.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -49.2 -60.79 2.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.613 -0.679 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -50.86 -39.06 52.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.311 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -17.26 61.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.436 -0.79 . . . . 0.0 109.217 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -81.62 -45.68 7.19 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.67 -34.8 72.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -1.162 . . . . 0.0 108.674 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 13' ' ' ALA . 70.4 t -61.97 -66.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 64.55 -143.61 47.22 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 48.37 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.584 -0.951 . . . . 0.0 109.978 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 18' ' ' GLY . 80.7 m-70 -151.81 19.53 0.7 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.42 -65.19 1.04 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.715 -0.616 . . . . 0.0 109.794 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.58 -14.77 0.24 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' ALA . 2.1 mm-40 -83.07 -56.46 3.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -1.19 . . . . 0.0 109.726 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.8 m-30 -55.95 -35.3 66.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.852 . . . . 0.0 109.13 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.11 -22.76 60.97 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.58 -38.28 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -1.168 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.73 -19.69 63.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.684 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.44 -22.41 51.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.117 -0.989 . . . . 0.0 109.708 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.42 -43.97 37.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -65.68 -12.82 56.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.2 -0.937 . . . . 0.0 109.695 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -58.98 2.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptm -62.31 -25.61 67.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.476 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 48' ' ' LEU . 1.3 t80 -58.65 -55.99 27.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 0.0 109.653 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -82.41 -42.46 18.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.126 -0.984 . . . . 0.0 110.227 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.527 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 12.6 t -59.65 -9.3 2.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.02 -1.05 . . . . 0.0 109.687 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 1.003 ' CZ ' ' NE2' ' B' ' 131' ' ' GLN . 79.3 m-85 -155.35 81.71 3.99 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.155 -0.966 . . . . 0.0 109.503 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 39' ' ' THR . 52.6 Cg_exo -52.5 -24.92 23.51 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.704 2.269 . . . . 0.0 112.273 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.485 HG22 ' HB2' ' D' ' 97' ' ' HIS . 9.0 p -46.88 -19.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 37' ' ' PRO . 51.2 p -82.89 -26.2 31.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.656 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 37' ' ' PRO . 26.6 ttpt -79.3 -53.66 6.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.181 -0.95 . . . . 0.0 109.658 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.563 -179.942 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.569 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 22.4 p80 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.489 0.661 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.543 ' O ' ' C ' ' A' ' 47' ' ' ASP . 3.9 t80 -104.38 31.57 4.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.561 -0.712 . . . . 0.0 109.736 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 46' ' ' PHE . 15.0 m-20 28.63 67.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.884 -0.51 . . . . 0.0 110.533 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.528 ' O ' ' CE2' ' A' ' 33' ' ' PHE . 87.3 mt -85.16 22.33 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.428 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 50' ' ' HIS . 19.3 m -76.65 26.67 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.358 -0.839 . . . . 0.0 109.418 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.456 ' H ' ' C ' ' A' ' 48' ' ' LEU . 54.6 t60 58.08 158.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 0.0 109.57 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.65 17.92 5.02 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.553 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 9.1 t -80.25 -17.76 51.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -1.111 . . . . 0.0 109.512 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 68.6 -58.52 0.48 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 109.798 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 52' ' ' SER . 0.6 OUTLIER -43.76 -20.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.775 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 53' ' ' ALA . 89.8 t -77.55 -27.17 15.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.136 -0.977 . . . . 0.0 109.28 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.9 ptmt -63.7 -27.2 69.05 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.266 -0.896 . . . . 0.0 109.327 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.84 -27.62 68.81 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -84.17 -30.65 25.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -1.17 . . . . 0.0 110.096 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.01 -49.47 55.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -60.1 -23.64 63.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -1.106 . . . . 0.0 110.082 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -34.04 65.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.087 -1.008 . . . . 0.0 109.135 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.29 -52.92 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.41 -0.806 . . . . 0.0 108.944 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.96 -28.44 69.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.297 -0.877 . . . . 0.0 109.166 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.26 -41.42 81.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.199 -0.938 . . . . 0.0 108.89 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.54 80.44 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 66' ' ' LEU . 9.8 mt -63.34 -46.17 87.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -63.24 -48.77 76.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.256 -0.902 . . . . 0.0 108.976 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.66 -22.56 66.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 108.835 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.21 -47.68 9.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -66.84 -22.56 29.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.98 -14.68 62.44 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.676 ' O ' HG12 ' A' ' 73' ' ' VAL . 21.5 m80 -141.87 -57.44 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.808 . . . . 0.0 109.648 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 72' ' ' HIS . 8.2 p 46.14 15.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 122.1 0.953 . . . . 0.0 108.76 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 72' ' ' HIS . 22.0 m-20 -136.36 12.41 3.26 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.9 30.39 0.06 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.554 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 1.2 mtm -66.54 -44.82 56.88 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.611 -0.681 . . . . 0.0 110.073 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 76' ' ' MET . 95.7 Cg_exo -42.12 -43.02 7.39 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.356 2.038 . . . . 0.0 112.727 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -94.23 -19.01 21.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 109.97 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.12 -58.44 3.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 109.165 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.5 mt -83.14 16.9 2.19 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -21.98 64.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.473 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -74.8 -57.97 3.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.538 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.465 ' N ' HD23 ' A' ' 83' ' ' LEU . 3.1 mt -44.75 -39.66 5.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' ALA . 26.5 t -54.48 -34.45 61.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 82' ' ' ALA . 4.0 m-20 -66.02 -24.39 66.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.144 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.46 ' CD1' ' NZ ' ' A' ' 90' ' ' LYS . 7.3 tp -80.45 -38.6 29.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.882 . . . . 0.0 109.176 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -92.28 -21.65 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.688 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 84' ' ' SER . . . -76.43 -39.02 54.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.244 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' LYS . 50.3 t-80 -146.58 -83.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 110.167 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.46 ' NZ ' ' CD1' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -43.88 105.98 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tp 63.61 59.14 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 109.293 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.657 HH12 ' HE1' ' D' ' 42' ' ' PHE . 10.6 ptp180 -60.64 -22.71 64.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.902 HG22 ' H ' ' A' ' 94' ' ' ASP . 12.8 p 42.1 -176.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.671 -0.643 . . . . 0.0 110.122 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.902 ' H ' HG22 ' A' ' 93' ' ' VAL . 50.7 m-20 -80.88 120.7 79.61 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.961 -1.087 . . . . 0.0 109.488 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.566 ' C ' ' H ' ' A' ' 97' ' ' ASN . 73.5 Cg_endo -78.67 -37.78 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.282 1.988 . . . . 0.0 112.183 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.479 HG21 ' OD1' ' D' ' 99' ' ' ASP . 6.2 t -55.38 -0.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.703 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.566 ' H ' ' C ' ' A' ' 95' ' ' PRO . 4.8 m120 -79.03 -24.77 43.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.695 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 95' ' ' PRO . 26.8 m-85 -49.3 -17.59 0.27 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.419 ' N ' ' C ' ' A' ' 97' ' ' ASN . 92.0 mttt -81.99 -28.23 32.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.888 . . . . 0.0 109.44 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 13.5 mt -84.11 -39.02 20.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.628 ' O ' HD23 ' A' ' 101' ' ' LEU . 2.0 tt -57.95 -40.12 79.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.379 -0.825 . . . . 0.0 109.456 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -66.14 -59.25 3.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.781 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -62.22 -26.57 68.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.736 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 57.9 m -74.06 -34.84 64.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.961 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.916 HD12 ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -84.25 -34.66 23.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.04 -1.037 . . . . 0.0 109.11 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.02 -44.02 97.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.421 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.58 -24.87 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.869 . . . . 0.0 109.213 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.5 m -64.62 -59.33 4.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 113' ' ' LEU . 59.0 mt -46.12 -37.9 7.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.86 -37.96 6.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.798 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.15 -55.91 4.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.812 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -74.81 -66.59 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 109.899 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -108.9 98.44 29.79 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 88.7 Cg_exo -44.08 179.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.404 2.069 . . . . 0.0 113.095 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.441 ' HB2' ' NE2' ' A' ' 122' ' ' HIS . . . -86.94 -34.64 19.27 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.599 0.714 . . . . 0.0 109.613 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 72.9 -0.51 3.34 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 1.492 ' CZ ' ' NE2' ' B' ' 116' ' ' HIS . 26.3 m-85 61.07 41.82 13.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.897 -0.502 . . . . 0.0 111.641 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.732 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -95.07 114.31 63.41 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.762 -1.211 . . . . 0.0 107.887 178.135 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.834 ' HA ' HG13 ' B' ' 33' ' ' VAL . 51.5 Cg_exo -49.77 18.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.087 1.858 . . . . 0.0 112.715 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -142.13 -23.39 0.69 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.048 -1.032 . . . . 0.0 110.579 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.763 HG13 ' N ' ' A' ' 122' ' ' HIS . 13.3 p -59.25 -58.04 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.027 -1.046 . . . . 0.0 110.179 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.763 ' N ' HG13 ' A' ' 121' ' ' VAL . 1.7 m-70 -71.29 -32.02 68.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 108.934 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' B' ' 33' ' ' VAL . . . -74.38 -20.41 60.08 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.435 -0.791 . . . . 0.0 108.939 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 128' ' ' PHE . 3.1 m -73.42 -63.42 1.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 110.038 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.706 HD13 HD11 ' A' ' 105' ' ' LEU . 10.5 mt -63.44 -28.17 69.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.85 -1.156 . . . . 0.0 109.382 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.752 ' OD1' ' CD2' ' B' ' 35' ' ' TYR . 8.7 t0 -69.67 -47.91 61.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.117 -0.99 . . . . 0.0 109.473 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.44 -40.83 11.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.099 -1.001 . . . . 0.0 109.931 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.515 ' CD1' HG21 ' A' ' 10' ' ' VAL . 72.7 t80 -48.45 -20.91 0.47 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.994 -1.066 . . . . 0.0 109.098 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 133' ' ' SER . 12.1 mt -71.43 -26.27 62.67 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -55.07 -30.57 59.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.1 t -81.17 -33.43 33.09 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.485 HG22 ' SD ' ' A' ' 76' ' ' MET . 55.2 t -85.1 -28.62 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.31 -0.869 . . . . 0.0 108.828 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 129' ' ' LEU . 18.3 p -80.52 -23.27 40.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.398 -0.814 . . . . 0.0 109.096 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.3 m -75.35 -39.88 58.86 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.31 -0.869 . . . . 0.0 109.163 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.67 -29.72 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.187 -0.945 . . . . 0.0 108.794 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -33.96 77.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.384 -0.823 . . . . 0.0 108.927 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 62.8 m -96.12 -21.46 17.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 109.517 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.497 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -146.36 169.13 19.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 109.232 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.4 p -67.26 152.01 96.56 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.92 -27.5 25.6 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.533 2.155 . . . . 0.0 112.033 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -57.7 -45.24 85.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.233 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.31 -49.23 15.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -0.887 . . . . 0.0 109.374 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.5 OUTLIER -50.52 -54.18 24.34 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.28 -0.887 . . . . 0.0 109.531 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -43.52 -24.14 0.1 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.745 -0.597 . . . . 0.0 110.267 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.3 -56.57 3.69 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.016 -1.052 . . . . 0.0 109.725 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.499 HG23 ' CD2' ' B' ' 130' ' ' TYR . 1.5 p -69.8 -24.61 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 16.5 m -72.19 -47.42 50.82 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.539 0.685 . . . . 0.0 109.431 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.13 -31.89 70.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.371 -0.831 . . . . 0.0 109.589 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.409 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -49.08 -33.2 11.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.112 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -23.78 1.34 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.82 -61.79 3.9 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.488 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -58.33 -30.07 66.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -1.126 . . . . 0.0 109.224 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 14' ' ' LEU . 49.2 t -54.11 114.71 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.558 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' B' ' 20' ' ' VAL . 45.0 m-80 -83.7 70.63 10.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 108.942 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' B' ' 19' ' ' ASN . 73.8 t -43.65 -26.6 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.425 -0.797 . . . . 0.0 109.658 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' B' ' 19' ' ' ASN . 1.2 p30 -58.41 -5.67 0.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.63 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' B' ' 20' ' ' VAL . 54.3 mt-10 -154.92 -42.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.533 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 81.5 t -49.68 -24.49 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.46 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.11 -55.53 3.49 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.78 -31.06 66.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.78 -26.67 57.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -1.162 . . . . 0.0 109.44 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.92 -52.58 64.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.366 -0.834 . . . . 0.0 109.625 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.544 ' N ' HD22 ' B' ' 28' ' ' LEU . 3.7 mm? -64.49 -56.81 11.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.977 . . . . 0.0 109.394 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.26 -48.8 46.45 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.975 ' NH2' ' CD1' ' A' ' 117' ' ' PHE . 28.2 mmt180 -56.54 -47.71 78.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -1.152 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.26 -34.76 15.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 39.9 mt -80.69 -21.55 41.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.834 HG13 ' HA ' ' A' ' 119' ' ' PRO . 88.2 t -86.97 -64.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 0.0 109.726 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.648 HG13 ' HB3' ' A' ' 122' ' ' HIS . 2.8 t -52.04 -45.21 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 110.003 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.752 ' CD2' ' OD1' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -160.35 102.64 1.37 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.1 -1.0 . . . . 0.0 109.591 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.14 69.8 6.9 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.526 2.15 . . . . 0.0 112.149 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' B' ' 37' ' ' TRP . 0.0 OUTLIER -79.6 -19.53 49.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.399 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' B' ' 39' ' ' GLN . 28.4 p -48.05 -69.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.945 . . . . 0.0 109.621 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLN . . . . . 0.497 ' N ' ' OG1' ' B' ' 38' ' ' THR . 19.6 tt0 51.36 46.17 26.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.254 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -153.22 -58.67 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -84.7 8.34 17.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.487 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.616 ' HE1' HH12 ' C' ' 92' ' ' ARG . 29.0 p90 -58.07 -35.42 71.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -80.4 -21.63 42.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 109.382 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 16.5 m -58.5 -50.24 74.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.98 -8.83 1.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.517 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.02 -94.51 0.15 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -45.2 122.46 3.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.331 -1.1 . . . . 0.0 109.747 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -153.5 15.15 0.51 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.24 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.0 t -46.77 -39.07 11.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.625 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 8.1 p -144.63 152.24 52.3 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.492 -0.755 . . . . 0.0 108.965 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -44.92 -45.12 14.26 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.064 1.843 . . . . 0.0 112.143 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 53' ' ' ALA . 1.7 p30 -59.07 -39.79 83.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.527 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' B' ' 52' ' ' ASP . . . -52.25 -19.82 2.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.11 -63.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.492 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 39.6 mtm -73.63 9.77 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.511 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.21 -13.79 63.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -90.79 148.59 38.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.174 -1.192 . . . . 0.0 109.355 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.19 -19.6 17.29 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.619 2.213 . . . . 0.0 112.098 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.75 -28.25 33.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.632 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -78.36 -40.34 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.681 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -79.08 -28.54 43.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.1 -48.71 19.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.694 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' HIS . . . . . 0.449 ' O ' ' ND1' ' B' ' 63' ' ' HIS . 3.1 t-80 -48.21 -23.87 1.0 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.41 -54.91 13.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -46.78 -34.62 5.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -1.154 . . . . 0.0 109.609 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -75.81 -37.62 58.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.318 -0.864 . . . . 0.0 109.669 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 33.6 t -71.73 -46.6 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.79 -32.56 67.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 109.253 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.81 -53.7 42.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.61 -48.85 66.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.397 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.49 -36.17 73.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.316 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 29.8 p -80.09 -24.23 40.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.479 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -51.87 -42.49 62.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.411 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.06 -60.25 8.3 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.553 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -58.26 -30.76 66.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.248 -1.148 . . . . 0.0 109.32 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.78 -3.01 58.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.595 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.452 ' C ' ' H ' ' B' ' 79' ' ' ASP . 10.3 t-80 -168.0 61.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.629 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mt -73.37 14.38 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.141 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' B' ' 77' ' ' HIS . 30.1 t70 -69.07 -32.19 71.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.496 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' B' ' 79' ' ' ASP . 70.0 m-20 -163.23 104.2 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 109.461 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 37.6 mt -80.28 -58.8 2.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.378 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -48.6 -24.23 1.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.415 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.03 -62.15 3.46 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.7 t -62.82 -47.18 84.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -1.223 . . . . 0.0 109.437 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.5 m-85 -66.84 0.91 2.13 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.491 -0.756 . . . . 0.0 109.447 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.86 -47.36 86.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.405 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 4.9 p -72.68 -53.6 11.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.376 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 24.7 mt -49.87 -46.49 51.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 85.9 p -56.37 -46.67 79.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.347 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.73 -40.6 95.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.301 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.31 -44.58 87.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.374 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' B' ' 97' ' ' HIS . 76.0 m80 -73.38 -24.25 60.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 110.247 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.72 -60.91 1.97 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.028 -1.045 . . . . 0.0 111.24 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.1 -57.1 3.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.861 -1.15 . . . . 0.0 111.671 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' LYS . . . . . 0.499 ' O ' HD12 ' B' ' 96' ' ' LEU . 55.9 mmtt -66.15 -9.92 36.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 111.515 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.563 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 1.0 OUTLIER -143.11 -33.89 0.44 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.741 -1.224 . . . . 0.0 109.987 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 33.2 p-80 43.62 25.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' B' ' 96' ' ' LEU . 24.9 t -53.73 138.96 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.089 -1.007 . . . . 0.0 109.104 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' ASP . . . . . 0.438 ' OD1' HG21 ' C' ' 96' ' ' VAL . 7.4 m-20 -46.43 149.43 1.38 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.443 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.19 -17.47 45.17 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.575 2.184 . . . . 0.0 112.217 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -89.76 47.05 1.42 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' B' ' 99' ' ' ASP . 2.9 m120 -137.29 -3.44 1.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -0.886 . . . . 0.0 109.794 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -97.68 -60.46 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.432 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -50.92 -19.97 1.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.691 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.597 HD12 ' N ' ' B' ' 105' ' ' LEU . 7.9 mp -77.9 -52.84 8.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.621 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.404 HD23 ' C ' ' B' ' 106' ' ' LEU . 5.0 tt -54.6 -52.17 63.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 109.341 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.56 -22.02 7.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -85.65 -53.69 5.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -1.184 . . . . 0.0 109.69 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 91.9 t -46.66 -30.28 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.808 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 113' ' ' VAL . 5.2 tp -62.07 -55.32 30.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.597 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' B' ' 130' ' ' TYR . 90.3 t -46.75 -26.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 109.784 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 34.6 t -74.75 -26.22 59.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 109.643 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' B' ' 110' ' ' LEU . 39.3 t -83.45 -25.32 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.022 . . . . 0.0 109.525 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.6 -25.6 33.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.467 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -75.69 -19.58 59.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.705 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 1.492 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.3 OUTLIER -83.42 -52.48 6.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.165 -0.96 . . . . 0.0 109.458 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.487 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 61.0 m170 -73.32 -17.62 61.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.452 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.487 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 11.1 m-85 -149.41 55.78 0.98 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.857 . . . . 0.0 109.39 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -61.6 -14.78 44.46 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.62 -20.94 27.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -1.122 . . . . 0.0 109.512 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.4 mm-40 -83.85 -7.37 59.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -73.54 33.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.572 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.481 ' H ' ' C ' ' B' ' 121' ' ' GLU . 77.8 p -47.51 148.38 2.47 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 0.0 109.374 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.471 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.4 Cg_exo -44.64 -56.13 2.83 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.505 2.137 . . . . 0.0 112.941 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 19.8 Cg_endo -60.5 -35.28 91.03 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.162 1.908 . . . . 0.0 112.104 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.469 HG23 ' OG1' ' B' ' 123' ' ' THR . 78.2 t -72.02 -17.34 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 109.581 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -83.42 -59.75 2.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 109.75 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.626 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -53.74 -33.38 55.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.58 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.44 27.5 0.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.499 ' CD2' HG23 ' B' ' 11' ' ' VAL . 4.2 t80 -125.09 -38.27 2.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.317 -0.864 . . . . 0.0 109.606 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 1.003 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 46.0 tt0 -67.56 -23.94 65.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.898 . . . . 0.0 109.822 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -84.5 -36.42 22.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 109.716 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.68 -49.34 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.968 . . . . 0.0 109.786 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.444 HG22 ' H ' ' B' ' 134' ' ' VAL . 4.5 m -79.5 -23.82 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.895 . . . . 0.0 109.768 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.4 -27.94 11.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 109.456 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.16 -23.05 61.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.3 t -79.07 -27.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.46 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.98 -42.8 56.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 139' ' ' ASN . . . . . 0.532 ' OD1' ' OD1' ' D' ' 139' ' ' ASN . 37.8 t30 -76.83 -21.22 55.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.57 -60.34 2.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 17.1 mt -55.21 -22.33 17.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.459 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.25 -17.99 24.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.882 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -46.3 -46.55 18.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' B' ' 146' ' ' HIS . 5.7 tppt? -77.08 -57.56 3.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.472 ' CD1' ' C ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -51.53 -10.61 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.533 -0.729 . . . . 0.0 109.23 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.468 ' H ' ' C ' ' B' ' 144' ' ' LYS . 11.6 m-70 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.735 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' C' ' 2' ' ' LEU . 1.3 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.507 ' N ' HD12 ' C' ' 2' ' ' LEU . 10.8 mp 53.17 176.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 109.541 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.513 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 174.56 -47.79 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 0.0 109.976 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' C' ' 6' ' ' ASP . 71.8 Cg_exo -47.16 169.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.549 2.166 . . . . 0.0 112.759 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.47 -15.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.43 -0.794 . . . . 0.0 110.126 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' C' ' 4' ' ' PRO . 25.1 t70 -38.8 -40.53 0.63 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 109.888 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.453 ' H ' ' HG2' ' C' ' 7' ' ' LYS . 13.5 ptpt -67.93 -45.68 73.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.113 -0.992 . . . . 0.0 109.299 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.418 ' N ' ' O ' ' C' ' 5' ' ' ALA . 37.4 m -52.99 -31.06 38.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -78.08 -35.98 48.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.521 HG21 ' CD1' ' C' ' 128' ' ' PHE . 92.0 t -69.67 -49.1 61.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.82 -47.45 64.31 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.17 -60.77 2.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.585 -0.697 . . . . 0.0 109.569 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.746 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -50.94 -38.96 53.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.322 -0.861 . . . . 0.0 109.319 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -17.31 61.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.207 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.57 -45.68 7.22 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.63 -34.92 72.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -1.165 . . . . 0.0 108.696 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.746 HG23 ' O ' ' C' ' 13' ' ' ALA . 70.2 t -61.94 -66.91 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 64.51 -143.62 47.26 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.42 48.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.443 -1.034 . . . . 0.0 110.0 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' C' ' 18' ' ' GLY . 80.7 m-70 -151.73 19.64 0.7 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.45 -65.24 1.03 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.66 -0.65 . . . . 0.0 109.769 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.65 -14.58 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' C' ' 21' ' ' ALA . 2.1 mm-40 -83.19 -56.46 3.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -1.168 . . . . 0.0 109.673 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.8 m-30 -55.95 -35.29 66.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.41 -0.806 . . . . 0.0 109.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.06 -22.83 60.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.52 -38.32 29.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -1.118 . . . . 0.0 109.795 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.61 -19.71 63.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.72 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.52 -22.39 51.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 109.683 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.5 mt -76.38 -43.99 38.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 109.706 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -65.7 -12.81 56.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.699 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -59.01 2.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptm -62.26 -25.67 67.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' PHE . . . . . 0.525 ' CE2' ' O ' ' C' ' 48' ' ' LEU . 1.3 t80 -58.56 -56.09 26.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 109.621 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.63 ' CD1' ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -82.34 -42.51 18.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 110.234 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 12.6 t -59.69 -9.21 2.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.01 . . . . 0.0 109.659 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 1.01 ' CZ ' ' NE2' ' D' ' 131' ' ' GLN . 79.5 m-85 -155.33 81.66 4.01 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.582 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' C' ' 39' ' ' THR . 52.6 Cg_exo -52.48 -24.96 23.56 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.689 2.259 . . . . 0.0 112.245 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.496 HG22 ' HB2' ' B' ' 97' ' ' HIS . 8.7 p -46.78 -19.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.877 . . . . 0.0 109.517 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.445 ' N ' ' O ' ' C' ' 37' ' ' PRO . 51.5 p -82.89 -26.15 31.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 109.676 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' C' ' 37' ' ' PRO . 26.6 ttpt -79.37 -53.62 6.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.653 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.907 . . . . 0.0 109.576 -179.929 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.571 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 22.0 p80 . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 121.495 0.664 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.544 ' O ' ' C ' ' C' ' 47' ' ' ASP . 3.9 t80 -104.31 31.46 4.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.756 . . . . 0.0 109.705 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' C' ' 46' ' ' PHE . 15.1 m-20 28.69 67.71 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.817 -0.552 . . . . 0.0 110.524 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.525 ' O ' ' CE2' ' C' ' 33' ' ' PHE . 87.2 mt -85.15 22.25 1.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.978 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.434 ' O ' ' O ' ' C' ' 50' ' ' HIS . 19.3 m -76.61 26.6 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 50' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' C' ' 48' ' ' LEU . 54.9 t60 58.07 158.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.842 . . . . 0.0 109.557 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.72 17.91 5.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 9.0 t -80.33 -17.73 51.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -1.152 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 68.62 -58.54 0.48 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.688 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' C' ' 52' ' ' SER . 0.7 OUTLIER -43.74 -20.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.401 -0.812 . . . . 0.0 109.818 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' C' ' 53' ' ' ALA . 89.1 t -77.41 -27.33 15.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.277 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' C' ' 53' ' ' ALA . 5.9 ptmt -63.6 -27.18 69.06 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.293 -0.879 . . . . 0.0 109.395 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.86 -27.63 68.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 58' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -84.15 -30.66 25.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -1.17 . . . . 0.0 110.103 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.06 -49.41 55.73 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -60.1 -23.66 64.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -1.146 . . . . 0.0 110.068 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.32 -33.96 65.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.192 -0.942 . . . . 0.0 109.146 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.41 -52.83 21.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.434 -0.791 . . . . 0.0 108.991 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.47 69.86 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.324 -0.86 . . . . 0.0 109.186 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -68.3 -41.38 81.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 108.848 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.07 -42.47 80.38 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' C' ' 66' ' ' LEU . 9.9 mt -63.4 -46.2 87.5 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -63.24 -48.68 77.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.206 -0.934 . . . . 0.0 109.029 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -62.72 -22.55 66.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 108.829 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -85.22 -47.69 9.85 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.83 -22.69 29.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -14.57 62.42 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.669 ' O ' HG12 ' C' ' 73' ' ' VAL . 21.5 m80 -141.92 -57.45 0.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.796 . . . . 0.0 109.65 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.669 HG12 ' O ' ' C' ' 72' ' ' HIS . 8.2 p 46.16 15.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 122.067 0.937 . . . . 0.0 108.718 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' C' ' 72' ' ' HIS . 21.9 m-20 -136.39 12.53 3.25 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.96 30.52 0.06 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.557 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 1.2 mtm -66.63 -44.69 55.38 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.658 -0.651 . . . . 0.0 110.098 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' C' ' 76' ' ' MET . 95.5 Cg_exo -42.24 -43.03 7.67 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.431 2.087 . . . . 0.0 112.601 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -94.15 -18.97 21.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.001 . . . . 0.0 110.025 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 -58.5 3.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.034 -1.041 . . . . 0.0 109.081 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 18.7 mt -83.14 16.91 2.19 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 81' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' C' ' 77' ' ' PRO . 0.5 OUTLIER -61.67 -21.93 64.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.848 . . . . 0.0 109.363 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -74.79 -57.97 3.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.454 ' N ' HD23 ' C' ' 83' ' ' LEU . 3.1 mt -44.74 -39.74 5.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.524 ' O ' ' N ' ' C' ' 88' ' ' ALA . 26.5 t -54.51 -34.45 61.68 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' C' ' 82' ' ' ALA . 4.0 m-20 -66.09 -24.28 66.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.136 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.454 ' CD1' ' NZ ' ' C' ' 90' ' ' LYS . 7.3 tp -80.52 -38.52 29.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.327 -0.858 . . . . 0.0 109.203 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -92.32 -21.64 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.723 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' C' ' 84' ' ' SER . . . -76.49 -38.95 54.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 89' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' C' ' 90' ' ' LYS . 50.1 t-80 -146.6 -83.43 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.101 -0.999 . . . . 0.0 110.114 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.454 ' NZ ' ' CD1' ' C' ' 86' ' ' LEU . 0.9 OUTLIER -43.85 105.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 109.67 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tp 63.61 59.22 1.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.343 -0.848 . . . . 0.0 109.29 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 92' ' ' ARG . . . . . 0.616 HH12 ' HE1' ' B' ' 42' ' ' PHE . 10.6 ptp180 -60.74 -22.63 64.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.578 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.899 HG22 ' H ' ' C' ' 94' ' ' ASP . 12.7 p 42.08 -176.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.642 -0.661 . . . . 0.0 110.084 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.899 ' H ' HG22 ' C' ' 93' ' ' VAL . 50.7 m-20 -80.85 120.68 79.6 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.969 -1.082 . . . . 0.0 109.459 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' C' ' 97' ' ' ASN . 73.5 Cg_endo -78.61 -37.86 0.6 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.359 2.039 . . . . 0.0 112.124 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.438 HG21 ' OD1' ' B' ' 99' ' ' ASP . 6.2 t -55.36 -0.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.707 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.564 ' H ' ' C ' ' C' ' 95' ' ' PRO . 4.8 m120 -79.03 -24.85 43.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.065 -1.022 . . . . 0.0 109.693 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 98' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' C' ' 95' ' ' PRO . 26.9 m-85 -49.27 -17.64 0.27 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.421 ' N ' ' C ' ' C' ' 97' ' ' ASN . 91.9 mttt -81.99 -28.22 32.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.377 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 13.5 mt -84.1 -39.04 19.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.384 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 101' ' ' LEU . . . . . 0.633 ' O ' HD23 ' C' ' 101' ' ' LEU . 2.0 tt -57.97 -40.08 79.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -66.28 -59.18 3.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.986 . . . . 0.0 109.772 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -62.15 -26.59 68.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 109.809 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 57.8 m -74.12 -34.8 64.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.894 ' O ' HD12 ' C' ' 105' ' ' LEU . 0.0 OUTLIER -84.2 -34.67 23.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.11 -0.994 . . . . 0.0 109.182 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 20.0 mt -62.99 -44.09 96.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.455 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.47 -24.92 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 54.8 m -64.6 -59.33 4.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.564 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.408 HD11 HD11 ' C' ' 105' ' ' LEU . 59.1 mt -46.21 -37.84 7.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.601 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.8 -38.05 6.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.849 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.04 -55.95 4.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.861 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -74.82 -66.59 0.73 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 109.895 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -108.9 98.45 29.84 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.481 -0.762 . . . . 0.0 108.96 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' C' ' 113' ' ' LEU . 89.8 Cg_exo -44.02 179.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.45 2.1 . . . . 0.0 113.036 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.448 ' HB2' ' NE2' ' C' ' 122' ' ' HIS . . . -86.94 -34.76 19.23 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.594 0.711 . . . . 0.0 109.584 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 72.97 -0.53 3.35 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 1.493 ' CZ ' ' NE2' ' D' ' 116' ' ' HIS . 26.6 m-85 61.05 41.79 13.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.884 -0.51 . . . . 0.0 111.624 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.3 OUTLIER -95.01 114.22 63.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.773 -1.204 . . . . 0.0 107.922 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 119' ' ' PRO . . . . . 0.806 ' HA ' HG13 ' D' ' 33' ' ' VAL . 51.8 Cg_exo -49.68 18.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.224 1.949 . . . . 0.0 112.678 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -142.1 -23.41 0.69 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 110.599 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.773 HG13 ' N ' ' C' ' 122' ' ' HIS . 13.4 p -59.27 -57.99 8.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.003 -1.06 . . . . 0.0 110.206 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.773 ' N ' HG13 ' C' ' 121' ' ' VAL . 1.7 m-70 -71.23 -32.19 68.47 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 108.879 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 123' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' D' ' 33' ' ' VAL . . . -74.24 -20.5 60.14 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.398 -0.814 . . . . 0.0 108.968 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' C' ' 128' ' ' PHE . 3.1 m -73.44 -63.37 1.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.247 -0.908 . . . . 0.0 109.979 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.706 HD13 HD11 ' C' ' 105' ' ' LEU . 10.5 mt -63.55 -28.09 69.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.978 -1.077 . . . . 0.0 109.339 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 126' ' ' ASP . . . . . 0.744 ' OD1' ' CD2' ' D' ' 35' ' ' TYR . 8.7 t0 -69.63 -47.99 61.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.113 -0.992 . . . . 0.0 109.527 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.32 -40.82 11.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.064 -1.022 . . . . 0.0 109.938 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.521 ' CD1' HG21 ' C' ' 10' ' ' VAL . 72.8 t80 -48.64 -20.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.954 -1.091 . . . . 0.0 109.043 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' C' ' 133' ' ' SER . 12.1 mt -71.48 -26.33 62.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -55.0 -30.58 59.72 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 4.2 t -81.17 -33.36 33.13 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.449 -0.782 . . . . 0.0 108.897 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 132' ' ' VAL . . . . . 0.486 HG22 ' SD ' ' C' ' 76' ' ' MET . 55.5 t -85.15 -28.61 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.354 -0.841 . . . . 0.0 108.817 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.547 ' N ' ' O ' ' C' ' 129' ' ' LEU . 18.6 p -80.61 -23.17 39.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.515 -0.741 . . . . 0.0 109.009 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 134' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 29.5 m -75.34 -40.0 58.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 109.15 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.55 -29.75 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.915 . . . . 0.0 108.783 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -34.01 77.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.4 -0.812 . . . . 0.0 108.885 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 63.0 m -96.13 -21.42 17.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.508 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 -179.933 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.49 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.2 OUTLIER -146.33 169.13 19.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 109.257 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 3.4 p -67.27 152.04 96.53 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.01 -27.54 25.17 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.562 2.175 . . . . 0.0 111.947 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -57.63 -45.21 85.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.34 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.22 -49.38 15.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.349 -0.844 . . . . 0.0 109.359 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.5 OUTLIER -50.4 -54.22 23.42 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.312 -0.868 . . . . 0.0 109.582 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -43.56 -24.06 0.1 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.72 -0.612 . . . . 0.0 110.278 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.36 -56.54 3.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.061 -1.024 . . . . 0.0 109.677 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.498 HG23 ' CD2' ' D' ' 130' ' ' TYR . 1.5 p -69.84 -24.63 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 16.3 m -72.25 -47.29 51.38 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.432 0.634 . . . . 0.0 109.462 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.19 -31.91 70.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.546 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.05 -33.13 10.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.22 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -49.1 -23.86 1.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 109.427 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.69 -61.87 3.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.467 ' CD ' ' H ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -58.32 -30.02 66.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.203 -1.175 . . . . 0.0 109.259 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 49.8 t -54.14 114.67 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.887 . . . . 0.0 109.598 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' D' ' 21' ' ' ASP . 45.1 m-80 -83.74 70.6 10.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 108.89 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' D' ' 22' ' ' GLU . 73.5 t -43.46 -26.76 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.416 -0.802 . . . . 0.0 109.691 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' D' ' 19' ' ' ASN . 1.2 p30 -58.37 -5.66 0.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.644 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' D' ' 20' ' ' VAL . 54.3 mt-10 -155.0 -42.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 81.4 t -49.76 -24.44 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -0.942 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.13 -55.53 3.49 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.84 -31.06 67.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.79 -26.57 57.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -1.187 . . . . 0.0 109.444 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.11 -52.56 64.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 28' ' ' LEU . . . . . 0.537 ' N ' HD22 ' D' ' 28' ' ' LEU . 3.7 mm? -64.52 -56.75 12.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.128 -0.983 . . . . 0.0 109.384 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.33 -48.75 47.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 30' ' ' ARG . . . . . 0.961 ' NH2' ' CD1' ' C' ' 117' ' ' PHE . 28.3 mmt180 -56.61 -47.63 79.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.334 -1.097 . . . . 0.0 109.517 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.29 -34.81 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.568 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 40.1 mt -80.67 -21.52 41.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' VAL . . . . . 0.806 HG13 ' HA ' ' C' ' 119' ' ' PRO . 88.3 t -87.01 -64.07 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.915 . . . . 0.0 109.744 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' C' ' 122' ' ' HIS . 2.8 t -52.06 -45.19 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 110.007 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 35' ' ' TYR . . . . . 0.744 ' CD2' ' OD1' ' C' ' 126' ' ' ASP . 0.2 OUTLIER -160.42 102.53 1.36 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.105 -0.997 . . . . 0.0 109.614 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.04 69.92 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.491 2.127 . . . . 0.0 112.076 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -19.66 48.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.422 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' D' ' 39' ' ' GLN . 28.5 p -48.04 -69.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.59 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 39' ' ' GLN . . . . . 0.494 ' N ' ' OG1' ' D' ' 38' ' ' THR . 19.5 tt0 51.39 46.13 26.94 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.139 -0.976 . . . . 0.0 109.304 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -153.26 -58.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.355 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -84.66 8.25 17.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.657 ' HE1' HH12 ' A' ' 92' ' ' ARG . 29.1 p90 -57.97 -35.49 71.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 43' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' D' ' 42' ' ' PHE . 19.7 pt-20 -80.35 -21.64 42.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.841 . . . . 0.0 109.398 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 16.6 m -58.5 -50.26 74.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.482 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.01 -8.81 1.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.43 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.01 -94.57 0.15 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -45.11 122.47 3.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -1.108 . . . . 0.0 109.779 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -153.57 15.2 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.235 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.0 t -46.76 -39.15 11.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.603 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 50' ' ' THR . . . . . 0.424 ' HG1' ' CG ' ' D' ' 52' ' ' ASP . 8.0 p -144.64 152.23 52.22 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.416 -0.802 . . . . 0.0 108.902 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -44.9 -45.13 14.18 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.072 1.848 . . . . 0.0 112.151 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 52' ' ' ASP . . . . . 0.424 ' CG ' ' HG1' ' D' ' 50' ' ' THR . 1.7 p30 -59.12 -39.67 83.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.606 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.414 ' N ' ' OD1' ' D' ' 52' ' ' ASP . . . -52.32 -19.82 2.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.416 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.02 -64.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 39.6 mtm -73.56 9.67 1.32 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.15 -13.75 63.51 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.76 148.47 38.47 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.18 -1.188 . . . . 0.0 109.369 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.15 -19.54 17.43 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.58 2.187 . . . . 0.0 112.154 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.76 -28.28 33.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.654 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.31 -40.32 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 0.0 109.697 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -79.13 -28.55 42.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.649 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.11 -48.73 19.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.735 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 63' ' ' HIS . . . . . 0.426 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 3.1 t-80 -48.13 -23.88 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.691 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.44 -54.98 13.47 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -46.69 -34.65 5.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -1.132 . . . . 0.0 109.582 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -75.9 -37.64 58.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.351 -0.843 . . . . 0.0 109.558 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 34.1 t -71.73 -46.63 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.411 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.75 -32.56 67.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 0.0 109.279 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.81 -53.65 42.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.68 -48.79 66.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 109.364 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.63 -36.03 73.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.237 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 30.1 p -80.19 -24.2 40.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.468 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -51.92 -42.6 62.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.0 -60.12 8.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.551 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -58.38 -30.79 67.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -1.123 . . . . 0.0 109.238 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.68 -3.15 58.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 109.543 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.454 ' C ' ' H ' ' D' ' 79' ' ' ASP . 10.2 t-80 -167.96 61.81 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.666 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mt -73.42 14.43 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -0.971 . . . . 0.0 109.145 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.454 ' H ' ' C ' ' D' ' 77' ' ' HIS . 30.2 t70 -68.99 -32.32 71.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.482 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -163.19 104.14 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.337 -0.852 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 37.3 mt -80.24 -58.8 2.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.409 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -48.59 -24.14 1.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.444 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.09 -62.21 3.42 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.7 t -62.76 -47.18 84.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.166 . . . . 0.0 109.452 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.4 m-85 -66.94 0.96 2.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.521 -0.737 . . . . 0.0 109.486 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.42 85.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.966 . . . . 0.0 109.466 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 5.1 p -72.64 -53.63 11.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 0.0 109.42 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 24.7 mt -49.87 -46.52 51.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.432 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 85.5 p -56.3 -46.7 79.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.419 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.69 -40.6 95.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.327 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.25 -44.7 87.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 109.338 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' D' ' 97' ' ' HIS . 76.0 m80 -73.39 -24.24 60.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 110.207 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.71 -60.94 1.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 0.0 111.245 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -88.05 -57.12 3.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.884 -1.135 . . . . 0.0 111.691 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 95' ' ' LYS . . . . . 0.493 ' O ' HD12 ' D' ' 96' ' ' LEU . 56.0 mmtt -66.23 -9.83 36.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.319 -0.863 . . . . 0.0 111.494 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.559 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 1.0 OUTLIER -143.13 -33.89 0.43 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.771 -1.206 . . . . 0.0 110.028 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 33.2 p-80 43.62 25.51 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.264 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 98' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' D' ' 96' ' ' LEU . 24.9 t -53.7 139.09 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.065 -1.022 . . . . 0.0 109.045 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 99' ' ' ASP . . . . . 0.479 ' OD1' HG21 ' A' ' 96' ' ' VAL . 7.4 m-20 -46.54 149.41 1.42 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.509 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.19 -17.43 45.18 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.584 2.189 . . . . 0.0 112.263 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -89.74 46.94 1.41 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 109.668 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 102' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' D' ' 99' ' ' ASP . 2.9 m120 -137.29 -3.42 1.95 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 109.811 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -97.73 -60.41 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.118 -0.989 . . . . 0.0 109.435 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -51.05 -19.93 1.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 109.588 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 105' ' ' LEU . . . . . 0.602 ' N ' HD12 ' D' ' 105' ' ' LEU . 7.9 mp -77.98 -52.87 8.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.0 tt -54.48 -52.19 62.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.58 -22.0 7.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -85.64 -53.7 5.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -1.19 . . . . 0.0 109.723 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 92.9 t -46.66 -30.27 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 109.88 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.99 -55.39 29.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.644 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 111' ' ' VAL . . . . . 0.404 HG22 ' CE1' ' D' ' 130' ' ' TYR . 90.2 t -46.71 -26.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.774 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 34.4 t -74.63 -26.31 59.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.893 . . . . 0.0 109.704 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.48 -25.28 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.6 -25.6 33.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.742 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -75.72 -19.48 59.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.673 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 1.493 ' NE2' ' CZ ' ' C' ' 117' ' ' PHE . 0.3 OUTLIER -83.52 -52.44 6.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 117' ' ' HIS . . . . . 0.493 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 61.0 m170 -73.29 -17.62 61.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 11.2 m-85 -149.39 55.73 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -61.47 -14.81 43.62 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.7 -20.89 27.07 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.213 -1.169 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' D' ' 123' ' ' THR . 59.4 mm-40 -83.87 -7.34 59.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.683 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.71 33.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 109.527 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.488 ' H ' ' C ' ' D' ' 121' ' ' GLU . 77.4 p -47.55 148.42 2.49 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.434 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.3 Cg_exo -44.63 -56.15 2.81 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.491 2.127 . . . . 0.0 112.956 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 19.8 Cg_endo -60.46 -35.26 91.34 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.187 1.924 . . . . 0.0 112.078 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.471 HG23 ' OG1' ' D' ' 123' ' ' THR . 78.5 t -72.09 -17.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -83.33 -59.78 2.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 109.789 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.63 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -53.69 -33.43 55.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.624 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.48 27.64 0.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.541 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.498 ' CD2' HG23 ' D' ' 11' ' ' VAL . 4.3 t80 -125.2 -38.22 2.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.411 -0.805 . . . . 0.0 109.512 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 1.01 ' NE2' ' CZ ' ' C' ' 36' ' ' PHE . 45.9 tt0 -67.51 -23.97 65.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 109.835 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -84.46 -36.49 22.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 109.679 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.65 -49.39 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.787 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.447 ' H ' HG22 ' D' ' 134' ' ' VAL . 4.5 m -79.43 -23.87 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 109.783 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.4 -27.84 11.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.106 -0.996 . . . . 0.0 109.463 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.28 -23.1 61.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 93.9 t -78.93 -27.65 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -1.173 . . . . 0.0 109.55 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.92 -42.84 56.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.933 . . . . 0.0 109.446 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 139' ' ' ASN . . . . . 0.532 ' OD1' ' OD1' ' B' ' 139' ' ' ASN . 37.8 t30 -76.8 -21.17 55.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.578 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.67 -60.29 2.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 0.0 109.54 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 17.1 mt -55.24 -22.26 17.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.429 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.32 -17.88 24.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -46.34 -46.51 18.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' D' ' 146' ' ' HIS . 5.7 tppt? -77.2 -57.43 3.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 145' ' ' TYR . . . . . 0.484 ' CD1' ' C ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -51.58 -10.59 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.519 -0.738 . . . . 0.0 109.193 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.471 ' H ' ' C ' ' D' ' 144' ' ' LYS . 11.4 m-70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.666 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.449 HD13 ' CE2' ' A' ' 128' ' ' PHE . 14.7 mt -138.96 -174.21 3.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.248 -0.907 . . . . 0.0 109.412 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.496 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 175.9 -49.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 3' ' ' SER . 71.9 Cg_exo -47.01 173.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.507 2.138 . . . . 0.0 112.568 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -65.11 -16.33 63.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 5' ' ' ALA . 1.2 m-20 -39.71 -40.62 0.96 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 109.595 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.403 ' NZ ' ' CB ' ' A' ' 7' ' ' LYS . 8.3 mtmp? -60.51 -59.29 5.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.206 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 m -50.26 -28.68 8.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.198 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -80.09 -35.32 37.09 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.413 HG21 ' CG ' ' A' ' 128' ' ' PHE . 41.1 t -74.81 -44.57 45.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.74 -39.63 89.39 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.414 -0.803 . . . . 0.0 108.86 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.78 46.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.153 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.738 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.97 -35.43 64.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.445 -0.784 . . . . 0.0 109.073 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.54 -17.51 61.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.051 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.47 -46.34 8.96 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -68.9 -37.47 78.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.198 -1.177 . . . . 0.0 108.766 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 13' ' ' ALA . 99.2 t -61.17 -65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 59.59 -137.54 49.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.23 29.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.471 -1.017 . . . . 0.0 110.296 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.564 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.1 m-70 -131.82 23.35 4.62 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -87.3 -61.48 1.71 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.613 -0.68 . . . . 0.0 109.639 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.34 -14.62 0.35 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 21' ' ' ALA . 3.7 mm-40 -84.08 -56.45 3.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -1.111 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.1 m-30 -59.61 -33.17 71.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.396 -0.815 . . . . 0.0 109.322 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.33 -22.96 76.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.73 -43.54 20.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -1.176 . . . . 0.0 109.752 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.86 -19.91 65.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 -20.0 59.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.911 . . . . 0.0 109.366 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.531 HD13 ' CD2' ' A' ' 58' ' ' HIS . 18.6 mt -73.0 -46.04 54.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.588 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -61.98 -17.73 58.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 109.604 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.0 mmt-85 -81.18 -31.9 33.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 0.0 109.598 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -73.02 -37.63 66.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 109.525 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -62.95 -60.0 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 12.3 mt -59.32 -48.88 79.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.655 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.503 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 40.3 t -46.04 -27.4 0.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.923 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CD1' ' O ' ' A' ' 35' ' ' SER . 47.7 m-85 -154.18 123.88 3.25 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.026 -1.046 . . . . 0.0 109.55 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 40' ' ' LYS . 73.3 Cg_endo -77.9 -19.52 12.41 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.412 2.075 . . . . 0.0 112.159 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.2 p -43.9 -19.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 109.889 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 37' ' ' PRO . 3.4 p -90.27 -22.83 21.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.174 -0.954 . . . . 0.0 109.575 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 37' ' ' PRO . 27.8 ttmt -50.16 -18.74 0.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 109.954 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.863 -179.614 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.528 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.593 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -156.17 71.19 0.71 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.568 ' C ' ' H ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -46.41 -13.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.453 -0.779 . . . . 0.0 111.203 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 9.5 mt 59.0 -5.43 0.06 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.772 -1.205 . . . . 0.0 109.608 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.568 ' H ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -46.79 124.88 6.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 109.552 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -53.3 138.96 31.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.46 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.27 27.81 65.93 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 3.2 m -60.9 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.273 -1.134 . . . . 0.0 109.31 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 167.8 -64.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.424 -0.797 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -45.61 -17.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.47 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' ALA . 61.3 t -73.93 -29.98 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 109.791 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -70.96 -26.49 63.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.71 -22.92 68.38 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.4 OUTLIER -79.2 -39.89 32.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.171 -1.194 . . . . 0.0 109.549 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.27 -49.96 54.23 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 49.8 mttp -51.98 -23.87 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -1.104 . . . . 0.0 110.0 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -72.41 -45.11 61.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.19 -0.944 . . . . 0.0 109.107 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.3 t -67.62 -46.14 83.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.475 -0.765 . . . . 0.0 109.261 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.79 -31.0 68.68 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.2 -0.937 . . . . 0.0 109.313 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.4 t70 -69.39 -34.57 74.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.973 . . . . 0.0 108.752 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.85 -51.37 62.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.32 -0.863 . . . . 0.0 108.96 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.8 mt -56.34 -46.29 80.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 108.82 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -62.68 -51.57 66.69 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.274 -0.891 . . . . 0.0 108.871 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -59.67 -22.74 62.35 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.56 -46.98 11.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.65 -22.91 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.7 -16.95 64.59 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' A' ' 74' ' ' ASP . 15.8 m80 -143.88 -60.16 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.402 -0.811 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 69' ' ' ALA . 12.7 p 44.66 14.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.751 0.786 . . . . 0.0 109.286 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 72' ' ' HIS . 13.7 m-20 -131.22 11.44 5.0 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.438 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.8 p-10 -177.82 31.79 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.944 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.696 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -77.99 -24.21 0.44 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.398 -0.814 . . . . 0.0 111.709 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 76' ' ' MET . 75.6 Cg_exo -50.21 -33.92 37.8 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.71 1.607 . . . . 0.0 112.239 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -94.29 -16.04 23.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 0.0 109.503 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.65 -57.96 3.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 109.087 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.18 10.23 2.55 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.405 -0.809 . . . . 0.0 108.946 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -61.09 -28.73 69.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.396 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -63.9 -50.58 68.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.543 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.526 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 4.5 mt -47.22 -47.34 24.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 108.785 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 20.7 t -55.31 -25.9 37.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.426 -0.796 . . . . 0.0 109.299 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 89' ' ' HIS . 1.9 m-20 -78.45 -53.05 7.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.25 -28.65 65.1 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.327 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 8.4 m80 -92.6 -21.76 19.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.046 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -112.14 -2.39 14.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.133 -0.979 . . . . 0.0 110.354 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 85' ' ' ASP . 78.1 m80 -142.59 36.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.983 -1.073 . . . . 0.0 110.176 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -171.55 -77.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 0.0 109.723 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 91' ' ' LEU . 4.3 mm? -72.49 -37.34 68.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.09 -1.006 . . . . 0.0 109.346 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.666 ' HG2' ' NH1' ' D' ' 40' ' ' ARG . 28.1 ttm180 55.63 52.4 11.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.122 -0.987 . . . . 0.0 109.492 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.562 ' O ' ' NH2' ' D' ' 40' ' ' ARG . 0.3 OUTLIER -78.7 -173.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.154 -0.966 . . . . 0.0 109.44 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 96' ' ' VAL . 1.8 m-20 -123.91 113.65 28.35 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.482 -0.761 . . . . 0.0 109.139 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 98' ' ' PHE . 84.3 Cg_exo -43.34 -14.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.265 1.976 . . . . 0.0 112.378 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 94' ' ' ASP . 94.9 t -48.07 -25.65 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.595 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -79.38 -24.86 42.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.621 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' A' ' 95' ' ' PRO . 28.5 t80 -46.38 -40.76 12.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 109.623 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -59.42 -25.18 64.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.591 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.1 mt -84.01 -61.32 1.85 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.576 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tp -47.95 -41.08 24.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.2 t -61.99 -42.31 99.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.669 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -80.91 -26.51 36.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.762 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 79.9 m -58.38 -56.86 16.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.603 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.6 mt -47.01 -37.14 8.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.365 -0.834 . . . . 0.0 109.568 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.09 -30.93 68.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.866 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.9 t -82.97 -24.81 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.2 m -81.82 -62.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.61 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 113' ' ' LEU . 12.5 mt -46.26 -39.94 10.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.311 -0.868 . . . . 0.0 109.64 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.5 -42.49 7.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.818 . . . . 0.0 109.927 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.04 -44.37 69.37 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.312 -0.868 . . . . 0.0 109.483 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -91.52 -77.24 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.561 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 109' ' ' LEU . 1.9 tt -96.88 119.59 63.28 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.49 165.38 32.58 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.242 1.962 . . . . 0.0 112.821 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.469 ' C ' ' N ' ' A' ' 117' ' ' PHE . . . -87.81 -28.5 21.61 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.53 0.681 . . . . 0.0 109.68 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.542 ' O ' ' CG ' ' A' ' 117' ' ' PHE . 83.8 mt-10 57.09 10.62 0.84 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' A' ' 116' ' ' GLU . 27.7 p90 40.6 32.5 0.15 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.339 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 120' ' ' ALA . 3.2 p -56.02 134.39 74.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -49.51 18.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.401 2.068 . . . . 0.0 113.251 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -157.37 -20.2 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.595 -1.316 . . . . 0.0 111.555 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 122' ' ' HIS . 2.8 t -65.64 -63.13 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.543 -1.348 . . . . 0.0 110.055 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.599 ' CD2' HG22 ' B' ' 34' ' ' VAL . 0.0 OUTLIER -50.5 -31.14 14.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 108.977 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.65 -19.94 32.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.341 -0.85 . . . . 0.0 109.777 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 20.4 p -64.89 -62.33 1.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.201 -0.937 . . . . 0.0 110.599 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.507 ' N ' ' OG ' ' A' ' 124' ' ' SER . 2.0 mt -72.91 -19.78 61.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.119 -0.988 . . . . 0.0 110.051 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -81.45 -43.51 18.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 109.896 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -87.28 -47.59 8.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 109.86 -179.597 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 31.2 t80 -48.73 -21.5 0.63 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.122 -0.986 . . . . 0.0 109.47 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 133' ' ' SER . 18.7 mt -73.75 -21.06 60.32 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.15 -32.96 68.67 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.447 ' OG ' HD11 ' A' ' 2' ' ' LEU . 0.7 OUTLIER -78.67 -30.42 46.19 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.404 -0.81 . . . . 0.0 108.869 179.373 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.06 -30.18 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 108.85 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 129' ' ' LEU . 78.8 p -79.09 -25.08 43.08 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.392 -0.817 . . . . 0.0 108.968 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 53.6 m -70.68 -37.57 73.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.299 -0.875 . . . . 0.0 109.244 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.402 ' H ' HG12 ' A' ' 135' ' ' VAL . 5.0 p -79.52 -22.04 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.307 -0.871 . . . . 0.0 108.955 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -33.83 40.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.356 -0.84 . . . . 0.0 109.149 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 71.4 p -91.34 -1.46 57.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.48 -179.983 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' HIS . . . . . 0.579 ' O ' ' CG ' ' B' ' 2' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.314 0.578 . . . . 0.0 109.603 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.985 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -122.17 -174.11 2.82 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.344 -0.847 . . . . 0.0 109.286 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.498 ' O ' ' N ' ' B' ' 6' ' ' GLU . 9.6 p -104.77 143.67 27.17 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.471 -0.768 . . . . 0.0 109.129 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -39.33 -22.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.561 2.174 . . . . 0.0 112.349 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' B' ' 4' ' ' THR . 25.1 mt-10 -75.5 -57.05 4.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.903 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -80.75 -22.93 39.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 109.798 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.708 ' HB2' HD13 ' B' ' 3' ' ' LEU . 2.5 tttm -79.77 -31.99 40.94 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.222 -0.924 . . . . 0.0 109.281 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 11.1 t -63.92 -23.36 67.32 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.686 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.08 -57.68 3.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.074 -1.016 . . . . 0.0 110.062 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.43 ' H ' HG12 ' B' ' 11' ' ' VAL . 1.8 p -62.12 -24.44 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 73.9 m -84.06 -35.47 23.76 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.364 0.602 . . . . 0.0 109.588 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -64.25 -60.05 3.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.812 . . . . 0.0 109.751 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.447 ' O ' HG23 ' B' ' 18' ' ' VAL . 7.9 mp -43.59 -18.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.51 -0.744 . . . . 0.0 110.139 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' TRP . . . . . 0.537 ' N ' ' O ' ' B' ' 13' ' ' ALA . 25.9 t90 -75.45 -33.39 60.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 0.0 109.499 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 13' ' ' ALA . . . -67.28 -52.54 30.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.687 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -56.22 -36.41 68.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.364 -1.08 . . . . 0.0 109.236 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 14' ' ' LEU . 6.6 t -57.32 117.35 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.421 -0.8 . . . . 0.0 109.695 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' B' ' 21' ' ' ASP . 60.9 t30 -87.96 81.08 7.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.343 -0.848 . . . . 0.0 108.964 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.412 ' C ' ' N ' ' B' ' 22' ' ' GLU . 91.2 t -44.41 -17.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 109.781 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' B' ' 19' ' ' ASN . 22.2 t70 -51.12 -15.35 0.33 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.674 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.412 ' N ' ' C ' ' B' ' 20' ' ' VAL . 33.7 mt-10 -156.17 -37.55 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.619 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -47.44 -54.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.617 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.32 -33.33 70.27 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.62 -49.63 74.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' B' ' 28' ' ' LEU . 90.6 mt-10 -73.08 -44.27 60.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.0 109.501 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.52 -22.23 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' B' ' 26' ' ' GLU . 0.2 OUTLIER -82.78 -57.97 3.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.292 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.6 -43.74 59.37 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -50.17 -33.57 19.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -1.137 . . . . 0.0 109.43 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 42.0 tp -52.27 -36.94 54.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 24.4 mt -81.26 -42.57 20.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 109.844 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.423 HG23 ' H ' ' B' ' 33' ' ' VAL . 6.5 t -56.74 -54.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 0.0 109.427 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.599 HG22 ' CD2' ' A' ' 122' ' ' HIS . 21.6 t -68.41 -23.0 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.525 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -160.8 87.1 1.76 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 109.382 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.22 18.59 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.666 2.244 . . . . 0.0 112.22 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.506 ' C ' ' H ' ' B' ' 39' ' ' GLN . 1.3 p-90 -69.8 -19.95 63.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.476 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.493 HG23 ' CD1' ' B' ' 37' ' ' TRP . 75.8 p -69.83 35.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.857 . . . . 0.0 109.531 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 12.1 tt0 -73.27 14.78 0.28 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.644 ' NH1' ' HG2' ' C' ' 92' ' ' ARG . 64.7 mtt-85 -98.03 -48.95 4.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.384 -0.823 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -91.09 2.73 56.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 109.516 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' B' ' 39' ' ' GLN . 1.4 p90 -67.83 -4.34 12.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.58 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -46.86 -37.16 8.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 60.8 m -67.09 -43.46 82.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 109.436 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' B' ' 47' ' ' ASP . 2.6 m-85 -84.4 27.3 0.71 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 109.23 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.01 87.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' B' ' 45' ' ' PHE . 18.6 t0 -174.2 47.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.333 -1.098 . . . . 0.0 109.227 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.579 ' N ' HD12 ' B' ' 48' ' ' LEU . 9.5 mp -88.77 27.91 1.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 109.575 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -46.95 -37.67 9.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 109.321 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' THR . . . . . 0.401 ' O ' ' N ' ' B' ' 53' ' ' ALA . 5.6 p -146.98 148.89 33.98 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.45 -0.781 . . . . 0.0 109.012 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.13 -42.51 2.22 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.518 2.145 . . . . 0.0 112.516 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.406 ' C ' ' N ' ' B' ' 54' ' ' VAL . 7.6 p-10 -77.37 -29.62 53.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.0 109.746 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -47.98 -19.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.619 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.406 ' N ' ' C ' ' B' ' 52' ' ' ASP . 68.2 t -63.87 -61.45 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.656 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -81.5 4.41 21.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.535 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.37 1.33 84.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -87.32 150.23 48.73 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.236 -1.156 . . . . 0.0 109.304 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.73 -28.33 9.77 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.598 2.199 . . . . 0.0 112.377 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -39.34 19.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.933 . . . . 0.0 109.846 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 53.9 t -52.43 -42.67 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.468 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -78.97 -26.86 43.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.108 -0.995 . . . . 0.0 109.484 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.73 -58.06 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.487 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' HIS . . . . . 0.464 ' O ' ' ND1' ' B' ' 63' ' ' HIS . 1.6 t-80 -48.1 -23.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.191 -0.943 . . . . 0.0 109.545 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.23 -47.47 90.83 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -62.29 -35.57 79.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.182 . . . . 0.0 109.441 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -60.58 -44.34 96.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.27 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 36.6 t -71.26 -58.83 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.22 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.448 HD23 ' O ' ' B' ' 68' ' ' LEU . 6.2 tt -48.78 -44.6 39.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.277 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.05 -47.06 41.62 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.57 32.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -1.156 . . . . 0.0 109.475 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -53.05 -22.8 6.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.247 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.46 -41.01 22.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.445 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.39 -27.65 1.76 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.42 -60.16 5.27 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.23 -17.98 9.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -1.121 . . . . 0.0 109.302 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.52 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -80.53 -26.25 38.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.695 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 39.5 m80 -157.23 59.99 0.51 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.76 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 23.3 mt -56.41 -4.7 0.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 109.295 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' B' ' 77' ' ' HIS . 7.5 m-20 -51.82 -26.48 9.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.723 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.408 ' N ' ' OD1' ' B' ' 80' ' ' ASN . 11.0 p30 -165.98 95.01 0.58 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.626 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.547 HD12 ' N ' ' B' ' 81' ' ' LEU . 6.3 mp -80.27 -58.75 2.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.36 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.468 ' HG3' ' HZ3' ' B' ' 82' ' ' LYS . 16.6 ttmm -47.44 -23.94 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 109.573 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.64 -49.29 11.18 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 1.3 t -73.9 -45.58 49.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -1.165 . . . . 0.0 109.647 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.531 ' N ' ' CG2' ' B' ' 84' ' ' THR . 48.4 m-85 -64.63 4.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.365 -0.834 . . . . 0.0 109.572 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -64.08 -34.02 77.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.944 . . . . 0.0 109.475 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.2 p -77.25 -53.06 8.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.606 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.54 ' N ' HD12 ' B' ' 88' ' ' LEU . 9.4 mp -51.25 -49.21 61.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.321 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 3.5 m -53.33 -49.37 67.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.362 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.53 -22.7 66.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.359 -0.838 . . . . 0.0 109.369 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.95 -57.87 3.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 0.0 109.667 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' B' ' 97' ' ' HIS . 45.2 m80 -68.64 -20.25 64.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 110.31 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 53.7 t -83.8 -60.92 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.03 . . . . 0.0 110.747 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -87.75 -56.08 3.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.023 . . . . 0.0 111.246 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -51.7 68.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.893 . . . . 0.0 110.759 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.679 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -98.47 -59.71 1.69 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.012 -1.055 . . . . 0.0 109.893 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.679 ' ND1' ' O ' ' B' ' 96' ' ' LEU . 0.0 OUTLIER 83.94 20.66 0.16 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.773 -0.579 . . . . 0.0 109.77 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.516 HG23 HD12 ' B' ' 96' ' ' LEU . 68.5 t -48.35 140.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.048 -1.032 . . . . 0.0 109.292 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -56.93 150.61 37.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.273 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.49 -7.76 21.9 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.539 2.159 . . . . 0.0 112.15 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.52 60.89 2.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 109.542 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -156.96 -34.69 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.14 -14.05 52.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.504 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.412 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 90.1 mtt-85 -86.25 -20.04 29.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.95 . . . . 0.0 109.778 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 37.2 mt -82.68 -53.61 5.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.792 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 tt -50.82 -46.32 59.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.79 -28.81 63.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 21.9 m120 -85.56 -20.78 29.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -1.173 . . . . 0.0 109.628 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 81.0 t -81.14 -28.86 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.56 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.94 -58.8 3.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.231 -0.918 . . . . 0.0 109.607 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.538 HG12 ' CD1' ' B' ' 130' ' ' TYR . 3.8 m -52.26 -26.07 8.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.296 -0.877 . . . . 0.0 109.929 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 t -70.43 -34.81 72.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 49.6 t -71.61 -22.48 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 109.56 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.423 ' CD1' ' OH ' ' B' ' 130' ' ' TYR . 14.6 mt -80.93 -47.11 14.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.488 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.484 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -51.96 -19.98 2.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 109.442 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 116' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -84.93 -63.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.544 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.79 -17.77 64.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.579 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -143.22 52.23 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.334 -0.854 . . . . 0.0 109.429 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -68.68 -13.01 65.28 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -77.99 -29.92 49.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -1.136 . . . . 0.0 109.395 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -94.29 14.48 20.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.569 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -84.0 34.01 0.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.902 . . . . 0.0 109.533 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.464 ' H ' HG23 ' B' ' 123' ' ' THR . 1.2 p -48.11 148.78 2.86 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.268 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 4.9 Cg_exo -45.73 -53.41 5.66 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.397 2.065 . . . . 0.0 113.007 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 28.1 Cg_endo -63.09 -29.13 74.52 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.031 1.821 . . . . 0.0 112.228 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.435 HG23 ' OG1' ' B' ' 123' ' ' THR . 63.2 t -74.13 -13.73 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.51 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -83.47 -59.74 2.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 109.575 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -56.19 -32.69 64.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.405 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.82 26.24 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.538 ' CD1' HG12 ' B' ' 111' ' ' VAL . 1.3 t80 -131.19 -34.28 1.44 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -0.846 . . . . 0.0 109.246 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -76.64 -63.44 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.736 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -47.29 -21.95 0.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.554 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 133' ' ' VAL . . . . . 0.584 HG22 HD21 ' B' ' 3' ' ' LEU . 2.9 t -71.14 -64.95 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.02 -26.83 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.81 -29.95 8.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.01 -32.52 69.61 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.06 -37.35 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -1.148 . . . . 0.0 109.362 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.32 -33.36 75.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.427 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -72.57 -36.55 68.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.85 -48.49 74.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.364 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.27 -30.1 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.97 0.55 49.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 109.7 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -67.2 -27.9 67.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.18 -0.95 . . . . 0.0 109.608 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -89.4 -23.04 22.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -55.34 -5.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' B' ' 144' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.515 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.455 HD13 ' CE2' ' C' ' 128' ' ' PHE . 14.6 mt -139.02 -174.23 3.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.311 -0.868 . . . . 0.0 109.34 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.495 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 175.94 -49.25 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 109.945 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' C' ' 3' ' ' SER . 72.1 Cg_exo -46.99 173.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.421 2.081 . . . . 0.0 112.641 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -65.12 -16.26 63.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.812 . . . . 0.0 109.64 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.457 ' C ' ' O ' ' C' ' 5' ' ' ALA . 1.2 m-20 -39.67 -40.63 0.94 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 0.0 109.647 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -60.51 -59.33 5.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 109.216 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 48.8 m -50.26 -28.63 8.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 109.156 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -80.16 -35.3 36.75 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.417 HG21 ' CG ' ' C' ' 128' ' ' PHE . 41.2 t -74.86 -44.54 45.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.69 -39.74 89.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.408 -0.807 . . . . 0.0 108.84 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.87 -52.87 46.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.865 . . . . 0.0 109.154 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.719 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.95 -35.43 64.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.365 -0.834 . . . . 0.0 109.056 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -17.46 61.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.314 -0.866 . . . . 0.0 109.007 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.52 -46.35 8.9 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 13.3 mmmt -68.93 -37.43 78.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 108.772 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.719 HG23 ' O ' ' C' ' 13' ' ' ALA . 99.4 t -61.14 -65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 59.67 -137.6 49.64 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 29.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.5 -1.0 . . . . 0.0 110.363 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.584 ' H ' ' C ' ' C' ' 18' ' ' GLY . 93.0 m-70 -131.73 23.33 4.65 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -87.3 -61.55 1.7 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.672 -0.643 . . . . 0.0 109.573 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.41 -14.49 0.35 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' C' ' 21' ' ' ALA . 3.7 mm-40 -84.14 -56.48 3.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -1.076 . . . . 0.0 109.484 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.1 m-30 -59.59 -33.16 71.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.396 -0.815 . . . . 0.0 109.332 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.32 -22.95 76.49 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.7 -43.58 20.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.184 -1.186 . . . . 0.0 109.689 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.75 -20.05 65.88 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.4 -19.98 59.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' C' ' 58' ' ' HIS . 18.7 mt -73.03 -45.94 54.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.652 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -61.89 -17.86 58.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.677 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 36.2 mmt-85 -81.17 -31.82 33.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.552 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -73.06 -37.6 66.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.605 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' C' ' 33' ' ' PHE . 0.7 OUTLIER -63.06 -59.94 4.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 12.2 mt -59.25 -48.93 79.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.0 109.63 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.505 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 40.4 t -46.02 -27.43 0.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.922 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' C' ' 35' ' ' SER . 47.3 m-85 -154.13 123.79 3.25 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 0.0 109.476 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' C' ' 40' ' ' LYS . 73.2 Cg_endo -77.8 -19.47 12.59 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.425 2.083 . . . . 0.0 112.272 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 21.2 p -43.91 -19.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 109.851 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.515 ' N ' ' O ' ' C' ' 37' ' ' PRO . 3.5 p -90.18 -22.89 21.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' C' ' 37' ' ' PRO . 27.9 ttmt -50.16 -18.7 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 109.922 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 109.835 -179.655 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.51 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.592 ' O ' ' HG ' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -156.15 71.08 0.71 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' C' ' 49' ' ' SER . 0.9 OUTLIER -46.34 -13.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.602 -0.687 . . . . 0.0 111.242 -178.252 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' C' ' 46' ' ' PHE . 9.6 mt 58.93 -5.34 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.787 -1.196 . . . . 0.0 109.664 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.59 ' H ' ' C ' ' C' ' 47' ' ' ASP . 0.0 OUTLIER -46.88 124.95 6.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.0 109.544 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -53.38 138.99 31.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.25 27.82 65.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' C' ' 53' ' ' ALA . 3.2 m -60.89 -97.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -1.141 . . . . 0.0 109.336 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' C' ' 52' ' ' SER . . . 167.83 -64.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.459 -0.776 . . . . 0.0 109.175 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -45.56 -17.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.541 -0.724 . . . . 0.0 109.534 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' C' ' 53' ' ' ALA . 61.6 t -73.86 -30.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.284 -0.885 . . . . 0.0 109.758 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -70.96 -26.46 63.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.85 -22.81 68.25 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.4 OUTLIER -79.22 -39.9 32.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.298 -1.119 . . . . 0.0 109.603 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.15 -50.02 53.54 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 49.7 mttp -52.06 -23.73 5.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -1.149 . . . . 0.0 109.966 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -72.55 -45.15 60.65 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.117 -0.99 . . . . 0.0 109.072 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.59 -46.12 83.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.531 -0.731 . . . . 0.0 109.277 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.86 -30.94 68.53 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.222 -0.923 . . . . 0.0 109.346 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 64' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 2.4 t70 -69.44 -34.49 74.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 108.83 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.84 -51.38 62.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 108.918 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 mt -56.28 -46.47 79.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.241 -0.912 . . . . 0.0 108.739 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -62.61 -51.66 66.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.328 -0.857 . . . . 0.0 108.81 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.6 -22.75 62.25 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.58 -47.06 10.94 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.64 -22.88 31.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.75 -16.91 64.58 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.597 ' O ' ' N ' ' C' ' 74' ' ' ASP . 15.8 m80 -143.88 -60.07 0.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.515 -0.741 . . . . 0.0 109.388 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.553 HG12 ' O ' ' C' ' 72' ' ' HIS . 12.8 p 44.63 14.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.817 0.818 . . . . 0.0 109.376 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' C' ' 72' ' ' HIS . 13.7 m-20 -131.23 11.41 4.99 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.439 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 1.8 p-10 -177.77 31.76 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.962 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.694 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -77.98 -24.23 0.44 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.458 -0.776 . . . . 0.0 111.655 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' C' ' 76' ' ' MET . 75.3 Cg_exo -50.3 -33.82 38.19 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.689 1.593 . . . . 0.0 112.279 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -94.34 -16.05 23.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.53 -58.04 3.39 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.123 -0.986 . . . . 0.0 109.139 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 mt -77.16 10.18 2.58 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.395 -0.815 . . . . 0.0 108.962 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -61.0 -28.81 69.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -63.85 -50.68 67.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.509 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 4.5 mt -47.27 -47.29 25.1 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 20.7 t -55.36 -25.8 37.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.498 -0.751 . . . . 0.0 109.247 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' C' ' 89' ' ' HIS . 1.9 m-20 -78.55 -53.01 7.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.935 . . . . 0.0 109.463 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.2 -28.76 65.11 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.302 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 87' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 8.3 m80 -92.58 -21.66 19.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 110.048 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -112.21 -2.28 14.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.234 -0.916 . . . . 0.0 110.414 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 89' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' C' ' 85' ' ' ASP . 78.0 m80 -142.6 36.08 1.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.984 -1.073 . . . . 0.0 110.096 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -171.57 -77.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.04 -1.037 . . . . 0.0 109.72 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' C' ' 91' ' ' LEU . 4.3 mm? -72.52 -37.34 68.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 109.327 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 92' ' ' ARG . . . . . 0.644 ' HG2' ' NH1' ' B' ' 40' ' ' ARG . 28.1 ttm180 55.64 52.38 11.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.575 ' O ' ' NH2' ' B' ' 40' ' ' ARG . 0.3 OUTLIER -78.68 -173.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.45 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' C' ' 96' ' ' VAL . 1.8 m-20 -123.8 113.67 28.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.464 -0.773 . . . . 0.0 109.169 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' C' ' 98' ' ' PHE . 84.8 Cg_exo -43.43 -14.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.216 1.944 . . . . 0.0 112.406 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' C' ' 94' ' ' ASP . 94.2 t -48.05 -25.66 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 109.551 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -79.44 -24.8 42.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.644 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 98' ' ' PHE . . . . . 0.42 ' N ' ' O ' ' C' ' 95' ' ' PRO . 28.5 t80 -46.43 -40.79 12.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 109.55 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -59.5 -24.93 64.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 20.2 mt -84.13 -61.26 1.86 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.628 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tp -48.01 -41.02 24.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 9.2 t -61.96 -42.3 98.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.715 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -80.94 -26.59 36.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.676 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 79.8 m -58.31 -56.86 16.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 0.0 109.625 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -47.07 -37.06 8.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.526 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.19 -31.01 68.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.782 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.89 -24.88 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.586 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 28.1 m -81.78 -62.95 1.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.596 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' C' ' 113' ' ' LEU . 12.5 mt -46.26 -39.9 10.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.895 . . . . 0.0 109.581 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.62 -42.33 7.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.958 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.1 -44.45 69.01 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.507 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -91.41 -77.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.63 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' C' ' 109' ' ' LEU . 1.9 tt -96.82 119.44 63.64 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.41 165.34 32.76 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.287 1.991 . . . . 0.0 112.821 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -87.79 -28.57 21.6 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.565 0.698 . . . . 0.0 109.647 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' C' ' 117' ' ' PHE . 83.8 mt-10 57.07 10.63 0.84 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' C' ' 116' ' ' GLU . 27.8 p90 40.58 32.51 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.314 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.703 ' O ' ' N ' ' C' ' 120' ' ' ALA . 3.2 p -56.03 134.35 74.06 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.44 18.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.387 2.058 . . . . 0.0 113.293 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.703 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -157.44 -20.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.623 -1.298 . . . . 0.0 111.543 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.438 HG12 ' N ' ' C' ' 122' ' ' HIS . 2.8 t -65.65 -63.01 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.513 -1.367 . . . . 0.0 110.106 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.598 ' CD2' HG22 ' D' ' 34' ' ' VAL . 0.0 OUTLIER -50.71 -31.02 15.29 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.28 -0.888 . . . . 0.0 108.868 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.65 -20.03 31.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.742 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 20.4 p -64.8 -62.33 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.671 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.505 ' N ' ' OG ' ' C' ' 124' ' ' SER . 2.0 mt -72.98 -19.68 61.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.1 -1.0 . . . . 0.0 110.081 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -81.48 -43.42 18.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.029 -1.044 . . . . 0.0 109.948 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -87.33 -47.64 8.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.873 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 31.1 t80 -48.68 -21.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.447 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' C' ' 133' ' ' SER . 18.8 mt -73.62 -21.23 60.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.05 -32.96 68.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.445 ' OG ' HD11 ' C' ' 2' ' ' LEU . 0.7 OUTLIER -78.71 -30.43 45.95 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.44 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.07 -30.25 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.845 . . . . 0.0 108.764 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.458 ' N ' ' O ' ' C' ' 129' ' ' LEU . 79.1 p -79.03 -25.1 43.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.347 -0.846 . . . . 0.0 108.968 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 53.5 m -70.69 -37.54 73.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.284 -0.885 . . . . 0.0 109.215 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.9 p -79.59 -22.0 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 108.871 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.65 -33.9 40.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.39 -0.818 . . . . 0.0 109.144 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 69.8 p -91.23 -1.54 57.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 109.58 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 2' ' ' HIS . . . . . 0.581 ' O ' ' CG ' ' D' ' 2' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.394 0.616 . . . . 0.0 109.634 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 1.035 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -122.25 -174.11 2.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.278 -0.889 . . . . 0.0 109.258 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.498 ' O ' ' N ' ' D' ' 6' ' ' GLU . 9.7 p -104.75 143.73 27.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 109.122 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -39.26 -22.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.637 2.224 . . . . 0.0 112.296 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 6' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' D' ' 4' ' ' THR . 25.2 mt-10 -75.55 -56.92 4.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.937 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -80.82 -22.82 39.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.944 . . . . 0.0 109.861 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.698 ' HB2' HD13 ' D' ' 3' ' ' LEU . 2.5 tttm -79.8 -31.97 40.75 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.254 -0.904 . . . . 0.0 109.296 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 9' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 11.2 t -63.84 -23.45 67.36 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.718 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.07 -57.66 3.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.057 -1.027 . . . . 0.0 110.086 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.43 ' H ' HG12 ' D' ' 11' ' ' VAL . 1.8 p -62.1 -24.42 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 75.1 m -84.13 -35.5 23.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.327 0.584 . . . . 0.0 109.547 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 13' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -64.29 -59.95 3.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.441 -0.787 . . . . 0.0 109.71 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.448 ' O ' HG23 ' D' ' 18' ' ' VAL . 7.9 mp -43.72 -18.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 0.0 110.117 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 15' ' ' TRP . . . . . 0.53 ' N ' ' O ' ' D' ' 13' ' ' ALA . 25.6 t90 -75.39 -33.37 61.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.917 -1.114 . . . . 0.0 109.532 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.31 -52.57 30.55 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.678 ' H ' ' CD ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -56.25 -36.37 68.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.326 -1.102 . . . . 0.0 109.189 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 14' ' ' LEU . 6.6 t -57.45 117.38 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.819 . . . . 0.0 109.676 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' D' ' 21' ' ' ASP . 61.0 t30 -88.03 81.12 7.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 108.912 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' D' ' 22' ' ' GLU . 92.0 t -44.47 -17.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 0.0 109.846 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' D' ' 19' ' ' ASN . 22.2 t70 -51.15 -15.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' D' ' 20' ' ' VAL . 33.6 mt-10 -156.12 -37.67 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.4 HG11 HG13 ' D' ' 18' ' ' VAL . 77.2 t -47.38 -53.97 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 109.703 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.35 -33.28 70.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.67 -49.66 74.23 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 26' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' D' ' 28' ' ' LEU . 90.5 mt-10 -73.06 -44.27 60.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -1.171 . . . . 0.0 109.505 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.51 -22.28 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.618 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 28' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' D' ' 26' ' ' GLU . 0.2 OUTLIER -82.65 -58.01 3.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.288 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.64 -43.68 59.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -50.13 -33.61 19.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -1.134 . . . . 0.0 109.482 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 42.1 tp -52.3 -36.93 54.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.935 . . . . 0.0 109.494 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.17 -42.69 20.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -56.72 -54.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.155 -0.965 . . . . 0.0 109.432 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' C' ' 122' ' ' HIS . 21.6 t -68.41 -23.05 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.525 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -160.8 86.99 1.77 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -83.0 18.36 1.5 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.74 2.293 . . . . 0.0 112.281 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 37' ' ' TRP . . . . . 0.528 ' C ' ' H ' ' D' ' 39' ' ' GLN . 1.3 p-90 -69.68 -19.98 63.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.464 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.49 HG23 ' CD1' ' D' ' 37' ' ' TRP . 75.8 p -69.92 35.63 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.175 -0.953 . . . . 0.0 109.568 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 39' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' D' ' 37' ' ' TRP . 12.1 tt0 -73.23 14.77 0.28 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.322 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 40' ' ' ARG . . . . . 0.666 ' NH1' ' HG2' ' A' ' 92' ' ' ARG . 64.7 mtt-85 -98.03 -48.9 4.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.483 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -91.17 2.73 56.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.983 . . . . 0.0 109.531 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' D' ' 39' ' ' GLN . 1.4 p90 -67.87 -4.33 12.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.619 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -46.81 -37.17 8.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 109.657 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 60.5 m -67.13 -43.39 82.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' D' ' 47' ' ' ASP . 2.6 m-85 -84.34 27.3 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.248 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.97 87.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' D' ' 45' ' ' PHE . 18.7 t0 -174.2 47.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -1.101 . . . . 0.0 109.252 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' D' ' 48' ' ' LEU . 9.5 mp -88.78 27.92 1.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 109.564 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -46.94 -37.67 9.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.297 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 50' ' ' THR . . . . . 0.41 ' O ' ' N ' ' D' ' 53' ' ' ALA . 5.6 p -147.07 148.8 33.46 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.034 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -39.04 -42.54 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.552 2.168 . . . . 0.0 112.447 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 52' ' ' ASP . . . . . 0.404 ' C ' ' N ' ' D' ' 54' ' ' VAL . 7.6 p-10 -77.39 -29.62 53.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 0.0 109.728 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -48.04 -19.64 0.27 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 109.572 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 54' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 52' ' ' ASP . 67.1 t -63.93 -61.43 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.608 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 55' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -81.52 4.4 21.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.505 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.4 1.34 84.14 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 57' ' ' ASN . . . . . 0.404 HD21 ' CB ' ' D' ' 47' ' ' ASP . 20.6 m120 -87.39 150.21 48.53 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.222 -1.163 . . . . 0.0 109.348 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.79 -28.26 9.72 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.576 2.184 . . . . 0.0 112.314 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -39.32 19.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 109.848 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 53.8 t -52.38 -42.75 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.024 . . . . 0.0 109.428 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -79.01 -26.8 43.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.933 . . . . 0.0 109.458 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.76 -58.01 3.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.55 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 63' ' ' HIS . . . . . 0.5 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 1.6 t-80 -48.14 -23.9 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.561 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.3 -47.37 91.25 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -62.24 -35.67 79.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -1.203 . . . . 0.0 109.475 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -60.56 -44.39 96.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.837 . . . . 0.0 109.248 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 36.3 t -71.21 -58.77 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.25 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.449 ' O ' HD23 ' D' ' 68' ' ' LEU . 6.2 tt -48.88 -44.54 40.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.275 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.03 -47.06 41.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.96 -55.63 32.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -1.199 . . . . 0.0 109.393 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -53.0 -22.85 6.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.321 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.33 -41.1 22.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -0.834 . . . . 0.0 109.565 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.34 -27.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.408 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.41 -60.16 5.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.56 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -56.25 -17.93 8.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -1.119 . . . . 0.0 109.342 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 76' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -80.6 -26.13 38.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.237 -0.914 . . . . 0.0 109.701 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 39.5 m80 -157.36 60.01 0.5 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.688 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 23.2 mt -56.36 -4.8 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.045 -1.034 . . . . 0.0 109.309 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' D' ' 77' ' ' HIS . 7.5 m-20 -51.8 -26.47 9.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.714 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 80' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' D' ' 80' ' ' ASN . 10.9 p30 -166.04 94.96 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 81' ' ' LEU . . . . . 0.531 HD12 ' N ' ' D' ' 81' ' ' LEU . 6.3 mp -80.26 -58.71 3.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 82' ' ' LYS . . . . . 0.435 ' HZ3' ' HG3' ' D' ' 82' ' ' LYS . 16.6 ttmm -47.44 -23.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.915 . . . . 0.0 109.567 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.81 -49.12 10.81 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.522 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 1.3 t -73.93 -45.67 49.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -1.207 . . . . 0.0 109.599 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.522 ' N ' ' CG2' ' D' ' 84' ' ' THR . 48.5 m-85 -64.66 4.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.398 -0.813 . . . . 0.0 109.613 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 86' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -64.1 -33.94 76.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.507 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.4 p -77.31 -53.09 8.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.54 HD12 ' N ' ' D' ' 88' ' ' LEU . 9.4 mp -51.17 -49.31 61.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 3.5 m -53.3 -49.37 67.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.339 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -62.55 -22.72 66.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.335 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.86 -57.99 3.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.316 -0.865 . . . . 0.0 109.617 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.574 ' O ' ' N ' ' D' ' 97' ' ' HIS . 45.2 m80 -68.54 -20.35 64.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.844 . . . . 0.0 110.337 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 53.6 t -83.72 -60.94 1.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 110.781 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -87.78 -56.07 3.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -0.982 . . . . 0.0 111.283 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -51.66 68.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.794 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.665 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -98.47 -59.61 1.71 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.983 -1.073 . . . . 0.0 109.956 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.665 ' ND1' ' O ' ' D' ' 96' ' ' LEU . 0.0 OUTLIER 83.77 20.79 0.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.812 -0.555 . . . . 0.0 109.761 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 98' ' ' VAL . . . . . 0.525 HG23 HD12 ' D' ' 96' ' ' LEU . 67.3 t -48.43 140.63 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 109.231 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -57.02 150.64 38.54 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.285 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.44 -7.78 21.97 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.524 2.149 . . . . 0.0 112.208 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.56 60.83 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 109.503 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 -34.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.602 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -64.09 -14.02 51.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.969 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 104' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 89.9 mtt-85 -86.31 -19.97 29.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.769 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 37.3 mt -82.74 -53.56 5.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.821 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 tt -50.79 -46.41 59.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 109.485 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.74 -28.86 63.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 108' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 21.9 m120 -85.57 -20.71 29.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -1.215 . . . . 0.0 109.606 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.25 -28.69 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 8.8 tp -68.11 -58.7 4.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.627 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 111' ' ' VAL . . . . . 0.538 HG12 ' CD1' ' D' ' 130' ' ' TYR . 3.8 m -52.31 -26.16 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.179 -0.951 . . . . 0.0 109.819 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 18.4 t -70.31 -34.78 73.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.743 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 49.8 t -71.7 -22.33 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.947 . . . . 0.0 109.6 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 114' ' ' LEU . . . . . 0.42 ' CD1' ' OH ' ' D' ' 130' ' ' TYR . 14.6 mt -81.03 -47.11 14.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -51.96 -19.93 2.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.473 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 116' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -84.95 -62.99 1.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.9 -17.67 64.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.92 . . . . 0.0 109.575 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -143.22 52.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.555 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -68.72 -12.92 65.24 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -78.06 -29.9 49.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -1.134 . . . . 0.0 109.394 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -94.27 14.5 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.892 . . . . 0.0 109.569 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -83.96 34.04 0.5 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.0 109.597 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.434 ' H ' HG23 ' D' ' 123' ' ' THR . 1.2 p -48.17 148.84 2.88 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 109.228 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.1 Cg_exo -45.88 -53.31 5.86 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.395 2.063 . . . . 0.0 112.923 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 28.3 Cg_endo -63.12 -29.04 74.12 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.004 1.803 . . . . 0.0 112.297 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.433 HG23 ' OG1' ' D' ' 123' ' ' THR . 63.0 t -74.23 -13.64 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.496 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -83.52 -59.76 2.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -56.24 -32.56 64.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.374 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.92 26.3 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.857 . . . . 0.0 109.471 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.538 ' CD1' HG12 ' D' ' 111' ' ' VAL . 1.3 t80 -131.27 -34.24 1.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.409 -0.807 . . . . 0.0 109.291 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -76.64 -63.5 1.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.646 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -47.34 -21.86 0.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 109.569 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 133' ' ' VAL . . . . . 0.569 HG22 HD21 ' D' ' 3' ' ' LEU . 2.9 t -71.22 -64.91 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.546 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.402 HG23 ' H ' ' D' ' 134' ' ' VAL . 2.6 t -69.06 -26.79 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.9 -29.9 9.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.41 69.49 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.11 -37.32 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.396 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.34 -33.42 75.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.375 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -72.55 -36.46 68.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.92 -48.46 74.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 mt -60.16 -30.19 69.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.92 0.56 49.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 109.681 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -67.12 -27.97 67.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.9 OUTLIER -89.54 -22.85 22.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.955 . . . . 0.0 109.593 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -55.44 -5.4 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.493 ' H ' ' C ' ' D' ' 144' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.428 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.517 HD11 ' HD3' ' A' ' 127' ' ' LYS . 9.5 tp -172.34 163.4 5.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 109.857 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -75.74 -176.92 0.63 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.368 -0.832 . . . . 0.0 109.058 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 58.4 Cg_endo -86.87 -68.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.664 2.243 . . . . 0.0 112.716 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -47.54 -40.44 18.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.054 -1.029 . . . . 0.0 109.485 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 10' ' ' VAL . 63.9 m-20 -43.55 -29.46 0.48 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.86 . . . . 0.0 109.02 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 10' ' ' VAL . 58.4 mttt -83.08 -53.72 5.59 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' LYS . 35.9 m -44.65 -38.51 4.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.448 -0.782 . . . . 0.0 109.282 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -72.46 -29.69 63.9 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 6' ' ' ASP . 54.1 t -75.12 -55.0 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' CD ' ' H ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -51.65 -39.11 57.52 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.23 179.102 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.18 -63.12 1.37 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.322 -0.861 . . . . 0.0 109.296 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.564 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.68 -38.61 67.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.388 -0.82 . . . . 0.0 108.892 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.94 -17.58 63.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.466 -0.772 . . . . 0.0 108.981 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.14 -44.98 16.61 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 39.1 mmtt -68.23 -41.4 81.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -1.137 . . . . 0.0 108.859 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 13' ' ' ALA . 61.2 t -60.28 -64.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 50.0 -127.87 25.1 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.47 24.68 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.474 -1.015 . . . . 0.0 110.381 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.544 ' H ' ' C ' ' A' ' 18' ' ' GLY . 87.4 m-70 -130.38 28.49 4.95 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -93.36 -61.31 1.59 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.671 -0.643 . . . . 0.0 109.778 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.27 -14.3 0.16 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.6 mt-10 -86.54 -56.29 3.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -1.117 . . . . 0.0 109.761 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.1 m-30 -59.79 -32.36 70.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 109.59 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.04 -22.92 76.13 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.92 -41.86 18.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -1.17 . . . . 0.0 109.959 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -65.93 -19.88 66.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.294 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.77 -20.4 60.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.436 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.554 HD11 ' ND1' ' A' ' 58' ' ' HIS . 14.1 mt -74.52 -51.11 15.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.739 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.66 -22.43 65.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.164 -0.96 . . . . 0.0 109.584 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.997 HH21 ' HB2' ' B' ' 127' ' ' GLN . 2.3 tpt180 -73.37 -20.75 60.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.311 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 46.1 ttp -78.36 -53.64 7.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.862 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -48.36 -24.2 1.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.351 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.079 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.5 mt -82.32 -46.2 13.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.978 . . . . 0.0 109.579 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 46.0 m -69.21 -20.78 63.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 35' ' ' SER . 95.5 m-85 -158.4 79.23 3.14 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.988 . . . . 0.0 109.737 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.31 -26.42 15.67 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.659 2.239 . . . . 0.0 112.07 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.433 ' O ' ' CG2' ' A' ' 41' ' ' THR . 12.6 p -49.45 -18.24 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.918 . . . . 0.0 109.477 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.6 p -79.01 -22.34 45.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -46.01 -42.91 13.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.583 HG21 ' HD1' ' D' ' 97' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.461 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 15.9 p80 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.662 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -149.81 69.32 1.02 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.548 ' C ' ' O ' ' A' ' 46' ' ' PHE . 1.1 m-20 -24.38 -37.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.855 -0.528 . . . . 0.0 111.203 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.662 ' N ' ' O ' ' A' ' 46' ' ' PHE . 4.3 mt 53.58 7.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.072 -1.017 . . . . 0.0 109.373 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 47' ' ' ASP . 4.9 m -64.34 5.7 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.507 ' H ' ' C ' ' A' ' 48' ' ' LEU . 37.8 t60 61.32 125.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.5 14.14 66.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.5 t -77.86 -103.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.164 -1.198 . . . . 0.0 109.41 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.91 -29.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 0.0 109.496 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -80.03 -17.98 51.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.199 -0.938 . . . . 0.0 109.169 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -84.52 -40.14 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.295 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -77.3 -32.37 55.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.16 -21.82 75.02 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.554 ' ND1' HD11 ' A' ' 29' ' ' LEU . 7.8 t-80 -75.65 -37.54 59.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.314 -1.11 . . . . 0.0 109.781 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.12 -48.5 46.39 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -51.77 -23.13 4.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -1.05 . . . . 0.0 109.979 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.39 -39.84 64.79 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.218 -0.926 . . . . 0.0 109.184 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.37 -33.6 19.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.457 -0.777 . . . . 0.0 108.935 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.16 -32.9 44.4 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.389 -0.82 . . . . 0.0 109.415 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -70.39 -33.37 71.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 108.861 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.13 19.02 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.429 -0.794 . . . . 0.0 108.898 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.23 -38.24 70.8 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.254 -0.904 . . . . 0.0 108.717 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -71.5 -50.29 32.88 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.196 -0.94 . . . . 0.0 108.608 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -59.78 -21.15 60.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.202 -0.936 . . . . 0.0 108.496 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.07 -47.35 13.66 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.417 HG13 ' CE ' ' A' ' 11' ' ' LYS . 9.7 t -65.94 -22.85 31.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.72 -15.1 63.41 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 74' ' ' ASP . 78.4 m-70 -139.5 -63.01 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.479 -0.763 . . . . 0.0 109.423 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 73' ' ' VAL . 12.3 p 43.92 13.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.752 0.787 . . . . 0.0 109.65 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.612 ' N ' ' O ' ' A' ' 72' ' ' HIS . 16.2 m-20 -134.25 10.39 3.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 20.3 t0 -177.02 28.35 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.148 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.7 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 11.4 ptt? -78.81 -22.45 0.38 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 111.805 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 76' ' ' MET . 71.8 Cg_exo -49.02 -29.0 14.69 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.473 1.449 . . . . 0.0 112.424 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -94.23 -24.41 17.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 0.0 109.653 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.29 -53.58 8.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 0.0 109.143 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 mt -78.02 9.06 3.95 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.441 -0.787 . . . . 0.0 108.98 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 t -66.06 -41.5 90.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.412 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -52.46 -52.87 51.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.465 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 82' ' ' ALA . 4.9 mt -44.89 -45.05 10.11 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 9.9 p -55.75 -39.87 71.76 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' ALA . 25.7 t70 -67.58 -17.95 64.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.147 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.446 ' O ' HD23 ' A' ' 86' ' ' LEU . 1.2 tt -82.85 -43.46 16.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.333 -0.855 . . . . 0.0 109.378 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -92.45 -21.27 20.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.952 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -60.63 -87.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.106 -0.996 . . . . 0.0 110.741 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 90' ' ' LYS . 44.9 t-80 -96.62 -46.3 6.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.245 -0.909 . . . . 0.0 111.02 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 89' ' ' HIS . 35.9 mttm -41.22 -94.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.22 -0.925 . . . . 0.0 110.324 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mp -67.54 -34.97 78.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.012 -1.055 . . . . 0.0 109.623 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.393 ' NH2' ' HE ' ' D' ' 40' ' ' ARG . 45.5 ttp85 60.89 58.2 2.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.607 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 t -84.33 161.64 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 109.373 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.45 151.43 50.78 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.21 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' ASN . 58.4 Cg_endo -73.08 -18.8 23.6 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.55 2.167 . . . . 0.0 112.195 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.511 HG21 ' CB ' ' D' ' 99' ' ' ASP . 24.4 t -47.22 -20.04 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.743 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' PRO . 4.1 m-20 -79.15 -24.73 43.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.709 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.546 ' CZ ' HD23 ' A' ' 136' ' ' LEU . 4.8 m-85 -46.66 -32.57 3.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 109.659 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.498 ' O ' ' ND1' ' A' ' 103' ' ' HIS . 55.8 mttm -83.89 -36.78 23.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 0.0 109.814 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 100' ' ' LEU . 7.2 mp -66.37 -61.93 1.74 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.131 -0.981 . . . . 0.0 109.516 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 101' ' ' LEU . 6.4 tt -49.97 -47.4 52.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.239 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.8 t -61.9 -38.85 89.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.603 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' LYS . 22.9 m80 -77.37 -27.73 52.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.935 . . . . 0.0 109.609 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.74 -46.93 80.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.728 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.25 -48.64 65.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.435 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 106' ' ' LEU . 9.6 mp -61.54 -59.1 5.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.713 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.04 -34.3 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.237 -0.914 . . . . 0.0 109.386 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.8 m -75.77 -60.87 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.392 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 113' ' ' LEU . 13.1 mt -46.11 -41.44 12.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.91 -28.58 0.68 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 110.182 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.89 -56.38 4.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 109.768 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -85.77 -65.13 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.466 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -95.92 106.89 30.89 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.2 171.17 9.48 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.718 1.612 . . . . 0.0 112.3 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 117' ' ' PHE . . . -87.22 -34.37 19.0 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.487 0.66 . . . . 0.0 109.88 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 117' ' ' PHE . 23.2 mt-10 55.63 9.96 0.46 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 116' ' ' GLU . 29.3 p90 40.63 32.34 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.54 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 120' ' ' ALA . 4.9 p -60.88 145.55 88.59 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.41 29.56 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 121.946 1.764 . . . . 0.0 111.773 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 124' ' ' SER . . . -162.61 -23.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.12 -0.988 . . . . 0.0 111.06 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.474 HG23 ' OG1' ' A' ' 118' ' ' THR . 2.6 t -59.86 -62.62 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.794 -1.191 . . . . 0.0 109.799 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.47 ' N ' HG12 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -60.72 -27.12 67.68 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.126 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.54 -20.09 32.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 120' ' ' ALA . 95.5 p -67.19 -62.0 1.64 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 110.8 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.6 mt -80.23 -19.88 45.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.925 -1.109 . . . . 0.0 110.81 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.69 -42.68 27.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.663 -1.273 . . . . 0.0 110.241 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.517 ' HD3' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -90.04 -45.0 9.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.958 -1.089 . . . . 0.0 110.126 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 10' ' ' VAL . 71.1 t80 -47.31 -21.55 0.3 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.01 -1.056 . . . . 0.0 109.454 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 129' ' ' LEU . 15.8 mt -69.63 -17.68 63.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.19 78.58 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.464 ' HB3' HD13 ' A' ' 2' ' ' LEU . 60.5 p -78.68 -25.92 44.88 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.362 -0.836 . . . . 0.0 108.747 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.1 t -84.99 -40.54 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.234 -0.916 . . . . 0.0 108.598 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.8 t -68.84 -28.76 67.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.397 -0.814 . . . . 0.0 109.297 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 51.6 m -64.65 -40.0 94.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.138 -0.976 . . . . 0.0 108.985 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 135' ' ' VAL . 2.7 p -82.68 -21.89 9.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.26 -0.9 . . . . 0.0 108.584 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.546 HD23 ' CZ ' ' A' ' 98' ' ' PHE . 1.1 tp -78.82 -28.26 44.4 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 138' ' ' SER . 49.1 m -68.14 -23.34 64.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.846 . . . . 0.0 109.405 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 2' ' ' HIS . . . . . 1.199 ' NE2' ' ND1' ' D' ' 146' ' ' HIS . 6.2 p80 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.23 0.538 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.847 ' N ' HD12 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -141.87 -162.63 1.43 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.26 -0.9 . . . . 0.0 109.149 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -93.77 131.08 32.9 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.0 109.237 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.45 -23.77 0.32 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.365 2.043 . . . . 0.0 112.308 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -81.46 -53.02 6.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.968 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 5.5 mp0 -61.3 -55.58 30.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.662 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.727 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -57.04 -35.44 69.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.869 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -58.67 -23.81 60.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 110.047 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.61 -56.45 3.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.094 -1.004 . . . . 0.0 109.712 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.599 HG23 ' CD2' ' B' ' 130' ' ' TYR . 0.9 OUTLIER -64.07 -25.15 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.574 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 75.9 m -78.7 -35.26 45.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -60.38 -61.52 2.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.425 -0.797 . . . . 0.0 109.328 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.522 ' O ' HG23 ' B' ' 18' ' ' VAL . 8.0 mp -43.62 -18.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.672 -0.642 . . . . 0.0 109.765 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' B' ' 13' ' ' ALA . 22.1 t-105 -78.09 -17.96 56.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.972 . . . . 0.0 109.646 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.09 -42.61 7.49 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.665 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -68.75 -31.95 71.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -1.093 . . . . 0.0 109.214 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.522 HG23 ' O ' ' B' ' 14' ' ' LEU . 4.8 t -52.33 119.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -0.819 . . . . 0.0 109.692 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' B' ' 21' ' ' ASP . 54.9 m-20 -86.98 82.86 7.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.035 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' B' ' 22' ' ' GLU . 94.7 t -44.14 -20.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.816 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' B' ' 19' ' ' ASN . 12.6 m-20 -51.72 -8.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.73 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' B' ' 20' ' ' VAL . 34.8 mt-10 -155.53 -49.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.5 t -46.08 -26.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 109.779 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.09 -31.18 32.4 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -82.47 -25.67 49.96 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.73 -29.94 25.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.697 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.55 -23.45 63.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.949 . . . . 0.0 109.807 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.67 -58.16 3.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 109.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.19 -29.35 68.36 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.5 ' NH2' HG13 ' B' ' 113' ' ' VAL . 3.3 ttp180 -68.37 -29.44 68.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -1.114 . . . . 0.0 109.745 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp -51.62 -39.7 58.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.244 -0.91 . . . . 0.0 109.652 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 mt -78.12 -21.85 49.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.825 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 45.7 t -71.83 -47.96 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.875 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -63.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.019 -1.051 . . . . 0.0 109.787 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -119.42 97.09 50.16 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.396 -0.815 . . . . 0.0 109.754 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' B' ' 38' ' ' THR . 90.6 Cg_endo -85.59 10.52 3.67 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.717 2.278 . . . . 0.0 111.888 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -45.21 -19.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 109.694 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.662 ' C ' ' H ' ' B' ' 40' ' ' ARG . 11.0 p -46.96 -34.36 5.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.616 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 61.06 -13.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 1.403 ' HE ' ' NH2' ' C' ' 92' ' ' ARG . 79.8 mtt180 -88.94 -25.63 21.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.955 . . . . 0.0 108.946 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' PHE . . . . . 0.405 ' CD2' HD22 ' B' ' 48' ' ' LEU . 3.4 m-85 53.79 6.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.415 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.624 ' CD2' ' CE1' ' B' ' 45' ' ' PHE . 3.0 m-85 48.11 30.08 2.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 109.163 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -48.41 -20.19 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 32.5 p -74.39 -14.66 60.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.952 . . . . 0.0 109.409 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.624 ' CE1' ' CD2' ' B' ' 42' ' ' PHE . 17.5 m-85 -85.53 -2.3 58.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.364 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.08 -101.9 0.21 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' B' ' 49' ' ' SER . 1.9 p-10 -178.24 111.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -1.115 . . . . 0.0 109.525 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.563 ' N ' HD12 ' B' ' 48' ' ' LEU . 8.6 mp -81.3 28.18 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 108.687 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.421 ' H ' ' C ' ' B' ' 47' ' ' ASP . 12.2 t -43.97 -29.66 0.61 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.733 . . . . 0.0 110.25 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 13.8 p -140.22 146.93 48.09 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.014 -1.054 . . . . 0.0 109.728 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -40.13 -49.65 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.652 2.235 . . . . 0.0 112.293 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -69.47 -27.95 65.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 109.954 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.5 -19.43 37.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.067 -1.021 . . . . 0.0 109.545 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.05 -59.88 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 109.624 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 11.4 mtm -95.96 20.04 10.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.35 -17.23 50.85 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -86.54 149.99 50.18 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.181 -1.188 . . . . 0.0 109.443 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.13 -45.59 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.678 2.252 . . . . 0.0 112.341 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' B' ' 63' ' ' HIS . 50.1 mtpt -54.17 -51.91 62.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -52.67 -42.51 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.54 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -79.13 -25.98 42.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.595 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.55 -59.04 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.644 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' HIS . . . . . 0.475 ' O ' ' ND1' ' B' ' 63' ' ' HIS . 13.5 t-80 -49.28 -23.94 1.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 109.595 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.68 -28.51 73.08 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -65.97 -32.27 73.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -1.135 . . . . 0.0 109.187 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -70.32 -60.09 2.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 0.0 109.511 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 28.3 t -46.33 -29.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 109.42 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -77.75 -34.86 52.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.287 -0.883 . . . . 0.0 109.369 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.66 -46.66 93.25 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.8 -44.57 82.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -1.175 . . . . 0.0 109.6 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' B' ' 75' ' ' LEU . 4.8 t80 -60.35 -53.52 56.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.457 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' SER . . . . . 0.507 ' OG ' ' NE1' ' B' ' 15' ' ' TRP . 62.5 m -51.94 -27.42 13.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' B' ' 84' ' ' THR . 10.5 t0 -49.74 -34.44 19.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.24 -59.85 6.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.497 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.2 mp -59.09 -17.93 30.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.374 -1.074 . . . . 0.0 109.398 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -84.89 -16.61 40.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 79.6 m-70 -160.11 64.23 0.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.915 . . . . 0.0 109.607 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.74 4.17 0.44 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.399 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' B' ' 77' ' ' HIS . 59.1 m-20 -75.54 -22.93 56.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -0.875 . . . . 0.0 109.404 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -157.31 103.44 1.98 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.88 . . . . 0.0 109.378 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.583 ' N ' HD22 ' B' ' 81' ' ' LEU . 3.6 mm? -80.2 -58.78 2.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.416 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 1.432 ' NZ ' ' HZ1' ' D' ' 82' ' ' LYS . 83.5 mttt -55.25 -24.0 25.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.24 -60.23 7.84 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.0 t -69.43 -46.28 67.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 0.0 109.36 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.552 ' N ' ' CG2' ' B' ' 84' ' ' THR . 46.9 m-85 -70.34 16.81 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.547 -0.721 . . . . 0.0 109.613 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -73.75 -38.97 64.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 11.3 p -80.44 -46.18 16.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.524 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 42.8 mt -56.11 -54.84 40.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.242 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -50.15 -29.8 9.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.221 -0.924 . . . . 0.0 109.007 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.63 -63.01 1.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.116 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 tt -49.65 -23.44 1.72 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 109.078 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' B' ' 88' ' ' LEU . 7.8 m80 -76.17 -54.27 7.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 24.3 t -82.59 -19.42 38.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.003 . . . . 0.0 109.868 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.27 -25.02 25.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.088 -1.008 . . . . 0.0 111.026 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 95' ' ' LYS . . . . . 0.492 ' CA ' ' NE2' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -125.8 -51.96 1.57 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.843 -1.161 . . . . 0.0 110.796 -179.24 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.599 ' N ' HD12 ' B' ' 96' ' ' LEU . 8.0 mp -70.1 -58.12 4.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.974 -1.079 . . . . 0.0 110.096 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.582 ' CD2' ' N ' ' B' ' 97' ' ' HIS . 1.0 OUTLIER 72.18 19.84 4.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.326 -0.859 . . . . 0.0 109.584 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -57.86 132.11 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.138 -0.976 . . . . 0.0 109.199 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 99' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' B' ' 100' ' ' PRO . 0.7 OUTLIER -64.64 152.54 89.6 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.362 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' B' ' 99' ' ' ASP . 74.1 Cg_exo -45.65 -175.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.43 2.087 . . . . 0.0 112.408 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 55.35 76.89 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -173.52 -56.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -58.34 -19.65 36.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -80.15 -44.59 19.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -0.925 . . . . 0.0 109.533 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.3 -48.85 79.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.49 HD23 ' C ' ' B' ' 106' ' ' LEU . 5.2 tt -56.43 -54.43 45.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.357 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.06 -31.74 62.05 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -66.78 -53.49 32.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -1.216 . . . . 0.0 109.684 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.54 -47.53 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.475 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 tp -49.01 -26.75 2.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.86 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.0 t -70.78 -38.83 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.092 -1.005 . . . . 0.0 109.937 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 t -76.79 -22.93 52.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.001 . . . . 0.0 109.932 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' VAL . . . . . 0.5 HG13 ' NH2' ' B' ' 30' ' ' ARG . 97.1 t -68.74 -24.32 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.891 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' B' ' 116' ' ' HIS . 48.7 mt -82.58 -54.33 5.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.103 -0.998 . . . . 0.0 109.678 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.476 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.64 -19.88 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.63 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.49 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.82 -62.87 1.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -0.963 . . . . 0.0 109.427 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -17.81 59.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.438 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -151.41 61.5 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.495 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -70.8 -19.53 76.86 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.54 -30.82 70.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -1.161 . . . . 0.0 109.372 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' B' ' 123' ' ' THR . 30.9 mt-10 -90.48 14.3 13.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.465 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.524 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.4 OUTLIER -70.78 35.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.0 109.596 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.515 ' H ' ' C ' ' B' ' 121' ' ' GLU . 30.4 p -59.79 144.59 85.44 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.161 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.78 ' HA ' HH22 ' A' ' 31' ' ' ARG . 31.7 Cg_exo -44.82 -43.44 14.98 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.464 2.109 . . . . 0.0 113.408 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' B' ' 124' ' ' PRO . 3.0 Cg_exo -75.17 20.19 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.447 2.098 . . . . 0.0 112.175 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.49 HG23 ' OG1' ' B' ' 123' ' ' THR . 79.6 t -125.06 -29.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 109.565 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 127' ' ' GLN . . . . . 0.997 ' HB2' HH21 ' A' ' 31' ' ' ARG . 86.6 mm-40 -83.15 -59.7 2.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.99 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 1.079 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -56.64 -42.66 79.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.425 ' O ' HG23 ' B' ' 133' ' ' VAL . . . -70.06 11.07 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.536 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.599 ' CD2' HG23 ' B' ' 11' ' ' VAL . 4.9 t80 -105.2 -61.31 1.5 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.317 -0.864 . . . . 0.0 109.567 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.605 ' CD ' ' H ' ' B' ' 131' ' ' GLN . 3.8 mp0 -50.02 -38.39 37.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -0.949 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 1.126 ' HD3' ' O ' ' D' ' 146' ' ' HIS . 18.7 ttpp -64.68 -28.58 69.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.771 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 133' ' ' VAL . . . . . 0.697 HG22 HD21 ' B' ' 3' ' ' LEU . 79.4 t -71.45 -67.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.733 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.448 HG22 ' H ' ' B' ' 134' ' ' VAL . 2.4 m -61.3 -24.66 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.74 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -49.25 -29.32 5.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.6 -29.1 56.1 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.418 HG13 ' CE1' ' B' ' 85' ' ' PHE . 67.0 t -72.93 -34.28 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -1.133 . . . . 0.0 109.404 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.71 -48.18 63.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.469 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 139' ' ' ASN . . . . . 0.48 ' C ' HD22 ' B' ' 139' ' ' ASN . 0.2 OUTLIER -77.76 -29.62 51.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.495 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.25 82.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.409 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.24 13.21 1.96 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.47 4.53 1.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 143' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' B' ' 139' ' ' ASN . 12.3 t-80 -79.39 -26.29 42.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.203 -0.935 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.8 OUTLIER -81.95 -1.38 47.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.521 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -66.07 7.64 0.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 109.27 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 1.256 ' ND1' ' NE2' ' D' ' 2' ' ' HIS . 63.7 m170 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.461 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.522 HD11 ' HD3' ' C' ' 127' ' ' LYS . 9.5 tp -172.41 163.46 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 109.777 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.8 OUTLIER -75.79 -177.06 0.65 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.016 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 58.4 Cg_endo -86.84 -68.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.606 2.204 . . . . 0.0 112.711 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -47.62 -40.31 19.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 109.542 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.597 ' O ' HG23 ' C' ' 10' ' ' VAL . 63.9 m-20 -43.6 -29.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 0.0 109.039 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' C' ' 10' ' ' VAL . 58.4 mttt -83.05 -53.78 5.55 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.414 ' C ' ' O ' ' C' ' 7' ' ' LYS . 35.4 m -44.7 -38.52 4.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.488 -0.757 . . . . 0.0 109.227 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -72.38 -29.7 64.01 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.597 HG23 ' O ' ' C' ' 6' ' ' ASP . 54.2 t -75.13 -55.07 12.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 11' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' C' ' 11' ' ' LYS . 0.1 OUTLIER -51.53 -39.25 57.34 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.649 -1.221 . . . . 0.0 108.229 179.109 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.05 -63.18 1.35 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 109.321 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.559 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.66 -38.64 67.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.388 -0.82 . . . . 0.0 108.836 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.91 -17.64 63.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.469 -0.769 . . . . 0.0 108.988 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.04 -45.09 16.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.425 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 39.2 mmtt -68.15 -41.48 81.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 108.862 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.559 HG23 ' O ' ' C' ' 13' ' ' ALA . 61.4 t -60.16 -64.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 49.93 -127.9 24.86 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.39 24.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.388 -1.066 . . . . 0.0 110.426 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.548 ' H ' ' C ' ' C' ' 18' ' ' GLY . 87.4 m-70 -130.45 28.41 4.94 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -93.2 -61.24 1.61 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.642 -0.661 . . . . 0.0 109.849 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.41 -14.27 0.18 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.6 mt-10 -86.56 -56.27 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -1.056 . . . . 0.0 109.764 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 4.1 m-30 -59.78 -32.44 70.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 0.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.9 -23.02 75.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.89 -41.8 18.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -1.213 . . . . 0.0 109.974 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' C' ' 27' ' ' GLU . 0.1 OUTLIER -66.03 -19.84 65.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.261 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.77 -20.35 60.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.552 HD11 ' ND1' ' C' ' 58' ' ' HIS . 14.1 mt -74.48 -51.23 15.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 109.672 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.59 -22.35 65.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.943 HH21 ' HB2' ' D' ' 127' ' ' GLN . 2.3 tpt180 -73.38 -20.87 60.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 46.0 ttp -78.19 -53.76 6.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.333 -0.854 . . . . 0.0 109.57 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 0.0 OUTLIER -48.3 -24.25 1.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.397 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 1.087 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.6 mt -82.27 -46.11 14.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.656 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 45.8 m -69.27 -20.72 63.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.854 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' C' ' 35' ' ' SER . 95.5 m-85 -158.42 79.11 3.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.033 -1.042 . . . . 0.0 109.758 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' C' ' 39' ' ' THR . 51.8 Cg_exo -50.19 -26.43 15.22 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.612 2.208 . . . . 0.0 112.049 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' C' ' 41' ' ' THR . 12.6 p -49.44 -18.33 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.405 ' N ' ' C ' ' C' ' 37' ' ' PRO . 53.9 p -78.91 -22.32 46.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.722 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -46.11 -42.84 14.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.913 . . . . 0.0 109.776 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.502 HG21 ' HD1' ' B' ' 97' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.459 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 15.9 p80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.667 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -149.76 69.28 1.02 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' C' ' 46' ' ' PHE . 1.1 m-20 -24.35 -37.74 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.925 -0.484 . . . . 0.0 111.183 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.667 ' N ' ' O ' ' C' ' 46' ' ' PHE . 4.3 mt 53.7 7.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.06 -1.025 . . . . 0.0 109.344 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.484 ' H ' ' C ' ' C' ' 47' ' ' ASP . 5.0 m -64.32 5.69 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.601 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 50' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' C' ' 48' ' ' LEU . 38.1 t60 61.42 125.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.311 -0.868 . . . . 0.0 109.501 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.46 14.24 66.32 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 13.5 t -77.81 -103.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -1.159 . . . . 0.0 109.48 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.96 -29.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.439 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -80.04 -17.97 51.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.265 -0.897 . . . . 0.0 109.157 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -84.35 -40.25 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -77.37 -32.37 54.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -0.924 . . . . 0.0 109.082 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.14 -21.8 75.13 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.552 ' ND1' HD11 ' C' ' 29' ' ' LEU . 7.8 t-80 -75.7 -37.46 59.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -1.103 . . . . 0.0 109.721 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.22 -48.49 47.05 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -51.7 -23.15 4.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -1.079 . . . . 0.0 110.063 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -39.83 64.68 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.109 -0.994 . . . . 0.0 109.218 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.29 -33.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.11 -32.95 44.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.378 -0.826 . . . . 0.0 109.462 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -70.33 -33.41 71.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.077 -1.014 . . . . 0.0 108.841 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.03 -53.14 18.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.412 -0.805 . . . . 0.0 108.843 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.29 -38.23 70.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 108.642 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -71.54 -50.28 32.78 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.83 -21.02 60.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.21 -47.37 13.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.424 HG13 ' CE ' ' C' ' 11' ' ' LYS . 10.0 t -65.84 -23.02 31.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.52 -15.21 63.46 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.62 ' O ' ' N ' ' C' ' 74' ' ' ASP . 78.5 m-70 -139.42 -63.17 0.52 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.379 -0.825 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.59 HG22 ' O ' ' C' ' 73' ' ' VAL . 12.3 p 43.97 13.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.813 0.816 . . . . 0.0 109.634 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.62 ' N ' ' O ' ' C' ' 72' ' ' HIS . 16.2 m-20 -134.25 10.39 3.81 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.464 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 20.2 t0 -176.95 28.29 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.037 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 11.4 ptt? -78.87 -22.44 0.38 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 111.745 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 72.7 Cg_exo -49.02 -29.03 14.75 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.569 1.513 . . . . 0.0 112.4 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -94.3 -24.29 17.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.709 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.36 -53.49 8.1 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.179 -0.951 . . . . 0.0 109.191 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 15.0 mt -78.05 9.13 3.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.43 -0.794 . . . . 0.0 109.022 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 81' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' C' ' 84' ' ' SER . 11.1 t -66.1 -41.59 90.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -52.3 -53.01 49.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.486 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' C' ' 83' ' ' LEU . 4.9 mt -44.83 -45.0 9.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 10.0 p -55.85 -39.77 71.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' C' ' 82' ' ' ALA . 25.8 t70 -67.64 -17.9 64.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.443 ' O ' HD23 ' C' ' 86' ' ' LEU . 1.2 tt -82.81 -43.45 16.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.35 -0.844 . . . . 0.0 109.469 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -92.42 -21.23 20.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 109.979 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -60.73 -87.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 110.729 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 89' ' ' HIS . . . . . 0.459 ' O ' ' O ' ' C' ' 90' ' ' LYS . 45.1 t-80 -96.61 -46.21 6.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 111.043 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' C' ' 89' ' ' HIS . 35.9 mttm -41.33 -94.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.145 -0.972 . . . . 0.0 110.346 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.55 -34.95 78.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.017 . . . . 0.0 109.65 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 92' ' ' ARG . . . . . 1.403 ' NH2' ' HE ' ' B' ' 40' ' ' ARG . 45.6 ttp85 60.87 58.19 2.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 109.602 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 t -84.29 161.56 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 109.451 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.38 151.37 50.85 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.957 . . . . 0.0 109.342 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' C' ' 97' ' ' ASN . 58.6 Cg_endo -72.99 -18.86 23.8 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.524 2.149 . . . . 0.0 112.234 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.455 HG21 ' CB ' ' B' ' 99' ' ' ASP . 24.5 t -47.21 -19.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.733 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' C' ' 95' ' ' PRO . 4.1 m-20 -79.12 -24.86 43.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.732 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 98' ' ' PHE . . . . . 0.538 ' CZ ' HD23 ' C' ' 136' ' ' LEU . 4.8 m-85 -46.63 -32.53 3.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 109.686 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.504 ' O ' ' ND1' ' C' ' 103' ' ' HIS . 55.7 mttm -83.94 -36.78 23.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 109.781 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.576 ' N ' HD12 ' C' ' 100' ' ' LEU . 7.2 mp -66.35 -62.02 1.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.491 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 101' ' ' LEU . . . . . 0.402 HD23 ' C ' ' C' ' 101' ' ' LEU . 6.4 tt -49.94 -47.39 52.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 42.7 t -61.95 -38.76 89.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.634 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 103' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' C' ' 99' ' ' LYS . 22.9 m80 -77.4 -27.59 52.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.621 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 70.8 m -64.8 -46.99 79.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.728 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.24 -48.6 65.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.454 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.471 ' N ' HD12 ' C' ' 106' ' ' LEU . 9.5 mp -61.51 -59.22 5.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.94 -34.25 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 16.8 m -75.77 -60.87 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 13.0 mt -46.11 -41.44 12.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 0.0 109.676 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.83 -28.74 0.68 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.153 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.83 -56.35 4.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.132 -0.98 . . . . 0.0 109.722 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -85.83 -65.08 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.472 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 109' ' ' LEU . 0.1 OUTLIER -95.94 106.86 30.72 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.21 171.23 9.38 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.73 1.62 . . . . 0.0 112.352 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -87.28 -34.34 18.94 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.441 0.639 . . . . 0.0 109.87 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' C' ' 117' ' ' PHE . 23.2 mt-10 55.66 9.87 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' C' ' 116' ' ' GLU . 29.2 p90 40.63 32.42 0.15 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.522 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.491 ' OG1' HG23 ' C' ' 121' ' ' VAL . 5.0 p -60.96 145.66 88.75 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.47 29.51 0.13 Allowed 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.957 1.771 . . . . 0.0 111.734 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' C' ' 118' ' ' THR . . . -162.62 -23.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.174 -0.954 . . . . 0.0 111.072 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.491 HG23 ' OG1' ' C' ' 118' ' ' THR . 2.6 t -59.94 -62.55 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.829 -1.17 . . . . 0.0 109.818 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.455 ' N ' HG12 ' C' ' 121' ' ' VAL . 0.1 OUTLIER -60.76 -27.2 67.78 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.426 -0.797 . . . . 0.0 109.087 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.04 32.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.645 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.476 ' N ' ' O ' ' C' ' 120' ' ' ALA . 95.7 p -67.25 -61.94 1.67 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 110.828 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 9.7 mt -80.15 -19.97 45.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.065 -1.022 . . . . 0.0 110.844 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.73 -42.49 28.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.759 -1.213 . . . . 0.0 110.332 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.522 ' HD3' HD11 ' C' ' 2' ' ' LEU . 0.0 OUTLIER -90.15 -44.88 9.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.999 -1.063 . . . . 0.0 110.17 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.424 ' CD1' HG21 ' C' ' 10' ' ' VAL . 71.2 t80 -47.3 -21.53 0.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.029 -1.044 . . . . 0.0 109.564 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.401 ' N ' ' C ' ' C' ' 127' ' ' LYS . 15.8 mt -69.66 -17.67 63.52 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.97 -38.25 78.66 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.448 ' HB3' HD13 ' C' ' 2' ' ' LEU . 60.5 p -78.66 -25.89 44.98 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.31 -0.869 . . . . 0.0 108.756 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -85.05 -40.48 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 2.7 t -68.85 -28.85 67.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.453 -0.779 . . . . 0.0 109.239 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 51.5 m -64.63 -39.99 94.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 109.015 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.402 ' H ' HG12 ' C' ' 135' ' ' VAL . 2.7 p -82.62 -21.9 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 136' ' ' LEU . . . . . 0.538 HD23 ' CZ ' ' C' ' 98' ' ' PHE . 1.1 tp -78.83 -28.36 44.36 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 137' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' C' ' 138' ' ' SER . 49.8 m -68.15 -23.34 64.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 109.392 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 138' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' C' ' 137' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 2' ' ' HIS . . . . . 1.256 ' NE2' ' ND1' ' B' ' 146' ' ' HIS . 6.2 p80 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.253 0.549 . . . . 0.0 109.756 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.867 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -141.96 -162.64 1.43 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.276 -0.89 . . . . 0.0 109.183 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -93.74 131.04 33.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 109.263 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.45 -23.68 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.329 2.019 . . . . 0.0 112.402 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -81.57 -53.02 6.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.816 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 7' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' D' ' 7' ' ' GLU . 5.5 mp0 -61.34 -55.52 30.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.747 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -57.17 -35.42 69.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.806 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -58.71 -23.73 60.15 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 109.992 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.54 -56.61 3.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.978 -1.076 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.594 HG23 ' CD2' ' D' ' 130' ' ' TYR . 0.9 OUTLIER -63.98 -25.13 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 73.6 m -78.66 -35.24 45.55 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 13' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -60.5 -61.41 2.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.252 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.512 ' O ' HG23 ' D' ' 18' ' ' VAL . 8.0 mp -43.73 -18.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 109.759 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 15' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' D' ' 13' ' ' ALA . 22.1 t-105 -78.03 -18.04 56.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.148 -0.97 . . . . 0.0 109.646 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.97 -42.72 7.49 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.665 ' H ' ' CD ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -68.66 -31.97 71.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -1.12 . . . . 0.0 109.2 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.512 HG23 ' O ' ' D' ' 14' ' ' LEU . 4.7 t -52.4 119.89 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.655 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' D' ' 21' ' ' ASP . 55.8 m-20 -86.99 82.85 7.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 108.98 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' D' ' 22' ' ' GLU . 91.6 t -43.99 -20.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 109.789 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' D' ' 19' ' ' ASN . 12.7 m-20 -51.62 -8.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.802 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' D' ' 20' ' ' VAL . 34.8 mt-10 -155.48 -49.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 109.629 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 74.1 t -46.11 -26.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.788 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.05 -31.18 32.53 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -82.56 -25.65 49.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -84.67 -29.99 25.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -1.144 . . . . 0.0 109.682 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.47 -23.49 63.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.812 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.68 -58.25 3.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.477 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.21 -29.27 68.25 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 30' ' ' ARG . . . . . 0.498 ' NH2' HG13 ' D' ' 113' ' ' VAL . 3.3 ttp180 -68.43 -29.43 68.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.681 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp -51.61 -39.75 58.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.635 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.04 -21.88 50.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.878 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.85 -47.93 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.869 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -63.35 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 0.0 109.788 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -119.42 97.01 50.16 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 0.0 109.814 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' D' ' 38' ' ' THR . 90.9 Cg_endo -85.57 10.56 3.65 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.659 2.239 . . . . 0.0 111.906 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -45.24 -19.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 0.0 109.732 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.645 ' C ' ' H ' ' D' ' 40' ' ' ARG . 10.9 p -46.95 -34.37 5.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 109.637 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 61.09 -13.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.38 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' ARG . . . . . 1.393 ' HE ' ' NH2' ' A' ' 92' ' ' ARG . 79.9 mtt180 -89.01 -25.55 21.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 108.971 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 53.68 6.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 109.429 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.613 ' CD2' ' CE1' ' D' ' 45' ' ' PHE . 3.0 m-85 48.03 30.14 1.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.174 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -48.34 -20.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 109.72 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 33.1 p -74.46 -14.66 60.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.973 . . . . 0.0 109.392 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.613 ' CE1' ' CD2' ' D' ' 42' ' ' PHE . 17.4 m-85 -85.42 -2.38 58.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.08 -101.88 0.21 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' D' ' 49' ' ' SER . 1.9 p-10 -178.2 111.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.509 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' D' ' 48' ' ' LEU . 8.6 mp -81.27 28.1 0.39 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 108.753 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.414 ' H ' ' C ' ' D' ' 47' ' ' ASP . 12.0 t -43.86 -29.72 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.638 -0.664 . . . . 0.0 110.3 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 14.0 p -140.16 146.9 48.14 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.089 -1.007 . . . . 0.0 109.693 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -40.14 -49.61 3.71 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.676 2.251 . . . . 0.0 112.255 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -69.5 -27.98 65.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.91 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.48 -19.4 36.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.605 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.06 -59.97 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.584 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 11.4 mtm -95.87 20.14 10.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 109.458 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.44 -17.24 50.48 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -86.59 150.0 50.08 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.229 -1.159 . . . . 0.0 109.395 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.18 -45.58 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.579 2.186 . . . . 0.0 112.236 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' D' ' 63' ' ' HIS . 50.1 mtpt -54.12 -51.96 62.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 59.9 t -52.64 -42.55 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -79.0 -26.13 43.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.569 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.45 -59.07 2.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.657 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' HIS . . . . . 0.472 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 13.5 t-80 -49.37 -23.88 1.66 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.558 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.74 -28.51 73.06 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -65.92 -32.3 73.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -1.172 . . . . 0.0 109.21 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -70.29 -60.11 2.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 109.501 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 27.6 t -46.41 -29.68 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.375 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -77.71 -34.88 52.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.372 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.68 -46.69 93.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.57 81.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.59 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 71' ' ' PHE . . . . . 0.418 ' CZ ' HD11 ' D' ' 75' ' ' LEU . 4.7 t80 -60.43 -53.51 56.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -0.887 . . . . 0.0 109.375 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 72' ' ' SER . . . . . 0.522 ' HG ' ' HE1' ' D' ' 15' ' ' TRP . 63.2 m -51.96 -27.41 13.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.455 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 73' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' D' ' 84' ' ' THR . 10.6 t0 -49.71 -34.49 18.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.95 . . . . 0.0 109.391 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.26 -59.91 6.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.493 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.2 mp -59.03 -17.97 30.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -1.151 . . . . 0.0 109.427 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 76' ' ' ALA . . . . . 0.53 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -84.9 -16.61 40.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 79.8 m-70 -160.1 64.16 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.74 4.19 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.414 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' D' ' 77' ' ' HIS . 59.5 m-20 -75.41 -22.98 56.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.92 . . . . 0.0 109.421 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -157.3 103.47 1.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.354 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 81' ' ' LEU . . . . . 0.592 ' N ' HD22 ' D' ' 81' ' ' LEU . 3.6 mm? -80.23 -58.79 2.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.945 . . . . 0.0 109.427 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 82' ' ' LYS . . . . . 1.432 ' HZ1' ' NZ ' ' B' ' 82' ' ' LYS . 83.5 mttt -55.3 -23.9 25.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.577 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.23 -60.26 7.8 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.0 t -69.44 -46.23 67.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.151 -1.205 . . . . 0.0 109.378 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.555 ' N ' ' CG2' ' D' ' 84' ' ' THR . 46.8 m-85 -70.35 16.85 0.07 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.523 -0.736 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 86' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -73.85 -38.8 64.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.453 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 11.0 p -80.62 -46.14 16.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.414 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.515 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 42.3 mt -56.07 -54.86 39.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 109.287 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -50.19 -29.73 9.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.944 . . . . 0.0 109.037 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' D' ' 94' ' ' ASP . 42.4 tt0 -82.6 -63.03 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.128 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 tt -49.73 -23.42 1.78 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 109.046 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' D' ' 88' ' ' LEU . 7.9 m80 -76.13 -54.33 6.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.181 -0.949 . . . . 0.0 109.486 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 24.1 t -82.57 -19.42 38.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.161 -0.962 . . . . 0.0 109.916 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' D' ' 90' ' ' GLU . 1.4 m-20 -86.23 -24.96 25.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.082 -1.011 . . . . 0.0 111.086 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 95' ' ' LYS . . . . . 0.487 ' CA ' ' NE2' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -125.83 -52.04 1.57 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.829 -1.169 . . . . 0.0 110.725 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.606 HD12 ' N ' ' D' ' 96' ' ' LEU . 8.0 mp -70.16 -58.1 4.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.894 -1.129 . . . . 0.0 110.053 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.583 ' HD1' HG21 ' A' ' 41' ' ' THR . 1.0 OUTLIER 72.12 19.88 4.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.583 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.69 132.07 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.101 -0.999 . . . . 0.0 109.221 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 99' ' ' ASP . . . . . 0.511 ' CB ' HG21 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -64.6 152.6 89.31 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 109.309 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 100' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' D' ' 99' ' ' ASP . 74.3 Cg_exo -45.72 -175.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.504 2.136 . . . . 0.0 112.402 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 55.4 76.82 0.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -173.56 -56.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.859 . . . . 0.0 109.372 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -58.42 -19.55 37.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.0 109.515 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -80.23 -44.45 19.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.39 -48.88 79.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.382 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.479 HD23 ' C ' ' D' ' 106' ' ' LEU . 5.2 tt -56.41 -54.5 44.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.298 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.04 -31.7 61.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -66.82 -53.47 32.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -1.194 . . . . 0.0 109.686 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 79.3 t -49.44 -47.5 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tp -49.13 -26.66 2.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 109.823 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.77 -38.82 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.09 -1.006 . . . . 0.0 109.998 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 22.8 t -76.77 -22.99 52.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.898 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 113' ' ' VAL . . . . . 0.498 HG13 ' NH2' ' D' ' 30' ' ' ARG . 97.5 t -68.7 -24.34 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.948 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 114' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' D' ' 116' ' ' HIS . 48.6 mt -82.58 -54.4 5.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.14 -0.975 . . . . 0.0 109.668 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.487 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.62 -19.94 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 109.647 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.465 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.71 -62.89 1.44 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.429 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -17.78 59.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.865 . . . . 0.0 109.436 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -151.38 61.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -70.82 -19.49 76.86 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.58 -30.74 70.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -1.165 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' D' ' 123' ' ' THR . 30.9 mt-10 -90.57 14.36 13.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.4 OUTLIER -70.77 35.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.498 ' H ' ' C ' ' D' ' 121' ' ' GLU . 30.4 p -59.75 144.64 85.16 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.158 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.766 ' HA ' HH22 ' C' ' 31' ' ' ARG . 31.5 Cg_exo -44.85 -43.39 15.09 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.439 2.093 . . . . 0.0 113.517 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' D' ' 124' ' ' PRO . 3.1 Cg_exo -75.16 20.12 0.48 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.437 2.091 . . . . 0.0 112.174 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.481 HG23 ' OG1' ' D' ' 123' ' ' THR . 79.5 t -125.02 -29.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.341 -0.85 . . . . 0.0 109.602 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 127' ' ' GLN . . . . . 0.943 ' HB2' HH21 ' C' ' 31' ' ' ARG . 86.5 mm-40 -83.17 -59.78 2.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.446 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 1.087 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -56.68 -42.57 79.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.964 . . . . 0.0 109.363 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.434 ' O ' HG23 ' D' ' 133' ' ' VAL . . . -70.05 11.05 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.526 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.594 ' CD2' HG23 ' D' ' 11' ' ' VAL . 4.9 t80 -105.22 -61.3 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 0.606 ' CD ' ' H ' ' D' ' 131' ' ' GLN . 3.8 mp0 -50.05 -38.45 37.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 109.388 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 132' ' ' LYS . . . . . 1.096 ' HD3' ' O ' ' B' ' 146' ' ' HIS . 18.7 ttpp -64.54 -28.61 69.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.77 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 133' ' ' VAL . . . . . 0.684 HG22 HD21 ' D' ' 3' ' ' LEU . 79.3 t -71.49 -67.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.708 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.48 ' H ' HG22 ' D' ' 134' ' ' VAL . 2.4 m -61.23 -24.58 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.807 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -49.34 -29.29 5.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 0.0 109.287 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.63 -29.08 56.08 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 137' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' D' ' 85' ' ' PHE . 66.1 t -72.9 -34.15 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -1.116 . . . . 0.0 109.514 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.81 -48.13 64.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.506 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 139' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' D' ' 143' ' ' HIS . 29.9 t-20 -77.75 -29.55 51.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.589 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.14 83.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.411 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 30.9 mt -79.24 13.14 1.99 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.362 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.47 4.56 1.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.631 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 143' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' D' ' 139' ' ' ASN . 12.3 t-80 -79.34 -26.26 42.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.167 -0.958 . . . . 0.0 109.459 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.8 OUTLIER -82.04 -1.4 48.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.479 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -65.91 7.6 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 1.199 ' ND1' ' NE2' ' B' ' 2' ' ' HIS . 63.8 m170 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.472 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.485 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 36.4 mt -121.29 -171.74 2.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.829 . . . . 0.0 109.561 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -97.75 -179.08 0.81 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 109.296 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 26.0 Cg_exo -60.87 -68.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.605 2.203 . . . . 0.0 112.291 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -52.39 -36.12 53.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.797 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 3.3 m-20 -44.18 -33.7 1.62 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -83.41 -60.12 2.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.621 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.8 m -46.97 -29.74 2.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.419 -0.8 . . . . 0.0 109.979 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -77.33 -36.83 53.51 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.024 -1.048 . . . . 0.0 108.279 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -76.14 -47.97 29.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -53.17 -38.54 62.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.52 -62.99 1.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.411 -0.806 . . . . 0.0 109.357 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.27 67.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.421 -0.799 . . . . 0.0 109.204 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.451 ' HZ3' HD11 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -72.9 -17.31 61.52 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 108.967 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.59 -40.07 59.76 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -84.75 -49.79 8.16 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.503 -0.998 . . . . 0.0 109.327 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 20' ' ' HIS . 70.4 t -59.96 -35.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.56 -0.712 . . . . 0.0 109.675 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.586 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . -31.53 144.8 0.02 OUTLIER Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . 69.12 -32.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -1.07 . . . . 0.0 108.896 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.586 ' H ' ' C ' ' A' ' 18' ' ' GLY . 1.2 m80 -104.88 13.94 30.34 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' A' ' 17' ' ' VAL . . . -83.55 -48.69 9.99 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.939 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.46 -14.62 42.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -89.1 -56.62 3.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -1.095 . . . . 0.0 109.702 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.639 ' CZ ' ' CE1' ' A' ' 112' ' ' HIS . 2.9 m-30 -58.98 -33.14 70.34 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 109.176 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.82 -33.06 76.49 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.04 -50.8 10.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -1.174 . . . . 0.0 109.721 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -52.4 -19.8 2.4 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.55 -25.54 65.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.506 HD11 ' CG ' ' A' ' 58' ' ' HIS . 33.5 mt -72.27 -58.02 3.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.671 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.71 -14.29 30.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.524 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 1.052 ' NH1' ' CG ' ' B' ' 127' ' ' GLN . 1.8 tpm_? -75.45 -38.98 59.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 109.357 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.512 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -80.02 -48.5 13.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.218 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 32' ' ' MET . 37.1 t80 -43.72 -19.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.396 -0.815 . . . . 0.0 109.831 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.815 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 11.0 mt -79.88 -60.2 2.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.136 -0.978 . . . . 0.0 109.701 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.854 ' OG ' ' NE2' ' B' ' 131' ' ' GLN . 29.6 m -81.39 -31.37 33.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 109.676 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 60.3 m-85 -113.63 95.04 35.22 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.411 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.12 -20.1 8.9 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.447 2.098 . . . . 0.0 112.228 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.693 ' O ' HG22 ' A' ' 41' ' ' THR . 71.1 p -47.64 -42.1 23.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 109.274 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 39' ' ' THR . 12.6 p -44.03 -22.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.83 . . . . 0.0 109.854 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' THR . 30.6 ttpt -70.87 -19.11 62.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.638 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 1.137 HG21 ' CD2' ' D' ' 97' ' ' HIS . 8.7 t . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.542 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.586 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.231 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.47 ' C ' ' H ' ' A' ' 48' ' ' LEU . 2.1 p90 -142.54 44.91 1.62 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.532 -1.355 . . . . 0.0 110.11 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.12 -35.32 0.3 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 110.453 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER 61.86 55.85 2.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.043 . . . . 0.0 109.0 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.1 m -165.39 157.06 14.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 0.0 109.541 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.464 ' C ' ' H ' ' A' ' 52' ' ' SER . 2.7 m-70 -59.6 160.94 6.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.877 . . . . 0.0 109.385 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.73 -18.14 1.92 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 54' ' ' GLN . 29.5 p -48.78 -25.94 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -1.145 . . . . 0.0 109.322 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.05 -40.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.835 . . . . 0.0 109.688 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.52 ' H ' ' C ' ' A' ' 52' ' ' SER . 20.5 mt-30 -69.76 -23.73 63.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.304 -0.873 . . . . 0.0 109.304 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.432 HG23 ' OG ' ' A' ' 52' ' ' SER . 57.6 t -69.61 -40.57 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.97 . . . . 0.0 109.129 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -65.73 -54.38 28.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.241 -0.912 . . . . 0.0 108.62 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.19 -36.09 21.1 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.506 ' CG ' HD11 ' A' ' 29' ' ' LEU . 6.1 t-80 -60.5 -36.57 78.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.315 . . . . 0.0 109.895 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.42 -29.28 38.27 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 56.8 mttm -65.18 -23.57 67.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -1.162 . . . . 0.0 110.263 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.41 ' HD2' ' H ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -69.16 -58.13 4.47 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.962 -1.086 . . . . 0.0 108.656 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.3 t -56.46 -44.76 81.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.655 -0.653 . . . . 0.0 109.315 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.51 74.46 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.298 -0.876 . . . . 0.0 109.225 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.9 t70 -66.03 -37.98 87.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -67.56 -53.33 29.22 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.1 mt -58.53 -42.34 87.54 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 71' ' ' ALA . 15.5 m -69.68 -51.58 33.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.273 -0.892 . . . . 0.0 108.696 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -62.23 -25.97 68.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.08 -46.38 11.21 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 66' ' ' LEU . 38.1 t -66.7 -22.75 30.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -69.51 -36.37 76.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.589 ' O ' ' N ' ' A' ' 74' ' ' ASP . 26.1 m80 -103.29 -66.74 0.92 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.615 -0.678 . . . . 0.0 109.424 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 73' ' ' VAL . 14.9 p 44.37 14.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.953 0.882 . . . . 0.0 109.287 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 72' ' ' HIS . 5.5 m-20 -137.96 12.02 2.87 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 0.2 OUTLIER 171.72 31.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 3.5 ptt? -78.29 -23.67 0.42 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.334 -0.854 . . . . 0.0 111.842 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.8 Cg_exo -53.58 -19.46 13.94 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.665 1.576 . . . . 0.0 112.477 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -94.19 -40.43 10.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.68 -48.9 67.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.918 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.61 6.04 6.53 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.446 -0.784 . . . . 0.0 109.198 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.1 t -54.53 -19.56 6.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 109.614 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -83.12 -58.53 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 109.916 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.434 ' N ' HD23 ' A' ' 83' ' ' LEU . 3.8 mt -45.34 -44.58 11.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -0.847 . . . . 0.0 109.082 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.407 ' CB ' ' HG ' ' A' ' 138' ' ' SER . 23.3 t -60.06 -18.93 50.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.519 -0.738 . . . . 0.0 109.56 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 89' ' ' HIS . 36.8 t70 -81.06 -50.94 9.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.913 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.6 tt -64.16 -26.79 68.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.97 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.74 -21.78 26.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 110.328 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.56 -11.03 11.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 0.0 110.154 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.564 ' N ' ' O ' ' A' ' 85' ' ' ASP . 42.7 t60 -106.64 -74.6 0.65 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 109.919 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' ARG . 79.8 mttt -63.84 -110.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.058 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 mt -44.48 -17.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.017 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.455 ' CG ' ' NH2' ' D' ' 40' ' ' ARG . 31.8 ttm-85 46.75 41.56 10.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.142 -0.974 . . . . 0.0 109.481 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.9 t -45.94 144.8 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.867 . . . . 0.0 109.701 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 10.6 m-20 -80.52 150.2 69.77 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.65 -19.48 21.34 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.437 2.091 . . . . 0.0 112.229 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 96' ' ' VAL . 4.1 t -66.35 -7.75 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.666 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 94' ' ' ASP . 12.7 m120 -79.74 -36.26 37.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.478 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -46.33 -41.58 13.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.879 -1.138 . . . . 0.0 109.536 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.49 ' NZ ' ' CB ' ' A' ' 99' ' ' LYS . 8.0 mtmp? -51.38 -28.24 12.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.963 . . . . 0.0 109.291 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.577 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 15.4 mt -84.29 -61.95 1.68 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.682 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tp -49.78 -23.62 1.93 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.878 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -73.38 -49.45 27.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -80.62 -26.37 37.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 0.0 109.923 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 65.7 m -65.06 -60.29 3.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.158 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.722 HD12 ' C ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -57.45 -22.44 43.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 109.825 -179.401 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.18 -31.42 38.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.802 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.46 HG11 ' OE1' ' B' ' 127' ' ' GLN . 56.1 t -83.38 -24.94 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 110.051 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 1.5 t -79.68 -47.72 14.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.0 109.959 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.737 ' O ' HD12 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -69.72 -18.59 63.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.752 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.92 -22.22 46.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 110.257 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.4 -56.24 24.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 110.182 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.681 ' CG ' ' H ' ' A' ' 113' ' ' LEU . 9.4 p80 -72.48 -61.93 1.63 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.098 -1.001 . . . . 0.0 109.469 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.929 HD23 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -119.73 121.43 29.84 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.215 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.3 175.7 7.38 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.422 2.081 . . . . 0.0 112.99 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.654 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -45.36 -54.96 6.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.632 -0.668 . . . . 0.0 109.346 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.654 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 26.1 mt-10 122.9 -2.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.468 ' CG ' ' C ' ' A' ' 116' ' ' GLU . 1.8 m-85 72.22 32.88 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.714 -0.616 . . . . 0.0 111.278 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.772 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.3 p -97.59 121.27 58.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.895 -1.128 . . . . 0.0 108.16 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.62 24.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.934 1.756 . . . . 0.0 112.502 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -150.38 -32.41 0.18 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.981 -1.074 . . . . 0.0 110.401 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 122' ' ' HIS . 12.0 p -53.92 -50.04 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.04 -1.037 . . . . 0.0 110.329 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.671 ' N ' HG13 ' A' ' 121' ' ' VAL . 17.9 m80 -54.84 -44.98 74.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.36 -20.05 32.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 110.375 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 120' ' ' ALA . 94.0 p -52.19 -52.97 48.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.945 . . . . 0.0 110.545 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.451 HD11 ' HZ3' ' A' ' 14' ' ' TRP . 5.5 mt -84.11 -19.34 34.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.0 109.975 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.71 -51.83 9.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.296 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.449 ' HZ2' ' HG2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.63 -43.06 27.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.978 -1.076 . . . . 0.0 110.151 -179.17 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.485 ' CD2' ' CD1' ' A' ' 2' ' ' LEU . 33.9 t80 -50.59 -21.39 1.52 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.858 -1.151 . . . . 0.0 108.929 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 133' ' ' SER . 17.4 mt -73.78 -18.26 60.99 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -60.14 -35.48 75.37 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 135' ' ' VAL . 97.5 p -80.78 -27.02 36.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -84.73 -30.13 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 129' ' ' LEU . 51.6 m -79.17 -40.83 29.89 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 53.2 m -69.3 -26.4 64.71 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 131' ' ' SER . 23.4 t -81.49 -30.28 10.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.09 -23.34 62.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.365 -0.834 . . . . 0.0 109.052 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 138' ' ' SER . 37.8 p -87.29 -18.39 30.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 0.0 109.568 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' THR . 21.6 m . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.449 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 82.0 t60 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.169 0.509 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.858 ' N ' HD12 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -135.99 179.64 6.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 0.0 109.006 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 7' ' ' GLU . 7.3 p -76.15 132.55 73.4 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.104 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -41.28 -24.71 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.343 2.029 . . . . 0.0 112.457 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.2 -21.76 25.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.876 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' B' ' 4' ' ' THR . 32.2 tt0 -80.45 -63.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.959 . . . . 0.0 109.932 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.604 ' HB3' HD13 ' B' ' 3' ' ' LEU . 24.2 pttt -62.25 -31.69 72.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 110.051 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.2 t -44.57 -23.35 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.0 110.406 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -81.59 -57.35 3.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.945 -1.097 . . . . 0.0 110.102 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.442 HG23 ' CE2' ' B' ' 130' ' ' TYR . 14.9 p -68.74 -24.62 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.094 -1.003 . . . . 0.0 108.318 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 12.5 m -71.95 -42.07 67.01 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.339 0.59 . . . . 0.0 109.88 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.75 -30.46 69.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.344 -0.848 . . . . 0.0 109.802 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -50.28 -18.83 0.67 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.97 . . . . 0.0 109.349 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' TRP . . . . . 0.409 ' CZ2' HD13 ' B' ' 75' ' ' LEU . 0.7 OUTLIER -53.08 -51.48 61.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.15 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.09 -32.41 35.32 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -46.7 13.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -1.084 . . . . 0.0 109.177 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.99 114.85 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.732 . . . . 0.0 109.853 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' B' ' 21' ' ' ASP . 19.1 m120 -79.41 71.58 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 108.748 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 20' ' ' VAL . 57.8 t -46.98 -11.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.851 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' B' ' 19' ' ' ASN . 16.5 m-20 -73.45 -5.5 40.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 109.821 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -156.26 -40.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.119 -0.988 . . . . 0.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 78.0 t -46.5 -55.42 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.883 . . . . 0.0 109.64 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.76 -29.83 50.71 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.51 -30.05 69.27 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.92 -31.41 59.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.221 -1.164 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.17 -54.28 48.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.542 ' N ' HD22 ' B' ' 28' ' ' LEU . 3.8 mm? -61.87 -40.1 94.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.273 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.92 -42.91 76.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -72.69 -37.08 67.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -1.122 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 tp -50.07 -31.7 13.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.265 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.28 -22.47 38.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.04 -64.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.627 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.466 HG23 ' H ' ' B' ' 34' ' ' VAL . 0.2 OUTLIER -64.14 -22.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.422 -0.799 . . . . 0.0 109.663 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -140.25 79.17 21.94 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 109.559 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -83.48 -12.45 8.99 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.888 2.392 . . . . 0.0 112.369 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.53 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 3.4 p-90 -48.57 -33.99 10.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.523 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.53 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 3.2 m -78.95 2.65 19.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLN . . . . . 0.444 ' O ' ' OE1' ' B' ' 39' ' ' GLN . 1.4 tm0? -65.53 -19.08 65.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.45 ' HE ' ' HD3' ' C' ' 92' ' ' ARG . 32.9 mtp85 -68.59 -40.84 80.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.751 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -93.04 -18.96 22.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.956 . . . . 0.0 109.749 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.555 ' CE1' ' CE1' ' B' ' 45' ' ' PHE . 1.3 t80 -89.87 28.71 1.3 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -84.48 -13.97 50.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.614 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -80.2 -7.51 59.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.619 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.555 ' CE1' ' CE1' ' B' ' 42' ' ' PHE . 33.7 m-85 -83.65 -3.53 57.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.511 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.99 -172.77 25.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' B' ' 47' ' ' ASP . 2.0 p-10 -84.79 98.37 10.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -1.153 . . . . 0.0 109.42 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.717 ' N ' HD12 ' B' ' 48' ' ' LEU . 7.2 mp -88.0 30.8 0.82 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 108.972 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -45.05 -30.87 1.15 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 109.934 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -142.37 138.15 16.24 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -41.28 -28.4 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.406 2.071 . . . . 0.0 112.279 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.95 -39.79 49.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.93 -19.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.86 . . . . 0.0 109.603 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.1 -63.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.651 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -51.39 -20.0 1.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 109.741 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.07 -31.63 38.31 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -63.16 132.83 95.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -1.191 . . . . 0.0 109.357 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.31 -50.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.46 2.107 . . . . 0.0 112.551 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.04 -34.98 72.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.987 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -55.23 -49.88 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.033 -1.042 . . . . 0.0 109.217 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.464 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 26.2 mtmt -73.63 -29.33 62.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.289 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.92 -46.34 68.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -54.34 -25.28 23.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.553 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -32.35 83.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 0.4 OUTLIER -62.75 -36.91 84.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -1.198 . . . . 0.0 109.308 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -75.74 -35.05 60.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.354 -0.841 . . . . 0.0 109.417 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.03 -63.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.334 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.545 HD23 ' O ' ' B' ' 68' ' ' LEU . 1.8 tt -53.61 -32.94 53.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 108.91 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.83 -57.1 20.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.32 79.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -1.137 . . . . 0.0 109.447 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -67.2 -35.09 78.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.484 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' SER . . . . . 0.402 ' HB2' ' HE1' ' B' ' 15' ' ' TRP . 61.7 p -73.82 -35.69 64.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.409 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.49 -21.29 0.53 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.347 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.17 -60.08 4.66 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.642 ' H ' HD12 ' B' ' 75' ' ' LEU . 5.1 mp -53.47 -28.9 33.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -1.133 . . . . 0.0 109.254 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.75 3.49 41.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' B' ' 79' ' ' ASP . 23.5 t-80 -170.43 61.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.632 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 59.1 mt -73.72 15.16 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 109.327 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' B' ' 77' ' ' HIS . 16.8 t70 -76.43 -36.05 58.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.873 . . . . 0.0 109.513 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -161.55 100.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.377 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 33.7 mt -79.31 -50.19 11.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.362 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.447 ' HZ2' ' CG ' ' B' ' 143' ' ' HIS . 24.6 mmtp -48.41 -23.95 1.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.11 -63.31 3.69 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.3 t -63.9 -48.07 78.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -1.13 . . . . 0.0 109.493 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.555 ' N ' ' CG2' ' B' ' 84' ' ' THR . 46.9 m-85 -63.64 -8.5 10.21 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.538 -0.726 . . . . 0.0 109.348 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.32 -34.75 34.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 109.366 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 28.4 p -83.99 -50.99 7.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.09 -55.54 31.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.174 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' SER . . . . . 0.487 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 1.5 m -51.51 -39.02 56.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.365 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' B' ' 94' ' ' ASP . 29.0 tt0 -74.25 -54.58 7.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 tt -62.46 -29.36 70.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.718 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' B' ' 97' ' ' HIS . 1.3 m80 -79.32 -48.41 14.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 110.001 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 93' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' B' ' 89' ' ' SER . 6.5 m -82.91 -31.08 27.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.032 . . . . 0.0 110.386 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' B' ' 90' ' ' GLU . 6.4 t70 -86.75 -43.47 12.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.084 -1.01 . . . . 0.0 110.937 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -52.33 5.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 110.733 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.648 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 4.1 mm? -82.85 -43.49 16.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.868 -1.145 . . . . 0.0 109.528 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 1.1 ' CD2' HG21 ' C' ' 41' ' ' THR . 0.0 OUTLIER 74.85 19.77 2.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 109.637 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' B' ' 97' ' ' HIS . 8.8 t -45.18 122.1 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 109.449 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' ASP . . . . . 0.509 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 15.4 m-20 -69.05 151.34 97.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' B' ' 99' ' ' ASP . 74.5 Cg_exo -42.84 178.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.626 2.217 . . . . 0.0 112.369 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 57.58 64.75 1.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.839 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' B' ' 99' ' ' ASP . 73.2 m-20 -161.92 -52.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -0.86 . . . . 0.0 109.308 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -67.01 -26.01 66.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 39.5 ttt-85 -78.61 -25.7 45.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.515 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.89 -45.65 49.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.641 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 tt -49.48 -45.99 47.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.415 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.42 -48.82 64.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 108' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 30.1 m120 -50.25 -44.27 53.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -1.153 . . . . 0.0 109.737 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.95 -35.4 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.748 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tp -63.35 -38.8 92.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 109.669 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 66.3 t -51.34 -30.52 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.95 . . . . 0.0 109.693 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.26 -59.26 2.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.621 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 t -46.14 -28.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.816 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.452 HD13 ' OH ' ' B' ' 130' ' ' TYR . 16.8 mt -82.51 -53.23 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.593 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.464 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -65.31 -19.44 65.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.696 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -62.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 109.655 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -77.16 -48.36 17.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.892 . . . . 0.0 109.803 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.8 30.13 1.64 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.714 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -54.94 -27.82 46.04 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -64.55 7.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -1.111 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' B' ' 119' ' ' GLY . 61.1 mm-40 -133.12 6.82 3.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.41 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.556 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.3 34.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.491 ' H ' ' C ' ' B' ' 121' ' ' GLU . 2.9 p -45.02 148.99 0.91 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.463 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.515 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.4 Cg_exo -44.33 -54.07 4.3 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.449 2.099 . . . . 0.0 112.769 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 21.1 Cg_endo -61.37 -48.16 10.28 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.057 1.838 . . . . 0.0 111.975 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.435 ' O ' HG12 ' B' ' 126' ' ' VAL . 73.9 t -55.6 -13.03 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' GLN . . . . . 1.052 ' CG ' ' NH1' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -82.45 -59.94 2.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.606 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.815 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -66.46 -26.53 67.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.928 . . . . 0.0 109.504 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.76 26.38 0.83 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.499 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.452 ' OH ' HD13 ' B' ' 114' ' ' LEU . 0.1 OUTLIER -123.46 -61.25 1.42 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.382 -0.824 . . . . 0.0 109.368 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.854 ' NE2' ' OG ' ' A' ' 35' ' ' SER . 4.0 mp0 -53.62 -36.36 61.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.632 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -69.44 -25.11 63.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 109.567 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 63.6 t -77.35 -43.59 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.512 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.65 -17.05 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.628 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.39 -28.93 70.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.31 -36.57 59.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.501 HG13 ' CZ ' ' B' ' 85' ' ' PHE . 77.5 t -75.17 -36.49 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -1.092 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.25 -38.92 55.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.915 . . . . 0.0 109.468 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 139' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' B' ' 143' ' ' HIS . 9.9 m120 -85.18 -21.31 29.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.731 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.62 -55.52 33.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.114 -0.991 . . . . 0.0 109.478 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 41.5 mt -61.64 -24.68 66.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 142' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' B' ' 145' ' ' TYR . . . -100.27 1.71 41.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.403 -0.811 . . . . 0.0 109.412 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 139' ' ' ASN . 71.2 t60 -80.8 -1.78 44.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.0 109.466 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' B' ' 146' ' ' HIS . 5.4 tppt? -120.73 -31.9 4.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.822 . . . . 0.0 109.889 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' B' ' 142' ' ' ALA . 0.1 OUTLIER -49.29 -10.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 109.933 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' B' ' 144' ' ' LYS . 4.9 m-70 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.662 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.482 ' CD1' ' CD2' ' C' ' 128' ' ' PHE . 36.5 mt -121.2 -171.78 2.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.376 -0.827 . . . . 0.0 109.605 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.47 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.8 OUTLIER -97.75 -178.97 0.79 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.409 -0.807 . . . . 0.0 109.277 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 26.0 Cg_exo -60.97 -68.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.51 2.14 . . . . 0.0 112.329 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -52.33 -36.17 52.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.794 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.477 ' CG ' ' HZ1' ' C' ' 127' ' ' LYS . 3.3 m-20 -44.2 -33.67 1.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 109.444 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -83.38 -60.13 2.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.841 . . . . 0.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.2 m -46.92 -29.75 2.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.355 -0.841 . . . . 0.0 109.94 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -77.5 -36.69 52.37 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.985 -1.072 . . . . 0.0 108.233 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.19 -47.85 29.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -53.18 -38.58 62.93 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.49 -63.05 1.44 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.443 -0.785 . . . . 0.0 109.36 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.22 67.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.851 . . . . 0.0 109.286 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 14' ' ' TRP . . . . . 0.448 ' HZ3' HD11 ' C' ' 125' ' ' LEU . 0.1 OUTLIER -72.98 -17.24 61.48 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.417 -0.802 . . . . 0.0 108.892 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.69 -39.98 59.39 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -84.73 -49.77 8.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.521 -0.988 . . . . 0.0 109.333 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' C' ' 18' ' ' GLY . 71.1 t -60.06 -34.99 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.504 -0.747 . . . . 0.0 109.639 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . -31.56 144.79 0.02 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 19' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' C' ' 18' ' ' GLY . . . 69.16 -32.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -1.101 . . . . 0.0 108.874 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.593 ' H ' ' C ' ' C' ' 18' ' ' GLY . 1.2 m80 -104.96 13.83 30.38 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.43 ' HB2' HG12 ' C' ' 17' ' ' VAL . . . -83.52 -48.8 9.89 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.82 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -14.72 42.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -89.07 -56.6 3.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -1.137 . . . . 0.0 109.706 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.636 ' CZ ' ' CE1' ' C' ' 112' ' ' HIS . 2.9 m-30 -59.01 -33.13 70.38 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.424 -0.798 . . . . 0.0 109.191 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.73 -33.19 76.64 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.89 -50.83 10.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.168 -1.195 . . . . 0.0 109.828 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -52.4 -19.76 2.38 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.61 -25.53 65.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.505 HD11 ' ND1' ' C' ' 58' ' ' HIS . 33.2 mt -72.15 -58.09 3.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.744 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -61.57 -14.42 29.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.086 -1.009 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 1.063 ' NH1' ' CG ' ' D' ' 127' ' ' GLN . 1.9 tpm_? -75.41 -39.05 59.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.344 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 32' ' ' MET . . . . . 0.502 ' O ' ' N ' ' C' ' 34' ' ' LEU . 0.0 OUTLIER -79.98 -48.51 13.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.193 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 33' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' C' ' 32' ' ' MET . 36.6 t80 -43.78 -19.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.338 -0.851 . . . . 0.0 109.782 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.805 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.9 mt -79.85 -60.23 2.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.755 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.861 ' OG ' ' NE2' ' D' ' 131' ' ' GLN . 30.0 m -81.27 -31.48 33.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.891 . . . . 0.0 109.698 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.565 ' CZ ' HD22 ' C' ' 100' ' ' LEU . 60.2 m-85 -113.57 95.0 34.86 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.439 -0.788 . . . . 0.0 109.424 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.18 -20.01 8.88 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.435 2.09 . . . . 0.0 112.224 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.689 ' O ' HG22 ' C' ' 41' ' ' THR . 70.7 p -47.69 -42.07 24.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 109.253 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.416 ' H ' HG23 ' C' ' 39' ' ' THR . 12.9 p -44.1 -22.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.813 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' C' ' 38' ' ' THR . 30.5 ttpt -70.94 -19.18 62.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.61 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 41' ' ' THR . . . . . 1.1 HG21 ' CD2' ' B' ' 97' ' ' HIS . 8.5 t . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.593 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.282 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.493 ' C ' ' H ' ' C' ' 48' ' ' LEU . 2.1 p90 -142.48 44.89 1.63 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.444 -1.41 . . . . 0.0 110.095 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.05 -35.22 0.3 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 110.448 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' C' ' 46' ' ' PHE . 1.0 OUTLIER 61.72 55.84 2.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.02 -1.05 . . . . 0.0 109.097 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.0 m -165.35 157.01 14.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.992 -1.067 . . . . 0.0 109.534 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 50' ' ' HIS . . . . . 0.462 ' C ' ' H ' ' C' ' 52' ' ' SER . 2.7 m-70 -59.48 160.87 6.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.375 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.71 -18.14 1.91 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 30.6 p -48.66 -25.9 2.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -1.158 . . . . 0.0 109.395 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 66.97 -40.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.748 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' C' ' 52' ' ' SER . 20.4 mt-30 -69.73 -23.79 63.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.295 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.45 HG23 ' OG ' ' C' ' 52' ' ' SER . 56.6 t -69.64 -40.51 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.915 . . . . 0.0 109.133 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -65.7 -54.42 27.69 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.307 -0.87 . . . . 0.0 108.656 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.17 -36.12 21.08 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.505 ' ND1' HD11 ' C' ' 29' ' ' LEU . 6.1 t-80 -60.54 -36.5 78.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.957 -1.319 . . . . 0.0 109.874 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.36 -29.33 37.91 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 56.8 mttm -65.07 -23.67 67.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -1.207 . . . . 0.0 110.268 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 61' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' C' ' 61' ' ' LYS . 0.5 OUTLIER -69.18 -58.18 4.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.999 -1.063 . . . . 0.0 108.591 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 72.8 t -56.49 -44.71 81.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.579 -0.7 . . . . 0.0 109.299 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.93 -41.6 74.38 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.24 -0.912 . . . . 0.0 109.21 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 64' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 7.9 t70 -65.88 -38.1 87.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.13 -0.981 . . . . 0.0 108.493 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 65' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -67.5 -53.43 28.7 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.415 ' O ' HG23 ' C' ' 70' ' ' VAL . 1.0 OUTLIER -58.49 -42.25 87.14 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.425 ' O ' ' N ' ' C' ' 71' ' ' ALA . 15.7 m -69.64 -51.67 32.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.888 . . . . 0.0 108.731 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -62.22 -25.95 68.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 108.537 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.11 -46.4 11.17 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.415 HG23 ' O ' ' C' ' 66' ' ' LEU . 38.2 t -66.56 -22.85 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -69.56 -36.3 76.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.587 ' O ' ' N ' ' C' ' 74' ' ' ASP . 26.1 m80 -103.32 -66.69 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.609 -0.682 . . . . 0.0 109.443 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.547 HG22 ' O ' ' C' ' 73' ' ' VAL . 14.8 p 44.42 14.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.954 0.883 . . . . 0.0 109.323 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' C' ' 72' ' ' HIS . 5.5 m-20 -137.99 12.07 2.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.412 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 0.2 OUTLIER 171.78 31.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.139 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 3.5 ptt? -78.27 -23.66 0.42 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 111.849 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.8 Cg_exo -53.6 -19.35 13.76 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.705 1.604 . . . . 0.0 112.5 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -94.25 -40.44 9.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.08 -1.012 . . . . 0.0 109.741 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.73 -48.88 67.81 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.248 -0.908 . . . . 0.0 109.36 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.58 6.03 6.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 109.298 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 34.1 t -54.48 -19.59 6.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 109.602 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -83.16 -58.52 2.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 109.891 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.426 ' N ' HD23 ' C' ' 83' ' ' LEU . 3.8 mt -45.32 -44.69 11.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.424 -0.797 . . . . 0.0 109.068 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.496 ' CB ' ' HG ' ' C' ' 138' ' ' SER . 23.3 t -59.96 -18.93 49.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -0.775 . . . . 0.0 109.536 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' C' ' 89' ' ' HIS . 36.7 t70 -81.11 -50.9 9.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.95 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 4.6 tt -64.15 -26.71 68.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.89 . . . . 0.0 110.068 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.79 -21.78 26.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.312 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.47 -11.26 11.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.141 -0.975 . . . . 0.0 110.172 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 89' ' ' HIS . . . . . 0.56 ' N ' ' O ' ' C' ' 85' ' ' ASP . 42.4 t60 -106.51 -74.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.958 . . . . 0.0 109.996 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' C' ' 92' ' ' ARG . 79.7 mttt -63.74 -110.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 110.077 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 14.1 mt -44.45 -17.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.346 -0.846 . . . . 0.0 110.009 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 92' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' C' ' 90' ' ' LYS . 31.8 ttm-85 46.84 41.47 10.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.138 -0.977 . . . . 0.0 109.492 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 70.1 t -45.91 144.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.694 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' C' ' 97' ' ' ASN . 10.7 m-20 -80.68 150.29 69.43 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.71 -19.49 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.384 2.056 . . . . 0.0 112.22 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.31 -7.71 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.357 -0.84 . . . . 0.0 109.752 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' C' ' 94' ' ' ASP . 12.8 m120 -79.71 -36.25 37.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.475 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -46.35 -41.56 13.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.896 -1.127 . . . . 0.0 109.569 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.48 ' CB ' ' NZ ' ' C' ' 99' ' ' LYS . 8.0 mtmp? -51.39 -28.25 12.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.238 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.565 HD22 ' CZ ' ' C' ' 36' ' ' PHE . 15.4 mt -84.31 -61.8 1.72 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.719 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tp -49.92 -23.65 2.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.796 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -73.28 -49.47 27.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.906 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -80.68 -26.41 37.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.862 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 65.3 m -64.95 -60.37 3.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.167 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.717 HD12 ' C ' ' C' ' 105' ' ' LEU . 0.9 OUTLIER -57.51 -22.38 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 109.827 -179.402 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.08 -31.47 39.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.879 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 107' ' ' VAL . . . . . 0.469 HG11 ' OE1' ' D' ' 127' ' ' GLN . 57.0 t -83.32 -24.91 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.042 -1.036 . . . . 0.0 110.094 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' C' ' 109' ' ' LEU . 1.5 t -79.79 -47.68 14.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.06 -1.025 . . . . 0.0 109.919 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.732 ' O ' HD12 ' C' ' 109' ' ' LEU . 0.8 OUTLIER -69.77 -18.51 63.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 109.762 -179.583 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.95 -22.2 46.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 110.287 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.51 -56.16 25.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -0.995 . . . . 0.0 110.162 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 112' ' ' HIS . . . . . 0.681 ' CG ' ' H ' ' C' ' 113' ' ' LEU . 9.4 p80 -72.42 -61.85 1.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.016 . . . . 0.0 109.563 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.909 ' O ' HD23 ' C' ' 113' ' ' LEU . 0.0 OUTLIER -119.81 121.46 29.76 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.37 175.61 7.56 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.476 2.117 . . . . 0.0 112.932 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.649 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -45.22 -55.08 6.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.604 -0.685 . . . . 0.0 109.374 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.649 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 26.0 mt-10 122.98 -2.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.472 ' CG ' ' C ' ' C' ' 116' ' ' GLU . 1.8 m-85 72.23 32.86 1.64 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.708 -0.62 . . . . 0.0 111.259 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.772 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.3 p -97.54 121.26 58.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.927 -1.108 . . . . 0.0 108.231 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.55 24.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.059 1.839 . . . . 0.0 112.531 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -150.46 -32.31 0.18 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.928 -1.108 . . . . 0.0 110.46 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.657 HG13 ' N ' ' C' ' 122' ' ' HIS . 11.9 p -54.03 -50.11 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 110.292 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.657 ' N ' HG13 ' C' ' 121' ' ' VAL . 17.6 m80 -54.71 -45.07 73.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.577 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.37 -20.02 32.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 110.267 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.549 ' N ' ' O ' ' C' ' 120' ' ' ALA . 93.6 p -52.22 -52.93 49.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.931 . . . . 0.0 110.615 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.448 HD11 ' HZ3' ' C' ' 14' ' ' TRP . 5.5 mt -84.11 -19.24 34.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.081 -1.012 . . . . 0.0 110.047 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.76 -51.82 9.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.092 . . . . 0.0 110.333 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -78.68 -43.02 26.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.057 -1.027 . . . . 0.0 110.188 -179.219 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.482 ' CD2' ' CD1' ' C' ' 2' ' ' LEU . 33.7 t80 -50.5 -21.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 0.0 108.992 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' C' ' 133' ' ' SER . 17.4 mt -73.77 -18.26 60.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -60.14 -35.48 75.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.44 ' O ' HG23 ' C' ' 135' ' ' VAL . 97.3 p -80.74 -27.09 36.94 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -84.71 -30.06 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.492 ' N ' ' O ' ' C' ' 129' ' ' LEU . 50.3 m -79.31 -40.78 29.54 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 53.3 m -69.31 -26.35 64.68 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.289 -0.882 . . . . 0.0 108.644 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 131' ' ' SER . 23.6 t -81.56 -30.19 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -23.21 61.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.0 109.071 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 137' ' ' THR . . . . . 0.433 ' O ' ' O ' ' C' ' 138' ' ' SER . 38.3 p -87.28 -18.43 30.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.21 -0.931 . . . . 0.0 109.552 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 138' ' ' SER . . . . . 0.496 ' HG ' ' CB ' ' C' ' 84' ' ' SER . 21.7 m . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.433 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 82.1 t60 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.17 0.51 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.85 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -135.94 179.73 6.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 108.982 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.466 ' O ' ' N ' ' D' ' 7' ' ' GLU . 7.3 p -76.16 132.42 73.61 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.153 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -41.19 -24.75 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.369 2.046 . . . . 0.0 112.446 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.14 -21.84 25.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.927 . . . . 0.0 109.874 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 7' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' D' ' 4' ' ' THR . 32.2 tt0 -80.36 -63.09 1.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.097 -1.002 . . . . 0.0 109.938 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.59 ' HB3' HD13 ' D' ' 3' ' ' LEU . 24.1 pttt -62.38 -31.63 72.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.008 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.2 t -44.55 -23.44 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -81.57 -57.34 3.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.019 -1.051 . . . . 0.0 110.11 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.434 HG23 ' CE2' ' D' ' 130' ' ' TYR . 14.9 p -68.76 -24.64 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.055 -1.028 . . . . 0.0 108.256 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 12.6 m -71.91 -42.15 67.06 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.347 0.594 . . . . 0.0 109.852 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.77 -30.38 69.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.868 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -50.32 -18.79 0.67 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.95 . . . . 0.0 109.33 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 15' ' ' TRP . . . . . 0.412 ' CZ2' HD13 ' D' ' 75' ' ' LEU . 0.7 OUTLIER -53.18 -51.39 62.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 0.0 109.158 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.09 -32.47 35.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 -46.68 14.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -1.098 . . . . 0.0 109.214 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 69.6 t -59.02 114.91 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.546 -0.721 . . . . 0.0 109.842 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' D' ' 21' ' ' ASP . 19.0 m120 -79.43 71.58 6.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 108.742 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.443 ' O ' HG12 ' D' ' 20' ' ' VAL . 57.2 t -46.99 -11.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.89 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' D' ' 19' ' ' ASN . 16.5 m-20 -73.51 -5.35 39.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 109.847 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -156.31 -40.35 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 109.577 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -46.4 -55.54 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.0 109.66 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.72 -29.85 50.42 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.53 -29.93 69.34 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.94 -31.46 59.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -1.11 . . . . 0.0 109.467 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.11 -54.32 48.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 28' ' ' LEU . . . . . 0.535 ' N ' HD22 ' D' ' 28' ' ' LEU . 3.8 mm? -61.9 -40.06 94.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.935 . . . . 0.0 109.26 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.98 -42.78 76.31 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 60.2 mmt-85 -72.74 -36.97 67.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -1.098 . . . . 0.0 109.481 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 65.2 tp -50.12 -31.72 14.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.32 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.18 -22.59 38.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.625 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.97 -64.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.578 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.444 HG23 ' H ' ' D' ' 34' ' ' VAL . 0.2 OUTLIER -64.11 -22.69 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -0.828 . . . . 0.0 109.644 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -140.31 79.22 21.56 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -83.49 -12.42 8.98 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.865 2.377 . . . . 0.0 112.36 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 37' ' ' TRP . . . . . 0.524 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 3.3 p-90 -48.62 -33.95 10.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.586 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.524 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 3.2 m -78.96 2.59 19.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.509 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 39' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' D' ' 39' ' ' GLN . 1.4 tm0? -65.48 -19.08 65.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 40' ' ' ARG . . . . . 1.455 ' NH2' ' CG ' ' A' ' 92' ' ' ARG . 32.9 mtp85 -68.49 -40.94 80.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.746 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -93.03 -18.98 22.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' D' ' 45' ' ' PHE . 1.3 t80 -89.86 28.56 1.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 109.44 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -84.39 -13.99 50.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.351 -0.843 . . . . 0.0 109.608 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -80.12 -7.59 58.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.602 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' D' ' 42' ' ' PHE . 33.5 m-85 -83.68 -3.44 57.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.483 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.03 -172.78 25.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -84.81 98.39 10.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.125 . . . . 0.0 109.339 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 48' ' ' LEU . . . . . 0.708 ' N ' HD12 ' D' ' 48' ' ' LEU . 7.2 mp -88.0 30.85 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 108.956 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -45.0 -30.96 1.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 109.89 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 6.7 p -142.35 138.2 16.29 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -41.2 -28.45 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.423 2.082 . . . . 0.0 112.362 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 52' ' ' ASP . . . . . 0.4 ' C ' ' N ' ' D' ' 54' ' ' VAL . 12.0 t70 -76.96 -39.81 49.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.0 109.578 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.8 -19.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.355 -0.84 . . . . 0.0 109.653 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 54' ' ' VAL . . . . . 0.4 ' N ' ' C ' ' D' ' 52' ' ' ASP . 45.8 t -67.06 -63.87 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.656 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -51.48 -19.92 1.63 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.757 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.0 -31.75 38.23 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -63.18 132.74 95.19 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.232 -1.157 . . . . 0.0 109.318 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.26 -50.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.447 2.098 . . . . 0.0 112.523 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.05 -34.93 72.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.967 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -55.34 -49.88 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.032 . . . . 0.0 109.193 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 61' ' ' LYS . . . . . 0.431 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 26.2 mtmt -73.6 -29.34 62.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.169 -0.957 . . . . 0.0 109.277 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.31 68.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.449 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -54.39 -25.36 24.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.25 83.1 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 65' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 0.4 OUTLIER -62.88 -36.79 84.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.183 -1.186 . . . . 0.0 109.274 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -75.76 -35.1 60.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 109.344 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.03 -63.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.285 -0.885 . . . . 0.0 109.324 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.551 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.8 tt -53.75 -32.81 53.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 108.898 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.93 -56.98 21.07 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.81 -42.25 79.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -1.085 . . . . 0.0 109.455 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 71' ' ' PHE . . . . . 0.405 ' O ' ' CD1' ' D' ' 71' ' ' PHE . 3.0 t80 -67.24 -35.12 78.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 72' ' ' SER . . . . . 0.404 ' HB2' ' HE1' ' D' ' 15' ' ' TRP . 62.2 p -73.78 -35.61 64.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.63 -21.16 0.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.908 . . . . 0.0 109.361 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.13 -60.12 4.65 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.642 HD12 ' H ' ' D' ' 75' ' ' LEU . 5.1 mp -53.46 -28.9 32.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -1.161 . . . . 0.0 109.25 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.78 3.5 41.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' D' ' 79' ' ' ASP . 23.5 t-80 -170.41 61.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.692 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 59.2 mt -73.69 15.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.257 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' D' ' 77' ' ' HIS . 16.8 t70 -76.38 -36.02 58.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.216 -0.927 . . . . 0.0 109.522 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -161.61 100.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 109.401 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 33.2 mt -79.21 -50.23 11.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 82' ' ' LYS . . . . . 0.431 ' NZ ' ' ND1' ' D' ' 143' ' ' HIS . 24.6 mmtp -48.41 -23.92 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.08 -63.27 3.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.3 t -63.94 -48.11 77.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -1.14 . . . . 0.0 109.397 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' D' ' 84' ' ' THR . 46.6 m-85 -63.61 -8.5 10.11 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.435 -0.79 . . . . 0.0 109.374 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.25 -34.86 34.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.394 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 27.9 p -83.96 -50.97 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 0.0 109.535 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 35.8 mt -56.11 -55.56 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 109.161 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 89' ' ' SER . . . . . 0.491 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 1.5 m -51.55 -38.91 56.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.323 -0.861 . . . . 0.0 109.44 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' D' ' 94' ' ' ASP . 29.1 tt0 -74.24 -54.64 7.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -62.49 -29.3 70.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.687 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' D' ' 97' ' ' HIS . 1.3 m80 -79.31 -48.35 14.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.97 . . . . 0.0 110.043 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 93' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' D' ' 89' ' ' SER . 6.6 m -82.97 -31.14 27.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.028 -1.045 . . . . 0.0 110.301 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' D' ' 90' ' ' GLU . 6.4 t70 -86.66 -43.52 12.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.065 -1.022 . . . . 0.0 110.901 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -52.25 5.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 0.0 110.732 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.63 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 4.1 mm? -82.98 -43.48 16.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.0 109.486 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 1.137 ' CD2' HG21 ' A' ' 41' ' ' THR . 0.0 OUTLIER 74.81 19.77 2.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.427 -0.796 . . . . 0.0 109.727 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 98' ' ' VAL . . . . . 0.403 HG23 ' H ' ' D' ' 98' ' ' VAL . 8.6 t -45.11 122.24 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 109.471 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 99' ' ' ASP . . . . . 0.512 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 15.6 m-20 -69.18 151.46 97.05 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.41 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 100' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' D' ' 99' ' ' ASP . 75.7 Cg_exo -42.9 178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.631 2.22 . . . . 0.0 112.414 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 57.52 64.76 1.5 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 109.569 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 102' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' D' ' 99' ' ' ASP . 73.1 m-20 -161.92 -52.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.41 -0.806 . . . . 0.0 109.263 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -66.96 -25.96 66.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 104' ' ' ARG . . . . . 0.417 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 39.3 ttt-85 -78.53 -25.76 45.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.91 -45.7 49.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.915 . . . . 0.0 109.605 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 tt -49.39 -46.07 46.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.4 -48.83 64.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 108' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 30.1 m120 -50.22 -44.26 53.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -1.172 . . . . 0.0 109.739 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.04 -35.27 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.757 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tp -63.41 -38.8 92.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.662 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 66.8 t -51.37 -30.52 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.676 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.22 -59.38 2.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.615 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 113' ' ' VAL . . . . . 0.403 HG23 ' H ' ' D' ' 113' ' ' VAL . 29.3 t -46.17 -27.91 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.833 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 114' ' ' LEU . . . . . 0.451 HD13 ' OH ' ' D' ' 130' ' ' TYR . 17.0 mt -82.66 -53.12 6.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.527 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.454 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -65.38 -19.43 65.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.639 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.08 -62.84 1.25 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.689 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -77.26 -48.3 17.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.823 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -92.8 30.21 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.751 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -55.05 -27.73 46.51 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -64.65 7.09 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -1.136 . . . . 0.0 109.598 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' D' ' 119' ' ' GLY . 61.0 mm-40 -133.14 6.87 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 109.434 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.538 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -73.32 34.8 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.427 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.493 ' H ' ' C ' ' D' ' 121' ' ' GLU . 2.9 p -44.87 148.96 0.88 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.339 -0.85 . . . . 0.0 109.504 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.514 ' HA ' HH22 ' C' ' 31' ' ' ARG . 5.4 Cg_exo -44.36 -54.04 4.34 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.437 2.091 . . . . 0.0 112.78 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 21.2 Cg_endo -61.35 -48.25 10.11 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.934 1.756 . . . . 0.0 112.0 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.426 ' O ' HG12 ' D' ' 126' ' ' VAL . 72.8 t -55.48 -13.02 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -0.839 . . . . 0.0 109.518 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 127' ' ' GLN . . . . . 1.063 ' CG ' ' NH1' ' C' ' 31' ' ' ARG . 0.7 OUTLIER -82.47 -59.87 2.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.646 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.805 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -66.56 -26.52 67.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.435 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.78 26.44 0.83 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.451 ' OH ' HD13 ' D' ' 114' ' ' LEU . 0.1 OUTLIER -123.47 -61.36 1.41 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.295 -0.878 . . . . 0.0 109.303 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 0.861 ' NE2' ' OG ' ' C' ' 35' ' ' SER . 4.0 mp0 -53.56 -36.37 61.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.671 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -69.47 -25.13 63.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 64.4 t -77.27 -43.66 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.581 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.61 -17.1 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.36 -28.95 70.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.541 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -36.43 59.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 137' ' ' VAL . . . . . 0.492 HG13 ' CZ ' ' D' ' 85' ' ' PHE . 76.4 t -75.24 -36.47 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -1.153 . . . . 0.0 109.456 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.22 -38.91 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 139' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' D' ' 143' ' ' HIS . 9.9 m120 -85.21 -21.3 29.18 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.21 -0.931 . . . . 0.0 109.758 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.69 -55.52 33.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.514 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.52 -24.77 66.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.277 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 142' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' D' ' 145' ' ' TYR . . . -100.29 1.79 42.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 109.378 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 143' ' ' HIS . . . . . 0.527 ' N ' ' O ' ' D' ' 139' ' ' ASN . 71.2 t60 -80.91 -1.68 44.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.453 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' D' ' 146' ' ' HIS . 5.4 tppt? -120.75 -32.04 4.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 145' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' D' ' 142' ' ' ALA . 0.1 OUTLIER -49.12 -10.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.233 -0.917 . . . . 0.0 109.888 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' D' ' 144' ' ' LYS . 4.9 m-70 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.656 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 131' ' ' SER . 12.4 tp -171.74 145.51 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 109.634 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.6 168.29 20.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 109.319 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 5' ' ' ALA . 55.7 Cg_endo -73.13 -61.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.618 2.212 . . . . 0.0 112.666 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 4' ' ' PRO . . . -45.26 -38.27 5.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.934 . . . . 0.0 109.673 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 5' ' ' ALA . 4.8 m-20 -44.52 -28.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 108.977 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 10' ' ' VAL . 76.8 mttt -83.06 -60.33 2.19 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.437 -0.789 . . . . 0.0 109.093 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.1 m -46.37 -31.61 2.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.471 -0.768 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -76.72 -35.85 57.55 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.492 HG21 ' CG ' ' A' ' 128' ' ' PHE . 4.4 t -73.58 -50.25 31.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -49.15 -42.79 40.75 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.4 -63.57 1.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.257 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -55.37 -39.05 69.63 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 109.178 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.43 ' NE1' ' OG1' ' A' ' 67' ' ' THR . 0.1 OUTLIER -71.31 -17.19 62.47 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.044 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.26 -46.23 7.66 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -70.67 -34.61 72.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.146 . . . . 0.0 108.742 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 13' ' ' ALA . 70.1 t -63.02 -66.03 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 60.84 -140.82 48.08 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 20' ' ' HIS . . . -66.7 49.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.434 -1.039 . . . . 0.0 110.194 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 18' ' ' GLY . 80.0 m-70 -153.75 19.64 0.53 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -83.8 -62.87 1.46 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.701 -0.624 . . . . 0.0 109.781 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.2 -14.45 0.16 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 21' ' ' ALA . 3.4 mm-40 -86.71 -56.47 3.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -1.132 . . . . 0.0 109.744 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.9 m-30 -55.38 -52.23 64.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 109.159 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.14 -22.79 14.58 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB1' HG12 ' A' ' 55' ' ' VAL . . . -73.67 -45.4 52.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -1.129 . . . . 0.0 109.702 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.518 ' OE1' ' NE2' ' A' ' 112' ' ' HIS . 94.9 mt-10 -65.69 -19.83 66.05 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.509 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.58 -24.5 60.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.381 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.3 mt -65.81 -41.23 92.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.735 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -75.68 -12.54 60.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.09 -1.006 . . . . 0.0 109.739 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 31' ' ' ARG . 3.1 tpm_? -78.93 -47.36 16.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 0.0 110.155 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptm -65.74 -26.35 67.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.007 -1.058 . . . . 0.0 109.683 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.37 -36.45 82.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.101 -0.999 . . . . 0.0 109.436 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 12.1 mt -85.66 -44.88 12.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.708 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 40.2 t -51.5 -19.61 1.52 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.824 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' A' ' 35' ' ' SER . 60.1 m-85 -160.92 90.23 1.61 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.001 . . . . 0.0 109.733 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 39' ' ' THR . 52.4 Cg_exo -50.28 -26.15 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.594 2.196 . . . . 0.0 112.158 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.764 ' O ' HG22 ' A' ' 41' ' ' THR . 10.8 p -47.54 -18.51 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 37' ' ' PRO . 22.1 p -76.47 -22.89 53.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.273 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -74.22 -31.74 62.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.88 . . . . 0.0 109.84 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 1.413 HG21 ' ND1' ' D' ' 97' ' ' HIS . 14.3 t . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.333 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.546 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 21.7 p80 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.558 0.694 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.714 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -166.63 75.49 0.18 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.621 ' C ' ' O ' ' A' ' 46' ' ' PHE . 20.8 m-20 -8.8 -54.67 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.028 -0.42 . . . . 0.0 111.522 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.714 ' N ' ' O ' ' A' ' 46' ' ' PHE . 5.7 mt 56.71 4.81 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.244 -0.91 . . . . 0.0 109.386 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 47' ' ' ASP . 33.3 t -73.24 19.0 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.242 -0.911 . . . . 0.0 109.362 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' A' ' 48' ' ' LEU . 6.6 t-80 58.86 156.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.06 15.33 1.46 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 10.7 t -72.59 -21.27 61.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 109.403 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.5 -50.62 0.5 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.709 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 52' ' ' SER . 15.8 pt20 -45.37 -17.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.684 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.55 HG12 ' HB1' ' A' ' 26' ' ' ALA . 77.9 t -73.84 -32.85 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.83 -24.82 67.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.641 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.15 -51.1 40.94 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 24.7 t-80 -67.82 -27.81 67.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.13 -1.217 . . . . 0.0 110.282 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 26' ' ' ALA . . . -63.22 -31.05 79.39 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 16.9 mtpp -71.79 -23.63 61.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -1.157 . . . . 0.0 110.146 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -66.8 -58.1 5.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.124 -0.985 . . . . 0.0 108.644 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.8 t -55.2 -48.94 75.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.544 -0.723 . . . . 0.0 109.238 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -64.23 -42.57 96.5 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.23 -0.919 . . . . 0.0 108.959 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.5 t70 -72.02 -25.63 61.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.806 . . . . 0.0 109.056 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . -80.65 -44.74 18.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.94 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -76.57 -27.35 55.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.568 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 63' ' ' ALA . 52.8 m -75.92 -44.62 39.37 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 17.7 t-20 -57.41 -20.81 32.32 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.24 -45.88 12.42 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.46 ' CG2' HG11 ' A' ' 10' ' ' VAL . 6.0 t -59.62 -22.63 23.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 68' ' ' ASN . . . -65.39 -15.25 62.39 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.568 ' O ' ' N ' ' A' ' 74' ' ' ASP . 72.8 m-70 -153.04 -51.75 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.403 -0.811 . . . . 0.0 109.353 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.631 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.9 p 44.56 15.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.977 0.894 . . . . 0.0 109.32 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 72' ' ' HIS . 95.9 m-20 -134.3 10.57 3.81 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 31.1 t70 -175.23 27.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.14 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.1 ptt? -78.59 -24.19 0.43 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.47 -0.769 . . . . 0.0 111.829 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.3 Cg_exo -52.9 -19.8 11.91 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.701 1.601 . . . . 0.0 112.634 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.448 ' ND2' ' N ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -94.21 -33.12 13.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.114 -0.991 . . . . 0.0 109.822 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.448 ' N ' ' ND2' ' A' ' 78' ' ' ASN . . . -74.6 -40.79 61.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.27 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.64 12.12 13.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.024 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 66.5 p -70.6 -16.21 62.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.655 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 83' ' ' LEU . . . -82.07 -51.71 7.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 83' ' ' LEU . 3.4 mt -44.89 -43.0 8.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.382 -0.824 . . . . 0.0 109.043 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.1 p -57.14 -22.07 37.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -72.54 -32.75 66.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.686 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 90' ' ' LYS . 7.0 tt -81.4 -29.18 34.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.417 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -89.9 -28.42 19.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 109.529 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 90' ' ' LYS . . . -83.9 -80.41 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.665 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.539 ' O ' ' ND1' ' A' ' 89' ' ' HIS . 30.4 t-80 -61.09 2.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.841 . . . . 0.0 109.61 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 88' ' ' ALA . 6.1 mtmm -156.15 152.29 27.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.289 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' A' ' 93' ' ' VAL . 10.9 mp 56.95 63.89 1.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 108.983 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.287 ' HB3' ' NH1' ' D' ' 40' ' ' ARG . 8.4 ptp180 -62.77 14.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.578 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.636 ' H ' ' C ' ' A' ' 91' ' ' LEU . 73.7 t -41.43 121.69 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -0.812 . . . . 0.0 109.631 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.11 147.81 2.29 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.533 ' C ' ' H ' ' A' ' 97' ' ' ASN . 37.9 Cg_endo -68.23 -10.66 29.63 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.486 2.124 . . . . 0.0 112.069 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 96' ' ' VAL . 2.8 t -55.25 -1.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.716 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 95' ' ' PRO . 5.0 m120 -74.66 -42.34 58.65 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.084 -1.01 . . . . 0.0 109.808 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 2.2 m-85 -46.38 -42.05 14.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 0.0 109.275 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -58.1 -32.91 68.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.244 -0.91 . . . . 0.0 109.316 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.1 mt -84.08 -62.28 1.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -50.22 -41.84 50.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 0.0 109.291 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.4 m -63.26 -51.03 67.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -66.1 -26.82 67.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.513 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 96.6 m -63.51 -50.59 69.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.75 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.31 -43.02 22.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 106' ' ' LEU . 8.6 mp -64.17 -59.24 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.423 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.563 ' CG1' ' NE2' ' B' ' 127' ' ' GLN . 76.7 t -56.48 -30.99 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -75.7 -63.03 1.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.459 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 113' ' ' LEU . 13.1 mt -51.34 -30.65 19.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.0 109.495 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -47.43 -42.29 22.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.885 . . . . 0.0 109.679 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.11 -49.25 11.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.829 . . . . 0.0 109.787 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 27' ' ' GLU . 11.4 m170 -76.24 -69.98 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 109.868 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -110.96 97.05 32.57 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 109.054 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 113' ' ' LEU . 71.2 Cg_exo -47.31 -174.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.372 2.048 . . . . 0.0 112.879 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 122' ' ' HIS . . . -86.67 -35.09 19.53 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.664 0.745 . . . . 0.0 109.574 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 3.8 mt-10 78.4 0.86 2.63 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.943 ' HD1' ' NH2' ' B' ' 30' ' ' ARG . 21.7 t80 65.3 37.56 6.32 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.639 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.749 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -93.97 115.07 64.69 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.82 -1.175 . . . . 0.0 107.953 178.195 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.755 ' HA ' ' CG1' ' B' ' 33' ' ' VAL . 50.4 Cg_exo -50.36 21.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.021 1.814 . . . . 0.0 112.553 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.749 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -147.07 -21.7 0.4 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.003 -1.061 . . . . 0.0 110.961 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.77 HG13 ' N ' ' A' ' 122' ' ' HIS . 10.5 p -58.13 -58.75 5.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.976 -1.078 . . . . 0.0 110.48 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.77 ' N ' HG13 ' A' ' 121' ' ' VAL . 1.1 m-70 -71.03 -24.89 62.45 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.3 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' B' ' 33' ' ' VAL . . . -84.08 -20.74 32.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 128' ' ' PHE . 62.7 p -77.41 -63.19 1.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.248 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.46 -19.84 57.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.057 -1.027 . . . . 0.0 109.102 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.494 ' OD2' ' OH ' ' B' ' 35' ' ' TYR . 7.4 t70 -77.77 -51.18 10.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.482 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.28 -41.82 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.845 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 124' ' ' SER . 29.8 t80 -50.23 -22.88 1.92 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 109.037 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.0 mt -73.99 -24.76 59.64 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -56.77 -31.87 65.05 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.463 ' HB3' HD13 ' A' ' 2' ' ' LEU . 89.6 p -73.97 -32.56 63.51 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.37 -29.79 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 129' ' ' LEU . 9.9 p -81.92 -25.26 35.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.843 . . . . 0.0 108.913 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.8 m -74.91 -40.13 61.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.305 -0.872 . . . . 0.0 109.102 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.13 -21.79 17.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 108.782 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.75 -35.96 72.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.472 -0.767 . . . . 0.0 109.103 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 138' ' ' SER . 57.8 p -88.13 -2.3 58.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' THR . 28.3 m . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 109.471 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.906 ' N ' HD12 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -136.41 -163.11 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 109.265 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.412 ' O ' ' N ' ' B' ' 6' ' ' GLU . 11.9 p -88.98 130.64 43.87 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.19 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -42.05 -23.04 0.23 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.362 2.041 . . . . 0.0 112.271 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' B' ' 4' ' ' THR . 51.9 mt-10 -80.11 -54.26 5.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.812 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.42 -41.09 85.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.746 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.721 ' HB2' HD13 ' B' ' 3' ' ' LEU . 0.3 OUTLIER -68.54 -35.1 76.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.5 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 4.9 m -60.68 -23.58 64.95 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.885 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.49 -57.58 3.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.11 -0.994 . . . . 0.0 109.809 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.76 -24.39 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 85.6 m -83.85 -35.2 24.37 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.345 0.593 . . . . 0.0 109.606 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' B' ' 9' ' ' SER . . . -69.05 -29.27 67.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.386 -0.821 . . . . 0.0 109.791 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.1 -21.07 0.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.244 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' TRP . . . . . 0.463 ' HE1' ' HB2' ' B' ' 72' ' ' SER . 0.8 OUTLIER -53.54 -17.88 2.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.175 -0.953 . . . . 0.0 109.084 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.8 -33.31 46.97 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' B' ' 17' ' ' LYS . 4.3 mmtt -89.82 -41.46 11.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -1.178 . . . . 0.0 109.361 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -57.22 114.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 109.833 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' B' ' 21' ' ' ASP . 7.4 m120 -84.3 68.41 10.18 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -43.88 -18.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.392 -0.817 . . . . 0.0 109.73 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' B' ' 19' ' ' ASN . 1.1 m-20 -62.39 -10.79 12.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.709 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -154.42 -35.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -0.995 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 72.3 t -48.74 -34.89 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.3 -25.9 68.87 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.97 -36.3 25.37 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -67.67 -30.7 70.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -1.114 . . . . 0.0 109.472 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.68 -54.53 45.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.548 ' N ' HD12 ' B' ' 28' ' ' LEU . 9.9 mp -64.3 -55.76 19.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.399 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.03 -41.32 29.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ARG . . . . . 0.943 ' NH2' ' HD1' ' A' ' 117' ' ' PHE . 73.5 mtt-85 -80.01 -34.64 38.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -1.144 . . . . 0.0 109.499 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' LEU . . . . . 0.443 HD12 HG21 ' B' ' 109' ' ' VAL . 65.4 tp -47.11 -37.21 9.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 109.499 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' B' ' 36' ' ' PRO . 15.0 mt -81.32 -39.29 25.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.817 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.755 ' CG1' ' HA ' ' A' ' 119' ' ' PRO . 72.4 t -58.13 -61.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.12 -0.988 . . . . 0.0 109.442 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.686 HG13 ' HB3' ' A' ' 122' ' ' HIS . 1.7 t -68.69 -22.56 26.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.83 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.494 ' OH ' ' OD2' ' A' ' 126' ' ' ASP . 64.0 m-85 -146.75 76.47 11.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.776 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' PRO . . . . . 0.423 ' N ' ' O ' ' B' ' 32' ' ' LEU . 72.1 Cg_endo -82.95 28.98 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.95 2.433 . . . . 0.0 112.382 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.532 ' CD1' HG23 ' B' ' 38' ' ' THR . 3.8 p-90 -81.08 -19.85 42.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.167 -0.958 . . . . 0.0 109.654 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.532 HG23 ' CD1' ' B' ' 37' ' ' TRP . 44.8 p -78.39 -104.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.523 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLN . . . . . 0.521 ' N ' ' OG1' ' B' ' 38' ' ' THR . 13.9 mt-30 54.94 10.65 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.654 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 1.321 ' NH1' ' HB3' ' C' ' 92' ' ' ARG . 15.9 mmt180 -88.55 -58.98 2.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -71.44 -8.19 52.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.75 28.16 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.361 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.66 -27.3 65.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 93.9 p -84.15 -27.19 28.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 109.465 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -49.65 -24.39 2.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.331 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.87 173.05 0.19 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.97 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -1.142 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 12.6 mt -138.92 19.68 2.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -58.93 -33.9 71.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' THR . . . . . 0.487 ' HG1' ' CG ' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -140.61 154.34 69.06 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.49 -24.26 74.15 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.212 1.941 . . . . 0.0 111.756 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.487 ' CG ' ' HG1' ' B' ' 50' ' ' THR . 2.8 p30 -85.2 -21.02 29.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 109.608 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.96 -19.95 65.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 109.736 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.449 ' O ' HG21 ' B' ' 60' ' ' VAL . 4.4 t -67.05 -64.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.94 . . . . 0.0 109.473 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.09 8.13 1.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' B' ' 54' ' ' VAL . . . -74.57 -29.99 60.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -84.42 147.72 50.57 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.195 -1.179 . . . . 0.0 109.34 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.72 -7.08 19.66 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.564 2.176 . . . . 0.0 112.175 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -85.77 -28.45 24.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.162 -0.961 . . . . 0.0 109.659 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.449 HG21 ' O ' ' B' ' 54' ' ' VAL . 83.5 t -70.31 -53.0 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.174 -0.954 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -57.8 -26.38 61.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.0 -46.5 43.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -61.87 -23.82 66.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.376 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.06 -19.97 77.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -69.52 -37.31 77.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -1.197 . . . . 0.0 109.124 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -68.06 -40.78 82.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.337 -0.852 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.14 -59.15 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.285 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.521 HD23 ' O ' ' B' ' 68' ' ' LEU . 4.8 tt -58.56 -52.66 64.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.001 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.08 -45.02 26.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.45 96.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -1.129 . . . . 0.0 109.386 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' PHE . . . . . 0.526 ' O ' ' CD1' ' B' ' 71' ' ' PHE . 2.5 t80 -69.63 -27.3 64.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.378 -0.826 . . . . 0.0 109.332 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' SER . . . . . 0.463 ' HB2' ' HE1' ' B' ' 15' ' ' TRP . 88.1 p -76.77 -27.91 55.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.938 . . . . 0.0 109.557 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' B' ' 77' ' ' HIS . 10.6 t70 -47.34 -37.08 10.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.584 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.05 -60.63 6.6 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.71 -24.67 50.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -1.217 . . . . 0.0 109.176 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.542 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -93.91 -11.06 31.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.314 -0.866 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 80.3 m-70 -161.31 65.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 109.648 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.69 10.27 0.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 0.0 109.04 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' B' ' 77' ' ' HIS . 2.8 p30 -64.42 -30.24 71.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.286 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' B' ' 79' ' ' ASP . 34.5 t-20 -171.05 105.13 0.23 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.371 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.21 -58.79 2.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -48.24 -23.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.447 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -68.72 -54.77 13.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.9 t -75.19 -47.17 29.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -1.18 . . . . 0.0 109.427 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' B' ' 84' ' ' THR . 48.8 m-85 -62.72 -5.42 2.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.428 -0.795 . . . . 0.0 109.459 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.7 -34.59 62.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.329 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 37.3 p -79.82 -51.15 9.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.456 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 27.8 mt -59.69 -42.08 92.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.88 . . . . 0.0 109.333 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 5.1 m -65.08 -42.46 94.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -73.04 -40.19 65.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 4.6 tt -66.97 -34.98 78.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' B' ' 97' ' ' HIS . 60.1 m80 -84.35 -20.29 32.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.004 -1.06 . . . . 0.0 109.703 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 39.3 t -84.02 -60.04 2.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.915 . . . . 0.0 110.987 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -86.91 -29.86 21.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.991 -1.068 . . . . 0.0 111.601 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -85.8 -51.81 6.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.695 -1.253 . . . . 0.0 110.69 -178.533 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.613 ' C ' ' CG ' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -102.77 -24.21 13.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.021 -1.049 . . . . 0.0 109.853 -179.269 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 1.371 ' ND1' HG21 ' C' ' 41' ' ' THR . 0.5 OUTLIER 44.64 47.23 8.62 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.146 -0.971 . . . . 0.0 109.822 179.645 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.426 ' H ' HG23 ' B' ' 98' ' ' VAL . 4.0 t -60.73 121.48 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -0.995 . . . . 0.0 108.987 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 99' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' B' ' 100' ' ' PRO . 13.9 m-20 -59.08 143.99 83.41 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 0.0 109.236 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' B' ' 99' ' ' ASP . 76.1 Cg_exo -45.85 -174.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.356 2.038 . . . . 0.0 112.317 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 57.45 76.58 0.31 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.448 ' C ' ' N ' ' B' ' 104' ' ' ARG . 40.5 t-20 -171.57 -67.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.41 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -49.05 -15.78 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.93 . . . . 0.0 109.319 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 104' ' ' ARG . . . . . 0.448 ' N ' ' C ' ' B' ' 102' ' ' ASN . 10.3 mmt180 -76.27 -31.06 58.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 mt -77.83 -52.03 9.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 5.4 tt -51.03 -49.16 61.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.155 -0.966 . . . . 0.0 109.308 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.78 -21.32 65.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -85.62 -27.76 25.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -1.18 . . . . 0.0 109.731 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.443 HG21 HD12 ' B' ' 31' ' ' LEU . 76.4 t -69.15 -47.48 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 109.647 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 16.1 mt -48.39 -39.74 23.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 65.2 t -51.08 -36.41 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.657 ' SG ' ' CD2' ' A' ' 122' ' ' HIS . 14.4 t -78.19 -22.99 47.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.554 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.17 -27.2 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.603 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 28.6 mt -81.36 -22.39 38.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.972 . . . . 0.0 109.502 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' B' ' 119' ' ' GLY . . . -83.48 -37.0 23.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.468 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 9.1 t-80 -68.97 -49.04 61.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.496 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 0.3 OUTLIER -74.32 -17.68 60.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.475 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 6.1 m-85 -152.38 61.94 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.439 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.54 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -62.08 -25.52 66.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -74.1 -31.03 62.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -1.139 . . . . 0.0 109.544 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -82.25 11.73 5.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.321 -0.862 . . . . 0.0 109.626 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.553 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -85.0 35.05 0.56 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.557 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.465 ' OG1' HG23 ' B' ' 126' ' ' VAL . 63.4 p -54.53 147.31 30.04 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.373 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.512 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 4.0 Cg_exo -45.13 -54.53 4.22 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.541 2.16 . . . . 0.0 113.173 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 18.4 Cg_endo -59.41 -11.56 14.05 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.119 1.88 . . . . 0.0 112.236 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.465 HG23 ' OG1' ' B' ' 123' ' ' THR . 72.5 t -97.72 -20.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.222 -0.924 . . . . 0.0 109.626 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 127' ' ' GLN . . . . . 0.563 ' NE2' ' CG1' ' A' ' 107' ' ' VAL . 5.4 tp-100 -83.37 -59.99 2.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.159 -0.963 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.602 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -61.67 -34.81 76.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.21 -0.931 . . . . 0.0 109.623 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.02 23.93 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' B' ' 128' ' ' ALA . 23.4 t80 -118.9 -59.17 1.89 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.837 . . . . 0.0 109.68 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -47.07 -23.33 0.47 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.861 . . . . 0.0 109.955 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -82.52 -38.28 24.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 109.892 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.6 -41.04 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.885 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.443 HG22 ' H ' ' B' ' 134' ' ' VAL . 1.6 m -81.97 -40.72 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.77 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 1.061 ' C ' ' CE1' ' D' ' 146' ' ' HIS . . . -47.51 -20.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.008 . . . . 0.0 109.523 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 136' ' ' GLY . . . . . 0.691 ' N ' ' HE1' ' D' ' 146' ' ' HIS . . . -75.63 -41.63 28.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.21 -21.96 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -1.13 . . . . 0.0 109.483 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.55 -44.36 80.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.463 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 139' ' ' ASN . . . . . 0.864 HD21 ' HB2' ' D' ' 146' ' ' HIS . 0.9 OUTLIER -79.71 -35.35 39.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.2 -43.95 42.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.905 . . . . 0.0 109.53 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.1 17.79 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.415 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 142' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' B' ' 146' ' ' HIS . . . -141.07 8.18 2.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -67.03 -38.19 85.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.307 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.32 -13.42 62.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' B' ' 145' ' ' TYR . 23.1 p90 -160.55 55.36 0.32 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 1.031 ' CE1' ' C ' ' D' ' 135' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.446 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' C' ' 131' ' ' SER . 12.4 tp -171.71 145.52 1.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.953 . . . . 0.0 109.661 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.59 168.39 20.17 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.309 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' C' ' 5' ' ' ALA . 55.7 Cg_endo -73.22 -61.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.656 2.237 . . . . 0.0 112.662 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.2 -38.26 5.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.145 -0.972 . . . . 0.0 109.717 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' C' ' 5' ' ' ALA . 4.8 m-20 -44.63 -28.23 0.58 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.05 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' C' ' 10' ' ' VAL . 77.0 mttt -83.19 -60.24 2.21 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.443 -0.786 . . . . 0.0 109.033 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 46.1 m -46.46 -31.56 2.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.519 -0.738 . . . . 0.0 109.639 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -76.73 -35.93 57.48 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.492 HG21 ' CG ' ' C' ' 128' ' ' PHE . 4.5 t -73.53 -50.24 31.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -49.08 -42.98 40.61 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.32 -63.59 1.14 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.494 -0.754 . . . . 0.0 109.3 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.696 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -55.33 -39.12 69.59 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.428 -0.795 . . . . 0.0 109.191 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 14' ' ' TRP . . . . . 0.428 ' NE1' ' OG1' ' C' ' 67' ' ' THR . 0.1 OUTLIER -71.21 -17.31 62.52 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.285 -0.885 . . . . 0.0 109.088 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.19 -46.18 7.73 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 12.9 mmmt -70.6 -34.78 72.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -1.156 . . . . 0.0 108.806 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.696 HG23 ' O ' ' C' ' 13' ' ' ALA . 69.0 t -62.8 -66.19 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 60.9 -140.83 48.09 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 19' ' ' ALA . . . . . 0.405 ' O ' ' CG ' ' C' ' 20' ' ' HIS . . . -66.63 49.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.458 -1.025 . . . . 0.0 110.169 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' C' ' 18' ' ' GLY . 79.7 m-70 -153.79 19.66 0.52 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -83.87 -62.83 1.47 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.693 -0.63 . . . . 0.0 109.743 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.25 -14.37 0.16 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 21' ' ' ALA . 3.4 mm-40 -86.75 -56.5 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 109.703 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.8 m-30 -55.27 -52.35 63.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.175 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.05 -22.88 14.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' ALA . . . . . 0.548 ' HB1' HG12 ' C' ' 55' ' ' VAL . . . -73.57 -45.42 53.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 109.762 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 27' ' ' GLU . . . . . 0.512 ' OE1' ' NE2' ' C' ' 112' ' ' HIS . 94.9 mt-10 -65.65 -19.87 66.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.482 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.49 60.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.905 . . . . 0.0 109.377 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 21.4 mt -65.88 -41.2 91.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.711 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -75.64 -12.55 60.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.858 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.401 ' HA ' ' NE ' ' C' ' 31' ' ' ARG . 3.1 tpm_? -78.94 -47.34 16.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.154 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' MET . . . . . 0.415 ' HG2' ' H ' ' C' ' 32' ' ' MET . 1.1 ptm -65.76 -26.24 67.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 0.0 109.733 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.41 -36.52 83.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 0.0 109.373 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 12.1 mt -85.66 -44.88 12.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.678 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 40.3 t -51.51 -19.63 1.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.852 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' C' ' 35' ' ' SER . 59.9 m-85 -160.92 90.4 1.61 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 0.0 109.65 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' C' ' 39' ' ' THR . 52.2 Cg_exo -50.4 -26.17 15.52 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.488 2.125 . . . . 0.0 112.137 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.784 ' O ' HG22 ' C' ' 41' ' ' THR . 10.8 p -47.32 -18.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.439 ' N ' ' O ' ' C' ' 37' ' ' PRO . 21.8 p -76.6 -22.76 53.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.238 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -74.29 -31.77 62.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.777 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 41' ' ' THR . . . . . 1.371 HG21 ' ND1' ' B' ' 97' ' ' HIS . 14.2 t . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 109.354 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.534 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 21.6 p80 . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.542 0.687 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.705 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.9 OUTLIER -166.6 75.47 0.18 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.322 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.609 ' C ' ' O ' ' C' ' 46' ' ' PHE . 20.7 m-20 -8.76 -54.69 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 120.985 0.422 . . . . 0.0 111.493 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.705 ' N ' ' O ' ' C' ' 46' ' ' PHE . 5.7 mt 56.71 4.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.485 ' H ' ' C ' ' C' ' 47' ' ' ASP . 33.4 t -73.34 19.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 109.348 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 50' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' C' ' 48' ' ' LEU . 6.6 t-80 58.81 156.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.42 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.06 15.23 1.43 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 10.7 t -72.49 -21.33 61.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -1.127 . . . . 0.0 109.422 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 67.54 -50.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.463 -0.773 . . . . 0.0 109.717 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' C' ' 52' ' ' SER . 15.8 pt20 -45.39 -17.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.667 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.548 HG12 ' HB1' ' C' ' 26' ' ' ALA . 77.4 t -73.87 -32.94 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.75 -24.77 67.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.673 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.16 -51.07 41.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 24.9 t-80 -67.8 -27.92 67.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -1.202 . . . . 0.0 110.221 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' C' ' 26' ' ' ALA . . . -63.13 -31.05 79.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.419 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 16.9 mtpp -71.92 -23.48 61.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -1.152 . . . . 0.0 110.118 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 61' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' C' ' 65' ' ' ALA . 0.4 OUTLIER -66.91 -58.15 5.56 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.044 -1.035 . . . . 0.0 108.574 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -55.08 -48.98 75.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.536 -0.728 . . . . 0.0 109.245 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' C' ' 67' ' ' THR . . . -64.33 -42.55 96.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.299 -0.875 . . . . 0.0 108.854 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 64' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 7.4 t70 -72.0 -25.69 61.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.065 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 65' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' C' ' 61' ' ' LYS . . . -80.61 -44.75 18.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.375 -0.828 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 66' ' ' LEU . . . . . 0.936 ' O ' HD12 ' C' ' 66' ' ' LEU . 0.1 OUTLIER -76.5 -27.38 56.01 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.551 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.428 ' OG1' ' NE1' ' C' ' 14' ' ' TRP . 52.0 m -75.89 -44.66 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 68' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' C' ' 71' ' ' ALA . 17.7 t-20 -57.45 -20.72 32.34 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.33 -45.68 12.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' C' ' 10' ' ' VAL . 6.0 t -59.75 -22.57 24.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' C' ' 68' ' ' ASN . . . -65.48 -15.17 62.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.092 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' C' ' 74' ' ' ASP . 73.7 m-70 -153.03 -51.87 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.434 -0.791 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.1 p 44.59 15.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.85 0.833 . . . . 0.0 109.214 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' C' ' 72' ' ' HIS . 95.8 m-20 -134.36 10.43 3.78 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' C' ' 78' ' ' ASN . 31.2 t70 -175.1 27.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.248 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.693 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.1 ptt? -78.52 -24.29 0.43 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.433 -0.792 . . . . 0.0 111.839 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.4 Cg_exo -52.81 -19.79 11.62 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.711 1.607 . . . . 0.0 112.629 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 78' ' ' ASN . . . . . 0.452 ' ND2' ' N ' ' C' ' 79' ' ' ALA . 0.8 OUTLIER -94.25 -33.09 13.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.823 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 79' ' ' ALA . . . . . 0.452 ' N ' ' ND2' ' C' ' 78' ' ' ASN . . . -74.6 -40.81 61.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.62 12.13 13.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 108.983 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 81' ' ' SER . . . . . 0.417 ' O ' ' OD1' ' C' ' 85' ' ' ASP . 66.3 p -70.63 -16.19 62.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.632 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -82.1 -51.59 7.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.16 -0.963 . . . . 0.0 109.719 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.438 ' N ' HD23 ' C' ' 83' ' ' LEU . 3.5 mt -45.2 -42.82 9.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.804 . . . . 0.0 109.028 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 29.7 p -57.1 -22.15 37.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.493 -0.755 . . . . 0.0 109.574 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' C' ' 82' ' ' ALA . 0.8 OUTLIER -72.6 -32.7 66.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.94 . . . . 0.0 109.592 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' C' ' 90' ' ' LYS . 7.0 tt -81.37 -29.13 34.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 109.516 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -89.87 -28.47 19.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.58 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' C' ' 90' ' ' LYS . . . -83.84 -80.44 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 89' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' C' ' 89' ' ' HIS . 30.6 t-80 -61.2 2.49 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.57 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' C' ' 88' ' ' ALA . 6.1 mtmm -156.07 152.38 27.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.281 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' C' ' 93' ' ' VAL . 10.9 mp 56.97 63.81 1.82 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -0.865 . . . . 0.0 109.033 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 92' ' ' ARG . . . . . 1.321 ' HB3' ' NH1' ' B' ' 40' ' ' ARG . 8.4 ptp180 -62.73 14.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.47 -0.769 . . . . 0.0 109.501 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.636 ' H ' ' C ' ' C' ' 91' ' ' LEU . 74.1 t -41.38 121.66 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.384 -0.823 . . . . 0.0 109.64 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.06 147.87 2.2 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.465 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' C' ' 97' ' ' ASN . 38.0 Cg_endo -68.25 -10.7 29.74 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.512 2.141 . . . . 0.0 112.126 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 0.419 ' H ' HG23 ' C' ' 96' ' ' VAL . 2.8 t -55.27 -1.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' C' ' 95' ' ' PRO . 5.1 m120 -74.69 -42.27 58.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.857 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 98' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' C' ' 98' ' ' PHE . 2.2 m-85 -46.37 -42.1 14.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 0.0 109.337 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -57.95 -33.07 68.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.302 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' C' ' 97' ' ' ASN . 11.1 mt -84.09 -62.12 1.64 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -50.35 -41.91 52.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.199 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 39.0 m -63.17 -51.01 68.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.528 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -66.1 -26.76 67.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.544 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.55 -50.5 69.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.753 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.38 -43.02 23.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -0.931 . . . . 0.0 109.384 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.551 ' N ' HD12 ' C' ' 106' ' ' LEU . 8.6 mp -64.15 -59.39 4.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.356 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 107' ' ' VAL . . . . . 0.554 ' CG1' ' NE2' ' D' ' 127' ' ' GLN . 77.0 t -56.33 -30.93 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.379 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 26.6 m -75.75 -63.09 1.38 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.318 -0.864 . . . . 0.0 109.388 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 113' ' ' LEU . 13.1 mt -51.32 -30.66 19.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 109.486 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -47.42 -42.29 21.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.717 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.12 -49.21 11.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.422 -0.799 . . . . 0.0 109.763 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 112' ' ' HIS . . . . . 0.512 ' NE2' ' OE1' ' C' ' 27' ' ' GLU . 11.4 m170 -76.3 -70.0 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.871 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -110.88 97.07 32.27 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.433 -0.792 . . . . 0.0 109.132 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 114' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' C' ' 113' ' ' LEU . 73.0 Cg_exo -47.46 -174.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.399 2.066 . . . . 0.0 112.883 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.482 ' HB2' ' CE1' ' C' ' 122' ' ' HIS . . . -86.59 -35.18 19.6 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.696 0.76 . . . . 0.0 109.517 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 3.8 mt-10 78.45 0.84 2.61 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.94 ' HD1' HH21 ' D' ' 30' ' ' ARG . 22.0 t80 65.27 37.64 6.33 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.602 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.764 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -94.01 115.15 64.81 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.749 -1.22 . . . . 0.0 107.907 178.184 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 119' ' ' PRO . . . . . 0.76 ' HA ' ' CG1' ' D' ' 33' ' ' VAL . 50.5 Cg_exo -50.38 21.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.974 1.782 . . . . 0.0 112.571 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -147.08 -21.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.039 . . . . 0.0 110.966 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.76 HG13 ' N ' ' C' ' 122' ' ' HIS . 10.4 p -58.23 -58.76 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.95 -1.094 . . . . 0.0 110.385 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.76 ' N ' HG13 ' C' ' 121' ' ' VAL . 1.1 m-70 -70.98 -24.97 62.51 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.266 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 123' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' D' ' 33' ' ' VAL . . . -84.1 -20.68 32.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.508 ' N ' ' O ' ' C' ' 120' ' ' ALA . 62.5 p -77.38 -63.15 1.44 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.267 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' C' ' 125' ' ' LEU . 4.6 mt -60.5 -19.95 58.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.075 -1.016 . . . . 0.0 109.084 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 126' ' ' ASP . . . . . 0.487 ' OD2' ' OH ' ' D' ' 35' ' ' TYR . 7.4 t70 -77.71 -51.21 10.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.455 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.26 -41.75 11.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.817 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' C' ' 124' ' ' SER . 29.8 t80 -50.25 -22.94 1.96 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.985 -1.072 . . . . 0.0 108.991 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' C' ' 133' ' ' SER . 14.9 mt -74.05 -24.69 59.56 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -56.67 -31.99 64.97 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.481 ' HB3' HD13 ' C' ' 2' ' ' LEU . 89.4 p -73.99 -32.42 63.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.48 -29.74 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.45 ' N ' ' O ' ' C' ' 129' ' ' LEU . 9.8 p -81.86 -25.33 35.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.329 -0.857 . . . . 0.0 108.881 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 36.8 m -74.96 -40.08 60.95 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.361 -0.837 . . . . 0.0 109.1 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.08 -21.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.344 -0.847 . . . . 0.0 108.779 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.77 -35.99 72.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.434 -0.792 . . . . 0.0 109.072 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 137' ' ' THR . . . . . 0.434 ' O ' ' O ' ' C' ' 138' ' ' SER . 57.5 p -88.04 -2.44 58.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 109.571 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 138' ' ' SER . . . . . 0.434 ' O ' ' O ' ' C' ' 137' ' ' THR . 28.3 m . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 109.555 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.892 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -136.45 -163.14 1.36 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 109.254 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.403 ' O ' ' N ' ' D' ' 6' ' ' GLU . 11.9 p -89.02 130.64 43.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.132 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -42.05 -23.06 0.23 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.292 1.995 . . . . 0.0 112.24 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' D' ' 4' ' ' THR . 51.9 mt-10 -80.05 -54.34 5.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.925 . . . . 0.0 109.877 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.39 -40.98 85.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.946 . . . . 0.0 109.87 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.729 ' HB2' HD13 ' D' ' 3' ' ' LEU . 0.3 OUTLIER -68.64 -35.08 76.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.473 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 9' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 4.9 m -60.66 -23.64 64.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 109.879 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.38 -57.64 3.39 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.067 -1.02 . . . . 0.0 109.859 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.436 ' H ' HG12 ' D' ' 11' ' ' VAL . 1.3 p -62.69 -24.41 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 82.0 m -83.9 -35.1 24.35 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.349 0.595 . . . . 0.0 109.695 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 13' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' D' ' 9' ' ' SER . . . -69.11 -29.37 67.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.83 . . . . 0.0 109.668 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.1 -20.98 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.312 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 15' ' ' TRP . . . . . 0.46 ' HE1' ' HB2' ' D' ' 72' ' ' SER . 0.8 OUTLIER -53.61 -17.93 2.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 109.067 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.7 -33.35 47.3 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -89.72 -41.63 11.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -1.178 . . . . 0.0 109.35 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -57.17 114.83 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.847 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' D' ' 21' ' ' ASP . 7.4 m120 -84.1 68.41 10.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.296 -0.877 . . . . 0.0 108.686 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' D' ' 19' ' ' ASN . 72.3 t -43.94 -18.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 109.673 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' D' ' 19' ' ' ASN . 1.1 m-20 -62.39 -10.77 12.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.764 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -154.37 -35.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 109.517 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 72.8 t -48.72 -34.97 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.17 -25.99 68.8 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.04 -36.22 25.37 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -67.66 -30.67 70.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -1.125 . . . . 0.0 109.487 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.43 46.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 28' ' ' LEU . . . . . 0.55 HD12 ' N ' ' D' ' 28' ' ' LEU . 10.0 mp -64.32 -55.71 19.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.377 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.1 -41.35 29.86 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 30' ' ' ARG . . . . . 0.94 HH21 ' HD1' ' C' ' 117' ' ' PHE . 73.3 mtt-85 -80.0 -34.57 38.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -1.117 . . . . 0.0 109.502 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 31' ' ' LEU . . . . . 0.438 HD12 HG21 ' D' ' 109' ' ' VAL . 65.3 tp -47.19 -37.11 9.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 32' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' D' ' 36' ' ' PRO . 14.7 mt -81.31 -39.24 25.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.923 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 33' ' ' VAL . . . . . 0.76 ' CG1' ' HA ' ' C' ' 119' ' ' PRO . 73.1 t -58.11 -61.48 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.385 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' C' ' 122' ' ' HIS . 1.7 t -68.69 -22.55 26.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.397 -0.814 . . . . 0.0 109.828 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 35' ' ' TYR . . . . . 0.487 ' OH ' ' OD2' ' C' ' 126' ' ' ASP . 63.9 m-85 -146.77 76.43 11.65 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.153 -0.967 . . . . 0.0 109.767 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 36' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' D' ' 32' ' ' LEU . 72.2 Cg_endo -82.86 28.9 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.912 2.408 . . . . 0.0 112.323 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 37' ' ' TRP . . . . . 0.534 ' CD1' HG23 ' D' ' 38' ' ' THR . 3.8 p-90 -80.95 -20.0 42.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.095 -1.003 . . . . 0.0 109.717 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.534 HG23 ' CD1' ' D' ' 37' ' ' TRP . 44.8 p -78.37 -103.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.554 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 39' ' ' GLN . . . . . 0.524 ' N ' ' OG1' ' D' ' 38' ' ' THR . 13.9 mt-30 55.03 10.67 0.42 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.645 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 40' ' ' ARG . . . . . 1.287 ' NH1' ' HB3' ' A' ' 92' ' ' ARG . 15.8 mmt180 -88.7 -58.86 2.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -71.45 -8.28 52.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -87.72 28.22 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.7 -27.31 65.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.462 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 94.0 p -84.11 -27.22 28.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -49.55 -24.43 2.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.299 -0.876 . . . . 0.0 109.241 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.82 173.11 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.89 91.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -1.091 . . . . 0.0 109.572 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 12.6 mt -139.01 19.71 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 109.31 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -58.85 -34.02 71.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.15 -0.969 . . . . 0.0 109.434 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 50' ' ' THR . . . . . 0.479 ' HG1' ' CG ' ' D' ' 52' ' ' ASP . 0.1 OUTLIER -140.6 154.23 68.97 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.32 -24.34 73.94 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.253 1.969 . . . . 0.0 111.765 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 52' ' ' ASP . . . . . 0.479 ' CG ' ' HG1' ' D' ' 50' ' ' THR . 2.8 p30 -85.22 -21.0 29.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.608 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.98 -19.9 65.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 109.735 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 54' ' ' VAL . . . . . 0.445 ' O ' HG21 ' D' ' 60' ' ' VAL . 4.4 t -67.07 -64.03 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 0.0 109.465 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.05 8.13 1.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.537 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.68 -29.83 60.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -84.42 147.65 50.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.212 -1.169 . . . . 0.0 109.377 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.65 -7.14 19.79 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.584 2.19 . . . . 0.0 112.193 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -85.69 -28.56 24.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.666 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 60' ' ' VAL . . . . . 0.445 HG21 ' O ' ' D' ' 54' ' ' VAL . 83.9 t -70.24 -52.95 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -57.82 -26.42 61.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.89 -46.68 43.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -61.72 -23.84 66.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.887 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.07 -20.0 77.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -69.51 -37.3 77.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 109.084 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -68.13 -40.69 82.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.444 -0.785 . . . . 0.0 109.498 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 41.9 t -61.29 -59.1 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.203 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.518 ' O ' HD23 ' D' ' 68' ' ' LEU . 4.8 tt -58.59 -52.61 64.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 108.983 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.15 -44.98 27.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.46 96.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -1.128 . . . . 0.0 109.379 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 71' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' D' ' 71' ' ' PHE . 2.5 t80 -69.59 -27.22 64.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.853 . . . . 0.0 109.336 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 72' ' ' SER . . . . . 0.46 ' HB2' ' HE1' ' D' ' 15' ' ' TRP . 88.5 p -76.93 -27.85 55.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 73' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' D' ' 77' ' ' HIS . 10.6 t70 -47.42 -37.11 10.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.09 -60.6 6.62 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.544 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -56.61 -24.79 50.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -1.159 . . . . 0.0 109.156 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 76' ' ' ALA . . . . . 0.544 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -93.86 -11.11 31.86 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 109.583 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 80.0 m-70 -161.19 65.15 0.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.59 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.73 10.29 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.082 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' D' ' 77' ' ' HIS . 2.8 p30 -64.35 -30.23 71.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.378 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 80' ' ' ASN . . . . . 0.433 ' N ' ' OD1' ' D' ' 79' ' ' ASP . 34.5 t-20 -171.09 105.08 0.23 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.14 -58.87 2.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -48.23 -23.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.0 109.449 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 83' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -68.73 -54.82 13.23 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.54 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.9 t -75.2 -47.17 29.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -1.164 . . . . 0.0 109.417 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.54 ' N ' ' CG2' ' D' ' 84' ' ' THR . 48.6 m-85 -62.7 -5.41 2.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.67 62.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.273 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 37.1 p -79.75 -51.22 9.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.379 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.431 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 27.1 mt -59.68 -42.07 92.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 5.1 m -65.09 -42.41 94.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -73.1 -40.15 65.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 4.6 tt -67.02 -35.03 79.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.607 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.561 ' O ' ' N ' ' D' ' 97' ' ' HIS . 60.0 m80 -84.28 -20.28 32.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.926 -1.109 . . . . 0.0 109.722 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 39.4 t -84.01 -60.07 2.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 111.01 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -86.96 -29.8 21.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.001 -1.062 . . . . 0.0 111.59 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 95' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -85.77 -51.92 6.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.772 -1.205 . . . . 0.0 110.649 -178.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.607 ' C ' ' CG ' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -102.75 -24.12 13.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.06 -1.025 . . . . 0.0 109.856 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 1.413 ' ND1' HG21 ' A' ' 41' ' ' THR . 0.5 OUTLIER 44.64 47.08 8.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.104 -0.998 . . . . 0.0 109.892 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 t -60.6 121.51 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.119 -0.988 . . . . 0.0 109.033 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 99' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' D' ' 100' ' ' PRO . 13.9 m-20 -59.09 143.97 83.47 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.225 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 100' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' D' ' 99' ' ' ASP . 75.4 Cg_exo -45.85 -174.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.423 2.082 . . . . 0.0 112.342 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 57.44 76.61 0.31 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 102' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' D' ' 104' ' ' ARG . 40.5 t-20 -171.6 -67.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.432 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -49.0 -15.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 104' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' D' ' 102' ' ' ASN . 10.3 mmt180 -76.2 -31.15 58.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.336 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 mt -77.78 -51.99 9.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.859 . . . . 0.0 109.645 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.4 tt -51.09 -49.18 61.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.107 -0.996 . . . . 0.0 109.23 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.77 -21.24 65.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -85.75 -27.64 25.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -1.162 . . . . 0.0 109.715 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 109' ' ' VAL . . . . . 0.438 HG21 HD12 ' D' ' 31' ' ' LEU . 77.0 t -69.15 -47.48 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.646 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 16.2 mt -48.48 -39.7 23.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 109.503 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 65.4 t -51.11 -36.45 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 112' ' ' CYS . . . . . 0.649 ' SG ' ' CD2' ' C' ' 122' ' ' HIS . 14.4 t -78.09 -23.02 48.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -79.14 -27.18 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.644 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 29.0 mt -81.47 -22.31 38.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.903 . . . . 0.0 109.507 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' D' ' 119' ' ' GLY . . . -83.45 -36.93 23.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 109.635 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.456 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 9.2 t-80 -68.96 -49.08 61.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 117' ' ' HIS . . . . . 0.502 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 0.3 OUTLIER -74.32 -17.7 60.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.486 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 6.2 m-85 -152.37 62.07 0.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -62.07 -25.55 66.38 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -74.16 -31.0 62.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.535 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -82.27 11.75 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -84.98 34.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.961 . . . . 0.0 109.536 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.479 ' OG1' HG23 ' D' ' 126' ' ' VAL . 65.1 p -54.42 147.34 28.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.516 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.9 Cg_exo -45.11 -54.58 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.411 2.074 . . . . 0.0 113.16 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 18.3 Cg_endo -59.39 -11.5 13.81 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.113 1.875 . . . . 0.0 112.298 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.479 HG23 ' OG1' ' D' ' 123' ' ' THR . 72.1 t -97.86 -20.44 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 109.59 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 127' ' ' GLN . . . . . 0.554 ' NE2' ' CG1' ' C' ' 107' ' ' VAL . 5.4 tp-100 -83.34 -60.1 2.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 109.859 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -61.67 -34.78 76.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.96 23.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' D' ' 128' ' ' ALA . 23.5 t80 -118.96 -59.19 1.88 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.44 -0.788 . . . . 0.0 109.591 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -47.03 -23.35 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.983 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -82.56 -38.22 24.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -0.972 . . . . 0.0 109.932 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 45.2 t -61.59 -41.05 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -0.95 . . . . 0.0 109.881 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.43 ' H ' HG22 ' D' ' 134' ' ' VAL . 1.6 m -82.04 -40.71 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.98 . . . . 0.0 109.771 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 1.031 ' C ' ' CE1' ' B' ' 146' ' ' HIS . . . -47.5 -20.99 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.119 -0.988 . . . . 0.0 109.58 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 136' ' ' GLY . . . . . 0.68 ' N ' ' HE1' ' B' ' 146' ' ' HIS . . . -75.63 -41.51 29.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.31 -21.86 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -1.128 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.63 -44.29 81.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 139' ' ' ASN . . . . . 0.88 HD21 ' HB2' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -79.67 -35.4 39.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.539 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.23 -43.94 43.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.496 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 40.2 mt -84.07 17.72 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 142' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' D' ' 146' ' ' HIS . . . -140.99 8.15 2.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.264 -0.898 . . . . 0.0 109.467 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -67.02 -38.13 85.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.888 . . . . 0.0 109.31 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.38 -13.47 62.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.862 . . . . 0.0 109.355 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 145' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' D' ' 145' ' ' TYR . 23.2 p90 -160.51 55.4 0.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 1.061 ' CE1' ' C ' ' B' ' 135' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.416 ' C ' ' OG ' ' A' ' 3' ' ' SER . 14.7 mt -139.09 -178.34 5.3 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.375 -0.828 . . . . 0.0 109.18 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.497 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 178.77 -50.9 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.993 . . . . 0.0 110.065 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 6' ' ' ASP . 83.0 Cg_exo -43.63 155.64 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.43 2.087 . . . . 0.0 112.538 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -46.21 -16.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 109.803 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' PRO . 12.5 t70 -39.45 -44.86 1.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 109.816 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 8' ' ' THR . 6.5 ptmt -58.01 -50.41 73.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.125 -0.985 . . . . 0.0 108.992 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.415 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 22.7 m -54.73 -31.41 58.3 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 108.652 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -77.23 -34.84 55.87 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.85 -51.81 41.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -47.78 46.96 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.47 -61.14 2.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.645 -0.659 . . . . 0.0 109.458 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -50.27 -41.91 51.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.403 -0.811 . . . . 0.0 109.066 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -17.54 64.93 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.4 -0.813 . . . . 0.0 109.178 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.18 -45.48 10.11 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.438 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 39.5 mmtt -68.62 -39.59 80.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -1.174 . . . . 0.0 108.763 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 13' ' ' ALA . 58.1 t -61.88 -64.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 54.76 -132.77 47.83 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.73 27.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -1.063 . . . . 0.0 110.376 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.551 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.8 m-70 -131.83 25.2 4.67 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.232 -0.918 . . . . 0.0 108.538 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -89.41 -59.55 2.18 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.566 -0.709 . . . . 0.0 109.789 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.71 -13.89 0.2 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.6 mt-10 -87.58 -56.48 3.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 109.912 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.526 ' CD1' ' ND1' ' A' ' 112' ' ' HIS . 3.0 m-30 -60.11 -29.22 68.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.5 87.19 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.16 -39.13 29.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -1.165 . . . . 0.0 109.75 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -63.88 -25.54 68.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.261 -0.899 . . . . 0.0 109.318 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.35 -23.06 66.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.572 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.669 HD11 ' ND1' ' A' ' 58' ' ' HIS . 10.7 mt -76.65 -58.49 3.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.55 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -62.39 -12.42 21.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HE ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -69.65 -49.92 49.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 110.329 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.6 ptt? -84.11 -36.45 22.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.046 -1.034 . . . . 0.0 110.404 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -43.78 -23.84 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.171 -0.955 . . . . 0.0 110.107 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.548 ' CD1' ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -92.16 -28.8 16.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.125 -0.984 . . . . 0.0 109.951 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 81.2 p -89.21 -18.44 27.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.087 -1.008 . . . . 0.0 110.022 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 35' ' ' SER . 84.7 m-85 -157.95 75.82 3.81 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.104 -0.997 . . . . 0.0 109.719 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.34 -19.98 60.77 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.889 2.393 . . . . 0.0 112.247 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.442 ' O ' HG22 ' A' ' 41' ' ' THR . 24.4 p -48.61 -18.78 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.943 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.1 p -85.92 -52.98 5.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.957 . . . . 0.0 109.803 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 41' ' ' THR . 0.5 OUTLIER -80.01 -17.57 52.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 109.644 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 40' ' ' LYS . 10.7 t . . . . . 0 N--CA 1.494 1.771 0 O-C-N 121.453 -0.78 . . . . 0.0 109.894 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -139.35 63.78 1.49 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 49' ' ' SER . 33.7 m-20 -37.94 -22.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 46' ' ' PHE . 1.2 mt 52.6 6.33 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.218 -0.926 . . . . 0.0 109.583 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 47' ' ' ASP . 34.5 t -81.3 153.3 27.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -47.79 128.64 13.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.53 22.04 13.45 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 54' ' ' GLN . 36.9 m -95.03 66.02 2.95 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -1.155 . . . . 0.0 108.964 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -37.85 -25.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.818 -0.551 . . . . 0.0 110.237 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' A' ' 52' ' ' SER . 14.1 mt-30 -60.8 -46.22 91.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.476 HG22 ' CE2' ' A' ' 46' ' ' PHE . 15.9 t -55.99 -47.62 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.087 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -66.55 -54.19 26.45 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.12 -26.77 29.07 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.669 ' ND1' HD11 ' A' ' 29' ' ' LEU . 6.8 t-80 -69.85 -33.48 72.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.985 -1.303 . . . . 0.0 109.798 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.6 -48.61 83.68 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 51.3 mttp -51.0 -23.82 3.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -1.057 . . . . 0.0 109.811 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.43 -50.68 29.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.208 -0.933 . . . . 0.0 108.891 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.63 -43.61 90.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.603 -0.686 . . . . 0.0 109.327 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.04 -28.88 64.7 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.234 -0.916 . . . . 0.0 109.432 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 15.1 t70 -72.26 -40.12 67.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 108.782 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.33 82.03 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.372 -0.83 . . . . 0.0 108.875 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.15 -40.31 95.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -70.62 -51.03 30.87 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -59.39 -22.96 62.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.684 ' HB1' ' SD ' ' A' ' 76' ' ' MET . . . -83.58 -47.31 11.42 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.08 -22.63 31.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.44 -15.09 63.43 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.596 ' O ' ' N ' ' A' ' 74' ' ' ASP . 56.3 m-70 -143.78 -59.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.509 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 73' ' ' VAL . 14.5 p 44.57 13.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.713 0.768 . . . . 0.0 109.492 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' A' ' 72' ' ' HIS . 12.8 t70 -133.38 9.66 4.04 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 2.1 m-20 -179.58 27.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.942 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.684 ' SD ' ' HB1' ' A' ' 69' ' ' ALA . 17.7 ptt? -78.74 -22.75 0.39 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 112.006 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 76' ' ' MET . 52.3 Cg_exo -52.63 -22.01 15.99 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.578 1.519 . . . . 0.0 112.592 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -94.13 -24.03 17.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.728 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.47 -54.29 6.92 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.151 -0.968 . . . . 0.0 109.183 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.664 ' N ' HD12 ' A' ' 80' ' ' LEU . 7.0 mp -77.15 8.89 3.46 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.433 -0.792 . . . . 0.0 109.046 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.6 t -65.18 -15.83 62.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 109.886 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.79 -46.08 14.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 0.0 109.854 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.422 ' N ' HD23 ' A' ' 83' ' ' LEU . 4.2 mt -46.43 -45.93 18.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.314 -0.866 . . . . 0.0 108.94 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 135' ' ' VAL . 37.6 m -54.04 -29.15 42.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.552 -0.717 . . . . 0.0 109.45 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' ALA . 25.9 t0 -65.68 -33.93 77.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 109.499 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 90' ' ' LYS . 3.0 tt -82.99 -63.65 1.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -50.09 -21.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 109.954 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -97.76 -48.11 5.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.168 -0.957 . . . . 0.0 109.955 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -76.73 -70.95 0.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 86' ' ' LEU . 30.1 mttm -86.43 140.65 29.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.808 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.6 mp 53.88 57.91 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.07 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.565 ' HD3' ' CD ' ' D' ' 40' ' ' ARG . 72.5 ttt180 -47.89 -47.58 31.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.829 . . . . 0.0 109.288 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 94' ' ' ASP . 62.1 t 49.67 179.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.353 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.738 ' H ' HG12 ' A' ' 93' ' ' VAL . 34.7 m-20 -133.09 151.87 78.64 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.151 -0.968 . . . . 0.0 109.12 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 98' ' ' PHE . 82.3 Cg_exo -39.28 -19.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.571 2.181 . . . . 0.0 112.282 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 1.317 HG21 ' CB ' ' D' ' 99' ' ' ASP . 64.6 t -47.07 -32.91 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.697 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.452 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 1.5 m120 -79.23 -25.15 42.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 95' ' ' PRO . 77.4 t80 -67.88 -56.38 9.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.83 -28.8 2.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 109.545 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.407 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 17.0 mt -84.04 -52.37 6.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.7 tp -47.2 -39.75 14.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.948 . . . . 0.0 109.76 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.2 p -65.04 -59.22 4.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -52.97 -26.79 16.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.811 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 60.4 m -66.46 -58.44 5.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -45.98 -22.99 0.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 109.91 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 4.1 mm? -82.19 -32.33 29.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.029 -1.044 . . . . 0.0 109.808 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.92 -27.5 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.686 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.8 p -69.01 -60.45 2.35 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.156 -0.965 . . . . 0.0 109.549 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 113' ' ' LEU . 37.1 mt -55.88 -42.1 75.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 109.291 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.31 11.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.798 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.27 -55.79 4.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 109.901 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.526 ' ND1' ' CD1' ' A' ' 24' ' ' TYR . 22.3 m170 -59.59 -62.66 1.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.083 -1.011 . . . . 0.0 109.128 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.808 HD12 ' O ' ' A' ' 114' ' ' PRO . 2.4 pp -137.69 118.94 10.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.808 ' O ' HD12 ' A' ' 113' ' ' LEU . 88.2 Cg_exo -40.78 -178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.551 2.167 . . . . 0.0 113.292 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.791 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -57.42 -55.19 37.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.43 -0.794 . . . . 0.0 109.157 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.647 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 4.8 mm-40 120.48 -2.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.2 t80 64.52 52.19 1.83 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.962 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -133.04 111.5 13.17 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.571 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.838 ' HA ' HG13 ' B' ' 33' ' ' VAL . 76.7 Cg_exo -47.48 10.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.139 1.893 . . . . 0.0 112.582 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -132.65 -19.37 2.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.289 -0.882 . . . . 0.0 110.197 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.791 HG21 ' O ' ' A' ' 115' ' ' ALA . 11.6 p -60.36 -55.4 24.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.154 -0.966 . . . . 0.0 110.299 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 1.004 ' HB3' HG13 ' B' ' 34' ' ' VAL . 6.4 m170 -71.93 -33.35 68.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 0.0 108.947 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.99 -20.16 49.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.2 m -64.86 -62.71 1.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 110.003 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.54 -19.56 65.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.191 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.91 -50.11 11.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.718 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -85.55 -43.19 13.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.114 -0.991 . . . . 0.0 109.857 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' N ' ' CD ' ' A' ' 127' ' ' LYS . 53.6 t80 -49.44 -21.0 0.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.962 -1.086 . . . . 0.0 108.668 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.622 ' O ' ' N ' ' A' ' 133' ' ' SER . 12.8 mt -71.94 -17.48 62.08 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.98 -31.65 72.02 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.446 ' O ' HG23 ' A' ' 135' ' ' VAL . 57.4 p -83.29 -34.02 25.83 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.418 -0.801 . . . . 0.0 108.86 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.31 -28.01 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 108.654 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 129' ' ' LEU . 36.8 m -80.08 -28.85 39.05 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.495 -0.753 . . . . 0.0 109.236 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.9 m -71.31 -33.59 69.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.245 -0.909 . . . . 0.0 109.044 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 131' ' ' SER . 30.0 t -79.93 -28.19 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -35.81 73.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.468 -0.77 . . . . 0.0 109.106 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 133' ' ' SER . 14.9 t -101.86 -14.57 17.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 0.0 109.588 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.329 -179.979 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.265 0.555 . . . . 0.0 109.826 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.449 ' O ' HD12 ' B' ' 3' ' ' LEU . 0.3 OUTLIER -158.92 179.06 9.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.422 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 2.2 p -73.39 151.64 89.79 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.413 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.54 -28.61 21.28 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.558 2.172 . . . . 0.0 112.049 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -78.73 -41.23 31.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.573 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.77 -46.08 83.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.559 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.475 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -72.63 -37.44 68.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 109.624 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.403 ' C ' ' O ' ' B' ' 8' ' ' LYS . 3.3 t -45.63 -23.62 0.26 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.688 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.32 -56.51 3.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 109.949 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -65.21 -24.62 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 5.8 m -77.53 -45.73 24.52 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.398 0.618 . . . . 0.0 109.53 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.21 -34.54 72.3 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.396 -0.815 . . . . 0.0 109.573 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.43 ' C ' ' N ' ' B' ' 16' ' ' GLY . 0.8 OUTLIER -51.8 -32.12 30.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.922 . . . . 0.0 109.122 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -48.68 -17.99 0.22 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.343 -0.848 . . . . 0.0 109.267 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' B' ' 14' ' ' LEU . . . -76.78 -56.7 4.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.416 ' N ' ' CD ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -64.78 -27.48 68.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -1.203 . . . . 0.0 109.15 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.9 114.69 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' B' ' 21' ' ' ASP . 25.4 m-80 -80.42 69.15 6.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.231 -0.918 . . . . 0.0 109.048 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 74.2 t -44.32 -21.32 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.419 -0.801 . . . . 0.0 109.651 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' B' ' 19' ' ' ASN . 68.1 m-20 -74.08 3.87 6.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' B' ' 19' ' ' ASN . 35.1 mt-10 -153.01 -41.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.177 -0.952 . . . . 0.0 109.313 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.54 -46.63 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.288 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.32 -42.94 64.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.88 -44.02 63.75 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -68.01 -25.06 65.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.27 -49.44 66.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.551 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.613 ' N ' HD12 ' B' ' 28' ' ' LEU . 9.4 mp -79.12 -54.51 5.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.45 -33.4 8.3 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -82.08 -39.33 23.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -1.119 . . . . 0.0 109.337 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -49.2 -35.79 18.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 27.3 mt -79.88 -31.95 40.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 109.56 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.838 HG13 ' HA ' ' A' ' 119' ' ' PRO . 61.7 t -66.43 -64.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.423 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 1.004 HG13 ' HB3' ' A' ' 122' ' ' HIS . 1.3 t -64.43 -22.74 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.355 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -146.17 80.73 10.05 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.342 -0.849 . . . . 0.0 109.382 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.36 -5.6 14.33 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.672 2.248 . . . . 0.0 112.439 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.535 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 1.3 p-90 -58.86 -24.43 62.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.535 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 3.1 m -95.91 38.22 1.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.39 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLN . . . . . 0.422 ' H ' ' HG3' ' B' ' 39' ' ' GLN . 5.3 pp0? -90.98 9.52 30.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 109.624 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 1.665 ' CD ' ' HD3' ' C' ' 92' ' ' ARG . 55.1 ttt85 -81.56 -29.83 33.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' B' ' 42' ' ' PHE . 66.2 m-85 -90.91 30.08 1.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.948 . . . . 0.0 109.405 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' B' ' 41' ' ' PHE . 70.5 m-85 -145.66 22.61 1.45 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.48 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -78.93 -16.51 56.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.255 -0.903 . . . . 0.0 109.51 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.463 ' O ' ' N ' ' B' ' 46' ' ' GLY . 27.8 p -67.47 -43.23 81.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.598 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' B' ' 47' ' ' ASP . 88.4 m-85 -48.89 -14.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.506 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 66.89 -65.42 0.19 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' B' ' 45' ' ' PHE . 4.6 m-20 -46.18 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -1.163 . . . . 0.0 109.576 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 tp -159.47 22.62 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 12.9 p -70.45 -33.83 71.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.533 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' THR . . . . . 0.442 ' O ' ' N ' ' B' ' 53' ' ' ALA . 3.4 p -145.7 151.52 46.5 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 0.0 109.111 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -39.96 -42.09 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.373 2.049 . . . . 0.0 112.238 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.2 -31.05 72.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -61.93 -19.79 63.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.475 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 78.6 t -67.96 -63.83 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.657 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 22.4 ptp -83.18 4.49 26.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.723 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.88 -17.23 70.64 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.406 ' ND2' ' HD2' ' B' ' 58' ' ' PRO . 2.3 t-20 -82.19 138.18 45.67 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.0 109.024 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.406 ' HD2' ' ND2' ' B' ' 57' ' ' ASN . 50.2 Cg_endo -71.18 -12.88 30.7 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.247 1.964 . . . . 0.0 112.14 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -80.17 -57.47 3.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.332 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 43.0 t -48.02 -31.58 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.341 -0.85 . . . . 0.0 109.56 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.401 ' HB3' ' HZ2' ' B' ' 61' ' ' LYS . 16.2 mtpp -78.99 -32.94 45.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.508 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.62 -45.79 16.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.69 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' B' ' 63' ' ' HIS . 0.9 OUTLIER -62.72 -23.64 67.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.22 -0.925 . . . . 0.0 109.671 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.57 -36.34 83.15 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -60.15 -25.46 65.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -1.2 . . . . 0.0 109.58 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.69 -50.17 39.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.317 -0.865 . . . . 0.0 109.62 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.72 -36.73 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.445 HD23 ' C ' ' B' ' 68' ' ' LEU . 5.6 tt -71.58 -48.03 51.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.288 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.46 -44.91 16.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.62 -51.85 56.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -1.131 . . . . 0.0 109.44 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -49.5 -35.29 19.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.403 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -76.01 -24.49 55.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.4 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -52.37 -43.58 64.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.86 -60.12 8.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.495 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.2 mp -57.98 -28.08 64.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.117 . . . . 0.0 109.277 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -80.45 -9.28 59.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.29 -0.881 . . . . 0.0 109.556 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 57.2 m80 -160.27 65.94 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.389 -0.819 . . . . 0.0 109.539 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mt -68.4 11.62 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' B' ' 77' ' ' HIS . 81.5 m-20 -72.4 -31.07 65.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.124 -0.985 . . . . 0.0 109.553 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 16.4 t-20 -171.02 108.89 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.558 HD12 ' N ' ' B' ' 81' ' ' LEU . 9.5 mp -80.26 -54.75 5.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.5 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.446 ' H ' ' HD3' ' B' ' 82' ' ' LYS . 0.6 OUTLIER -49.92 -24.0 2.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.486 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 83' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -73.12 -52.44 8.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.1 t -76.48 -47.58 22.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -1.189 . . . . 0.0 109.528 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.547 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.2 m-85 -66.04 4.76 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.461 -0.775 . . . . 0.0 109.566 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -63.73 -33.4 75.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.423 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.1 p -79.36 -51.3 9.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.418 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' B' ' 92' ' ' HIS . 8.7 mp -53.33 -51.17 63.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.345 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 36.4 p -54.7 -45.4 73.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.927 . . . . 0.0 109.632 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.428 ' O ' ' OD2' ' B' ' 94' ' ' ASP . 32.9 tt0 -66.3 -41.58 89.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.663 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.53 -20.14 40.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.599 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' B' ' 88' ' ' LEU . 1.5 m80 -87.65 -41.21 13.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 110.239 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -82.99 -39.64 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.048 -1.032 . . . . 0.0 110.795 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' B' ' 90' ' ' GLU . 12.1 m-20 -86.18 -36.38 19.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.921 -1.112 . . . . 0.0 111.181 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -52.18 5.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.928 -1.108 . . . . 0.0 110.594 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.583 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 10.0 mp -86.29 -31.81 21.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.92 -1.112 . . . . 0.0 109.68 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 13.5 p80 41.89 29.39 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.382 -0.824 . . . . 0.0 109.858 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.09 124.65 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.178 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 99' ' ' ASP . . . . . 1.284 ' CB ' HG21 ' C' ' 96' ' ' VAL . 0.4 OUTLIER -47.67 154.24 0.94 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.09 -160.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.628 2.219 . . . . 0.0 111.959 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.447 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 29.6 mm-40 57.64 26.3 12.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' B' ' 101' ' ' GLU . 39.1 m-20 -137.53 -32.76 0.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.35 -0.844 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.48 -37.01 85.65 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.497 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -70.14 -23.74 63.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.589 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.583 HD12 ' N ' ' B' ' 105' ' ' LEU . 7.8 mp -79.74 -17.68 52.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.48 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.759 ' C ' HD13 ' B' ' 106' ' ' LEU . 2.6 tm? -78.92 -46.72 17.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.318 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.99 -20.46 77.67 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -70.52 -55.66 8.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.083 -1.245 . . . . 0.0 109.797 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -53.72 -24.06 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.634 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.517 HD23 ' O ' ' B' ' 110' ' ' LEU . 1.6 tt -64.44 -50.85 65.91 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.472 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.563 ' CG2' ' CE1' ' B' ' 130' ' ' TYR . 46.7 t -49.44 -45.21 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.716 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 56.5 m -51.55 -35.92 42.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.631 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.91 -28.58 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 41.6 mt -72.73 -40.68 65.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.21 -20.85 59.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 109.297 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.54 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 3.0 t-80 -84.75 -54.62 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.301 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.428 ' HD1' ' N ' ' B' ' 117' ' ' HIS . 0.5 OUTLIER -70.97 -17.54 62.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 0.0 109.671 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.41 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 68.3 m-85 -152.71 62.3 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.573 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.542 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -58.86 -26.99 61.3 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -68.37 -34.97 77.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -82.78 14.23 3.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.638 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.551 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -82.91 36.32 0.5 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.627 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.605 ' OG1' HG23 ' B' ' 126' ' ' VAL . 7.4 p -46.42 154.15 0.67 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.454 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.453 ' O ' HD13 ' A' ' 34' ' ' LEU . 24.5 Cg_exo -55.49 -44.81 44.85 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.358 2.039 . . . . 0.0 113.749 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' B' ' 124' ' ' PRO . 67.1 Cg_endo -78.17 -8.16 16.35 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.021 1.814 . . . . 0.0 112.615 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.605 HG23 ' OG1' ' B' ' 123' ' ' THR . 10.6 t -83.76 -31.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 109.198 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -83.26 -59.73 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 109.629 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 1.548 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -48.49 -41.96 31.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.18 -36.46 83.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.831 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.563 ' CE1' ' CG2' ' B' ' 111' ' ' VAL . 30.0 t80 -61.23 -60.9 3.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.067 -1.021 . . . . 0.0 109.402 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -47.77 -25.81 1.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.873 . . . . 0.0 109.563 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' B' ' 132' ' ' LYS . 5.0 ttpm? -85.53 -31.52 22.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 109.739 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.49 -65.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.54 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.418 ' H ' HG22 ' B' ' 134' ' ' VAL . 5.9 m -55.48 -15.67 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.597 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.648 ' CB ' ' OXT' ' D' ' 146' ' ' HIS . . . -56.22 -33.73 65.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.341 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.83 -30.52 57.62 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.15 -32.86 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.428 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.94 76.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.332 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -78.73 -21.26 48.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.299 -0.875 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.64 -60.73 2.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.942 . . . . 0.0 109.676 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 63.9 mt -54.22 -20.32 6.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.135 -0.978 . . . . 0.0 109.256 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 142' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' B' ' 145' ' ' TYR . . . -88.98 -4.6 58.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 109.116 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 143' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' B' ' 146' ' ' HIS . 71.4 t60 -49.45 -39.08 31.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.498 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -86.94 -55.15 3.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.133 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -52.8 -10.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.514 -0.741 . . . . 0.0 109.36 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.62 ' OXT' ' CB ' ' D' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.469 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.429 ' C ' ' OG ' ' C' ' 3' ' ' SER . 14.6 mt -139.05 -178.3 5.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.361 -0.837 . . . . 0.0 109.218 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.494 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 178.76 -50.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' C' ' 6' ' ' ASP . 83.1 Cg_exo -43.64 155.71 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.309 2.006 . . . . 0.0 112.576 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -46.27 -16.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.841 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' C' ' 4' ' ' PRO . 12.5 t70 -39.43 -44.91 1.43 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.39 -0.819 . . . . 0.0 109.792 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' C' ' 8' ' ' THR . 6.5 ptmt -57.95 -50.48 73.23 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.117 -0.989 . . . . 0.0 109.01 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.411 ' N ' ' CG ' ' C' ' 7' ' ' LYS . 22.6 m -54.67 -31.51 57.85 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 108.61 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -77.16 -34.85 56.38 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.79 -51.82 41.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.37 -47.74 47.33 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.45 -61.18 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.494 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.599 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -50.18 -42.0 50.44 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.392 -0.817 . . . . 0.0 109.06 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -17.57 64.93 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.437 -0.789 . . . . 0.0 109.156 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.2 -45.38 10.17 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 39.6 mmtt -68.72 -39.54 80.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 108.798 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.599 HG23 ' O ' ' C' ' 13' ' ' ALA . 58.1 t -61.86 -65.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 54.78 -132.82 47.94 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.75 27.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.456 -1.026 . . . . 0.0 110.383 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.556 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.7 m-70 -131.77 25.12 4.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -89.32 -59.6 2.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.679 -0.638 . . . . 0.0 109.827 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.73 -13.85 0.2 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.5 mt-10 -87.59 -56.45 3.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.39 -1.065 . . . . 0.0 109.897 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.526 ' CD1' ' ND1' ' C' ' 112' ' ' HIS . 3.0 m-30 -60.18 -29.15 68.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.06 -34.49 86.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.12 -39.13 30.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -1.159 . . . . 0.0 109.754 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.94 -25.55 68.19 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 109.271 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.4 -22.95 66.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.594 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.671 HD11 ' ND1' ' C' ' 58' ' ' HIS . 10.7 mt -76.65 -58.47 3.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -62.38 -12.57 22.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 109.923 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.458 ' HE ' ' HA ' ' C' ' 31' ' ' ARG . 0.3 OUTLIER -69.64 -49.79 50.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 110.327 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 32' ' ' MET . . . . . 0.432 ' O ' ' N ' ' C' ' 34' ' ' LEU . 2.6 ptt? -84.22 -36.53 22.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.136 -0.977 . . . . 0.0 110.335 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 33' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' C' ' 32' ' ' MET . 13.9 t80 -43.63 -23.93 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 110.175 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 1.56 ' CD1' ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -92.05 -28.85 16.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.001 -1.062 . . . . 0.0 110.03 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.516 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 81.5 p -89.25 -18.45 27.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 0.0 109.928 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.516 ' CG ' ' O ' ' C' ' 35' ' ' SER . 85.0 m-85 -157.89 75.78 3.84 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.127 -0.983 . . . . 0.0 109.797 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' C' ' 39' ' ' THR . 26.2 Cg_exo -60.36 -19.99 60.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.906 2.404 . . . . 0.0 112.166 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.436 ' O ' HG22 ' C' ' 41' ' ' THR . 24.4 p -48.63 -18.76 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 109.926 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.4 ' N ' ' C ' ' C' ' 37' ' ' PRO . 38.0 p -85.93 -53.07 5.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.712 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' C' ' 41' ' ' THR . 0.5 OUTLIER -79.93 -17.56 52.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.666 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.483 ' C ' ' O ' ' C' ' 40' ' ' LYS . 10.9 t . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.484 -0.76 . . . . 0.0 109.992 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -139.26 63.69 1.49 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' C' ' 49' ' ' SER . 33.9 m-20 -37.9 -22.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.365 -0.834 . . . . 0.0 110.226 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' C' ' 46' ' ' PHE . 1.2 mt 52.64 6.34 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.127 -0.983 . . . . 0.0 109.608 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.515 ' H ' ' C ' ' C' ' 47' ' ' ASP . 34.6 t -81.3 153.32 27.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.95 . . . . 0.0 109.351 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -47.92 128.71 13.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.372 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.48 22.06 13.48 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.554 ' O ' ' N ' ' C' ' 54' ' ' GLN . 37.9 m -95.15 66.15 2.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -1.124 . . . . 0.0 108.936 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' C' ' 52' ' ' SER . . . -37.92 -25.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.809 -0.557 . . . . 0.0 110.264 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' C' ' 52' ' ' SER . 14.2 mt-30 -60.64 -46.28 90.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 109.529 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.478 HG22 ' CE2' ' C' ' 46' ' ' PHE . 15.9 t -56.05 -47.51 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.976 . . . . 0.0 109.128 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -66.52 -54.22 26.25 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 57' ' ' GLY . . . . . 0.433 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -53.21 -26.64 29.33 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.671 ' ND1' HD11 ' C' ' 29' ' ' LEU . 6.8 t-80 -69.92 -33.55 72.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.08 -1.247 . . . . 0.0 109.736 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.48 -48.68 82.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 51.4 mttp -51.07 -23.81 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -1.095 . . . . 0.0 109.705 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 61' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' C' ' 57' ' ' GLY . 0.5 OUTLIER -71.49 -50.5 30.86 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 108.966 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.72 -43.61 89.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.601 -0.687 . . . . 0.0 109.303 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.12 -28.71 64.5 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.306 -0.872 . . . . 0.0 109.44 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 64' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 15.1 t70 -72.35 -40.09 67.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.034 . . . . 0.0 108.753 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.57 -47.38 81.75 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.01 -40.29 95.15 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -70.63 -51.01 30.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.264 -0.898 . . . . 0.0 108.604 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -59.35 -23.03 62.18 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.671 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -83.56 -47.27 11.48 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.96 -22.79 32.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.47 -14.99 63.38 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.602 ' O ' ' N ' ' C' ' 74' ' ' ASP . 56.8 m-70 -143.75 -59.56 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.581 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.542 HG22 ' O ' ' C' ' 73' ' ' VAL . 14.5 p 44.68 13.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.711 0.767 . . . . 0.0 109.507 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' C' ' 72' ' ' HIS . 12.8 t70 -133.37 9.58 4.04 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 2.1 m-20 -179.43 27.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.883 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 17.7 ptt? -78.82 -22.69 0.39 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.365 -0.834 . . . . 0.0 112.004 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.1 Cg_exo -52.54 -22.07 15.79 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.63 1.553 . . . . 0.0 112.522 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -94.16 -24.08 17.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.643 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 -54.27 6.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.15 -0.968 . . . . 0.0 109.142 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 80' ' ' LEU . . . . . 0.668 ' N ' HD12 ' C' ' 80' ' ' LEU . 7.0 mp -77.21 8.94 3.46 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.384 -0.823 . . . . 0.0 109.058 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t -65.21 -15.82 62.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.843 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.75 -46.13 14.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.183 -0.948 . . . . 0.0 109.846 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.417 ' N ' HD23 ' C' ' 83' ' ' LEU . 4.1 mt -46.26 -46.0 17.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.835 . . . . 0.0 109.044 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' C' ' 135' ' ' VAL . 37.6 m -54.02 -29.13 42.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.547 -0.721 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' C' ' 82' ' ' ALA . 25.9 t0 -65.81 -33.85 76.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.109 -0.994 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' C' ' 90' ' ' LYS . 3.0 tt -83.02 -63.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -49.97 -22.02 1.41 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.877 . . . . 0.0 110.028 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -97.69 -48.14 5.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 110.007 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -76.72 -71.05 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.956 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' C' ' 86' ' ' LEU . 30.1 mttm -86.29 140.58 29.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.736 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.56 HD12 ' N ' ' C' ' 91' ' ' LEU . 10.6 mp 54.0 57.82 5.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.021 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 92' ' ' ARG . . . . . 1.665 ' HD3' ' CD ' ' B' ' 40' ' ' ARG . 72.5 ttt180 -47.86 -47.52 31.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 0.0 109.374 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.74 HG12 ' H ' ' C' ' 94' ' ' ASP . 61.9 t 49.67 179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.314 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.74 ' H ' HG12 ' C' ' 93' ' ' VAL . 34.8 m-20 -133.12 151.81 78.49 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.266 -0.896 . . . . 0.0 109.119 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' C' ' 98' ' ' PHE . 81.7 Cg_exo -39.19 -19.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.612 2.208 . . . . 0.0 112.302 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 96' ' ' VAL . . . . . 1.284 HG21 ' CB ' ' B' ' 99' ' ' ASP . 63.9 t -46.98 -32.92 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.74 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' C' ' 97' ' ' ASN . 1.5 m120 -79.31 -25.07 42.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.942 . . . . 0.0 109.507 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 98' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' C' ' 95' ' ' PRO . 77.2 t80 -67.95 -56.37 9.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.8 -28.83 2.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.477 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 17.0 mt -83.98 -52.36 6.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.165 -0.959 . . . . 0.0 109.565 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 58.0 tp -47.27 -39.55 14.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.777 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 99.3 p -65.13 -59.25 4.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -53.01 -26.72 16.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.83 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 60.4 m -66.42 -58.48 5.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 109.825 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -45.93 -23.13 0.26 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.424 HD22 ' N ' ' C' ' 106' ' ' LEU . 4.1 mm? -82.12 -32.34 30.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.046 -1.034 . . . . 0.0 109.819 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 38.4 t -82.86 -27.61 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.173 -0.954 . . . . 0.0 109.689 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 6.8 p -68.92 -60.52 2.31 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.184 -0.948 . . . . 0.0 109.572 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 36.7 mt -55.79 -42.08 75.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.346 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.33 11.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.773 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.24 -55.79 4.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.941 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 112' ' ' HIS . . . . . 0.526 ' ND1' ' CD1' ' C' ' 24' ' ' TYR . 22.6 m170 -59.67 -62.64 1.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.983 -1.073 . . . . 0.0 109.062 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.806 HD12 ' O ' ' C' ' 114' ' ' PRO . 2.4 pp -137.71 118.91 10.63 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 114' ' ' PRO . . . . . 0.806 ' O ' HD12 ' C' ' 113' ' ' LEU . 89.4 Cg_exo -40.74 -178.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.561 2.174 . . . . 0.0 113.318 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.779 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -57.46 -55.07 39.52 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.422 -0.799 . . . . 0.0 109.164 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.649 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 4.8 mm-40 120.32 -2.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 20.0 t80 64.34 52.32 1.91 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.161 0.505 . . . . 0.0 110.989 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.0 OUTLIER -133.13 111.5 13.07 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.514 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 119' ' ' PRO . . . . . 0.85 ' HA ' HG13 ' D' ' 33' ' ' VAL . 78.1 Cg_exo -47.41 10.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.171 1.914 . . . . 0.0 112.561 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -132.72 -19.4 2.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.882 . . . . 0.0 110.279 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.779 HG21 ' O ' ' C' ' 115' ' ' ALA . 11.7 p -60.42 -55.33 25.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.119 -0.988 . . . . 0.0 110.302 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 1.03 ' HB3' HG13 ' D' ' 34' ' ' VAL . 6.4 m170 -72.05 -33.25 67.82 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.129 -0.982 . . . . 0.0 108.883 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.08 -20.18 49.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.485 -0.759 . . . . 0.0 109.137 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.581 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.1 m -64.86 -62.7 1.41 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.351 -0.843 . . . . 0.0 109.998 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.55 -19.5 65.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 109.203 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.99 -50.09 11.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.75 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -85.66 -43.12 13.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.117 -0.989 . . . . 0.0 109.795 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.434 ' N ' ' CD ' ' C' ' 127' ' ' LYS . 53.5 t80 -49.45 -20.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.898 -1.126 . . . . 0.0 108.672 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' C' ' 133' ' ' SER . 12.8 mt -71.9 -17.62 62.09 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.9 -31.72 72.04 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.434 ' O ' HG23 ' C' ' 135' ' ' VAL . 57.0 p -83.22 -34.01 25.98 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.325 -0.859 . . . . 0.0 108.947 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -85.31 -27.96 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 108.655 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.626 ' N ' ' O ' ' C' ' 129' ' ' LEU . 37.2 m -80.14 -28.92 38.83 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.408 -0.808 . . . . 0.0 109.159 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 41.8 m -71.24 -33.67 70.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 109.035 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 131' ' ' SER . 30.0 t -79.9 -28.13 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.26 -0.9 . . . . 0.0 108.623 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.63 -35.76 73.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.037 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 137' ' ' THR . . . . . 0.447 HG22 ' O ' ' C' ' 133' ' ' SER . 14.9 t -101.93 -14.55 17.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.83 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.146 -0.971 . . . . 0.0 109.401 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.325 0.583 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.443 HD12 ' O ' ' D' ' 3' ' ' LEU . 0.3 OUTLIER -159.05 179.04 9.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.365 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.419 ' OG1' ' OE2' ' D' ' 7' ' ' GLU . 2.2 p -73.36 151.57 89.84 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.46 -28.54 21.77 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.552 2.168 . . . . 0.0 112.107 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -78.83 -41.25 30.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.939 . . . . 0.0 109.534 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 7' ' ' GLU . . . . . 0.419 ' OE2' ' OG1' ' D' ' 4' ' ' THR . 46.2 mt-10 -64.76 -46.03 83.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.467 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -72.63 -37.53 68.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.605 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 3.4 t -45.52 -23.7 0.25 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.788 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.23 -56.51 3.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.147 -0.971 . . . . 0.0 109.999 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 6.7 p -65.24 -24.62 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 5.8 m -77.51 -45.66 24.83 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.395 0.616 . . . . 0.0 109.575 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.45 72.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.385 -0.822 . . . . 0.0 109.592 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.43 ' C ' ' N ' ' D' ' 16' ' ' GLY . 0.8 OUTLIER -51.9 -32.12 31.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.072 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -48.66 -17.96 0.22 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.275 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 16' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' D' ' 14' ' ' LEU . . . -76.8 -56.81 3.99 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.432 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -64.77 -27.39 68.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 109.217 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.91 114.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' D' ' 21' ' ' ASP . 25.3 m-80 -80.45 69.15 6.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.009 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -44.39 -21.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.748 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' D' ' 19' ' ' ASN . 68.0 m-20 -74.16 3.92 6.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.489 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' D' ' 19' ' ' ASN . 35.1 mt-10 -153.0 -41.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.316 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.52 -46.59 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.36 -42.9 65.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.87 -44.05 63.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.1 -24.94 65.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -1.163 . . . . 0.0 109.528 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.32 -49.46 67.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 28' ' ' LEU . . . . . 0.594 HD12 ' N ' ' D' ' 28' ' ' LEU . 9.4 mp -79.12 -54.38 6.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.57 -33.38 8.68 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -81.99 -39.33 23.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -1.142 . . . . 0.0 109.419 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -49.27 -35.76 18.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 27.0 mt -79.9 -31.83 40.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.618 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 33' ' ' VAL . . . . . 0.85 HG13 ' HA ' ' C' ' 119' ' ' PRO . 61.6 t -66.51 -64.41 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 109.38 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 1.03 HG13 ' HB3' ' C' ' 122' ' ' HIS . 1.3 t -64.47 -22.64 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -146.21 80.85 9.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.397 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.45 -5.56 14.23 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.692 2.261 . . . . 0.0 112.386 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 37' ' ' TRP . . . . . 0.546 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 1.3 p-90 -58.87 -24.37 62.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.965 . . . . 0.0 109.51 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.546 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 3.0 m -96.01 38.29 1.19 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -91.16 9.63 30.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 109.496 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 40' ' ' ARG . . . . . 1.565 ' CD ' ' HD3' ' A' ' 92' ' ' ARG . 55.0 ttt85 -81.6 -29.82 33.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.543 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' D' ' 42' ' ' PHE . 66.1 m-85 -90.9 30.12 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 109.384 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' D' ' 41' ' ' PHE . 70.4 m-85 -145.66 22.65 1.45 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 109.381 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -79.11 -16.45 56.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.407 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 44' ' ' SER . . . . . 0.468 ' O ' ' N ' ' D' ' 46' ' ' GLY . 27.6 p -67.48 -43.32 81.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' D' ' 47' ' ' ASP . 88.3 m-85 -48.73 -14.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 66.9 -65.38 0.19 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' D' ' 45' ' ' PHE . 4.6 m-20 -46.18 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -1.16 . . . . 0.0 109.555 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 tp -159.46 22.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 12.8 p -70.54 -33.8 71.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 50' ' ' THR . . . . . 0.427 ' O ' ' N ' ' D' ' 53' ' ' ALA . 3.4 p -145.64 151.56 46.82 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.325 -0.859 . . . . 0.0 109.031 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -39.97 -42.01 3.12 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.302 2.001 . . . . 0.0 112.256 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.32 -31.01 72.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.488 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -61.92 -19.81 63.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.98 -63.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 109.615 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 55' ' ' MET . . . . . 0.41 ' H ' ' HG2' ' D' ' 55' ' ' MET . 22.4 ptp -83.2 4.5 26.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.364 -0.835 . . . . 0.0 109.648 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.92 -17.25 70.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 57' ' ' ASN . . . . . 0.401 ' ND2' ' HD2' ' D' ' 58' ' ' PRO . 2.3 t-20 -82.1 138.05 46.03 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.276 -1.132 . . . . 0.0 109.071 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.401 ' HD2' ' ND2' ' D' ' 57' ' ' ASN . 49.9 Cg_endo -71.11 -12.84 30.81 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.232 1.955 . . . . 0.0 112.162 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -80.15 -57.45 3.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -48.0 -31.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 61' ' ' LYS . . . . . 0.418 ' HZ2' ' HB3' ' D' ' 61' ' ' LYS . 16.2 mtpp -79.03 -32.81 45.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.76 -45.64 16.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.679 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 63' ' ' HIS . . . . . 0.493 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 0.9 OUTLIER -62.79 -23.67 67.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.722 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.49 -36.32 83.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -60.17 -25.44 65.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.108 -1.23 . . . . 0.0 109.591 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.71 -50.13 39.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.81 -36.67 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.35 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.447 ' O ' HD23 ' D' ' 68' ' ' LEU . 5.6 tt -71.56 -48.09 50.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.42 -44.95 16.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.55 -51.94 56.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -1.102 . . . . 0.0 109.414 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -49.53 -35.32 19.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.269 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -75.98 -24.49 55.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -52.3 -43.64 64.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.381 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.84 -60.13 8.57 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.502 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.2 mp -57.98 -27.99 63.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -1.118 . . . . 0.0 109.317 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -80.62 -9.24 59.79 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.214 -0.929 . . . . 0.0 109.427 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 56.8 m80 -160.34 66.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.42 11.58 0.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.309 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' D' ' 77' ' ' HIS . 81.4 m-20 -72.38 -30.97 65.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.614 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 80' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 16.5 t-20 -171.07 108.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.605 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 81' ' ' LEU . . . . . 0.563 HD12 ' N ' ' D' ' 81' ' ' LEU . 9.5 mp -80.31 -54.68 5.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.502 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 82' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' D' ' 82' ' ' LYS . 0.6 OUTLIER -49.97 -24.03 2.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.421 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 83' ' ' GLY . . . . . 0.44 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -73.15 -52.37 8.94 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.1 t -76.51 -47.63 22.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -1.179 . . . . 0.0 109.484 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.1 m-85 -66.0 4.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.783 . . . . 0.0 109.505 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 86' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -63.63 -33.49 75.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.0 p -79.27 -51.43 9.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.411 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' D' ' 92' ' ' HIS . 8.7 mp -53.24 -51.19 63.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.352 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 34.8 p -54.57 -45.47 73.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.69 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.432 ' O ' ' OD2' ' D' ' 94' ' ' ASP . 32.9 tt0 -66.24 -41.64 89.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.155 -0.966 . . . . 0.0 109.624 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.43 -20.2 40.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.643 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.581 ' N ' ' O ' ' D' ' 88' ' ' LEU . 1.5 m80 -87.62 -41.16 13.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 110.267 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 35.6 t -83.11 -39.57 20.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.043 -1.035 . . . . 0.0 110.739 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' D' ' 90' ' ' GLU . 12.2 m-20 -86.27 -36.41 19.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.009 -1.057 . . . . 0.0 111.093 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -52.26 5.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.9 -1.125 . . . . 0.0 110.531 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.571 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 10.0 mp -86.28 -31.89 21.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.912 -1.117 . . . . 0.0 109.603 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 13.5 p80 42.04 29.32 0.13 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.426 -0.796 . . . . 0.0 109.818 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.16 124.61 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.862 . . . . 0.0 109.168 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 99' ' ' ASP . . . . . 1.317 ' CB ' HG21 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -47.55 154.21 0.92 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.18 -160.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.651 2.234 . . . . 0.0 112.001 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 101' ' ' GLU . . . . . 0.446 ' O ' ' OD1' ' D' ' 102' ' ' ASN . 29.8 mm-40 57.64 26.31 12.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.872 . . . . 0.0 109.499 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 102' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' D' ' 101' ' ' GLU . 39.1 m-20 -137.47 -32.88 0.75 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.369 -0.832 . . . . 0.0 109.341 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.39 -37.13 86.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -70.14 -23.6 63.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.987 . . . . 0.0 109.548 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 105' ' ' LEU . . . . . 0.589 ' N ' HD12 ' D' ' 105' ' ' LEU . 7.8 mp -79.85 -17.7 52.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 0.0 109.463 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.757 ' C ' HD13 ' D' ' 106' ' ' LEU . 2.6 tm? -78.87 -46.76 17.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.302 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.02 -20.41 77.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -70.45 -55.7 8.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -1.216 . . . . 0.0 109.787 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -53.66 -24.05 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.962 . . . . 0.0 109.71 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 110' ' ' LEU . . . . . 0.512 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.6 tt -64.48 -50.8 66.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.913 . . . . 0.0 109.501 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 111' ' ' VAL . . . . . 0.556 ' CG2' ' CE1' ' D' ' 130' ' ' TYR . 46.9 t -49.53 -45.19 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 56.4 m -51.6 -35.84 43.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.61 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.96 -28.59 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 41.6 mt -72.74 -40.73 65.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.353 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.0 59.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 109.259 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.535 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 3.0 t-80 -84.58 -54.69 4.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.322 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 117' ' ' HIS . . . . . 0.437 ' N ' ' HD1' ' D' ' 117' ' ' HIS . 0.5 OUTLIER -70.97 -17.45 62.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.704 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.402 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 68.3 m-85 -152.75 62.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.601 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -58.84 -27.0 61.26 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -68.42 -34.95 76.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -1.225 . . . . 0.0 109.559 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.84 14.35 3.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.624 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.558 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -83.01 36.4 0.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.592 ' OG1' HG23 ' D' ' 126' ' ' VAL . 7.4 p -46.45 154.14 0.68 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.115 -0.991 . . . . 0.0 109.445 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.453 ' O ' HD13 ' C' ' 34' ' ' LEU . 24.4 Cg_exo -55.4 -44.89 44.3 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.334 2.022 . . . . 0.0 113.786 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' D' ' 124' ' ' PRO . 67.1 Cg_endo -78.21 -8.06 16.28 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.994 1.796 . . . . 0.0 112.598 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.592 HG23 ' OG1' ' D' ' 123' ' ' THR . 10.6 t -83.79 -31.04 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 109.276 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.28 -59.67 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 109.637 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 1.56 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -48.55 -41.97 31.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 0.0 109.42 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.55 83.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.89 . . . . 0.0 109.881 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.556 ' CE1' ' CG2' ' D' ' 111' ' ' VAL . 29.7 t80 -61.11 -60.87 3.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.0 109.398 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -47.83 -25.8 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.584 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 132' ' ' LYS . . . . . 0.441 ' NZ ' ' CB ' ' D' ' 132' ' ' LYS . 5.0 ttpm? -85.5 -31.56 22.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.728 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.39 -65.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.527 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 5.9 m -55.53 -15.64 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.639 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.62 ' CB ' ' OXT' ' B' ' 146' ' ' HIS . . . -56.22 -33.68 65.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.929 . . . . 0.0 109.335 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.9 -30.52 57.5 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.14 -32.85 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -1.117 . . . . 0.0 109.433 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.97 76.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.345 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -78.7 -21.11 48.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 109.428 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.77 -60.63 2.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 63.6 mt -54.33 -20.25 6.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.315 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 142' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' D' ' 145' ' ' TYR . . . -89.01 -4.57 58.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 109.126 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 143' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' D' ' 146' ' ' HIS . 71.4 t60 -49.48 -39.13 32.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.484 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 0.8 OUTLIER -86.83 -55.13 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.944 . . . . 0.0 109.217 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 145' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -52.82 -10.41 0.16 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.56 -0.713 . . . . 0.0 109.387 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.648 ' OXT' ' CB ' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.484 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.429 ' C ' HD22 ' A' ' 2' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.576 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.9 mm? -95.01 -169.27 1.96 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.697 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.45 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -116.24 179.54 0.78 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.504 -0.747 . . . . 0.0 109.228 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 21.7 Cg_exo -62.81 -69.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.722 2.281 . . . . 0.0 112.752 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -83.09 -16.63 46.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.897 . . . . 0.0 110.391 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.55 ' OD2' HD12 ' A' ' 2' ' ' LEU . 7.8 t70 -40.1 -41.17 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.215 -0.928 . . . . 0.0 109.778 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 10' ' ' VAL . 68.8 mttt -69.44 -55.97 8.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.872 . . . . 0.0 109.639 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.0 m -45.03 -30.78 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 109.674 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -78.48 -36.4 45.24 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 7' ' ' LYS . 48.9 t -72.09 -48.84 47.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -53.05 -44.39 67.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 108.78 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.74 -57.4 12.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.434 -0.791 . . . . 0.0 109.32 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -56.41 -36.2 68.67 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.431 -0.793 . . . . 0.0 109.27 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.92 -17.22 60.6 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.248 -0.908 . . . . 0.0 108.936 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.76 -42.0 22.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -71.43 -42.12 68.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -1.178 . . . . 0.0 108.84 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 13' ' ' ALA . 61.2 t -60.71 -63.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 47.73 -127.2 14.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.3 24.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.457 -1.025 . . . . 0.0 110.446 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.537 ' H ' ' C ' ' A' ' 18' ' ' GLY . 88.3 m-70 -128.84 22.13 5.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.887 . . . . 0.0 108.609 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.73 -55.93 3.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.577 -0.702 . . . . 0.0 109.443 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.49 -14.43 0.61 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 21' ' ' ALA . 12.7 mm-40 -87.49 -56.52 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.396 -1.061 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.9 m-30 -60.87 -22.84 64.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 0.0 109.246 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.19 -23.54 63.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.93 -40.04 22.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -1.132 . . . . 0.0 109.619 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -69.43 -19.62 63.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.819 . . . . 0.0 109.25 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.3 -20.44 57.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 0.0 109.641 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.3 mt -78.15 -46.9 19.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.786 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.02 -38.13 75.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 109.738 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.4 mtt85 -63.18 -39.13 93.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.54 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 51.0 ttp -64.6 -50.44 67.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.203 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 1.8 t80 -44.07 -33.87 1.6 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.427 -0.796 . . . . 0.0 109.697 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.3 mt -84.95 -40.02 17.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.76 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.543 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 74.4 m -53.42 -38.4 63.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 109.665 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 35' ' ' SER . 30.5 m-85 -164.29 87.11 1.14 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 39' ' ' THR . 76.5 Cg_exo -48.18 -19.98 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.612 2.208 . . . . 0.0 112.141 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.818 ' HB ' ' HB3' ' D' ' 97' ' ' HIS . 9.1 p -46.82 -18.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.88 . . . . 0.0 109.738 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' PRO . 53.2 p -80.89 -63.11 1.48 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.13 -0.981 . . . . 0.0 109.989 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 41' ' ' THR . 8.6 mmpt? -59.09 -18.57 36.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.94 . . . . 0.0 109.955 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 38' ' ' THR . 5.8 t . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.143 -0.973 . . . . 0.0 109.835 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.622 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 121.473 0.654 . . . . 0.0 109.612 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.771 ' O ' ' N ' ' A' ' 48' ' ' LEU . 3.3 m-85 -82.89 14.2 3.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.315 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 49' ' ' SER . 4.7 m-20 60.42 -51.35 0.09 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.771 ' N ' ' O ' ' A' ' 46' ' ' PHE . 19.5 mt 41.59 20.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.677 -0.639 . . . . 0.0 109.961 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 47' ' ' ASP . 6.2 m -93.35 42.33 1.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.493 ' CG ' ' C ' ' A' ' 49' ' ' SER . 1.4 m-70 71.88 129.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.434 -0.792 . . . . 0.0 109.351 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.54 29.33 73.22 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.626 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 8.1 p -52.36 -36.68 54.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -1.064 . . . . 0.0 109.54 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 73.27 -64.45 0.4 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 53' ' ' ALA . 52.1 mt-30 -43.59 -35.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 109.48 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.32 -28.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 110.017 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 2.5 ptpt -61.53 -38.89 89.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 0.0 109.453 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' N ' ' CG ' ' A' ' 56' ' ' LYS . . . -52.43 -35.83 45.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 8.7 t-80 -76.6 -27.91 55.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.167 . . . . 0.0 109.913 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.59 -37.26 94.17 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 46.6 mtpt -62.68 -24.34 67.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -1.186 . . . . 0.0 110.268 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.504 ' HD2' ' H ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -65.01 -58.7 5.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.041 -1.037 . . . . 0.0 109.356 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 62' ' ' VAL . 11.5 t -54.0 -43.83 59.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.469 -0.77 . . . . 0.0 109.289 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.78 -46.88 62.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 0.0 108.924 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 62.4 m-20 -64.48 -34.4 78.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 108.661 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . -67.13 -50.36 61.64 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -55.69 -44.62 77.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 71' ' ' ALA . 19.3 m -65.5 -54.21 31.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.258 -0.901 . . . . 0.0 108.786 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -55.86 -27.35 51.27 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.446 ' HB1' ' SD ' ' A' ' 76' ' ' MET . . . -81.12 -47.68 13.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.32 -22.74 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -70.28 -13.01 61.98 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' A' ' 74' ' ' ASP . 51.7 m-70 -136.3 -67.17 0.52 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.457 -0.777 . . . . 0.0 109.251 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.2 p 44.77 14.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.952 0.882 . . . . 0.0 109.439 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 72' ' ' HIS . 35.0 m-20 -139.24 12.57 2.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 1.1 m-20 172.79 30.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.692 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 6.9 ptt? -78.31 -22.82 0.4 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 111.928 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.6 Cg_exo -53.84 -20.75 18.41 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.577 1.518 . . . . 0.0 112.387 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -94.11 -35.54 12.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 109.844 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.03 -46.89 61.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.097 -1.002 . . . . 0.0 109.257 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.8 mt -80.3 8.27 7.8 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 109.024 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.2 p -56.05 -21.92 24.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.907 . . . . 0.0 109.731 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -70.8 -53.79 14.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.788 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' ALA . 6.0 mt -44.78 -47.1 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 20.0 m -50.2 -39.61 44.62 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 82' ' ' ALA . 28.8 t70 -82.82 -17.33 44.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.817 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.745 ' C ' HD13 ' A' ' 86' ' ' LEU . 3.3 tm? -71.41 -58.19 3.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -83.11 -21.72 33.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.102 . . . . 0.0 110.736 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -67.04 -79.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.888 -1.132 . . . . 0.0 109.788 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -59.53 5.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.811 . . . . 0.0 109.475 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 86' ' ' LEU . 41.2 mttm -88.02 135.7 33.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' A' ' 93' ' ' VAL . 14.9 mt 61.16 66.43 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.833 . . . . 0.0 109.153 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 1.453 ' NE ' ' HB2' ' D' ' 40' ' ' ARG . 39.1 ttt-85 -66.33 18.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.504 -0.748 . . . . 0.0 109.347 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.59 ' H ' ' C ' ' A' ' 91' ' ' LEU . 11.9 p -42.61 129.52 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.895 . . . . 0.0 109.767 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.85 148.74 75.45 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.28 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ASN . 37.5 Cg_endo -67.56 -10.9 30.28 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.476 2.117 . . . . 0.0 112.046 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 95' ' ' PRO . 47.7 t -44.55 -19.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.715 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' PRO . 17.8 m120 -79.16 -24.77 43.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.545 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.534 ' CG ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -53.71 -45.01 70.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.372 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.534 ' N ' ' CG ' ' A' ' 98' ' ' PHE . 65.2 mttm -49.28 -41.02 36.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.498 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 12.4 mt -71.55 -43.24 66.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.892 . . . . 0.0 109.403 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.535 ' O ' HD23 ' A' ' 101' ' ' LEU . 3.5 tt -57.99 -57.09 14.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.317 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.5 p -61.86 -34.9 76.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.857 . . . . 0.0 109.687 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -77.68 -26.69 50.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.462 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 55.6 m -69.68 -41.52 75.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 0.0 109.686 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mt -52.35 -50.17 62.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.36 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 106' ' ' LEU . 3.8 mm? -58.83 -59.12 5.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 65.1 t -51.71 -49.68 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.197 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 110' ' ' ALA . 17.6 m -62.15 -60.27 3.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.394 -0.816 . . . . 0.0 109.3 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 113' ' ' LEU . 24.9 mt -47.13 -18.92 0.1 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 109.522 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -73.41 -36.24 65.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.01 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.13 -3.18 24.87 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.708 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -141.28 -83.9 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 0.0 109.908 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -106.06 83.37 1.07 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.085 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.32 -174.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.148 1.899 . . . . 0.0 112.356 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.84 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -46.19 -55.43 7.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.557 -0.715 . . . . 0.0 109.26 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.65 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 31.7 mt-10 118.87 -7.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 4.8 t80 79.08 34.48 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.969 -0.457 . . . . 0.0 111.2 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.722 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -109.47 122.7 38.67 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.476 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.39 18.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.32 2.013 . . . . 0.0 112.925 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.722 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -146.34 -33.17 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.886 -1.134 . . . . 0.0 110.404 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.84 HG21 ' O ' ' A' ' 115' ' ' ALA . 7.2 p -51.68 -47.26 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.111 -0.993 . . . . 0.0 110.117 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.615 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.0 t-160 -59.8 -37.27 78.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.955 . . . . 0.0 109.365 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.19 -19.71 33.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.711 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 14.8 p -64.86 -62.5 1.53 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 110.625 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.497 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.6 mt -72.24 -19.77 61.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 0.0 109.978 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -82.38 -44.46 16.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.974 -1.079 . . . . 0.0 109.594 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -84.88 -41.02 16.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 109.52 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.48 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 27.8 t80 -51.72 -21.1 2.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.897 -1.127 . . . . 0.0 108.446 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 133' ' ' SER . 20.2 mt -76.6 -26.55 55.13 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -54.52 -33.46 59.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.527 ' O ' HG23 ' A' ' 135' ' ' VAL . 1.6 m -77.65 -41.74 37.25 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.05 -33.13 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.224 -0.923 . . . . 0.0 108.578 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 129' ' ' LEU . 31.3 m -77.12 -42.21 38.9 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.399 -0.813 . . . . 0.0 109.172 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 92.3 m -70.39 -26.07 63.53 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.214 -0.929 . . . . 0.0 108.557 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 131' ' ' SER . 8.4 t -77.14 -37.78 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.06 -38.48 86.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 108.834 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 m -90.39 -14.6 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 -179.945 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 8.5 t60 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.913 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -127.76 177.82 6.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.391 -0.818 . . . . 0.0 109.186 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.44 ' OG1' ' OE2' ' B' ' 7' ' ' GLU . 0.6 OUTLIER -68.65 125.32 91.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 108.983 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -42.07 -35.55 3.32 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.349 2.032 . . . . 0.0 112.537 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' B' ' 6' ' ' GLU . 14.3 mp0 -76.16 -23.89 54.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 109.7 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 0.2 OUTLIER -84.17 -39.53 19.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 109.767 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.7 ' HB3' HD13 ' B' ' 3' ' ' LEU . 22.9 pttt -83.87 -39.18 20.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 110.114 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' B' ' 8' ' ' LYS . 19.5 m -43.9 -23.33 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.865 . . . . 0.0 110.192 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -82.25 -57.06 3.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.139 -0.976 . . . . 0.0 109.997 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.09 -24.63 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 5.1 m -75.02 -45.71 39.9 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.367 0.603 . . . . 0.0 109.565 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.52 94.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.53 -0.731 . . . . 0.0 109.626 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.5 OUTLIER -48.0 -34.47 9.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -45.84 -17.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.847 . . . . 0.0 109.413 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -76.56 -43.06 20.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' B' ' 17' ' ' LYS . 1.6 mmtt -79.76 -30.55 40.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -1.191 . . . . 0.0 109.254 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -47.82 114.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.552 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' B' ' 22' ' ' GLU . 5.8 m-20 -77.84 66.13 3.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.198 -0.939 . . . . 0.0 108.998 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' B' ' 22' ' ' GLU . 73.8 t -43.81 -26.87 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 109.754 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.76 7.21 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.504 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' B' ' 20' ' ' VAL . 36.6 mt-10 -155.24 -50.25 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.563 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 69.3 t -47.03 -33.75 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.627 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.57 -50.72 59.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.39 -36.87 78.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -73.74 -38.64 64.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -1.133 . . . . 0.0 109.449 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.85 -34.05 72.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.405 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -84.99 -34.53 22.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.53 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.36 -50.36 60.16 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -58.21 -30.55 66.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -1.204 . . . . 0.0 109.425 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -50.44 -39.21 46.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.469 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -81.01 -21.97 39.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.69 -64.13 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.724 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.52 HG13 ' CD2' ' A' ' 122' ' ' HIS . 2.3 t -64.46 -22.94 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.876 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.442 ' HB3' ' HE1' ' B' ' 37' ' ' TRP . 53.9 m-85 -139.71 78.61 25.5 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.271 -0.893 . . . . 0.0 109.392 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -82.82 -17.87 6.84 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.817 2.345 . . . . 0.0 112.381 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.536 ' O ' ' NH2' ' C' ' 92' ' ' ARG . 5.2 p-90 -49.64 -19.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.5 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.514 HG23 ' CE2' ' B' ' 37' ' ' TRP . 1.4 p -92.15 -11.34 35.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.241 -0.912 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -45.05 -34.24 2.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.711 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 1.379 ' HB2' ' NE ' ' C' ' 92' ' ' ARG . 37.6 mtp85 -61.08 -26.03 67.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.478 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' B' ' 38' ' ' THR . 32.1 t80 -100.88 30.64 3.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.315 -0.866 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -146.25 31.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 109.327 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' B' ' 43' ' ' GLU . 13.8 pt-20 -79.75 -14.04 59.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.402 ' O ' ' N ' ' B' ' 46' ' ' GLY . 28.5 t -65.47 -43.85 89.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.538 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' B' ' 47' ' ' ASP . 44.8 m-85 -48.87 -18.58 0.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 48' ' ' LEU . . . 65.77 -66.56 0.12 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' B' ' 45' ' ' PHE . 79.6 m-20 -54.05 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -1.136 . . . . 0.0 109.674 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 46' ' ' GLY . 0.8 OUTLIER -164.47 21.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.115 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 56.0 m -57.97 -41.1 82.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.413 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' THR . . . . . 0.431 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.3 p -146.25 152.4 46.56 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.424 -0.797 . . . . 0.0 109.045 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -40.63 -30.04 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.402 2.068 . . . . 0.0 112.345 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -75.05 -29.2 60.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.641 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -63.9 -20.5 65.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 109.557 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.55 -24.01 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' MET . . . . . 0.413 ' O ' ' OD1' ' B' ' 57' ' ' ASN . 16.3 mmt -90.01 -6.2 55.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 109.611 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.587 ' O ' ' CB ' ' B' ' 57' ' ' ASN . . . -47.93 -35.83 13.43 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' ASN . . . . . 0.71 ' N ' ' CD ' ' B' ' 58' ' ' PRO . 21.0 m-20 91.7 23.56 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 122.245 -0.562 . . . . 0.0 111.623 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' B' ' 57' ' ' ASN . 77.4 Cg_endo -81.34 -157.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.965 1.776 . . . . 0.0 112.125 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -47.66 -24.39 0.91 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.71 -50.05 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.566 -0.709 . . . . 0.0 109.294 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' B' ' 62' ' ' ALA . 0.0 OUTLIER -79.48 -32.49 42.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.363 -0.836 . . . . 0.0 109.637 -179.521 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.416 ' N ' ' HG2' ' B' ' 61' ' ' LYS . . . -56.99 -49.72 74.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 109.565 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -59.42 -26.3 65.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.589 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.56 -19.4 74.64 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -76.04 -24.98 55.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 109.122 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -74.29 -59.29 2.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 109.568 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 40.4 t -47.0 -34.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 109.473 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.33 -42.75 96.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -0.914 . . . . 0.0 109.16 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.73 -49.82 52.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.75 -33.44 66.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -1.127 . . . . 0.0 109.51 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -76.25 -37.66 57.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -80.49 -28.13 37.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.341 -0.849 . . . . 0.0 109.436 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -51.17 -38.89 54.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.21 -60.13 7.99 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.577 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -56.83 -18.65 13.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -1.106 . . . . 0.0 109.407 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -83.22 -19.31 36.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 71.5 m-70 -159.42 62.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.11 -0.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 109.315 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' B' ' 77' ' ' HIS . 45.7 t0 -57.62 -25.87 60.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 9.1 p-10 -170.58 105.85 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.56 HD12 ' N ' ' B' ' 81' ' ' LEU . 10.2 mp -79.98 -57.26 3.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.469 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -45.79 -24.06 0.34 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -0.973 . . . . 0.0 109.61 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.76 -63.21 2.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.0 t -61.01 -47.49 86.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -1.168 . . . . 0.0 109.516 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.547 ' N ' ' CG2' ' B' ' 84' ' ' THR . 64.2 m-85 -67.86 4.77 1.04 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.747 . . . . 0.0 109.597 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.82 -46.57 78.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.544 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -75.12 -52.59 10.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.526 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 55.6 mt -50.73 -47.36 59.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' SER . . . . . 0.483 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 14.7 m -57.52 -36.26 71.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.356 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.87 -22.28 43.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.91 -18.06 26.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.972 . . . . 0.0 109.815 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' B' ' 88' ' ' LEU . 9.9 m80 -87.89 -60.76 1.88 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.916 -1.115 . . . . 0.0 110.484 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 93' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' B' ' 89' ' ' SER . 12.8 p -83.82 -59.77 2.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.955 -1.091 . . . . 0.0 111.469 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.473 ' N ' ' SG ' ' B' ' 93' ' ' CYS . 14.2 m-20 -59.2 -26.76 65.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.071 -1.018 . . . . 0.0 111.724 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 95' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 3.1 tppp? -107.51 -51.97 2.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.737 -1.227 . . . . 0.0 110.795 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.447 ' C ' ' CD2' ' B' ' 97' ' ' HIS . 5.7 mp -87.19 -30.48 20.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.926 -1.109 . . . . 0.0 109.931 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.738 ' HB3' ' CG2' ' C' ' 38' ' ' THR . 9.6 m-70 66.47 49.16 1.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.117 -0.989 . . . . 0.0 110.013 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 33.1 t -96.62 114.18 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.198 -0.939 . . . . 0.0 109.031 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 99' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' B' ' 100' ' ' PRO . 0.9 OUTLIER -62.59 153.66 76.84 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.605 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 100' ' ' PRO . . . . . 0.571 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 51.0 Cg_exo -51.98 -156.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.442 2.095 . . . . 0.0 112.452 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 52.95 46.74 26.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.522 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' B' ' 100' ' ' PRO . 72.4 m-80 -158.08 -35.74 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.526 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.0 -39.22 93.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.152 -0.968 . . . . 0.0 109.526 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -65.47 -31.24 72.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 109.658 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.582 HD12 ' N ' ' B' ' 105' ' ' LEU . 9.8 mp -62.35 -57.95 9.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.118 -0.989 . . . . 0.0 109.462 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 tt -48.23 -22.75 0.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.928 . . . . 0.0 109.605 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' B' ' 109' ' ' VAL . . . -79.29 -45.35 8.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -46.61 -16.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -1.122 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' B' ' 107' ' ' GLY . 97.6 t -85.15 -62.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.41 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 14.6 mt -47.41 -26.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.92 -47.65 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.792 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 20.2 p -79.28 -41.32 28.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.018 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 77.7 t -47.4 -41.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.747 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' B' ' 118' ' ' PHE . 46.1 mt -79.47 -40.49 29.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 109.526 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.438 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.14 -30.41 2.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.526 ' HD1' ' C ' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.64 -56.98 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.265 -0.897 . . . . 0.0 109.288 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 117' ' ' HIS . . . . . 0.411 ' C ' ' CG ' ' B' ' 118' ' ' PHE . 85.7 m-70 -63.53 -17.72 63.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 0.0 109.57 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.452 ' N ' ' O ' ' B' ' 114' ' ' LEU . 65.2 m-85 -153.29 62.35 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.938 . . . . 0.0 109.543 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' B' ' 122' ' ' PHE . . . -68.92 -50.48 34.78 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -47.86 -31.05 4.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 109.38 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -82.7 -19.07 38.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' B' ' 119' ' ' GLY . 6.3 t80 -76.09 66.61 2.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.29 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.439 ' OG1' HG23 ' B' ' 126' ' ' VAL . 1.3 p -79.14 149.8 73.53 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.276 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.508 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.5 Cg_exo -45.36 -53.58 5.3 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.466 2.111 . . . . 0.0 112.968 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 26.0 Cg_endo -62.45 1.11 1.08 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.01 1.806 . . . . 0.0 112.192 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.455 ' O ' HG12 ' B' ' 126' ' ' VAL . 87.9 t -112.45 -8.23 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.316 -0.865 . . . . 0.0 109.306 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.3 -53.97 5.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.517 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -54.69 -33.81 61.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.886 . . . . 0.0 109.537 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.2 2.6 17.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.675 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.17 -29.6 13.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.218 -0.926 . . . . 0.0 109.374 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 131' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 88.9 mm-40 -84.4 -23.3 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 109.916 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 132' ' ' LYS . . . . . 0.723 ' HG3' ' HB3' ' D' ' 146' ' ' HIS . 14.4 ttmt -85.56 -36.08 20.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.13 -0.981 . . . . 0.0 110.121 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 133' ' ' VAL . . . . . 0.737 HG13 ' N ' ' B' ' 134' ' ' VAL . 11.8 p -65.38 -58.91 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.081 -1.012 . . . . 0.0 110.037 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.737 ' N ' HG13 ' B' ' 133' ' ' VAL . 11.3 t -62.1 -33.43 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.02 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -45.89 -21.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 0.0 109.684 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 136' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 134' ' ' VAL . . . -82.7 -26.83 44.59 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' B' ' 134' ' ' VAL . 97.7 t -78.88 -21.2 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -1.133 . . . . 0.0 109.585 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.02 -38.37 32.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.629 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.8 -21.09 30.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.785 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.21 -48.46 70.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.115 -0.991 . . . . 0.0 109.713 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' B' ' 92' ' ' HIS . 28.4 mt -58.26 -22.04 50.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.574 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 142' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' B' ' 145' ' ' TYR . . . -89.71 26.1 1.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 143' ' ' HIS . . . . . 0.431 ' O ' ' CD2' ' B' ' 143' ' ' HIS . 11.0 t-160 -80.53 -6.98 59.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.962 . . . . 0.0 109.13 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' B' ' 146' ' ' HIS . 11.6 mptt -122.14 -27.84 4.47 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.52 -0.737 . . . . 0.0 109.696 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 145' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 142' ' ' ALA . 0.1 OUTLIER -50.26 -7.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -0.993 . . . . 0.0 110.034 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.72 ' HB3' ' HG3' ' D' ' 132' ' ' LYS . 12.0 m-70 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.736 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 1' ' ' VAL . . . . . 0.426 ' C ' HD22 ' C' ' 2' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.289 0.566 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 2' ' ' LEU . . . . . 0.575 ' N ' HD22 ' C' ' 2' ' ' LEU . 3.9 mm? -94.95 -169.37 1.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.213 -0.929 . . . . 0.0 109.691 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.452 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.1 OUTLIER -116.13 179.55 0.78 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.491 -0.756 . . . . 0.0 109.233 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 21.8 Cg_exo -62.85 -69.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.69 2.26 . . . . 0.0 112.781 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -83.13 -16.69 45.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.931 . . . . 0.0 110.308 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.561 ' OD2' HD12 ' C' ' 2' ' ' LEU . 7.8 t70 -40.05 -41.18 1.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.955 . . . . 0.0 109.773 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' C' ' 10' ' ' VAL . 68.7 mttt -69.45 -56.04 8.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 53.5 m -45.04 -30.75 1.12 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.32 -0.863 . . . . 0.0 109.707 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -78.39 -36.41 45.92 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' C' ' 7' ' ' LYS . 49.2 t -72.01 -48.93 47.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -53.02 -44.45 67.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 108.783 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.77 -57.34 12.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.361 -0.837 . . . . 0.0 109.338 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.625 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -56.45 -36.27 68.85 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.377 -0.827 . . . . 0.0 109.24 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.79 -17.2 60.66 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.278 -0.889 . . . . 0.0 109.029 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.83 -41.98 21.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 16' ' ' LYS . . . . . 0.42 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 12.9 mmmt -71.43 -42.08 68.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -1.153 . . . . 0.0 108.837 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.625 HG23 ' O ' ' C' ' 13' ' ' ALA . 61.5 t -60.71 -63.79 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 47.8 -127.32 14.62 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 24.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.414 -1.05 . . . . 0.0 110.447 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.539 ' H ' ' C ' ' C' ' 18' ' ' GLY . 88.3 m-70 -128.85 22.05 5.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.905 . . . . 0.0 108.612 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.46 ' C ' ' N ' ' C' ' 23' ' ' GLU . . . -88.75 -55.85 3.53 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.585 -0.697 . . . . 0.0 109.464 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.59 -14.4 0.64 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.46 ' N ' ' C ' ' C' ' 21' ' ' ALA . 12.8 mm-40 -87.48 -56.56 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -1.079 . . . . 0.0 109.714 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.9 m-30 -60.78 -22.9 64.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.2 -23.49 63.22 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.96 -40.1 22.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -1.128 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -69.35 -19.59 63.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.284 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -20.39 57.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.684 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mt -78.3 -46.84 19.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 109.752 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -58.04 -38.1 75.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.74 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -63.2 -39.19 93.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 109.526 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 50.9 ttp -64.52 -50.54 66.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.196 -0.94 . . . . 0.0 109.176 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 33' ' ' PHE . . . . . 0.469 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 1.8 t80 -43.95 -33.99 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.682 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.774 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.4 mt -85.0 -39.87 17.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.793 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 74.5 m -53.44 -38.44 63.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.96 . . . . 0.0 109.749 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' C' ' 35' ' ' SER . 30.8 m-85 -164.22 87.12 1.15 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.877 . . . . 0.0 109.521 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' C' ' 39' ' ' THR . 76.6 Cg_exo -48.21 -19.92 2.0 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.551 2.167 . . . . 0.0 112.135 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.738 ' CG2' ' HB3' ' B' ' 97' ' ' HIS . 9.0 p -46.84 -18.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.889 . . . . 0.0 109.757 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.444 ' N ' ' O ' ' C' ' 37' ' ' PRO . 53.2 p -80.91 -63.1 1.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.981 . . . . 0.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' C' ' 41' ' ' THR . 8.6 mmpt? -59.05 -18.59 36.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.165 -0.96 . . . . 0.0 109.935 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.532 HG22 ' O ' ' C' ' 38' ' ' THR . 5.8 t . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.144 -0.972 . . . . 0.0 109.828 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.626 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.488 0.661 . . . . 0.0 109.648 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.778 ' O ' ' N ' ' C' ' 48' ' ' LEU . 3.3 m-85 -82.87 14.33 3.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.399 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' C' ' 49' ' ' SER . 4.6 m-20 60.39 -51.33 0.09 Allowed 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.778 ' N ' ' O ' ' C' ' 46' ' ' PHE . 19.4 mt 41.53 20.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.661 -0.649 . . . . 0.0 110.004 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.538 ' N ' ' O ' ' C' ' 47' ' ' ASP . 6.2 m -93.35 42.27 1.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 50' ' ' HIS . . . . . 0.49 ' CG ' ' C ' ' C' ' 49' ' ' SER . 1.4 m-70 71.98 129.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.516 -0.74 . . . . 0.0 109.295 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.42 29.4 73.24 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.65 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 8.1 p -52.34 -36.7 54.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -1.111 . . . . 0.0 109.595 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 73.26 -64.41 0.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.862 . . . . 0.0 109.549 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' C' ' 53' ' ' ALA . 18.9 mt-30 -43.57 -35.78 1.85 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.0 109.482 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -55.35 -28.15 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.433 -0.792 . . . . 0.0 109.986 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' C' ' 57' ' ' GLY . 2.5 ptpt -61.47 -38.97 89.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.031 -1.043 . . . . 0.0 109.461 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 57' ' ' GLY . . . . . 0.434 ' N ' ' CG ' ' C' ' 56' ' ' LYS . . . -52.41 -35.75 44.73 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 8.7 t-80 -76.65 -27.84 55.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -1.165 . . . . 0.0 109.922 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.61 -37.27 94.18 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -62.64 -24.3 67.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -1.153 . . . . 0.0 110.362 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 61' ' ' LYS . . . . . 0.501 ' H ' ' HD2' ' C' ' 61' ' ' LYS . 0.2 OUTLIER -65.04 -58.78 5.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.011 -1.056 . . . . 0.0 109.319 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.422 ' H ' HG23 ' C' ' 62' ' ' VAL . 11.6 t -54.02 -43.85 60.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.434 -0.791 . . . . 0.0 109.246 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.7 -46.9 62.26 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 108.921 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -64.44 -34.51 78.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 108.655 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.06 -50.31 62.26 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -55.75 -44.6 77.77 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 108.704 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.421 ' O ' ' N ' ' C' ' 71' ' ' ALA . 19.2 m -65.43 -54.22 31.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -0.847 . . . . 0.0 108.794 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -55.9 -27.39 51.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.46 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -81.02 -47.78 13.13 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.26 -22.69 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -70.36 -13.04 61.98 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' C' ' 74' ' ' ASP . 51.2 m-70 -136.31 -67.12 0.52 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.548 -0.72 . . . . 0.0 109.206 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.554 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.2 p 44.64 14.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.946 0.879 . . . . 0.0 109.37 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' C' ' 72' ' ' HIS . 35.2 m-20 -139.26 12.52 2.59 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 1.1 m-20 172.72 30.92 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.688 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 6.9 ptt? -78.29 -22.87 0.4 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.174 -0.954 . . . . 0.0 111.889 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.4 Cg_exo -53.82 -20.69 18.17 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.596 1.531 . . . . 0.0 112.405 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -94.15 -35.55 12.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.825 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.04 -46.91 61.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.157 -0.965 . . . . 0.0 109.303 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 11.7 mt -80.21 8.17 7.9 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.387 -0.821 . . . . 0.0 109.047 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 45.0 p -56.01 -21.87 23.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 109.797 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -70.88 -53.82 13.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.746 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' C' ' 83' ' ' LEU . 6.0 mt -44.82 -46.93 10.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -50.24 -39.62 45.24 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' C' ' 82' ' ' ALA . 28.7 t70 -82.79 -17.39 44.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.807 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.74 ' C ' HD13 ' C' ' 86' ' ' LEU . 3.3 tm? -71.4 -58.16 3.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 110.426 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -83.12 -21.79 33.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.956 -1.09 . . . . 0.0 110.697 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.11 -79.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 109.72 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.18 -59.53 5.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.491 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' C' ' 86' ' ' LEU . 41.2 mttm -87.99 135.77 33.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.6 ' C ' ' H ' ' C' ' 93' ' ' VAL . 14.9 mt 61.09 66.44 0.89 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.141 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 92' ' ' ARG . . . . . 1.379 ' NE ' ' HB2' ' B' ' 40' ' ' ARG . 38.9 ttt-85 -66.34 18.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.6 ' H ' ' C ' ' C' ' 91' ' ' LEU . 11.8 p -42.57 129.55 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 109.709 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.86 148.81 75.36 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.213 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' C' ' 97' ' ' ASN . 37.6 Cg_endo -67.57 -10.95 30.46 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.48 2.12 . . . . 0.0 112.059 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -44.56 -19.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.358 -0.839 . . . . 0.0 109.669 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 97' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' C' ' 95' ' ' PRO . 17.7 m120 -79.1 -24.71 43.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.653 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 98' ' ' PHE . . . . . 0.541 ' CG ' ' N ' ' C' ' 99' ' ' LYS . 0.1 OUTLIER -53.75 -44.96 70.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.426 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.541 ' N ' ' CG ' ' C' ' 98' ' ' PHE . 65.3 mttm -49.33 -41.05 37.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.5 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 12.4 mt -71.61 -43.16 66.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 101' ' ' LEU . . . . . 0.542 HD23 ' C ' ' C' ' 101' ' ' LEU . 3.6 tt -58.0 -57.03 14.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.341 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 84.3 p -61.87 -34.95 76.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 109.69 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -77.65 -26.62 50.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 55.3 m -69.84 -41.45 74.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 0.0 109.64 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mt -52.33 -50.19 62.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.962 . . . . 0.0 109.324 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.54 HD22 ' N ' ' C' ' 106' ' ' LEU . 3.8 mm? -58.87 -59.11 5.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.635 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 107' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 65.0 t -51.73 -49.64 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.197 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.44 ' O ' ' N ' ' C' ' 110' ' ' ALA . 17.6 m -62.06 -60.35 3.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.29 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' C' ' 113' ' ' LEU . 25.5 mt -47.18 -18.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.872 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -73.46 -36.14 65.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 110.069 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.11 -3.27 25.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.747 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -141.2 -83.95 0.21 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 109.904 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' C' ' 113' ' ' LEU . 0.3 OUTLIER -106.0 83.35 1.05 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.068 -179.629 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.28 -174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.087 1.858 . . . . 0.0 112.399 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.828 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -46.18 -55.51 6.99 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.558 -0.714 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.653 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 31.7 mt-10 118.93 -6.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.489 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 4.8 t80 79.01 34.54 0.21 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.968 -0.458 . . . . 0.0 111.228 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.732 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -109.52 122.7 38.63 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.04 . . . . 0.0 108.271 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.36 18.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.3 2.0 . . . . 0.0 112.915 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -146.32 -33.22 0.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.89 -1.131 . . . . 0.0 110.403 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.828 HG21 ' O ' ' C' ' 115' ' ' ALA . 7.2 p -51.66 -47.13 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 110.177 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.625 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.0 t-80 -59.8 -37.32 78.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.357 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.25 -19.72 33.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.646 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 14.8 p -64.79 -62.54 1.5 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 110.593 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.517 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.6 mt -72.34 -19.73 61.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.11 -0.993 . . . . 0.0 109.932 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.26 -44.5 16.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.981 -1.075 . . . . 0.0 109.64 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -84.94 -41.03 16.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.13 -0.981 . . . . 0.0 109.567 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.483 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 28.0 t80 -51.67 -21.01 2.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.937 -1.102 . . . . 0.0 108.559 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' C' ' 133' ' ' SER . 20.3 mt -76.66 -26.5 54.89 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -54.55 -33.41 60.09 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.54 ' OG ' HD21 ' C' ' 2' ' ' LEU . 1.6 m -77.57 -41.87 37.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 4.9 t -75.03 -33.14 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 133' ' ' SER . . . . . 0.513 ' N ' ' O ' ' C' ' 129' ' ' LEU . 31.5 m -77.11 -42.21 38.96 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.485 -0.759 . . . . 0.0 109.146 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 92.2 m -70.26 -26.1 63.66 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.174 -0.954 . . . . 0.0 108.569 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.538 HG23 ' O ' ' C' ' 131' ' ' SER . 8.6 t -77.17 -37.84 26.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.17 -38.45 86.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 108.846 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 24.9 m -90.34 -14.57 32.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.239 -0.913 . . . . 0.0 109.477 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.461 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 t60 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.904 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -127.74 177.74 6.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.343 -0.848 . . . . 0.0 109.138 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' D' ' 7' ' ' GLU . 0.6 OUTLIER -68.65 125.3 91.64 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.044 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -42.11 -35.47 3.32 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.325 2.017 . . . . 0.0 112.488 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 6' ' ' GLU . . . . . 0.453 ' N ' ' CD ' ' D' ' 6' ' ' GLU . 14.2 mp0 -76.2 -23.93 54.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 109.731 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 7' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' D' ' 7' ' ' GLU . 0.2 OUTLIER -84.09 -39.6 19.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.797 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.678 ' HB3' HD13 ' D' ' 3' ' ' LEU . 22.9 pttt -83.78 -39.27 20.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.0 110.074 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 9' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 19.7 m -43.78 -23.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 110.163 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -82.25 -57.05 3.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.114 -0.991 . . . . 0.0 109.979 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.08 -24.73 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 5.0 m -74.9 -45.83 40.06 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.387 0.613 . . . . 0.0 109.597 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.51 94.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.427 -0.796 . . . . 0.0 109.688 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.5 OUTLIER -48.06 -34.49 9.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.368 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -45.77 -17.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.827 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 16' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -76.44 -43.11 20.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' D' ' 17' ' ' LYS . 1.5 mmtt -79.72 -30.6 40.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.127 -1.219 . . . . 0.0 109.247 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -47.86 114.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 109.569 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' D' ' 22' ' ' GLU . 5.8 m-20 -77.87 66.04 3.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 108.988 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' D' ' 22' ' ' GLU . 73.7 t -43.66 -26.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.446 -0.784 . . . . 0.0 109.786 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.72 7.22 0.92 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' D' ' 19' ' ' ASN . 36.6 mt-10 -155.28 -50.25 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.567 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 69.7 t -46.98 -33.86 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.47 -50.78 59.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.35 -36.81 79.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -73.68 -38.76 64.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -1.158 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.82 -34.07 72.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 109.436 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -84.94 -34.56 22.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.45 -50.2 60.81 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -58.22 -30.6 66.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -1.117 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -50.41 -39.17 46.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.967 . . . . 0.0 109.499 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 mt -81.03 -22.0 39.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.163 -0.961 . . . . 0.0 109.597 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 21.1 t -82.7 -64.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.772 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.485 HG22 ' CG ' ' C' ' 122' ' ' HIS . 2.3 t -64.57 -22.9 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.875 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 35' ' ' TYR . . . . . 0.43 ' HB3' ' HE1' ' D' ' 37' ' ' TRP . 53.7 m-85 -139.77 78.63 25.16 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.285 -0.884 . . . . 0.0 109.399 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.81 -17.81 6.9 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.814 2.342 . . . . 0.0 112.417 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 37' ' ' TRP . . . . . 0.57 ' O ' ' NH2' ' A' ' 92' ' ' ARG . 5.2 p-90 -49.7 -19.89 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.514 HG23 ' CE2' ' D' ' 37' ' ' TRP . 1.4 p -92.1 -11.39 35.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.264 -0.897 . . . . 0.0 109.332 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -45.03 -34.17 2.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.337 -0.852 . . . . 0.0 109.736 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 40' ' ' ARG . . . . . 1.453 ' HB2' ' NE ' ' A' ' 92' ' ' ARG . 37.7 mtp85 -61.12 -26.08 67.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.441 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 41' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' D' ' 38' ' ' THR . 32.3 t80 -100.85 30.75 3.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -0.865 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -146.26 31.24 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 109.343 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.75 -14.08 58.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 44' ' ' SER . . . . . 0.406 ' C ' ' N ' ' D' ' 46' ' ' GLY . 28.5 t -65.52 -43.79 88.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.541 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.501 ' O ' ' N ' ' D' ' 47' ' ' ASP . 44.5 m-85 -48.99 -18.49 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.425 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' D' ' 48' ' ' LEU . . . 65.82 -66.58 0.12 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' D' ' 45' ' ' PHE . 79.6 m-20 -54.07 86.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -1.123 . . . . 0.0 109.632 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 48' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' D' ' 46' ' ' GLY . 0.8 OUTLIER -164.46 21.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.167 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.0 m -57.98 -41.04 82.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.419 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 50' ' ' THR . . . . . 0.434 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.3 p -146.28 152.29 46.16 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.0 109.092 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -40.49 -30.12 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.449 2.1 . . . . 0.0 112.361 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -75.13 -29.14 60.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.615 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 53' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -63.93 -20.39 65.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.63 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.58 -24.04 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 55' ' ' MET . . . . . 0.418 ' O ' ' OD1' ' D' ' 57' ' ' ASN . 16.3 mmt -90.0 -6.14 55.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.605 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.602 ' O ' ' CB ' ' D' ' 57' ' ' ASN . . . -47.94 -35.82 13.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 57' ' ' ASN . . . . . 0.725 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 21.3 m-20 91.7 23.55 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 122.137 -0.625 . . . . 0.0 111.568 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' D' ' 57' ' ' ASN . 75.3 Cg_endo -81.36 -157.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.948 1.765 . . . . 0.0 112.122 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -47.61 -24.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 60' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 58' ' ' PRO . 54.7 t -51.56 -50.18 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.494 -0.754 . . . . 0.0 109.279 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 61' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' D' ' 62' ' ' ALA . 0.0 OUTLIER -79.37 -32.62 43.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.38 -0.825 . . . . 0.0 109.631 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 62' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' D' ' 61' ' ' LYS . . . -57.02 -49.74 74.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.979 . . . . 0.0 109.532 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -59.42 -26.28 65.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 109.557 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.47 -19.46 74.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -76.09 -24.91 55.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -1.176 . . . . 0.0 109.082 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -74.36 -59.18 2.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.84 . . . . 0.0 109.564 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -47.15 -34.16 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.465 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.47 -42.61 95.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.142 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.71 -49.92 51.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.7 -33.5 66.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -1.144 . . . . 0.0 109.52 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -76.2 -37.66 57.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -80.42 -28.28 37.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 109.385 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -51.11 -38.86 54.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.915 . . . . 0.0 109.415 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.22 -60.15 7.96 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.599 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.9 mp -56.87 -18.63 13.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -1.131 . . . . 0.0 109.345 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 76' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -83.22 -19.32 36.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.883 . . . . 0.0 109.615 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 72.0 m-70 -159.37 62.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.689 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.1 -0.43 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.945 . . . . 0.0 109.409 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' D' ' 77' ' ' HIS . 45.8 t0 -57.66 -25.85 60.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.503 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 80' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' D' ' 80' ' ' ASN . 9.0 p-10 -170.64 105.9 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 81' ' ' LEU . . . . . 0.548 HD12 ' N ' ' D' ' 81' ' ' LEU . 10.2 mp -79.97 -57.3 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -45.83 -23.97 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 109.566 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.82 -63.27 2.75 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.0 t -61.02 -47.46 86.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -1.181 . . . . 0.0 109.557 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 64.4 m-85 -67.82 4.68 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.574 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 86' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.68 -46.68 77.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.544 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -75.08 -52.46 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.522 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 55.6 mt -50.74 -47.46 59.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 89' ' ' SER . . . . . 0.5 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 14.7 m -57.5 -36.19 71.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -79.88 -22.25 43.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.98 -18.01 26.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.766 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' D' ' 88' ' ' LEU . 10.0 m80 -87.88 -60.67 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.96 -1.088 . . . . 0.0 110.486 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 93' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' D' ' 89' ' ' SER . 12.5 p -83.94 -59.78 2.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.969 -1.082 . . . . 0.0 111.438 -178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.477 ' N ' ' SG ' ' D' ' 93' ' ' CYS . 14.2 m-20 -59.14 -26.76 65.02 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.095 -1.003 . . . . 0.0 111.709 -177.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 95' ' ' LYS . . . . . 0.526 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 3.2 tppp? -107.55 -51.93 2.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.658 -1.276 . . . . 0.0 110.796 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.451 ' C ' ' CD2' ' D' ' 97' ' ' HIS . 5.7 mp -87.22 -30.55 20.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.915 -1.115 . . . . 0.0 109.918 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.818 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 9.6 m-70 66.47 49.19 1.41 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.16 -0.962 . . . . 0.0 110.039 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 33.0 t -96.63 114.2 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.27 -0.894 . . . . 0.0 108.987 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 99' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' D' ' 100' ' ' PRO . 0.9 OUTLIER -62.65 153.59 77.63 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.553 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 100' ' ' PRO . . . . . 0.576 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 50.6 Cg_exo -51.86 -156.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.504 2.136 . . . . 0.0 112.409 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 52.93 46.66 26.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.578 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 102' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' D' ' 100' ' ' PRO . 72.4 m-80 -158.03 -35.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -65.0 -39.16 93.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.494 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -65.55 -31.2 72.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 109.666 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 105' ' ' LEU . . . . . 0.575 ' N ' HD12 ' D' ' 105' ' ' LEU . 9.8 mp -62.4 -57.98 9.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.437 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 tt -48.2 -22.73 0.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.627 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 107' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' D' ' 109' ' ' VAL . . . -79.3 -45.51 8.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -46.53 -16.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -1.176 . . . . 0.0 109.623 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 109' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' D' ' 107' ' ' GLY . 98.2 t -85.07 -62.62 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.503 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 14.7 mt -47.39 -26.18 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.661 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 70.8 t -68.96 -47.52 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.084 -1.01 . . . . 0.0 109.906 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 20.0 p -79.41 -41.22 28.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.138 -0.976 . . . . 0.0 110.037 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 78.2 t -47.57 -41.07 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.721 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 114' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' D' ' 118' ' ' PHE . 46.6 mt -79.52 -40.37 29.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.567 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.429 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.2 -30.38 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.399 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.535 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -84.75 -56.96 3.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 109.235 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 117' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 85.8 m-70 -63.48 -17.66 62.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.574 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.418 ' N ' ' O ' ' D' ' 114' ' ' LEU . 65.6 m-85 -153.33 62.32 0.76 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 109.544 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' D' ' 122' ' ' PHE . . . -68.84 -50.51 35.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -47.95 -30.93 4.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.191 . . . . 0.0 109.404 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -82.81 -18.98 38.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.557 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 122' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' D' ' 119' ' ' GLY . 6.3 t80 -76.17 66.6 2.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.129 -0.982 . . . . 0.0 109.293 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.429 ' OG1' HG23 ' D' ' 126' ' ' VAL . 1.3 p -79.1 149.68 73.51 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.288 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.508 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -45.3 -53.6 5.24 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.488 2.125 . . . . 0.0 112.972 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 25.7 Cg_endo -62.52 1.18 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.012 1.808 . . . . 0.0 112.21 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.453 ' O ' HG12 ' D' ' 126' ' ' VAL . 86.9 t -112.44 -8.31 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.21 -54.08 5.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 109.556 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.774 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -54.62 -33.84 61.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.14 2.52 17.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.21 -29.5 13.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 109.444 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 131' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 88.7 mm-40 -84.34 -23.49 30.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 109.901 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 132' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' B' ' 146' ' ' HIS . 14.4 ttmt -85.46 -36.06 20.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.141 -0.974 . . . . 0.0 110.183 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 133' ' ' VAL . . . . . 0.758 HG13 ' N ' ' D' ' 134' ' ' VAL . 11.9 p -65.44 -58.78 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.094 -1.004 . . . . 0.0 110.041 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.758 ' N ' HG13 ' D' ' 133' ' ' VAL . 11.5 t -62.23 -33.38 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 0.0 109.959 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -45.92 -21.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 0.0 109.743 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 136' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -82.79 -26.75 44.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 137' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' D' ' 134' ' ' VAL . 97.5 t -78.89 -21.15 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -1.148 . . . . 0.0 109.644 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.11 -38.3 31.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 109.644 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -84.66 -21.21 30.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.755 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.26 -48.44 70.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 0.0 109.697 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 141' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' D' ' 92' ' ' HIS . 28.3 mt -58.15 -22.08 49.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 142' ' ' ALA . . . . . 0.533 ' O ' ' CD1' ' D' ' 145' ' ' TYR . . . -89.65 26.07 1.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 0.0 109.568 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 143' ' ' HIS . . . . . 0.431 ' CD2' ' O ' ' D' ' 143' ' ' HIS . 11.0 t-160 -80.53 -6.91 58.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.108 -0.995 . . . . 0.0 109.128 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' D' ' 146' ' ' HIS . 11.6 mptt -122.15 -27.96 4.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.457 -0.777 . . . . 0.0 109.671 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 145' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' D' ' 142' ' ' ALA . 0.1 OUTLIER -50.21 -7.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 110.066 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.723 ' HB3' ' HG3' ' B' ' 132' ' ' LYS . 12.0 m-70 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.669 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.28 -169.92 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -0.907 . . . . 0.0 109.903 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.594 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -100.01 -179.2 0.78 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.35 -0.844 . . . . 0.0 109.566 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 23.0 Cg_exo -62.83 -58.51 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.893 2.395 . . . . 0.0 113.049 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -78.65 -16.44 57.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.03 -1.044 . . . . 0.0 110.204 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.594 ' CG ' ' H ' ' A' ' 3' ' ' SER . 33.5 m-20 -39.79 -30.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 0.0 109.72 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.638 ' H ' ' CD ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -83.7 -39.47 20.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.531 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' ALA . 37.2 m -44.82 -42.87 8.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.461 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -71.24 -25.33 62.44 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.578 ' N ' ' O ' ' A' ' 7' ' ' LYS . 53.2 t -78.82 -55.19 10.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -53.48 -37.19 62.47 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.459 -1.296 . . . . 0.0 107.875 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.78 -63.18 1.22 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.238 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.787 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -60.24 -36.17 77.15 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -0.843 . . . . 0.0 108.768 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -17.51 62.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 109.088 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -78.79 -46.43 8.54 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 13.2 mmmt -70.14 -36.62 74.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -1.098 . . . . 0.0 108.817 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 13' ' ' ALA . 95.4 t -60.65 -65.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 58.71 -134.9 52.32 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.41 27.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.429 -1.042 . . . . 0.0 110.437 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.541 ' H ' ' C ' ' A' ' 18' ' ' GLY . 92.4 m-70 -131.58 25.68 4.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.199 -0.938 . . . . 0.0 108.481 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.57 -61.66 1.66 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.613 -0.679 . . . . 0.0 109.754 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.68 -14.38 0.23 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 1.2 mm-40 -84.33 -56.33 3.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -1.091 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.605 ' CE1' ' CG ' ' A' ' 112' ' ' HIS . 2.8 m-30 -60.64 -27.78 68.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.458 -0.776 . . . . 0.0 109.172 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.82 -22.92 75.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.2 18.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -1.138 . . . . 0.0 109.795 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -64.29 -19.88 65.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 109.511 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.11 -19.68 60.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 109.313 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.491 HD11 ' ND1' ' A' ' 58' ' ' HIS . 12.8 mt -78.43 -54.1 6.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 109.6 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.26 -37.6 64.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.447 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -43.87 98.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 53.5 ttp -67.26 -49.92 62.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.425 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -51.54 -46.32 63.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 12.8 mt -64.09 -60.21 3.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 109.793 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 18.8 p -55.46 -18.98 8.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.646 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 35' ' ' SER . 79.6 m-85 -156.05 113.36 2.13 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 39' ' ' THR . 73.0 Cg_endo -79.56 -20.14 9.62 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.32 2.013 . . . . 0.0 111.945 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.85 ' O ' HG22 ' A' ' 41' ' ' THR . 41.0 p -47.12 -18.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.373 -0.829 . . . . 0.0 109.735 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 37' ' ' PRO . 42.6 p -74.68 -22.72 58.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 109.876 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -70.13 -20.05 63.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.0 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.85 HG22 ' O ' ' A' ' 38' ' ' THR . 12.2 t . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.818 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.574 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 15.1 p80 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 120.984 0.421 . . . . 0.0 111.297 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 47' ' ' ASP . 4.9 p90 -145.42 23.2 1.47 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.891 -1.131 . . . . 0.0 109.526 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' SER . 57.2 m-20 42.52 84.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.551 -0.718 . . . . 0.0 109.829 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.62 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -50.22 -11.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 47' ' ' ASP . 14.7 m -58.88 147.36 34.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.383 -0.823 . . . . 0.0 109.491 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -64.54 148.46 50.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.596 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.03 83.81 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 5.4 p -69.07 -23.72 64.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -1.221 . . . . 0.0 109.337 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.57 -56.15 0.46 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.837 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 52' ' ' SER . 43.1 mt-30 -43.89 -22.44 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.356 -0.84 . . . . 0.0 109.812 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 53' ' ' ALA . 41.0 t -74.35 -26.74 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.32 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.7 ptmt -65.7 -27.41 68.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.87 . . . . 0.0 109.552 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.08 -50.44 40.12 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.491 ' ND1' HD11 ' A' ' 29' ' ' LEU . 20.4 t-80 -53.85 -32.42 52.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -1.156 . . . . 0.0 109.476 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.22 -47.27 91.92 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -58.35 -23.43 56.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -1.081 . . . . 0.0 109.592 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.29 -39.49 62.9 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.228 -0.92 . . . . 0.0 108.88 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.7 -49.07 48.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.97 71.17 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.299 -0.876 . . . . 0.0 109.052 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -67.18 -38.73 85.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.299 -0.876 . . . . 0.0 108.759 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -64.07 -52.1 60.96 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -57.24 -44.6 83.98 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.243 -0.91 . . . . 0.0 108.731 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.4 m -68.74 -50.65 48.97 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -60.36 -24.28 64.95 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.96 -45.64 12.0 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.65 -23.38 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.66 -18.7 64.23 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.7 m80 -144.08 -58.89 0.39 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.404 -0.81 . . . . 0.0 109.339 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.3 p 44.19 13.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 121.879 0.847 . . . . 0.0 109.561 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.612 ' N ' ' O ' ' A' ' 72' ' ' HIS . 46.0 t0 -133.8 11.08 3.99 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.408 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.9 p-10 179.03 29.39 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.973 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.695 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 17.4 ptt? -78.62 -22.61 0.39 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.426 -0.796 . . . . 0.0 111.805 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.695 ' CD ' ' N ' ' A' ' 76' ' ' MET . 52.4 Cg_exo -54.12 -22.27 24.84 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.497 1.465 . . . . 0.0 112.347 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -94.16 -33.86 13.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.8 59.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.146 -0.971 . . . . 0.0 109.353 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.36 8.5 7.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.372 -0.83 . . . . 0.0 109.123 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.0 p -55.89 -17.11 5.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.929 . . . . 0.0 109.666 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.09 -55.97 4.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.454 ' N ' HD23 ' A' ' 83' ' ' LEU . 3.5 mt -45.4 -44.02 11.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 108.935 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 136' ' ' LEU . 29.7 t -57.23 -22.63 42.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.503 -0.748 . . . . 0.0 109.448 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 89' ' ' HIS . 23.1 t70 -82.01 -58.3 3.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.854 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.63 -27.45 17.17 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.757 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.448 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 38.6 m80 -91.84 -21.76 20.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.858 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.47 -11.35 15.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.214 -0.929 . . . . 0.0 109.902 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.581 ' N ' ' O ' ' A' ' 85' ' ' ASP . 14.4 m80 -113.94 -77.81 0.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 89' ' ' HIS . 9.9 mptt -45.79 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.481 ' C ' ' N ' ' A' ' 93' ' ' VAL . 19.6 mt -65.69 -17.33 64.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.838 . . . . 0.0 110.16 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.518 ' NH1' ' OE2' ' D' ' 43' ' ' GLU . 25.0 ttm180 48.93 15.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 109.003 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.481 ' N ' ' C ' ' A' ' 91' ' ' LEU . 10.8 p -46.01 156.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.0 109.878 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 93' ' ' VAL . 3.5 m-20 -100.23 153.03 37.98 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.39 -0.818 . . . . 0.0 109.046 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 98' ' ' PHE . 32.7 Cg_endo -65.79 -10.64 27.48 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.539 2.159 . . . . 0.0 111.954 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 95' ' ' PRO . 83.4 t -44.05 -29.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.343 -0.848 . . . . 0.0 109.767 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -79.32 -32.92 43.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.577 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -50.18 -34.9 24.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.347 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -49.99 -34.91 22.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.8 mt -82.12 -50.52 8.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.1 tp -45.77 -20.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.627 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' LEU . 93.3 p -73.3 -59.33 2.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 109.945 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.72 ' CD2' ' OD1' ' B' ' 108' ' ' ASN . 92.4 m-70 -71.81 -26.48 62.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.922 . . . . 0.0 109.769 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 62.4 m -58.11 -42.23 85.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.89 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.64 -22.74 62.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.186 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.594 ' N ' HD22 ' A' ' 106' ' ' LEU . 3.7 mm? -79.01 -35.96 41.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.0 -1.062 . . . . 0.0 110.137 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 45.3 t -62.89 -39.46 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.058 -1.026 . . . . 0.0 109.499 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.486 ' OG1' ' N ' ' A' ' 109' ' ' LEU . 12.2 p -65.23 -62.97 1.22 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.176 -0.952 . . . . 0.0 109.644 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.486 ' N ' ' OG1' ' A' ' 108' ' ' THR . 14.7 mt -48.2 -22.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -63.35 -36.47 83.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 109.896 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.16 -42.59 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.158 -0.964 . . . . 0.0 109.893 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.605 ' CG ' ' CE1' ' A' ' 24' ' ' TYR . 62.7 m80 -81.8 -75.36 0.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.011 . . . . 0.0 109.519 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 113' ' ' LEU . 1.5 pp -137.14 94.44 12.48 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.19 -171.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.248 1.965 . . . . 0.0 112.931 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.524 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -47.23 -38.55 12.44 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.52 0.676 . . . . 0.0 109.539 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 6.7 mt-10 85.37 9.52 0.33 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.805 ' CE1' ' NE2' ' B' ' 116' ' ' HIS . 6.9 m-85 65.04 34.86 8.48 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.83 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.713 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -94.42 121.3 63.76 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.745 -1.222 . . . . 0.0 107.971 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -51.31 23.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.039 1.826 . . . . 0.0 112.914 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -154.97 -30.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.778 -1.201 . . . . 0.0 110.851 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.731 HG13 ' N ' ' A' ' 122' ' ' HIS . 11.8 p -47.83 -50.38 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.086 -1.008 . . . . 0.0 110.375 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.731 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.4 t-80 -65.38 -43.5 90.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.453 -0.779 . . . . 0.0 109.999 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' B' ' 34' ' ' VAL . . . -79.07 -19.36 51.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.243 -0.911 . . . . 0.0 109.921 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 120' ' ' ALA . 64.3 m -72.45 -63.95 1.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 111.08 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.01 -18.25 64.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.947 -1.096 . . . . 0.0 109.48 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.26 -49.41 10.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.961 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.83 -57.77 2.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.906 -1.122 . . . . 0.0 111.441 -178.244 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.456 ' CD2' ' HA ' ' A' ' 124' ' ' SER . 21.9 m-85 -46.55 -21.53 0.19 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.776 -1.202 . . . . 0.0 110.239 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.768 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -66.58 -18.87 65.6 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 134' ' ' THR . . . -55.96 -33.21 64.55 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.489 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 7.9 t -66.77 -36.73 83.11 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.217 -0.927 . . . . 0.0 108.762 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.504 ' O ' HD13 ' A' ' 136' ' ' LEU . 1.8 t -78.34 -40.0 24.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.8 t -73.41 -37.8 65.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.324 -0.86 . . . . 0.0 108.905 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 130' ' ' ALA . 88.9 m -71.55 -31.08 66.62 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.234 -0.916 . . . . 0.0 108.555 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 131' ' ' SER . 2.9 t -70.44 -36.58 67.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 132' ' ' VAL . 3.3 mp -56.71 -32.93 65.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 109.008 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.9 m -89.34 -27.25 20.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.59 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.528 -179.927 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.904 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -86.47 178.11 7.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.188 -0.945 . . . . 0.0 109.25 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.415 ' O ' ' N ' ' B' ' 6' ' ' GLU . 7.5 p -92.09 145.42 30.81 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 109.368 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -39.96 -26.03 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.544 2.162 . . . . 0.0 112.17 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' B' ' 4' ' ' THR . 39.4 mt-10 -81.69 -51.91 7.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.565 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' B' ' 7' ' ' GLU . 0.7 OUTLIER -75.38 -22.6 57.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.913 . . . . 0.0 109.504 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.477 ' HB2' HD13 ' B' ' 3' ' ' LEU . 6.7 tttm -78.47 -37.1 44.21 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.33 -0.856 . . . . 0.0 109.121 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -63.12 -23.31 67.38 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.12 -57.64 3.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.148 -0.97 . . . . 0.0 110.166 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.46 -24.92 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.055 . . . . 0.0 108.574 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 96.4 m -78.26 -31.58 49.17 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.749 -0.594 . . . . 0.0 109.823 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -67.23 -63.79 0.99 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.767 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.563 ' N ' HD12 ' B' ' 14' ' ' LEU . 10.6 mp -45.83 -19.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.388 -0.82 . . . . 0.0 109.901 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' TRP . . . . . 0.463 ' N ' ' O ' ' B' ' 13' ' ' ALA . 4.0 t90 -78.78 -40.82 32.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.064 -1.023 . . . . 0.0 108.82 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.43 -24.07 59.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -79.87 -32.65 40.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -1.014 . . . . 0.0 109.286 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.56 HG23 ' O ' ' B' ' 14' ' ' LEU . 3.7 t -62.6 132.08 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.318 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' B' ' 21' ' ' ASP . 71.8 m-20 -81.26 78.28 8.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.246 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.465 HG12 ' O ' ' B' ' 20' ' ' VAL . 77.9 t -49.82 -10.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' B' ' 19' ' ' ASN . 21.4 m-20 -55.31 -29.95 59.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.895 . . . . 0.0 109.729 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' B' ' 25' ' ' GLY . 18.3 pt-20 -152.5 -32.16 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.96 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' B' ' 22' ' ' GLU . 92.8 t -44.71 -26.32 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 109.638 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.51 -26.27 47.57 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -66.85 -45.12 86.62 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.415 ' OE2' ' N ' ' B' ' 26' ' ' GLU . 1.2 mp0 -63.91 -47.75 79.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -1.144 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.41 -30.8 42.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.161 -0.962 . . . . 0.0 109.372 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.2 -54.27 5.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.37 -35.23 91.78 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -67.01 -32.38 73.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.12 . . . . 0.0 109.466 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 tp -47.24 -41.31 18.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 109.638 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.68 -23.91 39.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 109.712 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.17 -64.03 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.983 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.702 ' HA ' ' HB2' ' A' ' 123' ' ' ALA . 2.5 t -46.76 -43.9 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.322 -0.861 . . . . 0.0 109.373 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -171.79 130.0 0.69 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.336 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.59 62.32 7.71 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.302 2.002 . . . . 0.0 112.088 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' TRP . . . . . 0.493 ' CD1' ' N ' ' B' ' 37' ' ' TRP . 0.0 OUTLIER -57.65 -43.75 85.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.151 -0.968 . . . . 0.0 109.276 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.533 ' OG1' ' N ' ' B' ' 39' ' ' GLN . 1.7 p -49.78 -64.42 0.81 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.902 . . . . 0.0 109.373 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLN . . . . . 0.533 ' N ' ' OG1' ' B' ' 38' ' ' THR . 31.8 tt0 48.16 43.94 18.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.483 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 -163.44 -36.67 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.554 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -119.28 16.11 13.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 109.193 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' B' ' 43' ' ' GLU . 30.7 p90 -87.54 -35.15 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.534 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.489 ' OE2' ' NH1' ' C' ' 92' ' ' ARG . 12.1 pt-20 -81.98 -13.92 56.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.683 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 86.4 p -57.68 -29.05 64.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.6 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -85.23 19.23 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.514 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.62 1.87 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' B' ' 48' ' ' LEU . 35.7 t0 49.79 -145.96 0.41 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -1.196 . . . . 0.0 109.488 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.539 ' CB ' ' O ' ' B' ' 47' ' ' ASP . 2.4 tp 82.73 24.29 0.16 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.787 -0.571 . . . . 0.0 109.64 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -57.59 -35.16 70.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.935 . . . . 0.0 109.202 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' THR . . . . . 0.402 ' O ' ' N ' ' B' ' 52' ' ' ASP . 1.2 p -146.93 153.64 46.09 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 108.923 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.44 -22.74 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.258 1.972 . . . . 0.0 112.257 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' B' ' 50' ' ' THR . 26.2 t70 -85.13 -38.58 18.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.92 -19.52 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.34 -0.85 . . . . 0.0 109.53 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' B' ' 52' ' ' ASP . 14.4 t -60.63 -59.34 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 17.2 ptp -90.33 14.13 13.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.895 . . . . 0.0 109.572 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.85 -18.98 58.77 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -89.08 146.95 37.45 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.133 -1.216 . . . . 0.0 109.486 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.87 -20.44 17.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.565 2.177 . . . . 0.0 112.388 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.61 -32.37 25.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 109.796 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -60.65 -41.15 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.969 . . . . 0.0 109.654 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.493 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 11.9 ptpt -79.03 -35.87 42.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -0.989 . . . . 0.0 109.38 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.25 69.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.87 -24.05 60.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.91 . . . . 0.0 109.594 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.72 -19.08 80.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -68.5 -32.2 72.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -1.139 . . . . 0.0 109.323 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -75.95 -34.46 59.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.631 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.9 -62.87 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.766 HD23 ' O ' ' B' ' 68' ' ' LEU . 2.6 tt -50.21 -29.01 8.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.934 . . . . 0.0 109.315 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.73 -38.93 96.74 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.47 93.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -1.135 . . . . 0.0 109.822 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' PHE . . . . . 0.433 ' CE2' HD23 ' B' ' 110' ' ' LEU . 25.3 m-85 -46.98 -30.25 2.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.772 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 3.9 p -57.56 -49.7 75.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -60.38 -16.91 39.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.399 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.17 -31.04 79.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.861 HD23 ' H ' ' B' ' 75' ' ' LEU . 1.4 pt? -136.58 -22.38 1.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.268 -1.136 . . . . 0.0 110.031 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -77.59 5.11 9.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.03 -1.044 . . . . 0.0 109.733 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 46.5 m-70 -161.03 66.22 0.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' LEU . . . . . 0.418 HD21 ' HA ' ' B' ' 75' ' ' LEU . 87.1 mt -72.96 10.82 0.8 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.498 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' B' ' 77' ' ' HIS . 13.7 t70 -66.74 -45.68 77.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.422 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -162.21 96.2 0.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.805 . . . . 0.0 109.414 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 24.7 mt -76.16 -58.79 3.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -54.72 -23.94 19.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.486 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.13 -47.54 9.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.8 t -78.25 -48.28 16.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -1.158 . . . . 0.0 109.628 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 85' ' ' PHE . . . . . 0.563 ' N ' ' CG2' ' B' ' 84' ' ' THR . 27.9 m-85 -59.62 -1.71 0.28 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.5 -0.75 . . . . 0.0 109.425 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -56.3 -35.25 67.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.371 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 34.8 p -73.09 -57.77 3.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' B' ' 88' ' ' LEU . 32.5 mt -56.43 -29.5 61.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.312 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 69.6 m -81.14 -32.56 33.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -82.6 -22.28 34.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.869 . . . . 0.0 109.546 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' LEU . . . . . 0.493 HD23 ' C ' ' B' ' 91' ' ' LEU . 9.8 tt -78.78 -68.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.759 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 92' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' B' ' 97' ' ' HIS . 0.4 OUTLIER -55.31 -20.12 10.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.075 -179.198 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 93' ' ' CYS . . . . . 0.532 ' N ' ' ND1' ' B' ' 92' ' ' HIS . 36.4 t -83.53 -60.68 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 110.642 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 94' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' B' ' 94' ' ' ASP . 0.8 OUTLIER -87.78 -25.75 23.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.084 -1.01 . . . . 0.0 111.446 -178.566 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.96 -52.24 5.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.717 -1.239 . . . . 0.0 110.96 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.607 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 2.3 mm? -112.56 -11.63 13.56 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.941 -1.1 . . . . 0.0 109.828 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 97' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 49.2 p-80 41.84 41.51 1.87 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.351 -0.843 . . . . 0.0 109.761 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 59.6 t -51.41 132.32 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -0.819 . . . . 0.0 109.457 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.07 153.0 90.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.171 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.47 -164.76 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.544 2.162 . . . . 0.0 112.229 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 56.91 48.38 15.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -0.936 . . . . 0.0 109.36 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -160.62 -33.53 0.05 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.315 -0.865 . . . . 0.0 109.46 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -63.42 -60.94 2.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.37 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -57.53 -20.3 30.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.357 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.509 ' O ' HD23 ' B' ' 105' ' ' LEU . 1.6 tt -77.34 -49.79 14.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.383 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tt -49.38 -46.3 47.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.274 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.35 -45.82 95.45 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 108' ' ' ASN . . . . . 0.72 ' OD1' ' CD2' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -53.8 -34.7 59.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.151 -1.205 . . . . 0.0 109.565 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 109' ' ' VAL . . . . . 0.465 ' O ' ' SG ' ' B' ' 112' ' ' CYS . 89.7 t -80.28 -24.06 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.433 HD23 ' CE2' ' B' ' 71' ' ' PHE . 34.6 tp -78.06 -32.37 50.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.29 -49.59 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 109.754 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 112' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' B' ' 113' ' ' VAL . 18.7 p -53.08 -37.21 61.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.692 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 113' ' ' VAL . . . . . 0.468 ' N ' ' SG ' ' B' ' 112' ' ' CYS . 96.5 t -60.64 -21.37 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.661 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' B' ' 130' ' ' TYR . 23.6 mt -77.63 -57.02 4.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' ALA . . . . . 0.462 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.1 -19.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.372 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 116' ' ' HIS . . . . . 0.805 ' NE2' ' CE1' ' A' ' 117' ' ' PHE . 1.5 t-80 -79.33 -56.78 4.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -69.24 -17.72 63.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 109.71 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -151.22 60.96 0.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 0.0 109.588 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -77.76 -23.23 67.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.53 8.71 4.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -1.1 . . . . 0.0 109.447 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -134.63 12.88 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.18 43.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.0 109.119 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 123' ' ' THR . . . . . 0.488 ' OG1' HG23 ' B' ' 126' ' ' VAL . 1.0 OUTLIER -48.64 151.1 2.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.147 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.502 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.0 Cg_exo -45.98 -52.32 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.281 1.987 . . . . 0.0 113.029 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 125' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 46.8 Cg_endo -68.34 15.24 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.173 1.916 . . . . 0.0 112.973 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.488 HG23 ' OG1' ' B' ' 123' ' ' THR . 53.2 t -108.53 -42.69 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.988 -1.07 . . . . 0.0 109.878 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 127' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' B' ' 127' ' ' GLN . 0.0 OUTLIER -70.7 -59.87 2.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.086 -1.009 . . . . 0.0 109.798 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 128' ' ' ALA . . . . . 0.684 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -49.48 -34.79 17.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.099 -1.001 . . . . 0.0 109.358 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.34 27.75 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.29 -0.881 . . . . 0.0 109.641 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 130' ' ' TYR . . . . . 0.516 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 1.6 t80 -126.69 -34.68 2.39 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.356 -0.84 . . . . 0.0 109.637 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -71.22 -62.86 1.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.743 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -48.7 -21.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.774 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 133' ' ' VAL . . . . . 0.567 HG22 HD21 ' B' ' 3' ' ' LEU . 33.8 t -69.13 -65.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.741 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 9.2 m -74.15 -16.38 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.607 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' D' ' 146' ' ' HIS . . . -49.41 -30.26 7.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.331 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.59 -26.3 70.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.79 -39.81 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -1.11 . . . . 0.0 109.367 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.88 95.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 139' ' ' ASN . . . . . 0.745 HD21 ' N ' ' B' ' 139' ' ' ASN . 0.5 OUTLIER -73.72 -44.14 57.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.422 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.09 -37.68 47.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.331 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.529 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 18.1 mt -82.35 11.27 5.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 142' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' B' ' 144' ' ' LYS . . . -123.7 -30.97 3.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.382 -0.823 . . . . 0.0 109.514 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 143' ' ' HIS . . . . . 0.452 ' CE1' ' HE1' ' D' ' 143' ' ' HIS . 5.6 m170 -49.68 -13.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.355 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 144' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' B' ' 142' ' ' ALA . 3.2 tptp -77.88 -43.07 31.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.21 -0.931 . . . . 0.0 109.511 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -50.1 -25.25 3.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 146' ' ' HIS . . . . . 0.687 ' CE1' ' OD1' ' D' ' 139' ' ' ASN . 25.8 m170 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.495 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.36 -169.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.897 . . . . 0.0 109.862 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 3' ' ' SER . . . . . 0.604 ' H ' ' CG ' ' C' ' 6' ' ' ASP . 0.1 OUTLIER -99.93 -179.11 0.77 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.404 -0.81 . . . . 0.0 109.644 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 4' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 22.8 Cg_exo -62.92 -58.46 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.908 2.405 . . . . 0.0 113.091 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 5' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -78.7 -16.4 57.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.1 -1.0 . . . . 0.0 110.215 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' C' ' 3' ' ' SER . 33.5 m-20 -39.86 -30.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 7' ' ' LYS . . . . . 0.622 ' CD ' ' H ' ' C' ' 7' ' ' LYS . 0.0 OUTLIER -83.65 -39.52 20.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.493 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.45 ' N ' ' O ' ' C' ' 5' ' ' ALA . 36.4 m -44.85 -42.87 8.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.369 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -71.23 -25.37 62.47 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' C' ' 7' ' ' LYS . 52.9 t -78.83 -55.24 10.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 11' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' C' ' 15' ' ' GLY . 0.0 OUTLIER -53.41 -37.18 62.27 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.526 -1.27 . . . . 0.0 107.89 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.79 -63.16 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.332 -0.855 . . . . 0.0 109.241 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.766 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -60.29 -36.2 77.31 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -17.49 62.37 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 109.067 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 15' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' C' ' 11' ' ' LYS . . . -78.86 -46.42 8.48 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.04 -36.65 75.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -1.118 . . . . 0.0 108.869 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.766 HG23 ' O ' ' C' ' 13' ' ' ALA . 94.9 t -60.65 -66.02 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 58.77 -134.78 52.36 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.55 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -1.025 . . . . 0.0 110.427 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 20' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' C' ' 18' ' ' GLY . 92.2 m-70 -131.59 25.72 4.74 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 21' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.65 -61.55 1.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.61 -0.681 . . . . 0.0 109.755 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.7 -14.42 0.23 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 21' ' ' ALA . 1.2 mm-40 -84.28 -56.4 3.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -1.059 . . . . 0.0 109.526 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 24' ' ' TYR . . . . . 0.606 ' CE1' ' CG ' ' C' ' 112' ' ' HIS . 2.8 m-30 -60.6 -27.83 68.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 109.176 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.75 -22.94 75.66 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.72 -41.98 18.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.249 -1.147 . . . . 0.0 109.832 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -64.37 -19.99 65.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.405 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.05 -19.71 60.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.347 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.481 HD11 ' ND1' ' C' ' 58' ' ' HIS . 12.8 mt -78.41 -53.98 6.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.688 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.31 -37.64 65.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -43.84 98.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 53.4 ttp -67.29 -49.96 62.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.407 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -51.49 -46.32 63.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.673 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 12.8 mt -64.08 -60.22 3.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.927 . . . . 0.0 109.865 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 35' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 18.7 p -55.36 -19.05 7.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 36' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' C' ' 35' ' ' SER . 79.6 m-85 -156.16 113.27 2.11 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.578 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 37' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' C' ' 39' ' ' THR . 73.0 Cg_endo -79.47 -20.12 9.74 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.259 1.973 . . . . 0.0 111.982 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 38' ' ' THR . . . . . 0.844 ' O ' HG22 ' C' ' 41' ' ' THR . 40.9 p -47.17 -18.41 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 109.65 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.443 ' N ' ' O ' ' C' ' 37' ' ' PRO . 42.4 p -74.71 -22.79 58.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 109.854 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -69.96 -20.15 63.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 110.082 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.844 HG22 ' O ' ' C' ' 38' ' ' THR . 12.2 t . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.075 -1.016 . . . . 0.0 109.83 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 45' ' ' HIS . . . . . 0.573 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 15.1 p80 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 120.909 0.385 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 46' ' ' PHE . . . . . 0.415 ' O ' ' C ' ' C' ' 47' ' ' ASP . 5.0 p90 -145.36 23.2 1.48 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.9 -1.125 . . . . 0.0 109.541 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 47' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' C' ' 49' ' ' SER . 56.9 m-20 42.51 84.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.533 -0.73 . . . . 0.0 109.772 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.611 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -50.27 -11.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.421 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.482 ' N ' ' O ' ' C' ' 47' ' ' ASP . 14.7 m -58.97 147.38 34.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -64.57 148.37 50.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.63 -4.15 83.65 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 52' ' ' SER . . . . . 0.536 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 5.4 p -69.03 -23.66 64.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 109.328 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 67.5 -56.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.795 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 54' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' C' ' 52' ' ' SER . 43.0 mt-30 -43.95 -22.5 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.372 -0.83 . . . . 0.0 109.798 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 53' ' ' ALA . 40.9 t -74.23 -26.72 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.323 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 56' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' C' ' 53' ' ' ALA . 5.7 ptmt -65.75 -27.41 68.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.18 -50.51 39.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 58' ' ' HIS . . . . . 0.481 ' ND1' HD11 ' C' ' 29' ' ' LEU . 20.6 t-80 -53.73 -32.44 52.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -1.136 . . . . 0.0 109.567 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.23 -47.3 91.76 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -58.2 -23.46 55.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.385 -1.068 . . . . 0.0 109.694 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.26 -39.44 63.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.229 -0.919 . . . . 0.0 108.927 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.76 -49.05 48.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.48 -30.02 71.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.315 -0.866 . . . . 0.0 109.017 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -67.14 -38.66 85.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.898 . . . . 0.0 108.819 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 65' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -64.09 -52.13 60.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -57.08 -44.71 83.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.227 -0.92 . . . . 0.0 108.764 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 17.5 m -68.74 -50.61 49.28 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.294 -0.879 . . . . 0.0 108.703 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -60.38 -24.27 64.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.563 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -84.95 -45.64 12.0 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.56 -23.48 33.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -18.74 64.27 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 72' ' ' HIS . . . . . 0.614 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.7 m80 -144.06 -58.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.446 -0.783 . . . . 0.0 109.337 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 73' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.3 p 44.28 13.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.796 0.808 . . . . 0.0 109.475 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 74' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' C' ' 72' ' ' HIS . 46.0 t0 -133.86 11.11 3.97 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.416 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 2.0 p-10 179.0 29.25 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.003 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 17.4 ptt? -78.57 -22.63 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 111.796 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.4 Cg_exo -54.0 -22.36 24.45 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.559 1.506 . . . . 0.0 112.334 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -94.2 -33.86 13.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.13 -0.981 . . . . 0.0 109.775 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.29 -46.74 60.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -0.948 . . . . 0.0 109.427 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 12.9 mt -80.39 8.43 7.62 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 109.07 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 38.5 p -55.78 -17.14 5.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.742 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.16 -55.89 4.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 109.752 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.486 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 3.5 mt -45.41 -43.97 11.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 108.967 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 84' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' C' ' 136' ' ' LEU . 29.7 t -57.32 -22.55 42.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 109.44 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 85' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' C' ' 89' ' ' HIS . 23.0 t70 -82.01 -58.37 3.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.14 -0.975 . . . . 0.0 109.926 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.49 -27.42 16.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 109.77 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 87' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 38.8 m80 -91.97 -21.7 20.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.795 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.41 -11.41 15.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 109.914 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 89' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' C' ' 85' ' ' ASP . 14.3 m80 -113.94 -77.86 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.034 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' C' ' 89' ' ' HIS . 9.9 mptt -45.78 -97.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.868 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 91' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' C' ' 93' ' ' VAL . 19.6 mt -65.67 -17.32 64.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 110.178 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 92' ' ' ARG . . . . . 0.489 ' NH1' ' OE2' ' B' ' 43' ' ' GLU . 25.1 ttm180 48.86 15.34 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 0.0 108.938 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 93' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' C' ' 91' ' ' LEU . 10.8 p -46.05 156.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 0.0 109.886 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 94' ' ' ASP . . . . . 0.432 ' N ' HG22 ' C' ' 93' ' ' VAL . 3.5 m-20 -100.21 153.0 37.99 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.079 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' C' ' 98' ' ' PHE . 32.7 Cg_endo -65.87 -10.58 27.37 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.535 2.157 . . . . 0.0 111.947 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 84.0 t -44.01 -29.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.852 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -79.42 -32.86 42.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.621 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 98' ' ' PHE . . . . . 0.448 ' N ' ' O ' ' C' ' 95' ' ' PRO . 0.0 OUTLIER -50.18 -34.91 24.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.345 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -50.02 -34.91 22.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 9.9 mt -82.11 -50.53 8.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 53.2 tp -45.75 -20.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 0.0 109.64 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 102' ' ' SER . . . . . 0.445 ' N ' ' O ' ' C' ' 100' ' ' LEU . 93.1 p -73.4 -59.15 2.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.932 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 103' ' ' HIS . . . . . 0.716 ' CD2' ' OD1' ' D' ' 108' ' ' ASN . 92.4 m-70 -71.92 -26.52 62.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 104' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 62.1 m -58.07 -42.13 84.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.042 -1.036 . . . . 0.0 109.942 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.68 -22.85 62.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.123 -0.986 . . . . 0.0 110.123 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.598 HD22 ' N ' ' C' ' 106' ' ' LEU . 3.7 mm? -79.01 -35.98 41.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.021 -1.049 . . . . 0.0 110.146 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 107' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 45.7 t -62.8 -39.47 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.054 -1.029 . . . . 0.0 109.536 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' C' ' 109' ' ' LEU . 12.5 p -65.31 -62.86 1.28 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.171 -0.956 . . . . 0.0 109.639 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 109' ' ' LEU . . . . . 0.492 ' N ' ' OG1' ' C' ' 108' ' ' THR . 14.8 mt -48.3 -22.42 0.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.355 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -63.37 -36.5 83.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.932 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.54 20.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.961 . . . . 0.0 109.863 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 112' ' ' HIS . . . . . 0.606 ' CG ' ' CE1' ' C' ' 24' ' ' TYR . 62.7 m80 -81.78 -75.43 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -0.991 . . . . 0.0 109.54 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.638 ' O ' HD12 ' C' ' 113' ' ' LEU . 1.5 pp -137.05 94.42 12.62 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.2 -171.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.26 1.973 . . . . 0.0 112.899 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 115' ' ' ALA . . . . . 0.536 ' O ' HG11 ' C' ' 121' ' ' VAL . . . -47.3 -38.53 12.79 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.622 0.725 . . . . 0.0 109.598 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 116' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 6.7 mt-10 85.34 9.57 0.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 117' ' ' PHE . . . . . 0.812 ' CE1' ' NE2' ' D' ' 116' ' ' HIS . 6.9 m-85 65.11 34.93 8.28 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.779 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 118' ' ' THR . . . . . 0.727 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -94.58 121.33 63.43 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.783 -1.198 . . . . 0.0 107.942 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -51.35 23.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.124 1.883 . . . . 0.0 112.849 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 120' ' ' ALA . . . . . 0.727 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -155.06 -30.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.742 -1.223 . . . . 0.0 110.773 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 121' ' ' VAL . . . . . 0.718 HG13 ' N ' ' C' ' 122' ' ' HIS . 11.9 p -47.8 -50.35 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 122' ' ' HIS . . . . . 0.718 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.4 t-80 -65.41 -43.56 90.17 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.41 -0.806 . . . . 0.0 109.976 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 123' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' D' ' 34' ' ' VAL . . . -79.06 -19.38 51.5 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 109.914 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 124' ' ' SER . . . . . 0.58 ' N ' ' O ' ' C' ' 120' ' ' ALA . 63.7 m -72.42 -63.85 1.07 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 111.128 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.05 -18.18 64.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.06 -1.025 . . . . 0.0 109.562 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.24 -49.55 9.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.899 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 127' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.86 -57.64 2.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.903 -1.123 . . . . 0.0 111.476 -178.187 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 128' ' ' PHE . . . . . 0.47 ' CD2' ' HA ' ' C' ' 124' ' ' SER . 21.9 m-85 -46.57 -21.53 0.19 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.731 -1.231 . . . . 0.0 110.189 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 129' ' ' LEU . . . . . 0.768 ' O ' HD12 ' C' ' 129' ' ' LEU . 0.7 OUTLIER -66.6 -18.86 65.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' C' ' 134' ' ' THR . . . -56.01 -33.18 64.64 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.506 ' O ' HG23 ' C' ' 135' ' ' VAL . 7.9 t -66.67 -36.83 83.47 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.168 -0.958 . . . . 0.0 108.767 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 132' ' ' VAL . . . . . 0.498 ' O ' HD13 ' C' ' 136' ' ' LEU . 1.8 t -78.3 -39.98 24.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 34.9 t -73.52 -37.66 65.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.466 -0.771 . . . . 0.0 108.95 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 134' ' ' THR . . . . . 0.448 ' N ' ' O ' ' C' ' 130' ' ' ALA . 88.8 m -71.62 -31.1 66.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 135' ' ' VAL . . . . . 0.506 HG23 ' O ' ' C' ' 131' ' ' SER . 2.9 t -70.35 -36.58 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 136' ' ' LEU . . . . . 0.498 HD13 ' O ' ' C' ' 132' ' ' VAL . 3.2 mp -56.73 -32.85 65.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.361 -0.837 . . . . 0.0 108.998 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 51.4 m -89.36 -27.46 20.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.477 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.977 . . . . 0.0 109.501 -179.853 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 3' ' ' LEU . . . . . 0.923 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -86.4 178.15 7.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 109.338 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.412 ' O ' ' N ' ' D' ' 6' ' ' GLU . 7.3 p -92.2 145.54 30.95 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 109.285 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -40.09 -25.96 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.534 2.156 . . . . 0.0 112.177 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 6' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' D' ' 4' ' ' THR . 39.5 mt-10 -81.72 -51.91 7.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 7' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' D' ' 7' ' ' GLU . 0.7 OUTLIER -75.3 -22.75 57.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.47 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 8' ' ' LYS . . . . . 0.468 ' HB2' HD13 ' D' ' 3' ' ' LEU . 6.7 tttm -78.39 -37.17 44.73 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.299 -0.876 . . . . 0.0 109.131 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 37.5 t -63.07 -23.28 67.37 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.23 -57.5 3.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.962 . . . . 0.0 110.082 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.52 -24.88 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.977 -1.077 . . . . 0.0 108.54 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 96.7 m -78.35 -31.59 48.64 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.729 -0.607 . . . . 0.0 109.724 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 13' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -67.25 -63.82 0.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.747 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.576 ' N ' HD12 ' D' ' 14' ' ' LEU . 10.6 mp -45.79 -19.29 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.377 -0.827 . . . . 0.0 109.898 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 15' ' ' TRP . . . . . 0.472 ' N ' ' O ' ' D' ' 13' ' ' ALA . 4.1 t90 -78.95 -40.8 30.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.986 -1.071 . . . . 0.0 108.751 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.31 -24.19 59.57 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -79.77 -32.71 40.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.456 -1.026 . . . . 0.0 109.353 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.568 HG23 ' O ' ' D' ' 14' ' ' LEU . 3.7 t -62.62 132.13 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.4 -0.812 . . . . 0.0 109.399 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 19' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' D' ' 21' ' ' ASP . 71.7 m-20 -81.21 78.17 8.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.291 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 20' ' ' VAL . . . . . 0.455 ' O ' HG12 ' D' ' 20' ' ' VAL . 78.4 t -49.78 -10.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.498 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' D' ' 19' ' ' ASN . 21.4 m-20 -55.33 -29.89 59.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 22' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' D' ' 25' ' ' GLY . 18.3 pt-20 -152.57 -32.15 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.095 -1.003 . . . . 0.0 110.045 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' D' ' 22' ' ' GLU . 93.0 t -44.72 -26.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.113 -0.992 . . . . 0.0 109.597 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.5 -26.31 47.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 25' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -66.71 -45.22 86.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 26' ' ' GLU . . . . . 0.423 ' OE2' ' N ' ' D' ' 26' ' ' GLU . 1.2 mp0 -63.9 -47.82 79.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -1.125 . . . . 0.0 109.318 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.3 -30.86 41.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.339 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.22 -54.32 5.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.24 -35.29 91.88 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -66.98 -32.36 73.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -1.091 . . . . 0.0 109.495 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 64.5 tp -47.35 -41.24 19.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.599 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 mt -80.73 -23.88 39.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.699 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.09 -64.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.474 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 34' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' C' ' 123' ' ' ALA . 2.4 t -46.65 -43.89 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -171.88 130.05 0.68 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 109.304 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.51 62.17 7.63 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.366 2.044 . . . . 0.0 112.126 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 37' ' ' TRP . . . . . 0.487 ' CZ3' HD11 ' D' ' 105' ' ' LEU . 0.0 OUTLIER -57.6 -43.72 84.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.143 -0.973 . . . . 0.0 109.272 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 38' ' ' THR . . . . . 0.553 ' OG1' ' N ' ' D' ' 39' ' ' GLN . 1.8 p -49.86 -64.41 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.371 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 39' ' ' GLN . . . . . 0.553 ' N ' ' OG1' ' D' ' 38' ' ' THR . 31.9 tt0 48.09 44.09 18.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 109.429 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -163.55 -36.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -119.3 16.14 13.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.309 -0.869 . . . . 0.0 109.216 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 42' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' D' ' 43' ' ' GLU . 30.8 p90 -87.61 -35.07 18.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.542 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 43' ' ' GLU . . . . . 0.518 ' OE2' ' NH1' ' A' ' 92' ' ' ARG . 12.1 pt-20 -81.97 -13.89 56.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.696 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 86.2 p -57.63 -29.09 64.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.607 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -85.27 19.24 2.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.44 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.63 1.87 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 47' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' D' ' 48' ' ' LEU . 35.7 t0 49.98 -146.01 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -1.186 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 48' ' ' LEU . . . . . 0.531 ' CB ' ' O ' ' D' ' 47' ' ' ASP . 2.4 tp 82.77 24.19 0.16 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.807 -0.558 . . . . 0.0 109.622 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -57.56 -35.12 69.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.273 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -146.93 153.69 46.13 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 108.887 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -42.47 -22.7 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.249 1.966 . . . . 0.0 112.251 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -85.15 -38.6 18.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.562 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.82 -19.58 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.362 -0.836 . . . . 0.0 109.573 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 t -60.66 -59.45 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.514 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 17.1 ptp -90.25 14.19 13.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.0 109.493 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.03 -18.91 58.61 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -89.07 146.99 37.55 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 109.443 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.76 -20.56 17.34 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.609 2.206 . . . . 0.0 112.4 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.55 -32.39 25.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 109.785 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 67.0 t -60.72 -41.18 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.672 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 61' ' ' LYS . . . . . 0.462 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 12.0 ptpt -78.94 -35.79 42.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.34 -30.12 69.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.93 -24.08 60.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.71 -19.12 80.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 65' ' ' LYS . . . . . 0.462 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 0.3 OUTLIER -68.44 -32.32 72.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -1.128 . . . . 0.0 109.326 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -75.78 -34.55 60.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.313 -0.867 . . . . 0.0 109.738 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.85 -62.94 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.469 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.755 ' O ' HD23 ' D' ' 68' ' ' LEU . 2.5 tt -50.14 -29.07 8.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.373 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.02 96.84 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.56 93.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -1.165 . . . . 0.0 109.804 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 71' ' ' PHE . . . . . 0.436 ' CE2' HD23 ' D' ' 110' ' ' LEU . 25.1 m-85 -47.0 -30.29 2.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.173 -0.954 . . . . 0.0 109.634 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 3.8 p -57.6 -49.68 75.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.461 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -60.32 -17.01 39.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.09 79.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.855 HD23 ' H ' ' D' ' 75' ' ' LEU . 1.4 pt? -136.62 -22.34 1.27 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.317 -1.108 . . . . 0.0 109.973 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 76' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -77.61 5.09 9.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.072 -1.017 . . . . 0.0 109.679 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 77' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 46.8 m-70 -160.99 66.27 0.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.531 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 78' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' D' ' 75' ' ' LEU . 87.3 mt -73.08 11.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.533 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' D' ' 77' ' ' HIS . 13.7 t70 -66.73 -45.72 77.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.399 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -162.21 96.19 0.97 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.787 . . . . 0.0 109.417 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 24.9 mt -76.19 -58.77 3.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -54.76 -23.87 19.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.534 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.14 -47.51 9.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.8 t -78.28 -48.21 16.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -1.193 . . . . 0.0 109.67 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' D' ' 84' ' ' THR . 27.9 m-85 -59.72 -1.76 0.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 109.387 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 86' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -56.21 -35.24 67.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.158 -0.964 . . . . 0.0 109.423 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 34.5 p -73.2 -57.6 3.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 31.9 mt -56.49 -29.49 61.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.31 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 69.2 m -81.12 -32.64 33.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.439 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -82.62 -22.41 34.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.862 . . . . 0.0 109.482 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 91' ' ' LEU . . . . . 0.489 HD23 ' C ' ' D' ' 91' ' ' LEU . 9.8 tt -78.69 -68.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.853 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 92' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' D' ' 97' ' ' HIS . 0.4 OUTLIER -55.17 -20.28 10.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 0.0 110.092 -179.304 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 93' ' ' CYS . . . . . 0.526 ' N ' ' ND1' ' D' ' 92' ' ' HIS . 36.4 t -83.45 -60.66 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.1 -1.0 . . . . 0.0 110.706 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 94' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' D' ' 94' ' ' ASP . 0.8 OUTLIER -87.78 -25.64 23.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.087 -1.008 . . . . 0.0 111.45 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.02 -52.28 5.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.84 -1.163 . . . . 0.0 110.895 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 96' ' ' LEU . . . . . 0.609 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 2.3 mm? -112.5 -11.67 13.58 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.995 -1.065 . . . . 0.0 109.857 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 97' ' ' HIS . . . . . 0.609 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 49.3 p-80 41.89 41.48 1.89 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.31 -0.869 . . . . 0.0 109.786 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.42 132.32 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 0.0 109.472 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.01 152.96 90.0 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.245 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.54 -164.81 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.595 2.197 . . . . 0.0 112.162 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 57.01 48.34 15.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.32 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -160.61 -33.61 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -63.3 -60.91 2.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.445 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -57.63 -20.24 31.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 109.333 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 105' ' ' LEU . . . . . 0.51 ' O ' HD23 ' D' ' 105' ' ' LEU . 1.6 tt -77.37 -49.72 14.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.355 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tt -49.41 -46.29 47.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.859 . . . . 0.0 109.316 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.36 -45.78 95.53 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 108' ' ' ASN . . . . . 0.716 ' OD1' ' CD2' ' C' ' 103' ' ' HIS . 0.3 OUTLIER -53.76 -34.7 59.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -1.176 . . . . 0.0 109.583 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 109' ' ' VAL . . . . . 0.452 ' O ' ' SG ' ' D' ' 112' ' ' CYS . 90.7 t -80.25 -24.12 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 110' ' ' LEU . . . . . 0.436 HD23 ' CE2' ' D' ' 71' ' ' PHE . 34.2 tp -78.05 -32.43 50.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 109.412 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 94.3 t -65.15 -49.77 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.685 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 112' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' D' ' 113' ' ' VAL . 18.6 p -52.95 -37.23 60.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.939 . . . . 0.0 109.747 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 113' ' ' VAL . . . . . 0.462 ' N ' ' SG ' ' D' ' 112' ' ' CYS . 96.5 t -60.66 -21.38 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.675 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 114' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' D' ' 130' ' ' TYR . 23.6 mt -77.64 -57.07 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 109.571 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.03 -19.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.088 -1.007 . . . . 0.0 109.386 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 116' ' ' HIS . . . . . 0.812 ' NE2' ' CE1' ' C' ' 117' ' ' PHE . 1.5 t-80 -79.45 -56.69 4.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.147 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -69.27 -17.61 63.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.683 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -151.31 60.98 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 119' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -77.78 -23.32 67.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.41 8.63 4.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.363 -1.08 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -134.57 12.81 3.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.404 -0.81 . . . . 0.0 109.52 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.15 43.86 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.116 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 123' ' ' THR . . . . . 0.475 ' OG1' HG23 ' D' ' 126' ' ' VAL . 1.0 OUTLIER -48.61 151.1 2.15 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 109.161 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.501 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.0 Cg_exo -46.0 -52.3 7.25 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.307 2.005 . . . . 0.0 113.034 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 125' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 46.7 Cg_endo -68.29 15.16 0.16 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.157 1.905 . . . . 0.0 113.091 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.475 HG23 ' OG1' ' D' ' 123' ' ' THR . 53.1 t -108.4 -42.76 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.056 -1.027 . . . . 0.0 109.914 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 127' ' ' GLN . . . . . 0.616 ' H ' ' CD ' ' D' ' 127' ' ' GLN . 0.0 OUTLIER -70.66 -60.01 2.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.997 -1.064 . . . . 0.0 109.734 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 128' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -49.37 -34.77 16.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.11 -0.993 . . . . 0.0 109.461 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.39 27.76 1.04 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.306 -0.871 . . . . 0.0 109.686 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 130' ' ' TYR . . . . . 0.516 ' CZ ' ' CD1' ' D' ' 114' ' ' LEU . 1.6 t80 -126.65 -34.73 2.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.345 -0.847 . . . . 0.0 109.592 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -71.32 -62.86 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.642 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -48.77 -21.7 0.67 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 109.709 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 133' ' ' VAL . . . . . 0.581 HG22 HD21 ' D' ' 3' ' ' LEU . 34.2 t -69.17 -65.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.715 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.415 ' H ' HG22 ' D' ' 134' ' ' VAL . 9.0 m -74.22 -16.44 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -0.92 . . . . 0.0 109.569 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' B' ' 146' ' ' HIS . . . -49.32 -30.28 7.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.372 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.68 -26.22 70.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 137' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' D' ' 134' ' ' VAL . 89.1 t -68.84 -39.75 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -1.132 . . . . 0.0 109.336 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.01 94.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 139' ' ' ASN . . . . . 0.728 HD21 ' N ' ' D' ' 139' ' ' ASN . 0.4 OUTLIER -73.7 -44.03 57.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.13 -37.67 47.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.926 . . . . 0.0 109.351 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 141' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 18.0 mt -82.31 11.2 5.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 142' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' D' ' 144' ' ' LYS . . . -123.66 -30.94 3.53 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.414 -0.804 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 143' ' ' HIS . . . . . 0.452 ' HE1' ' CE1' ' B' ' 143' ' ' HIS . 5.6 m170 -49.69 -13.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.401 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 144' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' D' ' 142' ' ' ALA . 3.2 tptp -77.76 -43.0 32.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.25 -25.24 3.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.263 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 146' ' ' HIS . . . . . 0.735 ' CE1' ' OD1' ' B' ' 139' ' ' ASN . 25.9 m170 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.449 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 2' ' ' LEU . 29.8 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 7.8 mp 55.94 163.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.399 -0.813 . . . . 0.0 109.846 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.517 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 176.24 -47.8 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.021 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 3' ' ' SER . 54.2 Cg_exo -50.44 -170.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.473 2.115 . . . . 0.0 112.603 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -60.31 -16.17 32.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 109.667 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 5' ' ' ALA . 22.2 m-20 -39.51 -29.09 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.379 -0.826 . . . . 0.0 109.67 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 10' ' ' VAL . 4.6 ptpt -83.22 -49.99 8.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 7' ' ' LYS . 52.5 m -43.82 -32.77 1.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.474 -0.766 . . . . 0.0 109.751 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.85 -30.27 50.89 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.571 ' N ' ' O ' ' A' ' 7' ' ' LYS . 51.2 t -76.8 -51.57 18.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HZ1' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -57.64 -36.75 72.27 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.812 -1.155 . . . . 0.0 108.262 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.81 -58.25 8.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.13 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.99 -34.4 63.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 108.935 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -17.52 61.75 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.96 -44.6 18.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -70.1 -37.39 75.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -1.164 . . . . 0.0 108.51 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.574 ' CG1' ' HB2' ' A' ' 21' ' ' ALA . 4.2 t -60.16 -67.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 59.32 -136.81 50.59 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.28 29.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.487 -1.008 . . . . 0.0 110.485 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.565 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.9 m-70 -129.7 13.14 5.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 108.579 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.574 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . . . -75.0 -52.36 11.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.584 -0.697 . . . . 0.0 109.811 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.01 -14.53 10.68 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.31 -56.48 3.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -1.188 . . . . 0.0 109.72 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 20' ' ' HIS . 14.1 m-85 -59.86 -24.83 64.54 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 109.247 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.03 -33.77 84.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.93 -39.0 57.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.584 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.436 ' CG ' ' OG1' ' A' ' 108' ' ' THR . 13.2 tt0 -67.51 -20.0 65.38 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.361 -0.837 . . . . 0.0 109.552 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.43 61.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.078 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -75.98 -59.32 2.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -56.49 -12.55 1.78 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.282 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -65.21 -58.29 6.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.939 . . . . 0.0 109.835 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -84.52 -32.91 23.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 110.354 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 20.1 m-85 -63.54 -36.01 82.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.006 -1.058 . . . . 0.0 110.121 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 35' ' ' SER . 3.8 pp -46.92 -40.54 14.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.84 -1.163 . . . . 0.0 109.534 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.663 ' N ' HD12 ' A' ' 34' ' ' LEU . 1.4 p -76.56 -23.58 53.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.022 -1.049 . . . . 0.0 108.792 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.564 ' C ' ' O ' ' A' ' 35' ' ' SER . 0.3 OUTLIER 21.44 66.0 0.3 Allowed Pre-proline 0 N--CA 1.501 2.103 0 CA-C-O 121.155 0.502 . . . . 0.0 111.291 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.44 -62.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.46 2.107 . . . . 0.0 112.076 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.558 ' O ' HG22 ' A' ' 41' ' ' THR . 1.2 p -91.15 -57.52 2.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.546 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 39' ' ' THR . 3.0 p -44.12 -22.94 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -0.795 . . . . 0.0 110.333 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.3 ttmt -49.06 -45.17 42.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.087 -1.008 . . . . 0.0 109.569 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 38' ' ' THR . 0.6 OUTLIER -80.02 -18.96 48.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.59 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -77.06 -35.54 56.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.8 t80 55.04 79.9 0.32 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 109.298 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.708 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 72.1 Cg_exo -46.16 -27.99 5.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.654 2.236 . . . . 0.0 112.496 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.708 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 90.87 35.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 O-C-N 122.019 -0.426 . . . . 0.0 110.669 179.33 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.477 ' C ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -154.35 31.1 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.581 -1.324 . . . . 0.0 110.553 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 46' ' ' PHE . 35.6 m-20 42.26 88.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -0.798 . . . . 0.0 110.242 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.44 -13.06 57.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 109.035 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 50' ' ' HIS . 32.8 p -78.02 165.73 23.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.559 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.564 ' N ' ' ND1' ' A' ' 50' ' ' HIS . 0.3 OUTLIER -57.81 -162.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.319 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.7 34.49 10.49 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 54' ' ' GLN . 30.2 t -139.06 82.29 1.89 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.357 -1.084 . . . . 0.0 109.259 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.68 -10.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.414 -0.804 . . . . 0.0 109.806 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 52' ' ' SER . 11.7 mt-30 -74.81 -35.23 62.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.123 -0.986 . . . . 0.0 109.676 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.66 -48.51 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.52 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.579 ' CD ' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -69.18 -25.5 64.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.416 -0.802 . . . . 0.0 109.046 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.91 -21.68 78.93 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.8 t-80 -82.43 -39.9 21.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -1.129 . . . . 0.0 109.847 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.92 -51.65 44.21 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -51.17 -22.66 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -1.022 . . . . 0.0 110.101 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.76 -29.72 56.23 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.056 -1.027 . . . . 0.0 109.255 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -79.8 -49.0 19.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.519 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -68.57 -22.71 64.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.406 -0.809 . . . . 0.0 109.191 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -78.25 -30.68 48.76 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.1 -1.0 . . . . 0.0 108.778 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.76 53.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.388 -0.82 . . . . 0.0 108.969 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.57 -40.58 72.15 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.153 -0.967 . . . . 0.0 108.757 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 m -68.81 -56.78 6.93 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 46.6 t30 -55.38 -24.17 28.35 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -80.24 -46.93 15.41 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.586 HG13 ' HZ1' ' A' ' 11' ' ' LYS . 36.0 t -64.41 -22.93 32.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.43 -17.04 64.56 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.616 ' O ' ' N ' ' A' ' 74' ' ' ASP . 4.2 m-70 -141.9 -61.25 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.434 -0.791 . . . . 0.0 109.435 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.1 p 44.72 12.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.721 0.772 . . . . 0.0 109.64 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 72' ' ' HIS . 44.5 t0 -134.21 10.45 3.83 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 2.0 m-20 -178.53 28.02 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.733 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.701 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 6.5 ptt? -78.46 -23.36 0.41 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 111.67 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.3 Cg_exo -54.36 -18.82 15.45 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.617 1.545 . . . . 0.0 112.132 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -93.43 -38.08 11.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.421 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.45 -40.18 64.38 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 108.956 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.8 mt -87.65 11.34 15.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.7 t -65.32 -26.85 68.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.713 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.98 -49.03 66.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.726 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.439 ' N ' HD23 ' A' ' 83' ' ' LEU . 4.1 mt -47.69 -46.96 29.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 109.022 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 9.7 t -62.78 -28.55 70.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.626 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -79.96 -28.14 39.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 109.588 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 90' ' ' LYS . 3.7 tt -83.22 -32.29 26.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 109.87 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -92.04 -22.0 20.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.219 -0.926 . . . . 0.0 110.218 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -104.07 -48.01 4.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.112 -0.992 . . . . 0.0 110.123 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -93.44 21.93 5.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.13 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.504 ' C ' ' H ' ' A' ' 92' ' ' ARG . 28.6 ttmt -172.11 147.07 2.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.022 -1.049 . . . . 0.0 110.006 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER 71.31 -20.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.522 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.504 ' H ' ' C ' ' A' ' 90' ' ' LYS . 70.4 mtt85 43.12 27.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 109.741 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.534 HG22 ' N ' ' A' ' 94' ' ' ASP . 12.2 p -46.98 165.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.725 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.534 ' N ' HG22 ' A' ' 93' ' ' VAL . 6.1 p-10 -109.7 101.18 45.6 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.493 -0.754 . . . . 0.0 109.28 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.72 -10.85 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.407 2.072 . . . . 0.0 112.331 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 94' ' ' ASP . 52.6 t -50.98 -18.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 100' ' ' LEU . 3.1 m120 -79.22 -24.38 43.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.316 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -44.33 -35.75 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -67.98 -23.78 65.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.873 . . . . 0.0 109.579 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 100' ' ' LEU . 8.8 mp -84.18 -62.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.638 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.632 HD22 ' HAB' ' A' ' 142' ' ' HEC . 6.6 tt -55.47 -23.87 27.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.687 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.8 p -67.86 -50.4 56.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 109.727 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -78.02 -26.42 48.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.741 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 96.7 m -50.8 -50.45 56.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 109.629 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.26 -38.88 55.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.892 . . . . 0.0 109.765 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.88 -36.18 64.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.531 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.13 -27.67 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.069 -1.019 . . . . 0.0 109.852 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -81.07 -45.19 16.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.123 -0.986 . . . . 0.0 109.842 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.506 ' N ' ' CG2' ' A' ' 108' ' ' THR . 15.6 mt -66.89 -20.67 65.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.926 . . . . 0.0 109.057 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 112' ' ' HIS . . . -51.66 -43.01 62.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.427 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.76 -3.62 0.12 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 109.193 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.512 ' H ' ' C ' ' A' ' 110' ' ' ALA . 80.9 m80 -143.24 -85.59 0.15 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -0.888 . . . . 0.0 109.277 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.82 HD23 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -139.79 100.14 7.44 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.28 -98.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.646 2.231 . . . . 0.0 112.791 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.797 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -72.12 -56.58 5.34 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.557 -0.715 . . . . 0.0 110.064 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.667 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 17.5 mt-10 116.62 -6.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.485 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 4.9 t80 79.53 33.3 0.21 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.297 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.722 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -108.94 125.07 32.44 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.021 -1.049 . . . . 0.0 108.199 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.91 21.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.216 1.944 . . . . 0.0 112.801 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.722 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -149.44 -32.52 0.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.906 -1.121 . . . . 0.0 110.398 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.797 HG21 ' O ' ' A' ' 115' ' ' ALA . 9.5 p -55.04 -48.79 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 110.404 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.625 ' N ' HG13 ' A' ' 121' ' ' VAL . 4.4 t-160 -47.76 -36.2 11.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.45 -19.48 33.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.424 -0.797 . . . . 0.0 110.135 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 92.3 p -61.64 -62.42 1.82 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.087 -1.008 . . . . 0.0 110.647 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.43 -19.95 62.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.059 -1.026 . . . . 0.0 109.595 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.3 -40.77 17.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.094 -1.004 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.23 -40.41 12.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.122 -0.987 . . . . 0.0 109.868 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.461 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 40.3 t80 -50.48 -20.84 1.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.898 -1.126 . . . . 0.0 108.717 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 133' ' ' SER . 23.6 mt -68.97 -17.88 63.99 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.78 72.17 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 80.0 p -81.49 -26.82 34.89 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.27 -0.894 . . . . 0.0 108.596 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.42 -26.72 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.416 -0.802 . . . . 0.0 109.077 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 129' ' ' LEU . 1.9 t -82.68 -31.53 28.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.123 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.8 m -72.98 -36.77 67.16 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.31 -0.869 . . . . 0.0 109.553 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.61 -21.8 15.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.128 -0.983 . . . . 0.0 108.895 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -16.72 59.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.045 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 133' ' ' SER . 14.1 t -143.04 38.51 1.44 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.946 . . . . 0.0 109.6 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -48.46 132.24 16.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -75.45 -9.97 59.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 0.0 109.337 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.406 ' O ' ' O ' ' A' ' 141' ' ' ARG . 35.5 t80 56.95 90.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 140' ' ' TYR . 35.6 mtp85 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.571 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.443 ' C ' ' CD2' ' B' ' 2' ' ' HIS . 5.3 p . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 0.443 ' CD2' ' C ' ' B' ' 1' ' ' VAL . 2.6 p80 173.87 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.782 . . . . 0.0 109.14 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 1.025 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -130.3 172.03 12.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.381 -0.824 . . . . 0.0 109.352 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.425 ' O ' ' N ' ' B' ' 6' ' ' GLU . 7.7 p -90.51 141.59 27.39 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 109.301 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -40.63 -23.92 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.509 2.139 . . . . 0.0 112.376 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' B' ' 4' ' ' THR . 73.1 mm-40 -78.87 -54.67 5.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.831 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -74.85 -23.1 58.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.716 ' HB2' HD13 ' B' ' 3' ' ' LEU . 2.1 tttm -84.29 -32.2 24.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.339 -0.851 . . . . 0.0 109.234 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.9 m -63.67 -23.36 67.34 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.733 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.8 -57.59 3.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.075 -1.016 . . . . 0.0 110.113 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.474 HG23 ' CD2' ' B' ' 130' ' ' TYR . 1.7 p -62.67 -24.35 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 70.1 m -83.98 -35.37 23.98 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.27 0.557 . . . . 0.0 109.74 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.28 -27.4 61.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.391 -0.818 . . . . 0.0 109.663 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.18 -18.73 10.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 109.339 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' TRP . . . . . 0.665 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.5 OUTLIER -50.95 -50.95 56.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.119 -0.988 . . . . 0.0 109.038 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.68 -51.02 60.5 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 7.7 mtmt -53.91 -25.91 22.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.359 -1.083 . . . . 0.0 109.093 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.41 124.31 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 109.74 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' B' ' 21' ' ' ASP . 25.8 m-20 -81.86 68.31 8.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 108.94 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.403 HG22 HD13 ' B' ' 68' ' ' LEU . 70.0 t -45.98 -14.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.405 -0.809 . . . . 0.0 109.81 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' B' ' 19' ' ' ASN . 60.3 t0 -58.02 -18.04 21.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.839 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' B' ' 25' ' ' GLY . 35.1 mt-10 -155.79 -33.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.757 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.9 t -45.98 -23.91 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.249 -0.907 . . . . 0.0 109.702 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.54 -24.69 72.08 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -82.38 -33.03 26.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -74.74 -25.02 58.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -1.195 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.31 94.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.94 . . . . 0.0 109.559 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.41 -50.14 16.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.32 -28.2 8.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.1 -47.45 11.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.137 . . . . 0.0 109.35 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 tp -47.46 -31.55 4.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 109.435 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' B' ' 36' ' ' PRO . 14.4 mt -71.19 -46.1 62.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.23 -55.53 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.324 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.6 -22.93 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.563 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -150.4 76.9 8.29 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 109.492 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.503 ' N ' ' O ' ' B' ' 32' ' ' LEU . 77.5 Cg_endo -82.93 -7.68 11.22 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.813 2.342 . . . . 0.0 112.385 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.471 ' C ' ' H ' ' B' ' 39' ' ' GLN . 21.0 p-90 -63.93 -19.86 65.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 109.508 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 7.8 p -72.63 37.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' B' ' 37' ' ' TRP . 17.2 tt0 -80.71 10.53 4.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.447 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -89.16 -37.56 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.98 . . . . 0.0 109.556 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' PHE . . . . . 0.471 ' C ' ' H ' ' B' ' 43' ' ' GLU . 88.5 m-85 -89.68 -43.29 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 109.566 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.436 ' CE1' HBC3 ' B' ' 147' ' ' HEC . 1.6 m-85 -71.16 14.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 109.367 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' B' ' 41' ' ' PHE . 19.0 pt-20 -66.9 -13.88 62.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.418 ' C ' ' N ' ' B' ' 46' ' ' GLY . 49.9 m -77.63 -42.55 34.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.697 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.54 ' O ' ' N ' ' B' ' 47' ' ' ASP . 39.9 m-85 -47.5 -20.11 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' B' ' 44' ' ' SER . . . 59.14 -79.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' B' ' 45' ' ' PHE . 32.1 t0 -46.7 106.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -1.152 . . . . 0.0 109.555 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tp -163.08 21.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.262 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -52.53 -42.7 64.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 109.658 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.4 p -145.35 152.06 49.2 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.882 . . . . 0.0 109.211 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -40.25 -35.23 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.557 2.171 . . . . 0.0 112.325 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.75 -27.02 63.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.563 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -66.77 -19.97 65.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.2 -51.23 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.557 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 7.4 mmt -66.77 -22.0 66.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.52 -11.12 78.34 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' B' ' 59' ' ' LYS . 20.3 t-20 -71.6 136.28 83.44 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.264 -1.139 . . . . 0.0 109.335 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.11 -35.21 3.2 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.376 2.051 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.515 ' N ' ' OD1' ' B' ' 57' ' ' ASN . 41.0 mttm -63.91 -47.74 79.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.915 . . . . 0.0 109.856 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 96.3 t -46.9 -35.4 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -0.977 . . . . 0.0 109.625 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -49.91 52.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.347 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.78 -32.53 59.96 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.226 -0.921 . . . . 0.0 109.668 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.419 ' NE2' ' CHA' ' B' ' 147' ' ' HEC . 37.1 t-80 -69.71 -23.92 63.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.329 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.78 -37.76 92.57 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -65.85 -25.71 67.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -1.099 . . . . 0.0 109.325 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -74.73 -49.0 22.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.93 -60.7 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.337 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.645 HD23 ' O ' ' B' ' 68' ' ' LEU . 1.3 tt -62.87 -21.16 65.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 109.097 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.76 -52.56 14.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.07 -35.21 33.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -1.134 . . . . 0.0 109.59 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' B' ' 137' ' ' VAL . 22.7 m-85 -66.8 -49.81 64.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.665 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.1 t -56.83 -30.85 64.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.45 -0.781 . . . . 0.0 109.415 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -59.67 -40.33 87.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.323 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.86 -60.1 8.61 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.585 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -50.48 -26.42 5.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.335 -1.097 . . . . 0.0 109.31 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.68 -2.53 58.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.959 . . . . 0.0 109.484 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.517 ' CE1' ' OD2' ' B' ' 79' ' ' ASP . 71.1 t60 -171.07 62.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -0.912 . . . . 0.0 109.582 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 25.4 mt -70.3 2.19 4.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.178 -0.951 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.517 ' OD2' ' CE1' ' B' ' 77' ' ' HIS . 54.9 m-20 -55.79 -26.72 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.418 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 15.6 t-20 -170.62 112.0 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.6 mt -80.19 -58.18 3.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -47.23 -24.08 0.66 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -63.66 -51.47 53.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.452 ' C ' ' H ' ' B' ' 86' ' ' ALA . 0.7 OUTLIER -85.59 -39.56 17.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -1.158 . . . . 0.0 109.346 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.437 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.7 m-85 -70.54 10.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.614 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -67.84 -33.65 75.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -82.09 -53.34 6.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 109.432 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.464 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 35.8 mt -51.76 -49.72 62.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 0.0 109.29 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 7.3 m -59.74 -50.49 73.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.377 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.28 -38.77 92.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.869 . . . . 0.0 109.384 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 5.1 tt -74.53 -32.48 62.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.35 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' B' ' 97' ' ' HIS . 15.1 m80 -84.93 -20.3 30.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.108 -0.995 . . . . 0.0 109.644 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 46.6 t -83.74 -59.86 2.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.83 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -86.68 -34.78 19.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.12 -0.988 . . . . 0.0 111.531 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -79.73 -51.77 8.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.857 -1.152 . . . . 0.0 110.563 -178.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.33 -32.57 10.41 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.038 . . . . 0.0 110.244 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.569 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 11.3 t-160 54.07 54.07 10.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.967 . . . . 0.0 109.505 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.31 125.74 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 0.0 109.141 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -49.31 145.86 6.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.08 -11.86 31.22 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.612 2.208 . . . . 0.0 112.158 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -93.66 60.29 2.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -148.87 -46.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.526 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.0 OUTLIER -51.35 -47.43 62.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.65 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -48.31 -19.97 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' B' ' 103' ' ' PHE . 17.1 mt -88.54 -57.73 2.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.603 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.62 HD22 ' HAB' ' B' ' 147' ' ' HEC . 7.0 tt -47.93 -20.9 0.36 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.526 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' GLY . . . . . 0.413 ' O ' HG23 ' B' ' 111' ' ' VAL . . . -81.71 -33.23 28.06 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -83.49 -17.45 41.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -1.115 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 78.6 t -83.18 -56.61 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.496 HD23 ' O ' ' B' ' 110' ' ' LEU . 2.0 tt -48.71 -53.2 19.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.847 . . . . 0.0 109.476 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 107' ' ' GLY . 89.7 t -46.99 -40.85 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.612 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.66 -33.93 76.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.518 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 19.1 t -66.28 -29.29 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.333 -0.855 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 118' ' ' PHE . 8.9 mt -81.68 -52.94 6.65 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.478 ' C ' ' HB1' ' A' ' 110' ' ' ALA . . . -54.08 -24.4 17.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.469 ' N ' ' HB1' ' A' ' 110' ' ' ALA . 0.6 OUTLIER -84.82 -62.63 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 109.579 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -68.58 -17.56 64.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.756 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' B' ' 17' ' ' LYS . 72.4 m-85 -144.3 57.79 1.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -70.49 -23.05 77.87 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -72.62 10.78 0.76 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.252 -1.146 . . . . 0.0 109.509 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' B' ' 123' ' ' THR . 81.2 mm-40 -135.28 -0.34 2.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.39 -0.818 . . . . 0.0 109.642 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.542 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.81 33.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 109.339 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.488 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.0 OUTLIER -50.24 148.16 6.58 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.519 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.2 Cg_exo -46.73 -53.06 6.64 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.428 2.085 . . . . 0.0 113.159 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 26.4 Cg_endo -62.61 -21.83 73.32 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.024 1.816 . . . . 0.0 112.338 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.453 HG23 ' OG1' ' B' ' 123' ' ' THR . 75.2 t -81.58 -25.63 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.506 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' B' ' 123' ' ' THR . 5.5 mp0 -83.21 -59.81 2.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.12 -0.988 . . . . 0.0 109.492 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -45.88 -38.26 7.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.58 29.72 0.86 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 0.0 109.574 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.474 ' CD2' HG23 ' B' ' 11' ' ' VAL . 17.2 t80 -124.24 -22.4 4.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.448 -0.783 . . . . 0.0 109.701 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -83.95 -63.84 1.27 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.123 -0.986 . . . . 0.0 110.061 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -49.76 -21.63 1.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 0.0 109.952 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' VAL . . . . . 0.568 HG22 HD21 ' B' ' 3' ' ' LEU . 2.2 t -72.48 -68.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.972 . . . . 0.0 109.858 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.37 -19.95 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.793 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.94 -28.68 17.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.941 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.36 -36.45 89.23 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' B' ' 71' ' ' PHE . 99.4 t -63.48 -47.92 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -1.117 . . . . 0.0 109.468 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.18 -43.25 31.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 109.354 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -80.02 -38.36 32.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 0.0 109.451 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.34 -48.35 62.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 36.2 mt -75.63 11.04 1.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.42 -4.62 3.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 109.43 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.16 -27.49 64.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.92 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.86 -16.44 36.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -62.17 -61.5 2.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.303 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.467 ' ND1' ' N ' ' B' ' 146' ' ' HIS . 2.0 m-70 . . . . . 0 C--N 1.302 -1.495 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' C' ' 2' ' ' LEU . 29.8 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' C' ' 2' ' ' LEU . 7.8 mp 56.03 163.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.35 -0.844 . . . . 0.0 109.738 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 176.24 -47.92 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.998 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' C' ' 3' ' ' SER . 54.3 Cg_exo -50.31 -170.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.573 2.182 . . . . 0.0 112.579 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -60.24 -16.24 31.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.733 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' C' ' 5' ' ' ALA . 22.1 m-20 -39.45 -29.18 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.448 -0.782 . . . . 0.0 109.696 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' C' ' 10' ' ' VAL . 4.5 ptpt -83.18 -50.0 8.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.369 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.408 ' C ' ' O ' ' C' ' 7' ' ' LYS . 53.3 m -43.86 -32.7 1.14 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 109.733 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.85 -30.29 50.87 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' C' ' 7' ' ' LYS . 51.2 t -76.77 -51.54 18.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' LYS . . . . . 0.541 ' NZ ' HG13 ' C' ' 70' ' ' VAL . 0.1 OUTLIER -57.63 -36.72 72.19 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.767 -1.173 . . . . 0.0 108.285 179.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.74 -58.23 8.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 109.215 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.05 -34.38 63.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 108.877 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -17.49 61.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.355 -0.841 . . . . 0.0 108.886 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.94 -44.68 18.51 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.41 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 17.9 mmtp -70.12 -37.34 75.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.085 -1.244 . . . . 0.0 108.465 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' C' ' 21' ' ' ALA . 4.1 t -60.22 -67.41 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.575 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 59.24 -136.78 50.71 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.29 28.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.543 -0.975 . . . . 0.0 110.474 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.575 ' H ' ' C ' ' C' ' 18' ' ' GLY . 96.9 m-70 -129.63 13.18 5.92 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.568 ' HB2' ' CG1' ' C' ' 17' ' ' VAL . . . -75.05 -52.39 11.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.643 -0.661 . . . . 0.0 109.75 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.07 -14.45 10.95 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.36 -56.47 3.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -1.166 . . . . 0.0 109.691 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.558 ' CD2' ' O ' ' C' ' 20' ' ' HIS . 14.0 m-85 -59.85 -24.88 64.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.86 . . . . 0.0 109.285 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.91 -33.83 85.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.74 -39.12 57.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -1.193 . . . . 0.0 109.661 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' GLU . . . . . 0.431 ' CG ' ' OG1' ' C' ' 108' ' ' THR . 13.2 tt0 -67.45 -20.11 65.45 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.336 -0.853 . . . . 0.0 109.457 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.07 -25.37 61.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.106 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -76.04 -59.36 2.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 109.405 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -56.45 -12.54 1.75 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 109.354 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.536 ' O ' ' NE ' ' C' ' 31' ' ' ARG . 0.0 OUTLIER -65.2 -58.35 6.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -84.51 -32.83 23.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.092 -1.005 . . . . 0.0 110.312 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 20.2 m-85 -63.55 -35.97 82.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.938 -1.101 . . . . 0.0 110.198 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.683 HD12 ' N ' ' C' ' 35' ' ' SER . 3.8 pp -46.97 -40.51 14.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.901 -1.124 . . . . 0.0 109.504 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.683 ' N ' HD12 ' C' ' 34' ' ' LEU . 1.4 p -76.5 -23.66 53.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.931 -1.106 . . . . 0.0 108.875 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.573 ' C ' ' O ' ' C' ' 35' ' ' SER . 0.3 OUTLIER 21.56 65.96 0.3 Allowed Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 121.151 0.5 . . . . 0.0 111.211 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.39 -61.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.407 2.072 . . . . 0.0 112.147 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.545 ' O ' HG22 ' C' ' 41' ' ' THR . 1.1 p -91.18 -57.41 2.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.215 -0.928 . . . . 0.0 109.613 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.477 HG23 ' H ' ' C' ' 39' ' ' THR . 3.0 p -44.21 -22.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.47 -0.769 . . . . 0.0 110.31 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' C' ' 38' ' ' THR . 26.2 ttmt -49.03 -45.13 42.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.957 -1.089 . . . . 0.0 109.596 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.545 HG22 ' O ' ' C' ' 38' ' ' THR . 0.6 OUTLIER -80.0 -19.01 48.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.599 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -77.09 -35.52 56.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.639 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' PHE . . . . . . . . . . . . . 39.8 t80 55.08 79.88 0.32 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.251 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.702 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 72.0 Cg_exo -46.11 -28.01 5.0 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.649 2.233 . . . . 0.0 112.489 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.702 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 0.0 OUTLIER 90.89 35.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 O-C-N 122.055 -0.403 . . . . 0.0 110.686 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.468 ' C ' ' CD1' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -154.4 31.13 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.679 -1.263 . . . . 0.0 110.529 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' C' ' 46' ' ' PHE . 35.8 m-20 42.3 88.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.408 -0.808 . . . . 0.0 110.271 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.596 HD23 ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -65.33 -13.09 57.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.114 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.427 ' O ' ' O ' ' C' ' 50' ' ' HIS . 32.6 p -78.11 165.71 23.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.583 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' HIS . . . . . 0.568 ' N ' ' ND1' ' C' ' 50' ' ' HIS . 0.3 OUTLIER -57.83 -162.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.361 -0.837 . . . . 0.0 109.283 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.82 34.44 10.94 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.55 ' O ' ' N ' ' C' ' 54' ' ' GLN . 30.4 t -139.06 82.25 1.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.286 -1.126 . . . . 0.0 109.218 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.69 -10.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.808 . . . . 0.0 109.847 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' C' ' 52' ' ' SER . 11.7 mt-30 -74.85 -35.25 62.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.3 t -65.67 -48.45 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.54 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.577 ' CD ' ' H ' ' C' ' 56' ' ' LYS . 0.0 OUTLIER -69.18 -25.51 64.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 0.0 109.12 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.91 -21.65 78.97 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.9 t-80 -82.59 -39.79 21.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -1.082 . . . . 0.0 109.798 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.04 -51.56 45.42 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -51.19 -22.67 2.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.445 -1.032 . . . . 0.0 110.153 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.73 -29.7 56.29 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.15 -0.969 . . . . 0.0 109.24 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.488 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -79.81 -49.0 19.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 108.726 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -68.58 -22.84 64.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.308 -0.87 . . . . 0.0 109.189 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -78.17 -30.69 49.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.134 -0.979 . . . . 0.0 108.832 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.64 -48.66 53.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.86 . . . . 0.0 108.996 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.57 -40.62 72.22 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.203 -0.936 . . . . 0.0 108.749 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 15.3 m -68.72 -56.84 6.8 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' C' ' 72' ' ' HIS . 46.6 t30 -55.42 -24.08 28.46 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -80.24 -47.01 15.28 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.541 HG13 ' NZ ' ' C' ' 11' ' ' LYS . 36.2 t -64.35 -22.97 32.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.46 -17.06 64.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.611 ' O ' ' N ' ' C' ' 74' ' ' ASP . 4.3 m-70 -141.88 -61.31 0.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 109.422 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.554 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.2 p 44.78 12.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.728 0.775 . . . . 0.0 109.61 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' C' ' 72' ' ' HIS . 44.5 t0 -134.22 10.44 3.83 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 2.0 m-20 -178.59 28.03 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.762 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 6.5 ptt? -78.52 -23.33 0.41 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.413 -0.805 . . . . 0.0 111.703 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.0 Cg_exo -54.33 -18.83 15.38 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.565 1.51 . . . . 0.0 112.185 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -93.42 -38.06 11.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.17 64.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 108.897 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.62 11.27 15.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.349 -0.845 . . . . 0.0 108.755 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 14.8 t -65.33 -26.82 68.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 109.715 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.92 -49.04 66.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 109.741 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.439 ' N ' HD23 ' C' ' 83' ' ' LEU . 4.1 mt -47.76 -46.96 30.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.026 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.563 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 9.7 t -62.76 -28.52 70.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.64 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.94 -28.1 39.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 109.601 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' C' ' 90' ' ' LYS . 3.7 tt -83.25 -32.35 26.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.827 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 87' ' ' HIS . . . . . 0.413 ' CE1' HD22 ' C' ' 86' ' ' LEU . 67.0 m80 -92.12 -21.94 20.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.13 -0.982 . . . . 0.0 110.122 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -104.03 -48.1 3.99 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.183 -0.948 . . . . 0.0 110.113 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -93.42 21.94 5.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 110.138 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.506 ' C ' ' H ' ' C' ' 92' ' ' ARG . 28.7 ttmt -172.15 147.13 2.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.932 -1.105 . . . . 0.0 110.067 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' C' ' 93' ' ' VAL . 1.0 OUTLIER 71.29 -20.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.386 -0.821 . . . . 0.0 109.536 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 92' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' C' ' 90' ' ' LYS . 70.4 mtt85 43.04 27.36 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 0.0 109.7 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.539 HG22 ' N ' ' C' ' 94' ' ' ASP . 12.2 p -47.08 165.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.539 ' N ' HG22 ' C' ' 93' ' ' VAL . 6.1 p-10 -109.74 101.29 46.11 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.69 -11.01 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.383 2.055 . . . . 0.0 112.274 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 94' ' ' ASP . 51.1 t -50.74 -18.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' C' ' 100' ' ' LEU . 3.1 m120 -79.18 -24.38 43.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.309 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -44.31 -35.8 2.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.338 -0.851 . . . . 0.0 109.745 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -68.0 -23.72 65.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.484 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.583 ' N ' HD12 ' C' ' 100' ' ' LEU . 8.8 mp -84.22 -62.08 1.65 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.626 HD22 ' HAB' ' C' ' 142' ' ' HEC . 6.6 tt -55.52 -23.78 28.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 109.653 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 13.7 p -67.93 -50.33 56.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.762 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -78.05 -26.42 48.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.716 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 96.4 m -50.81 -50.47 56.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.669 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.23 -38.81 54.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 109.811 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.94 -36.21 64.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.478 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.06 -27.68 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.987 -1.071 . . . . 0.0 109.927 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.498 ' CG2' ' N ' ' C' ' 109' ' ' LEU . 0.6 OUTLIER -81.15 -45.1 16.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.831 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.498 ' N ' ' CG2' ' C' ' 108' ' ' THR . 15.5 mt -67.04 -20.52 65.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.089 -1.007 . . . . 0.0 109.068 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' C' ' 112' ' ' HIS . . . -51.78 -42.95 62.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.418 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.76 -3.67 0.12 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 109.212 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' HIS . . . . . 0.522 ' H ' ' C ' ' C' ' 110' ' ' ALA . 81.0 m80 -143.23 -85.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.38 -0.825 . . . . 0.0 109.249 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.833 ' O ' HD23 ' C' ' 113' ' ' LEU . 0.0 OUTLIER -139.88 100.04 7.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.26 -98.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.564 2.176 . . . . 0.0 112.807 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.808 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -72.22 -56.46 5.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.576 -0.702 . . . . 0.0 110.037 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.676 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 17.5 mt-10 116.56 -6.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 4.9 t80 79.56 33.28 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.318 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.714 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -108.92 125.11 32.36 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.93 21.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.239 1.959 . . . . 0.0 112.79 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.714 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -149.47 -32.59 0.21 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.901 -1.124 . . . . 0.0 110.336 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.808 HG21 ' O ' ' C' ' 115' ' ' ALA . 9.6 p -54.86 -48.91 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.058 -1.026 . . . . 0.0 110.413 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.632 ' N ' HG13 ' C' ' 121' ' ' VAL . 4.4 t-160 -47.78 -36.17 11.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.44 -19.45 33.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 110.149 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' C' ' 128' ' ' PHE . 92.5 p -61.64 -62.41 1.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 110.686 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.37 -20.03 62.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.997 -1.065 . . . . 0.0 109.619 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.28 -40.72 17.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.105 -0.997 . . . . 0.0 109.548 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.2 -40.42 12.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 109.845 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.465 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 40.4 t80 -50.51 -20.81 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.869 -1.145 . . . . 0.0 108.7 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' C' ' 133' ' ' SER . 23.4 mt -68.98 -17.95 64.0 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.79 72.13 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 79.6 p -81.48 -26.84 34.89 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.37 -26.84 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 109.108 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.54 ' N ' ' O ' ' C' ' 129' ' ' LEU . 1.9 t -82.51 -31.55 29.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.214 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 26.0 m -73.06 -36.71 66.94 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.373 -0.829 . . . . 0.0 109.486 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.61 -21.74 15.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.137 -0.977 . . . . 0.0 108.933 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -16.81 59.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.435 -0.791 . . . . 0.0 108.914 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 137' ' ' THR . . . . . 0.455 HG22 ' O ' ' C' ' 133' ' ' SER . 14.2 t -143.08 38.43 1.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 17.2 m -48.35 132.19 16.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.541 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -75.33 -10.11 59.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.387 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.407 ' O ' ' O ' ' C' ' 141' ' ' ARG . 35.4 t80 56.99 91.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.444 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 141' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' C' ' 140' ' ' TYR . 35.7 mtp85 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.438 ' C ' ' CD2' ' D' ' 2' ' ' HIS . 5.2 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 2' ' ' HIS . . . . . 0.438 ' CD2' ' C ' ' D' ' 1' ' ' VAL . 2.6 p80 173.8 93.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 109.127 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 1.054 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -130.32 171.95 12.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.306 -0.872 . . . . 0.0 109.382 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.416 ' O ' ' N ' ' D' ' 6' ' ' GLU . 7.6 p -90.54 141.63 27.37 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.262 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -40.59 -24.05 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.507 2.138 . . . . 0.0 112.398 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' D' ' 4' ' ' THR . 73.3 mm-40 -78.73 -54.79 5.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.932 . . . . 0.0 109.824 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -74.75 -23.13 58.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 109.614 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.726 ' HB2' HD13 ' D' ' 3' ' ' LEU . 2.2 tttm -84.29 -32.17 24.51 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.372 -0.83 . . . . 0.0 109.34 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 m -63.77 -23.31 67.31 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.677 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.82 -57.52 3.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.963 . . . . 0.0 110.125 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.477 HG23 ' CD2' ' D' ' 130' ' ' TYR . 1.7 p -62.68 -24.37 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 70.6 m -84.07 -35.24 23.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.773 -0.579 . . . . 0.0 109.717 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.33 -27.33 61.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.622 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.25 -18.75 11.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.33 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 15' ' ' TRP . . . . . 0.655 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.5 OUTLIER -50.98 -50.88 57.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.008 . . . . 0.0 109.062 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.73 -50.98 60.84 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.484 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 7.7 mtmt -53.9 -25.85 22.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.407 -1.054 . . . . 0.0 109.175 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.2 t -91.49 124.36 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 0.0 109.698 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' D' ' 21' ' ' ASP . 25.7 m-20 -81.89 68.26 8.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.874 . . . . 0.0 108.925 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.416 ' O ' HG12 ' D' ' 20' ' ' VAL . 69.0 t -45.96 -14.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 109.812 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' D' ' 19' ' ' ASN . 60.4 t0 -58.01 -18.1 21.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.764 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -155.78 -33.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.059 -1.025 . . . . 0.0 109.758 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -46.07 -23.89 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.644 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.57 -24.66 72.09 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.45 -32.96 26.61 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -74.78 -24.97 58.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -1.218 . . . . 0.0 109.548 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.25 -40.25 93.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.45 -50.03 17.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.38 -28.2 9.07 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.05 -47.57 11.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -1.117 . . . . 0.0 109.276 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 tp -47.34 -31.61 4.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' D' ' 36' ' ' PRO . 14.4 mt -71.16 -46.16 62.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.441 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.12 -55.58 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.373 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.409 ' H ' HG23 ' D' ' 34' ' ' VAL . 2.7 t -67.69 -22.86 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.886 . . . . 0.0 109.501 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -150.48 76.94 8.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' PRO . . . . . 0.517 ' N ' ' O ' ' D' ' 32' ' ' LEU . 77.8 Cg_endo -82.89 -7.75 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.878 2.385 . . . . 0.0 112.351 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 37' ' ' TRP . . . . . 0.474 ' C ' ' H ' ' D' ' 39' ' ' GLN . 20.9 p-90 -63.85 -20.0 65.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 7.9 p -72.6 37.44 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.396 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' D' ' 37' ' ' TRP . 17.2 tt0 -80.73 10.54 4.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -89.13 -37.66 14.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.49 ' C ' ' H ' ' D' ' 43' ' ' GLU . 88.4 m-85 -89.65 -43.32 10.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 109.574 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.426 ' CE1' HBC3 ' D' ' 147' ' ' HEC . 1.6 m-85 -71.09 14.73 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.379 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 43' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' D' ' 41' ' ' PHE . 19.0 pt-20 -66.89 -13.87 62.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.085 -1.009 . . . . 0.0 109.492 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' SER . . . . . 0.417 ' O ' ' N ' ' D' ' 46' ' ' GLY . 49.8 m -77.75 -42.5 33.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' D' ' 47' ' ' ASP . 39.9 m-85 -47.53 -20.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.461 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 59.09 -79.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' D' ' 45' ' ' PHE . 32.1 t0 -46.83 106.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -1.174 . . . . 0.0 109.553 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -163.08 21.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 0.0 109.269 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -52.61 -42.58 64.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 109.708 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' THR . . . . . 0.432 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.4 p -145.4 152.08 49.04 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.319 -0.863 . . . . 0.0 109.265 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -40.28 -35.16 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.421 2.081 . . . . 0.0 112.365 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.74 -27.1 63.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.588 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -66.76 -19.94 65.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 t -74.13 -51.35 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.463 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 7.4 mmt -66.73 -22.03 66.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.56 -11.07 78.35 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' D' ' 59' ' ' LYS . 20.1 t-20 -71.73 136.33 83.07 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.169 -1.195 . . . . 0.0 109.266 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.07 -35.26 3.19 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.431 2.087 . . . . 0.0 112.374 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' D' ' 57' ' ' ASN . 40.9 mttm -63.95 -47.78 79.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 97.6 t -46.76 -35.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 109.795 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -49.9 52.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 109.355 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.76 -32.65 60.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.417 ' NE2' ' CHA' ' D' ' 147' ' ' HEC . 36.9 t-80 -69.58 -24.0 63.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.8 -37.66 92.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -65.94 -25.63 67.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -1.143 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -74.71 -49.07 22.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 0.0 109.435 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.82 -60.76 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.312 -0.867 . . . . 0.0 109.362 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.642 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.3 tt -62.85 -21.16 65.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.124 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.78 -52.43 15.15 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.02 -35.3 33.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 109.571 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 71' ' ' PHE . . . . . 0.428 ' CE2' HMB1 ' D' ' 147' ' ' HEC . 22.7 m-85 -66.81 -49.83 64.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 109.446 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 72' ' ' SER . . . . . 0.655 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 8.1 t -56.75 -30.94 64.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.413 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -59.62 -40.36 87.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.324 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.75 -60.23 8.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.579 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.6 mp -50.38 -26.56 5.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -1.125 . . . . 0.0 109.347 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.61 -2.57 58.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.149 -0.97 . . . . 0.0 109.435 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.516 ' CE1' ' OD2' ' D' ' 79' ' ' ASP . 71.3 t60 -171.01 62.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.547 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 25.1 mt -70.21 2.16 4.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.516 ' OD2' ' CE1' ' D' ' 77' ' ' HIS . 55.0 m-20 -55.92 -26.6 48.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 80' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 15.6 t-20 -170.6 111.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.428 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 14.5 mt -80.2 -58.11 3.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 109.507 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -47.31 -24.1 0.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 83' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -63.61 -51.51 53.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.448 ' C ' ' H ' ' D' ' 86' ' ' ALA . 0.7 OUTLIER -85.48 -39.65 17.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -1.14 . . . . 0.0 109.426 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.443 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.5 m-85 -70.53 10.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 109.532 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 86' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -67.75 -33.8 75.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.328 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -82.1 -53.21 6.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.456 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 35.6 mt -51.91 -49.69 62.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.252 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 7.2 m -59.69 -50.42 73.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.423 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.34 -38.84 92.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.392 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 5.1 tt -74.35 -32.56 62.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' D' ' 97' ' ' HIS . 15.2 m80 -84.91 -20.3 30.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.083 -1.011 . . . . 0.0 109.615 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 46.5 t -83.76 -59.92 2.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 0.0 110.844 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 41' ' ' THR . 37.4 m-20 -86.6 -34.76 19.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.065 -1.022 . . . . 0.0 111.565 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 95' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -79.82 -51.67 8.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.772 -1.205 . . . . 0.0 110.619 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.31 -32.73 10.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.064 . . . . 0.0 110.258 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.56 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 11.3 t-160 54.3 54.12 9.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 109.348 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.39 125.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.947 . . . . 0.0 109.156 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -49.33 145.88 7.01 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 109.322 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.11 -11.82 31.1 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.559 2.173 . . . . 0.0 112.098 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -93.71 60.36 2.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -148.83 -46.99 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 109.573 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 103' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 1.0 OUTLIER -51.34 -47.43 62.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.671 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -48.35 -19.89 0.35 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.437 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 105' ' ' LEU . . . . . 0.411 ' N ' ' C ' ' D' ' 103' ' ' PHE . 17.3 mt -88.69 -57.63 2.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.565 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.604 HD22 ' HAB' ' D' ' 147' ' ' HEC . 7.0 tt -47.93 -20.94 0.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.528 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 107' ' ' GLY . . . . . 0.407 ' O ' HG23 ' D' ' 111' ' ' VAL . . . -81.72 -33.2 28.1 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -83.42 -17.51 41.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -1.191 . . . . 0.0 109.59 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 78.7 t -83.14 -56.66 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 110' ' ' LEU . . . . . 0.495 ' O ' HD23 ' D' ' 110' ' ' LEU . 2.0 tt -48.67 -53.17 19.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.456 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 111' ' ' VAL . . . . . 0.407 HG23 ' O ' ' D' ' 107' ' ' GLY . 88.6 t -47.03 -40.83 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.942 . . . . 0.0 109.631 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.74 -33.86 76.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.9 . . . . 0.0 109.521 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 t -66.3 -29.31 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 114' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' D' ' 118' ' ' PHE . 8.9 mt -81.61 -53.04 6.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.478 ' C ' ' HB1' ' C' ' 110' ' ' ALA . . . -54.02 -24.41 16.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.508 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.468 ' N ' ' HB1' ' C' ' 110' ' ' ALA . 0.6 OUTLIER -84.81 -62.58 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.606 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -68.59 -17.63 64.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.87 . . . . 0.0 109.664 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.484 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 72.2 m-85 -144.22 57.82 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 109.488 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -70.5 -23.06 77.87 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -72.61 10.81 0.75 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -1.151 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' D' ' 123' ' ' THR . 81.2 mm-40 -135.32 -0.26 2.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 0.0 109.762 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.529 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -73.77 33.54 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.486 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.0 OUTLIER -50.2 148.23 6.43 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.464 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.515 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.3 Cg_exo -46.85 -52.98 6.82 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.425 2.083 . . . . 0.0 113.119 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 26.1 Cg_endo -62.56 -21.99 73.48 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.115 1.877 . . . . 0.0 112.329 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.459 HG23 ' OG1' ' D' ' 123' ' ' THR . 75.8 t -81.59 -25.52 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.141 -0.974 . . . . 0.0 109.513 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 127' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' D' ' 123' ' ' THR . 5.4 mp0 -83.41 -59.66 2.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.508 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -45.87 -38.2 7.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.543 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.59 29.54 0.88 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.489 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.477 ' CD2' HG23 ' D' ' 11' ' ' VAL . 17.1 t80 -124.14 -22.4 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.707 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -83.99 -63.7 1.3 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.951 . . . . 0.0 110.099 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -49.75 -21.64 1.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 109.978 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 133' ' ' VAL . . . . . 0.588 HG22 HD21 ' D' ' 3' ' ' LEU . 2.2 t -72.45 -68.29 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.063 -1.023 . . . . 0.0 109.851 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.28 -19.95 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.844 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.03 -28.63 17.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.109 -0.994 . . . . 0.0 109.39 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.44 -36.4 88.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 137' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' D' ' 71' ' ' PHE . 99.4 t -63.47 -47.93 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -1.165 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.14 -43.21 31.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.894 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -80.2 -38.24 31.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.38 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.38 -48.43 62.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.346 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 36.0 mt -75.53 10.97 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.381 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.4 -4.66 3.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.365 -0.834 . . . . 0.0 109.441 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.11 -27.46 64.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.91 -16.38 36.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -62.19 -61.61 2.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.255 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.481 ' N ' ' ND1' ' D' ' 146' ' ' HIS . 2.0 m-70 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.519 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.94 HMB1 HBB3 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 0.62 ' HAB' HD22 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.974 HMB1 HBB3 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 0.604 ' HAB' HD22 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 2' ' ' LEU . 21.8 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.3 mp 55.12 166.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.76 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.568 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 176.14 -45.22 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.851 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 3' ' ' SER . 42.3 Cg_exo -55.36 -153.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.616 2.21 . . . . 0.0 112.864 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -78.61 -15.26 58.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.474 -0.766 . . . . 0.0 110.003 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 5' ' ' ALA . 16.4 m-20 -38.78 -29.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.379 -0.826 . . . . 0.0 109.735 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . 2.0 ptpm? -83.39 -41.79 17.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.187 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.481 ' N ' ' O ' ' A' ' 5' ' ' ALA . 45.9 m -51.35 -29.82 16.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.312 -0.868 . . . . 0.0 109.083 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.72 -36.87 42.74 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.486 HG21 ' CD2' ' A' ' 128' ' ' PHE . 53.7 t -70.99 -49.05 52.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -52.99 -46.02 68.11 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.02 -58.06 10.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.498 -0.751 . . . . 0.0 109.36 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.834 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -53.19 -35.96 60.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.406 -0.808 . . . . 0.0 109.129 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -17.14 62.29 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.256 -0.902 . . . . 0.0 109.302 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.08 22.6 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 12.9 mmmt -73.01 -35.89 66.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -1.115 . . . . 0.0 108.744 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 13' ' ' ALA . 57.9 t -62.02 -64.56 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 43.63 -122.35 3.93 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.31 22.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.403 -1.057 . . . . 0.0 110.345 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.545 ' H ' ' C ' ' A' ' 18' ' ' GLY . 78.2 m-70 -128.81 26.16 5.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' A' ' 63' ' ' ALA . . . -91.86 -63.1 1.29 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.621 -0.675 . . . . 0.0 109.9 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.7 -14.27 0.22 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 21' ' ' ALA . 10.4 mt-10 -84.72 -56.19 3.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -1.129 . . . . 0.0 109.814 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 20' ' ' HIS . 4.7 m-30 -60.24 -16.57 34.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.31 -34.14 30.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.07 39.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -1.2 . . . . 0.0 110.033 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.02 -19.73 64.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 109.662 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.72 -19.76 60.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 109.714 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.619 HD11 ' ND1' ' A' ' 58' ' ' HIS . 5.7 mt -78.73 -49.48 13.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 109.997 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' OE1' ' ND1' ' A' ' 50' ' ' HIS . 10.1 pt-20 -72.3 -33.25 67.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.091 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.575 ' NH1' ' SG ' ' A' ' 104' ' ' CYS . 45.8 ttt-85 -54.87 -44.58 74.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.927 . . . . 0.0 110.618 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.542 ' CE ' HBC2 ' A' ' 142' ' ' HEC . 12.0 ptt? -84.13 -45.35 13.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.889 -1.132 . . . . 0.0 110.153 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -49.23 -41.42 37.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 109.825 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 34' ' ' LEU . 2.5 pp -75.04 -38.75 61.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.982 -1.074 . . . . 0.0 109.586 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.43 ' N ' HD12 ' A' ' 34' ' ' LEU . 15.7 m -75.52 7.43 3.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.015 -1.053 . . . . 0.0 109.29 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 1.08 ' CZ ' ' NE2' ' B' ' 131' ' ' GLN . 77.0 m-85 -156.13 71.9 5.13 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.39 -19.86 0.77 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.727 2.285 . . . . 0.0 112.265 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 p -59.23 -22.79 61.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 p -89.48 -42.87 11.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -52.16 -38.97 59.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.533 ' C ' ' H ' ' A' ' 43' ' ' PHE . 2.7 t -68.43 -18.59 64.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -61.42 4.13 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 109.605 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.533 ' H ' ' C ' ' A' ' 41' ' ' THR . 42.1 m-85 54.17 65.79 4.96 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.584 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 74.4 Cg_endo -78.55 -12.6 15.22 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.856 2.371 . . . . 0.0 112.379 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 44' ' ' PRO . 26.9 p-80 40.48 29.42 0.06 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.405 -0.809 . . . . 0.0 109.588 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.523 ' O ' ' C ' ' A' ' 47' ' ' ASP . 5.3 t80 -120.15 27.8 8.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.666 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 46' ' ' PHE . 1.6 p30 28.2 72.86 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.853 -0.529 . . . . 0.0 110.819 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 48' ' ' LEU . 2.2 mm? -64.83 -7.77 12.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.129 -0.982 . . . . 0.0 109.316 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 t -49.25 152.15 1.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.537 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.532 ' ND1' ' OE1' ' A' ' 30' ' ' GLU . 83.2 t60 -76.04 152.84 36.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.78 18.72 59.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.0 t -68.0 -99.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.246 -1.15 . . . . 0.0 109.311 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 174.0 -78.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.506 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -44.85 -17.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.395 -0.816 . . . . 0.0 109.589 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ALA . 3.5 t -76.72 -27.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.214 -0.929 . . . . 0.0 109.433 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.9 ptmt -66.02 -26.99 67.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 0.0 109.458 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.47 -42.18 42.01 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.619 ' ND1' HD11 ' A' ' 29' ' ' LEU . 15.1 t-80 -63.08 -27.98 69.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -1.203 . . . . 0.0 109.688 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.59 -47.31 90.25 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 32.6 mttp -56.08 -23.8 36.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -1.134 . . . . 0.0 109.754 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.599 ' HB3' HMA3 ' A' ' 142' ' ' HEC . 10.0 mmpt? -72.54 -42.52 64.64 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.304 -0.872 . . . . 0.0 109.05 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.4 t -68.92 -47.69 74.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.517 -0.739 . . . . 0.0 109.2 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -69.91 -30.0 67.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.311 -0.868 . . . . 0.0 109.531 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.3 t70 -69.22 -41.88 76.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.122 -0.986 . . . . 0.0 108.821 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.38 -47.94 79.98 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 70' ' ' VAL . 4.8 mt -61.03 -47.14 87.81 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -62.22 -47.31 85.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 108.948 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -63.38 -26.71 68.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 108.682 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.14 -46.71 11.64 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 66' ' ' LEU . 78.4 t -65.99 -22.43 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.25 -21.67 66.3 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.586 ' O ' ' N ' ' A' ' 74' ' ' ASP . 13.2 m80 -144.18 -50.59 0.3 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.9 p 44.87 14.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 121.792 0.806 . . . . 0.0 109.489 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 72' ' ' HIS . 14.6 t70 -128.62 9.56 5.99 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -173.74 27.12 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.046 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.3 ptt? -78.36 -24.92 0.45 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.415 -0.803 . . . . 0.0 111.594 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 76' ' ' MET . 43.7 Cg_exo -55.56 -20.62 27.72 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.766 1.644 . . . . 0.0 112.538 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.52 HD22 ' C ' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -94.06 -28.75 15.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.868 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.54 -48.05 20.64 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.142 -0.974 . . . . 0.0 109.178 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 80' ' ' LEU . 6.9 mp -79.13 6.89 8.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.15 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -59.4 -15.74 18.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.635 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.83 -48.7 11.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 109.74 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 83' ' ' LEU . 4.7 mt -47.19 -48.35 23.83 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 88.3 p -50.18 -24.82 3.04 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.093 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 82' ' ' ALA . 15.0 t70 -74.45 -25.5 59.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.158 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.467 HD21 ' CBD' ' A' ' 142' ' ' HEC . 6.9 tp -81.82 -34.29 30.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.299 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -90.44 -21.78 21.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -71.21 -68.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.907 . . . . 0.0 109.675 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -88.4 -77.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.91 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 86' ' ' LEU . 19.3 mttm -59.31 171.18 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.868 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.528 ' C ' ' H ' ' A' ' 93' ' ' VAL . 4.0 tp 56.79 56.95 5.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 109.682 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -66.05 9.75 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.953 . . . . 0.0 109.315 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 94' ' ' ASP . 12.4 p -46.4 165.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.664 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.551 ' CG ' ' OD1' ' D' ' 99' ' ' ASP . 5.3 m-20 -84.34 116.96 67.47 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.299 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 97' ' ' ASN . 84.4 Cg_exo -44.28 -10.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.297 1.998 . . . . 0.0 112.357 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.723 ' CG2' ' OD2' ' D' ' 99' ' ' ASP . 98.2 t -53.88 -10.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 109.56 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 95' ' ' PRO . 2.7 m-80 -79.24 -24.9 42.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -53.16 -43.71 67.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.576 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 99' ' ' LYS . 7.5 mtmp? -69.32 -25.41 64.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.683 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 25.3 mt -81.67 -46.69 13.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.707 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.875 HD21 HBB3 ' A' ' 142' ' ' HEC . 6.3 tt -69.68 -20.76 63.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.694 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.7 p -78.75 -59.07 2.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 109.746 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -63.29 -26.72 68.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.806 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.575 ' SG ' ' NH1' ' A' ' 31' ' ' ARG . 35.0 m -65.08 -52.26 56.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 109.818 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -24.62 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.749 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.75 -34.85 60.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.083 -1.011 . . . . 0.0 109.926 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' HE ' ' A' ' 31' ' ' ARG . 71.1 t -83.33 -24.65 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.058 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -70.98 -63.64 1.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.137 -0.977 . . . . 0.0 110.458 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 113' ' ' LEU . 2.3 pp -64.04 -18.68 64.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.847 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.35 -33.29 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 0.0 109.709 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.79 -56.15 25.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.371 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -66.52 -68.28 0.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.115 -0.991 . . . . 0.0 108.422 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.1 pp -116.67 111.44 41.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.637 ' O ' HD12 ' A' ' 113' ' ' LEU . 89.2 Cg_exo -41.58 -177.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.571 2.18 . . . . 0.0 113.167 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.702 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -45.45 -52.48 10.1 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.64 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 19.4 mt-10 124.98 -1.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 61.21 31.47 19.51 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.194 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.776 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -103.82 120.47 51.26 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.48 23.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.007 1.805 . . . . 0.0 112.663 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.776 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -152.51 -32.53 0.13 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.965 -1.084 . . . . 0.0 110.514 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.702 HG21 ' O ' ' A' ' 115' ' ' ALA . 14.4 p -47.86 -48.26 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.957 -1.09 . . . . 0.0 110.081 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.64 ' N ' HG13 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -63.76 -39.01 93.23 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 109.365 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.29 -19.78 33.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 120' ' ' ALA . 7.6 p -58.44 -62.07 2.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 110.018 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.507 ' N ' ' OG ' ' A' ' 124' ' ' SER . 5.0 mt -68.57 -19.58 64.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 109.329 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -73.74 -52.18 14.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.747 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.463 ' CD ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -86.29 -44.4 12.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 109.971 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' CD2' HG21 ' A' ' 10' ' ' VAL . 39.5 t80 -47.43 -20.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.988 -1.07 . . . . 0.0 108.992 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 133' ' ' SER . 12.0 mt -71.88 -17.99 62.08 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.32 -33.56 73.8 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 135' ' ' VAL . 89.2 p -82.72 -29.88 29.5 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.408 -0.808 . . . . 0.0 108.834 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 t -85.23 -29.73 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 109.134 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 129' ' ' LEU . 18.0 m -82.79 -22.64 34.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 0.0 108.936 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 138' ' ' SER . 42.1 m -80.72 -39.93 26.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.332 -0.855 . . . . 0.0 109.223 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 131' ' ' SER . 26.8 m -71.05 -26.5 27.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.211 -0.931 . . . . 0.0 108.899 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.02 -31.92 73.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -0.788 . . . . 0.0 108.96 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.0 m -156.81 53.63 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 134' ' ' THR . 9.1 p -58.8 115.09 2.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.497 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 140' ' ' TYR . 14.5 pttm -73.07 -25.85 61.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.917 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.517 ' CG ' ' O ' ' A' ' 139' ' ' LYS . 64.1 m-85 -159.74 154.12 23.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.387 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' C' ' 141' ' ' ARG . 22.4 mtm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.535 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.528 ' O ' ' CG ' ' B' ' 2' ' ' HIS . 6.8 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.331 0.586 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' B' ' 1' ' ' VAL . 43.9 m80 -159.07 102.58 1.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.297 -0.877 . . . . 0.0 109.163 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.913 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.1 OUTLIER -142.74 164.53 29.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 109.362 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.83 159.43 68.83 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.827 . . . . 0.0 109.348 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.74 -18.64 65.3 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.632 2.221 . . . . 0.0 112.003 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.5 -34.25 23.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.5 -61.76 1.76 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 109.591 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.696 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -47.01 -26.74 1.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.91 . . . . 0.0 109.609 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.0 t -57.11 -23.39 46.73 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.59 -57.69 3.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.917 -1.115 . . . . 0.0 110.102 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.4 -24.58 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 48.1 m -82.09 -36.92 27.09 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.396 0.617 . . . . 0.0 109.759 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.5 -34.65 70.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.597 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.7 OUTLIER -50.49 -34.56 25.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 109.157 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -45.74 -17.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.372 -0.83 . . . . 0.0 109.66 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.25 -49.41 7.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.45 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 0.1 OUTLIER -71.95 -30.28 65.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.2 . . . . 0.0 109.396 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.434 HG22 ' CD2' ' B' ' 114' ' ' LEU . 77.5 t -53.46 114.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 109.649 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' B' ' 21' ' ' ASP . 36.3 m-80 -79.53 66.04 4.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 108.946 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' B' ' 22' ' ' GLU . 72.1 t -43.72 -26.13 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.471 -0.768 . . . . 0.0 109.852 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' B' ' 19' ' ' ASN . 18.0 t70 -65.51 5.13 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' B' ' 20' ' ' VAL . 37.5 mt-10 -154.03 -51.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.976 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 88.0 t -49.63 -53.3 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.76 -40.46 25.95 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.63 -37.14 61.94 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.05 -35.77 61.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -1.144 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.83 68.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.507 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 tp -84.94 -52.06 6.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.533 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.76 -28.49 70.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -79.22 -28.21 42.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -1.173 . . . . 0.0 109.477 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' LEU . . . . . 0.421 HD13 ' HB3' ' B' ' 106' ' ' LEU . 44.6 tp -48.08 -39.79 21.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.546 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.461 ' CD2' ' OG1' ' B' ' 38' ' ' THR . 21.1 mt -81.08 -23.01 38.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 71.5 t -66.23 -61.68 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.979 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -78.44 -22.63 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 110.047 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -134.57 77.03 59.77 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.067 -1.02 . . . . 0.0 109.926 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -84.2 27.89 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.014 2.476 . . . . 0.0 112.277 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -81.04 -20.13 42.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 109.89 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.532 ' C ' ' H ' ' B' ' 40' ' ' ARG . 6.1 p -47.7 -29.25 2.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.67 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 52.0 6.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' B' ' 38' ' ' THR . 42.6 ttm180 -110.21 -39.96 4.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 109.207 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 47.69 19.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 1.3 ' CE2' HMD3 ' B' ' 147' ' ' HEC . 77.2 m-85 54.53 55.18 8.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 109.388 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -46.3 -16.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.341 -0.849 . . . . 0.0 109.583 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.515 ' N ' ' O ' ' B' ' 42' ' ' PHE . 20.0 m -57.64 -54.68 44.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.432 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -70.12 3.75 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 109.235 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.16 -149.45 1.24 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 56.52 73.11 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -1.132 . . . . 0.0 109.669 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 89.8 mt -137.42 29.72 2.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.85 . . . . 0.0 109.384 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 41.5 t -72.49 -38.0 68.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -0.922 . . . . 0.0 109.541 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -146.16 151.91 45.72 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -40.93 -35.34 1.66 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.384 2.056 . . . . 0.0 112.38 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.99 -32.14 73.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 109.554 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.2 -24.0 66.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.565 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.33 -60.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -91.91 25.48 2.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.966 . . . . 0.0 109.629 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.2 -52.44 2.05 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.84 157.0 90.78 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 109.437 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' B' ' 62' ' ' ALA . 65.8 Cg_endo -74.96 -44.59 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.709 2.273 . . . . 0.0 112.322 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -45.95 -35.32 4.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.727 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 38.0 t -76.12 -41.57 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -79.18 -24.85 42.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.868 . . . . 0.0 109.545 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' B' ' 58' ' ' PRO . . . -76.55 -51.14 12.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.616 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 1.076 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 45.7 t-80 -51.28 -23.95 4.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.86 -45.63 95.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -50.74 -44.7 58.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -1.113 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -57.82 -51.52 69.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.51 -0.744 . . . . 0.0 109.434 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 0.874 HG13 ' C2B' ' B' ' 147' ' ' HEC . 53.7 t -57.88 -51.14 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.291 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.77 -45.35 94.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.256 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.76 -45.83 31.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.15 92.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -1.14 . . . . 0.0 109.614 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -57.59 -28.86 63.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 11.6 m -77.16 -33.62 56.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.476 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.38 -34.24 33.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.463 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.24 -60.0 7.25 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.59 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.8 mp -55.03 -27.5 45.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -1.104 . . . . 0.0 109.45 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -2.14 36.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -171.26 63.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.49 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.484 ' CD2' HG11 ' B' ' 1' ' ' VAL . 9.4 mt -70.99 -18.06 62.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 109.376 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -48.8 -26.05 2.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.445 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -171.34 65.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.276 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.437 HD12 ' N ' ' B' ' 82' ' ' LYS . 2.5 pp -55.69 -40.92 73.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.627 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.437 ' N ' HD12 ' B' ' 81' ' ' LEU . 39.5 mttp -50.35 -23.92 2.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.473 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.0 -42.88 7.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.7 OUTLIER -68.26 -42.92 78.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.148 -1.207 . . . . 0.0 109.629 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' B' ' 84' ' ' THR . 35.7 m-85 -67.3 -0.39 3.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -0.838 . . . . 0.0 109.459 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.46 -53.92 20.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.945 . . . . 0.0 109.383 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.5 p -61.6 -58.76 6.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' B' ' 92' ' ' HIS . 50.3 mt -51.21 -49.84 60.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.206 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' SER . . . . . 0.516 ' O ' ' N ' ' B' ' 93' ' ' CYS . 7.2 m -57.16 -46.24 82.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.249 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.536 ' HA ' ' HZ2' ' B' ' 144' ' ' LYS . 31.0 tt0 -62.21 -46.53 88.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.486 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 3.9 tt -72.62 -27.24 62.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 109.361 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' B' ' 88' ' ' LEU . 18.7 m80 -90.47 -20.29 22.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.978 . . . . 0.0 109.663 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' B' ' 89' ' ' SER . 26.6 t -83.17 -59.23 2.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 110.699 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.65 -40.51 15.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.988 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.1 OUTLIER -73.01 -51.96 16.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.945 -1.097 . . . . 0.0 110.642 -178.475 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.57 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 30.8 mt -95.79 -36.89 10.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.91 -1.119 . . . . 0.0 109.96 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 38.6 p-80 43.71 30.78 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.427 ' H ' HG23 ' B' ' 98' ' ' VAL . 3.4 t -52.32 153.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 0.0 109.215 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 0.681 ' OD2' ' CG2' ' C' ' 96' ' ' VAL . 1.6 m-20 -71.24 143.05 87.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 109.589 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -41.22 -43.87 5.38 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.608 2.206 . . . . 0.0 112.46 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -72.01 54.46 0.28 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.449 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.606 ' O ' HMC2 ' B' ' 147' ' ' HEC . 9.5 m120 -150.98 -31.17 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 109.969 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.52 -41.68 54.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.072 -1.017 . . . . 0.0 109.931 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.424 ' O ' ' ND2' ' B' ' 108' ' ' ASN . 73.8 ttt180 -79.59 -19.98 48.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 110.071 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.443 ' N ' HD22 ' B' ' 105' ' ' LEU . 4.3 mm? -50.56 -60.86 2.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.137 -0.977 . . . . 0.0 109.793 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 1.231 HD21 ' CHC' ' B' ' 147' ' ' HEC . 1.9 pp -81.7 -22.39 37.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.012 -1.055 . . . . 0.0 109.721 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.35 -36.57 37.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' B' ' 104' ' ' ARG . 14.2 p30 -85.55 -34.81 21.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -1.158 . . . . 0.0 109.648 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 74.3 t -51.35 -48.0 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 109.465 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 tp -51.92 -54.0 34.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 109.49 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 25.2 t -46.42 -38.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.414 ' O ' ' ND1' ' B' ' 116' ' ' HIS . 13.2 m -79.2 -56.31 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 85.6 t -47.99 -24.52 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.552 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.434 ' CD2' HG22 ' B' ' 18' ' ' VAL . 14.2 mt -77.29 -43.54 32.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.26 -19.37 63.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.417 ' HD1' ' N ' ' B' ' 116' ' ' HIS . 4.3 m80 -78.29 -62.82 1.56 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.696 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -70.93 -17.43 62.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 0.0 109.845 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.45 ' CZ ' ' O ' ' B' ' 17' ' ' LYS . 63.1 m-85 -144.94 58.17 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.665 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -79.67 -17.92 74.31 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -65.05 4.99 0.39 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -1.079 . . . . 0.0 109.694 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' B' ' 119' ' ' GLY . 46.8 mm-40 -135.12 9.55 3.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -77.67 32.61 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.132 -0.98 . . . . 0.0 109.287 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.429 ' H ' ' C ' ' B' ' 121' ' ' GLU . 36.8 p -46.85 148.69 1.75 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.867 . . . . 0.0 109.51 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.48 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.1 Cg_exo -45.16 -57.03 2.31 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.542 2.161 . . . . 0.0 112.918 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 14.3 Cg_endo -56.86 -36.12 98.7 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.064 1.843 . . . . 0.0 111.995 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.408 HG23 ' OG1' ' B' ' 123' ' ' THR . 63.0 t -76.39 -20.33 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.75 -44.98 26.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.329 -0.857 . . . . 0.0 109.494 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.32 84.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.942 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.51 29.28 0.89 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.606 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.99 -33.89 4.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.0 109.375 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 1.08 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 38.1 tt0 -83.95 -63.6 1.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 109.878 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -48.05 -21.88 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.844 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' VAL . . . . . 0.479 HG22 HD21 ' B' ' 3' ' ' LEU . 71.3 t -71.75 -67.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.726 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.401 ' H ' HG23 ' B' ' 134' ' ' VAL . 2.2 t -67.2 -40.29 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.637 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.75 -21.78 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.497 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.15 -22.11 63.84 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.8 t -74.14 -30.94 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -1.178 . . . . 0.0 109.536 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.37 71.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -81.43 -21.2 39.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.592 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.14 -60.52 2.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.653 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.0 mt -57.92 -17.75 18.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.547 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' B' ' 144' ' ' LYS . . . -100.6 -6.91 24.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.895 . . . . 0.0 109.532 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -59.05 -4.71 0.53 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.467 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.536 ' HZ2' ' HA ' ' B' ' 90' ' ' GLU . 21.6 mmtp -92.13 -30.85 15.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -71.3 14.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.0 109.325 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.514 ' HB2' ' N ' ' D' ' 1' ' ' VAL . 28.1 p-80 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' C' ' 2' ' ' LEU . 21.8 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.499 ' N ' HD12 ' C' ' 2' ' ' LEU . 7.4 mp 55.12 166.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 109.727 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.563 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 176.06 -45.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.877 . . . . 0.0 109.859 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' C' ' 3' ' ' SER . 42.6 Cg_exo -55.31 -153.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.633 2.222 . . . . 0.0 112.843 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -78.65 -15.27 58.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.416 -0.802 . . . . 0.0 110.018 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' C' ' 5' ' ' ALA . 15.9 m-20 -38.67 -29.16 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.829 . . . . 0.0 109.759 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' C' ' 5' ' ' ALA . 2.0 ptpm? -83.37 -41.83 17.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.192 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.481 ' N ' ' O ' ' C' ' 5' ' ' ALA . 45.8 m -51.25 -29.96 16.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.889 . . . . 0.0 109.057 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.71 -36.79 42.9 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.483 HG21 ' CD2' ' C' ' 128' ' ' PHE . 53.8 t -70.99 -49.06 52.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -53.04 -45.98 68.28 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.06 -58.12 9.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.475 -0.766 . . . . 0.0 109.31 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.823 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -53.13 -35.89 60.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.456 -0.777 . . . . 0.0 109.215 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -17.24 62.29 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 109.258 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.03 22.79 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -73.12 -35.73 66.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -1.118 . . . . 0.0 108.772 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.823 HG23 ' O ' ' C' ' 13' ' ' ALA . 57.7 t -62.16 -64.52 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 43.68 -122.42 4.01 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.29 22.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -1.096 . . . . 0.0 110.347 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.543 ' H ' ' C ' ' C' ' 18' ' ' GLY . 78.4 m-70 -128.87 26.25 5.55 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' C' ' 63' ' ' ALA . . . -91.91 -63.15 1.28 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.599 -0.688 . . . . 0.0 109.837 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.67 -14.29 0.22 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' C' ' 21' ' ' ALA . 10.4 mt-10 -84.64 -56.37 3.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.801 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.438 ' CE2' ' O ' ' C' ' 20' ' ' HIS . 4.7 m-30 -60.16 -16.64 34.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.848 . . . . 0.0 109.516 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.13 -34.19 30.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.14 -32.03 38.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -1.184 . . . . 0.0 109.984 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.97 -19.9 64.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.623 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.59 60.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.734 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.619 HD11 ' ND1' ' C' ' 58' ' ' HIS . 5.7 mt -78.86 -49.5 12.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.949 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.521 ' OE1' ' ND1' ' C' ' 50' ' ' HIS . 10.1 pt-20 -72.24 -33.28 67.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.925 . . . . 0.0 110.13 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.567 ' NH1' ' SG ' ' C' ' 104' ' ' CYS . 45.8 ttt-85 -54.82 -44.63 74.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 110.596 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 32' ' ' MET . . . . . 0.534 ' CE ' HBC2 ' C' ' 142' ' ' HEC . 12.1 ptt? -84.09 -45.46 13.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.887 -1.133 . . . . 0.0 110.114 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -49.21 -41.41 37.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.171 -0.956 . . . . 0.0 109.83 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.564 HD12 ' C ' ' C' ' 34' ' ' LEU . 2.5 pp -75.04 -38.74 61.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.019 -1.051 . . . . 0.0 109.594 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.432 ' N ' HD12 ' C' ' 34' ' ' LEU . 15.6 m -75.51 7.48 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 109.326 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 1.071 ' CZ ' ' NE2' ' D' ' 131' ' ' GLN . 76.7 m-85 -156.19 72.05 5.09 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.338 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -46.5 -19.84 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.732 2.288 . . . . 0.0 112.203 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 19.9 p -59.22 -22.83 61.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.53 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 70.4 p -89.49 -42.91 11.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.963 . . . . 0.0 109.482 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -52.01 -39.13 59.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 109.608 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.526 ' C ' ' H ' ' C' ' 43' ' ' PHE . 2.7 t -68.27 -18.7 64.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -61.47 4.15 0.1 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 0.0 109.568 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.526 ' H ' ' C ' ' C' ' 41' ' ' THR . 42.0 m-85 54.28 65.69 5.0 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.486 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.577 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 74.5 Cg_endo -78.59 -12.47 15.21 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.71 2.273 . . . . 0.0 112.424 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.577 ' ND1' ' O ' ' C' ' 44' ' ' PRO . 27.0 p-80 40.44 29.36 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 109.564 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.533 ' O ' ' C ' ' C' ' 47' ' ' ASP . 5.2 t80 -120.05 27.72 8.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 0.0 109.679 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.533 ' C ' ' O ' ' C' ' 46' ' ' PHE . 1.6 p30 28.35 72.67 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.087 0.47 . . . . 0.0 110.844 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' C' ' 48' ' ' LEU . 2.2 mm? -64.74 -7.8 12.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.147 -0.97 . . . . 0.0 109.364 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 33.7 t -49.25 152.13 1.27 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' HIS . . . . . 0.521 ' ND1' ' OE1' ' C' ' 30' ' ' GLU . 83.2 t60 -76.0 152.82 36.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.449 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.88 18.6 59.93 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' C' ' 53' ' ' ALA . 2.0 t -67.93 -99.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -1.151 . . . . 0.0 109.309 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.517 ' N ' ' OG ' ' C' ' 52' ' ' SER . . . 174.06 -78.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.567 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -44.78 -17.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.466 -0.771 . . . . 0.0 109.709 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' C' ' 53' ' ' ALA . 3.5 t -76.68 -27.48 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.192 -0.943 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -66.04 -27.0 67.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.281 -0.887 . . . . 0.0 109.467 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.46 -42.28 41.72 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.619 ' ND1' HD11 ' C' ' 29' ' ' LEU . 14.9 t-80 -62.97 -28.2 69.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -1.158 . . . . 0.0 109.63 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.52 -47.26 90.7 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 32.7 mttp -56.1 -23.89 36.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -1.083 . . . . 0.0 109.671 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.6 ' HB3' HMA3 ' C' ' 142' ' ' HEC . 10.0 mmpt? -72.42 -42.5 65.04 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.314 -0.866 . . . . 0.0 109.055 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.0 t -68.95 -47.67 74.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.501 -0.749 . . . . 0.0 109.229 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -69.92 -30.06 67.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 2.3 t70 -69.2 -41.79 76.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.0 108.886 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.45 -47.95 79.71 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.408 -0.807 . . . . 0.0 108.854 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.424 ' O ' HG23 ' C' ' 70' ' ' VAL . 4.8 mt -61.01 -47.15 87.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.219 -0.926 . . . . 0.0 108.654 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' C' ' 71' ' ' ALA . 20.9 m -62.13 -47.33 85.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.185 -0.947 . . . . 0.0 109.027 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -63.49 -26.63 68.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 108.647 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.588 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.16 -46.64 11.7 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.424 HG23 ' O ' ' C' ' 66' ' ' LEU . 78.2 t -66.04 -22.46 30.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' C' ' 67' ' ' THR . . . -66.26 -21.63 66.29 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' C' ' 74' ' ' ASP . 13.3 m80 -144.18 -50.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.8 p 44.99 13.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.659 0.742 . . . . 0.0 109.407 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' C' ' 72' ' ' HIS . 14.6 t70 -128.57 9.52 6.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -173.71 27.14 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.099 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.709 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.3 ptt? -78.37 -24.85 0.45 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.519 -0.738 . . . . 0.0 111.605 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' C' ' 76' ' ' MET . 44.0 Cg_exo -55.64 -20.57 28.08 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.748 1.632 . . . . 0.0 112.504 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.514 HD22 ' C ' ' C' ' 78' ' ' ASN . 0.1 OUTLIER -94.05 -28.82 15.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 109.867 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 -47.97 21.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.116 -0.99 . . . . 0.0 109.259 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 80' ' ' LEU . . . . . 0.588 ' N ' HD12 ' C' ' 80' ' ' LEU . 6.9 mp -79.25 6.9 8.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -59.28 -15.82 18.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.668 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.86 -48.61 11.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.112 -0.993 . . . . 0.0 109.775 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.436 ' N ' HD23 ' C' ' 83' ' ' LEU . 4.6 mt -47.2 -48.34 23.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 108.748 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 88.1 p -50.2 -24.76 3.03 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.458 -0.777 . . . . 0.0 109.079 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' C' ' 82' ' ' ALA . 14.9 t70 -74.44 -25.54 59.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.191 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.47 HD21 ' CBD' ' C' ' 142' ' ' HEC . 6.9 tp -81.75 -34.4 30.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.311 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -90.38 -21.75 21.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -71.24 -68.51 0.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.779 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -88.41 -77.16 0.37 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.89 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' C' ' 86' ' ' LEU . 19.2 mttm -59.28 171.14 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.889 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' C' ' 93' ' ' VAL . 4.0 tp 56.91 56.84 5.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.396 -0.815 . . . . 0.0 109.726 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -66.08 9.81 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 109.279 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.534 ' H ' ' C ' ' C' ' 91' ' ' LEU . 12.2 p -46.38 165.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.605 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' C' ' 96' ' ' VAL . 5.3 m-20 -84.27 117.02 67.66 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.915 . . . . 0.0 109.258 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.412 ' C ' ' N ' ' C' ' 97' ' ' ASN . 85.4 Cg_exo -44.41 -10.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.318 2.012 . . . . 0.0 112.318 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.681 ' CG2' ' OD2' ' B' ' 99' ' ' ASP . 98.8 t -53.91 -10.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.111 -0.993 . . . . 0.0 109.543 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.412 ' N ' ' C ' ' C' ' 95' ' ' PRO . 2.7 m-80 -79.17 -24.97 42.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -53.14 -43.71 67.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.918 . . . . 0.0 109.55 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.437 ' CB ' ' NZ ' ' C' ' 99' ' ' LYS . 7.6 mtmp? -69.41 -25.27 64.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.643 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 25.4 mt -81.68 -46.8 13.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 109.661 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.884 HD21 HBB3 ' C' ' 142' ' ' HEC . 6.3 tt -69.54 -20.88 63.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.735 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 32.8 p -78.68 -59.11 2.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 109.791 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -63.16 -26.73 68.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.871 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.567 ' SG ' ' NH1' ' C' ' 31' ' ' ARG . 34.5 m -65.17 -52.25 56.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.766 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.03 -24.68 0.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.721 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.78 -34.88 60.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -0.98 . . . . 0.0 109.855 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 107' ' ' VAL . . . . . 0.495 HG11 ' HE ' ' C' ' 31' ' ' ARG . 71.2 t -83.26 -24.82 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.045 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -70.8 -63.7 1.05 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.129 -0.982 . . . . 0.0 110.561 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' C' ' 113' ' ' LEU . 2.4 pp -64.02 -18.68 64.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 109.823 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.35 -33.36 63.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.712 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.65 -56.22 25.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -66.58 -68.31 0.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.0 108.385 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.668 ' O ' HD12 ' C' ' 113' ' ' LEU . 3.1 pp -116.56 111.46 41.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 114' ' ' PRO . . . . . 0.627 ' O ' HD12 ' C' ' 113' ' ' LEU . 89.9 Cg_exo -41.59 -177.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.507 2.138 . . . . 0.0 113.204 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.713 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -45.57 -52.42 10.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.479 -0.763 . . . . 0.0 109.038 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.645 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 19.4 mt-10 125.0 -1.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 61.28 31.33 19.4 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.262 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.775 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -103.88 120.54 50.95 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.53 23.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.049 1.833 . . . . 0.0 112.649 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.775 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -152.47 -32.5 0.14 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.864 -1.147 . . . . 0.0 110.568 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.713 HG21 ' O ' ' C' ' 115' ' ' ALA . 14.4 p -47.93 -48.23 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 110.1 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.643 ' N ' HG13 ' C' ' 121' ' ' VAL . 0.6 OUTLIER -63.74 -38.89 92.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.439 -0.788 . . . . 0.0 109.416 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.4 -19.75 33.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.885 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.608 ' N ' ' O ' ' C' ' 120' ' ' ALA . 7.6 p -58.36 -62.1 2.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 0.0 110.015 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.519 ' N ' ' OG ' ' C' ' 124' ' ' SER . 5.1 mt -68.54 -19.64 64.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 109.31 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -73.83 -52.21 13.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.701 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.459 ' CD ' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -86.26 -44.41 12.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.023 . . . . 0.0 109.936 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.483 ' CD2' HG21 ' C' ' 10' ' ' VAL . 39.7 t80 -47.32 -20.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.045 -1.035 . . . . 0.0 108.921 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' C' ' 133' ' ' SER . 12.0 mt -71.75 -18.0 62.16 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.28 -33.67 73.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.424 ' O ' HG13 ' C' ' 135' ' ' VAL . 89.3 p -82.7 -29.96 29.52 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 t -85.18 -29.72 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.157 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.488 ' N ' ' O ' ' C' ' 129' ' ' LEU . 17.8 m -82.79 -22.69 34.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.302 -0.873 . . . . 0.0 108.96 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 134' ' ' THR . . . . . 0.463 ' O ' ' N ' ' C' ' 138' ' ' SER . 41.9 m -80.67 -39.99 26.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 0.0 109.225 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.424 HG13 ' O ' ' C' ' 131' ' ' SER . 26.8 m -71.08 -26.45 27.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.266 -0.897 . . . . 0.0 108.846 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -31.95 73.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.413 -0.804 . . . . 0.0 108.978 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 7.1 m -156.74 53.65 0.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.413 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 138' ' ' SER . . . . . 0.463 ' N ' ' O ' ' C' ' 134' ' ' THR . 9.0 p -58.74 115.02 2.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' C' ' 140' ' ' TYR . 14.5 pttm -73.06 -25.78 61.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.474 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.513 ' CG ' ' O ' ' C' ' 139' ' ' LYS . 64.4 m-85 -159.76 154.16 23.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 109.419 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 141' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 141' ' ' ARG . 22.3 mtm180 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.52 ' O ' ' CG ' ' D' ' 2' ' ' HIS . 6.7 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.313 0.578 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 2' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' D' ' 1' ' ' VAL . 44.0 m80 -159.08 102.52 1.63 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.349 -0.844 . . . . 0.0 109.152 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.931 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.1 OUTLIER -142.72 164.54 29.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.368 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.89 159.48 68.57 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.265 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.82 -18.65 65.64 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.72 2.28 . . . . 0.0 111.946 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -84.58 -34.14 23.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.53 -61.75 1.76 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.628 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.697 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -46.99 -26.76 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.609 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.1 t -57.04 -23.5 46.98 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.153 -0.967 . . . . 0.0 110.194 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.62 -57.65 3.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.019 -1.051 . . . . 0.0 110.115 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.35 -24.59 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 48.8 m -82.11 -36.92 27.04 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.309 0.575 . . . . 0.0 109.704 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.54 -34.65 70.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.7 OUTLIER -50.54 -34.48 25.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.14 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -45.78 -17.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.375 -0.828 . . . . 0.0 109.637 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.27 -49.37 7.48 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.454 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 0.1 OUTLIER -72.0 -30.23 65.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.094 -1.239 . . . . 0.0 109.445 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.442 HG22 ' CD2' ' D' ' 114' ' ' LEU . 77.4 t -53.47 114.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.7 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' D' ' 20' ' ' VAL . 36.4 m-80 -79.56 65.99 4.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 108.937 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' D' ' 22' ' ' GLU . 72.5 t -43.69 -26.18 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.451 -0.781 . . . . 0.0 109.79 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' D' ' 19' ' ' ASN . 18.0 t70 -65.45 5.13 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.527 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' D' ' 20' ' ' VAL . 37.5 mt-10 -154.06 -51.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 0.0 109.484 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 88.0 t -49.71 -53.35 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 109.547 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.67 -40.56 25.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.55 -37.2 62.22 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.09 -35.7 61.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -1.123 . . . . 0.0 109.555 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.51 -28.71 68.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 tp -85.04 -51.97 6.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.78 -28.41 70.02 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -79.4 -28.11 41.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -1.117 . . . . 0.0 109.49 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' D' ' 106' ' ' LEU . 44.3 tp -48.09 -39.91 21.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 32' ' ' LEU . . . . . 0.452 ' CD2' ' OG1' ' D' ' 38' ' ' THR . 21.2 mt -81.03 -23.03 38.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.291 -0.88 . . . . 0.0 109.695 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.18 -61.81 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.142 -0.974 . . . . 0.0 109.918 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' C' ' 122' ' ' HIS . 0.0 OUTLIER -78.42 -22.54 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 0.0 110.112 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -134.6 76.99 59.74 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.109 -0.994 . . . . 0.0 109.925 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.18 27.88 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.028 2.486 . . . . 0.0 112.339 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -81.1 -20.04 42.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -0.953 . . . . 0.0 109.853 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.527 ' C ' ' H ' ' D' ' 40' ' ' ARG . 6.0 p -47.81 -29.16 2.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 109.66 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 51.91 6.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' ARG . . . . . 0.527 ' H ' ' C ' ' D' ' 38' ' ' THR . 42.5 ttm180 -110.13 -39.92 4.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 47.73 19.72 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.621 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 1.315 ' CE2' HMD3 ' D' ' 147' ' ' HEC . 77.3 m-85 54.73 55.01 8.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.359 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -46.2 -16.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 109.636 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 44' ' ' SER . . . . . 0.514 ' N ' ' O ' ' D' ' 42' ' ' PHE . 20.2 m -57.69 -54.68 44.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -70.07 3.74 2.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.219 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.05 -149.34 1.19 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 56.51 73.16 0.46 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.319 -1.106 . . . . 0.0 109.641 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 90.3 mt -137.5 29.69 2.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.858 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 41.5 t -72.46 -38.01 68.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.499 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -146.11 151.95 45.98 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.295 -0.878 . . . . 0.0 109.173 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -41.12 -35.23 1.82 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.404 2.07 . . . . 0.0 112.308 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.91 -32.28 73.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.11 -23.88 66.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.681 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.45 -60.73 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 55' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -91.97 25.59 2.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.33 -52.36 2.04 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.81 156.87 90.98 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.224 -1.162 . . . . 0.0 109.43 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.97 -44.49 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.645 2.23 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -45.98 -35.33 4.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 0.0 109.66 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -76.15 -41.58 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -79.17 -24.93 42.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.36 -0.837 . . . . 0.0 109.474 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.48 -51.26 12.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.53 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 1.08 ' CE1' ' CHA' ' D' ' 147' ' ' HEC . 45.7 t-80 -51.27 -23.94 4.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 109.47 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.93 -45.59 95.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -50.83 -44.63 59.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.374 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -57.81 -51.55 69.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.41 -0.806 . . . . 0.0 109.477 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.884 HG13 ' C2B' ' D' ' 147' ' ' HEC . 53.9 t -57.83 -51.15 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.314 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.77 -45.33 94.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.24 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.81 -45.79 31.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.24 92.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -1.103 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -57.42 -29.07 63.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 11.6 m -77.0 -33.68 57.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 109.496 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.45 -34.26 34.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.367 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.16 -60.08 7.19 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.57 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.8 mp -55.11 -27.44 45.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -1.14 . . . . 0.0 109.381 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -2.16 36.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -171.23 63.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 78' ' ' LEU . . . . . 0.483 ' CD2' HG11 ' D' ' 1' ' ' VAL . 9.4 mt -70.91 -18.06 62.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.442 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -48.84 -25.97 2.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -171.37 65.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.283 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 81' ' ' LEU . . . . . 0.439 HD12 ' N ' ' D' ' 82' ' ' LYS . 2.5 pp -55.65 -40.98 72.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 82' ' ' LYS . . . . . 0.439 ' N ' HD12 ' D' ' 81' ' ' LEU . 39.5 mttp -50.44 -23.77 2.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.055 -1.028 . . . . 0.0 109.438 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.18 -42.89 7.78 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.7 OUTLIER -68.18 -42.89 79.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.022 -1.281 . . . . 0.0 109.635 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' D' ' 84' ' ' THR . 35.4 m-85 -67.39 -0.27 3.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.498 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.52 -54.01 20.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.3 p -61.57 -58.66 7.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.366 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' D' ' 92' ' ' HIS . 49.1 mt -51.27 -49.88 60.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.256 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 89' ' ' SER . . . . . 0.536 ' O ' ' N ' ' D' ' 93' ' ' CYS . 7.2 m -57.12 -46.22 82.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 109.233 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.548 ' HA ' ' HZ2' ' D' ' 144' ' ' LYS . 30.9 tt0 -62.28 -46.58 88.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.419 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 3.9 tt -72.45 -27.27 62.21 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.135 -0.978 . . . . 0.0 109.461 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.459 ' N ' ' O ' ' D' ' 88' ' ' LEU . 19.0 m80 -90.52 -20.24 22.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.06 -1.025 . . . . 0.0 109.621 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 93' ' ' CYS . . . . . 0.536 ' N ' ' O ' ' D' ' 89' ' ' SER . 26.0 t -83.27 -59.27 2.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 110.563 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -86.6 -40.53 15.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.04 -1.037 . . . . 0.0 111.326 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 95' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.1 OUTLIER -72.99 -52.0 16.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.965 -1.084 . . . . 0.0 110.602 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.56 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 30.9 mt -95.74 -36.89 11.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.934 -1.104 . . . . 0.0 109.96 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 38.5 p-80 43.58 30.9 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.373 -0.829 . . . . 0.0 110.078 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 98' ' ' VAL . . . . . 0.463 HG23 ' H ' ' D' ' 98' ' ' VAL . 3.4 t -52.38 153.27 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.074 -1.016 . . . . 0.0 109.19 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 99' ' ' ASP . . . . . 0.723 ' OD2' ' CG2' ' A' ' 96' ' ' VAL . 1.6 m-20 -71.22 143.01 87.76 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 109.589 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -41.26 -43.83 5.48 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.573 2.182 . . . . 0.0 112.417 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -71.98 54.42 0.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 102' ' ' ASN . . . . . 0.609 ' O ' HMC2 ' D' ' 147' ' ' HEC . 9.4 m120 -150.93 -31.18 0.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 109.961 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.48 -41.7 54.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.993 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 104' ' ' ARG . . . . . 0.426 ' O ' ' ND2' ' D' ' 108' ' ' ASN . 73.9 ttt180 -79.49 -20.1 48.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 110.094 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 105' ' ' LEU . . . . . 0.44 ' N ' HD22 ' D' ' 105' ' ' LEU . 4.3 mm? -50.58 -60.84 2.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 109.737 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 1.231 HD21 ' CHC' ' D' ' 147' ' ' HEC . 1.9 pp -81.68 -22.43 37.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.056 -1.028 . . . . 0.0 109.766 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.28 -36.55 37.09 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 108' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' D' ' 104' ' ' ARG . 14.2 p30 -85.6 -34.8 21.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -1.149 . . . . 0.0 109.675 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 74.6 t -51.3 -48.0 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 109.462 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.94 -54.1 33.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.368 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 25.1 t -46.29 -38.14 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 109.533 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 112' ' ' CYS . . . . . 0.422 ' O ' ' ND1' ' D' ' 116' ' ' HIS . 13.3 m -79.1 -56.35 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.56 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 86.8 t -47.93 -24.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.945 . . . . 0.0 109.479 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 114' ' ' LEU . . . . . 0.442 ' CD2' HG22 ' D' ' 18' ' ' VAL . 14.2 mt -77.19 -43.65 32.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.389 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.52 63.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.407 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' D' ' 112' ' ' CYS . 4.4 m80 -78.18 -62.87 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 0.0 109.771 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -70.75 -17.56 62.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.869 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 63.5 m-85 -144.86 58.12 1.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 0.0 109.74 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -79.7 -17.93 74.23 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -65.03 4.92 0.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -1.083 . . . . 0.0 109.656 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' D' ' 119' ' ' GLY . 46.7 mm-40 -135.04 9.46 3.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.722 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.556 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -77.58 32.62 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.14 -0.975 . . . . 0.0 109.297 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.442 ' H ' ' C ' ' D' ' 121' ' ' GLU . 37.2 p -46.88 148.68 1.77 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.34 -0.85 . . . . 0.0 109.546 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.472 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.2 Cg_exo -45.28 -56.91 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.538 2.159 . . . . 0.0 112.887 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 14.3 Cg_endo -56.9 -36.16 98.86 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.16 1.907 . . . . 0.0 111.969 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.417 HG23 ' OG1' ' D' ' 123' ' ' THR . 63.3 t -76.4 -20.34 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.71 -45.05 25.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 0.0 109.481 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.34 83.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 109.57 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.5 29.29 0.89 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.634 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.02 -33.88 4.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 1.071 ' NE2' ' CZ ' ' C' ' 36' ' ' PHE . 38.1 tt0 -83.98 -63.48 1.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -48.12 -21.84 0.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.838 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 133' ' ' VAL . . . . . 0.48 HG22 HD21 ' D' ' 3' ' ' LEU . 70.8 t -71.73 -67.25 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.151 -0.968 . . . . 0.0 109.71 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.414 ' H ' HG23 ' D' ' 134' ' ' VAL . 2.2 t -67.3 -40.14 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.82 -21.85 0.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.14 -22.02 64.06 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 89.5 t -74.12 -31.0 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -1.155 . . . . 0.0 109.562 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.36 71.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.53 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -81.34 -21.29 39.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.587 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.13 -60.46 2.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.658 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.1 mt -57.99 -17.69 18.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.514 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 142' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' D' ' 144' ' ' LYS . . . -100.66 -6.9 24.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.863 . . . . 0.0 109.603 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -59.03 -4.75 0.53 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.473 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.548 ' HZ2' ' HA ' ' D' ' 90' ' ' GLU . 21.5 mmtp -92.0 -31.03 15.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.579 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -71.32 14.2 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.001 . . . . 0.0 109.36 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.52 ' HB2' ' N ' ' B' ' 1' ' ' VAL . 28.0 p-80 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.875 HBB3 HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 1.3 HMD3 ' CE2' ' B' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.884 HBB3 HD21 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 1.315 HMD3 ' CE2' ' D' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.515 HD11 ' HA ' ' A' ' 128' ' ' PHE . 4.3 mm? -105.07 -176.64 3.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.306 -0.871 . . . . 0.0 109.609 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.545 ' O ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -117.34 170.88 5.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.0 109.236 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 3' ' ' SER . 88.7 Cg_exo -41.39 -117.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 123.132 2.554 . . . . 0.0 113.304 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -43.99 -27.63 0.39 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.966 -1.084 . . . . 0.0 110.263 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 10' ' ' VAL . 29.9 m-20 -44.1 -35.07 2.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.973 . . . . 0.0 109.192 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -83.26 -34.02 25.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.267 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 m -59.22 -33.33 70.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.264 -0.897 . . . . 0.0 109.148 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -75.02 -32.64 61.66 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 6' ' ' ASP . 54.3 t -76.03 -51.4 20.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HE2' HG13 ' A' ' 70' ' ' VAL . 1.1 mptm? -56.96 -33.98 67.59 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.18 -59.62 5.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.446 -0.784 . . . . 0.0 109.459 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -53.21 -34.44 57.05 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.425 -0.797 . . . . 0.0 109.141 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -17.62 61.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.22 -44.69 9.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -70.19 -38.15 75.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -1.123 . . . . 0.0 108.901 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 13' ' ' ALA . 96.1 t -61.38 -64.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 53.93 -130.52 43.56 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.23 26.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.457 -1.025 . . . . 0.0 110.438 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.534 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.0 m-70 -130.56 23.85 5.09 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.81 -59.58 2.19 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.612 -0.68 . . . . 0.0 109.698 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -14.21 0.22 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 9.7 mt-10 -88.14 -56.63 3.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -1.141 . . . . 0.0 109.739 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.8 m-30 -57.46 -39.49 76.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.034 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.54 -22.95 53.63 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.51 -57.88 2.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -1.11 . . . . 0.0 109.735 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' OE1' ' NE2' ' A' ' 112' ' ' HIS . 72.4 mt-10 -50.26 -19.9 0.92 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.362 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.58 63.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.367 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.612 HD21 ' CE1' ' A' ' 58' ' ' HIS . 9.1 mt -73.13 -56.42 5.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 29' ' ' LEU . 56.3 mt-10 -43.87 -37.19 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.691 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -48.76 78.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.945 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.1 ttp -83.99 -42.82 15.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.63 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.596 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 26.1 m-85 -64.28 -32.57 74.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 0.0 110.301 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mt -45.68 -43.02 12.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.971 -1.081 . . . . 0.0 109.727 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 36' ' ' PHE . 14.9 m -86.65 -15.76 38.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.328 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER 19.14 64.48 0.24 Allowed Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.976 -0.453 . . . . 0.0 111.319 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.52 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 85.4 Cg_endo -93.63 -62.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.623 2.215 . . . . 0.0 112.552 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.741 ' O ' HG22 ' A' ' 41' ' ' THR . 3.5 p -91.43 -18.6 23.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 109.738 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 p -81.72 -23.03 36.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.968 . . . . 0.0 110.149 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -68.27 -34.93 77.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.063 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 38' ' ' THR . 14.1 t -49.82 -36.92 28.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 43' ' ' PHE . 60.7 m-85 -90.87 15.56 11.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 109.192 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 42' ' ' TYR . 20.2 m-85 60.02 142.6 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.467 -0.771 . . . . 0.0 109.536 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 59.7 Cg_endo -73.4 -42.74 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.446 2.097 . . . . 0.0 111.938 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 42.0 p-80 43.27 31.95 0.43 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.616 -0.677 . . . . 0.0 111.078 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.516 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -155.91 28.53 0.37 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.727 -1.233 . . . . 0.0 110.395 178.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 46' ' ' PHE . 7.3 m-20 33.31 81.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.635 -0.666 . . . . 0.0 110.33 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.862 HD23 ' H ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -60.13 -21.27 61.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.442 -0.786 . . . . 0.0 109.335 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 t -47.54 149.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.59 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 2.0 t60 -74.77 151.06 39.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.59 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 82.16 4.74 90.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.667 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 12.1 p -77.42 -19.77 55.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -1.143 . . . . 0.0 109.477 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 75.77 -16.95 0.55 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.37 -0.831 . . . . 0.0 109.869 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -86.14 -21.43 27.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.121 -0.987 . . . . 0.0 109.954 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG22 ' CE2' ' A' ' 46' ' ' PHE . 18.8 t -84.1 -28.29 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 0.0 109.834 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -77.98 -30.41 50.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.123 -0.986 . . . . 0.0 108.989 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.512 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . . . -66.61 -26.46 72.91 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.612 ' CE1' HD21 ' A' ' 29' ' ' LEU . 8.3 t-80 -75.46 -34.78 60.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.131 -1.217 . . . . 0.0 109.636 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.34 -51.08 44.34 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -51.66 -23.46 4.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -1.065 . . . . 0.0 109.968 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.535 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 0.8 OUTLIER -74.51 -42.38 59.02 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.125 -0.984 . . . . 0.0 109.082 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -72.5 -45.24 59.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.467 -0.77 . . . . 0.0 108.986 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.85 -27.59 65.97 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.291 -0.881 . . . . 0.0 109.188 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.39 -34.06 67.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 108.727 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.474 ' HB3' HMB3 ' A' ' 142' ' ' HEC . . . -66.87 -52.15 46.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.318 -0.864 . . . . 0.0 108.933 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 128' ' ' PHE . 9.1 mt -59.17 -42.77 91.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 0.0 108.653 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -69.35 -50.19 48.56 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 108.745 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -58.98 -24.78 63.01 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.95 -45.6 12.99 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' HE2' ' A' ' 11' ' ' LYS . 4.9 t -63.77 -22.99 32.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.38 -22.78 63.7 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.61 ' O ' ' N ' ' A' ' 74' ' ' ASP . 90.6 m-70 -147.22 -51.78 0.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.875 . . . . 0.0 109.532 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.4 p 44.49 13.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.758 0.79 . . . . 0.0 109.479 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' A' ' 72' ' ' HIS . 17.8 t70 -133.07 9.78 4.15 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 34.1 t70 -175.43 27.43 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.981 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 13.8 ptt? -78.66 -22.48 0.38 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.431 -0.793 . . . . 0.0 111.909 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.8 Cg_exo -53.48 -20.78 16.69 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.548 1.499 . . . . 0.0 112.33 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -94.17 -35.41 12.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.678 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.04 -47.55 61.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.306 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.5 mt -77.5 5.75 8.37 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.075 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.1 p -54.73 -24.64 23.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.291 -0.88 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -73.93 -55.21 6.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 109.557 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.464 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 4.6 mt -47.7 -48.13 29.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.808 . . . . 0.0 108.929 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -59.21 -22.65 61.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.549 -0.719 . . . . 0.0 109.398 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 89' ' ' HIS . 16.5 t70 -81.89 -46.52 13.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.3 -26.74 65.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 11.4 m80 -81.47 -21.65 38.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.724 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 90' ' ' LYS . . . -119.05 -55.46 2.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.294 -0.879 . . . . 0.0 109.746 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 85' ' ' ASP . 13.2 t-80 -71.41 17.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 109.751 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.599 ' C ' ' H ' ' A' ' 92' ' ' ARG . 9.8 ttmm -166.5 149.02 6.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 109.781 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.7 mt 61.81 -12.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 109.86 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.038 ' HD2' ' HG2' ' D' ' 40' ' ' ARG . 45.6 mmt-85 45.14 16.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 109.714 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 91' ' ' LEU . 12.1 p -57.68 131.02 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 1.08 ' OD1' ' NH1' ' D' ' 40' ' ' ARG . 0.8 OUTLIER -75.3 147.03 82.3 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.29 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 97' ' ' ASN . 58.1 Cg_endo -72.57 -23.9 19.38 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.543 2.162 . . . . 0.0 112.126 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.8 t -49.06 -10.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.77 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 95' ' ' PRO . 12.0 m-20 -79.05 -24.88 43.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.534 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -54.28 -30.04 49.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.425 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 92.4 mttt -54.33 -26.62 30.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.489 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.674 HD12 ' N ' ' A' ' 100' ' ' LEU . 8.1 mp -84.06 -57.37 3.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.529 HD22 ' CHC' ' A' ' 142' ' ' HEC . 7.3 tp -50.89 -27.35 7.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -66.09 -58.52 5.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.616 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -63.57 -26.45 68.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.882 . . . . 0.0 109.67 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 73.6 m -58.2 -55.97 28.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 109.596 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mt -47.82 -37.98 14.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 106' ' ' LEU . 7.7 mp -71.13 -41.89 69.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.05 -24.95 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 109.348 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 m -80.76 -63.28 1.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.447 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 113' ' ' LEU . 33.8 mt -46.98 -28.29 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.25 90.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 110.017 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.68 64.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.097 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' A' ' 27' ' ' GLU . 28.1 m170 -93.19 -80.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.073 -1.017 . . . . 0.0 109.721 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -107.94 102.74 47.07 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -43.8 173.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.546 2.164 . . . . 0.0 113.563 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -87.32 -35.44 18.42 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.782 0.801 . . . . 0.0 109.422 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 13.1 mt-10 81.29 1.35 1.63 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 1.209 ' CD1' ' NH2' ' B' ' 30' ' ' ARG . 11.2 m-85 58.49 40.91 23.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.806 -0.559 . . . . 0.0 111.282 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.752 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -88.12 118.7 69.89 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 120.756 -1.215 . . . . 0.0 108.001 178.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.596 ' HA ' HG21 ' B' ' 33' ' ' VAL . 54.1 Cg_exo -49.05 18.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.319 2.012 . . . . 0.0 112.644 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.752 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -140.08 -39.21 0.45 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.111 -0.993 . . . . 0.0 110.053 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 4.2 p -51.68 -48.35 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.102 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.576 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 2.8 m-70 -62.75 -54.37 40.21 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.412 -0.805 . . . . 0.0 109.334 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.92 -19.61 60.87 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.253 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 1.1 p -60.77 -61.6 2.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 110.271 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.539 ' N ' ' OG ' ' A' ' 124' ' ' SER . 6.4 mt -80.64 -21.05 41.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.113 -0.992 . . . . 0.0 110.073 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -78.51 -40.69 34.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 110.109 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.29 -41.29 11.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.949 -1.094 . . . . 0.0 110.13 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.515 ' HA ' HD11 ' A' ' 2' ' ' LEU . 32.3 t80 -50.56 -20.51 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.8 -1.188 . . . . 0.0 108.839 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 133' ' ' SER . 11.9 mt -72.59 -17.74 61.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.13 76.83 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.2 p -79.39 -36.19 39.57 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.339 -0.851 . . . . 0.0 108.82 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.09 -27.23 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.183 -0.948 . . . . 0.0 108.67 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 129' ' ' LEU . 97.2 p -78.17 -45.99 21.7 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.474 -0.766 . . . . 0.0 109.204 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 95.2 m -67.81 -23.01 65.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.223 -0.923 . . . . 0.0 108.654 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.85 -29.9 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -34.6 67.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.09 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 138' ' ' SER . 81.0 p -92.21 -29.73 16.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 137' ' ' THR . 3.5 t 61.96 132.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.521 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -170.53 109.43 0.35 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.494 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 49.55 74.94 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.899 . . . . 0.0 109.397 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.7 ptp85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.472 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.305 0.574 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' B' ' 2' ' ' HIS . 0.3 OUTLIER -171.75 93.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.842 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -140.81 145.25 36.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.342 -0.849 . . . . 0.0 109.034 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 7.8 p -69.65 148.75 96.84 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.543 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -42.65 -24.85 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.598 2.199 . . . . 0.0 112.236 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -80.82 -53.03 6.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.92 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -60.28 -36.08 77.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.182 -0.948 . . . . 0.0 109.98 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.508 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -84.08 -31.57 25.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 109.922 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.07 -23.56 8.02 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.148 -0.97 . . . . 0.0 110.458 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.4 -58.04 3.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.942 -1.099 . . . . 0.0 110.272 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.46 HG23 ' CD2' ' B' ' 130' ' ' TYR . 7.6 p -65.53 -24.53 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.9 m -78.38 -40.35 36.49 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.338 0.589 . . . . 0.0 109.711 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.36 -26.14 68.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.339 -0.851 . . . . 0.0 109.488 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.722 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.9 OUTLIER -62.53 -26.81 68.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.38 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.77 -17.7 64.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.42 -62.9 3.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.62 ' HD3' HD23 ' B' ' 14' ' ' LEU . 0.0 OUTLIER -78.71 7.1 7.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.099 -1.236 . . . . 0.0 110.815 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.722 HG23 ' O ' ' B' ' 14' ' ' LEU . 2.3 t -75.65 121.32 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.826 -1.171 . . . . 0.0 109.186 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.43 85.1 6.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.402 -0.811 . . . . 0.0 109.224 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 36.0 t -55.96 -20.36 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 109.573 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 1.0 OUTLIER -57.36 -55.78 30.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 43.1 mt-10 -98.89 -44.29 6.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.58 -23.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.882 . . . . 0.0 109.658 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.18 -43.07 11.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.98 -25.86 61.33 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -79.44 -25.45 41.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.198 -1.177 . . . . 0.0 109.662 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.64 -23.22 39.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 109.619 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 tp -85.02 -57.26 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 0.0 109.503 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.03 -19.82 32.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 1.209 ' NH2' ' CD1' ' A' ' 117' ' ' PHE . 47.0 mtt180 -79.37 -27.34 41.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -1.188 . . . . 0.0 109.377 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 39.7 tp -65.58 -24.77 67.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.879 . . . . 0.0 109.585 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 41.2 mt -78.01 -53.8 7.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.085 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.742 HG13 ' H ' ' B' ' 34' ' ' VAL . 7.9 p -71.07 -60.73 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 110.039 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.742 ' H ' HG13 ' B' ' 33' ' ' VAL . 95.3 t -46.28 -30.5 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.958 -1.089 . . . . 0.0 109.549 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.9 91.2 1.58 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.391 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.71 30.48 0.52 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.733 2.289 . . . . 0.0 112.427 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -57.17 -28.66 62.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.488 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.63 HG21 HBC1 ' B' ' 147' ' ' HEC . 30.5 p -56.19 -77.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.892 . . . . 0.0 109.419 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLN . . . . . 0.534 ' N ' ' OG1' ' B' ' 38' ' ' THR . 14.8 tt0 50.62 46.12 26.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.554 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 1.034 ' NH1' ' OD1' ' C' ' 94' ' ' ASP . 68.9 mtm180 -148.01 -49.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.151 -0.968 . . . . 0.0 109.55 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' B' ' 43' ' ' GLU . 1.3 p90 -96.72 -21.4 17.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.759 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -48.81 -11.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.98 . . . . 0.0 109.625 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' B' ' 41' ' ' PHE . 31.3 mt-10 -80.31 -20.3 44.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.171 -0.956 . . . . 0.0 109.475 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.474 ' O ' ' N ' ' B' ' 46' ' ' GLY . 11.2 t -58.25 -51.8 68.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.62 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' B' ' 47' ' ' ASP . 57.0 m-85 -47.92 -16.14 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.533 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 61.35 -77.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' B' ' 45' ' ' PHE . 0.9 OUTLIER -46.77 113.45 0.66 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -1.132 . . . . 0.0 109.605 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' B' ' 49' ' ' SER . 0.8 OUTLIER -161.15 22.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.009 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' B' ' 48' ' ' LEU . 17.9 m -45.13 -39.66 6.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 109.563 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -145.67 151.94 47.62 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.323 -0.861 . . . . 0.0 108.995 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -44.64 -21.84 0.53 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.295 1.996 . . . . 0.0 112.154 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.78 -29.21 27.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.657 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.57 -26.94 46.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 109.535 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.51 -62.01 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.574 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 14.9 mmt -53.7 -16.97 1.89 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.541 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.25 -4.19 61.24 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.444 HD21 ' HB3' ' B' ' 45' ' ' PHE . 65.4 m-20 -72.22 142.69 85.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.192 -1.181 . . . . 0.0 109.376 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.5 -52.1 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.509 2.14 . . . . 0.0 112.21 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -51.56 -48.11 63.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -0.86 . . . . 0.0 109.586 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.46 -27.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.529 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -79.16 -53.57 6.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.54 -59.04 3.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.909 ' HE1' ' CHA' ' B' ' 147' ' ' HEC . 1.2 t60 -49.06 -23.92 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.69 -37.62 92.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -71.7 -35.32 70.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.544 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' LYS . . . . . 0.548 ' HD3' HAA1 ' B' ' 147' ' ' HEC . 41.4 mttm -49.42 -44.87 45.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.179 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 0.992 HG22 ' C1B' ' B' ' 147' ' ' HEC . 54.4 t -73.57 -61.84 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.183 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.716 HD23 ' O ' ' B' ' 68' ' ' LEU . 1.8 tt -50.43 -23.24 2.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.092 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.35 -56.99 11.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.88 97.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -1.132 . . . . 0.0 109.439 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.55 ' CZ ' HG11 ' B' ' 134' ' ' VAL . 0.1 OUTLIER -48.82 -21.78 0.7 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 109.289 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p -87.89 -34.93 18.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.621 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -46.44 -34.36 4.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.59 -58.93 6.01 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.528 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -62.87 -23.3 67.25 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -1.092 . . . . 0.0 109.277 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.49 2.4 54.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.408 ' C ' ' H ' ' B' ' 79' ' ' ASP . 55.9 t60 -170.99 65.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.78 13.22 0.67 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' B' ' 77' ' ' HIS . 34.7 t70 -76.36 -27.65 56.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.563 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -170.98 106.4 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 109.512 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 mt -80.33 -44.01 20.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.436 ' CD ' ' H ' ' B' ' 82' ' ' LYS . 1.5 mptp? -49.41 -25.87 2.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.383 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.17 -53.71 3.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 3.9 p -65.9 -37.64 86.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.199 -1.177 . . . . 0.0 109.616 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -90.84 23.95 2.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.619 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.26 -41.55 40.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.392 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 21.1 p -72.69 -51.01 21.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.408 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -56.79 -48.85 76.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.33 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 28.1 t -61.57 -44.06 97.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.34 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -64.41 -23.75 67.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.377 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 7.4 tp -85.1 -68.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -49.59 -30.01 8.04 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.272 -0.893 . . . . 0.0 110.083 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' CYS . . . . . 0.571 ' SG ' ' CD1' ' B' ' 145' ' ' TYR . 38.0 t -83.98 -55.66 4.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 111.548 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.541 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 0.6 OUTLIER -86.26 -29.13 23.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.915 -1.116 . . . . 0.0 112.205 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.45 ' C ' HD22 ' B' ' 96' ' ' LEU . 5.6 mptp? -90.32 -52.06 5.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.639 -1.288 . . . . 0.0 110.981 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.537 HD22 ' N ' ' B' ' 96' ' ' LEU . 3.7 mm? -97.59 -22.79 16.31 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.753 -1.217 . . . . 0.0 110.208 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.604 ' O ' HG22 ' C' ' 38' ' ' THR . 81.9 m-70 51.03 37.62 18.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.004 -1.06 . . . . 0.0 109.424 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.04 138.75 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 0.0 109.362 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.94 151.28 3.42 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.73 30.57 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.575 2.183 . . . . 0.0 112.022 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -143.47 75.86 1.49 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.304 -0.873 . . . . 0.0 109.384 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -168.2 -40.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.454 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -52.52 -45.7 66.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.429 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 55.4 ttp180 -66.34 -42.32 88.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.46 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.606 HD12 ' N ' ' B' ' 105' ' ' LEU . 10.0 mp -54.37 -57.48 11.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 1.088 HD22 ' HAB' ' B' ' 147' ' ' HEC . 7.5 tt -52.15 -49.02 64.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.97 -22.41 54.96 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 27.4 m120 -80.76 -15.35 56.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.042 -1.269 . . . . 0.0 109.737 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 64.1 t -85.23 -44.78 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 109.609 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.523 HD23 ' O ' ' B' ' 110' ' ' LEU . 1.7 tt -47.87 -54.33 12.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.599 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.433 ' H ' HG23 ' B' ' 111' ' ' VAL . 3.5 t -45.57 -32.64 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.884 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.525 ' O ' ' ND1' ' B' ' 116' ' ' HIS . 45.6 m -77.3 -36.87 53.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 109.754 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 18.2 t -57.97 -46.36 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.739 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' B' ' 118' ' ' PHE . 19.0 mt -66.8 -30.54 70.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.697 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.458 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -61.08 -29.44 69.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.614 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' B' ' 112' ' ' CYS . 68.7 m80 -84.82 -62.89 1.44 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.708 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.518 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 1.0 OUTLIER -65.44 -18.45 65.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 40.5 m-85 -144.37 55.48 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 109.491 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.531 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -68.74 -21.32 74.85 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.06 -35.21 59.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.146 . . . . 0.0 109.421 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.482 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.0 mm-40 -75.31 3.05 9.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.439 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.552 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -72.33 35.43 0.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.555 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.557 ' OG1' HG23 ' B' ' 126' ' ' VAL . 4.8 p -47.12 147.4 2.47 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.369 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.2 Cg_exo -48.48 -51.28 10.53 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.31 2.007 . . . . 0.0 113.231 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 41.8 Cg_endo -67.99 -0.92 6.12 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.055 1.836 . . . . 0.0 112.754 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.557 HG23 ' OG1' ' B' ' 123' ' ' THR . 40.3 t -99.08 -12.57 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 109.598 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.36 -60.19 2.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 109.496 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.51 ' O ' ' NZ ' ' B' ' 132' ' ' LYS . . . -67.07 -25.71 66.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.95 . . . . 0.0 109.264 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.45 18.19 2.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 109.651 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.46 ' CD2' HG23 ' B' ' 11' ' ' VAL . 6.1 t80 -107.89 -61.3 1.59 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.652 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.415 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 53.6 tt0 -46.31 -48.28 18.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 109.742 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.821 ' HG2' ' OXT' ' D' ' 146' ' ' HIS . 33.1 mtmm -52.69 -21.89 4.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.781 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.34 -67.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.0 109.699 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.55 HG11 ' CZ ' ' B' ' 71' ' ' PHE . 30.9 m -73.33 -15.88 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 109.909 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.906 ' HB1' ' CG ' ' D' ' 146' ' ' HIS . . . -47.47 -28.86 2.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.469 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.29 -22.8 58.22 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 134' ' ' VAL . 82.3 t -82.1 -27.04 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -1.136 . . . . 0.0 109.538 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.98 82.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.596 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.783 ' OD1' ' OD1' ' D' ' 139' ' ' ASN . 64.4 m-80 -79.63 -25.93 41.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.917 . . . . 0.0 109.754 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.47 -49.15 78.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.0 109.726 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 21.8 mt -82.64 16.41 2.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 109.668 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.77 -0.77 1.88 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.22 -0.925 . . . . 0.0 109.697 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -80.36 -28.31 38.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -70.91 -16.6 62.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.439 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.571 ' CD1' ' SG ' ' B' ' 93' ' ' CYS . 13.9 m-85 -64.67 -28.83 69.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.361 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.867 ' CG ' ' HB1' ' D' ' 135' ' ' ALA . 20.9 m-70 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.447 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' C' ' 128' ' ' PHE . 4.3 mm? -105.13 -176.71 3.16 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.278 -0.889 . . . . 0.0 109.536 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.545 ' O ' ' O ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER -117.22 170.84 5.53 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.539 -0.726 . . . . 0.0 109.191 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' C' ' 3' ' ' SER . 89.1 Cg_exo -41.37 -117.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.126 2.551 . . . . 0.0 113.275 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -43.92 -27.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 110.272 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.505 ' O ' HG23 ' C' ' 10' ' ' VAL . 29.7 m-20 -44.16 -34.95 2.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.1 -1.0 . . . . 0.0 109.25 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -83.33 -33.95 25.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.319 -0.863 . . . . 0.0 109.307 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 55.1 m -59.29 -33.41 71.04 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.227 -0.921 . . . . 0.0 109.028 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' ASN . . . . . 0.401 ' CG ' ' HB1' ' C' ' 120' ' ' ALA . 6.5 m120 -74.95 -32.65 61.78 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.505 HG23 ' O ' ' C' ' 6' ' ' ASP . 53.6 t -76.05 -51.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 11' ' ' LYS . . . . . 0.507 ' HE2' HG13 ' C' ' 70' ' ' VAL . 1.1 mptm? -57.0 -34.01 67.72 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.2 -59.67 5.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.521 -0.737 . . . . 0.0 109.314 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.768 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -53.2 -34.43 56.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.383 -0.823 . . . . 0.0 109.109 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -17.64 61.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.308 -0.87 . . . . 0.0 109.263 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.17 -44.75 9.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -70.06 -38.29 75.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.168 -1.195 . . . . 0.0 108.89 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.768 HG23 ' O ' ' C' ' 13' ' ' ALA . 95.6 t -61.35 -64.93 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.552 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 53.94 -130.56 43.67 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.15 26.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.42 -1.047 . . . . 0.0 110.453 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.552 ' H ' ' C ' ' C' ' 18' ' ' GLY . 93.2 m-70 -130.59 24.07 5.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.95 -59.52 2.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.627 -0.67 . . . . 0.0 109.735 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -14.31 0.23 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' C' ' 21' ' ' ALA . 9.7 mt-10 -88.05 -56.6 3.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.139 . . . . 0.0 109.74 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.8 m-30 -57.4 -39.54 76.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.066 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.53 -23.05 53.83 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.4 -57.99 2.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.286 -1.126 . . . . 0.0 109.774 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' GLU . . . . . 0.526 ' OE1' ' NE2' ' C' ' 112' ' ' HIS . 72.7 mt-10 -50.18 -19.88 0.88 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.29 -21.64 63.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.494 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.615 HD21 ' CE1' ' C' ' 58' ' ' HIS . 9.1 mt -73.12 -56.49 5.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.571 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -43.79 -37.15 2.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.827 . . . . 0.0 109.773 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -48.71 78.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 61.0 ttp -83.97 -42.87 15.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' PHE . . . . . 0.594 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 26.2 m-85 -64.17 -32.71 74.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.908 . . . . 0.0 110.239 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' C' ' 33' ' ' PHE . 5.7 mt -45.66 -43.07 12.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.966 -1.083 . . . . 0.0 109.658 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.57 ' O ' ' C ' ' C' ' 36' ' ' PHE . 14.9 m -86.66 -15.67 38.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -0.9 . . . . 0.0 109.367 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.594 ' CD2' ' O ' ' C' ' 33' ' ' PHE . 0.2 OUTLIER 19.17 64.46 0.24 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.917 -0.489 . . . . 0.0 111.354 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.436 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 85.4 Cg_endo -93.68 -62.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.571 2.181 . . . . 0.0 112.551 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.719 ' O ' HG22 ' C' ' 41' ' ' THR . 3.4 p -91.45 -18.48 24.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 109.754 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -81.72 -23.08 36.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.15 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -68.25 -34.96 77.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.087 -1.008 . . . . 0.0 109.67 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.719 HG22 ' O ' ' C' ' 38' ' ' THR . 13.9 t -49.97 -36.85 29.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' C' ' 43' ' ' PHE . 60.6 m-85 -90.79 15.5 11.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.236 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' C' ' 42' ' ' TYR . 20.3 m-85 59.94 142.55 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.444 -0.785 . . . . 0.0 109.574 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.562 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 59.8 Cg_endo -73.33 -42.71 0.85 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.487 2.125 . . . . 0.0 111.976 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.562 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 42.1 p-80 43.23 31.86 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.625 -0.672 . . . . 0.0 111.106 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' C' ' 55' ' ' VAL . 0.7 OUTLIER -155.86 28.54 0.37 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.76 -1.212 . . . . 0.0 110.406 178.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' C' ' 46' ' ' PHE . 7.3 m-20 33.41 81.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.663 -0.648 . . . . 0.0 110.295 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.862 HD23 ' H ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -60.06 -21.35 61.33 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.462 -0.774 . . . . 0.0 109.356 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 20.9 t -47.54 149.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.614 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 2.0 t60 -74.81 151.08 39.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' GLY . . . . . 0.584 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 82.26 4.64 90.13 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.667 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 12.0 p -77.42 -19.81 55.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -1.11 . . . . 0.0 109.482 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 75.8 -16.99 0.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.367 -0.833 . . . . 0.0 109.888 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -86.1 -21.56 27.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.903 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.511 HG22 ' CE2' ' C' ' 46' ' ' PHE . 18.6 t -83.93 -28.42 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.062 -1.024 . . . . 0.0 109.901 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -77.96 -30.37 50.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.013 -1.055 . . . . 0.0 108.961 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' GLY . . . . . 0.512 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -66.68 -26.44 72.97 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.615 ' CE1' HD21 ' C' ' 29' ' ' LEU . 8.2 t-80 -75.41 -34.77 61.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.122 -1.222 . . . . 0.0 109.671 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.1 44.32 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -51.66 -23.42 4.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -1.077 . . . . 0.0 109.887 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.538 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 0.8 OUTLIER -74.54 -42.4 58.9 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.157 -0.965 . . . . 0.0 109.103 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -72.54 -45.23 59.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 108.98 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.85 -27.66 66.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.279 -0.888 . . . . 0.0 109.156 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -72.3 -34.01 67.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 108.866 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.449 ' HB3' HMB3 ' C' ' 142' ' ' HEC . . . -66.86 -52.1 47.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.01 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' C' ' 128' ' ' PHE . 9.2 mt -59.15 -42.8 91.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.912 . . . . 0.0 108.634 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -69.42 -50.13 48.65 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.282 -0.886 . . . . 0.0 108.695 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -59.01 -24.86 63.17 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.86 -45.64 13.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.507 HG13 ' HE2' ' C' ' 11' ' ' LYS . 4.9 t -63.65 -23.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.21 -22.86 63.5 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' C' ' 74' ' ' ASP . 90.8 m-70 -147.24 -51.87 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.357 -0.839 . . . . 0.0 109.56 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.3 p 44.42 13.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.856 0.836 . . . . 0.0 109.539 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' C' ' 72' ' ' HIS . 17.8 t70 -133.12 9.76 4.13 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.434 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 34.1 t70 -175.4 27.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.897 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.689 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 13.8 ptt? -78.64 -22.62 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.478 -0.764 . . . . 0.0 111.865 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.6 Cg_exo -53.46 -20.69 16.36 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.586 1.524 . . . . 0.0 112.276 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -94.21 -35.42 12.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 109.738 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.03 -47.58 61.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 0.0 109.32 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -77.45 5.69 8.38 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.112 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 64.4 p -54.74 -24.67 23.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -73.95 -55.15 6.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.579 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.47 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 4.7 mt -47.75 -48.07 30.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.385 -0.822 . . . . 0.0 108.821 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -59.32 -22.63 61.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.49 -0.756 . . . . 0.0 109.315 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' C' ' 89' ' ' HIS . 16.5 t70 -81.9 -46.53 13.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.24 -26.82 65.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 87' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 11.4 m80 -81.34 -21.74 38.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.166 -0.959 . . . . 0.0 109.783 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' C' ' 90' ' ' LYS . . . -118.98 -55.51 2.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.313 -0.867 . . . . 0.0 109.773 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 89' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' C' ' 85' ' ' ASP . 13.2 t-80 -71.26 17.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.813 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.618 ' C ' ' H ' ' C' ' 92' ' ' ARG . 9.8 ttmm -166.53 149.02 6.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -0.998 . . . . 0.0 109.728 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.7 mt 61.79 -12.47 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.893 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 92' ' ' ARG . . . . . 1.005 ' HD2' ' HG2' ' B' ' 40' ' ' ARG . 45.7 mmt-85 45.05 16.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.73 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' C' ' 91' ' ' LEU . 12.0 p -57.73 130.97 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 1.034 ' OD1' ' NH1' ' B' ' 40' ' ' ARG . 0.8 OUTLIER -75.31 146.99 82.24 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' C' ' 97' ' ' ASN . 58.0 Cg_endo -72.63 -23.82 19.27 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.436 2.091 . . . . 0.0 112.153 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.458 ' H ' HG23 ' C' ' 96' ' ' VAL . 5.6 t -48.95 -10.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.796 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' C' ' 95' ' ' PRO . 12.1 m-20 -79.21 -24.73 42.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 109.518 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 98' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' C' ' 99' ' ' LYS . 0.6 OUTLIER -54.27 -30.1 49.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 109.497 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.419 ' N ' ' CD1' ' C' ' 98' ' ' PHE . 92.3 mttt -54.25 -26.61 29.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.461 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.67 ' N ' HD12 ' C' ' 100' ' ' LEU . 8.1 mp -84.18 -57.31 3.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.537 HD22 ' CHC' ' C' ' 142' ' ' HEC . 7.2 tp -50.93 -27.3 7.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 109.534 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 6.1 m -66.23 -58.55 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 0.0 109.551 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -63.39 -26.61 68.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.68 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 73.4 m -58.15 -55.94 28.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.627 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mt -47.86 -37.98 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 109.541 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.571 ' N ' HD12 ' C' ' 106' ' ' LEU . 7.7 mp -71.09 -41.99 69.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.99 -24.93 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.376 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 22.5 m -80.85 -63.2 1.46 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.442 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' C' ' 113' ' ' LEU . 34.4 mt -46.97 -28.35 1.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.18 90.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 110.044 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.69 63.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.386 -0.821 . . . . 0.0 110.027 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 112' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' C' ' 27' ' ' GLU . 28.1 m170 -93.16 -80.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.107 -0.995 . . . . 0.0 109.697 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.853 ' O ' HD23 ' C' ' 113' ' ' LEU . 0.1 OUTLIER -107.83 102.7 46.58 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -43.8 173.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.626 2.217 . . . . 0.0 113.504 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -87.19 -35.43 18.58 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.684 0.754 . . . . 0.0 109.482 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 13.2 mt-10 81.34 1.28 1.62 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 1.194 ' CD1' ' NH2' ' D' ' 30' ' ' ARG . 11.1 m-85 58.55 40.8 23.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.895 -0.503 . . . . 0.0 111.255 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.754 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -88.05 118.69 69.91 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.703 -1.248 . . . . 0.0 108.068 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 119' ' ' PRO . . . . . 0.603 ' HA ' HG21 ' D' ' 33' ' ' VAL . 54.0 Cg_exo -49.05 18.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.293 1.995 . . . . 0.0 112.662 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.754 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -139.99 -39.23 0.45 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.077 -1.015 . . . . 0.0 110.057 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.575 HG13 ' N ' ' C' ' 122' ' ' HIS . 4.2 p -51.8 -48.33 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.103 -0.998 . . . . 0.0 109.952 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.575 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.9 m-70 -62.91 -54.32 40.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.399 -0.813 . . . . 0.0 109.259 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.81 -19.69 60.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.307 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 1.1 p -60.79 -61.5 2.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.345 -0.847 . . . . 0.0 110.303 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.535 ' N ' ' OG ' ' C' ' 124' ' ' SER . 6.4 mt -80.72 -21.04 41.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.089 -1.007 . . . . 0.0 110.05 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -78.51 -40.67 34.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 110.092 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.29 -41.3 11.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.987 -1.07 . . . . 0.0 110.097 -179.508 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.527 ' HA ' HD11 ' C' ' 2' ' ' LEU . 31.9 t80 -50.51 -20.59 1.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.8 -1.187 . . . . 0.0 108.841 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' C' ' 133' ' ' SER . 11.9 mt -72.53 -17.79 61.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.46 -38.1 76.85 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 60.8 p -79.46 -36.24 39.11 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.318 -0.864 . . . . 0.0 108.749 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.02 -27.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.218 -0.927 . . . . 0.0 108.638 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.587 ' N ' ' O ' ' C' ' 129' ' ' LEU . 96.8 p -78.32 -45.96 21.32 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.384 -0.822 . . . . 0.0 109.159 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 94.8 m -67.78 -22.99 65.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.258 -0.902 . . . . 0.0 108.705 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.77 -30.04 7.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -34.6 67.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.393 -0.817 . . . . 0.0 109.056 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 137' ' ' THR . . . . . 0.44 ' O ' ' O ' ' C' ' 138' ' ' SER . 81.1 p -92.32 -29.56 16.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.573 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 138' ' ' SER . . . . . 0.44 ' O ' ' O ' ' C' ' 137' ' ' THR . 3.5 t 61.91 132.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -170.54 109.41 0.35 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 49.55 74.93 0.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.428 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 2.7 ptp85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.463 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.324 0.583 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.72 93.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.832 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -140.84 145.18 35.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.164 -0.96 . . . . 0.0 109.059 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 7.9 p -69.6 148.83 96.95 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.531 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -42.8 -24.78 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.503 2.136 . . . . 0.0 112.229 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -80.79 -53.07 6.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.919 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -60.21 -36.07 76.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 109.989 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.531 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -84.06 -31.52 25.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 110.026 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.08 -23.49 7.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -0.959 . . . . 0.0 110.441 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.5 -58.02 3.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.935 -1.103 . . . . 0.0 110.222 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' D' ' 130' ' ' TYR . 7.7 p -65.55 -24.44 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 25.9 m -78.45 -40.32 36.0 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.317 0.58 . . . . 0.0 109.674 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -26.21 68.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.51 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.73 ' O ' HG23 ' D' ' 18' ' ' VAL . 0.9 OUTLIER -62.52 -26.84 68.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.329 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.77 -17.7 64.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.509 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.38 -62.87 3.66 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.494 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.627 ' HD3' HD23 ' D' ' 14' ' ' LEU . 0.0 OUTLIER -78.79 7.16 7.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.285 . . . . 0.0 110.849 -178.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.73 HG23 ' O ' ' D' ' 14' ' ' LEU . 2.3 t -75.73 121.39 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.742 -1.224 . . . . 0.0 109.138 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 19' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -81.42 85.21 6.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.212 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 36.5 t -55.97 -20.39 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.608 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' D' ' 22' ' ' GLU . 1.0 OUTLIER -57.32 -55.81 29.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.366 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' D' ' 21' ' ' ASP . 43.1 mt-10 -98.9 -44.31 6.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.66 -23.89 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.619 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.24 -43.11 10.93 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.87 -25.93 61.44 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -79.36 -25.56 42.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.213 -1.169 . . . . 0.0 109.674 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.61 -23.17 39.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 109.675 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 tp -85.03 -57.29 3.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 109.479 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.93 -19.92 31.71 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' ARG . . . . . 1.194 ' NH2' ' CD1' ' C' ' 117' ' ' PHE . 47.2 mtt180 -79.29 -27.28 42.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -1.176 . . . . 0.0 109.421 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 39.4 tp -65.68 -24.71 67.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 41.8 mt -78.19 -53.67 7.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.056 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.732 HG13 ' H ' ' D' ' 34' ' ' VAL . 7.9 p -71.16 -60.6 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.125 -0.985 . . . . 0.0 110.05 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.732 ' H ' HG13 ' D' ' 33' ' ' VAL . 94.9 t -46.41 -30.41 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.952 -1.093 . . . . 0.0 109.557 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.96 91.25 1.57 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 109.348 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -84.74 30.47 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.731 2.287 . . . . 0.0 112.409 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 -57.16 -28.75 63.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.623 HG21 HBC1 ' D' ' 147' ' ' HEC . 30.5 p -56.07 -77.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.379 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 39' ' ' GLN . . . . . 0.542 ' N ' ' OG1' ' D' ' 38' ' ' THR . 14.7 tt0 50.6 46.09 26.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 109.577 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 40' ' ' ARG . . . . . 1.08 ' NH1' ' OD1' ' A' ' 94' ' ' ASP . 69.3 mtm180 -147.97 -49.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' D' ' 43' ' ' GLU . 1.3 p90 -96.76 -21.24 17.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -48.86 -11.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.565 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' D' ' 41' ' ' PHE . 31.3 mt-10 -80.31 -20.3 44.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 44' ' ' SER . . . . . 0.471 ' O ' ' N ' ' D' ' 46' ' ' GLY . 11.3 t -58.2 -51.94 67.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.581 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' D' ' 47' ' ' ASP . 56.8 m-85 -47.75 -16.27 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.515 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 61.38 -77.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' D' ' 45' ' ' PHE . 0.9 OUTLIER -46.74 113.49 0.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -1.133 . . . . 0.0 109.607 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 48' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' D' ' 49' ' ' SER . 0.8 OUTLIER -161.22 22.18 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 108.971 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' D' ' 48' ' ' LEU . 17.8 m -45.06 -39.77 6.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 109.585 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -145.53 151.94 48.16 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.855 . . . . 0.0 109.056 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -44.61 -21.85 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.241 1.96 . . . . 0.0 112.16 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -83.81 -29.18 27.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 109.594 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.52 -26.94 45.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.655 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.51 -62.04 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.577 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 14.9 mmt -53.62 -17.0 1.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.556 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.27 -4.16 61.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 57' ' ' ASN . . . . . 0.433 HD21 ' HB3' ' D' ' 45' ' ' PHE . 64.8 m-20 -72.27 142.79 85.0 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.321 -1.105 . . . . 0.0 109.313 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.55 -52.11 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.515 2.144 . . . . 0.0 112.152 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -51.66 -47.96 63.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.624 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 95.5 t -47.51 -27.47 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -79.14 -53.52 6.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.68 -59.03 3.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.567 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.912 ' HE1' ' CHA' ' D' ' 147' ' ' HEC . 1.2 t60 -49.0 -24.03 1.36 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.933 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.59 -37.66 92.71 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 65' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' D' ' 69' ' ' GLY . 27.8 mttp -71.67 -35.42 70.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -1.197 . . . . 0.0 109.519 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 66' ' ' LYS . . . . . 0.538 ' HD3' HAA1 ' D' ' 147' ' ' HEC . 41.4 mttm -49.35 -44.82 44.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 109.235 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.992 HG22 ' C1B' ' D' ' 147' ' ' HEC . 54.3 t -73.66 -61.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -0.869 . . . . 0.0 109.212 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.72 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.8 tt -50.44 -23.35 2.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.155 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 69' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' D' ' 65' ' ' LYS . . . -66.23 -57.08 11.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.81 97.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.203 -1.174 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 71' ' ' PHE . . . . . 0.552 ' CZ ' HG11 ' D' ' 134' ' ' VAL . 0.1 OUTLIER -48.89 -21.73 0.71 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.314 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p -88.05 -34.86 17.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.57 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -46.35 -34.49 4.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.893 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.52 -58.91 6.05 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.531 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.5 mp -62.76 -23.48 67.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.175 -1.191 . . . . 0.0 109.26 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.35 2.32 54.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 109.454 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' D' ' 79' ' ' ASP . 55.9 t60 -170.95 65.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.79 13.3 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.304 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' D' ' 77' ' ' HIS . 34.7 t70 -76.46 -27.64 56.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -170.93 106.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.22 -44.09 20.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 82' ' ' LYS . . . . . 0.431 ' CD ' ' H ' ' D' ' 82' ' ' LYS . 1.5 mptp? -49.36 -25.89 2.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.469 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.18 -53.79 3.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 84' ' ' THR . . . . . . . . . . . . . 3.8 p -65.83 -37.63 86.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -1.144 . . . . 0.0 109.596 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 85' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -90.9 24.02 2.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.665 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.29 -41.58 40.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.337 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 21.2 p -72.79 -50.83 21.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 109.491 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.82 -48.94 76.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.352 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 27.7 t -61.48 -44.03 97.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.44 -23.75 67.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 7.4 tp -85.12 -68.78 0.7 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.842 . . . . 0.0 109.421 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -49.52 -30.14 7.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 93' ' ' CYS . . . . . 0.587 ' SG ' ' CD1' ' D' ' 145' ' ' TYR . 38.0 t -83.88 -55.55 4.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 111.633 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.543 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 0.6 OUTLIER -86.39 -29.07 23.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.957 -1.09 . . . . 0.0 112.161 -177.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 95' ' ' LYS . . . . . 0.447 ' C ' HD22 ' D' ' 96' ' ' LEU . 5.6 mptp? -90.34 -52.07 5.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.619 -1.301 . . . . 0.0 111.043 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.531 ' N ' HD22 ' D' ' 96' ' ' LEU . 3.7 mm? -97.53 -22.85 16.3 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.787 -1.196 . . . . 0.0 110.241 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.668 ' O ' HG22 ' A' ' 38' ' ' THR . 81.9 m-70 51.07 37.59 18.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.019 -1.05 . . . . 0.0 109.473 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 44.5 t -55.04 138.78 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.345 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.93 151.24 3.43 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.7 30.6 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.568 2.179 . . . . 0.0 112.086 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -143.46 75.88 1.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 109.349 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -168.27 -40.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -52.54 -45.79 66.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 104' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 55.3 ttp180 -66.16 -42.39 89.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 105' ' ' LEU . . . . . 0.594 ' N ' HD12 ' D' ' 105' ' ' LEU . 10.1 mp -54.45 -57.43 11.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.442 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 1.018 HD22 ' HAB' ' D' ' 147' ' ' HEC . 7.5 tt -52.13 -49.02 64.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.17 -0.956 . . . . 0.0 109.467 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -59.0 -22.37 55.01 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 108' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 27.4 m120 -80.66 -15.56 56.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.107 -1.231 . . . . 0.0 109.786 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 63.5 t -85.08 -44.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 109.65 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 110' ' ' LEU . . . . . 0.517 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.7 tt -47.98 -54.24 13.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 111' ' ' VAL . . . . . 0.452 HG23 ' H ' ' D' ' 111' ' ' VAL . 3.4 t -45.5 -32.69 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.955 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 112' ' ' CYS . . . . . 0.52 ' O ' ' ND1' ' D' ' 116' ' ' HIS . 46.3 m -77.3 -36.86 53.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.76 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.94 -46.45 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.767 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 19.0 mt -66.77 -30.42 70.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.794 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.458 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -61.22 -29.42 69.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.97 . . . . 0.0 109.575 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' D' ' 112' ' ' CYS . 68.8 m80 -84.74 -63.0 1.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.071 -1.018 . . . . 0.0 109.685 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 117' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 1.0 OUTLIER -65.38 -18.4 65.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 109.581 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 40.6 m-85 -144.45 55.44 1.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.529 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -68.62 -21.42 74.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -76.03 -35.19 59.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -1.118 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' D' ' 123' ' ' THR . 59.0 mm-40 -75.33 3.04 9.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.537 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -72.24 35.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.334 -0.854 . . . . 0.0 109.545 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.549 ' OG1' HG23 ' D' ' 126' ' ' VAL . 4.8 p -47.15 147.35 2.53 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.955 . . . . 0.0 109.393 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.499 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.2 Cg_exo -48.38 -51.29 10.45 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.366 2.044 . . . . 0.0 113.202 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 41.6 Cg_endo -68.0 -1.0 6.22 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.06 1.84 . . . . 0.0 112.748 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.549 HG23 ' OG1' ' D' ' 123' ' ' THR . 40.0 t -99.09 -12.52 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.174 -0.954 . . . . 0.0 109.607 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.25 -60.23 2.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 109.507 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.518 ' O ' ' NZ ' ' D' ' 132' ' ' LYS . . . -67.05 -25.79 66.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.37 18.06 2.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.356 -0.84 . . . . 0.0 109.621 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.45 ' CD2' HG23 ' D' ' 11' ' ' VAL . 6.2 t80 -107.83 -61.39 1.58 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.341 -0.85 . . . . 0.0 109.617 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 53.6 tt0 -46.4 -48.17 18.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.957 . . . . 0.0 109.724 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 132' ' ' LYS . . . . . 0.775 ' HG2' ' OXT' ' B' ' 146' ' ' HIS . 33.0 mtmm -52.65 -21.87 4.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.863 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 25.7 t -74.39 -67.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -0.949 . . . . 0.0 109.661 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.552 HG11 ' CZ ' ' D' ' 71' ' ' PHE . 31.4 m -73.5 -15.77 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.883 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.867 ' HB1' ' CG ' ' B' ' 146' ' ' HIS . . . -47.34 -29.0 2.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.23 -22.82 58.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 137' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' D' ' 134' ' ' VAL . 81.0 t -82.18 -26.95 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -1.133 . . . . 0.0 109.547 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.84 -47.96 83.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.93 . . . . 0.0 109.615 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.783 ' OD1' ' OD1' ' B' ' 139' ' ' ASN . 64.2 m-80 -79.62 -26.02 41.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.65 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.2 78.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.676 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 21.9 mt -82.68 16.41 2.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.651 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.75 -0.85 1.88 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.213 -0.929 . . . . 0.0 109.729 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -80.27 -28.24 38.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.778 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -70.91 -16.62 62.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.985 . . . . 0.0 109.465 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 145' ' ' TYR . . . . . 0.587 ' CD1' ' SG ' ' D' ' 93' ' ' CYS . 13.9 m-85 -64.66 -28.82 69.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.383 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.906 ' CG ' ' HB1' ' B' ' 135' ' ' ALA . 20.9 m-70 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.777 HBB2 HMB1 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 1.088 ' HAB' HD22 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.768 HBB2 HMB1 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 1.018 ' HAB' HD22 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.428 ' CG2' ' OG ' ' A' ' 131' ' ' SER . 16.8 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.438 HD13 ' CD1' ' A' ' 128' ' ' PHE . 25.0 mt -136.9 -161.01 1.11 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 0.0 109.354 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.453 ' N ' ' OD2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -133.15 174.43 4.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.332 -0.855 . . . . 0.0 109.285 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.23 -70.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.629 2.219 . . . . 0.0 112.689 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -48.54 -44.14 36.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.109 -0.995 . . . . 0.0 109.903 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 10' ' ' VAL . 1.3 m-20 -42.36 -35.76 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 10' ' ' VAL . 69.6 mttt -83.32 -56.43 3.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.32 -0.862 . . . . 0.0 109.524 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 94.5 m -45.43 -35.58 3.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 109.865 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.69 -33.49 62.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.01 -1.057 . . . . 0.0 108.15 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 6' ' ' ASP . 75.4 t -76.22 -49.37 25.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.45 -40.08 64.93 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.89 -61.64 2.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.516 -0.74 . . . . 0.0 109.462 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.64 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.6 -38.5 66.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.381 -0.824 . . . . 0.0 109.137 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.47 -17.44 62.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.24 -0.912 . . . . 0.0 109.008 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.58 -46.62 7.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -68.69 -36.76 78.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -1.163 . . . . 0.0 108.842 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 13' ' ' ALA . 70.5 t -62.0 -66.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 61.85 -141.08 47.3 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.17 39.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.493 -1.004 . . . . 0.0 110.355 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' GLY . 87.6 m-70 -142.94 20.34 1.96 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.63 -61.28 1.92 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.652 -0.655 . . . . 0.0 109.583 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.65 -13.91 0.19 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 21' ' ' ALA . 10.2 mm-40 -84.99 -56.33 3.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -1.102 . . . . 0.0 109.613 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.8 m-30 -61.69 -30.88 71.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 109.254 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.44 74.88 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -75.48 -40.41 57.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -1.198 . . . . 0.0 109.669 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -56.96 -20.75 25.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.325 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.57 72.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.88 . . . . 0.0 109.483 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.865 HD11 ' CG ' ' A' ' 58' ' ' HIS . 78.4 mt -64.41 -61.17 2.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.63 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.01 -12.66 12.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.631 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.518 ' NH2' ' CB ' ' B' ' 127' ' ' GLN . 6.2 tpm_? -74.35 -53.34 9.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.401 ' CE ' ' CBC' ' A' ' 142' ' ' HEC . 1.2 ptt? -84.18 -28.74 27.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.918 . . . . 0.0 110.084 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -46.37 -37.77 7.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 110.042 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.747 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -96.61 -36.92 10.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 110.268 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.8 m -44.43 -25.88 0.29 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 110.028 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.551 ' CG ' ' O ' ' A' ' 35' ' ' SER . 50.9 m-85 -162.46 139.11 5.97 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.169 -0.957 . . . . 0.0 109.287 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 40' ' ' LYS . 55.9 Cg_endo -71.98 -34.02 9.02 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.596 2.197 . . . . 0.0 111.984 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.965 ' HA ' ' HB3' ' D' ' 97' ' ' HIS . 76.6 p -47.51 -18.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 109.509 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 37' ' ' PRO . 25.7 p -84.85 -27.99 26.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 109.446 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 37' ' ' PRO . 82.7 mttt -71.43 -25.3 62.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.676 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 38' ' ' THR . 15.1 t -49.4 -38.89 30.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.169 -0.957 . . . . 0.0 109.529 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 43' ' ' PHE . 98.0 m-85 -71.29 -1.09 11.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.95 . . . . 0.0 109.406 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.514 ' O ' ' O ' ' A' ' 42' ' ' TYR . 84.9 m-85 58.26 141.71 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 0.0 109.728 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.7 ' O ' ' CD2' ' A' ' 46' ' ' PHE . 64.3 Cg_endo -75.04 -41.49 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.58 2.186 . . . . 0.0 112.048 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.662 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 14.9 p80 50.53 27.94 3.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.527 -0.733 . . . . 0.0 110.641 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.7 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 2.6 p90 -144.95 25.45 1.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.49 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.453 ' C ' ' N ' ' A' ' 49' ' ' SER . 2.4 m-20 43.97 84.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.463 -0.773 . . . . 0.0 109.791 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.675 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -51.82 -11.36 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.453 ' N ' ' C ' ' A' ' 47' ' ' ASP . 28.3 p -49.01 158.48 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -77.47 148.24 35.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.455 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.24 16.92 78.94 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 54.6 p -74.42 -17.06 60.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -1.154 . . . . 0.0 109.485 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.41 -39.54 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.338 -0.851 . . . . 0.0 109.641 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 52' ' ' SER . 56.6 mt-30 -65.87 -42.11 90.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.45 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.551 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 93.5 t -66.4 -44.67 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.298 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -39.4 67.0 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.15 -26.58 72.5 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.865 ' CG ' HD11 ' A' ' 29' ' ' LEU . 4.5 t-80 -68.15 -43.29 78.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -1.218 . . . . 0.0 109.317 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.75 -46.07 24.66 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -48.52 -23.66 1.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -1.047 . . . . 0.0 109.268 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -75.41 -38.94 59.56 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.283 -0.886 . . . . 0.0 108.672 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.49 -48.95 44.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.29 -32.86 74.74 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 109.083 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 68' ' ' ASN . 5.8 t0 -63.74 -36.49 84.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.238 -0.914 . . . . 0.0 108.626 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.501 ' HB3' HMB3 ' A' ' 142' ' ' HEC . . . -67.55 -52.77 34.86 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.01 -41.01 91.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.4 m -71.87 -50.2 31.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' ASP . 49.4 t30 -60.16 -24.3 64.62 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.616 ' HB1' ' SD ' ' A' ' 76' ' ' MET . . . -82.29 -46.69 13.31 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.11 -22.97 32.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.4 -14.92 63.34 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.606 ' O ' ' N ' ' A' ' 74' ' ' ASP . 35.5 m-70 -138.36 -62.97 0.56 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.517 -0.739 . . . . 0.0 109.287 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 73' ' ' VAL . 13.1 p 44.28 14.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.928 0.87 . . . . 0.0 109.37 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 72' ' ' HIS . 39.8 t0 -138.14 11.61 2.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.432 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.0 OUTLIER 174.92 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.246 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.685 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 14.3 ptt? -78.74 -22.68 0.39 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 111.981 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 76' ' ' MET . 59.5 Cg_exo -52.01 -19.67 9.02 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.705 1.603 . . . . 0.0 112.51 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -94.12 -35.76 12.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 109.764 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.96 -38.4 69.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.963 . . . . 0.0 109.285 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.79 11.49 15.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.392 -0.818 . . . . 0.0 109.049 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.3 p -68.08 -15.92 63.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 109.763 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -72.69 -55.8 6.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.031 . . . . 0.0 109.878 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 86' ' ' LEU . 6.1 mt -44.88 -47.26 11.15 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.81 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 62.6 m -46.79 -33.05 4.1 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' ALA . 1.5 m-20 -82.11 -17.32 46.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.188 -0.945 . . . . 0.0 109.558 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 83' ' ' LEU . 8.6 tp -74.06 -53.44 9.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.1 -1.0 . . . . 0.0 110.261 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.435 ' CE1' ' O ' ' A' ' 83' ' ' LEU . 6.0 p-80 -92.2 -21.66 20.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.975 -1.078 . . . . 0.0 110.643 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -97.27 -0.61 46.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.9 -1.125 . . . . 0.0 110.404 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 88' ' ' ALA . 70.9 m80 -154.91 42.94 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.787 -1.195 . . . . 0.0 110.256 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -172.39 -63.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.967 . . . . 0.0 109.329 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.1 mt -90.59 -23.79 20.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 53.99 53.3 11.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.665 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 94' ' ' ASP . 2.3 t -79.87 -136.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 109.447 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 96' ' ' VAL . 5.2 t70 -172.3 137.11 0.89 Allowed Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 109.234 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 98' ' ' PHE . 85.6 Cg_exo -41.86 -10.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.544 2.163 . . . . 0.0 112.639 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 94' ' ' ASP . 60.1 t -43.75 -28.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 109.955 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.19 -24.95 42.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 95' ' ' PRO . 38.4 t80 -44.96 -32.47 1.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.913 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.49 -27.22 27.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.007 . . . . 0.0 109.898 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.16 -62.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.036 -1.04 . . . . 0.0 110.024 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.995 ' CD2' ' HHC' ' A' ' 142' ' ' HEC . 36.7 tp -55.74 -20.96 16.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 109.878 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.8 p -78.44 -50.37 11.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.051 -1.031 . . . . 0.0 109.843 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -76.4 -26.6 55.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -0.952 . . . . 0.0 109.808 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 55.6 m -58.81 -50.92 72.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.777 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.35 -35.88 13.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 109.63 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.792 HD12 ' CE1' ' A' ' 122' ' ' HIS . 3.7 mm? -69.99 -59.17 3.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.079 -1.013 . . . . 0.0 109.895 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.8 t -50.08 -36.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.478 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 p -70.56 -63.11 1.16 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.264 -0.897 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' LEU . 17.5 mt -50.47 -31.42 15.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 -47.13 50.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.224 -0.923 . . . . 0.0 109.609 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.24 -41.35 22.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.89 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -80.1 -72.08 0.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.115 -0.991 . . . . 0.0 109.986 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -113.87 91.51 22.19 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 109.076 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 113' ' ' LEU . 84.7 Cg_exo -46.22 -175.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.329 2.019 . . . . 0.0 112.84 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.494 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.29 -42.21 13.94 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.636 0.732 . . . . 0.0 109.406 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER 85.0 3.66 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.897 ' CZ ' ' CE1' ' B' ' 116' ' ' HIS . 8.0 m-85 65.12 36.6 7.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.791 -0.568 . . . . 0.0 111.279 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.716 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -91.16 121.51 67.68 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.798 -1.189 . . . . 0.0 108.197 178.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.95 22.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.14 1.893 . . . . 0.0 112.656 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.716 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -151.23 -33.56 0.15 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.772 -1.205 . . . . 0.0 110.785 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.668 HG13 ' N ' ' A' ' 122' ' ' HIS . 11.4 p -46.63 -47.84 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.932 -1.105 . . . . 0.0 110.061 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.792 ' CE1' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -72.78 -33.51 66.34 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.555 -0.716 . . . . 0.0 109.349 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.06 -19.81 36.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 110.023 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 120' ' ' ALA . 10.2 p -65.95 -62.47 1.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.202 -0.936 . . . . 0.0 110.84 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.513 ' N ' ' OG ' ' A' ' 124' ' ' SER . 9.3 mt -70.18 -19.42 63.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.07 -1.019 . . . . 0.0 109.789 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -78.93 -45.43 20.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.046 -1.034 . . . . 0.0 110.219 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.445 ' CD ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -88.23 -43.24 11.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.988 -1.07 . . . . 0.0 110.14 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 10' ' ' VAL . 70.2 t80 -50.17 -21.02 1.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.957 -1.089 . . . . 0.0 109.271 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.4 mt -69.73 -17.7 63.47 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.25 -33.51 72.4 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.492 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 5.1 t -83.08 -30.41 28.0 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.417 -0.802 . . . . 0.0 108.992 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.5 t -85.41 -27.63 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 109.078 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 129' ' ' LEU . 77.9 p -83.75 -25.97 30.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.119 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.9 m -78.09 -36.94 47.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.213 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 131' ' ' SER . 33.3 m -76.57 -21.86 15.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.266 -0.896 . . . . 0.0 108.883 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.48 -37.87 68.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.451 -0.781 . . . . 0.0 108.985 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.5 p -89.14 -1.38 58.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.594 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t -61.93 103.06 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.428 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -81.3 76.46 8.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.441 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -158.58 108.06 2.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.501 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.479 HG13 ' N ' ' B' ' 2' ' ' HIS . 8.5 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 0.479 ' N ' HG13 ' B' ' 1' ' ' VAL . 12.3 t-80 -169.85 49.63 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 1.046 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -106.29 162.45 13.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.433 -0.792 . . . . 0.0 109.261 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.434 ' O ' ' N ' ' B' ' 7' ' ' GLU . 0.7 OUTLIER -84.61 150.93 57.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 109.109 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.01 -30.73 1.32 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.434 2.089 . . . . 0.0 112.026 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.36 -21.84 25.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.925 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 4' ' ' THR . 44.5 tt0 -77.11 -63.09 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.174 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.506 ' HB3' HD22 ' B' ' 3' ' ' LEU . 10.4 pttt -67.53 -25.73 65.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.963 . . . . 0.0 110.175 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -43.8 -24.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 110.134 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.18 -56.23 3.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.087 -1.008 . . . . 0.0 109.751 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.404 ' H ' HG12 ' B' ' 11' ' ' VAL . 0.9 OUTLIER -71.04 -24.74 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.7 m -68.35 -39.12 81.98 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.351 0.596 . . . . 0.0 109.805 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.4 -31.23 57.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.847 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.3 -21.86 6.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.341 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' TRP . . . . . 0.557 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.2 OUTLIER -56.31 -38.27 71.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 109.234 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.21 -40.26 61.48 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -26.19 66.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -1.143 . . . . 0.0 109.178 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.16 121.0 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 109.666 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' B' ' 21' ' ' ASP . 10.2 t-20 -80.04 71.83 6.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.0 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 82.8 t -45.89 -15.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 109.779 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 19' ' ' ASN . 34.8 m-20 -69.22 -4.09 16.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.624 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' B' ' 25' ' ' GLY . 47.9 mt-10 -155.79 -46.9 0.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.156 -0.965 . . . . 0.0 109.574 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -47.11 -23.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 109.723 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.95 -31.15 40.28 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -73.55 -39.52 49.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -70.24 -38.86 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 0.0 109.486 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.07 -30.25 61.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.556 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tp -81.47 -58.04 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.482 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.71 85.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -55.93 -39.35 71.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -1.126 . . . . 0.0 109.62 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.61 -35.98 4.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -81.19 -29.91 34.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 109.752 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.03 -64.48 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.425 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 34' ' ' VAL . 0.0 OUTLIER -63.97 -22.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.224 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -149.62 81.92 6.97 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.92 . . . . 0.0 109.562 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.95 9.85 3.15 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.562 2.175 . . . . 0.0 112.23 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' B' ' 38' ' ' THR . 0.4 OUTLIER -80.96 -19.96 42.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 109.694 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.554 ' N ' ' CD1' ' B' ' 37' ' ' TRP . 7.2 m -87.95 57.94 4.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.479 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -117.61 23.82 11.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.41 -0.807 . . . . 0.0 109.332 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -87.34 -39.76 15.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.958 . . . . 0.0 109.554 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -100.01 34.82 2.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 109.463 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.718 ' CE1' HMD3 ' B' ' 147' ' ' HEC . 0.9 OUTLIER -143.32 15.04 1.84 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.222 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.49 -14.09 61.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.408 ' C ' ' N ' ' B' ' 46' ' ' GLY . 5.3 m -69.14 -46.92 66.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.477 ' CE1' ' CD2' ' B' ' 42' ' ' PHE . 80.1 m-85 -50.17 -16.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 45' ' ' PHE . . . 51.3 179.61 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 38.0 t0 55.86 71.28 0.56 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -1.178 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 27.9 mt -131.21 35.05 3.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 109.379 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m -51.89 -49.29 63.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.27 160.17 46.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 108.837 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.4 -17.32 4.14 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.079 1.853 . . . . 0.0 111.972 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.418 ' C ' ' N ' ' B' ' 54' ' ' VAL . 19.6 t70 -83.26 -51.56 7.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.556 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.95 -20.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.431 -0.793 . . . . 0.0 109.471 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.418 ' N ' ' C ' ' B' ' 52' ' ' ASP . 57.8 t -73.01 -57.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mtt -59.98 -16.73 32.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.53 -26.62 71.29 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -78.79 132.22 65.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.152 -1.205 . . . . 0.0 109.327 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.02 -30.89 4.09 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.341 2.028 . . . . 0.0 112.34 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -70.41 -30.13 66.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.85 -40.68 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.516 ' NZ ' ' CB ' ' B' ' 61' ' ' LYS . 8.1 mtmp? -65.45 -37.43 86.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 109.68 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.96 -51.04 67.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.503 ' CE1' HBA1 ' B' ' 147' ' ' HEC . 41.0 t60 -55.82 -23.79 32.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.01 -48.94 65.33 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -52.29 -25.03 8.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -1.188 . . . . 0.0 109.587 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' LYS . . . . . 0.523 ' HB3' HBA2 ' B' ' 147' ' ' HEC . 0.3 OUTLIER -74.47 -61.94 1.7 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 109.491 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 0.852 HG13 ' C2B' ' B' ' 147' ' ' HEC . 35.0 t -52.18 -39.33 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.684 HD23 ' O ' ' B' ' 68' ' ' LEU . 8.0 tt -70.16 -37.41 75.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.903 . . . . 0.0 109.343 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.89 -44.08 61.25 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.53 71.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 109.787 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.418 ' O ' ' CD2' ' B' ' 75' ' ' LEU . 1.3 m-85 -66.3 -29.1 69.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.557 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.8 t -66.21 -33.77 76.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.515 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.17 -16.76 56.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.173 -0.954 . . . . 0.0 109.159 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.67 -19.76 63.15 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.838 ' N ' HD23 ' B' ' 75' ' ' LEU . 1.5 pt? -137.78 -28.44 0.89 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -1.181 . . . . 0.0 109.952 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' B' ' 72' ' ' SER . . . -80.1 19.02 0.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 109.586 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -171.55 70.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.465 HD21 ' HA ' ' B' ' 75' ' ' LEU . 70.5 mt -80.85 0.72 33.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.975 . . . . 0.0 109.492 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -54.04 -38.33 65.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -172.09 73.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.361 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.448 HD12 ' N ' ' B' ' 82' ' ' LYS . 2.2 pp -76.74 -41.73 43.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.628 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.448 ' N ' HD12 ' B' ' 81' ' ' LEU . 53.1 mttp -50.82 -27.2 6.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.096 -1.002 . . . . 0.0 109.41 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' B' ' 86' ' ' ALA . . . -83.19 -57.54 2.48 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.6 OUTLIER -47.86 -39.71 19.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -1.164 . . . . 0.0 109.557 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.459 ' CZ ' HG13 ' B' ' 137' ' ' VAL . 25.1 m-85 -69.83 -11.96 61.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.382 -0.824 . . . . 0.0 109.429 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' B' ' 83' ' ' GLY . . . -54.57 -43.72 72.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.438 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 11.4 p -64.38 -59.24 4.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' B' ' 88' ' ' LEU . 19.5 mt -54.97 -35.39 64.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.349 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -72.76 -46.43 53.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.337 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.54 -24.54 67.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.42 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.19 -68.36 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.557 ' O ' ' N ' ' B' ' 97' ' ' HIS . 75.1 m80 -54.35 -25.83 26.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 110.491 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.89 -60.66 2.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.013 -1.054 . . . . 0.0 111.501 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.561 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 11.8 m-20 -86.99 -39.75 15.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.92 -1.112 . . . . 0.0 111.701 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -83.17 -10.15 58.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.078 . . . . 0.0 111.07 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.519 ' O ' HD13 ' B' ' 96' ' ' LEU . 0.2 OUTLIER -137.9 -43.78 0.52 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.886 -1.134 . . . . 0.0 110.068 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.92 ' HB3' ' HA ' ' C' ' 38' ' ' THR . 4.1 m80 72.95 58.57 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.246 -0.909 . . . . 0.0 109.575 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 79.1 t -82.64 114.21 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.09 -1.006 . . . . 0.0 109.434 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.74 154.45 2.37 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.27 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.402 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 47.2 Cg_endo -70.09 -164.3 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.573 2.182 . . . . 0.0 112.149 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 53.31 51.97 14.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' B' ' 100' ' ' PRO . 31.0 m120 -158.25 -36.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.24 -37.57 85.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -72.94 -26.39 61.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.483 ' O ' HD23 ' B' ' 105' ' ' LEU . 1.3 tt -65.62 -55.49 17.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.402 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 1.017 HD13 ' CHC' ' B' ' 147' ' ' HEC . 7.9 tt -50.37 -47.0 56.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.24 -47.88 72.07 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.51 -50.29 65.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -1.161 . . . . 0.0 109.607 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 80.5 t -53.76 -38.5 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.17 -0.956 . . . . 0.0 109.524 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.96 -33.91 76.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.405 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.9 -26.24 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 60.7 m -79.27 -61.04 2.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.731 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' VAL . . . . . 0.407 HG23 ' H ' ' B' ' 113' ' ' VAL . 4.9 t -46.25 -30.0 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 31.9 mt -79.84 -31.45 40.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.601 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -82.26 -20.38 37.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.897 ' CE1' ' CZ ' ' A' ' 117' ' ' PHE . 11.0 t-80 -74.95 -55.73 5.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.531 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -74.46 -17.73 60.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.625 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -146.53 58.96 1.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.436 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -74.83 -21.92 77.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -72.89 -33.73 66.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -1.153 . . . . 0.0 109.433 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' B' ' 123' ' ' THR . 57.7 mm-40 -81.46 -4.52 56.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.8 34.33 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.36 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.468 ' H ' ' C ' ' B' ' 121' ' ' GLU . 28.7 p -48.4 148.45 3.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 109.096 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.507 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.3 Cg_exo -45.28 -52.85 6.04 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.196 1.931 . . . . 0.0 112.779 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 36.4 Cg_endo -65.68 13.67 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.053 1.835 . . . . 0.0 112.324 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.461 HG23 ' OG1' ' B' ' 123' ' ' THR . 90.2 t -124.87 -21.42 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' GLN . . . . . 0.549 HE22 ' CG ' ' B' ' 131' ' ' GLN . 18.2 tm0? -83.15 -42.9 16.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.747 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -62.01 -44.21 97.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.587 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.75 -7.17 25.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.692 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -92.43 -30.12 15.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 109.603 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.549 ' CG ' HE22 ' B' ' 127' ' ' GLN . 15.6 mm100 -81.45 -38.33 26.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.592 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -68.14 -49.43 61.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 109.646 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 2.6 p -58.47 -48.22 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.898 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.567 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 88.8 t -73.38 -34.57 43.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.842 ' CB ' ' O ' ' D' ' 146' ' ' HIS . . . -47.41 -22.28 0.42 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.35 -22.03 61.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.459 HG13 ' CZ ' ' B' ' 85' ' ' PHE . 85.9 t -77.84 -26.09 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -1.154 . . . . 0.0 109.541 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.08 -46.58 61.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -74.69 -21.17 59.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.36 -59.63 3.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.524 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -58.58 -24.9 61.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.23 22.36 4.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -77.25 -31.93 55.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.588 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.449 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 0.1 OUTLIER -79.55 -27.3 41.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.321 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -65.99 3.68 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.799 ' O ' ' CB ' ' D' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.427 ' CG2' ' OG ' ' C' ' 131' ' ' SER . 16.9 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.436 HD13 ' CD1' ' C' ' 128' ' ' PHE . 25.3 mt -136.96 -161.06 1.12 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.317 -0.865 . . . . 0.0 109.364 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.46 ' N ' ' OD2' ' C' ' 6' ' ' ASP . 0.3 OUTLIER -133.22 174.44 4.7 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.848 . . . . 0.0 109.199 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.22 -70.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.65 2.233 . . . . 0.0 112.638 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -48.62 -44.12 36.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.161 -0.962 . . . . 0.0 109.88 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.563 ' O ' HG23 ' C' ' 10' ' ' VAL . 1.3 m-20 -42.33 -35.77 1.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.88 . . . . 0.0 109.44 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' C' ' 10' ' ' VAL . 69.5 mttt -83.32 -56.42 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.827 . . . . 0.0 109.571 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 94.9 m -45.45 -35.62 3.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.406 -0.809 . . . . 0.0 109.906 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.51 -33.5 62.82 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.563 HG23 ' O ' ' C' ' 6' ' ' ASP . 76.2 t -76.37 -49.25 25.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.52 -40.04 65.14 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.95 -61.63 2.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.473 -0.767 . . . . 0.0 109.408 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.644 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.59 -38.51 66.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.842 . . . . 0.0 109.145 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -17.52 62.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 108.959 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.54 -46.71 7.8 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -68.63 -36.79 79.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -1.138 . . . . 0.0 108.828 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.644 HG23 ' O ' ' C' ' 13' ' ' ALA . 71.0 t -61.96 -66.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 61.93 -141.15 47.27 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.07 39.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.476 -1.014 . . . . 0.0 110.36 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' C' ' 18' ' ' GLY . 87.6 m-70 -142.96 20.43 1.96 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.72 -61.15 1.95 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.635 -0.666 . . . . 0.0 109.649 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -13.9 0.2 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' C' ' 21' ' ' ALA . 10.3 mm-40 -85.02 -56.3 3.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -1.172 . . . . 0.0 109.544 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 1.8 m-30 -61.75 -30.91 71.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.852 . . . . 0.0 109.186 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.26 -29.5 75.02 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' C' ' 55' ' ' VAL . . . -75.54 -40.29 57.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -1.179 . . . . 0.0 109.676 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -56.9 -20.83 25.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.342 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -31.58 72.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.905 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.86 HD11 ' CG ' ' C' ' 58' ' ' HIS . 78.4 mt -64.34 -61.3 2.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.57 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.97 -12.7 12.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.93 . . . . 0.0 109.563 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.508 ' NH2' ' CB ' ' D' ' 127' ' ' GLN . 6.2 tpm_? -74.34 -53.27 10.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.133 -0.979 . . . . 0.0 109.818 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' MET . . . . . 0.405 ' CE ' ' CBC' ' C' ' 142' ' ' HEC . 1.2 ptt? -84.22 -28.72 27.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.943 . . . . 0.0 110.101 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -46.37 -37.8 8.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.119 -0.988 . . . . 0.0 110.022 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.76 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -96.57 -36.95 10.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.204 -0.935 . . . . 0.0 110.3 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.7 m -44.4 -25.91 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' C' ' 35' ' ' SER . 51.1 m-85 -162.44 139.11 5.99 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.114 -0.992 . . . . 0.0 109.286 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' C' ' 40' ' ' LYS . 56.0 Cg_endo -71.96 -34.15 8.89 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.647 2.231 . . . . 0.0 111.986 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.92 ' HA ' ' HB3' ' B' ' 97' ' ' HIS . 76.7 p -47.42 -18.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.437 ' N ' ' O ' ' C' ' 37' ' ' PRO . 25.8 p -84.9 -28.04 26.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' C' ' 37' ' ' PRO . 82.7 mttt -71.42 -25.3 62.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.908 . . . . 0.0 109.702 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.653 HG22 ' O ' ' C' ' 38' ' ' THR . 15.1 t -49.38 -38.91 30.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.504 ' O ' ' O ' ' C' ' 43' ' ' PHE . 98.0 m-85 -71.34 -1.05 11.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 109.351 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.504 ' O ' ' O ' ' C' ' 42' ' ' TYR . 85.0 m-85 58.26 141.64 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.647 -0.658 . . . . 0.0 109.693 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.692 ' O ' ' CD2' ' C' ' 46' ' ' PHE . 64.0 Cg_endo -74.99 -41.45 0.66 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.468 2.112 . . . . 0.0 112.073 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.66 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 14.8 p80 50.65 27.81 3.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.536 -0.728 . . . . 0.0 110.582 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.692 ' CD2' ' O ' ' C' ' 44' ' ' PRO . 2.6 p90 -144.95 25.56 1.42 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.14 -0.975 . . . . 0.0 109.582 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.445 ' C ' ' N ' ' C' ' 49' ' ' SER . 2.4 m-20 44.0 84.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.507 -0.746 . . . . 0.0 109.817 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.672 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -51.81 -11.41 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.375 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.445 ' N ' ' C ' ' C' ' 47' ' ' ASP . 28.1 p -48.94 158.52 0.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.627 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -77.52 148.34 35.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.21 16.9 79.01 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 55.2 p -74.43 -17.03 60.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -1.167 . . . . 0.0 109.475 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 67.35 -39.46 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.373 -0.829 . . . . 0.0 109.629 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.529 ' H ' ' C ' ' C' ' 52' ' ' SER . 56.6 mt-30 -65.95 -42.07 90.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 109.409 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.557 ' O ' ' HB1' ' C' ' 26' ' ' ALA . 93.4 t -66.39 -44.74 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.178 -0.951 . . . . 0.0 109.274 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -39.39 67.13 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.16 -26.55 72.51 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.86 ' CG ' HD11 ' C' ' 29' ' ' LEU . 4.4 t-80 -68.25 -43.24 78.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -1.202 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.83 -46.06 25.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -48.48 -23.62 1.02 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.377 -1.072 . . . . 0.0 109.272 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -75.45 -38.92 59.38 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.264 -0.898 . . . . 0.0 108.659 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.44 -49.04 44.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.2 -32.93 74.87 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.358 -0.839 . . . . 0.0 109.077 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' C' ' 68' ' ' ASN . 5.9 t0 -63.71 -36.43 83.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.171 -0.956 . . . . 0.0 108.637 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.492 ' HB3' HMB3 ' C' ' 142' ' ' HEC . . . -67.68 -52.61 35.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.13 -40.98 91.66 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.2 m -71.85 -50.29 30.79 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' C' ' 64' ' ' ASP . 49.5 t30 -60.17 -24.16 64.52 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.614 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -82.28 -46.84 13.12 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.02 -22.92 32.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.41 -15.01 63.4 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.611 ' O ' ' N ' ' C' ' 74' ' ' ASP . 35.2 m-70 -138.3 -62.97 0.56 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.502 -0.749 . . . . 0.0 109.356 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.572 HG22 ' O ' ' C' ' 73' ' ' VAL . 13.1 p 44.24 14.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.937 0.875 . . . . 0.0 109.399 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' C' ' 72' ' ' HIS . 39.7 t0 -138.19 11.57 2.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 1.0 OUTLIER 174.95 29.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.683 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 14.3 ptt? -78.67 -22.77 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 111.898 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' C' ' 76' ' ' MET . 60.3 Cg_exo -52.05 -19.66 9.13 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.652 1.568 . . . . 0.0 112.521 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -94.02 -35.78 12.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.789 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.95 -38.39 69.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.078 -1.013 . . . . 0.0 109.317 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.81 11.46 15.46 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.423 -0.798 . . . . 0.0 109.047 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 68.4 p -68.05 -15.87 63.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.755 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -72.69 -55.84 6.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.886 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' C' ' 86' ' ' LEU . 6.1 mt -44.84 -47.26 11.03 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.794 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 62.4 m -46.87 -32.96 4.11 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' C' ' 82' ' ' ALA . 1.5 m-20 -82.16 -17.21 47.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.615 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' C' ' 83' ' ' LEU . 8.6 tp -74.11 -53.42 9.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 0.0 110.346 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 87' ' ' HIS . . . . . 0.437 ' CE1' ' O ' ' C' ' 83' ' ' LEU . 6.0 p-80 -92.18 -21.68 20.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.889 -1.132 . . . . 0.0 110.655 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -97.24 -0.63 46.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.864 -1.148 . . . . 0.0 110.4 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 89' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' C' ' 88' ' ' ALA . 70.7 m80 -154.93 42.95 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 110.227 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -172.39 -63.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 109.326 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 46.4 mt -90.66 -23.72 20.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 109.323 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 53.95 53.33 11.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 0.0 109.639 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.512 HG12 ' H ' ' C' ' 94' ' ' ASP . 2.3 t -79.9 -136.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 0.0 109.466 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' C' ' 96' ' ' VAL . 5.2 t70 -172.23 137.11 0.9 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.183 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' C' ' 98' ' ' PHE . 86.2 Cg_exo -41.75 -11.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.616 2.211 . . . . 0.0 112.627 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' C' ' 94' ' ' ASP . 59.1 t -43.65 -28.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.2 -24.96 42.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.542 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' C' ' 95' ' ' PRO . 38.4 t80 -44.98 -32.47 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 109.953 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.41 -27.23 27.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 0.0 109.977 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 mt -84.19 -62.25 1.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.993 -1.067 . . . . 0.0 109.94 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 1.012 ' CD2' ' HHC' ' C' ' 142' ' ' HEC . 36.9 tp -55.79 -20.91 16.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.914 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 17.0 p -78.42 -50.38 11.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 109.903 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -76.38 -26.58 55.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.836 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 55.7 m -58.66 -51.02 71.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.768 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.36 -35.88 13.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 109.618 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.786 HD12 ' CE1' ' C' ' 122' ' ' HIS . 3.7 mm? -70.02 -59.16 3.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.146 -0.971 . . . . 0.0 109.863 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 47.9 t -50.2 -36.77 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.962 . . . . 0.0 109.449 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 5.0 p -70.57 -63.09 1.16 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.224 -0.923 . . . . 0.0 109.417 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' C' ' 113' ' ' LEU . 17.6 mt -50.47 -31.55 15.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.334 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.51 -47.19 48.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.945 . . . . 0.0 109.631 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.32 -41.31 22.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.837 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -80.08 -72.13 0.42 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 110.003 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -113.86 91.56 22.31 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' C' ' 113' ' ' LEU . 84.5 Cg_exo -46.17 -175.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.447 2.098 . . . . 0.0 112.825 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.3 -42.21 13.92 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.555 -0.716 . . . . 0.0 109.393 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 0.0 OUTLIER 85.02 3.56 0.65 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.904 ' CZ ' ' CE1' ' D' ' 116' ' ' HIS . 8.1 m-85 65.1 36.74 7.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.798 -0.564 . . . . 0.0 111.225 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.718 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -91.06 121.59 67.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.719 -1.238 . . . . 0.0 108.179 178.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.15 22.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.11 1.874 . . . . 0.0 112.57 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.718 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -151.17 -33.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.963 -1.086 . . . . 0.0 110.84 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.649 HG13 ' N ' ' C' ' 122' ' ' HIS . 11.5 p -46.63 -47.86 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.013 -1.055 . . . . 0.0 110.005 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.786 ' CE1' HD12 ' C' ' 106' ' ' LEU . 0.3 OUTLIER -72.79 -33.5 66.31 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.51 -0.744 . . . . 0.0 109.307 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.11 -19.75 36.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.826 . . . . 0.0 110.059 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.6 ' N ' ' O ' ' C' ' 120' ' ' ALA . 10.2 p -66.04 -62.47 1.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.947 . . . . 0.0 110.783 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.524 ' N ' ' OG ' ' C' ' 124' ' ' SER . 9.4 mt -70.14 -19.4 63.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.047 -1.033 . . . . 0.0 109.885 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.92 -45.34 20.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.01 -1.056 . . . . 0.0 110.306 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.451 ' CD ' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -88.31 -43.19 11.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.0 110.18 -179.401 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.46 ' CD1' HG21 ' C' ' 10' ' ' VAL . 70.1 t80 -50.23 -21.03 1.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.911 -1.118 . . . . 0.0 109.316 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.6 mt -69.59 -17.77 63.57 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.21 -33.56 72.42 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.501 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 5.1 t -83.06 -30.41 28.04 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.349 -0.844 . . . . 0.0 108.988 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 72.7 t -85.41 -27.67 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.072 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.518 ' N ' ' O ' ' C' ' 129' ' ' LEU . 76.9 p -83.65 -26.01 30.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.817 . . . . 0.0 109.152 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 47.5 m -78.11 -36.91 47.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.343 -0.848 . . . . 0.0 109.183 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.458 HG13 ' O ' ' C' ' 131' ' ' SER . 33.4 m -76.49 -21.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.267 -0.895 . . . . 0.0 108.888 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -37.79 68.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 109.013 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 58.2 p -89.29 -1.23 57.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t -61.91 102.98 0.31 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -81.2 76.33 8.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -158.51 108.08 2.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.897 . . . . 0.0 109.448 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.449 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.495 HG13 ' N ' ' D' ' 2' ' ' HIS . 8.4 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.434 0.635 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 2' ' ' HIS . . . . . 0.495 ' N ' HG13 ' D' ' 1' ' ' VAL . 12.3 t-80 -169.88 49.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.108 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 1.147 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -106.38 162.49 13.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.469 -0.77 . . . . 0.0 109.28 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.438 ' O ' ' N ' ' D' ' 7' ' ' GLU . 0.7 OUTLIER -84.69 151.01 57.67 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 109.06 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -42.09 -30.62 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.33 2.02 . . . . 0.0 112.103 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.41 -21.82 25.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.891 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' D' ' 4' ' ' THR . 44.6 tt0 -77.12 -63.02 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.126 -0.984 . . . . 0.0 110.164 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.496 ' HB3' HD22 ' D' ' 3' ' ' LEU . 10.4 pttt -67.64 -25.71 65.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.163 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 9' ' ' SER . . . . . 0.409 ' C ' ' O ' ' D' ' 8' ' ' LYS . 0.4 OUTLIER -43.73 -24.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.23 -56.21 3.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.094 -1.004 . . . . 0.0 109.75 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.435 ' H ' HG12 ' D' ' 11' ' ' VAL . 0.9 OUTLIER -71.06 -24.78 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 25.4 m -68.26 -39.23 82.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.357 0.599 . . . . 0.0 109.844 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.18 -31.36 58.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.923 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -21.77 6.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 0.0 109.31 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 15' ' ' TRP . . . . . 0.551 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.2 OUTLIER -56.34 -38.37 71.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.983 . . . . 0.0 109.151 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.23 -40.2 61.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -26.07 66.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -1.096 . . . . 0.0 109.198 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.11 121.06 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.607 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' D' ' 21' ' ' ASP . 59.6 t30 -80.12 71.75 6.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.278 -0.889 . . . . 0.0 109.023 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 80.1 t -45.82 -15.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 0.0 109.793 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' D' ' 19' ' ' ASN . 35.2 m-20 -69.28 -4.02 16.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' D' ' 25' ' ' GLY . 47.9 mt-10 -155.8 -46.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -47.06 -23.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.683 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.86 -31.22 40.44 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -73.54 -39.48 49.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -70.21 -38.86 75.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -1.146 . . . . 0.0 109.56 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.04 -30.24 61.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tp -81.46 -58.09 3.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.973 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.7 85.07 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -55.98 -39.4 71.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -1.142 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.59 -35.99 4.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.602 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 mt -81.22 -29.82 34.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.787 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 66.8 t -66.01 -64.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 109.497 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.419 HG23 ' H ' ' D' ' 34' ' ' VAL . 0.0 OUTLIER -64.06 -22.6 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 109.232 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -149.6 81.8 7.03 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.618 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.05 9.98 3.13 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.552 2.168 . . . . 0.0 112.173 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' TRP . . . . . 0.568 ' CD1' ' N ' ' D' ' 38' ' ' THR . 0.4 OUTLIER -80.97 -20.02 42.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.568 ' N ' ' CD1' ' D' ' 37' ' ' TRP . 7.3 m -88.0 58.08 4.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 109.472 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -117.66 23.72 11.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.431 -0.793 . . . . 0.0 109.324 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -87.31 -39.72 15.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 109.552 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -100.01 34.75 2.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.223 -0.923 . . . . 0.0 109.432 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.723 ' CE1' HMD3 ' D' ' 147' ' ' HEC . 0.9 OUTLIER -143.3 15.12 1.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 109.222 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 43' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' D' ' 43' ' ' GLU . 7.2 pt-20 -72.47 -14.15 61.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.583 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' D' ' 46' ' ' GLY . 5.3 m -69.04 -46.9 66.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.487 ' CE1' ' CD2' ' D' ' 42' ' ' PHE . 80.0 m-85 -50.23 -16.16 0.3 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' D' ' 44' ' ' SER . . . 51.26 179.58 0.04 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 55.95 71.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -1.153 . . . . 0.0 109.481 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 27.6 mt -131.26 35.11 3.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 109.391 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 13.4 m -51.92 -49.37 63.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.937 . . . . 0.0 109.49 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.21 160.22 46.55 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.327 -0.858 . . . . 0.0 108.832 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.42 -17.3 4.18 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.112 1.874 . . . . 0.0 111.946 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ASP . . . . . 0.416 ' C ' ' N ' ' D' ' 54' ' ' VAL . 19.5 t70 -83.26 -51.51 7.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.345 -0.847 . . . . 0.0 109.593 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.07 -19.84 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 109.437 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' D' ' 52' ' ' ASP . 58.5 t -73.2 -57.86 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mtt -60.07 -16.65 33.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 0.0 109.41 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.5 -26.72 71.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -78.74 132.27 65.16 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.226 -1.161 . . . . 0.0 109.321 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.98 -31.02 4.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.365 2.043 . . . . 0.0 112.299 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -70.38 -30.11 66.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.616 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.83 -40.64 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 109.602 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 61' ' ' LYS . . . . . 0.512 ' NZ ' ' CB ' ' D' ' 61' ' ' LYS . 8.1 mtmp? -65.53 -37.43 86.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.681 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.94 -51.06 67.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.503 ' CE1' HBA1 ' D' ' 147' ' ' HEC . 41.0 t60 -55.7 -23.94 31.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.073 -1.017 . . . . 0.0 109.455 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.03 -48.87 65.98 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -52.4 -24.9 8.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -1.233 . . . . 0.0 109.522 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' LYS . . . . . 0.524 ' HB3' HBA2 ' D' ' 147' ' ' HEC . 0.3 OUTLIER -74.48 -62.0 1.67 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.259 -0.9 . . . . 0.0 109.501 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.844 HG13 ' C2B' ' D' ' 147' ' ' HEC . 35.3 t -52.17 -39.33 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.686 ' O ' HD23 ' D' ' 68' ' ' LEU . 8.0 tt -70.09 -37.46 75.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.326 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.85 -44.14 61.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.43 71.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -1.155 . . . . 0.0 109.803 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 71' ' ' PHE . . . . . 0.413 ' O ' ' CD2' ' D' ' 75' ' ' LEU . 1.3 m-85 -66.29 -29.14 69.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.077 -1.015 . . . . 0.0 109.537 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 72' ' ' SER . . . . . 0.551 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 8.8 t -66.36 -33.57 76.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.31 -16.7 55.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.14 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.62 -19.86 63.17 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.859 HD23 ' H ' ' D' ' 75' ' ' LEU . 1.5 pt? -137.66 -28.44 0.9 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.21 -1.17 . . . . 0.0 109.931 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 76' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' D' ' 72' ' ' SER . . . -80.05 19.0 0.75 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.095 -1.003 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -171.58 70.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 78' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' D' ' 75' ' ' LEU . 70.4 mt -80.87 0.66 34.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.425 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -53.99 -38.41 65.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 109.32 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -172.03 73.18 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.371 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 81' ' ' LEU . . . . . 0.446 HD12 ' N ' ' D' ' 82' ' ' LYS . 2.2 pp -76.72 -41.62 44.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 82' ' ' LYS . . . . . 0.446 ' N ' HD12 ' D' ' 81' ' ' LEU . 53.1 mttp -50.93 -27.12 6.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.08 -1.013 . . . . 0.0 109.426 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 83' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' D' ' 86' ' ' ALA . . . -83.22 -57.63 2.46 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.6 OUTLIER -47.64 -39.83 18.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -1.159 . . . . 0.0 109.584 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.459 ' CZ ' HG13 ' D' ' 137' ' ' VAL . 25.1 m-85 -69.78 -12.09 61.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.326 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 86' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' D' ' 83' ' ' GLY . . . -54.49 -43.69 72.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.154 -0.966 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 11.3 p -64.42 -59.22 4.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 109.384 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.7 mt -54.92 -35.51 64.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.304 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -72.73 -46.46 53.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.907 . . . . 0.0 109.314 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.52 -24.47 67.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.872 . . . . 0.0 109.452 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.31 -68.2 0.71 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.556 ' O ' ' N ' ' D' ' 97' ' ' HIS . 75.1 m80 -54.57 -25.67 27.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 110.493 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.92 -60.61 2.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.017 -1.052 . . . . 0.0 111.594 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.553 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 11.9 m-20 -87.07 -39.64 15.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.996 -1.065 . . . . 0.0 111.693 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -83.17 -10.2 58.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.913 -1.117 . . . . 0.0 111.11 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.529 ' O ' HD13 ' D' ' 96' ' ' LEU . 0.2 OUTLIER -137.89 -43.85 0.53 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.869 -1.144 . . . . 0.0 109.971 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.965 ' HB3' ' HA ' ' A' ' 38' ' ' THR . 4.1 m80 73.11 58.5 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.87 . . . . 0.0 109.509 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 98' ' ' VAL . . . . . 0.401 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 79.3 t -82.66 114.21 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 109.421 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.76 154.45 2.38 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.264 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.1 -164.4 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.61 2.206 . . . . 0.0 112.153 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 53.32 52.03 14.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.485 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -158.28 -36.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.34 -37.55 86.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -72.88 -26.43 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 105' ' ' LEU . . . . . 0.483 ' O ' HD23 ' D' ' 105' ' ' LEU . 1.3 tt -65.6 -55.58 16.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.357 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 1.044 HD22 ' HAB' ' D' ' 147' ' ' HEC . 7.9 tt -50.41 -46.98 56.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.919 . . . . 0.0 109.356 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.15 -47.93 71.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.43 -50.28 65.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -1.157 . . . . 0.0 109.616 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 80.5 t -53.85 -38.53 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 109.498 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.96 -33.87 76.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.423 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.95 -26.11 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.552 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 60.7 m -79.31 -61.0 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 109.738 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 113' ' ' VAL . . . . . 0.431 ' H ' HG23 ' D' ' 113' ' ' VAL . 4.9 t -46.34 -29.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 109.815 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 32.1 mt -79.76 -31.56 40.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -82.12 -20.47 37.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.897 . . . . 0.0 109.494 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.904 ' CE1' ' CZ ' ' C' ' 117' ' ' PHE . 11.0 t-80 -75.0 -55.72 5.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.176 -0.952 . . . . 0.0 109.471 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -74.53 -17.75 60.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.544 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -146.54 59.01 1.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -74.81 -22.0 77.66 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -72.87 -33.73 66.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -1.197 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' D' ' 123' ' ' THR . 57.4 mm-40 -81.38 -4.63 56.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.361 -0.837 . . . . 0.0 109.522 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.82 34.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.285 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.487 ' H ' ' C ' ' D' ' 121' ' ' GLU . 28.3 p -48.32 148.3 3.36 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.108 -0.995 . . . . 0.0 109.083 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.513 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.3 Cg_exo -45.1 -52.91 5.85 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.228 1.952 . . . . 0.0 112.812 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 36.4 Cg_endo -65.65 13.57 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.013 1.809 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.458 HG23 ' OG1' ' D' ' 123' ' ' THR . 90.8 t -124.84 -21.34 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.299 -0.876 . . . . 0.0 109.605 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 127' ' ' GLN . . . . . 0.549 HE22 ' CG ' ' D' ' 131' ' ' GLN . 18.2 tm0? -83.18 -42.96 16.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.76 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -61.91 -44.35 96.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.67 -7.15 24.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.683 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -92.43 -30.01 15.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 109.706 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 0.549 ' CG ' HE22 ' D' ' 127' ' ' GLN . 15.6 mm100 -81.62 -38.2 26.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -68.21 -49.33 61.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 109.691 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 133' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 2.6 p -58.49 -48.18 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.865 . . . . 0.0 109.966 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.569 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 88.5 t -73.44 -34.45 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.347 -0.846 . . . . 0.0 109.796 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.799 ' CB ' ' O ' ' B' ' 146' ' ' HIS . . . -47.45 -22.29 0.43 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.37 -22.01 61.31 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 137' ' ' VAL . . . . . 0.459 HG13 ' CZ ' ' D' ' 85' ' ' PHE . 85.8 t -77.83 -26.07 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -1.138 . . . . 0.0 109.537 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.14 -46.6 61.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.214 -0.929 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -74.71 -21.08 59.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.497 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.32 -59.71 3.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.553 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.52 -24.93 61.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.927 . . . . 0.0 109.438 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.24 22.45 4.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 109.39 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -77.34 -31.85 54.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.634 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.1 OUTLIER -79.55 -27.35 41.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.398 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 145' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' D' ' 98' ' ' VAL . 24.4 m-85 -65.88 3.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.842 ' O ' ' CB ' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.439 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.995 ' HHC' ' CD2' ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 1.017 ' CHC' HD13 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 1.012 ' HHC' ' CD2' ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 1.044 ' HAB' HD22 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.486 ' C ' HD12 ' A' ' 2' ' ' LEU . 3.7 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.572 HD13 ' OG ' ' A' ' 131' ' ' SER . 7.7 mp -108.21 -165.39 1.04 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.311 -0.868 . . . . 0.0 109.2 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.515 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 178.98 -49.53 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.936 . . . . 0.0 109.992 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' ASP . 73.9 Cg_exo -47.23 171.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.384 2.056 . . . . 0.0 112.448 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -45.8 -16.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.766 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' PRO . 3.1 p30 -39.55 -33.35 0.17 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 10' ' ' VAL . 9.6 ptpt -83.14 -46.59 12.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.338 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 m -45.44 -31.07 1.56 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.314 -0.866 . . . . 0.0 109.424 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -78.23 -36.94 46.42 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 7' ' ' LYS . 71.5 t -70.5 -49.52 52.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -51.07 -47.32 61.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.404 -0.81 . . . . 0.0 108.847 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -55.92 27.57 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.43 -0.794 . . . . 0.0 109.304 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.716 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -56.74 -37.23 70.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.251 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -17.41 61.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.223 -0.923 . . . . 0.0 108.933 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.63 -44.17 16.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 41.6 mmtt -70.2 -43.25 71.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -1.17 . . . . 0.0 108.637 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 13' ' ' ALA . 59.1 t -59.27 -63.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 44.2 -125.39 5.78 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 22.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.416 -1.05 . . . . 0.0 110.438 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.568 ' H ' ' C ' ' A' ' 18' ' ' GLY . 78.9 m-70 -129.11 25.99 5.5 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -91.51 -64.38 1.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.694 -0.629 . . . . 0.0 109.746 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.28 -14.37 0.17 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' ALA . 2.2 mm-40 -84.03 -56.47 3.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -1.052 . . . . 0.0 109.672 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.2 m-30 -60.67 -35.56 76.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 109.187 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.86 -22.88 68.84 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.51 -41.76 31.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -1.163 . . . . 0.0 109.715 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.42 -19.82 62.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 108.92 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.92 ' HB1' ' SG ' ' A' ' 104' ' ' CYS . . . -72.85 -21.88 60.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.371 -0.831 . . . . 0.0 109.132 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.1 mt -72.45 -53.68 11.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.349 -0.845 . . . . 0.0 109.712 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.13 -27.05 69.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.489 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 31' ' ' ARG . 0.9 OUTLIER -63.89 -30.68 71.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.547 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.513 ' CE ' ' CBC' ' A' ' 142' ' ' HEC . 39.6 ttp -70.75 -57.93 4.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.482 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -49.19 -33.68 12.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.45 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 11.7 mt -73.5 -51.55 16.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.852 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 52.4 m -67.76 -17.87 64.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.949 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CZ ' ' NH2' ' B' ' 104' ' ' ARG . 29.4 m-85 -152.62 109.52 2.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.052 -1.03 . . . . 0.0 109.499 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' THR . 72.4 Cg_endo -80.53 -27.21 3.49 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.331 2.02 . . . . 0.0 112.092 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.786 ' HB ' ' HB2' ' D' ' 97' ' ' HIS . 21.1 p -47.45 -18.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 109.447 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' PRO . 55.9 p -81.6 -22.74 37.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HZ1' HD21 ' A' ' 48' ' ' LEU . 1.8 tpmt? -64.71 -39.61 93.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 38' ' ' THR . 8.8 t -46.79 -37.16 8.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 109.642 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.416 ' N ' HG23 ' A' ' 41' ' ' THR . 3.9 m-85 -65.36 -58.54 5.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 109.111 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.505 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 81.7 t80 48.33 67.6 4.34 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.52 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.75 -34.38 0.29 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.919 2.413 . . . . 0.0 112.145 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.465 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -174.29 73.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.412 -0.805 . . . . 0.0 109.149 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.592 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -151.0 68.01 0.93 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' SER . 1.5 m-20 -48.35 -18.3 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 109.631 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.592 ' CD1' ' O ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER 46.4 21.33 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.24 -0.912 . . . . 0.0 109.638 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 50' ' ' HIS . 5.2 m -75.31 18.68 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -0.94 . . . . 0.0 109.404 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.492 ' N ' ' ND1' ' A' ' 50' ' ' HIS . 2.5 m80 57.51 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.615 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.03 10.5 83.83 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 3.2 p -54.48 -12.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -1.104 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 71.0 -16.79 0.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.381 -0.825 . . . . 0.0 109.736 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 52' ' ' SER . 5.1 pt20 -81.65 -28.87 33.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.508 HG22 ' CE2' ' A' ' 46' ' ' PHE . 22.2 t -73.52 -38.44 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.61 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.585 ' CD ' ' H ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.63 -22.83 46.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.083 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.13 -23.89 58.36 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.47 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.7 t-80 -78.47 -38.57 40.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -1.171 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.72 -48.95 49.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 53.7 mttm -51.61 -23.45 4.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -1.121 . . . . 0.0 109.948 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.555 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 0.5 OUTLIER -72.18 -42.46 65.83 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.127 -0.983 . . . . 0.0 109.024 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 t -69.85 -48.44 63.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.486 -0.758 . . . . 0.0 108.977 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.426 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -65.47 -28.57 69.31 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.384 -0.822 . . . . 0.0 109.275 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 30.4 m-20 -70.23 -36.49 74.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 0.0 108.872 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.68 47.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.402 -0.811 . . . . 0.0 108.964 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 70' ' ' VAL . 11.3 mt -58.01 -42.12 84.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.261 -0.899 . . . . 0.0 108.674 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' ALA . 25.8 m -67.59 -51.6 48.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.362 -0.836 . . . . 0.0 108.881 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -60.49 -29.31 68.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 108.781 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -82.98 -46.49 12.83 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 66' ' ' LEU . 48.4 t -67.19 -22.4 29.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -66.1 -24.21 66.65 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.205 0.526 . . . . 0.0 109.711 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.592 ' O ' HG12 ' A' ' 73' ' ' VAL . 11.8 m80 -137.27 -47.8 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 72' ' ' HIS . 11.0 p 45.06 13.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.665 0.745 . . . . 0.0 109.378 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 72' ' ' HIS . 26.2 t70 -135.76 11.37 3.41 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -173.72 28.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.043 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.704 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -77.96 -24.91 0.46 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 0.0 111.399 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 76' ' ' MET . 41.8 Cg_exo -56.52 -24.61 54.2 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.791 1.661 . . . . 0.0 112.324 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -89.38 -29.19 19.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.932 . . . . 0.0 109.65 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.05 -43.2 35.4 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.127 -0.983 . . . . 0.0 109.127 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 80' ' ' LEU . 6.4 mp -83.5 8.7 13.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.432 -0.792 . . . . 0.0 108.952 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.5 m -63.52 -23.18 67.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -76.35 -55.3 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.614 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.503 HD22 HBA1 ' A' ' 142' ' ' HEC . 4.5 mt -46.62 -46.81 19.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 m -56.8 -25.43 55.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.435 -0.79 . . . . 0.0 109.246 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' ALA . 11.6 t70 -81.02 -35.02 32.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.382 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tt -72.06 -26.95 62.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 109.198 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 90' ' ' LYS . 68.4 m80 -82.67 -31.49 28.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 109.472 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.14 -42.65 15.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.495 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -78.13 -18.84 55.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.535 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' HIS . 46.7 mttm -146.08 179.81 7.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 93' ' ' VAL . 12.6 mt 59.09 58.4 3.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -53.84 -6.88 0.1 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 109.336 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 91' ' ' LEU . 11.5 p -54.59 137.94 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.49 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.765 ' HB2' ' OD2' ' D' ' 99' ' ' ASP . 0.7 OUTLIER -77.27 157.92 80.11 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.086 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASN . 9.9 Cg_endo -54.72 -10.47 2.53 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.721 2.281 . . . . 0.0 111.882 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.518 HG21 ' CG ' ' D' ' 99' ' ' ASP . 85.3 t -42.98 -22.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 109.775 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 95' ' ' PRO . 3.1 m120 -79.07 -41.26 29.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.205 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 95' ' ' PRO . 31.7 t80 -48.62 -25.72 1.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.165 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -70.62 -30.32 66.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.208 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.551 HD13 ' CD1' ' A' ' 36' ' ' PHE . 20.6 mt -84.08 -61.34 1.84 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 0.0 109.642 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.777 HD21 HBB3 ' A' ' 142' ' ' HEC . 4.6 tt -49.23 -23.51 1.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.671 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.8 m -72.81 -44.05 61.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.059 -1.025 . . . . 0.0 109.759 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.509 ' CD2' ' OD1' ' B' ' 108' ' ' ASN . 41.3 t-80 -80.55 -26.63 37.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.783 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.92 ' SG ' ' HB1' ' A' ' 28' ' ' ALA . 11.2 p -58.04 -48.14 80.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.717 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.655 ' N ' ' SG ' ' A' ' 104' ' ' CYS . 2.5 mt -46.31 -39.14 9.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 106' ' ' LEU . 3.7 mm? -68.8 -30.28 68.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.607 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.592 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 86.0 t -75.12 -51.5 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 110' ' ' ALA . 27.8 m -60.05 -59.66 5.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 114' ' ' PRO . 12.3 mt -46.37 -18.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.457 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -69.66 -42.55 74.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.258 -0.902 . . . . 0.0 110.406 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.19 -3.67 43.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.132 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -129.73 -81.72 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 109.693 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -119.17 82.15 22.17 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 113' ' ' LEU . 53.6 Cg_exo -48.76 -169.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.51 2.14 . . . . 0.0 112.524 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.827 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -51.0 -56.21 13.61 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.556 -0.715 . . . . 0.0 109.302 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.67 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 3.0 mm-40 122.63 -8.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.497 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 5.6 t80 80.34 34.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 122.01 -0.431 . . . . 0.0 111.199 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -113.43 120.22 40.24 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.25 16.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.331 2.021 . . . . 0.0 112.87 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -140.98 -34.61 0.5 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.016 -1.052 . . . . 0.0 110.106 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.827 HG21 ' O ' ' A' ' 115' ' ' ALA . 9.4 p -51.79 -47.28 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.14 -0.975 . . . . 0.0 109.994 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.616 ' N ' HG13 ' A' ' 121' ' ' VAL . 1.0 OUTLIER -60.19 -39.9 88.16 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.331 -0.856 . . . . 0.0 109.283 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.39 -19.99 32.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.824 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 120' ' ' ALA . 24.2 p -61.83 -62.39 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 110.3 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.505 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.3 mt -68.2 -19.53 64.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.172 -0.955 . . . . 0.0 109.513 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.05 -45.54 13.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.974 . . . . 0.0 109.854 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -87.19 -41.48 13.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.155 -0.965 . . . . 0.0 109.883 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 37.1 t80 -50.14 -20.84 1.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.966 -1.084 . . . . 0.0 108.854 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' SER . 19.4 mt -70.56 -17.91 62.92 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.7 -31.64 69.77 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.572 ' OG ' HD13 ' A' ' 2' ' ' LEU . 0.8 OUTLIER -81.72 -34.05 30.75 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.362 -0.836 . . . . 0.0 108.902 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.0 t -83.8 -29.21 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.336 -0.852 . . . . 0.0 108.91 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 129' ' ' LEU . 23.3 t -80.3 -25.44 39.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.403 -0.811 . . . . 0.0 109.132 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 m -75.37 -39.67 58.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.264 -0.897 . . . . 0.0 109.215 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.04 -22.09 16.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.255 -0.903 . . . . 0.0 108.965 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.91 -35.13 72.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 109.02 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 83.6 m -87.21 -29.85 21.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.561 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.402 ' CB ' HH12 ' A' ' 141' ' ' ARG . 68.5 m 50.41 -166.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.47 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -60.86 156.45 17.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' A' ' 140' ' ' TYR . 78.1 t80 -82.11 40.9 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.402 HH12 ' CB ' ' A' ' 138' ' ' SER . 8.9 ptp85 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.609 HG22 ' N ' ' B' ' 2' ' ' HIS . 10.0 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 0.609 ' N ' HG22 ' B' ' 1' ' ' VAL . 1.5 t60 -140.37 123.42 16.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.165 -0.959 . . . . 0.0 109.688 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.916 ' N ' HD12 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -138.46 -162.94 1.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.331 -0.856 . . . . 0.0 109.071 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.409 ' HG1' ' CD ' ' B' ' 7' ' ' GLU . 1.0 OUTLIER -84.54 153.32 61.58 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 108.866 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.92 -26.32 66.86 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.491 2.127 . . . . 0.0 112.197 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.2 -27.86 22.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.973 . . . . 0.0 109.793 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.409 ' CD ' ' HG1' ' B' ' 4' ' ' THR . 61.2 mt-10 -84.14 -48.1 10.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.023 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.694 ' HB2' HD13 ' B' ' 3' ' ' LEU . 0.8 OUTLIER -68.78 -43.42 75.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.55 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -56.58 -23.58 41.57 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 110.059 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.54 -57.61 3.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.021 -1.05 . . . . 0.0 110.044 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.95 -24.33 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 47.1 m -80.88 -36.97 30.59 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.687 -0.633 . . . . 0.0 109.779 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 -22.38 63.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.927 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 16' ' ' GLY . 1.7 mt -59.82 -28.05 67.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.0 109.335 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' TRP . . . . . 0.657 ' HE1' ' HG ' ' B' ' 72' ' ' SER . 0.5 OUTLIER -47.57 -17.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.933 . . . . 0.0 109.178 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -76.88 -36.15 37.31 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.445 ' O ' ' CE2' ' B' ' 118' ' ' PHE . 3.3 mmtt -89.33 -35.82 15.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -1.148 . . . . 0.0 109.281 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.1 t -47.92 114.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.659 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' B' ' 21' ' ' ASP . 83.6 m-20 -77.86 65.82 3.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.327 -0.858 . . . . 0.0 108.933 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -44.6 -17.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.385 -0.822 . . . . 0.0 109.682 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' B' ' 19' ' ' ASN . 13.3 m-20 -78.8 6.76 8.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.232 -0.917 . . . . 0.0 109.539 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' B' ' 19' ' ' ASN . 58.2 mt-10 -155.65 -46.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.538 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' B' ' 27' ' ' ALA . 85.8 t -47.74 -42.24 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.621 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.81 -43.33 96.62 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.9 -39.08 25.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -76.25 -25.82 55.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -1.175 . . . . 0.0 109.561 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' B' ' 23' ' ' VAL . . . -75.54 -34.1 60.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.937 . . . . 0.0 109.515 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tp -82.91 -52.35 6.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.451 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.68 -26.68 17.31 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -77.86 -31.44 51.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.131 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' LEU . . . . . 0.44 HD21 HMC1 ' B' ' 147' ' ' HEC . 32.6 tp -49.04 -34.56 13.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.355 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.9 mt -80.39 -22.03 41.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -82.51 -64.22 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.627 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.453 ' H ' HG23 ' B' ' 34' ' ' VAL . 3.0 t -61.01 -22.9 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.888 . . . . 0.0 109.659 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -152.16 88.47 4.1 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 109.465 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.94 12.98 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.543 2.162 . . . . 0.0 112.227 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.592 ' CZ2' ' ND2' ' B' ' 102' ' ' ASN . 0.7 OUTLIER -71.91 -19.92 61.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.525 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.591 HG23 ' NE1' ' B' ' 37' ' ' TRP . 1.3 p -84.14 50.99 1.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.977 . . . . 0.0 109.27 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 38.5 tt0 -92.14 31.23 1.3 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -87.88 -42.84 12.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.674 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -93.18 14.32 18.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 109.578 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' B' ' 43' ' ' GLU . 1.6 p90 -68.21 -34.19 75.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.608 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.543 ' N ' ' CD1' ' B' ' 42' ' ' PHE . 12.0 pt-20 -53.28 -17.4 1.75 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.607 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 60.9 m -85.55 -34.73 21.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.583 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 47' ' ' ASP . 10.0 m-85 -51.04 -20.92 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.96 12.42 0.15 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' B' ' 45' ' ' PHE . 15.1 m-20 -160.64 110.52 1.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.151 . . . . 0.0 109.448 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tp -158.67 20.6 0.22 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.255 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.1 m -46.78 -41.1 14.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 109.646 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' THR . . . . . 0.431 ' HG1' ' CG ' ' B' ' 52' ' ' ASP . 4.7 p -146.6 150.33 39.79 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.851 . . . . 0.0 109.216 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -41.15 -43.65 5.19 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.444 2.096 . . . . 0.0 112.354 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.431 ' CG ' ' HG1' ' B' ' 50' ' ' THR . 1.7 p-10 -64.13 -31.01 72.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.534 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.92 -19.86 20.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.93 . . . . 0.0 109.42 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.43 -61.32 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -0.901 . . . . 0.0 109.573 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' B' ' 55' ' ' MET . 5.5 mmt -70.98 -0.51 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.77 31.08 7.17 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -143.09 137.06 14.51 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.26 -1.141 . . . . 0.0 109.31 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.11 -30.88 5.27 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.489 2.126 . . . . 0.0 112.26 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -21.1 59.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 109.777 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 69.8 t -75.82 -41.52 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.523 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -78.31 -25.26 46.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.57 71.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.932 ' CE1' ' O1A' ' B' ' 147' ' ' HEC . 72.6 t60 -62.62 -23.82 67.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.32 -50.31 22.17 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -49.51 -30.92 9.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.173 -1.192 . . . . 0.0 109.534 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' LYS . . . . . 0.468 ' HB3' HBA1 ' B' ' 147' ' ' HEC . 67.7 mmtt -65.45 -53.74 38.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.583 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 1.103 HG13 ' C2B' ' B' ' 147' ' ' HEC . 28.2 t -58.96 -36.94 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.43 HD23 ' C ' ' B' ' 68' ' ' LEU . 5.7 tt -65.57 -48.37 72.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.97 -41.05 10.31 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.05 -43.45 91.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.608 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.583 ' CE2' HMB1 ' B' ' 147' ' ' HEC . 29.0 m-85 -61.4 -47.31 86.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.657 ' HG ' ' HE1' ' B' ' 15' ' ' TRP . 19.2 m -62.44 -42.03 99.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 109.622 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -48.37 -34.79 11.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.416 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.68 -60.48 6.91 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -54.04 -22.09 9.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.248 -1.148 . . . . 0.0 109.35 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.16 2.68 56.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -170.27 66.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.68 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.452 HD22 HG12 ' B' ' 1' ' ' VAL . 96.3 mt -81.27 15.27 2.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.34 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.85 -23.21 60.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.46 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 37.1 t-20 -167.2 108.09 0.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 0.0 109.593 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.472 HD11 ' N ' ' B' ' 1' ' ' VAL . 6.3 mt -80.35 -51.53 8.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.431 ' HZ2' ' HB2' ' B' ' 143' ' ' HIS . 52.4 mttm -67.12 -23.97 65.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.812 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -78.7 -39.11 22.2 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.9 t -85.1 -47.43 10.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.153 -1.204 . . . . 0.0 109.715 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.557 ' N ' ' CG2' ' B' ' 84' ' ' THR . 40.5 m-85 -84.67 26.92 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.539 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.32 72.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 109.633 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 50.9 p -75.81 -53.82 7.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.752 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -48.13 -43.05 30.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 2.9 m -66.89 -48.35 68.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.849 . . . . 0.0 109.668 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -67.39 -22.64 65.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 109.734 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.71 -68.37 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.078 -1.013 . . . . 0.0 109.566 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.576 ' NE2' ' O ' ' B' ' 141' ' ' LEU . 1.1 p-80 -54.38 -20.67 7.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.974 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' CYS . . . . . 0.429 ' N ' ' ND1' ' B' ' 92' ' ' HIS . 41.4 t -83.51 -59.6 2.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 110.858 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.31 -56.44 3.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.067 -1.021 . . . . 0.0 111.379 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -57.71 -51.74 68.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 110.579 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.572 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 12.1 mt -97.32 -64.52 1.03 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.002 -1.062 . . . . 0.0 109.95 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.723 ' HB2' ' HB ' ' C' ' 38' ' ' THR . 0.0 OUTLIER 91.2 25.12 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.308 0.575 . . . . 0.0 109.865 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 98' ' ' VAL . 17.5 t -46.74 140.86 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.103 -0.998 . . . . 0.0 109.493 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 0.688 ' OD2' ' HB2' ' C' ' 94' ' ' ASP . 96.0 m-20 -54.0 149.41 18.05 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.363 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.9 36.46 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.478 2.119 . . . . 0.0 112.143 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -145.07 45.57 1.34 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.179 -0.95 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.592 ' ND2' ' CZ2' ' B' ' 37' ' ' TRP . 4.4 m120 -143.74 5.96 1.39 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.1 m-85 -89.74 -69.68 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 109.454 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.574 ' NH2' ' CZ ' ' A' ' 36' ' ' PHE . 43.9 ttt180 -54.94 -20.88 9.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.54 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 tp -75.31 -31.13 60.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 1.067 HD22 ' HAB' ' B' ' 147' ' ' HEC . 8.8 tt -68.19 -55.39 12.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.63 -20.55 39.41 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ASN . . . . . 0.509 ' OD1' ' CD2' ' A' ' 103' ' ' HIS . 61.8 t30 -60.09 -34.78 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -1.159 . . . . 0.0 109.684 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.53 -24.12 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 109.593 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.73 -36.4 82.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 109.501 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.447 ' CG1' ' CD1' ' B' ' 130' ' ' TYR . 4.4 m -74.91 -26.04 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.239 -0.913 . . . . 0.0 109.662 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 17.0 t -66.79 -63.4 1.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 109.612 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' VAL . . . . . 0.433 ' H ' HG23 ' B' ' 113' ' ' VAL . 10.6 t -49.14 -21.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 109.539 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.9 -57.03 4.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.66 -27.32 49.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.836 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.494 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.71 -60.25 2.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.052 -1.03 . . . . 0.0 109.443 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -62.3 -17.49 58.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.692 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.445 ' CE2' ' O ' ' B' ' 17' ' ' LYS . 65.5 m-85 -150.05 60.5 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 109.703 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 121' ' ' GLU . . . -66.52 -45.26 86.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' B' ' 120' ' ' LYS . 28.6 mmtp -47.39 -19.86 0.19 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -1.172 . . . . 0.0 109.289 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' B' ' 119' ' ' GLY . 70.1 mm-40 -94.77 -26.82 16.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.642 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.478 ' CD1' ' C ' ' B' ' 122' ' ' PHE . 0.7 OUTLIER -48.54 120.82 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.355 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 9.6 p -149.15 149.31 29.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 108.896 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.448 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 2.5 Cg_endo -46.15 -58.1 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.327 2.018 . . . . 0.0 113.177 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 19.5 Cg_endo -59.76 -11.1 13.53 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.174 1.916 . . . . 0.0 112.51 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 53.5 t -94.81 -53.12 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 109.907 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -61.34 -59.88 4.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 109.489 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -51.16 -37.43 46.27 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.484 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.24 18.53 2.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.447 ' CD1' ' CG1' ' B' ' 111' ' ' VAL . 15.2 t80 -109.56 -61.71 1.6 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.229 -0.92 . . . . 0.0 109.688 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.523 ' CD ' ' H ' ' B' ' 131' ' ' GLN . 22.8 mp0 -48.43 -24.09 1.15 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.0 -1.063 . . . . 0.0 109.726 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.447 ' HG3' ' CD2' ' D' ' 146' ' ' HIS . 35.8 ttpt -85.73 -37.38 19.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 0.0 110.169 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 0.4 OUTLIER -60.76 -44.36 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.859 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.477 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 7.0 m -83.56 -16.97 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 0.0 109.935 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.96 -25.15 1.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 0.0 109.404 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.95 -23.9 56.48 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' B' ' 134' ' ' VAL . 42.7 t -79.6 -31.78 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -1.164 . . . . 0.0 109.429 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.54 -50.79 57.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -67.07 -32.31 73.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.427 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.7 -42.27 34.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.291 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.576 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 38.4 mt -84.17 18.37 2.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.376 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.39 -31.08 2.32 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.536 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' HIS . . . . . 0.431 ' HB2' ' HZ2' ' B' ' 82' ' ' LYS . 15.1 t-80 -46.37 -41.87 14.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 109.285 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' B' ' 146' ' ' HIS . 35.7 mmtt -75.46 -54.43 7.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.037 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.497 ' O ' ' CG ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -57.43 -6.19 0.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.545 -0.722 . . . . 0.0 109.241 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.446 ' H ' ' C ' ' B' ' 144' ' ' LYS . 11.8 m-70 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.79 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.48 ' C ' HD12 ' C' ' 2' ' ' LEU . 3.7 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.581 HD13 ' OG ' ' C' ' 131' ' ' SER . 7.7 mp -108.21 -165.41 1.04 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.359 -0.838 . . . . 0.0 109.269 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.516 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 179.02 -49.6 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.018 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' C' ' 6' ' ' ASP . 74.3 Cg_exo -47.17 170.88 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.398 2.065 . . . . 0.0 112.521 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.73 -16.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 109.828 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' C' ' 4' ' ' PRO . 3.1 p30 -39.61 -33.35 0.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.765 . . . . 0.0 109.799 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' C' ' 10' ' ' VAL . 9.6 ptpt -83.1 -46.57 12.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.893 . . . . 0.0 109.431 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.407 ' C ' ' O ' ' C' ' 7' ' ' LYS . 49.6 m -45.48 -31.12 1.62 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.419 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -78.23 -36.81 46.6 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' C' ' 7' ' ' LYS . 71.8 t -70.49 -49.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -51.07 -47.33 61.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.45 -56.02 26.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.405 -0.81 . . . . 0.0 109.294 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.696 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -56.65 -37.3 70.58 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.285 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -17.48 61.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.156 -0.965 . . . . 0.0 108.907 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.6 -44.09 17.04 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' C' ' 16' ' ' LYS . 41.7 mmtt -70.22 -43.29 70.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -1.119 . . . . 0.0 108.56 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.696 HG23 ' O ' ' C' ' 13' ' ' ALA . 59.8 t -59.22 -63.89 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.566 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 44.24 -125.44 5.84 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.41 22.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.349 -1.089 . . . . 0.0 110.449 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.566 ' H ' ' C ' ' C' ' 18' ' ' GLY . 78.9 m-70 -129.08 26.07 5.5 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.52 -64.37 1.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.68 -0.638 . . . . 0.0 109.811 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.37 -14.28 0.18 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 21' ' ' ALA . 2.1 mm-40 -84.01 -56.52 3.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -1.055 . . . . 0.0 109.671 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 24' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -60.53 -35.7 76.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.165 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.84 -22.92 68.83 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.51 -41.71 31.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -1.121 . . . . 0.0 109.683 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.51 -19.79 62.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 108.947 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.922 ' HB1' ' SG ' ' C' ' 104' ' ' CYS . . . -72.89 -21.84 60.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.109 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 11.2 mt -72.57 -53.57 11.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 109.635 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.19 -27.01 69.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.484 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -30.81 71.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' MET . . . . . 0.515 ' CE ' ' CBC' ' C' ' 142' ' ' HEC . 39.5 ttp -70.79 -57.98 4.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.405 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 0.3 OUTLIER -49.2 -33.63 12.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.468 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.453 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 11.8 mt -73.44 -51.57 16.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 109.856 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 53.3 m -67.92 -17.73 64.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.938 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.568 ' CZ ' ' NH2' ' D' ' 104' ' ' ARG . 29.2 m-85 -152.64 109.51 2.74 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.972 . . . . 0.0 109.546 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' C' ' 39' ' ' THR . 72.1 Cg_endo -80.43 -27.29 3.53 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.388 2.058 . . . . 0.0 112.16 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.753 ' O ' HG22 ' C' ' 41' ' ' THR . 22.0 p -47.37 -18.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.863 . . . . 0.0 109.581 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.438 ' N ' ' O ' ' C' ' 37' ' ' PRO . 55.9 p -81.56 -22.74 37.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.532 ' HZ1' HD21 ' C' ' 48' ' ' LEU . 1.8 tpmt? -64.68 -39.59 93.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.878 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.753 HG22 ' O ' ' C' ' 38' ' ' THR . 8.8 t -46.83 -37.26 8.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 0.0 109.616 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.421 ' N ' HG23 ' C' ' 41' ' ' THR . 3.9 m-85 -65.32 -58.49 5.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.96 . . . . 0.0 109.148 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.502 ' CD2' ' O ' ' C' ' 43' ' ' PHE . 81.5 t80 48.37 67.51 4.43 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.544 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.73 -34.28 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.937 2.425 . . . . 0.0 112.175 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.476 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER -174.29 73.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 109.145 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' C' ' 48' ' ' LEU . 0.3 OUTLIER -150.99 68.1 0.93 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' C' ' 49' ' ' SER . 1.5 m-20 -48.42 -18.31 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.07 -1.019 . . . . 0.0 109.613 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.582 ' CD1' ' O ' ' C' ' 46' ' ' PHE . 0.9 OUTLIER 46.56 21.19 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.211 -0.93 . . . . 0.0 109.536 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.461 ' O ' ' O ' ' C' ' 50' ' ' HIS . 5.2 m -75.31 18.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' HIS . . . . . 0.496 ' N ' ' ND1' ' C' ' 50' ' ' HIS . 2.4 m80 57.53 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 109.661 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.02 10.5 83.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 3.2 p -54.43 -12.71 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 71.13 -16.87 0.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.382 -0.824 . . . . 0.0 109.729 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' C' ' 52' ' ' SER . 5.1 pt20 -81.57 -28.85 33.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.959 . . . . 0.0 109.684 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.514 HG22 ' CE2' ' C' ' 46' ' ' PHE . 22.4 t -73.54 -38.43 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.584 ' CD ' ' H ' ' C' ' 56' ' ' LYS . 0.0 OUTLIER -78.71 -22.75 46.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.395 -0.816 . . . . 0.0 109.011 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.2 -23.81 58.35 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.471 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.7 t-80 -78.6 -38.45 39.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -1.147 . . . . 0.0 109.506 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.79 -48.85 49.73 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.41 ' O ' ' CG ' ' C' ' 64' ' ' ASP . 53.7 mttm -51.8 -23.28 4.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.36 -1.082 . . . . 0.0 109.924 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.559 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 0.5 OUTLIER -72.26 -42.39 65.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.116 -0.99 . . . . 0.0 109.054 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t -69.82 -48.51 63.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.455 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -65.46 -28.59 69.32 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 64' ' ' ASP . . . . . 0.41 ' CG ' ' O ' ' C' ' 60' ' ' LYS . 30.2 m-20 -70.23 -36.4 74.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 108.926 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.95 -52.74 47.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.476 -0.765 . . . . 0.0 108.968 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.415 ' O ' HG23 ' C' ' 70' ' ' VAL . 11.3 mt -58.03 -42.16 84.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 108.665 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.478 ' O ' ' N ' ' C' ' 71' ' ' ALA . 26.1 m -67.54 -51.55 49.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.245 -0.91 . . . . 0.0 108.998 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -60.46 -29.34 68.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 108.744 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -82.95 -46.54 12.8 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.415 HG23 ' O ' ' C' ' 66' ' ' LEU . 48.6 t -67.16 -22.38 29.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -66.07 -24.26 66.68 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.658 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.593 ' O ' HG12 ' C' ' 73' ' ' VAL . 11.8 m80 -137.27 -47.86 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.754 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.593 HG12 ' O ' ' C' ' 72' ' ' HIS . 10.9 p 45.09 13.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.802 0.81 . . . . 0.0 109.411 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' C' ' 72' ' ' HIS . 26.3 t70 -135.71 11.46 3.42 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -173.77 28.26 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.007 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.712 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -77.94 -25.02 0.46 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.489 -0.757 . . . . 0.0 111.414 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' C' ' 76' ' ' MET . 41.9 Cg_exo -56.37 -24.7 53.3 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.851 1.701 . . . . 0.0 112.363 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -89.39 -29.21 19.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.0 -43.2 35.69 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.143 -0.973 . . . . 0.0 109.068 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 80' ' ' LEU . . . . . 0.471 ' N ' HD12 ' C' ' 80' ' ' LEU . 6.4 mp -83.5 8.7 13.19 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.358 -0.839 . . . . 0.0 108.962 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.6 m -63.43 -23.39 67.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.551 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -76.24 -55.33 5.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.629 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.507 HD22 HBA1 ' C' ' 142' ' ' HEC . 4.5 mt -46.59 -46.8 19.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.818 . . . . 0.0 108.861 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 5.0 m -56.91 -25.33 57.08 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.404 -0.81 . . . . 0.0 109.25 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' C' ' 82' ' ' ALA . 11.6 t70 -81.02 -35.06 32.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.91 -27.04 62.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.25 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' HIS . . . . . 0.439 ' O ' ' O ' ' C' ' 90' ' ' LYS . 68.2 m80 -82.74 -31.36 28.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.17 -42.64 15.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -78.16 -18.79 55.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.854 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' C' ' 87' ' ' HIS . 46.8 mttm -146.06 179.81 7.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.898 . . . . 0.0 109.511 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' C' ' 93' ' ' VAL . 12.5 mt 59.08 58.54 3.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.456 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -53.99 -6.82 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.248 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' C' ' 91' ' ' LEU . 11.5 p -54.64 137.89 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.688 ' HB2' ' OD2' ' B' ' 99' ' ' ASP . 0.7 OUTLIER -77.24 157.89 80.23 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.086 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' C' ' 97' ' ' ASN . 10.0 Cg_endo -54.74 -10.34 2.46 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.627 2.218 . . . . 0.0 111.953 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.478 HG21 ' CG ' ' B' ' 99' ' ' ASP . 85.4 t -43.09 -22.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -0.819 . . . . 0.0 109.743 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' C' ' 95' ' ' PRO . 3.1 m120 -79.15 -41.16 29.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.959 . . . . 0.0 109.206 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 98' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' C' ' 95' ' ' PRO . 31.9 t80 -48.59 -25.68 1.85 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 109.249 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -70.65 -30.37 66.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.18 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.559 HD13 ' CD1' ' C' ' 36' ' ' PHE . 20.4 mt -84.07 -61.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 109.63 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.755 HD21 HBB3 ' C' ' 142' ' ' HEC . 4.6 tt -49.15 -23.55 1.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.744 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 34.5 m -72.87 -43.91 61.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.798 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.514 ' CD2' ' OD1' ' D' ' 108' ' ' ASN . 41.3 t-80 -80.58 -26.69 37.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 109.732 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.922 ' SG ' ' HB1' ' C' ' 28' ' ' ALA . 11.1 p -57.98 -48.09 81.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.768 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.655 ' N ' ' SG ' ' C' ' 104' ' ' CYS . 2.5 mt -46.46 -39.12 10.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.393 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.613 HD12 ' CE1' ' C' ' 122' ' ' HIS . 3.7 mm? -68.72 -30.37 68.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.603 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 107' ' ' VAL . . . . . 0.597 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 85.7 t -75.04 -51.43 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.459 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.464 ' O ' ' N ' ' C' ' 110' ' ' ALA . 27.1 m -60.12 -59.63 5.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.244 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' C' ' 114' ' ' PRO . 12.4 mt -46.29 -18.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -69.66 -42.56 74.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.0 110.368 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.15 -3.63 43.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.0 110.17 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -129.72 -81.83 0.56 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 109.622 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.4 OUTLIER -119.17 82.2 22.28 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 114' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 53.3 Cg_exo -48.79 -169.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.427 2.085 . . . . 0.0 112.604 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.839 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -50.89 -56.27 13.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.491 -0.756 . . . . 0.0 109.289 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.658 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 3.0 mm-40 122.66 -8.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.503 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 5.6 t80 80.26 34.95 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.935 -0.478 . . . . 0.0 111.212 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.739 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -113.45 120.26 40.13 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -48.3 16.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.242 1.961 . . . . 0.0 112.992 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -140.93 -34.73 0.49 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.049 -1.032 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.839 HG21 ' O ' ' C' ' 115' ' ' ALA . 9.4 p -51.75 -47.18 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.613 ' CE1' HD12 ' C' ' 106' ' ' LEU . 1.0 OUTLIER -60.34 -39.81 88.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.26 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.44 -20.03 32.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.344 -0.847 . . . . 0.0 109.785 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.535 ' N ' ' O ' ' C' ' 120' ' ' ALA . 24.3 p -61.83 -62.42 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 110.283 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.5 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.3 mt -68.14 -19.51 64.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 0.0 109.544 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -83.13 -45.46 13.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 109.841 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.416 ' CG ' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -87.31 -41.36 13.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.974 . . . . 0.0 109.84 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.462 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 37.1 t80 -50.22 -20.83 1.13 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.879 -1.138 . . . . 0.0 108.81 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' C' ' 133' ' ' SER . 19.2 mt -70.57 -17.92 62.91 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.64 -31.69 69.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.581 ' OG ' HD13 ' C' ' 2' ' ' LEU . 0.8 OUTLIER -81.79 -33.94 30.59 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.429 -0.795 . . . . 0.0 108.933 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 26.4 t -83.85 -29.16 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.334 -0.854 . . . . 0.0 108.927 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.536 ' N ' ' O ' ' C' ' 129' ' ' LEU . 23.3 t -80.37 -25.39 39.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.393 -0.817 . . . . 0.0 109.109 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 44.9 m -75.35 -39.69 59.04 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 28.8 m -75.07 -22.12 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 108.887 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.95 -35.03 72.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.041 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 82.3 m -87.38 -29.79 21.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 138' ' ' SER . . . . . 0.4 ' CB ' HH12 ' C' ' 141' ' ' ARG . 68.7 m 50.37 -166.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 109.434 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -60.84 156.41 17.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.902 . . . . 0.0 109.52 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' C' ' 140' ' ' TYR . 78.3 t80 -82.05 40.84 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.457 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 141' ' ' ARG . . . . . 0.4 HH12 ' CB ' ' C' ' 138' ' ' SER . 8.9 ptp85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.598 HG22 ' N ' ' D' ' 2' ' ' HIS . 9.9 p . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 2' ' ' HIS . . . . . 0.598 ' N ' HG22 ' D' ' 1' ' ' VAL . 1.5 t60 -140.48 123.31 16.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.26 -0.9 . . . . 0.0 109.572 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.919 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -138.39 -162.92 1.37 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.331 -0.856 . . . . 0.0 109.068 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.53 153.2 61.52 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 108.939 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.71 -26.39 68.49 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.498 2.132 . . . . 0.0 112.3 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.15 -27.86 22.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.862 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -84.07 -48.06 10.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.095 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.705 ' HB2' HD13 ' D' ' 3' ' ' LEU . 0.8 OUTLIER -68.84 -43.39 75.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.149 -0.969 . . . . 0.0 109.52 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -56.65 -23.58 42.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.173 -0.955 . . . . 0.0 110.026 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.57 -57.63 3.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.98 -1.075 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.02 -24.32 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 46.1 m -80.89 -36.96 30.54 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.723 -0.611 . . . . 0.0 109.782 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.81 -22.3 63.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.941 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' D' ' 16' ' ' GLY . 1.8 mt -59.85 -28.1 67.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.11 -0.994 . . . . 0.0 109.379 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 15' ' ' TRP . . . . . 0.66 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.5 OUTLIER -47.53 -17.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.198 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 16' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -76.83 -36.13 37.68 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.454 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 3.2 mmtt -89.36 -35.8 15.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -1.196 . . . . 0.0 109.298 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -47.94 114.95 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.32 -0.863 . . . . 0.0 109.668 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' D' ' 21' ' ' ASP . 83.5 m-20 -77.91 65.78 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 0.0 108.85 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 71.5 t -44.55 -17.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' D' ' 19' ' ' ASN . 13.4 m-20 -78.84 6.74 8.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' D' ' 19' ' ' ASN . 58.1 mt-10 -155.58 -46.94 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' D' ' 27' ' ' ALA . 85.9 t -47.8 -42.22 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.629 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.76 -43.42 96.46 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.85 -39.18 25.21 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -76.21 -25.78 55.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -1.151 . . . . 0.0 109.557 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' D' ' 23' ' ' VAL . . . -75.6 -34.02 60.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.477 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tp -82.96 -52.38 6.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.426 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.66 -26.71 17.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -77.91 -31.34 51.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 0.0 109.447 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' LEU . . . . . 0.448 HD21 HMC1 ' D' ' 147' ' ' HEC . 32.5 tp -48.99 -34.61 13.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.352 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 29.1 mt -80.44 -21.97 41.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 23.8 t -82.54 -64.27 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.418 HG23 ' H ' ' D' ' 34' ' ' VAL . 3.0 t -61.05 -22.86 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 109.639 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -152.17 88.57 4.08 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.479 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.89 12.84 2.51 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.621 2.214 . . . . 0.0 112.251 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' TRP . . . . . 0.601 ' CZ2' ' ND2' ' D' ' 102' ' ' ASN . 0.7 OUTLIER -71.8 -20.01 61.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 109.546 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.592 HG23 ' NE1' ' D' ' 37' ' ' TRP . 1.3 p -84.09 51.06 1.97 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 109.273 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 39' ' ' GLN . . . . . 0.434 ' O ' ' CD1' ' D' ' 42' ' ' PHE . 38.6 tt0 -92.2 31.15 1.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.252 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -87.85 -42.92 12.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.589 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -93.1 14.3 18.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 109.551 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' D' ' 43' ' ' GLU . 1.6 p90 -68.28 -34.13 75.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.595 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 43' ' ' GLU . . . . . 0.54 ' N ' ' CD1' ' D' ' 42' ' ' PHE . 11.9 pt-20 -53.31 -17.4 1.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.543 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 60.8 m -85.56 -34.7 21.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 109.59 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' D' ' 47' ' ' ASP . 10.1 m-85 -51.08 -20.95 1.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.358 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.98 12.44 0.15 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' D' ' 45' ' ' PHE . 15.1 m-20 -160.63 110.51 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -1.102 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tp -158.72 20.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.294 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 58.7 m -46.91 -41.03 15.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.642 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' THR . . . . . 0.469 ' HG1' ' CG ' ' D' ' 52' ' ' ASP . 4.8 p -146.57 150.37 40.02 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.359 -0.838 . . . . 0.0 109.217 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -41.16 -43.65 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.467 2.111 . . . . 0.0 112.382 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ASP . . . . . 0.469 ' CG ' ' HG1' ' D' ' 50' ' ' THR . 1.7 p-10 -64.11 -31.09 72.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.152 -0.968 . . . . 0.0 109.447 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -56.94 -19.88 20.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 48.3 t -71.36 -61.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.571 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' D' ' 55' ' ' MET . 5.5 mmt -70.99 -0.48 9.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 0.0 109.443 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.72 30.92 7.32 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -142.94 137.02 14.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.211 -1.17 . . . . 0.0 109.385 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.04 -30.77 5.45 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.516 2.144 . . . . 0.0 112.336 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -21.07 59.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 109.739 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.92 -41.46 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.476 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -78.35 -25.35 46.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.57 71.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.924 ' CE1' ' O1A' ' D' ' 147' ' ' HEC . 72.7 t60 -62.61 -23.83 67.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.549 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.36 -50.23 22.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -49.57 -30.84 9.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -1.147 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' LYS . . . . . 0.462 ' HB3' HBA1 ' D' ' 147' ' ' HEC . 67.8 mmtt -65.5 -53.68 38.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.899 . . . . 0.0 109.591 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 1.111 HG13 ' C2B' ' D' ' 147' ' ' HEC . 28.2 t -59.03 -36.92 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.413 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.425 HD23 ' C ' ' D' ' 68' ' ' LEU . 5.7 tt -65.51 -48.43 72.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 109.345 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.94 -41.08 10.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.28 91.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.167 . . . . 0.0 109.64 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 71' ' ' PHE . . . . . 0.577 ' CE2' HMB1 ' D' ' 147' ' ' HEC . 28.8 m-85 -61.5 -47.27 86.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.612 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 72' ' ' SER . . . . . 0.66 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 19.4 m -62.56 -41.97 99.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.349 -0.844 . . . . 0.0 109.531 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -48.31 -34.85 11.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.44 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.71 -60.42 6.98 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.556 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.6 mp -54.04 -22.1 9.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.157 . . . . 0.0 109.32 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.06 2.51 56.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.942 . . . . 0.0 109.626 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -170.19 66.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 78' ' ' LEU . . . . . 0.442 HD22 HG12 ' D' ' 1' ' ' VAL . 96.3 mt -81.26 15.25 2.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.348 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.82 -23.22 60.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 80' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 37.1 t-20 -167.2 108.11 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.582 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 81' ' ' LEU . . . . . 0.481 HD11 ' N ' ' D' ' 1' ' ' VAL . 6.3 mt -80.31 -51.67 8.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 109.373 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 82' ' ' LYS . . . . . 0.43 ' HZ2' ' HB2' ' D' ' 143' ' ' HIS . 52.5 mttm -67.01 -24.13 65.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.707 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 83' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -78.6 -39.11 22.58 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.9 t -85.1 -47.44 10.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.15 -1.206 . . . . 0.0 109.696 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' D' ' 84' ' ' THR . 40.4 m-85 -84.72 27.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.486 -0.759 . . . . 0.0 109.519 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.28 -31.41 72.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.359 -0.838 . . . . 0.0 109.626 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 51.1 p -75.77 -53.84 7.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.715 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -48.12 -42.98 30.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 3.0 m -67.0 -48.33 68.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.574 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -67.35 -22.66 65.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.761 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.73 -68.36 0.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.124 -0.985 . . . . 0.0 109.567 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.577 ' NE2' ' O ' ' D' ' 141' ' ' LEU . 1.1 p-80 -54.44 -20.67 7.99 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.172 -0.955 . . . . 0.0 109.939 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 93' ' ' CYS . . . . . 0.426 ' N ' ' ND1' ' D' ' 92' ' ' HIS . 41.3 t -83.53 -59.57 2.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 110.818 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.36 -56.41 3.45 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.072 -1.018 . . . . 0.0 111.396 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -57.69 -51.73 68.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.095 -1.003 . . . . 0.0 110.599 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.568 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 12.2 mt -97.42 -64.32 1.05 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.081 -1.012 . . . . 0.0 109.94 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.786 ' HB2' ' HB ' ' A' ' 38' ' ' THR . 0.0 OUTLIER 91.03 25.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.297 0.57 . . . . 0.0 109.868 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 98' ' ' VAL . . . . . 0.431 HG23 ' H ' ' D' ' 98' ' ' VAL . 17.5 t -46.73 140.79 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.5 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 99' ' ' ASP . . . . . 0.765 ' OD2' ' HB2' ' A' ' 94' ' ' ASP . 96.0 m-20 -53.94 149.41 17.68 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.399 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.84 36.45 0.4 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.6 2.2 . . . . 0.0 112.119 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -145.12 45.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 102' ' ' ASN . . . . . 0.601 ' ND2' ' CZ2' ' D' ' 37' ' ' TRP . 4.4 m120 -143.8 5.95 1.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -0.843 . . . . 0.0 109.556 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 1.1 m-85 -89.73 -69.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 109.516 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 104' ' ' ARG . . . . . 0.568 ' NH2' ' CZ ' ' C' ' 36' ' ' PHE . 44.1 ttt180 -55.08 -20.88 10.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 tp -75.19 -31.14 60.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 1.078 HD22 ' HAB' ' D' ' 147' ' ' HEC . 8.8 tt -68.29 -55.33 12.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.7 -20.45 39.5 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 108' ' ' ASN . . . . . 0.514 ' OD1' ' CD2' ' C' ' 103' ' ' HIS . 61.7 t30 -60.18 -34.78 74.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -1.094 . . . . 0.0 109.636 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 6.8 t -86.47 -24.15 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 109.599 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.64 -36.42 82.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 109.553 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 111' ' ' VAL . . . . . 0.438 ' CG1' ' CD1' ' D' ' 130' ' ' TYR . 4.4 m -74.99 -25.92 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.248 -0.908 . . . . 0.0 109.665 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 16.9 t -66.84 -63.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.148 -0.97 . . . . 0.0 109.584 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 113' ' ' VAL . . . . . 0.401 ' H ' HG23 ' D' ' 113' ' ' VAL . 10.6 t -49.16 -21.59 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.506 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.91 -57.01 4.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.4 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -55.62 -27.37 49.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.892 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.489 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.75 -60.07 2.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.5 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -62.39 -17.55 59.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.611 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 65.7 m-85 -150.0 60.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.987 . . . . 0.0 109.675 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' D' ' 121' ' ' GLU . . . -66.53 -45.33 86.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -47.29 -19.88 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -1.181 . . . . 0.0 109.31 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' D' ' 119' ' ' GLY . 70.1 mm-40 -94.76 -26.78 16.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.652 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.475 ' CD1' ' C ' ' D' ' 122' ' ' PHE . 0.7 OUTLIER -48.67 120.86 4.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.348 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 9.7 p -149.12 149.32 29.4 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.009 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.434 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 2.5 Cg_endo -46.21 -58.01 1.9 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.366 2.044 . . . . 0.0 113.168 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 19.3 Cg_endo -59.84 -11.12 13.8 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.168 1.912 . . . . 0.0 112.474 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 53.6 t -94.8 -53.19 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.034 -1.041 . . . . 0.0 109.821 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -61.37 -59.73 4.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.503 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -51.3 -37.39 47.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.18 18.48 2.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.694 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.438 ' CD1' ' CG1' ' D' ' 111' ' ' VAL . 15.1 t80 -109.5 -61.73 1.59 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -0.908 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 0.519 ' CD ' ' H ' ' D' ' 131' ' ' GLN . 22.8 mp0 -48.46 -24.16 1.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.003 -1.061 . . . . 0.0 109.662 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 132' ' ' LYS . . . . . 0.401 ' HG3' ' CD2' ' B' ' 146' ' ' HIS . 35.7 ttpt -85.69 -37.38 19.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -0.888 . . . . 0.0 110.21 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 133' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 0.4 OUTLIER -60.88 -44.21 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.067 -1.021 . . . . 0.0 109.821 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.496 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 7.0 m -83.6 -16.94 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.2 -0.938 . . . . 0.0 109.877 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.99 -25.13 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.07 -1.019 . . . . 0.0 109.432 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.97 -23.94 56.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 137' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' D' ' 134' ' ' VAL . 42.4 t -79.49 -31.78 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -1.105 . . . . 0.0 109.522 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.57 -50.78 56.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.396 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -67.07 -32.27 73.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.68 -42.42 34.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.95 . . . . 0.0 109.237 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.577 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 38.3 mt -84.12 18.44 2.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.392 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.45 -31.03 2.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.163 -0.961 . . . . 0.0 109.556 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 143' ' ' HIS . . . . . 0.43 ' HB2' ' HZ2' ' D' ' 82' ' ' LYS . 15.1 t-80 -46.33 -41.92 14.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 109.285 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' D' ' 146' ' ' HIS . 35.7 mmtt -75.41 -54.39 7.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.419 -0.801 . . . . 0.0 109.127 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 145' ' ' TYR . . . . . 0.467 ' O ' ' CG ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -57.42 -6.21 0.42 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.501 -0.75 . . . . 0.0 109.234 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.447 ' CD2' ' HG3' ' B' ' 132' ' ' LYS . 11.6 m-70 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.759 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.777 HBB3 HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 1.103 ' C2B' HG13 ' B' ' 67' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.755 HBB3 HD21 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 1.111 ' C2B' HG13 ' D' ' 67' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 1' ' ' VAL . 73.9 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.585 HD21 ' OG ' ' A' ' 131' ' ' SER . 78.2 mt -144.7 178.82 7.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.995 . . . . 0.0 109.723 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.73 167.11 26.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.434 -0.791 . . . . 0.0 109.069 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.15 -43.72 2.98 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.599 2.199 . . . . 0.0 112.563 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.29 -19.35 33.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.977 -1.077 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.783 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.7 t0 -47.85 -37.14 13.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.413 ' CD ' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -81.19 -43.59 19.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.869 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.0 m -51.15 -37.53 46.79 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.123 -0.986 . . . . 0.0 109.558 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -74.93 -31.96 61.64 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 6' ' ' ASP . 58.6 t -72.36 -51.27 30.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -49.98 -47.44 52.81 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.9 -61.28 2.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.458 -0.776 . . . . 0.0 109.537 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.64 -40.06 68.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.424 -0.797 . . . . 0.0 109.058 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -17.16 64.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.425 -0.797 . . . . 0.0 108.955 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.34 -44.96 15.69 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 12.2 mmmt -70.66 -40.66 72.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -1.166 . . . . 0.0 108.802 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' ALA . 61.9 t -60.27 -64.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 46.1 -127.34 9.36 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 23.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -1.102 . . . . 0.0 110.569 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' A' ' 18' ' ' GLY . 86.0 m-70 -130.07 25.77 5.22 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -90.24 -63.8 1.23 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.693 -0.629 . . . . 0.0 109.754 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.77 -14.3 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.0 mm-40 -83.28 -56.51 3.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -1.076 . . . . 0.0 109.559 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.664 ' CD1' ' CE1' ' A' ' 112' ' ' HIS . 3.6 m-30 -62.07 -32.24 72.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.462 -0.773 . . . . 0.0 109.274 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.19 -23.4 77.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.08 -44.38 22.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -1.09 . . . . 0.0 109.587 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -61.1 -26.24 67.52 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -26.78 68.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.526 HD11 ' ND1' ' A' ' 58' ' ' HIS . 14.1 mt -72.51 -58.4 3.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.471 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -52.16 -38.91 59.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.61 ' HG3' ' OE1' ' B' ' 127' ' ' GLN . 0.9 OUTLIER -68.21 -50.58 53.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.299 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.469 ' C ' ' SD ' ' A' ' 32' ' ' MET . 15.2 tmm? -62.4 -29.15 70.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.351 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.69 -58.73 6.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 110.026 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.4 pp -73.89 -39.62 63.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.2 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.524 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 50.8 m -46.71 -16.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.081 -1.012 . . . . 0.0 109.825 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 35' ' ' SER . 15.2 m-85 -159.37 89.64 1.99 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 0.0 109.362 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 40' ' ' LYS . 52.5 Cg_exo -52.77 -20.07 12.07 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.457 2.105 . . . . 0.0 112.095 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 p -49.08 -18.91 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.403 ' N ' ' C ' ' A' ' 37' ' ' PRO . 30.3 p -84.17 -22.92 30.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' PRO . 29.9 ttmt -55.5 -47.01 76.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.567 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.667 HG21 ' O ' ' D' ' 94' ' ' ASP . 5.1 t -72.4 -18.85 61.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.8 . . . . 0.0 109.417 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 37.2 t80 -75.96 -15.64 60.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.587 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 41' ' ' THR . 21.2 m-85 55.66 87.07 0.15 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.661 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 45.4 Cg_exo -51.92 -38.83 69.39 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.436 2.09 . . . . 0.0 111.76 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.661 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 94.35 34.46 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 178.276 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.47 ' CE2' ' HB3' ' A' ' 44' ' ' PRO . 2.2 p90 -145.53 31.24 1.09 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.506 -1.371 . . . . 0.0 110.078 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 49' ' ' SER . 1.1 m-20 52.84 91.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.872 . . . . 0.0 109.614 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.19 1.87 0.43 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.373 -0.83 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 47' ' ' ASP . 9.2 m -62.48 140.95 58.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.421 ' ND1' ' O ' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -63.72 140.34 58.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.448 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.21 12.13 81.23 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.631 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 2.2 t -59.31 -20.58 55.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -1.174 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 72.61 -24.33 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -0.782 . . . . 0.0 109.61 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 52' ' ' SER . 33.5 mt-30 -80.31 -24.32 40.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.569 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.8 t -75.85 -35.14 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 56' ' ' LYS . 14.1 ptpt -79.17 -34.67 42.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.946 . . . . 0.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.19 -24.52 76.3 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.526 ' ND1' HD11 ' A' ' 29' ' ' LEU . 5.9 t-80 -68.15 -43.87 77.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.317 -1.108 . . . . 0.0 109.316 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.8 -46.97 25.19 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 48.5 mttm -54.6 -23.19 15.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.512 -0.993 . . . . 0.0 109.644 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -36.85 58.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.199 -0.938 . . . . 0.0 108.902 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -73.73 -47.39 44.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.499 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -68.64 -29.09 67.51 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.312 -0.868 . . . . 0.0 109.342 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 25.6 m-20 -66.79 -47.23 72.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.096 -1.002 . . . . 0.0 108.75 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.457 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -61.9 -49.46 76.11 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.3 mt -55.37 -46.03 76.5 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 71' ' ' ALA . 27.6 m -64.97 -55.55 18.43 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.301 -0.874 . . . . 0.0 108.749 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -55.9 -29.3 59.78 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.73 -48.12 12.06 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 66' ' ' LEU . 54.9 t -65.17 -22.5 31.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -68.94 -16.48 63.76 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 74' ' ' ASP . 63.2 m-70 -145.1 -56.9 0.33 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.306 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.4 p 44.94 13.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.665 0.745 . . . . 0.0 109.576 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 72' ' ' HIS . 99.2 m-20 -123.69 8.41 8.86 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -175.92 28.69 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.147 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 5.2 ptt? -78.09 -24.64 0.45 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 111.676 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 76' ' ' MET . 53.2 Cg_exo -54.83 -23.66 34.93 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.759 1.639 . . . . 0.0 112.195 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -93.32 -37.24 12.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.88 75.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.149 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.5 mt -81.74 8.79 9.15 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.325 -0.86 . . . . 0.0 109.048 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.0 t -56.11 -41.05 74.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.845 . . . . 0.0 109.618 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -56.22 -57.33 12.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.576 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.46 ' N ' HD23 ' A' ' 83' ' ' LEU . 4.2 mt -46.31 -46.69 18.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.376 -0.827 . . . . 0.0 108.819 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -59.96 -29.64 68.56 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.476 -0.765 . . . . 0.0 109.289 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 89' ' ' HIS . 76.0 m-20 -81.52 -38.93 25.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 0.0 109.339 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 87' ' ' HIS . 4.1 tt -59.18 -36.04 74.62 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.334 -0.853 . . . . 0.0 109.46 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.434 ' CE1' HD22 ' A' ' 86' ' ' LEU . 51.1 m80 -92.12 -23.07 19.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.949 . . . . 0.0 109.69 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.52 -9.49 29.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.238 -0.914 . . . . 0.0 109.922 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 85' ' ' ASP . 42.9 m80 -143.93 47.93 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -0.97 . . . . 0.0 109.698 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.13 -69.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 109.319 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.453 ' C ' ' N ' ' A' ' 93' ' ' VAL . 11.7 mt -88.76 -23.84 22.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 51.65 10.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.565 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.453 ' N ' ' C ' ' A' ' 91' ' ' LEU . 14.8 p -52.62 144.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.492 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 151.68 86.12 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.31 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 97' ' ' ASN . 47.6 Cg_endo -70.12 -20.98 32.45 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.558 2.172 . . . . 0.0 112.123 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.546 HG11 ' OD1' ' D' ' 99' ' ' ASP . 93.2 t -45.84 -15.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 109.756 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 95' ' ' PRO . 3.4 m120 -79.25 -24.88 42.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 109.577 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.495 ' CD1' ' C ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -69.1 -31.14 69.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.364 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -58.56 -29.94 66.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.504 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 17.6 mt -83.91 -62.18 1.63 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.581 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.544 HD22 ' HAB' ' A' ' 142' ' ' HEC . 7.1 tt -45.65 -24.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.597 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.7 t -65.22 -57.26 8.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.928 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -73.74 -26.5 60.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.981 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 9.5 m -70.32 -23.45 62.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.099 -1.001 . . . . 0.0 110.157 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.725 HD12 ' O ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -80.56 -22.87 40.37 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.937 -1.102 . . . . 0.0 108.926 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.99 -18.78 33.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.852 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.0 t -77.5 -50.33 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 110' ' ' ALA . 43.4 p -52.56 -51.91 57.46 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.161 -0.962 . . . . 0.0 109.678 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 113' ' ' LEU . 7.9 mt -43.74 -26.36 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.465 -0.772 . . . . 0.0 109.759 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -71.92 -25.65 61.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.924 . . . . 0.0 110.486 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.47 -3.79 54.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.106 -0.996 . . . . 0.0 110.902 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.664 ' CE1' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -150.15 -69.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.782 -1.199 . . . . 0.0 109.669 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -118.29 81.24 16.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.47 ' N ' ' O ' ' A' ' 109' ' ' LEU . 51.2 Cg_exo -49.32 -170.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.44 2.094 . . . . 0.0 112.589 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.729 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -48.65 -55.63 10.75 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.649 ' CG ' ' O ' ' A' ' 115' ' ' ALA . 2.8 mm-40 130.5 0.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.1 t80 66.3 30.37 9.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.842 -0.536 . . . . 0.0 111.138 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.706 ' O ' ' N ' ' A' ' 120' ' ' ALA . 2.1 p -103.79 128.12 27.97 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 120.996 -1.065 . . . . 0.0 108.249 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.64 23.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.102 1.868 . . . . 0.0 112.923 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.706 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -157.03 -32.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 0.0 110.669 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.729 HG21 ' O ' ' A' ' 115' ' ' ALA . 12.9 p -49.84 -47.24 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.13 -0.981 . . . . 0.0 110.299 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.656 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.4 t60 -61.74 -38.56 88.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.771 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.41 -20.12 34.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 109.95 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -66.28 -62.36 1.52 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.95 . . . . 0.0 110.245 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.568 HD22 HD21 ' A' ' 105' ' ' LEU . 1.4 mt -65.11 -19.81 66.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.071 -1.018 . . . . 0.0 109.467 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.17 -49.27 37.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.15 -42.1 11.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 109.635 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.574 ' CD2' HG21 ' A' ' 10' ' ' VAL . 32.0 t80 -50.0 -22.92 1.75 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 109.255 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.665 HD12 ' C ' ' A' ' 129' ' ' LEU . 1.2 pp -76.37 -22.08 55.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.14 -38.1 75.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.585 ' OG ' HD21 ' A' ' 2' ' ' LEU . 34.6 m -67.92 -26.8 66.16 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.469 ' O ' HD13 ' A' ' 136' ' ' LEU . 5.6 t -85.55 -37.67 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.8 t -80.06 -18.0 51.22 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.298 -0.876 . . . . 0.0 108.738 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 41.8 m -83.28 -42.44 17.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.468 -0.77 . . . . 0.0 109.208 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 131' ' ' SER . 27.3 m -70.06 -21.97 24.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.24 -0.913 . . . . 0.0 108.756 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 132' ' ' VAL . 0.9 OUTLIER -67.46 -31.8 72.22 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.1 m -153.27 57.1 0.77 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.7 t -63.56 -57.47 10.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 51.69 -122.93 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.404 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -152.8 50.21 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 109.463 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.441 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.526 ' O ' ' NZ ' ' B' ' 132' ' ' LYS . 7.6 p . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 52.31 47.91 23.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.094 -1.004 . . . . 0.0 108.949 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 1.078 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -107.63 -159.13 0.68 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.496 -0.752 . . . . 0.0 109.361 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 9.9 p -103.57 134.4 19.77 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.394 -0.816 . . . . 0.0 109.29 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -42.1 -22.79 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.438 2.092 . . . . 0.0 112.467 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -76.62 -55.6 5.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 110.065 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -68.16 -60.45 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.961 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.775 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -48.74 -30.14 5.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 2.9 m -62.05 -23.61 66.58 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.979 -1.075 . . . . 0.0 110.032 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.05 -57.68 3.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.886 -1.134 . . . . 0.0 109.958 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.55 -24.95 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 56.6 m -83.39 -37.36 23.4 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.453 0.644 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' B' ' 9' ' ' SER . . . -63.19 -29.92 71.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.369 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.7 OUTLIER -52.16 -32.46 36.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.119 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 15' ' ' TRP . . . . . 0.539 ' HE1' ' HG ' ' B' ' 72' ' ' SER . 0.2 OUTLIER -47.15 -17.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.509 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.34 -52.02 5.81 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' B' ' 17' ' ' LYS . 0.1 OUTLIER -70.48 -29.41 65.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -1.179 . . . . 0.0 109.263 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -48.72 114.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 22' ' ' GLU . 18.3 m120 -82.56 69.41 9.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 108.953 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' B' ' 22' ' ' GLU . 78.3 t -43.88 -29.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 0.0 109.72 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -64.69 1.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' B' ' 20' ' ' VAL . 33.0 mt-10 -155.89 -46.11 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 109.424 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -48.52 -53.96 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.41 -48.52 48.14 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.34 -46.35 79.09 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.44 -39.96 95.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.27 -1.136 . . . . 0.0 109.394 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.74 88.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.179 -0.95 . . . . 0.0 109.364 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -82.2 -51.22 8.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.309 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.91 -35.08 62.53 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -79.37 -30.65 42.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -1.158 . . . . 0.0 109.495 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 60.6 tp -49.42 -39.03 31.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.379 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.53 -23.45 56.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.583 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.79 -61.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.188 -0.945 . . . . 0.0 109.413 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.403 ' H ' HG23 ' B' ' 34' ' ' VAL . 3.2 t -69.36 -23.82 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -136.73 76.09 48.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.64 11.49 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.725 2.283 . . . . 0.0 112.335 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.468 ' CE2' HG23 ' B' ' 38' ' ' THR . 51.3 p-90 -80.62 -19.71 44.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 109.341 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.793 ' HB ' HBC1 ' B' ' 147' ' ' HEC . 42.0 p -79.77 40.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 109.36 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -92.16 12.84 20.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 0.0 109.55 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -87.86 -34.49 18.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' B' ' 42' ' ' PHE . 29.9 m-85 -95.79 32.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.507 ' CZ ' HBC3 ' B' ' 147' ' ' HEC . 57.5 m-85 -141.36 26.32 1.98 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.94 -25.08 37.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.483 ' C ' ' H ' ' B' ' 46' ' ' GLY . 66.8 m -82.13 -38.17 25.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.602 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -56.0 -5.41 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' B' ' 44' ' ' SER . . . 48.57 -167.67 0.16 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' B' ' 48' ' ' LEU . 18.9 t70 60.19 -150.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -1.149 . . . . 0.0 109.536 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.473 ' H ' ' CG ' ' B' ' 47' ' ' ASP . 24.2 mt 60.57 34.33 20.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 109.53 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.3 m -80.49 -22.52 40.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.41 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' THR . . . . . 0.502 ' O ' ' N ' ' B' ' 53' ' ' ALA . 21.4 p -146.11 149.02 37.24 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.279 -0.888 . . . . 0.0 109.166 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -36.75 -45.07 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.644 2.23 . . . . 0.0 112.591 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.88 -26.93 61.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 109.544 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -57.78 -19.64 29.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.05 -63.36 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.135 -0.978 . . . . 0.0 109.633 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' MET . . . . . 0.542 ' SD ' ' N ' ' B' ' 55' ' ' MET . 2.3 mpp? -79.69 14.81 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.05 -49.01 4.41 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.46 HD21 ' HE2' ' B' ' 59' ' ' LYS . 3.8 m-20 -77.82 149.61 77.54 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.227 -1.16 . . . . 0.0 109.46 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.36 -51.94 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.671 2.247 . . . . 0.0 112.176 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.46 ' HE2' HD21 ' B' ' 57' ' ' ASN . 54.2 pttt -46.92 -40.75 14.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.56 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' B' ' 59' ' ' LYS . 87.1 t -54.21 -44.85 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' B' ' 61' ' ' LYS . 7.0 mtmp? -77.39 -43.0 34.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.222 -0.924 . . . . 0.0 109.438 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.17 -33.12 18.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.573 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 5.8 t60 -67.67 -24.4 65.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.68 -30.25 74.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -68.15 -41.23 81.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.121 . . . . 0.0 109.318 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -64.08 -50.89 66.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.779 . . . . 0.0 109.36 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 0.794 HG22 ' C4A' ' B' ' 147' ' ' HEC . 25.3 t -61.78 -23.91 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.251 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tt -78.11 -29.8 49.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.475 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.22 -57.13 14.33 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.54 -22.03 63.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -74.46 -30.34 61.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.63 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.539 ' HG ' ' HE1' ' B' ' 15' ' ' TRP . 4.4 m -89.11 -20.48 24.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 109.762 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -46.15 -30.79 2.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 109.621 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.29 -59.24 7.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.558 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.75 -17.73 10.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 109.667 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -97.38 32.9 2.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.977 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.549 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 9.5 m-70 -176.67 -49.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.161 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' B' ' 77' ' ' HIS . 29.8 mt 39.64 35.3 0.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.637 -0.665 . . . . 0.0 109.614 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -138.62 -31.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.651 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 7.5 p-10 -151.91 72.71 1.03 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.171 -0.956 . . . . 0.0 109.363 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.552 HD12 ' N ' ' B' ' 81' ' ' LEU . 9.6 mp -60.4 -27.08 67.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.912 . . . . 0.0 109.461 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -80.62 -61.48 1.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.77 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.32 -23.9 43.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.432 HG23 ' O ' ' B' ' 80' ' ' ASN . 0.8 OUTLIER -62.4 -51.91 65.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.166 -1.196 . . . . 0.0 109.537 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.546 ' CZ ' ' O ' ' B' ' 81' ' ' LEU . 2.2 p90 -133.18 51.93 2.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.639 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.97 -29.47 4.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -0.994 . . . . 0.0 109.287 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' B' ' 88' ' ' LEU . 17.8 p -60.5 -58.5 8.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.326 -0.859 . . . . 0.0 109.392 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.404 ' N ' ' OG1' ' B' ' 87' ' ' THR . 90.7 mt -48.56 -37.43 17.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.026 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -69.06 -34.84 75.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.913 . . . . 0.0 109.002 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -82.91 -39.01 22.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 109.419 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.07 -25.31 64.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 109.397 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' B' ' 97' ' ' HIS . 6.8 m80 -90.98 -21.81 21.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.181 -0.95 . . . . 0.0 109.567 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.58 -59.05 2.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 111.059 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.592 ' O ' HG21 ' C' ' 41' ' ' THR . 1.3 m-20 -87.21 -57.0 3.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.976 -1.077 . . . . 0.0 112.009 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.484 ' CD ' ' N ' ' B' ' 95' ' ' LYS . 12.1 mptt -62.81 -52.16 64.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.122 -0.986 . . . . 0.0 111.195 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.608 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -95.43 -38.2 10.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.973 -1.079 . . . . 0.0 109.837 -178.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 25.3 p80 45.52 33.06 1.25 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.206 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.587 HG23 HD12 ' B' ' 96' ' ' LEU . 52.0 t -50.13 132.4 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.949 -1.094 . . . . 0.0 109.139 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 0.507 ' OD1' HG11 ' C' ' 96' ' ' VAL . 4.2 m-20 -51.15 151.24 5.02 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.266 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.03 -170.35 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.439 2.093 . . . . 0.0 112.026 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' D' ' 101' ' ' GLU . 69.1 mm-40 53.24 69.95 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.47 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.467 ' ND2' ' CD1' ' B' ' 103' ' ' PHE . 3.9 p-10 -171.24 -39.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.49 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.467 ' CD1' ' ND2' ' B' ' 102' ' ' ASN . 12.9 m-85 -50.34 -34.51 24.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -76.13 -43.94 40.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.613 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.521 HD12 ' N ' ' B' ' 105' ' ' LEU . 9.9 mp -49.32 -51.81 31.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 1.043 HD13 ' CHC' ' B' ' 147' ' ' HEC . 6.5 tt -51.69 -37.17 49.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.852 . . . . 0.0 109.353 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.98 -20.57 59.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -65.36 -34.26 77.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 109.561 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.86 -31.67 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 7.7 tp -51.67 -52.09 50.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.517 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.564 ' CG2' ' CE1' ' B' ' 130' ' ' TYR . 42.6 t -51.18 -42.86 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.596 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -60.06 -39.56 86.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.164 -0.96 . . . . 0.0 109.618 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.55 -55.03 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.606 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.03 -31.75 71.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.495 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -64.9 -27.8 69.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.403 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.463 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.79 -61.28 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.227 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.42 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 8.3 m-70 -63.3 -18.28 63.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 58.8 m-85 -148.44 59.53 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -71.95 -14.8 76.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -79.48 -20.29 47.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.271 -1.135 . . . . 0.0 109.528 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' B' ' 123' ' ' THR . 29.1 mm-40 -95.48 -2.49 48.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.953 . . . . 0.0 109.77 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -73.78 33.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 0.0 109.606 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.468 ' H ' ' C ' ' B' ' 121' ' ' GLU . 22.0 p -49.22 148.41 4.4 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.364 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.454 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 2.3 Cg_endo -46.83 -57.51 2.25 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.448 2.099 . . . . 0.0 113.002 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 17.8 Cg_endo -59.49 -42.36 48.86 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.093 1.862 . . . . 0.0 112.233 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 98.9 t -65.11 -20.76 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.458 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' GLN . . . . . 0.61 ' OE1' ' HG3' ' A' ' 31' ' ' ARG . 17.7 tt0 -83.31 -48.99 9.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.552 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.658 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -58.66 -30.06 67.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.437 ' O ' HG23 ' B' ' 133' ' ' VAL . . . -82.14 19.17 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.144 -0.972 . . . . 0.0 109.672 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.564 ' CE1' ' CG2' ' B' ' 111' ' ' VAL . 47.4 t80 -107.95 -61.4 1.58 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.283 -0.886 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 5.9 tp-100 -55.28 -23.26 22.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.947 . . . . 0.0 109.57 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' B' ' 1' ' ' VAL . 22.7 ttpp -83.04 -21.8 33.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.647 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' VAL . . . . . 0.437 HG23 ' O ' ' B' ' 129' ' ' ALA . 76.8 t -81.13 -68.31 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 109.696 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 22.4 m -53.76 -25.04 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.848 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -49.56 -29.78 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.461 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.4 -29.28 56.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 96.4 t -76.42 -38.14 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -1.169 . . . . 0.0 109.4 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.96 79.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.42 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 1.117 ' OD1' ' ND1' ' D' ' 146' ' ' HIS . 18.9 m-20 -79.67 -22.96 42.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.85 -60.52 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.601 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.74 -25.26 66.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.331 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 -16.35 27.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.472 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -51.33 -33.38 29.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 109.361 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -73.34 -27.15 61.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -71.94 -46.18 58.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.5 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 1.123 ' ND1' ' OD1' ' D' ' 139' ' ' ASN . 29.4 p80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.942 -1.027 . . . . 0.0 109.548 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.488 ' O ' HG12 ' C' ' 1' ' ' VAL . 73.2 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.571 HD21 ' OG ' ' C' ' 131' ' ' SER . 78.0 mt -144.72 178.84 7.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 109.772 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.77 167.17 25.85 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.05 -43.81 3.0 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.668 2.245 . . . . 0.0 112.62 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.3 -19.35 33.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.999 -1.063 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.771 ' O ' HG23 ' C' ' 10' ' ' VAL . 24.5 t0 -47.84 -37.24 13.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.735 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -43.61 19.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.953 . . . . 0.0 109.886 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 37.3 m -51.14 -37.5 46.53 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.184 -0.947 . . . . 0.0 109.562 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -74.94 -31.92 61.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.771 HG23 ' O ' ' C' ' 6' ' ' ASP . 58.5 t -72.46 -51.13 30.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -50.15 -47.3 54.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.87 -61.35 2.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.479 -0.763 . . . . 0.0 109.573 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.644 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.48 -40.21 68.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.278 -0.889 . . . . 0.0 109.039 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -17.1 64.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.309 -0.869 . . . . 0.0 108.959 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.36 -44.84 15.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -70.68 -40.68 72.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -1.153 . . . . 0.0 108.841 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.644 HG23 ' O ' ' C' ' 13' ' ' ALA . 61.7 t -60.28 -64.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 46.0 -127.27 9.15 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 23.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.465 -1.02 . . . . 0.0 110.544 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' C' ' 18' ' ' GLY . 85.9 m-70 -130.05 25.77 5.23 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -90.19 -63.88 1.21 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.74 -14.34 0.23 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.0 mm-40 -83.28 -56.42 3.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -1.044 . . . . 0.0 109.53 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.659 ' CD1' ' CE1' ' C' ' 112' ' ' HIS . 3.6 m-30 -62.11 -32.31 72.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.416 -0.802 . . . . 0.0 109.179 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.18 -23.46 77.23 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.93 -44.38 22.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.212 -1.169 . . . . 0.0 109.662 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.24 -26.08 67.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.31 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.37 -26.86 68.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.534 HD11 ' ND1' ' C' ' 58' ' ' HIS . 14.1 mt -72.44 -58.37 3.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.523 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -52.23 -38.82 59.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.57 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.607 ' HG3' ' OE1' ' D' ' 127' ' ' GLN . 0.9 OUTLIER -68.21 -50.67 52.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.224 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 32' ' ' MET . . . . . 0.482 ' C ' ' SD ' ' C' ' 32' ' ' MET . 15.2 tmm? -62.39 -29.07 70.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.953 . . . . 0.0 109.392 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -62.78 -58.69 6.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.953 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.4 pp -74.0 -39.57 63.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 110.144 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.528 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 50.5 m -46.81 -16.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.059 -1.026 . . . . 0.0 109.815 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' C' ' 35' ' ' SER . 15.2 m-85 -159.37 89.74 1.99 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.332 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.73 -20.18 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.519 2.146 . . . . 0.0 112.082 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 19.3 p -49.01 -18.96 0.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 30.2 p -84.12 -22.98 30.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.471 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -55.5 -46.97 76.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.576 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.592 HG21 ' O ' ' B' ' 94' ' ' ASP . 5.2 t -72.4 -18.92 61.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.36 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' C' ' 42' ' ' TYR . 37.3 t80 -75.93 -15.66 60.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 109.622 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' C' ' 41' ' ' THR . 21.2 m-85 55.67 87.08 0.15 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.66 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 46.0 Cg_exo -51.91 -38.85 69.27 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.425 2.083 . . . . 0.0 111.784 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.66 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 0.0 OUTLIER 94.28 34.62 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 178.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.48 ' CZ ' ' CB ' ' C' ' 44' ' ' PRO . 2.1 p90 -145.72 31.21 1.07 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.503 -1.373 . . . . 0.0 110.046 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' C' ' 47' ' ' ASP . 1.1 m-20 52.88 91.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.633 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.07 1.74 0.41 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 109.58 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.465 ' H ' ' C ' ' C' ' 47' ' ' ASP . 9.3 m -62.46 140.97 58.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.443 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 50' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' C' ' 50' ' ' HIS . 0.1 OUTLIER -63.64 140.32 58.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.938 . . . . 0.0 109.541 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.15 12.16 81.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 2.3 t -59.22 -20.68 56.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -1.205 . . . . 0.0 109.326 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 72.62 -24.29 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.629 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' C' ' 52' ' ' SER . 33.5 mt-30 -80.41 -24.17 39.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 16.8 t -75.96 -35.09 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.19 -34.61 42.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.871 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.23 -24.41 76.45 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.534 ' ND1' HD11 ' C' ' 29' ' ' LEU . 5.8 t-80 -68.19 -43.93 76.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -1.061 . . . . 0.0 109.277 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.77 -46.88 24.98 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' C' ' 64' ' ' ASP . 48.3 mttm -54.77 -23.12 16.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -1.027 . . . . 0.0 109.57 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.27 -36.91 58.21 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.178 -0.951 . . . . 0.0 108.9 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.467 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -73.77 -47.35 44.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.503 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -68.56 -29.09 67.56 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.428 -0.795 . . . . 0.0 109.416 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 64' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' C' ' 60' ' ' LYS . 25.8 m-20 -66.74 -47.23 72.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 108.697 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.456 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -62.08 -49.31 76.46 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.434 ' O ' HG23 ' C' ' 70' ' ' VAL . 1.3 mt -55.36 -46.11 76.46 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.514 ' O ' ' N ' ' C' ' 71' ' ' ALA . 27.4 m -65.03 -55.5 18.56 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -55.86 -29.37 59.8 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.72 -48.12 12.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 66' ' ' LEU . 54.9 t -65.14 -22.55 31.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -68.9 -16.5 63.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.58 ' O ' ' N ' ' C' ' 74' ' ' ASP . 62.7 m-70 -145.17 -56.82 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 0.0 109.217 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.5 p 44.85 13.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.744 0.783 . . . . 0.0 109.56 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' C' ' 72' ' ' HIS . 99.3 m-20 -123.63 8.35 8.89 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -175.84 28.73 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.178 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 5.2 ptt? -78.13 -24.55 0.45 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.765 . . . . 0.0 111.664 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.9 Cg_exo -54.8 -23.73 35.01 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.74 1.627 . . . . 0.0 112.197 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -93.26 -37.19 12.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.587 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.75 75.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.929 . . . . 0.0 109.203 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 mt -81.88 8.85 9.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 0.0 108.939 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 27.9 t -56.24 -40.95 74.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.882 . . . . 0.0 109.589 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -56.31 -57.33 12.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.536 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.457 ' N ' HD23 ' C' ' 83' ' ' LEU . 4.2 mt -46.25 -46.68 17.96 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 3.9 m -59.99 -29.56 68.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.564 -0.71 . . . . 0.0 109.285 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' C' ' 89' ' ' HIS . 75.9 m-20 -81.63 -38.88 25.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.324 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' C' ' 87' ' ' HIS . 4.1 tt -59.14 -36.11 74.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.375 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 87' ' ' HIS . . . . . 0.432 ' CE1' HD22 ' C' ' 86' ' ' LEU . 52.1 m80 -92.16 -23.04 19.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.684 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.52 -9.39 29.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.215 -0.928 . . . . 0.0 109.887 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' C' ' 85' ' ' ASP . 43.2 m80 -144.03 47.94 1.41 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.056 -1.027 . . . . 0.0 109.776 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.19 -69.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' C' ' 93' ' ' VAL . 11.6 mt -88.77 -23.8 22.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 109.51 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 51.67 10.06 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.466 ' H ' ' C ' ' C' ' 91' ' ' LEU . 14.9 p -52.69 144.52 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.1 151.71 86.13 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.313 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' C' ' 97' ' ' ASN . 47.7 Cg_endo -70.11 -21.0 32.45 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.546 2.164 . . . . 0.0 112.136 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.507 HG11 ' OD1' ' B' ' 99' ' ' ASP . 90.6 t -45.75 -15.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.769 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' C' ' 95' ' ' PRO . 3.3 m120 -79.21 -24.89 42.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.595 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 98' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' C' ' 98' ' ' PHE . 0.1 OUTLIER -68.99 -31.27 69.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 109.435 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -58.51 -29.9 66.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.6 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.471 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 17.7 mt -83.92 -62.14 1.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.584 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.528 HD22 ' HAB' ' C' ' 142' ' ' HEC . 7.1 tt -45.65 -24.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.616 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.7 t -65.33 -57.24 8.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.865 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -73.78 -26.43 60.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 109.998 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 9.6 m -70.41 -23.34 62.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 110.17 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.714 ' O ' HD12 ' C' ' 105' ' ' LEU . 0.1 OUTLIER -80.69 -22.7 40.15 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.943 -1.098 . . . . 0.0 108.936 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -85.12 -18.77 33.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.912 . . . . 0.0 109.702 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 107' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 74.1 t -77.51 -50.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.965 . . . . 0.0 109.742 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 43.5 p -52.46 -52.04 56.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.251 -0.906 . . . . 0.0 109.666 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' C' ' 114' ' ' PRO . 7.9 mt -43.61 -26.41 0.23 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.723 . . . . 0.0 109.756 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -71.9 -25.66 62.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 110.477 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.45 -3.88 54.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.053 -1.029 . . . . 0.0 110.835 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' HIS . . . . . 0.659 ' CE1' ' CD1' ' C' ' 24' ' ' TYR . 0.2 OUTLIER -150.11 -69.22 0.19 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.73 -1.231 . . . . 0.0 109.639 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.472 ' C ' ' O ' ' C' ' 109' ' ' LEU . 0.4 OUTLIER -118.22 81.27 16.59 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 114' ' ' PRO . . . . . 0.48 ' N ' ' O ' ' C' ' 109' ' ' LEU . 51.4 Cg_exo -49.24 -170.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.462 2.108 . . . . 0.0 112.567 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.738 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -48.7 -55.62 10.87 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.638 ' CG ' ' O ' ' C' ' 115' ' ' ALA . 2.8 mm-40 130.46 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 13.0 t80 66.37 30.38 8.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.717 -0.614 . . . . 0.0 111.08 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.7 ' O ' ' N ' ' C' ' 120' ' ' ALA . 2.1 p -103.83 128.04 28.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 108.287 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.59 23.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.217 1.945 . . . . 0.0 112.907 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.7 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -157.01 -32.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.746 -1.221 . . . . 0.0 110.675 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.738 HG21 ' O ' ' C' ' 115' ' ' ALA . 12.9 p -49.86 -47.31 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.035 . . . . 0.0 110.236 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.641 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.4 t60 -61.72 -38.5 88.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.85 . . . . 0.0 109.778 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.37 -20.19 34.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.995 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -62.29 1.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.576 HD22 HD21 ' C' ' 105' ' ' LEU . 1.4 mt -65.14 -19.87 66.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 109.411 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.12 -49.31 37.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.958 . . . . 0.0 109.66 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.18 -42.03 11.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 109.632 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.573 ' CD2' HG21 ' C' ' 10' ' ' VAL . 32.1 t80 -49.97 -22.88 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 109.364 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.665 HD12 ' C ' ' C' ' 129' ' ' LEU . 1.2 pp -76.43 -22.03 55.18 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.15 -38.11 75.97 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.571 ' OG ' HD21 ' C' ' 2' ' ' LEU . 33.8 m -67.88 -26.82 66.2 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 132' ' ' VAL . . . . . 0.449 ' O ' HD13 ' C' ' 136' ' ' LEU . 5.7 t -85.61 -37.61 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.358 -0.839 . . . . 0.0 108.879 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 14.9 t -79.97 -18.09 51.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.318 -0.864 . . . . 0.0 108.778 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 42.6 m -83.24 -42.46 17.18 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.452 -0.78 . . . . 0.0 109.238 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.461 HG13 ' O ' ' C' ' 131' ' ' SER . 27.4 m -70.13 -21.93 24.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.245 -0.909 . . . . 0.0 108.694 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.449 HD13 ' O ' ' C' ' 132' ' ' VAL . 0.9 OUTLIER -67.4 -31.91 72.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.448 -0.783 . . . . 0.0 108.941 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 7.2 m -153.19 57.1 0.77 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.296 -0.877 . . . . 0.0 109.47 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 25.5 t -63.52 -57.44 10.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.935 . . . . 0.0 109.518 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 51.58 -122.9 2.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.405 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -152.83 50.29 0.74 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.956 . . . . 0.0 109.367 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.493 179.943 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.527 ' O ' ' NZ ' ' D' ' 132' ' ' LYS . 7.6 p . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 52.31 47.95 23.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 108.964 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 1.05 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -107.64 -159.17 0.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.506 -0.747 . . . . 0.0 109.35 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.401 ' O ' ' N ' ' D' ' 6' ' ' GLU . 9.9 p -103.56 134.36 19.79 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.435 -0.791 . . . . 0.0 109.34 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -42.08 -22.73 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.397 2.065 . . . . 0.0 112.495 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' D' ' 4' ' ' THR . 79.3 mt-10 -76.71 -55.63 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 110.043 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -68.14 -60.39 2.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.033 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.786 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -48.68 -30.16 5.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.846 . . . . 0.0 110.198 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 9' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 2.8 m -62.08 -23.63 66.62 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.041 -1.037 . . . . 0.0 110.083 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.97 -57.59 3.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.014 -1.054 . . . . 0.0 110.035 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.6 -25.02 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 56.9 m -83.48 -37.26 23.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' D' ' 9' ' ' SER . . . -63.22 -29.93 71.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.346 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.7 OUTLIER -52.08 -32.54 35.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.092 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 15' ' ' TRP . . . . . 0.533 ' HE1' ' HG ' ' D' ' 72' ' ' SER . 0.2 OUTLIER -47.14 -17.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 16' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.31 -52.01 5.83 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.421 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.1 OUTLIER -70.47 -29.32 65.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.202 -1.175 . . . . 0.0 109.322 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -48.84 114.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.55 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' D' ' 22' ' ' GLU . 18.4 m120 -82.67 69.49 9.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 108.941 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' D' ' 22' ' ' GLU . 78.7 t -43.81 -29.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 109.713 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -64.63 1.87 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.617 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' D' ' 20' ' ' VAL . 33.0 mt-10 -155.88 -46.18 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.393 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -48.54 -53.93 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.4 -48.51 48.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.4 -46.36 78.59 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -62.36 -40.07 95.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -1.153 . . . . 0.0 109.314 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -37.79 88.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.364 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -82.1 -51.35 8.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.275 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.91 -35.09 62.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -79.4 -30.58 42.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -1.14 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 60.1 tp -49.52 -38.95 32.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 109.368 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.57 -23.42 56.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.595 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.7 -61.62 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.21 -0.931 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.32 -23.81 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.77 76.06 48.09 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 109.258 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.64 11.42 2.72 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.769 2.312 . . . . 0.0 112.358 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' TRP . . . . . 0.477 ' CE2' HG23 ' D' ' 38' ' ' THR . 50.7 p-90 -80.54 -19.75 45.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.36 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.809 ' HB ' HBC1 ' D' ' 147' ' ' HEC . 42.1 p -79.71 40.07 0.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -92.07 12.86 20.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -87.88 -34.44 18.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.591 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' D' ' 42' ' ' PHE . 29.4 m-85 -95.81 32.37 1.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 0.0 109.546 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.505 ' CZ ' HBC3 ' D' ' 147' ' ' HEC . 56.5 m-85 -141.38 26.36 1.98 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 109.454 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -80.94 -25.07 37.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 44' ' ' SER . . . . . 0.472 ' C ' ' H ' ' D' ' 46' ' ' GLY . 67.1 m -82.15 -38.31 24.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.922 . . . . 0.0 109.483 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -55.93 -5.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' D' ' 44' ' ' SER . . . 48.53 -167.77 0.15 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' D' ' 48' ' ' LEU . 18.9 t70 60.26 -150.21 0.42 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -1.154 . . . . 0.0 109.559 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 48' ' ' LEU . . . . . 0.455 ' H ' ' CG ' ' D' ' 47' ' ' ASP . 23.5 mt 60.46 34.39 20.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.562 -0.711 . . . . 0.0 109.656 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.2 m -80.47 -22.54 40.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' THR . . . . . 0.495 ' O ' ' N ' ' D' ' 53' ' ' ALA . 21.1 p -146.05 149.07 37.58 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 109.157 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -36.85 -45.06 1.19 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.593 2.195 . . . . 0.0 112.595 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.73 -27.04 61.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 109.6 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -57.81 -19.59 29.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.589 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.99 -63.45 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 109.63 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' D' ' 55' ' ' MET . 2.3 mpp? -79.71 14.86 1.53 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.436 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.98 -49.06 4.41 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' ASN . . . . . 0.456 HD21 ' HE2' ' D' ' 59' ' ' LYS . 3.8 m-20 -77.78 149.63 77.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.276 -1.132 . . . . 0.0 109.47 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.33 -52.03 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.642 2.228 . . . . 0.0 112.148 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' LYS . . . . . 0.456 ' HE2' HD21 ' D' ' 57' ' ' ASN . 54.2 pttt -46.88 -40.71 14.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.336 -0.853 . . . . 0.0 109.58 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 86.6 t -54.22 -44.83 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.397 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 61' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' D' ' 61' ' ' LYS . 7.0 mtmp? -77.4 -43.06 33.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.11 -33.15 17.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.568 ' CE1' ' CHA' ' D' ' 147' ' ' HEC . 5.8 t60 -67.55 -24.49 65.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.584 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.57 -30.31 74.79 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -68.16 -41.21 81.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.33 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -64.08 -50.95 66.34 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.338 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.799 HG22 ' C4A' ' D' ' 147' ' ' HEC . 25.4 t -61.74 -23.84 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.201 -0.937 . . . . 0.0 109.331 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -78.17 -29.78 48.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.32 -57.09 14.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.48 -22.03 63.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -1.135 . . . . 0.0 109.517 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -74.53 -30.23 61.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.607 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' SER . . . . . 0.533 ' HG ' ' HE1' ' D' ' 15' ' ' TRP . 4.5 m -89.21 -20.49 24.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.688 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -46.15 -30.73 2.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.692 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.41 -59.17 6.99 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.538 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -56.74 -17.82 10.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -1.153 . . . . 0.0 109.628 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 76' ' ' ALA . . . . . 0.558 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -97.36 33.04 2.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 109.993 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 2.3 m80 -176.81 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.143 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 78' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' D' ' 77' ' ' HIS . 29.9 mt 39.61 35.38 0.19 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.644 -0.66 . . . . 0.0 109.621 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -138.73 -31.4 0.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.788 . . . . 0.0 109.631 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 80' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' D' ' 80' ' ' ASN . 7.4 p-10 -151.95 72.85 1.03 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.296 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 81' ' ' LEU . . . . . 0.57 HD12 ' N ' ' D' ' 81' ' ' LEU . 9.5 mp -60.36 -27.15 67.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -80.6 -61.5 1.95 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.776 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.33 -23.79 42.75 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.426 HG23 ' O ' ' D' ' 80' ' ' ASN . 0.8 OUTLIER -62.34 -51.91 65.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 109.554 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.537 ' CZ ' ' O ' ' D' ' 81' ' ' LEU . 2.2 p90 -133.2 51.83 2.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 109.651 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.01 -29.31 4.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.322 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 87' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' D' ' 88' ' ' LEU . 17.8 p -60.59 -58.55 8.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.325 -0.859 . . . . 0.0 109.319 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.415 ' N ' ' OG1' ' D' ' 87' ' ' THR . 90.8 mt -48.47 -37.47 17.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.008 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -69.05 -34.95 76.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.034 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -82.87 -39.07 22.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -0.825 . . . . 0.0 109.4 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.05 -25.3 64.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.401 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' D' ' 97' ' ' HIS . 7.0 m80 -91.0 -21.74 21.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.625 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.56 -59.01 2.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 111.162 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.667 ' O ' HG21 ' A' ' 41' ' ' THR . 1.3 m-20 -87.28 -57.0 3.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.014 -1.054 . . . . 0.0 111.934 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 95' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' D' ' 95' ' ' LYS . 12.0 mptt -62.66 -52.25 64.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.131 -0.98 . . . . 0.0 111.263 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.606 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -95.41 -38.19 10.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.892 -1.13 . . . . 0.0 109.764 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.606 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 25.4 p80 45.36 33.26 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 98' ' ' VAL . . . . . 0.59 HG23 HD12 ' D' ' 96' ' ' LEU . 52.5 t -50.12 132.37 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.041 -1.037 . . . . 0.0 109.14 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 99' ' ' ASP . . . . . 0.546 ' OD1' HG11 ' A' ' 96' ' ' VAL . 4.2 m-20 -51.19 151.2 5.12 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.293 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.98 -170.32 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.464 2.109 . . . . 0.0 112.026 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' B' ' 101' ' ' GLU . 69.2 mm-40 53.14 70.04 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 102' ' ' ASN . . . . . 0.472 ' ND2' ' CD1' ' D' ' 103' ' ' PHE . 4.0 p-10 -171.23 -39.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -0.897 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' ND2' ' D' ' 102' ' ' ASN . 12.8 m-85 -50.25 -34.55 23.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -76.12 -43.99 40.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.559 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 105' ' ' LEU . . . . . 0.52 ' N ' HD12 ' D' ' 105' ' ' LEU . 9.9 mp -49.35 -51.85 31.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.441 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 1.036 HD13 ' CHC' ' D' ' 147' ' ' HEC . 6.5 tt -51.66 -37.21 49.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.137 -0.977 . . . . 0.0 109.303 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.93 -20.62 59.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -65.25 -34.36 78.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -1.179 . . . . 0.0 109.616 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.82 -31.71 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 7.6 tp -51.64 -52.12 50.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.559 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 111' ' ' VAL . . . . . 0.553 ' CG2' ' CE1' ' D' ' 130' ' ' TYR . 42.9 t -51.15 -42.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.577 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -60.18 -39.52 86.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.594 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.53 -55.0 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 109.681 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.96 -31.81 71.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -64.87 -27.83 69.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.469 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.48 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.79 -61.25 1.83 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 109.25 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 117' ' ' HIS . . . . . 0.417 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 8.3 m-70 -63.24 -18.42 63.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.525 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 58.9 m-85 -148.41 59.53 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 109.386 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -72.03 -14.74 76.24 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -79.45 -20.34 47.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.455 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.482 ' C ' ' H ' ' D' ' 123' ' ' THR . 29.2 mm-40 -95.4 -2.5 48.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.768 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.91 34.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.536 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.482 ' H ' ' C ' ' D' ' 121' ' ' GLU . 21.7 p -49.25 148.37 4.5 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.391 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.451 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 2.3 Cg_endo -46.71 -57.56 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.463 2.109 . . . . 0.0 113.03 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 17.7 Cg_endo -59.51 -42.38 48.48 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.12 1.88 . . . . 0.0 112.236 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 98.7 t -64.93 -20.95 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.917 . . . . 0.0 109.547 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 127' ' ' GLN . . . . . 0.607 ' OE1' ' HG3' ' C' ' 31' ' ' ARG . 17.7 tt0 -83.28 -48.91 9.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.576 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.658 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -58.72 -30.0 67.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.432 ' O ' HG23 ' D' ' 133' ' ' VAL . . . -82.14 19.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.653 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.553 ' CE1' ' CG2' ' D' ' 111' ' ' VAL . 47.1 t80 -107.92 -61.31 1.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.3 -0.875 . . . . 0.0 109.68 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 5.9 tp-100 -55.29 -23.25 22.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 132' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' D' ' 1' ' ' VAL . 22.7 ttpp -83.06 -21.83 33.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.933 . . . . 0.0 109.653 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 133' ' ' VAL . . . . . 0.432 HG23 ' O ' ' D' ' 129' ' ' ALA . 77.6 t -81.09 -68.27 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.945 . . . . 0.0 109.721 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 22.3 m -53.83 -25.06 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.28 -0.888 . . . . 0.0 109.869 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -49.56 -29.79 7.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -0.949 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.33 -29.31 56.38 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.4 -38.15 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 0.0 109.432 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.88 79.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 1.123 ' OD1' ' ND1' ' B' ' 146' ' ' HIS . 19.1 m-20 -79.68 -22.99 42.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.952 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.72 -60.64 2.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.628 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.83 -25.21 66.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.266 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 -16.41 27.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 109.422 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -51.23 -33.47 28.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 18.8 mmtm -73.32 -27.17 61.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 145' ' ' TYR . . . . . 0.412 ' OH ' ' O ' ' D' ' 92' ' ' HIS . 16.2 m-85 -71.85 -46.28 58.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.455 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 1.117 ' ND1' ' OD1' ' B' ' 139' ' ' ASN . 29.3 p80 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.483 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.866 HMB1 HBB3 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 1.043 ' CHC' HD13 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.91 HMB1 HBB3 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 1.036 ' CHC' HD13 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 1' ' ' VAL . 9.9 mt 54.48 170.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 0.0 109.638 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.488 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 176.32 -53.64 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.0 . . . . 0.0 110.317 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 6' ' ' ASP . 59.0 Cg_endo -73.97 -165.22 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.397 2.064 . . . . 0.0 112.777 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 8' ' ' THR . . . -43.93 -15.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.434 -0.792 . . . . 0.0 110.114 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' PRO . 53.5 m-20 -38.72 -37.22 0.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.806 . . . . 0.0 109.76 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -30.77 26.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.881 . . . . 0.0 109.685 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 5' ' ' ALA . 40.9 m -52.02 -37.48 53.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.173 -0.954 . . . . 0.0 109.213 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -73.87 -33.36 64.03 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.76 -52.29 26.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.94 -45.59 51.36 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.09 -61.76 2.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.579 -0.701 . . . . 0.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -55.65 -33.35 63.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.3 -0.875 . . . . 0.0 109.242 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.55 -17.38 60.09 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.31 -0.869 . . . . 0.0 109.062 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.06 -43.32 14.0 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -70.36 -39.96 74.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 108.828 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 13' ' ' ALA . 89.5 t -60.03 -65.4 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 57.29 -135.75 51.33 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 28.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.998 . . . . 0.0 110.48 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.556 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.9 m-70 -131.93 24.36 4.62 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.24 -62.76 1.42 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.624 -0.672 . . . . 0.0 109.727 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.41 -14.5 0.19 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' ALA . 1.3 mm-40 -84.15 -56.16 3.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -1.061 . . . . 0.0 109.433 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.641 ' CD1' ' CD2' ' A' ' 112' ' ' HIS . 3.1 m-30 -59.95 -37.09 78.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.374 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.73 -24.24 69.6 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.35 -45.05 20.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.629 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.01 -21.21 61.02 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.399 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.31 -21.53 62.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.693 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.617 HD11 ' ND1' ' A' ' 58' ' ' HIS . 12.5 mt -78.04 -51.54 10.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.505 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.34 -12.67 61.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.837 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.565 ' NH2' ' SG ' ' A' ' 104' ' ' CYS . 0.9 OUTLIER -76.48 -40.37 50.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 110.276 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.0 ptt? -84.16 -35.56 23.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 109.963 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -45.99 -41.72 12.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 109.665 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.885 ' CD1' ' HB2' ' B' ' 128' ' ' ALA . 2.2 pp -84.63 -35.89 22.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.067 -1.021 . . . . 0.0 109.82 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.4 p -85.33 1.45 48.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.538 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' MET . 67.0 m-85 -159.17 68.13 3.2 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 39' ' ' THR . 72.1 Cg_exo -47.75 -34.34 21.14 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.821 2.347 . . . . 0.0 112.279 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 1.318 HG22 ' ND1' ' D' ' 97' ' ' HIS . 2.2 p -47.05 -18.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.927 . . . . 0.0 109.591 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' PRO . 81.4 p -84.5 -31.33 24.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 0.0 109.709 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -68.6 -26.44 65.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 109.685 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.909 HG21 ' CD2' ' D' ' 97' ' ' HIS . 5.3 t -90.94 -17.94 25.55 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.259 -0.9 . . . . 0.0 109.87 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.6 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 2.0 t80 -60.99 -65.71 0.65 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.095 -1.003 . . . . 0.0 109.09 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 42' ' ' TYR . 0.6 OUTLIER 166.06 78.87 0.01 OUTLIER Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.443 -0.785 . . . . 0.0 109.578 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.582 ' O ' ' CD2' ' A' ' 46' ' ' PHE . 75.8 Cg_endo -83.53 -42.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.626 2.217 . . . . 0.0 111.573 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 26.6 p80 44.5 31.93 0.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.579 -0.701 . . . . 0.0 110.903 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 2.8 p90 -135.86 26.85 3.31 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.001 -1.062 . . . . 0.0 109.687 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 49' ' ' SER . 55.2 m-20 44.44 83.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.485 -0.759 . . . . 0.0 109.529 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.565 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -52.01 -8.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 109.5 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 47' ' ' ASP . 35.0 p -68.36 169.45 10.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 0.0 109.469 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -78.96 164.3 24.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.863 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.04 17.31 71.66 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.632 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 3.0 t -77.52 -28.62 52.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -1.156 . . . . 0.0 109.487 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 73.28 -31.66 0.23 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.602 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 52' ' ' SER . 38.0 mt-30 -80.51 -22.56 40.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -83.46 -35.93 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -81.42 -32.93 32.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.198 -0.939 . . . . 0.0 108.615 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.66 -21.96 78.85 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.617 ' ND1' HD11 ' A' ' 29' ' ' LEU . 10.1 t-80 -70.51 -29.97 66.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -1.055 . . . . 0.0 109.24 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.76 -51.45 57.95 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -48.36 -23.82 1.04 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -1.136 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.602 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 10.4 mmpt? -71.39 -51.12 25.8 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.179 -0.951 . . . . 0.0 108.608 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.7 t -60.85 -47.7 92.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.76 89.42 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.348 -0.845 . . . . 0.0 108.923 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -60.06 -39.07 84.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -65.01 -52.33 56.69 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.5 mt -57.59 -43.91 84.97 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 71' ' ' ALA . 19.0 m -69.34 -51.25 38.81 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -61.64 -26.14 67.81 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.17 -46.59 10.94 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.8 t -65.2 -22.67 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -64.09 -21.62 66.6 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' ' 74' ' ' ASP . 95.4 m-70 -146.44 -51.94 0.23 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.4 p 44.74 13.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.687 0.756 . . . . 0.0 109.407 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 72' ' ' HIS . 29.2 m-20 -127.04 9.5 6.83 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.411 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 49.8 t0 -173.68 27.3 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.046 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.689 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 4.8 ptt? -78.33 -24.2 0.43 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.44 -0.788 . . . . 0.0 111.668 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.8 Cg_exo -53.02 -27.73 37.26 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.634 1.556 . . . . 0.0 112.506 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -94.3 -24.79 17.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.74 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.79 -46.38 21.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.0 109.223 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.427 ' CD1' HG13 ' A' ' 132' ' ' VAL . 9.7 mt -82.05 9.3 8.7 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 108.981 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.5 m -65.69 -22.41 66.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 109.512 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -82.01 -59.64 2.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.135 -0.978 . . . . 0.0 109.694 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -50.8 -26.2 5.39 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 73.2 m -67.5 -33.4 75.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' ALA . 4.3 t70 -78.26 -30.07 48.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 108.806 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.099 HD11 ' CBD' ' A' ' 142' ' ' HEC . 2.1 tm? -54.31 -49.55 69.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.509 -0.744 . . . . 0.0 109.388 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.466 ' N ' HD13 ' A' ' 86' ' ' LEU . 8.2 p-80 -92.24 -21.78 20.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.008 . . . . 0.0 110.375 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -92.93 -2.62 55.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.042 -1.036 . . . . 0.0 110.293 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -128.56 -77.06 0.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.194 -0.941 . . . . 0.0 109.771 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -46.66 -78.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.761 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.2 mp -71.06 -39.05 72.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.106 -0.996 . . . . 0.0 109.647 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 61.84 59.28 1.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 109.42 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 94' ' ' ASP . 90.3 t -85.21 166.59 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 109.614 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.624 ' N ' HG12 ' A' ' 93' ' ' VAL . 3.8 m-20 -99.33 120.05 58.92 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.381 -0.824 . . . . 0.0 109.217 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' PHE . 83.3 Cg_exo -44.11 -10.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.225 1.95 . . . . 0.0 112.432 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 94' ' ' ASP . 96.1 t -45.55 -23.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 95' ' ' PRO . 73.3 m-20 -79.3 -24.84 42.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 109.57 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' OG ' ' A' ' 102' ' ' SER . 20.4 t80 -46.53 -35.05 5.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -64.61 -33.27 75.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.485 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.0 mt -84.06 -43.75 14.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.523 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.996 HD12 HMC3 ' A' ' 142' ' ' HEC . 4.8 tt -54.38 -52.04 62.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.537 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 98' ' ' PHE . 15.7 m -59.63 -33.52 71.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 103' ' ' HIS . 0.7 OUTLIER -80.65 -26.65 37.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.095 -1.003 . . . . 0.0 110.096 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.565 ' SG ' ' NH2' ' A' ' 31' ' ' ARG . 72.0 m -63.95 -58.36 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.246 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.43 -34.51 4.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.935 . . . . 0.0 110.093 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.8 mt -70.75 -28.2 64.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 110.176 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -83.04 -38.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.979 -1.076 . . . . 0.0 109.582 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 110' ' ' ALA . 19.1 p -70.58 -58.9 3.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.2 -0.938 . . . . 0.0 109.649 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 113' ' ' LEU . 9.5 mt -43.12 -26.28 0.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.765 . . . . 0.0 109.587 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -67.36 -22.64 65.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 110.589 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.37 -48.02 12.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.025 . . . . 0.0 111.006 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.641 ' CD2' ' CD1' ' A' ' 24' ' ' TYR . 1.1 p-80 -100.76 -58.87 1.8 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.025 -1.047 . . . . 0.0 111.037 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.538 ' C ' HD13 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -112.44 93.35 22.53 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 109.284 -178.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 113' ' ' LEU . 76.7 Cg_exo -47.0 -174.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.364 2.042 . . . . 0.0 112.685 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.795 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -61.56 -55.35 31.77 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.648 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 27.8 mt-10 119.92 1.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.506 ' O ' ' CD2' ' A' ' 117' ' ' PHE . 38.3 t80 59.62 31.63 21.04 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.298 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.794 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.3 p -104.4 120.8 49.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.985 -1.072 . . . . 0.0 108.14 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.1 23.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.09 1.86 . . . . 0.0 112.72 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.794 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -154.43 -29.96 0.11 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.853 -1.155 . . . . 0.0 110.676 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.795 HG21 ' O ' ' A' ' 115' ' ' ALA . 13.7 p -51.16 -50.16 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.996 -1.065 . . . . 0.0 110.274 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.667 ' N ' HG13 ' A' ' 121' ' ' VAL . 3.1 t-160 -61.31 -53.41 57.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.868 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' B' ' 34' ' ' VAL . . . -72.72 -19.83 61.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 120' ' ' ALA . 20.5 m -63.72 -62.51 1.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.164 -0.96 . . . . 0.0 110.277 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 1.2 mt -64.4 -16.85 63.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.352 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.07 -49.18 9.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 110.902 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.62 -59.03 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.818 -1.176 . . . . 0.0 111.264 -178.385 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.48 ' N ' ' HD2' ' A' ' 127' ' ' LYS . 21.4 m-85 -47.98 -21.23 0.41 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.717 -1.239 . . . . 0.0 109.752 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.918 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -72.1 -31.03 65.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 134' ' ' THR . . . -49.2 -33.18 11.9 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.467 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 43.2 t -60.36 -37.02 79.39 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 80' ' ' LEU . 6.3 t -77.06 -48.72 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.406 ' CB ' ' CE1' ' A' ' 98' ' ' PHE . 13.5 t -66.48 -22.72 66.19 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.278 -0.889 . . . . 0.0 108.635 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 130' ' ' ALA . 11.2 m -64.06 -31.75 73.06 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.411 -0.806 . . . . 0.0 108.827 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.62 -37.26 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 109.14 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 83' ' ' LEU . 5.6 mp -60.59 -35.29 75.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.299 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 134' ' ' THR . 34.9 p -67.9 -33.75 75.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 t 46.69 89.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 1.224 ' NZ ' ' NZ ' ' C' ' 139' ' ' LYS . 42.0 mtpt -65.55 -123.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 109.471 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -55.13 89.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.483 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 139' ' ' LYS . 75.9 mtt-85 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.479 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.463 HG22 ' H ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 45.0 52.75 8.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 109.813 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.717 HD13 ' HB3' ' B' ' 8' ' ' LYS . 1.9 mt -87.8 161.05 17.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.561 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.19 138.18 19.47 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.371 -0.83 . . . . 0.0 108.826 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -40.02 -54.19 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.524 2.149 . . . . 0.0 112.637 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -72.01 -21.84 61.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 110.02 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -76.62 -63.12 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 109.902 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.717 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -66.58 -29.59 69.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.068 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.6 t -47.5 -23.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 110.101 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.66 -56.85 3.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 109.992 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.428 ' H ' HG12 ' B' ' 11' ' ' VAL . 0.8 OUTLIER -68.13 -24.64 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.9 m -73.52 -40.28 64.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.746 -0.596 . . . . 0.0 109.607 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.42 -31.23 71.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.409 -0.807 . . . . 0.0 109.447 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.8 OUTLIER -50.7 -31.47 16.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 0.0 109.155 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -47.57 -17.82 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.382 -0.824 . . . . 0.0 109.537 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.97 -51.1 5.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.45 ' H ' ' HG2' ' B' ' 17' ' ' LYS . 0.1 OUTLIER -71.23 -29.56 65.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.169 -1.194 . . . . 0.0 109.33 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -49.42 114.79 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.925 . . . . 0.0 109.581 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' B' ' 22' ' ' GLU . 95.3 m-20 -78.39 67.65 4.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.01 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' B' ' 22' ' ' GLU . 68.8 t -44.32 -29.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.831 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.14 7.43 0.57 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' B' ' 20' ' ' VAL . 38.5 mt-10 -155.23 -49.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -48.59 -60.72 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.89 -39.22 17.69 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.09 -43.73 89.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.419 ' O ' ' CG ' ' B' ' 30' ' ' ARG . 57.0 mt-10 -79.47 -40.39 29.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.291 -1.123 . . . . 0.0 109.546 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 -34.32 8.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -82.6 -56.67 3.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.73 -44.83 80.35 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.571 HH21 HG11 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -53.89 -36.48 62.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -1.123 . . . . 0.0 109.26 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -55.95 -47.63 77.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 0.0 109.412 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.02 -22.73 67.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.571 HG11 HH21 ' B' ' 30' ' ' ARG . 74.8 t -81.65 -64.72 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 109.358 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 123' ' ' ALA . 2.2 t -67.64 -22.79 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.465 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.428 ' CG ' HD21 ' B' ' 105' ' ' LEU . 83.5 m-85 -139.46 80.97 21.13 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.428 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.86 -16.04 9.09 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.668 2.245 . . . . 0.0 112.515 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -51.02 -19.91 1.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.075 -1.016 . . . . 0.0 109.416 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.466 ' HB ' HBC1 ' B' ' 147' ' ' HEC . 3.6 p -85.54 55.51 3.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.215 -0.928 . . . . 0.0 109.147 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -109.77 41.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.435 -0.791 . . . . 0.0 109.255 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 mmt-85 -104.03 -49.29 3.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.0 109.479 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' B' ' 41' ' ' PHE . 27.7 m-85 -91.86 30.04 1.46 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.585 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' B' ' 44' ' ' SER . 9.4 p90 -92.55 -12.97 30.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -46.07 -13.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.909 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.544 ' N ' ' O ' ' B' ' 42' ' ' PHE . 23.8 p -124.3 23.49 8.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.245 -0.909 . . . . 0.0 109.583 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.34 -14.2 21.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 0.0 109.322 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.54 -116.76 2.21 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -144.26 105.23 4.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -1.11 . . . . 0.0 109.557 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.94 30.57 1.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.14 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.5 p -44.0 -32.37 1.13 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.817 . . . . 0.0 109.859 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 17.8 p -146.61 148.31 33.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -40.16 -50.2 3.57 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.517 2.145 . . . . 0.0 112.177 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.21 -35.09 76.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' B' ' 50' ' ' THR . . . -53.83 -19.77 4.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.507 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.18 -63.95 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 12.2 mmt -63.05 -7.58 5.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.38 -10.24 64.06 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -78.37 141.98 62.22 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.173 -1.192 . . . . 0.0 109.378 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -74.3 -57.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.59 2.193 . . . . 0.0 112.214 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' B' ' 63' ' ' HIS . 45.6 mtpt -51.98 -48.49 64.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.556 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' B' ' 59' ' ' LYS . 74.3 t -45.8 -39.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.0 109.289 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -79.35 -52.4 8.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.85 . . . . 0.0 109.321 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.36 -59.18 3.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.805 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.538 ' N ' ' O ' ' B' ' 59' ' ' LYS . 1.7 t60 -48.29 -24.85 1.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.41 -36.73 91.99 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -69.29 -25.14 64.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -1.125 . . . . 0.0 109.479 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -73.13 -35.35 66.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.559 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 0.582 HG13 ' C1B' ' B' ' 147' ' ' HEC . 39.6 t -75.75 -28.3 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.21 -34.94 68.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.302 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.51 -45.12 37.44 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.83 91.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -1.209 . . . . 0.0 109.65 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.421 ' CE2' HD21 ' B' ' 110' ' ' LEU . 25.5 t80 -57.29 -41.07 79.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 109.579 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.7 t -76.63 -37.75 55.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.653 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -47.5 -37.57 12.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.535 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -60.4 7.6 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.569 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -55.82 -30.04 60.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.248 -1.148 . . . . 0.0 109.401 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.09 5.4 29.82 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.201 -0.937 . . . . 0.0 109.65 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.522 ' NE2' ' OD1' ' B' ' 80' ' ' ASN . 7.5 t60 -170.93 67.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 109.525 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.93 17.96 1.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -79.63 -29.23 40.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.452 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.522 ' OD1' ' NE2' ' B' ' 77' ' ' HIS . 4.3 p-10 -163.21 95.82 0.86 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.235 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.493 HD12 ' H ' ' B' ' 81' ' ' LEU . 5.0 mp -80.28 -58.91 2.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.204 -0.935 . . . . 0.0 109.64 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -57.46 -23.83 52.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.075 -1.016 . . . . 0.0 109.568 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.06 -54.41 3.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.0 t -61.38 -47.58 85.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -1.157 . . . . 0.0 109.614 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.557 ' N ' ' CG2' ' B' ' 84' ' ' THR . 54.4 m-85 -76.7 22.04 0.19 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.351 -0.843 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.46 -26.8 44.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 75.3 p -78.85 -59.1 2.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.754 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.4 mt -48.63 -45.05 37.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.955 . . . . 0.0 109.288 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 53.9 p -64.72 -52.71 55.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.267 -0.896 . . . . 0.0 109.269 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -61.27 -22.7 65.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 tp -86.9 -68.71 0.73 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.417 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.509 ' O ' ' N ' ' B' ' 97' ' ' HIS . 48.8 m80 -51.01 -26.54 6.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.094 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' CYS . . . . . 0.407 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 27.5 t -83.73 -55.93 3.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 111.303 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.529 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 27.4 t0 -86.24 -32.2 21.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.001 -1.062 . . . . 0.0 111.945 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -89.36 -51.76 5.39 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.689 -1.257 . . . . 0.0 111.132 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.63 -27.03 15.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.852 -1.155 . . . . 0.0 110.43 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 1.24 ' ND1' HG22 ' C' ' 38' ' ' THR . 83.0 m-70 51.67 29.57 5.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.038 -1.039 . . . . 0.0 109.61 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.401 ' O ' ' OH ' ' B' ' 145' ' ' TYR . 40.0 t -47.14 130.2 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.968 . . . . 0.0 109.503 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.38 152.46 32.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.28 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.88 -164.09 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.553 2.169 . . . . 0.0 112.165 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.26 60.72 2.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.877 . . . . 0.0 109.578 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' B' ' 105' ' ' LEU . 33.2 t-20 -171.3 -41.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -46.21 -40.55 11.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 109.714 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -80.07 -19.92 46.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.554 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' B' ' 102' ' ' ASN . 12.3 tp -70.47 -59.77 2.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 109.639 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.833 HD13 ' CHC' ' B' ' 147' ' ' HEC . 7.0 tt -49.84 -46.22 51.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 109.354 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.06 -20.44 58.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -80.53 -25.2 38.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -1.105 . . . . 0.0 109.577 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 74.2 t -86.19 -43.09 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 109.683 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.421 HD21 ' CE2' ' B' ' 71' ' ' PHE . 6.3 tt -48.26 -33.05 8.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.464 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -83.05 -26.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.532 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.4 m -69.1 -24.79 64.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.538 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 42.4 t -76.34 -34.89 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' B' ' 118' ' ' PHE . 9.5 mt -69.83 -40.16 76.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 109.413 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -54.4 -28.92 46.93 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 109.438 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.525 ' HD1' ' C ' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.74 -62.41 1.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.106 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -63.36 -17.75 62.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.551 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' B' ' 114' ' ' LEU . 93.3 m-85 -149.72 60.4 1.0 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 109.402 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.535 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -69.22 -24.72 75.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -64.75 -29.67 70.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -1.153 . . . . 0.0 109.346 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.489 ' C ' ' H ' ' B' ' 123' ' ' THR . 78.3 mm-40 -87.81 5.71 38.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 109.736 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.543 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.64 33.09 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 109.422 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.489 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.4 p -52.41 149.13 10.88 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.353 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.516 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.1 Cg_exo -45.41 -53.66 5.23 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.452 2.101 . . . . 0.0 112.988 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 24.6 Cg_endo -62.16 -29.65 81.04 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.05 1.834 . . . . 0.0 112.223 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.441 HG23 ' OG1' ' B' ' 123' ' ' THR . 45.7 t -68.81 -28.15 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 109.423 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -83.15 -53.89 5.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.885 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -63.25 -26.49 68.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.576 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.51 -2.33 53.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.114 -0.991 . . . . 0.0 109.807 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' B' ' 132' ' ' LYS . 41.8 t80 -92.49 -61.52 1.58 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.717 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 1.5 tm0? -45.25 -23.32 0.17 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 109.931 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' B' ' 130' ' ' TYR . 51.1 mtmt -85.46 -34.6 21.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.217 -0.927 . . . . 0.0 110.322 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 0.6 OUTLIER -68.61 -44.15 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.075 . . . . 0.0 109.676 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.501 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 6.1 m -79.64 -20.91 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -50.51 -32.41 18.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -0.974 . . . . 0.0 109.364 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.63 -26.56 56.36 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.42 -32.96 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -1.148 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.44 90.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.67 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.89 -21.05 47.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.766 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.01 -58.86 6.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.663 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 48.4 mt -61.48 -31.88 71.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 109.497 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.06 25.15 4.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.251 -0.905 . . . . 0.0 109.599 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -80.0 -16.13 55.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.712 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 13.2 mptt -98.34 -26.72 14.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 0.0 109.613 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' B' ' 98' ' ' VAL . 12.3 m-85 -54.38 -6.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.11 -0.994 . . . . 0.0 109.425 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' B' ' 144' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.428 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' C' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' C' ' 1' ' ' VAL . 9.9 mt 54.47 170.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.353 -0.842 . . . . 0.0 109.621 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.49 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 176.31 -53.58 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.322 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' C' ' 6' ' ' ASP . 59.0 Cg_endo -74.05 -165.15 0.24 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.373 2.048 . . . . 0.0 112.776 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' C' ' 8' ' ' THR . . . -44.0 -15.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.497 -0.752 . . . . 0.0 110.129 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' C' ' 4' ' ' PRO . 53.1 m-20 -38.82 -37.11 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 109.779 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' C' ' 8' ' ' THR . 0.0 OUTLIER -83.8 -30.94 26.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.666 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.518 ' N ' ' O ' ' C' ' 5' ' ' ALA . 41.7 m -51.87 -37.52 52.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.068 -1.02 . . . . 0.0 109.283 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -73.87 -33.39 64.05 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -71.69 -52.38 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.87 -45.61 50.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.02 -61.9 2.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.629 -0.669 . . . . 0.0 109.883 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.661 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -55.57 -33.37 63.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.295 -0.878 . . . . 0.0 109.246 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -17.38 60.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.285 -0.884 . . . . 0.0 109.029 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.0 -43.24 14.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -70.41 -39.83 74.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -1.199 . . . . 0.0 108.856 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.661 HG23 ' O ' ' C' ' 13' ' ' ALA . 88.3 t -60.2 -65.39 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 57.27 -135.74 51.33 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 28.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.439 -1.036 . . . . 0.0 110.453 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.7 m-70 -131.92 24.27 4.62 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.19 -62.9 1.39 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.603 -0.686 . . . . 0.0 109.651 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.2 -14.7 0.17 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 21' ' ' ALA . 1.3 mm-40 -84.11 -56.11 3.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.461 -1.023 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.638 ' CD1' ' CD2' ' C' ' 112' ' ' HIS . 3.1 m-30 -60.05 -36.96 78.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.387 -0.821 . . . . 0.0 109.391 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.77 -24.27 69.7 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.31 -45.0 20.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 109.681 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.03 -21.28 61.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.25 -21.48 62.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.671 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.626 HD11 ' ND1' ' C' ' 58' ' ' HIS . 12.4 mt -78.08 -51.59 10.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.1 -12.9 61.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.825 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.557 ' NH2' ' SG ' ' C' ' 104' ' ' CYS . 0.9 OUTLIER -76.4 -40.48 50.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.137 -0.977 . . . . 0.0 110.25 -179.448 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 32' ' ' MET . . . . . 0.542 ' O ' ' N ' ' C' ' 36' ' ' PHE . 3.0 ptt? -84.04 -35.61 23.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.98 -1.075 . . . . 0.0 109.982 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' C' ' 33' ' ' PHE . 0.0 OUTLIER -45.87 -41.77 11.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.947 . . . . 0.0 109.719 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.883 ' CD1' ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -84.59 -35.93 22.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.962 . . . . 0.0 109.937 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.3 p -85.25 1.43 48.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' C' ' 32' ' ' MET . 67.3 m-85 -159.1 68.1 3.23 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' C' ' 39' ' ' THR . 69.3 Cg_exo -47.73 -34.29 20.9 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.8 2.334 . . . . 0.0 112.308 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 38' ' ' THR . . . . . 1.24 HG22 ' ND1' ' B' ' 97' ' ' HIS . 2.1 p -47.09 -18.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 109.568 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.441 ' N ' ' O ' ' C' ' 37' ' ' PRO . 81.6 p -84.52 -31.25 24.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.756 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -68.66 -26.43 65.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.951 . . . . 0.0 109.609 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.832 HG21 ' CD2' ' B' ' 97' ' ' HIS . 5.4 t -90.89 -17.99 25.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.862 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.595 ' O ' ' CD2' ' C' ' 43' ' ' PHE . 2.0 t80 -60.96 -65.64 0.66 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.157 -0.964 . . . . 0.0 109.154 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' C' ' 42' ' ' TYR . 0.6 OUTLIER 165.97 78.98 0.01 OUTLIER Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.817 . . . . 0.0 109.584 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.58 ' O ' ' CD2' ' C' ' 46' ' ' PHE . 76.3 Cg_endo -83.63 -41.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.577 2.185 . . . . 0.0 111.593 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.576 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 26.7 p80 44.51 31.98 0.68 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.564 -0.71 . . . . 0.0 110.858 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' C' ' 44' ' ' PRO . 2.8 p90 -135.91 26.93 3.29 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.047 -1.033 . . . . 0.0 109.611 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' C' ' 49' ' ' SER . 55.6 m-20 44.41 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.393 -0.817 . . . . 0.0 109.568 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.566 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.6 OUTLIER -51.98 -8.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.474 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.495 ' H ' ' C ' ' C' ' 47' ' ' ASP . 35.6 p -68.39 169.48 10.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -78.98 164.3 24.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.525 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.05 17.27 71.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.615 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 3.0 t -77.53 -28.54 52.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -1.128 . . . . 0.0 109.516 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 73.18 -31.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.606 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' C' ' 52' ' ' SER . 38.1 mt-30 -80.52 -22.67 40.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 0.0 109.389 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -83.38 -36.09 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.423 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -81.36 -32.89 32.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.138 -0.976 . . . . 0.0 108.674 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.6 -22.01 78.86 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.626 ' ND1' HD11 ' C' ' 29' ' ' LEU . 10.0 t-80 -70.44 -30.02 66.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -1.134 . . . . 0.0 109.254 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -51.47 57.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -48.29 -23.86 1.02 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 0.0 109.775 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.609 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 10.4 mmpt? -71.44 -51.08 25.81 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.257 -0.902 . . . . 0.0 108.577 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 25.6 t -60.78 -47.78 91.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.02 -38.71 89.12 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -59.97 -39.29 85.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 108.489 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -64.89 -52.39 56.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.58 -43.99 85.01 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.415 ' O ' ' N ' ' C' ' 71' ' ' ALA . 19.3 m -69.18 -51.36 38.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.285 -0.885 . . . . 0.0 108.702 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -61.53 -26.12 67.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.208 -0.932 . . . . 0.0 108.521 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -85.12 -46.61 10.96 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 20.8 t -65.11 -22.8 32.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -64.0 -21.69 66.61 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' C' ' 74' ' ' ASP . 95.4 m-70 -146.45 -51.89 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.878 . . . . 0.0 109.473 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.4 p 44.71 13.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.74 0.781 . . . . 0.0 109.406 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' C' ' 72' ' ' HIS . 29.2 m-20 -127.03 9.57 6.85 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.413 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 49.7 t0 -173.75 27.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.121 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 4.8 ptt? -78.3 -24.16 0.43 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.514 -0.741 . . . . 0.0 111.679 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.0 Cg_exo -52.97 -27.96 37.81 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.626 1.551 . . . . 0.0 112.398 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -94.09 -24.8 17.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.826 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 -46.41 21.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.094 -1.003 . . . . 0.0 109.203 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 80' ' ' LEU . . . . . 0.416 ' CD1' HG13 ' C' ' 132' ' ' VAL . 9.8 mt -82.03 9.26 8.73 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.42 -0.8 . . . . 0.0 109.024 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 4.5 m -65.59 -22.44 66.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.572 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -82.06 -59.67 2.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.623 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.723 HD12 ' O ' ' C' ' 83' ' ' LEU . 0.4 OUTLIER -50.85 -26.09 5.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 73.3 m -67.59 -33.27 74.67 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' C' ' 82' ' ' ALA . 4.2 t70 -78.41 -29.93 47.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 108.79 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 1.115 HD11 ' CBD' ' C' ' 142' ' ' HEC . 2.1 tm? -54.48 -49.46 70.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.501 -0.75 . . . . 0.0 109.338 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 87' ' ' HIS . . . . . 0.461 ' N ' HD13 ' C' ' 86' ' ' LEU . 8.2 p-80 -92.31 -21.67 20.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.407 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -92.9 -2.72 55.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.086 -1.009 . . . . 0.0 110.345 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -128.61 -77.01 0.56 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.953 . . . . 0.0 109.847 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -46.64 -78.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.981 . . . . 0.0 109.817 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.602 HD12 ' N ' ' C' ' 91' ' ' LEU . 8.2 mp -70.98 -39.17 72.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.569 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 61.86 59.35 1.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.389 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.63 HG12 ' N ' ' C' ' 94' ' ' ASP . 90.6 t -85.16 166.6 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 109.669 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.63 ' N ' HG12 ' C' ' 93' ' ' VAL . 3.8 m-20 -99.32 120.02 59.02 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.35 -0.843 . . . . 0.0 109.28 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' C' ' 98' ' ' PHE . 82.8 Cg_exo -44.12 -10.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.276 1.984 . . . . 0.0 112.394 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' C' ' 94' ' ' ASP . 95.7 t -45.63 -23.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.346 -0.846 . . . . 0.0 109.659 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' C' ' 95' ' ' PRO . 73.4 m-20 -79.24 -24.82 42.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.598 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 98' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' C' ' 102' ' ' SER . 20.5 t80 -46.51 -35.06 5.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.65 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' C' ' 99' ' ' LYS . 0.3 OUTLIER -64.55 -33.31 75.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.428 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 8.9 mt -84.05 -43.86 14.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.477 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.986 HD12 HMC3 ' C' ' 142' ' ' HEC . 4.8 tt -54.32 -52.09 62.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 102' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' C' ' 98' ' ' PHE . 15.6 m -59.52 -33.57 71.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 109.934 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.507 ' ND1' ' N ' ' C' ' 103' ' ' HIS . 0.7 OUTLIER -80.71 -26.56 37.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 110.068 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.557 ' SG ' ' NH2' ' C' ' 31' ' ' ARG . 71.8 m -63.9 -58.45 6.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.33 -34.58 4.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.153 -0.967 . . . . 0.0 110.094 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -70.71 -28.3 64.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.044 -1.035 . . . . 0.0 110.176 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.95 -38.22 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 109.579 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.42 ' O ' ' N ' ' C' ' 110' ' ' ALA . 19.2 p -70.67 -58.88 3.19 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.187 -0.945 . . . . 0.0 109.599 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' C' ' 113' ' ' LEU . 9.5 mt -43.18 -26.28 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' C' ' 108' ' ' THR . . . -67.29 -22.62 65.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 110.641 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.34 -47.99 12.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.074 -1.016 . . . . 0.0 111.017 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 112' ' ' HIS . . . . . 0.638 ' CD2' ' CD1' ' C' ' 24' ' ' TYR . 1.1 p-80 -100.85 -58.81 1.82 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.98 -1.075 . . . . 0.0 111.034 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.548 ' C ' HD13 ' C' ' 113' ' ' LEU . 0.9 OUTLIER -112.4 93.43 22.72 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.272 -178.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 114' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' C' ' 113' ' ' LEU . 78.0 Cg_exo -47.15 -174.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.355 2.037 . . . . 0.0 112.643 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.781 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -61.65 -55.42 30.79 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.657 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 27.7 mt-10 120.0 1.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' C' ' 117' ' ' PHE . 38.4 t80 59.69 31.7 21.03 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.225 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.781 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.3 p -104.46 120.73 49.62 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.01 23.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.164 1.909 . . . . 0.0 112.679 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.781 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -154.41 -29.95 0.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.945 -1.097 . . . . 0.0 110.701 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.781 HG21 ' O ' ' C' ' 115' ' ' ALA . 13.7 p -51.14 -50.17 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.95 -1.094 . . . . 0.0 110.302 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.675 ' N ' HG13 ' C' ' 121' ' ' VAL . 3.1 t-160 -61.34 -53.3 58.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 109.887 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 123' ' ' ALA . . . . . 0.516 ' HB2' ' HA ' ' D' ' 34' ' ' VAL . . . -72.79 -19.88 61.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.949 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.573 ' N ' ' O ' ' C' ' 120' ' ' ALA . 20.6 m -63.67 -62.56 1.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 110.254 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' C' ' 129' ' ' LEU . 1.2 mt -64.37 -16.91 63.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.348 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -84.08 -49.04 9.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.89 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.73 -59.04 2.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.879 -1.138 . . . . 0.0 111.302 -178.395 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.487 ' N ' ' HD2' ' C' ' 127' ' ' LYS . 21.4 m-85 -47.92 -21.31 0.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.82 -1.175 . . . . 0.0 109.811 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.898 ' O ' HD12 ' C' ' 129' ' ' LEU . 0.1 OUTLIER -71.99 -31.02 65.84 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' C' ' 134' ' ' THR . . . -49.28 -33.14 12.27 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.465 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 42.3 t -60.3 -37.07 79.4 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 132' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' C' ' 80' ' ' LEU . 6.5 t -77.02 -48.73 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.402 ' CB ' ' CE1' ' C' ' 98' ' ' PHE . 13.5 t -66.47 -22.78 66.2 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 134' ' ' THR . . . . . 0.52 ' N ' ' O ' ' C' ' 130' ' ' ALA . 11.2 m -64.08 -31.56 72.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.324 -0.86 . . . . 0.0 108.86 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.75 -37.21 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.134 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.467 HD11 HD11 ' C' ' 83' ' ' LEU . 5.6 mp -60.72 -35.21 75.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.277 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 137' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' C' ' 134' ' ' THR . 35.1 p -68.06 -33.6 74.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 11.7 t 46.72 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.371 -0.83 . . . . 0.0 109.492 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 1.224 ' NZ ' ' NZ ' ' A' ' 139' ' ' LYS . 41.9 mtpt -65.53 -123.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -55.19 89.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.468 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 141' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' C' ' 139' ' ' LYS . 76.1 mtt-85 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.413 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.472 HG22 ' H ' ' D' ' 3' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 45.04 52.75 8.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 109.84 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' D' ' 8' ' ' LYS . 1.9 mt -87.84 161.07 17.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.31 138.22 19.48 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -40.02 -54.19 2.19 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.526 2.151 . . . . 0.0 112.601 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.04 -21.74 61.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -76.69 -63.1 1.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 109.824 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.716 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -66.66 -29.6 69.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 109.936 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -47.52 -23.63 0.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.959 . . . . 0.0 110.048 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.74 -56.89 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.074 -1.016 . . . . 0.0 109.936 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.4 ' H ' HG12 ' D' ' 11' ' ' VAL . 0.8 OUTLIER -68.19 -24.51 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 26.0 m -73.55 -40.36 64.03 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.379 0.609 . . . . 0.0 109.591 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.37 -31.24 71.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.8 OUTLIER -50.7 -31.47 16.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.154 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -47.44 -18.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.491 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.91 -51.08 6.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.424 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.1 OUTLIER -71.25 -29.6 65.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -1.218 . . . . 0.0 109.335 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -49.26 114.76 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' D' ' 22' ' ' GLU . 95.4 m-20 -78.45 67.6 4.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.321 -0.862 . . . . 0.0 109.074 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' D' ' 22' ' ' GLU . 69.0 t -44.34 -29.1 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.73 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.08 7.39 0.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.557 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' D' ' 20' ' ' VAL . 38.7 mt-10 -155.29 -49.36 0.08 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.0 t -48.69 -60.74 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.92 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.87 -39.15 17.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.1 -43.8 89.29 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' D' ' 30' ' ' ARG . 57.0 mt-10 -79.51 -40.34 29.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -1.169 . . . . 0.0 109.487 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 -34.26 8.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -82.58 -56.75 3.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.307 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.67 -44.78 79.72 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 30' ' ' ARG . . . . . 0.58 HH21 HG11 ' D' ' 33' ' ' VAL . 0.0 OUTLIER -53.95 -36.44 62.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -1.123 . . . . 0.0 109.31 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -56.01 -47.57 77.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.37 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 mt -65.06 -22.74 67.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.595 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.58 HG11 HH21 ' D' ' 30' ' ' ARG . 74.7 t -81.63 -64.68 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.434 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' C' ' 123' ' ' ALA . 2.2 t -67.67 -22.79 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.501 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 35' ' ' TYR . . . . . 0.425 ' CG ' HD21 ' D' ' 105' ' ' LEU . 83.5 m-85 -139.41 80.86 21.58 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.77 -16.17 9.14 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.726 2.284 . . . . 0.0 112.437 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -51.04 -19.77 1.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 109.516 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.458 ' HB ' HBC1 ' D' ' 147' ' ' HEC . 3.7 p -85.56 55.56 3.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 109.231 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -109.81 41.27 1.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.258 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 57.5 mmt-85 -103.91 -49.34 3.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.82 . . . . 0.0 109.477 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -91.82 29.98 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.585 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' D' ' 44' ' ' SER . 9.4 p90 -92.63 -12.98 30.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -45.92 -14.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.338 -0.851 . . . . 0.0 109.971 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 44' ' ' SER . . . . . 0.543 ' N ' ' O ' ' D' ' 42' ' ' PHE . 23.4 p -124.26 23.47 8.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.87 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.4 -14.06 21.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.253 -0.904 . . . . 0.0 109.267 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.43 -116.86 2.25 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -144.3 105.34 4.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.355 -1.085 . . . . 0.0 109.535 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 mt -90.94 30.5 1.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.042 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.8 p -43.91 -32.47 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 109.925 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 17.9 p -146.52 148.4 33.81 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 109.389 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -40.37 -49.96 3.8 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.378 2.052 . . . . 0.0 112.232 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -61.29 -35.06 76.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.92 -19.69 4.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.23 -63.9 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -0.929 . . . . 0.0 109.542 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 12.2 mmt -63.07 -7.59 5.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.5 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.35 -10.25 64.12 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -78.43 141.92 61.89 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.228 -1.16 . . . . 0.0 109.325 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.26 -57.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.492 2.128 . . . . 0.0 112.242 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' D' ' 63' ' ' HIS . 45.7 mtpt -52.02 -48.4 64.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.619 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 73.9 t -45.86 -39.7 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 109.251 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -79.44 -52.34 8.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.315 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.29 -59.26 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.812 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' D' ' 59' ' ' LYS . 1.7 t60 -48.25 -24.87 1.31 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.646 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.32 -36.83 92.23 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -69.33 -25.18 64.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -1.12 . . . . 0.0 109.416 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -73.08 -35.32 66.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.575 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.585 HG13 ' C1B' ' D' ' 147' ' ' HEC . 39.8 t -75.72 -28.39 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.454 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.15 -34.92 68.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.33 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.53 -45.14 37.57 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.89 91.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -1.129 . . . . 0.0 109.656 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 71' ' ' PHE . . . . . 0.421 ' CE2' HD21 ' D' ' 110' ' ' LEU . 25.6 t80 -57.21 -41.14 78.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.626 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 5.7 t -76.64 -37.8 55.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.655 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -47.32 -37.79 11.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.928 . . . . 0.0 109.517 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.17 -60.31 7.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.559 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -55.95 -29.95 60.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.348 -1.089 . . . . 0.0 109.365 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.05 5.32 30.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.597 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.524 ' NE2' ' OD1' ' D' ' 80' ' ' ASN . 7.5 t60 -170.9 67.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.556 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.94 17.93 1.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.935 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -79.59 -29.22 41.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 80' ' ' ASN . . . . . 0.524 ' OD1' ' NE2' ' D' ' 77' ' ' HIS . 4.3 p-10 -163.28 95.83 0.85 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.284 -0.885 . . . . 0.0 109.198 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 81' ' ' LEU . . . . . 0.509 HD12 ' H ' ' D' ' 81' ' ' LEU . 5.0 mp -80.33 -58.85 2.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.58 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -57.61 -23.78 52.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.008 . . . . 0.0 109.46 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 83' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' D' ' 86' ' ' ALA . . . -82.98 -54.4 3.22 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.0 t -61.31 -47.55 85.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -1.166 . . . . 0.0 109.652 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' D' ' 84' ' ' THR . 54.7 m-85 -76.76 22.03 0.19 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.424 -0.797 . . . . 0.0 109.476 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 86' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.42 -26.87 44.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.898 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 76.0 p -78.81 -59.23 2.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.3 mt -48.48 -45.06 36.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.319 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 54.0 p -64.74 -52.8 55.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.229 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -61.21 -22.66 64.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.481 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 8.8 tp -87.0 -68.66 0.73 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.433 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' D' ' 97' ' ' HIS . 49.0 m80 -51.0 -26.57 6.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 110.08 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 93' ' ' CYS . . . . . 0.413 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 27.4 t -83.71 -55.87 4.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.187 -0.945 . . . . 0.0 111.361 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 27.4 t0 -86.27 -32.11 21.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.038 -1.039 . . . . 0.0 111.928 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -89.48 -51.83 5.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.696 -1.253 . . . . 0.0 111.055 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.55 -27.02 15.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.871 -1.143 . . . . 0.0 110.45 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 1.318 ' ND1' HG22 ' A' ' 38' ' ' THR . 82.8 m-70 51.68 29.55 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.052 -1.03 . . . . 0.0 109.581 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 98' ' ' VAL . . . . . 0.449 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 39.8 t -47.18 130.27 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.111 -0.993 . . . . 0.0 109.488 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.31 152.45 31.9 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.344 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.96 -164.09 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.494 2.13 . . . . 0.0 112.206 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.19 60.83 2.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.568 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 102' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' D' ' 105' ' ' LEU . 33.3 t-20 -171.27 -41.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.957 . . . . 0.0 109.457 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -46.21 -40.47 11.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.731 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -80.04 -19.99 46.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 0.0 109.577 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 105' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' D' ' 102' ' ' ASN . 12.2 tp -70.54 -59.76 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.613 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.836 HD13 ' CHC' ' D' ' 147' ' ' HEC . 7.0 tt -49.77 -46.33 50.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.33 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.08 -20.39 57.99 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -80.57 -25.1 38.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -1.165 . . . . 0.0 109.672 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 73.9 t -86.28 -43.09 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.659 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 110' ' ' LEU . . . . . 0.421 HD21 ' CE2' ' D' ' 71' ' ' PHE . 6.3 tt -48.08 -33.22 7.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.54 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 111' ' ' VAL . . . . . 0.416 ' H ' HG12 ' D' ' 111' ' ' VAL . 4.3 p -82.9 -26.16 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 72.0 m -69.05 -24.84 64.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.177 -0.952 . . . . 0.0 109.496 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.34 -34.8 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 114' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' D' ' 118' ' ' PHE . 9.4 mt -69.82 -40.14 76.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.472 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -54.47 -29.0 48.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.318 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.532 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -84.64 -62.42 1.55 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 109.113 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -63.4 -17.67 62.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 109.639 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' D' ' 114' ' ' LEU . 93.1 m-85 -149.65 60.29 1.01 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.462 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.534 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -69.28 -24.62 75.95 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -64.76 -29.67 70.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -1.154 . . . . 0.0 109.351 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' D' ' 123' ' ' THR . 78.3 mm-40 -87.83 5.76 38.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.862 . . . . 0.0 109.764 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.67 33.12 0.08 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.416 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.496 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.4 p -52.45 149.16 10.94 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.833 . . . . 0.0 109.367 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.1 Cg_exo -45.52 -53.6 5.35 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.452 2.101 . . . . 0.0 112.907 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 24.3 Cg_endo -62.22 -29.65 80.68 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.063 1.842 . . . . 0.0 112.211 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.447 HG23 ' OG1' ' D' ' 123' ' ' THR . 46.2 t -68.72 -28.16 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.185 -0.947 . . . . 0.0 109.537 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -83.18 -53.92 5.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 109.508 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.883 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -63.19 -26.5 68.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.622 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.54 -2.3 53.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 109.823 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' D' ' 132' ' ' LYS . 41.8 t80 -92.42 -61.7 1.55 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.968 . . . . 0.0 109.646 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 1.5 tm0? -45.23 -23.32 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 109.94 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 132' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' D' ' 130' ' ' TYR . 51.0 mtmt -85.46 -34.54 21.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.147 -0.971 . . . . 0.0 110.344 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 133' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 0.6 OUTLIER -68.59 -44.22 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.995 -1.066 . . . . 0.0 109.649 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.486 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 6.1 m -79.6 -20.98 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -50.41 -32.46 17.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.096 -1.002 . . . . 0.0 109.336 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.59 -26.66 56.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.32 -32.96 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -1.133 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.43 90.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.9 . . . . 0.0 109.626 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.98 -21.06 47.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.664 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.01 -58.92 6.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.42 -31.89 71.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.07 25.2 4.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.289 -0.882 . . . . 0.0 109.549 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -80.0 -16.11 55.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.131 -0.981 . . . . 0.0 109.733 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 13.2 mptt -98.42 -26.64 14.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 109.571 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 145' ' ' TYR . . . . . 0.449 ' OH ' ' O ' ' D' ' 98' ' ' VAL . 12.1 m-85 -54.43 -6.85 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.336 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' D' ' 144' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.44 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 1.099 ' CBD' HD11 ' A' ' 86' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 0.833 ' CHC' HD13 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 1.115 ' CBD' HD11 ' C' ' 86' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 0.836 ' CHC' HD13 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.535 HD21 ' OD2' ' A' ' 6' ' ' ASP . 14.0 tp -170.95 164.65 7.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 0.0 109.864 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.83 165.75 35.68 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.348 -0.845 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.64 -77.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.773 2.315 . . . . 0.0 112.655 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -45.22 -30.01 1.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 109.964 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.775 ' O ' HG23 ' A' ' 10' ' ' VAL . 26.2 t0 -43.77 -23.04 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.246 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -83.34 -60.61 2.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.372 -0.83 . . . . 0.0 109.324 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.5 m -44.45 -35.97 2.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.535 -0.728 . . . . 0.0 109.9 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.422 ' C ' ' OG ' ' A' ' 124' ' ' SER . 2.5 m-20 -74.49 -30.02 61.65 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 6' ' ' ASP . 76.6 t -76.31 -53.52 15.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -52.62 -38.28 59.9 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.081 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.04 -63.76 1.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.47 -0.769 . . . . 0.0 109.144 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.745 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -58.56 -37.7 76.27 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -17.23 62.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 109.03 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -79.02 -46.25 8.43 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 13.2 mmmt -69.17 -38.27 78.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 108.982 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 13' ' ' ALA . 98.9 t -61.07 -64.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 54.43 -132.59 46.55 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.87 26.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -1.073 . . . . 0.0 110.522 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.547 ' H ' ' C ' ' A' ' 18' ' ' GLY . 92.7 m-70 -129.94 22.29 5.36 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -86.7 -60.0 2.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.65 -0.656 . . . . 0.0 109.598 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.4 -14.28 0.18 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 21' ' ' ALA . 7.3 mm-40 -86.85 -56.52 3.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.425 -1.044 . . . . 0.0 109.781 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.8 m-30 -60.67 -37.55 81.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.15 -22.88 71.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -82.09 -51.43 8.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.144 -1.209 . . . . 0.0 109.839 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.59 -19.8 28.29 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.325 -0.859 . . . . 0.0 109.372 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.2 -23.74 62.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.269 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.534 HD11 ' ND1' ' A' ' 58' ' ' HIS . 26.5 mt -70.33 -56.15 7.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.303 -0.873 . . . . 0.0 109.459 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.03 -12.62 8.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.404 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -76.29 -61.1 2.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -19.45 65.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.49 -53.15 61.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 0.0 109.715 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.039 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.2 pp -88.01 -41.87 12.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.941 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.7 t -58.9 -2.27 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.663 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' A' ' 35' ' ' SER . 64.9 m-85 -160.24 81.85 2.27 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 109.418 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -49.17 -27.03 11.85 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.725 2.284 . . . . 0.0 112.316 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 41' ' ' THR . 5.5 p -49.04 -21.42 0.69 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -0.991 . . . . 0.0 109.388 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.9 p -90.36 -27.07 19.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -55.09 -47.51 74.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.636 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 1.108 HG21 ' CD2' ' D' ' 97' ' ' HIS . 13.1 t -49.22 -24.57 1.81 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 43' ' ' PHE . 16.0 t80 -73.95 4.06 5.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.432 ' O ' ' O ' ' A' ' 42' ' ' TYR . 7.0 m-85 61.56 144.53 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.805 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 60.0 Cg_endo -73.65 -42.69 0.78 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.385 2.057 . . . . 0.0 111.928 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.548 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 25.2 p80 40.74 31.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.67 -0.643 . . . . 0.0 110.62 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.465 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -164.73 29.63 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.029 -1.045 . . . . 0.0 110.371 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 46' ' ' PHE . 5.9 m-20 41.04 88.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.533 -0.729 . . . . 0.0 110.113 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.676 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -61.43 -19.53 62.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.505 -0.747 . . . . 0.0 109.15 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -47.3 121.49 3.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.64 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -65.25 107.86 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.91 -6.58 4.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.604 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 2.0 t -75.02 -0.23 18.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.39 -1.065 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 71.1 -14.94 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 109.589 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' A' ' 52' ' ' SER . 54.6 mt-30 -86.09 -28.9 23.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.506 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.598 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 4.2 t -82.96 -39.1 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -81.98 -25.56 34.66 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.508 ' HA2' ' HZ2' ' A' ' 60' ' ' LYS . . . -76.73 -25.56 64.72 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.534 ' ND1' HD11 ' A' ' 29' ' ' LEU . 5.8 t-80 -72.75 -42.38 64.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -1.183 . . . . 0.0 109.613 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.96 -46.44 32.46 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HZ2' ' HA2' ' A' ' 57' ' ' GLY . 6.4 mtmm -53.08 -22.66 6.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -1.081 . . . . 0.0 109.912 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.506 ' O ' HMA3 ' A' ' 142' ' ' HEC . 0.3 OUTLIER -73.99 -48.66 28.76 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.037 -1.039 . . . . 0.0 108.599 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.49 HG22 ' C2B' ' A' ' 142' ' ' HEC . 1.2 t -67.85 -45.99 83.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.467 ' N ' HG12 ' A' ' 62' ' ' VAL . . . -66.05 -35.28 80.12 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.488 -0.757 . . . . 0.0 109.398 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 11.7 t70 -65.17 -48.4 73.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.122 -0.986 . . . . 0.0 108.676 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.767 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -59.47 -50.68 73.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.47 -49.77 66.75 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -61.8 -54.52 41.12 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.901 . . . . 0.0 108.883 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -60.44 -20.89 61.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 108.777 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.2 -48.08 9.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.38 -22.84 27.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.97 -33.61 68.31 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.601 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.7 m170 -97.2 -66.58 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.441 -0.787 . . . . 0.0 109.557 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.1 p 44.89 14.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.883 0.849 . . . . 0.0 109.156 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 72' ' ' HIS . 91.6 m-20 -140.49 13.31 2.35 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -175.27 31.85 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.544 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -64.01 -46.46 80.67 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 110.062 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 76' ' ' MET . 81.5 Cg_exo -44.15 -40.78 12.65 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.471 2.114 . . . . 0.0 112.563 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -94.32 -17.21 22.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 109.975 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.8 -58.11 3.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.162 -0.961 . . . . 0.0 109.302 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' C ' ' N ' ' A' ' 82' ' ' ALA . 11.0 mt -77.69 11.21 2.21 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.367 -0.833 . . . . 0.0 109.045 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.67 -16.21 0.61 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.563 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -80.91 -57.8 3.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.45 ' N ' HD23 ' A' ' 83' ' ' LEU . 3.7 mt -44.88 -43.94 9.23 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.91 -27.33 18.21 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.501 -0.749 . . . . 0.0 109.056 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' ALA . 34.4 t70 -76.26 -21.44 56.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.935 . . . . 0.0 109.291 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.512 HD21 ' CBD' ' A' ' 142' ' ' HEC . 3.3 tp -82.99 -34.64 26.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -92.42 -21.72 20.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.519 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.33 -98.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.918 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -86.36 -76.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.0 ttmm -45.31 124.51 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 109.765 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 93' ' ' VAL . 16.2 mt 54.04 57.73 5.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.307 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.967 ' NE ' ' HG2' ' D' ' 40' ' ' ARG . 85.2 mtm-85 -49.81 -38.91 36.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.614 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 94' ' ' ASP . 59.4 t 47.22 -101.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.487 ' N ' HG12 ' A' ' 93' ' ' VAL . 0.3 OUTLIER 171.33 137.36 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 109.176 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.24 -16.78 19.5 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.371 2.047 . . . . 0.0 112.014 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 96' ' ' VAL . 61.5 t -60.66 -9.47 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.701 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 98' ' ' PHE . 29.6 p30 -78.91 -24.79 43.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.117 -0.989 . . . . 0.0 109.34 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.532 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.7 OUTLIER -50.1 -47.19 54.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.313 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.24 -22.66 66.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.908 . . . . 0.0 109.609 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.459 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 42.7 mt -84.01 -62.03 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.651 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.786 HD23 ' HAB' ' A' ' 142' ' ' HEC . 4.7 tp -52.46 -25.82 11.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.081 -1.012 . . . . 0.0 109.708 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 t -69.97 -59.18 3.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.87 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.766 ' ND1' ' OD1' ' B' ' 108' ' ' ASN . 43.2 m170 -63.26 -26.67 68.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.621 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 67.4 m -67.9 -48.25 66.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 109.567 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.88 -41.21 32.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.406 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 106' ' ' LEU . 9.4 mp -68.17 -50.78 52.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 109.522 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.606 ' CG1' HE22 ' B' ' 127' ' ' GLN . 70.4 t -53.99 -51.42 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 110' ' ' ALA . 40.2 m -59.82 -58.47 8.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 113' ' ' LEU . 4.6 mt -45.98 -19.95 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.875 . . . . 0.0 109.643 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -72.29 -35.47 68.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 110.135 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 1.313 ' HB2' ' CE2' ' B' ' 122' ' ' PHE . . . -75.04 -3.78 34.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.031 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.6 -82.3 0.31 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -106.82 94.4 10.42 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.8 175.87 9.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.093 1.862 . . . . 0.0 112.935 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -47.78 -44.84 28.82 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.438 0.637 . . . . 0.0 109.814 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 6.9 mt-10 87.1 5.65 0.31 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 t80 68.38 36.42 3.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.871 -0.518 . . . . 0.0 111.51 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.713 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -96.96 121.65 58.68 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.807 -1.183 . . . . 0.0 108.224 178.419 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.95 20.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.15 1.9 . . . . 0.0 112.765 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -145.43 -37.66 0.27 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.934 -1.104 . . . . 0.0 110.264 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.616 HG13 ' N ' ' A' ' 122' ' ' HIS . 7.8 p -46.91 -44.76 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.069 -1.019 . . . . 0.0 110.126 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.616 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.3 m80 -56.7 -50.0 73.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.81 -19.58 34.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.786 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 120' ' ' ALA . 15.5 t -54.82 -58.18 8.59 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.205 -0.934 . . . . 0.0 110.597 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.43 -19.73 30.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.199 -0.938 . . . . 0.0 110.156 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -83.25 -40.36 19.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.887 -1.133 . . . . 0.0 110.18 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.475 ' CD ' ' C ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -87.09 -47.21 9.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.005 -1.06 . . . . 0.0 109.63 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.51 ' CD1' HG21 ' A' ' 10' ' ' VAL . 70.9 t80 -48.63 -21.59 0.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.96 -1.088 . . . . 0.0 109.212 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.622 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.6 mt -69.73 -17.87 63.48 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.05 -29.97 70.04 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.48 ' HB3' HD13 ' A' ' 2' ' ' LEU . 53.3 p -82.78 -35.93 26.08 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.419 -0.801 . . . . 0.0 108.973 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.19 -27.34 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.234 -0.916 . . . . 0.0 108.897 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 129' ' ' LEU . 57.4 p -84.17 -24.91 29.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.427 -0.795 . . . . 0.0 109.052 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.7 m -78.16 -34.92 49.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.158 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.4 t -78.34 -26.4 14.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.156 -0.965 . . . . 0.0 108.577 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -33.67 76.41 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.3 m -85.26 -15.19 44.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.2 t 60.19 160.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.574 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -80.34 -33.35 37.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -72.7 93.11 1.61 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.495 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.534 -179.943 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.543 ' H3 ' ' C ' ' B' ' 132' ' ' LYS . 7.1 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 51.71 58.9 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.139 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 1.02 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -121.42 -175.15 3.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.557 -0.714 . . . . 0.0 109.196 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -79.57 152.76 75.71 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 109.016 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.83 -28.55 75.87 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.526 2.151 . . . . 0.0 112.01 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -86.7 -21.92 26.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.485 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.57 -63.11 1.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.723 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.711 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -57.21 -40.4 77.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.791 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.7 t -45.54 -23.71 0.26 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 110.038 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.44 -57.07 3.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.148 -0.97 . . . . 0.0 109.792 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.407 ' H ' HG12 ' B' ' 11' ' ' VAL . 0.8 OUTLIER -67.22 -24.55 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 8.4 m -71.18 -44.45 65.44 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.676 -0.64 . . . . 0.0 109.446 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.41 74.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.358 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.807 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -49.27 -21.06 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.193 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -17.3 60.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.5 -57.48 7.34 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.654 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.576 ' HE2' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -86.59 12.5 10.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.979 -1.307 . . . . 0.0 110.929 -178.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.807 HG23 ' O ' ' B' ' 14' ' ' LEU . 2.2 t -79.49 114.93 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.839 -1.163 . . . . 0.0 109.007 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.48 82.73 3.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.48 ' C ' ' H ' ' B' ' 22' ' ' GLU . 72.1 t -54.94 -18.21 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 5.0 m-20 -66.21 6.3 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.712 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' B' ' 20' ' ' VAL . 35.1 mt-10 -156.01 -52.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' B' ' 27' ' ' ALA . 95.3 t -47.57 -35.66 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.705 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.52 -57.55 4.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.5 -50.78 55.65 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.19 -45.98 90.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -1.138 . . . . 0.0 109.602 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' B' ' 23' ' ' VAL . . . -51.1 -35.22 34.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.688 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -84.96 -58.03 2.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 109.654 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.22 -37.45 72.91 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.513 HH21 HG22 ' B' ' 113' ' ' VAL . 8.1 ttp180 -69.74 -38.48 76.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -1.212 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 40.6 tp -52.99 -24.22 8.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.074 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' B' ' 36' ' ' PRO . 15.7 mt -75.54 -54.39 7.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.037 -1.04 . . . . 0.0 110.893 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.41 HG22 ' H ' ' B' ' 33' ' ' VAL . 2.2 m -52.72 -49.02 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.712 -1.242 . . . . 0.0 109.764 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -70.76 -22.72 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 109.126 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -149.43 74.94 9.63 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.48 ' N ' ' O ' ' B' ' 32' ' ' LEU . 72.3 Cg_endo -81.54 -22.87 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.788 2.326 . . . . 0.0 112.219 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -48.98 -19.92 0.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.908 . . . . 0.0 109.47 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.465 ' C ' ' H ' ' B' ' 40' ' ' ARG . 33.5 p -80.35 9.9 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -71.8 12.26 0.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.318 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.921 ' HG2' ' NE ' ' C' ' 92' ' ' ARG . 97.4 mtt180 -80.29 -19.77 45.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.52 26.27 4.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.306 -0.871 . . . . 0.0 109.129 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.507 ' CE1' ' CD2' ' B' ' 45' ' ' PHE . 33.4 t80 -148.77 11.73 0.86 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.89 -22.13 40.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.889 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 27.4 p -84.61 7.13 21.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' B' ' 42' ' ' PHE . 3.7 m-85 -81.44 -16.44 52.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.94 -175.37 45.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.443 ' O ' ' HB1' ' B' ' 53' ' ' ALA . 3.6 p-10 -83.14 103.84 12.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -1.088 . . . . 0.0 109.578 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.579 ' N ' HD12 ' B' ' 48' ' ' LEU . 10.2 mp -88.17 29.73 0.93 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.199 -0.938 . . . . 0.0 109.147 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.1 m -44.88 -35.88 3.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.838 . . . . 0.0 109.789 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 5.5 p -146.43 148.83 35.54 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.61 -36.35 4.71 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.565 2.177 . . . . 0.0 112.501 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.68 -33.58 72.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.743 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' B' ' 47' ' ' ASP . . . -62.16 -19.88 63.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.609 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.97 -59.69 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.963 . . . . 0.0 109.525 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' MET . . . . . 0.495 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -87.45 10.54 17.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.37 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.91 -31.22 32.89 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -81.94 147.96 59.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 109.434 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.63 -57.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.544 2.163 . . . . 0.0 112.427 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.03 -33.36 4.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.777 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 70.8 t -61.03 -57.92 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.459 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -64.96 -33.6 76.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.56 -53.65 44.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.589 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -53.3 -24.01 10.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.187 -0.946 . . . . 0.0 109.538 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.08 -23.88 73.08 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.88 -44.08 81.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -1.158 . . . . 0.0 109.164 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -55.35 -47.29 75.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.416 -0.802 . . . . 0.0 109.351 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 0.544 HG13 ' C2B' ' B' ' 147' ' ' HEC . 25.4 t -58.14 -47.01 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.42 -35.02 74.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 109.276 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.83 -53.18 46.05 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.11 63.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -1.201 . . . . 0.0 109.616 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -55.85 -31.16 62.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.398 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 33.2 t -76.56 -31.45 57.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.421 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -50.28 -40.02 47.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.368 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.89 -59.95 8.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.551 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -58.16 -26.92 63.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -1.166 . . . . 0.0 109.387 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.05 2.51 46.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.443 ' C ' ' H ' ' B' ' 79' ' ' ASP . 66.0 t60 -170.89 65.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.731 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 80.0 mt -75.85 19.58 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.955 . . . . 0.0 109.432 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' B' ' 77' ' ' HIS . 8.9 m-20 -79.6 -29.49 41.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' B' ' 80' ' ' ASN . 0.6 OUTLIER -173.32 107.09 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.564 HD12 ' N ' ' B' ' 81' ' ' LEU . 8.3 mp -80.28 -58.77 2.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.476 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' B' ' 82' ' ' LYS . 0.0 OUTLIER -46.5 -24.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.5 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.71 -50.24 9.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.7 t -82.35 -47.37 12.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -1.133 . . . . 0.0 109.366 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.552 ' N ' ' CG2' ' B' ' 84' ' ' THR . 27.6 m-85 -65.03 1.36 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.732 . . . . 0.0 109.482 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.9 -34.93 66.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.514 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -74.34 -57.55 3.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.479 ' N ' HD12 ' B' ' 88' ' ' LEU . 9.0 mp -49.3 -45.0 44.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -63.95 -52.15 61.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.67 -22.83 64.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 6.5 tt -85.51 -62.81 1.44 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' B' ' 97' ' ' HIS . 75.2 m80 -61.34 -20.14 62.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 110.13 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 51.7 t -83.51 -60.63 2.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.022 -1.049 . . . . 0.0 110.571 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.43 -28.32 22.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.047 -1.033 . . . . 0.0 110.994 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -83.99 -51.91 6.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.064 . . . . 0.0 110.686 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 11.7 mt -107.0 -21.29 13.05 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.08 -1.012 . . . . 0.0 109.966 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 1.073 ' CD2' HG21 ' C' ' 41' ' ' THR . 33.0 p80 43.02 37.46 1.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.346 -0.846 . . . . 0.0 109.971 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.0 130.89 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.195 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -46.94 147.35 2.31 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.39 -16.93 44.1 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.508 2.139 . . . . 0.0 112.086 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' B' ' 101' ' ' GLU . 58.7 mp0 -81.25 55.22 2.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.317 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -156.1 -37.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -64.16 -38.67 91.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.116 -0.99 . . . . 0.0 109.529 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -69.72 -28.18 65.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.677 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 16.1 mt -71.61 -52.76 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.768 HD22 ' HAB' ' B' ' 147' ' ' HEC . 6.7 tt -52.17 -47.81 65.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.353 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.73 -20.4 70.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ASN . . . . . 0.766 ' OD1' ' ND1' ' A' ' 103' ' ' HIS . 0.4 OUTLIER -83.27 -19.11 36.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -1.177 . . . . 0.0 109.743 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 72.8 t -80.34 -44.56 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.093 -1.004 . . . . 0.0 109.561 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 10.7 mt -47.38 -31.92 4.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.99 -33.47 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.429 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 11.9 m -79.15 -54.51 5.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.48 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' VAL . . . . . 0.513 HG22 HH21 ' B' ' 30' ' ' ARG . 14.0 t -49.52 -46.01 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.426 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.05 -22.83 64.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.855 . . . . 0.0 109.345 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.455 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -80.73 -24.29 38.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.478 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.47 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.77 -61.59 1.75 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 109.346 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.413 ' C ' ' CG ' ' B' ' 118' ' ' PHE . 55.3 m80 -60.25 -17.7 43.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.651 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.413 ' CG ' ' C ' ' B' ' 117' ' ' HIS . 19.2 m-85 -150.29 58.56 0.96 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.585 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -68.64 -28.6 73.05 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -68.99 6.37 0.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.412 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' B' ' 123' ' ' THR . 17.8 mm-40 -126.0 -1.2 7.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.448 -0.782 . . . . 0.0 109.438 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 1.313 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -72.75 35.37 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.552 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.504 ' OG1' HG23 ' B' ' 126' ' ' VAL . 13.2 p -50.85 146.64 9.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.51 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.3 Cg_exo -48.29 -51.39 10.21 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.382 2.055 . . . . 0.0 113.04 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 39.9 Cg_endo -67.57 -27.67 38.8 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.063 1.842 . . . . 0.0 112.496 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.504 HG23 ' OG1' ' B' ' 123' ' ' THR . 55.5 t -77.39 -24.14 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.494 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' GLN . . . . . 0.606 HE22 ' CG1' ' A' ' 107' ' ' VAL . 9.1 tt0 -83.28 -54.55 4.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 1.039 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -49.19 -44.07 42.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.488 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.37 13.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.884 . . . . 0.0 109.597 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' B' ' 128' ' ' ALA . 32.0 t80 -97.95 -59.89 1.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 38.2 tt0 -47.45 -30.53 3.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.543 ' C ' ' H3 ' ' B' ' 1' ' ' VAL . 8.7 mtpm? -66.15 -46.62 76.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 109.753 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.73 -55.55 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.109 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.442 HG22 ' H ' ' B' ' 134' ' ' VAL . 3.5 m -67.95 -36.76 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -0.942 . . . . 0.0 110.02 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -50.16 -24.57 2.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.486 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.99 -31.41 55.6 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.2 t -82.78 -29.89 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.18 -1.188 . . . . 0.0 109.523 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.77 77.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.471 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 1.169 ' OD1' ' CE1' ' D' ' 146' ' ' HIS . 4.2 m120 -71.33 -27.75 63.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.514 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.36 -60.38 2.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.92 -16.14 2.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.26 -3.07 13.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.368 -0.832 . . . . 0.0 109.516 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 139' ' ' ASN . 21.9 t-80 -64.27 -33.28 75.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.505 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -82.45 -29.74 30.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.561 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -51.37 -20.98 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 1.222 ' CE1' ' OD1' ' D' ' 139' ' ' ASN . 43.0 m80 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.477 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.543 HD21 ' OD2' ' C' ' 6' ' ' ASP . 14.0 tp -170.86 164.68 7.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.113 -0.992 . . . . 0.0 109.869 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.76 165.88 35.11 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.496 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.72 -77.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.79 2.327 . . . . 0.0 112.591 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -45.17 -30.1 1.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 109.953 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.771 ' O ' HG23 ' C' ' 10' ' ' VAL . 26.3 t0 -43.62 -23.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.323 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' C' ' 10' ' ' VAL . 0.0 OUTLIER -83.39 -60.51 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.385 -0.822 . . . . 0.0 109.33 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.402 ' C ' ' O ' ' C' ' 7' ' ' LYS . 45.6 m -44.43 -36.0 2.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 109.805 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' ASN . . . . . 0.424 ' C ' ' OG ' ' C' ' 124' ' ' SER . 2.5 m-20 -74.46 -30.12 61.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.771 HG23 ' O ' ' C' ' 6' ' ' ASP . 76.8 t -76.27 -53.49 15.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 11' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' C' ' 7' ' ' LYS . 0.0 OUTLIER -52.78 -38.17 60.69 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.03 -63.72 1.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.203 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.729 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -58.55 -37.77 76.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.396 -0.815 . . . . 0.0 108.818 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -17.22 62.53 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.049 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 15' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' C' ' 11' ' ' LYS . . . -79.07 -46.24 8.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 13.3 mmmt -69.21 -38.25 78.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 0.0 108.922 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.729 HG23 ' O ' ' C' ' 13' ' ' ALA . 98.3 t -61.11 -65.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.567 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 54.42 -132.49 46.48 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.9 26.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.481 -1.011 . . . . 0.0 110.49 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.567 ' H ' ' C ' ' C' ' 18' ' ' GLY . 92.7 m-70 -129.89 22.25 5.38 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -86.72 -60.09 2.08 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.681 -0.637 . . . . 0.0 109.512 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.33 -14.27 0.17 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' C' ' 21' ' ' ALA . 7.3 mm-40 -86.84 -56.57 3.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -1.087 . . . . 0.0 109.795 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.8 m-30 -60.73 -37.51 81.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -22.89 71.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' C' ' 55' ' ' VAL . . . -82.2 -51.33 8.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -1.199 . . . . 0.0 109.841 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.58 -19.89 28.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.17 -23.76 62.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.286 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.539 HD11 ' ND1' ' C' ' 58' ' ' HIS . 26.8 mt -70.28 -56.12 7.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 109.444 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.06 -12.63 8.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -76.3 -61.18 2.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.894 . . . . 0.0 109.726 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -19.44 65.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.607 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.49 -53.27 60.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.639 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 1.061 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.2 pp -87.87 -41.99 12.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 0.0 109.919 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.8 t -58.89 -2.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.096 -1.002 . . . . 0.0 109.637 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' C' ' 35' ' ' SER . 64.9 m-85 -160.07 81.78 2.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.468 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -49.17 -26.93 11.71 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.696 2.264 . . . . 0.0 112.302 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.418 ' O ' HG22 ' C' ' 41' ' ' THR . 5.2 p -49.1 -21.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.363 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.3 p -90.28 -27.17 19.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.55 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -55.11 -47.43 74.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.608 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' THR . . . . . 1.073 HG21 ' CD2' ' B' ' 97' ' ' HIS . 13.0 t -49.36 -24.5 1.94 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 0.0 109.398 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' C' ' 43' ' ' PHE . 15.8 t80 -73.84 3.94 5.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.215 -0.928 . . . . 0.0 109.343 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' C' ' 42' ' ' TYR . 7.0 m-85 61.59 144.52 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.472 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.536 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 60.2 Cg_endo -73.64 -42.68 0.79 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.468 2.112 . . . . 0.0 111.97 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 25.0 p80 40.75 31.98 0.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.685 -0.634 . . . . 0.0 110.625 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.47 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -164.74 29.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.981 -1.074 . . . . 0.0 110.301 179.206 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' C' ' 46' ' ' PHE . 5.9 m-20 41.0 88.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.554 -0.716 . . . . 0.0 110.119 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.675 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -61.44 -19.58 62.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.448 -0.782 . . . . 0.0 109.239 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -47.25 121.51 3.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.632 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.15 107.87 1.69 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 109.369 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.87 -6.54 4.44 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.597 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 2.0 t -75.07 -0.12 17.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -1.042 . . . . 0.0 109.427 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 71.02 -14.87 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.845 . . . . 0.0 109.63 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' C' ' 52' ' ' SER . 54.8 mt-30 -86.07 -29.04 23.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.611 ' O ' ' HB1' ' C' ' 26' ' ' ALA . 4.2 t -82.85 -39.11 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.955 . . . . 0.0 109.328 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -82.0 -25.62 34.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 108.542 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' GLY . . . . . 0.553 ' HA2' ' HZ2' ' C' ' 60' ' ' LYS . . . -76.73 -25.56 64.7 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.539 ' ND1' HD11 ' C' ' 29' ' ' LEU . 5.7 t-80 -72.79 -42.38 63.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -1.179 . . . . 0.0 109.631 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.93 -46.5 32.28 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.553 ' HZ2' ' HA2' ' C' ' 57' ' ' GLY . 6.4 mtmm -53.04 -22.61 6.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.997 . . . . 0.0 109.911 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.498 ' O ' HMA3 ' C' ' 142' ' ' HEC . 0.3 OUTLIER -74.01 -48.76 28.02 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.115 -0.991 . . . . 0.0 108.502 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.495 HG22 ' C2B' ' C' ' 142' ' ' HEC . 1.2 t -67.75 -46.05 83.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.445 ' N ' HG12 ' C' ' 62' ' ' VAL . . . -65.92 -35.42 80.56 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.454 -0.778 . . . . 0.0 109.355 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 64' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 11.6 t70 -65.19 -48.36 73.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.946 . . . . 0.0 108.654 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.768 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -59.53 -50.64 73.14 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.44 -49.85 66.5 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -61.67 -54.62 40.29 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.205 -0.934 . . . . 0.0 108.897 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -60.31 -21.03 61.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 108.756 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.2 -48.1 9.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -68.32 -22.83 27.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.62 68.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.596 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.7 m170 -97.26 -66.47 0.9 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.428 -0.795 . . . . 0.0 109.556 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.532 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.1 p 44.78 14.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.978 0.894 . . . . 0.0 109.214 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' C' ' 72' ' ' HIS . 91.2 m-20 -140.57 13.37 2.33 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -175.23 31.81 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.537 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -63.9 -46.47 81.34 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 110.099 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' C' ' 76' ' ' MET . 81.6 Cg_exo -44.21 -40.72 12.81 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.468 2.112 . . . . 0.0 112.607 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -94.25 -17.31 22.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.985 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.8 -57.95 3.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 109.309 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 80' ' ' LEU . . . . . 0.403 ' C ' ' N ' ' C' ' 82' ' ' ALA . 11.0 mt -77.79 11.22 2.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.06 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.68 -16.24 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.513 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -80.89 -57.69 3.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.669 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.452 ' N ' HD23 ' C' ' 83' ' ' LEU . 3.8 mt -44.95 -43.96 9.43 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.85 -27.33 17.86 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' C' ' 82' ' ' ALA . 34.4 t70 -76.32 -21.55 56.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.283 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.507 HD21 ' CBD' ' C' ' 142' ' ' HEC . 3.3 tp -82.9 -34.56 26.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.281 -0.887 . . . . 0.0 109.47 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -92.47 -21.75 19.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 109.495 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.28 -98.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.901 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -86.26 -76.41 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.853 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' C' ' 86' ' ' LEU . 6.9 ttmm -45.27 124.54 4.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.799 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.441 ' O ' HG23 ' C' ' 93' ' ' VAL . 16.1 mt 53.97 57.7 5.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.846 . . . . 0.0 109.345 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 92' ' ' ARG . . . . . 0.921 ' NE ' ' HG2' ' B' ' 40' ' ' ARG . 85.3 mtm-85 -49.87 -38.77 36.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.822 . . . . 0.0 109.649 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.485 HG12 ' N ' ' C' ' 94' ' ' ASP . 58.3 t 47.14 -101.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 109.335 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.485 ' N ' HG12 ' C' ' 93' ' ' VAL . 0.3 OUTLIER 171.42 137.39 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.134 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.28 -16.75 19.44 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.366 2.044 . . . . 0.0 112.036 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.432 HG12 ' O ' ' C' ' 96' ' ' VAL . 60.9 t -60.66 -9.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.86 . . . . 0.0 109.671 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' C' ' 98' ' ' PHE . 29.7 p30 -78.94 -24.78 43.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 109.29 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 98' ' ' PHE . . . . . 0.523 ' N ' ' OD1' ' C' ' 97' ' ' ASN . 0.7 OUTLIER -50.18 -47.14 54.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.292 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.21 -22.7 66.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.594 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.489 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 43.5 mt -84.04 -62.04 1.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.585 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.775 HD23 ' HAB' ' C' ' 142' ' ' HEC . 4.7 tp -52.37 -25.81 10.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 109.725 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -70.02 -59.16 3.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.18 -0.95 . . . . 0.0 109.805 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.77 ' ND1' ' OD1' ' D' ' 108' ' ' ASN . 43.4 m170 -63.37 -26.58 68.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.644 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 67.9 m -67.99 -48.17 66.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.89 -41.24 32.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.962 . . . . 0.0 109.362 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.494 ' N ' HD12 ' C' ' 106' ' ' LEU . 9.4 mp -68.1 -50.74 52.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 109.568 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 107' ' ' VAL . . . . . 0.61 ' CG1' HE22 ' D' ' 127' ' ' GLN . 70.0 t -54.06 -51.3 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.356 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.452 ' O ' ' N ' ' C' ' 110' ' ' ALA . 39.9 m -59.91 -58.46 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' C' ' 113' ' ' LEU . 4.5 mt -45.99 -19.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.374 -0.829 . . . . 0.0 109.592 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -72.36 -35.38 68.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.147 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 111' ' ' ALA . . . . . 1.319 ' HB2' ' CE2' ' D' ' 122' ' ' PHE . . . -75.15 -3.67 34.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 110.012 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.72 -82.23 0.3 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 109.386 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' C' ' 113' ' ' LEU . 0.3 OUTLIER -106.91 94.47 10.67 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 175.9 9.67 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.169 1.913 . . . . 0.0 112.903 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -47.82 -44.84 29.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.641 -0.662 . . . . 0.0 109.85 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 6.9 mt-10 87.06 5.81 0.31 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 t80 68.27 36.46 3.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.826 -0.546 . . . . 0.0 111.523 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.718 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -96.93 121.63 58.79 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.796 -1.19 . . . . 0.0 108.226 178.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -51.02 20.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.104 1.869 . . . . 0.0 112.826 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.718 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -145.37 -37.72 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.897 -1.127 . . . . 0.0 110.258 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.618 HG13 ' N ' ' C' ' 122' ' ' HIS . 7.8 p -46.88 -44.77 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.156 -0.965 . . . . 0.0 110.172 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.618 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.2 m80 -56.68 -49.9 73.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.412 -0.805 . . . . 0.0 109.78 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.87 -19.57 34.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.771 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.536 ' N ' ' O ' ' C' ' 120' ' ' ALA . 15.3 t -54.78 -58.33 7.97 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 110.606 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 mt -85.22 -19.71 31.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.147 -0.971 . . . . 0.0 110.227 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -83.33 -40.29 19.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.898 -1.126 . . . . 0.0 110.202 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.472 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -87.17 -47.17 9.09 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.863 -1.148 . . . . 0.0 109.649 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.511 ' CD1' HG21 ' C' ' 10' ' ' VAL . 71.1 t80 -48.71 -21.55 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.018 -1.052 . . . . 0.0 109.22 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.613 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.7 mt -69.69 -17.9 63.51 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.09 -29.96 70.07 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.493 ' HB3' HD13 ' C' ' 2' ' ' LEU . 53.2 p -82.73 -35.86 26.28 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.475 -0.766 . . . . 0.0 109.033 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.34 -27.32 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -0.946 . . . . 0.0 108.793 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.613 ' N ' ' O ' ' C' ' 129' ' ' LEU . 56.8 p -84.08 -24.9 30.18 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.455 -0.778 . . . . 0.0 109.162 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 18.8 m -78.04 -35.1 50.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 109.146 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 96.6 t -78.16 -26.41 14.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.226 -0.921 . . . . 0.0 108.641 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.83 -33.59 76.21 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 76.0 m -85.29 -15.17 44.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.446 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 4.2 t 60.23 160.85 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.577 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -80.35 -33.45 37.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -72.6 93.22 1.58 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.44 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.456 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.557 ' H3 ' ' C ' ' D' ' 132' ' ' LYS . 7.2 p . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 51.77 58.77 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.169 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 1.08 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -121.35 -175.04 2.98 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.443 -0.786 . . . . 0.0 109.2 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -79.77 152.79 75.2 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.344 -0.847 . . . . 0.0 109.045 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.83 -28.42 75.78 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.528 2.152 . . . . 0.0 112.024 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -86.85 -21.87 26.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.61 -63.02 1.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.733 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.731 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -57.27 -40.42 77.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 109.742 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.7 t -45.58 -23.61 0.25 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 110.08 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -81.44 -57.19 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.074 -1.016 . . . . 0.0 109.795 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.402 ' H ' HG12 ' D' ' 11' ' ' VAL . 0.9 OUTLIER -67.13 -24.49 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 8.4 m -71.17 -44.59 65.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.7 -0.625 . . . . 0.0 109.391 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.46 74.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.791 ' O ' HG23 ' D' ' 18' ' ' VAL . 0.7 OUTLIER -49.31 -21.06 0.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.839 . . . . 0.0 109.148 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -17.3 60.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 109.632 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.41 -57.51 7.38 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.665 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.584 ' H ' ' HE2' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -86.68 12.62 10.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.007 -1.29 . . . . 0.0 110.922 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.791 HG23 ' O ' ' D' ' 14' ' ' LEU . 2.2 t -79.65 115.03 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.822 -1.174 . . . . 0.0 108.959 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 19' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -76.53 82.72 3.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 109.488 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' D' ' 22' ' ' GLU . 71.1 t -54.8 -18.39 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' D' ' 21' ' ' ASP . 5.1 m-20 -66.15 6.3 0.42 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.89 . . . . 0.0 109.632 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' D' ' 20' ' ' VAL . 35.3 mt-10 -155.95 -52.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' D' ' 27' ' ' ALA . 95.7 t -47.53 -35.74 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.693 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.48 -57.57 4.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.51 -50.79 55.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.19 -45.94 91.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -1.119 . . . . 0.0 109.541 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' D' ' 23' ' ' VAL . . . -51.21 -35.23 35.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.621 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -84.97 -58.03 2.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.176 -0.952 . . . . 0.0 109.613 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.23 -37.48 73.06 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' ARG . . . . . 0.529 HH21 HG22 ' D' ' 113' ' ' VAL . 8.1 ttp180 -69.73 -38.44 76.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -1.209 . . . . 0.0 109.775 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 40.7 tp -53.0 -24.18 8.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 110.149 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' D' ' 36' ' ' PRO . 15.8 mt -75.48 -54.5 6.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.01 -1.057 . . . . 0.0 110.882 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.43 HG22 ' H ' ' D' ' 33' ' ' VAL . 2.3 m -52.73 -48.95 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.743 -1.223 . . . . 0.0 109.769 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.469 HG22 ' O ' ' D' ' 30' ' ' ARG . 0.0 OUTLIER -70.78 -22.69 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.077 -1.015 . . . . 0.0 109.158 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -149.42 74.87 9.64 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' PRO . . . . . 0.49 ' N ' ' O ' ' D' ' 32' ' ' LEU . 72.4 Cg_endo -81.49 -22.92 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.84 2.36 . . . . 0.0 112.244 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -48.91 -20.0 0.45 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.456 ' C ' ' H ' ' D' ' 40' ' ' ARG . 33.5 p -80.29 9.86 5.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.905 . . . . 0.0 109.563 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -71.8 12.26 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 109.388 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' ARG . . . . . 0.967 ' HG2' ' NE ' ' A' ' 92' ' ' ARG . 97.4 mtt180 -80.26 -19.8 45.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 109.409 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.55 26.27 4.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.172 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.515 ' CE1' ' CD2' ' D' ' 45' ' ' PHE . 33.3 t80 -148.78 11.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.406 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.95 -22.09 39.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 27.2 p -84.65 7.01 21.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.515 ' CD2' ' CE1' ' D' ' 42' ' ' PHE . 3.6 m-85 -81.38 -16.42 52.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.18 -0.95 . . . . 0.0 109.442 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.03 -175.32 45.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.444 ' O ' ' HB1' ' D' ' 53' ' ' ALA . 3.6 p-10 -83.13 103.86 12.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -1.123 . . . . 0.0 109.531 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 48' ' ' LEU . . . . . 0.583 ' N ' HD12 ' D' ' 48' ' ' LEU . 10.2 mp -88.27 29.75 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.849 . . . . 0.0 109.116 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.9 m -44.84 -35.85 2.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.379 -0.826 . . . . 0.0 109.807 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -146.47 148.73 35.09 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -42.57 -36.39 4.68 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.546 2.164 . . . . 0.0 112.444 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.68 -33.52 72.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.12 -0.987 . . . . 0.0 109.706 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' D' ' 47' ' ' ASP . . . -62.29 -19.7 63.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.406 -0.809 . . . . 0.0 109.561 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 62.6 t -61.08 -59.68 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -87.43 10.55 17.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.87 -31.22 33.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -81.92 147.92 59.48 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.155 -1.203 . . . . 0.0 109.426 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.56 -57.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.57 2.18 . . . . 0.0 112.542 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -33.38 4.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 109.775 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.05 -57.92 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.977 . . . . 0.0 109.434 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -65.01 -33.53 76.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.251 -0.906 . . . . 0.0 109.618 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.56 -53.71 43.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.56 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -53.27 -24.01 10.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.571 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.12 -23.7 73.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.96 -44.08 81.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -1.107 . . . . 0.0 109.192 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -55.4 -47.14 76.35 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.384 -0.822 . . . . 0.0 109.388 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.558 HG13 ' C2B' ' D' ' 147' ' ' HEC . 25.3 t -58.23 -46.94 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.31 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.48 -34.98 74.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.268 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.93 -53.16 46.43 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.11 63.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -1.193 . . . . 0.0 109.523 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -55.87 -31.08 62.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.449 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 33.1 t -76.58 -31.47 57.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -50.23 -40.06 46.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.88 -59.96 8.39 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.544 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.6 mp -58.19 -26.89 63.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -1.132 . . . . 0.0 109.358 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.02 2.41 46.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.617 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.444 ' C ' ' H ' ' D' ' 79' ' ' ASP . 66.2 t60 -170.84 66.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.928 . . . . 0.0 109.654 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 78' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' D' ' 78' ' ' LEU . 79.7 mt -75.83 19.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.407 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' D' ' 77' ' ' HIS . 8.8 m-20 -79.61 -29.47 41.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.529 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 80' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' D' ' 80' ' ' ASN . 0.6 OUTLIER -173.3 107.0 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.467 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 81' ' ' LEU . . . . . 0.56 HD12 ' N ' ' D' ' 81' ' ' LEU . 8.3 mp -80.21 -58.77 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.915 . . . . 0.0 109.494 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 82' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' D' ' 82' ' ' LYS . 0.0 OUTLIER -46.45 -24.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.582 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.73 -50.21 9.52 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.7 t -82.34 -47.3 12.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -1.173 . . . . 0.0 109.409 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.545 ' N ' ' CG2' ' D' ' 84' ' ' THR . 27.9 m-85 -65.08 1.35 0.99 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.55 -0.719 . . . . 0.0 109.504 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 86' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.85 -35.05 66.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.188 -0.945 . . . . 0.0 109.388 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 29.9 p -74.37 -57.54 3.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.426 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.483 HD12 ' N ' ' D' ' 88' ' ' LEU . 9.0 mp -49.37 -44.95 45.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -63.89 -52.2 61.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.474 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.68 -22.8 64.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 6.5 tt -85.65 -62.6 1.49 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.694 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' D' ' 97' ' ' HIS . 75.1 m80 -61.43 -20.17 62.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 110.079 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 51.6 t -83.51 -60.71 2.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.582 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.36 -28.32 22.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.991 -1.068 . . . . 0.0 111.026 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 95' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -83.88 -52.04 6.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.0 -1.062 . . . . 0.0 110.742 -178.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.589 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 11.6 mt -106.87 -21.31 13.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.024 -1.047 . . . . 0.0 110.05 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 1.108 ' CD2' HG21 ' A' ' 41' ' ' THR . 33.1 p80 43.03 37.47 1.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.842 . . . . 0.0 109.931 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.09 130.92 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.167 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -46.94 147.36 2.31 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.33 -16.94 44.39 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.495 2.13 . . . . 0.0 112.119 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 101' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' D' ' 101' ' ' GLU . 58.7 mp0 -81.3 55.27 2.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.344 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -156.19 -37.67 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.982 . . . . 0.0 109.688 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -64.12 -38.76 92.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -69.68 -28.1 65.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.66 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.71 -52.76 16.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.749 HD22 ' HAB' ' D' ' 147' ' ' HEC . 6.7 tt -52.2 -47.75 65.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.405 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.71 -20.45 70.22 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 108' ' ' ASN . . . . . 0.77 ' OD1' ' ND1' ' C' ' 103' ' ' HIS . 0.4 OUTLIER -83.24 -19.12 36.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -1.167 . . . . 0.0 109.753 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 73.0 t -80.31 -44.54 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.616 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 mt -47.37 -32.0 4.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.423 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 111' ' ' VAL . . . . . 0.426 ' H ' HG23 ' D' ' 111' ' ' VAL . 10.5 t -58.86 -33.64 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 11.8 m -79.06 -54.54 5.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 113' ' ' VAL . . . . . 0.529 HG22 HH21 ' D' ' 30' ' ' ARG . 14.0 t -49.47 -46.04 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.406 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.0 -22.92 64.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.463 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -80.62 -24.37 39.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.471 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.73 -61.65 1.74 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.359 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 117' ' ' HIS . . . . . 0.416 ' C ' ' CG ' ' D' ' 118' ' ' PHE . 55.2 m80 -60.18 -17.73 43.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.416 ' CG ' ' C ' ' D' ' 117' ' ' HIS . 19.0 m-85 -150.27 58.57 0.96 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.88 . . . . 0.0 109.633 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.463 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -68.6 -28.65 73.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -68.92 6.35 0.92 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -1.108 . . . . 0.0 109.41 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' D' ' 123' ' ' THR . 17.7 mm-40 -126.0 -1.22 7.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.436 -0.79 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 1.319 ' CE2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -72.67 35.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.849 . . . . 0.0 109.517 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.504 ' OG1' HG23 ' D' ' 126' ' ' VAL . 13.1 p -50.82 146.58 9.85 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.427 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.497 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.3 Cg_exo -48.22 -51.44 10.08 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.315 2.01 . . . . 0.0 113.057 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 39.4 Cg_endo -67.63 -27.7 38.39 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.013 1.809 . . . . 0.0 112.436 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.504 HG23 ' OG1' ' D' ' 123' ' ' THR . 55.6 t -77.3 -24.1 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.143 -0.973 . . . . 0.0 109.523 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 127' ' ' GLN . . . . . 0.61 HE22 ' CG1' ' C' ' 107' ' ' VAL . 9.1 tt0 -83.34 -54.52 4.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 1.061 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -49.14 -44.1 42.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.497 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.39 13.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.573 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.437 ' H ' ' C ' ' D' ' 128' ' ' ALA . 32.0 t80 -97.89 -59.89 1.67 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.64 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 38.2 tt0 -47.46 -30.49 3.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 132' ' ' LYS . . . . . 0.557 ' C ' ' H3 ' ' D' ' 1' ' ' VAL . 8.7 mtpm? -66.05 -46.72 76.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.774 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 38.4 t -59.77 -55.55 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 110.043 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.4 HG22 ' H ' ' D' ' 134' ' ' VAL . 3.5 m -67.91 -36.85 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.991 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -50.0 -24.64 2.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.511 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.96 -31.43 55.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -82.69 -30.06 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -1.166 . . . . 0.0 109.495 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.64 77.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.91 . . . . 0.0 109.46 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 1.222 ' OD1' ' CE1' ' B' ' 146' ' ' HIS . 4.2 m120 -71.35 -27.89 63.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.414 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.23 -60.42 2.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.428 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.96 -16.13 2.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.348 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.2 -3.04 13.96 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.309 -0.869 . . . . 0.0 109.569 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' D' ' 139' ' ' ASN . 22.0 t-80 -64.22 -33.28 75.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.867 . . . . 0.0 109.581 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -82.42 -29.76 30.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -51.33 -21.05 1.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 1.169 ' CE1' ' OD1' ' B' ' 139' ' ' ASN . 43.0 m80 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.872 HMB1 HBB3 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 0.768 ' HAB' HD22 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.872 HMB1 HBB3 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 0.749 ' HAB' HD22 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.475 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.568 HD11 ' HE3' ' A' ' 127' ' ' LYS . 7.1 tp 73.73 170.63 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.564 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.483 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 174.42 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.937 . . . . 0.0 110.106 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 3' ' ' SER . 95.5 Cg_exo -41.41 168.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.597 2.198 . . . . 0.0 112.902 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -50.76 -16.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.444 -0.785 . . . . 0.0 109.994 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 5' ' ' ALA . 2.8 p30 -39.78 -28.33 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.382 -0.824 . . . . 0.0 109.819 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 5' ' ' ALA . 5.9 ptmm? -83.27 -52.38 6.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.408 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 48.9 m -47.93 -26.75 1.84 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 108.928 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.433 ' CG ' ' HB1' ' A' ' 120' ' ' ALA . 10.0 m120 -79.99 -39.34 30.23 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.597 HG21 ' CG ' ' A' ' 128' ' ' PHE . 21.2 t -69.43 -47.01 75.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HZ2' ' HZ3' ' A' ' 7' ' ' LYS . 2.4 mptm? -50.22 -48.5 54.41 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.58 -63.1 1.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.502 0.667 . . . . 0.0 109.303 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -50.75 -41.75 56.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -0.817 . . . . 0.0 109.112 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.95 -17.4 64.43 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.377 -0.827 . . . . 0.0 109.047 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -79.62 -47.5 7.26 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -68.39 -36.74 79.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -1.121 . . . . 0.0 108.766 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 13' ' ' ALA . 69.4 t -60.96 -66.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 63.44 -141.44 45.87 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.13 37.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.462 -1.022 . . . . 0.0 110.177 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.551 ' H ' ' C ' ' A' ' 18' ' ' GLY . 89.5 m-70 -140.2 24.61 2.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . . . -88.3 -48.78 7.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.664 -0.647 . . . . 0.0 109.961 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.38 -14.71 28.23 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' O ' ' OE1' ' A' ' 27' ' ' GLU . 12.6 mt-10 -85.68 -56.28 3.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.9 m-30 -55.18 -27.11 43.42 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.369 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.05 -24.45 76.5 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.69 -36.3 28.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -1.123 . . . . 0.0 109.625 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 23' ' ' GLU . 1.4 mp0 -70.4 -19.88 62.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.96 . . . . 0.0 109.296 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.65 -19.73 60.76 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.277 -0.889 . . . . 0.0 109.072 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 58' ' ' HIS . 17.3 mt -77.86 -58.14 3.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 109.712 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -51.01 -43.68 60.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 109.655 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -56.25 -30.57 62.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 109.642 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 38.6 ttp -84.24 -57.16 3.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.906 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.438 ' CZ ' ' CZ ' ' A' ' 46' ' ' PHE . 25.7 m-85 -47.66 -36.94 11.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.978 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.844 HD13 ' HB2' ' B' ' 128' ' ' ALA . 3.5 pp -84.48 -25.74 28.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.925 -1.11 . . . . 0.0 109.809 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.533 ' N ' HD12 ' A' ' 34' ' ' LEU . 28.1 t -60.93 -21.97 63.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 109.534 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 1.174 ' HZ ' ' NE2' ' B' ' 131' ' ' GLN . 66.6 m-85 -156.2 128.76 4.15 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.965 . . . . 0.0 109.2 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.59 -20.23 15.92 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.348 2.032 . . . . 0.0 111.986 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.6 p -62.67 -18.77 62.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 109.572 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.4 p -80.99 -35.55 31.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.779 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -67.59 -36.5 81.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.963 . . . . 0.0 109.662 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -84.77 -18.18 35.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.209 -0.932 . . . . 0.0 109.844 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -64.27 -66.91 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.169 -0.957 . . . . 0.0 109.449 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.539 ' CD2' ' ND1' ' A' ' 45' ' ' HIS . 35.9 t80 -175.27 85.26 0.31 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.449 -0.782 . . . . 0.0 109.814 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 70.2 Cg_endo -80.64 -43.06 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.404 2.069 . . . . 0.0 111.814 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.539 ' ND1' ' CD2' ' A' ' 43' ' ' PHE . 45.3 p-80 38.27 33.05 0.05 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.606 -0.683 . . . . 0.0 110.645 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.479 ' C ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -165.44 26.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.071 -1.018 . . . . 0.0 110.385 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 49' ' ' SER . 22.3 m-20 41.63 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.534 -0.729 . . . . 0.0 110.249 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.015 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -56.5 0.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 47' ' ' ASP . 2.8 t -46.56 132.18 10.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.96 . . . . 0.0 109.668 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.526 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 11.3 t-80 -76.23 144.15 40.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.413 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.526 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 73.2 10.15 77.92 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.527 ' OG ' ' N ' ' A' ' 53' ' ' ALA . 88.7 p -68.98 -100.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -1.184 . . . . 0.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.527 ' N ' ' OG ' ' A' ' 52' ' ' SER . . . -178.39 -31.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.377 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -81.23 -17.71 48.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.926 . . . . 0.0 109.087 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.48 -33.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 109.682 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.408 ' HG2' ' H ' ' A' ' 56' ' ' LYS . 14.7 ptpt -70.81 -28.34 64.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.076 -1.015 . . . . 0.0 109.262 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' O ' ' CE ' ' A' ' 61' ' ' LYS . . . -69.71 -48.1 44.59 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.538 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.6 OUTLIER -54.2 -35.56 62.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -1.11 . . . . 0.0 109.392 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.29 -58.69 10.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -51.65 -24.03 5.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -1.174 . . . . 0.0 109.593 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.552 ' O ' HMA3 ' A' ' 142' ' ' HEC . 0.0 OUTLIER -77.35 -23.47 50.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.332 -0.855 . . . . 0.0 108.896 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.36 -52.91 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 108.712 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -66.27 -24.21 66.53 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.421 -0.8 . . . . 0.0 109.574 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.14 -33.0 33.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.954 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -82.63 -34.32 27.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.912 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -81.63 -23.03 37.25 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.98 -1.075 . . . . 0.0 108.116 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 63' ' ' ALA . 18.5 m -78.05 -43.87 28.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.052 -1.03 . . . . 0.0 108.704 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.556 HD21 HD21 ' A' ' 80' ' ' LEU . 1.6 p-10 -58.15 -21.91 48.93 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.61 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -78.78 -47.47 16.68 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.62 -22.37 30.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.01 -17.67 63.28 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.419 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.566 ' O ' HG12 ' A' ' 73' ' ' VAL . 85.4 m-70 -143.81 -53.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.343 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.3 p 45.03 15.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.776 0.798 . . . . 0.0 109.286 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 72' ' ' HIS . 89.8 m-20 -131.73 9.64 4.63 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.403 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 22.4 t0 -174.33 27.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.358 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.694 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.3 ptt? -78.56 -24.41 0.43 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.519 -0.738 . . . . 0.0 111.804 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.2 Cg_exo -53.19 -29.49 46.55 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.79 1.66 . . . . 0.0 112.573 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.428 ' O ' ' OG ' ' A' ' 81' ' ' SER . 8.5 t-20 -94.1 -11.29 30.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 109.828 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.22 -58.23 3.04 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.107 -0.995 . . . . 0.0 109.258 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 68' ' ' ASN . 6.0 mt -81.35 13.94 2.69 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 2.5 p -59.22 -15.8 17.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.785 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.4 -53.61 6.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.0 109.912 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.713 HD22 HBA1 ' A' ' 142' ' ' HEC . 3.5 mt -44.79 -42.3 7.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.0 108.901 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.642 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 64.4 p -54.56 -29.21 50.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.545 -0.722 . . . . 0.0 109.517 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' ALA . 49.4 t0 -82.53 -16.92 46.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.334 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.446 HD11 ' CBD' ' A' ' 142' ' ' HEC . 5.9 tt -81.04 -62.23 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.956 -1.09 . . . . 0.0 111.249 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.4 p-80 -77.0 -21.53 54.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.886 -1.133 . . . . 0.0 111.163 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -85.94 -29.74 23.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.778 -1.201 . . . . 0.0 110.151 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 90' ' ' LYS . 15.4 t-80 -99.78 -74.81 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.171 -0.956 . . . . 0.0 110.132 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 89' ' ' HIS . 17.8 mtpp -52.0 -101.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 109.986 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.0 mp -45.12 -31.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 58.17 41.91 22.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.495 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' HIS . 5.9 t -66.84 168.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 109.353 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' VAL . 1.1 p-10 -123.46 152.09 64.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.336 -0.852 . . . . 0.0 109.333 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -41.6 -14.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.681 2.254 . . . . 0.0 112.558 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.937 HG11 ' HB3' ' D' ' 99' ' ' ASP . 46.9 t -59.29 -28.29 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 0.0 109.877 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.5 -24.8 42.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.95 . . . . 0.0 109.7 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -65.65 -41.95 91.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -47.28 -30.21 2.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.558 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 100' ' ' LEU . 3.7 mm? -84.11 -60.04 2.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.733 HD21 HBB3 ' A' ' 142' ' ' HEC . 6.5 tt -53.34 -20.78 4.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 109.76 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -77.65 -59.06 2.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.818 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.799 ' NE2' ' OH ' ' B' ' 35' ' ' TYR . 32.1 m170 -64.55 -26.57 68.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 109.915 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 95.4 m -61.06 -58.01 10.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.895 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.92 -30.88 1.91 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 109.576 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.5 mt -75.06 -52.18 11.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.593 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.3 -24.76 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 109.445 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.6 m -73.61 -63.32 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.672 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 113' ' ' LEU . 18.9 mt -53.77 -33.57 56.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.386 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.41 -42.17 9.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.324 -0.86 . . . . 0.0 109.742 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.47 -56.04 4.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.436 -0.79 . . . . 0.0 109.943 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -68.28 -67.51 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.545 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -111.85 93.46 20.8 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 113' ' ' LEU . 99.1 Cg_exo -43.39 178.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.478 2.119 . . . . 0.0 113.068 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.57 -38.26 17.33 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.611 0.72 . . . . 0.0 109.281 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 4.7 mt-10 77.85 1.3 2.85 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 61.91 38.46 14.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.74 -0.6 . . . . 0.0 111.24 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.73 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -87.59 120.9 71.23 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 120.633 -1.292 . . . . 0.0 108.21 178.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.35 19.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.26 1.973 . . . . 0.0 112.889 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.73 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -150.74 -33.3 0.16 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.715 -1.24 . . . . 0.0 110.984 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.664 HG13 ' N ' ' A' ' 122' ' ' HIS . 10.7 p -45.43 -48.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.013 -1.055 . . . . 0.0 109.934 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.664 ' N ' HG13 ' A' ' 121' ' ' VAL . 20.3 m-70 -71.19 -43.73 66.84 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.444 -0.785 . . . . 0.0 108.952 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.86 -20.2 64.27 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.33 -0.856 . . . . 0.0 109.107 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 120' ' ' ALA . 12.2 p -66.33 -62.75 1.31 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.506 ' N ' ' OG ' ' A' ' 124' ' ' SER . 5.5 mt -70.31 -25.1 63.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.151 -0.968 . . . . 0.0 109.719 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.36 -45.52 46.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.058 -1.026 . . . . 0.0 109.813 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.568 ' HE3' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -90.37 -50.54 5.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.106 -0.996 . . . . 0.0 110.113 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CG ' HG21 ' A' ' 10' ' ' VAL . 28.5 t80 -48.43 -22.27 0.68 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.049 -1.032 . . . . 0.0 109.485 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 133' ' ' SER . 6.4 mt -74.57 -22.6 58.9 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.45 -32.36 72.34 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.434 ' HB2' HD13 ' A' ' 2' ' ' LEU . 14.0 t -80.09 -35.49 36.86 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.391 -0.818 . . . . 0.0 109.012 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.54 -30.62 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 129' ' ' LEU . 42.2 t -76.19 -26.27 56.0 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.422 -0.799 . . . . 0.0 108.853 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 138' ' ' SER . 19.3 m -66.89 -28.72 68.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.327 -0.858 . . . . 0.0 109.021 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.12 -47.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.091 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.25 -38.15 73.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.013 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.3 p -93.71 -15.8 24.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 134' ' ' THR . 23.3 t 52.3 -144.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.898 . . . . 0.0 109.518 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -170.87 -6.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -152.65 108.3 3.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 109.4 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.429 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.507 HG22 ' N ' ' B' ' 2' ' ' HIS . 11.0 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 0.507 ' N ' HG22 ' B' ' 1' ' ' VAL . 0.5 OUTLIER -99.13 77.2 2.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.387 -0.82 . . . . 0.0 109.665 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mt -92.5 -170.94 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.185 -0.947 . . . . 0.0 109.254 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.409 ' O ' ' N ' ' B' ' 6' ' ' GLU . 2.9 p -111.06 129.78 23.64 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.377 -0.827 . . . . 0.0 108.97 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.78 -25.02 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.392 2.061 . . . . 0.0 112.401 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' B' ' 4' ' ' THR . 48.6 mt-10 -86.62 -48.58 8.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 0.0 109.894 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.77 -34.39 39.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.853 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -64.97 -34.95 79.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.014 . . . . 0.0 109.425 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 26.8 t -69.04 -23.62 64.09 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 109.374 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.52 -55.0 4.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.215 -0.928 . . . . 0.0 110.238 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.7 -26.45 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 34.2 m -84.64 -54.25 4.85 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.363 0.601 . . . . 0.0 109.893 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' B' ' 9' ' ' SER . . . -45.0 -31.18 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.451 -0.781 . . . . 0.0 109.859 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.494 HD23 ' HB2' ' B' ' 17' ' ' LYS . 0.6 OUTLIER -59.21 -24.64 63.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.226 -0.921 . . . . 0.0 109.623 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 15' ' ' TRP . . . . . 0.649 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 2.1 t90 -48.3 -27.49 2.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.17 -52.33 7.88 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.494 ' HB2' HD23 ' B' ' 14' ' ' LEU . 1.1 mppt? -64.39 -15.59 60.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -1.121 . . . . 0.0 109.084 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.23 114.96 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.356 -0.84 . . . . 0.0 109.67 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' B' ' 22' ' ' GLU . 5.1 m120 -81.3 77.41 8.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.318 -0.864 . . . . 0.0 108.794 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' B' ' 19' ' ' ASN . 76.8 t -43.14 -21.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 109.966 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 19' ' ' ASN . 0.8 OUTLIER -83.86 11.71 7.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.59 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' B' ' 19' ' ' ASN . 36.6 mt-10 -156.15 -55.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.492 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 75.1 t -47.86 -36.37 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -57.71 9.45 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.82 -35.84 40.14 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -75.18 -26.97 59.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -1.139 . . . . 0.0 109.575 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.21 -48.1 65.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 40.3 mt -82.96 -30.58 28.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.895 . . . . 0.0 109.498 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.03 -59.19 10.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.584 ' NH2' ' SD ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -57.45 -40.84 79.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -1.133 . . . . 0.0 109.376 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 31' ' ' LEU . . . . . 0.693 ' O ' HD23 ' B' ' 31' ' ' LEU . 2.3 tt -43.79 -38.3 3.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.291 -0.88 . . . . 0.0 109.464 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.96 -21.83 43.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' B' ' 30' ' ' ARG . 15.6 t -86.09 -64.0 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.156 -0.965 . . . . 0.0 109.532 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 30' ' ' ARG . 0.1 OUTLIER -62.18 -22.93 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.366 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.799 ' OH ' ' NE2' ' A' ' 103' ' ' HIS . 48.5 m-85 -150.05 78.75 7.91 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 109.479 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' B' ' 38' ' ' THR . 16.6 Cg_exo -65.38 -28.22 54.75 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.042 2.494 . . . . 0.0 112.584 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.533 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 0.5 OUTLIER -46.56 -20.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.022 . . . . 0.0 109.708 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.612 HG22 HBC1 ' B' ' 147' ' ' HEC . 17.3 m -96.16 61.47 2.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.168 -0.957 . . . . 0.0 109.411 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.13 24.38 6.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.363 -0.835 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -84.44 -25.79 28.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -101.06 34.63 2.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.84 . . . . 0.0 109.494 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.489 ' HE1' ' CBC' ' B' ' 147' ' ' HEC . 64.7 m-85 -135.9 17.46 3.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.331 -0.855 . . . . 0.0 109.425 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' B' ' 44' ' ' SER . 0.0 OUTLIER -84.98 -30.76 23.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.495 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 39.4 t -83.11 -10.81 58.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.514 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.44 ' O ' ' ND2' ' B' ' 57' ' ' ASN . 15.6 m-85 -73.82 1.02 11.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.89 178.73 0.18 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 48.77 89.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -1.108 . . . . 0.0 109.408 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 tp -158.8 19.35 0.2 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.46 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -53.16 -39.14 63.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' THR . . . . . 0.421 ' O ' ' N ' ' B' ' 52' ' ' ASP . 1.3 p -145.65 153.7 51.26 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.408 -0.808 . . . . 0.0 109.009 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -43.61 -19.36 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.265 1.977 . . . . 0.0 112.241 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.6 OUTLIER -81.48 -44.29 17.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.36 -20.0 0.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.315 -0.866 . . . . 0.0 109.398 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.03 -63.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.529 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' MET . . . . . 0.584 ' SD ' ' NH2' ' B' ' 30' ' ' ARG . 11.4 mmt -52.32 -22.02 4.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.605 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.23 -15.81 70.93 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' B' ' 45' ' ' PHE . 25.3 t-20 -73.46 136.39 78.22 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.225 -1.162 . . . . 0.0 109.294 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.34 -53.36 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.339 2.026 . . . . 0.0 112.381 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -52.49 -48.99 65.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.531 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 99.2 t -49.6 -37.58 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.318 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 51.0 mtpt -79.16 -33.94 43.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.83 -29.08 35.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.583 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.922 ' HE1' ' CHA' ' B' ' 147' ' ' HEC . 1.8 t60 -69.1 -23.79 64.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.568 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.32 -38.02 91.11 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 30.8 mmtm -60.93 -32.11 71.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -1.181 . . . . 0.0 109.351 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.78 -61.34 2.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 1.216 HG13 ' C2B' ' B' ' 147' ' ' HEC . 43.8 t -56.88 -24.51 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.83 -42.53 60.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.226 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.77 -39.8 17.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.71 -38.22 67.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -61.84 -32.8 73.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.146 -0.971 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.649 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 13.4 m -88.5 -31.9 18.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 109.532 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -49.52 -42.49 43.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 109.473 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.12 -60.06 8.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.612 ' H ' HD12 ' B' ' 75' ' ' LEU . 5.0 mp -57.03 -26.44 60.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -1.127 . . . . 0.0 109.389 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.2 -0.35 48.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.958 . . . . 0.0 109.488 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.441 ' C ' ' H ' ' B' ' 79' ' ' ASP . 75.9 t60 -171.2 64.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.534 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 54.3 mt -72.36 12.15 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' B' ' 77' ' ' HIS . 2.8 m-20 -71.83 -20.79 61.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.434 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -171.6 109.74 0.28 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -79.69 -58.54 3.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -47.63 -24.01 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.97 -61.85 4.09 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.6 t -66.62 -47.09 73.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -1.177 . . . . 0.0 109.355 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.548 ' N ' ' CG2' ' B' ' 84' ' ' THR . 69.0 m-85 -70.88 15.14 0.11 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.558 -0.714 . . . . 0.0 109.526 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -69.4 -38.88 78.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 109.573 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 17.8 p -83.62 -51.69 7.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.639 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 26.5 mt -53.04 -24.87 10.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.478 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 99.5 p -81.92 -40.61 22.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.505 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -81.43 -22.59 38.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.622 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 4.2 tt -82.29 -48.39 11.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.061 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.537 ' NE2' ' O ' ' B' ' 141' ' ' LEU . 1.9 p-80 -75.18 -22.28 58.15 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.918 -1.114 . . . . 0.0 110.22 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' CYS . . . . . 0.461 ' SG ' ' CE1' ' B' ' 145' ' ' TYR . 51.2 t -83.73 -60.25 2.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.132 -0.98 . . . . 0.0 111.356 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 12.8 t70 -86.8 -27.4 23.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.983 -1.073 . . . . 0.0 111.784 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.53 ' O ' ' CE1' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -84.56 -49.99 8.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.704 -1.248 . . . . 0.0 110.655 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.521 ' N ' HD12 ' B' ' 96' ' ' LEU . 8.3 mp -86.52 -34.64 19.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.793 -1.192 . . . . 0.0 109.931 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' B' ' 94' ' ' ASP . 3.3 m80 71.77 36.92 1.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 109.545 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.85 134.84 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 0.848 ' HB3' HG11 ' C' ' 96' ' ' VAL . 3.7 m-20 -81.72 151.68 68.28 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.405 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.519 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 65.3 Cg_exo -47.23 -173.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.39 2.06 . . . . 0.0 112.358 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 57.62 53.2 7.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.52 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' B' ' 100' ' ' PRO . 69.3 m-80 -159.31 -34.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.6 m-85 -73.75 -54.55 7.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.333 -0.854 . . . . 0.0 109.585 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -57.1 -22.35 39.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.713 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 tt -76.77 -41.62 44.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -0.969 . . . . 0.0 109.517 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 1.151 ' CD1' ' CHC' ' B' ' 147' ' ' HEC . 4.9 tt -68.58 -56.59 7.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.231 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.45 -20.24 2.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -85.62 -55.61 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -1.116 . . . . 0.0 109.984 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.12 -24.8 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.055 -1.028 . . . . 0.0 109.49 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.503 HD23 ' C ' ' B' ' 110' ' ' LEU . 2.5 tt -57.41 -59.18 5.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.255 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.92 -39.94 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.229 -0.919 . . . . 0.0 109.677 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.423 ' O ' ' CE1' ' B' ' 116' ' ' HIS . 76.3 m -48.87 -43.77 39.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.591 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 70.4 t -55.99 -53.42 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.353 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.627 ' N ' HD12 ' B' ' 114' ' ' LEU . 9.3 mp -49.81 -41.99 45.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 119' ' ' GLY . . . -47.88 -41.54 24.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.78 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.65 ' N ' ' ND1' ' B' ' 116' ' ' HIS . 0.4 OUTLIER -68.87 -52.16 32.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.612 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' B' ' 118' ' ' PHE . 74.9 m80 -69.24 -17.55 63.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.713 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 63.8 m-85 -156.84 64.34 0.52 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.955 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 115' ' ' ALA . . . -76.25 -21.36 75.81 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -72.85 -29.22 63.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -1.128 . . . . 0.0 109.362 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 123' ' ' THR . 63.4 mm-40 -78.53 -15.49 58.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.271 -0.893 . . . . 0.0 109.554 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' B' ' 115' ' ' ALA . 3.8 m-85 -69.82 59.66 0.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.472 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 11.7 p -59.04 150.98 58.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.94 . . . . 0.0 108.917 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.444 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.3 Cg_exo -44.15 -58.15 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.446 2.097 . . . . 0.0 112.716 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 27.5 Cg_endo -61.89 -46.52 13.24 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.161 1.907 . . . . 0.0 112.027 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.472 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 40.6 t -66.86 -18.2 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' GLN . . . . . 0.497 ' OE1' HD11 ' A' ' 34' ' ' LEU . 14.1 tm0? -83.14 -26.29 31.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.844 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -68.8 -32.1 71.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.37 26.38 0.92 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.935 . . . . 0.0 109.648 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.647 ' CG ' ' N ' ' B' ' 131' ' ' GLN . 5.8 p90 -74.53 -52.31 12.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.14 -0.975 . . . . 0.0 109.791 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 1.174 ' NE2' ' HZ ' ' A' ' 36' ' ' PHE . 20.6 tt0 -86.06 -38.93 17.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.162 -0.961 . . . . 0.0 109.999 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.993 ' HG3' ' O ' ' D' ' 146' ' ' HIS . 32.1 ttpt -50.9 -34.56 28.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.233 -0.917 . . . . 0.0 110.959 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 133' ' ' VAL . . . . . 0.89 HG13 ' H ' ' B' ' 134' ' ' VAL . 7.1 p -65.27 -63.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.844 -1.16 . . . . 0.0 109.891 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.89 ' H ' HG13 ' B' ' 133' ' ' VAL . 1.8 m -73.77 -14.82 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.361 -0.837 . . . . 0.0 109.75 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . -45.78 -23.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.55 -26.41 46.84 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' B' ' 134' ' ' VAL . 74.9 t -80.05 -21.28 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -1.104 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.86 -51.11 71.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.555 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.69 -22.52 53.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.34 -45.94 88.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.537 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 19.9 mt -84.01 15.57 3.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.544 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.62 -1.5 2.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 109.505 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -79.87 -26.57 40.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.518 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -73.26 -11.39 60.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.379 -0.826 . . . . 0.0 109.342 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.461 ' CE1' ' SG ' ' B' ' 93' ' ' CYS . 15.6 m-85 -72.84 7.19 2.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.301 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 1.01 ' O ' ' HG3' ' D' ' 132' ' ' LYS . 7.5 p-80 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.453 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' C' ' 2' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.579 HD11 ' HE3' ' C' ' 127' ' ' LYS . 7.1 tp 73.63 170.67 0.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 109.545 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.492 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 174.45 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.166 -0.959 . . . . 0.0 110.041 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' C' ' 3' ' ' SER . 96.6 Cg_exo -41.4 168.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.683 2.255 . . . . 0.0 112.837 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -50.77 -16.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.436 -0.79 . . . . 0.0 110.003 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' C' ' 5' ' ' ALA . 2.8 p30 -39.7 -28.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.746 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' C' ' 5' ' ' ALA . 5.9 ptmm? -83.2 -52.31 6.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.514 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.417 ' N ' ' CG ' ' C' ' 7' ' ' LYS . 49.2 m -47.93 -26.76 1.85 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 108.954 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' ASN . . . . . 0.434 ' CG ' ' HB1' ' C' ' 120' ' ' ALA . 10.0 m120 -80.01 -39.43 29.96 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.603 HG21 ' CG ' ' C' ' 128' ' ' PHE . 21.4 t -69.35 -47.01 75.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 11' ' ' LYS . . . . . 0.408 ' HZ2' ' HZ3' ' C' ' 7' ' ' LYS . 2.4 mptm? -50.12 -48.57 53.49 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.65 -63.13 1.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.628 -0.67 . . . . 0.0 109.316 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.652 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -50.57 -41.82 54.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.2 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' TRP . . . . . 0.401 ' NE1' ' OG1' ' C' ' 67' ' ' THR . 0.1 OUTLIER -68.04 -17.34 64.37 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.412 -0.805 . . . . 0.0 109.05 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.71 -47.38 7.29 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -68.41 -36.71 79.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -1.113 . . . . 0.0 108.85 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.652 HG23 ' O ' ' C' ' 13' ' ' ALA . 69.5 t -60.99 -66.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 63.39 -141.4 45.89 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 37.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.519 -0.989 . . . . 0.0 110.157 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.548 ' H ' ' C ' ' C' ' 18' ' ' GLY . 89.4 m-70 -140.27 24.5 2.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.431 ' HB2' ' CG1' ' C' ' 17' ' ' VAL . . . -88.36 -48.73 7.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.561 -0.712 . . . . 0.0 109.927 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.3 -14.74 27.82 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' C' ' 27' ' ' GLU . 12.6 mt-10 -85.64 -56.32 3.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -1.156 . . . . 0.0 109.653 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.0 m-30 -55.4 -26.86 44.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 109.288 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.18 -24.41 76.62 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.73 -36.33 28.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -1.165 . . . . 0.0 109.627 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' C' ' 23' ' ' GLU . 1.4 mp0 -70.27 -20.03 63.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.5 -19.88 60.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.038 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' C' ' 58' ' ' HIS . 17.1 mt -77.74 -58.19 3.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.353 -0.842 . . . . 0.0 109.735 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -50.94 -43.77 60.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 109.685 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -56.3 -30.46 62.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.651 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 38.5 ttp -84.27 -57.22 3.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.815 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' PHE . . . . . 0.434 ' CZ ' ' CZ ' ' C' ' 46' ' ' PHE . 25.8 m-85 -47.7 -36.86 11.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.998 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.816 HD13 ' HB2' ' D' ' 128' ' ' ALA . 3.4 pp -84.49 -25.76 28.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.994 -1.067 . . . . 0.0 109.808 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.531 ' N ' HD12 ' C' ' 34' ' ' LEU . 28.1 t -60.88 -22.06 63.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 109.472 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 1.197 ' HZ ' ' NE2' ' D' ' 131' ' ' GLN . 66.7 m-85 -156.18 128.69 4.13 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.21 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.58 -20.17 16.01 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.292 1.995 . . . . 0.0 112.08 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 68.2 p -62.62 -18.92 63.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 76.8 p -80.88 -35.61 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.0 109.756 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -67.61 -36.45 80.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 109.7 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -84.85 -18.15 35.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.778 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -64.25 -66.91 0.48 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.112 -0.992 . . . . 0.0 109.531 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.539 ' CD2' ' ND1' ' C' ' 45' ' ' HIS . 35.7 t80 -175.3 85.26 0.31 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.843 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.514 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 69.2 Cg_endo -80.77 -42.94 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.325 2.016 . . . . 0.0 111.802 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.539 ' ND1' ' CD2' ' C' ' 43' ' ' PHE . 45.2 p-80 38.25 33.04 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.627 -0.67 . . . . 0.0 110.686 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -165.44 26.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 110.346 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' C' ' 49' ' ' SER . 22.5 m-20 41.74 88.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.701 . . . . 0.0 110.25 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 1.011 ' H ' HD13 ' C' ' 48' ' ' LEU . 0.0 OUTLIER -56.52 0.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.385 -0.822 . . . . 0.0 109.538 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.583 ' H ' ' C ' ' C' ' 47' ' ' ASP . 2.8 t -46.58 132.1 10.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.163 -0.961 . . . . 0.0 109.681 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' HIS . . . . . 0.518 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 11.4 t-80 -76.16 144.12 40.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.388 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' GLY . . . . . 0.518 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 73.26 10.14 78.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' C' ' 53' ' ' ALA . 88.5 p -68.88 -100.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -1.147 . . . . 0.0 109.392 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.524 ' N ' ' OG ' ' C' ' 52' ' ' SER . . . -178.41 -31.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.41 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -81.26 -17.58 48.94 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.264 -0.897 . . . . 0.0 109.171 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.57 -33.99 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.626 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -70.78 -28.27 64.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.314 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' GLY . . . . . 0.427 ' O ' ' CE ' ' C' ' 61' ' ' LYS . . . -69.82 -48.18 43.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.6 OUTLIER -54.01 -35.63 62.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -1.155 . . . . 0.0 109.366 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.43 -58.59 10.92 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -51.7 -23.95 5.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -1.099 . . . . 0.0 109.625 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.568 ' O ' HMA3 ' C' ' 142' ' ' HEC . 0.0 OUTLIER -77.39 -23.46 50.7 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 108.911 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.43 -52.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.26 -24.23 66.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.32 -0.862 . . . . 0.0 109.581 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.02 -32.97 33.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.99 . . . . 0.0 109.821 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.974 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -82.68 -34.33 27.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.122 -0.986 . . . . 0.0 109.549 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.911 ' O ' HD12 ' C' ' 66' ' ' LEU . 0.1 OUTLIER -81.51 -23.05 37.57 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.401 ' OG1' ' NE1' ' C' ' 14' ' ' TRP . 18.3 m -78.05 -43.86 28.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.068 -1.02 . . . . 0.0 108.711 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.555 HD21 HD21 ' C' ' 80' ' ' LEU . 1.6 p-10 -58.15 -21.86 48.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.611 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -78.79 -47.53 16.53 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.55 -22.42 30.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.0 -17.66 63.29 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.438 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.573 ' O ' HG12 ' C' ' 73' ' ' VAL . 85.6 m-70 -143.87 -53.45 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 0.0 109.291 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.2 p 45.04 15.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.799 0.809 . . . . 0.0 109.283 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' C' ' 72' ' ' HIS . 89.8 m-20 -131.76 9.66 4.62 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 22.3 t0 -174.28 27.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.265 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.3 ptt? -78.57 -24.37 0.43 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.472 -0.767 . . . . 0.0 111.783 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.0 Cg_exo -53.24 -29.47 46.94 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.79 1.66 . . . . 0.0 112.571 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.438 ' O ' ' OG ' ' C' ' 81' ' ' SER . 8.5 t-20 -94.15 -11.16 31.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 109.828 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.27 -58.16 3.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.153 -0.967 . . . . 0.0 109.281 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 80' ' ' LEU . . . . . 0.555 HD21 HD21 ' C' ' 68' ' ' ASN . 6.0 mt -81.34 13.87 2.72 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 108.796 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 81' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 2.5 p -59.15 -15.84 16.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 109.809 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.51 -53.58 6.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.0 109.831 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.705 HD22 HBA1 ' C' ' 142' ' ' HEC . 3.5 mt -44.73 -42.24 7.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.389 -0.819 . . . . 0.0 108.928 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.646 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 66.7 p -54.69 -29.17 52.18 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.552 -0.717 . . . . 0.0 109.446 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' C' ' 82' ' ' ALA . 49.2 t0 -82.55 -16.93 46.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.396 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.45 HD21 HBD2 ' C' ' 142' ' ' HEC . 5.8 tt -81.0 -62.32 1.7 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.918 -1.113 . . . . 0.0 111.241 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 87' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.4 p-80 -76.95 -21.47 54.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.86 -1.15 . . . . 0.0 111.16 -178.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -85.91 -29.78 23.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.77 -1.206 . . . . 0.0 110.207 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 89' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' C' ' 90' ' ' LYS . 15.5 t-80 -99.79 -74.85 0.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 110.139 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' C' ' 89' ' ' HIS . 17.8 mtpp -51.96 -101.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.967 . . . . 0.0 109.985 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.611 HD12 ' N ' ' C' ' 91' ' ' LEU . 10.0 mp -45.17 -31.77 1.58 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.827 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 58.16 41.93 22.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.503 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' C' ' 87' ' ' HIS . 5.9 t -66.95 168.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.372 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' C' ' 96' ' ' VAL . 1.1 p-10 -123.51 152.14 64.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.34 -0.85 . . . . 0.0 109.272 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -41.73 -14.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.666 2.244 . . . . 0.0 112.584 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.848 HG11 ' HB3' ' B' ' 99' ' ' ASP . 46.7 t -59.24 -28.33 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 109.934 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.45 -24.91 42.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.664 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -65.62 -42.03 91.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.584 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -47.22 -30.26 2.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.592 ' N ' HD22 ' C' ' 100' ' ' LEU . 3.7 mm? -84.07 -60.04 2.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.593 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.725 HD21 HBB3 ' C' ' 142' ' ' HEC . 6.5 tt -53.25 -20.9 4.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.736 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -77.6 -59.08 2.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 109.763 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.787 ' NE2' ' OH ' ' D' ' 35' ' ' TYR . 32.1 m170 -64.61 -26.6 68.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.837 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 95.2 m -61.0 -58.02 10.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 0.0 109.869 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.94 -30.9 1.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.5 mt -74.97 -52.29 11.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.155 -0.966 . . . . 0.0 109.616 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.29 -24.69 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.493 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 24.7 m -73.71 -63.25 1.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' C' ' 113' ' ' LEU . 18.9 mt -53.77 -33.68 56.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.372 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.3 -42.28 9.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.74 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.37 -56.0 4.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -68.28 -67.5 0.46 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.608 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -111.87 93.52 21.1 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 114' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' C' ' 113' ' ' LEU . 98.5 Cg_exo -43.44 178.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.406 2.071 . . . . 0.0 113.105 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.59 -38.25 17.31 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.666 0.746 . . . . 0.0 109.312 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 4.8 mt-10 77.87 1.24 2.84 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 61.88 38.5 14.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.793 -0.567 . . . . 0.0 111.268 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.735 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.7 OUTLIER -87.59 120.95 71.24 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.73 -1.231 . . . . 0.0 108.197 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.43 19.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.285 1.99 . . . . 0.0 112.816 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -150.74 -33.22 0.16 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.726 -1.234 . . . . 0.0 110.962 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.646 HG13 ' N ' ' C' ' 122' ' ' HIS . 10.8 p -45.57 -48.09 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.876 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.646 ' N ' HG13 ' C' ' 121' ' ' VAL . 20.2 m-70 -71.18 -43.81 66.73 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.451 -0.78 . . . . 0.0 108.917 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.74 -20.23 64.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.329 -0.857 . . . . 0.0 109.15 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.57 ' N ' ' O ' ' C' ' 120' ' ' ALA . 12.1 p -66.38 -62.72 1.32 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.21 -0.931 . . . . 0.0 110.215 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.513 ' N ' ' OG ' ' C' ' 124' ' ' SER . 5.6 mt -70.23 -25.1 63.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.166 -0.959 . . . . 0.0 109.736 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -74.47 -45.39 46.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.087 -1.008 . . . . 0.0 109.784 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.579 ' HE3' HD11 ' C' ' 2' ' ' LEU . 0.0 OUTLIER -90.45 -50.47 5.93 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.044 -1.035 . . . . 0.0 110.127 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.603 ' CG ' HG21 ' C' ' 10' ' ' VAL . 28.5 t80 -48.44 -22.35 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.912 -1.118 . . . . 0.0 109.453 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' C' ' 133' ' ' SER . 6.4 mt -74.55 -22.57 58.94 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.42 -32.31 72.26 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.425 ' HB2' HD13 ' C' ' 2' ' ' LEU . 13.8 t -80.16 -35.44 36.52 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.382 -0.824 . . . . 0.0 109.095 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 22.4 t -83.51 -30.71 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.149 -0.969 . . . . 0.0 108.57 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.564 ' N ' ' O ' ' C' ' 129' ' ' LEU . 42.1 t -76.25 -26.17 55.74 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.434 -0.792 . . . . 0.0 108.873 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 134' ' ' THR . . . . . 0.53 ' O ' ' N ' ' C' ' 138' ' ' SER . 19.5 m -66.85 -28.76 68.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.278 -0.889 . . . . 0.0 109.091 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.09 -47.52 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.11 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.19 -38.05 73.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.112 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 70.4 p -93.83 -15.76 24.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 138' ' ' SER . . . . . 0.53 ' N ' ' O ' ' C' ' 134' ' ' THR . 23.3 t 52.29 -144.51 0.61 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.885 . . . . 0.0 109.476 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -170.79 -6.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.409 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -152.67 108.24 3.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 0.0 109.431 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.513 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.514 HG22 ' N ' ' D' ' 2' ' ' HIS . 11.0 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 2' ' ' HIS . . . . . 0.514 ' N ' HG22 ' D' ' 1' ' ' VAL . 0.5 OUTLIER -99.17 77.3 2.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.245 -0.91 . . . . 0.0 109.641 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mt -92.65 -170.89 2.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 109.193 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.403 ' O ' ' N ' ' D' ' 6' ' ' GLU . 2.9 p -111.14 129.8 23.64 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.828 . . . . 0.0 108.938 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -40.82 -24.95 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.305 2.003 . . . . 0.0 112.439 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' D' ' 4' ' ' THR . 48.6 mt-10 -86.67 -48.63 8.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.858 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -79.61 -34.41 40.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.94 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.478 ' CD ' ' C ' ' D' ' 8' ' ' LYS . 0.0 OUTLIER -65.04 -34.86 79.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -0.964 . . . . 0.0 109.362 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 9' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 27.1 t -69.1 -23.6 64.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.11 -0.994 . . . . 0.0 109.335 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.55 -54.96 4.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.903 . . . . 0.0 110.189 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.71 -26.47 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.004 -1.06 . . . . 0.0 108.277 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 34.2 m -84.61 -54.31 4.81 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.395 0.616 . . . . 0.0 109.859 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' D' ' 9' ' ' SER . . . -45.04 -31.09 1.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 0.0 109.898 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.48 HD23 ' HB2' ' D' ' 17' ' ' LYS . 0.6 OUTLIER -59.22 -24.68 63.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.625 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 15' ' ' TRP . . . . . 0.65 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 2.1 t90 -48.27 -27.51 2.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.14 -52.37 7.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.505 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 1.1 mppt? -64.44 -15.59 60.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.356 -1.085 . . . . 0.0 109.047 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.2 114.84 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.671 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' D' ' 22' ' ' GLU . 5.1 m120 -81.21 77.35 8.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 108.855 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' D' ' 19' ' ' ASN . 76.5 t -43.11 -21.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.439 -0.788 . . . . 0.0 109.926 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' D' ' 19' ' ' ASN . 0.8 OUTLIER -83.84 11.72 7.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.658 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' D' ' 19' ' ' ASN . 36.6 mt-10 -156.13 -55.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 109.477 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -48.03 -36.23 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.534 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.79 -57.67 9.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.77 -35.87 39.81 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.21 -26.87 59.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.21 -48.12 65.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.948 . . . . 0.0 109.516 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 40.9 mt -83.09 -30.49 27.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.452 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.08 -59.11 10.62 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' ARG . . . . . 0.583 ' NH2' ' SD ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -57.53 -40.78 79.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -1.085 . . . . 0.0 109.346 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 31' ' ' LEU . . . . . 0.695 ' O ' HD23 ' D' ' 31' ' ' LEU . 2.3 tt -43.81 -38.31 3.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -79.94 -21.79 43.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' D' ' 30' ' ' ARG . 15.6 t -86.11 -63.98 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 30' ' ' ARG . 0.1 OUTLIER -62.25 -22.88 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 109.297 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 35' ' ' TYR . . . . . 0.787 ' OH ' ' NE2' ' C' ' 103' ' ' HIS . 48.5 m-85 -150.13 78.79 7.84 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 109.501 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 36' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' D' ' 38' ' ' THR . 16.6 Cg_exo -65.5 -28.12 53.83 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.988 2.459 . . . . 0.0 112.621 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 37' ' ' TRP . . . . . 0.538 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 0.5 OUTLIER -46.63 -19.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.81 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.616 HG22 HBC1 ' D' ' 147' ' ' HEC . 17.5 m -96.16 61.37 2.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.219 -0.926 . . . . 0.0 109.375 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.02 24.3 6.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 109.557 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -84.35 -25.86 28.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.119 -0.988 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -100.97 34.53 2.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.479 ' HE1' ' CBC' ' D' ' 147' ' ' HEC . 64.5 m-85 -135.92 17.51 3.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 109.431 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 43' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' D' ' 44' ' ' SER . 0.0 OUTLIER -85.05 -30.67 23.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.418 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 44' ' ' SER . . . . . 0.491 ' H ' ' CD ' ' D' ' 43' ' ' GLU . 39.3 t -83.13 -10.78 58.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.491 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.435 ' O ' ' ND2' ' D' ' 57' ' ' ASN . 15.6 m-85 -73.91 1.12 11.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.315 -0.866 . . . . 0.0 109.435 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.9 178.7 0.18 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 48.78 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.157 . . . . 0.0 109.441 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 tp -158.91 19.49 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.355 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -53.28 -39.06 63.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' THR . . . . . 0.428 ' O ' ' N ' ' D' ' 52' ' ' ASP . 1.2 p -145.66 153.7 51.2 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.844 . . . . 0.0 109.053 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.64 -19.37 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.276 1.984 . . . . 0.0 112.168 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' D' ' 52' ' ' ASP . 0.6 OUTLIER -81.39 -44.54 17.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.23 -19.92 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' VAL . . . . . 0.412 ' N ' ' C ' ' D' ' 52' ' ' ASP . 97.5 t -66.2 -63.16 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 55' ' ' MET . . . . . 0.583 ' SD ' ' NH2' ' D' ' 30' ' ' ARG . 11.4 mmt -52.25 -22.08 4.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.581 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.18 -15.92 70.77 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 57' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' D' ' 45' ' ' PHE . 25.3 t-20 -73.38 136.46 78.44 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.294 -1.121 . . . . 0.0 109.269 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.38 -53.41 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.343 2.028 . . . . 0.0 112.33 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -52.42 -48.99 65.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 99.5 t -49.73 -37.47 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 61' ' ' LYS . . . . . 0.523 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 50.9 mtpt -79.15 -33.91 43.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.502 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.84 -29.05 35.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 109.619 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.948 ' HE1' ' CHA' ' D' ' 147' ' ' HEC . 1.8 t60 -69.09 -23.81 64.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.57 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.27 -38.0 91.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 65' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 30.8 mmtm -60.96 -32.1 71.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -1.15 . . . . 0.0 109.264 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.8 -61.44 2.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 109.419 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 1.198 HG13 ' C2B' ' D' ' 147' ' ' HEC . 43.8 t -56.94 -24.42 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.8 -42.55 60.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.184 -0.947 . . . . 0.0 109.275 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.79 -39.76 17.7 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.73 -38.25 67.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 0.0 109.475 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -61.93 -32.64 73.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 72' ' ' SER . . . . . 0.65 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 13.6 m -88.53 -31.89 18.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -49.54 -42.35 43.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.89 . . . . 0.0 109.515 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.2 -60.07 8.52 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.631 HD12 ' H ' ' D' ' 75' ' ' LEU . 5.0 mp -57.02 -26.43 60.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -1.101 . . . . 0.0 109.406 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.18 -0.42 49.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.444 ' C ' ' H ' ' D' ' 79' ' ' ASP . 76.0 t60 -171.07 64.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.536 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 53.9 mt -72.34 12.21 0.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' D' ' 77' ' ' HIS . 2.8 m-20 -71.88 -20.76 61.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.428 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -171.62 109.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.414 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -79.78 -58.48 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -47.68 -23.99 0.82 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.95 -61.93 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.5 t -66.56 -47.14 73.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -1.154 . . . . 0.0 109.425 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 68.8 m-85 -70.85 15.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.495 -0.753 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 86' ' ' ALA . . . . . 0.491 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -69.5 -38.74 77.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.625 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 17.9 p -83.72 -51.75 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.605 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 26.1 mt -52.92 -24.93 10.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.564 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 99.1 p -81.88 -40.66 22.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.234 -0.916 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -81.42 -22.59 38.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.609 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 4.2 tt -82.17 -48.51 11.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 110.089 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.532 ' NE2' ' O ' ' D' ' 141' ' ' LEU . 1.9 p-80 -75.11 -22.26 58.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.915 -1.116 . . . . 0.0 110.19 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' CE1' ' D' ' 145' ' ' TYR . 51.2 t -83.76 -60.17 2.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.142 -0.974 . . . . 0.0 111.358 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 12.8 t70 -86.82 -27.38 23.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.074 -1.016 . . . . 0.0 111.835 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 95' ' ' LYS . . . . . 0.531 ' O ' ' CE1' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -84.65 -49.94 8.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.727 -1.233 . . . . 0.0 110.613 -178.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.521 HD12 ' N ' ' D' ' 96' ' ' LEU . 8.3 mp -86.55 -34.61 19.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.823 -1.173 . . . . 0.0 109.905 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' D' ' 94' ' ' ASP . 3.3 m80 71.72 36.98 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.89 . . . . 0.0 109.612 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.91 134.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.194 -0.942 . . . . 0.0 109.314 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 99' ' ' ASP . . . . . 0.937 ' HB3' HG11 ' A' ' 96' ' ' VAL . 3.8 m-20 -81.76 151.63 68.1 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.356 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 100' ' ' PRO . . . . . 0.508 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 66.7 Cg_exo -47.25 -173.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.433 2.088 . . . . 0.0 112.277 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 57.67 53.09 7.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.521 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 102' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' D' ' 100' ' ' PRO . 69.3 m-80 -159.23 -34.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.515 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.84 -54.56 7.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -57.08 -22.37 38.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 tt -76.7 -41.7 44.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.509 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 1.166 ' CD1' ' CHC' ' D' ' 147' ' ' HEC . 4.9 tt -68.54 -56.64 7.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.203 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.4 -20.18 2.28 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -85.68 -55.65 3.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -1.139 . . . . 0.0 109.978 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.07 -24.78 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.078 -1.014 . . . . 0.0 109.613 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 110' ' ' LEU . . . . . 0.501 HD23 ' C ' ' D' ' 110' ' ' LEU . 2.5 tt -57.45 -59.12 5.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.284 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 t -59.01 -39.92 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.595 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 112' ' ' CYS . . . . . 0.421 ' O ' ' CE1' ' D' ' 116' ' ' HIS . 76.2 m -48.88 -43.7 39.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 109.622 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 70.0 t -55.97 -53.43 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.412 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 114' ' ' LEU . . . . . 0.637 HD12 ' N ' ' D' ' 114' ' ' LEU . 9.3 mp -49.88 -41.92 46.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' D' ' 119' ' ' GLY . . . -47.9 -41.54 24.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.735 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.661 ' N ' ' ND1' ' D' ' 116' ' ' HIS . 0.4 OUTLIER -68.84 -52.32 31.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.537 -179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 117' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 74.9 m80 -69.1 -17.65 63.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.738 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 64.0 m-85 -156.82 64.45 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.522 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' D' ' 115' ' ' ALA . . . -76.4 -21.26 75.7 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -72.78 -29.3 63.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.157 . . . . 0.0 109.375 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' D' ' 123' ' ' THR . 63.3 mm-40 -78.56 -15.46 58.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' D' ' 115' ' ' ALA . 3.8 m-85 -69.84 59.77 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.321 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.466 ' OG1' ' CG2' ' D' ' 126' ' ' VAL . 12.0 p -59.05 150.95 59.09 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 108.916 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.445 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.3 Cg_exo -44.09 -58.12 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.414 2.076 . . . . 0.0 112.755 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 27.6 Cg_endo -61.9 -46.62 12.88 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.117 1.878 . . . . 0.0 112.033 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.466 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 40.3 t -66.68 -18.33 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.695 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 127' ' ' GLN . . . . . 0.505 ' OE1' HD11 ' C' ' 34' ' ' LEU . 14.1 tm0? -83.13 -26.4 31.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.114 -0.992 . . . . 0.0 109.703 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.816 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -68.73 -32.08 71.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.051 -1.03 . . . . 0.0 109.572 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.37 26.45 0.91 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.644 ' CG ' ' N ' ' D' ' 131' ' ' GLN . 5.8 p90 -74.6 -52.19 12.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.813 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 1.197 ' NE2' ' HZ ' ' C' ' 36' ' ' PHE . 20.6 tt0 -86.03 -38.98 17.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.146 -0.972 . . . . 0.0 110.023 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 132' ' ' LYS . . . . . 1.01 ' HG3' ' O ' ' B' ' 146' ' ' HIS . 32.1 ttpt -50.9 -34.55 28.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 110.981 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 133' ' ' VAL . . . . . 0.889 HG13 ' H ' ' D' ' 134' ' ' VAL . 7.1 p -65.18 -64.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.865 -1.147 . . . . 0.0 109.87 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.889 ' H ' HG13 ' D' ' 133' ' ' VAL . 1.8 m -73.83 -14.65 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.409 -0.807 . . . . 0.0 109.826 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' D' ' 131' ' ' GLN . . . -45.87 -23.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.099 -1.001 . . . . 0.0 109.662 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 136' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -82.6 -26.36 46.82 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 137' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' D' ' 134' ' ' VAL . 75.0 t -80.04 -21.36 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -1.159 . . . . 0.0 109.441 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.8 -51.06 71.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 109.659 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.78 -22.42 53.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.0 88.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 20.2 mt -84.03 15.65 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.587 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.69 -1.42 2.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.304 -0.872 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -79.98 -26.53 39.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -73.28 -11.35 60.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 145' ' ' TYR . . . . . 0.448 ' CE1' ' SG ' ' D' ' 93' ' ' CYS . 15.8 m-85 -72.84 7.11 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.942 . . . . 0.0 109.24 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.993 ' O ' ' HG3' ' B' ' 132' ' ' LYS . 7.6 p-80 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.954 HMA1 ' HB2' ' A' ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 1.216 ' C2B' HG13 ' B' ' 67' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.974 HMA1 ' HB2' ' C' ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 1.198 ' C2B' HG13 ' D' ' 67' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 3.0 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 3' ' ' SER . 3.3 tp 75.68 174.32 0.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.335 -0.853 . . . . 0.0 109.537 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.623 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 164.56 -38.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 110.516 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 3' ' ' SER . 76.4 Cg_exo -49.62 -173.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.327 2.018 . . . . 0.0 112.966 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -75.81 -15.86 60.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 0.0 110.073 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' A' ' 127' ' ' LYS . 4.9 p30 -39.03 -38.29 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.301 -0.875 . . . . 0.0 109.554 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 12.9 mtmm -57.41 -58.41 8.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 108.958 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 m -51.51 -31.83 25.33 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 108.989 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -76.61 -34.71 58.36 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.625 HG21 ' CD2' ' A' ' 128' ' ' PHE . 51.8 t -72.73 -49.91 37.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HE2' HG13 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -52.16 -42.31 63.3 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.66 -60.78 3.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.409 -0.807 . . . . 0.0 109.389 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -53.62 -34.11 57.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.113 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -17.69 61.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.379 -0.826 . . . . 0.0 109.077 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.44 -45.11 10.07 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.41 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 13.1 mmmt -68.72 -39.8 80.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -1.134 . . . . 0.0 108.859 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 13' ' ' ALA . 89.1 t -60.92 -65.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 58.06 -136.73 50.63 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.06 27.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.474 -1.016 . . . . 0.0 110.329 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.563 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.7 m-70 -131.44 27.1 4.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -90.96 -63.83 1.21 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.695 -0.628 . . . . 0.0 109.917 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.98 -14.47 0.13 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.4 mt-10 -85.06 -56.33 3.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -1.056 . . . . 0.0 109.633 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.8 m-30 -57.95 -43.93 86.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.328 -0.858 . . . . 0.0 109.111 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.03 -22.88 56.33 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.05 -33.91 59.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -1.129 . . . . 0.0 109.689 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' OE2' ' NE2' ' A' ' 112' ' ' HIS . 47.2 mt-10 -69.17 -20.18 64.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.282 -0.886 . . . . 0.0 109.687 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -19.68 59.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.344 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.7 mt -72.14 -48.11 46.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 109.6 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.46 -24.79 63.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.211 -0.93 . . . . 0.0 109.503 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.927 HH11 ' HG2' ' B' ' 127' ' ' GLN . 50.2 ttm-85 -76.1 -21.16 56.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.206 -0.934 . . . . 0.0 109.345 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.49 ' CE ' HBC2 ' A' ' 142' ' ' HEC . 54.0 ttp -82.24 -50.7 8.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CD2' ' OG1' ' A' ' 39' ' ' THR . 9.4 m-85 -52.59 -44.34 65.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.701 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.755 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 6.5 mt -67.59 -58.7 4.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.975 . . . . 0.0 109.682 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.676 ' HA ' ' OE1' ' B' ' 131' ' ' GLN . 40.2 m -48.47 -34.03 10.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.905 . . . . 0.0 109.755 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 35' ' ' SER . 3.0 m-85 -146.73 90.46 5.5 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.232 -0.918 . . . . 0.0 109.397 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 39' ' ' THR . 48.4 Cg_exo -53.51 -19.32 13.32 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.72 2.28 . . . . 0.0 112.149 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 37' ' ' PRO . 12.9 p -42.64 -18.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.405 -0.809 . . . . 0.0 110.092 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 37' ' ' PRO . 46.7 p -75.42 -22.29 57.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.928 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.537 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 1.8 mptm? -46.55 -44.92 18.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.912 . . . . 0.0 109.853 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.475 HG21 ' CD2' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -62.52 -18.33 61.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.658 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 39' ' ' THR . 55.8 m-85 -108.78 42.74 1.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 109.166 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.664 ' O ' ' CG ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -123.67 47.92 1.96 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.52 -0.737 . . . . 0.0 110.327 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 43' ' ' PHE . 31.9 Cg_endo -65.34 -3.53 7.71 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.469 2.113 . . . . 0.0 111.904 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.477 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -169.14 59.31 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.594 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -146.1 66.36 1.2 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 49' ' ' SER . 17.0 m-20 -41.05 -18.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.265 -0.897 . . . . 0.0 110.214 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 46' ' ' PHE . 1.1 mt 51.94 9.8 0.1 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 47' ' ' ASP . 10.7 t -67.18 155.87 37.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.38 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.506 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 11.4 t-80 -65.24 139.84 58.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.542 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.506 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 54.52 30.62 50.63 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.554 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 36.9 t -63.24 -98.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -1.15 . . . . 0.0 109.376 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 172.56 -39.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.862 . . . . 0.0 109.487 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -74.77 -20.1 59.94 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.275 -0.891 . . . . 0.0 109.44 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -84.72 -41.09 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -78.95 -26.48 43.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.862 . . . . 0.0 109.054 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.55 -21.94 63.23 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.565 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -79.02 -39.31 34.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -1.125 . . . . 0.0 109.558 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.79 -47.67 30.69 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 51.2 mttp -52.45 -23.78 6.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 0.0 109.804 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.651 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 1.7 mmpp? -72.08 -42.49 66.11 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.149 -0.969 . . . . 0.0 109.034 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 t -70.69 -48.24 59.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.52 -30.5 70.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.286 -0.884 . . . . 0.0 109.071 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.9 t0 -68.4 -32.59 72.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.927 . . . . 0.0 108.738 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.485 ' HB3' HMB3 ' A' ' 142' ' ' HEC . . . -68.46 -49.42 59.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.407 -0.808 . . . . 0.0 108.983 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.61 -39.93 93.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.274 -0.891 . . . . 0.0 108.817 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -70.69 -49.77 43.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.264 -0.898 . . . . 0.0 108.612 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -58.39 -21.03 48.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.47 -46.83 12.03 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.415 HG13 ' HE2' ' A' ' 11' ' ' LYS . 3.9 t -63.59 -22.83 31.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.97 64.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 74' ' ' ASP . 93.2 m-70 -147.14 -48.4 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.855 . . . . 0.0 109.402 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.4 p 44.99 13.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.752 0.787 . . . . 0.0 109.47 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 72' ' ' HIS . 37.3 m-20 -135.52 10.75 3.45 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 3.9 m-20 -174.94 26.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 15.0 ptt? -78.53 -22.59 0.39 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 111.706 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 76' ' ' MET . 49.7 Cg_exo -55.05 -17.93 15.85 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.506 1.471 . . . . 0.0 112.221 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -94.14 -46.81 6.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.272 -0.893 . . . . 0.0 109.387 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.02 -42.3 99.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.825 . . . . 0.0 109.15 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.76 9.16 8.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.489 -0.757 . . . . 0.0 108.996 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -57.33 -25.55 59.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.375 -0.828 . . . . 0.0 109.637 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -56.4 -57.99 9.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.119 -0.988 . . . . 0.0 109.463 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.477 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 6.6 mt -45.31 -50.45 11.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 3.4 m -49.25 -38.45 26.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 82' ' ' ALA . 27.9 t70 -82.52 -17.29 45.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.839 . . . . 0.0 109.865 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -70.7 -51.9 24.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.58 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 14.3 p-80 -92.16 -21.92 20.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.89 -1.131 . . . . 0.0 110.689 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -60.64 -51.32 69.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.852 -1.155 . . . . 0.0 109.907 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -155.69 63.78 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.94 . . . . 0.0 109.906 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -163.06 0.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.865 . . . . 0.0 109.29 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.6 tp -171.78 -31.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 51.76 47.74 24.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.46 136.97 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.484 ' OD2' ' CE1' ' D' ' 97' ' ' HIS . 22.5 m-20 -58.33 128.41 82.39 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 97' ' ' ASN . 73.0 Cg_endo -77.09 -18.62 14.3 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.302 2.002 . . . . 0.0 112.056 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.443 ' H ' HG23 ' A' ' 96' ' ' VAL . 3.3 t -46.75 -14.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.499 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 95' ' ' PRO . 20.7 m-80 -79.04 -24.6 43.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.506 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -52.98 -50.59 63.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.527 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' O ' ' CE1' ' A' ' 103' ' ' HIS . 47.0 mttp -56.61 -25.98 54.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.71 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.8 mt -84.2 -34.81 23.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 109.492 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.518 HD22 ' CHC' ' A' ' 142' ' ' HEC . 8.3 tp -74.86 -29.14 60.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 109.717 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -73.33 -39.13 65.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.963 . . . . 0.0 109.718 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 99' ' ' LYS . 7.1 m170 -80.73 -26.85 37.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.649 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 33.5 m -64.26 -53.79 43.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.168 -0.958 . . . . 0.0 109.755 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -46.7 -28.67 1.57 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.937 . . . . 0.0 109.601 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.92 -31.53 35.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 109.955 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.7 t -82.64 -26.59 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 109.649 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 p -74.41 -62.07 1.65 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 109.567 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 113' ' ' LEU . 17.7 mt -46.06 -35.31 4.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 0.0 109.416 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.77 -40.75 66.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.952 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' B' ' 122' ' ' PHE . . . -73.3 -40.9 64.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.702 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.531 ' NE2' ' OE2' ' A' ' 27' ' ' GLU . 64.5 m-70 -89.67 -78.77 0.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.545 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -107.7 113.49 61.34 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.511 ' O ' ' O ' ' A' ' 113' ' ' LEU . 77.8 Cg_exo -45.93 -173.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.235 1.957 . . . . 0.0 112.282 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.642 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -69.25 -53.2 21.06 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.473 -0.767 . . . . 0.0 109.078 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.642 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 26.0 mt-10 125.65 -0.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.502 ' O ' ' CD2' ' A' ' 117' ' ' PHE . 56.6 t80 58.04 33.56 23.31 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.408 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.795 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -106.59 117.22 57.5 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.513 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.14 20.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.146 1.898 . . . . 0.0 112.708 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.795 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -146.42 -34.07 0.3 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 0.0 110.211 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 115' ' ' ALA . 14.0 p -47.71 -47.04 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 109.926 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.61 ' N ' HG13 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -67.85 -33.64 75.15 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.4 -0.813 . . . . 0.0 109.287 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.32 -20.24 32.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.696 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.5 m -69.06 -62.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.12 -19.71 64.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.0 -1.062 . . . . 0.0 109.1 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.15 -46.79 13.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.71 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -89.84 -39.06 13.32 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.792 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.625 ' CD2' HG21 ' A' ' 10' ' ' VAL . 27.8 t80 -47.86 -20.66 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.915 -1.116 . . . . 0.0 108.666 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' N ' ' C ' ' A' ' 127' ' ' LYS . 29.1 mt -70.73 -19.64 62.72 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -55.08 -38.38 68.01 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.502 ' HB2' HD13 ' A' ' 2' ' ' LEU . 5.4 t -77.92 -29.72 50.17 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 135' ' ' VAL . 22.0 t -80.32 -39.11 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -68.08 -20.97 64.99 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.192 -0.943 . . . . 0.0 109.04 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 138' ' ' SER . 94.9 m -69.11 -39.53 78.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.505 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 132' ' ' VAL . 1.0 OUTLIER -76.51 -31.12 19.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.264 -0.897 . . . . 0.0 109.433 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.511 ' O ' ' NE2' ' A' ' 87' ' ' HIS . 0.5 OUTLIER -84.74 -23.84 29.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.868 . . . . 0.0 109.18 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.5 m -100.25 -15.57 18.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.371 -0.83 . . . . 0.0 109.453 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 134' ' ' THR . 1.8 t -63.61 140.35 58.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.5 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -84.96 -131.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -71.27 -111.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.47 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.982 HG22 ' H ' ' B' ' 2' ' ' HIS . 7.7 p . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 0.982 ' H ' HG22 ' B' ' 1' ' ' VAL . 20.6 t-80 51.3 88.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.897 -1.127 . . . . 0.0 109.057 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.784 ' N ' HD12 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -133.82 -171.96 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.449 -0.782 . . . . 0.0 109.317 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.419 ' O ' ' N ' ' B' ' 6' ' ' GLU . 12.6 p -90.0 134.86 30.96 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.25 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -41.61 -22.88 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.421 2.081 . . . . 0.0 112.357 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' B' ' 4' ' ' THR . 9.6 mp0 -79.28 -52.25 8.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.953 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.03 -60.58 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.692 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.559 ' HG3' HD13 ' B' ' 3' ' ' LEU . 5.0 ttpp -49.74 -51.75 36.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.823 . . . . 0.0 109.976 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -43.57 -23.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.63 -0.669 . . . . 0.0 110.235 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -82.94 -56.17 3.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.057 -1.027 . . . . 0.0 109.826 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' B' ' 130' ' ' TYR . 1.2 p -68.78 -24.56 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 10.9 m -71.61 -42.79 67.24 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.441 0.638 . . . . 0.0 109.544 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.59 67.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.05 -27.45 8.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.965 . . . . 0.0 109.445 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' TRP . . . . . 0.605 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.4 OUTLIER -52.37 -17.7 1.3 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.184 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.63 -41.77 28.43 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -28.75 35.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -1.22 . . . . 0.0 109.231 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 78.0 t -58.47 114.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.844 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' B' ' 21' ' ' ASP . 7.9 t-20 -81.76 67.08 7.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.237 -0.915 . . . . 0.0 108.726 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' B' ' 19' ' ' ASN . 84.4 t -42.75 -20.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.475 -0.766 . . . . 0.0 109.792 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' B' ' 19' ' ' ASN . 78.5 m-20 -75.55 2.72 10.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' B' ' 19' ' ' ASN . 33.9 mt-10 -155.57 -47.94 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -47.09 -33.06 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.507 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.72 -55.58 19.25 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.44 -36.75 93.01 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -76.09 -47.32 24.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -1.162 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.25 -33.84 59.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.15 -57.81 3.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.875 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.81 -45.06 55.67 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -50.33 -36.39 31.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -1.119 . . . . 0.0 109.489 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' LEU . . . . . 0.725 ' CD2' HBC2 ' B' ' 147' ' ' HEC . 42.9 tp -49.46 -38.9 31.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -81.1 -21.83 39.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 109.538 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 t -77.86 -64.32 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 0.0 109.703 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.403 ' H ' HG23 ' B' ' 34' ' ' VAL . 0.2 OUTLIER -69.11 -22.76 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.604 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -141.33 81.34 15.64 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.272 -0.892 . . . . 0.0 109.404 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.75 7.47 4.84 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.687 2.258 . . . . 0.0 112.475 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.55 ' CD1' HG23 ' B' ' 38' ' ' THR . 1.5 p-90 -66.01 -19.79 65.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.097 -1.002 . . . . 0.0 109.476 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.55 HG23 ' CD1' ' B' ' 37' ' ' TRP . 82.3 p -76.89 41.78 0.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLN . . . . . 0.427 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 35.1 tt0 -84.1 26.41 0.75 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.89 . . . . 0.0 109.372 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.13 -49.2 4.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.347 -0.845 . . . . 0.0 109.582 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -88.22 3.35 49.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' B' ' 39' ' ' GLN . 8.0 p90 -52.49 -30.12 28.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.675 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -49.16 -24.89 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.606 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 39.1 t -95.36 -9.02 34.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 0.0 109.536 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' B' ' 42' ' ' PHE . 16.1 m-85 -87.03 21.82 2.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 109.497 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -98.99 2.44 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' B' ' 47' ' ' ASP . 27.2 p-10 -156.86 112.66 2.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -1.125 . . . . 0.0 109.606 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.524 ' N ' HD12 ' B' ' 48' ' ' LEU . 9.4 mp -80.01 24.54 0.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.15 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.425 ' C ' ' O ' ' B' ' 48' ' ' LEU . 29.2 t -43.09 -29.97 0.4 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.385 -0.822 . . . . 0.0 109.686 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' THR . . . . . 0.415 ' O ' ' N ' ' B' ' 53' ' ' ALA . 73.1 p -148.74 139.02 13.15 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 109.16 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -39.35 -36.12 0.88 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.442 2.095 . . . . 0.0 112.411 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.29 -33.77 61.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.847 . . . . 0.0 109.624 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -48.86 -19.81 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.563 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.56 -64.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.606 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' B' ' 55' ' ' MET . 1.9 mpt? -80.26 4.22 18.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.983 . . . . 0.0 109.467 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.02 -26.84 47.56 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' B' ' 53' ' ' ALA . 67.3 m-80 -84.79 141.84 38.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.095 -1.238 . . . . 0.0 109.423 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.05 -40.01 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.612 2.208 . . . . 0.0 112.245 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -47.39 78.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.549 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 89.9 t -50.79 -41.01 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.895 . . . . 0.0 109.58 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -79.09 -42.44 26.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.741 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.55 -30.27 71.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.492 ' CE1' HBA1 ' B' ' 147' ' ' HEC . 1.3 t-80 -66.21 -23.88 66.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.542 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.62 -46.69 74.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.489 ' HZ3' ' C ' ' B' ' 21' ' ' ASP . 8.3 mtpp -54.49 -29.42 50.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.576 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' LYS . . . . . 0.43 ' HB3' HBA2 ' B' ' 147' ' ' HEC . 38.5 mmtm -73.85 -32.79 63.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.925 . . . . 0.0 109.579 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 0.86 HG22 ' C4A' ' B' ' 147' ' ' HEC . 34.8 t -81.32 -30.75 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.46 -44.61 57.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 109.39 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.95 -44.87 19.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.12 -45.75 86.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -1.175 . . . . 0.0 109.621 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.544 ' CE2' HMB1 ' B' ' 147' ' ' HEC . 14.0 m-85 -57.43 -51.29 70.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.625 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.605 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.9 t -57.54 -43.05 84.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -0.824 . . . . 0.0 109.644 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -48.38 -29.99 4.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.986 . . . . 0.0 109.445 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.43 -60.25 5.61 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.601 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -54.95 -23.69 20.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -1.113 . . . . 0.0 109.264 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.51 9.41 43.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -170.77 70.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.958 . . . . 0.0 109.739 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.785 HD22 HG21 ' B' ' 1' ' ' VAL . 91.1 mt -86.14 -7.75 58.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.185 -0.947 . . . . 0.0 109.387 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.63 -26.73 5.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.433 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 8.6 p-10 -172.33 41.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.289 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.702 HD23 ' N ' ' B' ' 81' ' ' LEU . 1.6 pt? -46.63 -18.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.36 -0.837 . . . . 0.0 109.849 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' B' ' 80' ' ' ASN . 59.6 mttm -79.93 -32.32 40.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.06 -1.025 . . . . 0.0 109.638 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.26 -23.01 55.9 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.7 OUTLIER -70.78 -42.99 69.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.102 -1.234 . . . . 0.0 109.733 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.483 ' N ' ' CG2' ' B' ' 84' ' ' THR . 30.9 m-85 -84.81 25.96 0.88 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.6 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.51 -26.94 55.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.264 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.447 ' O ' ' N ' ' B' ' 91' ' ' LEU . 81.2 p -79.69 -54.89 5.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.311 -0.868 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.1 mt -47.97 -43.12 29.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.163 -0.961 . . . . 0.0 109.266 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' SER . . . . . 0.514 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 1.5 m -64.72 -38.89 92.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.192 -0.942 . . . . 0.0 109.555 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.482 ' HA ' ' HG ' ' B' ' 93' ' ' CYS . 56.8 tt0 -82.1 -22.6 36.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.5 tt -90.29 -39.22 12.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.977 . . . . 0.0 109.744 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' B' ' 97' ' ' HIS . 4.0 m80 -77.75 -29.92 51.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.02 -1.05 . . . . 0.0 110.176 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' B' ' 94' ' ' ASP . 13.2 p -83.51 -48.62 10.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.048 -1.032 . . . . 0.0 110.81 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.639 ' N ' ' SG ' ' B' ' 93' ' ' CYS . 23.6 m-20 -87.33 -34.38 18.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.904 -1.123 . . . . 0.0 111.523 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -89.01 -51.84 5.4 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.815 -1.178 . . . . 0.0 111.01 -178.259 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 12.9 mt -98.3 -17.79 18.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.95 -1.094 . . . . 0.0 110.314 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 31.0 p80 42.6 33.8 0.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.396 -0.815 . . . . 0.0 110.204 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 68.0 t -58.25 127.44 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.158 -0.964 . . . . 0.0 109.031 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' B' ' 99' ' ' ASP . 4.6 p-10 -45.61 148.33 1.3 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 109.494 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' B' ' 102' ' ' ASN . 59.8 Cg_endo -72.99 -40.09 1.94 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.61 2.207 . . . . 0.0 112.342 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -67.76 52.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.486 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' B' ' 100' ' ' PRO . 56.0 t-20 -140.68 -49.7 0.44 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.274 -0.891 . . . . 0.0 109.644 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -46.23 -24.22 0.44 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.832 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -74.54 -20.01 60.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' B' ' 108' ' ' ASN . 43.1 mt -80.65 -59.55 2.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.548 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.972 HD22 ' CAB' ' B' ' 147' ' ' HEC . 8.2 tt -46.94 -35.13 6.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.523 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.27 -26.4 74.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ASN . . . . . 0.534 HD21 ' C ' ' B' ' 108' ' ' ASN . 0.1 OUTLIER -85.52 -19.24 31.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -1.172 . . . . 0.0 109.778 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 77.4 t -84.15 -24.69 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.596 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.453 HD23 ' O ' ' B' ' 110' ' ' LEU . 1.4 tt -71.73 -60.0 2.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.44 ' H ' HG23 ' B' ' 111' ' ' VAL . 11.7 t -51.39 -29.02 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 14.5 t -65.3 -41.35 94.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.183 -0.948 . . . . 0.0 109.571 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.06 -45.94 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.584 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.74 -26.55 68.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.634 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.493 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -68.12 -34.43 76.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.492 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.96 -62.85 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 109.398 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.614 ' ND1' ' CZ ' ' B' ' 118' ' ' PHE . 12.4 t-80 -55.82 -19.68 12.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 109.74 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.614 ' CZ ' ' ND1' ' B' ' 117' ' ' HIS . 67.5 m-85 -151.6 60.8 0.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -72.63 -16.93 77.78 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -69.41 -30.03 67.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.481 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -94.01 13.54 22.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.915 . . . . 0.0 109.822 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.585 ' CD2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -81.43 33.31 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.46 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 13.1 p -47.73 130.11 11.2 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.516 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 45.5 Cg_exo -43.38 -51.9 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.194 1.929 . . . . 0.0 113.029 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 18.9 Cg_endo -58.84 -33.97 98.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.823 1.682 . . . . 0.0 111.883 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 49.7 t -82.41 -9.98 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 0.0 109.579 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' GLN . . . . . 0.927 ' HG2' HH11 ' A' ' 31' ' ' ARG . 13.9 tp60 -75.85 -59.78 2.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -61.08 -34.04 74.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.451 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.19 11.77 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 109.545 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' B' ' 128' ' ' ALA . 6.3 t80 -105.0 -55.25 2.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 109.704 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.676 ' OE1' ' HA ' ' A' ' 35' ' ' SER . 6.5 pt20 -45.82 -44.2 13.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.928 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' B' ' 1' ' ' VAL . 21.0 mtmm -57.14 -50.04 74.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.979 . . . . 0.0 109.997 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.92 -46.95 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.133 -0.98 . . . . 0.0 109.984 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.39 -33.78 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.919 . . . . 0.0 110.197 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.89 -27.26 2.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.975 -1.078 . . . . 0.0 109.394 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.77 -25.67 73.02 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.35 -49.25 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -1.125 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.62 -42.79 35.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -78.22 -23.47 47.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.41 3.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.86 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.53 -14.15 0.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.879 . . . . 0.0 109.368 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' B' ' 144' ' ' LYS . . . -93.95 4.67 53.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.362 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' HIS . . . . . 0.515 ' O ' ' CG ' ' B' ' 143' ' ' HIS . 11.0 t-160 -68.47 7.8 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.335 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' B' ' 142' ' ' ALA . 39.7 mmtt -139.25 -41.31 0.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.352 -0.842 . . . . 0.0 109.498 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.513 ' CE1' ' OXT' ' B' ' 146' ' ' HIS . 0.0 OUTLIER -56.19 -12.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 109.491 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.513 ' OXT' ' CE1' ' B' ' 145' ' ' TYR . 15.7 m-70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.711 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' C' ' 2' ' ' LEU . 2.9 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' C' ' 3' ' ' SER . 3.3 tp 75.68 174.4 0.24 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -0.849 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.618 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 164.45 -38.1 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.363 -0.835 . . . . 0.0 110.46 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' C' ' 3' ' ' SER . 77.3 Cg_exo -49.6 -173.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.305 2.003 . . . . 0.0 112.972 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.484 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -75.75 -15.84 60.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.405 -0.81 . . . . 0.0 110.147 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' C' ' 127' ' ' LYS . 4.8 p30 -39.11 -38.21 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.554 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.477 ' N ' ' OD1' ' C' ' 6' ' ' ASP . 12.9 mtmm -57.43 -58.37 8.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 108.932 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.8 m -51.57 -31.84 26.08 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 108.942 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -76.62 -34.75 58.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.631 HG21 ' CD2' ' C' ' 128' ' ' PHE . 51.7 t -72.62 -49.97 37.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 11' ' ' LYS . . . . . 0.433 ' HE2' HG13 ' C' ' 70' ' ' VAL . 0.6 OUTLIER -52.03 -42.46 63.08 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.62 -60.78 3.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.361 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.668 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -53.73 -33.98 57.4 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.378 -0.826 . . . . 0.0 109.162 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -17.73 61.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.081 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.35 -45.13 10.18 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -68.82 -39.74 79.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.227 -1.161 . . . . 0.0 108.849 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.668 HG23 ' O ' ' C' ' 13' ' ' ALA . 89.8 t -60.86 -65.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.59 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 58.12 -136.69 50.69 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.12 27.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.464 -1.021 . . . . 0.0 110.302 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.59 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.6 m-70 -131.5 27.16 4.73 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.02 -63.88 1.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.611 -0.68 . . . . 0.0 109.869 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.91 -14.38 0.12 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.5 mt-10 -85.1 -56.34 3.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -1.055 . . . . 0.0 109.683 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.9 m-30 -58.03 -43.83 86.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.125 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.08 -22.83 56.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.07 -33.97 59.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.165 . . . . 0.0 109.69 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' GLU . . . . . 0.525 ' OE2' ' NE2' ' C' ' 112' ' ' HIS . 47.1 mt-10 -69.01 -20.27 64.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.716 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.61 -19.73 59.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.27 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -72.1 -48.07 46.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.349 -0.845 . . . . 0.0 109.681 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.54 -24.68 63.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.91 HH11 ' HG2' ' D' ' 127' ' ' GLN . 50.3 ttm-85 -76.15 -21.23 56.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' MET . . . . . 0.508 ' HB3' ' HE2' ' C' ' 32' ' ' MET . 54.1 ttp -82.12 -50.65 8.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.49 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 33' ' ' PHE . . . . . 0.441 ' CD2' ' OG1' ' C' ' 39' ' ' THR . 9.4 m-85 -52.72 -44.29 66.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.699 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.786 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 6.5 mt -67.51 -58.83 4.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.671 ' HA ' ' OE1' ' D' ' 131' ' ' GLN . 40.9 m -48.34 -34.08 10.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.802 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -146.67 90.42 5.53 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.94 . . . . 0.0 109.356 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' C' ' 39' ' ' THR . 48.2 Cg_exo -53.48 -19.33 13.21 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.745 2.297 . . . . 0.0 112.172 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.407 ' O ' HG22 ' C' ' 41' ' ' THR . 12.8 p -42.65 -18.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.43 -0.794 . . . . 0.0 110.117 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.561 ' N ' ' O ' ' C' ' 37' ' ' PRO . 45.6 p -75.44 -22.22 57.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 110.09 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' C' ' 43' ' ' PHE . 1.8 mptm? -46.59 -44.96 18.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.431 HG21 ' CD2' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -62.46 -18.37 61.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -108.81 42.85 1.33 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 109.135 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.656 ' O ' ' CG ' ' C' ' 43' ' ' PHE . 0.1 OUTLIER -123.79 47.94 2.01 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.475 -0.766 . . . . 0.0 110.343 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' C' ' 43' ' ' PHE . 31.8 Cg_endo -65.32 -3.56 7.74 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.459 2.106 . . . . 0.0 111.868 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.491 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER -169.11 59.3 0.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.879 . . . . 0.0 109.304 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -146.16 66.34 1.2 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' C' ' 49' ' ' SER . 17.0 m-20 -40.99 -18.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.274 -0.892 . . . . 0.0 110.299 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.578 ' N ' ' O ' ' C' ' 46' ' ' PHE . 1.1 mt 52.03 9.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.069 -1.02 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.474 ' H ' ' C ' ' C' ' 47' ' ' ASP . 10.7 t -67.09 155.85 37.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' HIS . . . . . 0.51 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 11.3 t-80 -65.34 139.84 58.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 51' ' ' GLY . . . . . 0.51 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 54.57 30.66 51.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' C' ' 53' ' ' ALA . 37.1 t -63.27 -98.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -1.122 . . . . 0.0 109.396 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' C' ' 52' ' ' SER . . . 172.56 -39.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.545 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -74.68 -20.22 59.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.41 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.0 t -84.63 -41.02 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -79.03 -26.4 43.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 109.083 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.67 -21.79 63.23 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.577 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.3 OUTLIER -79.05 -39.28 34.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -1.132 . . . . 0.0 109.575 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.87 -47.66 31.18 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 51.3 mttp -52.45 -23.79 6.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -1.083 . . . . 0.0 109.696 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.646 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 1.7 mmpp? -72.11 -42.53 65.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.171 -0.955 . . . . 0.0 109.042 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 t -70.58 -48.31 59.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.453 -0.78 . . . . 0.0 108.969 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.55 -30.41 70.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.242 -0.911 . . . . 0.0 109.11 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 8.0 t0 -68.46 -32.54 72.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 108.693 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.48 ' HB3' HMB3 ' C' ' 142' ' ' HEC . . . -68.56 -49.36 60.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.473 -0.767 . . . . 0.0 108.954 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.56 -40.05 93.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 108.744 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -70.67 -49.82 43.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -58.38 -20.96 48.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.51 -46.83 12.0 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.433 HG13 ' HE2' ' C' ' 11' ' ' LYS . 3.9 t -63.44 -23.0 32.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.3 -26.1 64.7 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' C' ' 74' ' ' ASP . 93.2 m-70 -147.08 -48.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.424 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.4 p 45.06 12.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.783 0.802 . . . . 0.0 109.525 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' C' ' 72' ' ' HIS . 37.4 m-20 -135.45 10.68 3.47 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.414 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 3.9 m-20 -174.96 26.68 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.686 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 15.1 ptt? -78.63 -22.54 0.39 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.403 -0.811 . . . . 0.0 111.705 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' C' ' 76' ' ' MET . 49.7 Cg_exo -54.98 -18.02 15.73 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.547 1.498 . . . . 0.0 112.208 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -94.12 -46.77 6.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.96 . . . . 0.0 109.381 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.96 -42.36 99.03 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.294 -0.878 . . . . 0.0 109.183 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.76 9.22 8.28 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 108.994 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -57.48 -25.45 59.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 109.608 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -56.49 -58.02 9.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.377 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.478 ' O ' ' CE1' ' C' ' 87' ' ' HIS . 6.5 mt -45.17 -50.5 11.36 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 3.4 m -49.29 -38.36 27.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' C' ' 82' ' ' ALA . 27.9 t70 -82.51 -17.44 45.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 109.782 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -70.69 -51.83 25.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.567 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' HIS . . . . . 0.52 ' NE2' ' O ' ' C' ' 136' ' ' LEU . 14.3 p-80 -92.2 -21.8 20.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.965 -1.084 . . . . 0.0 110.754 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -60.67 -51.37 69.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.838 -1.164 . . . . 0.0 109.881 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -155.66 63.9 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.88 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.403 ' H ' ' H ' ' C' ' 91' ' ' LEU . 26.3 ttmt -163.16 1.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.259 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.403 ' H ' ' H ' ' C' ' 90' ' ' LYS . 60.5 tp -171.77 -32.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.299 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 51.7 47.82 24.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.626 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.62 136.88 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.407 ' OD2' ' CE1' ' B' ' 97' ' ' HIS . 22.3 m-20 -58.25 128.36 81.98 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.269 -0.894 . . . . 0.0 109.507 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' C' ' 97' ' ' ASN . 74.3 Cg_endo -77.01 -18.57 14.48 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.336 2.024 . . . . 0.0 112.194 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -46.72 -15.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 109.569 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' C' ' 95' ' ' PRO . 20.7 m-80 -78.97 -24.5 43.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.99 -50.65 63.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.4 ' O ' ' CE1' ' C' ' 103' ' ' HIS . 46.9 mttp -56.61 -25.96 54.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.73 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 9.8 mt -84.24 -34.62 23.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 109.592 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.516 HD22 ' CHC' ' C' ' 142' ' ' HEC . 8.3 tp -74.99 -29.09 60.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 109.714 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 66.6 m -73.36 -39.13 65.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.668 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' C' ' 99' ' ' LYS . 7.2 m170 -80.77 -26.81 37.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.299 -0.876 . . . . 0.0 109.644 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 33.0 m -64.32 -53.69 44.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.739 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -46.79 -28.59 1.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.968 . . . . 0.0 109.63 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 15.8 mt -80.94 -31.52 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 109.941 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 87.9 t -82.59 -26.66 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.03 -1.044 . . . . 0.0 109.683 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 5.2 p -74.41 -62.06 1.65 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.189 -0.944 . . . . 0.0 109.585 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 113' ' ' LEU . 17.5 mt -46.06 -35.22 4.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.87 -40.74 66.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.931 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 111' ' ' ALA . . . . . 0.595 ' HB2' ' CD2' ' D' ' 122' ' ' PHE . . . -73.37 -40.83 64.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.661 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 112' ' ' HIS . . . . . 0.525 ' NE2' ' OE2' ' C' ' 27' ' ' GLU . 64.7 m-70 -89.67 -78.77 0.35 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.571 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.4 OUTLIER -107.75 113.53 61.23 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 114' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' C' ' 113' ' ' LEU . 78.9 Cg_exo -45.99 -173.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.198 1.932 . . . . 0.0 112.292 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.65 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -69.46 -52.98 21.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 109.098 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.65 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 26.1 mt-10 125.48 -0.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' C' ' 117' ' ' PHE . 56.8 t80 58.02 33.52 23.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.344 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.784 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -106.51 117.3 57.39 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.3 20.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.134 1.889 . . . . 0.0 112.689 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.784 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -146.39 -34.11 0.3 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.026 -1.046 . . . . 0.0 110.232 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.617 HG13 ' N ' ' C' ' 122' ' ' HIS . 14.0 p -47.71 -47.05 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 109.871 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.617 ' N ' HG13 ' C' ' 121' ' ' VAL . 0.0 OUTLIER -67.94 -33.55 74.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.813 . . . . 0.0 109.259 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.27 -20.35 32.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.905 . . . . 0.0 109.713 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.542 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.5 m -68.99 -62.84 1.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.11 -19.69 64.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.951 -1.093 . . . . 0.0 109.076 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.18 -46.75 13.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.679 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -89.85 -39.02 13.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.007 . . . . 0.0 109.836 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.631 ' CD2' HG21 ' C' ' 10' ' ' VAL . 27.6 t80 -47.82 -20.74 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.966 -1.083 . . . . 0.0 108.629 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.431 ' N ' ' C ' ' C' ' 127' ' ' LYS . 29.5 mt -70.66 -19.66 62.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -55.09 -38.37 68.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.495 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 5.4 t -77.9 -29.74 50.3 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 132' ' ' VAL . . . . . 0.42 ' O ' HG22 ' C' ' 135' ' ' VAL . 22.0 t -80.28 -39.21 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.352 -0.842 . . . . 0.0 108.787 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -67.96 -21.03 65.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.922 . . . . 0.0 109.063 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 134' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' C' ' 138' ' ' SER . 93.7 m -69.15 -39.46 78.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.845 . . . . 0.0 109.46 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.452 ' H ' HG13 ' C' ' 135' ' ' VAL . 1.0 OUTLIER -76.62 -31.01 19.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.297 -0.877 . . . . 0.0 109.41 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' C' ' 87' ' ' HIS . 0.5 OUTLIER -84.76 -23.89 29.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.889 . . . . 0.0 109.13 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 43.0 m -100.23 -15.57 18.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.319 -0.863 . . . . 0.0 109.443 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 138' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' C' ' 134' ' ' THR . 1.8 t -63.62 140.32 58.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -84.97 -131.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -71.33 -111.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.426 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.486 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.957 HG22 ' H ' ' D' ' 2' ' ' HIS . 7.6 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 2' ' ' HIS . . . . . 0.957 ' H ' HG22 ' D' ' 1' ' ' VAL . 20.2 t-80 51.29 88.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.098 -1.001 . . . . 0.0 109.082 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.79 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -133.79 -171.87 2.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.292 -179.473 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.417 ' O ' ' N ' ' D' ' 6' ' ' GLU . 12.6 p -90.06 134.88 30.83 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.88 . . . . 0.0 109.322 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -41.61 -22.94 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.423 2.082 . . . . 0.0 112.365 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' GLU . . . . . 0.421 ' N ' ' CD ' ' D' ' 6' ' ' GLU . 9.6 mp0 -79.16 -52.37 8.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -62.99 -60.56 3.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 109.754 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.574 ' HG3' HD13 ' D' ' 3' ' ' LEU . 5.0 ttpp -49.71 -51.87 35.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.94 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -43.51 -23.69 0.08 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.61 -0.681 . . . . 0.0 110.285 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.01 -56.14 3.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.027 -1.045 . . . . 0.0 109.763 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.46 HG23 ' CD2' ' D' ' 130' ' ' TYR . 1.2 p -68.75 -24.63 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 10.5 m -71.5 -42.83 67.53 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.455 0.645 . . . . 0.0 109.594 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.4 -27.63 68.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.746 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.94 -27.53 7.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 15' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.4 OUTLIER -52.35 -17.82 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 109.155 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.47 -41.92 28.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.99 -28.73 35.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -1.204 . . . . 0.0 109.219 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 78.4 t -58.45 114.91 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.804 . . . . 0.0 109.886 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' D' ' 21' ' ' ASP . 7.9 t-20 -81.84 67.07 7.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.262 -0.899 . . . . 0.0 108.737 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' D' ' 19' ' ' ASN . 84.3 t -42.72 -20.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.467 -0.77 . . . . 0.0 109.835 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.56 ' C ' ' HZ3' ' D' ' 65' ' ' LYS . 78.5 m-20 -75.68 2.82 10.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.88 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' D' ' 19' ' ' ASN . 33.9 mt-10 -155.6 -47.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 53.1 t -47.1 -33.08 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 109.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.74 -55.61 19.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.47 -36.63 92.85 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -76.23 -47.21 24.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -1.119 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.27 -33.86 59.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.394 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.18 -57.77 3.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.958 . . . . 0.0 109.385 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.81 -45.03 55.69 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -50.37 -36.43 32.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -1.096 . . . . 0.0 109.486 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' LEU . . . . . 0.715 ' CD2' HBC2 ' D' ' 147' ' ' HEC . 42.9 tp -49.41 -38.85 30.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.354 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.13 -21.94 39.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 t -77.81 -64.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -0.99 . . . . 0.0 109.705 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.427 HG23 ' H ' ' D' ' 34' ' ' VAL . 0.2 OUTLIER -68.92 -22.88 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.639 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -141.26 81.36 15.73 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.325 -0.86 . . . . 0.0 109.396 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.8 7.47 4.85 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.703 2.269 . . . . 0.0 112.449 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' TRP . . . . . 0.546 ' NE1' HG23 ' D' ' 38' ' ' THR . 1.5 p-90 -65.97 -19.86 66.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.512 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.546 HG23 ' NE1' ' D' ' 37' ' ' TRP . 82.4 p -76.83 41.74 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.413 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 39' ' ' GLN . . . . . 0.421 ' O ' ' CD1' ' D' ' 42' ' ' PHE . 35.1 tt0 -84.03 26.34 0.74 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.383 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.11 -49.19 4.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.905 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -88.16 3.37 49.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' D' ' 39' ' ' GLN . 7.8 p90 -52.63 -30.14 29.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.601 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -49.11 -24.89 1.81 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.649 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 39.2 t -95.38 -8.99 34.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.537 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -87.05 21.88 2.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -99.13 2.45 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' D' ' 47' ' ' ASP . 27.2 p-10 -156.8 112.7 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 48' ' ' LEU . . . . . 0.533 ' N ' HD12 ' D' ' 48' ' ' LEU . 9.4 mp -80.04 24.57 0.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.172 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' D' ' 48' ' ' LEU . 29.1 t -43.09 -30.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.428 -0.795 . . . . 0.0 109.624 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 50' ' ' THR . . . . . 0.431 ' O ' ' N ' ' D' ' 53' ' ' ALA . 73.1 p -148.77 138.95 13.09 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 109.154 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -39.36 -36.1 0.88 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.458 2.105 . . . . 0.0 112.415 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.2 -33.86 61.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.16 -0.962 . . . . 0.0 109.652 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -48.92 -19.78 0.43 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 93.9 t -67.45 -64.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.733 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' D' ' 55' ' ' MET . 1.9 mpt? -80.17 4.14 18.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 109.496 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.08 -26.74 47.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 57' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' D' ' 53' ' ' ALA . 67.2 m-80 -84.84 141.83 38.56 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 0.0 109.489 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.1 -39.91 1.49 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.497 2.132 . . . . 0.0 112.254 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.92 -47.38 77.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.48 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 89.4 t -50.83 -40.94 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -79.19 -42.41 26.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.624 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.53 -30.23 71.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.621 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.488 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 1.3 t-80 -66.26 -23.85 66.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.561 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.7 -46.65 73.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 65' ' ' LYS . . . . . 0.56 ' HZ3' ' C ' ' D' ' 21' ' ' ASP . 8.2 mtpp -54.41 -29.54 49.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -1.192 . . . . 0.0 109.556 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 66' ' ' LYS . . . . . 0.41 ' HB3' HBA2 ' D' ' 147' ' ' HEC . 38.5 mmtm -73.75 -32.86 64.05 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 109.625 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.855 HG22 ' C4A' ' D' ' 147' ' ' HEC . 34.7 t -81.23 -30.78 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.54 -44.54 57.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.339 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.92 -44.84 18.87 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.61 87.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -1.137 . . . . 0.0 109.621 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 71' ' ' PHE . . . . . 0.546 ' CE2' HMB1 ' D' ' 147' ' ' HEC . 13.9 m-85 -57.46 -51.3 69.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 109.594 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 72' ' ' SER . . . . . 0.6 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 9.0 t -57.54 -43.03 84.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.699 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -48.36 -30.13 4.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.42 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.32 -60.21 5.69 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.594 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.9 mp -55.07 -23.64 21.28 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.223 -1.163 . . . . 0.0 109.239 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.54 9.48 43.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.622 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -170.84 70.01 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 109.787 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 78' ' ' LEU . . . . . 0.787 HD22 HG21 ' D' ' 1' ' ' VAL . 91.0 mt -85.98 -7.83 58.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.58 -26.74 5.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 80' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' D' ' 80' ' ' ASN . 8.5 p-10 -172.3 41.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 109.233 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 81' ' ' LEU . . . . . 0.698 HD23 ' N ' ' D' ' 81' ' ' LEU . 1.5 pt? -46.66 -18.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.884 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 82' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' D' ' 80' ' ' ASN . 59.5 mttm -80.02 -32.29 39.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.106 -0.996 . . . . 0.0 109.609 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.26 -23.04 55.79 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.7 OUTLIER -70.78 -43.05 69.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.039 -1.271 . . . . 0.0 109.676 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.485 ' N ' ' CG2' ' D' ' 84' ' ' THR . 30.8 m-85 -84.81 26.01 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.57 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.56 -26.93 56.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.918 . . . . 0.0 109.274 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 87' ' ' THR . . . . . 0.457 ' O ' ' N ' ' D' ' 91' ' ' LEU . 81.3 p -79.67 -54.99 5.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -47.86 -43.16 28.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.358 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 89' ' ' SER . . . . . 0.523 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 1.5 m -64.81 -38.81 92.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 109.513 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.483 ' HA ' ' HG ' ' D' ' 93' ' ' CYS . 57.2 tt0 -82.09 -22.6 36.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.676 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' D' ' 87' ' ' THR . 7.5 tt -90.24 -39.29 12.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 109.753 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' D' ' 97' ' ' HIS . 4.0 m80 -77.64 -29.92 51.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.054 -1.028 . . . . 0.0 110.234 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 93' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' D' ' 94' ' ' ASP . 13.1 p -83.51 -48.59 10.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.129 -0.982 . . . . 0.0 110.807 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.638 ' N ' ' SG ' ' D' ' 93' ' ' CYS . 23.9 m-20 -87.31 -34.42 18.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.91 -1.119 . . . . 0.0 111.493 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 95' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -89.03 -51.8 5.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.807 -1.183 . . . . 0.0 111.006 -178.237 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.582 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 12.9 mt -98.29 -17.79 18.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.942 -1.099 . . . . 0.0 110.26 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 31.0 p80 42.39 34.03 0.48 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.301 -0.874 . . . . 0.0 110.213 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 67.7 t -58.32 127.27 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 109.093 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 99' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' D' ' 99' ' ' ASP . 4.7 p-10 -45.4 148.41 1.18 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.563 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 100' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' D' ' 102' ' ' ASN . 59.3 Cg_endo -73.13 -40.05 1.89 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.614 2.209 . . . . 0.0 112.316 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -67.69 52.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.482 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 102' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' D' ' 100' ' ' PRO . 56.1 t-20 -140.75 -49.61 0.44 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -46.27 -24.24 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 109.764 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -74.61 -19.95 60.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 105' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' D' ' 108' ' ' ASN . 43.5 mt -80.7 -59.59 2.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.963 . . . . 0.0 109.453 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.959 HD22 ' CAB' ' D' ' 147' ' ' HEC . 8.2 tt -46.91 -35.17 6.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.23 -26.43 74.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 108' ' ' ASN . . . . . 0.542 HD21 ' C ' ' D' ' 108' ' ' ASN . 0.1 OUTLIER -85.49 -19.26 31.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -1.163 . . . . 0.0 109.794 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 77.4 t -84.05 -24.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 110' ' ' LEU . . . . . 0.449 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.5 tt -71.82 -59.99 2.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.465 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 11.6 t -51.3 -29.12 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.592 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 14.6 t -65.36 -41.24 94.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.22 -45.9 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.542 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.71 -26.56 68.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.643 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.501 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -68.17 -34.29 76.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 109.524 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.454 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -85.06 -62.84 1.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 0.0 109.388 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 117' ' ' HIS . . . . . 0.615 ' ND1' ' CZ ' ' D' ' 118' ' ' PHE . 12.3 t-80 -55.75 -19.76 12.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 109.748 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.615 ' CZ ' ' ND1' ' D' ' 117' ' ' HIS . 67.6 m-85 -151.62 60.83 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.539 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -72.54 -17.05 77.68 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -69.36 -30.06 67.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.144 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -94.0 13.58 22.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.807 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -81.46 33.26 0.35 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.663 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.46 ' OG1' ' CG2' ' D' ' 126' ' ' VAL . 13.3 p -47.67 130.07 11.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.312 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.525 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 45.6 Cg_exo -43.43 -51.88 5.57 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.134 1.89 . . . . 0.0 113.037 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 18.8 Cg_endo -58.78 -33.92 98.71 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.791 1.661 . . . . 0.0 111.955 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 49.1 t -82.37 -10.06 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.535 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 127' ' ' GLN . . . . . 0.91 ' HG2' HH11 ' C' ' 31' ' ' ARG . 14.0 tp60 -75.94 -59.75 2.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 109.423 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.786 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -61.12 -33.99 74.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.26 11.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' D' ' 128' ' ' ALA . 6.3 t80 -104.88 -55.34 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.299 -0.876 . . . . 0.0 109.738 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 0.671 ' OE1' ' HA ' ' C' ' 35' ' ' SER . 6.5 pt20 -45.87 -44.12 14.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.88 . . . . 0.0 109.899 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 132' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' D' ' 1' ' ' VAL . 21.1 mtmm -57.17 -50.11 73.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.991 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.84 -46.93 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.024 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.449 ' H ' HG22 ' D' ' 134' ' ' VAL . 15.6 m -83.36 -33.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.113 -0.992 . . . . 0.0 110.203 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.89 -27.32 2.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.968 -1.082 . . . . 0.0 109.404 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.69 -25.67 72.93 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.34 -49.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -1.151 . . . . 0.0 109.441 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.65 -42.81 35.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.435 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -78.21 -23.43 47.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.464 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.01 -60.4 3.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.51 -14.14 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 142' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' D' ' 144' ' ' LYS . . . -94.01 4.75 53.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.91 . . . . 0.0 109.386 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 143' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' D' ' 143' ' ' HIS . 11.0 t-160 -68.52 7.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 109.342 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' D' ' 142' ' ' ALA . 39.7 mmtt -139.32 -41.28 0.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.367 -0.833 . . . . 0.0 109.466 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 145' ' ' TYR . . . . . 0.521 ' CE1' ' OXT' ' D' ' 146' ' ' HIS . 0.0 OUTLIER -56.26 -12.04 1.43 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.406 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.521 ' OXT' ' CE1' ' D' ' 145' ' ' TYR . 15.5 m-70 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.742 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.839 HBB2 HMB1 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 0.972 ' CAB' HD22 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.826 HBB2 HMB1 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 0.959 ' CAB' HD22 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.42 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 48.9 mt -125.32 -162.32 1.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.354 -0.841 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 177.12 -48.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.865 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 3' ' ' SER . 68.3 Cg_exo -49.18 174.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.391 2.061 . . . . 0.0 112.437 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -56.98 -16.56 7.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.614 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.472 ' C ' ' O ' ' A' ' 5' ' ' ALA . 14.8 t70 -39.92 -31.67 0.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 109.524 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 5' ' ' ALA . 9.3 mtmp? -73.34 -55.97 5.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.407 -0.808 . . . . 0.0 109.216 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 m -47.53 -28.63 2.33 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.139 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -78.33 -38.58 41.83 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.514 HG21 ' CD2' ' A' ' 128' ' ' PHE . 40.9 t -70.8 -48.91 54.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -51.58 -44.66 62.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 108.839 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.81 -58.55 7.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.818 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -55.68 -31.83 62.73 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.47 -17.4 58.07 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.201 -0.937 . . . . 0.0 108.914 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.35 -38.77 44.85 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -84.4 -40.86 17.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.381 -1.07 . . . . 0.0 109.32 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.573 ' O ' ' C ' ' A' ' 18' ' ' GLY . 93.7 t -66.69 -45.93 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 109.709 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.632 ' O ' ' HB3' ' A' ' 19' ' ' ALA . . . -25.1 137.81 0.01 OUTLIER Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . 74.26 -29.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.43 -1.041 . . . . 0.0 109.331 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.511 ' H ' ' C ' ' A' ' 18' ' ' GLY . 38.0 m-70 -110.76 16.79 21.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HB1' ' HB1' ' A' ' 63' ' ' ALA . . . -82.39 -60.8 2.08 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.008 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.46 -14.84 0.39 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.0 mt-10 -85.47 -56.35 3.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -1.177 . . . . 0.0 109.758 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.4 m-30 -60.69 -35.2 75.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.0 109.398 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.37 -23.01 73.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.74 -47.03 14.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -1.154 . . . . 0.0 109.64 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -63.57 -19.87 65.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 109.327 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.03 -27.6 63.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.44 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.416 HD11 ' ND1' ' A' ' 58' ' ' HIS . 9.0 mt -70.4 -53.68 15.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.907 . . . . 0.0 109.57 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.16 -29.37 69.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.251 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.38 -30.34 67.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.299 -0.876 . . . . 0.0 109.224 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.52 ' HE2' ' HB3' ' A' ' 32' ' ' MET . 47.9 ttp -72.83 -52.7 13.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.186 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.38 -32.04 10.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.239 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.6 mt -78.42 -39.76 37.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -0.903 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.524 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 15.0 m -51.67 -29.67 18.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 35' ' ' SER . 57.1 m-85 -160.85 130.39 3.28 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.248 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.27 -19.89 14.89 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.317 2.011 . . . . 0.0 112.158 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.672 ' O ' HG22 ' A' ' 41' ' ' THR . 22.3 p -46.53 -46.0 18.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.785 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -45.39 -22.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 109.93 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.5 ttmt -51.81 -42.46 62.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.169 -0.957 . . . . 0.0 110.113 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 1.615 HG21 ' CD2' ' D' ' 97' ' ' HIS . 0.7 OUTLIER -75.63 -18.86 59.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 0.0 109.757 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.402 ' O ' ' CB ' ' A' ' 43' ' ' PHE . 58.5 t80 -55.88 -5.48 0.17 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 41' ' ' THR . 0.1 OUTLIER 70.4 67.38 0.41 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.283 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 54.2 Cg_exo -48.71 -42.06 37.11 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.641 2.227 . . . . 0.0 111.821 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 4.2 p80 40.7 33.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.735 -0.603 . . . . 0.0 110.413 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -157.71 28.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 110.074 179.409 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' SER . 73.9 m-20 43.67 89.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.478 -0.764 . . . . 0.0 110.345 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.024 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.6 1.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.356 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.512 ' N ' HD22 ' A' ' 48' ' ' LEU . 5.0 m -84.77 157.0 21.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.15 -0.968 . . . . 0.0 109.769 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.604 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 40.2 t-80 -76.44 170.58 16.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.396 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.604 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 76.18 -21.88 2.14 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.7 p -55.95 -18.7 9.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -1.098 . . . . 0.0 109.374 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 72.82 -23.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.814 . . . . 0.0 109.732 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 52' ' ' SER . 24.1 mt-30 -84.83 -17.94 36.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 0.0 109.565 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.52 HG23 ' OG ' ' A' ' 52' ' ' SER . 44.5 t -84.09 -32.64 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.576 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -72.92 -29.39 63.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 0.0 109.211 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.98 66.09 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.495 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.2 t-80 -60.71 -30.72 70.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.126 -1.22 . . . . 0.0 110.076 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.79 -31.38 79.58 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 59.2 mttp -68.89 -23.01 64.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -1.115 . . . . 0.0 110.253 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.741 ' HG2' ' CAA' ' A' ' 142' ' ' HEC . 0.0 OUTLIER -69.49 -58.19 4.28 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.883 -1.136 . . . . 0.0 108.748 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.52 -41.52 64.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.6 -0.688 . . . . 0.0 109.599 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.571 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -75.53 -43.86 46.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.158 -0.964 . . . . 0.0 109.237 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 34.9 t0 -68.85 -33.85 74.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.149 -0.97 . . . . 0.0 108.639 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.632 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -66.87 -49.14 66.62 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -53.06 -47.06 68.74 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.282 -0.886 . . . . 0.0 108.627 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.2 m -57.01 -56.57 20.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 108.755 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.534 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 28.5 t30 -58.86 -21.09 56.36 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.08 -47.38 10.24 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.4 t -68.44 -22.74 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.43 75.58 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.609 ' O ' ' N ' ' A' ' 74' ' ' ASP . 5.5 m-70 -115.87 -60.57 1.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.493 -0.754 . . . . 0.0 109.509 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.3 p 45.09 12.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.726 0.774 . . . . 0.0 109.549 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 72' ' ' HIS . 28.8 m-20 -138.34 11.11 2.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -177.3 27.79 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.697 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 3.0 ptt? -78.51 -23.81 0.42 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 111.69 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 76' ' ' MET . 53.2 Cg_exo -54.47 -19.62 18.19 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.559 1.506 . . . . 0.0 112.193 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -93.16 -40.68 10.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.323 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.76 -43.45 65.76 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.308 -0.87 . . . . 0.0 109.014 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.35 10.37 12.86 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.7 t -51.84 -47.68 64.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -46.13 -58.07 3.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 109.726 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.463 ' N ' HD23 ' A' ' 83' ' ' LEU . 3.8 mt -45.24 -44.29 11.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 108.827 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.9 p -55.18 -30.05 59.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.467 -0.77 . . . . 0.0 108.978 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 89' ' ' HIS . 1.6 m-20 -82.08 -49.65 9.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.837 . . . . 0.0 109.263 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 tp -51.03 -30.02 14.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 109.25 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -92.89 -21.79 19.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -0.843 . . . . 0.0 110.371 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.72 20.82 5.52 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.113 -0.992 . . . . 0.0 110.322 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.666 ' N ' ' O ' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -140.51 -78.27 0.3 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 109.78 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 92' ' ' ARG . 16.9 mttp -67.36 -119.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 109.816 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.3 mp -44.58 -19.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.82 . . . . 0.0 109.774 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 90' ' ' LYS . 49.7 ttt180 57.21 45.95 19.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.302 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.431 ' H ' HG23 ' A' ' 93' ' ' VAL . 4.7 t -48.43 133.15 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.647 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -91.58 126.06 55.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.273 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -43.84 -10.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.374 2.05 . . . . 0.0 112.377 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 1.265 HG11 ' CG ' ' D' ' 99' ' ' ASP . 25.1 t -56.39 -31.79 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.088 -1.008 . . . . 0.0 109.648 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -79.57 -38.14 34.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 0.0 109.662 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -46.06 -30.29 1.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.27 -28.02 69.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.89 . . . . 0.0 109.646 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 11.4 mt -84.29 -34.3 23.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.803 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.708 HD23 ' HAB' ' A' ' 142' ' ' HEC . 5.5 tp -64.14 -61.15 2.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.98 . . . . 0.0 109.741 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 t -47.76 -34.76 8.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.759 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 107' ' ' VAL . 12.3 t-80 -80.84 -26.66 36.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.826 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 97.7 m -76.35 -38.06 56.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.49 -52.04 67.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.118 -0.989 . . . . 0.0 109.716 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.7 mt -60.19 -32.35 71.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 34.4 t -63.65 -59.62 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 0.0 109.19 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.7 p -54.76 -53.55 53.68 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.244 -0.91 . . . . 0.0 109.276 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 114' ' ' PRO . 7.7 mt -45.41 -26.71 0.58 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.266 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -68.45 -39.26 81.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 0.0 109.979 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.659 ' HB2' ' CE2' ' B' ' 122' ' ' PHE . . . -78.99 -3.54 45.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 109.931 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -134.51 -80.09 0.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 109.7 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -118.4 82.53 19.16 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' N ' ' O ' ' A' ' 109' ' ' LEU . 51.3 Cg_exo -49.61 -169.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.454 2.102 . . . . 0.0 112.432 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.807 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -52.85 -55.72 21.08 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.656 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 46.3 mt-10 123.24 -5.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 7.6 t80 73.24 30.97 1.48 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.732 -0.605 . . . . 0.0 111.116 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.8 p -104.54 126.25 31.89 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 108.38 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.665 ' HB3' ' HB3' ' B' ' 51' ' ' PRO . 54.2 Cg_exo -49.73 22.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.353 2.036 . . . . 0.0 112.897 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -153.3 -32.94 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.83 -1.169 . . . . 0.0 110.645 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.807 HG21 ' O ' ' A' ' 115' ' ' ALA . 9.6 p -52.8 -49.5 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.982 -1.074 . . . . 0.0 110.154 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.643 ' N ' HG13 ' A' ' 121' ' ' VAL . 4.7 t-160 -59.47 -37.46 78.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 109.218 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.08 -19.41 34.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -0.839 . . . . 0.0 109.487 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 120' ' ' ALA . 23.3 p -64.18 -62.1 1.83 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 110.848 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.488 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.6 mt -68.46 -19.76 64.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.982 -1.074 . . . . 0.0 109.757 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.66 -46.62 12.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 109.36 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -80.44 -46.23 16.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -0.964 . . . . 0.0 109.278 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.514 ' CD2' HG21 ' A' ' 10' ' ' VAL . 26.8 t80 -49.93 -21.79 1.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.93 . . . . 0.0 108.969 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.488 HD22 HBB1 ' A' ' 142' ' ' HEC . 15.1 mt -73.96 -21.76 59.9 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -57.88 -31.83 67.1 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 90.0 p -79.83 -33.61 40.11 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.378 -0.826 . . . . 0.0 108.954 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.24 -35.52 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 108.636 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 47.4 t -72.23 -28.62 63.28 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.436 -0.79 . . . . 0.0 109.172 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 32.2 m -66.51 -34.34 77.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.171 -0.956 . . . . 0.0 109.082 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 97.5 t -77.38 -40.43 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.29 -0.881 . . . . 0.0 108.998 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.79 -27.28 68.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 108.955 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.3 m -86.24 -26.47 25.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 109.455 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.9 m -54.35 136.36 43.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.45 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -85.3 -165.32 1.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -56.85 -72.93 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.485 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.684 179.852 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.562 HG13 ' N ' ' B' ' 2' ' ' HIS . 7.2 p . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 0.562 ' N ' HG13 ' B' ' 1' ' ' VAL . 21.3 t-160 -172.8 71.34 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 109.177 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.525 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -127.95 155.81 43.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 109.356 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -54.51 152.71 11.65 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 108.914 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.07 -18.57 44.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.463 2.109 . . . . 0.0 112.06 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -87.13 -37.86 16.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.628 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -84.0 -23.22 31.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 109.891 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -84.12 -55.12 4.37 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.148 -0.97 . . . . 0.0 109.095 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.8 t -48.03 -23.52 0.83 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.125 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.15 -59.68 2.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.966 -1.084 . . . . 0.0 109.894 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.03 -24.44 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -74.79 -51.93 12.8 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.405 0.622 . . . . 0.0 109.649 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.36 -24.88 47.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.571 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.663 ' O ' HG23 ' B' ' 18' ' ' VAL . 1.2 mt -59.65 -28.26 67.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.344 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.83 -17.06 62.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.415 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.28 -63.77 3.13 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.596 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.5 ' HD3' HD23 ' B' ' 14' ' ' LEU . 0.0 OUTLIER -70.68 -11.72 61.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.033 -1.274 . . . . 0.0 110.809 -178.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.663 HG23 ' O ' ' B' ' 14' ' ' LEU . 12.9 t -70.73 121.35 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.833 -1.167 . . . . 0.0 109.348 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' B' ' 21' ' ' ASP . 4.1 m-20 -77.15 73.26 3.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.247 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.513 HG12 ' O ' ' B' ' 20' ' ' VAL . 75.5 t -52.89 -6.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.64 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 9.8 p30 -67.88 -20.73 65.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.914 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 9.2 pt-20 -150.11 -32.49 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.897 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.16 -28.27 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.667 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.1 -41.26 99.81 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.11 -55.04 17.83 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.422 ' O ' ' NH1' ' B' ' 30' ' ' ARG . 58.2 mt-10 -49.87 -26.99 4.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -1.141 . . . . 0.0 109.367 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.24 -32.62 22.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.06 -36.41 21.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.6 -40.58 90.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' B' ' 26' ' ' GLU . 0.0 OUTLIER -62.85 -21.88 66.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -1.17 . . . . 0.0 109.426 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.98 -28.38 65.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.965 . . . . 0.0 109.539 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' B' ' 36' ' ' PRO . 27.7 mt -81.24 -53.89 5.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.995 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.494 HG13 ' N ' ' B' ' 34' ' ' VAL . 6.2 p -56.18 -43.21 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.0 109.607 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.494 ' N ' HG13 ' B' ' 33' ' ' VAL . 57.8 t -79.53 -22.92 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 109.364 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -153.04 75.52 6.69 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.327 -0.858 . . . . 0.0 109.127 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.47 ' N ' ' O ' ' B' ' 32' ' ' LEU . 92.1 Cg_endo -83.69 3.79 7.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.971 2.448 . . . . 0.0 112.562 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.407 ' NE1' HG23 ' B' ' 38' ' ' THR . 3.1 p-90 -57.42 -19.82 26.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 109.547 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.407 HG23 ' NE1' ' B' ' 37' ' ' TRP . 6.2 p -79.96 5.44 13.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -48.28 -22.74 0.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.912 . . . . 0.0 109.531 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -62.36 -38.81 90.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.39 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' PHE . . . . . 0.433 ' O ' ' CG ' ' B' ' 42' ' ' PHE . 80.7 m-85 -88.01 27.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.979 ' CZ ' HBC3 ' B' ' 147' ' ' HEC . 75.2 m-85 -154.82 32.93 0.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.9 . . . . 0.0 109.518 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.33 -27.84 52.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 67.6 m -76.28 -29.7 57.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.526 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' B' ' 47' ' ' ASP . 3.8 m-85 -48.68 -22.71 0.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.319 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' B' ' 47' ' ' ASP . . . 68.04 -53.16 0.4 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 45' ' ' PHE . 51.2 m-20 -60.35 -151.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -1.144 . . . . 0.0 109.552 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt 58.82 17.91 5.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.492 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 30.2 p -69.45 -28.34 66.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.36 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' THR . . . . . 0.523 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.4 p -145.24 151.31 47.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 109.021 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.665 ' HB3' ' HB3' ' A' ' 119' ' ' PRO . 81.0 Cg_exo -38.27 -32.51 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.619 2.213 . . . . 0.0 112.574 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.19 -24.14 40.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.721 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -68.89 -19.57 64.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.893 . . . . 0.0 109.727 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.45 ' O ' HG11 ' B' ' 60' ' ' VAL . 18.6 t -65.24 -64.03 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 109.571 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 25.5 mtm -95.38 29.33 2.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.12 -58.58 0.66 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -69.4 150.26 97.1 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.293 -1.122 . . . . 0.0 109.478 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' B' ' 60' ' ' VAL . 69.2 Cg_endo -75.05 -56.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.609 2.206 . . . . 0.0 112.395 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -18.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 109.743 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' B' ' 58' ' ' PRO . 91.4 t -81.66 -44.96 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.426 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -79.01 -27.1 43.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.16 -20.93 63.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 109.64 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.511 ' CE1' ' C4D' ' B' ' 147' ' ' HEC . 59.4 t-80 -72.3 -23.94 61.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -0.99 . . . . 0.0 109.406 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.04 -25.99 74.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -55.97 -42.82 76.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 109.063 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 66' ' ' LYS . . . . . 0.514 ' HB3' HMA3 ' B' ' 147' ' ' HEC . 91.9 mttt -64.34 -41.49 96.74 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 109.557 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 0.721 HG22 ' C1B' ' B' ' 147' ' ' HEC . 29.0 t -65.27 -62.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.296 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.66 HD23 ' O ' ' B' ' 68' ' ' LEU . 2.4 tt -54.32 -40.2 67.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.194 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.52 -53.85 38.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.1 -44.38 42.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.097 . . . . 0.0 109.632 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -63.31 -45.89 89.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 98.6 p -61.07 -34.83 75.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 0.0 109.563 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -53.98 -39.63 66.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -0.961 . . . . 0.0 109.431 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.24 -60.14 8.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.589 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -53.73 -30.07 42.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.173 -1.193 . . . . 0.0 109.168 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.21 4.32 46.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.32 -0.863 . . . . 0.0 109.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -170.22 67.48 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 109.675 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.96 12.78 2.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.237 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.0 -29.75 68.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 24.9 t-20 -164.02 111.32 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 109.56 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.576 HD12 ' N ' ' B' ' 81' ' ' LEU . 7.5 mp -80.29 -56.07 4.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.524 ' HZ1' ' CE1' ' B' ' 143' ' ' HIS . 77.0 tttt -62.31 -24.12 67.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.608 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -75.07 -51.11 7.86 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.7 t -73.41 -46.29 49.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -1.133 . . . . 0.0 109.475 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.542 ' N ' ' CG2' ' B' ' 84' ' ' THR . 54.4 m-85 -84.29 26.13 0.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.445 -0.785 . . . . 0.0 109.575 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.11 -28.05 67.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.469 ' O ' ' N ' ' B' ' 91' ' ' LEU . 82.0 p -77.22 -58.14 3.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.83 . . . . 0.0 109.607 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.24 -41.6 18.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -68.71 -37.62 79.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.907 . . . . 0.0 109.58 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -82.67 -28.14 30.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 109.499 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' B' ' 87' ' ' THR . 10.3 tt -75.5 -69.05 0.51 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.232 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' B' ' 97' ' ' HIS . 70.8 m80 -50.1 -23.85 2.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.183 -0.948 . . . . 0.0 109.735 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 38.8 t -83.92 -56.23 3.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.92 . . . . 0.0 111.066 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.538 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 73.4 m-20 -86.17 -24.49 26.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.967 -1.083 . . . . 0.0 111.856 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.469 ' CD ' ' N ' ' B' ' 95' ' ' LYS . 10.7 mptt -94.25 -51.73 4.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.678 -1.264 . . . . 0.0 110.676 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -27.69 13.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.049 -1.032 . . . . 0.0 109.934 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 1.58 ' CD2' HG21 ' C' ' 41' ' ' THR . 21.4 m-70 57.71 53.71 6.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 109.716 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.435 HG12 HD22 ' B' ' 102' ' ' ASN . 11.2 t -73.37 124.29 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.151 -0.968 . . . . 0.0 109.295 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 1.291 ' OD2' HG11 ' C' ' 96' ' ' VAL . 68.7 m-20 -47.99 149.27 2.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.389 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.32 62.93 5.31 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.554 2.169 . . . . 0.0 112.046 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -172.09 73.92 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.434 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.435 HD22 HG12 ' B' ' 98' ' ' VAL . 2.3 p30 -178.95 -27.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.86 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 0.1 OUTLIER -56.28 -20.53 19.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.002 -1.061 . . . . 0.0 109.689 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -86.15 -41.13 14.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.428 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 tp -48.97 -40.18 29.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.319 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.556 HD13 ' CAB' ' B' ' 147' ' ' HEC . 5.7 tt -69.28 -47.59 64.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.272 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.46 -20.09 54.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -81.72 -55.74 4.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -1.164 . . . . 0.0 110.164 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 p -61.92 -24.15 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.078 -1.013 . . . . 0.0 109.682 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.474 HD23 ' O ' ' B' ' 110' ' ' LEU . 1.6 tt -61.57 -58.06 9.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.401 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' B' ' 130' ' ' TYR . 69.5 t -46.64 -26.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 109.772 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.49 -32.66 74.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 109.63 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.48 -31.57 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.965 . . . . 0.0 109.497 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.14 -29.4 60.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.158 -0.964 . . . . 0.0 109.497 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.424 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -74.97 -32.23 61.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.572 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.479 ' HD1' ' C ' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.85 -56.98 3.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.224 -0.923 . . . . 0.0 109.404 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' B' ' 118' ' ' PHE . 13.7 m170 -56.83 -17.78 10.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.621 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.408 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 72.1 m-85 -154.48 60.59 0.69 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -70.97 -26.24 74.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 120' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' B' ' 120' ' ' LYS . 11.8 mptt -70.0 9.86 0.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -1.168 . . . . 0.0 109.289 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' B' ' 119' ' ' GLY . 68.7 mm-40 -136.64 2.53 2.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.828 . . . . 0.0 109.387 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.659 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -72.91 39.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.502 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.572 ' C ' HE22 ' B' ' 127' ' ' GLN . 0.8 OUTLIER -52.46 149.08 11.09 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 109.331 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.3 Cg_exo -47.62 -52.38 8.14 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.46 2.107 . . . . 0.0 113.246 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 35.8 Cg_endo -65.35 -3.88 8.35 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.087 1.858 . . . . 0.0 112.708 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.454 HG23 ' OG1' ' B' ' 123' ' ' THR . 56.8 t -96.81 -22.09 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.044 -1.035 . . . . 0.0 109.724 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 127' ' ' GLN . . . . . 0.572 HE22 ' C ' ' B' ' 123' ' ' THR . 1.8 mp0 -83.27 -59.95 2.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.029 -1.044 . . . . 0.0 109.715 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -54.03 -35.02 61.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.991 . . . . 0.0 109.408 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.89 26.48 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.69 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.414 ' CE1' HG22 ' B' ' 111' ' ' VAL . 32.7 t80 -118.82 -61.47 1.64 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.304 -0.873 . . . . 0.0 109.654 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 93.1 mt-30 -52.81 -23.42 6.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.636 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -71.58 -39.02 70.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.112 -0.992 . . . . 0.0 109.731 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.71 -55.85 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 109.799 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' B' ' 137' ' ' VAL . 11.4 m -69.78 -28.57 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 110.041 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -47.57 -25.89 1.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 109.354 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.79 -24.6 57.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' B' ' 134' ' ' VAL . 74.8 t -79.42 -37.6 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -1.1 . . . . 0.0 109.345 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.81 79.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.433 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -72.1 -44.03 63.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.36 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.3 -40.82 49.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 109.341 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 36.5 mt -81.94 12.79 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.338 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' B' ' 103' ' ' PHE . . . -139.78 1.63 1.91 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 109.81 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 143' ' ' HIS . . . . . 0.524 ' CE1' ' HZ1' ' B' ' 82' ' ' LYS . 56.8 t-80 -79.37 -34.05 42.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.51 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 5.0 tptp -67.41 -25.44 65.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.409 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -64.03 -14.14 52.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.526 ' CG ' ' OXT' ' B' ' 146' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.503 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.417 ' CD1' ' CD2' ' C' ' 128' ' ' PHE . 48.9 mt -125.35 -162.29 1.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.824 . . . . 0.0 109.435 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.502 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 177.1 -48.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.954 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' C' ' 3' ' ' SER . 67.4 Cg_exo -49.21 174.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.381 2.054 . . . . 0.0 112.477 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -56.92 -16.54 7.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.639 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' C' ' 5' ' ' ALA . 14.9 t70 -40.0 -31.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 109.525 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' C' ' 5' ' ' ALA . 9.3 mtmp? -73.41 -55.91 5.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.211 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 44.6 m -47.51 -28.63 2.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.381 -0.824 . . . . 0.0 109.211 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -78.3 -38.6 42.09 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.51 HG21 ' CD2' ' C' ' 128' ' ' PHE . 40.7 t -70.86 -48.83 54.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -51.63 -44.62 63.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.404 -0.81 . . . . 0.0 108.853 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.86 -58.58 7.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.447 -0.783 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.481 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -55.55 -31.93 62.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.309 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.42 -17.37 58.18 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.155 -0.966 . . . . 0.0 109.004 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.33 -38.84 44.84 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -84.26 -40.9 17.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -1.067 . . . . 0.0 109.355 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.566 ' O ' ' C ' ' C' ' 18' ' ' GLY . 93.5 t -66.71 -46.0 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.821 . . . . 0.0 109.687 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' C' ' 19' ' ' ALA . . . -25.08 137.73 0.01 OUTLIER Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 19' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' C' ' 18' ' ' GLY . . . 74.45 -29.39 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.517 -0.99 . . . . 0.0 109.237 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.513 ' H ' ' C ' ' C' ' 18' ' ' GLY . 37.6 m-70 -110.56 16.82 21.27 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.599 ' HB1' ' HB1' ' C' ' 63' ' ' ALA . . . -82.32 -60.86 2.06 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.957 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.53 -14.7 0.39 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.0 mt-10 -85.52 -56.4 3.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -1.148 . . . . 0.0 109.728 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.4 m-30 -60.71 -35.2 75.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.445 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.39 -22.9 73.31 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.79 -47.09 14.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -1.165 . . . . 0.0 109.598 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -63.66 -19.77 65.16 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.298 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.64 63.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 109.509 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.42 HD11 ' ND1' ' C' ' 58' ' ' HIS . 9.0 mt -70.39 -53.7 15.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.13 -29.37 69.73 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 109.226 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.37 -30.4 67.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.259 -0.901 . . . . 0.0 109.197 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 32' ' ' MET . . . . . 0.494 ' HB3' ' HE2' ' C' ' 32' ' ' MET . 47.8 ttp -72.81 -52.72 13.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -0.838 . . . . 0.0 109.191 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.36 -31.96 10.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.888 . . . . 0.0 109.293 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.5 mt -78.46 -39.77 37.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.3 -0.875 . . . . 0.0 109.421 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.521 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 15.0 m -51.75 -29.55 19.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' C' ' 35' ' ' SER . 57.3 m-85 -160.89 130.34 3.25 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.273 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -76.24 -19.92 14.93 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.375 2.05 . . . . 0.0 112.203 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.68 ' O ' HG22 ' C' ' 41' ' ' THR . 22.4 p -46.53 -46.01 18.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.705 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -45.46 -22.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 109.868 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' C' ' 38' ' ' THR . 26.6 ttmt -51.83 -42.42 62.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.137 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 41' ' ' THR . . . . . 1.58 HG21 ' CD2' ' B' ' 97' ' ' HIS . 0.7 OUTLIER -75.63 -18.85 59.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 109.789 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.431 ' O ' ' CB ' ' C' ' 43' ' ' PHE . 58.6 t80 -55.87 -5.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.986 . . . . 0.0 109.531 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.467 ' H ' ' C ' ' C' ' 41' ' ' THR . 0.2 OUTLIER 70.43 67.35 0.41 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.92 . . . . 0.0 109.325 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.541 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 54.4 Cg_exo -48.79 -41.89 37.88 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.696 2.264 . . . . 0.0 111.778 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.541 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 4.1 p80 40.5 33.69 0.2 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.765 -0.585 . . . . 0.0 110.4 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -157.77 28.38 0.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.117 -0.99 . . . . 0.0 110.077 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' C' ' 49' ' ' SER . 73.9 m-20 43.61 89.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.548 -0.72 . . . . 0.0 110.376 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 1.002 ' H ' HD13 ' C' ' 48' ' ' LEU . 0.0 OUTLIER -60.69 1.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 0.0 109.26 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.517 ' H ' ' C ' ' C' ' 47' ' ' ASP . 5.0 m -84.83 157.03 21.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.955 . . . . 0.0 109.734 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 50' ' ' HIS . . . . . 0.612 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 40.4 t-80 -76.45 170.56 16.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.446 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 51' ' ' GLY . . . . . 0.612 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 76.26 -22.08 2.13 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 4.7 p -55.85 -18.68 9.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -1.105 . . . . 0.0 109.368 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 72.82 -23.3 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 109.669 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' C' ' 52' ' ' SER . 24.1 mt-30 -84.76 -17.96 36.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.568 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.519 HG23 ' OG ' ' C' ' 52' ' ' SER . 44.2 t -84.02 -32.62 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 109.639 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' C' ' 56' ' ' LYS . 13.7 ptpt -72.98 -29.39 63.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.166 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.82 -45.0 66.48 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.496 ' C ' ' ND1' ' C' ' 58' ' ' HIS . 6.2 t-80 -60.66 -30.74 70.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.245 . . . . 0.0 110.071 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.87 -31.29 79.22 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 59.2 mttp -68.93 -23.02 64.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -1.106 . . . . 0.0 110.213 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.731 ' HG2' ' CAA' ' C' ' 142' ' ' HEC . 0.0 OUTLIER -69.41 -58.17 4.33 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.982 -1.074 . . . . 0.0 108.755 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 13.3 t -55.59 -41.47 64.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.605 -0.684 . . . . 0.0 109.578 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.599 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -75.6 -43.81 46.24 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.102 -0.999 . . . . 0.0 109.195 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 64' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 35.0 t0 -68.99 -33.84 74.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 108.563 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.639 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -66.94 -49.01 66.83 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -53.05 -47.08 68.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.1 m -57.06 -56.59 19.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.9 . . . . 0.0 108.701 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.535 ' O ' ' CD2' ' C' ' 72' ' ' HIS . 28.5 t30 -58.82 -21.1 55.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 108.57 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.09 -47.42 10.2 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.36 -22.72 27.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.95 -33.32 75.31 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' C' ' 74' ' ' ASP . 5.6 m-70 -115.96 -60.47 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.534 -0.729 . . . . 0.0 109.527 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.556 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.2 p 45.02 12.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.744 0.783 . . . . 0.0 109.583 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' C' ' 72' ' ' HIS . 28.9 m-20 -138.33 11.18 2.78 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -177.36 27.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.696 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 3.0 ptt? -78.54 -23.91 0.42 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.837 . . . . 0.0 111.642 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' C' ' 76' ' ' MET . 53.1 Cg_exo -54.4 -19.72 18.18 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.582 1.521 . . . . 0.0 112.207 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -93.01 -40.75 10.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.178 -0.951 . . . . 0.0 109.435 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.82 -43.45 65.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.261 -0.899 . . . . 0.0 108.948 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -85.29 10.32 12.88 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 7.6 t -51.87 -47.65 64.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.324 -0.86 . . . . 0.0 109.683 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -46.09 -58.15 3.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 109.707 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.46 ' N ' HD23 ' C' ' 83' ' ' LEU . 3.8 mt -45.18 -44.33 10.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 0.0 108.785 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.9 p -55.19 -30.03 59.1 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.68 ' O ' ' N ' ' C' ' 89' ' ' HIS . 1.6 m-20 -82.15 -49.53 10.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.198 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.19 -29.95 15.53 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.095 -1.003 . . . . 0.0 109.173 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -92.82 -21.92 19.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.833 . . . . 0.0 110.336 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.72 20.87 5.52 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.076 -1.015 . . . . 0.0 110.398 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 89' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' C' ' 85' ' ' ASP . 0.7 OUTLIER -140.57 -78.26 0.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.078 -1.013 . . . . 0.0 109.806 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' C' ' 92' ' ' ARG . 16.9 mttp -67.38 -119.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.843 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.585 HD12 ' N ' ' C' ' 91' ' ' LEU . 10.3 mp -44.5 -19.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 109.802 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 92' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' C' ' 90' ' ' LYS . 49.7 ttt180 57.28 45.92 19.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.928 . . . . 0.0 109.304 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.416 HG23 ' H ' ' C' ' 93' ' ' VAL . 4.7 t -48.48 133.21 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 109.599 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' C' ' 96' ' ' VAL . 0.6 OUTLIER -91.55 126.03 55.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.281 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.81 -11.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.268 1.979 . . . . 0.0 112.396 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 1.291 HG11 ' OD2' ' B' ' 99' ' ' ASP . 24.8 t -56.22 -31.89 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 109.693 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -79.44 -38.16 35.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.662 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -46.12 -30.25 1.85 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 109.62 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.3 -27.97 69.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.942 . . . . 0.0 109.637 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 11.2 mt -84.22 -34.34 23.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 109.84 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.707 HD23 ' HAB' ' C' ' 142' ' ' HEC . 5.4 tp -64.22 -61.03 2.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 109.806 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 24.4 t -47.7 -34.73 8.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 109.836 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.459 ' O ' HG23 ' C' ' 107' ' ' VAL . 12.3 t-80 -80.96 -26.59 36.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.735 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 97.9 m -76.35 -38.1 56.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 109.953 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -52.19 66.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 109.681 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' C' ' 106' ' ' LEU . 36.8 mt -60.14 -32.28 70.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.947 . . . . 0.0 110.006 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 107' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 34.3 t -63.72 -59.56 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 109.264 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 41.3 p -54.77 -53.59 53.1 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.229 -0.92 . . . . 0.0 109.224 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' C' ' 114' ' ' PRO . 7.7 mt -45.29 -26.74 0.55 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.459 -0.775 . . . . 0.0 109.299 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -68.44 -39.26 81.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.304 -0.872 . . . . 0.0 110.039 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 111' ' ' ALA . . . . . 0.657 ' HB2' ' CE2' ' D' ' 122' ' ' PHE . . . -78.94 -3.6 45.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -134.44 -80.06 0.45 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.232 -0.917 . . . . 0.0 109.713 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -118.41 82.6 19.31 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 114' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' C' ' 113' ' ' LEU . 51.3 Cg_exo -49.78 -169.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.402 2.068 . . . . 0.0 112.402 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.822 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -52.85 -55.71 21.1 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.662 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 46.4 mt-10 123.24 -5.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.414 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 7.6 t80 73.21 30.97 1.49 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.803 -0.561 . . . . 0.0 111.033 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.75 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.8 p -104.48 126.26 31.9 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.07 -1.019 . . . . 0.0 108.439 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 119' ' ' PRO . . . . . 0.657 ' HB3' ' HB3' ' D' ' 51' ' ' PRO . 53.9 Cg_exo -49.74 22.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.407 2.071 . . . . 0.0 112.901 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.75 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -153.37 -32.98 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.777 -1.202 . . . . 0.0 110.553 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.822 HG21 ' O ' ' C' ' 115' ' ' ALA . 9.7 p -52.76 -49.47 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.057 -1.027 . . . . 0.0 110.18 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.645 ' N ' HG13 ' C' ' 121' ' ' VAL . 4.7 t-160 -59.48 -37.5 78.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 0.0 109.176 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.12 -19.43 34.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.411 -0.806 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.523 ' N ' ' O ' ' C' ' 120' ' ' ALA . 23.1 p -64.12 -62.12 1.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 110.844 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.488 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.6 mt -68.49 -19.72 64.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.016 -1.053 . . . . 0.0 109.761 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.67 -46.64 12.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.99 -1.069 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.473 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -80.38 -46.37 16.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.155 -0.966 . . . . 0.0 109.277 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.51 ' CD2' HG21 ' C' ' 10' ' ' VAL . 26.9 t80 -49.88 -21.68 1.24 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.016 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.484 HD22 HBB1 ' C' ' 142' ' ' HEC . 15.3 mt -73.98 -21.82 59.85 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -57.93 -31.76 67.13 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 90.0 p -79.86 -33.65 39.91 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.341 -0.85 . . . . 0.0 108.925 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 42.6 t -82.27 -35.51 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 108.578 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 47.5 t -72.18 -28.61 63.33 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.408 -0.808 . . . . 0.0 109.237 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 32.3 m -66.55 -34.31 77.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.954 . . . . 0.0 109.108 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.32 -40.45 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.316 -0.865 . . . . 0.0 109.08 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.7 -27.42 68.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 108.945 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 61.7 m -86.2 -26.46 25.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 41.1 m -54.37 136.38 43.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -85.28 -165.33 1.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.867 . . . . 0.0 109.556 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' C' ' 141' ' ' ARG . 89.3 t80 -56.77 -72.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.514 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 141' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' C' ' 140' ' ' TYR . 92.1 mtt180 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.618 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.569 HG13 ' N ' ' D' ' 2' ' ' HIS . 7.4 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 2' ' ' HIS . . . . . 0.569 ' N ' HG13 ' D' ' 1' ' ' VAL . 21.3 t-160 -172.74 71.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.51 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -127.92 155.78 43.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.436 -0.79 . . . . 0.0 109.306 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -54.48 152.76 11.45 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 108.878 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.01 -18.63 44.1 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.477 2.118 . . . . 0.0 112.068 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -87.11 -37.92 16.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.914 . . . . 0.0 109.622 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -84.1 -23.15 30.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.836 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -84.12 -55.19 4.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.229 -0.919 . . . . 0.0 109.102 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -48.04 -23.49 0.83 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.09 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.16 -59.64 2.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.891 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.01 -24.47 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -74.81 -51.9 12.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.698 -0.626 . . . . 0.0 109.65 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.31 -24.92 46.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.662 ' O ' HG23 ' D' ' 18' ' ' VAL . 1.2 mt -59.64 -28.28 67.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.78 -17.04 62.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -0.952 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.25 -63.73 3.15 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.585 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.503 ' HD3' HD23 ' D' ' 14' ' ' LEU . 0.0 OUTLIER -70.77 -11.74 61.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.036 -1.273 . . . . 0.0 110.778 -178.781 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.662 HG23 ' O ' ' D' ' 14' ' ' LEU . 12.9 t -70.66 121.27 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.856 -1.152 . . . . 0.0 109.343 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' D' ' 21' ' ' ASP . 4.1 m-20 -77.12 73.4 3.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.226 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.525 ' O ' HG12 ' D' ' 20' ' ' VAL . 76.1 t -53.05 -6.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.556 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' D' ' 19' ' ' ASN . 9.8 p30 -67.92 -20.69 65.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.936 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.505 ' N ' ' OD1' ' D' ' 21' ' ' ASP . 9.3 pt-20 -150.27 -32.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.067 -1.02 . . . . 0.0 109.884 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.22 -28.36 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 109.626 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.03 -41.41 99.86 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.06 -55.07 17.89 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 26' ' ' GLU . . . . . 0.416 ' O ' ' NH1' ' D' ' 30' ' ' ARG . 58.3 mt-10 -49.79 -27.03 4.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -1.155 . . . . 0.0 109.432 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.31 -32.55 22.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.06 -36.35 21.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.63 -40.66 90.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 30' ' ' ARG . . . . . 0.416 ' NH1' ' O ' ' D' ' 26' ' ' GLU . 0.0 OUTLIER -62.93 -21.7 66.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -1.12 . . . . 0.0 109.467 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tt -70.07 -28.32 65.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.152 -0.968 . . . . 0.0 109.523 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 32' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' D' ' 36' ' ' PRO . 27.7 mt -81.32 -53.86 5.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.925 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.505 HG13 ' N ' ' D' ' 34' ' ' VAL . 6.2 p -56.21 -43.18 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.003 . . . . 0.0 109.628 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.505 ' N ' HG13 ' D' ' 33' ' ' VAL . 57.8 t -79.56 -22.83 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -153.11 75.5 6.65 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.848 . . . . 0.0 109.126 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' D' ' 32' ' ' LEU . 92.6 Cg_endo -83.6 3.69 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.935 2.423 . . . . 0.0 112.553 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -57.39 -19.87 26.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.485 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 6.0 p -80.0 5.41 14.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 109.414 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -48.17 -22.76 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.593 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -62.34 -38.84 91.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.366 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' D' ' 42' ' ' PHE . 80.2 m-85 -87.95 27.87 1.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.975 ' CZ ' HBC3 ' D' ' 147' ' ' HEC . 75.1 m-85 -154.8 32.85 0.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.524 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.37 -27.7 52.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 109.538 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 67.5 m -76.34 -29.67 57.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 109.476 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' D' ' 47' ' ' ASP . 3.8 m-85 -48.7 -22.71 0.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' D' ' 47' ' ' ASP . . . 68.02 -53.11 0.39 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' D' ' 45' ' ' PHE . 51.6 m-20 -60.38 -151.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -1.123 . . . . 0.0 109.485 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt 58.73 17.97 5.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 30.4 p -69.46 -28.38 66.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.923 . . . . 0.0 109.309 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' THR . . . . . 0.526 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.5 p -145.32 151.24 47.21 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.071 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 51' ' ' PRO . . . . . 0.657 ' HB3' ' HB3' ' C' ' 119' ' ' PRO . 80.8 Cg_exo -38.12 -32.6 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.598 2.199 . . . . 0.0 112.599 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.19 -24.04 40.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.737 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -69.03 -19.45 64.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.671 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 54' ' ' VAL . . . . . 0.437 ' O ' HG11 ' D' ' 60' ' ' VAL . 18.4 t -65.31 -63.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.618 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 25.5 mtm -95.41 29.43 2.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.12 -58.58 0.66 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -69.36 150.25 97.15 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.224 -1.162 . . . . 0.0 109.608 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.463 ' O ' ' N ' ' D' ' 60' ' ' VAL . 68.4 Cg_endo -75.01 -56.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.639 2.226 . . . . 0.0 112.331 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -18.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 60' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' D' ' 58' ' ' PRO . 91.2 t -81.66 -44.98 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.421 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -79.04 -27.12 43.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.9 63.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.75 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.503 ' CE1' ' C4D' ' D' ' 147' ' ' HEC . 59.5 t-80 -72.27 -24.02 61.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.408 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.01 -25.98 74.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.99 -42.86 77.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.207 -1.172 . . . . 0.0 109.044 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 66' ' ' LYS . . . . . 0.496 ' HB3' HMA3 ' D' ' 147' ' ' HEC . 91.9 mttt -64.34 -41.46 96.76 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.589 -0.694 . . . . 0.0 109.561 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.71 HG22 ' C1B' ' D' ' 147' ' ' HEC . 28.7 t -65.19 -62.93 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.288 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.676 ' O ' HD23 ' D' ' 68' ' ' LEU . 2.4 tt -54.35 -40.15 67.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.205 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.55 -53.87 38.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.16 -44.38 42.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -1.122 . . . . 0.0 109.54 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.33 -45.82 89.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 98.4 p -61.08 -34.89 75.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.459 -0.776 . . . . 0.0 109.526 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -54.02 -39.66 66.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.14 -60.16 8.4 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.605 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.9 mp -53.75 -30.06 42.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.324 -1.103 . . . . 0.0 109.193 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.13 4.31 45.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -170.35 67.45 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.669 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt -78.9 12.73 2.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.246 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.0 -29.76 68.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 80' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 24.8 t-20 -164.0 111.29 1.12 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.636 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 81' ' ' LEU . . . . . 0.563 HD12 ' N ' ' D' ' 81' ' ' LEU . 7.5 mp -80.26 -56.11 4.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 82' ' ' LYS . . . . . 0.415 ' HZ1' ' CE1' ' D' ' 143' ' ' HIS . 77.2 tttt -62.42 -24.06 67.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 83' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -75.04 -51.06 7.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.7 t -73.43 -46.31 49.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 0.0 109.498 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.538 ' N ' ' CG2' ' D' ' 84' ' ' THR . 54.5 m-85 -84.28 26.11 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.583 -0.698 . . . . 0.0 109.624 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.08 -28.08 67.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 0.0 109.422 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 87' ' ' THR . . . . . 0.464 ' O ' ' N ' ' D' ' 91' ' ' LEU . 82.6 p -77.13 -58.17 3.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.646 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.26 -41.57 18.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -68.67 -37.67 79.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.527 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -82.73 -28.15 30.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 0.0 109.378 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' D' ' 87' ' ' THR . 10.3 tt -75.58 -68.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.234 -0.917 . . . . 0.0 109.238 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.583 ' O ' ' N ' ' D' ' 97' ' ' HIS . 71.0 m80 -50.08 -23.87 2.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.757 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 38.8 t -83.94 -56.21 3.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 111.03 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.538 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 73.3 m-20 -86.21 -24.6 26.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.074 -1.016 . . . . 0.0 111.749 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 95' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' D' ' 95' ' ' LYS . 10.7 mptt -94.21 -51.63 4.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.638 -1.289 . . . . 0.0 110.742 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.96 -27.73 13.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 0.0 109.907 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 1.615 ' CD2' HG21 ' A' ' 41' ' ' THR . 21.4 m-70 57.77 53.67 6.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 98' ' ' VAL . . . . . 0.435 HG12 HD22 ' D' ' 102' ' ' ASN . 11.2 t -73.33 124.26 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.134 -0.979 . . . . 0.0 109.261 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 99' ' ' ASP . . . . . 1.265 ' CG ' HG11 ' A' ' 96' ' ' VAL . 68.7 m-20 -47.93 149.29 2.44 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.123 -0.986 . . . . 0.0 109.426 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.3 62.91 5.29 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.532 2.155 . . . . 0.0 112.082 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -172.05 73.84 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 102' ' ' ASN . . . . . 0.435 HD22 HG12 ' D' ' 98' ' ' VAL . 2.3 p30 -178.85 -27.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.867 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 103' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 0.1 OUTLIER -56.38 -20.37 19.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.094 -1.004 . . . . 0.0 109.633 -179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -86.28 -41.04 14.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.056 -1.028 . . . . 0.0 109.36 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 tp -48.99 -40.14 29.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.386 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.563 HD13 ' CAB' ' D' ' 147' ' ' HEC . 5.7 tt -69.35 -47.56 63.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.295 -0.878 . . . . 0.0 109.315 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.39 -19.98 54.28 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -81.79 -55.82 4.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -1.196 . . . . 0.0 110.01 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.96 -24.09 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.032 -1.042 . . . . 0.0 109.682 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 110' ' ' LEU . . . . . 0.482 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.6 tt -61.62 -57.97 9.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 111' ' ' VAL . . . . . 0.408 HG22 ' CE1' ' D' ' 130' ' ' TYR . 70.0 t -46.67 -26.06 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.772 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.45 -32.65 74.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.112 -0.993 . . . . 0.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.51 -31.56 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.534 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 12.4 mt -75.04 -29.5 60.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.504 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.42 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -74.93 -32.29 61.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.937 . . . . 0.0 109.483 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.476 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.89 -56.99 3.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 0.0 109.359 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 117' ' ' HIS . . . . . 0.409 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 13.7 m170 -56.81 -17.73 10.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 109.569 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.409 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 72.2 m-85 -154.54 60.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 109.64 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -71.04 -26.22 74.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 120' ' ' LYS . . . . . 0.494 ' CD ' ' N ' ' D' ' 120' ' ' LYS . 11.9 mptt -70.03 9.95 0.49 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -1.102 . . . . 0.0 109.343 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' D' ' 119' ' ' GLY . 68.8 mm-40 -136.71 2.54 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.39 -0.819 . . . . 0.0 109.45 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.657 ' CE2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -72.94 39.05 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.56 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.563 ' C ' HE22 ' D' ' 127' ' ' GLN . 0.8 OUTLIER -52.42 149.06 10.98 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.289 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.507 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -47.72 -52.38 8.19 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.449 2.099 . . . . 0.0 113.229 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 36.0 Cg_endo -65.27 -3.92 8.31 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.11 1.873 . . . . 0.0 112.7 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.462 HG23 ' OG1' ' D' ' 123' ' ' THR . 55.7 t -96.85 -22.04 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.05 -1.032 . . . . 0.0 109.699 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 127' ' ' GLN . . . . . 0.563 HE22 ' C ' ' D' ' 123' ' ' THR . 1.8 mp0 -83.27 -60.0 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 0.0 109.687 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -53.93 -35.11 61.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.9 26.46 0.99 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.679 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.408 ' CE1' HG22 ' D' ' 111' ' ' VAL . 32.9 t80 -118.8 -61.37 1.66 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.366 -0.834 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 93.0 mt-30 -52.83 -23.46 7.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.625 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -71.49 -39.2 71.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.747 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 74.6 t -62.71 -55.77 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.088 -1.008 . . . . 0.0 109.816 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' D' ' 137' ' ' VAL . 11.4 m -69.75 -28.56 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -0.853 . . . . 0.0 110.036 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -47.55 -25.96 1.29 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.99 -1.069 . . . . 0.0 109.383 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.78 -24.52 58.07 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 137' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' D' ' 134' ' ' VAL . 75.4 t -79.36 -37.65 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -1.126 . . . . 0.0 109.343 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.78 79.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -72.05 -44.08 63.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.417 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.24 -40.94 49.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 37.1 mt -81.95 12.9 3.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.272 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 142' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' D' ' 103' ' ' PHE . . . -139.91 1.63 1.88 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.284 -0.885 . . . . 0.0 109.711 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 143' ' ' HIS . . . . . 0.415 ' CE1' ' HZ1' ' D' ' 82' ' ' LYS . 57.1 t-80 -79.32 -34.09 42.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.512 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 5.0 tptp -67.42 -25.5 65.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.381 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -63.99 -14.16 51.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.92 . . . . 0.0 109.529 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.526 ' CG ' ' OXT' ' D' ' 146' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.551 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.945 HMB1 HBB3 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 0.979 HBC3 ' CZ ' ' B' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.986 HMB1 HBB3 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 0.975 HBC3 ' CZ ' ' D' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.498 ' CG1' ' OG ' ' A' ' 131' ' ' SER . 96.6 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.337 0.589 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp 59.06 163.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.359 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 174.77 -44.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.92 . . . . 0.0 110.033 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 3' ' ' SER . 52.9 Cg_exo -53.7 172.85 0.22 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.691 2.261 . . . . 0.0 113.105 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.598 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -46.9 -14.6 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 4' ' ' PRO . 3.0 p30 -38.59 -22.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.445 -0.785 . . . . 0.0 110.121 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 5' ' ' ALA . 38.0 mttt -80.42 -56.78 3.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.115 -0.991 . . . . 0.0 109.407 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 m -46.82 -28.65 1.62 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.511 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -78.35 -38.07 42.89 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.439 HG21 ' CD2' ' A' ' 128' ' ' PHE . 25.4 t -71.61 -49.28 47.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -50.99 -44.23 60.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.21 -61.21 2.77 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.97 -35.38 69.09 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -0.756 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -77.01 -17.16 59.03 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.204 -0.935 . . . . 0.0 108.888 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.57 -38.23 44.45 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -84.46 -35.21 23.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.402 -1.058 . . . . 0.0 109.495 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 21' ' ' ALA . 42.6 t -73.64 -36.91 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 109.674 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 19' ' ' ALA . . . -30.58 143.72 0.01 OUTLIER Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . 71.07 -31.96 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -1.043 . . . . 0.0 109.113 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.557 ' H ' ' C ' ' A' ' 18' ' ' GLY . 49.8 m-70 -107.94 17.13 22.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 17' ' ' VAL . . . -85.49 -36.05 20.79 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.879 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.3 -14.44 64.14 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -87.99 -56.14 3.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -1.113 . . . . 0.0 109.876 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.4 m-30 -58.42 -35.38 71.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.365 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.73 -23.06 64.89 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.38 -49.91 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -1.188 . . . . 0.0 109.696 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -56.62 -19.76 17.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.83 -21.25 60.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 109.597 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.528 HD11 ' ND1' ' A' ' 58' ' ' HIS . 11.0 mt -82.61 -54.31 5.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -64.43 -34.04 77.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.553 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.502 ' CG ' HH11 ' A' ' 31' ' ' ARG . 0.5 OUTLIER -66.4 -38.57 87.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 109.631 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 32' ' ' MET . 15.1 tmm? -75.13 -31.97 61.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.313 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -54.14 -49.93 68.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.78 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 36' ' ' PHE . 1.3 pp -81.27 -43.61 18.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 m -62.95 4.48 0.17 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.617 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.533 ' CE2' ' OG1' ' A' ' 38' ' ' THR . 2.5 t80 -162.74 93.76 1.2 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.222 -0.923 . . . . 0.0 109.165 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.76 -23.38 6.95 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.495 2.13 . . . . 0.0 112.404 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.533 ' OG1' ' CE2' ' A' ' 36' ' ' PHE . 9.5 p -54.65 -28.57 48.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 109.283 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 42' ' ' TYR . 8.8 p -89.98 -22.8 21.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 109.547 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -46.12 -31.1 2.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 1.281 HG21 ' CG ' ' D' ' 97' ' ' HIS . 0.6 OUTLIER -77.96 -18.93 55.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 39' ' ' THR . 33.7 t80 -60.38 -22.56 63.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.575 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.6 t80 53.73 83.83 0.22 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.408 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.713 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 76.3 Cg_exo -47.25 -41.2 27.98 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.611 2.207 . . . . 0.0 112.2 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.713 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 97.69 33.79 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 120.589 0.233 . . . . 0.0 111.177 179.136 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.563 ' CZ ' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -137.06 35.21 2.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.832 -1.168 . . . . 0.0 109.917 178.481 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 49' ' ' SER . 14.5 m-20 52.79 91.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 109.53 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.03 -1.65 0.33 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 47' ' ' ASP . 92.8 p -54.31 126.74 24.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.915 . . . . 0.0 109.463 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -57.25 136.01 56.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.472 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.41 70.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.597 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.5 t -64.04 -14.56 55.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -1.141 . . . . 0.0 109.457 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 70.88 -18.82 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.622 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 52' ' ' SER . 32.9 mt-30 -85.67 -18.09 34.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 109.376 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.64 -36.12 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -75.92 -33.47 59.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 108.96 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.72 -25.19 74.11 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.528 ' ND1' HD11 ' A' ' 29' ' ' LEU . 6.3 t-80 -71.49 -43.29 66.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -1.117 . . . . 0.0 109.392 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -49.38 -48.17 34.28 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 86.4 mttt -52.71 -22.62 5.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.995 . . . . 0.0 110.005 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.85 -40.91 60.73 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.146 -0.971 . . . . 0.0 108.792 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -73.05 -47.28 48.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.535 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -65.88 -32.59 74.19 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 26.1 t0 -71.93 -32.46 67.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.081 -1.012 . . . . 0.0 108.599 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -68.19 -52.57 32.87 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.01 -41.38 59.75 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.246 -0.909 . . . . 0.0 108.97 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 71' ' ' ALA . 16.3 m -68.26 -57.81 5.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.182 -0.949 . . . . 0.0 108.728 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -59.76 -23.84 63.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 108.758 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.08 -46.93 10.68 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.56 -22.93 27.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -67.75 -36.13 79.97 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' A' ' 74' ' ' ASP . 84.8 m-70 -102.78 -65.61 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.491 -0.756 . . . . 0.0 109.465 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 72' ' ' HIS . 12.6 p 44.83 14.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.863 0.839 . . . . 0.0 109.437 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 72' ' ' HIS . 71.0 m-20 -137.18 11.89 3.05 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.404 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 0.3 OUTLIER 172.23 31.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.205 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.686 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 8.1 ptt? -78.32 -22.89 0.4 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.929 . . . . 0.0 111.937 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.4 Cg_exo -53.27 -22.4 20.15 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.558 1.506 . . . . 0.0 112.335 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -92.98 -40.52 10.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.05 84.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 109.175 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.6 mt -83.93 9.48 12.11 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.451 -0.781 . . . . 0.0 108.918 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -58.43 -50.39 73.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 109.53 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 83' ' ' LEU . . . -50.11 -58.52 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.579 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.528 HD22 HBA1 ' A' ' 142' ' ' HEC . 4.5 mt -46.02 -46.2 16.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 108.894 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 5.7 p -64.89 -32.11 73.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.541 -0.724 . . . . 0.0 109.404 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -75.5 -23.84 56.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.849 HD21 HBD2 ' A' ' 142' ' ' HEC . 5.7 tt -82.99 -34.16 26.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 109.518 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.537 ' NE2' ' ND ' ' A' ' 142' ' ' HEC . 47.1 m80 -92.14 -21.88 20.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.927 . . . . 0.0 109.524 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -69.34 -84.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.732 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -78.54 -70.42 0.49 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.85 . . . . 0.0 109.918 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.593 ' C ' ' H ' ' A' ' 92' ' ' ARG . 25.5 ttmt -46.31 137.97 5.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.988 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.1 mt 66.19 -20.43 0.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.652 -0.655 . . . . 0.0 109.754 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.375 ' NH2' HBD2 ' D' ' 147' ' ' HEC . 65.5 mtt180 38.9 27.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.41 -0.806 . . . . 0.0 109.685 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.565 ' CG2' ' ND2' ' A' ' 97' ' ' ASN . 7.5 p -45.45 141.19 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.872 . . . . 0.0 109.669 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.3 149.55 86.89 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 109.376 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 97' ' ' ASN . 59.8 Cg_endo -73.56 -22.25 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.526 2.151 . . . . 0.0 112.271 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 96' ' ' VAL . 21.9 t -56.5 -3.63 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 109.609 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.565 ' ND2' ' CG2' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -79.36 -41.93 26.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.928 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -51.25 -48.73 62.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 109.433 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -48.28 -30.61 4.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.487 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 18.7 mt -84.24 -62.03 1.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.467 HD23 ' HAB' ' A' ' 142' ' ' HEC . 4.9 tp -49.89 -20.94 1.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.728 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 t -69.34 -59.11 3.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.454 ' ND1' ' OD1' ' B' ' 108' ' ' ASN . 32.1 m170 -68.43 -26.61 65.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.882 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 50.4 m -62.93 -45.48 92.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 109.927 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.97 -55.39 33.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.95 . . . . 0.0 109.429 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 4.1 mm? -47.83 -29.15 3.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.613 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.5 t -83.41 -24.63 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.409 ' OG1' HD23 ' A' ' 109' ' ' LEU . 27.9 p -71.46 -63.39 1.13 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.986 -1.071 . . . . 0.0 110.345 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -64.67 -26.22 68.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 109.636 -179.511 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 106' ' ' LEU . . . -49.4 -37.39 25.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.16 -56.24 4.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 110.07 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -71.38 -67.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.808 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.62 ' C ' HD13 ' A' ' 113' ' ' LEU . 2.1 tm? -110.7 98.52 37.86 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 66.6 Cg_exo -49.17 -170.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.277 1.984 . . . . 0.0 112.296 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.652 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -73.04 -55.33 6.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 108.827 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.652 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 18.3 mt-10 118.69 -8.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 5.3 t80 77.14 33.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.881 -0.512 . . . . 0.0 111.146 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.4 OUTLIER -101.62 116.0 64.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.448 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.04 20.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.982 1.788 . . . . 0.0 112.468 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -144.83 -29.47 0.46 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.159 -0.963 . . . . 0.0 110.431 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.668 HG13 ' N ' ' A' ' 122' ' ' HIS . 10.6 p -49.34 -50.77 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.139 -0.975 . . . . 0.0 109.967 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.668 ' N ' HG13 ' A' ' 121' ' ' VAL . 3.0 m80 -60.87 -34.67 74.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.121 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.18 -20.19 32.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.386 -0.821 . . . . 0.0 109.707 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.3 m -64.84 -62.12 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.541 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.88 -19.8 62.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.145 -0.972 . . . . 0.0 109.972 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.43 -44.47 19.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.033 . . . . 0.0 110.114 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.411 ' CD ' ' C ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -89.04 -41.49 12.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.985 -1.072 . . . . 0.0 109.954 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 10' ' ' VAL . 41.4 t80 -50.48 -20.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.878 -1.138 . . . . 0.0 108.907 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.596 ' O ' ' N ' ' A' ' 133' ' ' SER . 18.1 mt -71.42 -17.67 62.38 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.04 -31.69 71.32 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.498 ' OG ' ' CG1' ' A' ' 1' ' ' VAL . 4.0 t -83.53 -33.08 25.56 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.379 -0.826 . . . . 0.0 108.911 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.4 t -85.17 -26.63 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 108.907 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 129' ' ' LEU . 33.0 t -84.02 -25.52 29.85 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 108.873 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.5 m -77.62 -39.06 46.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.15 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 131' ' ' SER . 34.7 m -73.18 -27.04 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.262 -0.898 . . . . 0.0 108.69 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -29.98 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 137' ' ' THR . 93.5 m -112.52 24.02 12.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.409 -0.807 . . . . 0.0 109.437 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.6 t -46.91 -65.41 0.57 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.666 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.494 ' NZ ' ' CB ' ' A' ' 139' ' ' LYS . 8.4 mtmp? 52.38 -106.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.907 . . . . 0.0 109.525 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -150.81 -55.53 0.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.399 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.419 -179.979 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 1' ' ' VAL . 8.1 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 49.62 42.11 22.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.087 -1.008 . . . . 0.0 109.332 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.988 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -92.04 155.58 18.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 0.0 109.328 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.14 153.9 84.03 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.013 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.02 -15.91 36.09 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.655 2.237 . . . . 0.0 112.313 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -85.28 -42.75 14.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.71 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.16 -22.56 30.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.917 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.603 ' HB2' HD13 ' B' ' 3' ' ' LEU . 7.7 tttm -79.23 -40.41 30.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.184 -0.947 . . . . 0.0 109.315 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 9.0 t -61.63 -23.64 66.18 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.815 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.11 -55.49 4.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 110.121 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.17 -24.72 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.078 -1.014 . . . . 0.0 108.414 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 50.9 m -82.21 -37.03 26.65 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.385 0.612 . . . . 0.0 109.617 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.46 96.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.528 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 17' ' ' LYS . 0.8 OUTLIER -61.82 -35.1 77.24 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.471 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -48.07 -21.52 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 109.046 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' B' ' 14' ' ' LEU . . . -86.5 -32.63 15.5 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' B' ' 14' ' ' LEU . 1.0 OUTLIER -78.02 -31.42 50.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -1.151 . . . . 0.0 109.087 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' B' ' 20' ' ' VAL . 69.7 t -54.09 114.88 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.551 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' B' ' 21' ' ' ASP . 3.1 m120 -71.41 64.06 0.4 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 109.168 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' B' ' 18' ' ' VAL . 42.1 t -45.68 -16.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.516 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' B' ' 19' ' ' ASN . 21.8 t70 -77.1 5.46 8.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.454 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -154.17 -43.84 0.09 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -0.87 . . . . 0.0 109.467 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -55.16 -24.9 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.507 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.41 -42.52 93.8 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.72 -35.92 54.18 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -73.44 -36.49 65.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 109.376 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.45 -52.94 62.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.47 -51.57 66.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 109.2 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.75 -40.65 95.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' B' ' 33' ' ' VAL . 16.7 mmt85 -58.13 -44.36 87.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -1.13 . . . . 0.0 109.524 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 35' ' ' TYR . 34.0 tp -46.83 -32.53 3.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.319 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 mt -81.18 -21.84 39.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' B' ' 30' ' ' ARG . 21.2 t -87.12 -64.29 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 109.549 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.432 ' H ' HG23 ' B' ' 34' ' ' VAL . 0.2 OUTLIER -60.05 -49.57 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.874 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.417 ' O ' ' O ' ' B' ' 31' ' ' LEU . 0.1 OUTLIER -118.53 85.68 27.03 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.365 -0.834 . . . . 0.0 109.45 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -84.26 34.47 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.702 2.268 . . . . 0.0 112.315 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.542 ' NE1' HG23 ' B' ' 38' ' ' THR . 1.9 p-90 -81.04 -29.74 34.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.13 -0.981 . . . . 0.0 109.602 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.542 HG23 ' NE1' ' B' ' 37' ' ' TRP . 65.1 p -60.62 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.433 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 48.95 45.2 22.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.471 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.507 ' HA ' ' NH1' ' C' ' 92' ' ' ARG . 19.2 ptt180 -137.82 -39.18 0.56 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.249 -0.907 . . . . 0.0 109.367 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' PHE . . . . . 0.598 ' CE2' HMD1 ' B' ' 147' ' ' HEC . 38.0 t80 -100.41 -25.47 14.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 1.209 ' CZ ' ' CBC' ' B' ' 147' ' ' HEC . 62.8 m-85 -74.48 6.11 4.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.14 -23.28 51.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 20.3 p -59.62 -40.31 87.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.507 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -51.63 -17.61 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.69 55.12 11.65 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -159.55 79.33 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -1.162 . . . . 0.0 109.394 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 36.6 mt -131.56 14.63 4.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 109.421 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.8 m -46.91 -41.75 16.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.221 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 5.9 p -146.64 148.68 34.41 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.438 -0.789 . . . . 0.0 108.896 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -41.07 -39.52 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.37 2.047 . . . . 0.0 112.292 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.403 ' C ' ' N ' ' B' ' 54' ' ' VAL . 1.0 OUTLIER -67.04 -40.43 87.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 109.643 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.14 -19.84 0.31 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.385 -0.822 . . . . 0.0 109.552 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.403 ' N ' ' C ' ' B' ' 52' ' ' ASP . 83.5 t -67.56 -64.01 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 10.4 mtt -86.12 -6.1 59.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 109.601 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.13 -35.6 88.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -81.24 148.36 63.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.205 -1.173 . . . . 0.0 109.418 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.13 -51.7 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.548 2.165 . . . . 0.0 112.287 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.3 -39.4 14.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 109.758 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.68 -45.47 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.435 ' HZ2' ' HB3' ' B' ' 61' ' ' LYS . 13.4 mtpp -75.17 -24.84 57.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.43 -43.05 70.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.574 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.831 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 55.2 t60 -64.1 -23.9 67.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.685 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.29 75.84 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.5 ' NZ ' ' OD1' ' B' ' 21' ' ' ASP . 19.3 mtpt -67.13 -25.02 65.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -1.15 . . . . 0.0 109.619 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' LYS . . . . . 0.473 ' O ' HMA3 ' B' ' 147' ' ' HEC . 66.8 mttm -72.02 -28.75 63.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.583 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 1.036 HG13 ' C2B' ' B' ' 147' ' ' HEC . 41.6 t -80.11 -48.79 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.667 HD23 ' O ' ' B' ' 68' ' ' LEU . 1.3 tt -60.54 -16.92 42.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.31 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.14 -48.64 45.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.51 90.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -1.157 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -47.31 -41.2 18.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 0.0 109.559 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 14.0 m -49.42 -44.3 45.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 109.48 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -67.78 -16.72 64.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.06 -26.54 69.25 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.722 HD23 ' H ' ' B' ' 75' ' ' LEU . 2.0 pt? -136.08 -18.6 1.55 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.236 -1.155 . . . . 0.0 110.153 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -82.24 1.44 36.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.061 -1.024 . . . . 0.0 109.731 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 59.4 m-70 -163.06 67.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 109.549 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.09 4.85 3.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.49 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.02 -37.21 79.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.487 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 14.1 t-20 -171.45 99.43 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.492 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.04 -57.25 3.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.536 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -47.12 -24.02 0.6 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.558 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -66.43 -54.91 20.58 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.551 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.8 t -75.5 -47.32 27.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 0.0 109.488 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.551 ' N ' ' CG2' ' B' ' 84' ' ' THR . 53.3 m-85 -62.73 -1.18 0.78 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.5 -0.75 . . . . 0.0 109.381 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -59.22 -35.85 74.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.453 ' O ' ' N ' ' B' ' 91' ' ' LEU . 21.5 p -83.28 -47.96 10.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.932 . . . . 0.0 109.531 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' B' ' 85' ' ' PHE . 40.5 mt -55.42 -43.12 75.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -67.41 -51.3 53.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.53 -22.41 64.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.868 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.672 HD23 ' C ' ' B' ' 91' ' ' LEU . 7.6 tt -81.42 -60.11 2.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.77 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.584 ' N ' HD23 ' B' ' 91' ' ' LEU . 66.5 m80 -61.78 -22.42 65.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.288 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 39.4 t -83.1 -60.58 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 110.729 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.538 ' O ' ' CE1' ' B' ' 97' ' ' HIS . 5.1 m-20 -87.23 -27.74 22.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.137 -0.977 . . . . 0.0 111.149 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.2 OUTLIER -87.68 -16.68 33.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.889 -1.132 . . . . 0.0 110.646 -178.641 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.498 ' C ' ' ND1' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -138.37 -39.26 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.942 -1.099 . . . . 0.0 109.929 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 1.257 ' CG ' HG21 ' C' ' 41' ' ' THR . 4.9 m80 64.87 58.78 0.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.101 -1.0 . . . . 0.0 109.754 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.7 132.63 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.081 -1.012 . . . . 0.0 109.335 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.44 152.55 2.22 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.359 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.04 -29.84 17.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.66 2.24 . . . . 0.0 112.187 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.33 53.68 0.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.768 ' OD1' ' CMC' ' B' ' 147' ' ' HEC . 31.4 t-20 -149.35 -38.95 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.586 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.69 -29.78 70.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.545 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.402 ' NH1' ' CB ' ' B' ' 104' ' ' ARG . 31.4 mtm105 -77.82 -20.03 53.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 109.678 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.73 -50.04 9.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 1.076 HD13 ' CHC' ' B' ' 147' ' ' HEC . 6.0 tt -52.04 -49.04 64.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.39 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.5 -20.39 63.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' ASN . . . . . 0.454 ' OD1' ' ND1' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -81.76 -19.43 41.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -1.135 . . . . 0.0 109.658 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 92.6 t -86.36 -53.01 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.242 -0.911 . . . . 0.0 109.675 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.512 HD23 ' C ' ' B' ' 110' ' ' LEU . 2.8 tt -45.98 -60.2 2.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.336 -0.853 . . . . 0.0 109.717 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 61.5 t -46.68 -33.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.934 . . . . 0.0 109.748 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.21 -23.94 43.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.657 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 110' ' ' LEU . 98.2 t -75.0 -21.34 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.569 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.523 ' CD1' ' CZ ' ' B' ' 130' ' ' TYR . 21.5 mt -79.06 -48.59 14.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 109.49 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.27 -23.1 3.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.498 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 6.5 t-80 -83.81 -57.75 3.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.59 ' HD1' ' N ' ' B' ' 117' ' ' HIS . 0.3 OUTLIER -72.4 -17.78 61.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.524 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' B' ' 114' ' ' LEU . 95.1 m-85 -141.64 56.53 1.51 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -73.16 -24.94 74.61 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.2 9.32 1.02 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -1.132 . . . . 0.0 109.624 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' B' ' 119' ' ' GLY . 59.1 mm-40 -142.68 8.78 1.75 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.541 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -78.68 34.19 0.22 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.971 . . . . 0.0 109.442 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.481 ' OG1' HG23 ' B' ' 126' ' ' VAL . 69.2 p -48.67 148.47 3.62 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.265 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.513 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.4 Cg_exo -44.09 -55.82 2.88 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.544 2.163 . . . . 0.0 112.983 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 12.4 Cg_endo -56.22 -23.23 44.29 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.188 1.925 . . . . 0.0 112.22 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.481 HG23 ' OG1' ' B' ' 123' ' ' THR . 76.5 t -82.87 -23.31 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 109.559 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -83.18 -59.67 2.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.25 -36.85 14.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.903 . . . . 0.0 109.842 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.6 -5.22 56.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.131 -0.98 . . . . 0.0 110.065 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.523 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 0.1 OUTLIER -92.58 -40.72 10.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.006 . . . . 0.0 109.47 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -83.97 -23.05 31.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 109.633 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -71.14 -42.36 69.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 110.141 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' VAL . . . . . 0.93 HG13 ' H ' ' B' ' 134' ' ' VAL . 6.3 p -71.96 -66.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.112 -0.992 . . . . 0.0 110.327 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.93 ' H ' HG13 ' B' ' 133' ' ' VAL . 33.1 m -43.32 -19.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.949 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' B' ' 133' ' ' VAL . . . -59.55 -28.11 66.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.267 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.85 -30.85 58.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.41 -36.31 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -1.156 . . . . 0.0 109.451 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.42 -40.11 89.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -75.88 -25.98 56.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.67 -48.98 74.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.2 -4.24 28.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.393 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' B' ' 145' ' ' TYR . . . -102.36 -39.51 7.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 0.0 109.545 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -45.32 -40.26 7.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 109.784 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.26 27.33 1.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.113 -0.992 . . . . 0.0 109.559 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.576 ' O ' ' CG ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -140.43 1.27 1.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.515 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.461 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.499 ' CG1' ' OG ' ' C' ' 131' ' ' SER . 97.6 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp 58.91 163.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 174.82 -44.9 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 110.005 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' C' ' 3' ' ' SER . 52.9 Cg_exo -53.55 172.86 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.702 2.268 . . . . 0.0 113.14 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -47.02 -14.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.637 -0.664 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' C' ' 4' ' ' PRO . 3.0 p30 -38.68 -22.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.391 -0.818 . . . . 0.0 110.146 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' C' ' 5' ' ' ALA . 37.9 mttt -80.51 -56.77 3.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.109 -0.994 . . . . 0.0 109.378 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 54.5 m -46.82 -28.62 1.61 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.349 -0.844 . . . . 0.0 109.504 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -78.42 -38.07 42.29 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.448 HG21 ' CD2' ' C' ' 128' ' ' PHE . 25.4 t -71.58 -49.16 48.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -51.15 -44.16 61.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 108.621 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.22 -61.13 2.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.458 -0.776 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.09 -35.33 69.27 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.41 -0.806 . . . . 0.0 109.333 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -77.09 -17.12 58.93 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.188 -0.945 . . . . 0.0 108.877 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.49 -38.41 44.54 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -84.37 -35.21 23.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.294 -1.121 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.559 HG12 ' HB2' ' C' ' 21' ' ' ALA . 42.6 t -73.58 -36.94 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.813 . . . . 0.0 109.684 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' C' ' 19' ' ' ALA . . . -30.63 143.72 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 19' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' C' ' 18' ' ' GLY . . . 71.09 -31.92 0.24 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.409 -1.053 . . . . 0.0 109.121 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' C' ' 18' ' ' GLY . 49.7 m-70 -107.92 17.2 22.72 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.559 ' HB2' HG12 ' C' ' 17' ' ' VAL . . . -85.63 -35.98 20.63 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.847 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.38 -14.44 64.34 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -87.87 -56.13 3.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.3 -1.118 . . . . 0.0 109.97 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 1.4 m-30 -58.52 -35.33 72.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.374 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.65 -23.02 64.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.42 -49.91 8.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.225 -1.162 . . . . 0.0 109.759 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.53 -19.85 17.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.659 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.75 -21.31 61.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 109.542 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.545 HD11 ' ND1' ' C' ' 58' ' ' HIS . 11.1 mt -82.53 -54.3 5.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.877 . . . . 0.0 109.653 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -33.95 77.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.564 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.508 ' CG ' HH11 ' C' ' 31' ' ' ARG . 0.5 OUTLIER -66.48 -38.55 87.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.647 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 32' ' ' MET . . . . . 1.238 ' CE ' ' HAB' ' C' ' 142' ' ' HEC . 15.1 tmm? -75.09 -32.0 61.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 109.32 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 33' ' ' PHE . . . . . 0.64 ' HE1' ' C4D' ' C' ' 142' ' ' HEC . 74.5 t80 -54.11 -49.87 68.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.843 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' C' ' 36' ' ' PHE . 1.3 pp -81.3 -43.71 18.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.165 -0.96 . . . . 0.0 110.024 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -62.92 4.47 0.17 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 0.0 109.582 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.978 ' HB3' ' CMC' ' C' ' 142' ' ' HEC . 2.5 t80 -162.74 93.75 1.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.16 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -79.81 -23.29 6.96 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.496 2.131 . . . . 0.0 112.405 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.53 ' OG1' ' CE2' ' C' ' 36' ' ' PHE . 9.1 p -54.77 -28.49 49.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.0 109.253 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.9 ' HB ' ' CHC' ' C' ' 142' ' ' HEC . 8.6 p -90.12 -22.65 21.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 109.515 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.948 ' O ' ' C3D' ' C' ' 142' ' ' HEC . 29.3 ttpt -46.23 -31.13 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.576 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 41' ' ' THR . . . . . 1.257 HG21 ' CG ' ' B' ' 97' ' ' HIS . 0.5 OUTLIER -77.9 -18.96 55.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' C' ' 39' ' ' THR . 33.6 t80 -60.26 -22.67 63.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.641 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.516 ' HA ' ' C1A' ' C' ' 142' ' ' HEC . 49.6 t80 53.69 83.88 0.22 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.388 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.72 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 76.0 Cg_exo -47.33 -41.11 28.6 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.529 2.153 . . . . 0.0 112.202 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 1.239 ' N ' HMA2 ' C' ' 142' ' ' HEC . 0.0 OUTLIER 97.71 33.74 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.267 -0.271 . . . . 0.0 111.174 179.106 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 1.013 ' CD1' HMA3 ' C' ' 142' ' ' HEC . 0.1 OUTLIER -137.07 35.09 2.57 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.83 -1.169 . . . . 0.0 109.924 178.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' C' ' 49' ' ' SER . 14.4 m-20 52.97 91.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 1.535 HD11 ' CHA' ' C' ' 142' ' ' HEC . 11.3 mt -60.1 -1.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.39 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.468 ' H ' ' C ' ' C' ' 47' ' ' ASP . 92.4 p -54.38 126.81 24.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -57.29 136.03 56.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.47 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.79 15.41 70.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 4.4 t -64.08 -14.46 54.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.164 . . . . 0.0 109.468 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 70.82 -18.86 0.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.833 . . . . 0.0 109.659 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' C' ' 52' ' ' SER . 32.9 mt-30 -85.69 -18.11 34.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.08 -1.012 . . . . 0.0 109.367 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.65 -36.01 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -76.04 -33.51 59.62 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.257 -0.902 . . . . 0.0 108.895 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.66 -25.17 74.04 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.545 ' ND1' HD11 ' C' ' 29' ' ' LEU . 6.3 t-80 -71.46 -43.26 66.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -1.151 . . . . 0.0 109.417 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -49.5 -48.1 35.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 86.5 mttt -52.79 -22.51 5.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -1.002 . . . . 0.0 109.965 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -40.91 60.66 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.158 -0.964 . . . . 0.0 108.772 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.48 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -73.04 -47.24 48.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.521 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -65.86 -32.6 74.21 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.442 -0.786 . . . . 0.0 109.152 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 64' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 26.4 t0 -71.88 -32.46 67.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.045 . . . . 0.0 108.61 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -68.22 -52.47 33.74 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.06 -41.36 59.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 108.926 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.433 ' O ' ' N ' ' C' ' 71' ' ' ALA . 16.3 m -68.27 -57.82 5.37 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.947 . . . . 0.0 108.739 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -59.81 -23.79 63.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 108.701 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.11 -46.92 10.68 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.53 -22.93 27.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -67.71 -36.18 80.15 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' C' ' 74' ' ' ASP . 84.9 m-70 -102.79 -65.5 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.558 HG12 ' O ' ' C' ' 72' ' ' HIS . 12.6 p 44.8 14.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.791 0.805 . . . . 0.0 109.39 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' C' ' 72' ' ' HIS . 71.2 m-20 -137.12 11.93 3.06 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.415 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 0.3 OUTLIER 172.22 31.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.153 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 8.2 ptt? -78.32 -22.82 0.4 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 111.987 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.6 Cg_exo -53.24 -22.47 20.16 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.556 1.504 . . . . 0.0 112.361 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -92.95 -40.44 10.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.483 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.11 83.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.9 . . . . 0.0 109.137 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 28.9 mt -83.79 9.34 12.13 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 108.932 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -58.27 -50.52 73.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.575 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' C' ' 83' ' ' LEU . . . -50.04 -58.57 5.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.569 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.418 ' N ' HD23 ' C' ' 83' ' ' LEU . 4.5 mt -46.07 -46.15 16.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 5.8 p -64.94 -32.11 73.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.535 -0.728 . . . . 0.0 109.391 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' C' ' 82' ' ' ALA . 31.9 t70 -75.43 -23.85 57.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tt -83.01 -34.25 26.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.858 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -91.97 -21.97 20.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -69.32 -84.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.713 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -78.45 -70.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.893 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' C' ' 92' ' ' ARG . 25.5 ttmt -46.3 137.99 5.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 110.013 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.1 mt 66.23 -20.41 0.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.711 -0.618 . . . . 0.0 109.759 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 92' ' ' ARG . . . . . 0.592 ' H ' ' C ' ' C' ' 90' ' ' LYS . 65.3 mtt180 38.8 27.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.539 -0.726 . . . . 0.0 109.676 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.576 ' CG2' ' ND2' ' C' ' 97' ' ' ASN . 7.5 p -45.47 141.2 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.828 . . . . 0.0 109.681 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -74.31 149.51 86.86 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.894 . . . . 0.0 109.371 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' C' ' 97' ' ' ASN . 59.5 Cg_endo -73.61 -22.2 18.39 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.435 2.09 . . . . 0.0 112.204 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.42 HG12 ' O ' ' C' ' 96' ' ' VAL . 21.9 t -56.56 -3.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.576 ' ND2' ' CG2' ' C' ' 93' ' ' VAL . 0.7 OUTLIER -79.24 -41.92 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 109.998 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -51.29 -48.7 62.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 109.41 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -48.34 -30.57 5.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.176 -0.952 . . . . 0.0 109.434 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.47 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 18.6 mt -84.21 -62.09 1.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 109.622 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tp -49.88 -20.92 0.99 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.725 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 10.2 t -69.29 -59.14 3.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.939 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.463 ' ND1' ' OD1' ' D' ' 108' ' ' ASN . 32.1 m170 -68.42 -26.61 65.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.821 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 50.9 m -63.03 -45.36 92.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.887 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.0 -55.41 33.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.987 . . . . 0.0 109.456 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' C' ' 110' ' ' ALA . 4.1 mm? -47.79 -29.18 2.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.135 -0.978 . . . . 0.0 109.591 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.36 -24.79 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 0.0 110.113 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.407 ' OG1' HD23 ' C' ' 109' ' ' LEU . 28.0 p -71.45 -63.34 1.14 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.026 -1.046 . . . . 0.0 110.352 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.57 HD23 ' H ' ' C' ' 109' ' ' LEU . 0.1 OUTLIER -64.64 -26.29 68.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.056 -1.027 . . . . 0.0 109.636 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' C' ' 106' ' ' LEU . . . -49.35 -37.43 24.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.107 -0.995 . . . . 0.0 109.707 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.18 -56.17 4.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 110.075 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -71.45 -67.51 0.52 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.821 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.615 ' C ' HD13 ' C' ' 113' ' ' LEU . 2.1 tm? -110.68 98.49 37.66 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 114' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' C' ' 113' ' ' LEU . 65.7 Cg_exo -49.18 -170.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.269 1.98 . . . . 0.0 112.304 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.654 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -72.99 -55.22 6.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 108.866 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.654 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 18.3 mt-10 118.58 -8.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.464 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 5.3 t80 77.13 33.74 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.937 -0.477 . . . . 0.0 111.139 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.4 OUTLIER -101.62 116.08 64.02 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.1 20.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.935 1.757 . . . . 0.0 112.482 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -144.81 -29.37 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.038 -1.039 . . . . 0.0 110.423 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.669 HG13 ' N ' ' C' ' 122' ' ' HIS . 10.5 p -49.39 -50.8 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.06 -1.025 . . . . 0.0 109.899 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.669 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.9 m80 -60.81 -34.76 75.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.119 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.18 -20.06 33.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.765 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.522 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.4 m -64.93 -62.08 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 110.518 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.94 -19.69 62.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.187 -0.945 . . . . 0.0 109.949 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.48 -44.52 19.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.068 -1.02 . . . . 0.0 110.109 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.413 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -89.07 -41.37 12.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.004 -1.06 . . . . 0.0 109.977 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.448 ' CD2' HG21 ' C' ' 10' ' ' VAL . 41.7 t80 -50.52 -20.91 1.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.99 -1.069 . . . . 0.0 108.899 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' C' ' 133' ' ' SER . 18.2 mt -71.42 -17.66 62.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.411 ' O ' ' OG1' ' C' ' 134' ' ' THR . . . -61.0 -31.6 71.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.499 ' OG ' ' CG1' ' C' ' 1' ' ' VAL . 4.0 t -83.59 -33.05 25.46 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.289 -0.882 . . . . 0.0 108.918 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.18 -26.66 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.0 108.922 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.594 ' N ' ' O ' ' C' ' 129' ' ' LEU . 33.0 t -84.01 -25.45 29.93 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.383 -0.823 . . . . 0.0 108.969 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 134' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 33.2 m -77.69 -38.93 46.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 109.189 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.407 HG13 ' O ' ' C' ' 131' ' ' SER . 34.8 m -73.39 -26.85 22.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.3 -0.875 . . . . 0.0 108.677 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.81 -30.03 70.6 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 137' ' ' THR . . . . . 0.712 HG22 ' O ' ' C' ' 137' ' ' THR . 93.5 m -112.45 24.07 12.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.413 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 3.6 t -46.91 -65.43 0.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 0.494 ' CB ' ' NZ ' ' C' ' 139' ' ' LYS . 8.4 mtmp? 52.39 -106.19 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.129 -0.982 . . . . 0.0 109.563 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -150.82 -55.53 0.15 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.415 179.94 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.598 ' H1 ' ' CB ' ' D' ' 133' ' ' VAL . 8.2 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 49.78 42.04 23.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.288 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.976 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -92.11 155.61 17.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.442 ' H ' HG22 ' D' ' 4' ' ' THR . 0.2 OUTLIER -64.16 153.95 83.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 108.933 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.01 -15.96 36.31 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.616 2.21 . . . . 0.0 112.263 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.3 -42.77 14.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.682 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.17 -22.53 30.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.886 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.604 ' HB2' HD13 ' D' ' 3' ' ' LEU . 7.7 tttm -79.25 -40.5 30.46 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.124 -0.985 . . . . 0.0 109.245 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -61.58 -23.64 66.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 109.821 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.1 -55.43 4.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.065 -1.022 . . . . 0.0 110.144 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.26 -24.62 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.01 -1.056 . . . . 0.0 108.418 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 49.9 m -82.18 -37.14 26.56 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.752 -0.593 . . . . 0.0 109.591 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.5 96.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -0.848 . . . . 0.0 109.456 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' D' ' 17' ' ' LYS . 0.8 OUTLIER -61.81 -35.12 77.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.43 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -47.95 -21.63 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.138 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 16' ' ' GLY . . . . . 0.414 ' N ' ' C ' ' D' ' 14' ' ' LEU . . . -86.52 -32.52 15.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' D' ' 14' ' ' LEU . 1.0 OUTLIER -77.97 -31.46 50.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -1.123 . . . . 0.0 109.101 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -54.23 114.98 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.535 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' D' ' 21' ' ' ASP . 3.1 m120 -71.45 64.15 0.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.133 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 42.1 t -45.74 -16.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' D' ' 19' ' ' ASN . 21.4 t70 -77.32 5.67 8.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.937 . . . . 0.0 109.312 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' D' ' 19' ' ' ASN . 81.2 mt-10 -154.31 -43.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.352 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 78.7 t -55.03 -25.07 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 109.474 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.43 -42.55 93.74 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.67 -35.88 54.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -73.43 -36.52 65.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -1.138 . . . . 0.0 109.399 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.39 -53.05 61.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.179 -0.95 . . . . 0.0 109.417 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.42 -51.55 67.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.271 -0.893 . . . . 0.0 109.271 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.6 -40.77 95.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 30' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' D' ' 33' ' ' VAL . 16.6 mmt85 -58.1 -44.38 87.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 31' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' D' ' 35' ' ' TYR . 33.6 tp -46.86 -32.44 3.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 109.247 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 mt -81.24 -21.87 39.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.893 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' D' ' 30' ' ' ARG . 21.2 t -87.13 -64.2 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.417 HG23 ' H ' ' D' ' 34' ' ' VAL . 0.2 OUTLIER -60.16 -49.53 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.925 . . . . 0.0 109.841 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 35' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' D' ' 31' ' ' LEU . 0.1 OUTLIER -118.48 85.71 26.8 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.282 -0.886 . . . . 0.0 109.425 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 36' ' ' PRO . . . . . 0.808 ' O ' ' C2C' ' D' ' 147' ' ' HEC . 89.7 Cg_endo -84.18 34.44 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.787 2.324 . . . . 0.0 112.356 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 37' ' ' TRP . . . . . 0.529 ' NE1' HG23 ' D' ' 38' ' ' THR . 1.9 p-90 -81.09 -29.79 34.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 38' ' ' THR . . . . . 1.352 ' C ' ' C1C' ' D' ' 147' ' ' HEC . 65.5 p -60.58 -96.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.937 . . . . 0.0 109.325 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 39' ' ' GLN . . . . . 1.178 ' N ' ' C4B' ' D' ' 147' ' ' HEC . 78.7 mm-40 49.12 45.06 23.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.478 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 40' ' ' ARG . . . . . 0.595 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 19.1 ptt180 -137.76 -39.24 0.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.855 . . . . 0.0 109.357 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -100.38 -25.4 14.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 1.427 ' HB3' ' CMA' ' D' ' 147' ' ' HEC . 61.9 m-85 -74.49 6.04 4.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.467 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.14 -23.19 51.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.554 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 20.4 p -59.61 -40.43 87.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.438 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -51.49 -17.73 0.89 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.77 55.14 11.77 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -159.55 79.19 0.72 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -1.087 . . . . 0.0 109.422 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 48' ' ' LEU . . . . . 0.73 HD21 HMA3 ' D' ' 147' ' ' HEC . 35.9 mt -131.46 14.57 5.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.427 -0.795 . . . . 0.0 109.383 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 24.4 m -46.85 -41.75 16.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.211 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 6.1 p -146.73 148.67 34.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -41.16 -39.4 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.305 2.003 . . . . 0.0 112.333 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ASP . . . . . 0.404 ' C ' ' N ' ' D' ' 54' ' ' VAL . 1.0 OUTLIER -67.04 -40.47 87.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.703 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.14 -19.83 0.31 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 109.523 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 52' ' ' ASP . 83.2 t -67.52 -64.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 109.681 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 10.4 mtt -86.21 -6.12 59.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.527 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.69 87.99 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -81.28 148.35 63.01 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.188 -1.183 . . . . 0.0 109.424 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.14 -51.71 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.559 2.173 . . . . 0.0 112.213 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.3 -39.32 14.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.709 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.79 -45.4 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.118 -0.989 . . . . 0.0 109.289 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -75.25 -24.76 57.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 109.294 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.51 -42.98 70.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.605 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -64.04 -24.02 67.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.709 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.58 -33.24 76.07 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 65' ' ' LYS . . . . . 0.509 ' NZ ' ' OD1' ' D' ' 21' ' ' ASP . 19.4 mtpt -67.28 -24.87 65.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -1.216 . . . . 0.0 109.642 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -71.95 -28.88 63.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.628 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.1 -48.76 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.655 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.3 tt -60.5 -16.91 41.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.376 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.11 -48.71 45.24 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.89 -46.61 89.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -1.181 . . . . 0.0 109.852 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 71' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' D' ' 74' ' ' GLY . 1.1 m-85 -47.25 -41.19 18.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 109.588 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 14.0 m -49.51 -44.21 46.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.459 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -67.85 -16.65 64.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.221 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 74' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' D' ' 71' ' ' PHE . . . -63.01 -26.61 69.27 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.735 HD23 ' H ' ' D' ' 75' ' ' LEU . 2.0 pt? -136.09 -18.54 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.271 -1.134 . . . . 0.0 110.176 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 76' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -82.25 1.49 36.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.997 -1.065 . . . . 0.0 109.746 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 59.8 m-70 -163.06 67.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.16 4.89 3.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.411 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.13 -37.14 79.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 80' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 14.1 t-20 -171.42 99.39 0.19 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.532 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -80.18 -57.2 3.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -47.19 -23.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 0.0 109.524 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 83' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -66.37 -54.88 20.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.8 t -75.54 -47.45 26.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -1.18 . . . . 0.0 109.384 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.556 ' N ' ' CG2' ' D' ' 84' ' ' THR . 53.4 m-85 -62.53 -1.26 0.76 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.541 -0.724 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 86' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -59.2 -35.79 74.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 87' ' ' THR . . . . . 0.483 ' O ' ' N ' ' D' ' 91' ' ' LEU . 21.3 p -83.39 -47.93 10.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.432 HD12 ' CD1' ' D' ' 85' ' ' PHE . 40.9 mt -55.53 -43.0 75.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -67.36 -51.41 52.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.437 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.38 -22.55 64.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.482 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.672 HD23 ' C ' ' D' ' 91' ' ' LEU . 7.5 tt -81.36 -60.21 2.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.227 -0.921 . . . . 0.0 109.727 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.591 ' N ' HD23 ' D' ' 91' ' ' LEU . 66.5 m80 -61.64 -22.51 65.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.225 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 93' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 39.4 t -83.09 -60.61 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 110.768 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.539 ' O ' ' CE1' ' D' ' 97' ' ' HIS . 5.1 m-20 -87.18 -27.7 22.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.122 -0.986 . . . . 0.0 111.098 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 95' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.2 OUTLIER -87.71 -16.73 33.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.851 -1.156 . . . . 0.0 110.644 -178.567 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.501 ' C ' ' ND1' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -138.38 -39.33 0.53 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.963 -1.086 . . . . 0.0 109.831 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 1.281 ' CG ' HG21 ' A' ' 41' ' ' THR . 5.0 m80 64.83 58.81 0.94 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 109.778 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.62 132.62 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.1 -1.0 . . . . 0.0 109.363 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.39 152.5 2.2 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.399 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.02 -29.76 17.43 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.536 2.157 . . . . 0.0 112.195 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.45 53.82 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -149.31 -39.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.58 -29.77 70.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.575 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 104' ' ' ARG . . . . . 0.411 ' NH1' ' CB ' ' D' ' 104' ' ' ARG . 31.4 mtm105 -77.87 -20.05 53.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.599 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 13.6 mt -82.64 -50.14 9.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.9 tt -51.97 -49.1 63.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.361 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.49 -20.3 63.39 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 108' ' ' ASN . . . . . 0.463 ' OD1' ' ND1' ' C' ' 103' ' ' HIS . 0.2 OUTLIER -81.86 -19.45 40.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -1.195 . . . . 0.0 109.613 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 92.4 t -86.36 -52.95 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -0.984 . . . . 0.0 109.721 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 110' ' ' LEU . . . . . 0.504 HD23 ' C ' ' D' ' 110' ' ' LEU . 2.8 tt -45.96 -60.13 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 0.0 109.787 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 61.3 t -46.68 -33.26 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.812 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.23 -23.95 43.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 113' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' D' ' 110' ' ' LEU . 98.7 t -74.94 -21.34 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.591 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 114' ' ' LEU . . . . . 0.519 ' CD1' ' CZ ' ' D' ' 130' ' ' TYR . 21.4 mt -78.98 -48.7 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 109.494 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.12 -23.31 3.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.443 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.484 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 6.5 t-80 -83.72 -57.81 3.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 117' ' ' HIS . . . . . 0.6 ' N ' ' HD1' ' D' ' 117' ' ' HIS . 0.3 OUTLIER -72.4 -17.75 61.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 109.511 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' D' ' 114' ' ' LEU . 95.2 m-85 -141.7 56.66 1.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.28 -24.85 74.52 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.31 9.46 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -1.098 . . . . 0.0 109.577 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -142.75 8.84 1.73 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.541 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -78.67 34.15 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.471 ' OG1' HG23 ' D' ' 126' ' ' VAL . 69.6 p -48.59 148.46 3.54 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.206 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.507 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.5 Cg_exo -44.15 -55.76 2.94 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.565 2.177 . . . . 0.0 112.97 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 12.6 Cg_endo -56.21 -23.35 44.85 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.249 1.966 . . . . 0.0 112.208 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.471 HG23 ' OG1' ' D' ' 123' ' ' THR . 75.5 t -82.8 -23.3 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.569 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -83.28 -59.6 2.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.73 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.2 -36.87 14.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.62 -5.11 56.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 0.0 110.042 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.519 ' CZ ' ' CD1' ' D' ' 114' ' ' LEU . 0.1 OUTLIER -92.65 -40.74 10.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.025 -1.047 . . . . 0.0 109.474 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -84.0 -22.99 31.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.685 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -71.11 -42.4 69.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.113 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 133' ' ' VAL . . . . . 0.965 HG13 ' H ' ' D' ' 134' ' ' VAL . 6.4 p -71.97 -66.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -0.983 . . . . 0.0 110.349 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.965 ' H ' HG13 ' D' ' 133' ' ' VAL . 33.1 m -43.43 -19.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 0.0 109.941 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' D' ' 133' ' ' VAL . . . -59.62 -27.97 66.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.384 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.9 -30.94 58.66 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.31 -36.39 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -1.139 . . . . 0.0 109.418 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.37 -40.17 89.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.88 -25.97 56.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.439 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.64 -49.04 74.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.419 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.16 -4.29 28.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.127 -0.983 . . . . 0.0 109.36 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 142' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' D' ' 145' ' ' TYR . . . -102.37 -39.42 7.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.417 -0.802 . . . . 0.0 109.515 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -45.39 -40.25 7.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 109.733 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.406 ' HB2' ' HZ2' ' D' ' 144' ' ' LYS . 0.0 OUTLIER -87.26 27.29 1.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.564 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 145' ' ' TYR . . . . . 0.57 ' O ' ' CG ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -140.46 1.21 1.74 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.408 ' HB3' ' CB ' ' B' ' 135' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.9 HMB1 HBB3 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 1.209 ' CBC' ' CZ ' ' B' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 1.535 ' CHA' HD11 ' C' ' 48' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 1.427 ' CMA' ' HB3' ' D' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 2' ' ' LEU . 10.8 mp 53.21 176.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.158 -0.963 . . . . 0.0 109.553 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.51 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 174.59 -47.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 110.066 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' ASP . 71.1 Cg_exo -47.24 169.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.571 2.18 . . . . 0.0 112.744 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -45.35 -15.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.407 -0.808 . . . . 0.0 110.123 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' PRO . 25.0 t70 -38.78 -40.49 0.62 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 109.928 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 7' ' ' LYS . 13.5 ptpt -67.97 -45.74 73.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.131 -0.981 . . . . 0.0 109.224 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 5' ' ' ALA . 36.0 m -52.98 -31.1 38.82 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 108.782 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -78.07 -36.06 48.73 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 128' ' ' PHE . 91.2 t -69.74 -49.05 61.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.79 -47.47 64.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -49.2 -60.79 2.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.613 -0.679 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -50.86 -39.06 52.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.311 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -17.26 61.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.436 -0.79 . . . . 0.0 109.217 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -81.62 -45.68 7.19 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.67 -34.8 72.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -1.162 . . . . 0.0 108.674 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 13' ' ' ALA . 70.4 t -61.97 -66.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 64.55 -143.61 47.22 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 48.37 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.584 -0.951 . . . . 0.0 109.978 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 18' ' ' GLY . 80.7 m-70 -151.81 19.53 0.7 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.42 -65.19 1.04 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.715 -0.616 . . . . 0.0 109.794 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.58 -14.77 0.24 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' ALA . 2.1 mm-40 -83.07 -56.46 3.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -1.19 . . . . 0.0 109.726 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.8 m-30 -55.95 -35.3 66.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.852 . . . . 0.0 109.13 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.11 -22.76 60.97 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.58 -38.28 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -1.168 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.73 -19.69 63.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.684 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.44 -22.41 51.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.117 -0.989 . . . . 0.0 109.708 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.42 -43.97 37.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -65.68 -12.82 56.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.2 -0.937 . . . . 0.0 109.695 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -58.98 2.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptm -62.31 -25.61 67.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.476 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 48' ' ' LEU . 1.3 t80 -58.65 -55.99 27.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 0.0 109.653 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -82.41 -42.46 18.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.126 -0.984 . . . . 0.0 110.227 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.527 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 12.6 t -59.65 -9.3 2.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.02 -1.05 . . . . 0.0 109.687 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 1.003 ' CZ ' ' NE2' ' B' ' 131' ' ' GLN . 79.3 m-85 -155.35 81.71 3.99 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.155 -0.966 . . . . 0.0 109.503 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 39' ' ' THR . 52.6 Cg_exo -52.5 -24.92 23.51 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.704 2.269 . . . . 0.0 112.273 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.485 HG22 ' HB2' ' D' ' 97' ' ' HIS . 9.0 p -46.88 -19.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 37' ' ' PRO . 51.2 p -82.89 -26.2 31.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.656 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 42' ' ' TYR . 26.6 ttpt -79.3 -53.66 6.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.181 -0.95 . . . . 0.0 109.658 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t -46.97 -18.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.563 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.473 ' O ' ' CG ' ' A' ' 42' ' ' TYR . 82.0 t80 -78.8 3.15 17.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 49.24 66.51 5.6 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 65.8 Cg_endo -76.91 -1.62 11.79 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.679 2.252 . . . . 0.0 112.524 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.569 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 22.4 p80 41.47 24.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 109.502 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.543 ' O ' ' C ' ' A' ' 47' ' ' ASP . 3.9 t80 -104.38 31.57 4.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.561 -0.712 . . . . 0.0 109.736 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 46' ' ' PHE . 15.0 m-20 28.63 67.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.884 -0.51 . . . . 0.0 110.533 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.528 ' O ' ' CE2' ' A' ' 33' ' ' PHE . 87.3 mt -85.16 22.33 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.428 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 50' ' ' HIS . 19.3 m -76.65 26.67 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.358 -0.839 . . . . 0.0 109.418 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.456 ' H ' ' C ' ' A' ' 48' ' ' LEU . 54.6 t60 58.08 158.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 0.0 109.57 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.65 17.92 5.02 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.553 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 9.1 t -80.25 -17.76 51.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -1.111 . . . . 0.0 109.512 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 68.6 -58.52 0.48 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 109.798 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 52' ' ' SER . 0.6 OUTLIER -43.76 -20.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.775 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 53' ' ' ALA . 89.8 t -77.55 -27.17 15.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.136 -0.977 . . . . 0.0 109.28 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.9 ptmt -63.7 -27.2 69.05 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.266 -0.896 . . . . 0.0 109.327 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.84 -27.62 68.81 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -84.17 -30.65 25.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -1.17 . . . . 0.0 110.096 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.01 -49.47 55.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -60.1 -23.64 63.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -1.106 . . . . 0.0 110.082 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' O ' ' CMA' ' A' ' 142' ' ' HEC . 0.3 OUTLIER -73.29 -34.04 65.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.087 -1.008 . . . . 0.0 109.135 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.29 -52.92 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.41 -0.806 . . . . 0.0 108.944 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.96 -28.44 69.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.297 -0.877 . . . . 0.0 109.166 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.26 -41.42 81.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.199 -0.938 . . . . 0.0 108.89 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.467 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -68.03 -42.54 80.44 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 66' ' ' LEU . 9.8 mt -63.34 -46.17 87.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -63.24 -48.77 76.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.256 -0.902 . . . . 0.0 108.976 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.66 -22.56 66.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 108.835 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.21 -47.68 9.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -66.84 -22.56 29.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.98 -14.68 62.44 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.676 ' O ' HG12 ' A' ' 73' ' ' VAL . 21.5 m80 -141.87 -57.44 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.808 . . . . 0.0 109.648 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 72' ' ' HIS . 8.2 p 46.14 15.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 122.1 0.953 . . . . 0.0 108.76 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 72' ' ' HIS . 22.0 m-20 -136.36 12.41 3.26 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.9 30.39 0.06 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.554 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 1.2 mtm -66.54 -44.82 56.88 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.611 -0.681 . . . . 0.0 110.073 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 76' ' ' MET . 95.7 Cg_exo -42.12 -43.02 7.39 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.356 2.038 . . . . 0.0 112.727 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -94.23 -19.01 21.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 109.97 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.12 -58.44 3.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 109.165 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.5 mt -83.14 16.9 2.19 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -21.98 64.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.473 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -74.8 -57.97 3.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.538 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.465 ' N ' HD23 ' A' ' 83' ' ' LEU . 3.1 mt -44.75 -39.66 5.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' ALA . 26.5 t -54.48 -34.45 61.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 82' ' ' ALA . 4.0 m-20 -66.02 -24.39 66.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.144 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.584 HD21 ' CBD' ' A' ' 142' ' ' HEC . 7.3 tp -80.45 -38.6 29.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.882 . . . . 0.0 109.176 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -92.28 -21.65 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.688 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 84' ' ' SER . . . -76.43 -39.02 54.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.244 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' LYS . 50.3 t-80 -146.58 -83.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 110.167 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.46 ' NZ ' ' CD1' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -43.88 105.98 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tp 63.61 59.14 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 109.293 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.657 HH12 ' HE1' ' D' ' 42' ' ' PHE . 10.6 ptp180 -60.64 -22.71 64.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.902 HG22 ' H ' ' A' ' 94' ' ' ASP . 12.8 p 42.1 -176.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.671 -0.643 . . . . 0.0 110.122 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.902 ' H ' HG22 ' A' ' 93' ' ' VAL . 50.7 m-20 -80.88 120.7 79.61 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.961 -1.087 . . . . 0.0 109.488 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.566 ' C ' ' H ' ' A' ' 97' ' ' ASN . 73.5 Cg_endo -78.67 -37.78 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.282 1.988 . . . . 0.0 112.183 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.479 HG21 ' OD1' ' D' ' 99' ' ' ASP . 6.2 t -55.38 -0.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.703 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.566 ' H ' ' C ' ' A' ' 95' ' ' PRO . 4.8 m120 -79.03 -24.77 43.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.695 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 95' ' ' PRO . 26.8 m-85 -49.3 -17.59 0.27 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.419 ' N ' ' C ' ' A' ' 97' ' ' ASN . 92.0 mttt -81.99 -28.23 32.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.888 . . . . 0.0 109.44 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 13.5 mt -84.11 -39.02 20.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.841 ' CD1' ' CHC' ' A' ' 142' ' ' HEC . 2.0 tt -57.95 -40.12 79.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.379 -0.825 . . . . 0.0 109.456 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -66.14 -59.25 3.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.781 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -62.22 -26.57 68.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.736 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 57.9 m -74.06 -34.84 64.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.961 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.916 HD12 ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -84.25 -34.66 23.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.04 -1.037 . . . . 0.0 109.11 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.02 -44.02 97.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.421 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.58 -24.87 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.869 . . . . 0.0 109.213 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.5 m -64.62 -59.33 4.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 113' ' ' LEU . 59.0 mt -46.12 -37.9 7.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.86 -37.96 6.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.798 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.15 -55.91 4.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.812 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -74.81 -66.59 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 109.899 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -108.9 98.44 29.79 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 88.7 Cg_exo -44.08 179.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.404 2.069 . . . . 0.0 113.095 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.441 ' HB2' ' NE2' ' A' ' 122' ' ' HIS . . . -86.94 -34.64 19.27 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.599 0.714 . . . . 0.0 109.613 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 72.9 -0.51 3.34 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 1.492 ' CZ ' ' NE2' ' B' ' 116' ' ' HIS . 26.3 m-85 61.07 41.82 13.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.897 -0.502 . . . . 0.0 111.641 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.732 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -95.07 114.31 63.41 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.762 -1.211 . . . . 0.0 107.887 178.135 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.834 ' HA ' HG13 ' B' ' 33' ' ' VAL . 51.5 Cg_exo -49.77 18.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.087 1.858 . . . . 0.0 112.715 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -142.13 -23.39 0.69 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.048 -1.032 . . . . 0.0 110.579 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.763 HG13 ' N ' ' A' ' 122' ' ' HIS . 13.3 p -59.25 -58.04 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.027 -1.046 . . . . 0.0 110.179 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.763 ' N ' HG13 ' A' ' 121' ' ' VAL . 1.7 m-70 -71.29 -32.02 68.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 108.934 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' B' ' 33' ' ' VAL . . . -74.38 -20.41 60.08 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.435 -0.791 . . . . 0.0 108.939 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 128' ' ' PHE . 3.1 m -73.42 -63.42 1.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 110.038 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.706 HD13 HD11 ' A' ' 105' ' ' LEU . 10.5 mt -63.44 -28.17 69.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.85 -1.156 . . . . 0.0 109.382 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.752 ' OD1' ' CD2' ' B' ' 35' ' ' TYR . 8.7 t0 -69.67 -47.91 61.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.117 -0.99 . . . . 0.0 109.473 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.44 -40.83 11.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.099 -1.001 . . . . 0.0 109.931 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.515 ' CD1' HG21 ' A' ' 10' ' ' VAL . 72.7 t80 -48.45 -20.91 0.47 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.994 -1.066 . . . . 0.0 109.098 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.725 ' CD2' HBB1 ' A' ' 142' ' ' HEC . 12.1 mt -71.43 -26.27 62.67 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -55.07 -30.57 59.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.1 t -81.17 -33.43 33.09 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.485 HG22 ' SD ' ' A' ' 76' ' ' MET . 55.2 t -85.1 -28.62 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.31 -0.869 . . . . 0.0 108.828 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 129' ' ' LEU . 18.3 p -80.52 -23.27 40.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.398 -0.814 . . . . 0.0 109.096 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.3 m -75.35 -39.88 58.86 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.31 -0.869 . . . . 0.0 109.163 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.67 -29.72 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.187 -0.945 . . . . 0.0 108.794 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -33.96 77.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.384 -0.823 . . . . 0.0 108.927 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 62.8 m -96.12 -21.46 17.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.3 t -51.09 121.16 5.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 109.517 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.46 ' NZ ' ' CB ' ' A' ' 139' ' ' LYS . 6.9 mtpm? -84.3 48.54 1.51 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -48.43 104.21 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.43 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.5 mtt85 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.53 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.956 HG22 ' H ' ' B' ' 2' ' ' HIS . 9.2 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 0.956 ' H ' HG22 ' B' ' 1' ' ' VAL . 2.0 t-80 56.05 83.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.375 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.497 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -146.36 169.13 19.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 109.232 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.4 p -67.26 152.01 96.56 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.92 -27.5 25.6 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.533 2.155 . . . . 0.0 112.033 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -57.7 -45.24 85.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.233 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.31 -49.23 15.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -0.887 . . . . 0.0 109.374 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.5 OUTLIER -50.52 -54.18 24.34 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.28 -0.887 . . . . 0.0 109.531 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -43.52 -24.14 0.1 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.745 -0.597 . . . . 0.0 110.267 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.3 -56.57 3.69 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.016 -1.052 . . . . 0.0 109.725 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.499 HG23 ' CD2' ' B' ' 130' ' ' TYR . 1.5 p -69.8 -24.61 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 16.5 m -72.19 -47.42 50.82 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.539 0.685 . . . . 0.0 109.431 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.13 -31.89 70.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.371 -0.831 . . . . 0.0 109.589 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.409 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -49.08 -33.2 11.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.112 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -23.78 1.34 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.82 -61.79 3.9 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.488 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -58.33 -30.07 66.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -1.126 . . . . 0.0 109.224 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 14' ' ' LEU . 49.2 t -54.11 114.71 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.558 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' B' ' 20' ' ' VAL . 45.0 m-80 -83.7 70.63 10.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 108.942 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' B' ' 19' ' ' ASN . 73.8 t -43.65 -26.6 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.425 -0.797 . . . . 0.0 109.658 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' B' ' 19' ' ' ASN . 1.2 p30 -58.41 -5.67 0.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.63 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' B' ' 20' ' ' VAL . 54.3 mt-10 -154.92 -42.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.533 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 81.5 t -49.68 -24.49 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.46 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.11 -55.53 3.49 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.78 -31.06 66.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.78 -26.67 57.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -1.162 . . . . 0.0 109.44 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.92 -52.58 64.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.366 -0.834 . . . . 0.0 109.625 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.544 ' N ' HD22 ' B' ' 28' ' ' LEU . 3.7 mm? -64.49 -56.81 11.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.977 . . . . 0.0 109.394 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.26 -48.8 46.45 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.975 ' NH2' ' CD1' ' A' ' 117' ' ' PHE . 28.2 mmt180 -56.54 -47.71 78.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -1.152 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.26 -34.76 15.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 39.9 mt -80.69 -21.55 41.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.834 HG13 ' HA ' ' A' ' 119' ' ' PRO . 88.2 t -86.97 -64.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 0.0 109.726 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.648 HG13 ' HB3' ' A' ' 122' ' ' HIS . 2.8 t -52.04 -45.21 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 110.003 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.752 ' CD2' ' OD1' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -160.35 102.64 1.37 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.1 -1.0 . . . . 0.0 109.591 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.14 69.8 6.9 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.526 2.15 . . . . 0.0 112.149 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' B' ' 37' ' ' TRP . 0.0 OUTLIER -79.6 -19.53 49.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.399 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' B' ' 39' ' ' GLN . 28.4 p -48.05 -69.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.945 . . . . 0.0 109.621 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLN . . . . . 0.497 ' N ' ' OG1' ' B' ' 38' ' ' THR . 19.6 tt0 51.36 46.17 26.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.254 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -153.22 -58.67 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -84.7 8.34 17.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.487 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.616 ' HE1' HH12 ' C' ' 92' ' ' ARG . 29.0 p90 -58.07 -35.42 71.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -80.4 -21.63 42.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 109.382 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 16.5 m -58.5 -50.24 74.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.98 -8.83 1.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.517 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.02 -94.51 0.15 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -45.2 122.46 3.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.331 -1.1 . . . . 0.0 109.747 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -153.5 15.15 0.51 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.24 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.0 t -46.77 -39.07 11.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.625 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 8.1 p -144.63 152.24 52.3 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.492 -0.755 . . . . 0.0 108.965 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -44.92 -45.12 14.26 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.064 1.843 . . . . 0.0 112.143 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 53' ' ' ALA . 1.7 p30 -59.07 -39.79 83.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.527 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' B' ' 52' ' ' ASP . . . -52.25 -19.82 2.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.11 -63.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.492 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 39.6 mtm -73.63 9.77 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.511 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.21 -13.79 63.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -90.79 148.59 38.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.174 -1.192 . . . . 0.0 109.355 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.19 -19.6 17.29 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.619 2.213 . . . . 0.0 112.098 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.75 -28.25 33.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.632 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -78.36 -40.34 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.681 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -79.08 -28.54 43.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.1 -48.71 19.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.694 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.999 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 3.1 t-80 -48.21 -23.87 1.0 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.41 -54.91 13.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -46.78 -34.62 5.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -1.154 . . . . 0.0 109.609 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' LYS . . . . . 0.924 ' HD3' ' O2A' ' B' ' 147' ' ' HEC . 86.8 mttt -75.81 -37.62 58.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.318 -0.864 . . . . 0.0 109.669 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 0.758 HG22 ' C4A' ' B' ' 147' ' ' HEC . 33.6 t -71.73 -46.6 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.79 -32.56 67.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 109.253 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.81 -53.7 42.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.61 -48.85 66.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.397 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.49 -36.17 73.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.316 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 29.8 p -80.09 -24.23 40.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.479 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -51.87 -42.49 62.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.411 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.06 -60.25 8.3 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.553 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -58.26 -30.76 66.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.248 -1.148 . . . . 0.0 109.32 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.78 -3.01 58.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.595 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.452 ' C ' ' H ' ' B' ' 79' ' ' ASP . 10.3 t-80 -168.0 61.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.629 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.681 HD21 HG21 ' B' ' 1' ' ' VAL . 1.2 mt -73.37 14.38 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.141 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' B' ' 77' ' ' HIS . 30.1 t70 -69.07 -32.19 71.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.496 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' B' ' 79' ' ' ASP . 70.0 m-20 -163.23 104.2 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 109.461 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 37.6 mt -80.28 -58.8 2.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.378 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -48.6 -24.23 1.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.415 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.03 -62.15 3.46 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.7 t -62.82 -47.18 84.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -1.223 . . . . 0.0 109.437 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.5 m-85 -66.84 0.91 2.13 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.491 -0.756 . . . . 0.0 109.447 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.86 -47.36 86.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.405 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 4.9 p -72.68 -53.6 11.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.376 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 24.7 mt -49.87 -46.49 51.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 85.9 p -56.37 -46.67 79.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.347 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.73 -40.6 95.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.301 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.31 -44.58 87.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.374 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' B' ' 97' ' ' HIS . 76.0 m80 -73.38 -24.25 60.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 110.247 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.72 -60.91 1.97 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.028 -1.045 . . . . 0.0 111.24 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.1 -57.1 3.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.861 -1.15 . . . . 0.0 111.671 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.499 ' O ' HD12 ' B' ' 96' ' ' LEU . 55.9 mmtt -66.15 -9.92 36.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 111.515 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.563 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 1.0 OUTLIER -143.11 -33.89 0.44 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.741 -1.224 . . . . 0.0 109.987 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 33.2 p-80 43.62 25.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' B' ' 96' ' ' LEU . 24.9 t -53.73 138.96 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.089 -1.007 . . . . 0.0 109.104 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 0.438 ' OD1' HG21 ' C' ' 96' ' ' VAL . 7.4 m-20 -46.43 149.43 1.38 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.443 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.19 -17.47 45.17 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.575 2.184 . . . . 0.0 112.217 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -89.76 47.05 1.42 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.472 ' O ' HMC2 ' B' ' 147' ' ' HEC . 2.9 m120 -137.29 -3.44 1.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -0.886 . . . . 0.0 109.794 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.46 ' HA ' HBB2 ' B' ' 147' ' ' HEC . 2.4 m-85 -97.68 -60.46 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.432 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -50.92 -19.97 1.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.691 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.597 HD12 ' N ' ' B' ' 105' ' ' LEU . 7.9 mp -77.9 -52.84 8.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.621 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.874 HD13 ' C3B' ' B' ' 147' ' ' HEC . 5.0 tt -54.6 -52.17 63.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 109.341 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.56 -22.02 7.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -85.65 -53.69 5.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -1.184 . . . . 0.0 109.69 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 91.9 t -46.66 -30.28 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.808 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 113' ' ' VAL . 5.2 tp -62.07 -55.32 30.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.597 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' B' ' 130' ' ' TYR . 90.3 t -46.75 -26.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 109.784 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 34.6 t -74.75 -26.22 59.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 109.643 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' B' ' 110' ' ' LEU . 39.3 t -83.45 -25.32 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.022 . . . . 0.0 109.525 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.6 -25.6 33.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.467 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -75.69 -19.58 59.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.705 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 1.492 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.3 OUTLIER -83.42 -52.48 6.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.165 -0.96 . . . . 0.0 109.458 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.487 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 61.0 m170 -73.32 -17.62 61.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.452 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.487 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 11.1 m-85 -149.41 55.78 0.98 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.857 . . . . 0.0 109.39 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -61.6 -14.78 44.46 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.62 -20.94 27.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -1.122 . . . . 0.0 109.512 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.4 mm-40 -83.85 -7.37 59.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -73.54 33.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.572 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.481 ' H ' ' C ' ' B' ' 121' ' ' GLU . 77.8 p -47.51 148.38 2.47 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 0.0 109.374 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.471 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.4 Cg_exo -44.64 -56.13 2.83 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.505 2.137 . . . . 0.0 112.941 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 19.8 Cg_endo -60.5 -35.28 91.03 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.162 1.908 . . . . 0.0 112.104 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.469 HG23 ' OG1' ' B' ' 123' ' ' THR . 78.2 t -72.02 -17.34 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 109.581 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -83.42 -59.75 2.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 109.75 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.626 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -53.74 -33.38 55.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.58 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.44 27.5 0.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.499 ' CD2' HG23 ' B' ' 11' ' ' VAL . 4.2 t80 -125.09 -38.27 2.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.317 -0.864 . . . . 0.0 109.606 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 1.003 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 46.0 tt0 -67.56 -23.94 65.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.898 . . . . 0.0 109.822 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' B' ' 1' ' ' VAL . 35.4 mtmt -84.5 -36.42 22.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 109.716 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.68 -49.34 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.968 . . . . 0.0 109.786 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.444 HG22 ' H ' ' B' ' 134' ' ' VAL . 4.5 m -79.5 -23.82 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.895 . . . . 0.0 109.768 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.4 -27.94 11.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 109.456 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.16 -23.05 61.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.3 t -79.07 -27.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.46 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.98 -42.8 56.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.532 ' OD1' ' OD1' ' D' ' 139' ' ' ASN . 37.8 t30 -76.83 -21.22 55.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.57 -60.34 2.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 17.1 mt -55.21 -22.33 17.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.459 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.25 -17.99 24.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.882 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -46.3 -46.55 18.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' B' ' 146' ' ' HIS . 5.7 tppt? -77.08 -57.56 3.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.472 ' CD1' ' C ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -51.53 -10.61 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.533 -0.729 . . . . 0.0 109.23 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.468 ' H ' ' C ' ' B' ' 144' ' ' LYS . 11.6 m-70 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.735 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' C' ' 2' ' ' LEU . 1.3 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.507 ' N ' HD12 ' C' ' 2' ' ' LEU . 10.8 mp 53.17 176.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 109.541 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.513 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 174.56 -47.79 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 0.0 109.976 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' C' ' 6' ' ' ASP . 71.8 Cg_exo -47.16 169.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.549 2.166 . . . . 0.0 112.759 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.47 -15.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.43 -0.794 . . . . 0.0 110.126 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' C' ' 4' ' ' PRO . 25.1 t70 -38.8 -40.53 0.63 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 109.888 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.453 ' H ' ' HG2' ' C' ' 7' ' ' LYS . 13.5 ptpt -67.93 -45.68 73.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.113 -0.992 . . . . 0.0 109.299 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.418 ' N ' ' O ' ' C' ' 5' ' ' ALA . 37.4 m -52.99 -31.06 38.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -78.08 -35.98 48.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.521 HG21 ' CD1' ' C' ' 128' ' ' PHE . 92.0 t -69.67 -49.1 61.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.82 -47.45 64.31 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.17 -60.77 2.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.585 -0.697 . . . . 0.0 109.569 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.746 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -50.94 -38.96 53.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.322 -0.861 . . . . 0.0 109.319 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -17.31 61.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.207 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.57 -45.68 7.22 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.63 -34.92 72.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -1.165 . . . . 0.0 108.696 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.746 HG23 ' O ' ' C' ' 13' ' ' ALA . 70.2 t -61.94 -66.91 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 64.51 -143.62 47.26 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.42 48.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.443 -1.034 . . . . 0.0 110.0 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' C' ' 18' ' ' GLY . 80.7 m-70 -151.73 19.64 0.7 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.45 -65.24 1.03 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.66 -0.65 . . . . 0.0 109.769 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.65 -14.58 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' C' ' 21' ' ' ALA . 2.1 mm-40 -83.19 -56.46 3.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -1.168 . . . . 0.0 109.673 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.8 m-30 -55.95 -35.29 66.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.41 -0.806 . . . . 0.0 109.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.06 -22.83 60.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.52 -38.32 29.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -1.118 . . . . 0.0 109.795 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.61 -19.71 63.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.72 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.52 -22.39 51.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 109.683 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.5 mt -76.38 -43.99 38.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 109.706 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -65.7 -12.81 56.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.699 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -59.01 2.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptm -62.26 -25.67 67.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' PHE . . . . . 0.525 ' CE2' ' O ' ' C' ' 48' ' ' LEU . 1.3 t80 -58.56 -56.09 26.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 109.621 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.63 ' CD1' ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -82.34 -42.51 18.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 110.234 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 12.6 t -59.69 -9.21 2.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.01 . . . . 0.0 109.659 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 1.01 ' CZ ' ' NE2' ' D' ' 131' ' ' GLN . 79.5 m-85 -155.33 81.66 4.01 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.582 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' C' ' 39' ' ' THR . 52.6 Cg_exo -52.48 -24.96 23.56 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.689 2.259 . . . . 0.0 112.245 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.496 HG22 ' HB2' ' B' ' 97' ' ' HIS . 8.7 p -46.78 -19.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.877 . . . . 0.0 109.517 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.445 ' N ' ' O ' ' C' ' 37' ' ' PRO . 51.5 p -82.89 -26.15 31.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 109.676 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' C' ' 42' ' ' TYR . 26.6 ttpt -79.37 -53.62 6.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.653 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t -47.06 -18.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.907 . . . . 0.0 109.576 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.469 ' O ' ' CG ' ' C' ' 42' ' ' TYR . 82.4 t80 -78.79 3.21 17.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.481 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 43' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 49.16 66.62 5.46 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.345 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.554 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 64.8 Cg_endo -77.02 -1.56 11.74 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.808 2.338 . . . . 0.0 112.389 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.571 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 22.0 p80 41.43 24.63 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.34 -0.85 . . . . 0.0 109.516 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.544 ' O ' ' C ' ' C' ' 47' ' ' ASP . 3.9 t80 -104.31 31.46 4.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.756 . . . . 0.0 109.705 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' C' ' 46' ' ' PHE . 15.1 m-20 28.69 67.71 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.817 -0.552 . . . . 0.0 110.524 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.525 ' O ' ' CE2' ' C' ' 33' ' ' PHE . 87.2 mt -85.15 22.25 1.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.978 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.434 ' O ' ' O ' ' C' ' 50' ' ' HIS . 19.3 m -76.61 26.6 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 50' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' C' ' 48' ' ' LEU . 54.9 t60 58.07 158.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.842 . . . . 0.0 109.557 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.72 17.91 5.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 9.0 t -80.33 -17.73 51.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -1.152 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 68.62 -58.54 0.48 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.688 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' C' ' 52' ' ' SER . 0.7 OUTLIER -43.74 -20.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.401 -0.812 . . . . 0.0 109.818 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' C' ' 53' ' ' ALA . 89.1 t -77.41 -27.33 15.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.277 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' C' ' 53' ' ' ALA . 5.9 ptmt -63.6 -27.18 69.06 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.293 -0.879 . . . . 0.0 109.395 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.86 -27.63 68.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 58' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -84.15 -30.66 25.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -1.17 . . . . 0.0 110.103 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.06 -49.41 55.73 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -60.1 -23.66 64.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -1.146 . . . . 0.0 110.068 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.45 ' O ' HMA3 ' C' ' 142' ' ' HEC . 0.3 OUTLIER -73.32 -33.96 65.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.192 -0.942 . . . . 0.0 109.146 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.41 -52.83 21.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.434 -0.791 . . . . 0.0 108.991 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.47 69.86 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.324 -0.86 . . . . 0.0 109.186 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -68.3 -41.38 81.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 108.848 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.463 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -68.07 -42.47 80.38 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' C' ' 66' ' ' LEU . 9.9 mt -63.4 -46.2 87.5 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -63.24 -48.68 77.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.206 -0.934 . . . . 0.0 109.029 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -62.72 -22.55 66.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 108.829 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -85.22 -47.69 9.85 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.83 -22.69 29.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -14.57 62.42 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.669 ' O ' HG12 ' C' ' 73' ' ' VAL . 21.5 m80 -141.92 -57.45 0.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.796 . . . . 0.0 109.65 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.669 HG12 ' O ' ' C' ' 72' ' ' HIS . 8.2 p 46.16 15.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 122.067 0.937 . . . . 0.0 108.718 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' C' ' 72' ' ' HIS . 21.9 m-20 -136.39 12.53 3.25 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.96 30.52 0.06 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.557 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 1.2 mtm -66.63 -44.69 55.38 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.658 -0.651 . . . . 0.0 110.098 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' C' ' 76' ' ' MET . 95.5 Cg_exo -42.24 -43.03 7.67 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.431 2.087 . . . . 0.0 112.601 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -94.15 -18.97 21.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.001 . . . . 0.0 110.025 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 -58.5 3.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.034 -1.041 . . . . 0.0 109.081 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 18.7 mt -83.14 16.91 2.19 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 81' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' C' ' 77' ' ' PRO . 0.5 OUTLIER -61.67 -21.93 64.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.848 . . . . 0.0 109.363 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -74.79 -57.97 3.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.454 ' N ' HD23 ' C' ' 83' ' ' LEU . 3.1 mt -44.74 -39.74 5.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.524 ' O ' ' N ' ' C' ' 88' ' ' ALA . 26.5 t -54.51 -34.45 61.68 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' C' ' 82' ' ' ALA . 4.0 m-20 -66.09 -24.28 66.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.136 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.585 HD21 ' CBD' ' C' ' 142' ' ' HEC . 7.3 tp -80.52 -38.52 29.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.327 -0.858 . . . . 0.0 109.203 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -92.32 -21.64 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.723 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' C' ' 84' ' ' SER . . . -76.49 -38.95 54.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 89' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' C' ' 90' ' ' LYS . 50.1 t-80 -146.6 -83.43 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.101 -0.999 . . . . 0.0 110.114 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.454 ' NZ ' ' CD1' ' C' ' 86' ' ' LEU . 0.9 OUTLIER -43.85 105.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 109.67 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tp 63.61 59.22 1.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.343 -0.848 . . . . 0.0 109.29 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 92' ' ' ARG . . . . . 0.616 HH12 ' HE1' ' B' ' 42' ' ' PHE . 10.6 ptp180 -60.74 -22.63 64.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.578 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.899 HG22 ' H ' ' C' ' 94' ' ' ASP . 12.7 p 42.08 -176.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.642 -0.661 . . . . 0.0 110.084 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.899 ' H ' HG22 ' C' ' 93' ' ' VAL . 50.7 m-20 -80.85 120.68 79.6 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.969 -1.082 . . . . 0.0 109.459 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' C' ' 97' ' ' ASN . 73.5 Cg_endo -78.61 -37.86 0.6 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.359 2.039 . . . . 0.0 112.124 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.438 HG21 ' OD1' ' B' ' 99' ' ' ASP . 6.2 t -55.36 -0.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.707 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.564 ' H ' ' C ' ' C' ' 95' ' ' PRO . 4.8 m120 -79.03 -24.85 43.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.065 -1.022 . . . . 0.0 109.693 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 98' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' C' ' 95' ' ' PRO . 26.9 m-85 -49.27 -17.64 0.27 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.421 ' N ' ' C ' ' C' ' 97' ' ' ASN . 91.9 mttt -81.99 -28.22 32.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.377 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 13.5 mt -84.1 -39.04 19.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.384 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.843 ' CD1' ' CHC' ' C' ' 142' ' ' HEC . 2.0 tt -57.97 -40.08 79.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -66.28 -59.18 3.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.986 . . . . 0.0 109.772 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -62.15 -26.59 68.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 109.809 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 57.8 m -74.12 -34.8 64.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.894 ' O ' HD12 ' C' ' 105' ' ' LEU . 0.0 OUTLIER -84.2 -34.67 23.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.11 -0.994 . . . . 0.0 109.182 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 20.0 mt -62.99 -44.09 96.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.455 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.47 -24.92 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 54.8 m -64.6 -59.33 4.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.564 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.408 HD11 HD11 ' C' ' 105' ' ' LEU . 59.1 mt -46.21 -37.84 7.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.601 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.8 -38.05 6.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.849 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.04 -55.95 4.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.861 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -74.82 -66.59 0.73 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 109.895 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -108.9 98.45 29.84 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.481 -0.762 . . . . 0.0 108.96 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' C' ' 113' ' ' LEU . 89.8 Cg_exo -44.02 179.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.45 2.1 . . . . 0.0 113.036 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.448 ' HB2' ' NE2' ' C' ' 122' ' ' HIS . . . -86.94 -34.76 19.23 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.594 0.711 . . . . 0.0 109.584 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 72.97 -0.53 3.35 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 1.493 ' CZ ' ' NE2' ' D' ' 116' ' ' HIS . 26.6 m-85 61.05 41.79 13.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.884 -0.51 . . . . 0.0 111.624 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.3 OUTLIER -95.01 114.22 63.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.773 -1.204 . . . . 0.0 107.922 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 119' ' ' PRO . . . . . 0.806 ' HA ' HG13 ' D' ' 33' ' ' VAL . 51.8 Cg_exo -49.68 18.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.224 1.949 . . . . 0.0 112.678 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -142.1 -23.41 0.69 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 110.599 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.773 HG13 ' N ' ' C' ' 122' ' ' HIS . 13.4 p -59.27 -57.99 8.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.003 -1.06 . . . . 0.0 110.206 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.773 ' N ' HG13 ' C' ' 121' ' ' VAL . 1.7 m-70 -71.23 -32.19 68.47 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 108.879 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 123' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' D' ' 33' ' ' VAL . . . -74.24 -20.5 60.14 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.398 -0.814 . . . . 0.0 108.968 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' C' ' 128' ' ' PHE . 3.1 m -73.44 -63.37 1.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.247 -0.908 . . . . 0.0 109.979 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.706 HD13 HD11 ' C' ' 105' ' ' LEU . 10.5 mt -63.55 -28.09 69.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.978 -1.077 . . . . 0.0 109.339 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 126' ' ' ASP . . . . . 0.744 ' OD1' ' CD2' ' D' ' 35' ' ' TYR . 8.7 t0 -69.63 -47.99 61.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.113 -0.992 . . . . 0.0 109.527 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.32 -40.82 11.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.064 -1.022 . . . . 0.0 109.938 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.521 ' CD1' HG21 ' C' ' 10' ' ' VAL . 72.8 t80 -48.64 -20.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.954 -1.091 . . . . 0.0 109.043 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.71 ' CD2' HBB1 ' C' ' 142' ' ' HEC . 12.1 mt -71.48 -26.33 62.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -55.0 -30.58 59.72 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 4.2 t -81.17 -33.36 33.13 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.449 -0.782 . . . . 0.0 108.897 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 132' ' ' VAL . . . . . 0.486 HG22 ' SD ' ' C' ' 76' ' ' MET . 55.5 t -85.15 -28.61 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.354 -0.841 . . . . 0.0 108.817 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.547 ' N ' ' O ' ' C' ' 129' ' ' LEU . 18.6 p -80.61 -23.17 39.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.515 -0.741 . . . . 0.0 109.009 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 134' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 29.5 m -75.34 -40.0 58.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 109.15 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.55 -29.75 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.915 . . . . 0.0 108.783 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -34.01 77.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.4 -0.812 . . . . 0.0 108.885 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 63.0 m -96.13 -21.42 17.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.508 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 44.0 t -51.17 121.1 5.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 0.463 ' CB ' ' NZ ' ' C' ' 139' ' ' LYS . 6.9 mtpm? -84.2 48.49 1.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.519 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -48.39 104.19 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.463 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 50.5 mtt85 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.465 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.936 HG22 ' H ' ' D' ' 2' ' ' HIS . 9.0 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 2' ' ' HIS . . . . . 0.936 ' H ' HG22 ' D' ' 1' ' ' VAL . 2.0 t-80 55.94 83.89 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.383 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.49 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.2 OUTLIER -146.33 169.13 19.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 109.257 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 3.4 p -67.27 152.04 96.53 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.01 -27.54 25.17 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.562 2.175 . . . . 0.0 111.947 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -57.63 -45.21 85.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.34 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.22 -49.38 15.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.349 -0.844 . . . . 0.0 109.359 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.5 OUTLIER -50.4 -54.22 23.42 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.312 -0.868 . . . . 0.0 109.582 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -43.56 -24.06 0.1 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.72 -0.612 . . . . 0.0 110.278 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.36 -56.54 3.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.061 -1.024 . . . . 0.0 109.677 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.498 HG23 ' CD2' ' D' ' 130' ' ' TYR . 1.5 p -69.84 -24.63 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 16.3 m -72.25 -47.29 51.38 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.432 0.634 . . . . 0.0 109.462 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.19 -31.91 70.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.546 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.05 -33.13 10.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.22 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -49.1 -23.86 1.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 109.427 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.69 -61.87 3.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.467 ' CD ' ' H ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -58.32 -30.02 66.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.203 -1.175 . . . . 0.0 109.259 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 49.8 t -54.14 114.67 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.887 . . . . 0.0 109.598 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' D' ' 21' ' ' ASP . 45.1 m-80 -83.74 70.6 10.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 108.89 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' D' ' 22' ' ' GLU . 73.5 t -43.46 -26.76 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.416 -0.802 . . . . 0.0 109.691 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' D' ' 19' ' ' ASN . 1.2 p30 -58.37 -5.66 0.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.644 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' D' ' 20' ' ' VAL . 54.3 mt-10 -155.0 -42.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 81.4 t -49.76 -24.44 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -0.942 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.13 -55.53 3.49 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.84 -31.06 67.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.79 -26.57 57.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -1.187 . . . . 0.0 109.444 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.11 -52.56 64.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 28' ' ' LEU . . . . . 0.537 ' N ' HD22 ' D' ' 28' ' ' LEU . 3.7 mm? -64.52 -56.75 12.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.128 -0.983 . . . . 0.0 109.384 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.33 -48.75 47.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 30' ' ' ARG . . . . . 0.961 ' NH2' ' CD1' ' C' ' 117' ' ' PHE . 28.3 mmt180 -56.61 -47.63 79.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.334 -1.097 . . . . 0.0 109.517 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.29 -34.81 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.568 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 40.1 mt -80.67 -21.52 41.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.806 HG13 ' HA ' ' C' ' 119' ' ' PRO . 88.3 t -87.01 -64.07 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.915 . . . . 0.0 109.744 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' C' ' 122' ' ' HIS . 2.8 t -52.06 -45.19 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 110.007 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 35' ' ' TYR . . . . . 0.744 ' CD2' ' OD1' ' C' ' 126' ' ' ASP . 0.2 OUTLIER -160.42 102.53 1.36 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.105 -0.997 . . . . 0.0 109.614 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.04 69.92 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.491 2.127 . . . . 0.0 112.076 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -19.66 48.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.422 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' D' ' 39' ' ' GLN . 28.5 p -48.04 -69.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.59 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 39' ' ' GLN . . . . . 0.494 ' N ' ' OG1' ' D' ' 38' ' ' THR . 19.5 tt0 51.39 46.13 26.94 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.139 -0.976 . . . . 0.0 109.304 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -153.26 -58.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.355 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -84.66 8.25 17.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.657 ' HE1' HH12 ' A' ' 92' ' ' ARG . 29.1 p90 -57.97 -35.49 71.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 43' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' D' ' 42' ' ' PHE . 19.7 pt-20 -80.35 -21.64 42.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.841 . . . . 0.0 109.398 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 16.6 m -58.5 -50.26 74.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.482 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.01 -8.81 1.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.43 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.01 -94.57 0.15 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -45.11 122.47 3.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -1.108 . . . . 0.0 109.779 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -153.57 15.2 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.235 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.0 t -46.76 -39.15 11.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.603 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 50' ' ' THR . . . . . 0.424 ' HG1' ' CG ' ' D' ' 52' ' ' ASP . 8.0 p -144.64 152.23 52.22 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.416 -0.802 . . . . 0.0 108.902 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -44.9 -45.13 14.18 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.072 1.848 . . . . 0.0 112.151 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ASP . . . . . 0.424 ' CG ' ' HG1' ' D' ' 50' ' ' THR . 1.7 p30 -59.12 -39.67 83.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.606 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.414 ' N ' ' OD1' ' D' ' 52' ' ' ASP . . . -52.32 -19.82 2.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.416 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.02 -64.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 39.6 mtm -73.56 9.67 1.32 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.15 -13.75 63.51 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.76 148.47 38.47 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.18 -1.188 . . . . 0.0 109.369 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.15 -19.54 17.43 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.58 2.187 . . . . 0.0 112.154 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.76 -28.28 33.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.654 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.31 -40.32 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 0.0 109.697 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -79.13 -28.55 42.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.649 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.11 -48.73 19.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.735 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 1.011 ' CE1' ' CHA' ' D' ' 147' ' ' HEC . 3.1 t-80 -48.13 -23.88 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.691 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.44 -54.98 13.47 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -46.69 -34.65 5.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -1.132 . . . . 0.0 109.582 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 66' ' ' LYS . . . . . 0.914 ' HD3' ' O2A' ' D' ' 147' ' ' HEC . 86.7 mttt -75.9 -37.64 58.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.351 -0.843 . . . . 0.0 109.558 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.757 HG13 ' C2B' ' D' ' 147' ' ' HEC . 34.1 t -71.73 -46.63 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.411 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.75 -32.56 67.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 0.0 109.279 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.81 -53.65 42.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.68 -48.79 66.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 109.364 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.63 -36.03 73.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.237 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 30.1 p -80.19 -24.2 40.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.468 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -51.92 -42.6 62.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.0 -60.12 8.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.551 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -58.38 -30.79 67.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -1.123 . . . . 0.0 109.238 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.68 -3.15 58.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 109.543 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.454 ' C ' ' H ' ' D' ' 79' ' ' ASP . 10.2 t-80 -167.96 61.81 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.666 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 78' ' ' LEU . . . . . 0.675 HD21 HG21 ' D' ' 1' ' ' VAL . 1.2 mt -73.42 14.43 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -0.971 . . . . 0.0 109.145 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.454 ' H ' ' C ' ' D' ' 77' ' ' HIS . 30.2 t70 -68.99 -32.32 71.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.482 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -163.19 104.14 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.337 -0.852 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 37.3 mt -80.24 -58.8 2.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.409 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -48.59 -24.14 1.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.444 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.09 -62.21 3.42 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.7 t -62.76 -47.18 84.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.166 . . . . 0.0 109.452 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.4 m-85 -66.94 0.96 2.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.521 -0.737 . . . . 0.0 109.486 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.42 85.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.966 . . . . 0.0 109.466 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 5.1 p -72.64 -53.63 11.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 0.0 109.42 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 24.7 mt -49.87 -46.52 51.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.432 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 85.5 p -56.3 -46.7 79.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.419 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.69 -40.6 95.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.327 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.25 -44.7 87.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 109.338 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' D' ' 97' ' ' HIS . 76.0 m80 -73.39 -24.24 60.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 110.207 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.71 -60.94 1.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 0.0 111.245 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -88.05 -57.12 3.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.884 -1.135 . . . . 0.0 111.691 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 95' ' ' LYS . . . . . 0.493 ' O ' HD12 ' D' ' 96' ' ' LEU . 56.0 mmtt -66.23 -9.83 36.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.319 -0.863 . . . . 0.0 111.494 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.559 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 1.0 OUTLIER -143.13 -33.89 0.43 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.771 -1.206 . . . . 0.0 110.028 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 33.2 p-80 43.62 25.51 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.264 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 98' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' D' ' 96' ' ' LEU . 24.9 t -53.7 139.09 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.065 -1.022 . . . . 0.0 109.045 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 99' ' ' ASP . . . . . 0.479 ' OD1' HG21 ' A' ' 96' ' ' VAL . 7.4 m-20 -46.54 149.41 1.42 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.509 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.19 -17.43 45.18 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.584 2.189 . . . . 0.0 112.263 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -89.74 46.94 1.41 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 109.668 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 102' ' ' ASN . . . . . 0.472 ' O ' HMC2 ' D' ' 147' ' ' HEC . 2.9 m120 -137.29 -3.42 1.95 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 109.811 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 103' ' ' PHE . . . . . 0.455 ' HA ' HBB2 ' D' ' 147' ' ' HEC . 2.4 m-85 -97.73 -60.41 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.118 -0.989 . . . . 0.0 109.435 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -51.05 -19.93 1.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 109.588 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 105' ' ' LEU . . . . . 0.602 ' N ' HD12 ' D' ' 105' ' ' LEU . 7.9 mp -77.98 -52.87 8.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.877 HD13 ' C3B' ' D' ' 147' ' ' HEC . 5.0 tt -54.48 -52.19 62.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.58 -22.0 7.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -85.64 -53.7 5.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -1.19 . . . . 0.0 109.723 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 92.9 t -46.66 -30.27 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 109.88 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.99 -55.39 29.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.644 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 111' ' ' VAL . . . . . 0.404 HG22 ' CE1' ' D' ' 130' ' ' TYR . 90.2 t -46.71 -26.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.774 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 34.4 t -74.63 -26.31 59.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.893 . . . . 0.0 109.704 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.48 -25.28 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.6 -25.6 33.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.742 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -75.72 -19.48 59.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.673 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 1.493 ' NE2' ' CZ ' ' C' ' 117' ' ' PHE . 0.3 OUTLIER -83.52 -52.44 6.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 117' ' ' HIS . . . . . 0.493 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 61.0 m170 -73.29 -17.62 61.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 11.2 m-85 -149.39 55.73 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -61.47 -14.81 43.62 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.7 -20.89 27.07 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.213 -1.169 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' D' ' 123' ' ' THR . 59.4 mm-40 -83.87 -7.34 59.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.683 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.71 33.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 109.527 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.488 ' H ' ' C ' ' D' ' 121' ' ' GLU . 77.4 p -47.55 148.42 2.49 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.434 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.3 Cg_exo -44.63 -56.15 2.81 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.491 2.127 . . . . 0.0 112.956 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 19.8 Cg_endo -60.46 -35.26 91.34 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.187 1.924 . . . . 0.0 112.078 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.471 HG23 ' OG1' ' D' ' 123' ' ' THR . 78.5 t -72.09 -17.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -83.33 -59.78 2.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 109.789 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.63 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -53.69 -33.43 55.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.624 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.48 27.64 0.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.541 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.498 ' CD2' HG23 ' D' ' 11' ' ' VAL . 4.3 t80 -125.2 -38.22 2.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.411 -0.805 . . . . 0.0 109.512 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 1.01 ' NE2' ' CZ ' ' C' ' 36' ' ' PHE . 45.9 tt0 -67.51 -23.97 65.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 109.835 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 132' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' D' ' 1' ' ' VAL . 35.4 mtmt -84.46 -36.49 22.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 109.679 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.65 -49.39 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.787 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.447 ' H ' HG22 ' D' ' 134' ' ' VAL . 4.5 m -79.43 -23.87 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 109.783 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.4 -27.84 11.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.106 -0.996 . . . . 0.0 109.463 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.28 -23.1 61.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 93.9 t -78.93 -27.65 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -1.173 . . . . 0.0 109.55 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.92 -42.84 56.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.933 . . . . 0.0 109.446 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.532 ' OD1' ' OD1' ' B' ' 139' ' ' ASN . 37.8 t30 -76.8 -21.17 55.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.578 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.67 -60.29 2.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 0.0 109.54 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 17.1 mt -55.24 -22.26 17.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.429 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.32 -17.88 24.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -46.34 -46.51 18.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' D' ' 146' ' ' HIS . 5.7 tppt? -77.2 -57.43 3.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 145' ' ' TYR . . . . . 0.484 ' CD1' ' C ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -51.58 -10.59 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.519 -0.738 . . . . 0.0 109.193 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.471 ' H ' ' C ' ' D' ' 144' ' ' LYS . 11.4 m-70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.666 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.841 ' CHC' ' CD1' ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 0.999 ' CHA' ' CE1' ' B' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.843 ' CHC' ' CD1' ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 1.011 ' CHA' ' CE1' ' D' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.449 HD13 ' CE2' ' A' ' 128' ' ' PHE . 14.7 mt -138.96 -174.21 3.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.248 -0.907 . . . . 0.0 109.412 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.496 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 175.9 -49.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 3' ' ' SER . 71.9 Cg_exo -47.01 173.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.507 2.138 . . . . 0.0 112.568 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -65.11 -16.33 63.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 5' ' ' ALA . 1.2 m-20 -39.71 -40.62 0.96 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 109.595 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.403 ' NZ ' ' CB ' ' A' ' 7' ' ' LYS . 8.3 mtmp? -60.51 -59.29 5.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.206 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 m -50.26 -28.68 8.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.198 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -80.09 -35.32 37.09 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.413 HG21 ' CG ' ' A' ' 128' ' ' PHE . 41.1 t -74.81 -44.57 45.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.74 -39.63 89.39 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.414 -0.803 . . . . 0.0 108.86 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.78 46.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.153 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.738 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.97 -35.43 64.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.445 -0.784 . . . . 0.0 109.073 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.54 -17.51 61.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.051 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.47 -46.34 8.96 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -68.9 -37.47 78.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.198 -1.177 . . . . 0.0 108.766 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 13' ' ' ALA . 99.2 t -61.17 -65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 59.59 -137.54 49.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.23 29.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.471 -1.017 . . . . 0.0 110.296 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.564 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.1 m-70 -131.82 23.35 4.62 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -87.3 -61.48 1.71 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.613 -0.68 . . . . 0.0 109.639 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.34 -14.62 0.35 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 21' ' ' ALA . 3.7 mm-40 -84.08 -56.45 3.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -1.111 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.1 m-30 -59.61 -33.17 71.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.396 -0.815 . . . . 0.0 109.322 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.33 -22.96 76.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.73 -43.54 20.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -1.176 . . . . 0.0 109.752 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.86 -19.91 65.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 -20.0 59.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.911 . . . . 0.0 109.366 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.531 HD13 ' CD2' ' A' ' 58' ' ' HIS . 18.6 mt -73.0 -46.04 54.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.588 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -61.98 -17.73 58.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 109.604 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.0 mmt-85 -81.18 -31.9 33.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 0.0 109.598 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -73.02 -37.63 66.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 109.525 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -62.95 -60.0 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 12.3 mt -59.32 -48.88 79.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.655 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.503 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 40.3 t -46.04 -27.4 0.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.923 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CD1' ' O ' ' A' ' 35' ' ' SER . 47.7 m-85 -154.18 123.88 3.25 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.026 -1.046 . . . . 0.0 109.55 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 40' ' ' LYS . 73.3 Cg_endo -77.9 -19.52 12.41 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.412 2.075 . . . . 0.0 112.159 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.2 p -43.9 -19.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 109.889 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 37' ' ' PRO . 3.4 p -90.27 -22.83 21.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.174 -0.954 . . . . 0.0 109.575 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 37' ' ' PRO . 27.8 ttmt -50.16 -18.74 0.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 109.954 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t -105.61 -18.4 14.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.863 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.52 38.13 1.57 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.348 -0.845 . . . . 0.0 109.168 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.688 ' O ' ' CG ' ' A' ' 43' ' ' PHE . 6.2 p90 -115.14 81.15 7.69 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.463 -0.773 . . . . 0.0 109.975 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.34 -6.28 15.48 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.372 2.048 . . . . 0.0 111.873 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.528 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.3 OUTLIER -165.61 50.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.593 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -156.17 71.19 0.71 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.568 ' C ' ' H ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -46.41 -13.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.453 -0.779 . . . . 0.0 111.203 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 9.5 mt 59.0 -5.43 0.06 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.772 -1.205 . . . . 0.0 109.608 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.568 ' H ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -46.79 124.88 6.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 109.552 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -53.3 138.96 31.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.46 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.27 27.81 65.93 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 3.2 m -60.9 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.273 -1.134 . . . . 0.0 109.31 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 167.8 -64.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.424 -0.797 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -45.61 -17.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.47 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' ALA . 61.3 t -73.93 -29.98 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 109.791 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -70.96 -26.49 63.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.71 -22.92 68.38 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.4 OUTLIER -79.2 -39.89 32.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.171 -1.194 . . . . 0.0 109.549 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.27 -49.96 54.23 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 49.8 mttp -51.98 -23.87 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -1.104 . . . . 0.0 110.0 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.678 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 10.1 mmpt? -72.41 -45.11 61.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.19 -0.944 . . . . 0.0 109.107 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.3 t -67.62 -46.14 83.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.475 -0.765 . . . . 0.0 109.261 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.79 -31.0 68.68 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.2 -0.937 . . . . 0.0 109.313 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.4 t70 -69.39 -34.57 74.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.973 . . . . 0.0 108.752 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.85 -51.37 62.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.32 -0.863 . . . . 0.0 108.96 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.8 mt -56.34 -46.29 80.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 108.82 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -62.68 -51.57 66.69 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.274 -0.891 . . . . 0.0 108.871 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -59.67 -22.74 62.35 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.56 -46.98 11.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.65 -22.91 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.7 -16.95 64.59 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' A' ' 74' ' ' ASP . 15.8 m80 -143.88 -60.16 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.402 -0.811 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 69' ' ' ALA . 12.7 p 44.66 14.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.751 0.786 . . . . 0.0 109.286 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 72' ' ' HIS . 13.7 m-20 -131.22 11.44 5.0 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.438 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.8 p-10 -177.82 31.79 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.944 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.696 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -77.99 -24.21 0.44 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.398 -0.814 . . . . 0.0 111.709 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 76' ' ' MET . 75.6 Cg_exo -50.21 -33.92 37.8 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.71 1.607 . . . . 0.0 112.239 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -94.29 -16.04 23.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 0.0 109.503 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.65 -57.96 3.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 109.087 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.18 10.23 2.55 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.405 -0.809 . . . . 0.0 108.946 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -61.09 -28.73 69.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.396 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -63.9 -50.58 68.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.543 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.526 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 4.5 mt -47.22 -47.34 24.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 108.785 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 20.7 t -55.31 -25.9 37.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.426 -0.796 . . . . 0.0 109.299 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 89' ' ' HIS . 1.9 m-20 -78.45 -53.05 7.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.503 HD11 ' O1D' ' A' ' 142' ' ' HEC . 5.2 tt -58.25 -28.65 65.1 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.327 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 8.4 m80 -92.6 -21.76 19.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.046 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -112.14 -2.39 14.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.133 -0.979 . . . . 0.0 110.354 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 85' ' ' ASP . 78.1 m80 -142.59 36.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.983 -1.073 . . . . 0.0 110.176 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -171.55 -77.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 0.0 109.723 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 91' ' ' LEU . 4.3 mm? -72.49 -37.34 68.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.09 -1.006 . . . . 0.0 109.346 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.666 ' HG2' ' NH1' ' D' ' 40' ' ' ARG . 28.1 ttm180 55.63 52.4 11.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.122 -0.987 . . . . 0.0 109.492 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.562 ' O ' ' NH2' ' D' ' 40' ' ' ARG . 0.3 OUTLIER -78.7 -173.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.154 -0.966 . . . . 0.0 109.44 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 96' ' ' VAL . 1.8 m-20 -123.91 113.65 28.35 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.482 -0.761 . . . . 0.0 109.139 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 98' ' ' PHE . 84.3 Cg_exo -43.34 -14.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.265 1.976 . . . . 0.0 112.378 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 94' ' ' ASP . 94.9 t -48.07 -25.65 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.595 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -79.38 -24.86 42.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.621 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' A' ' 95' ' ' PRO . 28.5 t80 -46.38 -40.76 12.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 109.623 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -59.42 -25.18 64.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.591 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.1 mt -84.01 -61.32 1.85 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.576 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.556 HD22 ' CHC' ' A' ' 142' ' ' HEC . 6.3 tp -47.95 -41.08 24.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.655 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.2 t -61.99 -42.31 99.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.669 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -80.91 -26.51 36.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.762 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 79.9 m -58.38 -56.86 16.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.603 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.6 mt -47.01 -37.14 8.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.365 -0.834 . . . . 0.0 109.568 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.09 -30.93 68.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.866 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.9 t -82.97 -24.81 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.2 m -81.82 -62.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.61 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 113' ' ' LEU . 12.5 mt -46.26 -39.94 10.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.311 -0.868 . . . . 0.0 109.64 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.5 -42.49 7.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.818 . . . . 0.0 109.927 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.04 -44.37 69.37 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.312 -0.868 . . . . 0.0 109.483 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -91.52 -77.24 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.561 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 109' ' ' LEU . 1.9 tt -96.88 119.59 63.28 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.49 165.38 32.58 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.242 1.962 . . . . 0.0 112.821 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.469 ' C ' ' N ' ' A' ' 117' ' ' PHE . . . -87.81 -28.5 21.61 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.53 0.681 . . . . 0.0 109.68 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.542 ' O ' ' CG ' ' A' ' 117' ' ' PHE . 83.8 mt-10 57.09 10.62 0.84 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' A' ' 116' ' ' GLU . 27.7 p90 40.6 32.5 0.15 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.339 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 120' ' ' ALA . 3.2 p -56.02 134.39 74.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -49.51 18.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.401 2.068 . . . . 0.0 113.251 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -157.37 -20.2 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.595 -1.316 . . . . 0.0 111.555 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 122' ' ' HIS . 2.8 t -65.64 -63.13 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.543 -1.348 . . . . 0.0 110.055 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.599 ' CD2' HG22 ' B' ' 34' ' ' VAL . 0.0 OUTLIER -50.5 -31.14 14.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 108.977 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.65 -19.94 32.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.341 -0.85 . . . . 0.0 109.777 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 20.4 p -64.89 -62.33 1.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.201 -0.937 . . . . 0.0 110.599 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.507 ' N ' ' OG ' ' A' ' 124' ' ' SER . 2.0 mt -72.91 -19.78 61.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.119 -0.988 . . . . 0.0 110.051 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -81.45 -43.51 18.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 109.896 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -87.28 -47.59 8.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 109.86 -179.597 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 31.2 t80 -48.73 -21.5 0.63 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.122 -0.986 . . . . 0.0 109.47 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 133' ' ' SER . 18.7 mt -73.75 -21.06 60.32 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.15 -32.96 68.67 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.447 ' OG ' HD11 ' A' ' 2' ' ' LEU . 0.7 OUTLIER -78.67 -30.42 46.19 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.404 -0.81 . . . . 0.0 108.869 179.373 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.06 -30.18 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 108.85 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 129' ' ' LEU . 78.8 p -79.09 -25.08 43.08 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.392 -0.817 . . . . 0.0 108.968 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 53.6 m -70.68 -37.57 73.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.299 -0.875 . . . . 0.0 109.244 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.402 ' H ' HG12 ' A' ' 135' ' ' VAL . 5.0 p -79.52 -22.04 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.307 -0.871 . . . . 0.0 108.955 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -33.83 40.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.356 -0.84 . . . . 0.0 109.149 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 139' ' ' LYS . 71.4 p -91.34 -1.46 57.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 78.3 p -48.09 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.48 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 137' ' ' THR . 44.4 mttp -65.25 -19.29 65.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.554 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -162.14 -24.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.565 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.47 179.961 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.525 HG13 ' N ' ' B' ' 2' ' ' HIS . 7.9 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 0.579 ' O ' ' CG ' ' B' ' 2' ' ' HIS . 0.0 OUTLIER -167.01 56.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -0.957 . . . . 0.0 109.603 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.985 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -122.17 -174.11 2.82 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.344 -0.847 . . . . 0.0 109.286 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.498 ' O ' ' N ' ' B' ' 6' ' ' GLU . 9.6 p -104.77 143.67 27.17 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.471 -0.768 . . . . 0.0 109.129 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -39.33 -22.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.561 2.174 . . . . 0.0 112.349 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' B' ' 4' ' ' THR . 25.1 mt-10 -75.5 -57.05 4.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.903 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -80.75 -22.93 39.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 109.798 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.708 ' HB2' HD13 ' B' ' 3' ' ' LEU . 2.5 tttm -79.77 -31.99 40.94 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.222 -0.924 . . . . 0.0 109.281 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 11.1 t -63.92 -23.36 67.32 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.686 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.08 -57.68 3.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.074 -1.016 . . . . 0.0 110.062 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.43 ' H ' HG12 ' B' ' 11' ' ' VAL . 1.8 p -62.12 -24.44 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 73.9 m -84.06 -35.47 23.76 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.364 0.602 . . . . 0.0 109.588 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -64.25 -60.05 3.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.812 . . . . 0.0 109.751 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.447 ' O ' HG23 ' B' ' 18' ' ' VAL . 7.9 mp -43.59 -18.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.51 -0.744 . . . . 0.0 110.139 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' TRP . . . . . 0.537 ' N ' ' O ' ' B' ' 13' ' ' ALA . 25.9 t90 -75.45 -33.39 60.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 0.0 109.499 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 13' ' ' ALA . . . -67.28 -52.54 30.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.687 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -56.22 -36.41 68.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.364 -1.08 . . . . 0.0 109.236 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 14' ' ' LEU . 6.6 t -57.32 117.35 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.421 -0.8 . . . . 0.0 109.695 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' B' ' 21' ' ' ASP . 60.9 t30 -87.96 81.08 7.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.343 -0.848 . . . . 0.0 108.964 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.412 ' C ' ' N ' ' B' ' 22' ' ' GLU . 91.2 t -44.41 -17.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 109.781 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' B' ' 19' ' ' ASN . 22.2 t70 -51.12 -15.35 0.33 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.674 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.412 ' N ' ' C ' ' B' ' 20' ' ' VAL . 33.7 mt-10 -156.17 -37.55 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.619 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -47.44 -54.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.617 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.32 -33.33 70.27 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.62 -49.63 74.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' B' ' 28' ' ' LEU . 90.6 mt-10 -73.08 -44.27 60.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.0 109.501 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.52 -22.23 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' B' ' 26' ' ' GLU . 0.2 OUTLIER -82.78 -57.97 3.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.292 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.6 -43.74 59.37 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -50.17 -33.57 19.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -1.137 . . . . 0.0 109.43 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' LEU . . . . . 0.478 HD21 ' CMC' ' B' ' 147' ' ' HEC . 42.0 tp -52.27 -36.94 54.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 24.4 mt -81.26 -42.57 20.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 109.844 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.423 HG23 ' H ' ' B' ' 33' ' ' VAL . 6.5 t -56.74 -54.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 0.0 109.427 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.599 HG22 ' CD2' ' A' ' 122' ' ' HIS . 21.6 t -68.41 -23.0 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.525 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -160.8 87.1 1.76 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 109.382 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.22 18.59 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.666 2.244 . . . . 0.0 112.22 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.506 ' C ' ' H ' ' B' ' 39' ' ' GLN . 1.3 p-90 -69.8 -19.95 63.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.476 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.493 HG23 ' CD1' ' B' ' 37' ' ' TRP . 75.8 p -69.83 35.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.857 . . . . 0.0 109.531 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 12.1 tt0 -73.27 14.78 0.28 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.644 ' NH1' ' HG2' ' C' ' 92' ' ' ARG . 64.7 mtt-85 -98.03 -48.95 4.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.384 -0.823 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -91.09 2.73 56.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 109.516 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' B' ' 39' ' ' GLN . 1.4 p90 -67.83 -4.34 12.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.58 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -46.86 -37.16 8.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 60.8 m -67.09 -43.46 82.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 109.436 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' B' ' 47' ' ' ASP . 2.6 m-85 -84.4 27.3 0.71 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 109.23 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.01 87.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' B' ' 45' ' ' PHE . 18.6 t0 -174.2 47.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.333 -1.098 . . . . 0.0 109.227 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.579 ' N ' HD12 ' B' ' 48' ' ' LEU . 9.5 mp -88.77 27.91 1.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 109.575 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -46.95 -37.67 9.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 109.321 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' THR . . . . . 0.401 ' O ' ' N ' ' B' ' 53' ' ' ALA . 5.6 p -146.98 148.89 33.98 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.45 -0.781 . . . . 0.0 109.012 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.13 -42.51 2.22 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.518 2.145 . . . . 0.0 112.516 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.406 ' C ' ' N ' ' B' ' 54' ' ' VAL . 7.6 p-10 -77.37 -29.62 53.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.0 109.746 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -47.98 -19.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.619 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.406 ' N ' ' C ' ' B' ' 52' ' ' ASP . 68.2 t -63.87 -61.45 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.656 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -81.5 4.41 21.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.535 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.37 1.33 84.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -87.32 150.23 48.73 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.236 -1.156 . . . . 0.0 109.304 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.73 -28.33 9.77 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.598 2.199 . . . . 0.0 112.377 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -39.34 19.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.933 . . . . 0.0 109.846 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 53.9 t -52.43 -42.67 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.468 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -78.97 -26.86 43.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.108 -0.995 . . . . 0.0 109.484 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.73 -58.06 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.487 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.804 ' NE2' ' C4D' ' B' ' 147' ' ' HEC . 1.6 t-80 -48.1 -23.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.191 -0.943 . . . . 0.0 109.545 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.23 -47.47 90.83 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -62.29 -35.57 79.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.182 . . . . 0.0 109.441 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' LYS . . . . . 0.76 ' HD3' ' CGA' ' B' ' 147' ' ' HEC . 53.2 mttm -60.58 -44.34 96.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.27 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 0.865 HG13 ' C2B' ' B' ' 147' ' ' HEC . 36.6 t -71.26 -58.83 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.22 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.448 HD23 ' O ' ' B' ' 68' ' ' LEU . 6.2 tt -48.78 -44.6 39.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.277 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.05 -47.06 41.62 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.57 32.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -1.156 . . . . 0.0 109.475 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -53.05 -22.8 6.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.247 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.46 -41.01 22.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.445 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.39 -27.65 1.76 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.42 -60.16 5.27 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.23 -17.98 9.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -1.121 . . . . 0.0 109.302 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.52 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -80.53 -26.25 38.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.695 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 39.5 m80 -157.23 59.99 0.51 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.76 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 23.3 mt -56.41 -4.7 0.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 109.295 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' B' ' 77' ' ' HIS . 7.5 m-20 -51.82 -26.48 9.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.723 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.408 ' N ' ' OD1' ' B' ' 80' ' ' ASN . 11.0 p30 -165.98 95.01 0.58 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.626 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.547 HD12 ' N ' ' B' ' 81' ' ' LEU . 6.3 mp -80.27 -58.75 2.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.36 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.468 ' HG3' ' HZ3' ' B' ' 82' ' ' LYS . 16.6 ttmm -47.44 -23.94 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 109.573 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.64 -49.29 11.18 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 1.3 t -73.9 -45.58 49.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -1.165 . . . . 0.0 109.647 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.531 ' N ' ' CG2' ' B' ' 84' ' ' THR . 48.4 m-85 -64.63 4.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.365 -0.834 . . . . 0.0 109.572 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -64.08 -34.02 77.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.944 . . . . 0.0 109.475 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.2 p -77.25 -53.06 8.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.606 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.54 ' N ' HD12 ' B' ' 88' ' ' LEU . 9.4 mp -51.25 -49.21 61.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.321 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 3.5 m -53.33 -49.37 67.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.362 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.53 -22.7 66.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.359 -0.838 . . . . 0.0 109.369 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.95 -57.87 3.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 0.0 109.667 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' B' ' 97' ' ' HIS . 45.2 m80 -68.64 -20.25 64.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 110.31 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 53.7 t -83.8 -60.92 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.03 . . . . 0.0 110.747 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -87.75 -56.08 3.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.023 . . . . 0.0 111.246 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -51.7 68.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.893 . . . . 0.0 110.759 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.679 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -98.47 -59.71 1.69 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.012 -1.055 . . . . 0.0 109.893 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.679 ' ND1' ' O ' ' B' ' 96' ' ' LEU . 0.0 OUTLIER 83.94 20.66 0.16 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.773 -0.579 . . . . 0.0 109.77 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.516 HG23 HD12 ' B' ' 96' ' ' LEU . 68.5 t -48.35 140.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.048 -1.032 . . . . 0.0 109.292 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -56.93 150.61 37.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.273 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.49 -7.76 21.9 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.539 2.159 . . . . 0.0 112.15 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.52 60.89 2.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 109.542 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -156.96 -34.69 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.14 -14.05 52.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.504 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.412 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 90.1 mtt-85 -86.25 -20.04 29.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.95 . . . . 0.0 109.778 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 37.2 mt -82.68 -53.61 5.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.792 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.922 HD22 ' HAB' ' B' ' 147' ' ' HEC . 4.1 tt -50.82 -46.32 59.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.79 -28.81 63.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 21.9 m120 -85.56 -20.78 29.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -1.173 . . . . 0.0 109.628 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 81.0 t -81.14 -28.86 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.56 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.94 -58.8 3.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.231 -0.918 . . . . 0.0 109.607 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.538 HG12 ' CD1' ' B' ' 130' ' ' TYR . 3.8 m -52.26 -26.07 8.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.296 -0.877 . . . . 0.0 109.929 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 t -70.43 -34.81 72.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 49.6 t -71.61 -22.48 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 109.56 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.423 ' CD1' ' OH ' ' B' ' 130' ' ' TYR . 14.6 mt -80.93 -47.11 14.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.488 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.484 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -51.96 -19.98 2.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 109.442 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 116' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -84.93 -63.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.544 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.79 -17.77 64.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.579 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -143.22 52.23 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.334 -0.854 . . . . 0.0 109.429 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -68.68 -13.01 65.28 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -77.99 -29.92 49.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -1.136 . . . . 0.0 109.395 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -94.29 14.48 20.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.569 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -84.0 34.01 0.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.902 . . . . 0.0 109.533 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.464 ' H ' HG23 ' B' ' 123' ' ' THR . 1.2 p -48.11 148.78 2.86 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.268 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 4.9 Cg_exo -45.73 -53.41 5.66 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.397 2.065 . . . . 0.0 113.007 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 28.1 Cg_endo -63.09 -29.13 74.52 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.031 1.821 . . . . 0.0 112.228 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.435 HG23 ' OG1' ' B' ' 123' ' ' THR . 63.2 t -74.13 -13.73 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.51 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -83.47 -59.74 2.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 109.575 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -56.19 -32.69 64.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.405 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.82 26.24 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.538 ' CD1' HG12 ' B' ' 111' ' ' VAL . 1.3 t80 -131.19 -34.28 1.44 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -0.846 . . . . 0.0 109.246 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -76.64 -63.44 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.736 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -47.29 -21.95 0.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.554 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' VAL . . . . . 0.584 HG22 HD21 ' B' ' 3' ' ' LEU . 2.9 t -71.14 -64.95 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.02 -26.83 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.81 -29.95 8.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.01 -32.52 69.61 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.06 -37.35 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -1.148 . . . . 0.0 109.362 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.32 -33.36 75.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.427 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -72.57 -36.55 68.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.85 -48.49 74.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.364 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.27 -30.1 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.97 0.55 49.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 109.7 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -67.2 -27.9 67.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.18 -0.95 . . . . 0.0 109.608 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -89.4 -23.04 22.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -55.34 -5.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' B' ' 144' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.515 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.455 HD13 ' CE2' ' C' ' 128' ' ' PHE . 14.6 mt -139.02 -174.23 3.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.311 -0.868 . . . . 0.0 109.34 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.495 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 175.94 -49.25 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 109.945 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' C' ' 3' ' ' SER . 72.1 Cg_exo -46.99 173.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.421 2.081 . . . . 0.0 112.641 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -65.12 -16.26 63.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.812 . . . . 0.0 109.64 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.457 ' C ' ' O ' ' C' ' 5' ' ' ALA . 1.2 m-20 -39.67 -40.63 0.94 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 0.0 109.647 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -60.51 -59.33 5.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 109.216 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 48.8 m -50.26 -28.63 8.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 109.156 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -80.16 -35.3 36.75 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.417 HG21 ' CG ' ' C' ' 128' ' ' PHE . 41.2 t -74.86 -44.54 45.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.69 -39.74 89.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.408 -0.807 . . . . 0.0 108.84 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.87 -52.87 46.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.865 . . . . 0.0 109.154 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.719 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.95 -35.43 64.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.365 -0.834 . . . . 0.0 109.056 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -17.46 61.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.314 -0.866 . . . . 0.0 109.007 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.52 -46.35 8.9 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 13.3 mmmt -68.93 -37.43 78.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 108.772 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.719 HG23 ' O ' ' C' ' 13' ' ' ALA . 99.4 t -61.14 -65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 59.67 -137.6 49.64 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 29.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.5 -1.0 . . . . 0.0 110.363 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.584 ' H ' ' C ' ' C' ' 18' ' ' GLY . 93.0 m-70 -131.73 23.33 4.65 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -87.3 -61.55 1.7 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.672 -0.643 . . . . 0.0 109.573 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.41 -14.49 0.35 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' C' ' 21' ' ' ALA . 3.7 mm-40 -84.14 -56.48 3.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -1.076 . . . . 0.0 109.484 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.1 m-30 -59.59 -33.16 71.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.396 -0.815 . . . . 0.0 109.332 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.32 -22.95 76.49 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.7 -43.58 20.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.184 -1.186 . . . . 0.0 109.689 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.75 -20.05 65.88 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.4 -19.98 59.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' C' ' 58' ' ' HIS . 18.7 mt -73.03 -45.94 54.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.652 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -61.89 -17.86 58.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.677 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 36.2 mmt-85 -81.17 -31.82 33.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.552 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -73.06 -37.6 66.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.605 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' C' ' 33' ' ' PHE . 0.7 OUTLIER -63.06 -59.94 4.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 12.2 mt -59.25 -48.93 79.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.0 109.63 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.505 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 40.4 t -46.02 -27.43 0.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.922 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' C' ' 35' ' ' SER . 47.3 m-85 -154.13 123.79 3.25 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 0.0 109.476 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' C' ' 40' ' ' LYS . 73.2 Cg_endo -77.8 -19.47 12.59 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.425 2.083 . . . . 0.0 112.272 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 21.2 p -43.91 -19.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 109.851 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.515 ' N ' ' O ' ' C' ' 37' ' ' PRO . 3.5 p -90.18 -22.89 21.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' C' ' 37' ' ' PRO . 27.9 ttmt -50.16 -18.7 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 109.922 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 9.1 t -105.65 -18.45 14.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 109.835 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.4 38.12 1.56 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.695 ' O ' ' CG ' ' C' ' 43' ' ' PHE . 6.3 p90 -115.07 81.18 7.56 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.33 -6.24 15.47 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.398 2.065 . . . . 0.0 111.917 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.51 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 0.3 OUTLIER -165.69 50.91 0.09 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.387 -0.82 . . . . 0.0 108.941 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.592 ' O ' ' HG ' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -156.15 71.08 0.71 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' C' ' 49' ' ' SER . 0.9 OUTLIER -46.34 -13.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.602 -0.687 . . . . 0.0 111.242 -178.252 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' C' ' 46' ' ' PHE . 9.6 mt 58.93 -5.34 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.787 -1.196 . . . . 0.0 109.664 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.59 ' H ' ' C ' ' C' ' 47' ' ' ASP . 0.0 OUTLIER -46.88 124.95 6.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.0 109.544 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -53.38 138.99 31.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.25 27.82 65.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' C' ' 53' ' ' ALA . 3.2 m -60.89 -97.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -1.141 . . . . 0.0 109.336 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' C' ' 52' ' ' SER . . . 167.83 -64.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.459 -0.776 . . . . 0.0 109.175 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -45.56 -17.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.541 -0.724 . . . . 0.0 109.534 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' C' ' 53' ' ' ALA . 61.6 t -73.86 -30.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.284 -0.885 . . . . 0.0 109.758 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -70.96 -26.46 63.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.85 -22.81 68.25 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.4 OUTLIER -79.22 -39.9 32.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.298 -1.119 . . . . 0.0 109.603 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.15 -50.02 53.54 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 49.7 mttp -52.06 -23.73 5.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -1.149 . . . . 0.0 109.966 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.664 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 10.2 mmpt? -72.55 -45.15 60.65 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.117 -0.99 . . . . 0.0 109.072 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.59 -46.12 83.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.531 -0.731 . . . . 0.0 109.277 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.86 -30.94 68.53 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.222 -0.923 . . . . 0.0 109.346 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 64' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 2.4 t70 -69.44 -34.49 74.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 108.83 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.84 -51.38 62.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 108.918 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 mt -56.28 -46.47 79.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.241 -0.912 . . . . 0.0 108.739 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -62.61 -51.66 66.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.328 -0.857 . . . . 0.0 108.81 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.6 -22.75 62.25 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.58 -47.06 10.94 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.64 -22.88 31.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.75 -16.91 64.58 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.597 ' O ' ' N ' ' C' ' 74' ' ' ASP . 15.8 m80 -143.88 -60.07 0.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.515 -0.741 . . . . 0.0 109.388 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.553 HG12 ' O ' ' C' ' 72' ' ' HIS . 12.8 p 44.63 14.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.817 0.818 . . . . 0.0 109.376 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' C' ' 72' ' ' HIS . 13.7 m-20 -131.23 11.41 4.99 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.439 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 1.8 p-10 -177.77 31.76 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.962 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.694 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -77.98 -24.23 0.44 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.458 -0.776 . . . . 0.0 111.655 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' C' ' 76' ' ' MET . 75.3 Cg_exo -50.3 -33.82 38.19 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.689 1.593 . . . . 0.0 112.279 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -94.34 -16.05 23.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.53 -58.04 3.39 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.123 -0.986 . . . . 0.0 109.139 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 mt -77.16 10.18 2.58 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.395 -0.815 . . . . 0.0 108.962 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -61.0 -28.81 69.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -63.85 -50.68 67.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.509 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 4.5 mt -47.27 -47.29 25.1 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 20.7 t -55.36 -25.8 37.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.498 -0.751 . . . . 0.0 109.247 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' C' ' 89' ' ' HIS . 1.9 m-20 -78.55 -53.01 7.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.935 . . . . 0.0 109.463 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.512 HD11 ' O1D' ' C' ' 142' ' ' HEC . 5.2 tt -58.2 -28.76 65.11 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.302 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 87' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 8.3 m80 -92.58 -21.66 19.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 110.048 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -112.21 -2.28 14.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.234 -0.916 . . . . 0.0 110.414 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 89' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' C' ' 85' ' ' ASP . 78.0 m80 -142.6 36.08 1.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.984 -1.073 . . . . 0.0 110.096 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -171.57 -77.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.04 -1.037 . . . . 0.0 109.72 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' C' ' 91' ' ' LEU . 4.3 mm? -72.52 -37.34 68.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 109.327 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 92' ' ' ARG . . . . . 0.644 ' HG2' ' NH1' ' B' ' 40' ' ' ARG . 28.1 ttm180 55.64 52.38 11.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.575 ' O ' ' NH2' ' B' ' 40' ' ' ARG . 0.3 OUTLIER -78.68 -173.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.45 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' C' ' 96' ' ' VAL . 1.8 m-20 -123.8 113.67 28.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.464 -0.773 . . . . 0.0 109.169 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' C' ' 98' ' ' PHE . 84.8 Cg_exo -43.43 -14.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.216 1.944 . . . . 0.0 112.406 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' C' ' 94' ' ' ASP . 94.2 t -48.05 -25.66 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 109.551 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -79.44 -24.8 42.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.644 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 98' ' ' PHE . . . . . 0.42 ' N ' ' O ' ' C' ' 95' ' ' PRO . 28.5 t80 -46.43 -40.79 12.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 109.55 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -59.5 -24.93 64.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 20.2 mt -84.13 -61.26 1.86 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.628 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.543 HD22 ' CHC' ' C' ' 142' ' ' HEC . 6.3 tp -48.01 -41.02 24.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 9.2 t -61.96 -42.3 98.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.715 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -80.94 -26.59 36.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.676 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 79.8 m -58.31 -56.86 16.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 0.0 109.625 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -47.07 -37.06 8.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.526 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.19 -31.01 68.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.782 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.89 -24.88 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.586 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 28.1 m -81.78 -62.95 1.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.596 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' C' ' 113' ' ' LEU . 12.5 mt -46.26 -39.9 10.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.895 . . . . 0.0 109.581 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.62 -42.33 7.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.958 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.1 -44.45 69.01 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.507 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -91.41 -77.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.63 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' C' ' 109' ' ' LEU . 1.9 tt -96.82 119.44 63.64 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.41 165.34 32.76 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.287 1.991 . . . . 0.0 112.821 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -87.79 -28.57 21.6 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.565 0.698 . . . . 0.0 109.647 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' C' ' 117' ' ' PHE . 83.8 mt-10 57.07 10.63 0.84 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' C' ' 116' ' ' GLU . 27.8 p90 40.58 32.51 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.314 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.703 ' O ' ' N ' ' C' ' 120' ' ' ALA . 3.2 p -56.03 134.35 74.06 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.44 18.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.387 2.058 . . . . 0.0 113.293 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.703 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -157.44 -20.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.623 -1.298 . . . . 0.0 111.543 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.438 HG12 ' N ' ' C' ' 122' ' ' HIS . 2.8 t -65.65 -63.01 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.513 -1.367 . . . . 0.0 110.106 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.598 ' CD2' HG22 ' D' ' 34' ' ' VAL . 0.0 OUTLIER -50.71 -31.02 15.29 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.28 -0.888 . . . . 0.0 108.868 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.65 -20.03 31.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.742 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 20.4 p -64.8 -62.33 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.671 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.505 ' N ' ' OG ' ' C' ' 124' ' ' SER . 2.0 mt -72.98 -19.68 61.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.1 -1.0 . . . . 0.0 110.081 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -81.48 -43.42 18.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.029 -1.044 . . . . 0.0 109.948 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -87.33 -47.64 8.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.873 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 31.1 t80 -48.68 -21.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.447 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' C' ' 133' ' ' SER . 18.8 mt -73.62 -21.23 60.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.05 -32.96 68.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.445 ' OG ' HD11 ' C' ' 2' ' ' LEU . 0.7 OUTLIER -78.71 -30.43 45.95 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.44 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.07 -30.25 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.845 . . . . 0.0 108.764 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.458 ' N ' ' O ' ' C' ' 129' ' ' LEU . 79.1 p -79.03 -25.1 43.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.347 -0.846 . . . . 0.0 108.968 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 53.5 m -70.69 -37.54 73.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.284 -0.885 . . . . 0.0 109.215 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.9 p -79.59 -22.0 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 108.871 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.65 -33.9 40.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.39 -0.818 . . . . 0.0 109.144 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 137' ' ' THR . . . . . 0.446 ' O ' ' N ' ' C' ' 139' ' ' LYS . 69.8 p -91.23 -1.54 57.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 109.58 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 78.4 p -48.07 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' C' ' 137' ' ' THR . 44.4 mttp -65.29 -19.22 65.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -162.2 -24.48 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.438 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.535 HG13 ' N ' ' D' ' 2' ' ' HIS . 7.9 p . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 2' ' ' HIS . . . . . 0.581 ' O ' ' CG ' ' D' ' 2' ' ' HIS . 0.0 OUTLIER -166.99 56.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.155 -0.966 . . . . 0.0 109.634 179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 1.035 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -122.25 -174.11 2.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.278 -0.889 . . . . 0.0 109.258 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.498 ' O ' ' N ' ' D' ' 6' ' ' GLU . 9.7 p -104.75 143.73 27.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 109.122 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -39.26 -22.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.637 2.224 . . . . 0.0 112.296 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 6' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' D' ' 4' ' ' THR . 25.2 mt-10 -75.55 -56.92 4.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.937 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -80.82 -22.82 39.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.944 . . . . 0.0 109.861 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.698 ' HB2' HD13 ' D' ' 3' ' ' LEU . 2.5 tttm -79.8 -31.97 40.75 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.254 -0.904 . . . . 0.0 109.296 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 9' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 11.2 t -63.84 -23.45 67.36 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.718 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.07 -57.66 3.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.057 -1.027 . . . . 0.0 110.086 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.43 ' H ' HG12 ' D' ' 11' ' ' VAL . 1.8 p -62.1 -24.42 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 75.1 m -84.13 -35.5 23.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.327 0.584 . . . . 0.0 109.547 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 13' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -64.29 -59.95 3.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.441 -0.787 . . . . 0.0 109.71 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.448 ' O ' HG23 ' D' ' 18' ' ' VAL . 7.9 mp -43.72 -18.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 0.0 110.117 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 15' ' ' TRP . . . . . 0.53 ' N ' ' O ' ' D' ' 13' ' ' ALA . 25.6 t90 -75.39 -33.37 61.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.917 -1.114 . . . . 0.0 109.532 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.31 -52.57 30.55 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.678 ' H ' ' CD ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -56.25 -36.37 68.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.326 -1.102 . . . . 0.0 109.189 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 14' ' ' LEU . 6.6 t -57.45 117.38 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.819 . . . . 0.0 109.676 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' D' ' 21' ' ' ASP . 61.0 t30 -88.03 81.12 7.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 108.912 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' D' ' 22' ' ' GLU . 92.0 t -44.47 -17.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 0.0 109.846 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' D' ' 19' ' ' ASN . 22.2 t70 -51.15 -15.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' D' ' 20' ' ' VAL . 33.6 mt-10 -156.12 -37.67 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.4 HG11 HG13 ' D' ' 18' ' ' VAL . 77.2 t -47.38 -53.97 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 109.703 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.35 -33.28 70.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.67 -49.66 74.23 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 26' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' D' ' 28' ' ' LEU . 90.5 mt-10 -73.06 -44.27 60.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -1.171 . . . . 0.0 109.505 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.51 -22.28 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.618 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 28' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' D' ' 26' ' ' GLU . 0.2 OUTLIER -82.65 -58.01 3.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.288 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.64 -43.68 59.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -50.13 -33.61 19.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -1.134 . . . . 0.0 109.482 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 31' ' ' LEU . . . . . 0.474 HD21 ' CMC' ' D' ' 147' ' ' HEC . 42.1 tp -52.3 -36.93 54.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.935 . . . . 0.0 109.494 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.17 -42.69 20.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -56.72 -54.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.155 -0.965 . . . . 0.0 109.432 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' C' ' 122' ' ' HIS . 21.6 t -68.41 -23.05 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.525 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -160.8 86.99 1.77 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -83.0 18.36 1.5 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.74 2.293 . . . . 0.0 112.281 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 37' ' ' TRP . . . . . 0.528 ' C ' ' H ' ' D' ' 39' ' ' GLN . 1.3 p-90 -69.68 -19.98 63.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.464 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.49 HG23 ' CD1' ' D' ' 37' ' ' TRP . 75.8 p -69.92 35.63 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.175 -0.953 . . . . 0.0 109.568 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 39' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' D' ' 37' ' ' TRP . 12.1 tt0 -73.23 14.77 0.28 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.322 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 40' ' ' ARG . . . . . 0.666 ' NH1' ' HG2' ' A' ' 92' ' ' ARG . 64.7 mtt-85 -98.03 -48.9 4.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.483 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -91.17 2.73 56.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.983 . . . . 0.0 109.531 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' D' ' 39' ' ' GLN . 1.4 p90 -67.87 -4.33 12.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.619 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -46.81 -37.17 8.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 109.657 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 60.5 m -67.13 -43.39 82.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' D' ' 47' ' ' ASP . 2.6 m-85 -84.34 27.3 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.248 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.97 87.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' D' ' 45' ' ' PHE . 18.7 t0 -174.2 47.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -1.101 . . . . 0.0 109.252 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' D' ' 48' ' ' LEU . 9.5 mp -88.78 27.92 1.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 109.564 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -46.94 -37.67 9.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.297 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 50' ' ' THR . . . . . 0.41 ' O ' ' N ' ' D' ' 53' ' ' ALA . 5.6 p -147.07 148.8 33.46 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.034 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -39.04 -42.54 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.552 2.168 . . . . 0.0 112.447 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ASP . . . . . 0.404 ' C ' ' N ' ' D' ' 54' ' ' VAL . 7.6 p-10 -77.39 -29.62 53.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 0.0 109.728 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -48.04 -19.64 0.27 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 109.572 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 54' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 52' ' ' ASP . 67.1 t -63.93 -61.43 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.608 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 55' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -81.52 4.4 21.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.505 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.4 1.34 84.14 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 57' ' ' ASN . . . . . 0.404 HD21 ' CB ' ' D' ' 47' ' ' ASP . 20.6 m120 -87.39 150.21 48.53 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.222 -1.163 . . . . 0.0 109.348 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.79 -28.26 9.72 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.576 2.184 . . . . 0.0 112.314 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -39.32 19.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 109.848 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 53.8 t -52.38 -42.75 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.024 . . . . 0.0 109.428 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -79.01 -26.8 43.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.933 . . . . 0.0 109.458 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.76 -58.01 3.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.55 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.803 ' NE2' ' C4D' ' D' ' 147' ' ' HEC . 1.6 t-80 -48.14 -23.9 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.561 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.3 -47.37 91.25 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -62.24 -35.67 79.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -1.203 . . . . 0.0 109.475 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 66' ' ' LYS . . . . . 0.761 ' HD3' ' CGA' ' D' ' 147' ' ' HEC . 53.0 mttm -60.56 -44.39 96.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.837 . . . . 0.0 109.248 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.862 HG13 ' C2B' ' D' ' 147' ' ' HEC . 36.3 t -71.21 -58.77 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.25 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.449 ' O ' HD23 ' D' ' 68' ' ' LEU . 6.2 tt -48.88 -44.54 40.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.275 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.03 -47.06 41.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.96 -55.63 32.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -1.199 . . . . 0.0 109.393 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -53.0 -22.85 6.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.321 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.33 -41.1 22.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -0.834 . . . . 0.0 109.565 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.34 -27.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.408 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.41 -60.16 5.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.56 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -56.25 -17.93 8.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -1.119 . . . . 0.0 109.342 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 76' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -80.6 -26.13 38.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.237 -0.914 . . . . 0.0 109.701 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 39.5 m80 -157.36 60.01 0.5 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.688 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 23.2 mt -56.36 -4.8 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.045 -1.034 . . . . 0.0 109.309 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' D' ' 77' ' ' HIS . 7.5 m-20 -51.8 -26.47 9.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.714 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 80' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' D' ' 80' ' ' ASN . 10.9 p30 -166.04 94.96 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 81' ' ' LEU . . . . . 0.531 HD12 ' N ' ' D' ' 81' ' ' LEU . 6.3 mp -80.26 -58.71 3.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 82' ' ' LYS . . . . . 0.435 ' HZ3' ' HG3' ' D' ' 82' ' ' LYS . 16.6 ttmm -47.44 -23.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.915 . . . . 0.0 109.567 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.81 -49.12 10.81 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.522 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 1.3 t -73.93 -45.67 49.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -1.207 . . . . 0.0 109.599 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.522 ' N ' ' CG2' ' D' ' 84' ' ' THR . 48.5 m-85 -64.66 4.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.398 -0.813 . . . . 0.0 109.613 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 86' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -64.1 -33.94 76.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.507 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.4 p -77.31 -53.09 8.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.54 HD12 ' N ' ' D' ' 88' ' ' LEU . 9.4 mp -51.17 -49.31 61.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 3.5 m -53.3 -49.37 67.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.339 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -62.55 -22.72 66.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.335 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.86 -57.99 3.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.316 -0.865 . . . . 0.0 109.617 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.574 ' O ' ' N ' ' D' ' 97' ' ' HIS . 45.2 m80 -68.54 -20.35 64.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.844 . . . . 0.0 110.337 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 53.6 t -83.72 -60.94 1.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 110.781 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -87.78 -56.07 3.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -0.982 . . . . 0.0 111.283 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -51.66 68.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.794 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.665 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -98.47 -59.61 1.71 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.983 -1.073 . . . . 0.0 109.956 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.665 ' ND1' ' O ' ' D' ' 96' ' ' LEU . 0.0 OUTLIER 83.77 20.79 0.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.812 -0.555 . . . . 0.0 109.761 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 98' ' ' VAL . . . . . 0.525 HG23 HD12 ' D' ' 96' ' ' LEU . 67.3 t -48.43 140.63 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 109.231 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -57.02 150.64 38.54 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.285 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.44 -7.78 21.97 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.524 2.149 . . . . 0.0 112.208 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.56 60.83 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 109.503 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -156.86 -34.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.602 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -64.09 -14.02 51.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.969 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 104' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 89.9 mtt-85 -86.31 -19.97 29.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.769 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 37.3 mt -82.74 -53.56 5.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.821 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.925 HD22 ' HAB' ' D' ' 147' ' ' HEC . 4.1 tt -50.79 -46.41 59.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 109.485 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.74 -28.86 63.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 108' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 21.9 m120 -85.57 -20.71 29.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -1.215 . . . . 0.0 109.606 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.25 -28.69 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 8.8 tp -68.11 -58.7 4.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.627 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 111' ' ' VAL . . . . . 0.538 HG12 ' CD1' ' D' ' 130' ' ' TYR . 3.8 m -52.31 -26.16 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.179 -0.951 . . . . 0.0 109.819 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 18.4 t -70.31 -34.78 73.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.743 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 49.8 t -71.7 -22.33 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.947 . . . . 0.0 109.6 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 114' ' ' LEU . . . . . 0.42 ' CD1' ' OH ' ' D' ' 130' ' ' TYR . 14.6 mt -81.03 -47.11 14.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -51.96 -19.93 2.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.473 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 116' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -84.95 -62.99 1.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.9 -17.67 64.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.92 . . . . 0.0 109.575 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -143.22 52.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.555 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -68.72 -12.92 65.24 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -78.06 -29.9 49.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -1.134 . . . . 0.0 109.394 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -94.27 14.5 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.892 . . . . 0.0 109.569 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -83.96 34.04 0.5 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.0 109.597 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.434 ' H ' HG23 ' D' ' 123' ' ' THR . 1.2 p -48.17 148.84 2.88 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 109.228 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.1 Cg_exo -45.88 -53.31 5.86 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.395 2.063 . . . . 0.0 112.923 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 28.3 Cg_endo -63.12 -29.04 74.12 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.004 1.803 . . . . 0.0 112.297 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.433 HG23 ' OG1' ' D' ' 123' ' ' THR . 63.0 t -74.23 -13.64 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.496 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -83.52 -59.76 2.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -56.24 -32.56 64.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.374 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.92 26.3 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.857 . . . . 0.0 109.471 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.538 ' CD1' HG12 ' D' ' 111' ' ' VAL . 1.3 t80 -131.27 -34.24 1.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.409 -0.807 . . . . 0.0 109.291 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -76.64 -63.5 1.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.646 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -47.34 -21.86 0.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 109.569 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 133' ' ' VAL . . . . . 0.569 HG22 HD21 ' D' ' 3' ' ' LEU . 2.9 t -71.22 -64.91 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.546 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.402 HG23 ' H ' ' D' ' 134' ' ' VAL . 2.6 t -69.06 -26.79 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.9 -29.9 9.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.41 69.49 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.11 -37.32 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.396 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.34 -33.42 75.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.375 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -72.55 -36.46 68.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.92 -48.46 74.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 mt -60.16 -30.19 69.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.92 0.56 49.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 109.681 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -67.12 -27.97 67.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.9 OUTLIER -89.54 -22.85 22.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.955 . . . . 0.0 109.593 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -55.44 -5.4 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.493 ' H ' ' C ' ' D' ' 144' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.428 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.79 HBB2 HMB1 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 0.922 ' HAB' HD22 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.793 HBB2 HMB1 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 0.925 ' HAB' HD22 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.517 HD11 ' HD3' ' A' ' 127' ' ' LYS . 9.5 tp -172.34 163.4 5.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 109.857 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -75.74 -176.92 0.63 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.368 -0.832 . . . . 0.0 109.058 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 58.4 Cg_endo -86.87 -68.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.664 2.243 . . . . 0.0 112.716 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -47.54 -40.44 18.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.054 -1.029 . . . . 0.0 109.485 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 10' ' ' VAL . 63.9 m-20 -43.55 -29.46 0.48 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.86 . . . . 0.0 109.02 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 10' ' ' VAL . 58.4 mttt -83.08 -53.72 5.59 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' LYS . 35.9 m -44.65 -38.51 4.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.448 -0.782 . . . . 0.0 109.282 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -72.46 -29.69 63.9 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 6' ' ' ASP . 54.1 t -75.12 -55.0 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' CD ' ' H ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -51.65 -39.11 57.52 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.23 179.102 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.18 -63.12 1.37 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.322 -0.861 . . . . 0.0 109.296 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.564 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.68 -38.61 67.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.388 -0.82 . . . . 0.0 108.892 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.94 -17.58 63.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.466 -0.772 . . . . 0.0 108.981 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.14 -44.98 16.61 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 39.1 mmtt -68.23 -41.4 81.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -1.137 . . . . 0.0 108.859 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 13' ' ' ALA . 61.2 t -60.28 -64.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 50.0 -127.87 25.1 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.47 24.68 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.474 -1.015 . . . . 0.0 110.381 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.544 ' H ' ' C ' ' A' ' 18' ' ' GLY . 87.4 m-70 -130.38 28.49 4.95 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -93.36 -61.31 1.59 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.671 -0.643 . . . . 0.0 109.778 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.27 -14.3 0.16 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.6 mt-10 -86.54 -56.29 3.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -1.117 . . . . 0.0 109.761 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.1 m-30 -59.79 -32.36 70.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 109.59 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.04 -22.92 76.13 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.92 -41.86 18.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -1.17 . . . . 0.0 109.959 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -65.93 -19.88 66.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.294 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.77 -20.4 60.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.436 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.554 HD11 ' ND1' ' A' ' 58' ' ' HIS . 14.1 mt -74.52 -51.11 15.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.739 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.66 -22.43 65.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.164 -0.96 . . . . 0.0 109.584 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.997 HH21 ' HB2' ' B' ' 127' ' ' GLN . 2.3 tpt180 -73.37 -20.75 60.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.311 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 46.1 ttp -78.36 -53.64 7.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.862 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -48.36 -24.2 1.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.351 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.079 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.5 mt -82.32 -46.2 13.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.978 . . . . 0.0 109.579 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 46.0 m -69.21 -20.78 63.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 35' ' ' SER . 95.5 m-85 -158.4 79.23 3.14 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.988 . . . . 0.0 109.737 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.31 -26.42 15.67 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.659 2.239 . . . . 0.0 112.07 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.433 ' O ' ' CG2' ' A' ' 41' ' ' THR . 12.6 p -49.45 -18.24 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.918 . . . . 0.0 109.477 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.6 p -79.01 -22.34 45.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -46.01 -42.91 13.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.583 HG21 ' HD1' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -62.42 -35.76 80.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.461 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -76.79 22.46 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.173 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 41' ' ' THR . 39.1 m-85 -146.03 59.75 5.8 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 -0.75 8.01 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.669 2.246 . . . . 0.0 111.942 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 15.9 p80 -141.79 56.95 1.5 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.165 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.662 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -149.81 69.32 1.02 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.548 ' C ' ' O ' ' A' ' 46' ' ' PHE . 1.1 m-20 -24.38 -37.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.855 -0.528 . . . . 0.0 111.203 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.662 ' N ' ' O ' ' A' ' 46' ' ' PHE . 4.3 mt 53.58 7.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.072 -1.017 . . . . 0.0 109.373 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 47' ' ' ASP . 4.9 m -64.34 5.7 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.507 ' H ' ' C ' ' A' ' 48' ' ' LEU . 37.8 t60 61.32 125.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.5 14.14 66.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.5 t -77.86 -103.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.164 -1.198 . . . . 0.0 109.41 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.91 -29.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 0.0 109.496 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -80.03 -17.98 51.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.199 -0.938 . . . . 0.0 109.169 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -84.52 -40.14 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.295 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -77.3 -32.37 55.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.16 -21.82 75.02 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.554 ' ND1' HD11 ' A' ' 29' ' ' LEU . 7.8 t-80 -75.65 -37.54 59.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.314 -1.11 . . . . 0.0 109.781 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.12 -48.5 46.39 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -51.77 -23.13 4.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -1.05 . . . . 0.0 109.979 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.39 -39.84 64.79 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.218 -0.926 . . . . 0.0 109.184 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.37 -33.6 19.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.457 -0.777 . . . . 0.0 108.935 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.16 -32.9 44.4 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.389 -0.82 . . . . 0.0 109.415 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -70.39 -33.37 71.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 108.861 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.557 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -70.01 -53.13 19.02 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.429 -0.794 . . . . 0.0 108.898 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.23 -38.24 70.8 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.254 -0.904 . . . . 0.0 108.717 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -71.5 -50.29 32.88 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.196 -0.94 . . . . 0.0 108.608 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -59.78 -21.15 60.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.202 -0.936 . . . . 0.0 108.496 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.07 -47.35 13.66 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.417 HG13 ' CE ' ' A' ' 11' ' ' LYS . 9.7 t -65.94 -22.85 31.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.72 -15.1 63.41 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 74' ' ' ASP . 78.4 m-70 -139.5 -63.01 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.479 -0.763 . . . . 0.0 109.423 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 73' ' ' VAL . 12.3 p 43.92 13.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.752 0.787 . . . . 0.0 109.65 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.612 ' N ' ' O ' ' A' ' 72' ' ' HIS . 16.2 m-20 -134.25 10.39 3.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 20.3 t0 -177.02 28.35 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.148 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.7 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 11.4 ptt? -78.81 -22.45 0.38 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 111.805 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 76' ' ' MET . 71.8 Cg_exo -49.02 -29.0 14.69 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.473 1.449 . . . . 0.0 112.424 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -94.23 -24.41 17.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 0.0 109.653 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.29 -53.58 8.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 0.0 109.143 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 mt -78.02 9.06 3.95 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.441 -0.787 . . . . 0.0 108.98 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 t -66.06 -41.5 90.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.412 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -52.46 -52.87 51.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.465 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 82' ' ' ALA . 4.9 mt -44.89 -45.05 10.11 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 9.9 p -55.75 -39.87 71.76 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' ALA . 25.7 t70 -67.58 -17.95 64.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.147 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.569 HD11 HBD1 ' A' ' 142' ' ' HEC . 1.2 tt -82.85 -43.46 16.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.333 -0.855 . . . . 0.0 109.378 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -92.45 -21.27 20.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.952 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -60.63 -87.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.106 -0.996 . . . . 0.0 110.741 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 90' ' ' LYS . 44.9 t-80 -96.62 -46.3 6.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.245 -0.909 . . . . 0.0 111.02 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 89' ' ' HIS . 35.9 mttm -41.22 -94.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.22 -0.925 . . . . 0.0 110.324 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mp -67.54 -34.97 78.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.012 -1.055 . . . . 0.0 109.623 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.393 ' NH2' ' HE ' ' D' ' 40' ' ' ARG . 45.5 ttp85 60.89 58.2 2.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.607 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 t -84.33 161.64 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 109.373 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.45 151.43 50.78 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.21 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' ASN . 58.4 Cg_endo -73.08 -18.8 23.6 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.55 2.167 . . . . 0.0 112.195 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.511 HG21 ' CB ' ' D' ' 99' ' ' ASP . 24.4 t -47.22 -20.04 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.743 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.5 ' HB3' HMC1 ' A' ' 142' ' ' HEC . 4.1 m-20 -79.15 -24.73 43.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.709 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.546 ' CZ ' HD23 ' A' ' 136' ' ' LEU . 4.8 m-85 -46.66 -32.57 3.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 109.659 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.498 ' O ' ' ND1' ' A' ' 103' ' ' HIS . 55.8 mttm -83.89 -36.78 23.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 0.0 109.814 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 100' ' ' LEU . 7.2 mp -66.37 -61.93 1.74 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.131 -0.981 . . . . 0.0 109.516 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.567 HD22 ' CBB' ' A' ' 142' ' ' HEC . 6.4 tt -49.97 -47.4 52.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.239 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.8 t -61.9 -38.85 89.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.603 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' LYS . 22.9 m80 -77.37 -27.73 52.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.935 . . . . 0.0 109.609 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.74 -46.93 80.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.728 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.25 -48.64 65.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.435 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 106' ' ' LEU . 9.6 mp -61.54 -59.1 5.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.713 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.04 -34.3 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.237 -0.914 . . . . 0.0 109.386 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.8 m -75.77 -60.87 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.392 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 113' ' ' LEU . 13.1 mt -46.11 -41.44 12.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.91 -28.58 0.68 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 110.182 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.89 -56.38 4.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 109.768 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -85.77 -65.13 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.466 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -95.92 106.89 30.89 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.2 171.17 9.48 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.718 1.612 . . . . 0.0 112.3 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 117' ' ' PHE . . . -87.22 -34.37 19.0 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.487 0.66 . . . . 0.0 109.88 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 117' ' ' PHE . 23.2 mt-10 55.63 9.96 0.46 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 116' ' ' GLU . 29.3 p90 40.63 32.34 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.54 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 120' ' ' ALA . 4.9 p -60.88 145.55 88.59 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.41 29.56 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 121.946 1.764 . . . . 0.0 111.773 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 124' ' ' SER . . . -162.61 -23.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.12 -0.988 . . . . 0.0 111.06 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.474 HG23 ' OG1' ' A' ' 118' ' ' THR . 2.6 t -59.86 -62.62 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.794 -1.191 . . . . 0.0 109.799 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.47 ' N ' HG12 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -60.72 -27.12 67.68 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.126 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.54 -20.09 32.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 120' ' ' ALA . 95.5 p -67.19 -62.0 1.64 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 110.8 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.6 mt -80.23 -19.88 45.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.925 -1.109 . . . . 0.0 110.81 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.69 -42.68 27.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.663 -1.273 . . . . 0.0 110.241 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.517 ' HD3' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -90.04 -45.0 9.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.958 -1.089 . . . . 0.0 110.126 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 10' ' ' VAL . 71.1 t80 -47.31 -21.55 0.3 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.01 -1.056 . . . . 0.0 109.454 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 129' ' ' LEU . 15.8 mt -69.63 -17.68 63.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.19 78.58 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.464 ' HB3' HD13 ' A' ' 2' ' ' LEU . 60.5 p -78.68 -25.92 44.88 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.362 -0.836 . . . . 0.0 108.747 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.1 t -84.99 -40.54 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.234 -0.916 . . . . 0.0 108.598 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.8 t -68.84 -28.76 67.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.397 -0.814 . . . . 0.0 109.297 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 51.6 m -64.65 -40.0 94.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.138 -0.976 . . . . 0.0 108.985 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 135' ' ' VAL . 2.7 p -82.68 -21.89 9.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.26 -0.9 . . . . 0.0 108.584 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.546 HD23 ' CZ ' ' A' ' 98' ' ' PHE . 1.1 tp -78.82 -28.26 44.4 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 138' ' ' SER . 49.1 m -68.14 -23.34 64.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.846 . . . . 0.0 109.405 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.7 OUTLIER 73.15 110.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -62.75 -98.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.405 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 47.45 76.25 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.534 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.724 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.75 HG13 ' N ' ' B' ' 2' ' ' HIS . 2.9 p . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 1.199 ' NE2' ' ND1' ' D' ' 146' ' ' HIS . 6.2 p80 -172.81 112.42 0.24 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.919 -1.113 . . . . 0.0 109.818 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.847 ' N ' HD12 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -141.87 -162.63 1.43 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.26 -0.9 . . . . 0.0 109.149 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -93.77 131.08 32.9 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.0 109.237 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.45 -23.77 0.32 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.365 2.043 . . . . 0.0 112.308 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -81.46 -53.02 6.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.968 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 5.5 mp0 -61.3 -55.58 30.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.662 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.727 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -57.04 -35.44 69.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.869 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -58.67 -23.81 60.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 110.047 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.61 -56.45 3.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.094 -1.004 . . . . 0.0 109.712 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.599 HG23 ' CD2' ' B' ' 130' ' ' TYR . 0.9 OUTLIER -64.07 -25.15 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.574 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 75.9 m -78.7 -35.26 45.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -60.38 -61.52 2.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.425 -0.797 . . . . 0.0 109.328 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.522 ' O ' HG23 ' B' ' 18' ' ' VAL . 8.0 mp -43.62 -18.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.672 -0.642 . . . . 0.0 109.765 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' B' ' 13' ' ' ALA . 22.1 t-105 -78.09 -17.96 56.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.972 . . . . 0.0 109.646 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.09 -42.61 7.49 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.665 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -68.75 -31.95 71.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -1.093 . . . . 0.0 109.214 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.522 HG23 ' O ' ' B' ' 14' ' ' LEU . 4.8 t -52.33 119.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -0.819 . . . . 0.0 109.692 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' B' ' 21' ' ' ASP . 54.9 m-20 -86.98 82.86 7.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.035 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' B' ' 22' ' ' GLU . 94.7 t -44.14 -20.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.816 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' B' ' 19' ' ' ASN . 12.6 m-20 -51.72 -8.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.73 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' B' ' 20' ' ' VAL . 34.8 mt-10 -155.53 -49.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.5 t -46.08 -26.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 109.779 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.09 -31.18 32.4 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -82.47 -25.67 49.96 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.73 -29.94 25.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.697 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.55 -23.45 63.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.949 . . . . 0.0 109.807 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.67 -58.16 3.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 109.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.19 -29.35 68.36 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.5 ' NH2' HG13 ' B' ' 113' ' ' VAL . 3.3 ttp180 -68.37 -29.44 68.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -1.114 . . . . 0.0 109.745 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp -51.62 -39.7 58.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.244 -0.91 . . . . 0.0 109.652 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 mt -78.12 -21.85 49.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.825 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 45.7 t -71.83 -47.96 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.875 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -63.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.019 -1.051 . . . . 0.0 109.787 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -119.42 97.09 50.16 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.396 -0.815 . . . . 0.0 109.754 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' B' ' 38' ' ' THR . 90.6 Cg_endo -85.59 10.52 3.67 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.717 2.278 . . . . 0.0 111.888 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -45.21 -19.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 109.694 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.662 ' C ' ' H ' ' B' ' 40' ' ' ARG . 11.0 p -46.96 -34.36 5.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.616 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 61.06 -13.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 1.403 ' HE ' ' NH2' ' C' ' 92' ' ' ARG . 79.8 mtt180 -88.94 -25.63 21.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.955 . . . . 0.0 108.946 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' PHE . . . . . 0.405 ' CD2' HD22 ' B' ' 48' ' ' LEU . 3.4 m-85 53.79 6.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.415 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.624 ' CD2' ' CE1' ' B' ' 45' ' ' PHE . 3.0 m-85 48.11 30.08 2.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 109.163 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -48.41 -20.19 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 32.5 p -74.39 -14.66 60.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.952 . . . . 0.0 109.409 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.624 ' CE1' ' CD2' ' B' ' 42' ' ' PHE . 17.5 m-85 -85.53 -2.3 58.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.364 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.08 -101.9 0.21 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' B' ' 49' ' ' SER . 1.9 p-10 -178.24 111.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -1.115 . . . . 0.0 109.525 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.563 ' N ' HD12 ' B' ' 48' ' ' LEU . 8.6 mp -81.3 28.18 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 108.687 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.421 ' H ' ' C ' ' B' ' 47' ' ' ASP . 12.2 t -43.97 -29.66 0.61 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.733 . . . . 0.0 110.25 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 13.8 p -140.22 146.93 48.09 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.014 -1.054 . . . . 0.0 109.728 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -40.13 -49.65 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.652 2.235 . . . . 0.0 112.293 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -69.47 -27.95 65.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 109.954 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.5 -19.43 37.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.067 -1.021 . . . . 0.0 109.545 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.05 -59.88 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 109.624 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 11.4 mtm -95.96 20.04 10.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.35 -17.23 50.85 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -86.54 149.99 50.18 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.181 -1.188 . . . . 0.0 109.443 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.13 -45.59 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.678 2.252 . . . . 0.0 112.341 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' B' ' 63' ' ' HIS . 50.1 mtpt -54.17 -51.91 62.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -52.67 -42.51 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.54 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -79.13 -25.98 42.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.595 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.55 -59.04 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.644 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.475 ' O ' ' ND1' ' B' ' 63' ' ' HIS . 13.5 t-80 -49.28 -23.94 1.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 109.595 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.68 -28.51 73.08 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -65.97 -32.27 73.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -1.135 . . . . 0.0 109.187 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -70.32 -60.09 2.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 0.0 109.511 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 28.3 t -46.33 -29.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 109.42 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -77.75 -34.86 52.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.287 -0.883 . . . . 0.0 109.369 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.66 -46.66 93.25 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.8 -44.57 82.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -1.175 . . . . 0.0 109.6 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' B' ' 75' ' ' LEU . 4.8 t80 -60.35 -53.52 56.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.457 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.507 ' OG ' ' NE1' ' B' ' 15' ' ' TRP . 62.5 m -51.94 -27.42 13.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' B' ' 84' ' ' THR . 10.5 t0 -49.74 -34.44 19.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.24 -59.85 6.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.497 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.2 mp -59.09 -17.93 30.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.374 -1.074 . . . . 0.0 109.398 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -84.89 -16.61 40.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 79.6 m-70 -160.11 64.23 0.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.915 . . . . 0.0 109.607 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.416 HD22 HG12 ' B' ' 1' ' ' VAL . 93.2 mt -64.74 4.17 0.44 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.399 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' B' ' 77' ' ' HIS . 59.1 m-20 -75.54 -22.93 56.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -0.875 . . . . 0.0 109.404 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -157.31 103.44 1.98 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.88 . . . . 0.0 109.378 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.583 ' N ' HD22 ' B' ' 81' ' ' LEU . 3.6 mm? -80.2 -58.78 2.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.416 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 1.432 ' NZ ' ' HZ1' ' D' ' 82' ' ' LYS . 83.5 mttt -55.25 -24.0 25.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.24 -60.23 7.84 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.0 t -69.43 -46.28 67.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 0.0 109.36 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.552 ' N ' ' CG2' ' B' ' 84' ' ' THR . 46.9 m-85 -70.34 16.81 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.547 -0.721 . . . . 0.0 109.613 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -73.75 -38.97 64.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 11.3 p -80.44 -46.18 16.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.524 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 42.8 mt -56.11 -54.84 40.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.242 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -50.15 -29.8 9.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.221 -0.924 . . . . 0.0 109.007 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.63 -63.01 1.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.116 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 tt -49.65 -23.44 1.72 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 109.078 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' B' ' 88' ' ' LEU . 7.8 m80 -76.17 -54.27 7.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 24.3 t -82.59 -19.42 38.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.003 . . . . 0.0 109.868 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.27 -25.02 25.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.088 -1.008 . . . . 0.0 111.026 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.492 ' CA ' ' NE2' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -125.8 -51.96 1.57 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.843 -1.161 . . . . 0.0 110.796 -179.24 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.599 ' N ' HD12 ' B' ' 96' ' ' LEU . 8.0 mp -70.1 -58.12 4.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.974 -1.079 . . . . 0.0 110.096 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.582 ' CD2' ' N ' ' B' ' 97' ' ' HIS . 1.0 OUTLIER 72.18 19.84 4.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.326 -0.859 . . . . 0.0 109.584 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -57.86 132.11 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.138 -0.976 . . . . 0.0 109.199 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' B' ' 100' ' ' PRO . 0.7 OUTLIER -64.64 152.54 89.6 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.362 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' B' ' 99' ' ' ASP . 74.1 Cg_exo -45.65 -175.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.43 2.087 . . . . 0.0 112.408 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 55.35 76.89 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -173.52 -56.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -58.34 -19.65 36.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -80.15 -44.59 19.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -0.925 . . . . 0.0 109.533 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.3 -48.85 79.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.49 HD23 ' C ' ' B' ' 106' ' ' LEU . 5.2 tt -56.43 -54.43 45.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.357 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.06 -31.74 62.05 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -66.78 -53.49 32.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -1.216 . . . . 0.0 109.684 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.54 -47.53 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.475 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 tp -49.01 -26.75 2.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.86 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.0 t -70.78 -38.83 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.092 -1.005 . . . . 0.0 109.937 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 t -76.79 -22.93 52.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.001 . . . . 0.0 109.932 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' VAL . . . . . 0.5 HG13 ' NH2' ' B' ' 30' ' ' ARG . 97.1 t -68.74 -24.32 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.891 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' B' ' 116' ' ' HIS . 48.7 mt -82.58 -54.33 5.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.103 -0.998 . . . . 0.0 109.678 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.476 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.64 -19.88 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.63 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.49 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.82 -62.87 1.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -0.963 . . . . 0.0 109.427 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -17.81 59.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.438 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -151.41 61.5 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.495 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -70.8 -19.53 76.86 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.54 -30.82 70.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -1.161 . . . . 0.0 109.372 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' B' ' 123' ' ' THR . 30.9 mt-10 -90.48 14.3 13.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.465 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.524 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.4 OUTLIER -70.78 35.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.0 109.596 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.515 ' H ' ' C ' ' B' ' 121' ' ' GLU . 30.4 p -59.79 144.59 85.44 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.161 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.78 ' HA ' HH22 ' A' ' 31' ' ' ARG . 31.7 Cg_exo -44.82 -43.44 14.98 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.464 2.109 . . . . 0.0 113.408 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' B' ' 124' ' ' PRO . 3.0 Cg_exo -75.17 20.19 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.447 2.098 . . . . 0.0 112.175 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.49 HG23 ' OG1' ' B' ' 123' ' ' THR . 79.6 t -125.06 -29.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 109.565 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 127' ' ' GLN . . . . . 0.997 ' HB2' HH21 ' A' ' 31' ' ' ARG . 86.6 mm-40 -83.15 -59.7 2.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.99 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 1.079 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -56.64 -42.66 79.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.425 ' O ' HG23 ' B' ' 133' ' ' VAL . . . -70.06 11.07 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.536 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.599 ' CD2' HG23 ' B' ' 11' ' ' VAL . 4.9 t80 -105.2 -61.31 1.5 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.317 -0.864 . . . . 0.0 109.567 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.605 ' CD ' ' H ' ' B' ' 131' ' ' GLN . 3.8 mp0 -50.02 -38.39 37.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -0.949 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 1.126 ' HD3' ' O ' ' D' ' 146' ' ' HIS . 18.7 ttpp -64.68 -28.58 69.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.771 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 133' ' ' VAL . . . . . 0.697 HG22 HD21 ' B' ' 3' ' ' LEU . 79.4 t -71.45 -67.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.733 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.448 HG22 ' H ' ' B' ' 134' ' ' VAL . 2.4 m -61.3 -24.66 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.74 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -49.25 -29.32 5.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.6 -29.1 56.1 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.418 HG13 ' CE1' ' B' ' 85' ' ' PHE . 67.0 t -72.93 -34.28 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -1.133 . . . . 0.0 109.404 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.71 -48.18 63.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.469 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.48 ' C ' HD22 ' B' ' 139' ' ' ASN . 0.2 OUTLIER -77.76 -29.62 51.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.495 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.25 82.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.409 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.24 13.21 1.96 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.47 4.53 1.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 143' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' B' ' 139' ' ' ASN . 12.3 t-80 -79.39 -26.29 42.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.203 -0.935 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.8 OUTLIER -81.95 -1.38 47.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.521 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -66.07 7.64 0.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 109.27 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 1.256 ' ND1' ' NE2' ' D' ' 2' ' ' HIS . 63.7 m170 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.461 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.522 HD11 ' HD3' ' C' ' 127' ' ' LYS . 9.5 tp -172.41 163.46 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 109.777 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.8 OUTLIER -75.79 -177.06 0.65 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.016 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 58.4 Cg_endo -86.84 -68.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.606 2.204 . . . . 0.0 112.711 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -47.62 -40.31 19.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 109.542 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.597 ' O ' HG23 ' C' ' 10' ' ' VAL . 63.9 m-20 -43.6 -29.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 0.0 109.039 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' C' ' 10' ' ' VAL . 58.4 mttt -83.05 -53.78 5.55 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.414 ' C ' ' O ' ' C' ' 7' ' ' LYS . 35.4 m -44.7 -38.52 4.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.488 -0.757 . . . . 0.0 109.227 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -72.38 -29.7 64.01 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.597 HG23 ' O ' ' C' ' 6' ' ' ASP . 54.2 t -75.13 -55.07 12.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 11' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' C' ' 11' ' ' LYS . 0.1 OUTLIER -51.53 -39.25 57.34 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.649 -1.221 . . . . 0.0 108.229 179.109 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.05 -63.18 1.35 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 109.321 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.559 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.66 -38.64 67.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.388 -0.82 . . . . 0.0 108.836 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.91 -17.64 63.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.469 -0.769 . . . . 0.0 108.988 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.04 -45.09 16.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.425 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 39.2 mmtt -68.15 -41.48 81.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 108.862 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.559 HG23 ' O ' ' C' ' 13' ' ' ALA . 61.4 t -60.16 -64.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 49.93 -127.9 24.86 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.39 24.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.388 -1.066 . . . . 0.0 110.426 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.548 ' H ' ' C ' ' C' ' 18' ' ' GLY . 87.4 m-70 -130.45 28.41 4.94 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -93.2 -61.24 1.61 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.642 -0.661 . . . . 0.0 109.849 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.41 -14.27 0.18 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.6 mt-10 -86.56 -56.27 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -1.056 . . . . 0.0 109.764 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 4.1 m-30 -59.78 -32.44 70.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 0.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.9 -23.02 75.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.89 -41.8 18.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -1.213 . . . . 0.0 109.974 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' C' ' 27' ' ' GLU . 0.1 OUTLIER -66.03 -19.84 65.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.261 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.77 -20.35 60.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.552 HD11 ' ND1' ' C' ' 58' ' ' HIS . 14.1 mt -74.48 -51.23 15.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 109.672 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.59 -22.35 65.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.943 HH21 ' HB2' ' D' ' 127' ' ' GLN . 2.3 tpt180 -73.38 -20.87 60.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 32' ' ' MET . . . . . 0.407 ' HB3' ' HE2' ' C' ' 32' ' ' MET . 46.0 ttp -78.19 -53.76 6.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.333 -0.854 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 33' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 0.0 OUTLIER -48.3 -24.25 1.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.397 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 1.087 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.6 mt -82.27 -46.11 14.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.656 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 45.8 m -69.27 -20.72 63.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.854 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' C' ' 35' ' ' SER . 95.5 m-85 -158.42 79.11 3.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.033 -1.042 . . . . 0.0 109.758 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' C' ' 39' ' ' THR . 51.8 Cg_exo -50.19 -26.43 15.22 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.612 2.208 . . . . 0.0 112.049 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' C' ' 41' ' ' THR . 12.6 p -49.44 -18.33 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.405 ' N ' ' C ' ' C' ' 37' ' ' PRO . 53.9 p -78.91 -22.32 46.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.722 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -46.11 -42.84 14.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.913 . . . . 0.0 109.776 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.502 HG21 ' HD1' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -62.47 -35.74 80.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.459 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -76.74 22.31 0.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.145 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' C' ' 41' ' ' THR . 39.3 m-85 -145.95 59.73 5.84 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.54 -0.7 7.95 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.648 2.232 . . . . 0.0 111.914 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 15.9 p80 -141.82 56.93 1.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.787 . . . . 0.0 109.138 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.667 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -149.76 69.28 1.02 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' C' ' 46' ' ' PHE . 1.1 m-20 -24.35 -37.74 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.925 -0.484 . . . . 0.0 111.183 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.667 ' N ' ' O ' ' C' ' 46' ' ' PHE . 4.3 mt 53.7 7.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.06 -1.025 . . . . 0.0 109.344 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.484 ' H ' ' C ' ' C' ' 47' ' ' ASP . 5.0 m -64.32 5.69 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.601 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 50' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' C' ' 48' ' ' LEU . 38.1 t60 61.42 125.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.311 -0.868 . . . . 0.0 109.501 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.46 14.24 66.32 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 13.5 t -77.81 -103.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -1.159 . . . . 0.0 109.48 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.96 -29.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.439 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -80.04 -17.97 51.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.265 -0.897 . . . . 0.0 109.157 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -84.35 -40.25 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -77.37 -32.37 54.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -0.924 . . . . 0.0 109.082 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.14 -21.8 75.13 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.552 ' ND1' HD11 ' C' ' 29' ' ' LEU . 7.8 t-80 -75.7 -37.46 59.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -1.103 . . . . 0.0 109.721 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.22 -48.49 47.05 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -51.7 -23.15 4.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -1.079 . . . . 0.0 110.063 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -39.83 64.68 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.109 -0.994 . . . . 0.0 109.218 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.29 -33.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.11 -32.95 44.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.378 -0.826 . . . . 0.0 109.462 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -70.33 -33.41 71.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.077 -1.014 . . . . 0.0 108.841 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.563 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -70.03 -53.14 18.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.412 -0.805 . . . . 0.0 108.843 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.29 -38.23 70.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 108.642 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -71.54 -50.28 32.78 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.83 -21.02 60.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.21 -47.37 13.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.424 HG13 ' CE ' ' C' ' 11' ' ' LYS . 10.0 t -65.84 -23.02 31.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.52 -15.21 63.46 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.62 ' O ' ' N ' ' C' ' 74' ' ' ASP . 78.5 m-70 -139.42 -63.17 0.52 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.379 -0.825 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.59 HG22 ' O ' ' C' ' 73' ' ' VAL . 12.3 p 43.97 13.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.813 0.816 . . . . 0.0 109.634 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.62 ' N ' ' O ' ' C' ' 72' ' ' HIS . 16.2 m-20 -134.25 10.39 3.81 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.464 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 20.2 t0 -176.95 28.29 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.037 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 11.4 ptt? -78.87 -22.44 0.38 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 111.745 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 72.7 Cg_exo -49.02 -29.03 14.75 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.569 1.513 . . . . 0.0 112.4 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -94.3 -24.29 17.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.709 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.36 -53.49 8.1 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.179 -0.951 . . . . 0.0 109.191 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 15.0 mt -78.05 9.13 3.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.43 -0.794 . . . . 0.0 109.022 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 81' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' C' ' 84' ' ' SER . 11.1 t -66.1 -41.59 90.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -52.3 -53.01 49.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.486 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' C' ' 83' ' ' LEU . 4.9 mt -44.83 -45.0 9.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 10.0 p -55.85 -39.77 71.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' C' ' 82' ' ' ALA . 25.8 t70 -67.64 -17.9 64.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.566 HD11 HBD1 ' C' ' 142' ' ' HEC . 1.2 tt -82.81 -43.45 16.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.35 -0.844 . . . . 0.0 109.469 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -92.42 -21.23 20.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 109.979 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -60.73 -87.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 110.729 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 89' ' ' HIS . . . . . 0.459 ' O ' ' O ' ' C' ' 90' ' ' LYS . 45.1 t-80 -96.61 -46.21 6.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 111.043 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' C' ' 89' ' ' HIS . 35.9 mttm -41.33 -94.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.145 -0.972 . . . . 0.0 110.346 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.55 -34.95 78.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.017 . . . . 0.0 109.65 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' ARG . . . . . 1.403 ' NH2' ' HE ' ' B' ' 40' ' ' ARG . 45.6 ttp85 60.87 58.19 2.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 109.602 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 t -84.29 161.56 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 109.451 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.38 151.37 50.85 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.957 . . . . 0.0 109.342 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' C' ' 97' ' ' ASN . 58.6 Cg_endo -72.99 -18.86 23.8 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.524 2.149 . . . . 0.0 112.234 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.455 HG21 ' CB ' ' B' ' 99' ' ' ASP . 24.5 t -47.21 -19.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.733 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.493 ' HB3' HMC1 ' C' ' 142' ' ' HEC . 4.1 m-20 -79.12 -24.86 43.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.732 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 98' ' ' PHE . . . . . 0.538 ' CZ ' HD23 ' C' ' 136' ' ' LEU . 4.8 m-85 -46.63 -32.53 3.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 109.686 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.504 ' O ' ' ND1' ' C' ' 103' ' ' HIS . 55.7 mttm -83.94 -36.78 23.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 109.781 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.576 ' N ' HD12 ' C' ' 100' ' ' LEU . 7.2 mp -66.35 -62.02 1.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.491 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 1.554 HD22 ' CBB' ' C' ' 142' ' ' HEC . 6.4 tt -49.94 -47.39 52.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 42.7 t -61.95 -38.76 89.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.634 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' C' ' 99' ' ' LYS . 22.9 m80 -77.4 -27.59 52.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.621 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 70.8 m -64.8 -46.99 79.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.728 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.24 -48.6 65.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.454 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.471 ' N ' HD12 ' C' ' 106' ' ' LEU . 9.5 mp -61.51 -59.22 5.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.94 -34.25 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 16.8 m -75.77 -60.87 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 13.0 mt -46.11 -41.44 12.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 0.0 109.676 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.83 -28.74 0.68 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.153 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.83 -56.35 4.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.132 -0.98 . . . . 0.0 109.722 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -85.83 -65.08 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.472 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 109' ' ' LEU . 0.1 OUTLIER -95.94 106.86 30.72 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.21 171.23 9.38 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.73 1.62 . . . . 0.0 112.352 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -87.28 -34.34 18.94 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.441 0.639 . . . . 0.0 109.87 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' C' ' 117' ' ' PHE . 23.2 mt-10 55.66 9.87 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' C' ' 116' ' ' GLU . 29.2 p90 40.63 32.42 0.15 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.522 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.491 ' OG1' HG23 ' C' ' 121' ' ' VAL . 5.0 p -60.96 145.66 88.75 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.47 29.51 0.13 Allowed 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.957 1.771 . . . . 0.0 111.734 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' C' ' 118' ' ' THR . . . -162.62 -23.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.174 -0.954 . . . . 0.0 111.072 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.491 HG23 ' OG1' ' C' ' 118' ' ' THR . 2.6 t -59.94 -62.55 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.829 -1.17 . . . . 0.0 109.818 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.455 ' N ' HG12 ' C' ' 121' ' ' VAL . 0.1 OUTLIER -60.76 -27.2 67.78 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.426 -0.797 . . . . 0.0 109.087 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.04 32.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.645 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.476 ' N ' ' O ' ' C' ' 120' ' ' ALA . 95.7 p -67.25 -61.94 1.67 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 110.828 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 9.7 mt -80.15 -19.97 45.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.065 -1.022 . . . . 0.0 110.844 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.73 -42.49 28.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.759 -1.213 . . . . 0.0 110.332 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.522 ' HD3' HD11 ' C' ' 2' ' ' LEU . 0.0 OUTLIER -90.15 -44.88 9.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.999 -1.063 . . . . 0.0 110.17 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.424 ' CD1' HG21 ' C' ' 10' ' ' VAL . 71.2 t80 -47.3 -21.53 0.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.029 -1.044 . . . . 0.0 109.564 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.401 ' N ' ' C ' ' C' ' 127' ' ' LYS . 15.8 mt -69.66 -17.67 63.52 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.97 -38.25 78.66 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.448 ' HB3' HD13 ' C' ' 2' ' ' LEU . 60.5 p -78.66 -25.89 44.98 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.31 -0.869 . . . . 0.0 108.756 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -85.05 -40.48 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 2.7 t -68.85 -28.85 67.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.453 -0.779 . . . . 0.0 109.239 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 51.5 m -64.63 -39.99 94.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 109.015 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.402 ' H ' HG12 ' C' ' 135' ' ' VAL . 2.7 p -82.62 -21.9 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.538 HD23 ' CZ ' ' C' ' 98' ' ' PHE . 1.1 tp -78.83 -28.36 44.36 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 137' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' C' ' 138' ' ' SER . 49.8 m -68.15 -23.34 64.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 109.392 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 138' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' C' ' 137' ' ' THR . 0.7 OUTLIER 73.25 110.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -62.87 -98.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' C' ' 141' ' ' ARG . 64.5 m-85 47.3 76.29 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.613 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 141' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' C' ' 140' ' ' TYR . 74.2 mtt-85 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.664 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.745 HG13 ' N ' ' D' ' 2' ' ' HIS . 2.9 p . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 2' ' ' HIS . . . . . 1.256 ' NE2' ' ND1' ' B' ' 146' ' ' HIS . 6.2 p80 -172.91 112.53 0.23 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.895 -1.128 . . . . 0.0 109.756 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.867 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -141.96 -162.64 1.43 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.276 -0.89 . . . . 0.0 109.183 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -93.74 131.04 33.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 109.263 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.45 -23.68 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.329 2.019 . . . . 0.0 112.402 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -81.57 -53.02 6.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.816 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' D' ' 7' ' ' GLU . 5.5 mp0 -61.34 -55.52 30.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.747 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -57.17 -35.42 69.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.806 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -58.71 -23.73 60.15 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 109.992 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.54 -56.61 3.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.978 -1.076 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.594 HG23 ' CD2' ' D' ' 130' ' ' TYR . 0.9 OUTLIER -63.98 -25.13 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 73.6 m -78.66 -35.24 45.55 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 13' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -60.5 -61.41 2.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.252 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.512 ' O ' HG23 ' D' ' 18' ' ' VAL . 8.0 mp -43.73 -18.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 109.759 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 15' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' D' ' 13' ' ' ALA . 22.1 t-105 -78.03 -18.04 56.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.148 -0.97 . . . . 0.0 109.646 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.97 -42.72 7.49 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.665 ' H ' ' CD ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -68.66 -31.97 71.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -1.12 . . . . 0.0 109.2 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.512 HG23 ' O ' ' D' ' 14' ' ' LEU . 4.7 t -52.4 119.89 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.655 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' D' ' 21' ' ' ASP . 55.8 m-20 -86.99 82.85 7.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 108.98 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' D' ' 22' ' ' GLU . 91.6 t -43.99 -20.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 109.789 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' D' ' 19' ' ' ASN . 12.7 m-20 -51.62 -8.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.802 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' D' ' 20' ' ' VAL . 34.8 mt-10 -155.48 -49.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 109.629 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 74.1 t -46.11 -26.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.788 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.05 -31.18 32.53 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -82.56 -25.65 49.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -84.67 -29.99 25.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -1.144 . . . . 0.0 109.682 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.47 -23.49 63.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.812 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.68 -58.25 3.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.477 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.21 -29.27 68.25 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 30' ' ' ARG . . . . . 0.498 ' NH2' HG13 ' D' ' 113' ' ' VAL . 3.3 ttp180 -68.43 -29.43 68.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.681 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 31' ' ' LEU . . . . . 0.616 ' CD2' HBC2 ' B' ' 147' ' ' HEC . 35.7 tp -51.61 -39.75 58.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.635 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 32' ' ' LEU . . . . . 1.195 ' O ' HMB1 ' D' ' 147' ' ' HEC . 16.8 mt -78.04 -21.88 50.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.878 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.85 -47.93 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.869 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -63.35 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 0.0 109.788 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -119.42 97.01 50.16 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 0.0 109.814 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' D' ' 38' ' ' THR . 90.9 Cg_endo -85.57 10.56 3.65 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.659 2.239 . . . . 0.0 111.906 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -45.24 -19.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 0.0 109.732 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.645 ' C ' ' H ' ' D' ' 40' ' ' ARG . 10.9 p -46.95 -34.37 5.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 109.637 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 61.09 -13.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.38 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' ARG . . . . . 1.393 ' HE ' ' NH2' ' A' ' 92' ' ' ARG . 79.9 mtt180 -89.01 -25.55 21.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 108.971 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.602 ' HE1' ' NB ' ' D' ' 147' ' ' HEC . 3.4 m-85 53.68 6.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 109.429 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.851 ' HZ ' ' HHD' ' B' ' 147' ' ' HEC . 3.0 m-85 48.03 30.14 1.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.174 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -48.34 -20.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 109.72 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 33.1 p -74.46 -14.66 60.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.973 . . . . 0.0 109.392 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.613 ' CE1' ' CD2' ' D' ' 42' ' ' PHE . 17.4 m-85 -85.42 -2.38 58.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.08 -101.88 0.21 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' D' ' 49' ' ' SER . 1.9 p-10 -178.2 111.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.509 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' D' ' 48' ' ' LEU . 8.6 mp -81.27 28.1 0.39 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 108.753 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.414 ' H ' ' C ' ' D' ' 47' ' ' ASP . 12.0 t -43.86 -29.72 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.638 -0.664 . . . . 0.0 110.3 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 14.0 p -140.16 146.9 48.14 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.089 -1.007 . . . . 0.0 109.693 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -40.14 -49.61 3.71 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.676 2.251 . . . . 0.0 112.255 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -69.5 -27.98 65.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.91 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.48 -19.4 36.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.605 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.06 -59.97 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.584 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 11.4 mtm -95.87 20.14 10.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 109.458 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.44 -17.24 50.48 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -86.59 150.0 50.08 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.229 -1.159 . . . . 0.0 109.395 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.18 -45.58 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.579 2.186 . . . . 0.0 112.236 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' D' ' 63' ' ' HIS . 50.1 mtpt -54.12 -51.96 62.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 59.9 t -52.64 -42.55 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -79.0 -26.13 43.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.569 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.45 -59.07 2.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.657 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.67 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 13.5 t-80 -49.37 -23.88 1.66 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.558 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.74 -28.51 73.06 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -65.92 -32.3 73.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -1.172 . . . . 0.0 109.21 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 66' ' ' LYS . . . . . 0.671 ' HB3' HBA2 ' B' ' 147' ' ' HEC . 45.9 mmtt -70.29 -60.11 2.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.9 HG13 ' C2B' ' B' ' 147' ' ' HEC . 27.6 t -46.41 -29.68 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.375 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -77.71 -34.88 52.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.372 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.68 -46.69 93.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.57 81.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.59 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 71' ' ' PHE . . . . . 0.418 ' CZ ' HD11 ' D' ' 75' ' ' LEU . 4.7 t80 -60.43 -53.51 56.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -0.887 . . . . 0.0 109.375 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 72' ' ' SER . . . . . 0.522 ' HG ' ' HE1' ' D' ' 15' ' ' TRP . 63.2 m -51.96 -27.41 13.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.455 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 73' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' D' ' 84' ' ' THR . 10.6 t0 -49.71 -34.49 18.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.95 . . . . 0.0 109.391 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.26 -59.91 6.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.493 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.2 mp -59.03 -17.97 30.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -1.151 . . . . 0.0 109.427 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 76' ' ' ALA . . . . . 0.53 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -84.9 -16.61 40.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 79.8 m-70 -160.1 64.16 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 78' ' ' LEU . . . . . 0.438 HD22 HG12 ' D' ' 1' ' ' VAL . 93.1 mt -64.74 4.19 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.414 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' D' ' 77' ' ' HIS . 59.5 m-20 -75.41 -22.98 56.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.92 . . . . 0.0 109.421 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -157.3 103.47 1.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.354 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 81' ' ' LEU . . . . . 0.592 ' N ' HD22 ' D' ' 81' ' ' LEU . 3.6 mm? -80.23 -58.79 2.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.945 . . . . 0.0 109.427 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 82' ' ' LYS . . . . . 1.432 ' HZ1' ' NZ ' ' B' ' 82' ' ' LYS . 83.5 mttt -55.3 -23.9 25.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.577 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.23 -60.26 7.8 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.0 t -69.44 -46.23 67.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.151 -1.205 . . . . 0.0 109.378 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.555 ' N ' ' CG2' ' D' ' 84' ' ' THR . 46.8 m-85 -70.35 16.85 0.07 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.523 -0.736 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 86' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -73.85 -38.8 64.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.453 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 11.0 p -80.62 -46.14 16.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.414 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.515 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 42.3 mt -56.07 -54.86 39.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 109.287 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -50.19 -29.73 9.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.944 . . . . 0.0 109.037 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' D' ' 94' ' ' ASP . 42.4 tt0 -82.6 -63.03 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.128 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 tt -49.73 -23.42 1.78 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 109.046 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' D' ' 88' ' ' LEU . 7.9 m80 -76.13 -54.33 6.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.181 -0.949 . . . . 0.0 109.486 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 24.1 t -82.57 -19.42 38.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.161 -0.962 . . . . 0.0 109.916 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' D' ' 90' ' ' GLU . 1.4 m-20 -86.23 -24.96 25.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.082 -1.011 . . . . 0.0 111.086 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 95' ' ' LYS . . . . . 0.487 ' CA ' ' NE2' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -125.83 -52.04 1.57 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.829 -1.169 . . . . 0.0 110.725 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.606 HD12 ' N ' ' D' ' 96' ' ' LEU . 8.0 mp -70.16 -58.1 4.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.894 -1.129 . . . . 0.0 110.053 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.583 ' HD1' HG21 ' A' ' 41' ' ' THR . 1.0 OUTLIER 72.12 19.88 4.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.583 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.69 132.07 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.101 -0.999 . . . . 0.0 109.221 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 99' ' ' ASP . . . . . 0.511 ' CB ' HG21 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -64.6 152.6 89.31 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 109.309 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 100' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' D' ' 99' ' ' ASP . 74.3 Cg_exo -45.72 -175.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.504 2.136 . . . . 0.0 112.402 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 55.4 76.82 0.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -173.56 -56.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.859 . . . . 0.0 109.372 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -58.42 -19.55 37.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.0 109.515 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -80.23 -44.45 19.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.39 -48.88 79.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.382 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 1.352 ' CD1' ' CHC' ' B' ' 147' ' ' HEC . 5.2 tt -56.41 -54.5 44.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.298 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.04 -31.7 61.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -66.82 -53.47 32.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -1.194 . . . . 0.0 109.686 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 79.3 t -49.44 -47.5 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tp -49.13 -26.66 2.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 109.823 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.77 -38.82 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.09 -1.006 . . . . 0.0 109.998 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 22.8 t -76.77 -22.99 52.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.898 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 113' ' ' VAL . . . . . 0.498 HG13 ' NH2' ' D' ' 30' ' ' ARG . 97.5 t -68.7 -24.34 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.948 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 114' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' D' ' 116' ' ' HIS . 48.6 mt -82.58 -54.4 5.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.14 -0.975 . . . . 0.0 109.668 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.487 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.62 -19.94 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 109.647 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.465 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.71 -62.89 1.44 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.429 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -17.78 59.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.865 . . . . 0.0 109.436 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -151.38 61.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -70.82 -19.49 76.86 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.58 -30.74 70.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -1.165 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' D' ' 123' ' ' THR . 30.9 mt-10 -90.57 14.36 13.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.527 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.4 OUTLIER -70.77 35.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.498 ' H ' ' C ' ' D' ' 121' ' ' GLU . 30.4 p -59.75 144.64 85.16 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.158 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.766 ' HA ' HH22 ' C' ' 31' ' ' ARG . 31.5 Cg_exo -44.85 -43.39 15.09 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.439 2.093 . . . . 0.0 113.517 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' D' ' 124' ' ' PRO . 3.1 Cg_exo -75.16 20.12 0.48 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.437 2.091 . . . . 0.0 112.174 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.481 HG23 ' OG1' ' D' ' 123' ' ' THR . 79.5 t -125.02 -29.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.341 -0.85 . . . . 0.0 109.602 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 127' ' ' GLN . . . . . 0.943 ' HB2' HH21 ' C' ' 31' ' ' ARG . 86.5 mm-40 -83.17 -59.78 2.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.446 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 1.087 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -56.68 -42.57 79.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.964 . . . . 0.0 109.363 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.434 ' O ' HG23 ' D' ' 133' ' ' VAL . . . -70.05 11.05 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.526 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.594 ' CD2' HG23 ' D' ' 11' ' ' VAL . 4.9 t80 -105.22 -61.3 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 0.606 ' CD ' ' H ' ' D' ' 131' ' ' GLN . 3.8 mp0 -50.05 -38.45 37.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 109.388 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 132' ' ' LYS . . . . . 1.096 ' HD3' ' O ' ' B' ' 146' ' ' HIS . 18.7 ttpp -64.54 -28.61 69.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.77 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 133' ' ' VAL . . . . . 0.684 HG22 HD21 ' D' ' 3' ' ' LEU . 79.3 t -71.49 -67.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.708 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.48 ' H ' HG22 ' D' ' 134' ' ' VAL . 2.4 m -61.23 -24.58 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.807 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -49.34 -29.29 5.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 0.0 109.287 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.63 -29.08 56.08 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 137' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' D' ' 85' ' ' PHE . 66.1 t -72.9 -34.15 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -1.116 . . . . 0.0 109.514 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.81 -48.13 64.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.506 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' D' ' 143' ' ' HIS . 29.9 t-20 -77.75 -29.55 51.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.589 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.14 83.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.411 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 30.9 mt -79.24 13.14 1.99 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.362 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.47 4.56 1.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.631 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 143' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' D' ' 139' ' ' ASN . 12.3 t-80 -79.34 -26.26 42.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.167 -0.958 . . . . 0.0 109.459 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.8 OUTLIER -82.04 -1.4 48.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.479 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -65.91 7.6 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 1.199 ' ND1' ' NE2' ' B' ' 2' ' ' HIS . 63.8 m170 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.472 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 1.567 ' CBB' HD22 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 1.352 ' CHC' ' CD1' ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 1.554 ' CBB' HD22 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 1.195 HMB1 ' O ' ' D' ' 32' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.485 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 36.4 mt -121.29 -171.74 2.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.829 . . . . 0.0 109.561 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -97.75 -179.08 0.81 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 109.296 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 26.0 Cg_exo -60.87 -68.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.605 2.203 . . . . 0.0 112.291 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -52.39 -36.12 53.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.797 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 3.3 m-20 -44.18 -33.7 1.62 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -83.41 -60.12 2.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.621 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.8 m -46.97 -29.74 2.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.419 -0.8 . . . . 0.0 109.979 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -77.33 -36.83 53.51 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.024 -1.048 . . . . 0.0 108.279 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -76.14 -47.97 29.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -53.17 -38.54 62.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.52 -62.99 1.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.411 -0.806 . . . . 0.0 109.357 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.27 67.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.421 -0.799 . . . . 0.0 109.204 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.451 ' HZ3' HD11 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -72.9 -17.31 61.52 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 108.967 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.59 -40.07 59.76 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -84.75 -49.79 8.16 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.503 -0.998 . . . . 0.0 109.327 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 20' ' ' HIS . 70.4 t -59.96 -35.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.56 -0.712 . . . . 0.0 109.675 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.586 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . -31.53 144.8 0.02 OUTLIER Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . 69.12 -32.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -1.07 . . . . 0.0 108.896 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.586 ' H ' ' C ' ' A' ' 18' ' ' GLY . 1.2 m80 -104.88 13.94 30.34 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' A' ' 17' ' ' VAL . . . -83.55 -48.69 9.99 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.939 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.46 -14.62 42.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -89.1 -56.62 3.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -1.095 . . . . 0.0 109.702 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.639 ' CZ ' ' CE1' ' A' ' 112' ' ' HIS . 2.9 m-30 -58.98 -33.14 70.34 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 109.176 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.82 -33.06 76.49 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.04 -50.8 10.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -1.174 . . . . 0.0 109.721 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -52.4 -19.8 2.4 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.55 -25.54 65.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.506 HD11 ' CG ' ' A' ' 58' ' ' HIS . 33.5 mt -72.27 -58.02 3.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.671 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.71 -14.29 30.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.524 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.052 ' NH1' ' CG ' ' B' ' 127' ' ' GLN . 1.8 tpm_? -75.45 -38.98 59.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 109.357 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.512 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -80.02 -48.5 13.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.218 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 32' ' ' MET . 37.1 t80 -43.72 -19.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.396 -0.815 . . . . 0.0 109.831 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.815 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 11.0 mt -79.88 -60.2 2.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.136 -0.978 . . . . 0.0 109.701 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.854 ' OG ' ' NE2' ' B' ' 131' ' ' GLN . 29.6 m -81.39 -31.37 33.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 109.676 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 60.3 m-85 -113.63 95.04 35.22 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.411 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.12 -20.1 8.9 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.447 2.098 . . . . 0.0 112.228 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.693 ' O ' HG22 ' A' ' 41' ' ' THR . 71.1 p -47.64 -42.1 23.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 109.274 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 39' ' ' THR . 12.6 p -44.03 -22.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.83 . . . . 0.0 109.854 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' THR . 30.6 ttpt -70.87 -19.11 62.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.638 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 1.137 HG21 ' CD2' ' D' ' 97' ' ' HIS . 8.7 t -80.37 -20.63 43.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.542 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -85.0 -14.78 46.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 53.4 83.1 0.23 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.674 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 46.0 Cg_exo -52.0 -41.23 65.16 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.582 2.188 . . . . 0.0 111.874 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.674 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 96.15 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 178.189 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.499 ' CZ ' ' CB ' ' A' ' 44' ' ' PRO . 2.1 p90 -142.54 44.91 1.62 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.532 -1.355 . . . . 0.0 110.11 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.12 -35.32 0.3 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 110.453 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER 61.86 55.85 2.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.043 . . . . 0.0 109.0 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.1 m -165.39 157.06 14.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 0.0 109.541 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.464 ' C ' ' H ' ' A' ' 52' ' ' SER . 2.7 m-70 -59.6 160.94 6.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.877 . . . . 0.0 109.385 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.73 -18.14 1.92 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 54' ' ' GLN . 29.5 p -48.78 -25.94 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -1.145 . . . . 0.0 109.322 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.05 -40.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.835 . . . . 0.0 109.688 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.52 ' H ' ' C ' ' A' ' 52' ' ' SER . 20.5 mt-30 -69.76 -23.73 63.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.304 -0.873 . . . . 0.0 109.304 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.432 HG23 ' OG ' ' A' ' 52' ' ' SER . 57.6 t -69.61 -40.57 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.97 . . . . 0.0 109.129 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -65.73 -54.38 28.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.241 -0.912 . . . . 0.0 108.62 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.19 -36.09 21.1 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.506 ' CG ' HD11 ' A' ' 29' ' ' LEU . 6.1 t-80 -60.5 -36.57 78.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.315 . . . . 0.0 109.895 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.42 -29.28 38.27 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 56.8 mttm -65.18 -23.57 67.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -1.162 . . . . 0.0 110.263 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.527 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 0.5 OUTLIER -69.16 -58.13 4.47 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.962 -1.086 . . . . 0.0 108.656 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.3 t -56.46 -44.76 81.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.655 -0.653 . . . . 0.0 109.315 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.51 74.46 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.298 -0.876 . . . . 0.0 109.225 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.9 t70 -66.03 -37.98 87.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.798 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -67.56 -53.33 29.22 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.1 mt -58.53 -42.34 87.54 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 71' ' ' ALA . 15.5 m -69.68 -51.58 33.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.273 -0.892 . . . . 0.0 108.696 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -62.23 -25.97 68.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.08 -46.38 11.21 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 66' ' ' LEU . 38.1 t -66.7 -22.75 30.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -69.51 -36.37 76.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.589 ' O ' ' N ' ' A' ' 74' ' ' ASP . 26.1 m80 -103.29 -66.74 0.92 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.615 -0.678 . . . . 0.0 109.424 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 73' ' ' VAL . 14.9 p 44.37 14.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.953 0.882 . . . . 0.0 109.287 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 72' ' ' HIS . 5.5 m-20 -137.96 12.02 2.87 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 0.2 OUTLIER 171.72 31.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 3.5 ptt? -78.29 -23.67 0.42 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.334 -0.854 . . . . 0.0 111.842 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.8 Cg_exo -53.58 -19.46 13.94 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.665 1.576 . . . . 0.0 112.477 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -94.19 -40.43 10.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.68 -48.9 67.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.918 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.61 6.04 6.53 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.446 -0.784 . . . . 0.0 109.198 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.1 t -54.53 -19.56 6.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 109.614 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -83.12 -58.53 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 109.916 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.604 HD22 HBA1 ' A' ' 142' ' ' HEC . 3.8 mt -45.34 -44.58 11.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -0.847 . . . . 0.0 109.082 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.407 ' CB ' ' HG ' ' A' ' 138' ' ' SER . 23.3 t -60.06 -18.93 50.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.519 -0.738 . . . . 0.0 109.56 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 89' ' ' HIS . 36.8 t70 -81.06 -50.94 9.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.913 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.457 ' CD1' HBD2 ' A' ' 142' ' ' HEC . 4.6 tt -64.16 -26.79 68.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.97 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.74 -21.78 26.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 110.328 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.56 -11.03 11.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 0.0 110.154 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.564 ' N ' ' O ' ' A' ' 85' ' ' ASP . 42.7 t60 -106.64 -74.6 0.65 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 109.919 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' ARG . 79.8 mttt -63.84 -110.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.058 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 mt -44.48 -17.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.017 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.455 ' CG ' ' NH2' ' D' ' 40' ' ' ARG . 31.8 ttm-85 46.75 41.56 10.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.142 -0.974 . . . . 0.0 109.481 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.9 t -45.94 144.8 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.867 . . . . 0.0 109.701 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 10.6 m-20 -80.52 150.2 69.77 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.65 -19.48 21.34 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.437 2.091 . . . . 0.0 112.229 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 96' ' ' VAL . 4.1 t -66.35 -7.75 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.666 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 94' ' ' ASP . 12.7 m120 -79.74 -36.26 37.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.478 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -46.33 -41.58 13.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.879 -1.138 . . . . 0.0 109.536 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.49 ' NZ ' ' CB ' ' A' ' 99' ' ' LYS . 8.0 mtmp? -51.38 -28.24 12.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.963 . . . . 0.0 109.291 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.577 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 15.4 mt -84.29 -61.95 1.68 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.682 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.796 HD22 ' CHC' ' A' ' 142' ' ' HEC . 5.4 tp -49.78 -23.62 1.93 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.878 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -73.38 -49.45 27.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -80.62 -26.37 37.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 0.0 109.923 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 65.7 m -65.06 -60.29 3.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.158 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.722 HD12 ' C ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -57.45 -22.44 43.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 109.825 -179.401 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.18 -31.42 38.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.802 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.46 HG11 ' OE1' ' B' ' 127' ' ' GLN . 56.1 t -83.38 -24.94 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 110.051 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 1.5 t -79.68 -47.72 14.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.0 109.959 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.737 ' O ' HD12 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -69.72 -18.59 63.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.752 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.92 -22.22 46.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 110.257 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.4 -56.24 24.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 110.182 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.681 ' CG ' ' H ' ' A' ' 113' ' ' LEU . 9.4 p80 -72.48 -61.93 1.63 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.098 -1.001 . . . . 0.0 109.469 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.929 HD23 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -119.73 121.43 29.84 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.215 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.3 175.7 7.38 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.422 2.081 . . . . 0.0 112.99 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.654 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -45.36 -54.96 6.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.632 -0.668 . . . . 0.0 109.346 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.654 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 26.1 mt-10 122.9 -2.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.468 ' CG ' ' C ' ' A' ' 116' ' ' GLU . 1.8 m-85 72.22 32.88 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.714 -0.616 . . . . 0.0 111.278 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.772 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.3 p -97.59 121.27 58.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.895 -1.128 . . . . 0.0 108.16 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.62 24.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.934 1.756 . . . . 0.0 112.502 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -150.38 -32.41 0.18 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.981 -1.074 . . . . 0.0 110.401 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 122' ' ' HIS . 12.0 p -53.92 -50.04 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.04 -1.037 . . . . 0.0 110.329 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.671 ' N ' HG13 ' A' ' 121' ' ' VAL . 17.9 m80 -54.84 -44.98 74.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.36 -20.05 32.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 110.375 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 120' ' ' ALA . 94.0 p -52.19 -52.97 48.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.945 . . . . 0.0 110.545 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.451 HD11 ' HZ3' ' A' ' 14' ' ' TRP . 5.5 mt -84.11 -19.34 34.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.0 109.975 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.71 -51.83 9.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.296 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.449 ' HZ2' ' HG2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.63 -43.06 27.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.978 -1.076 . . . . 0.0 110.151 -179.17 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.485 ' CD2' ' CD1' ' A' ' 2' ' ' LEU . 33.9 t80 -50.59 -21.39 1.52 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.858 -1.151 . . . . 0.0 108.929 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.709 ' CD2' HBB1 ' A' ' 142' ' ' HEC . 17.4 mt -73.78 -18.26 60.99 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -60.14 -35.48 75.37 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 135' ' ' VAL . 97.5 p -80.78 -27.02 36.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -84.73 -30.13 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 129' ' ' LEU . 51.6 m -79.17 -40.83 29.89 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 53.2 m -69.3 -26.4 64.71 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 131' ' ' SER . 23.4 t -81.49 -30.28 10.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.09 -23.34 62.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.365 -0.834 . . . . 0.0 109.052 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 138' ' ' SER . 37.8 p -87.29 -18.39 30.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 0.0 109.568 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' THR . 21.6 m 51.65 98.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.449 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -62.03 -160.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.947 . . . . 0.0 109.58 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -76.8 -44.91 30.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.452 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.835 HG13 ' H ' ' B' ' 2' ' ' HIS . 13.1 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 0.835 ' H ' HG13 ' B' ' 1' ' ' VAL . 82.0 t60 47.76 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.009 -1.057 . . . . 0.0 109.767 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.858 ' N ' HD12 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -135.99 179.64 6.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 0.0 109.006 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 7' ' ' GLU . 7.3 p -76.15 132.55 73.4 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.104 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -41.28 -24.71 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.343 2.029 . . . . 0.0 112.457 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.2 -21.76 25.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.876 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' B' ' 4' ' ' THR . 32.2 tt0 -80.45 -63.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.959 . . . . 0.0 109.932 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.604 ' HB3' HD13 ' B' ' 3' ' ' LEU . 24.2 pttt -62.25 -31.69 72.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 110.051 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.2 t -44.57 -23.35 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.0 110.406 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -81.59 -57.35 3.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.945 -1.097 . . . . 0.0 110.102 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.442 HG23 ' CE2' ' B' ' 130' ' ' TYR . 14.9 p -68.74 -24.62 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.094 -1.003 . . . . 0.0 108.318 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 12.5 m -71.95 -42.07 67.01 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.339 0.59 . . . . 0.0 109.88 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.75 -30.46 69.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.344 -0.848 . . . . 0.0 109.802 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -50.28 -18.83 0.67 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.97 . . . . 0.0 109.349 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' TRP . . . . . 0.409 ' CZ2' HD13 ' B' ' 75' ' ' LEU . 0.7 OUTLIER -53.08 -51.48 61.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.15 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.09 -32.41 35.32 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -46.7 13.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -1.084 . . . . 0.0 109.177 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.99 114.85 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.732 . . . . 0.0 109.853 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' B' ' 21' ' ' ASP . 19.1 m120 -79.41 71.58 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 108.748 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 20' ' ' VAL . 57.8 t -46.98 -11.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.851 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' B' ' 19' ' ' ASN . 16.5 m-20 -73.45 -5.5 40.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 109.821 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -156.26 -40.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.119 -0.988 . . . . 0.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 78.0 t -46.5 -55.42 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.883 . . . . 0.0 109.64 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.76 -29.83 50.71 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.51 -30.05 69.27 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.92 -31.41 59.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.221 -1.164 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.17 -54.28 48.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.542 ' N ' HD22 ' B' ' 28' ' ' LEU . 3.8 mm? -61.87 -40.1 94.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.273 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.92 -42.91 76.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -72.69 -37.08 67.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -1.122 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 tp -50.07 -31.7 13.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.265 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.28 -22.47 38.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.04 -64.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.627 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.466 HG23 ' H ' ' B' ' 34' ' ' VAL . 0.2 OUTLIER -64.14 -22.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.422 -0.799 . . . . 0.0 109.663 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -140.25 79.17 21.94 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 109.559 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -83.48 -12.45 8.99 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.888 2.392 . . . . 0.0 112.369 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.53 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 3.4 p-90 -48.57 -33.99 10.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.523 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.53 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 3.2 m -78.95 2.65 19.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLN . . . . . 0.444 ' O ' ' OE1' ' B' ' 39' ' ' GLN . 1.4 tm0? -65.53 -19.08 65.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.45 ' HE ' ' HD3' ' C' ' 92' ' ' ARG . 32.9 mtp85 -68.59 -40.84 80.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.751 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -93.04 -18.96 22.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.956 . . . . 0.0 109.749 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.555 ' CE1' ' CE1' ' B' ' 45' ' ' PHE . 1.3 t80 -89.87 28.71 1.3 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -84.48 -13.97 50.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.614 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -80.2 -7.51 59.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.619 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.651 ' HZ ' ' CMD' ' B' ' 147' ' ' HEC . 33.7 m-85 -83.65 -3.53 57.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.511 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.99 -172.77 25.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' B' ' 47' ' ' ASP . 2.0 p-10 -84.79 98.37 10.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -1.153 . . . . 0.0 109.42 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.717 ' N ' HD12 ' B' ' 48' ' ' LEU . 7.2 mp -88.0 30.8 0.82 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 108.972 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -45.05 -30.87 1.15 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 109.934 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -142.37 138.15 16.24 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -41.28 -28.4 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.406 2.071 . . . . 0.0 112.279 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.95 -39.79 49.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.93 -19.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.86 . . . . 0.0 109.603 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.1 -63.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.651 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -51.39 -20.0 1.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 109.741 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.07 -31.63 38.31 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 39.9 m-20 -63.16 132.83 95.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -1.191 . . . . 0.0 109.357 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.31 -50.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.46 2.107 . . . . 0.0 112.551 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.04 -34.98 72.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.987 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -55.23 -49.88 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.033 -1.042 . . . . 0.0 109.217 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.464 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 26.2 mtmt -73.63 -29.33 62.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.289 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.92 -46.34 68.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 1.23 ' NE2' ' CHA' ' B' ' 147' ' ' HEC . 2.5 t60 -54.34 -25.28 23.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.553 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -32.35 83.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 0.4 OUTLIER -62.75 -36.91 84.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -1.198 . . . . 0.0 109.308 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -75.74 -35.05 60.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.354 -0.841 . . . . 0.0 109.417 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 0.698 HG22 ' CHB' ' B' ' 147' ' ' HEC . 47.8 t -69.03 -63.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.334 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.545 HD23 ' O ' ' B' ' 68' ' ' LEU . 1.8 tt -53.61 -32.94 53.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 108.91 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.83 -57.1 20.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.32 79.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -1.137 . . . . 0.0 109.447 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -67.2 -35.09 78.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.484 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.402 ' HB2' ' HE1' ' B' ' 15' ' ' TRP . 61.7 p -73.82 -35.69 64.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.409 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.49 -21.29 0.53 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.347 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.17 -60.08 4.66 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.642 ' H ' HD12 ' B' ' 75' ' ' LEU . 5.1 mp -53.47 -28.9 33.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -1.133 . . . . 0.0 109.254 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.75 3.49 41.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' B' ' 79' ' ' ASP . 23.5 t-80 -170.43 61.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.632 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.667 HD22 HG21 ' B' ' 1' ' ' VAL . 59.1 mt -73.72 15.16 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 109.327 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' B' ' 77' ' ' HIS . 16.8 t70 -76.43 -36.05 58.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.873 . . . . 0.0 109.513 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -161.55 100.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.377 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 33.7 mt -79.31 -50.19 11.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.362 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.447 ' HZ2' ' CG ' ' B' ' 143' ' ' HIS . 24.6 mmtp -48.41 -23.95 1.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.11 -63.31 3.69 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.3 t -63.9 -48.07 78.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -1.13 . . . . 0.0 109.493 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.555 ' N ' ' CG2' ' B' ' 84' ' ' THR . 46.9 m-85 -63.64 -8.5 10.21 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.538 -0.726 . . . . 0.0 109.348 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.32 -34.75 34.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 109.366 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 28.4 p -83.99 -50.99 7.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.09 -55.54 31.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.174 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' SER . . . . . 0.487 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 1.5 m -51.51 -39.02 56.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.365 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' B' ' 94' ' ' ASP . 29.0 tt0 -74.25 -54.58 7.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 tt -62.46 -29.36 70.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.718 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' B' ' 97' ' ' HIS . 1.3 m80 -79.32 -48.41 14.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 110.001 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' B' ' 89' ' ' SER . 6.5 m -82.91 -31.08 27.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.032 . . . . 0.0 110.386 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' B' ' 90' ' ' GLU . 6.4 t70 -86.75 -43.47 12.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.084 -1.01 . . . . 0.0 110.937 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -52.33 5.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 110.733 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.648 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 4.1 mm? -82.85 -43.49 16.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.868 -1.145 . . . . 0.0 109.528 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 1.1 ' CD2' HG21 ' C' ' 41' ' ' THR . 0.0 OUTLIER 74.85 19.77 2.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 109.637 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' B' ' 97' ' ' HIS . 8.8 t -45.18 122.1 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 109.449 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 0.509 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 15.4 m-20 -69.05 151.34 97.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' B' ' 99' ' ' ASP . 74.5 Cg_exo -42.84 178.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.626 2.217 . . . . 0.0 112.369 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 57.58 64.75 1.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.839 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' B' ' 99' ' ' ASP . 73.2 m-20 -161.92 -52.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -0.86 . . . . 0.0 109.308 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.697 ' HA ' HBB2 ' B' ' 147' ' ' HEC . 4.2 p90 -67.01 -26.01 66.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 39.5 ttt-85 -78.61 -25.7 45.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.515 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.89 -45.65 49.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.641 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.964 HD13 ' C3B' ' B' ' 147' ' ' HEC . 4.6 tt -49.48 -45.99 47.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.415 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.42 -48.82 64.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 30.1 m120 -50.25 -44.27 53.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -1.153 . . . . 0.0 109.737 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.95 -35.4 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.748 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tp -63.35 -38.8 92.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 109.669 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 66.3 t -51.34 -30.52 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.95 . . . . 0.0 109.693 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.26 -59.26 2.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.621 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 t -46.14 -28.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.816 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.452 HD13 ' OH ' ' B' ' 130' ' ' TYR . 16.8 mt -82.51 -53.23 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.593 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.464 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -65.31 -19.44 65.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.696 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -62.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 109.655 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -77.16 -48.36 17.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.892 . . . . 0.0 109.803 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.8 30.13 1.64 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.714 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -54.94 -27.82 46.04 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -64.55 7.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -1.111 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' B' ' 119' ' ' GLY . 61.1 mm-40 -133.12 6.82 3.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.41 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.556 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.3 34.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.491 ' H ' ' C ' ' B' ' 121' ' ' GLU . 2.9 p -45.02 148.99 0.91 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.463 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.515 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.4 Cg_exo -44.33 -54.07 4.3 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.449 2.099 . . . . 0.0 112.769 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 21.1 Cg_endo -61.37 -48.16 10.28 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.057 1.838 . . . . 0.0 111.975 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.435 ' O ' HG12 ' B' ' 126' ' ' VAL . 73.9 t -55.6 -13.03 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' GLN . . . . . 1.052 ' CG ' ' NH1' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -82.45 -59.94 2.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.606 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.815 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -66.46 -26.53 67.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.928 . . . . 0.0 109.504 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.76 26.38 0.83 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.499 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.452 ' OH ' HD13 ' B' ' 114' ' ' LEU . 0.1 OUTLIER -123.46 -61.25 1.42 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.382 -0.824 . . . . 0.0 109.368 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.854 ' NE2' ' OG ' ' A' ' 35' ' ' SER . 4.0 mp0 -53.62 -36.36 61.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.632 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -69.44 -25.11 63.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 109.567 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 63.6 t -77.35 -43.59 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.512 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.65 -17.05 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.628 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.39 -28.93 70.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.31 -36.57 59.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.501 HG13 ' CZ ' ' B' ' 85' ' ' PHE . 77.5 t -75.17 -36.49 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -1.092 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.25 -38.92 55.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.915 . . . . 0.0 109.468 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' B' ' 143' ' ' HIS . 9.9 m120 -85.18 -21.31 29.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.731 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.62 -55.52 33.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.114 -0.991 . . . . 0.0 109.478 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 41.5 mt -61.64 -24.68 66.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' B' ' 145' ' ' TYR . . . -100.27 1.71 41.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.403 -0.811 . . . . 0.0 109.412 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 139' ' ' ASN . 71.2 t60 -80.8 -1.78 44.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.0 109.466 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' B' ' 146' ' ' HIS . 5.4 tppt? -120.73 -31.9 4.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.822 . . . . 0.0 109.889 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' B' ' 142' ' ' ALA . 0.1 OUTLIER -49.29 -10.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 109.933 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' B' ' 144' ' ' LYS . 4.9 m-70 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.662 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.482 ' CD1' ' CD2' ' C' ' 128' ' ' PHE . 36.5 mt -121.2 -171.78 2.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.376 -0.827 . . . . 0.0 109.605 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.47 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.8 OUTLIER -97.75 -178.97 0.79 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.409 -0.807 . . . . 0.0 109.277 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 26.0 Cg_exo -60.97 -68.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.51 2.14 . . . . 0.0 112.329 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -52.33 -36.17 52.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.794 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.477 ' CG ' ' HZ1' ' C' ' 127' ' ' LYS . 3.3 m-20 -44.2 -33.67 1.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 109.444 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -83.38 -60.13 2.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.841 . . . . 0.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.2 m -46.92 -29.75 2.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.355 -0.841 . . . . 0.0 109.94 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -77.5 -36.69 52.37 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.985 -1.072 . . . . 0.0 108.233 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.19 -47.85 29.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -53.18 -38.58 62.93 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.49 -63.05 1.44 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.443 -0.785 . . . . 0.0 109.36 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.22 67.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.851 . . . . 0.0 109.286 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 14' ' ' TRP . . . . . 0.448 ' HZ3' HD11 ' C' ' 125' ' ' LEU . 0.1 OUTLIER -72.98 -17.24 61.48 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.417 -0.802 . . . . 0.0 108.892 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.69 -39.98 59.39 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -84.73 -49.77 8.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.521 -0.988 . . . . 0.0 109.333 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' C' ' 18' ' ' GLY . 71.1 t -60.06 -34.99 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.504 -0.747 . . . . 0.0 109.639 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . -31.56 144.79 0.02 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 19' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' C' ' 18' ' ' GLY . . . 69.16 -32.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -1.101 . . . . 0.0 108.874 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.593 ' H ' ' C ' ' C' ' 18' ' ' GLY . 1.2 m80 -104.96 13.83 30.38 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.43 ' HB2' HG12 ' C' ' 17' ' ' VAL . . . -83.52 -48.8 9.89 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.82 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -14.72 42.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -89.07 -56.6 3.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -1.137 . . . . 0.0 109.706 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.636 ' CZ ' ' CE1' ' C' ' 112' ' ' HIS . 2.9 m-30 -59.01 -33.13 70.38 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.424 -0.798 . . . . 0.0 109.191 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.73 -33.19 76.64 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.89 -50.83 10.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.168 -1.195 . . . . 0.0 109.828 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -52.4 -19.76 2.38 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.61 -25.53 65.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.505 HD11 ' ND1' ' C' ' 58' ' ' HIS . 33.2 mt -72.15 -58.09 3.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.744 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -61.57 -14.42 29.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.086 -1.009 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 1.063 ' NH1' ' CG ' ' D' ' 127' ' ' GLN . 1.9 tpm_? -75.41 -39.05 59.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.344 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 32' ' ' MET . . . . . 0.502 ' O ' ' N ' ' C' ' 34' ' ' LEU . 0.0 OUTLIER -79.98 -48.51 13.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.193 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 33' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' C' ' 32' ' ' MET . 36.6 t80 -43.78 -19.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.338 -0.851 . . . . 0.0 109.782 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.805 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.9 mt -79.85 -60.23 2.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.755 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.861 ' OG ' ' NE2' ' D' ' 131' ' ' GLN . 30.0 m -81.27 -31.48 33.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.891 . . . . 0.0 109.698 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.565 ' CZ ' HD22 ' C' ' 100' ' ' LEU . 60.2 m-85 -113.57 95.0 34.86 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.439 -0.788 . . . . 0.0 109.424 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.18 -20.01 8.88 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.435 2.09 . . . . 0.0 112.224 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.689 ' O ' HG22 ' C' ' 41' ' ' THR . 70.7 p -47.69 -42.07 24.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 109.253 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.416 ' H ' HG23 ' C' ' 39' ' ' THR . 12.9 p -44.1 -22.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.813 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' C' ' 38' ' ' THR . 30.5 ttpt -70.94 -19.18 62.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.61 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 41' ' ' THR . . . . . 1.1 HG21 ' CD2' ' B' ' 97' ' ' HIS . 8.5 t -80.28 -20.58 44.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -84.99 -14.93 45.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.361 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 43' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 53.45 83.06 0.23 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.669 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 46.2 Cg_exo -52.04 -41.16 65.89 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.552 2.168 . . . . 0.0 111.866 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.669 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 0.0 OUTLIER 96.1 35.8 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.212 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.495 ' CZ ' ' CB ' ' C' ' 44' ' ' PRO . 2.1 p90 -142.48 44.89 1.63 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.444 -1.41 . . . . 0.0 110.095 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.05 -35.22 0.3 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 110.448 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' C' ' 46' ' ' PHE . 1.0 OUTLIER 61.72 55.84 2.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.02 -1.05 . . . . 0.0 109.097 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.0 m -165.35 157.01 14.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.992 -1.067 . . . . 0.0 109.534 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 50' ' ' HIS . . . . . 0.462 ' C ' ' H ' ' C' ' 52' ' ' SER . 2.7 m-70 -59.48 160.87 6.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.375 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.71 -18.14 1.91 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 30.6 p -48.66 -25.9 2.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -1.158 . . . . 0.0 109.395 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 66.97 -40.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.748 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' C' ' 52' ' ' SER . 20.4 mt-30 -69.73 -23.79 63.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.295 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.45 HG23 ' OG ' ' C' ' 52' ' ' SER . 56.6 t -69.64 -40.51 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.915 . . . . 0.0 109.133 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -65.7 -54.42 27.69 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.307 -0.87 . . . . 0.0 108.656 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.17 -36.12 21.08 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.505 ' ND1' HD11 ' C' ' 29' ' ' LEU . 6.1 t-80 -60.54 -36.5 78.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.957 -1.319 . . . . 0.0 109.874 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.36 -29.33 37.91 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 56.8 mttm -65.07 -23.67 67.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -1.207 . . . . 0.0 110.268 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.531 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 0.5 OUTLIER -69.18 -58.18 4.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.999 -1.063 . . . . 0.0 108.591 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 72.8 t -56.49 -44.71 81.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.579 -0.7 . . . . 0.0 109.299 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.93 -41.6 74.38 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.24 -0.912 . . . . 0.0 109.21 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 64' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 7.9 t70 -65.88 -38.1 87.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.13 -0.981 . . . . 0.0 108.493 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.793 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -67.5 -53.43 28.7 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.415 ' O ' HG23 ' C' ' 70' ' ' VAL . 1.0 OUTLIER -58.49 -42.25 87.14 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.425 ' O ' ' N ' ' C' ' 71' ' ' ALA . 15.7 m -69.64 -51.67 32.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.888 . . . . 0.0 108.731 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -62.22 -25.95 68.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 108.537 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.11 -46.4 11.17 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.415 HG23 ' O ' ' C' ' 66' ' ' LEU . 38.2 t -66.56 -22.85 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -69.56 -36.3 76.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.587 ' O ' ' N ' ' C' ' 74' ' ' ASP . 26.1 m80 -103.32 -66.69 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.609 -0.682 . . . . 0.0 109.443 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.547 HG22 ' O ' ' C' ' 73' ' ' VAL . 14.8 p 44.42 14.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.954 0.883 . . . . 0.0 109.323 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' C' ' 72' ' ' HIS . 5.5 m-20 -137.99 12.07 2.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.412 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 0.2 OUTLIER 171.78 31.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.139 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 3.5 ptt? -78.27 -23.66 0.42 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 111.849 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.8 Cg_exo -53.6 -19.35 13.76 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.705 1.604 . . . . 0.0 112.5 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -94.25 -40.44 9.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.08 -1.012 . . . . 0.0 109.741 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.73 -48.88 67.81 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.248 -0.908 . . . . 0.0 109.36 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.58 6.03 6.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 109.298 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 34.1 t -54.48 -19.59 6.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 109.602 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -83.16 -58.52 2.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 109.891 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.613 HD22 HBA1 ' C' ' 142' ' ' HEC . 3.8 mt -45.32 -44.69 11.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.424 -0.797 . . . . 0.0 109.068 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.496 ' CB ' ' HG ' ' C' ' 138' ' ' SER . 23.3 t -59.96 -18.93 49.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -0.775 . . . . 0.0 109.536 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' C' ' 89' ' ' HIS . 36.7 t70 -81.11 -50.9 9.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.95 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.451 ' CD1' HBD2 ' C' ' 142' ' ' HEC . 4.6 tt -64.15 -26.71 68.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.89 . . . . 0.0 110.068 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.79 -21.78 26.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.312 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.47 -11.26 11.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.141 -0.975 . . . . 0.0 110.172 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 89' ' ' HIS . . . . . 0.56 ' N ' ' O ' ' C' ' 85' ' ' ASP . 42.4 t60 -106.51 -74.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.958 . . . . 0.0 109.996 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' C' ' 92' ' ' ARG . 79.7 mttt -63.74 -110.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 110.077 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 14.1 mt -44.45 -17.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.346 -0.846 . . . . 0.0 110.009 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 92' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' C' ' 90' ' ' LYS . 31.8 ttm-85 46.84 41.47 10.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.138 -0.977 . . . . 0.0 109.492 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 70.1 t -45.91 144.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.694 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' C' ' 97' ' ' ASN . 10.7 m-20 -80.68 150.29 69.43 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.71 -19.49 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.384 2.056 . . . . 0.0 112.22 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.31 -7.71 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.357 -0.84 . . . . 0.0 109.752 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' C' ' 94' ' ' ASP . 12.8 m120 -79.71 -36.25 37.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.475 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -46.35 -41.56 13.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.896 -1.127 . . . . 0.0 109.569 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.48 ' CB ' ' NZ ' ' C' ' 99' ' ' LYS . 8.0 mtmp? -51.39 -28.25 12.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.238 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.565 HD22 ' CZ ' ' C' ' 36' ' ' PHE . 15.4 mt -84.31 -61.8 1.72 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.719 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.79 HD22 ' CHC' ' C' ' 142' ' ' HEC . 5.4 tp -49.92 -23.65 2.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.796 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -73.28 -49.47 27.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.906 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -80.68 -26.41 37.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.862 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 65.3 m -64.95 -60.37 3.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.167 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.717 HD12 ' C ' ' C' ' 105' ' ' LEU . 0.9 OUTLIER -57.51 -22.38 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 109.827 -179.402 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.08 -31.47 39.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.879 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 107' ' ' VAL . . . . . 0.469 HG11 ' OE1' ' D' ' 127' ' ' GLN . 57.0 t -83.32 -24.91 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.042 -1.036 . . . . 0.0 110.094 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' C' ' 109' ' ' LEU . 1.5 t -79.79 -47.68 14.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.06 -1.025 . . . . 0.0 109.919 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.732 ' O ' HD12 ' C' ' 109' ' ' LEU . 0.8 OUTLIER -69.77 -18.51 63.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 109.762 -179.583 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.95 -22.2 46.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 110.287 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.51 -56.16 25.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -0.995 . . . . 0.0 110.162 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 112' ' ' HIS . . . . . 0.681 ' CG ' ' H ' ' C' ' 113' ' ' LEU . 9.4 p80 -72.42 -61.85 1.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.016 . . . . 0.0 109.563 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.909 ' O ' HD23 ' C' ' 113' ' ' LEU . 0.0 OUTLIER -119.81 121.46 29.76 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.37 175.61 7.56 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.476 2.117 . . . . 0.0 112.932 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.649 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -45.22 -55.08 6.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.604 -0.685 . . . . 0.0 109.374 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.649 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 26.0 mt-10 122.98 -2.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.472 ' CG ' ' C ' ' C' ' 116' ' ' GLU . 1.8 m-85 72.23 32.86 1.64 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.708 -0.62 . . . . 0.0 111.259 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.772 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.3 p -97.54 121.26 58.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.927 -1.108 . . . . 0.0 108.231 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.55 24.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.059 1.839 . . . . 0.0 112.531 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -150.46 -32.31 0.18 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.928 -1.108 . . . . 0.0 110.46 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.657 HG13 ' N ' ' C' ' 122' ' ' HIS . 11.9 p -54.03 -50.11 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 110.292 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.657 ' N ' HG13 ' C' ' 121' ' ' VAL . 17.6 m80 -54.71 -45.07 73.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.577 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.37 -20.02 32.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 110.267 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.549 ' N ' ' O ' ' C' ' 120' ' ' ALA . 93.6 p -52.22 -52.93 49.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.931 . . . . 0.0 110.615 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.448 HD11 ' HZ3' ' C' ' 14' ' ' TRP . 5.5 mt -84.11 -19.24 34.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.081 -1.012 . . . . 0.0 110.047 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.76 -51.82 9.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.092 . . . . 0.0 110.333 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -78.68 -43.02 26.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.057 -1.027 . . . . 0.0 110.188 -179.219 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.482 ' CD2' ' CD1' ' C' ' 2' ' ' LEU . 33.7 t80 -50.5 -21.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 0.0 108.992 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.723 ' CD2' HBB1 ' C' ' 142' ' ' HEC . 17.4 mt -73.77 -18.26 60.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -60.14 -35.48 75.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.44 ' O ' HG23 ' C' ' 135' ' ' VAL . 97.3 p -80.74 -27.09 36.94 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -84.71 -30.06 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.492 ' N ' ' O ' ' C' ' 129' ' ' LEU . 50.3 m -79.31 -40.78 29.54 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 53.3 m -69.31 -26.35 64.68 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.289 -0.882 . . . . 0.0 108.644 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 131' ' ' SER . 23.6 t -81.56 -30.19 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -23.21 61.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.0 109.071 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 137' ' ' THR . . . . . 0.433 ' O ' ' O ' ' C' ' 138' ' ' SER . 38.3 p -87.28 -18.43 30.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.21 -0.931 . . . . 0.0 109.552 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 138' ' ' SER . . . . . 0.496 ' HG ' ' CB ' ' C' ' 84' ' ' SER . 21.7 m 51.72 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.433 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -61.92 -160.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.928 . . . . 0.0 109.548 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -76.75 -45.0 30.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.571 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.507 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.848 HG13 ' H ' ' D' ' 2' ' ' HIS . 13.0 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 2' ' ' HIS . . . . . 0.848 ' H ' HG13 ' D' ' 1' ' ' VAL . 82.1 t60 47.72 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.987 -1.071 . . . . 0.0 109.724 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.85 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -135.94 179.73 6.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 108.982 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.466 ' O ' ' N ' ' D' ' 7' ' ' GLU . 7.3 p -76.16 132.42 73.61 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.153 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -41.19 -24.75 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.369 2.046 . . . . 0.0 112.446 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.14 -21.84 25.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.927 . . . . 0.0 109.874 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' D' ' 4' ' ' THR . 32.2 tt0 -80.36 -63.09 1.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.097 -1.002 . . . . 0.0 109.938 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.59 ' HB3' HD13 ' D' ' 3' ' ' LEU . 24.1 pttt -62.38 -31.63 72.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.008 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.2 t -44.55 -23.44 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -81.57 -57.34 3.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.019 -1.051 . . . . 0.0 110.11 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.434 HG23 ' CE2' ' D' ' 130' ' ' TYR . 14.9 p -68.76 -24.64 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.055 -1.028 . . . . 0.0 108.256 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 12.6 m -71.91 -42.15 67.06 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.347 0.594 . . . . 0.0 109.852 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.77 -30.38 69.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.868 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -50.32 -18.79 0.67 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.95 . . . . 0.0 109.33 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 15' ' ' TRP . . . . . 0.412 ' CZ2' HD13 ' D' ' 75' ' ' LEU . 0.7 OUTLIER -53.18 -51.39 62.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 0.0 109.158 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.09 -32.47 35.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 -46.68 14.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -1.098 . . . . 0.0 109.214 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 69.6 t -59.02 114.91 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.546 -0.721 . . . . 0.0 109.842 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' D' ' 21' ' ' ASP . 19.0 m120 -79.43 71.58 6.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 108.742 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.443 ' O ' HG12 ' D' ' 20' ' ' VAL . 57.2 t -46.99 -11.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.89 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' D' ' 19' ' ' ASN . 16.5 m-20 -73.51 -5.35 39.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 109.847 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -156.31 -40.35 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 109.577 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -46.4 -55.54 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.0 109.66 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.72 -29.85 50.42 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.53 -29.93 69.34 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.94 -31.46 59.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -1.11 . . . . 0.0 109.467 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.11 -54.32 48.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 28' ' ' LEU . . . . . 0.535 ' N ' HD22 ' D' ' 28' ' ' LEU . 3.8 mm? -61.9 -40.06 94.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.935 . . . . 0.0 109.26 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.98 -42.78 76.31 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 60.2 mmt-85 -72.74 -36.97 67.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -1.098 . . . . 0.0 109.481 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 65.2 tp -50.12 -31.72 14.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.32 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.18 -22.59 38.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.625 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.97 -64.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.578 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.444 HG23 ' H ' ' D' ' 34' ' ' VAL . 0.2 OUTLIER -64.11 -22.69 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -0.828 . . . . 0.0 109.644 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -140.31 79.22 21.56 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -83.49 -12.42 8.98 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.865 2.377 . . . . 0.0 112.36 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 37' ' ' TRP . . . . . 0.524 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 3.3 p-90 -48.62 -33.95 10.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.586 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.524 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 3.2 m -78.96 2.59 19.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.509 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 39' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' D' ' 39' ' ' GLN . 1.4 tm0? -65.48 -19.08 65.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 40' ' ' ARG . . . . . 1.455 ' NH2' ' CG ' ' A' ' 92' ' ' ARG . 32.9 mtp85 -68.49 -40.94 80.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.746 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -93.03 -18.98 22.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' D' ' 45' ' ' PHE . 1.3 t80 -89.86 28.56 1.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 109.44 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -84.39 -13.99 50.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.351 -0.843 . . . . 0.0 109.608 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -80.12 -7.59 58.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.602 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.656 ' HZ ' ' CMD' ' D' ' 147' ' ' HEC . 33.5 m-85 -83.68 -3.44 57.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.483 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.03 -172.78 25.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -84.81 98.39 10.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.125 . . . . 0.0 109.339 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 48' ' ' LEU . . . . . 0.708 ' N ' HD12 ' D' ' 48' ' ' LEU . 7.2 mp -88.0 30.85 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 108.956 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -45.0 -30.96 1.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 109.89 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 6.7 p -142.35 138.2 16.29 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -41.2 -28.45 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.423 2.082 . . . . 0.0 112.362 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 52' ' ' ASP . . . . . 0.4 ' C ' ' N ' ' D' ' 54' ' ' VAL . 12.0 t70 -76.96 -39.81 49.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.0 109.578 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.8 -19.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.355 -0.84 . . . . 0.0 109.653 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 54' ' ' VAL . . . . . 0.4 ' N ' ' C ' ' D' ' 52' ' ' ASP . 45.8 t -67.06 -63.87 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.656 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -51.48 -19.92 1.63 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.757 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.0 -31.75 38.23 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -63.18 132.74 95.19 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.232 -1.157 . . . . 0.0 109.318 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.26 -50.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.447 2.098 . . . . 0.0 112.523 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.05 -34.93 72.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.967 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -55.34 -49.88 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.032 . . . . 0.0 109.193 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 61' ' ' LYS . . . . . 0.431 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 26.2 mtmt -73.6 -29.34 62.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.169 -0.957 . . . . 0.0 109.277 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.31 68.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.449 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 1.257 ' NE2' ' CHA' ' D' ' 147' ' ' HEC . 2.5 t60 -54.39 -25.36 24.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.25 83.1 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 65' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 0.4 OUTLIER -62.88 -36.79 84.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.183 -1.186 . . . . 0.0 109.274 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -75.76 -35.1 60.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 109.344 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.687 HG22 ' CHB' ' D' ' 147' ' ' HEC . 47.7 t -69.03 -63.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.285 -0.885 . . . . 0.0 109.324 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.551 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.8 tt -53.75 -32.81 53.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 108.898 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.93 -56.98 21.07 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.81 -42.25 79.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -1.085 . . . . 0.0 109.455 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 71' ' ' PHE . . . . . 0.405 ' O ' ' CD1' ' D' ' 71' ' ' PHE . 3.0 t80 -67.24 -35.12 78.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 72' ' ' SER . . . . . 0.404 ' HB2' ' HE1' ' D' ' 15' ' ' TRP . 62.2 p -73.78 -35.61 64.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.63 -21.16 0.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.908 . . . . 0.0 109.361 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.13 -60.12 4.65 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.642 HD12 ' H ' ' D' ' 75' ' ' LEU . 5.1 mp -53.46 -28.9 32.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -1.161 . . . . 0.0 109.25 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.78 3.5 41.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' D' ' 79' ' ' ASP . 23.5 t-80 -170.41 61.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.692 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 78' ' ' LEU . . . . . 0.659 HD22 HG21 ' D' ' 1' ' ' VAL . 59.2 mt -73.69 15.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.257 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' D' ' 77' ' ' HIS . 16.8 t70 -76.38 -36.02 58.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.216 -0.927 . . . . 0.0 109.522 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -161.61 100.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 109.401 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 33.2 mt -79.21 -50.23 11.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 82' ' ' LYS . . . . . 0.431 ' NZ ' ' ND1' ' D' ' 143' ' ' HIS . 24.6 mmtp -48.41 -23.92 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.08 -63.27 3.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.3 t -63.94 -48.11 77.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -1.14 . . . . 0.0 109.397 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' D' ' 84' ' ' THR . 46.6 m-85 -63.61 -8.5 10.11 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.435 -0.79 . . . . 0.0 109.374 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.25 -34.86 34.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.394 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 27.9 p -83.96 -50.97 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 0.0 109.535 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 35.8 mt -56.11 -55.56 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 109.161 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 89' ' ' SER . . . . . 0.491 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 1.5 m -51.55 -38.91 56.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.323 -0.861 . . . . 0.0 109.44 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' D' ' 94' ' ' ASP . 29.1 tt0 -74.24 -54.64 7.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -62.49 -29.3 70.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.687 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' D' ' 97' ' ' HIS . 1.3 m80 -79.31 -48.35 14.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.97 . . . . 0.0 110.043 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 93' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' D' ' 89' ' ' SER . 6.6 m -82.97 -31.14 27.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.028 -1.045 . . . . 0.0 110.301 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' D' ' 90' ' ' GLU . 6.4 t70 -86.66 -43.52 12.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.065 -1.022 . . . . 0.0 110.901 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -52.25 5.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 0.0 110.732 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.63 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 4.1 mm? -82.98 -43.48 16.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.0 109.486 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 1.137 ' CD2' HG21 ' A' ' 41' ' ' THR . 0.0 OUTLIER 74.81 19.77 2.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.427 -0.796 . . . . 0.0 109.727 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 98' ' ' VAL . . . . . 0.403 HG23 ' H ' ' D' ' 98' ' ' VAL . 8.6 t -45.11 122.24 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 109.471 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 99' ' ' ASP . . . . . 0.512 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 15.6 m-20 -69.18 151.46 97.05 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.41 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 100' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' D' ' 99' ' ' ASP . 75.7 Cg_exo -42.9 178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.631 2.22 . . . . 0.0 112.414 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 57.52 64.76 1.5 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 109.569 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 102' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' D' ' 99' ' ' ASP . 73.1 m-20 -161.92 -52.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.41 -0.806 . . . . 0.0 109.263 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 103' ' ' PHE . . . . . 0.702 ' HA ' HBB2 ' D' ' 147' ' ' HEC . 4.2 p90 -66.96 -25.96 66.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 104' ' ' ARG . . . . . 0.417 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 39.3 ttt-85 -78.53 -25.76 45.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.91 -45.7 49.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.915 . . . . 0.0 109.605 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.963 HD13 ' C3B' ' D' ' 147' ' ' HEC . 4.6 tt -49.39 -46.07 46.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.4 -48.83 64.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 108' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 30.1 m120 -50.22 -44.26 53.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -1.172 . . . . 0.0 109.739 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.04 -35.27 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.757 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tp -63.41 -38.8 92.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.662 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 66.8 t -51.37 -30.52 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.676 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.22 -59.38 2.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.615 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 113' ' ' VAL . . . . . 0.403 HG23 ' H ' ' D' ' 113' ' ' VAL . 29.3 t -46.17 -27.91 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.833 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 114' ' ' LEU . . . . . 0.451 HD13 ' OH ' ' D' ' 130' ' ' TYR . 17.0 mt -82.66 -53.12 6.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.527 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.454 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -65.38 -19.43 65.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.639 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.08 -62.84 1.25 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.689 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -77.26 -48.3 17.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.823 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -92.8 30.21 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.751 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -55.05 -27.73 46.51 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -64.65 7.09 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -1.136 . . . . 0.0 109.598 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' D' ' 119' ' ' GLY . 61.0 mm-40 -133.14 6.87 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 109.434 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.538 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -73.32 34.8 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.427 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.493 ' H ' ' C ' ' D' ' 121' ' ' GLU . 2.9 p -44.87 148.96 0.88 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.339 -0.85 . . . . 0.0 109.504 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.514 ' HA ' HH22 ' C' ' 31' ' ' ARG . 5.4 Cg_exo -44.36 -54.04 4.34 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.437 2.091 . . . . 0.0 112.78 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 21.2 Cg_endo -61.35 -48.25 10.11 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.934 1.756 . . . . 0.0 112.0 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.426 ' O ' HG12 ' D' ' 126' ' ' VAL . 72.8 t -55.48 -13.02 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -0.839 . . . . 0.0 109.518 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 127' ' ' GLN . . . . . 1.063 ' CG ' ' NH1' ' C' ' 31' ' ' ARG . 0.7 OUTLIER -82.47 -59.87 2.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.646 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.805 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -66.56 -26.52 67.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.435 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.78 26.44 0.83 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.451 ' OH ' HD13 ' D' ' 114' ' ' LEU . 0.1 OUTLIER -123.47 -61.36 1.41 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.295 -0.878 . . . . 0.0 109.303 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 0.861 ' NE2' ' OG ' ' C' ' 35' ' ' SER . 4.0 mp0 -53.56 -36.37 61.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.671 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -69.47 -25.13 63.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 64.4 t -77.27 -43.66 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.581 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.61 -17.1 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.36 -28.95 70.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.541 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -36.43 59.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 137' ' ' VAL . . . . . 0.492 HG13 ' CZ ' ' D' ' 85' ' ' PHE . 76.4 t -75.24 -36.47 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -1.153 . . . . 0.0 109.456 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.22 -38.91 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' D' ' 143' ' ' HIS . 9.9 m120 -85.21 -21.3 29.18 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.21 -0.931 . . . . 0.0 109.758 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.69 -55.52 33.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.514 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.52 -24.77 66.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.277 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 142' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' D' ' 145' ' ' TYR . . . -100.29 1.79 42.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 109.378 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 143' ' ' HIS . . . . . 0.527 ' N ' ' O ' ' D' ' 139' ' ' ASN . 71.2 t60 -80.91 -1.68 44.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.453 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' D' ' 146' ' ' HIS . 5.4 tppt? -120.75 -32.04 4.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 145' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' D' ' 142' ' ' ALA . 0.1 OUTLIER -49.12 -10.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.233 -0.917 . . . . 0.0 109.888 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' D' ' 144' ' ' LYS . 4.9 m-70 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.656 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.916 HBB2 HMB1 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 1.23 ' CHA' ' NE2' ' B' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.917 HBB2 HMB1 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 1.257 ' CHA' ' NE2' ' D' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 131' ' ' SER . 12.4 tp -171.74 145.51 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 109.634 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.6 168.29 20.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 109.319 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 5' ' ' ALA . 55.7 Cg_endo -73.13 -61.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.618 2.212 . . . . 0.0 112.666 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 4' ' ' PRO . . . -45.26 -38.27 5.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.934 . . . . 0.0 109.673 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 5' ' ' ALA . 4.8 m-20 -44.52 -28.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 108.977 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 10' ' ' VAL . 76.8 mttt -83.06 -60.33 2.19 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.437 -0.789 . . . . 0.0 109.093 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.1 m -46.37 -31.61 2.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.471 -0.768 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -76.72 -35.85 57.55 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.492 HG21 ' CG ' ' A' ' 128' ' ' PHE . 4.4 t -73.58 -50.25 31.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -49.15 -42.79 40.75 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.4 -63.57 1.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.257 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -55.37 -39.05 69.63 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 109.178 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.43 ' NE1' ' OG1' ' A' ' 67' ' ' THR . 0.1 OUTLIER -71.31 -17.19 62.47 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.044 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.26 -46.23 7.66 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -70.67 -34.61 72.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.146 . . . . 0.0 108.742 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 13' ' ' ALA . 70.1 t -63.02 -66.03 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 60.84 -140.82 48.08 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 20' ' ' HIS . . . -66.7 49.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.434 -1.039 . . . . 0.0 110.194 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 18' ' ' GLY . 80.0 m-70 -153.75 19.64 0.53 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -83.8 -62.87 1.46 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.701 -0.624 . . . . 0.0 109.781 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.2 -14.45 0.16 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 21' ' ' ALA . 3.4 mm-40 -86.71 -56.47 3.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -1.132 . . . . 0.0 109.744 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.9 m-30 -55.38 -52.23 64.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 109.159 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.14 -22.79 14.58 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB1' HG12 ' A' ' 55' ' ' VAL . . . -73.67 -45.4 52.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -1.129 . . . . 0.0 109.702 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.518 ' OE1' ' NE2' ' A' ' 112' ' ' HIS . 94.9 mt-10 -65.69 -19.83 66.05 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.509 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.58 -24.5 60.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.381 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.3 mt -65.81 -41.23 92.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.735 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -75.68 -12.54 60.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.09 -1.006 . . . . 0.0 109.739 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 31' ' ' ARG . 3.1 tpm_? -78.93 -47.36 16.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 0.0 110.155 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.551 ' HE1' HBC3 ' A' ' 142' ' ' HEC . 1.1 ptm -65.74 -26.35 67.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.007 -1.058 . . . . 0.0 109.683 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.37 -36.45 82.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.101 -0.999 . . . . 0.0 109.436 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 12.1 mt -85.66 -44.88 12.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.708 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 40.2 t -51.5 -19.61 1.52 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.824 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' A' ' 35' ' ' SER . 60.1 m-85 -160.92 90.23 1.61 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.001 . . . . 0.0 109.733 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 39' ' ' THR . 52.4 Cg_exo -50.28 -26.15 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.594 2.196 . . . . 0.0 112.158 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.764 ' O ' HG22 ' A' ' 41' ' ' THR . 10.8 p -47.54 -18.51 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 37' ' ' PRO . 22.1 p -76.47 -22.89 53.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.273 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 43' ' ' PHE . 28.8 ttmt -74.22 -31.74 62.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.88 . . . . 0.0 109.84 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 1.413 HG21 ' ND1' ' D' ' 97' ' ' HIS . 14.3 t -47.13 -25.74 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.333 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.474 ' C ' ' CG ' ' A' ' 43' ' ' PHE . 97.5 m-85 -87.86 30.95 0.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.474 ' CG ' ' C ' ' A' ' 42' ' ' TYR . 0.9 OUTLIER 70.26 149.55 0.12 Allowed Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.16 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 46' ' ' PHE . 40.0 Cg_endo -68.73 -42.92 4.17 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.058 1.838 . . . . 0.0 112.337 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.546 ' ND1' ' O ' ' A' ' 45' ' ' HIS . 21.7 p80 34.38 34.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.549 -0.72 . . . . 0.0 109.248 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.714 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -166.63 75.49 0.18 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.621 ' C ' ' O ' ' A' ' 46' ' ' PHE . 20.8 m-20 -8.8 -54.67 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.028 -0.42 . . . . 0.0 111.522 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.714 ' N ' ' O ' ' A' ' 46' ' ' PHE . 5.7 mt 56.71 4.81 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.244 -0.91 . . . . 0.0 109.386 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 47' ' ' ASP . 33.3 t -73.24 19.0 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.242 -0.911 . . . . 0.0 109.362 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' A' ' 48' ' ' LEU . 6.6 t-80 58.86 156.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.06 15.33 1.46 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 10.7 t -72.59 -21.27 61.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 109.403 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.5 -50.62 0.5 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.709 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 52' ' ' SER . 15.8 pt20 -45.37 -17.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.684 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.55 HG12 ' HB1' ' A' ' 26' ' ' ALA . 77.9 t -73.84 -32.85 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.83 -24.82 67.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.641 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.15 -51.1 40.94 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 24.7 t-80 -67.82 -27.81 67.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.13 -1.217 . . . . 0.0 110.282 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 26' ' ' ALA . . . -63.22 -31.05 79.39 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 16.9 mtpp -71.79 -23.63 61.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -1.157 . . . . 0.0 110.146 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.817 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 0.4 OUTLIER -66.8 -58.1 5.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.124 -0.985 . . . . 0.0 108.644 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.8 t -55.2 -48.94 75.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.544 -0.723 . . . . 0.0 109.238 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -64.23 -42.57 96.5 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.23 -0.919 . . . . 0.0 108.959 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.5 t70 -72.02 -25.63 61.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.806 . . . . 0.0 109.056 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.094 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -80.65 -44.74 18.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.94 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -76.57 -27.35 55.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.568 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 63' ' ' ALA . 52.8 m -75.92 -44.62 39.37 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 17.7 t-20 -57.41 -20.81 32.32 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.24 -45.88 12.42 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.46 ' CG2' HG11 ' A' ' 10' ' ' VAL . 6.0 t -59.62 -22.63 23.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 68' ' ' ASN . . . -65.39 -15.25 62.39 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.568 ' O ' ' N ' ' A' ' 74' ' ' ASP . 72.8 m-70 -153.04 -51.75 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.403 -0.811 . . . . 0.0 109.353 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.631 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.9 p 44.56 15.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.977 0.894 . . . . 0.0 109.32 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 72' ' ' HIS . 95.9 m-20 -134.3 10.57 3.81 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 31.1 t70 -175.23 27.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.14 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.1 ptt? -78.59 -24.19 0.43 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.47 -0.769 . . . . 0.0 111.829 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.3 Cg_exo -52.9 -19.8 11.91 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.701 1.601 . . . . 0.0 112.634 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.448 ' ND2' ' N ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -94.21 -33.12 13.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.114 -0.991 . . . . 0.0 109.822 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.448 ' N ' ' ND2' ' A' ' 78' ' ' ASN . . . -74.6 -40.79 61.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.27 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.64 12.12 13.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.024 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 66.5 p -70.6 -16.21 62.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.655 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 83' ' ' LEU . . . -82.07 -51.71 7.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 83' ' ' LEU . 3.4 mt -44.89 -43.0 8.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.382 -0.824 . . . . 0.0 109.043 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.1 p -57.14 -22.07 37.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -72.54 -32.75 66.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.686 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 90' ' ' LYS . 7.0 tt -81.4 -29.18 34.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.417 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -89.9 -28.42 19.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 109.529 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 90' ' ' LYS . . . -83.9 -80.41 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.665 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.539 ' O ' ' ND1' ' A' ' 89' ' ' HIS . 30.4 t-80 -61.09 2.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.841 . . . . 0.0 109.61 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 88' ' ' ALA . 6.1 mtmm -156.15 152.29 27.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.289 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' A' ' 93' ' ' VAL . 10.9 mp 56.95 63.89 1.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 108.983 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.287 ' HB3' ' NH1' ' D' ' 40' ' ' ARG . 8.4 ptp180 -62.77 14.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.578 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.636 ' H ' ' C ' ' A' ' 91' ' ' LEU . 73.7 t -41.43 121.69 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -0.812 . . . . 0.0 109.631 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.11 147.81 2.29 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.533 ' C ' ' H ' ' A' ' 97' ' ' ASN . 37.9 Cg_endo -68.23 -10.66 29.63 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.486 2.124 . . . . 0.0 112.069 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 96' ' ' VAL . 2.8 t -55.25 -1.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.716 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 1.045 ' HB3' HMC1 ' A' ' 142' ' ' HEC . 5.0 m120 -74.66 -42.34 58.65 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.084 -1.01 . . . . 0.0 109.808 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 2.2 m-85 -46.38 -42.05 14.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 0.0 109.275 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -58.1 -32.91 68.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.244 -0.91 . . . . 0.0 109.316 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.1 mt -84.08 -62.28 1.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.105 HD22 HBB3 ' A' ' 142' ' ' HEC . 6.3 tt -50.22 -41.84 50.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 0.0 109.291 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.4 m -63.26 -51.03 67.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -66.1 -26.82 67.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.513 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 96.6 m -63.51 -50.59 69.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.75 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.31 -43.02 22.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 106' ' ' LEU . 8.6 mp -64.17 -59.24 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.423 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.563 ' CG1' ' NE2' ' B' ' 127' ' ' GLN . 76.7 t -56.48 -30.99 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -75.7 -63.03 1.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.459 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 113' ' ' LEU . 13.1 mt -51.34 -30.65 19.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.0 109.495 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -47.43 -42.29 22.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.885 . . . . 0.0 109.679 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.11 -49.25 11.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.829 . . . . 0.0 109.787 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 27' ' ' GLU . 11.4 m170 -76.24 -69.98 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 109.868 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -110.96 97.05 32.57 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 109.054 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 113' ' ' LEU . 71.2 Cg_exo -47.31 -174.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.372 2.048 . . . . 0.0 112.879 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 122' ' ' HIS . . . -86.67 -35.09 19.53 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.664 0.745 . . . . 0.0 109.574 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 3.8 mt-10 78.4 0.86 2.63 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.943 ' HD1' ' NH2' ' B' ' 30' ' ' ARG . 21.7 t80 65.3 37.56 6.32 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.639 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.749 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -93.97 115.07 64.69 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.82 -1.175 . . . . 0.0 107.953 178.195 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.755 ' HA ' ' CG1' ' B' ' 33' ' ' VAL . 50.4 Cg_exo -50.36 21.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.021 1.814 . . . . 0.0 112.553 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.749 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -147.07 -21.7 0.4 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.003 -1.061 . . . . 0.0 110.961 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.77 HG13 ' N ' ' A' ' 122' ' ' HIS . 10.5 p -58.13 -58.75 5.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.976 -1.078 . . . . 0.0 110.48 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.77 ' N ' HG13 ' A' ' 121' ' ' VAL . 1.1 m-70 -71.03 -24.89 62.45 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.3 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' B' ' 33' ' ' VAL . . . -84.08 -20.74 32.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 128' ' ' PHE . 62.7 p -77.41 -63.19 1.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.248 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.46 -19.84 57.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.057 -1.027 . . . . 0.0 109.102 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.494 ' OD2' ' OH ' ' B' ' 35' ' ' TYR . 7.4 t70 -77.77 -51.18 10.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.482 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.28 -41.82 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.845 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 124' ' ' SER . 29.8 t80 -50.23 -22.88 1.92 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 109.037 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.0 mt -73.99 -24.76 59.64 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -56.77 -31.87 65.05 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.463 ' HB3' HD13 ' A' ' 2' ' ' LEU . 89.6 p -73.97 -32.56 63.51 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.37 -29.79 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 129' ' ' LEU . 9.9 p -81.92 -25.26 35.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.843 . . . . 0.0 108.913 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.8 m -74.91 -40.13 61.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.305 -0.872 . . . . 0.0 109.102 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.13 -21.79 17.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 108.782 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.75 -35.96 72.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.472 -0.767 . . . . 0.0 109.103 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 138' ' ' SER . 57.8 p -88.13 -2.3 58.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' THR . 28.3 m 51.79 98.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 109.471 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 138' ' ' SER . 5.9 mtpm? -55.11 -170.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.537 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -61.34 -67.76 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.832 HH12 HH12 ' C' ' 141' ' ' ARG . 43.3 mtp180 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.479 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.942 HG22 ' H ' ' B' ' 2' ' ' HIS . 8.2 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 0.942 ' H ' HG22 ' B' ' 1' ' ' VAL . 36.9 m80 52.13 98.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 109.34 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.906 ' N ' HD12 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -136.41 -163.11 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 109.265 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.412 ' O ' ' N ' ' B' ' 6' ' ' GLU . 11.9 p -88.98 130.64 43.87 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.19 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -42.05 -23.04 0.23 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.362 2.041 . . . . 0.0 112.271 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' B' ' 4' ' ' THR . 51.9 mt-10 -80.11 -54.26 5.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.812 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.42 -41.09 85.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.746 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.721 ' HB2' HD13 ' B' ' 3' ' ' LEU . 0.3 OUTLIER -68.54 -35.1 76.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.5 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 4.9 m -60.68 -23.58 64.95 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.885 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.49 -57.58 3.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.11 -0.994 . . . . 0.0 109.809 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.76 -24.39 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 85.6 m -83.85 -35.2 24.37 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.345 0.593 . . . . 0.0 109.606 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' B' ' 9' ' ' SER . . . -69.05 -29.27 67.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.386 -0.821 . . . . 0.0 109.791 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.1 -21.07 0.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.244 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' TRP . . . . . 0.463 ' HE1' ' HB2' ' B' ' 72' ' ' SER . 0.8 OUTLIER -53.54 -17.88 2.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.175 -0.953 . . . . 0.0 109.084 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.8 -33.31 46.97 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' B' ' 17' ' ' LYS . 4.3 mmtt -89.82 -41.46 11.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -1.178 . . . . 0.0 109.361 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -57.22 114.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 109.833 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' B' ' 21' ' ' ASP . 7.4 m120 -84.3 68.41 10.18 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -43.88 -18.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.392 -0.817 . . . . 0.0 109.73 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' B' ' 19' ' ' ASN . 1.1 m-20 -62.39 -10.79 12.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.709 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -154.42 -35.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -0.995 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 72.3 t -48.74 -34.89 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.3 -25.9 68.87 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.97 -36.3 25.37 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -67.67 -30.7 70.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -1.114 . . . . 0.0 109.472 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.68 -54.53 45.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.548 ' N ' HD12 ' B' ' 28' ' ' LEU . 9.9 mp -64.3 -55.76 19.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.399 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.03 -41.32 29.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.943 ' NH2' ' HD1' ' A' ' 117' ' ' PHE . 73.5 mtt-85 -80.01 -34.64 38.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -1.144 . . . . 0.0 109.499 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' LEU . . . . . 0.443 HD12 HG21 ' B' ' 109' ' ' VAL . 65.4 tp -47.11 -37.21 9.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 109.499 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' B' ' 36' ' ' PRO . 15.0 mt -81.32 -39.29 25.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.817 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.755 ' CG1' ' HA ' ' A' ' 119' ' ' PRO . 72.4 t -58.13 -61.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.12 -0.988 . . . . 0.0 109.442 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.686 HG13 ' HB3' ' A' ' 122' ' ' HIS . 1.7 t -68.69 -22.56 26.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.83 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.494 ' OH ' ' OD2' ' A' ' 126' ' ' ASP . 64.0 m-85 -146.75 76.47 11.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.776 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' PRO . . . . . 0.423 ' N ' ' O ' ' B' ' 32' ' ' LEU . 72.1 Cg_endo -82.95 28.98 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.95 2.433 . . . . 0.0 112.382 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.532 ' CD1' HG23 ' B' ' 38' ' ' THR . 3.8 p-90 -81.08 -19.85 42.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.167 -0.958 . . . . 0.0 109.654 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.532 HG23 ' CD1' ' B' ' 37' ' ' TRP . 44.8 p -78.39 -104.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.523 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLN . . . . . 0.521 ' N ' ' OG1' ' B' ' 38' ' ' THR . 13.9 mt-30 54.94 10.65 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.654 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 1.321 ' NH1' ' HB3' ' C' ' 92' ' ' ARG . 15.9 mmt180 -88.55 -58.98 2.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -71.44 -8.19 52.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 1.418 ' CZ ' ' CBC' ' B' ' 147' ' ' HEC . 50.4 m-85 -87.75 28.16 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.361 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.66 -27.3 65.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 93.9 p -84.15 -27.19 28.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 109.465 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -49.65 -24.39 2.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.331 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.87 173.05 0.19 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.97 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -1.142 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 12.6 mt -138.92 19.68 2.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -58.93 -33.9 71.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' THR . . . . . 0.487 ' HG1' ' CG ' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -140.61 154.34 69.06 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.49 -24.26 74.15 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.212 1.941 . . . . 0.0 111.756 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.487 ' CG ' ' HG1' ' B' ' 50' ' ' THR . 2.8 p30 -85.2 -21.02 29.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 109.608 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.96 -19.95 65.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 109.736 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.449 ' O ' HG21 ' B' ' 60' ' ' VAL . 4.4 t -67.05 -64.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.94 . . . . 0.0 109.473 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.09 8.13 1.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' B' ' 54' ' ' VAL . . . -74.57 -29.99 60.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -84.42 147.72 50.57 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.195 -1.179 . . . . 0.0 109.34 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.72 -7.08 19.66 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.564 2.176 . . . . 0.0 112.175 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -85.77 -28.45 24.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.162 -0.961 . . . . 0.0 109.659 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.449 HG21 ' O ' ' B' ' 54' ' ' VAL . 83.5 t -70.31 -53.0 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.174 -0.954 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -57.8 -26.38 61.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.0 -46.5 43.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.619 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 58.0 t-80 -61.87 -23.82 66.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.376 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.06 -19.97 77.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -69.52 -37.31 77.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -1.197 . . . . 0.0 109.124 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' LYS . . . . . 0.599 ' CB ' HBA2 ' B' ' 147' ' ' HEC . 62.1 mmtt -68.06 -40.78 82.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.337 -0.852 . . . . 0.0 109.539 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 0.591 HG13 ' C2B' ' B' ' 147' ' ' HEC . 42.1 t -61.14 -59.15 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.285 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.521 HD23 ' O ' ' B' ' 68' ' ' LEU . 4.8 tt -58.56 -52.66 64.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.001 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.08 -45.02 26.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.429 ' HB2' HMA1 ' B' ' 147' ' ' HEC . . . -60.62 -44.45 96.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -1.129 . . . . 0.0 109.386 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.526 ' O ' ' CD1' ' B' ' 71' ' ' PHE . 2.5 t80 -69.63 -27.3 64.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.378 -0.826 . . . . 0.0 109.332 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.463 ' HB2' ' HE1' ' B' ' 15' ' ' TRP . 88.1 p -76.77 -27.91 55.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.938 . . . . 0.0 109.557 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' B' ' 77' ' ' HIS . 10.6 t70 -47.34 -37.08 10.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.584 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.05 -60.63 6.6 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.71 -24.67 50.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -1.217 . . . . 0.0 109.176 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.542 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -93.91 -11.06 31.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.314 -0.866 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 80.3 m-70 -161.31 65.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 109.648 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.568 HD21 HG21 ' B' ' 1' ' ' VAL . 2.0 mt -71.69 10.27 0.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 0.0 109.04 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' B' ' 77' ' ' HIS . 2.8 p30 -64.42 -30.24 71.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.286 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' B' ' 79' ' ' ASP . 34.5 t-20 -171.05 105.13 0.23 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.371 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.21 -58.79 2.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -48.24 -23.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.447 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -68.72 -54.77 13.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.9 t -75.19 -47.17 29.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -1.18 . . . . 0.0 109.427 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' B' ' 84' ' ' THR . 48.8 m-85 -62.72 -5.42 2.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.428 -0.795 . . . . 0.0 109.459 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.7 -34.59 62.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.329 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 37.3 p -79.82 -51.15 9.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.456 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 27.8 mt -59.69 -42.08 92.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.88 . . . . 0.0 109.333 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 5.1 m -65.08 -42.46 94.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -73.04 -40.19 65.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 4.6 tt -66.97 -34.98 78.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' B' ' 97' ' ' HIS . 60.1 m80 -84.35 -20.29 32.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.004 -1.06 . . . . 0.0 109.703 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 39.3 t -84.02 -60.04 2.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.915 . . . . 0.0 110.987 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -86.91 -29.86 21.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.991 -1.068 . . . . 0.0 111.601 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -85.8 -51.81 6.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.695 -1.253 . . . . 0.0 110.69 -178.533 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.613 ' C ' ' CG ' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -102.77 -24.21 13.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.021 -1.049 . . . . 0.0 109.853 -179.269 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 1.371 ' ND1' HG21 ' C' ' 41' ' ' THR . 0.5 OUTLIER 44.64 47.23 8.62 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.146 -0.971 . . . . 0.0 109.822 179.645 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.426 ' H ' HG23 ' B' ' 98' ' ' VAL . 4.0 t -60.73 121.48 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -0.995 . . . . 0.0 108.987 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' B' ' 100' ' ' PRO . 13.9 m-20 -59.08 143.99 83.41 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 0.0 109.236 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' B' ' 99' ' ' ASP . 76.1 Cg_exo -45.85 -174.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.356 2.038 . . . . 0.0 112.317 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 57.45 76.58 0.31 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.448 ' C ' ' N ' ' B' ' 104' ' ' ARG . 40.5 t-20 -171.57 -67.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.41 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -49.05 -15.78 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.93 . . . . 0.0 109.319 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ARG . . . . . 0.448 ' N ' ' C ' ' B' ' 102' ' ' ASN . 10.3 mmt180 -76.27 -31.06 58.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 mt -77.83 -52.03 9.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.917 HD13 ' CHC' ' B' ' 147' ' ' HEC . 5.4 tt -51.03 -49.16 61.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.155 -0.966 . . . . 0.0 109.308 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.78 -21.32 65.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -85.62 -27.76 25.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -1.18 . . . . 0.0 109.731 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.443 HG21 HD12 ' B' ' 31' ' ' LEU . 76.4 t -69.15 -47.48 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 109.647 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 16.1 mt -48.39 -39.74 23.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 65.2 t -51.08 -36.41 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.657 ' SG ' ' CD2' ' A' ' 122' ' ' HIS . 14.4 t -78.19 -22.99 47.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.554 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.17 -27.2 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.603 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 28.6 mt -81.36 -22.39 38.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.972 . . . . 0.0 109.502 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' B' ' 119' ' ' GLY . . . -83.48 -37.0 23.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.468 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 9.1 t-80 -68.97 -49.04 61.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.496 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 0.3 OUTLIER -74.32 -17.68 60.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.475 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 6.1 m-85 -152.38 61.94 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.439 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.54 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -62.08 -25.52 66.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -74.1 -31.03 62.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -1.139 . . . . 0.0 109.544 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -82.25 11.73 5.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.321 -0.862 . . . . 0.0 109.626 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.553 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -85.0 35.05 0.56 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.557 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.465 ' OG1' HG23 ' B' ' 126' ' ' VAL . 63.4 p -54.53 147.31 30.04 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.373 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.512 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 4.0 Cg_exo -45.13 -54.53 4.22 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.541 2.16 . . . . 0.0 113.173 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 18.4 Cg_endo -59.41 -11.56 14.05 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.119 1.88 . . . . 0.0 112.236 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.465 HG23 ' OG1' ' B' ' 123' ' ' THR . 72.5 t -97.72 -20.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.222 -0.924 . . . . 0.0 109.626 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 127' ' ' GLN . . . . . 0.563 ' NE2' ' CG1' ' A' ' 107' ' ' VAL . 5.4 tp-100 -83.37 -59.99 2.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.159 -0.963 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.602 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -61.67 -34.81 76.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.21 -0.931 . . . . 0.0 109.623 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.02 23.93 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' B' ' 128' ' ' ALA . 23.4 t80 -118.9 -59.17 1.89 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.837 . . . . 0.0 109.68 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -47.07 -23.33 0.47 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.861 . . . . 0.0 109.955 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -82.52 -38.28 24.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 109.892 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 133' ' ' VAL . . . . . 0.587 ' HA ' HG23 ' B' ' 1' ' ' VAL . 45.0 t -61.6 -41.04 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.885 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.443 HG22 ' H ' ' B' ' 134' ' ' VAL . 1.6 m -81.97 -40.72 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.77 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 1.061 ' C ' ' CE1' ' D' ' 146' ' ' HIS . . . -47.51 -20.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.008 . . . . 0.0 109.523 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 136' ' ' GLY . . . . . 0.691 ' N ' ' HE1' ' D' ' 146' ' ' HIS . . . -75.63 -41.63 28.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.21 -21.96 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -1.13 . . . . 0.0 109.483 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.55 -44.36 80.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.463 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.864 HD21 ' HB2' ' D' ' 146' ' ' HIS . 0.9 OUTLIER -79.71 -35.35 39.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.2 -43.95 42.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.905 . . . . 0.0 109.53 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.1 17.79 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.415 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' B' ' 146' ' ' HIS . . . -141.07 8.18 2.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -67.03 -38.19 85.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.307 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.32 -13.42 62.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' B' ' 145' ' ' TYR . 23.1 p90 -160.55 55.36 0.32 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 1.031 ' CE1' ' C ' ' D' ' 135' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.446 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' C' ' 131' ' ' SER . 12.4 tp -171.71 145.52 1.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.953 . . . . 0.0 109.661 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.59 168.39 20.17 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.309 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' C' ' 5' ' ' ALA . 55.7 Cg_endo -73.22 -61.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.656 2.237 . . . . 0.0 112.662 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.2 -38.26 5.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.145 -0.972 . . . . 0.0 109.717 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' C' ' 5' ' ' ALA . 4.8 m-20 -44.63 -28.23 0.58 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.05 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' C' ' 10' ' ' VAL . 77.0 mttt -83.19 -60.24 2.21 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.443 -0.786 . . . . 0.0 109.033 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 46.1 m -46.46 -31.56 2.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.519 -0.738 . . . . 0.0 109.639 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -76.73 -35.93 57.48 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.492 HG21 ' CG ' ' C' ' 128' ' ' PHE . 4.5 t -73.53 -50.24 31.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -49.08 -42.98 40.61 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.32 -63.59 1.14 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.494 -0.754 . . . . 0.0 109.3 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.696 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -55.33 -39.12 69.59 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.428 -0.795 . . . . 0.0 109.191 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 14' ' ' TRP . . . . . 0.428 ' NE1' ' OG1' ' C' ' 67' ' ' THR . 0.1 OUTLIER -71.21 -17.31 62.52 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.285 -0.885 . . . . 0.0 109.088 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.19 -46.18 7.73 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 12.9 mmmt -70.6 -34.78 72.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -1.156 . . . . 0.0 108.806 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.696 HG23 ' O ' ' C' ' 13' ' ' ALA . 69.0 t -62.8 -66.19 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 60.9 -140.83 48.09 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 19' ' ' ALA . . . . . 0.405 ' O ' ' CG ' ' C' ' 20' ' ' HIS . . . -66.63 49.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.458 -1.025 . . . . 0.0 110.169 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' C' ' 18' ' ' GLY . 79.7 m-70 -153.79 19.66 0.52 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -83.87 -62.83 1.47 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.693 -0.63 . . . . 0.0 109.743 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.25 -14.37 0.16 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 21' ' ' ALA . 3.4 mm-40 -86.75 -56.5 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 109.703 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.8 m-30 -55.27 -52.35 63.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.175 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.05 -22.88 14.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' ALA . . . . . 0.548 ' HB1' HG12 ' C' ' 55' ' ' VAL . . . -73.57 -45.42 53.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 109.762 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 27' ' ' GLU . . . . . 0.512 ' OE1' ' NE2' ' C' ' 112' ' ' HIS . 94.9 mt-10 -65.65 -19.87 66.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.482 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.49 60.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.905 . . . . 0.0 109.377 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.463 HD11 ' HD1' ' C' ' 58' ' ' HIS . 21.4 mt -65.88 -41.2 91.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.711 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -75.64 -12.55 60.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.858 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.401 ' HA ' ' NE ' ' C' ' 31' ' ' ARG . 3.1 tpm_? -78.94 -47.34 16.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.154 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' MET . . . . . 0.491 ' HE1' HBC3 ' C' ' 142' ' ' HEC . 1.1 ptm -65.76 -26.24 67.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 0.0 109.733 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.41 -36.52 83.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 0.0 109.373 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 12.1 mt -85.66 -44.88 12.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.678 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 40.3 t -51.51 -19.63 1.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.852 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' C' ' 35' ' ' SER . 59.9 m-85 -160.92 90.4 1.61 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 0.0 109.65 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' C' ' 39' ' ' THR . 52.2 Cg_exo -50.4 -26.17 15.52 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.488 2.125 . . . . 0.0 112.137 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.784 ' O ' HG22 ' C' ' 41' ' ' THR . 10.8 p -47.32 -18.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.439 ' N ' ' O ' ' C' ' 37' ' ' PRO . 21.8 p -76.6 -22.76 53.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.238 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' C' ' 43' ' ' PHE . 28.8 ttmt -74.29 -31.77 62.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.777 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 41' ' ' THR . . . . . 1.371 HG21 ' ND1' ' B' ' 97' ' ' HIS . 14.2 t -47.03 -25.75 0.89 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 109.354 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.474 ' C ' ' CG ' ' C' ' 43' ' ' PHE . 97.4 m-85 -87.92 31.02 0.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.474 ' CG ' ' C ' ' C' ' 42' ' ' TYR . 0.9 OUTLIER 70.2 149.64 0.12 Allowed Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.531 ' O ' ' C ' ' C' ' 45' ' ' HIS . 39.9 Cg_endo -68.86 -42.88 3.99 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.036 1.824 . . . . 0.0 112.261 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.534 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 21.6 p80 34.42 34.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.586 -0.696 . . . . 0.0 109.244 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.705 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.9 OUTLIER -166.6 75.47 0.18 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.322 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.609 ' C ' ' O ' ' C' ' 46' ' ' PHE . 20.7 m-20 -8.76 -54.69 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 120.985 0.422 . . . . 0.0 111.493 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.705 ' N ' ' O ' ' C' ' 46' ' ' PHE . 5.7 mt 56.71 4.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.485 ' H ' ' C ' ' C' ' 47' ' ' ASP . 33.4 t -73.34 19.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 109.348 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 50' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' C' ' 48' ' ' LEU . 6.6 t-80 58.81 156.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.42 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.06 15.23 1.43 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 10.7 t -72.49 -21.33 61.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -1.127 . . . . 0.0 109.422 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 67.54 -50.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.463 -0.773 . . . . 0.0 109.717 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' C' ' 52' ' ' SER . 15.8 pt20 -45.39 -17.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.667 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.548 HG12 ' HB1' ' C' ' 26' ' ' ALA . 77.4 t -73.87 -32.94 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.75 -24.77 67.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.673 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.16 -51.07 41.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 24.9 t-80 -67.8 -27.92 67.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -1.202 . . . . 0.0 110.221 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' C' ' 26' ' ' ALA . . . -63.13 -31.05 79.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.419 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 16.9 mtpp -71.92 -23.48 61.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -1.152 . . . . 0.0 110.118 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.817 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 0.4 OUTLIER -66.91 -58.15 5.56 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.044 -1.035 . . . . 0.0 108.574 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -55.08 -48.98 75.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.536 -0.728 . . . . 0.0 109.245 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' C' ' 67' ' ' THR . . . -64.33 -42.55 96.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.299 -0.875 . . . . 0.0 108.854 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 64' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 7.4 t70 -72.0 -25.69 61.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.065 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 1.076 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -80.61 -44.75 18.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.375 -0.828 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 66' ' ' LEU . . . . . 0.936 ' O ' HD12 ' C' ' 66' ' ' LEU . 0.1 OUTLIER -76.5 -27.38 56.01 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.551 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.428 ' OG1' ' NE1' ' C' ' 14' ' ' TRP . 52.0 m -75.89 -44.66 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 68' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' C' ' 71' ' ' ALA . 17.7 t-20 -57.45 -20.72 32.34 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.33 -45.68 12.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' C' ' 10' ' ' VAL . 6.0 t -59.75 -22.57 24.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' C' ' 68' ' ' ASN . . . -65.48 -15.17 62.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.092 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' C' ' 74' ' ' ASP . 73.7 m-70 -153.03 -51.87 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.434 -0.791 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.1 p 44.59 15.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.85 0.833 . . . . 0.0 109.214 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' C' ' 72' ' ' HIS . 95.8 m-20 -134.36 10.43 3.78 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' C' ' 78' ' ' ASN . 31.2 t70 -175.1 27.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.248 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.693 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.1 ptt? -78.52 -24.29 0.43 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.433 -0.792 . . . . 0.0 111.839 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.4 Cg_exo -52.81 -19.79 11.62 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.711 1.607 . . . . 0.0 112.629 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 78' ' ' ASN . . . . . 0.452 ' ND2' ' N ' ' C' ' 79' ' ' ALA . 0.8 OUTLIER -94.25 -33.09 13.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.823 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 79' ' ' ALA . . . . . 0.452 ' N ' ' ND2' ' C' ' 78' ' ' ASN . . . -74.6 -40.81 61.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.62 12.13 13.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 108.983 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 81' ' ' SER . . . . . 0.417 ' O ' ' OD1' ' C' ' 85' ' ' ASP . 66.3 p -70.63 -16.19 62.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.632 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -82.1 -51.59 7.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.16 -0.963 . . . . 0.0 109.719 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.438 ' N ' HD23 ' C' ' 83' ' ' LEU . 3.5 mt -45.2 -42.82 9.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.804 . . . . 0.0 109.028 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 29.7 p -57.1 -22.15 37.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.493 -0.755 . . . . 0.0 109.574 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' C' ' 82' ' ' ALA . 0.8 OUTLIER -72.6 -32.7 66.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.94 . . . . 0.0 109.592 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' C' ' 90' ' ' LYS . 7.0 tt -81.37 -29.13 34.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 109.516 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -89.87 -28.47 19.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.58 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' C' ' 90' ' ' LYS . . . -83.84 -80.44 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 89' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' C' ' 89' ' ' HIS . 30.6 t-80 -61.2 2.49 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.57 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' C' ' 88' ' ' ALA . 6.1 mtmm -156.07 152.38 27.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.281 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' C' ' 93' ' ' VAL . 10.9 mp 56.97 63.81 1.82 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -0.865 . . . . 0.0 109.033 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 92' ' ' ARG . . . . . 1.321 ' HB3' ' NH1' ' B' ' 40' ' ' ARG . 8.4 ptp180 -62.73 14.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.47 -0.769 . . . . 0.0 109.501 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.636 ' H ' ' C ' ' C' ' 91' ' ' LEU . 74.1 t -41.38 121.66 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.384 -0.823 . . . . 0.0 109.64 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.06 147.87 2.2 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.465 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' C' ' 97' ' ' ASN . 38.0 Cg_endo -68.25 -10.7 29.74 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.512 2.141 . . . . 0.0 112.126 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 0.419 ' H ' HG23 ' C' ' 96' ' ' VAL . 2.8 t -55.27 -1.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 1.047 ' HB3' HMC1 ' C' ' 142' ' ' HEC . 5.1 m120 -74.69 -42.27 58.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.857 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 98' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' C' ' 98' ' ' PHE . 2.2 m-85 -46.37 -42.1 14.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 0.0 109.337 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -57.95 -33.07 68.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.302 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' C' ' 97' ' ' ASN . 11.1 mt -84.09 -62.12 1.64 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 1.102 HD22 HBB3 ' C' ' 142' ' ' HEC . 6.3 tt -50.35 -41.91 52.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.199 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 39.0 m -63.17 -51.01 68.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.528 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -66.1 -26.76 67.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.544 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.55 -50.5 69.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.753 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.38 -43.02 23.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -0.931 . . . . 0.0 109.384 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.551 ' N ' HD12 ' C' ' 106' ' ' LEU . 8.6 mp -64.15 -59.39 4.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.356 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 107' ' ' VAL . . . . . 0.554 ' CG1' ' NE2' ' D' ' 127' ' ' GLN . 77.0 t -56.33 -30.93 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.379 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 26.6 m -75.75 -63.09 1.38 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.318 -0.864 . . . . 0.0 109.388 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 113' ' ' LEU . 13.1 mt -51.32 -30.66 19.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 109.486 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -47.42 -42.29 21.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.717 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.12 -49.21 11.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.422 -0.799 . . . . 0.0 109.763 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 112' ' ' HIS . . . . . 0.512 ' NE2' ' OE1' ' C' ' 27' ' ' GLU . 11.4 m170 -76.3 -70.0 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.871 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -110.88 97.07 32.27 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.433 -0.792 . . . . 0.0 109.132 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 114' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' C' ' 113' ' ' LEU . 73.0 Cg_exo -47.46 -174.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.399 2.066 . . . . 0.0 112.883 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.482 ' HB2' ' CE1' ' C' ' 122' ' ' HIS . . . -86.59 -35.18 19.6 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.696 0.76 . . . . 0.0 109.517 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 3.8 mt-10 78.45 0.84 2.61 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.94 ' HD1' HH21 ' D' ' 30' ' ' ARG . 22.0 t80 65.27 37.64 6.33 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.602 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.764 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -94.01 115.15 64.81 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.749 -1.22 . . . . 0.0 107.907 178.184 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 119' ' ' PRO . . . . . 0.76 ' HA ' ' CG1' ' D' ' 33' ' ' VAL . 50.5 Cg_exo -50.38 21.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.974 1.782 . . . . 0.0 112.571 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -147.08 -21.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.039 . . . . 0.0 110.966 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.76 HG13 ' N ' ' C' ' 122' ' ' HIS . 10.4 p -58.23 -58.76 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.95 -1.094 . . . . 0.0 110.385 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.76 ' N ' HG13 ' C' ' 121' ' ' VAL . 1.1 m-70 -70.98 -24.97 62.51 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.266 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 123' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' D' ' 33' ' ' VAL . . . -84.1 -20.68 32.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.508 ' N ' ' O ' ' C' ' 120' ' ' ALA . 62.5 p -77.38 -63.15 1.44 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.267 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' C' ' 125' ' ' LEU . 4.6 mt -60.5 -19.95 58.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.075 -1.016 . . . . 0.0 109.084 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 126' ' ' ASP . . . . . 0.487 ' OD2' ' OH ' ' D' ' 35' ' ' TYR . 7.4 t70 -77.71 -51.21 10.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.455 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.26 -41.75 11.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.817 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' C' ' 124' ' ' SER . 29.8 t80 -50.25 -22.94 1.96 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.985 -1.072 . . . . 0.0 108.991 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.495 HD22 HBB1 ' C' ' 142' ' ' HEC . 14.9 mt -74.05 -24.69 59.56 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -56.67 -31.99 64.97 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.481 ' HB3' HD13 ' C' ' 2' ' ' LEU . 89.4 p -73.99 -32.42 63.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.48 -29.74 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.45 ' N ' ' O ' ' C' ' 129' ' ' LEU . 9.8 p -81.86 -25.33 35.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.329 -0.857 . . . . 0.0 108.881 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 36.8 m -74.96 -40.08 60.95 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.361 -0.837 . . . . 0.0 109.1 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.08 -21.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.344 -0.847 . . . . 0.0 108.779 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.77 -35.99 72.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.434 -0.792 . . . . 0.0 109.072 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 137' ' ' THR . . . . . 0.434 ' O ' ' O ' ' C' ' 138' ' ' SER . 57.5 p -88.04 -2.44 58.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 109.571 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 138' ' ' SER . . . . . 0.434 ' O ' ' O ' ' C' ' 137' ' ' THR . 28.3 m 51.89 98.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 109.555 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' C' ' 138' ' ' SER . 5.9 mtpm? -55.04 -170.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 109.532 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -61.42 -67.75 0.38 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.435 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 141' ' ' ARG . . . . . 0.832 HH12 HH12 ' A' ' 141' ' ' ARG . 43.4 mtp180 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.441 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.935 HG22 ' H ' ' D' ' 2' ' ' HIS . 8.3 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 2' ' ' HIS . . . . . 0.935 ' H ' HG22 ' D' ' 1' ' ' VAL . 36.9 m80 52.03 98.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.384 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.892 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -136.45 -163.14 1.36 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 109.254 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.403 ' O ' ' N ' ' D' ' 6' ' ' GLU . 11.9 p -89.02 130.64 43.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.132 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -42.05 -23.06 0.23 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.292 1.995 . . . . 0.0 112.24 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' D' ' 4' ' ' THR . 51.9 mt-10 -80.05 -54.34 5.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.925 . . . . 0.0 109.877 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.39 -40.98 85.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.946 . . . . 0.0 109.87 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.729 ' HB2' HD13 ' D' ' 3' ' ' LEU . 0.3 OUTLIER -68.64 -35.08 76.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.473 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 9' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 4.9 m -60.66 -23.64 64.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 109.879 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.38 -57.64 3.39 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.067 -1.02 . . . . 0.0 109.859 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.436 ' H ' HG12 ' D' ' 11' ' ' VAL . 1.3 p -62.69 -24.41 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 82.0 m -83.9 -35.1 24.35 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.349 0.595 . . . . 0.0 109.695 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 13' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' D' ' 9' ' ' SER . . . -69.11 -29.37 67.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.83 . . . . 0.0 109.668 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.1 -20.98 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.312 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 15' ' ' TRP . . . . . 0.46 ' HE1' ' HB2' ' D' ' 72' ' ' SER . 0.8 OUTLIER -53.61 -17.93 2.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 109.067 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.7 -33.35 47.3 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -89.72 -41.63 11.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -1.178 . . . . 0.0 109.35 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -57.17 114.83 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.847 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' D' ' 21' ' ' ASP . 7.4 m120 -84.1 68.41 10.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.296 -0.877 . . . . 0.0 108.686 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' D' ' 19' ' ' ASN . 72.3 t -43.94 -18.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 109.673 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' D' ' 19' ' ' ASN . 1.1 m-20 -62.39 -10.77 12.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.764 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -154.37 -35.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 109.517 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 72.8 t -48.72 -34.97 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.17 -25.99 68.8 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.04 -36.22 25.37 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -67.66 -30.67 70.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -1.125 . . . . 0.0 109.487 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.43 46.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 28' ' ' LEU . . . . . 0.55 HD12 ' N ' ' D' ' 28' ' ' LEU . 10.0 mp -64.32 -55.71 19.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.377 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.1 -41.35 29.86 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 30' ' ' ARG . . . . . 0.94 HH21 ' HD1' ' C' ' 117' ' ' PHE . 73.3 mtt-85 -80.0 -34.57 38.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -1.117 . . . . 0.0 109.502 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 31' ' ' LEU . . . . . 0.438 HD12 HG21 ' D' ' 109' ' ' VAL . 65.3 tp -47.19 -37.11 9.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 32' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' D' ' 36' ' ' PRO . 14.7 mt -81.31 -39.24 25.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.923 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.76 ' CG1' ' HA ' ' C' ' 119' ' ' PRO . 73.1 t -58.11 -61.48 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.385 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' C' ' 122' ' ' HIS . 1.7 t -68.69 -22.55 26.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.397 -0.814 . . . . 0.0 109.828 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 35' ' ' TYR . . . . . 0.487 ' OH ' ' OD2' ' C' ' 126' ' ' ASP . 63.9 m-85 -146.77 76.43 11.65 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.153 -0.967 . . . . 0.0 109.767 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 36' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' D' ' 32' ' ' LEU . 72.2 Cg_endo -82.86 28.9 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.912 2.408 . . . . 0.0 112.323 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 37' ' ' TRP . . . . . 0.534 ' CD1' HG23 ' D' ' 38' ' ' THR . 3.8 p-90 -80.95 -20.0 42.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.095 -1.003 . . . . 0.0 109.717 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.534 HG23 ' CD1' ' D' ' 37' ' ' TRP . 44.8 p -78.37 -103.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.554 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 39' ' ' GLN . . . . . 0.524 ' N ' ' OG1' ' D' ' 38' ' ' THR . 13.9 mt-30 55.03 10.67 0.42 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.645 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 40' ' ' ARG . . . . . 1.287 ' NH1' ' HB3' ' A' ' 92' ' ' ARG . 15.8 mmt180 -88.7 -58.86 2.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -71.45 -8.28 52.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 1.399 ' CZ ' ' CBC' ' D' ' 147' ' ' HEC . 49.4 m-85 -87.72 28.22 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.7 -27.31 65.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.462 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 94.0 p -84.11 -27.22 28.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -49.55 -24.43 2.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.299 -0.876 . . . . 0.0 109.241 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.82 173.11 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.89 91.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -1.091 . . . . 0.0 109.572 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 12.6 mt -139.01 19.71 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 109.31 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -58.85 -34.02 71.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.15 -0.969 . . . . 0.0 109.434 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 50' ' ' THR . . . . . 0.479 ' HG1' ' CG ' ' D' ' 52' ' ' ASP . 0.1 OUTLIER -140.6 154.23 68.97 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.32 -24.34 73.94 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.253 1.969 . . . . 0.0 111.765 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 52' ' ' ASP . . . . . 0.479 ' CG ' ' HG1' ' D' ' 50' ' ' THR . 2.8 p30 -85.22 -21.0 29.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.608 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.98 -19.9 65.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 109.735 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 54' ' ' VAL . . . . . 0.445 ' O ' HG21 ' D' ' 60' ' ' VAL . 4.4 t -67.07 -64.03 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 0.0 109.465 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.05 8.13 1.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.537 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.68 -29.83 60.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -84.42 147.65 50.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.212 -1.169 . . . . 0.0 109.377 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.65 -7.14 19.79 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.584 2.19 . . . . 0.0 112.193 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -85.69 -28.56 24.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.666 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 60' ' ' VAL . . . . . 0.445 HG21 ' O ' ' D' ' 54' ' ' VAL . 83.9 t -70.24 -52.95 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -57.82 -26.42 61.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.89 -46.68 43.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.625 ' CE1' ' CHA' ' D' ' 147' ' ' HEC . 58.2 t-80 -61.72 -23.84 66.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.887 . . . . 0.0 109.443 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.07 -20.0 77.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -69.51 -37.3 77.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 109.084 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 66' ' ' LYS . . . . . 0.599 ' CB ' HBA2 ' D' ' 147' ' ' HEC . 62.1 mmtt -68.13 -40.69 82.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.444 -0.785 . . . . 0.0 109.498 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.581 HG13 ' C2B' ' D' ' 147' ' ' HEC . 41.9 t -61.29 -59.1 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.203 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.518 ' O ' HD23 ' D' ' 68' ' ' LEU . 4.8 tt -58.59 -52.61 64.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 108.983 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.15 -44.98 27.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 70' ' ' ALA . . . . . 0.437 ' HB2' HMA1 ' D' ' 147' ' ' HEC . . . -60.7 -44.46 96.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -1.128 . . . . 0.0 109.379 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 71' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' D' ' 71' ' ' PHE . 2.5 t80 -69.59 -27.22 64.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.853 . . . . 0.0 109.336 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 72' ' ' SER . . . . . 0.46 ' HB2' ' HE1' ' D' ' 15' ' ' TRP . 88.5 p -76.93 -27.85 55.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 73' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' D' ' 77' ' ' HIS . 10.6 t70 -47.42 -37.11 10.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.09 -60.6 6.62 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.544 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.7 mp -56.61 -24.79 50.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -1.159 . . . . 0.0 109.156 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 76' ' ' ALA . . . . . 0.544 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -93.86 -11.11 31.86 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 109.583 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 80.0 m-70 -161.19 65.15 0.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.59 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 78' ' ' LEU . . . . . 0.574 HD21 HG21 ' D' ' 1' ' ' VAL . 2.0 mt -71.73 10.29 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.082 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' D' ' 77' ' ' HIS . 2.8 p30 -64.35 -30.23 71.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.378 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 80' ' ' ASN . . . . . 0.433 ' N ' ' OD1' ' D' ' 79' ' ' ASP . 34.5 t-20 -171.09 105.08 0.23 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.14 -58.87 2.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -48.23 -23.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.0 109.449 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 83' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -68.73 -54.82 13.23 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.54 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.9 t -75.2 -47.17 29.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -1.164 . . . . 0.0 109.417 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.54 ' N ' ' CG2' ' D' ' 84' ' ' THR . 48.6 m-85 -62.7 -5.41 2.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.67 62.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.273 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 37.1 p -79.75 -51.22 9.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.379 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.431 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 27.1 mt -59.68 -42.07 92.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 5.1 m -65.09 -42.41 94.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -73.1 -40.15 65.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 4.6 tt -67.02 -35.03 79.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.607 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.561 ' O ' ' N ' ' D' ' 97' ' ' HIS . 60.0 m80 -84.28 -20.28 32.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.926 -1.109 . . . . 0.0 109.722 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 39.4 t -84.01 -60.07 2.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 111.01 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -86.96 -29.8 21.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.001 -1.062 . . . . 0.0 111.59 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 95' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -85.77 -51.92 6.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.772 -1.205 . . . . 0.0 110.649 -178.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.607 ' C ' ' CG ' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -102.75 -24.12 13.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.06 -1.025 . . . . 0.0 109.856 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 1.413 ' ND1' HG21 ' A' ' 41' ' ' THR . 0.5 OUTLIER 44.64 47.08 8.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.104 -0.998 . . . . 0.0 109.892 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 t -60.6 121.51 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.119 -0.988 . . . . 0.0 109.033 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 99' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' D' ' 100' ' ' PRO . 13.9 m-20 -59.09 143.97 83.47 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.225 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 100' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' D' ' 99' ' ' ASP . 75.4 Cg_exo -45.85 -174.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.423 2.082 . . . . 0.0 112.342 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 57.44 76.61 0.31 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 102' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' D' ' 104' ' ' ARG . 40.5 t-20 -171.6 -67.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.432 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -49.0 -15.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 104' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' D' ' 102' ' ' ASN . 10.3 mmt180 -76.2 -31.15 58.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.336 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 mt -77.78 -51.99 9.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.859 . . . . 0.0 109.645 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.914 HD13 ' CHC' ' D' ' 147' ' ' HEC . 5.4 tt -51.09 -49.18 61.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.107 -0.996 . . . . 0.0 109.23 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.77 -21.24 65.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -85.75 -27.64 25.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -1.162 . . . . 0.0 109.715 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 109' ' ' VAL . . . . . 0.438 HG21 HD12 ' D' ' 31' ' ' LEU . 77.0 t -69.15 -47.48 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.646 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 16.2 mt -48.48 -39.7 23.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 109.503 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 65.4 t -51.11 -36.45 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 112' ' ' CYS . . . . . 0.649 ' SG ' ' CD2' ' C' ' 122' ' ' HIS . 14.4 t -78.09 -23.02 48.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -79.14 -27.18 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.644 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 29.0 mt -81.47 -22.31 38.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.903 . . . . 0.0 109.507 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' D' ' 119' ' ' GLY . . . -83.45 -36.93 23.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 109.635 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.456 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 9.2 t-80 -68.96 -49.08 61.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 117' ' ' HIS . . . . . 0.502 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 0.3 OUTLIER -74.32 -17.7 60.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.486 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 6.2 m-85 -152.37 62.07 0.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -62.07 -25.55 66.38 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -74.16 -31.0 62.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.535 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -82.27 11.75 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -84.98 34.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.961 . . . . 0.0 109.536 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.479 ' OG1' HG23 ' D' ' 126' ' ' VAL . 65.1 p -54.42 147.34 28.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.516 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.9 Cg_exo -45.11 -54.58 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.411 2.074 . . . . 0.0 113.16 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 18.3 Cg_endo -59.39 -11.5 13.81 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.113 1.875 . . . . 0.0 112.298 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.479 HG23 ' OG1' ' D' ' 123' ' ' THR . 72.1 t -97.86 -20.44 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 109.59 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 127' ' ' GLN . . . . . 0.554 ' NE2' ' CG1' ' C' ' 107' ' ' VAL . 5.4 tp-100 -83.34 -60.1 2.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 109.859 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -61.67 -34.78 76.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.96 23.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' D' ' 128' ' ' ALA . 23.5 t80 -118.96 -59.19 1.88 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.44 -0.788 . . . . 0.0 109.591 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -47.03 -23.35 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.983 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -82.56 -38.22 24.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -0.972 . . . . 0.0 109.932 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 133' ' ' VAL . . . . . 0.585 ' HA ' HG23 ' D' ' 1' ' ' VAL . 45.2 t -61.59 -41.05 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -0.95 . . . . 0.0 109.881 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.43 ' H ' HG22 ' D' ' 134' ' ' VAL . 1.6 m -82.04 -40.71 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.98 . . . . 0.0 109.771 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 1.031 ' C ' ' CE1' ' B' ' 146' ' ' HIS . . . -47.5 -20.99 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.119 -0.988 . . . . 0.0 109.58 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 136' ' ' GLY . . . . . 0.68 ' N ' ' HE1' ' B' ' 146' ' ' HIS . . . -75.63 -41.51 29.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.31 -21.86 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -1.128 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.63 -44.29 81.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.88 HD21 ' HB2' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -79.67 -35.4 39.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.539 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.23 -43.94 43.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.496 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 40.2 mt -84.07 17.72 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 142' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' D' ' 146' ' ' HIS . . . -140.99 8.15 2.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.264 -0.898 . . . . 0.0 109.467 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -67.02 -38.13 85.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.888 . . . . 0.0 109.31 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.38 -13.47 62.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.862 . . . . 0.0 109.355 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 145' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' D' ' 145' ' ' TYR . 23.2 p90 -160.51 55.4 0.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 1.061 ' CE1' ' C ' ' B' ' 135' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 1.105 HBB3 HD22 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 1.418 ' CBC' ' CZ ' ' B' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 1.102 HBB3 HD22 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 1.399 ' CBC' ' CZ ' ' D' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.416 ' C ' ' OG ' ' A' ' 3' ' ' SER . 14.7 mt -139.09 -178.34 5.3 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.375 -0.828 . . . . 0.0 109.18 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.497 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 178.77 -50.9 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.993 . . . . 0.0 110.065 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 6' ' ' ASP . 83.0 Cg_exo -43.63 155.64 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.43 2.087 . . . . 0.0 112.538 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -46.21 -16.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 109.803 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' PRO . 12.5 t70 -39.45 -44.86 1.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 109.816 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 8' ' ' THR . 6.5 ptmt -58.01 -50.41 73.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.125 -0.985 . . . . 0.0 108.992 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.415 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 22.7 m -54.73 -31.41 58.3 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 108.652 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -77.23 -34.84 55.87 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.85 -51.81 41.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -47.78 46.96 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.47 -61.14 2.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.645 -0.659 . . . . 0.0 109.458 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -50.27 -41.91 51.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.403 -0.811 . . . . 0.0 109.066 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -17.54 64.93 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.4 -0.813 . . . . 0.0 109.178 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.18 -45.48 10.11 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.438 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 39.5 mmtt -68.62 -39.59 80.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -1.174 . . . . 0.0 108.763 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 13' ' ' ALA . 58.1 t -61.88 -64.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 54.76 -132.77 47.83 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.73 27.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -1.063 . . . . 0.0 110.376 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.551 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.8 m-70 -131.83 25.2 4.67 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.232 -0.918 . . . . 0.0 108.538 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -89.41 -59.55 2.18 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.566 -0.709 . . . . 0.0 109.789 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.71 -13.89 0.2 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.6 mt-10 -87.58 -56.48 3.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 109.912 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.526 ' CD1' ' ND1' ' A' ' 112' ' ' HIS . 3.0 m-30 -60.11 -29.22 68.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.5 87.19 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.16 -39.13 29.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -1.165 . . . . 0.0 109.75 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -63.88 -25.54 68.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.261 -0.899 . . . . 0.0 109.318 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.35 -23.06 66.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.572 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.669 HD11 ' ND1' ' A' ' 58' ' ' HIS . 10.7 mt -76.65 -58.49 3.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.55 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -62.39 -12.42 21.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HE ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -69.65 -49.92 49.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 110.329 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.6 ptt? -84.11 -36.45 22.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.046 -1.034 . . . . 0.0 110.404 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -43.78 -23.84 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.171 -0.955 . . . . 0.0 110.107 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.548 ' CD1' ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -92.16 -28.8 16.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.125 -0.984 . . . . 0.0 109.951 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 81.2 p -89.21 -18.44 27.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.087 -1.008 . . . . 0.0 110.022 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 35' ' ' SER . 84.7 m-85 -157.95 75.82 3.81 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.104 -0.997 . . . . 0.0 109.719 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.34 -19.98 60.77 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.889 2.393 . . . . 0.0 112.247 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.442 ' O ' HG22 ' A' ' 41' ' ' THR . 24.4 p -48.61 -18.78 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.943 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.1 p -85.92 -52.98 5.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.957 . . . . 0.0 109.803 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 42' ' ' TYR . 0.5 OUTLIER -80.01 -17.57 52.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 109.644 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 40' ' ' LYS . 10.7 t -37.55 -28.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.453 -0.78 . . . . 0.0 109.894 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 40' ' ' LYS . 23.6 m-85 -51.31 -36.5 42.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.101 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.527 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 77.8 t80 45.54 56.6 15.49 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.44 -0.787 . . . . 0.0 110.099 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 43' ' ' PHE . 80.8 Cg_endo -79.6 -41.69 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.637 2.225 . . . . 0.0 111.901 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -176.58 56.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -139.35 63.78 1.49 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 49' ' ' SER . 33.7 m-20 -37.94 -22.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 46' ' ' PHE . 1.2 mt 52.6 6.33 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.218 -0.926 . . . . 0.0 109.583 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 47' ' ' ASP . 34.5 t -81.3 153.3 27.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -47.79 128.64 13.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.53 22.04 13.45 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 54' ' ' GLN . 36.9 m -95.03 66.02 2.95 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -1.155 . . . . 0.0 108.964 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -37.85 -25.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.818 -0.551 . . . . 0.0 110.237 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' A' ' 52' ' ' SER . 14.1 mt-30 -60.8 -46.22 91.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.476 HG22 ' CE2' ' A' ' 46' ' ' PHE . 15.9 t -55.99 -47.62 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.087 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -66.55 -54.19 26.45 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.12 -26.77 29.07 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.669 ' ND1' HD11 ' A' ' 29' ' ' LEU . 6.8 t-80 -69.85 -33.48 72.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.985 -1.303 . . . . 0.0 109.798 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.6 -48.61 83.68 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 51.3 mttp -51.0 -23.82 3.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -1.057 . . . . 0.0 109.811 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.678 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 0.5 OUTLIER -71.43 -50.68 29.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.208 -0.933 . . . . 0.0 108.891 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.63 -43.61 90.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.603 -0.686 . . . . 0.0 109.327 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.04 -28.88 64.7 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.234 -0.916 . . . . 0.0 109.432 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 15.1 t70 -72.26 -40.12 67.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 108.782 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.33 82.03 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.372 -0.83 . . . . 0.0 108.875 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.15 -40.31 95.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -70.62 -51.03 30.87 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -59.39 -22.96 62.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.684 ' HB1' ' SD ' ' A' ' 76' ' ' MET . . . -83.58 -47.31 11.42 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.08 -22.63 31.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.44 -15.09 63.43 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.596 ' O ' ' N ' ' A' ' 74' ' ' ASP . 56.3 m-70 -143.78 -59.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.509 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 73' ' ' VAL . 14.5 p 44.57 13.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.713 0.768 . . . . 0.0 109.492 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' A' ' 72' ' ' HIS . 12.8 t70 -133.38 9.66 4.04 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 2.1 m-20 -179.58 27.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.942 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.684 ' SD ' ' HB1' ' A' ' 69' ' ' ALA . 17.7 ptt? -78.74 -22.75 0.39 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 112.006 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 76' ' ' MET . 52.3 Cg_exo -52.63 -22.01 15.99 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.578 1.519 . . . . 0.0 112.592 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -94.13 -24.03 17.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.728 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.47 -54.29 6.92 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.151 -0.968 . . . . 0.0 109.183 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.664 ' N ' HD12 ' A' ' 80' ' ' LEU . 7.0 mp -77.15 8.89 3.46 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.433 -0.792 . . . . 0.0 109.046 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.6 t -65.18 -15.83 62.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 109.886 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.79 -46.08 14.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 0.0 109.854 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.422 ' N ' HD23 ' A' ' 83' ' ' LEU . 4.2 mt -46.43 -45.93 18.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.314 -0.866 . . . . 0.0 108.94 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 135' ' ' VAL . 37.6 m -54.04 -29.15 42.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.552 -0.717 . . . . 0.0 109.45 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' ALA . 25.9 t0 -65.68 -33.93 77.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 109.499 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.543 ' CD1' ' CBD' ' A' ' 142' ' ' HEC . 3.0 tt -82.99 -63.65 1.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -50.09 -21.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 109.954 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -97.76 -48.11 5.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.168 -0.957 . . . . 0.0 109.955 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -76.73 -70.95 0.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 86' ' ' LEU . 30.1 mttm -86.43 140.65 29.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.808 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.6 mp 53.88 57.91 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.07 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.565 ' HD3' ' CD ' ' D' ' 40' ' ' ARG . 72.5 ttt180 -47.89 -47.58 31.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.829 . . . . 0.0 109.288 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 94' ' ' ASP . 62.1 t 49.67 179.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.353 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.738 ' H ' HG12 ' A' ' 93' ' ' VAL . 34.7 m-20 -133.09 151.87 78.64 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.151 -0.968 . . . . 0.0 109.12 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 98' ' ' PHE . 82.3 Cg_exo -39.28 -19.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.571 2.181 . . . . 0.0 112.282 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 1.317 HG21 ' CB ' ' D' ' 99' ' ' ASP . 64.6 t -47.07 -32.91 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.697 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.452 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 1.5 m120 -79.23 -25.15 42.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 95' ' ' PRO . 77.4 t80 -67.88 -56.38 9.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.83 -28.8 2.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 109.545 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.407 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 17.0 mt -84.04 -52.37 6.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.803 HD22 ' CHC' ' A' ' 142' ' ' HEC . 57.7 tp -47.2 -39.75 14.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.948 . . . . 0.0 109.76 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.2 p -65.04 -59.22 4.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -52.97 -26.79 16.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.811 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 60.4 m -66.46 -58.44 5.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -45.98 -22.99 0.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 109.91 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 4.1 mm? -82.19 -32.33 29.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.029 -1.044 . . . . 0.0 109.808 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.92 -27.5 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.686 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.8 p -69.01 -60.45 2.35 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.156 -0.965 . . . . 0.0 109.549 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 113' ' ' LEU . 37.1 mt -55.88 -42.1 75.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 109.291 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.31 11.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.798 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.27 -55.79 4.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 109.901 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.526 ' ND1' ' CD1' ' A' ' 24' ' ' TYR . 22.3 m170 -59.59 -62.66 1.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.083 -1.011 . . . . 0.0 109.128 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.808 HD12 ' O ' ' A' ' 114' ' ' PRO . 2.4 pp -137.69 118.94 10.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.808 ' O ' HD12 ' A' ' 113' ' ' LEU . 88.2 Cg_exo -40.78 -178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.551 2.167 . . . . 0.0 113.292 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.791 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -57.42 -55.19 37.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.43 -0.794 . . . . 0.0 109.157 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.647 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 4.8 mm-40 120.48 -2.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.2 t80 64.52 52.19 1.83 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.962 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -133.04 111.5 13.17 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.571 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.838 ' HA ' HG13 ' B' ' 33' ' ' VAL . 76.7 Cg_exo -47.48 10.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.139 1.893 . . . . 0.0 112.582 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -132.65 -19.37 2.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.289 -0.882 . . . . 0.0 110.197 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.791 HG21 ' O ' ' A' ' 115' ' ' ALA . 11.6 p -60.36 -55.4 24.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.154 -0.966 . . . . 0.0 110.299 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 1.004 ' HB3' HG13 ' B' ' 34' ' ' VAL . 6.4 m170 -71.93 -33.35 68.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 0.0 108.947 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.99 -20.16 49.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.2 m -64.86 -62.71 1.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 110.003 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.54 -19.56 65.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.191 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.91 -50.11 11.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.718 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -85.55 -43.19 13.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.114 -0.991 . . . . 0.0 109.857 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' N ' ' CD ' ' A' ' 127' ' ' LYS . 53.6 t80 -49.44 -21.0 0.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.962 -1.086 . . . . 0.0 108.668 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.622 ' O ' ' N ' ' A' ' 133' ' ' SER . 12.8 mt -71.94 -17.48 62.08 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.98 -31.65 72.02 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.446 ' O ' HG23 ' A' ' 135' ' ' VAL . 57.4 p -83.29 -34.02 25.83 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.418 -0.801 . . . . 0.0 108.86 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.31 -28.01 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 108.654 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 129' ' ' LEU . 36.8 m -80.08 -28.85 39.05 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.495 -0.753 . . . . 0.0 109.236 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.9 m -71.31 -33.59 69.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.245 -0.909 . . . . 0.0 109.044 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 131' ' ' SER . 30.0 t -79.93 -28.19 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -35.81 73.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.468 -0.77 . . . . 0.0 109.106 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 133' ' ' SER . 14.9 t -101.86 -14.57 17.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 0.0 109.588 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.5 t 55.73 -173.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.329 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 141' ' ' ARG . 56.5 mttp -49.61 -59.86 3.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.561 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.511 ' O ' ' CD2' ' A' ' 140' ' ' TYR . 67.9 t80 52.38 9.33 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.525 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 139' ' ' LYS . 26.0 mtm180 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.475 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.988 HG13 ' H ' ' B' ' 2' ' ' HIS . 2.7 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' HIS . . . . . 0.988 ' H ' HG13 ' B' ' 1' ' ' VAL . 0.5 OUTLIER 53.89 105.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.121 -0.987 . . . . 0.0 109.826 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.449 ' O ' HD12 ' B' ' 3' ' ' LEU . 0.3 OUTLIER -158.92 179.06 9.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.422 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 2.2 p -73.39 151.64 89.79 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.413 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.54 -28.61 21.28 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.558 2.172 . . . . 0.0 112.049 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -78.73 -41.23 31.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.573 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.77 -46.08 83.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.559 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.475 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -72.63 -37.44 68.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 109.624 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.403 ' C ' ' O ' ' B' ' 8' ' ' LYS . 3.3 t -45.63 -23.62 0.26 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.688 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.32 -56.51 3.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 109.949 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -65.21 -24.62 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 5.8 m -77.53 -45.73 24.52 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.398 0.618 . . . . 0.0 109.53 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.21 -34.54 72.3 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.396 -0.815 . . . . 0.0 109.573 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.43 ' C ' ' N ' ' B' ' 16' ' ' GLY . 0.8 OUTLIER -51.8 -32.12 30.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.922 . . . . 0.0 109.122 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -48.68 -17.99 0.22 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.343 -0.848 . . . . 0.0 109.267 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' B' ' 14' ' ' LEU . . . -76.78 -56.7 4.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.416 ' N ' ' CD ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -64.78 -27.48 68.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -1.203 . . . . 0.0 109.15 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.9 114.69 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' B' ' 21' ' ' ASP . 25.4 m-80 -80.42 69.15 6.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.231 -0.918 . . . . 0.0 109.048 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 74.2 t -44.32 -21.32 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.419 -0.801 . . . . 0.0 109.651 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' B' ' 19' ' ' ASN . 68.1 m-20 -74.08 3.87 6.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' B' ' 19' ' ' ASN . 35.1 mt-10 -153.01 -41.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.177 -0.952 . . . . 0.0 109.313 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.54 -46.63 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.288 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.32 -42.94 64.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.88 -44.02 63.75 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -68.01 -25.06 65.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.27 -49.44 66.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.551 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.613 ' N ' HD12 ' B' ' 28' ' ' LEU . 9.4 mp -79.12 -54.51 5.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.45 -33.4 8.3 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -82.08 -39.33 23.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -1.119 . . . . 0.0 109.337 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -49.2 -35.79 18.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 27.3 mt -79.88 -31.95 40.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 109.56 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.838 HG13 ' HA ' ' A' ' 119' ' ' PRO . 61.7 t -66.43 -64.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.423 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 1.004 HG13 ' HB3' ' A' ' 122' ' ' HIS . 1.3 t -64.43 -22.74 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.355 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -146.17 80.73 10.05 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.342 -0.849 . . . . 0.0 109.382 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.36 -5.6 14.33 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.672 2.248 . . . . 0.0 112.439 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.535 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 1.3 p-90 -58.86 -24.43 62.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.535 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 3.1 m -95.91 38.22 1.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.39 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLN . . . . . 0.422 ' H ' ' HG3' ' B' ' 39' ' ' GLN . 5.3 pp0? -90.98 9.52 30.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 109.624 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 1.665 ' CD ' ' HD3' ' C' ' 92' ' ' ARG . 55.1 ttt85 -81.56 -29.83 33.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' B' ' 42' ' ' PHE . 66.2 m-85 -90.91 30.08 1.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.948 . . . . 0.0 109.405 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 1.023 ' HE1' ' CBC' ' B' ' 147' ' ' HEC . 70.5 m-85 -145.66 22.61 1.45 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.48 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -78.93 -16.51 56.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.255 -0.903 . . . . 0.0 109.51 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.463 ' O ' ' N ' ' B' ' 46' ' ' GLY . 27.8 p -67.47 -43.23 81.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.598 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' B' ' 47' ' ' ASP . 88.4 m-85 -48.89 -14.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.506 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 66.89 -65.42 0.19 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' B' ' 45' ' ' PHE . 4.6 m-20 -46.18 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -1.163 . . . . 0.0 109.576 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 tp -159.47 22.62 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 12.9 p -70.45 -33.83 71.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.533 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' THR . . . . . 0.442 ' O ' ' N ' ' B' ' 53' ' ' ALA . 3.4 p -145.7 151.52 46.5 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 0.0 109.111 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -39.96 -42.09 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.373 2.049 . . . . 0.0 112.238 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.2 -31.05 72.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -61.93 -19.79 63.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.475 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 78.6 t -67.96 -63.83 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.657 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 22.4 ptp -83.18 4.49 26.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.723 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.88 -17.23 70.64 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.406 ' ND2' ' HD2' ' B' ' 58' ' ' PRO . 2.3 t-20 -82.19 138.18 45.67 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.0 109.024 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.406 ' HD2' ' ND2' ' B' ' 57' ' ' ASN . 50.2 Cg_endo -71.18 -12.88 30.7 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.247 1.964 . . . . 0.0 112.14 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -80.17 -57.47 3.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.332 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 43.0 t -48.02 -31.58 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.341 -0.85 . . . . 0.0 109.56 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.401 ' HB3' ' HZ2' ' B' ' 61' ' ' LYS . 16.2 mtpp -78.99 -32.94 45.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.508 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.62 -45.79 16.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.69 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.999 ' NE2' HAD2 ' B' ' 147' ' ' HEC . 0.9 OUTLIER -62.72 -23.64 67.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.22 -0.925 . . . . 0.0 109.671 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.57 -36.34 83.15 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -60.15 -25.46 65.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -1.2 . . . . 0.0 109.58 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.69 -50.17 39.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.317 -0.865 . . . . 0.0 109.62 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 1.159 HG13 ' C2B' ' B' ' 147' ' ' HEC . 42.3 t -57.72 -36.73 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.445 HD23 ' C ' ' B' ' 68' ' ' LEU . 5.6 tt -71.58 -48.03 51.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.288 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.46 -44.91 16.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.62 -51.85 56.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -1.131 . . . . 0.0 109.44 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -49.5 -35.29 19.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.403 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -76.01 -24.49 55.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.4 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -52.37 -43.58 64.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.86 -60.12 8.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.495 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.2 mp -57.98 -28.08 64.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.117 . . . . 0.0 109.277 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -80.45 -9.28 59.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.29 -0.881 . . . . 0.0 109.556 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 57.2 m80 -160.27 65.94 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.389 -0.819 . . . . 0.0 109.539 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mt -68.4 11.62 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' B' ' 77' ' ' HIS . 81.5 m-20 -72.4 -31.07 65.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.124 -0.985 . . . . 0.0 109.553 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 16.4 t-20 -171.02 108.89 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.558 HD12 ' N ' ' B' ' 81' ' ' LEU . 9.5 mp -80.26 -54.75 5.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.5 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.446 ' H ' ' HD3' ' B' ' 82' ' ' LYS . 0.6 OUTLIER -49.92 -24.0 2.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.486 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 83' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -73.12 -52.44 8.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.1 t -76.48 -47.58 22.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -1.189 . . . . 0.0 109.528 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.547 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.2 m-85 -66.04 4.76 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.461 -0.775 . . . . 0.0 109.566 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -63.73 -33.4 75.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.423 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.1 p -79.36 -51.3 9.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.418 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' B' ' 92' ' ' HIS . 8.7 mp -53.33 -51.17 63.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.345 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 36.4 p -54.7 -45.4 73.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.927 . . . . 0.0 109.632 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.428 ' O ' ' OD2' ' B' ' 94' ' ' ASP . 32.9 tt0 -66.3 -41.58 89.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.663 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.53 -20.14 40.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.599 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' B' ' 88' ' ' LEU . 1.5 m80 -87.65 -41.21 13.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 110.239 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -82.99 -39.64 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.048 -1.032 . . . . 0.0 110.795 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' B' ' 90' ' ' GLU . 12.1 m-20 -86.18 -36.38 19.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.921 -1.112 . . . . 0.0 111.181 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -52.18 5.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.928 -1.108 . . . . 0.0 110.594 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.583 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 10.0 mp -86.29 -31.81 21.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.92 -1.112 . . . . 0.0 109.68 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 13.5 p80 41.89 29.39 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.382 -0.824 . . . . 0.0 109.858 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.09 124.65 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.178 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 1.284 ' CB ' HG21 ' C' ' 96' ' ' VAL . 0.4 OUTLIER -47.67 154.24 0.94 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.09 -160.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.628 2.219 . . . . 0.0 111.959 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.447 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 29.6 mm-40 57.64 26.3 12.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' B' ' 101' ' ' GLU . 39.1 m-20 -137.53 -32.76 0.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.35 -0.844 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.48 -37.01 85.65 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.497 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -70.14 -23.74 63.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.589 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.583 HD12 ' N ' ' B' ' 105' ' ' LEU . 7.8 mp -79.74 -17.68 52.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.48 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 1.657 ' CD1' ' HAB' ' B' ' 147' ' ' HEC . 2.6 tm? -78.92 -46.72 17.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.318 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.99 -20.46 77.67 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -70.52 -55.66 8.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.083 -1.245 . . . . 0.0 109.797 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -53.72 -24.06 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.634 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.517 HD23 ' O ' ' B' ' 110' ' ' LEU . 1.6 tt -64.44 -50.85 65.91 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.472 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.563 ' CG2' ' CE1' ' B' ' 130' ' ' TYR . 46.7 t -49.44 -45.21 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.716 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 56.5 m -51.55 -35.92 42.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.631 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.91 -28.58 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 41.6 mt -72.73 -40.68 65.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.21 -20.85 59.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 109.297 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.54 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 3.0 t-80 -84.75 -54.62 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.301 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.428 ' HD1' ' N ' ' B' ' 117' ' ' HIS . 0.5 OUTLIER -70.97 -17.54 62.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 0.0 109.671 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.41 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 68.3 m-85 -152.71 62.3 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.573 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.542 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -58.86 -26.99 61.3 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -68.37 -34.97 77.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -82.78 14.23 3.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.638 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.551 ' O ' ' CG ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -82.91 36.32 0.5 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.627 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.605 ' OG1' HG23 ' B' ' 126' ' ' VAL . 7.4 p -46.42 154.15 0.67 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.454 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.453 ' O ' HD13 ' A' ' 34' ' ' LEU . 24.5 Cg_exo -55.49 -44.81 44.85 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.358 2.039 . . . . 0.0 113.749 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' B' ' 124' ' ' PRO . 67.1 Cg_endo -78.17 -8.16 16.35 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.021 1.814 . . . . 0.0 112.615 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.605 HG23 ' OG1' ' B' ' 123' ' ' THR . 10.6 t -83.76 -31.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 109.198 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -83.26 -59.73 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 109.629 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 1.548 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -48.49 -41.96 31.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.18 -36.46 83.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.831 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.563 ' CE1' ' CG2' ' B' ' 111' ' ' VAL . 30.0 t80 -61.23 -60.9 3.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.067 -1.021 . . . . 0.0 109.402 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -47.77 -25.81 1.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.873 . . . . 0.0 109.563 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' B' ' 132' ' ' LYS . 5.0 ttpm? -85.53 -31.52 22.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 109.739 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.49 -65.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.54 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.418 ' H ' HG22 ' B' ' 134' ' ' VAL . 5.9 m -55.48 -15.67 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.597 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.648 ' CB ' ' OXT' ' D' ' 146' ' ' HIS . . . -56.22 -33.73 65.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.341 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.83 -30.52 57.62 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.15 -32.86 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.428 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.94 76.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.332 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -78.73 -21.26 48.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.299 -0.875 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.64 -60.73 2.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.942 . . . . 0.0 109.676 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 63.9 mt -54.22 -20.32 6.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.135 -0.978 . . . . 0.0 109.256 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' B' ' 145' ' ' TYR . . . -88.98 -4.6 58.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 109.116 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 143' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' B' ' 146' ' ' HIS . 71.4 t60 -49.45 -39.08 31.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.498 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -86.94 -55.15 3.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.133 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -52.8 -10.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.514 -0.741 . . . . 0.0 109.36 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.62 ' OXT' ' CB ' ' D' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.469 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.429 ' C ' ' OG ' ' C' ' 3' ' ' SER . 14.6 mt -139.05 -178.3 5.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.361 -0.837 . . . . 0.0 109.218 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.494 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 178.76 -50.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' C' ' 6' ' ' ASP . 83.1 Cg_exo -43.64 155.71 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.309 2.006 . . . . 0.0 112.576 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -46.27 -16.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.841 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' C' ' 4' ' ' PRO . 12.5 t70 -39.43 -44.91 1.43 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.39 -0.819 . . . . 0.0 109.792 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' C' ' 8' ' ' THR . 6.5 ptmt -57.95 -50.48 73.23 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.117 -0.989 . . . . 0.0 109.01 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.411 ' N ' ' CG ' ' C' ' 7' ' ' LYS . 22.6 m -54.67 -31.51 57.85 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 108.61 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -77.16 -34.85 56.38 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.79 -51.82 41.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.37 -47.74 47.33 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.45 -61.18 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.494 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.599 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -50.18 -42.0 50.44 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.392 -0.817 . . . . 0.0 109.06 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -17.57 64.93 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.437 -0.789 . . . . 0.0 109.156 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.2 -45.38 10.17 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 39.6 mmtt -68.72 -39.54 80.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 108.798 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.599 HG23 ' O ' ' C' ' 13' ' ' ALA . 58.1 t -61.86 -65.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 54.78 -132.82 47.94 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.75 27.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.456 -1.026 . . . . 0.0 110.383 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.556 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.7 m-70 -131.77 25.12 4.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -89.32 -59.6 2.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.679 -0.638 . . . . 0.0 109.827 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.73 -13.85 0.2 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.5 mt-10 -87.59 -56.45 3.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.39 -1.065 . . . . 0.0 109.897 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.526 ' CD1' ' ND1' ' C' ' 112' ' ' HIS . 3.0 m-30 -60.18 -29.15 68.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.06 -34.49 86.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.12 -39.13 30.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -1.159 . . . . 0.0 109.754 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.94 -25.55 68.19 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 109.271 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.4 -22.95 66.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.594 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.671 HD11 ' ND1' ' C' ' 58' ' ' HIS . 10.7 mt -76.65 -58.47 3.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -62.38 -12.57 22.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 109.923 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.458 ' HE ' ' HA ' ' C' ' 31' ' ' ARG . 0.3 OUTLIER -69.64 -49.79 50.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 110.327 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 32' ' ' MET . . . . . 0.432 ' O ' ' N ' ' C' ' 34' ' ' LEU . 2.6 ptt? -84.22 -36.53 22.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.136 -0.977 . . . . 0.0 110.335 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 33' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' C' ' 32' ' ' MET . 13.9 t80 -43.63 -23.93 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 110.175 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 1.56 ' CD1' ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -92.05 -28.85 16.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.001 -1.062 . . . . 0.0 110.03 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.516 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 81.5 p -89.25 -18.45 27.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 0.0 109.928 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.516 ' CG ' ' O ' ' C' ' 35' ' ' SER . 85.0 m-85 -157.89 75.78 3.84 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.127 -0.983 . . . . 0.0 109.797 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' C' ' 39' ' ' THR . 26.2 Cg_exo -60.36 -19.99 60.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.906 2.404 . . . . 0.0 112.166 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.436 ' O ' HG22 ' C' ' 41' ' ' THR . 24.4 p -48.63 -18.76 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 109.926 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.4 ' N ' ' C ' ' C' ' 37' ' ' PRO . 38.0 p -85.93 -53.07 5.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.712 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' C' ' 42' ' ' TYR . 0.5 OUTLIER -79.93 -17.56 52.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.666 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.483 ' C ' ' O ' ' C' ' 40' ' ' LYS . 10.9 t -37.45 -28.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.484 -0.76 . . . . 0.0 109.992 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.544 ' N ' ' O ' ' C' ' 40' ' ' LYS . 23.6 m-85 -51.32 -36.54 43.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.018 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.53 ' CD2' ' O ' ' C' ' 43' ' ' PHE . 77.6 t80 45.56 56.6 15.51 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.461 -0.774 . . . . 0.0 110.076 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' C' ' 43' ' ' PHE . 82.5 Cg_endo -79.56 -41.62 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.551 2.167 . . . . 0.0 111.964 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER -176.52 56.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.568 -0.708 . . . . 0.0 109.117 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -139.26 63.69 1.49 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' C' ' 49' ' ' SER . 33.9 m-20 -37.9 -22.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.365 -0.834 . . . . 0.0 110.226 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' C' ' 46' ' ' PHE . 1.2 mt 52.64 6.34 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.127 -0.983 . . . . 0.0 109.608 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.515 ' H ' ' C ' ' C' ' 47' ' ' ASP . 34.6 t -81.3 153.32 27.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.95 . . . . 0.0 109.351 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -47.92 128.71 13.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.372 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.48 22.06 13.48 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.554 ' O ' ' N ' ' C' ' 54' ' ' GLN . 37.9 m -95.15 66.15 2.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -1.124 . . . . 0.0 108.936 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' C' ' 52' ' ' SER . . . -37.92 -25.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.809 -0.557 . . . . 0.0 110.264 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' C' ' 52' ' ' SER . 14.2 mt-30 -60.64 -46.28 90.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 109.529 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.478 HG22 ' CE2' ' C' ' 46' ' ' PHE . 15.9 t -56.05 -47.51 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.976 . . . . 0.0 109.128 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -66.52 -54.22 26.25 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 57' ' ' GLY . . . . . 0.433 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -53.21 -26.64 29.33 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.671 ' ND1' HD11 ' C' ' 29' ' ' LEU . 6.8 t-80 -69.92 -33.55 72.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.08 -1.247 . . . . 0.0 109.736 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.48 -48.68 82.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 51.4 mttp -51.07 -23.81 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -1.095 . . . . 0.0 109.705 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.691 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 0.5 OUTLIER -71.49 -50.5 30.86 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 108.966 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.72 -43.61 89.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.601 -0.687 . . . . 0.0 109.303 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.12 -28.71 64.5 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.306 -0.872 . . . . 0.0 109.44 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 64' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 15.1 t70 -72.35 -40.09 67.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.034 . . . . 0.0 108.753 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.57 -47.38 81.75 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.01 -40.29 95.15 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -70.63 -51.01 30.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.264 -0.898 . . . . 0.0 108.604 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -59.35 -23.03 62.18 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.671 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -83.56 -47.27 11.48 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.96 -22.79 32.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.47 -14.99 63.38 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.602 ' O ' ' N ' ' C' ' 74' ' ' ASP . 56.8 m-70 -143.75 -59.56 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.581 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.542 HG22 ' O ' ' C' ' 73' ' ' VAL . 14.5 p 44.68 13.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.711 0.767 . . . . 0.0 109.507 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' C' ' 72' ' ' HIS . 12.8 t70 -133.37 9.58 4.04 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 2.1 m-20 -179.43 27.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.883 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 17.7 ptt? -78.82 -22.69 0.39 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.365 -0.834 . . . . 0.0 112.004 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.1 Cg_exo -52.54 -22.07 15.79 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.63 1.553 . . . . 0.0 112.522 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -94.16 -24.08 17.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.643 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 -54.27 6.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.15 -0.968 . . . . 0.0 109.142 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 80' ' ' LEU . . . . . 0.668 ' N ' HD12 ' C' ' 80' ' ' LEU . 7.0 mp -77.21 8.94 3.46 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.384 -0.823 . . . . 0.0 109.058 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t -65.21 -15.82 62.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.843 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.75 -46.13 14.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.183 -0.948 . . . . 0.0 109.846 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.417 ' N ' HD23 ' C' ' 83' ' ' LEU . 4.1 mt -46.26 -46.0 17.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.835 . . . . 0.0 109.044 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' C' ' 135' ' ' VAL . 37.6 m -54.02 -29.13 42.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.547 -0.721 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' C' ' 82' ' ' ALA . 25.9 t0 -65.81 -33.85 76.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.109 -0.994 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.537 ' CD1' ' CBD' ' C' ' 142' ' ' HEC . 3.0 tt -83.02 -63.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -49.97 -22.02 1.41 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.877 . . . . 0.0 110.028 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -97.69 -48.14 5.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 110.007 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -76.72 -71.05 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.956 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' C' ' 86' ' ' LEU . 30.1 mttm -86.29 140.58 29.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.736 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.56 HD12 ' N ' ' C' ' 91' ' ' LEU . 10.6 mp 54.0 57.82 5.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.021 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 92' ' ' ARG . . . . . 1.665 ' HD3' ' CD ' ' B' ' 40' ' ' ARG . 72.5 ttt180 -47.86 -47.52 31.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 0.0 109.374 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.74 HG12 ' H ' ' C' ' 94' ' ' ASP . 61.9 t 49.67 179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.314 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.74 ' H ' HG12 ' C' ' 93' ' ' VAL . 34.8 m-20 -133.12 151.81 78.49 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.266 -0.896 . . . . 0.0 109.119 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' C' ' 98' ' ' PHE . 81.7 Cg_exo -39.19 -19.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.612 2.208 . . . . 0.0 112.302 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 96' ' ' VAL . . . . . 1.284 HG21 ' CB ' ' B' ' 99' ' ' ASP . 63.9 t -46.98 -32.92 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.74 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.446 ' N ' ' OD1' ' C' ' 97' ' ' ASN . 1.5 m120 -79.31 -25.07 42.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.942 . . . . 0.0 109.507 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 98' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' C' ' 95' ' ' PRO . 77.2 t80 -67.95 -56.37 9.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.8 -28.83 2.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.477 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 17.0 mt -83.98 -52.36 6.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.165 -0.959 . . . . 0.0 109.565 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.798 HD22 ' CHC' ' C' ' 142' ' ' HEC . 58.0 tp -47.27 -39.55 14.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.777 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 99.3 p -65.13 -59.25 4.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -53.01 -26.72 16.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.83 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 60.4 m -66.42 -58.48 5.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 109.825 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -45.93 -23.13 0.26 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.424 HD22 ' N ' ' C' ' 106' ' ' LEU . 4.1 mm? -82.12 -32.34 30.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.046 -1.034 . . . . 0.0 109.819 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 38.4 t -82.86 -27.61 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.173 -0.954 . . . . 0.0 109.689 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 6.8 p -68.92 -60.52 2.31 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.184 -0.948 . . . . 0.0 109.572 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 36.7 mt -55.79 -42.08 75.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.346 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.33 11.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.773 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.24 -55.79 4.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.941 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 112' ' ' HIS . . . . . 0.526 ' ND1' ' CD1' ' C' ' 24' ' ' TYR . 22.6 m170 -59.67 -62.64 1.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.983 -1.073 . . . . 0.0 109.062 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.806 HD12 ' O ' ' C' ' 114' ' ' PRO . 2.4 pp -137.71 118.91 10.63 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 114' ' ' PRO . . . . . 0.806 ' O ' HD12 ' C' ' 113' ' ' LEU . 89.4 Cg_exo -40.74 -178.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.561 2.174 . . . . 0.0 113.318 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.779 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -57.46 -55.07 39.52 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.422 -0.799 . . . . 0.0 109.164 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.649 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 4.8 mm-40 120.32 -2.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 20.0 t80 64.34 52.32 1.91 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.161 0.505 . . . . 0.0 110.989 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.0 OUTLIER -133.13 111.5 13.07 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.514 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 119' ' ' PRO . . . . . 0.85 ' HA ' HG13 ' D' ' 33' ' ' VAL . 78.1 Cg_exo -47.41 10.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.171 1.914 . . . . 0.0 112.561 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -132.72 -19.4 2.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.882 . . . . 0.0 110.279 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.779 HG21 ' O ' ' C' ' 115' ' ' ALA . 11.7 p -60.42 -55.33 25.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.119 -0.988 . . . . 0.0 110.302 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 1.03 ' HB3' HG13 ' D' ' 34' ' ' VAL . 6.4 m170 -72.05 -33.25 67.82 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.129 -0.982 . . . . 0.0 108.883 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.08 -20.18 49.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.485 -0.759 . . . . 0.0 109.137 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.581 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.1 m -64.86 -62.7 1.41 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.351 -0.843 . . . . 0.0 109.998 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.55 -19.5 65.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 109.203 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.99 -50.09 11.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.75 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -85.66 -43.12 13.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.117 -0.989 . . . . 0.0 109.795 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.434 ' N ' ' CD ' ' C' ' 127' ' ' LYS . 53.5 t80 -49.45 -20.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.898 -1.126 . . . . 0.0 108.672 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' C' ' 133' ' ' SER . 12.8 mt -71.9 -17.62 62.09 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.9 -31.72 72.04 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.434 ' O ' HG23 ' C' ' 135' ' ' VAL . 57.0 p -83.22 -34.01 25.98 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.325 -0.859 . . . . 0.0 108.947 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -85.31 -27.96 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 108.655 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.626 ' N ' ' O ' ' C' ' 129' ' ' LEU . 37.2 m -80.14 -28.92 38.83 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.408 -0.808 . . . . 0.0 109.159 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 41.8 m -71.24 -33.67 70.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 109.035 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 131' ' ' SER . 30.0 t -79.9 -28.13 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.26 -0.9 . . . . 0.0 108.623 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.63 -35.76 73.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.037 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 137' ' ' THR . . . . . 0.447 HG22 ' O ' ' C' ' 133' ' ' SER . 14.9 t -101.93 -14.55 17.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.83 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 8.5 t 55.66 -173.39 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.146 -0.971 . . . . 0.0 109.401 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' C' ' 141' ' ' ARG . 56.5 mttp -49.6 -59.83 3.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.937 . . . . 0.0 109.56 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.509 ' CD2' ' O ' ' C' ' 140' ' ' TYR . 68.0 t80 52.35 9.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 141' ' ' ARG . . . . . 0.467 ' H ' ' C ' ' C' ' 139' ' ' LYS . 26.0 mtm180 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.923 -1.036 . . . . 0.0 109.464 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 1.028 HG13 ' H ' ' D' ' 2' ' ' HIS . 2.6 p . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 2' ' ' HIS . . . . . 1.028 ' H ' HG13 ' D' ' 1' ' ' VAL . 0.5 OUTLIER 53.87 106.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.085 -1.009 . . . . 0.0 109.782 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.443 HD12 ' O ' ' D' ' 3' ' ' LEU . 0.3 OUTLIER -159.05 179.04 9.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.365 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.419 ' OG1' ' OE2' ' D' ' 7' ' ' GLU . 2.2 p -73.36 151.57 89.84 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.46 -28.54 21.77 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.552 2.168 . . . . 0.0 112.107 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -78.83 -41.25 30.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.939 . . . . 0.0 109.534 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.419 ' OE2' ' OG1' ' D' ' 4' ' ' THR . 46.2 mt-10 -64.76 -46.03 83.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.467 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -72.63 -37.53 68.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.605 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 3.4 t -45.52 -23.7 0.25 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.788 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.23 -56.51 3.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.147 -0.971 . . . . 0.0 109.999 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 6.7 p -65.24 -24.62 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 5.8 m -77.51 -45.66 24.83 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.395 0.616 . . . . 0.0 109.575 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.45 72.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.385 -0.822 . . . . 0.0 109.592 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.43 ' C ' ' N ' ' D' ' 16' ' ' GLY . 0.8 OUTLIER -51.9 -32.12 31.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.072 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -48.66 -17.96 0.22 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.275 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 16' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' D' ' 14' ' ' LEU . . . -76.8 -56.81 3.99 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.432 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -64.77 -27.39 68.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 109.217 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.91 114.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' D' ' 21' ' ' ASP . 25.3 m-80 -80.45 69.15 6.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.009 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -44.39 -21.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.748 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' D' ' 19' ' ' ASN . 68.0 m-20 -74.16 3.92 6.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.489 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' D' ' 19' ' ' ASN . 35.1 mt-10 -153.0 -41.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.316 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.52 -46.59 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.36 -42.9 65.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.87 -44.05 63.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.1 -24.94 65.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -1.163 . . . . 0.0 109.528 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.32 -49.46 67.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 28' ' ' LEU . . . . . 0.594 HD12 ' N ' ' D' ' 28' ' ' LEU . 9.4 mp -79.12 -54.38 6.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.57 -33.38 8.68 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -81.99 -39.33 23.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -1.142 . . . . 0.0 109.419 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -49.27 -35.76 18.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 27.0 mt -79.9 -31.83 40.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.618 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 33' ' ' VAL . . . . . 0.85 HG13 ' HA ' ' C' ' 119' ' ' PRO . 61.6 t -66.51 -64.41 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 109.38 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 1.03 HG13 ' HB3' ' C' ' 122' ' ' HIS . 1.3 t -64.47 -22.64 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -146.21 80.85 9.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.397 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.45 -5.56 14.23 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.692 2.261 . . . . 0.0 112.386 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 37' ' ' TRP . . . . . 0.546 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 1.3 p-90 -58.87 -24.37 62.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.965 . . . . 0.0 109.51 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.546 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 3.0 m -96.01 38.29 1.19 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -91.16 9.63 30.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 109.496 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 40' ' ' ARG . . . . . 1.565 ' CD ' ' HD3' ' A' ' 92' ' ' ARG . 55.0 ttt85 -81.6 -29.82 33.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.543 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' D' ' 42' ' ' PHE . 66.1 m-85 -90.9 30.12 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 109.384 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 1.045 ' HE1' ' CBC' ' D' ' 147' ' ' HEC . 70.4 m-85 -145.66 22.65 1.45 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 109.381 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -79.11 -16.45 56.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.407 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 44' ' ' SER . . . . . 0.468 ' O ' ' N ' ' D' ' 46' ' ' GLY . 27.6 p -67.48 -43.32 81.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' D' ' 47' ' ' ASP . 88.3 m-85 -48.73 -14.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 66.9 -65.38 0.19 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' D' ' 45' ' ' PHE . 4.6 m-20 -46.18 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -1.16 . . . . 0.0 109.555 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 tp -159.46 22.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 12.8 p -70.54 -33.8 71.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 50' ' ' THR . . . . . 0.427 ' O ' ' N ' ' D' ' 53' ' ' ALA . 3.4 p -145.64 151.56 46.82 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.325 -0.859 . . . . 0.0 109.031 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -39.97 -42.01 3.12 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.302 2.001 . . . . 0.0 112.256 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.32 -31.01 72.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.488 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -61.92 -19.81 63.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.98 -63.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 109.615 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 55' ' ' MET . . . . . 0.41 ' H ' ' HG2' ' D' ' 55' ' ' MET . 22.4 ptp -83.2 4.5 26.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.364 -0.835 . . . . 0.0 109.648 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.92 -17.25 70.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 57' ' ' ASN . . . . . 0.401 ' ND2' ' HD2' ' D' ' 58' ' ' PRO . 2.3 t-20 -82.1 138.05 46.03 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.276 -1.132 . . . . 0.0 109.071 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.401 ' HD2' ' ND2' ' D' ' 57' ' ' ASN . 49.9 Cg_endo -71.11 -12.84 30.81 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.232 1.955 . . . . 0.0 112.162 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -80.15 -57.45 3.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -48.0 -31.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 61' ' ' LYS . . . . . 0.418 ' HZ2' ' HB3' ' D' ' 61' ' ' LYS . 16.2 mtpp -79.03 -32.81 45.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.76 -45.64 16.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.679 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.991 ' NE2' HAD2 ' D' ' 147' ' ' HEC . 0.9 OUTLIER -62.79 -23.67 67.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.722 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.49 -36.32 83.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -60.17 -25.44 65.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.108 -1.23 . . . . 0.0 109.591 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.71 -50.13 39.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 1.157 HG13 ' C2B' ' D' ' 147' ' ' HEC . 42.3 t -57.81 -36.67 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.35 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.447 ' O ' HD23 ' D' ' 68' ' ' LEU . 5.6 tt -71.56 -48.09 50.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.42 -44.95 16.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.55 -51.94 56.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -1.102 . . . . 0.0 109.414 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -49.53 -35.32 19.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.269 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -75.98 -24.49 55.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -52.3 -43.64 64.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.381 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.84 -60.13 8.57 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.502 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.2 mp -57.98 -27.99 63.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -1.118 . . . . 0.0 109.317 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -80.62 -9.24 59.79 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.214 -0.929 . . . . 0.0 109.427 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 56.8 m80 -160.34 66.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.42 11.58 0.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.309 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' D' ' 77' ' ' HIS . 81.4 m-20 -72.38 -30.97 65.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.614 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 80' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 16.5 t-20 -171.07 108.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.605 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 81' ' ' LEU . . . . . 0.563 HD12 ' N ' ' D' ' 81' ' ' LEU . 9.5 mp -80.31 -54.68 5.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.502 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 82' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' D' ' 82' ' ' LYS . 0.6 OUTLIER -49.97 -24.03 2.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.421 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 83' ' ' GLY . . . . . 0.44 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -73.15 -52.37 8.94 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.1 t -76.51 -47.63 22.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -1.179 . . . . 0.0 109.484 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.1 m-85 -66.0 4.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.783 . . . . 0.0 109.505 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 86' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -63.63 -33.49 75.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.0 p -79.27 -51.43 9.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.411 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' D' ' 92' ' ' HIS . 8.7 mp -53.24 -51.19 63.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.352 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 34.8 p -54.57 -45.47 73.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.69 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.432 ' O ' ' OD2' ' D' ' 94' ' ' ASP . 32.9 tt0 -66.24 -41.64 89.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.155 -0.966 . . . . 0.0 109.624 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.43 -20.2 40.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.643 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.581 ' N ' ' O ' ' D' ' 88' ' ' LEU . 1.5 m80 -87.62 -41.16 13.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 110.267 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 35.6 t -83.11 -39.57 20.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.043 -1.035 . . . . 0.0 110.739 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' D' ' 90' ' ' GLU . 12.2 m-20 -86.27 -36.41 19.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.009 -1.057 . . . . 0.0 111.093 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -52.26 5.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.9 -1.125 . . . . 0.0 110.531 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.571 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 10.0 mp -86.28 -31.89 21.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.912 -1.117 . . . . 0.0 109.603 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 13.5 p80 42.04 29.32 0.13 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.426 -0.796 . . . . 0.0 109.818 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.16 124.61 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.862 . . . . 0.0 109.168 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 99' ' ' ASP . . . . . 1.317 ' CB ' HG21 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -47.55 154.21 0.92 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.18 -160.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.651 2.234 . . . . 0.0 112.001 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 101' ' ' GLU . . . . . 0.446 ' O ' ' OD1' ' D' ' 102' ' ' ASN . 29.8 mm-40 57.64 26.31 12.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.872 . . . . 0.0 109.499 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 102' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' D' ' 101' ' ' GLU . 39.1 m-20 -137.47 -32.88 0.75 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.369 -0.832 . . . . 0.0 109.341 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.39 -37.13 86.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -70.14 -23.6 63.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.987 . . . . 0.0 109.548 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 105' ' ' LEU . . . . . 0.589 ' N ' HD12 ' D' ' 105' ' ' LEU . 7.8 mp -79.85 -17.7 52.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 0.0 109.463 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 1.599 ' CD1' ' HAB' ' D' ' 147' ' ' HEC . 2.6 tm? -78.87 -46.76 17.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.302 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.02 -20.41 77.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -70.45 -55.7 8.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -1.216 . . . . 0.0 109.787 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -53.66 -24.05 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.962 . . . . 0.0 109.71 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 110' ' ' LEU . . . . . 0.512 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.6 tt -64.48 -50.8 66.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.913 . . . . 0.0 109.501 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 111' ' ' VAL . . . . . 0.556 ' CG2' ' CE1' ' D' ' 130' ' ' TYR . 46.9 t -49.53 -45.19 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 56.4 m -51.6 -35.84 43.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.61 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.96 -28.59 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 41.6 mt -72.74 -40.73 65.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.353 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.0 59.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 109.259 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.535 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 3.0 t-80 -84.58 -54.69 4.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.322 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 117' ' ' HIS . . . . . 0.437 ' N ' ' HD1' ' D' ' 117' ' ' HIS . 0.5 OUTLIER -70.97 -17.45 62.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.704 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.402 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 68.3 m-85 -152.75 62.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.601 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -58.84 -27.0 61.26 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -68.42 -34.95 76.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -1.225 . . . . 0.0 109.559 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.84 14.35 3.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.624 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.558 ' O ' ' CG ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -83.01 36.4 0.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.592 ' OG1' HG23 ' D' ' 126' ' ' VAL . 7.4 p -46.45 154.14 0.68 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.115 -0.991 . . . . 0.0 109.445 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.453 ' O ' HD13 ' C' ' 34' ' ' LEU . 24.4 Cg_exo -55.4 -44.89 44.3 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.334 2.022 . . . . 0.0 113.786 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' D' ' 124' ' ' PRO . 67.1 Cg_endo -78.21 -8.06 16.28 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.994 1.796 . . . . 0.0 112.598 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.592 HG23 ' OG1' ' D' ' 123' ' ' THR . 10.6 t -83.79 -31.04 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 109.276 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.28 -59.67 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 109.637 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 1.56 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -48.55 -41.97 31.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 0.0 109.42 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.55 83.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.89 . . . . 0.0 109.881 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.556 ' CE1' ' CG2' ' D' ' 111' ' ' VAL . 29.7 t80 -61.11 -60.87 3.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.0 109.398 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -47.83 -25.8 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.584 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 132' ' ' LYS . . . . . 0.441 ' NZ ' ' CB ' ' D' ' 132' ' ' LYS . 5.0 ttpm? -85.5 -31.56 22.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.728 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.39 -65.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.527 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 5.9 m -55.53 -15.64 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.639 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.62 ' CB ' ' OXT' ' B' ' 146' ' ' HIS . . . -56.22 -33.68 65.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.929 . . . . 0.0 109.335 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.9 -30.52 57.5 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.14 -32.85 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -1.117 . . . . 0.0 109.433 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.97 76.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.345 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -78.7 -21.11 48.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 109.428 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.77 -60.63 2.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 63.6 mt -54.33 -20.25 6.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.315 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 142' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' D' ' 145' ' ' TYR . . . -89.01 -4.57 58.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 109.126 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 143' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' D' ' 146' ' ' HIS . 71.4 t60 -49.48 -39.13 32.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.484 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 0.8 OUTLIER -86.83 -55.13 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.944 . . . . 0.0 109.217 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 145' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -52.82 -10.41 0.16 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.56 -0.713 . . . . 0.0 109.387 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.648 ' OXT' ' CB ' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.484 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.803 ' CHC' HD22 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 1.657 ' HAB' ' CD1' ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.798 ' CHC' HD22 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 1.599 ' HAB' ' CD1' ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.429 ' C ' HD22 ' A' ' 2' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.576 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.9 mm? -95.01 -169.27 1.96 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.697 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.45 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -116.24 179.54 0.78 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.504 -0.747 . . . . 0.0 109.228 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 21.7 Cg_exo -62.81 -69.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.722 2.281 . . . . 0.0 112.752 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -83.09 -16.63 46.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.897 . . . . 0.0 110.391 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.55 ' OD2' HD12 ' A' ' 2' ' ' LEU . 7.8 t70 -40.1 -41.17 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.215 -0.928 . . . . 0.0 109.778 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 10' ' ' VAL . 68.8 mttt -69.44 -55.97 8.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.872 . . . . 0.0 109.639 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.0 m -45.03 -30.78 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 109.674 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -78.48 -36.4 45.24 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 7' ' ' LYS . 48.9 t -72.09 -48.84 47.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -53.05 -44.39 67.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 108.78 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.74 -57.4 12.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.434 -0.791 . . . . 0.0 109.32 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -56.41 -36.2 68.67 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.431 -0.793 . . . . 0.0 109.27 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.92 -17.22 60.6 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.248 -0.908 . . . . 0.0 108.936 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.76 -42.0 22.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -71.43 -42.12 68.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -1.178 . . . . 0.0 108.84 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 13' ' ' ALA . 61.2 t -60.71 -63.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 47.73 -127.2 14.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.3 24.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.457 -1.025 . . . . 0.0 110.446 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.537 ' H ' ' C ' ' A' ' 18' ' ' GLY . 88.3 m-70 -128.84 22.13 5.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.887 . . . . 0.0 108.609 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.73 -55.93 3.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.577 -0.702 . . . . 0.0 109.443 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.49 -14.43 0.61 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 21' ' ' ALA . 12.7 mm-40 -87.49 -56.52 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.396 -1.061 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.9 m-30 -60.87 -22.84 64.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 0.0 109.246 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.19 -23.54 63.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.93 -40.04 22.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -1.132 . . . . 0.0 109.619 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -69.43 -19.62 63.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.819 . . . . 0.0 109.25 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.3 -20.44 57.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 0.0 109.641 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.3 mt -78.15 -46.9 19.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.786 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.02 -38.13 75.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 109.738 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.4 mtt85 -63.18 -39.13 93.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.54 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.734 ' HE1' HBC2 ' A' ' 142' ' ' HEC . 51.0 ttp -64.6 -50.44 67.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 1.8 t80 -44.07 -33.87 1.6 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.427 -0.796 . . . . 0.0 109.697 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.3 mt -84.95 -40.02 17.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.76 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.543 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 74.4 m -53.42 -38.4 63.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 109.665 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 35' ' ' SER . 30.5 m-85 -164.29 87.11 1.14 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 39' ' ' THR . 76.5 Cg_exo -48.18 -19.98 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.612 2.208 . . . . 0.0 112.141 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.818 ' HB ' ' HB3' ' D' ' 97' ' ' HIS . 9.1 p -46.82 -18.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.88 . . . . 0.0 109.738 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' PRO . 53.2 p -80.89 -63.11 1.48 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.13 -0.981 . . . . 0.0 109.989 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' TYR . 8.6 mmpt? -59.09 -18.57 36.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.94 . . . . 0.0 109.955 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 38' ' ' THR . 5.8 t -44.37 -19.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.143 -0.973 . . . . 0.0 109.835 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 40' ' ' LYS . 38.6 m-85 -73.3 4.05 5.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.55 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 83.2 t80 47.57 74.18 0.86 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.179 -0.951 . . . . 0.0 109.471 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.685 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 69.8 Cg_endo -78.1 -14.9 14.87 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.742 2.295 . . . . 0.0 112.23 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.685 ' ND1' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 81.33 26.19 0.22 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.473 0.654 . . . . 0.0 109.612 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.771 ' O ' ' N ' ' A' ' 48' ' ' LEU . 3.3 m-85 -82.89 14.2 3.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.315 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 49' ' ' SER . 4.7 m-20 60.42 -51.35 0.09 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.771 ' N ' ' O ' ' A' ' 46' ' ' PHE . 19.5 mt 41.59 20.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.677 -0.639 . . . . 0.0 109.961 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 47' ' ' ASP . 6.2 m -93.35 42.33 1.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.493 ' CG ' ' C ' ' A' ' 49' ' ' SER . 1.4 m-70 71.88 129.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.434 -0.792 . . . . 0.0 109.351 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.54 29.33 73.22 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.626 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 8.1 p -52.36 -36.68 54.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -1.064 . . . . 0.0 109.54 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 73.27 -64.45 0.4 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 53' ' ' ALA . 52.1 mt-30 -43.59 -35.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 109.48 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.32 -28.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 110.017 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 2.5 ptpt -61.53 -38.89 89.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 0.0 109.453 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' N ' ' CG ' ' A' ' 56' ' ' LYS . . . -52.43 -35.83 45.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 8.7 t-80 -76.6 -27.91 55.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.167 . . . . 0.0 109.913 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.59 -37.26 94.17 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 46.6 mtpt -62.68 -24.34 67.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -1.186 . . . . 0.0 110.268 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.893 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 0.2 OUTLIER -65.01 -58.7 5.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.041 -1.037 . . . . 0.0 109.356 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 62' ' ' VAL . 11.5 t -54.0 -43.83 59.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.469 -0.77 . . . . 0.0 109.289 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.78 -46.88 62.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 0.0 108.924 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 62.4 m-20 -64.48 -34.4 78.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 108.661 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . -67.13 -50.36 61.64 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -55.69 -44.62 77.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 71' ' ' ALA . 19.3 m -65.5 -54.21 31.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.258 -0.901 . . . . 0.0 108.786 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -55.86 -27.35 51.27 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.446 ' HB1' ' SD ' ' A' ' 76' ' ' MET . . . -81.12 -47.68 13.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.32 -22.74 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -70.28 -13.01 61.98 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' A' ' 74' ' ' ASP . 51.7 m-70 -136.3 -67.17 0.52 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.457 -0.777 . . . . 0.0 109.251 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.2 p 44.77 14.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.952 0.882 . . . . 0.0 109.439 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 72' ' ' HIS . 35.0 m-20 -139.24 12.57 2.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 1.1 m-20 172.79 30.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.692 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 6.9 ptt? -78.31 -22.82 0.4 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 111.928 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.6 Cg_exo -53.84 -20.75 18.41 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.577 1.518 . . . . 0.0 112.387 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -94.11 -35.54 12.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 109.844 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.03 -46.89 61.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.097 -1.002 . . . . 0.0 109.257 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.8 mt -80.3 8.27 7.8 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 109.024 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.2 p -56.05 -21.92 24.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.907 . . . . 0.0 109.731 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -70.8 -53.79 14.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.788 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' ALA . 6.0 mt -44.78 -47.1 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 20.0 m -50.2 -39.61 44.62 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 82' ' ' ALA . 28.8 t70 -82.82 -17.33 44.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.817 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.745 ' C ' HD13 ' A' ' 86' ' ' LEU . 3.3 tm? -71.41 -58.19 3.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -83.11 -21.72 33.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.102 . . . . 0.0 110.736 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -67.04 -79.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.888 -1.132 . . . . 0.0 109.788 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -59.53 5.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.811 . . . . 0.0 109.475 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 86' ' ' LEU . 41.2 mttm -88.02 135.7 33.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' A' ' 93' ' ' VAL . 14.9 mt 61.16 66.43 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.833 . . . . 0.0 109.153 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 1.453 ' NE ' ' HB2' ' D' ' 40' ' ' ARG . 39.1 ttt-85 -66.33 18.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.504 -0.748 . . . . 0.0 109.347 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.59 ' H ' ' C ' ' A' ' 91' ' ' LEU . 11.9 p -42.61 129.52 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.895 . . . . 0.0 109.767 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.85 148.74 75.45 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.28 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ASN . 37.5 Cg_endo -67.56 -10.9 30.28 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.476 2.117 . . . . 0.0 112.046 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 95' ' ' PRO . 47.7 t -44.55 -19.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.715 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' PRO . 17.8 m120 -79.16 -24.77 43.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.545 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.534 ' CG ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -53.71 -45.01 70.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.372 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.534 ' N ' ' CG ' ' A' ' 98' ' ' PHE . 65.2 mttm -49.28 -41.02 36.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.498 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 12.4 mt -71.55 -43.24 66.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.892 . . . . 0.0 109.403 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.085 ' CD1' ' CHC' ' A' ' 142' ' ' HEC . 3.5 tt -57.99 -57.09 14.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.317 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.5 p -61.86 -34.9 76.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.857 . . . . 0.0 109.687 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -77.68 -26.69 50.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.462 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 55.6 m -69.68 -41.52 75.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 0.0 109.686 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mt -52.35 -50.17 62.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.36 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 106' ' ' LEU . 3.8 mm? -58.83 -59.12 5.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 65.1 t -51.71 -49.68 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.197 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 110' ' ' ALA . 17.6 m -62.15 -60.27 3.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.394 -0.816 . . . . 0.0 109.3 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 113' ' ' LEU . 24.9 mt -47.13 -18.92 0.1 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 109.522 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -73.41 -36.24 65.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.01 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.13 -3.18 24.87 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.708 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -141.28 -83.9 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 0.0 109.908 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -106.06 83.37 1.07 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.085 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.32 -174.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.148 1.899 . . . . 0.0 112.356 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.84 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -46.19 -55.43 7.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.557 -0.715 . . . . 0.0 109.26 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.65 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 31.7 mt-10 118.87 -7.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 4.8 t80 79.08 34.48 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.969 -0.457 . . . . 0.0 111.2 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.722 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -109.47 122.7 38.67 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.476 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.39 18.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.32 2.013 . . . . 0.0 112.925 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.722 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -146.34 -33.17 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.886 -1.134 . . . . 0.0 110.404 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.84 HG21 ' O ' ' A' ' 115' ' ' ALA . 7.2 p -51.68 -47.26 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.111 -0.993 . . . . 0.0 110.117 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.615 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.0 t-160 -59.8 -37.27 78.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.955 . . . . 0.0 109.365 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.19 -19.71 33.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.711 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 14.8 p -64.86 -62.5 1.53 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 110.625 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.497 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.6 mt -72.24 -19.77 61.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 0.0 109.978 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -82.38 -44.46 16.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.974 -1.079 . . . . 0.0 109.594 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -84.88 -41.02 16.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 109.52 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.48 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 27.8 t80 -51.72 -21.1 2.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.897 -1.127 . . . . 0.0 108.446 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 133' ' ' SER . 20.2 mt -76.6 -26.55 55.13 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -54.52 -33.46 59.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.527 ' O ' HG23 ' A' ' 135' ' ' VAL . 1.6 m -77.65 -41.74 37.25 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.05 -33.13 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.224 -0.923 . . . . 0.0 108.578 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 129' ' ' LEU . 31.3 m -77.12 -42.21 38.9 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.399 -0.813 . . . . 0.0 109.172 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 92.3 m -70.39 -26.07 63.53 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.214 -0.929 . . . . 0.0 108.557 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 131' ' ' SER . 8.4 t -77.14 -37.78 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.06 -38.48 86.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 108.834 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 m -90.39 -14.6 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 53.8 p 49.02 -150.6 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -150.92 -79.81 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 0.0 109.433 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.434 ' OH ' HG22 ' C' ' 1' ' ' VAL . 77.4 m-85 -74.51 -60.08 2.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.381 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.417 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.781 ' H2 ' HD11 ' B' ' 3' ' ' LEU . 14.4 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 8.5 t60 55.32 62.21 2.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.913 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -127.76 177.82 6.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.391 -0.818 . . . . 0.0 109.186 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.44 ' OG1' ' OE2' ' B' ' 7' ' ' GLU . 0.6 OUTLIER -68.65 125.32 91.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 108.983 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -42.07 -35.55 3.32 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.349 2.032 . . . . 0.0 112.537 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' B' ' 6' ' ' GLU . 14.3 mp0 -76.16 -23.89 54.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 109.7 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 0.2 OUTLIER -84.17 -39.53 19.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 109.767 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.7 ' HB3' HD13 ' B' ' 3' ' ' LEU . 22.9 pttt -83.87 -39.18 20.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 110.114 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' B' ' 8' ' ' LYS . 19.5 m -43.9 -23.33 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.865 . . . . 0.0 110.192 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -82.25 -57.06 3.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.139 -0.976 . . . . 0.0 109.997 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.09 -24.63 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 5.1 m -75.02 -45.71 39.9 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.367 0.603 . . . . 0.0 109.565 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.52 94.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.53 -0.731 . . . . 0.0 109.626 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.5 OUTLIER -48.0 -34.47 9.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -45.84 -17.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.847 . . . . 0.0 109.413 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -76.56 -43.06 20.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' B' ' 17' ' ' LYS . 1.6 mmtt -79.76 -30.55 40.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -1.191 . . . . 0.0 109.254 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -47.82 114.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.552 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' B' ' 22' ' ' GLU . 5.8 m-20 -77.84 66.13 3.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.198 -0.939 . . . . 0.0 108.998 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' B' ' 22' ' ' GLU . 73.8 t -43.81 -26.87 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 109.754 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.76 7.21 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.504 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' B' ' 20' ' ' VAL . 36.6 mt-10 -155.24 -50.25 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.563 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 69.3 t -47.03 -33.75 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.627 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.57 -50.72 59.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.39 -36.87 78.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -73.74 -38.64 64.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -1.133 . . . . 0.0 109.449 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.85 -34.05 72.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.405 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -84.99 -34.53 22.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.53 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.36 -50.36 60.16 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -58.21 -30.55 66.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -1.204 . . . . 0.0 109.425 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' LEU . . . . . 0.476 ' CD2' HBC2 ' B' ' 147' ' ' HEC . 9.3 tp -50.44 -39.21 46.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.469 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -81.01 -21.97 39.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.69 -64.13 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.724 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.52 HG13 ' CD2' ' A' ' 122' ' ' HIS . 2.3 t -64.46 -22.94 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.876 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.442 ' HB3' ' HE1' ' B' ' 37' ' ' TRP . 53.9 m-85 -139.71 78.61 25.5 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.271 -0.893 . . . . 0.0 109.392 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -82.82 -17.87 6.84 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.817 2.345 . . . . 0.0 112.381 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.536 ' O ' ' NH2' ' C' ' 92' ' ' ARG . 5.2 p-90 -49.64 -19.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.5 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.514 HG23 ' CE2' ' B' ' 37' ' ' TRP . 1.4 p -92.15 -11.34 35.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.241 -0.912 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -45.05 -34.24 2.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.711 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 1.379 ' HB2' ' NE ' ' C' ' 92' ' ' ARG . 37.6 mtp85 -61.08 -26.03 67.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.478 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' B' ' 38' ' ' THR . 32.1 t80 -100.88 30.64 3.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.315 -0.866 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -146.25 31.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 109.327 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' B' ' 43' ' ' GLU . 13.8 pt-20 -79.75 -14.04 59.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.402 ' O ' ' N ' ' B' ' 46' ' ' GLY . 28.5 t -65.47 -43.85 89.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.538 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' B' ' 47' ' ' ASP . 44.8 m-85 -48.87 -18.58 0.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 48' ' ' LEU . . . 65.77 -66.56 0.12 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' B' ' 45' ' ' PHE . 79.6 m-20 -54.05 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -1.136 . . . . 0.0 109.674 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 46' ' ' GLY . 0.8 OUTLIER -164.47 21.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.115 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 56.0 m -57.97 -41.1 82.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.413 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' THR . . . . . 0.431 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.3 p -146.25 152.4 46.56 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.424 -0.797 . . . . 0.0 109.045 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -40.63 -30.04 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.402 2.068 . . . . 0.0 112.345 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -75.05 -29.2 60.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.641 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -63.9 -20.5 65.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 109.557 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.55 -24.01 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' MET . . . . . 0.413 ' O ' ' OD1' ' B' ' 57' ' ' ASN . 16.3 mmt -90.01 -6.2 55.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 109.611 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.587 ' O ' ' CB ' ' B' ' 57' ' ' ASN . . . -47.93 -35.83 13.43 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ASN . . . . . 0.71 ' N ' ' CD ' ' B' ' 58' ' ' PRO . 21.0 m-20 91.7 23.56 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 122.245 -0.562 . . . . 0.0 111.623 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' B' ' 57' ' ' ASN . 77.4 Cg_endo -81.34 -157.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.965 1.776 . . . . 0.0 112.125 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -47.66 -24.39 0.91 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.71 -50.05 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.566 -0.709 . . . . 0.0 109.294 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' B' ' 62' ' ' ALA . 0.0 OUTLIER -79.48 -32.49 42.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.363 -0.836 . . . . 0.0 109.637 -179.521 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.416 ' N ' ' HG2' ' B' ' 61' ' ' LYS . . . -56.99 -49.72 74.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 109.565 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 1.179 ' NE2' HAD2 ' B' ' 147' ' ' HEC . 46.3 t-80 -59.42 -26.3 65.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.589 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.56 -19.4 74.64 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -76.04 -24.98 55.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 109.122 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -74.29 -59.29 2.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 109.568 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 1.537 HG13 ' C1B' ' B' ' 147' ' ' HEC . 40.4 t -47.0 -34.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 109.473 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.33 -42.75 96.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -0.914 . . . . 0.0 109.16 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.73 -49.82 52.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.75 -33.44 66.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -1.127 . . . . 0.0 109.51 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -76.25 -37.66 57.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -80.49 -28.13 37.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.341 -0.849 . . . . 0.0 109.436 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -51.17 -38.89 54.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.21 -60.13 7.99 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.577 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -56.83 -18.65 13.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -1.106 . . . . 0.0 109.407 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -83.22 -19.31 36.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 71.5 m-70 -159.42 62.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.11 -0.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 109.315 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' B' ' 77' ' ' HIS . 45.7 t0 -57.62 -25.87 60.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 9.1 p-10 -170.58 105.85 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.56 HD12 ' N ' ' B' ' 81' ' ' LEU . 10.2 mp -79.98 -57.26 3.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.469 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -45.79 -24.06 0.34 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -0.973 . . . . 0.0 109.61 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.76 -63.21 2.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.0 t -61.01 -47.49 86.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -1.168 . . . . 0.0 109.516 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.547 ' N ' ' CG2' ' B' ' 84' ' ' THR . 64.2 m-85 -67.86 4.77 1.04 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.747 . . . . 0.0 109.597 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.82 -46.57 78.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.544 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -75.12 -52.59 10.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.526 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 55.6 mt -50.73 -47.36 59.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' SER . . . . . 0.483 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 14.7 m -57.52 -36.26 71.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.356 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.87 -22.28 43.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.91 -18.06 26.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.972 . . . . 0.0 109.815 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' B' ' 88' ' ' LEU . 9.9 m80 -87.89 -60.76 1.88 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.916 -1.115 . . . . 0.0 110.484 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' B' ' 89' ' ' SER . 12.8 p -83.82 -59.77 2.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.955 -1.091 . . . . 0.0 111.469 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.473 ' N ' ' SG ' ' B' ' 93' ' ' CYS . 14.2 m-20 -59.2 -26.76 65.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.071 -1.018 . . . . 0.0 111.724 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 3.1 tppp? -107.51 -51.97 2.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.737 -1.227 . . . . 0.0 110.795 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.447 ' C ' ' CD2' ' B' ' 97' ' ' HIS . 5.7 mp -87.19 -30.48 20.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.926 -1.109 . . . . 0.0 109.931 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.738 ' HB3' ' CG2' ' C' ' 38' ' ' THR . 9.6 m-70 66.47 49.16 1.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.117 -0.989 . . . . 0.0 110.013 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 33.1 t -96.62 114.18 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.198 -0.939 . . . . 0.0 109.031 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' B' ' 100' ' ' PRO . 0.9 OUTLIER -62.59 153.66 76.84 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.605 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 100' ' ' PRO . . . . . 0.571 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 51.0 Cg_exo -51.98 -156.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.442 2.095 . . . . 0.0 112.452 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 52.95 46.74 26.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.522 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' B' ' 100' ' ' PRO . 72.4 m-80 -158.08 -35.74 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.526 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.0 -39.22 93.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.152 -0.968 . . . . 0.0 109.526 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -65.47 -31.24 72.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 109.658 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.582 HD12 ' N ' ' B' ' 105' ' ' LEU . 9.8 mp -62.35 -57.95 9.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.118 -0.989 . . . . 0.0 109.462 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 1.558 ' CD2' HBB3 ' B' ' 147' ' ' HEC . 6.4 tt -48.23 -22.75 0.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.928 . . . . 0.0 109.605 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 107' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' B' ' 109' ' ' VAL . . . -79.29 -45.35 8.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -46.61 -16.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -1.122 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' B' ' 107' ' ' GLY . 97.6 t -85.15 -62.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.41 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 14.6 mt -47.41 -26.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.92 -47.65 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.792 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 20.2 p -79.28 -41.32 28.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.018 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 77.7 t -47.4 -41.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.747 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' B' ' 118' ' ' PHE . 46.1 mt -79.47 -40.49 29.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 109.526 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.438 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.14 -30.41 2.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.526 ' HD1' ' C ' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.64 -56.98 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.265 -0.897 . . . . 0.0 109.288 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 117' ' ' HIS . . . . . 0.411 ' C ' ' CG ' ' B' ' 118' ' ' PHE . 85.7 m-70 -63.53 -17.72 63.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 0.0 109.57 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.452 ' N ' ' O ' ' B' ' 114' ' ' LEU . 65.2 m-85 -153.29 62.35 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.938 . . . . 0.0 109.543 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' B' ' 122' ' ' PHE . . . -68.92 -50.48 34.78 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -47.86 -31.05 4.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 109.38 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -82.7 -19.07 38.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' B' ' 119' ' ' GLY . 6.3 t80 -76.09 66.61 2.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.29 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.439 ' OG1' HG23 ' B' ' 126' ' ' VAL . 1.3 p -79.14 149.8 73.53 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.276 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.508 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.5 Cg_exo -45.36 -53.58 5.3 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.466 2.111 . . . . 0.0 112.968 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 26.0 Cg_endo -62.45 1.11 1.08 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.01 1.806 . . . . 0.0 112.192 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.455 ' O ' HG12 ' B' ' 126' ' ' VAL . 87.9 t -112.45 -8.23 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.316 -0.865 . . . . 0.0 109.306 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.3 -53.97 5.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.517 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -54.69 -33.81 61.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.886 . . . . 0.0 109.537 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.2 2.6 17.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.675 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.17 -29.6 13.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.218 -0.926 . . . . 0.0 109.374 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 131' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 88.9 mm-40 -84.4 -23.3 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 109.916 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.723 ' HG3' ' HB3' ' D' ' 146' ' ' HIS . 14.4 ttmt -85.56 -36.08 20.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.13 -0.981 . . . . 0.0 110.121 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 133' ' ' VAL . . . . . 0.737 HG13 ' N ' ' B' ' 134' ' ' VAL . 11.8 p -65.38 -58.91 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.081 -1.012 . . . . 0.0 110.037 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.737 ' N ' HG13 ' B' ' 133' ' ' VAL . 11.3 t -62.1 -33.43 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.02 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -45.89 -21.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 0.0 109.684 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 136' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 134' ' ' VAL . . . -82.7 -26.83 44.59 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' B' ' 134' ' ' VAL . 97.7 t -78.88 -21.2 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -1.133 . . . . 0.0 109.585 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.02 -38.37 32.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.629 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.8 -21.09 30.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.785 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.21 -48.46 70.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.115 -0.991 . . . . 0.0 109.713 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' B' ' 92' ' ' HIS . 28.4 mt -58.26 -22.04 50.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.574 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' B' ' 145' ' ' TYR . . . -89.71 26.1 1.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 143' ' ' HIS . . . . . 0.431 ' O ' ' CD2' ' B' ' 143' ' ' HIS . 11.0 t-160 -80.53 -6.98 59.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.962 . . . . 0.0 109.13 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' B' ' 146' ' ' HIS . 11.6 mptt -122.14 -27.84 4.47 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.52 -0.737 . . . . 0.0 109.696 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 142' ' ' ALA . 0.1 OUTLIER -50.26 -7.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -0.993 . . . . 0.0 110.034 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.72 ' HB3' ' HG3' ' D' ' 132' ' ' LYS . 12.0 m-70 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.736 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 1' ' ' VAL . . . . . 0.434 HG22 ' OH ' ' A' ' 140' ' ' TYR . 40.2 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.289 0.566 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 2' ' ' LEU . . . . . 0.575 ' N ' HD22 ' C' ' 2' ' ' LEU . 3.9 mm? -94.95 -169.37 1.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.213 -0.929 . . . . 0.0 109.691 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.452 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.1 OUTLIER -116.13 179.55 0.78 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.491 -0.756 . . . . 0.0 109.233 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 21.8 Cg_exo -62.85 -69.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.69 2.26 . . . . 0.0 112.781 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -83.13 -16.69 45.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.931 . . . . 0.0 110.308 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.561 ' OD2' HD12 ' C' ' 2' ' ' LEU . 7.8 t70 -40.05 -41.18 1.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.955 . . . . 0.0 109.773 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' C' ' 10' ' ' VAL . 68.7 mttt -69.45 -56.04 8.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 53.5 m -45.04 -30.75 1.12 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.32 -0.863 . . . . 0.0 109.707 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -78.39 -36.41 45.92 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' C' ' 7' ' ' LYS . 49.2 t -72.01 -48.93 47.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -53.02 -44.45 67.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 108.783 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.77 -57.34 12.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.361 -0.837 . . . . 0.0 109.338 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.625 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -56.45 -36.27 68.85 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.377 -0.827 . . . . 0.0 109.24 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.79 -17.2 60.66 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.278 -0.889 . . . . 0.0 109.029 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.83 -41.98 21.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 16' ' ' LYS . . . . . 0.42 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 12.9 mmmt -71.43 -42.08 68.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -1.153 . . . . 0.0 108.837 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.625 HG23 ' O ' ' C' ' 13' ' ' ALA . 61.5 t -60.71 -63.79 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 47.8 -127.32 14.62 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 24.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.414 -1.05 . . . . 0.0 110.447 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.539 ' H ' ' C ' ' C' ' 18' ' ' GLY . 88.3 m-70 -128.85 22.05 5.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.905 . . . . 0.0 108.612 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.46 ' C ' ' N ' ' C' ' 23' ' ' GLU . . . -88.75 -55.85 3.53 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.585 -0.697 . . . . 0.0 109.464 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.59 -14.4 0.64 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.46 ' N ' ' C ' ' C' ' 21' ' ' ALA . 12.8 mm-40 -87.48 -56.56 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -1.079 . . . . 0.0 109.714 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.9 m-30 -60.78 -22.9 64.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.2 -23.49 63.22 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.96 -40.1 22.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -1.128 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -69.35 -19.59 63.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.284 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -20.39 57.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.684 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mt -78.3 -46.84 19.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 109.752 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -58.04 -38.1 75.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.74 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -63.2 -39.19 93.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 109.526 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 32' ' ' MET . . . . . 0.685 ' HE1' HBC2 ' C' ' 142' ' ' HEC . 50.9 ttp -64.52 -50.54 66.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.196 -0.94 . . . . 0.0 109.176 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 33' ' ' PHE . . . . . 0.469 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 1.8 t80 -43.95 -33.99 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.682 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.774 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.4 mt -85.0 -39.87 17.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.793 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 74.5 m -53.44 -38.44 63.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.96 . . . . 0.0 109.749 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' C' ' 35' ' ' SER . 30.8 m-85 -164.22 87.12 1.15 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.877 . . . . 0.0 109.521 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' C' ' 39' ' ' THR . 76.6 Cg_exo -48.21 -19.92 2.0 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.551 2.167 . . . . 0.0 112.135 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.738 ' CG2' ' HB3' ' B' ' 97' ' ' HIS . 9.0 p -46.84 -18.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.889 . . . . 0.0 109.757 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.444 ' N ' ' O ' ' C' ' 37' ' ' PRO . 53.2 p -80.91 -63.1 1.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.981 . . . . 0.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' C' ' 42' ' ' TYR . 8.6 mmpt? -59.05 -18.59 36.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.165 -0.96 . . . . 0.0 109.935 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.532 HG22 ' O ' ' C' ' 38' ' ' THR . 5.8 t -44.46 -19.11 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.144 -0.972 . . . . 0.0 109.828 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' C' ' 40' ' ' LYS . 38.5 m-85 -73.34 4.04 5.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 109.582 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 43' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' C' ' 43' ' ' PHE . 83.1 t80 47.58 74.16 0.86 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 109.452 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.688 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 70.5 Cg_endo -78.03 -14.87 15.01 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.772 2.314 . . . . 0.0 112.308 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.688 ' ND1' ' O ' ' C' ' 44' ' ' PRO . 0.0 OUTLIER 81.25 26.12 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.621 -0.675 . . . . 0.0 109.648 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.778 ' O ' ' N ' ' C' ' 48' ' ' LEU . 3.3 m-85 -82.87 14.33 3.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.399 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' C' ' 49' ' ' SER . 4.6 m-20 60.39 -51.33 0.09 Allowed 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.778 ' N ' ' O ' ' C' ' 46' ' ' PHE . 19.4 mt 41.53 20.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.661 -0.649 . . . . 0.0 110.004 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.538 ' N ' ' O ' ' C' ' 47' ' ' ASP . 6.2 m -93.35 42.27 1.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 50' ' ' HIS . . . . . 0.49 ' CG ' ' C ' ' C' ' 49' ' ' SER . 1.4 m-70 71.98 129.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.516 -0.74 . . . . 0.0 109.295 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.42 29.4 73.24 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.65 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 8.1 p -52.34 -36.7 54.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -1.111 . . . . 0.0 109.595 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 73.26 -64.41 0.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.862 . . . . 0.0 109.549 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' C' ' 53' ' ' ALA . 18.9 mt-30 -43.57 -35.78 1.85 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.0 109.482 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -55.35 -28.15 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.433 -0.792 . . . . 0.0 109.986 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' C' ' 57' ' ' GLY . 2.5 ptpt -61.47 -38.97 89.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.031 -1.043 . . . . 0.0 109.461 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 57' ' ' GLY . . . . . 0.434 ' N ' ' CG ' ' C' ' 56' ' ' LYS . . . -52.41 -35.75 44.73 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 8.7 t-80 -76.65 -27.84 55.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -1.165 . . . . 0.0 109.922 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.61 -37.27 94.18 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -62.64 -24.3 67.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -1.153 . . . . 0.0 110.362 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.905 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 0.2 OUTLIER -65.04 -58.78 5.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.011 -1.056 . . . . 0.0 109.319 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.422 ' H ' HG23 ' C' ' 62' ' ' VAL . 11.6 t -54.02 -43.85 60.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.434 -0.791 . . . . 0.0 109.246 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.7 -46.9 62.26 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 108.921 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -64.44 -34.51 78.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 108.655 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.06 -50.31 62.26 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -55.75 -44.6 77.77 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 108.704 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.421 ' O ' ' N ' ' C' ' 71' ' ' ALA . 19.2 m -65.43 -54.22 31.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -0.847 . . . . 0.0 108.794 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -55.9 -27.39 51.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.46 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -81.02 -47.78 13.13 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.26 -22.69 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -70.36 -13.04 61.98 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' C' ' 74' ' ' ASP . 51.2 m-70 -136.31 -67.12 0.52 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.548 -0.72 . . . . 0.0 109.206 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.554 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.2 p 44.64 14.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.946 0.879 . . . . 0.0 109.37 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' C' ' 72' ' ' HIS . 35.2 m-20 -139.26 12.52 2.59 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 1.1 m-20 172.72 30.92 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.688 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 6.9 ptt? -78.29 -22.87 0.4 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.174 -0.954 . . . . 0.0 111.889 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.4 Cg_exo -53.82 -20.69 18.17 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.596 1.531 . . . . 0.0 112.405 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -94.15 -35.55 12.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.825 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.04 -46.91 61.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.157 -0.965 . . . . 0.0 109.303 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 11.7 mt -80.21 8.17 7.9 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.387 -0.821 . . . . 0.0 109.047 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 45.0 p -56.01 -21.87 23.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 109.797 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -70.88 -53.82 13.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.746 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' C' ' 83' ' ' LEU . 6.0 mt -44.82 -46.93 10.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -50.24 -39.62 45.24 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' C' ' 82' ' ' ALA . 28.7 t70 -82.79 -17.39 44.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.807 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.74 ' C ' HD13 ' C' ' 86' ' ' LEU . 3.3 tm? -71.4 -58.16 3.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 110.426 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -83.12 -21.79 33.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.956 -1.09 . . . . 0.0 110.697 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.11 -79.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 109.72 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.18 -59.53 5.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.491 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' C' ' 86' ' ' LEU . 41.2 mttm -87.99 135.77 33.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.6 ' C ' ' H ' ' C' ' 93' ' ' VAL . 14.9 mt 61.09 66.44 0.89 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.141 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 92' ' ' ARG . . . . . 1.379 ' NE ' ' HB2' ' B' ' 40' ' ' ARG . 38.9 ttt-85 -66.34 18.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.6 ' H ' ' C ' ' C' ' 91' ' ' LEU . 11.8 p -42.57 129.55 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 109.709 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.86 148.81 75.36 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.213 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' C' ' 97' ' ' ASN . 37.6 Cg_endo -67.57 -10.95 30.46 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.48 2.12 . . . . 0.0 112.059 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -44.56 -19.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.358 -0.839 . . . . 0.0 109.669 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 97' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' C' ' 95' ' ' PRO . 17.7 m120 -79.1 -24.71 43.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.653 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 98' ' ' PHE . . . . . 0.541 ' CG ' ' N ' ' C' ' 99' ' ' LYS . 0.1 OUTLIER -53.75 -44.96 70.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.426 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.541 ' N ' ' CG ' ' C' ' 98' ' ' PHE . 65.3 mttm -49.33 -41.05 37.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.5 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 12.4 mt -71.61 -43.16 66.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 1.106 ' CD1' ' CHC' ' C' ' 142' ' ' HEC . 3.6 tt -58.0 -57.03 14.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.341 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 84.3 p -61.87 -34.95 76.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 109.69 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -77.65 -26.62 50.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 55.3 m -69.84 -41.45 74.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 0.0 109.64 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mt -52.33 -50.19 62.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.962 . . . . 0.0 109.324 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.54 HD22 ' N ' ' C' ' 106' ' ' LEU . 3.8 mm? -58.87 -59.11 5.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.635 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 107' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 65.0 t -51.73 -49.64 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.197 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.44 ' O ' ' N ' ' C' ' 110' ' ' ALA . 17.6 m -62.06 -60.35 3.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.29 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' C' ' 113' ' ' LEU . 25.5 mt -47.18 -18.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.872 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -73.46 -36.14 65.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 110.069 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.11 -3.27 25.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.747 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -141.2 -83.95 0.21 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 109.904 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' C' ' 113' ' ' LEU . 0.3 OUTLIER -106.0 83.35 1.05 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.068 -179.629 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.28 -174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.087 1.858 . . . . 0.0 112.399 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.828 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -46.18 -55.51 6.99 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.558 -0.714 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.653 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 31.7 mt-10 118.93 -6.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.489 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 4.8 t80 79.01 34.54 0.21 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.968 -0.458 . . . . 0.0 111.228 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.732 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -109.52 122.7 38.63 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.04 . . . . 0.0 108.271 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.36 18.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.3 2.0 . . . . 0.0 112.915 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -146.32 -33.22 0.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.89 -1.131 . . . . 0.0 110.403 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.828 HG21 ' O ' ' C' ' 115' ' ' ALA . 7.2 p -51.66 -47.13 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 110.177 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.625 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.0 t-80 -59.8 -37.32 78.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.357 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.25 -19.72 33.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.646 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 14.8 p -64.79 -62.54 1.5 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 110.593 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.517 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.6 mt -72.34 -19.73 61.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.11 -0.993 . . . . 0.0 109.932 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.26 -44.5 16.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.981 -1.075 . . . . 0.0 109.64 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -84.94 -41.03 16.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.13 -0.981 . . . . 0.0 109.567 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.483 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 28.0 t80 -51.67 -21.01 2.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.937 -1.102 . . . . 0.0 108.559 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' C' ' 133' ' ' SER . 20.3 mt -76.66 -26.5 54.89 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -54.55 -33.41 60.09 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.54 ' OG ' HD21 ' C' ' 2' ' ' LEU . 1.6 m -77.57 -41.87 37.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 4.9 t -75.03 -33.14 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 133' ' ' SER . . . . . 0.513 ' N ' ' O ' ' C' ' 129' ' ' LEU . 31.5 m -77.11 -42.21 38.96 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.485 -0.759 . . . . 0.0 109.146 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 92.2 m -70.26 -26.1 63.66 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.174 -0.954 . . . . 0.0 108.569 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.538 HG23 ' O ' ' C' ' 131' ' ' SER . 8.6 t -77.17 -37.84 26.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.17 -38.45 86.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 108.846 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 24.9 m -90.34 -14.57 32.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.239 -0.913 . . . . 0.0 109.477 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 53.7 p 48.95 -150.56 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.461 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -150.94 -79.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 109.43 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.403 ' OH ' HG22 ' A' ' 1' ' ' VAL . 77.7 m-85 -74.43 -60.09 2.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.414 179.935 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.817 ' H2 ' HD11 ' D' ' 3' ' ' LEU . 14.4 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 t60 55.29 62.27 2.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.935 . . . . 0.0 109.512 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.904 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -127.74 177.74 6.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.343 -0.848 . . . . 0.0 109.138 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' D' ' 7' ' ' GLU . 0.6 OUTLIER -68.65 125.3 91.64 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.044 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -42.11 -35.47 3.32 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.325 2.017 . . . . 0.0 112.488 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 6' ' ' GLU . . . . . 0.453 ' N ' ' CD ' ' D' ' 6' ' ' GLU . 14.2 mp0 -76.2 -23.93 54.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 109.731 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' D' ' 7' ' ' GLU . 0.2 OUTLIER -84.09 -39.6 19.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.797 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.678 ' HB3' HD13 ' D' ' 3' ' ' LEU . 22.9 pttt -83.78 -39.27 20.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.0 110.074 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 9' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 19.7 m -43.78 -23.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 110.163 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -82.25 -57.05 3.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.114 -0.991 . . . . 0.0 109.979 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.08 -24.73 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 5.0 m -74.9 -45.83 40.06 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.387 0.613 . . . . 0.0 109.597 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.51 94.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.427 -0.796 . . . . 0.0 109.688 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.5 OUTLIER -48.06 -34.49 9.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.368 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -45.77 -17.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.827 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 16' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -76.44 -43.11 20.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' D' ' 17' ' ' LYS . 1.5 mmtt -79.72 -30.6 40.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.127 -1.219 . . . . 0.0 109.247 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -47.86 114.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 109.569 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' D' ' 22' ' ' GLU . 5.8 m-20 -77.87 66.04 3.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 108.988 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' D' ' 22' ' ' GLU . 73.7 t -43.66 -26.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.446 -0.784 . . . . 0.0 109.786 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.72 7.22 0.92 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' D' ' 19' ' ' ASN . 36.6 mt-10 -155.28 -50.25 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.567 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 69.7 t -46.98 -33.86 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.47 -50.78 59.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.35 -36.81 79.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -73.68 -38.76 64.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -1.158 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.82 -34.07 72.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 109.436 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -84.94 -34.56 22.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.45 -50.2 60.81 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -58.22 -30.6 66.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -1.117 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 31' ' ' LEU . . . . . 0.468 ' CD2' HBC2 ' D' ' 147' ' ' HEC . 9.3 tp -50.41 -39.17 46.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.967 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 mt -81.03 -22.0 39.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.163 -0.961 . . . . 0.0 109.597 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 21.1 t -82.7 -64.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.772 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.485 HG22 ' CG ' ' C' ' 122' ' ' HIS . 2.3 t -64.57 -22.9 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.875 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 35' ' ' TYR . . . . . 0.43 ' HB3' ' HE1' ' D' ' 37' ' ' TRP . 53.7 m-85 -139.77 78.63 25.16 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.285 -0.884 . . . . 0.0 109.399 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.81 -17.81 6.9 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.814 2.342 . . . . 0.0 112.417 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 37' ' ' TRP . . . . . 0.57 ' O ' ' NH2' ' A' ' 92' ' ' ARG . 5.2 p-90 -49.7 -19.89 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.514 HG23 ' CE2' ' D' ' 37' ' ' TRP . 1.4 p -92.1 -11.39 35.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.264 -0.897 . . . . 0.0 109.332 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -45.03 -34.17 2.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.337 -0.852 . . . . 0.0 109.736 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 40' ' ' ARG . . . . . 1.453 ' HB2' ' NE ' ' A' ' 92' ' ' ARG . 37.7 mtp85 -61.12 -26.08 67.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.441 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 41' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' D' ' 38' ' ' THR . 32.3 t80 -100.85 30.75 3.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -0.865 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -146.26 31.24 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 109.343 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.75 -14.08 58.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 44' ' ' SER . . . . . 0.406 ' C ' ' N ' ' D' ' 46' ' ' GLY . 28.5 t -65.52 -43.79 88.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.541 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.501 ' O ' ' N ' ' D' ' 47' ' ' ASP . 44.5 m-85 -48.99 -18.49 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.425 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' D' ' 48' ' ' LEU . . . 65.82 -66.58 0.12 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' D' ' 45' ' ' PHE . 79.6 m-20 -54.07 86.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -1.123 . . . . 0.0 109.632 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 48' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' D' ' 46' ' ' GLY . 0.8 OUTLIER -164.46 21.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.167 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.0 m -57.98 -41.04 82.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.419 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 50' ' ' THR . . . . . 0.434 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.3 p -146.28 152.29 46.16 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.0 109.092 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -40.49 -30.12 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.449 2.1 . . . . 0.0 112.361 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -75.13 -29.14 60.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.615 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 53' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -63.93 -20.39 65.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.63 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.58 -24.04 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 55' ' ' MET . . . . . 0.418 ' O ' ' OD1' ' D' ' 57' ' ' ASN . 16.3 mmt -90.0 -6.14 55.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.605 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.602 ' O ' ' CB ' ' D' ' 57' ' ' ASN . . . -47.94 -35.82 13.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 57' ' ' ASN . . . . . 0.725 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 21.3 m-20 91.7 23.55 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 122.137 -0.625 . . . . 0.0 111.568 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' D' ' 57' ' ' ASN . 75.3 Cg_endo -81.36 -157.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.948 1.765 . . . . 0.0 112.122 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -47.61 -24.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 60' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 58' ' ' PRO . 54.7 t -51.56 -50.18 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.494 -0.754 . . . . 0.0 109.279 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 61' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' D' ' 62' ' ' ALA . 0.0 OUTLIER -79.37 -32.62 43.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.38 -0.825 . . . . 0.0 109.631 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 62' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' D' ' 61' ' ' LYS . . . -57.02 -49.74 74.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.979 . . . . 0.0 109.532 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 1.197 ' NE2' HAD2 ' D' ' 147' ' ' HEC . 46.5 t-80 -59.42 -26.28 65.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 109.557 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.47 -19.46 74.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -76.09 -24.91 55.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -1.176 . . . . 0.0 109.082 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -74.36 -59.18 2.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.84 . . . . 0.0 109.564 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 1.565 HG13 ' C1B' ' D' ' 147' ' ' HEC . 40.5 t -47.15 -34.16 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.465 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.47 -42.61 95.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.142 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.71 -49.92 51.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.7 -33.5 66.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -1.144 . . . . 0.0 109.52 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -76.2 -37.66 57.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -80.42 -28.28 37.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 109.385 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -51.11 -38.86 54.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.915 . . . . 0.0 109.415 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.22 -60.15 7.96 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.599 HD12 ' H ' ' D' ' 75' ' ' LEU . 4.9 mp -56.87 -18.63 13.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -1.131 . . . . 0.0 109.345 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 76' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -83.22 -19.32 36.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.883 . . . . 0.0 109.615 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 72.0 m-70 -159.37 62.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.689 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.1 -0.43 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.945 . . . . 0.0 109.409 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' D' ' 77' ' ' HIS . 45.8 t0 -57.66 -25.85 60.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.503 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 80' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' D' ' 80' ' ' ASN . 9.0 p-10 -170.64 105.9 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 81' ' ' LEU . . . . . 0.548 HD12 ' N ' ' D' ' 81' ' ' LEU . 10.2 mp -79.97 -57.3 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -45.83 -23.97 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 109.566 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.82 -63.27 2.75 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.0 t -61.02 -47.46 86.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -1.181 . . . . 0.0 109.557 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 64.4 m-85 -67.82 4.68 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.574 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 86' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.68 -46.68 77.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.544 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -75.08 -52.46 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.522 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 55.6 mt -50.74 -47.46 59.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 89' ' ' SER . . . . . 0.5 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 14.7 m -57.5 -36.19 71.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -79.88 -22.25 43.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.98 -18.01 26.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.766 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' D' ' 88' ' ' LEU . 10.0 m80 -87.88 -60.67 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.96 -1.088 . . . . 0.0 110.486 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 93' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' D' ' 89' ' ' SER . 12.5 p -83.94 -59.78 2.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.969 -1.082 . . . . 0.0 111.438 -178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.477 ' N ' ' SG ' ' D' ' 93' ' ' CYS . 14.2 m-20 -59.14 -26.76 65.02 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.095 -1.003 . . . . 0.0 111.709 -177.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 95' ' ' LYS . . . . . 0.526 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 3.2 tppp? -107.55 -51.93 2.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.658 -1.276 . . . . 0.0 110.796 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.451 ' C ' ' CD2' ' D' ' 97' ' ' HIS . 5.7 mp -87.22 -30.55 20.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.915 -1.115 . . . . 0.0 109.918 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.818 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 9.6 m-70 66.47 49.19 1.41 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.16 -0.962 . . . . 0.0 110.039 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 33.0 t -96.63 114.2 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.27 -0.894 . . . . 0.0 108.987 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 99' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' D' ' 100' ' ' PRO . 0.9 OUTLIER -62.65 153.59 77.63 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.553 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 100' ' ' PRO . . . . . 0.576 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 50.6 Cg_exo -51.86 -156.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.504 2.136 . . . . 0.0 112.409 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 52.93 46.66 26.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.578 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 102' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' D' ' 100' ' ' PRO . 72.4 m-80 -158.03 -35.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -65.0 -39.16 93.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.494 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -65.55 -31.2 72.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 109.666 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 105' ' ' LEU . . . . . 0.575 ' N ' HD12 ' D' ' 105' ' ' LEU . 9.8 mp -62.4 -57.98 9.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.437 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 1.613 ' CD2' HBB3 ' D' ' 147' ' ' HEC . 6.4 tt -48.2 -22.73 0.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.627 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 107' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' D' ' 109' ' ' VAL . . . -79.3 -45.51 8.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -46.53 -16.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -1.176 . . . . 0.0 109.623 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 109' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' D' ' 107' ' ' GLY . 98.2 t -85.07 -62.62 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.503 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 14.7 mt -47.39 -26.18 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.661 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 70.8 t -68.96 -47.52 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.084 -1.01 . . . . 0.0 109.906 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 20.0 p -79.41 -41.22 28.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.138 -0.976 . . . . 0.0 110.037 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 78.2 t -47.57 -41.07 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.721 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 114' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' D' ' 118' ' ' PHE . 46.6 mt -79.52 -40.37 29.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.567 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.429 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.2 -30.38 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.399 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.535 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -84.75 -56.96 3.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 109.235 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 117' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 85.8 m-70 -63.48 -17.66 62.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.574 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.418 ' N ' ' O ' ' D' ' 114' ' ' LEU . 65.6 m-85 -153.33 62.32 0.76 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 109.544 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' D' ' 122' ' ' PHE . . . -68.84 -50.51 35.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -47.95 -30.93 4.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.191 . . . . 0.0 109.404 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -82.81 -18.98 38.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.557 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 122' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' D' ' 119' ' ' GLY . 6.3 t80 -76.17 66.6 2.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.129 -0.982 . . . . 0.0 109.293 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.429 ' OG1' HG23 ' D' ' 126' ' ' VAL . 1.3 p -79.1 149.68 73.51 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.288 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.508 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -45.3 -53.6 5.24 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.488 2.125 . . . . 0.0 112.972 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 25.7 Cg_endo -62.52 1.18 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.012 1.808 . . . . 0.0 112.21 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.453 ' O ' HG12 ' D' ' 126' ' ' VAL . 86.9 t -112.44 -8.31 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.21 -54.08 5.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 109.556 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.774 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -54.62 -33.84 61.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.14 2.52 17.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.21 -29.5 13.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 109.444 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 131' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 88.7 mm-40 -84.34 -23.49 30.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 109.901 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 132' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' B' ' 146' ' ' HIS . 14.4 ttmt -85.46 -36.06 20.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.141 -0.974 . . . . 0.0 110.183 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 133' ' ' VAL . . . . . 0.758 HG13 ' N ' ' D' ' 134' ' ' VAL . 11.9 p -65.44 -58.78 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.094 -1.004 . . . . 0.0 110.041 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.758 ' N ' HG13 ' D' ' 133' ' ' VAL . 11.5 t -62.23 -33.38 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 0.0 109.959 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -45.92 -21.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 0.0 109.743 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 136' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -82.79 -26.75 44.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 137' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' D' ' 134' ' ' VAL . 97.5 t -78.89 -21.15 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -1.148 . . . . 0.0 109.644 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.11 -38.3 31.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 109.644 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -84.66 -21.21 30.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.755 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.26 -48.44 70.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 0.0 109.697 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' D' ' 92' ' ' HIS . 28.3 mt -58.15 -22.08 49.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 142' ' ' ALA . . . . . 0.533 ' O ' ' CD1' ' D' ' 145' ' ' TYR . . . -89.65 26.07 1.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 0.0 109.568 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 143' ' ' HIS . . . . . 0.431 ' CD2' ' O ' ' D' ' 143' ' ' HIS . 11.0 t-160 -80.53 -6.91 58.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.108 -0.995 . . . . 0.0 109.128 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' D' ' 146' ' ' HIS . 11.6 mptt -122.15 -27.96 4.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.457 -0.777 . . . . 0.0 109.671 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 145' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' D' ' 142' ' ' ALA . 0.1 OUTLIER -50.21 -7.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 110.066 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.723 ' HB3' ' HG3' ' B' ' 132' ' ' LYS . 12.0 m-70 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.669 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 1.085 ' CHC' ' CD1' ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 1.558 HBB3 ' CD2' ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 1.106 ' CHC' ' CD1' ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 1.613 HBB3 ' CD2' ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.28 -169.92 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -0.907 . . . . 0.0 109.903 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.594 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -100.01 -179.2 0.78 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.35 -0.844 . . . . 0.0 109.566 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 23.0 Cg_exo -62.83 -58.51 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.893 2.395 . . . . 0.0 113.049 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -78.65 -16.44 57.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.03 -1.044 . . . . 0.0 110.204 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.594 ' CG ' ' H ' ' A' ' 3' ' ' SER . 33.5 m-20 -39.79 -30.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 0.0 109.72 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.638 ' H ' ' CD ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -83.7 -39.47 20.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.531 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' ALA . 37.2 m -44.82 -42.87 8.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.461 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -71.24 -25.33 62.44 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.578 ' N ' ' O ' ' A' ' 7' ' ' LYS . 53.2 t -78.82 -55.19 10.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -53.48 -37.19 62.47 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.459 -1.296 . . . . 0.0 107.875 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.78 -63.18 1.22 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.238 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.787 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -60.24 -36.17 77.15 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -0.843 . . . . 0.0 108.768 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -17.51 62.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 109.088 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -78.79 -46.43 8.54 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 13.2 mmmt -70.14 -36.62 74.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -1.098 . . . . 0.0 108.817 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 13' ' ' ALA . 95.4 t -60.65 -65.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 58.71 -134.9 52.32 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.41 27.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.429 -1.042 . . . . 0.0 110.437 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.541 ' H ' ' C ' ' A' ' 18' ' ' GLY . 92.4 m-70 -131.58 25.68 4.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.199 -0.938 . . . . 0.0 108.481 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.57 -61.66 1.66 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.613 -0.679 . . . . 0.0 109.754 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.68 -14.38 0.23 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 1.2 mm-40 -84.33 -56.33 3.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -1.091 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.605 ' CE1' ' CG ' ' A' ' 112' ' ' HIS . 2.8 m-30 -60.64 -27.78 68.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.458 -0.776 . . . . 0.0 109.172 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.82 -22.92 75.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.2 18.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -1.138 . . . . 0.0 109.795 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -64.29 -19.88 65.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 109.511 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.11 -19.68 60.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 109.313 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.491 HD11 ' ND1' ' A' ' 58' ' ' HIS . 12.8 mt -78.43 -54.1 6.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 109.6 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.26 -37.6 64.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.447 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -43.87 98.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.502 ' HE2' ' HB3' ' A' ' 32' ' ' MET . 53.5 ttp -67.26 -49.92 62.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.425 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -51.54 -46.32 63.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 12.8 mt -64.09 -60.21 3.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 109.793 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 18.8 p -55.46 -18.98 8.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.646 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 35' ' ' SER . 79.6 m-85 -156.05 113.36 2.13 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 39' ' ' THR . 73.0 Cg_endo -79.56 -20.14 9.62 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.32 2.013 . . . . 0.0 111.945 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.85 ' O ' HG22 ' A' ' 41' ' ' THR . 41.0 p -47.12 -18.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.373 -0.829 . . . . 0.0 109.735 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 37' ' ' PRO . 42.6 p -74.68 -22.72 58.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 109.876 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -70.13 -20.05 63.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.0 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.85 HG22 ' O ' ' A' ' 38' ' ' THR . 12.2 t -73.69 -18.9 60.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.818 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.441 ' CZ ' HG23 ' A' ' 93' ' ' VAL . 33.3 m-85 -80.1 19.38 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.969 . . . . 0.0 109.576 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 51.5 94.04 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.996 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.665 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 71.5 Cg_endo -81.58 -34.56 0.51 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.653 2.236 . . . . 0.0 111.791 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.665 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 15.1 p80 51.56 30.65 6.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.744 -0.597 . . . . 0.0 111.297 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.605 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 4.9 p90 -145.42 23.2 1.47 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.891 -1.131 . . . . 0.0 109.526 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' SER . 57.2 m-20 42.52 84.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.551 -0.718 . . . . 0.0 109.829 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.62 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -50.22 -11.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 47' ' ' ASP . 14.7 m -58.88 147.36 34.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.383 -0.823 . . . . 0.0 109.491 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -64.54 148.46 50.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.596 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.03 83.81 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 5.4 p -69.07 -23.72 64.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -1.221 . . . . 0.0 109.337 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.57 -56.15 0.46 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.837 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 52' ' ' SER . 43.1 mt-30 -43.89 -22.44 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.356 -0.84 . . . . 0.0 109.812 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 53' ' ' ALA . 41.0 t -74.35 -26.74 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.32 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.7 ptmt -65.7 -27.41 68.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.87 . . . . 0.0 109.552 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.08 -50.44 40.12 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.491 ' ND1' HD11 ' A' ' 29' ' ' LEU . 20.4 t-80 -53.85 -32.42 52.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -1.156 . . . . 0.0 109.476 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.22 -47.27 91.92 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -58.35 -23.43 56.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -1.081 . . . . 0.0 109.592 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.686 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 0.7 OUTLIER -74.29 -39.49 62.9 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.228 -0.92 . . . . 0.0 108.88 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.7 -49.07 48.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.97 71.17 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.299 -0.876 . . . . 0.0 109.052 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -67.18 -38.73 85.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.299 -0.876 . . . . 0.0 108.759 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.562 ' HB3' HMB3 ' A' ' 142' ' ' HEC . . . -64.07 -52.1 60.96 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -57.24 -44.6 83.98 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.243 -0.91 . . . . 0.0 108.731 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.4 m -68.74 -50.65 48.97 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -60.36 -24.28 64.95 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.96 -45.64 12.0 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.65 -23.38 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.66 -18.7 64.23 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.7 m80 -144.08 -58.89 0.39 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.404 -0.81 . . . . 0.0 109.339 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.3 p 44.19 13.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 121.879 0.847 . . . . 0.0 109.561 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.612 ' N ' ' O ' ' A' ' 72' ' ' HIS . 46.0 t0 -133.8 11.08 3.99 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.408 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.9 p-10 179.03 29.39 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.973 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.695 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 17.4 ptt? -78.62 -22.61 0.39 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.426 -0.796 . . . . 0.0 111.805 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.695 ' CD ' ' N ' ' A' ' 76' ' ' MET . 52.4 Cg_exo -54.12 -22.27 24.84 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.497 1.465 . . . . 0.0 112.347 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -94.16 -33.86 13.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.8 59.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.146 -0.971 . . . . 0.0 109.353 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.36 8.5 7.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.372 -0.83 . . . . 0.0 109.123 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.0 p -55.89 -17.11 5.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.929 . . . . 0.0 109.666 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.09 -55.97 4.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.454 ' N ' HD23 ' A' ' 83' ' ' LEU . 3.5 mt -45.4 -44.02 11.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 108.935 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 136' ' ' LEU . 29.7 t -57.23 -22.63 42.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.503 -0.748 . . . . 0.0 109.448 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 89' ' ' HIS . 23.1 t70 -82.01 -58.3 3.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.854 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.63 -27.45 17.17 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.757 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.448 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 38.6 m80 -91.84 -21.76 20.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.858 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.47 -11.35 15.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.214 -0.929 . . . . 0.0 109.902 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.581 ' N ' ' O ' ' A' ' 85' ' ' ASP . 14.4 m80 -113.94 -77.81 0.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 89' ' ' HIS . 9.9 mptt -45.79 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.481 ' C ' ' N ' ' A' ' 93' ' ' VAL . 19.6 mt -65.69 -17.33 64.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.838 . . . . 0.0 110.16 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.518 ' NH1' ' OE2' ' D' ' 43' ' ' GLU . 25.0 ttm180 48.93 15.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 109.003 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.481 ' N ' ' C ' ' A' ' 91' ' ' LEU . 10.8 p -46.01 156.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.0 109.878 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 93' ' ' VAL . 3.5 m-20 -100.23 153.03 37.98 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.39 -0.818 . . . . 0.0 109.046 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 98' ' ' PHE . 32.7 Cg_endo -65.79 -10.64 27.48 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.539 2.159 . . . . 0.0 111.954 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 95' ' ' PRO . 83.4 t -44.05 -29.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.343 -0.848 . . . . 0.0 109.767 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -79.32 -32.92 43.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.577 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -50.18 -34.9 24.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.347 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -49.99 -34.91 22.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.8 mt -82.12 -50.52 8.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.812 HD21 HBB3 ' A' ' 142' ' ' HEC . 53.1 tp -45.77 -20.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.627 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' LEU . 93.3 p -73.3 -59.33 2.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 109.945 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.72 ' CD2' ' OD1' ' B' ' 108' ' ' ASN . 92.4 m-70 -71.81 -26.48 62.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.922 . . . . 0.0 109.769 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 62.4 m -58.11 -42.23 85.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.89 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.64 -22.74 62.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.186 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.594 ' N ' HD22 ' A' ' 106' ' ' LEU . 3.7 mm? -79.01 -35.96 41.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.0 -1.062 . . . . 0.0 110.137 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 45.3 t -62.89 -39.46 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.058 -1.026 . . . . 0.0 109.499 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.486 ' OG1' ' N ' ' A' ' 109' ' ' LEU . 12.2 p -65.23 -62.97 1.22 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.176 -0.952 . . . . 0.0 109.644 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.486 ' N ' ' OG1' ' A' ' 108' ' ' THR . 14.7 mt -48.2 -22.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -63.35 -36.47 83.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 109.896 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.16 -42.59 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.158 -0.964 . . . . 0.0 109.893 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.605 ' CG ' ' CE1' ' A' ' 24' ' ' TYR . 62.7 m80 -81.8 -75.36 0.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.011 . . . . 0.0 109.519 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 113' ' ' LEU . 1.5 pp -137.14 94.44 12.48 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.19 -171.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.248 1.965 . . . . 0.0 112.931 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.524 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -47.23 -38.55 12.44 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.52 0.676 . . . . 0.0 109.539 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 6.7 mt-10 85.37 9.52 0.33 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.805 ' CE1' ' NE2' ' B' ' 116' ' ' HIS . 6.9 m-85 65.04 34.86 8.48 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.83 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.713 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -94.42 121.3 63.76 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.745 -1.222 . . . . 0.0 107.971 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -51.31 23.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.039 1.826 . . . . 0.0 112.914 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -154.97 -30.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.778 -1.201 . . . . 0.0 110.851 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.731 HG13 ' N ' ' A' ' 122' ' ' HIS . 11.8 p -47.83 -50.38 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.086 -1.008 . . . . 0.0 110.375 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.731 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.4 t-80 -65.38 -43.5 90.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.453 -0.779 . . . . 0.0 109.999 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' B' ' 34' ' ' VAL . . . -79.07 -19.36 51.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.243 -0.911 . . . . 0.0 109.921 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 120' ' ' ALA . 64.3 m -72.45 -63.95 1.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 111.08 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.01 -18.25 64.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.947 -1.096 . . . . 0.0 109.48 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.26 -49.41 10.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.961 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.83 -57.77 2.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.906 -1.122 . . . . 0.0 111.441 -178.244 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.456 ' CD2' ' HA ' ' A' ' 124' ' ' SER . 21.9 m-85 -46.55 -21.53 0.19 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.776 -1.202 . . . . 0.0 110.239 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.768 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -66.58 -18.87 65.6 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 134' ' ' THR . . . -55.96 -33.21 64.55 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.489 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 7.9 t -66.77 -36.73 83.11 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.217 -0.927 . . . . 0.0 108.762 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.504 ' O ' HD13 ' A' ' 136' ' ' LEU . 1.8 t -78.34 -40.0 24.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.8 t -73.41 -37.8 65.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.324 -0.86 . . . . 0.0 108.905 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 130' ' ' ALA . 88.9 m -71.55 -31.08 66.62 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.234 -0.916 . . . . 0.0 108.555 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 131' ' ' SER . 2.9 t -70.44 -36.58 67.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 132' ' ' VAL . 3.3 mp -56.71 -32.93 65.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 109.008 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.9 m -89.34 -27.25 20.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.59 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.2 p -66.59 132.09 47.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.528 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.459 ' C ' ' CG ' ' A' ' 140' ' ' TYR . 18.9 pttp -169.28 172.09 7.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.403 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.459 ' CG ' ' C ' ' A' ' 139' ' ' LYS . 28.1 m-85 -154.43 -44.49 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.534 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.469 ' CA ' ' HE ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.447 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.685 ' H1 ' ' HA ' ' B' ' 133' ' ' VAL . 13.2 p . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 50.79 35.57 12.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.285 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.904 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -86.47 178.11 7.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.188 -0.945 . . . . 0.0 109.25 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.415 ' O ' ' N ' ' B' ' 6' ' ' GLU . 7.5 p -92.09 145.42 30.81 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 109.368 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -39.96 -26.03 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.544 2.162 . . . . 0.0 112.17 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' B' ' 4' ' ' THR . 39.4 mt-10 -81.69 -51.91 7.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.565 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' B' ' 7' ' ' GLU . 0.7 OUTLIER -75.38 -22.6 57.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.913 . . . . 0.0 109.504 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.477 ' HB2' HD13 ' B' ' 3' ' ' LEU . 6.7 tttm -78.47 -37.1 44.21 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.33 -0.856 . . . . 0.0 109.121 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -63.12 -23.31 67.38 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.12 -57.64 3.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.148 -0.97 . . . . 0.0 110.166 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.46 -24.92 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.055 . . . . 0.0 108.574 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 96.4 m -78.26 -31.58 49.17 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.749 -0.594 . . . . 0.0 109.823 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -67.23 -63.79 0.99 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.767 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.563 ' N ' HD12 ' B' ' 14' ' ' LEU . 10.6 mp -45.83 -19.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.388 -0.82 . . . . 0.0 109.901 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' TRP . . . . . 0.463 ' N ' ' O ' ' B' ' 13' ' ' ALA . 4.0 t90 -78.78 -40.82 32.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.064 -1.023 . . . . 0.0 108.82 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.43 -24.07 59.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -79.87 -32.65 40.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -1.014 . . . . 0.0 109.286 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.56 HG23 ' O ' ' B' ' 14' ' ' LEU . 3.7 t -62.6 132.08 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.318 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' B' ' 21' ' ' ASP . 71.8 m-20 -81.26 78.28 8.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.246 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.465 HG12 ' O ' ' B' ' 20' ' ' VAL . 77.9 t -49.82 -10.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' B' ' 19' ' ' ASN . 21.4 m-20 -55.31 -29.95 59.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.895 . . . . 0.0 109.729 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' B' ' 25' ' ' GLY . 18.3 pt-20 -152.5 -32.16 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.96 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' B' ' 22' ' ' GLU . 92.8 t -44.71 -26.32 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 109.638 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.51 -26.27 47.57 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -66.85 -45.12 86.62 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.415 ' OE2' ' N ' ' B' ' 26' ' ' GLU . 1.2 mp0 -63.91 -47.75 79.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -1.144 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.41 -30.8 42.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.161 -0.962 . . . . 0.0 109.372 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.2 -54.27 5.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.37 -35.23 91.78 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -67.01 -32.38 73.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.12 . . . . 0.0 109.466 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 tp -47.24 -41.31 18.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 109.638 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.68 -23.91 39.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 109.712 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.17 -64.03 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.983 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.702 ' HA ' ' HB2' ' A' ' 123' ' ' ALA . 2.5 t -46.76 -43.9 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.322 -0.861 . . . . 0.0 109.373 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -171.79 130.0 0.69 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.336 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.59 62.32 7.71 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.302 2.002 . . . . 0.0 112.088 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' TRP . . . . . 0.493 ' CD1' ' N ' ' B' ' 37' ' ' TRP . 0.0 OUTLIER -57.65 -43.75 85.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.151 -0.968 . . . . 0.0 109.276 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.992 ' CG2' HBC1 ' B' ' 147' ' ' HEC . 1.7 p -49.78 -64.42 0.81 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.902 . . . . 0.0 109.373 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLN . . . . . 0.533 ' N ' ' OG1' ' B' ' 38' ' ' THR . 31.8 tt0 48.16 43.94 18.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.483 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 -163.44 -36.67 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.554 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -119.28 16.11 13.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 109.193 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' B' ' 43' ' ' GLU . 30.7 p90 -87.54 -35.15 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.534 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.489 ' OE2' ' NH1' ' C' ' 92' ' ' ARG . 12.1 pt-20 -81.98 -13.92 56.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.683 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 86.4 p -57.68 -29.05 64.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.6 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -85.23 19.23 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.514 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.62 1.87 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' B' ' 48' ' ' LEU . 35.7 t0 49.79 -145.96 0.41 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -1.196 . . . . 0.0 109.488 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.539 ' CB ' ' O ' ' B' ' 47' ' ' ASP . 2.4 tp 82.73 24.29 0.16 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.787 -0.571 . . . . 0.0 109.64 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -57.59 -35.16 70.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.935 . . . . 0.0 109.202 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' THR . . . . . 0.402 ' O ' ' N ' ' B' ' 52' ' ' ASP . 1.2 p -146.93 153.64 46.09 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 108.923 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.44 -22.74 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.258 1.972 . . . . 0.0 112.257 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' B' ' 50' ' ' THR . 26.2 t70 -85.13 -38.58 18.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.92 -19.52 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.34 -0.85 . . . . 0.0 109.53 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' B' ' 52' ' ' ASP . 14.4 t -60.63 -59.34 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 17.2 ptp -90.33 14.13 13.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.895 . . . . 0.0 109.572 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.85 -18.98 58.77 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -89.08 146.95 37.45 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.133 -1.216 . . . . 0.0 109.486 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.87 -20.44 17.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.565 2.177 . . . . 0.0 112.388 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.61 -32.37 25.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 109.796 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -60.65 -41.15 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.969 . . . . 0.0 109.654 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.493 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 11.9 ptpt -79.03 -35.87 42.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -0.989 . . . . 0.0 109.38 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.25 69.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' HIS . . . . . 0.798 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 0.8 OUTLIER -72.87 -24.05 60.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.91 . . . . 0.0 109.594 -179.86 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.72 -19.08 80.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -68.5 -32.2 72.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -1.139 . . . . 0.0 109.323 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -75.95 -34.46 59.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.631 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' VAL . . . . . 0.84 HG22 ' CHB' ' B' ' 147' ' ' HEC . 53.9 t -68.9 -62.87 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.5 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.766 HD23 ' O ' ' B' ' 68' ' ' LEU . 2.6 tt -50.21 -29.01 8.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.934 . . . . 0.0 109.315 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.73 -38.93 96.74 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.47 93.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -1.135 . . . . 0.0 109.822 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.433 ' CE2' HD23 ' B' ' 110' ' ' LEU . 25.3 m-85 -46.98 -30.25 2.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.772 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 3.9 p -57.56 -49.7 75.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -60.38 -16.91 39.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.399 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.17 -31.04 79.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.861 HD23 ' H ' ' B' ' 75' ' ' LEU . 1.4 pt? -136.58 -22.38 1.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.268 -1.136 . . . . 0.0 110.031 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -77.59 5.11 9.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.03 -1.044 . . . . 0.0 109.733 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 46.5 m-70 -161.03 66.22 0.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.418 HD21 ' HA ' ' B' ' 75' ' ' LEU . 87.1 mt -72.96 10.82 0.8 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.498 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' B' ' 77' ' ' HIS . 13.7 t70 -66.74 -45.68 77.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.422 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -162.21 96.2 0.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.805 . . . . 0.0 109.414 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 24.7 mt -76.16 -58.79 3.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -54.72 -23.94 19.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.486 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.13 -47.54 9.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.8 t -78.25 -48.28 16.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -1.158 . . . . 0.0 109.628 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 85' ' ' PHE . . . . . 0.563 ' N ' ' CG2' ' B' ' 84' ' ' THR . 27.9 m-85 -59.62 -1.71 0.28 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.5 -0.75 . . . . 0.0 109.425 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -56.3 -35.25 67.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.371 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 34.8 p -73.09 -57.77 3.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' B' ' 88' ' ' LEU . 32.5 mt -56.43 -29.5 61.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.312 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 69.6 m -81.14 -32.56 33.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -82.6 -22.28 34.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.869 . . . . 0.0 109.546 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' LEU . . . . . 0.493 HD23 ' C ' ' B' ' 91' ' ' LEU . 9.8 tt -78.78 -68.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.759 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' B' ' 97' ' ' HIS . 0.4 OUTLIER -55.31 -20.12 10.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.075 -179.198 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 93' ' ' CYS . . . . . 0.532 ' N ' ' ND1' ' B' ' 92' ' ' HIS . 36.4 t -83.53 -60.68 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 110.642 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 94' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' B' ' 94' ' ' ASP . 0.8 OUTLIER -87.78 -25.75 23.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.084 -1.01 . . . . 0.0 111.446 -178.566 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.96 -52.24 5.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.717 -1.239 . . . . 0.0 110.96 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.607 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 2.3 mm? -112.56 -11.63 13.56 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.941 -1.1 . . . . 0.0 109.828 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 97' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 49.2 p-80 41.84 41.51 1.87 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.351 -0.843 . . . . 0.0 109.761 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 59.6 t -51.41 132.32 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -0.819 . . . . 0.0 109.457 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.07 153.0 90.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.171 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.47 -164.76 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.544 2.162 . . . . 0.0 112.229 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 56.91 48.38 15.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -0.936 . . . . 0.0 109.36 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -160.62 -33.53 0.05 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.315 -0.865 . . . . 0.0 109.46 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -63.42 -60.94 2.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.37 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -57.53 -20.3 30.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.357 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.509 ' O ' HD23 ' B' ' 105' ' ' LEU . 1.6 tt -77.34 -49.79 14.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.383 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.871 HD13 ' CHC' ' B' ' 147' ' ' HEC . 6.7 tt -49.38 -46.3 47.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.274 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.35 -45.82 95.45 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 108' ' ' ASN . . . . . 0.72 ' OD1' ' CD2' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -53.8 -34.7 59.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.151 -1.205 . . . . 0.0 109.565 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 109' ' ' VAL . . . . . 0.465 ' O ' ' SG ' ' B' ' 112' ' ' CYS . 89.7 t -80.28 -24.06 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.433 HD23 ' CE2' ' B' ' 71' ' ' PHE . 34.6 tp -78.06 -32.37 50.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.29 -49.59 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 109.754 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' B' ' 113' ' ' VAL . 18.7 p -53.08 -37.21 61.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.692 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 113' ' ' VAL . . . . . 0.468 ' N ' ' SG ' ' B' ' 112' ' ' CYS . 96.5 t -60.64 -21.37 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.661 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' B' ' 130' ' ' TYR . 23.6 mt -77.63 -57.02 4.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' ALA . . . . . 0.462 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.1 -19.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.372 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' HIS . . . . . 0.805 ' NE2' ' CE1' ' A' ' 117' ' ' PHE . 1.5 t-80 -79.33 -56.78 4.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -69.24 -17.72 63.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 109.71 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -151.22 60.96 0.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 0.0 109.588 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -77.76 -23.23 67.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.53 8.71 4.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -1.1 . . . . 0.0 109.447 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -134.63 12.88 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.18 43.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.0 109.119 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' THR . . . . . 0.488 ' OG1' HG23 ' B' ' 126' ' ' VAL . 1.0 OUTLIER -48.64 151.1 2.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.147 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.502 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.0 Cg_exo -45.98 -52.32 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.281 1.987 . . . . 0.0 113.029 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 125' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 46.8 Cg_endo -68.34 15.24 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.173 1.916 . . . . 0.0 112.973 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.488 HG23 ' OG1' ' B' ' 123' ' ' THR . 53.2 t -108.53 -42.69 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.988 -1.07 . . . . 0.0 109.878 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 127' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' B' ' 127' ' ' GLN . 0.0 OUTLIER -70.7 -59.87 2.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.086 -1.009 . . . . 0.0 109.798 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.684 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -49.48 -34.79 17.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.099 -1.001 . . . . 0.0 109.358 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.34 27.75 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.29 -0.881 . . . . 0.0 109.641 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 130' ' ' TYR . . . . . 0.516 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 1.6 t80 -126.69 -34.68 2.39 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.356 -0.84 . . . . 0.0 109.637 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -71.22 -62.86 1.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.743 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -48.7 -21.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.774 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 133' ' ' VAL . . . . . 0.685 ' HA ' ' H1 ' ' B' ' 1' ' ' VAL . 33.8 t -69.13 -65.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.741 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 9.2 m -74.15 -16.38 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.607 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' D' ' 146' ' ' HIS . . . -49.41 -30.26 7.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.331 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.59 -26.3 70.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.79 -39.81 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -1.11 . . . . 0.0 109.367 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.88 95.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.745 HD21 ' N ' ' B' ' 139' ' ' ASN . 0.5 OUTLIER -73.72 -44.14 57.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.422 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.09 -37.68 47.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.331 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.529 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 18.1 mt -82.35 11.27 5.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' B' ' 144' ' ' LYS . . . -123.7 -30.97 3.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.382 -0.823 . . . . 0.0 109.514 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 143' ' ' HIS . . . . . 0.452 ' CE1' ' HE1' ' D' ' 143' ' ' HIS . 5.6 m170 -49.68 -13.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.355 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 144' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' B' ' 142' ' ' ALA . 3.2 tptp -77.88 -43.07 31.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.21 -0.931 . . . . 0.0 109.511 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -50.1 -25.25 3.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 146' ' ' HIS . . . . . 0.687 ' CE1' ' OD1' ' D' ' 139' ' ' ASN . 25.8 m170 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.495 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.36 -169.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.897 . . . . 0.0 109.862 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' SER . . . . . 0.604 ' H ' ' CG ' ' C' ' 6' ' ' ASP . 0.1 OUTLIER -99.93 -179.11 0.77 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.404 -0.81 . . . . 0.0 109.644 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 22.8 Cg_exo -62.92 -58.46 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.908 2.405 . . . . 0.0 113.091 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 5' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -78.7 -16.4 57.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.1 -1.0 . . . . 0.0 110.215 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' C' ' 3' ' ' SER . 33.5 m-20 -39.86 -30.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 7' ' ' LYS . . . . . 0.622 ' CD ' ' H ' ' C' ' 7' ' ' LYS . 0.0 OUTLIER -83.65 -39.52 20.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.493 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.45 ' N ' ' O ' ' C' ' 5' ' ' ALA . 36.4 m -44.85 -42.87 8.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.369 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -71.23 -25.37 62.47 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' C' ' 7' ' ' LYS . 52.9 t -78.83 -55.24 10.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 11' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' C' ' 15' ' ' GLY . 0.0 OUTLIER -53.41 -37.18 62.27 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.526 -1.27 . . . . 0.0 107.89 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.79 -63.16 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.332 -0.855 . . . . 0.0 109.241 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.766 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -60.29 -36.2 77.31 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -17.49 62.37 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 109.067 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 15' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' C' ' 11' ' ' LYS . . . -78.86 -46.42 8.48 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.04 -36.65 75.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -1.118 . . . . 0.0 108.869 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.766 HG23 ' O ' ' C' ' 13' ' ' ALA . 94.9 t -60.65 -66.02 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 58.77 -134.78 52.36 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.55 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -1.025 . . . . 0.0 110.427 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 20' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' C' ' 18' ' ' GLY . 92.2 m-70 -131.59 25.72 4.74 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 21' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.65 -61.55 1.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.61 -0.681 . . . . 0.0 109.755 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.7 -14.42 0.23 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 21' ' ' ALA . 1.2 mm-40 -84.28 -56.4 3.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -1.059 . . . . 0.0 109.526 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 24' ' ' TYR . . . . . 0.606 ' CE1' ' CG ' ' C' ' 112' ' ' HIS . 2.8 m-30 -60.6 -27.83 68.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 109.176 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.75 -22.94 75.66 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.72 -41.98 18.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.249 -1.147 . . . . 0.0 109.832 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -64.37 -19.99 65.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.405 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.05 -19.71 60.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.347 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.481 HD11 ' ND1' ' C' ' 58' ' ' HIS . 12.8 mt -78.41 -53.98 6.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.688 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.31 -37.64 65.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -43.84 98.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 32' ' ' MET . . . . . 0.523 ' HB3' ' HE2' ' C' ' 32' ' ' MET . 53.4 ttp -67.29 -49.96 62.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.407 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -51.49 -46.32 63.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.673 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 12.8 mt -64.08 -60.22 3.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.927 . . . . 0.0 109.865 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 35' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 18.7 p -55.36 -19.05 7.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 36' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' C' ' 35' ' ' SER . 79.6 m-85 -156.16 113.27 2.11 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.578 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 37' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' C' ' 39' ' ' THR . 73.0 Cg_endo -79.47 -20.12 9.74 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.259 1.973 . . . . 0.0 111.982 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 38' ' ' THR . . . . . 0.844 ' O ' HG22 ' C' ' 41' ' ' THR . 40.9 p -47.17 -18.41 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 109.65 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.443 ' N ' ' O ' ' C' ' 37' ' ' PRO . 42.4 p -74.71 -22.79 58.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 109.854 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -69.96 -20.15 63.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 110.082 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.844 HG22 ' O ' ' C' ' 38' ' ' THR . 12.2 t -73.69 -18.85 60.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.075 -1.016 . . . . 0.0 109.83 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.437 ' CZ ' HG23 ' C' ' 93' ' ' VAL . 33.0 m-85 -80.2 19.48 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 43' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 51.48 94.02 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.999 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.668 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 71.2 Cg_endo -81.59 -34.49 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.556 2.171 . . . . 0.0 111.763 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 45' ' ' HIS . . . . . 0.668 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 15.1 p80 51.67 30.51 6.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.279 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 46' ' ' PHE . . . . . 0.608 ' CD2' ' O ' ' C' ' 44' ' ' PRO . 5.0 p90 -145.36 23.2 1.48 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.9 -1.125 . . . . 0.0 109.541 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 47' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' C' ' 49' ' ' SER . 56.9 m-20 42.51 84.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.533 -0.73 . . . . 0.0 109.772 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.611 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -50.27 -11.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.421 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.482 ' N ' ' O ' ' C' ' 47' ' ' ASP . 14.7 m -58.97 147.38 34.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -64.57 148.37 50.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.63 -4.15 83.65 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 52' ' ' SER . . . . . 0.536 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 5.4 p -69.03 -23.66 64.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 109.328 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 67.5 -56.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.795 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 54' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' C' ' 52' ' ' SER . 43.0 mt-30 -43.95 -22.5 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.372 -0.83 . . . . 0.0 109.798 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 53' ' ' ALA . 40.9 t -74.23 -26.72 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.323 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 56' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' C' ' 53' ' ' ALA . 5.7 ptmt -65.75 -27.41 68.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.18 -50.51 39.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 58' ' ' HIS . . . . . 0.481 ' ND1' HD11 ' C' ' 29' ' ' LEU . 20.6 t-80 -53.73 -32.44 52.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -1.136 . . . . 0.0 109.567 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.23 -47.3 91.76 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -58.2 -23.46 55.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.385 -1.068 . . . . 0.0 109.694 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 61' ' ' LYS . . . . . 0.674 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 0.7 OUTLIER -74.26 -39.44 63.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.229 -0.919 . . . . 0.0 108.927 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.76 -49.05 48.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.48 -30.02 71.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.315 -0.866 . . . . 0.0 109.017 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -67.14 -38.66 85.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.898 . . . . 0.0 108.819 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 65' ' ' ALA . . . . . 0.547 ' HB3' HMB3 ' C' ' 142' ' ' HEC . . . -64.09 -52.13 60.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -57.08 -44.71 83.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.227 -0.92 . . . . 0.0 108.764 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 17.5 m -68.74 -50.61 49.28 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.294 -0.879 . . . . 0.0 108.703 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -60.38 -24.27 64.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.563 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -84.95 -45.64 12.0 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.56 -23.48 33.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -18.74 64.27 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 72' ' ' HIS . . . . . 0.614 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.7 m80 -144.06 -58.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.446 -0.783 . . . . 0.0 109.337 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 73' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.3 p 44.28 13.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.796 0.808 . . . . 0.0 109.475 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 74' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' C' ' 72' ' ' HIS . 46.0 t0 -133.86 11.11 3.97 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.416 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 2.0 p-10 179.0 29.25 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.003 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 17.4 ptt? -78.57 -22.63 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 111.796 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.4 Cg_exo -54.0 -22.36 24.45 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.559 1.506 . . . . 0.0 112.334 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -94.2 -33.86 13.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.13 -0.981 . . . . 0.0 109.775 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.29 -46.74 60.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -0.948 . . . . 0.0 109.427 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 12.9 mt -80.39 8.43 7.62 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 109.07 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 38.5 p -55.78 -17.14 5.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.742 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.16 -55.89 4.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 109.752 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.486 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 3.5 mt -45.41 -43.97 11.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 108.967 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 84' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' C' ' 136' ' ' LEU . 29.7 t -57.32 -22.55 42.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 109.44 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 85' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' C' ' 89' ' ' HIS . 23.0 t70 -82.01 -58.37 3.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.14 -0.975 . . . . 0.0 109.926 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.49 -27.42 16.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 109.77 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 87' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 38.8 m80 -91.97 -21.7 20.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.795 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.41 -11.41 15.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 109.914 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 89' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' C' ' 85' ' ' ASP . 14.3 m80 -113.94 -77.86 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.034 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' C' ' 89' ' ' HIS . 9.9 mptt -45.78 -97.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.868 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 91' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' C' ' 93' ' ' VAL . 19.6 mt -65.67 -17.32 64.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 110.178 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 92' ' ' ARG . . . . . 0.489 ' NH1' ' OE2' ' B' ' 43' ' ' GLU . 25.1 ttm180 48.86 15.34 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 0.0 108.938 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 93' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' C' ' 91' ' ' LEU . 10.8 p -46.05 156.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 0.0 109.886 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 94' ' ' ASP . . . . . 0.432 ' N ' HG22 ' C' ' 93' ' ' VAL . 3.5 m-20 -100.21 153.0 37.99 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.079 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' C' ' 98' ' ' PHE . 32.7 Cg_endo -65.87 -10.58 27.37 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.535 2.157 . . . . 0.0 111.947 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 84.0 t -44.01 -29.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.852 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -79.42 -32.86 42.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.621 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 98' ' ' PHE . . . . . 0.448 ' N ' ' O ' ' C' ' 95' ' ' PRO . 0.0 OUTLIER -50.18 -34.91 24.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.345 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -50.02 -34.91 22.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 9.9 mt -82.11 -50.53 8.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.792 HD21 HBB3 ' C' ' 142' ' ' HEC . 53.2 tp -45.75 -20.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 0.0 109.64 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 102' ' ' SER . . . . . 0.445 ' N ' ' O ' ' C' ' 100' ' ' LEU . 93.1 p -73.4 -59.15 2.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.932 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.716 ' CD2' ' OD1' ' D' ' 108' ' ' ASN . 92.4 m-70 -71.92 -26.52 62.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 104' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 62.1 m -58.07 -42.13 84.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.042 -1.036 . . . . 0.0 109.942 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.68 -22.85 62.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.123 -0.986 . . . . 0.0 110.123 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.598 HD22 ' N ' ' C' ' 106' ' ' LEU . 3.7 mm? -79.01 -35.98 41.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.021 -1.049 . . . . 0.0 110.146 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 107' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 45.7 t -62.8 -39.47 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.054 -1.029 . . . . 0.0 109.536 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' C' ' 109' ' ' LEU . 12.5 p -65.31 -62.86 1.28 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.171 -0.956 . . . . 0.0 109.639 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 109' ' ' LEU . . . . . 0.492 ' N ' ' OG1' ' C' ' 108' ' ' THR . 14.8 mt -48.3 -22.42 0.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.355 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -63.37 -36.5 83.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.932 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.54 20.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.961 . . . . 0.0 109.863 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 112' ' ' HIS . . . . . 0.606 ' CG ' ' CE1' ' C' ' 24' ' ' TYR . 62.7 m80 -81.78 -75.43 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -0.991 . . . . 0.0 109.54 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.638 ' O ' HD12 ' C' ' 113' ' ' LEU . 1.5 pp -137.05 94.42 12.62 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.2 -171.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.26 1.973 . . . . 0.0 112.899 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 115' ' ' ALA . . . . . 0.536 ' O ' HG11 ' C' ' 121' ' ' VAL . . . -47.3 -38.53 12.79 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.622 0.725 . . . . 0.0 109.598 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 116' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 6.7 mt-10 85.34 9.57 0.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 117' ' ' PHE . . . . . 0.812 ' CE1' ' NE2' ' D' ' 116' ' ' HIS . 6.9 m-85 65.11 34.93 8.28 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.779 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 118' ' ' THR . . . . . 0.727 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -94.58 121.33 63.43 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.783 -1.198 . . . . 0.0 107.942 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -51.35 23.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.124 1.883 . . . . 0.0 112.849 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 120' ' ' ALA . . . . . 0.727 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -155.06 -30.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.742 -1.223 . . . . 0.0 110.773 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 121' ' ' VAL . . . . . 0.718 HG13 ' N ' ' C' ' 122' ' ' HIS . 11.9 p -47.8 -50.35 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 122' ' ' HIS . . . . . 0.718 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.4 t-80 -65.41 -43.56 90.17 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.41 -0.806 . . . . 0.0 109.976 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 123' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' D' ' 34' ' ' VAL . . . -79.06 -19.38 51.5 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 109.914 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 124' ' ' SER . . . . . 0.58 ' N ' ' O ' ' C' ' 120' ' ' ALA . 63.7 m -72.42 -63.85 1.07 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 111.128 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.05 -18.18 64.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.06 -1.025 . . . . 0.0 109.562 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.24 -49.55 9.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.899 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 127' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.86 -57.64 2.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.903 -1.123 . . . . 0.0 111.476 -178.187 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 128' ' ' PHE . . . . . 0.47 ' CD2' ' HA ' ' C' ' 124' ' ' SER . 21.9 m-85 -46.57 -21.53 0.19 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.731 -1.231 . . . . 0.0 110.189 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 129' ' ' LEU . . . . . 0.768 ' O ' HD12 ' C' ' 129' ' ' LEU . 0.7 OUTLIER -66.6 -18.86 65.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' C' ' 134' ' ' THR . . . -56.01 -33.18 64.64 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.506 ' O ' HG23 ' C' ' 135' ' ' VAL . 7.9 t -66.67 -36.83 83.47 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.168 -0.958 . . . . 0.0 108.767 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 132' ' ' VAL . . . . . 0.498 ' O ' HD13 ' C' ' 136' ' ' LEU . 1.8 t -78.3 -39.98 24.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 34.9 t -73.52 -37.66 65.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.466 -0.771 . . . . 0.0 108.95 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 134' ' ' THR . . . . . 0.448 ' N ' ' O ' ' C' ' 130' ' ' ALA . 88.8 m -71.62 -31.1 66.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 135' ' ' VAL . . . . . 0.506 HG23 ' O ' ' C' ' 131' ' ' SER . 2.9 t -70.35 -36.58 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.498 HD13 ' O ' ' C' ' 132' ' ' VAL . 3.2 mp -56.73 -32.85 65.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.361 -0.837 . . . . 0.0 108.998 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 51.4 m -89.36 -27.46 20.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.477 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 25.1 p -66.47 132.03 47.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.977 . . . . 0.0 109.501 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 0.46 ' C ' ' CG ' ' C' ' 140' ' ' TYR . 18.9 pttp -169.24 172.1 7.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.46 ' CG ' ' C ' ' C' ' 139' ' ' LYS . 27.8 m-85 -154.4 -44.54 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.971 . . . . 0.0 109.521 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 141' ' ' ARG . . . . . 0.462 ' CA ' ' HE ' ' C' ' 141' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.438 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 1' ' ' VAL . . . . . 0.675 ' H1 ' ' HA ' ' D' ' 133' ' ' VAL . 13.5 p . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 50.84 35.5 12.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.32 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 3' ' ' LEU . . . . . 0.923 ' H ' HD12 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -86.4 178.15 7.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 109.338 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.412 ' O ' ' N ' ' D' ' 6' ' ' GLU . 7.3 p -92.2 145.54 30.95 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 109.285 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -40.09 -25.96 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.534 2.156 . . . . 0.0 112.177 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 6' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' D' ' 4' ' ' THR . 39.5 mt-10 -81.72 -51.91 7.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 7' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' D' ' 7' ' ' GLU . 0.7 OUTLIER -75.3 -22.75 57.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.47 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 8' ' ' LYS . . . . . 0.468 ' HB2' HD13 ' D' ' 3' ' ' LEU . 6.7 tttm -78.39 -37.17 44.73 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.299 -0.876 . . . . 0.0 109.131 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 37.5 t -63.07 -23.28 67.37 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.23 -57.5 3.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.962 . . . . 0.0 110.082 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.52 -24.88 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.977 -1.077 . . . . 0.0 108.54 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 96.7 m -78.35 -31.59 48.64 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.729 -0.607 . . . . 0.0 109.724 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 13' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -67.25 -63.82 0.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.747 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.576 ' N ' HD12 ' D' ' 14' ' ' LEU . 10.6 mp -45.79 -19.29 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.377 -0.827 . . . . 0.0 109.898 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 15' ' ' TRP . . . . . 0.472 ' N ' ' O ' ' D' ' 13' ' ' ALA . 4.1 t90 -78.95 -40.8 30.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.986 -1.071 . . . . 0.0 108.751 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.31 -24.19 59.57 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -79.77 -32.71 40.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.456 -1.026 . . . . 0.0 109.353 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.568 HG23 ' O ' ' D' ' 14' ' ' LEU . 3.7 t -62.62 132.13 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.4 -0.812 . . . . 0.0 109.399 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 19' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' D' ' 21' ' ' ASP . 71.7 m-20 -81.21 78.17 8.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.291 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 20' ' ' VAL . . . . . 0.455 ' O ' HG12 ' D' ' 20' ' ' VAL . 78.4 t -49.78 -10.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.498 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' D' ' 19' ' ' ASN . 21.4 m-20 -55.33 -29.89 59.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 22' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' D' ' 25' ' ' GLY . 18.3 pt-20 -152.57 -32.15 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.095 -1.003 . . . . 0.0 110.045 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' D' ' 22' ' ' GLU . 93.0 t -44.72 -26.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.113 -0.992 . . . . 0.0 109.597 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.5 -26.31 47.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 25' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -66.71 -45.22 86.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 26' ' ' GLU . . . . . 0.423 ' OE2' ' N ' ' D' ' 26' ' ' GLU . 1.2 mp0 -63.9 -47.82 79.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -1.125 . . . . 0.0 109.318 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.3 -30.86 41.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.339 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.22 -54.32 5.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.24 -35.29 91.88 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -66.98 -32.36 73.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -1.091 . . . . 0.0 109.495 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 64.5 tp -47.35 -41.24 19.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.599 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 mt -80.73 -23.88 39.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.699 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.09 -64.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.474 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 34' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' C' ' 123' ' ' ALA . 2.4 t -46.65 -43.89 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -171.88 130.05 0.68 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 109.304 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.51 62.17 7.63 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.366 2.044 . . . . 0.0 112.126 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 37' ' ' TRP . . . . . 0.487 ' CZ3' HD11 ' D' ' 105' ' ' LEU . 0.0 OUTLIER -57.6 -43.72 84.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.143 -0.973 . . . . 0.0 109.272 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 38' ' ' THR . . . . . 0.99 HG21 HBC1 ' D' ' 147' ' ' HEC . 1.8 p -49.86 -64.41 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.371 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 39' ' ' GLN . . . . . 0.553 ' N ' ' OG1' ' D' ' 38' ' ' THR . 31.9 tt0 48.09 44.09 18.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 109.429 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -163.55 -36.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -119.3 16.14 13.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.309 -0.869 . . . . 0.0 109.216 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 42' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' D' ' 43' ' ' GLU . 30.8 p90 -87.61 -35.07 18.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.542 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 43' ' ' GLU . . . . . 0.518 ' OE2' ' NH1' ' A' ' 92' ' ' ARG . 12.1 pt-20 -81.97 -13.89 56.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.696 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 86.2 p -57.63 -29.09 64.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.607 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -85.27 19.24 2.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.44 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.63 1.87 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 47' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' D' ' 48' ' ' LEU . 35.7 t0 49.98 -146.01 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -1.186 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 48' ' ' LEU . . . . . 0.531 ' CB ' ' O ' ' D' ' 47' ' ' ASP . 2.4 tp 82.77 24.19 0.16 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.807 -0.558 . . . . 0.0 109.622 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -57.56 -35.12 69.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.273 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -146.93 153.69 46.13 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 108.887 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -42.47 -22.7 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.249 1.966 . . . . 0.0 112.251 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -85.15 -38.6 18.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.562 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.82 -19.58 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.362 -0.836 . . . . 0.0 109.573 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 t -60.66 -59.45 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.514 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 17.1 ptp -90.25 14.19 13.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.0 109.493 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.03 -18.91 58.61 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -89.07 146.99 37.55 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 109.443 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.76 -20.56 17.34 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.609 2.206 . . . . 0.0 112.4 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.55 -32.39 25.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 109.785 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 67.0 t -60.72 -41.18 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.672 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 61' ' ' LYS . . . . . 0.462 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 12.0 ptpt -78.94 -35.79 42.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.34 -30.12 69.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 63' ' ' HIS . . . . . 0.792 ' CE1' ' CHA' ' D' ' 147' ' ' HEC . 0.8 OUTLIER -72.93 -24.08 60.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.71 -19.12 80.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 65' ' ' LYS . . . . . 0.462 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 0.3 OUTLIER -68.44 -32.32 72.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -1.128 . . . . 0.0 109.326 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -75.78 -34.55 60.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.313 -0.867 . . . . 0.0 109.738 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 67' ' ' VAL . . . . . 0.832 HG22 ' CHB' ' D' ' 147' ' ' HEC . 53.9 t -68.85 -62.94 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.755 ' O ' HD23 ' D' ' 68' ' ' LEU . 2.5 tt -50.14 -29.07 8.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.373 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.02 96.84 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.56 93.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -1.165 . . . . 0.0 109.804 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 71' ' ' PHE . . . . . 0.436 ' CE2' HD23 ' D' ' 110' ' ' LEU . 25.1 m-85 -47.0 -30.29 2.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.173 -0.954 . . . . 0.0 109.634 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 3.8 p -57.6 -49.68 75.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.461 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -60.32 -17.01 39.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.09 79.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.855 HD23 ' H ' ' D' ' 75' ' ' LEU . 1.4 pt? -136.62 -22.34 1.27 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.317 -1.108 . . . . 0.0 109.973 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 76' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -77.61 5.09 9.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.072 -1.017 . . . . 0.0 109.679 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 77' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 46.8 m-70 -160.99 66.27 0.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.531 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 78' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' D' ' 75' ' ' LEU . 87.3 mt -73.08 11.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.533 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' D' ' 77' ' ' HIS . 13.7 t70 -66.73 -45.72 77.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.399 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -162.21 96.19 0.97 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.787 . . . . 0.0 109.417 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 24.9 mt -76.19 -58.77 3.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -54.76 -23.87 19.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.534 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.14 -47.51 9.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.8 t -78.28 -48.21 16.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -1.193 . . . . 0.0 109.67 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' D' ' 84' ' ' THR . 27.9 m-85 -59.72 -1.76 0.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 109.387 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 86' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -56.21 -35.24 67.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.158 -0.964 . . . . 0.0 109.423 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 34.5 p -73.2 -57.6 3.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 31.9 mt -56.49 -29.49 61.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.31 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 69.2 m -81.12 -32.64 33.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.439 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -82.62 -22.41 34.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.862 . . . . 0.0 109.482 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 91' ' ' LEU . . . . . 0.489 HD23 ' C ' ' D' ' 91' ' ' LEU . 9.8 tt -78.69 -68.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.853 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 92' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' D' ' 97' ' ' HIS . 0.4 OUTLIER -55.17 -20.28 10.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 0.0 110.092 -179.304 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 93' ' ' CYS . . . . . 0.526 ' N ' ' ND1' ' D' ' 92' ' ' HIS . 36.4 t -83.45 -60.66 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.1 -1.0 . . . . 0.0 110.706 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 94' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' D' ' 94' ' ' ASP . 0.8 OUTLIER -87.78 -25.64 23.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.087 -1.008 . . . . 0.0 111.45 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.02 -52.28 5.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.84 -1.163 . . . . 0.0 110.895 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 96' ' ' LEU . . . . . 0.609 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 2.3 mm? -112.5 -11.67 13.58 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.995 -1.065 . . . . 0.0 109.857 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 97' ' ' HIS . . . . . 0.609 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 49.3 p-80 41.89 41.48 1.89 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.31 -0.869 . . . . 0.0 109.786 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.42 132.32 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 0.0 109.472 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.01 152.96 90.0 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.245 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.54 -164.81 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.595 2.197 . . . . 0.0 112.162 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 57.01 48.34 15.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.32 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -160.61 -33.61 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -63.3 -60.91 2.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.445 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -57.63 -20.24 31.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 109.333 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 105' ' ' LEU . . . . . 0.51 ' O ' HD23 ' D' ' 105' ' ' LEU . 1.6 tt -77.37 -49.72 14.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.355 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.877 HD13 ' CHC' ' D' ' 147' ' ' HEC . 6.7 tt -49.41 -46.29 47.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.859 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.36 -45.78 95.53 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 108' ' ' ASN . . . . . 0.716 ' OD1' ' CD2' ' C' ' 103' ' ' HIS . 0.3 OUTLIER -53.76 -34.7 59.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -1.176 . . . . 0.0 109.583 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 109' ' ' VAL . . . . . 0.452 ' O ' ' SG ' ' D' ' 112' ' ' CYS . 90.7 t -80.25 -24.12 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 110' ' ' LEU . . . . . 0.436 HD23 ' CE2' ' D' ' 71' ' ' PHE . 34.2 tp -78.05 -32.43 50.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 109.412 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 94.3 t -65.15 -49.77 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.685 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 112' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' D' ' 113' ' ' VAL . 18.6 p -52.95 -37.23 60.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.939 . . . . 0.0 109.747 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 113' ' ' VAL . . . . . 0.462 ' N ' ' SG ' ' D' ' 112' ' ' CYS . 96.5 t -60.66 -21.38 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.675 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 114' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' D' ' 130' ' ' TYR . 23.6 mt -77.64 -57.07 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 109.571 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.03 -19.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.088 -1.007 . . . . 0.0 109.386 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 116' ' ' HIS . . . . . 0.812 ' NE2' ' CE1' ' C' ' 117' ' ' PHE . 1.5 t-80 -79.45 -56.69 4.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.147 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -69.27 -17.61 63.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.683 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -151.31 60.98 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 119' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -77.78 -23.32 67.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.41 8.63 4.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.363 -1.08 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -134.57 12.81 3.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.404 -0.81 . . . . 0.0 109.52 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.15 43.86 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.116 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 123' ' ' THR . . . . . 0.475 ' OG1' HG23 ' D' ' 126' ' ' VAL . 1.0 OUTLIER -48.61 151.1 2.15 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 109.161 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.501 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.0 Cg_exo -46.0 -52.3 7.25 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.307 2.005 . . . . 0.0 113.034 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 125' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 46.7 Cg_endo -68.29 15.16 0.16 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.157 1.905 . . . . 0.0 113.091 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.475 HG23 ' OG1' ' D' ' 123' ' ' THR . 53.1 t -108.4 -42.76 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.056 -1.027 . . . . 0.0 109.914 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 127' ' ' GLN . . . . . 0.616 ' H ' ' CD ' ' D' ' 127' ' ' GLN . 0.0 OUTLIER -70.66 -60.01 2.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.997 -1.064 . . . . 0.0 109.734 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 128' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -49.37 -34.77 16.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.11 -0.993 . . . . 0.0 109.461 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.39 27.76 1.04 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.306 -0.871 . . . . 0.0 109.686 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 130' ' ' TYR . . . . . 0.516 ' CZ ' ' CD1' ' D' ' 114' ' ' LEU . 1.6 t80 -126.65 -34.73 2.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.345 -0.847 . . . . 0.0 109.592 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -71.32 -62.86 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.642 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -48.77 -21.7 0.67 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 109.709 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 133' ' ' VAL . . . . . 0.675 ' HA ' ' H1 ' ' D' ' 1' ' ' VAL . 34.2 t -69.17 -65.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.715 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.415 ' H ' HG22 ' D' ' 134' ' ' VAL . 9.0 m -74.22 -16.44 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -0.92 . . . . 0.0 109.569 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' B' ' 146' ' ' HIS . . . -49.32 -30.28 7.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.372 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.68 -26.22 70.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 137' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' D' ' 134' ' ' VAL . 89.1 t -68.84 -39.75 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -1.132 . . . . 0.0 109.336 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.01 94.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.728 HD21 ' N ' ' D' ' 139' ' ' ASN . 0.4 OUTLIER -73.7 -44.03 57.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.13 -37.67 47.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.926 . . . . 0.0 109.351 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 18.0 mt -82.31 11.2 5.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 142' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' D' ' 144' ' ' LYS . . . -123.66 -30.94 3.53 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.414 -0.804 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 143' ' ' HIS . . . . . 0.452 ' HE1' ' CE1' ' B' ' 143' ' ' HIS . 5.6 m170 -49.69 -13.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.401 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 144' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' D' ' 142' ' ' ALA . 3.2 tptp -77.76 -43.0 32.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.25 -25.24 3.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.263 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 146' ' ' HIS . . . . . 0.735 ' CE1' ' OD1' ' B' ' 139' ' ' ASN . 25.9 m170 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.449 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' HEC . . . . . 0.812 HBB3 HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' HEC . . . . . 0.992 HBC1 ' CG2' ' B' ' 38' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 142' ' ' HEC . . . . . 0.792 HBB3 HD21 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 147' ' ' HEC . . . . . 0.99 HBC1 HG21 ' D' ' 38' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 2' ' ' LEU . 29.8 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 7.8 mp 55.94 163.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.399 -0.813 . . . . 0.0 109.846 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.517 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 176.24 -47.8 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.021 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 3' ' ' SER . 54.2 Cg_exo -50.44 -170.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.473 2.115 . . . . 0.0 112.603 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -60.31 -16.17 32.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 109.667 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 5' ' ' ALA . 22.2 m-20 -39.51 -29.09 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.379 -0.826 . . . . 0.0 109.67 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 10' ' ' VAL . 4.6 ptpt -83.22 -49.99 8.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 7' ' ' LYS . 52.5 m -43.82 -32.77 1.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.474 -0.766 . . . . 0.0 109.751 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.85 -30.27 50.89 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.571 ' N ' ' O ' ' A' ' 7' ' ' LYS . 51.2 t -76.8 -51.57 18.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HZ1' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -57.64 -36.75 72.27 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.812 -1.155 . . . . 0.0 108.262 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.81 -58.25 8.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.13 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.99 -34.4 63.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 108.935 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -17.52 61.75 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.96 -44.6 18.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -70.1 -37.39 75.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -1.164 . . . . 0.0 108.51 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.574 ' CG1' ' HB2' ' A' ' 21' ' ' ALA . 4.2 t -60.16 -67.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 59.32 -136.81 50.59 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.28 29.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.487 -1.008 . . . . 0.0 110.485 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.565 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.9 m-70 -129.7 13.14 5.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 108.579 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.574 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . . . -75.0 -52.36 11.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.584 -0.697 . . . . 0.0 109.811 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.01 -14.53 10.68 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.31 -56.48 3.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -1.188 . . . . 0.0 109.72 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 20' ' ' HIS . 14.1 m-85 -59.86 -24.83 64.54 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 109.247 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.03 -33.77 84.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.93 -39.0 57.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.584 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.436 ' CG ' ' OG1' ' A' ' 108' ' ' THR . 13.2 tt0 -67.51 -20.0 65.38 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.361 -0.837 . . . . 0.0 109.552 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.43 61.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.078 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -75.98 -59.32 2.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -56.49 -12.55 1.78 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.282 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -65.21 -58.29 6.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.939 . . . . 0.0 109.835 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -84.52 -32.91 23.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 110.354 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 20.1 m-85 -63.54 -36.01 82.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.006 -1.058 . . . . 0.0 110.121 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 35' ' ' SER . 3.8 pp -46.92 -40.54 14.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.84 -1.163 . . . . 0.0 109.534 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.663 ' N ' HD12 ' A' ' 34' ' ' LEU . 1.4 p -76.56 -23.58 53.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.022 -1.049 . . . . 0.0 108.792 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.564 ' C ' ' O ' ' A' ' 35' ' ' SER . 0.3 OUTLIER 21.44 66.0 0.3 Allowed Pre-proline 0 N--CA 1.501 2.103 0 CA-C-O 121.155 0.502 . . . . 0.0 111.291 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.44 -62.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.46 2.107 . . . . 0.0 112.076 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.558 ' O ' HG22 ' A' ' 41' ' ' THR . 1.2 p -91.15 -57.52 2.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.546 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 39' ' ' THR . 3.0 p -44.12 -22.94 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -0.795 . . . . 0.0 110.333 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.3 ttmt -49.06 -45.17 42.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.087 -1.008 . . . . 0.0 109.569 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 38' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.59 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.645 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.258 0 CA-C-O 120.983 0.42 . . . . 0.0 110.669 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.477 ' C ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -154.35 31.1 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.581 -1.324 . . . . 0.0 110.553 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 46' ' ' PHE . 35.6 m-20 42.26 88.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -0.798 . . . . 0.0 110.242 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.44 -13.06 57.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 109.035 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 50' ' ' HIS . 32.8 p -78.02 165.73 23.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.559 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.564 ' ND1' ' N ' ' A' ' 50' ' ' HIS . 0.3 OUTLIER -57.81 -162.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.319 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.7 34.49 10.49 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 54' ' ' GLN . 30.2 t -139.06 82.29 1.89 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.357 -1.084 . . . . 0.0 109.259 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.68 -10.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.414 -0.804 . . . . 0.0 109.806 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 52' ' ' SER . 11.7 mt-30 -74.81 -35.23 62.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.123 -0.986 . . . . 0.0 109.676 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.66 -48.51 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.52 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.579 ' H ' ' CD ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -69.18 -25.5 64.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.416 -0.802 . . . . 0.0 109.046 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.91 -21.68 78.93 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.8 t-80 -82.43 -39.9 21.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -1.129 . . . . 0.0 109.847 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.92 -51.65 44.21 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -51.17 -22.66 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -1.022 . . . . 0.0 110.101 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.76 -29.72 56.23 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.056 -1.027 . . . . 0.0 109.255 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -79.8 -49.0 19.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.519 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -68.57 -22.71 64.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.406 -0.809 . . . . 0.0 109.191 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -78.25 -30.68 48.76 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.1 -1.0 . . . . 0.0 108.778 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.76 53.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.388 -0.82 . . . . 0.0 108.969 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.57 -40.58 72.15 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.153 -0.967 . . . . 0.0 108.757 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 m -68.81 -56.78 6.93 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 46.6 t30 -55.38 -24.17 28.35 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -80.24 -46.93 15.41 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.586 HG13 ' HZ1' ' A' ' 11' ' ' LYS . 36.0 t -64.41 -22.93 32.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.43 -17.04 64.56 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.616 ' O ' ' N ' ' A' ' 74' ' ' ASP . 4.2 m-70 -141.9 -61.25 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.434 -0.791 . . . . 0.0 109.435 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.1 p 44.72 12.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.721 0.772 . . . . 0.0 109.64 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 72' ' ' HIS . 44.5 t0 -134.21 10.45 3.83 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 2.0 m-20 -178.53 28.02 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.733 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.701 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 6.5 ptt? -78.46 -23.36 0.41 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 111.67 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.3 Cg_exo -54.36 -18.82 15.45 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.617 1.545 . . . . 0.0 112.132 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -93.43 -38.08 11.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.421 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.45 -40.18 64.38 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 108.956 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.8 mt -87.65 11.34 15.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.7 t -65.32 -26.85 68.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.713 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.98 -49.03 66.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.726 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.439 ' N ' HD23 ' A' ' 83' ' ' LEU . 4.1 mt -47.69 -46.96 29.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 109.022 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 9.7 t -62.78 -28.55 70.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.626 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -79.96 -28.14 39.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 109.588 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 90' ' ' LYS . 3.7 tt -83.22 -32.29 26.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 109.87 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -92.04 -22.0 20.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.219 -0.926 . . . . 0.0 110.218 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -104.07 -48.01 4.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.112 -0.992 . . . . 0.0 110.123 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -93.44 21.93 5.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.13 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.504 ' C ' ' H ' ' A' ' 92' ' ' ARG . 28.6 ttmt -172.11 147.07 2.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.022 -1.049 . . . . 0.0 110.006 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER 71.31 -20.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.522 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.504 ' H ' ' C ' ' A' ' 90' ' ' LYS . 70.4 mtt85 43.12 27.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 109.741 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.534 HG22 ' N ' ' A' ' 94' ' ' ASP . 12.2 p -46.98 165.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.725 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.534 ' N ' HG22 ' A' ' 93' ' ' VAL . 6.1 p-10 -109.7 101.18 45.6 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.493 -0.754 . . . . 0.0 109.28 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.72 -10.85 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.407 2.072 . . . . 0.0 112.331 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 94' ' ' ASP . 52.6 t -50.98 -18.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 100' ' ' LEU . 3.1 m120 -79.22 -24.38 43.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.316 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -44.33 -35.75 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -67.98 -23.78 65.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.873 . . . . 0.0 109.579 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 100' ' ' LEU . 8.8 mp -84.18 -62.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.638 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.47 -23.87 27.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.8 p -67.86 -50.4 56.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 109.727 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -78.02 -26.42 48.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.741 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 96.7 m -50.8 -50.45 56.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 109.629 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.26 -38.88 55.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.892 . . . . 0.0 109.765 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.88 -36.18 64.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.531 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.13 -27.67 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.069 -1.019 . . . . 0.0 109.852 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -81.07 -45.19 16.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.123 -0.986 . . . . 0.0 109.842 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.506 ' N ' ' CG2' ' A' ' 108' ' ' THR . 15.6 mt -66.89 -20.67 65.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.926 . . . . 0.0 109.057 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 112' ' ' HIS . . . -51.66 -43.01 62.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.427 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.76 -3.62 0.12 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 109.193 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.512 ' H ' ' C ' ' A' ' 110' ' ' ALA . 79.7 m-70 -143.24 -85.59 0.15 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -0.888 . . . . 0.0 109.277 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.82 HD23 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -139.79 100.14 7.44 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.28 -98.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.646 2.231 . . . . 0.0 112.791 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.797 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -72.12 -56.58 5.34 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.557 -0.715 . . . . 0.0 110.064 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.667 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 17.5 mt-10 116.62 -6.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.485 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 4.9 t80 79.53 33.3 0.21 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.297 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.722 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -108.94 125.07 32.44 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.021 -1.049 . . . . 0.0 108.199 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.91 21.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.216 1.944 . . . . 0.0 112.801 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.722 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -149.44 -32.52 0.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.906 -1.121 . . . . 0.0 110.398 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.797 HG21 ' O ' ' A' ' 115' ' ' ALA . 9.5 p -55.04 -48.79 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 110.404 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.625 ' N ' HG13 ' A' ' 121' ' ' VAL . 4.4 t-160 -47.76 -36.2 11.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.45 -19.48 33.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.424 -0.797 . . . . 0.0 110.135 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 92.3 p -61.64 -62.42 1.82 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.087 -1.008 . . . . 0.0 110.647 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.43 -19.95 62.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.059 -1.026 . . . . 0.0 109.595 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.3 -40.77 17.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.094 -1.004 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.23 -40.41 12.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.122 -0.987 . . . . 0.0 109.868 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.461 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 40.3 t80 -50.48 -20.84 1.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.898 -1.126 . . . . 0.0 108.717 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 133' ' ' SER . 23.6 mt -68.97 -17.88 63.99 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.78 72.17 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 80.0 p -81.49 -26.82 34.89 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.27 -0.894 . . . . 0.0 108.596 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.42 -26.72 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.416 -0.802 . . . . 0.0 109.077 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 129' ' ' LEU . 1.9 t -82.68 -31.53 28.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.123 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.8 m -72.98 -36.77 67.16 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.31 -0.869 . . . . 0.0 109.553 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.61 -21.8 15.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.128 -0.983 . . . . 0.0 108.895 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -16.72 59.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.045 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 133' ' ' SER . 14.1 t -143.04 38.51 1.44 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.946 . . . . 0.0 109.6 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 2.6 p80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 1.025 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -130.3 172.03 12.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.381 -0.824 . . . . 0.0 109.352 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.425 ' O ' ' N ' ' B' ' 6' ' ' GLU . 7.7 p -90.51 141.59 27.39 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 109.301 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -40.63 -23.92 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.509 2.139 . . . . 0.0 112.376 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' B' ' 4' ' ' THR . 73.1 mm-40 -78.87 -54.67 5.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.831 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -74.85 -23.1 58.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.716 ' HB2' HD13 ' B' ' 3' ' ' LEU . 2.1 tttm -84.29 -32.2 24.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.339 -0.851 . . . . 0.0 109.234 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.9 m -63.67 -23.36 67.34 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.733 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.8 -57.59 3.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.075 -1.016 . . . . 0.0 110.113 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.474 HG23 ' CD2' ' B' ' 130' ' ' TYR . 1.7 p -62.67 -24.35 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 70.1 m -83.98 -35.37 23.98 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.27 0.557 . . . . 0.0 109.74 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.28 -27.4 61.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.391 -0.818 . . . . 0.0 109.663 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.18 -18.73 10.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 109.339 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . 0.665 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.5 OUTLIER -50.95 -50.95 56.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.119 -0.988 . . . . 0.0 109.038 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.68 -51.02 60.5 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 7.7 mtmt -53.91 -25.91 22.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.359 -1.083 . . . . 0.0 109.093 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.41 124.31 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 109.74 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' B' ' 21' ' ' ASP . 1.8 m120 -81.86 68.31 8.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 108.94 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.403 HG22 HD13 ' B' ' 68' ' ' LEU . 70.0 t -45.98 -14.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.405 -0.809 . . . . 0.0 109.81 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' B' ' 19' ' ' ASN . 60.3 t0 -58.02 -18.04 21.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.839 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' B' ' 25' ' ' GLY . 35.1 mt-10 -155.79 -33.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.757 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.9 t -45.98 -23.91 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.249 -0.907 . . . . 0.0 109.702 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.54 -24.69 72.08 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -82.38 -33.03 26.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -74.74 -25.02 58.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -1.195 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.31 94.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.94 . . . . 0.0 109.559 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.41 -50.14 16.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.32 -28.2 8.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.1 -47.45 11.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.137 . . . . 0.0 109.35 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 tp -47.46 -31.55 4.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 109.435 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' B' ' 36' ' ' PRO . 14.4 mt -71.19 -46.1 62.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.23 -55.53 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.324 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.6 -22.93 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.563 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -150.4 76.9 8.29 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 109.492 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.503 ' N ' ' O ' ' B' ' 32' ' ' LEU . 77.5 Cg_endo -82.93 -7.68 11.22 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.813 2.342 . . . . 0.0 112.385 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.471 ' C ' ' H ' ' B' ' 39' ' ' GLN . 21.0 p-90 -63.93 -19.86 65.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 109.508 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 7.8 p -72.63 37.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' B' ' 37' ' ' TRP . 17.2 tt0 -80.71 10.53 4.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.447 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -89.16 -37.56 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.98 . . . . 0.0 109.556 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . 0.471 ' C ' ' H ' ' B' ' 43' ' ' GLU . 88.5 m-85 -89.68 -43.29 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 109.566 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.16 14.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 109.367 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' B' ' 41' ' ' PHE . 19.0 pt-20 -66.9 -13.88 62.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.418 ' C ' ' N ' ' B' ' 46' ' ' GLY . 49.9 m -77.63 -42.55 34.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.697 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.54 ' O ' ' N ' ' B' ' 47' ' ' ASP . 39.9 m-85 -47.5 -20.11 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' B' ' 44' ' ' SER . . . 59.14 -79.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' B' ' 45' ' ' PHE . 32.1 t0 -46.7 106.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -1.152 . . . . 0.0 109.555 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tp -163.08 21.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.262 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -52.53 -42.7 64.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 109.658 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.4 p -145.35 152.06 49.2 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.882 . . . . 0.0 109.211 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -40.25 -35.23 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.557 2.171 . . . . 0.0 112.325 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.75 -27.02 63.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.563 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -66.77 -19.97 65.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.2 -51.23 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.557 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 7.4 mmt -66.77 -22.0 66.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.52 -11.12 78.34 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' B' ' 59' ' ' LYS . 20.3 t-20 -71.6 136.28 83.44 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.264 -1.139 . . . . 0.0 109.335 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.11 -35.21 3.2 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.376 2.051 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.515 ' N ' ' OD1' ' B' ' 57' ' ' ASN . 41.0 mttm -63.91 -47.74 79.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.915 . . . . 0.0 109.856 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 96.3 t -46.9 -35.4 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -0.977 . . . . 0.0 109.625 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -49.91 52.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.347 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.78 -32.53 59.96 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.226 -0.921 . . . . 0.0 109.668 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -69.71 -23.92 63.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.329 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.78 -37.76 92.57 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -65.85 -25.71 67.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -1.099 . . . . 0.0 109.325 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -74.73 -49.0 22.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.93 -60.7 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.337 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.645 ' O ' HD23 ' B' ' 68' ' ' LEU . 1.3 tt -62.87 -21.16 65.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 109.097 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.76 -52.56 14.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.07 -35.21 33.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -1.134 . . . . 0.0 109.59 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' B' ' 137' ' ' VAL . 22.7 m-85 -66.8 -49.81 64.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . 0.665 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.1 t -56.83 -30.85 64.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.45 -0.781 . . . . 0.0 109.415 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -59.67 -40.33 87.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.323 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.86 -60.1 8.61 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.585 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -50.48 -26.42 5.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.335 -1.097 . . . . 0.0 109.31 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.68 -2.53 58.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.959 . . . . 0.0 109.484 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.517 ' CE1' ' OD2' ' B' ' 79' ' ' ASP . 71.1 t60 -171.07 62.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -0.912 . . . . 0.0 109.582 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 25.4 mt -70.3 2.19 4.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.178 -0.951 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.517 ' OD2' ' CE1' ' B' ' 77' ' ' HIS . 54.9 m-20 -55.79 -26.72 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.418 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 15.6 t-20 -170.62 112.0 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.6 mt -80.19 -58.18 3.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -47.23 -24.08 0.66 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -63.66 -51.47 53.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.452 ' C ' ' H ' ' B' ' 86' ' ' ALA . 0.7 OUTLIER -85.59 -39.56 17.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -1.158 . . . . 0.0 109.346 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.437 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.7 m-85 -70.54 10.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.614 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -67.84 -33.65 75.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -82.09 -53.34 6.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 109.432 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.464 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 35.8 mt -51.76 -49.72 62.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 0.0 109.29 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 7.3 m -59.74 -50.49 73.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.377 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.28 -38.77 92.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.869 . . . . 0.0 109.384 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 5.1 tt -74.53 -32.48 62.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.35 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' B' ' 97' ' ' HIS . 15.1 m80 -84.93 -20.3 30.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.108 -0.995 . . . . 0.0 109.644 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 46.6 t -83.74 -59.86 2.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.83 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -86.68 -34.78 19.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.12 -0.988 . . . . 0.0 111.531 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -79.73 -51.77 8.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.857 -1.152 . . . . 0.0 110.563 -178.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.33 -32.57 10.41 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.038 . . . . 0.0 110.244 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.569 ' CG ' ' O ' ' B' ' 97' ' ' HIS . 11.3 t-160 54.07 54.07 10.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.967 . . . . 0.0 109.505 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.31 125.74 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 0.0 109.141 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -49.31 145.86 6.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.08 -11.86 31.22 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.612 2.208 . . . . 0.0 112.158 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -93.66 60.29 2.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -148.87 -46.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.526 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.0 OUTLIER -51.35 -47.43 62.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.65 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -48.31 -19.97 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' B' ' 103' ' ' PHE . 17.1 mt -88.54 -57.73 2.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.603 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -47.93 -20.9 0.36 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.526 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . 0.413 ' O ' HG23 ' B' ' 111' ' ' VAL . . . -81.71 -33.23 28.06 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -83.49 -17.45 41.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -1.115 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 78.6 t -83.18 -56.61 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.496 ' O ' HD23 ' B' ' 110' ' ' LEU . 2.0 tt -48.71 -53.2 19.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.847 . . . . 0.0 109.476 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 107' ' ' GLY . 89.7 t -46.99 -40.85 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.612 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.66 -33.93 76.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.518 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 19.1 t -66.28 -29.29 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.333 -0.855 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 118' ' ' PHE . 8.9 mt -81.68 -52.94 6.65 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.478 ' C ' ' HB1' ' A' ' 110' ' ' ALA . . . -54.08 -24.4 17.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.469 ' N ' ' HB1' ' A' ' 110' ' ' ALA . 0.6 OUTLIER -84.82 -62.63 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 109.579 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -68.58 -17.56 64.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.756 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' B' ' 17' ' ' LYS . 72.4 m-85 -144.3 57.79 1.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -70.49 -23.05 77.87 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -72.62 10.78 0.76 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.252 -1.146 . . . . 0.0 109.509 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' B' ' 123' ' ' THR . 81.2 mm-40 -135.28 -0.34 2.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.39 -0.818 . . . . 0.0 109.642 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.81 33.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 109.339 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.488 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.0 OUTLIER -50.24 148.16 6.58 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.519 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.2 Cg_exo -46.73 -53.06 6.64 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.428 2.085 . . . . 0.0 113.159 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 26.4 Cg_endo -62.61 -21.83 73.32 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.024 1.816 . . . . 0.0 112.338 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.453 HG23 ' OG1' ' B' ' 123' ' ' THR . 75.2 t -81.58 -25.63 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.506 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' B' ' 123' ' ' THR . 5.5 mp0 -83.21 -59.81 2.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.12 -0.988 . . . . 0.0 109.492 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -45.88 -38.26 7.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.58 29.72 0.86 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 0.0 109.574 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.474 ' CD2' HG23 ' B' ' 11' ' ' VAL . 17.2 t80 -124.24 -22.4 4.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.448 -0.783 . . . . 0.0 109.701 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -83.95 -63.84 1.27 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.123 -0.986 . . . . 0.0 110.061 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -49.76 -21.63 1.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 0.0 109.952 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . 0.568 HG22 HD21 ' B' ' 3' ' ' LEU . 2.2 t -72.48 -68.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.972 . . . . 0.0 109.858 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.37 -19.95 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.793 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.94 -28.68 17.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.941 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.36 -36.45 89.23 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' B' ' 71' ' ' PHE . 99.4 t -63.48 -47.92 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -1.117 . . . . 0.0 109.468 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.18 -43.25 31.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 109.354 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -80.02 -38.36 32.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 0.0 109.451 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.34 -48.35 62.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 36.2 mt -75.63 11.04 1.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.42 -4.62 3.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 109.43 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.16 -27.49 64.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.92 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.86 -16.44 36.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -62.17 -61.5 2.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.303 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.467 ' ND1' ' N ' ' B' ' 146' ' ' HIS . 2.0 m-70 . . . . . 0 C--N 1.302 -1.495 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' C' ' 2' ' ' LEU . 29.8 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' C' ' 2' ' ' LEU . 7.8 mp 56.03 163.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.35 -0.844 . . . . 0.0 109.738 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 176.24 -47.92 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.998 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' C' ' 3' ' ' SER . 54.3 Cg_exo -50.31 -170.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.573 2.182 . . . . 0.0 112.579 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -60.24 -16.24 31.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.733 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' C' ' 5' ' ' ALA . 22.1 m-20 -39.45 -29.18 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.448 -0.782 . . . . 0.0 109.696 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' C' ' 10' ' ' VAL . 4.5 ptpt -83.18 -50.0 8.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.369 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.408 ' C ' ' O ' ' C' ' 7' ' ' LYS . 53.3 m -43.86 -32.7 1.14 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 109.733 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.85 -30.29 50.87 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' C' ' 7' ' ' LYS . 51.2 t -76.77 -51.54 18.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . 0.541 ' NZ ' HG13 ' C' ' 70' ' ' VAL . 0.1 OUTLIER -57.63 -36.72 72.19 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.767 -1.173 . . . . 0.0 108.285 179.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.74 -58.23 8.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 109.215 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.05 -34.38 63.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 108.877 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -17.49 61.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.355 -0.841 . . . . 0.0 108.886 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.94 -44.68 18.51 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.41 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 17.9 mmtp -70.12 -37.34 75.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.085 -1.244 . . . . 0.0 108.465 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' C' ' 21' ' ' ALA . 4.1 t -60.22 -67.41 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.575 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 59.24 -136.78 50.71 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.29 28.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.543 -0.975 . . . . 0.0 110.474 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.575 ' H ' ' C ' ' C' ' 18' ' ' GLY . 96.9 m-70 -129.63 13.18 5.92 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.568 ' HB2' ' CG1' ' C' ' 17' ' ' VAL . . . -75.05 -52.39 11.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.643 -0.661 . . . . 0.0 109.75 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.07 -14.45 10.95 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.36 -56.47 3.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -1.166 . . . . 0.0 109.691 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.558 ' CD2' ' O ' ' C' ' 20' ' ' HIS . 14.0 m-85 -59.85 -24.88 64.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.86 . . . . 0.0 109.285 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.91 -33.83 85.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.74 -39.12 57.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -1.193 . . . . 0.0 109.661 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . 0.431 ' CG ' ' OG1' ' C' ' 108' ' ' THR . 13.2 tt0 -67.45 -20.11 65.45 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.336 -0.853 . . . . 0.0 109.457 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.07 -25.37 61.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.106 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -76.04 -59.36 2.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 109.405 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -56.45 -12.54 1.75 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 109.354 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' C' ' 31' ' ' ARG . 0.0 OUTLIER -65.2 -58.35 6.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -84.51 -32.83 23.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.092 -1.005 . . . . 0.0 110.312 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 20.2 m-85 -63.55 -35.97 82.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.938 -1.101 . . . . 0.0 110.198 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.683 HD12 ' N ' ' C' ' 35' ' ' SER . 3.8 pp -46.97 -40.51 14.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.901 -1.124 . . . . 0.0 109.504 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.683 ' N ' HD12 ' C' ' 34' ' ' LEU . 1.4 p -76.5 -23.66 53.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.931 -1.106 . . . . 0.0 108.875 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.573 ' C ' ' O ' ' C' ' 35' ' ' SER . 0.3 OUTLIER 21.56 65.96 0.3 Allowed Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 121.151 0.5 . . . . 0.0 111.211 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.39 -61.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.407 2.072 . . . . 0.0 112.147 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.545 ' O ' HG22 ' C' ' 41' ' ' THR . 1.1 p -91.18 -57.41 2.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.215 -0.928 . . . . 0.0 109.613 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.477 ' H ' HG23 ' C' ' 39' ' ' THR . 3.0 p -44.21 -22.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.47 -0.769 . . . . 0.0 110.31 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' C' ' 38' ' ' THR . 26.2 ttmt -49.03 -45.13 42.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.957 -1.089 . . . . 0.0 109.596 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.545 HG22 ' O ' ' C' ' 38' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.599 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.649 ' CG ' ' O ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.274 0 CA-C-O 120.937 0.399 . . . . 0.0 110.686 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.468 ' C ' ' CD1' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -154.4 31.13 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.679 -1.263 . . . . 0.0 110.529 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' C' ' 46' ' ' PHE . 35.8 m-20 42.3 88.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.408 -0.808 . . . . 0.0 110.271 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.596 HD23 ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -65.33 -13.09 57.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.114 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.427 ' O ' ' O ' ' C' ' 50' ' ' HIS . 32.6 p -78.11 165.71 23.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.583 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.568 ' ND1' ' N ' ' C' ' 50' ' ' HIS . 0.3 OUTLIER -57.83 -162.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.361 -0.837 . . . . 0.0 109.283 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.82 34.44 10.94 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.55 ' O ' ' N ' ' C' ' 54' ' ' GLN . 30.4 t -139.06 82.25 1.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.286 -1.126 . . . . 0.0 109.218 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.69 -10.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.808 . . . . 0.0 109.847 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' C' ' 52' ' ' SER . 11.7 mt-30 -74.85 -35.25 62.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.3 t -65.67 -48.45 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.54 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.577 ' H ' ' CD ' ' C' ' 56' ' ' LYS . 0.0 OUTLIER -69.18 -25.51 64.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 0.0 109.12 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.91 -21.65 78.97 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.453 ' ND1' ' C ' ' C' ' 58' ' ' HIS . 6.9 t-80 -82.59 -39.79 21.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -1.082 . . . . 0.0 109.798 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.04 -51.56 45.42 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -51.19 -22.67 2.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.445 -1.032 . . . . 0.0 110.153 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.73 -29.7 56.29 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.15 -0.969 . . . . 0.0 109.24 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.488 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -79.81 -49.0 19.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 108.726 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -68.58 -22.84 64.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.308 -0.87 . . . . 0.0 109.189 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -78.17 -30.69 49.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.134 -0.979 . . . . 0.0 108.832 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.64 -48.66 53.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.86 . . . . 0.0 108.996 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.57 -40.62 72.22 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.203 -0.936 . . . . 0.0 108.749 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 15.3 m -68.72 -56.84 6.8 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' C' ' 72' ' ' HIS . 46.6 t30 -55.42 -24.08 28.46 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -80.24 -47.01 15.28 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.541 HG13 ' NZ ' ' C' ' 11' ' ' LYS . 36.2 t -64.35 -22.97 32.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.46 -17.06 64.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.611 ' O ' ' N ' ' C' ' 74' ' ' ASP . 4.3 m-70 -141.88 -61.31 0.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 109.422 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.554 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.2 p 44.78 12.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.728 0.775 . . . . 0.0 109.61 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' C' ' 72' ' ' HIS . 44.5 t0 -134.22 10.44 3.83 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 2.0 m-20 -178.59 28.03 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.762 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 6.5 ptt? -78.52 -23.33 0.41 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.413 -0.805 . . . . 0.0 111.703 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.0 Cg_exo -54.33 -18.83 15.38 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.565 1.51 . . . . 0.0 112.185 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -93.42 -38.06 11.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.17 64.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 108.897 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.62 11.27 15.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.349 -0.845 . . . . 0.0 108.755 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 14.8 t -65.33 -26.82 68.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 109.715 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.92 -49.04 66.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 109.741 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.439 HD23 ' N ' ' C' ' 83' ' ' LEU . 4.1 mt -47.76 -46.96 30.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.026 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.563 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 9.7 t -62.76 -28.52 70.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.64 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.94 -28.1 39.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 109.601 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' C' ' 90' ' ' LYS . 3.7 tt -83.25 -32.35 26.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.827 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . 0.413 ' CE1' HD22 ' C' ' 86' ' ' LEU . 67.0 m80 -92.12 -21.94 20.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.13 -0.982 . . . . 0.0 110.122 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -104.03 -48.1 3.99 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.183 -0.948 . . . . 0.0 110.113 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -93.42 21.94 5.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 110.138 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.506 ' C ' ' H ' ' C' ' 92' ' ' ARG . 28.7 ttmt -172.15 147.13 2.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.932 -1.105 . . . . 0.0 110.067 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' C' ' 93' ' ' VAL . 1.0 OUTLIER 71.29 -20.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.386 -0.821 . . . . 0.0 109.536 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' C' ' 90' ' ' LYS . 70.4 mtt85 43.04 27.36 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 0.0 109.7 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.539 HG22 ' N ' ' C' ' 94' ' ' ASP . 12.2 p -47.08 165.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.539 ' N ' HG22 ' C' ' 93' ' ' VAL . 6.1 p-10 -109.74 101.29 46.11 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.69 -11.01 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.383 2.055 . . . . 0.0 112.274 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 94' ' ' ASP . 51.1 t -50.74 -18.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' C' ' 100' ' ' LEU . 3.1 m120 -79.18 -24.38 43.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.309 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -44.31 -35.8 2.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.338 -0.851 . . . . 0.0 109.745 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -68.0 -23.72 65.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.484 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.583 HD12 ' N ' ' C' ' 100' ' ' LEU . 8.8 mp -84.22 -62.08 1.65 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -55.52 -23.78 28.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 109.653 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 13.7 p -67.93 -50.33 56.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.762 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -78.05 -26.42 48.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.716 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 96.4 m -50.81 -50.47 56.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.669 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.23 -38.81 54.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 109.811 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.94 -36.21 64.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.478 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.06 -27.68 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.987 -1.071 . . . . 0.0 109.927 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.498 ' CG2' ' N ' ' C' ' 109' ' ' LEU . 0.6 OUTLIER -81.15 -45.1 16.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.831 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.498 ' N ' ' CG2' ' C' ' 108' ' ' THR . 15.5 mt -67.04 -20.52 65.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.089 -1.007 . . . . 0.0 109.068 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' C' ' 112' ' ' HIS . . . -51.78 -42.95 62.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.418 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.76 -3.67 0.12 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 109.212 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . 0.522 ' H ' ' C ' ' C' ' 110' ' ' ALA . 79.8 m-70 -143.23 -85.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.38 -0.825 . . . . 0.0 109.249 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.833 HD23 ' O ' ' C' ' 113' ' ' LEU . 0.0 OUTLIER -139.88 100.04 7.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.26 -98.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.564 2.176 . . . . 0.0 112.807 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.808 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -72.22 -56.46 5.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.576 -0.702 . . . . 0.0 110.037 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.676 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 17.5 mt-10 116.56 -6.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 4.9 t80 79.56 33.28 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.318 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.714 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -108.92 125.11 32.36 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.93 21.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.239 1.959 . . . . 0.0 112.79 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.714 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -149.47 -32.59 0.21 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.901 -1.124 . . . . 0.0 110.336 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.808 HG21 ' O ' ' C' ' 115' ' ' ALA . 9.6 p -54.86 -48.91 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.058 -1.026 . . . . 0.0 110.413 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.632 ' N ' HG13 ' C' ' 121' ' ' VAL . 4.4 t-160 -47.78 -36.17 11.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.44 -19.45 33.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 110.149 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' C' ' 128' ' ' PHE . 92.5 p -61.64 -62.41 1.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 110.686 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.37 -20.03 62.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.997 -1.065 . . . . 0.0 109.619 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.28 -40.72 17.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.105 -0.997 . . . . 0.0 109.548 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.2 -40.42 12.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 109.845 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.465 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 40.4 t80 -50.51 -20.81 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.869 -1.145 . . . . 0.0 108.7 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' C' ' 133' ' ' SER . 23.4 mt -68.98 -17.95 64.0 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.79 72.13 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 79.6 p -81.48 -26.84 34.89 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.37 -26.84 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 109.108 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.54 ' N ' ' O ' ' C' ' 129' ' ' LEU . 1.9 t -82.51 -31.55 29.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.214 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 26.0 m -73.06 -36.71 66.94 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.373 -0.829 . . . . 0.0 109.486 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.61 -21.74 15.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.137 -0.977 . . . . 0.0 108.933 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -16.81 59.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.435 -0.791 . . . . 0.0 108.914 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . 0.455 HG22 ' O ' ' C' ' 133' ' ' SER . 14.2 t -143.08 38.43 1.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.541 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 2.6 p80 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 1.054 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -130.32 171.95 12.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.306 -0.872 . . . . 0.0 109.382 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.416 ' O ' ' N ' ' D' ' 6' ' ' GLU . 7.6 p -90.54 141.63 27.37 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.262 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -40.59 -24.05 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.507 2.138 . . . . 0.0 112.398 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' D' ' 4' ' ' THR . 73.3 mm-40 -78.73 -54.79 5.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.932 . . . . 0.0 109.824 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -74.75 -23.13 58.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 109.614 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.726 ' HB2' HD13 ' D' ' 3' ' ' LEU . 2.2 tttm -84.29 -32.17 24.51 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.372 -0.83 . . . . 0.0 109.34 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 m -63.77 -23.31 67.31 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.677 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.82 -57.52 3.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.963 . . . . 0.0 110.125 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.477 HG23 ' CD2' ' D' ' 130' ' ' TYR . 1.7 p -62.68 -24.37 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 70.6 m -84.07 -35.24 23.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.773 -0.579 . . . . 0.0 109.717 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.33 -27.33 61.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.622 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.25 -18.75 11.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.33 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . 0.655 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.5 OUTLIER -50.98 -50.88 57.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.008 . . . . 0.0 109.062 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.73 -50.98 60.84 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.484 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 7.7 mtmt -53.9 -25.85 22.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.407 -1.054 . . . . 0.0 109.175 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.2 t -91.49 124.36 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 0.0 109.698 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' D' ' 21' ' ' ASP . 1.8 m120 -81.89 68.26 8.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.874 . . . . 0.0 108.925 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.416 ' O ' HG12 ' D' ' 20' ' ' VAL . 69.0 t -45.96 -14.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 109.812 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' D' ' 19' ' ' ASN . 60.4 t0 -58.01 -18.1 21.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.764 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -155.78 -33.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.059 -1.025 . . . . 0.0 109.758 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -46.07 -23.89 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.644 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.57 -24.66 72.09 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.45 -32.96 26.61 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -74.78 -24.97 58.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -1.218 . . . . 0.0 109.548 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.25 -40.25 93.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.45 -50.03 17.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.38 -28.2 9.07 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.05 -47.57 11.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -1.117 . . . . 0.0 109.276 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 tp -47.34 -31.61 4.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' D' ' 36' ' ' PRO . 14.4 mt -71.16 -46.16 62.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.441 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.12 -55.58 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.373 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.409 ' H ' HG23 ' D' ' 34' ' ' VAL . 2.7 t -67.69 -22.86 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.886 . . . . 0.0 109.501 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -150.48 76.94 8.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . 0.517 ' N ' ' O ' ' D' ' 32' ' ' LEU . 77.8 Cg_endo -82.89 -7.75 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.878 2.385 . . . . 0.0 112.351 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . 0.474 ' C ' ' H ' ' D' ' 39' ' ' GLN . 20.9 p-90 -63.85 -20.0 65.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 7.9 p -72.6 37.44 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.396 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' D' ' 37' ' ' TRP . 17.2 tt0 -80.73 10.54 4.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -89.13 -37.66 14.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.49 ' C ' ' H ' ' D' ' 43' ' ' GLU . 88.4 m-85 -89.65 -43.32 10.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 109.574 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.09 14.73 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.379 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' D' ' 41' ' ' PHE . 19.0 pt-20 -66.89 -13.87 62.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.085 -1.009 . . . . 0.0 109.492 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . 0.417 ' O ' ' N ' ' D' ' 46' ' ' GLY . 49.8 m -77.75 -42.5 33.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' D' ' 47' ' ' ASP . 39.9 m-85 -47.53 -20.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.461 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 59.09 -79.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' D' ' 45' ' ' PHE . 32.1 t0 -46.83 106.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -1.174 . . . . 0.0 109.553 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -163.08 21.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 0.0 109.269 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -52.61 -42.58 64.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 109.708 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . 0.432 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.4 p -145.4 152.08 49.04 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.319 -0.863 . . . . 0.0 109.265 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -40.28 -35.16 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.421 2.081 . . . . 0.0 112.365 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.74 -27.1 63.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.588 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -66.76 -19.94 65.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 t -74.13 -51.35 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.463 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 7.4 mmt -66.73 -22.03 66.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.56 -11.07 78.35 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' D' ' 59' ' ' LYS . 20.1 t-20 -71.73 136.33 83.07 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.169 -1.195 . . . . 0.0 109.266 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.07 -35.26 3.19 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.431 2.087 . . . . 0.0 112.374 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' D' ' 57' ' ' ASN . 40.9 mttm -63.95 -47.78 79.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 97.6 t -46.76 -35.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 109.795 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -49.9 52.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 109.355 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.76 -32.65 60.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -69.58 -24.0 63.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.8 -37.66 92.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -65.94 -25.63 67.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -1.143 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -74.71 -49.07 22.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 0.0 109.435 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.82 -60.76 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.312 -0.867 . . . . 0.0 109.362 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.642 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.3 tt -62.85 -21.16 65.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.124 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.78 -52.43 15.15 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.02 -35.3 33.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 109.571 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' D' ' 137' ' ' VAL . 22.7 m-85 -66.81 -49.83 64.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 109.446 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . 0.655 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 8.1 t -56.75 -30.94 64.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.413 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -59.62 -40.36 87.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.324 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.75 -60.23 8.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.579 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.6 mp -50.38 -26.56 5.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -1.125 . . . . 0.0 109.347 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.61 -2.57 58.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.149 -0.97 . . . . 0.0 109.435 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.516 ' CE1' ' OD2' ' D' ' 79' ' ' ASP . 71.3 t60 -171.01 62.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.547 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 25.1 mt -70.21 2.16 4.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.516 ' OD2' ' CE1' ' D' ' 77' ' ' HIS . 55.0 m-20 -55.92 -26.6 48.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 15.6 t-20 -170.6 111.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.428 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 14.5 mt -80.2 -58.11 3.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 109.507 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -47.31 -24.1 0.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -63.61 -51.51 53.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.448 ' C ' ' H ' ' D' ' 86' ' ' ALA . 0.7 OUTLIER -85.48 -39.65 17.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -1.14 . . . . 0.0 109.426 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.443 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.5 m-85 -70.53 10.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 109.532 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -67.75 -33.8 75.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.328 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -82.1 -53.21 6.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.456 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 35.6 mt -51.91 -49.69 62.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.252 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 7.2 m -59.69 -50.42 73.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.423 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.34 -38.84 92.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.392 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 5.1 tt -74.35 -32.56 62.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' D' ' 97' ' ' HIS . 15.2 m80 -84.91 -20.3 30.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.083 -1.011 . . . . 0.0 109.615 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 46.5 t -83.76 -59.92 2.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 0.0 110.844 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 41' ' ' THR . 37.4 m-20 -86.6 -34.76 19.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.065 -1.022 . . . . 0.0 111.565 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -79.82 -51.67 8.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.772 -1.205 . . . . 0.0 110.619 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.31 -32.73 10.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.064 . . . . 0.0 110.258 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' D' ' 97' ' ' HIS . 11.3 t-160 54.3 54.12 9.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 109.348 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.39 125.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.947 . . . . 0.0 109.156 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -49.33 145.88 7.01 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 109.322 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.11 -11.82 31.1 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.559 2.173 . . . . 0.0 112.098 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -93.71 60.36 2.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -148.83 -46.99 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 109.573 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 1.0 OUTLIER -51.34 -47.43 62.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.671 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -48.35 -19.89 0.35 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.437 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . 0.411 ' N ' ' C ' ' D' ' 103' ' ' PHE . 17.3 mt -88.69 -57.63 2.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.565 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -47.93 -20.94 0.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.528 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . 0.407 ' O ' HG23 ' D' ' 111' ' ' VAL . . . -81.72 -33.2 28.1 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -83.42 -17.51 41.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -1.191 . . . . 0.0 109.59 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 78.7 t -83.14 -56.66 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . 0.495 ' O ' HD23 ' D' ' 110' ' ' LEU . 2.0 tt -48.67 -53.17 19.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.456 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . 0.407 HG23 ' O ' ' D' ' 107' ' ' GLY . 88.6 t -47.03 -40.83 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.942 . . . . 0.0 109.631 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.74 -33.86 76.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.9 . . . . 0.0 109.521 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 t -66.3 -29.31 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' D' ' 118' ' ' PHE . 8.9 mt -81.61 -53.04 6.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.478 ' C ' ' HB1' ' C' ' 110' ' ' ALA . . . -54.02 -24.41 16.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.508 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.468 ' N ' ' HB1' ' C' ' 110' ' ' ALA . 0.6 OUTLIER -84.81 -62.58 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.606 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -68.59 -17.63 64.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.87 . . . . 0.0 109.664 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.484 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 72.2 m-85 -144.22 57.82 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 109.488 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -70.5 -23.06 77.87 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -72.61 10.81 0.75 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -1.151 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' D' ' 123' ' ' THR . 81.2 mm-40 -135.32 -0.26 2.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 0.0 109.762 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -73.77 33.54 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.486 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.0 OUTLIER -50.2 148.23 6.43 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.464 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.515 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.3 Cg_exo -46.85 -52.98 6.82 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.425 2.083 . . . . 0.0 113.119 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 26.1 Cg_endo -62.56 -21.99 73.48 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.115 1.877 . . . . 0.0 112.329 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.459 HG23 ' OG1' ' D' ' 123' ' ' THR . 75.8 t -81.59 -25.52 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.141 -0.974 . . . . 0.0 109.513 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' D' ' 123' ' ' THR . 5.4 mp0 -83.41 -59.66 2.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.508 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -45.87 -38.2 7.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.543 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.59 29.54 0.88 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.489 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.477 ' CD2' HG23 ' D' ' 11' ' ' VAL . 17.1 t80 -124.14 -22.4 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.707 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -83.99 -63.7 1.3 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.951 . . . . 0.0 110.099 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -49.75 -21.64 1.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 109.978 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . 0.588 HG22 HD21 ' D' ' 3' ' ' LEU . 2.2 t -72.45 -68.29 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.063 -1.023 . . . . 0.0 109.851 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.28 -19.95 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.844 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.03 -28.63 17.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.109 -0.994 . . . . 0.0 109.39 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.44 -36.4 88.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' D' ' 71' ' ' PHE . 99.4 t -63.47 -47.93 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -1.165 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.14 -43.21 31.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.894 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -80.2 -38.24 31.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.38 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.38 -48.43 62.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.346 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 36.0 mt -75.53 10.97 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.381 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.4 -4.66 3.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.365 -0.834 . . . . 0.0 109.441 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.11 -27.46 64.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.91 -16.38 36.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -62.19 -61.61 2.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.255 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.481 ' ND1' ' N ' ' D' ' 146' ' ' HIS . 2.0 m-70 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.519 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 2' ' ' LEU . 21.8 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.3 mp 55.12 166.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.76 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.568 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 176.14 -45.22 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.851 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 3' ' ' SER . 42.3 Cg_exo -55.36 -153.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.616 2.21 . . . . 0.0 112.864 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -78.61 -15.26 58.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.474 -0.766 . . . . 0.0 110.003 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 5' ' ' ALA . 16.4 m-20 -38.78 -29.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.379 -0.826 . . . . 0.0 109.735 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . 2.0 ptpm? -83.39 -41.79 17.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.187 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.481 ' N ' ' O ' ' A' ' 5' ' ' ALA . 45.9 m -51.35 -29.82 16.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.312 -0.868 . . . . 0.0 109.083 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.72 -36.87 42.74 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.486 HG21 ' CD2' ' A' ' 128' ' ' PHE . 53.7 t -70.99 -49.05 52.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -52.99 -46.02 68.11 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.02 -58.06 10.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.498 -0.751 . . . . 0.0 109.36 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.834 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -53.19 -35.96 60.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.406 -0.808 . . . . 0.0 109.129 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -17.14 62.29 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.256 -0.902 . . . . 0.0 109.302 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.08 22.6 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 12.9 mmmt -73.01 -35.89 66.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -1.115 . . . . 0.0 108.744 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 13' ' ' ALA . 57.9 t -62.02 -64.56 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 43.63 -122.35 3.93 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.31 22.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.403 -1.057 . . . . 0.0 110.345 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.545 ' H ' ' C ' ' A' ' 18' ' ' GLY . 78.2 m-70 -128.81 26.16 5.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' A' ' 63' ' ' ALA . . . -91.86 -63.1 1.29 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.621 -0.675 . . . . 0.0 109.9 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.7 -14.27 0.22 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 21' ' ' ALA . 10.4 mt-10 -84.72 -56.19 3.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -1.129 . . . . 0.0 109.814 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 20' ' ' HIS . 4.7 m-30 -60.24 -16.57 34.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.31 -34.14 30.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.07 39.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -1.2 . . . . 0.0 110.033 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.02 -19.73 64.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 109.662 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.72 -19.76 60.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 109.714 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.619 HD11 ' ND1' ' A' ' 58' ' ' HIS . 5.7 mt -78.73 -49.48 13.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 109.997 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' OE1' ' ND1' ' A' ' 50' ' ' HIS . 10.1 pt-20 -72.3 -33.25 67.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.091 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.575 ' NH1' ' SG ' ' A' ' 104' ' ' CYS . 45.8 ttt-85 -54.87 -44.58 74.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.927 . . . . 0.0 110.618 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.0 ptt? -84.13 -45.35 13.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.889 -1.132 . . . . 0.0 110.153 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -49.23 -41.42 37.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 109.825 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 34' ' ' LEU . 2.5 pp -75.04 -38.75 61.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.982 -1.074 . . . . 0.0 109.586 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.43 ' N ' HD12 ' A' ' 34' ' ' LEU . 15.7 m -75.52 7.43 3.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.015 -1.053 . . . . 0.0 109.29 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.93 ' CZ ' ' OE1' ' B' ' 131' ' ' GLN . 77.0 m-85 -156.13 71.9 5.13 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.39 -19.86 0.77 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.727 2.285 . . . . 0.0 112.265 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 p -59.23 -22.79 61.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 p -89.48 -42.87 11.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -52.16 -38.97 59.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.562 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 26.9 p-80 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.29 0.567 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.523 ' O ' ' C ' ' A' ' 47' ' ' ASP . 5.3 t80 -120.15 27.8 8.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.666 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 46' ' ' PHE . 1.6 p30 28.2 72.86 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.853 -0.529 . . . . 0.0 110.819 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 48' ' ' LEU . 2.2 mm? -64.83 -7.77 12.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.129 -0.982 . . . . 0.0 109.316 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 t -49.25 152.15 1.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.537 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.532 ' ND1' ' OE1' ' A' ' 30' ' ' GLU . 83.2 t60 -76.04 152.84 36.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.78 18.72 59.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.0 t -68.0 -99.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.246 -1.15 . . . . 0.0 109.311 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 174.0 -78.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.506 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -44.85 -17.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.395 -0.816 . . . . 0.0 109.589 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ALA . 3.5 t -76.72 -27.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.214 -0.929 . . . . 0.0 109.433 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.9 ptmt -66.02 -26.99 67.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 0.0 109.458 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.47 -42.18 42.01 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.619 ' ND1' HD11 ' A' ' 29' ' ' LEU . 15.1 t-80 -63.08 -27.98 69.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -1.203 . . . . 0.0 109.688 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.59 -47.31 90.25 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 32.6 mttp -56.08 -23.8 36.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -1.134 . . . . 0.0 109.754 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -72.54 -42.52 64.64 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.304 -0.872 . . . . 0.0 109.05 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.4 t -68.92 -47.69 74.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.517 -0.739 . . . . 0.0 109.2 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -69.91 -30.0 67.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.311 -0.868 . . . . 0.0 109.531 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.3 t70 -69.22 -41.88 76.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.122 -0.986 . . . . 0.0 108.821 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.38 -47.94 79.98 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 70' ' ' VAL . 4.8 mt -61.03 -47.14 87.81 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -62.22 -47.31 85.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 108.948 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -63.38 -26.71 68.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 108.682 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.14 -46.71 11.64 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 66' ' ' LEU . 78.4 t -65.99 -22.43 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.25 -21.67 66.3 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.586 ' O ' ' N ' ' A' ' 74' ' ' ASP . 13.2 m80 -144.18 -50.59 0.3 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.9 p 44.87 14.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 121.792 0.806 . . . . 0.0 109.489 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 72' ' ' HIS . 14.6 t70 -128.62 9.56 5.99 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -173.74 27.12 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.046 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.3 ptt? -78.36 -24.92 0.45 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.415 -0.803 . . . . 0.0 111.594 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 76' ' ' MET . 43.7 Cg_exo -55.56 -20.62 27.72 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.766 1.644 . . . . 0.0 112.538 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.52 HD22 ' C ' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -94.06 -28.75 15.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.868 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.54 -48.05 20.64 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.142 -0.974 . . . . 0.0 109.178 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 80' ' ' LEU . 6.9 mp -79.13 6.89 8.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.15 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -59.4 -15.74 18.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.635 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.83 -48.7 11.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 109.74 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 83' ' ' LEU . 4.7 mt -47.19 -48.35 23.83 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 88.3 p -50.18 -24.82 3.04 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.093 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 82' ' ' ALA . 15.0 t70 -74.45 -25.5 59.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.158 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 90' ' ' LYS . 6.9 tp -81.82 -34.29 30.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.299 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -90.44 -21.78 21.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -71.21 -68.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.907 . . . . 0.0 109.675 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -88.4 -77.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.91 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 86' ' ' LEU . 19.3 mttm -59.31 171.18 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.868 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.528 ' C ' ' H ' ' A' ' 93' ' ' VAL . 4.0 tp 56.79 56.95 5.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 109.682 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -66.05 9.75 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.953 . . . . 0.0 109.315 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 94' ' ' ASP . 12.4 p -46.4 165.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.664 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.551 ' CG ' ' OD1' ' D' ' 99' ' ' ASP . 5.3 m-20 -84.34 116.96 67.47 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.299 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 97' ' ' ASN . 84.4 Cg_exo -44.28 -10.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.297 1.998 . . . . 0.0 112.357 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.723 ' CG2' ' OD2' ' D' ' 99' ' ' ASP . 98.2 t -53.88 -10.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 109.56 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 95' ' ' PRO . 2.7 m-80 -79.24 -24.9 42.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -53.16 -43.71 67.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.576 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.428 ' CB ' ' NZ ' ' A' ' 99' ' ' LYS . 7.5 mtmp? -69.32 -25.41 64.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.683 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 25.3 mt -81.67 -46.69 13.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.707 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -69.68 -20.76 63.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.694 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.7 p -78.75 -59.07 2.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 109.746 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -63.29 -26.72 68.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.806 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.575 ' SG ' ' NH1' ' A' ' 31' ' ' ARG . 35.0 m -65.08 -52.26 56.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 109.818 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -24.62 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.749 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.75 -34.85 60.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.083 -1.011 . . . . 0.0 109.926 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' HE ' ' A' ' 31' ' ' ARG . 71.1 t -83.33 -24.65 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.058 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -70.98 -63.64 1.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.137 -0.977 . . . . 0.0 110.458 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 113' ' ' LEU . 2.3 pp -64.04 -18.68 64.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.847 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.35 -33.29 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 0.0 109.709 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.79 -56.15 25.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.371 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -66.52 -68.28 0.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.115 -0.991 . . . . 0.0 108.422 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.1 pp -116.67 111.44 41.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.637 ' O ' HD12 ' A' ' 113' ' ' LEU . 89.2 Cg_exo -41.58 -177.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.571 2.18 . . . . 0.0 113.167 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.702 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -45.45 -52.48 10.1 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.64 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 19.4 mt-10 124.98 -1.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 61.21 31.47 19.51 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.194 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.776 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -103.82 120.47 51.26 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.48 23.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.007 1.805 . . . . 0.0 112.663 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.776 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -152.51 -32.53 0.13 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.965 -1.084 . . . . 0.0 110.514 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.702 HG21 ' O ' ' A' ' 115' ' ' ALA . 14.4 p -47.86 -48.26 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.957 -1.09 . . . . 0.0 110.081 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.64 ' N ' HG13 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -63.76 -39.01 93.23 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 109.365 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.29 -19.78 33.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 120' ' ' ALA . 7.6 p -58.44 -62.07 2.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 110.018 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.507 ' N ' ' OG ' ' A' ' 124' ' ' SER . 5.0 mt -68.57 -19.58 64.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 109.329 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -73.74 -52.18 14.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.747 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.463 ' CD ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -86.29 -44.4 12.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 109.971 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' CD2' HG21 ' A' ' 10' ' ' VAL . 39.5 t80 -47.43 -20.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.988 -1.07 . . . . 0.0 108.992 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 133' ' ' SER . 12.0 mt -71.88 -17.99 62.08 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.32 -33.56 73.8 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 135' ' ' VAL . 89.2 p -82.72 -29.88 29.5 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.408 -0.808 . . . . 0.0 108.834 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 t -85.23 -29.73 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 109.134 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 129' ' ' LEU . 18.0 m -82.79 -22.64 34.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 0.0 108.936 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 138' ' ' SER . 42.1 m -80.72 -39.93 26.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.332 -0.855 . . . . 0.0 109.223 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 131' ' ' SER . 26.8 m -71.05 -26.5 27.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.211 -0.931 . . . . 0.0 108.899 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.02 -31.92 73.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -0.788 . . . . 0.0 108.96 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.0 m -156.81 53.63 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 134' ' ' THR . 9.1 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.497 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 43.9 m80 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.913 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.1 OUTLIER -142.74 164.53 29.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 109.362 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.83 159.43 68.83 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.827 . . . . 0.0 109.348 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.74 -18.64 65.3 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.632 2.221 . . . . 0.0 112.003 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.5 -34.25 23.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.5 -61.76 1.76 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 109.591 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.696 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -47.01 -26.74 1.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.91 . . . . 0.0 109.609 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.0 t -57.11 -23.39 46.73 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.59 -57.69 3.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.917 -1.115 . . . . 0.0 110.102 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.4 -24.58 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 48.1 m -82.09 -36.92 27.09 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.396 0.617 . . . . 0.0 109.759 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.5 -34.65 70.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.597 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.7 OUTLIER -50.49 -34.56 25.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 109.157 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -45.74 -17.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.372 -0.83 . . . . 0.0 109.66 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.25 -49.41 7.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.45 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 0.1 OUTLIER -71.95 -30.28 65.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.2 . . . . 0.0 109.396 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.434 HG22 ' CD2' ' B' ' 114' ' ' LEU . 77.5 t -53.46 114.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 109.649 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' B' ' 21' ' ' ASP . 36.3 m-80 -79.53 66.04 4.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 108.946 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' B' ' 22' ' ' GLU . 72.1 t -43.72 -26.13 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.471 -0.768 . . . . 0.0 109.852 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' B' ' 19' ' ' ASN . 18.0 t70 -65.51 5.13 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' B' ' 20' ' ' VAL . 37.5 mt-10 -154.03 -51.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.976 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 88.0 t -49.63 -53.3 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.76 -40.46 25.95 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.63 -37.14 61.94 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.05 -35.77 61.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -1.144 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.83 68.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.507 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 tp -84.94 -52.06 6.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.533 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.76 -28.49 70.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -79.22 -28.21 42.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -1.173 . . . . 0.0 109.477 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . 0.421 HD13 ' HB3' ' B' ' 106' ' ' LEU . 44.6 tp -48.08 -39.79 21.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.546 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.461 ' CD2' ' OG1' ' B' ' 38' ' ' THR . 21.1 mt -81.08 -23.01 38.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 71.5 t -66.23 -61.68 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.979 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -78.44 -22.63 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 110.047 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -134.57 77.03 59.77 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.067 -1.02 . . . . 0.0 109.926 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -84.2 27.89 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.014 2.476 . . . . 0.0 112.277 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -81.04 -20.13 42.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 109.89 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.532 ' C ' ' H ' ' B' ' 40' ' ' ARG . 6.1 p -47.7 -29.25 2.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.67 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 52.0 6.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' B' ' 38' ' ' THR . 42.6 ttm180 -110.21 -39.96 4.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 109.207 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 47.69 19.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' B' ' 44' ' ' SER . 77.2 m-85 54.53 55.18 8.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 109.388 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -46.3 -16.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.341 -0.849 . . . . 0.0 109.583 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.515 ' N ' ' O ' ' B' ' 42' ' ' PHE . 20.0 m -57.64 -54.68 44.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.432 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -70.12 3.75 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 109.235 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.16 -149.45 1.24 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 56.52 73.11 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -1.132 . . . . 0.0 109.669 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 89.8 mt -137.42 29.72 2.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.85 . . . . 0.0 109.384 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 41.5 t -72.49 -38.0 68.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -0.922 . . . . 0.0 109.541 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -146.16 151.91 45.72 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -40.93 -35.34 1.66 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.384 2.056 . . . . 0.0 112.38 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.99 -32.14 73.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 109.554 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.2 -24.0 66.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.565 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.33 -60.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -91.91 25.48 2.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.966 . . . . 0.0 109.629 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.2 -52.44 2.05 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.84 157.0 90.78 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 109.437 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' B' ' 62' ' ' ALA . 65.8 Cg_endo -74.96 -44.59 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.709 2.273 . . . . 0.0 112.322 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -45.95 -35.32 4.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.727 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 38.0 t -76.12 -41.57 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -79.18 -24.85 42.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.868 . . . . 0.0 109.545 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' B' ' 58' ' ' PRO . . . -76.55 -51.14 12.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.616 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -51.28 -23.95 4.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.86 -45.63 95.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -50.74 -44.7 58.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -1.113 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -57.82 -51.52 69.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.51 -0.744 . . . . 0.0 109.434 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.88 -51.14 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.291 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.77 -45.35 94.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.256 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.76 -45.83 31.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.15 92.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -1.14 . . . . 0.0 109.614 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -57.59 -28.86 63.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 11.6 m -77.16 -33.62 56.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.476 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.38 -34.24 33.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.463 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.24 -60.0 7.25 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.59 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.8 mp -55.03 -27.5 45.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -1.104 . . . . 0.0 109.45 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -2.14 36.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -171.26 63.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.49 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.99 -18.06 62.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -48.8 -26.05 2.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.445 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.34 65.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.276 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.437 HD12 ' N ' ' B' ' 82' ' ' LYS . 2.5 pp -55.69 -40.92 73.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.627 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.437 ' N ' HD12 ' B' ' 81' ' ' LEU . 39.5 mttp -50.35 -23.92 2.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.473 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.0 -42.88 7.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.7 OUTLIER -68.26 -42.92 78.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.148 -1.207 . . . . 0.0 109.629 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' B' ' 84' ' ' THR . 35.7 m-85 -67.3 -0.39 3.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -0.838 . . . . 0.0 109.459 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.46 -53.92 20.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.945 . . . . 0.0 109.383 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.5 p -61.6 -58.76 6.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' B' ' 92' ' ' HIS . 50.3 mt -51.21 -49.84 60.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.206 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . 0.516 ' O ' ' N ' ' B' ' 93' ' ' CYS . 7.2 m -57.16 -46.24 82.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.249 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.536 ' HA ' ' HZ2' ' B' ' 144' ' ' LYS . 31.0 tt0 -62.21 -46.53 88.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.486 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 3.9 tt -72.62 -27.24 62.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 109.361 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' B' ' 88' ' ' LEU . 18.7 m80 -90.47 -20.29 22.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.978 . . . . 0.0 109.663 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' B' ' 89' ' ' SER . 26.6 t -83.17 -59.23 2.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 110.699 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.65 -40.51 15.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.988 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.1 OUTLIER -73.01 -51.96 16.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.945 -1.097 . . . . 0.0 110.642 -178.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.57 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 30.8 mt -95.79 -36.89 10.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.91 -1.119 . . . . 0.0 109.96 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 38.6 p-80 43.71 30.78 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.427 ' H ' HG23 ' B' ' 98' ' ' VAL . 3.4 t -52.32 153.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 0.0 109.215 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 0.681 ' OD2' ' CG2' ' C' ' 96' ' ' VAL . 1.6 m-20 -71.24 143.05 87.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 109.589 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -41.22 -43.87 5.38 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.608 2.206 . . . . 0.0 112.46 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -72.01 54.46 0.28 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.449 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -150.98 -31.17 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 109.969 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.52 -41.68 54.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.072 -1.017 . . . . 0.0 109.931 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.424 ' O ' ' ND2' ' B' ' 108' ' ' ASN . 73.8 ttt180 -79.59 -19.98 48.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 110.071 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.443 ' N ' HD22 ' B' ' 105' ' ' LEU . 4.3 mm? -50.56 -60.86 2.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.137 -0.977 . . . . 0.0 109.793 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.421 ' HB3' HD13 ' B' ' 31' ' ' LEU . 1.9 pp -81.7 -22.39 37.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.012 -1.055 . . . . 0.0 109.721 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.35 -36.57 37.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' B' ' 104' ' ' ARG . 14.2 p30 -85.55 -34.81 21.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -1.158 . . . . 0.0 109.648 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 74.3 t -51.35 -48.0 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 109.465 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 tp -51.92 -54.0 34.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 109.49 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 25.2 t -46.42 -38.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.414 ' O ' ' ND1' ' B' ' 116' ' ' HIS . 13.2 m -79.2 -56.31 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 85.6 t -47.99 -24.52 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.552 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.434 ' CD2' HG22 ' B' ' 18' ' ' VAL . 14.2 mt -77.29 -43.54 32.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.26 -19.37 63.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.417 ' N ' ' HD1' ' B' ' 116' ' ' HIS . 4.3 m80 -78.29 -62.82 1.56 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.696 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -70.93 -17.43 62.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 0.0 109.845 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.45 ' CZ ' ' O ' ' B' ' 17' ' ' LYS . 63.1 m-85 -144.94 58.17 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.665 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -79.67 -17.92 74.31 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -65.05 4.99 0.39 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -1.079 . . . . 0.0 109.694 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' B' ' 119' ' ' GLY . 46.8 mm-40 -135.12 9.55 3.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -77.67 32.61 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.132 -0.98 . . . . 0.0 109.287 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.429 ' H ' ' C ' ' B' ' 121' ' ' GLU . 36.8 p -46.85 148.69 1.75 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.867 . . . . 0.0 109.51 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.48 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.1 Cg_exo -45.16 -57.03 2.31 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.542 2.161 . . . . 0.0 112.918 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 14.3 Cg_endo -56.86 -36.12 98.7 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.064 1.843 . . . . 0.0 111.995 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.408 HG23 ' OG1' ' B' ' 123' ' ' THR . 63.0 t -76.39 -20.33 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.75 -44.98 26.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.329 -0.857 . . . . 0.0 109.494 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.32 84.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.942 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.51 29.28 0.89 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.606 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.99 -33.89 4.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.0 109.375 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.93 ' OE1' ' CZ ' ' A' ' 36' ' ' PHE . 19.4 tt0 -83.95 -63.6 1.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 109.878 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -48.05 -21.88 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.844 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . 0.479 HG22 HD21 ' B' ' 3' ' ' LEU . 71.3 t -71.75 -67.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.726 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.401 ' H ' HG23 ' B' ' 134' ' ' VAL . 2.2 t -67.2 -40.29 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.637 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.75 -21.78 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.497 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.15 -22.11 63.84 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.8 t -74.14 -30.94 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -1.178 . . . . 0.0 109.536 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.37 71.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -81.43 -21.2 39.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.592 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.14 -60.52 2.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.653 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.0 mt -57.92 -17.75 18.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.547 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' B' ' 144' ' ' LYS . . . -100.6 -6.91 24.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.895 . . . . 0.0 109.532 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -59.05 -4.71 0.53 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.467 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.536 ' HZ2' ' HA ' ' B' ' 90' ' ' GLU . 21.6 mmtp -92.13 -30.85 15.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -71.3 14.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.0 109.325 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' B' ' 144' ' ' LYS . 28.1 p-80 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' C' ' 2' ' ' LEU . 21.8 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.499 HD12 ' N ' ' C' ' 2' ' ' LEU . 7.4 mp 55.12 166.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 109.727 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.563 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 176.06 -45.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.877 . . . . 0.0 109.859 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' C' ' 3' ' ' SER . 42.6 Cg_exo -55.31 -153.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.633 2.222 . . . . 0.0 112.843 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -78.65 -15.27 58.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.416 -0.802 . . . . 0.0 110.018 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' C' ' 5' ' ' ALA . 15.9 m-20 -38.67 -29.16 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.829 . . . . 0.0 109.759 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' C' ' 5' ' ' ALA . 2.0 ptpm? -83.37 -41.83 17.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.192 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.481 ' N ' ' O ' ' C' ' 5' ' ' ALA . 45.8 m -51.25 -29.96 16.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.889 . . . . 0.0 109.057 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.71 -36.79 42.9 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.483 HG21 ' CD2' ' C' ' 128' ' ' PHE . 53.8 t -70.99 -49.06 52.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -53.04 -45.98 68.28 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.06 -58.12 9.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.475 -0.766 . . . . 0.0 109.31 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.823 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -53.13 -35.89 60.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.456 -0.777 . . . . 0.0 109.215 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -17.24 62.29 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 109.258 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.03 22.79 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -73.12 -35.73 66.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -1.118 . . . . 0.0 108.772 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.823 HG23 ' O ' ' C' ' 13' ' ' ALA . 57.7 t -62.16 -64.52 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 43.68 -122.42 4.01 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.29 22.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -1.096 . . . . 0.0 110.347 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.543 ' H ' ' C ' ' C' ' 18' ' ' GLY . 78.4 m-70 -128.87 26.25 5.55 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' C' ' 63' ' ' ALA . . . -91.91 -63.15 1.28 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.599 -0.688 . . . . 0.0 109.837 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.67 -14.29 0.22 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' C' ' 21' ' ' ALA . 10.4 mt-10 -84.64 -56.37 3.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.801 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.438 ' CE2' ' O ' ' C' ' 20' ' ' HIS . 4.7 m-30 -60.16 -16.64 34.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.848 . . . . 0.0 109.516 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.13 -34.19 30.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.14 -32.03 38.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -1.184 . . . . 0.0 109.984 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.97 -19.9 64.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.623 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.59 60.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.734 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.619 HD11 ' ND1' ' C' ' 58' ' ' HIS . 5.7 mt -78.86 -49.5 12.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.949 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.521 ' OE1' ' ND1' ' C' ' 50' ' ' HIS . 10.1 pt-20 -72.24 -33.28 67.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.925 . . . . 0.0 110.13 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.567 ' NH1' ' SG ' ' C' ' 104' ' ' CYS . 45.8 ttt-85 -54.82 -44.63 74.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 110.596 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . 0.409 ' H ' ' HG2' ' C' ' 32' ' ' MET . 12.1 ptt? -84.09 -45.46 13.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.887 -1.133 . . . . 0.0 110.114 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -49.21 -41.41 37.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.171 -0.956 . . . . 0.0 109.83 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.564 ' C ' HD12 ' C' ' 34' ' ' LEU . 2.5 pp -75.04 -38.74 61.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.019 -1.051 . . . . 0.0 109.594 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.432 ' N ' HD12 ' C' ' 34' ' ' LEU . 15.6 m -75.51 7.48 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 109.326 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.93 ' CZ ' ' OE1' ' D' ' 131' ' ' GLN . 76.7 m-85 -156.19 72.05 5.09 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.338 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -46.5 -19.84 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.732 2.288 . . . . 0.0 112.203 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 19.9 p -59.22 -22.83 61.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.53 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 70.4 p -89.49 -42.91 11.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.963 . . . . 0.0 109.482 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -52.01 -39.13 59.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 109.608 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.404 HG22 ' H ' ' C' ' 41' ' ' THR . 2.7 t . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.568 ' O ' ' CD2' ' C' ' 45' ' ' HIS . 27.0 p-80 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.291 0.567 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.533 ' O ' ' C ' ' C' ' 47' ' ' ASP . 5.2 t80 -120.05 27.72 8.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 0.0 109.679 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.533 ' C ' ' O ' ' C' ' 46' ' ' PHE . 1.6 p30 28.35 72.67 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.087 0.47 . . . . 0.0 110.844 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' C' ' 48' ' ' LEU . 2.2 mm? -64.74 -7.8 12.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.147 -0.97 . . . . 0.0 109.364 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 33.7 t -49.25 152.13 1.27 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.521 ' ND1' ' OE1' ' C' ' 30' ' ' GLU . 83.2 t60 -76.0 152.82 36.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.449 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.88 18.6 59.93 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' C' ' 53' ' ' ALA . 2.0 t -67.93 -99.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -1.151 . . . . 0.0 109.309 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.517 ' N ' ' OG ' ' C' ' 52' ' ' SER . . . 174.06 -78.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.567 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -44.78 -17.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.466 -0.771 . . . . 0.0 109.709 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' C' ' 53' ' ' ALA . 3.5 t -76.68 -27.48 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.192 -0.943 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -66.04 -27.0 67.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.281 -0.887 . . . . 0.0 109.467 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.46 -42.28 41.72 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.619 ' ND1' HD11 ' C' ' 29' ' ' LEU . 14.9 t-80 -62.97 -28.2 69.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -1.158 . . . . 0.0 109.63 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.52 -47.26 90.7 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 32.7 mttp -56.1 -23.89 36.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -1.083 . . . . 0.0 109.671 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -72.42 -42.5 65.04 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.314 -0.866 . . . . 0.0 109.055 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.0 t -68.95 -47.67 74.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.501 -0.749 . . . . 0.0 109.229 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -69.92 -30.06 67.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 2.3 t70 -69.2 -41.79 76.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.0 108.886 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.45 -47.95 79.71 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.408 -0.807 . . . . 0.0 108.854 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.424 ' O ' HG23 ' C' ' 70' ' ' VAL . 4.8 mt -61.01 -47.15 87.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.219 -0.926 . . . . 0.0 108.654 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' C' ' 71' ' ' ALA . 20.9 m -62.13 -47.33 85.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.185 -0.947 . . . . 0.0 109.027 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -63.49 -26.63 68.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 108.647 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.588 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.16 -46.64 11.7 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.424 HG23 ' O ' ' C' ' 66' ' ' LEU . 78.2 t -66.04 -22.46 30.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' C' ' 67' ' ' THR . . . -66.26 -21.63 66.29 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' C' ' 74' ' ' ASP . 13.3 m80 -144.18 -50.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.8 p 44.99 13.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.659 0.742 . . . . 0.0 109.407 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' C' ' 72' ' ' HIS . 14.6 t70 -128.57 9.52 6.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -173.71 27.14 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.099 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.709 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.3 ptt? -78.37 -24.85 0.45 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.519 -0.738 . . . . 0.0 111.605 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' C' ' 76' ' ' MET . 44.0 Cg_exo -55.64 -20.57 28.08 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.748 1.632 . . . . 0.0 112.504 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.514 HD22 ' C ' ' C' ' 78' ' ' ASN . 0.1 OUTLIER -94.05 -28.82 15.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 109.867 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 -47.97 21.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.116 -0.99 . . . . 0.0 109.259 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . 0.588 ' N ' HD12 ' C' ' 80' ' ' LEU . 6.9 mp -79.25 6.9 8.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -59.28 -15.82 18.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.668 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.86 -48.61 11.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.112 -0.993 . . . . 0.0 109.775 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.436 HD23 ' N ' ' C' ' 83' ' ' LEU . 4.6 mt -47.2 -48.34 23.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 108.748 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 88.1 p -50.2 -24.76 3.03 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.458 -0.777 . . . . 0.0 109.079 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' C' ' 82' ' ' ALA . 14.9 t70 -74.44 -25.54 59.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.191 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' C' ' 90' ' ' LYS . 6.9 tp -81.75 -34.4 30.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.311 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -90.38 -21.75 21.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -71.24 -68.51 0.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.779 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -88.41 -77.16 0.37 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.89 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' C' ' 86' ' ' LEU . 19.2 mttm -59.28 171.14 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.889 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' C' ' 93' ' ' VAL . 4.0 tp 56.91 56.84 5.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.396 -0.815 . . . . 0.0 109.726 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -66.08 9.81 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 109.279 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.534 ' H ' ' C ' ' C' ' 91' ' ' LEU . 12.2 p -46.38 165.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.605 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' C' ' 96' ' ' VAL . 5.3 m-20 -84.27 117.02 67.66 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.915 . . . . 0.0 109.258 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.412 ' C ' ' N ' ' C' ' 97' ' ' ASN . 85.4 Cg_exo -44.41 -10.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.318 2.012 . . . . 0.0 112.318 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.681 ' CG2' ' OD2' ' B' ' 99' ' ' ASP . 98.8 t -53.91 -10.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.111 -0.993 . . . . 0.0 109.543 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.412 ' N ' ' C ' ' C' ' 95' ' ' PRO . 2.7 m-80 -79.17 -24.97 42.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -53.14 -43.71 67.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.918 . . . . 0.0 109.55 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.437 ' NZ ' ' CB ' ' C' ' 99' ' ' LYS . 7.6 mtmp? -69.41 -25.27 64.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.643 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 25.4 mt -81.68 -46.8 13.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 109.661 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -69.54 -20.88 63.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.735 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 32.8 p -78.68 -59.11 2.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 109.791 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -63.16 -26.73 68.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.871 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.567 ' SG ' ' NH1' ' C' ' 31' ' ' ARG . 34.5 m -65.17 -52.25 56.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.766 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.03 -24.68 0.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.721 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.78 -34.88 60.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -0.98 . . . . 0.0 109.855 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . 0.495 HG11 ' HE ' ' C' ' 31' ' ' ARG . 71.2 t -83.26 -24.82 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.045 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -70.8 -63.7 1.05 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.129 -0.982 . . . . 0.0 110.561 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' C' ' 113' ' ' LEU . 2.4 pp -64.02 -18.68 64.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 109.823 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.35 -33.36 63.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.712 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.65 -56.22 25.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -66.58 -68.31 0.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.0 108.385 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.668 ' O ' HD12 ' C' ' 113' ' ' LEU . 3.1 pp -116.56 111.46 41.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . 0.627 ' O ' HD12 ' C' ' 113' ' ' LEU . 89.9 Cg_exo -41.59 -177.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.507 2.138 . . . . 0.0 113.204 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.713 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -45.57 -52.42 10.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.479 -0.763 . . . . 0.0 109.038 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.645 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 19.4 mt-10 125.0 -1.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 61.28 31.33 19.4 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.262 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.775 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -103.88 120.54 50.95 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.53 23.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.049 1.833 . . . . 0.0 112.649 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.775 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -152.47 -32.5 0.14 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.864 -1.147 . . . . 0.0 110.568 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.713 HG21 ' O ' ' C' ' 115' ' ' ALA . 14.4 p -47.93 -48.23 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 110.1 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.643 ' N ' HG13 ' C' ' 121' ' ' VAL . 0.3 OUTLIER -63.74 -38.89 92.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.439 -0.788 . . . . 0.0 109.416 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.4 -19.75 33.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.885 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.608 ' N ' ' O ' ' C' ' 120' ' ' ALA . 7.6 p -58.36 -62.1 2.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 0.0 110.015 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.519 ' N ' ' OG ' ' C' ' 124' ' ' SER . 5.1 mt -68.54 -19.64 64.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 109.31 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -73.83 -52.21 13.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.701 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.459 ' CD ' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -86.26 -44.41 12.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.023 . . . . 0.0 109.936 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.483 ' CD2' HG21 ' C' ' 10' ' ' VAL . 39.7 t80 -47.32 -20.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.045 -1.035 . . . . 0.0 108.921 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' C' ' 133' ' ' SER . 12.0 mt -71.75 -18.0 62.16 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.28 -33.67 73.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.424 ' O ' HG13 ' C' ' 135' ' ' VAL . 89.3 p -82.7 -29.96 29.52 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 t -85.18 -29.72 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.157 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.488 ' N ' ' O ' ' C' ' 129' ' ' LEU . 17.8 m -82.79 -22.69 34.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.302 -0.873 . . . . 0.0 108.96 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . 0.463 ' O ' ' N ' ' C' ' 138' ' ' SER . 41.9 m -80.67 -39.99 26.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 0.0 109.225 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.424 HG13 ' O ' ' C' ' 131' ' ' SER . 26.8 m -71.08 -26.45 27.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.266 -0.897 . . . . 0.0 108.846 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -31.95 73.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.413 -0.804 . . . . 0.0 108.978 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 7.1 m -156.74 53.65 0.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.413 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . 0.463 ' N ' ' O ' ' C' ' 134' ' ' THR . 9.0 p . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 44.0 m80 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.931 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.1 OUTLIER -142.72 164.54 29.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.368 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.89 159.48 68.57 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.265 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.82 -18.65 65.64 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.72 2.28 . . . . 0.0 111.946 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -84.58 -34.14 23.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.53 -61.75 1.76 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.628 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.697 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -46.99 -26.76 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.609 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.1 t -57.04 -23.5 46.98 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.153 -0.967 . . . . 0.0 110.194 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.62 -57.65 3.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.019 -1.051 . . . . 0.0 110.115 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.35 -24.59 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 48.8 m -82.11 -36.92 27.04 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.309 0.575 . . . . 0.0 109.704 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.54 -34.65 70.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.7 OUTLIER -50.54 -34.48 25.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.14 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -45.78 -17.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.375 -0.828 . . . . 0.0 109.637 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.27 -49.37 7.48 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.454 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 0.1 OUTLIER -72.0 -30.23 65.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.094 -1.239 . . . . 0.0 109.445 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.442 HG22 ' CD2' ' D' ' 114' ' ' LEU . 77.4 t -53.47 114.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.7 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' D' ' 20' ' ' VAL . 36.4 m-80 -79.56 65.99 4.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 108.937 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' D' ' 22' ' ' GLU . 72.5 t -43.69 -26.18 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.451 -0.781 . . . . 0.0 109.79 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' D' ' 19' ' ' ASN . 18.0 t70 -65.45 5.13 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.527 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' D' ' 20' ' ' VAL . 37.5 mt-10 -154.06 -51.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 0.0 109.484 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 88.0 t -49.71 -53.35 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 109.547 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.67 -40.56 25.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.55 -37.2 62.22 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.09 -35.7 61.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -1.123 . . . . 0.0 109.555 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.51 -28.71 68.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 tp -85.04 -51.97 6.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.78 -28.41 70.02 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -79.4 -28.11 41.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -1.117 . . . . 0.0 109.49 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' D' ' 106' ' ' LEU . 44.3 tp -48.09 -39.91 21.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . 0.452 ' CD2' ' OG1' ' D' ' 38' ' ' THR . 21.2 mt -81.03 -23.03 38.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.291 -0.88 . . . . 0.0 109.695 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.18 -61.81 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.142 -0.974 . . . . 0.0 109.918 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' C' ' 122' ' ' HIS . 0.0 OUTLIER -78.42 -22.54 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 0.0 110.112 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -134.6 76.99 59.74 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.109 -0.994 . . . . 0.0 109.925 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.18 27.88 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.028 2.486 . . . . 0.0 112.339 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -81.1 -20.04 42.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -0.953 . . . . 0.0 109.853 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.527 ' C ' ' H ' ' D' ' 40' ' ' ARG . 6.0 p -47.81 -29.16 2.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 109.66 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 51.91 6.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . 0.527 ' H ' ' C ' ' D' ' 38' ' ' THR . 42.5 ttm180 -110.13 -39.92 4.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 47.73 19.72 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.621 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.514 ' O ' ' N ' ' D' ' 44' ' ' SER . 77.3 m-85 54.73 55.01 8.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.359 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -46.2 -16.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 109.636 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . 0.514 ' N ' ' O ' ' D' ' 42' ' ' PHE . 20.2 m -57.69 -54.68 44.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -70.07 3.74 2.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.219 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.05 -149.34 1.19 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 56.51 73.16 0.46 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.319 -1.106 . . . . 0.0 109.641 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 90.3 mt -137.5 29.69 2.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.858 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 41.5 t -72.46 -38.01 68.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.499 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -146.11 151.95 45.98 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.295 -0.878 . . . . 0.0 109.173 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -41.12 -35.23 1.82 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.404 2.07 . . . . 0.0 112.308 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.91 -32.28 73.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.11 -23.88 66.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.681 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.45 -60.73 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -91.97 25.59 2.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.33 -52.36 2.04 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.81 156.87 90.98 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.224 -1.162 . . . . 0.0 109.43 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.97 -44.49 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.645 2.23 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -45.98 -35.33 4.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 0.0 109.66 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -76.15 -41.58 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -79.17 -24.93 42.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.36 -0.837 . . . . 0.0 109.474 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.48 -51.26 12.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.53 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -51.27 -23.94 4.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 109.47 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.93 -45.59 95.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -50.83 -44.63 59.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.374 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -57.81 -51.55 69.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.41 -0.806 . . . . 0.0 109.477 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.83 -51.15 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.314 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.77 -45.33 94.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.24 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.81 -45.79 31.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.24 92.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -1.103 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -57.42 -29.07 63.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 11.6 m -77.0 -33.68 57.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 109.496 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.45 -34.26 34.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.367 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.16 -60.08 7.19 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.57 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.8 mp -55.11 -27.44 45.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -1.14 . . . . 0.0 109.381 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -2.16 36.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -171.23 63.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.91 -18.06 62.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.442 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -48.84 -25.97 2.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.37 65.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.283 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . 0.439 HD12 ' N ' ' D' ' 82' ' ' LYS . 2.5 pp -55.65 -40.98 72.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . 0.439 ' N ' HD12 ' D' ' 81' ' ' LEU . 39.5 mttp -50.44 -23.77 2.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.055 -1.028 . . . . 0.0 109.438 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.18 -42.89 7.78 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.7 OUTLIER -68.18 -42.89 79.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.022 -1.281 . . . . 0.0 109.635 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' D' ' 84' ' ' THR . 35.4 m-85 -67.39 -0.27 3.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.498 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.52 -54.01 20.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.3 p -61.57 -58.66 7.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.366 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' D' ' 92' ' ' HIS . 49.1 mt -51.27 -49.88 60.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.256 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . 0.536 ' O ' ' N ' ' D' ' 93' ' ' CYS . 7.2 m -57.12 -46.22 82.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 109.233 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.548 ' HA ' ' HZ2' ' D' ' 144' ' ' LYS . 30.9 tt0 -62.28 -46.58 88.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.419 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 3.9 tt -72.45 -27.27 62.21 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.135 -0.978 . . . . 0.0 109.461 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.459 ' N ' ' O ' ' D' ' 88' ' ' LEU . 19.0 m80 -90.52 -20.24 22.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.06 -1.025 . . . . 0.0 109.621 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . 0.536 ' N ' ' O ' ' D' ' 89' ' ' SER . 26.0 t -83.27 -59.27 2.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 110.563 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -86.6 -40.53 15.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.04 -1.037 . . . . 0.0 111.326 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.1 OUTLIER -72.99 -52.0 16.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.965 -1.084 . . . . 0.0 110.602 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.56 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 30.9 mt -95.74 -36.89 11.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.934 -1.104 . . . . 0.0 109.96 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 38.5 p-80 43.58 30.9 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.373 -0.829 . . . . 0.0 110.078 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . 0.463 ' H ' HG23 ' D' ' 98' ' ' VAL . 3.4 t -52.38 153.27 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.074 -1.016 . . . . 0.0 109.19 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . 0.723 ' OD2' ' CG2' ' A' ' 96' ' ' VAL . 1.6 m-20 -71.22 143.01 87.76 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 109.589 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -41.26 -43.83 5.48 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.573 2.182 . . . . 0.0 112.417 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -71.98 54.42 0.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -150.93 -31.18 0.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 109.961 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.48 -41.7 54.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.993 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . 0.426 ' O ' ' ND2' ' D' ' 108' ' ' ASN . 73.9 ttt180 -79.49 -20.1 48.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 110.094 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . 0.44 ' N ' HD22 ' D' ' 105' ' ' LEU . 4.3 mm? -50.58 -60.84 2.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 109.737 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.424 ' HB3' HD13 ' D' ' 31' ' ' LEU . 1.9 pp -81.68 -22.43 37.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.056 -1.028 . . . . 0.0 109.766 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.28 -36.55 37.09 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' D' ' 104' ' ' ARG . 14.2 p30 -85.6 -34.8 21.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -1.149 . . . . 0.0 109.675 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 74.6 t -51.3 -48.0 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 109.462 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.94 -54.1 33.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.368 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 25.1 t -46.29 -38.14 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 109.533 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . 0.422 ' O ' ' ND1' ' D' ' 116' ' ' HIS . 13.3 m -79.1 -56.35 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.56 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 86.8 t -47.93 -24.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.945 . . . . 0.0 109.479 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . 0.442 ' CD2' HG22 ' D' ' 18' ' ' VAL . 14.2 mt -77.19 -43.65 32.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.389 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.52 63.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.407 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' D' ' 112' ' ' CYS . 4.4 m80 -78.18 -62.87 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 0.0 109.771 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -70.75 -17.56 62.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.869 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 63.5 m-85 -144.86 58.12 1.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 0.0 109.74 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -79.7 -17.93 74.23 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -65.03 4.92 0.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -1.083 . . . . 0.0 109.656 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' D' ' 119' ' ' GLY . 46.7 mm-40 -135.04 9.46 3.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.722 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.556 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -77.58 32.62 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.14 -0.975 . . . . 0.0 109.297 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.442 ' H ' ' C ' ' D' ' 121' ' ' GLU . 37.2 p -46.88 148.68 1.77 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.34 -0.85 . . . . 0.0 109.546 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.472 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.2 Cg_exo -45.28 -56.91 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.538 2.159 . . . . 0.0 112.887 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 14.3 Cg_endo -56.9 -36.16 98.86 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.16 1.907 . . . . 0.0 111.969 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.417 HG23 ' OG1' ' D' ' 123' ' ' THR . 63.3 t -76.4 -20.34 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.71 -45.05 25.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 0.0 109.481 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.34 83.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 109.57 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.5 29.29 0.89 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.634 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.02 -33.88 4.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 0.93 ' OE1' ' CZ ' ' C' ' 36' ' ' PHE . 19.4 tt0 -83.98 -63.48 1.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -48.12 -21.84 0.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.838 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . 0.48 HG22 HD21 ' D' ' 3' ' ' LEU . 70.8 t -71.73 -67.25 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.151 -0.968 . . . . 0.0 109.71 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.414 HG23 ' H ' ' D' ' 134' ' ' VAL . 2.2 t -67.3 -40.14 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.82 -21.85 0.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.14 -22.02 64.06 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 89.5 t -74.12 -31.0 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -1.155 . . . . 0.0 109.562 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.36 71.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.53 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -81.34 -21.29 39.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.587 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.13 -60.46 2.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.658 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.1 mt -57.99 -17.69 18.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.514 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' D' ' 144' ' ' LYS . . . -100.66 -6.9 24.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.863 . . . . 0.0 109.603 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -59.03 -4.75 0.53 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.473 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.548 ' HZ2' ' HA ' ' D' ' 90' ' ' GLU . 21.5 mmtp -92.0 -31.03 15.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.579 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -71.32 14.2 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.001 . . . . 0.0 109.36 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' D' ' 144' ' ' LYS . 28.0 p-80 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.515 HD11 ' HA ' ' A' ' 128' ' ' PHE . 4.3 mm? -105.07 -176.64 3.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.306 -0.871 . . . . 0.0 109.609 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.545 ' O ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -117.34 170.88 5.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.0 109.236 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 3' ' ' SER . 88.7 Cg_exo -41.39 -117.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 123.132 2.554 . . . . 0.0 113.304 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -43.99 -27.63 0.39 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.966 -1.084 . . . . 0.0 110.263 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 10' ' ' VAL . 29.9 m-20 -44.1 -35.07 2.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.973 . . . . 0.0 109.192 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -83.26 -34.02 25.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.267 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 m -59.22 -33.33 70.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.264 -0.897 . . . . 0.0 109.148 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -75.02 -32.64 61.66 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 6' ' ' ASP . 54.3 t -76.03 -51.4 20.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HE2' HG13 ' A' ' 70' ' ' VAL . 1.1 mptm? -56.96 -33.98 67.59 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.18 -59.62 5.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.446 -0.784 . . . . 0.0 109.459 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -53.21 -34.44 57.05 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.425 -0.797 . . . . 0.0 109.141 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -17.62 61.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.22 -44.69 9.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -70.19 -38.15 75.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -1.123 . . . . 0.0 108.901 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 13' ' ' ALA . 96.1 t -61.38 -64.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 53.93 -130.52 43.56 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.23 26.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.457 -1.025 . . . . 0.0 110.438 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.534 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.0 m-70 -130.56 23.85 5.09 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.81 -59.58 2.19 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.612 -0.68 . . . . 0.0 109.698 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -14.21 0.22 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 9.7 mt-10 -88.14 -56.63 3.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -1.141 . . . . 0.0 109.739 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.8 m-30 -57.46 -39.49 76.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.034 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.54 -22.95 53.63 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.51 -57.88 2.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -1.11 . . . . 0.0 109.735 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' OE1' ' NE2' ' A' ' 112' ' ' HIS . 72.4 mt-10 -50.26 -19.9 0.92 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.362 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.58 63.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.367 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.48 HD21 ' CD2' ' A' ' 58' ' ' HIS . 9.1 mt -73.13 -56.42 5.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 29' ' ' LEU . 56.3 mt-10 -43.87 -37.19 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.691 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -48.76 78.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.945 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.1 ttp -83.99 -42.82 15.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.63 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.596 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 26.1 m-85 -64.28 -32.57 74.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 0.0 110.301 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mt -45.68 -43.02 12.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.971 -1.081 . . . . 0.0 109.727 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 36' ' ' PHE . 14.9 m -86.65 -15.76 38.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.328 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER 19.14 64.48 0.24 Allowed Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.976 -0.453 . . . . 0.0 111.319 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.52 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 85.4 Cg_endo -93.63 -62.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.623 2.215 . . . . 0.0 112.552 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.741 ' O ' HG22 ' A' ' 41' ' ' THR . 3.5 p -91.43 -18.6 23.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 109.738 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 p -81.72 -23.03 36.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.968 . . . . 0.0 110.149 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -68.27 -34.93 77.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.063 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 38' ' ' THR . 14.1 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.508 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.441 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 42.0 p-80 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.516 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -155.91 28.53 0.37 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.727 -1.233 . . . . 0.0 110.395 178.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 46' ' ' PHE . 7.3 m-20 33.31 81.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.635 -0.666 . . . . 0.0 110.33 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.862 HD23 ' H ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -60.13 -21.27 61.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.442 -0.786 . . . . 0.0 109.335 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 t -47.54 149.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.59 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 2.0 t60 -74.77 151.06 39.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.59 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 82.16 4.74 90.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.667 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 12.1 p -77.42 -19.77 55.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -1.143 . . . . 0.0 109.477 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 75.77 -16.95 0.55 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.37 -0.831 . . . . 0.0 109.869 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -86.14 -21.43 27.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.121 -0.987 . . . . 0.0 109.954 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.516 HG22 ' CE2' ' A' ' 46' ' ' PHE . 18.8 t -84.1 -28.29 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 0.0 109.834 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -77.98 -30.41 50.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.123 -0.986 . . . . 0.0 108.989 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.512 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . . . -66.61 -26.46 72.91 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.48 ' CD2' HD21 ' A' ' 29' ' ' LEU . 7.4 t60 -75.46 -34.78 60.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.131 -1.217 . . . . 0.0 109.636 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.34 -51.08 44.34 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -51.66 -23.46 4.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -1.065 . . . . 0.0 109.968 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -74.51 -42.38 59.02 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.125 -0.984 . . . . 0.0 109.082 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -72.5 -45.24 59.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.467 -0.77 . . . . 0.0 108.986 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.85 -27.59 65.97 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.291 -0.881 . . . . 0.0 109.188 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.39 -34.06 67.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 108.727 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.87 -52.15 46.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.318 -0.864 . . . . 0.0 108.933 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 128' ' ' PHE . 9.1 mt -59.17 -42.77 91.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 0.0 108.653 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -69.35 -50.19 48.56 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 108.745 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -58.98 -24.78 63.01 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.95 -45.6 12.99 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' HE2' ' A' ' 11' ' ' LYS . 4.9 t -63.77 -22.99 32.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.407 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -60.38 -22.78 63.7 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.61 ' O ' ' N ' ' A' ' 74' ' ' ASP . 40.2 m80 -147.22 -51.78 0.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.875 . . . . 0.0 109.532 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.4 p 44.49 13.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.758 0.79 . . . . 0.0 109.479 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' A' ' 72' ' ' HIS . 17.8 t70 -133.07 9.78 4.15 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 34.1 t70 -175.43 27.43 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.981 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 13.8 ptt? -78.66 -22.48 0.38 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.431 -0.793 . . . . 0.0 111.909 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.8 Cg_exo -53.48 -20.78 16.69 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.548 1.499 . . . . 0.0 112.33 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.17 -35.41 12.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.678 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.04 -47.55 61.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.306 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.5 mt -77.5 5.75 8.37 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.075 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.1 p -54.73 -24.64 23.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.291 -0.88 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -73.93 -55.21 6.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 109.557 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.464 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 4.6 mt -47.7 -48.13 29.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.808 . . . . 0.0 108.929 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -59.21 -22.65 61.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.549 -0.719 . . . . 0.0 109.398 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 89' ' ' HIS . 16.5 t70 -81.89 -46.52 13.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.3 -26.74 65.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 11.4 m80 -81.47 -21.65 38.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.724 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 90' ' ' LYS . . . -119.05 -55.46 2.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.294 -0.879 . . . . 0.0 109.746 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 85' ' ' ASP . 13.2 t-80 -71.41 17.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 109.751 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.599 ' C ' ' H ' ' A' ' 92' ' ' ARG . 9.8 ttmm -166.5 149.02 6.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 109.781 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.7 mt 61.81 -12.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 109.86 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.038 ' HD2' ' HG2' ' D' ' 40' ' ' ARG . 45.6 mmt-85 45.14 16.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 109.714 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 91' ' ' LEU . 12.1 p -57.68 131.02 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 1.08 ' OD1' ' NH1' ' D' ' 40' ' ' ARG . 0.8 OUTLIER -75.3 147.03 82.3 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.29 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 97' ' ' ASN . 58.1 Cg_endo -72.57 -23.9 19.38 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.543 2.162 . . . . 0.0 112.126 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.8 t -49.06 -10.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.77 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 95' ' ' PRO . 12.0 m-20 -79.05 -24.88 43.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.534 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -54.28 -30.04 49.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.425 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 92.4 mttt -54.33 -26.62 30.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.489 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.674 HD12 ' N ' ' A' ' 100' ' ' LEU . 8.1 mp -84.06 -57.37 3.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.3 tp -50.89 -27.35 7.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -66.09 -58.52 5.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.616 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -63.57 -26.45 68.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.882 . . . . 0.0 109.67 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 73.6 m -58.2 -55.97 28.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 109.596 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mt -47.82 -37.98 14.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 106' ' ' LEU . 7.7 mp -71.13 -41.89 69.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.05 -24.95 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 109.348 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 m -80.76 -63.28 1.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.447 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 113' ' ' LEU . 33.8 mt -46.98 -28.29 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.25 90.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 110.017 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.68 64.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.097 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' A' ' 27' ' ' GLU . 28.1 m170 -93.19 -80.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.073 -1.017 . . . . 0.0 109.721 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -107.94 102.74 47.07 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -43.8 173.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.546 2.164 . . . . 0.0 113.563 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -87.32 -35.44 18.42 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.782 0.801 . . . . 0.0 109.422 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 13.1 mt-10 81.29 1.35 1.63 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 1.209 ' CD1' ' NH2' ' B' ' 30' ' ' ARG . 11.2 m-85 58.49 40.91 23.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.806 -0.559 . . . . 0.0 111.282 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.752 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -88.12 118.7 69.89 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 120.756 -1.215 . . . . 0.0 108.001 178.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.596 ' HA ' HG21 ' B' ' 33' ' ' VAL . 54.1 Cg_exo -49.05 18.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.319 2.012 . . . . 0.0 112.644 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.752 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -140.08 -39.21 0.45 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.111 -0.993 . . . . 0.0 110.053 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 4.2 p -51.68 -48.35 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.102 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.576 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 2.8 m-70 -62.75 -54.37 40.21 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.412 -0.805 . . . . 0.0 109.334 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.92 -19.61 60.87 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.253 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 1.1 p -60.77 -61.6 2.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 110.271 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.539 ' N ' ' OG ' ' A' ' 124' ' ' SER . 6.4 mt -80.64 -21.05 41.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.113 -0.992 . . . . 0.0 110.073 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -78.51 -40.69 34.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 110.109 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.29 -41.29 11.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.949 -1.094 . . . . 0.0 110.13 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.515 ' HA ' HD11 ' A' ' 2' ' ' LEU . 32.3 t80 -50.56 -20.51 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.8 -1.188 . . . . 0.0 108.839 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 133' ' ' SER . 11.9 mt -72.59 -17.74 61.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.13 76.83 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.2 p -79.39 -36.19 39.57 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.339 -0.851 . . . . 0.0 108.82 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.09 -27.23 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.183 -0.948 . . . . 0.0 108.67 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 129' ' ' LEU . 97.2 p -78.17 -45.99 21.7 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.474 -0.766 . . . . 0.0 109.204 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 95.2 m -67.81 -23.01 65.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.223 -0.923 . . . . 0.0 108.654 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.85 -29.9 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -34.6 67.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.09 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 138' ' ' SER . 81.0 p -92.21 -29.73 16.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 137' ' ' THR . 3.5 t . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.521 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' B' ' 2' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.842 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -140.81 145.25 36.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.342 -0.849 . . . . 0.0 109.034 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 7.8 p -69.65 148.75 96.84 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.543 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -42.65 -24.85 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.598 2.199 . . . . 0.0 112.236 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -80.82 -53.03 6.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.92 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -60.28 -36.08 77.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.182 -0.948 . . . . 0.0 109.98 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.508 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -84.08 -31.57 25.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 109.922 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.07 -23.56 8.02 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.148 -0.97 . . . . 0.0 110.458 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.4 -58.04 3.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.942 -1.099 . . . . 0.0 110.272 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.46 HG23 ' CD2' ' B' ' 130' ' ' TYR . 7.6 p -65.53 -24.53 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.9 m -78.38 -40.35 36.49 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.338 0.589 . . . . 0.0 109.711 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.36 -26.14 68.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.339 -0.851 . . . . 0.0 109.488 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.722 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.9 OUTLIER -62.53 -26.81 68.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.38 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.77 -17.7 64.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.42 -62.9 3.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.62 ' HD3' HD23 ' B' ' 14' ' ' LEU . 0.0 OUTLIER -78.71 7.1 7.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.099 -1.236 . . . . 0.0 110.815 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.722 HG23 ' O ' ' B' ' 14' ' ' LEU . 2.3 t -75.65 121.32 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.826 -1.171 . . . . 0.0 109.186 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.43 85.1 6.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.402 -0.811 . . . . 0.0 109.224 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 36.0 t -55.96 -20.36 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 109.573 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 1.0 OUTLIER -57.36 -55.78 30.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 43.1 mt-10 -98.89 -44.29 6.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.58 -23.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.882 . . . . 0.0 109.658 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.18 -43.07 11.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.98 -25.86 61.33 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -79.44 -25.45 41.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.198 -1.177 . . . . 0.0 109.662 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.64 -23.22 39.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 109.619 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 tp -85.02 -57.26 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 0.0 109.503 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.03 -19.82 32.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 1.209 ' NH2' ' CD1' ' A' ' 117' ' ' PHE . 47.0 mtt180 -79.37 -27.34 41.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -1.188 . . . . 0.0 109.377 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 39.7 tp -65.58 -24.77 67.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.879 . . . . 0.0 109.585 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 41.2 mt -78.01 -53.8 7.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.085 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.742 HG13 ' H ' ' B' ' 34' ' ' VAL . 7.9 p -71.07 -60.73 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 110.039 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.742 ' H ' HG13 ' B' ' 33' ' ' VAL . 95.3 t -46.28 -30.5 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.958 -1.089 . . . . 0.0 109.549 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.9 91.2 1.58 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.391 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.71 30.48 0.52 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.733 2.289 . . . . 0.0 112.427 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -57.17 -28.66 62.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.488 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' B' ' 39' ' ' GLN . 30.5 p -56.19 -77.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.892 . . . . 0.0 109.419 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . 0.534 ' N ' ' OG1' ' B' ' 38' ' ' THR . 14.8 tt0 50.62 46.12 26.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.554 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 1.034 ' NH1' ' OD1' ' C' ' 94' ' ' ASP . 68.9 mtm180 -148.01 -49.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.151 -0.968 . . . . 0.0 109.55 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' B' ' 43' ' ' GLU . 1.3 p90 -96.72 -21.4 17.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.759 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -48.81 -11.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.98 . . . . 0.0 109.625 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' B' ' 41' ' ' PHE . 31.3 mt-10 -80.31 -20.3 44.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.171 -0.956 . . . . 0.0 109.475 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.474 ' O ' ' N ' ' B' ' 46' ' ' GLY . 11.2 t -58.25 -51.8 68.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.62 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' B' ' 47' ' ' ASP . 57.0 m-85 -47.92 -16.14 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.533 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 61.35 -77.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' B' ' 45' ' ' PHE . 0.9 OUTLIER -46.77 113.45 0.66 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -1.132 . . . . 0.0 109.605 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' B' ' 49' ' ' SER . 0.8 OUTLIER -161.15 22.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.009 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' B' ' 48' ' ' LEU . 17.9 m -45.13 -39.66 6.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 109.563 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -145.67 151.94 47.62 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.323 -0.861 . . . . 0.0 108.995 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -44.64 -21.84 0.53 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.295 1.996 . . . . 0.0 112.154 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.78 -29.21 27.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.657 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.547 ' O ' ' ND2' ' B' ' 57' ' ' ASN . . . -55.57 -26.94 46.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 109.535 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.51 -62.01 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.574 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 14.9 mmt -53.7 -16.97 1.89 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.541 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.25 -4.19 61.24 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' B' ' 53' ' ' ALA . 3.8 m120 -72.22 142.69 85.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.192 -1.181 . . . . 0.0 109.376 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.5 -52.1 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.509 2.14 . . . . 0.0 112.21 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -51.56 -48.11 63.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -0.86 . . . . 0.0 109.586 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.46 -27.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.529 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -79.16 -53.57 6.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.54 -59.04 3.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -49.06 -23.92 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.69 -37.62 92.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -71.7 -35.32 70.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.544 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -49.42 -44.87 45.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.179 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 54.4 t -73.57 -61.84 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.183 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.716 ' O ' HD23 ' B' ' 68' ' ' LEU . 1.8 tt -50.43 -23.24 2.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.092 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.35 -56.99 11.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.88 97.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -1.132 . . . . 0.0 109.439 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . 0.55 ' CZ ' HG11 ' B' ' 134' ' ' VAL . 0.1 OUTLIER -48.82 -21.78 0.7 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 109.289 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p -87.89 -34.93 18.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.621 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -46.44 -34.36 4.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.59 -58.93 6.01 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.528 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -62.87 -23.3 67.25 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -1.092 . . . . 0.0 109.277 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.49 2.4 54.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.408 ' C ' ' H ' ' B' ' 79' ' ' ASP . 55.9 t60 -170.99 65.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.78 13.22 0.67 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' B' ' 77' ' ' HIS . 34.7 t70 -76.36 -27.65 56.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.563 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -170.98 106.4 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 109.512 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 mt -80.33 -44.01 20.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.436 ' CD ' ' H ' ' B' ' 82' ' ' LYS . 1.5 mptp? -49.41 -25.87 2.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.383 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.17 -53.71 3.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 3.9 p -65.9 -37.64 86.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.199 -1.177 . . . . 0.0 109.616 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -90.84 23.95 2.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.619 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.26 -41.55 40.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.392 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 21.1 p -72.69 -51.01 21.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.408 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -56.79 -48.85 76.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.33 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 28.1 t -61.57 -44.06 97.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.34 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -64.41 -23.75 67.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.377 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 7.4 tp -85.1 -68.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -49.59 -30.01 8.04 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.272 -0.893 . . . . 0.0 110.083 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . 0.571 ' SG ' ' CD1' ' B' ' 145' ' ' TYR . 38.0 t -83.98 -55.66 4.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 111.548 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.541 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 0.6 OUTLIER -86.26 -29.13 23.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.915 -1.116 . . . . 0.0 112.205 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . 0.45 ' C ' HD22 ' B' ' 96' ' ' LEU . 5.6 mptp? -90.32 -52.06 5.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.639 -1.288 . . . . 0.0 110.981 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.537 ' N ' HD22 ' B' ' 96' ' ' LEU . 3.7 mm? -97.59 -22.79 16.31 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.753 -1.217 . . . . 0.0 110.208 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.604 ' O ' HG22 ' C' ' 38' ' ' THR . 81.9 m-70 51.03 37.62 18.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.004 -1.06 . . . . 0.0 109.424 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.04 138.75 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 0.0 109.362 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.94 151.28 3.42 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.73 30.57 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.575 2.183 . . . . 0.0 112.022 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -143.47 75.86 1.49 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.304 -0.873 . . . . 0.0 109.384 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -168.2 -40.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.454 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -52.52 -45.7 66.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.429 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 55.4 ttp180 -66.34 -42.32 88.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.46 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.606 HD12 ' N ' ' B' ' 105' ' ' LEU . 10.0 mp -54.37 -57.48 11.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.692 ' C ' HD23 ' B' ' 106' ' ' LEU . 7.5 tt -52.15 -49.02 64.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.97 -22.41 54.96 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 27.4 m120 -80.76 -15.35 56.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.042 -1.269 . . . . 0.0 109.737 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 64.1 t -85.23 -44.78 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 109.609 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.523 ' O ' HD23 ' B' ' 110' ' ' LEU . 1.7 tt -47.87 -54.33 12.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.599 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.433 ' H ' HG23 ' B' ' 111' ' ' VAL . 3.5 t -45.57 -32.64 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.884 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.525 ' O ' ' ND1' ' B' ' 116' ' ' HIS . 45.6 m -77.3 -36.87 53.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 109.754 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 18.2 t -57.97 -46.36 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.739 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' B' ' 118' ' ' PHE . 19.0 mt -66.8 -30.54 70.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.697 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.458 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -61.08 -29.44 69.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.614 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' B' ' 112' ' ' CYS . 68.7 m80 -84.82 -62.89 1.44 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.708 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.518 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 6.6 t-160 -65.44 -18.45 65.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 40.5 m-85 -144.37 55.48 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 109.491 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.531 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -68.74 -21.32 74.85 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.06 -35.21 59.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.146 . . . . 0.0 109.421 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.482 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.0 mm-40 -75.31 3.05 9.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.439 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.552 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -72.33 35.43 0.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.555 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.557 ' OG1' HG23 ' B' ' 126' ' ' VAL . 4.8 p -47.12 147.4 2.47 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.369 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.2 Cg_exo -48.48 -51.28 10.53 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.31 2.007 . . . . 0.0 113.231 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 41.8 Cg_endo -67.99 -0.92 6.12 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.055 1.836 . . . . 0.0 112.754 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.557 HG23 ' OG1' ' B' ' 123' ' ' THR . 40.3 t -99.08 -12.57 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 109.598 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.36 -60.19 2.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 109.496 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.51 ' O ' ' NZ ' ' B' ' 132' ' ' LYS . . . -67.07 -25.71 66.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.95 . . . . 0.0 109.264 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.45 18.19 2.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 109.651 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.46 ' CD2' HG23 ' B' ' 11' ' ' VAL . 6.1 t80 -107.89 -61.3 1.59 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.652 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.415 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 53.6 tt0 -46.31 -48.28 18.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 109.742 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.821 ' HG2' ' OXT' ' D' ' 146' ' ' HIS . 33.1 mtmm -52.69 -21.89 4.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.781 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.34 -67.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.0 109.699 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.55 HG11 ' CZ ' ' B' ' 71' ' ' PHE . 30.9 m -73.33 -15.88 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 109.909 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.906 ' HB1' ' CG ' ' D' ' 146' ' ' HIS . . . -47.47 -28.86 2.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.469 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.29 -22.8 58.22 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 134' ' ' VAL . 82.3 t -82.1 -27.04 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -1.136 . . . . 0.0 109.538 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.98 82.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.596 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 1.07 ' ND2' ' ND2' ' D' ' 139' ' ' ASN . 23.9 m120 -79.63 -25.93 41.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.917 . . . . 0.0 109.754 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.47 -49.15 78.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.0 109.726 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 21.8 mt -82.64 16.41 2.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 109.668 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.77 -0.77 1.88 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.22 -0.925 . . . . 0.0 109.697 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -80.36 -28.31 38.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -70.91 -16.6 62.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.439 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.571 ' CD1' ' SG ' ' B' ' 93' ' ' CYS . 13.9 m-85 -64.67 -28.83 69.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.361 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.867 ' CG ' ' HB1' ' D' ' 135' ' ' ALA . 20.9 m-70 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.447 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' C' ' 128' ' ' PHE . 4.3 mm? -105.13 -176.71 3.16 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.278 -0.889 . . . . 0.0 109.536 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.545 ' O ' ' O ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER -117.22 170.84 5.53 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.539 -0.726 . . . . 0.0 109.191 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' C' ' 3' ' ' SER . 89.1 Cg_exo -41.37 -117.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.126 2.551 . . . . 0.0 113.275 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -43.92 -27.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 110.272 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.505 ' O ' HG23 ' C' ' 10' ' ' VAL . 29.7 m-20 -44.16 -34.95 2.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.1 -1.0 . . . . 0.0 109.25 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -83.33 -33.95 25.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.319 -0.863 . . . . 0.0 109.307 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 55.1 m -59.29 -33.41 71.04 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.227 -0.921 . . . . 0.0 109.028 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . 0.401 ' CG ' ' HB1' ' C' ' 120' ' ' ALA . 6.5 m120 -74.95 -32.65 61.78 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.505 HG23 ' O ' ' C' ' 6' ' ' ASP . 53.6 t -76.05 -51.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . 0.507 ' HE2' HG13 ' C' ' 70' ' ' VAL . 1.1 mptm? -57.0 -34.01 67.72 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.2 -59.67 5.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.521 -0.737 . . . . 0.0 109.314 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.768 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -53.2 -34.43 56.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.383 -0.823 . . . . 0.0 109.109 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -17.64 61.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.308 -0.87 . . . . 0.0 109.263 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.17 -44.75 9.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -70.06 -38.29 75.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.168 -1.195 . . . . 0.0 108.89 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.768 HG23 ' O ' ' C' ' 13' ' ' ALA . 95.6 t -61.35 -64.93 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.552 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 53.94 -130.56 43.67 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.15 26.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.42 -1.047 . . . . 0.0 110.453 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.552 ' H ' ' C ' ' C' ' 18' ' ' GLY . 93.2 m-70 -130.59 24.07 5.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.95 -59.52 2.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.627 -0.67 . . . . 0.0 109.735 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -14.31 0.23 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' C' ' 21' ' ' ALA . 9.7 mt-10 -88.05 -56.6 3.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.139 . . . . 0.0 109.74 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.8 m-30 -57.4 -39.54 76.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.066 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.53 -23.05 53.83 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.4 -57.99 2.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.286 -1.126 . . . . 0.0 109.774 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . 0.526 ' OE1' ' NE2' ' C' ' 112' ' ' HIS . 72.7 mt-10 -50.18 -19.88 0.88 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.29 -21.64 63.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.494 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.49 HD21 ' CD2' ' C' ' 58' ' ' HIS . 9.1 mt -73.12 -56.49 5.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.571 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -43.79 -37.15 2.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.827 . . . . 0.0 109.773 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -48.71 78.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 61.0 ttp -83.97 -42.87 15.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . 0.594 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 26.2 m-85 -64.17 -32.71 74.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.908 . . . . 0.0 110.239 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' C' ' 33' ' ' PHE . 5.7 mt -45.66 -43.07 12.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.966 -1.083 . . . . 0.0 109.658 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.57 ' O ' ' C ' ' C' ' 36' ' ' PHE . 14.9 m -86.66 -15.67 38.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -0.9 . . . . 0.0 109.367 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.594 ' CD2' ' O ' ' C' ' 33' ' ' PHE . 0.2 OUTLIER 19.17 64.46 0.24 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.917 -0.489 . . . . 0.0 111.354 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.436 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 85.4 Cg_endo -93.68 -62.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.571 2.181 . . . . 0.0 112.551 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.719 ' O ' HG22 ' C' ' 41' ' ' THR . 3.4 p -91.45 -18.48 24.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 109.754 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -81.72 -23.08 36.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.15 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -68.25 -34.96 77.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.087 -1.008 . . . . 0.0 109.67 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.719 HG22 ' O ' ' C' ' 38' ' ' THR . 13.9 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.428 ' O ' ' CD2' ' C' ' 45' ' ' HIS . 42.1 p-80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.776 0.322 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' C' ' 55' ' ' VAL . 0.7 OUTLIER -155.86 28.54 0.37 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.76 -1.212 . . . . 0.0 110.406 178.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' C' ' 46' ' ' PHE . 7.3 m-20 33.41 81.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.663 -0.648 . . . . 0.0 110.295 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.862 HD23 ' H ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -60.06 -21.35 61.33 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.462 -0.774 . . . . 0.0 109.356 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 20.9 t -47.54 149.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.614 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 2.0 t60 -74.81 151.08 39.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . 0.584 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 82.26 4.64 90.13 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.667 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 12.0 p -77.42 -19.81 55.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -1.11 . . . . 0.0 109.482 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 75.8 -16.99 0.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.367 -0.833 . . . . 0.0 109.888 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -86.1 -21.56 27.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.903 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.511 HG22 ' CE2' ' C' ' 46' ' ' PHE . 18.6 t -83.93 -28.42 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.062 -1.024 . . . . 0.0 109.901 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -77.96 -30.37 50.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.013 -1.055 . . . . 0.0 108.961 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . 0.512 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -66.68 -26.44 72.97 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.49 ' CD2' HD21 ' C' ' 29' ' ' LEU . 7.4 t60 -75.41 -34.77 61.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.122 -1.222 . . . . 0.0 109.671 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.1 44.32 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -51.66 -23.42 4.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -1.077 . . . . 0.0 109.887 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' C' ' 57' ' ' GLY . 0.8 OUTLIER -74.54 -42.4 58.9 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.157 -0.965 . . . . 0.0 109.103 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -72.54 -45.23 59.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 108.98 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.85 -27.66 66.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.279 -0.888 . . . . 0.0 109.156 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -72.3 -34.01 67.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 108.866 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.86 -52.1 47.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.01 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' C' ' 128' ' ' PHE . 9.2 mt -59.15 -42.8 91.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.912 . . . . 0.0 108.634 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -69.42 -50.13 48.65 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.282 -0.886 . . . . 0.0 108.695 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -59.01 -24.86 63.17 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.86 -45.64 13.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.507 HG13 ' HE2' ' C' ' 11' ' ' LYS . 4.9 t -63.65 -23.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' C' ' 72' ' ' HIS . . . -60.21 -22.86 63.5 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' C' ' 74' ' ' ASP . 40.3 m80 -147.24 -51.87 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.357 -0.839 . . . . 0.0 109.56 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.3 p 44.42 13.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.856 0.836 . . . . 0.0 109.539 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' C' ' 72' ' ' HIS . 17.8 t70 -133.12 9.76 4.13 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.434 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 34.1 t70 -175.4 27.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.897 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.689 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 13.8 ptt? -78.64 -22.62 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.478 -0.764 . . . . 0.0 111.865 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.6 Cg_exo -53.46 -20.69 16.36 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.586 1.524 . . . . 0.0 112.276 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.21 -35.42 12.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 109.738 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.03 -47.58 61.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 0.0 109.32 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -77.45 5.69 8.38 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.112 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 64.4 p -54.74 -24.67 23.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -73.95 -55.15 6.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.579 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.47 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 4.7 mt -47.75 -48.07 30.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.385 -0.822 . . . . 0.0 108.821 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -59.32 -22.63 61.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.49 -0.756 . . . . 0.0 109.315 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' C' ' 89' ' ' HIS . 16.5 t70 -81.9 -46.53 13.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.24 -26.82 65.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 11.4 m80 -81.34 -21.74 38.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.166 -0.959 . . . . 0.0 109.783 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' C' ' 90' ' ' LYS . . . -118.98 -55.51 2.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.313 -0.867 . . . . 0.0 109.773 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' C' ' 85' ' ' ASP . 13.2 t-80 -71.26 17.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.813 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.618 ' C ' ' H ' ' C' ' 92' ' ' ARG . 9.8 ttmm -166.53 149.02 6.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -0.998 . . . . 0.0 109.728 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.7 mt 61.79 -12.47 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.893 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . 1.005 ' HD2' ' HG2' ' B' ' 40' ' ' ARG . 45.7 mmt-85 45.05 16.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.73 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' C' ' 91' ' ' LEU . 12.0 p -57.73 130.97 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 1.034 ' OD1' ' NH1' ' B' ' 40' ' ' ARG . 0.8 OUTLIER -75.31 146.99 82.24 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' C' ' 97' ' ' ASN . 58.0 Cg_endo -72.63 -23.82 19.27 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.436 2.091 . . . . 0.0 112.153 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.458 ' H ' HG23 ' C' ' 96' ' ' VAL . 5.6 t -48.95 -10.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.796 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' C' ' 95' ' ' PRO . 12.1 m-20 -79.21 -24.73 42.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 109.518 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' C' ' 99' ' ' LYS . 0.6 OUTLIER -54.27 -30.1 49.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 109.497 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.419 ' N ' ' CD1' ' C' ' 98' ' ' PHE . 92.3 mttt -54.25 -26.61 29.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.461 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.67 HD12 ' N ' ' C' ' 100' ' ' LEU . 8.1 mp -84.18 -57.31 3.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 7.2 tp -50.93 -27.3 7.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 109.534 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 6.1 m -66.23 -58.55 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 0.0 109.551 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -63.39 -26.61 68.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.68 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 73.4 m -58.15 -55.94 28.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.627 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mt -47.86 -37.98 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 109.541 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.571 ' N ' HD12 ' C' ' 106' ' ' LEU . 7.7 mp -71.09 -41.99 69.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.99 -24.93 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.376 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 22.5 m -80.85 -63.2 1.46 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.442 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' C' ' 113' ' ' LEU . 34.4 mt -46.97 -28.35 1.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.18 90.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 110.044 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.69 63.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.386 -0.821 . . . . 0.0 110.027 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' C' ' 27' ' ' GLU . 28.1 m170 -93.16 -80.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.107 -0.995 . . . . 0.0 109.697 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.853 HD23 ' O ' ' C' ' 113' ' ' LEU . 0.1 OUTLIER -107.83 102.7 46.58 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -43.8 173.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.626 2.217 . . . . 0.0 113.504 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -87.19 -35.43 18.58 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.684 0.754 . . . . 0.0 109.482 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 13.2 mt-10 81.34 1.28 1.62 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 1.194 ' CD1' ' NH2' ' D' ' 30' ' ' ARG . 11.1 m-85 58.55 40.8 23.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.895 -0.503 . . . . 0.0 111.255 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.754 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -88.05 118.69 69.91 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.703 -1.248 . . . . 0.0 108.068 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . 0.603 ' HA ' HG21 ' D' ' 33' ' ' VAL . 54.0 Cg_exo -49.05 18.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.293 1.995 . . . . 0.0 112.662 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.754 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -139.99 -39.23 0.45 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.077 -1.015 . . . . 0.0 110.057 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.575 HG13 ' N ' ' C' ' 122' ' ' HIS . 4.2 p -51.8 -48.33 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.103 -0.998 . . . . 0.0 109.952 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.575 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.9 m-70 -62.91 -54.32 40.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.399 -0.813 . . . . 0.0 109.259 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.81 -19.69 60.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.307 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 1.1 p -60.79 -61.5 2.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.345 -0.847 . . . . 0.0 110.303 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.535 ' N ' ' OG ' ' C' ' 124' ' ' SER . 6.4 mt -80.72 -21.04 41.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.089 -1.007 . . . . 0.0 110.05 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -78.51 -40.67 34.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 110.092 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.29 -41.3 11.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.987 -1.07 . . . . 0.0 110.097 -179.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.527 ' HA ' HD11 ' C' ' 2' ' ' LEU . 31.9 t80 -50.51 -20.59 1.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.8 -1.187 . . . . 0.0 108.841 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' C' ' 133' ' ' SER . 11.9 mt -72.53 -17.79 61.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.46 -38.1 76.85 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 60.8 p -79.46 -36.24 39.11 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.318 -0.864 . . . . 0.0 108.749 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.02 -27.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.218 -0.927 . . . . 0.0 108.638 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.587 ' N ' ' O ' ' C' ' 129' ' ' LEU . 96.8 p -78.32 -45.96 21.32 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.384 -0.822 . . . . 0.0 109.159 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 94.8 m -67.78 -22.99 65.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.258 -0.902 . . . . 0.0 108.705 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.77 -30.04 7.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -34.6 67.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.393 -0.817 . . . . 0.0 109.056 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . 0.44 ' O ' ' O ' ' C' ' 138' ' ' SER . 81.1 p -92.32 -29.56 16.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.573 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . 0.44 ' O ' ' O ' ' C' ' 137' ' ' THR . 3.5 t . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.832 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -140.84 145.18 35.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.164 -0.96 . . . . 0.0 109.059 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 7.9 p -69.6 148.83 96.95 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.531 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -42.8 -24.78 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.503 2.136 . . . . 0.0 112.229 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -80.79 -53.07 6.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.919 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -60.21 -36.07 76.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 109.989 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.531 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -84.06 -31.52 25.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 110.026 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.08 -23.49 7.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -0.959 . . . . 0.0 110.441 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.5 -58.02 3.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.935 -1.103 . . . . 0.0 110.222 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' D' ' 130' ' ' TYR . 7.7 p -65.55 -24.44 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 25.9 m -78.45 -40.32 36.0 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.317 0.58 . . . . 0.0 109.674 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -26.21 68.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.51 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.73 ' O ' HG23 ' D' ' 18' ' ' VAL . 0.9 OUTLIER -62.52 -26.84 68.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.329 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.77 -17.7 64.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.509 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.38 -62.87 3.66 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.494 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.627 ' HD3' HD23 ' D' ' 14' ' ' LEU . 0.0 OUTLIER -78.79 7.16 7.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.285 . . . . 0.0 110.849 -178.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.73 HG23 ' O ' ' D' ' 14' ' ' LEU . 2.3 t -75.73 121.39 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.742 -1.224 . . . . 0.0 109.138 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -81.42 85.21 6.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.212 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 36.5 t -55.97 -20.39 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.608 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' D' ' 22' ' ' GLU . 1.0 OUTLIER -57.32 -55.81 29.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.366 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' D' ' 21' ' ' ASP . 43.1 mt-10 -98.9 -44.31 6.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.66 -23.89 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.619 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.24 -43.11 10.93 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.87 -25.93 61.44 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -79.36 -25.56 42.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.213 -1.169 . . . . 0.0 109.674 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.61 -23.17 39.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 109.675 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 tp -85.03 -57.29 3.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 109.479 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.93 -19.92 31.71 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . 1.194 ' NH2' ' CD1' ' C' ' 117' ' ' PHE . 47.2 mtt180 -79.29 -27.28 42.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -1.176 . . . . 0.0 109.421 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 39.4 tp -65.68 -24.71 67.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 41.8 mt -78.19 -53.67 7.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.056 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . 0.732 HG13 ' H ' ' D' ' 34' ' ' VAL . 7.9 p -71.16 -60.6 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.125 -0.985 . . . . 0.0 110.05 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.732 ' H ' HG13 ' D' ' 33' ' ' VAL . 94.9 t -46.41 -30.41 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.952 -1.093 . . . . 0.0 109.557 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.96 91.25 1.57 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 109.348 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -84.74 30.47 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.731 2.287 . . . . 0.0 112.409 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 -57.16 -28.75 63.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' D' ' 39' ' ' GLN . 30.5 p -56.07 -77.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.379 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . 0.542 ' N ' ' OG1' ' D' ' 38' ' ' THR . 14.7 tt0 50.6 46.09 26.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 109.577 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . 1.08 ' NH1' ' OD1' ' A' ' 94' ' ' ASP . 69.3 mtm180 -147.97 -49.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' D' ' 43' ' ' GLU . 1.3 p90 -96.76 -21.24 17.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -48.86 -11.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.565 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' D' ' 41' ' ' PHE . 31.3 mt-10 -80.31 -20.3 44.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . 0.471 ' O ' ' N ' ' D' ' 46' ' ' GLY . 11.3 t -58.2 -51.94 67.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.581 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' D' ' 47' ' ' ASP . 56.8 m-85 -47.75 -16.27 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.515 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 61.38 -77.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' D' ' 45' ' ' PHE . 0.9 OUTLIER -46.74 113.49 0.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -1.133 . . . . 0.0 109.607 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' D' ' 49' ' ' SER . 0.8 OUTLIER -161.22 22.18 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 108.971 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' D' ' 48' ' ' LEU . 17.8 m -45.06 -39.77 6.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 109.585 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -145.53 151.94 48.16 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.855 . . . . 0.0 109.056 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -44.61 -21.85 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.241 1.96 . . . . 0.0 112.16 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -83.81 -29.18 27.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 109.594 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.54 ' O ' ' ND2' ' D' ' 57' ' ' ASN . . . -55.52 -26.94 45.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.655 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.51 -62.04 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.577 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 14.9 mmt -53.62 -17.0 1.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.556 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.27 -4.16 61.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' D' ' 53' ' ' ALA . 3.8 m120 -72.27 142.79 85.0 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.321 -1.105 . . . . 0.0 109.313 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.55 -52.11 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.515 2.144 . . . . 0.0 112.152 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -51.66 -47.96 63.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.624 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 95.5 t -47.51 -27.47 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -79.14 -53.52 6.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.68 -59.03 3.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.567 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -49.0 -24.03 1.36 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.933 . . . . 0.0 109.587 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.59 -37.66 92.71 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' D' ' 69' ' ' GLY . 27.8 mttp -71.67 -35.42 70.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -1.197 . . . . 0.0 109.519 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -49.35 -44.82 44.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 109.235 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 54.3 t -73.66 -61.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -0.869 . . . . 0.0 109.212 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.72 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.8 tt -50.44 -23.35 2.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.155 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' D' ' 65' ' ' LYS . . . -66.23 -57.08 11.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.81 97.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.203 -1.174 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . 0.552 ' CZ ' HG11 ' D' ' 134' ' ' VAL . 0.1 OUTLIER -48.89 -21.73 0.71 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.314 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p -88.05 -34.86 17.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.57 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -46.35 -34.49 4.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.893 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.52 -58.91 6.05 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.531 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.5 mp -62.76 -23.48 67.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.175 -1.191 . . . . 0.0 109.26 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.35 2.32 54.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 109.454 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' D' ' 79' ' ' ASP . 55.9 t60 -170.95 65.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.79 13.3 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.304 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' D' ' 77' ' ' HIS . 34.7 t70 -76.46 -27.64 56.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -170.93 106.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.22 -44.09 20.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . 0.431 ' CD ' ' H ' ' D' ' 82' ' ' LYS . 1.5 mptp? -49.36 -25.89 2.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.469 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.18 -53.79 3.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . . . . . . . . . 3.8 p -65.83 -37.63 86.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -1.144 . . . . 0.0 109.596 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -90.9 24.02 2.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.665 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.29 -41.58 40.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.337 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 21.2 p -72.79 -50.83 21.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 109.491 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.82 -48.94 76.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.352 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 27.7 t -61.48 -44.03 97.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.44 -23.75 67.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 7.4 tp -85.12 -68.78 0.7 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.842 . . . . 0.0 109.421 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -49.52 -30.14 7.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . 0.587 ' SG ' ' CD1' ' D' ' 145' ' ' TYR . 38.0 t -83.88 -55.55 4.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 111.633 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.543 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 0.6 OUTLIER -86.39 -29.07 23.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.957 -1.09 . . . . 0.0 112.161 -177.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . 0.447 ' C ' HD22 ' D' ' 96' ' ' LEU . 5.6 mptp? -90.34 -52.07 5.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.619 -1.301 . . . . 0.0 111.043 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.531 ' N ' HD22 ' D' ' 96' ' ' LEU . 3.7 mm? -97.53 -22.85 16.3 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.787 -1.196 . . . . 0.0 110.241 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.668 ' O ' HG22 ' A' ' 38' ' ' THR . 81.9 m-70 51.07 37.59 18.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.019 -1.05 . . . . 0.0 109.473 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 44.5 t -55.04 138.78 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.345 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.93 151.24 3.43 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.7 30.6 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.568 2.179 . . . . 0.0 112.086 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -143.46 75.88 1.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 109.349 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -168.27 -40.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -52.54 -45.79 66.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 55.3 ttp180 -66.16 -42.39 89.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . 0.594 HD12 ' N ' ' D' ' 105' ' ' LEU . 10.1 mp -54.45 -57.43 11.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.442 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.691 ' C ' HD23 ' D' ' 106' ' ' LEU . 7.5 tt -52.13 -49.02 64.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.17 -0.956 . . . . 0.0 109.467 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -59.0 -22.37 55.01 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 27.4 m120 -80.66 -15.56 56.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.107 -1.231 . . . . 0.0 109.786 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 63.5 t -85.08 -44.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 109.65 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . 0.517 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.7 tt -47.98 -54.24 13.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . 0.452 HG23 ' H ' ' D' ' 111' ' ' VAL . 3.4 t -45.5 -32.69 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.955 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . 0.52 ' O ' ' ND1' ' D' ' 116' ' ' HIS . 46.3 m -77.3 -36.86 53.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.76 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.94 -46.45 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.767 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 19.0 mt -66.77 -30.42 70.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.794 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.458 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -61.22 -29.42 69.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.97 . . . . 0.0 109.575 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' D' ' 112' ' ' CYS . 68.8 m80 -84.74 -63.0 1.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.071 -1.018 . . . . 0.0 109.685 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 6.6 t-160 -65.38 -18.4 65.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 109.581 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 40.6 m-85 -144.45 55.44 1.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.529 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -68.62 -21.42 74.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -76.03 -35.19 59.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -1.118 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' D' ' 123' ' ' THR . 59.0 mm-40 -75.33 3.04 9.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -72.24 35.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.334 -0.854 . . . . 0.0 109.545 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.549 ' OG1' HG23 ' D' ' 126' ' ' VAL . 4.8 p -47.15 147.35 2.53 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.955 . . . . 0.0 109.393 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.499 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.2 Cg_exo -48.38 -51.29 10.45 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.366 2.044 . . . . 0.0 113.202 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 41.6 Cg_endo -68.0 -1.0 6.22 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.06 1.84 . . . . 0.0 112.748 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.549 HG23 ' OG1' ' D' ' 123' ' ' THR . 40.0 t -99.09 -12.52 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.174 -0.954 . . . . 0.0 109.607 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.25 -60.23 2.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 109.507 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.518 ' O ' ' NZ ' ' D' ' 132' ' ' LYS . . . -67.05 -25.79 66.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.37 18.06 2.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.356 -0.84 . . . . 0.0 109.621 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.45 ' CD2' HG23 ' D' ' 11' ' ' VAL . 6.2 t80 -107.83 -61.39 1.58 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.341 -0.85 . . . . 0.0 109.617 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 53.6 tt0 -46.4 -48.17 18.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.957 . . . . 0.0 109.724 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . 0.775 ' HG2' ' OXT' ' B' ' 146' ' ' HIS . 33.0 mtmm -52.65 -21.87 4.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.863 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 25.7 t -74.39 -67.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -0.949 . . . . 0.0 109.661 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.552 HG11 ' CZ ' ' D' ' 71' ' ' PHE . 31.4 m -73.5 -15.77 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.883 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.867 ' HB1' ' CG ' ' B' ' 146' ' ' HIS . . . -47.34 -29.0 2.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.23 -22.82 58.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' D' ' 134' ' ' VAL . 81.0 t -82.18 -26.95 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -1.133 . . . . 0.0 109.547 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.84 -47.96 83.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.93 . . . . 0.0 109.615 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . 1.07 ' ND2' ' ND2' ' B' ' 139' ' ' ASN . 23.7 m120 -79.62 -26.02 41.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.65 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.2 78.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.676 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 21.9 mt -82.68 16.41 2.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.651 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.75 -0.85 1.88 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.213 -0.929 . . . . 0.0 109.729 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -80.27 -28.24 38.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.778 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -70.91 -16.62 62.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.985 . . . . 0.0 109.465 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . 0.587 ' CD1' ' SG ' ' D' ' 93' ' ' CYS . 13.9 m-85 -64.66 -28.82 69.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.383 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.906 ' CG ' ' HB1' ' B' ' 135' ' ' ALA . 20.9 m-70 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.428 ' CG2' ' OG ' ' A' ' 131' ' ' SER . 16.8 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.438 HD13 ' CD1' ' A' ' 128' ' ' PHE . 25.0 mt -136.9 -161.01 1.11 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 0.0 109.354 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.453 ' N ' ' OD2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -133.15 174.43 4.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.332 -0.855 . . . . 0.0 109.285 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.23 -70.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.629 2.219 . . . . 0.0 112.689 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.451 ' O ' ' ND2' ' A' ' 9' ' ' ASN . . . -48.54 -44.14 36.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.109 -0.995 . . . . 0.0 109.903 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 10' ' ' VAL . 1.3 m-20 -42.36 -35.76 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 10' ' ' VAL . 69.6 mttt -83.32 -56.43 3.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.32 -0.862 . . . . 0.0 109.524 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 94.5 m -45.43 -35.58 3.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 109.865 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 5' ' ' ALA . 9.0 m-20 -74.69 -33.49 62.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.01 -1.057 . . . . 0.0 108.15 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 6' ' ' ASP . 75.4 t -76.22 -49.37 25.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.45 -40.08 64.93 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.89 -61.64 2.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.516 -0.74 . . . . 0.0 109.462 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.64 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.6 -38.5 66.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.381 -0.824 . . . . 0.0 109.137 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.47 -17.44 62.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.24 -0.912 . . . . 0.0 109.008 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.58 -46.62 7.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -68.69 -36.76 78.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -1.163 . . . . 0.0 108.842 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 13' ' ' ALA . 70.5 t -62.0 -66.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 61.85 -141.08 47.3 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.17 39.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.493 -1.004 . . . . 0.0 110.355 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' GLY . 87.6 m-70 -142.94 20.34 1.96 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.63 -61.28 1.92 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.652 -0.655 . . . . 0.0 109.583 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.65 -13.91 0.19 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 21' ' ' ALA . 10.2 mm-40 -84.99 -56.33 3.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -1.102 . . . . 0.0 109.613 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.8 m-30 -61.69 -30.88 71.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 109.254 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.44 74.88 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -75.48 -40.41 57.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -1.198 . . . . 0.0 109.669 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -56.96 -20.75 25.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.325 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.57 72.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.88 . . . . 0.0 109.483 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.865 HD11 ' CG ' ' A' ' 58' ' ' HIS . 78.4 mt -64.41 -61.17 2.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.63 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.01 -12.66 12.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.631 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.518 ' NH2' ' CB ' ' B' ' 127' ' ' GLN . 6.2 tpm_? -74.35 -53.34 9.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -84.18 -28.74 27.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.918 . . . . 0.0 110.084 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -46.37 -37.77 7.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 110.042 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.747 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -96.61 -36.92 10.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 110.268 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.8 m -44.43 -25.88 0.29 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 110.028 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.551 ' CG ' ' O ' ' A' ' 35' ' ' SER . 50.9 m-85 -162.46 139.11 5.97 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.169 -0.957 . . . . 0.0 109.287 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 40' ' ' LYS . 55.9 Cg_endo -71.98 -34.02 9.02 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.596 2.197 . . . . 0.0 111.984 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.965 ' HA ' ' HB3' ' D' ' 97' ' ' HIS . 76.6 p -47.51 -18.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 109.509 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 37' ' ' PRO . 25.7 p -84.85 -27.99 26.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 109.446 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 37' ' ' PRO . 82.7 mttt -71.43 -25.3 62.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.676 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 38' ' ' THR . 15.1 t . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.169 -0.957 . . . . 0.0 109.529 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.566 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 14.9 p80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.13 0.491 . . . . 0.0 110.641 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -144.95 25.45 1.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.49 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.453 ' C ' ' N ' ' A' ' 49' ' ' SER . 2.4 m-20 43.97 84.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.463 -0.773 . . . . 0.0 109.791 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.675 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -51.82 -11.36 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.453 ' N ' ' C ' ' A' ' 47' ' ' ASP . 28.3 p -49.01 158.48 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -77.47 148.24 35.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.455 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.24 16.92 78.94 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 54.6 p -74.42 -17.06 60.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -1.154 . . . . 0.0 109.485 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.41 -39.54 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.338 -0.851 . . . . 0.0 109.641 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 52' ' ' SER . 56.6 mt-30 -65.87 -42.11 90.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.45 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.551 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 93.5 t -66.4 -44.67 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.298 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -39.4 67.0 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.15 -26.58 72.5 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.865 ' CG ' HD11 ' A' ' 29' ' ' LEU . 4.5 t-80 -68.15 -43.29 78.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -1.218 . . . . 0.0 109.317 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.75 -46.07 24.66 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -48.52 -23.66 1.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -1.047 . . . . 0.0 109.268 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -75.41 -38.94 59.56 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.283 -0.886 . . . . 0.0 108.672 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.49 -48.95 44.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.29 -32.86 74.74 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 109.083 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 68' ' ' ASN . 5.8 t0 -63.74 -36.49 84.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.238 -0.914 . . . . 0.0 108.626 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.55 -52.77 34.86 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.01 -41.01 91.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.4 m -71.87 -50.2 31.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' ASP . 49.4 t30 -60.16 -24.3 64.62 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.616 ' HB1' ' SD ' ' A' ' 76' ' ' MET . . . -82.29 -46.69 13.31 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.11 -22.97 32.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.4 -14.92 63.34 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.606 ' O ' ' N ' ' A' ' 74' ' ' ASP . 35.5 m-70 -138.36 -62.97 0.56 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.517 -0.739 . . . . 0.0 109.287 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 73' ' ' VAL . 13.1 p 44.28 14.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.928 0.87 . . . . 0.0 109.37 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 72' ' ' HIS . 39.8 t0 -138.14 11.61 2.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.432 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.0 OUTLIER 174.92 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.246 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.685 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 14.3 ptt? -78.74 -22.68 0.39 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 111.981 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 76' ' ' MET . 59.5 Cg_exo -52.01 -19.67 9.02 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.705 1.603 . . . . 0.0 112.51 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -94.12 -35.76 12.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 109.764 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.96 -38.4 69.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.963 . . . . 0.0 109.285 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.79 11.49 15.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.392 -0.818 . . . . 0.0 109.049 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.3 p -68.08 -15.92 63.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 109.763 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -72.69 -55.8 6.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.031 . . . . 0.0 109.878 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 86' ' ' LEU . 6.1 mt -44.88 -47.26 11.15 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.81 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 62.6 m -46.79 -33.05 4.1 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' ALA . 1.5 m-20 -82.11 -17.32 46.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.188 -0.945 . . . . 0.0 109.558 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 83' ' ' LEU . 8.6 tp -74.06 -53.44 9.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.1 -1.0 . . . . 0.0 110.261 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.435 ' CE1' ' O ' ' A' ' 83' ' ' LEU . 6.0 p-80 -92.2 -21.66 20.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.975 -1.078 . . . . 0.0 110.643 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -97.27 -0.61 46.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.9 -1.125 . . . . 0.0 110.404 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 88' ' ' ALA . 70.9 m80 -154.91 42.94 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.787 -1.195 . . . . 0.0 110.256 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -172.39 -63.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.967 . . . . 0.0 109.329 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.1 mt -90.59 -23.79 20.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 53.99 53.3 11.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.665 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 94' ' ' ASP . 2.3 t -79.87 -136.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 109.447 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 96' ' ' VAL . 5.2 t70 -172.3 137.11 0.89 Allowed Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 109.234 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 98' ' ' PHE . 85.6 Cg_exo -41.86 -10.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.544 2.163 . . . . 0.0 112.639 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 94' ' ' ASP . 60.1 t -43.75 -28.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 109.955 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.19 -24.95 42.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 95' ' ' PRO . 38.4 t80 -44.96 -32.47 1.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.913 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.49 -27.22 27.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.007 . . . . 0.0 109.898 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.16 -62.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.036 -1.04 . . . . 0.0 110.024 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.7 tp -55.74 -20.96 16.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 109.878 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.8 p -78.44 -50.37 11.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.051 -1.031 . . . . 0.0 109.843 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -76.4 -26.6 55.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -0.952 . . . . 0.0 109.808 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 55.6 m -58.81 -50.92 72.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.777 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.35 -35.88 13.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 109.63 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.792 HD12 ' CE1' ' A' ' 122' ' ' HIS . 3.7 mm? -69.99 -59.17 3.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.079 -1.013 . . . . 0.0 109.895 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.8 t -50.08 -36.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.478 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 p -70.56 -63.11 1.16 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.264 -0.897 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' LEU . 17.5 mt -50.47 -31.42 15.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 -47.13 50.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.224 -0.923 . . . . 0.0 109.609 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.24 -41.35 22.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.89 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -80.1 -72.08 0.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.115 -0.991 . . . . 0.0 109.986 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -113.87 91.51 22.19 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 109.076 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 113' ' ' LEU . 84.7 Cg_exo -46.22 -175.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.329 2.019 . . . . 0.0 112.84 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.494 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.29 -42.21 13.94 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.636 0.732 . . . . 0.0 109.406 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER 85.0 3.66 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.897 ' CZ ' ' CE1' ' B' ' 116' ' ' HIS . 8.0 m-85 65.12 36.6 7.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.791 -0.568 . . . . 0.0 111.279 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.716 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -91.16 121.51 67.68 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.798 -1.189 . . . . 0.0 108.197 178.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.95 22.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.14 1.893 . . . . 0.0 112.656 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.716 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -151.23 -33.56 0.15 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.772 -1.205 . . . . 0.0 110.785 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.668 HG13 ' N ' ' A' ' 122' ' ' HIS . 11.4 p -46.63 -47.84 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.932 -1.105 . . . . 0.0 110.061 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.792 ' CE1' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -72.78 -33.51 66.34 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.555 -0.716 . . . . 0.0 109.349 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.06 -19.81 36.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 110.023 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 120' ' ' ALA . 10.2 p -65.95 -62.47 1.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.202 -0.936 . . . . 0.0 110.84 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.513 ' N ' ' OG ' ' A' ' 124' ' ' SER . 9.3 mt -70.18 -19.42 63.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.07 -1.019 . . . . 0.0 109.789 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -78.93 -45.43 20.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.046 -1.034 . . . . 0.0 110.219 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.445 ' CD ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -88.23 -43.24 11.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.988 -1.07 . . . . 0.0 110.14 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 10' ' ' VAL . 70.2 t80 -50.17 -21.02 1.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.957 -1.089 . . . . 0.0 109.271 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.4 mt -69.73 -17.7 63.47 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.25 -33.51 72.4 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.492 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 5.1 t -83.08 -30.41 28.0 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.417 -0.802 . . . . 0.0 108.992 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.5 t -85.41 -27.63 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 109.078 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 129' ' ' LEU . 77.9 p -83.75 -25.97 30.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.119 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.9 m -78.09 -36.94 47.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.213 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 131' ' ' SER . 33.3 m -76.57 -21.86 15.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.266 -0.896 . . . . 0.0 108.883 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.48 -37.87 68.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.451 -0.781 . . . . 0.0 108.985 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.5 p -89.14 -1.38 58.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.594 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.428 -179.889 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . 0.415 ' O ' ' CG ' ' B' ' 2' ' ' HIS . 12.3 t-80 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 1.046 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -106.29 162.45 13.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.433 -0.792 . . . . 0.0 109.261 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.434 ' O ' ' N ' ' B' ' 7' ' ' GLU . 0.7 OUTLIER -84.61 150.93 57.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 109.109 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.01 -30.73 1.32 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.434 2.089 . . . . 0.0 112.026 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.36 -21.84 25.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.925 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 4' ' ' THR . 44.5 tt0 -77.11 -63.09 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.174 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.506 ' HB3' HD22 ' B' ' 3' ' ' LEU . 10.4 pttt -67.53 -25.73 65.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.963 . . . . 0.0 110.175 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -43.8 -24.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 110.134 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.18 -56.23 3.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.087 -1.008 . . . . 0.0 109.751 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.404 ' H ' HG12 ' B' ' 11' ' ' VAL . 0.9 OUTLIER -71.04 -24.74 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.7 m -68.35 -39.12 81.98 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.351 0.596 . . . . 0.0 109.805 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.4 -31.23 57.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.847 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.3 -21.86 6.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.341 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . 0.557 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.2 OUTLIER -56.31 -38.27 71.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 109.234 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.21 -40.26 61.48 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -26.19 66.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -1.143 . . . . 0.0 109.178 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.16 121.0 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 109.666 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' B' ' 21' ' ' ASP . 59.6 t30 -80.04 71.83 6.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.0 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 82.8 t -45.89 -15.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 109.779 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 19' ' ' ASN . 34.8 m-20 -69.22 -4.09 16.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.624 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' B' ' 25' ' ' GLY . 47.9 mt-10 -155.79 -46.9 0.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.156 -0.965 . . . . 0.0 109.574 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -47.11 -23.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 109.723 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.95 -31.15 40.28 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -73.55 -39.52 49.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -70.24 -38.86 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 0.0 109.486 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.07 -30.25 61.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.556 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tp -81.47 -58.04 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.482 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.71 85.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -55.93 -39.35 71.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -1.126 . . . . 0.0 109.62 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.61 -35.98 4.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -81.19 -29.91 34.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 109.752 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.03 -64.48 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.425 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 34' ' ' VAL . 0.0 OUTLIER -63.97 -22.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.224 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -149.62 81.92 6.97 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.92 . . . . 0.0 109.562 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.95 9.85 3.15 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.562 2.175 . . . . 0.0 112.23 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' B' ' 38' ' ' THR . 0.4 OUTLIER -80.96 -19.96 42.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 109.694 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.554 ' N ' ' CD1' ' B' ' 37' ' ' TRP . 7.2 m -87.95 57.94 4.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.479 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -117.61 23.82 11.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.41 -0.807 . . . . 0.0 109.332 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -87.34 -39.76 15.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.958 . . . . 0.0 109.554 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -100.01 34.82 2.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 109.463 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' CE1' ' B' ' 45' ' ' PHE . 0.9 OUTLIER -143.32 15.04 1.84 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.222 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.49 -14.09 61.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.408 ' C ' ' N ' ' B' ' 46' ' ' GLY . 5.3 m -69.14 -46.92 66.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.477 ' CE1' ' CD2' ' B' ' 42' ' ' PHE . 80.1 m-85 -50.17 -16.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 45' ' ' PHE . . . 51.3 179.61 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 38.0 t0 55.86 71.28 0.56 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -1.178 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 27.9 mt -131.21 35.05 3.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 109.379 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m -51.89 -49.29 63.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.27 160.17 46.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 108.837 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.4 -17.32 4.14 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.079 1.853 . . . . 0.0 111.972 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.418 ' C ' ' N ' ' B' ' 54' ' ' VAL . 19.6 t70 -83.26 -51.56 7.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.556 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.95 -20.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.431 -0.793 . . . . 0.0 109.471 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.418 ' N ' ' C ' ' B' ' 52' ' ' ASP . 57.8 t -73.01 -57.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mtt -59.98 -16.73 32.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.53 -26.62 71.29 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -78.79 132.22 65.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.152 -1.205 . . . . 0.0 109.327 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.02 -30.89 4.09 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.341 2.028 . . . . 0.0 112.34 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -70.41 -30.13 66.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.85 -40.68 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.516 ' NZ ' ' CB ' ' B' ' 61' ' ' LYS . 8.1 mtmp? -65.45 -37.43 86.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 109.68 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.96 -51.04 67.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -55.82 -23.79 32.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.01 -48.94 65.33 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -52.29 -25.03 8.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -1.188 . . . . 0.0 109.587 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -61.94 1.7 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 109.491 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 t -52.18 -39.33 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.684 ' O ' HD23 ' B' ' 68' ' ' LEU . 8.0 tt -70.16 -37.41 75.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.903 . . . . 0.0 109.343 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.89 -44.08 61.25 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.53 71.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 109.787 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . 0.418 ' O ' ' CD2' ' B' ' 75' ' ' LEU . 1.3 m-85 -66.3 -29.1 69.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . 0.557 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.8 t -66.21 -33.77 76.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.515 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.17 -16.76 56.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.173 -0.954 . . . . 0.0 109.159 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.67 -19.76 63.15 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.838 HD23 ' N ' ' B' ' 75' ' ' LEU . 1.5 pt? -137.78 -28.44 0.89 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -1.181 . . . . 0.0 109.952 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' B' ' 72' ' ' SER . . . -80.1 19.02 0.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 109.586 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -171.55 70.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.465 HD21 ' HA ' ' B' ' 75' ' ' LEU . 70.5 mt -80.85 0.72 33.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.975 . . . . 0.0 109.492 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -54.04 -38.33 65.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.465 HD22 ' C ' ' B' ' 80' ' ' ASN . 0.3 OUTLIER -172.09 73.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.361 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.448 HD12 ' N ' ' B' ' 82' ' ' LYS . 2.2 pp -76.74 -41.73 43.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.628 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.448 ' N ' HD12 ' B' ' 81' ' ' LEU . 53.1 mttp -50.82 -27.2 6.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.096 -1.002 . . . . 0.0 109.41 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' B' ' 86' ' ' ALA . . . -83.19 -57.54 2.48 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.6 OUTLIER -47.86 -39.71 19.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -1.164 . . . . 0.0 109.557 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.459 ' CZ ' HG13 ' B' ' 137' ' ' VAL . 25.1 m-85 -69.83 -11.96 61.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.382 -0.824 . . . . 0.0 109.429 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' B' ' 83' ' ' GLY . . . -54.57 -43.72 72.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.438 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 11.4 p -64.38 -59.24 4.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' B' ' 88' ' ' LEU . 19.5 mt -54.97 -35.39 64.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.349 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -72.76 -46.43 53.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.337 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.54 -24.54 67.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.42 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.19 -68.36 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.557 ' O ' ' N ' ' B' ' 97' ' ' HIS . 75.1 m80 -54.35 -25.83 26.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 110.491 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.89 -60.66 2.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.013 -1.054 . . . . 0.0 111.501 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.561 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 11.8 m-20 -86.99 -39.75 15.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.92 -1.112 . . . . 0.0 111.701 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -83.17 -10.15 58.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.078 . . . . 0.0 111.07 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.519 HD13 ' O ' ' B' ' 96' ' ' LEU . 0.2 OUTLIER -137.9 -43.78 0.52 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.886 -1.134 . . . . 0.0 110.068 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.92 ' HB3' ' HA ' ' C' ' 38' ' ' THR . 4.1 m80 72.95 58.57 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.246 -0.909 . . . . 0.0 109.575 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 79.1 t -82.64 114.21 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.09 -1.006 . . . . 0.0 109.434 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.74 154.45 2.37 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.27 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.402 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 47.2 Cg_endo -70.09 -164.3 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.573 2.182 . . . . 0.0 112.149 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 53.31 51.97 14.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' B' ' 100' ' ' PRO . 31.0 m120 -158.25 -36.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.24 -37.57 85.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -72.94 -26.39 61.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.483 HD23 ' O ' ' B' ' 105' ' ' LEU . 1.3 tt -65.62 -55.49 17.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.402 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 tt -50.37 -47.0 56.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.24 -47.88 72.07 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.51 -50.29 65.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -1.161 . . . . 0.0 109.607 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 80.5 t -53.76 -38.5 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.17 -0.956 . . . . 0.0 109.524 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.96 -33.91 76.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.405 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.9 -26.24 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 60.7 m -79.27 -61.04 2.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.731 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . 0.407 HG23 ' H ' ' B' ' 113' ' ' VAL . 4.9 t -46.25 -30.0 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 31.9 mt -79.84 -31.45 40.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.601 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -82.26 -20.38 37.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.897 ' CE1' ' CZ ' ' A' ' 117' ' ' PHE . 11.0 t-80 -74.95 -55.73 5.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.531 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -74.46 -17.73 60.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.625 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -146.53 58.96 1.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.436 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -74.83 -21.92 77.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -72.89 -33.73 66.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -1.153 . . . . 0.0 109.433 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' B' ' 123' ' ' THR . 57.7 mm-40 -81.46 -4.52 56.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.8 34.33 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.36 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.468 ' H ' ' C ' ' B' ' 121' ' ' GLU . 28.7 p -48.4 148.45 3.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 109.096 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.507 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.3 Cg_exo -45.28 -52.85 6.04 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.196 1.931 . . . . 0.0 112.779 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 36.4 Cg_endo -65.68 13.67 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.053 1.835 . . . . 0.0 112.324 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.461 HG23 ' OG1' ' B' ' 123' ' ' THR . 90.2 t -124.87 -21.42 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . 0.549 HE22 ' CG ' ' B' ' 131' ' ' GLN . 18.2 tm0? -83.15 -42.9 16.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.747 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -62.01 -44.21 97.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.587 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.75 -7.17 25.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.692 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -92.43 -30.12 15.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 109.603 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.549 ' CG ' HE22 ' B' ' 127' ' ' GLN . 15.6 mm100 -81.45 -38.33 26.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.592 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -68.14 -49.43 61.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 109.646 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 2.6 p -58.47 -48.22 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.898 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.567 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 88.8 t -73.38 -34.57 43.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.842 ' CB ' ' O ' ' D' ' 146' ' ' HIS . . . -47.41 -22.28 0.42 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.35 -22.03 61.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.459 HG13 ' CZ ' ' B' ' 85' ' ' PHE . 85.9 t -77.84 -26.09 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -1.154 . . . . 0.0 109.541 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.08 -46.58 61.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -74.69 -21.17 59.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.36 -59.63 3.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.524 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -58.58 -24.9 61.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.23 22.36 4.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -77.25 -31.93 55.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.588 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.449 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 0.1 OUTLIER -79.55 -27.3 41.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.321 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -65.99 3.68 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.799 ' O ' ' CB ' ' D' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.427 ' CG2' ' OG ' ' C' ' 131' ' ' SER . 16.9 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.436 HD13 ' CD1' ' C' ' 128' ' ' PHE . 25.3 mt -136.96 -161.06 1.12 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.317 -0.865 . . . . 0.0 109.364 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.46 ' N ' ' OD2' ' C' ' 6' ' ' ASP . 0.3 OUTLIER -133.22 174.44 4.7 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.848 . . . . 0.0 109.199 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.22 -70.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.65 2.233 . . . . 0.0 112.638 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.45 ' O ' ' ND2' ' C' ' 9' ' ' ASN . . . -48.62 -44.12 36.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.161 -0.962 . . . . 0.0 109.88 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.563 ' O ' HG23 ' C' ' 10' ' ' VAL . 1.3 m-20 -42.33 -35.77 1.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.88 . . . . 0.0 109.44 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' C' ' 10' ' ' VAL . 69.5 mttt -83.32 -56.42 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.827 . . . . 0.0 109.571 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 94.9 m -45.45 -35.62 3.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.406 -0.809 . . . . 0.0 109.906 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' C' ' 5' ' ' ALA . 8.9 m-20 -74.51 -33.5 62.82 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.563 HG23 ' O ' ' C' ' 6' ' ' ASP . 76.2 t -76.37 -49.25 25.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.52 -40.04 65.14 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.95 -61.63 2.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.473 -0.767 . . . . 0.0 109.408 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.644 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.59 -38.51 66.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.842 . . . . 0.0 109.145 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -17.52 62.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 108.959 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.54 -46.71 7.8 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -68.63 -36.79 79.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -1.138 . . . . 0.0 108.828 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.644 HG23 ' O ' ' C' ' 13' ' ' ALA . 71.0 t -61.96 -66.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 61.93 -141.15 47.27 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.07 39.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.476 -1.014 . . . . 0.0 110.36 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' C' ' 18' ' ' GLY . 87.6 m-70 -142.96 20.43 1.96 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.72 -61.15 1.95 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.635 -0.666 . . . . 0.0 109.649 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -13.9 0.2 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' C' ' 21' ' ' ALA . 10.3 mm-40 -85.02 -56.3 3.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -1.172 . . . . 0.0 109.544 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 1.8 m-30 -61.75 -30.91 71.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.852 . . . . 0.0 109.186 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.26 -29.5 75.02 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' C' ' 55' ' ' VAL . . . -75.54 -40.29 57.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -1.179 . . . . 0.0 109.676 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -56.9 -20.83 25.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.342 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -31.58 72.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.905 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.86 HD11 ' CG ' ' C' ' 58' ' ' HIS . 78.4 mt -64.34 -61.3 2.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.57 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.97 -12.7 12.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.93 . . . . 0.0 109.563 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.508 ' NH2' ' CB ' ' D' ' 127' ' ' GLN . 6.2 tpm_? -74.34 -53.27 10.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.133 -0.979 . . . . 0.0 109.818 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -84.22 -28.72 27.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.943 . . . . 0.0 110.101 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -46.37 -37.8 8.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.119 -0.988 . . . . 0.0 110.022 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.76 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -96.57 -36.95 10.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.204 -0.935 . . . . 0.0 110.3 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.7 m -44.4 -25.91 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' C' ' 35' ' ' SER . 51.1 m-85 -162.44 139.11 5.99 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.114 -0.992 . . . . 0.0 109.286 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' C' ' 40' ' ' LYS . 56.0 Cg_endo -71.96 -34.15 8.89 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.647 2.231 . . . . 0.0 111.986 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.92 ' HA ' ' HB3' ' B' ' 97' ' ' HIS . 76.7 p -47.42 -18.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.437 ' N ' ' O ' ' C' ' 37' ' ' PRO . 25.8 p -84.9 -28.04 26.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' C' ' 37' ' ' PRO . 82.7 mttt -71.42 -25.3 62.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.908 . . . . 0.0 109.702 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.653 HG22 ' O ' ' C' ' 38' ' ' THR . 15.1 t . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 109.466 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.564 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 14.8 p80 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.013 0.435 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -144.95 25.56 1.42 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.14 -0.975 . . . . 0.0 109.582 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.445 ' C ' ' N ' ' C' ' 49' ' ' SER . 2.4 m-20 44.0 84.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.507 -0.746 . . . . 0.0 109.817 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.672 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -51.81 -11.41 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.375 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.445 ' N ' ' C ' ' C' ' 47' ' ' ASP . 28.1 p -48.94 158.52 0.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.627 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -77.52 148.34 35.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.21 16.9 79.01 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 55.2 p -74.43 -17.03 60.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -1.167 . . . . 0.0 109.475 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 67.35 -39.46 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.373 -0.829 . . . . 0.0 109.629 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.529 ' H ' ' C ' ' C' ' 52' ' ' SER . 56.6 mt-30 -65.95 -42.07 90.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 109.409 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.557 ' O ' ' HB1' ' C' ' 26' ' ' ALA . 93.4 t -66.39 -44.74 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.178 -0.951 . . . . 0.0 109.274 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -39.39 67.13 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.16 -26.55 72.51 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.86 ' CG ' HD11 ' C' ' 29' ' ' LEU . 4.4 t-80 -68.25 -43.24 78.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -1.202 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.83 -46.06 25.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -48.48 -23.62 1.02 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.377 -1.072 . . . . 0.0 109.272 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -75.45 -38.92 59.38 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.264 -0.898 . . . . 0.0 108.659 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.44 -49.04 44.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.2 -32.93 74.87 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.358 -0.839 . . . . 0.0 109.077 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' C' ' 68' ' ' ASN . 5.9 t0 -63.71 -36.43 83.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.171 -0.956 . . . . 0.0 108.637 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.68 -52.61 35.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.13 -40.98 91.66 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.2 m -71.85 -50.29 30.79 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' C' ' 64' ' ' ASP . 49.5 t30 -60.17 -24.16 64.52 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.614 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -82.28 -46.84 13.12 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.02 -22.92 32.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.41 -15.01 63.4 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.611 ' O ' ' N ' ' C' ' 74' ' ' ASP . 35.2 m-70 -138.3 -62.97 0.56 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.502 -0.749 . . . . 0.0 109.356 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.572 HG22 ' O ' ' C' ' 73' ' ' VAL . 13.1 p 44.24 14.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.937 0.875 . . . . 0.0 109.399 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' C' ' 72' ' ' HIS . 39.7 t0 -138.19 11.57 2.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 1.0 OUTLIER 174.95 29.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.683 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 14.3 ptt? -78.67 -22.77 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 111.898 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' C' ' 76' ' ' MET . 60.3 Cg_exo -52.05 -19.66 9.13 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.652 1.568 . . . . 0.0 112.521 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -94.02 -35.78 12.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.789 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.95 -38.39 69.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.078 -1.013 . . . . 0.0 109.317 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.81 11.46 15.46 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.423 -0.798 . . . . 0.0 109.047 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 68.4 p -68.05 -15.87 63.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.755 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -72.69 -55.84 6.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.886 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' C' ' 86' ' ' LEU . 6.1 mt -44.84 -47.26 11.03 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.794 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 62.4 m -46.87 -32.96 4.11 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' C' ' 82' ' ' ALA . 1.5 m-20 -82.16 -17.21 47.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.615 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' C' ' 83' ' ' LEU . 8.6 tp -74.11 -53.42 9.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 0.0 110.346 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . 0.437 ' CE1' ' O ' ' C' ' 83' ' ' LEU . 6.0 p-80 -92.18 -21.68 20.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.889 -1.132 . . . . 0.0 110.655 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -97.24 -0.63 46.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.864 -1.148 . . . . 0.0 110.4 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' C' ' 88' ' ' ALA . 70.7 m80 -154.93 42.95 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 110.227 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -172.39 -63.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 109.326 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 46.4 mt -90.66 -23.72 20.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 109.323 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 53.95 53.33 11.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 0.0 109.639 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.512 HG12 ' H ' ' C' ' 94' ' ' ASP . 2.3 t -79.9 -136.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 0.0 109.466 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' C' ' 96' ' ' VAL . 5.2 t70 -172.23 137.11 0.9 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.183 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' C' ' 98' ' ' PHE . 86.2 Cg_exo -41.75 -11.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.616 2.211 . . . . 0.0 112.627 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' C' ' 94' ' ' ASP . 59.1 t -43.65 -28.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.2 -24.96 42.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.542 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' C' ' 95' ' ' PRO . 38.4 t80 -44.98 -32.47 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 109.953 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.41 -27.23 27.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 0.0 109.977 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 mt -84.19 -62.25 1.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.993 -1.067 . . . . 0.0 109.94 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 36.9 tp -55.79 -20.91 16.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.914 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 17.0 p -78.42 -50.38 11.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 109.903 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -76.38 -26.58 55.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.836 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 55.7 m -58.66 -51.02 71.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.768 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.36 -35.88 13.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 109.618 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.786 HD12 ' CE1' ' C' ' 122' ' ' HIS . 3.7 mm? -70.02 -59.16 3.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.146 -0.971 . . . . 0.0 109.863 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 47.9 t -50.2 -36.77 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.962 . . . . 0.0 109.449 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 5.0 p -70.57 -63.09 1.16 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.224 -0.923 . . . . 0.0 109.417 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' C' ' 113' ' ' LEU . 17.6 mt -50.47 -31.55 15.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.334 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.51 -47.19 48.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.945 . . . . 0.0 109.631 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.32 -41.31 22.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.837 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -80.08 -72.13 0.42 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 110.003 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -113.86 91.56 22.31 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' C' ' 113' ' ' LEU . 84.5 Cg_exo -46.17 -175.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.447 2.098 . . . . 0.0 112.825 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.3 -42.21 13.92 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.555 -0.716 . . . . 0.0 109.393 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 0.0 OUTLIER 85.02 3.56 0.65 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.904 ' CZ ' ' CE1' ' D' ' 116' ' ' HIS . 8.1 m-85 65.1 36.74 7.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.798 -0.564 . . . . 0.0 111.225 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.718 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -91.06 121.59 67.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.719 -1.238 . . . . 0.0 108.179 178.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.15 22.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.11 1.874 . . . . 0.0 112.57 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.718 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -151.17 -33.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.963 -1.086 . . . . 0.0 110.84 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.649 HG13 ' N ' ' C' ' 122' ' ' HIS . 11.5 p -46.63 -47.86 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.013 -1.055 . . . . 0.0 110.005 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.786 ' CE1' HD12 ' C' ' 106' ' ' LEU . 0.3 OUTLIER -72.79 -33.5 66.31 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.51 -0.744 . . . . 0.0 109.307 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.11 -19.75 36.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.826 . . . . 0.0 110.059 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.6 ' N ' ' O ' ' C' ' 120' ' ' ALA . 10.2 p -66.04 -62.47 1.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.947 . . . . 0.0 110.783 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.524 ' N ' ' OG ' ' C' ' 124' ' ' SER . 9.4 mt -70.14 -19.4 63.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.047 -1.033 . . . . 0.0 109.885 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.92 -45.34 20.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.01 -1.056 . . . . 0.0 110.306 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.451 ' CD ' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -88.31 -43.19 11.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.0 110.18 -179.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.46 ' CD1' HG21 ' C' ' 10' ' ' VAL . 70.1 t80 -50.23 -21.03 1.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.911 -1.118 . . . . 0.0 109.316 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.6 mt -69.59 -17.77 63.57 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.21 -33.56 72.42 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.501 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 5.1 t -83.06 -30.41 28.04 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.349 -0.844 . . . . 0.0 108.988 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 72.7 t -85.41 -27.67 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.072 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.518 ' N ' ' O ' ' C' ' 129' ' ' LEU . 76.9 p -83.65 -26.01 30.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.817 . . . . 0.0 109.152 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 47.5 m -78.11 -36.91 47.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.343 -0.848 . . . . 0.0 109.183 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.458 HG13 ' O ' ' C' ' 131' ' ' SER . 33.4 m -76.49 -21.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.267 -0.895 . . . . 0.0 108.888 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -37.79 68.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 109.013 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 58.2 p -89.29 -1.23 57.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 1.147 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -106.38 162.49 13.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.469 -0.77 . . . . 0.0 109.28 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.438 ' O ' ' N ' ' D' ' 7' ' ' GLU . 0.7 OUTLIER -84.69 151.01 57.67 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 109.06 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -42.09 -30.62 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.33 2.02 . . . . 0.0 112.103 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.41 -21.82 25.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.891 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' D' ' 4' ' ' THR . 44.6 tt0 -77.12 -63.02 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.126 -0.984 . . . . 0.0 110.164 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.496 ' HB3' HD22 ' D' ' 3' ' ' LEU . 10.4 pttt -67.64 -25.71 65.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.163 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . 0.409 ' C ' ' O ' ' D' ' 8' ' ' LYS . 0.4 OUTLIER -43.73 -24.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.23 -56.21 3.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.094 -1.004 . . . . 0.0 109.75 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.435 ' H ' HG12 ' D' ' 11' ' ' VAL . 0.9 OUTLIER -71.06 -24.78 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 25.4 m -68.26 -39.23 82.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.357 0.599 . . . . 0.0 109.844 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.18 -31.36 58.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.923 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -21.77 6.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 0.0 109.31 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . 0.551 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.2 OUTLIER -56.34 -38.37 71.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.983 . . . . 0.0 109.151 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.23 -40.2 61.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -26.07 66.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -1.096 . . . . 0.0 109.198 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.11 121.06 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.607 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' D' ' 21' ' ' ASP . 59.6 t30 -80.12 71.75 6.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.278 -0.889 . . . . 0.0 109.023 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 80.1 t -45.82 -15.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 0.0 109.793 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' D' ' 19' ' ' ASN . 35.2 m-20 -69.28 -4.02 16.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' D' ' 25' ' ' GLY . 47.9 mt-10 -155.8 -46.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -47.06 -23.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.683 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.86 -31.22 40.44 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -73.54 -39.48 49.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -70.21 -38.86 75.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -1.146 . . . . 0.0 109.56 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.04 -30.24 61.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tp -81.46 -58.09 3.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.973 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.7 85.07 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -55.98 -39.4 71.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -1.142 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.59 -35.99 4.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.602 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 mt -81.22 -29.82 34.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.787 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 66.8 t -66.01 -64.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 109.497 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.419 ' H ' HG23 ' D' ' 34' ' ' VAL . 0.0 OUTLIER -64.06 -22.6 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 109.232 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -149.6 81.8 7.03 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.618 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.05 9.98 3.13 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.552 2.168 . . . . 0.0 112.173 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . 0.568 ' CD1' ' N ' ' D' ' 38' ' ' THR . 0.4 OUTLIER -80.97 -20.02 42.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.568 ' N ' ' CD1' ' D' ' 37' ' ' TRP . 7.3 m -88.0 58.08 4.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 109.472 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -117.66 23.72 11.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.431 -0.793 . . . . 0.0 109.324 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -87.31 -39.72 15.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 109.552 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -100.01 34.75 2.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.223 -0.923 . . . . 0.0 109.432 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.487 ' CD2' ' CE1' ' D' ' 45' ' ' PHE . 0.9 OUTLIER -143.3 15.12 1.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 109.222 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' D' ' 43' ' ' GLU . 7.2 pt-20 -72.47 -14.15 61.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.583 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' D' ' 46' ' ' GLY . 5.3 m -69.04 -46.9 66.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.487 ' CE1' ' CD2' ' D' ' 42' ' ' PHE . 80.0 m-85 -50.23 -16.16 0.3 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' D' ' 44' ' ' SER . . . 51.26 179.58 0.04 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 55.95 71.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -1.153 . . . . 0.0 109.481 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 27.6 mt -131.26 35.11 3.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 109.391 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 13.4 m -51.92 -49.37 63.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.937 . . . . 0.0 109.49 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.21 160.22 46.55 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.327 -0.858 . . . . 0.0 108.832 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.42 -17.3 4.18 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.112 1.874 . . . . 0.0 111.946 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . 0.416 ' C ' ' N ' ' D' ' 54' ' ' VAL . 19.5 t70 -83.26 -51.51 7.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.345 -0.847 . . . . 0.0 109.593 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.07 -19.84 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 109.437 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' D' ' 52' ' ' ASP . 58.5 t -73.2 -57.86 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mtt -60.07 -16.65 33.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 0.0 109.41 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.5 -26.72 71.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -78.74 132.27 65.16 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.226 -1.161 . . . . 0.0 109.321 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.98 -31.02 4.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.365 2.043 . . . . 0.0 112.299 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -70.38 -30.11 66.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.616 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.83 -40.64 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 109.602 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . 0.512 ' NZ ' ' CB ' ' D' ' 61' ' ' LYS . 8.1 mtmp? -65.53 -37.43 86.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.681 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.94 -51.06 67.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -55.7 -23.94 31.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.073 -1.017 . . . . 0.0 109.455 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.03 -48.87 65.98 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -52.4 -24.9 8.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -1.233 . . . . 0.0 109.522 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.48 -62.0 1.67 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.259 -0.9 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 t -52.17 -39.33 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.686 ' O ' HD23 ' D' ' 68' ' ' LEU . 8.0 tt -70.09 -37.46 75.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.326 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.85 -44.14 61.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.43 71.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -1.155 . . . . 0.0 109.803 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . 0.413 ' O ' ' CD2' ' D' ' 75' ' ' LEU . 1.3 m-85 -66.29 -29.14 69.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.077 -1.015 . . . . 0.0 109.537 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . 0.551 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 8.8 t -66.36 -33.57 76.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.31 -16.7 55.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.14 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.62 -19.86 63.17 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.859 ' H ' HD23 ' D' ' 75' ' ' LEU . 1.5 pt? -137.66 -28.44 0.9 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.21 -1.17 . . . . 0.0 109.931 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' D' ' 72' ' ' SER . . . -80.05 19.0 0.75 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.095 -1.003 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -171.58 70.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' D' ' 75' ' ' LEU . 70.4 mt -80.87 0.66 34.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.425 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -53.99 -38.41 65.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 109.32 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.466 HD22 ' C ' ' D' ' 80' ' ' ASN . 0.3 OUTLIER -172.03 73.18 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.371 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . 0.446 HD12 ' N ' ' D' ' 82' ' ' LYS . 2.2 pp -76.72 -41.62 44.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . 0.446 ' N ' HD12 ' D' ' 81' ' ' LEU . 53.1 mttp -50.93 -27.12 6.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.08 -1.013 . . . . 0.0 109.426 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' D' ' 86' ' ' ALA . . . -83.22 -57.63 2.46 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.6 OUTLIER -47.64 -39.83 18.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -1.159 . . . . 0.0 109.584 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.459 ' CZ ' HG13 ' D' ' 137' ' ' VAL . 25.1 m-85 -69.78 -12.09 61.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.326 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' D' ' 83' ' ' GLY . . . -54.49 -43.69 72.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.154 -0.966 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 11.3 p -64.42 -59.22 4.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 109.384 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.7 mt -54.92 -35.51 64.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.304 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -72.73 -46.46 53.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.907 . . . . 0.0 109.314 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.52 -24.47 67.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.872 . . . . 0.0 109.452 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.31 -68.2 0.71 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.556 ' O ' ' N ' ' D' ' 97' ' ' HIS . 75.1 m80 -54.57 -25.67 27.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 110.493 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.92 -60.61 2.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.017 -1.052 . . . . 0.0 111.594 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.553 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 11.9 m-20 -87.07 -39.64 15.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.996 -1.065 . . . . 0.0 111.693 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -83.17 -10.2 58.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.913 -1.117 . . . . 0.0 111.11 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.529 HD13 ' O ' ' D' ' 96' ' ' LEU . 0.2 OUTLIER -137.89 -43.85 0.53 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.869 -1.144 . . . . 0.0 109.971 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.965 ' HB3' ' HA ' ' A' ' 38' ' ' THR . 4.1 m80 73.11 58.5 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.87 . . . . 0.0 109.509 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . 0.401 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 79.3 t -82.66 114.21 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 109.421 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.76 154.45 2.38 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.264 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.1 -164.4 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.61 2.206 . . . . 0.0 112.153 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 53.32 52.03 14.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.485 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -158.28 -36.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.34 -37.55 86.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -72.88 -26.43 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . 0.483 HD23 ' O ' ' D' ' 105' ' ' LEU . 1.3 tt -65.6 -55.58 16.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.357 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 tt -50.41 -46.98 56.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.919 . . . . 0.0 109.356 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.15 -47.93 71.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.43 -50.28 65.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -1.157 . . . . 0.0 109.616 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 80.5 t -53.85 -38.53 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 109.498 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.96 -33.87 76.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.423 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.95 -26.11 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.552 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 60.7 m -79.31 -61.0 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 109.738 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . 0.431 HG23 ' H ' ' D' ' 113' ' ' VAL . 4.9 t -46.34 -29.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 109.815 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 32.1 mt -79.76 -31.56 40.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -82.12 -20.47 37.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.897 . . . . 0.0 109.494 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.904 ' CE1' ' CZ ' ' C' ' 117' ' ' PHE . 11.0 t-80 -75.0 -55.72 5.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.176 -0.952 . . . . 0.0 109.471 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -74.53 -17.75 60.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.544 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -146.54 59.01 1.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -74.81 -22.0 77.66 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -72.87 -33.73 66.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -1.197 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' D' ' 123' ' ' THR . 57.4 mm-40 -81.38 -4.63 56.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.361 -0.837 . . . . 0.0 109.522 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.82 34.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.285 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.487 ' H ' ' C ' ' D' ' 121' ' ' GLU . 28.3 p -48.32 148.3 3.36 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.108 -0.995 . . . . 0.0 109.083 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.513 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.3 Cg_exo -45.1 -52.91 5.85 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.228 1.952 . . . . 0.0 112.812 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 36.4 Cg_endo -65.65 13.57 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.013 1.809 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.458 HG23 ' OG1' ' D' ' 123' ' ' THR . 90.8 t -124.84 -21.34 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.299 -0.876 . . . . 0.0 109.605 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . 0.549 HE22 ' CG ' ' D' ' 131' ' ' GLN . 18.2 tm0? -83.18 -42.96 16.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.76 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -61.91 -44.35 96.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.67 -7.15 24.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.683 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -92.43 -30.01 15.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 109.706 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 0.549 ' CG ' HE22 ' D' ' 127' ' ' GLN . 15.6 mm100 -81.62 -38.2 26.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -68.21 -49.33 61.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 109.691 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 2.6 p -58.49 -48.18 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.865 . . . . 0.0 109.966 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.569 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 88.5 t -73.44 -34.45 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.347 -0.846 . . . . 0.0 109.796 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.799 ' CB ' ' O ' ' B' ' 146' ' ' HIS . . . -47.45 -22.29 0.43 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.37 -22.01 61.31 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . 0.459 HG13 ' CZ ' ' D' ' 85' ' ' PHE . 85.8 t -77.83 -26.07 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -1.138 . . . . 0.0 109.537 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.14 -46.6 61.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.214 -0.929 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -74.71 -21.08 59.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.497 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.32 -59.71 3.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.553 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.52 -24.93 61.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.927 . . . . 0.0 109.438 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.24 22.45 4.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 109.39 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -77.34 -31.85 54.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.634 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.1 OUTLIER -79.55 -27.35 41.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.398 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' D' ' 98' ' ' VAL . 24.4 m-85 -65.88 3.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.842 ' O ' ' CB ' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.439 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.486 ' C ' HD12 ' A' ' 2' ' ' LEU . 3.7 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.572 HD13 ' OG ' ' A' ' 131' ' ' SER . 7.7 mp -108.21 -165.39 1.04 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.311 -0.868 . . . . 0.0 109.2 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.515 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 178.98 -49.53 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.936 . . . . 0.0 109.992 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' ASP . 73.9 Cg_exo -47.23 171.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.384 2.056 . . . . 0.0 112.448 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -45.8 -16.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.766 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' PRO . 3.1 p30 -39.55 -33.35 0.17 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 10' ' ' VAL . 9.6 ptpt -83.14 -46.59 12.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.338 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 m -45.44 -31.07 1.56 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.314 -0.866 . . . . 0.0 109.424 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -78.23 -36.94 46.42 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 7' ' ' LYS . 71.5 t -70.5 -49.52 52.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -51.07 -47.32 61.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.404 -0.81 . . . . 0.0 108.847 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -55.92 27.57 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.43 -0.794 . . . . 0.0 109.304 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.716 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -56.74 -37.23 70.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.251 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -17.41 61.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.223 -0.923 . . . . 0.0 108.933 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.63 -44.17 16.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 41.6 mmtt -70.2 -43.25 71.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -1.17 . . . . 0.0 108.637 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 13' ' ' ALA . 59.1 t -59.27 -63.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 44.2 -125.39 5.78 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 22.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.416 -1.05 . . . . 0.0 110.438 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.568 ' H ' ' C ' ' A' ' 18' ' ' GLY . 78.9 m-70 -129.11 25.99 5.5 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -91.51 -64.38 1.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.694 -0.629 . . . . 0.0 109.746 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.28 -14.37 0.17 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' ALA . 2.2 mm-40 -84.03 -56.47 3.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -1.052 . . . . 0.0 109.672 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.2 m-30 -60.67 -35.56 76.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 109.187 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.86 -22.88 68.84 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.51 -41.76 31.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -1.163 . . . . 0.0 109.715 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.42 -19.82 62.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 108.92 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.92 ' HB1' ' SG ' ' A' ' 104' ' ' CYS . . . -72.85 -21.88 60.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.371 -0.831 . . . . 0.0 109.132 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.1 mt -72.45 -53.68 11.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.349 -0.845 . . . . 0.0 109.712 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.13 -27.05 69.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.489 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 31' ' ' ARG . 0.9 OUTLIER -63.89 -30.68 71.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.547 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 39.6 ttp -70.75 -57.93 4.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.482 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -49.19 -33.68 12.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.45 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 11.7 mt -73.5 -51.55 16.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.852 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 52.4 m -67.76 -17.87 64.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.949 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CZ ' ' NH2' ' B' ' 104' ' ' ARG . 29.4 m-85 -152.62 109.52 2.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.052 -1.03 . . . . 0.0 109.499 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' THR . 72.4 Cg_endo -80.53 -27.21 3.49 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.331 2.02 . . . . 0.0 112.092 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.786 ' HB ' ' HB2' ' D' ' 97' ' ' HIS . 21.1 p -47.45 -18.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 109.447 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' PRO . 55.9 p -81.6 -22.74 37.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HZ1' HD21 ' A' ' 48' ' ' LEU . 1.8 tpmt? -64.71 -39.61 93.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 38' ' ' THR . 8.8 t . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 109.642 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.465 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.592 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -151.0 68.01 0.93 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' SER . 1.5 m-20 -48.35 -18.3 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 109.631 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.592 ' CD1' ' O ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER 46.4 21.33 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.24 -0.912 . . . . 0.0 109.638 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 50' ' ' HIS . 5.2 m -75.31 18.68 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -0.94 . . . . 0.0 109.404 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.492 ' ND1' ' N ' ' A' ' 50' ' ' HIS . 2.5 m80 57.51 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.615 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.03 10.5 83.83 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 3.2 p -54.48 -12.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -1.104 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 71.0 -16.79 0.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.381 -0.825 . . . . 0.0 109.736 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 52' ' ' SER . 5.1 pt20 -81.65 -28.87 33.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.508 HG22 ' CE2' ' A' ' 46' ' ' PHE . 22.2 t -73.52 -38.44 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.61 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.585 ' H ' ' CD ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.63 -22.83 46.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.083 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.13 -23.89 58.36 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.47 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.7 t-80 -78.47 -38.57 40.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -1.171 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.72 -48.95 49.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 53.7 mttm -51.61 -23.45 4.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -1.121 . . . . 0.0 109.948 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.18 -42.46 65.83 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.127 -0.983 . . . . 0.0 109.024 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 t -69.85 -48.44 63.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.486 -0.758 . . . . 0.0 108.977 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.426 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -65.47 -28.57 69.31 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.384 -0.822 . . . . 0.0 109.275 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 30.4 m-20 -70.23 -36.49 74.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 0.0 108.872 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.68 47.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.402 -0.811 . . . . 0.0 108.964 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 70' ' ' VAL . 11.3 mt -58.01 -42.12 84.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.261 -0.899 . . . . 0.0 108.674 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' ALA . 25.8 m -67.59 -51.6 48.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.362 -0.836 . . . . 0.0 108.881 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.544 HD21 ' CB ' ' A' ' 79' ' ' ALA . 9.4 t30 -60.49 -29.31 68.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 108.781 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -82.98 -46.49 12.83 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 66' ' ' LEU . 48.4 t -67.19 -22.4 29.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -66.1 -24.21 66.65 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.205 0.526 . . . . 0.0 109.711 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.592 ' O ' HG12 ' A' ' 73' ' ' VAL . 11.8 m80 -137.27 -47.8 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 72' ' ' HIS . 11.0 p 45.06 13.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.665 0.745 . . . . 0.0 109.378 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 72' ' ' HIS . 26.2 t70 -135.76 11.37 3.41 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -173.72 28.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.043 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.704 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -77.96 -24.91 0.46 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 0.0 111.399 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 76' ' ' MET . 41.8 Cg_exo -56.52 -24.61 54.2 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.791 1.661 . . . . 0.0 112.324 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -89.38 -29.19 19.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.932 . . . . 0.0 109.65 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.544 ' CB ' HD21 ' A' ' 68' ' ' ASN . . . -77.05 -43.2 35.4 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.127 -0.983 . . . . 0.0 109.127 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 80' ' ' LEU . 6.4 mp -83.5 8.7 13.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.432 -0.792 . . . . 0.0 108.952 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.5 m -63.52 -23.18 67.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -76.35 -55.3 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.614 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 83' ' ' LEU . 4.5 mt -46.62 -46.81 19.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 m -56.8 -25.43 55.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.435 -0.79 . . . . 0.0 109.246 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' ALA . 11.6 t70 -81.02 -35.02 32.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.382 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tt -72.06 -26.95 62.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 109.198 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 90' ' ' LYS . 68.4 m80 -82.67 -31.49 28.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 109.472 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.14 -42.65 15.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.495 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -78.13 -18.84 55.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.535 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' HIS . 46.7 mttm -146.08 179.81 7.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 93' ' ' VAL . 12.6 mt 59.09 58.4 3.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -53.84 -6.88 0.1 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 109.336 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 91' ' ' LEU . 11.5 p -54.59 137.94 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.49 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.765 ' HB2' ' OD2' ' D' ' 99' ' ' ASP . 0.7 OUTLIER -77.27 157.92 80.11 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.086 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASN . 9.9 Cg_endo -54.72 -10.47 2.53 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.721 2.281 . . . . 0.0 111.882 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.518 HG21 ' CG ' ' D' ' 99' ' ' ASP . 85.3 t -42.98 -22.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 109.775 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 95' ' ' PRO . 3.1 m120 -79.07 -41.26 29.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.205 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 95' ' ' PRO . 31.7 t80 -48.62 -25.72 1.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.165 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -70.62 -30.32 66.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.208 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.551 HD13 ' CD1' ' A' ' 36' ' ' PHE . 20.6 mt -84.08 -61.34 1.84 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 0.0 109.642 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 4.6 tt -49.23 -23.51 1.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.671 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.8 m -72.81 -44.05 61.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.059 -1.025 . . . . 0.0 109.759 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.509 ' CD2' ' OD1' ' B' ' 108' ' ' ASN . 41.3 t-80 -80.55 -26.63 37.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.783 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.92 ' SG ' ' HB1' ' A' ' 28' ' ' ALA . 11.2 p -58.04 -48.14 80.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.717 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.655 ' N ' ' SG ' ' A' ' 104' ' ' CYS . 2.5 mt -46.31 -39.14 9.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 106' ' ' LEU . 3.7 mm? -68.8 -30.28 68.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.607 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.592 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 86.0 t -75.12 -51.5 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 110' ' ' ALA . 27.8 m -60.05 -59.66 5.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 114' ' ' PRO . 12.3 mt -46.37 -18.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.457 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -69.66 -42.55 74.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.258 -0.902 . . . . 0.0 110.406 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.19 -3.67 43.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.132 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -129.73 -81.72 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 109.693 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -119.17 82.15 22.17 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 113' ' ' LEU . 53.6 Cg_exo -48.76 -169.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.51 2.14 . . . . 0.0 112.524 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.827 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -51.0 -56.21 13.61 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.556 -0.715 . . . . 0.0 109.302 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.67 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 3.0 mm-40 122.63 -8.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.497 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 5.6 t80 80.34 34.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 122.01 -0.431 . . . . 0.0 111.199 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -113.43 120.22 40.24 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.25 16.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.331 2.021 . . . . 0.0 112.87 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -140.98 -34.61 0.5 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.016 -1.052 . . . . 0.0 110.106 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.827 HG21 ' O ' ' A' ' 115' ' ' ALA . 9.4 p -51.79 -47.28 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.14 -0.975 . . . . 0.0 109.994 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.616 ' N ' HG13 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -60.19 -39.9 88.16 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.331 -0.856 . . . . 0.0 109.283 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.39 -19.99 32.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.824 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 120' ' ' ALA . 24.2 p -61.83 -62.39 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 110.3 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.505 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.3 mt -68.2 -19.53 64.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.172 -0.955 . . . . 0.0 109.513 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.05 -45.54 13.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.974 . . . . 0.0 109.854 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -87.19 -41.48 13.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.155 -0.965 . . . . 0.0 109.883 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 37.1 t80 -50.14 -20.84 1.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.966 -1.084 . . . . 0.0 108.854 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' SER . 19.4 mt -70.56 -17.91 62.92 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.7 -31.64 69.77 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.572 ' OG ' HD13 ' A' ' 2' ' ' LEU . 0.8 OUTLIER -81.72 -34.05 30.75 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.362 -0.836 . . . . 0.0 108.902 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.0 t -83.8 -29.21 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.336 -0.852 . . . . 0.0 108.91 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 129' ' ' LEU . 23.3 t -80.3 -25.44 39.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.403 -0.811 . . . . 0.0 109.132 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 m -75.37 -39.67 58.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.264 -0.897 . . . . 0.0 109.215 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.04 -22.09 16.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.255 -0.903 . . . . 0.0 108.965 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.91 -35.13 72.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 109.02 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 83.6 m -87.21 -29.85 21.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.561 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.47 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 1.5 t60 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.248 0.546 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.916 HD12 ' N ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -138.46 -162.94 1.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.331 -0.856 . . . . 0.0 109.071 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.409 ' HG1' ' CD ' ' B' ' 7' ' ' GLU . 1.0 OUTLIER -84.54 153.32 61.58 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 108.866 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.92 -26.32 66.86 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.491 2.127 . . . . 0.0 112.197 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.2 -27.86 22.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.973 . . . . 0.0 109.793 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.409 ' CD ' ' HG1' ' B' ' 4' ' ' THR . 61.2 mt-10 -84.14 -48.1 10.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.023 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.694 ' HB2' HD13 ' B' ' 3' ' ' LEU . 0.8 OUTLIER -68.78 -43.42 75.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.55 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -56.58 -23.58 41.57 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 110.059 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.54 -57.61 3.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.021 -1.05 . . . . 0.0 110.044 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.95 -24.33 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 47.1 m -80.88 -36.97 30.59 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.687 -0.633 . . . . 0.0 109.779 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 -22.38 63.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.927 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 16' ' ' GLY . 1.7 mt -59.82 -28.05 67.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.0 109.335 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . 0.657 ' HE1' ' HG ' ' B' ' 72' ' ' SER . 0.5 OUTLIER -47.57 -17.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.933 . . . . 0.0 109.178 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -76.88 -36.15 37.31 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.445 ' O ' ' CE2' ' B' ' 118' ' ' PHE . 3.3 mmtt -89.33 -35.82 15.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -1.148 . . . . 0.0 109.281 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.1 t -47.92 114.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.659 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' B' ' 21' ' ' ASP . 83.6 m-20 -77.86 65.82 3.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.327 -0.858 . . . . 0.0 108.933 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -44.6 -17.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.385 -0.822 . . . . 0.0 109.682 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' B' ' 19' ' ' ASN . 13.3 m-20 -78.8 6.76 8.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.232 -0.917 . . . . 0.0 109.539 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' B' ' 19' ' ' ASN . 58.2 mt-10 -155.65 -46.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.538 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' B' ' 27' ' ' ALA . 85.8 t -47.74 -42.24 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.621 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.81 -43.33 96.62 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.9 -39.08 25.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -76.25 -25.82 55.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -1.175 . . . . 0.0 109.561 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' B' ' 23' ' ' VAL . . . -75.54 -34.1 60.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.937 . . . . 0.0 109.515 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tp -82.91 -52.35 6.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.451 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.68 -26.68 17.31 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -77.86 -31.44 51.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.131 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 32.6 tp -49.04 -34.56 13.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.355 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.9 mt -80.39 -22.03 41.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -82.51 -64.22 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.627 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.453 ' H ' HG23 ' B' ' 34' ' ' VAL . 3.0 t -61.01 -22.9 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.888 . . . . 0.0 109.659 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -152.16 88.47 4.1 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 109.465 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.94 12.98 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.543 2.162 . . . . 0.0 112.227 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.592 ' CZ2' ' ND2' ' B' ' 102' ' ' ASN . 0.7 OUTLIER -71.91 -19.92 61.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.525 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.591 HG23 ' NE1' ' B' ' 37' ' ' TRP . 1.3 p -84.14 50.99 1.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.977 . . . . 0.0 109.27 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 38.5 tt0 -92.14 31.23 1.3 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -87.88 -42.84 12.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.674 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -93.18 14.32 18.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 109.578 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' B' ' 43' ' ' GLU . 1.6 p90 -68.21 -34.19 75.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.608 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.543 ' N ' ' CD1' ' B' ' 42' ' ' PHE . 12.0 pt-20 -53.28 -17.4 1.75 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.607 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 60.9 m -85.55 -34.73 21.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.583 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 47' ' ' ASP . 10.0 m-85 -51.04 -20.92 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.96 12.42 0.15 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' B' ' 45' ' ' PHE . 15.1 m-20 -160.64 110.52 1.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.151 . . . . 0.0 109.448 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tp -158.67 20.6 0.22 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.255 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.1 m -46.78 -41.1 14.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 109.646 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . 0.431 ' HG1' ' CG ' ' B' ' 52' ' ' ASP . 4.7 p -146.6 150.33 39.79 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.851 . . . . 0.0 109.216 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -41.15 -43.65 5.19 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.444 2.096 . . . . 0.0 112.354 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.431 ' CG ' ' HG1' ' B' ' 50' ' ' THR . 1.7 p-10 -64.13 -31.01 72.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.534 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.92 -19.86 20.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.93 . . . . 0.0 109.42 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.43 -61.32 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -0.901 . . . . 0.0 109.573 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' B' ' 55' ' ' MET . 5.5 mmt -70.98 -0.51 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.77 31.08 7.17 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -143.09 137.06 14.51 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.26 -1.141 . . . . 0.0 109.31 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.11 -30.88 5.27 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.489 2.126 . . . . 0.0 112.26 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -21.1 59.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 109.777 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 69.8 t -75.82 -41.52 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.523 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -78.31 -25.26 46.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.57 71.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -62.62 -23.82 67.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.32 -50.31 22.17 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -49.51 -30.92 9.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.173 -1.192 . . . . 0.0 109.534 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -65.45 -53.74 38.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.583 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 28.2 t -58.96 -36.94 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.43 HD23 ' C ' ' B' ' 68' ' ' LEU . 5.7 tt -65.57 -48.37 72.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.97 -41.05 10.31 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.05 -43.45 91.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.608 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -61.4 -47.31 86.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . 0.657 ' HG ' ' HE1' ' B' ' 15' ' ' TRP . 19.2 m -62.44 -42.03 99.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 109.622 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -48.37 -34.79 11.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.416 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.68 -60.48 6.91 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -54.04 -22.09 9.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.248 -1.148 . . . . 0.0 109.35 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.16 2.68 56.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -170.27 66.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.68 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.27 15.27 2.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.34 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.85 -23.21 60.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.46 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 37.1 t-20 -167.2 108.09 0.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 0.0 109.593 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mt -80.35 -51.53 8.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -67.12 -23.97 65.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.812 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -78.7 -39.11 22.2 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.9 t -85.1 -47.43 10.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.153 -1.204 . . . . 0.0 109.715 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.557 ' N ' ' CG2' ' B' ' 84' ' ' THR . 40.5 m-85 -84.67 26.92 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.539 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.32 72.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 109.633 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 50.9 p -75.81 -53.82 7.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.752 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -48.13 -43.05 30.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 2.9 m -66.89 -48.35 68.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.849 . . . . 0.0 109.668 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -67.39 -22.64 65.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 109.734 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.71 -68.37 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.078 -1.013 . . . . 0.0 109.566 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.576 ' NE2' ' O ' ' B' ' 141' ' ' LEU . 1.1 p-80 -54.38 -20.67 7.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.974 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . 0.429 ' N ' ' ND1' ' B' ' 92' ' ' HIS . 41.4 t -83.51 -59.6 2.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 110.858 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.31 -56.44 3.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.067 -1.021 . . . . 0.0 111.379 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -57.71 -51.74 68.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 110.579 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.614 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 12.1 mt -97.32 -64.52 1.03 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.002 -1.062 . . . . 0.0 109.95 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.723 ' HB2' ' HB ' ' C' ' 38' ' ' THR . 0.0 OUTLIER 91.2 25.12 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.308 0.575 . . . . 0.0 109.865 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 98' ' ' VAL . 17.5 t -46.74 140.86 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.103 -0.998 . . . . 0.0 109.493 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 0.688 ' OD2' ' HB2' ' C' ' 94' ' ' ASP . 96.0 m-20 -54.0 149.41 18.05 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.363 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.9 36.46 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.478 2.119 . . . . 0.0 112.143 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -145.07 45.57 1.34 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.179 -0.95 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.592 ' ND2' ' CZ2' ' B' ' 37' ' ' TRP . 4.4 m120 -143.74 5.96 1.39 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.1 m-85 -89.74 -69.68 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 109.454 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.574 ' NH2' ' CZ ' ' A' ' 36' ' ' PHE . 43.9 ttt180 -54.94 -20.88 9.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.54 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 tp -75.31 -31.13 60.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tt -68.19 -55.39 12.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.63 -20.55 39.41 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . 0.509 ' OD1' ' CD2' ' A' ' 103' ' ' HIS . 61.8 t30 -60.09 -34.78 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -1.159 . . . . 0.0 109.684 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.53 -24.12 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 109.593 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.73 -36.4 82.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 109.501 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.447 ' CG1' ' CD1' ' B' ' 130' ' ' TYR . 4.4 m -74.91 -26.04 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.239 -0.913 . . . . 0.0 109.662 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.516 ' HG ' ' CE1' ' A' ' 122' ' ' HIS . 17.0 t -66.79 -63.4 1.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 109.612 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . 0.433 ' H ' HG23 ' B' ' 113' ' ' VAL . 10.6 t -49.14 -21.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 109.539 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.9 -57.03 4.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.66 -27.32 49.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.836 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.494 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.71 -60.25 2.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.052 -1.03 . . . . 0.0 109.443 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -62.3 -17.49 58.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.692 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.445 ' CE2' ' O ' ' B' ' 17' ' ' LYS . 65.5 m-85 -150.05 60.5 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 109.703 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 121' ' ' GLU . . . -66.52 -45.26 86.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' B' ' 120' ' ' LYS . 28.6 mmtp -47.39 -19.86 0.19 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -1.172 . . . . 0.0 109.289 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' B' ' 119' ' ' GLY . 70.1 mm-40 -94.77 -26.82 16.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.642 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.478 ' CD1' ' C ' ' B' ' 122' ' ' PHE . 0.7 OUTLIER -48.54 120.82 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.355 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 9.6 p -149.15 149.31 29.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 108.896 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.448 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 2.5 Cg_endo -46.15 -58.1 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.327 2.018 . . . . 0.0 113.177 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 19.5 Cg_endo -59.76 -11.1 13.53 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.174 1.916 . . . . 0.0 112.51 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 53.5 t -94.81 -53.12 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 109.907 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . 0.515 ' O ' ' NE2' ' B' ' 131' ' ' GLN . 41.1 mm-40 -61.34 -59.88 4.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 109.489 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -51.16 -37.43 46.27 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.484 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.24 18.53 2.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.447 ' CD1' ' CG1' ' B' ' 111' ' ' VAL . 15.2 t80 -109.56 -61.71 1.6 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.229 -0.92 . . . . 0.0 109.688 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.674 ' NE2' ' H ' ' B' ' 131' ' ' GLN . 4.1 mp0 -48.43 -24.09 1.15 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.0 -1.063 . . . . 0.0 109.726 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.447 ' HG3' ' CD2' ' D' ' 146' ' ' HIS . 35.8 ttpt -85.73 -37.38 19.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 0.0 110.169 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 0.4 OUTLIER -60.76 -44.36 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.859 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.477 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 7.0 m -83.56 -16.97 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 0.0 109.935 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.96 -25.15 1.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 0.0 109.404 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.95 -23.9 56.48 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' B' ' 134' ' ' VAL . 42.7 t -79.6 -31.78 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -1.164 . . . . 0.0 109.429 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.54 -50.79 57.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -67.07 -32.31 73.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.427 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.7 -42.27 34.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.291 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.576 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 38.4 mt -84.17 18.37 2.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.376 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.39 -31.08 2.32 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.536 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -46.37 -41.87 14.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 109.285 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' B' ' 146' ' ' HIS . 35.7 mmtt -75.46 -54.43 7.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.037 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.497 ' O ' ' CG ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -57.43 -6.19 0.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.545 -0.722 . . . . 0.0 109.241 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.446 ' H ' ' C ' ' B' ' 144' ' ' LYS . 11.8 m-70 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.79 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.48 ' C ' HD12 ' C' ' 2' ' ' LEU . 3.7 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.581 HD13 ' OG ' ' C' ' 131' ' ' SER . 7.7 mp -108.21 -165.41 1.04 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.359 -0.838 . . . . 0.0 109.269 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.516 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 179.02 -49.6 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.018 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' C' ' 6' ' ' ASP . 74.3 Cg_exo -47.17 170.88 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.398 2.065 . . . . 0.0 112.521 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.73 -16.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 109.828 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' C' ' 4' ' ' PRO . 3.1 p30 -39.61 -33.35 0.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.765 . . . . 0.0 109.799 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' C' ' 10' ' ' VAL . 9.6 ptpt -83.1 -46.57 12.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.893 . . . . 0.0 109.431 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.407 ' C ' ' O ' ' C' ' 7' ' ' LYS . 49.6 m -45.48 -31.12 1.62 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.419 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -78.23 -36.81 46.6 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' C' ' 7' ' ' LYS . 71.8 t -70.49 -49.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -51.07 -47.33 61.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.45 -56.02 26.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.405 -0.81 . . . . 0.0 109.294 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.696 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -56.65 -37.3 70.58 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.285 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -17.48 61.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.156 -0.965 . . . . 0.0 108.907 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.6 -44.09 17.04 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' C' ' 16' ' ' LYS . 41.7 mmtt -70.22 -43.29 70.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -1.119 . . . . 0.0 108.56 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.696 HG23 ' O ' ' C' ' 13' ' ' ALA . 59.8 t -59.22 -63.89 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.566 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 44.24 -125.44 5.84 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.41 22.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.349 -1.089 . . . . 0.0 110.449 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.566 ' H ' ' C ' ' C' ' 18' ' ' GLY . 78.9 m-70 -129.08 26.07 5.5 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.52 -64.37 1.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.68 -0.638 . . . . 0.0 109.811 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.37 -14.28 0.18 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 21' ' ' ALA . 2.1 mm-40 -84.01 -56.52 3.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -1.055 . . . . 0.0 109.671 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -60.53 -35.7 76.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.165 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.84 -22.92 68.83 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.51 -41.71 31.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -1.121 . . . . 0.0 109.683 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.51 -19.79 62.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 108.947 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.922 ' HB1' ' SG ' ' C' ' 104' ' ' CYS . . . -72.89 -21.84 60.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.109 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 11.2 mt -72.57 -53.57 11.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 109.635 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.19 -27.01 69.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.484 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -30.81 71.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 39.5 ttp -70.79 -57.98 4.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.405 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 0.3 OUTLIER -49.2 -33.63 12.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.468 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.453 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 11.8 mt -73.44 -51.57 16.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 109.856 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 53.3 m -67.92 -17.73 64.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.938 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.568 ' CZ ' ' NH2' ' D' ' 104' ' ' ARG . 29.2 m-85 -152.64 109.51 2.74 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.972 . . . . 0.0 109.546 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' C' ' 39' ' ' THR . 72.1 Cg_endo -80.43 -27.29 3.53 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.388 2.058 . . . . 0.0 112.16 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.753 ' O ' HG22 ' C' ' 41' ' ' THR . 22.0 p -47.37 -18.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.863 . . . . 0.0 109.581 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.438 ' N ' ' O ' ' C' ' 37' ' ' PRO . 55.9 p -81.56 -22.74 37.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.532 ' HZ1' HD21 ' C' ' 48' ' ' LEU . 1.8 tpmt? -64.68 -39.59 93.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.878 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.753 HG22 ' O ' ' C' ' 38' ' ' THR . 8.8 t . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 0.0 109.616 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.476 ' CG ' ' O ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' C' ' 48' ' ' LEU . 0.3 OUTLIER -150.99 68.1 0.93 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' C' ' 49' ' ' SER . 1.5 m-20 -48.42 -18.31 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.07 -1.019 . . . . 0.0 109.613 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.582 ' CD1' ' O ' ' C' ' 46' ' ' PHE . 0.9 OUTLIER 46.56 21.19 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.211 -0.93 . . . . 0.0 109.536 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.461 ' O ' ' O ' ' C' ' 50' ' ' HIS . 5.2 m -75.31 18.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.496 ' ND1' ' N ' ' C' ' 50' ' ' HIS . 2.4 m80 57.53 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 109.661 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.02 10.5 83.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 3.2 p -54.43 -12.71 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 71.13 -16.87 0.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.382 -0.824 . . . . 0.0 109.729 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' C' ' 52' ' ' SER . 5.1 pt20 -81.57 -28.85 33.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.959 . . . . 0.0 109.684 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.514 HG22 ' CE2' ' C' ' 46' ' ' PHE . 22.4 t -73.54 -38.43 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.584 ' H ' ' CD ' ' C' ' 56' ' ' LYS . 0.0 OUTLIER -78.71 -22.75 46.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.395 -0.816 . . . . 0.0 109.011 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.2 -23.81 58.35 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.471 ' ND1' ' C ' ' C' ' 58' ' ' HIS . 6.7 t-80 -78.6 -38.45 39.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -1.147 . . . . 0.0 109.506 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.79 -48.85 49.73 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.41 ' O ' ' CG ' ' C' ' 64' ' ' ASP . 53.7 mttm -51.8 -23.28 4.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.36 -1.082 . . . . 0.0 109.924 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.26 -42.39 65.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.116 -0.99 . . . . 0.0 109.054 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t -69.82 -48.51 63.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.455 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -65.46 -28.59 69.32 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . 0.41 ' CG ' ' O ' ' C' ' 60' ' ' LYS . 30.2 m-20 -70.23 -36.4 74.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 108.926 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.95 -52.74 47.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.476 -0.765 . . . . 0.0 108.968 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.415 ' O ' HG23 ' C' ' 70' ' ' VAL . 11.3 mt -58.03 -42.16 84.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 108.665 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.478 ' O ' ' N ' ' C' ' 71' ' ' ALA . 26.1 m -67.54 -51.55 49.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.245 -0.91 . . . . 0.0 108.998 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.56 HD21 ' CB ' ' C' ' 79' ' ' ALA . 9.4 t30 -60.46 -29.34 68.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 108.744 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -82.95 -46.54 12.8 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.415 HG23 ' O ' ' C' ' 66' ' ' LEU . 48.6 t -67.16 -22.38 29.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -66.07 -24.26 66.68 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.658 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.593 ' O ' HG12 ' C' ' 73' ' ' VAL . 11.8 m80 -137.27 -47.86 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.754 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.593 HG12 ' O ' ' C' ' 72' ' ' HIS . 10.9 p 45.09 13.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.802 0.81 . . . . 0.0 109.411 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' C' ' 72' ' ' HIS . 26.3 t70 -135.71 11.46 3.42 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -173.77 28.26 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.007 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.712 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -77.94 -25.02 0.46 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.489 -0.757 . . . . 0.0 111.414 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' C' ' 76' ' ' MET . 41.9 Cg_exo -56.37 -24.7 53.3 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.851 1.701 . . . . 0.0 112.363 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -89.39 -29.21 19.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . 0.56 ' CB ' HD21 ' C' ' 68' ' ' ASN . . . -77.0 -43.2 35.69 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.143 -0.973 . . . . 0.0 109.068 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . 0.471 ' N ' HD12 ' C' ' 80' ' ' LEU . 6.4 mp -83.5 8.7 13.19 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.358 -0.839 . . . . 0.0 108.962 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.6 m -63.43 -23.39 67.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.551 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -76.24 -55.33 5.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.629 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.42 ' N ' HD23 ' C' ' 83' ' ' LEU . 4.5 mt -46.59 -46.8 19.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.818 . . . . 0.0 108.861 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 5.0 m -56.91 -25.33 57.08 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.404 -0.81 . . . . 0.0 109.25 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' C' ' 82' ' ' ALA . 11.6 t70 -81.02 -35.06 32.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.91 -27.04 62.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.25 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . 0.439 ' O ' ' O ' ' C' ' 90' ' ' LYS . 68.2 m80 -82.74 -31.36 28.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.17 -42.64 15.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -78.16 -18.79 55.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.854 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' C' ' 87' ' ' HIS . 46.8 mttm -146.06 179.81 7.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.898 . . . . 0.0 109.511 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' C' ' 93' ' ' VAL . 12.5 mt 59.08 58.54 3.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.456 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -53.99 -6.82 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.248 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' C' ' 91' ' ' LEU . 11.5 p -54.64 137.89 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.688 ' HB2' ' OD2' ' B' ' 99' ' ' ASP . 0.7 OUTLIER -77.24 157.89 80.23 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.086 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' C' ' 97' ' ' ASN . 10.0 Cg_endo -54.74 -10.34 2.46 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.627 2.218 . . . . 0.0 111.953 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.478 HG21 ' CG ' ' B' ' 99' ' ' ASP . 85.4 t -43.09 -22.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -0.819 . . . . 0.0 109.743 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' C' ' 95' ' ' PRO . 3.1 m120 -79.15 -41.16 29.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.959 . . . . 0.0 109.206 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' C' ' 95' ' ' PRO . 31.9 t80 -48.59 -25.68 1.85 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 109.249 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -70.65 -30.37 66.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.18 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.559 HD13 ' CD1' ' C' ' 36' ' ' PHE . 20.4 mt -84.07 -61.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 109.63 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . 0.471 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 4.6 tt -49.15 -23.55 1.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.744 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 34.5 m -72.87 -43.91 61.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.798 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . 0.514 ' CD2' ' OD1' ' D' ' 108' ' ' ASN . 41.3 t-80 -80.58 -26.69 37.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 109.732 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.922 ' SG ' ' HB1' ' C' ' 28' ' ' ALA . 11.1 p -57.98 -48.09 81.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.768 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.655 ' N ' ' SG ' ' C' ' 104' ' ' CYS . 2.5 mt -46.46 -39.12 10.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.393 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.597 ' N ' HD22 ' C' ' 106' ' ' LEU . 3.7 mm? -68.72 -30.37 68.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.603 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . 0.597 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 85.7 t -75.04 -51.43 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.459 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.464 ' O ' ' N ' ' C' ' 110' ' ' ALA . 27.1 m -60.12 -59.63 5.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.244 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' C' ' 114' ' ' PRO . 12.4 mt -46.29 -18.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -69.66 -42.56 74.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.0 110.368 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.15 -3.63 43.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.0 110.17 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -129.72 -81.83 0.56 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 109.622 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.4 OUTLIER -119.17 82.2 22.28 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 53.3 Cg_exo -48.79 -169.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.427 2.085 . . . . 0.0 112.604 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.839 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -50.89 -56.27 13.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.491 -0.756 . . . . 0.0 109.289 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.658 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 3.0 mm-40 122.66 -8.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.503 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 5.6 t80 80.26 34.95 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.935 -0.478 . . . . 0.0 111.212 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.739 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -113.45 120.26 40.13 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -48.3 16.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.242 1.961 . . . . 0.0 112.992 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -140.93 -34.73 0.49 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.049 -1.032 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.839 HG21 ' O ' ' C' ' 115' ' ' ALA . 9.4 p -51.75 -47.18 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.596 ' N ' HG13 ' C' ' 121' ' ' VAL . 0.1 OUTLIER -60.34 -39.81 88.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.26 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.44 -20.03 32.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.344 -0.847 . . . . 0.0 109.785 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.535 ' N ' ' O ' ' C' ' 120' ' ' ALA . 24.3 p -61.83 -62.42 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 110.283 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.5 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.3 mt -68.14 -19.51 64.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 0.0 109.544 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -83.13 -45.46 13.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 109.841 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.416 ' CG ' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -87.31 -41.36 13.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.974 . . . . 0.0 109.84 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.462 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 37.1 t80 -50.22 -20.83 1.13 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.879 -1.138 . . . . 0.0 108.81 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' C' ' 133' ' ' SER . 19.2 mt -70.57 -17.92 62.91 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.64 -31.69 69.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.581 ' OG ' HD13 ' C' ' 2' ' ' LEU . 0.8 OUTLIER -81.79 -33.94 30.59 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.429 -0.795 . . . . 0.0 108.933 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 26.4 t -83.85 -29.16 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.334 -0.854 . . . . 0.0 108.927 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.536 ' N ' ' O ' ' C' ' 129' ' ' LEU . 23.3 t -80.37 -25.39 39.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.393 -0.817 . . . . 0.0 109.109 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 44.9 m -75.35 -39.69 59.04 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 28.8 m -75.07 -22.12 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 108.887 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.95 -35.03 72.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.041 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 82.3 m -87.38 -29.79 21.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 109.434 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 1.5 t60 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.314 0.578 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.919 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -138.39 -162.92 1.37 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.331 -0.856 . . . . 0.0 109.068 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.53 153.2 61.52 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 108.939 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.71 -26.39 68.49 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.498 2.132 . . . . 0.0 112.3 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.15 -27.86 22.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.862 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -84.07 -48.06 10.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.095 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.705 ' HB2' HD13 ' D' ' 3' ' ' LEU . 0.8 OUTLIER -68.84 -43.39 75.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.149 -0.969 . . . . 0.0 109.52 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -56.65 -23.58 42.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.173 -0.955 . . . . 0.0 110.026 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.57 -57.63 3.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.98 -1.075 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.02 -24.32 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 46.1 m -80.89 -36.96 30.54 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.723 -0.611 . . . . 0.0 109.782 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.81 -22.3 63.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.941 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' D' ' 16' ' ' GLY . 1.8 mt -59.85 -28.1 67.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.11 -0.994 . . . . 0.0 109.379 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . 0.66 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.5 OUTLIER -47.53 -17.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.198 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -76.83 -36.13 37.68 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.454 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 3.2 mmtt -89.36 -35.8 15.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -1.196 . . . . 0.0 109.298 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -47.94 114.95 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.32 -0.863 . . . . 0.0 109.668 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' D' ' 21' ' ' ASP . 83.5 m-20 -77.91 65.78 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 0.0 108.85 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 71.5 t -44.55 -17.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' D' ' 19' ' ' ASN . 13.4 m-20 -78.84 6.74 8.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' D' ' 19' ' ' ASN . 58.1 mt-10 -155.58 -46.94 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' D' ' 27' ' ' ALA . 85.9 t -47.8 -42.22 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.629 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.76 -43.42 96.46 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.85 -39.18 25.21 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -76.21 -25.78 55.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -1.151 . . . . 0.0 109.557 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' D' ' 23' ' ' VAL . . . -75.6 -34.02 60.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.477 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tp -82.96 -52.38 6.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.426 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.66 -26.71 17.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -77.91 -31.34 51.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 0.0 109.447 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 32.5 tp -48.99 -34.61 13.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.352 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 29.1 mt -80.44 -21.97 41.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 23.8 t -82.54 -64.27 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.418 HG23 ' H ' ' D' ' 34' ' ' VAL . 3.0 t -61.05 -22.86 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 109.639 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -152.17 88.57 4.08 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.479 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.89 12.84 2.51 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.621 2.214 . . . . 0.0 112.251 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . 0.601 ' CZ2' ' ND2' ' D' ' 102' ' ' ASN . 0.7 OUTLIER -71.8 -20.01 61.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 109.546 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.592 HG23 ' NE1' ' D' ' 37' ' ' TRP . 1.3 p -84.09 51.06 1.97 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 109.273 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . 0.434 ' O ' ' CD1' ' D' ' 42' ' ' PHE . 38.6 tt0 -92.2 31.15 1.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.252 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -87.85 -42.92 12.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.589 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -93.1 14.3 18.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 109.551 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' D' ' 43' ' ' GLU . 1.6 p90 -68.28 -34.13 75.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.595 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . 0.54 ' N ' ' CD1' ' D' ' 42' ' ' PHE . 11.9 pt-20 -53.31 -17.4 1.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.543 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 60.8 m -85.56 -34.7 21.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 109.59 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' D' ' 47' ' ' ASP . 10.1 m-85 -51.08 -20.95 1.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.358 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.98 12.44 0.15 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' D' ' 45' ' ' PHE . 15.1 m-20 -160.63 110.51 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -1.102 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tp -158.72 20.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.294 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 58.7 m -46.91 -41.03 15.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.642 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . 0.469 ' HG1' ' CG ' ' D' ' 52' ' ' ASP . 4.8 p -146.57 150.37 40.02 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.359 -0.838 . . . . 0.0 109.217 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -41.16 -43.65 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.467 2.111 . . . . 0.0 112.382 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . 0.469 ' CG ' ' HG1' ' D' ' 50' ' ' THR . 1.7 p-10 -64.11 -31.09 72.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.152 -0.968 . . . . 0.0 109.447 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -56.94 -19.88 20.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 48.3 t -71.36 -61.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.571 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' D' ' 55' ' ' MET . 5.5 mmt -70.99 -0.48 9.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 0.0 109.443 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.72 30.92 7.32 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -142.94 137.02 14.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.211 -1.17 . . . . 0.0 109.385 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.04 -30.77 5.45 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.516 2.144 . . . . 0.0 112.336 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -21.07 59.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 109.739 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.92 -41.46 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.476 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -78.35 -25.35 46.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.57 71.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -62.61 -23.83 67.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.549 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.36 -50.23 22.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -49.57 -30.84 9.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -1.147 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -65.5 -53.68 38.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.899 . . . . 0.0 109.591 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 28.2 t -59.03 -36.92 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.413 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.425 HD23 ' C ' ' D' ' 68' ' ' LEU . 5.7 tt -65.51 -48.43 72.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 109.345 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.94 -41.08 10.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.28 91.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.167 . . . . 0.0 109.64 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -61.5 -47.27 86.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.612 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . 0.66 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 19.4 m -62.56 -41.97 99.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.349 -0.844 . . . . 0.0 109.531 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -48.31 -34.85 11.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.44 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.71 -60.42 6.98 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.556 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.6 mp -54.04 -22.1 9.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.157 . . . . 0.0 109.32 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.06 2.51 56.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.942 . . . . 0.0 109.626 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -170.19 66.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.26 15.25 2.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.348 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.82 -23.22 60.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 37.1 t-20 -167.2 108.11 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.582 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mt -80.31 -51.67 8.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 109.373 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -67.01 -24.13 65.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.707 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -78.6 -39.11 22.58 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.9 t -85.1 -47.44 10.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.15 -1.206 . . . . 0.0 109.696 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' D' ' 84' ' ' THR . 40.4 m-85 -84.72 27.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.486 -0.759 . . . . 0.0 109.519 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.28 -31.41 72.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.359 -0.838 . . . . 0.0 109.626 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 51.1 p -75.77 -53.84 7.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.715 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -48.12 -42.98 30.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 3.0 m -67.0 -48.33 68.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.574 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -67.35 -22.66 65.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.761 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.73 -68.36 0.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.124 -0.985 . . . . 0.0 109.567 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.577 ' NE2' ' O ' ' D' ' 141' ' ' LEU . 1.1 p-80 -54.44 -20.67 7.99 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.172 -0.955 . . . . 0.0 109.939 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . 0.426 ' N ' ' ND1' ' D' ' 92' ' ' HIS . 41.3 t -83.53 -59.57 2.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 110.818 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.36 -56.41 3.45 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.072 -1.018 . . . . 0.0 111.396 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -57.69 -51.73 68.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.095 -1.003 . . . . 0.0 110.599 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.615 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 12.2 mt -97.42 -64.32 1.05 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.081 -1.012 . . . . 0.0 109.94 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.786 ' HB2' ' HB ' ' A' ' 38' ' ' THR . 0.0 OUTLIER 91.03 25.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.297 0.57 . . . . 0.0 109.868 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . 0.431 ' H ' HG23 ' D' ' 98' ' ' VAL . 17.5 t -46.73 140.79 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.5 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . 0.765 ' OD2' ' HB2' ' A' ' 94' ' ' ASP . 96.0 m-20 -53.94 149.41 17.68 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.399 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.84 36.45 0.4 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.6 2.2 . . . . 0.0 112.119 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -145.12 45.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . 0.601 ' ND2' ' CZ2' ' D' ' 37' ' ' TRP . 4.4 m120 -143.8 5.95 1.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -0.843 . . . . 0.0 109.556 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 1.1 m-85 -89.73 -69.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 109.516 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . 0.568 ' NH2' ' CZ ' ' C' ' 36' ' ' PHE . 44.1 ttt180 -55.08 -20.88 10.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 tp -75.19 -31.14 60.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tt -68.29 -55.33 12.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.7 -20.45 39.5 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . 0.514 ' OD1' ' CD2' ' C' ' 103' ' ' HIS . 61.7 t30 -60.18 -34.78 74.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -1.094 . . . . 0.0 109.636 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 6.8 t -86.47 -24.15 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 109.599 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.64 -36.42 82.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 109.553 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . 0.438 ' CG1' ' CD1' ' D' ' 130' ' ' TYR . 4.4 m -74.99 -25.92 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.248 -0.908 . . . . 0.0 109.665 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . 0.516 ' HG ' ' CE1' ' C' ' 122' ' ' HIS . 16.9 t -66.84 -63.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.148 -0.97 . . . . 0.0 109.584 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . 0.401 ' H ' HG23 ' D' ' 113' ' ' VAL . 10.6 t -49.16 -21.59 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.506 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.91 -57.01 4.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.4 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -55.62 -27.37 49.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.892 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.489 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.75 -60.07 2.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.5 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -62.39 -17.55 59.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.611 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 65.7 m-85 -150.0 60.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.987 . . . . 0.0 109.675 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' D' ' 121' ' ' GLU . . . -66.53 -45.33 86.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -47.29 -19.88 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -1.181 . . . . 0.0 109.31 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' D' ' 119' ' ' GLY . 70.1 mm-40 -94.76 -26.78 16.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.652 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.475 ' CD1' ' C ' ' D' ' 122' ' ' PHE . 0.7 OUTLIER -48.67 120.86 4.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.348 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 9.7 p -149.12 149.32 29.4 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.009 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.434 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 2.5 Cg_endo -46.21 -58.01 1.9 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.366 2.044 . . . . 0.0 113.168 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 19.3 Cg_endo -59.84 -11.12 13.8 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.168 1.912 . . . . 0.0 112.474 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 53.6 t -94.8 -53.19 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.034 -1.041 . . . . 0.0 109.821 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . 0.517 ' O ' ' NE2' ' D' ' 131' ' ' GLN . 41.0 mm-40 -61.37 -59.73 4.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.503 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -51.3 -37.39 47.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.18 18.48 2.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.694 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.438 ' CD1' ' CG1' ' D' ' 111' ' ' VAL . 15.1 t80 -109.5 -61.73 1.59 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -0.908 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 0.674 ' NE2' ' H ' ' D' ' 131' ' ' GLN . 4.1 mp0 -48.46 -24.16 1.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.003 -1.061 . . . . 0.0 109.662 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . 0.401 ' HG3' ' CD2' ' B' ' 146' ' ' HIS . 35.7 ttpt -85.69 -37.38 19.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -0.888 . . . . 0.0 110.21 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 0.4 OUTLIER -60.88 -44.21 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.067 -1.021 . . . . 0.0 109.821 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.496 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 7.0 m -83.6 -16.94 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.2 -0.938 . . . . 0.0 109.877 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.99 -25.13 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.07 -1.019 . . . . 0.0 109.432 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.97 -23.94 56.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' D' ' 134' ' ' VAL . 42.4 t -79.49 -31.78 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -1.105 . . . . 0.0 109.522 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.57 -50.78 56.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.396 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -67.07 -32.27 73.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.68 -42.42 34.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.95 . . . . 0.0 109.237 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . 0.577 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 38.3 mt -84.12 18.44 2.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.392 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.45 -31.03 2.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.163 -0.961 . . . . 0.0 109.556 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -46.33 -41.92 14.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 109.285 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' D' ' 146' ' ' HIS . 35.7 mmtt -75.41 -54.39 7.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.419 -0.801 . . . . 0.0 109.127 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . 0.467 ' O ' ' CG ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -57.42 -6.21 0.42 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.501 -0.75 . . . . 0.0 109.234 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.447 ' CD2' ' HG3' ' B' ' 132' ' ' LYS . 11.6 m-70 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.759 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 1' ' ' VAL . 73.9 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.585 HD21 ' OG ' ' A' ' 131' ' ' SER . 78.2 mt -144.7 178.82 7.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.995 . . . . 0.0 109.723 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.73 167.11 26.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.434 -0.791 . . . . 0.0 109.069 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.15 -43.72 2.98 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.599 2.199 . . . . 0.0 112.563 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.29 -19.35 33.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.977 -1.077 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.783 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.7 t0 -47.85 -37.14 13.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.413 ' CD ' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -81.19 -43.59 19.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.869 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.0 m -51.15 -37.53 46.79 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.123 -0.986 . . . . 0.0 109.558 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -74.93 -31.96 61.64 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 6' ' ' ASP . 58.6 t -72.36 -51.27 30.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -49.98 -47.44 52.81 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.9 -61.28 2.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.458 -0.776 . . . . 0.0 109.537 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.64 -40.06 68.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.424 -0.797 . . . . 0.0 109.058 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -17.16 64.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.425 -0.797 . . . . 0.0 108.955 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.34 -44.96 15.69 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 12.2 mmmt -70.66 -40.66 72.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -1.166 . . . . 0.0 108.802 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' ALA . 61.9 t -60.27 -64.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 46.1 -127.34 9.36 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 23.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -1.102 . . . . 0.0 110.569 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' A' ' 18' ' ' GLY . 86.0 m-70 -130.07 25.77 5.22 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -90.24 -63.8 1.23 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.693 -0.629 . . . . 0.0 109.754 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.77 -14.3 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.0 mm-40 -83.28 -56.51 3.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -1.076 . . . . 0.0 109.559 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.625 ' CD1' ' CD2' ' A' ' 112' ' ' HIS . 3.6 m-30 -62.07 -32.24 72.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.462 -0.773 . . . . 0.0 109.274 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.19 -23.4 77.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.08 -44.38 22.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -1.09 . . . . 0.0 109.587 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -61.1 -26.24 67.52 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -26.78 68.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.526 HD11 ' ND1' ' A' ' 58' ' ' HIS . 14.1 mt -72.51 -58.4 3.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.471 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -52.16 -38.91 59.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.887 ' HG3' HE22 ' B' ' 127' ' ' GLN . 0.9 OUTLIER -68.21 -50.58 53.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.299 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.469 ' SD ' ' C ' ' A' ' 32' ' ' MET . 15.2 tmm? -62.4 -29.15 70.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.351 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.69 -58.73 6.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 110.026 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.4 pp -73.89 -39.62 63.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.2 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.524 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 50.8 m -46.71 -16.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.081 -1.012 . . . . 0.0 109.825 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 35' ' ' SER . 15.2 m-85 -159.37 89.64 1.99 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 0.0 109.362 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 40' ' ' LYS . 52.5 Cg_exo -52.77 -20.07 12.07 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.457 2.105 . . . . 0.0 112.095 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 p -49.08 -18.91 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.403 ' N ' ' C ' ' A' ' 37' ' ' PRO . 30.3 p -84.17 -22.92 30.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' PRO . 29.9 ttmt -55.5 -47.01 76.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.567 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.667 HG21 ' O ' ' D' ' 94' ' ' ASP . 5.1 t . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.8 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.598 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.19 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -145.53 31.24 1.09 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.506 -1.371 . . . . 0.0 110.078 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 49' ' ' SER . 1.1 m-20 52.84 91.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.872 . . . . 0.0 109.614 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.19 1.87 0.43 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.373 -0.83 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 47' ' ' ASP . 9.2 m -62.48 140.95 58.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.421 ' ND1' ' O ' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -63.72 140.34 58.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.448 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.21 12.13 81.23 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.631 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 2.2 t -59.31 -20.58 55.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -1.174 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 72.61 -24.33 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -0.782 . . . . 0.0 109.61 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 52' ' ' SER . 33.5 mt-30 -80.31 -24.32 40.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.569 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.8 t -75.85 -35.14 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 56' ' ' LYS . 14.1 ptpt -79.17 -34.67 42.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.946 . . . . 0.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.19 -24.52 76.3 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.526 ' ND1' HD11 ' A' ' 29' ' ' LEU . 5.9 t-80 -68.15 -43.87 77.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.317 -1.108 . . . . 0.0 109.316 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.8 -46.97 25.19 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 48.5 mttm -54.6 -23.19 15.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.512 -0.993 . . . . 0.0 109.644 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -36.85 58.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.199 -0.938 . . . . 0.0 108.902 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -73.73 -47.39 44.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.499 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -68.64 -29.09 67.51 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.312 -0.868 . . . . 0.0 109.342 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 25.6 m-20 -66.79 -47.23 72.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.096 -1.002 . . . . 0.0 108.75 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.9 -49.46 76.11 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.3 mt -55.37 -46.03 76.5 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 71' ' ' ALA . 27.6 m -64.97 -55.55 18.43 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.301 -0.874 . . . . 0.0 108.749 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -55.9 -29.3 59.78 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.73 -48.12 12.06 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 66' ' ' LEU . 54.9 t -65.17 -22.5 31.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -68.94 -16.48 63.76 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 74' ' ' ASP . 34.2 m170 -145.1 -56.9 0.33 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.306 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.4 p 44.94 13.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.665 0.745 . . . . 0.0 109.576 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 72' ' ' HIS . 99.2 m-20 -123.69 8.41 8.86 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -175.92 28.69 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.147 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 5.2 ptt? -78.09 -24.64 0.45 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 111.676 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 76' ' ' MET . 53.2 Cg_exo -54.83 -23.66 34.93 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.759 1.639 . . . . 0.0 112.195 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -93.32 -37.24 12.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.88 75.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.149 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.5 mt -81.74 8.79 9.15 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.325 -0.86 . . . . 0.0 109.048 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.0 t -56.11 -41.05 74.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.845 . . . . 0.0 109.618 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -56.22 -57.33 12.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.576 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 83' ' ' LEU . 4.2 mt -46.31 -46.69 18.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.376 -0.827 . . . . 0.0 108.819 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -59.96 -29.64 68.56 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.476 -0.765 . . . . 0.0 109.289 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 89' ' ' HIS . 76.0 m-20 -81.52 -38.93 25.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 0.0 109.339 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 87' ' ' HIS . 4.1 tt -59.18 -36.04 74.62 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.334 -0.853 . . . . 0.0 109.46 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.434 ' CE1' HD22 ' A' ' 86' ' ' LEU . 51.1 m80 -92.12 -23.07 19.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.949 . . . . 0.0 109.69 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.52 -9.49 29.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.238 -0.914 . . . . 0.0 109.922 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 85' ' ' ASP . 42.9 m80 -143.93 47.93 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -0.97 . . . . 0.0 109.698 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.13 -69.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 109.319 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.453 ' C ' ' N ' ' A' ' 93' ' ' VAL . 11.7 mt -88.76 -23.84 22.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 51.65 10.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.565 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.453 ' N ' ' C ' ' A' ' 91' ' ' LEU . 14.8 p -52.62 144.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.492 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 151.68 86.12 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.31 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 97' ' ' ASN . 47.6 Cg_endo -70.12 -20.98 32.45 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.558 2.172 . . . . 0.0 112.123 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.546 HG11 ' OD1' ' D' ' 99' ' ' ASP . 93.2 t -45.84 -15.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 109.756 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 95' ' ' PRO . 3.4 m120 -79.25 -24.88 42.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 109.577 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.495 ' CD1' ' C ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -69.1 -31.14 69.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.364 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -58.56 -29.94 66.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.504 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 17.6 mt -83.91 -62.18 1.63 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.581 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.1 tt -45.65 -24.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.597 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.7 t -65.22 -57.26 8.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.928 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -73.74 -26.5 60.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.981 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 9.5 m -70.32 -23.45 62.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.099 -1.001 . . . . 0.0 110.157 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.725 ' O ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -80.56 -22.87 40.37 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.937 -1.102 . . . . 0.0 108.926 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.99 -18.78 33.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.852 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.0 t -77.5 -50.33 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 110' ' ' ALA . 43.4 p -52.56 -51.91 57.46 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.161 -0.962 . . . . 0.0 109.678 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 113' ' ' LEU . 7.9 mt -43.74 -26.36 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.465 -0.772 . . . . 0.0 109.759 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -71.92 -25.65 61.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.924 . . . . 0.0 110.486 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.47 -3.79 54.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.106 -0.996 . . . . 0.0 110.902 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.625 ' CD2' ' CD1' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -150.15 -69.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.782 -1.199 . . . . 0.0 109.669 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.481 ' H ' ' CD2' ' A' ' 112' ' ' HIS . 0.4 OUTLIER -118.29 81.24 16.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.47 ' N ' ' O ' ' A' ' 109' ' ' LEU . 51.2 Cg_exo -49.32 -170.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.44 2.094 . . . . 0.0 112.589 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.729 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -48.65 -55.63 10.75 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.649 ' CG ' ' O ' ' A' ' 115' ' ' ALA . 2.8 mm-40 130.5 0.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.1 t80 66.3 30.37 9.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.842 -0.536 . . . . 0.0 111.138 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.706 ' O ' ' N ' ' A' ' 120' ' ' ALA . 2.1 p -103.79 128.12 27.97 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 120.996 -1.065 . . . . 0.0 108.249 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.64 23.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.102 1.868 . . . . 0.0 112.923 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.706 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -157.03 -32.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 0.0 110.669 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.729 HG21 ' O ' ' A' ' 115' ' ' ALA . 12.9 p -49.84 -47.24 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.13 -0.981 . . . . 0.0 110.299 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.656 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.4 t60 -61.74 -38.56 88.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.771 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.41 -20.12 34.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 109.95 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -66.28 -62.36 1.52 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.95 . . . . 0.0 110.245 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.568 HD22 HD21 ' A' ' 105' ' ' LEU . 1.4 mt -65.11 -19.81 66.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.071 -1.018 . . . . 0.0 109.467 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.17 -49.27 37.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.15 -42.1 11.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 109.635 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.574 ' CD2' HG21 ' A' ' 10' ' ' VAL . 32.0 t80 -50.0 -22.92 1.75 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 109.255 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 129' ' ' LEU . 1.2 pp -76.37 -22.08 55.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.14 -38.1 75.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.585 ' OG ' HD21 ' A' ' 2' ' ' LEU . 34.6 m -67.92 -26.8 66.16 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.469 ' O ' HD13 ' A' ' 136' ' ' LEU . 5.6 t -85.55 -37.67 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.8 t -80.06 -18.0 51.22 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.298 -0.876 . . . . 0.0 108.738 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 41.8 m -83.28 -42.44 17.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.468 -0.77 . . . . 0.0 109.208 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 131' ' ' SER . 27.3 m -70.06 -21.97 24.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.24 -0.913 . . . . 0.0 108.756 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 132' ' ' VAL . 0.9 OUTLIER -67.46 -31.8 72.22 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.1 m -153.27 57.1 0.77 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 1.078 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -107.63 -159.13 0.68 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.496 -0.752 . . . . 0.0 109.361 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 9.9 p -103.57 134.4 19.77 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.394 -0.816 . . . . 0.0 109.29 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -42.1 -22.79 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.438 2.092 . . . . 0.0 112.467 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -76.62 -55.6 5.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 110.065 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -68.16 -60.45 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.961 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.775 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -48.74 -30.14 5.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 2.9 m -62.05 -23.61 66.58 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.979 -1.075 . . . . 0.0 110.032 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.05 -57.68 3.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.886 -1.134 . . . . 0.0 109.958 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.55 -24.95 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 56.6 m -83.39 -37.36 23.4 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.453 0.644 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' B' ' 9' ' ' SER . . . -63.19 -29.92 71.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.369 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.7 OUTLIER -52.16 -32.46 36.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.119 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . 0.539 ' HE1' ' HG ' ' B' ' 72' ' ' SER . 0.2 OUTLIER -47.15 -17.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.509 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.34 -52.02 5.81 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' B' ' 17' ' ' LYS . 0.1 OUTLIER -70.48 -29.41 65.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -1.179 . . . . 0.0 109.263 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -48.72 114.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 22' ' ' GLU . 18.3 m120 -82.56 69.41 9.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 108.953 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' B' ' 22' ' ' GLU . 78.3 t -43.88 -29.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 0.0 109.72 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -64.69 1.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' B' ' 20' ' ' VAL . 33.0 mt-10 -155.89 -46.11 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 109.424 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -48.52 -53.96 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.41 -48.52 48.14 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.34 -46.35 79.09 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.44 -39.96 95.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.27 -1.136 . . . . 0.0 109.394 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.74 88.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.179 -0.95 . . . . 0.0 109.364 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -82.2 -51.22 8.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.309 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.91 -35.08 62.53 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -79.37 -30.65 42.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -1.158 . . . . 0.0 109.495 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 60.6 tp -49.42 -39.03 31.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.379 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.53 -23.45 56.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.583 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.79 -61.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.188 -0.945 . . . . 0.0 109.413 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.403 ' H ' HG23 ' B' ' 34' ' ' VAL . 3.2 t -69.36 -23.82 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -136.73 76.09 48.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.64 11.49 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.725 2.283 . . . . 0.0 112.335 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.468 ' CE2' HG23 ' B' ' 38' ' ' THR . 51.3 p-90 -80.62 -19.71 44.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 109.341 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.468 HG23 ' CE2' ' B' ' 37' ' ' TRP . 42.0 p -79.77 40.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 109.36 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -92.16 12.84 20.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 0.0 109.55 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -87.86 -34.49 18.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' B' ' 42' ' ' PHE . 29.9 m-85 -95.79 32.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' B' ' 41' ' ' PHE . 57.5 m-85 -141.36 26.32 1.98 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.94 -25.08 37.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.483 ' C ' ' H ' ' B' ' 46' ' ' GLY . 66.8 m -82.13 -38.17 25.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.602 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -56.0 -5.41 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' B' ' 44' ' ' SER . . . 48.57 -167.67 0.16 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' B' ' 48' ' ' LEU . 18.9 t70 60.19 -150.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -1.149 . . . . 0.0 109.536 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.473 ' H ' ' CG ' ' B' ' 47' ' ' ASP . 24.2 mt 60.57 34.33 20.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 109.53 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.3 m -80.49 -22.52 40.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.41 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . 0.502 ' O ' ' N ' ' B' ' 53' ' ' ALA . 21.4 p -146.11 149.02 37.24 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.279 -0.888 . . . . 0.0 109.166 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -36.75 -45.07 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.644 2.23 . . . . 0.0 112.591 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.88 -26.93 61.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 109.544 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -57.78 -19.64 29.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.05 -63.36 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.135 -0.978 . . . . 0.0 109.633 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . 0.542 ' SD ' ' N ' ' B' ' 55' ' ' MET . 2.3 mpp? -79.69 14.81 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.05 -49.01 4.41 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.497 ' N ' HD22 ' B' ' 57' ' ' ASN . 1.0 OUTLIER -77.82 149.61 77.54 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.227 -1.16 . . . . 0.0 109.46 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.36 -51.94 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.671 2.247 . . . . 0.0 112.176 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.403 ' CG ' ' N ' ' B' ' 60' ' ' VAL . 54.2 pttt -46.92 -40.75 14.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.56 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' B' ' 59' ' ' LYS . 87.1 t -54.21 -44.85 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' B' ' 61' ' ' LYS . 7.0 mtmp? -77.39 -43.0 34.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.222 -0.924 . . . . 0.0 109.438 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.17 -33.12 18.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -67.67 -24.4 65.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.68 -30.25 74.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -68.15 -41.23 81.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.121 . . . . 0.0 109.318 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -64.08 -50.89 66.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.779 . . . . 0.0 109.36 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -61.78 -23.91 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.251 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tt -78.11 -29.8 49.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.475 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.22 -57.13 14.33 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.54 -22.03 63.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -74.46 -30.34 61.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.63 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . 0.539 ' HG ' ' HE1' ' B' ' 15' ' ' TRP . 4.4 m -89.11 -20.48 24.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 109.762 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -46.15 -30.79 2.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 109.621 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.29 -59.24 7.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.558 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.75 -17.73 10.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 109.667 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -97.38 32.9 2.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.977 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.549 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 9.5 m-70 -176.67 -49.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.161 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' B' ' 77' ' ' HIS . 29.8 mt 39.64 35.3 0.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.637 -0.665 . . . . 0.0 109.614 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -138.62 -31.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.651 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 7.5 p-10 -151.91 72.71 1.03 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.171 -0.956 . . . . 0.0 109.363 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.552 ' N ' HD12 ' B' ' 81' ' ' LEU . 9.6 mp -60.4 -27.08 67.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.912 . . . . 0.0 109.461 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -80.62 -61.48 1.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.77 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.32 -23.9 43.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.432 HG23 ' O ' ' B' ' 80' ' ' ASN . 0.8 OUTLIER -62.4 -51.91 65.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.166 -1.196 . . . . 0.0 109.537 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.546 ' CZ ' ' O ' ' B' ' 81' ' ' LEU . 2.2 p90 -133.18 51.93 2.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.639 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.97 -29.47 4.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -0.994 . . . . 0.0 109.287 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' B' ' 88' ' ' LEU . 17.8 p -60.5 -58.5 8.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.326 -0.859 . . . . 0.0 109.392 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.404 ' N ' ' OG1' ' B' ' 87' ' ' THR . 90.7 mt -48.56 -37.43 17.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.026 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -69.06 -34.84 75.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.913 . . . . 0.0 109.002 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -82.91 -39.01 22.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 109.419 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.07 -25.31 64.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 109.397 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' B' ' 97' ' ' HIS . 6.8 m80 -90.98 -21.81 21.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.181 -0.95 . . . . 0.0 109.567 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.58 -59.05 2.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 111.059 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.592 ' O ' HG21 ' C' ' 41' ' ' THR . 1.3 m-20 -87.21 -57.0 3.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.976 -1.077 . . . . 0.0 112.009 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' B' ' 95' ' ' LYS . 12.1 mptt -62.81 -52.16 64.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.122 -0.986 . . . . 0.0 111.195 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.608 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -95.43 -38.2 10.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.973 -1.079 . . . . 0.0 109.837 -178.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 25.3 p80 45.52 33.06 1.25 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.206 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.587 HG23 HD12 ' B' ' 96' ' ' LEU . 52.0 t -50.13 132.4 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.949 -1.094 . . . . 0.0 109.139 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 0.507 ' OD1' HG11 ' C' ' 96' ' ' VAL . 4.2 m-20 -51.15 151.24 5.02 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.266 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.03 -170.35 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.439 2.093 . . . . 0.0 112.026 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' D' ' 101' ' ' GLU . 69.1 mm-40 53.24 69.95 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.47 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.467 ' ND2' ' CD1' ' B' ' 103' ' ' PHE . 3.9 p-10 -171.24 -39.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.49 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.467 ' CD1' ' ND2' ' B' ' 102' ' ' ASN . 12.9 m-85 -50.34 -34.51 24.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -76.13 -43.94 40.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.613 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.521 HD12 ' N ' ' B' ' 105' ' ' LEU . 9.9 mp -49.32 -51.81 31.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 tt -51.69 -37.17 49.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.852 . . . . 0.0 109.353 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.98 -20.57 59.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -65.36 -34.26 77.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 109.561 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.86 -31.67 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 7.7 tp -51.67 -52.09 50.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.517 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.564 ' CG2' ' CE1' ' B' ' 130' ' ' TYR . 42.6 t -51.18 -42.86 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.596 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -60.06 -39.56 86.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.164 -0.96 . . . . 0.0 109.618 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.55 -55.03 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.606 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.03 -31.75 71.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.495 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -64.9 -27.8 69.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.403 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.463 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.79 -61.28 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.227 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.42 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 8.3 m-70 -63.3 -18.28 63.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 58.8 m-85 -148.44 59.53 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -71.95 -14.8 76.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -79.48 -20.29 47.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.271 -1.135 . . . . 0.0 109.528 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' B' ' 123' ' ' THR . 29.1 mm-40 -95.48 -2.49 48.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.953 . . . . 0.0 109.77 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -73.78 33.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 0.0 109.606 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.468 ' H ' ' C ' ' B' ' 121' ' ' GLU . 22.0 p -49.22 148.41 4.4 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.364 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.454 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 2.3 Cg_endo -46.83 -57.51 2.25 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.448 2.099 . . . . 0.0 113.002 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 17.8 Cg_endo -59.49 -42.36 48.86 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.093 1.862 . . . . 0.0 112.233 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 98.9 t -65.11 -20.76 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.458 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . 0.887 HE22 ' HG3' ' A' ' 31' ' ' ARG . 37.0 tt0 -83.31 -48.99 9.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.552 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.658 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -58.66 -30.06 67.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.437 ' O ' HG23 ' B' ' 133' ' ' VAL . . . -82.14 19.17 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.144 -0.972 . . . . 0.0 109.672 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.564 ' CE1' ' CG2' ' B' ' 111' ' ' VAL . 47.4 t80 -107.95 -61.4 1.58 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.283 -0.886 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 5.9 tp-100 -55.28 -23.26 22.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.947 . . . . 0.0 109.57 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -83.04 -21.8 33.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.647 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . 0.437 HG23 ' O ' ' B' ' 129' ' ' ALA . 76.8 t -81.13 -68.31 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 109.696 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 22.4 m -53.76 -25.04 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.848 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -49.56 -29.78 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.461 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.4 -29.28 56.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 96.4 t -76.42 -38.14 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -1.169 . . . . 0.0 109.4 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.96 79.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.42 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 1.653 HD21 ' CD2' ' D' ' 146' ' ' HIS . 1.8 m120 -79.67 -22.96 42.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.85 -60.52 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.601 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.74 -25.26 66.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.331 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 -16.35 27.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.472 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -51.33 -33.38 29.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 109.361 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -73.34 -27.15 61.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -71.94 -46.18 58.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.5 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 1.605 ' CD2' HD21 ' D' ' 139' ' ' ASN . 43.5 p-80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.942 -1.027 . . . . 0.0 109.548 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.488 HG12 ' O ' ' C' ' 1' ' ' VAL . 73.2 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.571 HD21 ' OG ' ' C' ' 131' ' ' SER . 78.0 mt -144.72 178.84 7.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 109.772 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.77 167.17 25.85 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.05 -43.81 3.0 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.668 2.245 . . . . 0.0 112.62 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.3 -19.35 33.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.999 -1.063 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.771 ' O ' HG23 ' C' ' 10' ' ' VAL . 24.5 t0 -47.84 -37.24 13.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.735 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -43.61 19.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.953 . . . . 0.0 109.886 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 37.3 m -51.14 -37.5 46.53 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.184 -0.947 . . . . 0.0 109.562 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -74.94 -31.92 61.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.771 HG23 ' O ' ' C' ' 6' ' ' ASP . 58.5 t -72.46 -51.13 30.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -50.15 -47.3 54.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.87 -61.35 2.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.479 -0.763 . . . . 0.0 109.573 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.644 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.48 -40.21 68.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.278 -0.889 . . . . 0.0 109.039 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -17.1 64.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.309 -0.869 . . . . 0.0 108.959 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.36 -44.84 15.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -70.68 -40.68 72.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -1.153 . . . . 0.0 108.841 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.644 HG23 ' O ' ' C' ' 13' ' ' ALA . 61.7 t -60.28 -64.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 46.0 -127.27 9.15 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 23.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.465 -1.02 . . . . 0.0 110.544 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' C' ' 18' ' ' GLY . 85.9 m-70 -130.05 25.77 5.23 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -90.19 -63.88 1.21 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.74 -14.34 0.23 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.0 mm-40 -83.28 -56.42 3.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -1.044 . . . . 0.0 109.53 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.622 ' CE1' ' CD2' ' C' ' 112' ' ' HIS . 3.6 m-30 -62.11 -32.31 72.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.416 -0.802 . . . . 0.0 109.179 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.18 -23.46 77.23 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.93 -44.38 22.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.212 -1.169 . . . . 0.0 109.662 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.24 -26.08 67.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.31 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.37 -26.86 68.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.534 HD11 ' ND1' ' C' ' 58' ' ' HIS . 14.1 mt -72.44 -58.37 3.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.523 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -52.23 -38.82 59.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.57 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.901 ' HG3' HE22 ' D' ' 127' ' ' GLN . 0.9 OUTLIER -68.21 -50.67 52.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.224 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . 0.482 ' SD ' ' C ' ' C' ' 32' ' ' MET . 15.2 tmm? -62.39 -29.07 70.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.953 . . . . 0.0 109.392 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -62.78 -58.69 6.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.953 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.4 pp -74.0 -39.57 63.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 110.144 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.528 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 50.5 m -46.81 -16.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.059 -1.026 . . . . 0.0 109.815 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' C' ' 35' ' ' SER . 15.2 m-85 -159.37 89.74 1.99 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.332 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.73 -20.18 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.519 2.146 . . . . 0.0 112.082 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 19.3 p -49.01 -18.96 0.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 30.2 p -84.12 -22.98 30.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.471 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -55.5 -46.97 76.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.576 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.592 HG21 ' O ' ' B' ' 94' ' ' ASP . 5.2 t . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.36 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.573 ' CG ' ' O ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.201 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -145.72 31.21 1.07 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.503 -1.373 . . . . 0.0 110.046 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' C' ' 49' ' ' SER . 1.1 m-20 52.88 91.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.633 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.07 1.74 0.41 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 109.58 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.465 ' H ' ' C ' ' C' ' 47' ' ' ASP . 9.3 m -62.46 140.97 58.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.443 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' C' ' 50' ' ' HIS . 0.1 OUTLIER -63.64 140.32 58.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.938 . . . . 0.0 109.541 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.15 12.16 81.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 2.3 t -59.22 -20.68 56.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -1.205 . . . . 0.0 109.326 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 72.62 -24.29 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.629 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' C' ' 52' ' ' SER . 33.5 mt-30 -80.41 -24.17 39.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 16.8 t -75.96 -35.09 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.19 -34.61 42.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.871 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.23 -24.41 76.45 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.534 ' ND1' HD11 ' C' ' 29' ' ' LEU . 5.8 t-80 -68.19 -43.93 76.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -1.061 . . . . 0.0 109.277 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.77 -46.88 24.98 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' C' ' 64' ' ' ASP . 48.3 mttm -54.77 -23.12 16.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -1.027 . . . . 0.0 109.57 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.27 -36.91 58.21 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.178 -0.951 . . . . 0.0 108.9 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.467 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -73.77 -47.35 44.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.503 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -68.56 -29.09 67.56 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.428 -0.795 . . . . 0.0 109.416 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' C' ' 60' ' ' LYS . 25.8 m-20 -66.74 -47.23 72.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 108.697 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -62.08 -49.31 76.46 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.434 ' O ' HG23 ' C' ' 70' ' ' VAL . 1.3 mt -55.36 -46.11 76.46 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.514 ' O ' ' N ' ' C' ' 71' ' ' ALA . 27.4 m -65.03 -55.5 18.56 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -55.86 -29.37 59.8 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.72 -48.12 12.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 66' ' ' LEU . 54.9 t -65.14 -22.55 31.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -68.9 -16.5 63.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.58 ' O ' ' N ' ' C' ' 74' ' ' ASP . 34.2 m170 -145.17 -56.82 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 0.0 109.217 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.5 p 44.85 13.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.744 0.783 . . . . 0.0 109.56 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' C' ' 72' ' ' HIS . 99.3 m-20 -123.63 8.35 8.89 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -175.84 28.73 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.178 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 5.2 ptt? -78.13 -24.55 0.45 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.765 . . . . 0.0 111.664 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.9 Cg_exo -54.8 -23.73 35.01 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.74 1.627 . . . . 0.0 112.197 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -93.26 -37.19 12.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.587 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.75 75.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.929 . . . . 0.0 109.203 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 mt -81.88 8.85 9.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 0.0 108.939 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 27.9 t -56.24 -40.95 74.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.882 . . . . 0.0 109.589 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -56.31 -57.33 12.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.536 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.457 HD23 ' N ' ' C' ' 83' ' ' LEU . 4.2 mt -46.25 -46.68 17.96 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 3.9 m -59.99 -29.56 68.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.564 -0.71 . . . . 0.0 109.285 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' C' ' 89' ' ' HIS . 75.9 m-20 -81.63 -38.88 25.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.324 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' C' ' 87' ' ' HIS . 4.1 tt -59.14 -36.11 74.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.375 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . 0.432 ' CE1' HD22 ' C' ' 86' ' ' LEU . 52.1 m80 -92.16 -23.04 19.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.684 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.52 -9.39 29.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.215 -0.928 . . . . 0.0 109.887 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' C' ' 85' ' ' ASP . 43.2 m80 -144.03 47.94 1.41 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.056 -1.027 . . . . 0.0 109.776 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.19 -69.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' C' ' 93' ' ' VAL . 11.6 mt -88.77 -23.8 22.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 109.51 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 51.67 10.06 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.466 ' H ' ' C ' ' C' ' 91' ' ' LEU . 14.9 p -52.69 144.52 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.1 151.71 86.13 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.313 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' C' ' 97' ' ' ASN . 47.7 Cg_endo -70.11 -21.0 32.45 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.546 2.164 . . . . 0.0 112.136 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.507 HG11 ' OD1' ' B' ' 99' ' ' ASP . 90.6 t -45.75 -15.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.769 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' C' ' 95' ' ' PRO . 3.3 m120 -79.21 -24.89 42.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.595 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' C' ' 98' ' ' PHE . 0.1 OUTLIER -68.99 -31.27 69.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 109.435 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -58.51 -29.9 66.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.6 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.471 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 17.7 mt -83.92 -62.14 1.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.584 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 7.1 tt -45.65 -24.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.616 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.7 t -65.33 -57.24 8.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.865 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -73.78 -26.43 60.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 109.998 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 9.6 m -70.41 -23.34 62.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 110.17 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.714 ' O ' HD12 ' C' ' 105' ' ' LEU . 0.1 OUTLIER -80.69 -22.7 40.15 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.943 -1.098 . . . . 0.0 108.936 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -85.12 -18.77 33.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.912 . . . . 0.0 109.702 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 74.1 t -77.51 -50.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.965 . . . . 0.0 109.742 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 43.5 p -52.46 -52.04 56.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.251 -0.906 . . . . 0.0 109.666 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' C' ' 114' ' ' PRO . 7.9 mt -43.61 -26.41 0.23 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.723 . . . . 0.0 109.756 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -71.9 -25.66 62.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 110.477 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.45 -3.88 54.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.053 -1.029 . . . . 0.0 110.835 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . 0.622 ' CD2' ' CE1' ' C' ' 24' ' ' TYR . 0.2 OUTLIER -150.11 -69.22 0.19 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.73 -1.231 . . . . 0.0 109.639 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.478 ' H ' ' CD2' ' C' ' 112' ' ' HIS . 0.4 OUTLIER -118.22 81.27 16.59 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . 0.48 ' N ' ' O ' ' C' ' 109' ' ' LEU . 51.4 Cg_exo -49.24 -170.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.462 2.108 . . . . 0.0 112.567 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.738 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -48.7 -55.62 10.87 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.638 ' CG ' ' O ' ' C' ' 115' ' ' ALA . 2.8 mm-40 130.46 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 13.0 t80 66.37 30.38 8.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.717 -0.614 . . . . 0.0 111.08 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.7 ' O ' ' N ' ' C' ' 120' ' ' ALA . 2.1 p -103.83 128.04 28.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 108.287 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.59 23.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.217 1.945 . . . . 0.0 112.907 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.7 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -157.01 -32.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.746 -1.221 . . . . 0.0 110.675 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.738 HG21 ' O ' ' C' ' 115' ' ' ALA . 12.9 p -49.86 -47.31 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.035 . . . . 0.0 110.236 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.641 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.4 t60 -61.72 -38.5 88.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.85 . . . . 0.0 109.778 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.37 -20.19 34.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.995 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -62.29 1.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.576 HD22 HD21 ' C' ' 105' ' ' LEU . 1.4 mt -65.14 -19.87 66.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 109.411 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.12 -49.31 37.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.958 . . . . 0.0 109.66 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.18 -42.03 11.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 109.632 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.573 ' CD2' HG21 ' C' ' 10' ' ' VAL . 32.1 t80 -49.97 -22.88 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 109.364 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.665 ' C ' HD12 ' C' ' 129' ' ' LEU . 1.2 pp -76.43 -22.03 55.18 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.15 -38.11 75.97 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.571 ' OG ' HD21 ' C' ' 2' ' ' LEU . 33.8 m -67.88 -26.82 66.2 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . 0.449 ' O ' HD13 ' C' ' 136' ' ' LEU . 5.7 t -85.61 -37.61 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.358 -0.839 . . . . 0.0 108.879 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 14.9 t -79.97 -18.09 51.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.318 -0.864 . . . . 0.0 108.778 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 42.6 m -83.24 -42.46 17.18 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.452 -0.78 . . . . 0.0 109.238 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.461 HG13 ' O ' ' C' ' 131' ' ' SER . 27.4 m -70.13 -21.93 24.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.245 -0.909 . . . . 0.0 108.694 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . 0.449 HD13 ' O ' ' C' ' 132' ' ' VAL . 0.9 OUTLIER -67.4 -31.91 72.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.448 -0.783 . . . . 0.0 108.941 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 7.2 m -153.19 57.1 0.77 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.296 -0.877 . . . . 0.0 109.47 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 25.5 t . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.935 . . . . 0.0 109.518 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 1.05 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -107.64 -159.17 0.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.506 -0.747 . . . . 0.0 109.35 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.401 ' O ' ' N ' ' D' ' 6' ' ' GLU . 9.9 p -103.56 134.36 19.79 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.435 -0.791 . . . . 0.0 109.34 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -42.08 -22.73 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.397 2.065 . . . . 0.0 112.495 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' D' ' 4' ' ' THR . 79.3 mt-10 -76.71 -55.63 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 110.043 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -68.14 -60.39 2.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.033 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.786 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -48.68 -30.16 5.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.846 . . . . 0.0 110.198 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 2.8 m -62.08 -23.63 66.62 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.041 -1.037 . . . . 0.0 110.083 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.97 -57.59 3.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.014 -1.054 . . . . 0.0 110.035 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.6 -25.02 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 56.9 m -83.48 -37.26 23.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' D' ' 9' ' ' SER . . . -63.22 -29.93 71.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.346 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.7 OUTLIER -52.08 -32.54 35.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.092 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . 0.533 ' HE1' ' HG ' ' D' ' 72' ' ' SER . 0.2 OUTLIER -47.14 -17.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.31 -52.01 5.83 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.421 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.1 OUTLIER -70.47 -29.32 65.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.202 -1.175 . . . . 0.0 109.322 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -48.84 114.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.55 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' D' ' 22' ' ' GLU . 18.4 m120 -82.67 69.49 9.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 108.941 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' D' ' 22' ' ' GLU . 78.7 t -43.81 -29.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 109.713 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -64.63 1.87 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.617 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' D' ' 20' ' ' VAL . 33.0 mt-10 -155.88 -46.18 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.393 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -48.54 -53.93 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.4 -48.51 48.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.4 -46.36 78.59 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -62.36 -40.07 95.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -1.153 . . . . 0.0 109.314 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -37.79 88.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.364 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -82.1 -51.35 8.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.275 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.91 -35.09 62.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -79.4 -30.58 42.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -1.14 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 60.1 tp -49.52 -38.95 32.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 109.368 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.57 -23.42 56.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.595 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.7 -61.62 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.21 -0.931 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.32 -23.81 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.77 76.06 48.09 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 109.258 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.64 11.42 2.72 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.769 2.312 . . . . 0.0 112.358 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . 0.477 ' CE2' HG23 ' D' ' 38' ' ' THR . 50.7 p-90 -80.54 -19.75 45.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.36 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.477 HG23 ' CE2' ' D' ' 37' ' ' TRP . 42.1 p -79.71 40.07 0.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -92.07 12.86 20.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -87.88 -34.44 18.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.591 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' D' ' 42' ' ' PHE . 29.4 m-85 -95.81 32.37 1.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 0.0 109.546 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.434 ' CD1' ' C ' ' D' ' 41' ' ' PHE . 56.5 m-85 -141.38 26.36 1.98 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 109.454 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -80.94 -25.07 37.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . 0.472 ' C ' ' H ' ' D' ' 46' ' ' GLY . 67.1 m -82.15 -38.31 24.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.922 . . . . 0.0 109.483 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -55.93 -5.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' D' ' 44' ' ' SER . . . 48.53 -167.77 0.15 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' D' ' 48' ' ' LEU . 18.9 t70 60.26 -150.21 0.42 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -1.154 . . . . 0.0 109.559 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . 0.455 ' H ' ' CG ' ' D' ' 47' ' ' ASP . 23.5 mt 60.46 34.39 20.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.562 -0.711 . . . . 0.0 109.656 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.2 m -80.47 -22.54 40.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . 0.495 ' O ' ' N ' ' D' ' 53' ' ' ALA . 21.1 p -146.05 149.07 37.58 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 109.157 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -36.85 -45.06 1.19 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.593 2.195 . . . . 0.0 112.595 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.73 -27.04 61.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 109.6 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -57.81 -19.59 29.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.589 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.99 -63.45 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 109.63 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' D' ' 55' ' ' MET . 2.3 mpp? -79.71 14.86 1.53 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.436 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.98 -49.06 4.41 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . 0.498 HD22 ' N ' ' D' ' 57' ' ' ASN . 1.0 OUTLIER -77.78 149.63 77.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.276 -1.132 . . . . 0.0 109.47 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.33 -52.03 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.642 2.228 . . . . 0.0 112.148 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -46.88 -40.71 14.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.336 -0.853 . . . . 0.0 109.58 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 86.6 t -54.22 -44.83 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.397 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' D' ' 61' ' ' LYS . 7.0 mtmp? -77.4 -43.06 33.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.11 -33.15 17.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -67.55 -24.49 65.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.584 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.57 -30.31 74.79 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -68.16 -41.21 81.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.33 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -64.08 -50.95 66.34 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.338 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 25.4 t -61.74 -23.84 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.201 -0.937 . . . . 0.0 109.331 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -78.17 -29.78 48.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.32 -57.09 14.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.48 -22.03 63.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -1.135 . . . . 0.0 109.517 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -74.53 -30.23 61.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.607 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . 0.533 ' HG ' ' HE1' ' D' ' 15' ' ' TRP . 4.5 m -89.21 -20.49 24.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.688 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -46.15 -30.73 2.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.692 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.41 -59.17 6.99 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.538 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.7 mp -56.74 -17.82 10.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -1.153 . . . . 0.0 109.628 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . 0.558 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -97.36 33.04 2.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 109.993 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 9.5 m-70 -176.81 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.143 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' D' ' 77' ' ' HIS . 29.9 mt 39.61 35.38 0.19 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.644 -0.66 . . . . 0.0 109.621 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -138.73 -31.4 0.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.788 . . . . 0.0 109.631 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' D' ' 80' ' ' ASN . 7.4 p-10 -151.95 72.85 1.03 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.296 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . 0.57 ' N ' HD12 ' D' ' 81' ' ' LEU . 9.5 mp -60.36 -27.15 67.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -80.6 -61.5 1.95 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.776 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.33 -23.79 42.75 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.426 HG23 ' O ' ' D' ' 80' ' ' ASN . 0.8 OUTLIER -62.34 -51.91 65.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 109.554 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.537 ' CZ ' ' O ' ' D' ' 81' ' ' LEU . 2.2 p90 -133.2 51.83 2.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 109.651 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.01 -29.31 4.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.322 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' D' ' 88' ' ' LEU . 17.8 p -60.59 -58.55 8.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.325 -0.859 . . . . 0.0 109.319 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.415 ' N ' ' OG1' ' D' ' 87' ' ' THR . 90.8 mt -48.47 -37.47 17.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.008 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -69.05 -34.95 76.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.034 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -82.87 -39.07 22.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -0.825 . . . . 0.0 109.4 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.05 -25.3 64.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.401 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' D' ' 97' ' ' HIS . 7.0 m80 -91.0 -21.74 21.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.625 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.56 -59.01 2.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 111.162 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.667 ' O ' HG21 ' A' ' 41' ' ' THR . 1.3 m-20 -87.28 -57.0 3.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.014 -1.054 . . . . 0.0 111.934 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' D' ' 95' ' ' LYS . 12.0 mptt -62.66 -52.25 64.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.131 -0.98 . . . . 0.0 111.263 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.606 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -95.41 -38.19 10.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.892 -1.13 . . . . 0.0 109.764 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.606 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 25.4 p80 45.36 33.26 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . 0.59 HG23 HD12 ' D' ' 96' ' ' LEU . 52.5 t -50.12 132.37 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.041 -1.037 . . . . 0.0 109.14 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . 0.546 ' OD1' HG11 ' A' ' 96' ' ' VAL . 4.2 m-20 -51.19 151.2 5.12 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.293 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.98 -170.32 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.464 2.109 . . . . 0.0 112.026 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' B' ' 101' ' ' GLU . 69.2 mm-40 53.14 70.04 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . 0.472 ' ND2' ' CD1' ' D' ' 103' ' ' PHE . 4.0 p-10 -171.23 -39.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -0.897 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' ND2' ' D' ' 102' ' ' ASN . 12.8 m-85 -50.25 -34.55 23.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -76.12 -43.99 40.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.559 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . 0.52 HD12 ' N ' ' D' ' 105' ' ' LEU . 9.9 mp -49.35 -51.85 31.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.441 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 tt -51.66 -37.21 49.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.137 -0.977 . . . . 0.0 109.303 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.93 -20.62 59.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -65.25 -34.36 78.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -1.179 . . . . 0.0 109.616 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.82 -31.71 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 7.6 tp -51.64 -52.12 50.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.559 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . 0.553 ' CG2' ' CE1' ' D' ' 130' ' ' TYR . 42.9 t -51.15 -42.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.577 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -60.18 -39.52 86.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.594 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.53 -55.0 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 109.681 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.96 -31.81 71.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -64.87 -27.83 69.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.469 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.48 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.79 -61.25 1.83 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 109.25 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . 0.417 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 8.3 m-70 -63.24 -18.42 63.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.525 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 58.9 m-85 -148.41 59.53 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 109.386 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -72.03 -14.74 76.24 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -79.45 -20.34 47.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.455 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.482 ' C ' ' H ' ' D' ' 123' ' ' THR . 29.2 mm-40 -95.4 -2.5 48.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.768 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.91 34.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.536 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.482 ' H ' ' C ' ' D' ' 121' ' ' GLU . 21.7 p -49.25 148.37 4.5 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.391 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.451 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 2.3 Cg_endo -46.71 -57.56 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.463 2.109 . . . . 0.0 113.03 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 17.7 Cg_endo -59.51 -42.38 48.48 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.12 1.88 . . . . 0.0 112.236 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 98.7 t -64.93 -20.95 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.917 . . . . 0.0 109.547 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . 0.901 HE22 ' HG3' ' C' ' 31' ' ' ARG . 37.0 tt0 -83.28 -48.91 9.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.576 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.658 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -58.72 -30.0 67.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.432 ' O ' HG23 ' D' ' 133' ' ' VAL . . . -82.14 19.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.653 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.553 ' CE1' ' CG2' ' D' ' 111' ' ' VAL . 47.1 t80 -107.92 -61.31 1.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.3 -0.875 . . . . 0.0 109.68 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 5.9 tp-100 -55.29 -23.25 22.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -83.06 -21.83 33.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.933 . . . . 0.0 109.653 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . 0.432 HG23 ' O ' ' D' ' 129' ' ' ALA . 77.6 t -81.09 -68.27 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.945 . . . . 0.0 109.721 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 22.3 m -53.83 -25.06 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.28 -0.888 . . . . 0.0 109.869 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -49.56 -29.79 7.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -0.949 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.33 -29.31 56.38 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.4 -38.15 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 0.0 109.432 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.88 79.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . 1.605 HD21 ' CD2' ' B' ' 146' ' ' HIS . 1.8 m120 -79.68 -22.99 42.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.952 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.72 -60.64 2.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.628 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.83 -25.21 66.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.266 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 -16.41 27.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 109.422 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -51.23 -33.47 28.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 18.8 mmtm -73.32 -27.17 61.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . 0.412 ' OH ' ' O ' ' D' ' 92' ' ' HIS . 16.2 m-85 -71.85 -46.28 58.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.455 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 1.653 ' CD2' HD21 ' B' ' 139' ' ' ASN . 43.7 p-80 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.483 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 1' ' ' VAL . 9.9 mt 54.48 170.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 0.0 109.638 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.488 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 176.32 -53.64 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.0 . . . . 0.0 110.317 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 6' ' ' ASP . 59.0 Cg_endo -73.97 -165.22 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.397 2.064 . . . . 0.0 112.777 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 8' ' ' THR . . . -43.93 -15.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.434 -0.792 . . . . 0.0 110.114 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' PRO . 53.5 m-20 -38.72 -37.22 0.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.806 . . . . 0.0 109.76 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -30.77 26.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.881 . . . . 0.0 109.685 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 5' ' ' ALA . 40.9 m -52.02 -37.48 53.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.173 -0.954 . . . . 0.0 109.213 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -73.87 -33.36 64.03 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.76 -52.29 26.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.94 -45.59 51.36 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.09 -61.76 2.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.579 -0.701 . . . . 0.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -55.65 -33.35 63.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.3 -0.875 . . . . 0.0 109.242 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.55 -17.38 60.09 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.31 -0.869 . . . . 0.0 109.062 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.06 -43.32 14.0 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -70.36 -39.96 74.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 108.828 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 13' ' ' ALA . 89.5 t -60.03 -65.4 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 57.29 -135.75 51.33 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 28.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.998 . . . . 0.0 110.48 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.556 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.9 m-70 -131.93 24.36 4.62 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.24 -62.76 1.42 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.624 -0.672 . . . . 0.0 109.727 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.41 -14.5 0.19 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' ALA . 1.3 mm-40 -84.15 -56.16 3.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -1.061 . . . . 0.0 109.433 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.641 ' CD1' ' CD2' ' A' ' 112' ' ' HIS . 3.1 m-30 -59.95 -37.09 78.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.374 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.73 -24.24 69.6 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.35 -45.05 20.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.629 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.01 -21.21 61.02 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.399 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.31 -21.53 62.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.693 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.617 HD11 ' ND1' ' A' ' 58' ' ' HIS . 12.5 mt -78.04 -51.54 10.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.505 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.34 -12.67 61.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.837 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.565 ' NH2' ' SG ' ' A' ' 104' ' ' CYS . 0.9 OUTLIER -76.48 -40.37 50.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 110.276 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.0 ptt? -84.16 -35.56 23.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 109.963 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -45.99 -41.72 12.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 109.665 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.885 ' CD1' ' HB2' ' B' ' 128' ' ' ALA . 2.2 pp -84.63 -35.89 22.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.067 -1.021 . . . . 0.0 109.82 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.4 p -85.33 1.45 48.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.538 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' MET . 67.0 m-85 -159.17 68.13 3.2 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 39' ' ' THR . 72.1 Cg_exo -47.75 -34.34 21.14 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.821 2.347 . . . . 0.0 112.279 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 1.318 HG22 ' ND1' ' D' ' 97' ' ' HIS . 2.2 p -47.05 -18.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.927 . . . . 0.0 109.591 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' PRO . 81.4 p -84.5 -31.33 24.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 0.0 109.709 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -68.6 -26.44 65.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 109.685 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.909 HG21 ' CD2' ' D' ' 97' ' ' HIS . 5.3 t . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.259 -0.9 . . . . 0.0 109.87 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.532 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 26.6 p80 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 120.867 0.365 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -135.86 26.85 3.31 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.001 -1.062 . . . . 0.0 109.687 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 49' ' ' SER . 55.2 m-20 44.44 83.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.485 -0.759 . . . . 0.0 109.529 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.565 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -52.01 -8.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 109.5 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 47' ' ' ASP . 35.0 p -68.36 169.45 10.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 0.0 109.469 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -78.96 164.3 24.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.863 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.04 17.31 71.66 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.632 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 3.0 t -77.52 -28.62 52.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -1.156 . . . . 0.0 109.487 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 73.28 -31.66 0.23 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.602 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 52' ' ' SER . 38.0 mt-30 -80.51 -22.56 40.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -83.46 -35.93 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -81.42 -32.93 32.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.198 -0.939 . . . . 0.0 108.615 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.66 -21.96 78.85 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.617 ' ND1' HD11 ' A' ' 29' ' ' LEU . 10.1 t-80 -70.51 -29.97 66.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -1.055 . . . . 0.0 109.24 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.76 -51.45 57.95 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -48.36 -23.82 1.04 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -1.136 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -71.39 -51.12 25.8 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.179 -0.951 . . . . 0.0 108.608 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.7 t -60.85 -47.7 92.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.76 89.42 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.348 -0.845 . . . . 0.0 108.923 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -60.06 -39.07 84.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -65.01 -52.33 56.69 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.5 mt -57.59 -43.91 84.97 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 71' ' ' ALA . 19.0 m -69.34 -51.25 38.81 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -61.64 -26.14 67.81 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.17 -46.59 10.94 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.8 t -65.2 -22.67 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -64.09 -21.62 66.6 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' ' 74' ' ' ASP . 42.4 m80 -146.44 -51.94 0.23 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.4 p 44.74 13.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.687 0.756 . . . . 0.0 109.407 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 72' ' ' HIS . 29.2 m-20 -127.04 9.5 6.83 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.411 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 49.8 t0 -173.68 27.3 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.046 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.689 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 4.8 ptt? -78.33 -24.2 0.43 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.44 -0.788 . . . . 0.0 111.668 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.8 Cg_exo -53.02 -27.73 37.26 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.634 1.556 . . . . 0.0 112.506 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.487 HD22 ' N ' ' A' ' 78' ' ' ASN . 1.4 m-80 -94.3 -24.79 17.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.74 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.79 -46.38 21.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.0 109.223 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.427 ' CD1' HG13 ' A' ' 132' ' ' VAL . 9.7 mt -82.05 9.3 8.7 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 108.981 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.5 m -65.69 -22.41 66.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 109.512 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -82.01 -59.64 2.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.135 -0.978 . . . . 0.0 109.694 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -50.8 -26.2 5.39 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 73.2 m -67.5 -33.4 75.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' ALA . 4.3 t70 -78.26 -30.07 48.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 108.806 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 86' ' ' LEU . 2.1 tm? -54.31 -49.55 69.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.509 -0.744 . . . . 0.0 109.388 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.466 ' N ' HD13 ' A' ' 86' ' ' LEU . 8.2 p-80 -92.24 -21.78 20.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.008 . . . . 0.0 110.375 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -92.93 -2.62 55.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.042 -1.036 . . . . 0.0 110.293 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -128.56 -77.06 0.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.194 -0.941 . . . . 0.0 109.771 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -46.66 -78.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.761 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.2 mp -71.06 -39.05 72.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.106 -0.996 . . . . 0.0 109.647 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 61.84 59.28 1.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 109.42 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 94' ' ' ASP . 90.3 t -85.21 166.59 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 109.614 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.624 ' N ' HG12 ' A' ' 93' ' ' VAL . 3.8 m-20 -99.33 120.05 58.92 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.381 -0.824 . . . . 0.0 109.217 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' PHE . 83.3 Cg_exo -44.11 -10.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.225 1.95 . . . . 0.0 112.432 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 94' ' ' ASP . 96.1 t -45.55 -23.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 95' ' ' PRO . 73.3 m-20 -79.3 -24.84 42.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 109.57 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' OG ' ' A' ' 102' ' ' SER . 20.4 t80 -46.53 -35.05 5.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -64.61 -33.27 75.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.485 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.0 mt -84.06 -43.75 14.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.523 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 101' ' ' LEU . 4.8 tt -54.38 -52.04 62.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.537 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 98' ' ' PHE . 15.7 m -59.63 -33.52 71.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 103' ' ' HIS . 0.7 OUTLIER -80.65 -26.65 37.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.095 -1.003 . . . . 0.0 110.096 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.565 ' SG ' ' NH2' ' A' ' 31' ' ' ARG . 72.0 m -63.95 -58.36 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.246 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.43 -34.51 4.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.935 . . . . 0.0 110.093 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.8 mt -70.75 -28.2 64.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 110.176 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -83.04 -38.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.979 -1.076 . . . . 0.0 109.582 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 110' ' ' ALA . 19.1 p -70.58 -58.9 3.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.2 -0.938 . . . . 0.0 109.649 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 113' ' ' LEU . 9.5 mt -43.12 -26.28 0.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.765 . . . . 0.0 109.587 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -67.36 -22.64 65.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 110.589 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.37 -48.02 12.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.025 . . . . 0.0 111.006 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.641 ' CD2' ' CD1' ' A' ' 24' ' ' TYR . 1.1 p-80 -100.76 -58.87 1.8 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.025 -1.047 . . . . 0.0 111.037 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.538 HD13 ' C ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -112.44 93.35 22.53 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 109.284 -178.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 113' ' ' LEU . 76.7 Cg_exo -47.0 -174.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.364 2.042 . . . . 0.0 112.685 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.795 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -61.56 -55.35 31.77 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.648 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 27.8 mt-10 119.92 1.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 117' ' ' PHE . 38.3 t80 59.62 31.63 21.04 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.298 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.794 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.3 p -104.4 120.8 49.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.985 -1.072 . . . . 0.0 108.14 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.1 23.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.09 1.86 . . . . 0.0 112.72 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.794 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -154.43 -29.96 0.11 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.853 -1.155 . . . . 0.0 110.676 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.795 HG21 ' O ' ' A' ' 115' ' ' ALA . 13.7 p -51.16 -50.16 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.996 -1.065 . . . . 0.0 110.274 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.667 ' N ' HG13 ' A' ' 121' ' ' VAL . 3.1 t-160 -61.31 -53.41 57.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.868 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' B' ' 34' ' ' VAL . . . -72.72 -19.83 61.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 120' ' ' ALA . 20.5 m -63.72 -62.51 1.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.164 -0.96 . . . . 0.0 110.277 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 1.2 mt -64.4 -16.85 63.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.352 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.07 -49.18 9.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 110.902 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.62 -59.03 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.818 -1.176 . . . . 0.0 111.264 -178.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.48 ' N ' ' HD2' ' A' ' 127' ' ' LYS . 21.4 m-85 -47.98 -21.23 0.41 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.717 -1.239 . . . . 0.0 109.752 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.918 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -72.1 -31.03 65.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 134' ' ' THR . . . -49.2 -33.18 11.9 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.467 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 43.2 t -60.36 -37.02 79.39 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 80' ' ' LEU . 6.3 t -77.06 -48.72 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.406 ' CB ' ' CE1' ' A' ' 98' ' ' PHE . 13.5 t -66.48 -22.72 66.19 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.278 -0.889 . . . . 0.0 108.635 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 130' ' ' ALA . 11.2 m -64.06 -31.75 73.06 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.411 -0.806 . . . . 0.0 108.827 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.62 -37.26 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 109.14 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 83' ' ' LEU . 5.6 mp -60.59 -35.29 75.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.299 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 134' ' ' THR . 34.9 p -67.9 -33.75 75.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.21 0.529 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.717 HD13 ' HB3' ' B' ' 8' ' ' LYS . 1.9 mt -87.8 161.05 17.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.561 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.19 138.18 19.47 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.371 -0.83 . . . . 0.0 108.826 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -40.02 -54.19 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.524 2.149 . . . . 0.0 112.637 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -72.01 -21.84 61.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 110.02 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -76.62 -63.12 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 109.902 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.717 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -66.58 -29.59 69.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.068 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.6 t -47.5 -23.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 110.101 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.66 -56.85 3.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 109.992 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.428 ' H ' HG12 ' B' ' 11' ' ' VAL . 0.8 OUTLIER -68.13 -24.64 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.9 m -73.52 -40.28 64.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.746 -0.596 . . . . 0.0 109.607 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.42 -31.23 71.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.409 -0.807 . . . . 0.0 109.447 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.8 OUTLIER -50.7 -31.47 16.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 0.0 109.155 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -47.57 -17.82 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.382 -0.824 . . . . 0.0 109.537 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.97 -51.1 5.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' B' ' 17' ' ' LYS . 0.1 OUTLIER -71.23 -29.56 65.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.169 -1.194 . . . . 0.0 109.33 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -49.42 114.79 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.925 . . . . 0.0 109.581 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' B' ' 22' ' ' GLU . 95.3 m-20 -78.39 67.65 4.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.01 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' B' ' 22' ' ' GLU . 68.8 t -44.32 -29.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.831 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.14 7.43 0.57 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' B' ' 20' ' ' VAL . 38.5 mt-10 -155.23 -49.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -48.59 -60.72 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.89 -39.22 17.69 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.09 -43.73 89.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.419 ' O ' ' CG ' ' B' ' 30' ' ' ARG . 57.0 mt-10 -79.47 -40.39 29.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.291 -1.123 . . . . 0.0 109.546 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 -34.32 8.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -82.6 -56.67 3.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.73 -44.83 80.35 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.571 HH21 HG11 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -53.89 -36.48 62.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -1.123 . . . . 0.0 109.26 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -55.95 -47.63 77.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 0.0 109.412 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.02 -22.73 67.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.571 HG11 HH21 ' B' ' 30' ' ' ARG . 74.8 t -81.65 -64.72 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 109.358 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 123' ' ' ALA . 2.2 t -67.64 -22.79 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.465 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.428 ' CG ' HD21 ' B' ' 105' ' ' LEU . 83.5 m-85 -139.46 80.97 21.13 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.428 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.86 -16.04 9.09 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.668 2.245 . . . . 0.0 112.515 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -51.02 -19.91 1.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.075 -1.016 . . . . 0.0 109.416 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 3.6 p -85.54 55.51 3.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.215 -0.928 . . . . 0.0 109.147 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -109.77 41.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.435 -0.791 . . . . 0.0 109.255 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 mmt-85 -104.03 -49.29 3.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.0 109.479 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' B' ' 41' ' ' PHE . 27.7 m-85 -91.86 30.04 1.46 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.585 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' B' ' 44' ' ' SER . 9.4 p90 -92.55 -12.97 30.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -46.07 -13.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.909 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.544 ' N ' ' O ' ' B' ' 42' ' ' PHE . 23.8 p -124.3 23.49 8.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.245 -0.909 . . . . 0.0 109.583 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.34 -14.2 21.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 0.0 109.322 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.54 -116.76 2.21 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -144.26 105.23 4.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -1.11 . . . . 0.0 109.557 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.94 30.57 1.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.14 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.5 p -44.0 -32.37 1.13 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.817 . . . . 0.0 109.859 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 17.8 p -146.61 148.31 33.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -40.16 -50.2 3.57 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.517 2.145 . . . . 0.0 112.177 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.21 -35.09 76.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' B' ' 50' ' ' THR . . . -53.83 -19.77 4.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.507 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.18 -63.95 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 12.2 mmt -63.05 -7.58 5.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.38 -10.24 64.06 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -78.37 141.98 62.22 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.173 -1.192 . . . . 0.0 109.378 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -74.3 -57.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.59 2.193 . . . . 0.0 112.214 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' B' ' 63' ' ' HIS . 45.6 mtpt -51.98 -48.49 64.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.556 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' B' ' 59' ' ' LYS . 74.3 t -45.8 -39.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.0 109.289 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -79.35 -52.4 8.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.85 . . . . 0.0 109.321 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.36 -59.18 3.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.805 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . 0.538 ' N ' ' O ' ' B' ' 59' ' ' LYS . 1.7 t60 -48.29 -24.85 1.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.41 -36.73 91.99 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -69.29 -25.14 64.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -1.125 . . . . 0.0 109.479 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -73.13 -35.35 66.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.559 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 39.6 t -75.75 -28.3 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.21 -34.94 68.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.302 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.51 -45.12 37.44 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.83 91.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -1.209 . . . . 0.0 109.65 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . 0.421 ' CE2' HD21 ' B' ' 110' ' ' LEU . 25.5 t80 -57.29 -41.07 79.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 109.579 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.7 t -76.63 -37.75 55.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.653 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -47.5 -37.57 12.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.535 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -60.4 7.6 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.569 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -55.82 -30.04 60.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.248 -1.148 . . . . 0.0 109.401 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.09 5.4 29.82 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.201 -0.937 . . . . 0.0 109.65 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.522 ' NE2' ' OD1' ' B' ' 80' ' ' ASN . 7.5 t60 -170.93 67.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 109.525 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.93 17.96 1.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -79.63 -29.23 40.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.452 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.522 ' OD1' ' NE2' ' B' ' 77' ' ' HIS . 4.3 p-10 -163.21 95.82 0.86 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.235 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.493 ' H ' HD12 ' B' ' 81' ' ' LEU . 5.0 mp -80.28 -58.91 2.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.204 -0.935 . . . . 0.0 109.64 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -57.46 -23.83 52.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.075 -1.016 . . . . 0.0 109.568 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.06 -54.41 3.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.0 t -61.38 -47.58 85.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -1.157 . . . . 0.0 109.614 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.557 ' N ' ' CG2' ' B' ' 84' ' ' THR . 54.4 m-85 -76.7 22.04 0.19 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.351 -0.843 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.46 -26.8 44.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 75.3 p -78.85 -59.1 2.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.754 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.4 mt -48.63 -45.05 37.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.955 . . . . 0.0 109.288 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 53.9 p -64.72 -52.71 55.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.267 -0.896 . . . . 0.0 109.269 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -61.27 -22.7 65.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 tp -86.9 -68.71 0.73 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.417 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.509 ' O ' ' N ' ' B' ' 97' ' ' HIS . 48.8 m80 -51.01 -26.54 6.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.094 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . 0.407 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 27.5 t -83.73 -55.93 3.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 111.303 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.529 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 27.4 t0 -86.24 -32.2 21.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.001 -1.062 . . . . 0.0 111.945 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -89.36 -51.76 5.39 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.689 -1.257 . . . . 0.0 111.132 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.63 -27.03 15.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.852 -1.155 . . . . 0.0 110.43 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 1.24 ' ND1' HG22 ' C' ' 38' ' ' THR . 83.0 m-70 51.67 29.57 5.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.038 -1.039 . . . . 0.0 109.61 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.401 ' O ' ' OH ' ' B' ' 145' ' ' TYR . 40.0 t -47.14 130.2 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.968 . . . . 0.0 109.503 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.38 152.46 32.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.28 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.88 -164.09 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.553 2.169 . . . . 0.0 112.165 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.26 60.72 2.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.877 . . . . 0.0 109.578 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.542 ' C ' HD22 ' B' ' 102' ' ' ASN . 0.1 OUTLIER -171.3 -41.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.457 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -46.21 -40.55 11.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 109.714 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -80.07 -19.92 46.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.554 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' B' ' 102' ' ' ASN . 12.3 tp -70.47 -59.77 2.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 109.639 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -49.84 -46.22 51.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 109.354 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.06 -20.44 58.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -80.53 -25.2 38.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -1.105 . . . . 0.0 109.577 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 74.2 t -86.19 -43.09 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 109.683 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.421 HD21 ' CE2' ' B' ' 71' ' ' PHE . 6.3 tt -48.26 -33.05 8.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.464 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -83.05 -26.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.532 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.4 m -69.1 -24.79 64.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.538 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 42.4 t -76.34 -34.89 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' B' ' 118' ' ' PHE . 9.5 mt -69.83 -40.16 76.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 109.413 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -54.4 -28.92 46.93 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 109.438 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.525 ' C ' ' HD1' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.74 -62.41 1.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.106 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -63.36 -17.75 62.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.551 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' B' ' 114' ' ' LEU . 93.3 m-85 -149.72 60.4 1.0 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 109.402 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.535 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -69.22 -24.72 75.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -64.75 -29.67 70.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -1.153 . . . . 0.0 109.346 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.489 ' C ' ' H ' ' B' ' 123' ' ' THR . 78.3 mm-40 -87.81 5.71 38.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 109.736 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.543 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.64 33.09 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 109.422 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.489 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.4 p -52.41 149.13 10.88 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.353 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.516 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.1 Cg_exo -45.41 -53.66 5.23 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.452 2.101 . . . . 0.0 112.988 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 24.6 Cg_endo -62.16 -29.65 81.04 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.05 1.834 . . . . 0.0 112.223 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.441 HG23 ' OG1' ' B' ' 123' ' ' THR . 45.7 t -68.81 -28.15 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 109.423 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -83.15 -53.89 5.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.885 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -63.25 -26.49 68.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.576 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.51 -2.33 53.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.114 -0.991 . . . . 0.0 109.807 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' B' ' 132' ' ' LYS . 41.8 t80 -92.49 -61.52 1.58 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.717 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 1.5 tm0? -45.25 -23.32 0.17 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 109.931 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' B' ' 130' ' ' TYR . 51.1 mtmt -85.46 -34.6 21.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.217 -0.927 . . . . 0.0 110.322 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 0.6 OUTLIER -68.61 -44.15 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.075 . . . . 0.0 109.676 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.501 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 6.1 m -79.64 -20.91 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -50.51 -32.41 18.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -0.974 . . . . 0.0 109.364 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.63 -26.56 56.36 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.42 -32.96 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -1.148 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.44 90.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.67 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.89 -21.05 47.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.766 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.01 -58.86 6.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.663 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 48.4 mt -61.48 -31.88 71.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 109.497 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.06 25.15 4.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.251 -0.905 . . . . 0.0 109.599 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -80.0 -16.13 55.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.712 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 13.2 mptt -98.34 -26.72 14.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 0.0 109.613 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' B' ' 98' ' ' VAL . 12.3 m-85 -54.38 -6.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.11 -0.994 . . . . 0.0 109.425 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' B' ' 144' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.428 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' C' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' C' ' 1' ' ' VAL . 9.9 mt 54.47 170.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.353 -0.842 . . . . 0.0 109.621 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.49 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 176.31 -53.58 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.322 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' C' ' 6' ' ' ASP . 59.0 Cg_endo -74.05 -165.15 0.24 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.373 2.048 . . . . 0.0 112.776 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' C' ' 8' ' ' THR . . . -44.0 -15.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.497 -0.752 . . . . 0.0 110.129 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' C' ' 4' ' ' PRO . 53.1 m-20 -38.82 -37.11 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 109.779 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' C' ' 8' ' ' THR . 0.0 OUTLIER -83.8 -30.94 26.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.666 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.518 ' N ' ' O ' ' C' ' 5' ' ' ALA . 41.7 m -51.87 -37.52 52.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.068 -1.02 . . . . 0.0 109.283 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -73.87 -33.39 64.05 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -71.69 -52.38 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.87 -45.61 50.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.02 -61.9 2.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.629 -0.669 . . . . 0.0 109.883 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.661 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -55.57 -33.37 63.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.295 -0.878 . . . . 0.0 109.246 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -17.38 60.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.285 -0.884 . . . . 0.0 109.029 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.0 -43.24 14.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -70.41 -39.83 74.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -1.199 . . . . 0.0 108.856 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.661 HG23 ' O ' ' C' ' 13' ' ' ALA . 88.3 t -60.2 -65.39 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 57.27 -135.74 51.33 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 28.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.439 -1.036 . . . . 0.0 110.453 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.7 m-70 -131.92 24.27 4.62 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.19 -62.9 1.39 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.603 -0.686 . . . . 0.0 109.651 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.2 -14.7 0.17 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 21' ' ' ALA . 1.3 mm-40 -84.11 -56.11 3.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.461 -1.023 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.638 ' CD1' ' CD2' ' C' ' 112' ' ' HIS . 3.1 m-30 -60.05 -36.96 78.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.387 -0.821 . . . . 0.0 109.391 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.77 -24.27 69.7 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.31 -45.0 20.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 109.681 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.03 -21.28 61.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.25 -21.48 62.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.671 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.626 HD11 ' ND1' ' C' ' 58' ' ' HIS . 12.4 mt -78.08 -51.59 10.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.1 -12.9 61.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.825 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.557 ' NH2' ' SG ' ' C' ' 104' ' ' CYS . 0.9 OUTLIER -76.4 -40.48 50.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.137 -0.977 . . . . 0.0 110.25 -179.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . 0.542 ' O ' ' N ' ' C' ' 36' ' ' PHE . 3.0 ptt? -84.04 -35.61 23.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.98 -1.075 . . . . 0.0 109.982 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' C' ' 33' ' ' PHE . 0.0 OUTLIER -45.87 -41.77 11.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.947 . . . . 0.0 109.719 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.883 ' CD1' ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -84.59 -35.93 22.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.962 . . . . 0.0 109.937 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.3 p -85.25 1.43 48.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' C' ' 32' ' ' MET . 67.3 m-85 -159.1 68.1 3.23 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' C' ' 39' ' ' THR . 69.3 Cg_exo -47.73 -34.29 20.9 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.8 2.334 . . . . 0.0 112.308 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 1.24 HG22 ' ND1' ' B' ' 97' ' ' HIS . 2.1 p -47.09 -18.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 109.568 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.441 ' N ' ' O ' ' C' ' 37' ' ' PRO . 81.6 p -84.52 -31.25 24.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.756 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -68.66 -26.43 65.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.951 . . . . 0.0 109.609 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.832 HG21 ' CD2' ' B' ' 97' ' ' HIS . 5.4 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.862 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.53 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 26.7 p80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.838 0.352 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.422 ' O ' ' OG ' ' C' ' 52' ' ' SER . 2.8 p90 -135.91 26.93 3.29 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.047 -1.033 . . . . 0.0 109.611 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' C' ' 49' ' ' SER . 55.6 m-20 44.41 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.393 -0.817 . . . . 0.0 109.568 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.566 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.6 OUTLIER -51.98 -8.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.474 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.495 ' H ' ' C ' ' C' ' 47' ' ' ASP . 35.6 p -68.39 169.48 10.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -78.98 164.3 24.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.525 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.05 17.27 71.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.615 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 3.0 t -77.53 -28.54 52.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -1.128 . . . . 0.0 109.516 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 73.18 -31.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.606 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' C' ' 52' ' ' SER . 38.1 mt-30 -80.52 -22.67 40.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 0.0 109.389 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -83.38 -36.09 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.423 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -81.36 -32.89 32.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.138 -0.976 . . . . 0.0 108.674 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.6 -22.01 78.86 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.626 ' ND1' HD11 ' C' ' 29' ' ' LEU . 10.0 t-80 -70.44 -30.02 66.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -1.134 . . . . 0.0 109.254 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -51.47 57.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -48.29 -23.86 1.02 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 0.0 109.775 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -71.44 -51.08 25.81 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.257 -0.902 . . . . 0.0 108.577 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 25.6 t -60.78 -47.78 91.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.02 -38.71 89.12 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -59.97 -39.29 85.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 108.489 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -64.89 -52.39 56.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.58 -43.99 85.01 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.415 ' O ' ' N ' ' C' ' 71' ' ' ALA . 19.3 m -69.18 -51.36 38.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.285 -0.885 . . . . 0.0 108.702 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -61.53 -26.12 67.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.208 -0.932 . . . . 0.0 108.521 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -85.12 -46.61 10.96 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 20.8 t -65.11 -22.8 32.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -64.0 -21.69 66.61 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' C' ' 74' ' ' ASP . 42.5 m80 -146.45 -51.89 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.878 . . . . 0.0 109.473 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.4 p 44.71 13.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.74 0.781 . . . . 0.0 109.406 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' C' ' 72' ' ' HIS . 29.2 m-20 -127.03 9.57 6.85 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.413 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 49.7 t0 -173.75 27.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.121 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 4.8 ptt? -78.3 -24.16 0.43 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.514 -0.741 . . . . 0.0 111.679 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.0 Cg_exo -52.97 -27.96 37.81 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.626 1.551 . . . . 0.0 112.398 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.477 HD22 ' N ' ' C' ' 78' ' ' ASN . 1.4 m-80 -94.09 -24.8 17.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.826 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 -46.41 21.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.094 -1.003 . . . . 0.0 109.203 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . 0.416 ' CD1' HG13 ' C' ' 132' ' ' VAL . 9.8 mt -82.03 9.26 8.73 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.42 -0.8 . . . . 0.0 109.024 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 4.5 m -65.59 -22.44 66.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.572 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -82.06 -59.67 2.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.623 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.723 ' O ' HD12 ' C' ' 83' ' ' LEU . 0.4 OUTLIER -50.85 -26.09 5.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 73.3 m -67.59 -33.27 74.67 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' C' ' 82' ' ' ALA . 4.2 t70 -78.41 -29.93 47.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 108.79 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.777 HD13 ' C ' ' C' ' 86' ' ' LEU . 2.1 tm? -54.48 -49.46 70.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.501 -0.75 . . . . 0.0 109.338 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . 0.461 ' N ' HD13 ' C' ' 86' ' ' LEU . 8.2 p-80 -92.31 -21.67 20.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.407 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -92.9 -2.72 55.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.086 -1.009 . . . . 0.0 110.345 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -128.61 -77.01 0.56 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.953 . . . . 0.0 109.847 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -46.64 -78.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.981 . . . . 0.0 109.817 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.602 ' N ' HD12 ' C' ' 91' ' ' LEU . 8.2 mp -70.98 -39.17 72.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.569 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 61.86 59.35 1.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.389 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.63 HG12 ' N ' ' C' ' 94' ' ' ASP . 90.6 t -85.16 166.6 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 109.669 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.63 ' N ' HG12 ' C' ' 93' ' ' VAL . 3.8 m-20 -99.32 120.02 59.02 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.35 -0.843 . . . . 0.0 109.28 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' C' ' 98' ' ' PHE . 82.8 Cg_exo -44.12 -10.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.276 1.984 . . . . 0.0 112.394 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' C' ' 94' ' ' ASP . 95.7 t -45.63 -23.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.346 -0.846 . . . . 0.0 109.659 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' C' ' 95' ' ' PRO . 73.4 m-20 -79.24 -24.82 42.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.598 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' C' ' 102' ' ' SER . 20.5 t80 -46.51 -35.06 5.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.65 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' C' ' 99' ' ' LYS . 0.3 OUTLIER -64.55 -33.31 75.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.428 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 8.9 mt -84.05 -43.86 14.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.477 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . 0.433 ' C ' HD23 ' C' ' 101' ' ' LEU . 4.8 tt -54.32 -52.09 62.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' C' ' 98' ' ' PHE . 15.6 m -59.52 -33.57 71.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 109.934 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . 0.507 ' N ' ' ND1' ' C' ' 103' ' ' HIS . 0.7 OUTLIER -80.71 -26.56 37.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 110.068 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.557 ' SG ' ' NH2' ' C' ' 31' ' ' ARG . 71.8 m -63.9 -58.45 6.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.33 -34.58 4.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.153 -0.967 . . . . 0.0 110.094 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -70.71 -28.3 64.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.044 -1.035 . . . . 0.0 110.176 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.95 -38.22 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 109.579 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.42 ' O ' ' N ' ' C' ' 110' ' ' ALA . 19.2 p -70.67 -58.88 3.19 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.187 -0.945 . . . . 0.0 109.599 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' C' ' 113' ' ' LEU . 9.5 mt -43.18 -26.28 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' C' ' 108' ' ' THR . . . -67.29 -22.62 65.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 110.641 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.34 -47.99 12.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.074 -1.016 . . . . 0.0 111.017 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . 0.638 ' CD2' ' CD1' ' C' ' 24' ' ' TYR . 1.1 p-80 -100.85 -58.81 1.82 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.98 -1.075 . . . . 0.0 111.034 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.548 HD13 ' C ' ' C' ' 113' ' ' LEU . 0.9 OUTLIER -112.4 93.43 22.72 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.272 -178.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' C' ' 113' ' ' LEU . 78.0 Cg_exo -47.15 -174.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.355 2.037 . . . . 0.0 112.643 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.781 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -61.65 -55.42 30.79 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.657 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 27.7 mt-10 120.0 1.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' C' ' 117' ' ' PHE . 38.4 t80 59.69 31.7 21.03 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.225 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.781 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.3 p -104.46 120.73 49.62 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.01 23.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.164 1.909 . . . . 0.0 112.679 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.781 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -154.41 -29.95 0.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.945 -1.097 . . . . 0.0 110.701 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.781 HG21 ' O ' ' C' ' 115' ' ' ALA . 13.7 p -51.14 -50.17 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.95 -1.094 . . . . 0.0 110.302 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.675 ' N ' HG13 ' C' ' 121' ' ' VAL . 3.1 t-160 -61.34 -53.3 58.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 109.887 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . 0.516 ' HB2' ' HA ' ' D' ' 34' ' ' VAL . . . -72.79 -19.88 61.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.949 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.573 ' N ' ' O ' ' C' ' 120' ' ' ALA . 20.6 m -63.67 -62.56 1.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 110.254 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' C' ' 129' ' ' LEU . 1.2 mt -64.37 -16.91 63.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.348 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -84.08 -49.04 9.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.89 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.73 -59.04 2.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.879 -1.138 . . . . 0.0 111.302 -178.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.487 ' N ' ' HD2' ' C' ' 127' ' ' LYS . 21.4 m-85 -47.92 -21.31 0.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.82 -1.175 . . . . 0.0 109.811 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.898 ' O ' HD12 ' C' ' 129' ' ' LEU . 0.1 OUTLIER -71.99 -31.02 65.84 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' C' ' 134' ' ' THR . . . -49.28 -33.14 12.27 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.465 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 42.3 t -60.3 -37.07 79.4 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' C' ' 80' ' ' LEU . 6.5 t -77.02 -48.73 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.402 ' CB ' ' CE1' ' C' ' 98' ' ' PHE . 13.5 t -66.47 -22.78 66.2 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . 0.52 ' N ' ' O ' ' C' ' 130' ' ' ALA . 11.2 m -64.08 -31.56 72.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.324 -0.86 . . . . 0.0 108.86 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.75 -37.21 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.134 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . 0.467 HD11 HD11 ' C' ' 83' ' ' LEU . 5.6 mp -60.72 -35.21 75.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.277 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' C' ' 134' ' ' THR . 35.1 p -68.06 -33.6 74.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.371 -0.83 . . . . 0.0 109.492 179.893 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.234 0.54 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' D' ' 8' ' ' LYS . 1.9 mt -87.84 161.07 17.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.31 138.22 19.48 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -40.02 -54.19 2.19 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.526 2.151 . . . . 0.0 112.601 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.04 -21.74 61.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -76.69 -63.1 1.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 109.824 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.716 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -66.66 -29.6 69.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 109.936 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -47.52 -23.63 0.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.959 . . . . 0.0 110.048 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.74 -56.89 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.074 -1.016 . . . . 0.0 109.936 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.4 ' H ' HG12 ' D' ' 11' ' ' VAL . 0.8 OUTLIER -68.19 -24.51 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 26.0 m -73.55 -40.36 64.03 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.379 0.609 . . . . 0.0 109.591 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.37 -31.24 71.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.8 OUTLIER -50.7 -31.47 16.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.154 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -47.44 -18.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.491 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.91 -51.08 6.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.424 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.1 OUTLIER -71.25 -29.6 65.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -1.218 . . . . 0.0 109.335 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -49.26 114.76 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' D' ' 22' ' ' GLU . 95.4 m-20 -78.45 67.6 4.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.321 -0.862 . . . . 0.0 109.074 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' D' ' 22' ' ' GLU . 69.0 t -44.34 -29.1 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.73 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.08 7.39 0.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.557 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' D' ' 20' ' ' VAL . 38.7 mt-10 -155.29 -49.36 0.08 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.0 t -48.69 -60.74 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.92 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.87 -39.15 17.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.1 -43.8 89.29 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' D' ' 30' ' ' ARG . 57.0 mt-10 -79.51 -40.34 29.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -1.169 . . . . 0.0 109.487 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 -34.26 8.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -82.58 -56.75 3.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.307 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.67 -44.78 79.72 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . 0.58 HH21 HG11 ' D' ' 33' ' ' VAL . 0.0 OUTLIER -53.95 -36.44 62.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -1.123 . . . . 0.0 109.31 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -56.01 -47.57 77.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.37 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 mt -65.06 -22.74 67.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.595 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . 0.58 HG11 HH21 ' D' ' 30' ' ' ARG . 74.7 t -81.63 -64.68 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.434 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' C' ' 123' ' ' ALA . 2.2 t -67.67 -22.79 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.501 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . 0.425 ' CG ' HD21 ' D' ' 105' ' ' LEU . 83.5 m-85 -139.41 80.86 21.58 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.77 -16.17 9.14 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.726 2.284 . . . . 0.0 112.437 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -51.04 -19.77 1.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 109.516 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 3.7 p -85.56 55.56 3.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 109.231 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -109.81 41.27 1.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.258 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 57.5 mmt-85 -103.91 -49.34 3.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.82 . . . . 0.0 109.477 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -91.82 29.98 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.585 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' D' ' 44' ' ' SER . 9.4 p90 -92.63 -12.98 30.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -45.92 -14.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.338 -0.851 . . . . 0.0 109.971 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . 0.543 ' N ' ' O ' ' D' ' 42' ' ' PHE . 23.4 p -124.26 23.47 8.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.87 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.4 -14.06 21.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.253 -0.904 . . . . 0.0 109.267 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.43 -116.86 2.25 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -144.3 105.34 4.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.355 -1.085 . . . . 0.0 109.535 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 mt -90.94 30.5 1.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.042 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.8 p -43.91 -32.47 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 109.925 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 17.9 p -146.52 148.4 33.81 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 109.389 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -40.37 -49.96 3.8 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.378 2.052 . . . . 0.0 112.232 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -61.29 -35.06 76.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.92 -19.69 4.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.23 -63.9 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -0.929 . . . . 0.0 109.542 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 12.2 mmt -63.07 -7.59 5.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.5 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.35 -10.25 64.12 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -78.43 141.92 61.89 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.228 -1.16 . . . . 0.0 109.325 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.26 -57.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.492 2.128 . . . . 0.0 112.242 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' D' ' 63' ' ' HIS . 45.7 mtpt -52.02 -48.4 64.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.619 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 73.9 t -45.86 -39.7 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 109.251 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -79.44 -52.34 8.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.315 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.29 -59.26 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.812 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' D' ' 59' ' ' LYS . 1.7 t60 -48.25 -24.87 1.31 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.646 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.32 -36.83 92.23 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -69.33 -25.18 64.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -1.12 . . . . 0.0 109.416 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -73.08 -35.32 66.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.575 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 39.8 t -75.72 -28.39 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.454 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.15 -34.92 68.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.33 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.53 -45.14 37.57 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.89 91.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -1.129 . . . . 0.0 109.656 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . 0.421 ' CE2' HD21 ' D' ' 110' ' ' LEU . 25.6 t80 -57.21 -41.14 78.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.626 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 5.7 t -76.64 -37.8 55.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.655 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -47.32 -37.79 11.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.928 . . . . 0.0 109.517 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.17 -60.31 7.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.559 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.7 mp -55.95 -29.95 60.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.348 -1.089 . . . . 0.0 109.365 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.05 5.32 30.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.597 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.524 ' NE2' ' OD1' ' D' ' 80' ' ' ASN . 7.5 t60 -170.9 67.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.556 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.94 17.93 1.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.935 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -79.59 -29.22 41.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.524 ' OD1' ' NE2' ' D' ' 77' ' ' HIS . 4.3 p-10 -163.28 95.83 0.85 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.284 -0.885 . . . . 0.0 109.198 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . 0.509 ' H ' HD12 ' D' ' 81' ' ' LEU . 5.0 mp -80.33 -58.85 2.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.58 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -57.61 -23.78 52.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.008 . . . . 0.0 109.46 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' D' ' 86' ' ' ALA . . . -82.98 -54.4 3.22 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.0 t -61.31 -47.55 85.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -1.166 . . . . 0.0 109.652 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' D' ' 84' ' ' THR . 54.7 m-85 -76.76 22.03 0.19 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.424 -0.797 . . . . 0.0 109.476 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.42 -26.87 44.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.898 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 76.0 p -78.81 -59.23 2.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.3 mt -48.48 -45.06 36.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.319 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 54.0 p -64.74 -52.8 55.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.229 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -61.21 -22.66 64.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.481 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 8.8 tp -87.0 -68.66 0.73 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.433 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' D' ' 97' ' ' HIS . 49.0 m80 -51.0 -26.57 6.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 110.08 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . 0.413 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 27.4 t -83.71 -55.87 4.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.187 -0.945 . . . . 0.0 111.361 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 27.4 t0 -86.27 -32.11 21.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.038 -1.039 . . . . 0.0 111.928 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -89.48 -51.83 5.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.696 -1.253 . . . . 0.0 111.055 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.55 -27.02 15.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.871 -1.143 . . . . 0.0 110.45 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 1.318 ' ND1' HG22 ' A' ' 38' ' ' THR . 82.8 m-70 51.68 29.55 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.052 -1.03 . . . . 0.0 109.581 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . 0.449 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 39.8 t -47.18 130.27 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.111 -0.993 . . . . 0.0 109.488 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.31 152.45 31.9 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.344 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.96 -164.09 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.494 2.13 . . . . 0.0 112.206 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.19 60.83 2.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.568 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . 0.543 ' C ' HD22 ' D' ' 102' ' ' ASN . 0.1 OUTLIER -171.27 -41.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.957 . . . . 0.0 109.457 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -46.21 -40.47 11.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.731 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -80.04 -19.99 46.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 0.0 109.577 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' D' ' 102' ' ' ASN . 12.2 tp -70.54 -59.76 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.613 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -49.77 -46.33 50.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.33 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.08 -20.39 57.99 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -80.57 -25.1 38.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -1.165 . . . . 0.0 109.672 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 73.9 t -86.28 -43.09 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.659 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . 0.421 HD21 ' CE2' ' D' ' 71' ' ' PHE . 6.3 tt -48.08 -33.22 7.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.54 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . 0.416 ' H ' HG12 ' D' ' 111' ' ' VAL . 4.3 p -82.9 -26.16 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 72.0 m -69.05 -24.84 64.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.177 -0.952 . . . . 0.0 109.496 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.34 -34.8 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' D' ' 118' ' ' PHE . 9.4 mt -69.82 -40.14 76.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.472 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -54.47 -29.0 48.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.318 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.532 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -84.64 -62.42 1.55 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 109.113 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -63.4 -17.67 62.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 109.639 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' D' ' 114' ' ' LEU . 93.1 m-85 -149.65 60.29 1.01 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.462 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.534 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -69.28 -24.62 75.95 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -64.76 -29.67 70.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -1.154 . . . . 0.0 109.351 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' D' ' 123' ' ' THR . 78.3 mm-40 -87.83 5.76 38.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.862 . . . . 0.0 109.764 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.67 33.12 0.08 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.416 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.496 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.4 p -52.45 149.16 10.94 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.833 . . . . 0.0 109.367 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.1 Cg_exo -45.52 -53.6 5.35 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.452 2.101 . . . . 0.0 112.907 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 24.3 Cg_endo -62.22 -29.65 80.68 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.063 1.842 . . . . 0.0 112.211 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.447 HG23 ' OG1' ' D' ' 123' ' ' THR . 46.2 t -68.72 -28.16 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.185 -0.947 . . . . 0.0 109.537 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -83.18 -53.92 5.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 109.508 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.883 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -63.19 -26.5 68.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.622 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.54 -2.3 53.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 109.823 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' D' ' 132' ' ' LYS . 41.8 t80 -92.42 -61.7 1.55 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.968 . . . . 0.0 109.646 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 1.5 tm0? -45.23 -23.32 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 109.94 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' D' ' 130' ' ' TYR . 51.0 mtmt -85.46 -34.54 21.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.147 -0.971 . . . . 0.0 110.344 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 0.6 OUTLIER -68.59 -44.22 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.995 -1.066 . . . . 0.0 109.649 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.486 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 6.1 m -79.6 -20.98 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -50.41 -32.46 17.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.096 -1.002 . . . . 0.0 109.336 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.59 -26.66 56.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.32 -32.96 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -1.133 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.43 90.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.9 . . . . 0.0 109.626 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.98 -21.06 47.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.664 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.01 -58.92 6.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.42 -31.89 71.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.07 25.2 4.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.289 -0.882 . . . . 0.0 109.549 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -80.0 -16.11 55.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.131 -0.981 . . . . 0.0 109.733 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 13.2 mptt -98.42 -26.64 14.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 109.571 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . 0.449 ' OH ' ' O ' ' D' ' 98' ' ' VAL . 12.1 m-85 -54.43 -6.85 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.336 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' D' ' 144' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.44 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.535 HD21 ' OD2' ' A' ' 6' ' ' ASP . 14.0 tp -170.95 164.65 7.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 0.0 109.864 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.83 165.75 35.68 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.348 -0.845 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.64 -77.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.773 2.315 . . . . 0.0 112.655 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -45.22 -30.01 1.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 109.964 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.775 ' O ' HG23 ' A' ' 10' ' ' VAL . 26.2 t0 -43.77 -23.04 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.246 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -83.34 -60.61 2.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.372 -0.83 . . . . 0.0 109.324 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.5 m -44.45 -35.97 2.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.535 -0.728 . . . . 0.0 109.9 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.422 ' C ' ' OG ' ' A' ' 124' ' ' SER . 2.5 m-20 -74.49 -30.02 61.65 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 6' ' ' ASP . 76.6 t -76.31 -53.52 15.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -52.62 -38.28 59.9 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.081 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.04 -63.76 1.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.47 -0.769 . . . . 0.0 109.144 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.745 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -58.56 -37.7 76.27 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -17.23 62.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 109.03 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -79.02 -46.25 8.43 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 13.2 mmmt -69.17 -38.27 78.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 108.982 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 13' ' ' ALA . 98.9 t -61.07 -64.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 54.43 -132.59 46.55 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.87 26.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -1.073 . . . . 0.0 110.522 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.547 ' H ' ' C ' ' A' ' 18' ' ' GLY . 92.7 m-70 -129.94 22.29 5.36 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -86.7 -60.0 2.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.65 -0.656 . . . . 0.0 109.598 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.4 -14.28 0.18 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 21' ' ' ALA . 7.3 mm-40 -86.85 -56.52 3.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.425 -1.044 . . . . 0.0 109.781 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.8 m-30 -60.67 -37.55 81.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.15 -22.88 71.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -82.09 -51.43 8.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.144 -1.209 . . . . 0.0 109.839 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.59 -19.8 28.29 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.325 -0.859 . . . . 0.0 109.372 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.2 -23.74 62.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.269 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.534 HD11 ' ND1' ' A' ' 58' ' ' HIS . 26.5 mt -70.33 -56.15 7.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.303 -0.873 . . . . 0.0 109.459 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.03 -12.62 8.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.404 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -76.29 -61.1 2.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -19.45 65.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.49 -53.15 61.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 0.0 109.715 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.039 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.2 pp -88.01 -41.87 12.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.941 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.7 t -58.9 -2.27 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.663 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' A' ' 35' ' ' SER . 64.9 m-85 -160.24 81.85 2.27 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 109.418 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -49.17 -27.03 11.85 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.725 2.284 . . . . 0.0 112.316 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 41' ' ' THR . 5.5 p -49.04 -21.42 0.69 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -0.991 . . . . 0.0 109.388 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.9 p -90.36 -27.07 19.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -55.09 -47.51 74.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.636 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 1.108 HG21 ' CD2' ' D' ' 97' ' ' HIS . 13.1 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.457 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 25.2 p80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.041 0.448 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.465 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -164.73 29.63 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.029 -1.045 . . . . 0.0 110.371 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 46' ' ' PHE . 5.9 m-20 41.04 88.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.533 -0.729 . . . . 0.0 110.113 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.676 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -61.43 -19.53 62.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.505 -0.747 . . . . 0.0 109.15 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -47.3 121.49 3.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.64 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -65.25 107.86 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.91 -6.58 4.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.604 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 2.0 t -75.02 -0.23 18.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.39 -1.065 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 71.1 -14.94 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 109.589 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' A' ' 52' ' ' SER . 54.6 mt-30 -86.09 -28.9 23.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.506 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.598 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 4.2 t -82.96 -39.1 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -81.98 -25.56 34.66 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.508 ' HA2' ' HZ2' ' A' ' 60' ' ' LYS . . . -76.73 -25.56 64.72 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.534 ' ND1' HD11 ' A' ' 29' ' ' LEU . 5.8 t-80 -72.75 -42.38 64.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -1.183 . . . . 0.0 109.613 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.96 -46.44 32.46 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HZ2' ' HA2' ' A' ' 57' ' ' GLY . 6.4 mtmm -53.08 -22.66 6.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -1.081 . . . . 0.0 109.912 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HZ1' ' HZ1' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -73.99 -48.66 28.76 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.037 -1.039 . . . . 0.0 108.599 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -67.85 -45.99 83.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.467 ' N ' HG12 ' A' ' 62' ' ' VAL . . . -66.05 -35.28 80.12 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.488 -0.757 . . . . 0.0 109.398 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 11.7 t70 -65.17 -48.4 73.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.122 -0.986 . . . . 0.0 108.676 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -59.47 -50.68 73.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.47 -49.77 66.75 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -61.8 -54.52 41.12 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.901 . . . . 0.0 108.883 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -60.44 -20.89 61.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 108.777 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.2 -48.08 9.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.38 -22.84 27.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.97 -33.61 68.31 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.601 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.7 m170 -97.2 -66.58 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.441 -0.787 . . . . 0.0 109.557 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.1 p 44.89 14.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.883 0.849 . . . . 0.0 109.156 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 72' ' ' HIS . 91.6 m-20 -140.49 13.31 2.35 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -175.27 31.85 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.544 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -64.01 -46.46 80.67 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 110.062 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 76' ' ' MET . 81.5 Cg_exo -44.15 -40.78 12.65 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.471 2.114 . . . . 0.0 112.563 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -94.32 -17.21 22.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 109.975 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.8 -58.11 3.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.162 -0.961 . . . . 0.0 109.302 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.401 ' C ' ' N ' ' A' ' 82' ' ' ALA . 11.0 mt -77.69 11.21 2.21 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.367 -0.833 . . . . 0.0 109.045 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.67 -16.21 0.61 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.563 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -80.91 -57.8 3.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 83' ' ' LEU . 3.7 mt -44.88 -43.94 9.23 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.91 -27.33 18.21 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.501 -0.749 . . . . 0.0 109.056 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' ALA . 34.4 t70 -76.26 -21.44 56.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.935 . . . . 0.0 109.291 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 90' ' ' LYS . 3.3 tp -82.99 -34.64 26.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -92.42 -21.72 20.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.519 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.33 -98.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.918 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -86.36 -76.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.0 ttmm -45.31 124.51 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 109.765 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 93' ' ' VAL . 16.2 mt 54.04 57.73 5.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.307 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.967 ' NE ' ' HG2' ' D' ' 40' ' ' ARG . 85.2 mtm-85 -49.81 -38.91 36.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.614 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 94' ' ' ASP . 59.4 t 47.22 -101.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.487 ' N ' HG12 ' A' ' 93' ' ' VAL . 0.3 OUTLIER 171.33 137.36 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 109.176 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.24 -16.78 19.5 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.371 2.047 . . . . 0.0 112.014 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 96' ' ' VAL . 61.5 t -60.66 -9.47 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.701 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 98' ' ' PHE . 29.6 p30 -78.91 -24.79 43.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.117 -0.989 . . . . 0.0 109.34 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.532 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.7 OUTLIER -50.1 -47.19 54.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.313 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.24 -22.66 66.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.908 . . . . 0.0 109.609 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.459 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 42.7 mt -84.01 -62.03 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.651 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.46 -25.82 11.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.081 -1.012 . . . . 0.0 109.708 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 t -69.97 -59.18 3.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.87 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.766 ' ND1' ' OD1' ' B' ' 108' ' ' ASN . 43.2 m170 -63.26 -26.67 68.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.621 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 67.4 m -67.9 -48.25 66.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 109.567 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.88 -41.21 32.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.406 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 106' ' ' LEU . 9.4 mp -68.17 -50.78 52.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 109.522 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.606 ' CG1' HE22 ' B' ' 127' ' ' GLN . 70.4 t -53.99 -51.42 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 110' ' ' ALA . 40.2 m -59.82 -58.47 8.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 113' ' ' LEU . 4.6 mt -45.98 -19.95 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.875 . . . . 0.0 109.643 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -72.29 -35.47 68.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 110.135 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 1.313 ' HB2' ' CE2' ' B' ' 122' ' ' PHE . . . -75.04 -3.78 34.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.031 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.6 -82.3 0.31 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -106.82 94.4 10.42 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.8 175.87 9.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.093 1.862 . . . . 0.0 112.935 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -47.78 -44.84 28.82 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.438 0.637 . . . . 0.0 109.814 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 6.9 mt-10 87.1 5.65 0.31 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 t80 68.38 36.42 3.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.871 -0.518 . . . . 0.0 111.51 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.713 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -96.96 121.65 58.68 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.807 -1.183 . . . . 0.0 108.224 178.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.95 20.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.15 1.9 . . . . 0.0 112.765 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -145.43 -37.66 0.27 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.934 -1.104 . . . . 0.0 110.264 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.616 HG13 ' N ' ' A' ' 122' ' ' HIS . 7.8 p -46.91 -44.76 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.069 -1.019 . . . . 0.0 110.126 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.616 ' N ' HG13 ' A' ' 121' ' ' VAL . 4.8 m-70 -56.7 -50.0 73.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.81 -19.58 34.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.786 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 120' ' ' ALA . 15.5 t -54.82 -58.18 8.59 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.205 -0.934 . . . . 0.0 110.597 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.43 -19.73 30.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.199 -0.938 . . . . 0.0 110.156 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -83.25 -40.36 19.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.887 -1.133 . . . . 0.0 110.18 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' CD ' ' C ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -87.09 -47.21 9.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.005 -1.06 . . . . 0.0 109.63 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.51 ' CD1' HG21 ' A' ' 10' ' ' VAL . 70.9 t80 -48.63 -21.59 0.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.96 -1.088 . . . . 0.0 109.212 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.622 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.6 mt -69.73 -17.87 63.48 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.05 -29.97 70.04 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.48 ' HB3' HD13 ' A' ' 2' ' ' LEU . 53.3 p -82.78 -35.93 26.08 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.419 -0.801 . . . . 0.0 108.973 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.19 -27.34 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.234 -0.916 . . . . 0.0 108.897 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 129' ' ' LEU . 57.4 p -84.17 -24.91 29.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.427 -0.795 . . . . 0.0 109.052 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.7 m -78.16 -34.92 49.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.158 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.4 t -78.34 -26.4 14.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.156 -0.965 . . . . 0.0 108.577 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -33.67 76.41 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.3 m -85.26 -15.19 44.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.574 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 1.02 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -121.42 -175.15 3.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.557 -0.714 . . . . 0.0 109.196 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -79.57 152.76 75.71 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 109.016 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.83 -28.55 75.87 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.526 2.151 . . . . 0.0 112.01 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -86.7 -21.92 26.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.485 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.57 -63.11 1.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.723 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.711 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -57.21 -40.4 77.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.791 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.7 t -45.54 -23.71 0.26 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 110.038 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.44 -57.07 3.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.148 -0.97 . . . . 0.0 109.792 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.407 ' H ' HG12 ' B' ' 11' ' ' VAL . 0.8 OUTLIER -67.22 -24.55 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 8.4 m -71.18 -44.45 65.44 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.676 -0.64 . . . . 0.0 109.446 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.41 74.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.358 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.807 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -49.27 -21.06 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.193 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -17.3 60.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.5 -57.48 7.34 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.654 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.576 ' HE2' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -86.59 12.5 10.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.979 -1.307 . . . . 0.0 110.929 -178.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.807 HG23 ' O ' ' B' ' 14' ' ' LEU . 2.2 t -79.49 114.93 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.839 -1.163 . . . . 0.0 109.007 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.48 82.73 3.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.48 ' C ' ' H ' ' B' ' 22' ' ' GLU . 72.1 t -54.94 -18.21 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 5.0 m-20 -66.21 6.3 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.712 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' B' ' 20' ' ' VAL . 35.1 mt-10 -156.01 -52.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' B' ' 27' ' ' ALA . 95.3 t -47.57 -35.66 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.705 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.52 -57.55 4.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.5 -50.78 55.65 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.19 -45.98 90.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -1.138 . . . . 0.0 109.602 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' B' ' 23' ' ' VAL . . . -51.1 -35.22 34.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.688 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -84.96 -58.03 2.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 109.654 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.22 -37.45 72.91 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.513 HH21 HG22 ' B' ' 113' ' ' VAL . 8.1 ttp180 -69.74 -38.48 76.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -1.212 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 40.6 tp -52.99 -24.22 8.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.074 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' B' ' 36' ' ' PRO . 15.7 mt -75.54 -54.39 7.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.037 -1.04 . . . . 0.0 110.893 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.41 HG22 ' H ' ' B' ' 33' ' ' VAL . 2.2 m -52.72 -49.02 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.712 -1.242 . . . . 0.0 109.764 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -70.76 -22.72 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 109.126 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -149.43 74.94 9.63 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.48 ' N ' ' O ' ' B' ' 32' ' ' LEU . 72.3 Cg_endo -81.54 -22.87 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.788 2.326 . . . . 0.0 112.219 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -48.98 -19.92 0.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.908 . . . . 0.0 109.47 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.465 ' C ' ' H ' ' B' ' 40' ' ' ARG . 33.5 p -80.35 9.9 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -71.8 12.26 0.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.318 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.921 ' HG2' ' NE ' ' C' ' 92' ' ' ARG . 97.4 mtt180 -80.29 -19.77 45.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.52 26.27 4.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.306 -0.871 . . . . 0.0 109.129 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.507 ' CE1' ' CD2' ' B' ' 45' ' ' PHE . 33.4 t80 -148.77 11.73 0.86 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.89 -22.13 40.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.889 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 27.4 p -84.61 7.13 21.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' B' ' 42' ' ' PHE . 3.7 m-85 -81.44 -16.44 52.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.94 -175.37 45.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . 0.443 ' O ' ' HB1' ' B' ' 53' ' ' ALA . 3.6 p-10 -83.14 103.84 12.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -1.088 . . . . 0.0 109.578 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.579 HD12 ' N ' ' B' ' 48' ' ' LEU . 10.2 mp -88.17 29.73 0.93 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.199 -0.938 . . . . 0.0 109.147 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.1 m -44.88 -35.88 3.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.838 . . . . 0.0 109.789 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 5.5 p -146.43 148.83 35.54 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.61 -36.35 4.71 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.565 2.177 . . . . 0.0 112.501 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.68 -33.58 72.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.743 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' B' ' 47' ' ' ASP . . . -62.16 -19.88 63.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.609 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.97 -59.69 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.963 . . . . 0.0 109.525 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . 0.495 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -87.45 10.54 17.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.37 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.91 -31.22 32.89 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -81.94 147.96 59.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 109.434 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.63 -57.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.544 2.163 . . . . 0.0 112.427 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.03 -33.36 4.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.777 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 70.8 t -61.03 -57.92 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.459 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -64.96 -33.6 76.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.56 -53.65 44.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.589 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -53.3 -24.01 10.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.187 -0.946 . . . . 0.0 109.538 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.08 -23.88 73.08 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.88 -44.08 81.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -1.158 . . . . 0.0 109.164 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -55.35 -47.29 75.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.416 -0.802 . . . . 0.0 109.351 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 25.4 t -58.14 -47.01 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.321 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.42 -35.02 74.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 109.276 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.83 -53.18 46.05 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.11 63.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -1.201 . . . . 0.0 109.616 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -55.85 -31.16 62.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.398 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 33.2 t -76.56 -31.45 57.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.421 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -50.28 -40.02 47.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.368 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.89 -59.95 8.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.551 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -58.16 -26.92 63.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -1.166 . . . . 0.0 109.387 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.05 2.51 46.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.443 ' C ' ' H ' ' B' ' 79' ' ' ASP . 66.0 t60 -170.89 65.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.731 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 80.0 mt -75.85 19.58 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.955 . . . . 0.0 109.432 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' B' ' 77' ' ' HIS . 8.9 m-20 -79.6 -29.49 41.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' B' ' 80' ' ' ASN . 5.4 p30 -173.32 107.09 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.564 ' N ' HD12 ' B' ' 81' ' ' LEU . 8.3 mp -80.28 -58.77 2.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.476 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.463 ' H ' ' HD2' ' B' ' 82' ' ' LYS . 0.0 OUTLIER -46.5 -24.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.5 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.71 -50.24 9.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.7 t -82.35 -47.37 12.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -1.133 . . . . 0.0 109.366 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.552 ' N ' ' CG2' ' B' ' 84' ' ' THR . 27.6 m-85 -65.03 1.36 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.732 . . . . 0.0 109.482 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.9 -34.93 66.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.514 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -74.34 -57.55 3.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.479 ' N ' HD12 ' B' ' 88' ' ' LEU . 9.0 mp -49.3 -45.0 44.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -63.95 -52.15 61.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.67 -22.83 64.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 6.5 tt -85.51 -62.81 1.44 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' B' ' 97' ' ' HIS . 75.2 m80 -61.34 -20.14 62.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 110.13 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 51.7 t -83.51 -60.63 2.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.022 -1.049 . . . . 0.0 110.571 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.43 -28.32 22.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.047 -1.033 . . . . 0.0 110.994 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -83.99 -51.91 6.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.064 . . . . 0.0 110.686 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 11.7 mt -107.0 -21.29 13.05 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.08 -1.012 . . . . 0.0 109.966 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 1.073 ' CD2' HG21 ' C' ' 41' ' ' THR . 33.0 p80 43.02 37.46 1.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.346 -0.846 . . . . 0.0 109.971 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.0 130.89 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.195 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 0.411 ' HB2' HD21 ' B' ' 102' ' ' ASN . 39.3 m-20 -46.94 147.35 2.31 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.39 -16.93 44.1 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.508 2.139 . . . . 0.0 112.086 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' B' ' 101' ' ' GLU . 58.7 mp0 -81.25 55.22 2.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.317 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.441 ' ND2' ' C ' ' B' ' 101' ' ' GLU . 9.8 m-80 -156.1 -37.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -64.16 -38.67 91.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.116 -0.99 . . . . 0.0 109.529 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -69.72 -28.18 65.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.677 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 16.1 mt -71.61 -52.76 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tt -52.17 -47.81 65.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.353 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.73 -20.4 70.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . 0.766 ' OD1' ' ND1' ' A' ' 103' ' ' HIS . 0.4 OUTLIER -83.27 -19.11 36.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -1.177 . . . . 0.0 109.743 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 72.8 t -80.34 -44.56 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.093 -1.004 . . . . 0.0 109.561 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 10.7 mt -47.38 -31.92 4.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.99 -33.47 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.429 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 11.9 m -79.15 -54.51 5.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.48 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . 0.513 HG22 HH21 ' B' ' 30' ' ' ARG . 14.0 t -49.52 -46.01 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.426 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.05 -22.83 64.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.855 . . . . 0.0 109.345 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.455 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -80.73 -24.29 38.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.478 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.47 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.77 -61.59 1.75 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 109.346 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.413 ' C ' ' CG ' ' B' ' 118' ' ' PHE . 55.3 m80 -60.25 -17.7 43.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.651 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.413 ' CG ' ' C ' ' B' ' 117' ' ' HIS . 19.2 m-85 -150.29 58.56 0.96 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.585 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -68.64 -28.6 73.05 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -68.99 6.37 0.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.412 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' B' ' 123' ' ' THR . 17.8 mm-40 -126.0 -1.2 7.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.448 -0.782 . . . . 0.0 109.438 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 1.313 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -72.75 35.37 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.552 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.504 ' OG1' HG23 ' B' ' 126' ' ' VAL . 13.2 p -50.85 146.64 9.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.51 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.3 Cg_exo -48.29 -51.39 10.21 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.382 2.055 . . . . 0.0 113.04 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 39.9 Cg_endo -67.57 -27.67 38.8 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.063 1.842 . . . . 0.0 112.496 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.504 HG23 ' OG1' ' B' ' 123' ' ' THR . 55.5 t -77.39 -24.14 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.494 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . 0.606 HE22 ' CG1' ' A' ' 107' ' ' VAL . 9.1 tt0 -83.28 -54.55 4.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 1.039 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -49.19 -44.07 42.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.488 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.37 13.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.884 . . . . 0.0 109.597 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' B' ' 128' ' ' ALA . 32.0 t80 -97.95 -59.89 1.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 38.2 tt0 -47.45 -30.53 3.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -66.15 -46.62 76.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 109.753 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.73 -55.55 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.109 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.442 HG22 ' H ' ' B' ' 134' ' ' VAL . 3.5 m -67.95 -36.76 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -0.942 . . . . 0.0 110.02 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -50.16 -24.57 2.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.486 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.99 -31.41 55.6 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.2 t -82.78 -29.89 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.18 -1.188 . . . . 0.0 109.523 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.77 77.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.471 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 1.169 ' OD1' ' CE1' ' D' ' 146' ' ' HIS . 4.2 m120 -71.33 -27.75 63.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.514 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.36 -60.38 2.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.92 -16.14 2.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.26 -3.07 13.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.368 -0.832 . . . . 0.0 109.516 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 139' ' ' ASN . 21.9 t-80 -64.27 -33.28 75.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.505 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -82.45 -29.74 30.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.561 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -51.37 -20.98 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 1.222 ' CE1' ' OD1' ' D' ' 139' ' ' ASN . 43.0 m80 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.477 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.543 HD21 ' OD2' ' C' ' 6' ' ' ASP . 14.0 tp -170.86 164.68 7.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.113 -0.992 . . . . 0.0 109.869 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.76 165.88 35.11 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.496 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.72 -77.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.79 2.327 . . . . 0.0 112.591 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -45.17 -30.1 1.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 109.953 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.771 ' O ' HG23 ' C' ' 10' ' ' VAL . 26.3 t0 -43.62 -23.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.323 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' C' ' 10' ' ' VAL . 0.0 OUTLIER -83.39 -60.51 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.385 -0.822 . . . . 0.0 109.33 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.402 ' C ' ' O ' ' C' ' 7' ' ' LYS . 45.6 m -44.43 -36.0 2.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 109.805 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . 0.424 ' C ' ' OG ' ' C' ' 124' ' ' SER . 2.5 m-20 -74.46 -30.12 61.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.771 HG23 ' O ' ' C' ' 6' ' ' ASP . 76.8 t -76.27 -53.49 15.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' C' ' 7' ' ' LYS . 0.0 OUTLIER -52.78 -38.17 60.69 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.03 -63.72 1.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.203 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.729 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -58.55 -37.77 76.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.396 -0.815 . . . . 0.0 108.818 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -17.22 62.53 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.049 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' C' ' 11' ' ' LYS . . . -79.07 -46.24 8.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 13.3 mmmt -69.21 -38.25 78.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 0.0 108.922 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.729 HG23 ' O ' ' C' ' 13' ' ' ALA . 98.3 t -61.11 -65.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.567 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 54.42 -132.49 46.48 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.9 26.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.481 -1.011 . . . . 0.0 110.49 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.567 ' H ' ' C ' ' C' ' 18' ' ' GLY . 92.7 m-70 -129.89 22.25 5.38 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -86.72 -60.09 2.08 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.681 -0.637 . . . . 0.0 109.512 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.33 -14.27 0.17 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' C' ' 21' ' ' ALA . 7.3 mm-40 -86.84 -56.57 3.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -1.087 . . . . 0.0 109.795 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.8 m-30 -60.73 -37.51 81.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -22.89 71.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' C' ' 55' ' ' VAL . . . -82.2 -51.33 8.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -1.199 . . . . 0.0 109.841 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.58 -19.89 28.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.17 -23.76 62.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.286 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.539 HD11 ' ND1' ' C' ' 58' ' ' HIS . 26.8 mt -70.28 -56.12 7.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 109.444 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.06 -12.63 8.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -76.3 -61.18 2.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.894 . . . . 0.0 109.726 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -19.44 65.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.607 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.49 -53.27 60.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.639 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 1.061 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.2 pp -87.87 -41.99 12.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 0.0 109.919 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.8 t -58.89 -2.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.096 -1.002 . . . . 0.0 109.637 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' C' ' 35' ' ' SER . 64.9 m-85 -160.07 81.78 2.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.468 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -49.17 -26.93 11.71 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.696 2.264 . . . . 0.0 112.302 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.418 ' O ' HG22 ' C' ' 41' ' ' THR . 5.2 p -49.1 -21.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.363 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.3 p -90.28 -27.17 19.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.55 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -55.11 -47.43 74.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.608 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 1.073 HG21 ' CD2' ' B' ' 97' ' ' HIS . 13.0 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 0.0 109.398 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.451 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 25.0 p80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.056 0.455 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.47 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -164.74 29.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.981 -1.074 . . . . 0.0 110.301 179.206 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' C' ' 46' ' ' PHE . 5.9 m-20 41.0 88.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.554 -0.716 . . . . 0.0 110.119 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.675 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -61.44 -19.58 62.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.448 -0.782 . . . . 0.0 109.239 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -47.25 121.51 3.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.632 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.15 107.87 1.69 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 109.369 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.87 -6.54 4.44 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.597 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 2.0 t -75.07 -0.12 17.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -1.042 . . . . 0.0 109.427 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 71.02 -14.87 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.845 . . . . 0.0 109.63 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' C' ' 52' ' ' SER . 54.8 mt-30 -86.07 -29.04 23.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.611 ' O ' ' HB1' ' C' ' 26' ' ' ALA . 4.2 t -82.85 -39.11 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.955 . . . . 0.0 109.328 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -82.0 -25.62 34.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 108.542 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . 0.553 ' HA2' ' HZ2' ' C' ' 60' ' ' LYS . . . -76.73 -25.56 64.7 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.539 ' ND1' HD11 ' C' ' 29' ' ' LEU . 5.7 t-80 -72.79 -42.38 63.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -1.179 . . . . 0.0 109.631 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.93 -46.5 32.28 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.553 ' HZ2' ' HA2' ' C' ' 57' ' ' GLY . 6.4 mtmm -53.04 -22.61 6.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.997 . . . . 0.0 109.911 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . 0.438 ' HZ1' ' HZ1' ' C' ' 60' ' ' LYS . 0.3 OUTLIER -74.01 -48.76 28.02 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.115 -0.991 . . . . 0.0 108.502 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.445 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -67.75 -46.05 83.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.445 ' N ' HG12 ' C' ' 62' ' ' VAL . . . -65.92 -35.42 80.56 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.454 -0.778 . . . . 0.0 109.355 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 11.6 t70 -65.19 -48.36 73.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.946 . . . . 0.0 108.654 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -59.53 -50.64 73.14 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.44 -49.85 66.5 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -61.67 -54.62 40.29 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.205 -0.934 . . . . 0.0 108.897 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -60.31 -21.03 61.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 108.756 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.2 -48.1 9.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -68.32 -22.83 27.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.62 68.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.596 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.7 m170 -97.26 -66.47 0.9 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.428 -0.795 . . . . 0.0 109.556 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.532 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.1 p 44.78 14.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.978 0.894 . . . . 0.0 109.214 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' C' ' 72' ' ' HIS . 91.2 m-20 -140.57 13.37 2.33 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -175.23 31.81 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.537 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -63.9 -46.47 81.34 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 110.099 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' C' ' 76' ' ' MET . 81.6 Cg_exo -44.21 -40.72 12.81 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.468 2.112 . . . . 0.0 112.607 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -94.25 -17.31 22.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.985 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.8 -57.95 3.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 109.309 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . 0.403 ' C ' ' N ' ' C' ' 82' ' ' ALA . 11.0 mt -77.79 11.22 2.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.06 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.68 -16.24 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.513 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -80.89 -57.69 3.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.669 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.452 HD23 ' N ' ' C' ' 83' ' ' LEU . 3.8 mt -44.95 -43.96 9.43 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.85 -27.33 17.86 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' C' ' 82' ' ' ALA . 34.4 t70 -76.32 -21.55 56.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.283 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' C' ' 90' ' ' LYS . 3.3 tp -82.9 -34.56 26.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.281 -0.887 . . . . 0.0 109.47 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -92.47 -21.75 19.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 109.495 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.28 -98.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.901 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -86.26 -76.41 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.853 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' C' ' 86' ' ' LEU . 6.9 ttmm -45.27 124.54 4.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.799 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.441 ' O ' HG23 ' C' ' 93' ' ' VAL . 16.1 mt 53.97 57.7 5.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.846 . . . . 0.0 109.345 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . 0.921 ' NE ' ' HG2' ' B' ' 40' ' ' ARG . 85.3 mtm-85 -49.87 -38.77 36.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.822 . . . . 0.0 109.649 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.485 HG12 ' N ' ' C' ' 94' ' ' ASP . 58.3 t 47.14 -101.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 109.335 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.485 ' N ' HG12 ' C' ' 93' ' ' VAL . 0.3 OUTLIER 171.42 137.39 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.134 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.28 -16.75 19.44 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.366 2.044 . . . . 0.0 112.036 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.432 HG12 ' O ' ' C' ' 96' ' ' VAL . 60.9 t -60.66 -9.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.86 . . . . 0.0 109.671 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' C' ' 98' ' ' PHE . 29.7 p30 -78.94 -24.78 43.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 109.29 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . 0.523 ' N ' ' OD1' ' C' ' 97' ' ' ASN . 0.7 OUTLIER -50.18 -47.14 54.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.292 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.21 -22.7 66.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.594 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.489 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 43.5 mt -84.04 -62.04 1.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.585 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.37 -25.81 10.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 109.725 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -70.02 -59.16 3.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.18 -0.95 . . . . 0.0 109.805 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . 0.77 ' ND1' ' OD1' ' D' ' 108' ' ' ASN . 43.4 m170 -63.37 -26.58 68.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.644 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 67.9 m -67.99 -48.17 66.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.89 -41.24 32.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.962 . . . . 0.0 109.362 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.494 ' N ' HD12 ' C' ' 106' ' ' LEU . 9.4 mp -68.1 -50.74 52.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 109.568 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . 0.61 ' CG1' HE22 ' D' ' 127' ' ' GLN . 70.0 t -54.06 -51.3 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.356 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.452 ' O ' ' N ' ' C' ' 110' ' ' ALA . 39.9 m -59.91 -58.46 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' C' ' 113' ' ' LEU . 4.5 mt -45.99 -19.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.374 -0.829 . . . . 0.0 109.592 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -72.36 -35.38 68.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.147 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . 1.319 ' HB2' ' CE2' ' D' ' 122' ' ' PHE . . . -75.15 -3.67 34.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 110.012 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.72 -82.23 0.3 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 109.386 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' C' ' 113' ' ' LEU . 0.3 OUTLIER -106.91 94.47 10.67 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 175.9 9.67 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.169 1.913 . . . . 0.0 112.903 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -47.82 -44.84 29.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.641 -0.662 . . . . 0.0 109.85 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 6.9 mt-10 87.06 5.81 0.31 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 t80 68.27 36.46 3.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.826 -0.546 . . . . 0.0 111.523 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.718 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -96.93 121.63 58.79 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.796 -1.19 . . . . 0.0 108.226 178.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -51.02 20.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.104 1.869 . . . . 0.0 112.826 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.718 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -145.37 -37.72 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.897 -1.127 . . . . 0.0 110.258 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.618 HG13 ' N ' ' C' ' 122' ' ' HIS . 7.8 p -46.88 -44.77 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.156 -0.965 . . . . 0.0 110.172 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.618 ' N ' HG13 ' C' ' 121' ' ' VAL . 4.7 m-70 -56.68 -49.9 73.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.412 -0.805 . . . . 0.0 109.78 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.87 -19.57 34.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.771 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.536 ' N ' ' O ' ' C' ' 120' ' ' ALA . 15.3 t -54.78 -58.33 7.97 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 110.606 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 mt -85.22 -19.71 31.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.147 -0.971 . . . . 0.0 110.227 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -83.33 -40.29 19.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.898 -1.126 . . . . 0.0 110.202 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.472 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -87.17 -47.17 9.09 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.863 -1.148 . . . . 0.0 109.649 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.511 ' CD1' HG21 ' C' ' 10' ' ' VAL . 71.1 t80 -48.71 -21.55 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.018 -1.052 . . . . 0.0 109.22 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.613 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.7 mt -69.69 -17.9 63.51 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.09 -29.96 70.07 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.493 ' HB3' HD13 ' C' ' 2' ' ' LEU . 53.2 p -82.73 -35.86 26.28 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.475 -0.766 . . . . 0.0 109.033 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.34 -27.32 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -0.946 . . . . 0.0 108.793 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.613 ' N ' ' O ' ' C' ' 129' ' ' LEU . 56.8 p -84.08 -24.9 30.18 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.455 -0.778 . . . . 0.0 109.162 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 18.8 m -78.04 -35.1 50.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 109.146 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 96.6 t -78.16 -26.41 14.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.226 -0.921 . . . . 0.0 108.641 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.83 -33.59 76.21 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 76.0 m -85.29 -15.17 44.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.446 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.577 179.978 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 1.08 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -121.35 -175.04 2.98 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.443 -0.786 . . . . 0.0 109.2 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -79.77 152.79 75.2 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.344 -0.847 . . . . 0.0 109.045 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.83 -28.42 75.78 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.528 2.152 . . . . 0.0 112.024 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -86.85 -21.87 26.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.61 -63.02 1.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.733 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.731 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -57.27 -40.42 77.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 109.742 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.7 t -45.58 -23.61 0.25 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 110.08 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -81.44 -57.19 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.074 -1.016 . . . . 0.0 109.795 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.402 ' H ' HG12 ' D' ' 11' ' ' VAL . 0.9 OUTLIER -67.13 -24.49 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 8.4 m -71.17 -44.59 65.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.7 -0.625 . . . . 0.0 109.391 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.46 74.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.791 ' O ' HG23 ' D' ' 18' ' ' VAL . 0.7 OUTLIER -49.31 -21.06 0.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.839 . . . . 0.0 109.148 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -17.3 60.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 109.632 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.41 -57.51 7.38 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.665 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.584 ' HE2' ' H ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -86.68 12.62 10.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.007 -1.29 . . . . 0.0 110.922 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.791 HG23 ' O ' ' D' ' 14' ' ' LEU . 2.2 t -79.65 115.03 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.822 -1.174 . . . . 0.0 108.959 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -76.53 82.72 3.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 109.488 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' D' ' 22' ' ' GLU . 71.1 t -54.8 -18.39 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' D' ' 21' ' ' ASP . 5.1 m-20 -66.15 6.3 0.42 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.89 . . . . 0.0 109.632 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' D' ' 20' ' ' VAL . 35.3 mt-10 -155.95 -52.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' D' ' 27' ' ' ALA . 95.7 t -47.53 -35.74 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.693 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.48 -57.57 4.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.51 -50.79 55.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.19 -45.94 91.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -1.119 . . . . 0.0 109.541 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' D' ' 23' ' ' VAL . . . -51.21 -35.23 35.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.621 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -84.97 -58.03 2.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.176 -0.952 . . . . 0.0 109.613 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.23 -37.48 73.06 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . 0.529 HH21 HG22 ' D' ' 113' ' ' VAL . 8.1 ttp180 -69.73 -38.44 76.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -1.209 . . . . 0.0 109.775 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 40.7 tp -53.0 -24.18 8.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 110.149 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' D' ' 36' ' ' PRO . 15.8 mt -75.48 -54.5 6.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.01 -1.057 . . . . 0.0 110.882 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . 0.43 HG22 ' H ' ' D' ' 33' ' ' VAL . 2.3 m -52.73 -48.95 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.743 -1.223 . . . . 0.0 109.769 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.469 HG22 ' O ' ' D' ' 30' ' ' ARG . 0.0 OUTLIER -70.78 -22.69 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.077 -1.015 . . . . 0.0 109.158 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -149.42 74.87 9.64 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . 0.49 ' N ' ' O ' ' D' ' 32' ' ' LEU . 72.4 Cg_endo -81.49 -22.92 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.84 2.36 . . . . 0.0 112.244 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -48.91 -20.0 0.45 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.456 ' C ' ' H ' ' D' ' 40' ' ' ARG . 33.5 p -80.29 9.86 5.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.905 . . . . 0.0 109.563 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -71.8 12.26 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 109.388 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . 0.967 ' HG2' ' NE ' ' A' ' 92' ' ' ARG . 97.4 mtt180 -80.26 -19.8 45.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 109.409 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.55 26.27 4.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.172 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.515 ' CE1' ' CD2' ' D' ' 45' ' ' PHE . 33.3 t80 -148.78 11.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.406 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.95 -22.09 39.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 27.2 p -84.65 7.01 21.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.515 ' CD2' ' CE1' ' D' ' 42' ' ' PHE . 3.6 m-85 -81.38 -16.42 52.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.18 -0.95 . . . . 0.0 109.442 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.03 -175.32 45.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.444 ' O ' ' HB1' ' D' ' 53' ' ' ALA . 3.6 p-10 -83.13 103.86 12.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -1.123 . . . . 0.0 109.531 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . 0.583 HD12 ' N ' ' D' ' 48' ' ' LEU . 10.2 mp -88.27 29.75 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.849 . . . . 0.0 109.116 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.9 m -44.84 -35.85 2.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.379 -0.826 . . . . 0.0 109.807 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -146.47 148.73 35.09 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -42.57 -36.39 4.68 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.546 2.164 . . . . 0.0 112.444 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.68 -33.52 72.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.12 -0.987 . . . . 0.0 109.706 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' D' ' 47' ' ' ASP . . . -62.29 -19.7 63.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.406 -0.809 . . . . 0.0 109.561 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 62.6 t -61.08 -59.68 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -87.43 10.55 17.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.87 -31.22 33.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -81.92 147.92 59.48 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.155 -1.203 . . . . 0.0 109.426 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.56 -57.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.57 2.18 . . . . 0.0 112.542 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -33.38 4.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 109.775 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.05 -57.92 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.977 . . . . 0.0 109.434 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -65.01 -33.53 76.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.251 -0.906 . . . . 0.0 109.618 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.56 -53.71 43.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.56 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -53.27 -24.01 10.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.571 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.12 -23.7 73.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.96 -44.08 81.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -1.107 . . . . 0.0 109.192 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -55.4 -47.14 76.35 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.384 -0.822 . . . . 0.0 109.388 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.23 -46.94 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.31 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.48 -34.98 74.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.268 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.93 -53.16 46.43 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.11 63.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -1.193 . . . . 0.0 109.523 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -55.87 -31.08 62.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.449 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 33.1 t -76.58 -31.47 57.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -50.23 -40.06 46.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.88 -59.96 8.39 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.544 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.6 mp -58.19 -26.89 63.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -1.132 . . . . 0.0 109.358 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.02 2.41 46.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.617 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.444 ' C ' ' H ' ' D' ' 79' ' ' ASP . 66.2 t60 -170.84 66.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.928 . . . . 0.0 109.654 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' D' ' 78' ' ' LEU . 79.7 mt -75.83 19.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.407 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' D' ' 77' ' ' HIS . 8.8 m-20 -79.61 -29.47 41.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.529 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.42 ' O ' ' OD1' ' D' ' 80' ' ' ASN . 5.5 p30 -173.3 107.0 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . 0.56 ' N ' HD12 ' D' ' 81' ' ' LEU . 8.3 mp -80.21 -58.77 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.915 . . . . 0.0 109.494 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' D' ' 82' ' ' LYS . 0.0 OUTLIER -46.45 -24.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.582 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.73 -50.21 9.52 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.7 t -82.34 -47.3 12.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -1.173 . . . . 0.0 109.409 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.545 ' N ' ' CG2' ' D' ' 84' ' ' THR . 27.9 m-85 -65.08 1.35 0.99 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.55 -0.719 . . . . 0.0 109.504 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.85 -35.05 66.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.188 -0.945 . . . . 0.0 109.388 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 29.9 p -74.37 -57.54 3.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.426 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.483 ' N ' HD12 ' D' ' 88' ' ' LEU . 9.0 mp -49.37 -44.95 45.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -63.89 -52.2 61.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.474 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.68 -22.8 64.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 6.5 tt -85.65 -62.6 1.49 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.694 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' D' ' 97' ' ' HIS . 75.1 m80 -61.43 -20.17 62.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 110.079 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 51.6 t -83.51 -60.71 2.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.582 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.36 -28.32 22.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.991 -1.068 . . . . 0.0 111.026 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -83.88 -52.04 6.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.0 -1.062 . . . . 0.0 110.742 -178.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.589 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 11.6 mt -106.87 -21.31 13.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.024 -1.047 . . . . 0.0 110.05 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 1.108 ' CD2' HG21 ' A' ' 41' ' ' THR . 33.1 p80 43.03 37.47 1.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.842 . . . . 0.0 109.931 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.09 130.92 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.167 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -46.94 147.36 2.31 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.33 -16.94 44.39 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.495 2.13 . . . . 0.0 112.119 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' D' ' 101' ' ' GLU . 58.7 mp0 -81.3 55.27 2.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.344 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . 0.437 ' ND2' ' C ' ' D' ' 101' ' ' GLU . 10.0 m-80 -156.19 -37.67 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.982 . . . . 0.0 109.688 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -64.12 -38.76 92.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -69.68 -28.1 65.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.66 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.71 -52.76 16.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tt -52.2 -47.75 65.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.405 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.71 -20.45 70.22 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . 0.77 ' OD1' ' ND1' ' C' ' 103' ' ' HIS . 0.4 OUTLIER -83.24 -19.12 36.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -1.167 . . . . 0.0 109.753 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 73.0 t -80.31 -44.54 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.616 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 mt -47.37 -32.0 4.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.423 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . 0.426 ' H ' HG23 ' D' ' 111' ' ' VAL . 10.5 t -58.86 -33.64 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 11.8 m -79.06 -54.54 5.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . 0.529 HG22 HH21 ' D' ' 30' ' ' ARG . 14.0 t -49.47 -46.04 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.406 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.0 -22.92 64.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.463 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -80.62 -24.37 39.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.471 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.73 -61.65 1.74 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.359 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . 0.416 ' C ' ' CG ' ' D' ' 118' ' ' PHE . 55.2 m80 -60.18 -17.73 43.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.416 ' CG ' ' C ' ' D' ' 117' ' ' HIS . 19.0 m-85 -150.27 58.57 0.96 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.88 . . . . 0.0 109.633 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.463 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -68.6 -28.65 73.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -68.92 6.35 0.92 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -1.108 . . . . 0.0 109.41 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' D' ' 123' ' ' THR . 17.7 mm-40 -126.0 -1.22 7.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.436 -0.79 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 1.319 ' CE2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -72.67 35.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.849 . . . . 0.0 109.517 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.504 ' OG1' HG23 ' D' ' 126' ' ' VAL . 13.1 p -50.82 146.58 9.85 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.427 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.497 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.3 Cg_exo -48.22 -51.44 10.08 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.315 2.01 . . . . 0.0 113.057 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 39.4 Cg_endo -67.63 -27.7 38.39 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.013 1.809 . . . . 0.0 112.436 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.504 HG23 ' OG1' ' D' ' 123' ' ' THR . 55.6 t -77.3 -24.1 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.143 -0.973 . . . . 0.0 109.523 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . 0.61 HE22 ' CG1' ' C' ' 107' ' ' VAL . 9.1 tt0 -83.34 -54.52 4.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 1.061 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -49.14 -44.1 42.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.497 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.39 13.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.573 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.437 ' H ' ' C ' ' D' ' 128' ' ' ALA . 32.0 t80 -97.89 -59.89 1.67 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.64 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 38.2 tt0 -47.46 -30.49 3.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -66.05 -46.72 76.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.774 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 38.4 t -59.77 -55.55 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 110.043 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.4 HG22 ' H ' ' D' ' 134' ' ' VAL . 3.5 m -67.91 -36.85 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.991 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -50.0 -24.64 2.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.511 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.96 -31.43 55.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -82.69 -30.06 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -1.166 . . . . 0.0 109.495 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.64 77.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.91 . . . . 0.0 109.46 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . 1.222 ' OD1' ' CE1' ' B' ' 146' ' ' HIS . 4.2 m120 -71.35 -27.89 63.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.414 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.23 -60.42 2.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.428 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.96 -16.13 2.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.348 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.2 -3.04 13.96 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.309 -0.869 . . . . 0.0 109.569 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' D' ' 139' ' ' ASN . 22.0 t-80 -64.22 -33.28 75.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.867 . . . . 0.0 109.581 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -82.42 -29.76 30.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -51.33 -21.05 1.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 1.169 ' CE1' ' OD1' ' B' ' 139' ' ' ASN . 43.0 m80 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.475 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.568 HD11 ' HE3' ' A' ' 127' ' ' LYS . 7.1 tp 73.73 170.63 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.564 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.483 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 174.42 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.937 . . . . 0.0 110.106 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 3' ' ' SER . 95.5 Cg_exo -41.41 168.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.597 2.198 . . . . 0.0 112.902 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -50.76 -16.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.444 -0.785 . . . . 0.0 109.994 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 5' ' ' ALA . 2.8 p30 -39.78 -28.33 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.382 -0.824 . . . . 0.0 109.819 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 5' ' ' ALA . 5.9 ptmm? -83.27 -52.38 6.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.408 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 48.9 m -47.93 -26.75 1.84 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 108.928 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.433 ' CG ' ' HB1' ' A' ' 120' ' ' ALA . 40.7 m-20 -79.99 -39.34 30.23 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.597 HG21 ' CG ' ' A' ' 128' ' ' PHE . 21.2 t -69.43 -47.01 75.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HZ2' ' HZ3' ' A' ' 7' ' ' LYS . 2.4 mptm? -50.22 -48.5 54.41 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.58 -63.1 1.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.502 0.667 . . . . 0.0 109.303 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -50.75 -41.75 56.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -0.817 . . . . 0.0 109.112 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.95 -17.4 64.43 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.377 -0.827 . . . . 0.0 109.047 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -79.62 -47.5 7.26 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -68.39 -36.74 79.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -1.121 . . . . 0.0 108.766 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 13' ' ' ALA . 69.4 t -60.96 -66.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 63.44 -141.44 45.87 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.13 37.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.462 -1.022 . . . . 0.0 110.177 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.551 ' H ' ' C ' ' A' ' 18' ' ' GLY . 89.5 m-70 -140.2 24.61 2.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . . . -88.3 -48.78 7.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.664 -0.647 . . . . 0.0 109.961 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.38 -14.71 28.23 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' O ' ' OE1' ' A' ' 27' ' ' GLU . 12.6 mt-10 -85.68 -56.28 3.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.9 m-30 -55.18 -27.11 43.42 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.369 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.05 -24.45 76.5 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.69 -36.3 28.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -1.123 . . . . 0.0 109.625 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 23' ' ' GLU . 1.4 mp0 -70.4 -19.88 62.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.96 . . . . 0.0 109.296 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.65 -19.73 60.76 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.277 -0.889 . . . . 0.0 109.072 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 58' ' ' HIS . 17.3 mt -77.86 -58.14 3.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 109.712 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -51.01 -43.68 60.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 109.655 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -56.25 -30.57 62.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 109.642 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 38.6 ttp -84.24 -57.16 3.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.906 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.438 ' CZ ' ' CZ ' ' A' ' 46' ' ' PHE . 25.7 m-85 -47.66 -36.94 11.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.978 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.844 HD13 ' HB2' ' B' ' 128' ' ' ALA . 3.5 pp -84.48 -25.74 28.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.925 -1.11 . . . . 0.0 109.809 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.533 ' N ' HD12 ' A' ' 34' ' ' LEU . 28.1 t -60.93 -21.97 63.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 109.534 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 1.024 ' HZ ' ' OE1' ' B' ' 131' ' ' GLN . 66.6 m-85 -156.2 128.76 4.15 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.965 . . . . 0.0 109.2 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.59 -20.23 15.92 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.348 2.032 . . . . 0.0 111.986 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.6 p -62.67 -18.77 62.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 109.572 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.4 p -80.99 -35.55 31.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.779 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -67.59 -36.5 81.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.963 . . . . 0.0 109.662 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.209 -0.932 . . . . 0.0 109.844 -179.73 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.066 0.46 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.479 ' C ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -165.44 26.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.071 -1.018 . . . . 0.0 110.385 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 49' ' ' SER . 22.3 m-20 41.63 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.534 -0.729 . . . . 0.0 110.249 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.015 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -56.5 0.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 47' ' ' ASP . 2.8 t -46.56 132.18 10.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.96 . . . . 0.0 109.668 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.526 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 11.3 t-80 -76.23 144.15 40.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.413 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.526 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 73.2 10.15 77.92 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.527 ' OG ' ' N ' ' A' ' 53' ' ' ALA . 88.7 p -68.98 -100.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -1.184 . . . . 0.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.527 ' N ' ' OG ' ' A' ' 52' ' ' SER . . . -178.39 -31.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.377 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -81.23 -17.71 48.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.926 . . . . 0.0 109.087 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.48 -33.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 109.682 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.408 ' HG2' ' H ' ' A' ' 56' ' ' LYS . 14.7 ptpt -70.81 -28.34 64.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.076 -1.015 . . . . 0.0 109.262 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' O ' ' CE ' ' A' ' 61' ' ' LYS . . . -69.71 -48.1 44.59 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.538 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.6 OUTLIER -54.2 -35.56 62.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -1.11 . . . . 0.0 109.392 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.29 -58.69 10.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -51.65 -24.03 5.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -1.174 . . . . 0.0 109.593 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' CE ' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -77.35 -23.47 50.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.332 -0.855 . . . . 0.0 108.896 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.36 -52.91 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 108.712 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -66.27 -24.21 66.53 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.421 -0.8 . . . . 0.0 109.574 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.14 -33.0 33.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' A' ' 68' ' ' ASN . . . -82.63 -34.32 27.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.912 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -81.63 -23.03 37.25 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.98 -1.075 . . . . 0.0 108.116 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 63' ' ' ALA . 18.5 m -78.05 -43.87 28.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.052 -1.03 . . . . 0.0 108.704 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.556 HD21 HD21 ' A' ' 80' ' ' LEU . 1.6 p-10 -58.15 -21.91 48.93 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.61 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -78.78 -47.47 16.68 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.62 -22.37 30.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.01 -17.67 63.28 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.419 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.566 ' O ' HG12 ' A' ' 73' ' ' VAL . 38.3 m80 -143.81 -53.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.343 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.3 p 45.03 15.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.776 0.798 . . . . 0.0 109.286 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 72' ' ' HIS . 89.8 m-20 -131.73 9.64 4.63 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.403 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 22.4 t0 -174.33 27.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.358 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.694 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.3 ptt? -78.56 -24.41 0.43 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.519 -0.738 . . . . 0.0 111.804 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.2 Cg_exo -53.19 -29.49 46.55 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.79 1.66 . . . . 0.0 112.573 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.428 ' O ' ' OG ' ' A' ' 81' ' ' SER . 8.5 t-20 -94.1 -11.29 30.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 109.828 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.22 -58.23 3.04 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.107 -0.995 . . . . 0.0 109.258 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 68' ' ' ASN . 6.0 mt -81.35 13.94 2.69 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 2.5 p -59.22 -15.8 17.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.785 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.4 -53.61 6.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.0 109.912 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 83' ' ' LEU . 3.5 mt -44.79 -42.3 7.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.0 108.901 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.642 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 64.4 p -54.56 -29.21 50.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.545 -0.722 . . . . 0.0 109.517 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' ALA . 49.4 t0 -82.53 -16.92 46.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.334 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 tt -81.04 -62.23 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.956 -1.09 . . . . 0.0 111.249 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.4 p-80 -77.0 -21.53 54.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.886 -1.133 . . . . 0.0 111.163 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -85.94 -29.74 23.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.778 -1.201 . . . . 0.0 110.151 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 90' ' ' LYS . 15.4 t-80 -99.78 -74.81 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.171 -0.956 . . . . 0.0 110.132 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 89' ' ' HIS . 17.8 mtpp -52.0 -101.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 109.986 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.0 mp -45.12 -31.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 58.17 41.91 22.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.495 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' HIS . 5.9 t -66.84 168.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 109.353 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' VAL . 1.1 p-10 -123.46 152.09 64.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.336 -0.852 . . . . 0.0 109.333 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -41.6 -14.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.681 2.254 . . . . 0.0 112.558 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.937 HG11 ' HB3' ' D' ' 99' ' ' ASP . 46.9 t -59.29 -28.29 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 0.0 109.877 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.729 ' H ' HD22 ' A' ' 97' ' ' ASN . 0.6 OUTLIER -79.5 -24.8 42.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.95 . . . . 0.0 109.7 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -65.65 -41.95 91.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -47.28 -30.21 2.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.558 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 100' ' ' LEU . 3.7 mm? -84.11 -60.04 2.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.5 tt -53.34 -20.78 4.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 109.76 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -77.65 -59.06 2.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.818 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.799 ' NE2' ' OH ' ' B' ' 35' ' ' TYR . 32.1 m170 -64.55 -26.57 68.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 109.915 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 95.4 m -61.06 -58.01 10.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.895 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.92 -30.88 1.91 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 109.576 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.5 mt -75.06 -52.18 11.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.593 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.3 -24.76 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 109.445 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.6 m -73.61 -63.32 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.672 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 113' ' ' LEU . 18.9 mt -53.77 -33.57 56.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.386 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.41 -42.17 9.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.324 -0.86 . . . . 0.0 109.742 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.47 -56.04 4.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.436 -0.79 . . . . 0.0 109.943 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -68.28 -67.51 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.545 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -111.85 93.46 20.8 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 113' ' ' LEU . 99.1 Cg_exo -43.39 178.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.478 2.119 . . . . 0.0 113.068 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.57 -38.26 17.33 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.611 0.72 . . . . 0.0 109.281 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 4.7 mt-10 77.85 1.3 2.85 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 61.91 38.46 14.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.74 -0.6 . . . . 0.0 111.24 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.73 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -87.59 120.9 71.23 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 120.633 -1.292 . . . . 0.0 108.21 178.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.35 19.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.26 1.973 . . . . 0.0 112.889 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.73 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -150.74 -33.3 0.16 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.715 -1.24 . . . . 0.0 110.984 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.664 HG13 ' N ' ' A' ' 122' ' ' HIS . 10.7 p -45.43 -48.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.013 -1.055 . . . . 0.0 109.934 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.664 ' N ' HG13 ' A' ' 121' ' ' VAL . 20.3 m-70 -71.19 -43.73 66.84 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.444 -0.785 . . . . 0.0 108.952 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.86 -20.2 64.27 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.33 -0.856 . . . . 0.0 109.107 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 120' ' ' ALA . 12.2 p -66.33 -62.75 1.31 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.506 ' N ' ' OG ' ' A' ' 124' ' ' SER . 5.5 mt -70.31 -25.1 63.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.151 -0.968 . . . . 0.0 109.719 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.36 -45.52 46.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.058 -1.026 . . . . 0.0 109.813 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.568 ' HE3' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -90.37 -50.54 5.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.106 -0.996 . . . . 0.0 110.113 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CG ' HG21 ' A' ' 10' ' ' VAL . 28.5 t80 -48.43 -22.27 0.68 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.049 -1.032 . . . . 0.0 109.485 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 133' ' ' SER . 6.4 mt -74.57 -22.6 58.9 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.45 -32.36 72.34 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.434 ' HB2' HD13 ' A' ' 2' ' ' LEU . 14.0 t -80.09 -35.49 36.86 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.391 -0.818 . . . . 0.0 109.012 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.54 -30.62 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 129' ' ' LEU . 42.2 t -76.19 -26.27 56.0 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.422 -0.799 . . . . 0.0 108.853 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 138' ' ' SER . 19.3 m -66.89 -28.72 68.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.327 -0.858 . . . . 0.0 109.021 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.12 -47.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.091 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.25 -38.15 73.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.013 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.3 p -93.71 -15.8 24.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 134' ' ' THR . 23.3 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.898 . . . . 0.0 109.518 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.234 0.54 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mt -92.5 -170.94 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.185 -0.947 . . . . 0.0 109.254 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.409 ' O ' ' N ' ' B' ' 6' ' ' GLU . 2.9 p -111.06 129.78 23.64 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.377 -0.827 . . . . 0.0 108.97 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.78 -25.02 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.392 2.061 . . . . 0.0 112.401 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' B' ' 4' ' ' THR . 48.6 mt-10 -86.62 -48.58 8.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 0.0 109.894 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.77 -34.39 39.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.853 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -64.97 -34.95 79.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.014 . . . . 0.0 109.425 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 26.8 t -69.04 -23.62 64.09 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 109.374 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.52 -55.0 4.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.215 -0.928 . . . . 0.0 110.238 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.7 -26.45 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 34.2 m -84.64 -54.25 4.85 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.363 0.601 . . . . 0.0 109.893 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' B' ' 9' ' ' SER . . . -45.0 -31.18 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.451 -0.781 . . . . 0.0 109.859 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.494 HD23 ' HB2' ' B' ' 17' ' ' LYS . 0.6 OUTLIER -59.21 -24.64 63.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.226 -0.921 . . . . 0.0 109.623 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . 0.649 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 2.1 t90 -48.3 -27.49 2.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.17 -52.33 7.88 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.494 ' HB2' HD23 ' B' ' 14' ' ' LEU . 1.1 mppt? -64.39 -15.59 60.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -1.121 . . . . 0.0 109.084 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.23 114.96 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.356 -0.84 . . . . 0.0 109.67 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' B' ' 22' ' ' GLU . 2.4 m-80 -81.3 77.41 8.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.318 -0.864 . . . . 0.0 108.794 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' B' ' 19' ' ' ASN . 76.8 t -43.14 -21.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 109.966 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 19' ' ' ASN . 0.8 OUTLIER -83.86 11.71 7.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.59 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' B' ' 19' ' ' ASN . 36.6 mt-10 -156.15 -55.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.492 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 75.1 t -47.86 -36.37 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -57.71 9.45 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.82 -35.84 40.14 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -75.18 -26.97 59.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -1.139 . . . . 0.0 109.575 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.21 -48.1 65.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 40.3 mt -82.96 -30.58 28.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.895 . . . . 0.0 109.498 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.03 -59.19 10.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.584 ' NH2' ' SD ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -57.45 -40.84 79.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -1.133 . . . . 0.0 109.376 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . 0.693 HD23 ' O ' ' B' ' 31' ' ' LEU . 2.3 tt -43.79 -38.3 3.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.291 -0.88 . . . . 0.0 109.464 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.96 -21.83 43.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' B' ' 30' ' ' ARG . 15.6 t -86.09 -64.0 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.156 -0.965 . . . . 0.0 109.532 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 30' ' ' ARG . 0.1 OUTLIER -62.18 -22.93 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.366 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.799 ' OH ' ' NE2' ' A' ' 103' ' ' HIS . 48.5 m-85 -150.05 78.75 7.91 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 109.479 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' B' ' 38' ' ' THR . 16.6 Cg_exo -65.38 -28.22 54.75 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.042 2.494 . . . . 0.0 112.584 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.533 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 0.5 OUTLIER -46.56 -20.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.022 . . . . 0.0 109.708 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.533 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 17.3 m -96.16 61.47 2.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.168 -0.957 . . . . 0.0 109.411 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.13 24.38 6.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.363 -0.835 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -84.44 -25.79 28.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -101.06 34.63 2.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.84 . . . . 0.0 109.494 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -135.9 17.46 3.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.331 -0.855 . . . . 0.0 109.425 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' B' ' 44' ' ' SER . 0.0 OUTLIER -84.98 -30.76 23.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.495 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 39.4 t -83.11 -10.81 58.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.514 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -73.82 1.02 11.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.89 178.73 0.18 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 48.77 89.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -1.108 . . . . 0.0 109.408 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 tp -158.8 19.35 0.2 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.46 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -53.16 -39.14 63.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . 0.421 ' O ' ' N ' ' B' ' 52' ' ' ASP . 1.3 p -145.65 153.7 51.26 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.408 -0.808 . . . . 0.0 109.009 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -43.61 -19.36 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.265 1.977 . . . . 0.0 112.241 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 52' ' ' ASP . 0.6 OUTLIER -81.48 -44.29 17.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.36 -20.0 0.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.315 -0.866 . . . . 0.0 109.398 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.03 -63.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.529 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . 0.584 ' SD ' ' NH2' ' B' ' 30' ' ' ARG . 11.4 mmt -52.32 -22.02 4.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.605 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.23 -15.81 70.93 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.575 ' ND2' ' H ' ' B' ' 60' ' ' VAL . 0.3 OUTLIER -73.46 136.39 78.22 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.225 -1.162 . . . . 0.0 109.294 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.401 ' N ' HD22 ' B' ' 57' ' ' ASN . 59.1 Cg_endo -73.34 -53.36 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.339 2.026 . . . . 0.0 112.381 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.475 ' N ' ' ND2' ' B' ' 57' ' ' ASN . 17.2 mtpp -52.49 -48.99 65.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.531 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.575 ' H ' ' ND2' ' B' ' 57' ' ' ASN . 99.2 t -49.6 -37.58 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 51.0 mtpt -79.16 -33.94 43.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.83 -29.08 35.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.583 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -69.1 -23.79 64.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.568 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.32 -38.02 91.11 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 30.8 mmtm -60.93 -32.11 71.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -1.181 . . . . 0.0 109.351 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.78 -61.34 2.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.88 -24.51 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.83 -42.53 60.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.226 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.77 -39.8 17.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.71 -38.22 67.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -61.84 -32.8 73.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.146 -0.971 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . 0.649 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 13.4 m -88.5 -31.9 18.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 109.532 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -49.52 -42.49 43.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 109.473 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.12 -60.06 8.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.612 ' H ' HD12 ' B' ' 75' ' ' LEU . 5.0 mp -57.03 -26.44 60.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -1.127 . . . . 0.0 109.389 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.2 -0.35 48.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.958 . . . . 0.0 109.488 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.441 ' C ' ' H ' ' B' ' 79' ' ' ASP . 75.9 t60 -171.2 64.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.534 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 54.3 mt -72.36 12.15 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' B' ' 77' ' ' HIS . 2.8 m-20 -71.83 -20.79 61.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.434 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -171.6 109.74 0.28 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -79.69 -58.54 3.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -47.63 -24.01 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.97 -61.85 4.09 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.6 t -66.62 -47.09 73.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -1.177 . . . . 0.0 109.355 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.548 ' N ' ' CG2' ' B' ' 84' ' ' THR . 69.0 m-85 -70.88 15.14 0.11 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.558 -0.714 . . . . 0.0 109.526 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -69.4 -38.88 78.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 109.573 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 17.8 p -83.62 -51.69 7.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.639 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 26.5 mt -53.04 -24.87 10.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.478 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 99.5 p -81.92 -40.61 22.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.505 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -81.43 -22.59 38.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.622 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 4.2 tt -82.29 -48.39 11.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.061 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.537 ' NE2' ' O ' ' B' ' 141' ' ' LEU . 1.9 p-80 -75.18 -22.28 58.15 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.918 -1.114 . . . . 0.0 110.22 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . 0.461 ' SG ' ' CE1' ' B' ' 145' ' ' TYR . 51.2 t -83.73 -60.25 2.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.132 -0.98 . . . . 0.0 111.356 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 12.8 t70 -86.8 -27.4 23.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.983 -1.073 . . . . 0.0 111.784 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . 0.53 ' O ' ' CE1' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -84.56 -49.99 8.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.704 -1.248 . . . . 0.0 110.655 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.521 ' N ' HD12 ' B' ' 96' ' ' LEU . 8.3 mp -86.52 -34.64 19.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.793 -1.192 . . . . 0.0 109.931 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' B' ' 94' ' ' ASP . 3.3 m80 71.77 36.92 1.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 109.545 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.85 134.84 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 0.848 ' HB3' HG11 ' C' ' 96' ' ' VAL . 3.7 m-20 -81.72 151.68 68.28 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.405 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.519 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 65.3 Cg_exo -47.23 -173.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.39 2.06 . . . . 0.0 112.358 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 57.62 53.2 7.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.52 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' B' ' 100' ' ' PRO . 69.3 m-80 -159.31 -34.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.6 m-85 -73.75 -54.55 7.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.333 -0.854 . . . . 0.0 109.585 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -57.1 -22.35 39.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.713 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 tt -76.77 -41.62 44.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -0.969 . . . . 0.0 109.517 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.531 ' C ' HD23 ' B' ' 106' ' ' LEU . 4.9 tt -68.58 -56.59 7.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.231 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.45 -20.24 2.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -85.62 -55.61 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -1.116 . . . . 0.0 109.984 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.12 -24.8 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.055 -1.028 . . . . 0.0 109.49 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.503 HD23 ' C ' ' B' ' 110' ' ' LEU . 2.5 tt -57.41 -59.18 5.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.255 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.92 -39.94 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.229 -0.919 . . . . 0.0 109.677 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.423 ' O ' ' CE1' ' B' ' 116' ' ' HIS . 76.3 m -48.87 -43.77 39.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.591 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 70.4 t -55.99 -53.42 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.353 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.627 ' N ' HD12 ' B' ' 114' ' ' LEU . 9.3 mp -49.81 -41.99 45.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 119' ' ' GLY . . . -47.88 -41.54 24.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.78 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.65 ' N ' ' ND1' ' B' ' 116' ' ' HIS . 0.4 OUTLIER -68.87 -52.16 32.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.612 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' B' ' 118' ' ' PHE . 74.9 m80 -69.24 -17.55 63.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.713 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 63.8 m-85 -156.84 64.34 0.52 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.955 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 115' ' ' ALA . . . -76.25 -21.36 75.81 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -72.85 -29.22 63.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -1.128 . . . . 0.0 109.362 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 123' ' ' THR . 63.4 mm-40 -78.53 -15.49 58.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.271 -0.893 . . . . 0.0 109.554 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' B' ' 115' ' ' ALA . 3.8 m-85 -69.82 59.66 0.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.472 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 11.7 p -59.04 150.98 58.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.94 . . . . 0.0 108.917 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.444 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.3 Cg_exo -44.15 -58.15 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.446 2.097 . . . . 0.0 112.716 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 27.5 Cg_endo -61.89 -46.52 13.24 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.161 1.907 . . . . 0.0 112.027 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.472 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 40.6 t -66.86 -18.2 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . 0.647 ' NE2' HD11 ' A' ' 34' ' ' LEU . 1.1 tm0? -83.14 -26.29 31.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.844 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -68.8 -32.1 71.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.37 26.38 0.92 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.935 . . . . 0.0 109.648 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.647 ' CG ' ' N ' ' B' ' 131' ' ' GLN . 5.8 p90 -74.53 -52.31 12.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.14 -0.975 . . . . 0.0 109.791 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 1.024 ' OE1' ' HZ ' ' A' ' 36' ' ' PHE . 36.5 tt0 -86.06 -38.93 17.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.162 -0.961 . . . . 0.0 109.999 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.993 ' HG3' ' O ' ' D' ' 146' ' ' HIS . 32.1 ttpt -50.9 -34.56 28.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.233 -0.917 . . . . 0.0 110.959 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . 0.89 HG13 ' H ' ' B' ' 134' ' ' VAL . 7.1 p -65.27 -63.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.844 -1.16 . . . . 0.0 109.891 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.89 ' H ' HG13 ' B' ' 133' ' ' VAL . 1.8 m -73.77 -14.82 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.361 -0.837 . . . . 0.0 109.75 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . -45.78 -23.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.55 -26.41 46.84 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' B' ' 134' ' ' VAL . 74.9 t -80.05 -21.28 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -1.104 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.86 -51.11 71.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.555 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.69 -22.52 53.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.34 -45.94 88.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.537 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 19.9 mt -84.01 15.57 3.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.544 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.62 -1.5 2.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 109.505 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . 0.433 ' O ' ' CD2' ' B' ' 143' ' ' HIS . 21.9 t-160 -79.87 -26.57 40.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.518 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -73.26 -11.39 60.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.379 -0.826 . . . . 0.0 109.342 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.461 ' CE1' ' SG ' ' B' ' 93' ' ' CYS . 15.6 m-85 -72.84 7.19 2.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.301 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 1.01 ' O ' ' HG3' ' D' ' 132' ' ' LYS . 7.5 p-80 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.453 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' C' ' 2' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.579 HD11 ' HE3' ' C' ' 127' ' ' LYS . 7.1 tp 73.63 170.67 0.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 109.545 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.492 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 174.45 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.166 -0.959 . . . . 0.0 110.041 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' C' ' 3' ' ' SER . 96.6 Cg_exo -41.4 168.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.683 2.255 . . . . 0.0 112.837 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -50.77 -16.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.436 -0.79 . . . . 0.0 110.003 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' C' ' 5' ' ' ALA . 2.8 p30 -39.7 -28.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.746 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' C' ' 5' ' ' ALA . 5.9 ptmm? -83.2 -52.31 6.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.514 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.417 ' N ' ' CG ' ' C' ' 7' ' ' LYS . 49.2 m -47.93 -26.76 1.85 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 108.954 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . 0.434 ' CG ' ' HB1' ' C' ' 120' ' ' ALA . 40.6 m-20 -80.01 -39.43 29.96 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.603 HG21 ' CG ' ' C' ' 128' ' ' PHE . 21.4 t -69.35 -47.01 75.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . 0.408 ' HZ2' ' HZ3' ' C' ' 7' ' ' LYS . 2.4 mptm? -50.12 -48.57 53.49 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.65 -63.13 1.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.628 -0.67 . . . . 0.0 109.316 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.652 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -50.57 -41.82 54.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.2 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . 0.401 ' NE1' ' OG1' ' C' ' 67' ' ' THR . 0.1 OUTLIER -68.04 -17.34 64.37 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.412 -0.805 . . . . 0.0 109.05 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.71 -47.38 7.29 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -68.41 -36.71 79.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -1.113 . . . . 0.0 108.85 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.652 HG23 ' O ' ' C' ' 13' ' ' ALA . 69.5 t -60.99 -66.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 63.39 -141.4 45.89 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 37.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.519 -0.989 . . . . 0.0 110.157 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.548 ' H ' ' C ' ' C' ' 18' ' ' GLY . 89.4 m-70 -140.27 24.5 2.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.431 ' HB2' ' CG1' ' C' ' 17' ' ' VAL . . . -88.36 -48.73 7.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.561 -0.712 . . . . 0.0 109.927 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.3 -14.74 27.82 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' C' ' 27' ' ' GLU . 12.6 mt-10 -85.64 -56.32 3.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -1.156 . . . . 0.0 109.653 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.0 m-30 -55.4 -26.86 44.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 109.288 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.18 -24.41 76.62 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.73 -36.33 28.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -1.165 . . . . 0.0 109.627 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' C' ' 23' ' ' GLU . 1.4 mp0 -70.27 -20.03 63.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.5 -19.88 60.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.038 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' C' ' 58' ' ' HIS . 17.1 mt -77.74 -58.19 3.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.353 -0.842 . . . . 0.0 109.735 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -50.94 -43.77 60.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 109.685 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -56.3 -30.46 62.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.651 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 38.5 ttp -84.27 -57.22 3.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.815 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . 0.434 ' CZ ' ' CZ ' ' C' ' 46' ' ' PHE . 25.8 m-85 -47.7 -36.86 11.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.998 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.816 HD13 ' HB2' ' D' ' 128' ' ' ALA . 3.4 pp -84.49 -25.76 28.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.994 -1.067 . . . . 0.0 109.808 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.531 ' N ' HD12 ' C' ' 34' ' ' LEU . 28.1 t -60.88 -22.06 63.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 109.472 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 1.047 ' HZ ' ' OE1' ' D' ' 131' ' ' GLN . 66.7 m-85 -156.18 128.69 4.13 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.21 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.58 -20.17 16.01 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.292 1.995 . . . . 0.0 112.08 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 68.2 p -62.62 -18.92 63.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 76.8 p -80.88 -35.61 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.0 109.756 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -67.61 -36.45 80.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 109.7 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.778 -179.708 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.121 0.486 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -165.44 26.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 110.346 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' C' ' 49' ' ' SER . 22.5 m-20 41.74 88.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.701 . . . . 0.0 110.25 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 1.011 ' H ' HD13 ' C' ' 48' ' ' LEU . 0.0 OUTLIER -56.52 0.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.385 -0.822 . . . . 0.0 109.538 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.583 ' H ' ' C ' ' C' ' 47' ' ' ASP . 2.8 t -46.58 132.1 10.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.163 -0.961 . . . . 0.0 109.681 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.518 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 11.4 t-80 -76.16 144.12 40.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.388 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . 0.518 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 73.26 10.14 78.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' C' ' 53' ' ' ALA . 88.5 p -68.88 -100.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -1.147 . . . . 0.0 109.392 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.524 ' N ' ' OG ' ' C' ' 52' ' ' SER . . . -178.41 -31.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.41 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -81.26 -17.58 48.94 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.264 -0.897 . . . . 0.0 109.171 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.57 -33.99 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.626 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -70.78 -28.27 64.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.314 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . 0.427 ' O ' ' CE ' ' C' ' 61' ' ' LYS . . . -69.82 -48.18 43.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.6 OUTLIER -54.01 -35.63 62.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -1.155 . . . . 0.0 109.366 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.43 -58.59 10.92 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -51.7 -23.95 5.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -1.099 . . . . 0.0 109.625 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' C' ' 57' ' ' GLY . 0.0 OUTLIER -77.39 -23.46 50.7 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 108.911 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.43 -52.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.26 -24.23 66.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.32 -0.862 . . . . 0.0 109.581 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.02 -32.97 33.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.99 . . . . 0.0 109.821 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . 0.453 ' O ' ' OD1' ' C' ' 68' ' ' ASN . . . -82.68 -34.33 27.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.122 -0.986 . . . . 0.0 109.549 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.911 ' O ' HD12 ' C' ' 66' ' ' LEU . 0.1 OUTLIER -81.51 -23.05 37.57 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.401 ' OG1' ' NE1' ' C' ' 14' ' ' TRP . 18.3 m -78.05 -43.86 28.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.068 -1.02 . . . . 0.0 108.711 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.555 HD21 HD21 ' C' ' 80' ' ' LEU . 1.6 p-10 -58.15 -21.86 48.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.611 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -78.79 -47.53 16.53 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.55 -22.42 30.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.0 -17.66 63.29 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.438 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.573 ' O ' HG12 ' C' ' 73' ' ' VAL . 38.3 m80 -143.87 -53.45 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 0.0 109.291 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.2 p 45.04 15.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.799 0.809 . . . . 0.0 109.283 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' C' ' 72' ' ' HIS . 89.8 m-20 -131.76 9.66 4.62 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 22.3 t0 -174.28 27.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.265 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.3 ptt? -78.57 -24.37 0.43 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.472 -0.767 . . . . 0.0 111.783 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.0 Cg_exo -53.24 -29.47 46.94 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.79 1.66 . . . . 0.0 112.571 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.438 ' O ' ' OG ' ' C' ' 81' ' ' SER . 8.5 t-20 -94.15 -11.16 31.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 109.828 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.27 -58.16 3.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.153 -0.967 . . . . 0.0 109.281 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . 0.555 HD21 HD21 ' C' ' 68' ' ' ASN . 6.0 mt -81.34 13.87 2.72 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 108.796 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 2.5 p -59.15 -15.84 16.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 109.809 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.51 -53.58 6.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.0 109.831 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.444 ' O ' ' CE1' ' C' ' 87' ' ' HIS . 3.5 mt -44.73 -42.24 7.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.389 -0.819 . . . . 0.0 108.928 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.646 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 66.7 p -54.69 -29.17 52.18 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.552 -0.717 . . . . 0.0 109.446 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' C' ' 82' ' ' ALA . 49.2 t0 -82.55 -16.93 46.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.396 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.8 tt -81.0 -62.32 1.7 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.918 -1.113 . . . . 0.0 111.241 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.4 p-80 -76.95 -21.47 54.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.86 -1.15 . . . . 0.0 111.16 -178.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -85.91 -29.78 23.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.77 -1.206 . . . . 0.0 110.207 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' C' ' 90' ' ' LYS . 15.5 t-80 -99.79 -74.85 0.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 110.139 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' C' ' 89' ' ' HIS . 17.8 mtpp -51.96 -101.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.967 . . . . 0.0 109.985 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.611 ' N ' HD12 ' C' ' 91' ' ' LEU . 10.0 mp -45.17 -31.77 1.58 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.827 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 58.16 41.93 22.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.503 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' C' ' 87' ' ' HIS . 5.9 t -66.95 168.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.372 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' C' ' 96' ' ' VAL . 1.1 p-10 -123.51 152.14 64.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.34 -0.85 . . . . 0.0 109.272 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -41.73 -14.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.666 2.244 . . . . 0.0 112.584 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.848 HG11 ' HB3' ' B' ' 99' ' ' ASP . 46.7 t -59.24 -28.33 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 109.934 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.708 ' H ' HD22 ' C' ' 97' ' ' ASN . 0.6 OUTLIER -79.45 -24.91 42.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.664 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -65.62 -42.03 91.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.584 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -47.22 -30.26 2.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.592 HD22 ' N ' ' C' ' 100' ' ' LEU . 3.7 mm? -84.07 -60.04 2.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.593 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.5 tt -53.25 -20.9 4.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.736 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -77.6 -59.08 2.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 109.763 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . 0.787 ' NE2' ' OH ' ' D' ' 35' ' ' TYR . 32.1 m170 -64.61 -26.6 68.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.837 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 95.2 m -61.0 -58.02 10.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 0.0 109.869 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.94 -30.9 1.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.5 mt -74.97 -52.29 11.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.155 -0.966 . . . . 0.0 109.616 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.29 -24.69 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.493 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 24.7 m -73.71 -63.25 1.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' C' ' 113' ' ' LEU . 18.9 mt -53.77 -33.68 56.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.372 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.3 -42.28 9.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.74 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.37 -56.0 4.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -68.28 -67.5 0.46 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.608 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -111.87 93.52 21.1 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' C' ' 113' ' ' LEU . 98.5 Cg_exo -43.44 178.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.406 2.071 . . . . 0.0 113.105 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.59 -38.25 17.31 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.666 0.746 . . . . 0.0 109.312 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 4.8 mt-10 77.87 1.24 2.84 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 61.88 38.5 14.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.793 -0.567 . . . . 0.0 111.268 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.735 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.7 OUTLIER -87.59 120.95 71.24 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.73 -1.231 . . . . 0.0 108.197 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.43 19.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.285 1.99 . . . . 0.0 112.816 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -150.74 -33.22 0.16 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.726 -1.234 . . . . 0.0 110.962 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.646 HG13 ' N ' ' C' ' 122' ' ' HIS . 10.8 p -45.57 -48.09 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.876 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.646 ' N ' HG13 ' C' ' 121' ' ' VAL . 20.2 m-70 -71.18 -43.81 66.73 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.451 -0.78 . . . . 0.0 108.917 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.74 -20.23 64.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.329 -0.857 . . . . 0.0 109.15 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.57 ' N ' ' O ' ' C' ' 120' ' ' ALA . 12.1 p -66.38 -62.72 1.32 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.21 -0.931 . . . . 0.0 110.215 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.513 ' N ' ' OG ' ' C' ' 124' ' ' SER . 5.6 mt -70.23 -25.1 63.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.166 -0.959 . . . . 0.0 109.736 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -74.47 -45.39 46.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.087 -1.008 . . . . 0.0 109.784 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.579 ' HE3' HD11 ' C' ' 2' ' ' LEU . 0.0 OUTLIER -90.45 -50.47 5.93 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.044 -1.035 . . . . 0.0 110.127 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.603 ' CG ' HG21 ' C' ' 10' ' ' VAL . 28.5 t80 -48.44 -22.35 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.912 -1.118 . . . . 0.0 109.453 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' C' ' 133' ' ' SER . 6.4 mt -74.55 -22.57 58.94 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.42 -32.31 72.26 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.425 ' HB2' HD13 ' C' ' 2' ' ' LEU . 13.8 t -80.16 -35.44 36.52 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.382 -0.824 . . . . 0.0 109.095 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 22.4 t -83.51 -30.71 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.149 -0.969 . . . . 0.0 108.57 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.564 ' N ' ' O ' ' C' ' 129' ' ' LEU . 42.1 t -76.25 -26.17 55.74 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.434 -0.792 . . . . 0.0 108.873 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . 0.53 ' O ' ' N ' ' C' ' 138' ' ' SER . 19.5 m -66.85 -28.76 68.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.278 -0.889 . . . . 0.0 109.091 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.09 -47.52 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.11 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.19 -38.05 73.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.112 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 70.4 p -93.83 -15.76 24.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . 0.53 ' N ' ' O ' ' C' ' 134' ' ' THR . 23.3 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.885 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.251 0.548 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mt -92.65 -170.89 2.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 109.193 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.403 ' O ' ' N ' ' D' ' 6' ' ' GLU . 2.9 p -111.14 129.8 23.64 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.828 . . . . 0.0 108.938 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -40.82 -24.95 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.305 2.003 . . . . 0.0 112.439 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' D' ' 4' ' ' THR . 48.6 mt-10 -86.67 -48.63 8.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.858 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -79.61 -34.41 40.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.94 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.478 ' CD ' ' C ' ' D' ' 8' ' ' LYS . 0.0 OUTLIER -65.04 -34.86 79.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -0.964 . . . . 0.0 109.362 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 27.1 t -69.1 -23.6 64.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.11 -0.994 . . . . 0.0 109.335 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.55 -54.96 4.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.903 . . . . 0.0 110.189 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.71 -26.47 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.004 -1.06 . . . . 0.0 108.277 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 34.2 m -84.61 -54.31 4.81 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.395 0.616 . . . . 0.0 109.859 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' D' ' 9' ' ' SER . . . -45.04 -31.09 1.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 0.0 109.898 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.48 HD23 ' HB2' ' D' ' 17' ' ' LYS . 0.6 OUTLIER -59.22 -24.68 63.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.625 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . 0.65 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 2.1 t90 -48.27 -27.51 2.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.14 -52.37 7.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.505 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 1.1 mppt? -64.44 -15.59 60.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.356 -1.085 . . . . 0.0 109.047 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.2 114.84 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.671 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' D' ' 22' ' ' GLU . 2.4 m-80 -81.21 77.35 8.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 108.855 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' D' ' 19' ' ' ASN . 76.5 t -43.11 -21.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.439 -0.788 . . . . 0.0 109.926 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' D' ' 19' ' ' ASN . 0.8 OUTLIER -83.84 11.72 7.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.658 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' D' ' 19' ' ' ASN . 36.6 mt-10 -156.13 -55.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 109.477 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -48.03 -36.23 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.534 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.79 -57.67 9.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.77 -35.87 39.81 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.21 -26.87 59.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.21 -48.12 65.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.948 . . . . 0.0 109.516 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 40.9 mt -83.09 -30.49 27.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.452 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.08 -59.11 10.62 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . 0.583 ' NH2' ' SD ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -57.53 -40.78 79.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -1.085 . . . . 0.0 109.346 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . 0.695 HD23 ' O ' ' D' ' 31' ' ' LEU . 2.3 tt -43.81 -38.31 3.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -79.94 -21.79 43.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' D' ' 30' ' ' ARG . 15.6 t -86.11 -63.98 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 30' ' ' ARG . 0.1 OUTLIER -62.25 -22.88 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 109.297 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . 0.787 ' OH ' ' NE2' ' C' ' 103' ' ' HIS . 48.5 m-85 -150.13 78.79 7.84 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 109.501 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' D' ' 38' ' ' THR . 16.6 Cg_exo -65.5 -28.12 53.83 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.988 2.459 . . . . 0.0 112.621 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . 0.538 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 0.5 OUTLIER -46.63 -19.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.81 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.538 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 17.5 m -96.16 61.37 2.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.219 -0.926 . . . . 0.0 109.375 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.02 24.3 6.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 109.557 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -84.35 -25.86 28.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.119 -0.988 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -100.97 34.53 2.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -135.92 17.51 3.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 109.431 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' D' ' 44' ' ' SER . 0.0 OUTLIER -85.05 -30.67 23.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.418 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . 0.491 ' H ' ' CD ' ' D' ' 43' ' ' GLU . 39.3 t -83.13 -10.78 58.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.491 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -73.91 1.12 11.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.315 -0.866 . . . . 0.0 109.435 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.9 178.7 0.18 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 48.78 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.157 . . . . 0.0 109.441 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 tp -158.91 19.49 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.355 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -53.28 -39.06 63.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . 0.428 ' O ' ' N ' ' D' ' 52' ' ' ASP . 1.2 p -145.66 153.7 51.2 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.844 . . . . 0.0 109.053 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.64 -19.37 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.276 1.984 . . . . 0.0 112.168 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' D' ' 52' ' ' ASP . 0.6 OUTLIER -81.39 -44.54 17.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.23 -19.92 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . 0.412 ' N ' ' C ' ' D' ' 52' ' ' ASP . 97.5 t -66.2 -63.16 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . 0.583 ' SD ' ' NH2' ' D' ' 30' ' ' ARG . 11.4 mmt -52.25 -22.08 4.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.581 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.18 -15.92 70.77 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . 0.579 ' ND2' ' H ' ' D' ' 60' ' ' VAL . 0.3 OUTLIER -73.38 136.46 78.44 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.294 -1.121 . . . . 0.0 109.269 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.409 ' N ' HD22 ' D' ' 57' ' ' ASN . 59.0 Cg_endo -73.38 -53.41 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.343 2.028 . . . . 0.0 112.33 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . 0.468 ' N ' ' ND2' ' D' ' 57' ' ' ASN . 17.3 mtpp -52.42 -48.99 65.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . 0.579 ' H ' ' ND2' ' D' ' 57' ' ' ASN . 99.5 t -49.73 -37.47 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . 0.523 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 50.9 mtpt -79.15 -33.91 43.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.502 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.84 -29.05 35.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 109.619 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -69.09 -23.81 64.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.57 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.27 -38.0 91.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 30.8 mmtm -60.96 -32.1 71.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -1.15 . . . . 0.0 109.264 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.8 -61.44 2.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 109.419 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.94 -24.42 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.8 -42.55 60.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.184 -0.947 . . . . 0.0 109.275 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.79 -39.76 17.7 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.73 -38.25 67.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 0.0 109.475 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -61.93 -32.64 73.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . 0.65 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 13.6 m -88.53 -31.89 18.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -49.54 -42.35 43.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.89 . . . . 0.0 109.515 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.2 -60.07 8.52 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.631 ' H ' HD12 ' D' ' 75' ' ' LEU . 5.0 mp -57.02 -26.43 60.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -1.101 . . . . 0.0 109.406 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.18 -0.42 49.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.444 ' C ' ' H ' ' D' ' 79' ' ' ASP . 76.0 t60 -171.07 64.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.536 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 53.9 mt -72.34 12.21 0.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' D' ' 77' ' ' HIS . 2.8 m-20 -71.88 -20.76 61.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.428 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -171.62 109.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.414 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -79.78 -58.48 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -47.68 -23.99 0.82 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.95 -61.93 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.5 t -66.56 -47.14 73.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -1.154 . . . . 0.0 109.425 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 68.8 m-85 -70.85 15.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.495 -0.753 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . 0.491 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -69.5 -38.74 77.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.625 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 17.9 p -83.72 -51.75 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.605 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 26.1 mt -52.92 -24.93 10.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.564 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 99.1 p -81.88 -40.66 22.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.234 -0.916 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -81.42 -22.59 38.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.609 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 4.2 tt -82.17 -48.51 11.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 110.089 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.532 ' NE2' ' O ' ' D' ' 141' ' ' LEU . 1.9 p-80 -75.11 -22.26 58.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.915 -1.116 . . . . 0.0 110.19 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' CE1' ' D' ' 145' ' ' TYR . 51.2 t -83.76 -60.17 2.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.142 -0.974 . . . . 0.0 111.358 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 12.8 t70 -86.82 -27.38 23.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.074 -1.016 . . . . 0.0 111.835 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . 0.531 ' O ' ' CE1' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -84.65 -49.94 8.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.727 -1.233 . . . . 0.0 110.613 -178.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.521 ' N ' HD12 ' D' ' 96' ' ' LEU . 8.3 mp -86.55 -34.61 19.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.823 -1.173 . . . . 0.0 109.905 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' D' ' 94' ' ' ASP . 3.3 m80 71.72 36.98 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.89 . . . . 0.0 109.612 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.91 134.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.194 -0.942 . . . . 0.0 109.314 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . 0.937 ' HB3' HG11 ' A' ' 96' ' ' VAL . 3.8 m-20 -81.76 151.63 68.1 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.356 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . 0.508 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 66.7 Cg_exo -47.25 -173.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.433 2.088 . . . . 0.0 112.277 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 57.67 53.09 7.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.521 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' D' ' 100' ' ' PRO . 69.3 m-80 -159.23 -34.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.515 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.84 -54.56 7.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -57.08 -22.37 38.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 tt -76.7 -41.7 44.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.509 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.542 ' C ' HD23 ' D' ' 106' ' ' LEU . 4.9 tt -68.54 -56.64 7.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.203 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.4 -20.18 2.28 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -85.68 -55.65 3.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -1.139 . . . . 0.0 109.978 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.07 -24.78 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.078 -1.014 . . . . 0.0 109.613 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . 0.501 HD23 ' C ' ' D' ' 110' ' ' LEU . 2.5 tt -57.45 -59.12 5.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.284 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 t -59.01 -39.92 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.595 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . 0.421 ' O ' ' CE1' ' D' ' 116' ' ' HIS . 76.2 m -48.88 -43.7 39.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 109.622 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 70.0 t -55.97 -53.43 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.412 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . 0.637 HD12 ' N ' ' D' ' 114' ' ' LEU . 9.3 mp -49.88 -41.92 46.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' D' ' 119' ' ' GLY . . . -47.9 -41.54 24.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.735 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.661 ' N ' ' ND1' ' D' ' 116' ' ' HIS . 0.4 OUTLIER -68.84 -52.32 31.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.537 -179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 74.9 m80 -69.1 -17.65 63.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.738 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 64.0 m-85 -156.82 64.45 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.522 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' D' ' 115' ' ' ALA . . . -76.4 -21.26 75.7 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -72.78 -29.3 63.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.157 . . . . 0.0 109.375 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' D' ' 123' ' ' THR . 63.3 mm-40 -78.56 -15.46 58.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' D' ' 115' ' ' ALA . 3.8 m-85 -69.84 59.77 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.321 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.466 ' OG1' ' CG2' ' D' ' 126' ' ' VAL . 12.0 p -59.05 150.95 59.09 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 108.916 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.445 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.3 Cg_exo -44.09 -58.12 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.414 2.076 . . . . 0.0 112.755 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 27.6 Cg_endo -61.9 -46.62 12.88 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.117 1.878 . . . . 0.0 112.033 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.466 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 40.3 t -66.68 -18.33 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.695 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . 0.655 ' NE2' HD11 ' C' ' 34' ' ' LEU . 1.1 tm0? -83.13 -26.4 31.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.114 -0.992 . . . . 0.0 109.703 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.816 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -68.73 -32.08 71.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.051 -1.03 . . . . 0.0 109.572 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.37 26.45 0.91 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.644 ' CG ' ' N ' ' D' ' 131' ' ' GLN . 5.8 p90 -74.6 -52.19 12.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.813 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 1.047 ' OE1' ' HZ ' ' C' ' 36' ' ' PHE . 36.6 tt0 -86.03 -38.98 17.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.146 -0.972 . . . . 0.0 110.023 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . 1.01 ' HG3' ' O ' ' B' ' 146' ' ' HIS . 32.1 ttpt -50.9 -34.55 28.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 110.981 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . 0.889 HG13 ' H ' ' D' ' 134' ' ' VAL . 7.1 p -65.18 -64.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.865 -1.147 . . . . 0.0 109.87 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.889 ' H ' HG13 ' D' ' 133' ' ' VAL . 1.8 m -73.83 -14.65 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.409 -0.807 . . . . 0.0 109.826 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' D' ' 131' ' ' GLN . . . -45.87 -23.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.099 -1.001 . . . . 0.0 109.662 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -82.6 -26.36 46.82 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' D' ' 134' ' ' VAL . 75.0 t -80.04 -21.36 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -1.159 . . . . 0.0 109.441 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.8 -51.06 71.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 109.659 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.78 -22.42 53.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.0 88.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 20.2 mt -84.03 15.65 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.587 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.69 -1.42 2.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.304 -0.872 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . 0.432 ' CD2' ' O ' ' D' ' 143' ' ' HIS . 21.8 t-160 -79.98 -26.53 39.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.47 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -73.28 -11.35 60.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . 0.448 ' CE1' ' SG ' ' D' ' 93' ' ' CYS . 15.8 m-85 -72.84 7.11 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.942 . . . . 0.0 109.24 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.993 ' O ' ' HG3' ' B' ' 132' ' ' LYS . 7.6 p-80 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 3.0 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 3' ' ' SER . 3.3 tp 75.68 174.32 0.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.335 -0.853 . . . . 0.0 109.537 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.623 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 164.56 -38.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 110.516 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 3' ' ' SER . 76.4 Cg_exo -49.62 -173.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.327 2.018 . . . . 0.0 112.966 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -75.81 -15.86 60.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 0.0 110.073 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' A' ' 127' ' ' LYS . 4.9 p30 -39.03 -38.29 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.301 -0.875 . . . . 0.0 109.554 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 12.9 mtmm -57.41 -58.41 8.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 108.958 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 m -51.51 -31.83 25.33 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 108.989 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -76.61 -34.71 58.36 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.625 HG21 ' CD2' ' A' ' 128' ' ' PHE . 51.8 t -72.73 -49.91 37.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HE2' HG13 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -52.16 -42.31 63.3 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.66 -60.78 3.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.409 -0.807 . . . . 0.0 109.389 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -53.62 -34.11 57.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.113 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -17.69 61.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.379 -0.826 . . . . 0.0 109.077 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.44 -45.11 10.07 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.41 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 13.1 mmmt -68.72 -39.8 80.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -1.134 . . . . 0.0 108.859 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 13' ' ' ALA . 89.1 t -60.92 -65.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 58.06 -136.73 50.63 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.06 27.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.474 -1.016 . . . . 0.0 110.329 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.563 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.7 m-70 -131.44 27.1 4.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -90.96 -63.83 1.21 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.695 -0.628 . . . . 0.0 109.917 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.98 -14.47 0.13 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.4 mt-10 -85.06 -56.33 3.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -1.056 . . . . 0.0 109.633 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.8 m-30 -57.95 -43.93 86.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.328 -0.858 . . . . 0.0 109.111 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.03 -22.88 56.33 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.05 -33.91 59.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -1.129 . . . . 0.0 109.689 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' OE2' ' NE2' ' A' ' 112' ' ' HIS . 47.2 mt-10 -69.17 -20.18 64.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.282 -0.886 . . . . 0.0 109.687 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -19.68 59.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.344 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.7 mt -72.14 -48.11 46.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 109.6 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.46 -24.79 63.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.211 -0.93 . . . . 0.0 109.503 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.927 HH11 ' HG2' ' B' ' 127' ' ' GLN . 50.2 ttm-85 -76.1 -21.16 56.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.206 -0.934 . . . . 0.0 109.345 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 54.0 ttp -82.24 -50.7 8.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CD2' ' OG1' ' A' ' 39' ' ' THR . 9.4 m-85 -52.59 -44.34 65.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.701 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.755 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 6.5 mt -67.59 -58.7 4.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.975 . . . . 0.0 109.682 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.676 ' HA ' ' OE1' ' B' ' 131' ' ' GLN . 40.2 m -48.47 -34.03 10.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.905 . . . . 0.0 109.755 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 35' ' ' SER . 3.0 m-85 -146.73 90.46 5.5 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.232 -0.918 . . . . 0.0 109.397 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 39' ' ' THR . 48.4 Cg_exo -53.51 -19.32 13.32 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.72 2.28 . . . . 0.0 112.149 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 37' ' ' PRO . 12.9 p -42.64 -18.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.405 -0.809 . . . . 0.0 110.092 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 37' ' ' PRO . 46.7 p -75.42 -22.29 57.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.928 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -46.55 -44.92 18.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.912 . . . . 0.0 109.853 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.475 HG21 ' CD2' ' D' ' 97' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.658 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.594 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -146.1 66.36 1.2 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 49' ' ' SER . 17.0 m-20 -41.05 -18.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.265 -0.897 . . . . 0.0 110.214 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 46' ' ' PHE . 1.1 mt 51.94 9.8 0.1 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 47' ' ' ASP . 10.7 t -67.18 155.87 37.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.38 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.506 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 11.4 t-80 -65.24 139.84 58.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.542 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.506 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 54.52 30.62 50.63 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.554 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 36.9 t -63.24 -98.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -1.15 . . . . 0.0 109.376 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 172.56 -39.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.862 . . . . 0.0 109.487 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -74.77 -20.1 59.94 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.275 -0.891 . . . . 0.0 109.44 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -84.72 -41.09 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -78.95 -26.48 43.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.862 . . . . 0.0 109.054 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.55 -21.94 63.23 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.565 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -79.02 -39.31 34.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -1.125 . . . . 0.0 109.558 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.79 -47.67 30.69 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 51.2 mttp -52.45 -23.78 6.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 0.0 109.804 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -72.08 -42.49 66.11 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.149 -0.969 . . . . 0.0 109.034 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 t -70.69 -48.24 59.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.52 -30.5 70.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.286 -0.884 . . . . 0.0 109.071 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.9 t0 -68.4 -32.59 72.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.927 . . . . 0.0 108.738 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.46 -49.42 59.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.407 -0.808 . . . . 0.0 108.983 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.61 -39.93 93.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.274 -0.891 . . . . 0.0 108.817 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -70.69 -49.77 43.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.264 -0.898 . . . . 0.0 108.612 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -58.39 -21.03 48.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.47 -46.83 12.03 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.415 HG13 ' HE2' ' A' ' 11' ' ' LYS . 3.9 t -63.59 -22.83 31.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -59.34 -25.97 64.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 74' ' ' ASP . 40.5 m80 -147.14 -48.4 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.855 . . . . 0.0 109.402 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.4 p 44.99 13.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.752 0.787 . . . . 0.0 109.47 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 72' ' ' HIS . 37.3 m-20 -135.52 10.75 3.45 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 3.9 m-20 -174.94 26.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 15.0 ptt? -78.53 -22.59 0.39 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 111.706 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 76' ' ' MET . 49.7 Cg_exo -55.05 -17.93 15.85 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.506 1.471 . . . . 0.0 112.221 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 78' ' ' ASN . 1.6 m-80 -94.14 -46.81 6.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.272 -0.893 . . . . 0.0 109.387 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.02 -42.3 99.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.825 . . . . 0.0 109.15 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.76 9.16 8.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.489 -0.757 . . . . 0.0 108.996 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -57.33 -25.55 59.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.375 -0.828 . . . . 0.0 109.637 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -56.4 -57.99 9.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.119 -0.988 . . . . 0.0 109.463 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.477 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 6.6 mt -45.31 -50.45 11.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 3.4 m -49.25 -38.45 26.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 82' ' ' ALA . 27.9 t70 -82.52 -17.29 45.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.839 . . . . 0.0 109.865 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -70.7 -51.9 24.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.58 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 14.3 p-80 -92.16 -21.92 20.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.89 -1.131 . . . . 0.0 110.689 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -60.64 -51.32 69.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.852 -1.155 . . . . 0.0 109.907 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -155.69 63.78 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.94 . . . . 0.0 109.906 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -163.06 0.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.865 . . . . 0.0 109.29 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.6 tp -171.78 -31.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 51.76 47.74 24.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.46 136.97 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.484 ' OD2' ' CE1' ' D' ' 97' ' ' HIS . 22.5 m-20 -58.33 128.41 82.39 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 97' ' ' ASN . 73.0 Cg_endo -77.09 -18.62 14.3 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.302 2.002 . . . . 0.0 112.056 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.443 ' H ' HG23 ' A' ' 96' ' ' VAL . 3.3 t -46.75 -14.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.499 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 95' ' ' PRO . 20.7 m-80 -79.04 -24.6 43.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.506 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -52.98 -50.59 63.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.527 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' O ' ' CE1' ' A' ' 103' ' ' HIS . 47.0 mttp -56.61 -25.98 54.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.71 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.8 mt -84.2 -34.81 23.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 109.492 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.3 tp -74.86 -29.14 60.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 109.717 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -73.33 -39.13 65.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.963 . . . . 0.0 109.718 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.745 ' CB ' HD21 ' B' ' 108' ' ' ASN . 7.1 m170 -80.73 -26.85 37.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.649 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 33.5 m -64.26 -53.79 43.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.168 -0.958 . . . . 0.0 109.755 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -46.7 -28.67 1.57 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.937 . . . . 0.0 109.601 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.92 -31.53 35.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 109.955 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.7 t -82.64 -26.59 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 109.649 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 p -74.41 -62.07 1.65 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 109.567 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 113' ' ' LEU . 17.7 mt -46.06 -35.31 4.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 0.0 109.416 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.77 -40.75 66.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.952 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' B' ' 122' ' ' PHE . . . -73.3 -40.9 64.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.702 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.531 ' NE2' ' OE2' ' A' ' 27' ' ' GLU . 64.5 m-70 -89.67 -78.77 0.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.545 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -107.7 113.49 61.34 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.511 ' O ' ' O ' ' A' ' 113' ' ' LEU . 77.8 Cg_exo -45.93 -173.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.235 1.957 . . . . 0.0 112.282 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.642 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -69.25 -53.2 21.06 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.473 -0.767 . . . . 0.0 109.078 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.642 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 26.0 mt-10 125.65 -0.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.502 ' CD2' ' O ' ' A' ' 117' ' ' PHE . 56.6 t80 58.04 33.56 23.31 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.408 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.795 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -106.59 117.22 57.5 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.14 20.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.146 1.898 . . . . 0.0 112.708 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.795 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -146.42 -34.07 0.3 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 0.0 110.211 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 115' ' ' ALA . 14.0 p -47.71 -47.04 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 109.926 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.61 ' N ' HG13 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -67.85 -33.64 75.15 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.4 -0.813 . . . . 0.0 109.287 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.32 -20.24 32.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.696 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.5 m -69.06 -62.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.12 -19.71 64.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.0 -1.062 . . . . 0.0 109.1 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.15 -46.79 13.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.71 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -89.84 -39.06 13.32 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.792 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.625 ' CD2' HG21 ' A' ' 10' ' ' VAL . 27.8 t80 -47.86 -20.66 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.915 -1.116 . . . . 0.0 108.666 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' N ' ' C ' ' A' ' 127' ' ' LYS . 29.1 mt -70.73 -19.64 62.72 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -55.08 -38.38 68.01 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.502 ' HB2' HD13 ' A' ' 2' ' ' LEU . 5.4 t -77.92 -29.72 50.17 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 135' ' ' VAL . 22.0 t -80.32 -39.11 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -68.08 -20.97 64.99 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.192 -0.943 . . . . 0.0 109.04 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 138' ' ' SER . 94.9 m -69.11 -39.53 78.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.505 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 132' ' ' VAL . 1.0 OUTLIER -76.51 -31.12 19.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.264 -0.897 . . . . 0.0 109.433 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.511 ' O ' ' NE2' ' A' ' 87' ' ' HIS . 0.5 OUTLIER -84.74 -23.84 29.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.868 . . . . 0.0 109.18 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.5 m -100.25 -15.57 18.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.371 -0.83 . . . . 0.0 109.453 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 134' ' ' THR . 1.8 t . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.5 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.784 HD12 ' N ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -133.82 -171.96 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.449 -0.782 . . . . 0.0 109.317 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.419 ' O ' ' N ' ' B' ' 6' ' ' GLU . 12.6 p -90.0 134.86 30.96 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.25 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -41.61 -22.88 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.421 2.081 . . . . 0.0 112.357 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' B' ' 4' ' ' THR . 9.6 mp0 -79.28 -52.25 8.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.953 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.03 -60.58 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.692 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.559 ' HG3' HD13 ' B' ' 3' ' ' LEU . 5.0 ttpp -49.74 -51.75 36.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.823 . . . . 0.0 109.976 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -43.57 -23.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.63 -0.669 . . . . 0.0 110.235 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -82.94 -56.17 3.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.057 -1.027 . . . . 0.0 109.826 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' B' ' 130' ' ' TYR . 1.2 p -68.78 -24.56 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 10.9 m -71.61 -42.79 67.24 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.441 0.638 . . . . 0.0 109.544 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.59 67.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.05 -27.45 8.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.965 . . . . 0.0 109.445 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . 0.605 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.4 OUTLIER -52.37 -17.7 1.3 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.184 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.63 -41.77 28.43 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -28.75 35.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -1.22 . . . . 0.0 109.231 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 78.0 t -58.47 114.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.844 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' B' ' 21' ' ' ASP . 7.9 t-20 -81.76 67.08 7.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.237 -0.915 . . . . 0.0 108.726 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' B' ' 19' ' ' ASN . 84.4 t -42.75 -20.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.475 -0.766 . . . . 0.0 109.792 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' B' ' 19' ' ' ASN . 78.5 m-20 -75.55 2.72 10.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' B' ' 19' ' ' ASN . 33.9 mt-10 -155.57 -47.94 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -47.09 -33.06 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.507 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.72 -55.58 19.25 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.44 -36.75 93.01 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -76.09 -47.32 24.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -1.162 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.25 -33.84 59.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.15 -57.81 3.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.875 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.81 -45.06 55.67 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -50.33 -36.39 31.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -1.119 . . . . 0.0 109.489 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 42.9 tp -49.46 -38.9 31.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.351 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -81.1 -21.83 39.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 109.538 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 t -77.86 -64.32 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 0.0 109.703 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.403 ' H ' HG23 ' B' ' 34' ' ' VAL . 0.2 OUTLIER -69.11 -22.76 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.604 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -141.33 81.34 15.64 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.272 -0.892 . . . . 0.0 109.404 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.75 7.47 4.84 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.687 2.258 . . . . 0.0 112.475 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.55 ' CD1' HG23 ' B' ' 38' ' ' THR . 1.5 p-90 -66.01 -19.79 65.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.097 -1.002 . . . . 0.0 109.476 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.55 HG23 ' CD1' ' B' ' 37' ' ' TRP . 82.3 p -76.89 41.78 0.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . 0.427 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 35.1 tt0 -84.1 26.41 0.75 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.89 . . . . 0.0 109.372 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.13 -49.2 4.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.347 -0.845 . . . . 0.0 109.582 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -88.22 3.35 49.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' B' ' 39' ' ' GLN . 8.0 p90 -52.49 -30.12 28.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.675 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -49.16 -24.89 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.606 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 39.1 t -95.36 -9.02 34.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 0.0 109.536 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' B' ' 42' ' ' PHE . 16.1 m-85 -87.03 21.82 2.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 109.497 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -98.99 2.44 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' B' ' 47' ' ' ASP . 27.2 p-10 -156.86 112.66 2.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -1.125 . . . . 0.0 109.606 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.524 HD12 ' N ' ' B' ' 48' ' ' LEU . 9.4 mp -80.01 24.54 0.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.15 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.425 ' C ' ' O ' ' B' ' 48' ' ' LEU . 29.2 t -43.09 -29.97 0.4 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.385 -0.822 . . . . 0.0 109.686 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . 0.415 ' O ' ' N ' ' B' ' 53' ' ' ALA . 73.1 p -148.74 139.02 13.15 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 109.16 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -39.35 -36.12 0.88 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.442 2.095 . . . . 0.0 112.411 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.29 -33.77 61.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.847 . . . . 0.0 109.624 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -48.86 -19.81 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.563 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.56 -64.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.606 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' B' ' 55' ' ' MET . 1.9 mpt? -80.26 4.22 18.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.983 . . . . 0.0 109.467 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.02 -26.84 47.56 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' B' ' 53' ' ' ALA . 67.3 m-80 -84.79 141.84 38.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.095 -1.238 . . . . 0.0 109.423 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.05 -40.01 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.612 2.208 . . . . 0.0 112.245 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -47.39 78.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.549 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 89.9 t -50.79 -41.01 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.895 . . . . 0.0 109.58 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -79.09 -42.44 26.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.741 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.55 -30.27 71.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . 0.49 ' O ' ' ND1' ' B' ' 63' ' ' HIS . 1.3 t-80 -66.21 -23.88 66.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.542 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.62 -46.69 74.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.489 ' HZ3' ' C ' ' B' ' 21' ' ' ASP . 8.3 mtpp -54.49 -29.42 50.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.576 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.85 -32.79 63.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.925 . . . . 0.0 109.579 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 t -81.32 -30.75 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.46 -44.61 57.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 109.39 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.95 -44.87 19.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.12 -45.75 86.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -1.175 . . . . 0.0 109.621 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -57.43 -51.29 70.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.625 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . 0.605 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.9 t -57.54 -43.05 84.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -0.824 . . . . 0.0 109.644 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -48.38 -29.99 4.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.986 . . . . 0.0 109.445 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.43 -60.25 5.61 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.601 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -54.95 -23.69 20.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -1.113 . . . . 0.0 109.264 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.51 9.41 43.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.523 ' CE1' ' OD1' ' B' ' 80' ' ' ASN . 9.5 t-80 -170.77 70.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.958 . . . . 0.0 109.739 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.14 -7.75 58.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.185 -0.947 . . . . 0.0 109.387 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.63 -26.73 5.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.433 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.523 ' OD1' ' CE1' ' B' ' 77' ' ' HIS . 8.6 p-10 -172.33 41.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.289 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.702 ' N ' HD23 ' B' ' 81' ' ' LEU . 1.6 pt? -46.63 -18.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.36 -0.837 . . . . 0.0 109.849 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' B' ' 80' ' ' ASN . 59.6 mttm -79.93 -32.32 40.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.06 -1.025 . . . . 0.0 109.638 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.26 -23.01 55.9 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.7 OUTLIER -70.78 -42.99 69.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.102 -1.234 . . . . 0.0 109.733 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.483 ' N ' ' CG2' ' B' ' 84' ' ' THR . 30.9 m-85 -84.81 25.96 0.88 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.6 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.51 -26.94 55.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.264 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.447 ' O ' ' N ' ' B' ' 91' ' ' LEU . 81.2 p -79.69 -54.89 5.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.311 -0.868 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.1 mt -47.97 -43.12 29.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.163 -0.961 . . . . 0.0 109.266 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . 0.514 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 1.5 m -64.72 -38.89 92.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.192 -0.942 . . . . 0.0 109.555 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.482 ' HA ' ' HG ' ' B' ' 93' ' ' CYS . 56.8 tt0 -82.1 -22.6 36.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.5 tt -90.29 -39.22 12.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.977 . . . . 0.0 109.744 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' B' ' 97' ' ' HIS . 4.0 m80 -77.75 -29.92 51.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.02 -1.05 . . . . 0.0 110.176 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' B' ' 94' ' ' ASP . 13.2 p -83.51 -48.62 10.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.048 -1.032 . . . . 0.0 110.81 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.639 ' N ' ' SG ' ' B' ' 93' ' ' CYS . 23.6 m-20 -87.33 -34.38 18.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.904 -1.123 . . . . 0.0 111.523 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -89.01 -51.84 5.4 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.815 -1.178 . . . . 0.0 111.01 -178.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 12.9 mt -98.3 -17.79 18.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.95 -1.094 . . . . 0.0 110.314 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 31.0 p80 42.6 33.8 0.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.396 -0.815 . . . . 0.0 110.204 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 68.0 t -58.25 127.44 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.158 -0.964 . . . . 0.0 109.031 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' B' ' 99' ' ' ASP . 4.6 p-10 -45.61 148.33 1.3 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 109.494 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' B' ' 102' ' ' ASN . 59.8 Cg_endo -72.99 -40.09 1.94 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.61 2.207 . . . . 0.0 112.342 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -67.76 52.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.486 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' B' ' 100' ' ' PRO . 56.0 t-20 -140.68 -49.7 0.44 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.274 -0.891 . . . . 0.0 109.644 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -46.23 -24.22 0.44 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.832 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -74.54 -20.01 60.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' B' ' 108' ' ' ASN . 43.1 mt -80.65 -59.55 2.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.548 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 8.2 tt -46.94 -35.13 6.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.523 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.27 -26.4 74.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . 0.745 HD21 ' CB ' ' A' ' 103' ' ' HIS . 32.1 t-20 -85.52 -19.24 31.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -1.172 . . . . 0.0 109.778 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 77.4 t -84.15 -24.69 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.596 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.453 ' O ' HD23 ' B' ' 110' ' ' LEU . 1.4 tt -71.73 -60.0 2.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.44 ' H ' HG23 ' B' ' 111' ' ' VAL . 11.7 t -51.39 -29.02 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 14.5 t -65.3 -41.35 94.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.183 -0.948 . . . . 0.0 109.571 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.06 -45.94 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.584 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.74 -26.55 68.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.634 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.493 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -68.12 -34.43 76.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.492 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.96 -62.85 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 109.398 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.614 ' ND1' ' CZ ' ' B' ' 118' ' ' PHE . 12.4 t-80 -55.82 -19.68 12.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 109.74 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.614 ' CZ ' ' ND1' ' B' ' 117' ' ' HIS . 67.5 m-85 -151.6 60.8 0.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -72.63 -16.93 77.78 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -69.41 -30.03 67.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.481 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -94.01 13.54 22.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.915 . . . . 0.0 109.822 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.585 ' CD2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -81.43 33.31 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.46 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 13.1 p -47.73 130.11 11.2 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.516 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 45.5 Cg_exo -43.38 -51.9 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.194 1.929 . . . . 0.0 113.029 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 18.9 Cg_endo -58.84 -33.97 98.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.823 1.682 . . . . 0.0 111.883 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 49.7 t -82.41 -9.98 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 0.0 109.579 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . 0.927 ' HG2' HH11 ' A' ' 31' ' ' ARG . 13.9 tp60 -75.85 -59.78 2.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -61.08 -34.04 74.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.451 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.19 11.77 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 109.545 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' B' ' 128' ' ' ALA . 6.3 t80 -105.0 -55.25 2.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 109.704 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.676 ' OE1' ' HA ' ' A' ' 35' ' ' SER . 6.5 pt20 -45.82 -44.2 13.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.928 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -57.14 -50.04 74.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.979 . . . . 0.0 109.997 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.92 -46.95 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.133 -0.98 . . . . 0.0 109.984 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.39 -33.78 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.919 . . . . 0.0 110.197 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.89 -27.26 2.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.975 -1.078 . . . . 0.0 109.394 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.77 -25.67 73.02 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.35 -49.25 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -1.125 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.62 -42.79 35.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -78.22 -23.47 47.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.41 3.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.86 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.53 -14.15 0.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.879 . . . . 0.0 109.368 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' B' ' 144' ' ' LYS . . . -93.95 4.67 53.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.362 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' B' ' 143' ' ' HIS . 11.0 t-160 -68.47 7.8 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.335 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' B' ' 142' ' ' ALA . 39.7 mmtt -139.25 -41.31 0.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.352 -0.842 . . . . 0.0 109.498 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.513 ' CE1' ' OXT' ' B' ' 146' ' ' HIS . 0.0 OUTLIER -56.19 -12.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 109.491 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.513 ' OXT' ' CE1' ' B' ' 145' ' ' TYR . 15.7 m-70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.711 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' C' ' 2' ' ' LEU . 2.9 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' C' ' 3' ' ' SER . 3.3 tp 75.68 174.4 0.24 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -0.849 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.618 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 164.45 -38.1 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.363 -0.835 . . . . 0.0 110.46 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' C' ' 3' ' ' SER . 77.3 Cg_exo -49.6 -173.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.305 2.003 . . . . 0.0 112.972 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.484 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -75.75 -15.84 60.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.405 -0.81 . . . . 0.0 110.147 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' C' ' 127' ' ' LYS . 4.8 p30 -39.11 -38.21 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.554 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.477 ' N ' ' OD1' ' C' ' 6' ' ' ASP . 12.9 mtmm -57.43 -58.37 8.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 108.932 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.8 m -51.57 -31.84 26.08 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 108.942 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -76.62 -34.75 58.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.631 HG21 ' CD2' ' C' ' 128' ' ' PHE . 51.7 t -72.62 -49.97 37.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . 0.433 ' HE2' HG13 ' C' ' 70' ' ' VAL . 0.6 OUTLIER -52.03 -42.46 63.08 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.62 -60.78 3.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.361 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.668 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -53.73 -33.98 57.4 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.378 -0.826 . . . . 0.0 109.162 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -17.73 61.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.081 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.35 -45.13 10.18 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -68.82 -39.74 79.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.227 -1.161 . . . . 0.0 108.849 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.668 HG23 ' O ' ' C' ' 13' ' ' ALA . 89.8 t -60.86 -65.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.59 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 58.12 -136.69 50.69 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.12 27.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.464 -1.021 . . . . 0.0 110.302 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.59 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.6 m-70 -131.5 27.16 4.73 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.02 -63.88 1.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.611 -0.68 . . . . 0.0 109.869 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.91 -14.38 0.12 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.5 mt-10 -85.1 -56.34 3.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -1.055 . . . . 0.0 109.683 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.9 m-30 -58.03 -43.83 86.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.125 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.08 -22.83 56.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.07 -33.97 59.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.165 . . . . 0.0 109.69 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . 0.525 ' OE2' ' NE2' ' C' ' 112' ' ' HIS . 47.1 mt-10 -69.01 -20.27 64.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.716 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.61 -19.73 59.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.27 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -72.1 -48.07 46.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.349 -0.845 . . . . 0.0 109.681 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.54 -24.68 63.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.91 HH11 ' HG2' ' D' ' 127' ' ' GLN . 50.3 ttm-85 -76.15 -21.23 56.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 54.1 ttp -82.12 -50.65 8.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.49 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . 0.441 ' CD2' ' OG1' ' C' ' 39' ' ' THR . 9.4 m-85 -52.72 -44.29 66.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.699 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.786 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 6.5 mt -67.51 -58.83 4.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.671 ' HA ' ' OE1' ' D' ' 131' ' ' GLN . 40.9 m -48.34 -34.08 10.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.802 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -146.67 90.42 5.53 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.94 . . . . 0.0 109.356 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' C' ' 39' ' ' THR . 48.2 Cg_exo -53.48 -19.33 13.21 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.745 2.297 . . . . 0.0 112.172 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.407 ' O ' HG22 ' C' ' 41' ' ' THR . 12.8 p -42.65 -18.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.43 -0.794 . . . . 0.0 110.117 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.561 ' N ' ' O ' ' C' ' 37' ' ' PRO . 45.6 p -75.44 -22.22 57.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 110.09 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -46.59 -44.96 18.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.431 HG21 ' CD2' ' B' ' 97' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -146.16 66.34 1.2 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' C' ' 49' ' ' SER . 17.0 m-20 -40.99 -18.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.274 -0.892 . . . . 0.0 110.299 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.578 ' N ' ' O ' ' C' ' 46' ' ' PHE . 1.1 mt 52.03 9.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.069 -1.02 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.474 ' H ' ' C ' ' C' ' 47' ' ' ASP . 10.7 t -67.09 155.85 37.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.51 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 11.3 t-80 -65.34 139.84 58.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . 0.51 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 54.57 30.66 51.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' C' ' 53' ' ' ALA . 37.1 t -63.27 -98.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -1.122 . . . . 0.0 109.396 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' C' ' 52' ' ' SER . . . 172.56 -39.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.545 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -74.68 -20.22 59.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.41 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.0 t -84.63 -41.02 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -79.03 -26.4 43.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 109.083 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.67 -21.79 63.23 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.577 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.3 OUTLIER -79.05 -39.28 34.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -1.132 . . . . 0.0 109.575 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.87 -47.66 31.18 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 51.3 mttp -52.45 -23.79 6.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -1.083 . . . . 0.0 109.696 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -72.11 -42.53 65.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.171 -0.955 . . . . 0.0 109.042 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 t -70.58 -48.31 59.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.453 -0.78 . . . . 0.0 108.969 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.55 -30.41 70.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.242 -0.911 . . . . 0.0 109.11 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 8.0 t0 -68.46 -32.54 72.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 108.693 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.56 -49.36 60.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.473 -0.767 . . . . 0.0 108.954 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.56 -40.05 93.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 108.744 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -70.67 -49.82 43.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -58.38 -20.96 48.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.51 -46.83 12.0 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.433 HG13 ' HE2' ' C' ' 11' ' ' LYS . 3.9 t -63.44 -23.0 32.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' C' ' 72' ' ' HIS . . . -59.3 -26.1 64.7 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' C' ' 74' ' ' ASP . 40.5 m80 -147.08 -48.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.424 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.4 p 45.06 12.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.783 0.802 . . . . 0.0 109.525 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' C' ' 72' ' ' HIS . 37.4 m-20 -135.45 10.68 3.47 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.414 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 3.9 m-20 -174.96 26.68 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.686 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 15.1 ptt? -78.63 -22.54 0.39 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.403 -0.811 . . . . 0.0 111.705 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' C' ' 76' ' ' MET . 49.7 Cg_exo -54.98 -18.02 15.73 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.547 1.498 . . . . 0.0 112.208 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.412 HD22 ' N ' ' C' ' 78' ' ' ASN . 1.6 m-80 -94.12 -46.77 6.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.96 . . . . 0.0 109.381 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.96 -42.36 99.03 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.294 -0.878 . . . . 0.0 109.183 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.76 9.22 8.28 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 108.994 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -57.48 -25.45 59.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 109.608 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -56.49 -58.02 9.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.377 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.478 ' O ' ' CE1' ' C' ' 87' ' ' HIS . 6.5 mt -45.17 -50.5 11.36 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 3.4 m -49.29 -38.36 27.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' C' ' 82' ' ' ALA . 27.9 t70 -82.51 -17.44 45.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 109.782 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -70.69 -51.83 25.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.567 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . 0.52 ' NE2' ' O ' ' C' ' 136' ' ' LEU . 14.3 p-80 -92.2 -21.8 20.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.965 -1.084 . . . . 0.0 110.754 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -60.67 -51.37 69.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.838 -1.164 . . . . 0.0 109.881 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -155.66 63.9 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.88 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.403 ' H ' ' H ' ' C' ' 91' ' ' LEU . 26.3 ttmt -163.16 1.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.259 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.403 ' H ' ' H ' ' C' ' 90' ' ' LYS . 60.5 tp -171.77 -32.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.299 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 51.7 47.82 24.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.626 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.62 136.88 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.407 ' OD2' ' CE1' ' B' ' 97' ' ' HIS . 22.3 m-20 -58.25 128.36 81.98 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.269 -0.894 . . . . 0.0 109.507 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' C' ' 97' ' ' ASN . 74.3 Cg_endo -77.01 -18.57 14.48 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.336 2.024 . . . . 0.0 112.194 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -46.72 -15.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 109.569 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' C' ' 95' ' ' PRO . 20.7 m-80 -78.97 -24.5 43.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.99 -50.65 63.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.4 ' O ' ' CE1' ' C' ' 103' ' ' HIS . 46.9 mttp -56.61 -25.96 54.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.73 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 9.8 mt -84.24 -34.62 23.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 109.592 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 8.3 tp -74.99 -29.09 60.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 109.714 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 66.6 m -73.36 -39.13 65.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.668 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . 0.728 ' CB ' HD21 ' D' ' 108' ' ' ASN . 7.2 m170 -80.77 -26.81 37.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.299 -0.876 . . . . 0.0 109.644 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 33.0 m -64.32 -53.69 44.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.739 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -46.79 -28.59 1.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.968 . . . . 0.0 109.63 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 15.8 mt -80.94 -31.52 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 109.941 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 87.9 t -82.59 -26.66 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.03 -1.044 . . . . 0.0 109.683 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 5.2 p -74.41 -62.06 1.65 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.189 -0.944 . . . . 0.0 109.585 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 113' ' ' LEU . 17.5 mt -46.06 -35.22 4.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.87 -40.74 66.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.931 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . 0.595 ' HB2' ' CD2' ' D' ' 122' ' ' PHE . . . -73.37 -40.83 64.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.661 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . 0.525 ' NE2' ' OE2' ' C' ' 27' ' ' GLU . 64.7 m-70 -89.67 -78.77 0.35 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.571 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.4 OUTLIER -107.75 113.53 61.23 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' C' ' 113' ' ' LEU . 78.9 Cg_exo -45.99 -173.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.198 1.932 . . . . 0.0 112.292 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.65 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -69.46 -52.98 21.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 109.098 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.65 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 26.1 mt-10 125.48 -0.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' C' ' 117' ' ' PHE . 56.8 t80 58.02 33.52 23.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.344 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.784 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -106.51 117.3 57.39 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.3 20.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.134 1.889 . . . . 0.0 112.689 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.784 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -146.39 -34.11 0.3 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.026 -1.046 . . . . 0.0 110.232 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.617 HG13 ' N ' ' C' ' 122' ' ' HIS . 14.0 p -47.71 -47.05 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 109.871 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.617 ' N ' HG13 ' C' ' 121' ' ' VAL . 0.0 OUTLIER -67.94 -33.55 74.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.813 . . . . 0.0 109.259 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.27 -20.35 32.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.905 . . . . 0.0 109.713 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.542 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.5 m -68.99 -62.84 1.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.11 -19.69 64.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.951 -1.093 . . . . 0.0 109.076 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.18 -46.75 13.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.679 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -89.85 -39.02 13.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.007 . . . . 0.0 109.836 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.631 ' CD2' HG21 ' C' ' 10' ' ' VAL . 27.6 t80 -47.82 -20.74 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.966 -1.083 . . . . 0.0 108.629 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.431 ' N ' ' C ' ' C' ' 127' ' ' LYS . 29.5 mt -70.66 -19.66 62.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -55.09 -38.37 68.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.495 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 5.4 t -77.9 -29.74 50.3 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . 0.42 ' O ' HG22 ' C' ' 135' ' ' VAL . 22.0 t -80.28 -39.21 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.352 -0.842 . . . . 0.0 108.787 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -67.96 -21.03 65.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.922 . . . . 0.0 109.063 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' C' ' 138' ' ' SER . 93.7 m -69.15 -39.46 78.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.845 . . . . 0.0 109.46 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.452 HG13 ' H ' ' C' ' 135' ' ' VAL . 1.0 OUTLIER -76.62 -31.01 19.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.297 -0.877 . . . . 0.0 109.41 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' C' ' 87' ' ' HIS . 0.5 OUTLIER -84.76 -23.89 29.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.889 . . . . 0.0 109.13 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 43.0 m -100.23 -15.57 18.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.319 -0.863 . . . . 0.0 109.443 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' C' ' 134' ' ' THR . 1.8 t . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.79 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -133.79 -171.87 2.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.292 -179.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.417 ' O ' ' N ' ' D' ' 6' ' ' GLU . 12.6 p -90.06 134.88 30.83 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.88 . . . . 0.0 109.322 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -41.61 -22.94 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.423 2.082 . . . . 0.0 112.365 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . 0.421 ' CD ' ' N ' ' D' ' 6' ' ' GLU . 9.6 mp0 -79.16 -52.37 8.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -62.99 -60.56 3.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 109.754 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.574 ' HG3' HD13 ' D' ' 3' ' ' LEU . 5.0 ttpp -49.71 -51.87 35.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.94 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -43.51 -23.69 0.08 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.61 -0.681 . . . . 0.0 110.285 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.01 -56.14 3.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.027 -1.045 . . . . 0.0 109.763 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.46 HG23 ' CD2' ' D' ' 130' ' ' TYR . 1.2 p -68.75 -24.63 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 10.5 m -71.5 -42.83 67.53 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.455 0.645 . . . . 0.0 109.594 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.4 -27.63 68.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.746 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.94 -27.53 7.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.4 OUTLIER -52.35 -17.82 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 109.155 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.47 -41.92 28.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.99 -28.73 35.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -1.204 . . . . 0.0 109.219 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 78.4 t -58.45 114.91 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.804 . . . . 0.0 109.886 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' D' ' 21' ' ' ASP . 7.9 t-20 -81.84 67.07 7.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.262 -0.899 . . . . 0.0 108.737 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' D' ' 19' ' ' ASN . 84.3 t -42.72 -20.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.467 -0.77 . . . . 0.0 109.835 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.56 ' C ' ' HZ3' ' D' ' 65' ' ' LYS . 78.5 m-20 -75.68 2.82 10.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.88 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' D' ' 19' ' ' ASN . 33.9 mt-10 -155.6 -47.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 53.1 t -47.1 -33.08 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 109.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.74 -55.61 19.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.47 -36.63 92.85 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -76.23 -47.21 24.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -1.119 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.27 -33.86 59.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.394 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.18 -57.77 3.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.958 . . . . 0.0 109.385 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.81 -45.03 55.69 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -50.37 -36.43 32.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -1.096 . . . . 0.0 109.486 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 42.9 tp -49.41 -38.85 30.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.354 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.13 -21.94 39.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 t -77.81 -64.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -0.99 . . . . 0.0 109.705 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.427 HG23 ' H ' ' D' ' 34' ' ' VAL . 0.2 OUTLIER -68.92 -22.88 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.639 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -141.26 81.36 15.73 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.325 -0.86 . . . . 0.0 109.396 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.8 7.47 4.85 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.703 2.269 . . . . 0.0 112.449 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . 0.546 ' NE1' HG23 ' D' ' 38' ' ' THR . 1.5 p-90 -65.97 -19.86 66.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.512 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.546 HG23 ' NE1' ' D' ' 37' ' ' TRP . 82.4 p -76.83 41.74 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.413 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . 0.421 ' O ' ' CD1' ' D' ' 42' ' ' PHE . 35.1 tt0 -84.03 26.34 0.74 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.383 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.11 -49.19 4.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.905 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -88.16 3.37 49.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' D' ' 39' ' ' GLN . 7.8 p90 -52.63 -30.14 29.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.601 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -49.11 -24.89 1.81 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.649 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 39.2 t -95.38 -8.99 34.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.537 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -87.05 21.88 2.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -99.13 2.45 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' D' ' 47' ' ' ASP . 27.2 p-10 -156.8 112.7 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . 0.533 HD12 ' N ' ' D' ' 48' ' ' LEU . 9.4 mp -80.04 24.57 0.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.172 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' D' ' 48' ' ' LEU . 29.1 t -43.09 -30.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.428 -0.795 . . . . 0.0 109.624 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . 0.431 ' O ' ' N ' ' D' ' 53' ' ' ALA . 73.1 p -148.77 138.95 13.09 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 109.154 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -39.36 -36.1 0.88 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.458 2.105 . . . . 0.0 112.415 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.2 -33.86 61.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.16 -0.962 . . . . 0.0 109.652 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -48.92 -19.78 0.43 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 93.9 t -67.45 -64.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.733 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' D' ' 55' ' ' MET . 1.9 mpt? -80.17 4.14 18.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 109.496 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.08 -26.74 47.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' D' ' 53' ' ' ALA . 67.2 m-80 -84.84 141.83 38.56 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 0.0 109.489 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.1 -39.91 1.49 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.497 2.132 . . . . 0.0 112.254 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.92 -47.38 77.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.48 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 89.4 t -50.83 -40.94 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -79.19 -42.41 26.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.624 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.53 -30.23 71.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.621 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . 0.488 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 1.3 t-80 -66.26 -23.85 66.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.561 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.7 -46.65 73.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . 0.56 ' HZ3' ' C ' ' D' ' 21' ' ' ASP . 8.2 mtpp -54.41 -29.54 49.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -1.192 . . . . 0.0 109.556 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -73.75 -32.86 64.05 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 109.625 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 34.7 t -81.23 -30.78 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.54 -44.54 57.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.339 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.92 -44.84 18.87 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.61 87.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -1.137 . . . . 0.0 109.621 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -57.46 -51.3 69.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 109.594 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . 0.6 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 9.0 t -57.54 -43.03 84.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.699 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -48.36 -30.13 4.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.42 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.32 -60.21 5.69 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.594 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.9 mp -55.07 -23.64 21.28 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.223 -1.163 . . . . 0.0 109.239 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.54 9.48 43.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.622 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.527 ' CE1' ' OD1' ' D' ' 80' ' ' ASN . 9.5 t-80 -170.84 70.01 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 109.787 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 91.0 mt -85.98 -7.83 58.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.58 -26.74 5.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.527 ' OD1' ' CE1' ' D' ' 77' ' ' HIS . 8.5 p-10 -172.3 41.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 109.233 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . 0.698 ' N ' HD23 ' D' ' 81' ' ' LEU . 1.5 pt? -46.66 -18.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.884 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' D' ' 80' ' ' ASN . 59.5 mttm -80.02 -32.29 39.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.106 -0.996 . . . . 0.0 109.609 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.26 -23.04 55.79 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.7 OUTLIER -70.78 -43.05 69.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.039 -1.271 . . . . 0.0 109.676 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.485 ' N ' ' CG2' ' D' ' 84' ' ' THR . 30.8 m-85 -84.81 26.01 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.57 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.56 -26.93 56.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.918 . . . . 0.0 109.274 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . 0.457 ' O ' ' N ' ' D' ' 91' ' ' LEU . 81.3 p -79.67 -54.99 5.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -47.86 -43.16 28.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.358 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . 0.523 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 1.5 m -64.81 -38.81 92.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 109.513 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.483 ' HA ' ' HG ' ' D' ' 93' ' ' CYS . 57.2 tt0 -82.09 -22.6 36.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.676 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' D' ' 87' ' ' THR . 7.5 tt -90.24 -39.29 12.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 109.753 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' D' ' 97' ' ' HIS . 4.0 m80 -77.64 -29.92 51.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.054 -1.028 . . . . 0.0 110.234 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' D' ' 94' ' ' ASP . 13.1 p -83.51 -48.59 10.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.129 -0.982 . . . . 0.0 110.807 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.638 ' N ' ' SG ' ' D' ' 93' ' ' CYS . 23.9 m-20 -87.31 -34.42 18.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.91 -1.119 . . . . 0.0 111.493 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -89.03 -51.8 5.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.807 -1.183 . . . . 0.0 111.006 -178.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.582 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 12.9 mt -98.29 -17.79 18.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.942 -1.099 . . . . 0.0 110.26 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 31.0 p80 42.39 34.03 0.48 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.301 -0.874 . . . . 0.0 110.213 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 67.7 t -58.32 127.27 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 109.093 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' D' ' 99' ' ' ASP . 4.7 p-10 -45.4 148.41 1.18 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.563 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' D' ' 102' ' ' ASN . 59.3 Cg_endo -73.13 -40.05 1.89 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.614 2.209 . . . . 0.0 112.316 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -67.69 52.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.482 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' D' ' 100' ' ' PRO . 56.1 t-20 -140.75 -49.61 0.44 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -46.27 -24.24 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 109.764 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -74.61 -19.95 60.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' D' ' 108' ' ' ASN . 43.5 mt -80.7 -59.59 2.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.963 . . . . 0.0 109.453 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 8.2 tt -46.91 -35.17 6.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.23 -26.43 74.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . 0.728 HD21 ' CB ' ' C' ' 103' ' ' HIS . 32.1 t-20 -85.49 -19.26 31.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -1.163 . . . . 0.0 109.794 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 77.4 t -84.05 -24.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . 0.449 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.5 tt -71.82 -59.99 2.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.465 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 11.6 t -51.3 -29.12 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.592 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 14.6 t -65.36 -41.24 94.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.22 -45.9 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.542 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.71 -26.56 68.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.643 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.501 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -68.17 -34.29 76.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 109.524 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.454 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -85.06 -62.84 1.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 0.0 109.388 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . 0.615 ' ND1' ' CZ ' ' D' ' 118' ' ' PHE . 12.3 t-80 -55.75 -19.76 12.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 109.748 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.615 ' CZ ' ' ND1' ' D' ' 117' ' ' HIS . 67.6 m-85 -151.62 60.83 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.539 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -72.54 -17.05 77.68 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -69.36 -30.06 67.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.144 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -94.0 13.58 22.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.807 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -81.46 33.26 0.35 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.663 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.46 ' OG1' ' CG2' ' D' ' 126' ' ' VAL . 13.3 p -47.67 130.07 11.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.312 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.525 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 45.6 Cg_exo -43.43 -51.88 5.57 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.134 1.89 . . . . 0.0 113.037 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 18.8 Cg_endo -58.78 -33.92 98.71 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.791 1.661 . . . . 0.0 111.955 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 49.1 t -82.37 -10.06 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.535 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . 0.91 ' HG2' HH11 ' C' ' 31' ' ' ARG . 14.0 tp60 -75.94 -59.75 2.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 109.423 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.786 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -61.12 -33.99 74.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.26 11.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' D' ' 128' ' ' ALA . 6.3 t80 -104.88 -55.34 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.299 -0.876 . . . . 0.0 109.738 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 0.671 ' OE1' ' HA ' ' C' ' 35' ' ' SER . 6.5 pt20 -45.87 -44.12 14.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.88 . . . . 0.0 109.899 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -57.17 -50.11 73.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.991 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.84 -46.93 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.024 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.449 ' H ' HG22 ' D' ' 134' ' ' VAL . 15.6 m -83.36 -33.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.113 -0.992 . . . . 0.0 110.203 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.89 -27.32 2.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.968 -1.082 . . . . 0.0 109.404 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.69 -25.67 72.93 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.34 -49.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -1.151 . . . . 0.0 109.441 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.65 -42.81 35.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.435 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -78.21 -23.43 47.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.464 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.01 -60.4 3.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.51 -14.14 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' D' ' 144' ' ' LYS . . . -94.01 4.75 53.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.91 . . . . 0.0 109.386 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' D' ' 143' ' ' HIS . 11.0 t-160 -68.52 7.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 109.342 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' D' ' 142' ' ' ALA . 39.7 mmtt -139.32 -41.28 0.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.367 -0.833 . . . . 0.0 109.466 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . 0.521 ' CE1' ' OXT' ' D' ' 146' ' ' HIS . 0.0 OUTLIER -56.26 -12.04 1.43 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.406 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.521 ' OXT' ' CE1' ' D' ' 145' ' ' TYR . 15.5 m-70 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.742 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.42 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 48.9 mt -125.32 -162.32 1.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.354 -0.841 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 177.12 -48.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.865 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 3' ' ' SER . 68.3 Cg_exo -49.18 174.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.391 2.061 . . . . 0.0 112.437 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -56.98 -16.56 7.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.614 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.472 ' C ' ' O ' ' A' ' 5' ' ' ALA . 14.8 t70 -39.92 -31.67 0.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 109.524 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 5' ' ' ALA . 9.3 mtmp? -73.34 -55.97 5.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.407 -0.808 . . . . 0.0 109.216 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 m -47.53 -28.63 2.33 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.139 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -78.33 -38.58 41.83 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.514 HG21 ' CD2' ' A' ' 128' ' ' PHE . 40.9 t -70.8 -48.91 54.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -51.58 -44.66 62.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 108.839 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.81 -58.55 7.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.818 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -55.68 -31.83 62.73 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.47 -17.4 58.07 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.201 -0.937 . . . . 0.0 108.914 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.35 -38.77 44.85 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -84.4 -40.86 17.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.381 -1.07 . . . . 0.0 109.32 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.573 ' O ' ' C ' ' A' ' 18' ' ' GLY . 93.7 t -66.69 -45.93 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 109.709 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.632 ' O ' ' HB3' ' A' ' 19' ' ' ALA . . . -25.1 137.81 0.01 OUTLIER Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . 74.26 -29.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.43 -1.041 . . . . 0.0 109.331 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.511 ' H ' ' C ' ' A' ' 18' ' ' GLY . 38.0 m-70 -110.76 16.79 21.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HB1' ' HB1' ' A' ' 63' ' ' ALA . . . -82.39 -60.8 2.08 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.008 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.46 -14.84 0.39 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.0 mt-10 -85.47 -56.35 3.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -1.177 . . . . 0.0 109.758 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.4 m-30 -60.69 -35.2 75.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.0 109.398 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.37 -23.01 73.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.74 -47.03 14.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -1.154 . . . . 0.0 109.64 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -63.57 -19.87 65.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 109.327 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.03 -27.6 63.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.44 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.416 HD11 ' ND1' ' A' ' 58' ' ' HIS . 9.0 mt -70.4 -53.68 15.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.907 . . . . 0.0 109.57 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.16 -29.37 69.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.251 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.38 -30.34 67.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.299 -0.876 . . . . 0.0 109.224 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 47.9 ttp -72.83 -52.7 13.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.186 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.38 -32.04 10.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.239 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.6 mt -78.42 -39.76 37.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -0.903 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.524 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 15.0 m -51.67 -29.67 18.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 35' ' ' SER . 57.1 m-85 -160.85 130.39 3.28 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.248 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.27 -19.89 14.89 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.317 2.011 . . . . 0.0 112.158 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.672 ' O ' HG22 ' A' ' 41' ' ' THR . 22.3 p -46.53 -46.0 18.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.785 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -45.39 -22.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 109.93 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.5 ttmt -51.81 -42.46 62.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.169 -0.957 . . . . 0.0 110.113 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 1.615 HG21 ' CD2' ' D' ' 97' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 0.0 109.757 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.531 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 4.2 p80 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.098 0.475 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -157.71 28.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 110.074 179.409 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' SER . 73.9 m-20 43.67 89.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.478 -0.764 . . . . 0.0 110.345 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.024 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.6 1.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.356 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.512 ' N ' HD22 ' A' ' 48' ' ' LEU . 5.0 m -84.77 157.0 21.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.15 -0.968 . . . . 0.0 109.769 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.604 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 40.2 t-80 -76.44 170.58 16.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.396 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.604 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 76.18 -21.88 2.14 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.7 p -55.95 -18.7 9.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -1.098 . . . . 0.0 109.374 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 72.82 -23.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.814 . . . . 0.0 109.732 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 52' ' ' SER . 24.1 mt-30 -84.83 -17.94 36.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 0.0 109.565 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.52 HG23 ' OG ' ' A' ' 52' ' ' SER . 44.5 t -84.09 -32.64 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.576 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -72.92 -29.39 63.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 0.0 109.211 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.98 66.09 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.495 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.2 t-80 -60.71 -30.72 70.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.126 -1.22 . . . . 0.0 110.076 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.79 -31.38 79.58 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 59.2 mttp -68.89 -23.01 64.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -1.115 . . . . 0.0 110.253 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -69.49 -58.19 4.28 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.883 -1.136 . . . . 0.0 108.748 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.52 -41.52 64.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.6 -0.688 . . . . 0.0 109.599 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.571 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -75.53 -43.86 46.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.158 -0.964 . . . . 0.0 109.237 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 34.9 t0 -68.85 -33.85 74.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.149 -0.97 . . . . 0.0 108.639 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . -66.87 -49.14 66.62 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -53.06 -47.06 68.74 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.282 -0.886 . . . . 0.0 108.627 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.2 m -57.01 -56.57 20.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 108.755 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.534 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 28.5 t30 -58.86 -21.09 56.36 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.08 -47.38 10.24 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.4 t -68.44 -22.74 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.43 75.58 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.609 ' O ' ' N ' ' A' ' 74' ' ' ASP . 5.5 m-70 -115.87 -60.57 1.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.493 -0.754 . . . . 0.0 109.509 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.3 p 45.09 12.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.726 0.774 . . . . 0.0 109.549 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 72' ' ' HIS . 28.8 m-20 -138.34 11.11 2.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -177.3 27.79 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.697 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 3.0 ptt? -78.51 -23.81 0.42 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 111.69 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 76' ' ' MET . 53.2 Cg_exo -54.47 -19.62 18.19 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.559 1.506 . . . . 0.0 112.193 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -93.16 -40.68 10.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.323 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.76 -43.45 65.76 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.308 -0.87 . . . . 0.0 109.014 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.35 10.37 12.86 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.7 t -51.84 -47.68 64.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -46.13 -58.07 3.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 109.726 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 83' ' ' LEU . 3.8 mt -45.24 -44.29 11.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 108.827 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.9 p -55.18 -30.05 59.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.467 -0.77 . . . . 0.0 108.978 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 89' ' ' HIS . 1.6 m-20 -82.08 -49.65 9.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.837 . . . . 0.0 109.263 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 tp -51.03 -30.02 14.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 109.25 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -92.89 -21.79 19.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -0.843 . . . . 0.0 110.371 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.72 20.82 5.52 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.113 -0.992 . . . . 0.0 110.322 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.666 ' N ' ' O ' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -140.51 -78.27 0.3 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 109.78 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 92' ' ' ARG . 16.9 mttp -67.36 -119.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 109.816 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.3 mp -44.58 -19.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.82 . . . . 0.0 109.774 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 90' ' ' LYS . 49.7 ttt180 57.21 45.95 19.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.302 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.431 ' H ' HG23 ' A' ' 93' ' ' VAL . 4.7 t -48.43 133.15 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.647 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -91.58 126.06 55.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.273 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -43.84 -10.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.374 2.05 . . . . 0.0 112.377 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 1.265 HG11 ' CG ' ' D' ' 99' ' ' ASP . 25.1 t -56.39 -31.79 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.088 -1.008 . . . . 0.0 109.648 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -79.57 -38.14 34.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 0.0 109.662 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -46.06 -30.29 1.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.27 -28.02 69.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.89 . . . . 0.0 109.646 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 11.4 mt -84.29 -34.3 23.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.803 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 tp -64.14 -61.15 2.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.98 . . . . 0.0 109.741 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 t -47.76 -34.76 8.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.759 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 107' ' ' VAL . 12.3 t-80 -80.84 -26.66 36.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.826 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 97.7 m -76.35 -38.06 56.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.49 -52.04 67.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.118 -0.989 . . . . 0.0 109.716 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.7 mt -60.19 -32.35 71.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 34.4 t -63.65 -59.62 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 0.0 109.19 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.7 p -54.76 -53.55 53.68 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.244 -0.91 . . . . 0.0 109.276 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 114' ' ' PRO . 7.7 mt -45.41 -26.71 0.58 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.266 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -68.45 -39.26 81.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 0.0 109.979 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.659 ' HB2' ' CE2' ' B' ' 122' ' ' PHE . . . -78.99 -3.54 45.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 109.931 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -134.51 -80.09 0.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 109.7 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -118.4 82.53 19.16 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.438 ' N ' ' O ' ' A' ' 109' ' ' LEU . 51.3 Cg_exo -49.61 -169.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.454 2.102 . . . . 0.0 112.432 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.807 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -52.85 -55.72 21.08 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.656 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 46.3 mt-10 123.24 -5.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 7.6 t80 73.24 30.97 1.48 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.732 -0.605 . . . . 0.0 111.116 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.8 p -104.54 126.25 31.89 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 108.38 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.665 ' HB3' ' HB3' ' B' ' 51' ' ' PRO . 54.2 Cg_exo -49.73 22.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.353 2.036 . . . . 0.0 112.897 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -153.3 -32.94 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.83 -1.169 . . . . 0.0 110.645 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.807 HG21 ' O ' ' A' ' 115' ' ' ALA . 9.6 p -52.8 -49.5 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.982 -1.074 . . . . 0.0 110.154 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.643 ' N ' HG13 ' A' ' 121' ' ' VAL . 4.7 t-160 -59.47 -37.46 78.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 109.218 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.08 -19.41 34.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -0.839 . . . . 0.0 109.487 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 120' ' ' ALA . 23.3 p -64.18 -62.1 1.83 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 110.848 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.488 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.6 mt -68.46 -19.76 64.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.982 -1.074 . . . . 0.0 109.757 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.66 -46.62 12.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 109.36 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -80.44 -46.23 16.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -0.964 . . . . 0.0 109.278 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.514 ' CD2' HG21 ' A' ' 10' ' ' VAL . 26.8 t80 -49.93 -21.79 1.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.93 . . . . 0.0 108.969 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 129' ' ' LEU . 15.1 mt -73.96 -21.76 59.9 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -57.88 -31.83 67.1 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 90.0 p -79.83 -33.61 40.11 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.378 -0.826 . . . . 0.0 108.954 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.24 -35.52 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 108.636 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 47.4 t -72.23 -28.62 63.28 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.436 -0.79 . . . . 0.0 109.172 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 32.2 m -66.51 -34.34 77.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.171 -0.956 . . . . 0.0 109.082 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 97.5 t -77.38 -40.43 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.29 -0.881 . . . . 0.0 108.998 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.79 -27.28 68.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 108.955 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.3 m -86.24 -26.47 25.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 109.455 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.45 -179.93 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.525 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -127.95 155.81 43.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 109.356 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -54.51 152.71 11.65 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 108.914 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.07 -18.57 44.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.463 2.109 . . . . 0.0 112.06 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -87.13 -37.86 16.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.628 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -84.0 -23.22 31.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 109.891 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -84.12 -55.12 4.37 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.148 -0.97 . . . . 0.0 109.095 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.8 t -48.03 -23.52 0.83 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.125 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.15 -59.68 2.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.966 -1.084 . . . . 0.0 109.894 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.03 -24.44 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -74.79 -51.93 12.8 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.405 0.622 . . . . 0.0 109.649 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.36 -24.88 47.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.571 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.663 ' O ' HG23 ' B' ' 18' ' ' VAL . 1.2 mt -59.65 -28.26 67.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.344 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.83 -17.06 62.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.415 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.28 -63.77 3.13 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.596 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.5 ' HD3' HD23 ' B' ' 14' ' ' LEU . 0.0 OUTLIER -70.68 -11.72 61.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.033 -1.274 . . . . 0.0 110.809 -178.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.663 HG23 ' O ' ' B' ' 14' ' ' LEU . 12.9 t -70.73 121.35 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.833 -1.167 . . . . 0.0 109.348 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.541 HD22 ' N ' ' B' ' 19' ' ' ASN . 0.9 OUTLIER -77.15 73.26 3.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.247 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.513 HG12 ' O ' ' B' ' 20' ' ' VAL . 75.5 t -52.89 -6.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.64 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 9.8 p30 -67.88 -20.73 65.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.914 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 9.2 pt-20 -150.11 -32.49 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.897 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.16 -28.27 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.667 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.1 -41.26 99.81 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.11 -55.04 17.83 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.422 ' O ' ' NH1' ' B' ' 30' ' ' ARG . 58.2 mt-10 -49.87 -26.99 4.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -1.141 . . . . 0.0 109.367 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.24 -32.62 22.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.06 -36.41 21.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.6 -40.58 90.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' B' ' 26' ' ' GLU . 0.0 OUTLIER -62.85 -21.88 66.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -1.17 . . . . 0.0 109.426 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.98 -28.38 65.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.965 . . . . 0.0 109.539 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' B' ' 36' ' ' PRO . 27.7 mt -81.24 -53.89 5.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.995 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.494 HG13 ' N ' ' B' ' 34' ' ' VAL . 6.2 p -56.18 -43.21 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.0 109.607 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.494 ' N ' HG13 ' B' ' 33' ' ' VAL . 57.8 t -79.53 -22.92 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 109.364 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -153.04 75.52 6.69 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.327 -0.858 . . . . 0.0 109.127 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.47 ' N ' ' O ' ' B' ' 32' ' ' LEU . 92.1 Cg_endo -83.69 3.79 7.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.971 2.448 . . . . 0.0 112.562 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.407 ' NE1' HG23 ' B' ' 38' ' ' THR . 3.1 p-90 -57.42 -19.82 26.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 109.547 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.407 HG23 ' NE1' ' B' ' 37' ' ' TRP . 6.2 p -79.96 5.44 13.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -48.28 -22.74 0.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.912 . . . . 0.0 109.531 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -62.36 -38.81 90.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.39 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . 0.433 ' O ' ' CG ' ' B' ' 42' ' ' PHE . 80.7 m-85 -88.01 27.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.433 ' CG ' ' O ' ' B' ' 41' ' ' PHE . 75.2 m-85 -154.82 32.93 0.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.9 . . . . 0.0 109.518 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.33 -27.84 52.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 67.6 m -76.28 -29.7 57.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.526 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' B' ' 47' ' ' ASP . 3.8 m-85 -48.68 -22.71 0.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.319 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' B' ' 47' ' ' ASP . . . 68.04 -53.16 0.4 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 45' ' ' PHE . 51.2 m-20 -60.35 -151.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -1.144 . . . . 0.0 109.552 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt 58.82 17.91 5.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.492 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 30.2 p -69.45 -28.34 66.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.36 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . 0.523 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.4 p -145.24 151.31 47.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 109.021 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.665 ' HB3' ' HB3' ' A' ' 119' ' ' PRO . 81.0 Cg_exo -38.27 -32.51 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.619 2.213 . . . . 0.0 112.574 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.19 -24.14 40.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.721 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -68.89 -19.57 64.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.893 . . . . 0.0 109.727 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.45 ' O ' HG11 ' B' ' 60' ' ' VAL . 18.6 t -65.24 -64.03 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 109.571 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 25.5 mtm -95.38 29.33 2.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.12 -58.58 0.66 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -69.4 150.26 97.1 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.293 -1.122 . . . . 0.0 109.478 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' B' ' 60' ' ' VAL . 69.2 Cg_endo -75.05 -56.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.609 2.206 . . . . 0.0 112.395 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -18.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 109.743 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' B' ' 58' ' ' PRO . 91.4 t -81.66 -44.96 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.426 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -79.01 -27.1 43.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.16 -20.93 63.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 109.64 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -72.3 -23.94 61.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -0.99 . . . . 0.0 109.406 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.04 -25.99 74.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -55.97 -42.82 76.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 109.063 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -64.34 -41.49 96.74 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 109.557 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 29.0 t -65.27 -62.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.296 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.66 ' O ' HD23 ' B' ' 68' ' ' LEU . 2.4 tt -54.32 -40.2 67.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.194 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.52 -53.85 38.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.1 -44.38 42.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.097 . . . . 0.0 109.632 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -63.31 -45.89 89.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 98.6 p -61.07 -34.83 75.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 0.0 109.563 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -53.98 -39.63 66.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -0.961 . . . . 0.0 109.431 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.24 -60.14 8.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.589 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -53.73 -30.07 42.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.173 -1.193 . . . . 0.0 109.168 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.21 4.32 46.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.32 -0.863 . . . . 0.0 109.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -170.22 67.48 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 109.675 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.96 12.78 2.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.237 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.0 -29.75 68.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 24.9 t-20 -164.02 111.32 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 109.56 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.576 ' N ' HD12 ' B' ' 81' ' ' LEU . 7.5 mp -80.29 -56.07 4.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.517 ' HZ2' ' CD2' ' B' ' 143' ' ' HIS . 77.0 tttt -62.31 -24.12 67.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.608 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -75.07 -51.11 7.86 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.7 t -73.41 -46.29 49.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -1.133 . . . . 0.0 109.475 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.542 ' N ' ' CG2' ' B' ' 84' ' ' THR . 54.4 m-85 -84.29 26.13 0.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.445 -0.785 . . . . 0.0 109.575 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.11 -28.05 67.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.469 ' O ' ' N ' ' B' ' 91' ' ' LEU . 82.0 p -77.22 -58.14 3.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.83 . . . . 0.0 109.607 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.24 -41.6 18.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -68.71 -37.62 79.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.907 . . . . 0.0 109.58 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -82.67 -28.14 30.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 109.499 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' B' ' 87' ' ' THR . 10.3 tt -75.5 -69.05 0.51 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.232 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' B' ' 97' ' ' HIS . 70.8 m80 -50.1 -23.85 2.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.183 -0.948 . . . . 0.0 109.735 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 38.8 t -83.92 -56.23 3.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.92 . . . . 0.0 111.066 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.538 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 73.4 m-20 -86.17 -24.49 26.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.967 -1.083 . . . . 0.0 111.856 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . 0.469 ' N ' ' CD ' ' B' ' 95' ' ' LYS . 10.7 mptt -94.25 -51.73 4.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.678 -1.264 . . . . 0.0 110.676 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -27.69 13.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.049 -1.032 . . . . 0.0 109.934 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 1.58 ' CD2' HG21 ' C' ' 41' ' ' THR . 21.4 m-70 57.71 53.71 6.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 109.716 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.37 124.29 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.151 -0.968 . . . . 0.0 109.295 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 1.291 ' OD2' HG11 ' C' ' 96' ' ' VAL . 68.7 m-20 -47.99 149.27 2.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.389 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.32 62.93 5.31 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.554 2.169 . . . . 0.0 112.046 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -172.09 73.92 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.434 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.95 -27.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.86 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 0.1 OUTLIER -56.28 -20.53 19.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.002 -1.061 . . . . 0.0 109.689 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -86.15 -41.13 14.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.428 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 tp -48.97 -40.18 29.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.319 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.28 -47.59 64.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.272 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.46 -20.09 54.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -81.72 -55.74 4.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -1.164 . . . . 0.0 110.164 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 p -61.92 -24.15 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.078 -1.013 . . . . 0.0 109.682 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.474 ' O ' HD23 ' B' ' 110' ' ' LEU . 1.6 tt -61.57 -58.06 9.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.401 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' B' ' 130' ' ' TYR . 69.5 t -46.64 -26.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 109.772 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.49 -32.66 74.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 109.63 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.48 -31.57 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.965 . . . . 0.0 109.497 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.14 -29.4 60.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.158 -0.964 . . . . 0.0 109.497 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.424 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -74.97 -32.23 61.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.572 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.479 ' C ' ' HD1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.85 -56.98 3.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.224 -0.923 . . . . 0.0 109.404 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' B' ' 118' ' ' PHE . 13.7 m170 -56.83 -17.78 10.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.621 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.408 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 72.1 m-85 -154.48 60.59 0.69 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -70.97 -26.24 74.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' B' ' 120' ' ' LYS . 11.8 mptt -70.0 9.86 0.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -1.168 . . . . 0.0 109.289 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' B' ' 119' ' ' GLY . 68.7 mm-40 -136.64 2.53 2.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.828 . . . . 0.0 109.387 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.659 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -72.91 39.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.502 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.572 ' C ' HE22 ' B' ' 127' ' ' GLN . 0.8 OUTLIER -52.46 149.08 11.09 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 109.331 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.3 Cg_exo -47.62 -52.38 8.14 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.46 2.107 . . . . 0.0 113.246 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 35.8 Cg_endo -65.35 -3.88 8.35 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.087 1.858 . . . . 0.0 112.708 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.454 HG23 ' OG1' ' B' ' 123' ' ' THR . 56.8 t -96.81 -22.09 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.044 -1.035 . . . . 0.0 109.724 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . 0.572 HE22 ' C ' ' B' ' 123' ' ' THR . 1.8 mp0 -83.27 -59.95 2.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.029 -1.044 . . . . 0.0 109.715 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -54.03 -35.02 61.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.991 . . . . 0.0 109.408 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.89 26.48 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.69 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.414 ' CE1' HG22 ' B' ' 111' ' ' VAL . 32.7 t80 -118.82 -61.47 1.64 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.304 -0.873 . . . . 0.0 109.654 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 28.1 mt-30 -52.81 -23.42 6.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.636 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -71.58 -39.02 70.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.112 -0.992 . . . . 0.0 109.731 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.71 -55.85 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 109.799 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' B' ' 137' ' ' VAL . 11.4 m -69.78 -28.57 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 110.041 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -47.57 -25.89 1.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 109.354 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.79 -24.6 57.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' B' ' 134' ' ' VAL . 74.8 t -79.42 -37.6 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -1.1 . . . . 0.0 109.345 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.81 79.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.433 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 0.492 HD21 HD21 ' D' ' 139' ' ' ASN . 65.1 t30 -72.1 -44.03 63.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.36 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.3 -40.82 49.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 109.341 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 36.5 mt -81.94 12.79 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.338 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' B' ' 103' ' ' PHE . . . -139.78 1.63 1.91 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 109.81 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . 0.517 ' CD2' ' HZ2' ' B' ' 82' ' ' LYS . 10.4 t60 -79.37 -34.05 42.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.51 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 5.0 tptp -67.41 -25.44 65.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.409 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -64.03 -14.14 52.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.526 ' OXT' ' CG ' ' B' ' 146' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.503 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.417 ' CD1' ' CD2' ' C' ' 128' ' ' PHE . 48.9 mt -125.35 -162.29 1.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.824 . . . . 0.0 109.435 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.502 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 177.1 -48.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.954 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' C' ' 3' ' ' SER . 67.4 Cg_exo -49.21 174.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.381 2.054 . . . . 0.0 112.477 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -56.92 -16.54 7.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.639 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' C' ' 5' ' ' ALA . 14.9 t70 -40.0 -31.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 109.525 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' C' ' 5' ' ' ALA . 9.3 mtmp? -73.41 -55.91 5.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.211 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 44.6 m -47.51 -28.63 2.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.381 -0.824 . . . . 0.0 109.211 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -78.3 -38.6 42.09 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.51 HG21 ' CD2' ' C' ' 128' ' ' PHE . 40.7 t -70.86 -48.83 54.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -51.63 -44.62 63.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.404 -0.81 . . . . 0.0 108.853 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.86 -58.58 7.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.447 -0.783 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.481 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -55.55 -31.93 62.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.309 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.42 -17.37 58.18 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.155 -0.966 . . . . 0.0 109.004 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.33 -38.84 44.84 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -84.26 -40.9 17.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -1.067 . . . . 0.0 109.355 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.566 ' O ' ' C ' ' C' ' 18' ' ' GLY . 93.5 t -66.71 -46.0 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.821 . . . . 0.0 109.687 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' C' ' 19' ' ' ALA . . . -25.08 137.73 0.01 OUTLIER Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' C' ' 18' ' ' GLY . . . 74.45 -29.39 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.517 -0.99 . . . . 0.0 109.237 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.513 ' H ' ' C ' ' C' ' 18' ' ' GLY . 37.6 m-70 -110.56 16.82 21.27 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.599 ' HB1' ' HB1' ' C' ' 63' ' ' ALA . . . -82.32 -60.86 2.06 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.957 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.53 -14.7 0.39 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.0 mt-10 -85.52 -56.4 3.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -1.148 . . . . 0.0 109.728 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.4 m-30 -60.71 -35.2 75.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.445 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.39 -22.9 73.31 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.79 -47.09 14.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -1.165 . . . . 0.0 109.598 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -63.66 -19.77 65.16 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.298 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.64 63.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 109.509 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.42 HD11 ' ND1' ' C' ' 58' ' ' HIS . 9.0 mt -70.39 -53.7 15.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.13 -29.37 69.73 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 109.226 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.37 -30.4 67.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.259 -0.901 . . . . 0.0 109.197 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 47.8 ttp -72.81 -52.72 13.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -0.838 . . . . 0.0 109.191 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.36 -31.96 10.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.888 . . . . 0.0 109.293 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.5 mt -78.46 -39.77 37.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.3 -0.875 . . . . 0.0 109.421 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.521 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 15.0 m -51.75 -29.55 19.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' C' ' 35' ' ' SER . 57.3 m-85 -160.89 130.34 3.25 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.273 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -76.24 -19.92 14.93 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.375 2.05 . . . . 0.0 112.203 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.68 ' O ' HG22 ' C' ' 41' ' ' THR . 22.4 p -46.53 -46.01 18.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.705 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -45.46 -22.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 109.868 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' C' ' 38' ' ' THR . 26.6 ttmt -51.83 -42.42 62.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.137 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 1.58 HG21 ' CD2' ' B' ' 97' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 109.789 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.511 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 4.1 p80 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.042 0.449 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -157.77 28.38 0.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.117 -0.99 . . . . 0.0 110.077 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' C' ' 49' ' ' SER . 73.9 m-20 43.61 89.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.548 -0.72 . . . . 0.0 110.376 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 1.002 ' H ' HD13 ' C' ' 48' ' ' LEU . 0.0 OUTLIER -60.69 1.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 0.0 109.26 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.517 ' H ' ' C ' ' C' ' 47' ' ' ASP . 5.0 m -84.83 157.03 21.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.955 . . . . 0.0 109.734 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.612 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 40.4 t-80 -76.45 170.56 16.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.446 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . 0.612 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 76.26 -22.08 2.13 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 4.7 p -55.85 -18.68 9.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -1.105 . . . . 0.0 109.368 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 72.82 -23.3 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 109.669 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' C' ' 52' ' ' SER . 24.1 mt-30 -84.76 -17.96 36.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.568 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.519 HG23 ' OG ' ' C' ' 52' ' ' SER . 44.2 t -84.02 -32.62 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 109.639 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' C' ' 56' ' ' LYS . 13.7 ptpt -72.98 -29.39 63.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.166 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.82 -45.0 66.48 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.496 ' ND1' ' C ' ' C' ' 58' ' ' HIS . 6.2 t-80 -60.66 -30.74 70.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.245 . . . . 0.0 110.071 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.87 -31.29 79.22 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 59.2 mttp -68.93 -23.02 64.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -1.106 . . . . 0.0 110.213 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' C' ' 65' ' ' ALA . 0.0 OUTLIER -69.41 -58.17 4.33 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.982 -1.074 . . . . 0.0 108.755 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 13.3 t -55.59 -41.47 64.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.605 -0.684 . . . . 0.0 109.578 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.599 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -75.6 -43.81 46.24 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.102 -0.999 . . . . 0.0 109.195 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 35.0 t0 -68.99 -33.84 74.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 108.563 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' C' ' 61' ' ' LYS . . . -66.94 -49.01 66.83 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -53.05 -47.08 68.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.1 m -57.06 -56.59 19.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.9 . . . . 0.0 108.701 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.535 ' O ' ' CD2' ' C' ' 72' ' ' HIS . 28.5 t30 -58.82 -21.1 55.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 108.57 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.09 -47.42 10.2 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.36 -22.72 27.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.95 -33.32 75.31 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' C' ' 74' ' ' ASP . 5.6 m-70 -115.96 -60.47 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.534 -0.729 . . . . 0.0 109.527 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.556 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.2 p 45.02 12.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.744 0.783 . . . . 0.0 109.583 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' C' ' 72' ' ' HIS . 28.9 m-20 -138.33 11.18 2.78 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -177.36 27.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.696 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 3.0 ptt? -78.54 -23.91 0.42 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.837 . . . . 0.0 111.642 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' C' ' 76' ' ' MET . 53.1 Cg_exo -54.4 -19.72 18.18 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.582 1.521 . . . . 0.0 112.207 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -93.01 -40.75 10.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.178 -0.951 . . . . 0.0 109.435 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.82 -43.45 65.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.261 -0.899 . . . . 0.0 108.948 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -85.29 10.32 12.88 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 7.6 t -51.87 -47.65 64.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.324 -0.86 . . . . 0.0 109.683 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -46.09 -58.15 3.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 109.707 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.46 HD23 ' N ' ' C' ' 83' ' ' LEU . 3.8 mt -45.18 -44.33 10.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 0.0 108.785 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.9 p -55.19 -30.03 59.1 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.68 ' O ' ' N ' ' C' ' 89' ' ' HIS . 1.6 m-20 -82.15 -49.53 10.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.198 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.19 -29.95 15.53 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.095 -1.003 . . . . 0.0 109.173 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -92.82 -21.92 19.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.833 . . . . 0.0 110.336 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.72 20.87 5.52 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.076 -1.015 . . . . 0.0 110.398 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' C' ' 85' ' ' ASP . 0.7 OUTLIER -140.57 -78.26 0.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.078 -1.013 . . . . 0.0 109.806 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' C' ' 92' ' ' ARG . 16.9 mttp -67.38 -119.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.843 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.585 ' N ' HD12 ' C' ' 91' ' ' LEU . 10.3 mp -44.5 -19.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 109.802 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' C' ' 90' ' ' LYS . 49.7 ttt180 57.28 45.92 19.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.928 . . . . 0.0 109.304 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.416 ' H ' HG23 ' C' ' 93' ' ' VAL . 4.7 t -48.48 133.21 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 109.599 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' C' ' 96' ' ' VAL . 0.6 OUTLIER -91.55 126.03 55.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.281 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.81 -11.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.268 1.979 . . . . 0.0 112.396 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 1.291 HG11 ' OD2' ' B' ' 99' ' ' ASP . 24.8 t -56.22 -31.89 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 109.693 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -79.44 -38.16 35.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.662 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -46.12 -30.25 1.85 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 109.62 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.3 -27.97 69.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.942 . . . . 0.0 109.637 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 11.2 mt -84.22 -34.34 23.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 109.84 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tp -64.22 -61.03 2.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 109.806 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 24.4 t -47.7 -34.73 8.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 109.836 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . 0.459 ' O ' HG23 ' C' ' 107' ' ' VAL . 12.3 t-80 -80.96 -26.59 36.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.735 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 97.9 m -76.35 -38.1 56.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 109.953 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -52.19 66.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 109.681 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' C' ' 106' ' ' LEU . 36.8 mt -60.14 -32.28 70.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.947 . . . . 0.0 110.006 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 34.3 t -63.72 -59.56 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 109.264 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 41.3 p -54.77 -53.59 53.1 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.229 -0.92 . . . . 0.0 109.224 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' C' ' 114' ' ' PRO . 7.7 mt -45.29 -26.74 0.55 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.459 -0.775 . . . . 0.0 109.299 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -68.44 -39.26 81.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.304 -0.872 . . . . 0.0 110.039 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . 0.657 ' HB2' ' CE2' ' D' ' 122' ' ' PHE . . . -78.94 -3.6 45.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -134.44 -80.06 0.45 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.232 -0.917 . . . . 0.0 109.713 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -118.41 82.6 19.31 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' C' ' 113' ' ' LEU . 51.3 Cg_exo -49.78 -169.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.402 2.068 . . . . 0.0 112.402 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.822 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -52.85 -55.71 21.1 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.662 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 46.4 mt-10 123.24 -5.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.414 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 7.6 t80 73.21 30.97 1.49 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.803 -0.561 . . . . 0.0 111.033 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.75 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.8 p -104.48 126.26 31.9 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.07 -1.019 . . . . 0.0 108.439 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . 0.657 ' HB3' ' HB3' ' D' ' 51' ' ' PRO . 53.9 Cg_exo -49.74 22.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.407 2.071 . . . . 0.0 112.901 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.75 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -153.37 -32.98 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.777 -1.202 . . . . 0.0 110.553 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.822 HG21 ' O ' ' C' ' 115' ' ' ALA . 9.7 p -52.76 -49.47 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.057 -1.027 . . . . 0.0 110.18 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.645 ' N ' HG13 ' C' ' 121' ' ' VAL . 4.7 t-160 -59.48 -37.5 78.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 0.0 109.176 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.12 -19.43 34.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.411 -0.806 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.523 ' N ' ' O ' ' C' ' 120' ' ' ALA . 23.1 p -64.12 -62.12 1.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 110.844 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.488 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.6 mt -68.49 -19.72 64.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.016 -1.053 . . . . 0.0 109.761 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.67 -46.64 12.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.99 -1.069 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.473 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -80.38 -46.37 16.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.155 -0.966 . . . . 0.0 109.277 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.51 ' CD2' HG21 ' C' ' 10' ' ' VAL . 26.9 t80 -49.88 -21.68 1.24 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.016 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' C' ' 129' ' ' LEU . 15.3 mt -73.98 -21.82 59.85 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -57.93 -31.76 67.13 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 90.0 p -79.86 -33.65 39.91 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.341 -0.85 . . . . 0.0 108.925 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 42.6 t -82.27 -35.51 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 108.578 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 47.5 t -72.18 -28.61 63.33 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.408 -0.808 . . . . 0.0 109.237 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 32.3 m -66.55 -34.31 77.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.954 . . . . 0.0 109.108 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.32 -40.45 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.316 -0.865 . . . . 0.0 109.08 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.7 -27.42 68.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 108.945 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 61.7 m -86.2 -26.46 25.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.923 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.51 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -127.92 155.78 43.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.436 -0.79 . . . . 0.0 109.306 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -54.48 152.76 11.45 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 108.878 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.01 -18.63 44.1 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.477 2.118 . . . . 0.0 112.068 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -87.11 -37.92 16.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.914 . . . . 0.0 109.622 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -84.1 -23.15 30.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.836 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -84.12 -55.19 4.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.229 -0.919 . . . . 0.0 109.102 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -48.04 -23.49 0.83 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.09 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.16 -59.64 2.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.891 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.01 -24.47 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -74.81 -51.9 12.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.698 -0.626 . . . . 0.0 109.65 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.31 -24.92 46.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.662 ' O ' HG23 ' D' ' 18' ' ' VAL . 1.2 mt -59.64 -28.28 67.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.78 -17.04 62.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -0.952 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.25 -63.73 3.15 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.585 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.503 ' HD3' HD23 ' D' ' 14' ' ' LEU . 0.0 OUTLIER -70.77 -11.74 61.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.036 -1.273 . . . . 0.0 110.778 -178.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.662 HG23 ' O ' ' D' ' 14' ' ' LEU . 12.9 t -70.66 121.27 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.856 -1.152 . . . . 0.0 109.343 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.539 HD22 ' N ' ' D' ' 19' ' ' ASN . 0.9 OUTLIER -77.12 73.4 3.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.226 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.525 HG12 ' O ' ' D' ' 20' ' ' VAL . 76.1 t -53.05 -6.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.556 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' D' ' 19' ' ' ASN . 9.8 p30 -67.92 -20.69 65.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.936 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.505 ' N ' ' OD1' ' D' ' 21' ' ' ASP . 9.3 pt-20 -150.27 -32.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.067 -1.02 . . . . 0.0 109.884 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.22 -28.36 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 109.626 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.03 -41.41 99.86 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.06 -55.07 17.89 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . 0.416 ' O ' ' NH1' ' D' ' 30' ' ' ARG . 58.3 mt-10 -49.79 -27.03 4.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -1.155 . . . . 0.0 109.432 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.31 -32.55 22.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.06 -36.35 21.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.63 -40.66 90.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . 0.416 ' NH1' ' O ' ' D' ' 26' ' ' GLU . 0.0 OUTLIER -62.93 -21.7 66.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -1.12 . . . . 0.0 109.467 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tt -70.07 -28.32 65.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.152 -0.968 . . . . 0.0 109.523 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' D' ' 36' ' ' PRO . 27.7 mt -81.32 -53.86 5.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.925 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . 0.505 HG13 ' N ' ' D' ' 34' ' ' VAL . 6.2 p -56.21 -43.18 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.003 . . . . 0.0 109.628 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.505 ' N ' HG13 ' D' ' 33' ' ' VAL . 57.8 t -79.56 -22.83 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -153.11 75.5 6.65 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.848 . . . . 0.0 109.126 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' D' ' 32' ' ' LEU . 92.6 Cg_endo -83.6 3.69 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.935 2.423 . . . . 0.0 112.553 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -57.39 -19.87 26.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.485 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 6.0 p -80.0 5.41 14.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 109.414 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -48.17 -22.76 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.593 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -62.34 -38.84 91.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.366 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' D' ' 42' ' ' PHE . 80.2 m-85 -87.95 27.87 1.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.429 ' CG ' ' O ' ' D' ' 41' ' ' PHE . 75.1 m-85 -154.8 32.85 0.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.524 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.37 -27.7 52.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 109.538 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 67.5 m -76.34 -29.67 57.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 109.476 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' D' ' 47' ' ' ASP . 3.8 m-85 -48.7 -22.71 0.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' D' ' 47' ' ' ASP . . . 68.02 -53.11 0.39 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' D' ' 45' ' ' PHE . 51.6 m-20 -60.38 -151.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -1.123 . . . . 0.0 109.485 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt 58.73 17.97 5.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 30.4 p -69.46 -28.38 66.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.923 . . . . 0.0 109.309 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . 0.526 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.5 p -145.32 151.24 47.21 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.071 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . 0.657 ' HB3' ' HB3' ' C' ' 119' ' ' PRO . 80.8 Cg_exo -38.12 -32.6 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.598 2.199 . . . . 0.0 112.599 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.19 -24.04 40.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.737 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -69.03 -19.45 64.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.671 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . 0.437 ' O ' HG11 ' D' ' 60' ' ' VAL . 18.4 t -65.31 -63.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.618 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 25.5 mtm -95.41 29.43 2.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.12 -58.58 0.66 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -69.36 150.25 97.15 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.224 -1.162 . . . . 0.0 109.608 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.463 ' O ' ' N ' ' D' ' 60' ' ' VAL . 68.4 Cg_endo -75.01 -56.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.639 2.226 . . . . 0.0 112.331 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -18.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' D' ' 58' ' ' PRO . 91.2 t -81.66 -44.98 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.421 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -79.04 -27.12 43.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.9 63.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.75 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -72.27 -24.02 61.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.408 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.01 -25.98 74.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.99 -42.86 77.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.207 -1.172 . . . . 0.0 109.044 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -64.34 -41.46 96.76 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.589 -0.694 . . . . 0.0 109.561 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 28.7 t -65.19 -62.93 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.288 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.676 ' O ' HD23 ' D' ' 68' ' ' LEU . 2.4 tt -54.35 -40.15 67.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.205 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.55 -53.87 38.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.16 -44.38 42.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -1.122 . . . . 0.0 109.54 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.33 -45.82 89.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 98.4 p -61.08 -34.89 75.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.459 -0.776 . . . . 0.0 109.526 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -54.02 -39.66 66.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.14 -60.16 8.4 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.605 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.9 mp -53.75 -30.06 42.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.324 -1.103 . . . . 0.0 109.193 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.13 4.31 45.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -170.35 67.45 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.669 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt -78.9 12.73 2.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.246 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.0 -29.76 68.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 24.8 t-20 -164.0 111.29 1.12 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.636 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . 0.563 ' N ' HD12 ' D' ' 81' ' ' LEU . 7.5 mp -80.26 -56.11 4.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . 0.492 ' HZ2' ' CD2' ' D' ' 143' ' ' HIS . 77.2 tttt -62.42 -24.06 67.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -75.04 -51.06 7.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.7 t -73.43 -46.31 49.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 0.0 109.498 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.538 ' N ' ' CG2' ' D' ' 84' ' ' THR . 54.5 m-85 -84.28 26.11 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.583 -0.698 . . . . 0.0 109.624 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.08 -28.08 67.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 0.0 109.422 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . 0.464 ' O ' ' N ' ' D' ' 91' ' ' LEU . 82.6 p -77.13 -58.17 3.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.646 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.26 -41.57 18.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -68.67 -37.67 79.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.527 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -82.73 -28.15 30.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 0.0 109.378 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' D' ' 87' ' ' THR . 10.3 tt -75.58 -68.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.234 -0.917 . . . . 0.0 109.238 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.583 ' O ' ' N ' ' D' ' 97' ' ' HIS . 71.0 m80 -50.08 -23.87 2.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.757 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 38.8 t -83.94 -56.21 3.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 111.03 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.538 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 73.3 m-20 -86.21 -24.6 26.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.074 -1.016 . . . . 0.0 111.749 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' D' ' 95' ' ' LYS . 10.7 mptt -94.21 -51.63 4.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.638 -1.289 . . . . 0.0 110.742 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.96 -27.73 13.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 0.0 109.907 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 1.615 ' CD2' HG21 ' A' ' 41' ' ' THR . 21.4 m-70 57.77 53.67 6.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.33 124.26 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.134 -0.979 . . . . 0.0 109.261 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . 1.265 ' CG ' HG11 ' A' ' 96' ' ' VAL . 68.7 m-20 -47.93 149.29 2.44 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.123 -0.986 . . . . 0.0 109.426 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.3 62.91 5.29 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.532 2.155 . . . . 0.0 112.082 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -172.05 73.84 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.85 -27.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.867 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 0.1 OUTLIER -56.38 -20.37 19.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.094 -1.004 . . . . 0.0 109.633 -179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -86.28 -41.04 14.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.056 -1.028 . . . . 0.0 109.36 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 tp -48.99 -40.14 29.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.386 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.35 -47.56 63.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.295 -0.878 . . . . 0.0 109.315 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.39 -19.98 54.28 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -81.79 -55.82 4.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -1.196 . . . . 0.0 110.01 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.96 -24.09 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.032 -1.042 . . . . 0.0 109.682 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . 0.482 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.6 tt -61.62 -57.97 9.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . 0.408 HG22 ' CE1' ' D' ' 130' ' ' TYR . 70.0 t -46.67 -26.06 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.772 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.45 -32.65 74.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.112 -0.993 . . . . 0.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.51 -31.56 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.534 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 12.4 mt -75.04 -29.5 60.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.504 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.42 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -74.93 -32.29 61.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.937 . . . . 0.0 109.483 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.476 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.89 -56.99 3.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 0.0 109.359 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . 0.409 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 13.7 m170 -56.81 -17.73 10.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 109.569 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.409 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 72.2 m-85 -154.54 60.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 109.64 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -71.04 -26.22 74.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . 0.494 ' N ' ' CD ' ' D' ' 120' ' ' LYS . 11.9 mptt -70.03 9.95 0.49 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -1.102 . . . . 0.0 109.343 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' D' ' 119' ' ' GLY . 68.8 mm-40 -136.71 2.54 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.39 -0.819 . . . . 0.0 109.45 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.657 ' CE2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -72.94 39.05 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.56 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.563 ' C ' HE22 ' D' ' 127' ' ' GLN . 0.8 OUTLIER -52.42 149.06 10.98 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.289 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.507 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -47.72 -52.38 8.19 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.449 2.099 . . . . 0.0 113.229 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 36.0 Cg_endo -65.27 -3.92 8.31 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.11 1.873 . . . . 0.0 112.7 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.462 HG23 ' OG1' ' D' ' 123' ' ' THR . 55.7 t -96.85 -22.04 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.05 -1.032 . . . . 0.0 109.699 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . 0.563 HE22 ' C ' ' D' ' 123' ' ' THR . 1.8 mp0 -83.27 -60.0 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 0.0 109.687 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -53.93 -35.11 61.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.9 26.46 0.99 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.679 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.408 ' CE1' HG22 ' D' ' 111' ' ' VAL . 32.9 t80 -118.8 -61.37 1.66 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.366 -0.834 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 28.1 mt-30 -52.83 -23.46 7.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.625 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -71.49 -39.2 71.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.747 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 74.6 t -62.71 -55.77 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.088 -1.008 . . . . 0.0 109.816 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' D' ' 137' ' ' VAL . 11.4 m -69.75 -28.56 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -0.853 . . . . 0.0 110.036 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -47.55 -25.96 1.29 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.99 -1.069 . . . . 0.0 109.383 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.78 -24.52 58.07 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' D' ' 134' ' ' VAL . 75.4 t -79.36 -37.65 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -1.126 . . . . 0.0 109.343 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.78 79.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . 0.492 HD21 HD21 ' B' ' 139' ' ' ASN . 65.0 t30 -72.05 -44.08 63.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.24 -40.94 49.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 37.1 mt -81.95 12.9 3.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.272 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' D' ' 103' ' ' PHE . . . -139.91 1.63 1.88 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.284 -0.885 . . . . 0.0 109.711 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . 0.492 ' CD2' ' HZ2' ' D' ' 82' ' ' LYS . 10.4 t60 -79.32 -34.09 42.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.512 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 5.0 tptp -67.42 -25.5 65.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.381 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -63.99 -14.16 51.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.92 . . . . 0.0 109.529 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.526 ' OXT' ' CG ' ' D' ' 146' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.551 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.498 ' CG1' ' OG ' ' A' ' 131' ' ' SER . 96.6 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.337 0.589 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp 59.06 163.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.359 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 174.77 -44.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.92 . . . . 0.0 110.033 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 3' ' ' SER . 52.9 Cg_exo -53.7 172.85 0.22 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.691 2.261 . . . . 0.0 113.105 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.598 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -46.9 -14.6 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 4' ' ' PRO . 3.0 p30 -38.59 -22.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.445 -0.785 . . . . 0.0 110.121 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 5' ' ' ALA . 38.0 mttt -80.42 -56.78 3.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.115 -0.991 . . . . 0.0 109.407 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 m -46.82 -28.65 1.62 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.511 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -78.35 -38.07 42.89 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.439 HG21 ' CD2' ' A' ' 128' ' ' PHE . 25.4 t -71.61 -49.28 47.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -50.99 -44.23 60.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.21 -61.21 2.77 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.97 -35.38 69.09 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -0.756 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -77.01 -17.16 59.03 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.204 -0.935 . . . . 0.0 108.888 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.57 -38.23 44.45 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -84.46 -35.21 23.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.402 -1.058 . . . . 0.0 109.495 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 21' ' ' ALA . 42.6 t -73.64 -36.91 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 109.674 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 19' ' ' ALA . . . -30.58 143.72 0.01 OUTLIER Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . 71.07 -31.96 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -1.043 . . . . 0.0 109.113 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.557 ' H ' ' C ' ' A' ' 18' ' ' GLY . 49.8 m-70 -107.94 17.13 22.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 17' ' ' VAL . . . -85.49 -36.05 20.79 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.879 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.3 -14.44 64.14 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -87.99 -56.14 3.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -1.113 . . . . 0.0 109.876 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.4 m-30 -58.42 -35.38 71.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.365 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.73 -23.06 64.89 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.38 -49.91 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -1.188 . . . . 0.0 109.696 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -56.62 -19.76 17.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.83 -21.25 60.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 109.597 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.528 HD11 ' ND1' ' A' ' 58' ' ' HIS . 11.0 mt -82.61 -54.31 5.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -64.43 -34.04 77.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.553 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.502 ' CG ' HH11 ' A' ' 31' ' ' ARG . 0.5 OUTLIER -66.4 -38.57 87.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 109.631 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 32' ' ' MET . 15.1 tmm? -75.13 -31.97 61.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.313 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -54.14 -49.93 68.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.78 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 36' ' ' PHE . 1.3 pp -81.27 -43.61 18.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 m -62.95 4.48 0.17 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.617 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.533 ' CE2' ' OG1' ' A' ' 38' ' ' THR . 2.5 t80 -162.74 93.76 1.2 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.222 -0.923 . . . . 0.0 109.165 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.76 -23.38 6.95 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.495 2.13 . . . . 0.0 112.404 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.533 ' OG1' ' CE2' ' A' ' 36' ' ' PHE . 9.5 p -54.65 -28.57 48.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 109.283 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -89.98 -22.8 21.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 109.547 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -46.12 -31.1 2.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 1.281 HG21 ' CG ' ' D' ' 97' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.23 0 CA-C-O 120.589 0.233 . . . . 0.0 111.177 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.06 35.21 2.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.832 -1.168 . . . . 0.0 109.917 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 49' ' ' SER . 14.5 m-20 52.79 91.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 109.53 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.03 -1.65 0.33 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 47' ' ' ASP . 92.8 p -54.31 126.74 24.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.915 . . . . 0.0 109.463 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -57.25 136.01 56.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.472 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.41 70.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.597 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.5 t -64.04 -14.56 55.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -1.141 . . . . 0.0 109.457 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 70.88 -18.82 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.622 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 52' ' ' SER . 32.9 mt-30 -85.67 -18.09 34.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 109.376 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.64 -36.12 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -75.92 -33.47 59.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 108.96 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.72 -25.19 74.11 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.528 ' ND1' HD11 ' A' ' 29' ' ' LEU . 6.3 t-80 -71.49 -43.29 66.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -1.117 . . . . 0.0 109.392 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -49.38 -48.17 34.28 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 86.4 mttt -52.71 -22.62 5.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.995 . . . . 0.0 110.005 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.85 -40.91 60.73 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.146 -0.971 . . . . 0.0 108.792 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -73.05 -47.28 48.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.535 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -65.88 -32.59 74.19 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 26.1 t0 -71.93 -32.46 67.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.081 -1.012 . . . . 0.0 108.599 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -68.19 -52.57 32.87 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.01 -41.38 59.75 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.246 -0.909 . . . . 0.0 108.97 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 71' ' ' ALA . 16.3 m -68.26 -57.81 5.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.182 -0.949 . . . . 0.0 108.728 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -59.76 -23.84 63.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 108.758 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.08 -46.93 10.68 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.56 -22.93 27.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -67.75 -36.13 79.97 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' A' ' 74' ' ' ASP . 84.8 m-70 -102.78 -65.61 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.491 -0.756 . . . . 0.0 109.465 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 72' ' ' HIS . 12.6 p 44.83 14.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.863 0.839 . . . . 0.0 109.437 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 72' ' ' HIS . 71.0 m-20 -137.18 11.89 3.05 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.404 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 0.3 OUTLIER 172.23 31.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.205 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.686 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 8.1 ptt? -78.32 -22.89 0.4 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.929 . . . . 0.0 111.937 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.4 Cg_exo -53.27 -22.4 20.15 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.558 1.506 . . . . 0.0 112.335 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -92.98 -40.52 10.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.05 84.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 109.175 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.6 mt -83.93 9.48 12.11 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.451 -0.781 . . . . 0.0 108.918 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -58.43 -50.39 73.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 109.53 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 83' ' ' LEU . . . -50.11 -58.52 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.579 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 83' ' ' LEU . 4.5 mt -46.02 -46.2 16.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 108.894 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 5.7 p -64.89 -32.11 73.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.541 -0.724 . . . . 0.0 109.404 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -75.5 -23.84 56.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.99 -34.16 26.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 109.518 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -92.14 -21.88 20.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.927 . . . . 0.0 109.524 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -69.34 -84.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.732 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -78.54 -70.42 0.49 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.85 . . . . 0.0 109.918 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.593 ' C ' ' H ' ' A' ' 92' ' ' ARG . 25.5 ttmt -46.31 137.97 5.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.988 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.1 mt 66.19 -20.43 0.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.652 -0.655 . . . . 0.0 109.754 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.595 ' NH1' ' HA ' ' D' ' 40' ' ' ARG . 65.5 mtt180 38.9 27.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.41 -0.806 . . . . 0.0 109.685 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.565 ' CG2' ' ND2' ' A' ' 97' ' ' ASN . 7.5 p -45.45 141.19 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.872 . . . . 0.0 109.669 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.3 149.55 86.89 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 109.376 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 97' ' ' ASN . 59.8 Cg_endo -73.56 -22.25 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.526 2.151 . . . . 0.0 112.271 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 96' ' ' VAL . 21.9 t -56.5 -3.63 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 109.609 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.565 ' ND2' ' CG2' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -79.36 -41.93 26.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.928 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -51.25 -48.73 62.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 109.433 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -48.28 -30.61 4.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.487 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 18.7 mt -84.24 -62.03 1.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tp -49.89 -20.94 1.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.728 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 t -69.34 -59.11 3.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.454 ' ND1' ' OD1' ' B' ' 108' ' ' ASN . 32.1 m170 -68.43 -26.61 65.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.882 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 50.4 m -62.93 -45.48 92.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 109.927 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.97 -55.39 33.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.95 . . . . 0.0 109.429 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 4.1 mm? -47.83 -29.15 3.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.613 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.5 t -83.41 -24.63 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.409 ' OG1' HD23 ' A' ' 109' ' ' LEU . 27.9 p -71.46 -63.39 1.13 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.986 -1.071 . . . . 0.0 110.345 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -64.67 -26.22 68.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 109.636 -179.511 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 106' ' ' LEU . . . -49.4 -37.39 25.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.16 -56.24 4.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 110.07 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -71.38 -67.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.808 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.62 HD13 ' C ' ' A' ' 113' ' ' LEU . 2.1 tm? -110.7 98.52 37.86 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 66.6 Cg_exo -49.17 -170.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.277 1.984 . . . . 0.0 112.296 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.652 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -73.04 -55.33 6.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 108.827 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.652 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 18.3 mt-10 118.69 -8.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 5.3 t80 77.14 33.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.881 -0.512 . . . . 0.0 111.146 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.4 OUTLIER -101.62 116.0 64.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.04 20.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.982 1.788 . . . . 0.0 112.468 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -144.83 -29.47 0.46 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.159 -0.963 . . . . 0.0 110.431 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.668 HG13 ' N ' ' A' ' 122' ' ' HIS . 10.6 p -49.34 -50.77 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.139 -0.975 . . . . 0.0 109.967 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.668 ' N ' HG13 ' A' ' 121' ' ' VAL . 3.0 m80 -60.87 -34.67 74.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.121 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.18 -20.19 32.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.386 -0.821 . . . . 0.0 109.707 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.3 m -64.84 -62.12 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.541 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.88 -19.8 62.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.145 -0.972 . . . . 0.0 109.972 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.43 -44.47 19.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.033 . . . . 0.0 110.114 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.411 ' CD ' ' C ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -89.04 -41.49 12.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.985 -1.072 . . . . 0.0 109.954 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 10' ' ' VAL . 41.4 t80 -50.48 -20.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.878 -1.138 . . . . 0.0 108.907 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.596 ' O ' ' N ' ' A' ' 133' ' ' SER . 18.1 mt -71.42 -17.67 62.38 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.04 -31.69 71.32 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.498 ' OG ' ' CG1' ' A' ' 1' ' ' VAL . 4.0 t -83.53 -33.08 25.56 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.379 -0.826 . . . . 0.0 108.911 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.4 t -85.17 -26.63 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 108.907 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 129' ' ' LEU . 33.0 t -84.02 -25.52 29.85 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 108.873 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.5 m -77.62 -39.06 46.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.15 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 131' ' ' SER . 34.7 m -73.18 -27.04 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.262 -0.898 . . . . 0.0 108.69 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -29.98 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 137' ' ' THR . 93.5 m -112.52 24.02 12.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.409 -0.807 . . . . 0.0 109.437 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.666 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.988 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -92.04 155.58 18.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 0.0 109.328 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.14 153.9 84.03 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.013 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.02 -15.91 36.09 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.655 2.237 . . . . 0.0 112.313 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -85.28 -42.75 14.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.71 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.16 -22.56 30.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.917 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.603 ' HB2' HD13 ' B' ' 3' ' ' LEU . 7.7 tttm -79.23 -40.41 30.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.184 -0.947 . . . . 0.0 109.315 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 9.0 t -61.63 -23.64 66.18 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.815 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.11 -55.49 4.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 110.121 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.17 -24.72 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.078 -1.014 . . . . 0.0 108.414 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 50.9 m -82.21 -37.03 26.65 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.385 0.612 . . . . 0.0 109.617 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.46 96.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.528 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 17' ' ' LYS . 0.8 OUTLIER -61.82 -35.1 77.24 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.471 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -48.07 -21.52 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 109.046 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' B' ' 14' ' ' LEU . . . -86.5 -32.63 15.5 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' B' ' 14' ' ' LEU . 1.0 OUTLIER -78.02 -31.42 50.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -1.151 . . . . 0.0 109.087 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' B' ' 20' ' ' VAL . 69.7 t -54.09 114.88 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.551 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' B' ' 21' ' ' ASP . 3.1 m120 -71.41 64.06 0.4 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 109.168 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' B' ' 18' ' ' VAL . 42.1 t -45.68 -16.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.516 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' B' ' 19' ' ' ASN . 21.8 t70 -77.1 5.46 8.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.454 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -154.17 -43.84 0.09 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -0.87 . . . . 0.0 109.467 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -55.16 -24.9 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.507 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.41 -42.52 93.8 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.72 -35.92 54.18 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -73.44 -36.49 65.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 109.376 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.45 -52.94 62.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.47 -51.57 66.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 109.2 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.75 -40.65 95.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' B' ' 33' ' ' VAL . 16.7 mmt85 -58.13 -44.36 87.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -1.13 . . . . 0.0 109.524 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 35' ' ' TYR . 34.0 tp -46.83 -32.53 3.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.319 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 mt -81.18 -21.84 39.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' B' ' 30' ' ' ARG . 21.2 t -87.12 -64.29 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 109.549 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.432 ' H ' HG23 ' B' ' 34' ' ' VAL . 0.2 OUTLIER -60.05 -49.57 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.874 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.417 ' O ' ' O ' ' B' ' 31' ' ' LEU . 0.1 OUTLIER -118.53 85.68 27.03 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.365 -0.834 . . . . 0.0 109.45 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -84.26 34.47 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.702 2.268 . . . . 0.0 112.315 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.542 ' NE1' HG23 ' B' ' 38' ' ' THR . 1.9 p-90 -81.04 -29.74 34.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.13 -0.981 . . . . 0.0 109.602 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.542 HG23 ' NE1' ' B' ' 37' ' ' TRP . 65.1 p -60.62 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.433 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 48.95 45.2 22.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.471 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.507 ' HA ' ' NH1' ' C' ' 92' ' ' ARG . 19.2 ptt180 -137.82 -39.18 0.56 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.249 -0.907 . . . . 0.0 109.367 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -100.41 -25.47 14.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 109.44 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -74.48 6.11 4.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.424 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.14 -23.28 51.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 20.3 p -59.62 -40.31 87.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.507 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -51.63 -17.61 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.69 55.12 11.65 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -159.55 79.33 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -1.162 . . . . 0.0 109.394 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 36.6 mt -131.56 14.63 4.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 109.421 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.8 m -46.91 -41.75 16.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.221 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 5.9 p -146.64 148.68 34.41 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.438 -0.789 . . . . 0.0 108.896 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -41.07 -39.52 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.37 2.047 . . . . 0.0 112.292 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.403 ' C ' ' N ' ' B' ' 54' ' ' VAL . 1.0 OUTLIER -67.04 -40.43 87.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 109.643 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.14 -19.84 0.31 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.385 -0.822 . . . . 0.0 109.552 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.403 ' N ' ' C ' ' B' ' 52' ' ' ASP . 83.5 t -67.56 -64.01 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 10.4 mtt -86.12 -6.1 59.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 109.601 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.13 -35.6 88.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -81.24 148.36 63.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.205 -1.173 . . . . 0.0 109.418 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.13 -51.7 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.548 2.165 . . . . 0.0 112.287 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.3 -39.4 14.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 109.758 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.68 -45.47 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.435 ' HB3' ' HZ2' ' B' ' 61' ' ' LYS . 13.4 mtpp -75.17 -24.84 57.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.43 -43.05 70.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.574 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -64.1 -23.9 67.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.685 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.29 75.84 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.5 ' NZ ' ' OD1' ' B' ' 21' ' ' ASP . 19.3 mtpt -67.13 -25.02 65.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -1.15 . . . . 0.0 109.619 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -72.02 -28.75 63.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.583 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.11 -48.79 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.667 ' O ' HD23 ' B' ' 68' ' ' LEU . 1.3 tt -60.54 -16.92 42.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.31 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.14 -48.64 45.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.51 90.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -1.157 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -47.31 -41.2 18.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 0.0 109.559 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 14.0 m -49.42 -44.3 45.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 109.48 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -67.78 -16.72 64.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.06 -26.54 69.25 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.722 ' H ' HD23 ' B' ' 75' ' ' LEU . 2.0 pt? -136.08 -18.6 1.55 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.236 -1.155 . . . . 0.0 110.153 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -82.24 1.44 36.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.061 -1.024 . . . . 0.0 109.731 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 59.4 m-70 -163.06 67.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 109.549 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.09 4.85 3.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.49 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.02 -37.21 79.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.487 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 14.1 t-20 -171.45 99.43 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.492 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.04 -57.25 3.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.536 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -47.12 -24.02 0.6 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.558 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -66.43 -54.91 20.58 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.551 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.8 t -75.5 -47.32 27.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 0.0 109.488 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.551 ' N ' ' CG2' ' B' ' 84' ' ' THR . 53.3 m-85 -62.73 -1.18 0.78 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.5 -0.75 . . . . 0.0 109.381 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -59.22 -35.85 74.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . 0.453 ' O ' ' N ' ' B' ' 91' ' ' LEU . 21.5 p -83.28 -47.96 10.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.932 . . . . 0.0 109.531 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' B' ' 85' ' ' PHE . 40.5 mt -55.42 -43.12 75.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -67.41 -51.3 53.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.53 -22.41 64.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.868 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.672 ' C ' HD23 ' B' ' 91' ' ' LEU . 7.6 tt -81.42 -60.11 2.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.77 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.584 ' N ' HD23 ' B' ' 91' ' ' LEU . 66.5 m80 -61.78 -22.42 65.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.288 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 39.4 t -83.1 -60.58 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 110.729 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.538 ' O ' ' CE1' ' B' ' 97' ' ' HIS . 5.1 m-20 -87.23 -27.74 22.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.137 -0.977 . . . . 0.0 111.149 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.2 OUTLIER -87.68 -16.68 33.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.889 -1.132 . . . . 0.0 110.646 -178.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.498 ' C ' ' ND1' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -138.37 -39.26 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.942 -1.099 . . . . 0.0 109.929 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 1.257 ' CG ' HG21 ' C' ' 41' ' ' THR . 4.9 m80 64.87 58.78 0.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.101 -1.0 . . . . 0.0 109.754 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.7 132.63 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.081 -1.012 . . . . 0.0 109.335 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.44 152.55 2.22 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.359 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.04 -29.84 17.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.66 2.24 . . . . 0.0 112.187 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.33 53.68 0.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -149.35 -38.95 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.586 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.69 -29.78 70.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.545 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.402 ' NH1' ' CB ' ' B' ' 104' ' ' ARG . 31.4 mtm105 -77.82 -20.03 53.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 109.678 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.73 -50.04 9.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 tt -52.04 -49.04 64.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.39 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.5 -20.39 63.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . 0.454 ' OD1' ' ND1' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -81.76 -19.43 41.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -1.135 . . . . 0.0 109.658 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 92.6 t -86.36 -53.01 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.242 -0.911 . . . . 0.0 109.675 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.512 HD23 ' C ' ' B' ' 110' ' ' LEU . 2.8 tt -45.98 -60.2 2.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.336 -0.853 . . . . 0.0 109.717 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 61.5 t -46.68 -33.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.934 . . . . 0.0 109.748 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.21 -23.94 43.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.657 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 110' ' ' LEU . 98.2 t -75.0 -21.34 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.569 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.523 ' CD1' ' CZ ' ' B' ' 130' ' ' TYR . 21.5 mt -79.06 -48.59 14.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 109.49 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.27 -23.1 3.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.498 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 6.5 t-80 -83.81 -57.75 3.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.59 ' N ' ' HD1' ' B' ' 117' ' ' HIS . 0.3 OUTLIER -72.4 -17.78 61.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.524 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' B' ' 114' ' ' LEU . 95.1 m-85 -141.64 56.53 1.51 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -73.16 -24.94 74.61 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.2 9.32 1.02 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -1.132 . . . . 0.0 109.624 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' B' ' 119' ' ' GLY . 59.1 mm-40 -142.68 8.78 1.75 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.541 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -78.68 34.19 0.22 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.971 . . . . 0.0 109.442 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.481 ' OG1' HG23 ' B' ' 126' ' ' VAL . 69.2 p -48.67 148.47 3.62 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.265 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.513 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.4 Cg_exo -44.09 -55.82 2.88 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.544 2.163 . . . . 0.0 112.983 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 12.4 Cg_endo -56.22 -23.23 44.29 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.188 1.925 . . . . 0.0 112.22 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.481 HG23 ' OG1' ' B' ' 123' ' ' THR . 76.5 t -82.87 -23.31 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 109.559 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -83.18 -59.67 2.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.25 -36.85 14.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.903 . . . . 0.0 109.842 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.6 -5.22 56.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.131 -0.98 . . . . 0.0 110.065 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.523 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 0.1 OUTLIER -92.58 -40.72 10.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.006 . . . . 0.0 109.47 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -83.97 -23.05 31.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 109.633 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -71.14 -42.36 69.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 110.141 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . 0.93 HG13 ' H ' ' B' ' 134' ' ' VAL . 6.3 p -71.96 -66.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.112 -0.992 . . . . 0.0 110.327 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.93 ' H ' HG13 ' B' ' 133' ' ' VAL . 33.1 m -43.32 -19.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.949 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' B' ' 133' ' ' VAL . . . -59.55 -28.11 66.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.267 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.85 -30.85 58.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.41 -36.31 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -1.156 . . . . 0.0 109.451 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.42 -40.11 89.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 0.91 HD21 HD21 ' D' ' 139' ' ' ASN . 53.7 t30 -75.88 -25.98 56.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.67 -48.98 74.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.2 -4.24 28.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.393 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' B' ' 145' ' ' TYR . . . -102.36 -39.51 7.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 0.0 109.545 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -45.32 -40.26 7.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 109.784 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.26 27.33 1.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.113 -0.992 . . . . 0.0 109.559 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.576 ' O ' ' CG ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -140.43 1.27 1.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.515 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.461 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.499 ' CG1' ' OG ' ' C' ' 131' ' ' SER . 97.6 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp 58.91 163.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 174.82 -44.9 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 110.005 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' C' ' 3' ' ' SER . 52.9 Cg_exo -53.55 172.86 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.702 2.268 . . . . 0.0 113.14 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -47.02 -14.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.637 -0.664 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' C' ' 4' ' ' PRO . 3.0 p30 -38.68 -22.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.391 -0.818 . . . . 0.0 110.146 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' C' ' 5' ' ' ALA . 37.9 mttt -80.51 -56.77 3.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.109 -0.994 . . . . 0.0 109.378 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 54.5 m -46.82 -28.62 1.61 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.349 -0.844 . . . . 0.0 109.504 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -78.42 -38.07 42.29 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.448 HG21 ' CD2' ' C' ' 128' ' ' PHE . 25.4 t -71.58 -49.16 48.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -51.15 -44.16 61.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 108.621 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.22 -61.13 2.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.458 -0.776 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.09 -35.33 69.27 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.41 -0.806 . . . . 0.0 109.333 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -77.09 -17.12 58.93 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.188 -0.945 . . . . 0.0 108.877 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.49 -38.41 44.54 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -84.37 -35.21 23.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.294 -1.121 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.559 HG12 ' HB2' ' C' ' 21' ' ' ALA . 42.6 t -73.58 -36.94 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.813 . . . . 0.0 109.684 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' C' ' 19' ' ' ALA . . . -30.63 143.72 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' C' ' 18' ' ' GLY . . . 71.09 -31.92 0.24 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.409 -1.053 . . . . 0.0 109.121 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' C' ' 18' ' ' GLY . 49.7 m-70 -107.92 17.2 22.72 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.559 ' HB2' HG12 ' C' ' 17' ' ' VAL . . . -85.63 -35.98 20.63 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.847 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.38 -14.44 64.34 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -87.87 -56.13 3.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.3 -1.118 . . . . 0.0 109.97 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 1.4 m-30 -58.52 -35.33 72.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.374 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.65 -23.02 64.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.42 -49.91 8.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.225 -1.162 . . . . 0.0 109.759 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.53 -19.85 17.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.659 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.75 -21.31 61.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 109.542 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.545 HD11 ' ND1' ' C' ' 58' ' ' HIS . 11.1 mt -82.53 -54.3 5.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.877 . . . . 0.0 109.653 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -33.95 77.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.564 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.508 ' CG ' HH11 ' C' ' 31' ' ' ARG . 0.5 OUTLIER -66.48 -38.55 87.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.647 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' C' ' 32' ' ' MET . 15.1 tmm? -75.09 -32.0 61.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 109.32 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -54.11 -49.87 68.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.843 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' C' ' 36' ' ' PHE . 1.3 pp -81.3 -43.71 18.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.165 -0.96 . . . . 0.0 110.024 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -62.92 4.47 0.17 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 0.0 109.582 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.53 ' CE2' ' OG1' ' C' ' 38' ' ' THR . 2.5 t80 -162.74 93.75 1.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.16 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -79.81 -23.29 6.96 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.496 2.131 . . . . 0.0 112.405 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.53 ' OG1' ' CE2' ' C' ' 36' ' ' PHE . 9.1 p -54.77 -28.49 49.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.0 109.253 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 8.6 p -90.12 -22.65 21.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 109.515 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -46.23 -31.13 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.576 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 1.257 HG21 ' CG ' ' B' ' 97' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.552 ' C ' ' ND1' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 120.572 0.225 . . . . 0.0 111.174 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.07 35.09 2.57 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.83 -1.169 . . . . 0.0 109.924 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' C' ' 49' ' ' SER . 14.4 m-20 52.97 91.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.1 -1.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.39 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.468 ' H ' ' C ' ' C' ' 47' ' ' ASP . 92.4 p -54.38 126.81 24.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -57.29 136.03 56.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.47 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.79 15.41 70.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 4.4 t -64.08 -14.46 54.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.164 . . . . 0.0 109.468 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 70.82 -18.86 0.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.833 . . . . 0.0 109.659 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' C' ' 52' ' ' SER . 32.9 mt-30 -85.69 -18.11 34.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.08 -1.012 . . . . 0.0 109.367 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.65 -36.01 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -76.04 -33.51 59.62 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.257 -0.902 . . . . 0.0 108.895 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.66 -25.17 74.04 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.545 ' ND1' HD11 ' C' ' 29' ' ' LEU . 6.3 t-80 -71.46 -43.26 66.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -1.151 . . . . 0.0 109.417 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -49.5 -48.1 35.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 86.5 mttt -52.79 -22.51 5.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -1.002 . . . . 0.0 109.965 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -40.91 60.66 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.158 -0.964 . . . . 0.0 108.772 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.48 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -73.04 -47.24 48.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.521 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -65.86 -32.6 74.21 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.442 -0.786 . . . . 0.0 109.152 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 26.4 t0 -71.88 -32.46 67.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.045 . . . . 0.0 108.61 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -68.22 -52.47 33.74 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.06 -41.36 59.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 108.926 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.433 ' O ' ' N ' ' C' ' 71' ' ' ALA . 16.3 m -68.27 -57.82 5.37 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.947 . . . . 0.0 108.739 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -59.81 -23.79 63.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 108.701 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.11 -46.92 10.68 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.53 -22.93 27.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -67.71 -36.18 80.15 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' C' ' 74' ' ' ASP . 84.9 m-70 -102.79 -65.5 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.558 HG12 ' O ' ' C' ' 72' ' ' HIS . 12.6 p 44.8 14.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.791 0.805 . . . . 0.0 109.39 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' C' ' 72' ' ' HIS . 71.2 m-20 -137.12 11.93 3.06 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.415 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 0.3 OUTLIER 172.22 31.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.153 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 8.2 ptt? -78.32 -22.82 0.4 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 111.987 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.6 Cg_exo -53.24 -22.47 20.16 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.556 1.504 . . . . 0.0 112.361 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -92.95 -40.44 10.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.483 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.11 83.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.9 . . . . 0.0 109.137 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 28.9 mt -83.79 9.34 12.13 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 108.932 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -58.27 -50.52 73.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.575 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' C' ' 83' ' ' LEU . . . -50.04 -58.57 5.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.569 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.418 HD23 ' N ' ' C' ' 83' ' ' LEU . 4.5 mt -46.07 -46.15 16.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 5.8 p -64.94 -32.11 73.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.535 -0.728 . . . . 0.0 109.391 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' C' ' 82' ' ' ALA . 31.9 t70 -75.43 -23.85 57.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tt -83.01 -34.25 26.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.858 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -91.97 -21.97 20.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -69.32 -84.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.713 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -78.45 -70.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.893 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' C' ' 92' ' ' ARG . 25.5 ttmt -46.3 137.99 5.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 110.013 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.1 mt 66.23 -20.41 0.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.711 -0.618 . . . . 0.0 109.759 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . 0.592 ' H ' ' C ' ' C' ' 90' ' ' LYS . 65.3 mtt180 38.8 27.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.539 -0.726 . . . . 0.0 109.676 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.576 ' CG2' ' ND2' ' C' ' 97' ' ' ASN . 7.5 p -45.47 141.2 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.828 . . . . 0.0 109.681 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -74.31 149.51 86.86 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.894 . . . . 0.0 109.371 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' C' ' 97' ' ' ASN . 59.5 Cg_endo -73.61 -22.2 18.39 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.435 2.09 . . . . 0.0 112.204 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.42 HG12 ' O ' ' C' ' 96' ' ' VAL . 21.9 t -56.56 -3.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.576 ' ND2' ' CG2' ' C' ' 93' ' ' VAL . 0.7 OUTLIER -79.24 -41.92 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 109.998 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -51.29 -48.7 62.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 109.41 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -48.34 -30.57 5.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.176 -0.952 . . . . 0.0 109.434 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.47 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 18.6 mt -84.21 -62.09 1.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 109.622 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tp -49.88 -20.92 0.99 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.725 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 10.2 t -69.29 -59.14 3.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.939 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . 0.463 ' ND1' ' OD1' ' D' ' 108' ' ' ASN . 32.1 m170 -68.42 -26.61 65.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.821 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 50.9 m -63.03 -45.36 92.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.887 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.0 -55.41 33.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.987 . . . . 0.0 109.456 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' C' ' 110' ' ' ALA . 4.1 mm? -47.79 -29.18 2.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.135 -0.978 . . . . 0.0 109.591 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.36 -24.79 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 0.0 110.113 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.407 ' OG1' HD23 ' C' ' 109' ' ' LEU . 28.0 p -71.45 -63.34 1.14 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.026 -1.046 . . . . 0.0 110.352 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.57 HD23 ' H ' ' C' ' 109' ' ' LEU . 0.1 OUTLIER -64.64 -26.29 68.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.056 -1.027 . . . . 0.0 109.636 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' C' ' 106' ' ' LEU . . . -49.35 -37.43 24.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.107 -0.995 . . . . 0.0 109.707 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.18 -56.17 4.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 110.075 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -71.45 -67.51 0.52 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.821 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.615 HD13 ' C ' ' C' ' 113' ' ' LEU . 2.1 tm? -110.68 98.49 37.66 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' C' ' 113' ' ' LEU . 65.7 Cg_exo -49.18 -170.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.269 1.98 . . . . 0.0 112.304 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.654 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -72.99 -55.22 6.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 108.866 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.654 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 18.3 mt-10 118.58 -8.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.464 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 5.3 t80 77.13 33.74 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.937 -0.477 . . . . 0.0 111.139 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.4 OUTLIER -101.62 116.08 64.02 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.1 20.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.935 1.757 . . . . 0.0 112.482 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -144.81 -29.37 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.038 -1.039 . . . . 0.0 110.423 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.669 HG13 ' N ' ' C' ' 122' ' ' HIS . 10.5 p -49.39 -50.8 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.06 -1.025 . . . . 0.0 109.899 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.669 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.9 m80 -60.81 -34.76 75.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.119 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.18 -20.06 33.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.765 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.522 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.4 m -64.93 -62.08 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 110.518 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.94 -19.69 62.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.187 -0.945 . . . . 0.0 109.949 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.48 -44.52 19.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.068 -1.02 . . . . 0.0 110.109 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.413 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -89.07 -41.37 12.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.004 -1.06 . . . . 0.0 109.977 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.448 ' CD2' HG21 ' C' ' 10' ' ' VAL . 41.7 t80 -50.52 -20.91 1.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.99 -1.069 . . . . 0.0 108.899 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' C' ' 133' ' ' SER . 18.2 mt -71.42 -17.66 62.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.411 ' O ' ' OG1' ' C' ' 134' ' ' THR . . . -61.0 -31.6 71.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.499 ' OG ' ' CG1' ' C' ' 1' ' ' VAL . 4.0 t -83.59 -33.05 25.46 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.289 -0.882 . . . . 0.0 108.918 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.18 -26.66 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.0 108.922 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.594 ' N ' ' O ' ' C' ' 129' ' ' LEU . 33.0 t -84.01 -25.45 29.93 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.383 -0.823 . . . . 0.0 108.969 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 33.2 m -77.69 -38.93 46.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 109.189 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.407 HG13 ' O ' ' C' ' 131' ' ' SER . 34.8 m -73.39 -26.85 22.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.3 -0.875 . . . . 0.0 108.677 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.81 -30.03 70.6 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . 0.712 HG22 ' O ' ' C' ' 137' ' ' THR . 93.5 m -112.45 24.07 12.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.413 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 -179.983 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.976 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -92.11 155.61 17.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.442 ' H ' HG22 ' D' ' 4' ' ' THR . 0.2 OUTLIER -64.16 153.95 83.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 108.933 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.01 -15.96 36.31 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.616 2.21 . . . . 0.0 112.263 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.3 -42.77 14.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.682 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.17 -22.53 30.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.886 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.604 ' HB2' HD13 ' D' ' 3' ' ' LEU . 7.7 tttm -79.25 -40.5 30.46 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.124 -0.985 . . . . 0.0 109.245 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -61.58 -23.64 66.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 109.821 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.1 -55.43 4.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.065 -1.022 . . . . 0.0 110.144 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.26 -24.62 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.01 -1.056 . . . . 0.0 108.418 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 49.9 m -82.18 -37.14 26.56 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.752 -0.593 . . . . 0.0 109.591 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.5 96.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -0.848 . . . . 0.0 109.456 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' D' ' 17' ' ' LYS . 0.8 OUTLIER -61.81 -35.12 77.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.43 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -47.95 -21.63 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.138 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . 0.414 ' N ' ' C ' ' D' ' 14' ' ' LEU . . . -86.52 -32.52 15.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' D' ' 14' ' ' LEU . 1.0 OUTLIER -77.97 -31.46 50.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -1.123 . . . . 0.0 109.101 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -54.23 114.98 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.535 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' D' ' 21' ' ' ASP . 3.1 m120 -71.45 64.15 0.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.133 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 42.1 t -45.74 -16.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' D' ' 19' ' ' ASN . 21.4 t70 -77.32 5.67 8.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.937 . . . . 0.0 109.312 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' D' ' 19' ' ' ASN . 81.2 mt-10 -154.31 -43.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.352 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 78.7 t -55.03 -25.07 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 109.474 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.43 -42.55 93.74 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.67 -35.88 54.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -73.43 -36.52 65.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -1.138 . . . . 0.0 109.399 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.39 -53.05 61.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.179 -0.95 . . . . 0.0 109.417 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.42 -51.55 67.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.271 -0.893 . . . . 0.0 109.271 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.6 -40.77 95.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' D' ' 33' ' ' VAL . 16.6 mmt85 -58.1 -44.38 87.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' D' ' 35' ' ' TYR . 33.6 tp -46.86 -32.44 3.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 109.247 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 mt -81.24 -21.87 39.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.893 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' D' ' 30' ' ' ARG . 21.2 t -87.13 -64.2 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.417 ' H ' HG23 ' D' ' 34' ' ' VAL . 0.2 OUTLIER -60.16 -49.53 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.925 . . . . 0.0 109.841 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' D' ' 31' ' ' LEU . 0.1 OUTLIER -118.48 85.71 26.8 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.282 -0.886 . . . . 0.0 109.425 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.18 34.44 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.787 2.324 . . . . 0.0 112.356 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . 0.529 ' NE1' HG23 ' D' ' 38' ' ' THR . 1.9 p-90 -81.09 -29.79 34.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.529 HG23 ' NE1' ' D' ' 37' ' ' TRP . 65.5 p -60.58 -96.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.937 . . . . 0.0 109.325 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 49.12 45.06 23.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.478 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . 0.595 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 19.1 ptt180 -137.76 -39.24 0.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.855 . . . . 0.0 109.357 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -100.38 -25.4 14.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -74.49 6.04 4.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.14 -23.19 51.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.554 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 20.4 p -59.61 -40.43 87.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.438 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -51.49 -17.73 0.89 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.77 55.14 11.77 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -159.55 79.19 0.72 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -1.087 . . . . 0.0 109.422 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 35.9 mt -131.46 14.57 5.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.427 -0.795 . . . . 0.0 109.383 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 24.4 m -46.85 -41.75 16.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.211 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 6.1 p -146.73 148.67 34.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -41.16 -39.4 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.305 2.003 . . . . 0.0 112.333 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . 0.404 ' C ' ' N ' ' D' ' 54' ' ' VAL . 1.0 OUTLIER -67.04 -40.47 87.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.703 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.14 -19.83 0.31 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 109.523 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 52' ' ' ASP . 83.2 t -67.52 -64.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 109.681 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 10.4 mtt -86.21 -6.12 59.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.527 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.69 87.99 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -81.28 148.35 63.01 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.188 -1.183 . . . . 0.0 109.424 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.14 -51.71 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.559 2.173 . . . . 0.0 112.213 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.3 -39.32 14.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.709 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.79 -45.4 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.118 -0.989 . . . . 0.0 109.289 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -75.25 -24.76 57.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 109.294 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.51 -42.98 70.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.605 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -64.04 -24.02 67.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.709 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.58 -33.24 76.07 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . 0.509 ' NZ ' ' OD1' ' D' ' 21' ' ' ASP . 19.4 mtpt -67.28 -24.87 65.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -1.216 . . . . 0.0 109.642 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -71.95 -28.88 63.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.628 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.1 -48.76 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.655 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.3 tt -60.5 -16.91 41.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.376 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.11 -48.71 45.24 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.89 -46.61 89.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -1.181 . . . . 0.0 109.852 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' D' ' 74' ' ' GLY . 1.1 m-85 -47.25 -41.19 18.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 109.588 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 14.0 m -49.51 -44.21 46.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.459 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -67.85 -16.65 64.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.221 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' D' ' 71' ' ' PHE . . . -63.01 -26.61 69.27 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.735 ' H ' HD23 ' D' ' 75' ' ' LEU . 2.0 pt? -136.09 -18.54 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.271 -1.134 . . . . 0.0 110.176 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -82.25 1.49 36.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.997 -1.065 . . . . 0.0 109.746 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 59.8 m-70 -163.06 67.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.16 4.89 3.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.411 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.13 -37.14 79.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 14.1 t-20 -171.42 99.39 0.19 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.532 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -80.18 -57.2 3.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -47.19 -23.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 0.0 109.524 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -66.37 -54.88 20.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.8 t -75.54 -47.45 26.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -1.18 . . . . 0.0 109.384 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.556 ' N ' ' CG2' ' D' ' 84' ' ' THR . 53.4 m-85 -62.53 -1.26 0.76 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.541 -0.724 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -59.2 -35.79 74.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . 0.483 ' O ' ' N ' ' D' ' 91' ' ' LEU . 21.3 p -83.39 -47.93 10.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.432 HD12 ' CD1' ' D' ' 85' ' ' PHE . 40.9 mt -55.53 -43.0 75.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -67.36 -51.41 52.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.437 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.38 -22.55 64.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.482 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.672 ' C ' HD23 ' D' ' 91' ' ' LEU . 7.5 tt -81.36 -60.21 2.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.227 -0.921 . . . . 0.0 109.727 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.591 ' N ' HD23 ' D' ' 91' ' ' LEU . 66.5 m80 -61.64 -22.51 65.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.225 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 39.4 t -83.09 -60.61 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 110.768 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.539 ' O ' ' CE1' ' D' ' 97' ' ' HIS . 5.1 m-20 -87.18 -27.7 22.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.122 -0.986 . . . . 0.0 111.098 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.2 OUTLIER -87.71 -16.73 33.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.851 -1.156 . . . . 0.0 110.644 -178.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.501 ' C ' ' ND1' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -138.38 -39.33 0.53 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.963 -1.086 . . . . 0.0 109.831 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 1.281 ' CG ' HG21 ' A' ' 41' ' ' THR . 5.0 m80 64.83 58.81 0.94 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 109.778 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.62 132.62 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.1 -1.0 . . . . 0.0 109.363 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.39 152.5 2.2 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.399 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.02 -29.76 17.43 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.536 2.157 . . . . 0.0 112.195 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.45 53.82 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -149.31 -39.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.58 -29.77 70.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.575 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . 0.411 ' NH1' ' CB ' ' D' ' 104' ' ' ARG . 31.4 mtm105 -77.87 -20.05 53.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.599 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 13.6 mt -82.64 -50.14 9.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.9 tt -51.97 -49.1 63.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.361 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.49 -20.3 63.39 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . 0.463 ' OD1' ' ND1' ' C' ' 103' ' ' HIS . 0.2 OUTLIER -81.86 -19.45 40.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -1.195 . . . . 0.0 109.613 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 92.4 t -86.36 -52.95 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -0.984 . . . . 0.0 109.721 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . 0.504 HD23 ' C ' ' D' ' 110' ' ' LEU . 2.8 tt -45.96 -60.13 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 0.0 109.787 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 61.3 t -46.68 -33.26 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.812 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.23 -23.95 43.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' D' ' 110' ' ' LEU . 98.7 t -74.94 -21.34 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.591 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . 0.519 ' CD1' ' CZ ' ' D' ' 130' ' ' TYR . 21.4 mt -78.98 -48.7 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 109.494 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.12 -23.31 3.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.443 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.484 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 6.5 t-80 -83.72 -57.81 3.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . 0.6 ' N ' ' HD1' ' D' ' 117' ' ' HIS . 0.3 OUTLIER -72.4 -17.75 61.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 109.511 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' D' ' 114' ' ' LEU . 95.2 m-85 -141.7 56.66 1.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.28 -24.85 74.52 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.31 9.46 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -1.098 . . . . 0.0 109.577 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -142.75 8.84 1.73 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.541 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -78.67 34.15 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.471 ' OG1' HG23 ' D' ' 126' ' ' VAL . 69.6 p -48.59 148.46 3.54 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.206 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.507 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.5 Cg_exo -44.15 -55.76 2.94 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.565 2.177 . . . . 0.0 112.97 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 12.6 Cg_endo -56.21 -23.35 44.85 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.249 1.966 . . . . 0.0 112.208 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.471 HG23 ' OG1' ' D' ' 123' ' ' THR . 75.5 t -82.8 -23.3 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.569 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -83.28 -59.6 2.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.73 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.2 -36.87 14.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.62 -5.11 56.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 0.0 110.042 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.519 ' CZ ' ' CD1' ' D' ' 114' ' ' LEU . 0.1 OUTLIER -92.65 -40.74 10.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.025 -1.047 . . . . 0.0 109.474 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -84.0 -22.99 31.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.685 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -71.11 -42.4 69.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.113 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . 0.965 HG13 ' H ' ' D' ' 134' ' ' VAL . 6.4 p -71.97 -66.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -0.983 . . . . 0.0 110.349 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.965 ' H ' HG13 ' D' ' 133' ' ' VAL . 33.1 m -43.43 -19.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 0.0 109.941 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' D' ' 133' ' ' VAL . . . -59.62 -27.97 66.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.384 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.9 -30.94 58.66 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.31 -36.39 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -1.139 . . . . 0.0 109.418 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.37 -40.17 89.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . 0.91 HD21 HD21 ' B' ' 139' ' ' ASN . 53.7 t30 -75.88 -25.97 56.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.439 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.64 -49.04 74.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.419 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.16 -4.29 28.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.127 -0.983 . . . . 0.0 109.36 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' D' ' 145' ' ' TYR . . . -102.37 -39.42 7.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.417 -0.802 . . . . 0.0 109.515 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -45.39 -40.25 7.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 109.733 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.406 ' HB2' ' HZ2' ' D' ' 144' ' ' LYS . 0.0 OUTLIER -87.26 27.29 1.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.564 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . 0.57 ' O ' ' CG ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -140.46 1.21 1.74 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.408 ' HB3' ' CB ' ' B' ' 135' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 2' ' ' LEU . 10.8 mp 53.21 176.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.158 -0.963 . . . . 0.0 109.553 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.51 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 174.59 -47.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 110.066 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' ASP . 71.1 Cg_exo -47.24 169.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.571 2.18 . . . . 0.0 112.744 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -45.35 -15.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.407 -0.808 . . . . 0.0 110.123 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' PRO . 25.0 t70 -38.78 -40.49 0.62 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 109.928 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 7' ' ' LYS . 13.5 ptpt -67.97 -45.74 73.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.131 -0.981 . . . . 0.0 109.224 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 5' ' ' ALA . 36.0 m -52.98 -31.1 38.82 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 108.782 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -78.07 -36.06 48.73 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 128' ' ' PHE . 91.2 t -69.74 -49.05 61.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.79 -47.47 64.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -49.2 -60.79 2.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.613 -0.679 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -50.86 -39.06 52.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.311 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -17.26 61.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.436 -0.79 . . . . 0.0 109.217 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -81.62 -45.68 7.19 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.67 -34.8 72.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -1.162 . . . . 0.0 108.674 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 13' ' ' ALA . 70.4 t -61.97 -66.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 64.55 -143.61 47.22 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 48.37 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.584 -0.951 . . . . 0.0 109.978 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 18' ' ' GLY . 80.7 m-70 -151.81 19.53 0.7 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.42 -65.19 1.04 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.715 -0.616 . . . . 0.0 109.794 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.58 -14.77 0.24 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' ALA . 2.1 mm-40 -83.07 -56.46 3.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -1.19 . . . . 0.0 109.726 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.8 m-30 -55.95 -35.3 66.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.852 . . . . 0.0 109.13 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.11 -22.76 60.97 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.58 -38.28 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -1.168 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.73 -19.69 63.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.684 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.44 -22.41 51.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.117 -0.989 . . . . 0.0 109.708 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.42 -43.97 37.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -65.68 -12.82 56.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.2 -0.937 . . . . 0.0 109.695 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -58.98 2.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptm -62.31 -25.61 67.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.476 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 48' ' ' LEU . 1.3 t80 -58.65 -55.99 27.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 0.0 109.653 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -82.41 -42.46 18.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.126 -0.984 . . . . 0.0 110.227 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.527 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 12.6 t -59.65 -9.3 2.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.02 -1.05 . . . . 0.0 109.687 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 1.003 ' CZ ' ' NE2' ' B' ' 131' ' ' GLN . 79.3 m-85 -155.35 81.71 3.99 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.155 -0.966 . . . . 0.0 109.503 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 39' ' ' THR . 52.6 Cg_exo -52.5 -24.92 23.51 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.704 2.269 . . . . 0.0 112.273 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.485 HG22 ' HB2' ' D' ' 97' ' ' HIS . 9.0 p -46.88 -19.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 37' ' ' PRO . 51.2 p -82.89 -26.2 31.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.656 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 37' ' ' PRO . 26.6 ttpt -79.3 -53.66 6.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.181 -0.95 . . . . 0.0 109.658 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.563 -179.942 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.569 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 22.4 p80 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.489 0.661 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.543 ' O ' ' C ' ' A' ' 47' ' ' ASP . 3.9 t80 -104.38 31.57 4.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.561 -0.712 . . . . 0.0 109.736 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 46' ' ' PHE . 15.0 m-20 28.63 67.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.884 -0.51 . . . . 0.0 110.533 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.528 ' O ' ' CE2' ' A' ' 33' ' ' PHE . 87.3 mt -85.16 22.33 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.428 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 50' ' ' HIS . 19.3 m -76.65 26.67 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.358 -0.839 . . . . 0.0 109.418 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.456 ' H ' ' C ' ' A' ' 48' ' ' LEU . 54.6 t60 58.08 158.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 0.0 109.57 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.65 17.92 5.02 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.553 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 9.1 t -80.25 -17.76 51.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -1.111 . . . . 0.0 109.512 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 68.6 -58.52 0.48 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 109.798 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 52' ' ' SER . 0.6 OUTLIER -43.76 -20.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.775 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 53' ' ' ALA . 89.8 t -77.55 -27.17 15.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.136 -0.977 . . . . 0.0 109.28 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.9 ptmt -63.7 -27.2 69.05 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.266 -0.896 . . . . 0.0 109.327 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.84 -27.62 68.81 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -84.17 -30.65 25.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -1.17 . . . . 0.0 110.096 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.01 -49.47 55.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -60.1 -23.64 63.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -1.106 . . . . 0.0 110.082 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -34.04 65.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.087 -1.008 . . . . 0.0 109.135 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.29 -52.92 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.41 -0.806 . . . . 0.0 108.944 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.96 -28.44 69.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.297 -0.877 . . . . 0.0 109.166 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.26 -41.42 81.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.199 -0.938 . . . . 0.0 108.89 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.54 80.44 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 66' ' ' LEU . 9.8 mt -63.34 -46.17 87.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -63.24 -48.77 76.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.256 -0.902 . . . . 0.0 108.976 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.42 HD21 ' HB1' ' A' ' 79' ' ' ALA . 1.8 t30 -62.66 -22.56 66.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 108.835 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.21 -47.68 9.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -66.84 -22.56 29.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.98 -14.68 62.44 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.676 ' O ' HG12 ' A' ' 73' ' ' VAL . 21.5 m80 -141.87 -57.44 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.808 . . . . 0.0 109.648 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 72' ' ' HIS . 8.2 p 46.14 15.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 122.1 0.953 . . . . 0.0 108.76 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 72' ' ' HIS . 22.0 m-20 -136.36 12.41 3.26 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.9 30.39 0.06 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.554 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 1.2 mtm -66.54 -44.82 56.88 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.611 -0.681 . . . . 0.0 110.073 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 76' ' ' MET . 95.7 Cg_exo -42.12 -43.02 7.39 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.356 2.038 . . . . 0.0 112.727 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.23 -19.01 21.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 109.97 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.42 ' HB1' HD21 ' A' ' 68' ' ' ASN . . . -78.12 -58.44 3.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 109.165 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.5 mt -83.14 16.9 2.19 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -21.98 64.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.473 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -74.8 -57.97 3.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.538 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 83' ' ' LEU . 3.1 mt -44.75 -39.66 5.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' ALA . 26.5 t -54.48 -34.45 61.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 82' ' ' ALA . 4.0 m-20 -66.02 -24.39 66.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.144 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.46 ' CD1' ' NZ ' ' A' ' 90' ' ' LYS . 7.3 tp -80.45 -38.6 29.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.882 . . . . 0.0 109.176 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -92.28 -21.65 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.688 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 84' ' ' SER . . . -76.43 -39.02 54.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.244 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' LYS . 50.3 t-80 -146.58 -83.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 110.167 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.46 ' NZ ' ' CD1' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -43.88 105.98 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tp 63.61 59.14 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 109.293 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.657 HH12 ' HE1' ' D' ' 42' ' ' PHE . 10.6 ptp180 -60.64 -22.71 64.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.902 HG22 ' H ' ' A' ' 94' ' ' ASP . 12.8 p 42.1 -176.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.671 -0.643 . . . . 0.0 110.122 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.902 ' H ' HG22 ' A' ' 93' ' ' VAL . 50.7 m-20 -80.88 120.7 79.61 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.961 -1.087 . . . . 0.0 109.488 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.566 ' C ' ' H ' ' A' ' 97' ' ' ASN . 73.5 Cg_endo -78.67 -37.78 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.282 1.988 . . . . 0.0 112.183 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.479 HG21 ' OD1' ' D' ' 99' ' ' ASP . 6.2 t -55.38 -0.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.703 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.566 ' H ' ' C ' ' A' ' 95' ' ' PRO . 4.8 m120 -79.03 -24.77 43.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.695 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 95' ' ' PRO . 26.8 m-85 -49.3 -17.59 0.27 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.419 ' N ' ' C ' ' A' ' 97' ' ' ASN . 92.0 mttt -81.99 -28.23 32.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.888 . . . . 0.0 109.44 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 13.5 mt -84.11 -39.02 20.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.628 HD23 ' O ' ' A' ' 101' ' ' LEU . 2.0 tt -57.95 -40.12 79.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.379 -0.825 . . . . 0.0 109.456 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -66.14 -59.25 3.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.781 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -62.22 -26.57 68.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.736 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 57.9 m -74.06 -34.84 64.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.961 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.916 ' O ' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -84.25 -34.66 23.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.04 -1.037 . . . . 0.0 109.11 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.02 -44.02 97.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.421 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.58 -24.87 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.869 . . . . 0.0 109.213 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.5 m -64.62 -59.33 4.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 113' ' ' LEU . 59.0 mt -46.12 -37.9 7.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.86 -37.96 6.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.798 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.15 -55.91 4.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.812 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -74.81 -66.59 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 109.899 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -108.9 98.44 29.79 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 88.7 Cg_exo -44.08 179.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.404 2.069 . . . . 0.0 113.095 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.441 ' HB2' ' NE2' ' A' ' 122' ' ' HIS . . . -86.94 -34.64 19.27 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.599 0.714 . . . . 0.0 109.613 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 72.9 -0.51 3.34 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 1.492 ' CZ ' ' NE2' ' B' ' 116' ' ' HIS . 26.3 m-85 61.07 41.82 13.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.897 -0.502 . . . . 0.0 111.641 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.732 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -95.07 114.31 63.41 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.762 -1.211 . . . . 0.0 107.887 178.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.834 ' HA ' HG13 ' B' ' 33' ' ' VAL . 51.5 Cg_exo -49.77 18.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.087 1.858 . . . . 0.0 112.715 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -142.13 -23.39 0.69 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.048 -1.032 . . . . 0.0 110.579 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.763 HG13 ' N ' ' A' ' 122' ' ' HIS . 13.3 p -59.25 -58.04 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.027 -1.046 . . . . 0.0 110.179 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.763 ' N ' HG13 ' A' ' 121' ' ' VAL . 1.7 m-70 -71.29 -32.02 68.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 108.934 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' B' ' 33' ' ' VAL . . . -74.38 -20.41 60.08 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.435 -0.791 . . . . 0.0 108.939 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 128' ' ' PHE . 3.1 m -73.42 -63.42 1.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 110.038 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.706 HD13 HD11 ' A' ' 105' ' ' LEU . 10.5 mt -63.44 -28.17 69.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.85 -1.156 . . . . 0.0 109.382 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.752 ' OD1' ' CD2' ' B' ' 35' ' ' TYR . 8.7 t0 -69.67 -47.91 61.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.117 -0.99 . . . . 0.0 109.473 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.44 -40.83 11.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.099 -1.001 . . . . 0.0 109.931 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.515 ' CD1' HG21 ' A' ' 10' ' ' VAL . 72.7 t80 -48.45 -20.91 0.47 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.994 -1.066 . . . . 0.0 109.098 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 133' ' ' SER . 12.1 mt -71.43 -26.27 62.67 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -55.07 -30.57 59.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.1 t -81.17 -33.43 33.09 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.485 HG22 ' SD ' ' A' ' 76' ' ' MET . 55.2 t -85.1 -28.62 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.31 -0.869 . . . . 0.0 108.828 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 129' ' ' LEU . 18.3 p -80.52 -23.27 40.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.398 -0.814 . . . . 0.0 109.096 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.3 m -75.35 -39.88 58.86 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.31 -0.869 . . . . 0.0 109.163 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.67 -29.72 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.187 -0.945 . . . . 0.0 108.794 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -33.96 77.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.384 -0.823 . . . . 0.0 108.927 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 62.8 m -96.12 -21.46 17.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 109.517 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.497 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -146.36 169.13 19.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 109.232 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.4 p -67.26 152.01 96.56 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.92 -27.5 25.6 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.533 2.155 . . . . 0.0 112.033 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -57.7 -45.24 85.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.233 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.31 -49.23 15.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -0.887 . . . . 0.0 109.374 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.5 OUTLIER -50.52 -54.18 24.34 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.28 -0.887 . . . . 0.0 109.531 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -43.52 -24.14 0.1 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.745 -0.597 . . . . 0.0 110.267 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.3 -56.57 3.69 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.016 -1.052 . . . . 0.0 109.725 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.499 HG23 ' CD2' ' B' ' 130' ' ' TYR . 1.5 p -69.8 -24.61 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 16.5 m -72.19 -47.42 50.82 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.539 0.685 . . . . 0.0 109.431 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.13 -31.89 70.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.371 -0.831 . . . . 0.0 109.589 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.409 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -49.08 -33.2 11.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.112 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -23.78 1.34 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.82 -61.79 3.9 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.488 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -58.33 -30.07 66.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -1.126 . . . . 0.0 109.224 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 14' ' ' LEU . 49.2 t -54.11 114.71 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.558 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' B' ' 20' ' ' VAL . 45.0 m-80 -83.7 70.63 10.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 108.942 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' B' ' 19' ' ' ASN . 73.8 t -43.65 -26.6 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.425 -0.797 . . . . 0.0 109.658 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' B' ' 19' ' ' ASN . 1.2 p30 -58.41 -5.67 0.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.63 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' B' ' 20' ' ' VAL . 54.3 mt-10 -154.92 -42.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.533 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 81.5 t -49.68 -24.49 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.46 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.11 -55.53 3.49 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.78 -31.06 66.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.78 -26.67 57.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -1.162 . . . . 0.0 109.44 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.92 -52.58 64.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.366 -0.834 . . . . 0.0 109.625 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.544 HD22 ' N ' ' B' ' 28' ' ' LEU . 3.7 mm? -64.49 -56.81 11.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.977 . . . . 0.0 109.394 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.26 -48.8 46.45 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.975 ' NH2' ' CD1' ' A' ' 117' ' ' PHE . 28.2 mmt180 -56.54 -47.71 78.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -1.152 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.26 -34.76 15.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 39.9 mt -80.69 -21.55 41.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.834 HG13 ' HA ' ' A' ' 119' ' ' PRO . 88.2 t -86.97 -64.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 0.0 109.726 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.648 HG13 ' HB3' ' A' ' 122' ' ' HIS . 2.8 t -52.04 -45.21 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 110.003 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.752 ' CD2' ' OD1' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -160.35 102.64 1.37 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.1 -1.0 . . . . 0.0 109.591 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.14 69.8 6.9 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.526 2.15 . . . . 0.0 112.149 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' B' ' 37' ' ' TRP . 0.0 OUTLIER -79.6 -19.53 49.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.399 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' B' ' 39' ' ' GLN . 28.4 p -48.05 -69.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.945 . . . . 0.0 109.621 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . 0.497 ' N ' ' OG1' ' B' ' 38' ' ' THR . 19.6 tt0 51.36 46.17 26.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.254 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -153.22 -58.67 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -84.7 8.34 17.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.487 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.616 ' HE1' HH12 ' C' ' 92' ' ' ARG . 29.0 p90 -58.07 -35.42 71.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -80.4 -21.63 42.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 109.382 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 16.5 m -58.5 -50.24 74.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.98 -8.83 1.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.517 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.02 -94.51 0.15 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -45.2 122.46 3.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.331 -1.1 . . . . 0.0 109.747 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -153.5 15.15 0.51 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.24 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.0 t -46.77 -39.07 11.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.625 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 8.1 p -144.63 152.24 52.3 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.492 -0.755 . . . . 0.0 108.965 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -44.92 -45.12 14.26 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.064 1.843 . . . . 0.0 112.143 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 53' ' ' ALA . 1.7 p30 -59.07 -39.79 83.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.527 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' B' ' 52' ' ' ASP . . . -52.25 -19.82 2.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.11 -63.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.492 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 39.6 mtm -73.63 9.77 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.511 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.21 -13.79 63.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -90.79 148.59 38.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.174 -1.192 . . . . 0.0 109.355 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.19 -19.6 17.29 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.619 2.213 . . . . 0.0 112.098 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.75 -28.25 33.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.632 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -78.36 -40.34 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.681 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -79.08 -28.54 43.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.1 -48.71 19.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.694 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . 0.449 ' O ' ' ND1' ' B' ' 63' ' ' HIS . 3.1 t-80 -48.21 -23.87 1.0 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.41 -54.91 13.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -46.78 -34.62 5.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -1.154 . . . . 0.0 109.609 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -75.81 -37.62 58.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.318 -0.864 . . . . 0.0 109.669 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 33.6 t -71.73 -46.6 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.79 -32.56 67.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 109.253 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.81 -53.7 42.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.61 -48.85 66.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.397 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.49 -36.17 73.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.316 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 29.8 p -80.09 -24.23 40.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.479 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -51.87 -42.49 62.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.411 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.06 -60.25 8.3 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.553 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -58.26 -30.76 66.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.248 -1.148 . . . . 0.0 109.32 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.78 -3.01 58.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.595 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.452 ' C ' ' H ' ' B' ' 79' ' ' ASP . 10.3 t-80 -168.0 61.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.629 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mt -73.37 14.38 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.141 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.46 ' O ' ' ND2' ' B' ' 80' ' ' ASN . 30.1 t70 -69.07 -32.19 71.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.496 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' B' ' 79' ' ' ASP . 9.8 m120 -163.23 104.2 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 109.461 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 37.6 mt -80.28 -58.8 2.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.378 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -48.6 -24.23 1.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.415 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.03 -62.15 3.46 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.7 t -62.82 -47.18 84.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -1.223 . . . . 0.0 109.437 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.5 m-85 -66.84 0.91 2.13 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.491 -0.756 . . . . 0.0 109.447 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.86 -47.36 86.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.405 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 4.9 p -72.68 -53.6 11.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.376 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 24.7 mt -49.87 -46.49 51.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 85.9 p -56.37 -46.67 79.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.347 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.73 -40.6 95.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.301 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.31 -44.58 87.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.374 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' B' ' 97' ' ' HIS . 76.0 m80 -73.38 -24.25 60.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 110.247 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.72 -60.91 1.97 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.028 -1.045 . . . . 0.0 111.24 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.1 -57.1 3.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.861 -1.15 . . . . 0.0 111.671 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . 0.499 ' O ' HD12 ' B' ' 96' ' ' LEU . 55.9 mmtt -66.15 -9.92 36.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 111.515 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.563 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 1.0 OUTLIER -143.11 -33.89 0.44 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.741 -1.224 . . . . 0.0 109.987 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 33.2 p-80 43.62 25.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' B' ' 96' ' ' LEU . 24.9 t -53.73 138.96 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.089 -1.007 . . . . 0.0 109.104 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 0.438 ' OD1' HG21 ' C' ' 96' ' ' VAL . 7.4 m-20 -46.43 149.43 1.38 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.443 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.19 -17.47 45.17 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.575 2.184 . . . . 0.0 112.217 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -89.76 47.05 1.42 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' B' ' 99' ' ' ASP . 2.9 m120 -137.29 -3.44 1.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -0.886 . . . . 0.0 109.794 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -97.68 -60.46 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.432 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -50.92 -19.97 1.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.691 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.597 HD12 ' N ' ' B' ' 105' ' ' LEU . 7.9 mp -77.9 -52.84 8.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.621 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.404 HD23 ' C ' ' B' ' 106' ' ' LEU . 5.0 tt -54.6 -52.17 63.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 109.341 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.56 -22.02 7.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -85.65 -53.69 5.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -1.184 . . . . 0.0 109.69 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 91.9 t -46.66 -30.28 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.808 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 113' ' ' VAL . 5.2 tp -62.07 -55.32 30.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.597 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' B' ' 130' ' ' TYR . 90.3 t -46.75 -26.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 109.784 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 34.6 t -74.75 -26.22 59.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 109.643 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' B' ' 110' ' ' LEU . 39.3 t -83.45 -25.32 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.022 . . . . 0.0 109.525 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.6 -25.6 33.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.467 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -75.69 -19.58 59.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.705 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 1.492 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.3 OUTLIER -83.42 -52.48 6.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.165 -0.96 . . . . 0.0 109.458 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.487 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 61.0 m170 -73.32 -17.62 61.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.452 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.487 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 11.1 m-85 -149.41 55.78 0.98 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.857 . . . . 0.0 109.39 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -61.6 -14.78 44.46 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.62 -20.94 27.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -1.122 . . . . 0.0 109.512 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.4 mm-40 -83.85 -7.37 59.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -73.54 33.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.572 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.481 ' H ' ' C ' ' B' ' 121' ' ' GLU . 77.8 p -47.51 148.38 2.47 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 0.0 109.374 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.471 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.4 Cg_exo -44.64 -56.13 2.83 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.505 2.137 . . . . 0.0 112.941 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 19.8 Cg_endo -60.5 -35.28 91.03 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.162 1.908 . . . . 0.0 112.104 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.469 HG23 ' OG1' ' B' ' 123' ' ' THR . 78.2 t -72.02 -17.34 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 109.581 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -83.42 -59.75 2.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 109.75 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.626 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -53.74 -33.38 55.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.58 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.44 27.5 0.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.499 ' CD2' HG23 ' B' ' 11' ' ' VAL . 4.2 t80 -125.09 -38.27 2.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.317 -0.864 . . . . 0.0 109.606 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 1.003 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 46.0 tt0 -67.56 -23.94 65.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.898 . . . . 0.0 109.822 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -84.5 -36.42 22.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 109.716 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.68 -49.34 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.968 . . . . 0.0 109.786 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.444 ' H ' HG22 ' B' ' 134' ' ' VAL . 4.5 m -79.5 -23.82 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.895 . . . . 0.0 109.768 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.4 -27.94 11.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 109.456 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.16 -23.05 61.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.3 t -79.07 -27.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.46 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.98 -42.8 56.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 0.532 ' OD1' ' OD1' ' D' ' 139' ' ' ASN . 37.8 t30 -76.83 -21.22 55.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.57 -60.34 2.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 17.1 mt -55.21 -22.33 17.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.459 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.25 -17.99 24.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.882 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -46.3 -46.55 18.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' B' ' 146' ' ' HIS . 5.7 tppt? -77.08 -57.56 3.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.472 ' CD1' ' C ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -51.53 -10.61 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.533 -0.729 . . . . 0.0 109.23 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.468 ' H ' ' C ' ' B' ' 144' ' ' LYS . 11.6 m-70 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.735 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' C' ' 2' ' ' LEU . 1.3 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.507 HD12 ' N ' ' C' ' 2' ' ' LEU . 10.8 mp 53.17 176.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 109.541 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.513 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 174.56 -47.79 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 0.0 109.976 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' C' ' 6' ' ' ASP . 71.8 Cg_exo -47.16 169.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.549 2.166 . . . . 0.0 112.759 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.47 -15.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.43 -0.794 . . . . 0.0 110.126 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' C' ' 4' ' ' PRO . 25.1 t70 -38.8 -40.53 0.63 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 109.888 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.453 ' H ' ' HG2' ' C' ' 7' ' ' LYS . 13.5 ptpt -67.93 -45.68 73.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.113 -0.992 . . . . 0.0 109.299 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.418 ' N ' ' O ' ' C' ' 5' ' ' ALA . 37.4 m -52.99 -31.06 38.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -78.08 -35.98 48.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.521 HG21 ' CD1' ' C' ' 128' ' ' PHE . 92.0 t -69.67 -49.1 61.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.82 -47.45 64.31 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.17 -60.77 2.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.585 -0.697 . . . . 0.0 109.569 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.746 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -50.94 -38.96 53.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.322 -0.861 . . . . 0.0 109.319 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -17.31 61.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.207 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.57 -45.68 7.22 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.63 -34.92 72.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -1.165 . . . . 0.0 108.696 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.746 HG23 ' O ' ' C' ' 13' ' ' ALA . 70.2 t -61.94 -66.91 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 64.51 -143.62 47.26 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.42 48.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.443 -1.034 . . . . 0.0 110.0 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' C' ' 18' ' ' GLY . 80.7 m-70 -151.73 19.64 0.7 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.45 -65.24 1.03 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.66 -0.65 . . . . 0.0 109.769 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.65 -14.58 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' C' ' 21' ' ' ALA . 2.1 mm-40 -83.19 -56.46 3.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -1.168 . . . . 0.0 109.673 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.8 m-30 -55.95 -35.29 66.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.41 -0.806 . . . . 0.0 109.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.06 -22.83 60.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.52 -38.32 29.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -1.118 . . . . 0.0 109.795 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.61 -19.71 63.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.72 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.52 -22.39 51.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 109.683 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.5 mt -76.38 -43.99 38.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 109.706 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -65.7 -12.81 56.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.699 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -59.01 2.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptm -62.26 -25.67 67.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . 0.525 ' CE2' ' O ' ' C' ' 48' ' ' LEU . 1.3 t80 -58.56 -56.09 26.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 109.621 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.63 ' CD1' ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -82.34 -42.51 18.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 110.234 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 12.6 t -59.69 -9.21 2.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.01 . . . . 0.0 109.659 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 1.01 ' CZ ' ' NE2' ' D' ' 131' ' ' GLN . 79.5 m-85 -155.33 81.66 4.01 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.582 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' C' ' 39' ' ' THR . 52.6 Cg_exo -52.48 -24.96 23.56 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.689 2.259 . . . . 0.0 112.245 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.496 HG22 ' HB2' ' B' ' 97' ' ' HIS . 8.7 p -46.78 -19.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.877 . . . . 0.0 109.517 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.445 ' N ' ' O ' ' C' ' 37' ' ' PRO . 51.5 p -82.89 -26.15 31.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 109.676 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' C' ' 37' ' ' PRO . 26.6 ttpt -79.37 -53.62 6.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.653 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.907 . . . . 0.0 109.576 -179.929 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.571 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 22.0 p80 . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 121.495 0.664 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.544 ' O ' ' C ' ' C' ' 47' ' ' ASP . 3.9 t80 -104.31 31.46 4.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.756 . . . . 0.0 109.705 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' C' ' 46' ' ' PHE . 15.1 m-20 28.69 67.71 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.817 -0.552 . . . . 0.0 110.524 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.525 ' O ' ' CE2' ' C' ' 33' ' ' PHE . 87.2 mt -85.15 22.25 1.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.978 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.434 ' O ' ' O ' ' C' ' 50' ' ' HIS . 19.3 m -76.61 26.6 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' C' ' 48' ' ' LEU . 54.9 t60 58.07 158.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.842 . . . . 0.0 109.557 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.72 17.91 5.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 9.0 t -80.33 -17.73 51.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -1.152 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 68.62 -58.54 0.48 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.688 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' C' ' 52' ' ' SER . 0.7 OUTLIER -43.74 -20.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.401 -0.812 . . . . 0.0 109.818 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' C' ' 53' ' ' ALA . 89.1 t -77.41 -27.33 15.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.277 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' C' ' 53' ' ' ALA . 5.9 ptmt -63.6 -27.18 69.06 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.293 -0.879 . . . . 0.0 109.395 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.86 -27.63 68.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -84.15 -30.66 25.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -1.17 . . . . 0.0 110.103 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.06 -49.41 55.73 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -60.1 -23.66 64.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -1.146 . . . . 0.0 110.068 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.32 -33.96 65.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.192 -0.942 . . . . 0.0 109.146 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.41 -52.83 21.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.434 -0.791 . . . . 0.0 108.991 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.47 69.86 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.324 -0.86 . . . . 0.0 109.186 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -68.3 -41.38 81.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 108.848 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.07 -42.47 80.38 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' C' ' 66' ' ' LEU . 9.9 mt -63.4 -46.2 87.5 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -63.24 -48.68 77.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.206 -0.934 . . . . 0.0 109.029 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.403 HD21 ' HB1' ' C' ' 79' ' ' ALA . 1.8 t30 -62.72 -22.55 66.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 108.829 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -85.22 -47.69 9.85 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.83 -22.69 29.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -14.57 62.42 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.669 ' O ' HG12 ' C' ' 73' ' ' VAL . 21.5 m80 -141.92 -57.45 0.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.796 . . . . 0.0 109.65 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.669 HG12 ' O ' ' C' ' 72' ' ' HIS . 8.2 p 46.16 15.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 122.067 0.937 . . . . 0.0 108.718 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' C' ' 72' ' ' HIS . 21.9 m-20 -136.39 12.53 3.25 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.96 30.52 0.06 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.557 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 1.2 mtm -66.63 -44.69 55.38 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.658 -0.651 . . . . 0.0 110.098 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' C' ' 76' ' ' MET . 95.5 Cg_exo -42.24 -43.03 7.67 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.431 2.087 . . . . 0.0 112.601 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.15 -18.97 21.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.001 . . . . 0.0 110.025 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . 0.403 ' HB1' HD21 ' C' ' 68' ' ' ASN . . . -78.15 -58.5 3.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.034 -1.041 . . . . 0.0 109.081 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 18.7 mt -83.14 16.91 2.19 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' C' ' 77' ' ' PRO . 0.5 OUTLIER -61.67 -21.93 64.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.848 . . . . 0.0 109.363 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -74.79 -57.97 3.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.454 HD23 ' N ' ' C' ' 83' ' ' LEU . 3.1 mt -44.74 -39.74 5.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.524 ' O ' ' N ' ' C' ' 88' ' ' ALA . 26.5 t -54.51 -34.45 61.68 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' C' ' 82' ' ' ALA . 4.0 m-20 -66.09 -24.28 66.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.136 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.454 ' CD1' ' NZ ' ' C' ' 90' ' ' LYS . 7.3 tp -80.52 -38.52 29.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.327 -0.858 . . . . 0.0 109.203 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -92.32 -21.64 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.723 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' C' ' 84' ' ' SER . . . -76.49 -38.95 54.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' C' ' 90' ' ' LYS . 50.1 t-80 -146.6 -83.43 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.101 -0.999 . . . . 0.0 110.114 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.454 ' NZ ' ' CD1' ' C' ' 86' ' ' LEU . 0.9 OUTLIER -43.85 105.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 109.67 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tp 63.61 59.22 1.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.343 -0.848 . . . . 0.0 109.29 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . 0.616 HH12 ' HE1' ' B' ' 42' ' ' PHE . 10.6 ptp180 -60.74 -22.63 64.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.578 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.899 HG22 ' H ' ' C' ' 94' ' ' ASP . 12.7 p 42.08 -176.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.642 -0.661 . . . . 0.0 110.084 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.899 ' H ' HG22 ' C' ' 93' ' ' VAL . 50.7 m-20 -80.85 120.68 79.6 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.969 -1.082 . . . . 0.0 109.459 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' C' ' 97' ' ' ASN . 73.5 Cg_endo -78.61 -37.86 0.6 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.359 2.039 . . . . 0.0 112.124 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.438 HG21 ' OD1' ' B' ' 99' ' ' ASP . 6.2 t -55.36 -0.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.707 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.564 ' H ' ' C ' ' C' ' 95' ' ' PRO . 4.8 m120 -79.03 -24.85 43.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.065 -1.022 . . . . 0.0 109.693 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' C' ' 95' ' ' PRO . 26.9 m-85 -49.27 -17.64 0.27 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.421 ' N ' ' C ' ' C' ' 97' ' ' ASN . 91.9 mttt -81.99 -28.22 32.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.377 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 13.5 mt -84.1 -39.04 19.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.384 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . 0.633 ' O ' HD23 ' C' ' 101' ' ' LEU . 2.0 tt -57.97 -40.08 79.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -66.28 -59.18 3.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.986 . . . . 0.0 109.772 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -62.15 -26.59 68.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 109.809 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 57.8 m -74.12 -34.8 64.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.894 ' O ' HD12 ' C' ' 105' ' ' LEU . 0.0 OUTLIER -84.2 -34.67 23.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.11 -0.994 . . . . 0.0 109.182 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 20.0 mt -62.99 -44.09 96.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.455 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.47 -24.92 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 54.8 m -64.6 -59.33 4.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.564 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.408 HD11 HD11 ' C' ' 105' ' ' LEU . 59.1 mt -46.21 -37.84 7.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.601 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.8 -38.05 6.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.849 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.04 -55.95 4.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.861 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -74.82 -66.59 0.73 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 109.895 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -108.9 98.45 29.84 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.481 -0.762 . . . . 0.0 108.96 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' C' ' 113' ' ' LEU . 89.8 Cg_exo -44.02 179.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.45 2.1 . . . . 0.0 113.036 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.448 ' HB2' ' NE2' ' C' ' 122' ' ' HIS . . . -86.94 -34.76 19.23 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.594 0.711 . . . . 0.0 109.584 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 72.97 -0.53 3.35 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 1.493 ' CZ ' ' NE2' ' D' ' 116' ' ' HIS . 26.6 m-85 61.05 41.79 13.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.884 -0.51 . . . . 0.0 111.624 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.3 OUTLIER -95.01 114.22 63.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.773 -1.204 . . . . 0.0 107.922 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . 0.806 ' HA ' HG13 ' D' ' 33' ' ' VAL . 51.8 Cg_exo -49.68 18.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.224 1.949 . . . . 0.0 112.678 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -142.1 -23.41 0.69 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 110.599 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.773 HG13 ' N ' ' C' ' 122' ' ' HIS . 13.4 p -59.27 -57.99 8.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.003 -1.06 . . . . 0.0 110.206 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.773 ' N ' HG13 ' C' ' 121' ' ' VAL . 1.7 m-70 -71.23 -32.19 68.47 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 108.879 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' D' ' 33' ' ' VAL . . . -74.24 -20.5 60.14 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.398 -0.814 . . . . 0.0 108.968 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' C' ' 128' ' ' PHE . 3.1 m -73.44 -63.37 1.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.247 -0.908 . . . . 0.0 109.979 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.706 HD13 HD11 ' C' ' 105' ' ' LEU . 10.5 mt -63.55 -28.09 69.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.978 -1.077 . . . . 0.0 109.339 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . 0.744 ' OD1' ' CD2' ' D' ' 35' ' ' TYR . 8.7 t0 -69.63 -47.99 61.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.113 -0.992 . . . . 0.0 109.527 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.32 -40.82 11.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.064 -1.022 . . . . 0.0 109.938 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.521 ' CD1' HG21 ' C' ' 10' ' ' VAL . 72.8 t80 -48.64 -20.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.954 -1.091 . . . . 0.0 109.043 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' C' ' 133' ' ' SER . 12.1 mt -71.48 -26.33 62.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -55.0 -30.58 59.72 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 4.2 t -81.17 -33.36 33.13 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.449 -0.782 . . . . 0.0 108.897 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . 0.486 HG22 ' SD ' ' C' ' 76' ' ' MET . 55.5 t -85.15 -28.61 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.354 -0.841 . . . . 0.0 108.817 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.547 ' N ' ' O ' ' C' ' 129' ' ' LEU . 18.6 p -80.61 -23.17 39.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.515 -0.741 . . . . 0.0 109.009 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 29.5 m -75.34 -40.0 58.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 109.15 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.55 -29.75 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.915 . . . . 0.0 108.783 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -34.01 77.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.4 -0.812 . . . . 0.0 108.885 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 63.0 m -96.13 -21.42 17.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.508 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 -179.933 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.49 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.2 OUTLIER -146.33 169.13 19.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 109.257 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 3.4 p -67.27 152.04 96.53 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.01 -27.54 25.17 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.562 2.175 . . . . 0.0 111.947 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -57.63 -45.21 85.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.34 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.22 -49.38 15.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.349 -0.844 . . . . 0.0 109.359 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.5 OUTLIER -50.4 -54.22 23.42 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.312 -0.868 . . . . 0.0 109.582 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -43.56 -24.06 0.1 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.72 -0.612 . . . . 0.0 110.278 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.36 -56.54 3.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.061 -1.024 . . . . 0.0 109.677 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.498 HG23 ' CD2' ' D' ' 130' ' ' TYR . 1.5 p -69.84 -24.63 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 16.3 m -72.25 -47.29 51.38 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.432 0.634 . . . . 0.0 109.462 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.19 -31.91 70.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.546 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.05 -33.13 10.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.22 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -49.1 -23.86 1.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 109.427 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.69 -61.87 3.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.467 ' CD ' ' H ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -58.32 -30.02 66.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.203 -1.175 . . . . 0.0 109.259 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 49.8 t -54.14 114.67 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.887 . . . . 0.0 109.598 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' D' ' 21' ' ' ASP . 45.1 m-80 -83.74 70.6 10.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 108.89 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' D' ' 22' ' ' GLU . 73.5 t -43.46 -26.76 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.416 -0.802 . . . . 0.0 109.691 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' D' ' 19' ' ' ASN . 1.2 p30 -58.37 -5.66 0.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.644 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' D' ' 20' ' ' VAL . 54.3 mt-10 -155.0 -42.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 81.4 t -49.76 -24.44 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -0.942 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.13 -55.53 3.49 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.84 -31.06 67.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.79 -26.57 57.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -1.187 . . . . 0.0 109.444 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.11 -52.56 64.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . 0.537 HD22 ' N ' ' D' ' 28' ' ' LEU . 3.7 mm? -64.52 -56.75 12.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.128 -0.983 . . . . 0.0 109.384 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.33 -48.75 47.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . 0.961 ' NH2' ' CD1' ' C' ' 117' ' ' PHE . 28.3 mmt180 -56.61 -47.63 79.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.334 -1.097 . . . . 0.0 109.517 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.29 -34.81 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.568 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 40.1 mt -80.67 -21.52 41.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . 0.806 HG13 ' HA ' ' C' ' 119' ' ' PRO . 88.3 t -87.01 -64.07 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.915 . . . . 0.0 109.744 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' C' ' 122' ' ' HIS . 2.8 t -52.06 -45.19 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 110.007 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . 0.744 ' CD2' ' OD1' ' C' ' 126' ' ' ASP . 0.2 OUTLIER -160.42 102.53 1.36 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.105 -0.997 . . . . 0.0 109.614 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.04 69.92 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.491 2.127 . . . . 0.0 112.076 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -19.66 48.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.422 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' D' ' 39' ' ' GLN . 28.5 p -48.04 -69.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.59 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . 0.494 ' N ' ' OG1' ' D' ' 38' ' ' THR . 19.5 tt0 51.39 46.13 26.94 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.139 -0.976 . . . . 0.0 109.304 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -153.26 -58.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.355 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -84.66 8.25 17.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.657 ' HE1' HH12 ' A' ' 92' ' ' ARG . 29.1 p90 -57.97 -35.49 71.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' D' ' 42' ' ' PHE . 19.7 pt-20 -80.35 -21.64 42.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.841 . . . . 0.0 109.398 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 16.6 m -58.5 -50.26 74.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.482 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.01 -8.81 1.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.43 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.01 -94.57 0.15 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -45.11 122.47 3.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -1.108 . . . . 0.0 109.779 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -153.57 15.2 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.235 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.0 t -46.76 -39.15 11.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.603 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . 0.424 ' HG1' ' CG ' ' D' ' 52' ' ' ASP . 8.0 p -144.64 152.23 52.22 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.416 -0.802 . . . . 0.0 108.902 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -44.9 -45.13 14.18 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.072 1.848 . . . . 0.0 112.151 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . 0.424 ' CG ' ' HG1' ' D' ' 50' ' ' THR . 1.7 p30 -59.12 -39.67 83.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.606 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.414 ' N ' ' OD1' ' D' ' 52' ' ' ASP . . . -52.32 -19.82 2.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.416 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.02 -64.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 39.6 mtm -73.56 9.67 1.32 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.15 -13.75 63.51 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.76 148.47 38.47 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.18 -1.188 . . . . 0.0 109.369 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.15 -19.54 17.43 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.58 2.187 . . . . 0.0 112.154 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.76 -28.28 33.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.654 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.31 -40.32 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 0.0 109.697 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -79.13 -28.55 42.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.649 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.11 -48.73 19.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.735 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . 0.426 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 3.1 t-80 -48.13 -23.88 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.691 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.44 -54.98 13.47 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -46.69 -34.65 5.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -1.132 . . . . 0.0 109.582 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -75.9 -37.64 58.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.351 -0.843 . . . . 0.0 109.558 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 34.1 t -71.73 -46.63 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.411 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.75 -32.56 67.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 0.0 109.279 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.81 -53.65 42.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.68 -48.79 66.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 109.364 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.63 -36.03 73.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.237 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 30.1 p -80.19 -24.2 40.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.468 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -51.92 -42.6 62.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.0 -60.12 8.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.551 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.7 mp -58.38 -30.79 67.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -1.123 . . . . 0.0 109.238 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.68 -3.15 58.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 109.543 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.454 ' C ' ' H ' ' D' ' 79' ' ' ASP . 10.2 t-80 -167.96 61.81 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.666 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mt -73.42 14.43 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -0.971 . . . . 0.0 109.145 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.461 ' O ' ' ND2' ' D' ' 80' ' ' ASN . 30.2 t70 -68.99 -32.32 71.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.482 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' D' ' 79' ' ' ASP . 9.8 m120 -163.19 104.14 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.337 -0.852 . . . . 0.0 109.45 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 37.3 mt -80.24 -58.8 2.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.409 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -48.59 -24.14 1.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.444 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.09 -62.21 3.42 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.7 t -62.76 -47.18 84.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.166 . . . . 0.0 109.452 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.4 m-85 -66.94 0.96 2.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.521 -0.737 . . . . 0.0 109.486 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.42 85.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.966 . . . . 0.0 109.466 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 5.1 p -72.64 -53.63 11.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 0.0 109.42 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 24.7 mt -49.87 -46.52 51.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.432 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 85.5 p -56.3 -46.7 79.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.419 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.69 -40.6 95.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.327 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.25 -44.7 87.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 109.338 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' D' ' 97' ' ' HIS . 76.0 m80 -73.39 -24.24 60.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 110.207 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.71 -60.94 1.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 0.0 111.245 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -88.05 -57.12 3.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.884 -1.135 . . . . 0.0 111.691 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . 0.493 ' O ' HD12 ' D' ' 96' ' ' LEU . 56.0 mmtt -66.23 -9.83 36.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.319 -0.863 . . . . 0.0 111.494 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.559 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 1.0 OUTLIER -143.13 -33.89 0.43 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.771 -1.206 . . . . 0.0 110.028 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 33.2 p-80 43.62 25.51 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.264 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' D' ' 96' ' ' LEU . 24.9 t -53.7 139.09 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.065 -1.022 . . . . 0.0 109.045 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . 0.479 ' OD1' HG21 ' A' ' 96' ' ' VAL . 7.4 m-20 -46.54 149.41 1.42 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.509 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.19 -17.43 45.18 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.584 2.189 . . . . 0.0 112.263 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -89.74 46.94 1.41 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 109.668 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' D' ' 99' ' ' ASP . 2.9 m120 -137.29 -3.42 1.95 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 109.811 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -97.73 -60.41 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.118 -0.989 . . . . 0.0 109.435 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -51.05 -19.93 1.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 109.588 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . 0.602 HD12 ' N ' ' D' ' 105' ' ' LEU . 7.9 mp -77.98 -52.87 8.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.0 tt -54.48 -52.19 62.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.58 -22.0 7.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -85.64 -53.7 5.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -1.19 . . . . 0.0 109.723 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 92.9 t -46.66 -30.27 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 109.88 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.99 -55.39 29.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.644 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . 0.404 HG22 ' CE1' ' D' ' 130' ' ' TYR . 90.2 t -46.71 -26.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.774 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 34.4 t -74.63 -26.31 59.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.893 . . . . 0.0 109.704 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.48 -25.28 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.6 -25.6 33.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.742 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -75.72 -19.48 59.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.673 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 1.493 ' NE2' ' CZ ' ' C' ' 117' ' ' PHE . 0.3 OUTLIER -83.52 -52.44 6.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . 0.493 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 61.0 m170 -73.29 -17.62 61.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 11.2 m-85 -149.39 55.73 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -61.47 -14.81 43.62 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.7 -20.89 27.07 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.213 -1.169 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' D' ' 123' ' ' THR . 59.4 mm-40 -83.87 -7.34 59.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.683 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.71 33.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 109.527 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.488 ' H ' ' C ' ' D' ' 121' ' ' GLU . 77.4 p -47.55 148.42 2.49 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.434 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.3 Cg_exo -44.63 -56.15 2.81 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.491 2.127 . . . . 0.0 112.956 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 19.8 Cg_endo -60.46 -35.26 91.34 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.187 1.924 . . . . 0.0 112.078 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.471 HG23 ' OG1' ' D' ' 123' ' ' THR . 78.5 t -72.09 -17.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -83.33 -59.78 2.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 109.789 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.63 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -53.69 -33.43 55.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.624 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.48 27.64 0.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.541 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.498 ' CD2' HG23 ' D' ' 11' ' ' VAL . 4.3 t80 -125.2 -38.22 2.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.411 -0.805 . . . . 0.0 109.512 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 1.01 ' NE2' ' CZ ' ' C' ' 36' ' ' PHE . 45.9 tt0 -67.51 -23.97 65.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 109.835 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -84.46 -36.49 22.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 109.679 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.65 -49.39 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.787 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.447 ' H ' HG22 ' D' ' 134' ' ' VAL . 4.5 m -79.43 -23.87 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 109.783 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.4 -27.84 11.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.106 -0.996 . . . . 0.0 109.463 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.28 -23.1 61.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 93.9 t -78.93 -27.65 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -1.173 . . . . 0.0 109.55 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.92 -42.84 56.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.933 . . . . 0.0 109.446 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . 0.532 ' OD1' ' OD1' ' B' ' 139' ' ' ASN . 37.8 t30 -76.8 -21.17 55.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.578 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.67 -60.29 2.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 0.0 109.54 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 17.1 mt -55.24 -22.26 17.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.429 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.32 -17.88 24.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -46.34 -46.51 18.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' D' ' 146' ' ' HIS . 5.7 tppt? -77.2 -57.43 3.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . 0.484 ' CD1' ' C ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -51.58 -10.59 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.519 -0.738 . . . . 0.0 109.193 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.471 ' H ' ' C ' ' D' ' 144' ' ' LYS . 11.4 m-70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.666 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.449 HD13 ' CE2' ' A' ' 128' ' ' PHE . 14.7 mt -138.96 -174.21 3.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.248 -0.907 . . . . 0.0 109.412 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.496 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 175.9 -49.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 3' ' ' SER . 71.9 Cg_exo -47.01 173.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.507 2.138 . . . . 0.0 112.568 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -65.11 -16.33 63.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 5' ' ' ALA . 1.2 m-20 -39.71 -40.62 0.96 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 109.595 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.403 ' NZ ' ' CB ' ' A' ' 7' ' ' LYS . 8.3 mtmp? -60.51 -59.29 5.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.206 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 m -50.26 -28.68 8.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.198 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 5' ' ' ALA . 55.5 m-80 -80.09 -35.32 37.09 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.413 HG21 ' CG ' ' A' ' 128' ' ' PHE . 41.1 t -74.81 -44.57 45.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.74 -39.63 89.39 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.414 -0.803 . . . . 0.0 108.86 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.78 46.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.153 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.738 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.97 -35.43 64.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.445 -0.784 . . . . 0.0 109.073 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.54 -17.51 61.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.051 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.47 -46.34 8.96 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -68.9 -37.47 78.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.198 -1.177 . . . . 0.0 108.766 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 13' ' ' ALA . 99.2 t -61.17 -65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 59.59 -137.54 49.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.23 29.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.471 -1.017 . . . . 0.0 110.296 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.564 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.1 m-70 -131.82 23.35 4.62 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -87.3 -61.48 1.71 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.613 -0.68 . . . . 0.0 109.639 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.34 -14.62 0.35 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 21' ' ' ALA . 3.7 mm-40 -84.08 -56.45 3.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -1.111 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.1 m-30 -59.61 -33.17 71.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.396 -0.815 . . . . 0.0 109.322 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.33 -22.96 76.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.73 -43.54 20.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -1.176 . . . . 0.0 109.752 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.86 -19.91 65.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 -20.0 59.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.911 . . . . 0.0 109.366 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.531 HD13 ' CD2' ' A' ' 58' ' ' HIS . 18.6 mt -73.0 -46.04 54.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.588 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -61.98 -17.73 58.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 109.604 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.0 mmt-85 -81.18 -31.9 33.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 0.0 109.598 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -73.02 -37.63 66.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 109.525 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.473 ' CD1' ' C ' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -62.95 -60.0 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 12.3 mt -59.32 -48.88 79.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.655 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' B' ' 131' ' ' GLN . 40.3 t -46.04 -27.4 0.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.923 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CD1' ' O ' ' A' ' 35' ' ' SER . 47.7 m-85 -154.18 123.88 3.25 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.026 -1.046 . . . . 0.0 109.55 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 40' ' ' LYS . 73.3 Cg_endo -77.9 -19.52 12.41 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.412 2.075 . . . . 0.0 112.159 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.2 p -43.9 -19.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 109.889 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 37' ' ' PRO . 3.4 p -90.27 -22.83 21.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.174 -0.954 . . . . 0.0 109.575 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 37' ' ' PRO . 27.8 ttmt -50.16 -18.74 0.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 109.954 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.863 -179.614 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.593 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -156.17 71.19 0.71 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.568 ' C ' ' H ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -46.41 -13.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.453 -0.779 . . . . 0.0 111.203 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 9.5 mt 59.0 -5.43 0.06 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.772 -1.205 . . . . 0.0 109.608 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.568 ' H ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -46.79 124.88 6.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 109.552 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -53.3 138.96 31.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.46 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.27 27.81 65.93 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 3.2 m -60.9 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.273 -1.134 . . . . 0.0 109.31 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 167.8 -64.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.424 -0.797 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -45.61 -17.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.47 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' ALA . 61.3 t -73.93 -29.98 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 109.791 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -70.96 -26.49 63.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.71 -22.92 68.38 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.4 OUTLIER -79.2 -39.89 32.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.171 -1.194 . . . . 0.0 109.549 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.27 -49.96 54.23 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 49.8 mttp -51.98 -23.87 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -1.104 . . . . 0.0 110.0 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -72.41 -45.11 61.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.19 -0.944 . . . . 0.0 109.107 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.3 t -67.62 -46.14 83.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.475 -0.765 . . . . 0.0 109.261 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.79 -31.0 68.68 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.2 -0.937 . . . . 0.0 109.313 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.4 t70 -69.39 -34.57 74.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.973 . . . . 0.0 108.752 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.85 -51.37 62.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.32 -0.863 . . . . 0.0 108.96 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.8 mt -56.34 -46.29 80.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 108.82 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -62.68 -51.57 66.69 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.274 -0.891 . . . . 0.0 108.871 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -59.67 -22.74 62.35 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.56 -46.98 11.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.65 -22.91 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.7 -16.95 64.59 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' A' ' 74' ' ' ASP . 15.8 m80 -143.88 -60.16 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.402 -0.811 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 69' ' ' ALA . 12.7 p 44.66 14.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.751 0.786 . . . . 0.0 109.286 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 72' ' ' HIS . 13.7 m-20 -131.22 11.44 5.0 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.438 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.8 p-10 -177.82 31.79 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.944 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.696 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -77.99 -24.21 0.44 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.398 -0.814 . . . . 0.0 111.709 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 76' ' ' MET . 75.6 Cg_exo -50.21 -33.92 37.8 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.71 1.607 . . . . 0.0 112.239 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -94.29 -16.04 23.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 0.0 109.503 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.65 -57.96 3.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 109.087 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.18 10.23 2.55 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.405 -0.809 . . . . 0.0 108.946 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -61.09 -28.73 69.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.396 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -63.9 -50.58 68.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.543 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.526 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 4.5 mt -47.22 -47.34 24.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 108.785 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 20.7 t -55.31 -25.9 37.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.426 -0.796 . . . . 0.0 109.299 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 89' ' ' HIS . 1.9 m-20 -78.45 -53.05 7.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.25 -28.65 65.1 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.327 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 8.4 m80 -92.6 -21.76 19.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.046 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -112.14 -2.39 14.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.133 -0.979 . . . . 0.0 110.354 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 85' ' ' ASP . 78.1 m80 -142.59 36.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.983 -1.073 . . . . 0.0 110.176 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -171.55 -77.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 0.0 109.723 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 91' ' ' LEU . 4.3 mm? -72.49 -37.34 68.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.09 -1.006 . . . . 0.0 109.346 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.666 ' HG2' ' NH1' ' D' ' 40' ' ' ARG . 28.1 ttm180 55.63 52.4 11.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.122 -0.987 . . . . 0.0 109.492 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.562 ' O ' ' NH2' ' D' ' 40' ' ' ARG . 0.3 OUTLIER -78.7 -173.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.154 -0.966 . . . . 0.0 109.44 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 96' ' ' VAL . 1.8 m-20 -123.91 113.65 28.35 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.482 -0.761 . . . . 0.0 109.139 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 98' ' ' PHE . 84.3 Cg_exo -43.34 -14.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.265 1.976 . . . . 0.0 112.378 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 94' ' ' ASP . 94.9 t -48.07 -25.65 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.595 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -79.38 -24.86 42.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.621 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' A' ' 95' ' ' PRO . 28.5 t80 -46.38 -40.76 12.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 109.623 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -59.42 -25.18 64.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.591 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.1 mt -84.01 -61.32 1.85 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.576 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tp -47.95 -41.08 24.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.2 t -61.99 -42.31 99.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.669 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -80.91 -26.51 36.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.762 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 79.9 m -58.38 -56.86 16.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.603 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.6 mt -47.01 -37.14 8.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.365 -0.834 . . . . 0.0 109.568 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.09 -30.93 68.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.866 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.9 t -82.97 -24.81 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.2 m -81.82 -62.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.61 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 113' ' ' LEU . 12.5 mt -46.26 -39.94 10.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.311 -0.868 . . . . 0.0 109.64 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.5 -42.49 7.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.818 . . . . 0.0 109.927 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.04 -44.37 69.37 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.312 -0.868 . . . . 0.0 109.483 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -91.52 -77.24 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.561 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 109' ' ' LEU . 1.9 tt -96.88 119.59 63.28 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.49 165.38 32.58 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.242 1.962 . . . . 0.0 112.821 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.469 ' C ' ' N ' ' A' ' 117' ' ' PHE . . . -87.81 -28.5 21.61 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.53 0.681 . . . . 0.0 109.68 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.542 ' O ' ' CG ' ' A' ' 117' ' ' PHE . 83.8 mt-10 57.09 10.62 0.84 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' A' ' 116' ' ' GLU . 27.7 p90 40.6 32.5 0.15 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.339 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 120' ' ' ALA . 3.2 p -56.02 134.39 74.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -49.51 18.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.401 2.068 . . . . 0.0 113.251 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -157.37 -20.2 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.595 -1.316 . . . . 0.0 111.555 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 122' ' ' HIS . 2.8 t -65.64 -63.13 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.543 -1.348 . . . . 0.0 110.055 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.599 ' CD2' HG22 ' B' ' 34' ' ' VAL . 0.0 OUTLIER -50.5 -31.14 14.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 108.977 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.65 -19.94 32.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.341 -0.85 . . . . 0.0 109.777 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 20.4 p -64.89 -62.33 1.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.201 -0.937 . . . . 0.0 110.599 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.507 ' N ' ' OG ' ' A' ' 124' ' ' SER . 2.0 mt -72.91 -19.78 61.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.119 -0.988 . . . . 0.0 110.051 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -81.45 -43.51 18.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 109.896 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -87.28 -47.59 8.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 109.86 -179.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 31.2 t80 -48.73 -21.5 0.63 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.122 -0.986 . . . . 0.0 109.47 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 133' ' ' SER . 18.7 mt -73.75 -21.06 60.32 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.15 -32.96 68.67 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.447 ' OG ' HD11 ' A' ' 2' ' ' LEU . 0.7 OUTLIER -78.67 -30.42 46.19 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.404 -0.81 . . . . 0.0 108.869 179.373 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.06 -30.18 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 108.85 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 129' ' ' LEU . 78.8 p -79.09 -25.08 43.08 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.392 -0.817 . . . . 0.0 108.968 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 53.6 m -70.68 -37.57 73.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.299 -0.875 . . . . 0.0 109.244 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.402 ' H ' HG12 ' A' ' 135' ' ' VAL . 5.0 p -79.52 -22.04 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.307 -0.871 . . . . 0.0 108.955 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -33.83 40.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.356 -0.84 . . . . 0.0 109.149 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 71.4 p -91.34 -1.46 57.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.48 -179.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' B' ' 2' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.314 0.578 . . . . 0.0 109.603 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.985 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -122.17 -174.11 2.82 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.344 -0.847 . . . . 0.0 109.286 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.498 ' O ' ' N ' ' B' ' 6' ' ' GLU . 9.6 p -104.77 143.67 27.17 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.471 -0.768 . . . . 0.0 109.129 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -39.33 -22.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.561 2.174 . . . . 0.0 112.349 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' B' ' 4' ' ' THR . 25.1 mt-10 -75.5 -57.05 4.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.903 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -80.75 -22.93 39.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 109.798 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.708 ' HB2' HD13 ' B' ' 3' ' ' LEU . 2.5 tttm -79.77 -31.99 40.94 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.222 -0.924 . . . . 0.0 109.281 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 11.1 t -63.92 -23.36 67.32 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.686 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.08 -57.68 3.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.074 -1.016 . . . . 0.0 110.062 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.43 ' H ' HG12 ' B' ' 11' ' ' VAL . 1.8 p -62.12 -24.44 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 73.9 m -84.06 -35.47 23.76 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.364 0.602 . . . . 0.0 109.588 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -64.25 -60.05 3.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.812 . . . . 0.0 109.751 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.447 ' O ' HG23 ' B' ' 18' ' ' VAL . 7.9 mp -43.59 -18.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.51 -0.744 . . . . 0.0 110.139 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . 0.537 ' N ' ' O ' ' B' ' 13' ' ' ALA . 25.9 t90 -75.45 -33.39 60.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 0.0 109.499 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 13' ' ' ALA . . . -67.28 -52.54 30.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.687 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -56.22 -36.41 68.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.364 -1.08 . . . . 0.0 109.236 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 14' ' ' LEU . 6.6 t -57.32 117.35 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.421 -0.8 . . . . 0.0 109.695 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' B' ' 21' ' ' ASP . 60.9 t30 -87.96 81.08 7.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.343 -0.848 . . . . 0.0 108.964 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.412 ' C ' ' N ' ' B' ' 22' ' ' GLU . 91.2 t -44.41 -17.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 109.781 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' B' ' 19' ' ' ASN . 22.2 t70 -51.12 -15.35 0.33 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.674 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.412 ' N ' ' C ' ' B' ' 20' ' ' VAL . 33.7 mt-10 -156.17 -37.55 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.619 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -47.44 -54.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.617 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.32 -33.33 70.27 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.62 -49.63 74.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' B' ' 28' ' ' LEU . 90.6 mt-10 -73.08 -44.27 60.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.0 109.501 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.52 -22.23 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' B' ' 26' ' ' GLU . 0.2 OUTLIER -82.78 -57.97 3.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.292 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.6 -43.74 59.37 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -50.17 -33.57 19.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -1.137 . . . . 0.0 109.43 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 42.0 tp -52.27 -36.94 54.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 24.4 mt -81.26 -42.57 20.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 109.844 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.423 HG23 ' H ' ' B' ' 33' ' ' VAL . 6.5 t -56.74 -54.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 0.0 109.427 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.599 HG22 ' CD2' ' A' ' 122' ' ' HIS . 21.6 t -68.41 -23.0 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.525 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -160.8 87.1 1.76 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 109.382 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.22 18.59 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.666 2.244 . . . . 0.0 112.22 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.506 ' C ' ' H ' ' B' ' 39' ' ' GLN . 1.3 p-90 -69.8 -19.95 63.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.476 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.493 HG23 ' CD1' ' B' ' 37' ' ' TRP . 75.8 p -69.83 35.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.857 . . . . 0.0 109.531 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 12.1 tt0 -73.27 14.78 0.28 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.644 ' NH1' ' HG2' ' C' ' 92' ' ' ARG . 64.7 mtt-85 -98.03 -48.95 4.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.384 -0.823 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -91.09 2.73 56.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 109.516 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' B' ' 39' ' ' GLN . 1.4 p90 -67.83 -4.34 12.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.58 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -46.86 -37.16 8.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 60.8 m -67.09 -43.46 82.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 109.436 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' B' ' 47' ' ' ASP . 2.6 m-85 -84.4 27.3 0.71 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 109.23 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.01 87.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' B' ' 45' ' ' PHE . 18.6 t0 -174.2 47.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.333 -1.098 . . . . 0.0 109.227 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.579 HD12 ' N ' ' B' ' 48' ' ' LEU . 9.5 mp -88.77 27.91 1.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 109.575 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -46.95 -37.67 9.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 109.321 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . 0.401 ' O ' ' N ' ' B' ' 53' ' ' ALA . 5.6 p -146.98 148.89 33.98 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.45 -0.781 . . . . 0.0 109.012 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.13 -42.51 2.22 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.518 2.145 . . . . 0.0 112.516 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.406 ' C ' ' N ' ' B' ' 54' ' ' VAL . 7.6 p-10 -77.37 -29.62 53.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.0 109.746 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -47.98 -19.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.619 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.406 ' N ' ' C ' ' B' ' 52' ' ' ASP . 68.2 t -63.87 -61.45 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.656 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -81.5 4.41 21.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.535 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.37 1.33 84.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -87.32 150.23 48.73 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.236 -1.156 . . . . 0.0 109.304 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.73 -28.33 9.77 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.598 2.199 . . . . 0.0 112.377 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -39.34 19.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.933 . . . . 0.0 109.846 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 53.9 t -52.43 -42.67 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.468 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -78.97 -26.86 43.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.108 -0.995 . . . . 0.0 109.484 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.73 -58.06 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.487 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . 0.464 ' O ' ' ND1' ' B' ' 63' ' ' HIS . 1.6 t-80 -48.1 -23.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.191 -0.943 . . . . 0.0 109.545 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.23 -47.47 90.83 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -62.29 -35.57 79.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.182 . . . . 0.0 109.441 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -60.58 -44.34 96.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.27 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 36.6 t -71.26 -58.83 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.22 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.448 ' O ' HD23 ' B' ' 68' ' ' LEU . 6.2 tt -48.78 -44.6 39.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.277 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.05 -47.06 41.62 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.57 32.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -1.156 . . . . 0.0 109.475 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -53.05 -22.8 6.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.247 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.46 -41.01 22.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.445 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.39 -27.65 1.76 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.42 -60.16 5.27 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.23 -17.98 9.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -1.121 . . . . 0.0 109.302 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.52 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -80.53 -26.25 38.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.695 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 39.5 m80 -157.23 59.99 0.51 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.76 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 23.3 mt -56.41 -4.7 0.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 109.295 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' B' ' 77' ' ' HIS . 7.5 m-20 -51.82 -26.48 9.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.723 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.571 ' N ' HD22 ' B' ' 80' ' ' ASN . 0.0 OUTLIER -165.98 95.01 0.58 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.626 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.547 ' N ' HD12 ' B' ' 81' ' ' LEU . 6.3 mp -80.27 -58.75 2.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.36 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.468 ' HG3' ' HZ3' ' B' ' 82' ' ' LYS . 16.6 ttmm -47.44 -23.94 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 109.573 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.64 -49.29 11.18 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 1.3 t -73.9 -45.58 49.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -1.165 . . . . 0.0 109.647 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.531 ' N ' ' CG2' ' B' ' 84' ' ' THR . 48.4 m-85 -64.63 4.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.365 -0.834 . . . . 0.0 109.572 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -64.08 -34.02 77.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.944 . . . . 0.0 109.475 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.2 p -77.25 -53.06 8.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.606 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.54 ' N ' HD12 ' B' ' 88' ' ' LEU . 9.4 mp -51.25 -49.21 61.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.321 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 3.5 m -53.33 -49.37 67.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.362 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.53 -22.7 66.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.359 -0.838 . . . . 0.0 109.369 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.95 -57.87 3.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 0.0 109.667 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' B' ' 97' ' ' HIS . 45.2 m80 -68.64 -20.25 64.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 110.31 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 53.7 t -83.8 -60.92 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.03 . . . . 0.0 110.747 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -87.75 -56.08 3.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.023 . . . . 0.0 111.246 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -51.7 68.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.893 . . . . 0.0 110.759 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.679 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -98.47 -59.71 1.69 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.012 -1.055 . . . . 0.0 109.893 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.679 ' ND1' ' O ' ' B' ' 96' ' ' LEU . 0.0 OUTLIER 83.94 20.66 0.16 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.773 -0.579 . . . . 0.0 109.77 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.516 HG23 HD12 ' B' ' 96' ' ' LEU . 68.5 t -48.35 140.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.048 -1.032 . . . . 0.0 109.292 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -56.93 150.61 37.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.273 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.49 -7.76 21.9 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.539 2.159 . . . . 0.0 112.15 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.52 60.89 2.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 109.542 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.96 -34.69 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.14 -14.05 52.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.504 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.412 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 90.1 mtt-85 -86.25 -20.04 29.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.95 . . . . 0.0 109.778 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 37.2 mt -82.68 -53.61 5.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.792 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 tt -50.82 -46.32 59.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.79 -28.81 63.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 21.9 m120 -85.56 -20.78 29.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -1.173 . . . . 0.0 109.628 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 81.0 t -81.14 -28.86 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.56 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.94 -58.8 3.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.231 -0.918 . . . . 0.0 109.607 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.538 HG12 ' CD1' ' B' ' 130' ' ' TYR . 3.8 m -52.26 -26.07 8.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.296 -0.877 . . . . 0.0 109.929 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 t -70.43 -34.81 72.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 49.6 t -71.61 -22.48 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 109.56 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.423 ' CD1' ' OH ' ' B' ' 130' ' ' TYR . 14.6 mt -80.93 -47.11 14.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.488 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.484 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -51.96 -19.98 2.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 109.442 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -84.93 -63.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.544 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.79 -17.77 64.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.579 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -143.22 52.23 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.334 -0.854 . . . . 0.0 109.429 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -68.68 -13.01 65.28 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -77.99 -29.92 49.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -1.136 . . . . 0.0 109.395 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -94.29 14.48 20.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.569 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -84.0 34.01 0.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.902 . . . . 0.0 109.533 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.464 ' H ' HG23 ' B' ' 123' ' ' THR . 1.2 p -48.11 148.78 2.86 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.268 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 4.9 Cg_exo -45.73 -53.41 5.66 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.397 2.065 . . . . 0.0 113.007 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 28.1 Cg_endo -63.09 -29.13 74.52 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.031 1.821 . . . . 0.0 112.228 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.435 HG23 ' OG1' ' B' ' 123' ' ' THR . 63.2 t -74.13 -13.73 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.51 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -83.47 -59.74 2.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 109.575 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -56.19 -32.69 64.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.405 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.82 26.24 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.538 ' CD1' HG12 ' B' ' 111' ' ' VAL . 1.3 t80 -131.19 -34.28 1.44 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -0.846 . . . . 0.0 109.246 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 35' ' ' SER . 12.3 mt-30 -76.64 -63.44 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.736 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -47.29 -21.95 0.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.554 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . 0.584 HG22 HD21 ' B' ' 3' ' ' LEU . 2.9 t -71.14 -64.95 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.02 -26.83 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.81 -29.95 8.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.01 -32.52 69.61 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.06 -37.35 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -1.148 . . . . 0.0 109.362 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.32 -33.36 75.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.427 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 0.627 HD21 HD21 ' D' ' 139' ' ' ASN . 65.3 t30 -72.57 -36.55 68.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.85 -48.49 74.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.364 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.27 -30.1 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.97 0.55 49.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 109.7 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -67.2 -27.9 67.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.18 -0.95 . . . . 0.0 109.608 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -89.4 -23.04 22.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -55.34 -5.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' B' ' 144' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.515 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.455 HD13 ' CE2' ' C' ' 128' ' ' PHE . 14.6 mt -139.02 -174.23 3.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.311 -0.868 . . . . 0.0 109.34 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.495 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 175.94 -49.25 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 109.945 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' C' ' 3' ' ' SER . 72.1 Cg_exo -46.99 173.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.421 2.081 . . . . 0.0 112.641 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -65.12 -16.26 63.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.812 . . . . 0.0 109.64 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.457 ' C ' ' O ' ' C' ' 5' ' ' ALA . 1.2 m-20 -39.67 -40.63 0.94 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 0.0 109.647 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -60.51 -59.33 5.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 109.216 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 48.8 m -50.26 -28.63 8.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 109.156 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' C' ' 5' ' ' ALA . 55.6 m-80 -80.16 -35.3 36.75 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.417 HG21 ' CG ' ' C' ' 128' ' ' PHE . 41.2 t -74.86 -44.54 45.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.69 -39.74 89.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.408 -0.807 . . . . 0.0 108.84 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.87 -52.87 46.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.865 . . . . 0.0 109.154 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.719 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.95 -35.43 64.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.365 -0.834 . . . . 0.0 109.056 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -17.46 61.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.314 -0.866 . . . . 0.0 109.007 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.52 -46.35 8.9 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 13.3 mmmt -68.93 -37.43 78.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 108.772 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.719 HG23 ' O ' ' C' ' 13' ' ' ALA . 99.4 t -61.14 -65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 59.67 -137.6 49.64 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 29.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.5 -1.0 . . . . 0.0 110.363 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.584 ' H ' ' C ' ' C' ' 18' ' ' GLY . 93.0 m-70 -131.73 23.33 4.65 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -87.3 -61.55 1.7 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.672 -0.643 . . . . 0.0 109.573 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.41 -14.49 0.35 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' C' ' 21' ' ' ALA . 3.7 mm-40 -84.14 -56.48 3.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -1.076 . . . . 0.0 109.484 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.1 m-30 -59.59 -33.16 71.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.396 -0.815 . . . . 0.0 109.332 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.32 -22.95 76.49 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.7 -43.58 20.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.184 -1.186 . . . . 0.0 109.689 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.75 -20.05 65.88 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.4 -19.98 59.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' C' ' 58' ' ' HIS . 18.7 mt -73.03 -45.94 54.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.652 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -61.89 -17.86 58.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.677 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 36.2 mmt-85 -81.17 -31.82 33.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.552 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -73.06 -37.6 66.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.605 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' C' ' 33' ' ' PHE . 0.7 OUTLIER -63.06 -59.94 4.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 12.2 mt -59.25 -48.93 79.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.0 109.63 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.549 ' HG ' ' HD1' ' C' ' 36' ' ' PHE . 40.4 t -46.02 -27.43 0.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.922 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.549 ' HD1' ' HG ' ' C' ' 35' ' ' SER . 47.3 m-85 -154.13 123.79 3.25 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 0.0 109.476 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' C' ' 40' ' ' LYS . 73.2 Cg_endo -77.8 -19.47 12.59 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.425 2.083 . . . . 0.0 112.272 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 21.2 p -43.91 -19.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 109.851 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.515 ' N ' ' O ' ' C' ' 37' ' ' PRO . 3.5 p -90.18 -22.89 21.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' C' ' 37' ' ' PRO . 27.9 ttmt -50.16 -18.7 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 109.922 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 109.835 -179.655 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.51 ' CG ' ' O ' ' C' ' 45' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.592 ' O ' ' HG ' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -156.15 71.08 0.71 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' C' ' 49' ' ' SER . 0.9 OUTLIER -46.34 -13.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.602 -0.687 . . . . 0.0 111.242 -178.252 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' C' ' 46' ' ' PHE . 9.6 mt 58.93 -5.34 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.787 -1.196 . . . . 0.0 109.664 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.59 ' H ' ' C ' ' C' ' 47' ' ' ASP . 0.0 OUTLIER -46.88 124.95 6.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.0 109.544 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -53.38 138.99 31.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.25 27.82 65.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' C' ' 53' ' ' ALA . 3.2 m -60.89 -97.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -1.141 . . . . 0.0 109.336 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' C' ' 52' ' ' SER . . . 167.83 -64.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.459 -0.776 . . . . 0.0 109.175 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -45.56 -17.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.541 -0.724 . . . . 0.0 109.534 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' C' ' 53' ' ' ALA . 61.6 t -73.86 -30.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.284 -0.885 . . . . 0.0 109.758 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -70.96 -26.46 63.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.85 -22.81 68.25 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.4 OUTLIER -79.22 -39.9 32.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.298 -1.119 . . . . 0.0 109.603 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.15 -50.02 53.54 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 49.7 mttp -52.06 -23.73 5.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -1.149 . . . . 0.0 109.966 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -72.55 -45.15 60.65 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.117 -0.99 . . . . 0.0 109.072 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.59 -46.12 83.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.531 -0.731 . . . . 0.0 109.277 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.86 -30.94 68.53 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.222 -0.923 . . . . 0.0 109.346 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 2.4 t70 -69.44 -34.49 74.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 108.83 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.84 -51.38 62.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 108.918 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 mt -56.28 -46.47 79.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.241 -0.912 . . . . 0.0 108.739 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -62.61 -51.66 66.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.328 -0.857 . . . . 0.0 108.81 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.6 -22.75 62.25 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.58 -47.06 10.94 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.64 -22.88 31.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.75 -16.91 64.58 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.597 ' O ' ' N ' ' C' ' 74' ' ' ASP . 15.8 m80 -143.88 -60.07 0.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.515 -0.741 . . . . 0.0 109.388 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.553 HG12 ' O ' ' C' ' 72' ' ' HIS . 12.8 p 44.63 14.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.817 0.818 . . . . 0.0 109.376 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' C' ' 72' ' ' HIS . 13.7 m-20 -131.23 11.41 4.99 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.439 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 1.8 p-10 -177.77 31.76 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.962 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.694 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -77.98 -24.23 0.44 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.458 -0.776 . . . . 0.0 111.655 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' C' ' 76' ' ' MET . 75.3 Cg_exo -50.3 -33.82 38.19 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.689 1.593 . . . . 0.0 112.279 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -94.34 -16.05 23.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.53 -58.04 3.39 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.123 -0.986 . . . . 0.0 109.139 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 mt -77.16 10.18 2.58 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.395 -0.815 . . . . 0.0 108.962 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -61.0 -28.81 69.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -63.85 -50.68 67.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.509 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 4.5 mt -47.27 -47.29 25.1 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 20.7 t -55.36 -25.8 37.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.498 -0.751 . . . . 0.0 109.247 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' C' ' 89' ' ' HIS . 1.9 m-20 -78.55 -53.01 7.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.935 . . . . 0.0 109.463 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.2 -28.76 65.11 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.302 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 8.3 m80 -92.58 -21.66 19.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 110.048 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -112.21 -2.28 14.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.234 -0.916 . . . . 0.0 110.414 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' C' ' 85' ' ' ASP . 78.0 m80 -142.6 36.08 1.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.984 -1.073 . . . . 0.0 110.096 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -171.57 -77.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.04 -1.037 . . . . 0.0 109.72 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' C' ' 91' ' ' LEU . 4.3 mm? -72.52 -37.34 68.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 109.327 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . 0.644 ' HG2' ' NH1' ' B' ' 40' ' ' ARG . 28.1 ttm180 55.64 52.38 11.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.575 ' O ' ' NH2' ' B' ' 40' ' ' ARG . 0.3 OUTLIER -78.68 -173.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.45 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' C' ' 96' ' ' VAL . 1.8 m-20 -123.8 113.67 28.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.464 -0.773 . . . . 0.0 109.169 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' C' ' 98' ' ' PHE . 84.8 Cg_exo -43.43 -14.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.216 1.944 . . . . 0.0 112.406 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' C' ' 94' ' ' ASP . 94.2 t -48.05 -25.66 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 109.551 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -79.44 -24.8 42.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.644 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . 0.42 ' N ' ' O ' ' C' ' 95' ' ' PRO . 28.5 t80 -46.43 -40.79 12.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 109.55 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -59.5 -24.93 64.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 20.2 mt -84.13 -61.26 1.86 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.628 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tp -48.01 -41.02 24.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 9.2 t -61.96 -42.3 98.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.715 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -80.94 -26.59 36.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.676 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 79.8 m -58.31 -56.86 16.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 0.0 109.625 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -47.07 -37.06 8.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.526 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.19 -31.01 68.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.782 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.89 -24.88 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.586 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 28.1 m -81.78 -62.95 1.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.596 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' C' ' 113' ' ' LEU . 12.5 mt -46.26 -39.9 10.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.895 . . . . 0.0 109.581 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.62 -42.33 7.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.958 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.1 -44.45 69.01 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.507 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -91.41 -77.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.63 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' C' ' 109' ' ' LEU . 1.9 tt -96.82 119.44 63.64 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.41 165.34 32.76 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.287 1.991 . . . . 0.0 112.821 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -87.79 -28.57 21.6 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.565 0.698 . . . . 0.0 109.647 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' C' ' 117' ' ' PHE . 83.8 mt-10 57.07 10.63 0.84 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' C' ' 116' ' ' GLU . 27.8 p90 40.58 32.51 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.314 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.703 ' O ' ' N ' ' C' ' 120' ' ' ALA . 3.2 p -56.03 134.35 74.06 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.44 18.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.387 2.058 . . . . 0.0 113.293 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.703 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -157.44 -20.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.623 -1.298 . . . . 0.0 111.543 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.438 HG12 ' N ' ' C' ' 122' ' ' HIS . 2.8 t -65.65 -63.01 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.513 -1.367 . . . . 0.0 110.106 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.598 ' CD2' HG22 ' D' ' 34' ' ' VAL . 0.0 OUTLIER -50.71 -31.02 15.29 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.28 -0.888 . . . . 0.0 108.868 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.65 -20.03 31.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.742 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 20.4 p -64.8 -62.33 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.671 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.505 ' N ' ' OG ' ' C' ' 124' ' ' SER . 2.0 mt -72.98 -19.68 61.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.1 -1.0 . . . . 0.0 110.081 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -81.48 -43.42 18.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.029 -1.044 . . . . 0.0 109.948 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -87.33 -47.64 8.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.873 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 31.1 t80 -48.68 -21.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.447 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' C' ' 133' ' ' SER . 18.8 mt -73.62 -21.23 60.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.05 -32.96 68.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.445 ' OG ' HD11 ' C' ' 2' ' ' LEU . 0.7 OUTLIER -78.71 -30.43 45.95 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.44 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.07 -30.25 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.845 . . . . 0.0 108.764 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.458 ' N ' ' O ' ' C' ' 129' ' ' LEU . 79.1 p -79.03 -25.1 43.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.347 -0.846 . . . . 0.0 108.968 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 53.5 m -70.69 -37.54 73.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.284 -0.885 . . . . 0.0 109.215 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.9 p -79.59 -22.0 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 108.871 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.65 -33.9 40.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.39 -0.818 . . . . 0.0 109.144 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 69.8 p -91.23 -1.54 57.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 109.58 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . 0.581 ' CG ' ' O ' ' D' ' 2' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.394 0.616 . . . . 0.0 109.634 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 1.035 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -122.25 -174.11 2.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.278 -0.889 . . . . 0.0 109.258 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.498 ' O ' ' N ' ' D' ' 6' ' ' GLU . 9.7 p -104.75 143.73 27.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 109.122 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -39.26 -22.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.637 2.224 . . . . 0.0 112.296 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' D' ' 4' ' ' THR . 25.2 mt-10 -75.55 -56.92 4.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.937 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -80.82 -22.82 39.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.944 . . . . 0.0 109.861 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.698 ' HB2' HD13 ' D' ' 3' ' ' LEU . 2.5 tttm -79.8 -31.97 40.75 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.254 -0.904 . . . . 0.0 109.296 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 11.2 t -63.84 -23.45 67.36 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.718 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.07 -57.66 3.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.057 -1.027 . . . . 0.0 110.086 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.43 ' H ' HG12 ' D' ' 11' ' ' VAL . 1.8 p -62.1 -24.42 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 75.1 m -84.13 -35.5 23.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.327 0.584 . . . . 0.0 109.547 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -64.29 -59.95 3.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.441 -0.787 . . . . 0.0 109.71 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.448 ' O ' HG23 ' D' ' 18' ' ' VAL . 7.9 mp -43.72 -18.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 0.0 110.117 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . 0.53 ' N ' ' O ' ' D' ' 13' ' ' ALA . 25.6 t90 -75.39 -33.37 61.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.917 -1.114 . . . . 0.0 109.532 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.31 -52.57 30.55 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.678 ' CD ' ' H ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -56.25 -36.37 68.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.326 -1.102 . . . . 0.0 109.189 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 14' ' ' LEU . 6.6 t -57.45 117.38 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.819 . . . . 0.0 109.676 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' D' ' 21' ' ' ASP . 61.0 t30 -88.03 81.12 7.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 108.912 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' D' ' 22' ' ' GLU . 92.0 t -44.47 -17.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 0.0 109.846 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' D' ' 19' ' ' ASN . 22.2 t70 -51.15 -15.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' D' ' 20' ' ' VAL . 33.6 mt-10 -156.12 -37.67 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.4 HG11 HG13 ' D' ' 18' ' ' VAL . 77.2 t -47.38 -53.97 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 109.703 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.35 -33.28 70.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.67 -49.66 74.23 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' D' ' 28' ' ' LEU . 90.5 mt-10 -73.06 -44.27 60.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -1.171 . . . . 0.0 109.505 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.51 -22.28 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.618 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' D' ' 26' ' ' GLU . 0.2 OUTLIER -82.65 -58.01 3.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.288 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.64 -43.68 59.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -50.13 -33.61 19.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -1.134 . . . . 0.0 109.482 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 42.1 tp -52.3 -36.93 54.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.935 . . . . 0.0 109.494 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.17 -42.69 20.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -56.72 -54.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.155 -0.965 . . . . 0.0 109.432 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' C' ' 122' ' ' HIS . 21.6 t -68.41 -23.05 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.525 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -160.8 86.99 1.77 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -83.0 18.36 1.5 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.74 2.293 . . . . 0.0 112.281 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . 0.528 ' C ' ' H ' ' D' ' 39' ' ' GLN . 1.3 p-90 -69.68 -19.98 63.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.464 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.49 HG23 ' CD1' ' D' ' 37' ' ' TRP . 75.8 p -69.92 35.63 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.175 -0.953 . . . . 0.0 109.568 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' D' ' 37' ' ' TRP . 12.1 tt0 -73.23 14.77 0.28 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.322 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . 0.666 ' NH1' ' HG2' ' A' ' 92' ' ' ARG . 64.7 mtt-85 -98.03 -48.9 4.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.483 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -91.17 2.73 56.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.983 . . . . 0.0 109.531 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' D' ' 39' ' ' GLN . 1.4 p90 -67.87 -4.33 12.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.619 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -46.81 -37.17 8.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 109.657 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 60.5 m -67.13 -43.39 82.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' D' ' 47' ' ' ASP . 2.6 m-85 -84.34 27.3 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.248 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.97 87.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' D' ' 45' ' ' PHE . 18.7 t0 -174.2 47.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -1.101 . . . . 0.0 109.252 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . 0.574 HD12 ' N ' ' D' ' 48' ' ' LEU . 9.5 mp -88.78 27.92 1.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 109.564 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -46.94 -37.67 9.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.297 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . 0.41 ' O ' ' N ' ' D' ' 53' ' ' ALA . 5.6 p -147.07 148.8 33.46 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.034 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -39.04 -42.54 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.552 2.168 . . . . 0.0 112.447 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . 0.404 ' C ' ' N ' ' D' ' 54' ' ' VAL . 7.6 p-10 -77.39 -29.62 53.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 0.0 109.728 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -48.04 -19.64 0.27 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 109.572 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 52' ' ' ASP . 67.1 t -63.93 -61.43 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.608 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -81.52 4.4 21.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.505 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.4 1.34 84.14 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . 0.404 HD21 ' CB ' ' D' ' 47' ' ' ASP . 20.6 m120 -87.39 150.21 48.53 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.222 -1.163 . . . . 0.0 109.348 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.79 -28.26 9.72 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.576 2.184 . . . . 0.0 112.314 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -39.32 19.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 109.848 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 53.8 t -52.38 -42.75 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.024 . . . . 0.0 109.428 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -79.01 -26.8 43.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.933 . . . . 0.0 109.458 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.76 -58.01 3.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.55 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . 0.5 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 1.6 t-80 -48.14 -23.9 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.561 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.3 -47.37 91.25 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -62.24 -35.67 79.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -1.203 . . . . 0.0 109.475 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -60.56 -44.39 96.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.837 . . . . 0.0 109.248 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 36.3 t -71.21 -58.77 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.25 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.449 ' O ' HD23 ' D' ' 68' ' ' LEU . 6.2 tt -48.88 -44.54 40.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.275 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.03 -47.06 41.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.96 -55.63 32.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -1.199 . . . . 0.0 109.393 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -53.0 -22.85 6.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.321 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.33 -41.1 22.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -0.834 . . . . 0.0 109.565 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.34 -27.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.408 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.41 -60.16 5.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.7 mp -56.25 -17.93 8.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -1.119 . . . . 0.0 109.342 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -80.6 -26.13 38.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.237 -0.914 . . . . 0.0 109.701 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 39.5 m80 -157.36 60.01 0.5 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.688 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 23.2 mt -56.36 -4.8 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.045 -1.034 . . . . 0.0 109.309 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' D' ' 77' ' ' HIS . 7.5 m-20 -51.8 -26.47 9.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.714 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.556 ' N ' HD22 ' D' ' 80' ' ' ASN . 0.0 OUTLIER -166.04 94.96 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . 0.531 ' N ' HD12 ' D' ' 81' ' ' LEU . 6.3 mp -80.26 -58.71 3.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . 0.435 ' HG3' ' HZ3' ' D' ' 82' ' ' LYS . 16.6 ttmm -47.44 -23.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.915 . . . . 0.0 109.567 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.81 -49.12 10.81 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.522 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 1.3 t -73.93 -45.67 49.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -1.207 . . . . 0.0 109.599 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.522 ' N ' ' CG2' ' D' ' 84' ' ' THR . 48.5 m-85 -64.66 4.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.398 -0.813 . . . . 0.0 109.613 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -64.1 -33.94 76.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.507 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.4 p -77.31 -53.09 8.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.54 ' N ' HD12 ' D' ' 88' ' ' LEU . 9.4 mp -51.17 -49.31 61.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 3.5 m -53.3 -49.37 67.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.339 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -62.55 -22.72 66.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.335 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.86 -57.99 3.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.316 -0.865 . . . . 0.0 109.617 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.574 ' O ' ' N ' ' D' ' 97' ' ' HIS . 45.2 m80 -68.54 -20.35 64.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.844 . . . . 0.0 110.337 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 53.6 t -83.72 -60.94 1.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 110.781 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -87.78 -56.07 3.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -0.982 . . . . 0.0 111.283 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -51.66 68.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.794 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.665 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -98.47 -59.61 1.71 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.983 -1.073 . . . . 0.0 109.956 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.665 ' ND1' ' O ' ' D' ' 96' ' ' LEU . 0.0 OUTLIER 83.77 20.79 0.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.812 -0.555 . . . . 0.0 109.761 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . 0.525 HG23 HD12 ' D' ' 96' ' ' LEU . 67.3 t -48.43 140.63 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 109.231 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -57.02 150.64 38.54 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.285 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.44 -7.78 21.97 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.524 2.149 . . . . 0.0 112.208 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.56 60.83 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 109.503 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 -34.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.602 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -64.09 -14.02 51.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.969 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 89.9 mtt-85 -86.31 -19.97 29.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.769 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 37.3 mt -82.74 -53.56 5.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.821 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 tt -50.79 -46.41 59.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 109.485 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.74 -28.86 63.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 21.9 m120 -85.57 -20.71 29.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -1.215 . . . . 0.0 109.606 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.25 -28.69 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 8.8 tp -68.11 -58.7 4.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.627 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . 0.538 HG12 ' CD1' ' D' ' 130' ' ' TYR . 3.8 m -52.31 -26.16 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.179 -0.951 . . . . 0.0 109.819 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 18.4 t -70.31 -34.78 73.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.743 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 49.8 t -71.7 -22.33 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.947 . . . . 0.0 109.6 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . 0.42 ' CD1' ' OH ' ' D' ' 130' ' ' TYR . 14.6 mt -81.03 -47.11 14.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -51.96 -19.93 2.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.473 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -84.95 -62.99 1.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.9 -17.67 64.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.92 . . . . 0.0 109.575 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -143.22 52.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.555 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -68.72 -12.92 65.24 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -78.06 -29.9 49.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -1.134 . . . . 0.0 109.394 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -94.27 14.5 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.892 . . . . 0.0 109.569 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -83.96 34.04 0.5 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.0 109.597 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.434 ' H ' HG23 ' D' ' 123' ' ' THR . 1.2 p -48.17 148.84 2.88 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 109.228 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.1 Cg_exo -45.88 -53.31 5.86 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.395 2.063 . . . . 0.0 112.923 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 28.3 Cg_endo -63.12 -29.04 74.12 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.004 1.803 . . . . 0.0 112.297 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.433 HG23 ' OG1' ' D' ' 123' ' ' THR . 63.0 t -74.23 -13.64 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.496 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -83.52 -59.76 2.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -56.24 -32.56 64.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.374 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.92 26.3 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.857 . . . . 0.0 109.471 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.538 ' CD1' HG12 ' D' ' 111' ' ' VAL . 1.3 t80 -131.27 -34.24 1.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.409 -0.807 . . . . 0.0 109.291 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 0.52 ' NE2' ' OG ' ' C' ' 35' ' ' SER . 12.3 mt-30 -76.64 -63.5 1.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.646 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -47.34 -21.86 0.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 109.569 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . 0.569 HG22 HD21 ' D' ' 3' ' ' LEU . 2.9 t -71.22 -64.91 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.546 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.402 HG23 ' H ' ' D' ' 134' ' ' VAL . 2.6 t -69.06 -26.79 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.9 -29.9 9.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.41 69.49 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.11 -37.32 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.396 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.34 -33.42 75.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.375 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . 0.627 HD21 HD21 ' B' ' 139' ' ' ASN . 65.3 t30 -72.55 -36.46 68.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.92 -48.46 74.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 mt -60.16 -30.19 69.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.92 0.56 49.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 109.681 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -67.12 -27.97 67.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.9 OUTLIER -89.54 -22.85 22.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.955 . . . . 0.0 109.593 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -55.44 -5.4 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.493 ' H ' ' C ' ' D' ' 144' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.428 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.517 HD11 ' HD3' ' A' ' 127' ' ' LYS . 9.5 tp -172.34 163.4 5.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 109.857 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -75.74 -176.92 0.63 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.368 -0.832 . . . . 0.0 109.058 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 58.4 Cg_endo -86.87 -68.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.664 2.243 . . . . 0.0 112.716 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -47.54 -40.44 18.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.054 -1.029 . . . . 0.0 109.485 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 10' ' ' VAL . 63.9 m-20 -43.55 -29.46 0.48 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.86 . . . . 0.0 109.02 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 10' ' ' VAL . 58.4 mttt -83.08 -53.72 5.59 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' LYS . 35.9 m -44.65 -38.51 4.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.448 -0.782 . . . . 0.0 109.282 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -72.46 -29.69 63.9 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 6' ' ' ASP . 54.1 t -75.12 -55.0 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' H ' ' CD ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -51.65 -39.11 57.52 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.23 179.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.18 -63.12 1.37 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.322 -0.861 . . . . 0.0 109.296 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.564 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.68 -38.61 67.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.388 -0.82 . . . . 0.0 108.892 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.94 -17.58 63.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.466 -0.772 . . . . 0.0 108.981 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.14 -44.98 16.61 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 39.1 mmtt -68.23 -41.4 81.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -1.137 . . . . 0.0 108.859 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 13' ' ' ALA . 61.2 t -60.28 -64.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 50.0 -127.87 25.1 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.47 24.68 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.474 -1.015 . . . . 0.0 110.381 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.544 ' H ' ' C ' ' A' ' 18' ' ' GLY . 87.4 m-70 -130.38 28.49 4.95 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -93.36 -61.31 1.59 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.671 -0.643 . . . . 0.0 109.778 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.27 -14.3 0.16 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.6 mt-10 -86.54 -56.29 3.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -1.117 . . . . 0.0 109.761 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.1 m-30 -59.79 -32.36 70.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 109.59 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.04 -22.92 76.13 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.92 -41.86 18.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -1.17 . . . . 0.0 109.959 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -65.93 -19.88 66.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.294 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.77 -20.4 60.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.436 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.554 HD11 ' ND1' ' A' ' 58' ' ' HIS . 14.1 mt -74.52 -51.11 15.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.739 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.66 -22.43 65.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.164 -0.96 . . . . 0.0 109.584 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.997 HH21 ' HB2' ' B' ' 127' ' ' GLN . 2.3 tpt180 -73.37 -20.75 60.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.311 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 46.1 ttp -78.36 -53.64 7.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.862 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -48.36 -24.2 1.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.351 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.079 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.5 mt -82.32 -46.2 13.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.978 . . . . 0.0 109.579 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 46.0 m -69.21 -20.78 63.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 35' ' ' SER . 95.5 m-85 -158.4 79.23 3.14 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.988 . . . . 0.0 109.737 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.31 -26.42 15.67 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.659 2.239 . . . . 0.0 112.07 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.433 ' O ' ' CG2' ' A' ' 41' ' ' THR . 12.6 p -49.45 -18.24 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.918 . . . . 0.0 109.477 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.6 p -79.01 -22.34 45.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -46.01 -42.91 13.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.583 HG21 ' HD1' ' D' ' 97' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.461 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 15.9 p80 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.662 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -149.81 69.32 1.02 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.548 ' C ' ' O ' ' A' ' 46' ' ' PHE . 1.1 m-20 -24.38 -37.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.855 -0.528 . . . . 0.0 111.203 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.662 ' N ' ' O ' ' A' ' 46' ' ' PHE . 4.3 mt 53.58 7.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.072 -1.017 . . . . 0.0 109.373 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 47' ' ' ASP . 4.9 m -64.34 5.7 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.507 ' H ' ' C ' ' A' ' 48' ' ' LEU . 37.8 t60 61.32 125.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.5 14.14 66.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.5 t -77.86 -103.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.164 -1.198 . . . . 0.0 109.41 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.91 -29.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 0.0 109.496 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -80.03 -17.98 51.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.199 -0.938 . . . . 0.0 109.169 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -84.52 -40.14 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.295 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -77.3 -32.37 55.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.16 -21.82 75.02 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.554 ' ND1' HD11 ' A' ' 29' ' ' LEU . 7.8 t-80 -75.65 -37.54 59.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.314 -1.11 . . . . 0.0 109.781 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.12 -48.5 46.39 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -51.77 -23.13 4.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -1.05 . . . . 0.0 109.979 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.39 -39.84 64.79 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.218 -0.926 . . . . 0.0 109.184 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.37 -33.6 19.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.457 -0.777 . . . . 0.0 108.935 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.16 -32.9 44.4 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.389 -0.82 . . . . 0.0 109.415 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -70.39 -33.37 71.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 108.861 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.13 19.02 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.429 -0.794 . . . . 0.0 108.898 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.23 -38.24 70.8 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.254 -0.904 . . . . 0.0 108.717 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -71.5 -50.29 32.88 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.196 -0.94 . . . . 0.0 108.608 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -59.78 -21.15 60.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.202 -0.936 . . . . 0.0 108.496 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.07 -47.35 13.66 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.417 HG13 ' CE ' ' A' ' 11' ' ' LYS . 9.7 t -65.94 -22.85 31.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.72 -15.1 63.41 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 74' ' ' ASP . 36.8 m80 -139.5 -63.01 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.479 -0.763 . . . . 0.0 109.423 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 73' ' ' VAL . 12.3 p 43.92 13.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.752 0.787 . . . . 0.0 109.65 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.612 ' N ' ' O ' ' A' ' 72' ' ' HIS . 16.2 m-20 -134.25 10.39 3.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 20.3 t0 -177.02 28.35 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.148 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.7 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 11.4 ptt? -78.81 -22.45 0.38 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 111.805 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 76' ' ' MET . 71.8 Cg_exo -49.02 -29.0 14.69 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.473 1.449 . . . . 0.0 112.424 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -94.23 -24.41 17.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 0.0 109.653 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.29 -53.58 8.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 0.0 109.143 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 mt -78.02 9.06 3.95 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.441 -0.787 . . . . 0.0 108.98 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 t -66.06 -41.5 90.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.412 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -52.46 -52.87 51.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.465 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 82' ' ' ALA . 4.9 mt -44.89 -45.05 10.11 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 9.9 p -55.75 -39.87 71.76 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' ALA . 25.7 t70 -67.58 -17.95 64.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.147 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 86' ' ' LEU . 1.2 tt -82.85 -43.46 16.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.333 -0.855 . . . . 0.0 109.378 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -92.45 -21.27 20.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.952 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -60.63 -87.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.106 -0.996 . . . . 0.0 110.741 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 90' ' ' LYS . 44.9 t-80 -96.62 -46.3 6.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.245 -0.909 . . . . 0.0 111.02 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 89' ' ' HIS . 35.9 mttm -41.22 -94.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.22 -0.925 . . . . 0.0 110.324 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mp -67.54 -34.97 78.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.012 -1.055 . . . . 0.0 109.623 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.393 ' NH2' ' HE ' ' D' ' 40' ' ' ARG . 45.5 ttp85 60.89 58.2 2.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.607 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 t -84.33 161.64 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 109.373 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.45 151.43 50.78 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.21 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' ASN . 58.4 Cg_endo -73.08 -18.8 23.6 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.55 2.167 . . . . 0.0 112.195 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.511 HG21 ' CB ' ' D' ' 99' ' ' ASP . 24.4 t -47.22 -20.04 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.743 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.672 HD22 ' N ' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -79.15 -24.73 43.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.709 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.546 ' CZ ' HD23 ' A' ' 136' ' ' LEU . 4.8 m-85 -46.66 -32.57 3.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 109.659 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.498 ' O ' ' ND1' ' A' ' 103' ' ' HIS . 55.8 mttm -83.89 -36.78 23.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 0.0 109.814 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 100' ' ' LEU . 7.2 mp -66.37 -61.93 1.74 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.131 -0.981 . . . . 0.0 109.516 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 101' ' ' LEU . 6.4 tt -49.97 -47.4 52.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.239 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.8 t -61.9 -38.85 89.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.603 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' LYS . 22.9 m80 -77.37 -27.73 52.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.935 . . . . 0.0 109.609 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.74 -46.93 80.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.728 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.25 -48.64 65.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.435 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 106' ' ' LEU . 9.6 mp -61.54 -59.1 5.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.713 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.04 -34.3 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.237 -0.914 . . . . 0.0 109.386 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.8 m -75.77 -60.87 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.392 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 113' ' ' LEU . 13.1 mt -46.11 -41.44 12.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.91 -28.58 0.68 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 110.182 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.89 -56.38 4.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 109.768 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -85.77 -65.13 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.466 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -95.92 106.89 30.89 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.2 171.17 9.48 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.718 1.612 . . . . 0.0 112.3 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 117' ' ' PHE . . . -87.22 -34.37 19.0 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.487 0.66 . . . . 0.0 109.88 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 117' ' ' PHE . 23.2 mt-10 55.63 9.96 0.46 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 116' ' ' GLU . 29.3 p90 40.63 32.34 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.54 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 120' ' ' ALA . 4.9 p -60.88 145.55 88.59 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.41 29.56 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 121.946 1.764 . . . . 0.0 111.773 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 124' ' ' SER . . . -162.61 -23.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.12 -0.988 . . . . 0.0 111.06 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.474 HG23 ' OG1' ' A' ' 118' ' ' THR . 2.6 t -59.86 -62.62 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.794 -1.191 . . . . 0.0 109.799 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.47 ' N ' HG12 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -60.72 -27.12 67.68 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.126 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.54 -20.09 32.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 120' ' ' ALA . 95.5 p -67.19 -62.0 1.64 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 110.8 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.6 mt -80.23 -19.88 45.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.925 -1.109 . . . . 0.0 110.81 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.69 -42.68 27.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.663 -1.273 . . . . 0.0 110.241 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.517 ' HD3' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -90.04 -45.0 9.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.958 -1.089 . . . . 0.0 110.126 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 10' ' ' VAL . 71.1 t80 -47.31 -21.55 0.3 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.01 -1.056 . . . . 0.0 109.454 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 129' ' ' LEU . 15.8 mt -69.63 -17.68 63.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.19 78.58 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.464 ' HB3' HD13 ' A' ' 2' ' ' LEU . 60.5 p -78.68 -25.92 44.88 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.362 -0.836 . . . . 0.0 108.747 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.1 t -84.99 -40.54 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.234 -0.916 . . . . 0.0 108.598 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.8 t -68.84 -28.76 67.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.397 -0.814 . . . . 0.0 109.297 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 51.6 m -64.65 -40.0 94.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.138 -0.976 . . . . 0.0 108.985 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 135' ' ' VAL . 2.7 p -82.68 -21.89 9.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.26 -0.9 . . . . 0.0 108.584 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.546 HD23 ' CZ ' ' A' ' 98' ' ' PHE . 1.1 tp -78.82 -28.26 44.4 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 138' ' ' SER . 49.1 m -68.14 -23.34 64.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.846 . . . . 0.0 109.405 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . 1.524 ' NE2' ' CD2' ' D' ' 146' ' ' HIS . 6.2 p80 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.23 0.538 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.847 HD12 ' N ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -141.87 -162.63 1.43 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.26 -0.9 . . . . 0.0 109.149 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -93.77 131.08 32.9 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.0 109.237 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.45 -23.77 0.32 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.365 2.043 . . . . 0.0 112.308 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -81.46 -53.02 6.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.968 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' B' ' 7' ' ' GLU . 5.5 mp0 -61.3 -55.58 30.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.662 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.727 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -57.04 -35.44 69.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.869 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -58.67 -23.81 60.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 110.047 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.61 -56.45 3.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.094 -1.004 . . . . 0.0 109.712 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.599 HG23 ' CD2' ' B' ' 130' ' ' TYR . 0.9 OUTLIER -64.07 -25.15 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 75.9 m -78.7 -35.26 45.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -60.38 -61.52 2.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.425 -0.797 . . . . 0.0 109.328 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.522 ' O ' HG23 ' B' ' 18' ' ' VAL . 8.0 mp -43.62 -18.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.672 -0.642 . . . . 0.0 109.765 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' B' ' 13' ' ' ALA . 22.1 t-105 -78.09 -17.96 56.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.972 . . . . 0.0 109.646 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.09 -42.61 7.49 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.665 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -68.75 -31.95 71.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -1.093 . . . . 0.0 109.214 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.522 HG23 ' O ' ' B' ' 14' ' ' LEU . 4.8 t -52.33 119.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -0.819 . . . . 0.0 109.692 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' B' ' 21' ' ' ASP . 54.9 m-20 -86.98 82.86 7.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.035 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' B' ' 22' ' ' GLU . 94.7 t -44.14 -20.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.816 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' B' ' 19' ' ' ASN . 12.6 m-20 -51.72 -8.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.73 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' B' ' 20' ' ' VAL . 34.8 mt-10 -155.53 -49.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.5 t -46.08 -26.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 109.779 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.09 -31.18 32.4 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -82.47 -25.67 49.96 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.73 -29.94 25.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.697 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.55 -23.45 63.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.949 . . . . 0.0 109.807 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.67 -58.16 3.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 109.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.19 -29.35 68.36 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.5 ' NH2' HG13 ' B' ' 113' ' ' VAL . 3.3 ttp180 -68.37 -29.44 68.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -1.114 . . . . 0.0 109.745 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp -51.62 -39.7 58.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.244 -0.91 . . . . 0.0 109.652 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 mt -78.12 -21.85 49.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.825 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 45.7 t -71.83 -47.96 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.875 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -63.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.019 -1.051 . . . . 0.0 109.787 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -119.42 97.09 50.16 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.396 -0.815 . . . . 0.0 109.754 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' B' ' 38' ' ' THR . 90.6 Cg_endo -85.59 10.52 3.67 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.717 2.278 . . . . 0.0 111.888 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -45.21 -19.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 109.694 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.662 ' C ' ' H ' ' B' ' 40' ' ' ARG . 11.0 p -46.96 -34.36 5.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.616 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 61.06 -13.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 1.403 ' HE ' ' NH2' ' C' ' 92' ' ' ARG . 79.8 mtt180 -88.94 -25.63 21.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.955 . . . . 0.0 108.946 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . 0.405 ' CD2' HD22 ' B' ' 48' ' ' LEU . 3.4 m-85 53.79 6.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.415 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.624 ' CD2' ' CE1' ' B' ' 45' ' ' PHE . 3.0 m-85 48.11 30.08 2.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 109.163 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -48.41 -20.19 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 32.5 p -74.39 -14.66 60.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.952 . . . . 0.0 109.409 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.624 ' CE1' ' CD2' ' B' ' 42' ' ' PHE . 17.5 m-85 -85.53 -2.3 58.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.364 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.08 -101.9 0.21 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' B' ' 49' ' ' SER . 1.9 p-10 -178.24 111.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -1.115 . . . . 0.0 109.525 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.563 HD12 ' N ' ' B' ' 48' ' ' LEU . 8.6 mp -81.3 28.18 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 108.687 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.421 ' H ' ' C ' ' B' ' 47' ' ' ASP . 12.2 t -43.97 -29.66 0.61 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.733 . . . . 0.0 110.25 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 13.8 p -140.22 146.93 48.09 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.014 -1.054 . . . . 0.0 109.728 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -40.13 -49.65 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.652 2.235 . . . . 0.0 112.293 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -69.47 -27.95 65.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 109.954 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.5 -19.43 37.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.067 -1.021 . . . . 0.0 109.545 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.05 -59.88 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 109.624 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 11.4 mtm -95.96 20.04 10.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.35 -17.23 50.85 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -86.54 149.99 50.18 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.181 -1.188 . . . . 0.0 109.443 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.13 -45.59 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.678 2.252 . . . . 0.0 112.341 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' B' ' 63' ' ' HIS . 50.1 mtpt -54.17 -51.91 62.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -52.67 -42.51 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.54 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -79.13 -25.98 42.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.595 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.55 -59.04 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.644 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . 0.475 ' O ' ' ND1' ' B' ' 63' ' ' HIS . 13.5 t-80 -49.28 -23.94 1.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 109.595 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.68 -28.51 73.08 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -65.97 -32.27 73.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -1.135 . . . . 0.0 109.187 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -70.32 -60.09 2.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 0.0 109.511 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 28.3 t -46.33 -29.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 109.42 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -77.75 -34.86 52.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.287 -0.883 . . . . 0.0 109.369 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.66 -46.66 93.25 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.8 -44.57 82.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -1.175 . . . . 0.0 109.6 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' B' ' 75' ' ' LEU . 4.8 t80 -60.35 -53.52 56.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.457 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . 0.507 ' OG ' ' NE1' ' B' ' 15' ' ' TRP . 62.5 m -51.94 -27.42 13.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' B' ' 84' ' ' THR . 10.5 t0 -49.74 -34.44 19.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.24 -59.85 6.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.497 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.2 mp -59.09 -17.93 30.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.374 -1.074 . . . . 0.0 109.398 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -84.89 -16.61 40.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 31.0 m80 -160.11 64.23 0.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.915 . . . . 0.0 109.607 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.74 4.17 0.44 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.399 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' B' ' 77' ' ' HIS . 59.1 m-20 -75.54 -22.93 56.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -0.875 . . . . 0.0 109.404 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -157.31 103.44 1.98 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.88 . . . . 0.0 109.378 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.583 HD22 ' N ' ' B' ' 81' ' ' LEU . 3.6 mm? -80.2 -58.78 2.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.416 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 1.432 ' NZ ' ' HZ1' ' D' ' 82' ' ' LYS . 83.5 mttt -55.25 -24.0 25.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.24 -60.23 7.84 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.0 t -69.43 -46.28 67.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 0.0 109.36 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.552 ' N ' ' CG2' ' B' ' 84' ' ' THR . 46.9 m-85 -70.34 16.81 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.547 -0.721 . . . . 0.0 109.613 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -73.75 -38.97 64.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 11.3 p -80.44 -46.18 16.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.524 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 42.8 mt -56.11 -54.84 40.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.242 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -50.15 -29.8 9.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.221 -0.924 . . . . 0.0 109.007 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.63 -63.01 1.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.116 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 tt -49.65 -23.44 1.72 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 109.078 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' B' ' 88' ' ' LEU . 7.8 m80 -76.17 -54.27 7.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 24.3 t -82.59 -19.42 38.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.003 . . . . 0.0 109.868 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.27 -25.02 25.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.088 -1.008 . . . . 0.0 111.026 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . 0.492 ' CA ' ' NE2' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -125.8 -51.96 1.57 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.843 -1.161 . . . . 0.0 110.796 -179.24 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.599 ' N ' HD12 ' B' ' 96' ' ' LEU . 8.0 mp -70.1 -58.12 4.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.974 -1.079 . . . . 0.0 110.096 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.582 ' N ' ' CD2' ' B' ' 97' ' ' HIS . 1.0 OUTLIER 72.18 19.84 4.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.326 -0.859 . . . . 0.0 109.584 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -57.86 132.11 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.138 -0.976 . . . . 0.0 109.199 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' B' ' 100' ' ' PRO . 0.7 OUTLIER -64.64 152.54 89.6 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.362 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.538 ' C ' HD22 ' B' ' 102' ' ' ASN . 74.1 Cg_exo -45.65 -175.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.43 2.087 . . . . 0.0 112.408 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 55.35 76.89 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.538 HD22 ' C ' ' B' ' 100' ' ' PRO . 0.8 OUTLIER -173.52 -56.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -58.34 -19.65 36.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -80.15 -44.59 19.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -0.925 . . . . 0.0 109.533 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.3 -48.85 79.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.49 ' C ' HD23 ' B' ' 106' ' ' LEU . 5.2 tt -56.43 -54.43 45.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.357 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.06 -31.74 62.05 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -66.78 -53.49 32.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -1.216 . . . . 0.0 109.684 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.54 -47.53 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.475 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 tp -49.01 -26.75 2.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.86 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.0 t -70.78 -38.83 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.092 -1.005 . . . . 0.0 109.937 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 t -76.79 -22.93 52.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.001 . . . . 0.0 109.932 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . 0.5 HG13 ' NH2' ' B' ' 30' ' ' ARG . 97.1 t -68.74 -24.32 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.891 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' B' ' 116' ' ' HIS . 48.7 mt -82.58 -54.33 5.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.103 -0.998 . . . . 0.0 109.678 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.476 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.64 -19.88 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.63 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.49 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.82 -62.87 1.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -0.963 . . . . 0.0 109.427 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -62.34 -17.81 59.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.438 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -151.41 61.5 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.495 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -70.8 -19.53 76.86 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.54 -30.82 70.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -1.161 . . . . 0.0 109.372 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' B' ' 123' ' ' THR . 30.9 mt-10 -90.48 14.3 13.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.465 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.4 OUTLIER -70.78 35.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.0 109.596 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.515 ' H ' ' C ' ' B' ' 121' ' ' GLU . 30.4 p -59.79 144.59 85.44 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.161 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.78 ' HA ' HH22 ' A' ' 31' ' ' ARG . 31.7 Cg_exo -44.82 -43.44 14.98 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.464 2.109 . . . . 0.0 113.408 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' B' ' 124' ' ' PRO . 3.0 Cg_exo -75.17 20.19 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.447 2.098 . . . . 0.0 112.175 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.49 HG23 ' OG1' ' B' ' 123' ' ' THR . 79.6 t -125.06 -29.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 109.565 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . 0.997 ' HB2' HH21 ' A' ' 31' ' ' ARG . 86.6 mm-40 -83.15 -59.7 2.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.99 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 1.079 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -56.64 -42.66 79.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.425 ' O ' HG23 ' B' ' 133' ' ' VAL . . . -70.06 11.07 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.536 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.599 ' CD2' HG23 ' B' ' 11' ' ' VAL . 4.9 t80 -105.2 -61.31 1.5 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.317 -0.864 . . . . 0.0 109.567 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.605 ' CD ' ' H ' ' B' ' 131' ' ' GLN . 3.8 mp0 -50.02 -38.39 37.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -0.949 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 1.126 ' HD3' ' O ' ' D' ' 146' ' ' HIS . 18.7 ttpp -64.68 -28.58 69.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.771 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . 0.697 HG22 HD21 ' B' ' 3' ' ' LEU . 79.4 t -71.45 -67.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.733 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.448 ' H ' HG22 ' B' ' 134' ' ' VAL . 2.4 m -61.3 -24.66 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.74 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -49.25 -29.32 5.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.6 -29.1 56.1 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.418 HG13 ' CE1' ' B' ' 85' ' ' PHE . 67.0 t -72.93 -34.28 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -1.133 . . . . 0.0 109.404 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.71 -48.18 63.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.469 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 0.48 ' C ' HD22 ' B' ' 139' ' ' ASN . 0.2 OUTLIER -77.76 -29.62 51.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.495 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.25 82.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.409 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.24 13.21 1.96 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.47 4.53 1.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' B' ' 139' ' ' ASN . 12.3 t-80 -79.39 -26.29 42.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.203 -0.935 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.8 OUTLIER -81.95 -1.38 47.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.521 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -66.07 7.64 0.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 109.27 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 1.568 ' CD2' ' NE2' ' D' ' 2' ' ' HIS . 4.7 m-70 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.461 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.522 HD11 ' HD3' ' C' ' 127' ' ' LYS . 9.5 tp -172.41 163.46 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 109.777 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.8 OUTLIER -75.79 -177.06 0.65 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.016 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 58.4 Cg_endo -86.84 -68.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.606 2.204 . . . . 0.0 112.711 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -47.62 -40.31 19.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 109.542 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.597 ' O ' HG23 ' C' ' 10' ' ' VAL . 63.9 m-20 -43.6 -29.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 0.0 109.039 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' C' ' 10' ' ' VAL . 58.4 mttt -83.05 -53.78 5.55 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.414 ' C ' ' O ' ' C' ' 7' ' ' LYS . 35.4 m -44.7 -38.52 4.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.488 -0.757 . . . . 0.0 109.227 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -72.38 -29.7 64.01 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.597 HG23 ' O ' ' C' ' 6' ' ' ASP . 54.2 t -75.13 -55.07 12.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' C' ' 11' ' ' LYS . 0.1 OUTLIER -51.53 -39.25 57.34 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.649 -1.221 . . . . 0.0 108.229 179.109 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.05 -63.18 1.35 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 109.321 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.559 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.66 -38.64 67.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.388 -0.82 . . . . 0.0 108.836 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.91 -17.64 63.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.469 -0.769 . . . . 0.0 108.988 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.04 -45.09 16.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.425 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 39.2 mmtt -68.15 -41.48 81.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 108.862 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.559 HG23 ' O ' ' C' ' 13' ' ' ALA . 61.4 t -60.16 -64.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 49.93 -127.9 24.86 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.39 24.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.388 -1.066 . . . . 0.0 110.426 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.548 ' H ' ' C ' ' C' ' 18' ' ' GLY . 87.4 m-70 -130.45 28.41 4.94 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -93.2 -61.24 1.61 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.642 -0.661 . . . . 0.0 109.849 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.41 -14.27 0.18 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.6 mt-10 -86.56 -56.27 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -1.056 . . . . 0.0 109.764 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 4.1 m-30 -59.78 -32.44 70.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 0.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.9 -23.02 75.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.89 -41.8 18.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -1.213 . . . . 0.0 109.974 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' C' ' 27' ' ' GLU . 0.1 OUTLIER -66.03 -19.84 65.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.261 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.77 -20.35 60.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.552 HD11 ' ND1' ' C' ' 58' ' ' HIS . 14.1 mt -74.48 -51.23 15.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 109.672 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.59 -22.35 65.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.943 HH21 ' HB2' ' D' ' 127' ' ' GLN . 2.3 tpt180 -73.38 -20.87 60.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 46.0 ttp -78.19 -53.76 6.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.333 -0.854 . . . . 0.0 109.57 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 0.0 OUTLIER -48.3 -24.25 1.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.397 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 1.087 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.6 mt -82.27 -46.11 14.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.656 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 45.8 m -69.27 -20.72 63.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.854 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' C' ' 35' ' ' SER . 95.5 m-85 -158.42 79.11 3.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.033 -1.042 . . . . 0.0 109.758 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' C' ' 39' ' ' THR . 51.8 Cg_exo -50.19 -26.43 15.22 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.612 2.208 . . . . 0.0 112.049 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' C' ' 41' ' ' THR . 12.6 p -49.44 -18.33 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.405 ' N ' ' C ' ' C' ' 37' ' ' PRO . 53.9 p -78.91 -22.32 46.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.722 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -46.11 -42.84 14.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.913 . . . . 0.0 109.776 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.502 HG21 ' HD1' ' B' ' 97' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.459 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 15.9 p80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.667 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -149.76 69.28 1.02 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' C' ' 46' ' ' PHE . 1.1 m-20 -24.35 -37.74 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.925 -0.484 . . . . 0.0 111.183 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.667 ' N ' ' O ' ' C' ' 46' ' ' PHE . 4.3 mt 53.7 7.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.06 -1.025 . . . . 0.0 109.344 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.484 ' H ' ' C ' ' C' ' 47' ' ' ASP . 5.0 m -64.32 5.69 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.601 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' C' ' 48' ' ' LEU . 38.1 t60 61.42 125.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.311 -0.868 . . . . 0.0 109.501 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.46 14.24 66.32 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 13.5 t -77.81 -103.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -1.159 . . . . 0.0 109.48 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.96 -29.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.439 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -80.04 -17.97 51.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.265 -0.897 . . . . 0.0 109.157 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -84.35 -40.25 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -77.37 -32.37 54.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -0.924 . . . . 0.0 109.082 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.14 -21.8 75.13 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.552 ' ND1' HD11 ' C' ' 29' ' ' LEU . 7.8 t-80 -75.7 -37.46 59.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -1.103 . . . . 0.0 109.721 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.22 -48.49 47.05 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -51.7 -23.15 4.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -1.079 . . . . 0.0 110.063 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -39.83 64.68 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.109 -0.994 . . . . 0.0 109.218 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.29 -33.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.11 -32.95 44.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.378 -0.826 . . . . 0.0 109.462 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -70.33 -33.41 71.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.077 -1.014 . . . . 0.0 108.841 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.03 -53.14 18.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.412 -0.805 . . . . 0.0 108.843 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.29 -38.23 70.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 108.642 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -71.54 -50.28 32.78 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.83 -21.02 60.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.21 -47.37 13.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.424 HG13 ' CE ' ' C' ' 11' ' ' LYS . 10.0 t -65.84 -23.02 31.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.52 -15.21 63.46 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.62 ' O ' ' N ' ' C' ' 74' ' ' ASP . 36.8 m80 -139.42 -63.17 0.52 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.379 -0.825 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.59 HG22 ' O ' ' C' ' 73' ' ' VAL . 12.3 p 43.97 13.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.813 0.816 . . . . 0.0 109.634 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.62 ' N ' ' O ' ' C' ' 72' ' ' HIS . 16.2 m-20 -134.25 10.39 3.81 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.464 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 20.2 t0 -176.95 28.29 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.037 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 11.4 ptt? -78.87 -22.44 0.38 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 111.745 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 72.7 Cg_exo -49.02 -29.03 14.75 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.569 1.513 . . . . 0.0 112.4 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -94.3 -24.29 17.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.709 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.36 -53.49 8.1 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.179 -0.951 . . . . 0.0 109.191 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 15.0 mt -78.05 9.13 3.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.43 -0.794 . . . . 0.0 109.022 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' C' ' 84' ' ' SER . 11.1 t -66.1 -41.59 90.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -52.3 -53.01 49.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.486 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' C' ' 83' ' ' LEU . 4.9 mt -44.83 -45.0 9.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 10.0 p -55.85 -39.77 71.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' C' ' 82' ' ' ALA . 25.8 t70 -67.64 -17.9 64.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.443 HD23 ' O ' ' C' ' 86' ' ' LEU . 1.2 tt -82.81 -43.45 16.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.35 -0.844 . . . . 0.0 109.469 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -92.42 -21.23 20.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 109.979 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -60.73 -87.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 110.729 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . 0.459 ' O ' ' O ' ' C' ' 90' ' ' LYS . 45.1 t-80 -96.61 -46.21 6.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 111.043 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' C' ' 89' ' ' HIS . 35.9 mttm -41.33 -94.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.145 -0.972 . . . . 0.0 110.346 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.55 -34.95 78.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.017 . . . . 0.0 109.65 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . 1.403 ' NH2' ' HE ' ' B' ' 40' ' ' ARG . 45.6 ttp85 60.87 58.19 2.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 109.602 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 t -84.29 161.56 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 109.451 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.38 151.37 50.85 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.957 . . . . 0.0 109.342 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' C' ' 97' ' ' ASN . 58.6 Cg_endo -72.99 -18.86 23.8 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.524 2.149 . . . . 0.0 112.234 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.455 HG21 ' CB ' ' B' ' 99' ' ' ASP . 24.5 t -47.21 -19.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.733 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.671 HD22 ' N ' ' C' ' 97' ' ' ASN . 0.8 OUTLIER -79.12 -24.86 43.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.732 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . 0.538 ' CZ ' HD23 ' C' ' 136' ' ' LEU . 4.8 m-85 -46.63 -32.53 3.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 109.686 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.504 ' O ' ' ND1' ' C' ' 103' ' ' HIS . 55.7 mttm -83.94 -36.78 23.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 109.781 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.576 HD12 ' N ' ' C' ' 100' ' ' LEU . 7.2 mp -66.35 -62.02 1.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.491 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . 0.402 ' C ' HD23 ' C' ' 101' ' ' LEU . 6.4 tt -49.94 -47.39 52.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 42.7 t -61.95 -38.76 89.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.634 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' C' ' 99' ' ' LYS . 22.9 m80 -77.4 -27.59 52.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.621 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 70.8 m -64.8 -46.99 79.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.728 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.24 -48.6 65.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.454 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.471 ' N ' HD12 ' C' ' 106' ' ' LEU . 9.5 mp -61.51 -59.22 5.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.94 -34.25 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 16.8 m -75.77 -60.87 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 13.0 mt -46.11 -41.44 12.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 0.0 109.676 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.83 -28.74 0.68 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.153 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.83 -56.35 4.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.132 -0.98 . . . . 0.0 109.722 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -85.83 -65.08 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.472 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 109' ' ' LEU . 0.1 OUTLIER -95.94 106.86 30.72 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.21 171.23 9.38 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.73 1.62 . . . . 0.0 112.352 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -87.28 -34.34 18.94 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.441 0.639 . . . . 0.0 109.87 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' C' ' 117' ' ' PHE . 23.2 mt-10 55.66 9.87 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' C' ' 116' ' ' GLU . 29.2 p90 40.63 32.42 0.15 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.522 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.491 ' OG1' HG23 ' C' ' 121' ' ' VAL . 5.0 p -60.96 145.66 88.75 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.47 29.51 0.13 Allowed 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.957 1.771 . . . . 0.0 111.734 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' C' ' 118' ' ' THR . . . -162.62 -23.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.174 -0.954 . . . . 0.0 111.072 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.491 HG23 ' OG1' ' C' ' 118' ' ' THR . 2.6 t -59.94 -62.55 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.829 -1.17 . . . . 0.0 109.818 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.455 ' N ' HG12 ' C' ' 121' ' ' VAL . 0.1 OUTLIER -60.76 -27.2 67.78 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.426 -0.797 . . . . 0.0 109.087 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.04 32.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.645 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.476 ' N ' ' O ' ' C' ' 120' ' ' ALA . 95.7 p -67.25 -61.94 1.67 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 110.828 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 9.7 mt -80.15 -19.97 45.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.065 -1.022 . . . . 0.0 110.844 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.73 -42.49 28.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.759 -1.213 . . . . 0.0 110.332 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.522 ' HD3' HD11 ' C' ' 2' ' ' LEU . 0.0 OUTLIER -90.15 -44.88 9.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.999 -1.063 . . . . 0.0 110.17 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.424 ' CD1' HG21 ' C' ' 10' ' ' VAL . 71.2 t80 -47.3 -21.53 0.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.029 -1.044 . . . . 0.0 109.564 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.401 ' N ' ' C ' ' C' ' 127' ' ' LYS . 15.8 mt -69.66 -17.67 63.52 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.97 -38.25 78.66 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.448 ' HB3' HD13 ' C' ' 2' ' ' LEU . 60.5 p -78.66 -25.89 44.98 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.31 -0.869 . . . . 0.0 108.756 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -85.05 -40.48 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 2.7 t -68.85 -28.85 67.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.453 -0.779 . . . . 0.0 109.239 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 51.5 m -64.63 -39.99 94.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 109.015 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.402 ' H ' HG12 ' C' ' 135' ' ' VAL . 2.7 p -82.62 -21.9 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . 0.538 HD23 ' CZ ' ' C' ' 98' ' ' PHE . 1.1 tp -78.83 -28.36 44.36 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' C' ' 138' ' ' SER . 49.8 m -68.15 -23.34 64.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 109.392 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' C' ' 137' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . 1.568 ' NE2' ' CD2' ' B' ' 146' ' ' HIS . 6.2 p80 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.253 0.549 . . . . 0.0 109.756 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.867 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -141.96 -162.64 1.43 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.276 -0.89 . . . . 0.0 109.183 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -93.74 131.04 33.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 109.263 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.45 -23.68 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.329 2.019 . . . . 0.0 112.402 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -81.57 -53.02 6.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.816 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' D' ' 7' ' ' GLU . 5.5 mp0 -61.34 -55.52 30.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.747 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -57.17 -35.42 69.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.806 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -58.71 -23.73 60.15 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 109.992 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.54 -56.61 3.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.978 -1.076 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.594 HG23 ' CD2' ' D' ' 130' ' ' TYR . 0.9 OUTLIER -63.98 -25.13 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 73.6 m -78.66 -35.24 45.55 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -60.5 -61.41 2.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.252 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.512 ' O ' HG23 ' D' ' 18' ' ' VAL . 8.0 mp -43.73 -18.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 109.759 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' D' ' 13' ' ' ALA . 22.1 t-105 -78.03 -18.04 56.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.148 -0.97 . . . . 0.0 109.646 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.97 -42.72 7.49 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.665 ' CD ' ' H ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -68.66 -31.97 71.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -1.12 . . . . 0.0 109.2 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.512 HG23 ' O ' ' D' ' 14' ' ' LEU . 4.7 t -52.4 119.89 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.655 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' D' ' 21' ' ' ASP . 55.8 m-20 -86.99 82.85 7.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 108.98 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' D' ' 22' ' ' GLU . 91.6 t -43.99 -20.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 109.789 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' D' ' 19' ' ' ASN . 12.7 m-20 -51.62 -8.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.802 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' D' ' 20' ' ' VAL . 34.8 mt-10 -155.48 -49.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 109.629 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 74.1 t -46.11 -26.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.788 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.05 -31.18 32.53 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -82.56 -25.65 49.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -84.67 -29.99 25.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -1.144 . . . . 0.0 109.682 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.47 -23.49 63.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.812 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.68 -58.25 3.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.477 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.21 -29.27 68.25 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . 0.498 ' NH2' HG13 ' D' ' 113' ' ' VAL . 3.3 ttp180 -68.43 -29.43 68.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.681 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp -51.61 -39.75 58.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.635 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.04 -21.88 50.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.878 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.85 -47.93 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.869 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -63.35 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 0.0 109.788 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -119.42 97.01 50.16 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 0.0 109.814 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' D' ' 38' ' ' THR . 90.9 Cg_endo -85.57 10.56 3.65 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.659 2.239 . . . . 0.0 111.906 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -45.24 -19.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 0.0 109.732 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.645 ' C ' ' H ' ' D' ' 40' ' ' ARG . 10.9 p -46.95 -34.37 5.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 109.637 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 61.09 -13.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.38 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . 1.393 ' HE ' ' NH2' ' A' ' 92' ' ' ARG . 79.9 mtt180 -89.01 -25.55 21.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 108.971 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 53.68 6.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 109.429 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.613 ' CD2' ' CE1' ' D' ' 45' ' ' PHE . 3.0 m-85 48.03 30.14 1.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.174 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -48.34 -20.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 109.72 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 33.1 p -74.46 -14.66 60.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.973 . . . . 0.0 109.392 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.613 ' CE1' ' CD2' ' D' ' 42' ' ' PHE . 17.4 m-85 -85.42 -2.38 58.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.08 -101.88 0.21 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' D' ' 49' ' ' SER . 1.9 p-10 -178.2 111.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.509 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . 0.574 HD12 ' N ' ' D' ' 48' ' ' LEU . 8.6 mp -81.27 28.1 0.39 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 108.753 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.414 ' H ' ' C ' ' D' ' 47' ' ' ASP . 12.0 t -43.86 -29.72 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.638 -0.664 . . . . 0.0 110.3 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 14.0 p -140.16 146.9 48.14 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.089 -1.007 . . . . 0.0 109.693 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -40.14 -49.61 3.71 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.676 2.251 . . . . 0.0 112.255 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -69.5 -27.98 65.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.91 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.48 -19.4 36.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.605 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.06 -59.97 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.584 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 11.4 mtm -95.87 20.14 10.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 109.458 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.44 -17.24 50.48 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -86.59 150.0 50.08 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.229 -1.159 . . . . 0.0 109.395 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.18 -45.58 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.579 2.186 . . . . 0.0 112.236 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' D' ' 63' ' ' HIS . 50.1 mtpt -54.12 -51.96 62.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 59.9 t -52.64 -42.55 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -79.0 -26.13 43.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.569 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.45 -59.07 2.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.657 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . 0.472 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 13.5 t-80 -49.37 -23.88 1.66 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.558 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.74 -28.51 73.06 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -65.92 -32.3 73.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -1.172 . . . . 0.0 109.21 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -70.29 -60.11 2.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 109.501 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 27.6 t -46.41 -29.68 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.375 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -77.71 -34.88 52.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.372 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.68 -46.69 93.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.57 81.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.59 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . 0.418 ' CZ ' HD11 ' D' ' 75' ' ' LEU . 4.7 t80 -60.43 -53.51 56.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -0.887 . . . . 0.0 109.375 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . 0.522 ' HG ' ' HE1' ' D' ' 15' ' ' TRP . 63.2 m -51.96 -27.41 13.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.455 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' D' ' 84' ' ' THR . 10.6 t0 -49.71 -34.49 18.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.95 . . . . 0.0 109.391 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.26 -59.91 6.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.493 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.2 mp -59.03 -17.97 30.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -1.151 . . . . 0.0 109.427 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . 0.53 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -84.9 -16.61 40.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 31.1 m80 -160.1 64.16 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.74 4.19 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.414 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' D' ' 77' ' ' HIS . 59.5 m-20 -75.41 -22.98 56.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.92 . . . . 0.0 109.421 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -157.3 103.47 1.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.354 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . 0.592 HD22 ' N ' ' D' ' 81' ' ' LEU . 3.6 mm? -80.23 -58.79 2.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.945 . . . . 0.0 109.427 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . 1.432 ' HZ1' ' NZ ' ' B' ' 82' ' ' LYS . 83.5 mttt -55.3 -23.9 25.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.577 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.23 -60.26 7.8 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.0 t -69.44 -46.23 67.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.151 -1.205 . . . . 0.0 109.378 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.555 ' N ' ' CG2' ' D' ' 84' ' ' THR . 46.8 m-85 -70.35 16.85 0.07 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.523 -0.736 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -73.85 -38.8 64.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.453 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 11.0 p -80.62 -46.14 16.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.414 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.515 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 42.3 mt -56.07 -54.86 39.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 109.287 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -50.19 -29.73 9.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.944 . . . . 0.0 109.037 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' D' ' 94' ' ' ASP . 42.4 tt0 -82.6 -63.03 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.128 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 tt -49.73 -23.42 1.78 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 109.046 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' D' ' 88' ' ' LEU . 7.9 m80 -76.13 -54.33 6.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.181 -0.949 . . . . 0.0 109.486 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 24.1 t -82.57 -19.42 38.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.161 -0.962 . . . . 0.0 109.916 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' D' ' 90' ' ' GLU . 1.4 m-20 -86.23 -24.96 25.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.082 -1.011 . . . . 0.0 111.086 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . 0.487 ' CA ' ' NE2' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -125.83 -52.04 1.57 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.829 -1.169 . . . . 0.0 110.725 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.606 ' N ' HD12 ' D' ' 96' ' ' LEU . 8.0 mp -70.16 -58.1 4.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.894 -1.129 . . . . 0.0 110.053 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.583 ' HD1' HG21 ' A' ' 41' ' ' THR . 1.0 OUTLIER 72.12 19.88 4.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.583 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.69 132.07 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.101 -0.999 . . . . 0.0 109.221 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . 0.511 ' CB ' HG21 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -64.6 152.6 89.31 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 109.309 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . 0.538 ' C ' HD22 ' D' ' 102' ' ' ASN . 74.3 Cg_exo -45.72 -175.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.504 2.136 . . . . 0.0 112.402 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 55.4 76.82 0.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . 0.538 HD22 ' C ' ' D' ' 100' ' ' PRO . 0.8 OUTLIER -173.56 -56.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.859 . . . . 0.0 109.372 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -58.42 -19.55 37.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.0 109.515 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -80.23 -44.45 19.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.39 -48.88 79.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.382 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.479 ' C ' HD23 ' D' ' 106' ' ' LEU . 5.2 tt -56.41 -54.5 44.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.298 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.04 -31.7 61.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -66.82 -53.47 32.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -1.194 . . . . 0.0 109.686 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 79.3 t -49.44 -47.5 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tp -49.13 -26.66 2.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 109.823 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.77 -38.82 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.09 -1.006 . . . . 0.0 109.998 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 22.8 t -76.77 -22.99 52.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.898 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . 0.498 HG13 ' NH2' ' D' ' 30' ' ' ARG . 97.5 t -68.7 -24.34 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.948 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' D' ' 116' ' ' HIS . 48.6 mt -82.58 -54.4 5.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.14 -0.975 . . . . 0.0 109.668 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.487 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.62 -19.94 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 109.647 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.465 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.71 -62.89 1.44 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.429 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -62.36 -17.78 59.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.865 . . . . 0.0 109.436 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -151.38 61.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -70.82 -19.49 76.86 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.58 -30.74 70.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -1.165 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' D' ' 123' ' ' THR . 30.9 mt-10 -90.57 14.36 13.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.4 OUTLIER -70.77 35.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.498 ' H ' ' C ' ' D' ' 121' ' ' GLU . 30.4 p -59.75 144.64 85.16 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.158 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.766 ' HA ' HH22 ' C' ' 31' ' ' ARG . 31.5 Cg_exo -44.85 -43.39 15.09 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.439 2.093 . . . . 0.0 113.517 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' D' ' 124' ' ' PRO . 3.1 Cg_exo -75.16 20.12 0.48 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.437 2.091 . . . . 0.0 112.174 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.481 HG23 ' OG1' ' D' ' 123' ' ' THR . 79.5 t -125.02 -29.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.341 -0.85 . . . . 0.0 109.602 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . 0.943 ' HB2' HH21 ' C' ' 31' ' ' ARG . 86.5 mm-40 -83.17 -59.78 2.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.446 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 1.087 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -56.68 -42.57 79.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.964 . . . . 0.0 109.363 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.434 ' O ' HG23 ' D' ' 133' ' ' VAL . . . -70.05 11.05 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.526 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.594 ' CD2' HG23 ' D' ' 11' ' ' VAL . 4.9 t80 -105.22 -61.3 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 0.606 ' CD ' ' H ' ' D' ' 131' ' ' GLN . 3.8 mp0 -50.05 -38.45 37.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 109.388 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . 1.096 ' HD3' ' O ' ' B' ' 146' ' ' HIS . 18.7 ttpp -64.54 -28.61 69.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.77 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . 0.684 HG22 HD21 ' D' ' 3' ' ' LEU . 79.3 t -71.49 -67.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.708 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.48 ' H ' HG22 ' D' ' 134' ' ' VAL . 2.4 m -61.23 -24.58 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.807 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -49.34 -29.29 5.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 0.0 109.287 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.63 -29.08 56.08 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' D' ' 85' ' ' PHE . 66.1 t -72.9 -34.15 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -1.116 . . . . 0.0 109.514 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.81 -48.13 64.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.506 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . 0.482 ' C ' HD22 ' D' ' 139' ' ' ASN . 0.2 OUTLIER -77.75 -29.55 51.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.589 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.14 83.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.411 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 30.9 mt -79.24 13.14 1.99 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.362 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.47 4.56 1.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.631 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' D' ' 139' ' ' ASN . 12.3 t-80 -79.34 -26.26 42.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.167 -0.958 . . . . 0.0 109.459 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.8 OUTLIER -82.04 -1.4 48.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.479 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -65.91 7.6 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 1.524 ' CD2' ' NE2' ' B' ' 2' ' ' HIS . 4.7 m-70 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.472 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.485 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 36.4 mt -121.29 -171.74 2.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.829 . . . . 0.0 109.561 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -97.75 -179.08 0.81 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 109.296 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 26.0 Cg_exo -60.87 -68.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.605 2.203 . . . . 0.0 112.291 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.452 ' O ' ' ND2' ' A' ' 9' ' ' ASN . . . -52.39 -36.12 53.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.797 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 3.3 m-20 -44.18 -33.7 1.62 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -83.41 -60.12 2.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.621 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.8 m -46.97 -29.74 2.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.419 -0.8 . . . . 0.0 109.979 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 5' ' ' ALA . 22.9 m-20 -77.33 -36.83 53.51 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.024 -1.048 . . . . 0.0 108.279 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -76.14 -47.97 29.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -53.17 -38.54 62.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.52 -62.99 1.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.411 -0.806 . . . . 0.0 109.357 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.27 67.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.421 -0.799 . . . . 0.0 109.204 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.451 ' HZ3' HD11 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -72.9 -17.31 61.52 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 108.967 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.59 -40.07 59.76 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -84.75 -49.79 8.16 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.503 -0.998 . . . . 0.0 109.327 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 20' ' ' HIS . 70.4 t -59.96 -35.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.56 -0.712 . . . . 0.0 109.675 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.586 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . -31.53 144.8 0.02 OUTLIER Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . 69.12 -32.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -1.07 . . . . 0.0 108.896 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.586 ' H ' ' C ' ' A' ' 18' ' ' GLY . 1.2 m80 -104.88 13.94 30.34 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' A' ' 17' ' ' VAL . . . -83.55 -48.69 9.99 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.939 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.46 -14.62 42.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -89.1 -56.62 3.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -1.095 . . . . 0.0 109.702 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.639 ' CZ ' ' CE1' ' A' ' 112' ' ' HIS . 2.9 m-30 -58.98 -33.14 70.34 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 109.176 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.82 -33.06 76.49 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.04 -50.8 10.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -1.174 . . . . 0.0 109.721 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -52.4 -19.8 2.4 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.55 -25.54 65.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.506 HD11 ' CG ' ' A' ' 58' ' ' HIS . 33.5 mt -72.27 -58.02 3.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.671 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.71 -14.29 30.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.524 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 1.052 ' NH1' ' CG ' ' B' ' 127' ' ' GLN . 1.8 tpm_? -75.45 -38.98 59.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 109.357 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.512 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -80.02 -48.5 13.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.218 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 32' ' ' MET . 37.1 t80 -43.72 -19.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.396 -0.815 . . . . 0.0 109.831 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.815 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 11.0 mt -79.88 -60.2 2.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.136 -0.978 . . . . 0.0 109.701 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.694 ' OG ' ' OE1' ' B' ' 131' ' ' GLN . 29.6 m -81.39 -31.37 33.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 109.676 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 60.3 m-85 -113.63 95.04 35.22 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.411 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.12 -20.1 8.9 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.447 2.098 . . . . 0.0 112.228 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.693 ' O ' HG22 ' A' ' 41' ' ' THR . 71.1 p -47.64 -42.1 23.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 109.274 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 39' ' ' THR . 12.6 p -44.03 -22.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.83 . . . . 0.0 109.854 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' THR . 30.6 ttpt -70.87 -19.11 62.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.638 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 1.137 HG21 ' CD2' ' D' ' 97' ' ' HIS . 8.7 t . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.542 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.231 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.47 ' C ' ' H ' ' A' ' 48' ' ' LEU . 2.1 p90 -142.54 44.91 1.62 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.532 -1.355 . . . . 0.0 110.11 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.12 -35.32 0.3 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 110.453 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER 61.86 55.85 2.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.043 . . . . 0.0 109.0 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.1 m -165.39 157.06 14.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 0.0 109.541 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.464 ' C ' ' H ' ' A' ' 52' ' ' SER . 2.7 m-70 -59.6 160.94 6.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.877 . . . . 0.0 109.385 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.73 -18.14 1.92 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 54' ' ' GLN . 29.5 p -48.78 -25.94 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -1.145 . . . . 0.0 109.322 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.05 -40.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.835 . . . . 0.0 109.688 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.52 ' H ' ' C ' ' A' ' 52' ' ' SER . 20.5 mt-30 -69.76 -23.73 63.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.304 -0.873 . . . . 0.0 109.304 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.432 HG23 ' OG ' ' A' ' 52' ' ' SER . 57.6 t -69.61 -40.57 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.97 . . . . 0.0 109.129 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -65.73 -54.38 28.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.241 -0.912 . . . . 0.0 108.62 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.19 -36.09 21.1 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.506 ' CG ' HD11 ' A' ' 29' ' ' LEU . 6.1 t-80 -60.5 -36.57 78.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.315 . . . . 0.0 109.895 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.42 -29.28 38.27 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 56.8 mttm -65.18 -23.57 67.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -1.162 . . . . 0.0 110.263 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.41 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -69.16 -58.13 4.47 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.962 -1.086 . . . . 0.0 108.656 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.3 t -56.46 -44.76 81.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.655 -0.653 . . . . 0.0 109.315 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.51 74.46 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.298 -0.876 . . . . 0.0 109.225 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.9 t70 -66.03 -37.98 87.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -67.56 -53.33 29.22 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.1 mt -58.53 -42.34 87.54 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 71' ' ' ALA . 15.5 m -69.68 -51.58 33.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.273 -0.892 . . . . 0.0 108.696 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -62.23 -25.97 68.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.08 -46.38 11.21 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 66' ' ' LEU . 38.1 t -66.7 -22.75 30.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -69.51 -36.37 76.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.589 ' O ' ' N ' ' A' ' 74' ' ' ASP . 26.1 m80 -103.29 -66.74 0.92 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.615 -0.678 . . . . 0.0 109.424 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 73' ' ' VAL . 14.9 p 44.37 14.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.953 0.882 . . . . 0.0 109.287 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 72' ' ' HIS . 5.5 m-20 -137.96 12.02 2.87 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 0.2 OUTLIER 171.72 31.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 3.5 ptt? -78.29 -23.67 0.42 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.334 -0.854 . . . . 0.0 111.842 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.8 Cg_exo -53.58 -19.46 13.94 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.665 1.576 . . . . 0.0 112.477 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -94.19 -40.43 10.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.68 -48.9 67.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.918 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.61 6.04 6.53 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.446 -0.784 . . . . 0.0 109.198 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.1 t -54.53 -19.56 6.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 109.614 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -83.12 -58.53 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 109.916 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 83' ' ' LEU . 3.8 mt -45.34 -44.58 11.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -0.847 . . . . 0.0 109.082 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.407 ' CB ' ' HG ' ' A' ' 138' ' ' SER . 23.3 t -60.06 -18.93 50.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.519 -0.738 . . . . 0.0 109.56 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 89' ' ' HIS . 36.8 t70 -81.06 -50.94 9.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.913 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.6 tt -64.16 -26.79 68.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.97 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.74 -21.78 26.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 110.328 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.56 -11.03 11.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 0.0 110.154 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.564 ' N ' ' O ' ' A' ' 85' ' ' ASP . 42.7 t60 -106.64 -74.6 0.65 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 109.919 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' ARG . 79.8 mttt -63.84 -110.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.058 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 mt -44.48 -17.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.017 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.455 ' CG ' ' NH2' ' D' ' 40' ' ' ARG . 31.8 ttm-85 46.75 41.56 10.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.142 -0.974 . . . . 0.0 109.481 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.9 t -45.94 144.8 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.867 . . . . 0.0 109.701 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 10.6 m-20 -80.52 150.2 69.77 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.65 -19.48 21.34 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.437 2.091 . . . . 0.0 112.229 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 96' ' ' VAL . 4.1 t -66.35 -7.75 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.666 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 94' ' ' ASP . 12.7 m120 -79.74 -36.26 37.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.478 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -46.33 -41.58 13.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.879 -1.138 . . . . 0.0 109.536 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.49 ' CB ' ' NZ ' ' A' ' 99' ' ' LYS . 8.0 mtmp? -51.38 -28.24 12.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.963 . . . . 0.0 109.291 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.577 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 15.4 mt -84.29 -61.95 1.68 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.682 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tp -49.78 -23.62 1.93 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.878 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -73.38 -49.45 27.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -80.62 -26.37 37.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 0.0 109.923 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 65.7 m -65.06 -60.29 3.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.158 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.722 ' C ' HD12 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -57.45 -22.44 43.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 109.825 -179.401 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.18 -31.42 38.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.802 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.46 HG11 ' OE1' ' B' ' 127' ' ' GLN . 56.1 t -83.38 -24.94 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 110.051 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 1.5 t -79.68 -47.72 14.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.0 109.959 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.737 HD12 ' O ' ' A' ' 109' ' ' LEU . 0.8 OUTLIER -69.72 -18.59 63.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.752 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.92 -22.22 46.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 110.257 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.4 -56.24 24.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 110.182 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.681 ' CG ' ' H ' ' A' ' 113' ' ' LEU . 9.4 p80 -72.48 -61.93 1.63 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.098 -1.001 . . . . 0.0 109.469 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.929 HD23 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -119.73 121.43 29.84 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.3 175.7 7.38 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.422 2.081 . . . . 0.0 112.99 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.654 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -45.36 -54.96 6.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.632 -0.668 . . . . 0.0 109.346 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.654 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 26.1 mt-10 122.9 -2.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.468 ' CG ' ' C ' ' A' ' 116' ' ' GLU . 1.8 m-85 72.22 32.88 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.714 -0.616 . . . . 0.0 111.278 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.772 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.3 p -97.59 121.27 58.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.895 -1.128 . . . . 0.0 108.16 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.62 24.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.934 1.756 . . . . 0.0 112.502 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -150.38 -32.41 0.18 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.981 -1.074 . . . . 0.0 110.401 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 122' ' ' HIS . 12.0 p -53.92 -50.04 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.04 -1.037 . . . . 0.0 110.329 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.671 ' N ' HG13 ' A' ' 121' ' ' VAL . 23.2 m-70 -54.84 -44.98 74.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.36 -20.05 32.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 110.375 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 120' ' ' ALA . 94.0 p -52.19 -52.97 48.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.945 . . . . 0.0 110.545 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.451 HD11 ' HZ3' ' A' ' 14' ' ' TRP . 5.5 mt -84.11 -19.34 34.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.0 109.975 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.71 -51.83 9.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.296 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.449 ' HZ2' ' HG2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.63 -43.06 27.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.978 -1.076 . . . . 0.0 110.151 -179.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.485 ' CD2' ' CD1' ' A' ' 2' ' ' LEU . 33.9 t80 -50.59 -21.39 1.52 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.858 -1.151 . . . . 0.0 108.929 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 133' ' ' SER . 17.4 mt -73.78 -18.26 60.99 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -60.14 -35.48 75.37 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 135' ' ' VAL . 97.5 p -80.78 -27.02 36.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -84.73 -30.13 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 129' ' ' LEU . 51.6 m -79.17 -40.83 29.89 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 53.2 m -69.3 -26.4 64.71 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 131' ' ' SER . 23.4 t -81.49 -30.28 10.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.09 -23.34 62.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.365 -0.834 . . . . 0.0 109.052 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 138' ' ' SER . 37.8 p -87.29 -18.39 30.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 0.0 109.568 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' THR . 21.6 m . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.449 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 82.0 t60 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.169 0.509 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.858 HD12 ' N ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -135.99 179.64 6.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 0.0 109.006 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 7' ' ' GLU . 7.3 p -76.15 132.55 73.4 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.104 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -41.28 -24.71 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.343 2.029 . . . . 0.0 112.457 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.2 -21.76 25.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.876 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' B' ' 4' ' ' THR . 32.2 tt0 -80.45 -63.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.959 . . . . 0.0 109.932 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.604 ' HB3' HD13 ' B' ' 3' ' ' LEU . 24.2 pttt -62.25 -31.69 72.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 110.051 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.2 t -44.57 -23.35 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.0 110.406 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -81.59 -57.35 3.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.945 -1.097 . . . . 0.0 110.102 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.442 HG23 ' CE2' ' B' ' 130' ' ' TYR . 14.9 p -68.74 -24.62 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.094 -1.003 . . . . 0.0 108.318 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 12.5 m -71.95 -42.07 67.01 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.339 0.59 . . . . 0.0 109.88 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.75 -30.46 69.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.344 -0.848 . . . . 0.0 109.802 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -50.28 -18.83 0.67 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.97 . . . . 0.0 109.349 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . 0.409 ' CZ2' HD13 ' B' ' 75' ' ' LEU . 0.7 OUTLIER -53.08 -51.48 61.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.15 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.09 -32.41 35.32 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -46.7 13.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -1.084 . . . . 0.0 109.177 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.99 114.85 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.732 . . . . 0.0 109.853 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' B' ' 21' ' ' ASP . 19.1 m120 -79.41 71.58 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 108.748 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 20' ' ' VAL . 57.8 t -46.98 -11.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.851 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' B' ' 19' ' ' ASN . 16.5 m-20 -73.45 -5.5 40.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 109.821 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -156.26 -40.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.119 -0.988 . . . . 0.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 78.0 t -46.5 -55.42 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.883 . . . . 0.0 109.64 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.76 -29.83 50.71 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.51 -30.05 69.27 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.92 -31.41 59.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.221 -1.164 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.17 -54.28 48.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.542 HD22 ' N ' ' B' ' 28' ' ' LEU . 3.8 mm? -61.87 -40.1 94.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.273 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.92 -42.91 76.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -72.69 -37.08 67.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -1.122 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 tp -50.07 -31.7 13.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.265 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.28 -22.47 38.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.04 -64.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.627 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.466 HG23 ' H ' ' B' ' 34' ' ' VAL . 0.2 OUTLIER -64.14 -22.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.422 -0.799 . . . . 0.0 109.663 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -140.25 79.17 21.94 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 109.559 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -83.48 -12.45 8.99 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.888 2.392 . . . . 0.0 112.369 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.53 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 3.4 p-90 -48.57 -33.99 10.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.523 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.53 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 3.2 m -78.95 2.65 19.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . 0.444 ' O ' ' OE1' ' B' ' 39' ' ' GLN . 1.4 tm0? -65.53 -19.08 65.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.45 ' HE ' ' HD3' ' C' ' 92' ' ' ARG . 32.9 mtp85 -68.59 -40.84 80.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.751 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -93.04 -18.96 22.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.956 . . . . 0.0 109.749 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.555 ' CE1' ' CE1' ' B' ' 45' ' ' PHE . 1.3 t80 -89.87 28.71 1.3 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -84.48 -13.97 50.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.614 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -80.2 -7.51 59.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.619 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.555 ' CE1' ' CE1' ' B' ' 42' ' ' PHE . 33.7 m-85 -83.65 -3.53 57.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.511 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.99 -172.77 25.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' B' ' 47' ' ' ASP . 2.0 p-10 -84.79 98.37 10.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -1.153 . . . . 0.0 109.42 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.717 HD12 ' N ' ' B' ' 48' ' ' LEU . 7.2 mp -88.0 30.8 0.82 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 108.972 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -45.05 -30.87 1.15 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 109.934 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -142.37 138.15 16.24 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -41.28 -28.4 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.406 2.071 . . . . 0.0 112.279 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.95 -39.79 49.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.93 -19.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.86 . . . . 0.0 109.603 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.1 -63.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.651 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -51.39 -20.0 1.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 109.741 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.07 -31.63 38.31 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.16 132.83 95.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -1.191 . . . . 0.0 109.357 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.31 -50.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.46 2.107 . . . . 0.0 112.551 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.04 -34.98 72.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.987 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -55.23 -49.88 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.033 -1.042 . . . . 0.0 109.217 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.464 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 26.2 mtmt -73.63 -29.33 62.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.289 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.92 -46.34 68.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -54.34 -25.28 23.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.553 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -32.35 83.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 0.4 OUTLIER -62.75 -36.91 84.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -1.198 . . . . 0.0 109.308 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -75.74 -35.05 60.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.354 -0.841 . . . . 0.0 109.417 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 47.8 t -69.03 -63.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.334 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.545 ' O ' HD23 ' B' ' 68' ' ' LEU . 1.8 tt -53.61 -32.94 53.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 108.91 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.83 -57.1 20.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.32 79.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -1.137 . . . . 0.0 109.447 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -67.2 -35.09 78.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.484 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . 0.402 ' HB2' ' HE1' ' B' ' 15' ' ' TRP . 61.7 p -73.82 -35.69 64.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.409 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.49 -21.29 0.53 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.347 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.17 -60.08 4.66 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.642 ' H ' HD12 ' B' ' 75' ' ' LEU . 5.1 mp -53.47 -28.9 33.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -1.133 . . . . 0.0 109.254 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.75 3.49 41.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' B' ' 79' ' ' ASP . 23.5 t-80 -170.43 61.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.632 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 59.1 mt -73.72 15.16 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 109.327 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' B' ' 77' ' ' HIS . 16.8 t70 -76.43 -36.05 58.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.873 . . . . 0.0 109.513 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -161.55 100.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.377 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 33.7 mt -79.31 -50.19 11.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.362 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.447 ' HZ2' ' CG ' ' B' ' 143' ' ' HIS . 24.6 mmtp -48.41 -23.95 1.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.11 -63.31 3.69 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.3 t -63.9 -48.07 78.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -1.13 . . . . 0.0 109.493 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.555 ' N ' ' CG2' ' B' ' 84' ' ' THR . 46.9 m-85 -63.64 -8.5 10.21 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.538 -0.726 . . . . 0.0 109.348 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.32 -34.75 34.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 109.366 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 28.4 p -83.99 -50.99 7.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.09 -55.54 31.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.174 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . 0.487 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 1.5 m -51.51 -39.02 56.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.365 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' B' ' 94' ' ' ASP . 29.0 tt0 -74.25 -54.58 7.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 tt -62.46 -29.36 70.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.718 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' B' ' 97' ' ' HIS . 1.3 m80 -79.32 -48.41 14.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 110.001 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' B' ' 89' ' ' SER . 6.5 m -82.91 -31.08 27.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.032 . . . . 0.0 110.386 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' B' ' 90' ' ' GLU . 6.4 t70 -86.75 -43.47 12.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.084 -1.01 . . . . 0.0 110.937 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -52.33 5.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 110.733 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.648 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 4.1 mm? -82.85 -43.49 16.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.868 -1.145 . . . . 0.0 109.528 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 1.1 ' CD2' HG21 ' C' ' 41' ' ' THR . 0.0 OUTLIER 74.85 19.77 2.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 109.637 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' B' ' 97' ' ' HIS . 8.8 t -45.18 122.1 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 109.449 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 0.509 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 15.4 m-20 -69.05 151.34 97.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' B' ' 99' ' ' ASP . 74.5 Cg_exo -42.84 178.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.626 2.217 . . . . 0.0 112.369 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 57.58 64.75 1.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.839 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' B' ' 99' ' ' ASP . 73.2 m-20 -161.92 -52.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -0.86 . . . . 0.0 109.308 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -67.01 -26.01 66.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 39.5 ttt-85 -78.61 -25.7 45.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.515 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.89 -45.65 49.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.641 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 tt -49.48 -45.99 47.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.415 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.42 -48.82 64.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 30.1 m120 -50.25 -44.27 53.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -1.153 . . . . 0.0 109.737 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.95 -35.4 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.748 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tp -63.35 -38.8 92.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 109.669 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.418 HG21 HE21 ' B' ' 131' ' ' GLN . 66.3 t -51.34 -30.52 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.95 . . . . 0.0 109.693 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.26 -59.26 2.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.621 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 t -46.14 -28.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.816 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.452 HD13 ' OH ' ' B' ' 130' ' ' TYR . 16.8 mt -82.51 -53.23 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.593 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.464 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -65.31 -19.44 65.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.696 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -62.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 109.655 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -77.16 -48.36 17.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.892 . . . . 0.0 109.803 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.8 30.13 1.64 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.714 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -54.94 -27.82 46.04 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -64.55 7.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -1.111 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' B' ' 119' ' ' GLY . 61.1 mm-40 -133.12 6.82 3.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.41 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.556 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.3 34.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.491 ' H ' ' C ' ' B' ' 121' ' ' GLU . 2.9 p -45.02 148.99 0.91 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.463 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.515 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.4 Cg_exo -44.33 -54.07 4.3 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.449 2.099 . . . . 0.0 112.769 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 21.1 Cg_endo -61.37 -48.16 10.28 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.057 1.838 . . . . 0.0 111.975 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.435 ' O ' HG12 ' B' ' 126' ' ' VAL . 73.9 t -55.6 -13.03 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . 1.052 ' CG ' ' NH1' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -82.45 -59.94 2.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.606 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.815 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -66.46 -26.53 67.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.928 . . . . 0.0 109.504 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.76 26.38 0.83 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.499 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.452 ' OH ' HD13 ' B' ' 114' ' ' LEU . 0.1 OUTLIER -123.46 -61.25 1.42 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.382 -0.824 . . . . 0.0 109.368 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.694 ' OE1' ' OG ' ' A' ' 35' ' ' SER . 26.0 mp0 -53.62 -36.36 61.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.632 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -69.44 -25.11 63.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 109.567 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 63.6 t -77.35 -43.59 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.512 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.65 -17.05 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.628 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.39 -28.93 70.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.31 -36.57 59.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.501 HG13 ' CZ ' ' B' ' 85' ' ' PHE . 77.5 t -75.17 -36.49 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -1.092 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.25 -38.92 55.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.915 . . . . 0.0 109.468 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' B' ' 143' ' ' HIS . 9.9 m120 -85.18 -21.31 29.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.731 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.62 -55.52 33.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.114 -0.991 . . . . 0.0 109.478 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 41.5 mt -61.64 -24.68 66.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' B' ' 145' ' ' TYR . . . -100.27 1.71 41.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.403 -0.811 . . . . 0.0 109.412 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 139' ' ' ASN . 71.2 t60 -80.8 -1.78 44.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.0 109.466 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' B' ' 146' ' ' HIS . 5.4 tppt? -120.73 -31.9 4.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.822 . . . . 0.0 109.889 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' B' ' 142' ' ' ALA . 0.1 OUTLIER -49.29 -10.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 109.933 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' B' ' 144' ' ' LYS . 4.9 m-70 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.662 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.482 ' CD1' ' CD2' ' C' ' 128' ' ' PHE . 36.5 mt -121.2 -171.78 2.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.376 -0.827 . . . . 0.0 109.605 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.47 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.8 OUTLIER -97.75 -178.97 0.79 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.409 -0.807 . . . . 0.0 109.277 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 26.0 Cg_exo -60.97 -68.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.51 2.14 . . . . 0.0 112.329 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.464 ' O ' ' ND2' ' C' ' 9' ' ' ASN . . . -52.33 -36.17 52.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.794 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.477 ' CG ' ' HZ1' ' C' ' 127' ' ' LYS . 3.3 m-20 -44.2 -33.67 1.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 109.444 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -83.38 -60.13 2.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.841 . . . . 0.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.2 m -46.92 -29.75 2.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.355 -0.841 . . . . 0.0 109.94 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' C' ' 5' ' ' ALA . 23.1 m-20 -77.5 -36.69 52.37 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.985 -1.072 . . . . 0.0 108.233 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.19 -47.85 29.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -53.18 -38.58 62.93 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.49 -63.05 1.44 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.443 -0.785 . . . . 0.0 109.36 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.22 67.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.851 . . . . 0.0 109.286 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . 0.448 ' HZ3' HD11 ' C' ' 125' ' ' LEU . 0.1 OUTLIER -72.98 -17.24 61.48 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.417 -0.802 . . . . 0.0 108.892 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.69 -39.98 59.39 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -84.73 -49.77 8.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.521 -0.988 . . . . 0.0 109.333 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' C' ' 18' ' ' GLY . 71.1 t -60.06 -34.99 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.504 -0.747 . . . . 0.0 109.639 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . -31.56 144.79 0.02 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' C' ' 18' ' ' GLY . . . 69.16 -32.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -1.101 . . . . 0.0 108.874 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.593 ' H ' ' C ' ' C' ' 18' ' ' GLY . 1.2 m80 -104.96 13.83 30.38 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.43 ' HB2' HG12 ' C' ' 17' ' ' VAL . . . -83.52 -48.8 9.89 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.82 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -14.72 42.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -89.07 -56.6 3.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -1.137 . . . . 0.0 109.706 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.636 ' CZ ' ' CE1' ' C' ' 112' ' ' HIS . 2.9 m-30 -59.01 -33.13 70.38 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.424 -0.798 . . . . 0.0 109.191 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.73 -33.19 76.64 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.89 -50.83 10.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.168 -1.195 . . . . 0.0 109.828 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -52.4 -19.76 2.38 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.61 -25.53 65.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.505 HD11 ' ND1' ' C' ' 58' ' ' HIS . 33.2 mt -72.15 -58.09 3.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.744 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -61.57 -14.42 29.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.086 -1.009 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 1.063 ' NH1' ' CG ' ' D' ' 127' ' ' GLN . 1.9 tpm_? -75.41 -39.05 59.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.344 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . 0.502 ' O ' ' N ' ' C' ' 34' ' ' LEU . 0.0 OUTLIER -79.98 -48.51 13.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.193 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' C' ' 32' ' ' MET . 36.6 t80 -43.78 -19.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.338 -0.851 . . . . 0.0 109.782 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.805 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.9 mt -79.85 -60.23 2.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.755 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.711 ' OG ' ' OE1' ' D' ' 131' ' ' GLN . 30.0 m -81.27 -31.48 33.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.891 . . . . 0.0 109.698 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.565 ' CZ ' HD22 ' C' ' 100' ' ' LEU . 60.2 m-85 -113.57 95.0 34.86 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.439 -0.788 . . . . 0.0 109.424 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.18 -20.01 8.88 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.435 2.09 . . . . 0.0 112.224 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.689 ' O ' HG22 ' C' ' 41' ' ' THR . 70.7 p -47.69 -42.07 24.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 109.253 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.416 ' H ' HG23 ' C' ' 39' ' ' THR . 12.9 p -44.1 -22.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.813 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' C' ' 38' ' ' THR . 30.5 ttpt -70.94 -19.18 62.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.61 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 1.1 HG21 ' CD2' ' B' ' 97' ' ' HIS . 8.5 t . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.593 ' CG ' ' O ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.282 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.493 ' C ' ' H ' ' C' ' 48' ' ' LEU . 2.1 p90 -142.48 44.89 1.63 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.444 -1.41 . . . . 0.0 110.095 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.05 -35.22 0.3 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 110.448 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' C' ' 46' ' ' PHE . 1.0 OUTLIER 61.72 55.84 2.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.02 -1.05 . . . . 0.0 109.097 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.0 m -165.35 157.01 14.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.992 -1.067 . . . . 0.0 109.534 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.462 ' C ' ' H ' ' C' ' 52' ' ' SER . 2.7 m-70 -59.48 160.87 6.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.375 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.71 -18.14 1.91 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 30.6 p -48.66 -25.9 2.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -1.158 . . . . 0.0 109.395 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 66.97 -40.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.748 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' C' ' 52' ' ' SER . 20.4 mt-30 -69.73 -23.79 63.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.295 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.45 HG23 ' OG ' ' C' ' 52' ' ' SER . 56.6 t -69.64 -40.51 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.915 . . . . 0.0 109.133 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -65.7 -54.42 27.69 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.307 -0.87 . . . . 0.0 108.656 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.17 -36.12 21.08 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.505 ' ND1' HD11 ' C' ' 29' ' ' LEU . 6.1 t-80 -60.54 -36.5 78.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.957 -1.319 . . . . 0.0 109.874 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.36 -29.33 37.91 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 56.8 mttm -65.07 -23.67 67.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -1.207 . . . . 0.0 110.268 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' C' ' 61' ' ' LYS . 0.5 OUTLIER -69.18 -58.18 4.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.999 -1.063 . . . . 0.0 108.591 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 72.8 t -56.49 -44.71 81.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.579 -0.7 . . . . 0.0 109.299 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.93 -41.6 74.38 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.24 -0.912 . . . . 0.0 109.21 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 7.9 t70 -65.88 -38.1 87.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.13 -0.981 . . . . 0.0 108.493 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -67.5 -53.43 28.7 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.415 ' O ' HG23 ' C' ' 70' ' ' VAL . 1.0 OUTLIER -58.49 -42.25 87.14 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.425 ' O ' ' N ' ' C' ' 71' ' ' ALA . 15.7 m -69.64 -51.67 32.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.888 . . . . 0.0 108.731 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -62.22 -25.95 68.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 108.537 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.11 -46.4 11.17 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.415 HG23 ' O ' ' C' ' 66' ' ' LEU . 38.2 t -66.56 -22.85 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -69.56 -36.3 76.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.587 ' O ' ' N ' ' C' ' 74' ' ' ASP . 26.1 m80 -103.32 -66.69 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.609 -0.682 . . . . 0.0 109.443 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.547 HG22 ' O ' ' C' ' 73' ' ' VAL . 14.8 p 44.42 14.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.954 0.883 . . . . 0.0 109.323 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' C' ' 72' ' ' HIS . 5.5 m-20 -137.99 12.07 2.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.412 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 0.2 OUTLIER 171.78 31.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.139 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 3.5 ptt? -78.27 -23.66 0.42 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 111.849 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.8 Cg_exo -53.6 -19.35 13.76 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.705 1.604 . . . . 0.0 112.5 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -94.25 -40.44 9.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.08 -1.012 . . . . 0.0 109.741 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.73 -48.88 67.81 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.248 -0.908 . . . . 0.0 109.36 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.58 6.03 6.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 109.298 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 34.1 t -54.48 -19.59 6.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 109.602 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -83.16 -58.52 2.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 109.891 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.426 HD23 ' N ' ' C' ' 83' ' ' LEU . 3.8 mt -45.32 -44.69 11.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.424 -0.797 . . . . 0.0 109.068 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.496 ' CB ' ' HG ' ' C' ' 138' ' ' SER . 23.3 t -59.96 -18.93 49.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -0.775 . . . . 0.0 109.536 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' C' ' 89' ' ' HIS . 36.7 t70 -81.11 -50.9 9.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.95 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 4.6 tt -64.15 -26.71 68.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.89 . . . . 0.0 110.068 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.79 -21.78 26.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.312 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.47 -11.26 11.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.141 -0.975 . . . . 0.0 110.172 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . 0.56 ' N ' ' O ' ' C' ' 85' ' ' ASP . 42.4 t60 -106.51 -74.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.958 . . . . 0.0 109.996 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' C' ' 92' ' ' ARG . 79.7 mttt -63.74 -110.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 110.077 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 14.1 mt -44.45 -17.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.346 -0.846 . . . . 0.0 110.009 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' C' ' 90' ' ' LYS . 31.8 ttm-85 46.84 41.47 10.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.138 -0.977 . . . . 0.0 109.492 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 70.1 t -45.91 144.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.694 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' C' ' 97' ' ' ASN . 10.7 m-20 -80.68 150.29 69.43 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.71 -19.49 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.384 2.056 . . . . 0.0 112.22 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.31 -7.71 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.357 -0.84 . . . . 0.0 109.752 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' C' ' 94' ' ' ASP . 12.8 m120 -79.71 -36.25 37.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.475 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -46.35 -41.56 13.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.896 -1.127 . . . . 0.0 109.569 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.48 ' NZ ' ' CB ' ' C' ' 99' ' ' LYS . 8.0 mtmp? -51.39 -28.25 12.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.238 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.565 HD22 ' CZ ' ' C' ' 36' ' ' PHE . 15.4 mt -84.31 -61.8 1.72 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.719 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tp -49.92 -23.65 2.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.796 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -73.28 -49.47 27.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.906 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -80.68 -26.41 37.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.862 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 65.3 m -64.95 -60.37 3.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.167 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.717 ' C ' HD12 ' C' ' 105' ' ' LEU . 0.9 OUTLIER -57.51 -22.38 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 109.827 -179.402 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.08 -31.47 39.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.879 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . 0.469 HG11 ' OE1' ' D' ' 127' ' ' GLN . 57.0 t -83.32 -24.91 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.042 -1.036 . . . . 0.0 110.094 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' C' ' 109' ' ' LEU . 1.5 t -79.79 -47.68 14.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.06 -1.025 . . . . 0.0 109.919 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.732 HD12 ' O ' ' C' ' 109' ' ' LEU . 0.8 OUTLIER -69.77 -18.51 63.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 109.762 -179.583 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.95 -22.2 46.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 110.287 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.51 -56.16 25.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -0.995 . . . . 0.0 110.162 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . 0.681 ' CG ' ' H ' ' C' ' 113' ' ' LEU . 9.4 p80 -72.42 -61.85 1.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.016 . . . . 0.0 109.563 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.909 HD23 ' O ' ' C' ' 113' ' ' LEU . 0.0 OUTLIER -119.81 121.46 29.76 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.37 175.61 7.56 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.476 2.117 . . . . 0.0 112.932 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.649 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -45.22 -55.08 6.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.604 -0.685 . . . . 0.0 109.374 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.649 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 26.0 mt-10 122.98 -2.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.472 ' CG ' ' C ' ' C' ' 116' ' ' GLU . 1.8 m-85 72.23 32.86 1.64 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.708 -0.62 . . . . 0.0 111.259 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.772 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.3 p -97.54 121.26 58.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.927 -1.108 . . . . 0.0 108.231 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.55 24.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.059 1.839 . . . . 0.0 112.531 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -150.46 -32.31 0.18 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.928 -1.108 . . . . 0.0 110.46 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.657 HG13 ' N ' ' C' ' 122' ' ' HIS . 11.9 p -54.03 -50.11 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 110.292 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.657 ' N ' HG13 ' C' ' 121' ' ' VAL . 23.1 m-70 -54.71 -45.07 73.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.577 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.37 -20.02 32.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 110.267 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.549 ' N ' ' O ' ' C' ' 120' ' ' ALA . 93.6 p -52.22 -52.93 49.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.931 . . . . 0.0 110.615 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.448 HD11 ' HZ3' ' C' ' 14' ' ' TRP . 5.5 mt -84.11 -19.24 34.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.081 -1.012 . . . . 0.0 110.047 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.76 -51.82 9.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.092 . . . . 0.0 110.333 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -78.68 -43.02 26.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.057 -1.027 . . . . 0.0 110.188 -179.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.482 ' CD2' ' CD1' ' C' ' 2' ' ' LEU . 33.7 t80 -50.5 -21.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 0.0 108.992 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' C' ' 133' ' ' SER . 17.4 mt -73.77 -18.26 60.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -60.14 -35.48 75.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.44 ' O ' HG23 ' C' ' 135' ' ' VAL . 97.3 p -80.74 -27.09 36.94 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -84.71 -30.06 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.492 ' N ' ' O ' ' C' ' 129' ' ' LEU . 50.3 m -79.31 -40.78 29.54 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 53.3 m -69.31 -26.35 64.68 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.289 -0.882 . . . . 0.0 108.644 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 131' ' ' SER . 23.6 t -81.56 -30.19 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -23.21 61.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.0 109.071 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . 0.433 ' O ' ' O ' ' C' ' 138' ' ' SER . 38.3 p -87.28 -18.43 30.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.21 -0.931 . . . . 0.0 109.552 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . 0.496 ' HG ' ' CB ' ' C' ' 84' ' ' SER . 21.7 m . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.433 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 82.1 t60 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.17 0.51 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.85 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -135.94 179.73 6.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 108.982 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.466 ' O ' ' N ' ' D' ' 7' ' ' GLU . 7.3 p -76.16 132.42 73.61 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.153 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -41.19 -24.75 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.369 2.046 . . . . 0.0 112.446 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.14 -21.84 25.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.927 . . . . 0.0 109.874 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' D' ' 4' ' ' THR . 32.2 tt0 -80.36 -63.09 1.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.097 -1.002 . . . . 0.0 109.938 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.59 ' HB3' HD13 ' D' ' 3' ' ' LEU . 24.1 pttt -62.38 -31.63 72.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.008 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.2 t -44.55 -23.44 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -81.57 -57.34 3.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.019 -1.051 . . . . 0.0 110.11 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.434 HG23 ' CE2' ' D' ' 130' ' ' TYR . 14.9 p -68.76 -24.64 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.055 -1.028 . . . . 0.0 108.256 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 12.6 m -71.91 -42.15 67.06 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.347 0.594 . . . . 0.0 109.852 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.77 -30.38 69.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.868 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -50.32 -18.79 0.67 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.95 . . . . 0.0 109.33 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . 0.412 ' CZ2' HD13 ' D' ' 75' ' ' LEU . 0.7 OUTLIER -53.18 -51.39 62.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 0.0 109.158 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.09 -32.47 35.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 -46.68 14.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -1.098 . . . . 0.0 109.214 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 69.6 t -59.02 114.91 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.546 -0.721 . . . . 0.0 109.842 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' D' ' 21' ' ' ASP . 19.0 m120 -79.43 71.58 6.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 108.742 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.443 HG12 ' O ' ' D' ' 20' ' ' VAL . 57.2 t -46.99 -11.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.89 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' D' ' 19' ' ' ASN . 16.5 m-20 -73.51 -5.35 39.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 109.847 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -156.31 -40.35 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 109.577 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -46.4 -55.54 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.0 109.66 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.72 -29.85 50.42 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.53 -29.93 69.34 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.94 -31.46 59.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -1.11 . . . . 0.0 109.467 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.11 -54.32 48.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . 0.535 HD22 ' N ' ' D' ' 28' ' ' LEU . 3.8 mm? -61.9 -40.06 94.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.935 . . . . 0.0 109.26 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.98 -42.78 76.31 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 60.2 mmt-85 -72.74 -36.97 67.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -1.098 . . . . 0.0 109.481 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 65.2 tp -50.12 -31.72 14.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.32 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.18 -22.59 38.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.625 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.97 -64.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.578 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.444 ' H ' HG23 ' D' ' 34' ' ' VAL . 0.2 OUTLIER -64.11 -22.69 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -0.828 . . . . 0.0 109.644 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -140.31 79.22 21.56 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -83.49 -12.42 8.98 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.865 2.377 . . . . 0.0 112.36 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . 0.524 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 3.3 p-90 -48.62 -33.95 10.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.586 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.524 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 3.2 m -78.96 2.59 19.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.509 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' D' ' 39' ' ' GLN . 1.4 tm0? -65.48 -19.08 65.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . 1.455 ' NH2' ' CG ' ' A' ' 92' ' ' ARG . 32.9 mtp85 -68.49 -40.94 80.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.746 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -93.03 -18.98 22.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' D' ' 45' ' ' PHE . 1.3 t80 -89.86 28.56 1.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 109.44 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -84.39 -13.99 50.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.351 -0.843 . . . . 0.0 109.608 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -80.12 -7.59 58.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.602 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' D' ' 42' ' ' PHE . 33.5 m-85 -83.68 -3.44 57.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.483 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.03 -172.78 25.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -84.81 98.39 10.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.125 . . . . 0.0 109.339 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . 0.708 HD12 ' N ' ' D' ' 48' ' ' LEU . 7.2 mp -88.0 30.85 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 108.956 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -45.0 -30.96 1.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 109.89 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 6.7 p -142.35 138.2 16.29 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -41.2 -28.45 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.423 2.082 . . . . 0.0 112.362 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . 0.4 ' C ' ' N ' ' D' ' 54' ' ' VAL . 12.0 t70 -76.96 -39.81 49.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.0 109.578 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.8 -19.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.355 -0.84 . . . . 0.0 109.653 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . 0.4 ' N ' ' C ' ' D' ' 52' ' ' ASP . 45.8 t -67.06 -63.87 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.656 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -51.48 -19.92 1.63 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.757 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.0 -31.75 38.23 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . 0.408 ' N ' HD22 ' D' ' 57' ' ' ASN . 2.7 m120 -63.18 132.74 95.19 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.232 -1.157 . . . . 0.0 109.318 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.26 -50.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.447 2.098 . . . . 0.0 112.523 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.05 -34.93 72.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.967 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -55.34 -49.88 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.032 . . . . 0.0 109.193 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . 0.431 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 26.2 mtmt -73.6 -29.34 62.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.169 -0.957 . . . . 0.0 109.277 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.31 68.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.449 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -54.39 -25.36 24.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.25 83.1 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 0.4 OUTLIER -62.88 -36.79 84.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.183 -1.186 . . . . 0.0 109.274 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -75.76 -35.1 60.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 109.344 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.03 -63.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.285 -0.885 . . . . 0.0 109.324 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.551 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.8 tt -53.75 -32.81 53.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 108.898 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.93 -56.98 21.07 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.81 -42.25 79.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -1.085 . . . . 0.0 109.455 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . 0.405 ' O ' ' CD1' ' D' ' 71' ' ' PHE . 3.0 t80 -67.24 -35.12 78.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . 0.404 ' HB2' ' HE1' ' D' ' 15' ' ' TRP . 62.2 p -73.78 -35.61 64.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.63 -21.16 0.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.908 . . . . 0.0 109.361 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.13 -60.12 4.65 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.642 ' H ' HD12 ' D' ' 75' ' ' LEU . 5.1 mp -53.46 -28.9 32.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -1.161 . . . . 0.0 109.25 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.78 3.5 41.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' D' ' 79' ' ' ASP . 23.5 t-80 -170.41 61.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.692 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 59.2 mt -73.69 15.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.257 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' D' ' 77' ' ' HIS . 16.8 t70 -76.38 -36.02 58.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.216 -0.927 . . . . 0.0 109.522 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -161.61 100.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 109.401 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 33.2 mt -79.21 -50.23 11.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . 0.431 ' NZ ' ' ND1' ' D' ' 143' ' ' HIS . 24.6 mmtp -48.41 -23.92 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.08 -63.27 3.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.3 t -63.94 -48.11 77.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -1.14 . . . . 0.0 109.397 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' D' ' 84' ' ' THR . 46.6 m-85 -63.61 -8.5 10.11 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.435 -0.79 . . . . 0.0 109.374 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.25 -34.86 34.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.394 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 27.9 p -83.96 -50.97 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 0.0 109.535 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 35.8 mt -56.11 -55.56 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 109.161 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . 0.491 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 1.5 m -51.55 -38.91 56.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.323 -0.861 . . . . 0.0 109.44 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' D' ' 94' ' ' ASP . 29.1 tt0 -74.24 -54.64 7.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -62.49 -29.3 70.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.687 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' D' ' 97' ' ' HIS . 1.3 m80 -79.31 -48.35 14.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.97 . . . . 0.0 110.043 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' D' ' 89' ' ' SER . 6.6 m -82.97 -31.14 27.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.028 -1.045 . . . . 0.0 110.301 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' D' ' 90' ' ' GLU . 6.4 t70 -86.66 -43.52 12.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.065 -1.022 . . . . 0.0 110.901 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -52.25 5.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 0.0 110.732 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.63 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 4.1 mm? -82.98 -43.48 16.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.0 109.486 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 1.137 ' CD2' HG21 ' A' ' 41' ' ' THR . 0.0 OUTLIER 74.81 19.77 2.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.427 -0.796 . . . . 0.0 109.727 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . 0.403 HG23 ' H ' ' D' ' 98' ' ' VAL . 8.6 t -45.11 122.24 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 109.471 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . 0.512 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 15.6 m-20 -69.18 151.46 97.05 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.41 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' D' ' 99' ' ' ASP . 75.7 Cg_exo -42.9 178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.631 2.22 . . . . 0.0 112.414 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 57.52 64.76 1.5 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 109.569 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' D' ' 99' ' ' ASP . 73.1 m-20 -161.92 -52.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.41 -0.806 . . . . 0.0 109.263 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -66.96 -25.96 66.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . 0.417 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 39.3 ttt-85 -78.53 -25.76 45.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.91 -45.7 49.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.915 . . . . 0.0 109.605 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 tt -49.39 -46.07 46.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.4 -48.83 64.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 30.1 m120 -50.22 -44.26 53.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -1.172 . . . . 0.0 109.739 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.04 -35.27 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.757 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tp -63.41 -38.8 92.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.662 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . 0.435 HG21 HE21 ' D' ' 131' ' ' GLN . 66.8 t -51.37 -30.52 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.676 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.22 -59.38 2.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.615 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . 0.403 HG23 ' H ' ' D' ' 113' ' ' VAL . 29.3 t -46.17 -27.91 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.833 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . 0.451 HD13 ' OH ' ' D' ' 130' ' ' TYR . 17.0 mt -82.66 -53.12 6.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.527 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.454 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -65.38 -19.43 65.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.639 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.08 -62.84 1.25 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.689 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -77.26 -48.3 17.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.823 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -92.8 30.21 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.751 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -55.05 -27.73 46.51 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -64.65 7.09 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -1.136 . . . . 0.0 109.598 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' D' ' 119' ' ' GLY . 61.0 mm-40 -133.14 6.87 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 109.434 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.538 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -73.32 34.8 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.427 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.493 ' H ' ' C ' ' D' ' 121' ' ' GLU . 2.9 p -44.87 148.96 0.88 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.339 -0.85 . . . . 0.0 109.504 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.514 ' HA ' HH22 ' C' ' 31' ' ' ARG . 5.4 Cg_exo -44.36 -54.04 4.34 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.437 2.091 . . . . 0.0 112.78 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 21.2 Cg_endo -61.35 -48.25 10.11 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.934 1.756 . . . . 0.0 112.0 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.426 ' O ' HG12 ' D' ' 126' ' ' VAL . 72.8 t -55.48 -13.02 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -0.839 . . . . 0.0 109.518 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . 1.063 ' CG ' ' NH1' ' C' ' 31' ' ' ARG . 0.7 OUTLIER -82.47 -59.87 2.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.646 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.805 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -66.56 -26.52 67.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.435 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.78 26.44 0.83 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.451 ' OH ' HD13 ' D' ' 114' ' ' LEU . 0.1 OUTLIER -123.47 -61.36 1.41 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.295 -0.878 . . . . 0.0 109.303 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 0.711 ' OE1' ' OG ' ' C' ' 35' ' ' SER . 26.1 mp0 -53.56 -36.37 61.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.671 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -69.47 -25.13 63.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 64.4 t -77.27 -43.66 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.581 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.61 -17.1 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.36 -28.95 70.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.541 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -36.43 59.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . 0.492 HG13 ' CZ ' ' D' ' 85' ' ' PHE . 76.4 t -75.24 -36.47 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -1.153 . . . . 0.0 109.456 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.22 -38.91 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' D' ' 143' ' ' HIS . 9.9 m120 -85.21 -21.3 29.18 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.21 -0.931 . . . . 0.0 109.758 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.69 -55.52 33.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.514 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.52 -24.77 66.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.277 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' D' ' 145' ' ' TYR . . . -100.29 1.79 42.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 109.378 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . 0.527 ' N ' ' O ' ' D' ' 139' ' ' ASN . 71.2 t60 -80.91 -1.68 44.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.453 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' D' ' 146' ' ' HIS . 5.4 tppt? -120.75 -32.04 4.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' D' ' 142' ' ' ALA . 0.1 OUTLIER -49.12 -10.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.233 -0.917 . . . . 0.0 109.888 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' D' ' 144' ' ' LYS . 4.9 m-70 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.656 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 131' ' ' SER . 12.4 tp -171.74 145.51 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 109.634 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.6 168.29 20.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 109.319 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 5' ' ' ALA . 55.7 Cg_endo -73.13 -61.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.618 2.212 . . . . 0.0 112.666 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 4' ' ' PRO . . . -45.26 -38.27 5.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.934 . . . . 0.0 109.673 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 5' ' ' ALA . 4.8 m-20 -44.52 -28.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 108.977 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 10' ' ' VAL . 76.8 mttt -83.06 -60.33 2.19 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.437 -0.789 . . . . 0.0 109.093 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.1 m -46.37 -31.61 2.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.471 -0.768 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -76.72 -35.85 57.55 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.492 HG21 ' CG ' ' A' ' 128' ' ' PHE . 4.4 t -73.58 -50.25 31.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -49.15 -42.79 40.75 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.4 -63.57 1.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.257 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -55.37 -39.05 69.63 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 109.178 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.43 ' NE1' ' OG1' ' A' ' 67' ' ' THR . 0.1 OUTLIER -71.31 -17.19 62.47 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.044 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.26 -46.23 7.66 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -70.67 -34.61 72.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.146 . . . . 0.0 108.742 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 13' ' ' ALA . 70.1 t -63.02 -66.03 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 60.84 -140.82 48.08 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 20' ' ' HIS . . . -66.7 49.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.434 -1.039 . . . . 0.0 110.194 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 18' ' ' GLY . 80.0 m-70 -153.75 19.64 0.53 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -83.8 -62.87 1.46 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.701 -0.624 . . . . 0.0 109.781 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.2 -14.45 0.16 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 21' ' ' ALA . 3.4 mm-40 -86.71 -56.47 3.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -1.132 . . . . 0.0 109.744 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.9 m-30 -55.38 -52.23 64.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 109.159 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.14 -22.79 14.58 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB1' HG12 ' A' ' 55' ' ' VAL . . . -73.67 -45.4 52.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -1.129 . . . . 0.0 109.702 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.518 ' OE1' ' NE2' ' A' ' 112' ' ' HIS . 94.9 mt-10 -65.69 -19.83 66.05 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.509 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.58 -24.5 60.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.381 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.3 mt -65.81 -41.23 92.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.735 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -75.68 -12.54 60.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.09 -1.006 . . . . 0.0 109.739 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 31' ' ' ARG . 3.1 tpm_? -78.93 -47.36 16.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 0.0 110.155 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 1.1 ptm -65.74 -26.35 67.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.007 -1.058 . . . . 0.0 109.683 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.37 -36.45 82.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.101 -0.999 . . . . 0.0 109.436 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 12.1 mt -85.66 -44.88 12.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.708 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 40.2 t -51.5 -19.61 1.52 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.824 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' A' ' 35' ' ' SER . 60.1 m-85 -160.92 90.23 1.61 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.001 . . . . 0.0 109.733 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 39' ' ' THR . 52.4 Cg_exo -50.28 -26.15 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.594 2.196 . . . . 0.0 112.158 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.764 ' O ' HG22 ' A' ' 41' ' ' THR . 10.8 p -47.54 -18.51 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 37' ' ' PRO . 22.1 p -76.47 -22.89 53.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.273 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -74.22 -31.74 62.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.88 . . . . 0.0 109.84 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 1.413 HG21 ' ND1' ' D' ' 97' ' ' HIS . 14.3 t . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.333 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.546 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 21.7 p80 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.558 0.694 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.714 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -166.63 75.49 0.18 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.621 ' C ' ' O ' ' A' ' 46' ' ' PHE . 20.8 m-20 -8.8 -54.67 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.028 -0.42 . . . . 0.0 111.522 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.714 ' N ' ' O ' ' A' ' 46' ' ' PHE . 5.7 mt 56.71 4.81 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.244 -0.91 . . . . 0.0 109.386 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 47' ' ' ASP . 33.3 t -73.24 19.0 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.242 -0.911 . . . . 0.0 109.362 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' A' ' 48' ' ' LEU . 6.6 t-80 58.86 156.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.06 15.33 1.46 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 10.7 t -72.59 -21.27 61.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 109.403 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.5 -50.62 0.5 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.709 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 52' ' ' SER . 15.8 pt20 -45.37 -17.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.684 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.55 HG12 ' HB1' ' A' ' 26' ' ' ALA . 77.9 t -73.84 -32.85 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.83 -24.82 67.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.641 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.15 -51.1 40.94 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 24.7 t-80 -67.82 -27.81 67.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.13 -1.217 . . . . 0.0 110.282 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 26' ' ' ALA . . . -63.22 -31.05 79.39 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 16.9 mtpp -71.79 -23.63 61.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -1.157 . . . . 0.0 110.146 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -66.8 -58.1 5.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.124 -0.985 . . . . 0.0 108.644 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.8 t -55.2 -48.94 75.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.544 -0.723 . . . . 0.0 109.238 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -64.23 -42.57 96.5 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.23 -0.919 . . . . 0.0 108.959 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.5 t70 -72.02 -25.63 61.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.806 . . . . 0.0 109.056 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . -80.65 -44.74 18.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.94 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -76.57 -27.35 55.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.568 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 63' ' ' ALA . 52.8 m -75.92 -44.62 39.37 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 36.3 t30 -57.41 -20.81 32.32 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.24 -45.88 12.42 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.46 ' CG2' HG11 ' A' ' 10' ' ' VAL . 6.0 t -59.62 -22.63 23.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -65.39 -15.25 62.39 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.568 ' O ' ' N ' ' A' ' 74' ' ' ASP . 31.6 m80 -153.04 -51.75 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.403 -0.811 . . . . 0.0 109.353 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.631 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.9 p 44.56 15.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.977 0.894 . . . . 0.0 109.32 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 72' ' ' HIS . 95.9 m-20 -134.3 10.57 3.81 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 31.1 t70 -175.23 27.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.14 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.1 ptt? -78.59 -24.19 0.43 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.47 -0.769 . . . . 0.0 111.829 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.3 Cg_exo -52.9 -19.8 11.91 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.701 1.601 . . . . 0.0 112.634 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.448 ' ND2' ' N ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -94.21 -33.12 13.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.114 -0.991 . . . . 0.0 109.822 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.448 ' N ' ' ND2' ' A' ' 78' ' ' ASN . . . -74.6 -40.79 61.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.27 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.64 12.12 13.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.024 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 66.5 p -70.6 -16.21 62.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.655 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 83' ' ' LEU . . . -82.07 -51.71 7.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 83' ' ' LEU . 3.4 mt -44.89 -43.0 8.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.382 -0.824 . . . . 0.0 109.043 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.1 p -57.14 -22.07 37.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -72.54 -32.75 66.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.686 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 90' ' ' LYS . 7.0 tt -81.4 -29.18 34.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.417 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -89.9 -28.42 19.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 109.529 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 90' ' ' LYS . . . -83.9 -80.41 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.665 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.539 ' O ' ' ND1' ' A' ' 89' ' ' HIS . 30.4 t-80 -61.09 2.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.841 . . . . 0.0 109.61 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 88' ' ' ALA . 6.1 mtmm -156.15 152.29 27.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.289 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' A' ' 93' ' ' VAL . 10.9 mp 56.95 63.89 1.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 108.983 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.287 ' HB3' ' NH1' ' D' ' 40' ' ' ARG . 8.4 ptp180 -62.77 14.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.578 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.636 ' H ' ' C ' ' A' ' 91' ' ' LEU . 73.7 t -41.43 121.69 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -0.812 . . . . 0.0 109.631 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.11 147.81 2.29 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.533 ' C ' ' H ' ' A' ' 97' ' ' ASN . 37.9 Cg_endo -68.23 -10.66 29.63 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.486 2.124 . . . . 0.0 112.069 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 96' ' ' VAL . 2.8 t -55.25 -1.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.716 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 95' ' ' PRO . 5.0 m120 -74.66 -42.34 58.65 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.084 -1.01 . . . . 0.0 109.808 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 2.2 m-85 -46.38 -42.05 14.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 0.0 109.275 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -58.1 -32.91 68.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.244 -0.91 . . . . 0.0 109.316 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.1 mt -84.08 -62.28 1.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -50.22 -41.84 50.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 0.0 109.291 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.4 m -63.26 -51.03 67.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -66.1 -26.82 67.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.513 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 96.6 m -63.51 -50.59 69.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.75 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.31 -43.02 22.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 106' ' ' LEU . 8.6 mp -64.17 -59.24 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.423 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.563 ' CG1' ' NE2' ' B' ' 127' ' ' GLN . 76.7 t -56.48 -30.99 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -75.7 -63.03 1.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.459 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 113' ' ' LEU . 13.1 mt -51.34 -30.65 19.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.0 109.495 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -47.43 -42.29 22.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.885 . . . . 0.0 109.679 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.11 -49.25 11.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.829 . . . . 0.0 109.787 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 27' ' ' GLU . 11.4 m170 -76.24 -69.98 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 109.868 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -110.96 97.05 32.57 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 109.054 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 113' ' ' LEU . 71.2 Cg_exo -47.31 -174.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.372 2.048 . . . . 0.0 112.879 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 122' ' ' HIS . . . -86.67 -35.09 19.53 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.664 0.745 . . . . 0.0 109.574 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 3.8 mt-10 78.4 0.86 2.63 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.943 ' HD1' ' NH2' ' B' ' 30' ' ' ARG . 21.7 t80 65.3 37.56 6.32 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.639 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.749 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -93.97 115.07 64.69 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.82 -1.175 . . . . 0.0 107.953 178.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.755 ' HA ' ' CG1' ' B' ' 33' ' ' VAL . 50.4 Cg_exo -50.36 21.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.021 1.814 . . . . 0.0 112.553 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.749 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -147.07 -21.7 0.4 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.003 -1.061 . . . . 0.0 110.961 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.77 HG13 ' N ' ' A' ' 122' ' ' HIS . 10.5 p -58.13 -58.75 5.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.976 -1.078 . . . . 0.0 110.48 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.77 ' N ' HG13 ' A' ' 121' ' ' VAL . 1.1 m-70 -71.03 -24.89 62.45 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.3 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' B' ' 33' ' ' VAL . . . -84.08 -20.74 32.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 128' ' ' PHE . 62.7 p -77.41 -63.19 1.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.248 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.46 -19.84 57.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.057 -1.027 . . . . 0.0 109.102 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.494 ' OD2' ' OH ' ' B' ' 35' ' ' TYR . 7.4 t70 -77.77 -51.18 10.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.482 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.28 -41.82 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.845 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 124' ' ' SER . 29.8 t80 -50.23 -22.88 1.92 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 109.037 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.0 mt -73.99 -24.76 59.64 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -56.77 -31.87 65.05 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.463 ' HB3' HD13 ' A' ' 2' ' ' LEU . 89.6 p -73.97 -32.56 63.51 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.37 -29.79 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 129' ' ' LEU . 9.9 p -81.92 -25.26 35.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.843 . . . . 0.0 108.913 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.8 m -74.91 -40.13 61.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.305 -0.872 . . . . 0.0 109.102 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.13 -21.79 17.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 108.782 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.75 -35.96 72.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.472 -0.767 . . . . 0.0 109.103 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 138' ' ' SER . 57.8 p -88.13 -2.3 58.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' THR . 28.3 m . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 109.471 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.906 HD12 ' N ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -136.41 -163.11 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 109.265 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.412 ' O ' ' N ' ' B' ' 6' ' ' GLU . 11.9 p -88.98 130.64 43.87 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.19 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -42.05 -23.04 0.23 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.362 2.041 . . . . 0.0 112.271 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' B' ' 4' ' ' THR . 51.9 mt-10 -80.11 -54.26 5.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.812 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.42 -41.09 85.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.746 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.721 ' HB2' HD13 ' B' ' 3' ' ' LEU . 0.3 OUTLIER -68.54 -35.1 76.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.5 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 4.9 m -60.68 -23.58 64.95 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.885 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.49 -57.58 3.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.11 -0.994 . . . . 0.0 109.809 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.76 -24.39 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 85.6 m -83.85 -35.2 24.37 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.345 0.593 . . . . 0.0 109.606 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' B' ' 9' ' ' SER . . . -69.05 -29.27 67.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.386 -0.821 . . . . 0.0 109.791 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.1 -21.07 0.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.244 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . 0.463 ' HE1' ' HB2' ' B' ' 72' ' ' SER . 0.8 OUTLIER -53.54 -17.88 2.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.175 -0.953 . . . . 0.0 109.084 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.8 -33.31 46.97 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' B' ' 17' ' ' LYS . 4.3 mmtt -89.82 -41.46 11.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -1.178 . . . . 0.0 109.361 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -57.22 114.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 109.833 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' B' ' 21' ' ' ASP . 7.4 m120 -84.3 68.41 10.18 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -43.88 -18.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.392 -0.817 . . . . 0.0 109.73 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' B' ' 19' ' ' ASN . 1.1 m-20 -62.39 -10.79 12.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.709 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -154.42 -35.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -0.995 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 72.3 t -48.74 -34.89 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.3 -25.9 68.87 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.97 -36.3 25.37 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -67.67 -30.7 70.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -1.114 . . . . 0.0 109.472 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.68 -54.53 45.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.548 HD12 ' N ' ' B' ' 28' ' ' LEU . 9.9 mp -64.3 -55.76 19.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.399 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.03 -41.32 29.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . 0.943 ' NH2' ' HD1' ' A' ' 117' ' ' PHE . 73.5 mtt-85 -80.01 -34.64 38.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -1.144 . . . . 0.0 109.499 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . 0.443 HD12 HG21 ' B' ' 109' ' ' VAL . 65.4 tp -47.11 -37.21 9.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 109.499 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' B' ' 36' ' ' PRO . 15.0 mt -81.32 -39.29 25.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.817 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.755 ' CG1' ' HA ' ' A' ' 119' ' ' PRO . 72.4 t -58.13 -61.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.12 -0.988 . . . . 0.0 109.442 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.686 HG13 ' HB3' ' A' ' 122' ' ' HIS . 1.7 t -68.69 -22.56 26.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.83 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.494 ' OH ' ' OD2' ' A' ' 126' ' ' ASP . 64.0 m-85 -146.75 76.47 11.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.776 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . 0.423 ' N ' ' O ' ' B' ' 32' ' ' LEU . 72.1 Cg_endo -82.95 28.98 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.95 2.433 . . . . 0.0 112.382 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.532 ' CD1' HG23 ' B' ' 38' ' ' THR . 3.8 p-90 -81.08 -19.85 42.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.167 -0.958 . . . . 0.0 109.654 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.532 HG23 ' CD1' ' B' ' 37' ' ' TRP . 44.8 p -78.39 -104.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.523 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . 0.521 ' N ' ' OG1' ' B' ' 38' ' ' THR . 13.9 mt-30 54.94 10.65 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.654 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 1.321 ' NH1' ' HB3' ' C' ' 92' ' ' ARG . 15.9 mmt180 -88.55 -58.98 2.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -71.44 -8.19 52.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.75 28.16 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.361 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.66 -27.3 65.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 93.9 p -84.15 -27.19 28.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 109.465 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -49.65 -24.39 2.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.331 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.87 173.05 0.19 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.97 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -1.142 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 12.6 mt -138.92 19.68 2.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -58.93 -33.9 71.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . 0.487 ' HG1' ' CG ' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -140.61 154.34 69.06 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.49 -24.26 74.15 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.212 1.941 . . . . 0.0 111.756 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.487 ' CG ' ' HG1' ' B' ' 50' ' ' THR . 2.8 p30 -85.2 -21.02 29.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 109.608 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.96 -19.95 65.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 109.736 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.449 ' O ' HG21 ' B' ' 60' ' ' VAL . 4.4 t -67.05 -64.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.94 . . . . 0.0 109.473 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.09 8.13 1.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' B' ' 54' ' ' VAL . . . -74.57 -29.99 60.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -84.42 147.72 50.57 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.195 -1.179 . . . . 0.0 109.34 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.72 -7.08 19.66 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.564 2.176 . . . . 0.0 112.175 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -85.77 -28.45 24.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.162 -0.961 . . . . 0.0 109.659 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.449 HG21 ' O ' ' B' ' 54' ' ' VAL . 83.5 t -70.31 -53.0 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.174 -0.954 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -57.8 -26.38 61.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.0 -46.5 43.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -61.87 -23.82 66.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.376 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.06 -19.97 77.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -69.52 -37.31 77.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -1.197 . . . . 0.0 109.124 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -68.06 -40.78 82.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.337 -0.852 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 42.1 t -61.14 -59.15 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.285 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.521 ' O ' HD23 ' B' ' 68' ' ' LEU . 4.8 tt -58.56 -52.66 64.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.001 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.08 -45.02 26.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.45 96.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -1.129 . . . . 0.0 109.386 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' B' ' 71' ' ' PHE . 2.5 t80 -69.63 -27.3 64.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.378 -0.826 . . . . 0.0 109.332 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . 0.463 ' HB2' ' HE1' ' B' ' 15' ' ' TRP . 88.1 p -76.77 -27.91 55.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.938 . . . . 0.0 109.557 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' B' ' 77' ' ' HIS . 10.6 t70 -47.34 -37.08 10.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.584 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.05 -60.63 6.6 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.71 -24.67 50.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -1.217 . . . . 0.0 109.176 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.542 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -93.91 -11.06 31.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.314 -0.866 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 80.3 m-70 -161.31 65.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 109.648 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.69 10.27 0.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 0.0 109.04 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' B' ' 77' ' ' HIS . 2.8 p30 -64.42 -30.24 71.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.286 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' B' ' 79' ' ' ASP . 34.5 t-20 -171.05 105.13 0.23 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.371 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.21 -58.79 2.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -48.24 -23.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.447 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -68.72 -54.77 13.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.9 t -75.19 -47.17 29.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -1.18 . . . . 0.0 109.427 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' B' ' 84' ' ' THR . 48.8 m-85 -62.72 -5.42 2.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.428 -0.795 . . . . 0.0 109.459 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.7 -34.59 62.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.329 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 37.3 p -79.82 -51.15 9.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.456 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 27.8 mt -59.69 -42.08 92.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.88 . . . . 0.0 109.333 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 5.1 m -65.08 -42.46 94.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -73.04 -40.19 65.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 4.6 tt -66.97 -34.98 78.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' B' ' 97' ' ' HIS . 60.1 m80 -84.35 -20.29 32.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.004 -1.06 . . . . 0.0 109.703 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 39.3 t -84.02 -60.04 2.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.915 . . . . 0.0 110.987 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -86.91 -29.86 21.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.991 -1.068 . . . . 0.0 111.601 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -85.8 -51.81 6.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.695 -1.253 . . . . 0.0 110.69 -178.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.613 ' C ' ' CG ' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -102.77 -24.21 13.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.021 -1.049 . . . . 0.0 109.853 -179.269 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 1.371 ' ND1' HG21 ' C' ' 41' ' ' THR . 0.5 OUTLIER 44.64 47.23 8.62 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.146 -0.971 . . . . 0.0 109.822 179.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.426 ' H ' HG23 ' B' ' 98' ' ' VAL . 4.0 t -60.73 121.48 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -0.995 . . . . 0.0 108.987 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' B' ' 100' ' ' PRO . 13.9 m-20 -59.08 143.99 83.41 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 0.0 109.236 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' B' ' 99' ' ' ASP . 76.1 Cg_exo -45.85 -174.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.356 2.038 . . . . 0.0 112.317 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 57.45 76.58 0.31 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.448 ' C ' ' N ' ' B' ' 104' ' ' ARG . 40.5 t-20 -171.57 -67.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.41 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -49.05 -15.78 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.93 . . . . 0.0 109.319 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . 0.448 ' N ' ' C ' ' B' ' 102' ' ' ASN . 10.3 mmt180 -76.27 -31.06 58.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 mt -77.83 -52.03 9.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 5.4 tt -51.03 -49.16 61.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.155 -0.966 . . . . 0.0 109.308 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.78 -21.32 65.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -85.62 -27.76 25.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -1.18 . . . . 0.0 109.731 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.443 HG21 HD12 ' B' ' 31' ' ' LEU . 76.4 t -69.15 -47.48 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 109.647 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 16.1 mt -48.39 -39.74 23.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 65.2 t -51.08 -36.41 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.657 ' SG ' ' CD2' ' A' ' 122' ' ' HIS . 14.4 t -78.19 -22.99 47.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.554 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.17 -27.2 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.603 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 28.6 mt -81.36 -22.39 38.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.972 . . . . 0.0 109.502 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' B' ' 119' ' ' GLY . . . -83.48 -37.0 23.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.468 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 9.1 t-80 -68.97 -49.04 61.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.496 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 0.3 OUTLIER -74.32 -17.68 60.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.475 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 6.1 m-85 -152.38 61.94 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.439 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.54 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -62.08 -25.52 66.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -74.1 -31.03 62.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -1.139 . . . . 0.0 109.544 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -82.25 11.73 5.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.321 -0.862 . . . . 0.0 109.626 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -85.0 35.05 0.56 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.557 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.465 ' OG1' HG23 ' B' ' 126' ' ' VAL . 63.4 p -54.53 147.31 30.04 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.373 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.512 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 4.0 Cg_exo -45.13 -54.53 4.22 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.541 2.16 . . . . 0.0 113.173 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 18.4 Cg_endo -59.41 -11.56 14.05 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.119 1.88 . . . . 0.0 112.236 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.465 HG23 ' OG1' ' B' ' 123' ' ' THR . 72.5 t -97.72 -20.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.222 -0.924 . . . . 0.0 109.626 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . 0.563 ' NE2' ' CG1' ' A' ' 107' ' ' VAL . 5.4 tp-100 -83.37 -59.99 2.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.159 -0.963 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.602 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -61.67 -34.81 76.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.21 -0.931 . . . . 0.0 109.623 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.02 23.93 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' B' ' 128' ' ' ALA . 23.4 t80 -118.9 -59.17 1.89 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.837 . . . . 0.0 109.68 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -47.07 -23.33 0.47 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.861 . . . . 0.0 109.955 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -82.52 -38.28 24.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 109.892 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.6 -41.04 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.885 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.443 HG22 ' H ' ' B' ' 134' ' ' VAL . 1.6 m -81.97 -40.72 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.77 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 1.06 ' O ' ' CD2' ' D' ' 146' ' ' HIS . . . -47.51 -20.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.008 . . . . 0.0 109.523 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 134' ' ' VAL . . . -75.63 -41.63 28.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.21 -21.96 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -1.13 . . . . 0.0 109.483 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.55 -44.36 80.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.463 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 0.864 HD21 ' HB2' ' D' ' 146' ' ' HIS . 0.9 OUTLIER -79.71 -35.35 39.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.2 -43.95 42.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.905 . . . . 0.0 109.53 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.1 17.79 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.415 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' B' ' 146' ' ' HIS . . . -141.07 8.18 2.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -67.03 -38.19 85.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.307 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.32 -13.42 62.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' B' ' 145' ' ' TYR . 23.1 p90 -160.55 55.36 0.32 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 1.035 ' CD2' ' O ' ' D' ' 135' ' ' ALA . 2.2 p-80 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' C' ' 131' ' ' SER . 12.4 tp -171.71 145.52 1.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.953 . . . . 0.0 109.661 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.59 168.39 20.17 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.309 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' C' ' 5' ' ' ALA . 55.7 Cg_endo -73.22 -61.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.656 2.237 . . . . 0.0 112.662 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.2 -38.26 5.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.145 -0.972 . . . . 0.0 109.717 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' C' ' 5' ' ' ALA . 4.8 m-20 -44.63 -28.23 0.58 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.05 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' C' ' 10' ' ' VAL . 77.0 mttt -83.19 -60.24 2.21 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.443 -0.786 . . . . 0.0 109.033 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 46.1 m -46.46 -31.56 2.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.519 -0.738 . . . . 0.0 109.639 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -76.73 -35.93 57.48 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.492 HG21 ' CG ' ' C' ' 128' ' ' PHE . 4.5 t -73.53 -50.24 31.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -49.08 -42.98 40.61 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.32 -63.59 1.14 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.494 -0.754 . . . . 0.0 109.3 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.696 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -55.33 -39.12 69.59 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.428 -0.795 . . . . 0.0 109.191 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . 0.428 ' NE1' ' OG1' ' C' ' 67' ' ' THR . 0.1 OUTLIER -71.21 -17.31 62.52 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.285 -0.885 . . . . 0.0 109.088 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.19 -46.18 7.73 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 12.9 mmmt -70.6 -34.78 72.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -1.156 . . . . 0.0 108.806 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.696 HG23 ' O ' ' C' ' 13' ' ' ALA . 69.0 t -62.8 -66.19 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 60.9 -140.83 48.09 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . 0.405 ' O ' ' CG ' ' C' ' 20' ' ' HIS . . . -66.63 49.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.458 -1.025 . . . . 0.0 110.169 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' C' ' 18' ' ' GLY . 79.7 m-70 -153.79 19.66 0.52 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -83.87 -62.83 1.47 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.693 -0.63 . . . . 0.0 109.743 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.25 -14.37 0.16 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 21' ' ' ALA . 3.4 mm-40 -86.75 -56.5 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 109.703 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.8 m-30 -55.27 -52.35 63.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.175 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.05 -22.88 14.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . 0.548 ' HB1' HG12 ' C' ' 55' ' ' VAL . . . -73.57 -45.42 53.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 109.762 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . 0.512 ' OE1' ' NE2' ' C' ' 112' ' ' HIS . 94.9 mt-10 -65.65 -19.87 66.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.482 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.49 60.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.905 . . . . 0.0 109.377 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 21.4 mt -65.88 -41.2 91.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.711 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -75.64 -12.55 60.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.858 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.401 ' HA ' ' NE ' ' C' ' 31' ' ' ARG . 3.1 tpm_? -78.94 -47.34 16.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.154 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . 0.415 ' HG2' ' H ' ' C' ' 32' ' ' MET . 1.1 ptm -65.76 -26.24 67.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 0.0 109.733 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.41 -36.52 83.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 0.0 109.373 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 12.1 mt -85.66 -44.88 12.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.678 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 40.3 t -51.51 -19.63 1.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.852 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' C' ' 35' ' ' SER . 59.9 m-85 -160.92 90.4 1.61 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 0.0 109.65 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' C' ' 39' ' ' THR . 52.2 Cg_exo -50.4 -26.17 15.52 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.488 2.125 . . . . 0.0 112.137 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.784 ' O ' HG22 ' C' ' 41' ' ' THR . 10.8 p -47.32 -18.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.439 ' N ' ' O ' ' C' ' 37' ' ' PRO . 21.8 p -76.6 -22.76 53.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.238 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -74.29 -31.77 62.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.777 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 1.371 HG21 ' ND1' ' B' ' 97' ' ' HIS . 14.2 t . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 109.354 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.534 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 21.6 p80 . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.542 0.687 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.705 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.9 OUTLIER -166.6 75.47 0.18 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.609 ' C ' ' O ' ' C' ' 46' ' ' PHE . 20.7 m-20 -8.76 -54.69 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 120.985 0.422 . . . . 0.0 111.493 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.705 ' N ' ' O ' ' C' ' 46' ' ' PHE . 5.7 mt 56.71 4.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.485 ' H ' ' C ' ' C' ' 47' ' ' ASP . 33.4 t -73.34 19.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 109.348 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' C' ' 48' ' ' LEU . 6.6 t-80 58.81 156.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.42 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.06 15.23 1.43 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 10.7 t -72.49 -21.33 61.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -1.127 . . . . 0.0 109.422 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 67.54 -50.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.463 -0.773 . . . . 0.0 109.717 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' C' ' 52' ' ' SER . 15.8 pt20 -45.39 -17.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.667 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.548 HG12 ' HB1' ' C' ' 26' ' ' ALA . 77.4 t -73.87 -32.94 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.75 -24.77 67.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.673 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.16 -51.07 41.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 24.9 t-80 -67.8 -27.92 67.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -1.202 . . . . 0.0 110.221 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' C' ' 26' ' ' ALA . . . -63.13 -31.05 79.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.419 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 16.9 mtpp -71.92 -23.48 61.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -1.152 . . . . 0.0 110.118 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' C' ' 65' ' ' ALA . 0.4 OUTLIER -66.91 -58.15 5.56 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.044 -1.035 . . . . 0.0 108.574 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -55.08 -48.98 75.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.536 -0.728 . . . . 0.0 109.245 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' C' ' 67' ' ' THR . . . -64.33 -42.55 96.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.299 -0.875 . . . . 0.0 108.854 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 7.4 t70 -72.0 -25.69 61.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.065 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' C' ' 61' ' ' LYS . . . -80.61 -44.75 18.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.375 -0.828 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . 0.936 ' O ' HD12 ' C' ' 66' ' ' LEU . 0.1 OUTLIER -76.5 -27.38 56.01 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.428 ' OG1' ' NE1' ' C' ' 14' ' ' TRP . 52.0 m -75.89 -44.66 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' C' ' 71' ' ' ALA . 36.5 t30 -57.45 -20.72 32.34 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.33 -45.68 12.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' C' ' 10' ' ' VAL . 6.0 t -59.75 -22.57 24.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.521 ' O ' ' CD2' ' C' ' 72' ' ' HIS . . . -65.48 -15.17 62.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.092 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' C' ' 74' ' ' ASP . 32.0 m80 -153.03 -51.87 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.434 -0.791 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.1 p 44.59 15.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.85 0.833 . . . . 0.0 109.214 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' C' ' 72' ' ' HIS . 95.8 m-20 -134.36 10.43 3.78 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' C' ' 78' ' ' ASN . 31.2 t70 -175.1 27.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.248 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.693 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.1 ptt? -78.52 -24.29 0.43 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.433 -0.792 . . . . 0.0 111.839 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.4 Cg_exo -52.81 -19.79 11.62 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.711 1.607 . . . . 0.0 112.629 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . 0.452 ' ND2' ' N ' ' C' ' 79' ' ' ALA . 0.8 OUTLIER -94.25 -33.09 13.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.823 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . 0.452 ' N ' ' ND2' ' C' ' 78' ' ' ASN . . . -74.6 -40.81 61.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.62 12.13 13.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 108.983 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . 0.417 ' O ' ' OD1' ' C' ' 85' ' ' ASP . 66.3 p -70.63 -16.19 62.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.632 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -82.1 -51.59 7.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.16 -0.963 . . . . 0.0 109.719 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.438 ' N ' HD23 ' C' ' 83' ' ' LEU . 3.5 mt -45.2 -42.82 9.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.804 . . . . 0.0 109.028 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 29.7 p -57.1 -22.15 37.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.493 -0.755 . . . . 0.0 109.574 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' C' ' 82' ' ' ALA . 0.8 OUTLIER -72.6 -32.7 66.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.94 . . . . 0.0 109.592 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' C' ' 90' ' ' LYS . 7.0 tt -81.37 -29.13 34.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 109.516 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -89.87 -28.47 19.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.58 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' C' ' 90' ' ' LYS . . . -83.84 -80.44 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' C' ' 89' ' ' HIS . 30.6 t-80 -61.2 2.49 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.57 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' C' ' 88' ' ' ALA . 6.1 mtmm -156.07 152.38 27.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.281 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' C' ' 93' ' ' VAL . 10.9 mp 56.97 63.81 1.82 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -0.865 . . . . 0.0 109.033 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . 1.321 ' HB3' ' NH1' ' B' ' 40' ' ' ARG . 8.4 ptp180 -62.73 14.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.47 -0.769 . . . . 0.0 109.501 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.636 ' H ' ' C ' ' C' ' 91' ' ' LEU . 74.1 t -41.38 121.66 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.384 -0.823 . . . . 0.0 109.64 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.06 147.87 2.2 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.465 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' C' ' 97' ' ' ASN . 38.0 Cg_endo -68.25 -10.7 29.74 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.512 2.141 . . . . 0.0 112.126 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 0.419 ' H ' HG23 ' C' ' 96' ' ' VAL . 2.8 t -55.27 -1.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' C' ' 95' ' ' PRO . 5.1 m120 -74.69 -42.27 58.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.857 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' C' ' 98' ' ' PHE . 2.2 m-85 -46.37 -42.1 14.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 0.0 109.337 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -57.95 -33.07 68.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.302 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' C' ' 97' ' ' ASN . 11.1 mt -84.09 -62.12 1.64 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -50.35 -41.91 52.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.199 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 39.0 m -63.17 -51.01 68.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.528 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -66.1 -26.76 67.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.544 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.55 -50.5 69.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.753 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.38 -43.02 23.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -0.931 . . . . 0.0 109.384 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.551 ' N ' HD12 ' C' ' 106' ' ' LEU . 8.6 mp -64.15 -59.39 4.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.356 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . 0.554 ' CG1' ' NE2' ' D' ' 127' ' ' GLN . 77.0 t -56.33 -30.93 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.379 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 26.6 m -75.75 -63.09 1.38 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.318 -0.864 . . . . 0.0 109.388 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 113' ' ' LEU . 13.1 mt -51.32 -30.66 19.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 109.486 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -47.42 -42.29 21.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.717 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.12 -49.21 11.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.422 -0.799 . . . . 0.0 109.763 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . 0.512 ' NE2' ' OE1' ' C' ' 27' ' ' GLU . 11.4 m170 -76.3 -70.0 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.871 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -110.88 97.07 32.27 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.433 -0.792 . . . . 0.0 109.132 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' C' ' 113' ' ' LEU . 73.0 Cg_exo -47.46 -174.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.399 2.066 . . . . 0.0 112.883 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.482 ' HB2' ' CE1' ' C' ' 122' ' ' HIS . . . -86.59 -35.18 19.6 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.696 0.76 . . . . 0.0 109.517 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 3.8 mt-10 78.45 0.84 2.61 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.94 ' HD1' HH21 ' D' ' 30' ' ' ARG . 22.0 t80 65.27 37.64 6.33 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.602 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.764 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -94.01 115.15 64.81 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.749 -1.22 . . . . 0.0 107.907 178.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . 0.76 ' HA ' ' CG1' ' D' ' 33' ' ' VAL . 50.5 Cg_exo -50.38 21.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.974 1.782 . . . . 0.0 112.571 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -147.08 -21.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.039 . . . . 0.0 110.966 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.76 HG13 ' N ' ' C' ' 122' ' ' HIS . 10.4 p -58.23 -58.76 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.95 -1.094 . . . . 0.0 110.385 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.76 ' N ' HG13 ' C' ' 121' ' ' VAL . 1.1 m-70 -70.98 -24.97 62.51 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.266 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' D' ' 33' ' ' VAL . . . -84.1 -20.68 32.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.508 ' N ' ' O ' ' C' ' 120' ' ' ALA . 62.5 p -77.38 -63.15 1.44 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.267 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' C' ' 125' ' ' LEU . 4.6 mt -60.5 -19.95 58.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.075 -1.016 . . . . 0.0 109.084 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . 0.487 ' OD2' ' OH ' ' D' ' 35' ' ' TYR . 7.4 t70 -77.71 -51.21 10.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.455 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.26 -41.75 11.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.817 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' C' ' 124' ' ' SER . 29.8 t80 -50.25 -22.94 1.96 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.985 -1.072 . . . . 0.0 108.991 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' C' ' 133' ' ' SER . 14.9 mt -74.05 -24.69 59.56 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -56.67 -31.99 64.97 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.481 ' HB3' HD13 ' C' ' 2' ' ' LEU . 89.4 p -73.99 -32.42 63.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.48 -29.74 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.45 ' N ' ' O ' ' C' ' 129' ' ' LEU . 9.8 p -81.86 -25.33 35.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.329 -0.857 . . . . 0.0 108.881 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 36.8 m -74.96 -40.08 60.95 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.361 -0.837 . . . . 0.0 109.1 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.08 -21.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.344 -0.847 . . . . 0.0 108.779 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.77 -35.99 72.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.434 -0.792 . . . . 0.0 109.072 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . 0.434 ' O ' ' O ' ' C' ' 138' ' ' SER . 57.5 p -88.04 -2.44 58.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 109.571 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . 0.434 ' O ' ' O ' ' C' ' 137' ' ' THR . 28.3 m . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 109.555 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.892 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -136.45 -163.14 1.36 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 109.254 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.403 ' O ' ' N ' ' D' ' 6' ' ' GLU . 11.9 p -89.02 130.64 43.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.132 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -42.05 -23.06 0.23 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.292 1.995 . . . . 0.0 112.24 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' D' ' 4' ' ' THR . 51.9 mt-10 -80.05 -54.34 5.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.925 . . . . 0.0 109.877 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.39 -40.98 85.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.946 . . . . 0.0 109.87 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.729 ' HB2' HD13 ' D' ' 3' ' ' LEU . 0.3 OUTLIER -68.64 -35.08 76.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.473 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 4.9 m -60.66 -23.64 64.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 109.879 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.38 -57.64 3.39 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.067 -1.02 . . . . 0.0 109.859 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.436 ' H ' HG12 ' D' ' 11' ' ' VAL . 1.3 p -62.69 -24.41 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 82.0 m -83.9 -35.1 24.35 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.349 0.595 . . . . 0.0 109.695 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' D' ' 9' ' ' SER . . . -69.11 -29.37 67.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.83 . . . . 0.0 109.668 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.1 -20.98 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.312 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . 0.46 ' HE1' ' HB2' ' D' ' 72' ' ' SER . 0.8 OUTLIER -53.61 -17.93 2.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 109.067 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.7 -33.35 47.3 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -89.72 -41.63 11.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -1.178 . . . . 0.0 109.35 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -57.17 114.83 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.847 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' D' ' 21' ' ' ASP . 7.4 m120 -84.1 68.41 10.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.296 -0.877 . . . . 0.0 108.686 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' D' ' 19' ' ' ASN . 72.3 t -43.94 -18.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 109.673 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' D' ' 19' ' ' ASN . 1.1 m-20 -62.39 -10.77 12.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.764 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -154.37 -35.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 109.517 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 72.8 t -48.72 -34.97 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.17 -25.99 68.8 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.04 -36.22 25.37 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -67.66 -30.67 70.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -1.125 . . . . 0.0 109.487 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.43 46.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . 0.55 HD12 ' N ' ' D' ' 28' ' ' LEU . 10.0 mp -64.32 -55.71 19.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.377 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.1 -41.35 29.86 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . 0.94 HH21 ' HD1' ' C' ' 117' ' ' PHE . 73.3 mtt-85 -80.0 -34.57 38.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -1.117 . . . . 0.0 109.502 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . 0.438 HD12 HG21 ' D' ' 109' ' ' VAL . 65.3 tp -47.19 -37.11 9.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' D' ' 36' ' ' PRO . 14.7 mt -81.31 -39.24 25.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.923 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . 0.76 ' CG1' ' HA ' ' C' ' 119' ' ' PRO . 73.1 t -58.11 -61.48 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.385 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' C' ' 122' ' ' HIS . 1.7 t -68.69 -22.55 26.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.397 -0.814 . . . . 0.0 109.828 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . 0.487 ' OH ' ' OD2' ' C' ' 126' ' ' ASP . 63.9 m-85 -146.77 76.43 11.65 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.153 -0.967 . . . . 0.0 109.767 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' D' ' 32' ' ' LEU . 72.2 Cg_endo -82.86 28.9 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.912 2.408 . . . . 0.0 112.323 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . 0.534 ' CD1' HG23 ' D' ' 38' ' ' THR . 3.8 p-90 -80.95 -20.0 42.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.095 -1.003 . . . . 0.0 109.717 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.534 HG23 ' CD1' ' D' ' 37' ' ' TRP . 44.8 p -78.37 -103.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.554 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . 0.524 ' N ' ' OG1' ' D' ' 38' ' ' THR . 13.9 mt-30 55.03 10.67 0.42 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.645 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . 1.287 ' NH1' ' HB3' ' A' ' 92' ' ' ARG . 15.8 mmt180 -88.7 -58.86 2.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -71.45 -8.28 52.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -87.72 28.22 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.7 -27.31 65.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.462 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 94.0 p -84.11 -27.22 28.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -49.55 -24.43 2.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.299 -0.876 . . . . 0.0 109.241 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.82 173.11 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.89 91.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -1.091 . . . . 0.0 109.572 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 12.6 mt -139.01 19.71 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 109.31 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -58.85 -34.02 71.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.15 -0.969 . . . . 0.0 109.434 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . 0.479 ' HG1' ' CG ' ' D' ' 52' ' ' ASP . 0.1 OUTLIER -140.6 154.23 68.97 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.32 -24.34 73.94 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.253 1.969 . . . . 0.0 111.765 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . 0.479 ' CG ' ' HG1' ' D' ' 50' ' ' THR . 2.8 p30 -85.22 -21.0 29.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.608 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.98 -19.9 65.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 109.735 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . 0.445 ' O ' HG21 ' D' ' 60' ' ' VAL . 4.4 t -67.07 -64.03 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 0.0 109.465 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.05 8.13 1.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.537 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.68 -29.83 60.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -84.42 147.65 50.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.212 -1.169 . . . . 0.0 109.377 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.65 -7.14 19.79 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.584 2.19 . . . . 0.0 112.193 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -85.69 -28.56 24.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.666 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . 0.445 HG21 ' O ' ' D' ' 54' ' ' VAL . 83.9 t -70.24 -52.95 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -57.82 -26.42 61.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.89 -46.68 43.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -61.72 -23.84 66.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.887 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.07 -20.0 77.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -69.51 -37.3 77.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 109.084 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -68.13 -40.69 82.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.444 -0.785 . . . . 0.0 109.498 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 41.9 t -61.29 -59.1 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.203 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.518 ' O ' HD23 ' D' ' 68' ' ' LEU . 4.8 tt -58.59 -52.61 64.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 108.983 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.15 -44.98 27.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.46 96.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -1.128 . . . . 0.0 109.379 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' D' ' 71' ' ' PHE . 2.5 t80 -69.59 -27.22 64.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.853 . . . . 0.0 109.336 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . 0.46 ' HB2' ' HE1' ' D' ' 15' ' ' TRP . 88.5 p -76.93 -27.85 55.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' D' ' 77' ' ' HIS . 10.6 t70 -47.42 -37.11 10.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.09 -60.6 6.62 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.544 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.7 mp -56.61 -24.79 50.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -1.159 . . . . 0.0 109.156 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . 0.544 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -93.86 -11.11 31.86 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 109.583 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 80.0 m-70 -161.19 65.15 0.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.59 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 2.0 mt -71.73 10.29 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.082 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' D' ' 77' ' ' HIS . 2.8 p30 -64.35 -30.23 71.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.378 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.433 ' N ' ' OD1' ' D' ' 79' ' ' ASP . 34.5 t-20 -171.09 105.08 0.23 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.14 -58.87 2.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -48.23 -23.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.0 109.449 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -68.73 -54.82 13.23 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.54 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.9 t -75.2 -47.17 29.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -1.164 . . . . 0.0 109.417 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.54 ' N ' ' CG2' ' D' ' 84' ' ' THR . 48.6 m-85 -62.7 -5.41 2.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.67 62.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.273 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 37.1 p -79.75 -51.22 9.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.379 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.431 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 27.1 mt -59.68 -42.07 92.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 5.1 m -65.09 -42.41 94.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -73.1 -40.15 65.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 4.6 tt -67.02 -35.03 79.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.607 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.561 ' O ' ' N ' ' D' ' 97' ' ' HIS . 60.0 m80 -84.28 -20.28 32.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.926 -1.109 . . . . 0.0 109.722 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 39.4 t -84.01 -60.07 2.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 111.01 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -86.96 -29.8 21.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.001 -1.062 . . . . 0.0 111.59 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -85.77 -51.92 6.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.772 -1.205 . . . . 0.0 110.649 -178.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.607 ' C ' ' CG ' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -102.75 -24.12 13.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.06 -1.025 . . . . 0.0 109.856 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 1.413 ' ND1' HG21 ' A' ' 41' ' ' THR . 0.5 OUTLIER 44.64 47.08 8.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.104 -0.998 . . . . 0.0 109.892 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 t -60.6 121.51 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.119 -0.988 . . . . 0.0 109.033 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' D' ' 100' ' ' PRO . 13.9 m-20 -59.09 143.97 83.47 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.225 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' D' ' 99' ' ' ASP . 75.4 Cg_exo -45.85 -174.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.423 2.082 . . . . 0.0 112.342 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 57.44 76.61 0.31 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' D' ' 104' ' ' ARG . 40.5 t-20 -171.6 -67.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.432 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -49.0 -15.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' D' ' 102' ' ' ASN . 10.3 mmt180 -76.2 -31.15 58.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.336 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 mt -77.78 -51.99 9.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.859 . . . . 0.0 109.645 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.4 tt -51.09 -49.18 61.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.107 -0.996 . . . . 0.0 109.23 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.77 -21.24 65.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -85.75 -27.64 25.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -1.162 . . . . 0.0 109.715 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . 0.438 HG21 HD12 ' D' ' 31' ' ' LEU . 77.0 t -69.15 -47.48 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.646 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 16.2 mt -48.48 -39.7 23.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 109.503 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 65.4 t -51.11 -36.45 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . 0.649 ' SG ' ' CD2' ' C' ' 122' ' ' HIS . 14.4 t -78.09 -23.02 48.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -79.14 -27.18 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.644 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 29.0 mt -81.47 -22.31 38.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.903 . . . . 0.0 109.507 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' D' ' 119' ' ' GLY . . . -83.45 -36.93 23.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 109.635 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.456 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 9.2 t-80 -68.96 -49.08 61.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . 0.502 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 0.3 OUTLIER -74.32 -17.7 60.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.486 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 6.2 m-85 -152.37 62.07 0.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -62.07 -25.55 66.38 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -74.16 -31.0 62.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.535 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -82.27 11.75 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -84.98 34.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.961 . . . . 0.0 109.536 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.479 ' OG1' HG23 ' D' ' 126' ' ' VAL . 65.1 p -54.42 147.34 28.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.516 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.9 Cg_exo -45.11 -54.58 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.411 2.074 . . . . 0.0 113.16 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 18.3 Cg_endo -59.39 -11.5 13.81 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.113 1.875 . . . . 0.0 112.298 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.479 HG23 ' OG1' ' D' ' 123' ' ' THR . 72.1 t -97.86 -20.44 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 109.59 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . 0.554 ' NE2' ' CG1' ' C' ' 107' ' ' VAL . 5.4 tp-100 -83.34 -60.1 2.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 109.859 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -61.67 -34.78 76.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.96 23.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' D' ' 128' ' ' ALA . 23.5 t80 -118.96 -59.19 1.88 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.44 -0.788 . . . . 0.0 109.591 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -47.03 -23.35 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.983 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -82.56 -38.22 24.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -0.972 . . . . 0.0 109.932 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 45.2 t -61.59 -41.05 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -0.95 . . . . 0.0 109.881 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.43 ' H ' HG22 ' D' ' 134' ' ' VAL . 1.6 m -82.04 -40.71 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.98 . . . . 0.0 109.771 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 1.035 ' O ' ' CD2' ' B' ' 146' ' ' HIS . . . -47.5 -20.99 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.119 -0.988 . . . . 0.0 109.58 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -75.63 -41.51 29.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.31 -21.86 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -1.128 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.63 -44.29 81.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . 0.88 HD21 ' HB2' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -79.67 -35.4 39.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.539 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.23 -43.94 43.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.496 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 40.2 mt -84.07 17.72 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' D' ' 146' ' ' HIS . . . -140.99 8.15 2.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.264 -0.898 . . . . 0.0 109.467 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -67.02 -38.13 85.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.888 . . . . 0.0 109.31 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.38 -13.47 62.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.862 . . . . 0.0 109.355 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' D' ' 145' ' ' TYR . 23.2 p90 -160.51 55.4 0.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 1.06 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 2.2 p-80 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.416 ' C ' ' OG ' ' A' ' 3' ' ' SER . 14.7 mt -139.09 -178.34 5.3 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.375 -0.828 . . . . 0.0 109.18 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.497 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 178.77 -50.9 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.993 . . . . 0.0 110.065 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 6' ' ' ASP . 83.0 Cg_exo -43.63 155.64 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.43 2.087 . . . . 0.0 112.538 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -46.21 -16.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 109.803 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' PRO . 12.5 t70 -39.45 -44.86 1.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 109.816 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 8' ' ' THR . 6.5 ptmt -58.01 -50.41 73.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.125 -0.985 . . . . 0.0 108.992 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.415 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 22.7 m -54.73 -31.41 58.3 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 108.652 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -77.23 -34.84 55.87 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.85 -51.81 41.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -47.78 46.96 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.47 -61.14 2.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.645 -0.659 . . . . 0.0 109.458 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -50.27 -41.91 51.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.403 -0.811 . . . . 0.0 109.066 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -17.54 64.93 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.4 -0.813 . . . . 0.0 109.178 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.18 -45.48 10.11 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.438 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 39.5 mmtt -68.62 -39.59 80.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -1.174 . . . . 0.0 108.763 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 13' ' ' ALA . 58.1 t -61.88 -64.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 54.76 -132.77 47.83 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.73 27.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -1.063 . . . . 0.0 110.376 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.551 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.8 m-70 -131.83 25.2 4.67 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.232 -0.918 . . . . 0.0 108.538 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -89.41 -59.55 2.18 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.566 -0.709 . . . . 0.0 109.789 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.71 -13.89 0.2 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.6 mt-10 -87.58 -56.48 3.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 109.912 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.526 ' CD1' ' ND1' ' A' ' 112' ' ' HIS . 3.0 m-30 -60.11 -29.22 68.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.5 87.19 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.16 -39.13 29.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -1.165 . . . . 0.0 109.75 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -63.88 -25.54 68.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.261 -0.899 . . . . 0.0 109.318 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.35 -23.06 66.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.572 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.669 HD11 ' ND1' ' A' ' 58' ' ' HIS . 10.7 mt -76.65 -58.49 3.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.55 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -62.39 -12.42 21.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -69.65 -49.92 49.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 110.329 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.6 ptt? -84.11 -36.45 22.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.046 -1.034 . . . . 0.0 110.404 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -43.78 -23.84 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.171 -0.955 . . . . 0.0 110.107 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.548 ' CD1' ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -92.16 -28.8 16.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.125 -0.984 . . . . 0.0 109.951 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 81.2 p -89.21 -18.44 27.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.087 -1.008 . . . . 0.0 110.022 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 35' ' ' SER . 84.7 m-85 -157.95 75.82 3.81 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.104 -0.997 . . . . 0.0 109.719 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.34 -19.98 60.77 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.889 2.393 . . . . 0.0 112.247 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.442 ' O ' HG22 ' A' ' 41' ' ' THR . 24.4 p -48.61 -18.78 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.943 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.1 p -85.92 -52.98 5.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.957 . . . . 0.0 109.803 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.462 ' O ' ' C ' ' A' ' 41' ' ' THR . 0.5 OUTLIER -80.01 -17.57 52.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 109.644 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 40' ' ' LYS . 10.7 t . . . . . 0 N--CA 1.494 1.771 0 O-C-N 121.453 -0.78 . . . . 0.0 109.894 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -139.35 63.78 1.49 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 49' ' ' SER . 33.7 m-20 -37.94 -22.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 46' ' ' PHE . 1.2 mt 52.6 6.33 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.218 -0.926 . . . . 0.0 109.583 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 47' ' ' ASP . 34.5 t -81.3 153.3 27.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 28.3 m170 -47.79 128.64 13.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.53 22.04 13.45 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 54' ' ' GLN . 36.9 m -95.03 66.02 2.95 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -1.155 . . . . 0.0 108.964 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -37.85 -25.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.818 -0.551 . . . . 0.0 110.237 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' A' ' 52' ' ' SER . 14.1 mt-30 -60.8 -46.22 91.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.476 HG22 ' CE2' ' A' ' 46' ' ' PHE . 15.9 t -55.99 -47.62 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.087 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -66.55 -54.19 26.45 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.12 -26.77 29.07 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.669 ' ND1' HD11 ' A' ' 29' ' ' LEU . 6.8 t-80 -69.85 -33.48 72.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.985 -1.303 . . . . 0.0 109.798 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.6 -48.61 83.68 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 51.3 mttp -51.0 -23.82 3.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -1.057 . . . . 0.0 109.811 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.43 -50.68 29.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.208 -0.933 . . . . 0.0 108.891 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.63 -43.61 90.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.603 -0.686 . . . . 0.0 109.327 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.04 -28.88 64.7 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.234 -0.916 . . . . 0.0 109.432 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 15.1 t70 -72.26 -40.12 67.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 108.782 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.33 82.03 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.372 -0.83 . . . . 0.0 108.875 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.15 -40.31 95.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -70.62 -51.03 30.87 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -59.39 -22.96 62.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.684 ' HB1' ' SD ' ' A' ' 76' ' ' MET . . . -83.58 -47.31 11.42 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.08 -22.63 31.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.44 -15.09 63.43 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.596 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.1 m80 -143.78 -59.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.509 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 73' ' ' VAL . 14.5 p 44.57 13.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.713 0.768 . . . . 0.0 109.492 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' A' ' 72' ' ' HIS . 12.8 t70 -133.38 9.66 4.04 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 2.1 m-20 -179.58 27.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.942 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.684 ' SD ' ' HB1' ' A' ' 69' ' ' ALA . 17.7 ptt? -78.74 -22.75 0.39 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 112.006 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 76' ' ' MET . 52.3 Cg_exo -52.63 -22.01 15.99 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.578 1.519 . . . . 0.0 112.592 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.13 -24.03 17.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.728 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.47 -54.29 6.92 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.151 -0.968 . . . . 0.0 109.183 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.664 ' N ' HD12 ' A' ' 80' ' ' LEU . 7.0 mp -77.15 8.89 3.46 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.433 -0.792 . . . . 0.0 109.046 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.6 t -65.18 -15.83 62.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 109.886 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.79 -46.08 14.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 0.0 109.854 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 83' ' ' LEU . 4.2 mt -46.43 -45.93 18.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.314 -0.866 . . . . 0.0 108.94 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 135' ' ' VAL . 37.6 m -54.04 -29.15 42.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.552 -0.717 . . . . 0.0 109.45 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' ALA . 25.9 t0 -65.68 -33.93 77.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 109.499 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 90' ' ' LYS . 3.0 tt -82.99 -63.65 1.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -50.09 -21.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 109.954 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -97.76 -48.11 5.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.168 -0.957 . . . . 0.0 109.955 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -76.73 -70.95 0.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 86' ' ' LEU . 30.1 mttm -86.43 140.65 29.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.808 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.6 mp 53.88 57.91 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.07 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.565 ' HD3' ' CD ' ' D' ' 40' ' ' ARG . 72.5 ttt180 -47.89 -47.58 31.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.829 . . . . 0.0 109.288 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 94' ' ' ASP . 62.1 t 49.67 179.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.353 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.738 ' H ' HG12 ' A' ' 93' ' ' VAL . 34.7 m-20 -133.09 151.87 78.64 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.151 -0.968 . . . . 0.0 109.12 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 98' ' ' PHE . 82.3 Cg_exo -39.28 -19.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.571 2.181 . . . . 0.0 112.282 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 1.317 HG21 ' CB ' ' D' ' 99' ' ' ASP . 64.6 t -47.07 -32.91 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.697 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 1.5 m120 -79.23 -25.15 42.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 95' ' ' PRO . 77.4 t80 -67.88 -56.38 9.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.83 -28.8 2.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 109.545 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.407 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 17.0 mt -84.04 -52.37 6.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.7 tp -47.2 -39.75 14.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.948 . . . . 0.0 109.76 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.2 p -65.04 -59.22 4.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -52.97 -26.79 16.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.811 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 60.4 m -66.46 -58.44 5.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -45.98 -22.99 0.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 109.91 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 4.1 mm? -82.19 -32.33 29.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.029 -1.044 . . . . 0.0 109.808 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.92 -27.5 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.686 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.8 p -69.01 -60.45 2.35 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.156 -0.965 . . . . 0.0 109.549 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 113' ' ' LEU . 37.1 mt -55.88 -42.1 75.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 109.291 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.31 11.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.798 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.27 -55.79 4.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 109.901 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.526 ' ND1' ' CD1' ' A' ' 24' ' ' TYR . 22.3 m170 -59.59 -62.66 1.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.083 -1.011 . . . . 0.0 109.128 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.808 HD12 ' O ' ' A' ' 114' ' ' PRO . 2.4 pp -137.69 118.94 10.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.808 ' O ' HD12 ' A' ' 113' ' ' LEU . 88.2 Cg_exo -40.78 -178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.551 2.167 . . . . 0.0 113.292 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.791 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -57.42 -55.19 37.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.43 -0.794 . . . . 0.0 109.157 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.647 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 4.8 mm-40 120.48 -2.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.2 t80 64.52 52.19 1.83 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.962 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -133.04 111.5 13.17 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.838 ' HA ' HG13 ' B' ' 33' ' ' VAL . 76.7 Cg_exo -47.48 10.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.139 1.893 . . . . 0.0 112.582 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -132.65 -19.37 2.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.289 -0.882 . . . . 0.0 110.197 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.791 HG21 ' O ' ' A' ' 115' ' ' ALA . 11.6 p -60.36 -55.4 24.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.154 -0.966 . . . . 0.0 110.299 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 1.004 ' HB3' HG13 ' B' ' 34' ' ' VAL . 6.4 m170 -71.93 -33.35 68.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 0.0 108.947 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.99 -20.16 49.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.2 m -64.86 -62.71 1.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 110.003 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.54 -19.56 65.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.191 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.91 -50.11 11.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.718 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -85.55 -43.19 13.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.114 -0.991 . . . . 0.0 109.857 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' N ' ' CD ' ' A' ' 127' ' ' LYS . 53.6 t80 -49.44 -21.0 0.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.962 -1.086 . . . . 0.0 108.668 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.622 ' O ' ' N ' ' A' ' 133' ' ' SER . 12.8 mt -71.94 -17.48 62.08 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.98 -31.65 72.02 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.446 ' O ' HG23 ' A' ' 135' ' ' VAL . 57.4 p -83.29 -34.02 25.83 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.418 -0.801 . . . . 0.0 108.86 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.31 -28.01 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 108.654 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 129' ' ' LEU . 36.8 m -80.08 -28.85 39.05 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.495 -0.753 . . . . 0.0 109.236 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.9 m -71.31 -33.59 69.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.245 -0.909 . . . . 0.0 109.044 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 131' ' ' SER . 30.0 t -79.93 -28.19 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -35.81 73.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.468 -0.77 . . . . 0.0 109.106 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 133' ' ' SER . 14.9 t -101.86 -14.57 17.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 0.0 109.588 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.329 -179.979 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.265 0.555 . . . . 0.0 109.826 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.449 HD12 ' O ' ' B' ' 3' ' ' LEU . 0.3 OUTLIER -158.92 179.06 9.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.422 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 2.2 p -73.39 151.64 89.79 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.413 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.54 -28.61 21.28 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.558 2.172 . . . . 0.0 112.049 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -78.73 -41.23 31.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.573 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.77 -46.08 83.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.559 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.475 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -72.63 -37.44 68.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 109.624 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.403 ' C ' ' O ' ' B' ' 8' ' ' LYS . 3.3 t -45.63 -23.62 0.26 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.688 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.32 -56.51 3.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 109.949 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -65.21 -24.62 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 5.8 m -77.53 -45.73 24.52 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.398 0.618 . . . . 0.0 109.53 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.21 -34.54 72.3 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.396 -0.815 . . . . 0.0 109.573 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.43 ' C ' ' N ' ' B' ' 16' ' ' GLY . 0.8 OUTLIER -51.8 -32.12 30.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.922 . . . . 0.0 109.122 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -48.68 -17.99 0.22 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.343 -0.848 . . . . 0.0 109.267 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' B' ' 14' ' ' LEU . . . -76.78 -56.7 4.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.416 ' N ' ' CD ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -64.78 -27.48 68.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -1.203 . . . . 0.0 109.15 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.9 114.69 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' B' ' 21' ' ' ASP . 25.4 m-80 -80.42 69.15 6.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.231 -0.918 . . . . 0.0 109.048 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 74.2 t -44.32 -21.32 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.419 -0.801 . . . . 0.0 109.651 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' B' ' 19' ' ' ASN . 68.1 m-20 -74.08 3.87 6.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' B' ' 19' ' ' ASN . 35.1 mt-10 -153.01 -41.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.177 -0.952 . . . . 0.0 109.313 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.54 -46.63 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.288 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.32 -42.94 64.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.88 -44.02 63.75 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -68.01 -25.06 65.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.27 -49.44 66.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.551 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.613 HD12 ' N ' ' B' ' 28' ' ' LEU . 9.4 mp -79.12 -54.51 5.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.45 -33.4 8.3 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -82.08 -39.33 23.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -1.119 . . . . 0.0 109.337 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -49.2 -35.79 18.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 27.3 mt -79.88 -31.95 40.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 109.56 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.838 HG13 ' HA ' ' A' ' 119' ' ' PRO . 61.7 t -66.43 -64.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.423 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 1.004 HG13 ' HB3' ' A' ' 122' ' ' HIS . 1.3 t -64.43 -22.74 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.355 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -146.17 80.73 10.05 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.342 -0.849 . . . . 0.0 109.382 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.36 -5.6 14.33 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.672 2.248 . . . . 0.0 112.439 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.535 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 1.3 p-90 -58.86 -24.43 62.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.535 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 3.1 m -95.91 38.22 1.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.39 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . 0.422 ' H ' ' HG3' ' B' ' 39' ' ' GLN . 5.3 pp0? -90.98 9.52 30.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 109.624 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 1.665 ' CD ' ' HD3' ' C' ' 92' ' ' ARG . 55.1 ttt85 -81.56 -29.83 33.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' B' ' 42' ' ' PHE . 66.2 m-85 -90.91 30.08 1.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.948 . . . . 0.0 109.405 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' B' ' 41' ' ' PHE . 70.5 m-85 -145.66 22.61 1.45 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.48 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -78.93 -16.51 56.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.255 -0.903 . . . . 0.0 109.51 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.463 ' O ' ' N ' ' B' ' 46' ' ' GLY . 27.8 p -67.47 -43.23 81.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.598 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' B' ' 47' ' ' ASP . 88.4 m-85 -48.89 -14.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.506 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 66.89 -65.42 0.19 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' B' ' 45' ' ' PHE . 4.6 m-20 -46.18 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -1.163 . . . . 0.0 109.576 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 tp -159.47 22.62 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 12.9 p -70.45 -33.83 71.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.533 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . 0.442 ' O ' ' N ' ' B' ' 53' ' ' ALA . 3.4 p -145.7 151.52 46.5 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 0.0 109.111 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -39.96 -42.09 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.373 2.049 . . . . 0.0 112.238 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.2 -31.05 72.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -61.93 -19.79 63.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.475 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 78.6 t -67.96 -63.83 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.657 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 22.4 ptp -83.18 4.49 26.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.723 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.88 -17.23 70.64 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -82.19 138.18 45.67 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.0 109.024 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.18 -12.88 30.7 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.247 1.964 . . . . 0.0 112.14 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -80.17 -57.47 3.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.332 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 43.0 t -48.02 -31.58 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.341 -0.85 . . . . 0.0 109.56 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.401 ' HB3' ' HZ2' ' B' ' 61' ' ' LYS . 16.2 mtpp -78.99 -32.94 45.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.508 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.62 -45.79 16.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.69 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' B' ' 63' ' ' HIS . 0.9 OUTLIER -62.72 -23.64 67.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.22 -0.925 . . . . 0.0 109.671 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.57 -36.34 83.15 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -60.15 -25.46 65.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -1.2 . . . . 0.0 109.58 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.69 -50.17 39.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.317 -0.865 . . . . 0.0 109.62 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.72 -36.73 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.445 HD23 ' C ' ' B' ' 68' ' ' LEU . 5.6 tt -71.58 -48.03 51.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.288 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.46 -44.91 16.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.62 -51.85 56.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -1.131 . . . . 0.0 109.44 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -49.5 -35.29 19.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.403 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -76.01 -24.49 55.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.4 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -52.37 -43.58 64.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.86 -60.12 8.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.495 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.2 mp -57.98 -28.08 64.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.117 . . . . 0.0 109.277 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -80.45 -9.28 59.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.29 -0.881 . . . . 0.0 109.556 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 57.2 m80 -160.27 65.94 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.389 -0.819 . . . . 0.0 109.539 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mt -68.4 11.62 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' B' ' 77' ' ' HIS . 81.5 m-20 -72.4 -31.07 65.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.124 -0.985 . . . . 0.0 109.553 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 16.4 t-20 -171.02 108.89 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.558 ' N ' HD12 ' B' ' 81' ' ' LEU . 9.5 mp -80.26 -54.75 5.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.5 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.446 ' HD3' ' H ' ' B' ' 82' ' ' LYS . 0.6 OUTLIER -49.92 -24.0 2.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.486 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -73.12 -52.44 8.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.1 t -76.48 -47.58 22.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -1.189 . . . . 0.0 109.528 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.547 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.2 m-85 -66.04 4.76 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.461 -0.775 . . . . 0.0 109.566 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -63.73 -33.4 75.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.423 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.1 p -79.36 -51.3 9.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.418 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' B' ' 92' ' ' HIS . 8.7 mp -53.33 -51.17 63.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.345 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 36.4 p -54.7 -45.4 73.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.927 . . . . 0.0 109.632 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.428 ' O ' ' OD2' ' B' ' 94' ' ' ASP . 32.9 tt0 -66.3 -41.58 89.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.663 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.53 -20.14 40.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.599 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' B' ' 88' ' ' LEU . 1.5 m80 -87.65 -41.21 13.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 110.239 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -82.99 -39.64 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.048 -1.032 . . . . 0.0 110.795 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' B' ' 90' ' ' GLU . 12.1 m-20 -86.18 -36.38 19.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.921 -1.112 . . . . 0.0 111.181 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -52.18 5.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.928 -1.108 . . . . 0.0 110.594 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.583 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 10.0 mp -86.29 -31.81 21.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.92 -1.112 . . . . 0.0 109.68 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 13.5 p80 41.89 29.39 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.382 -0.824 . . . . 0.0 109.858 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.09 124.65 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.178 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 1.284 ' CB ' HG21 ' C' ' 96' ' ' VAL . 0.4 OUTLIER -47.67 154.24 0.94 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.09 -160.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.628 2.219 . . . . 0.0 111.959 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.447 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 29.6 mm-40 57.64 26.3 12.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' B' ' 101' ' ' GLU . 39.1 m-20 -137.53 -32.76 0.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.35 -0.844 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.48 -37.01 85.65 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.497 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -70.14 -23.74 63.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.589 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.583 HD12 ' N ' ' B' ' 105' ' ' LEU . 7.8 mp -79.74 -17.68 52.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.48 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.759 HD13 ' C ' ' B' ' 106' ' ' LEU . 2.6 tm? -78.92 -46.72 17.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.318 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.99 -20.46 77.67 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -70.52 -55.66 8.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.083 -1.245 . . . . 0.0 109.797 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -53.72 -24.06 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.634 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.517 ' O ' HD23 ' B' ' 110' ' ' LEU . 1.6 tt -64.44 -50.85 65.91 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.472 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.563 ' CG2' ' CE1' ' B' ' 130' ' ' TYR . 46.7 t -49.44 -45.21 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.716 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 56.5 m -51.55 -35.92 42.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.631 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.91 -28.58 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 41.6 mt -72.73 -40.68 65.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.21 -20.85 59.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 109.297 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.54 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 3.0 t-80 -84.75 -54.62 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.301 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.428 ' N ' ' HD1' ' B' ' 117' ' ' HIS . 0.5 OUTLIER -70.97 -17.54 62.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 0.0 109.671 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.41 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 68.3 m-85 -152.71 62.3 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.573 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.542 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -58.86 -26.99 61.3 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -68.37 -34.97 77.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -82.78 14.23 3.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.638 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.551 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -82.91 36.32 0.5 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.627 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.605 ' OG1' HG23 ' B' ' 126' ' ' VAL . 7.4 p -46.42 154.15 0.67 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.454 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.453 ' O ' HD13 ' A' ' 34' ' ' LEU . 24.5 Cg_exo -55.49 -44.81 44.85 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.358 2.039 . . . . 0.0 113.749 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' B' ' 124' ' ' PRO . 67.1 Cg_endo -78.17 -8.16 16.35 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.021 1.814 . . . . 0.0 112.615 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.605 HG23 ' OG1' ' B' ' 123' ' ' THR . 10.6 t -83.76 -31.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 109.198 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -83.26 -59.73 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 109.629 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 1.548 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -48.49 -41.96 31.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.18 -36.46 83.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.831 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.563 ' CE1' ' CG2' ' B' ' 111' ' ' VAL . 30.0 t80 -61.23 -60.9 3.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.067 -1.021 . . . . 0.0 109.402 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -47.77 -25.81 1.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.873 . . . . 0.0 109.563 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.442 ' NZ ' ' CB ' ' B' ' 132' ' ' LYS . 5.0 ttpm? -85.53 -31.52 22.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 109.739 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.49 -65.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.54 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.418 ' H ' HG22 ' B' ' 134' ' ' VAL . 5.9 m -55.48 -15.67 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.597 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.648 ' CB ' ' OXT' ' D' ' 146' ' ' HIS . . . -56.22 -33.73 65.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.341 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.83 -30.52 57.62 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.15 -32.86 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.428 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.94 76.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.332 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -78.73 -21.26 48.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.299 -0.875 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.64 -60.73 2.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.942 . . . . 0.0 109.676 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 63.9 mt -54.22 -20.32 6.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.135 -0.978 . . . . 0.0 109.256 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' B' ' 145' ' ' TYR . . . -88.98 -4.6 58.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 109.116 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' B' ' 146' ' ' HIS . 71.4 t60 -49.45 -39.08 31.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.498 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -86.94 -55.15 3.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.133 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -52.8 -10.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.514 -0.741 . . . . 0.0 109.36 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.62 ' OXT' ' CB ' ' D' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.469 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.429 ' C ' ' OG ' ' C' ' 3' ' ' SER . 14.6 mt -139.05 -178.3 5.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.361 -0.837 . . . . 0.0 109.218 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.494 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 178.76 -50.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' C' ' 6' ' ' ASP . 83.1 Cg_exo -43.64 155.71 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.309 2.006 . . . . 0.0 112.576 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -46.27 -16.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.841 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' C' ' 4' ' ' PRO . 12.5 t70 -39.43 -44.91 1.43 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.39 -0.819 . . . . 0.0 109.792 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' C' ' 8' ' ' THR . 6.5 ptmt -57.95 -50.48 73.23 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.117 -0.989 . . . . 0.0 109.01 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.411 ' N ' ' CG ' ' C' ' 7' ' ' LYS . 22.6 m -54.67 -31.51 57.85 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 108.61 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -77.16 -34.85 56.38 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.79 -51.82 41.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.37 -47.74 47.33 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.45 -61.18 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.494 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.599 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -50.18 -42.0 50.44 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.392 -0.817 . . . . 0.0 109.06 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -17.57 64.93 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.437 -0.789 . . . . 0.0 109.156 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.2 -45.38 10.17 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 39.6 mmtt -68.72 -39.54 80.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 108.798 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.599 HG23 ' O ' ' C' ' 13' ' ' ALA . 58.1 t -61.86 -65.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 54.78 -132.82 47.94 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.75 27.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.456 -1.026 . . . . 0.0 110.383 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.556 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.7 m-70 -131.77 25.12 4.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -89.32 -59.6 2.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.679 -0.638 . . . . 0.0 109.827 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.73 -13.85 0.2 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.5 mt-10 -87.59 -56.45 3.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.39 -1.065 . . . . 0.0 109.897 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.526 ' CD1' ' ND1' ' C' ' 112' ' ' HIS . 3.0 m-30 -60.18 -29.15 68.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.06 -34.49 86.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.12 -39.13 30.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -1.159 . . . . 0.0 109.754 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.94 -25.55 68.19 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 109.271 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.4 -22.95 66.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.594 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.671 HD11 ' ND1' ' C' ' 58' ' ' HIS . 10.7 mt -76.65 -58.47 3.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -62.38 -12.57 22.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 109.923 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.458 ' HA ' ' HE ' ' C' ' 31' ' ' ARG . 0.3 OUTLIER -69.64 -49.79 50.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 110.327 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . 0.432 ' O ' ' N ' ' C' ' 34' ' ' LEU . 2.6 ptt? -84.22 -36.53 22.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.136 -0.977 . . . . 0.0 110.335 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' C' ' 32' ' ' MET . 13.9 t80 -43.63 -23.93 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 110.175 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 1.56 ' CD1' ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -92.05 -28.85 16.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.001 -1.062 . . . . 0.0 110.03 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.516 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 81.5 p -89.25 -18.45 27.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 0.0 109.928 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.516 ' CG ' ' O ' ' C' ' 35' ' ' SER . 85.0 m-85 -157.89 75.78 3.84 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.127 -0.983 . . . . 0.0 109.797 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' C' ' 39' ' ' THR . 26.2 Cg_exo -60.36 -19.99 60.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.906 2.404 . . . . 0.0 112.166 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.436 ' O ' HG22 ' C' ' 41' ' ' THR . 24.4 p -48.63 -18.76 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 109.926 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.4 ' N ' ' C ' ' C' ' 37' ' ' PRO . 38.0 p -85.93 -53.07 5.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.712 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' C' ' 41' ' ' THR . 0.5 OUTLIER -79.93 -17.56 52.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.666 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.483 ' C ' ' O ' ' C' ' 40' ' ' LYS . 10.9 t . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.484 -0.76 . . . . 0.0 109.992 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -139.26 63.69 1.49 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' C' ' 49' ' ' SER . 33.9 m-20 -37.9 -22.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.365 -0.834 . . . . 0.0 110.226 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' C' ' 46' ' ' PHE . 1.2 mt 52.64 6.34 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.127 -0.983 . . . . 0.0 109.608 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.515 ' H ' ' C ' ' C' ' 47' ' ' ASP . 34.6 t -81.3 153.32 27.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.95 . . . . 0.0 109.351 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' C' ' 50' ' ' HIS . 28.6 m170 -47.92 128.71 13.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.372 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.48 22.06 13.48 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.554 ' O ' ' N ' ' C' ' 54' ' ' GLN . 37.9 m -95.15 66.15 2.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -1.124 . . . . 0.0 108.936 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' C' ' 52' ' ' SER . . . -37.92 -25.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.809 -0.557 . . . . 0.0 110.264 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' C' ' 52' ' ' SER . 14.2 mt-30 -60.64 -46.28 90.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 109.529 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.478 HG22 ' CE2' ' C' ' 46' ' ' PHE . 15.9 t -56.05 -47.51 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.976 . . . . 0.0 109.128 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -66.52 -54.22 26.25 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . 0.433 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -53.21 -26.64 29.33 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.671 ' ND1' HD11 ' C' ' 29' ' ' LEU . 6.8 t-80 -69.92 -33.55 72.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.08 -1.247 . . . . 0.0 109.736 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.48 -48.68 82.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 51.4 mttp -51.07 -23.81 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -1.095 . . . . 0.0 109.705 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' C' ' 57' ' ' GLY . 0.5 OUTLIER -71.49 -50.5 30.86 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 108.966 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.72 -43.61 89.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.601 -0.687 . . . . 0.0 109.303 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.12 -28.71 64.5 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.306 -0.872 . . . . 0.0 109.44 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 15.1 t70 -72.35 -40.09 67.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.034 . . . . 0.0 108.753 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.57 -47.38 81.75 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.01 -40.29 95.15 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -70.63 -51.01 30.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.264 -0.898 . . . . 0.0 108.604 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -59.35 -23.03 62.18 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.671 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -83.56 -47.27 11.48 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.96 -22.79 32.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.47 -14.99 63.38 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.602 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.2 m80 -143.75 -59.56 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.581 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.542 HG22 ' O ' ' C' ' 73' ' ' VAL . 14.5 p 44.68 13.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.711 0.767 . . . . 0.0 109.507 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' C' ' 72' ' ' HIS . 12.8 t70 -133.37 9.58 4.04 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 2.1 m-20 -179.43 27.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.883 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 17.7 ptt? -78.82 -22.69 0.39 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.365 -0.834 . . . . 0.0 112.004 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.1 Cg_exo -52.54 -22.07 15.79 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.63 1.553 . . . . 0.0 112.522 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.16 -24.08 17.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.643 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 -54.27 6.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.15 -0.968 . . . . 0.0 109.142 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . 0.668 ' N ' HD12 ' C' ' 80' ' ' LEU . 7.0 mp -77.21 8.94 3.46 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.384 -0.823 . . . . 0.0 109.058 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t -65.21 -15.82 62.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.843 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.75 -46.13 14.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.183 -0.948 . . . . 0.0 109.846 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.417 HD23 ' N ' ' C' ' 83' ' ' LEU . 4.1 mt -46.26 -46.0 17.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.835 . . . . 0.0 109.044 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' C' ' 135' ' ' VAL . 37.6 m -54.02 -29.13 42.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.547 -0.721 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' C' ' 82' ' ' ALA . 25.9 t0 -65.81 -33.85 76.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.109 -0.994 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' C' ' 90' ' ' LYS . 3.0 tt -83.02 -63.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -49.97 -22.02 1.41 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.877 . . . . 0.0 110.028 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -97.69 -48.14 5.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 110.007 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -76.72 -71.05 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.956 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' C' ' 86' ' ' LEU . 30.1 mttm -86.29 140.58 29.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.736 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.56 ' N ' HD12 ' C' ' 91' ' ' LEU . 10.6 mp 54.0 57.82 5.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.021 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . 1.665 ' HD3' ' CD ' ' B' ' 40' ' ' ARG . 72.5 ttt180 -47.86 -47.52 31.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 0.0 109.374 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.74 HG12 ' H ' ' C' ' 94' ' ' ASP . 61.9 t 49.67 179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.314 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.74 ' H ' HG12 ' C' ' 93' ' ' VAL . 34.8 m-20 -133.12 151.81 78.49 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.266 -0.896 . . . . 0.0 109.119 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' C' ' 98' ' ' PHE . 81.7 Cg_exo -39.19 -19.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.612 2.208 . . . . 0.0 112.302 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . 1.284 HG21 ' CB ' ' B' ' 99' ' ' ASP . 63.9 t -46.98 -32.92 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.74 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' C' ' 97' ' ' ASN . 1.5 m120 -79.31 -25.07 42.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.942 . . . . 0.0 109.507 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' C' ' 95' ' ' PRO . 77.2 t80 -67.95 -56.37 9.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.8 -28.83 2.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.477 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 17.0 mt -83.98 -52.36 6.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.165 -0.959 . . . . 0.0 109.565 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 58.0 tp -47.27 -39.55 14.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.777 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 99.3 p -65.13 -59.25 4.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -53.01 -26.72 16.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.83 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 60.4 m -66.42 -58.48 5.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 109.825 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -45.93 -23.13 0.26 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.424 ' N ' HD22 ' C' ' 106' ' ' LEU . 4.1 mm? -82.12 -32.34 30.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.046 -1.034 . . . . 0.0 109.819 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 38.4 t -82.86 -27.61 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.173 -0.954 . . . . 0.0 109.689 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 6.8 p -68.92 -60.52 2.31 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.184 -0.948 . . . . 0.0 109.572 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 36.7 mt -55.79 -42.08 75.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.346 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.33 11.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.773 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.24 -55.79 4.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.941 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . 0.526 ' ND1' ' CD1' ' C' ' 24' ' ' TYR . 22.6 m170 -59.67 -62.64 1.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.983 -1.073 . . . . 0.0 109.062 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.806 HD12 ' O ' ' C' ' 114' ' ' PRO . 2.4 pp -137.71 118.91 10.63 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . 0.806 ' O ' HD12 ' C' ' 113' ' ' LEU . 89.4 Cg_exo -40.74 -178.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.561 2.174 . . . . 0.0 113.318 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.779 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -57.46 -55.07 39.52 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.422 -0.799 . . . . 0.0 109.164 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.649 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 4.8 mm-40 120.32 -2.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 20.0 t80 64.34 52.32 1.91 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.161 0.505 . . . . 0.0 110.989 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.0 OUTLIER -133.13 111.5 13.07 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . 0.85 ' HA ' HG13 ' D' ' 33' ' ' VAL . 78.1 Cg_exo -47.41 10.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.171 1.914 . . . . 0.0 112.561 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -132.72 -19.4 2.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.882 . . . . 0.0 110.279 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.779 HG21 ' O ' ' C' ' 115' ' ' ALA . 11.7 p -60.42 -55.33 25.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.119 -0.988 . . . . 0.0 110.302 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 1.03 ' HB3' HG13 ' D' ' 34' ' ' VAL . 6.4 m170 -72.05 -33.25 67.82 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.129 -0.982 . . . . 0.0 108.883 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.08 -20.18 49.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.485 -0.759 . . . . 0.0 109.137 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.581 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.1 m -64.86 -62.7 1.41 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.351 -0.843 . . . . 0.0 109.998 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.55 -19.5 65.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 109.203 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.99 -50.09 11.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.75 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -85.66 -43.12 13.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.117 -0.989 . . . . 0.0 109.795 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.434 ' N ' ' CD ' ' C' ' 127' ' ' LYS . 53.5 t80 -49.45 -20.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.898 -1.126 . . . . 0.0 108.672 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' C' ' 133' ' ' SER . 12.8 mt -71.9 -17.62 62.09 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.9 -31.72 72.04 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.434 ' O ' HG23 ' C' ' 135' ' ' VAL . 57.0 p -83.22 -34.01 25.98 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.325 -0.859 . . . . 0.0 108.947 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -85.31 -27.96 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 108.655 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.626 ' N ' ' O ' ' C' ' 129' ' ' LEU . 37.2 m -80.14 -28.92 38.83 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.408 -0.808 . . . . 0.0 109.159 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 41.8 m -71.24 -33.67 70.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 109.035 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 131' ' ' SER . 30.0 t -79.9 -28.13 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.26 -0.9 . . . . 0.0 108.623 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.63 -35.76 73.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.037 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . 0.447 HG22 ' O ' ' C' ' 133' ' ' SER . 14.9 t -101.93 -14.55 17.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.83 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.146 -0.971 . . . . 0.0 109.401 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.325 0.583 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.443 HD12 ' O ' ' D' ' 3' ' ' LEU . 0.3 OUTLIER -159.05 179.04 9.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.365 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.419 ' OG1' ' OE2' ' D' ' 7' ' ' GLU . 2.2 p -73.36 151.57 89.84 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.46 -28.54 21.77 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.552 2.168 . . . . 0.0 112.107 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -78.83 -41.25 30.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.939 . . . . 0.0 109.534 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . 0.419 ' OE2' ' OG1' ' D' ' 4' ' ' THR . 46.2 mt-10 -64.76 -46.03 83.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.467 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -72.63 -37.53 68.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.605 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 3.4 t -45.52 -23.7 0.25 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.788 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.23 -56.51 3.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.147 -0.971 . . . . 0.0 109.999 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 6.7 p -65.24 -24.62 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 5.8 m -77.51 -45.66 24.83 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.395 0.616 . . . . 0.0 109.575 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.45 72.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.385 -0.822 . . . . 0.0 109.592 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.43 ' C ' ' N ' ' D' ' 16' ' ' GLY . 0.8 OUTLIER -51.9 -32.12 31.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.072 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -48.66 -17.96 0.22 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.275 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' D' ' 14' ' ' LEU . . . -76.8 -56.81 3.99 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.432 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -64.77 -27.39 68.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 109.217 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.91 114.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' D' ' 21' ' ' ASP . 25.3 m-80 -80.45 69.15 6.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.009 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -44.39 -21.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.748 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' D' ' 19' ' ' ASN . 68.0 m-20 -74.16 3.92 6.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.489 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' D' ' 19' ' ' ASN . 35.1 mt-10 -153.0 -41.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.316 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.52 -46.59 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.36 -42.9 65.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.87 -44.05 63.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.1 -24.94 65.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -1.163 . . . . 0.0 109.528 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.32 -49.46 67.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . 0.594 HD12 ' N ' ' D' ' 28' ' ' LEU . 9.4 mp -79.12 -54.38 6.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.57 -33.38 8.68 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -81.99 -39.33 23.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -1.142 . . . . 0.0 109.419 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -49.27 -35.76 18.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 27.0 mt -79.9 -31.83 40.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.618 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . 0.85 HG13 ' HA ' ' C' ' 119' ' ' PRO . 61.6 t -66.51 -64.41 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 109.38 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 1.03 HG13 ' HB3' ' C' ' 122' ' ' HIS . 1.3 t -64.47 -22.64 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -146.21 80.85 9.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.397 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.45 -5.56 14.23 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.692 2.261 . . . . 0.0 112.386 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . 0.546 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 1.3 p-90 -58.87 -24.37 62.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.965 . . . . 0.0 109.51 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.546 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 3.0 m -96.01 38.29 1.19 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -91.16 9.63 30.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 109.496 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . 1.565 ' CD ' ' HD3' ' A' ' 92' ' ' ARG . 55.0 ttt85 -81.6 -29.82 33.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.543 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' D' ' 42' ' ' PHE . 66.1 m-85 -90.9 30.12 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 109.384 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' D' ' 41' ' ' PHE . 70.4 m-85 -145.66 22.65 1.45 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 109.381 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -79.11 -16.45 56.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.407 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . 0.468 ' O ' ' N ' ' D' ' 46' ' ' GLY . 27.6 p -67.48 -43.32 81.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' D' ' 47' ' ' ASP . 88.3 m-85 -48.73 -14.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 66.9 -65.38 0.19 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' D' ' 45' ' ' PHE . 4.6 m-20 -46.18 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -1.16 . . . . 0.0 109.555 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 tp -159.46 22.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 12.8 p -70.54 -33.8 71.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . 0.427 ' O ' ' N ' ' D' ' 53' ' ' ALA . 3.4 p -145.64 151.56 46.82 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.325 -0.859 . . . . 0.0 109.031 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -39.97 -42.01 3.12 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.302 2.001 . . . . 0.0 112.256 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.32 -31.01 72.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.488 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -61.92 -19.81 63.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.98 -63.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 109.615 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . 0.41 ' H ' ' HG2' ' D' ' 55' ' ' MET . 22.4 ptp -83.2 4.5 26.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.364 -0.835 . . . . 0.0 109.648 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.92 -17.25 70.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -82.1 138.05 46.03 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.276 -1.132 . . . . 0.0 109.071 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.11 -12.84 30.81 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.232 1.955 . . . . 0.0 112.162 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -80.15 -57.45 3.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -48.0 -31.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . 0.418 ' HB3' ' HZ2' ' D' ' 61' ' ' LYS . 16.2 mtpp -79.03 -32.81 45.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.76 -45.64 16.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.679 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . 0.493 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 0.9 OUTLIER -62.79 -23.67 67.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.722 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.49 -36.32 83.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -60.17 -25.44 65.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.108 -1.23 . . . . 0.0 109.591 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.71 -50.13 39.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.81 -36.67 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.35 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.447 ' O ' HD23 ' D' ' 68' ' ' LEU . 5.6 tt -71.56 -48.09 50.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.42 -44.95 16.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.55 -51.94 56.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -1.102 . . . . 0.0 109.414 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -49.53 -35.32 19.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.269 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -75.98 -24.49 55.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -52.3 -43.64 64.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.381 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.84 -60.13 8.57 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.502 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.2 mp -57.98 -27.99 63.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -1.118 . . . . 0.0 109.317 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -80.62 -9.24 59.79 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.214 -0.929 . . . . 0.0 109.427 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 56.8 m80 -160.34 66.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.42 11.58 0.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.309 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' D' ' 77' ' ' HIS . 81.4 m-20 -72.38 -30.97 65.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.614 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 16.5 t-20 -171.07 108.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.605 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . 0.563 ' N ' HD12 ' D' ' 81' ' ' LEU . 9.5 mp -80.31 -54.68 5.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.502 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' D' ' 82' ' ' LYS . 0.6 OUTLIER -49.97 -24.03 2.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.421 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . 0.44 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -73.15 -52.37 8.94 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.1 t -76.51 -47.63 22.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -1.179 . . . . 0.0 109.484 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.1 m-85 -66.0 4.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.783 . . . . 0.0 109.505 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -63.63 -33.49 75.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.0 p -79.27 -51.43 9.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.411 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' D' ' 92' ' ' HIS . 8.7 mp -53.24 -51.19 63.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.352 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 34.8 p -54.57 -45.47 73.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.69 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.432 ' O ' ' OD2' ' D' ' 94' ' ' ASP . 32.9 tt0 -66.24 -41.64 89.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.155 -0.966 . . . . 0.0 109.624 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.43 -20.2 40.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.643 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.581 ' N ' ' O ' ' D' ' 88' ' ' LEU . 1.5 m80 -87.62 -41.16 13.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 110.267 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 35.6 t -83.11 -39.57 20.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.043 -1.035 . . . . 0.0 110.739 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' D' ' 90' ' ' GLU . 12.2 m-20 -86.27 -36.41 19.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.009 -1.057 . . . . 0.0 111.093 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -52.26 5.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.9 -1.125 . . . . 0.0 110.531 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.571 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 10.0 mp -86.28 -31.89 21.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.912 -1.117 . . . . 0.0 109.603 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 13.5 p80 42.04 29.32 0.13 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.426 -0.796 . . . . 0.0 109.818 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.16 124.61 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.862 . . . . 0.0 109.168 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . 1.317 ' CB ' HG21 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -47.55 154.21 0.92 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.18 -160.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.651 2.234 . . . . 0.0 112.001 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . 0.446 ' O ' ' OD1' ' D' ' 102' ' ' ASN . 29.8 mm-40 57.64 26.31 12.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.872 . . . . 0.0 109.499 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' D' ' 101' ' ' GLU . 39.1 m-20 -137.47 -32.88 0.75 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.369 -0.832 . . . . 0.0 109.341 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.39 -37.13 86.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -70.14 -23.6 63.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.987 . . . . 0.0 109.548 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . 0.589 HD12 ' N ' ' D' ' 105' ' ' LEU . 7.8 mp -79.85 -17.7 52.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 0.0 109.463 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.757 HD13 ' C ' ' D' ' 106' ' ' LEU . 2.6 tm? -78.87 -46.76 17.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.302 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.02 -20.41 77.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -70.45 -55.7 8.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -1.216 . . . . 0.0 109.787 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -53.66 -24.05 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.962 . . . . 0.0 109.71 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . 0.512 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.6 tt -64.48 -50.8 66.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.913 . . . . 0.0 109.501 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . 0.556 ' CG2' ' CE1' ' D' ' 130' ' ' TYR . 46.9 t -49.53 -45.19 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 56.4 m -51.6 -35.84 43.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.61 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.96 -28.59 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 41.6 mt -72.74 -40.73 65.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.353 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.0 59.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 109.259 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.535 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 3.0 t-80 -84.58 -54.69 4.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.322 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . 0.437 ' N ' ' HD1' ' D' ' 117' ' ' HIS . 0.5 OUTLIER -70.97 -17.45 62.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.704 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.402 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 68.3 m-85 -152.75 62.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.601 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -58.84 -27.0 61.26 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -68.42 -34.95 76.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -1.225 . . . . 0.0 109.559 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.84 14.35 3.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.624 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -83.01 36.4 0.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.592 ' OG1' HG23 ' D' ' 126' ' ' VAL . 7.4 p -46.45 154.14 0.68 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.115 -0.991 . . . . 0.0 109.445 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.453 ' O ' HD13 ' C' ' 34' ' ' LEU . 24.4 Cg_exo -55.4 -44.89 44.3 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.334 2.022 . . . . 0.0 113.786 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' D' ' 124' ' ' PRO . 67.1 Cg_endo -78.21 -8.06 16.28 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.994 1.796 . . . . 0.0 112.598 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.592 HG23 ' OG1' ' D' ' 123' ' ' THR . 10.6 t -83.79 -31.04 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 109.276 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.28 -59.67 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 109.637 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 1.56 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -48.55 -41.97 31.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 0.0 109.42 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.55 83.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.89 . . . . 0.0 109.881 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.556 ' CE1' ' CG2' ' D' ' 111' ' ' VAL . 29.7 t80 -61.11 -60.87 3.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.0 109.398 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -47.83 -25.8 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.584 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . 0.441 ' NZ ' ' CB ' ' D' ' 132' ' ' LYS . 5.0 ttpm? -85.5 -31.56 22.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.728 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.39 -65.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.527 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 5.9 m -55.53 -15.64 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.639 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.62 ' CB ' ' OXT' ' B' ' 146' ' ' HIS . . . -56.22 -33.68 65.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.929 . . . . 0.0 109.335 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.9 -30.52 57.5 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.14 -32.85 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -1.117 . . . . 0.0 109.433 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.97 76.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.345 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -78.7 -21.11 48.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 109.428 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.77 -60.63 2.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 63.6 mt -54.33 -20.25 6.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.315 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' D' ' 145' ' ' TYR . . . -89.01 -4.57 58.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 109.126 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' D' ' 146' ' ' HIS . 71.4 t60 -49.48 -39.13 32.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.484 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 0.8 OUTLIER -86.83 -55.13 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.944 . . . . 0.0 109.217 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . 0.494 ' CD1' ' C ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -52.82 -10.41 0.16 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.56 -0.713 . . . . 0.0 109.387 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.648 ' OXT' ' CB ' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.484 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.429 ' C ' HD22 ' A' ' 2' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.576 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.9 mm? -95.01 -169.27 1.96 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.697 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.45 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -116.24 179.54 0.78 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.504 -0.747 . . . . 0.0 109.228 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 21.7 Cg_exo -62.81 -69.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.722 2.281 . . . . 0.0 112.752 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -83.09 -16.63 46.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.897 . . . . 0.0 110.391 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.55 ' OD2' HD12 ' A' ' 2' ' ' LEU . 7.8 t70 -40.1 -41.17 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.215 -0.928 . . . . 0.0 109.778 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 10' ' ' VAL . 68.8 mttt -69.44 -55.97 8.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.872 . . . . 0.0 109.639 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.0 m -45.03 -30.78 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 109.674 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -78.48 -36.4 45.24 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 7' ' ' LYS . 48.9 t -72.09 -48.84 47.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -53.05 -44.39 67.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 108.78 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.74 -57.4 12.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.434 -0.791 . . . . 0.0 109.32 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -56.41 -36.2 68.67 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.431 -0.793 . . . . 0.0 109.27 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.92 -17.22 60.6 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.248 -0.908 . . . . 0.0 108.936 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.76 -42.0 22.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -71.43 -42.12 68.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -1.178 . . . . 0.0 108.84 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 13' ' ' ALA . 61.2 t -60.71 -63.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 47.73 -127.2 14.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.3 24.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.457 -1.025 . . . . 0.0 110.446 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.537 ' H ' ' C ' ' A' ' 18' ' ' GLY . 88.3 m-70 -128.84 22.13 5.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.887 . . . . 0.0 108.609 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.73 -55.93 3.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.577 -0.702 . . . . 0.0 109.443 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.49 -14.43 0.61 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 21' ' ' ALA . 12.7 mm-40 -87.49 -56.52 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.396 -1.061 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.9 m-30 -60.87 -22.84 64.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 0.0 109.246 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.19 -23.54 63.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.93 -40.04 22.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -1.132 . . . . 0.0 109.619 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -69.43 -19.62 63.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.819 . . . . 0.0 109.25 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.3 -20.44 57.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 0.0 109.641 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.3 mt -78.15 -46.9 19.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.786 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.02 -38.13 75.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 109.738 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.4 mtt85 -63.18 -39.13 93.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.54 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 51.0 ttp -64.6 -50.44 67.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.203 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 1.8 t80 -44.07 -33.87 1.6 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.427 -0.796 . . . . 0.0 109.697 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.3 mt -84.95 -40.02 17.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.76 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.543 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 74.4 m -53.42 -38.4 63.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 109.665 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 35' ' ' SER . 30.5 m-85 -164.29 87.11 1.14 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 39' ' ' THR . 76.5 Cg_exo -48.18 -19.98 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.612 2.208 . . . . 0.0 112.141 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.818 ' HB ' ' HB3' ' D' ' 97' ' ' HIS . 9.1 p -46.82 -18.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.88 . . . . 0.0 109.738 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' PRO . 53.2 p -80.89 -63.11 1.48 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.13 -0.981 . . . . 0.0 109.989 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 41' ' ' THR . 8.6 mmpt? -59.09 -18.57 36.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.94 . . . . 0.0 109.955 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 38' ' ' THR . 5.8 t . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.143 -0.973 . . . . 0.0 109.835 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.622 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 121.473 0.654 . . . . 0.0 109.612 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.771 ' O ' ' N ' ' A' ' 48' ' ' LEU . 3.3 m-85 -82.89 14.2 3.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.315 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 49' ' ' SER . 4.7 m-20 60.42 -51.35 0.09 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.771 ' N ' ' O ' ' A' ' 46' ' ' PHE . 19.5 mt 41.59 20.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.677 -0.639 . . . . 0.0 109.961 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 47' ' ' ASP . 6.2 m -93.35 42.33 1.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.493 ' CG ' ' C ' ' A' ' 49' ' ' SER . 0.7 OUTLIER 71.88 129.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.434 -0.792 . . . . 0.0 109.351 -179.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.54 29.33 73.22 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.626 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 8.1 p -52.36 -36.68 54.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -1.064 . . . . 0.0 109.54 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 73.27 -64.45 0.4 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 53' ' ' ALA . 18.9 mt-30 -43.59 -35.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 109.48 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.32 -28.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 110.017 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 2.5 ptpt -61.53 -38.89 89.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 0.0 109.453 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' N ' ' CG ' ' A' ' 56' ' ' LYS . . . -52.43 -35.83 45.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 8.7 t-80 -76.6 -27.91 55.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.167 . . . . 0.0 109.913 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.59 -37.26 94.17 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 46.6 mtpt -62.68 -24.34 67.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -1.186 . . . . 0.0 110.268 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.504 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -65.01 -58.7 5.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.041 -1.037 . . . . 0.0 109.356 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 62' ' ' VAL . 11.5 t -54.0 -43.83 59.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.469 -0.77 . . . . 0.0 109.289 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.78 -46.88 62.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 0.0 108.924 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 62.4 m-20 -64.48 -34.4 78.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 108.661 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . -67.13 -50.36 61.64 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -55.69 -44.62 77.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 71' ' ' ALA . 19.3 m -65.5 -54.21 31.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.258 -0.901 . . . . 0.0 108.786 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.461 HD22 HD21 ' A' ' 80' ' ' LEU . 49.1 t30 -55.86 -27.35 51.27 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.446 ' HB1' ' SD ' ' A' ' 76' ' ' MET . . . -81.12 -47.68 13.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.32 -22.74 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -70.28 -13.01 61.98 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' A' ' 74' ' ' ASP . 34.0 m170 -136.3 -67.17 0.52 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.457 -0.777 . . . . 0.0 109.251 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.2 p 44.77 14.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.952 0.882 . . . . 0.0 109.439 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 72' ' ' HIS . 35.0 m-20 -139.24 12.57 2.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 1.1 m-20 172.79 30.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.692 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 6.9 ptt? -78.31 -22.82 0.4 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 111.928 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.6 Cg_exo -53.84 -20.75 18.41 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.577 1.518 . . . . 0.0 112.387 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -94.11 -35.54 12.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 109.844 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.03 -46.89 61.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.097 -1.002 . . . . 0.0 109.257 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.461 HD21 HD22 ' A' ' 68' ' ' ASN . 11.8 mt -80.3 8.27 7.8 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 109.024 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.2 p -56.05 -21.92 24.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.907 . . . . 0.0 109.731 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -70.8 -53.79 14.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.788 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' ALA . 6.0 mt -44.78 -47.1 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 20.0 m -50.2 -39.61 44.62 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 82' ' ' ALA . 28.8 t70 -82.82 -17.33 44.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.817 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.745 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.3 tm? -71.41 -58.19 3.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -83.11 -21.72 33.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.102 . . . . 0.0 110.736 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -67.04 -79.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.888 -1.132 . . . . 0.0 109.788 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -59.53 5.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.811 . . . . 0.0 109.475 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 86' ' ' LEU . 41.2 mttm -88.02 135.7 33.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' A' ' 93' ' ' VAL . 14.9 mt 61.16 66.43 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.833 . . . . 0.0 109.153 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 1.453 ' NE ' ' HB2' ' D' ' 40' ' ' ARG . 39.1 ttt-85 -66.33 18.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.504 -0.748 . . . . 0.0 109.347 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.59 ' H ' ' C ' ' A' ' 91' ' ' LEU . 11.9 p -42.61 129.52 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.895 . . . . 0.0 109.767 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.85 148.74 75.45 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.28 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ASN . 37.5 Cg_endo -67.56 -10.9 30.28 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.476 2.117 . . . . 0.0 112.046 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 95' ' ' PRO . 47.7 t -44.55 -19.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.715 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' PRO . 17.8 m120 -79.16 -24.77 43.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.545 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.534 ' CG ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -53.71 -45.01 70.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.372 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.534 ' N ' ' CG ' ' A' ' 98' ' ' PHE . 65.2 mttm -49.28 -41.02 36.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.498 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 12.4 mt -71.55 -43.24 66.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.892 . . . . 0.0 109.403 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 101' ' ' LEU . 3.5 tt -57.99 -57.09 14.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.317 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.5 p -61.86 -34.9 76.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.857 . . . . 0.0 109.687 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 103' ' ' HIS . 22.8 t-160 -77.68 -26.69 50.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.462 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 55.6 m -69.68 -41.52 75.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 0.0 109.686 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mt -52.35 -50.17 62.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.36 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 106' ' ' LEU . 3.8 mm? -58.83 -59.12 5.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 65.1 t -51.71 -49.68 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.197 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 110' ' ' ALA . 17.6 m -62.15 -60.27 3.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.394 -0.816 . . . . 0.0 109.3 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 113' ' ' LEU . 24.9 mt -47.13 -18.92 0.1 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 109.522 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -73.41 -36.24 65.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.01 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.13 -3.18 24.87 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.708 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -141.28 -83.9 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 0.0 109.908 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -106.06 83.37 1.07 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.085 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.32 -174.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.148 1.899 . . . . 0.0 112.356 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.84 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -46.19 -55.43 7.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.557 -0.715 . . . . 0.0 109.26 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.65 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 31.7 mt-10 118.87 -7.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 4.8 t80 79.08 34.48 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.969 -0.457 . . . . 0.0 111.2 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.722 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -109.47 122.7 38.67 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.39 18.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.32 2.013 . . . . 0.0 112.925 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.722 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -146.34 -33.17 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.886 -1.134 . . . . 0.0 110.404 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.84 HG21 ' O ' ' A' ' 115' ' ' ALA . 7.2 p -51.68 -47.26 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.111 -0.993 . . . . 0.0 110.117 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.615 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.0 t-160 -59.8 -37.27 78.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.955 . . . . 0.0 109.365 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.19 -19.71 33.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.711 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 14.8 p -64.86 -62.5 1.53 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 110.625 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.497 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.6 mt -72.24 -19.77 61.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 0.0 109.978 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -82.38 -44.46 16.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.974 -1.079 . . . . 0.0 109.594 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -84.88 -41.02 16.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 109.52 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.48 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 27.8 t80 -51.72 -21.1 2.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.897 -1.127 . . . . 0.0 108.446 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 133' ' ' SER . 20.2 mt -76.6 -26.55 55.13 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -54.52 -33.46 59.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.527 ' O ' HG23 ' A' ' 135' ' ' VAL . 1.6 m -77.65 -41.74 37.25 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.05 -33.13 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.224 -0.923 . . . . 0.0 108.578 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 129' ' ' LEU . 31.3 m -77.12 -42.21 38.9 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.399 -0.813 . . . . 0.0 109.172 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 92.3 m -70.39 -26.07 63.53 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.214 -0.929 . . . . 0.0 108.557 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 131' ' ' SER . 8.4 t -77.14 -37.78 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.06 -38.48 86.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 108.834 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 m -90.39 -14.6 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 -179.945 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 8.5 t60 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.913 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -127.76 177.82 6.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.391 -0.818 . . . . 0.0 109.186 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.44 ' OG1' ' OE2' ' B' ' 7' ' ' GLU . 0.6 OUTLIER -68.65 125.32 91.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 108.983 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -42.07 -35.55 3.32 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.349 2.032 . . . . 0.0 112.537 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' B' ' 6' ' ' GLU . 14.3 mp0 -76.16 -23.89 54.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 109.7 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' B' ' 7' ' ' GLU . 0.2 OUTLIER -84.17 -39.53 19.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 109.767 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.7 ' HB3' HD13 ' B' ' 3' ' ' LEU . 22.9 pttt -83.87 -39.18 20.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 110.114 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' B' ' 8' ' ' LYS . 19.5 m -43.9 -23.33 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.865 . . . . 0.0 110.192 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -82.25 -57.06 3.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.139 -0.976 . . . . 0.0 109.997 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.09 -24.63 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 5.1 m -75.02 -45.71 39.9 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.367 0.603 . . . . 0.0 109.565 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.52 94.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.53 -0.731 . . . . 0.0 109.626 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.5 OUTLIER -48.0 -34.47 9.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -45.84 -17.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.847 . . . . 0.0 109.413 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -76.56 -43.06 20.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' B' ' 17' ' ' LYS . 1.6 mmtt -79.76 -30.55 40.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -1.191 . . . . 0.0 109.254 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -47.82 114.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.552 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' B' ' 22' ' ' GLU . 5.8 m-20 -77.84 66.13 3.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.198 -0.939 . . . . 0.0 108.998 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' B' ' 22' ' ' GLU . 73.8 t -43.81 -26.87 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 109.754 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.76 7.21 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.504 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' B' ' 20' ' ' VAL . 36.6 mt-10 -155.24 -50.25 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.563 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 69.3 t -47.03 -33.75 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.627 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.57 -50.72 59.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.39 -36.87 78.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -73.74 -38.64 64.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -1.133 . . . . 0.0 109.449 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.85 -34.05 72.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.405 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -84.99 -34.53 22.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.53 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.36 -50.36 60.16 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -58.21 -30.55 66.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -1.204 . . . . 0.0 109.425 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -50.44 -39.21 46.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.469 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -81.01 -21.97 39.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.69 -64.13 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.724 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.52 HG13 ' CD2' ' A' ' 122' ' ' HIS . 2.3 t -64.46 -22.94 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.876 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.442 ' HB3' ' HE1' ' B' ' 37' ' ' TRP . 53.9 m-85 -139.71 78.61 25.5 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.271 -0.893 . . . . 0.0 109.392 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -82.82 -17.87 6.84 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.817 2.345 . . . . 0.0 112.381 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.536 ' O ' ' NH2' ' C' ' 92' ' ' ARG . 5.2 p-90 -49.64 -19.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.5 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.514 HG23 ' CE2' ' B' ' 37' ' ' TRP . 1.4 p -92.15 -11.34 35.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.241 -0.912 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -45.05 -34.24 2.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.711 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 1.379 ' HB2' ' NE ' ' C' ' 92' ' ' ARG . 37.6 mtp85 -61.08 -26.03 67.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.478 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' B' ' 38' ' ' THR . 32.1 t80 -100.88 30.64 3.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.315 -0.866 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -146.25 31.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 109.327 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' B' ' 43' ' ' GLU . 13.8 pt-20 -79.75 -14.04 59.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.402 ' O ' ' N ' ' B' ' 46' ' ' GLY . 28.5 t -65.47 -43.85 89.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.538 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' B' ' 47' ' ' ASP . 44.8 m-85 -48.87 -18.58 0.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 48' ' ' LEU . . . 65.77 -66.56 0.12 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' B' ' 45' ' ' PHE . 79.6 m-20 -54.05 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -1.136 . . . . 0.0 109.674 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 46' ' ' GLY . 0.8 OUTLIER -164.47 21.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.115 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 56.0 m -57.97 -41.1 82.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.413 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . 0.431 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.3 p -146.25 152.4 46.56 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.424 -0.797 . . . . 0.0 109.045 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -40.63 -30.04 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.402 2.068 . . . . 0.0 112.345 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -75.05 -29.2 60.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.641 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -63.9 -20.5 65.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 109.557 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.55 -24.01 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . 0.413 ' O ' ' OD1' ' B' ' 57' ' ' ASN . 16.3 mmt -90.01 -6.2 55.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 109.611 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.587 ' O ' ' CB ' ' B' ' 57' ' ' ASN . . . -47.93 -35.83 13.43 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . 0.71 ' N ' ' CD ' ' B' ' 58' ' ' PRO . 21.0 m-20 91.7 23.56 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 122.245 -0.562 . . . . 0.0 111.623 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' B' ' 57' ' ' ASN . 77.4 Cg_endo -81.34 -157.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.965 1.776 . . . . 0.0 112.125 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -47.66 -24.39 0.91 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.71 -50.05 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.566 -0.709 . . . . 0.0 109.294 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' B' ' 62' ' ' ALA . 0.0 OUTLIER -79.48 -32.49 42.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.363 -0.836 . . . . 0.0 109.637 -179.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.416 ' N ' ' HG2' ' B' ' 61' ' ' LYS . . . -56.99 -49.72 74.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 109.565 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -59.42 -26.3 65.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.589 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.56 -19.4 74.64 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -76.04 -24.98 55.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 109.122 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -74.29 -59.29 2.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 109.568 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 40.4 t -47.0 -34.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 109.473 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.33 -42.75 96.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -0.914 . . . . 0.0 109.16 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.73 -49.82 52.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.75 -33.44 66.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -1.127 . . . . 0.0 109.51 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -76.25 -37.66 57.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -80.49 -28.13 37.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.341 -0.849 . . . . 0.0 109.436 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -51.17 -38.89 54.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.21 -60.13 7.99 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.577 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -56.83 -18.65 13.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -1.106 . . . . 0.0 109.407 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -83.22 -19.31 36.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 71.5 m-70 -159.42 62.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.11 -0.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 109.315 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' B' ' 77' ' ' HIS . 45.7 t0 -57.62 -25.87 60.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 9.1 p-10 -170.58 105.85 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.56 ' N ' HD12 ' B' ' 81' ' ' LEU . 10.2 mp -79.98 -57.26 3.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.469 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -45.79 -24.06 0.34 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -0.973 . . . . 0.0 109.61 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.76 -63.21 2.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.0 t -61.01 -47.49 86.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -1.168 . . . . 0.0 109.516 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.547 ' N ' ' CG2' ' B' ' 84' ' ' THR . 64.2 m-85 -67.86 4.77 1.04 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.747 . . . . 0.0 109.597 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.82 -46.57 78.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.544 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -75.12 -52.59 10.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.526 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 55.6 mt -50.73 -47.36 59.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . 0.483 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 14.7 m -57.52 -36.26 71.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.356 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.87 -22.28 43.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.91 -18.06 26.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.972 . . . . 0.0 109.815 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' B' ' 88' ' ' LEU . 9.9 m80 -87.89 -60.76 1.88 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.916 -1.115 . . . . 0.0 110.484 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' B' ' 89' ' ' SER . 12.8 p -83.82 -59.77 2.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.955 -1.091 . . . . 0.0 111.469 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.473 ' N ' ' SG ' ' B' ' 93' ' ' CYS . 14.2 m-20 -59.2 -26.76 65.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.071 -1.018 . . . . 0.0 111.724 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 3.1 tppp? -107.51 -51.97 2.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.737 -1.227 . . . . 0.0 110.795 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.447 ' C ' ' CD2' ' B' ' 97' ' ' HIS . 5.7 mp -87.19 -30.48 20.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.926 -1.109 . . . . 0.0 109.931 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.738 ' HB3' ' CG2' ' C' ' 38' ' ' THR . 9.6 m-70 66.47 49.16 1.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.117 -0.989 . . . . 0.0 110.013 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 33.1 t -96.62 114.18 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.198 -0.939 . . . . 0.0 109.031 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' B' ' 100' ' ' PRO . 0.9 OUTLIER -62.59 153.66 76.84 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.605 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' B' ' 99' ' ' ASP . 51.0 Cg_exo -51.98 -156.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.442 2.095 . . . . 0.0 112.452 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 52.95 46.74 26.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.522 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' B' ' 100' ' ' PRO . 35.3 m120 -158.08 -35.74 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.526 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.0 -39.22 93.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.152 -0.968 . . . . 0.0 109.526 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -65.47 -31.24 72.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 109.658 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.582 HD12 ' N ' ' B' ' 105' ' ' LEU . 9.8 mp -62.35 -57.95 9.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.118 -0.989 . . . . 0.0 109.462 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 tt -48.23 -22.75 0.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.928 . . . . 0.0 109.605 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' B' ' 109' ' ' VAL . . . -79.29 -45.35 8.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -46.61 -16.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -1.122 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' B' ' 107' ' ' GLY . 97.6 t -85.15 -62.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.41 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 14.6 mt -47.41 -26.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.92 -47.65 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.792 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 20.2 p -79.28 -41.32 28.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.018 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 77.7 t -47.4 -41.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.747 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' B' ' 118' ' ' PHE . 46.1 mt -79.47 -40.49 29.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 109.526 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.438 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.14 -30.41 2.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.526 ' C ' ' HD1' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.64 -56.98 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.265 -0.897 . . . . 0.0 109.288 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . 0.411 ' C ' ' CG ' ' B' ' 118' ' ' PHE . 85.7 m-70 -63.53 -17.72 63.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 0.0 109.57 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.452 ' N ' ' O ' ' B' ' 114' ' ' LEU . 65.2 m-85 -153.29 62.35 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.938 . . . . 0.0 109.543 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' B' ' 122' ' ' PHE . . . -68.92 -50.48 34.78 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -47.86 -31.05 4.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 109.38 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -82.7 -19.07 38.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' B' ' 119' ' ' GLY . 6.3 t80 -76.09 66.61 2.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.29 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.439 ' OG1' HG23 ' B' ' 126' ' ' VAL . 1.3 p -79.14 149.8 73.53 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.276 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.508 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.5 Cg_exo -45.36 -53.58 5.3 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.466 2.111 . . . . 0.0 112.968 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 26.0 Cg_endo -62.45 1.11 1.08 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.01 1.806 . . . . 0.0 112.192 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.455 HG12 ' O ' ' B' ' 126' ' ' VAL . 87.9 t -112.45 -8.23 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.316 -0.865 . . . . 0.0 109.306 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.3 -53.97 5.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.517 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -54.69 -33.81 61.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.886 . . . . 0.0 109.537 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.2 2.6 17.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.675 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.17 -29.6 13.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.218 -0.926 . . . . 0.0 109.374 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 88.9 mm-40 -84.4 -23.3 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 109.916 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . 0.723 ' HG3' ' HB3' ' D' ' 146' ' ' HIS . 14.4 ttmt -85.56 -36.08 20.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.13 -0.981 . . . . 0.0 110.121 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . 0.737 HG13 ' N ' ' B' ' 134' ' ' VAL . 11.8 p -65.38 -58.91 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.081 -1.012 . . . . 0.0 110.037 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.737 ' N ' HG13 ' B' ' 133' ' ' VAL . 11.3 t -62.1 -33.43 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.02 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -45.89 -21.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 0.0 109.684 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 134' ' ' VAL . . . -82.7 -26.83 44.59 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' B' ' 134' ' ' VAL . 97.7 t -78.88 -21.2 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -1.133 . . . . 0.0 109.585 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.02 -38.37 32.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.629 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.8 -21.09 30.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.785 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.21 -48.46 70.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.115 -0.991 . . . . 0.0 109.713 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' B' ' 92' ' ' HIS . 28.4 mt -58.26 -22.04 50.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.574 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' B' ' 145' ' ' TYR . . . -89.71 26.1 1.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -80.53 -6.98 59.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.962 . . . . 0.0 109.13 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' B' ' 146' ' ' HIS . 11.6 mptt -122.14 -27.84 4.47 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.52 -0.737 . . . . 0.0 109.696 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 142' ' ' ALA . 0.1 OUTLIER -50.26 -7.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -0.993 . . . . 0.0 110.034 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.72 ' HB3' ' HG3' ' D' ' 132' ' ' LYS . 12.0 m-70 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.736 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . 0.426 ' C ' HD22 ' C' ' 2' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.289 0.566 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . 0.575 HD22 ' N ' ' C' ' 2' ' ' LEU . 3.9 mm? -94.95 -169.37 1.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.213 -0.929 . . . . 0.0 109.691 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.452 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.1 OUTLIER -116.13 179.55 0.78 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.491 -0.756 . . . . 0.0 109.233 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 21.8 Cg_exo -62.85 -69.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.69 2.26 . . . . 0.0 112.781 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -83.13 -16.69 45.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.931 . . . . 0.0 110.308 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.561 ' OD2' HD12 ' C' ' 2' ' ' LEU . 7.8 t70 -40.05 -41.18 1.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.955 . . . . 0.0 109.773 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' C' ' 10' ' ' VAL . 68.7 mttt -69.45 -56.04 8.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 53.5 m -45.04 -30.75 1.12 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.32 -0.863 . . . . 0.0 109.707 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -78.39 -36.41 45.92 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' C' ' 7' ' ' LYS . 49.2 t -72.01 -48.93 47.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -53.02 -44.45 67.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 108.783 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.77 -57.34 12.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.361 -0.837 . . . . 0.0 109.338 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.625 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -56.45 -36.27 68.85 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.377 -0.827 . . . . 0.0 109.24 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.79 -17.2 60.66 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.278 -0.889 . . . . 0.0 109.029 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.83 -41.98 21.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . 0.42 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 12.9 mmmt -71.43 -42.08 68.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -1.153 . . . . 0.0 108.837 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.625 HG23 ' O ' ' C' ' 13' ' ' ALA . 61.5 t -60.71 -63.79 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 47.8 -127.32 14.62 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 24.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.414 -1.05 . . . . 0.0 110.447 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.539 ' H ' ' C ' ' C' ' 18' ' ' GLY . 88.3 m-70 -128.85 22.05 5.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.905 . . . . 0.0 108.612 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.46 ' C ' ' N ' ' C' ' 23' ' ' GLU . . . -88.75 -55.85 3.53 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.585 -0.697 . . . . 0.0 109.464 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.59 -14.4 0.64 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.46 ' N ' ' C ' ' C' ' 21' ' ' ALA . 12.8 mm-40 -87.48 -56.56 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -1.079 . . . . 0.0 109.714 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.9 m-30 -60.78 -22.9 64.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.2 -23.49 63.22 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.96 -40.1 22.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -1.128 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -69.35 -19.59 63.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.284 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -20.39 57.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.684 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mt -78.3 -46.84 19.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 109.752 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -58.04 -38.1 75.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.74 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -63.2 -39.19 93.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 109.526 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 50.9 ttp -64.52 -50.54 66.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.196 -0.94 . . . . 0.0 109.176 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . 0.469 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 1.8 t80 -43.95 -33.99 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.682 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.774 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.4 mt -85.0 -39.87 17.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.793 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 74.5 m -53.44 -38.44 63.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.96 . . . . 0.0 109.749 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' C' ' 35' ' ' SER . 30.8 m-85 -164.22 87.12 1.15 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.877 . . . . 0.0 109.521 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' C' ' 39' ' ' THR . 76.6 Cg_exo -48.21 -19.92 2.0 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.551 2.167 . . . . 0.0 112.135 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.738 ' CG2' ' HB3' ' B' ' 97' ' ' HIS . 9.0 p -46.84 -18.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.889 . . . . 0.0 109.757 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.444 ' N ' ' O ' ' C' ' 37' ' ' PRO . 53.2 p -80.91 -63.1 1.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.981 . . . . 0.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' C' ' 41' ' ' THR . 8.6 mmpt? -59.05 -18.59 36.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.165 -0.96 . . . . 0.0 109.935 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.532 HG22 ' O ' ' C' ' 38' ' ' THR . 5.8 t . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.144 -0.972 . . . . 0.0 109.828 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.626 ' CG ' ' O ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.488 0.661 . . . . 0.0 109.648 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.778 ' O ' ' N ' ' C' ' 48' ' ' LEU . 3.3 m-85 -82.87 14.33 3.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.399 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' C' ' 49' ' ' SER . 4.6 m-20 60.39 -51.33 0.09 Allowed 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.778 ' N ' ' O ' ' C' ' 46' ' ' PHE . 19.4 mt 41.53 20.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.661 -0.649 . . . . 0.0 110.004 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.538 ' N ' ' O ' ' C' ' 47' ' ' ASP . 6.2 m -93.35 42.27 1.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . 0.49 ' CG ' ' C ' ' C' ' 49' ' ' SER . 0.7 OUTLIER 71.98 129.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.516 -0.74 . . . . 0.0 109.295 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.42 29.4 73.24 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.65 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 8.1 p -52.34 -36.7 54.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -1.111 . . . . 0.0 109.595 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 73.26 -64.41 0.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.862 . . . . 0.0 109.549 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' C' ' 53' ' ' ALA . 18.9 mt-30 -43.57 -35.78 1.85 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.0 109.482 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -55.35 -28.15 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.433 -0.792 . . . . 0.0 109.986 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' C' ' 57' ' ' GLY . 2.5 ptpt -61.47 -38.97 89.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.031 -1.043 . . . . 0.0 109.461 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . 0.434 ' N ' ' CG ' ' C' ' 56' ' ' LYS . . . -52.41 -35.75 44.73 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 8.7 t-80 -76.65 -27.84 55.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -1.165 . . . . 0.0 109.922 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.61 -37.27 94.18 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -62.64 -24.3 67.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -1.153 . . . . 0.0 110.362 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . 0.501 ' H ' ' HD2' ' C' ' 61' ' ' LYS . 0.2 OUTLIER -65.04 -58.78 5.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.011 -1.056 . . . . 0.0 109.319 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.422 ' H ' HG23 ' C' ' 62' ' ' VAL . 11.6 t -54.02 -43.85 60.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.434 -0.791 . . . . 0.0 109.246 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.7 -46.9 62.26 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 108.921 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -64.44 -34.51 78.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 108.655 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.06 -50.31 62.26 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -55.75 -44.6 77.77 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 108.704 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.421 ' O ' ' N ' ' C' ' 71' ' ' ALA . 19.2 m -65.43 -54.22 31.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -0.847 . . . . 0.0 108.794 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.463 HD22 HD21 ' C' ' 80' ' ' LEU . 48.9 t30 -55.9 -27.39 51.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.46 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -81.02 -47.78 13.13 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.26 -22.69 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -70.36 -13.04 61.98 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' C' ' 74' ' ' ASP . 34.0 m170 -136.31 -67.12 0.52 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.548 -0.72 . . . . 0.0 109.206 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.554 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.2 p 44.64 14.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.946 0.879 . . . . 0.0 109.37 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' C' ' 72' ' ' HIS . 35.2 m-20 -139.26 12.52 2.59 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 1.1 m-20 172.72 30.92 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.688 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 6.9 ptt? -78.29 -22.87 0.4 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.174 -0.954 . . . . 0.0 111.889 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.4 Cg_exo -53.82 -20.69 18.17 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.596 1.531 . . . . 0.0 112.405 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -94.15 -35.55 12.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.825 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.04 -46.91 61.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.157 -0.965 . . . . 0.0 109.303 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . 0.463 HD21 HD22 ' C' ' 68' ' ' ASN . 11.7 mt -80.21 8.17 7.9 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.387 -0.821 . . . . 0.0 109.047 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 45.0 p -56.01 -21.87 23.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 109.797 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -70.88 -53.82 13.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.746 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' C' ' 83' ' ' LEU . 6.0 mt -44.82 -46.93 10.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -50.24 -39.62 45.24 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' C' ' 82' ' ' ALA . 28.7 t70 -82.79 -17.39 44.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.807 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.74 HD13 ' C ' ' C' ' 86' ' ' LEU . 3.3 tm? -71.4 -58.16 3.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 110.426 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -83.12 -21.79 33.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.956 -1.09 . . . . 0.0 110.697 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.11 -79.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 109.72 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.18 -59.53 5.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.491 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' C' ' 86' ' ' LEU . 41.2 mttm -87.99 135.77 33.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.6 ' C ' ' H ' ' C' ' 93' ' ' VAL . 14.9 mt 61.09 66.44 0.89 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.141 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . 1.379 ' NE ' ' HB2' ' B' ' 40' ' ' ARG . 38.9 ttt-85 -66.34 18.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.6 ' H ' ' C ' ' C' ' 91' ' ' LEU . 11.8 p -42.57 129.55 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 109.709 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.86 148.81 75.36 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.213 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' C' ' 97' ' ' ASN . 37.6 Cg_endo -67.57 -10.95 30.46 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.48 2.12 . . . . 0.0 112.059 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -44.56 -19.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.358 -0.839 . . . . 0.0 109.669 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' C' ' 95' ' ' PRO . 17.7 m120 -79.1 -24.71 43.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.653 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . 0.541 ' CG ' ' N ' ' C' ' 99' ' ' LYS . 0.1 OUTLIER -53.75 -44.96 70.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.426 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.541 ' N ' ' CG ' ' C' ' 98' ' ' PHE . 65.3 mttm -49.33 -41.05 37.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.5 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 12.4 mt -71.61 -43.16 66.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . 0.542 ' C ' HD23 ' C' ' 101' ' ' LEU . 3.6 tt -58.0 -57.03 14.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.341 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 84.3 p -61.87 -34.95 76.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 109.69 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . 0.421 ' CD2' ' O ' ' C' ' 103' ' ' HIS . 22.8 t-160 -77.65 -26.62 50.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 55.3 m -69.84 -41.45 74.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 0.0 109.64 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mt -52.33 -50.19 62.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.962 . . . . 0.0 109.324 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.54 ' N ' HD22 ' C' ' 106' ' ' LEU . 3.8 mm? -58.87 -59.11 5.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.635 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 65.0 t -51.73 -49.64 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.197 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.44 ' O ' ' N ' ' C' ' 110' ' ' ALA . 17.6 m -62.06 -60.35 3.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.29 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' C' ' 113' ' ' LEU . 25.5 mt -47.18 -18.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.872 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -73.46 -36.14 65.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 110.069 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.11 -3.27 25.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.747 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -141.2 -83.95 0.21 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 109.904 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' C' ' 113' ' ' LEU . 0.3 OUTLIER -106.0 83.35 1.05 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.068 -179.629 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.28 -174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.087 1.858 . . . . 0.0 112.399 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.828 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -46.18 -55.51 6.99 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.558 -0.714 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.653 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 31.7 mt-10 118.93 -6.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.489 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 4.8 t80 79.01 34.54 0.21 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.968 -0.458 . . . . 0.0 111.228 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.732 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -109.52 122.7 38.63 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.04 . . . . 0.0 108.271 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.36 18.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.3 2.0 . . . . 0.0 112.915 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -146.32 -33.22 0.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.89 -1.131 . . . . 0.0 110.403 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.828 HG21 ' O ' ' C' ' 115' ' ' ALA . 7.2 p -51.66 -47.13 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 110.177 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.625 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.0 t-160 -59.8 -37.32 78.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.357 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.25 -19.72 33.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.646 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 14.8 p -64.79 -62.54 1.5 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 110.593 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.517 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.6 mt -72.34 -19.73 61.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.11 -0.993 . . . . 0.0 109.932 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.26 -44.5 16.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.981 -1.075 . . . . 0.0 109.64 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -84.94 -41.03 16.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.13 -0.981 . . . . 0.0 109.567 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.483 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 28.0 t80 -51.67 -21.01 2.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.937 -1.102 . . . . 0.0 108.559 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' C' ' 133' ' ' SER . 20.3 mt -76.66 -26.5 54.89 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -54.55 -33.41 60.09 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.54 ' OG ' HD21 ' C' ' 2' ' ' LEU . 1.6 m -77.57 -41.87 37.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 4.9 t -75.03 -33.14 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . 0.513 ' N ' ' O ' ' C' ' 129' ' ' LEU . 31.5 m -77.11 -42.21 38.96 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.485 -0.759 . . . . 0.0 109.146 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 92.2 m -70.26 -26.1 63.66 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.174 -0.954 . . . . 0.0 108.569 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.538 HG23 ' O ' ' C' ' 131' ' ' SER . 8.6 t -77.17 -37.84 26.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.17 -38.45 86.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 108.846 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 24.9 m -90.34 -14.57 32.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.239 -0.913 . . . . 0.0 109.477 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.461 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 t60 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.904 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -127.74 177.74 6.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.343 -0.848 . . . . 0.0 109.138 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' D' ' 7' ' ' GLU . 0.6 OUTLIER -68.65 125.3 91.64 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.044 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -42.11 -35.47 3.32 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.325 2.017 . . . . 0.0 112.488 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' D' ' 6' ' ' GLU . 14.2 mp0 -76.2 -23.93 54.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 109.731 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' D' ' 7' ' ' GLU . 0.2 OUTLIER -84.09 -39.6 19.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.797 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.678 ' HB3' HD13 ' D' ' 3' ' ' LEU . 22.9 pttt -83.78 -39.27 20.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.0 110.074 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 19.7 m -43.78 -23.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 110.163 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -82.25 -57.05 3.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.114 -0.991 . . . . 0.0 109.979 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.08 -24.73 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 5.0 m -74.9 -45.83 40.06 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.387 0.613 . . . . 0.0 109.597 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.51 94.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.427 -0.796 . . . . 0.0 109.688 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.5 OUTLIER -48.06 -34.49 9.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.368 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -45.77 -17.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.827 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -76.44 -43.11 20.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' D' ' 17' ' ' LYS . 1.5 mmtt -79.72 -30.6 40.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.127 -1.219 . . . . 0.0 109.247 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -47.86 114.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 109.569 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' D' ' 22' ' ' GLU . 5.8 m-20 -77.87 66.04 3.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 108.988 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' D' ' 22' ' ' GLU . 73.7 t -43.66 -26.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.446 -0.784 . . . . 0.0 109.786 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.72 7.22 0.92 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' D' ' 19' ' ' ASN . 36.6 mt-10 -155.28 -50.25 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.567 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 69.7 t -46.98 -33.86 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.47 -50.78 59.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.35 -36.81 79.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -73.68 -38.76 64.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -1.158 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.82 -34.07 72.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 109.436 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -84.94 -34.56 22.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.45 -50.2 60.81 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -58.22 -30.6 66.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -1.117 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 tp -50.41 -39.17 46.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.967 . . . . 0.0 109.499 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 mt -81.03 -22.0 39.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.163 -0.961 . . . . 0.0 109.597 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 21.1 t -82.7 -64.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.772 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.529 HG13 ' CD2' ' C' ' 122' ' ' HIS . 2.3 t -64.57 -22.9 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.875 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . 0.43 ' HB3' ' HE1' ' D' ' 37' ' ' TRP . 53.7 m-85 -139.77 78.63 25.16 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.285 -0.884 . . . . 0.0 109.399 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.81 -17.81 6.9 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.814 2.342 . . . . 0.0 112.417 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . 0.57 ' O ' ' NH2' ' A' ' 92' ' ' ARG . 5.2 p-90 -49.7 -19.89 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.514 HG23 ' CE2' ' D' ' 37' ' ' TRP . 1.4 p -92.1 -11.39 35.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.264 -0.897 . . . . 0.0 109.332 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -45.03 -34.17 2.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.337 -0.852 . . . . 0.0 109.736 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . 1.453 ' HB2' ' NE ' ' A' ' 92' ' ' ARG . 37.7 mtp85 -61.12 -26.08 67.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.441 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' D' ' 38' ' ' THR . 32.3 t80 -100.85 30.75 3.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -0.865 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -146.26 31.24 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 109.343 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.75 -14.08 58.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . 0.406 ' C ' ' N ' ' D' ' 46' ' ' GLY . 28.5 t -65.52 -43.79 88.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.541 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.501 ' O ' ' N ' ' D' ' 47' ' ' ASP . 44.5 m-85 -48.99 -18.49 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.425 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' D' ' 48' ' ' LEU . . . 65.82 -66.58 0.12 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' D' ' 45' ' ' PHE . 79.6 m-20 -54.07 86.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -1.123 . . . . 0.0 109.632 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' D' ' 46' ' ' GLY . 0.8 OUTLIER -164.46 21.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.167 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.0 m -57.98 -41.04 82.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.419 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . 0.434 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.3 p -146.28 152.29 46.16 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.0 109.092 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -40.49 -30.12 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.449 2.1 . . . . 0.0 112.361 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -75.13 -29.14 60.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.615 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -63.93 -20.39 65.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.63 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.58 -24.04 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . 0.418 ' O ' ' OD1' ' D' ' 57' ' ' ASN . 16.3 mmt -90.0 -6.14 55.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.605 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.602 ' O ' ' CB ' ' D' ' 57' ' ' ASN . . . -47.94 -35.82 13.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . 0.725 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 21.3 m-20 91.7 23.55 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 122.137 -0.625 . . . . 0.0 111.568 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' D' ' 57' ' ' ASN . 75.3 Cg_endo -81.36 -157.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.948 1.765 . . . . 0.0 112.122 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -47.61 -24.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 58' ' ' PRO . 54.7 t -51.56 -50.18 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.494 -0.754 . . . . 0.0 109.279 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' D' ' 62' ' ' ALA . 0.0 OUTLIER -79.37 -32.62 43.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.38 -0.825 . . . . 0.0 109.631 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' D' ' 61' ' ' LYS . . . -57.02 -49.74 74.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.979 . . . . 0.0 109.532 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -59.42 -26.28 65.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 109.557 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.47 -19.46 74.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -76.09 -24.91 55.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -1.176 . . . . 0.0 109.082 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -74.36 -59.18 2.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.84 . . . . 0.0 109.564 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 40.5 t -47.15 -34.16 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.465 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.47 -42.61 95.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.142 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.71 -49.92 51.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.7 -33.5 66.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -1.144 . . . . 0.0 109.52 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -76.2 -37.66 57.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -80.42 -28.28 37.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 109.385 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -51.11 -38.86 54.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.915 . . . . 0.0 109.415 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.22 -60.15 7.96 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.599 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.9 mp -56.87 -18.63 13.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -1.131 . . . . 0.0 109.345 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -83.22 -19.32 36.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.883 . . . . 0.0 109.615 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 72.0 m-70 -159.37 62.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.689 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.1 -0.43 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.945 . . . . 0.0 109.409 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' D' ' 77' ' ' HIS . 45.8 t0 -57.66 -25.85 60.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.503 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' D' ' 80' ' ' ASN . 9.0 p-10 -170.64 105.9 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . 0.548 ' N ' HD12 ' D' ' 81' ' ' LEU . 10.2 mp -79.97 -57.3 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -45.83 -23.97 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 109.566 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.82 -63.27 2.75 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.0 t -61.02 -47.46 86.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -1.181 . . . . 0.0 109.557 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 64.4 m-85 -67.82 4.68 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.574 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.68 -46.68 77.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.544 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -75.08 -52.46 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.522 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 55.6 mt -50.74 -47.46 59.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . 0.5 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 14.7 m -57.5 -36.19 71.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -79.88 -22.25 43.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.98 -18.01 26.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.766 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' D' ' 88' ' ' LEU . 10.0 m80 -87.88 -60.67 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.96 -1.088 . . . . 0.0 110.486 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' D' ' 89' ' ' SER . 12.5 p -83.94 -59.78 2.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.969 -1.082 . . . . 0.0 111.438 -178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.477 ' N ' ' SG ' ' D' ' 93' ' ' CYS . 14.2 m-20 -59.14 -26.76 65.02 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.095 -1.003 . . . . 0.0 111.709 -177.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . 0.526 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 3.2 tppp? -107.55 -51.93 2.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.658 -1.276 . . . . 0.0 110.796 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.451 ' C ' ' CD2' ' D' ' 97' ' ' HIS . 5.7 mp -87.22 -30.55 20.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.915 -1.115 . . . . 0.0 109.918 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.818 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 9.6 m-70 66.47 49.19 1.41 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.16 -0.962 . . . . 0.0 110.039 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 33.0 t -96.63 114.2 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.27 -0.894 . . . . 0.0 108.987 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' D' ' 100' ' ' PRO . 0.9 OUTLIER -62.65 153.59 77.63 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.553 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' D' ' 99' ' ' ASP . 50.6 Cg_exo -51.86 -156.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.504 2.136 . . . . 0.0 112.409 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 52.93 46.66 26.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.578 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' D' ' 100' ' ' PRO . 35.3 m120 -158.03 -35.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -65.0 -39.16 93.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.494 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -65.55 -31.2 72.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 109.666 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . 0.575 HD12 ' N ' ' D' ' 105' ' ' LEU . 9.8 mp -62.4 -57.98 9.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.437 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 tt -48.2 -22.73 0.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.627 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' D' ' 109' ' ' VAL . . . -79.3 -45.51 8.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -46.53 -16.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -1.176 . . . . 0.0 109.623 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' D' ' 107' ' ' GLY . 98.2 t -85.07 -62.62 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.503 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 14.7 mt -47.39 -26.18 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.661 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 70.8 t -68.96 -47.52 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.084 -1.01 . . . . 0.0 109.906 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 20.0 p -79.41 -41.22 28.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.138 -0.976 . . . . 0.0 110.037 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 78.2 t -47.57 -41.07 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.721 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' D' ' 118' ' ' PHE . 46.6 mt -79.52 -40.37 29.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.567 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.429 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.2 -30.38 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.399 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.535 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -84.75 -56.96 3.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 109.235 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 85.8 m-70 -63.48 -17.66 62.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.574 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.418 ' N ' ' O ' ' D' ' 114' ' ' LEU . 65.6 m-85 -153.33 62.32 0.76 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 109.544 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' D' ' 122' ' ' PHE . . . -68.84 -50.51 35.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -47.95 -30.93 4.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.191 . . . . 0.0 109.404 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -82.81 -18.98 38.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.557 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' D' ' 119' ' ' GLY . 6.3 t80 -76.17 66.6 2.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.129 -0.982 . . . . 0.0 109.293 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.429 ' OG1' HG23 ' D' ' 126' ' ' VAL . 1.3 p -79.1 149.68 73.51 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.288 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.508 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -45.3 -53.6 5.24 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.488 2.125 . . . . 0.0 112.972 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 25.7 Cg_endo -62.52 1.18 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.012 1.808 . . . . 0.0 112.21 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.453 ' O ' HG12 ' D' ' 126' ' ' VAL . 86.9 t -112.44 -8.31 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.21 -54.08 5.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 109.556 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.774 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -54.62 -33.84 61.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.14 2.52 17.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.21 -29.5 13.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 109.444 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 88.7 mm-40 -84.34 -23.49 30.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 109.901 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' B' ' 146' ' ' HIS . 14.4 ttmt -85.46 -36.06 20.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.141 -0.974 . . . . 0.0 110.183 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . 0.758 HG13 ' N ' ' D' ' 134' ' ' VAL . 11.9 p -65.44 -58.78 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.094 -1.004 . . . . 0.0 110.041 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.758 ' N ' HG13 ' D' ' 133' ' ' VAL . 11.5 t -62.23 -33.38 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 0.0 109.959 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -45.92 -21.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 0.0 109.743 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -82.79 -26.75 44.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' D' ' 134' ' ' VAL . 97.5 t -78.89 -21.15 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -1.148 . . . . 0.0 109.644 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.11 -38.3 31.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 109.644 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.66 -21.21 30.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.755 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.26 -48.44 70.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 0.0 109.697 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' D' ' 92' ' ' HIS . 28.3 mt -58.15 -22.08 49.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . 0.533 ' O ' ' CD1' ' D' ' 145' ' ' TYR . . . -89.65 26.07 1.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 0.0 109.568 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -80.53 -6.91 58.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.108 -0.995 . . . . 0.0 109.128 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' D' ' 146' ' ' HIS . 11.6 mptt -122.15 -27.96 4.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.457 -0.777 . . . . 0.0 109.671 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' D' ' 142' ' ' ALA . 0.1 OUTLIER -50.21 -7.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 110.066 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.723 ' HB3' ' HG3' ' B' ' 132' ' ' LYS . 12.0 m-70 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.669 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.28 -169.92 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -0.907 . . . . 0.0 109.903 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.594 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -100.01 -179.2 0.78 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.35 -0.844 . . . . 0.0 109.566 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 23.0 Cg_exo -62.83 -58.51 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.893 2.395 . . . . 0.0 113.049 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -78.65 -16.44 57.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.03 -1.044 . . . . 0.0 110.204 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.594 ' CG ' ' H ' ' A' ' 3' ' ' SER . 33.5 m-20 -39.79 -30.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 0.0 109.72 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.638 ' CD ' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -83.7 -39.47 20.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.531 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' ALA . 37.2 m -44.82 -42.87 8.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.461 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.24 -25.33 62.44 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.578 ' N ' ' O ' ' A' ' 7' ' ' LYS . 53.2 t -78.82 -55.19 10.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -53.48 -37.19 62.47 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.459 -1.296 . . . . 0.0 107.875 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.78 -63.18 1.22 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.238 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.787 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -60.24 -36.17 77.15 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -0.843 . . . . 0.0 108.768 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -17.51 62.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 109.088 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -78.79 -46.43 8.54 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 13.2 mmmt -70.14 -36.62 74.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -1.098 . . . . 0.0 108.817 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 13' ' ' ALA . 95.4 t -60.65 -65.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 58.71 -134.9 52.32 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.41 27.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.429 -1.042 . . . . 0.0 110.437 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.541 ' H ' ' C ' ' A' ' 18' ' ' GLY . 92.4 m-70 -131.58 25.68 4.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.199 -0.938 . . . . 0.0 108.481 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.57 -61.66 1.66 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.613 -0.679 . . . . 0.0 109.754 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.68 -14.38 0.23 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 1.2 mm-40 -84.33 -56.33 3.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -1.091 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.605 ' CE1' ' CG ' ' A' ' 112' ' ' HIS . 2.8 m-30 -60.64 -27.78 68.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.458 -0.776 . . . . 0.0 109.172 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.82 -22.92 75.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.2 18.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -1.138 . . . . 0.0 109.795 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -64.29 -19.88 65.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 109.511 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.11 -19.68 60.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 109.313 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.491 HD11 ' ND1' ' A' ' 58' ' ' HIS . 12.8 mt -78.43 -54.1 6.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 109.6 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.26 -37.6 64.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.447 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -43.87 98.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 53.5 ttp -67.26 -49.92 62.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.425 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -51.54 -46.32 63.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 12.8 mt -64.09 -60.21 3.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 109.793 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 18.8 p -55.46 -18.98 8.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.646 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 35' ' ' SER . 79.6 m-85 -156.05 113.36 2.13 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 39' ' ' THR . 73.0 Cg_endo -79.56 -20.14 9.62 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.32 2.013 . . . . 0.0 111.945 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.85 ' O ' HG22 ' A' ' 41' ' ' THR . 41.0 p -47.12 -18.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.373 -0.829 . . . . 0.0 109.735 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 37' ' ' PRO . 42.6 p -74.68 -22.72 58.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 109.876 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -70.13 -20.05 63.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.0 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.85 HG22 ' O ' ' A' ' 38' ' ' THR . 12.2 t . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.818 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.574 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 15.1 p80 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 120.984 0.421 . . . . 0.0 111.297 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 47' ' ' ASP . 4.9 p90 -145.42 23.2 1.47 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.891 -1.131 . . . . 0.0 109.526 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' SER . 57.2 m-20 42.52 84.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.551 -0.718 . . . . 0.0 109.829 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.62 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -50.22 -11.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 47' ' ' ASP . 14.7 m -58.88 147.36 34.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.383 -0.823 . . . . 0.0 109.491 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -64.54 148.46 50.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.596 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.03 83.81 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 5.4 p -69.07 -23.72 64.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -1.221 . . . . 0.0 109.337 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.57 -56.15 0.46 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.837 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 52' ' ' SER . 43.1 mt-30 -43.89 -22.44 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.356 -0.84 . . . . 0.0 109.812 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 53' ' ' ALA . 41.0 t -74.35 -26.74 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.32 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.7 ptmt -65.7 -27.41 68.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.87 . . . . 0.0 109.552 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.08 -50.44 40.12 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.491 ' ND1' HD11 ' A' ' 29' ' ' LEU . 20.4 t-80 -53.85 -32.42 52.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -1.156 . . . . 0.0 109.476 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.22 -47.27 91.92 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -58.35 -23.43 56.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -1.081 . . . . 0.0 109.592 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.29 -39.49 62.9 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.228 -0.92 . . . . 0.0 108.88 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.7 -49.07 48.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.97 71.17 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.299 -0.876 . . . . 0.0 109.052 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -67.18 -38.73 85.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.299 -0.876 . . . . 0.0 108.759 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -64.07 -52.1 60.96 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -57.24 -44.6 83.98 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.243 -0.91 . . . . 0.0 108.731 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.4 m -68.74 -50.65 48.97 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.44 HD22 HD21 ' A' ' 80' ' ' LEU . 61.0 t30 -60.36 -24.28 64.95 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.96 -45.64 12.0 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.65 -23.38 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.66 -18.7 64.23 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.7 m80 -144.08 -58.89 0.39 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.404 -0.81 . . . . 0.0 109.339 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.3 p 44.19 13.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 121.879 0.847 . . . . 0.0 109.561 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.612 ' N ' ' O ' ' A' ' 72' ' ' HIS . 46.0 t0 -133.8 11.08 3.99 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.408 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.9 p-10 179.03 29.39 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.973 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.695 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 17.4 ptt? -78.62 -22.61 0.39 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.426 -0.796 . . . . 0.0 111.805 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.695 ' CD ' ' N ' ' A' ' 76' ' ' MET . 52.4 Cg_exo -54.12 -22.27 24.84 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.497 1.465 . . . . 0.0 112.347 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -94.16 -33.86 13.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.8 59.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.146 -0.971 . . . . 0.0 109.353 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 68' ' ' ASN . 12.8 mt -80.36 8.5 7.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.372 -0.83 . . . . 0.0 109.123 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.0 p -55.89 -17.11 5.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.929 . . . . 0.0 109.666 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.09 -55.97 4.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 83' ' ' LEU . 3.5 mt -45.4 -44.02 11.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 108.935 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 136' ' ' LEU . 29.7 t -57.23 -22.63 42.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.503 -0.748 . . . . 0.0 109.448 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 89' ' ' HIS . 23.1 t70 -82.01 -58.3 3.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.854 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.63 -27.45 17.17 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.757 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.448 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 38.6 m80 -91.84 -21.76 20.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.858 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.47 -11.35 15.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.214 -0.929 . . . . 0.0 109.902 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.581 ' N ' ' O ' ' A' ' 85' ' ' ASP . 14.4 m80 -113.94 -77.81 0.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 89' ' ' HIS . 9.9 mptt -45.79 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.481 ' C ' ' N ' ' A' ' 93' ' ' VAL . 19.6 mt -65.69 -17.33 64.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.838 . . . . 0.0 110.16 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.518 ' NH1' ' OE2' ' D' ' 43' ' ' GLU . 25.0 ttm180 48.93 15.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 109.003 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.481 ' N ' ' C ' ' A' ' 91' ' ' LEU . 10.8 p -46.01 156.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.0 109.878 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 93' ' ' VAL . 3.5 m-20 -100.23 153.03 37.98 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.39 -0.818 . . . . 0.0 109.046 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 98' ' ' PHE . 32.7 Cg_endo -65.79 -10.64 27.48 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.539 2.159 . . . . 0.0 111.954 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 95' ' ' PRO . 83.4 t -44.05 -29.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.343 -0.848 . . . . 0.0 109.767 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -79.32 -32.92 43.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.577 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -50.18 -34.9 24.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.347 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -49.99 -34.91 22.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.8 mt -82.12 -50.52 8.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.1 tp -45.77 -20.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.627 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' LEU . 93.3 p -73.3 -59.33 2.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 109.945 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.822 ' CG ' HD21 ' B' ' 108' ' ' ASN . 40.7 m80 -71.81 -26.48 62.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.922 . . . . 0.0 109.769 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 62.4 m -58.11 -42.23 85.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.89 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.64 -22.74 62.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.186 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.594 ' N ' HD22 ' A' ' 106' ' ' LEU . 3.7 mm? -79.01 -35.96 41.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.0 -1.062 . . . . 0.0 110.137 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 45.3 t -62.89 -39.46 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.058 -1.026 . . . . 0.0 109.499 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.486 ' OG1' ' N ' ' A' ' 109' ' ' LEU . 12.2 p -65.23 -62.97 1.22 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.176 -0.952 . . . . 0.0 109.644 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.486 ' N ' ' OG1' ' A' ' 108' ' ' THR . 14.7 mt -48.2 -22.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -63.35 -36.47 83.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 109.896 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.16 -42.59 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.158 -0.964 . . . . 0.0 109.893 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.605 ' CG ' ' CE1' ' A' ' 24' ' ' TYR . 93.3 m-70 -81.8 -75.36 0.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.011 . . . . 0.0 109.519 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 113' ' ' LEU . 1.5 pp -137.14 94.44 12.48 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.19 -171.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.248 1.965 . . . . 0.0 112.931 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.524 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -47.23 -38.55 12.44 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.52 0.676 . . . . 0.0 109.539 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 6.7 mt-10 85.37 9.52 0.33 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.805 ' CE1' ' NE2' ' B' ' 116' ' ' HIS . 6.9 m-85 65.04 34.86 8.48 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.83 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.713 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -94.42 121.3 63.76 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.745 -1.222 . . . . 0.0 107.971 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -51.31 23.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.039 1.826 . . . . 0.0 112.914 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -154.97 -30.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.778 -1.201 . . . . 0.0 110.851 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.731 HG13 ' N ' ' A' ' 122' ' ' HIS . 11.8 p -47.83 -50.38 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.086 -1.008 . . . . 0.0 110.375 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.731 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.4 t-80 -65.38 -43.5 90.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.453 -0.779 . . . . 0.0 109.999 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' B' ' 34' ' ' VAL . . . -79.07 -19.36 51.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.243 -0.911 . . . . 0.0 109.921 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 120' ' ' ALA . 64.3 m -72.45 -63.95 1.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 111.08 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.01 -18.25 64.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.947 -1.096 . . . . 0.0 109.48 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.26 -49.41 10.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.961 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.83 -57.77 2.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.906 -1.122 . . . . 0.0 111.441 -178.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.456 ' CD2' ' HA ' ' A' ' 124' ' ' SER . 21.9 m-85 -46.55 -21.53 0.19 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.776 -1.202 . . . . 0.0 110.239 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.768 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -66.58 -18.87 65.6 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 134' ' ' THR . . . -55.96 -33.21 64.55 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.489 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 7.9 t -66.77 -36.73 83.11 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.217 -0.927 . . . . 0.0 108.762 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.504 ' O ' HD13 ' A' ' 136' ' ' LEU . 1.8 t -78.34 -40.0 24.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.8 t -73.41 -37.8 65.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.324 -0.86 . . . . 0.0 108.905 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 130' ' ' ALA . 88.9 m -71.55 -31.08 66.62 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.234 -0.916 . . . . 0.0 108.555 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 131' ' ' SER . 2.9 t -70.44 -36.58 67.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 132' ' ' VAL . 3.3 mp -56.71 -32.93 65.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 109.008 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.9 m -89.34 -27.25 20.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.59 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.528 -179.927 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 19.0 m170 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.904 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -86.47 178.11 7.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.188 -0.945 . . . . 0.0 109.25 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.415 ' O ' ' N ' ' B' ' 6' ' ' GLU . 7.5 p -92.09 145.42 30.81 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 109.368 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -39.96 -26.03 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.544 2.162 . . . . 0.0 112.17 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' B' ' 4' ' ' THR . 39.4 mt-10 -81.69 -51.91 7.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.565 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' B' ' 7' ' ' GLU . 0.7 OUTLIER -75.38 -22.6 57.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.913 . . . . 0.0 109.504 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.477 ' HB2' HD13 ' B' ' 3' ' ' LEU . 6.7 tttm -78.47 -37.1 44.21 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.33 -0.856 . . . . 0.0 109.121 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -63.12 -23.31 67.38 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.12 -57.64 3.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.148 -0.97 . . . . 0.0 110.166 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.46 -24.92 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.055 . . . . 0.0 108.574 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 96.4 m -78.26 -31.58 49.17 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.749 -0.594 . . . . 0.0 109.823 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -67.23 -63.79 0.99 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.767 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.563 HD12 ' N ' ' B' ' 14' ' ' LEU . 10.6 mp -45.83 -19.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.388 -0.82 . . . . 0.0 109.901 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' TRP . . . . . 0.463 ' N ' ' O ' ' B' ' 13' ' ' ALA . 4.0 t90 -78.78 -40.82 32.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.064 -1.023 . . . . 0.0 108.82 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.43 -24.07 59.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -79.87 -32.65 40.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -1.014 . . . . 0.0 109.286 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.56 HG23 ' O ' ' B' ' 14' ' ' LEU . 3.7 t -62.6 132.08 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.318 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' B' ' 21' ' ' ASP . 71.8 m-20 -81.26 78.28 8.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.246 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.465 HG12 ' O ' ' B' ' 20' ' ' VAL . 77.9 t -49.82 -10.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' B' ' 19' ' ' ASN . 21.4 m-20 -55.31 -29.95 59.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.895 . . . . 0.0 109.729 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' B' ' 25' ' ' GLY . 18.3 pt-20 -152.5 -32.16 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.96 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' B' ' 22' ' ' GLU . 92.8 t -44.71 -26.32 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 109.638 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.51 -26.27 47.57 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -66.85 -45.12 86.62 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.415 ' N ' ' OE2' ' B' ' 26' ' ' GLU . 1.2 mp0 -63.91 -47.75 79.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -1.144 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.41 -30.8 42.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.161 -0.962 . . . . 0.0 109.372 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.2 -54.27 5.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.37 -35.23 91.78 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -67.01 -32.38 73.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.12 . . . . 0.0 109.466 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 tp -47.24 -41.31 18.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 109.638 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.68 -23.91 39.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 109.712 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.17 -64.03 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.983 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.702 ' HA ' ' HB2' ' A' ' 123' ' ' ALA . 2.5 t -46.76 -43.9 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.322 -0.861 . . . . 0.0 109.373 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -171.79 130.0 0.69 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.336 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.59 62.32 7.71 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.302 2.002 . . . . 0.0 112.088 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' TRP . . . . . 0.493 ' CD1' ' N ' ' B' ' 37' ' ' TRP . 0.0 OUTLIER -57.65 -43.75 85.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.151 -0.968 . . . . 0.0 109.276 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.533 ' OG1' ' N ' ' B' ' 39' ' ' GLN . 1.7 p -49.78 -64.42 0.81 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.902 . . . . 0.0 109.373 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . 0.533 ' N ' ' OG1' ' B' ' 38' ' ' THR . 31.8 tt0 48.16 43.94 18.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.483 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 -163.44 -36.67 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.554 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -119.28 16.11 13.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 109.193 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' B' ' 43' ' ' GLU . 30.7 p90 -87.54 -35.15 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.534 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.489 ' OE2' ' NH1' ' C' ' 92' ' ' ARG . 12.1 pt-20 -81.98 -13.92 56.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.683 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 86.4 p -57.68 -29.05 64.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.6 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -85.23 19.23 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.514 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.62 1.87 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' B' ' 48' ' ' LEU . 35.7 t0 49.79 -145.96 0.41 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -1.196 . . . . 0.0 109.488 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.539 ' CB ' ' O ' ' B' ' 47' ' ' ASP . 2.4 tp 82.73 24.29 0.16 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.787 -0.571 . . . . 0.0 109.64 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -57.59 -35.16 70.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.935 . . . . 0.0 109.202 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . 0.402 ' O ' ' N ' ' B' ' 52' ' ' ASP . 1.2 p -146.93 153.64 46.09 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 108.923 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.44 -22.74 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.258 1.972 . . . . 0.0 112.257 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' B' ' 50' ' ' THR . 26.2 t70 -85.13 -38.58 18.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.92 -19.52 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.34 -0.85 . . . . 0.0 109.53 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' B' ' 52' ' ' ASP . 14.4 t -60.63 -59.34 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 17.2 ptp -90.33 14.13 13.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.895 . . . . 0.0 109.572 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.85 -18.98 58.77 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -89.08 146.95 37.45 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.133 -1.216 . . . . 0.0 109.486 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.87 -20.44 17.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.565 2.177 . . . . 0.0 112.388 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.61 -32.37 25.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 109.796 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -60.65 -41.15 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.969 . . . . 0.0 109.654 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.493 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 11.9 ptpt -79.03 -35.87 42.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -0.989 . . . . 0.0 109.38 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.25 69.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.87 -24.05 60.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.91 . . . . 0.0 109.594 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.72 -19.08 80.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -68.5 -32.2 72.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -1.139 . . . . 0.0 109.323 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -75.95 -34.46 59.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.631 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.9 -62.87 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.766 ' O ' HD23 ' B' ' 68' ' ' LEU . 2.6 tt -50.21 -29.01 8.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.934 . . . . 0.0 109.315 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.73 -38.93 96.74 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.47 93.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -1.135 . . . . 0.0 109.822 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' PHE . . . . . 0.433 ' CE2' HD23 ' B' ' 110' ' ' LEU . 25.3 m-85 -46.98 -30.25 2.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.772 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 3.9 p -57.56 -49.7 75.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -60.38 -16.91 39.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.399 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.17 -31.04 79.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.861 ' H ' HD23 ' B' ' 75' ' ' LEU . 1.4 pt? -136.58 -22.38 1.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.268 -1.136 . . . . 0.0 110.031 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -77.59 5.11 9.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.03 -1.044 . . . . 0.0 109.733 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 46.5 m-70 -161.03 66.22 0.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . 0.418 HD21 ' HA ' ' B' ' 75' ' ' LEU . 87.1 mt -72.96 10.82 0.8 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.498 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' B' ' 77' ' ' HIS . 13.7 t70 -66.74 -45.68 77.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.422 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -162.21 96.2 0.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.805 . . . . 0.0 109.414 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 24.7 mt -76.16 -58.79 3.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.579 ' NZ ' ' CD2' ' B' ' 143' ' ' HIS . 11.0 ttmm -54.72 -23.94 19.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.486 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.13 -47.54 9.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.8 t -78.25 -48.28 16.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -1.158 . . . . 0.0 109.628 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' PHE . . . . . 0.563 ' N ' ' CG2' ' B' ' 84' ' ' THR . 27.9 m-85 -59.62 -1.71 0.28 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.5 -0.75 . . . . 0.0 109.425 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -56.3 -35.25 67.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.371 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 34.8 p -73.09 -57.77 3.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' B' ' 88' ' ' LEU . 32.5 mt -56.43 -29.5 61.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.312 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 69.6 m -81.14 -32.56 33.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -82.6 -22.28 34.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.869 . . . . 0.0 109.546 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' LEU . . . . . 0.493 ' C ' HD23 ' B' ' 91' ' ' LEU . 9.8 tt -78.78 -68.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.759 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' B' ' 97' ' ' HIS . 0.4 OUTLIER -55.31 -20.12 10.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.075 -179.198 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' CYS . . . . . 0.532 ' N ' ' ND1' ' B' ' 92' ' ' HIS . 36.4 t -83.53 -60.68 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 110.642 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 94' ' ' ASP . 0.8 OUTLIER -87.78 -25.75 23.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.084 -1.01 . . . . 0.0 111.446 -178.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.96 -52.24 5.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.717 -1.239 . . . . 0.0 110.96 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.607 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 2.3 mm? -112.56 -11.63 13.56 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.941 -1.1 . . . . 0.0 109.828 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 49.2 p-80 41.84 41.51 1.87 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.351 -0.843 . . . . 0.0 109.761 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 59.6 t -51.41 132.32 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -0.819 . . . . 0.0 109.457 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.07 153.0 90.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.171 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.47 -164.76 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.544 2.162 . . . . 0.0 112.229 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 56.91 48.38 15.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -0.936 . . . . 0.0 109.36 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -160.62 -33.53 0.05 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.315 -0.865 . . . . 0.0 109.46 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -63.42 -60.94 2.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.37 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -57.53 -20.3 30.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.357 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.509 HD23 ' O ' ' B' ' 105' ' ' LEU . 1.6 tt -77.34 -49.79 14.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.383 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tt -49.38 -46.3 47.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.274 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.35 -45.82 95.45 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' ASN . . . . . 0.822 HD21 ' CG ' ' A' ' 103' ' ' HIS . 11.8 t-20 -53.8 -34.7 59.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.151 -1.205 . . . . 0.0 109.565 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' VAL . . . . . 0.465 ' O ' ' SG ' ' B' ' 112' ' ' CYS . 89.7 t -80.28 -24.06 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.433 HD23 ' CE2' ' B' ' 71' ' ' PHE . 34.6 tp -78.06 -32.37 50.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.29 -49.59 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 109.754 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' B' ' 113' ' ' VAL . 18.7 p -53.08 -37.21 61.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.692 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' VAL . . . . . 0.468 ' N ' ' SG ' ' B' ' 112' ' ' CYS . 96.5 t -60.64 -21.37 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.661 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' B' ' 130' ' ' TYR . 23.6 mt -77.63 -57.02 4.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' ALA . . . . . 0.462 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.1 -19.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.372 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' HIS . . . . . 0.805 ' NE2' ' CE1' ' A' ' 117' ' ' PHE . 1.5 t-80 -79.33 -56.78 4.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -69.24 -17.72 63.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 109.71 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -151.22 60.96 0.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 0.0 109.588 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -77.76 -23.23 67.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.53 8.71 4.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -1.1 . . . . 0.0 109.447 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -134.63 12.88 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.18 43.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.0 109.119 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . 0.488 ' OG1' HG23 ' B' ' 126' ' ' VAL . 1.0 OUTLIER -48.64 151.1 2.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.147 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.502 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.0 Cg_exo -45.98 -52.32 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.281 1.987 . . . . 0.0 113.029 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 46.8 Cg_endo -68.34 15.24 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.173 1.916 . . . . 0.0 112.973 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.488 HG23 ' OG1' ' B' ' 123' ' ' THR . 53.2 t -108.53 -42.69 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.988 -1.07 . . . . 0.0 109.878 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' B' ' 127' ' ' GLN . 0.0 OUTLIER -70.7 -59.87 2.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.086 -1.009 . . . . 0.0 109.798 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' ALA . . . . . 0.684 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -49.48 -34.79 17.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.099 -1.001 . . . . 0.0 109.358 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.34 27.75 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.29 -0.881 . . . . 0.0 109.641 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' TYR . . . . . 0.516 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 1.6 t80 -126.69 -34.68 2.39 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.356 -0.84 . . . . 0.0 109.637 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -71.22 -62.86 1.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.743 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -48.7 -21.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.774 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' VAL . . . . . 0.567 HG22 HD21 ' B' ' 3' ' ' LEU . 33.8 t -69.13 -65.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.741 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 9.2 m -74.15 -16.38 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.607 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' D' ' 146' ' ' HIS . . . -49.41 -30.26 7.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.331 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.59 -26.3 70.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.79 -39.81 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -1.11 . . . . 0.0 109.367 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.88 95.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 0.873 ' ND2' ' CE1' ' D' ' 146' ' ' HIS . 1.2 m-20 -73.72 -44.14 57.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.422 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.09 -37.68 47.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.331 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.529 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 18.1 mt -82.35 11.27 5.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' B' ' 144' ' ' LYS . . . -123.7 -30.97 3.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.382 -0.823 . . . . 0.0 109.514 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . 0.579 ' CD2' ' NZ ' ' B' ' 82' ' ' LYS . 1.5 m80 -49.68 -13.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.355 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 144' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' B' ' 142' ' ' ALA . 3.2 tptp -77.88 -43.07 31.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.21 -0.931 . . . . 0.0 109.511 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -50.1 -25.25 3.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 146' ' ' HIS . . . . . 0.837 ' CE1' ' ND2' ' D' ' 139' ' ' ASN . 25.8 m170 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.495 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.36 -169.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.897 . . . . 0.0 109.862 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 3' ' ' SER . . . . . 0.604 ' H ' ' CG ' ' C' ' 6' ' ' ASP . 0.1 OUTLIER -99.93 -179.11 0.77 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.404 -0.81 . . . . 0.0 109.644 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 4' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 22.8 Cg_exo -62.92 -58.46 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.908 2.405 . . . . 0.0 113.091 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 5' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -78.7 -16.4 57.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.1 -1.0 . . . . 0.0 110.215 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' C' ' 3' ' ' SER . 33.5 m-20 -39.86 -30.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 7' ' ' LYS . . . . . 0.622 ' CD ' ' H ' ' C' ' 7' ' ' LYS . 0.0 OUTLIER -83.65 -39.52 20.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.493 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.45 ' N ' ' O ' ' C' ' 5' ' ' ALA . 36.4 m -44.85 -42.87 8.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.369 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.23 -25.37 62.47 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' C' ' 7' ' ' LYS . 52.9 t -78.83 -55.24 10.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' C' ' 15' ' ' GLY . 0.0 OUTLIER -53.41 -37.18 62.27 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.526 -1.27 . . . . 0.0 107.89 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.79 -63.16 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.332 -0.855 . . . . 0.0 109.241 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.766 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -60.29 -36.2 77.31 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -17.49 62.37 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 109.067 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' C' ' 11' ' ' LYS . . . -78.86 -46.42 8.48 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.04 -36.65 75.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -1.118 . . . . 0.0 108.869 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.766 HG23 ' O ' ' C' ' 13' ' ' ALA . 94.9 t -60.65 -66.02 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 58.77 -134.78 52.36 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.55 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -1.025 . . . . 0.0 110.427 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' C' ' 18' ' ' GLY . 92.2 m-70 -131.59 25.72 4.74 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.65 -61.55 1.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.61 -0.681 . . . . 0.0 109.755 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.7 -14.42 0.23 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 21' ' ' ALA . 1.2 mm-40 -84.28 -56.4 3.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -1.059 . . . . 0.0 109.526 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' TYR . . . . . 0.606 ' CE1' ' CG ' ' C' ' 112' ' ' HIS . 2.8 m-30 -60.6 -27.83 68.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 109.176 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.75 -22.94 75.66 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.72 -41.98 18.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.249 -1.147 . . . . 0.0 109.832 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -64.37 -19.99 65.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.405 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.05 -19.71 60.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.347 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.481 HD11 ' ND1' ' C' ' 58' ' ' HIS . 12.8 mt -78.41 -53.98 6.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.688 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.31 -37.64 65.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -43.84 98.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 53.4 ttp -67.29 -49.96 62.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.407 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -51.49 -46.32 63.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.673 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 12.8 mt -64.08 -60.22 3.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.927 . . . . 0.0 109.865 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 18.7 p -55.36 -19.05 7.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' C' ' 35' ' ' SER . 79.6 m-85 -156.16 113.27 2.11 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.578 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' C' ' 39' ' ' THR . 73.0 Cg_endo -79.47 -20.12 9.74 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.259 1.973 . . . . 0.0 111.982 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' THR . . . . . 0.844 ' O ' HG22 ' C' ' 41' ' ' THR . 40.9 p -47.17 -18.41 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 109.65 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.443 ' N ' ' O ' ' C' ' 37' ' ' PRO . 42.4 p -74.71 -22.79 58.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 109.854 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -69.96 -20.15 63.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 110.082 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.844 HG22 ' O ' ' C' ' 38' ' ' THR . 12.2 t . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.075 -1.016 . . . . 0.0 109.83 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' HIS . . . . . 0.573 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 15.1 p80 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 120.909 0.385 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' PHE . . . . . 0.415 ' O ' ' C ' ' C' ' 47' ' ' ASP . 5.0 p90 -145.36 23.2 1.48 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.9 -1.125 . . . . 0.0 109.541 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' C' ' 49' ' ' SER . 56.9 m-20 42.51 84.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.533 -0.73 . . . . 0.0 109.772 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.611 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -50.27 -11.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.421 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.482 ' N ' ' O ' ' C' ' 47' ' ' ASP . 14.7 m -58.97 147.38 34.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -64.57 148.37 50.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.63 -4.15 83.65 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' SER . . . . . 0.536 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 5.4 p -69.03 -23.66 64.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 109.328 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 67.5 -56.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.795 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' C' ' 52' ' ' SER . 43.0 mt-30 -43.95 -22.5 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.372 -0.83 . . . . 0.0 109.798 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 53' ' ' ALA . 40.9 t -74.23 -26.72 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.323 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' C' ' 53' ' ' ALA . 5.7 ptmt -65.75 -27.41 68.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.18 -50.51 39.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' HIS . . . . . 0.481 ' ND1' HD11 ' C' ' 29' ' ' LEU . 20.6 t-80 -53.73 -32.44 52.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -1.136 . . . . 0.0 109.567 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.23 -47.3 91.76 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -58.2 -23.46 55.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.385 -1.068 . . . . 0.0 109.694 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.26 -39.44 63.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.229 -0.919 . . . . 0.0 108.927 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.76 -49.05 48.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.48 -30.02 71.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.315 -0.866 . . . . 0.0 109.017 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -67.14 -38.66 85.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.898 . . . . 0.0 108.819 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -64.09 -52.13 60.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -57.08 -44.71 83.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.227 -0.92 . . . . 0.0 108.764 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 17.5 m -68.74 -50.61 49.28 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.294 -0.879 . . . . 0.0 108.703 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . 0.432 HD22 HD21 ' C' ' 80' ' ' LEU . 61.0 t30 -60.38 -24.27 64.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.563 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -84.95 -45.64 12.0 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.56 -23.48 33.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -18.74 64.27 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' HIS . . . . . 0.614 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.7 m80 -144.06 -58.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.446 -0.783 . . . . 0.0 109.337 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.3 p 44.28 13.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.796 0.808 . . . . 0.0 109.475 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' C' ' 72' ' ' HIS . 46.0 t0 -133.86 11.11 3.97 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.416 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 2.0 p-10 179.0 29.25 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.003 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 17.4 ptt? -78.57 -22.63 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 111.796 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.4 Cg_exo -54.0 -22.36 24.45 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.559 1.506 . . . . 0.0 112.334 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -94.2 -33.86 13.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.13 -0.981 . . . . 0.0 109.775 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.29 -46.74 60.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -0.948 . . . . 0.0 109.427 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' LEU . . . . . 0.432 HD21 HD22 ' C' ' 68' ' ' ASN . 12.9 mt -80.39 8.43 7.62 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 109.07 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 38.5 p -55.78 -17.14 5.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.742 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.16 -55.89 4.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 109.752 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.486 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 3.5 mt -45.41 -43.97 11.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 108.967 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' C' ' 136' ' ' LEU . 29.7 t -57.32 -22.55 42.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 109.44 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' C' ' 89' ' ' HIS . 23.0 t70 -82.01 -58.37 3.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.14 -0.975 . . . . 0.0 109.926 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.49 -27.42 16.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 109.77 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 38.8 m80 -91.97 -21.7 20.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.795 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.41 -11.41 15.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 109.914 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' C' ' 85' ' ' ASP . 14.3 m80 -113.94 -77.86 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.034 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' C' ' 89' ' ' HIS . 9.9 mptt -45.78 -97.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.868 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' C' ' 93' ' ' VAL . 19.6 mt -65.67 -17.32 64.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 110.178 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 92' ' ' ARG . . . . . 0.489 ' NH1' ' OE2' ' B' ' 43' ' ' GLU . 25.1 ttm180 48.86 15.34 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 0.0 108.938 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' C' ' 91' ' ' LEU . 10.8 p -46.05 156.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 0.0 109.886 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' ASP . . . . . 0.432 ' N ' HG22 ' C' ' 93' ' ' VAL . 3.5 m-20 -100.21 153.0 37.99 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.079 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' C' ' 98' ' ' PHE . 32.7 Cg_endo -65.87 -10.58 27.37 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.535 2.157 . . . . 0.0 111.947 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 84.0 t -44.01 -29.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.852 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -79.42 -32.86 42.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.621 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 98' ' ' PHE . . . . . 0.448 ' N ' ' O ' ' C' ' 95' ' ' PRO . 0.0 OUTLIER -50.18 -34.91 24.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.345 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -50.02 -34.91 22.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 9.9 mt -82.11 -50.53 8.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 53.2 tp -45.75 -20.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 0.0 109.64 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 102' ' ' SER . . . . . 0.445 ' N ' ' O ' ' C' ' 100' ' ' LEU . 93.1 p -73.4 -59.15 2.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.932 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 103' ' ' HIS . . . . . 0.834 ' CG ' HD21 ' D' ' 108' ' ' ASN . 40.7 m80 -71.92 -26.52 62.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 104' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 62.1 m -58.07 -42.13 84.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.042 -1.036 . . . . 0.0 109.942 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.68 -22.85 62.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.123 -0.986 . . . . 0.0 110.123 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.598 ' N ' HD22 ' C' ' 106' ' ' LEU . 3.7 mm? -79.01 -35.98 41.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.021 -1.049 . . . . 0.0 110.146 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 107' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 45.7 t -62.8 -39.47 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.054 -1.029 . . . . 0.0 109.536 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' C' ' 109' ' ' LEU . 12.5 p -65.31 -62.86 1.28 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.171 -0.956 . . . . 0.0 109.639 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 109' ' ' LEU . . . . . 0.492 ' N ' ' OG1' ' C' ' 108' ' ' THR . 14.8 mt -48.3 -22.42 0.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.355 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -63.37 -36.5 83.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.932 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.54 20.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.961 . . . . 0.0 109.863 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 112' ' ' HIS . . . . . 0.606 ' CG ' ' CE1' ' C' ' 24' ' ' TYR . 93.3 m-70 -81.78 -75.43 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -0.991 . . . . 0.0 109.54 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.638 ' O ' HD12 ' C' ' 113' ' ' LEU . 1.5 pp -137.05 94.42 12.62 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.2 -171.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.26 1.973 . . . . 0.0 112.899 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 115' ' ' ALA . . . . . 0.536 ' O ' HG11 ' C' ' 121' ' ' VAL . . . -47.3 -38.53 12.79 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.622 0.725 . . . . 0.0 109.598 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 116' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 6.7 mt-10 85.34 9.57 0.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 117' ' ' PHE . . . . . 0.812 ' CE1' ' NE2' ' D' ' 116' ' ' HIS . 6.9 m-85 65.11 34.93 8.28 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.779 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 118' ' ' THR . . . . . 0.727 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -94.58 121.33 63.43 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.783 -1.198 . . . . 0.0 107.942 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -51.35 23.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.124 1.883 . . . . 0.0 112.849 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 120' ' ' ALA . . . . . 0.727 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -155.06 -30.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.742 -1.223 . . . . 0.0 110.773 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 121' ' ' VAL . . . . . 0.718 HG13 ' N ' ' C' ' 122' ' ' HIS . 11.9 p -47.8 -50.35 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 122' ' ' HIS . . . . . 0.718 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.4 t-80 -65.41 -43.56 90.17 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.41 -0.806 . . . . 0.0 109.976 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 123' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' D' ' 34' ' ' VAL . . . -79.06 -19.38 51.5 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 109.914 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 124' ' ' SER . . . . . 0.58 ' N ' ' O ' ' C' ' 120' ' ' ALA . 63.7 m -72.42 -63.85 1.07 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 111.128 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.05 -18.18 64.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.06 -1.025 . . . . 0.0 109.562 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.24 -49.55 9.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.899 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 127' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.86 -57.64 2.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.903 -1.123 . . . . 0.0 111.476 -178.187 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 128' ' ' PHE . . . . . 0.47 ' CD2' ' HA ' ' C' ' 124' ' ' SER . 21.9 m-85 -46.57 -21.53 0.19 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.731 -1.231 . . . . 0.0 110.189 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 129' ' ' LEU . . . . . 0.768 ' O ' HD12 ' C' ' 129' ' ' LEU . 0.7 OUTLIER -66.6 -18.86 65.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' C' ' 134' ' ' THR . . . -56.01 -33.18 64.64 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.506 ' O ' HG23 ' C' ' 135' ' ' VAL . 7.9 t -66.67 -36.83 83.47 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.168 -0.958 . . . . 0.0 108.767 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 132' ' ' VAL . . . . . 0.498 ' O ' HD13 ' C' ' 136' ' ' LEU . 1.8 t -78.3 -39.98 24.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 34.9 t -73.52 -37.66 65.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.466 -0.771 . . . . 0.0 108.95 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 134' ' ' THR . . . . . 0.448 ' N ' ' O ' ' C' ' 130' ' ' ALA . 88.8 m -71.62 -31.1 66.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 135' ' ' VAL . . . . . 0.506 HG23 ' O ' ' C' ' 131' ' ' SER . 2.9 t -70.35 -36.58 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . 0.498 HD13 ' O ' ' C' ' 132' ' ' VAL . 3.2 mp -56.73 -32.85 65.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.361 -0.837 . . . . 0.0 108.998 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 51.4 m -89.36 -27.46 20.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.477 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.977 . . . . 0.0 109.501 -179.853 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 18.9 m170 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 3' ' ' LEU . . . . . 0.923 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -86.4 178.15 7.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 109.338 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.412 ' O ' ' N ' ' D' ' 6' ' ' GLU . 7.3 p -92.2 145.54 30.95 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 109.285 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -40.09 -25.96 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.534 2.156 . . . . 0.0 112.177 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 6' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' D' ' 4' ' ' THR . 39.5 mt-10 -81.72 -51.91 7.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' D' ' 7' ' ' GLU . 0.7 OUTLIER -75.3 -22.75 57.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.47 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 8' ' ' LYS . . . . . 0.468 ' HB2' HD13 ' D' ' 3' ' ' LEU . 6.7 tttm -78.39 -37.17 44.73 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.299 -0.876 . . . . 0.0 109.131 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 37.5 t -63.07 -23.28 67.37 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.23 -57.5 3.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.962 . . . . 0.0 110.082 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.52 -24.88 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.977 -1.077 . . . . 0.0 108.54 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 96.7 m -78.35 -31.59 48.64 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.729 -0.607 . . . . 0.0 109.724 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -67.25 -63.82 0.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.747 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.576 HD12 ' N ' ' D' ' 14' ' ' LEU . 10.6 mp -45.79 -19.29 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.377 -0.827 . . . . 0.0 109.898 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 15' ' ' TRP . . . . . 0.472 ' N ' ' O ' ' D' ' 13' ' ' ALA . 4.1 t90 -78.95 -40.8 30.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.986 -1.071 . . . . 0.0 108.751 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.31 -24.19 59.57 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -79.77 -32.71 40.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.456 -1.026 . . . . 0.0 109.353 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.568 HG23 ' O ' ' D' ' 14' ' ' LEU . 3.7 t -62.62 132.13 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.4 -0.812 . . . . 0.0 109.399 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 19' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' D' ' 21' ' ' ASP . 71.7 m-20 -81.21 78.17 8.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.291 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 20' ' ' VAL . . . . . 0.455 HG12 ' O ' ' D' ' 20' ' ' VAL . 78.4 t -49.78 -10.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.498 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' D' ' 19' ' ' ASN . 21.4 m-20 -55.33 -29.89 59.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 22' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' D' ' 25' ' ' GLY . 18.3 pt-20 -152.57 -32.15 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.095 -1.003 . . . . 0.0 110.045 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' D' ' 22' ' ' GLU . 93.0 t -44.72 -26.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.113 -0.992 . . . . 0.0 109.597 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.5 -26.31 47.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 25' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -66.71 -45.22 86.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 26' ' ' GLU . . . . . 0.423 ' N ' ' OE2' ' D' ' 26' ' ' GLU . 1.2 mp0 -63.9 -47.82 79.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -1.125 . . . . 0.0 109.318 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.3 -30.86 41.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.339 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.22 -54.32 5.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.24 -35.29 91.88 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -66.98 -32.36 73.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -1.091 . . . . 0.0 109.495 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 64.5 tp -47.35 -41.24 19.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.599 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 mt -80.73 -23.88 39.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.699 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.09 -64.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.474 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 34' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' C' ' 123' ' ' ALA . 2.4 t -46.65 -43.89 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -171.88 130.05 0.68 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 109.304 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.51 62.17 7.63 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.366 2.044 . . . . 0.0 112.126 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 37' ' ' TRP . . . . . 0.487 ' CZ3' HD11 ' D' ' 105' ' ' LEU . 0.0 OUTLIER -57.6 -43.72 84.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.143 -0.973 . . . . 0.0 109.272 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 38' ' ' THR . . . . . 0.553 ' OG1' ' N ' ' D' ' 39' ' ' GLN . 1.8 p -49.86 -64.41 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.371 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 39' ' ' GLN . . . . . 0.553 ' N ' ' OG1' ' D' ' 38' ' ' THR . 31.9 tt0 48.09 44.09 18.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 109.429 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -163.55 -36.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -119.3 16.14 13.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.309 -0.869 . . . . 0.0 109.216 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 42' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' D' ' 43' ' ' GLU . 30.8 p90 -87.61 -35.07 18.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.542 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 43' ' ' GLU . . . . . 0.518 ' OE2' ' NH1' ' A' ' 92' ' ' ARG . 12.1 pt-20 -81.97 -13.89 56.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.696 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 86.2 p -57.63 -29.09 64.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.607 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -85.27 19.24 2.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.44 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.63 1.87 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 47' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' D' ' 48' ' ' LEU . 35.7 t0 49.98 -146.01 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -1.186 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 48' ' ' LEU . . . . . 0.531 ' CB ' ' O ' ' D' ' 47' ' ' ASP . 2.4 tp 82.77 24.19 0.16 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.807 -0.558 . . . . 0.0 109.622 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -57.56 -35.12 69.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.273 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -146.93 153.69 46.13 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 108.887 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -42.47 -22.7 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.249 1.966 . . . . 0.0 112.251 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -85.15 -38.6 18.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.562 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.82 -19.58 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.362 -0.836 . . . . 0.0 109.573 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 t -60.66 -59.45 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.514 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 17.1 ptp -90.25 14.19 13.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.0 109.493 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.03 -18.91 58.61 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -89.07 146.99 37.55 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 109.443 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.76 -20.56 17.34 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.609 2.206 . . . . 0.0 112.4 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.55 -32.39 25.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 109.785 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 67.0 t -60.72 -41.18 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.672 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 61' ' ' LYS . . . . . 0.462 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 12.0 ptpt -78.94 -35.79 42.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.34 -30.12 69.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.93 -24.08 60.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.71 -19.12 80.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 65' ' ' LYS . . . . . 0.462 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 0.3 OUTLIER -68.44 -32.32 72.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -1.128 . . . . 0.0 109.326 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -75.78 -34.55 60.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.313 -0.867 . . . . 0.0 109.738 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.85 -62.94 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.469 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.755 ' O ' HD23 ' D' ' 68' ' ' LEU . 2.5 tt -50.14 -29.07 8.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.373 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.02 96.84 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.56 93.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -1.165 . . . . 0.0 109.804 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 71' ' ' PHE . . . . . 0.436 ' CE2' HD23 ' D' ' 110' ' ' LEU . 25.1 m-85 -47.0 -30.29 2.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.173 -0.954 . . . . 0.0 109.634 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 3.8 p -57.6 -49.68 75.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.461 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -60.32 -17.01 39.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.09 79.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.855 ' H ' HD23 ' D' ' 75' ' ' LEU . 1.4 pt? -136.62 -22.34 1.27 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.317 -1.108 . . . . 0.0 109.973 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 76' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -77.61 5.09 9.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.072 -1.017 . . . . 0.0 109.679 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 77' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 46.8 m-70 -160.99 66.27 0.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.531 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 78' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' D' ' 75' ' ' LEU . 87.3 mt -73.08 11.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.533 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' D' ' 77' ' ' HIS . 13.7 t70 -66.73 -45.72 77.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.399 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -162.21 96.19 0.97 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.787 . . . . 0.0 109.417 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 24.9 mt -76.19 -58.77 3.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 82' ' ' LYS . . . . . 0.584 ' NZ ' ' CD2' ' D' ' 143' ' ' HIS . 11.0 ttmm -54.76 -23.87 19.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.534 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.14 -47.51 9.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.8 t -78.28 -48.21 16.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -1.193 . . . . 0.0 109.67 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' D' ' 84' ' ' THR . 27.9 m-85 -59.72 -1.76 0.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 109.387 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 86' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -56.21 -35.24 67.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.158 -0.964 . . . . 0.0 109.423 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 34.5 p -73.2 -57.6 3.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 31.9 mt -56.49 -29.49 61.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.31 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 69.2 m -81.12 -32.64 33.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.439 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -82.62 -22.41 34.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.862 . . . . 0.0 109.482 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 91' ' ' LEU . . . . . 0.489 ' C ' HD23 ' D' ' 91' ' ' LEU . 9.8 tt -78.69 -68.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.853 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 92' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' D' ' 97' ' ' HIS . 0.4 OUTLIER -55.17 -20.28 10.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 0.0 110.092 -179.304 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 93' ' ' CYS . . . . . 0.526 ' N ' ' ND1' ' D' ' 92' ' ' HIS . 36.4 t -83.45 -60.66 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.1 -1.0 . . . . 0.0 110.706 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 94' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' D' ' 94' ' ' ASP . 0.8 OUTLIER -87.78 -25.64 23.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.087 -1.008 . . . . 0.0 111.45 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.02 -52.28 5.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.84 -1.163 . . . . 0.0 110.895 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 96' ' ' LEU . . . . . 0.609 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 2.3 mm? -112.5 -11.67 13.58 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.995 -1.065 . . . . 0.0 109.857 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 97' ' ' HIS . . . . . 0.609 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 49.3 p-80 41.89 41.48 1.89 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.31 -0.869 . . . . 0.0 109.786 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.42 132.32 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 0.0 109.472 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.01 152.96 90.0 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.245 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.54 -164.81 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.595 2.197 . . . . 0.0 112.162 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 57.01 48.34 15.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.32 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -160.61 -33.61 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -63.3 -60.91 2.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.445 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -57.63 -20.24 31.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 109.333 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 105' ' ' LEU . . . . . 0.51 HD23 ' O ' ' D' ' 105' ' ' LEU . 1.6 tt -77.37 -49.72 14.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.355 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 tt -49.41 -46.29 47.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.859 . . . . 0.0 109.316 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.36 -45.78 95.53 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 108' ' ' ASN . . . . . 0.834 HD21 ' CG ' ' C' ' 103' ' ' HIS . 11.8 t-20 -53.76 -34.7 59.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -1.176 . . . . 0.0 109.583 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 109' ' ' VAL . . . . . 0.452 ' O ' ' SG ' ' D' ' 112' ' ' CYS . 90.7 t -80.25 -24.12 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 110' ' ' LEU . . . . . 0.436 HD23 ' CE2' ' D' ' 71' ' ' PHE . 34.2 tp -78.05 -32.43 50.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 109.412 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 94.3 t -65.15 -49.77 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.685 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 112' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' D' ' 113' ' ' VAL . 18.6 p -52.95 -37.23 60.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.939 . . . . 0.0 109.747 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 113' ' ' VAL . . . . . 0.462 ' N ' ' SG ' ' D' ' 112' ' ' CYS . 96.5 t -60.66 -21.38 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.675 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 114' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' D' ' 130' ' ' TYR . 23.6 mt -77.64 -57.07 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 109.571 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.03 -19.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.088 -1.007 . . . . 0.0 109.386 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 116' ' ' HIS . . . . . 0.812 ' NE2' ' CE1' ' C' ' 117' ' ' PHE . 1.5 t-80 -79.45 -56.69 4.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.147 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -69.27 -17.61 63.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.683 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -151.31 60.98 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 119' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -77.78 -23.32 67.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.41 8.63 4.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.363 -1.08 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -134.57 12.81 3.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.404 -0.81 . . . . 0.0 109.52 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.15 43.86 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.116 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . 0.475 ' OG1' HG23 ' D' ' 126' ' ' VAL . 1.0 OUTLIER -48.61 151.1 2.15 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 109.161 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.501 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.0 Cg_exo -46.0 -52.3 7.25 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.307 2.005 . . . . 0.0 113.034 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 125' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 46.7 Cg_endo -68.29 15.16 0.16 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.157 1.905 . . . . 0.0 113.091 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.475 HG23 ' OG1' ' D' ' 123' ' ' THR . 53.1 t -108.4 -42.76 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.056 -1.027 . . . . 0.0 109.914 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 127' ' ' GLN . . . . . 0.616 ' CD ' ' H ' ' D' ' 127' ' ' GLN . 0.0 OUTLIER -70.66 -60.01 2.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.997 -1.064 . . . . 0.0 109.734 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 128' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -49.37 -34.77 16.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.11 -0.993 . . . . 0.0 109.461 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.39 27.76 1.04 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.306 -0.871 . . . . 0.0 109.686 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 130' ' ' TYR . . . . . 0.516 ' CZ ' ' CD1' ' D' ' 114' ' ' LEU . 1.6 t80 -126.65 -34.73 2.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.345 -0.847 . . . . 0.0 109.592 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -71.32 -62.86 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.642 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -48.77 -21.7 0.67 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 109.709 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 133' ' ' VAL . . . . . 0.581 HG22 HD21 ' D' ' 3' ' ' LEU . 34.2 t -69.17 -65.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.715 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.415 ' H ' HG22 ' D' ' 134' ' ' VAL . 9.0 m -74.22 -16.44 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -0.92 . . . . 0.0 109.569 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' B' ' 146' ' ' HIS . . . -49.32 -30.28 7.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.372 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.68 -26.22 70.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 137' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' D' ' 134' ' ' VAL . 89.1 t -68.84 -39.75 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -1.132 . . . . 0.0 109.336 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.01 94.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 139' ' ' ASN . . . . . 0.837 ' ND2' ' CE1' ' B' ' 146' ' ' HIS . 1.2 m-20 -73.7 -44.03 57.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.13 -37.67 47.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.926 . . . . 0.0 109.351 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 141' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 18.0 mt -82.31 11.2 5.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' D' ' 144' ' ' LYS . . . -123.66 -30.94 3.53 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.414 -0.804 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 143' ' ' HIS . . . . . 0.584 ' CD2' ' NZ ' ' D' ' 82' ' ' LYS . 1.5 m80 -49.69 -13.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.401 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 144' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' D' ' 142' ' ' ALA . 3.2 tptp -77.76 -43.0 32.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.25 -25.24 3.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.263 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 146' ' ' HIS . . . . . 0.873 ' CE1' ' ND2' ' B' ' 139' ' ' ASN . 25.9 m170 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.449 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 2' ' ' LEU . 29.8 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 7.8 mp 55.94 163.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.399 -0.813 . . . . 0.0 109.846 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.517 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 176.24 -47.8 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.021 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 3' ' ' SER . 54.2 Cg_exo -50.44 -170.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.473 2.115 . . . . 0.0 112.603 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -60.31 -16.17 32.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 109.667 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 5' ' ' ALA . 22.2 m-20 -39.51 -29.09 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.379 -0.826 . . . . 0.0 109.67 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 10' ' ' VAL . 4.6 ptpt -83.22 -49.99 8.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 7' ' ' LYS . 52.5 m -43.82 -32.77 1.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.474 -0.766 . . . . 0.0 109.751 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.85 -30.27 50.89 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.571 ' N ' ' O ' ' A' ' 7' ' ' LYS . 51.2 t -76.8 -51.57 18.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HZ1' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -57.64 -36.75 72.27 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.812 -1.155 . . . . 0.0 108.262 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.81 -58.25 8.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.13 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.99 -34.4 63.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 0.0 108.935 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -17.52 61.75 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.96 -44.6 18.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -70.1 -37.39 75.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -1.164 . . . . 0.0 108.51 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.574 ' CG1' ' HB2' ' A' ' 21' ' ' ALA . 4.2 t -60.16 -67.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 59.32 -136.81 50.59 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.28 29.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.487 -1.008 . . . . 0.0 110.485 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.565 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.9 m-70 -129.7 13.14 5.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 108.579 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.574 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . . . -75.0 -52.36 11.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.584 -0.697 . . . . 0.0 109.811 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.01 -14.53 10.68 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.31 -56.48 3.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -1.188 . . . . 0.0 109.72 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 20' ' ' HIS . 14.1 m-85 -59.86 -24.83 64.54 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 109.247 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.03 -33.77 84.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.93 -39.0 57.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.584 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.436 ' CG ' ' OG1' ' A' ' 108' ' ' THR . 13.2 tt0 -67.51 -20.0 65.38 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.361 -0.837 . . . . 0.0 109.552 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.08 -25.43 61.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.078 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -75.98 -59.32 2.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -56.49 -12.55 1.78 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.282 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -65.21 -58.29 6.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.197 -0.939 . . . . 0.0 109.835 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -84.52 -32.91 23.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 110.354 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 20.1 m-85 -63.54 -36.01 82.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.006 -1.058 . . . . 0.0 110.121 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 35' ' ' SER . 3.8 pp -46.92 -40.54 14.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.84 -1.163 . . . . 0.0 109.534 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.663 ' N ' HD12 ' A' ' 34' ' ' LEU . 1.4 p -76.56 -23.58 53.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.022 -1.049 . . . . 0.0 108.792 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.564 ' C ' ' O ' ' A' ' 35' ' ' SER . 0.3 OUTLIER 21.44 66.0 0.3 Allowed Pre-proline 0 N--CA 1.501 2.103 0 CA-C-O 121.155 0.502 . . . . 0.0 111.291 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.44 -62.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.46 2.107 . . . . 0.0 112.076 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.558 ' O ' HG22 ' A' ' 41' ' ' THR . 1.2 p -91.15 -57.52 2.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.546 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 39' ' ' THR . 3.0 p -44.12 -22.94 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -0.795 . . . . 0.0 110.333 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.3 ttmt -49.06 -45.17 42.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.087 -1.008 . . . . 0.0 109.569 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 38' ' ' THR . 0.6 OUTLIER -80.02 -18.96 48.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.59 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -77.06 -35.54 56.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.8 t80 55.04 79.9 0.32 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 109.298 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.708 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 72.1 Cg_exo -46.16 -27.99 5.07 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.654 2.236 . . . . 0.0 112.496 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.708 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 90.87 35.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 O-C-N 122.019 -0.426 . . . . 0.0 110.669 179.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.477 ' C ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -154.35 31.1 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.581 -1.324 . . . . 0.0 110.553 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 46' ' ' PHE . 35.6 m-20 42.26 88.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.423 -0.798 . . . . 0.0 110.242 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.44 -13.06 57.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.363 -0.836 . . . . 0.0 109.035 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 50' ' ' HIS . 32.8 p -78.02 165.73 23.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.559 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.564 ' ND1' ' N ' ' A' ' 50' ' ' HIS . 0.3 OUTLIER -57.81 -162.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.319 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.7 34.49 10.49 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 54' ' ' GLN . 30.2 t -139.06 82.29 1.89 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.357 -1.084 . . . . 0.0 109.259 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.68 -10.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.414 -0.804 . . . . 0.0 109.806 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 52' ' ' SER . 11.7 mt-30 -74.81 -35.23 62.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.123 -0.986 . . . . 0.0 109.676 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.66 -48.51 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.52 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.579 ' H ' ' CD ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -69.18 -25.5 64.38 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.416 -0.802 . . . . 0.0 109.046 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.91 -21.68 78.93 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.441 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.8 t-80 -82.43 -39.9 21.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -1.129 . . . . 0.0 109.847 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.92 -51.65 44.21 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -51.17 -22.66 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -1.022 . . . . 0.0 110.101 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.76 -29.72 56.23 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.056 -1.027 . . . . 0.0 109.255 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -79.8 -49.0 19.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.519 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -68.57 -22.71 64.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.406 -0.809 . . . . 0.0 109.191 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -78.25 -30.68 48.76 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.1 -1.0 . . . . 0.0 108.778 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.76 53.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.388 -0.82 . . . . 0.0 108.969 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.57 -40.58 72.15 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.153 -0.967 . . . . 0.0 108.757 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 m -68.81 -56.78 6.93 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 46.6 t30 -55.38 -24.17 28.35 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -80.24 -46.93 15.41 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.586 HG13 ' HZ1' ' A' ' 11' ' ' LYS . 36.0 t -64.41 -22.93 32.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.43 -17.04 64.56 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.616 ' O ' ' N ' ' A' ' 74' ' ' ASP . 4.2 m-70 -141.9 -61.25 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.434 -0.791 . . . . 0.0 109.435 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.1 p 44.72 12.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.721 0.772 . . . . 0.0 109.64 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.616 ' N ' ' O ' ' A' ' 72' ' ' HIS . 44.5 t0 -134.21 10.45 3.83 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 2.0 m-20 -178.53 28.02 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.733 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.701 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 6.5 ptt? -78.46 -23.36 0.41 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 111.67 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.3 Cg_exo -54.36 -18.82 15.45 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.617 1.545 . . . . 0.0 112.132 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -93.43 -38.08 11.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.421 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.45 -40.18 64.38 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 108.956 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.8 mt -87.65 11.34 15.38 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.7 t -65.32 -26.85 68.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.713 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.98 -49.03 66.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 109.726 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.439 ' N ' HD23 ' A' ' 83' ' ' LEU . 4.1 mt -47.69 -46.96 29.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 109.022 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 9.7 t -62.78 -28.55 70.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.626 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -79.96 -28.14 39.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 109.588 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 90' ' ' LYS . 3.7 tt -83.22 -32.29 26.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 109.87 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -92.04 -22.0 20.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.219 -0.926 . . . . 0.0 110.218 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -104.07 -48.01 4.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.112 -0.992 . . . . 0.0 110.123 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -93.44 21.93 5.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.13 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.504 ' C ' ' H ' ' A' ' 92' ' ' ARG . 28.6 ttmt -172.11 147.07 2.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.022 -1.049 . . . . 0.0 110.006 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER 71.31 -20.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.522 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.504 ' H ' ' C ' ' A' ' 90' ' ' LYS . 70.4 mtt85 43.12 27.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 109.741 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.534 HG22 ' N ' ' A' ' 94' ' ' ASP . 12.2 p -46.98 165.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.725 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.534 ' N ' HG22 ' A' ' 93' ' ' VAL . 6.1 p-10 -109.7 101.18 45.6 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.493 -0.754 . . . . 0.0 109.28 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -46.72 -10.85 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.407 2.072 . . . . 0.0 112.331 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 94' ' ' ASP . 52.6 t -50.98 -18.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 100' ' ' LEU . 3.1 m120 -79.22 -24.38 43.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.908 . . . . 0.0 109.316 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -44.33 -35.75 2.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -67.98 -23.78 65.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.304 -0.873 . . . . 0.0 109.579 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 100' ' ' LEU . 8.8 mp -84.18 -62.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 109.638 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.632 HD22 ' HAB' ' A' ' 142' ' ' HEC . 6.6 tt -55.47 -23.87 27.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.687 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.8 p -67.86 -50.4 56.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 109.727 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -78.02 -26.42 48.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.741 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 96.7 m -50.8 -50.45 56.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 109.629 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.26 -38.88 55.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.272 -0.892 . . . . 0.0 109.765 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.88 -36.18 64.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.531 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.13 -27.67 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.069 -1.019 . . . . 0.0 109.852 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -81.07 -45.19 16.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.123 -0.986 . . . . 0.0 109.842 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.506 ' N ' ' CG2' ' A' ' 108' ' ' THR . 15.6 mt -66.89 -20.67 65.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.926 . . . . 0.0 109.057 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 112' ' ' HIS . . . -51.66 -43.01 62.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.427 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.76 -3.62 0.12 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 109.193 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.512 ' H ' ' C ' ' A' ' 110' ' ' ALA . 79.7 m-70 -143.24 -85.59 0.15 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -0.888 . . . . 0.0 109.277 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.82 HD23 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -139.79 100.14 7.44 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -84.28 -98.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.646 2.231 . . . . 0.0 112.791 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.797 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -72.12 -56.58 5.34 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.557 -0.715 . . . . 0.0 110.064 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.667 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 17.5 mt-10 116.62 -6.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.485 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 4.9 t80 79.53 33.3 0.21 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.297 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.722 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -108.94 125.07 32.44 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.021 -1.049 . . . . 0.0 108.199 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.91 21.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.216 1.944 . . . . 0.0 112.801 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.722 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -149.44 -32.52 0.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.906 -1.121 . . . . 0.0 110.398 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.797 HG21 ' O ' ' A' ' 115' ' ' ALA . 9.5 p -55.04 -48.79 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 110.404 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.625 ' N ' HG13 ' A' ' 121' ' ' VAL . 4.4 t-160 -47.76 -36.2 11.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.45 -19.48 33.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.424 -0.797 . . . . 0.0 110.135 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 92.3 p -61.64 -62.42 1.82 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.087 -1.008 . . . . 0.0 110.647 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.43 -19.95 62.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.059 -1.026 . . . . 0.0 109.595 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.3 -40.77 17.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.094 -1.004 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.23 -40.41 12.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.122 -0.987 . . . . 0.0 109.868 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.461 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 40.3 t80 -50.48 -20.84 1.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.898 -1.126 . . . . 0.0 108.717 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 133' ' ' SER . 23.6 mt -68.97 -17.88 63.99 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.78 72.17 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 80.0 p -81.49 -26.82 34.89 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.27 -0.894 . . . . 0.0 108.596 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.42 -26.72 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.416 -0.802 . . . . 0.0 109.077 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 129' ' ' LEU . 1.9 t -82.68 -31.53 28.58 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 109.123 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 25.8 m -72.98 -36.77 67.16 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.31 -0.869 . . . . 0.0 109.553 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.61 -21.8 15.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.128 -0.983 . . . . 0.0 108.895 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -16.72 59.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.045 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 133' ' ' SER . 14.1 t -143.04 38.51 1.44 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -0.946 . . . . 0.0 109.6 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 m -48.46 132.24 16.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -75.45 -9.97 59.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 0.0 109.337 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.406 ' O ' ' O ' ' A' ' 141' ' ' ARG . 35.5 t80 56.95 90.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 140' ' ' TYR . 35.6 mtp85 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.571 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.443 ' C ' ' CD2' ' B' ' 2' ' ' HIS . 5.3 p . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 0.443 ' CD2' ' C ' ' B' ' 1' ' ' VAL . 2.6 p80 173.87 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.782 . . . . 0.0 109.14 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 1.025 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -130.3 172.03 12.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.381 -0.824 . . . . 0.0 109.352 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.425 ' O ' ' N ' ' B' ' 6' ' ' GLU . 7.7 p -90.51 141.59 27.39 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 109.301 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -40.63 -23.92 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.509 2.139 . . . . 0.0 112.376 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' B' ' 4' ' ' THR . 73.1 mm-40 -78.87 -54.67 5.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.831 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -74.85 -23.1 58.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.716 ' HB2' HD13 ' B' ' 3' ' ' LEU . 2.1 tttm -84.29 -32.2 24.5 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.339 -0.851 . . . . 0.0 109.234 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.9 m -63.67 -23.36 67.34 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.733 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.8 -57.59 3.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.075 -1.016 . . . . 0.0 110.113 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.474 HG23 ' CD2' ' B' ' 130' ' ' TYR . 1.7 p -62.67 -24.35 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 70.1 m -83.98 -35.37 23.98 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.27 0.557 . . . . 0.0 109.74 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.28 -27.4 61.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.391 -0.818 . . . . 0.0 109.663 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.18 -18.73 10.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 109.339 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . 0.665 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.5 OUTLIER -50.95 -50.95 56.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.119 -0.988 . . . . 0.0 109.038 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.68 -51.02 60.5 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 7.7 mtmt -53.91 -25.91 22.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.359 -1.083 . . . . 0.0 109.093 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.9 t -91.41 124.31 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.846 . . . . 0.0 109.74 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' B' ' 21' ' ' ASP . 1.8 m120 -81.86 68.31 8.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 108.94 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.403 HG22 HD13 ' B' ' 68' ' ' LEU . 70.0 t -45.98 -14.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.405 -0.809 . . . . 0.0 109.81 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' B' ' 19' ' ' ASN . 60.3 t0 -58.02 -18.04 21.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.839 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' B' ' 25' ' ' GLY . 35.1 mt-10 -155.79 -33.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.161 -0.962 . . . . 0.0 109.757 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 61.9 t -45.98 -23.91 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.249 -0.907 . . . . 0.0 109.702 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.54 -24.69 72.08 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -82.38 -33.03 26.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -74.74 -25.02 58.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -1.195 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.31 94.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.94 . . . . 0.0 109.559 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.41 -50.14 16.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.32 -28.2 8.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.1 -47.45 11.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.137 . . . . 0.0 109.35 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 tp -47.46 -31.55 4.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 109.435 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' B' ' 36' ' ' PRO . 14.4 mt -71.19 -46.1 62.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.23 -55.53 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.324 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.6 -22.93 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.563 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -150.4 76.9 8.29 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 109.492 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.503 ' N ' ' O ' ' B' ' 32' ' ' LEU . 77.5 Cg_endo -82.93 -7.68 11.22 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.813 2.342 . . . . 0.0 112.385 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.471 ' C ' ' H ' ' B' ' 39' ' ' GLN . 21.0 p-90 -63.93 -19.86 65.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 109.508 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 7.8 p -72.63 37.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' B' ' 37' ' ' TRP . 17.2 tt0 -80.71 10.53 4.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.298 -0.876 . . . . 0.0 109.447 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -89.16 -37.56 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.98 . . . . 0.0 109.556 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . 0.471 ' C ' ' H ' ' B' ' 43' ' ' GLU . 88.5 m-85 -89.68 -43.29 10.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 109.566 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.436 ' CE1' HBC3 ' B' ' 147' ' ' HEC . 1.6 m-85 -71.16 14.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 109.367 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' B' ' 41' ' ' PHE . 19.0 pt-20 -66.9 -13.88 62.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.418 ' C ' ' N ' ' B' ' 46' ' ' GLY . 49.9 m -77.63 -42.55 34.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.697 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.54 ' O ' ' N ' ' B' ' 47' ' ' ASP . 39.9 m-85 -47.5 -20.11 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' B' ' 44' ' ' SER . . . 59.14 -79.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' B' ' 45' ' ' PHE . 32.1 t0 -46.7 106.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -1.152 . . . . 0.0 109.555 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tp -163.08 21.56 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.262 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -52.53 -42.7 64.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 109.658 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.4 p -145.35 152.06 49.2 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.882 . . . . 0.0 109.211 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -40.25 -35.23 1.24 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.557 2.171 . . . . 0.0 112.325 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.75 -27.02 63.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.563 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -66.77 -19.97 65.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.2 -51.23 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.557 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 7.4 mmt -66.77 -22.0 66.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.52 -11.12 78.34 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' B' ' 59' ' ' LYS . 20.3 t-20 -71.6 136.28 83.44 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.264 -1.139 . . . . 0.0 109.335 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.11 -35.21 3.2 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.376 2.051 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.515 ' N ' ' OD1' ' B' ' 57' ' ' ASN . 41.0 mttm -63.91 -47.74 79.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.915 . . . . 0.0 109.856 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 96.3 t -46.9 -35.4 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.137 -0.977 . . . . 0.0 109.625 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -49.91 52.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 109.347 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.78 -32.53 59.96 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.226 -0.921 . . . . 0.0 109.668 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.419 ' NE2' ' CHA' ' B' ' 147' ' ' HEC . 37.1 t-80 -69.71 -23.92 63.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.329 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.78 -37.76 92.57 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -65.85 -25.71 67.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -1.099 . . . . 0.0 109.325 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -74.73 -49.0 22.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.93 -60.7 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.337 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.645 ' O ' HD23 ' B' ' 68' ' ' LEU . 1.3 tt -62.87 -21.16 65.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 109.097 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.76 -52.56 14.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.07 -35.21 33.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -1.134 . . . . 0.0 109.59 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' B' ' 137' ' ' VAL . 22.7 m-85 -66.8 -49.81 64.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 0.0 109.483 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.665 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.1 t -56.83 -30.85 64.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.45 -0.781 . . . . 0.0 109.415 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -59.67 -40.33 87.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.323 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.86 -60.1 8.61 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.585 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -50.48 -26.42 5.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.335 -1.097 . . . . 0.0 109.31 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.68 -2.53 58.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.959 . . . . 0.0 109.484 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.517 ' CE1' ' OD2' ' B' ' 79' ' ' ASP . 71.1 t60 -171.07 62.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.241 -0.912 . . . . 0.0 109.582 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 25.4 mt -70.3 2.19 4.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.178 -0.951 . . . . 0.0 109.44 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.517 ' OD2' ' CE1' ' B' ' 77' ' ' HIS . 54.9 m-20 -55.79 -26.72 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.418 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 15.6 t-20 -170.62 112.0 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 14.6 mt -80.19 -58.18 3.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -47.23 -24.08 0.66 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -63.66 -51.47 53.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.452 ' C ' ' H ' ' B' ' 86' ' ' ALA . 0.7 OUTLIER -85.59 -39.56 17.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -1.158 . . . . 0.0 109.346 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.437 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.7 m-85 -70.54 10.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.614 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -67.84 -33.65 75.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -82.09 -53.34 6.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 109.432 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.464 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 35.8 mt -51.76 -49.72 62.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.921 . . . . 0.0 109.29 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 7.3 m -59.74 -50.49 73.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.377 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.28 -38.77 92.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.869 . . . . 0.0 109.384 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 5.1 tt -74.53 -32.48 62.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.35 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' B' ' 97' ' ' HIS . 15.1 m80 -84.93 -20.3 30.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.108 -0.995 . . . . 0.0 109.644 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 46.6 t -83.74 -59.86 2.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.83 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -86.68 -34.78 19.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.12 -0.988 . . . . 0.0 111.531 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -79.73 -51.77 8.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.857 -1.152 . . . . 0.0 110.563 -178.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.33 -32.57 10.41 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.038 . . . . 0.0 110.244 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.569 ' CG ' ' O ' ' B' ' 97' ' ' HIS . 11.3 t-160 54.07 54.07 10.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.152 -0.967 . . . . 0.0 109.505 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.31 125.74 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.185 -0.947 . . . . 0.0 109.141 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -49.31 145.86 6.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.08 -11.86 31.22 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.612 2.208 . . . . 0.0 112.158 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -93.66 60.29 2.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -148.87 -46.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.526 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.0 OUTLIER -51.35 -47.43 62.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.65 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -48.31 -19.97 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.445 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' B' ' 103' ' ' PHE . 17.1 mt -88.54 -57.73 2.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.603 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.62 HD22 ' HAB' ' B' ' 147' ' ' HEC . 7.0 tt -47.93 -20.9 0.36 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.526 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . 0.413 ' O ' HG23 ' B' ' 111' ' ' VAL . . . -81.71 -33.23 28.06 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -83.49 -17.45 41.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -1.115 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 78.6 t -83.18 -56.61 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.517 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.496 ' O ' HD23 ' B' ' 110' ' ' LEU . 2.0 tt -48.71 -53.2 19.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.344 -0.847 . . . . 0.0 109.476 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 107' ' ' GLY . 89.7 t -46.99 -40.85 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.612 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.66 -33.93 76.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.518 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 19.1 t -66.28 -29.29 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.333 -0.855 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 118' ' ' PHE . 8.9 mt -81.68 -52.94 6.65 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.478 ' C ' ' HB1' ' A' ' 110' ' ' ALA . . . -54.08 -24.4 17.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.469 ' N ' ' HB1' ' A' ' 110' ' ' ALA . 0.6 OUTLIER -84.82 -62.63 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.241 -0.912 . . . . 0.0 109.579 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -68.58 -17.56 64.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.756 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.479 ' CZ ' ' O ' ' B' ' 17' ' ' LYS . 72.4 m-85 -144.3 57.79 1.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -70.49 -23.05 77.87 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -72.62 10.78 0.76 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.252 -1.146 . . . . 0.0 109.509 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' B' ' 123' ' ' THR . 81.2 mm-40 -135.28 -0.34 2.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.39 -0.818 . . . . 0.0 109.642 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.81 33.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 109.339 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.488 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.0 OUTLIER -50.24 148.16 6.58 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.519 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.2 Cg_exo -46.73 -53.06 6.64 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.428 2.085 . . . . 0.0 113.159 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 26.4 Cg_endo -62.61 -21.83 73.32 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.024 1.816 . . . . 0.0 112.338 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.453 HG23 ' OG1' ' B' ' 123' ' ' THR . 75.2 t -81.58 -25.63 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.506 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' B' ' 123' ' ' THR . 5.5 mp0 -83.21 -59.81 2.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.12 -0.988 . . . . 0.0 109.492 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -45.88 -38.26 7.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.58 29.72 0.86 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 0.0 109.574 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.474 ' CD2' HG23 ' B' ' 11' ' ' VAL . 17.2 t80 -124.24 -22.4 4.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.448 -0.783 . . . . 0.0 109.701 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -83.95 -63.84 1.27 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.123 -0.986 . . . . 0.0 110.061 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -49.76 -21.63 1.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 0.0 109.952 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . 0.568 HG22 HD21 ' B' ' 3' ' ' LEU . 2.2 t -72.48 -68.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.972 . . . . 0.0 109.858 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.37 -19.95 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.793 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.94 -28.68 17.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.941 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.36 -36.45 89.23 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.424 HG21 ' CE1' ' B' ' 71' ' ' PHE . 99.4 t -63.48 -47.92 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -1.117 . . . . 0.0 109.468 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.18 -43.25 31.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 109.354 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -80.02 -38.36 32.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 0.0 109.451 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.34 -48.35 62.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.393 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 36.2 mt -75.63 11.04 1.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.42 -4.62 3.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 109.43 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.16 -27.49 64.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.92 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.86 -16.44 36.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -62.17 -61.5 2.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.303 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.467 ' ND1' ' N ' ' B' ' 146' ' ' HIS . 2.0 m-70 . . . . . 0 C--N 1.302 -1.495 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.49 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' C' ' 2' ' ' LEU . 29.8 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' C' ' 2' ' ' LEU . 7.8 mp 56.03 163.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.35 -0.844 . . . . 0.0 109.738 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 176.24 -47.92 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.998 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' C' ' 3' ' ' SER . 54.3 Cg_exo -50.31 -170.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.573 2.182 . . . . 0.0 112.579 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -60.24 -16.24 31.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.733 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' C' ' 5' ' ' ALA . 22.1 m-20 -39.45 -29.18 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.448 -0.782 . . . . 0.0 109.696 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' C' ' 10' ' ' VAL . 4.5 ptpt -83.18 -50.0 8.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.369 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.408 ' C ' ' O ' ' C' ' 7' ' ' LYS . 53.3 m -43.86 -32.7 1.14 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 109.733 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -77.85 -30.29 50.87 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' C' ' 7' ' ' LYS . 51.2 t -76.77 -51.54 18.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . 0.541 ' NZ ' HG13 ' C' ' 70' ' ' VAL . 0.1 OUTLIER -57.63 -36.72 72.19 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.767 -1.173 . . . . 0.0 108.285 179.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.74 -58.23 8.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -0.851 . . . . 0.0 109.215 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.05 -34.38 63.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 108.877 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -17.49 61.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.355 -0.841 . . . . 0.0 108.886 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.94 -44.68 18.51 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.41 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 17.9 mmtp -70.12 -37.34 75.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.085 -1.244 . . . . 0.0 108.465 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' C' ' 21' ' ' ALA . 4.1 t -60.22 -67.41 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.575 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 59.24 -136.78 50.71 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.29 28.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.543 -0.975 . . . . 0.0 110.474 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.575 ' H ' ' C ' ' C' ' 18' ' ' GLY . 96.9 m-70 -129.63 13.18 5.92 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.568 ' HB2' ' CG1' ' C' ' 17' ' ' VAL . . . -75.05 -52.39 11.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.643 -0.661 . . . . 0.0 109.75 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.07 -14.45 10.95 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.36 -56.47 3.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -1.166 . . . . 0.0 109.691 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.558 ' CD2' ' O ' ' C' ' 20' ' ' HIS . 14.0 m-85 -59.85 -24.88 64.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.86 . . . . 0.0 109.285 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.91 -33.83 85.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.74 -39.12 57.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -1.193 . . . . 0.0 109.661 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . 0.431 ' CG ' ' OG1' ' C' ' 108' ' ' THR . 13.2 tt0 -67.45 -20.11 65.45 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.336 -0.853 . . . . 0.0 109.457 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.07 -25.37 61.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.106 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 10.6 mt -76.04 -59.36 2.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 109.405 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -56.45 -12.54 1.75 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 109.354 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' C' ' 31' ' ' ARG . 0.0 OUTLIER -65.2 -58.35 6.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -84.51 -32.83 23.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.092 -1.005 . . . . 0.0 110.312 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 20.2 m-85 -63.55 -35.97 82.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.938 -1.101 . . . . 0.0 110.198 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.683 HD12 ' N ' ' C' ' 35' ' ' SER . 3.8 pp -46.97 -40.51 14.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.901 -1.124 . . . . 0.0 109.504 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.683 ' N ' HD12 ' C' ' 34' ' ' LEU . 1.4 p -76.5 -23.66 53.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.931 -1.106 . . . . 0.0 108.875 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.573 ' C ' ' O ' ' C' ' 35' ' ' SER . 0.3 OUTLIER 21.56 65.96 0.3 Allowed Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 121.151 0.5 . . . . 0.0 111.211 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.39 -61.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.407 2.072 . . . . 0.0 112.147 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.545 ' O ' HG22 ' C' ' 41' ' ' THR . 1.1 p -91.18 -57.41 2.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.215 -0.928 . . . . 0.0 109.613 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.477 ' H ' HG23 ' C' ' 39' ' ' THR . 3.0 p -44.21 -22.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.47 -0.769 . . . . 0.0 110.31 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' C' ' 38' ' ' THR . 26.2 ttmt -49.03 -45.13 42.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.957 -1.089 . . . . 0.0 109.596 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.545 HG22 ' O ' ' C' ' 38' ' ' THR . 0.6 OUTLIER -80.0 -19.01 48.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.599 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -77.09 -35.52 56.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.639 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . . . . . . . . . 39.8 t80 55.08 79.88 0.32 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.251 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.702 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 72.0 Cg_exo -46.11 -28.01 5.0 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.649 2.233 . . . . 0.0 112.489 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.702 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 0.0 OUTLIER 90.89 35.13 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 O-C-N 122.055 -0.403 . . . . 0.0 110.686 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.468 ' C ' ' CD1' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -154.4 31.13 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.679 -1.263 . . . . 0.0 110.529 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' C' ' 46' ' ' PHE . 35.8 m-20 42.3 88.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.408 -0.808 . . . . 0.0 110.271 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.596 HD23 ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -65.33 -13.09 57.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 109.114 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.427 ' O ' ' O ' ' C' ' 50' ' ' HIS . 32.6 p -78.11 165.71 23.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.583 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.568 ' ND1' ' N ' ' C' ' 50' ' ' HIS . 0.3 OUTLIER -57.83 -162.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.361 -0.837 . . . . 0.0 109.283 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.82 34.44 10.94 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.55 ' O ' ' N ' ' C' ' 54' ' ' GLN . 30.4 t -139.06 82.25 1.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.286 -1.126 . . . . 0.0 109.218 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.69 -10.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.808 . . . . 0.0 109.847 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' C' ' 52' ' ' SER . 11.7 mt-30 -74.85 -35.25 62.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 109.627 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.3 t -65.67 -48.45 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.54 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.577 ' H ' ' CD ' ' C' ' 56' ' ' LYS . 0.0 OUTLIER -69.18 -25.51 64.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 0.0 109.12 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.91 -21.65 78.97 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.453 ' ND1' ' C ' ' C' ' 58' ' ' HIS . 6.9 t-80 -82.59 -39.79 21.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -1.082 . . . . 0.0 109.798 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.04 -51.56 45.42 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -51.19 -22.67 2.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.445 -1.032 . . . . 0.0 110.153 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.73 -29.7 56.29 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.15 -0.969 . . . . 0.0 109.24 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.488 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -79.81 -49.0 19.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 108.726 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.531 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -68.58 -22.84 64.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.308 -0.87 . . . . 0.0 109.189 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -78.17 -30.69 49.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.134 -0.979 . . . . 0.0 108.832 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.64 -48.66 53.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.323 -0.86 . . . . 0.0 108.996 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.57 -40.62 72.22 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.203 -0.936 . . . . 0.0 108.749 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 15.3 m -68.72 -56.84 6.8 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' C' ' 72' ' ' HIS . 46.6 t30 -55.42 -24.08 28.46 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -80.24 -47.01 15.28 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.541 HG13 ' NZ ' ' C' ' 11' ' ' LYS . 36.2 t -64.35 -22.97 32.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.46 -17.06 64.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.611 ' O ' ' N ' ' C' ' 74' ' ' ASP . 4.3 m-70 -141.88 -61.31 0.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 109.422 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.554 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.2 p 44.78 12.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.728 0.775 . . . . 0.0 109.61 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' C' ' 72' ' ' HIS . 44.5 t0 -134.22 10.44 3.83 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 2.0 m-20 -178.59 28.03 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.762 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 6.5 ptt? -78.52 -23.33 0.41 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.413 -0.805 . . . . 0.0 111.703 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.0 Cg_exo -54.33 -18.83 15.38 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.565 1.51 . . . . 0.0 112.185 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -93.42 -38.06 11.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.391 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.17 64.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 108.897 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.62 11.27 15.51 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.349 -0.845 . . . . 0.0 108.755 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 14.8 t -65.33 -26.82 68.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.357 -0.839 . . . . 0.0 109.715 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.92 -49.04 66.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 109.741 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.439 HD23 ' N ' ' C' ' 83' ' ' LEU . 4.1 mt -47.76 -46.96 30.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.026 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.563 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 9.7 t -62.76 -28.52 70.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.64 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.94 -28.1 39.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 109.601 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' C' ' 90' ' ' LYS . 3.7 tt -83.25 -32.35 26.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.827 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . 0.413 ' CE1' HD22 ' C' ' 86' ' ' LEU . 67.0 m80 -92.12 -21.94 20.15 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.13 -0.982 . . . . 0.0 110.122 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -104.03 -48.1 3.99 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.183 -0.948 . . . . 0.0 110.113 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -93.42 21.94 5.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 110.138 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.506 ' C ' ' H ' ' C' ' 92' ' ' ARG . 28.7 ttmt -172.15 147.13 2.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.932 -1.105 . . . . 0.0 110.067 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' C' ' 93' ' ' VAL . 1.0 OUTLIER 71.29 -20.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.386 -0.821 . . . . 0.0 109.536 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' C' ' 90' ' ' LYS . 70.4 mtt85 43.04 27.36 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 0.0 109.7 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.539 HG22 ' N ' ' C' ' 94' ' ' ASP . 12.2 p -47.08 165.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.539 ' N ' HG22 ' C' ' 93' ' ' VAL . 6.1 p-10 -109.74 101.29 46.11 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -46.69 -11.01 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.383 2.055 . . . . 0.0 112.274 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 94' ' ' ASP . 51.1 t -50.74 -18.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.189 -0.944 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' C' ' 100' ' ' LEU . 3.1 m120 -79.18 -24.38 43.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.309 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -44.31 -35.8 2.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.338 -0.851 . . . . 0.0 109.745 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -68.0 -23.72 65.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.484 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.583 HD12 ' N ' ' C' ' 100' ' ' LEU . 8.8 mp -84.22 -62.08 1.65 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.626 HD22 ' HAB' ' C' ' 142' ' ' HEC . 6.6 tt -55.52 -23.78 28.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 109.653 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 13.7 p -67.93 -50.33 56.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.762 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -78.05 -26.42 48.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.716 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.462 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 96.4 m -50.81 -50.47 56.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.669 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.23 -38.81 54.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 109.811 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.94 -36.21 64.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.113 -0.992 . . . . 0.0 110.478 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.06 -27.68 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.987 -1.071 . . . . 0.0 109.927 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.498 ' CG2' ' N ' ' C' ' 109' ' ' LEU . 0.6 OUTLIER -81.15 -45.1 16.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.831 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.498 ' N ' ' CG2' ' C' ' 108' ' ' THR . 15.5 mt -67.04 -20.52 65.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.089 -1.007 . . . . 0.0 109.068 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' C' ' 112' ' ' HIS . . . -51.78 -42.95 62.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.418 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.76 -3.67 0.12 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 109.212 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . 0.522 ' H ' ' C ' ' C' ' 110' ' ' ALA . 79.8 m-70 -143.23 -85.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.38 -0.825 . . . . 0.0 109.249 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.833 HD23 ' O ' ' C' ' 113' ' ' LEU . 0.0 OUTLIER -139.88 100.04 7.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.26 -98.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.564 2.176 . . . . 0.0 112.807 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.808 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -72.22 -56.46 5.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.576 -0.702 . . . . 0.0 110.037 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.676 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 17.5 mt-10 116.56 -6.69 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 4.9 t80 79.56 33.28 0.21 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.318 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.714 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -108.92 125.11 32.36 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.93 21.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.239 1.959 . . . . 0.0 112.79 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.714 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -149.47 -32.59 0.21 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.901 -1.124 . . . . 0.0 110.336 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.808 HG21 ' O ' ' C' ' 115' ' ' ALA . 9.6 p -54.86 -48.91 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.058 -1.026 . . . . 0.0 110.413 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.632 ' N ' HG13 ' C' ' 121' ' ' VAL . 4.4 t-160 -47.78 -36.17 11.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.44 -19.45 33.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 110.149 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' C' ' 128' ' ' PHE . 92.5 p -61.64 -62.41 1.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 110.686 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.37 -20.03 62.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.997 -1.065 . . . . 0.0 109.619 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.28 -40.72 17.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.105 -0.997 . . . . 0.0 109.548 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.2 -40.42 12.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 109.845 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.465 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 40.4 t80 -50.51 -20.81 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.869 -1.145 . . . . 0.0 108.7 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' C' ' 133' ' ' SER . 23.4 mt -68.98 -17.95 64.0 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.79 72.13 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 79.6 p -81.48 -26.84 34.89 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.37 -26.84 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 109.108 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.54 ' N ' ' O ' ' C' ' 129' ' ' LEU . 1.9 t -82.51 -31.55 29.19 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.214 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 26.0 m -73.06 -36.71 66.94 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.373 -0.829 . . . . 0.0 109.486 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.61 -21.74 15.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.137 -0.977 . . . . 0.0 108.933 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -16.81 59.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.435 -0.791 . . . . 0.0 108.914 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . 0.455 HG22 ' O ' ' C' ' 133' ' ' SER . 14.2 t -143.08 38.43 1.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 17.2 m -48.35 132.19 16.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.541 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -75.33 -10.11 59.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.387 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.407 ' O ' ' O ' ' C' ' 141' ' ' ARG . 35.4 t80 56.99 91.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.444 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' C' ' 140' ' ' TYR . 35.7 mtp85 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.44 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.438 ' C ' ' CD2' ' D' ' 2' ' ' HIS . 5.2 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . 0.438 ' CD2' ' C ' ' D' ' 1' ' ' VAL . 2.6 p80 173.8 93.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 109.127 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 1.054 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -130.32 171.95 12.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.306 -0.872 . . . . 0.0 109.382 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.416 ' O ' ' N ' ' D' ' 6' ' ' GLU . 7.6 p -90.54 141.63 27.37 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 109.262 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -40.59 -24.05 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.507 2.138 . . . . 0.0 112.398 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' D' ' 4' ' ' THR . 73.3 mm-40 -78.73 -54.79 5.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.932 . . . . 0.0 109.824 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -74.75 -23.13 58.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 109.614 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.726 ' HB2' HD13 ' D' ' 3' ' ' LEU . 2.2 tttm -84.29 -32.17 24.51 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.372 -0.83 . . . . 0.0 109.34 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 m -63.77 -23.31 67.31 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.677 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.82 -57.52 3.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.963 . . . . 0.0 110.125 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.477 HG23 ' CD2' ' D' ' 130' ' ' TYR . 1.7 p -62.68 -24.37 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 70.6 m -84.07 -35.24 23.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.773 -0.579 . . . . 0.0 109.717 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.33 -27.33 61.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.622 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.25 -18.75 11.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.33 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . 0.655 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.5 OUTLIER -50.98 -50.88 57.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.008 . . . . 0.0 109.062 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.73 -50.98 60.84 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.484 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 7.7 mtmt -53.9 -25.85 22.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.407 -1.054 . . . . 0.0 109.175 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.2 t -91.49 124.36 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 0.0 109.698 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' D' ' 21' ' ' ASP . 1.8 m120 -81.89 68.26 8.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.874 . . . . 0.0 108.925 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.416 ' O ' HG12 ' D' ' 20' ' ' VAL . 69.0 t -45.96 -14.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.413 -0.805 . . . . 0.0 109.812 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' D' ' 19' ' ' ASN . 60.4 t0 -58.01 -18.1 21.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.764 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -155.78 -33.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.059 -1.025 . . . . 0.0 109.758 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 61.6 t -46.07 -23.89 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.644 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.57 -24.66 72.09 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.45 -32.96 26.61 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -74.78 -24.97 58.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.13 -1.218 . . . . 0.0 109.548 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.25 -40.25 93.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.45 -50.03 17.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.38 -28.2 9.07 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.05 -47.57 11.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -1.117 . . . . 0.0 109.276 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 21.0 tp -47.34 -31.61 4.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' D' ' 36' ' ' PRO . 14.4 mt -71.16 -46.16 62.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.441 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 46.8 t -57.12 -55.58 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.373 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.409 ' H ' HG23 ' D' ' 34' ' ' VAL . 2.7 t -67.69 -22.86 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.886 . . . . 0.0 109.501 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -150.48 76.94 8.21 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . 0.517 ' N ' ' O ' ' D' ' 32' ' ' LEU . 77.8 Cg_endo -82.89 -7.75 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.878 2.385 . . . . 0.0 112.351 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . 0.474 ' C ' ' H ' ' D' ' 39' ' ' GLN . 20.9 p-90 -63.85 -20.0 65.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 7.9 p -72.6 37.44 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.396 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' D' ' 37' ' ' TRP . 17.2 tt0 -80.73 10.54 4.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.443 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -89.13 -37.66 14.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.49 ' C ' ' H ' ' D' ' 43' ' ' GLU . 88.4 m-85 -89.65 -43.32 10.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 109.574 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.426 ' CE1' HBC3 ' D' ' 147' ' ' HEC . 1.6 m-85 -71.09 14.73 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.379 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' D' ' 41' ' ' PHE . 19.0 pt-20 -66.89 -13.87 62.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.085 -1.009 . . . . 0.0 109.492 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . 0.417 ' O ' ' N ' ' D' ' 46' ' ' GLY . 49.8 m -77.75 -42.5 33.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' D' ' 47' ' ' ASP . 39.9 m-85 -47.53 -20.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.461 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 59.09 -79.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' D' ' 45' ' ' PHE . 32.1 t0 -46.83 106.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -1.174 . . . . 0.0 109.553 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tp -163.08 21.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 0.0 109.269 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 75.0 m -52.61 -42.58 64.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 109.708 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . 0.432 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.4 p -145.4 152.08 49.04 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.319 -0.863 . . . . 0.0 109.265 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -40.28 -35.16 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.421 2.081 . . . . 0.0 112.365 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.74 -27.1 63.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.588 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -66.76 -19.94 65.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 3.8 t -74.13 -51.35 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.463 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 7.4 mmt -66.73 -22.03 66.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.56 -11.07 78.35 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' D' ' 59' ' ' LYS . 20.1 t-20 -71.73 136.33 83.07 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.169 -1.195 . . . . 0.0 109.266 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.07 -35.26 3.19 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.431 2.087 . . . . 0.0 112.374 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' D' ' 57' ' ' ASN . 40.9 mttm -63.95 -47.78 79.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.834 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 97.6 t -46.76 -35.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 109.795 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -49.9 52.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 109.355 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.76 -32.65 60.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.417 ' NE2' ' CHA' ' D' ' 147' ' ' HEC . 36.9 t-80 -69.58 -24.0 63.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.8 -37.66 92.47 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -65.94 -25.63 67.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -1.143 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -74.71 -49.07 22.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 0.0 109.435 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.82 -60.76 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.312 -0.867 . . . . 0.0 109.362 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.642 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.3 tt -62.85 -21.16 65.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.124 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.78 -52.43 15.15 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.02 -35.3 33.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 109.571 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . 0.428 ' CE2' HMB1 ' D' ' 147' ' ' HEC . 22.7 m-85 -66.81 -49.83 64.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 109.446 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . 0.655 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 8.1 t -56.75 -30.94 64.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.413 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -59.62 -40.36 87.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.324 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.75 -60.23 8.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.579 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.6 mp -50.38 -26.56 5.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -1.125 . . . . 0.0 109.347 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.61 -2.57 58.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.149 -0.97 . . . . 0.0 109.435 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.516 ' CE1' ' OD2' ' D' ' 79' ' ' ASP . 71.3 t60 -171.01 62.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.547 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 25.1 mt -70.21 2.16 4.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.516 ' OD2' ' CE1' ' D' ' 77' ' ' HIS . 55.0 m-20 -55.92 -26.6 48.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 15.6 t-20 -170.6 111.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.428 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 14.5 mt -80.2 -58.11 3.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 109.507 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -47.31 -24.1 0.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . 0.434 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -63.61 -51.51 53.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.448 ' C ' ' H ' ' D' ' 86' ' ' ALA . 0.7 OUTLIER -85.48 -39.65 17.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -1.14 . . . . 0.0 109.426 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.443 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.5 m-85 -70.53 10.35 0.5 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 109.532 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -67.75 -33.8 75.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.328 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -82.1 -53.21 6.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.407 -0.808 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.456 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 35.6 mt -51.91 -49.69 62.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 109.252 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 7.2 m -59.69 -50.42 73.91 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.257 -0.902 . . . . 0.0 109.423 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.34 -38.84 92.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.392 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 5.1 tt -74.35 -32.56 62.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' D' ' 97' ' ' HIS . 15.2 m80 -84.91 -20.3 30.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.083 -1.011 . . . . 0.0 109.615 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 46.5 t -83.76 -59.92 2.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 0.0 110.844 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 41' ' ' THR . 37.4 m-20 -86.6 -34.76 19.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.065 -1.022 . . . . 0.0 111.565 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -79.82 -51.67 8.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.772 -1.205 . . . . 0.0 110.619 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.31 -32.73 10.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.064 . . . . 0.0 110.258 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' D' ' 97' ' ' HIS . 11.3 t-160 54.3 54.12 9.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 109.348 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.39 125.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.947 . . . . 0.0 109.156 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -49.33 145.88 7.01 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 109.322 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.11 -11.82 31.1 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.559 2.173 . . . . 0.0 112.098 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -93.71 60.36 2.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -148.83 -46.99 0.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 109.573 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 1.0 OUTLIER -51.34 -47.43 62.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 0.0 109.671 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -48.35 -19.89 0.35 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.437 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . 0.411 ' N ' ' C ' ' D' ' 103' ' ' PHE . 17.3 mt -88.69 -57.63 2.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.565 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.604 HD22 ' HAB' ' D' ' 147' ' ' HEC . 7.0 tt -47.93 -20.94 0.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.528 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . 0.407 ' O ' HG23 ' D' ' 111' ' ' VAL . . . -81.72 -33.2 28.1 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -83.42 -17.51 41.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -1.191 . . . . 0.0 109.59 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 78.7 t -83.14 -56.66 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . 0.495 ' O ' HD23 ' D' ' 110' ' ' LEU . 2.0 tt -48.67 -53.17 19.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.456 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . 0.407 HG23 ' O ' ' D' ' 107' ' ' GLY . 88.6 t -47.03 -40.83 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.942 . . . . 0.0 109.631 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.74 -33.86 76.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.9 . . . . 0.0 109.521 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 19.0 t -66.3 -29.31 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.468 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' D' ' 118' ' ' PHE . 8.9 mt -81.61 -53.04 6.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.478 ' C ' ' HB1' ' C' ' 110' ' ' ALA . . . -54.02 -24.41 16.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.508 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.468 ' N ' ' HB1' ' C' ' 110' ' ' ALA . 0.6 OUTLIER -84.81 -62.58 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.606 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -68.59 -17.63 64.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.87 . . . . 0.0 109.664 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.484 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 72.2 m-85 -144.22 57.82 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 109.488 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -70.5 -23.06 77.87 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -72.61 10.81 0.75 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -1.151 . . . . 0.0 109.471 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' D' ' 123' ' ' THR . 81.2 mm-40 -135.32 -0.26 2.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 0.0 109.762 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -73.77 33.54 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.486 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.0 OUTLIER -50.2 148.23 6.43 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 109.464 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.515 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.3 Cg_exo -46.85 -52.98 6.82 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.425 2.083 . . . . 0.0 113.119 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 26.1 Cg_endo -62.56 -21.99 73.48 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.115 1.877 . . . . 0.0 112.329 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.459 HG23 ' OG1' ' D' ' 123' ' ' THR . 75.8 t -81.59 -25.52 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.141 -0.974 . . . . 0.0 109.513 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' D' ' 123' ' ' THR . 5.4 mp0 -83.41 -59.66 2.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.508 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -45.87 -38.2 7.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.543 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.59 29.54 0.88 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.489 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.477 ' CD2' HG23 ' D' ' 11' ' ' VAL . 17.1 t80 -124.14 -22.4 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.707 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -83.99 -63.7 1.3 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.951 . . . . 0.0 110.099 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -49.75 -21.64 1.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 109.978 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . 0.588 HG22 HD21 ' D' ' 3' ' ' LEU . 2.2 t -72.45 -68.29 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.063 -1.023 . . . . 0.0 109.851 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.28 -19.95 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.844 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.03 -28.63 17.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.109 -0.994 . . . . 0.0 109.39 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.44 -36.4 88.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' D' ' 71' ' ' PHE . 99.4 t -63.47 -47.93 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -1.165 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.14 -43.21 31.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.894 . . . . 0.0 109.44 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -80.2 -38.24 31.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.38 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.38 -48.43 62.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.346 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 36.0 mt -75.53 10.97 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.381 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.4 -4.66 3.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.365 -0.834 . . . . 0.0 109.441 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.11 -27.46 64.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.91 -16.38 36.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -62.19 -61.61 2.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.255 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.481 ' ND1' ' N ' ' D' ' 146' ' ' HIS . 2.0 m-70 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.519 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.94 HBB3 HMB1 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 0.62 ' HAB' HD22 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.974 HBB3 HMB1 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 0.604 ' HAB' HD22 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 2' ' ' LEU . 21.8 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.3 mp 55.12 166.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.76 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.568 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 176.14 -45.22 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.851 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 3' ' ' SER . 42.3 Cg_exo -55.36 -153.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.616 2.21 . . . . 0.0 112.864 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -78.61 -15.26 58.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.474 -0.766 . . . . 0.0 110.003 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 5' ' ' ALA . 16.4 m-20 -38.78 -29.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.379 -0.826 . . . . 0.0 109.735 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . 2.0 ptpm? -83.39 -41.79 17.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.187 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.481 ' N ' ' O ' ' A' ' 5' ' ' ALA . 45.9 m -51.35 -29.82 16.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.312 -0.868 . . . . 0.0 109.083 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.72 -36.87 42.74 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.486 HG21 ' CD2' ' A' ' 128' ' ' PHE . 53.7 t -70.99 -49.05 52.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -52.99 -46.02 68.11 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.02 -58.06 10.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.498 -0.751 . . . . 0.0 109.36 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.834 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -53.19 -35.96 60.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.406 -0.808 . . . . 0.0 109.129 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -17.14 62.29 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.256 -0.902 . . . . 0.0 109.302 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.08 22.6 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 12.9 mmmt -73.01 -35.89 66.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.304 -1.115 . . . . 0.0 108.744 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 13' ' ' ALA . 57.9 t -62.02 -64.56 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 43.63 -122.35 3.93 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.31 22.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.403 -1.057 . . . . 0.0 110.345 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.545 ' H ' ' C ' ' A' ' 18' ' ' GLY . 78.2 m-70 -128.81 26.16 5.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' A' ' 63' ' ' ALA . . . -91.86 -63.1 1.29 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.621 -0.675 . . . . 0.0 109.9 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.7 -14.27 0.22 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 21' ' ' ALA . 10.4 mt-10 -84.72 -56.19 3.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -1.129 . . . . 0.0 109.814 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 20' ' ' HIS . 4.7 m-30 -60.24 -16.57 34.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.31 -34.14 30.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.07 39.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -1.2 . . . . 0.0 110.033 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.02 -19.73 64.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.097 -1.002 . . . . 0.0 109.662 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.72 -19.76 60.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 109.714 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.619 HD11 ' ND1' ' A' ' 58' ' ' HIS . 5.7 mt -78.73 -49.48 13.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 109.997 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' OE1' ' ND1' ' A' ' 50' ' ' HIS . 10.1 pt-20 -72.3 -33.25 67.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.091 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.575 ' NH1' ' SG ' ' A' ' 104' ' ' CYS . 45.8 ttt-85 -54.87 -44.58 74.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.927 . . . . 0.0 110.618 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.542 ' CE ' HBC2 ' A' ' 142' ' ' HEC . 12.0 ptt? -84.13 -45.35 13.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.889 -1.132 . . . . 0.0 110.153 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -49.23 -41.42 37.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 109.825 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 34' ' ' LEU . 2.5 pp -75.04 -38.75 61.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.982 -1.074 . . . . 0.0 109.586 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.43 ' N ' HD12 ' A' ' 34' ' ' LEU . 15.7 m -75.52 7.43 3.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.015 -1.053 . . . . 0.0 109.29 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.93 ' CZ ' ' OE1' ' B' ' 131' ' ' GLN . 77.0 m-85 -156.13 71.9 5.13 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.39 -19.86 0.77 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.727 2.285 . . . . 0.0 112.265 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 p -59.23 -22.79 61.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 p -89.48 -42.87 11.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.539 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.5 ttmt -52.16 -38.97 59.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.533 ' C ' ' H ' ' A' ' 43' ' ' PHE . 2.7 t -68.43 -18.59 64.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -61.42 4.13 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 109.605 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.533 ' H ' ' C ' ' A' ' 41' ' ' THR . 42.1 m-85 54.17 65.79 4.96 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.584 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 74.4 Cg_endo -78.55 -12.6 15.22 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.856 2.371 . . . . 0.0 112.379 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.584 ' ND1' ' O ' ' A' ' 44' ' ' PRO . 26.9 p-80 40.48 29.42 0.06 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.405 -0.809 . . . . 0.0 109.588 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.523 ' O ' ' C ' ' A' ' 47' ' ' ASP . 5.3 t80 -120.15 27.8 8.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.666 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 46' ' ' PHE . 1.6 p30 28.2 72.86 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.853 -0.529 . . . . 0.0 110.819 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 48' ' ' LEU . 2.2 mm? -64.83 -7.77 12.53 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.129 -0.982 . . . . 0.0 109.316 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 t -49.25 152.15 1.27 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.537 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.532 ' ND1' ' OE1' ' A' ' 30' ' ' GLU . 83.2 t60 -76.04 152.84 36.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.78 18.72 59.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 2.0 t -68.0 -99.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.246 -1.15 . . . . 0.0 109.311 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 174.0 -78.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.506 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -44.85 -17.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.395 -0.816 . . . . 0.0 109.589 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ALA . 3.5 t -76.72 -27.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.214 -0.929 . . . . 0.0 109.433 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.9 ptmt -66.02 -26.99 67.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 0.0 109.458 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.47 -42.18 42.01 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.619 ' ND1' HD11 ' A' ' 29' ' ' LEU . 15.1 t-80 -63.08 -27.98 69.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -1.203 . . . . 0.0 109.688 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.59 -47.31 90.25 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 32.6 mttp -56.08 -23.8 36.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -1.134 . . . . 0.0 109.754 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.599 ' HB3' HMA3 ' A' ' 142' ' ' HEC . 10.0 mmpt? -72.54 -42.52 64.64 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.304 -0.872 . . . . 0.0 109.05 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.4 t -68.92 -47.69 74.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.517 -0.739 . . . . 0.0 109.2 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -69.91 -30.0 67.3 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.311 -0.868 . . . . 0.0 109.531 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.3 t70 -69.22 -41.88 76.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.122 -0.986 . . . . 0.0 108.821 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.38 -47.94 79.98 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 70' ' ' VAL . 4.8 mt -61.03 -47.14 87.81 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -62.22 -47.31 85.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.882 . . . . 0.0 108.948 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -63.38 -26.71 68.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 108.682 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.14 -46.71 11.64 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 66' ' ' LEU . 78.4 t -65.99 -22.43 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.25 -21.67 66.3 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.586 ' O ' ' N ' ' A' ' 74' ' ' ASP . 13.2 m80 -144.18 -50.59 0.3 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.517 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.9 p 44.87 14.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 121.792 0.806 . . . . 0.0 109.489 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 72' ' ' HIS . 14.6 t70 -128.62 9.56 5.99 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -173.74 27.12 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.046 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.3 ptt? -78.36 -24.92 0.45 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.415 -0.803 . . . . 0.0 111.594 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 76' ' ' MET . 43.7 Cg_exo -55.56 -20.62 27.72 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.766 1.644 . . . . 0.0 112.538 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.52 HD22 ' C ' ' A' ' 78' ' ' ASN . 0.1 OUTLIER -94.06 -28.75 15.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.868 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.54 -48.05 20.64 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.142 -0.974 . . . . 0.0 109.178 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 80' ' ' LEU . 6.9 mp -79.13 6.89 8.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 109.15 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -59.4 -15.74 18.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 109.635 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.83 -48.7 11.25 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 109.74 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 83' ' ' LEU . 4.7 mt -47.19 -48.35 23.83 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 88.3 p -50.18 -24.82 3.04 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.093 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 82' ' ' ALA . 15.0 t70 -74.45 -25.5 59.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.158 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.467 HD21 ' CBD' ' A' ' 142' ' ' HEC . 6.9 tp -81.82 -34.29 30.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.299 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -90.44 -21.78 21.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -71.21 -68.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.907 . . . . 0.0 109.675 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -88.4 -77.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.91 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 86' ' ' LEU . 19.3 mttm -59.31 171.18 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -0.87 . . . . 0.0 109.868 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.528 ' C ' ' H ' ' A' ' 93' ' ' VAL . 4.0 tp 56.79 56.95 5.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.416 -0.802 . . . . 0.0 109.682 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -66.05 9.75 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.953 . . . . 0.0 109.315 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 94' ' ' ASP . 12.4 p -46.4 165.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.664 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.551 ' CG ' ' OD1' ' D' ' 99' ' ' ASP . 5.3 m-20 -84.34 116.96 67.47 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.299 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 97' ' ' ASN . 84.4 Cg_exo -44.28 -10.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.297 1.998 . . . . 0.0 112.357 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.723 ' CG2' ' OD2' ' D' ' 99' ' ' ASP . 98.2 t -53.88 -10.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 109.56 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 95' ' ' PRO . 2.7 m-80 -79.24 -24.9 42.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -53.16 -43.71 67.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.576 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.428 ' CB ' ' NZ ' ' A' ' 99' ' ' LYS . 7.5 mtmp? -69.32 -25.41 64.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.683 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 25.3 mt -81.67 -46.69 13.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.707 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.875 HD21 HBB3 ' A' ' 142' ' ' HEC . 6.3 tt -69.68 -20.76 63.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.694 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.7 p -78.75 -59.07 2.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 109.746 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -63.29 -26.72 68.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.806 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.575 ' SG ' ' NH1' ' A' ' 31' ' ' ARG . 35.0 m -65.08 -52.26 56.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 109.818 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -24.62 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.749 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.75 -34.85 60.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.083 -1.011 . . . . 0.0 109.926 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' HE ' ' A' ' 31' ' ' ARG . 71.1 t -83.33 -24.65 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.058 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -70.98 -63.64 1.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.137 -0.977 . . . . 0.0 110.458 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 113' ' ' LEU . 2.3 pp -64.04 -18.68 64.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.847 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.35 -33.29 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 0.0 109.709 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.79 -56.15 25.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.371 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -66.52 -68.28 0.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.115 -0.991 . . . . 0.0 108.422 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.1 pp -116.67 111.44 41.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.637 ' O ' HD12 ' A' ' 113' ' ' LEU . 89.2 Cg_exo -41.58 -177.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.571 2.18 . . . . 0.0 113.167 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.702 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -45.45 -52.48 10.1 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.64 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 19.4 mt-10 124.98 -1.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 61.21 31.47 19.51 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.194 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.776 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -103.82 120.47 51.26 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.48 23.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.007 1.805 . . . . 0.0 112.663 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.776 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -152.51 -32.53 0.13 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.965 -1.084 . . . . 0.0 110.514 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.702 HG21 ' O ' ' A' ' 115' ' ' ALA . 14.4 p -47.86 -48.26 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.957 -1.09 . . . . 0.0 110.081 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.64 ' N ' HG13 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -63.76 -39.01 93.23 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 109.365 -179.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.29 -19.78 33.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.888 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 120' ' ' ALA . 7.6 p -58.44 -62.07 2.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 110.018 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.507 ' N ' ' OG ' ' A' ' 124' ' ' SER . 5.0 mt -68.57 -19.58 64.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 109.329 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -73.74 -52.18 14.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.747 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.463 ' CD ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -86.29 -44.4 12.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.111 -0.993 . . . . 0.0 109.971 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' CD2' HG21 ' A' ' 10' ' ' VAL . 39.5 t80 -47.43 -20.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.988 -1.07 . . . . 0.0 108.992 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 133' ' ' SER . 12.0 mt -71.88 -17.99 62.08 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.32 -33.56 73.8 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 135' ' ' VAL . 89.2 p -82.72 -29.88 29.5 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.408 -0.808 . . . . 0.0 108.834 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 t -85.23 -29.73 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 109.134 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 129' ' ' LEU . 18.0 m -82.79 -22.64 34.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.299 -0.876 . . . . 0.0 108.936 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 138' ' ' SER . 42.1 m -80.72 -39.93 26.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.332 -0.855 . . . . 0.0 109.223 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 131' ' ' SER . 26.8 m -71.05 -26.5 27.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.211 -0.931 . . . . 0.0 108.899 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.02 -31.92 73.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.439 -0.788 . . . . 0.0 108.96 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.0 m -156.81 53.63 0.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 134' ' ' THR . 9.1 p -58.8 115.09 2.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.497 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 140' ' ' TYR . 14.5 pttm -73.07 -25.85 61.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.917 . . . . 0.0 109.45 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.517 ' CG ' ' O ' ' A' ' 139' ' ' LYS . 64.1 m-85 -159.74 154.12 23.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.387 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' C' ' 141' ' ' ARG . 22.4 mtm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.535 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.528 ' O ' ' CG ' ' B' ' 2' ' ' HIS . 6.8 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.331 0.586 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' B' ' 1' ' ' VAL . 43.9 m80 -159.07 102.58 1.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.297 -0.877 . . . . 0.0 109.163 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.913 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.1 OUTLIER -142.74 164.53 29.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 109.362 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.83 159.43 68.83 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.827 . . . . 0.0 109.348 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.74 -18.64 65.3 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.632 2.221 . . . . 0.0 112.003 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.5 -34.25 23.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.5 -61.76 1.76 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 109.591 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.696 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -47.01 -26.74 1.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.91 . . . . 0.0 109.609 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.0 t -57.11 -23.39 46.73 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.59 -57.69 3.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.917 -1.115 . . . . 0.0 110.102 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.4 -24.58 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 48.1 m -82.09 -36.92 27.09 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.396 0.617 . . . . 0.0 109.759 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.5 -34.65 70.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 109.597 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.7 OUTLIER -50.49 -34.56 25.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 109.157 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -45.74 -17.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.372 -0.83 . . . . 0.0 109.66 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.25 -49.41 7.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.45 ' O ' ' CZ ' ' B' ' 118' ' ' PHE . 0.1 OUTLIER -71.95 -30.28 65.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.2 . . . . 0.0 109.396 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.434 HG22 ' CD2' ' B' ' 114' ' ' LEU . 77.5 t -53.46 114.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 109.649 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' B' ' 21' ' ' ASP . 36.3 m-80 -79.53 66.04 4.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 108.946 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' B' ' 22' ' ' GLU . 72.1 t -43.72 -26.13 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.471 -0.768 . . . . 0.0 109.852 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' B' ' 19' ' ' ASN . 18.0 t70 -65.51 5.13 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' B' ' 20' ' ' VAL . 37.5 mt-10 -154.03 -51.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.976 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 88.0 t -49.63 -53.3 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.559 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.76 -40.46 25.95 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.63 -37.14 61.94 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.05 -35.77 61.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -1.144 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -28.83 68.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.507 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 tp -84.94 -52.06 6.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.533 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.76 -28.49 70.12 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -79.22 -28.21 42.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -1.173 . . . . 0.0 109.477 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . 0.421 HD13 ' HB3' ' B' ' 106' ' ' LEU . 44.6 tp -48.08 -39.79 21.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.546 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.461 ' CD2' ' OG1' ' B' ' 38' ' ' THR . 21.1 mt -81.08 -23.01 38.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.746 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 71.5 t -66.23 -61.68 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.979 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -78.44 -22.63 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 110.047 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -134.57 77.03 59.77 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.067 -1.02 . . . . 0.0 109.926 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -84.2 27.89 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.014 2.476 . . . . 0.0 112.277 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -81.04 -20.13 42.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.971 . . . . 0.0 109.89 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.532 ' C ' ' H ' ' B' ' 40' ' ' ARG . 6.1 p -47.7 -29.25 2.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.67 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 52.0 6.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.573 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' B' ' 38' ' ' THR . 42.6 ttm180 -110.21 -39.96 4.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 109.207 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 47.69 19.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 1.3 ' CE2' HMD3 ' B' ' 147' ' ' HEC . 77.2 m-85 54.53 55.18 8.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 109.388 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -46.3 -16.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.341 -0.849 . . . . 0.0 109.583 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.515 ' N ' ' O ' ' B' ' 42' ' ' PHE . 20.0 m -57.64 -54.68 44.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.432 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -70.12 3.75 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.3 -0.875 . . . . 0.0 109.235 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.16 -149.45 1.24 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 56.52 73.11 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -1.132 . . . . 0.0 109.669 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 89.8 mt -137.42 29.72 2.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.85 . . . . 0.0 109.384 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 41.5 t -72.49 -38.0 68.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -0.922 . . . . 0.0 109.541 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -146.16 151.91 45.72 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -40.93 -35.34 1.66 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.384 2.056 . . . . 0.0 112.38 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.99 -32.14 73.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 109.554 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.2 -24.0 66.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.565 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.33 -60.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -91.91 25.48 2.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.966 . . . . 0.0 109.629 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.2 -52.44 2.05 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.84 157.0 90.78 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.227 -1.161 . . . . 0.0 109.437 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' B' ' 62' ' ' ALA . 65.8 Cg_endo -74.96 -44.59 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.709 2.273 . . . . 0.0 112.322 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -45.95 -35.32 4.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.727 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 38.0 t -76.12 -41.57 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -79.18 -24.85 42.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.868 . . . . 0.0 109.545 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' B' ' 58' ' ' PRO . . . -76.55 -51.14 12.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.616 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 1.076 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 45.7 t-80 -51.28 -23.95 4.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.86 -45.63 95.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -50.74 -44.7 58.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.308 -1.113 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -57.82 -51.52 69.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.51 -0.744 . . . . 0.0 109.434 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 0.874 HG13 ' C2B' ' B' ' 147' ' ' HEC . 53.7 t -57.88 -51.14 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.291 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.77 -45.35 94.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.256 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.76 -45.83 31.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.15 92.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -1.14 . . . . 0.0 109.614 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -57.59 -28.86 63.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 11.6 m -77.16 -33.62 56.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.476 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.38 -34.24 33.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.463 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.24 -60.0 7.25 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.59 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.8 mp -55.03 -27.5 45.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -1.104 . . . . 0.0 109.45 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -2.14 36.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -171.26 63.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.49 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.484 ' CD2' HG11 ' B' ' 1' ' ' VAL . 9.4 mt -70.99 -18.06 62.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 109.376 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -48.8 -26.05 2.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.445 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.34 65.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.276 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.437 HD12 ' N ' ' B' ' 82' ' ' LYS . 2.5 pp -55.69 -40.92 73.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.627 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.437 ' N ' HD12 ' B' ' 81' ' ' LEU . 39.5 mttp -50.35 -23.92 2.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.473 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.0 -42.88 7.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.7 OUTLIER -68.26 -42.92 78.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.148 -1.207 . . . . 0.0 109.629 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' B' ' 84' ' ' THR . 35.7 m-85 -67.3 -0.39 3.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -0.838 . . . . 0.0 109.459 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.46 -53.92 20.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.945 . . . . 0.0 109.383 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.5 p -61.6 -58.76 6.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' B' ' 92' ' ' HIS . 50.3 mt -51.21 -49.84 60.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.206 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . 0.516 ' O ' ' N ' ' B' ' 93' ' ' CYS . 7.2 m -57.16 -46.24 82.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.249 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.536 ' HA ' ' HZ2' ' B' ' 144' ' ' LYS . 31.0 tt0 -62.21 -46.53 88.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.486 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 3.9 tt -72.62 -27.24 62.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 109.361 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' B' ' 88' ' ' LEU . 18.7 m80 -90.47 -20.29 22.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.978 . . . . 0.0 109.663 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' B' ' 89' ' ' SER . 26.6 t -83.17 -59.23 2.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 110.699 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.65 -40.51 15.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.988 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.1 OUTLIER -73.01 -51.96 16.24 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.945 -1.097 . . . . 0.0 110.642 -178.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.57 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 30.8 mt -95.79 -36.89 10.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.91 -1.119 . . . . 0.0 109.96 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 38.6 p-80 43.71 30.78 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.427 ' H ' HG23 ' B' ' 98' ' ' VAL . 3.4 t -52.32 153.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 0.0 109.215 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.681 ' OD2' ' CG2' ' C' ' 96' ' ' VAL . 1.6 m-20 -71.24 143.05 87.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 109.589 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -41.22 -43.87 5.38 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.608 2.206 . . . . 0.0 112.46 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -72.01 54.46 0.28 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.449 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.606 ' O ' HMC2 ' B' ' 147' ' ' HEC . 9.5 m120 -150.98 -31.17 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 109.969 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.52 -41.68 54.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.072 -1.017 . . . . 0.0 109.931 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.424 ' O ' ' ND2' ' B' ' 108' ' ' ASN . 73.8 ttt180 -79.59 -19.98 48.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 110.071 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.443 ' N ' HD22 ' B' ' 105' ' ' LEU . 4.3 mm? -50.56 -60.86 2.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.137 -0.977 . . . . 0.0 109.793 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 1.231 HD21 ' CHC' ' B' ' 147' ' ' HEC . 1.9 pp -81.7 -22.39 37.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.012 -1.055 . . . . 0.0 109.721 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.35 -36.57 37.69 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' B' ' 104' ' ' ARG . 14.2 p30 -85.55 -34.81 21.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -1.158 . . . . 0.0 109.648 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 74.3 t -51.35 -48.0 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.924 . . . . 0.0 109.465 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 tp -51.92 -54.0 34.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 109.49 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 25.2 t -46.42 -38.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.414 ' O ' ' ND1' ' B' ' 116' ' ' HIS . 13.2 m -79.2 -56.31 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 85.6 t -47.99 -24.52 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.552 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.434 ' CD2' HG22 ' B' ' 18' ' ' VAL . 14.2 mt -77.29 -43.54 32.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.26 -19.37 63.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.417 ' N ' ' HD1' ' B' ' 116' ' ' HIS . 4.3 m80 -78.29 -62.82 1.56 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.696 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -70.93 -17.43 62.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 0.0 109.845 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.45 ' CZ ' ' O ' ' B' ' 17' ' ' LYS . 63.1 m-85 -144.94 58.17 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.665 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -79.67 -17.92 74.31 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -65.05 4.99 0.39 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.365 -1.079 . . . . 0.0 109.694 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' B' ' 119' ' ' GLY . 46.8 mm-40 -135.12 9.55 3.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -77.67 32.61 0.16 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.132 -0.98 . . . . 0.0 109.287 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.429 ' H ' ' C ' ' B' ' 121' ' ' GLU . 36.8 p -46.85 148.69 1.75 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.867 . . . . 0.0 109.51 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.48 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.1 Cg_exo -45.16 -57.03 2.31 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.542 2.161 . . . . 0.0 112.918 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 14.3 Cg_endo -56.86 -36.12 98.7 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.064 1.843 . . . . 0.0 111.995 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.408 HG23 ' OG1' ' B' ' 123' ' ' THR . 63.0 t -76.39 -20.33 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.75 -44.98 26.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.329 -0.857 . . . . 0.0 109.494 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.32 84.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.942 . . . . 0.0 109.506 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.51 29.28 0.89 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.606 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.99 -33.89 4.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.481 -0.762 . . . . 0.0 109.375 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.93 ' OE1' ' CZ ' ' A' ' 36' ' ' PHE . 19.4 tt0 -83.95 -63.6 1.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -0.967 . . . . 0.0 109.878 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -48.05 -21.88 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.844 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . 0.479 HG22 HD21 ' B' ' 3' ' ' LEU . 71.3 t -71.75 -67.18 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.726 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.401 ' H ' HG23 ' B' ' 134' ' ' VAL . 2.2 t -67.2 -40.29 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.637 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.75 -21.78 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.497 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.15 -22.11 63.84 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.8 t -74.14 -30.94 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -1.178 . . . . 0.0 109.536 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.37 71.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -81.43 -21.2 39.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.592 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.14 -60.52 2.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.653 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.0 mt -57.92 -17.75 18.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.547 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' B' ' 144' ' ' LYS . . . -100.6 -6.91 24.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.895 . . . . 0.0 109.532 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -59.05 -4.71 0.53 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.467 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.536 ' HZ2' ' HA ' ' B' ' 90' ' ' GLU . 21.6 mmtp -92.13 -30.85 15.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -71.3 14.18 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.0 109.325 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.514 ' HB2' ' N ' ' D' ' 1' ' ' VAL . 28.1 p-80 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' C' ' 2' ' ' LEU . 21.8 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.499 HD12 ' N ' ' C' ' 2' ' ' LEU . 7.4 mp 55.12 166.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 109.727 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.563 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 176.06 -45.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.877 . . . . 0.0 109.859 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' C' ' 3' ' ' SER . 42.6 Cg_exo -55.31 -153.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.633 2.222 . . . . 0.0 112.843 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -78.65 -15.27 58.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.416 -0.802 . . . . 0.0 110.018 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.48 ' C ' ' O ' ' C' ' 5' ' ' ALA . 15.9 m-20 -38.67 -29.16 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.829 . . . . 0.0 109.759 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' C' ' 5' ' ' ALA . 2.0 ptpm? -83.37 -41.83 17.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.192 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.481 ' N ' ' O ' ' C' ' 5' ' ' ALA . 45.8 m -51.25 -29.96 16.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.889 . . . . 0.0 109.057 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -78.71 -36.79 42.9 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.483 HG21 ' CD2' ' C' ' 128' ' ' PHE . 53.8 t -70.99 -49.06 52.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -53.04 -45.98 68.28 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.06 -58.12 9.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.475 -0.766 . . . . 0.0 109.31 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.823 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -53.13 -35.89 60.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.456 -0.777 . . . . 0.0 109.215 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -17.24 62.29 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 109.258 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.03 22.79 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -73.12 -35.73 66.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -1.118 . . . . 0.0 108.772 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.823 HG23 ' O ' ' C' ' 13' ' ' ALA . 57.7 t -62.16 -64.52 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 43.68 -122.42 4.01 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.29 22.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -1.096 . . . . 0.0 110.347 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.543 ' H ' ' C ' ' C' ' 18' ' ' GLY . 78.4 m-70 -128.87 26.25 5.55 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' C' ' 63' ' ' ALA . . . -91.91 -63.15 1.28 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.599 -0.688 . . . . 0.0 109.837 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.67 -14.29 0.22 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' C' ' 21' ' ' ALA . 10.4 mt-10 -84.64 -56.37 3.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.801 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.438 ' CE2' ' O ' ' C' ' 20' ' ' HIS . 4.7 m-30 -60.16 -16.64 34.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.848 . . . . 0.0 109.516 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.13 -34.19 30.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.14 -32.03 38.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -1.184 . . . . 0.0 109.984 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.97 -19.9 64.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.623 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.7 -19.59 60.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.734 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.619 HD11 ' ND1' ' C' ' 58' ' ' HIS . 5.7 mt -78.86 -49.5 12.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.949 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.521 ' OE1' ' ND1' ' C' ' 50' ' ' HIS . 10.1 pt-20 -72.24 -33.28 67.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.925 . . . . 0.0 110.13 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.567 ' NH1' ' SG ' ' C' ' 104' ' ' CYS . 45.8 ttt-85 -54.82 -44.63 74.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.0 110.596 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 0.534 ' CE ' HBC2 ' C' ' 142' ' ' HEC . 12.1 ptt? -84.09 -45.46 13.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.887 -1.133 . . . . 0.0 110.114 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -49.21 -41.41 37.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.171 -0.956 . . . . 0.0 109.83 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.564 ' C ' HD12 ' C' ' 34' ' ' LEU . 2.5 pp -75.04 -38.74 61.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.019 -1.051 . . . . 0.0 109.594 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.432 ' N ' HD12 ' C' ' 34' ' ' LEU . 15.6 m -75.51 7.48 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 109.326 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.93 ' CZ ' ' OE1' ' D' ' 131' ' ' GLN . 76.7 m-85 -156.19 72.05 5.09 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.338 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -46.5 -19.84 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.732 2.288 . . . . 0.0 112.203 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 19.9 p -59.22 -22.83 61.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.53 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 70.4 p -89.49 -42.91 11.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.963 . . . . 0.0 109.482 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -52.01 -39.13 59.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 109.608 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.526 ' C ' ' H ' ' C' ' 43' ' ' PHE . 2.7 t -68.27 -18.7 64.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.478 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -61.47 4.15 0.1 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 0.0 109.568 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.526 ' H ' ' C ' ' C' ' 41' ' ' THR . 42.0 m-85 54.28 65.69 5.0 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.486 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.577 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 74.5 Cg_endo -78.59 -12.47 15.21 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.71 2.273 . . . . 0.0 112.424 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.577 ' ND1' ' O ' ' C' ' 44' ' ' PRO . 27.0 p-80 40.44 29.36 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 109.564 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.533 ' O ' ' C ' ' C' ' 47' ' ' ASP . 5.2 t80 -120.05 27.72 8.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 0.0 109.679 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.533 ' C ' ' O ' ' C' ' 46' ' ' PHE . 1.6 p30 28.35 72.67 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.087 0.47 . . . . 0.0 110.844 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' C' ' 48' ' ' LEU . 2.2 mm? -64.74 -7.8 12.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.147 -0.97 . . . . 0.0 109.364 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 33.7 t -49.25 152.13 1.27 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.587 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.521 ' ND1' ' OE1' ' C' ' 30' ' ' GLU . 83.2 t60 -76.0 152.82 36.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.449 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.88 18.6 59.93 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' C' ' 53' ' ' ALA . 2.0 t -67.93 -99.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -1.151 . . . . 0.0 109.309 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.517 ' N ' ' OG ' ' C' ' 52' ' ' SER . . . 174.06 -78.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.567 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -44.78 -17.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.466 -0.771 . . . . 0.0 109.709 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' C' ' 53' ' ' ALA . 3.5 t -76.68 -27.48 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.192 -0.943 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -66.04 -27.0 67.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.281 -0.887 . . . . 0.0 109.467 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.46 -42.28 41.72 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.619 ' ND1' HD11 ' C' ' 29' ' ' LEU . 14.9 t-80 -62.97 -28.2 69.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -1.158 . . . . 0.0 109.63 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.52 -47.26 90.7 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 32.7 mttp -56.1 -23.89 36.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -1.083 . . . . 0.0 109.671 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.6 ' HB3' HMA3 ' C' ' 142' ' ' HEC . 10.0 mmpt? -72.42 -42.5 65.04 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.314 -0.866 . . . . 0.0 109.055 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.0 t -68.95 -47.67 74.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.501 -0.749 . . . . 0.0 109.229 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -69.92 -30.06 67.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.316 -0.865 . . . . 0.0 109.498 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 2.3 t70 -69.2 -41.79 76.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.0 108.886 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.45 -47.95 79.71 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.408 -0.807 . . . . 0.0 108.854 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.424 ' O ' HG23 ' C' ' 70' ' ' VAL . 4.8 mt -61.01 -47.15 87.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.219 -0.926 . . . . 0.0 108.654 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' C' ' 71' ' ' ALA . 20.9 m -62.13 -47.33 85.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.185 -0.947 . . . . 0.0 109.027 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -63.49 -26.63 68.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 108.647 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.588 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.16 -46.64 11.7 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.424 HG23 ' O ' ' C' ' 66' ' ' LEU . 78.2 t -66.04 -22.46 30.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' C' ' 67' ' ' THR . . . -66.26 -21.63 66.29 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' C' ' 74' ' ' ASP . 13.3 m80 -144.18 -50.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.8 p 44.99 13.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.659 0.742 . . . . 0.0 109.407 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' C' ' 72' ' ' HIS . 14.6 t70 -128.57 9.52 6.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -173.71 27.14 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.099 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.709 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.3 ptt? -78.37 -24.85 0.45 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.519 -0.738 . . . . 0.0 111.605 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' C' ' 76' ' ' MET . 44.0 Cg_exo -55.64 -20.57 28.08 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.748 1.632 . . . . 0.0 112.504 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.514 HD22 ' C ' ' C' ' 78' ' ' ASN . 0.1 OUTLIER -94.05 -28.82 15.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 109.867 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 -47.97 21.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.116 -0.99 . . . . 0.0 109.259 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . 0.588 ' N ' HD12 ' C' ' 80' ' ' LEU . 6.9 mp -79.25 6.9 8.72 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -59.28 -15.82 18.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 109.668 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.86 -48.61 11.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.112 -0.993 . . . . 0.0 109.775 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.436 HD23 ' N ' ' C' ' 83' ' ' LEU . 4.6 mt -47.2 -48.34 23.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 108.748 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 88.1 p -50.2 -24.76 3.03 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.458 -0.777 . . . . 0.0 109.079 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' C' ' 82' ' ' ALA . 14.9 t70 -74.44 -25.54 59.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.191 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.47 HD21 ' CBD' ' C' ' 142' ' ' HEC . 6.9 tp -81.75 -34.4 30.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.311 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -90.38 -21.75 21.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -71.24 -68.51 0.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.779 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -88.41 -77.16 0.37 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.89 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' C' ' 86' ' ' LEU . 19.2 mttm -59.28 171.14 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.889 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' C' ' 93' ' ' VAL . 4.0 tp 56.91 56.84 5.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.396 -0.815 . . . . 0.0 109.726 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -66.08 9.81 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 109.279 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.534 ' H ' ' C ' ' C' ' 91' ' ' LEU . 12.2 p -46.38 165.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.605 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' C' ' 96' ' ' VAL . 5.3 m-20 -84.27 117.02 67.66 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.915 . . . . 0.0 109.258 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.412 ' C ' ' N ' ' C' ' 97' ' ' ASN . 85.4 Cg_exo -44.41 -10.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.318 2.012 . . . . 0.0 112.318 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.681 ' CG2' ' OD2' ' B' ' 99' ' ' ASP . 98.8 t -53.91 -10.95 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.111 -0.993 . . . . 0.0 109.543 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.412 ' N ' ' C ' ' C' ' 95' ' ' PRO . 2.7 m-80 -79.17 -24.97 42.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -53.14 -43.71 67.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.918 . . . . 0.0 109.55 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.437 ' NZ ' ' CB ' ' C' ' 99' ' ' LYS . 7.6 mtmp? -69.41 -25.27 64.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.643 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 25.4 mt -81.68 -46.8 13.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 109.661 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.884 HD21 HBB3 ' C' ' 142' ' ' HEC . 6.3 tt -69.54 -20.88 63.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.735 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 32.8 p -78.68 -59.11 2.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 109.791 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -63.16 -26.73 68.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.871 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.567 ' SG ' ' NH1' ' C' ' 31' ' ' ARG . 34.5 m -65.17 -52.25 56.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.766 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -45.03 -24.68 0.25 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.721 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 19.4 mt -75.78 -34.88 60.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.131 -0.98 . . . . 0.0 109.855 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . 0.495 HG11 ' HE ' ' C' ' 31' ' ' ARG . 71.2 t -83.26 -24.82 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 110.045 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -70.8 -63.7 1.05 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.129 -0.982 . . . . 0.0 110.561 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' C' ' 113' ' ' LEU . 2.4 pp -64.02 -18.68 64.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 109.823 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.35 -33.36 63.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.712 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.65 -56.22 25.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -66.58 -68.31 0.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.0 108.385 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.668 ' O ' HD12 ' C' ' 113' ' ' LEU . 3.1 pp -116.56 111.46 41.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . 0.627 ' O ' HD12 ' C' ' 113' ' ' LEU . 89.9 Cg_exo -41.59 -177.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.507 2.138 . . . . 0.0 113.204 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.713 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -45.57 -52.42 10.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.479 -0.763 . . . . 0.0 109.038 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.645 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 19.4 mt-10 125.0 -1.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 61.28 31.33 19.4 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.262 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.775 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -103.88 120.54 50.95 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.53 23.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.049 1.833 . . . . 0.0 112.649 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.775 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -152.47 -32.5 0.14 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.864 -1.147 . . . . 0.0 110.568 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.713 HG21 ' O ' ' C' ' 115' ' ' ALA . 14.4 p -47.93 -48.23 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 110.1 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.643 ' N ' HG13 ' C' ' 121' ' ' VAL . 0.3 OUTLIER -63.74 -38.89 92.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.439 -0.788 . . . . 0.0 109.416 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.4 -19.75 33.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.885 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.608 ' N ' ' O ' ' C' ' 120' ' ' ALA . 7.6 p -58.36 -62.1 2.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.899 . . . . 0.0 110.015 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.519 ' N ' ' OG ' ' C' ' 124' ' ' SER . 5.1 mt -68.54 -19.64 64.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.137 -0.977 . . . . 0.0 109.31 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -73.83 -52.21 13.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.701 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.459 ' CD ' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -86.26 -44.41 12.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.063 -1.023 . . . . 0.0 109.936 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.483 ' CD2' HG21 ' C' ' 10' ' ' VAL . 39.7 t80 -47.32 -20.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.045 -1.035 . . . . 0.0 108.921 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' C' ' 133' ' ' SER . 12.0 mt -71.75 -18.0 62.16 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.28 -33.67 73.93 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.424 ' O ' HG13 ' C' ' 135' ' ' VAL . 89.3 p -82.7 -29.96 29.52 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 t -85.18 -29.72 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.157 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.488 ' N ' ' O ' ' C' ' 129' ' ' LEU . 17.8 m -82.79 -22.69 34.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.302 -0.873 . . . . 0.0 108.96 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . 0.463 ' O ' ' N ' ' C' ' 138' ' ' SER . 41.9 m -80.67 -39.99 26.26 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 0.0 109.225 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.424 HG13 ' O ' ' C' ' 131' ' ' SER . 26.8 m -71.08 -26.45 27.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.266 -0.897 . . . . 0.0 108.846 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -31.95 73.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.413 -0.804 . . . . 0.0 108.978 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 7.1 m -156.74 53.65 0.52 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.413 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . 0.463 ' N ' ' O ' ' C' ' 134' ' ' THR . 9.0 p -58.74 115.02 2.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' C' ' 140' ' ' TYR . 14.5 pttm -73.06 -25.78 61.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.474 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.513 ' CG ' ' O ' ' C' ' 139' ' ' LYS . 64.4 m-85 -159.76 154.16 23.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 109.419 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 141' ' ' ARG . 22.3 mtm180 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.52 ' O ' ' CG ' ' D' ' 2' ' ' HIS . 6.7 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.313 0.578 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' D' ' 1' ' ' VAL . 44.0 m80 -159.08 102.52 1.63 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.349 -0.844 . . . . 0.0 109.152 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.931 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.1 OUTLIER -142.72 164.54 29.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.368 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.89 159.48 68.57 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.265 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.82 -18.65 65.64 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.72 2.28 . . . . 0.0 111.946 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -84.58 -34.14 23.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -83.53 -61.75 1.76 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.628 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.697 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -46.99 -26.76 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.609 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.1 t -57.04 -23.5 46.98 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.153 -0.967 . . . . 0.0 110.194 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.62 -57.65 3.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.019 -1.051 . . . . 0.0 110.115 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 13.2 p -64.35 -24.59 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 48.8 m -82.11 -36.92 27.04 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.309 0.575 . . . . 0.0 109.704 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.54 -34.65 70.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.7 OUTLIER -50.54 -34.48 25.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.14 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -45.78 -17.89 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.375 -0.828 . . . . 0.0 109.637 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.27 -49.37 7.48 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.454 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 0.1 OUTLIER -72.0 -30.23 65.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.094 -1.239 . . . . 0.0 109.445 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.442 HG22 ' CD2' ' D' ' 114' ' ' LEU . 77.4 t -53.47 114.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.7 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' D' ' 20' ' ' VAL . 36.4 m-80 -79.56 65.99 4.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 108.937 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' D' ' 22' ' ' GLU . 72.5 t -43.69 -26.18 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.451 -0.781 . . . . 0.0 109.79 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' D' ' 19' ' ' ASN . 18.0 t70 -65.45 5.13 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.527 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' D' ' 20' ' ' VAL . 37.5 mt-10 -154.06 -51.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 0.0 109.484 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 88.0 t -49.71 -53.35 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 109.547 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -48.67 -40.56 25.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.55 -37.2 62.22 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.09 -35.7 61.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -1.123 . . . . 0.0 109.555 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.51 -28.71 68.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.904 . . . . 0.0 109.451 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 tp -85.04 -51.97 6.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.78 -28.41 70.02 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -79.4 -28.11 41.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -1.117 . . . . 0.0 109.49 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' D' ' 106' ' ' LEU . 44.3 tp -48.09 -39.91 21.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.475 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . 0.452 ' CD2' ' OG1' ' D' ' 38' ' ' THR . 21.2 mt -81.03 -23.03 38.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.291 -0.88 . . . . 0.0 109.695 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.18 -61.81 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.142 -0.974 . . . . 0.0 109.918 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' C' ' 122' ' ' HIS . 0.0 OUTLIER -78.42 -22.54 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 0.0 110.112 -179.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -134.6 76.99 59.74 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.109 -0.994 . . . . 0.0 109.925 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.18 27.88 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.028 2.486 . . . . 0.0 112.339 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -81.1 -20.04 42.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -0.953 . . . . 0.0 109.853 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.527 ' C ' ' H ' ' D' ' 40' ' ' ARG . 6.0 p -47.81 -29.16 2.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.194 -0.941 . . . . 0.0 109.66 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 51.91 6.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . 0.527 ' H ' ' C ' ' D' ' 38' ' ' THR . 42.5 ttm180 -110.13 -39.92 4.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.345 -0.847 . . . . 0.0 109.221 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 47.73 19.72 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.621 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 1.315 ' CE2' HMD3 ' D' ' 147' ' ' HEC . 77.3 m-85 54.73 55.01 8.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.359 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -46.2 -16.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 109.636 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . 0.514 ' N ' ' O ' ' D' ' 42' ' ' PHE . 20.2 m -57.69 -54.68 44.15 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -70.07 3.74 2.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.219 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.05 -149.34 1.19 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 56.51 73.16 0.46 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.319 -1.106 . . . . 0.0 109.641 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 90.3 mt -137.5 29.69 2.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.858 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 41.5 t -72.46 -38.01 68.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.499 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.3 p -146.11 151.95 45.98 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.295 -0.878 . . . . 0.0 109.173 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -41.12 -35.23 1.82 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.404 2.07 . . . . 0.0 112.308 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.91 -32.28 73.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.11 -23.88 66.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.318 -0.864 . . . . 0.0 109.681 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -65.45 -60.73 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -91.97 25.59 2.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.33 -52.36 2.04 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -69.81 156.87 90.98 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.224 -1.162 . . . . 0.0 109.43 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.97 -44.49 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.645 2.23 . . . . 0.0 112.355 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -45.98 -35.33 4.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 0.0 109.66 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -76.15 -41.58 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.42 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -79.17 -24.93 42.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.36 -0.837 . . . . 0.0 109.474 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.48 -51.26 12.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.53 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 1.08 ' CE1' ' CHA' ' D' ' 147' ' ' HEC . 45.7 t-80 -51.27 -23.94 4.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 109.47 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.93 -45.59 95.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -50.83 -44.63 59.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.374 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -57.81 -51.55 69.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.41 -0.806 . . . . 0.0 109.477 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.884 HG13 ' C2B' ' D' ' 147' ' ' HEC . 53.9 t -57.83 -51.15 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.314 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.77 -45.33 94.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.24 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.81 -45.79 31.48 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.24 92.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -1.103 . . . . 0.0 109.599 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -57.42 -29.07 63.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 11.6 m -77.0 -33.68 57.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 109.496 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -51.45 -34.26 34.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.367 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.16 -60.08 7.19 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.57 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.8 mp -55.11 -27.44 45.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -1.14 . . . . 0.0 109.381 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.19 -2.16 36.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -171.23 63.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . 0.483 ' CD2' HG11 ' D' ' 1' ' ' VAL . 9.4 mt -70.91 -18.06 62.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 109.442 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -48.84 -25.97 2.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.427 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.37 65.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.286 -0.884 . . . . 0.0 109.283 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . 0.439 HD12 ' N ' ' D' ' 82' ' ' LYS . 2.5 pp -55.65 -40.98 72.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . 0.439 ' N ' HD12 ' D' ' 81' ' ' LEU . 39.5 mttp -50.44 -23.77 2.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.055 -1.028 . . . . 0.0 109.438 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.18 -42.89 7.78 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.7 OUTLIER -68.18 -42.89 79.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.022 -1.281 . . . . 0.0 109.635 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' D' ' 84' ' ' THR . 35.4 m-85 -67.39 -0.27 3.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.498 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.52 -54.01 20.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.3 p -61.57 -58.66 7.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.366 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' D' ' 92' ' ' HIS . 49.1 mt -51.27 -49.88 60.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.256 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . 0.536 ' O ' ' N ' ' D' ' 93' ' ' CYS . 7.2 m -57.12 -46.22 82.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 109.233 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.548 ' HA ' ' HZ2' ' D' ' 144' ' ' LYS . 30.9 tt0 -62.28 -46.58 88.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.419 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 3.9 tt -72.45 -27.27 62.21 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.135 -0.978 . . . . 0.0 109.461 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.459 ' N ' ' O ' ' D' ' 88' ' ' LEU . 19.0 m80 -90.52 -20.24 22.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.06 -1.025 . . . . 0.0 109.621 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . 0.536 ' N ' ' O ' ' D' ' 89' ' ' SER . 26.0 t -83.27 -59.27 2.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 110.563 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -86.6 -40.53 15.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.04 -1.037 . . . . 0.0 111.326 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.1 OUTLIER -72.99 -52.0 16.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.965 -1.084 . . . . 0.0 110.602 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.56 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 30.9 mt -95.74 -36.89 11.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.934 -1.104 . . . . 0.0 109.96 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.56 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 38.5 p-80 43.58 30.9 0.38 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.373 -0.829 . . . . 0.0 110.078 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . 0.463 ' H ' HG23 ' D' ' 98' ' ' VAL . 3.4 t -52.38 153.27 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.074 -1.016 . . . . 0.0 109.19 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . 0.723 ' OD2' ' CG2' ' A' ' 96' ' ' VAL . 1.6 m-20 -71.22 143.01 87.76 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 109.589 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -41.26 -43.83 5.48 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.573 2.182 . . . . 0.0 112.417 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -71.98 54.42 0.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.609 ' O ' HMC2 ' D' ' 147' ' ' HEC . 9.4 m120 -150.93 -31.18 0.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 109.961 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -75.48 -41.7 54.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.993 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . 0.426 ' O ' ' ND2' ' D' ' 108' ' ' ASN . 73.9 ttt180 -79.49 -20.1 48.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 110.094 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . 0.44 ' N ' HD22 ' D' ' 105' ' ' LEU . 4.3 mm? -50.58 -60.84 2.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.14 -0.975 . . . . 0.0 109.737 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 1.231 HD21 ' CHC' ' D' ' 147' ' ' HEC . 1.9 pp -81.68 -22.43 37.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.056 -1.028 . . . . 0.0 109.766 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.28 -36.55 37.09 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' D' ' 104' ' ' ARG . 14.2 p30 -85.6 -34.8 21.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -1.149 . . . . 0.0 109.675 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 74.6 t -51.3 -48.0 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 109.462 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.94 -54.1 33.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.368 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 25.1 t -46.29 -38.14 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 109.533 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . 0.422 ' O ' ' ND1' ' D' ' 116' ' ' HIS . 13.3 m -79.1 -56.35 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.56 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 86.8 t -47.93 -24.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.945 . . . . 0.0 109.479 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . 0.442 ' CD2' HG22 ' D' ' 18' ' ' VAL . 14.2 mt -77.19 -43.65 32.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.389 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.16 -19.52 63.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.407 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.422 ' ND1' ' O ' ' D' ' 112' ' ' CYS . 4.4 m80 -78.18 -62.87 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.877 . . . . 0.0 109.771 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -70.75 -17.56 62.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.869 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 63.5 m-85 -144.86 58.12 1.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 0.0 109.74 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -79.7 -17.93 74.23 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -65.03 4.92 0.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -1.083 . . . . 0.0 109.656 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' D' ' 119' ' ' GLY . 46.7 mm-40 -135.04 9.46 3.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.722 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.556 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -77.58 32.62 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.14 -0.975 . . . . 0.0 109.297 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.442 ' H ' ' C ' ' D' ' 121' ' ' GLU . 37.2 p -46.88 148.68 1.77 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.34 -0.85 . . . . 0.0 109.546 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.472 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.2 Cg_exo -45.28 -56.91 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.538 2.159 . . . . 0.0 112.887 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 14.3 Cg_endo -56.9 -36.16 98.86 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.16 1.907 . . . . 0.0 111.969 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.417 HG23 ' OG1' ' D' ' 123' ' ' THR . 63.3 t -76.4 -20.34 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.71 -45.05 25.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 0.0 109.481 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.34 83.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 109.57 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.5 29.29 0.89 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.634 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.02 -33.88 4.92 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 0.93 ' OE1' ' CZ ' ' C' ' 36' ' ' PHE . 19.4 tt0 -83.98 -63.48 1.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -48.12 -21.84 0.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 109.838 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . 0.48 HG22 HD21 ' D' ' 3' ' ' LEU . 70.8 t -71.73 -67.25 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.151 -0.968 . . . . 0.0 109.71 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.414 HG23 ' H ' ' D' ' 134' ' ' VAL . 2.2 t -67.3 -40.14 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.617 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.82 -21.85 0.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.14 -22.02 64.06 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 89.5 t -74.12 -31.0 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -1.155 . . . . 0.0 109.562 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.36 71.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.53 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -81.34 -21.29 39.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.587 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.13 -60.46 2.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.658 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.1 mt -57.99 -17.69 18.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 109.514 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' D' ' 144' ' ' LYS . . . -100.66 -6.9 24.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.863 . . . . 0.0 109.603 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -59.03 -4.75 0.53 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.473 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.548 ' HZ2' ' HA ' ' D' ' 90' ' ' GLU . 21.5 mmtp -92.0 -31.03 15.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.579 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -71.32 14.2 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.001 . . . . 0.0 109.36 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.52 ' HB2' ' N ' ' B' ' 1' ' ' VAL . 28.0 p-80 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.875 HBB3 HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 1.3 HMD3 ' CE2' ' B' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.884 HBB3 HD21 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 1.315 HMD3 ' CE2' ' D' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.515 HD11 ' HA ' ' A' ' 128' ' ' PHE . 4.3 mm? -105.07 -176.64 3.14 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.306 -0.871 . . . . 0.0 109.609 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.545 ' O ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -117.34 170.88 5.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.0 109.236 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' A' ' 3' ' ' SER . 88.7 Cg_exo -41.39 -117.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 123.132 2.554 . . . . 0.0 113.304 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -43.99 -27.63 0.39 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.966 -1.084 . . . . 0.0 110.263 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 10' ' ' VAL . 29.9 m-20 -44.1 -35.07 2.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -0.973 . . . . 0.0 109.192 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -83.26 -34.02 25.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.267 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 m -59.22 -33.33 70.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.264 -0.897 . . . . 0.0 109.148 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -75.02 -32.64 61.66 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 6' ' ' ASP . 54.3 t -76.03 -51.4 20.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HE2' HG13 ' A' ' 70' ' ' VAL . 1.1 mptm? -56.96 -33.98 67.59 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.18 -59.62 5.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.446 -0.784 . . . . 0.0 109.459 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.785 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -53.21 -34.44 57.05 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.425 -0.797 . . . . 0.0 109.141 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -17.62 61.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.22 -44.69 9.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -70.19 -38.15 75.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -1.123 . . . . 0.0 108.901 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 13' ' ' ALA . 96.1 t -61.38 -64.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 53.93 -130.52 43.56 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.23 26.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.457 -1.025 . . . . 0.0 110.438 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.534 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.0 m-70 -130.56 23.85 5.09 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.81 -59.58 2.19 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.612 -0.68 . . . . 0.0 109.698 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -14.21 0.22 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 9.7 mt-10 -88.14 -56.63 3.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -1.141 . . . . 0.0 109.739 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.8 m-30 -57.46 -39.49 76.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.034 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.54 -22.95 53.63 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.51 -57.88 2.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -1.11 . . . . 0.0 109.735 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' OE1' ' NE2' ' A' ' 112' ' ' HIS . 72.4 mt-10 -50.26 -19.9 0.92 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.362 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.58 63.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.367 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.48 HD21 ' CD2' ' A' ' 58' ' ' HIS . 9.1 mt -73.13 -56.42 5.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 29' ' ' LEU . 56.3 mt-10 -43.87 -37.19 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.691 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -48.76 78.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.945 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.1 ttp -83.99 -42.82 15.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.63 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.596 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 26.1 m-85 -64.28 -32.57 74.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 0.0 110.301 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mt -45.68 -43.02 12.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.971 -1.081 . . . . 0.0 109.727 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 36' ' ' PHE . 14.9 m -86.65 -15.76 38.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.328 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.596 ' CD2' ' O ' ' A' ' 33' ' ' PHE . 0.2 OUTLIER 19.14 64.48 0.24 Allowed Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.976 -0.453 . . . . 0.0 111.319 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.52 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 85.4 Cg_endo -93.63 -62.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.623 2.215 . . . . 0.0 112.552 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.741 ' O ' HG22 ' A' ' 41' ' ' THR . 3.5 p -91.43 -18.6 23.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 109.738 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 p -81.72 -23.03 36.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.968 . . . . 0.0 110.149 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -68.27 -34.93 77.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.063 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.741 HG22 ' O ' ' A' ' 38' ' ' THR . 14.1 t -49.82 -36.92 28.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 43' ' ' PHE . 60.7 m-85 -90.87 15.56 11.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 109.192 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 42' ' ' TYR . 20.2 m-85 60.02 142.6 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.467 -0.771 . . . . 0.0 109.536 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 59.7 Cg_endo -73.4 -42.74 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.446 2.097 . . . . 0.0 111.938 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 42.0 p-80 43.27 31.95 0.43 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.616 -0.677 . . . . 0.0 111.078 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.516 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -155.91 28.53 0.37 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.727 -1.233 . . . . 0.0 110.395 178.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 46' ' ' PHE . 7.3 m-20 33.31 81.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.635 -0.666 . . . . 0.0 110.33 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.862 HD23 ' H ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -60.13 -21.27 61.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.442 -0.786 . . . . 0.0 109.335 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 t -47.54 149.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.59 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 2.0 t60 -74.77 151.06 39.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.887 . . . . 0.0 109.426 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.59 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 82.16 4.74 90.12 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.667 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 12.1 p -77.42 -19.77 55.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -1.143 . . . . 0.0 109.477 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 75.77 -16.95 0.55 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.37 -0.831 . . . . 0.0 109.869 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -86.14 -21.43 27.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.121 -0.987 . . . . 0.0 109.954 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG22 ' CE2' ' A' ' 46' ' ' PHE . 18.8 t -84.1 -28.29 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.153 -0.967 . . . . 0.0 109.834 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -77.98 -30.41 50.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.123 -0.986 . . . . 0.0 108.989 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.512 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . . . -66.61 -26.46 72.91 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.48 ' CD2' HD21 ' A' ' 29' ' ' LEU . 7.4 t60 -75.46 -34.78 60.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.131 -1.217 . . . . 0.0 109.636 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.34 -51.08 44.34 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -51.66 -23.46 4.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -1.065 . . . . 0.0 109.968 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.535 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 0.8 OUTLIER -74.51 -42.38 59.02 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.125 -0.984 . . . . 0.0 109.082 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -72.5 -45.24 59.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.467 -0.77 . . . . 0.0 108.986 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.85 -27.59 65.97 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.291 -0.881 . . . . 0.0 109.188 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.39 -34.06 67.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 108.727 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.474 ' HB3' HMB3 ' A' ' 142' ' ' HEC . . . -66.87 -52.15 46.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.318 -0.864 . . . . 0.0 108.933 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' A' ' 128' ' ' PHE . 9.1 mt -59.17 -42.77 91.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.918 . . . . 0.0 108.653 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -69.35 -50.19 48.56 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 108.745 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -58.98 -24.78 63.01 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.95 -45.6 12.99 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' HE2' ' A' ' 11' ' ' LYS . 4.9 t -63.77 -22.99 32.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.407 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -60.38 -22.78 63.7 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.61 ' O ' ' N ' ' A' ' 74' ' ' ASP . 40.2 m80 -147.22 -51.78 0.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.875 . . . . 0.0 109.532 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.4 p 44.49 13.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.758 0.79 . . . . 0.0 109.479 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' A' ' 72' ' ' HIS . 17.8 t70 -133.07 9.78 4.15 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 34.1 t70 -175.43 27.43 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.981 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 13.8 ptt? -78.66 -22.48 0.38 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.431 -0.793 . . . . 0.0 111.909 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.8 Cg_exo -53.48 -20.78 16.69 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.548 1.499 . . . . 0.0 112.33 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.17 -35.41 12.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.678 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.04 -47.55 61.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.306 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.5 mt -77.5 5.75 8.37 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.075 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.1 p -54.73 -24.64 23.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.291 -0.88 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -73.93 -55.21 6.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 109.557 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.464 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 4.6 mt -47.7 -48.13 29.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.408 -0.808 . . . . 0.0 108.929 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -59.21 -22.65 61.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.549 -0.719 . . . . 0.0 109.398 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 89' ' ' HIS . 16.5 t70 -81.89 -46.52 13.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.3 -26.74 65.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 11.4 m80 -81.47 -21.65 38.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.724 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 90' ' ' LYS . . . -119.05 -55.46 2.16 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.294 -0.879 . . . . 0.0 109.746 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 85' ' ' ASP . 13.2 t-80 -71.41 17.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.358 -0.839 . . . . 0.0 109.751 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.599 ' C ' ' H ' ' A' ' 92' ' ' ARG . 9.8 ttmm -166.5 149.02 6.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 109.781 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.7 mt 61.81 -12.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.322 -0.861 . . . . 0.0 109.86 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.038 ' HD2' ' HG2' ' D' ' 40' ' ' ARG . 45.6 mmt-85 45.14 16.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 109.714 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 91' ' ' LEU . 12.1 p -57.68 131.02 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 1.08 ' OD1' ' NH1' ' D' ' 40' ' ' ARG . 0.8 OUTLIER -75.3 147.03 82.3 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.29 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 97' ' ' ASN . 58.1 Cg_endo -72.57 -23.9 19.38 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.543 2.162 . . . . 0.0 112.126 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.8 t -49.06 -10.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.77 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 95' ' ' PRO . 12.0 m-20 -79.05 -24.88 43.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.534 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -54.28 -30.04 49.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.425 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 92.4 mttt -54.33 -26.62 30.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.489 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.674 HD12 ' N ' ' A' ' 100' ' ' LEU . 8.1 mp -84.06 -57.37 3.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.529 HD22 ' CHC' ' A' ' 142' ' ' HEC . 7.3 tp -50.89 -27.35 7.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -66.09 -58.52 5.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.616 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -63.57 -26.45 68.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -0.882 . . . . 0.0 109.67 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 73.6 m -58.2 -55.97 28.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 109.596 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mt -47.82 -37.98 14.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 106' ' ' LEU . 7.7 mp -71.13 -41.89 69.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 109.535 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.05 -24.95 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 109.348 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.6 m -80.76 -63.28 1.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.447 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 113' ' ' LEU . 33.8 mt -46.98 -28.29 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.25 90.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 110.017 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.39 -31.68 64.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 110.097 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' A' ' 27' ' ' GLU . 28.1 m170 -93.19 -80.5 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.073 -1.017 . . . . 0.0 109.721 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -107.94 102.74 47.07 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -43.8 173.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.546 2.164 . . . . 0.0 113.563 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -87.32 -35.44 18.42 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.782 0.801 . . . . 0.0 109.422 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 13.1 mt-10 81.29 1.35 1.63 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 1.209 ' CD1' ' NH2' ' B' ' 30' ' ' ARG . 11.2 m-85 58.49 40.91 23.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.806 -0.559 . . . . 0.0 111.282 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.752 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -88.12 118.7 69.89 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 120.756 -1.215 . . . . 0.0 108.001 178.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.596 ' HA ' HG21 ' B' ' 33' ' ' VAL . 54.1 Cg_exo -49.05 18.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.319 2.012 . . . . 0.0 112.644 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.752 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -140.08 -39.21 0.45 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.111 -0.993 . . . . 0.0 110.053 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 122' ' ' HIS . 4.2 p -51.68 -48.35 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.102 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.576 ' N ' ' CG1' ' A' ' 121' ' ' VAL . 2.8 m-70 -62.75 -54.37 40.21 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.412 -0.805 . . . . 0.0 109.334 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.92 -19.61 60.87 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.253 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 1.1 p -60.77 -61.6 2.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 110.271 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.539 ' N ' ' OG ' ' A' ' 124' ' ' SER . 6.4 mt -80.64 -21.05 41.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.113 -0.992 . . . . 0.0 110.073 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -78.51 -40.69 34.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 110.109 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.29 -41.29 11.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.949 -1.094 . . . . 0.0 110.13 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.515 ' HA ' HD11 ' A' ' 2' ' ' LEU . 32.3 t80 -50.56 -20.51 1.19 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.8 -1.188 . . . . 0.0 108.839 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' A' ' 133' ' ' SER . 11.9 mt -72.59 -17.74 61.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.13 76.83 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.2 p -79.39 -36.19 39.57 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.339 -0.851 . . . . 0.0 108.82 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.09 -27.23 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.183 -0.948 . . . . 0.0 108.67 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 129' ' ' LEU . 97.2 p -78.17 -45.99 21.7 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.474 -0.766 . . . . 0.0 109.204 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 95.2 m -67.81 -23.01 65.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.223 -0.923 . . . . 0.0 108.654 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.85 -29.9 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.51 -34.6 67.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.09 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 138' ' ' SER . 81.0 p -92.21 -29.73 16.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 137' ' ' THR . 3.5 t 61.96 132.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.521 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -170.53 109.43 0.35 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.494 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 49.55 74.94 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.899 . . . . 0.0 109.397 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.7 ptp85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.472 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.305 0.574 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' B' ' 2' ' ' HIS . 0.3 OUTLIER -171.75 93.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.842 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -140.81 145.25 36.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.342 -0.849 . . . . 0.0 109.034 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 7.8 p -69.65 148.75 96.84 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.543 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -42.65 -24.85 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.598 2.199 . . . . 0.0 112.236 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -80.82 -53.03 6.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.92 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -60.28 -36.08 77.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.182 -0.948 . . . . 0.0 109.98 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.508 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -84.08 -31.57 25.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.191 -0.943 . . . . 0.0 109.922 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.07 -23.56 8.02 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.148 -0.97 . . . . 0.0 110.458 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.4 -58.04 3.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.942 -1.099 . . . . 0.0 110.272 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.46 HG23 ' CD2' ' B' ' 130' ' ' TYR . 7.6 p -65.53 -24.53 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.9 m -78.38 -40.35 36.49 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.338 0.589 . . . . 0.0 109.711 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.36 -26.14 68.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.339 -0.851 . . . . 0.0 109.488 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.722 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.9 OUTLIER -62.53 -26.81 68.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.38 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.77 -17.7 64.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.915 . . . . 0.0 109.451 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.42 -62.9 3.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.62 ' HD3' HD23 ' B' ' 14' ' ' LEU . 0.0 OUTLIER -78.71 7.1 7.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.099 -1.236 . . . . 0.0 110.815 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.722 HG23 ' O ' ' B' ' 14' ' ' LEU . 2.3 t -75.65 121.32 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.826 -1.171 . . . . 0.0 109.186 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.43 85.1 6.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.402 -0.811 . . . . 0.0 109.224 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 36.0 t -55.96 -20.36 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 109.573 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 1.0 OUTLIER -57.36 -55.78 30.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 43.1 mt-10 -98.89 -44.29 6.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.496 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.58 -23.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.882 . . . . 0.0 109.658 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.18 -43.07 11.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.98 -25.86 61.33 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -79.44 -25.45 41.98 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.198 -1.177 . . . . 0.0 109.662 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.64 -23.22 39.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 109.619 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 tp -85.02 -57.26 3.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.153 -0.967 . . . . 0.0 109.503 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.03 -19.82 32.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 1.209 ' NH2' ' CD1' ' A' ' 117' ' ' PHE . 47.0 mtt180 -79.37 -27.34 41.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -1.188 . . . . 0.0 109.377 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 39.7 tp -65.58 -24.77 67.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.293 -0.879 . . . . 0.0 109.585 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 41.2 mt -78.01 -53.8 7.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.085 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.742 HG13 ' H ' ' B' ' 34' ' ' VAL . 7.9 p -71.07 -60.73 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 110.039 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.742 ' H ' HG13 ' B' ' 33' ' ' VAL . 95.3 t -46.28 -30.5 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.958 -1.089 . . . . 0.0 109.549 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.9 91.2 1.58 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.391 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.71 30.48 0.52 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.733 2.289 . . . . 0.0 112.427 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -57.17 -28.66 62.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.488 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.63 HG21 HBC1 ' B' ' 147' ' ' HEC . 30.5 p -56.19 -77.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.892 . . . . 0.0 109.419 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . 0.534 ' N ' ' OG1' ' B' ' 38' ' ' THR . 14.8 tt0 50.62 46.12 26.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.554 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 1.034 ' NH1' ' OD1' ' C' ' 94' ' ' ASP . 68.9 mtm180 -148.01 -49.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.151 -0.968 . . . . 0.0 109.55 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' B' ' 43' ' ' GLU . 1.3 p90 -96.72 -21.4 17.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 109.759 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -48.81 -11.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.98 . . . . 0.0 109.625 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' B' ' 41' ' ' PHE . 31.3 mt-10 -80.31 -20.3 44.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.171 -0.956 . . . . 0.0 109.475 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.474 ' O ' ' N ' ' B' ' 46' ' ' GLY . 11.2 t -58.25 -51.8 68.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.62 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' B' ' 47' ' ' ASP . 57.0 m-85 -47.92 -16.14 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.533 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 61.35 -77.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' B' ' 45' ' ' PHE . 0.9 OUTLIER -46.77 113.45 0.66 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -1.132 . . . . 0.0 109.605 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' B' ' 49' ' ' SER . 0.8 OUTLIER -161.15 22.12 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.833 . . . . 0.0 109.009 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' B' ' 48' ' ' LEU . 17.9 m -45.13 -39.66 6.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 109.563 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -145.67 151.94 47.62 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.323 -0.861 . . . . 0.0 108.995 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -44.64 -21.84 0.53 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.295 1.996 . . . . 0.0 112.154 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.78 -29.21 27.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.657 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.547 ' O ' ' ND2' ' B' ' 57' ' ' ASN . . . -55.57 -26.94 46.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 109.535 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.51 -62.01 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.574 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 14.9 mmt -53.7 -16.97 1.89 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.541 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.25 -4.19 61.24 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' B' ' 53' ' ' ALA . 3.8 m120 -72.22 142.69 85.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.192 -1.181 . . . . 0.0 109.376 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.5 -52.1 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.509 2.14 . . . . 0.0 112.21 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -51.56 -48.11 63.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -0.86 . . . . 0.0 109.586 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.46 -27.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.529 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -79.16 -53.57 6.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.54 -59.04 3.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.909 ' HE1' ' CHA' ' B' ' 147' ' ' HEC . 1.2 t60 -49.06 -23.92 1.38 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.69 -37.62 92.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -71.7 -35.32 70.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -1.148 . . . . 0.0 109.544 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . 0.548 ' HD3' HAA1 ' B' ' 147' ' ' HEC . 41.4 mttm -49.42 -44.87 45.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.179 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 0.992 HG22 ' C1B' ' B' ' 147' ' ' HEC . 54.4 t -73.57 -61.84 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.183 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.716 ' O ' HD23 ' B' ' 68' ' ' LEU . 1.8 tt -50.43 -23.24 2.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.092 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.35 -56.99 11.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.88 97.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -1.132 . . . . 0.0 109.439 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.55 ' CZ ' HG11 ' B' ' 134' ' ' VAL . 0.1 OUTLIER -48.82 -21.78 0.7 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 0.0 109.289 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p -87.89 -34.93 18.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.621 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -46.44 -34.36 4.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.59 -58.93 6.01 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.528 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -62.87 -23.3 67.25 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.344 -1.092 . . . . 0.0 109.277 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.49 2.4 54.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.408 ' C ' ' H ' ' B' ' 79' ' ' ASP . 55.9 t60 -170.99 65.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.78 13.22 0.67 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' B' ' 77' ' ' HIS . 34.7 t70 -76.36 -27.65 56.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.563 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -170.98 106.4 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 109.512 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 mt -80.33 -44.01 20.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.436 ' CD ' ' H ' ' B' ' 82' ' ' LYS . 1.5 mptp? -49.41 -25.87 2.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.383 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.17 -53.71 3.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 3.9 p -65.9 -37.64 86.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.199 -1.177 . . . . 0.0 109.616 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -90.84 23.95 2.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.619 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.26 -41.55 40.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.392 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 21.1 p -72.69 -51.01 21.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.408 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 33.8 mt -56.79 -48.85 76.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.33 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 28.1 t -61.57 -44.06 97.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.34 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -64.41 -23.75 67.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.899 . . . . 0.0 109.377 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 7.4 tp -85.1 -68.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.448 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -49.59 -30.01 8.04 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.272 -0.893 . . . . 0.0 110.083 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . 0.571 ' SG ' ' CD1' ' B' ' 145' ' ' TYR . 38.0 t -83.98 -55.66 4.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 111.548 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.541 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 0.6 OUTLIER -86.26 -29.13 23.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.915 -1.116 . . . . 0.0 112.205 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.45 ' C ' HD22 ' B' ' 96' ' ' LEU . 5.6 mptp? -90.32 -52.06 5.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.639 -1.288 . . . . 0.0 110.981 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.537 ' N ' HD22 ' B' ' 96' ' ' LEU . 3.7 mm? -97.59 -22.79 16.31 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.753 -1.217 . . . . 0.0 110.208 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.604 ' O ' HG22 ' C' ' 38' ' ' THR . 81.9 m-70 51.03 37.62 18.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.004 -1.06 . . . . 0.0 109.424 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.04 138.75 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 0.0 109.362 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.94 151.28 3.42 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.73 30.57 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.575 2.183 . . . . 0.0 112.022 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -143.47 75.86 1.49 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.304 -0.873 . . . . 0.0 109.384 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -168.2 -40.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.454 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -52.52 -45.7 66.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.429 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 55.4 ttp180 -66.34 -42.32 88.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.46 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.606 HD12 ' N ' ' B' ' 105' ' ' LEU . 10.0 mp -54.37 -57.48 11.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 1.088 HD22 ' HAB' ' B' ' 147' ' ' HEC . 7.5 tt -52.15 -49.02 64.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.97 -22.41 54.96 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 27.4 m120 -80.76 -15.35 56.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.042 -1.269 . . . . 0.0 109.737 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 64.1 t -85.23 -44.78 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 109.609 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.523 ' O ' HD23 ' B' ' 110' ' ' LEU . 1.7 tt -47.87 -54.33 12.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 109.599 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.433 ' H ' HG23 ' B' ' 111' ' ' VAL . 3.5 t -45.57 -32.64 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.884 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.525 ' O ' ' ND1' ' B' ' 116' ' ' HIS . 45.6 m -77.3 -36.87 53.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 109.754 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 18.2 t -57.97 -46.36 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.739 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' B' ' 118' ' ' PHE . 19.0 mt -66.8 -30.54 70.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.697 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.458 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -61.08 -29.44 69.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 0.0 109.614 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' B' ' 112' ' ' CYS . 68.7 m80 -84.82 -62.89 1.44 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.708 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.518 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 6.6 t-160 -65.44 -18.45 65.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 109.535 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 40.5 m-85 -144.37 55.48 1.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 109.491 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.531 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -68.74 -21.32 74.85 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.06 -35.21 59.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.146 . . . . 0.0 109.421 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.482 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.0 mm-40 -75.31 3.05 9.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.439 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.552 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -72.33 35.43 0.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.555 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.557 ' OG1' HG23 ' B' ' 126' ' ' VAL . 4.8 p -47.12 147.4 2.47 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.369 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.2 Cg_exo -48.48 -51.28 10.53 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.31 2.007 . . . . 0.0 113.231 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 41.8 Cg_endo -67.99 -0.92 6.12 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.055 1.836 . . . . 0.0 112.754 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.557 HG23 ' OG1' ' B' ' 123' ' ' THR . 40.3 t -99.08 -12.57 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 109.598 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.36 -60.19 2.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 109.496 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.51 ' O ' ' NZ ' ' B' ' 132' ' ' LYS . . . -67.07 -25.71 66.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.95 . . . . 0.0 109.264 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.45 18.19 2.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.349 -0.844 . . . . 0.0 109.651 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.46 ' CD2' HG23 ' B' ' 11' ' ' VAL . 6.1 t80 -107.89 -61.3 1.59 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.652 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.415 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 53.6 tt0 -46.31 -48.28 18.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 109.742 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.821 ' HG2' ' OXT' ' D' ' 146' ' ' HIS . 33.1 mtmm -52.69 -21.89 4.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.781 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.34 -67.1 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.0 109.699 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.55 HG11 ' CZ ' ' B' ' 71' ' ' PHE . 30.9 m -73.33 -15.88 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 109.909 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.906 ' HB1' ' CG ' ' D' ' 146' ' ' HIS . . . -47.47 -28.86 2.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.469 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.29 -22.8 58.22 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 134' ' ' VAL . 82.3 t -82.1 -27.04 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.269 -1.136 . . . . 0.0 109.538 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.98 82.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.596 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 1.07 ' ND2' ' ND2' ' D' ' 139' ' ' ASN . 23.9 m120 -79.63 -25.93 41.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.917 . . . . 0.0 109.754 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.47 -49.15 78.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.0 109.726 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 21.8 mt -82.64 16.41 2.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 109.668 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.77 -0.77 1.88 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.22 -0.925 . . . . 0.0 109.697 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -80.36 -28.31 38.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -70.91 -16.6 62.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.439 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.571 ' CD1' ' SG ' ' B' ' 93' ' ' CYS . 13.9 m-85 -64.67 -28.83 69.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.361 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.867 ' CG ' ' HB1' ' D' ' 135' ' ' ALA . 20.9 m-70 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.447 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' C' ' 128' ' ' PHE . 4.3 mm? -105.13 -176.71 3.16 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.278 -0.889 . . . . 0.0 109.536 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.545 ' O ' ' O ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER -117.22 170.84 5.53 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.539 -0.726 . . . . 0.0 109.191 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.545 ' O ' ' O ' ' C' ' 3' ' ' SER . 89.1 Cg_exo -41.37 -117.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.126 2.551 . . . . 0.0 113.275 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -43.92 -27.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 110.272 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.505 ' O ' HG23 ' C' ' 10' ' ' VAL . 29.7 m-20 -44.16 -34.95 2.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.1 -1.0 . . . . 0.0 109.25 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -83.33 -33.95 25.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.319 -0.863 . . . . 0.0 109.307 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 55.1 m -59.29 -33.41 71.04 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.227 -0.921 . . . . 0.0 109.028 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . 0.401 ' CG ' ' HB1' ' C' ' 120' ' ' ALA . 6.5 m120 -74.95 -32.65 61.78 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.505 HG23 ' O ' ' C' ' 6' ' ' ASP . 53.6 t -76.05 -51.38 20.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . 0.507 ' HE2' HG13 ' C' ' 70' ' ' VAL . 1.1 mptm? -57.0 -34.01 67.72 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.2 -59.67 5.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.521 -0.737 . . . . 0.0 109.314 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.768 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -53.2 -34.43 56.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.383 -0.823 . . . . 0.0 109.109 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -17.64 61.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.308 -0.87 . . . . 0.0 109.263 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.17 -44.75 9.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -70.06 -38.29 75.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.168 -1.195 . . . . 0.0 108.89 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.768 HG23 ' O ' ' C' ' 13' ' ' ALA . 95.6 t -61.35 -64.93 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.552 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 53.94 -130.56 43.67 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.15 26.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.42 -1.047 . . . . 0.0 110.453 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.552 ' H ' ' C ' ' C' ' 18' ' ' GLY . 93.2 m-70 -130.59 24.07 5.09 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.95 -59.52 2.2 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.627 -0.67 . . . . 0.0 109.735 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -14.31 0.23 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' C' ' 21' ' ' ALA . 9.7 mt-10 -88.05 -56.6 3.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -1.139 . . . . 0.0 109.74 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.8 m-30 -57.4 -39.54 76.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.066 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.53 -23.05 53.83 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.4 -57.99 2.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.286 -1.126 . . . . 0.0 109.774 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . 0.526 ' OE1' ' NE2' ' C' ' 112' ' ' HIS . 72.7 mt-10 -50.18 -19.88 0.88 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.29 -21.64 63.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.494 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.49 HD21 ' CD2' ' C' ' 58' ' ' HIS . 9.1 mt -73.12 -56.49 5.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.571 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -43.79 -37.15 2.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.827 . . . . 0.0 109.773 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -48.71 78.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 61.0 ttp -83.97 -42.87 15.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . 0.594 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 26.2 m-85 -64.17 -32.71 74.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.908 . . . . 0.0 110.239 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' C' ' 33' ' ' PHE . 5.7 mt -45.66 -43.07 12.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.966 -1.083 . . . . 0.0 109.658 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.57 ' O ' ' C ' ' C' ' 36' ' ' PHE . 14.9 m -86.66 -15.67 38.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.261 -0.9 . . . . 0.0 109.367 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.594 ' CD2' ' O ' ' C' ' 33' ' ' PHE . 0.2 OUTLIER 19.17 64.46 0.24 Allowed Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 121.917 -0.489 . . . . 0.0 111.354 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.436 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 85.4 Cg_endo -93.68 -62.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.571 2.181 . . . . 0.0 112.551 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.719 ' O ' HG22 ' C' ' 41' ' ' THR . 3.4 p -91.45 -18.48 24.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 0.0 109.754 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -81.72 -23.08 36.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.15 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -68.25 -34.96 77.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.087 -1.008 . . . . 0.0 109.67 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.719 HG22 ' O ' ' C' ' 38' ' ' THR . 13.9 t -49.97 -36.85 29.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' C' ' 43' ' ' PHE . 60.6 m-85 -90.79 15.5 11.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.158 -0.964 . . . . 0.0 109.236 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' C' ' 42' ' ' TYR . 20.3 m-85 59.94 142.55 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.444 -0.785 . . . . 0.0 109.574 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.562 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 59.8 Cg_endo -73.33 -42.71 0.85 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.487 2.125 . . . . 0.0 111.976 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.562 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 42.1 p-80 43.23 31.86 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.625 -0.672 . . . . 0.0 111.106 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' C' ' 55' ' ' VAL . 0.7 OUTLIER -155.86 28.54 0.37 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.76 -1.212 . . . . 0.0 110.406 178.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.503 ' C ' ' O ' ' C' ' 46' ' ' PHE . 7.3 m-20 33.41 81.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.663 -0.648 . . . . 0.0 110.295 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.862 HD23 ' H ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -60.06 -21.35 61.33 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.462 -0.774 . . . . 0.0 109.356 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 20.9 t -47.54 149.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.614 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 2.0 t60 -74.81 151.08 39.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 0.0 109.403 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . 0.584 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 82.26 4.64 90.13 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.667 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 12.0 p -77.42 -19.81 55.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -1.11 . . . . 0.0 109.482 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 75.8 -16.99 0.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.367 -0.833 . . . . 0.0 109.888 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -86.1 -21.56 27.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.903 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.511 HG22 ' CE2' ' C' ' 46' ' ' PHE . 18.6 t -83.93 -28.42 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.062 -1.024 . . . . 0.0 109.901 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -77.96 -30.37 50.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.013 -1.055 . . . . 0.0 108.961 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . 0.512 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -66.68 -26.44 72.97 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.49 ' CD2' HD21 ' C' ' 29' ' ' LEU . 7.4 t60 -75.41 -34.77 61.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.122 -1.222 . . . . 0.0 109.671 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.1 44.32 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -51.66 -23.42 4.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.369 -1.077 . . . . 0.0 109.887 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.538 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 0.8 OUTLIER -74.54 -42.4 58.9 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.157 -0.965 . . . . 0.0 109.103 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -72.54 -45.23 59.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 108.98 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.85 -27.66 66.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.279 -0.888 . . . . 0.0 109.156 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -72.3 -34.01 67.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 108.866 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.449 ' HB3' HMB3 ' C' ' 142' ' ' HEC . . . -66.86 -52.1 47.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.01 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.423 HD23 ' CE1' ' C' ' 128' ' ' PHE . 9.2 mt -59.15 -42.8 91.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.912 . . . . 0.0 108.634 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -69.42 -50.13 48.65 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.282 -0.886 . . . . 0.0 108.695 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -59.01 -24.86 63.17 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.86 -45.64 13.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.507 HG13 ' HE2' ' C' ' 11' ' ' LYS . 4.9 t -63.65 -23.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' C' ' 72' ' ' HIS . . . -60.21 -22.86 63.5 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' C' ' 74' ' ' ASP . 40.3 m80 -147.24 -51.87 0.2 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.357 -0.839 . . . . 0.0 109.56 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.3 p 44.42 13.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.856 0.836 . . . . 0.0 109.539 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' C' ' 72' ' ' HIS . 17.8 t70 -133.12 9.76 4.13 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.434 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 34.1 t70 -175.4 27.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.897 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.689 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 13.8 ptt? -78.64 -22.62 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.478 -0.764 . . . . 0.0 111.865 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.6 Cg_exo -53.46 -20.69 16.36 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.586 1.524 . . . . 0.0 112.276 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.21 -35.42 12.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 109.738 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.03 -47.58 61.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.122 -0.986 . . . . 0.0 109.32 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -77.45 5.69 8.38 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.112 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 64.4 p -54.74 -24.67 23.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.866 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -73.95 -55.15 6.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.579 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.47 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 4.7 mt -47.75 -48.07 30.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.385 -0.822 . . . . 0.0 108.821 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -59.32 -22.63 61.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.49 -0.756 . . . . 0.0 109.315 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' C' ' 89' ' ' HIS . 16.5 t70 -81.9 -46.53 13.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.24 -26.82 65.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 11.4 m80 -81.34 -21.74 38.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.166 -0.959 . . . . 0.0 109.783 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' C' ' 90' ' ' LYS . . . -118.98 -55.51 2.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.313 -0.867 . . . . 0.0 109.773 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' C' ' 85' ' ' ASP . 13.2 t-80 -71.26 17.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.813 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.618 ' C ' ' H ' ' C' ' 92' ' ' ARG . 9.8 ttmm -166.53 149.02 6.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.102 -0.998 . . . . 0.0 109.728 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.7 mt 61.79 -12.47 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.893 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . 1.005 ' HD2' ' HG2' ' B' ' 40' ' ' ARG . 45.7 mmt-85 45.05 16.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.73 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' C' ' 91' ' ' LEU . 12.0 p -57.73 130.97 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 1.034 ' OD1' ' NH1' ' B' ' 40' ' ' ARG . 0.8 OUTLIER -75.31 146.99 82.24 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.32 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' C' ' 97' ' ' ASN . 58.0 Cg_endo -72.63 -23.82 19.27 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.436 2.091 . . . . 0.0 112.153 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.458 ' H ' HG23 ' C' ' 96' ' ' VAL . 5.6 t -48.95 -10.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.796 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' C' ' 95' ' ' PRO . 12.1 m-20 -79.21 -24.73 42.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 109.518 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' C' ' 99' ' ' LYS . 0.6 OUTLIER -54.27 -30.1 49.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 109.497 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.419 ' N ' ' CD1' ' C' ' 98' ' ' PHE . 92.3 mttt -54.25 -26.61 29.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.461 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.67 HD12 ' N ' ' C' ' 100' ' ' LEU . 8.1 mp -84.18 -57.31 3.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.537 HD22 ' CHC' ' C' ' 142' ' ' HEC . 7.2 tp -50.93 -27.3 7.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.263 -0.898 . . . . 0.0 109.534 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 6.1 m -66.23 -58.55 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 0.0 109.551 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -63.39 -26.61 68.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.68 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 73.4 m -58.15 -55.94 28.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.627 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mt -47.86 -37.98 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 109.541 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.571 ' N ' HD12 ' C' ' 106' ' ' LEU . 7.7 mp -71.09 -41.99 69.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.99 -24.93 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.376 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 22.5 m -80.85 -63.2 1.46 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.442 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' C' ' 113' ' ' LEU . 34.4 mt -46.97 -28.35 1.6 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.18 90.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 110.044 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.69 63.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.386 -0.821 . . . . 0.0 110.027 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . 0.526 ' NE2' ' OE1' ' C' ' 27' ' ' GLU . 28.1 m170 -93.16 -80.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.107 -0.995 . . . . 0.0 109.697 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.853 HD23 ' O ' ' C' ' 113' ' ' LEU . 0.1 OUTLIER -107.83 102.7 46.58 Favored Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -43.8 173.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.626 2.217 . . . . 0.0 113.504 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.478 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -87.19 -35.43 18.58 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.684 0.754 . . . . 0.0 109.482 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 13.2 mt-10 81.34 1.28 1.62 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 1.194 ' CD1' ' NH2' ' D' ' 30' ' ' ARG . 11.1 m-85 58.55 40.8 23.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.895 -0.503 . . . . 0.0 111.255 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.754 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -88.05 118.69 69.91 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.703 -1.248 . . . . 0.0 108.068 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . 0.603 ' HA ' HG21 ' D' ' 33' ' ' VAL . 54.0 Cg_exo -49.05 18.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.293 1.995 . . . . 0.0 112.662 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.754 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -139.99 -39.23 0.45 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.077 -1.015 . . . . 0.0 110.057 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.575 HG13 ' N ' ' C' ' 122' ' ' HIS . 4.2 p -51.8 -48.33 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.103 -0.998 . . . . 0.0 109.952 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.575 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.9 m-70 -62.91 -54.32 40.39 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.399 -0.813 . . . . 0.0 109.259 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.81 -19.69 60.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.307 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 1.1 p -60.79 -61.5 2.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.345 -0.847 . . . . 0.0 110.303 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.535 ' N ' ' OG ' ' C' ' 124' ' ' SER . 6.4 mt -80.72 -21.04 41.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.089 -1.007 . . . . 0.0 110.05 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -78.51 -40.67 34.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 110.092 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.29 -41.3 11.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.987 -1.07 . . . . 0.0 110.097 -179.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.527 ' HA ' HD11 ' C' ' 2' ' ' LEU . 31.9 t80 -50.51 -20.59 1.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.8 -1.187 . . . . 0.0 108.841 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' C' ' 133' ' ' SER . 11.9 mt -72.53 -17.79 61.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.46 -38.1 76.85 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 60.8 p -79.46 -36.24 39.11 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.318 -0.864 . . . . 0.0 108.749 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 43.3 t -77.02 -27.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.218 -0.927 . . . . 0.0 108.638 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.587 ' N ' ' O ' ' C' ' 129' ' ' LEU . 96.8 p -78.32 -45.96 21.32 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.384 -0.822 . . . . 0.0 109.159 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 94.8 m -67.78 -22.99 65.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.258 -0.902 . . . . 0.0 108.705 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.77 -30.04 7.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -34.6 67.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.393 -0.817 . . . . 0.0 109.056 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . 0.44 ' O ' ' O ' ' C' ' 138' ' ' SER . 81.1 p -92.32 -29.56 16.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.573 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . 0.44 ' O ' ' O ' ' C' ' 137' ' ' THR . 3.5 t 61.91 132.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -170.54 109.41 0.35 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 49.55 74.93 0.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.428 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 2.7 ptp85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.463 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.324 0.583 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.72 93.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.832 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -140.84 145.18 35.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.164 -0.96 . . . . 0.0 109.059 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 7.9 p -69.6 148.83 96.95 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.531 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -42.8 -24.78 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.503 2.136 . . . . 0.0 112.229 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -80.79 -53.07 6.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.919 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -60.21 -36.07 76.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -0.919 . . . . 0.0 109.989 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.531 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -84.06 -31.52 25.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 110.026 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -53.08 -23.49 7.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -0.959 . . . . 0.0 110.441 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.5 -58.02 3.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.935 -1.103 . . . . 0.0 110.222 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' D' ' 130' ' ' TYR . 7.7 p -65.55 -24.44 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 25.9 m -78.45 -40.32 36.0 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.317 0.58 . . . . 0.0 109.674 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -26.21 68.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.51 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.73 ' O ' HG23 ' D' ' 18' ' ' VAL . 0.9 OUTLIER -62.52 -26.84 68.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.329 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -67.77 -17.7 64.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.509 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.38 -62.87 3.66 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 120.101 -1.047 . . . . 0.0 110.494 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.627 ' HD3' HD23 ' D' ' 14' ' ' LEU . 0.0 OUTLIER -78.79 7.16 7.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.285 . . . . 0.0 110.849 -178.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.73 HG23 ' O ' ' D' ' 14' ' ' LEU . 2.3 t -75.73 121.39 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.742 -1.224 . . . . 0.0 109.138 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -81.42 85.21 6.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.212 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 36.5 t -55.97 -20.39 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.608 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' D' ' 22' ' ' GLU . 1.0 OUTLIER -57.32 -55.81 29.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.366 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' D' ' 21' ' ' ASP . 43.1 mt-10 -98.9 -44.31 6.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.66 -23.89 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.619 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.24 -43.11 10.93 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.87 -25.93 61.44 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -79.36 -25.56 42.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.213 -1.169 . . . . 0.0 109.674 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.61 -23.17 39.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 109.675 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 tp -85.03 -57.29 3.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 109.479 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.93 -19.92 31.71 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . 1.194 ' NH2' ' CD1' ' C' ' 117' ' ' PHE . 47.2 mtt180 -79.29 -27.28 42.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -1.176 . . . . 0.0 109.421 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 39.4 tp -65.68 -24.71 67.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 41.8 mt -78.19 -53.67 7.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.056 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.732 HG13 ' H ' ' D' ' 34' ' ' VAL . 7.9 p -71.16 -60.6 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.125 -0.985 . . . . 0.0 110.05 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.732 ' H ' HG13 ' D' ' 33' ' ' VAL . 94.9 t -46.41 -30.41 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.952 -1.093 . . . . 0.0 109.557 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.96 91.25 1.57 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 109.348 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -84.74 30.47 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.731 2.287 . . . . 0.0 112.409 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 62.3 p-90 -57.16 -28.75 63.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.623 HG21 HBC1 ' D' ' 147' ' ' HEC . 30.5 p -56.07 -77.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.379 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . 0.542 ' N ' ' OG1' ' D' ' 38' ' ' THR . 14.7 tt0 50.6 46.09 26.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 109.577 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . 1.08 ' NH1' ' OD1' ' A' ' 94' ' ' ASP . 69.3 mtm180 -147.97 -49.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' D' ' 43' ' ' GLU . 1.3 p90 -96.76 -21.24 17.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -48.86 -11.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.565 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' D' ' 41' ' ' PHE . 31.3 mt-10 -80.31 -20.3 44.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . 0.471 ' O ' ' N ' ' D' ' 46' ' ' GLY . 11.3 t -58.2 -51.94 67.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.581 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' D' ' 47' ' ' ASP . 56.8 m-85 -47.75 -16.27 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.515 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 61.38 -77.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' D' ' 45' ' ' PHE . 0.9 OUTLIER -46.74 113.49 0.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -1.133 . . . . 0.0 109.607 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' D' ' 49' ' ' SER . 0.8 OUTLIER -161.22 22.18 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 108.971 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' D' ' 48' ' ' LEU . 17.8 m -45.06 -39.77 6.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 109.585 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.7 p -145.53 151.94 48.16 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.331 -0.855 . . . . 0.0 109.056 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -44.61 -21.85 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.241 1.96 . . . . 0.0 112.16 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -83.81 -29.18 27.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 109.594 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.54 ' O ' ' ND2' ' D' ' 57' ' ' ASN . . . -55.52 -26.94 45.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.655 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.51 -62.04 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.577 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 14.9 mmt -53.62 -17.0 1.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.556 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.27 -4.16 61.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' D' ' 53' ' ' ALA . 3.8 m120 -72.27 142.79 85.0 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.321 -1.105 . . . . 0.0 109.313 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.55 -52.11 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.515 2.144 . . . . 0.0 112.152 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -51.66 -47.96 63.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.624 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 95.5 t -47.51 -27.47 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -79.14 -53.52 6.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.68 -59.03 3.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.567 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.912 ' HE1' ' CHA' ' D' ' 147' ' ' HEC . 1.2 t60 -49.0 -24.03 1.36 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.933 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.59 -37.66 92.71 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' D' ' 69' ' ' GLY . 27.8 mttp -71.67 -35.42 70.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -1.197 . . . . 0.0 109.519 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . 0.538 ' HD3' HAA1 ' D' ' 147' ' ' HEC . 41.4 mttm -49.35 -44.82 44.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 109.235 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.992 HG22 ' C1B' ' D' ' 147' ' ' HEC . 54.3 t -73.66 -61.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -0.869 . . . . 0.0 109.212 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.72 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.8 tt -50.44 -23.35 2.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.155 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' D' ' 65' ' ' LYS . . . -66.23 -57.08 11.12 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.81 97.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.203 -1.174 . . . . 0.0 109.479 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . 0.552 ' CZ ' HG11 ' D' ' 134' ' ' VAL . 0.1 OUTLIER -48.89 -21.73 0.71 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.314 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p -88.05 -34.86 17.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.57 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -46.35 -34.49 4.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.893 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.52 -58.91 6.05 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.531 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.5 mp -62.76 -23.48 67.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.175 -1.191 . . . . 0.0 109.26 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.35 2.32 54.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 109.454 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.414 ' C ' ' H ' ' D' ' 79' ' ' ASP . 55.9 t60 -170.95 65.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -74.79 13.3 0.66 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.304 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' D' ' 77' ' ' HIS . 34.7 t70 -76.46 -27.64 56.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -170.93 106.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.22 -44.09 20.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . 0.431 ' CD ' ' H ' ' D' ' 82' ' ' LYS . 1.5 mptp? -49.36 -25.89 2.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.469 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.18 -53.79 3.36 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . . . . . . . . . 3.8 p -65.83 -37.63 86.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -1.144 . . . . 0.0 109.596 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -90.9 24.02 2.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.665 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.29 -41.58 40.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.337 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 21.2 p -72.79 -50.83 21.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 109.491 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.82 -48.94 76.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.352 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 27.7 t -61.48 -44.03 97.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.44 -23.75 67.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 7.4 tp -85.12 -68.78 0.7 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.842 . . . . 0.0 109.421 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -49.52 -30.14 7.94 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 110.047 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . 0.587 ' SG ' ' CD1' ' D' ' 145' ' ' TYR . 38.0 t -83.88 -55.55 4.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.223 -0.923 . . . . 0.0 111.633 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.543 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 0.6 OUTLIER -86.39 -29.07 23.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.957 -1.09 . . . . 0.0 112.161 -177.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . 0.447 ' C ' HD22 ' D' ' 96' ' ' LEU . 5.6 mptp? -90.34 -52.07 5.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.619 -1.301 . . . . 0.0 111.043 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.531 ' N ' HD22 ' D' ' 96' ' ' LEU . 3.7 mm? -97.53 -22.85 16.3 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.787 -1.196 . . . . 0.0 110.241 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.668 ' O ' HG22 ' A' ' 38' ' ' THR . 81.9 m-70 51.07 37.59 18.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.019 -1.05 . . . . 0.0 109.473 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 44.5 t -55.04 138.78 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.345 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.93 151.24 3.43 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.7 30.6 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.568 2.179 . . . . 0.0 112.086 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -143.46 75.88 1.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.933 . . . . 0.0 109.349 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -168.27 -40.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.464 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -52.54 -45.79 66.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.482 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 55.3 ttp180 -66.16 -42.39 89.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . 0.594 HD12 ' N ' ' D' ' 105' ' ' LEU . 10.1 mp -54.45 -57.43 11.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.878 . . . . 0.0 109.442 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 1.018 HD22 ' HAB' ' D' ' 147' ' ' HEC . 7.5 tt -52.13 -49.02 64.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.17 -0.956 . . . . 0.0 109.467 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -59.0 -22.37 55.01 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 27.4 m120 -80.66 -15.56 56.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.107 -1.231 . . . . 0.0 109.786 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 63.5 t -85.08 -44.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 109.65 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . 0.517 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.7 tt -47.98 -54.24 13.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.902 . . . . 0.0 109.612 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . 0.452 HG23 ' H ' ' D' ' 111' ' ' VAL . 3.4 t -45.5 -32.69 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.955 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . 0.52 ' O ' ' ND1' ' D' ' 116' ' ' HIS . 46.3 m -77.3 -36.86 53.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.76 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.94 -46.45 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.767 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 19.0 mt -66.77 -30.42 70.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.794 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.458 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -61.22 -29.42 69.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.97 . . . . 0.0 109.575 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' D' ' 112' ' ' CYS . 68.8 m80 -84.74 -63.0 1.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.071 -1.018 . . . . 0.0 109.685 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . 0.529 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 6.6 t-160 -65.38 -18.4 65.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 109.581 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 40.6 m-85 -144.45 55.44 1.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.529 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -68.62 -21.42 74.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -76.03 -35.19 59.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -1.118 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' D' ' 123' ' ' THR . 59.0 mm-40 -75.33 3.04 9.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -72.24 35.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.334 -0.854 . . . . 0.0 109.545 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.549 ' OG1' HG23 ' D' ' 126' ' ' VAL . 4.8 p -47.15 147.35 2.53 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.955 . . . . 0.0 109.393 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.499 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.2 Cg_exo -48.38 -51.29 10.45 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.366 2.044 . . . . 0.0 113.202 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 41.6 Cg_endo -68.0 -1.0 6.22 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.06 1.84 . . . . 0.0 112.748 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.549 HG23 ' OG1' ' D' ' 123' ' ' THR . 40.0 t -99.09 -12.52 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.174 -0.954 . . . . 0.0 109.607 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.25 -60.23 2.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 109.507 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.518 ' O ' ' NZ ' ' D' ' 132' ' ' LYS . . . -67.05 -25.79 66.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.37 18.06 2.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.356 -0.84 . . . . 0.0 109.621 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.45 ' CD2' HG23 ' D' ' 11' ' ' VAL . 6.2 t80 -107.83 -61.39 1.58 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.341 -0.85 . . . . 0.0 109.617 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 53.6 tt0 -46.4 -48.17 18.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.957 . . . . 0.0 109.724 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . 0.775 ' HG2' ' OXT' ' B' ' 146' ' ' HIS . 33.0 mtmm -52.65 -21.87 4.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.863 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 25.7 t -74.39 -67.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -0.949 . . . . 0.0 109.661 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.552 HG11 ' CZ ' ' D' ' 71' ' ' PHE . 31.4 m -73.5 -15.77 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.883 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.867 ' HB1' ' CG ' ' B' ' 146' ' ' HIS . . . -47.34 -29.0 2.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.946 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.23 -22.82 58.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' D' ' 134' ' ' VAL . 81.0 t -82.18 -26.95 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -1.133 . . . . 0.0 109.547 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.84 -47.96 83.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.93 . . . . 0.0 109.615 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 1.07 ' ND2' ' ND2' ' B' ' 139' ' ' ASN . 23.7 m120 -79.62 -26.02 41.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 109.65 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.2 78.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.676 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 21.9 mt -82.68 16.41 2.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.651 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.75 -0.85 1.88 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.213 -0.929 . . . . 0.0 109.729 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -80.27 -28.24 38.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.778 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -70.91 -16.62 62.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.985 . . . . 0.0 109.465 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . 0.587 ' CD1' ' SG ' ' D' ' 93' ' ' CYS . 13.9 m-85 -64.66 -28.82 69.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.383 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.906 ' CG ' ' HB1' ' B' ' 135' ' ' ALA . 20.9 m-70 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.777 HMB1 HBB2 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 1.088 ' HAB' HD22 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.768 HMB1 HBB2 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 1.018 ' HAB' HD22 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.428 ' CG2' ' OG ' ' A' ' 131' ' ' SER . 16.8 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.438 HD13 ' CD1' ' A' ' 128' ' ' PHE . 25.0 mt -136.9 -161.01 1.11 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 0.0 109.354 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.453 ' N ' ' OD2' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -133.15 174.43 4.72 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.332 -0.855 . . . . 0.0 109.285 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.23 -70.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.629 2.219 . . . . 0.0 112.689 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.451 ' O ' ' ND2' ' A' ' 9' ' ' ASN . . . -48.54 -44.14 36.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.109 -0.995 . . . . 0.0 109.903 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 10' ' ' VAL . 1.3 m-20 -42.36 -35.76 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.48 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 10' ' ' VAL . 69.6 mttt -83.32 -56.43 3.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.32 -0.862 . . . . 0.0 109.524 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 94.5 m -45.43 -35.58 3.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 109.865 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 5' ' ' ALA . 9.0 m-20 -74.69 -33.49 62.46 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.01 -1.057 . . . . 0.0 108.15 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 6' ' ' ASP . 75.4 t -76.22 -49.37 25.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.45 -40.08 64.93 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.89 -61.64 2.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.516 -0.74 . . . . 0.0 109.462 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.64 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.6 -38.5 66.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.381 -0.824 . . . . 0.0 109.137 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.47 -17.44 62.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.24 -0.912 . . . . 0.0 109.008 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.58 -46.62 7.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -68.69 -36.76 78.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -1.163 . . . . 0.0 108.842 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 13' ' ' ALA . 70.5 t -62.0 -66.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 61.85 -141.08 47.3 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.17 39.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.493 -1.004 . . . . 0.0 110.355 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' GLY . 87.6 m-70 -142.94 20.34 1.96 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.63 -61.28 1.92 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.652 -0.655 . . . . 0.0 109.583 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.65 -13.91 0.19 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 21' ' ' ALA . 10.2 mm-40 -84.99 -56.33 3.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -1.102 . . . . 0.0 109.613 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.8 m-30 -61.69 -30.88 71.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 109.254 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.44 74.88 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -75.48 -40.41 57.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -1.198 . . . . 0.0 109.669 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -56.96 -20.75 25.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.325 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.13 -31.57 72.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.88 . . . . 0.0 109.483 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.865 HD11 ' CG ' ' A' ' 58' ' ' HIS . 78.4 mt -64.41 -61.17 2.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.63 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.01 -12.66 12.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.631 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.518 ' NH2' ' CB ' ' B' ' 127' ' ' GLN . 6.2 tpm_? -74.35 -53.34 9.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.401 ' CE ' ' CBC' ' A' ' 142' ' ' HEC . 1.2 ptt? -84.18 -28.74 27.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.23 -0.918 . . . . 0.0 110.084 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -46.37 -37.77 7.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 110.042 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.747 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -96.61 -36.92 10.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 110.268 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.8 m -44.43 -25.88 0.29 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 110.028 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.551 ' CG ' ' O ' ' A' ' 35' ' ' SER . 50.9 m-85 -162.46 139.11 5.97 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.169 -0.957 . . . . 0.0 109.287 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 40' ' ' LYS . 55.9 Cg_endo -71.98 -34.02 9.02 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.596 2.197 . . . . 0.0 111.984 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.965 ' HA ' ' HB3' ' D' ' 97' ' ' HIS . 76.6 p -47.51 -18.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -0.836 . . . . 0.0 109.509 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 37' ' ' PRO . 25.7 p -84.85 -27.99 26.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 109.446 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 37' ' ' PRO . 82.7 mttt -71.43 -25.3 62.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.676 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 38' ' ' THR . 15.1 t -49.4 -38.89 30.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.169 -0.957 . . . . 0.0 109.529 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.514 ' O ' ' O ' ' A' ' 43' ' ' PHE . 98.0 m-85 -71.29 -1.09 11.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.95 . . . . 0.0 109.406 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.514 ' O ' ' O ' ' A' ' 42' ' ' TYR . 84.9 m-85 58.26 141.71 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 0.0 109.728 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.7 ' O ' ' CD2' ' A' ' 46' ' ' PHE . 64.3 Cg_endo -75.04 -41.49 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.58 2.186 . . . . 0.0 112.048 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.662 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 14.9 p80 50.53 27.94 3.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.527 -0.733 . . . . 0.0 110.641 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.7 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 2.6 p90 -144.95 25.45 1.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.122 -0.986 . . . . 0.0 109.49 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.453 ' C ' ' N ' ' A' ' 49' ' ' SER . 2.4 m-20 43.97 84.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.463 -0.773 . . . . 0.0 109.791 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.675 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -51.82 -11.36 0.15 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.453 ' N ' ' C ' ' A' ' 47' ' ' ASP . 28.3 p -49.01 158.48 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.64 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -77.47 148.24 35.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.455 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.24 16.92 78.94 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 54.6 p -74.42 -17.06 60.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -1.154 . . . . 0.0 109.485 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.41 -39.54 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.338 -0.851 . . . . 0.0 109.641 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 52' ' ' SER . 56.6 mt-30 -65.87 -42.11 90.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.45 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.551 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 93.5 t -66.4 -44.67 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.298 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -39.4 67.0 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.15 -26.58 72.5 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.865 ' CG ' HD11 ' A' ' 29' ' ' LEU . 4.5 t-80 -68.15 -43.29 78.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -1.218 . . . . 0.0 109.317 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.75 -46.07 24.66 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -48.52 -23.66 1.05 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -1.047 . . . . 0.0 109.268 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -75.41 -38.94 59.56 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.283 -0.886 . . . . 0.0 108.672 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.49 -48.95 44.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.29 -32.86 74.74 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 109.083 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 68' ' ' ASN . 5.8 t0 -63.74 -36.49 84.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.238 -0.914 . . . . 0.0 108.626 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.501 ' HB3' HMB3 ' A' ' 142' ' ' HEC . . . -67.55 -52.77 34.86 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.01 -41.01 91.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.4 m -71.87 -50.2 31.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' ASP . 49.4 t30 -60.16 -24.3 64.62 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.616 ' HB1' ' SD ' ' A' ' 76' ' ' MET . . . -82.29 -46.69 13.31 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.11 -22.97 32.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.4 -14.92 63.34 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.606 ' O ' ' N ' ' A' ' 74' ' ' ASP . 35.5 m-70 -138.36 -62.97 0.56 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.517 -0.739 . . . . 0.0 109.287 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 73' ' ' VAL . 13.1 p 44.28 14.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 121.928 0.87 . . . . 0.0 109.37 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 72' ' ' HIS . 39.8 t0 -138.14 11.61 2.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.432 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.0 OUTLIER 174.92 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.246 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.685 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 14.3 ptt? -78.74 -22.68 0.39 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 111.981 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 76' ' ' MET . 59.5 Cg_exo -52.01 -19.67 9.02 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.705 1.603 . . . . 0.0 112.51 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -94.12 -35.76 12.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 109.764 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.96 -38.4 69.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.963 . . . . 0.0 109.285 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.79 11.49 15.34 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.392 -0.818 . . . . 0.0 109.049 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.3 p -68.08 -15.92 63.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 109.763 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -72.69 -55.8 6.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.031 . . . . 0.0 109.878 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 86' ' ' LEU . 6.1 mt -44.88 -47.26 11.15 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.81 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 62.6 m -46.79 -33.05 4.1 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' ALA . 1.5 m-20 -82.11 -17.32 46.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.188 -0.945 . . . . 0.0 109.558 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 83' ' ' LEU . 8.6 tp -74.06 -53.44 9.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.1 -1.0 . . . . 0.0 110.261 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.435 ' CE1' ' O ' ' A' ' 83' ' ' LEU . 6.0 p-80 -92.2 -21.66 20.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.975 -1.078 . . . . 0.0 110.643 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -97.27 -0.61 46.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.9 -1.125 . . . . 0.0 110.404 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 88' ' ' ALA . 70.9 m80 -154.91 42.94 0.47 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.787 -1.195 . . . . 0.0 110.256 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -172.39 -63.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.967 . . . . 0.0 109.329 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.1 mt -90.59 -23.79 20.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 53.99 53.3 11.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.665 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 94' ' ' ASP . 2.3 t -79.87 -136.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 109.447 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 96' ' ' VAL . 5.2 t70 -172.3 137.11 0.89 Allowed Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.84 . . . . 0.0 109.234 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 98' ' ' PHE . 85.6 Cg_exo -41.86 -10.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.544 2.163 . . . . 0.0 112.639 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 94' ' ' ASP . 60.1 t -43.75 -28.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 109.955 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.19 -24.95 42.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 95' ' ' PRO . 38.4 t80 -44.96 -32.47 1.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.913 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.49 -27.22 27.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.09 -1.007 . . . . 0.0 109.898 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.16 -62.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.036 -1.04 . . . . 0.0 110.024 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.995 ' CD2' ' HHC' ' A' ' 142' ' ' HEC . 36.7 tp -55.74 -20.96 16.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 109.878 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.8 p -78.44 -50.37 11.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.051 -1.031 . . . . 0.0 109.843 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -76.4 -26.6 55.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -0.952 . . . . 0.0 109.808 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 55.6 m -58.81 -50.92 72.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.777 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.35 -35.88 13.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 109.63 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.792 HD12 ' CE1' ' A' ' 122' ' ' HIS . 3.7 mm? -69.99 -59.17 3.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.079 -1.013 . . . . 0.0 109.895 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.8 t -50.08 -36.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.478 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 p -70.56 -63.11 1.16 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.264 -0.897 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' LEU . 17.5 mt -50.47 -31.42 15.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 -47.13 50.59 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.224 -0.923 . . . . 0.0 109.609 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.24 -41.35 22.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.89 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -80.1 -72.08 0.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.115 -0.991 . . . . 0.0 109.986 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -113.87 91.51 22.19 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 109.076 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 113' ' ' LEU . 84.7 Cg_exo -46.22 -175.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.329 2.019 . . . . 0.0 112.84 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.494 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.29 -42.21 13.94 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.636 0.732 . . . . 0.0 109.406 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER 85.0 3.66 0.65 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.897 ' CZ ' ' CE1' ' B' ' 116' ' ' HIS . 8.0 m-85 65.12 36.6 7.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.791 -0.568 . . . . 0.0 111.279 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.716 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -91.16 121.51 67.68 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.798 -1.189 . . . . 0.0 108.197 178.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.95 22.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.14 1.893 . . . . 0.0 112.656 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.716 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -151.23 -33.56 0.15 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.772 -1.205 . . . . 0.0 110.785 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.668 HG13 ' N ' ' A' ' 122' ' ' HIS . 11.4 p -46.63 -47.84 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.932 -1.105 . . . . 0.0 110.061 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.792 ' CE1' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -72.78 -33.51 66.34 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.555 -0.716 . . . . 0.0 109.349 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.06 -19.81 36.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 110.023 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 120' ' ' ALA . 10.2 p -65.95 -62.47 1.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.202 -0.936 . . . . 0.0 110.84 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.513 ' N ' ' OG ' ' A' ' 124' ' ' SER . 9.3 mt -70.18 -19.42 63.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.07 -1.019 . . . . 0.0 109.789 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -78.93 -45.43 20.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.046 -1.034 . . . . 0.0 110.219 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.445 ' CD ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -88.23 -43.24 11.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.988 -1.07 . . . . 0.0 110.14 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 10' ' ' VAL . 70.2 t80 -50.17 -21.02 1.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.957 -1.089 . . . . 0.0 109.271 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.4 mt -69.73 -17.7 63.47 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.25 -33.51 72.4 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.492 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 5.1 t -83.08 -30.41 28.0 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.417 -0.802 . . . . 0.0 108.992 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.5 t -85.41 -27.63 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.925 . . . . 0.0 109.078 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 129' ' ' LEU . 77.9 p -83.75 -25.97 30.09 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.119 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 47.9 m -78.09 -36.94 47.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.213 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 131' ' ' SER . 33.3 m -76.57 -21.86 15.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.266 -0.896 . . . . 0.0 108.883 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.48 -37.87 68.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.451 -0.781 . . . . 0.0 108.985 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 57.5 p -89.14 -1.38 58.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.594 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t -61.93 103.06 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.428 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -81.3 76.46 8.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.441 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -158.58 108.06 2.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.473 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.501 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.479 HG13 ' N ' ' B' ' 2' ' ' HIS . 8.5 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 0.479 ' N ' HG13 ' B' ' 1' ' ' VAL . 12.3 t-80 -169.85 49.63 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 1.046 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -106.29 162.45 13.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.433 -0.792 . . . . 0.0 109.261 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.434 ' O ' ' N ' ' B' ' 7' ' ' GLU . 0.7 OUTLIER -84.61 150.93 57.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 109.109 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.01 -30.73 1.32 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.434 2.089 . . . . 0.0 112.026 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.36 -21.84 25.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.925 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 4' ' ' THR . 44.5 tt0 -77.11 -63.09 1.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.983 . . . . 0.0 110.174 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.506 ' HB3' HD22 ' B' ' 3' ' ' LEU . 10.4 pttt -67.53 -25.73 65.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.158 -0.963 . . . . 0.0 110.175 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -43.8 -24.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 110.134 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.18 -56.23 3.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.087 -1.008 . . . . 0.0 109.751 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.404 ' H ' HG12 ' B' ' 11' ' ' VAL . 0.9 OUTLIER -71.04 -24.74 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.7 m -68.35 -39.12 81.98 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.351 0.596 . . . . 0.0 109.805 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.4 -31.23 57.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.847 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.3 -21.86 6.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.341 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . 0.557 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.2 OUTLIER -56.31 -38.27 71.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 109.234 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.21 -40.26 61.48 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -26.19 66.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -1.143 . . . . 0.0 109.178 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.16 121.0 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 109.666 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' B' ' 21' ' ' ASP . 59.6 t30 -80.04 71.83 6.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.0 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 82.8 t -45.89 -15.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.844 . . . . 0.0 109.779 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' B' ' 19' ' ' ASN . 34.8 m-20 -69.22 -4.09 16.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.624 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' B' ' 25' ' ' GLY . 47.9 mt-10 -155.79 -46.9 0.08 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.156 -0.965 . . . . 0.0 109.574 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -47.11 -23.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 109.723 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.95 -31.15 40.28 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -73.55 -39.52 49.47 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -70.24 -38.86 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.283 -1.128 . . . . 0.0 109.486 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.07 -30.25 61.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.556 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tp -81.47 -58.04 3.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.482 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.71 85.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -55.93 -39.35 71.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -1.126 . . . . 0.0 109.62 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.61 -35.98 4.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -81.19 -29.91 34.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.916 . . . . 0.0 109.752 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 67.1 t -66.03 -64.48 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.425 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 34' ' ' VAL . 0.0 OUTLIER -63.97 -22.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.224 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -149.62 81.92 6.97 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.92 . . . . 0.0 109.562 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.95 9.85 3.15 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.562 2.175 . . . . 0.0 112.23 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' B' ' 38' ' ' THR . 0.4 OUTLIER -80.96 -19.96 42.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 109.694 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.554 ' N ' ' CD1' ' B' ' 37' ' ' TRP . 7.2 m -87.95 57.94 4.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.479 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -117.61 23.82 11.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.41 -0.807 . . . . 0.0 109.332 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -87.34 -39.76 15.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.958 . . . . 0.0 109.554 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -100.01 34.82 2.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 109.463 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.718 ' CE1' HMD3 ' B' ' 147' ' ' HEC . 0.9 OUTLIER -143.32 15.04 1.84 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.222 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -72.49 -14.09 61.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.408 ' C ' ' N ' ' B' ' 46' ' ' GLY . 5.3 m -69.14 -46.92 66.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.477 ' CE1' ' CD2' ' B' ' 42' ' ' PHE . 80.1 m-85 -50.17 -16.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 45' ' ' PHE . . . 51.3 179.61 0.04 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 38.0 t0 55.86 71.28 0.56 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -1.178 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 27.9 mt -131.21 35.05 3.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 109.379 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.6 m -51.89 -49.29 63.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.27 160.17 46.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 108.837 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.4 -17.32 4.14 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.079 1.853 . . . . 0.0 111.972 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.418 ' C ' ' N ' ' B' ' 54' ' ' VAL . 19.6 t70 -83.26 -51.56 7.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.556 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.95 -20.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.431 -0.793 . . . . 0.0 109.471 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.418 ' N ' ' C ' ' B' ' 52' ' ' ASP . 57.8 t -73.01 -57.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mtt -59.98 -16.73 32.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.53 -26.62 71.29 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -78.79 132.22 65.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.152 -1.205 . . . . 0.0 109.327 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.02 -30.89 4.09 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.341 2.028 . . . . 0.0 112.34 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -70.41 -30.13 66.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.85 -40.68 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.516 ' NZ ' ' CB ' ' B' ' 61' ' ' LYS . 8.1 mtmp? -65.45 -37.43 86.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 109.68 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.96 -51.04 67.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.503 ' CE1' HBA1 ' B' ' 147' ' ' HEC . 41.0 t60 -55.82 -23.79 32.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.467 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.01 -48.94 65.33 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -52.29 -25.03 8.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -1.188 . . . . 0.0 109.587 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . 0.523 ' HB3' HBA2 ' B' ' 147' ' ' HEC . 0.3 OUTLIER -74.47 -61.94 1.7 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 109.491 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 0.852 HG13 ' C2B' ' B' ' 147' ' ' HEC . 35.0 t -52.18 -39.33 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.684 ' O ' HD23 ' B' ' 68' ' ' LEU . 8.0 tt -70.16 -37.41 75.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.903 . . . . 0.0 109.343 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.89 -44.08 61.25 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.53 71.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 109.787 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.418 ' O ' ' CD2' ' B' ' 75' ' ' LEU . 1.3 m-85 -66.3 -29.1 69.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.557 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.8 t -66.21 -33.77 76.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.515 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.17 -16.76 56.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.173 -0.954 . . . . 0.0 109.159 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.67 -19.76 63.15 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.838 HD23 ' N ' ' B' ' 75' ' ' LEU . 1.5 pt? -137.78 -28.44 0.89 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -1.181 . . . . 0.0 109.952 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' B' ' 72' ' ' SER . . . -80.1 19.02 0.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 109.586 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -171.55 70.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.465 HD21 ' HA ' ' B' ' 75' ' ' LEU . 70.5 mt -80.85 0.72 33.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.975 . . . . 0.0 109.492 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -54.04 -38.33 65.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.465 HD22 ' C ' ' B' ' 80' ' ' ASN . 0.3 OUTLIER -172.09 73.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.465 -0.772 . . . . 0.0 109.361 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.448 HD12 ' N ' ' B' ' 82' ' ' LYS . 2.2 pp -76.74 -41.73 43.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.628 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.448 ' N ' HD12 ' B' ' 81' ' ' LEU . 53.1 mttp -50.82 -27.2 6.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.096 -1.002 . . . . 0.0 109.41 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' B' ' 86' ' ' ALA . . . -83.19 -57.54 2.48 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.6 OUTLIER -47.86 -39.71 19.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -1.164 . . . . 0.0 109.557 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.459 ' CZ ' HG13 ' B' ' 137' ' ' VAL . 25.1 m-85 -69.83 -11.96 61.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.382 -0.824 . . . . 0.0 109.429 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' B' ' 83' ' ' GLY . . . -54.57 -43.72 72.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.438 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 11.4 p -64.38 -59.24 4.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' B' ' 88' ' ' LEU . 19.5 mt -54.97 -35.39 64.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.349 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -72.76 -46.43 53.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.337 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.54 -24.54 67.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.42 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.19 -68.36 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.557 ' O ' ' N ' ' B' ' 97' ' ' HIS . 75.1 m80 -54.35 -25.83 26.38 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 110.491 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.89 -60.66 2.04 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.013 -1.054 . . . . 0.0 111.501 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.561 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 11.8 m-20 -86.99 -39.75 15.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.92 -1.112 . . . . 0.0 111.701 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -83.17 -10.15 58.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.976 -1.078 . . . . 0.0 111.07 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.519 HD13 ' O ' ' B' ' 96' ' ' LEU . 0.2 OUTLIER -137.9 -43.78 0.52 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.886 -1.134 . . . . 0.0 110.068 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.92 ' HB3' ' HA ' ' C' ' 38' ' ' THR . 4.1 m80 72.95 58.57 0.11 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.246 -0.909 . . . . 0.0 109.575 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 79.1 t -82.64 114.21 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.09 -1.006 . . . . 0.0 109.434 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.74 154.45 2.37 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.27 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.402 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 47.2 Cg_endo -70.09 -164.3 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.573 2.182 . . . . 0.0 112.149 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 53.31 51.97 14.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' B' ' 100' ' ' PRO . 31.0 m120 -158.25 -36.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.24 -37.57 85.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -72.94 -26.39 61.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.483 HD23 ' O ' ' B' ' 105' ' ' LEU . 1.3 tt -65.62 -55.49 17.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.402 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 1.017 HD13 ' CHC' ' B' ' 147' ' ' HEC . 7.9 tt -50.37 -47.0 56.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.24 -47.88 72.07 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.51 -50.29 65.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -1.161 . . . . 0.0 109.607 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 80.5 t -53.76 -38.5 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.17 -0.956 . . . . 0.0 109.524 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.96 -33.91 76.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.405 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.9 -26.24 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 60.7 m -79.27 -61.04 2.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.731 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . 0.407 HG23 ' H ' ' B' ' 113' ' ' VAL . 4.9 t -46.25 -30.0 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 31.9 mt -79.84 -31.45 40.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 109.601 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -82.26 -20.38 37.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.897 ' CE1' ' CZ ' ' A' ' 117' ' ' PHE . 11.0 t-80 -74.95 -55.73 5.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.531 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -74.46 -17.73 60.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.899 . . . . 0.0 109.625 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -146.53 58.96 1.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.436 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -74.83 -21.92 77.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -72.89 -33.73 66.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -1.153 . . . . 0.0 109.433 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' B' ' 123' ' ' THR . 57.7 mm-40 -81.46 -4.52 56.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.8 34.33 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.36 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.468 ' H ' ' C ' ' B' ' 121' ' ' GLU . 28.7 p -48.4 148.45 3.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 109.096 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.507 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.3 Cg_exo -45.28 -52.85 6.04 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.196 1.931 . . . . 0.0 112.779 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 36.4 Cg_endo -65.68 13.67 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.053 1.835 . . . . 0.0 112.324 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.461 HG23 ' OG1' ' B' ' 123' ' ' THR . 90.2 t -124.87 -21.42 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . 0.549 HE22 ' CG ' ' B' ' 131' ' ' GLN . 18.2 tm0? -83.15 -42.9 16.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.747 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -62.01 -44.21 97.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.587 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.75 -7.17 25.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.692 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -92.43 -30.12 15.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 109.603 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.549 ' CG ' HE22 ' B' ' 127' ' ' GLN . 15.6 mm100 -81.45 -38.33 26.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.592 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -68.14 -49.43 61.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 109.646 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 2.6 p -58.47 -48.22 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.898 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.567 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 88.8 t -73.38 -34.57 43.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.842 ' CB ' ' O ' ' D' ' 146' ' ' HIS . . . -47.41 -22.28 0.42 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.35 -22.03 61.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.459 HG13 ' CZ ' ' B' ' 85' ' ' PHE . 85.9 t -77.84 -26.09 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -1.154 . . . . 0.0 109.541 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.08 -46.58 61.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -74.69 -21.17 59.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.36 -59.63 3.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.524 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -58.58 -24.9 61.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.23 22.36 4.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -77.25 -31.93 55.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.588 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.449 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 0.1 OUTLIER -79.55 -27.3 41.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 109.321 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -65.99 3.68 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.799 ' O ' ' CB ' ' D' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.427 ' CG2' ' OG ' ' C' ' 131' ' ' SER . 16.9 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.436 HD13 ' CD1' ' C' ' 128' ' ' PHE . 25.3 mt -136.96 -161.06 1.12 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.317 -0.865 . . . . 0.0 109.364 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.46 ' N ' ' OD2' ' C' ' 6' ' ' ASP . 0.3 OUTLIER -133.22 174.44 4.7 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.344 -0.848 . . . . 0.0 109.199 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.22 -70.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.65 2.233 . . . . 0.0 112.638 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.45 ' O ' ' ND2' ' C' ' 9' ' ' ASN . . . -48.62 -44.12 36.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.161 -0.962 . . . . 0.0 109.88 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.563 ' O ' HG23 ' C' ' 10' ' ' VAL . 1.3 m-20 -42.33 -35.77 1.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.88 . . . . 0.0 109.44 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' C' ' 10' ' ' VAL . 69.5 mttt -83.32 -56.42 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.827 . . . . 0.0 109.571 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 94.9 m -45.45 -35.62 3.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.406 -0.809 . . . . 0.0 109.906 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' C' ' 5' ' ' ALA . 8.9 m-20 -74.51 -33.5 62.82 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.563 HG23 ' O ' ' C' ' 6' ' ' ASP . 76.2 t -76.37 -49.25 25.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -53.52 -40.04 65.14 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.95 -61.63 2.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.473 -0.767 . . . . 0.0 109.408 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.644 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.59 -38.51 66.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.842 . . . . 0.0 109.145 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -17.52 62.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.42 -0.8 . . . . 0.0 108.959 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.54 -46.71 7.8 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -68.63 -36.79 79.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.265 -1.138 . . . . 0.0 108.828 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.644 HG23 ' O ' ' C' ' 13' ' ' ALA . 71.0 t -61.96 -66.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 61.93 -141.15 47.27 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.07 39.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.476 -1.014 . . . . 0.0 110.36 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' C' ' 18' ' ' GLY . 87.6 m-70 -142.96 20.43 1.96 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.72 -61.15 1.95 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.635 -0.666 . . . . 0.0 109.649 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.72 -13.9 0.2 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' C' ' 21' ' ' ALA . 10.3 mm-40 -85.02 -56.3 3.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -1.172 . . . . 0.0 109.544 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 1.8 m-30 -61.75 -30.91 71.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.852 . . . . 0.0 109.186 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.26 -29.5 75.02 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' C' ' 55' ' ' VAL . . . -75.54 -40.29 57.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -1.179 . . . . 0.0 109.676 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -56.9 -20.83 25.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.342 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.15 -31.58 72.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.905 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.86 HD11 ' CG ' ' C' ' 58' ' ' HIS . 78.4 mt -64.34 -61.3 2.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.57 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.97 -12.7 12.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.93 . . . . 0.0 109.563 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.508 ' NH2' ' CB ' ' D' ' 127' ' ' GLN . 6.2 tpm_? -74.34 -53.27 10.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.133 -0.979 . . . . 0.0 109.818 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 0.405 ' CE ' ' CBC' ' C' ' 142' ' ' HEC . 1.2 ptt? -84.22 -28.72 27.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.943 . . . . 0.0 110.101 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -46.37 -37.8 8.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.119 -0.988 . . . . 0.0 110.022 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.76 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -96.57 -36.95 10.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.204 -0.935 . . . . 0.0 110.3 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.7 m -44.4 -25.91 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' C' ' 35' ' ' SER . 51.1 m-85 -162.44 139.11 5.99 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.114 -0.992 . . . . 0.0 109.286 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' C' ' 40' ' ' LYS . 56.0 Cg_endo -71.96 -34.15 8.89 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.647 2.231 . . . . 0.0 111.986 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.92 ' HA ' ' HB3' ' B' ' 97' ' ' HIS . 76.7 p -47.42 -18.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.437 ' N ' ' O ' ' C' ' 37' ' ' PRO . 25.8 p -84.9 -28.04 26.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' C' ' 37' ' ' PRO . 82.7 mttt -71.42 -25.3 62.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.908 . . . . 0.0 109.702 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.653 HG22 ' O ' ' C' ' 38' ' ' THR . 15.1 t -49.38 -38.91 30.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.201 -0.937 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.504 ' O ' ' O ' ' C' ' 43' ' ' PHE . 98.0 m-85 -71.34 -1.05 11.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.186 -0.946 . . . . 0.0 109.351 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.504 ' O ' ' O ' ' C' ' 42' ' ' TYR . 85.0 m-85 58.26 141.64 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.647 -0.658 . . . . 0.0 109.693 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.692 ' O ' ' CD2' ' C' ' 46' ' ' PHE . 64.0 Cg_endo -74.99 -41.45 0.66 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.468 2.112 . . . . 0.0 112.073 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.66 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 14.8 p80 50.65 27.81 3.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.536 -0.728 . . . . 0.0 110.582 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.692 ' CD2' ' O ' ' C' ' 44' ' ' PRO . 2.6 p90 -144.95 25.56 1.42 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.14 -0.975 . . . . 0.0 109.582 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.445 ' C ' ' N ' ' C' ' 49' ' ' SER . 2.4 m-20 44.0 84.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.507 -0.746 . . . . 0.0 109.817 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.672 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -51.81 -11.41 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.375 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.445 ' N ' ' C ' ' C' ' 47' ' ' ASP . 28.1 p -48.94 158.52 0.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.627 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -77.52 148.34 35.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.21 16.9 79.01 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 55.2 p -74.43 -17.03 60.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -1.167 . . . . 0.0 109.475 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 67.35 -39.46 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.373 -0.829 . . . . 0.0 109.629 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.529 ' H ' ' C ' ' C' ' 52' ' ' SER . 56.6 mt-30 -65.95 -42.07 90.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.308 -0.87 . . . . 0.0 109.409 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.557 ' O ' ' HB1' ' C' ' 26' ' ' ALA . 93.4 t -66.39 -44.74 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.178 -0.951 . . . . 0.0 109.274 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -39.39 67.13 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.16 -26.55 72.51 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.86 ' CG ' HD11 ' C' ' 29' ' ' LEU . 4.4 t-80 -68.25 -43.24 78.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -1.202 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.83 -46.06 25.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -48.48 -23.62 1.02 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.377 -1.072 . . . . 0.0 109.272 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -75.45 -38.92 59.38 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.264 -0.898 . . . . 0.0 108.659 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.44 -49.04 44.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.2 -32.93 74.87 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.358 -0.839 . . . . 0.0 109.077 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' C' ' 68' ' ' ASN . 5.9 t0 -63.71 -36.43 83.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.171 -0.956 . . . . 0.0 108.637 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.492 ' HB3' HMB3 ' C' ' 142' ' ' HEC . . . -67.68 -52.61 35.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.13 -40.98 91.66 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 25.2 m -71.85 -50.29 30.79 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' C' ' 64' ' ' ASP . 49.5 t30 -60.17 -24.16 64.52 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.614 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -82.28 -46.84 13.12 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -65.02 -22.92 32.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.41 -15.01 63.4 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.611 ' O ' ' N ' ' C' ' 74' ' ' ASP . 35.2 m-70 -138.3 -62.97 0.56 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.502 -0.749 . . . . 0.0 109.356 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.572 HG22 ' O ' ' C' ' 73' ' ' VAL . 13.1 p 44.24 14.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.937 0.875 . . . . 0.0 109.399 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' C' ' 72' ' ' HIS . 39.7 t0 -138.19 11.57 2.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 1.0 OUTLIER 174.95 29.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.683 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 14.3 ptt? -78.67 -22.77 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 111.898 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' C' ' 76' ' ' MET . 60.3 Cg_exo -52.05 -19.66 9.13 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.652 1.568 . . . . 0.0 112.521 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -94.02 -35.78 12.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.789 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.95 -38.39 69.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.078 -1.013 . . . . 0.0 109.317 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.81 11.46 15.46 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.423 -0.798 . . . . 0.0 109.047 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 68.4 p -68.05 -15.87 63.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 0.0 109.755 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -72.69 -55.84 6.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.886 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' C' ' 86' ' ' LEU . 6.1 mt -44.84 -47.26 11.03 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.794 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 62.4 m -46.87 -32.96 4.11 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' C' ' 82' ' ' ALA . 1.5 m-20 -82.16 -17.21 47.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.615 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' C' ' 83' ' ' LEU . 8.6 tp -74.11 -53.42 9.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 0.0 110.346 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . 0.437 ' CE1' ' O ' ' C' ' 83' ' ' LEU . 6.0 p-80 -92.18 -21.68 20.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.889 -1.132 . . . . 0.0 110.655 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -97.24 -0.63 46.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.864 -1.148 . . . . 0.0 110.4 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' C' ' 88' ' ' ALA . 70.7 m80 -154.93 42.95 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 110.227 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -172.39 -63.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 109.326 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 46.4 mt -90.66 -23.72 20.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 109.323 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 53.95 53.33 11.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 0.0 109.639 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.512 HG12 ' H ' ' C' ' 94' ' ' ASP . 2.3 t -79.9 -136.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 0.0 109.466 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' C' ' 96' ' ' VAL . 5.2 t70 -172.23 137.11 0.9 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.183 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' C' ' 98' ' ' PHE . 86.2 Cg_exo -41.75 -11.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.616 2.211 . . . . 0.0 112.627 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' C' ' 94' ' ' ASP . 59.1 t -43.65 -28.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 0.0 110.03 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.2 -24.96 42.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.542 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' C' ' 95' ' ' PRO . 38.4 t80 -44.98 -32.47 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 109.953 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.41 -27.23 27.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 0.0 109.977 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 mt -84.19 -62.25 1.61 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.993 -1.067 . . . . 0.0 109.94 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 1.012 ' CD2' ' HHC' ' C' ' 142' ' ' HEC . 36.9 tp -55.79 -20.91 16.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 109.914 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 17.0 p -78.42 -50.38 11.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 109.903 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -76.38 -26.58 55.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.836 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 55.7 m -58.66 -51.02 71.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.768 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -48.36 -35.88 13.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 109.618 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.786 HD12 ' CE1' ' C' ' 122' ' ' HIS . 3.7 mm? -70.02 -59.16 3.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.146 -0.971 . . . . 0.0 109.863 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 47.9 t -50.2 -36.77 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.16 -0.962 . . . . 0.0 109.449 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 5.0 p -70.57 -63.09 1.16 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.224 -0.923 . . . . 0.0 109.417 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' C' ' 113' ' ' LEU . 17.6 mt -50.47 -31.55 15.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.334 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.51 -47.19 48.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.945 . . . . 0.0 109.631 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.32 -41.31 22.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.837 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -80.08 -72.13 0.42 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 110.003 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -113.86 91.56 22.31 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' C' ' 113' ' ' LEU . 84.5 Cg_exo -46.17 -175.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.447 2.098 . . . . 0.0 112.825 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.3 -42.21 13.92 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.555 -0.716 . . . . 0.0 109.393 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.512 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 0.0 OUTLIER 85.02 3.56 0.65 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -178.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.904 ' CZ ' ' CE1' ' D' ' 116' ' ' HIS . 8.1 m-85 65.1 36.74 7.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.798 -0.564 . . . . 0.0 111.225 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.718 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -91.06 121.59 67.69 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.719 -1.238 . . . . 0.0 108.179 178.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.15 22.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.11 1.874 . . . . 0.0 112.57 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.718 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -151.17 -33.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.963 -1.086 . . . . 0.0 110.84 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.649 HG13 ' N ' ' C' ' 122' ' ' HIS . 11.5 p -46.63 -47.86 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.013 -1.055 . . . . 0.0 110.005 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.786 ' CE1' HD12 ' C' ' 106' ' ' LEU . 0.3 OUTLIER -72.79 -33.5 66.31 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.51 -0.744 . . . . 0.0 109.307 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.11 -19.75 36.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.826 . . . . 0.0 110.059 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.6 ' N ' ' O ' ' C' ' 120' ' ' ALA . 10.2 p -66.04 -62.47 1.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.947 . . . . 0.0 110.783 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.524 ' N ' ' OG ' ' C' ' 124' ' ' SER . 9.4 mt -70.14 -19.4 63.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.047 -1.033 . . . . 0.0 109.885 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.92 -45.34 20.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.01 -1.056 . . . . 0.0 110.306 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.451 ' CD ' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -88.31 -43.19 11.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.028 -1.045 . . . . 0.0 110.18 -179.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.46 ' CD1' HG21 ' C' ' 10' ' ' VAL . 70.1 t80 -50.23 -21.03 1.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.911 -1.118 . . . . 0.0 109.316 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.6 mt -69.59 -17.77 63.57 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.21 -33.56 72.42 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.501 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 5.1 t -83.06 -30.41 28.04 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.349 -0.844 . . . . 0.0 108.988 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 72.7 t -85.41 -27.67 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.072 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.518 ' N ' ' O ' ' C' ' 129' ' ' LEU . 76.9 p -83.65 -26.01 30.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.817 . . . . 0.0 109.152 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 47.5 m -78.11 -36.91 47.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.343 -0.848 . . . . 0.0 109.183 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.458 HG13 ' O ' ' C' ' 131' ' ' SER . 33.4 m -76.49 -21.93 15.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.267 -0.895 . . . . 0.0 108.888 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.52 -37.79 68.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 109.013 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 58.2 p -89.29 -1.23 57.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t -61.91 102.98 0.31 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -81.2 76.33 8.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.48 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -158.51 108.08 2.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.897 . . . . 0.0 109.448 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.449 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.495 HG13 ' N ' ' D' ' 2' ' ' HIS . 8.4 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.434 0.635 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . 0.495 ' N ' HG13 ' D' ' 1' ' ' VAL . 12.3 t-80 -169.88 49.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.108 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 1.147 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -106.38 162.49 13.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.469 -0.77 . . . . 0.0 109.28 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.438 ' O ' ' N ' ' D' ' 7' ' ' GLU . 0.7 OUTLIER -84.69 151.01 57.67 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.939 . . . . 0.0 109.06 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -42.09 -30.62 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.33 2.02 . . . . 0.0 112.103 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.41 -21.82 25.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.891 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' D' ' 4' ' ' THR . 44.6 tt0 -77.12 -63.02 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.126 -0.984 . . . . 0.0 110.164 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.496 ' HB3' HD22 ' D' ' 3' ' ' LEU . 10.4 pttt -67.64 -25.71 65.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -0.964 . . . . 0.0 110.163 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . 0.409 ' C ' ' O ' ' D' ' 8' ' ' LYS . 0.4 OUTLIER -43.73 -24.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.23 -56.21 3.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.094 -1.004 . . . . 0.0 109.75 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.435 ' H ' HG12 ' D' ' 11' ' ' VAL . 0.9 OUTLIER -71.06 -24.78 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 25.4 m -68.26 -39.23 82.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.357 0.599 . . . . 0.0 109.844 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.18 -31.36 58.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.923 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -21.77 6.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 0.0 109.31 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . 0.551 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.2 OUTLIER -56.34 -38.37 71.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.983 . . . . 0.0 109.151 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.23 -40.2 61.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -26.07 66.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -1.096 . . . . 0.0 109.198 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.11 121.06 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.607 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' D' ' 21' ' ' ASP . 59.6 t30 -80.12 71.75 6.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.278 -0.889 . . . . 0.0 109.023 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 80.1 t -45.82 -15.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.368 -0.833 . . . . 0.0 109.793 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' D' ' 19' ' ' ASN . 35.2 m-20 -69.28 -4.02 16.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' D' ' 25' ' ' GLY . 47.9 mt-10 -155.8 -46.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -47.06 -23.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.683 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.86 -31.22 40.44 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -73.54 -39.48 49.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -70.21 -38.86 75.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -1.146 . . . . 0.0 109.56 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.04 -30.24 61.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.593 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 tp -81.46 -58.09 3.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.973 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.7 85.07 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpp180 -55.98 -39.4 71.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -1.142 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp -45.59 -35.99 4.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.602 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 mt -81.22 -29.82 34.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.787 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 66.8 t -66.01 -64.46 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 109.497 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.419 ' H ' HG23 ' D' ' 34' ' ' VAL . 0.0 OUTLIER -64.06 -22.6 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 109.232 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -149.6 81.8 7.03 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.618 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.05 9.98 3.13 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.552 2.168 . . . . 0.0 112.173 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . 0.568 ' CD1' ' N ' ' D' ' 38' ' ' THR . 0.4 OUTLIER -80.97 -20.02 42.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.568 ' N ' ' CD1' ' D' ' 37' ' ' TRP . 7.3 m -88.0 58.08 4.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 109.472 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -117.66 23.72 11.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.431 -0.793 . . . . 0.0 109.324 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -87.31 -39.72 15.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.912 . . . . 0.0 109.552 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -100.01 34.75 2.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.223 -0.923 . . . . 0.0 109.432 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.723 ' CE1' HMD3 ' D' ' 147' ' ' HEC . 0.9 OUTLIER -143.3 15.12 1.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -0.875 . . . . 0.0 109.222 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' D' ' 43' ' ' GLU . 7.2 pt-20 -72.47 -14.15 61.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.583 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' D' ' 46' ' ' GLY . 5.3 m -69.04 -46.9 66.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.487 ' CE1' ' CD2' ' D' ' 42' ' ' PHE . 80.0 m-85 -50.23 -16.16 0.3 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' D' ' 44' ' ' SER . . . 51.26 179.58 0.04 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t0 55.95 71.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -1.153 . . . . 0.0 109.481 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 27.6 mt -131.26 35.11 3.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 109.391 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 13.4 m -51.92 -49.37 63.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.937 . . . . 0.0 109.49 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.21 160.22 46.55 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.327 -0.858 . . . . 0.0 108.832 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.42 -17.3 4.18 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.112 1.874 . . . . 0.0 111.946 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . 0.416 ' C ' ' N ' ' D' ' 54' ' ' VAL . 19.5 t70 -83.26 -51.51 7.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.345 -0.847 . . . . 0.0 109.593 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.07 -19.84 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.423 -0.798 . . . . 0.0 109.437 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' D' ' 52' ' ' ASP . 58.5 t -73.2 -57.86 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 13.3 mtt -60.07 -16.65 33.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 0.0 109.41 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.5 -26.72 71.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -78.74 132.27 65.16 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.226 -1.161 . . . . 0.0 109.321 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.98 -31.02 4.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.365 2.043 . . . . 0.0 112.299 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -70.38 -30.11 66.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.616 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.83 -40.64 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 109.602 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . 0.512 ' NZ ' ' CB ' ' D' ' 61' ' ' LYS . 8.1 mtmp? -65.53 -37.43 86.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.681 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.94 -51.06 67.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.615 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.503 ' CE1' HBA1 ' D' ' 147' ' ' HEC . 41.0 t60 -55.7 -23.94 31.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.073 -1.017 . . . . 0.0 109.455 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -65.03 -48.87 65.98 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -52.4 -24.9 8.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -1.233 . . . . 0.0 109.522 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . 0.524 ' HB3' HBA2 ' D' ' 147' ' ' HEC . 0.3 OUTLIER -74.48 -62.0 1.67 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.259 -0.9 . . . . 0.0 109.501 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.844 HG13 ' C2B' ' D' ' 147' ' ' HEC . 35.3 t -52.17 -39.33 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.686 ' O ' HD23 ' D' ' 68' ' ' LEU . 8.0 tt -70.09 -37.46 75.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.326 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.85 -44.14 61.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.43 71.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -1.155 . . . . 0.0 109.803 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . 0.413 ' O ' ' CD2' ' D' ' 75' ' ' LEU . 1.3 m-85 -66.29 -29.14 69.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.077 -1.015 . . . . 0.0 109.537 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . 0.551 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 8.8 t -66.36 -33.57 76.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.31 -16.7 55.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.14 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.62 -19.86 63.17 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.859 ' H ' HD23 ' D' ' 75' ' ' LEU . 1.5 pt? -137.66 -28.44 0.9 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.21 -1.17 . . . . 0.0 109.931 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' D' ' 72' ' ' SER . . . -80.05 19.0 0.75 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.095 -1.003 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -171.58 70.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' D' ' 75' ' ' LEU . 70.4 mt -80.87 0.66 34.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.425 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -53.99 -38.41 65.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.953 . . . . 0.0 109.32 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.466 HD22 ' C ' ' D' ' 80' ' ' ASN . 0.3 OUTLIER -172.03 73.18 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.371 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . 0.446 HD12 ' N ' ' D' ' 82' ' ' LYS . 2.2 pp -76.72 -41.62 44.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . 0.446 ' N ' HD12 ' D' ' 81' ' ' LEU . 53.1 mttp -50.93 -27.12 6.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.08 -1.013 . . . . 0.0 109.426 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' D' ' 86' ' ' ALA . . . -83.22 -57.63 2.46 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.6 OUTLIER -47.64 -39.83 18.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -1.159 . . . . 0.0 109.584 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.459 ' CZ ' HG13 ' D' ' 137' ' ' VAL . 25.1 m-85 -69.78 -12.09 61.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.326 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' D' ' 83' ' ' GLY . . . -54.49 -43.69 72.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.154 -0.966 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 11.3 p -64.42 -59.22 4.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 109.384 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.7 mt -54.92 -35.51 64.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.304 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -72.73 -46.46 53.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.907 . . . . 0.0 109.314 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.52 -24.47 67.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.872 . . . . 0.0 109.452 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.31 -68.2 0.71 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.556 ' O ' ' N ' ' D' ' 97' ' ' HIS . 75.1 m80 -54.57 -25.67 27.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.428 -0.795 . . . . 0.0 110.493 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.92 -60.61 2.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.017 -1.052 . . . . 0.0 111.594 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.553 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 11.9 m-20 -87.07 -39.64 15.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.996 -1.065 . . . . 0.0 111.693 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -83.17 -10.2 58.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.913 -1.117 . . . . 0.0 111.11 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.529 HD13 ' O ' ' D' ' 96' ' ' LEU . 0.2 OUTLIER -137.89 -43.85 0.53 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.869 -1.144 . . . . 0.0 109.971 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.965 ' HB3' ' HA ' ' A' ' 38' ' ' THR . 4.1 m80 73.11 58.5 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.87 . . . . 0.0 109.509 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . 0.401 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 79.3 t -82.66 114.21 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 109.421 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.76 154.45 2.38 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.264 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.1 -164.4 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.61 2.206 . . . . 0.0 112.153 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 53.32 52.03 14.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.485 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -158.28 -36.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -62.34 -37.55 86.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -72.88 -26.43 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . 0.483 HD23 ' O ' ' D' ' 105' ' ' LEU . 1.3 tt -65.6 -55.58 16.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.357 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 1.044 HD22 ' HAB' ' D' ' 147' ' ' HEC . 7.9 tt -50.41 -46.98 56.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.229 -0.919 . . . . 0.0 109.356 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -55.15 -47.93 71.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.43 -50.28 65.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -1.157 . . . . 0.0 109.616 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 80.5 t -53.85 -38.53 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 109.498 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.96 -33.87 76.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.316 -0.865 . . . . 0.0 109.423 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.95 -26.11 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.552 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 60.7 m -79.31 -61.0 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 109.738 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . 0.431 HG23 ' H ' ' D' ' 113' ' ' VAL . 4.9 t -46.34 -29.94 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 109.815 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 32.1 mt -79.76 -31.56 40.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -82.12 -20.47 37.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.897 . . . . 0.0 109.494 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.904 ' CE1' ' CZ ' ' C' ' 117' ' ' PHE . 11.0 t-80 -75.0 -55.72 5.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.176 -0.952 . . . . 0.0 109.471 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -74.53 -17.75 60.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.544 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -146.54 59.01 1.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -74.81 -22.0 77.66 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -72.87 -33.73 66.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -1.197 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' D' ' 123' ' ' THR . 57.4 mm-40 -81.38 -4.63 56.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.361 -0.837 . . . . 0.0 109.522 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.82 34.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.285 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.487 ' H ' ' C ' ' D' ' 121' ' ' GLU . 28.3 p -48.32 148.3 3.36 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.108 -0.995 . . . . 0.0 109.083 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.513 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.3 Cg_exo -45.1 -52.91 5.85 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.228 1.952 . . . . 0.0 112.812 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 36.4 Cg_endo -65.65 13.57 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.013 1.809 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.458 HG23 ' OG1' ' D' ' 123' ' ' THR . 90.8 t -124.84 -21.34 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.299 -0.876 . . . . 0.0 109.605 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . 0.549 HE22 ' CG ' ' D' ' 131' ' ' GLN . 18.2 tm0? -83.18 -42.96 16.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.76 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -61.91 -44.35 96.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.67 -7.15 24.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.683 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -92.43 -30.01 15.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 109.706 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 0.549 ' CG ' HE22 ' D' ' 127' ' ' GLN . 15.6 mm100 -81.62 -38.2 26.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -68.21 -49.33 61.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 0.0 109.691 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 2.6 p -58.49 -48.18 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.865 . . . . 0.0 109.966 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.569 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 88.5 t -73.44 -34.45 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.347 -0.846 . . . . 0.0 109.796 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.799 ' CB ' ' O ' ' B' ' 146' ' ' HIS . . . -47.45 -22.29 0.43 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.37 -22.01 61.31 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . 0.459 HG13 ' CZ ' ' D' ' 85' ' ' PHE . 85.8 t -77.83 -26.07 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -1.138 . . . . 0.0 109.537 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.14 -46.6 61.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.214 -0.929 . . . . 0.0 109.476 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -74.71 -21.08 59.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.497 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.32 -59.71 3.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.553 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 13.5 mt -58.52 -24.93 61.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.927 . . . . 0.0 109.438 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.24 22.45 4.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 109.39 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -77.34 -31.85 54.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.634 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.1 OUTLIER -79.55 -27.35 41.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 0.0 109.398 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' D' ' 98' ' ' VAL . 24.4 m-85 -65.88 3.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.478 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.842 ' O ' ' CB ' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.439 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.995 ' HHC' ' CD2' ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 1.017 ' CHC' HD13 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 1.012 ' HHC' ' CD2' ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 1.044 ' HAB' HD22 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.486 ' C ' HD12 ' A' ' 2' ' ' LEU . 3.7 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.572 HD13 ' OG ' ' A' ' 131' ' ' SER . 7.7 mp -108.21 -165.39 1.04 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.311 -0.868 . . . . 0.0 109.2 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.515 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 178.98 -49.53 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.936 . . . . 0.0 109.992 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 6' ' ' ASP . 73.9 Cg_exo -47.23 171.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.384 2.056 . . . . 0.0 112.448 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -45.8 -16.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.766 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 4' ' ' PRO . 3.1 p30 -39.55 -33.35 0.17 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 10' ' ' VAL . 9.6 ptpt -83.14 -46.59 12.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.338 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 m -45.44 -31.07 1.56 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.314 -0.866 . . . . 0.0 109.424 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -78.23 -36.94 46.42 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 7' ' ' LYS . 71.5 t -70.5 -49.52 52.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -51.07 -47.32 61.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.404 -0.81 . . . . 0.0 108.847 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -55.92 27.57 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.43 -0.794 . . . . 0.0 109.304 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.716 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -56.74 -37.23 70.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.251 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -17.41 61.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.223 -0.923 . . . . 0.0 108.933 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.63 -44.17 16.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.42 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 41.6 mmtt -70.2 -43.25 71.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -1.17 . . . . 0.0 108.637 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 13' ' ' ALA . 59.1 t -59.27 -63.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 44.2 -125.39 5.78 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 22.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.416 -1.05 . . . . 0.0 110.438 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.568 ' H ' ' C ' ' A' ' 18' ' ' GLY . 78.9 m-70 -129.11 25.99 5.5 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -91.51 -64.38 1.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.694 -0.629 . . . . 0.0 109.746 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.28 -14.37 0.17 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' ALA . 2.2 mm-40 -84.03 -56.47 3.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -1.052 . . . . 0.0 109.672 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.2 m-30 -60.67 -35.56 76.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 109.187 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.86 -22.88 68.84 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.51 -41.76 31.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -1.163 . . . . 0.0 109.715 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.42 -19.82 62.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 108.92 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.92 ' HB1' ' SG ' ' A' ' 104' ' ' CYS . . . -72.85 -21.88 60.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.371 -0.831 . . . . 0.0 109.132 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 11.1 mt -72.45 -53.68 11.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.349 -0.845 . . . . 0.0 109.712 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.13 -27.05 69.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.489 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 31' ' ' ARG . 0.9 OUTLIER -63.89 -30.68 71.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.547 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.513 ' CE ' ' CBC' ' A' ' 142' ' ' HEC . 39.6 ttp -70.75 -57.93 4.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.482 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -49.19 -33.68 12.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.45 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 11.7 mt -73.5 -51.55 16.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.852 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 52.4 m -67.76 -17.87 64.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.949 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CZ ' ' NH2' ' B' ' 104' ' ' ARG . 29.4 m-85 -152.62 109.52 2.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.052 -1.03 . . . . 0.0 109.499 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' THR . 72.4 Cg_endo -80.53 -27.21 3.49 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.331 2.02 . . . . 0.0 112.092 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.786 ' HB ' ' HB2' ' D' ' 97' ' ' HIS . 21.1 p -47.45 -18.31 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 0.0 109.447 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' PRO . 55.9 p -81.6 -22.74 37.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HZ1' HD21 ' A' ' 48' ' ' LEU . 1.8 tpmt? -64.71 -39.61 93.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 38' ' ' THR . 8.8 t -46.79 -37.16 8.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.333 -0.854 . . . . 0.0 109.642 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.575 ' HE2' ' CE1' ' D' ' 97' ' ' HIS . 3.9 m-85 -65.36 -58.54 5.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 109.111 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 43' ' ' PHE . 81.7 t80 48.33 67.6 4.34 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.52 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.75 -34.38 0.29 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.919 2.413 . . . . 0.0 112.145 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.465 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -174.29 73.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.412 -0.805 . . . . 0.0 109.149 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.592 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -151.0 68.01 0.93 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 49' ' ' SER . 1.5 m-20 -48.35 -18.3 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 109.631 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.592 ' CD1' ' O ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER 46.4 21.33 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.24 -0.912 . . . . 0.0 109.638 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 50' ' ' HIS . 5.2 m -75.31 18.68 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -0.94 . . . . 0.0 109.404 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.492 ' ND1' ' N ' ' A' ' 50' ' ' HIS . 2.5 m80 57.51 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.615 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.03 10.5 83.83 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.599 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 3.2 p -54.48 -12.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -1.104 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 71.0 -16.79 0.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.381 -0.825 . . . . 0.0 109.736 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 52' ' ' SER . 5.1 pt20 -81.65 -28.87 33.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.508 HG22 ' CE2' ' A' ' 46' ' ' PHE . 22.2 t -73.52 -38.44 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.61 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.585 ' H ' ' CD ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.63 -22.83 46.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.083 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.13 -23.89 58.36 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.47 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.7 t-80 -78.47 -38.57 40.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -1.171 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.72 -48.95 49.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 53.7 mttm -51.61 -23.45 4.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -1.121 . . . . 0.0 109.948 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.555 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 0.5 OUTLIER -72.18 -42.46 65.83 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.127 -0.983 . . . . 0.0 109.024 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 t -69.85 -48.44 63.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.486 -0.758 . . . . 0.0 108.977 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.426 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -65.47 -28.57 69.31 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.384 -0.822 . . . . 0.0 109.275 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 30.4 m-20 -70.23 -36.49 74.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 0.0 108.872 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.68 47.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.402 -0.811 . . . . 0.0 108.964 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 70' ' ' VAL . 11.3 mt -58.01 -42.12 84.54 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.261 -0.899 . . . . 0.0 108.674 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 71' ' ' ALA . 25.8 m -67.59 -51.6 48.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.362 -0.836 . . . . 0.0 108.881 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.544 HD21 ' CB ' ' A' ' 79' ' ' ALA . 9.4 t30 -60.49 -29.31 68.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.0 108.781 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -82.98 -46.49 12.83 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 66' ' ' LEU . 48.4 t -67.19 -22.4 29.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -66.1 -24.21 66.65 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.205 0.526 . . . . 0.0 109.711 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.592 ' O ' HG12 ' A' ' 73' ' ' VAL . 11.8 m80 -137.27 -47.8 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 72' ' ' HIS . 11.0 p 45.06 13.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.665 0.745 . . . . 0.0 109.378 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 72' ' ' HIS . 26.2 t70 -135.76 11.37 3.41 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -173.72 28.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.043 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.704 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -77.96 -24.91 0.46 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.432 -0.792 . . . . 0.0 111.399 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 76' ' ' MET . 41.8 Cg_exo -56.52 -24.61 54.2 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.791 1.661 . . . . 0.0 112.324 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -89.38 -29.19 19.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.932 . . . . 0.0 109.65 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.544 ' CB ' HD21 ' A' ' 68' ' ' ASN . . . -77.05 -43.2 35.4 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.127 -0.983 . . . . 0.0 109.127 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 80' ' ' LEU . 6.4 mp -83.5 8.7 13.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.432 -0.792 . . . . 0.0 108.952 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.5 m -63.52 -23.18 67.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -76.35 -55.3 5.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.614 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.503 HD22 HBA1 ' A' ' 142' ' ' HEC . 4.5 mt -46.62 -46.81 19.97 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 m -56.8 -25.43 55.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.435 -0.79 . . . . 0.0 109.246 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' ALA . 11.6 t70 -81.02 -35.02 32.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.382 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tt -72.06 -26.95 62.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 109.198 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 90' ' ' LYS . 68.4 m80 -82.67 -31.49 28.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 109.472 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.14 -42.65 15.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.495 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -78.13 -18.84 55.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.535 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' HIS . 46.7 mttm -146.08 179.81 7.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 93' ' ' VAL . 12.6 mt 59.09 58.4 3.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -53.84 -6.88 0.1 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 109.336 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 91' ' ' LEU . 11.5 p -54.59 137.94 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.49 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.765 ' HB2' ' OD2' ' D' ' 99' ' ' ASP . 0.7 OUTLIER -77.27 157.92 80.11 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.086 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 97' ' ' ASN . 9.9 Cg_endo -54.72 -10.47 2.53 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.721 2.281 . . . . 0.0 111.882 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.518 HG21 ' CG ' ' D' ' 99' ' ' ASP . 85.3 t -42.98 -22.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 109.775 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 95' ' ' PRO . 3.1 m120 -79.07 -41.26 29.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.205 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 95' ' ' PRO . 31.7 t80 -48.62 -25.72 1.89 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.165 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -70.62 -30.32 66.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.208 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.551 HD13 ' CD1' ' A' ' 36' ' ' PHE . 20.6 mt -84.08 -61.34 1.84 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 0.0 109.642 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.777 HD21 HBB3 ' A' ' 142' ' ' HEC . 4.6 tt -49.23 -23.51 1.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.671 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.8 m -72.81 -44.05 61.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.059 -1.025 . . . . 0.0 109.759 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.509 ' CD2' ' OD1' ' B' ' 108' ' ' ASN . 41.3 t-80 -80.55 -26.63 37.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 109.783 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.92 ' SG ' ' HB1' ' A' ' 28' ' ' ALA . 11.2 p -58.04 -48.14 80.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.717 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.655 ' N ' ' SG ' ' A' ' 104' ' ' CYS . 2.5 mt -46.31 -39.14 9.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.611 ' N ' HD22 ' A' ' 106' ' ' LEU . 3.7 mm? -68.8 -30.28 68.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.607 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.592 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 86.0 t -75.12 -51.5 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 110' ' ' ALA . 27.8 m -60.05 -59.66 5.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 114' ' ' PRO . 12.3 mt -46.37 -18.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.457 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -69.66 -42.55 74.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.258 -0.902 . . . . 0.0 110.406 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.19 -3.67 43.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 110.132 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -129.73 -81.72 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 109.693 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -119.17 82.15 22.17 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 113' ' ' LEU . 53.6 Cg_exo -48.76 -169.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.51 2.14 . . . . 0.0 112.524 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.827 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -51.0 -56.21 13.61 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.556 -0.715 . . . . 0.0 109.302 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.67 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 3.0 mm-40 122.63 -8.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.497 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 5.6 t80 80.34 34.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 122.01 -0.431 . . . . 0.0 111.199 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -113.43 120.22 40.24 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.25 16.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.331 2.021 . . . . 0.0 112.87 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -140.98 -34.61 0.5 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.016 -1.052 . . . . 0.0 110.106 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.827 HG21 ' O ' ' A' ' 115' ' ' ALA . 9.4 p -51.79 -47.28 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.14 -0.975 . . . . 0.0 109.994 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.616 ' N ' HG13 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -60.19 -39.9 88.16 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.331 -0.856 . . . . 0.0 109.283 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.39 -19.99 32.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.824 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 120' ' ' ALA . 24.2 p -61.83 -62.39 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 110.3 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.505 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.3 mt -68.2 -19.53 64.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.172 -0.955 . . . . 0.0 109.513 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -83.05 -45.54 13.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.974 . . . . 0.0 109.854 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -87.19 -41.48 13.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.155 -0.965 . . . . 0.0 109.883 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 37.1 t80 -50.14 -20.84 1.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.966 -1.084 . . . . 0.0 108.854 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' SER . 19.4 mt -70.56 -17.91 62.92 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.7 -31.64 69.77 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.572 ' OG ' HD13 ' A' ' 2' ' ' LEU . 0.8 OUTLIER -81.72 -34.05 30.75 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.362 -0.836 . . . . 0.0 108.902 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.0 t -83.8 -29.21 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.336 -0.852 . . . . 0.0 108.91 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 129' ' ' LEU . 23.3 t -80.3 -25.44 39.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.403 -0.811 . . . . 0.0 109.132 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 45.2 m -75.37 -39.67 58.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.264 -0.897 . . . . 0.0 109.215 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.04 -22.09 16.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.255 -0.903 . . . . 0.0 108.965 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.91 -35.13 72.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 109.02 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 83.6 m -87.21 -29.85 21.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.561 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.402 ' CB ' HH12 ' A' ' 141' ' ' ARG . 68.5 m 50.41 -166.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.47 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -60.86 156.45 17.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 140' ' ' TYR . 78.1 t80 -82.11 40.9 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.402 HH12 ' CB ' ' A' ' 138' ' ' SER . 8.9 ptp85 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.609 HG22 ' N ' ' B' ' 2' ' ' HIS . 10.0 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 0.609 ' N ' HG22 ' B' ' 1' ' ' VAL . 1.5 t60 -140.37 123.42 16.62 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.165 -0.959 . . . . 0.0 109.688 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.916 HD12 ' N ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -138.46 -162.94 1.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.331 -0.856 . . . . 0.0 109.071 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.409 ' HG1' ' CD ' ' B' ' 7' ' ' GLU . 1.0 OUTLIER -84.54 153.32 61.58 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 108.866 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.92 -26.32 66.86 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.491 2.127 . . . . 0.0 112.197 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.2 -27.86 22.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.973 . . . . 0.0 109.793 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.409 ' CD ' ' HG1' ' B' ' 4' ' ' THR . 61.2 mt-10 -84.14 -48.1 10.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.023 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.694 ' HB2' HD13 ' B' ' 3' ' ' LEU . 0.8 OUTLIER -68.78 -43.42 75.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 109.55 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.0 t -56.58 -23.58 41.57 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.219 -0.926 . . . . 0.0 110.059 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.54 -57.61 3.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.021 -1.05 . . . . 0.0 110.044 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.95 -24.33 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 47.1 m -80.88 -36.97 30.59 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.687 -0.633 . . . . 0.0 109.779 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 -22.38 63.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.927 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 16' ' ' GLY . 1.7 mt -59.82 -28.05 67.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.0 109.335 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . 0.657 ' HE1' ' HG ' ' B' ' 72' ' ' SER . 0.5 OUTLIER -47.57 -17.73 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.933 . . . . 0.0 109.178 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -76.88 -36.15 37.31 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.445 ' O ' ' CE2' ' B' ' 118' ' ' PHE . 3.3 mmtt -89.33 -35.82 15.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -1.148 . . . . 0.0 109.281 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.1 t -47.92 114.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.659 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' B' ' 21' ' ' ASP . 83.6 m-20 -77.86 65.82 3.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.327 -0.858 . . . . 0.0 108.933 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -44.6 -17.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.385 -0.822 . . . . 0.0 109.682 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' B' ' 19' ' ' ASN . 13.3 m-20 -78.8 6.76 8.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.232 -0.917 . . . . 0.0 109.539 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' B' ' 19' ' ' ASN . 58.2 mt-10 -155.65 -46.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.538 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' B' ' 27' ' ' ALA . 85.8 t -47.74 -42.24 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.207 -0.933 . . . . 0.0 109.621 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.81 -43.33 96.62 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.9 -39.08 25.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -76.25 -25.82 55.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -1.175 . . . . 0.0 109.561 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' B' ' 23' ' ' VAL . . . -75.54 -34.1 60.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.937 . . . . 0.0 109.515 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tp -82.91 -52.35 6.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.451 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.68 -26.68 17.31 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -77.86 -31.44 51.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.131 . . . . 0.0 109.467 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . 0.44 HD21 HMC1 ' B' ' 147' ' ' HEC . 32.6 tp -49.04 -34.56 13.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.355 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 28.9 mt -80.39 -22.03 41.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 23.5 t -82.51 -64.22 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.627 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.453 ' H ' HG23 ' B' ' 34' ' ' VAL . 3.0 t -61.01 -22.9 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.888 . . . . 0.0 109.659 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -152.16 88.47 4.1 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 109.465 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.94 12.98 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.543 2.162 . . . . 0.0 112.227 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.592 ' CZ2' ' ND2' ' B' ' 102' ' ' ASN . 0.7 OUTLIER -71.91 -19.92 61.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 109.525 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.591 HG23 ' NE1' ' B' ' 37' ' ' TRP . 1.3 p -84.14 50.99 1.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.977 . . . . 0.0 109.27 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 38.5 tt0 -92.14 31.23 1.3 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -87.88 -42.84 12.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.674 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -93.18 14.32 18.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 109.578 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' B' ' 43' ' ' GLU . 1.6 p90 -68.21 -34.19 75.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.608 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.543 ' N ' ' CD1' ' B' ' 42' ' ' PHE . 12.0 pt-20 -53.28 -17.4 1.75 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.607 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 60.9 m -85.55 -34.73 21.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.583 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 47' ' ' ASP . 10.0 m-85 -51.04 -20.92 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.96 12.42 0.15 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' B' ' 45' ' ' PHE . 15.1 m-20 -160.64 110.52 1.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.151 . . . . 0.0 109.448 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tp -158.67 20.6 0.22 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.255 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.1 m -46.78 -41.1 14.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 109.646 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . 0.431 ' HG1' ' CG ' ' B' ' 52' ' ' ASP . 4.7 p -146.6 150.33 39.79 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.851 . . . . 0.0 109.216 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -41.15 -43.65 5.19 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.444 2.096 . . . . 0.0 112.354 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.431 ' CG ' ' HG1' ' B' ' 50' ' ' THR . 1.7 p-10 -64.13 -31.01 72.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.534 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.92 -19.86 20.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.93 . . . . 0.0 109.42 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.43 -61.32 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -0.901 . . . . 0.0 109.573 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' B' ' 55' ' ' MET . 5.5 mmt -70.98 -0.51 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.77 31.08 7.17 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -143.09 137.06 14.51 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.26 -1.141 . . . . 0.0 109.31 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.11 -30.88 5.27 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.489 2.126 . . . . 0.0 112.26 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -21.1 59.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 109.777 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 69.8 t -75.82 -41.52 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.523 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -78.31 -25.26 46.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.57 71.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.932 ' CE1' ' O1A' ' B' ' 147' ' ' HEC . 72.6 t60 -62.62 -23.82 67.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.32 -50.31 22.17 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -49.51 -30.92 9.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.173 -1.192 . . . . 0.0 109.534 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . 0.468 ' HB3' HBA1 ' B' ' 147' ' ' HEC . 67.7 mmtt -65.45 -53.74 38.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.583 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 1.103 HG13 ' C2B' ' B' ' 147' ' ' HEC . 28.2 t -58.96 -36.94 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.43 HD23 ' C ' ' B' ' 68' ' ' LEU . 5.7 tt -65.57 -48.37 72.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.97 -41.05 10.31 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.05 -43.45 91.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.608 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.583 ' CE2' HMB1 ' B' ' 147' ' ' HEC . 29.0 m-85 -61.4 -47.31 86.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.657 ' HG ' ' HE1' ' B' ' 15' ' ' TRP . 19.2 m -62.44 -42.03 99.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 109.622 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -48.37 -34.79 11.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.416 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.68 -60.48 6.91 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -54.04 -22.09 9.87 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.248 -1.148 . . . . 0.0 109.35 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.16 2.68 56.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -170.27 66.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.68 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.452 HD22 HG12 ' B' ' 1' ' ' VAL . 96.3 mt -81.27 15.27 2.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.34 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.85 -23.21 60.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.46 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 37.1 t-20 -167.2 108.09 0.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 0.0 109.593 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.472 HD11 ' N ' ' B' ' 1' ' ' VAL . 6.3 mt -80.35 -51.53 8.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 109.526 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -67.12 -23.97 65.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.812 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -78.7 -39.11 22.2 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.9 t -85.1 -47.43 10.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.153 -1.204 . . . . 0.0 109.715 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.557 ' N ' ' CG2' ' B' ' 84' ' ' THR . 40.5 m-85 -84.67 26.92 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 109.539 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.32 72.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 109.633 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 50.9 p -75.81 -53.82 7.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.752 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -48.13 -43.05 30.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 2.9 m -66.89 -48.35 68.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.342 -0.849 . . . . 0.0 109.668 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -67.39 -22.64 65.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 109.734 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.71 -68.37 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.078 -1.013 . . . . 0.0 109.566 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.576 ' NE2' ' O ' ' B' ' 141' ' ' LEU . 1.1 p-80 -54.38 -20.67 7.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.974 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . 0.429 ' N ' ' ND1' ' B' ' 92' ' ' HIS . 41.4 t -83.51 -59.6 2.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 110.858 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.31 -56.44 3.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.067 -1.021 . . . . 0.0 111.379 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -57.71 -51.74 68.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 110.579 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.614 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 12.1 mt -97.32 -64.52 1.03 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.002 -1.062 . . . . 0.0 109.95 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.723 ' HB2' ' HB ' ' C' ' 38' ' ' THR . 0.0 OUTLIER 91.2 25.12 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.308 0.575 . . . . 0.0 109.865 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 98' ' ' VAL . 17.5 t -46.74 140.86 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.103 -0.998 . . . . 0.0 109.493 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.688 ' OD2' ' HB2' ' C' ' 94' ' ' ASP . 96.0 m-20 -54.0 149.41 18.05 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.363 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.9 36.46 0.4 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.478 2.119 . . . . 0.0 112.143 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -145.07 45.57 1.34 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.179 -0.95 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.592 ' ND2' ' CZ2' ' B' ' 37' ' ' TRP . 4.4 m120 -143.74 5.96 1.39 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.1 m-85 -89.74 -69.68 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 109.454 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.574 ' NH2' ' CZ ' ' A' ' 36' ' ' PHE . 43.9 ttt180 -54.94 -20.88 9.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.54 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 tp -75.31 -31.13 60.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.431 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 1.067 HD22 ' HAB' ' B' ' 147' ' ' HEC . 8.8 tt -68.19 -55.39 12.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.63 -20.55 39.41 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . 0.509 ' OD1' ' CD2' ' A' ' 103' ' ' HIS . 61.8 t30 -60.09 -34.78 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -1.159 . . . . 0.0 109.684 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 6.7 t -86.53 -24.12 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 109.593 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.73 -36.4 82.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 109.501 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.447 ' CG1' ' CD1' ' B' ' 130' ' ' TYR . 4.4 m -74.91 -26.04 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.239 -0.913 . . . . 0.0 109.662 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.516 ' HG ' ' CE1' ' A' ' 122' ' ' HIS . 17.0 t -66.79 -63.4 1.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 109.612 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . 0.433 ' H ' HG23 ' B' ' 113' ' ' VAL . 10.6 t -49.14 -21.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 109.539 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.9 -57.03 4.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.66 -27.32 49.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.836 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.494 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.71 -60.25 2.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.052 -1.03 . . . . 0.0 109.443 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -62.3 -17.49 58.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.692 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.445 ' CE2' ' O ' ' B' ' 17' ' ' LYS . 65.5 m-85 -150.05 60.5 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 109.703 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' B' ' 121' ' ' GLU . . . -66.52 -45.26 86.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' B' ' 120' ' ' LYS . 28.6 mmtp -47.39 -19.86 0.19 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -1.172 . . . . 0.0 109.289 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' B' ' 119' ' ' GLY . 70.1 mm-40 -94.77 -26.82 16.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.642 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.478 ' CD1' ' C ' ' B' ' 122' ' ' PHE . 0.7 OUTLIER -48.54 120.82 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.355 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 9.6 p -149.15 149.31 29.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.263 -0.898 . . . . 0.0 108.896 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.448 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 2.5 Cg_endo -46.15 -58.1 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.327 2.018 . . . . 0.0 113.177 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 19.5 Cg_endo -59.76 -11.1 13.53 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.174 1.916 . . . . 0.0 112.51 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 53.5 t -94.81 -53.12 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 109.907 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . 0.515 ' O ' ' NE2' ' B' ' 131' ' ' GLN . 41.1 mm-40 -61.34 -59.88 4.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 109.489 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -51.16 -37.43 46.27 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.484 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.24 18.53 2.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.447 ' CD1' ' CG1' ' B' ' 111' ' ' VAL . 15.2 t80 -109.56 -61.71 1.6 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.229 -0.92 . . . . 0.0 109.688 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.674 ' NE2' ' H ' ' B' ' 131' ' ' GLN . 4.1 mp0 -48.43 -24.09 1.15 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.0 -1.063 . . . . 0.0 109.726 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.447 ' HG3' ' CD2' ' D' ' 146' ' ' HIS . 35.8 ttpt -85.73 -37.38 19.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 0.0 110.169 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 0.4 OUTLIER -60.76 -44.36 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.859 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.477 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 7.0 m -83.56 -16.97 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 0.0 109.935 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.96 -25.15 1.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 0.0 109.404 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.95 -23.9 56.48 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' B' ' 134' ' ' VAL . 42.7 t -79.6 -31.78 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -1.164 . . . . 0.0 109.429 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.54 -50.79 57.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -67.07 -32.31 73.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.247 -0.908 . . . . 0.0 109.427 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.7 -42.27 34.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.291 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.576 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 38.4 mt -84.17 18.37 2.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.376 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.39 -31.08 2.32 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.536 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -46.37 -41.87 14.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 109.285 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' B' ' 146' ' ' HIS . 35.7 mmtt -75.46 -54.43 7.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.037 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.497 ' O ' ' CG ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -57.43 -6.19 0.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.545 -0.722 . . . . 0.0 109.241 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.446 ' H ' ' C ' ' B' ' 144' ' ' LYS . 11.8 m-70 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.79 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.48 ' C ' HD12 ' C' ' 2' ' ' LEU . 3.7 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.581 HD13 ' OG ' ' C' ' 131' ' ' SER . 7.7 mp -108.21 -165.41 1.04 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.359 -0.838 . . . . 0.0 109.269 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.516 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 179.02 -49.6 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.018 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' C' ' 6' ' ' ASP . 74.3 Cg_exo -47.17 170.88 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.398 2.065 . . . . 0.0 112.521 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.73 -16.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 109.828 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' C' ' 4' ' ' PRO . 3.1 p30 -39.61 -33.35 0.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.765 . . . . 0.0 109.799 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' C' ' 10' ' ' VAL . 9.6 ptpt -83.1 -46.57 12.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.893 . . . . 0.0 109.431 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.407 ' C ' ' O ' ' C' ' 7' ' ' LYS . 49.6 m -45.48 -31.12 1.62 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.419 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -78.23 -36.81 46.6 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' C' ' 7' ' ' LYS . 71.8 t -70.49 -49.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -51.07 -47.33 61.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.45 -56.02 26.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.405 -0.81 . . . . 0.0 109.294 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.696 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -56.65 -37.3 70.58 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.285 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -17.48 61.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.156 -0.965 . . . . 0.0 108.907 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.6 -44.09 17.04 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' C' ' 16' ' ' LYS . 41.7 mmtt -70.22 -43.29 70.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -1.119 . . . . 0.0 108.56 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.696 HG23 ' O ' ' C' ' 13' ' ' ALA . 59.8 t -59.22 -63.89 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.566 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 44.24 -125.44 5.84 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.41 22.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.349 -1.089 . . . . 0.0 110.449 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.566 ' H ' ' C ' ' C' ' 18' ' ' GLY . 78.9 m-70 -129.08 26.07 5.5 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.52 -64.37 1.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.68 -0.638 . . . . 0.0 109.811 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.37 -14.28 0.18 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 21' ' ' ALA . 2.1 mm-40 -84.01 -56.52 3.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.406 -1.055 . . . . 0.0 109.671 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -60.53 -35.7 76.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.165 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.84 -22.92 68.83 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.51 -41.71 31.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -1.121 . . . . 0.0 109.683 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.51 -19.79 62.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 108.947 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.922 ' HB1' ' SG ' ' C' ' 104' ' ' CYS . . . -72.89 -21.84 60.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.109 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 11.2 mt -72.57 -53.57 11.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 109.635 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.19 -27.01 69.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.484 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -30.81 71.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 0.515 ' CE ' ' CBC' ' C' ' 142' ' ' HEC . 39.5 ttp -70.79 -57.98 4.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.405 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . 0.533 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 0.3 OUTLIER -49.2 -33.63 12.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.468 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.453 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 11.8 mt -73.44 -51.57 16.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 109.856 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 53.3 m -67.92 -17.73 64.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.938 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.568 ' CZ ' ' NH2' ' D' ' 104' ' ' ARG . 29.2 m-85 -152.64 109.51 2.74 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.972 . . . . 0.0 109.546 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' C' ' 39' ' ' THR . 72.1 Cg_endo -80.43 -27.29 3.53 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.388 2.058 . . . . 0.0 112.16 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.753 ' O ' HG22 ' C' ' 41' ' ' THR . 22.0 p -47.37 -18.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.863 . . . . 0.0 109.581 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.438 ' N ' ' O ' ' C' ' 37' ' ' PRO . 55.9 p -81.56 -22.74 37.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.532 ' HZ1' HD21 ' C' ' 48' ' ' LEU . 1.8 tpmt? -64.68 -39.59 93.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.878 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.753 HG22 ' O ' ' C' ' 38' ' ' THR . 8.8 t -46.83 -37.26 8.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 0.0 109.616 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.535 ' HE2' ' CE1' ' B' ' 97' ' ' HIS . 3.9 m-85 -65.32 -58.49 5.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.96 . . . . 0.0 109.148 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.502 ' CD2' ' O ' ' C' ' 43' ' ' PHE . 81.5 t80 48.37 67.51 4.43 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.872 . . . . 0.0 109.544 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -83.73 -34.28 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.937 2.425 . . . . 0.0 112.175 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.476 ' CG ' ' O ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER -174.29 73.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.0 109.145 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' C' ' 48' ' ' LEU . 0.3 OUTLIER -150.99 68.1 0.93 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' C' ' 49' ' ' SER . 1.5 m-20 -48.42 -18.31 0.22 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.07 -1.019 . . . . 0.0 109.613 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.582 ' CD1' ' O ' ' C' ' 46' ' ' PHE . 0.9 OUTLIER 46.56 21.19 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.211 -0.93 . . . . 0.0 109.536 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.461 ' O ' ' O ' ' C' ' 50' ' ' HIS . 5.2 m -75.31 18.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.496 ' ND1' ' N ' ' C' ' 50' ' ' HIS . 2.4 m80 57.53 114.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.387 -0.821 . . . . 0.0 109.661 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.02 10.5 83.84 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 3.2 p -54.43 -12.71 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.455 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 71.13 -16.87 0.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.382 -0.824 . . . . 0.0 109.729 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' C' ' 52' ' ' SER . 5.1 pt20 -81.57 -28.85 33.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.959 . . . . 0.0 109.684 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.514 HG22 ' CE2' ' C' ' 46' ' ' PHE . 22.4 t -73.54 -38.43 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.584 ' H ' ' CD ' ' C' ' 56' ' ' LYS . 0.0 OUTLIER -78.71 -22.75 46.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.395 -0.816 . . . . 0.0 109.011 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.2 -23.81 58.35 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.471 ' ND1' ' C ' ' C' ' 58' ' ' HIS . 6.7 t-80 -78.6 -38.45 39.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -1.147 . . . . 0.0 109.506 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.79 -48.85 49.73 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.41 ' O ' ' CG ' ' C' ' 64' ' ' ASP . 53.7 mttm -51.8 -23.28 4.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.36 -1.082 . . . . 0.0 109.924 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.559 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 0.5 OUTLIER -72.26 -42.39 65.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.116 -0.99 . . . . 0.0 109.054 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t -69.82 -48.51 63.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.455 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -65.46 -28.59 69.32 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.267 -0.896 . . . . 0.0 109.262 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . 0.41 ' CG ' ' O ' ' C' ' 60' ' ' LYS . 30.2 m-20 -70.23 -36.4 74.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 108.926 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.95 -52.74 47.05 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.476 -0.765 . . . . 0.0 108.968 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.415 ' O ' HG23 ' C' ' 70' ' ' VAL . 11.3 mt -58.03 -42.16 84.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 108.665 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.478 ' O ' ' N ' ' C' ' 71' ' ' ALA . 26.1 m -67.54 -51.55 49.46 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.245 -0.91 . . . . 0.0 108.998 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.56 HD21 ' CB ' ' C' ' 79' ' ' ALA . 9.4 t30 -60.46 -29.34 68.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 108.744 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -82.95 -46.54 12.8 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.415 HG23 ' O ' ' C' ' 66' ' ' LEU . 48.6 t -67.16 -22.38 29.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -66.07 -24.26 66.68 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.658 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.593 ' O ' HG12 ' C' ' 73' ' ' VAL . 11.8 m80 -137.27 -47.86 0.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.754 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.593 HG12 ' O ' ' C' ' 72' ' ' HIS . 10.9 p 45.09 13.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.802 0.81 . . . . 0.0 109.411 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' C' ' 72' ' ' HIS . 26.3 t70 -135.71 11.46 3.42 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -173.77 28.26 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.007 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.712 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -77.94 -25.02 0.46 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.489 -0.757 . . . . 0.0 111.414 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' C' ' 76' ' ' MET . 41.9 Cg_exo -56.37 -24.7 53.3 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.851 1.701 . . . . 0.0 112.363 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -89.39 -29.21 19.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . 0.56 ' CB ' HD21 ' C' ' 68' ' ' ASN . . . -77.0 -43.2 35.69 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.143 -0.973 . . . . 0.0 109.068 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . 0.471 ' N ' HD12 ' C' ' 80' ' ' LEU . 6.4 mp -83.5 8.7 13.19 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.358 -0.839 . . . . 0.0 108.962 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.6 m -63.43 -23.39 67.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.551 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -76.24 -55.33 5.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.629 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.507 HD22 HBA1 ' C' ' 142' ' ' HEC . 4.5 mt -46.59 -46.8 19.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.818 . . . . 0.0 108.861 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 5.0 m -56.91 -25.33 57.08 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.404 -0.81 . . . . 0.0 109.25 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' C' ' 82' ' ' ALA . 11.6 t70 -81.02 -35.06 32.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.91 -27.04 62.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.25 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . 0.439 ' O ' ' O ' ' C' ' 90' ' ' LYS . 68.2 m80 -82.74 -31.36 28.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.17 -42.64 15.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -78.16 -18.79 55.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.854 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' C' ' 87' ' ' HIS . 46.8 mttm -146.06 179.81 7.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.898 . . . . 0.0 109.511 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' C' ' 93' ' ' VAL . 12.5 mt 59.08 58.54 3.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.456 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -53.99 -6.82 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.248 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' C' ' 91' ' ' LEU . 11.5 p -54.64 137.89 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.688 ' HB2' ' OD2' ' B' ' 99' ' ' ASP . 0.7 OUTLIER -77.24 157.89 80.23 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 0.0 109.086 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' C' ' 97' ' ' ASN . 10.0 Cg_endo -54.74 -10.34 2.46 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.627 2.218 . . . . 0.0 111.953 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.478 HG21 ' CG ' ' B' ' 99' ' ' ASP . 85.4 t -43.09 -22.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -0.819 . . . . 0.0 109.743 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.472 ' N ' ' O ' ' C' ' 95' ' ' PRO . 3.1 m120 -79.15 -41.16 29.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.959 . . . . 0.0 109.206 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . 0.409 ' N ' ' O ' ' C' ' 95' ' ' PRO . 31.9 t80 -48.59 -25.68 1.85 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 109.249 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -70.65 -30.37 66.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.18 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.559 HD13 ' CD1' ' C' ' 36' ' ' PHE . 20.4 mt -84.07 -61.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.0 109.63 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.755 HD21 HBB3 ' C' ' 142' ' ' HEC . 4.6 tt -49.15 -23.55 1.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.744 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 34.5 m -72.87 -43.91 61.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.798 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.514 ' CD2' ' OD1' ' D' ' 108' ' ' ASN . 41.3 t-80 -80.58 -26.69 37.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 109.732 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.922 ' SG ' ' HB1' ' C' ' 28' ' ' ALA . 11.1 p -57.98 -48.09 81.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.768 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.655 ' N ' ' SG ' ' C' ' 104' ' ' CYS . 2.5 mt -46.46 -39.12 10.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.393 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.597 ' N ' HD22 ' C' ' 106' ' ' LEU . 3.7 mm? -68.72 -30.37 68.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.603 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . 0.597 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 85.7 t -75.04 -51.43 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.459 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.464 ' O ' ' N ' ' C' ' 110' ' ' ALA . 27.1 m -60.12 -59.63 5.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.244 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' C' ' 114' ' ' PRO . 12.4 mt -46.29 -18.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -69.66 -42.56 74.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.0 110.368 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.15 -3.63 43.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.0 110.17 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -129.72 -81.83 0.56 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 109.622 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.4 OUTLIER -119.17 82.2 22.28 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 53.3 Cg_exo -48.79 -169.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.427 2.085 . . . . 0.0 112.604 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.839 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -50.89 -56.27 13.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.491 -0.756 . . . . 0.0 109.289 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.658 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 3.0 mm-40 122.66 -8.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.503 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 5.6 t80 80.26 34.95 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.935 -0.478 . . . . 0.0 111.212 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.739 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -113.45 120.26 40.13 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -48.3 16.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.242 1.961 . . . . 0.0 112.992 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -140.93 -34.73 0.49 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.049 -1.032 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.839 HG21 ' O ' ' C' ' 115' ' ' ALA . 9.4 p -51.75 -47.18 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.066 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.596 ' N ' HG13 ' C' ' 121' ' ' VAL . 0.1 OUTLIER -60.34 -39.81 88.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.26 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.44 -20.03 32.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.344 -0.847 . . . . 0.0 109.785 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.535 ' N ' ' O ' ' C' ' 120' ' ' ALA . 24.3 p -61.83 -62.42 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 110.283 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.5 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.3 mt -68.14 -19.51 64.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.163 -0.961 . . . . 0.0 109.544 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -83.13 -45.46 13.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 109.841 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.416 ' CG ' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -87.31 -41.36 13.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.974 . . . . 0.0 109.84 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.462 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 37.1 t80 -50.22 -20.83 1.13 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.879 -1.138 . . . . 0.0 108.81 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' C' ' 133' ' ' SER . 19.2 mt -70.57 -17.92 62.91 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.64 -31.69 69.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.581 ' OG ' HD13 ' C' ' 2' ' ' LEU . 0.8 OUTLIER -81.79 -33.94 30.59 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.429 -0.795 . . . . 0.0 108.933 179.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 26.4 t -83.85 -29.16 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.334 -0.854 . . . . 0.0 108.927 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.536 ' N ' ' O ' ' C' ' 129' ' ' LEU . 23.3 t -80.37 -25.39 39.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.393 -0.817 . . . . 0.0 109.109 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 44.9 m -75.35 -39.69 59.04 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.211 -0.931 . . . . 0.0 109.228 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 28.8 m -75.07 -22.12 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.276 -0.89 . . . . 0.0 108.887 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.95 -35.03 72.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.041 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 82.3 m -87.38 -29.79 21.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . 0.4 ' CB ' HH12 ' C' ' 141' ' ' ARG . 68.7 m 50.37 -166.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 109.434 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -60.84 156.41 17.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.902 . . . . 0.0 109.52 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' C' ' 140' ' ' TYR . 78.3 t80 -82.05 40.84 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.457 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . 0.4 HH12 ' CB ' ' C' ' 138' ' ' SER . 8.9 ptp85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.504 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.598 HG22 ' N ' ' D' ' 2' ' ' HIS . 9.9 p . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . 0.598 ' N ' HG22 ' D' ' 1' ' ' VAL . 1.5 t60 -140.48 123.31 16.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.26 -0.9 . . . . 0.0 109.572 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.919 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -138.39 -162.92 1.37 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.331 -0.856 . . . . 0.0 109.068 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.53 153.2 61.52 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 108.939 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.71 -26.39 68.49 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.498 2.132 . . . . 0.0 112.3 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.15 -27.86 22.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.862 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -84.07 -48.06 10.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.095 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.705 ' HB2' HD13 ' D' ' 3' ' ' LEU . 0.8 OUTLIER -68.84 -43.39 75.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.149 -0.969 . . . . 0.0 109.52 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -56.65 -23.58 42.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.173 -0.955 . . . . 0.0 110.026 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.57 -57.63 3.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.98 -1.075 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.02 -24.32 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 46.1 m -80.89 -36.96 30.54 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.723 -0.611 . . . . 0.0 109.782 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.81 -22.3 63.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.941 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' D' ' 16' ' ' GLY . 1.8 mt -59.85 -28.1 67.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.11 -0.994 . . . . 0.0 109.379 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . 0.66 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.5 OUTLIER -47.53 -17.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.198 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -76.83 -36.13 37.68 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.454 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 3.2 mmtt -89.36 -35.8 15.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -1.196 . . . . 0.0 109.298 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -47.94 114.95 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.32 -0.863 . . . . 0.0 109.668 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' D' ' 21' ' ' ASP . 83.5 m-20 -77.91 65.78 3.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 0.0 108.85 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 71.5 t -44.55 -17.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' D' ' 19' ' ' ASN . 13.4 m-20 -78.84 6.74 8.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' D' ' 19' ' ' ASN . 58.1 mt-10 -155.58 -46.94 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' D' ' 27' ' ' ALA . 85.9 t -47.8 -42.22 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.629 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.76 -43.42 96.46 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.85 -39.18 25.21 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -76.21 -25.78 55.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -1.151 . . . . 0.0 109.557 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' D' ' 23' ' ' VAL . . . -75.6 -34.02 60.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.477 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tp -82.96 -52.38 6.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.426 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.66 -26.71 17.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -77.91 -31.34 51.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -1.134 . . . . 0.0 109.447 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . 0.448 HD21 HMC1 ' D' ' 147' ' ' HEC . 32.5 tp -48.99 -34.61 13.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.352 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 29.1 mt -80.44 -21.97 41.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 23.8 t -82.54 -64.27 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.418 HG23 ' H ' ' D' ' 34' ' ' VAL . 3.0 t -61.05 -22.86 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 109.639 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -152.17 88.57 4.08 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.479 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.89 12.84 2.51 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.621 2.214 . . . . 0.0 112.251 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . 0.601 ' CZ2' ' ND2' ' D' ' 102' ' ' ASN . 0.7 OUTLIER -71.8 -20.01 61.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 109.546 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.592 HG23 ' NE1' ' D' ' 37' ' ' TRP . 1.3 p -84.09 51.06 1.97 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 109.273 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . 0.434 ' O ' ' CD1' ' D' ' 42' ' ' PHE . 38.6 tt0 -92.2 31.15 1.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 109.252 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -87.85 -42.92 12.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.589 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -93.1 14.3 18.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 109.551 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' D' ' 43' ' ' GLU . 1.6 p90 -68.28 -34.13 75.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.595 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . 0.54 ' N ' ' CD1' ' D' ' 42' ' ' PHE . 11.9 pt-20 -53.31 -17.4 1.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 0.0 109.543 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 60.8 m -85.56 -34.7 21.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -0.926 . . . . 0.0 109.59 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.526 ' O ' ' N ' ' D' ' 47' ' ' ASP . 10.1 m-85 -51.08 -20.95 1.62 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.358 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.98 12.44 0.15 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' D' ' 45' ' ' PHE . 15.1 m-20 -160.63 110.51 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -1.102 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 tp -158.72 20.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.294 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 58.7 m -46.91 -41.03 15.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.642 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . 0.469 ' HG1' ' CG ' ' D' ' 52' ' ' ASP . 4.8 p -146.57 150.37 40.02 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.359 -0.838 . . . . 0.0 109.217 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -41.16 -43.65 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.467 2.111 . . . . 0.0 112.382 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . 0.469 ' CG ' ' HG1' ' D' ' 50' ' ' THR . 1.7 p-10 -64.11 -31.09 72.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.152 -0.968 . . . . 0.0 109.447 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -56.94 -19.88 20.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 48.3 t -71.36 -61.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.571 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' D' ' 55' ' ' MET . 5.5 mmt -70.99 -0.48 9.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.88 . . . . 0.0 109.443 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.72 30.92 7.32 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -142.94 137.02 14.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.211 -1.17 . . . . 0.0 109.385 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.04 -30.77 5.45 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.516 2.144 . . . . 0.0 112.336 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -21.07 59.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 109.739 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.92 -41.46 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -0.955 . . . . 0.0 109.476 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -78.35 -25.35 46.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.36 -42.57 71.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.924 ' CE1' ' O1A' ' D' ' 147' ' ' HEC . 72.7 t60 -62.61 -23.83 67.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.549 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.36 -50.23 22.29 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -49.57 -30.84 9.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -1.147 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . 0.462 ' HB3' HBA1 ' D' ' 147' ' ' HEC . 67.8 mmtt -65.5 -53.68 38.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.899 . . . . 0.0 109.591 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 1.111 HG13 ' C2B' ' D' ' 147' ' ' HEC . 28.2 t -59.03 -36.92 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.413 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.425 HD23 ' C ' ' D' ' 68' ' ' LEU . 5.7 tt -65.51 -48.43 72.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 109.345 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.94 -41.08 10.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.28 91.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.167 . . . . 0.0 109.64 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . 0.577 ' CE2' HMB1 ' D' ' 147' ' ' HEC . 28.8 m-85 -61.5 -47.27 86.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.612 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . 0.66 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 19.4 m -62.56 -41.97 99.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.349 -0.844 . . . . 0.0 109.531 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -48.31 -34.85 11.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.44 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.71 -60.42 6.98 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.556 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.6 mp -54.04 -22.1 9.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.157 . . . . 0.0 109.32 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.06 2.51 56.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.942 . . . . 0.0 109.626 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -170.19 66.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.658 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . 0.442 HD22 HG12 ' D' ' 1' ' ' VAL . 96.3 mt -81.26 15.25 2.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.348 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.82 -23.22 60.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 37.1 t-20 -167.2 108.11 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.582 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . 0.481 HD11 ' N ' ' D' ' 1' ' ' VAL . 6.3 mt -80.31 -51.67 8.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.922 . . . . 0.0 109.373 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -67.01 -24.13 65.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.707 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -78.6 -39.11 22.58 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.9 t -85.1 -47.44 10.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.15 -1.206 . . . . 0.0 109.696 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' D' ' 84' ' ' THR . 40.4 m-85 -84.72 27.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.486 -0.759 . . . . 0.0 109.519 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.28 -31.41 72.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.359 -0.838 . . . . 0.0 109.626 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 51.1 p -75.77 -53.84 7.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.715 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -48.12 -42.98 30.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.595 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 3.0 m -67.0 -48.33 68.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.574 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -67.35 -22.66 65.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.761 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -81.73 -68.36 0.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.124 -0.985 . . . . 0.0 109.567 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.577 ' NE2' ' O ' ' D' ' 141' ' ' LEU . 1.1 p-80 -54.44 -20.67 7.99 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.172 -0.955 . . . . 0.0 109.939 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . 0.426 ' N ' ' ND1' ' D' ' 92' ' ' HIS . 41.3 t -83.53 -59.57 2.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 0.0 110.818 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.36 -56.41 3.45 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.072 -1.018 . . . . 0.0 111.396 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -57.69 -51.73 68.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.095 -1.003 . . . . 0.0 110.599 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.615 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 12.2 mt -97.42 -64.32 1.05 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.081 -1.012 . . . . 0.0 109.94 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.786 ' HB2' ' HB ' ' A' ' 38' ' ' THR . 0.0 OUTLIER 91.03 25.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.297 0.57 . . . . 0.0 109.868 -179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . 0.431 ' H ' HG23 ' D' ' 98' ' ' VAL . 17.5 t -46.73 140.79 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.5 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . 0.765 ' OD2' ' HB2' ' A' ' 94' ' ' ASP . 96.0 m-20 -53.94 149.41 17.68 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.399 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.84 36.45 0.4 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.6 2.2 . . . . 0.0 112.119 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -145.12 45.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.194 -0.941 . . . . 0.0 109.471 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.601 ' ND2' ' CZ2' ' D' ' 37' ' ' TRP . 4.4 m120 -143.8 5.95 1.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -0.843 . . . . 0.0 109.556 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 1.1 m-85 -89.73 -69.54 0.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 109.516 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . 0.568 ' NH2' ' CZ ' ' C' ' 36' ' ' PHE . 44.1 ttt180 -55.08 -20.88 10.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.895 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 tp -75.19 -31.14 60.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 1.078 HD22 ' HAB' ' D' ' 147' ' ' HEC . 8.8 tt -68.29 -55.33 12.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.7 -20.45 39.5 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . 0.514 ' OD1' ' CD2' ' C' ' 103' ' ' HIS . 61.7 t30 -60.18 -34.78 74.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.34 -1.094 . . . . 0.0 109.636 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 6.8 t -86.47 -24.15 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 109.599 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.64 -36.42 82.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.169 -0.957 . . . . 0.0 109.553 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . 0.438 ' CG1' ' CD1' ' D' ' 130' ' ' TYR . 4.4 m -74.99 -25.92 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.248 -0.908 . . . . 0.0 109.665 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . 0.516 ' HG ' ' CE1' ' C' ' 122' ' ' HIS . 16.9 t -66.84 -63.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.148 -0.97 . . . . 0.0 109.584 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . 0.401 ' H ' HG23 ' D' ' 113' ' ' VAL . 10.6 t -49.16 -21.59 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.506 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.91 -57.01 4.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.4 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -55.62 -27.37 49.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.892 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.489 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.75 -60.07 2.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.5 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -62.39 -17.55 59.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.611 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' D' ' 17' ' ' LYS . 65.7 m-85 -150.0 60.47 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.12 -0.987 . . . . 0.0 109.675 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' D' ' 121' ' ' GLU . . . -66.53 -45.33 86.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -47.29 -19.88 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -1.181 . . . . 0.0 109.31 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' D' ' 119' ' ' GLY . 70.1 mm-40 -94.76 -26.78 16.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.652 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.475 ' CD1' ' C ' ' D' ' 122' ' ' PHE . 0.7 OUTLIER -48.67 120.86 4.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.348 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 9.7 p -149.12 149.32 29.4 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.009 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.434 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 2.5 Cg_endo -46.21 -58.01 1.9 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.366 2.044 . . . . 0.0 113.168 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 19.3 Cg_endo -59.84 -11.12 13.8 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.168 1.912 . . . . 0.0 112.474 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 53.6 t -94.8 -53.19 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.034 -1.041 . . . . 0.0 109.821 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . 0.517 ' O ' ' NE2' ' D' ' 131' ' ' GLN . 41.0 mm-40 -61.37 -59.73 4.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.503 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -51.3 -37.39 47.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.313 -0.867 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.18 18.48 2.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.299 -0.876 . . . . 0.0 109.694 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.438 ' CD1' ' CG1' ' D' ' 111' ' ' VAL . 15.1 t80 -109.5 -61.73 1.59 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -0.908 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 0.674 ' NE2' ' H ' ' D' ' 131' ' ' GLN . 4.1 mp0 -48.46 -24.16 1.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.003 -1.061 . . . . 0.0 109.662 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . 0.401 ' HG3' ' CD2' ' B' ' 146' ' ' HIS . 35.7 ttpt -85.69 -37.38 19.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.279 -0.888 . . . . 0.0 110.21 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 0.4 OUTLIER -60.88 -44.21 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.067 -1.021 . . . . 0.0 109.821 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.496 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 7.0 m -83.6 -16.94 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.2 -0.938 . . . . 0.0 109.877 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.99 -25.13 1.26 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.07 -1.019 . . . . 0.0 109.432 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.97 -23.94 56.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' D' ' 134' ' ' VAL . 42.4 t -79.49 -31.78 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -1.105 . . . . 0.0 109.522 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.57 -50.78 56.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.396 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -67.07 -32.27 73.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.68 -42.42 34.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.95 . . . . 0.0 109.237 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.577 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 38.3 mt -84.12 18.44 2.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.392 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.45 -31.03 2.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.163 -0.961 . . . . 0.0 109.556 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -46.33 -41.92 14.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.206 -0.934 . . . . 0.0 109.285 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' D' ' 146' ' ' HIS . 35.7 mmtt -75.41 -54.39 7.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.419 -0.801 . . . . 0.0 109.127 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . 0.467 ' O ' ' CG ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -57.42 -6.21 0.42 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.501 -0.75 . . . . 0.0 109.234 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.447 ' CD2' ' HG3' ' B' ' 132' ' ' LYS . 11.6 m-70 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.759 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.777 HBB3 HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 1.103 ' C2B' HG13 ' B' ' 67' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.755 HBB3 HD21 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 1.111 ' C2B' HG13 ' D' ' 67' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 1' ' ' VAL . 73.9 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.585 HD21 ' OG ' ' A' ' 131' ' ' SER . 78.2 mt -144.7 178.82 7.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.995 . . . . 0.0 109.723 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.73 167.11 26.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.434 -0.791 . . . . 0.0 109.069 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.15 -43.72 2.98 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.599 2.199 . . . . 0.0 112.563 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.29 -19.35 33.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.977 -1.077 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.783 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.7 t0 -47.85 -37.14 13.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.413 ' CD ' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -81.19 -43.59 19.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.869 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.0 m -51.15 -37.53 46.79 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.123 -0.986 . . . . 0.0 109.558 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -74.93 -31.96 61.64 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 6' ' ' ASP . 58.6 t -72.36 -51.27 30.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -49.98 -47.44 52.81 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.9 -61.28 2.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.458 -0.776 . . . . 0.0 109.537 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.64 -40.06 68.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.424 -0.797 . . . . 0.0 109.058 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -17.16 64.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.425 -0.797 . . . . 0.0 108.955 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.34 -44.96 15.69 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 12.2 mmmt -70.66 -40.66 72.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -1.166 . . . . 0.0 108.802 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' ALA . 61.9 t -60.27 -64.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 46.1 -127.34 9.36 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 23.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -1.102 . . . . 0.0 110.569 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' A' ' 18' ' ' GLY . 86.0 m-70 -130.07 25.77 5.22 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -90.24 -63.8 1.23 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.693 -0.629 . . . . 0.0 109.754 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.77 -14.3 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.0 mm-40 -83.28 -56.51 3.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.371 -1.076 . . . . 0.0 109.559 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.625 ' CD1' ' CD2' ' A' ' 112' ' ' HIS . 3.6 m-30 -62.07 -32.24 72.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.462 -0.773 . . . . 0.0 109.274 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.19 -23.4 77.29 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.08 -44.38 22.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -1.09 . . . . 0.0 109.587 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -61.1 -26.24 67.52 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -26.78 68.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.526 HD11 ' ND1' ' A' ' 58' ' ' HIS . 14.1 mt -72.51 -58.4 3.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.471 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -52.16 -38.91 59.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.887 ' HG3' HE22 ' B' ' 127' ' ' GLN . 0.9 OUTLIER -68.21 -50.58 53.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.299 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.469 ' SD ' ' C ' ' A' ' 32' ' ' MET . 15.2 tmm? -62.4 -29.15 70.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.876 . . . . 0.0 109.351 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.69 -58.73 6.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 110.026 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.4 pp -73.89 -39.62 63.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.2 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.524 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 50.8 m -46.71 -16.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.081 -1.012 . . . . 0.0 109.825 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 35' ' ' SER . 15.2 m-85 -159.37 89.64 1.99 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 0.0 109.362 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 40' ' ' LYS . 52.5 Cg_exo -52.77 -20.07 12.07 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.457 2.105 . . . . 0.0 112.095 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.2 p -49.08 -18.91 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.403 ' N ' ' C ' ' A' ' 37' ' ' PRO . 30.3 p -84.17 -22.92 30.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' PRO . 29.9 ttmt -55.5 -47.01 76.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.567 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.667 HG21 ' O ' ' D' ' 94' ' ' ASP . 5.1 t -72.4 -18.85 61.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.8 . . . . 0.0 109.417 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' O ' ' CD1' ' A' ' 42' ' ' TYR . 37.2 t80 -75.96 -15.64 60.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.587 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' A' ' 41' ' ' THR . 21.2 m-85 55.66 87.07 0.15 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.661 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 45.4 Cg_exo -51.92 -38.83 69.39 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.436 2.09 . . . . 0.0 111.76 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.661 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 94.35 34.46 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 178.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.47 ' CE2' ' HB3' ' A' ' 44' ' ' PRO . 2.2 p90 -145.53 31.24 1.09 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.506 -1.371 . . . . 0.0 110.078 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 49' ' ' SER . 1.1 m-20 52.84 91.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.872 . . . . 0.0 109.614 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.19 1.87 0.43 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.373 -0.83 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 47' ' ' ASP . 9.2 m -62.48 140.95 58.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.421 ' ND1' ' O ' ' A' ' 50' ' ' HIS . 0.1 OUTLIER -63.72 140.34 58.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.448 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.21 12.13 81.23 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.631 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 2.2 t -59.31 -20.58 55.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -1.174 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 72.61 -24.33 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -0.782 . . . . 0.0 109.61 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 52' ' ' SER . 33.5 mt-30 -80.31 -24.32 40.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.569 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.8 t -75.85 -35.14 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.436 ' HG2' ' H ' ' A' ' 56' ' ' LYS . 14.1 ptpt -79.17 -34.67 42.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.946 . . . . 0.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.19 -24.52 76.3 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.526 ' ND1' HD11 ' A' ' 29' ' ' LEU . 5.9 t-80 -68.15 -43.87 77.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.317 -1.108 . . . . 0.0 109.316 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.8 -46.97 25.19 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 48.5 mttm -54.6 -23.19 15.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.512 -0.993 . . . . 0.0 109.644 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -36.85 58.09 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.199 -0.938 . . . . 0.0 108.902 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -73.73 -47.39 44.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.499 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -68.64 -29.09 67.51 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.312 -0.868 . . . . 0.0 109.342 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 25.6 m-20 -66.79 -47.23 72.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.096 -1.002 . . . . 0.0 108.75 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.457 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -61.9 -49.46 76.11 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.3 mt -55.37 -46.03 76.5 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 71' ' ' ALA . 27.6 m -64.97 -55.55 18.43 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.301 -0.874 . . . . 0.0 108.749 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -55.9 -29.3 59.78 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.73 -48.12 12.06 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 66' ' ' LEU . 54.9 t -65.17 -22.5 31.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -68.94 -16.48 63.76 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.588 ' O ' ' N ' ' A' ' 74' ' ' ASP . 34.2 m170 -145.1 -56.9 0.33 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.306 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.4 p 44.94 13.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.665 0.745 . . . . 0.0 109.576 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 72' ' ' HIS . 99.2 m-20 -123.69 8.41 8.86 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -175.92 28.69 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.147 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 5.2 ptt? -78.09 -24.64 0.45 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 111.676 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 76' ' ' MET . 53.2 Cg_exo -54.83 -23.66 34.93 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.759 1.639 . . . . 0.0 112.195 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -93.32 -37.24 12.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.88 75.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.149 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.5 mt -81.74 8.79 9.15 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.325 -0.86 . . . . 0.0 109.048 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.0 t -56.11 -41.05 74.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.845 . . . . 0.0 109.618 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -56.22 -57.33 12.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 109.576 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 83' ' ' LEU . 4.2 mt -46.31 -46.69 18.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.376 -0.827 . . . . 0.0 108.819 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 m -59.96 -29.64 68.56 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.476 -0.765 . . . . 0.0 109.289 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 89' ' ' HIS . 76.0 m-20 -81.52 -38.93 25.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 0.0 109.339 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 87' ' ' HIS . 4.1 tt -59.18 -36.04 74.62 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.334 -0.853 . . . . 0.0 109.46 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.434 ' CE1' HD22 ' A' ' 86' ' ' LEU . 51.1 m80 -92.12 -23.07 19.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.949 . . . . 0.0 109.69 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.52 -9.49 29.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.238 -0.914 . . . . 0.0 109.922 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 85' ' ' ASP . 42.9 m80 -143.93 47.93 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -0.97 . . . . 0.0 109.698 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.13 -69.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 109.319 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.453 ' C ' ' N ' ' A' ' 93' ' ' VAL . 11.7 mt -88.76 -23.84 22.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 109.447 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 51.65 10.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.565 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.453 ' N ' ' C ' ' A' ' 91' ' ' LEU . 14.8 p -52.62 144.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.492 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 151.68 86.12 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.31 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 97' ' ' ASN . 47.6 Cg_endo -70.12 -20.98 32.45 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.558 2.172 . . . . 0.0 112.123 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.546 HG11 ' OD1' ' D' ' 99' ' ' ASP . 93.2 t -45.84 -15.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 109.756 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 95' ' ' PRO . 3.4 m120 -79.25 -24.88 42.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 109.577 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.495 ' CD1' ' C ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -69.1 -31.14 69.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.364 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -58.56 -29.94 66.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.504 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 17.6 mt -83.91 -62.18 1.63 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.581 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.544 HD22 ' HAB' ' A' ' 142' ' ' HEC . 7.1 tt -45.65 -24.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.597 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.7 t -65.22 -57.26 8.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.928 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -73.74 -26.5 60.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.981 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 9.5 m -70.32 -23.45 62.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.099 -1.001 . . . . 0.0 110.157 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.725 ' O ' HD12 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -80.56 -22.87 40.37 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.937 -1.102 . . . . 0.0 108.926 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -84.99 -18.78 33.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.852 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.0 t -77.5 -50.33 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 110' ' ' ALA . 43.4 p -52.56 -51.91 57.46 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.161 -0.962 . . . . 0.0 109.678 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 113' ' ' LEU . 7.9 mt -43.74 -26.36 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.465 -0.772 . . . . 0.0 109.759 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -71.92 -25.65 61.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.924 . . . . 0.0 110.486 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.47 -3.79 54.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.106 -0.996 . . . . 0.0 110.902 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.625 ' CD2' ' CD1' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -150.15 -69.08 0.19 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.782 -1.199 . . . . 0.0 109.669 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.481 ' H ' ' CD2' ' A' ' 112' ' ' HIS . 0.4 OUTLIER -118.29 81.24 16.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.47 ' N ' ' O ' ' A' ' 109' ' ' LEU . 51.2 Cg_exo -49.32 -170.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.44 2.094 . . . . 0.0 112.589 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.729 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -48.65 -55.63 10.75 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.649 ' CG ' ' O ' ' A' ' 115' ' ' ALA . 2.8 mm-40 130.5 0.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.1 t80 66.3 30.37 9.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.842 -0.536 . . . . 0.0 111.138 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.706 ' O ' ' N ' ' A' ' 120' ' ' ALA . 2.1 p -103.79 128.12 27.97 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 120.996 -1.065 . . . . 0.0 108.249 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.64 23.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.102 1.868 . . . . 0.0 112.923 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.706 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -157.03 -32.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 0.0 110.669 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.729 HG21 ' O ' ' A' ' 115' ' ' ALA . 12.9 p -49.84 -47.24 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.13 -0.981 . . . . 0.0 110.299 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.656 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.4 t60 -61.74 -38.56 88.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.771 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.41 -20.12 34.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 109.95 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -66.28 -62.36 1.52 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.95 . . . . 0.0 110.245 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.568 HD22 HD21 ' A' ' 105' ' ' LEU . 1.4 mt -65.11 -19.81 66.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.071 -1.018 . . . . 0.0 109.467 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.17 -49.27 37.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.15 -42.1 11.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 109.635 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.574 ' CD2' HG21 ' A' ' 10' ' ' VAL . 32.0 t80 -50.0 -22.92 1.75 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 109.255 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.665 ' C ' HD12 ' A' ' 129' ' ' LEU . 1.2 pp -76.37 -22.08 55.29 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.14 -38.1 75.91 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.585 ' OG ' HD21 ' A' ' 2' ' ' LEU . 34.6 m -67.92 -26.8 66.16 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.469 ' O ' HD13 ' A' ' 136' ' ' LEU . 5.6 t -85.55 -37.67 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.8 t -80.06 -18.0 51.22 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.298 -0.876 . . . . 0.0 108.738 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 130' ' ' ALA . 41.8 m -83.28 -42.44 17.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.468 -0.77 . . . . 0.0 109.208 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 131' ' ' SER . 27.3 m -70.06 -21.97 24.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.24 -0.913 . . . . 0.0 108.756 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 132' ' ' VAL . 0.9 OUTLIER -67.46 -31.8 72.22 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.1 m -153.27 57.1 0.77 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.7 t -63.56 -57.47 10.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.478 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 51.69 -122.93 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.404 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -152.8 50.21 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -0.954 . . . . 0.0 109.463 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.441 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.526 ' O ' ' NZ ' ' B' ' 132' ' ' LYS . 7.6 p . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 52.31 47.91 23.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.094 -1.004 . . . . 0.0 108.949 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 1.078 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -107.63 -159.13 0.68 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.496 -0.752 . . . . 0.0 109.361 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 9.9 p -103.57 134.4 19.77 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.394 -0.816 . . . . 0.0 109.29 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -42.1 -22.79 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.438 2.092 . . . . 0.0 112.467 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -76.62 -55.6 5.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 110.065 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -68.16 -60.45 2.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.961 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.775 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -48.74 -30.14 5.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 2.9 m -62.05 -23.61 66.58 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.979 -1.075 . . . . 0.0 110.032 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.05 -57.68 3.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.886 -1.134 . . . . 0.0 109.958 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.55 -24.95 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 56.6 m -83.39 -37.36 23.4 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.453 0.644 . . . . 0.0 109.538 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' B' ' 9' ' ' SER . . . -63.19 -29.92 71.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.369 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.7 OUTLIER -52.16 -32.46 36.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.119 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . 0.539 ' HE1' ' HG ' ' B' ' 72' ' ' SER . 0.2 OUTLIER -47.15 -17.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.509 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.34 -52.02 5.81 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.431 ' HG2' ' H ' ' B' ' 17' ' ' LYS . 0.1 OUTLIER -70.48 -29.41 65.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -1.179 . . . . 0.0 109.263 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -48.72 114.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 22' ' ' GLU . 18.3 m120 -82.56 69.41 9.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 108.953 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' B' ' 22' ' ' GLU . 78.3 t -43.88 -29.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 0.0 109.72 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -64.69 1.91 0.77 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.567 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' B' ' 20' ' ' VAL . 33.0 mt-10 -155.89 -46.11 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 109.424 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -48.52 -53.96 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.41 -48.52 48.14 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.34 -46.35 79.09 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -62.44 -39.96 95.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.27 -1.136 . . . . 0.0 109.394 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.74 88.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.179 -0.95 . . . . 0.0 109.364 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -82.2 -51.22 8.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.309 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.91 -35.08 62.53 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -79.37 -30.65 42.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -1.158 . . . . 0.0 109.495 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 60.6 tp -49.42 -39.03 31.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.379 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.53 -23.45 56.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.583 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.79 -61.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.188 -0.945 . . . . 0.0 109.413 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.403 ' H ' HG23 ' B' ' 34' ' ' VAL . 3.2 t -69.36 -23.82 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -136.73 76.09 48.27 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.64 11.49 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.725 2.283 . . . . 0.0 112.335 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.468 ' CE2' HG23 ' B' ' 38' ' ' THR . 51.3 p-90 -80.62 -19.71 44.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 109.341 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.793 ' HB ' HBC1 ' B' ' 147' ' ' HEC . 42.0 p -79.77 40.2 0.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 109.36 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -92.16 12.84 20.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 0.0 109.55 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -87.86 -34.49 18.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' B' ' 42' ' ' PHE . 29.9 m-85 -95.79 32.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 109.59 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.507 ' CZ ' HBC3 ' B' ' 147' ' ' HEC . 57.5 m-85 -141.36 26.32 1.98 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.94 -25.08 37.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.561 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.483 ' C ' ' H ' ' B' ' 46' ' ' GLY . 66.8 m -82.13 -38.17 25.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.602 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -56.0 -5.41 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' B' ' 44' ' ' SER . . . 48.57 -167.67 0.16 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' B' ' 48' ' ' LEU . 18.9 t70 60.19 -150.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -1.149 . . . . 0.0 109.536 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.473 ' H ' ' CG ' ' B' ' 47' ' ' ASP . 24.2 mt 60.57 34.33 20.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 109.53 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.3 m -80.49 -22.52 40.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.41 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . 0.502 ' O ' ' N ' ' B' ' 53' ' ' ALA . 21.4 p -146.11 149.02 37.24 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.279 -0.888 . . . . 0.0 109.166 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -36.75 -45.07 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.644 2.23 . . . . 0.0 112.591 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.88 -26.93 61.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 109.544 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -57.78 -19.64 29.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.05 -63.36 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.135 -0.978 . . . . 0.0 109.633 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . 0.542 ' SD ' ' N ' ' B' ' 55' ' ' MET . 2.3 mpp? -79.69 14.81 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.05 -49.01 4.41 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.497 ' N ' HD22 ' B' ' 57' ' ' ASN . 1.0 OUTLIER -77.82 149.61 77.54 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.227 -1.16 . . . . 0.0 109.46 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.36 -51.94 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.671 2.247 . . . . 0.0 112.176 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.403 ' CG ' ' N ' ' B' ' 60' ' ' VAL . 54.2 pttt -46.92 -40.75 14.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.56 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' B' ' 59' ' ' LYS . 87.1 t -54.21 -44.85 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' B' ' 61' ' ' LYS . 7.0 mtmp? -77.39 -43.0 34.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.222 -0.924 . . . . 0.0 109.438 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.17 -33.12 18.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.573 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 5.8 t60 -67.67 -24.4 65.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.68 -30.25 74.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 mmtm -68.15 -41.23 81.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.121 . . . . 0.0 109.318 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -64.08 -50.89 66.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.779 . . . . 0.0 109.36 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 0.794 HG22 ' C4A' ' B' ' 147' ' ' HEC . 25.3 t -61.78 -23.91 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.251 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tt -78.11 -29.8 49.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.475 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.22 -57.13 14.33 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.54 -22.03 63.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -74.46 -30.34 61.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.63 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.539 ' HG ' ' HE1' ' B' ' 15' ' ' TRP . 4.4 m -89.11 -20.48 24.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 109.762 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -46.15 -30.79 2.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 109.621 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.29 -59.24 7.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.558 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.75 -17.73 10.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 109.667 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -97.38 32.9 2.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.977 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.549 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 9.5 m-70 -176.67 -49.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.161 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' B' ' 77' ' ' HIS . 29.8 mt 39.64 35.3 0.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.637 -0.665 . . . . 0.0 109.614 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -138.62 -31.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.651 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 7.5 p-10 -151.91 72.71 1.03 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.171 -0.956 . . . . 0.0 109.363 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.552 ' N ' HD12 ' B' ' 81' ' ' LEU . 9.6 mp -60.4 -27.08 67.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.912 . . . . 0.0 109.461 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -80.62 -61.48 1.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.77 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.32 -23.9 43.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.432 HG23 ' O ' ' B' ' 80' ' ' ASN . 0.8 OUTLIER -62.4 -51.91 65.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.166 -1.196 . . . . 0.0 109.537 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.546 ' CZ ' ' O ' ' B' ' 81' ' ' LEU . 2.2 p90 -133.18 51.93 2.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.554 -0.716 . . . . 0.0 109.639 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -48.97 -29.47 4.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -0.994 . . . . 0.0 109.287 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.404 ' OG1' ' N ' ' B' ' 88' ' ' LEU . 17.8 p -60.5 -58.5 8.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.326 -0.859 . . . . 0.0 109.392 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.404 ' N ' ' OG1' ' B' ' 87' ' ' THR . 90.7 mt -48.56 -37.43 17.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.026 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -69.06 -34.84 75.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.913 . . . . 0.0 109.002 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -82.91 -39.01 22.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 109.419 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.07 -25.31 64.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.897 . . . . 0.0 109.397 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' B' ' 97' ' ' HIS . 6.8 m80 -90.98 -21.81 21.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.181 -0.95 . . . . 0.0 109.567 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.58 -59.05 2.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 111.059 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.592 ' O ' HG21 ' C' ' 41' ' ' THR . 1.3 m-20 -87.21 -57.0 3.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.976 -1.077 . . . . 0.0 112.009 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' B' ' 95' ' ' LYS . 12.1 mptt -62.81 -52.16 64.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.122 -0.986 . . . . 0.0 111.195 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.608 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -95.43 -38.2 10.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.973 -1.079 . . . . 0.0 109.837 -178.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 25.3 p80 45.52 33.06 1.25 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.206 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.587 HG23 HD12 ' B' ' 96' ' ' LEU . 52.0 t -50.13 132.4 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.949 -1.094 . . . . 0.0 109.139 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.507 ' OD1' HG11 ' C' ' 96' ' ' VAL . 4.2 m-20 -51.15 151.24 5.02 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.266 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.03 -170.35 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.439 2.093 . . . . 0.0 112.026 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' D' ' 101' ' ' GLU . 69.1 mm-40 53.24 69.95 0.64 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.47 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.467 ' ND2' ' CD1' ' B' ' 103' ' ' PHE . 3.9 p-10 -171.24 -39.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.49 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.467 ' CD1' ' ND2' ' B' ' 102' ' ' ASN . 12.9 m-85 -50.34 -34.51 24.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -76.13 -43.94 40.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.613 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.521 HD12 ' N ' ' B' ' 105' ' ' LEU . 9.9 mp -49.32 -51.81 31.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 1.043 HD13 ' CHC' ' B' ' 147' ' ' HEC . 6.5 tt -51.69 -37.17 49.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.852 . . . . 0.0 109.353 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.98 -20.57 59.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -65.36 -34.26 77.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -1.169 . . . . 0.0 109.561 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.86 -31.67 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 7.7 tp -51.67 -52.09 50.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.517 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.564 ' CG2' ' CE1' ' B' ' 130' ' ' TYR . 42.6 t -51.18 -42.86 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.596 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -60.06 -39.56 86.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.164 -0.96 . . . . 0.0 109.618 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.55 -55.03 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.165 -0.959 . . . . 0.0 109.606 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.03 -31.75 71.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.495 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -64.9 -27.8 69.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.403 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.463 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.79 -61.28 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.227 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.42 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 8.3 m-70 -63.3 -18.28 63.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.42 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 58.8 m-85 -148.44 59.53 1.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -71.95 -14.8 76.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -79.48 -20.29 47.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.271 -1.135 . . . . 0.0 109.528 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' B' ' 123' ' ' THR . 29.1 mm-40 -95.48 -2.49 48.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.953 . . . . 0.0 109.77 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -73.78 33.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 0.0 109.606 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.468 ' H ' ' C ' ' B' ' 121' ' ' GLU . 22.0 p -49.22 148.41 4.4 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.364 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.454 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 2.3 Cg_endo -46.83 -57.51 2.25 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.448 2.099 . . . . 0.0 113.002 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 17.8 Cg_endo -59.49 -42.36 48.86 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.093 1.862 . . . . 0.0 112.233 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 98.9 t -65.11 -20.76 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.458 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . 0.887 HE22 ' HG3' ' A' ' 31' ' ' ARG . 37.0 tt0 -83.31 -48.99 9.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.552 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.658 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -58.66 -30.06 67.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.437 ' O ' HG23 ' B' ' 133' ' ' VAL . . . -82.14 19.17 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.144 -0.972 . . . . 0.0 109.672 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.564 ' CE1' ' CG2' ' B' ' 111' ' ' VAL . 47.4 t80 -107.95 -61.4 1.58 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.283 -0.886 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 5.9 tp-100 -55.28 -23.26 22.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.947 . . . . 0.0 109.57 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' B' ' 1' ' ' VAL . 22.7 ttpp -83.04 -21.8 33.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.647 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . 0.437 HG23 ' O ' ' B' ' 129' ' ' ALA . 76.8 t -81.13 -68.31 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 109.696 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 22.4 m -53.76 -25.04 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.848 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -49.56 -29.78 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.461 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.4 -29.28 56.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 96.4 t -76.42 -38.14 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -1.169 . . . . 0.0 109.4 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.96 79.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.42 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 1.653 HD21 ' CD2' ' D' ' 146' ' ' HIS . 1.8 m120 -79.67 -22.96 42.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.85 -60.52 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.601 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.74 -25.26 66.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.331 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 -16.35 27.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.472 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -51.33 -33.38 29.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 109.361 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -73.34 -27.15 61.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -71.94 -46.18 58.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.5 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 1.605 ' CD2' HD21 ' D' ' 139' ' ' ASN . 43.5 p-80 . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.942 -1.027 . . . . 0.0 109.548 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.488 HG12 ' O ' ' C' ' 1' ' ' VAL . 73.2 t . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.571 HD21 ' OG ' ' C' ' 131' ' ' SER . 78.0 mt -144.72 178.84 7.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.975 . . . . 0.0 109.772 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.77 167.17 25.85 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.05 -43.81 3.0 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.668 2.245 . . . . 0.0 112.62 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.3 -19.35 33.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.999 -1.063 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.771 ' O ' HG23 ' C' ' 10' ' ' VAL . 24.5 t0 -47.84 -37.24 13.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.735 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -43.61 19.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.953 . . . . 0.0 109.886 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 37.3 m -51.14 -37.5 46.53 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.184 -0.947 . . . . 0.0 109.562 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -74.94 -31.92 61.62 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.771 HG23 ' O ' ' C' ' 6' ' ' ASP . 58.5 t -72.46 -51.13 30.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -50.15 -47.3 54.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.87 -61.35 2.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.479 -0.763 . . . . 0.0 109.573 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.644 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.48 -40.21 68.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.278 -0.889 . . . . 0.0 109.039 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -17.1 64.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.309 -0.869 . . . . 0.0 108.959 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.36 -44.84 15.96 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -70.68 -40.68 72.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -1.153 . . . . 0.0 108.841 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.644 HG23 ' O ' ' C' ' 13' ' ' ALA . 61.7 t -60.28 -64.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 46.0 -127.27 9.15 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 23.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.465 -1.02 . . . . 0.0 110.544 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' C' ' 18' ' ' GLY . 85.9 m-70 -130.05 25.77 5.23 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -90.19 -63.88 1.21 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.74 -14.34 0.23 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.0 mm-40 -83.28 -56.42 3.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.425 -1.044 . . . . 0.0 109.53 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.622 ' CE1' ' CD2' ' C' ' 112' ' ' HIS . 3.6 m-30 -62.11 -32.31 72.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.416 -0.802 . . . . 0.0 109.179 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.18 -23.46 77.23 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.93 -44.38 22.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.212 -1.169 . . . . 0.0 109.662 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.24 -26.08 67.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.31 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.37 -26.86 68.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.534 HD11 ' ND1' ' C' ' 58' ' ' HIS . 14.1 mt -72.44 -58.37 3.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.523 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -52.23 -38.82 59.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.57 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.901 ' HG3' HE22 ' D' ' 127' ' ' GLN . 0.9 OUTLIER -68.21 -50.67 52.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.177 -0.952 . . . . 0.0 109.224 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 0.482 ' SD ' ' C ' ' C' ' 32' ' ' MET . 15.2 tmm? -62.39 -29.07 70.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.953 . . . . 0.0 109.392 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -62.78 -58.69 6.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 0.0 109.953 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.4 pp -74.0 -39.57 63.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 110.144 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.528 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 50.5 m -46.81 -16.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.059 -1.026 . . . . 0.0 109.815 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' C' ' 35' ' ' SER . 15.2 m-85 -159.37 89.74 1.99 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.332 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.73 -20.18 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.519 2.146 . . . . 0.0 112.082 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 19.3 p -49.01 -18.96 0.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.552 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 30.2 p -84.12 -22.98 30.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.471 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -55.5 -46.97 76.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.576 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.592 HG21 ' O ' ' B' ' 94' ' ' ASP . 5.2 t -72.4 -18.92 61.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.36 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.414 ' O ' ' CD1' ' C' ' 42' ' ' TYR . 37.3 t80 -75.93 -15.66 60.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 109.622 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.44 ' CE2' ' O ' ' C' ' 41' ' ' THR . 21.2 m-85 55.67 87.08 0.15 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.66 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 46.0 Cg_exo -51.91 -38.85 69.27 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.425 2.083 . . . . 0.0 111.784 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.66 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 0.0 OUTLIER 94.28 34.62 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 178.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.48 ' CZ ' ' CB ' ' C' ' 44' ' ' PRO . 2.1 p90 -145.72 31.21 1.07 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.503 -1.373 . . . . 0.0 110.046 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' C' ' 49' ' ' SER . 1.1 m-20 52.88 91.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.633 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.07 1.74 0.41 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 109.58 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.465 ' H ' ' C ' ' C' ' 47' ' ' ASP . 9.3 m -62.46 140.97 58.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.443 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' C' ' 50' ' ' HIS . 0.1 OUTLIER -63.64 140.32 58.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.938 . . . . 0.0 109.541 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.15 12.16 81.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 2.3 t -59.22 -20.68 56.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -1.205 . . . . 0.0 109.326 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 72.62 -24.29 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.629 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' C' ' 52' ' ' SER . 33.5 mt-30 -80.41 -24.17 39.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 16.8 t -75.96 -35.09 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.492 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.19 -34.61 42.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 108.871 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.23 -24.41 76.45 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.534 ' ND1' HD11 ' C' ' 29' ' ' LEU . 5.8 t-80 -68.19 -43.93 76.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.397 -1.061 . . . . 0.0 109.277 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -47.77 -46.88 24.98 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' C' ' 64' ' ' ASP . 48.3 mttm -54.77 -23.12 16.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -1.027 . . . . 0.0 109.57 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.27 -36.91 58.21 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.178 -0.951 . . . . 0.0 108.9 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.467 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -73.77 -47.35 44.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.503 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -68.56 -29.09 67.56 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.428 -0.795 . . . . 0.0 109.416 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' C' ' 60' ' ' LYS . 25.8 m-20 -66.74 -47.23 72.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.093 -1.004 . . . . 0.0 108.697 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.456 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -62.08 -49.31 76.46 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.434 ' O ' HG23 ' C' ' 70' ' ' VAL . 1.3 mt -55.36 -46.11 76.46 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.514 ' O ' ' N ' ' C' ' 71' ' ' ALA . 27.4 m -65.03 -55.5 18.56 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -55.86 -29.37 59.8 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.72 -48.12 12.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 66' ' ' LEU . 54.9 t -65.14 -22.55 31.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -68.9 -16.5 63.77 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.58 ' O ' ' N ' ' C' ' 74' ' ' ASP . 34.2 m170 -145.17 -56.82 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 0.0 109.217 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.5 p 44.85 13.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.744 0.783 . . . . 0.0 109.56 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' C' ' 72' ' ' HIS . 99.3 m-20 -123.63 8.35 8.89 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -175.84 28.73 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.178 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 5.2 ptt? -78.13 -24.55 0.45 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.765 . . . . 0.0 111.664 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.9 Cg_exo -54.8 -23.73 35.01 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.74 1.627 . . . . 0.0 112.197 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -93.26 -37.19 12.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.587 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.75 75.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.213 -0.929 . . . . 0.0 109.203 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 mt -81.88 8.85 9.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 0.0 108.939 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 27.9 t -56.24 -40.95 74.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.882 . . . . 0.0 109.589 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -56.31 -57.33 12.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.536 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.457 HD23 ' N ' ' C' ' 83' ' ' LEU . 4.2 mt -46.25 -46.68 17.96 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 3.9 m -59.99 -29.56 68.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.564 -0.71 . . . . 0.0 109.285 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' C' ' 89' ' ' HIS . 75.9 m-20 -81.63 -38.88 25.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.324 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.432 HD22 ' CE1' ' C' ' 87' ' ' HIS . 4.1 tt -59.14 -36.11 74.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.375 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . 0.432 ' CE1' HD22 ' C' ' 86' ' ' LEU . 52.1 m80 -92.16 -23.04 19.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 109.684 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.52 -9.39 29.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.215 -0.928 . . . . 0.0 109.887 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' C' ' 85' ' ' ASP . 43.2 m80 -144.03 47.94 1.41 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.056 -1.027 . . . . 0.0 109.776 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.19 -69.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.338 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' C' ' 93' ' ' VAL . 11.6 mt -88.77 -23.8 22.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 109.51 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 51.67 10.06 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.466 ' H ' ' C ' ' C' ' 91' ' ' LEU . 14.9 p -52.69 144.52 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.1 151.71 86.13 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.313 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' C' ' 97' ' ' ASN . 47.7 Cg_endo -70.11 -21.0 32.45 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.546 2.164 . . . . 0.0 112.136 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.507 HG11 ' OD1' ' B' ' 99' ' ' ASP . 90.6 t -45.75 -15.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 109.769 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' C' ' 95' ' ' PRO . 3.3 m120 -79.21 -24.89 42.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.595 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' C' ' 98' ' ' PHE . 0.1 OUTLIER -68.99 -31.27 69.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 109.435 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -58.51 -29.9 66.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.6 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.471 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 17.7 mt -83.92 -62.14 1.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.584 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.528 HD22 ' HAB' ' C' ' 142' ' ' HEC . 7.1 tt -45.65 -24.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.616 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.7 t -65.33 -57.24 8.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.865 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -73.78 -26.43 60.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 109.998 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 9.6 m -70.41 -23.34 62.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 110.17 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.714 ' O ' HD12 ' C' ' 105' ' ' LEU . 0.1 OUTLIER -80.69 -22.7 40.15 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.943 -1.098 . . . . 0.0 108.936 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.9 mt -85.12 -18.77 33.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.912 . . . . 0.0 109.702 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 74.1 t -77.51 -50.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.965 . . . . 0.0 109.742 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 43.5 p -52.46 -52.04 56.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.251 -0.906 . . . . 0.0 109.666 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' C' ' 114' ' ' PRO . 7.9 mt -43.61 -26.41 0.23 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.544 -0.723 . . . . 0.0 109.756 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -71.9 -25.66 62.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 110.477 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.45 -3.88 54.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.053 -1.029 . . . . 0.0 110.835 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . 0.622 ' CD2' ' CE1' ' C' ' 24' ' ' TYR . 0.2 OUTLIER -150.11 -69.22 0.19 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.73 -1.231 . . . . 0.0 109.639 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.478 ' H ' ' CD2' ' C' ' 112' ' ' HIS . 0.4 OUTLIER -118.22 81.27 16.59 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . 0.48 ' N ' ' O ' ' C' ' 109' ' ' LEU . 51.4 Cg_exo -49.24 -170.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.462 2.108 . . . . 0.0 112.567 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.738 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -48.7 -55.62 10.87 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.638 ' CG ' ' O ' ' C' ' 115' ' ' ALA . 2.8 mm-40 130.46 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 13.0 t80 66.37 30.38 8.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.717 -0.614 . . . . 0.0 111.08 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.7 ' O ' ' N ' ' C' ' 120' ' ' ALA . 2.1 p -103.83 128.04 28.12 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 108.287 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.59 23.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.217 1.945 . . . . 0.0 112.907 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.7 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -157.01 -32.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.746 -1.221 . . . . 0.0 110.675 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.738 HG21 ' O ' ' C' ' 115' ' ' ALA . 12.9 p -49.86 -47.31 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.035 . . . . 0.0 110.236 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.641 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.4 t60 -61.72 -38.5 88.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.85 . . . . 0.0 109.778 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.37 -20.19 34.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.995 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -62.29 1.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.259 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.576 HD22 HD21 ' C' ' 105' ' ' LEU . 1.4 mt -65.14 -19.87 66.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 109.411 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -72.12 -49.31 37.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.958 . . . . 0.0 109.66 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.18 -42.03 11.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -0.929 . . . . 0.0 109.632 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.573 ' CD2' HG21 ' C' ' 10' ' ' VAL . 32.1 t80 -49.97 -22.88 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 109.364 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.665 ' C ' HD12 ' C' ' 129' ' ' LEU . 1.2 pp -76.43 -22.03 55.18 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.15 -38.11 75.97 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.571 ' OG ' HD21 ' C' ' 2' ' ' LEU . 33.8 m -67.88 -26.82 66.2 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . 0.449 ' O ' HD13 ' C' ' 136' ' ' LEU . 5.7 t -85.61 -37.61 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.358 -0.839 . . . . 0.0 108.879 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 14.9 t -79.97 -18.09 51.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.318 -0.864 . . . . 0.0 108.778 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 42.6 m -83.24 -42.46 17.18 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.452 -0.78 . . . . 0.0 109.238 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.461 HG13 ' O ' ' C' ' 131' ' ' SER . 27.4 m -70.13 -21.93 24.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.245 -0.909 . . . . 0.0 108.694 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.449 HD13 ' O ' ' C' ' 132' ' ' VAL . 0.9 OUTLIER -67.4 -31.91 72.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.448 -0.783 . . . . 0.0 108.941 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 7.2 m -153.19 57.1 0.77 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.296 -0.877 . . . . 0.0 109.47 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 25.5 t -63.52 -57.44 10.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.935 . . . . 0.0 109.518 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? 51.58 -122.9 2.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.405 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -152.83 50.29 0.74 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.956 . . . . 0.0 109.367 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.493 179.943 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.527 ' O ' ' NZ ' ' D' ' 132' ' ' LYS . 7.6 p . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 50.0 m80 52.31 47.95 23.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 0.0 108.964 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 1.05 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -107.64 -159.17 0.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.506 -0.747 . . . . 0.0 109.35 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.401 ' O ' ' N ' ' D' ' 6' ' ' GLU . 9.9 p -103.56 134.36 19.79 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.435 -0.791 . . . . 0.0 109.34 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -42.08 -22.73 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.397 2.065 . . . . 0.0 112.495 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' D' ' 4' ' ' THR . 79.3 mt-10 -76.71 -55.63 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 110.043 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -68.14 -60.39 2.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.94 . . . . 0.0 110.033 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.786 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -48.68 -30.16 5.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.846 . . . . 0.0 110.198 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 2.8 m -62.08 -23.63 66.62 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.041 -1.037 . . . . 0.0 110.083 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.97 -57.59 3.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.014 -1.054 . . . . 0.0 110.035 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.6 -25.02 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 56.9 m -83.48 -37.26 23.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' D' ' 9' ' ' SER . . . -63.22 -29.93 71.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.346 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.7 OUTLIER -52.08 -32.54 35.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.092 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . 0.533 ' HE1' ' HG ' ' D' ' 72' ' ' SER . 0.2 OUTLIER -47.14 -17.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.31 -52.01 5.83 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.421 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.1 OUTLIER -70.47 -29.32 65.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.202 -1.175 . . . . 0.0 109.322 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -48.84 114.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.55 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' D' ' 22' ' ' GLU . 18.4 m120 -82.67 69.49 9.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 108.941 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' D' ' 22' ' ' GLU . 78.7 t -43.81 -29.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 109.713 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -64.63 1.87 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.617 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' D' ' 20' ' ' VAL . 33.0 mt-10 -155.88 -46.18 0.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.393 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -48.54 -53.93 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -51.4 -48.51 48.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.4 -46.36 78.59 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -62.36 -40.07 95.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -1.153 . . . . 0.0 109.314 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.69 -37.79 88.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.364 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -82.1 -51.35 8.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.275 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.91 -35.09 62.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -79.4 -30.58 42.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -1.14 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 60.1 tp -49.52 -38.95 32.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 109.368 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.57 -23.42 56.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.595 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.7 -61.62 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.21 -0.931 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.32 -23.81 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.77 76.06 48.09 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 109.258 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.64 11.42 2.72 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.769 2.312 . . . . 0.0 112.358 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . 0.477 ' CE2' HG23 ' D' ' 38' ' ' THR . 50.7 p-90 -80.54 -19.75 45.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.36 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.809 ' HB ' HBC1 ' D' ' 147' ' ' HEC . 42.1 p -79.71 40.07 0.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -92.07 12.86 20.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -0.931 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -87.88 -34.44 18.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.591 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' D' ' 42' ' ' PHE . 29.4 m-85 -95.81 32.37 1.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.213 -0.929 . . . . 0.0 109.546 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.505 ' CZ ' HBC3 ' D' ' 147' ' ' HEC . 56.5 m-85 -141.38 26.36 1.98 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 109.454 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -80.94 -25.07 37.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . 0.472 ' C ' ' H ' ' D' ' 46' ' ' GLY . 67.1 m -82.15 -38.31 24.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.922 . . . . 0.0 109.483 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -55.93 -5.4 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' D' ' 44' ' ' SER . . . 48.53 -167.77 0.15 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' D' ' 48' ' ' LEU . 18.9 t70 60.26 -150.21 0.42 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -1.154 . . . . 0.0 109.559 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . 0.455 ' H ' ' CG ' ' D' ' 47' ' ' ASP . 23.5 mt 60.46 34.39 20.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.562 -0.711 . . . . 0.0 109.656 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.2 m -80.47 -22.54 40.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . 0.495 ' O ' ' N ' ' D' ' 53' ' ' ALA . 21.1 p -146.05 149.07 37.58 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 109.157 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -36.85 -45.06 1.19 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.593 2.195 . . . . 0.0 112.595 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.73 -27.04 61.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.191 -0.943 . . . . 0.0 109.6 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -57.81 -19.59 29.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.589 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.99 -63.45 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 109.63 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' D' ' 55' ' ' MET . 2.3 mpp? -79.71 14.86 1.53 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.436 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.98 -49.06 4.41 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . 0.498 HD22 ' N ' ' D' ' 57' ' ' ASN . 1.0 OUTLIER -77.78 149.63 77.68 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.276 -1.132 . . . . 0.0 109.47 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.33 -52.03 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.642 2.228 . . . . 0.0 112.148 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -46.88 -40.71 14.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.336 -0.853 . . . . 0.0 109.58 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 86.6 t -54.22 -44.83 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.397 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' D' ' 61' ' ' LYS . 7.0 mtmp? -77.4 -43.06 33.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.11 -33.15 17.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.568 ' CE1' ' CHA' ' D' ' 147' ' ' HEC . 5.8 t60 -67.55 -24.49 65.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.584 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.57 -30.31 74.79 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -68.16 -41.21 81.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 109.33 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -64.08 -50.95 66.34 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.338 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.799 HG22 ' C4A' ' D' ' 147' ' ' HEC . 25.4 t -61.74 -23.84 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.201 -0.937 . . . . 0.0 109.331 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -78.17 -29.78 48.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.32 -57.09 14.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.48 -22.03 63.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -1.135 . . . . 0.0 109.517 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -74.53 -30.23 61.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.607 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . 0.533 ' HG ' ' HE1' ' D' ' 15' ' ' TRP . 4.5 m -89.21 -20.49 24.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 109.688 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -46.15 -30.73 2.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.692 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.41 -59.17 6.99 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.538 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.7 mp -56.74 -17.82 10.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -1.153 . . . . 0.0 109.628 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . 0.558 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -97.36 33.04 2.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.165 -0.959 . . . . 0.0 109.993 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 9.5 m-70 -176.81 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.143 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . 0.459 ' C ' ' O ' ' D' ' 77' ' ' HIS . 29.9 mt 39.61 35.38 0.19 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.644 -0.66 . . . . 0.0 109.621 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -138.73 -31.4 0.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.788 . . . . 0.0 109.631 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' D' ' 80' ' ' ASN . 7.4 p-10 -151.95 72.85 1.03 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.296 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . 0.57 ' N ' HD12 ' D' ' 81' ' ' LEU . 9.5 mp -60.36 -27.15 67.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -80.6 -61.5 1.95 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.776 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.33 -23.79 42.75 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.426 HG23 ' O ' ' D' ' 80' ' ' ASN . 0.8 OUTLIER -62.34 -51.91 65.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 109.554 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.537 ' CZ ' ' O ' ' D' ' 81' ' ' LEU . 2.2 p90 -133.2 51.83 2.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 109.651 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -49.01 -29.31 4.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.322 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' D' ' 88' ' ' LEU . 17.8 p -60.59 -58.55 8.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.325 -0.859 . . . . 0.0 109.319 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.415 ' N ' ' OG1' ' D' ' 87' ' ' THR . 90.8 mt -48.47 -37.47 17.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.008 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 2.8 m -69.05 -34.95 76.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.034 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -82.87 -39.07 22.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.38 -0.825 . . . . 0.0 109.4 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -69.05 -25.3 64.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.401 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' D' ' 97' ' ' HIS . 7.0 m80 -91.0 -21.74 21.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.625 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 49.0 t -83.56 -59.01 2.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 111.162 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.667 ' O ' HG21 ' A' ' 41' ' ' THR . 1.3 m-20 -87.28 -57.0 3.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.014 -1.054 . . . . 0.0 111.934 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' D' ' 95' ' ' LYS . 12.0 mptt -62.66 -52.25 64.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.131 -0.98 . . . . 0.0 111.263 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.606 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -95.41 -38.19 10.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.892 -1.13 . . . . 0.0 109.764 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.606 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 25.4 p80 45.36 33.26 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 110.178 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . 0.59 HG23 HD12 ' D' ' 96' ' ' LEU . 52.5 t -50.12 132.37 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.041 -1.037 . . . . 0.0 109.14 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . 0.546 ' OD1' HG11 ' A' ' 96' ' ' VAL . 4.2 m-20 -51.19 151.2 5.12 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.293 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.98 -170.32 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.464 2.109 . . . . 0.0 112.026 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' B' ' 101' ' ' GLU . 69.2 mm-40 53.14 70.04 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.472 ' ND2' ' CD1' ' D' ' 103' ' ' PHE . 4.0 p-10 -171.23 -39.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -0.897 . . . . 0.0 109.549 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' ND2' ' D' ' 102' ' ' ASN . 12.8 m-85 -50.25 -34.55 23.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -76.12 -43.99 40.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.559 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . 0.52 HD12 ' N ' ' D' ' 105' ' ' LEU . 9.9 mp -49.35 -51.85 31.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.441 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 1.036 HD13 ' CHC' ' D' ' 147' ' ' HEC . 6.5 tt -51.66 -37.21 49.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.137 -0.977 . . . . 0.0 109.303 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.93 -20.62 59.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -65.25 -34.36 78.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -1.179 . . . . 0.0 109.616 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.82 -31.71 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.571 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 7.6 tp -51.64 -52.12 50.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.559 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . 0.553 ' CG2' ' CE1' ' D' ' 130' ' ' TYR . 42.9 t -51.15 -42.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 109.577 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -60.18 -39.52 86.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.594 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 46.2 t -63.53 -55.0 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 109.681 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.96 -31.81 71.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -64.87 -27.83 69.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.903 . . . . 0.0 109.469 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.48 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.79 -61.25 1.83 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 109.25 179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . 0.417 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 8.3 m-70 -63.24 -18.42 63.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.525 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 58.9 m-85 -148.41 59.53 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 109.386 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -72.03 -14.74 76.24 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -79.45 -20.34 47.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -1.171 . . . . 0.0 109.455 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.482 ' C ' ' H ' ' D' ' 123' ' ' THR . 29.2 mm-40 -95.4 -2.5 48.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.768 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.91 34.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.536 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.482 ' H ' ' C ' ' D' ' 121' ' ' GLU . 21.7 p -49.25 148.37 4.5 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.391 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.451 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 2.3 Cg_endo -46.71 -57.56 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.463 2.109 . . . . 0.0 113.03 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 17.7 Cg_endo -59.51 -42.38 48.48 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.12 1.88 . . . . 0.0 112.236 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 98.7 t -64.93 -20.95 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.917 . . . . 0.0 109.547 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . 0.901 HE22 ' HG3' ' C' ' 31' ' ' ARG . 37.0 tt0 -83.28 -48.91 9.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.576 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.658 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -58.72 -30.0 67.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.432 ' O ' HG23 ' D' ' 133' ' ' VAL . . . -82.14 19.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.653 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.553 ' CE1' ' CG2' ' D' ' 111' ' ' VAL . 47.1 t80 -107.92 -61.31 1.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.3 -0.875 . . . . 0.0 109.68 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 5.9 tp-100 -55.29 -23.25 22.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' D' ' 1' ' ' VAL . 22.7 ttpp -83.06 -21.83 33.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.933 . . . . 0.0 109.653 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . 0.432 HG23 ' O ' ' D' ' 129' ' ' ALA . 77.6 t -81.09 -68.27 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.945 . . . . 0.0 109.721 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 22.3 m -53.83 -25.06 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.28 -0.888 . . . . 0.0 109.869 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -49.56 -29.79 7.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.182 -0.949 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.33 -29.31 56.38 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.4 -38.15 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 0.0 109.432 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.88 79.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 1.605 HD21 ' CD2' ' B' ' 146' ' ' HIS . 1.8 m120 -79.68 -22.99 42.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.952 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.72 -60.64 2.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.628 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.83 -25.21 66.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.266 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 -16.41 27.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 109.422 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -51.23 -33.47 28.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 18.8 mmtm -73.32 -27.17 61.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . 0.412 ' OH ' ' O ' ' D' ' 92' ' ' HIS . 16.2 m-85 -71.85 -46.28 58.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.455 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 1.653 ' CD2' HD21 ' B' ' 139' ' ' ASN . 43.7 p-80 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.483 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.866 HBB3 HMB1 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 1.043 ' CHC' HD13 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.91 HBB3 HMB1 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 1.036 ' CHC' HD13 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 1' ' ' VAL . 9.9 mt 54.48 170.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 0.0 109.638 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.488 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 176.32 -53.64 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.101 -1.0 . . . . 0.0 110.317 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 6' ' ' ASP . 59.0 Cg_endo -73.97 -165.22 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.397 2.064 . . . . 0.0 112.777 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 8' ' ' THR . . . -43.93 -15.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.434 -0.792 . . . . 0.0 110.114 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 4' ' ' PRO . 53.5 m-20 -38.72 -37.22 0.32 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.806 . . . . 0.0 109.76 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -30.77 26.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.881 . . . . 0.0 109.685 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 5' ' ' ALA . 40.9 m -52.02 -37.48 53.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.173 -0.954 . . . . 0.0 109.213 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -73.87 -33.36 64.03 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.76 -52.29 26.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.94 -45.59 51.36 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.09 -61.76 2.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.579 -0.701 . . . . 0.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -55.65 -33.35 63.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.3 -0.875 . . . . 0.0 109.242 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.55 -17.38 60.09 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.31 -0.869 . . . . 0.0 109.062 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.06 -43.32 14.0 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -70.36 -39.96 74.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -1.165 . . . . 0.0 108.828 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 13' ' ' ALA . 89.5 t -60.03 -65.4 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 57.29 -135.75 51.33 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 28.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.998 . . . . 0.0 110.48 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.556 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.9 m-70 -131.93 24.36 4.62 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.24 -62.76 1.42 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.624 -0.672 . . . . 0.0 109.727 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.41 -14.5 0.19 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' ALA . 1.3 mm-40 -84.15 -56.16 3.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.396 -1.061 . . . . 0.0 109.433 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.641 ' CD1' ' CD2' ' A' ' 112' ' ' HIS . 3.1 m-30 -59.95 -37.09 78.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.374 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.73 -24.24 69.6 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.35 -45.05 20.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.629 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.01 -21.21 61.02 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.399 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.31 -21.53 62.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.693 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.617 HD11 ' ND1' ' A' ' 58' ' ' HIS . 12.5 mt -78.04 -51.54 10.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.505 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.34 -12.67 61.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.837 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.565 ' NH2' ' SG ' ' A' ' 104' ' ' CYS . 0.9 OUTLIER -76.48 -40.37 50.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 110.276 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.0 ptt? -84.16 -35.56 23.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 109.963 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -45.99 -41.72 12.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 109.665 -179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.885 ' CD1' ' HB2' ' B' ' 128' ' ' ALA . 2.2 pp -84.63 -35.89 22.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.067 -1.021 . . . . 0.0 109.82 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.4 p -85.33 1.45 48.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.538 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' MET . 67.0 m-85 -159.17 68.13 3.2 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 39' ' ' THR . 72.1 Cg_exo -47.75 -34.34 21.14 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.821 2.347 . . . . 0.0 112.279 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 1.318 HG22 ' ND1' ' D' ' 97' ' ' HIS . 2.2 p -47.05 -18.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.927 . . . . 0.0 109.591 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' PRO . 81.4 p -84.5 -31.33 24.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.239 -0.913 . . . . 0.0 109.709 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -68.6 -26.44 65.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 109.685 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.909 HG21 ' CD2' ' D' ' 97' ' ' HIS . 5.3 t -90.94 -17.94 25.55 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.259 -0.9 . . . . 0.0 109.87 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.6 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 2.0 t80 -60.99 -65.71 0.65 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.095 -1.003 . . . . 0.0 109.09 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 42' ' ' TYR . 0.6 OUTLIER 166.06 78.87 0.01 OUTLIER Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.443 -0.785 . . . . 0.0 109.578 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.582 ' O ' ' CD2' ' A' ' 46' ' ' PHE . 75.8 Cg_endo -83.53 -42.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.626 2.217 . . . . 0.0 111.573 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 26.6 p80 44.5 31.93 0.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.579 -0.701 . . . . 0.0 110.903 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 2.8 p90 -135.86 26.85 3.31 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.001 -1.062 . . . . 0.0 109.687 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 49' ' ' SER . 55.2 m-20 44.44 83.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.485 -0.759 . . . . 0.0 109.529 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.565 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -52.01 -8.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 109.5 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 47' ' ' ASP . 35.0 p -68.36 169.45 10.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 0.0 109.469 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -78.96 164.3 24.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.863 . . . . 0.0 109.541 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.04 17.31 71.66 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.632 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 3.0 t -77.52 -28.62 52.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -1.156 . . . . 0.0 109.487 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 73.28 -31.66 0.23 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.325 -0.859 . . . . 0.0 109.602 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 52' ' ' SER . 38.0 mt-30 -80.51 -22.56 40.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -83.46 -35.93 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.456 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -81.42 -32.93 32.47 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.198 -0.939 . . . . 0.0 108.615 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.66 -21.96 78.85 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.617 ' ND1' HD11 ' A' ' 29' ' ' LEU . 10.1 t-80 -70.51 -29.97 66.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -1.055 . . . . 0.0 109.24 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.76 -51.45 57.95 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -48.36 -23.82 1.04 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -1.136 . . . . 0.0 109.741 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.602 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 10.4 mmpt? -71.39 -51.12 25.8 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.179 -0.951 . . . . 0.0 108.608 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.7 t -60.85 -47.7 92.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.76 89.42 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.348 -0.845 . . . . 0.0 108.923 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -60.06 -39.07 84.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -65.01 -52.33 56.69 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.5 mt -57.59 -43.91 84.97 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 71' ' ' ALA . 19.0 m -69.34 -51.25 38.81 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -61.64 -26.14 67.81 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.17 -46.59 10.94 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.8 t -65.2 -22.67 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -64.09 -21.62 66.6 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' A' ' 74' ' ' ASP . 42.4 m80 -146.44 -51.94 0.23 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.4 p 44.74 13.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.687 0.756 . . . . 0.0 109.407 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 72' ' ' HIS . 29.2 m-20 -127.04 9.5 6.83 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.411 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 49.8 t0 -173.68 27.3 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.046 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.689 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 4.8 ptt? -78.33 -24.2 0.43 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.44 -0.788 . . . . 0.0 111.668 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.8 Cg_exo -53.02 -27.73 37.26 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.634 1.556 . . . . 0.0 112.506 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.487 HD22 ' N ' ' A' ' 78' ' ' ASN . 1.4 m-80 -94.3 -24.79 17.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 0.0 109.74 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.79 -46.38 21.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.0 109.223 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.427 ' CD1' HG13 ' A' ' 132' ' ' VAL . 9.7 mt -82.05 9.3 8.7 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 108.981 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.5 m -65.69 -22.41 66.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 109.512 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -82.01 -59.64 2.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.135 -0.978 . . . . 0.0 109.694 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -50.8 -26.2 5.39 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 73.2 m -67.5 -33.4 75.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' ALA . 4.3 t70 -78.26 -30.07 48.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.309 -0.869 . . . . 0.0 108.806 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.099 HD11 ' CBD' ' A' ' 142' ' ' HEC . 2.1 tm? -54.31 -49.55 69.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.509 -0.744 . . . . 0.0 109.388 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.466 ' N ' HD13 ' A' ' 86' ' ' LEU . 8.2 p-80 -92.24 -21.78 20.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.008 . . . . 0.0 110.375 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -92.93 -2.62 55.64 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.042 -1.036 . . . . 0.0 110.293 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -128.56 -77.06 0.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.194 -0.941 . . . . 0.0 109.771 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -46.66 -78.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.761 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.2 mp -71.06 -39.05 72.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.106 -0.996 . . . . 0.0 109.647 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 61.84 59.28 1.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.153 -0.967 . . . . 0.0 109.42 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 94' ' ' ASP . 90.3 t -85.21 166.59 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.279 -0.888 . . . . 0.0 109.614 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.624 ' N ' HG12 ' A' ' 93' ' ' VAL . 3.8 m-20 -99.33 120.05 58.92 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.381 -0.824 . . . . 0.0 109.217 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' PHE . 83.3 Cg_exo -44.11 -10.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.225 1.95 . . . . 0.0 112.432 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 94' ' ' ASP . 96.1 t -45.55 -23.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 95' ' ' PRO . 73.3 m-20 -79.3 -24.84 42.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 109.57 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.517 ' CE1' ' OG ' ' A' ' 102' ' ' SER . 20.4 t80 -46.53 -35.05 5.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -64.61 -33.27 75.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.485 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.0 mt -84.06 -43.75 14.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.523 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.996 HD12 HMC3 ' A' ' 142' ' ' HEC . 4.8 tt -54.38 -52.04 62.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -0.857 . . . . 0.0 109.537 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.517 ' OG ' ' CE1' ' A' ' 98' ' ' PHE . 15.7 m -59.63 -33.52 71.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 103' ' ' HIS . 0.7 OUTLIER -80.65 -26.65 37.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.095 -1.003 . . . . 0.0 110.096 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.565 ' SG ' ' NH2' ' A' ' 31' ' ' ARG . 72.0 m -63.95 -58.36 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.246 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.43 -34.51 4.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.935 . . . . 0.0 110.093 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.8 mt -70.75 -28.2 64.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.07 -1.019 . . . . 0.0 110.176 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 54.7 t -83.04 -38.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.979 -1.076 . . . . 0.0 109.582 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 110' ' ' ALA . 19.1 p -70.58 -58.9 3.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.2 -0.938 . . . . 0.0 109.649 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 113' ' ' LEU . 9.5 mt -43.12 -26.28 0.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.765 . . . . 0.0 109.587 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -67.36 -22.64 65.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 110.589 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.37 -48.02 12.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.025 . . . . 0.0 111.006 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.641 ' CD2' ' CD1' ' A' ' 24' ' ' TYR . 1.1 p-80 -100.76 -58.87 1.8 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.025 -1.047 . . . . 0.0 111.037 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.538 HD13 ' C ' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -112.44 93.35 22.53 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 109.284 -178.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 113' ' ' LEU . 76.7 Cg_exo -47.0 -174.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.364 2.042 . . . . 0.0 112.685 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.795 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -61.56 -55.35 31.77 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.648 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 27.8 mt-10 119.92 1.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 117' ' ' PHE . 38.3 t80 59.62 31.63 21.04 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.298 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.794 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.3 p -104.4 120.8 49.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.985 -1.072 . . . . 0.0 108.14 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.1 23.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.09 1.86 . . . . 0.0 112.72 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.794 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -154.43 -29.96 0.11 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.853 -1.155 . . . . 0.0 110.676 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.795 HG21 ' O ' ' A' ' 115' ' ' ALA . 13.7 p -51.16 -50.16 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.996 -1.065 . . . . 0.0 110.274 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.667 ' N ' HG13 ' A' ' 121' ' ' VAL . 3.1 t-160 -61.31 -53.41 57.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.868 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' B' ' 34' ' ' VAL . . . -72.72 -19.83 61.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 120' ' ' ALA . 20.5 m -63.72 -62.51 1.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.164 -0.96 . . . . 0.0 110.277 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 1.2 mt -64.4 -16.85 63.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.352 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.07 -49.18 9.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 0.0 110.902 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.62 -59.03 2.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.818 -1.176 . . . . 0.0 111.264 -178.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.48 ' N ' ' HD2' ' A' ' 127' ' ' LYS . 21.4 m-85 -47.98 -21.23 0.41 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.717 -1.239 . . . . 0.0 109.752 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.918 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -72.1 -31.03 65.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 134' ' ' THR . . . -49.2 -33.18 11.9 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.467 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 43.2 t -60.36 -37.02 79.39 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 80' ' ' LEU . 6.3 t -77.06 -48.72 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.406 ' CB ' ' CE1' ' A' ' 98' ' ' PHE . 13.5 t -66.48 -22.72 66.19 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.278 -0.889 . . . . 0.0 108.635 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 130' ' ' ALA . 11.2 m -64.06 -31.75 73.06 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.411 -0.806 . . . . 0.0 108.827 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.62 -37.26 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 109.14 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 83' ' ' LEU . 5.6 mp -60.59 -35.29 75.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.299 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 134' ' ' THR . 34.9 p -67.9 -33.75 75.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 t 46.69 89.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.528 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 1.224 ' NZ ' ' NZ ' ' C' ' 139' ' ' LYS . 42.0 mtpt -65.55 -123.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 109.471 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -55.13 89.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.483 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 139' ' ' LYS . 75.9 mtt-85 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.479 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.463 HG22 ' H ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 45.0 52.75 8.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.164 -0.96 . . . . 0.0 109.813 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.717 HD13 ' HB3' ' B' ' 8' ' ' LYS . 1.9 mt -87.8 161.05 17.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.561 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.19 138.18 19.47 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.371 -0.83 . . . . 0.0 108.826 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -40.02 -54.19 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.524 2.149 . . . . 0.0 112.637 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -72.01 -21.84 61.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 110.02 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -76.62 -63.12 1.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 109.902 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.717 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -66.58 -29.59 69.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.068 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.6 t -47.5 -23.69 0.68 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 110.101 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.66 -56.85 3.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.065 -1.022 . . . . 0.0 109.992 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.428 ' H ' HG12 ' B' ' 11' ' ' VAL . 0.8 OUTLIER -68.13 -24.64 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 25.9 m -73.52 -40.28 64.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.746 -0.596 . . . . 0.0 109.607 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.42 -31.23 71.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.409 -0.807 . . . . 0.0 109.447 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.8 OUTLIER -50.7 -31.47 16.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 0.0 109.155 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -47.57 -17.82 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.382 -0.824 . . . . 0.0 109.537 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -77.97 -51.1 5.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' B' ' 17' ' ' LYS . 0.1 OUTLIER -71.23 -29.56 65.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.169 -1.194 . . . . 0.0 109.33 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.3 t -49.42 114.79 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.925 . . . . 0.0 109.581 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' B' ' 22' ' ' GLU . 95.3 m-20 -78.39 67.65 4.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.01 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' B' ' 22' ' ' GLU . 68.8 t -44.32 -29.08 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.423 -0.798 . . . . 0.0 109.831 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.14 7.43 0.57 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' B' ' 20' ' ' VAL . 38.5 mt-10 -155.23 -49.57 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.1 t -48.59 -60.72 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.89 -39.22 17.69 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.09 -43.73 89.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.419 ' O ' ' CG ' ' B' ' 30' ' ' ARG . 57.0 mt-10 -79.47 -40.39 29.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.291 -1.123 . . . . 0.0 109.546 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 -34.32 8.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -82.6 -56.67 3.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.73 -44.83 80.35 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.571 HH21 HG11 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -53.89 -36.48 62.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -1.123 . . . . 0.0 109.26 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -55.95 -47.63 77.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 0.0 109.412 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -65.02 -22.73 67.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.571 HG11 HH21 ' B' ' 30' ' ' ARG . 74.8 t -81.65 -64.72 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 109.358 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 123' ' ' ALA . 2.2 t -67.64 -22.79 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.465 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.428 ' CG ' HD21 ' B' ' 105' ' ' LEU . 83.5 m-85 -139.46 80.97 21.13 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.428 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.86 -16.04 9.09 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.668 2.245 . . . . 0.0 112.515 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -51.02 -19.91 1.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.075 -1.016 . . . . 0.0 109.416 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.466 ' HB ' HBC1 ' B' ' 147' ' ' HEC . 3.6 p -85.54 55.51 3.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.215 -0.928 . . . . 0.0 109.147 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -109.77 41.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.435 -0.791 . . . . 0.0 109.255 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 mmt-85 -104.03 -49.29 3.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.0 109.479 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' B' ' 41' ' ' PHE . 27.7 m-85 -91.86 30.04 1.46 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 109.585 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' B' ' 44' ' ' SER . 9.4 p90 -92.55 -12.97 30.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -46.07 -13.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.909 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.544 ' N ' ' O ' ' B' ' 42' ' ' PHE . 23.8 p -124.3 23.49 8.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.245 -0.909 . . . . 0.0 109.583 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.34 -14.2 21.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 0.0 109.322 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.54 -116.76 2.21 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -144.26 105.23 4.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -1.11 . . . . 0.0 109.557 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.94 30.57 1.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.14 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.5 p -44.0 -32.37 1.13 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.817 . . . . 0.0 109.859 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' B' ' 53' ' ' ALA . 17.8 p -146.61 148.31 33.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -40.16 -50.2 3.57 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.517 2.145 . . . . 0.0 112.177 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.21 -35.09 76.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.637 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' B' ' 50' ' ' THR . . . -53.83 -19.77 4.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.507 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.18 -63.95 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 12.2 mmt -63.05 -7.58 5.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.38 -10.24 64.06 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -78.37 141.98 62.22 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.173 -1.192 . . . . 0.0 109.378 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -74.3 -57.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.59 2.193 . . . . 0.0 112.214 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' B' ' 63' ' ' HIS . 45.6 mtpt -51.98 -48.49 64.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.556 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' B' ' 59' ' ' LYS . 74.3 t -45.8 -39.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.0 109.289 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -79.35 -52.4 8.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -0.85 . . . . 0.0 109.321 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.36 -59.18 3.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 109.805 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.538 ' N ' ' O ' ' B' ' 59' ' ' LYS . 1.7 t60 -48.29 -24.85 1.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.41 -36.73 91.99 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mtpt -69.29 -25.14 64.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -1.125 . . . . 0.0 109.479 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -73.13 -35.35 66.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.559 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 0.582 HG13 ' C1B' ' B' ' 147' ' ' HEC . 39.6 t -75.75 -28.3 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.21 -34.94 68.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.302 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.51 -45.12 37.44 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.83 91.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -1.209 . . . . 0.0 109.65 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.421 ' CE2' HD21 ' B' ' 110' ' ' LEU . 25.5 t80 -57.29 -41.07 79.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 109.579 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.7 t -76.63 -37.75 55.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.653 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -47.5 -37.57 12.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.222 -0.924 . . . . 0.0 109.535 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -60.4 7.6 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.569 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -55.82 -30.04 60.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.248 -1.148 . . . . 0.0 109.401 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.09 5.4 29.82 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.201 -0.937 . . . . 0.0 109.65 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.522 ' NE2' ' OD1' ' B' ' 80' ' ' ASN . 7.5 t60 -170.93 67.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 109.525 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.93 17.96 1.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 0.0 109.487 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -79.63 -29.23 40.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.452 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.522 ' OD1' ' NE2' ' B' ' 77' ' ' HIS . 4.3 p-10 -163.21 95.82 0.86 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.235 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.493 ' H ' HD12 ' B' ' 81' ' ' LEU . 5.0 mp -80.28 -58.91 2.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.204 -0.935 . . . . 0.0 109.64 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -57.46 -23.83 52.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.075 -1.016 . . . . 0.0 109.568 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.06 -54.41 3.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.0 t -61.38 -47.58 85.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -1.157 . . . . 0.0 109.614 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.557 ' N ' ' CG2' ' B' ' 84' ' ' THR . 54.4 m-85 -76.7 22.04 0.19 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.351 -0.843 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.46 -26.8 44.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 75.3 p -78.85 -59.1 2.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.754 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 19.4 mt -48.63 -45.05 37.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.955 . . . . 0.0 109.288 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 53.9 p -64.72 -52.71 55.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.267 -0.896 . . . . 0.0 109.269 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -61.27 -22.7 65.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 tp -86.9 -68.71 0.73 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.417 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.509 ' O ' ' N ' ' B' ' 97' ' ' HIS . 48.8 m80 -51.01 -26.54 6.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.094 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . 0.407 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 27.5 t -83.73 -55.93 3.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 111.303 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.529 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 27.4 t0 -86.24 -32.2 21.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.001 -1.062 . . . . 0.0 111.945 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -89.36 -51.76 5.39 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.689 -1.257 . . . . 0.0 111.132 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.63 -27.03 15.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.852 -1.155 . . . . 0.0 110.43 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 1.24 ' ND1' HG22 ' C' ' 38' ' ' THR . 83.0 m-70 51.67 29.57 5.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.038 -1.039 . . . . 0.0 109.61 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.401 ' O ' ' OH ' ' B' ' 145' ' ' TYR . 40.0 t -47.14 130.2 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.968 . . . . 0.0 109.503 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.38 152.46 32.56 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 109.28 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.88 -164.09 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.553 2.169 . . . . 0.0 112.165 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.26 60.72 2.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.877 . . . . 0.0 109.578 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.542 ' C ' HD22 ' B' ' 102' ' ' ASN . 0.1 OUTLIER -171.3 -41.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.457 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -46.21 -40.55 11.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 0.0 109.714 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -80.07 -19.92 46.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.554 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' B' ' 102' ' ' ASN . 12.3 tp -70.47 -59.77 2.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 109.639 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.833 HD13 ' CHC' ' B' ' 147' ' ' HEC . 7.0 tt -49.84 -46.22 51.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 109.354 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.06 -20.44 58.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -80.53 -25.2 38.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -1.105 . . . . 0.0 109.577 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 74.2 t -86.19 -43.09 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 109.683 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.421 HD21 ' CE2' ' B' ' 71' ' ' PHE . 6.3 tt -48.26 -33.05 8.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.91 . . . . 0.0 109.464 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -83.05 -26.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.532 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 72.4 m -69.1 -24.79 64.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.538 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 42.4 t -76.34 -34.89 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' B' ' 118' ' ' PHE . 9.5 mt -69.83 -40.16 76.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 109.413 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.475 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -54.4 -28.92 46.93 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 109.438 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.525 ' C ' ' HD1' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.74 -62.41 1.55 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.106 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -63.36 -17.75 62.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.551 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' B' ' 114' ' ' LEU . 93.3 m-85 -149.72 60.4 1.0 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 0.0 109.402 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.535 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -69.22 -24.72 75.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -64.75 -29.67 70.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -1.153 . . . . 0.0 109.346 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.489 ' C ' ' H ' ' B' ' 123' ' ' THR . 78.3 mm-40 -87.81 5.71 38.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 0.0 109.736 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.543 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.64 33.09 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.042 -1.036 . . . . 0.0 109.422 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.489 ' H ' ' C ' ' B' ' 121' ' ' GLU . 1.4 p -52.41 149.13 10.88 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.353 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.516 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.1 Cg_exo -45.41 -53.66 5.23 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.452 2.101 . . . . 0.0 112.988 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 24.6 Cg_endo -62.16 -29.65 81.04 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.05 1.834 . . . . 0.0 112.223 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.441 HG23 ' OG1' ' B' ' 123' ' ' THR . 45.7 t -68.81 -28.15 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 109.423 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -83.15 -53.89 5.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.885 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -63.25 -26.49 68.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 109.576 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.51 -2.33 53.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.114 -0.991 . . . . 0.0 109.807 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' B' ' 132' ' ' LYS . 41.8 t80 -92.49 -61.52 1.58 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.717 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 1.5 tm0? -45.25 -23.32 0.17 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 109.931 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' B' ' 130' ' ' TYR . 51.1 mtmt -85.46 -34.6 21.6 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.217 -0.927 . . . . 0.0 110.322 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' B' ' 134' ' ' VAL . 0.6 OUTLIER -68.61 -44.15 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.075 . . . . 0.0 109.676 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.501 ' N ' ' CG1' ' B' ' 133' ' ' VAL . 6.1 m -79.64 -20.91 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -50.51 -32.41 18.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -0.974 . . . . 0.0 109.364 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.63 -26.56 56.36 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.42 -32.96 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -1.148 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.44 90.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.67 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.89 -21.05 47.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.766 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.01 -58.86 6.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.663 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 48.4 mt -61.48 -31.88 71.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 109.497 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.06 25.15 4.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.251 -0.905 . . . . 0.0 109.599 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -80.0 -16.13 55.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.712 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 13.2 mptt -98.34 -26.72 14.4 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 0.0 109.613 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.401 ' OH ' ' O ' ' B' ' 98' ' ' VAL . 12.3 m-85 -54.38 -6.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.11 -0.994 . . . . 0.0 109.425 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' B' ' 144' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.428 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' C' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' C' ' 1' ' ' VAL . 9.9 mt 54.47 170.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.353 -0.842 . . . . 0.0 109.621 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.49 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 176.31 -53.58 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.322 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' C' ' 6' ' ' ASP . 59.0 Cg_endo -74.05 -165.15 0.24 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.373 2.048 . . . . 0.0 112.776 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' C' ' 8' ' ' THR . . . -44.0 -15.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.497 -0.752 . . . . 0.0 110.129 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' C' ' 4' ' ' PRO . 53.1 m-20 -38.82 -37.11 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 109.779 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' C' ' 8' ' ' THR . 0.0 OUTLIER -83.8 -30.94 26.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.666 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.518 ' N ' ' O ' ' C' ' 5' ' ' ALA . 41.7 m -51.87 -37.52 52.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.068 -1.02 . . . . 0.0 109.283 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -73.87 -33.39 64.05 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -71.69 -52.38 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.87 -45.61 50.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.02 -61.9 2.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.629 -0.669 . . . . 0.0 109.883 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.661 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -55.57 -33.37 63.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.295 -0.878 . . . . 0.0 109.246 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.59 -17.38 60.05 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.285 -0.884 . . . . 0.0 109.029 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.0 -43.24 14.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -70.41 -39.83 74.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -1.199 . . . . 0.0 108.856 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.661 HG23 ' O ' ' C' ' 13' ' ' ALA . 88.3 t -60.2 -65.39 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 57.27 -135.74 51.33 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 28.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.439 -1.036 . . . . 0.0 110.453 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.7 m-70 -131.92 24.27 4.62 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.19 -62.9 1.39 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.603 -0.686 . . . . 0.0 109.651 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.2 -14.7 0.17 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' C' ' 21' ' ' ALA . 1.3 mm-40 -84.11 -56.11 3.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.461 -1.023 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.638 ' CD1' ' CD2' ' C' ' 112' ' ' HIS . 3.1 m-30 -60.05 -36.96 78.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.387 -0.821 . . . . 0.0 109.391 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.77 -24.27 69.7 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.31 -45.0 20.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -1.163 . . . . 0.0 109.681 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.03 -21.28 61.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.25 -21.48 62.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.671 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.626 HD11 ' ND1' ' C' ' 58' ' ' HIS . 12.4 mt -78.08 -51.59 10.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.1 -12.9 61.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.825 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.557 ' NH2' ' SG ' ' C' ' 104' ' ' CYS . 0.9 OUTLIER -76.4 -40.48 50.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.137 -0.977 . . . . 0.0 110.25 -179.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 0.542 ' O ' ' N ' ' C' ' 36' ' ' PHE . 3.0 ptt? -84.04 -35.61 23.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.98 -1.075 . . . . 0.0 109.982 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' C' ' 33' ' ' PHE . 0.0 OUTLIER -45.87 -41.77 11.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.947 . . . . 0.0 109.719 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.883 ' CD1' ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -84.59 -35.93 22.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.962 . . . . 0.0 109.937 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.3 p -85.25 1.43 48.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' C' ' 32' ' ' MET . 67.3 m-85 -159.1 68.1 3.23 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' C' ' 39' ' ' THR . 69.3 Cg_exo -47.73 -34.29 20.9 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.8 2.334 . . . . 0.0 112.308 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 1.24 HG22 ' ND1' ' B' ' 97' ' ' HIS . 2.1 p -47.09 -18.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.193 -0.942 . . . . 0.0 109.568 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.441 ' N ' ' O ' ' C' ' 37' ' ' PRO . 81.6 p -84.52 -31.25 24.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.756 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -68.66 -26.43 65.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.951 . . . . 0.0 109.609 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.832 HG21 ' CD2' ' B' ' 97' ' ' HIS . 5.4 t -90.89 -17.99 25.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.862 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.595 ' O ' ' CD2' ' C' ' 43' ' ' PHE . 2.0 t80 -60.96 -65.64 0.66 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.157 -0.964 . . . . 0.0 109.154 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.595 ' CD2' ' O ' ' C' ' 42' ' ' TYR . 0.6 OUTLIER 165.97 78.98 0.01 OUTLIER Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.817 . . . . 0.0 109.584 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.58 ' O ' ' CD2' ' C' ' 46' ' ' PHE . 76.3 Cg_endo -83.63 -41.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.577 2.185 . . . . 0.0 111.593 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.576 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 26.7 p80 44.51 31.98 0.68 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.564 -0.71 . . . . 0.0 110.858 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' C' ' 44' ' ' PRO . 2.8 p90 -135.91 26.93 3.29 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.047 -1.033 . . . . 0.0 109.611 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' C' ' 49' ' ' SER . 55.6 m-20 44.41 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.393 -0.817 . . . . 0.0 109.568 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.566 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.6 OUTLIER -51.98 -8.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.474 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.495 ' H ' ' C ' ' C' ' 47' ' ' ASP . 35.6 p -68.39 169.48 10.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -78.98 164.3 24.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.525 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.05 17.27 71.64 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.615 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 3.0 t -77.53 -28.54 52.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -1.128 . . . . 0.0 109.516 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 73.18 -31.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 109.606 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' C' ' 52' ' ' SER . 38.1 mt-30 -80.52 -22.67 40.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 0.0 109.389 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -83.38 -36.09 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.423 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -81.36 -32.89 32.71 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.138 -0.976 . . . . 0.0 108.674 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.6 -22.01 78.86 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.626 ' ND1' HD11 ' C' ' 29' ' ' LEU . 10.0 t-80 -70.44 -30.02 66.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.272 -1.134 . . . . 0.0 109.254 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.72 -51.47 57.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -48.29 -23.86 1.02 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -1.115 . . . . 0.0 109.775 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.609 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 10.4 mmpt? -71.44 -51.08 25.81 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.257 -0.902 . . . . 0.0 108.577 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 25.6 t -60.78 -47.78 91.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.02 -38.71 89.12 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -59.97 -39.29 85.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 108.489 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -64.89 -52.39 56.79 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 15.6 mt -57.58 -43.99 85.01 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.415 ' O ' ' N ' ' C' ' 71' ' ' ALA . 19.3 m -69.18 -51.36 38.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.285 -0.885 . . . . 0.0 108.702 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -61.53 -26.12 67.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.208 -0.932 . . . . 0.0 108.521 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -85.12 -46.61 10.96 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 20.8 t -65.11 -22.8 32.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -64.0 -21.69 66.61 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.6 ' O ' ' N ' ' C' ' 74' ' ' ASP . 42.5 m80 -146.45 -51.89 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.878 . . . . 0.0 109.473 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' C' ' 69' ' ' ALA . 13.4 p 44.71 13.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.74 0.781 . . . . 0.0 109.406 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' C' ' 72' ' ' HIS . 29.2 m-20 -127.03 9.57 6.85 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.413 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 49.7 t0 -173.75 27.27 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.121 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 4.8 ptt? -78.3 -24.16 0.43 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.514 -0.741 . . . . 0.0 111.679 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.0 Cg_exo -52.97 -27.96 37.81 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.626 1.551 . . . . 0.0 112.398 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.477 HD22 ' N ' ' C' ' 78' ' ' ASN . 1.4 m-80 -94.09 -24.8 17.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.826 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 -46.41 21.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.094 -1.003 . . . . 0.0 109.203 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . 0.416 ' CD1' HG13 ' C' ' 132' ' ' VAL . 9.8 mt -82.03 9.26 8.73 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.42 -0.8 . . . . 0.0 109.024 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 4.5 m -65.59 -22.44 66.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.572 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -82.06 -59.67 2.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.623 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.723 ' O ' HD12 ' C' ' 83' ' ' LEU . 0.4 OUTLIER -50.85 -26.09 5.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 73.3 m -67.59 -33.27 74.67 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' C' ' 82' ' ' ALA . 4.2 t70 -78.41 -29.93 47.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 108.79 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 1.115 HD11 ' CBD' ' C' ' 142' ' ' HEC . 2.1 tm? -54.48 -49.46 70.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.501 -0.75 . . . . 0.0 109.338 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . 0.461 ' N ' HD13 ' C' ' 86' ' ' LEU . 8.2 p-80 -92.31 -21.67 20.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.407 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -92.9 -2.72 55.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.086 -1.009 . . . . 0.0 110.345 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -128.61 -77.01 0.56 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.953 . . . . 0.0 109.847 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -46.64 -78.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.131 -0.981 . . . . 0.0 109.817 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.602 ' N ' HD12 ' C' ' 91' ' ' LEU . 8.2 mp -70.98 -39.17 72.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.569 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 61.86 59.35 1.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.389 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.63 HG12 ' N ' ' C' ' 94' ' ' ASP . 90.6 t -85.16 166.6 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 109.669 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.63 ' N ' HG12 ' C' ' 93' ' ' VAL . 3.8 m-20 -99.32 120.02 59.02 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.35 -0.843 . . . . 0.0 109.28 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' C' ' 98' ' ' PHE . 82.8 Cg_exo -44.12 -10.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.276 1.984 . . . . 0.0 112.394 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' C' ' 94' ' ' ASP . 95.7 t -45.63 -23.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.346 -0.846 . . . . 0.0 109.659 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' C' ' 95' ' ' PRO . 73.4 m-20 -79.24 -24.82 42.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.598 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' C' ' 102' ' ' SER . 20.5 t80 -46.51 -35.06 5.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.65 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' C' ' 99' ' ' LYS . 0.3 OUTLIER -64.55 -33.31 75.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.428 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 8.9 mt -84.05 -43.86 14.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.477 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.986 HD12 HMC3 ' C' ' 142' ' ' HEC . 4.8 tt -54.32 -52.09 62.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' C' ' 98' ' ' PHE . 15.6 m -59.52 -33.57 71.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 109.934 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.507 ' N ' ' ND1' ' C' ' 103' ' ' HIS . 0.7 OUTLIER -80.71 -26.56 37.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 110.068 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.557 ' SG ' ' NH2' ' C' ' 31' ' ' ARG . 71.8 m -63.9 -58.45 6.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -46.33 -34.58 4.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.153 -0.967 . . . . 0.0 110.094 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -70.71 -28.3 64.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.044 -1.035 . . . . 0.0 110.176 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.95 -38.22 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 109.579 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.42 ' O ' ' N ' ' C' ' 110' ' ' ALA . 19.2 p -70.67 -58.88 3.19 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.187 -0.945 . . . . 0.0 109.599 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' C' ' 113' ' ' LEU . 9.5 mt -43.18 -26.28 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' C' ' 108' ' ' THR . . . -67.29 -22.62 65.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 110.641 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.34 -47.99 12.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.074 -1.016 . . . . 0.0 111.017 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . 0.638 ' CD2' ' CD1' ' C' ' 24' ' ' TYR . 1.1 p-80 -100.85 -58.81 1.82 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.98 -1.075 . . . . 0.0 111.034 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.548 HD13 ' C ' ' C' ' 113' ' ' LEU . 0.9 OUTLIER -112.4 93.43 22.72 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.335 -0.853 . . . . 0.0 109.272 -178.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' C' ' 113' ' ' LEU . 78.0 Cg_exo -47.15 -174.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.355 2.037 . . . . 0.0 112.643 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.781 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -61.65 -55.42 30.79 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.657 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 27.7 mt-10 120.0 1.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' C' ' 117' ' ' PHE . 38.4 t80 59.69 31.7 21.03 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.225 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.781 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.3 p -104.46 120.73 49.62 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -49.01 23.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.164 1.909 . . . . 0.0 112.679 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.781 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -154.41 -29.95 0.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.945 -1.097 . . . . 0.0 110.701 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.781 HG21 ' O ' ' C' ' 115' ' ' ALA . 13.7 p -51.14 -50.17 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.95 -1.094 . . . . 0.0 110.302 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.675 ' N ' HG13 ' C' ' 121' ' ' VAL . 3.1 t-160 -61.34 -53.3 58.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.336 -0.852 . . . . 0.0 109.887 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . 0.516 ' HB2' ' HA ' ' D' ' 34' ' ' VAL . . . -72.79 -19.88 61.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.949 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.573 ' N ' ' O ' ' C' ' 120' ' ' ALA . 20.6 m -63.67 -62.56 1.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.134 -0.979 . . . . 0.0 110.254 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' C' ' 129' ' ' LEU . 1.2 mt -64.37 -16.91 63.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -0.917 . . . . 0.0 109.348 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -84.08 -49.04 9.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.89 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.73 -59.04 2.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.879 -1.138 . . . . 0.0 111.302 -178.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.487 ' N ' ' HD2' ' C' ' 127' ' ' LYS . 21.4 m-85 -47.92 -21.31 0.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.82 -1.175 . . . . 0.0 109.811 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.898 ' O ' HD12 ' C' ' 129' ' ' LEU . 0.1 OUTLIER -71.99 -31.02 65.84 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' C' ' 134' ' ' THR . . . -49.28 -33.14 12.27 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.465 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 42.3 t -60.3 -37.07 79.4 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' C' ' 80' ' ' LEU . 6.5 t -77.02 -48.73 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.402 ' CB ' ' CE1' ' C' ' 98' ' ' PHE . 13.5 t -66.47 -22.78 66.2 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . 0.52 ' N ' ' O ' ' C' ' 130' ' ' ALA . 11.2 m -64.08 -31.56 72.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.324 -0.86 . . . . 0.0 108.86 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.75 -37.21 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.134 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.467 HD11 HD11 ' C' ' 83' ' ' LEU . 5.6 mp -60.72 -35.21 75.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.277 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' C' ' 134' ' ' THR . 35.1 p -68.06 -33.6 74.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 11.7 t 46.72 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.371 -0.83 . . . . 0.0 109.492 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 1.224 ' NZ ' ' NZ ' ' A' ' 139' ' ' LYS . 41.9 mtpt -65.53 -123.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -55.19 89.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.468 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' C' ' 139' ' ' LYS . 76.1 mtt-85 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.413 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.472 HG22 ' H ' ' D' ' 3' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 45.04 52.75 8.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 109.84 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' D' ' 8' ' ' LYS . 1.9 mt -87.84 161.07 17.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.31 138.22 19.48 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -40.02 -54.19 2.19 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.526 2.151 . . . . 0.0 112.601 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.04 -21.74 61.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -76.69 -63.1 1.42 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 109.824 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.716 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -66.66 -29.6 69.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 109.936 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -47.52 -23.63 0.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.959 . . . . 0.0 110.048 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.74 -56.89 3.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.074 -1.016 . . . . 0.0 109.936 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.4 ' H ' HG12 ' D' ' 11' ' ' VAL . 0.8 OUTLIER -68.19 -24.51 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 26.0 m -73.55 -40.36 64.03 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.379 0.609 . . . . 0.0 109.591 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.37 -31.24 71.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.8 OUTLIER -50.7 -31.47 16.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.154 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -47.44 -18.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.491 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -77.91 -51.08 6.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.424 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.1 OUTLIER -71.25 -29.6 65.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -1.218 . . . . 0.0 109.335 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -49.26 114.76 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' D' ' 22' ' ' GLU . 95.4 m-20 -78.45 67.6 4.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.321 -0.862 . . . . 0.0 109.074 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' D' ' 22' ' ' GLU . 69.0 t -44.34 -29.1 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.73 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.08 7.39 0.56 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.557 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' D' ' 20' ' ' VAL . 38.7 mt-10 -155.29 -49.36 0.08 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.0 t -48.69 -60.74 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.92 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -47.87 -39.15 17.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.1 -43.8 89.29 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . 0.422 ' O ' ' CG ' ' D' ' 30' ' ' ARG . 57.0 mt-10 -79.51 -40.34 29.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -1.169 . . . . 0.0 109.487 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.77 -34.26 8.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.94 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -82.58 -56.75 3.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.307 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.67 -44.78 79.72 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . 0.58 HH21 HG11 ' D' ' 33' ' ' VAL . 0.0 OUTLIER -53.95 -36.44 62.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -1.123 . . . . 0.0 109.31 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -56.01 -47.57 77.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.37 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 mt -65.06 -22.74 67.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.595 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.58 HG11 HH21 ' D' ' 30' ' ' ARG . 74.7 t -81.63 -64.68 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.434 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' C' ' 123' ' ' ALA . 2.2 t -67.67 -22.79 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.501 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . 0.425 ' CG ' HD21 ' D' ' 105' ' ' LEU . 83.5 m-85 -139.41 80.86 21.58 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.77 -16.17 9.14 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.726 2.284 . . . . 0.0 112.437 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -51.04 -19.77 1.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 109.516 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.458 ' HB ' HBC1 ' D' ' 147' ' ' HEC . 3.7 p -85.56 55.56 3.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 109.231 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -109.81 41.27 1.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.258 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 57.5 mmt-85 -103.91 -49.34 3.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.82 . . . . 0.0 109.477 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -91.82 29.98 1.46 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.585 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' D' ' 44' ' ' SER . 9.4 p90 -92.63 -12.98 30.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -45.92 -14.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.338 -0.851 . . . . 0.0 109.971 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . 0.543 ' N ' ' O ' ' D' ' 42' ' ' PHE . 23.4 p -124.26 23.47 8.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.87 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -97.4 -14.06 21.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.253 -0.904 . . . . 0.0 109.267 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.43 -116.86 2.25 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -144.3 105.34 4.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.355 -1.085 . . . . 0.0 109.535 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 mt -90.94 30.5 1.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.042 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.8 p -43.91 -32.47 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 109.925 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 17.9 p -146.52 148.4 33.81 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.21 -0.931 . . . . 0.0 109.389 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -40.37 -49.96 3.8 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.378 2.052 . . . . 0.0 112.232 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -61.29 -35.06 76.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.92 -19.69 4.95 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.23 -63.9 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -0.929 . . . . 0.0 109.542 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 12.2 mmt -63.07 -7.59 5.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.5 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.35 -10.25 64.12 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -78.43 141.92 61.89 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.228 -1.16 . . . . 0.0 109.325 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.26 -57.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.492 2.128 . . . . 0.0 112.242 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' D' ' 63' ' ' HIS . 45.7 mtpt -52.02 -48.4 64.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.619 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 73.9 t -45.86 -39.7 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.927 . . . . 0.0 109.251 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -79.44 -52.34 8.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.315 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.29 -59.26 3.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.812 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' D' ' 59' ' ' LYS . 1.7 t60 -48.25 -24.87 1.31 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.646 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.32 -36.83 92.23 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -69.33 -25.18 64.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -1.12 . . . . 0.0 109.416 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -73.08 -35.32 66.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 109.575 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.585 HG13 ' C1B' ' D' ' 147' ' ' HEC . 39.8 t -75.72 -28.39 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.454 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.15 -34.92 68.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.33 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.53 -45.14 37.57 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.89 91.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -1.129 . . . . 0.0 109.656 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . 0.421 ' CE2' HD21 ' D' ' 110' ' ' LEU . 25.6 t80 -57.21 -41.14 78.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.626 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 5.7 t -76.64 -37.8 55.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.655 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -47.32 -37.79 11.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.928 . . . . 0.0 109.517 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.17 -60.31 7.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.559 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.7 mp -55.95 -29.95 60.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.348 -1.089 . . . . 0.0 109.365 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.05 5.32 30.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.597 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.524 ' NE2' ' OD1' ' D' ' 80' ' ' ASN . 7.5 t60 -170.9 67.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.556 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 96.5 mt -81.94 17.93 1.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.935 . . . . 0.0 109.455 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -79.59 -29.22 41.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.524 ' OD1' ' NE2' ' D' ' 77' ' ' HIS . 4.3 p-10 -163.28 95.83 0.85 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.284 -0.885 . . . . 0.0 109.198 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . 0.509 ' H ' HD12 ' D' ' 81' ' ' LEU . 5.0 mp -80.33 -58.85 2.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.58 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -57.61 -23.78 52.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.008 . . . . 0.0 109.46 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' D' ' 86' ' ' ALA . . . -82.98 -54.4 3.22 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.546 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.0 t -61.31 -47.55 85.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -1.166 . . . . 0.0 109.652 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' D' ' 84' ' ' THR . 54.7 m-85 -76.76 22.03 0.19 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.424 -0.797 . . . . 0.0 109.476 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.42 -26.87 44.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.898 . . . . 0.0 109.492 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 76.0 p -78.81 -59.23 2.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 19.3 mt -48.48 -45.06 36.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.319 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 54.0 p -64.74 -52.8 55.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.229 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -61.21 -22.66 64.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.481 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 8.8 tp -87.0 -68.66 0.73 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.935 . . . . 0.0 109.433 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' D' ' 97' ' ' HIS . 49.0 m80 -51.0 -26.57 6.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 110.08 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . 0.413 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 27.4 t -83.71 -55.87 4.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.187 -0.945 . . . . 0.0 111.361 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 27.4 t0 -86.27 -32.11 21.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.038 -1.039 . . . . 0.0 111.928 -177.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -89.48 -51.83 5.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.696 -1.253 . . . . 0.0 111.055 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.55 -27.02 15.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.871 -1.143 . . . . 0.0 110.45 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 1.318 ' ND1' HG22 ' A' ' 38' ' ' THR . 82.8 m-70 51.68 29.55 5.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.052 -1.03 . . . . 0.0 109.581 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . 0.449 ' O ' ' OH ' ' D' ' 145' ' ' TYR . 39.8 t -47.18 130.27 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.111 -0.993 . . . . 0.0 109.488 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.31 152.45 31.9 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.344 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.96 -164.09 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.494 2.13 . . . . 0.0 112.206 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 58.19 60.83 2.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.568 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.543 ' C ' HD22 ' D' ' 102' ' ' ASN . 0.1 OUTLIER -171.27 -41.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.957 . . . . 0.0 109.457 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -46.21 -40.47 11.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.731 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -80.04 -19.99 46.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 0.0 109.577 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' D' ' 102' ' ' ASN . 12.2 tp -70.54 -59.76 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.613 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.836 HD13 ' CHC' ' D' ' 147' ' ' HEC . 7.0 tt -49.77 -46.33 50.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 0.0 109.33 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.08 -20.39 57.99 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -80.57 -25.1 38.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -1.165 . . . . 0.0 109.672 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 73.9 t -86.28 -43.09 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.659 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . 0.421 HD21 ' CE2' ' D' ' 71' ' ' PHE . 6.3 tt -48.08 -33.22 7.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.54 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . 0.416 ' H ' HG12 ' D' ' 111' ' ' VAL . 4.3 p -82.9 -26.16 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 72.0 m -69.05 -24.84 64.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.177 -0.952 . . . . 0.0 109.496 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 42.6 t -76.34 -34.8 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.908 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' D' ' 118' ' ' PHE . 9.4 mt -69.82 -40.14 76.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.472 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -54.47 -29.0 48.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.318 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.532 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -84.64 -62.42 1.55 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 109.113 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -63.4 -17.67 62.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 109.639 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' D' ' 114' ' ' LEU . 93.1 m-85 -149.65 60.29 1.01 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.462 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.534 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -69.28 -24.62 75.95 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -64.76 -29.67 70.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -1.154 . . . . 0.0 109.351 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' D' ' 123' ' ' THR . 78.3 mm-40 -87.83 5.76 38.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.862 . . . . 0.0 109.764 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.67 33.12 0.08 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.416 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.496 ' H ' ' C ' ' D' ' 121' ' ' GLU . 1.4 p -52.45 149.16 10.94 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.833 . . . . 0.0 109.367 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.1 Cg_exo -45.52 -53.6 5.35 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.452 2.101 . . . . 0.0 112.907 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 24.3 Cg_endo -62.22 -29.65 80.68 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.063 1.842 . . . . 0.0 112.211 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.447 HG23 ' OG1' ' D' ' 123' ' ' THR . 46.2 t -68.72 -28.16 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.185 -0.947 . . . . 0.0 109.537 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -83.18 -53.92 5.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 109.508 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.883 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -63.19 -26.5 68.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.905 . . . . 0.0 109.622 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.54 -2.3 53.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 109.823 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' D' ' 132' ' ' LYS . 41.8 t80 -92.42 -61.7 1.55 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.152 -0.968 . . . . 0.0 109.646 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 1.5 tm0? -45.23 -23.32 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 109.94 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' D' ' 130' ' ' TYR . 51.0 mtmt -85.46 -34.54 21.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.147 -0.971 . . . . 0.0 110.344 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' D' ' 134' ' ' VAL . 0.6 OUTLIER -68.59 -44.22 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.995 -1.066 . . . . 0.0 109.649 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.486 ' N ' ' CG1' ' D' ' 133' ' ' VAL . 6.1 m -79.6 -20.98 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -50.41 -32.46 17.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.096 -1.002 . . . . 0.0 109.336 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.59 -26.66 56.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 67.4 t -80.32 -32.96 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -1.133 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.07 -46.43 90.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.9 . . . . 0.0 109.626 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.98 -21.06 47.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.664 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.01 -58.92 6.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.582 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.42 -31.89 71.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.07 25.2 4.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.289 -0.882 . . . . 0.0 109.549 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -80.0 -16.11 55.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.131 -0.981 . . . . 0.0 109.733 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.491 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 13.2 mptt -98.42 -26.64 14.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 109.571 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . 0.449 ' OH ' ' O ' ' D' ' 98' ' ' VAL . 12.1 m-85 -54.43 -6.85 0.12 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.336 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' D' ' 144' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.44 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 1.099 ' CBD' HD11 ' A' ' 86' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 0.833 ' CHC' HD13 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 1.115 ' CBD' HD11 ' C' ' 86' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 0.836 ' CHC' HD13 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.535 HD21 ' OD2' ' A' ' 6' ' ' ASP . 14.0 tp -170.95 164.65 7.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 0.0 109.864 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.83 165.75 35.68 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.348 -0.845 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.64 -77.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.773 2.315 . . . . 0.0 112.655 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -45.22 -30.01 1.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 109.964 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.775 ' O ' HG23 ' A' ' 10' ' ' VAL . 26.2 t0 -43.77 -23.04 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.246 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -83.34 -60.61 2.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.372 -0.83 . . . . 0.0 109.324 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.5 m -44.45 -35.97 2.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.535 -0.728 . . . . 0.0 109.9 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.422 ' C ' ' OG ' ' A' ' 124' ' ' SER . 2.5 m-20 -74.49 -30.02 61.65 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 6' ' ' ASP . 76.6 t -76.31 -53.52 15.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -52.62 -38.28 59.9 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 179.081 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.04 -63.76 1.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.47 -0.769 . . . . 0.0 109.144 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.745 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -58.56 -37.7 76.27 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -17.23 62.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 109.03 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -79.02 -46.25 8.43 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 13.2 mmmt -69.17 -38.27 78.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 108.982 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 13' ' ' ALA . 98.9 t -61.07 -64.96 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 54.43 -132.59 46.55 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.87 26.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -1.073 . . . . 0.0 110.522 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.547 ' H ' ' C ' ' A' ' 18' ' ' GLY . 92.7 m-70 -129.94 22.29 5.36 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -86.7 -60.0 2.11 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.65 -0.656 . . . . 0.0 109.598 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.4 -14.28 0.18 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 21' ' ' ALA . 7.3 mm-40 -86.85 -56.52 3.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.425 -1.044 . . . . 0.0 109.781 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.8 m-30 -60.67 -37.55 81.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.15 -22.88 71.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -82.09 -51.43 8.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.144 -1.209 . . . . 0.0 109.839 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.59 -19.8 28.29 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.325 -0.859 . . . . 0.0 109.372 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.2 -23.74 62.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.269 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.534 HD11 ' ND1' ' A' ' 58' ' ' HIS . 26.5 mt -70.33 -56.15 7.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.303 -0.873 . . . . 0.0 109.459 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.03 -12.62 8.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.404 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -76.29 -61.1 2.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -19.45 65.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.552 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.49 -53.15 61.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 0.0 109.715 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.039 HD13 ' HB2' ' B' ' 128' ' ' ALA . 2.2 pp -88.01 -41.87 12.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.941 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 5.7 t -58.9 -2.27 0.22 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.663 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' A' ' 35' ' ' SER . 64.9 m-85 -160.24 81.85 2.27 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 109.418 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -49.17 -27.03 11.85 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.725 2.284 . . . . 0.0 112.316 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 41' ' ' THR . 5.5 p -49.04 -21.42 0.69 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -0.991 . . . . 0.0 109.388 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 79.9 p -90.36 -27.07 19.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -55.09 -47.51 74.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.636 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 1.108 HG21 ' CD2' ' D' ' 97' ' ' HIS . 13.1 t -49.22 -24.57 1.81 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 43' ' ' PHE . 16.0 t80 -73.95 4.06 5.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.279 -0.888 . . . . 0.0 109.289 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.432 ' O ' ' O ' ' A' ' 42' ' ' TYR . 7.0 m-85 61.56 144.53 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.805 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 60.0 Cg_endo -73.65 -42.69 0.78 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.385 2.057 . . . . 0.0 111.928 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.548 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 25.2 p80 40.74 31.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.67 -0.643 . . . . 0.0 110.62 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.465 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -164.73 29.63 0.07 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.029 -1.045 . . . . 0.0 110.371 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 46' ' ' PHE . 5.9 m-20 41.04 88.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.533 -0.729 . . . . 0.0 110.113 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.676 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -61.43 -19.53 62.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.505 -0.747 . . . . 0.0 109.15 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -47.3 121.49 3.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.64 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -65.25 107.86 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.91 -6.58 4.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.604 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 2.0 t -75.02 -0.23 18.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.39 -1.065 . . . . 0.0 109.444 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 71.1 -14.94 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 109.589 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' H ' ' C ' ' A' ' 52' ' ' SER . 54.6 mt-30 -86.09 -28.9 23.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.506 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.598 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 4.2 t -82.96 -39.1 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -81.98 -25.56 34.66 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.508 ' HA2' ' HZ2' ' A' ' 60' ' ' LYS . . . -76.73 -25.56 64.72 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.534 ' ND1' HD11 ' A' ' 29' ' ' LEU . 5.8 t-80 -72.75 -42.38 64.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -1.183 . . . . 0.0 109.613 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.96 -46.44 32.46 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HZ2' ' HA2' ' A' ' 57' ' ' GLY . 6.4 mtmm -53.08 -22.66 6.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -1.081 . . . . 0.0 109.912 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.506 ' O ' HMA3 ' A' ' 142' ' ' HEC . 0.3 OUTLIER -73.99 -48.66 28.76 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.037 -1.039 . . . . 0.0 108.599 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.49 HG22 ' C2B' ' A' ' 142' ' ' HEC . 1.2 t -67.85 -45.99 83.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.467 ' N ' HG12 ' A' ' 62' ' ' VAL . . . -66.05 -35.28 80.12 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.488 -0.757 . . . . 0.0 109.398 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 11.7 t70 -65.17 -48.4 73.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.122 -0.986 . . . . 0.0 108.676 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.767 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -59.47 -50.68 73.0 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.47 -49.77 66.75 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -61.8 -54.52 41.12 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.258 -0.901 . . . . 0.0 108.883 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -60.44 -20.89 61.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 108.777 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.2 -48.08 9.47 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.38 -22.84 27.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.97 -33.61 68.31 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.601 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.7 m170 -97.2 -66.58 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.441 -0.787 . . . . 0.0 109.557 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.1 p 44.89 14.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.883 0.849 . . . . 0.0 109.156 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 72' ' ' HIS . 91.6 m-20 -140.49 13.31 2.35 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -175.27 31.85 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.544 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -64.01 -46.46 80.67 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 110.062 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 76' ' ' MET . 81.5 Cg_exo -44.15 -40.78 12.65 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.471 2.114 . . . . 0.0 112.563 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -94.32 -17.21 22.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 109.975 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.8 -58.11 3.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.162 -0.961 . . . . 0.0 109.302 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' C ' ' N ' ' A' ' 82' ' ' ALA . 11.0 mt -77.69 11.21 2.21 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.367 -0.833 . . . . 0.0 109.045 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.67 -16.21 0.61 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.563 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -80.91 -57.8 3.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 83' ' ' LEU . 3.7 mt -44.88 -43.94 9.23 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.91 -27.33 18.21 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.501 -0.749 . . . . 0.0 109.056 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 82' ' ' ALA . 34.4 t70 -76.26 -21.44 56.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.935 . . . . 0.0 109.291 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.512 HD21 ' CBD' ' A' ' 142' ' ' HEC . 3.3 tp -82.99 -34.64 26.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -92.42 -21.72 20.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.519 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.33 -98.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.918 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -86.36 -76.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 86' ' ' LEU . 7.0 ttmm -45.31 124.51 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 109.765 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 93' ' ' VAL . 16.2 mt 54.04 57.73 5.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.307 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.967 ' NE ' ' HG2' ' D' ' 40' ' ' ARG . 85.2 mtm-85 -49.81 -38.91 36.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.614 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 94' ' ' ASP . 59.4 t 47.22 -101.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.487 ' N ' HG12 ' A' ' 93' ' ' VAL . 0.3 OUTLIER 171.33 137.36 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 109.176 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -75.24 -16.78 19.5 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.371 2.047 . . . . 0.0 112.014 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 96' ' ' VAL . 61.5 t -60.66 -9.47 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.701 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 98' ' ' PHE . 29.6 p30 -78.91 -24.79 43.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.117 -0.989 . . . . 0.0 109.34 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.532 ' N ' ' OD1' ' A' ' 97' ' ' ASN . 0.7 OUTLIER -50.1 -47.19 54.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.313 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.24 -22.66 66.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.908 . . . . 0.0 109.609 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.459 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 42.7 mt -84.01 -62.03 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.651 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.786 HD23 ' HAB' ' A' ' 142' ' ' HEC . 4.7 tp -52.46 -25.82 11.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.081 -1.012 . . . . 0.0 109.708 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.8 t -69.97 -59.18 3.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.87 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.766 ' ND1' ' OD1' ' B' ' 108' ' ' ASN . 43.2 m170 -63.26 -26.67 68.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.621 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 67.4 m -67.9 -48.25 66.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 109.567 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.88 -41.21 32.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.406 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 106' ' ' LEU . 9.4 mp -68.17 -50.78 52.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 109.522 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.606 ' CG1' HE22 ' B' ' 127' ' ' GLN . 70.4 t -53.99 -51.42 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 110' ' ' ALA . 40.2 m -59.82 -58.47 8.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.331 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 113' ' ' LEU . 4.6 mt -45.98 -19.95 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.875 . . . . 0.0 109.643 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -72.29 -35.47 68.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 110.135 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 1.313 ' HB2' ' CE2' ' B' ' 122' ' ' PHE . . . -75.04 -3.78 34.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 110.031 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.6 -82.3 0.31 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -106.82 94.4 10.42 Favored Pre-proline 0 N--CA 1.487 1.42 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.8 175.87 9.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.093 1.862 . . . . 0.0 112.935 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -47.78 -44.84 28.82 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.438 0.637 . . . . 0.0 109.814 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 6.9 mt-10 87.1 5.65 0.31 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 t80 68.38 36.42 3.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.871 -0.518 . . . . 0.0 111.51 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.713 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -96.96 121.65 58.68 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.807 -1.183 . . . . 0.0 108.224 178.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.95 20.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.15 1.9 . . . . 0.0 112.765 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -145.43 -37.66 0.27 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.934 -1.104 . . . . 0.0 110.264 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.616 HG13 ' N ' ' A' ' 122' ' ' HIS . 7.8 p -46.91 -44.76 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.069 -1.019 . . . . 0.0 110.126 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.616 ' N ' HG13 ' A' ' 121' ' ' VAL . 4.8 m-70 -56.7 -50.0 73.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.81 -19.58 34.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.786 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 120' ' ' ALA . 15.5 t -54.82 -58.18 8.59 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.205 -0.934 . . . . 0.0 110.597 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mt -85.43 -19.73 30.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.199 -0.938 . . . . 0.0 110.156 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -83.25 -40.36 19.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.887 -1.133 . . . . 0.0 110.18 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.475 ' CD ' ' C ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -87.09 -47.21 9.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.005 -1.06 . . . . 0.0 109.63 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.51 ' CD1' HG21 ' A' ' 10' ' ' VAL . 70.9 t80 -48.63 -21.59 0.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.96 -1.088 . . . . 0.0 109.212 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.622 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.6 mt -69.73 -17.87 63.48 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.05 -29.97 70.04 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.48 ' HB3' HD13 ' A' ' 2' ' ' LEU . 53.3 p -82.78 -35.93 26.08 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.419 -0.801 . . . . 0.0 108.973 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.19 -27.34 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.234 -0.916 . . . . 0.0 108.897 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 129' ' ' LEU . 57.4 p -84.17 -24.91 29.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.427 -0.795 . . . . 0.0 109.052 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.7 m -78.16 -34.92 49.44 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.158 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 96.4 t -78.34 -26.4 14.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.156 -0.965 . . . . 0.0 108.577 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -33.67 76.41 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.3 m -85.26 -15.19 44.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.414 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.2 t 60.19 160.86 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.574 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -80.34 -33.35 37.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -72.7 93.11 1.61 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.495 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.534 -179.943 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.543 ' H3 ' ' C ' ' B' ' 132' ' ' LYS . 7.1 p . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 51.71 58.9 4.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.941 . . . . 0.0 109.139 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 1.02 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -121.42 -175.15 3.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.557 -0.714 . . . . 0.0 109.196 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -79.57 152.76 75.71 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 109.016 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.83 -28.55 75.87 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.526 2.151 . . . . 0.0 112.01 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -86.7 -21.92 26.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.485 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.57 -63.11 1.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.723 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.711 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -57.21 -40.4 77.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.791 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.7 t -45.54 -23.71 0.26 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 110.038 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.44 -57.07 3.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.148 -0.97 . . . . 0.0 109.792 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.407 ' H ' HG12 ' B' ' 11' ' ' VAL . 0.8 OUTLIER -67.22 -24.55 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 8.4 m -71.18 -44.45 65.44 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.676 -0.64 . . . . 0.0 109.446 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.41 74.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.358 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.807 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -49.27 -21.06 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 109.193 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -17.3 60.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.5 -57.48 7.34 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.654 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.576 ' HE2' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -86.59 12.5 10.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.979 -1.307 . . . . 0.0 110.929 -178.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.807 HG23 ' O ' ' B' ' 14' ' ' LEU . 2.2 t -79.49 114.93 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.839 -1.163 . . . . 0.0 109.007 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -76.48 82.73 3.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -0.909 . . . . 0.0 109.474 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.48 ' C ' ' H ' ' B' ' 22' ' ' GLU . 72.1 t -54.94 -18.21 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.202 -0.936 . . . . 0.0 109.404 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 5.0 m-20 -66.21 6.3 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.712 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' B' ' 20' ' ' VAL . 35.1 mt-10 -156.01 -52.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' B' ' 27' ' ' ALA . 95.3 t -47.57 -35.66 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.705 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.52 -57.55 4.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.5 -50.78 55.65 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.19 -45.98 90.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -1.138 . . . . 0.0 109.602 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' B' ' 23' ' ' VAL . . . -51.1 -35.22 34.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.688 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -84.96 -58.03 2.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 109.654 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.22 -37.45 72.91 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.513 HH21 HG22 ' B' ' 113' ' ' VAL . 8.1 ttp180 -69.74 -38.48 76.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -1.212 . . . . 0.0 109.734 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 40.6 tp -52.99 -24.22 8.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 0.0 110.074 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' B' ' 36' ' ' PRO . 15.7 mt -75.54 -54.39 7.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.037 -1.04 . . . . 0.0 110.893 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.41 HG22 ' H ' ' B' ' 33' ' ' VAL . 2.2 m -52.72 -49.02 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.712 -1.242 . . . . 0.0 109.764 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -70.76 -22.72 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 109.126 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -149.43 74.94 9.63 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.48 ' N ' ' O ' ' B' ' 32' ' ' LEU . 72.3 Cg_endo -81.54 -22.87 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.788 2.326 . . . . 0.0 112.219 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -48.98 -19.92 0.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.908 . . . . 0.0 109.47 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.465 ' C ' ' H ' ' B' ' 40' ' ' ARG . 33.5 p -80.35 9.9 5.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.595 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -71.8 12.26 0.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.318 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.921 ' HG2' ' NE ' ' C' ' 92' ' ' ARG . 97.4 mtt180 -80.29 -19.77 45.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.52 26.27 4.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.306 -0.871 . . . . 0.0 109.129 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.507 ' CE1' ' CD2' ' B' ' 45' ' ' PHE . 33.4 t80 -148.77 11.73 0.86 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.89 -22.13 40.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.889 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 27.4 p -84.61 7.13 21.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' B' ' 42' ' ' PHE . 3.7 m-85 -81.44 -16.44 52.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.94 -175.37 45.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.443 ' O ' ' HB1' ' B' ' 53' ' ' ALA . 3.6 p-10 -83.14 103.84 12.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.351 -1.088 . . . . 0.0 109.578 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.579 HD12 ' N ' ' B' ' 48' ' ' LEU . 10.2 mp -88.17 29.73 0.93 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.199 -0.938 . . . . 0.0 109.147 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.1 m -44.88 -35.88 3.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.36 -0.838 . . . . 0.0 109.789 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 5.5 p -146.43 148.83 35.54 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.61 -36.35 4.71 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.565 2.177 . . . . 0.0 112.501 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.68 -33.58 72.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.743 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' B' ' 47' ' ' ASP . . . -62.16 -19.88 63.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.609 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.97 -59.69 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.963 . . . . 0.0 109.525 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . 0.495 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -87.45 10.54 17.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.37 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.91 -31.22 32.89 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -81.94 147.96 59.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 109.434 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.63 -57.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.544 2.163 . . . . 0.0 112.427 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.03 -33.36 4.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.777 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 70.8 t -61.03 -57.92 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.199 -0.938 . . . . 0.0 109.459 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -64.96 -33.6 76.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.56 -53.65 44.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 109.589 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -53.3 -24.01 10.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.187 -0.946 . . . . 0.0 109.538 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.08 -23.88 73.08 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.88 -44.08 81.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -1.158 . . . . 0.0 109.164 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -55.35 -47.29 75.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.416 -0.802 . . . . 0.0 109.351 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 0.544 HG13 ' C2B' ' B' ' 147' ' ' HEC . 25.4 t -58.14 -47.01 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.42 -35.02 74.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.203 -0.936 . . . . 0.0 109.276 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.83 -53.18 46.05 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.6 -45.11 63.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -1.201 . . . . 0.0 109.616 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -55.85 -31.16 62.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.398 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 33.2 t -76.56 -31.45 57.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.421 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -50.28 -40.02 47.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.368 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.89 -59.95 8.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.551 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.6 mp -58.16 -26.92 63.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -1.166 . . . . 0.0 109.387 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.05 2.51 46.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.443 ' C ' ' H ' ' B' ' 79' ' ' ASP . 66.0 t60 -170.89 65.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.731 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 80.0 mt -75.85 19.58 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.955 . . . . 0.0 109.432 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' B' ' 77' ' ' HIS . 8.9 m-20 -79.6 -29.49 41.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.532 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.424 ' O ' ' OD1' ' B' ' 80' ' ' ASN . 5.4 p30 -173.32 107.09 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.564 ' N ' HD12 ' B' ' 81' ' ' LEU . 8.3 mp -80.28 -58.77 2.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.476 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.463 ' H ' ' HD2' ' B' ' 82' ' ' LYS . 0.0 OUTLIER -46.5 -24.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.5 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.71 -50.24 9.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.7 t -82.35 -47.37 12.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -1.133 . . . . 0.0 109.366 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.552 ' N ' ' CG2' ' B' ' 84' ' ' THR . 27.6 m-85 -65.03 1.36 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.732 . . . . 0.0 109.482 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.9 -34.93 66.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.514 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -74.34 -57.55 3.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.496 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.479 ' N ' HD12 ' B' ' 88' ' ' LEU . 9.0 mp -49.3 -45.0 44.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -0.931 . . . . 0.0 109.407 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -63.95 -52.15 61.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.175 -0.953 . . . . 0.0 109.454 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.67 -22.83 64.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 6.5 tt -85.51 -62.81 1.44 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' B' ' 97' ' ' HIS . 75.2 m80 -61.34 -20.14 62.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 110.13 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 51.7 t -83.51 -60.63 2.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.022 -1.049 . . . . 0.0 110.571 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.43 -28.32 22.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.047 -1.033 . . . . 0.0 110.994 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -83.99 -51.91 6.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.064 . . . . 0.0 110.686 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 11.7 mt -107.0 -21.29 13.05 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.08 -1.012 . . . . 0.0 109.966 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 1.073 ' CD2' HG21 ' C' ' 41' ' ' THR . 33.0 p80 43.02 37.46 1.14 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.346 -0.846 . . . . 0.0 109.971 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.0 130.89 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.195 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.411 ' HB2' HD21 ' B' ' 102' ' ' ASN . 39.3 m-20 -46.94 147.35 2.31 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.39 -16.93 44.1 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.508 2.139 . . . . 0.0 112.086 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' B' ' 101' ' ' GLU . 58.7 mp0 -81.25 55.22 2.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.312 -0.868 . . . . 0.0 109.317 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.441 ' ND2' ' C ' ' B' ' 101' ' ' GLU . 9.8 m-80 -156.1 -37.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -64.16 -38.67 91.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.116 -0.99 . . . . 0.0 109.529 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -69.72 -28.18 65.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.677 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 16.1 mt -71.61 -52.76 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 109.615 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.768 HD22 ' HAB' ' B' ' 147' ' ' HEC . 6.7 tt -52.17 -47.81 65.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 0.0 109.353 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.73 -20.4 70.23 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . 0.766 ' OD1' ' ND1' ' A' ' 103' ' ' HIS . 0.4 OUTLIER -83.27 -19.11 36.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -1.177 . . . . 0.0 109.743 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 72.8 t -80.34 -44.56 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.093 -1.004 . . . . 0.0 109.561 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 10.7 mt -47.38 -31.92 4.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.99 -33.47 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.429 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 11.9 m -79.15 -54.51 5.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.48 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . 0.513 HG22 HH21 ' B' ' 30' ' ' ARG . 14.0 t -49.52 -46.01 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.426 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.05 -22.83 64.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.855 . . . . 0.0 109.345 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.455 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -80.73 -24.29 38.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.478 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.47 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.77 -61.59 1.75 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 109.346 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.413 ' C ' ' CG ' ' B' ' 118' ' ' PHE . 55.3 m80 -60.25 -17.7 43.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.651 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.413 ' CG ' ' C ' ' B' ' 117' ' ' HIS . 19.2 m-85 -150.29 58.56 0.96 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.585 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -68.64 -28.6 73.05 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -68.99 6.37 0.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.412 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' B' ' 123' ' ' THR . 17.8 mm-40 -126.0 -1.2 7.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.448 -0.782 . . . . 0.0 109.438 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 1.313 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -72.75 35.37 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.552 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.504 ' OG1' HG23 ' B' ' 126' ' ' VAL . 13.2 p -50.85 146.64 9.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.51 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.3 Cg_exo -48.29 -51.39 10.21 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.382 2.055 . . . . 0.0 113.04 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 39.9 Cg_endo -67.57 -27.67 38.8 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.063 1.842 . . . . 0.0 112.496 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.504 HG23 ' OG1' ' B' ' 123' ' ' THR . 55.5 t -77.39 -24.14 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.494 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . 0.606 HE22 ' CG1' ' A' ' 107' ' ' VAL . 9.1 tt0 -83.28 -54.55 4.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 1.039 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -49.19 -44.07 42.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.488 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.37 13.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.884 . . . . 0.0 109.597 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' B' ' 128' ' ' ALA . 32.0 t80 -97.95 -59.89 1.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 38.2 tt0 -47.45 -30.53 3.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.543 ' C ' ' H3 ' ' B' ' 1' ' ' VAL . 8.7 mtpm? -66.15 -46.62 76.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 0.0 109.753 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.73 -55.55 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.109 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.442 HG22 ' H ' ' B' ' 134' ' ' VAL . 3.5 m -67.95 -36.76 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -0.942 . . . . 0.0 110.02 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -50.16 -24.57 2.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.486 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.99 -31.41 55.6 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.2 t -82.78 -29.89 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.18 -1.188 . . . . 0.0 109.523 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.77 77.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.471 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 1.169 ' OD1' ' CE1' ' D' ' 146' ' ' HIS . 4.2 m120 -71.33 -27.75 63.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.514 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.36 -60.38 2.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.92 -16.14 2.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 109.333 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.26 -3.07 13.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.368 -0.832 . . . . 0.0 109.516 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 139' ' ' ASN . 21.9 t-80 -64.27 -33.28 75.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.505 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -82.45 -29.74 30.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.561 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -51.37 -20.98 1.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 1.222 ' CE1' ' OD1' ' D' ' 139' ' ' ASN . 43.0 m80 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.477 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.543 HD21 ' OD2' ' C' ' 6' ' ' ASP . 14.0 tp -170.86 164.68 7.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.113 -0.992 . . . . 0.0 109.869 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.76 165.88 35.11 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.496 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.72 -77.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.79 2.327 . . . . 0.0 112.591 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -45.17 -30.1 1.09 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 0.0 109.953 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.771 ' O ' HG23 ' C' ' 10' ' ' VAL . 26.3 t0 -43.62 -23.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.323 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' C' ' 10' ' ' VAL . 0.0 OUTLIER -83.39 -60.51 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.385 -0.822 . . . . 0.0 109.33 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.402 ' C ' ' O ' ' C' ' 7' ' ' LYS . 45.6 m -44.43 -36.0 2.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.0 109.805 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . 0.424 ' C ' ' OG ' ' C' ' 124' ' ' SER . 2.5 m-20 -74.46 -30.12 61.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.771 HG23 ' O ' ' C' ' 6' ' ' ASP . 76.8 t -76.27 -53.49 15.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' C' ' 7' ' ' LYS . 0.0 OUTLIER -52.78 -38.17 60.69 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.03 -63.72 1.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.203 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.729 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -58.55 -37.77 76.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.396 -0.815 . . . . 0.0 108.818 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -17.22 62.53 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.049 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' C' ' 11' ' ' LYS . . . -79.07 -46.24 8.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 13.3 mmmt -69.21 -38.25 78.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -1.149 . . . . 0.0 108.922 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.729 HG23 ' O ' ' C' ' 13' ' ' ALA . 98.3 t -61.11 -65.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.567 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 54.42 -132.49 46.48 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.9 26.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.481 -1.011 . . . . 0.0 110.49 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.567 ' H ' ' C ' ' C' ' 18' ' ' GLY . 92.7 m-70 -129.89 22.25 5.38 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -86.72 -60.09 2.08 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.681 -0.637 . . . . 0.0 109.512 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.33 -14.27 0.17 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' C' ' 21' ' ' ALA . 7.3 mm-40 -86.84 -56.57 3.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -1.087 . . . . 0.0 109.795 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.8 m-30 -60.73 -37.51 81.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 109.367 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.19 -22.89 71.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' C' ' 55' ' ' VAL . . . -82.2 -51.33 8.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -1.199 . . . . 0.0 109.841 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.58 -19.89 28.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.17 -23.76 62.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.286 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.539 HD11 ' ND1' ' C' ' 58' ' ' HIS . 26.8 mt -70.28 -56.12 7.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 109.444 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.06 -12.63 8.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -76.3 -61.18 2.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.894 . . . . 0.0 109.726 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -19.44 65.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.607 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.49 -53.27 60.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.639 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 1.061 HD13 ' HB2' ' D' ' 128' ' ' ALA . 2.2 pp -87.87 -41.99 12.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 0.0 109.919 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 5.8 t -58.89 -2.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.096 -1.002 . . . . 0.0 109.637 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' C' ' 35' ' ' SER . 64.9 m-85 -160.07 81.78 2.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.468 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -49.17 -26.93 11.71 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.696 2.264 . . . . 0.0 112.302 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.418 ' O ' HG22 ' C' ' 41' ' ' THR . 5.2 p -49.1 -21.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.363 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 80.3 p -90.28 -27.17 19.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.55 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -55.11 -47.43 74.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.608 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 1.073 HG21 ' CD2' ' B' ' 97' ' ' HIS . 13.0 t -49.36 -24.5 1.94 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.357 -0.839 . . . . 0.0 109.398 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' C' ' 43' ' ' PHE . 15.8 t80 -73.84 3.94 5.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.215 -0.928 . . . . 0.0 109.343 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' C' ' 42' ' ' TYR . 7.0 m-85 61.59 144.52 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.472 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.536 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 60.2 Cg_endo -73.64 -42.68 0.79 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.468 2.112 . . . . 0.0 111.97 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 25.0 p80 40.75 31.98 0.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.685 -0.634 . . . . 0.0 110.625 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.47 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -164.74 29.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.981 -1.074 . . . . 0.0 110.301 179.206 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' C' ' 46' ' ' PHE . 5.9 m-20 41.0 88.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.554 -0.716 . . . . 0.0 110.119 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.675 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.0 OUTLIER -61.44 -19.58 62.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.448 -0.782 . . . . 0.0 109.239 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 85.9 p -47.25 121.51 3.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.632 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.15 107.87 1.69 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 109.369 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.87 -6.54 4.44 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.597 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 2.0 t -75.07 -0.12 17.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -1.042 . . . . 0.0 109.427 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 71.02 -14.87 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.845 . . . . 0.0 109.63 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' C' ' 52' ' ' SER . 54.8 mt-30 -86.07 -29.04 23.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.611 ' O ' ' HB1' ' C' ' 26' ' ' ALA . 4.2 t -82.85 -39.11 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.955 . . . . 0.0 109.328 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -82.0 -25.62 34.57 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 108.542 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . 0.553 ' HA2' ' HZ2' ' C' ' 60' ' ' LYS . . . -76.73 -25.56 64.7 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.539 ' ND1' HD11 ' C' ' 29' ' ' LEU . 5.7 t-80 -72.79 -42.38 63.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -1.179 . . . . 0.0 109.631 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.93 -46.5 32.28 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.553 ' HZ2' ' HA2' ' C' ' 57' ' ' GLY . 6.4 mtmm -53.04 -22.61 6.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.997 . . . . 0.0 109.911 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.498 ' O ' HMA3 ' C' ' 142' ' ' HEC . 0.3 OUTLIER -74.01 -48.76 28.02 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.115 -0.991 . . . . 0.0 108.502 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.495 HG22 ' C2B' ' C' ' 142' ' ' HEC . 1.2 t -67.75 -46.05 83.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.445 ' N ' HG12 ' C' ' 62' ' ' VAL . . . -65.92 -35.42 80.56 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.454 -0.778 . . . . 0.0 109.355 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 11.6 t70 -65.19 -48.36 73.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.946 . . . . 0.0 108.654 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.768 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -59.53 -50.64 73.14 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.44 -49.85 66.5 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -61.67 -54.62 40.29 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.205 -0.934 . . . . 0.0 108.897 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -60.31 -21.03 61.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 0.0 108.756 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.2 -48.1 9.46 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -68.32 -22.83 27.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.62 68.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.596 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.7 m170 -97.26 -66.47 0.9 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.428 -0.795 . . . . 0.0 109.556 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.532 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.1 p 44.78 14.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.978 0.894 . . . . 0.0 109.214 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' C' ' 72' ' ' HIS . 91.2 m-20 -140.57 13.37 2.33 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -175.23 31.81 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.537 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -63.9 -46.47 81.34 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 110.099 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' C' ' 76' ' ' MET . 81.6 Cg_exo -44.21 -40.72 12.81 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.468 2.112 . . . . 0.0 112.607 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -94.25 -17.31 22.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.985 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.8 -57.95 3.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 109.309 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . 0.403 ' C ' ' N ' ' C' ' 82' ' ' ALA . 11.0 mt -77.79 11.22 2.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.06 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.68 -16.24 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.513 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -80.89 -57.69 3.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.669 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.452 HD23 ' N ' ' C' ' 83' ' ' LEU . 3.8 mt -44.95 -43.96 9.43 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.85 -27.33 17.86 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' C' ' 82' ' ' ALA . 34.4 t70 -76.32 -21.55 56.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.283 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.507 HD21 ' CBD' ' C' ' 142' ' ' HEC . 3.3 tp -82.9 -34.56 26.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.281 -0.887 . . . . 0.0 109.47 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -92.47 -21.75 19.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 109.495 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.28 -98.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.901 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -86.26 -76.41 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.853 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' C' ' 86' ' ' LEU . 6.9 ttmm -45.27 124.54 4.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.799 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.441 ' O ' HG23 ' C' ' 93' ' ' VAL . 16.1 mt 53.97 57.7 5.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.846 . . . . 0.0 109.345 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . 0.921 ' NE ' ' HG2' ' B' ' 40' ' ' ARG . 85.3 mtm-85 -49.87 -38.77 36.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.822 . . . . 0.0 109.649 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.485 HG12 ' N ' ' C' ' 94' ' ' ASP . 58.3 t 47.14 -101.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 0.0 109.335 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.485 ' N ' HG12 ' C' ' 93' ' ' VAL . 0.3 OUTLIER 171.42 137.39 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.316 -0.865 . . . . 0.0 109.134 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.28 -16.75 19.44 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.366 2.044 . . . . 0.0 112.036 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.432 HG12 ' O ' ' C' ' 96' ' ' VAL . 60.9 t -60.66 -9.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.86 . . . . 0.0 109.671 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' C' ' 98' ' ' PHE . 29.7 p30 -78.94 -24.78 43.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 109.29 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . 0.523 ' N ' ' OD1' ' C' ' 97' ' ' ASN . 0.7 OUTLIER -50.18 -47.14 54.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.292 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -62.21 -22.7 66.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.594 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.489 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 43.5 mt -84.04 -62.04 1.66 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.585 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.775 HD23 ' HAB' ' C' ' 142' ' ' HEC . 4.7 tp -52.37 -25.81 10.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 109.725 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 4.7 t -70.02 -59.16 3.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.18 -0.95 . . . . 0.0 109.805 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.77 ' ND1' ' OD1' ' D' ' 108' ' ' ASN . 43.4 m170 -63.37 -26.58 68.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.644 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 67.9 m -67.99 -48.17 66.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.89 -41.24 32.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.962 . . . . 0.0 109.362 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.494 ' N ' HD12 ' C' ' 106' ' ' LEU . 9.4 mp -68.1 -50.74 52.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 109.568 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . 0.61 ' CG1' HE22 ' D' ' 127' ' ' GLN . 70.0 t -54.06 -51.3 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.356 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.452 ' O ' ' N ' ' C' ' 110' ' ' ALA . 39.9 m -59.91 -58.46 8.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' C' ' 113' ' ' LEU . 4.5 mt -45.99 -19.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.374 -0.829 . . . . 0.0 109.592 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -72.36 -35.38 68.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.147 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . 1.319 ' HB2' ' CE2' ' D' ' 122' ' ' PHE . . . -75.15 -3.67 34.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 110.012 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -138.72 -82.23 0.3 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 109.386 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' C' ' 113' ' ' LEU . 0.3 OUTLIER -106.91 94.47 10.67 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.77 175.9 9.67 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.169 1.913 . . . . 0.0 112.903 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -47.82 -44.84 29.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.641 -0.662 . . . . 0.0 109.85 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.529 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 6.9 mt-10 87.06 5.81 0.31 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 t80 68.27 36.46 3.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.826 -0.546 . . . . 0.0 111.523 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.718 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -96.93 121.63 58.79 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.796 -1.19 . . . . 0.0 108.226 178.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -51.02 20.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.104 1.869 . . . . 0.0 112.826 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.718 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -145.37 -37.72 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.897 -1.127 . . . . 0.0 110.258 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.618 HG13 ' N ' ' C' ' 122' ' ' HIS . 7.8 p -46.88 -44.77 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.156 -0.965 . . . . 0.0 110.172 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.618 ' N ' HG13 ' C' ' 121' ' ' VAL . 4.7 m-70 -56.68 -49.9 73.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.412 -0.805 . . . . 0.0 109.78 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.87 -19.57 34.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.771 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.536 ' N ' ' O ' ' C' ' 120' ' ' ALA . 15.3 t -54.78 -58.33 7.97 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 110.606 -178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 3.0 mt -85.22 -19.71 31.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.147 -0.971 . . . . 0.0 110.227 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -83.33 -40.29 19.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.898 -1.126 . . . . 0.0 110.202 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.472 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -87.17 -47.17 9.09 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.863 -1.148 . . . . 0.0 109.649 -179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.511 ' CD1' HG21 ' C' ' 10' ' ' VAL . 71.1 t80 -48.71 -21.55 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.018 -1.052 . . . . 0.0 109.22 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.613 ' O ' ' N ' ' C' ' 133' ' ' SER . 15.7 mt -69.69 -17.9 63.51 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.09 -29.96 70.07 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.493 ' HB3' HD13 ' C' ' 2' ' ' LEU . 53.2 p -82.73 -35.86 26.28 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.475 -0.766 . . . . 0.0 109.033 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t -85.34 -27.32 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -0.946 . . . . 0.0 108.793 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.613 ' N ' ' O ' ' C' ' 129' ' ' LEU . 56.8 p -84.08 -24.9 30.18 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.455 -0.778 . . . . 0.0 109.162 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 18.8 m -78.04 -35.1 50.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 109.146 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 96.6 t -78.16 -26.41 14.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.226 -0.921 . . . . 0.0 108.641 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.83 -33.59 76.21 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 76.0 m -85.29 -15.17 44.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.446 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 4.2 t 60.23 160.85 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.577 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -80.35 -33.45 37.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -72.6 93.22 1.58 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.44 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.456 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.557 ' H3 ' ' C ' ' D' ' 132' ' ' LYS . 7.2 p . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 51.77 58.77 5.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.169 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 1.08 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -121.35 -175.04 2.98 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.443 -0.786 . . . . 0.0 109.2 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -79.77 152.79 75.2 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.344 -0.847 . . . . 0.0 109.045 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -62.83 -28.42 75.78 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.528 2.152 . . . . 0.0 112.024 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -86.85 -21.87 26.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.61 -63.02 1.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.733 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.731 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -57.27 -40.42 77.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 109.742 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.7 t -45.58 -23.61 0.25 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 110.08 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -81.44 -57.19 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.074 -1.016 . . . . 0.0 109.795 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.402 ' H ' HG12 ' D' ' 11' ' ' VAL . 0.9 OUTLIER -67.13 -24.49 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 8.4 m -71.17 -44.59 65.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.7 -0.625 . . . . 0.0 109.391 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.46 74.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 0.0 109.327 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.791 ' O ' HG23 ' D' ' 18' ' ' VAL . 0.7 OUTLIER -49.31 -21.06 0.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.357 -0.839 . . . . 0.0 109.148 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -17.3 60.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 109.632 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.41 -57.51 7.38 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.665 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.584 ' HE2' ' H ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -86.68 12.62 10.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.007 -1.29 . . . . 0.0 110.922 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.791 HG23 ' O ' ' D' ' 14' ' ' LEU . 2.2 t -79.65 115.03 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.822 -1.174 . . . . 0.0 108.959 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -76.53 82.72 3.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 109.488 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' D' ' 22' ' ' GLU . 71.1 t -54.8 -18.39 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' D' ' 21' ' ' ASP . 5.1 m-20 -66.15 6.3 0.42 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.89 . . . . 0.0 109.632 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' D' ' 20' ' ' VAL . 35.3 mt-10 -155.95 -52.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.926 . . . . 0.0 109.513 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' D' ' 27' ' ' ALA . 95.7 t -47.53 -35.74 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.693 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.48 -57.57 4.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.51 -50.79 55.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -62.19 -45.94 91.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -1.119 . . . . 0.0 109.541 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' D' ' 23' ' ' VAL . . . -51.21 -35.23 35.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.621 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tp -84.97 -58.03 2.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.176 -0.952 . . . . 0.0 109.613 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.23 -37.48 73.06 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . 0.529 HH21 HG22 ' D' ' 113' ' ' VAL . 8.1 ttp180 -69.73 -38.44 76.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -1.209 . . . . 0.0 109.775 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 40.7 tp -53.0 -24.18 8.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 110.149 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' D' ' 36' ' ' PRO . 15.8 mt -75.48 -54.5 6.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.01 -1.057 . . . . 0.0 110.882 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.43 HG22 ' H ' ' D' ' 33' ' ' VAL . 2.3 m -52.73 -48.95 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.743 -1.223 . . . . 0.0 109.769 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.469 HG22 ' O ' ' D' ' 30' ' ' ARG . 0.0 OUTLIER -70.78 -22.69 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.077 -1.015 . . . . 0.0 109.158 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -149.42 74.87 9.64 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . 0.49 ' N ' ' O ' ' D' ' 32' ' ' LEU . 72.4 Cg_endo -81.49 -22.92 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.84 2.36 . . . . 0.0 112.244 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -48.91 -20.0 0.45 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.456 ' C ' ' H ' ' D' ' 40' ' ' ARG . 33.5 p -80.29 9.86 5.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.905 . . . . 0.0 109.563 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -71.8 12.26 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.905 . . . . 0.0 109.388 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . 0.967 ' HG2' ' NE ' ' A' ' 92' ' ' ARG . 97.4 mtt180 -80.26 -19.8 45.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 109.409 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.55 26.27 4.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.172 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.515 ' CE1' ' CD2' ' D' ' 45' ' ' PHE . 33.3 t80 -148.78 11.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.406 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.95 -22.09 39.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 27.2 p -84.65 7.01 21.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.515 ' CD2' ' CE1' ' D' ' 42' ' ' PHE . 3.6 m-85 -81.38 -16.42 52.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.18 -0.95 . . . . 0.0 109.442 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.03 -175.32 45.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.444 ' O ' ' HB1' ' D' ' 53' ' ' ALA . 3.6 p-10 -83.13 103.86 12.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -1.123 . . . . 0.0 109.531 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . 0.583 HD12 ' N ' ' D' ' 48' ' ' LEU . 10.2 mp -88.27 29.75 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.849 . . . . 0.0 109.116 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.9 m -44.84 -35.85 2.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.379 -0.826 . . . . 0.0 109.807 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 5.4 p -146.47 148.73 35.09 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -42.57 -36.39 4.68 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.546 2.164 . . . . 0.0 112.444 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.68 -33.52 72.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.12 -0.987 . . . . 0.0 109.706 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' D' ' 47' ' ' ASP . . . -62.29 -19.7 63.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.406 -0.809 . . . . 0.0 109.561 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 62.6 t -61.08 -59.68 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . 0.497 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -87.43 10.55 17.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.87 -31.22 33.0 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -81.92 147.92 59.48 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.155 -1.203 . . . . 0.0 109.426 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.56 -57.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.57 2.18 . . . . 0.0 112.542 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.0 -33.38 4.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 109.775 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.05 -57.92 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.977 . . . . 0.0 109.434 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -65.01 -33.53 76.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.251 -0.906 . . . . 0.0 109.618 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.56 -53.71 43.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.56 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -53.27 -24.01 10.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.571 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.12 -23.7 73.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -66.96 -44.08 81.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -1.107 . . . . 0.0 109.192 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -55.4 -47.14 76.35 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.384 -0.822 . . . . 0.0 109.388 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.558 HG13 ' C2B' ' D' ' 147' ' ' HEC . 25.3 t -58.23 -46.94 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.31 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.48 -34.98 74.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.268 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.93 -53.16 46.43 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.11 63.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.171 -1.193 . . . . 0.0 109.523 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -55.87 -31.08 62.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.449 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 33.1 t -76.58 -31.47 57.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -50.23 -40.06 46.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.289 -0.882 . . . . 0.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.88 -59.96 8.39 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.544 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.6 mp -58.19 -26.89 63.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -1.132 . . . . 0.0 109.358 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.02 2.41 46.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.617 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.444 ' C ' ' H ' ' D' ' 79' ' ' ASP . 66.2 t60 -170.84 66.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.928 . . . . 0.0 109.654 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' D' ' 78' ' ' LEU . 79.7 mt -75.83 19.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.407 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' D' ' 77' ' ' HIS . 8.8 m-20 -79.61 -29.47 41.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.529 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.42 ' O ' ' OD1' ' D' ' 80' ' ' ASN . 5.5 p30 -173.3 107.0 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . 0.56 ' N ' HD12 ' D' ' 81' ' ' LEU . 8.3 mp -80.21 -58.77 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.915 . . . . 0.0 109.494 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' D' ' 82' ' ' LYS . 0.0 OUTLIER -46.45 -24.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.582 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.73 -50.21 9.52 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.7 t -82.34 -47.3 12.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -1.173 . . . . 0.0 109.409 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.545 ' N ' ' CG2' ' D' ' 84' ' ' THR . 27.9 m-85 -65.08 1.35 0.99 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.55 -0.719 . . . . 0.0 109.504 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.85 -35.05 66.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.188 -0.945 . . . . 0.0 109.388 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 29.9 p -74.37 -57.54 3.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.426 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.483 ' N ' HD12 ' D' ' 88' ' ' LEU . 9.0 mp -49.37 -44.95 45.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -63.89 -52.2 61.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.474 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.68 -22.8 64.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 6.5 tt -85.65 -62.6 1.49 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.694 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.573 ' O ' ' N ' ' D' ' 97' ' ' HIS . 75.1 m80 -61.43 -20.17 62.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 110.079 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 51.6 t -83.51 -60.71 2.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.582 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.36 -28.32 22.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.991 -1.068 . . . . 0.0 111.026 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -83.88 -52.04 6.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.0 -1.062 . . . . 0.0 110.742 -178.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.589 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 11.6 mt -106.87 -21.31 13.06 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.024 -1.047 . . . . 0.0 110.05 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 1.108 ' CD2' HG21 ' A' ' 41' ' ' THR . 33.1 p80 43.03 37.47 1.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.354 -0.842 . . . . 0.0 109.931 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.09 130.92 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.167 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -46.94 147.36 2.31 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 0.0 109.53 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.33 -16.94 44.39 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.495 2.13 . . . . 0.0 112.119 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' D' ' 101' ' ' GLU . 58.7 mp0 -81.3 55.27 2.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.344 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.437 ' ND2' ' C ' ' D' ' 101' ' ' GLU . 10.0 m-80 -156.19 -37.67 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.13 -0.982 . . . . 0.0 109.688 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -64.12 -38.76 92.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.94 . . . . 0.0 109.518 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -69.68 -28.1 65.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.143 -0.973 . . . . 0.0 109.66 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.71 -52.76 16.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.749 HD22 ' HAB' ' D' ' 147' ' ' HEC . 6.7 tt -52.2 -47.75 65.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.405 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.71 -20.45 70.22 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . 0.77 ' OD1' ' ND1' ' C' ' 103' ' ' HIS . 0.4 OUTLIER -83.24 -19.12 36.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -1.167 . . . . 0.0 109.753 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 73.0 t -80.31 -44.54 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 109.616 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 mt -47.37 -32.0 4.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.423 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . 0.426 ' H ' HG23 ' D' ' 111' ' ' VAL . 10.5 t -58.86 -33.64 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 11.8 m -79.06 -54.54 5.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . 0.529 HG22 HH21 ' D' ' 30' ' ' ARG . 14.0 t -49.47 -46.04 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.406 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.0 -22.92 64.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.463 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -80.62 -24.37 39.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.471 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.73 -61.65 1.74 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.359 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . 0.416 ' C ' ' CG ' ' D' ' 118' ' ' PHE . 55.2 m80 -60.18 -17.73 43.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.416 ' CG ' ' C ' ' D' ' 117' ' ' HIS . 19.0 m-85 -150.27 58.57 0.96 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.88 . . . . 0.0 109.633 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.463 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -68.6 -28.65 73.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -68.92 6.35 0.92 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -1.108 . . . . 0.0 109.41 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' D' ' 123' ' ' THR . 17.7 mm-40 -126.0 -1.22 7.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.436 -0.79 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 1.319 ' CE2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -72.67 35.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.849 . . . . 0.0 109.517 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.504 ' OG1' HG23 ' D' ' 126' ' ' VAL . 13.1 p -50.82 146.58 9.85 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.427 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.497 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.3 Cg_exo -48.22 -51.44 10.08 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.315 2.01 . . . . 0.0 113.057 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 39.4 Cg_endo -67.63 -27.7 38.39 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.013 1.809 . . . . 0.0 112.436 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.504 HG23 ' OG1' ' D' ' 123' ' ' THR . 55.6 t -77.3 -24.1 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.143 -0.973 . . . . 0.0 109.523 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . 0.61 HE22 ' CG1' ' C' ' 107' ' ' VAL . 9.1 tt0 -83.34 -54.52 4.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 1.061 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -49.14 -44.1 42.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.497 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.39 13.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.573 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.437 ' H ' ' C ' ' D' ' 128' ' ' ALA . 32.0 t80 -97.89 -59.89 1.67 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.64 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 38.2 tt0 -47.46 -30.49 3.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . 0.557 ' C ' ' H3 ' ' D' ' 1' ' ' VAL . 8.7 mtpm? -66.05 -46.72 76.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.774 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 38.4 t -59.77 -55.55 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 110.043 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.4 HG22 ' H ' ' D' ' 134' ' ' VAL . 3.5 m -67.91 -36.85 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.991 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -50.0 -24.64 2.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.511 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.96 -31.43 55.64 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -82.69 -30.06 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -1.166 . . . . 0.0 109.495 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.64 77.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.91 . . . . 0.0 109.46 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 1.222 ' OD1' ' CE1' ' B' ' 146' ' ' HIS . 4.2 m120 -71.35 -27.89 63.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.414 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.23 -60.42 2.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.885 . . . . 0.0 109.428 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.96 -16.13 2.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.348 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.2 -3.04 13.96 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.309 -0.869 . . . . 0.0 109.569 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' D' ' 139' ' ' ASN . 22.0 t-80 -64.22 -33.28 75.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.867 . . . . 0.0 109.581 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -82.42 -29.76 30.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -51.33 -21.05 1.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 1.169 ' CE1' ' OD1' ' B' ' 139' ' ' ASN . 43.0 m80 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.872 HBB3 HMB1 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 0.768 ' HAB' HD22 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.872 HBB3 HMB1 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 0.749 ' HAB' HD22 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.475 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.568 HD11 ' HE3' ' A' ' 127' ' ' LYS . 7.1 tp 73.73 170.63 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.564 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.483 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 174.42 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.202 -0.937 . . . . 0.0 110.106 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 3' ' ' SER . 95.5 Cg_exo -41.41 168.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.597 2.198 . . . . 0.0 112.902 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -50.76 -16.13 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.444 -0.785 . . . . 0.0 109.994 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 5' ' ' ALA . 2.8 p30 -39.78 -28.33 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.382 -0.824 . . . . 0.0 109.819 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 5' ' ' ALA . 5.9 ptmm? -83.27 -52.38 6.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.408 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 48.9 m -47.93 -26.75 1.84 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 108.928 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.433 ' CG ' ' HB1' ' A' ' 120' ' ' ALA . 40.7 m-20 -79.99 -39.34 30.23 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.597 HG21 ' CG ' ' A' ' 128' ' ' PHE . 21.2 t -69.43 -47.01 75.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HZ2' ' HZ3' ' A' ' 7' ' ' LYS . 2.4 mptm? -50.22 -48.5 54.41 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -52.58 -63.1 1.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.502 0.667 . . . . 0.0 109.303 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -50.75 -41.75 56.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -0.817 . . . . 0.0 109.112 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.95 -17.4 64.43 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.377 -0.827 . . . . 0.0 109.047 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -79.62 -47.5 7.26 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -68.39 -36.74 79.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -1.121 . . . . 0.0 108.766 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 13' ' ' ALA . 69.4 t -60.96 -66.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 63.44 -141.44 45.87 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.13 37.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.462 -1.022 . . . . 0.0 110.177 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.551 ' H ' ' C ' ' A' ' 18' ' ' GLY . 89.5 m-70 -140.2 24.61 2.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . . . -88.3 -48.78 7.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.664 -0.647 . . . . 0.0 109.961 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.38 -14.71 28.23 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' O ' ' OE1' ' A' ' 27' ' ' GLU . 12.6 mt-10 -85.68 -56.28 3.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.9 m-30 -55.18 -27.11 43.42 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.369 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.05 -24.45 76.5 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.69 -36.3 28.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -1.123 . . . . 0.0 109.625 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 23' ' ' GLU . 1.4 mp0 -70.4 -19.88 62.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.96 . . . . 0.0 109.296 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.65 -19.73 60.76 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.277 -0.889 . . . . 0.0 109.072 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 58' ' ' HIS . 17.3 mt -77.86 -58.14 3.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 109.712 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -51.01 -43.68 60.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 109.655 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -56.25 -30.57 62.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.959 . . . . 0.0 109.642 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 38.6 ttp -84.24 -57.16 3.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.906 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.438 ' CZ ' ' CZ ' ' A' ' 46' ' ' PHE . 25.7 m-85 -47.66 -36.94 11.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 109.978 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.844 HD13 ' HB2' ' B' ' 128' ' ' ALA . 3.5 pp -84.48 -25.74 28.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.925 -1.11 . . . . 0.0 109.809 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.533 ' N ' HD12 ' A' ' 34' ' ' LEU . 28.1 t -60.93 -21.97 63.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 109.534 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 1.024 ' HZ ' ' OE1' ' B' ' 131' ' ' GLN . 66.6 m-85 -156.2 128.76 4.15 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.965 . . . . 0.0 109.2 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -75.59 -20.23 15.92 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.348 2.032 . . . . 0.0 111.986 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.6 p -62.67 -18.77 62.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 109.572 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.4 p -80.99 -35.55 31.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.779 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -67.59 -36.5 81.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.963 . . . . 0.0 109.662 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -84.77 -18.18 35.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.209 -0.932 . . . . 0.0 109.844 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -64.27 -66.91 0.48 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.169 -0.957 . . . . 0.0 109.449 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.539 ' CD2' ' ND1' ' A' ' 45' ' ' HIS . 35.9 t80 -175.27 85.26 0.31 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.449 -0.782 . . . . 0.0 109.814 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 70.2 Cg_endo -80.64 -43.06 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.404 2.069 . . . . 0.0 111.814 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.539 ' ND1' ' CD2' ' A' ' 43' ' ' PHE . 45.3 p-80 38.27 33.05 0.05 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.606 -0.683 . . . . 0.0 110.645 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.479 ' C ' ' CD1' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -165.44 26.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.071 -1.018 . . . . 0.0 110.385 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 49' ' ' SER . 22.3 m-20 41.63 88.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.534 -0.729 . . . . 0.0 110.249 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.015 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -56.5 0.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.369 -0.832 . . . . 0.0 109.453 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 47' ' ' ASP . 2.8 t -46.56 132.18 10.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.96 . . . . 0.0 109.668 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.526 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 11.3 t-80 -76.23 144.15 40.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.413 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.526 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 73.2 10.15 77.92 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.527 ' OG ' ' N ' ' A' ' 53' ' ' ALA . 88.7 p -68.98 -100.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -1.184 . . . . 0.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.527 ' N ' ' OG ' ' A' ' 52' ' ' SER . . . -178.39 -31.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.377 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -81.23 -17.71 48.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.926 . . . . 0.0 109.087 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.48 -33.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 109.682 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.408 ' HG2' ' H ' ' A' ' 56' ' ' LYS . 14.7 ptpt -70.81 -28.34 64.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.076 -1.015 . . . . 0.0 109.262 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' O ' ' CE ' ' A' ' 61' ' ' LYS . . . -69.71 -48.1 44.59 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.538 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.6 OUTLIER -54.2 -35.56 62.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -1.11 . . . . 0.0 109.392 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.29 -58.69 10.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -51.65 -24.03 5.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -1.174 . . . . 0.0 109.593 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.552 ' O ' HMA3 ' A' ' 142' ' ' HEC . 0.0 OUTLIER -77.35 -23.47 50.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.332 -0.855 . . . . 0.0 108.896 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.36 -52.91 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 108.712 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -66.27 -24.21 66.53 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.421 -0.8 . . . . 0.0 109.574 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.14 -33.0 33.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.954 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -82.63 -34.32 27.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.912 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -81.63 -23.03 37.25 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.98 -1.075 . . . . 0.0 108.116 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 63' ' ' ALA . 18.5 m -78.05 -43.87 28.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.052 -1.03 . . . . 0.0 108.704 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.556 HD21 HD21 ' A' ' 80' ' ' LEU . 1.6 p-10 -58.15 -21.91 48.93 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.61 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -78.78 -47.47 16.68 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.62 -22.37 30.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.01 -17.67 63.28 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.419 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.566 ' O ' HG12 ' A' ' 73' ' ' VAL . 38.3 m80 -143.81 -53.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.343 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.3 p 45.03 15.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.776 0.798 . . . . 0.0 109.286 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 72' ' ' HIS . 89.8 m-20 -131.73 9.64 4.63 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.403 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 22.4 t0 -174.33 27.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.358 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.694 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.3 ptt? -78.56 -24.41 0.43 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.519 -0.738 . . . . 0.0 111.804 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.2 Cg_exo -53.19 -29.49 46.55 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.79 1.66 . . . . 0.0 112.573 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.428 ' O ' ' OG ' ' A' ' 81' ' ' SER . 8.5 t-20 -94.1 -11.29 30.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 109.828 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.22 -58.23 3.04 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.107 -0.995 . . . . 0.0 109.258 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.556 HD21 HD21 ' A' ' 68' ' ' ASN . 6.0 mt -81.35 13.94 2.69 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 78' ' ' ASN . 2.5 p -59.22 -15.8 17.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.785 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.4 -53.61 6.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.0 109.912 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.713 HD22 HBA1 ' A' ' 142' ' ' HEC . 3.5 mt -44.79 -42.3 7.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.0 108.901 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.642 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 64.4 p -54.56 -29.21 50.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.545 -0.722 . . . . 0.0 109.517 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' ALA . 49.4 t0 -82.53 -16.92 46.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.334 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.446 HD11 ' CBD' ' A' ' 142' ' ' HEC . 5.9 tt -81.04 -62.23 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.956 -1.09 . . . . 0.0 111.249 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.4 p-80 -77.0 -21.53 54.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.886 -1.133 . . . . 0.0 111.163 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -85.94 -29.74 23.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.778 -1.201 . . . . 0.0 110.151 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 90' ' ' LYS . 15.4 t-80 -99.78 -74.81 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.171 -0.956 . . . . 0.0 110.132 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 89' ' ' HIS . 17.8 mtpp -52.0 -101.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 109.986 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.0 mp -45.12 -31.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 58.17 41.91 22.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.495 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' HIS . 5.9 t -66.84 168.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 109.353 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' VAL . 1.1 p-10 -123.46 152.09 64.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.336 -0.852 . . . . 0.0 109.333 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -41.6 -14.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.681 2.254 . . . . 0.0 112.558 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.937 HG11 ' HB3' ' D' ' 99' ' ' ASP . 46.9 t -59.29 -28.29 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.17 -0.956 . . . . 0.0 109.877 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.729 ' H ' HD22 ' A' ' 97' ' ' ASN . 0.6 OUTLIER -79.5 -24.8 42.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.95 . . . . 0.0 109.7 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -65.65 -41.95 91.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -47.28 -30.21 2.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.558 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 100' ' ' LEU . 3.7 mm? -84.11 -60.04 2.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.733 HD21 HBB3 ' A' ' 142' ' ' HEC . 6.5 tt -53.34 -20.78 4.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 109.76 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -77.65 -59.06 2.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.818 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.799 ' NE2' ' OH ' ' B' ' 35' ' ' TYR . 32.1 m170 -64.55 -26.57 68.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 109.915 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 95.4 m -61.06 -58.01 10.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.895 . . . . 0.0 109.895 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.92 -30.88 1.91 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.156 -0.965 . . . . 0.0 109.576 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.5 mt -75.06 -52.18 11.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.593 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.3 -24.76 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 109.445 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.6 m -73.61 -63.32 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.672 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 113' ' ' LEU . 18.9 mt -53.77 -33.57 56.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.386 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.41 -42.17 9.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.324 -0.86 . . . . 0.0 109.742 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.47 -56.04 4.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.436 -0.79 . . . . 0.0 109.943 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -68.28 -67.51 0.46 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.929 . . . . 0.0 109.545 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -111.85 93.46 20.8 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 113' ' ' LEU . 99.1 Cg_exo -43.39 178.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.478 2.119 . . . . 0.0 113.068 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -86.57 -38.26 17.33 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.611 0.72 . . . . 0.0 109.281 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 4.7 mt-10 77.85 1.3 2.85 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 61.91 38.46 14.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.74 -0.6 . . . . 0.0 111.24 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.73 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -87.59 120.9 71.23 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 120.633 -1.292 . . . . 0.0 108.21 178.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.35 19.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.26 1.973 . . . . 0.0 112.889 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.73 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -150.74 -33.3 0.16 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.715 -1.24 . . . . 0.0 110.984 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.664 HG13 ' N ' ' A' ' 122' ' ' HIS . 10.7 p -45.43 -48.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.013 -1.055 . . . . 0.0 109.934 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.664 ' N ' HG13 ' A' ' 121' ' ' VAL . 20.3 m-70 -71.19 -43.73 66.84 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.444 -0.785 . . . . 0.0 108.952 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.86 -20.2 64.27 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.33 -0.856 . . . . 0.0 109.107 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 120' ' ' ALA . 12.2 p -66.33 -62.75 1.31 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.204 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.506 ' N ' ' OG ' ' A' ' 124' ' ' SER . 5.5 mt -70.31 -25.1 63.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.151 -0.968 . . . . 0.0 109.719 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.36 -45.52 46.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.058 -1.026 . . . . 0.0 109.813 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.568 ' HE3' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -90.37 -50.54 5.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.106 -0.996 . . . . 0.0 110.113 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CG ' HG21 ' A' ' 10' ' ' VAL . 28.5 t80 -48.43 -22.27 0.68 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.049 -1.032 . . . . 0.0 109.485 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 133' ' ' SER . 6.4 mt -74.57 -22.6 58.9 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -61.45 -32.36 72.34 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.434 ' HB2' HD13 ' A' ' 2' ' ' LEU . 14.0 t -80.09 -35.49 36.86 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.391 -0.818 . . . . 0.0 109.012 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.54 -30.62 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 129' ' ' LEU . 42.2 t -76.19 -26.27 56.0 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.422 -0.799 . . . . 0.0 108.853 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 138' ' ' SER . 19.3 m -66.89 -28.72 68.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.327 -0.858 . . . . 0.0 109.021 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.12 -47.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.091 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.25 -38.15 73.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.013 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.3 p -93.71 -15.8 24.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 134' ' ' THR . 23.3 t 52.3 -144.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.898 . . . . 0.0 109.518 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -170.87 -6.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -152.65 108.3 3.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 109.4 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.429 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.507 HG22 ' N ' ' B' ' 2' ' ' HIS . 11.0 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 0.507 ' N ' HG22 ' B' ' 1' ' ' VAL . 0.5 OUTLIER -99.13 77.2 2.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.387 -0.82 . . . . 0.0 109.665 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mt -92.5 -170.94 2.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.185 -0.947 . . . . 0.0 109.254 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.409 ' O ' ' N ' ' B' ' 6' ' ' GLU . 2.9 p -111.06 129.78 23.64 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.377 -0.827 . . . . 0.0 108.97 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.78 -25.02 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.392 2.061 . . . . 0.0 112.401 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' B' ' 4' ' ' THR . 48.6 mt-10 -86.62 -48.58 8.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 0.0 109.894 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.77 -34.39 39.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.853 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -64.97 -34.95 79.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.014 . . . . 0.0 109.425 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 26.8 t -69.04 -23.62 64.09 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 109.374 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.52 -55.0 4.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.215 -0.928 . . . . 0.0 110.238 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.7 -26.45 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.962 -1.086 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 34.2 m -84.64 -54.25 4.85 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.363 0.601 . . . . 0.0 109.893 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' B' ' 9' ' ' SER . . . -45.0 -31.18 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.451 -0.781 . . . . 0.0 109.859 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.494 HD23 ' HB2' ' B' ' 17' ' ' LYS . 0.6 OUTLIER -59.21 -24.64 63.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.226 -0.921 . . . . 0.0 109.623 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . 0.649 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 2.1 t90 -48.3 -27.49 2.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.17 -52.33 7.88 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.494 ' HB2' HD23 ' B' ' 14' ' ' LEU . 1.1 mppt? -64.39 -15.59 60.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.295 -1.121 . . . . 0.0 109.084 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.23 114.96 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.356 -0.84 . . . . 0.0 109.67 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' B' ' 22' ' ' GLU . 2.4 m-80 -81.3 77.41 8.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.318 -0.864 . . . . 0.0 108.794 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' B' ' 19' ' ' ASN . 76.8 t -43.14 -21.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 109.966 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 19' ' ' ASN . 0.8 OUTLIER -83.86 11.71 7.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.59 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' B' ' 19' ' ' ASN . 36.6 mt-10 -156.15 -55.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.492 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 75.1 t -47.86 -36.37 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.78 -57.71 9.45 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.82 -35.84 40.14 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -75.18 -26.97 59.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -1.139 . . . . 0.0 109.575 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.21 -48.1 65.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 40.3 mt -82.96 -30.58 28.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.895 . . . . 0.0 109.498 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.03 -59.19 10.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.584 ' NH2' ' SD ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -57.45 -40.84 79.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.274 -1.133 . . . . 0.0 109.376 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . 0.693 HD23 ' O ' ' B' ' 31' ' ' LEU . 2.3 tt -43.79 -38.3 3.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.291 -0.88 . . . . 0.0 109.464 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.96 -21.83 43.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' B' ' 30' ' ' ARG . 15.6 t -86.09 -64.0 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.156 -0.965 . . . . 0.0 109.532 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 30' ' ' ARG . 0.1 OUTLIER -62.18 -22.93 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.366 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.799 ' OH ' ' NE2' ' A' ' 103' ' ' HIS . 48.5 m-85 -150.05 78.75 7.91 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.198 -0.939 . . . . 0.0 109.479 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' B' ' 38' ' ' THR . 16.6 Cg_exo -65.38 -28.22 54.75 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.042 2.494 . . . . 0.0 112.584 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.533 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 0.5 OUTLIER -46.56 -20.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.022 . . . . 0.0 109.708 -179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.612 HG22 HBC1 ' B' ' 147' ' ' HEC . 17.3 m -96.16 61.47 2.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.168 -0.957 . . . . 0.0 109.411 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.13 24.38 6.91 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.363 -0.835 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -84.44 -25.79 28.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -101.06 34.63 2.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.84 . . . . 0.0 109.494 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.489 ' HE1' ' CBC' ' B' ' 147' ' ' HEC . 64.7 m-85 -135.9 17.46 3.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.331 -0.855 . . . . 0.0 109.425 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' B' ' 44' ' ' SER . 0.0 OUTLIER -84.98 -30.76 23.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.495 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 39.4 t -83.11 -10.81 58.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.514 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -73.82 1.02 11.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.89 178.73 0.18 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 48.77 89.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.316 -1.108 . . . . 0.0 109.408 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 tp -158.8 19.35 0.2 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.46 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -53.16 -39.14 63.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . 0.421 ' O ' ' N ' ' B' ' 52' ' ' ASP . 1.3 p -145.65 153.7 51.26 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.408 -0.808 . . . . 0.0 109.009 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -43.61 -19.36 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.265 1.977 . . . . 0.0 112.241 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 52' ' ' ASP . 0.6 OUTLIER -81.48 -44.29 17.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.36 -20.0 0.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.315 -0.866 . . . . 0.0 109.398 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.03 -63.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.529 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . 0.584 ' SD ' ' NH2' ' B' ' 30' ' ' ARG . 11.4 mmt -52.32 -22.02 4.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 0.0 109.605 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.23 -15.81 70.93 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.575 ' ND2' ' H ' ' B' ' 60' ' ' VAL . 0.3 OUTLIER -73.46 136.39 78.22 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.225 -1.162 . . . . 0.0 109.294 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.401 ' N ' HD22 ' B' ' 57' ' ' ASN . 59.1 Cg_endo -73.34 -53.36 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.339 2.026 . . . . 0.0 112.381 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.475 ' N ' ' ND2' ' B' ' 57' ' ' ASN . 17.2 mtpp -52.49 -48.99 65.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.531 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.575 ' H ' ' ND2' ' B' ' 57' ' ' ASN . 99.2 t -49.6 -37.58 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 51.0 mtpt -79.16 -33.94 43.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.83 -29.08 35.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 109.583 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.922 ' HE1' ' CHA' ' B' ' 147' ' ' HEC . 1.8 t60 -69.1 -23.79 64.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.568 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.32 -38.02 91.11 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 30.8 mmtm -60.93 -32.11 71.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -1.181 . . . . 0.0 109.351 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.78 -61.34 2.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.501 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 1.216 HG13 ' C2B' ' B' ' 147' ' ' HEC . 43.8 t -56.88 -24.51 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.83 -42.53 60.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.226 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.77 -39.8 17.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.71 -38.22 67.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.467 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -61.84 -32.8 73.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.146 -0.971 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.649 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 13.4 m -88.5 -31.9 18.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 109.532 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -49.52 -42.49 43.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 109.473 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.12 -60.06 8.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.612 ' H ' HD12 ' B' ' 75' ' ' LEU . 5.0 mp -57.03 -26.44 60.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -1.127 . . . . 0.0 109.389 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.2 -0.35 48.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.168 -0.958 . . . . 0.0 109.488 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.441 ' C ' ' H ' ' B' ' 79' ' ' ASP . 75.9 t60 -171.2 64.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.534 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 54.3 mt -72.36 12.15 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' B' ' 77' ' ' HIS . 2.8 m-20 -71.83 -20.79 61.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.434 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -171.6 109.74 0.28 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -79.69 -58.54 3.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -47.63 -24.01 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.97 -61.85 4.09 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.6 t -66.62 -47.09 73.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -1.177 . . . . 0.0 109.355 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.548 ' N ' ' CG2' ' B' ' 84' ' ' THR . 69.0 m-85 -70.88 15.14 0.11 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.558 -0.714 . . . . 0.0 109.526 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -69.4 -38.88 78.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 109.573 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 17.8 p -83.62 -51.69 7.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.639 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 26.5 mt -53.04 -24.87 10.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.478 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 99.5 p -81.92 -40.61 22.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.505 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -81.43 -22.59 38.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.622 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 4.2 tt -82.29 -48.39 11.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.061 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.537 ' NE2' ' O ' ' B' ' 141' ' ' LEU . 1.9 p-80 -75.18 -22.28 58.15 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.918 -1.114 . . . . 0.0 110.22 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . 0.461 ' SG ' ' CE1' ' B' ' 145' ' ' TYR . 51.2 t -83.73 -60.25 2.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.132 -0.98 . . . . 0.0 111.356 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 12.8 t70 -86.8 -27.4 23.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.983 -1.073 . . . . 0.0 111.784 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.53 ' O ' ' CE1' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -84.56 -49.99 8.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.704 -1.248 . . . . 0.0 110.655 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.521 ' N ' HD12 ' B' ' 96' ' ' LEU . 8.3 mp -86.52 -34.64 19.93 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.793 -1.192 . . . . 0.0 109.931 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' B' ' 94' ' ' ASP . 3.3 m80 71.77 36.92 1.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 109.545 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.85 134.84 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.848 ' HB3' HG11 ' C' ' 96' ' ' VAL . 3.7 m-20 -81.72 151.68 68.28 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.19 -0.944 . . . . 0.0 109.405 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.519 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 65.3 Cg_exo -47.23 -173.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.39 2.06 . . . . 0.0 112.358 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 57.62 53.2 7.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.52 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' B' ' 100' ' ' PRO . 69.3 m-80 -159.31 -34.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.487 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 1.6 m-85 -73.75 -54.55 7.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.333 -0.854 . . . . 0.0 109.585 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -57.1 -22.35 39.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.713 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 tt -76.77 -41.62 44.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.15 -0.969 . . . . 0.0 109.517 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 1.151 ' CD1' ' CHC' ' B' ' 147' ' ' HEC . 4.9 tt -68.58 -56.59 7.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.231 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.45 -20.24 2.37 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -85.62 -55.61 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -1.116 . . . . 0.0 109.984 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.12 -24.8 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.055 -1.028 . . . . 0.0 109.49 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.503 HD23 ' C ' ' B' ' 110' ' ' LEU . 2.5 tt -57.41 -59.18 5.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.255 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.92 -39.94 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.229 -0.919 . . . . 0.0 109.677 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.423 ' O ' ' CE1' ' B' ' 116' ' ' HIS . 76.3 m -48.87 -43.77 39.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.591 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 70.4 t -55.99 -53.42 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 109.353 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.627 ' N ' HD12 ' B' ' 114' ' ' LEU . 9.3 mp -49.81 -41.99 45.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.528 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 119' ' ' GLY . . . -47.88 -41.54 24.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.78 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.65 ' N ' ' ND1' ' B' ' 116' ' ' HIS . 0.4 OUTLIER -68.87 -52.16 32.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 109.612 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' B' ' 118' ' ' PHE . 74.9 m80 -69.24 -17.55 63.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.713 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 63.8 m-85 -156.84 64.34 0.52 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.955 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 115' ' ' ALA . . . -76.25 -21.36 75.81 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -72.85 -29.22 63.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -1.128 . . . . 0.0 109.362 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 123' ' ' THR . 63.4 mm-40 -78.53 -15.49 58.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.271 -0.893 . . . . 0.0 109.554 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' B' ' 115' ' ' ALA . 3.8 m-85 -69.82 59.66 0.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.291 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.472 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 11.7 p -59.04 150.98 58.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.94 . . . . 0.0 108.917 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.444 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.3 Cg_exo -44.15 -58.15 1.61 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.446 2.097 . . . . 0.0 112.716 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 27.5 Cg_endo -61.89 -46.52 13.24 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.161 1.907 . . . . 0.0 112.027 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.472 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 40.6 t -66.86 -18.2 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . 0.647 ' NE2' HD11 ' A' ' 34' ' ' LEU . 1.1 tm0? -83.14 -26.29 31.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.844 ' HB2' HD13 ' A' ' 34' ' ' LEU . . . -68.8 -32.1 71.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.37 26.38 0.92 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.935 . . . . 0.0 109.648 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.647 ' CG ' ' N ' ' B' ' 131' ' ' GLN . 5.8 p90 -74.53 -52.31 12.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.14 -0.975 . . . . 0.0 109.791 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 1.024 ' OE1' ' HZ ' ' A' ' 36' ' ' PHE . 36.5 tt0 -86.06 -38.93 17.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.162 -0.961 . . . . 0.0 109.999 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.993 ' HG3' ' O ' ' D' ' 146' ' ' HIS . 32.1 ttpt -50.9 -34.56 28.85 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.233 -0.917 . . . . 0.0 110.959 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . 0.89 HG13 ' H ' ' B' ' 134' ' ' VAL . 7.1 p -65.27 -63.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.844 -1.16 . . . . 0.0 109.891 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.89 ' H ' HG13 ' B' ' 133' ' ' VAL . 1.8 m -73.77 -14.82 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.361 -0.837 . . . . 0.0 109.75 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 131' ' ' GLN . . . -45.78 -23.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.213 -0.929 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -82.55 -26.41 46.84 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' B' ' 134' ' ' VAL . 74.9 t -80.05 -21.28 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -1.104 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.86 -51.11 71.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.555 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.69 -22.52 53.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.638 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.34 -45.94 88.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.537 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 19.9 mt -84.01 15.57 3.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.544 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.62 -1.5 2.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 109.505 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . 0.433 ' O ' ' CD2' ' B' ' 143' ' ' HIS . 21.9 t-160 -79.87 -26.57 40.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.518 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -73.26 -11.39 60.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.379 -0.826 . . . . 0.0 109.342 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.461 ' CE1' ' SG ' ' B' ' 93' ' ' CYS . 15.6 m-85 -72.84 7.19 2.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.301 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 1.01 ' O ' ' HG3' ' D' ' 132' ' ' LYS . 7.5 p-80 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.453 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' C' ' 2' ' ' LEU . 6.3 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.579 HD11 ' HE3' ' C' ' 127' ' ' LYS . 7.1 tp 73.63 170.67 0.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 109.545 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.492 ' N ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 174.45 -50.65 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.166 -0.959 . . . . 0.0 110.041 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' C' ' 3' ' ' SER . 96.6 Cg_exo -41.4 168.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.683 2.255 . . . . 0.0 112.837 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -50.77 -16.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.436 -0.79 . . . . 0.0 110.003 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' C' ' 5' ' ' ALA . 2.8 p30 -39.7 -28.44 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.325 -0.859 . . . . 0.0 109.746 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' C' ' 5' ' ' ALA . 5.9 ptmm? -83.2 -52.31 6.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.514 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.417 ' N ' ' CG ' ' C' ' 7' ' ' LYS . 49.2 m -47.93 -26.76 1.85 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 108.954 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . 0.434 ' CG ' ' HB1' ' C' ' 120' ' ' ALA . 40.6 m-20 -80.01 -39.43 29.96 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.603 HG21 ' CG ' ' C' ' 128' ' ' PHE . 21.4 t -69.35 -47.01 75.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . 0.408 ' HZ2' ' HZ3' ' C' ' 7' ' ' LYS . 2.4 mptm? -50.12 -48.57 53.49 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.65 -63.13 1.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.628 -0.67 . . . . 0.0 109.316 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.652 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -50.57 -41.82 54.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.43 -0.794 . . . . 0.0 109.2 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . 0.401 ' NE1' ' OG1' ' C' ' 67' ' ' THR . 0.1 OUTLIER -68.04 -17.34 64.37 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.412 -0.805 . . . . 0.0 109.05 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.71 -47.38 7.29 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -68.41 -36.71 79.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -1.113 . . . . 0.0 108.85 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.652 HG23 ' O ' ' C' ' 13' ' ' ALA . 69.5 t -60.99 -66.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 63.39 -141.4 45.89 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 37.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.519 -0.989 . . . . 0.0 110.157 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.548 ' H ' ' C ' ' C' ' 18' ' ' GLY . 89.4 m-70 -140.27 24.5 2.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.431 ' HB2' ' CG1' ' C' ' 17' ' ' VAL . . . -88.36 -48.73 7.43 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.561 -0.712 . . . . 0.0 109.927 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.3 -14.74 27.82 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' C' ' 27' ' ' GLU . 12.6 mt-10 -85.64 -56.32 3.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -1.156 . . . . 0.0 109.653 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.0 m-30 -55.4 -26.86 44.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 109.288 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.18 -24.41 76.62 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.73 -36.33 28.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -1.165 . . . . 0.0 109.627 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' C' ' 23' ' ' GLU . 1.4 mp0 -70.27 -20.03 63.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.318 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.5 -19.88 60.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.038 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' C' ' 58' ' ' HIS . 17.1 mt -77.74 -58.19 3.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.353 -0.842 . . . . 0.0 109.735 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -50.94 -43.77 60.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 109.685 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtt85 -56.3 -30.46 62.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.651 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 38.5 ttp -84.27 -57.22 3.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.815 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . 0.434 ' CZ ' ' CZ ' ' C' ' 46' ' ' PHE . 25.8 m-85 -47.7 -36.86 11.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.998 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.816 HD13 ' HB2' ' D' ' 128' ' ' ALA . 3.4 pp -84.49 -25.76 28.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.994 -1.067 . . . . 0.0 109.808 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.531 ' N ' HD12 ' C' ' 34' ' ' LEU . 28.1 t -60.88 -22.06 63.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 109.472 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 1.047 ' HZ ' ' OE1' ' D' ' 131' ' ' GLN . 66.7 m-85 -156.18 128.69 4.13 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.21 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.58 -20.17 16.01 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.292 1.995 . . . . 0.0 112.08 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 68.2 p -62.62 -18.92 63.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 76.8 p -80.88 -35.61 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 0.0 109.756 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -67.61 -36.45 80.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 109.7 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -84.85 -18.15 35.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.778 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -64.25 -66.91 0.48 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.112 -0.992 . . . . 0.0 109.531 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.539 ' CD2' ' ND1' ' C' ' 45' ' ' HIS . 35.7 t80 -175.3 85.26 0.31 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.843 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.514 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 69.2 Cg_endo -80.77 -42.94 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.325 2.016 . . . . 0.0 111.802 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.539 ' ND1' ' CD2' ' C' ' 43' ' ' PHE . 45.2 p-80 38.25 33.04 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.627 -0.67 . . . . 0.0 110.686 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -165.44 26.01 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.039 . . . . 0.0 110.346 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' C' ' 49' ' ' SER . 22.5 m-20 41.74 88.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.701 . . . . 0.0 110.25 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 1.011 ' H ' HD13 ' C' ' 48' ' ' LEU . 0.0 OUTLIER -56.52 0.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.385 -0.822 . . . . 0.0 109.538 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.583 ' H ' ' C ' ' C' ' 47' ' ' ASP . 2.8 t -46.58 132.1 10.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.163 -0.961 . . . . 0.0 109.681 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.518 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 11.4 t-80 -76.16 144.12 40.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.388 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . 0.518 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 73.26 10.14 78.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' C' ' 53' ' ' ALA . 88.5 p -68.88 -100.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -1.147 . . . . 0.0 109.392 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.524 ' N ' ' OG ' ' C' ' 52' ' ' SER . . . -178.41 -31.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.41 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -81.26 -17.58 48.94 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.264 -0.897 . . . . 0.0 109.171 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.57 -33.99 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.626 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -70.78 -28.27 64.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.314 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . 0.427 ' O ' ' CE ' ' C' ' 61' ' ' LYS . . . -69.82 -48.18 43.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.6 OUTLIER -54.01 -35.63 62.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -1.155 . . . . 0.0 109.366 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.43 -58.59 10.92 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -51.7 -23.95 5.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -1.099 . . . . 0.0 109.625 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.568 ' O ' HMA3 ' C' ' 142' ' ' HEC . 0.0 OUTLIER -77.39 -23.46 50.7 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 108.911 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.43 -52.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.26 -24.23 66.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.32 -0.862 . . . . 0.0 109.581 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.02 -32.97 33.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.99 . . . . 0.0 109.821 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.974 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -82.68 -34.33 27.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.122 -0.986 . . . . 0.0 109.549 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.911 ' O ' HD12 ' C' ' 66' ' ' LEU . 0.1 OUTLIER -81.51 -23.05 37.57 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.401 ' OG1' ' NE1' ' C' ' 14' ' ' TRP . 18.3 m -78.05 -43.86 28.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.068 -1.02 . . . . 0.0 108.711 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.555 HD21 HD21 ' C' ' 80' ' ' LEU . 1.6 p-10 -58.15 -21.86 48.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.611 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -78.79 -47.53 16.53 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.55 -22.42 30.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.0 -17.66 63.29 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.438 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.573 ' O ' HG12 ' C' ' 73' ' ' VAL . 38.3 m80 -143.87 -53.45 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.843 . . . . 0.0 109.291 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.2 p 45.04 15.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.799 0.809 . . . . 0.0 109.283 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' C' ' 72' ' ' HIS . 89.8 m-20 -131.76 9.66 4.62 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 22.3 t0 -174.28 27.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.265 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.699 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.3 ptt? -78.57 -24.37 0.43 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.472 -0.767 . . . . 0.0 111.783 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.0 Cg_exo -53.24 -29.47 46.94 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.79 1.66 . . . . 0.0 112.571 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.438 ' O ' ' OG ' ' C' ' 81' ' ' SER . 8.5 t-20 -94.15 -11.16 31.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 109.828 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.27 -58.16 3.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.153 -0.967 . . . . 0.0 109.281 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . 0.555 HD21 HD21 ' C' ' 68' ' ' ASN . 6.0 mt -81.34 13.87 2.72 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 108.796 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' C' ' 78' ' ' ASN . 2.5 p -59.15 -15.84 16.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 109.809 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.51 -53.58 6.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.0 109.831 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.705 HD22 HBA1 ' C' ' 142' ' ' HEC . 3.5 mt -44.73 -42.24 7.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.389 -0.819 . . . . 0.0 108.928 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.646 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 66.7 p -54.69 -29.17 52.18 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.552 -0.717 . . . . 0.0 109.446 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' C' ' 82' ' ' ALA . 49.2 t0 -82.55 -16.93 46.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.396 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.45 HD21 HBD2 ' C' ' 142' ' ' HEC . 5.8 tt -81.0 -62.32 1.7 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.918 -1.113 . . . . 0.0 111.241 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.4 p-80 -76.95 -21.47 54.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.86 -1.15 . . . . 0.0 111.16 -178.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -85.91 -29.78 23.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.77 -1.206 . . . . 0.0 110.207 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' C' ' 90' ' ' LYS . 15.5 t-80 -99.79 -74.85 0.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.969 . . . . 0.0 110.139 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' C' ' 89' ' ' HIS . 17.8 mtpp -51.96 -101.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.154 -0.967 . . . . 0.0 109.985 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.611 ' N ' HD12 ' C' ' 91' ' ' LEU . 10.0 mp -45.17 -31.77 1.58 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.827 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 58.16 41.93 22.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.503 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' C' ' 87' ' ' HIS . 5.9 t -66.95 168.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.372 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' C' ' 96' ' ' VAL . 1.1 p-10 -123.51 152.14 64.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.34 -0.85 . . . . 0.0 109.272 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -41.73 -14.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.666 2.244 . . . . 0.0 112.584 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.848 HG11 ' HB3' ' B' ' 99' ' ' ASP . 46.7 t -59.24 -28.33 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.925 . . . . 0.0 109.934 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.708 ' H ' HD22 ' C' ' 97' ' ' ASN . 0.6 OUTLIER -79.45 -24.91 42.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.664 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -65.62 -42.03 91.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.584 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -47.22 -30.26 2.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.592 HD22 ' N ' ' C' ' 100' ' ' LEU . 3.7 mm? -84.07 -60.04 2.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.593 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.725 HD21 HBB3 ' C' ' 142' ' ' HEC . 6.5 tt -53.25 -20.9 4.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.736 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -77.6 -59.08 2.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.1 -1.0 . . . . 0.0 109.763 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.787 ' NE2' ' OH ' ' D' ' 35' ' ' TYR . 32.1 m170 -64.61 -26.6 68.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.837 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 95.2 m -61.0 -58.02 10.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.235 -0.916 . . . . 0.0 109.869 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mt -45.94 -30.9 1.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.5 mt -74.97 -52.29 11.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.155 -0.966 . . . . 0.0 109.616 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.29 -24.69 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.493 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 24.7 m -73.71 -63.25 1.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.632 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' C' ' 113' ' ' LEU . 18.9 mt -53.77 -33.68 56.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.372 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.3 -42.28 9.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.74 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.37 -56.0 4.33 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -68.28 -67.5 0.46 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.608 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -111.87 93.52 21.1 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' C' ' 113' ' ' LEU . 98.5 Cg_exo -43.44 178.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.406 2.071 . . . . 0.0 113.105 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -86.59 -38.25 17.31 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.666 0.746 . . . . 0.0 109.312 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 4.8 mt-10 77.87 1.24 2.84 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 61.88 38.5 14.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.793 -0.567 . . . . 0.0 111.268 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.735 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.7 OUTLIER -87.59 120.95 71.24 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.73 -1.231 . . . . 0.0 108.197 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.43 19.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.285 1.99 . . . . 0.0 112.816 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -150.74 -33.22 0.16 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.726 -1.234 . . . . 0.0 110.962 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.646 HG13 ' N ' ' C' ' 122' ' ' HIS . 10.8 p -45.57 -48.09 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.876 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.646 ' N ' HG13 ' C' ' 121' ' ' VAL . 20.2 m-70 -71.18 -43.81 66.73 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.451 -0.78 . . . . 0.0 108.917 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.74 -20.23 64.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.329 -0.857 . . . . 0.0 109.15 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.57 ' N ' ' O ' ' C' ' 120' ' ' ALA . 12.1 p -66.38 -62.72 1.32 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.21 -0.931 . . . . 0.0 110.215 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.513 ' N ' ' OG ' ' C' ' 124' ' ' SER . 5.6 mt -70.23 -25.1 63.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.166 -0.959 . . . . 0.0 109.736 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -74.47 -45.39 46.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.087 -1.008 . . . . 0.0 109.784 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.579 ' HE3' HD11 ' C' ' 2' ' ' LEU . 0.0 OUTLIER -90.45 -50.47 5.93 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.044 -1.035 . . . . 0.0 110.127 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.603 ' CG ' HG21 ' C' ' 10' ' ' VAL . 28.5 t80 -48.44 -22.35 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.912 -1.118 . . . . 0.0 109.453 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' C' ' 133' ' ' SER . 6.4 mt -74.55 -22.57 58.94 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.42 -32.31 72.26 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.425 ' HB2' HD13 ' C' ' 2' ' ' LEU . 13.8 t -80.16 -35.44 36.52 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.382 -0.824 . . . . 0.0 109.095 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 22.4 t -83.51 -30.71 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.149 -0.969 . . . . 0.0 108.57 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.564 ' N ' ' O ' ' C' ' 129' ' ' LEU . 42.1 t -76.25 -26.17 55.74 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.434 -0.792 . . . . 0.0 108.873 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . 0.53 ' O ' ' N ' ' C' ' 138' ' ' SER . 19.5 m -66.85 -28.76 68.61 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.278 -0.889 . . . . 0.0 109.091 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.09 -47.52 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.11 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.19 -38.05 73.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.112 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 70.4 p -93.83 -15.76 24.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . 0.53 ' N ' ' O ' ' C' ' 134' ' ' THR . 23.3 t 52.29 -144.51 0.61 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.885 . . . . 0.0 109.476 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -170.79 -6.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.409 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -152.67 108.24 3.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.925 . . . . 0.0 109.431 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.513 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.514 HG22 ' N ' ' D' ' 2' ' ' HIS . 11.0 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . 0.514 ' N ' HG22 ' D' ' 1' ' ' VAL . 0.5 OUTLIER -99.17 77.3 2.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.245 -0.91 . . . . 0.0 109.641 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . . . . . . . . . 7.8 mt -92.65 -170.89 2.58 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 109.193 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.403 ' O ' ' N ' ' D' ' 6' ' ' GLU . 2.9 p -111.14 129.8 23.64 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.376 -0.828 . . . . 0.0 108.938 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -40.82 -24.95 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.305 2.003 . . . . 0.0 112.439 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' D' ' 4' ' ' THR . 48.6 mt-10 -86.67 -48.63 8.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.858 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -79.61 -34.41 40.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.94 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.478 ' CD ' ' C ' ' D' ' 8' ' ' LYS . 0.0 OUTLIER -65.04 -34.86 79.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -0.964 . . . . 0.0 109.362 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 27.1 t -69.1 -23.6 64.02 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.11 -0.994 . . . . 0.0 109.335 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.55 -54.96 4.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.903 . . . . 0.0 110.189 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.71 -26.47 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.004 -1.06 . . . . 0.0 108.277 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 34.2 m -84.61 -54.31 4.81 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.395 0.616 . . . . 0.0 109.859 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' D' ' 9' ' ' SER . . . -45.04 -31.09 1.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 0.0 109.898 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.48 HD23 ' HB2' ' D' ' 17' ' ' LYS . 0.6 OUTLIER -59.22 -24.68 63.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.625 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . 0.65 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 2.1 t90 -48.27 -27.51 2.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.097 -1.002 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.14 -52.37 7.88 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.505 ' O ' ' CZ ' ' D' ' 118' ' ' PHE . 1.1 mppt? -64.44 -15.59 60.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.356 -1.085 . . . . 0.0 109.047 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.2 114.84 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 109.671 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' D' ' 22' ' ' GLU . 2.4 m-80 -81.21 77.35 8.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 108.855 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' D' ' 19' ' ' ASN . 76.5 t -43.11 -21.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.439 -0.788 . . . . 0.0 109.926 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' D' ' 19' ' ' ASN . 0.8 OUTLIER -83.84 11.72 7.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.94 . . . . 0.0 109.658 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' D' ' 19' ' ' ASN . 36.6 mt-10 -156.13 -55.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -0.967 . . . . 0.0 109.477 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -48.03 -36.23 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.534 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.79 -57.67 9.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.77 -35.87 39.81 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -75.21 -26.87 59.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.21 -48.12 65.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.948 . . . . 0.0 109.516 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 40.9 mt -83.09 -30.49 27.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.452 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.08 -59.11 10.62 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . 0.583 ' NH2' ' SD ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -57.53 -40.78 79.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -1.085 . . . . 0.0 109.346 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . 0.695 HD23 ' O ' ' D' ' 31' ' ' LEU . 2.3 tt -43.81 -38.31 3.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 0.0 109.495 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -79.94 -21.79 43.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' D' ' 30' ' ' ARG . 15.6 t -86.11 -63.98 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.108 -0.995 . . . . 0.0 109.552 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 30' ' ' ARG . 0.1 OUTLIER -62.25 -22.88 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 109.297 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . 0.787 ' OH ' ' NE2' ' C' ' 103' ' ' HIS . 48.5 m-85 -150.13 78.79 7.84 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 109.501 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' D' ' 38' ' ' THR . 16.6 Cg_exo -65.5 -28.12 53.83 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.988 2.459 . . . . 0.0 112.621 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . 0.538 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 0.5 OUTLIER -46.63 -19.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.81 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.616 HG22 HBC1 ' D' ' 147' ' ' HEC . 17.5 m -96.16 61.37 2.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.219 -0.926 . . . . 0.0 109.375 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.02 24.3 6.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 109.557 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -84.35 -25.86 28.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.119 -0.988 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -100.97 34.53 2.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.479 ' HE1' ' CBC' ' D' ' 147' ' ' HEC . 64.5 m-85 -135.92 17.51 3.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 0.0 109.431 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' D' ' 44' ' ' SER . 0.0 OUTLIER -85.05 -30.67 23.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.418 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . 0.491 ' H ' ' CD ' ' D' ' 43' ' ' GLU . 39.3 t -83.13 -10.78 58.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.491 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -73.91 1.12 11.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.315 -0.866 . . . . 0.0 109.435 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.9 178.7 0.18 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 48.78 89.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.157 . . . . 0.0 109.441 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 tp -158.91 19.49 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.355 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -53.28 -39.06 63.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.516 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . 0.428 ' O ' ' N ' ' D' ' 52' ' ' ASP . 1.2 p -145.66 153.7 51.2 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.844 . . . . 0.0 109.053 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.64 -19.37 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.276 1.984 . . . . 0.0 112.168 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' D' ' 52' ' ' ASP . 0.6 OUTLIER -81.39 -44.54 17.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.452 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.23 -19.92 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . 0.412 ' N ' ' C ' ' D' ' 52' ' ' ASP . 97.5 t -66.2 -63.16 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . 0.583 ' SD ' ' NH2' ' D' ' 30' ' ' ARG . 11.4 mmt -52.25 -22.08 4.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.581 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.18 -15.92 70.77 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . 0.579 ' ND2' ' H ' ' D' ' 60' ' ' VAL . 0.3 OUTLIER -73.38 136.46 78.44 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.294 -1.121 . . . . 0.0 109.269 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.409 ' N ' HD22 ' D' ' 57' ' ' ASN . 59.0 Cg_endo -73.38 -53.41 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.343 2.028 . . . . 0.0 112.33 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . 0.468 ' N ' ' ND2' ' D' ' 57' ' ' ASN . 17.3 mtpp -52.42 -48.99 65.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . 0.579 ' H ' ' ND2' ' D' ' 57' ' ' ASN . 99.5 t -49.73 -37.47 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.383 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . 0.523 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 50.9 mtpt -79.15 -33.91 43.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.502 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.84 -29.05 35.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 109.619 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.948 ' HE1' ' CHA' ' D' ' 147' ' ' HEC . 1.8 t60 -69.09 -23.81 64.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.57 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.27 -38.0 91.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 30.8 mmtm -60.96 -32.1 71.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -1.15 . . . . 0.0 109.264 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.8 -61.44 2.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 109.419 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 1.198 HG13 ' C2B' ' D' ' 147' ' ' HEC . 43.8 t -56.94 -24.42 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.8 -42.55 60.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.184 -0.947 . . . . 0.0 109.275 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -47.79 -39.76 17.7 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.73 -38.25 67.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 0.0 109.475 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -61.93 -32.64 73.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . 0.65 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 13.6 m -88.53 -31.89 18.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -49.54 -42.35 43.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.89 . . . . 0.0 109.515 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.2 -60.07 8.52 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.631 ' H ' HD12 ' D' ' 75' ' ' LEU . 5.0 mp -57.02 -26.43 60.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.329 -1.101 . . . . 0.0 109.406 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.18 -0.42 49.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.444 ' C ' ' H ' ' D' ' 79' ' ' ASP . 76.0 t60 -171.07 64.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.536 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 53.9 mt -72.34 12.21 0.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' D' ' 77' ' ' HIS . 2.8 m-20 -71.88 -20.76 61.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.918 . . . . 0.0 109.428 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -171.62 109.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.414 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -79.78 -58.48 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -47.68 -23.99 0.82 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.95 -61.93 4.06 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.5 t -66.56 -47.14 73.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -1.154 . . . . 0.0 109.425 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 68.8 m-85 -70.85 15.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.495 -0.753 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . 0.491 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -69.5 -38.74 77.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.625 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 17.9 p -83.72 -51.75 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.605 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 26.1 mt -52.92 -24.93 10.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.564 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 99.1 p -81.88 -40.66 22.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.234 -0.916 . . . . 0.0 109.475 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -81.42 -22.59 38.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.609 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 4.2 tt -82.17 -48.51 11.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 110.089 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.532 ' NE2' ' O ' ' D' ' 141' ' ' LEU . 1.9 p-80 -75.11 -22.26 58.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.915 -1.116 . . . . 0.0 110.19 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' CE1' ' D' ' 145' ' ' TYR . 51.2 t -83.76 -60.17 2.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.142 -0.974 . . . . 0.0 111.358 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 12.8 t70 -86.82 -27.38 23.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.074 -1.016 . . . . 0.0 111.835 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . 0.531 ' O ' ' CE1' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -84.65 -49.94 8.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.727 -1.233 . . . . 0.0 110.613 -178.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.521 ' N ' HD12 ' D' ' 96' ' ' LEU . 8.3 mp -86.55 -34.61 19.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.823 -1.173 . . . . 0.0 109.905 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' D' ' 94' ' ' ASP . 3.3 m80 71.72 36.98 1.14 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.89 . . . . 0.0 109.612 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.91 134.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.194 -0.942 . . . . 0.0 109.314 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . 0.937 ' HB3' HG11 ' A' ' 96' ' ' VAL . 3.8 m-20 -81.76 151.63 68.1 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.356 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . 0.508 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 66.7 Cg_exo -47.25 -173.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.433 2.088 . . . . 0.0 112.277 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 57.67 53.09 7.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.521 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' D' ' 100' ' ' PRO . 69.3 m-80 -159.23 -34.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.515 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -73.84 -54.56 7.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -57.08 -22.37 38.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 tt -76.7 -41.7 44.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.509 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 1.166 ' CD1' ' CHC' ' D' ' 147' ' ' HEC . 4.9 tt -68.54 -56.64 7.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.203 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.4 -20.18 2.28 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -85.68 -55.65 3.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -1.139 . . . . 0.0 109.978 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -62.07 -24.78 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.078 -1.014 . . . . 0.0 109.613 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . 0.501 HD23 ' C ' ' D' ' 110' ' ' LEU . 2.5 tt -57.45 -59.12 5.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.284 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 26.3 t -59.01 -39.92 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.595 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . 0.421 ' O ' ' CE1' ' D' ' 116' ' ' HIS . 76.2 m -48.88 -43.7 39.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 109.622 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 70.0 t -55.97 -53.43 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.412 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . 0.637 HD12 ' N ' ' D' ' 114' ' ' LEU . 9.3 mp -49.88 -41.92 46.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' D' ' 119' ' ' GLY . . . -47.9 -41.54 24.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.735 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.661 ' N ' ' ND1' ' D' ' 116' ' ' HIS . 0.4 OUTLIER -68.84 -52.32 31.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.537 -179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 74.9 m80 -69.1 -17.65 63.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 109.738 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 64.0 m-85 -156.82 64.45 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.522 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' D' ' 115' ' ' ALA . . . -76.4 -21.26 75.7 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -72.78 -29.3 63.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.157 . . . . 0.0 109.375 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' D' ' 123' ' ' THR . 63.3 mm-40 -78.56 -15.46 58.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' D' ' 115' ' ' ALA . 3.8 m-85 -69.84 59.77 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.321 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.466 ' OG1' ' CG2' ' D' ' 126' ' ' VAL . 12.0 p -59.05 150.95 59.09 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 108.916 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.445 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.3 Cg_exo -44.09 -58.12 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.414 2.076 . . . . 0.0 112.755 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 27.6 Cg_endo -61.9 -46.62 12.88 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.117 1.878 . . . . 0.0 112.033 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.466 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 40.3 t -66.68 -18.33 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.695 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . 0.655 ' NE2' HD11 ' C' ' 34' ' ' LEU . 1.1 tm0? -83.13 -26.4 31.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.114 -0.992 . . . . 0.0 109.703 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.816 ' HB2' HD13 ' C' ' 34' ' ' LEU . . . -68.73 -32.08 71.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.051 -1.03 . . . . 0.0 109.572 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.37 26.45 0.91 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.644 ' CG ' ' N ' ' D' ' 131' ' ' GLN . 5.8 p90 -74.6 -52.19 12.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.813 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 1.047 ' OE1' ' HZ ' ' C' ' 36' ' ' PHE . 36.6 tt0 -86.03 -38.98 17.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.146 -0.972 . . . . 0.0 110.023 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . 1.01 ' HG3' ' O ' ' B' ' 146' ' ' HIS . 32.1 ttpt -50.9 -34.55 28.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 110.981 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . 0.889 HG13 ' H ' ' D' ' 134' ' ' VAL . 7.1 p -65.18 -64.06 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.865 -1.147 . . . . 0.0 109.87 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.889 ' H ' HG13 ' D' ' 133' ' ' VAL . 1.8 m -73.83 -14.65 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.409 -0.807 . . . . 0.0 109.826 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' D' ' 131' ' ' GLN . . . -45.87 -23.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.099 -1.001 . . . . 0.0 109.662 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -82.6 -26.36 46.82 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' D' ' 134' ' ' VAL . 75.0 t -80.04 -21.36 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -1.159 . . . . 0.0 109.441 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.8 -51.06 71.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 109.659 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -76.78 -22.42 53.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.0 88.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.532 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 20.2 mt -84.03 15.65 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.587 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.69 -1.42 2.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.304 -0.872 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . 0.432 ' CD2' ' O ' ' D' ' 143' ' ' HIS . 21.8 t-160 -79.98 -26.53 39.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.47 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -73.28 -11.35 60.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . 0.448 ' CE1' ' SG ' ' D' ' 93' ' ' CYS . 15.8 m-85 -72.84 7.11 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.942 . . . . 0.0 109.24 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.993 ' O ' ' HG3' ' B' ' 132' ' ' LYS . 7.6 p-80 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.954 HMA1 ' HB2' ' A' ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 1.216 ' C2B' HG13 ' B' ' 67' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.974 HMA1 ' HB2' ' C' ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 1.198 ' C2B' HG13 ' D' ' 67' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.485 ' O ' ' CB ' ' A' ' 2' ' ' LEU . 3.0 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 3' ' ' SER . 3.3 tp 75.68 174.32 0.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.335 -0.853 . . . . 0.0 109.537 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.623 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 164.56 -38.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 110.516 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 3' ' ' SER . 76.4 Cg_exo -49.62 -173.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.327 2.018 . . . . 0.0 112.966 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -75.81 -15.86 60.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 0.0 110.073 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' A' ' 127' ' ' LYS . 4.9 p30 -39.03 -38.29 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.301 -0.875 . . . . 0.0 109.554 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 12.9 mtmm -57.41 -58.41 8.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.267 -0.896 . . . . 0.0 108.958 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 m -51.51 -31.83 25.33 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 108.989 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -76.61 -34.71 58.36 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.625 HG21 ' CD2' ' A' ' 128' ' ' PHE . 51.8 t -72.73 -49.91 37.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HE2' HG13 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -52.16 -42.31 63.3 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.66 -60.78 3.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.409 -0.807 . . . . 0.0 109.389 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -53.62 -34.11 57.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.113 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -17.69 61.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.379 -0.826 . . . . 0.0 109.077 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.44 -45.11 10.07 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.41 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 13.1 mmmt -68.72 -39.8 80.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -1.134 . . . . 0.0 108.859 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 13' ' ' ALA . 89.1 t -60.92 -65.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 58.06 -136.73 50.63 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.06 27.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.474 -1.016 . . . . 0.0 110.329 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.563 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.7 m-70 -131.44 27.1 4.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -90.96 -63.83 1.21 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.695 -0.628 . . . . 0.0 109.917 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.98 -14.47 0.13 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.4 mt-10 -85.06 -56.33 3.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -1.056 . . . . 0.0 109.633 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.8 m-30 -57.95 -43.93 86.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.328 -0.858 . . . . 0.0 109.111 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.03 -22.88 56.33 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.05 -33.91 59.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -1.129 . . . . 0.0 109.689 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' OE2' ' NE2' ' A' ' 112' ' ' HIS . 47.2 mt-10 -69.17 -20.18 64.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.282 -0.886 . . . . 0.0 109.687 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -19.68 59.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 0.0 109.344 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.7 mt -72.14 -48.11 46.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.358 -0.839 . . . . 0.0 109.6 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.46 -24.79 63.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.211 -0.93 . . . . 0.0 109.503 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.927 HH11 ' HG2' ' B' ' 127' ' ' GLN . 50.2 ttm-85 -76.1 -21.16 56.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.206 -0.934 . . . . 0.0 109.345 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.49 ' CE ' HBC2 ' A' ' 142' ' ' HEC . 54.0 ttp -82.24 -50.7 8.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' CD2' ' OG1' ' A' ' 39' ' ' THR . 9.4 m-85 -52.59 -44.34 65.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.701 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.755 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 6.5 mt -67.59 -58.7 4.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.975 . . . . 0.0 109.682 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.676 ' HA ' ' OE1' ' B' ' 131' ' ' GLN . 40.2 m -48.47 -34.03 10.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.905 . . . . 0.0 109.755 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 35' ' ' SER . 3.0 m-85 -146.73 90.46 5.5 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.232 -0.918 . . . . 0.0 109.397 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 39' ' ' THR . 48.4 Cg_exo -53.51 -19.32 13.32 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.72 2.28 . . . . 0.0 112.149 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 37' ' ' PRO . 12.9 p -42.64 -18.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.405 -0.809 . . . . 0.0 110.092 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 37' ' ' PRO . 46.7 p -75.42 -22.29 57.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.928 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.537 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 1.8 mptm? -46.55 -44.92 18.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.912 . . . . 0.0 109.853 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.475 HG21 ' CD2' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -62.52 -18.33 61.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 109.658 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 39' ' ' THR . 55.8 m-85 -108.78 42.74 1.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 109.166 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.664 ' O ' ' CG ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -123.67 47.92 1.96 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.52 -0.737 . . . . 0.0 110.327 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 43' ' ' PHE . 31.9 Cg_endo -65.34 -3.53 7.71 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.469 2.113 . . . . 0.0 111.904 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -169.14 59.31 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.594 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -146.1 66.36 1.2 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 49' ' ' SER . 17.0 m-20 -41.05 -18.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.265 -0.897 . . . . 0.0 110.214 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 46' ' ' PHE . 1.1 mt 51.94 9.8 0.1 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 47' ' ' ASP . 10.7 t -67.18 155.87 37.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.38 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.506 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 11.4 t-80 -65.24 139.84 58.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.542 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.506 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 54.52 30.62 50.63 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.554 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 36.9 t -63.24 -98.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -1.15 . . . . 0.0 109.376 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 172.56 -39.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.862 . . . . 0.0 109.487 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -74.77 -20.1 59.94 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.275 -0.891 . . . . 0.0 109.44 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -84.72 -41.09 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -78.95 -26.48 43.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.32 -0.862 . . . . 0.0 109.054 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.55 -21.94 63.23 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.565 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -79.02 -39.31 34.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.288 -1.125 . . . . 0.0 109.558 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.79 -47.67 30.69 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 51.2 mttp -52.45 -23.78 6.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -1.087 . . . . 0.0 109.804 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.651 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 1.7 mmpp? -72.08 -42.49 66.11 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.149 -0.969 . . . . 0.0 109.034 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 t -70.69 -48.24 59.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.52 -30.5 70.84 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.286 -0.884 . . . . 0.0 109.071 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.9 t0 -68.4 -32.59 72.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -0.927 . . . . 0.0 108.738 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.485 ' HB3' HMB3 ' A' ' 142' ' ' HEC . . . -68.46 -49.42 59.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.407 -0.808 . . . . 0.0 108.983 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.61 -39.93 93.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.274 -0.891 . . . . 0.0 108.817 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -70.69 -49.77 43.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.264 -0.898 . . . . 0.0 108.612 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -58.39 -21.03 48.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -83.47 -46.83 12.03 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.415 HG13 ' HE2' ' A' ' 11' ' ' LYS . 3.9 t -63.59 -22.83 31.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -59.34 -25.97 64.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.604 ' O ' ' N ' ' A' ' 74' ' ' ASP . 40.5 m80 -147.14 -48.4 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.855 . . . . 0.0 109.402 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 69' ' ' ALA . 11.4 p 44.99 13.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.752 0.787 . . . . 0.0 109.47 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 72' ' ' HIS . 37.3 m-20 -135.52 10.75 3.45 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 3.9 m-20 -174.94 26.58 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 15.0 ptt? -78.53 -22.59 0.39 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 111.706 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' A' ' 76' ' ' MET . 49.7 Cg_exo -55.05 -17.93 15.85 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.506 1.471 . . . . 0.0 112.221 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 78' ' ' ASN . 1.6 m-80 -94.14 -46.81 6.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.272 -0.893 . . . . 0.0 109.387 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.02 -42.3 99.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.379 -0.825 . . . . 0.0 109.15 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.6 mt -81.76 9.16 8.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.489 -0.757 . . . . 0.0 108.996 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -57.33 -25.55 59.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.375 -0.828 . . . . 0.0 109.637 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -56.4 -57.99 9.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.119 -0.988 . . . . 0.0 109.463 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.477 ' O ' ' CE1' ' A' ' 87' ' ' HIS . 6.6 mt -45.31 -50.45 11.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 3.4 m -49.25 -38.45 26.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 82' ' ' ALA . 27.9 t70 -82.52 -17.29 45.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.839 . . . . 0.0 109.865 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -70.7 -51.9 24.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.58 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 136' ' ' LEU . 14.3 p-80 -92.16 -21.92 20.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.89 -1.131 . . . . 0.0 110.689 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -60.64 -51.32 69.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.852 -1.155 . . . . 0.0 109.907 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -155.69 63.78 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.94 . . . . 0.0 109.906 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -163.06 0.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.865 . . . . 0.0 109.29 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.6 tp -171.78 -31.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 51.76 47.74 24.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.46 136.97 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.484 ' OD2' ' CE1' ' D' ' 97' ' ' HIS . 22.5 m-20 -58.33 128.41 82.39 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 97' ' ' ASN . 73.0 Cg_endo -77.09 -18.62 14.3 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.302 2.002 . . . . 0.0 112.056 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.443 ' H ' HG23 ' A' ' 96' ' ' VAL . 3.3 t -46.75 -14.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.499 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 95' ' ' PRO . 20.7 m-80 -79.04 -24.6 43.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.939 . . . . 0.0 109.506 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -52.98 -50.59 63.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 0.0 109.527 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' O ' ' CE1' ' A' ' 103' ' ' HIS . 47.0 mttp -56.61 -25.98 54.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.71 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.8 mt -84.2 -34.81 23.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 0.0 109.492 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.518 HD22 ' CHC' ' A' ' 142' ' ' HEC . 8.3 tp -74.86 -29.14 60.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 109.717 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.8 m -73.33 -39.13 65.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.963 . . . . 0.0 109.718 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.745 ' CB ' HD21 ' B' ' 108' ' ' ASN . 7.1 m170 -80.73 -26.85 37.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.649 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 33.5 m -64.26 -53.79 43.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.168 -0.958 . . . . 0.0 109.755 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -46.7 -28.67 1.57 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.2 -0.937 . . . . 0.0 109.601 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.92 -31.53 35.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 109.955 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.7 t -82.64 -26.59 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 109.649 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 p -74.41 -62.07 1.65 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 109.567 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 113' ' ' LEU . 17.7 mt -46.06 -35.31 4.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.872 . . . . 0.0 109.416 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.77 -40.75 66.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.952 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' B' ' 122' ' ' PHE . . . -73.3 -40.9 64.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.702 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.531 ' NE2' ' OE2' ' A' ' 27' ' ' GLU . 64.5 m-70 -89.67 -78.77 0.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.545 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.4 OUTLIER -107.7 113.49 61.34 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.511 ' O ' ' O ' ' A' ' 113' ' ' LEU . 77.8 Cg_exo -45.93 -173.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.235 1.957 . . . . 0.0 112.282 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.642 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -69.25 -53.2 21.06 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.473 -0.767 . . . . 0.0 109.078 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.642 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 26.0 mt-10 125.65 -0.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.502 ' CD2' ' O ' ' A' ' 117' ' ' PHE . 56.6 t80 58.04 33.56 23.31 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.408 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.795 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -106.59 117.22 57.5 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.14 20.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.146 1.898 . . . . 0.0 112.708 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.795 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -146.42 -34.07 0.3 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 0.0 110.211 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 115' ' ' ALA . 14.0 p -47.71 -47.04 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 109.926 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.61 ' N ' HG13 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -67.85 -33.64 75.15 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.4 -0.813 . . . . 0.0 109.287 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.32 -20.24 32.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.696 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.5 m -69.06 -62.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.12 -19.71 64.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.0 -1.062 . . . . 0.0 109.1 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.15 -46.79 13.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.963 . . . . 0.0 109.71 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -89.84 -39.06 13.32 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.792 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.625 ' CD2' HG21 ' A' ' 10' ' ' VAL . 27.8 t80 -47.86 -20.66 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.915 -1.116 . . . . 0.0 108.666 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' N ' ' C ' ' A' ' 127' ' ' LYS . 29.1 mt -70.73 -19.64 62.72 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -55.08 -38.38 68.01 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.502 ' HB2' HD13 ' A' ' 2' ' ' LEU . 5.4 t -77.92 -29.72 50.17 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 135' ' ' VAL . 22.0 t -80.32 -39.11 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -68.08 -20.97 64.99 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.192 -0.943 . . . . 0.0 109.04 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 138' ' ' SER . 94.9 m -69.11 -39.53 78.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.505 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 132' ' ' VAL . 1.0 OUTLIER -76.51 -31.12 19.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.264 -0.897 . . . . 0.0 109.433 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.511 ' O ' ' NE2' ' A' ' 87' ' ' HIS . 0.5 OUTLIER -84.74 -23.84 29.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.868 . . . . 0.0 109.18 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.5 m -100.25 -15.57 18.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.371 -0.83 . . . . 0.0 109.453 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 134' ' ' THR . 1.8 t -63.61 140.35 58.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.5 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -84.96 -131.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -71.27 -111.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.47 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.982 HG22 ' H ' ' B' ' 2' ' ' HIS . 7.7 p . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 0.982 ' H ' HG22 ' B' ' 1' ' ' VAL . 20.6 t-80 51.3 88.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.897 -1.127 . . . . 0.0 109.057 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.784 HD12 ' N ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -133.82 -171.96 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.449 -0.782 . . . . 0.0 109.317 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.419 ' O ' ' N ' ' B' ' 6' ' ' GLU . 12.6 p -90.0 134.86 30.96 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.25 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -41.61 -22.88 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.421 2.081 . . . . 0.0 112.357 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' B' ' 4' ' ' THR . 9.6 mp0 -79.28 -52.25 8.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.953 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.03 -60.58 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.692 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.559 ' HG3' HD13 ' B' ' 3' ' ' LEU . 5.0 ttpp -49.74 -51.75 36.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.823 . . . . 0.0 109.976 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -43.57 -23.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.63 -0.669 . . . . 0.0 110.235 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -82.94 -56.17 3.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.057 -1.027 . . . . 0.0 109.826 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' B' ' 130' ' ' TYR . 1.2 p -68.78 -24.56 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 10.9 m -71.61 -42.79 67.24 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.441 0.638 . . . . 0.0 109.544 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.59 67.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.05 -27.45 8.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.965 . . . . 0.0 109.445 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . 0.605 ' HE1' ' CB ' ' B' ' 72' ' ' SER . 0.4 OUTLIER -52.37 -17.7 1.3 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.184 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.63 -41.77 28.43 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -28.75 35.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -1.22 . . . . 0.0 109.231 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 78.0 t -58.47 114.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.844 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' B' ' 21' ' ' ASP . 7.9 t-20 -81.76 67.08 7.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.237 -0.915 . . . . 0.0 108.726 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' B' ' 19' ' ' ASN . 84.4 t -42.75 -20.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.475 -0.766 . . . . 0.0 109.792 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' B' ' 19' ' ' ASN . 78.5 m-20 -75.55 2.72 10.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' B' ' 19' ' ' ASN . 33.9 mt-10 -155.57 -47.94 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 53.2 t -47.09 -33.06 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.507 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.72 -55.58 19.25 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.44 -36.75 93.01 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -76.09 -47.32 24.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -1.162 . . . . 0.0 109.464 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.25 -33.84 59.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.15 -57.81 3.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.875 . . . . 0.0 109.384 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.81 -45.06 55.67 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -50.33 -36.39 31.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -1.119 . . . . 0.0 109.489 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . 0.725 ' CD2' HBC2 ' B' ' 147' ' ' HEC . 42.9 tp -49.46 -38.9 31.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -81.1 -21.83 39.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 109.538 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 31.1 t -77.86 -64.32 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 0.0 109.703 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.403 ' H ' HG23 ' B' ' 34' ' ' VAL . 0.2 OUTLIER -69.11 -22.76 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.604 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -141.33 81.34 15.64 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.272 -0.892 . . . . 0.0 109.404 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.75 7.47 4.84 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.687 2.258 . . . . 0.0 112.475 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.55 ' CD1' HG23 ' B' ' 38' ' ' THR . 1.5 p-90 -66.01 -19.79 65.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.097 -1.002 . . . . 0.0 109.476 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.55 HG23 ' CD1' ' B' ' 37' ' ' TRP . 82.3 p -76.89 41.78 0.29 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . 0.427 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 35.1 tt0 -84.1 26.41 0.75 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.89 . . . . 0.0 109.372 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.13 -49.2 4.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.347 -0.845 . . . . 0.0 109.582 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -88.22 3.35 49.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' B' ' 39' ' ' GLN . 8.0 p90 -52.49 -30.12 28.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.675 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -49.16 -24.89 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.606 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 39.1 t -95.36 -9.02 34.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 0.0 109.536 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' B' ' 42' ' ' PHE . 16.1 m-85 -87.03 21.82 2.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 109.497 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -98.99 2.44 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' B' ' 47' ' ' ASP . 27.2 p-10 -156.86 112.66 2.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -1.125 . . . . 0.0 109.606 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.524 HD12 ' N ' ' B' ' 48' ' ' LEU . 9.4 mp -80.01 24.54 0.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.15 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.425 ' C ' ' O ' ' B' ' 48' ' ' LEU . 29.2 t -43.09 -29.97 0.4 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.385 -0.822 . . . . 0.0 109.686 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . 0.415 ' O ' ' N ' ' B' ' 53' ' ' ALA . 73.1 p -148.74 139.02 13.15 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 109.16 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -39.35 -36.12 0.88 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.442 2.095 . . . . 0.0 112.411 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.29 -33.77 61.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.847 . . . . 0.0 109.624 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -48.86 -19.81 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.563 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 93.3 t -67.56 -64.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.606 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' B' ' 55' ' ' MET . 1.9 mpt? -80.26 4.22 18.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.128 -0.983 . . . . 0.0 109.467 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.02 -26.84 47.56 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' B' ' 53' ' ' ALA . 67.3 m-80 -84.79 141.84 38.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.095 -1.238 . . . . 0.0 109.423 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.05 -40.01 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.612 2.208 . . . . 0.0 112.245 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -47.39 78.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.549 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 89.9 t -50.79 -41.01 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.895 . . . . 0.0 109.58 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -79.09 -42.44 26.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.741 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.55 -30.27 71.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.492 ' CE1' HBA1 ' B' ' 147' ' ' HEC . 1.3 t-80 -66.21 -23.88 66.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.542 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.62 -46.69 74.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.489 ' HZ3' ' C ' ' B' ' 21' ' ' ASP . 8.3 mtpp -54.49 -29.42 50.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.576 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . 0.43 ' HB3' HBA2 ' B' ' 147' ' ' HEC . 38.5 mmtm -73.85 -32.79 63.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.925 . . . . 0.0 109.579 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 0.86 HG22 ' C4A' ' B' ' 147' ' ' HEC . 34.8 t -81.32 -30.75 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.46 -44.61 57.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 109.39 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.95 -44.87 19.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.12 -45.75 86.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -1.175 . . . . 0.0 109.621 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.544 ' CE2' HMB1 ' B' ' 147' ' ' HEC . 14.0 m-85 -57.43 -51.29 70.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.625 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.605 ' CB ' ' HE1' ' B' ' 15' ' ' TRP . 8.9 t -57.54 -43.05 84.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.381 -0.824 . . . . 0.0 109.644 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -48.38 -29.99 4.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.986 . . . . 0.0 109.445 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.43 -60.25 5.61 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.601 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -54.95 -23.69 20.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -1.113 . . . . 0.0 109.264 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.51 9.41 43.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.593 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.523 ' CE1' ' OD1' ' B' ' 80' ' ' ASN . 9.5 t-80 -170.77 70.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.958 . . . . 0.0 109.739 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.785 HD22 HG21 ' B' ' 1' ' ' VAL . 91.1 mt -86.14 -7.75 58.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.185 -0.947 . . . . 0.0 109.387 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.63 -26.73 5.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.433 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.523 ' OD1' ' CE1' ' B' ' 77' ' ' HIS . 8.6 p-10 -172.33 41.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.289 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.702 ' N ' HD23 ' B' ' 81' ' ' LEU . 1.6 pt? -46.63 -18.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.36 -0.837 . . . . 0.0 109.849 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' B' ' 80' ' ' ASN . 59.6 mttm -79.93 -32.32 40.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.06 -1.025 . . . . 0.0 109.638 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.26 -23.01 55.9 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 0.7 OUTLIER -70.78 -42.99 69.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.102 -1.234 . . . . 0.0 109.733 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.483 ' N ' ' CG2' ' B' ' 84' ' ' THR . 30.9 m-85 -84.81 25.96 0.88 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.6 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.51 -26.94 55.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.264 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.447 ' O ' ' N ' ' B' ' 91' ' ' LEU . 81.2 p -79.69 -54.89 5.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.311 -0.868 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 17.1 mt -47.97 -43.12 29.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.163 -0.961 . . . . 0.0 109.266 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . 0.514 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 1.5 m -64.72 -38.89 92.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.192 -0.942 . . . . 0.0 109.555 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.482 ' HA ' ' HG ' ' B' ' 93' ' ' CYS . 56.8 tt0 -82.1 -22.6 36.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' B' ' 87' ' ' THR . 7.5 tt -90.29 -39.22 12.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.977 . . . . 0.0 109.744 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' B' ' 97' ' ' HIS . 4.0 m80 -77.75 -29.92 51.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.02 -1.05 . . . . 0.0 110.176 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' B' ' 94' ' ' ASP . 13.2 p -83.51 -48.62 10.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.048 -1.032 . . . . 0.0 110.81 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.639 ' N ' ' SG ' ' B' ' 93' ' ' CYS . 23.6 m-20 -87.33 -34.38 18.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.904 -1.123 . . . . 0.0 111.523 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -89.01 -51.84 5.4 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.815 -1.178 . . . . 0.0 111.01 -178.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 12.9 mt -98.3 -17.79 18.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.95 -1.094 . . . . 0.0 110.314 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.586 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 31.0 p80 42.6 33.8 0.49 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.396 -0.815 . . . . 0.0 110.204 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 68.0 t -58.25 127.44 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.158 -0.964 . . . . 0.0 109.031 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' B' ' 99' ' ' ASP . 4.6 p-10 -45.61 148.33 1.3 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 109.494 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' B' ' 102' ' ' ASN . 59.8 Cg_endo -72.99 -40.09 1.94 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.61 2.207 . . . . 0.0 112.342 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -67.76 52.41 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.486 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' B' ' 100' ' ' PRO . 56.0 t-20 -140.68 -49.7 0.44 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.274 -0.891 . . . . 0.0 109.644 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -46.23 -24.22 0.44 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.832 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -74.54 -20.01 60.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' B' ' 108' ' ' ASN . 43.1 mt -80.65 -59.55 2.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.548 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.972 HD22 ' CAB' ' B' ' 147' ' ' HEC . 8.2 tt -46.94 -35.13 6.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 109.523 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.27 -26.4 74.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . 0.745 HD21 ' CB ' ' A' ' 103' ' ' HIS . 32.1 t-20 -85.52 -19.24 31.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -1.172 . . . . 0.0 109.778 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 77.4 t -84.15 -24.69 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.596 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.453 ' O ' HD23 ' B' ' 110' ' ' LEU . 1.4 tt -71.73 -60.0 2.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.44 ' H ' HG23 ' B' ' 111' ' ' VAL . 11.7 t -51.39 -29.02 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 14.5 t -65.3 -41.35 94.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.183 -0.948 . . . . 0.0 109.571 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.06 -45.94 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.584 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.74 -26.55 68.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.634 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.493 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -68.12 -34.43 76.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.492 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.96 -62.85 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 109.398 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.614 ' ND1' ' CZ ' ' B' ' 118' ' ' PHE . 12.4 t-80 -55.82 -19.68 12.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 109.74 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.614 ' CZ ' ' ND1' ' B' ' 117' ' ' HIS . 67.5 m-85 -151.6 60.8 0.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -72.63 -16.93 77.78 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -69.41 -30.03 67.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.481 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -94.01 13.54 22.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.915 . . . . 0.0 109.822 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.585 ' CD2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -81.43 33.31 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.46 ' OG1' ' CG2' ' B' ' 126' ' ' VAL . 13.1 p -47.73 130.11 11.2 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.516 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 45.5 Cg_exo -43.38 -51.9 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.194 1.929 . . . . 0.0 113.029 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 18.9 Cg_endo -58.84 -33.97 98.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.823 1.682 . . . . 0.0 111.883 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' OG1' ' B' ' 123' ' ' THR . 49.7 t -82.41 -9.98 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 0.0 109.579 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . 0.927 ' HG2' HH11 ' A' ' 31' ' ' ARG . 13.9 tp60 -75.85 -59.78 2.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -61.08 -34.04 74.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.451 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.19 11.77 0.2 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 109.545 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' B' ' 128' ' ' ALA . 6.3 t80 -105.0 -55.25 2.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 109.704 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.676 ' OE1' ' HA ' ' A' ' 35' ' ' SER . 6.5 pt20 -45.82 -44.2 13.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.928 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' B' ' 1' ' ' VAL . 21.0 mtmm -57.14 -50.04 74.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.979 . . . . 0.0 109.997 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.92 -46.95 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.133 -0.98 . . . . 0.0 109.984 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.39 -33.78 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.919 . . . . 0.0 110.197 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.89 -27.26 2.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.975 -1.078 . . . . 0.0 109.394 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.77 -25.67 73.02 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.35 -49.25 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.287 -1.125 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.62 -42.79 35.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -78.22 -23.47 47.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.96 -60.41 3.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.86 . . . . 0.0 109.503 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.53 -14.15 0.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.294 -0.879 . . . . 0.0 109.368 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' B' ' 144' ' ' LYS . . . -93.95 4.67 53.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.362 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' B' ' 143' ' ' HIS . 11.0 t-160 -68.47 7.8 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.335 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' B' ' 142' ' ' ALA . 39.7 mmtt -139.25 -41.31 0.46 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.352 -0.842 . . . . 0.0 109.498 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.513 ' CE1' ' OXT' ' B' ' 146' ' ' HIS . 0.0 OUTLIER -56.19 -12.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.869 . . . . 0.0 109.491 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.513 ' OXT' ' CE1' ' B' ' 145' ' ' TYR . 15.7 m-70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.711 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' C' ' 2' ' ' LEU . 2.9 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' C' ' 3' ' ' SER . 3.3 tp 75.68 174.4 0.24 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.341 -0.849 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.618 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 164.45 -38.1 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.363 -0.835 . . . . 0.0 110.46 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' C' ' 3' ' ' SER . 77.3 Cg_exo -49.6 -173.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.305 2.003 . . . . 0.0 112.972 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.484 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -75.75 -15.84 60.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.405 -0.81 . . . . 0.0 110.147 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' C' ' 127' ' ' LYS . 4.8 p30 -39.11 -38.21 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.554 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.477 ' N ' ' OD1' ' C' ' 6' ' ' ASP . 12.9 mtmm -57.43 -58.37 8.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 108.932 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.8 m -51.57 -31.84 26.08 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 108.942 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -76.62 -34.75 58.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.631 HG21 ' CD2' ' C' ' 128' ' ' PHE . 51.7 t -72.62 -49.97 37.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . 0.433 ' HE2' HG13 ' C' ' 70' ' ' VAL . 0.6 OUTLIER -52.03 -42.46 63.08 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.62 -60.78 3.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.361 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.668 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -53.73 -33.98 57.4 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.378 -0.826 . . . . 0.0 109.162 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -17.73 61.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 109.081 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.35 -45.13 10.18 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt -68.82 -39.74 79.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.227 -1.161 . . . . 0.0 108.849 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.668 HG23 ' O ' ' C' ' 13' ' ' ALA . 89.8 t -60.86 -65.34 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.59 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 58.12 -136.69 50.69 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.12 27.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.464 -1.021 . . . . 0.0 110.302 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.59 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.6 m-70 -131.5 27.16 4.73 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -91.02 -63.88 1.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.611 -0.68 . . . . 0.0 109.869 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.91 -14.38 0.12 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.5 mt-10 -85.1 -56.34 3.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.407 -1.055 . . . . 0.0 109.683 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.9 m-30 -58.03 -43.83 86.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.125 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.08 -22.83 56.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.07 -33.97 59.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.165 . . . . 0.0 109.69 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . 0.525 ' OE2' ' NE2' ' C' ' 112' ' ' HIS . 47.1 mt-10 -69.01 -20.27 64.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.716 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.61 -19.73 59.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.27 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -72.1 -48.07 46.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.349 -0.845 . . . . 0.0 109.681 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.54 -24.68 63.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 109.515 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.91 HH11 ' HG2' ' D' ' 127' ' ' GLN . 50.3 ttm-85 -76.15 -21.23 56.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 0.508 ' HB3' ' HE2' ' C' ' 32' ' ' MET . 54.1 ttp -82.12 -50.65 8.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.49 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . 0.441 ' CD2' ' OG1' ' C' ' 39' ' ' THR . 9.4 m-85 -52.72 -44.29 66.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.699 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.786 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 6.5 mt -67.51 -58.83 4.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.671 ' HA ' ' OE1' ' D' ' 131' ' ' GLN . 40.9 m -48.34 -34.08 10.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.802 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -146.67 90.42 5.53 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.94 . . . . 0.0 109.356 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' C' ' 39' ' ' THR . 48.2 Cg_exo -53.48 -19.33 13.21 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.745 2.297 . . . . 0.0 112.172 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.407 ' O ' HG22 ' C' ' 41' ' ' THR . 12.8 p -42.65 -18.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.43 -0.794 . . . . 0.0 110.117 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.561 ' N ' ' O ' ' C' ' 37' ' ' PRO . 45.6 p -75.44 -22.22 57.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.111 -0.993 . . . . 0.0 110.09 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' C' ' 43' ' ' PHE . 1.8 mptm? -46.59 -44.96 18.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.431 HG21 ' CD2' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -62.46 -18.37 61.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -108.81 42.85 1.33 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 109.135 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.656 ' O ' ' CG ' ' C' ' 43' ' ' PHE . 0.1 OUTLIER -123.79 47.94 2.01 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.475 -0.766 . . . . 0.0 110.343 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' C' ' 43' ' ' PHE . 31.8 Cg_endo -65.32 -3.56 7.74 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.459 2.106 . . . . 0.0 111.868 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER -169.11 59.3 0.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.879 . . . . 0.0 109.304 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -146.16 66.34 1.2 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' C' ' 49' ' ' SER . 17.0 m-20 -40.99 -18.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.274 -0.892 . . . . 0.0 110.299 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.578 ' N ' ' O ' ' C' ' 46' ' ' PHE . 1.1 mt 52.03 9.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.069 -1.02 . . . . 0.0 109.404 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.474 ' H ' ' C ' ' C' ' 47' ' ' ASP . 10.7 t -67.09 155.85 37.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.51 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 11.3 t-80 -65.34 139.84 58.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . 0.51 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 54.57 30.66 51.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' C' ' 53' ' ' ALA . 37.1 t -63.27 -98.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -1.122 . . . . 0.0 109.396 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' C' ' 52' ' ' SER . . . 172.56 -39.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.545 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -74.68 -20.22 59.96 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 109.41 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.0 t -84.63 -41.02 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -79.03 -26.4 43.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 109.083 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.67 -21.79 63.23 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.577 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.3 OUTLIER -79.05 -39.28 34.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -1.132 . . . . 0.0 109.575 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.87 -47.66 31.18 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 51.3 mttp -52.45 -23.79 6.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -1.083 . . . . 0.0 109.696 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.646 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 1.7 mmpp? -72.11 -42.53 65.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.171 -0.955 . . . . 0.0 109.042 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.8 t -70.58 -48.31 59.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.453 -0.78 . . . . 0.0 108.969 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.55 -30.41 70.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.242 -0.911 . . . . 0.0 109.11 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 8.0 t0 -68.46 -32.54 72.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 108.693 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.48 ' HB3' HMB3 ' C' ' 142' ' ' HEC . . . -68.56 -49.36 60.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.473 -0.767 . . . . 0.0 108.954 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.56 -40.05 93.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 108.744 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.5 m -70.67 -49.82 43.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -58.38 -20.96 48.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -83.51 -46.83 12.0 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.433 HG13 ' HE2' ' C' ' 11' ' ' LYS . 3.9 t -63.44 -23.0 32.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' C' ' 72' ' ' HIS . . . -59.3 -26.1 64.7 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.591 ' O ' ' N ' ' C' ' 74' ' ' ASP . 40.5 m80 -147.08 -48.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.424 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' C' ' 69' ' ' ALA . 11.4 p 45.06 12.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.783 0.802 . . . . 0.0 109.525 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' C' ' 72' ' ' HIS . 37.4 m-20 -135.45 10.68 3.47 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.414 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 3.9 m-20 -174.96 26.68 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.686 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 15.1 ptt? -78.63 -22.54 0.39 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.403 -0.811 . . . . 0.0 111.705 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' C' ' 76' ' ' MET . 49.7 Cg_exo -54.98 -18.02 15.73 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.547 1.498 . . . . 0.0 112.208 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.412 HD22 ' N ' ' C' ' 78' ' ' ASN . 1.6 m-80 -94.12 -46.77 6.96 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.96 . . . . 0.0 109.381 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.96 -42.36 99.03 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.294 -0.878 . . . . 0.0 109.183 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.76 9.22 8.28 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 108.994 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 41.1 t -57.48 -25.45 59.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 109.608 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -56.49 -58.02 9.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.377 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.478 ' O ' ' CE1' ' C' ' 87' ' ' HIS . 6.5 mt -45.17 -50.5 11.36 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 3.4 m -49.29 -38.36 27.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' C' ' 82' ' ' ALA . 27.9 t70 -82.51 -17.44 45.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 109.782 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -70.69 -51.83 25.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 110.567 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . 0.52 ' NE2' ' O ' ' C' ' 136' ' ' LEU . 14.3 p-80 -92.2 -21.8 20.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.965 -1.084 . . . . 0.0 110.754 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -60.67 -51.37 69.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.838 -1.164 . . . . 0.0 109.881 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -155.66 63.9 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.88 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.403 ' H ' ' H ' ' C' ' 91' ' ' LEU . 26.3 ttmt -163.16 1.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.259 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.403 ' H ' ' H ' ' C' ' 90' ' ' LYS . 60.5 tp -171.77 -32.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.299 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 51.7 47.82 24.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.626 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.62 136.88 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.407 ' OD2' ' CE1' ' B' ' 97' ' ' HIS . 22.3 m-20 -58.25 128.36 81.98 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.269 -0.894 . . . . 0.0 109.507 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' C' ' 97' ' ' ASN . 74.3 Cg_endo -77.01 -18.57 14.48 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.336 2.024 . . . . 0.0 112.194 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -46.72 -15.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 109.569 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' C' ' 95' ' ' PRO . 20.7 m-80 -78.97 -24.5 43.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.99 -50.65 63.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.4 ' O ' ' CE1' ' C' ' 103' ' ' HIS . 46.9 mttp -56.61 -25.96 54.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.73 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.503 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 9.8 mt -84.24 -34.62 23.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 109.592 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.516 HD22 ' CHC' ' C' ' 142' ' ' HEC . 8.3 tp -74.99 -29.09 60.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 109.714 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 66.6 m -73.36 -39.13 65.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.668 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.728 ' CB ' HD21 ' D' ' 108' ' ' ASN . 7.2 m170 -80.77 -26.81 37.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.299 -0.876 . . . . 0.0 109.644 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 33.0 m -64.32 -53.69 44.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.739 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -46.79 -28.59 1.59 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.968 . . . . 0.0 109.63 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 15.8 mt -80.94 -31.52 34.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 109.941 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 87.9 t -82.59 -26.66 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.03 -1.044 . . . . 0.0 109.683 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 5.2 p -74.41 -62.06 1.65 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.189 -0.944 . . . . 0.0 109.585 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 113' ' ' LEU . 17.5 mt -46.06 -35.22 4.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.87 -40.74 66.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.931 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . 0.595 ' HB2' ' CD2' ' D' ' 122' ' ' PHE . . . -73.37 -40.83 64.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.661 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . 0.525 ' NE2' ' OE2' ' C' ' 27' ' ' GLU . 64.7 m-70 -89.67 -78.77 0.35 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.571 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.513 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.4 OUTLIER -107.75 113.53 61.23 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' C' ' 113' ' ' LEU . 78.9 Cg_exo -45.99 -173.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.198 1.932 . . . . 0.0 112.292 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.65 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -69.46 -52.98 21.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 109.098 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.65 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 26.1 mt-10 125.48 -0.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.494 ' CD2' ' O ' ' C' ' 117' ' ' PHE . 56.8 t80 58.02 33.52 23.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.344 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.784 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -106.51 117.3 57.39 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -48.3 20.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.134 1.889 . . . . 0.0 112.689 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.784 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -146.39 -34.11 0.3 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.026 -1.046 . . . . 0.0 110.232 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.617 HG13 ' N ' ' C' ' 122' ' ' HIS . 14.0 p -47.71 -47.05 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 109.871 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.617 ' N ' HG13 ' C' ' 121' ' ' VAL . 0.0 OUTLIER -67.94 -33.55 74.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.4 -0.813 . . . . 0.0 109.259 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.27 -20.35 32.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.905 . . . . 0.0 109.713 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.542 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.5 m -68.99 -62.84 1.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.885 . . . . 0.0 110.266 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.11 -19.69 64.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.951 -1.093 . . . . 0.0 109.076 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.18 -46.75 13.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.679 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -89.85 -39.02 13.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.007 . . . . 0.0 109.836 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.631 ' CD2' HG21 ' C' ' 10' ' ' VAL . 27.6 t80 -47.82 -20.74 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.966 -1.083 . . . . 0.0 108.629 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.431 ' N ' ' C ' ' C' ' 127' ' ' LYS . 29.5 mt -70.66 -19.66 62.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -55.09 -38.37 68.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.495 ' OG ' ' CE ' ' C' ' 76' ' ' MET . 5.4 t -77.9 -29.74 50.3 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . 0.42 ' O ' HG22 ' C' ' 135' ' ' VAL . 22.0 t -80.28 -39.21 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.352 -0.842 . . . . 0.0 108.787 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 4.4 m -67.96 -21.03 65.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.224 -0.922 . . . . 0.0 109.063 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' C' ' 138' ' ' SER . 93.7 m -69.15 -39.46 78.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.845 . . . . 0.0 109.46 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.452 HG13 ' H ' ' C' ' 135' ' ' VAL . 1.0 OUTLIER -76.62 -31.01 19.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.297 -0.877 . . . . 0.0 109.41 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' C' ' 87' ' ' HIS . 0.5 OUTLIER -84.76 -23.89 29.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.277 -0.889 . . . . 0.0 109.13 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 43.0 m -100.23 -15.57 18.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.319 -0.863 . . . . 0.0 109.443 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' C' ' 134' ' ' THR . 1.8 t -63.62 140.32 58.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -84.97 -131.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -71.33 -111.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.426 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.486 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.957 HG22 ' H ' ' D' ' 2' ' ' HIS . 7.6 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . 0.957 ' H ' HG22 ' D' ' 1' ' ' VAL . 20.2 t-80 51.29 88.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.098 -1.001 . . . . 0.0 109.082 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.79 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -133.79 -171.87 2.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.292 -179.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.417 ' O ' ' N ' ' D' ' 6' ' ' GLU . 12.6 p -90.06 134.88 30.83 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.88 . . . . 0.0 109.322 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -41.61 -22.94 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.423 2.082 . . . . 0.0 112.365 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . 0.421 ' CD ' ' N ' ' D' ' 6' ' ' GLU . 9.6 mp0 -79.16 -52.37 8.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -62.99 -60.56 3.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 109.754 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.574 ' HG3' HD13 ' D' ' 3' ' ' LEU . 5.0 ttpp -49.71 -51.87 35.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.94 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -43.51 -23.69 0.08 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.61 -0.681 . . . . 0.0 110.285 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.01 -56.14 3.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.027 -1.045 . . . . 0.0 109.763 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.46 HG23 ' CD2' ' D' ' 130' ' ' TYR . 1.2 p -68.75 -24.63 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 10.5 m -71.5 -42.83 67.53 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.455 0.645 . . . . 0.0 109.594 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.4 -27.63 68.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.428 -0.795 . . . . 0.0 109.746 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.94 -27.53 7.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' D' ' 72' ' ' SER . 0.4 OUTLIER -52.35 -17.82 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 109.155 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.47 -41.92 28.83 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.99 -28.73 35.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.153 -1.204 . . . . 0.0 109.219 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 78.4 t -58.45 114.91 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.804 . . . . 0.0 109.886 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' D' ' 21' ' ' ASP . 7.9 t-20 -81.84 67.07 7.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.262 -0.899 . . . . 0.0 108.737 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' D' ' 19' ' ' ASN . 84.3 t -42.72 -20.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.467 -0.77 . . . . 0.0 109.835 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.56 ' C ' ' HZ3' ' D' ' 65' ' ' LYS . 78.5 m-20 -75.68 2.82 10.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.88 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' D' ' 19' ' ' ASN . 33.9 mt-10 -155.6 -47.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 53.1 t -47.1 -33.08 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 109.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.74 -55.61 19.08 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.47 -36.63 92.85 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -76.23 -47.21 24.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -1.119 . . . . 0.0 109.456 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.27 -33.86 59.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.0 109.394 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.18 -57.77 3.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.166 -0.958 . . . . 0.0 109.385 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.81 -45.03 55.69 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -50.37 -36.43 32.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.336 -1.096 . . . . 0.0 109.486 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . 0.715 ' CD2' HBC2 ' D' ' 147' ' ' HEC . 42.9 tp -49.41 -38.85 30.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.354 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.13 -21.94 39.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.455 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 t -77.81 -64.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -0.99 . . . . 0.0 109.705 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.427 HG23 ' H ' ' D' ' 34' ' ' VAL . 0.2 OUTLIER -68.92 -22.88 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.639 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -141.26 81.36 15.73 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.325 -0.86 . . . . 0.0 109.396 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.8 7.47 4.85 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.703 2.269 . . . . 0.0 112.449 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . 0.546 ' NE1' HG23 ' D' ' 38' ' ' THR . 1.5 p-90 -65.97 -19.86 66.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.173 -0.954 . . . . 0.0 109.512 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.546 HG23 ' NE1' ' D' ' 37' ' ' TRP . 82.4 p -76.83 41.74 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.413 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . 0.421 ' O ' ' CD1' ' D' ' 42' ' ' PHE . 35.1 tt0 -84.03 26.34 0.74 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 109.383 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.11 -49.19 4.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.905 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -88.16 3.37 49.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.493 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' D' ' 39' ' ' GLN . 7.8 p90 -52.63 -30.14 29.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.601 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -49.11 -24.89 1.81 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.649 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 39.2 t -95.38 -8.99 34.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 109.537 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -87.05 21.88 2.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -99.13 2.45 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' D' ' 47' ' ' ASP . 27.2 p-10 -156.8 112.7 2.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . 0.533 HD12 ' N ' ' D' ' 48' ' ' LEU . 9.4 mp -80.04 24.57 0.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 109.172 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.402 ' C ' ' O ' ' D' ' 48' ' ' LEU . 29.1 t -43.09 -30.0 0.41 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.428 -0.795 . . . . 0.0 109.624 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . 0.431 ' O ' ' N ' ' D' ' 53' ' ' ALA . 73.1 p -148.77 138.95 13.09 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 109.154 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -39.36 -36.1 0.88 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.458 2.105 . . . . 0.0 112.415 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -75.2 -33.86 61.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.16 -0.962 . . . . 0.0 109.652 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -48.92 -19.78 0.43 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 93.9 t -67.45 -64.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.733 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' D' ' 55' ' ' MET . 1.9 mpt? -80.17 4.14 18.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 109.496 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.08 -26.74 47.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' D' ' 53' ' ' ALA . 67.2 m-80 -84.84 141.83 38.56 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 0.0 109.489 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.1 -39.91 1.49 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.497 2.132 . . . . 0.0 112.254 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.92 -47.38 77.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.48 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 89.4 t -50.83 -40.94 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -79.19 -42.41 26.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.624 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.53 -30.23 71.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.621 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.488 ' O ' ' ND1' ' D' ' 63' ' ' HIS . 1.3 t-80 -66.26 -23.85 66.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.561 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.7 -46.65 73.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . 0.56 ' HZ3' ' C ' ' D' ' 21' ' ' ASP . 8.2 mtpp -54.41 -29.54 49.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -1.192 . . . . 0.0 109.556 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . 0.41 ' HB3' HBA2 ' D' ' 147' ' ' HEC . 38.5 mmtm -73.75 -32.86 64.05 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.318 -0.864 . . . . 0.0 109.625 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.855 HG22 ' C4A' ' D' ' 147' ' ' HEC . 34.7 t -81.23 -30.78 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.54 -44.54 57.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.339 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.92 -44.84 18.87 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.3 -45.61 87.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -1.137 . . . . 0.0 109.621 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . 0.546 ' CE2' HMB1 ' D' ' 147' ' ' HEC . 13.9 m-85 -57.46 -51.3 69.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 109.594 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . 0.6 ' CB ' ' HE1' ' D' ' 15' ' ' TRP . 9.0 t -57.54 -43.03 84.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.699 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -48.36 -30.13 4.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.42 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.32 -60.21 5.69 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.594 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.9 mp -55.07 -23.64 21.28 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.223 -1.163 . . . . 0.0 109.239 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.54 9.48 43.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.622 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.527 ' CE1' ' OD1' ' D' ' 80' ' ' ASN . 9.5 t-80 -170.84 70.01 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 109.787 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . 0.787 HD22 HG21 ' D' ' 1' ' ' VAL . 91.0 mt -85.98 -7.83 58.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -50.58 -26.74 5.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.527 ' OD1' ' CE1' ' D' ' 77' ' ' HIS . 8.5 p-10 -172.3 41.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 109.233 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . 0.698 ' N ' HD23 ' D' ' 81' ' ' LEU . 1.5 pt? -46.66 -18.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.357 -0.839 . . . . 0.0 109.884 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' D' ' 80' ' ' ASN . 59.5 mttm -80.02 -32.29 39.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.106 -0.996 . . . . 0.0 109.609 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.26 -23.04 55.79 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 0.7 OUTLIER -70.78 -43.05 69.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.039 -1.271 . . . . 0.0 109.676 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.485 ' N ' ' CG2' ' D' ' 84' ' ' THR . 30.8 m-85 -84.81 26.01 0.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.57 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.56 -26.93 56.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.918 . . . . 0.0 109.274 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . 0.457 ' O ' ' N ' ' D' ' 91' ' ' LEU . 81.3 p -79.67 -54.99 5.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 17.0 mt -47.86 -43.16 28.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.358 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . 0.523 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 1.5 m -64.81 -38.81 92.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 109.513 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.483 ' HA ' ' HG ' ' D' ' 93' ' ' CYS . 57.2 tt0 -82.09 -22.6 36.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 0.0 109.676 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' D' ' 87' ' ' THR . 7.5 tt -90.24 -39.29 12.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 109.753 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' D' ' 97' ' ' HIS . 4.0 m80 -77.64 -29.92 51.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.054 -1.028 . . . . 0.0 110.234 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' D' ' 94' ' ' ASP . 13.1 p -83.51 -48.59 10.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.129 -0.982 . . . . 0.0 110.807 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.638 ' N ' ' SG ' ' D' ' 93' ' ' CYS . 23.9 m-20 -87.31 -34.42 18.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.91 -1.119 . . . . 0.0 111.493 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -89.03 -51.8 5.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.807 -1.183 . . . . 0.0 111.006 -178.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.582 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 12.9 mt -98.29 -17.79 18.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.942 -1.099 . . . . 0.0 110.26 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 31.0 p80 42.39 34.03 0.48 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.301 -0.874 . . . . 0.0 110.213 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 67.7 t -58.32 127.27 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 109.093 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' D' ' 99' ' ' ASP . 4.7 p-10 -45.4 148.41 1.18 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.563 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' D' ' 102' ' ' ASN . 59.3 Cg_endo -73.13 -40.05 1.89 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.614 2.209 . . . . 0.0 112.316 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -67.69 52.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.482 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' D' ' 100' ' ' PRO . 56.1 t-20 -140.75 -49.61 0.44 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -46.27 -24.24 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.193 -0.942 . . . . 0.0 109.764 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -74.61 -19.95 60.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 109.438 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' D' ' 108' ' ' ASN . 43.5 mt -80.7 -59.59 2.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.963 . . . . 0.0 109.453 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.959 HD22 ' CAB' ' D' ' 147' ' ' HEC . 8.2 tt -46.91 -35.17 6.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.23 -26.43 74.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . 0.728 HD21 ' CB ' ' C' ' 103' ' ' HIS . 32.1 t-20 -85.49 -19.26 31.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -1.163 . . . . 0.0 109.794 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 77.4 t -84.05 -24.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 109.628 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . 0.449 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.5 tt -71.82 -59.99 2.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.465 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 11.6 t -51.3 -29.12 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.592 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 14.6 t -65.36 -41.24 94.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.554 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.22 -45.9 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.542 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.71 -26.56 68.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.643 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.501 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -68.17 -34.29 76.04 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 109.524 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.454 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -85.06 -62.84 1.44 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 0.0 109.388 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . 0.615 ' ND1' ' CZ ' ' D' ' 118' ' ' PHE . 12.3 t-80 -55.75 -19.76 12.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 109.748 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.615 ' CZ ' ' ND1' ' D' ' 117' ' ' HIS . 67.6 m-85 -151.62 60.83 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.457 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.539 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -72.54 -17.05 77.68 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -69.36 -30.06 67.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.144 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -94.0 13.58 22.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.807 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -81.46 33.26 0.35 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.663 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.46 ' OG1' ' CG2' ' D' ' 126' ' ' VAL . 13.3 p -47.67 130.07 11.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.312 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.525 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 45.6 Cg_exo -43.43 -51.88 5.57 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.134 1.89 . . . . 0.0 113.037 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 18.8 Cg_endo -58.78 -33.92 98.71 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.791 1.661 . . . . 0.0 111.955 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' OG1' ' D' ' 123' ' ' THR . 49.1 t -82.37 -10.06 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.535 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . 0.91 ' HG2' HH11 ' C' ' 31' ' ' ARG . 14.0 tp60 -75.94 -59.75 2.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 109.423 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.786 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -61.12 -33.99 74.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.26 11.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.552 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' D' ' 128' ' ' ALA . 6.3 t80 -104.88 -55.34 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.299 -0.876 . . . . 0.0 109.738 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 0.671 ' OE1' ' HA ' ' C' ' 35' ' ' SER . 6.5 pt20 -45.87 -44.12 14.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.88 . . . . 0.0 109.899 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' D' ' 1' ' ' VAL . 21.1 mtmm -57.17 -50.11 73.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.132 -0.98 . . . . 0.0 109.991 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.84 -46.93 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.024 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.449 ' H ' HG22 ' D' ' 134' ' ' VAL . 15.6 m -83.36 -33.84 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.113 -0.992 . . . . 0.0 110.203 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -47.89 -27.32 2.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.968 -1.082 . . . . 0.0 109.404 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.69 -25.67 72.93 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.34 -49.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -1.151 . . . . 0.0 109.441 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -48.65 -42.81 35.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.435 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -78.21 -23.43 47.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.464 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.01 -60.4 3.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 45.1 mt -53.51 -14.14 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' D' ' 144' ' ' LYS . . . -94.01 4.75 53.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.91 . . . . 0.0 109.386 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' D' ' 143' ' ' HIS . 11.0 t-160 -68.52 7.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 109.342 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' D' ' 142' ' ' ALA . 39.7 mmtt -139.32 -41.28 0.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.367 -0.833 . . . . 0.0 109.466 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . 0.521 ' CE1' ' OXT' ' D' ' 146' ' ' HIS . 0.0 OUTLIER -56.26 -12.04 1.43 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.406 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.521 ' OXT' ' CE1' ' D' ' 145' ' ' TYR . 15.5 m-70 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.742 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.839 HMB1 HBB2 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 0.972 ' CAB' HD22 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.826 HMB1 HBB2 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 0.959 ' CAB' HD22 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.42 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 48.9 mt -125.32 -162.32 1.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.354 -0.841 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 177.12 -48.8 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 109.865 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 3' ' ' SER . 68.3 Cg_exo -49.18 174.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.391 2.061 . . . . 0.0 112.437 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -56.98 -16.56 7.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.614 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.472 ' C ' ' O ' ' A' ' 5' ' ' ALA . 14.8 t70 -39.92 -31.67 0.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 109.524 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 5' ' ' ALA . 9.3 mtmp? -73.34 -55.97 5.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.407 -0.808 . . . . 0.0 109.216 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 m -47.53 -28.63 2.33 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.139 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -78.33 -38.58 41.83 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.514 HG21 ' CD2' ' A' ' 128' ' ' PHE . 40.9 t -70.8 -48.91 54.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -51.58 -44.66 62.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.404 -0.81 . . . . 0.0 108.839 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.81 -58.55 7.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.818 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -55.68 -31.83 62.73 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.47 -17.4 58.07 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.201 -0.937 . . . . 0.0 108.914 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.35 -38.77 44.85 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -84.4 -40.86 17.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.381 -1.07 . . . . 0.0 109.32 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.573 ' O ' ' C ' ' A' ' 18' ' ' GLY . 93.7 t -66.69 -45.93 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 109.709 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.632 ' O ' ' HB3' ' A' ' 19' ' ' ALA . . . -25.1 137.81 0.01 OUTLIER Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . 74.26 -29.16 0.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.43 -1.041 . . . . 0.0 109.331 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.511 ' H ' ' C ' ' A' ' 18' ' ' GLY . 38.0 m-70 -110.76 16.79 21.16 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HB1' ' HB1' ' A' ' 63' ' ' ALA . . . -82.39 -60.8 2.08 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.008 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.46 -14.84 0.39 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.0 mt-10 -85.47 -56.35 3.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -1.177 . . . . 0.0 109.758 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.4 m-30 -60.69 -35.2 75.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.0 109.398 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.37 -23.01 73.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.74 -47.03 14.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -1.154 . . . . 0.0 109.64 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -63.57 -19.87 65.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 109.327 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.03 -27.6 63.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.92 . . . . 0.0 109.44 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.416 HD11 ' ND1' ' A' ' 58' ' ' HIS . 9.0 mt -70.4 -53.68 15.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.907 . . . . 0.0 109.57 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.16 -29.37 69.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.251 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.38 -30.34 67.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.299 -0.876 . . . . 0.0 109.224 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.52 ' HE2' ' HB3' ' A' ' 32' ' ' MET . 47.9 ttp -72.83 -52.7 13.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.186 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.38 -32.04 10.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.239 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.6 mt -78.42 -39.76 37.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -0.903 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.524 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 15.0 m -51.67 -29.67 18.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 35' ' ' SER . 57.1 m-85 -160.85 130.39 3.28 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 0.0 109.248 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.27 -19.89 14.89 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.317 2.011 . . . . 0.0 112.158 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.672 ' O ' HG22 ' A' ' 41' ' ' THR . 22.3 p -46.53 -46.0 18.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.785 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -45.39 -22.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 109.93 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 38' ' ' THR . 26.5 ttmt -51.81 -42.46 62.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.169 -0.957 . . . . 0.0 110.113 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 1.615 HG21 ' CD2' ' D' ' 97' ' ' HIS . 0.7 OUTLIER -75.63 -18.86 59.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 0.0 109.757 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.402 ' O ' ' CB ' ' A' ' 43' ' ' PHE . 58.5 t80 -55.88 -5.48 0.17 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 41' ' ' THR . 0.1 OUTLIER 70.4 67.38 0.41 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.283 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 54.2 Cg_exo -48.71 -42.06 37.11 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.641 2.227 . . . . 0.0 111.821 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 4.2 p80 40.7 33.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.735 -0.603 . . . . 0.0 110.413 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -157.71 28.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 110.074 179.409 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 49' ' ' SER . 73.9 m-20 43.67 89.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.478 -0.764 . . . . 0.0 110.345 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.024 ' H ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.6 1.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.356 179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.512 ' N ' HD22 ' A' ' 48' ' ' LEU . 5.0 m -84.77 157.0 21.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.15 -0.968 . . . . 0.0 109.769 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.604 ' ND1' ' N ' ' A' ' 51' ' ' GLY . 40.2 t-80 -76.44 170.58 16.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.396 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.604 ' N ' ' ND1' ' A' ' 50' ' ' HIS . . . 76.18 -21.88 2.14 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.62 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.7 p -55.95 -18.7 9.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -1.098 . . . . 0.0 109.374 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 72.82 -23.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.814 . . . . 0.0 109.732 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 52' ' ' SER . 24.1 mt-30 -84.83 -17.94 36.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 0.0 109.565 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.52 HG23 ' OG ' ' A' ' 52' ' ' SER . 44.5 t -84.09 -32.64 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.576 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -72.92 -29.39 63.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 0.0 109.211 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.98 66.09 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.495 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 6.2 t-80 -60.71 -30.72 70.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.126 -1.22 . . . . 0.0 110.076 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.79 -31.38 79.58 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 59.2 mttp -68.89 -23.01 64.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -1.115 . . . . 0.0 110.253 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.741 ' HG2' ' CAA' ' A' ' 142' ' ' HEC . 0.0 OUTLIER -69.49 -58.19 4.28 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.883 -1.136 . . . . 0.0 108.748 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.52 -41.52 64.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.6 -0.688 . . . . 0.0 109.599 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.571 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -75.53 -43.86 46.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.158 -0.964 . . . . 0.0 109.237 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 34.9 t0 -68.85 -33.85 74.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.149 -0.97 . . . . 0.0 108.639 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.632 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -66.87 -49.14 66.62 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -53.06 -47.06 68.74 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.282 -0.886 . . . . 0.0 108.627 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.2 m -57.01 -56.57 20.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 108.755 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.534 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 28.5 t30 -58.86 -21.09 56.36 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.08 -47.38 10.24 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.4 t -68.44 -22.74 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.87 -33.43 75.58 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.609 ' O ' ' N ' ' A' ' 74' ' ' ASP . 5.5 m-70 -115.87 -60.57 1.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.493 -0.754 . . . . 0.0 109.509 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.3 p 45.09 12.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.726 0.774 . . . . 0.0 109.549 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.609 ' N ' ' O ' ' A' ' 72' ' ' HIS . 28.8 m-20 -138.34 11.11 2.77 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -177.3 27.79 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.697 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 3.0 ptt? -78.51 -23.81 0.42 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 111.69 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 76' ' ' MET . 53.2 Cg_exo -54.47 -19.62 18.19 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.559 1.506 . . . . 0.0 112.193 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -93.16 -40.68 10.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.323 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.76 -43.45 65.76 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.308 -0.87 . . . . 0.0 109.014 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.35 10.37 12.86 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.7 t -51.84 -47.68 64.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -46.13 -58.07 3.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 109.726 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 83' ' ' LEU . 3.8 mt -45.24 -44.29 11.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.394 -0.816 . . . . 0.0 108.827 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.9 p -55.18 -30.05 59.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.467 -0.77 . . . . 0.0 108.978 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 89' ' ' HIS . 1.6 m-20 -82.08 -49.65 9.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.837 . . . . 0.0 109.263 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 tp -51.03 -30.02 14.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 109.25 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -92.89 -21.79 19.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -0.843 . . . . 0.0 110.371 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.72 20.82 5.52 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.113 -0.992 . . . . 0.0 110.322 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.666 ' N ' ' O ' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -140.51 -78.27 0.3 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 109.78 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 92' ' ' ARG . 16.9 mttp -67.36 -119.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 109.816 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.3 mp -44.58 -19.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.82 . . . . 0.0 109.774 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 90' ' ' LYS . 49.7 ttt180 57.21 45.95 19.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.302 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.431 ' H ' HG23 ' A' ' 93' ' ' VAL . 4.7 t -48.43 133.15 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.647 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -91.58 126.06 55.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.273 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -43.84 -10.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.374 2.05 . . . . 0.0 112.377 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 1.265 HG11 ' CG ' ' D' ' 99' ' ' ASP . 25.1 t -56.39 -31.79 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.088 -1.008 . . . . 0.0 109.648 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -79.57 -38.14 34.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 0.0 109.662 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -46.06 -30.29 1.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.33 -0.856 . . . . 0.0 109.622 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.27 -28.02 69.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.89 . . . . 0.0 109.646 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 11.4 mt -84.29 -34.3 23.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.803 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.708 HD23 ' HAB' ' A' ' 142' ' ' HEC . 5.5 tp -64.14 -61.15 2.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.98 . . . . 0.0 109.741 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.6 t -47.76 -34.76 8.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.759 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.461 ' O ' HG23 ' A' ' 107' ' ' VAL . 12.3 t-80 -80.84 -26.66 36.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.142 -0.974 . . . . 0.0 109.826 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 97.7 m -76.35 -38.06 56.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.49 -52.04 67.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.118 -0.989 . . . . 0.0 109.716 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.7 mt -60.19 -32.35 71.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 109.964 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 34.4 t -63.65 -59.62 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 0.0 109.19 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.7 p -54.76 -53.55 53.68 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.244 -0.91 . . . . 0.0 109.276 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 114' ' ' PRO . 7.7 mt -45.41 -26.71 0.58 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.266 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -68.45 -39.26 81.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 0.0 109.979 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.659 ' HB2' ' CE2' ' B' ' 122' ' ' PHE . . . -78.99 -3.54 45.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.352 -0.842 . . . . 0.0 109.931 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -134.51 -80.09 0.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 109.7 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -118.4 82.53 19.16 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' N ' ' O ' ' A' ' 109' ' ' LEU . 51.3 Cg_exo -49.61 -169.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.454 2.102 . . . . 0.0 112.432 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.807 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -52.85 -55.72 21.08 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.656 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 46.3 mt-10 123.24 -5.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 7.6 t80 73.24 30.97 1.48 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.732 -0.605 . . . . 0.0 111.116 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.8 p -104.54 126.25 31.89 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.106 -0.996 . . . . 0.0 108.38 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.665 ' HB3' ' HB3' ' B' ' 51' ' ' PRO . 54.2 Cg_exo -49.73 22.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.353 2.036 . . . . 0.0 112.897 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -153.3 -32.94 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.83 -1.169 . . . . 0.0 110.645 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.807 HG21 ' O ' ' A' ' 115' ' ' ALA . 9.6 p -52.8 -49.5 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.982 -1.074 . . . . 0.0 110.154 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.643 ' N ' HG13 ' A' ' 121' ' ' VAL . 4.7 t-160 -59.47 -37.46 78.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 109.218 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.08 -19.41 34.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -0.839 . . . . 0.0 109.487 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 120' ' ' ALA . 23.3 p -64.18 -62.1 1.83 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 110.848 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.488 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.6 mt -68.46 -19.76 64.58 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.982 -1.074 . . . . 0.0 109.757 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.66 -46.62 12.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 109.36 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -80.44 -46.23 16.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -0.964 . . . . 0.0 109.278 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.514 ' CD2' HG21 ' A' ' 10' ' ' VAL . 26.8 t80 -49.93 -21.79 1.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.93 . . . . 0.0 108.969 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.488 HD22 HBB1 ' A' ' 142' ' ' HEC . 15.1 mt -73.96 -21.76 59.9 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -57.88 -31.83 67.1 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 90.0 p -79.83 -33.61 40.11 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.378 -0.826 . . . . 0.0 108.954 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.24 -35.52 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 108.636 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 47.4 t -72.23 -28.62 63.28 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.436 -0.79 . . . . 0.0 109.172 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 32.2 m -66.51 -34.34 77.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.171 -0.956 . . . . 0.0 109.082 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 97.5 t -77.38 -40.43 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.29 -0.881 . . . . 0.0 108.998 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.79 -27.28 68.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 108.955 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.3 m -86.24 -26.47 25.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 109.455 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.9 m -54.35 136.36 43.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.45 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -85.3 -165.32 1.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -56.85 -72.93 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.485 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.684 179.852 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.562 HG13 ' N ' ' B' ' 2' ' ' HIS . 7.2 p . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 0.562 ' N ' HG13 ' B' ' 1' ' ' VAL . 21.3 t-160 -172.8 71.34 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 109.177 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.525 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -127.95 155.81 43.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.391 -0.818 . . . . 0.0 109.356 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -54.51 152.71 11.65 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 108.914 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.07 -18.57 44.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.463 2.109 . . . . 0.0 112.06 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -87.13 -37.86 16.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.628 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -84.0 -23.22 31.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.9 . . . . 0.0 109.891 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -84.12 -55.12 4.37 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.148 -0.97 . . . . 0.0 109.095 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.8 t -48.03 -23.52 0.83 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.125 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.15 -59.68 2.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.966 -1.084 . . . . 0.0 109.894 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.03 -24.44 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -74.79 -51.93 12.8 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.405 0.622 . . . . 0.0 109.649 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.36 -24.88 47.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.388 -0.82 . . . . 0.0 109.571 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.663 ' O ' HG23 ' B' ' 18' ' ' VAL . 1.2 mt -59.65 -28.26 67.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.344 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.83 -17.06 62.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.415 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.28 -63.77 3.13 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.596 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.5 ' HD3' HD23 ' B' ' 14' ' ' LEU . 0.0 OUTLIER -70.68 -11.72 61.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.033 -1.274 . . . . 0.0 110.809 -178.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.663 HG23 ' O ' ' B' ' 14' ' ' LEU . 12.9 t -70.73 121.35 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.833 -1.167 . . . . 0.0 109.348 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.541 HD22 ' N ' ' B' ' 19' ' ' ASN . 0.9 OUTLIER -77.15 73.26 3.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.247 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.513 HG12 ' O ' ' B' ' 20' ' ' VAL . 75.5 t -52.89 -6.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.64 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 22' ' ' GLU . 9.8 p30 -67.88 -20.73 65.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.914 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' B' ' 21' ' ' ASP . 9.2 pt-20 -150.11 -32.49 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.897 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.16 -28.27 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.667 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.1 -41.26 99.81 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.11 -55.04 17.83 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.422 ' O ' ' NH1' ' B' ' 30' ' ' ARG . 58.2 mt-10 -49.87 -26.99 4.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -1.141 . . . . 0.0 109.367 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.24 -32.62 22.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.06 -36.41 21.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.6 -40.58 90.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' B' ' 26' ' ' GLU . 0.0 OUTLIER -62.85 -21.88 66.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -1.17 . . . . 0.0 109.426 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.98 -28.38 65.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.965 . . . . 0.0 109.539 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' B' ' 36' ' ' PRO . 27.7 mt -81.24 -53.89 5.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.995 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.494 HG13 ' N ' ' B' ' 34' ' ' VAL . 6.2 p -56.18 -43.21 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.0 109.607 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.494 ' N ' HG13 ' B' ' 33' ' ' VAL . 57.8 t -79.53 -22.92 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 109.364 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -153.04 75.52 6.69 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.327 -0.858 . . . . 0.0 109.127 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.47 ' N ' ' O ' ' B' ' 32' ' ' LEU . 92.1 Cg_endo -83.69 3.79 7.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.971 2.448 . . . . 0.0 112.562 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.407 ' NE1' HG23 ' B' ' 38' ' ' THR . 3.1 p-90 -57.42 -19.82 26.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 109.547 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.407 HG23 ' NE1' ' B' ' 37' ' ' TRP . 6.2 p -79.96 5.44 13.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -48.28 -22.74 0.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.912 . . . . 0.0 109.531 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -62.36 -38.81 90.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 109.39 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . 0.433 ' O ' ' CG ' ' B' ' 42' ' ' PHE . 80.7 m-85 -88.01 27.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.979 ' CZ ' HBC3 ' B' ' 147' ' ' HEC . 75.2 m-85 -154.82 32.93 0.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.9 . . . . 0.0 109.518 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.33 -27.84 52.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 67.6 m -76.28 -29.7 57.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.526 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.486 ' O ' ' N ' ' B' ' 47' ' ' ASP . 3.8 m-85 -48.68 -22.71 0.83 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.319 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' B' ' 47' ' ' ASP . . . 68.04 -53.16 0.4 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' B' ' 45' ' ' PHE . 51.2 m-20 -60.35 -151.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -1.144 . . . . 0.0 109.552 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt 58.82 17.91 5.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.843 . . . . 0.0 109.492 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 30.2 p -69.45 -28.34 66.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.36 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . 0.523 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.4 p -145.24 151.31 47.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 109.021 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.665 ' HB3' ' HB3' ' A' ' 119' ' ' PRO . 81.0 Cg_exo -38.27 -32.51 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.619 2.213 . . . . 0.0 112.574 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.19 -24.14 40.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.721 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -68.89 -19.57 64.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.893 . . . . 0.0 109.727 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.45 ' O ' HG11 ' B' ' 60' ' ' VAL . 18.6 t -65.24 -64.03 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 109.571 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 25.5 mtm -95.38 29.33 2.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.278 -0.889 . . . . 0.0 109.442 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.12 -58.58 0.66 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -69.4 150.26 97.1 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.293 -1.122 . . . . 0.0 109.478 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' B' ' 60' ' ' VAL . 69.2 Cg_endo -75.05 -56.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.609 2.206 . . . . 0.0 112.395 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -18.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 109.743 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' B' ' 58' ' ' PRO . 91.4 t -81.66 -44.96 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.426 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -79.01 -27.1 43.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.16 -20.93 63.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 109.64 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.511 ' CE1' ' C4D' ' B' ' 147' ' ' HEC . 59.4 t-80 -72.3 -23.94 61.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -0.99 . . . . 0.0 109.406 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.04 -25.99 74.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -55.97 -42.82 76.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 109.063 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . 0.514 ' HB3' HMA3 ' B' ' 147' ' ' HEC . 91.9 mttt -64.34 -41.49 96.74 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.589 -0.694 . . . . 0.0 109.557 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 0.721 HG22 ' C1B' ' B' ' 147' ' ' HEC . 29.0 t -65.27 -62.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.296 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.66 ' O ' HD23 ' B' ' 68' ' ' LEU . 2.4 tt -54.32 -40.2 67.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.194 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.52 -53.85 38.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.1 -44.38 42.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.097 . . . . 0.0 109.632 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -63.31 -45.89 89.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 98.6 p -61.07 -34.83 75.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 0.0 109.563 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -53.98 -39.63 66.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -0.961 . . . . 0.0 109.431 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.24 -60.14 8.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.589 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -53.73 -30.07 42.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.173 -1.193 . . . . 0.0 109.168 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.21 4.32 46.17 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.32 -0.863 . . . . 0.0 109.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -170.22 67.48 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 109.675 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 90.6 mt -78.96 12.78 2.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.237 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.0 -29.75 68.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 24.9 t-20 -164.02 111.32 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 109.56 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.576 ' N ' HD12 ' B' ' 81' ' ' LEU . 7.5 mp -80.29 -56.07 4.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.437 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.517 ' HZ2' ' CD2' ' B' ' 143' ' ' HIS . 77.0 tttt -62.31 -24.12 67.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.608 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -75.07 -51.11 7.86 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.7 t -73.41 -46.29 49.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -1.133 . . . . 0.0 109.475 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.542 ' N ' ' CG2' ' B' ' 84' ' ' THR . 54.4 m-85 -84.29 26.13 0.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.445 -0.785 . . . . 0.0 109.575 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.11 -28.05 67.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.469 ' O ' ' N ' ' B' ' 91' ' ' LEU . 82.0 p -77.22 -58.14 3.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.83 . . . . 0.0 109.607 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.24 -41.6 18.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -68.71 -37.62 79.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.907 . . . . 0.0 109.58 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -82.67 -28.14 30.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 109.499 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' B' ' 87' ' ' THR . 10.3 tt -75.5 -69.05 0.51 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.232 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' B' ' 97' ' ' HIS . 70.8 m80 -50.1 -23.85 2.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.183 -0.948 . . . . 0.0 109.735 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 38.8 t -83.92 -56.23 3.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.92 . . . . 0.0 111.066 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.538 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 73.4 m-20 -86.17 -24.49 26.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.967 -1.083 . . . . 0.0 111.856 -177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.469 ' N ' ' CD ' ' B' ' 95' ' ' LYS . 10.7 mptt -94.25 -51.73 4.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.678 -1.264 . . . . 0.0 110.676 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -27.69 13.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.049 -1.032 . . . . 0.0 109.934 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 1.58 ' CD2' HG21 ' C' ' 41' ' ' THR . 21.4 m-70 57.71 53.71 6.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.944 . . . . 0.0 109.716 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.37 124.29 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.151 -0.968 . . . . 0.0 109.295 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 1.291 ' OD2' HG11 ' C' ' 96' ' ' VAL . 68.7 m-20 -47.99 149.27 2.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.389 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.32 62.93 5.31 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.554 2.169 . . . . 0.0 112.046 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -172.09 73.92 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.434 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.95 -27.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.86 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' B' ' 103' ' ' PHE . 0.1 OUTLIER -56.28 -20.53 19.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.002 -1.061 . . . . 0.0 109.689 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -86.15 -41.13 14.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.428 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 tp -48.97 -40.18 29.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.319 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.556 HD13 ' CAB' ' B' ' 147' ' ' HEC . 5.7 tt -69.28 -47.59 64.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.272 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.46 -20.09 54.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -81.72 -55.74 4.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -1.164 . . . . 0.0 110.164 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 p -61.92 -24.15 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.078 -1.013 . . . . 0.0 109.682 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.474 ' O ' HD23 ' B' ' 110' ' ' LEU . 1.6 tt -61.57 -58.06 9.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 0.0 109.401 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' B' ' 130' ' ' TYR . 69.5 t -46.64 -26.01 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 109.772 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.49 -32.66 74.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 0.0 109.63 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.48 -31.57 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.965 . . . . 0.0 109.497 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.14 -29.4 60.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.158 -0.964 . . . . 0.0 109.497 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.424 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -74.97 -32.23 61.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 109.572 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.479 ' C ' ' HD1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.85 -56.98 3.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.224 -0.923 . . . . 0.0 109.404 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' B' ' 118' ' ' PHE . 13.7 m170 -56.83 -17.78 10.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.621 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.408 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 72.1 m-85 -154.48 60.59 0.69 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -70.97 -26.24 74.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' B' ' 120' ' ' LYS . 11.8 mptt -70.0 9.86 0.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -1.168 . . . . 0.0 109.289 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' B' ' 119' ' ' GLY . 68.7 mm-40 -136.64 2.53 2.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.828 . . . . 0.0 109.387 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.659 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -72.91 39.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.502 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.572 ' C ' HE22 ' B' ' 127' ' ' GLN . 0.8 OUTLIER -52.46 149.08 11.09 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 109.331 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.3 Cg_exo -47.62 -52.38 8.14 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.46 2.107 . . . . 0.0 113.246 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 35.8 Cg_endo -65.35 -3.88 8.35 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.087 1.858 . . . . 0.0 112.708 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.454 HG23 ' OG1' ' B' ' 123' ' ' THR . 56.8 t -96.81 -22.09 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.044 -1.035 . . . . 0.0 109.724 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . 0.572 HE22 ' C ' ' B' ' 123' ' ' THR . 1.8 mp0 -83.27 -59.95 2.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.029 -1.044 . . . . 0.0 109.715 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -54.03 -35.02 61.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.991 . . . . 0.0 109.408 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.89 26.48 0.98 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.69 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.414 ' CE1' HG22 ' B' ' 111' ' ' VAL . 32.7 t80 -118.82 -61.47 1.64 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.304 -0.873 . . . . 0.0 109.654 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 28.1 mt-30 -52.81 -23.42 6.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.636 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -71.58 -39.02 70.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.112 -0.992 . . . . 0.0 109.731 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.71 -55.85 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 109.799 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' B' ' 137' ' ' VAL . 11.4 m -69.78 -28.57 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 110.041 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -47.57 -25.89 1.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 109.354 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.79 -24.6 57.92 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' B' ' 134' ' ' VAL . 74.8 t -79.42 -37.6 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -1.1 . . . . 0.0 109.345 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.81 79.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.433 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.492 HD21 HD21 ' D' ' 139' ' ' ASN . 65.1 t30 -72.1 -44.03 63.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.36 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.3 -40.82 49.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 109.341 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 36.5 mt -81.94 12.79 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.338 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' B' ' 103' ' ' PHE . . . -139.78 1.63 1.91 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 109.81 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . 0.517 ' CD2' ' HZ2' ' B' ' 82' ' ' LYS . 10.4 t60 -79.37 -34.05 42.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.51 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 5.0 tptp -67.41 -25.44 65.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.409 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -64.03 -14.14 52.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.486 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.526 ' OXT' ' CG ' ' B' ' 146' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.503 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.417 ' CD1' ' CD2' ' C' ' 128' ' ' PHE . 48.9 mt -125.35 -162.29 1.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.824 . . . . 0.0 109.435 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.502 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 177.1 -48.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.954 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' C' ' 3' ' ' SER . 67.4 Cg_exo -49.21 174.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.381 2.054 . . . . 0.0 112.477 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -56.92 -16.54 7.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 109.639 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' C' ' 5' ' ' ALA . 14.9 t70 -40.0 -31.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 109.525 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' C' ' 5' ' ' ALA . 9.3 mtmp? -73.41 -55.91 5.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.211 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 44.6 m -47.51 -28.63 2.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.381 -0.824 . . . . 0.0 109.211 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -78.3 -38.6 42.09 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.51 HG21 ' CD2' ' C' ' 128' ' ' PHE . 40.7 t -70.86 -48.83 54.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -51.63 -44.62 63.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.404 -0.81 . . . . 0.0 108.853 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.86 -58.58 7.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.447 -0.783 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.481 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -55.55 -31.93 62.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.309 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -77.42 -17.37 58.18 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.155 -0.966 . . . . 0.0 109.004 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.33 -38.84 44.84 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -84.26 -40.9 17.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -1.067 . . . . 0.0 109.355 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.566 ' O ' ' C ' ' C' ' 18' ' ' GLY . 93.5 t -66.71 -46.0 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.387 -0.821 . . . . 0.0 109.687 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' C' ' 19' ' ' ALA . . . -25.08 137.73 0.01 OUTLIER Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' C' ' 18' ' ' GLY . . . 74.45 -29.39 0.19 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.517 -0.99 . . . . 0.0 109.237 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.513 ' H ' ' C ' ' C' ' 18' ' ' GLY . 37.6 m-70 -110.56 16.82 21.27 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.599 ' HB1' ' HB1' ' C' ' 63' ' ' ALA . . . -82.32 -60.86 2.06 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.957 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.53 -14.7 0.39 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.0 mt-10 -85.52 -56.4 3.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -1.148 . . . . 0.0 109.728 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.4 m-30 -60.71 -35.2 75.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.318 -0.864 . . . . 0.0 109.445 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.39 -22.9 73.31 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.79 -47.09 14.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -1.165 . . . . 0.0 109.598 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -63.66 -19.77 65.16 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.361 -0.837 . . . . 0.0 109.298 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.64 63.84 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 109.509 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.42 HD11 ' ND1' ' C' ' 58' ' ' HIS . 9.0 mt -70.39 -53.7 15.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.13 -29.37 69.73 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.175 -0.953 . . . . 0.0 109.226 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -70.37 -30.4 67.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.259 -0.901 . . . . 0.0 109.197 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 0.494 ' HB3' ' HE2' ' C' ' 32' ' ' MET . 47.8 ttp -72.81 -52.72 13.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -0.838 . . . . 0.0 109.191 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.36 -31.96 10.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.888 . . . . 0.0 109.293 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.5 mt -78.46 -39.77 37.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.3 -0.875 . . . . 0.0 109.421 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.521 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 15.0 m -51.75 -29.55 19.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' C' ' 35' ' ' SER . 57.3 m-85 -160.89 130.34 3.25 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.273 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -76.24 -19.92 14.93 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.375 2.05 . . . . 0.0 112.203 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.68 ' O ' HG22 ' C' ' 41' ' ' THR . 22.4 p -46.53 -46.01 18.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.705 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -45.46 -22.61 0.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 109.868 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' C' ' 38' ' ' THR . 26.6 ttmt -51.83 -42.42 62.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.954 . . . . 0.0 110.137 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 1.58 HG21 ' CD2' ' B' ' 97' ' ' HIS . 0.7 OUTLIER -75.63 -18.85 59.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 109.789 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.431 ' O ' ' CB ' ' C' ' 43' ' ' PHE . 58.6 t80 -55.87 -5.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.986 . . . . 0.0 109.531 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.467 ' H ' ' C ' ' C' ' 41' ' ' THR . 0.2 OUTLIER 70.43 67.35 0.41 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.92 . . . . 0.0 109.325 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.541 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 54.4 Cg_exo -48.79 -41.89 37.88 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.696 2.264 . . . . 0.0 111.778 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.541 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 4.1 p80 40.5 33.69 0.2 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.765 -0.585 . . . . 0.0 110.4 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' C' ' 46' ' ' PHE . 0.1 OUTLIER -157.77 28.38 0.27 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.117 -0.99 . . . . 0.0 110.077 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' C' ' 49' ' ' SER . 73.9 m-20 43.61 89.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.548 -0.72 . . . . 0.0 110.376 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 1.002 ' H ' HD13 ' C' ' 48' ' ' LEU . 0.0 OUTLIER -60.69 1.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 0.0 109.26 179.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.517 ' H ' ' C ' ' C' ' 47' ' ' ASP . 5.0 m -84.83 157.03 21.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.955 . . . . 0.0 109.734 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.612 ' ND1' ' N ' ' C' ' 51' ' ' GLY . 40.4 t-80 -76.45 170.56 16.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 109.446 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . 0.612 ' N ' ' ND1' ' C' ' 50' ' ' HIS . . . 76.26 -22.08 2.13 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.603 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 4.7 p -55.85 -18.68 9.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -1.105 . . . . 0.0 109.368 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 72.82 -23.3 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.819 . . . . 0.0 109.669 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' C' ' 52' ' ' SER . 24.1 mt-30 -84.76 -17.96 36.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.568 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.519 HG23 ' OG ' ' C' ' 52' ' ' SER . 44.2 t -84.02 -32.62 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 109.639 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' C' ' 56' ' ' LYS . 13.7 ptpt -72.98 -29.39 63.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.166 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.82 -45.0 66.48 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.496 ' ND1' ' C ' ' C' ' 58' ' ' HIS . 6.2 t-80 -60.66 -30.74 70.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.083 -1.245 . . . . 0.0 110.071 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.87 -31.29 79.22 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 59.2 mttp -68.93 -23.02 64.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -1.106 . . . . 0.0 110.213 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.731 ' HG2' ' CAA' ' C' ' 142' ' ' HEC . 0.0 OUTLIER -69.41 -58.17 4.33 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.982 -1.074 . . . . 0.0 108.755 -179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 13.3 t -55.59 -41.47 64.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.605 -0.684 . . . . 0.0 109.578 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.599 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -75.6 -43.81 46.24 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.102 -0.999 . . . . 0.0 109.195 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 35.0 t0 -68.99 -33.84 74.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 108.563 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.639 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -66.94 -49.01 66.83 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -53.05 -47.08 68.71 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 20.1 m -57.06 -56.59 19.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.259 -0.9 . . . . 0.0 108.701 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.535 ' O ' ' CD2' ' C' ' 72' ' ' HIS . 28.5 t30 -58.82 -21.1 55.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 108.57 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.09 -47.42 10.2 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.36 -22.72 27.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.95 -33.32 75.31 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' C' ' 74' ' ' ASP . 5.6 m-70 -115.96 -60.47 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.534 -0.729 . . . . 0.0 109.527 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.556 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.2 p 45.02 12.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.744 0.783 . . . . 0.0 109.583 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' C' ' 72' ' ' HIS . 28.9 m-20 -138.33 11.18 2.78 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -177.36 27.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.696 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 3.0 ptt? -78.54 -23.91 0.42 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.837 . . . . 0.0 111.642 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' C' ' 76' ' ' MET . 53.1 Cg_exo -54.4 -19.72 18.18 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.582 1.521 . . . . 0.0 112.207 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -93.01 -40.75 10.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.178 -0.951 . . . . 0.0 109.435 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.82 -43.45 65.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.261 -0.899 . . . . 0.0 108.948 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -85.29 10.32 12.88 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 7.6 t -51.87 -47.65 64.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.324 -0.86 . . . . 0.0 109.683 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -46.09 -58.15 3.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 109.707 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.46 HD23 ' N ' ' C' ' 83' ' ' LEU . 3.8 mt -45.18 -44.33 10.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 0.0 108.785 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 6.9 p -55.19 -30.03 59.1 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.68 ' O ' ' N ' ' C' ' 89' ' ' HIS . 1.6 m-20 -82.15 -49.53 10.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.198 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.19 -29.95 15.53 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.095 -1.003 . . . . 0.0 109.173 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -92.82 -21.92 19.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.833 . . . . 0.0 110.336 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.72 20.87 5.52 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.076 -1.015 . . . . 0.0 110.398 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' C' ' 85' ' ' ASP . 0.7 OUTLIER -140.57 -78.26 0.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.078 -1.013 . . . . 0.0 109.806 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' C' ' 92' ' ' ARG . 16.9 mttp -67.38 -119.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.843 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.585 ' N ' HD12 ' C' ' 91' ' ' LEU . 10.3 mp -44.5 -19.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 109.802 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' C' ' 90' ' ' LYS . 49.7 ttt180 57.28 45.92 19.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.928 . . . . 0.0 109.304 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.416 ' H ' HG23 ' C' ' 93' ' ' VAL . 4.7 t -48.48 133.21 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 109.599 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' C' ' 96' ' ' VAL . 0.6 OUTLIER -91.55 126.03 55.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.281 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.81 -11.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.268 1.979 . . . . 0.0 112.396 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 1.291 HG11 ' OD2' ' B' ' 99' ' ' ASP . 24.8 t -56.22 -31.89 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.0 109.693 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -79.44 -38.16 35.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.662 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -46.12 -30.25 1.85 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.265 -0.897 . . . . 0.0 109.62 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -63.3 -27.97 69.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.942 . . . . 0.0 109.637 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 11.2 mt -84.22 -34.34 23.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.197 -0.939 . . . . 0.0 109.84 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.707 HD23 ' HAB' ' C' ' 142' ' ' HEC . 5.4 tp -64.22 -61.03 2.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.157 -0.964 . . . . 0.0 109.806 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 24.4 t -47.7 -34.73 8.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 109.836 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.459 ' O ' HG23 ' C' ' 107' ' ' VAL . 12.3 t-80 -80.96 -26.59 36.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.735 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 97.9 m -76.35 -38.1 56.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 109.953 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -52.19 66.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 109.681 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' C' ' 106' ' ' LEU . 36.8 mt -60.14 -32.28 70.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.947 . . . . 0.0 110.006 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 34.3 t -63.72 -59.56 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 109.264 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 41.3 p -54.77 -53.59 53.1 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.229 -0.92 . . . . 0.0 109.224 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' C' ' 114' ' ' PRO . 7.7 mt -45.29 -26.74 0.55 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.459 -0.775 . . . . 0.0 109.299 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -68.44 -39.26 81.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.304 -0.872 . . . . 0.0 110.039 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . 0.657 ' HB2' ' CE2' ' D' ' 122' ' ' PHE . . . -78.94 -3.6 45.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.911 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -134.44 -80.06 0.45 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.232 -0.917 . . . . 0.0 109.713 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -118.41 82.6 19.31 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' C' ' 113' ' ' LEU . 51.3 Cg_exo -49.78 -169.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.402 2.068 . . . . 0.0 112.402 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.822 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -52.85 -55.71 21.1 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.662 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 46.4 mt-10 123.24 -5.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.414 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 7.6 t80 73.21 30.97 1.49 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.803 -0.561 . . . . 0.0 111.033 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.75 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.8 p -104.48 126.26 31.9 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.07 -1.019 . . . . 0.0 108.439 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . 0.657 ' HB3' ' HB3' ' D' ' 51' ' ' PRO . 53.9 Cg_exo -49.74 22.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.407 2.071 . . . . 0.0 112.901 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.75 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -153.37 -32.98 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.777 -1.202 . . . . 0.0 110.553 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.822 HG21 ' O ' ' C' ' 115' ' ' ALA . 9.7 p -52.76 -49.47 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.057 -1.027 . . . . 0.0 110.18 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.645 ' N ' HG13 ' C' ' 121' ' ' VAL . 4.7 t-160 -59.48 -37.5 78.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 0.0 109.176 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.12 -19.43 34.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.411 -0.806 . . . . 0.0 109.498 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.523 ' N ' ' O ' ' C' ' 120' ' ' ALA . 23.1 p -64.12 -62.12 1.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 110.844 -178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.488 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.6 mt -68.49 -19.72 64.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.016 -1.053 . . . . 0.0 109.761 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.67 -46.64 12.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.99 -1.069 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.473 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -80.38 -46.37 16.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.155 -0.966 . . . . 0.0 109.277 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.51 ' CD2' HG21 ' C' ' 10' ' ' VAL . 26.9 t80 -49.88 -21.68 1.24 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.016 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.484 HD22 HBB1 ' C' ' 142' ' ' HEC . 15.3 mt -73.98 -21.82 59.85 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -57.93 -31.76 67.13 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 90.0 p -79.86 -33.65 39.91 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.341 -0.85 . . . . 0.0 108.925 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 42.6 t -82.27 -35.51 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 108.578 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 47.5 t -72.18 -28.61 63.33 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.408 -0.808 . . . . 0.0 109.237 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 32.3 m -66.55 -34.31 77.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.173 -0.954 . . . . 0.0 109.108 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.32 -40.45 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.316 -0.865 . . . . 0.0 109.08 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.7 -27.42 68.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.872 . . . . 0.0 108.945 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 61.7 m -86.2 -26.46 25.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 41.1 m -54.37 136.38 43.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -85.28 -165.33 1.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.867 . . . . 0.0 109.556 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' C' ' 141' ' ' ARG . 89.3 t80 -56.77 -72.99 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.514 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' C' ' 140' ' ' TYR . 92.1 mtt180 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.618 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.569 HG13 ' N ' ' D' ' 2' ' ' HIS . 7.4 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . 0.569 ' N ' HG13 ' D' ' 1' ' ' VAL . 21.3 t-160 -172.74 71.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.51 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -127.92 155.78 43.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.436 -0.79 . . . . 0.0 109.306 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -54.48 152.76 11.45 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 108.878 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.01 -18.63 44.1 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.477 2.118 . . . . 0.0 112.068 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -87.11 -37.92 16.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.914 . . . . 0.0 109.622 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -84.1 -23.15 30.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.836 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -84.12 -55.19 4.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.229 -0.919 . . . . 0.0 109.102 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -48.04 -23.49 0.83 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.09 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.16 -59.64 2.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.891 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 p -63.01 -24.47 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -74.81 -51.9 12.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.698 -0.626 . . . . 0.0 109.65 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.31 -24.92 46.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.662 ' O ' HG23 ' D' ' 18' ' ' VAL . 1.2 mt -59.64 -28.28 67.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.78 -17.04 62.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -0.952 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.25 -63.73 3.15 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.585 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.503 ' HD3' HD23 ' D' ' 14' ' ' LEU . 0.0 OUTLIER -70.77 -11.74 61.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.036 -1.273 . . . . 0.0 110.778 -178.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.662 HG23 ' O ' ' D' ' 14' ' ' LEU . 12.9 t -70.66 121.27 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.856 -1.152 . . . . 0.0 109.343 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.539 HD22 ' N ' ' D' ' 19' ' ' ASN . 0.9 OUTLIER -77.12 73.4 3.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.226 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.525 HG12 ' O ' ' D' ' 20' ' ' VAL . 76.1 t -53.05 -6.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.556 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' D' ' 19' ' ' ASN . 9.8 p30 -67.92 -20.69 65.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.936 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.505 ' N ' ' OD1' ' D' ' 21' ' ' ASP . 9.3 pt-20 -150.27 -32.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.067 -1.02 . . . . 0.0 109.884 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.22 -28.36 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 109.626 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.03 -41.41 99.86 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.06 -55.07 17.89 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . 0.416 ' O ' ' NH1' ' D' ' 30' ' ' ARG . 58.3 mt-10 -49.79 -27.03 4.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -1.155 . . . . 0.0 109.432 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.31 -32.55 22.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 37.3 tp -85.06 -36.35 21.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -0.918 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.63 -40.66 90.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . 0.416 ' NH1' ' O ' ' D' ' 26' ' ' GLU . 0.0 OUTLIER -62.93 -21.7 66.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -1.12 . . . . 0.0 109.467 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tt -70.07 -28.32 65.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.152 -0.968 . . . . 0.0 109.523 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' D' ' 36' ' ' PRO . 27.7 mt -81.32 -53.86 5.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.925 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.505 HG13 ' N ' ' D' ' 34' ' ' VAL . 6.2 p -56.21 -43.18 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.094 -1.003 . . . . 0.0 109.628 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.505 ' N ' HG13 ' D' ' 33' ' ' VAL . 57.8 t -79.56 -22.83 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -153.11 75.5 6.65 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.344 -0.848 . . . . 0.0 109.126 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' D' ' 32' ' ' LEU . 92.6 Cg_endo -83.6 3.69 7.52 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.935 2.423 . . . . 0.0 112.553 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -57.39 -19.87 26.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.485 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . . . . . . . . . 6.0 p -80.0 5.41 14.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 109.414 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -48.17 -22.76 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.593 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpt85 -62.34 -38.84 91.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.366 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' D' ' 42' ' ' PHE . 80.2 m-85 -87.95 27.87 1.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.975 ' CZ ' HBC3 ' D' ' 147' ' ' HEC . 75.1 m-85 -154.8 32.85 0.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.524 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.37 -27.7 52.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 109.538 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 67.5 m -76.34 -29.67 57.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.323 -0.861 . . . . 0.0 109.476 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' D' ' 47' ' ' ASP . 3.8 m-85 -48.7 -22.71 0.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' D' ' 47' ' ' ASP . . . 68.02 -53.11 0.39 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' D' ' 45' ' ' PHE . 51.6 m-20 -60.38 -151.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -1.123 . . . . 0.0 109.485 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 mt 58.73 17.97 5.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.407 -0.808 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 30.4 p -69.46 -28.38 66.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.923 . . . . 0.0 109.309 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . 0.526 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.5 p -145.32 151.24 47.21 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 109.071 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . 0.657 ' HB3' ' HB3' ' C' ' 119' ' ' PRO . 80.8 Cg_exo -38.12 -32.6 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.598 2.199 . . . . 0.0 112.599 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.19 -24.04 40.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.737 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -69.03 -19.45 64.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.671 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . 0.437 ' O ' HG11 ' D' ' 60' ' ' VAL . 18.4 t -65.31 -63.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.618 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 25.5 mtm -95.41 29.43 2.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.12 -58.58 0.66 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -69.36 150.25 97.15 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.224 -1.162 . . . . 0.0 109.608 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.463 ' O ' ' N ' ' D' ' 60' ' ' VAL . 68.4 Cg_endo -75.01 -56.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.639 2.226 . . . . 0.0 112.331 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -18.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' D' ' 58' ' ' PRO . 91.2 t -81.66 -44.98 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.421 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -79.04 -27.12 43.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.9 63.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.75 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.503 ' CE1' ' C4D' ' D' ' 147' ' ' HEC . 59.5 t-80 -72.27 -24.02 61.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.408 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.01 -25.98 74.17 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.99 -42.86 77.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.207 -1.172 . . . . 0.0 109.044 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . 0.496 ' HB3' HMA3 ' D' ' 147' ' ' HEC . 91.9 mttt -64.34 -41.46 96.76 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.589 -0.694 . . . . 0.0 109.561 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.71 HG22 ' C1B' ' D' ' 147' ' ' HEC . 28.7 t -65.19 -62.93 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.288 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.676 ' O ' HD23 ' D' ' 68' ' ' LEU . 2.4 tt -54.35 -40.15 67.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 109.205 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.55 -53.87 38.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.16 -44.38 42.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -1.122 . . . . 0.0 109.54 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.33 -45.82 89.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 98.4 p -61.08 -34.89 75.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.459 -0.776 . . . . 0.0 109.526 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -54.02 -39.66 66.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.14 -60.16 8.4 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.605 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.9 mp -53.75 -30.06 42.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.324 -1.103 . . . . 0.0 109.193 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.13 4.31 45.94 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -170.35 67.45 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.669 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt -78.9 12.73 2.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.246 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.0 -29.76 68.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 24.8 t-20 -164.0 111.29 1.12 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.636 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . 0.563 ' N ' HD12 ' D' ' 81' ' ' LEU . 7.5 mp -80.26 -56.11 4.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . 0.492 ' HZ2' ' CD2' ' D' ' 143' ' ' HIS . 77.2 tttt -62.42 -24.06 67.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . 0.512 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -75.04 -51.06 7.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.7 t -73.43 -46.31 49.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -1.135 . . . . 0.0 109.498 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.538 ' N ' ' CG2' ' D' ' 84' ' ' THR . 54.5 m-85 -84.28 26.11 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.583 -0.698 . . . . 0.0 109.624 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.08 -28.08 67.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 0.0 109.422 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . 0.464 ' O ' ' N ' ' D' ' 91' ' ' LEU . 82.6 p -77.13 -58.17 3.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.646 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.26 -41.57 18.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.927 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 24.9 p -68.67 -37.67 79.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.527 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -82.73 -28.15 30.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 0.0 109.378 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' D' ' 87' ' ' THR . 10.3 tt -75.58 -68.97 0.51 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.234 -0.917 . . . . 0.0 109.238 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.583 ' O ' ' N ' ' D' ' 97' ' ' HIS . 71.0 m80 -50.08 -23.87 2.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.757 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 38.8 t -83.94 -56.21 3.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 111.03 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.538 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 73.3 m-20 -86.21 -24.6 26.02 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.074 -1.016 . . . . 0.0 111.749 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' D' ' 95' ' ' LYS . 10.7 mptt -94.21 -51.63 4.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.638 -1.289 . . . . 0.0 110.742 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.96 -27.73 13.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 0.0 109.907 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 1.615 ' CD2' HG21 ' A' ' 41' ' ' THR . 21.4 m-70 57.77 53.67 6.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.33 124.26 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.134 -0.979 . . . . 0.0 109.261 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . 1.265 ' CG ' HG11 ' A' ' 96' ' ' VAL . 68.7 m-20 -47.93 149.29 2.44 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.123 -0.986 . . . . 0.0 109.426 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.3 62.91 5.29 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.532 2.155 . . . . 0.0 112.082 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -172.05 73.84 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.918 . . . . 0.0 109.517 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.85 -27.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.867 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' D' ' 103' ' ' PHE . 0.1 OUTLIER -56.38 -20.37 19.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.094 -1.004 . . . . 0.0 109.633 -179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -86.28 -41.04 14.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.056 -1.028 . . . . 0.0 109.36 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 tp -48.99 -40.14 29.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.386 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.563 HD13 ' CAB' ' D' ' 147' ' ' HEC . 5.7 tt -69.35 -47.56 63.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.295 -0.878 . . . . 0.0 109.315 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.39 -19.98 54.28 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -81.79 -55.82 4.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -1.196 . . . . 0.0 110.01 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.96 -24.09 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.032 -1.042 . . . . 0.0 109.682 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . 0.482 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.6 tt -61.62 -57.97 9.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.093 -1.004 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . 0.408 HG22 ' CE1' ' D' ' 130' ' ' TYR . 70.0 t -46.67 -26.06 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.772 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 8.9 t -65.45 -32.65 74.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.112 -0.993 . . . . 0.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.51 -31.56 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.534 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 12.4 mt -75.04 -29.5 60.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.504 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.42 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -74.93 -32.29 61.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.202 -0.937 . . . . 0.0 109.483 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.476 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.89 -56.99 3.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 0.0 109.359 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . 0.409 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 13.7 m170 -56.81 -17.73 10.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 109.569 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.409 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 72.2 m-85 -154.54 60.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 109.64 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -71.04 -26.22 74.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . 0.494 ' N ' ' CD ' ' D' ' 120' ' ' LYS . 11.9 mptt -70.03 9.95 0.49 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -1.102 . . . . 0.0 109.343 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' D' ' 119' ' ' GLY . 68.8 mm-40 -136.71 2.54 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.39 -0.819 . . . . 0.0 109.45 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.657 ' CE2' ' HB2' ' C' ' 111' ' ' ALA . 0.1 OUTLIER -72.94 39.05 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.56 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.563 ' C ' HE22 ' D' ' 127' ' ' GLN . 0.8 OUTLIER -52.42 149.06 10.98 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.289 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.507 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -47.72 -52.38 8.19 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.449 2.099 . . . . 0.0 113.229 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 36.0 Cg_endo -65.27 -3.92 8.31 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.11 1.873 . . . . 0.0 112.7 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.462 HG23 ' OG1' ' D' ' 123' ' ' THR . 55.7 t -96.85 -22.04 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.05 -1.032 . . . . 0.0 109.699 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . 0.563 HE22 ' C ' ' D' ' 123' ' ' THR . 1.8 mp0 -83.27 -60.0 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 0.0 109.687 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -53.93 -35.11 61.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.418 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.9 26.46 0.99 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.679 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.408 ' CE1' HG22 ' D' ' 111' ' ' VAL . 32.9 t80 -118.8 -61.37 1.66 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.366 -0.834 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 28.1 mt-30 -52.83 -23.46 7.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.625 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -71.49 -39.2 71.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.747 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 74.6 t -62.71 -55.77 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.088 -1.008 . . . . 0.0 109.816 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' D' ' 137' ' ' VAL . 11.4 m -69.75 -28.56 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -0.853 . . . . 0.0 110.036 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -47.55 -25.96 1.29 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.99 -1.069 . . . . 0.0 109.383 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.78 -24.52 58.07 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' D' ' 134' ' ' VAL . 75.4 t -79.36 -37.65 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -1.126 . . . . 0.0 109.343 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.78 79.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.492 HD21 HD21 ' B' ' 139' ' ' ASN . 65.0 t30 -72.05 -44.08 63.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.417 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.24 -40.94 49.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.339 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 37.1 mt -81.95 12.9 3.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.272 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' D' ' 103' ' ' PHE . . . -139.91 1.63 1.88 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.284 -0.885 . . . . 0.0 109.711 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . 0.492 ' CD2' ' HZ2' ' D' ' 82' ' ' LYS . 10.4 t60 -79.32 -34.09 42.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.512 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 5.0 tptp -67.42 -25.5 65.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.381 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -63.99 -14.16 51.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.92 . . . . 0.0 109.529 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.526 ' OXT' ' CG ' ' D' ' 146' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.551 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.945 HBB3 HMB1 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 0.979 HBC3 ' CZ ' ' B' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.986 HBB3 HMB1 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 0.975 HBC3 ' CZ ' ' D' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.498 ' CG1' ' OG ' ' A' ' 131' ' ' SER . 96.6 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.337 0.589 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp 59.06 163.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.359 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 174.77 -44.77 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.92 . . . . 0.0 110.033 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 3' ' ' SER . 52.9 Cg_exo -53.7 172.85 0.22 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.691 2.261 . . . . 0.0 113.105 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.598 ' O ' ' N ' ' A' ' 7' ' ' LYS . . . -46.9 -14.6 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.609 -0.682 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 4' ' ' PRO . 3.0 p30 -38.59 -22.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.445 -0.785 . . . . 0.0 110.121 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 5' ' ' ALA . 38.0 mttt -80.42 -56.78 3.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.115 -0.991 . . . . 0.0 109.407 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.9 m -46.82 -28.65 1.62 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.511 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -78.35 -38.07 42.89 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.439 HG21 ' CD2' ' A' ' 128' ' ' PHE . 25.4 t -71.61 -49.28 47.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -50.99 -44.23 60.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.21 -61.21 2.77 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.97 -35.38 69.09 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -0.756 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -77.01 -17.16 59.03 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.204 -0.935 . . . . 0.0 108.888 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.57 -38.23 44.45 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -84.46 -35.21 23.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.402 -1.058 . . . . 0.0 109.495 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 21' ' ' ALA . 42.6 t -73.64 -36.91 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -0.842 . . . . 0.0 109.674 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 19' ' ' ALA . . . -30.58 143.72 0.01 OUTLIER Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . 71.07 -31.96 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -1.043 . . . . 0.0 109.113 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.557 ' H ' ' C ' ' A' ' 18' ' ' GLY . 49.8 m-70 -107.94 17.13 22.78 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 17' ' ' VAL . . . -85.49 -36.05 20.79 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.879 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.3 -14.44 64.14 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -87.99 -56.14 3.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -1.113 . . . . 0.0 109.876 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 1.4 m-30 -58.42 -35.38 71.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.365 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.73 -23.06 64.89 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.38 -49.91 8.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -1.188 . . . . 0.0 109.696 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -56.62 -19.76 17.75 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.83 -21.25 60.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 109.597 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.528 HD11 ' ND1' ' A' ' 58' ' ' HIS . 11.0 mt -82.61 -54.31 5.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -64.43 -34.04 77.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.553 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.502 ' CG ' HH11 ' A' ' 31' ' ' ARG . 0.5 OUTLIER -66.4 -38.57 87.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 109.631 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 32' ' ' MET . 15.1 tmm? -75.13 -31.97 61.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.313 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -54.14 -49.93 68.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.78 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 36' ' ' PHE . 1.3 pp -81.27 -43.61 18.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 m -62.95 4.48 0.17 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.617 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.533 ' CE2' ' OG1' ' A' ' 38' ' ' THR . 2.5 t80 -162.74 93.76 1.2 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.222 -0.923 . . . . 0.0 109.165 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.76 -23.38 6.95 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.495 2.13 . . . . 0.0 112.404 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.533 ' OG1' ' CE2' ' A' ' 36' ' ' PHE . 9.5 p -54.65 -28.57 48.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.132 -0.98 . . . . 0.0 109.283 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 42' ' ' TYR . 8.8 p -89.98 -22.8 21.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 109.547 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -46.12 -31.1 2.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 1.281 HG21 ' CG ' ' D' ' 97' ' ' HIS . 0.6 OUTLIER -77.96 -18.93 55.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 39' ' ' THR . 33.7 t80 -60.38 -22.56 63.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.575 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.6 t80 53.73 83.83 0.22 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.408 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.713 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 76.3 Cg_exo -47.25 -41.2 27.98 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.611 2.207 . . . . 0.0 112.2 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.713 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 97.69 33.79 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 120.589 0.233 . . . . 0.0 111.177 179.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.563 ' CZ ' ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -137.06 35.21 2.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.832 -1.168 . . . . 0.0 109.917 178.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 49' ' ' SER . 14.5 m-20 52.79 91.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 109.53 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.2 mt -60.03 -1.65 0.33 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 47' ' ' ASP . 92.8 p -54.31 126.74 24.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.915 . . . . 0.0 109.463 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -57.25 136.01 56.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.472 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.76 15.41 70.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.597 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.5 t -64.04 -14.56 55.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -1.141 . . . . 0.0 109.457 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 70.88 -18.82 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.622 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 52' ' ' SER . 32.9 mt-30 -85.67 -18.09 34.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 109.376 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.64 -36.12 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -75.92 -33.47 59.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 108.96 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.72 -25.19 74.11 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.528 ' ND1' HD11 ' A' ' 29' ' ' LEU . 6.3 t-80 -71.49 -43.29 66.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -1.117 . . . . 0.0 109.392 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -49.38 -48.17 34.28 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 86.4 mttt -52.71 -22.62 5.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.995 . . . . 0.0 110.005 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.85 -40.91 60.73 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.146 -0.971 . . . . 0.0 108.792 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 63' ' ' ALA . 1.2 t -73.05 -47.28 48.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.535 ' HB1' ' HB1' ' A' ' 21' ' ' ALA . . . -65.88 -32.59 74.19 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 26.1 t0 -71.93 -32.46 67.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.081 -1.012 . . . . 0.0 108.599 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 69' ' ' ALA . . . -68.19 -52.57 32.87 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.01 -41.38 59.75 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.246 -0.909 . . . . 0.0 108.97 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 71' ' ' ALA . 16.3 m -68.26 -57.81 5.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.182 -0.949 . . . . 0.0 108.728 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -59.76 -23.84 63.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 108.758 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.08 -46.93 10.68 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.56 -22.93 27.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -67.75 -36.13 79.97 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.581 ' O ' ' N ' ' A' ' 74' ' ' ASP . 84.8 m-70 -102.78 -65.61 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.491 -0.756 . . . . 0.0 109.465 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 72' ' ' HIS . 12.6 p 44.83 14.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.863 0.839 . . . . 0.0 109.437 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 72' ' ' HIS . 71.0 m-20 -137.18 11.89 3.05 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.404 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 0.3 OUTLIER 172.23 31.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.205 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.686 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 8.1 ptt? -78.32 -22.89 0.4 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.213 -0.929 . . . . 0.0 111.937 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.4 Cg_exo -53.27 -22.4 20.15 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.558 1.506 . . . . 0.0 112.335 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -92.98 -40.52 10.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.05 84.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 109.175 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.6 mt -83.93 9.48 12.11 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.451 -0.781 . . . . 0.0 108.918 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -58.43 -50.39 73.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 0.0 109.53 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 83' ' ' LEU . . . -50.11 -58.52 5.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 0.0 109.579 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.528 HD22 HBA1 ' A' ' 142' ' ' HEC . 4.5 mt -46.02 -46.2 16.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.855 . . . . 0.0 108.894 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 5.7 p -64.89 -32.11 73.67 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.541 -0.724 . . . . 0.0 109.404 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -75.5 -23.84 56.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.849 HD21 HBD2 ' A' ' 142' ' ' HEC . 5.7 tt -82.99 -34.16 26.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 0.0 109.518 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.537 ' NE2' ' ND ' ' A' ' 142' ' ' HEC . 47.1 m80 -92.14 -21.88 20.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.927 . . . . 0.0 109.524 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -69.34 -84.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.732 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -78.54 -70.42 0.49 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.85 . . . . 0.0 109.918 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.593 ' C ' ' H ' ' A' ' 92' ' ' ARG . 25.5 ttmt -46.31 137.97 5.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.988 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 93' ' ' VAL . 15.1 mt 66.19 -20.43 0.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.652 -0.655 . . . . 0.0 109.754 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.375 ' NH2' HBD2 ' D' ' 147' ' ' HEC . 65.5 mtt180 38.9 27.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.41 -0.806 . . . . 0.0 109.685 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.565 ' CG2' ' ND2' ' A' ' 97' ' ' ASN . 7.5 p -45.45 141.19 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.872 . . . . 0.0 109.669 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.3 149.55 86.89 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 109.376 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 97' ' ' ASN . 59.8 Cg_endo -73.56 -22.25 18.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.526 2.151 . . . . 0.0 112.271 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 96' ' ' VAL . 21.9 t -56.5 -3.63 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 109.609 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.565 ' ND2' ' CG2' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -79.36 -41.93 26.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.948 . . . . 0.0 109.928 -179.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -51.25 -48.73 62.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 109.433 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -48.28 -30.61 4.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.487 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 18.7 mt -84.24 -62.03 1.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.608 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.467 HD23 ' HAB' ' A' ' 142' ' ' HEC . 4.9 tp -49.89 -20.94 1.0 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 0.0 109.728 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 t -69.34 -59.11 3.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.454 ' ND1' ' OD1' ' B' ' 108' ' ' ASN . 32.1 m170 -68.43 -26.61 65.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.882 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 50.4 m -62.93 -45.48 92.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 109.927 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.97 -55.39 33.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.95 . . . . 0.0 109.429 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 4.1 mm? -47.83 -29.15 3.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.613 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.5 t -83.41 -24.63 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.409 ' OG1' HD23 ' A' ' 109' ' ' LEU . 27.9 p -71.46 -63.39 1.13 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.986 -1.071 . . . . 0.0 110.345 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -64.67 -26.22 68.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 109.636 -179.511 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 106' ' ' LEU . . . -49.4 -37.39 25.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.103 -0.998 . . . . 0.0 109.689 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.16 -56.24 4.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 110.07 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -71.38 -67.58 0.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.808 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.62 HD13 ' C ' ' A' ' 113' ' ' LEU . 2.1 tm? -110.7 98.52 37.86 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 66.6 Cg_exo -49.17 -170.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.277 1.984 . . . . 0.0 112.296 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.652 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -73.04 -55.33 6.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 108.827 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.652 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 18.3 mt-10 118.69 -8.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 5.3 t80 77.14 33.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.881 -0.512 . . . . 0.0 111.146 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.4 OUTLIER -101.62 116.0 64.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.04 20.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.982 1.788 . . . . 0.0 112.468 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -144.83 -29.47 0.46 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.159 -0.963 . . . . 0.0 110.431 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.668 HG13 ' N ' ' A' ' 122' ' ' HIS . 10.6 p -49.34 -50.77 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.139 -0.975 . . . . 0.0 109.967 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.668 ' N ' HG13 ' A' ' 121' ' ' VAL . 3.0 m80 -60.87 -34.67 74.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.121 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.18 -20.19 32.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.386 -0.821 . . . . 0.0 109.707 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.3 m -64.84 -62.12 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.541 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.88 -19.8 62.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.145 -0.972 . . . . 0.0 109.972 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.43 -44.47 19.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.033 . . . . 0.0 110.114 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.411 ' CD ' ' C ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -89.04 -41.49 12.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.985 -1.072 . . . . 0.0 109.954 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 10' ' ' VAL . 41.4 t80 -50.48 -20.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.878 -1.138 . . . . 0.0 108.907 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.596 ' O ' ' N ' ' A' ' 133' ' ' SER . 18.1 mt -71.42 -17.67 62.38 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.04 -31.69 71.32 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.498 ' OG ' ' CG1' ' A' ' 1' ' ' VAL . 4.0 t -83.53 -33.08 25.56 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.379 -0.826 . . . . 0.0 108.911 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.4 t -85.17 -26.63 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 108.907 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.596 ' N ' ' O ' ' A' ' 129' ' ' LEU . 33.0 t -84.02 -25.52 29.85 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.323 -0.861 . . . . 0.0 108.873 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.5 m -77.62 -39.06 46.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.15 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 131' ' ' SER . 34.7 m -73.18 -27.04 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.262 -0.898 . . . . 0.0 108.69 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -29.98 70.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 137' ' ' THR . 93.5 m -112.52 24.02 12.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.409 -0.807 . . . . 0.0 109.437 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.6 t -46.91 -65.41 0.57 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.666 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.494 ' NZ ' ' CB ' ' A' ' 139' ' ' LYS . 8.4 mtmp? 52.38 -106.16 0.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.907 . . . . 0.0 109.525 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -150.81 -55.53 0.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.399 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.419 -179.979 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.586 HG13 ' O ' ' B' ' 1' ' ' VAL . 8.1 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 49.62 42.11 22.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.087 -1.008 . . . . 0.0 109.332 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.988 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -92.04 155.58 18.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 0.0 109.328 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.14 153.9 84.03 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.013 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.02 -15.91 36.09 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.655 2.237 . . . . 0.0 112.313 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -85.28 -42.75 14.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.71 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.16 -22.56 30.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.917 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.603 ' HB2' HD13 ' B' ' 3' ' ' LEU . 7.7 tttm -79.23 -40.41 30.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.184 -0.947 . . . . 0.0 109.315 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 9.0 t -61.63 -23.64 66.18 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.815 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.11 -55.49 4.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 110.121 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.17 -24.72 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.078 -1.014 . . . . 0.0 108.414 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 50.9 m -82.21 -37.03 26.65 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.385 0.612 . . . . 0.0 109.617 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.75 -44.46 96.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.528 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 17' ' ' LYS . 0.8 OUTLIER -61.82 -35.1 77.24 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.471 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 7.1 t-105 -48.07 -21.52 0.48 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 109.046 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' B' ' 14' ' ' LEU . . . -86.5 -32.63 15.5 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' B' ' 14' ' ' LEU . 1.0 OUTLIER -78.02 -31.42 50.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -1.151 . . . . 0.0 109.087 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' B' ' 20' ' ' VAL . 69.7 t -54.09 114.88 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.551 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' B' ' 21' ' ' ASP . 3.1 m120 -71.41 64.06 0.4 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 109.168 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' B' ' 18' ' ' VAL . 42.1 t -45.68 -16.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.516 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' B' ' 19' ' ' ASN . 21.8 t70 -77.1 5.46 8.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.454 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -154.17 -43.84 0.09 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -0.87 . . . . 0.0 109.467 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -55.16 -24.9 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.507 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.41 -42.52 93.8 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.72 -35.92 54.18 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -73.44 -36.49 65.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 109.376 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.45 -52.94 62.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.47 -51.57 66.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -0.88 . . . . 0.0 109.2 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.75 -40.65 95.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' B' ' 33' ' ' VAL . 16.7 mmt85 -58.13 -44.36 87.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -1.13 . . . . 0.0 109.524 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 35' ' ' TYR . 34.0 tp -46.83 -32.53 3.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.319 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 mt -81.18 -21.84 39.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' B' ' 30' ' ' ARG . 21.2 t -87.12 -64.29 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.926 . . . . 0.0 109.549 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.432 ' H ' HG23 ' B' ' 34' ' ' VAL . 0.2 OUTLIER -60.05 -49.57 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.874 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.417 ' O ' ' O ' ' B' ' 31' ' ' LEU . 0.1 OUTLIER -118.53 85.68 27.03 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.365 -0.834 . . . . 0.0 109.45 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -84.26 34.47 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.702 2.268 . . . . 0.0 112.315 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.542 ' NE1' HG23 ' B' ' 38' ' ' THR . 1.9 p-90 -81.04 -29.74 34.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.13 -0.981 . . . . 0.0 109.602 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.542 HG23 ' NE1' ' B' ' 37' ' ' TRP . 65.1 p -60.62 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.433 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 48.95 45.2 22.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.471 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.507 ' HA ' ' NH1' ' C' ' 92' ' ' ARG . 19.2 ptt180 -137.82 -39.18 0.56 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.249 -0.907 . . . . 0.0 109.367 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . 0.598 ' CE2' HMD1 ' B' ' 147' ' ' HEC . 38.0 t80 -100.41 -25.47 14.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 1.209 ' CZ ' ' CBC' ' B' ' 147' ' ' HEC . 62.8 m-85 -74.48 6.11 4.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.424 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.14 -23.28 51.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 20.3 p -59.62 -40.31 87.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 109.507 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -51.63 -17.61 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 109.511 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.69 55.12 11.65 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -159.55 79.33 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -1.162 . . . . 0.0 109.394 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 36.6 mt -131.56 14.63 4.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 109.421 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.8 m -46.91 -41.75 16.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.221 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 5.9 p -146.64 148.68 34.41 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.438 -0.789 . . . . 0.0 108.896 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -41.07 -39.52 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.37 2.047 . . . . 0.0 112.292 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.403 ' C ' ' N ' ' B' ' 54' ' ' VAL . 1.0 OUTLIER -67.04 -40.43 87.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 109.643 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.14 -19.84 0.31 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.385 -0.822 . . . . 0.0 109.552 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.403 ' N ' ' C ' ' B' ' 52' ' ' ASP . 83.5 t -67.56 -64.01 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 10.4 mtt -86.12 -6.1 59.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 109.601 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.13 -35.6 88.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -81.24 148.36 63.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.205 -1.173 . . . . 0.0 109.418 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.13 -51.7 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.548 2.165 . . . . 0.0 112.287 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.3 -39.4 14.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 109.758 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.68 -45.47 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.435 ' HB3' ' HZ2' ' B' ' 61' ' ' LYS . 13.4 mtpp -75.17 -24.84 57.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 0.0 109.34 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.43 -43.05 70.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.574 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.831 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 55.2 t60 -64.1 -23.9 67.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.685 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.29 75.84 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.5 ' NZ ' ' OD1' ' B' ' 21' ' ' ASP . 19.3 mtpt -67.13 -25.02 65.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -1.15 . . . . 0.0 109.619 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . 0.473 ' O ' HMA3 ' B' ' 147' ' ' HEC . 66.8 mttm -72.02 -28.75 63.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.583 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 1.036 HG13 ' C2B' ' B' ' 147' ' ' HEC . 41.6 t -80.11 -48.79 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.667 ' O ' HD23 ' B' ' 68' ' ' LEU . 1.3 tt -60.54 -16.92 42.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.0 109.31 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.14 -48.64 45.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.51 90.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -1.157 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -47.31 -41.2 18.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.167 -0.958 . . . . 0.0 109.559 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 14.0 m -49.42 -44.3 45.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 109.48 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -67.78 -16.72 64.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.06 -26.54 69.25 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.722 ' H ' HD23 ' B' ' 75' ' ' LEU . 2.0 pt? -136.08 -18.6 1.55 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.236 -1.155 . . . . 0.0 110.153 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -82.24 1.44 36.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.061 -1.024 . . . . 0.0 109.731 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 59.4 m-70 -163.06 67.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.0 109.549 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.09 4.85 3.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.49 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.02 -37.21 79.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.487 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 14.1 t-20 -171.45 99.43 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.492 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.04 -57.25 3.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.536 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -47.12 -24.02 0.6 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.558 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -66.43 -54.91 20.58 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.551 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.8 t -75.5 -47.32 27.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 0.0 109.488 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.551 ' N ' ' CG2' ' B' ' 84' ' ' THR . 53.3 m-85 -62.73 -1.18 0.78 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.5 -0.75 . . . . 0.0 109.381 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -59.22 -35.85 74.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.89 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.453 ' O ' ' N ' ' B' ' 91' ' ' LEU . 21.5 p -83.28 -47.96 10.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.932 . . . . 0.0 109.531 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' B' ' 85' ' ' PHE . 40.5 mt -55.42 -43.12 75.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -67.41 -51.3 53.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.53 -22.41 64.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.868 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.672 ' C ' HD23 ' B' ' 91' ' ' LEU . 7.6 tt -81.42 -60.11 2.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.77 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.584 ' N ' HD23 ' B' ' 91' ' ' LEU . 66.5 m80 -61.78 -22.42 65.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.288 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' B' ' 97' ' ' HIS . 39.4 t -83.1 -60.58 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 110.729 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.538 ' O ' ' CE1' ' B' ' 97' ' ' HIS . 5.1 m-20 -87.23 -27.74 22.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.137 -0.977 . . . . 0.0 111.149 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.2 OUTLIER -87.68 -16.68 33.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.889 -1.132 . . . . 0.0 110.646 -178.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.498 ' C ' ' ND1' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -138.37 -39.26 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.942 -1.099 . . . . 0.0 109.929 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 1.257 ' CG ' HG21 ' C' ' 41' ' ' THR . 4.9 m80 64.87 58.78 0.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.101 -1.0 . . . . 0.0 109.754 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.7 132.63 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.081 -1.012 . . . . 0.0 109.335 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.44 152.55 2.22 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.948 . . . . 0.0 109.359 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.04 -29.84 17.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.66 2.24 . . . . 0.0 112.187 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.33 53.68 0.53 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.436 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.768 ' OD1' ' CMC' ' B' ' 147' ' ' HEC . 31.4 t-20 -149.35 -38.95 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.586 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.69 -29.78 70.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.545 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.402 ' NH1' ' CB ' ' B' ' 104' ' ' ARG . 31.4 mtm105 -77.82 -20.03 53.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.149 -0.969 . . . . 0.0 109.678 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.73 -50.04 9.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 1.076 HD13 ' CHC' ' B' ' 147' ' ' HEC . 6.0 tt -52.04 -49.04 64.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.39 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.5 -20.39 63.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . 0.454 ' OD1' ' ND1' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -81.76 -19.43 41.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -1.135 . . . . 0.0 109.658 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 92.6 t -86.36 -53.01 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.242 -0.911 . . . . 0.0 109.675 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.512 HD23 ' C ' ' B' ' 110' ' ' LEU . 2.8 tt -45.98 -60.2 2.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.336 -0.853 . . . . 0.0 109.717 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 61.5 t -46.68 -33.21 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.934 . . . . 0.0 109.748 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.21 -23.94 43.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.657 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' B' ' 110' ' ' LEU . 98.2 t -75.0 -21.34 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.569 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.523 ' CD1' ' CZ ' ' B' ' 130' ' ' TYR . 21.5 mt -79.06 -48.59 14.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 109.49 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.27 -23.1 3.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.498 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 6.5 t-80 -83.81 -57.75 3.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.59 ' N ' ' HD1' ' B' ' 117' ' ' HIS . 0.3 OUTLIER -72.4 -17.78 61.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.524 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' B' ' 114' ' ' LEU . 95.1 m-85 -141.64 56.53 1.51 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -73.16 -24.94 74.61 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.2 9.32 1.02 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -1.132 . . . . 0.0 109.624 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' B' ' 119' ' ' GLY . 59.1 mm-40 -142.68 8.78 1.75 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.541 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -78.68 34.19 0.22 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.146 -0.971 . . . . 0.0 109.442 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.481 ' OG1' HG23 ' B' ' 126' ' ' VAL . 69.2 p -48.67 148.47 3.62 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.265 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.513 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.4 Cg_exo -44.09 -55.82 2.88 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.544 2.163 . . . . 0.0 112.983 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 12.4 Cg_endo -56.22 -23.23 44.29 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.188 1.925 . . . . 0.0 112.22 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.481 HG23 ' OG1' ' B' ' 123' ' ' THR . 76.5 t -82.87 -23.31 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 109.559 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -83.18 -59.67 2.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.25 -36.85 14.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.903 . . . . 0.0 109.842 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.6 -5.22 56.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.131 -0.98 . . . . 0.0 110.065 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.523 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 0.1 OUTLIER -92.58 -40.72 10.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.006 . . . . 0.0 109.47 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -83.97 -23.05 31.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.231 -0.918 . . . . 0.0 109.633 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -71.14 -42.36 69.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 110.141 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . 0.93 HG13 ' H ' ' B' ' 134' ' ' VAL . 6.3 p -71.96 -66.85 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.112 -0.992 . . . . 0.0 110.327 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.93 ' H ' HG13 ' B' ' 133' ' ' VAL . 33.1 m -43.32 -19.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.949 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' B' ' 133' ' ' VAL . . . -59.55 -28.11 66.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.267 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.85 -30.85 58.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.41 -36.31 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -1.156 . . . . 0.0 109.451 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.42 -40.11 89.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.91 HD21 HD21 ' D' ' 139' ' ' ASN . 53.7 t30 -75.88 -25.98 56.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.67 -48.98 74.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.2 -4.24 28.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.934 . . . . 0.0 109.393 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' B' ' 145' ' ' TYR . . . -102.36 -39.51 7.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 0.0 109.545 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -45.32 -40.26 7.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 109.784 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.26 27.33 1.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.113 -0.992 . . . . 0.0 109.559 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.576 ' O ' ' CG ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -140.43 1.27 1.75 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.515 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.461 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.499 ' CG1' ' OG ' ' C' ' 131' ' ' SER . 97.6 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp 58.91 163.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.571 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 174.82 -44.9 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 110.005 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' C' ' 3' ' ' SER . 52.9 Cg_exo -53.55 172.86 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.702 2.268 . . . . 0.0 113.14 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' C' ' 7' ' ' LYS . . . -47.02 -14.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.637 -0.664 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' C' ' 4' ' ' PRO . 3.0 p30 -38.68 -22.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.391 -0.818 . . . . 0.0 110.146 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' C' ' 5' ' ' ALA . 37.9 mttt -80.51 -56.77 3.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.109 -0.994 . . . . 0.0 109.378 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 54.5 m -46.82 -28.62 1.61 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.349 -0.844 . . . . 0.0 109.504 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -78.42 -38.07 42.29 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.448 HG21 ' CD2' ' C' ' 128' ' ' PHE . 25.4 t -71.58 -49.16 48.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -51.15 -44.16 61.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 108.621 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.22 -61.13 2.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.458 -0.776 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.09 -35.33 69.27 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.41 -0.806 . . . . 0.0 109.333 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -77.09 -17.12 58.93 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.188 -0.945 . . . . 0.0 108.877 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.49 -38.41 44.54 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.014 -1.635 . . . . 0.0 109.014 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -84.37 -35.21 23.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.294 -1.121 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.559 HG12 ' HB2' ' C' ' 21' ' ' ALA . 42.6 t -73.58 -36.94 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.813 . . . . 0.0 109.684 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' C' ' 19' ' ' ALA . . . -30.63 143.72 0.01 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' C' ' 18' ' ' GLY . . . 71.09 -31.92 0.24 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.409 -1.053 . . . . 0.0 109.121 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' C' ' 18' ' ' GLY . 49.7 m-70 -107.92 17.2 22.72 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.559 ' HB2' HG12 ' C' ' 17' ' ' VAL . . . -85.63 -35.98 20.63 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.847 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.38 -14.44 64.34 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -87.87 -56.13 3.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.3 -1.118 . . . . 0.0 109.97 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 1.4 m-30 -58.52 -35.33 72.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.374 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.65 -23.02 64.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.42 -49.91 8.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.225 -1.162 . . . . 0.0 109.759 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.53 -19.85 17.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.659 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.75 -21.31 61.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 109.542 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.545 HD11 ' ND1' ' C' ' 58' ' ' HIS . 11.1 mt -82.53 -54.3 5.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.877 . . . . 0.0 109.653 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -33.95 77.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.564 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.508 ' CG ' HH11 ' C' ' 31' ' ' ARG . 0.5 OUTLIER -66.48 -38.55 87.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.647 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 1.238 ' CE ' ' HAB' ' C' ' 142' ' ' HEC . 15.1 tmm? -75.09 -32.0 61.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 109.32 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . 0.64 ' HE1' ' C4D' ' C' ' 142' ' ' HEC . 74.5 t80 -54.11 -49.87 68.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.353 -0.842 . . . . 0.0 109.843 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' C' ' 36' ' ' PHE . 1.3 pp -81.3 -43.71 18.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.165 -0.96 . . . . 0.0 110.024 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . . . . . . . . . 7.3 m -62.92 4.47 0.17 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.07 -1.019 . . . . 0.0 109.582 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.978 ' HB3' ' CMC' ' C' ' 142' ' ' HEC . 2.5 t80 -162.74 93.75 1.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.16 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -79.81 -23.29 6.96 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.496 2.131 . . . . 0.0 112.405 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.53 ' OG1' ' CE2' ' C' ' 36' ' ' PHE . 9.1 p -54.77 -28.49 49.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.0 109.253 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.9 ' HB ' ' CHC' ' C' ' 142' ' ' HEC . 8.6 p -90.12 -22.65 21.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.901 . . . . 0.0 109.515 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.948 ' O ' ' C3D' ' C' ' 142' ' ' HEC . 29.3 ttpt -46.23 -31.13 2.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.576 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 1.257 HG21 ' CG ' ' B' ' 97' ' ' HIS . 0.5 OUTLIER -77.9 -18.96 55.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' C' ' 39' ' ' THR . 33.6 t80 -60.26 -22.67 63.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.641 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.516 ' HA ' ' C1A' ' C' ' 142' ' ' HEC . 49.6 t80 53.69 83.88 0.22 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.388 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.72 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 76.0 Cg_exo -47.33 -41.11 28.6 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.529 2.153 . . . . 0.0 112.202 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 1.239 ' N ' HMA2 ' C' ' 142' ' ' HEC . 0.0 OUTLIER 97.71 33.74 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.267 -0.271 . . . . 0.0 111.174 179.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 1.013 ' CD1' HMA3 ' C' ' 142' ' ' HEC . 0.1 OUTLIER -137.07 35.09 2.57 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.83 -1.169 . . . . 0.0 109.924 178.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' C' ' 49' ' ' SER . 14.4 m-20 52.97 91.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 1.535 HD11 ' CHA' ' C' ' 142' ' ' HEC . 11.3 mt -60.1 -1.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.39 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.468 ' H ' ' C ' ' C' ' 47' ' ' ASP . 92.4 p -54.38 126.81 24.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -57.29 136.03 56.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.47 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.79 15.41 70.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 4.4 t -64.08 -14.46 54.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -1.164 . . . . 0.0 109.468 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 70.82 -18.86 0.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.833 . . . . 0.0 109.659 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' C' ' 52' ' ' SER . 32.9 mt-30 -85.69 -18.11 34.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.08 -1.012 . . . . 0.0 109.367 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.65 -36.01 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -76.04 -33.51 59.62 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.257 -0.902 . . . . 0.0 108.895 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.66 -25.17 74.04 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.545 ' ND1' HD11 ' C' ' 29' ' ' LEU . 6.3 t-80 -71.46 -43.26 66.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -1.151 . . . . 0.0 109.417 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -49.5 -48.1 35.29 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 86.5 mttt -52.79 -22.51 5.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.497 -1.002 . . . . 0.0 109.965 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -40.91 60.66 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.158 -0.964 . . . . 0.0 108.772 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.48 HG12 ' N ' ' C' ' 63' ' ' ALA . 1.2 t -73.04 -47.24 48.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.521 ' HB1' ' HB1' ' C' ' 21' ' ' ALA . . . -65.86 -32.6 74.21 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.442 -0.786 . . . . 0.0 109.152 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 26.4 t0 -71.88 -32.46 67.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.045 . . . . 0.0 108.61 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' C' ' 69' ' ' ALA . . . -68.22 -52.47 33.74 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mt -51.06 -41.36 59.86 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 108.926 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.433 ' O ' ' N ' ' C' ' 71' ' ' ALA . 16.3 m -68.27 -57.82 5.37 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.186 -0.947 . . . . 0.0 108.739 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -59.81 -23.79 63.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 108.701 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.11 -46.92 10.68 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.53 -22.93 27.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -67.71 -36.18 80.15 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' C' ' 74' ' ' ASP . 84.9 m-70 -102.79 -65.5 0.99 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -0.768 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.558 HG12 ' O ' ' C' ' 72' ' ' HIS . 12.6 p 44.8 14.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.791 0.805 . . . . 0.0 109.39 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' C' ' 72' ' ' HIS . 71.2 m-20 -137.12 11.93 3.06 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.415 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 0.3 OUTLIER 172.22 31.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.153 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 8.2 ptt? -78.32 -22.82 0.4 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 111.987 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.6 Cg_exo -53.24 -22.47 20.16 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.556 1.504 . . . . 0.0 112.361 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -92.95 -40.44 10.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.483 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.11 83.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.9 . . . . 0.0 109.137 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 28.9 mt -83.79 9.34 12.13 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 108.932 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -58.27 -50.52 73.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.575 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' C' ' 83' ' ' LEU . . . -50.04 -58.57 5.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.569 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.418 HD23 ' N ' ' C' ' 83' ' ' LEU . 4.5 mt -46.07 -46.15 16.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 5.8 p -64.94 -32.11 73.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.535 -0.728 . . . . 0.0 109.391 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' C' ' 82' ' ' ALA . 31.9 t70 -75.43 -23.85 57.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 tt -83.01 -34.25 26.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.858 . . . . 0.0 109.458 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -91.97 -21.97 20.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -69.32 -84.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.713 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -78.45 -70.51 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.893 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' C' ' 92' ' ' ARG . 25.5 ttmt -46.3 137.99 5.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 110.013 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' C' ' 93' ' ' VAL . 15.1 mt 66.23 -20.41 0.1 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.711 -0.618 . . . . 0.0 109.759 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . 0.592 ' H ' ' C ' ' C' ' 90' ' ' LYS . 65.3 mtt180 38.8 27.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.539 -0.726 . . . . 0.0 109.676 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.576 ' CG2' ' ND2' ' C' ' 97' ' ' ASN . 7.5 p -45.47 141.2 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.828 . . . . 0.0 109.681 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -74.31 149.51 86.86 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.894 . . . . 0.0 109.371 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' C' ' 97' ' ' ASN . 59.5 Cg_endo -73.61 -22.2 18.39 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.435 2.09 . . . . 0.0 112.204 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.42 HG12 ' O ' ' C' ' 96' ' ' VAL . 21.9 t -56.56 -3.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.576 ' ND2' ' CG2' ' C' ' 93' ' ' VAL . 0.7 OUTLIER -79.24 -41.92 27.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 109.998 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -51.29 -48.7 62.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 0.0 109.41 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -48.34 -30.57 5.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.176 -0.952 . . . . 0.0 109.434 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.47 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 18.6 mt -84.21 -62.09 1.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 109.622 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tp -49.88 -20.92 0.99 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -0.915 . . . . 0.0 109.725 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 10.2 t -69.29 -59.14 3.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.939 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.463 ' ND1' ' OD1' ' D' ' 108' ' ' ASN . 32.1 m170 -68.42 -26.61 65.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.821 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 50.9 m -63.03 -45.36 92.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.143 -0.973 . . . . 0.0 109.887 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.0 -55.41 33.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.987 . . . . 0.0 109.456 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' C' ' 110' ' ' ALA . 4.1 mm? -47.79 -29.18 2.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.135 -0.978 . . . . 0.0 109.591 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.36 -24.79 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 0.0 110.113 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.407 ' OG1' HD23 ' C' ' 109' ' ' LEU . 28.0 p -71.45 -63.34 1.14 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.026 -1.046 . . . . 0.0 110.352 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.57 HD23 ' H ' ' C' ' 109' ' ' LEU . 0.1 OUTLIER -64.64 -26.29 68.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.056 -1.027 . . . . 0.0 109.636 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' C' ' 106' ' ' LEU . . . -49.35 -37.43 24.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.107 -0.995 . . . . 0.0 109.707 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.18 -56.17 4.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 110.075 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -71.45 -67.51 0.52 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.821 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.615 HD13 ' C ' ' C' ' 113' ' ' LEU . 2.1 tm? -110.68 98.49 37.66 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' C' ' 113' ' ' LEU . 65.7 Cg_exo -49.18 -170.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.269 1.98 . . . . 0.0 112.304 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.654 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -72.99 -55.22 6.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.361 -0.837 . . . . 0.0 108.866 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.654 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 18.3 mt-10 118.58 -8.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.464 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 5.3 t80 77.13 33.74 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.937 -0.477 . . . . 0.0 111.139 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.4 OUTLIER -101.62 116.08 64.02 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.1 20.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.935 1.757 . . . . 0.0 112.482 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -144.81 -29.37 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.038 -1.039 . . . . 0.0 110.423 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.669 HG13 ' N ' ' C' ' 122' ' ' HIS . 10.5 p -49.39 -50.8 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.06 -1.025 . . . . 0.0 109.899 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.669 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.9 m80 -60.81 -34.76 75.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.119 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.18 -20.06 33.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.765 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.522 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.4 m -64.93 -62.08 1.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 110.518 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mt -70.94 -19.69 62.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.187 -0.945 . . . . 0.0 109.949 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.48 -44.52 19.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.068 -1.02 . . . . 0.0 110.109 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.413 ' CD ' ' C ' ' C' ' 127' ' ' LYS . 0.0 OUTLIER -89.07 -41.37 12.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.004 -1.06 . . . . 0.0 109.977 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.448 ' CD2' HG21 ' C' ' 10' ' ' VAL . 41.7 t80 -50.52 -20.91 1.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.99 -1.069 . . . . 0.0 108.899 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' C' ' 133' ' ' SER . 18.2 mt -71.42 -17.66 62.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.411 ' O ' ' OG1' ' C' ' 134' ' ' THR . . . -61.0 -31.6 71.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.499 ' OG ' ' CG1' ' C' ' 1' ' ' VAL . 4.0 t -83.59 -33.05 25.46 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.289 -0.882 . . . . 0.0 108.918 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.18 -26.66 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.0 108.922 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.594 ' N ' ' O ' ' C' ' 129' ' ' LEU . 33.0 t -84.01 -25.45 29.93 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.383 -0.823 . . . . 0.0 108.969 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 33.2 m -77.69 -38.93 46.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 109.189 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.407 HG13 ' O ' ' C' ' 131' ' ' SER . 34.8 m -73.39 -26.85 22.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.3 -0.875 . . . . 0.0 108.677 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.81 -30.03 70.6 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . 0.712 HG22 ' O ' ' C' ' 137' ' ' THR . 93.5 m -112.45 24.07 12.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.413 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 3.6 t -46.91 -65.43 0.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.494 ' NZ ' ' CB ' ' C' ' 139' ' ' LYS . 8.4 mtmp? 52.39 -106.19 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.129 -0.982 . . . . 0.0 109.563 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -150.82 -55.53 0.15 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.972 -1.014 . . . . 0.0 109.415 179.94 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.598 ' H1 ' HG23 ' D' ' 133' ' ' VAL . 8.2 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 49.78 42.04 23.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.288 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.976 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -92.11 155.61 17.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.442 ' H ' HG22 ' D' ' 4' ' ' THR . 0.2 OUTLIER -64.16 153.95 83.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 108.933 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.01 -15.96 36.31 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.616 2.21 . . . . 0.0 112.263 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.3 -42.77 14.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.682 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.17 -22.53 30.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.886 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.604 ' HB2' HD13 ' D' ' 3' ' ' LEU . 7.7 tttm -79.25 -40.5 30.46 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.124 -0.985 . . . . 0.0 109.245 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -61.58 -23.64 66.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 109.821 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.1 -55.43 4.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.065 -1.022 . . . . 0.0 110.144 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.26 -24.62 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.01 -1.056 . . . . 0.0 108.418 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 49.9 m -82.18 -37.14 26.56 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.752 -0.593 . . . . 0.0 109.591 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.5 96.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -0.848 . . . . 0.0 109.456 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' D' ' 17' ' ' LYS . 0.8 OUTLIER -61.81 -35.12 77.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.43 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -47.95 -21.63 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.138 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . 0.414 ' N ' ' C ' ' D' ' 14' ' ' LEU . . . -86.52 -32.52 15.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' D' ' 14' ' ' LEU . 1.0 OUTLIER -77.97 -31.46 50.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -1.123 . . . . 0.0 109.101 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -54.23 114.98 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.535 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' D' ' 21' ' ' ASP . 3.1 m120 -71.45 64.15 0.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.133 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 42.1 t -45.74 -16.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' D' ' 19' ' ' ASN . 21.4 t70 -77.32 5.67 8.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.937 . . . . 0.0 109.312 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' D' ' 19' ' ' ASN . 81.2 mt-10 -154.31 -43.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.352 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 78.7 t -55.03 -25.07 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 109.474 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.43 -42.55 93.74 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.67 -35.88 54.5 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -73.43 -36.52 65.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -1.138 . . . . 0.0 109.399 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.39 -53.05 61.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.179 -0.95 . . . . 0.0 109.417 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.42 -51.55 67.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.271 -0.893 . . . . 0.0 109.271 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.6 -40.77 95.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' D' ' 33' ' ' VAL . 16.6 mmt85 -58.1 -44.38 87.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' D' ' 35' ' ' TYR . 33.6 tp -46.86 -32.44 3.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 109.247 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 mt -81.24 -21.87 39.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.893 . . . . 0.0 109.506 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' D' ' 30' ' ' ARG . 21.2 t -87.13 -64.2 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.417 ' H ' HG23 ' D' ' 34' ' ' VAL . 0.2 OUTLIER -60.16 -49.53 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.219 -0.925 . . . . 0.0 109.841 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' D' ' 31' ' ' LEU . 0.1 OUTLIER -118.48 85.71 26.8 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.282 -0.886 . . . . 0.0 109.425 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . 0.808 ' O ' ' C2C' ' D' ' 147' ' ' HEC . 89.7 Cg_endo -84.18 34.44 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.787 2.324 . . . . 0.0 112.356 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . 0.529 ' NE1' HG23 ' D' ' 38' ' ' THR . 1.9 p-90 -81.09 -29.79 34.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 1.352 ' C ' ' C1C' ' D' ' 147' ' ' HEC . 65.5 p -60.58 -96.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.937 . . . . 0.0 109.325 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . 1.178 ' N ' ' C4B' ' D' ' 147' ' ' HEC . 78.7 mm-40 49.12 45.06 23.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.478 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . 0.595 ' HA ' ' NH1' ' A' ' 92' ' ' ARG . 19.1 ptt180 -137.76 -39.24 0.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.855 . . . . 0.0 109.357 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -100.38 -25.4 14.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.313 -0.867 . . . . 0.0 109.466 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 1.427 ' HB3' ' CMA' ' D' ' 147' ' ' HEC . 61.9 m-85 -74.49 6.04 4.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.467 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.14 -23.19 51.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.554 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 20.4 p -59.61 -40.43 87.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.438 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -51.49 -17.73 0.89 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.77 55.14 11.77 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -159.55 79.19 0.72 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -1.087 . . . . 0.0 109.422 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . 0.73 HD21 HMA3 ' D' ' 147' ' ' HEC . 35.9 mt -131.46 14.57 5.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.427 -0.795 . . . . 0.0 109.383 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 24.4 m -46.85 -41.75 16.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.211 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 6.1 p -146.73 148.67 34.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -41.16 -39.4 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.305 2.003 . . . . 0.0 112.333 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . 0.404 ' C ' ' N ' ' D' ' 54' ' ' VAL . 1.0 OUTLIER -67.04 -40.47 87.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.703 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.14 -19.83 0.31 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.292 -0.88 . . . . 0.0 109.523 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 52' ' ' ASP . 83.2 t -67.52 -64.02 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 109.681 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 10.4 mtt -86.21 -6.12 59.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.527 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.69 87.99 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -81.28 148.35 63.01 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.188 -1.183 . . . . 0.0 109.424 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.14 -51.71 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.559 2.173 . . . . 0.0 112.213 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.3 -39.32 14.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.709 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.79 -45.4 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.118 -0.989 . . . . 0.0 109.289 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -75.25 -24.76 57.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 109.294 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.51 -42.98 70.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.605 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -64.04 -24.02 67.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.709 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.58 -33.24 76.07 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . 0.509 ' NZ ' ' OD1' ' D' ' 21' ' ' ASP . 19.4 mtpt -67.28 -24.87 65.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -1.216 . . . . 0.0 109.642 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -71.95 -28.88 63.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.628 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.1 -48.76 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.655 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.3 tt -60.5 -16.91 41.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 0.0 109.376 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.11 -48.71 45.24 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.89 -46.61 89.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -1.181 . . . . 0.0 109.852 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' D' ' 74' ' ' GLY . 1.1 m-85 -47.25 -41.19 18.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.125 -0.984 . . . . 0.0 109.588 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 14.0 m -49.51 -44.21 46.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.459 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -67.85 -16.65 64.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.221 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' D' ' 71' ' ' PHE . . . -63.01 -26.61 69.27 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.735 ' H ' HD23 ' D' ' 75' ' ' LEU . 2.0 pt? -136.09 -18.54 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.271 -1.134 . . . . 0.0 110.176 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -82.25 1.49 36.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.997 -1.065 . . . . 0.0 109.746 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 59.8 m-70 -163.06 67.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.16 4.89 3.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.411 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.13 -37.14 79.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 14.1 t-20 -171.42 99.39 0.19 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.532 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 26.0 mt -80.18 -57.2 3.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -47.19 -23.98 0.62 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 0.0 109.524 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -66.37 -54.88 20.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.8 t -75.54 -47.45 26.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -1.18 . . . . 0.0 109.384 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.556 ' N ' ' CG2' ' D' ' 84' ' ' THR . 53.4 m-85 -62.53 -1.26 0.76 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.541 -0.724 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -59.2 -35.79 74.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . 0.483 ' O ' ' N ' ' D' ' 91' ' ' LEU . 21.3 p -83.39 -47.93 10.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.432 HD12 ' CD1' ' D' ' 85' ' ' PHE . 40.9 mt -55.53 -43.0 75.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 4.3 m -67.36 -51.41 52.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.437 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -68.38 -22.55 64.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.482 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.672 ' C ' HD23 ' D' ' 91' ' ' LEU . 7.5 tt -81.36 -60.21 2.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.227 -0.921 . . . . 0.0 109.727 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.591 ' N ' HD23 ' D' ' 91' ' ' LEU . 66.5 m80 -61.64 -22.51 65.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.225 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . 0.546 ' O ' ' CD2' ' D' ' 97' ' ' HIS . 39.4 t -83.09 -60.61 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 110.768 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.539 ' O ' ' CE1' ' D' ' 97' ' ' HIS . 5.1 m-20 -87.18 -27.7 22.87 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.122 -0.986 . . . . 0.0 111.098 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.2 OUTLIER -87.71 -16.73 33.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.851 -1.156 . . . . 0.0 110.644 -178.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.501 ' C ' ' ND1' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -138.38 -39.33 0.53 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.963 -1.086 . . . . 0.0 109.831 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 1.281 ' CG ' HG21 ' A' ' 41' ' ' THR . 5.0 m80 64.83 58.81 0.94 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 109.778 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 48.2 t -88.62 132.62 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.1 -1.0 . . . . 0.0 109.363 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.39 152.5 2.2 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.399 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.02 -29.76 17.43 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.536 2.157 . . . . 0.0 112.195 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.45 53.82 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.432 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -149.31 -39.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.575 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -65.58 -29.77 70.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.575 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . 0.411 ' NH1' ' CB ' ' D' ' 104' ' ' ARG . 31.4 mtm105 -77.87 -20.05 53.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.599 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 13.6 mt -82.64 -50.14 9.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.9 tt -51.97 -49.1 63.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.361 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.49 -20.3 63.39 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . 0.463 ' OD1' ' ND1' ' C' ' 103' ' ' HIS . 0.2 OUTLIER -81.86 -19.45 40.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -1.195 . . . . 0.0 109.613 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 92.4 t -86.36 -52.95 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.125 -0.984 . . . . 0.0 109.721 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . 0.504 HD23 ' C ' ' D' ' 110' ' ' LEU . 2.8 tt -45.96 -60.13 2.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 0.0 109.787 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 61.3 t -46.68 -33.26 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.812 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.23 -23.95 43.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' D' ' 110' ' ' LEU . 98.7 t -74.94 -21.34 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.591 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . 0.519 ' CD1' ' CZ ' ' D' ' 130' ' ' TYR . 21.4 mt -78.98 -48.7 14.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 109.494 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.12 -23.31 3.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.443 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.484 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 6.5 t-80 -83.72 -57.81 3.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . 0.6 ' N ' ' HD1' ' D' ' 117' ' ' HIS . 0.3 OUTLIER -72.4 -17.75 61.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 109.511 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' D' ' 114' ' ' LEU . 95.2 m-85 -141.7 56.66 1.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.28 -24.85 74.52 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -72.31 9.46 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -1.098 . . . . 0.0 109.577 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -142.75 8.84 1.73 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.597 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.541 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -78.67 34.15 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.471 ' OG1' HG23 ' D' ' 126' ' ' VAL . 69.6 p -48.59 148.46 3.54 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.206 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.507 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.5 Cg_exo -44.15 -55.76 2.94 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.565 2.177 . . . . 0.0 112.97 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 12.6 Cg_endo -56.21 -23.35 44.85 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.249 1.966 . . . . 0.0 112.208 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.471 HG23 ' OG1' ' D' ' 123' ' ' THR . 75.5 t -82.8 -23.3 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.569 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -83.28 -59.6 2.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.73 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.2 -36.87 14.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.62 -5.11 56.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 0.0 110.042 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.519 ' CZ ' ' CD1' ' D' ' 114' ' ' LEU . 0.1 OUTLIER -92.65 -40.74 10.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.025 -1.047 . . . . 0.0 109.474 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -84.0 -22.99 31.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.685 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -71.11 -42.4 69.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.113 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . 0.965 HG13 ' H ' ' D' ' 134' ' ' VAL . 6.4 p -71.97 -66.82 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.127 -0.983 . . . . 0.0 110.349 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.965 ' H ' HG13 ' D' ' 133' ' ' VAL . 33.1 m -43.43 -19.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 0.0 109.941 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' D' ' 133' ' ' VAL . . . -59.62 -27.97 66.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.384 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -74.9 -30.94 58.66 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 93.0 t -66.31 -36.39 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -1.139 . . . . 0.0 109.418 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.37 -40.17 89.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.91 HD21 HD21 ' B' ' 139' ' ' ASN . 53.7 t30 -75.88 -25.97 56.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.439 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.64 -49.04 74.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.419 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 28.4 mt -72.16 -4.29 28.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.127 -0.983 . . . . 0.0 109.36 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' D' ' 145' ' ' TYR . . . -102.37 -39.42 7.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.417 -0.802 . . . . 0.0 109.515 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -45.39 -40.25 7.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.186 -0.946 . . . . 0.0 109.733 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.406 ' HB2' ' HZ2' ' D' ' 144' ' ' LYS . 0.0 OUTLIER -87.26 27.29 1.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.564 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . 0.57 ' O ' ' CG ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -140.46 1.21 1.74 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.408 ' HB3' ' CB ' ' B' ' 135' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.9 HBB3 HMB1 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 1.209 ' CBC' ' CZ ' ' B' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 1.535 ' CHA' HD11 ' C' ' 48' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 1.427 ' CMA' ' HB3' ' D' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 2' ' ' LEU . 10.8 mp 53.21 176.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.158 -0.963 . . . . 0.0 109.553 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.51 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 174.59 -47.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 110.066 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 6' ' ' ASP . 71.1 Cg_exo -47.24 169.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.571 2.18 . . . . 0.0 112.744 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -45.35 -15.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.407 -0.808 . . . . 0.0 110.123 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' PRO . 25.0 t70 -38.78 -40.49 0.62 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 109.928 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 7' ' ' LYS . 13.5 ptpt -67.97 -45.74 73.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.131 -0.981 . . . . 0.0 109.224 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 5' ' ' ALA . 36.0 m -52.98 -31.1 38.82 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 108.782 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -78.07 -36.06 48.73 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 128' ' ' PHE . 91.2 t -69.74 -49.05 61.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.79 -47.47 64.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -49.2 -60.79 2.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.613 -0.679 . . . . 0.0 109.512 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -50.86 -39.06 52.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.311 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -17.26 61.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.436 -0.79 . . . . 0.0 109.217 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -81.62 -45.68 7.19 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.67 -34.8 72.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -1.162 . . . . 0.0 108.674 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 13' ' ' ALA . 70.4 t -61.97 -66.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 64.55 -143.61 47.22 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 48.37 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.584 -0.951 . . . . 0.0 109.978 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 18' ' ' GLY . 80.7 m-70 -151.81 19.53 0.7 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -82.42 -65.19 1.04 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.715 -0.616 . . . . 0.0 109.794 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.58 -14.77 0.24 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' ALA . 2.1 mm-40 -83.07 -56.46 3.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -1.19 . . . . 0.0 109.726 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.8 m-30 -55.95 -35.3 66.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.852 . . . . 0.0 109.13 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.11 -22.76 60.97 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.58 -38.28 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -1.168 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.73 -19.69 63.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.684 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.44 -22.41 51.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.117 -0.989 . . . . 0.0 109.708 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.42 -43.97 37.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 109.68 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -65.68 -12.82 56.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.2 -0.937 . . . . 0.0 109.695 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -58.98 2.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptm -62.31 -25.61 67.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.476 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 48' ' ' LEU . 1.3 t80 -58.65 -55.99 27.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 0.0 109.653 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -82.41 -42.46 18.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.126 -0.984 . . . . 0.0 110.227 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.527 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 12.6 t -59.65 -9.3 2.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.02 -1.05 . . . . 0.0 109.687 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 1.003 ' CZ ' ' NE2' ' B' ' 131' ' ' GLN . 79.3 m-85 -155.35 81.71 3.99 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.155 -0.966 . . . . 0.0 109.503 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 39' ' ' THR . 52.6 Cg_exo -52.5 -24.92 23.51 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.704 2.269 . . . . 0.0 112.273 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.485 HG22 ' HB2' ' D' ' 97' ' ' HIS . 9.0 p -46.88 -19.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.51 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 37' ' ' PRO . 51.2 p -82.89 -26.2 31.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.656 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 42' ' ' TYR . 26.6 ttpt -79.3 -53.66 6.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.181 -0.95 . . . . 0.0 109.658 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t -46.97 -18.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.563 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.473 ' CG ' ' O ' ' A' ' 42' ' ' TYR . 82.0 t80 -78.8 3.15 17.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 49.24 66.51 5.6 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.417 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 65.8 Cg_endo -76.91 -1.62 11.79 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.679 2.252 . . . . 0.0 112.524 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.569 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 22.4 p80 41.47 24.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.307 -0.871 . . . . 0.0 109.502 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.543 ' O ' ' C ' ' A' ' 47' ' ' ASP . 3.9 t80 -104.38 31.57 4.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.561 -0.712 . . . . 0.0 109.736 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 46' ' ' PHE . 15.0 m-20 28.63 67.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.884 -0.51 . . . . 0.0 110.533 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.528 ' O ' ' CE2' ' A' ' 33' ' ' PHE . 87.3 mt -85.16 22.33 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.428 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 50' ' ' HIS . 19.3 m -76.65 26.67 0.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.358 -0.839 . . . . 0.0 109.418 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.456 ' H ' ' C ' ' A' ' 48' ' ' LEU . 54.6 t60 58.08 158.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 0.0 109.57 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.65 17.92 5.02 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.553 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 9.1 t -80.25 -17.76 51.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -1.111 . . . . 0.0 109.512 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 68.6 -58.52 0.48 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 109.798 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 52' ' ' SER . 0.6 OUTLIER -43.76 -20.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.775 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 53' ' ' ALA . 89.8 t -77.55 -27.17 15.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.136 -0.977 . . . . 0.0 109.28 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.9 ptmt -63.7 -27.2 69.05 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.266 -0.896 . . . . 0.0 109.327 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.84 -27.62 68.81 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -84.17 -30.65 25.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -1.17 . . . . 0.0 110.096 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.01 -49.47 55.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -60.1 -23.64 63.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -1.106 . . . . 0.0 110.082 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' O ' ' CMA' ' A' ' 142' ' ' HEC . 0.3 OUTLIER -73.29 -34.04 65.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.087 -1.008 . . . . 0.0 109.135 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.29 -52.92 21.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.41 -0.806 . . . . 0.0 108.944 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.96 -28.44 69.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.297 -0.877 . . . . 0.0 109.166 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.26 -41.42 81.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.199 -0.938 . . . . 0.0 108.89 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.467 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -68.03 -42.54 80.44 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 66' ' ' LEU . 9.8 mt -63.34 -46.17 87.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -63.24 -48.77 76.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.256 -0.902 . . . . 0.0 108.976 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.42 HD21 ' HB1' ' A' ' 79' ' ' ALA . 1.8 t30 -62.66 -22.56 66.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 108.835 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -85.21 -47.68 9.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -66.84 -22.56 29.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.98 -14.68 62.44 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.676 ' O ' HG12 ' A' ' 73' ' ' VAL . 21.5 m80 -141.87 -57.44 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.808 . . . . 0.0 109.648 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 72' ' ' HIS . 8.2 p 46.14 15.73 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 122.1 0.953 . . . . 0.0 108.76 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 72' ' ' HIS . 22.0 m-20 -136.36 12.41 3.26 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.9 30.39 0.06 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.554 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 1.2 mtm -66.54 -44.82 56.88 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.611 -0.681 . . . . 0.0 110.073 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 76' ' ' MET . 95.7 Cg_exo -42.12 -43.02 7.39 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.356 2.038 . . . . 0.0 112.727 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.23 -19.01 21.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 109.97 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.42 ' HB1' HD21 ' A' ' 68' ' ' ASN . . . -78.12 -58.44 3.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.021 -1.049 . . . . 0.0 109.165 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.5 mt -83.14 16.9 2.19 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -21.98 64.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.473 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -74.8 -57.97 3.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 109.538 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 83' ' ' LEU . 3.1 mt -44.75 -39.66 5.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' ALA . 26.5 t -54.48 -34.45 61.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 82' ' ' ALA . 4.0 m-20 -66.02 -24.39 66.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.144 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.584 HD21 ' CBD' ' A' ' 142' ' ' HEC . 7.3 tp -80.45 -38.6 29.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.882 . . . . 0.0 109.176 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -92.28 -21.65 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.688 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 84' ' ' SER . . . -76.43 -39.02 54.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.244 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' LYS . 50.3 t-80 -146.58 -83.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 110.167 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.46 ' NZ ' ' CD1' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -43.88 105.98 0.06 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 -179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tp 63.61 59.14 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.815 . . . . 0.0 109.293 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.657 HH12 ' HE1' ' D' ' 42' ' ' PHE . 10.6 ptp180 -60.64 -22.71 64.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.902 HG22 ' H ' ' A' ' 94' ' ' ASP . 12.8 p 42.1 -176.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.671 -0.643 . . . . 0.0 110.122 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.902 ' H ' HG22 ' A' ' 93' ' ' VAL . 50.7 m-20 -80.88 120.7 79.61 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.961 -1.087 . . . . 0.0 109.488 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.566 ' C ' ' H ' ' A' ' 97' ' ' ASN . 73.5 Cg_endo -78.67 -37.78 0.6 Allowed 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.282 1.988 . . . . 0.0 112.183 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.479 HG21 ' OD1' ' D' ' 99' ' ' ASP . 6.2 t -55.38 -0.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.703 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.566 ' H ' ' C ' ' A' ' 95' ' ' PRO . 4.8 m120 -79.03 -24.77 43.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.695 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 95' ' ' PRO . 26.8 m-85 -49.3 -17.59 0.27 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.419 ' N ' ' C ' ' A' ' 97' ' ' ASN . 92.0 mttt -81.99 -28.23 32.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.888 . . . . 0.0 109.44 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 13.5 mt -84.11 -39.02 20.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.841 ' CD1' ' CHC' ' A' ' 142' ' ' HEC . 2.0 tt -57.95 -40.12 79.77 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.379 -0.825 . . . . 0.0 109.456 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -66.14 -59.25 3.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.781 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -62.22 -26.57 68.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.736 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 57.9 m -74.06 -34.84 64.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.171 -0.956 . . . . 0.0 109.961 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.916 ' O ' HD12 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -84.25 -34.66 23.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.04 -1.037 . . . . 0.0 109.11 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.02 -44.02 97.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.421 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.58 -24.87 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.869 . . . . 0.0 109.213 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.5 m -64.62 -59.33 4.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 113' ' ' LEU . 59.0 mt -46.12 -37.9 7.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.86 -37.96 6.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.798 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.15 -55.91 4.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.812 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -74.81 -66.59 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 109.899 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -108.9 98.44 29.79 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 88.7 Cg_exo -44.08 179.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.404 2.069 . . . . 0.0 113.095 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.441 ' HB2' ' NE2' ' A' ' 122' ' ' HIS . . . -86.94 -34.64 19.27 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.599 0.714 . . . . 0.0 109.613 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 72.9 -0.51 3.34 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 1.492 ' CZ ' ' NE2' ' B' ' 116' ' ' HIS . 26.3 m-85 61.07 41.82 13.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.897 -0.502 . . . . 0.0 111.641 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.732 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -95.07 114.31 63.41 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.762 -1.211 . . . . 0.0 107.887 178.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.834 ' HA ' HG13 ' B' ' 33' ' ' VAL . 51.5 Cg_exo -49.77 18.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.087 1.858 . . . . 0.0 112.715 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -142.13 -23.39 0.69 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.048 -1.032 . . . . 0.0 110.579 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.763 HG13 ' N ' ' A' ' 122' ' ' HIS . 13.3 p -59.25 -58.04 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.027 -1.046 . . . . 0.0 110.179 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.763 ' N ' HG13 ' A' ' 121' ' ' VAL . 1.7 m-70 -71.29 -32.02 68.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 108.934 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' B' ' 33' ' ' VAL . . . -74.38 -20.41 60.08 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.435 -0.791 . . . . 0.0 108.939 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 128' ' ' PHE . 3.1 m -73.42 -63.42 1.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 110.038 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.706 HD13 HD11 ' A' ' 105' ' ' LEU . 10.5 mt -63.44 -28.17 69.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.85 -1.156 . . . . 0.0 109.382 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.752 ' OD1' ' CD2' ' B' ' 35' ' ' TYR . 8.7 t0 -69.67 -47.91 61.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.117 -0.99 . . . . 0.0 109.473 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.44 -40.83 11.8 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.099 -1.001 . . . . 0.0 109.931 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.515 ' CD1' HG21 ' A' ' 10' ' ' VAL . 72.7 t80 -48.45 -20.91 0.47 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.994 -1.066 . . . . 0.0 109.098 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.725 ' CD2' HBB1 ' A' ' 142' ' ' HEC . 12.1 mt -71.43 -26.27 62.67 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -55.07 -30.57 59.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.1 t -81.17 -33.43 33.09 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.485 HG22 ' SD ' ' A' ' 76' ' ' MET . 55.2 t -85.1 -28.62 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.31 -0.869 . . . . 0.0 108.828 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 129' ' ' LEU . 18.3 p -80.52 -23.27 40.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.398 -0.814 . . . . 0.0 109.096 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.3 m -75.35 -39.88 58.86 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.31 -0.869 . . . . 0.0 109.163 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.67 -29.72 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.187 -0.945 . . . . 0.0 108.794 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -33.96 77.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.384 -0.823 . . . . 0.0 108.927 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 62.8 m -96.12 -21.46 17.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.3 t -51.09 121.16 5.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 109.517 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.46 ' NZ ' ' CB ' ' A' ' 139' ' ' LYS . 6.9 mtpm? -84.3 48.54 1.51 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -48.43 104.21 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.43 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.5 mtt85 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.53 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.956 HG22 ' H ' ' B' ' 2' ' ' HIS . 9.2 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 0.956 ' H ' HG22 ' B' ' 1' ' ' VAL . 2.0 t-80 56.05 83.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.375 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.497 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -146.36 169.13 19.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 109.232 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.4 p -67.26 152.01 96.56 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.92 -27.5 25.6 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.533 2.155 . . . . 0.0 112.033 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -57.7 -45.24 85.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.233 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.31 -49.23 15.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -0.887 . . . . 0.0 109.374 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.5 OUTLIER -50.52 -54.18 24.34 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.28 -0.887 . . . . 0.0 109.531 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -43.52 -24.14 0.1 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.745 -0.597 . . . . 0.0 110.267 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.3 -56.57 3.69 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.016 -1.052 . . . . 0.0 109.725 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.499 HG23 ' CD2' ' B' ' 130' ' ' TYR . 1.5 p -69.8 -24.61 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 16.5 m -72.19 -47.42 50.82 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.539 0.685 . . . . 0.0 109.431 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.13 -31.89 70.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.371 -0.831 . . . . 0.0 109.589 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.409 ' O ' HG23 ' B' ' 18' ' ' VAL . 0.7 OUTLIER -49.08 -33.2 11.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.112 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -49.07 -23.78 1.34 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.82 -61.79 3.9 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.488 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -58.33 -30.07 66.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -1.126 . . . . 0.0 109.224 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 14' ' ' LEU . 49.2 t -54.11 114.71 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.558 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' B' ' 20' ' ' VAL . 45.0 m-80 -83.7 70.63 10.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 108.942 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' B' ' 19' ' ' ASN . 73.8 t -43.65 -26.6 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.425 -0.797 . . . . 0.0 109.658 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' B' ' 19' ' ' ASN . 1.2 p30 -58.41 -5.67 0.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.63 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' B' ' 20' ' ' VAL . 54.3 mt-10 -154.92 -42.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.533 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 81.5 t -49.68 -24.49 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.46 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.11 -55.53 3.49 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.78 -31.06 66.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.78 -26.67 57.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -1.162 . . . . 0.0 109.44 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.92 -52.58 64.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.366 -0.834 . . . . 0.0 109.625 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.544 HD22 ' N ' ' B' ' 28' ' ' LEU . 3.7 mm? -64.49 -56.81 11.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.977 . . . . 0.0 109.394 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.26 -48.8 46.45 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.975 ' NH2' ' CD1' ' A' ' 117' ' ' PHE . 28.2 mmt180 -56.54 -47.71 78.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -1.152 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.26 -34.76 15.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 39.9 mt -80.69 -21.55 41.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.834 HG13 ' HA ' ' A' ' 119' ' ' PRO . 88.2 t -86.97 -64.18 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 0.0 109.726 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.648 HG13 ' HB3' ' A' ' 122' ' ' HIS . 2.8 t -52.04 -45.21 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 110.003 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.752 ' CD2' ' OD1' ' A' ' 126' ' ' ASP . 0.2 OUTLIER -160.35 102.64 1.37 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.1 -1.0 . . . . 0.0 109.591 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.14 69.8 6.9 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.526 2.15 . . . . 0.0 112.149 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' B' ' 37' ' ' TRP . 0.0 OUTLIER -79.6 -19.53 49.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.399 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' B' ' 39' ' ' GLN . 28.4 p -48.05 -69.55 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.945 . . . . 0.0 109.621 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . 0.497 ' N ' ' OG1' ' B' ' 38' ' ' THR . 19.6 tt0 51.36 46.17 26.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.254 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -153.22 -58.67 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -84.7 8.34 17.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.487 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.616 ' HE1' HH12 ' C' ' 92' ' ' ARG . 29.0 p90 -58.07 -35.42 71.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.936 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -80.4 -21.63 42.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 109.382 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 16.5 m -58.5 -50.24 74.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -57.98 -8.83 1.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.517 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.02 -94.51 0.15 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -45.2 122.46 3.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.331 -1.1 . . . . 0.0 109.747 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -153.5 15.15 0.51 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.24 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.0 t -46.77 -39.07 11.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.625 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 8.1 p -144.63 152.24 52.3 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.492 -0.755 . . . . 0.0 108.965 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -44.92 -45.12 14.26 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.064 1.843 . . . . 0.0 112.143 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 53' ' ' ALA . 1.7 p30 -59.07 -39.79 83.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.527 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' B' ' 52' ' ' ASP . . . -52.25 -19.82 2.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.454 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.11 -63.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.492 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 39.6 mtm -73.63 9.77 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.511 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.21 -13.79 63.31 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -90.79 148.59 38.69 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.174 -1.192 . . . . 0.0 109.355 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.19 -19.6 17.29 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.619 2.213 . . . . 0.0 112.098 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.75 -28.25 33.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.632 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -78.36 -40.34 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.681 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -79.08 -28.54 43.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.1 -48.71 19.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.694 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.999 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 3.1 t-80 -48.21 -23.87 1.0 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.41 -54.91 13.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -46.78 -34.62 5.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -1.154 . . . . 0.0 109.609 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . 0.924 ' HD3' ' O2A' ' B' ' 147' ' ' HEC . 86.8 mttt -75.81 -37.62 58.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.318 -0.864 . . . . 0.0 109.669 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 0.758 HG22 ' C4A' ' B' ' 147' ' ' HEC . 33.6 t -71.73 -46.6 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.79 -32.56 67.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 109.253 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.81 -53.7 42.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.61 -48.85 66.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.397 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.49 -36.17 73.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.316 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 29.8 p -80.09 -24.23 40.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.479 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -51.87 -42.49 62.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.411 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.06 -60.25 8.3 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.553 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -58.26 -30.76 66.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.248 -1.148 . . . . 0.0 109.32 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.78 -3.01 58.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.595 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.452 ' C ' ' H ' ' B' ' 79' ' ' ASP . 10.3 t-80 -168.0 61.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.629 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.681 HD21 HG21 ' B' ' 1' ' ' VAL . 1.2 mt -73.37 14.38 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.141 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.46 ' O ' ' ND2' ' B' ' 80' ' ' ASN . 30.1 t70 -69.07 -32.19 71.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.496 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' B' ' 79' ' ' ASP . 9.8 m120 -163.23 104.2 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 109.461 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 37.6 mt -80.28 -58.8 2.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.378 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -48.6 -24.23 1.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.415 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.03 -62.15 3.46 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.7 t -62.82 -47.18 84.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -1.223 . . . . 0.0 109.437 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.5 m-85 -66.84 0.91 2.13 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.491 -0.756 . . . . 0.0 109.447 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.86 -47.36 86.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.952 . . . . 0.0 109.405 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 4.9 p -72.68 -53.6 11.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.376 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 24.7 mt -49.87 -46.49 51.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 85.9 p -56.37 -46.67 79.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.347 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.73 -40.6 95.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.301 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.31 -44.58 87.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.374 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' B' ' 97' ' ' HIS . 76.0 m80 -73.38 -24.25 60.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 110.247 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.72 -60.91 1.97 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.028 -1.045 . . . . 0.0 111.24 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.1 -57.1 3.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.861 -1.15 . . . . 0.0 111.671 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.499 ' O ' HD12 ' B' ' 96' ' ' LEU . 55.9 mmtt -66.15 -9.92 36.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 111.515 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.563 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 1.0 OUTLIER -143.11 -33.89 0.44 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.741 -1.224 . . . . 0.0 109.987 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 33.2 p-80 43.62 25.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' B' ' 96' ' ' LEU . 24.9 t -53.73 138.96 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.089 -1.007 . . . . 0.0 109.104 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.438 ' OD1' HG21 ' C' ' 96' ' ' VAL . 7.4 m-20 -46.43 149.43 1.38 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.443 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.19 -17.47 45.17 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.575 2.184 . . . . 0.0 112.217 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -89.76 47.05 1.42 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.472 ' O ' HMC2 ' B' ' 147' ' ' HEC . 2.9 m120 -137.29 -3.44 1.95 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -0.886 . . . . 0.0 109.794 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.46 ' HA ' HBB2 ' B' ' 147' ' ' HEC . 2.4 m-85 -97.68 -60.46 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.432 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -50.92 -19.97 1.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.691 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.597 HD12 ' N ' ' B' ' 105' ' ' LEU . 7.9 mp -77.9 -52.84 8.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.621 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.874 HD13 ' C3B' ' B' ' 147' ' ' HEC . 5.0 tt -54.6 -52.17 63.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 109.341 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.56 -22.02 7.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -85.65 -53.69 5.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -1.184 . . . . 0.0 109.69 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 91.9 t -46.66 -30.28 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.808 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 113' ' ' VAL . 5.2 tp -62.07 -55.32 30.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.597 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' B' ' 130' ' ' TYR . 90.3 t -46.75 -26.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 109.784 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 34.6 t -74.75 -26.22 59.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 109.643 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' B' ' 110' ' ' LEU . 39.3 t -83.45 -25.32 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.022 . . . . 0.0 109.525 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.6 -25.6 33.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.467 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -75.69 -19.58 59.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.705 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 1.492 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.3 OUTLIER -83.42 -52.48 6.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.165 -0.96 . . . . 0.0 109.458 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.487 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 61.0 m170 -73.32 -17.62 61.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.452 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.487 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 11.1 m-85 -149.41 55.78 0.98 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.857 . . . . 0.0 109.39 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -61.6 -14.78 44.46 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.62 -20.94 27.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -1.122 . . . . 0.0 109.512 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' B' ' 123' ' ' THR . 59.4 mm-40 -83.85 -7.37 59.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -73.54 33.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.572 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.481 ' H ' ' C ' ' B' ' 121' ' ' GLU . 77.8 p -47.51 148.38 2.47 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 0.0 109.374 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.471 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 3.4 Cg_exo -44.64 -56.13 2.83 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.505 2.137 . . . . 0.0 112.941 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 19.8 Cg_endo -60.5 -35.28 91.03 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.162 1.908 . . . . 0.0 112.104 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.469 HG23 ' OG1' ' B' ' 123' ' ' THR . 78.2 t -72.02 -17.34 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 109.581 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -83.42 -59.75 2.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 109.75 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.626 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -53.74 -33.38 55.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.58 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.44 27.5 0.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.499 ' CD2' HG23 ' B' ' 11' ' ' VAL . 4.2 t80 -125.09 -38.27 2.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.317 -0.864 . . . . 0.0 109.606 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 1.003 ' NE2' ' CZ ' ' A' ' 36' ' ' PHE . 46.0 tt0 -67.56 -23.94 65.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.898 . . . . 0.0 109.822 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' B' ' 1' ' ' VAL . 35.4 mtmt -84.5 -36.42 22.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.209 -0.932 . . . . 0.0 109.716 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.68 -49.34 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.968 . . . . 0.0 109.786 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.444 ' H ' HG22 ' B' ' 134' ' ' VAL . 4.5 m -79.5 -23.82 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.895 . . . . 0.0 109.768 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.4 -27.94 11.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.121 -0.987 . . . . 0.0 109.456 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.16 -23.05 61.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 93.3 t -79.07 -27.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.46 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.98 -42.8 56.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.532 ' OD1' ' OD1' ' D' ' 139' ' ' ASN . 37.8 t30 -76.83 -21.22 55.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.558 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.57 -60.34 2.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 17.1 mt -55.21 -22.33 17.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.459 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.25 -17.99 24.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.882 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -46.3 -46.55 18.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 109.487 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' B' ' 146' ' ' HIS . 5.7 tppt? -77.08 -57.56 3.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.472 ' CD1' ' C ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -51.53 -10.61 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.533 -0.729 . . . . 0.0 109.23 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.468 ' H ' ' C ' ' B' ' 144' ' ' LYS . 11.6 m-70 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.735 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' C' ' 2' ' ' LEU . 1.3 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.507 HD12 ' N ' ' C' ' 2' ' ' LEU . 10.8 mp 53.17 176.92 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 109.541 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.513 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 174.56 -47.79 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.873 . . . . 0.0 109.976 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' C' ' 6' ' ' ASP . 71.8 Cg_exo -47.16 169.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.549 2.166 . . . . 0.0 112.759 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.478 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.47 -15.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.43 -0.794 . . . . 0.0 110.126 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' C' ' 4' ' ' PRO . 25.1 t70 -38.8 -40.53 0.63 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.311 -0.868 . . . . 0.0 109.888 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.453 ' H ' ' HG2' ' C' ' 7' ' ' LYS . 13.5 ptpt -67.93 -45.68 73.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.113 -0.992 . . . . 0.0 109.299 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.418 ' N ' ' O ' ' C' ' 5' ' ' ALA . 37.4 m -52.99 -31.06 38.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -78.08 -35.98 48.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.521 HG21 ' CD1' ' C' ' 128' ' ' PHE . 92.0 t -69.67 -49.1 61.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.82 -47.45 64.31 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.17 -60.77 2.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.585 -0.697 . . . . 0.0 109.569 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.746 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -50.94 -38.96 53.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.322 -0.861 . . . . 0.0 109.319 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -17.31 61.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.207 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.57 -45.68 7.22 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.63 -34.92 72.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -1.165 . . . . 0.0 108.696 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.746 HG23 ' O ' ' C' ' 13' ' ' ALA . 70.2 t -61.94 -66.91 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 64.51 -143.62 47.26 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.42 48.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.443 -1.034 . . . . 0.0 110.0 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' C' ' 18' ' ' GLY . 80.7 m-70 -151.73 19.64 0.7 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -82.45 -65.24 1.03 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.66 -0.65 . . . . 0.0 109.769 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.65 -14.58 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' C' ' 21' ' ' ALA . 2.1 mm-40 -83.19 -56.46 3.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -1.168 . . . . 0.0 109.673 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.8 m-30 -55.95 -35.29 66.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.41 -0.806 . . . . 0.0 109.141 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.06 -22.83 60.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.52 -38.32 29.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -1.118 . . . . 0.0 109.795 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.61 -19.71 63.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.72 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.52 -22.39 51.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 109.683 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.5 mt -76.38 -43.99 38.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 109.706 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -65.7 -12.81 56.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.699 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -59.01 2.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ptm -62.26 -25.67 67.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.917 . . . . 0.0 109.51 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . 0.525 ' CE2' ' O ' ' C' ' 48' ' ' LEU . 1.3 t80 -58.56 -56.09 26.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 109.621 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.63 ' CD1' ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -82.34 -42.51 18.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 110.234 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 12.6 t -59.69 -9.21 2.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.01 . . . . 0.0 109.659 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 1.01 ' CZ ' ' NE2' ' D' ' 131' ' ' GLN . 79.5 m-85 -155.33 81.66 4.01 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.582 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' C' ' 39' ' ' THR . 52.6 Cg_exo -52.48 -24.96 23.56 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.689 2.259 . . . . 0.0 112.245 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.496 HG22 ' HB2' ' B' ' 97' ' ' HIS . 8.7 p -46.78 -19.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.877 . . . . 0.0 109.517 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.445 ' N ' ' O ' ' C' ' 37' ' ' PRO . 51.5 p -82.89 -26.15 31.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 109.676 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' C' ' 42' ' ' TYR . 26.6 ttpt -79.37 -53.62 6.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.653 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t -47.06 -18.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.907 . . . . 0.0 109.576 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.469 ' CG ' ' O ' ' C' ' 42' ' ' TYR . 82.4 t80 -78.79 3.21 17.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.877 . . . . 0.0 109.481 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 49.16 66.62 5.46 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.345 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.554 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 64.8 Cg_endo -77.02 -1.56 11.74 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.808 2.338 . . . . 0.0 112.389 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.571 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 22.0 p80 41.43 24.63 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.34 -0.85 . . . . 0.0 109.516 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.544 ' O ' ' C ' ' C' ' 47' ' ' ASP . 3.9 t80 -104.31 31.46 4.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.491 -0.756 . . . . 0.0 109.705 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' C' ' 46' ' ' PHE . 15.1 m-20 28.69 67.71 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.817 -0.552 . . . . 0.0 110.524 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.525 ' O ' ' CE2' ' C' ' 33' ' ' PHE . 87.2 mt -85.15 22.25 1.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.978 . . . . 0.0 109.43 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.434 ' O ' ' O ' ' C' ' 50' ' ' HIS . 19.3 m -76.61 26.6 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.361 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' C' ' 48' ' ' LEU . 54.9 t60 58.07 158.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.842 . . . . 0.0 109.557 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.72 17.91 5.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 9.0 t -80.33 -17.73 51.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -1.152 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 68.62 -58.54 0.48 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.688 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' C' ' 52' ' ' SER . 0.7 OUTLIER -43.74 -20.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.401 -0.812 . . . . 0.0 109.818 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' C' ' 53' ' ' ALA . 89.1 t -77.41 -27.33 15.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 109.277 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' C' ' 53' ' ' ALA . 5.9 ptmt -63.6 -27.18 69.06 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.293 -0.879 . . . . 0.0 109.395 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.86 -27.63 68.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -84.15 -30.66 25.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -1.17 . . . . 0.0 110.103 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.06 -49.41 55.73 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -60.1 -23.66 64.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -1.146 . . . . 0.0 110.068 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.45 ' O ' HMA3 ' C' ' 142' ' ' HEC . 0.3 OUTLIER -73.32 -33.96 65.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.192 -0.942 . . . . 0.0 109.146 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 t -72.41 -52.83 21.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.434 -0.791 . . . . 0.0 108.991 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.88 -28.47 69.86 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.324 -0.86 . . . . 0.0 109.186 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -68.3 -41.38 81.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.25 -0.906 . . . . 0.0 108.848 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.463 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -68.07 -42.47 80.38 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' C' ' 66' ' ' LEU . 9.9 mt -63.4 -46.2 87.5 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 21.4 m -63.24 -48.68 77.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.206 -0.934 . . . . 0.0 109.029 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.403 HD21 ' HB1' ' C' ' 79' ' ' ALA . 1.8 t30 -62.72 -22.55 66.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 108.829 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -85.22 -47.69 9.85 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.83 -22.69 29.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -14.57 62.42 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.669 ' O ' HG12 ' C' ' 73' ' ' VAL . 21.5 m80 -141.92 -57.45 0.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.796 . . . . 0.0 109.65 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.669 HG12 ' O ' ' C' ' 72' ' ' HIS . 8.2 p 46.16 15.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 122.067 0.937 . . . . 0.0 108.718 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' C' ' 72' ' ' HIS . 21.9 m-20 -136.39 12.53 3.25 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -164.96 30.52 0.06 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.557 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 1.2 mtm -66.63 -44.69 55.38 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.658 -0.651 . . . . 0.0 110.098 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' C' ' 76' ' ' MET . 95.5 Cg_exo -42.24 -43.03 7.67 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.431 2.087 . . . . 0.0 112.601 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.15 -18.97 21.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.001 . . . . 0.0 110.025 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . 0.403 ' HB1' HD21 ' C' ' 68' ' ' ASN . . . -78.15 -58.5 3.23 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.034 -1.041 . . . . 0.0 109.081 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 18.7 mt -83.14 16.91 2.19 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' C' ' 77' ' ' PRO . 0.5 OUTLIER -61.67 -21.93 64.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.848 . . . . 0.0 109.363 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -74.79 -57.97 3.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.454 HD23 ' N ' ' C' ' 83' ' ' LEU . 3.1 mt -44.74 -39.74 5.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.524 ' O ' ' N ' ' C' ' 88' ' ' ALA . 26.5 t -54.51 -34.45 61.68 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' C' ' 82' ' ' ALA . 4.0 m-20 -66.09 -24.28 66.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.136 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.585 HD21 ' CBD' ' C' ' 142' ' ' HEC . 7.3 tp -80.52 -38.52 29.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.327 -0.858 . . . . 0.0 109.203 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -92.32 -21.64 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.723 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' C' ' 84' ' ' SER . . . -76.49 -38.95 54.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' C' ' 90' ' ' LYS . 50.1 t-80 -146.6 -83.43 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.101 -0.999 . . . . 0.0 110.114 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.454 ' NZ ' ' CD1' ' C' ' 86' ' ' LEU . 0.9 OUTLIER -43.85 105.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 109.67 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 tp 63.61 59.22 1.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.343 -0.848 . . . . 0.0 109.29 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . 0.616 HH12 ' HE1' ' B' ' 42' ' ' PHE . 10.6 ptp180 -60.74 -22.63 64.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.0 109.578 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.899 HG22 ' H ' ' C' ' 94' ' ' ASP . 12.7 p 42.08 -176.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.642 -0.661 . . . . 0.0 110.084 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.899 ' H ' HG22 ' C' ' 93' ' ' VAL . 50.7 m-20 -80.85 120.68 79.6 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.969 -1.082 . . . . 0.0 109.459 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' C' ' 97' ' ' ASN . 73.5 Cg_endo -78.61 -37.86 0.6 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.359 2.039 . . . . 0.0 112.124 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.438 HG21 ' OD1' ' B' ' 99' ' ' ASP . 6.2 t -55.36 -0.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.707 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.564 ' H ' ' C ' ' C' ' 95' ' ' PRO . 4.8 m120 -79.03 -24.85 43.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.065 -1.022 . . . . 0.0 109.693 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' C' ' 95' ' ' PRO . 26.9 m-85 -49.27 -17.64 0.27 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 109.532 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.421 ' N ' ' C ' ' C' ' 97' ' ' ASN . 91.9 mttt -81.99 -28.22 32.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.377 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.491 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 13.5 mt -84.1 -39.04 19.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.384 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.843 ' CD1' ' CHC' ' C' ' 142' ' ' HEC . 2.0 tt -57.97 -40.08 79.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -66.28 -59.18 3.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.986 . . . . 0.0 109.772 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -62.15 -26.59 68.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 0.0 109.809 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 57.8 m -74.12 -34.8 64.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.894 ' O ' HD12 ' C' ' 105' ' ' LEU . 0.0 OUTLIER -84.2 -34.67 23.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.11 -0.994 . . . . 0.0 109.182 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 20.0 mt -62.99 -44.09 96.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.455 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.47 -24.92 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 54.8 m -64.6 -59.33 4.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.564 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.408 HD11 HD11 ' C' ' 105' ' ' LEU . 59.1 mt -46.21 -37.84 7.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.601 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.8 -38.05 6.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.849 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.04 -55.95 4.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.861 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -74.82 -66.59 0.73 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 109.895 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -108.9 98.45 29.84 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.481 -0.762 . . . . 0.0 108.96 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' C' ' 113' ' ' LEU . 89.8 Cg_exo -44.02 179.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.45 2.1 . . . . 0.0 113.036 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.448 ' HB2' ' NE2' ' C' ' 122' ' ' HIS . . . -86.94 -34.76 19.23 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.594 0.711 . . . . 0.0 109.584 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 72.97 -0.53 3.35 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 1.493 ' CZ ' ' NE2' ' D' ' 116' ' ' HIS . 26.6 m-85 61.05 41.79 13.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.884 -0.51 . . . . 0.0 111.624 178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.3 OUTLIER -95.01 114.22 63.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.773 -1.204 . . . . 0.0 107.922 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . 0.806 ' HA ' HG13 ' D' ' 33' ' ' VAL . 51.8 Cg_exo -49.68 18.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.224 1.949 . . . . 0.0 112.678 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -142.1 -23.41 0.69 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 110.599 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.773 HG13 ' N ' ' C' ' 122' ' ' HIS . 13.4 p -59.27 -57.99 8.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.003 -1.06 . . . . 0.0 110.206 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.773 ' N ' HG13 ' C' ' 121' ' ' VAL . 1.7 m-70 -71.23 -32.19 68.47 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 108.879 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' D' ' 33' ' ' VAL . . . -74.24 -20.5 60.14 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.398 -0.814 . . . . 0.0 108.968 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' C' ' 128' ' ' PHE . 3.1 m -73.44 -63.37 1.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.247 -0.908 . . . . 0.0 109.979 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.706 HD13 HD11 ' C' ' 105' ' ' LEU . 10.5 mt -63.55 -28.09 69.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.978 -1.077 . . . . 0.0 109.339 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . 0.744 ' OD1' ' CD2' ' D' ' 35' ' ' TYR . 8.7 t0 -69.63 -47.99 61.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.113 -0.992 . . . . 0.0 109.527 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.32 -40.82 11.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.064 -1.022 . . . . 0.0 109.938 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.521 ' CD1' HG21 ' C' ' 10' ' ' VAL . 72.8 t80 -48.64 -20.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.954 -1.091 . . . . 0.0 109.043 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.71 ' CD2' HBB1 ' C' ' 142' ' ' HEC . 12.1 mt -71.48 -26.33 62.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -55.0 -30.58 59.72 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 4.2 t -81.17 -33.36 33.13 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.449 -0.782 . . . . 0.0 108.897 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . 0.486 HG22 ' SD ' ' C' ' 76' ' ' MET . 55.5 t -85.15 -28.61 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.354 -0.841 . . . . 0.0 108.817 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.547 ' N ' ' O ' ' C' ' 129' ' ' LEU . 18.6 p -80.61 -23.17 39.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.515 -0.741 . . . . 0.0 109.009 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' C' ' 130' ' ' ALA . 29.5 m -75.34 -40.0 58.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 109.15 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 p -74.55 -29.75 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.235 -0.915 . . . . 0.0 108.783 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -34.01 77.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.4 -0.812 . . . . 0.0 108.885 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 63.0 m -96.13 -21.42 17.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.508 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 44.0 t -51.17 121.1 5.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.463 ' NZ ' ' CB ' ' C' ' 139' ' ' LYS . 6.9 mtpm? -84.2 48.49 1.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.519 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -48.39 104.19 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.463 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 50.5 mtt85 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.465 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.936 HG22 ' H ' ' D' ' 2' ' ' HIS . 9.0 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . 0.936 ' H ' HG22 ' D' ' 1' ' ' VAL . 2.0 t-80 55.94 83.89 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.383 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.49 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.2 OUTLIER -146.33 169.13 19.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.204 -0.935 . . . . 0.0 109.257 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 3.4 p -67.27 152.04 96.53 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.45 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.01 -27.54 25.17 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.562 2.175 . . . . 0.0 111.947 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -57.63 -45.21 85.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.34 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.22 -49.38 15.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.349 -0.844 . . . . 0.0 109.359 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.5 OUTLIER -50.4 -54.22 23.42 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.312 -0.868 . . . . 0.0 109.582 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -43.56 -24.06 0.1 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.72 -0.612 . . . . 0.0 110.278 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.36 -56.54 3.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.061 -1.024 . . . . 0.0 109.677 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.498 HG23 ' CD2' ' D' ' 130' ' ' TYR . 1.5 p -69.84 -24.63 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 16.3 m -72.25 -47.29 51.38 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.432 0.634 . . . . 0.0 109.462 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.19 -31.91 70.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.546 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.05 -33.13 10.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.22 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -49.1 -23.86 1.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 109.427 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.69 -61.87 3.89 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.467 ' CD ' ' H ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -58.32 -30.02 66.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.203 -1.175 . . . . 0.0 109.259 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 49.8 t -54.14 114.67 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.887 . . . . 0.0 109.598 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' D' ' 21' ' ' ASP . 45.1 m-80 -83.74 70.6 10.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 108.89 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' D' ' 22' ' ' GLU . 73.5 t -43.46 -26.76 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.416 -0.802 . . . . 0.0 109.691 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' D' ' 19' ' ' ASN . 1.2 p30 -58.37 -5.66 0.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.644 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' D' ' 20' ' ' VAL . 54.3 mt-10 -155.0 -42.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 81.4 t -49.76 -24.44 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -0.942 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.13 -55.53 3.49 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.84 -31.06 67.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.79 -26.57 57.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -1.187 . . . . 0.0 109.444 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.11 -52.56 64.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.299 -0.876 . . . . 0.0 109.529 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . 0.537 HD22 ' N ' ' D' ' 28' ' ' LEU . 3.7 mm? -64.52 -56.75 12.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.128 -0.983 . . . . 0.0 109.384 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.33 -48.75 47.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . 0.961 ' NH2' ' CD1' ' C' ' 117' ' ' PHE . 28.3 mmt180 -56.61 -47.63 79.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.334 -1.097 . . . . 0.0 109.517 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tt -49.29 -34.81 16.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.568 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 40.1 mt -80.67 -21.52 41.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.806 HG13 ' HA ' ' C' ' 119' ' ' PRO . 88.3 t -87.01 -64.07 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.915 . . . . 0.0 109.744 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' C' ' 122' ' ' HIS . 2.8 t -52.06 -45.19 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 110.007 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . 0.744 ' CD2' ' OD1' ' C' ' 126' ' ' ASP . 0.2 OUTLIER -160.42 102.53 1.36 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.105 -0.997 . . . . 0.0 109.614 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.04 69.92 6.92 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.491 2.127 . . . . 0.0 112.076 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -19.66 48.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 0.0 109.422 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' D' ' 39' ' ' GLN . 28.5 p -48.04 -69.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.59 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . 0.494 ' N ' ' OG1' ' D' ' 38' ' ' THR . 19.5 tt0 51.39 46.13 26.94 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.139 -0.976 . . . . 0.0 109.304 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -153.26 -58.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.355 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -84.66 8.25 17.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.657 ' HE1' HH12 ' A' ' 92' ' ' ARG . 29.1 p90 -57.97 -35.49 71.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' D' ' 42' ' ' PHE . 19.7 pt-20 -80.35 -21.64 42.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.841 . . . . 0.0 109.398 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 16.6 m -58.5 -50.26 74.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.482 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.01 -8.81 1.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.43 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.01 -94.57 0.15 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -45.11 122.47 3.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -1.108 . . . . 0.0 109.779 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 tp -153.57 15.2 0.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.235 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.0 t -46.76 -39.15 11.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.94 . . . . 0.0 109.603 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . 0.424 ' HG1' ' CG ' ' D' ' 52' ' ' ASP . 8.0 p -144.64 152.23 52.22 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.416 -0.802 . . . . 0.0 108.902 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -44.9 -45.13 14.18 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.072 1.848 . . . . 0.0 112.151 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . 0.424 ' CG ' ' HG1' ' D' ' 50' ' ' THR . 1.7 p30 -59.12 -39.67 83.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.606 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.414 ' N ' ' OD1' ' D' ' 52' ' ' ASP . . . -52.32 -19.82 2.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.416 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.02 -64.09 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.497 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 39.6 mtm -73.56 9.67 1.32 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.15 -13.75 63.51 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.76 148.47 38.47 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.18 -1.188 . . . . 0.0 109.369 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.15 -19.54 17.43 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.58 2.187 . . . . 0.0 112.154 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -81.76 -28.28 33.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.654 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.31 -40.32 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 0.0 109.697 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -79.13 -28.55 42.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.649 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.11 -48.73 19.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.735 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 1.011 ' CE1' ' CHA' ' D' ' 147' ' ' HEC . 3.1 t-80 -48.13 -23.88 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.691 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.44 -54.98 13.47 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -46.69 -34.65 5.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -1.132 . . . . 0.0 109.582 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . 0.914 ' HD3' ' O2A' ' D' ' 147' ' ' HEC . 86.7 mttt -75.9 -37.64 58.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.351 -0.843 . . . . 0.0 109.558 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.757 HG13 ' C2B' ' D' ' 147' ' ' HEC . 34.1 t -71.73 -46.63 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.411 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.75 -32.56 67.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 0.0 109.279 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.81 -53.65 42.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.68 -48.79 66.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -1.142 . . . . 0.0 109.364 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.63 -36.03 73.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.237 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 30.1 p -80.19 -24.2 40.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.468 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -51.92 -42.6 62.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.0 -60.12 8.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.551 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.7 mp -58.38 -30.79 67.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -1.123 . . . . 0.0 109.238 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.68 -3.15 58.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 109.543 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.454 ' C ' ' H ' ' D' ' 79' ' ' ASP . 10.2 t-80 -167.96 61.81 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.666 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . 0.675 HD21 HG21 ' D' ' 1' ' ' VAL . 1.2 mt -73.42 14.43 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.146 -0.971 . . . . 0.0 109.145 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.461 ' O ' ' ND2' ' D' ' 80' ' ' ASN . 30.2 t70 -68.99 -32.32 71.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.482 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' D' ' 79' ' ' ASP . 9.8 m120 -163.19 104.14 0.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.337 -0.852 . . . . 0.0 109.45 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 37.3 mt -80.24 -58.8 2.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.409 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -48.59 -24.14 1.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.444 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.09 -62.21 3.42 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.7 t -62.76 -47.18 84.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.166 . . . . 0.0 109.452 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.4 m-85 -66.94 0.96 2.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.521 -0.737 . . . . 0.0 109.486 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.42 85.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.966 . . . . 0.0 109.466 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 5.1 p -72.64 -53.63 11.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 0.0 109.42 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 24.7 mt -49.87 -46.52 51.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.0 109.432 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 85.5 p -56.3 -46.7 79.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.419 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.69 -40.6 95.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.327 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.25 -44.7 87.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 109.338 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' D' ' 97' ' ' HIS . 76.0 m80 -73.39 -24.24 60.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 110.207 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 42.0 t -83.71 -60.94 1.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 0.0 111.245 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -88.05 -57.12 3.05 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.884 -1.135 . . . . 0.0 111.691 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . 0.493 ' O ' HD12 ' D' ' 96' ' ' LEU . 56.0 mmtt -66.23 -9.83 36.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.319 -0.863 . . . . 0.0 111.494 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.559 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 1.0 OUTLIER -143.13 -33.89 0.43 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.771 -1.206 . . . . 0.0 110.028 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 33.2 p-80 43.62 25.51 0.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.264 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' D' ' 96' ' ' LEU . 24.9 t -53.7 139.09 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.065 -1.022 . . . . 0.0 109.045 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . 0.479 ' OD1' HG21 ' A' ' 96' ' ' VAL . 7.4 m-20 -46.54 149.41 1.42 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.509 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.19 -17.43 45.18 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.584 2.189 . . . . 0.0 112.263 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -89.74 46.94 1.41 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 109.668 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.472 ' O ' HMC2 ' D' ' 147' ' ' HEC . 2.9 m120 -137.29 -3.42 1.95 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 109.811 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . 0.455 ' HA ' HBB2 ' D' ' 147' ' ' HEC . 2.4 m-85 -97.73 -60.41 1.57 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.118 -0.989 . . . . 0.0 109.435 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -51.05 -19.93 1.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 109.588 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . 0.602 HD12 ' N ' ' D' ' 105' ' ' LEU . 7.9 mp -77.98 -52.87 8.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.877 HD13 ' C3B' ' D' ' 147' ' ' HEC . 5.0 tt -54.48 -52.19 62.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -51.58 -22.0 7.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -85.64 -53.7 5.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -1.19 . . . . 0.0 109.723 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 92.9 t -46.66 -30.27 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 109.88 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.99 -55.39 29.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.644 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . 0.404 HG22 ' CE1' ' D' ' 130' ' ' TYR . 90.2 t -46.71 -26.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.774 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 34.4 t -74.63 -26.31 59.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.893 . . . . 0.0 109.704 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.48 -25.28 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 109.543 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mt -82.6 -25.6 33.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 109.742 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -75.72 -19.48 59.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.673 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 1.493 ' NE2' ' CZ ' ' C' ' 117' ' ' PHE . 0.3 OUTLIER -83.52 -52.44 6.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . 0.493 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 61.0 m170 -73.29 -17.62 61.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 11.2 m-85 -149.39 55.73 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -61.47 -14.81 43.62 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.7 -20.89 27.07 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.213 -1.169 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' D' ' 123' ' ' THR . 59.4 mm-40 -83.87 -7.34 59.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.683 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -73.71 33.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 109.527 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.488 ' H ' ' C ' ' D' ' 121' ' ' GLU . 77.4 p -47.55 148.42 2.49 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.434 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.479 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.3 Cg_exo -44.63 -56.15 2.81 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.491 2.127 . . . . 0.0 112.956 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 19.8 Cg_endo -60.46 -35.26 91.34 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.187 1.924 . . . . 0.0 112.078 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.471 HG23 ' OG1' ' D' ' 123' ' ' THR . 78.5 t -72.09 -17.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -83.33 -59.78 2.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.154 -0.966 . . . . 0.0 109.789 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.63 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -53.69 -33.43 55.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.624 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.48 27.64 0.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.541 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.498 ' CD2' HG23 ' D' ' 11' ' ' VAL . 4.3 t80 -125.2 -38.22 2.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.411 -0.805 . . . . 0.0 109.512 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 1.01 ' NE2' ' CZ ' ' C' ' 36' ' ' PHE . 45.9 tt0 -67.51 -23.97 65.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 109.835 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' D' ' 1' ' ' VAL . 35.4 mtmt -84.46 -36.49 22.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 109.679 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 61.4 t -53.65 -49.39 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.787 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.447 ' H ' HG22 ' D' ' 134' ' ' VAL . 4.5 m -79.43 -23.87 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.911 . . . . 0.0 109.783 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.4 -27.84 11.14 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.106 -0.996 . . . . 0.0 109.463 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -80.28 -23.1 61.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 93.9 t -78.93 -27.65 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -1.173 . . . . 0.0 109.55 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.92 -42.84 56.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.933 . . . . 0.0 109.446 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.532 ' OD1' ' OD1' ' B' ' 139' ' ' ASN . 37.8 t30 -76.8 -21.17 55.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.578 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.67 -60.29 2.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 0.0 109.54 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 17.1 mt -55.24 -22.26 17.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.429 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.32 -17.88 24.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -46.34 -46.51 18.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' D' ' 146' ' ' HIS . 5.7 tppt? -77.2 -57.43 3.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . 0.484 ' CD1' ' C ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -51.58 -10.59 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.519 -0.738 . . . . 0.0 109.193 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.471 ' H ' ' C ' ' D' ' 144' ' ' LYS . 11.4 m-70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.666 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.841 ' CHC' ' CD1' ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 0.999 ' CHA' ' CE1' ' B' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.843 ' CHC' ' CD1' ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 1.011 ' CHA' ' CE1' ' D' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.449 HD13 ' CE2' ' A' ' 128' ' ' PHE . 14.7 mt -138.96 -174.21 3.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.248 -0.907 . . . . 0.0 109.412 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.496 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.3 OUTLIER 175.9 -49.18 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.496 ' HD2' ' H ' ' A' ' 3' ' ' SER . 71.9 Cg_exo -47.01 173.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.507 2.138 . . . . 0.0 112.568 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -65.11 -16.33 63.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.359 -0.838 . . . . 0.0 109.704 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 5' ' ' ALA . 1.2 m-20 -39.71 -40.62 0.96 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.38 -0.825 . . . . 0.0 109.595 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.403 ' NZ ' ' CB ' ' A' ' 7' ' ' LYS . 8.3 mtmp? -60.51 -59.29 5.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.206 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 m -50.26 -28.68 8.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.198 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 5' ' ' ALA . 55.5 m-80 -80.09 -35.32 37.09 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.413 HG21 ' CG ' ' A' ' 128' ' ' PHE . 41.1 t -74.81 -44.57 45.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.74 -39.63 89.39 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.414 -0.803 . . . . 0.0 108.86 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.78 46.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.153 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.738 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.97 -35.43 64.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.445 -0.784 . . . . 0.0 109.073 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.54 -17.51 61.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.051 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.47 -46.34 8.96 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -68.9 -37.47 78.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.198 -1.177 . . . . 0.0 108.766 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 13' ' ' ALA . 99.2 t -61.17 -65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 59.59 -137.54 49.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.23 29.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.471 -1.017 . . . . 0.0 110.296 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.564 ' H ' ' C ' ' A' ' 18' ' ' GLY . 93.1 m-70 -131.82 23.35 4.62 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -87.3 -61.48 1.71 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.613 -0.68 . . . . 0.0 109.639 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.34 -14.62 0.35 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 21' ' ' ALA . 3.7 mm-40 -84.08 -56.45 3.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -1.111 . . . . 0.0 109.473 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.1 m-30 -59.61 -33.17 71.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.396 -0.815 . . . . 0.0 109.322 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.33 -22.96 76.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.73 -43.54 20.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -1.176 . . . . 0.0 109.752 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.86 -19.91 65.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 -20.0 59.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.911 . . . . 0.0 109.366 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.531 HD13 ' CD2' ' A' ' 58' ' ' HIS . 18.6 mt -73.0 -46.04 54.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.588 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -61.98 -17.73 58.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 109.604 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.0 mmt-85 -81.18 -31.9 33.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 0.0 109.598 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -73.02 -37.63 66.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 109.525 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.473 ' CD1' ' C ' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -62.95 -60.0 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 12.3 mt -59.32 -48.88 79.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.655 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' B' ' 131' ' ' GLN . 40.3 t -46.04 -27.4 0.93 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.923 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CD1' ' O ' ' A' ' 35' ' ' SER . 47.7 m-85 -154.18 123.88 3.25 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.026 -1.046 . . . . 0.0 109.55 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 40' ' ' LYS . 73.3 Cg_endo -77.9 -19.52 12.41 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.412 2.075 . . . . 0.0 112.159 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.2 p -43.9 -19.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 109.889 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 37' ' ' PRO . 3.4 p -90.27 -22.83 21.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.174 -0.954 . . . . 0.0 109.575 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 37' ' ' PRO . 27.8 ttmt -50.16 -18.74 0.62 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.862 . . . . 0.0 109.954 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t -105.61 -18.4 14.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.863 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.52 38.13 1.57 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.348 -0.845 . . . . 0.0 109.168 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.688 ' O ' ' CG ' ' A' ' 43' ' ' PHE . 6.2 p90 -115.14 81.15 7.69 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.463 -0.773 . . . . 0.0 109.975 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.34 -6.28 15.48 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.372 2.048 . . . . 0.0 111.873 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' A' ' 45' ' ' HIS . 0.3 OUTLIER -165.61 50.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.593 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -156.17 71.19 0.71 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.568 ' C ' ' H ' ' A' ' 49' ' ' SER . 0.9 OUTLIER -46.41 -13.11 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.453 -0.779 . . . . 0.0 111.203 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 46' ' ' PHE . 9.5 mt 59.0 -5.43 0.06 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.772 -1.205 . . . . 0.0 109.608 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.568 ' H ' ' C ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -46.79 124.88 6.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 109.552 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -53.3 138.96 31.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.46 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.27 27.81 65.93 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 3.2 m -60.9 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.273 -1.134 . . . . 0.0 109.31 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 167.8 -64.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.424 -0.797 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -45.61 -17.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.47 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' ALA . 61.3 t -73.93 -29.98 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 0.0 109.791 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -70.96 -26.49 63.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.71 -22.92 68.38 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 0.4 OUTLIER -79.2 -39.89 32.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.171 -1.194 . . . . 0.0 109.549 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.27 -49.96 54.23 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 49.8 mttp -51.98 -23.87 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -1.104 . . . . 0.0 110.0 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.678 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 10.1 mmpt? -72.41 -45.11 61.16 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.19 -0.944 . . . . 0.0 109.107 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.3 t -67.62 -46.14 83.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.475 -0.765 . . . . 0.0 109.261 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.79 -31.0 68.68 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.2 -0.937 . . . . 0.0 109.313 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 2.4 t70 -69.39 -34.57 74.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.144 -0.973 . . . . 0.0 108.752 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.85 -51.37 62.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.32 -0.863 . . . . 0.0 108.96 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.8 mt -56.34 -46.29 80.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 108.82 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.3 m -62.68 -51.57 66.69 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.274 -0.891 . . . . 0.0 108.871 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -59.67 -22.74 62.35 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.56 -46.98 11.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.65 -22.91 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.7 -16.95 64.59 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' A' ' 74' ' ' ASP . 15.8 m80 -143.88 -60.16 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.402 -0.811 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 69' ' ' ALA . 12.7 p 44.66 14.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.751 0.786 . . . . 0.0 109.286 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 72' ' ' HIS . 13.7 m-20 -131.22 11.44 5.0 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.438 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.8 p-10 -177.82 31.79 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.944 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.696 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -77.99 -24.21 0.44 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.398 -0.814 . . . . 0.0 111.709 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 76' ' ' MET . 75.6 Cg_exo -50.21 -33.92 37.8 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.71 1.607 . . . . 0.0 112.239 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -94.29 -16.04 23.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 0.0 109.503 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.65 -57.96 3.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.26 -0.9 . . . . 0.0 109.087 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.18 10.23 2.55 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.405 -0.809 . . . . 0.0 108.946 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -61.09 -28.73 69.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.396 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -63.9 -50.58 68.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.543 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.526 ' O ' ' ND1' ' A' ' 87' ' ' HIS . 4.5 mt -47.22 -47.34 24.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 108.785 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 20.7 t -55.31 -25.9 37.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.426 -0.796 . . . . 0.0 109.299 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 89' ' ' HIS . 1.9 m-20 -78.45 -53.05 7.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.503 HD11 ' O1D' ' A' ' 142' ' ' HEC . 5.2 tt -58.25 -28.65 65.1 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.327 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 8.4 m80 -92.6 -21.76 19.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 110.046 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -112.14 -2.39 14.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.133 -0.979 . . . . 0.0 110.354 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 85' ' ' ASP . 78.1 m80 -142.59 36.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.983 -1.073 . . . . 0.0 110.176 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -171.55 -77.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 0.0 109.723 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 91' ' ' LEU . 4.3 mm? -72.49 -37.34 68.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.09 -1.006 . . . . 0.0 109.346 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.666 ' HG2' ' NH1' ' D' ' 40' ' ' ARG . 28.1 ttm180 55.63 52.4 11.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.122 -0.987 . . . . 0.0 109.492 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.562 ' O ' ' NH2' ' D' ' 40' ' ' ARG . 0.3 OUTLIER -78.7 -173.07 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.154 -0.966 . . . . 0.0 109.44 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 96' ' ' VAL . 1.8 m-20 -123.91 113.65 28.35 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.482 -0.761 . . . . 0.0 109.139 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 98' ' ' PHE . 84.3 Cg_exo -43.34 -14.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.265 1.976 . . . . 0.0 112.378 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 94' ' ' ASP . 94.9 t -48.07 -25.65 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.595 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -79.38 -24.86 42.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.892 . . . . 0.0 109.621 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' A' ' 95' ' ' PRO . 28.5 t80 -46.38 -40.76 12.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 109.623 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -59.42 -25.18 64.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.591 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.1 mt -84.01 -61.32 1.85 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.576 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.556 HD22 ' CHC' ' A' ' 142' ' ' HEC . 6.3 tp -47.95 -41.08 24.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.655 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.2 t -61.99 -42.31 99.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.669 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -80.91 -26.51 36.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.762 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 79.9 m -58.38 -56.86 16.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.603 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.6 mt -47.01 -37.14 8.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.365 -0.834 . . . . 0.0 109.568 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.09 -30.93 68.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.866 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.9 t -82.97 -24.81 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 28.2 m -81.82 -62.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.61 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 113' ' ' LEU . 12.5 mt -46.26 -39.94 10.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.311 -0.868 . . . . 0.0 109.64 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.5 -42.49 7.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.818 . . . . 0.0 109.927 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.04 -44.37 69.37 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.312 -0.868 . . . . 0.0 109.483 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -91.52 -77.24 0.43 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.561 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 109' ' ' LEU . 1.9 tt -96.88 119.59 63.28 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.49 165.38 32.58 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.242 1.962 . . . . 0.0 112.821 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.469 ' C ' ' N ' ' A' ' 117' ' ' PHE . . . -87.81 -28.5 21.61 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.53 0.681 . . . . 0.0 109.68 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.542 ' O ' ' CG ' ' A' ' 117' ' ' PHE . 83.8 mt-10 57.09 10.62 0.84 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' A' ' 116' ' ' GLU . 27.7 p90 40.6 32.5 0.15 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.339 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 120' ' ' ALA . 3.2 p -56.02 134.39 74.05 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -49.51 18.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.401 2.068 . . . . 0.0 113.251 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -157.37 -20.2 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.595 -1.316 . . . . 0.0 111.555 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 122' ' ' HIS . 2.8 t -65.64 -63.13 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.543 -1.348 . . . . 0.0 110.055 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.599 ' CD2' HG22 ' B' ' 34' ' ' VAL . 0.0 OUTLIER -50.5 -31.14 14.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 108.977 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.65 -19.94 32.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.341 -0.85 . . . . 0.0 109.777 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 20.4 p -64.89 -62.33 1.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.201 -0.937 . . . . 0.0 110.599 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.507 ' N ' ' OG ' ' A' ' 124' ' ' SER . 2.0 mt -72.91 -19.78 61.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.119 -0.988 . . . . 0.0 110.051 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -81.45 -43.51 18.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 109.896 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -87.28 -47.59 8.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 109.86 -179.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 31.2 t80 -48.73 -21.5 0.63 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.122 -0.986 . . . . 0.0 109.47 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 133' ' ' SER . 18.7 mt -73.75 -21.06 60.32 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -58.15 -32.96 68.67 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.447 ' OG ' HD11 ' A' ' 2' ' ' LEU . 0.7 OUTLIER -78.67 -30.42 46.19 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.404 -0.81 . . . . 0.0 108.869 179.373 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.06 -30.18 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.0 108.85 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 129' ' ' LEU . 78.8 p -79.09 -25.08 43.08 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.392 -0.817 . . . . 0.0 108.968 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 53.6 m -70.68 -37.57 73.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.299 -0.875 . . . . 0.0 109.244 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.402 ' H ' HG12 ' A' ' 135' ' ' VAL . 5.0 p -79.52 -22.04 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.307 -0.871 . . . . 0.0 108.955 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -33.83 40.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.356 -0.84 . . . . 0.0 109.149 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 139' ' ' LYS . 71.4 p -91.34 -1.46 57.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 109.476 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 78.3 p -48.09 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.48 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 137' ' ' THR . 44.4 mttp -65.25 -19.29 65.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.554 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -162.14 -24.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.565 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.47 179.961 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.525 HG13 ' N ' ' B' ' 2' ' ' HIS . 7.9 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' B' ' 2' ' ' HIS . 0.4 OUTLIER -167.01 56.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.168 -0.957 . . . . 0.0 109.603 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.985 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -122.17 -174.11 2.82 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.344 -0.847 . . . . 0.0 109.286 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.498 ' O ' ' N ' ' B' ' 6' ' ' GLU . 9.6 p -104.77 143.67 27.17 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.471 -0.768 . . . . 0.0 109.129 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -39.33 -22.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.561 2.174 . . . . 0.0 112.349 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' B' ' 4' ' ' THR . 25.1 mt-10 -75.5 -57.05 4.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.903 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -80.75 -22.93 39.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 109.798 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.708 ' HB2' HD13 ' B' ' 3' ' ' LEU . 2.5 tttm -79.77 -31.99 40.94 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.222 -0.924 . . . . 0.0 109.281 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 11.1 t -63.92 -23.36 67.32 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.686 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.08 -57.68 3.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.074 -1.016 . . . . 0.0 110.062 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.43 ' H ' HG12 ' B' ' 11' ' ' VAL . 1.8 p -62.12 -24.44 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 73.9 m -84.06 -35.47 23.76 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.364 0.602 . . . . 0.0 109.588 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -64.25 -60.05 3.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.4 -0.812 . . . . 0.0 109.751 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.447 ' O ' HG23 ' B' ' 18' ' ' VAL . 7.9 mp -43.59 -18.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.51 -0.744 . . . . 0.0 110.139 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . 0.537 ' N ' ' O ' ' B' ' 13' ' ' ALA . 25.9 t90 -75.45 -33.39 60.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 0.0 109.499 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 13' ' ' ALA . . . -67.28 -52.54 30.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.687 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -56.22 -36.41 68.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.364 -1.08 . . . . 0.0 109.236 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 14' ' ' LEU . 6.6 t -57.32 117.35 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.421 -0.8 . . . . 0.0 109.695 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' B' ' 21' ' ' ASP . 60.9 t30 -87.96 81.08 7.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.343 -0.848 . . . . 0.0 108.964 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.412 ' C ' ' N ' ' B' ' 22' ' ' GLU . 91.2 t -44.41 -17.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.779 . . . . 0.0 109.781 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' B' ' 19' ' ' ASN . 22.2 t70 -51.12 -15.35 0.33 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.674 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.412 ' N ' ' C ' ' B' ' 20' ' ' VAL . 33.7 mt-10 -156.17 -37.55 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.619 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -47.44 -54.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.617 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.32 -33.33 70.27 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.62 -49.63 74.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' B' ' 28' ' ' LEU . 90.6 mt-10 -73.08 -44.27 60.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -1.137 . . . . 0.0 109.501 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.52 -22.23 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' B' ' 26' ' ' GLU . 0.2 OUTLIER -82.78 -57.97 3.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.292 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.6 -43.74 59.37 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -50.17 -33.57 19.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -1.137 . . . . 0.0 109.43 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . 0.478 HD21 ' CMC' ' B' ' 147' ' ' HEC . 42.0 tp -52.27 -36.94 54.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 24.4 mt -81.26 -42.57 20.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 109.844 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.423 HG23 ' H ' ' B' ' 33' ' ' VAL . 6.5 t -56.74 -54.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 0.0 109.427 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.599 HG22 ' CD2' ' A' ' 122' ' ' HIS . 21.6 t -68.41 -23.0 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.0 109.525 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -160.8 87.1 1.76 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.171 -0.956 . . . . 0.0 109.382 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.22 18.59 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.666 2.244 . . . . 0.0 112.22 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.506 ' C ' ' H ' ' B' ' 39' ' ' GLN . 1.3 p-90 -69.8 -19.95 63.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.476 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.493 HG23 ' CD1' ' B' ' 37' ' ' TRP . 75.8 p -69.83 35.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.857 . . . . 0.0 109.531 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . 0.532 ' O ' ' CD1' ' B' ' 42' ' ' PHE . 12.1 tt0 -73.27 14.78 0.28 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.644 ' NH1' ' HG2' ' C' ' 92' ' ' ARG . 64.7 mtt-85 -98.03 -48.95 4.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.384 -0.823 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -91.09 2.73 56.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 109.516 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' B' ' 39' ' ' GLN . 1.4 p90 -67.83 -4.34 12.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.58 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -46.86 -37.16 8.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 60.8 m -67.09 -43.46 82.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 109.436 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' B' ' 47' ' ' ASP . 2.6 m-85 -84.4 27.3 0.71 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.348 -0.845 . . . . 0.0 109.23 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.01 87.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' B' ' 45' ' ' PHE . 18.6 t0 -174.2 47.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.333 -1.098 . . . . 0.0 109.227 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.579 HD12 ' N ' ' B' ' 48' ' ' LEU . 9.5 mp -88.77 27.91 1.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 109.575 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 20.1 m -46.95 -37.67 9.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 109.321 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . 0.401 ' O ' ' N ' ' B' ' 53' ' ' ALA . 5.6 p -146.98 148.89 33.98 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.45 -0.781 . . . . 0.0 109.012 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.13 -42.51 2.22 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.518 2.145 . . . . 0.0 112.516 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.406 ' C ' ' N ' ' B' ' 54' ' ' VAL . 7.6 p-10 -77.37 -29.62 53.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.0 109.746 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -47.98 -19.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.879 . . . . 0.0 109.619 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.406 ' N ' ' C ' ' B' ' 52' ' ' ASP . 68.2 t -63.87 -61.45 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.656 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' B' ' 55' ' ' MET . 0.0 OUTLIER -81.5 4.41 21.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.535 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.37 1.33 84.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -87.32 150.23 48.73 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.236 -1.156 . . . . 0.0 109.304 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.73 -28.33 9.77 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.598 2.199 . . . . 0.0 112.377 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -39.34 19.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.933 . . . . 0.0 109.846 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 53.9 t -52.43 -42.67 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.468 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -78.97 -26.86 43.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.108 -0.995 . . . . 0.0 109.484 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.73 -58.06 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.487 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.804 ' NE2' ' C4D' ' B' ' 147' ' ' HEC . 1.6 t-80 -48.1 -23.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.191 -0.943 . . . . 0.0 109.545 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.23 -47.47 90.83 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -62.29 -35.57 79.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.182 . . . . 0.0 109.441 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . 0.76 ' HD3' ' CGA' ' B' ' 147' ' ' HEC . 53.2 mttm -60.58 -44.34 96.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.27 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 0.865 HG13 ' C2B' ' B' ' 147' ' ' HEC . 36.6 t -71.26 -58.83 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.274 -0.891 . . . . 0.0 109.22 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.448 ' O ' HD23 ' B' ' 68' ' ' LEU . 6.2 tt -48.78 -44.6 39.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.277 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.05 -47.06 41.62 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.57 32.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -1.156 . . . . 0.0 109.475 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -53.05 -22.8 6.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.898 . . . . 0.0 109.247 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.46 -41.01 22.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.445 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.39 -27.65 1.76 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.42 -60.16 5.27 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.23 -17.98 9.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -1.121 . . . . 0.0 109.302 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.52 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -80.53 -26.25 38.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.695 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 39.5 m80 -157.23 59.99 0.51 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.76 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 23.3 mt -56.41 -4.7 0.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 109.295 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' B' ' 77' ' ' HIS . 7.5 m-20 -51.82 -26.48 9.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.723 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.571 ' N ' HD22 ' B' ' 80' ' ' ASN . 0.0 OUTLIER -165.98 95.01 0.58 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.626 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.547 ' N ' HD12 ' B' ' 81' ' ' LEU . 6.3 mp -80.27 -58.75 2.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.36 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.468 ' HG3' ' HZ3' ' B' ' 82' ' ' LYS . 16.6 ttmm -47.44 -23.94 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 109.573 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.64 -49.29 11.18 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.531 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 1.3 t -73.9 -45.58 49.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -1.165 . . . . 0.0 109.647 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.531 ' N ' ' CG2' ' B' ' 84' ' ' THR . 48.4 m-85 -64.63 4.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.365 -0.834 . . . . 0.0 109.572 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -64.08 -34.02 77.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.944 . . . . 0.0 109.475 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.2 p -77.25 -53.06 8.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.606 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.54 ' N ' HD12 ' B' ' 88' ' ' LEU . 9.4 mp -51.25 -49.21 61.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.321 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 3.5 m -53.33 -49.37 67.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.362 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.53 -22.7 66.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.359 -0.838 . . . . 0.0 109.369 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.95 -57.87 3.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 0.0 109.667 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' B' ' 97' ' ' HIS . 45.2 m80 -68.64 -20.25 64.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 110.31 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 53.7 t -83.8 -60.92 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.03 . . . . 0.0 110.747 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -87.75 -56.08 3.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.023 . . . . 0.0 111.246 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -51.7 68.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.893 . . . . 0.0 110.759 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.679 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -98.47 -59.71 1.69 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.012 -1.055 . . . . 0.0 109.893 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.679 ' ND1' ' O ' ' B' ' 96' ' ' LEU . 0.0 OUTLIER 83.94 20.66 0.16 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.773 -0.579 . . . . 0.0 109.77 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.516 HG23 HD12 ' B' ' 96' ' ' LEU . 68.5 t -48.35 140.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.048 -1.032 . . . . 0.0 109.292 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -56.93 150.61 37.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.273 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.49 -7.76 21.9 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.539 2.159 . . . . 0.0 112.15 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.52 60.89 2.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.883 . . . . 0.0 109.542 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.414 ' ND2' ' CMC' ' B' ' 147' ' ' HEC . 0.3 OUTLIER -156.96 -34.69 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 109.633 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -64.14 -14.05 52.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.504 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.412 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 90.1 mtt-85 -86.25 -20.04 29.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.95 . . . . 0.0 109.778 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 37.2 mt -82.68 -53.61 5.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 109.792 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.922 HD22 ' HAB' ' B' ' 147' ' ' HEC . 4.1 tt -50.82 -46.32 59.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.79 -28.81 63.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 21.9 m120 -85.56 -20.78 29.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -1.173 . . . . 0.0 109.628 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 81.0 t -81.14 -28.86 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.56 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.94 -58.8 3.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.231 -0.918 . . . . 0.0 109.607 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.538 HG12 ' CD1' ' B' ' 130' ' ' TYR . 3.8 m -52.26 -26.07 8.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.296 -0.877 . . . . 0.0 109.929 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 t -70.43 -34.81 72.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 49.6 t -71.61 -22.48 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 109.56 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.423 ' CD1' ' OH ' ' B' ' 130' ' ' TYR . 14.6 mt -80.93 -47.11 14.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.488 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.484 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -51.96 -19.98 2.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.22 -0.925 . . . . 0.0 109.442 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -84.93 -63.05 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.544 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.79 -17.77 64.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.579 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -143.22 52.23 1.37 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.334 -0.854 . . . . 0.0 109.429 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -68.68 -13.01 65.28 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -77.99 -29.92 49.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -1.136 . . . . 0.0 109.395 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -94.29 14.48 20.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.569 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 0.1 OUTLIER -84.0 34.01 0.5 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.902 . . . . 0.0 109.533 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.464 ' H ' HG23 ' B' ' 123' ' ' THR . 1.2 p -48.11 148.78 2.86 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.268 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 4.9 Cg_exo -45.73 -53.41 5.66 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.397 2.065 . . . . 0.0 113.007 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 28.1 Cg_endo -63.09 -29.13 74.52 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.031 1.821 . . . . 0.0 112.228 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.435 HG23 ' OG1' ' B' ' 123' ' ' THR . 63.2 t -74.13 -13.73 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.51 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -83.47 -59.74 2.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 109.575 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -56.19 -32.69 64.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.405 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.82 26.24 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.538 ' CD1' HG12 ' B' ' 111' ' ' VAL . 1.3 t80 -131.19 -34.28 1.44 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.346 -0.846 . . . . 0.0 109.246 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 35' ' ' SER . 12.3 mt-30 -76.64 -63.44 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.736 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -47.29 -21.95 0.35 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.554 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . 0.584 HG22 HD21 ' B' ' 3' ' ' LEU . 2.9 t -71.14 -64.95 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.273 -0.892 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.02 -26.83 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.81 -29.95 8.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.255 -0.903 . . . . 0.0 109.435 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.01 -32.52 69.61 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.06 -37.35 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -1.148 . . . . 0.0 109.362 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.32 -33.36 75.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.427 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.627 HD21 HD21 ' D' ' 139' ' ' ASN . 65.3 t30 -72.57 -36.55 68.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.85 -48.49 74.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 109.364 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.27 -30.1 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.97 0.55 49.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 109.7 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -67.2 -27.9 67.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.18 -0.95 . . . . 0.0 109.608 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -89.4 -23.04 22.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.638 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -55.34 -5.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' B' ' 144' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.515 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.455 HD13 ' CE2' ' C' ' 128' ' ' PHE . 14.6 mt -139.02 -174.23 3.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.311 -0.868 . . . . 0.0 109.34 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.495 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.3 OUTLIER 175.94 -49.25 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.208 -0.933 . . . . 0.0 109.945 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' C' ' 3' ' ' SER . 72.1 Cg_exo -46.99 173.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.421 2.081 . . . . 0.0 112.641 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -65.12 -16.26 63.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.812 . . . . 0.0 109.64 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.457 ' C ' ' O ' ' C' ' 5' ' ' ALA . 1.2 m-20 -39.67 -40.63 0.94 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 0.0 109.647 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -60.51 -59.33 5.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 109.216 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 48.8 m -50.26 -28.63 8.03 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.356 -0.84 . . . . 0.0 109.156 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' C' ' 5' ' ' ALA . 55.6 m-80 -80.16 -35.3 36.75 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.417 HG21 ' CG ' ' C' ' 128' ' ' PHE . 41.2 t -74.86 -44.54 45.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.69 -39.74 89.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.408 -0.807 . . . . 0.0 108.84 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.87 -52.87 46.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.865 . . . . 0.0 109.154 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.719 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.95 -35.43 64.23 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.365 -0.834 . . . . 0.0 109.056 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.61 -17.46 61.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.314 -0.866 . . . . 0.0 109.007 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.52 -46.35 8.9 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 13.3 mmmt -68.93 -37.43 78.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 108.772 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.719 HG23 ' O ' ' C' ' 13' ' ' ALA . 99.4 t -61.14 -65.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 59.67 -137.6 49.64 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.15 29.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.5 -1.0 . . . . 0.0 110.363 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.584 ' H ' ' C ' ' C' ' 18' ' ' GLY . 93.0 m-70 -131.73 23.33 4.65 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -87.3 -61.55 1.7 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.672 -0.643 . . . . 0.0 109.573 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -48.41 -14.49 0.35 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' C' ' 21' ' ' ALA . 3.7 mm-40 -84.14 -56.48 3.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -1.076 . . . . 0.0 109.484 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.1 m-30 -59.59 -33.16 71.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.396 -0.815 . . . . 0.0 109.332 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.32 -22.95 76.49 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.7 -43.58 20.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.184 -1.186 . . . . 0.0 109.689 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.75 -20.05 65.88 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.283 -0.886 . . . . 0.0 109.374 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.4 -19.98 59.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' C' ' 58' ' ' HIS . 18.7 mt -73.03 -45.94 54.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.652 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -61.89 -17.86 58.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.677 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 36.2 mmt-85 -81.17 -31.82 33.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.552 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -73.06 -37.6 66.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.605 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' C' ' 33' ' ' PHE . 0.7 OUTLIER -63.06 -59.94 4.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 12.2 mt -59.25 -48.93 79.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.0 109.63 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.549 ' HG ' ' HD1' ' C' ' 36' ' ' PHE . 40.4 t -46.02 -27.43 0.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.922 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.549 ' HD1' ' HG ' ' C' ' 35' ' ' SER . 47.3 m-85 -154.13 123.79 3.25 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.126 -0.984 . . . . 0.0 109.476 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' C' ' 40' ' ' LYS . 73.2 Cg_endo -77.8 -19.47 12.59 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.425 2.083 . . . . 0.0 112.272 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 21.2 p -43.91 -19.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 109.851 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.515 ' N ' ' O ' ' C' ' 37' ' ' PRO . 3.5 p -90.18 -22.89 21.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' C' ' 37' ' ' PRO . 27.9 ttmt -50.16 -18.7 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 109.922 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 9.1 t -105.65 -18.45 14.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 109.835 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.4 38.12 1.56 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.695 ' O ' ' CG ' ' C' ' 43' ' ' PHE . 6.3 p90 -115.07 81.18 7.56 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.43 -0.794 . . . . 0.0 109.932 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.33 -6.24 15.47 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.398 2.065 . . . . 0.0 111.917 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.51 ' CG ' ' O ' ' C' ' 45' ' ' HIS . 0.3 OUTLIER -165.69 50.91 0.09 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.387 -0.82 . . . . 0.0 108.941 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.592 ' O ' ' HG ' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -156.15 71.08 0.71 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' C' ' 49' ' ' SER . 0.9 OUTLIER -46.34 -13.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.602 -0.687 . . . . 0.0 111.242 -178.252 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' C' ' 46' ' ' PHE . 9.6 mt 58.93 -5.34 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.787 -1.196 . . . . 0.0 109.664 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.59 ' H ' ' C ' ' C' ' 47' ' ' ASP . 0.0 OUTLIER -46.88 124.95 6.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.0 109.544 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -53.38 138.99 31.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.25 27.82 65.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' C' ' 53' ' ' ALA . 3.2 m -60.89 -97.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -1.141 . . . . 0.0 109.336 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' C' ' 52' ' ' SER . . . 167.83 -64.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.459 -0.776 . . . . 0.0 109.175 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -45.56 -17.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.541 -0.724 . . . . 0.0 109.534 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' C' ' 53' ' ' ALA . 61.6 t -73.86 -30.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.284 -0.885 . . . . 0.0 109.758 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -70.96 -26.46 63.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.85 -22.81 68.25 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 0.4 OUTLIER -79.22 -39.9 32.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.298 -1.119 . . . . 0.0 109.603 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.15 -50.02 53.54 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 49.7 mttp -52.06 -23.73 5.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -1.149 . . . . 0.0 109.966 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.664 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 10.2 mmpt? -72.55 -45.15 60.65 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.117 -0.99 . . . . 0.0 109.072 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.59 -46.12 83.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.531 -0.731 . . . . 0.0 109.277 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.86 -30.94 68.53 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.222 -0.923 . . . . 0.0 109.346 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 2.4 t70 -69.44 -34.49 74.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.957 . . . . 0.0 108.83 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.84 -51.38 62.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 108.918 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 13.7 mt -56.28 -46.47 79.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.241 -0.912 . . . . 0.0 108.739 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -62.61 -51.66 66.42 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.328 -0.857 . . . . 0.0 108.81 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.6 -22.75 62.25 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.58 -47.06 10.94 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.64 -22.88 31.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.75 -16.91 64.58 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.597 ' O ' ' N ' ' C' ' 74' ' ' ASP . 15.8 m80 -143.88 -60.07 0.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.515 -0.741 . . . . 0.0 109.388 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.553 HG12 ' O ' ' C' ' 72' ' ' HIS . 12.8 p 44.63 14.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.817 0.818 . . . . 0.0 109.376 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' C' ' 72' ' ' HIS . 13.7 m-20 -131.23 11.41 4.99 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.439 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 1.8 p-10 -177.77 31.76 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.962 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.694 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 0.0 OUTLIER -77.98 -24.23 0.44 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.458 -0.776 . . . . 0.0 111.655 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' C' ' 76' ' ' MET . 75.3 Cg_exo -50.3 -33.82 38.19 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.689 1.593 . . . . 0.0 112.279 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -94.34 -16.05 23.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.53 -58.04 3.39 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.123 -0.986 . . . . 0.0 109.139 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 mt -77.16 10.18 2.58 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.395 -0.815 . . . . 0.0 108.962 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -61.0 -28.81 69.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -63.85 -50.68 67.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.509 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 4.5 mt -47.27 -47.29 25.1 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' C' ' 88' ' ' ALA . 20.7 t -55.36 -25.8 37.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.498 -0.751 . . . . 0.0 109.247 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' C' ' 89' ' ' HIS . 1.9 m-20 -78.55 -53.01 7.66 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.935 . . . . 0.0 109.463 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.512 HD11 ' O1D' ' C' ' 142' ' ' HEC . 5.2 tt -58.2 -28.76 65.11 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.302 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 8.3 m80 -92.58 -21.66 19.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 110.048 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -112.21 -2.28 14.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.234 -0.916 . . . . 0.0 110.414 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' C' ' 85' ' ' ASP . 78.0 m80 -142.6 36.08 1.46 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.984 -1.073 . . . . 0.0 110.096 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -171.57 -77.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.04 -1.037 . . . . 0.0 109.72 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' C' ' 91' ' ' LEU . 4.3 mm? -72.52 -37.34 68.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 109.327 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . 0.644 ' HG2' ' NH1' ' B' ' 40' ' ' ARG . 28.1 ttm180 55.64 52.38 11.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.575 ' O ' ' NH2' ' B' ' 40' ' ' ARG . 0.3 OUTLIER -78.68 -173.15 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.45 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' C' ' 96' ' ' VAL . 1.8 m-20 -123.8 113.67 28.52 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.464 -0.773 . . . . 0.0 109.169 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' C' ' 98' ' ' PHE . 84.8 Cg_exo -43.43 -14.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.216 1.944 . . . . 0.0 112.406 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' C' ' 94' ' ' ASP . 94.2 t -48.05 -25.66 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 109.551 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -79.44 -24.8 42.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.644 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . 0.42 ' N ' ' O ' ' C' ' 95' ' ' PRO . 28.5 t80 -46.43 -40.79 12.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 109.55 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -59.5 -24.93 64.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 109.653 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 20.2 mt -84.13 -61.26 1.86 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.628 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.543 HD22 ' CHC' ' C' ' 142' ' ' HEC . 6.3 tp -48.01 -41.02 24.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 9.2 t -61.96 -42.3 98.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.715 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -80.94 -26.59 36.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 109.676 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 79.8 m -58.31 -56.86 16.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.161 -0.962 . . . . 0.0 109.625 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 4.5 mt -47.07 -37.06 8.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.526 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 14.0 mt -70.19 -31.01 68.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.782 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.89 -24.88 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.924 . . . . 0.0 109.586 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 28.1 m -81.78 -62.95 1.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.596 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' C' ' 113' ' ' LEU . 12.5 mt -46.26 -39.9 10.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.895 . . . . 0.0 109.581 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.62 -42.33 7.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.958 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.1 -44.45 69.01 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.507 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -91.41 -77.25 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.63 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' C' ' 109' ' ' LEU . 1.9 tt -96.82 119.44 63.64 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.41 165.34 32.76 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.287 1.991 . . . . 0.0 112.821 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -87.79 -28.57 21.6 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.565 0.698 . . . . 0.0 109.647 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' C' ' 117' ' ' PHE . 83.8 mt-10 57.07 10.63 0.84 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' C' ' 116' ' ' GLU . 27.8 p90 40.58 32.51 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.314 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.703 ' O ' ' N ' ' C' ' 120' ' ' ALA . 3.2 p -56.03 134.35 74.06 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.44 18.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.387 2.058 . . . . 0.0 113.293 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.703 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -157.44 -20.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.623 -1.298 . . . . 0.0 111.543 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.438 HG12 ' N ' ' C' ' 122' ' ' HIS . 2.8 t -65.65 -63.01 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.513 -1.367 . . . . 0.0 110.106 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.598 ' CD2' HG22 ' D' ' 34' ' ' VAL . 0.0 OUTLIER -50.71 -31.02 15.29 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.28 -0.888 . . . . 0.0 108.868 -179.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.65 -20.03 31.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.742 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 20.4 p -64.8 -62.33 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.186 -0.946 . . . . 0.0 110.671 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.505 ' N ' ' OG ' ' C' ' 124' ' ' SER . 2.0 mt -72.98 -19.68 61.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.1 -1.0 . . . . 0.0 110.081 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -81.48 -43.42 18.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.029 -1.044 . . . . 0.0 109.948 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -87.33 -47.64 8.64 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.873 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' C' ' 128' ' ' PHE . 31.1 t80 -48.68 -21.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 0.0 109.447 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' C' ' 133' ' ' SER . 18.8 mt -73.62 -21.23 60.37 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -58.05 -32.96 68.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.445 ' OG ' HD11 ' C' ' 2' ' ' LEU . 0.7 OUTLIER -78.71 -30.43 45.95 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.44 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.07 -30.25 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.349 -0.845 . . . . 0.0 108.764 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.458 ' N ' ' O ' ' C' ' 129' ' ' LEU . 79.1 p -79.03 -25.1 43.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.347 -0.846 . . . . 0.0 108.968 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 53.5 m -70.69 -37.54 73.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.284 -0.885 . . . . 0.0 109.215 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 4.9 p -79.59 -22.0 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 108.871 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.65 -33.9 40.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.39 -0.818 . . . . 0.0 109.144 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . 0.446 ' O ' ' N ' ' C' ' 139' ' ' LYS . 69.8 p -91.23 -1.54 57.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 109.58 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 78.4 p -48.07 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' C' ' 137' ' ' THR . 44.4 mttp -65.29 -19.22 65.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -162.2 -24.48 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.438 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.535 HG13 ' N ' ' D' ' 2' ' ' HIS . 7.9 p . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . 0.581 ' CG ' ' O ' ' D' ' 2' ' ' HIS . 0.4 OUTLIER -166.99 56.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.155 -0.966 . . . . 0.0 109.634 179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 1.035 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -122.25 -174.11 2.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.278 -0.889 . . . . 0.0 109.258 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.498 ' O ' ' N ' ' D' ' 6' ' ' GLU . 9.7 p -104.75 143.73 27.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 109.122 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -39.26 -22.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.637 2.224 . . . . 0.0 112.296 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' D' ' 4' ' ' THR . 25.2 mt-10 -75.55 -56.92 4.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.937 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -80.82 -22.82 39.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.944 . . . . 0.0 109.861 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.698 ' HB2' HD13 ' D' ' 3' ' ' LEU . 2.5 tttm -79.8 -31.97 40.75 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.254 -0.904 . . . . 0.0 109.296 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 11.2 t -63.84 -23.45 67.36 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.718 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.07 -57.66 3.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.057 -1.027 . . . . 0.0 110.086 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.43 ' H ' HG12 ' D' ' 11' ' ' VAL . 1.8 p -62.1 -24.42 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 75.1 m -84.13 -35.5 23.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.327 0.584 . . . . 0.0 109.547 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -64.29 -59.95 3.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.441 -0.787 . . . . 0.0 109.71 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.448 ' O ' HG23 ' D' ' 18' ' ' VAL . 7.9 mp -43.72 -18.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 0.0 110.117 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . 0.53 ' N ' ' O ' ' D' ' 13' ' ' ALA . 25.6 t90 -75.39 -33.37 61.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.917 -1.114 . . . . 0.0 109.532 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.31 -52.57 30.55 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.678 ' CD ' ' H ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -56.25 -36.37 68.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.326 -1.102 . . . . 0.0 109.189 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 14' ' ' LEU . 6.6 t -57.45 117.38 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.389 -0.819 . . . . 0.0 109.676 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' D' ' 21' ' ' ASP . 61.0 t30 -88.03 81.12 7.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 108.912 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' D' ' 22' ' ' GLU . 92.0 t -44.47 -17.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.413 -0.804 . . . . 0.0 109.846 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' D' ' 19' ' ' ASN . 22.2 t70 -51.15 -15.38 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.406 ' N ' ' C ' ' D' ' 20' ' ' VAL . 33.6 mt-10 -156.12 -37.67 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.4 HG11 HG13 ' D' ' 18' ' ' VAL . 77.2 t -47.38 -53.97 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 109.703 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.35 -33.28 70.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.67 -49.66 74.23 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' D' ' 28' ' ' LEU . 90.5 mt-10 -73.06 -44.27 60.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -1.171 . . . . 0.0 109.505 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.51 -22.28 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.618 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' D' ' 26' ' ' GLU . 0.2 OUTLIER -82.65 -58.01 3.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.288 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.64 -43.68 59.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -50.13 -33.61 19.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -1.134 . . . . 0.0 109.482 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . 0.474 HD21 ' CMC' ' D' ' 147' ' ' HEC . 42.1 tp -52.3 -36.93 54.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.935 . . . . 0.0 109.494 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.17 -42.69 20.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 6.5 t -56.72 -54.06 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.155 -0.965 . . . . 0.0 109.432 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.598 HG22 ' CD2' ' C' ' 122' ' ' HIS . 21.6 t -68.41 -23.05 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.525 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -160.8 86.99 1.77 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -83.0 18.36 1.5 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.74 2.293 . . . . 0.0 112.281 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . 0.528 ' C ' ' H ' ' D' ' 39' ' ' GLN . 1.3 p-90 -69.68 -19.98 63.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.464 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.49 HG23 ' CD1' ' D' ' 37' ' ' TRP . 75.8 p -69.92 35.63 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.175 -0.953 . . . . 0.0 109.568 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' D' ' 37' ' ' TRP . 12.1 tt0 -73.23 14.77 0.28 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.322 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . 0.666 ' NH1' ' HG2' ' A' ' 92' ' ' ARG . 64.7 mtt-85 -98.03 -48.9 4.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.483 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -91.17 2.73 56.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.128 -0.983 . . . . 0.0 109.531 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' D' ' 39' ' ' GLN . 1.4 p90 -67.87 -4.33 12.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 109.619 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -46.81 -37.17 8.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.876 . . . . 0.0 109.657 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 60.5 m -67.13 -43.39 82.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' D' ' 47' ' ' ASP . 2.6 m-85 -84.34 27.3 0.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.248 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.97 87.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' D' ' 45' ' ' PHE . 18.7 t0 -174.2 47.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -1.101 . . . . 0.0 109.252 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . 0.574 HD12 ' N ' ' D' ' 48' ' ' LEU . 9.5 mp -88.78 27.92 1.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.894 . . . . 0.0 109.564 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -46.94 -37.67 9.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.297 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . 0.41 ' O ' ' N ' ' D' ' 53' ' ' ALA . 5.6 p -147.07 148.8 33.46 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.034 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -39.04 -42.54 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.552 2.168 . . . . 0.0 112.447 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . 0.404 ' C ' ' N ' ' D' ' 54' ' ' VAL . 7.6 p-10 -77.39 -29.62 53.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 0.0 109.728 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -48.04 -19.64 0.27 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 109.572 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 52' ' ' ASP . 67.1 t -63.93 -61.43 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.608 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' D' ' 55' ' ' MET . 0.0 OUTLIER -81.52 4.4 21.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.505 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.4 1.34 84.14 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . 0.404 HD21 ' CB ' ' D' ' 47' ' ' ASP . 20.6 m120 -87.39 150.21 48.53 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.222 -1.163 . . . . 0.0 109.348 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.79 -28.26 9.72 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.576 2.184 . . . . 0.0 112.314 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -39.32 19.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 109.848 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 53.8 t -52.38 -42.75 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.062 -1.024 . . . . 0.0 109.428 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -79.01 -26.8 43.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.933 . . . . 0.0 109.458 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.76 -58.01 3.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.55 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.803 ' NE2' ' C4D' ' D' ' 147' ' ' HEC . 1.6 t-80 -48.14 -23.9 0.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.561 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -61.3 -47.37 91.25 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -62.24 -35.67 79.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -1.203 . . . . 0.0 109.475 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . 0.761 ' HD3' ' CGA' ' D' ' 147' ' ' HEC . 53.0 mttm -60.56 -44.39 96.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.837 . . . . 0.0 109.248 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.862 HG13 ' C2B' ' D' ' 147' ' ' HEC . 36.3 t -71.21 -58.77 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -0.879 . . . . 0.0 109.25 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.449 ' O ' HD23 ' D' ' 68' ' ' LEU . 6.2 tt -48.88 -44.54 40.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.275 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.03 -47.06 41.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.96 -55.63 32.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -1.199 . . . . 0.0 109.393 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -53.0 -22.85 6.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.321 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.33 -41.1 22.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -0.834 . . . . 0.0 109.565 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.34 -27.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.408 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.41 -60.16 5.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.7 mp -56.25 -17.93 8.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.298 -1.119 . . . . 0.0 109.342 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -80.6 -26.13 38.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.237 -0.914 . . . . 0.0 109.701 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 39.5 m80 -157.36 60.01 0.5 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.688 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 23.2 mt -56.36 -4.8 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.045 -1.034 . . . . 0.0 109.309 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' D' ' 77' ' ' HIS . 7.5 m-20 -51.8 -26.47 9.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.714 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.556 ' N ' HD22 ' D' ' 80' ' ' ASN . 0.0 OUTLIER -166.04 94.96 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . 0.531 ' N ' HD12 ' D' ' 81' ' ' LEU . 6.3 mp -80.26 -58.71 3.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . 0.435 ' HG3' ' HZ3' ' D' ' 82' ' ' LYS . 16.6 ttmm -47.44 -23.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.915 . . . . 0.0 109.567 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.81 -49.12 10.81 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.522 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 1.3 t -73.93 -45.67 49.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -1.207 . . . . 0.0 109.599 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.522 ' N ' ' CG2' ' D' ' 84' ' ' THR . 48.5 m-85 -64.66 4.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.398 -0.813 . . . . 0.0 109.613 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -64.1 -33.94 76.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.96 . . . . 0.0 109.507 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.4 p -77.31 -53.09 8.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.54 ' N ' HD12 ' D' ' 88' ' ' LEU . 9.4 mp -51.17 -49.31 61.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 3.5 m -53.3 -49.37 67.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.339 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -62.55 -22.72 66.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.335 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.1 tp -82.86 -57.99 3.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.316 -0.865 . . . . 0.0 109.617 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.574 ' O ' ' N ' ' D' ' 97' ' ' HIS . 45.2 m80 -68.54 -20.35 64.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.844 . . . . 0.0 110.337 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 53.6 t -83.72 -60.94 1.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.953 -1.092 . . . . 0.0 110.781 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -87.78 -56.07 3.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -0.982 . . . . 0.0 111.283 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -51.66 68.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.308 -0.87 . . . . 0.0 110.794 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.665 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -98.47 -59.61 1.71 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.983 -1.073 . . . . 0.0 109.956 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.665 ' ND1' ' O ' ' D' ' 96' ' ' LEU . 0.0 OUTLIER 83.77 20.79 0.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.812 -0.555 . . . . 0.0 109.761 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . 0.525 HG23 HD12 ' D' ' 96' ' ' LEU . 67.3 t -48.43 140.63 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 109.231 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -57.02 150.64 38.54 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.285 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.44 -7.78 21.97 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.524 2.149 . . . . 0.0 112.208 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -95.56 60.83 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 0.0 109.503 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.406 ' ND2' ' CMC' ' D' ' 147' ' ' HEC . 0.3 OUTLIER -156.86 -34.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 109.602 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -64.09 -14.02 51.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.969 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 89.9 mtt-85 -86.31 -19.97 29.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.769 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 37.3 mt -82.74 -53.56 5.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.821 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.925 HD22 ' HAB' ' D' ' 147' ' ' HEC . 4.1 tt -50.79 -46.41 59.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 109.485 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -58.74 -28.86 63.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 21.9 m120 -85.57 -20.71 29.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -1.215 . . . . 0.0 109.606 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.25 -28.69 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 8.8 tp -68.11 -58.7 4.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.627 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . 0.538 HG12 ' CD1' ' D' ' 130' ' ' TYR . 3.8 m -52.31 -26.16 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.179 -0.951 . . . . 0.0 109.819 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 18.4 t -70.31 -34.78 73.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.909 . . . . 0.0 109.743 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 49.8 t -71.7 -22.33 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.947 . . . . 0.0 109.6 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . 0.42 ' CD1' ' OH ' ' D' ' 130' ' ' TYR . 14.6 mt -81.03 -47.11 14.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -51.96 -19.93 2.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.928 . . . . 0.0 109.473 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -84.95 -62.99 1.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.9 -17.67 64.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.92 . . . . 0.0 109.575 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -143.22 52.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.555 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -68.72 -12.92 65.24 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -78.06 -29.9 49.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -1.134 . . . . 0.0 109.394 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -94.27 14.5 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.892 . . . . 0.0 109.569 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -83.96 34.04 0.5 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.0 109.597 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.434 ' H ' HG23 ' D' ' 123' ' ' THR . 1.2 p -48.17 148.84 2.88 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 109.228 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.514 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.1 Cg_exo -45.88 -53.31 5.86 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.395 2.063 . . . . 0.0 112.923 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 28.3 Cg_endo -63.12 -29.04 74.12 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.004 1.803 . . . . 0.0 112.297 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.433 HG23 ' OG1' ' D' ' 123' ' ' THR . 63.0 t -74.23 -13.64 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.496 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -83.52 -59.76 2.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -56.24 -32.56 64.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.374 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.92 26.3 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.33 -0.857 . . . . 0.0 109.471 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.538 ' CD1' HG12 ' D' ' 111' ' ' VAL . 1.3 t80 -131.27 -34.24 1.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.409 -0.807 . . . . 0.0 109.291 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 0.52 ' NE2' ' OG ' ' C' ' 35' ' ' SER . 12.3 mt-30 -76.64 -63.5 1.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.646 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -47.34 -21.86 0.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 109.569 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . 0.569 HG22 HD21 ' D' ' 3' ' ' LEU . 2.9 t -71.22 -64.91 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.546 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.402 HG23 ' H ' ' D' ' 134' ' ' VAL . 2.6 t -69.06 -26.79 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -49.9 -29.9 9.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.41 69.49 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.11 -37.32 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -1.141 . . . . 0.0 109.396 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.34 -33.42 75.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.375 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.627 HD21 HD21 ' B' ' 139' ' ' ASN . 65.3 t30 -72.55 -36.46 68.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.458 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.92 -48.46 74.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 mt -60.16 -30.19 69.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.426 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.92 0.56 49.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 109.681 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -67.12 -27.97 67.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.9 OUTLIER -89.54 -22.85 22.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.955 . . . . 0.0 109.593 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -55.44 -5.4 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.493 ' H ' ' C ' ' D' ' 144' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.428 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.79 HMB1 HBB2 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 0.922 ' HAB' HD22 ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.793 HMB1 HBB2 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 0.925 ' HAB' HD22 ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.517 HD11 ' HD3' ' A' ' 127' ' ' LYS . 9.5 tp -172.34 163.4 5.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 109.857 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -75.74 -176.92 0.63 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.368 -0.832 . . . . 0.0 109.058 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 58.4 Cg_endo -86.87 -68.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.664 2.243 . . . . 0.0 112.716 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -47.54 -40.44 18.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.054 -1.029 . . . . 0.0 109.485 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 10' ' ' VAL . 63.9 m-20 -43.55 -29.46 0.48 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.86 . . . . 0.0 109.02 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 10' ' ' VAL . 58.4 mttt -83.08 -53.72 5.59 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' LYS . 35.9 m -44.65 -38.51 4.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.448 -0.782 . . . . 0.0 109.282 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -72.46 -29.69 63.9 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 6' ' ' ASP . 54.1 t -75.12 -55.0 12.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' H ' ' CD ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -51.65 -39.11 57.52 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.23 179.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.18 -63.12 1.37 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.322 -0.861 . . . . 0.0 109.296 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.564 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -54.68 -38.61 67.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.388 -0.82 . . . . 0.0 108.892 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.94 -17.58 63.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.466 -0.772 . . . . 0.0 108.981 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.14 -44.98 16.61 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 39.1 mmtt -68.23 -41.4 81.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -1.137 . . . . 0.0 108.859 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 13' ' ' ALA . 61.2 t -60.28 -64.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 50.0 -127.87 25.1 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.47 24.68 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.474 -1.015 . . . . 0.0 110.381 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.544 ' H ' ' C ' ' A' ' 18' ' ' GLY . 87.4 m-70 -130.38 28.49 4.95 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -93.36 -61.31 1.59 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.671 -0.643 . . . . 0.0 109.778 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.27 -14.3 0.16 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.6 mt-10 -86.54 -56.29 3.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -1.117 . . . . 0.0 109.761 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 4.1 m-30 -59.79 -32.36 70.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 109.59 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.04 -22.92 76.13 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.92 -41.86 18.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -1.17 . . . . 0.0 109.959 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -65.93 -19.88 66.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.294 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.77 -20.4 60.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.436 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.554 HD11 ' ND1' ' A' ' 58' ' ' HIS . 14.1 mt -74.52 -51.11 15.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.739 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.66 -22.43 65.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.164 -0.96 . . . . 0.0 109.584 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.997 HH21 ' HB2' ' B' ' 127' ' ' GLN . 2.3 tpt180 -73.37 -20.75 60.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.311 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 46.1 ttp -78.36 -53.64 7.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.862 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -48.36 -24.2 1.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.351 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.079 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.5 mt -82.32 -46.2 13.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.136 -0.978 . . . . 0.0 109.579 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.523 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 46.0 m -69.21 -20.78 63.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 35' ' ' SER . 95.5 m-85 -158.4 79.23 3.14 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.988 . . . . 0.0 109.737 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.31 -26.42 15.67 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.659 2.239 . . . . 0.0 112.07 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.433 ' O ' ' CG2' ' A' ' 41' ' ' THR . 12.6 p -49.45 -18.24 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.918 . . . . 0.0 109.477 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.6 p -79.01 -22.34 45.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.656 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -46.01 -42.91 13.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.583 HG21 ' HD1' ' D' ' 97' ' ' HIS . 0.0 OUTLIER -62.42 -35.76 80.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.461 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -76.79 22.46 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.173 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.445 ' H ' ' C ' ' A' ' 41' ' ' THR . 39.1 m-85 -146.03 59.75 5.8 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 -0.75 8.01 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.669 2.246 . . . . 0.0 111.942 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 15.9 p80 -141.79 56.95 1.5 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.165 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.662 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -149.81 69.32 1.02 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.548 ' C ' ' O ' ' A' ' 46' ' ' PHE . 1.1 m-20 -24.38 -37.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.855 -0.528 . . . . 0.0 111.203 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.662 ' N ' ' O ' ' A' ' 46' ' ' PHE . 4.3 mt 53.58 7.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.072 -1.017 . . . . 0.0 109.373 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 47' ' ' ASP . 4.9 m -64.34 5.7 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.507 ' H ' ' C ' ' A' ' 48' ' ' LEU . 37.8 t60 61.32 125.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.5 14.14 66.43 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.5 t -77.86 -103.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.164 -1.198 . . . . 0.0 109.41 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.91 -29.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.881 . . . . 0.0 109.496 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -80.03 -17.98 51.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.199 -0.938 . . . . 0.0 109.169 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -84.52 -40.14 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.295 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -77.3 -32.37 55.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.16 -21.82 75.02 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.554 ' ND1' HD11 ' A' ' 29' ' ' LEU . 7.8 t-80 -75.65 -37.54 59.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.314 -1.11 . . . . 0.0 109.781 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.12 -48.5 46.39 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -51.77 -23.13 4.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.415 -1.05 . . . . 0.0 109.979 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.39 -39.84 64.79 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.218 -0.926 . . . . 0.0 109.184 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.37 -33.6 19.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.457 -0.777 . . . . 0.0 108.935 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.16 -32.9 44.4 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.389 -0.82 . . . . 0.0 109.415 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -70.39 -33.37 71.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 108.861 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.557 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -70.01 -53.13 19.02 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.429 -0.794 . . . . 0.0 108.898 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.23 -38.24 70.8 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.254 -0.904 . . . . 0.0 108.717 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -71.5 -50.29 32.88 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.196 -0.94 . . . . 0.0 108.608 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -59.78 -21.15 60.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.202 -0.936 . . . . 0.0 108.496 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -81.07 -47.35 13.66 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.417 HG13 ' CE ' ' A' ' 11' ' ' LYS . 9.7 t -65.94 -22.85 31.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.72 -15.1 63.41 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 74' ' ' ASP . 36.8 m80 -139.5 -63.01 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.479 -0.763 . . . . 0.0 109.423 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 73' ' ' VAL . 12.3 p 43.92 13.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.752 0.787 . . . . 0.0 109.65 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.612 ' N ' ' O ' ' A' ' 72' ' ' HIS . 16.2 m-20 -134.25 10.39 3.81 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 20.3 t0 -177.02 28.35 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.148 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.7 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 11.4 ptt? -78.81 -22.45 0.38 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 111.805 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 76' ' ' MET . 71.8 Cg_exo -49.02 -29.0 14.69 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.473 1.449 . . . . 0.0 112.424 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -94.23 -24.41 17.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.175 -0.953 . . . . 0.0 109.653 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.29 -53.58 8.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.964 . . . . 0.0 109.143 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 mt -78.02 9.06 3.95 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.441 -0.787 . . . . 0.0 108.98 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 t -66.06 -41.5 90.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.412 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -52.46 -52.87 51.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.465 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 82' ' ' ALA . 4.9 mt -44.89 -45.05 10.11 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 9.9 p -55.75 -39.87 71.76 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' ALA . 25.7 t70 -67.58 -17.95 64.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.228 -0.92 . . . . 0.0 109.147 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.569 HD11 HBD1 ' A' ' 142' ' ' HEC . 1.2 tt -82.85 -43.46 16.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.333 -0.855 . . . . 0.0 109.378 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -92.45 -21.27 20.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.952 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -60.63 -87.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.106 -0.996 . . . . 0.0 110.741 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' A' ' 90' ' ' LYS . 44.9 t-80 -96.62 -46.3 6.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.245 -0.909 . . . . 0.0 111.02 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 89' ' ' HIS . 35.9 mttm -41.22 -94.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.22 -0.925 . . . . 0.0 110.324 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mp -67.54 -34.97 78.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.012 -1.055 . . . . 0.0 109.623 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.393 ' NH2' ' HE ' ' D' ' 40' ' ' ARG . 45.5 ttp85 60.89 58.2 2.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -0.954 . . . . 0.0 109.607 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 t -84.33 161.64 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 109.373 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.45 151.43 50.78 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 0.0 109.21 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 97' ' ' ASN . 58.4 Cg_endo -73.08 -18.8 23.6 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.55 2.167 . . . . 0.0 112.195 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.511 HG21 ' CB ' ' D' ' 99' ' ' ASP . 24.4 t -47.22 -20.04 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.743 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.672 HD22 ' N ' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -79.15 -24.73 43.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.709 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.546 ' CZ ' HD23 ' A' ' 136' ' ' LEU . 4.8 m-85 -46.66 -32.57 3.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.244 -0.91 . . . . 0.0 109.659 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.498 ' O ' ' ND1' ' A' ' 103' ' ' HIS . 55.8 mttm -83.89 -36.78 23.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 0.0 109.814 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 100' ' ' LEU . 7.2 mp -66.37 -61.93 1.74 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.131 -0.981 . . . . 0.0 109.516 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.567 HD22 ' CBB' ' A' ' 142' ' ' HEC . 6.4 tt -49.97 -47.4 52.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.239 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.8 t -61.9 -38.85 89.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.603 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 99' ' ' LYS . 22.9 m80 -77.37 -27.73 52.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.935 . . . . 0.0 109.609 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 70.8 m -64.74 -46.93 80.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.728 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.25 -48.64 65.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.435 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 106' ' ' LEU . 9.6 mp -61.54 -59.1 5.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.713 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.6 t -52.04 -34.3 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.237 -0.914 . . . . 0.0 109.386 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.8 m -75.77 -60.87 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.392 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 113' ' ' LEU . 13.1 mt -46.11 -41.44 12.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.901 . . . . 0.0 109.631 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.91 -28.58 0.68 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 110.182 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.89 -56.38 4.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.121 -0.987 . . . . 0.0 109.768 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -85.77 -65.13 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.466 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -95.92 106.89 30.89 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.2 171.17 9.48 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.718 1.612 . . . . 0.0 112.3 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 117' ' ' PHE . . . -87.22 -34.37 19.0 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.487 0.66 . . . . 0.0 109.88 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.534 ' O ' ' CG ' ' A' ' 117' ' ' PHE . 23.2 mt-10 55.63 9.96 0.46 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 116' ' ' GLU . 29.3 p90 40.63 32.34 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.54 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 120' ' ' ALA . 4.9 p -60.88 145.55 88.59 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.41 29.56 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 121.946 1.764 . . . . 0.0 111.773 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 124' ' ' SER . . . -162.61 -23.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.12 -0.988 . . . . 0.0 111.06 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.474 HG23 ' OG1' ' A' ' 118' ' ' THR . 2.6 t -59.86 -62.62 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.794 -1.191 . . . . 0.0 109.799 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.47 ' N ' HG12 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -60.72 -27.12 67.68 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.126 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.54 -20.09 32.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.291 -0.881 . . . . 0.0 109.522 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 120' ' ' ALA . 95.5 p -67.19 -62.0 1.64 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 110.8 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.6 mt -80.23 -19.88 45.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.925 -1.109 . . . . 0.0 110.81 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.69 -42.68 27.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.663 -1.273 . . . . 0.0 110.241 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.517 ' HD3' HD11 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -90.04 -45.0 9.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.958 -1.089 . . . . 0.0 110.126 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 10' ' ' VAL . 71.1 t80 -47.31 -21.55 0.3 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.01 -1.056 . . . . 0.0 109.454 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 129' ' ' LEU . 15.8 mt -69.63 -17.68 63.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.19 78.58 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.464 ' HB3' HD13 ' A' ' 2' ' ' LEU . 60.5 p -78.68 -25.92 44.88 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.362 -0.836 . . . . 0.0 108.747 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.1 t -84.99 -40.54 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.234 -0.916 . . . . 0.0 108.598 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.8 t -68.84 -28.76 67.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.397 -0.814 . . . . 0.0 109.297 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 51.6 m -64.65 -40.0 94.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.138 -0.976 . . . . 0.0 108.985 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 135' ' ' VAL . 2.7 p -82.68 -21.89 9.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.26 -0.9 . . . . 0.0 108.584 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.546 HD23 ' CZ ' ' A' ' 98' ' ' PHE . 1.1 tp -78.82 -28.26 44.4 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 138' ' ' SER . 49.1 m -68.14 -23.34 64.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.846 . . . . 0.0 109.405 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.7 OUTLIER 73.15 110.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -62.75 -98.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.236 -0.915 . . . . 0.0 109.405 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 47.45 76.25 0.11 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.534 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.724 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.75 HG13 ' N ' ' B' ' 2' ' ' HIS . 2.9 p . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 1.524 ' NE2' ' CD2' ' D' ' 146' ' ' HIS . 6.2 p80 -172.81 112.42 0.24 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.919 -1.113 . . . . 0.0 109.818 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.847 HD12 ' N ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -141.87 -162.63 1.43 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.26 -0.9 . . . . 0.0 109.149 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -93.77 131.08 32.9 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.0 109.237 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.45 -23.77 0.32 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.365 2.043 . . . . 0.0 112.308 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -81.46 -53.02 6.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.968 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' B' ' 7' ' ' GLU . 5.5 mp0 -61.3 -55.58 30.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 109.662 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.727 ' HB3' HD13 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -57.04 -35.44 69.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.869 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -58.67 -23.81 60.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 110.047 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.61 -56.45 3.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.094 -1.004 . . . . 0.0 109.712 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.599 HG23 ' CD2' ' B' ' 130' ' ' TYR . 0.9 OUTLIER -64.07 -25.15 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 75.9 m -78.7 -35.26 45.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -60.38 -61.52 2.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.425 -0.797 . . . . 0.0 109.328 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.522 ' O ' HG23 ' B' ' 18' ' ' VAL . 8.0 mp -43.62 -18.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.672 -0.642 . . . . 0.0 109.765 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . 0.532 ' N ' ' O ' ' B' ' 13' ' ' ALA . 22.1 t-105 -78.09 -17.96 56.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.972 . . . . 0.0 109.646 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.09 -42.61 7.49 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.665 ' CD ' ' H ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -68.75 -31.95 71.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -1.093 . . . . 0.0 109.214 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.522 HG23 ' O ' ' B' ' 14' ' ' LEU . 4.8 t -52.33 119.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -0.819 . . . . 0.0 109.692 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' B' ' 21' ' ' ASP . 54.9 m-20 -86.98 82.86 7.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.035 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' B' ' 22' ' ' GLU . 94.7 t -44.14 -20.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.816 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' B' ' 19' ' ' ASN . 12.6 m-20 -51.72 -8.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.73 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' B' ' 20' ' ' VAL . 34.8 mt-10 -155.53 -49.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 73.5 t -46.08 -26.73 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 109.779 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.09 -31.18 32.4 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -82.47 -25.67 49.96 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -84.73 -29.94 25.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.697 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.55 -23.45 63.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.949 . . . . 0.0 109.807 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.67 -58.16 3.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -0.97 . . . . 0.0 109.538 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.19 -29.35 68.36 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.5 ' NH2' HG13 ' B' ' 113' ' ' VAL . 3.3 ttp180 -68.37 -29.44 68.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -1.114 . . . . 0.0 109.745 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 tp -51.62 -39.7 58.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.244 -0.91 . . . . 0.0 109.652 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 mt -78.12 -21.85 49.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.825 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 45.7 t -71.83 -47.96 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.875 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.23 -63.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.019 -1.051 . . . . 0.0 109.787 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -119.42 97.09 50.16 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.396 -0.815 . . . . 0.0 109.754 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.485 ' O ' ' N ' ' B' ' 38' ' ' THR . 90.6 Cg_endo -85.59 10.52 3.67 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.717 2.278 . . . . 0.0 111.888 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -45.21 -19.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 109.694 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.662 ' C ' ' H ' ' B' ' 40' ' ' ARG . 11.0 p -46.96 -34.36 5.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.616 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 61.06 -13.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 1.403 ' HE ' ' NH2' ' C' ' 92' ' ' ARG . 79.8 mtt180 -88.94 -25.63 21.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.955 . . . . 0.0 108.946 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . 0.405 ' CD2' HD22 ' B' ' 48' ' ' LEU . 3.4 m-85 53.79 6.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -0.855 . . . . 0.0 109.415 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.624 ' CD2' ' CE1' ' B' ' 45' ' ' PHE . 3.0 m-85 48.11 30.08 2.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 109.163 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -48.41 -20.19 0.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 32.5 p -74.39 -14.66 60.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.952 . . . . 0.0 109.409 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.624 ' CE1' ' CD2' ' B' ' 42' ' ' PHE . 17.5 m-85 -85.53 -2.3 58.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.364 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.08 -101.9 0.21 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' B' ' 49' ' ' SER . 1.9 p-10 -178.24 111.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -1.115 . . . . 0.0 109.525 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.563 HD12 ' N ' ' B' ' 48' ' ' LEU . 8.6 mp -81.3 28.18 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 108.687 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.421 ' H ' ' C ' ' B' ' 47' ' ' ASP . 12.2 t -43.97 -29.66 0.61 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.527 -0.733 . . . . 0.0 110.25 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 13.8 p -140.22 146.93 48.09 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.014 -1.054 . . . . 0.0 109.728 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -40.13 -49.65 3.69 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.652 2.235 . . . . 0.0 112.293 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -69.47 -27.95 65.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 109.954 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.5 -19.43 37.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.067 -1.021 . . . . 0.0 109.545 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.05 -59.88 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 109.624 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 11.4 mtm -95.96 20.04 10.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.35 -17.23 50.85 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -86.54 149.99 50.18 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.181 -1.188 . . . . 0.0 109.443 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.13 -45.59 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.678 2.252 . . . . 0.0 112.341 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' B' ' 63' ' ' HIS . 50.1 mtpt -54.17 -51.91 62.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.889 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 59.2 t -52.67 -42.51 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.0 109.54 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -79.13 -25.98 42.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.886 . . . . 0.0 109.595 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.55 -59.04 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.644 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.475 ' O ' ' ND1' ' B' ' 63' ' ' HIS . 13.5 t-80 -49.28 -23.94 1.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.257 -0.902 . . . . 0.0 109.595 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.68 -28.51 73.08 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -65.97 -32.27 73.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -1.135 . . . . 0.0 109.187 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -70.32 -60.09 2.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 0.0 109.511 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . . . . . . . . . 28.3 t -46.33 -29.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 109.42 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -77.75 -34.86 52.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.287 -0.883 . . . . 0.0 109.369 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.66 -46.66 93.25 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.8 -44.57 82.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -1.175 . . . . 0.0 109.6 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' B' ' 75' ' ' LEU . 4.8 t80 -60.35 -53.52 56.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.457 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.507 ' OG ' ' NE1' ' B' ' 15' ' ' TRP . 62.5 m -51.94 -27.42 13.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.457 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' B' ' 84' ' ' THR . 10.5 t0 -49.74 -34.44 19.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.24 -59.85 6.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.497 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.2 mp -59.09 -17.93 30.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.374 -1.074 . . . . 0.0 109.398 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -84.89 -16.61 40.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 31.0 m80 -160.11 64.23 0.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.915 . . . . 0.0 109.607 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.416 HD22 HG12 ' B' ' 1' ' ' VAL . 93.2 mt -64.74 4.17 0.44 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.399 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' B' ' 77' ' ' HIS . 59.1 m-20 -75.54 -22.93 56.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.299 -0.875 . . . . 0.0 109.404 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -157.31 103.44 1.98 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.88 . . . . 0.0 109.378 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.583 HD22 ' N ' ' B' ' 81' ' ' LEU . 3.6 mm? -80.2 -58.78 2.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.416 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 1.432 ' NZ ' ' HZ1' ' D' ' 82' ' ' LYS . 83.5 mttt -55.25 -24.0 25.57 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.24 -60.23 7.84 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.0 t -69.43 -46.28 67.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -1.137 . . . . 0.0 109.36 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.552 ' N ' ' CG2' ' B' ' 84' ' ' THR . 46.9 m-85 -70.34 16.81 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.547 -0.721 . . . . 0.0 109.613 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -73.75 -38.97 64.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 11.3 p -80.44 -46.18 16.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.524 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 42.8 mt -56.11 -54.84 40.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.242 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -50.15 -29.8 9.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.221 -0.924 . . . . 0.0 109.007 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.63 -63.01 1.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.116 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 tt -49.65 -23.44 1.72 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 109.078 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' B' ' 88' ' ' LEU . 7.8 m80 -76.17 -54.27 7.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.475 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 24.3 t -82.59 -19.42 38.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.003 . . . . 0.0 109.868 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.27 -25.02 25.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.088 -1.008 . . . . 0.0 111.026 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.492 ' CA ' ' NE2' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -125.8 -51.96 1.57 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.843 -1.161 . . . . 0.0 110.796 -179.24 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.599 ' N ' HD12 ' B' ' 96' ' ' LEU . 8.0 mp -70.1 -58.12 4.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.974 -1.079 . . . . 0.0 110.096 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.582 ' N ' ' CD2' ' B' ' 97' ' ' HIS . 1.0 OUTLIER 72.18 19.84 4.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.326 -0.859 . . . . 0.0 109.584 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -57.86 132.11 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.138 -0.976 . . . . 0.0 109.199 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' B' ' 100' ' ' PRO . 0.7 OUTLIER -64.64 152.54 89.6 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.362 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.538 ' C ' HD22 ' B' ' 102' ' ' ASN . 74.1 Cg_exo -45.65 -175.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.43 2.087 . . . . 0.0 112.408 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 55.35 76.89 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.538 HD22 ' C ' ' B' ' 100' ' ' PRO . 0.8 OUTLIER -173.52 -56.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -58.34 -19.65 36.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.452 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -80.15 -44.59 19.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.219 -0.925 . . . . 0.0 109.533 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.3 -48.85 79.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.49 ' C ' HD23 ' B' ' 106' ' ' LEU . 5.2 tt -56.43 -54.43 45.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.357 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.06 -31.74 62.05 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -66.78 -53.49 32.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -1.216 . . . . 0.0 109.684 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.54 -47.53 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.475 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 tp -49.01 -26.75 2.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.86 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 26.0 t -70.78 -38.83 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.092 -1.005 . . . . 0.0 109.937 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 t -76.79 -22.93 52.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.001 . . . . 0.0 109.932 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . 0.5 HG13 ' NH2' ' B' ' 30' ' ' ARG . 97.1 t -68.74 -24.32 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.891 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' B' ' 116' ' ' HIS . 48.7 mt -82.58 -54.33 5.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.103 -0.998 . . . . 0.0 109.678 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.476 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.64 -19.88 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.63 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.49 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 0.3 OUTLIER -84.82 -62.87 1.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.16 -0.963 . . . . 0.0 109.427 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -62.34 -17.81 59.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.438 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -151.41 61.5 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.495 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -70.8 -19.53 76.86 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.54 -30.82 70.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -1.161 . . . . 0.0 109.372 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' B' ' 123' ' ' THR . 30.9 mt-10 -90.48 14.3 13.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.465 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.4 OUTLIER -70.78 35.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.909 . . . . 0.0 109.596 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.515 ' H ' ' C ' ' B' ' 121' ' ' GLU . 30.4 p -59.79 144.59 85.44 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.161 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.78 ' HA ' HH22 ' A' ' 31' ' ' ARG . 31.7 Cg_exo -44.82 -43.44 14.98 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.464 2.109 . . . . 0.0 113.408 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' B' ' 124' ' ' PRO . 3.0 Cg_exo -75.17 20.19 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.447 2.098 . . . . 0.0 112.175 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.49 HG23 ' OG1' ' B' ' 123' ' ' THR . 79.6 t -125.06 -29.78 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 109.565 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . 0.997 ' HB2' HH21 ' A' ' 31' ' ' ARG . 86.6 mm-40 -83.15 -59.7 2.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.99 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 1.079 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -56.64 -42.66 79.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.425 ' O ' HG23 ' B' ' 133' ' ' VAL . . . -70.06 11.07 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.536 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.599 ' CD2' HG23 ' B' ' 11' ' ' VAL . 4.9 t80 -105.2 -61.31 1.5 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.317 -0.864 . . . . 0.0 109.567 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.605 ' CD ' ' H ' ' B' ' 131' ' ' GLN . 3.8 mp0 -50.02 -38.39 37.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -0.949 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 1.126 ' HD3' ' O ' ' D' ' 146' ' ' HIS . 18.7 ttpp -64.68 -28.58 69.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.771 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . 0.697 HG22 HD21 ' B' ' 3' ' ' LEU . 79.4 t -71.45 -67.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.202 -0.936 . . . . 0.0 109.733 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.448 ' H ' HG22 ' B' ' 134' ' ' VAL . 2.4 m -61.3 -24.66 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.74 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -49.25 -29.32 5.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.6 -29.1 56.1 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.418 HG13 ' CE1' ' B' ' 85' ' ' PHE . 67.0 t -72.93 -34.28 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -1.133 . . . . 0.0 109.404 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.71 -48.18 63.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.469 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.48 ' C ' HD22 ' B' ' 139' ' ' ASN . 0.2 OUTLIER -77.76 -29.62 51.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.495 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.25 82.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.409 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.24 13.21 1.96 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.47 4.53 1.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 109.574 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' B' ' 139' ' ' ASN . 12.3 t-80 -79.39 -26.29 42.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.203 -0.935 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' B' ' 146' ' ' HIS . 0.8 OUTLIER -81.95 -1.38 47.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.521 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -66.07 7.64 0.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.94 . . . . 0.0 109.27 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 1.568 ' CD2' ' NE2' ' D' ' 2' ' ' HIS . 4.7 m-70 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.461 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.522 HD11 ' HD3' ' C' ' 127' ' ' LYS . 9.5 tp -172.41 163.46 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 109.777 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.8 OUTLIER -75.79 -177.06 0.65 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.016 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 58.4 Cg_endo -86.84 -68.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.606 2.204 . . . . 0.0 112.711 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -47.62 -40.31 19.22 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 109.542 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.597 ' O ' HG23 ' C' ' 10' ' ' VAL . 63.9 m-20 -43.6 -29.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 0.0 109.039 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' C' ' 10' ' ' VAL . 58.4 mttt -83.05 -53.78 5.55 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.414 ' C ' ' O ' ' C' ' 7' ' ' LYS . 35.4 m -44.7 -38.52 4.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.488 -0.757 . . . . 0.0 109.227 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -72.38 -29.7 64.01 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.597 HG23 ' O ' ' C' ' 6' ' ' ASP . 54.2 t -75.13 -55.07 12.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' C' ' 11' ' ' LYS . 0.1 OUTLIER -51.53 -39.25 57.34 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 118.649 -1.221 . . . . 0.0 108.229 179.109 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.05 -63.18 1.35 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 109.321 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.559 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -54.66 -38.64 67.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.388 -0.82 . . . . 0.0 108.836 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.91 -17.64 63.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.469 -0.769 . . . . 0.0 108.988 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.04 -45.09 16.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.425 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 39.2 mmtt -68.15 -41.48 81.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -1.137 . . . . 0.0 108.862 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.559 HG23 ' O ' ' C' ' 13' ' ' ALA . 61.4 t -60.16 -64.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 49.93 -127.9 24.86 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.39 24.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.388 -1.066 . . . . 0.0 110.426 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.548 ' H ' ' C ' ' C' ' 18' ' ' GLY . 87.4 m-70 -130.45 28.41 4.94 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -93.2 -61.24 1.61 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.642 -0.661 . . . . 0.0 109.849 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.41 -14.27 0.18 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.6 mt-10 -86.56 -56.27 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.405 -1.056 . . . . 0.0 109.764 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 4.1 m-30 -59.78 -32.44 70.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 0.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.9 -23.02 75.94 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.89 -41.8 18.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.139 -1.213 . . . . 0.0 109.974 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' C' ' 27' ' ' GLU . 0.1 OUTLIER -66.03 -19.84 65.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.261 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.77 -20.35 60.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.552 HD11 ' ND1' ' C' ' 58' ' ' HIS . 14.1 mt -74.48 -51.23 15.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 109.672 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -67.59 -22.35 65.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.943 HH21 ' HB2' ' D' ' 127' ' ' GLN . 2.3 tpt180 -73.38 -20.87 60.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.308 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 0.407 ' HB3' ' HE2' ' C' ' 32' ' ' MET . 46.0 ttp -78.19 -53.76 6.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.333 -0.854 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 0.0 OUTLIER -48.3 -24.25 1.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.397 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 1.087 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.6 mt -82.27 -46.11 14.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.656 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.527 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 45.8 m -69.27 -20.72 63.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.854 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' C' ' 35' ' ' SER . 95.5 m-85 -158.42 79.11 3.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.033 -1.042 . . . . 0.0 109.758 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.405 ' C ' ' N ' ' C' ' 39' ' ' THR . 51.8 Cg_exo -50.19 -26.43 15.22 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.612 2.208 . . . . 0.0 112.049 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' C' ' 41' ' ' THR . 12.6 p -49.44 -18.33 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.405 ' N ' ' C ' ' C' ' 37' ' ' PRO . 53.9 p -78.91 -22.32 46.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.722 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -46.11 -42.84 14.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.913 . . . . 0.0 109.776 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.502 HG21 ' HD1' ' B' ' 97' ' ' HIS . 0.0 OUTLIER -62.47 -35.74 80.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.459 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -76.74 22.31 0.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.145 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' C' ' 41' ' ' THR . 39.3 m-85 -145.95 59.73 5.84 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.54 -0.7 7.95 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.648 2.232 . . . . 0.0 111.914 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 15.9 p80 -141.82 56.93 1.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.787 . . . . 0.0 109.138 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.667 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -149.76 69.28 1.02 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' C' ' 46' ' ' PHE . 1.1 m-20 -24.35 -37.74 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.925 -0.484 . . . . 0.0 111.183 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.667 ' N ' ' O ' ' C' ' 46' ' ' PHE . 4.3 mt 53.7 7.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.06 -1.025 . . . . 0.0 109.344 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.484 ' H ' ' C ' ' C' ' 47' ' ' ASP . 5.0 m -64.32 5.69 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.601 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' C' ' 48' ' ' LEU . 38.1 t60 61.42 125.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.311 -0.868 . . . . 0.0 109.501 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.46 14.24 66.32 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . . . . . . . . . 13.5 t -77.81 -103.81 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -1.159 . . . . 0.0 109.48 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.96 -29.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.439 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -80.04 -17.97 51.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.265 -0.897 . . . . 0.0 109.157 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -84.35 -40.25 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -77.37 -32.37 54.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.222 -0.924 . . . . 0.0 109.082 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.14 -21.8 75.13 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.552 ' ND1' HD11 ' C' ' 29' ' ' LEU . 7.8 t-80 -75.7 -37.46 59.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -1.103 . . . . 0.0 109.721 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.22 -48.49 47.05 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -51.7 -23.15 4.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.365 -1.079 . . . . 0.0 110.063 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -39.83 64.68 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.109 -0.994 . . . . 0.0 109.218 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.29 -33.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.11 -32.95 44.71 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.378 -0.826 . . . . 0.0 109.462 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -70.33 -33.41 71.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.077 -1.014 . . . . 0.0 108.841 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.563 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -70.03 -53.14 18.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.412 -0.805 . . . . 0.0 108.843 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mt -56.29 -38.23 70.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 108.642 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -71.54 -50.28 32.78 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.83 -21.02 60.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -81.21 -47.37 13.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.424 HG13 ' CE ' ' C' ' 11' ' ' LYS . 10.0 t -65.84 -23.02 31.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.52 -15.21 63.46 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.62 ' O ' ' N ' ' C' ' 74' ' ' ASP . 36.8 m80 -139.42 -63.17 0.52 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.379 -0.825 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.59 HG22 ' O ' ' C' ' 73' ' ' VAL . 12.3 p 43.97 13.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.813 0.816 . . . . 0.0 109.634 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.62 ' N ' ' O ' ' C' ' 72' ' ' HIS . 16.2 m-20 -134.25 10.39 3.81 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.464 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 20.2 t0 -176.95 28.29 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.037 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.687 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 11.4 ptt? -78.87 -22.44 0.38 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 111.745 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' C' ' 76' ' ' MET . 72.7 Cg_exo -49.02 -29.03 14.75 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.569 1.513 . . . . 0.0 112.4 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -94.3 -24.29 17.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.709 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.36 -53.49 8.1 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.179 -0.951 . . . . 0.0 109.191 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 15.0 mt -78.05 9.13 3.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.43 -0.794 . . . . 0.0 109.022 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' C' ' 84' ' ' SER . 11.1 t -66.1 -41.59 90.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -52.3 -53.01 49.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 0.0 109.486 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' C' ' 83' ' ' LEU . 4.9 mt -44.83 -45.0 9.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' C' ' 88' ' ' ALA . 10.0 p -55.85 -39.77 71.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' C' ' 82' ' ' ALA . 25.8 t70 -67.64 -17.9 64.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.566 HD11 HBD1 ' C' ' 142' ' ' HEC . 1.2 tt -82.81 -43.45 16.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.35 -0.844 . . . . 0.0 109.469 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -92.42 -21.23 20.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 109.979 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' C' ' 84' ' ' SER . . . -60.73 -87.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 110.729 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . 0.459 ' O ' ' O ' ' C' ' 90' ' ' LYS . 45.1 t-80 -96.61 -46.21 6.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 111.043 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' C' ' 89' ' ' HIS . 35.9 mttm -41.33 -94.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.145 -0.972 . . . . 0.0 110.346 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.55 -34.95 78.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.017 . . . . 0.0 109.65 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . 1.403 ' NH2' ' HE ' ' B' ' 40' ' ' ARG . 45.6 ttp85 60.87 58.19 2.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 109.602 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 t -84.29 161.56 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 109.451 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.38 151.37 50.85 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.957 . . . . 0.0 109.342 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' C' ' 97' ' ' ASN . 58.6 Cg_endo -72.99 -18.86 23.8 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.524 2.149 . . . . 0.0 112.234 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.455 HG21 ' CB ' ' B' ' 99' ' ' ASP . 24.5 t -47.21 -19.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.733 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.671 HD22 ' N ' ' C' ' 97' ' ' ASN . 0.8 OUTLIER -79.12 -24.86 43.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.732 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . 0.538 ' CZ ' HD23 ' C' ' 136' ' ' LEU . 4.8 m-85 -46.63 -32.53 3.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 109.686 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.504 ' O ' ' ND1' ' C' ' 103' ' ' HIS . 55.7 mttm -83.94 -36.78 23.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 109.781 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.576 HD12 ' N ' ' C' ' 100' ' ' LEU . 7.2 mp -66.35 -62.02 1.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.491 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 1.554 HD22 ' CBB' ' C' ' 142' ' ' HEC . 6.4 tt -49.94 -47.39 52.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 42.7 t -61.95 -38.76 89.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.634 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' C' ' 99' ' ' LYS . 22.9 m80 -77.4 -27.59 52.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.621 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 70.8 m -64.8 -46.99 79.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.728 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.24 -48.6 65.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.454 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.471 ' N ' HD12 ' C' ' 106' ' ' LEU . 9.5 mp -61.51 -59.22 5.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 72.5 t -51.94 -34.25 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.457 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 16.8 m -75.77 -60.87 2.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 13.0 mt -46.11 -41.44 12.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.358 -0.839 . . . . 0.0 109.676 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.83 -28.74 0.68 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.153 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.83 -56.35 4.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.132 -0.98 . . . . 0.0 109.722 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -85.83 -65.08 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.472 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 109' ' ' LEU . 0.1 OUTLIER -95.94 106.86 30.72 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.21 171.23 9.38 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.73 1.62 . . . . 0.0 112.352 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' C' ' 117' ' ' PHE . . . -87.28 -34.34 18.94 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.441 0.639 . . . . 0.0 109.87 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.532 ' O ' ' CG ' ' C' ' 117' ' ' PHE . 23.2 mt-10 55.66 9.87 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' C' ' 116' ' ' GLU . 29.2 p90 40.63 32.42 0.15 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.522 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.491 ' OG1' HG23 ' C' ' 121' ' ' VAL . 5.0 p -60.96 145.66 88.75 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.47 29.51 0.13 Allowed 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.957 1.771 . . . . 0.0 111.734 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' C' ' 118' ' ' THR . . . -162.62 -23.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.174 -0.954 . . . . 0.0 111.072 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.491 HG23 ' OG1' ' C' ' 118' ' ' THR . 2.6 t -59.94 -62.55 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.829 -1.17 . . . . 0.0 109.818 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.455 ' N ' HG12 ' C' ' 121' ' ' VAL . 0.1 OUTLIER -60.76 -27.2 67.78 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.426 -0.797 . . . . 0.0 109.087 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.04 32.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -0.879 . . . . 0.0 109.645 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.476 ' N ' ' O ' ' C' ' 120' ' ' ALA . 95.7 p -67.25 -61.94 1.67 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 110.828 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 9.7 mt -80.15 -19.97 45.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.065 -1.022 . . . . 0.0 110.844 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -78.73 -42.49 28.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.759 -1.213 . . . . 0.0 110.332 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.522 ' HD3' HD11 ' C' ' 2' ' ' LEU . 0.0 OUTLIER -90.15 -44.88 9.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.999 -1.063 . . . . 0.0 110.17 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.424 ' CD1' HG21 ' C' ' 10' ' ' VAL . 71.2 t80 -47.3 -21.53 0.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.029 -1.044 . . . . 0.0 109.564 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.401 ' N ' ' C ' ' C' ' 127' ' ' LYS . 15.8 mt -69.66 -17.67 63.52 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.97 -38.25 78.66 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.448 ' HB3' HD13 ' C' ' 2' ' ' LEU . 60.5 p -78.66 -25.89 44.98 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.31 -0.869 . . . . 0.0 108.756 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 57.3 t -85.05 -40.48 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 2.7 t -68.85 -28.85 67.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.453 -0.779 . . . . 0.0 109.239 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 51.5 m -64.63 -39.99 94.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.189 -0.944 . . . . 0.0 109.015 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.402 ' H ' HG12 ' C' ' 135' ' ' VAL . 2.7 p -82.62 -21.9 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.538 HD23 ' CZ ' ' C' ' 98' ' ' PHE . 1.1 tp -78.83 -28.36 44.36 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' C' ' 138' ' ' SER . 49.8 m -68.15 -23.34 64.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 109.392 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' C' ' 137' ' ' THR . 0.7 OUTLIER 73.25 110.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 109.436 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -62.87 -98.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' C' ' 141' ' ' ARG . 64.5 m-85 47.3 76.29 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.613 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' C' ' 140' ' ' TYR . 74.2 mtt-85 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.664 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.745 HG13 ' N ' ' D' ' 2' ' ' HIS . 2.9 p . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . 1.568 ' NE2' ' CD2' ' B' ' 146' ' ' HIS . 6.2 p80 -172.91 112.53 0.23 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.895 -1.128 . . . . 0.0 109.756 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.867 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -141.96 -162.64 1.43 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.276 -0.89 . . . . 0.0 109.183 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -93.74 131.04 33.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 109.263 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.45 -23.68 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.329 2.019 . . . . 0.0 112.402 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -81.57 -53.02 6.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.816 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' D' ' 7' ' ' GLU . 5.5 mp0 -61.34 -55.52 30.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.747 ' HB3' HD13 ' D' ' 3' ' ' LEU . 0.0 OUTLIER -57.17 -35.42 69.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.806 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -58.71 -23.73 60.15 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.243 -0.91 . . . . 0.0 109.992 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.54 -56.61 3.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.978 -1.076 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.594 HG23 ' CD2' ' D' ' 130' ' ' TYR . 0.9 OUTLIER -63.98 -25.13 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 73.6 m -78.66 -35.24 45.55 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -60.5 -61.41 2.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 109.252 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.512 ' O ' HG23 ' D' ' 18' ' ' VAL . 8.0 mp -43.73 -18.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 109.759 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' D' ' 13' ' ' ALA . 22.1 t-105 -78.03 -18.04 56.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.148 -0.97 . . . . 0.0 109.646 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.97 -42.72 7.49 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.665 ' CD ' ' H ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -68.66 -31.97 71.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -1.12 . . . . 0.0 109.2 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.512 HG23 ' O ' ' D' ' 14' ' ' LEU . 4.7 t -52.4 119.89 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.655 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' D' ' 21' ' ' ASP . 55.8 m-20 -86.99 82.85 7.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 108.98 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.479 ' C ' ' H ' ' D' ' 22' ' ' GLU . 91.6 t -43.99 -20.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.421 -0.799 . . . . 0.0 109.789 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' D' ' 19' ' ' ASN . 12.7 m-20 -51.62 -8.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.802 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' D' ' 20' ' ' VAL . 34.8 mt-10 -155.48 -49.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.162 -0.961 . . . . 0.0 109.629 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 74.1 t -46.11 -26.74 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.788 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.05 -31.18 32.53 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -82.56 -25.65 49.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -84.67 -29.99 25.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -1.144 . . . . 0.0 109.682 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.47 -23.49 63.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.812 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.68 -58.25 3.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.477 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.21 -29.27 68.25 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . 0.498 ' NH2' HG13 ' D' ' 113' ' ' VAL . 3.3 ttp180 -68.43 -29.43 68.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.681 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . 0.616 ' CD2' HBC2 ' B' ' 147' ' ' HEC . 35.7 tp -51.61 -39.75 58.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.635 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . 1.195 ' O ' HMB1 ' D' ' 147' ' ' HEC . 16.8 mt -78.04 -21.88 50.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.878 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.85 -47.93 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.869 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -63.35 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.09 -1.006 . . . . 0.0 109.788 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -119.42 97.01 50.16 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 0.0 109.814 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' D' ' 38' ' ' THR . 90.9 Cg_endo -85.57 10.56 3.65 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.659 2.239 . . . . 0.0 111.906 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 p-90 -45.24 -19.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 0.0 109.732 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.645 ' C ' ' H ' ' D' ' 40' ' ' ARG . 10.9 p -46.95 -34.37 5.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.366 -0.834 . . . . 0.0 109.637 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 61.09 -13.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.38 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . 1.393 ' HE ' ' NH2' ' A' ' 92' ' ' ARG . 79.9 mtt180 -89.01 -25.55 21.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 108.971 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.602 ' HE1' ' NB ' ' D' ' 147' ' ' HEC . 3.4 m-85 53.68 6.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 109.429 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.851 ' HZ ' ' HHD' ' B' ' 147' ' ' HEC . 3.0 m-85 48.03 30.14 1.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.174 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -48.34 -20.21 0.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 109.72 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 33.1 p -74.46 -14.66 60.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.973 . . . . 0.0 109.392 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.613 ' CE1' ' CD2' ' D' ' 42' ' ' PHE . 17.4 m-85 -85.42 -2.38 58.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.403 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.08 -101.88 0.21 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' D' ' 49' ' ' SER . 1.9 p-10 -178.2 111.33 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.509 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . 0.574 HD12 ' N ' ' D' ' 48' ' ' LEU . 8.6 mp -81.27 28.1 0.39 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 108.753 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.414 ' H ' ' C ' ' D' ' 47' ' ' ASP . 12.0 t -43.86 -29.72 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.638 -0.664 . . . . 0.0 110.3 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 14.0 p -140.16 146.9 48.14 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.089 -1.007 . . . . 0.0 109.693 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -40.14 -49.61 3.71 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.676 2.251 . . . . 0.0 112.255 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -69.5 -27.98 65.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.91 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.48 -19.4 36.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.605 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.06 -59.97 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.584 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 11.4 mtm -95.87 20.14 10.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 109.458 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.44 -17.24 50.48 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -86.59 150.0 50.08 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.229 -1.159 . . . . 0.0 109.395 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.18 -45.58 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.579 2.186 . . . . 0.0 112.236 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' D' ' 63' ' ' HIS . 50.1 mtpt -54.12 -51.96 62.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 59.9 t -52.64 -42.55 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -79.0 -26.13 43.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 109.569 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.45 -59.07 2.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.657 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.67 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 13.5 t-80 -49.37 -23.88 1.66 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.558 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.74 -28.51 73.06 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -65.92 -32.3 73.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -1.172 . . . . 0.0 109.21 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . 0.671 ' HB3' HBA2 ' B' ' 147' ' ' HEC . 45.9 mmtt -70.29 -60.11 2.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.9 HG13 ' C2B' ' B' ' 147' ' ' HEC . 27.6 t -46.41 -29.68 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 109.375 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -77.71 -34.88 52.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.244 -0.91 . . . . 0.0 109.372 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.68 -46.69 93.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.57 81.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.59 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . 0.418 ' CZ ' HD11 ' D' ' 75' ' ' LEU . 4.7 t80 -60.43 -53.51 56.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -0.887 . . . . 0.0 109.375 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . 0.522 ' HG ' ' HE1' ' D' ' 15' ' ' TRP . 63.2 m -51.96 -27.41 13.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.455 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' D' ' 84' ' ' THR . 10.6 t0 -49.71 -34.49 18.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.95 . . . . 0.0 109.391 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.26 -59.91 6.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.493 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.2 mp -59.03 -17.97 30.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -1.151 . . . . 0.0 109.427 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . 0.53 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -84.9 -16.61 40.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 31.1 m80 -160.1 64.16 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . 0.438 HD22 HG12 ' D' ' 1' ' ' VAL . 93.1 mt -64.74 4.19 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.414 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' D' ' 77' ' ' HIS . 59.5 m-20 -75.41 -22.98 56.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.92 . . . . 0.0 109.421 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -157.3 103.47 1.98 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.354 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . 0.592 HD22 ' N ' ' D' ' 81' ' ' LEU . 3.6 mm? -80.23 -58.79 2.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.945 . . . . 0.0 109.427 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . 1.432 ' HZ1' ' NZ ' ' B' ' 82' ' ' LYS . 83.5 mttt -55.3 -23.9 25.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.577 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.23 -60.26 7.8 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.0 t -69.44 -46.23 67.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.151 -1.205 . . . . 0.0 109.378 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.555 ' N ' ' CG2' ' D' ' 84' ' ' THR . 46.8 m-85 -70.35 16.85 0.07 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.523 -0.736 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -73.85 -38.8 64.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.453 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 11.0 p -80.62 -46.14 16.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.414 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.515 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 42.3 mt -56.07 -54.86 39.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 109.287 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 7.1 t -50.19 -29.73 9.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.189 -0.944 . . . . 0.0 109.037 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' D' ' 94' ' ' ASP . 42.4 tt0 -82.6 -63.03 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.128 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 tt -49.73 -23.42 1.78 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 109.046 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' D' ' 88' ' ' LEU . 7.9 m80 -76.13 -54.33 6.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.181 -0.949 . . . . 0.0 109.486 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 24.1 t -82.57 -19.42 38.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.161 -0.962 . . . . 0.0 109.916 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' D' ' 90' ' ' GLU . 1.4 m-20 -86.23 -24.96 25.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.082 -1.011 . . . . 0.0 111.086 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . 0.487 ' CA ' ' NE2' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -125.83 -52.04 1.57 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.829 -1.169 . . . . 0.0 110.725 -179.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.606 ' N ' HD12 ' D' ' 96' ' ' LEU . 8.0 mp -70.16 -58.1 4.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.894 -1.129 . . . . 0.0 110.053 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.583 ' HD1' HG21 ' A' ' 41' ' ' THR . 1.0 OUTLIER 72.12 19.88 4.42 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.35 -0.844 . . . . 0.0 109.583 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -57.69 132.07 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.101 -0.999 . . . . 0.0 109.221 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . 0.511 ' CB ' HG21 ' A' ' 96' ' ' VAL . 0.7 OUTLIER -64.6 152.6 89.31 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 109.309 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . 0.538 ' C ' HD22 ' D' ' 102' ' ' ASN . 74.3 Cg_exo -45.72 -175.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.504 2.136 . . . . 0.0 112.402 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 55.4 76.82 0.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 109.504 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.538 HD22 ' C ' ' D' ' 100' ' ' PRO . 0.8 OUTLIER -173.56 -56.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.859 . . . . 0.0 109.372 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -58.42 -19.55 37.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.0 109.515 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -80.23 -44.45 19.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 16.8 mt -58.39 -48.88 79.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.382 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 1.352 ' CD1' ' CHC' ' B' ' 147' ' ' HEC . 5.2 tt -56.41 -54.5 44.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.298 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -57.04 -31.7 61.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -66.82 -53.47 32.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -1.194 . . . . 0.0 109.686 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 79.3 t -49.44 -47.5 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.921 . . . . 0.0 109.532 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 8.6 tp -49.13 -26.66 2.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 109.823 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.77 -38.82 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.09 -1.006 . . . . 0.0 109.998 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 22.8 t -76.77 -22.99 52.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.148 -0.97 . . . . 0.0 109.898 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . 0.498 HG13 ' NH2' ' D' ' 30' ' ' ARG . 97.5 t -68.7 -24.34 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.948 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . 0.413 ' C ' ' N ' ' D' ' 116' ' ' HIS . 48.6 mt -82.58 -54.4 5.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.14 -0.975 . . . . 0.0 109.668 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.487 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.62 -19.94 0.23 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 109.647 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.465 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 0.3 OUTLIER -84.71 -62.89 1.44 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.429 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -62.36 -17.78 59.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.865 . . . . 0.0 109.436 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -151.38 61.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -70.82 -19.49 76.86 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -67.58 -30.74 70.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -1.165 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' D' ' 123' ' ' THR . 30.9 mt-10 -90.57 14.36 13.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.4 OUTLIER -70.77 35.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.941 . . . . 0.0 109.537 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.498 ' H ' ' C ' ' D' ' 121' ' ' GLU . 30.4 p -59.75 144.64 85.16 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.158 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.766 ' HA ' HH22 ' C' ' 31' ' ' ARG . 31.5 Cg_exo -44.85 -43.39 15.09 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.439 2.093 . . . . 0.0 113.517 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' D' ' 124' ' ' PRO . 3.1 Cg_exo -75.16 20.12 0.48 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.437 2.091 . . . . 0.0 112.174 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.481 HG23 ' OG1' ' D' ' 123' ' ' THR . 79.5 t -125.02 -29.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.341 -0.85 . . . . 0.0 109.602 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . 0.943 ' HB2' HH21 ' C' ' 31' ' ' ARG . 86.5 mm-40 -83.17 -59.78 2.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.446 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 1.087 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -56.68 -42.57 79.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.964 . . . . 0.0 109.363 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.434 ' O ' HG23 ' D' ' 133' ' ' VAL . . . -70.05 11.05 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.526 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.594 ' CD2' HG23 ' D' ' 11' ' ' VAL . 4.9 t80 -105.22 -61.3 1.5 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 0.606 ' CD ' ' H ' ' D' ' 131' ' ' GLN . 3.8 mp0 -50.05 -38.45 37.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.92 . . . . 0.0 109.388 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . 1.096 ' HD3' ' O ' ' B' ' 146' ' ' HIS . 18.7 ttpp -64.54 -28.61 69.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.77 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . 0.684 HG22 HD21 ' D' ' 3' ' ' LEU . 79.3 t -71.49 -67.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.708 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.48 ' H ' HG22 ' D' ' 134' ' ' VAL . 2.4 m -61.23 -24.58 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.807 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -49.34 -29.29 5.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.005 . . . . 0.0 109.287 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.63 -29.08 56.08 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' D' ' 85' ' ' PHE . 66.1 t -72.9 -34.15 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -1.116 . . . . 0.0 109.514 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.81 -48.13 64.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.506 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.482 ' C ' HD22 ' D' ' 139' ' ' ASN . 0.2 OUTLIER -77.75 -29.55 51.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.589 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.75 -47.14 83.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.411 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 30.9 mt -79.24 13.14 1.99 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.362 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.47 4.56 1.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.631 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' D' ' 139' ' ' ASN . 12.3 t-80 -79.34 -26.26 42.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.167 -0.958 . . . . 0.0 109.459 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' D' ' 146' ' ' HIS . 0.8 OUTLIER -82.04 -1.4 48.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.479 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -65.91 7.6 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 1.524 ' CD2' ' NE2' ' B' ' 2' ' ' HIS . 4.7 m-70 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.472 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 1.567 ' CBB' HD22 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 1.352 ' CHC' ' CD1' ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 1.554 ' CBB' HD22 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 1.195 HMB1 ' O ' ' D' ' 32' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.485 ' CD1' ' CD2' ' A' ' 128' ' ' PHE . 36.4 mt -121.29 -171.74 2.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.829 . . . . 0.0 109.561 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -97.75 -179.08 0.81 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.864 . . . . 0.0 109.296 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 26.0 Cg_exo -60.87 -68.23 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.605 2.203 . . . . 0.0 112.291 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.452 ' O ' ' ND2' ' A' ' 9' ' ' ASN . . . -52.39 -36.12 53.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.797 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 3.3 m-20 -44.18 -33.7 1.62 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -83.41 -60.12 2.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.621 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.8 m -46.97 -29.74 2.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.419 -0.8 . . . . 0.0 109.979 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 5' ' ' ALA . 22.9 m-20 -77.33 -36.83 53.51 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.024 -1.048 . . . . 0.0 108.279 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -76.14 -47.97 29.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -53.17 -38.54 62.88 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.52 -62.99 1.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.411 -0.806 . . . . 0.0 109.357 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.27 67.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.421 -0.799 . . . . 0.0 109.204 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.451 ' HZ3' HD11 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -72.9 -17.31 61.52 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 108.967 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.59 -40.07 59.76 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -84.75 -49.79 8.16 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.503 -0.998 . . . . 0.0 109.327 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 20' ' ' HIS . 70.4 t -59.96 -35.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.56 -0.712 . . . . 0.0 109.675 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.586 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . -31.53 144.8 0.02 OUTLIER Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . 69.12 -32.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -1.07 . . . . 0.0 108.896 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.586 ' H ' ' C ' ' A' ' 18' ' ' GLY . 1.2 m80 -104.88 13.94 30.34 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' A' ' 17' ' ' VAL . . . -83.55 -48.69 9.99 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.939 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.46 -14.62 42.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -89.1 -56.62 3.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -1.095 . . . . 0.0 109.702 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.639 ' CZ ' ' CE1' ' A' ' 112' ' ' HIS . 2.9 m-30 -58.98 -33.14 70.34 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 109.176 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.82 -33.06 76.49 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.04 -50.8 10.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -1.174 . . . . 0.0 109.721 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -52.4 -19.8 2.4 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.55 -25.54 65.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.506 HD11 ' CG ' ' A' ' 58' ' ' HIS . 33.5 mt -72.27 -58.02 3.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.671 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.71 -14.29 30.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.524 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.052 ' NH1' ' CG ' ' B' ' 127' ' ' GLN . 1.8 tpm_? -75.45 -38.98 59.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 109.357 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.512 ' O ' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -80.02 -48.5 13.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.218 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 32' ' ' MET . 37.1 t80 -43.72 -19.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.396 -0.815 . . . . 0.0 109.831 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.815 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 11.0 mt -79.88 -60.2 2.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.136 -0.978 . . . . 0.0 109.701 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.694 ' OG ' ' OE1' ' B' ' 131' ' ' GLN . 29.6 m -81.39 -31.37 33.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 109.676 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 60.3 m-85 -113.63 95.04 35.22 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.411 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.12 -20.1 8.9 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.447 2.098 . . . . 0.0 112.228 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.693 ' O ' HG22 ' A' ' 41' ' ' THR . 71.1 p -47.64 -42.1 23.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 109.274 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 39' ' ' THR . 12.6 p -44.03 -22.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.83 . . . . 0.0 109.854 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' THR . 30.6 ttpt -70.87 -19.11 62.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.638 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 1.137 HG21 ' CD2' ' D' ' 97' ' ' HIS . 8.7 t -80.37 -20.63 43.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.542 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -85.0 -14.78 46.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 53.4 83.1 0.23 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.674 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 46.0 Cg_exo -52.0 -41.23 65.16 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.582 2.188 . . . . 0.0 111.874 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.674 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 96.15 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 178.189 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.499 ' CZ ' ' CB ' ' A' ' 44' ' ' PRO . 2.1 p90 -142.54 44.91 1.62 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.532 -1.355 . . . . 0.0 110.11 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.12 -35.32 0.3 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 110.453 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER 61.86 55.85 2.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.043 . . . . 0.0 109.0 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.1 m -165.39 157.06 14.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 0.0 109.541 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.464 ' C ' ' H ' ' A' ' 52' ' ' SER . 2.7 m-70 -59.6 160.94 6.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.877 . . . . 0.0 109.385 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.73 -18.14 1.92 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 54' ' ' GLN . 29.5 p -48.78 -25.94 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -1.145 . . . . 0.0 109.322 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.05 -40.24 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.835 . . . . 0.0 109.688 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.52 ' H ' ' C ' ' A' ' 52' ' ' SER . 20.5 mt-30 -69.76 -23.73 63.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.304 -0.873 . . . . 0.0 109.304 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.432 HG23 ' OG ' ' A' ' 52' ' ' SER . 57.6 t -69.61 -40.57 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.97 . . . . 0.0 109.129 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -65.73 -54.38 28.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.241 -0.912 . . . . 0.0 108.62 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.19 -36.09 21.1 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.506 ' CG ' HD11 ' A' ' 29' ' ' LEU . 6.1 t-80 -60.5 -36.57 78.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.315 . . . . 0.0 109.895 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.42 -29.28 38.27 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 56.8 mttm -65.18 -23.57 67.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -1.162 . . . . 0.0 110.263 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.527 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 0.5 OUTLIER -69.16 -58.13 4.47 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.962 -1.086 . . . . 0.0 108.656 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.3 t -56.46 -44.76 81.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.655 -0.653 . . . . 0.0 109.315 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.51 74.46 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.298 -0.876 . . . . 0.0 109.225 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.9 t70 -66.03 -37.98 87.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.798 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -67.56 -53.33 29.22 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 70' ' ' VAL . 1.1 mt -58.53 -42.34 87.54 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 71' ' ' ALA . 15.5 m -69.68 -51.58 33.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.273 -0.892 . . . . 0.0 108.696 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -62.23 -25.97 68.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 65' ' ' ALA . . . -85.08 -46.38 11.21 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 66' ' ' LEU . 38.1 t -66.7 -22.75 30.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -69.51 -36.37 76.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.589 ' O ' ' N ' ' A' ' 74' ' ' ASP . 26.1 m80 -103.29 -66.74 0.92 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.615 -0.678 . . . . 0.0 109.424 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 73' ' ' VAL . 14.9 p 44.37 14.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.953 0.882 . . . . 0.0 109.287 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 72' ' ' HIS . 5.5 m-20 -137.96 12.02 2.87 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 0.2 OUTLIER 171.72 31.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 3.5 ptt? -78.29 -23.67 0.42 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.334 -0.854 . . . . 0.0 111.842 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 76' ' ' MET . 50.8 Cg_exo -53.58 -19.46 13.94 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.665 1.576 . . . . 0.0 112.477 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -94.19 -40.43 10.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.68 -48.9 67.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.918 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.61 6.04 6.53 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.446 -0.784 . . . . 0.0 109.198 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.1 t -54.53 -19.56 6.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 109.614 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -83.12 -58.53 2.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 0.0 109.916 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.604 HD22 HBA1 ' A' ' 142' ' ' HEC . 3.8 mt -45.34 -44.58 11.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -0.847 . . . . 0.0 109.082 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.407 ' CB ' ' HG ' ' A' ' 138' ' ' SER . 23.3 t -60.06 -18.93 50.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.519 -0.738 . . . . 0.0 109.56 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 89' ' ' HIS . 36.8 t70 -81.06 -50.94 9.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.913 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.457 ' CD1' HBD2 ' A' ' 142' ' ' HEC . 4.6 tt -64.16 -26.79 68.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.97 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.74 -21.78 26.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 110.328 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.56 -11.03 11.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.185 -0.947 . . . . 0.0 110.154 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.564 ' N ' ' O ' ' A' ' 85' ' ' ASP . 42.7 t60 -106.64 -74.6 0.65 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.19 -0.944 . . . . 0.0 109.919 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' ARG . 79.8 mttt -63.84 -110.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.058 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 mt -44.48 -17.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.308 -0.87 . . . . 0.0 110.017 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.455 ' CG ' ' NH2' ' D' ' 40' ' ' ARG . 31.8 ttm-85 46.75 41.56 10.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.142 -0.974 . . . . 0.0 109.481 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.9 t -45.94 144.8 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.867 . . . . 0.0 109.701 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 10.6 m-20 -80.52 150.2 69.77 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.65 -19.48 21.34 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.437 2.091 . . . . 0.0 112.229 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 96' ' ' VAL . 4.1 t -66.35 -7.75 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.666 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 94' ' ' ASP . 12.7 m120 -79.74 -36.26 37.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.17 -0.956 . . . . 0.0 110.478 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -46.33 -41.58 13.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.879 -1.138 . . . . 0.0 109.536 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.49 ' CB ' ' NZ ' ' A' ' 99' ' ' LYS . 8.0 mtmp? -51.38 -28.24 12.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.963 . . . . 0.0 109.291 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.577 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 15.4 mt -84.29 -61.95 1.68 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.682 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.796 HD22 ' CHC' ' A' ' 142' ' ' HEC . 5.4 tp -49.78 -23.62 1.93 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.878 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -73.38 -49.45 27.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -80.62 -26.37 37.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 0.0 109.923 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 65.7 m -65.06 -60.29 3.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.158 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.722 ' C ' HD12 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -57.45 -22.44 43.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 109.825 -179.401 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.18 -31.42 38.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.802 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.46 HG11 ' OE1' ' B' ' 127' ' ' GLN . 56.1 t -83.38 -24.94 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.129 -0.982 . . . . 0.0 110.051 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 1.5 t -79.68 -47.72 14.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.0 109.959 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.737 HD12 ' O ' ' A' ' 109' ' ' LEU . 0.8 OUTLIER -69.72 -18.59 63.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.752 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.92 -22.22 46.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 110.257 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.4 -56.24 24.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.118 -0.989 . . . . 0.0 110.182 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.681 ' CG ' ' H ' ' A' ' 113' ' ' LEU . 9.4 p80 -72.48 -61.93 1.63 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.098 -1.001 . . . . 0.0 109.469 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.929 HD23 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -119.73 121.43 29.84 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.3 175.7 7.38 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.422 2.081 . . . . 0.0 112.99 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.654 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -45.36 -54.96 6.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.632 -0.668 . . . . 0.0 109.346 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.654 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 26.1 mt-10 122.9 -2.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.468 ' CG ' ' C ' ' A' ' 116' ' ' GLU . 1.8 m-85 72.22 32.88 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.714 -0.616 . . . . 0.0 111.278 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.772 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.3 p -97.59 121.27 58.66 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.895 -1.128 . . . . 0.0 108.16 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.62 24.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 121.934 1.756 . . . . 0.0 112.502 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -150.38 -32.41 0.18 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.981 -1.074 . . . . 0.0 110.401 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 122' ' ' HIS . 12.0 p -53.92 -50.04 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.04 -1.037 . . . . 0.0 110.329 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.671 ' N ' HG13 ' A' ' 121' ' ' VAL . 23.2 m-70 -54.84 -44.98 74.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.36 -20.05 32.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 110.375 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 120' ' ' ALA . 94.0 p -52.19 -52.97 48.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.189 -0.945 . . . . 0.0 110.545 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.451 HD11 ' HZ3' ' A' ' 14' ' ' TRP . 5.5 mt -84.11 -19.34 34.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.0 109.975 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.71 -51.83 9.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.296 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.449 ' HZ2' ' HG2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -78.63 -43.06 27.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.978 -1.076 . . . . 0.0 110.151 -179.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.485 ' CD2' ' CD1' ' A' ' 2' ' ' LEU . 33.9 t80 -50.59 -21.39 1.52 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.858 -1.151 . . . . 0.0 108.929 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.709 ' CD2' HBB1 ' A' ' 142' ' ' HEC . 17.4 mt -73.78 -18.26 60.99 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -60.14 -35.48 75.37 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 135' ' ' VAL . 97.5 p -80.78 -27.02 36.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -84.73 -30.13 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 129' ' ' LEU . 51.6 m -79.17 -40.83 29.89 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 53.2 m -69.3 -26.4 64.71 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 131' ' ' SER . 23.4 t -81.49 -30.28 10.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.09 -23.34 62.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.365 -0.834 . . . . 0.0 109.052 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 138' ' ' SER . 37.8 p -87.29 -18.39 30.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 0.0 109.568 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' THR . 21.6 m 51.65 98.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.449 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -62.03 -160.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.947 . . . . 0.0 109.58 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -76.8 -44.91 30.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.452 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.835 HG13 ' H ' ' B' ' 2' ' ' HIS . 13.1 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 0.835 ' H ' HG13 ' B' ' 1' ' ' VAL . 82.0 t60 47.76 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.009 -1.057 . . . . 0.0 109.767 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.858 HD12 ' N ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -135.99 179.64 6.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 0.0 109.006 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 7' ' ' GLU . 7.3 p -76.15 132.55 73.4 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.917 . . . . 0.0 109.104 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -41.28 -24.71 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.343 2.029 . . . . 0.0 112.457 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.2 -21.76 25.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.876 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' B' ' 4' ' ' THR . 32.2 tt0 -80.45 -63.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -0.959 . . . . 0.0 109.932 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.604 ' HB3' HD13 ' B' ' 3' ' ' LEU . 24.2 pttt -62.25 -31.69 72.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 110.051 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.2 t -44.57 -23.35 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.0 110.406 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -81.59 -57.35 3.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.945 -1.097 . . . . 0.0 110.102 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.442 HG23 ' CE2' ' B' ' 130' ' ' TYR . 14.9 p -68.74 -24.62 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.094 -1.003 . . . . 0.0 108.318 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 12.5 m -71.95 -42.07 67.01 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.339 0.59 . . . . 0.0 109.88 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.75 -30.46 69.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.344 -0.848 . . . . 0.0 109.802 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -50.28 -18.83 0.67 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.97 . . . . 0.0 109.349 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . 0.409 ' CZ2' HD13 ' B' ' 75' ' ' LEU . 0.7 OUTLIER -53.08 -51.48 61.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.15 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.09 -32.41 35.32 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -46.7 13.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -1.084 . . . . 0.0 109.177 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -58.99 114.85 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.732 . . . . 0.0 109.853 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' B' ' 21' ' ' ASP . 19.1 m120 -79.41 71.58 5.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 108.748 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.453 HG12 ' O ' ' B' ' 20' ' ' VAL . 57.8 t -46.98 -11.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.851 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' B' ' 19' ' ' ASN . 16.5 m-20 -73.45 -5.5 40.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.189 -0.944 . . . . 0.0 109.821 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -156.26 -40.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.119 -0.988 . . . . 0.0 109.61 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 78.0 t -46.5 -55.42 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.883 . . . . 0.0 109.64 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.76 -29.83 50.71 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.51 -30.05 69.27 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.92 -31.41 59.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.221 -1.164 . . . . 0.0 109.466 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.17 -54.28 48.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.542 HD22 ' N ' ' B' ' 28' ' ' LEU . 3.8 mm? -61.87 -40.1 94.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.273 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.92 -42.91 76.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -72.69 -37.08 67.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -1.122 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 tp -50.07 -31.7 13.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.265 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.28 -22.47 38.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.606 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.04 -64.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.627 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.466 HG23 ' H ' ' B' ' 34' ' ' VAL . 0.2 OUTLIER -64.14 -22.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.422 -0.799 . . . . 0.0 109.663 -179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -140.25 79.17 21.94 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 109.559 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -83.48 -12.45 8.99 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.888 2.392 . . . . 0.0 112.369 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.53 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 3.4 p-90 -48.57 -33.99 10.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.188 -0.945 . . . . 0.0 109.523 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.53 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 3.2 m -78.95 2.65 19.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . 0.444 ' O ' ' OE1' ' B' ' 39' ' ' GLN . 1.4 tm0? -65.53 -19.08 65.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.45 ' HE ' ' HD3' ' C' ' 92' ' ' ARG . 32.9 mtp85 -68.59 -40.84 80.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.751 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -93.04 -18.96 22.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.956 . . . . 0.0 109.749 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.555 ' CE1' ' CE1' ' B' ' 45' ' ' PHE . 1.3 t80 -89.87 28.71 1.3 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -84.48 -13.97 50.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.614 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -80.2 -7.51 59.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.619 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.651 ' HZ ' ' CMD' ' B' ' 147' ' ' HEC . 33.7 m-85 -83.65 -3.53 57.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.511 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.99 -172.77 25.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' B' ' 47' ' ' ASP . 2.0 p-10 -84.79 98.37 10.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -1.153 . . . . 0.0 109.42 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.717 HD12 ' N ' ' B' ' 48' ' ' LEU . 7.2 mp -88.0 30.8 0.82 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 108.972 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -45.05 -30.87 1.15 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 109.934 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 6.6 p -142.37 138.15 16.24 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.187 -0.945 . . . . 0.0 109.494 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -41.28 -28.4 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.406 2.071 . . . . 0.0 112.279 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.95 -39.79 49.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.93 -19.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.86 . . . . 0.0 109.603 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.1 -63.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.651 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -51.39 -20.0 1.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 109.741 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.07 -31.63 38.31 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -63.16 132.83 95.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -1.191 . . . . 0.0 109.357 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.31 -50.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.46 2.107 . . . . 0.0 112.551 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.04 -34.98 72.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.987 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -55.23 -49.88 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.033 -1.042 . . . . 0.0 109.217 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.464 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 26.2 mtmt -73.63 -29.33 62.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.289 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.92 -46.34 68.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 1.23 ' NE2' ' CHA' ' B' ' 147' ' ' HEC . 2.5 t60 -54.34 -25.28 23.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.553 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.88 -32.35 83.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 0.4 OUTLIER -62.75 -36.91 84.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -1.198 . . . . 0.0 109.308 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -75.74 -35.05 60.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.354 -0.841 . . . . 0.0 109.417 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 0.698 HG22 ' CHB' ' B' ' 147' ' ' HEC . 47.8 t -69.03 -63.16 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.334 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.545 ' O ' HD23 ' B' ' 68' ' ' LEU . 1.8 tt -53.61 -32.94 53.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 108.91 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.83 -57.1 20.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.32 79.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -1.137 . . . . 0.0 109.447 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -67.2 -35.09 78.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.484 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.402 ' HB2' ' HE1' ' B' ' 15' ' ' TRP . 61.7 p -73.82 -35.69 64.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.409 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.49 -21.29 0.53 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.347 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.17 -60.08 4.66 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.642 ' H ' HD12 ' B' ' 75' ' ' LEU . 5.1 mp -53.47 -28.9 33.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -1.133 . . . . 0.0 109.254 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.75 3.49 41.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' B' ' 79' ' ' ASP . 23.5 t-80 -170.43 61.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.632 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.667 HD22 HG21 ' B' ' 1' ' ' VAL . 59.1 mt -73.72 15.16 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 109.327 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' B' ' 77' ' ' HIS . 16.8 t70 -76.43 -36.05 58.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.873 . . . . 0.0 109.513 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -161.55 100.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.377 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 33.7 mt -79.31 -50.19 11.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.866 . . . . 0.0 109.362 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.447 ' HZ2' ' CG ' ' B' ' 143' ' ' HIS . 24.6 mmtp -48.41 -23.95 1.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.11 -63.31 3.69 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.3 t -63.9 -48.07 78.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -1.13 . . . . 0.0 109.493 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.555 ' N ' ' CG2' ' B' ' 84' ' ' THR . 46.9 m-85 -63.64 -8.5 10.21 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.538 -0.726 . . . . 0.0 109.348 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.32 -34.75 34.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 109.366 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 28.4 p -83.99 -50.99 7.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 36.0 mt -56.09 -55.54 31.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.174 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . 0.487 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 1.5 m -51.51 -39.02 56.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.284 -0.885 . . . . 0.0 109.365 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' B' ' 94' ' ' ASP . 29.0 tt0 -74.25 -54.58 7.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 0.0 109.46 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 tt -62.46 -29.36 70.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.718 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.502 ' O ' ' N ' ' B' ' 97' ' ' HIS . 1.3 m80 -79.32 -48.41 14.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 110.001 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' B' ' 89' ' ' SER . 6.5 m -82.91 -31.08 27.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.049 -1.032 . . . . 0.0 110.386 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' B' ' 90' ' ' GLU . 6.4 t70 -86.75 -43.47 12.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.084 -1.01 . . . . 0.0 110.937 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -52.33 5.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 110.733 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.648 ' O ' ' ND1' ' B' ' 97' ' ' HIS . 4.1 mm? -82.85 -43.49 16.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.868 -1.145 . . . . 0.0 109.528 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 1.1 ' CD2' HG21 ' C' ' 41' ' ' THR . 0.0 OUTLIER 74.85 19.77 2.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.385 -0.822 . . . . 0.0 109.637 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' B' ' 97' ' ' HIS . 8.8 t -45.18 122.1 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 109.449 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.509 ' O ' ' ND2' ' B' ' 102' ' ' ASN . 15.4 m-20 -69.05 151.34 97.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' B' ' 99' ' ' ASP . 74.5 Cg_exo -42.84 178.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.626 2.217 . . . . 0.0 112.369 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 57.58 64.75 1.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.839 . . . . 0.0 109.514 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' B' ' 99' ' ' ASP . 73.2 m-20 -161.92 -52.08 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -0.86 . . . . 0.0 109.308 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.697 ' HA ' HBB2 ' B' ' 147' ' ' HEC . 4.2 p90 -67.01 -26.01 66.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' B' ' 108' ' ' ASN . 39.5 ttt-85 -78.61 -25.7 45.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.515 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.89 -45.65 49.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 109.641 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.964 HD13 ' C3B' ' B' ' 147' ' ' HEC . 4.6 tt -49.48 -45.99 47.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.415 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.42 -48.82 64.99 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' B' ' 104' ' ' ARG . 30.1 m120 -50.25 -44.27 53.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -1.153 . . . . 0.0 109.737 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.95 -35.4 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.748 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tp -63.35 -38.8 92.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 109.669 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.418 HG21 HE21 ' B' ' 131' ' ' GLN . 66.3 t -51.34 -30.52 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.95 . . . . 0.0 109.693 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.26 -59.26 2.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 109.621 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 t -46.14 -28.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.816 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.452 HD13 ' OH ' ' B' ' 130' ' ' TYR . 16.8 mt -82.51 -53.23 6.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.593 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.464 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -65.31 -19.44 65.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.696 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -62.89 1.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 109.655 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -77.16 -48.36 17.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.272 -0.892 . . . . 0.0 109.803 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -92.8 30.13 1.64 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.714 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' B' ' 121' ' ' GLU . . . -54.94 -27.82 46.04 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -64.55 7.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -1.111 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' B' ' 119' ' ' GLY . 61.1 mm-40 -133.12 6.82 3.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.41 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.556 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -73.3 34.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.491 ' H ' ' C ' ' B' ' 121' ' ' GLU . 2.9 p -45.02 148.99 0.91 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.463 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.515 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.4 Cg_exo -44.33 -54.07 4.3 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.449 2.099 . . . . 0.0 112.769 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 21.1 Cg_endo -61.37 -48.16 10.28 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.057 1.838 . . . . 0.0 111.975 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.435 ' O ' HG12 ' B' ' 126' ' ' VAL . 73.9 t -55.6 -13.03 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . 1.052 ' CG ' ' NH1' ' A' ' 31' ' ' ARG . 0.7 OUTLIER -82.45 -59.94 2.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.606 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.815 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -66.46 -26.53 67.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.928 . . . . 0.0 109.504 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.76 26.38 0.83 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.499 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.452 ' OH ' HD13 ' B' ' 114' ' ' LEU . 0.1 OUTLIER -123.46 -61.25 1.42 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.382 -0.824 . . . . 0.0 109.368 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.694 ' OE1' ' OG ' ' A' ' 35' ' ' SER . 26.0 mp0 -53.62 -36.36 61.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 109.632 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -69.44 -25.11 63.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 109.567 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 63.6 t -77.35 -43.59 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.512 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.65 -17.05 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.628 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.39 -28.93 70.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.31 -36.57 59.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.501 HG13 ' CZ ' ' B' ' 85' ' ' PHE . 77.5 t -75.17 -36.49 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -1.092 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.25 -38.92 55.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.915 . . . . 0.0 109.468 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' B' ' 143' ' ' HIS . 9.9 m120 -85.18 -21.31 29.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.731 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.62 -55.52 33.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.114 -0.991 . . . . 0.0 109.478 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 41.5 mt -61.64 -24.68 66.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.542 ' O ' ' CD1' ' B' ' 145' ' ' TYR . . . -100.27 1.71 41.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.403 -0.811 . . . . 0.0 109.412 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 139' ' ' ASN . 71.2 t60 -80.8 -1.78 44.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.0 109.466 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' B' ' 146' ' ' HIS . 5.4 tppt? -120.73 -31.9 4.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.822 . . . . 0.0 109.889 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' B' ' 142' ' ' ALA . 0.1 OUTLIER -49.29 -10.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 109.933 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' B' ' 144' ' ' LYS . 4.9 m-70 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.662 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.482 ' CD1' ' CD2' ' C' ' 128' ' ' PHE . 36.5 mt -121.2 -171.78 2.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.376 -0.827 . . . . 0.0 109.605 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.47 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.8 OUTLIER -97.75 -178.97 0.79 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.409 -0.807 . . . . 0.0 109.277 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 26.0 Cg_exo -60.97 -68.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.51 2.14 . . . . 0.0 112.329 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.464 ' O ' ' ND2' ' C' ' 9' ' ' ASN . . . -52.33 -36.17 52.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 109.794 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.477 ' CG ' ' HZ1' ' C' ' 127' ' ' LYS . 3.3 m-20 -44.2 -33.67 1.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 109.444 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -83.38 -60.13 2.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.841 . . . . 0.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 34.2 m -46.92 -29.75 2.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.355 -0.841 . . . . 0.0 109.94 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' C' ' 5' ' ' ALA . 23.1 m-20 -77.5 -36.69 52.37 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.985 -1.072 . . . . 0.0 108.233 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.19 -47.85 29.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -53.18 -38.58 62.93 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.49 -63.05 1.44 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.443 -0.785 . . . . 0.0 109.36 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.22 67.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.851 . . . . 0.0 109.286 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . 0.448 ' HZ3' HD11 ' C' ' 125' ' ' LEU . 0.1 OUTLIER -72.98 -17.24 61.48 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.417 -0.802 . . . . 0.0 108.892 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.69 -39.98 59.39 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -84.73 -49.77 8.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.521 -0.988 . . . . 0.0 109.333 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' C' ' 18' ' ' GLY . 71.1 t -60.06 -34.99 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.504 -0.747 . . . . 0.0 109.639 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . -31.56 144.79 0.02 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' C' ' 18' ' ' GLY . . . 69.16 -32.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -1.101 . . . . 0.0 108.874 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.593 ' H ' ' C ' ' C' ' 18' ' ' GLY . 1.2 m80 -104.96 13.83 30.38 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.43 ' HB2' HG12 ' C' ' 17' ' ' VAL . . . -83.52 -48.8 9.89 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.82 -178.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -14.72 42.71 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -89.07 -56.6 3.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -1.137 . . . . 0.0 109.706 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.636 ' CZ ' ' CE1' ' C' ' 112' ' ' HIS . 2.9 m-30 -59.01 -33.13 70.38 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.424 -0.798 . . . . 0.0 109.191 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.73 -33.19 76.64 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.89 -50.83 10.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.168 -1.195 . . . . 0.0 109.828 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -52.4 -19.76 2.38 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.61 -25.53 65.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.505 HD11 ' ND1' ' C' ' 58' ' ' HIS . 33.2 mt -72.15 -58.09 3.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 109.744 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -61.57 -14.42 29.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.086 -1.009 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 1.063 ' NH1' ' CG ' ' D' ' 127' ' ' GLN . 1.9 tpm_? -75.41 -39.05 59.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.344 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 0.502 ' O ' ' N ' ' C' ' 34' ' ' LEU . 0.0 OUTLIER -79.98 -48.51 13.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.193 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' C' ' 32' ' ' MET . 36.6 t80 -43.78 -19.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.338 -0.851 . . . . 0.0 109.782 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.805 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.9 mt -79.85 -60.23 2.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 0.0 109.755 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.711 ' OG ' ' OE1' ' D' ' 131' ' ' GLN . 30.0 m -81.27 -31.48 33.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.891 . . . . 0.0 109.698 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.565 ' CZ ' HD22 ' C' ' 100' ' ' LEU . 60.2 m-85 -113.57 95.0 34.86 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.439 -0.788 . . . . 0.0 109.424 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.18 -20.01 8.88 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.435 2.09 . . . . 0.0 112.224 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.689 ' O ' HG22 ' C' ' 41' ' ' THR . 70.7 p -47.69 -42.07 24.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 109.253 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.416 ' H ' HG23 ' C' ' 39' ' ' THR . 12.9 p -44.1 -22.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.813 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' C' ' 38' ' ' THR . 30.5 ttpt -70.94 -19.18 62.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.61 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 1.1 HG21 ' CD2' ' B' ' 97' ' ' HIS . 8.5 t -80.28 -20.58 44.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.618 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -84.99 -14.93 45.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.361 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 53.45 83.06 0.23 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.669 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 46.2 Cg_exo -52.04 -41.16 65.89 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.552 2.168 . . . . 0.0 111.866 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.669 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 0.0 OUTLIER 96.1 35.8 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.212 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.495 ' CZ ' ' CB ' ' C' ' 44' ' ' PRO . 2.1 p90 -142.48 44.89 1.63 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.444 -1.41 . . . . 0.0 110.095 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.05 -35.22 0.3 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.438 -0.789 . . . . 0.0 110.448 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' C' ' 46' ' ' PHE . 1.0 OUTLIER 61.72 55.84 2.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.02 -1.05 . . . . 0.0 109.097 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.0 m -165.35 157.01 14.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.992 -1.067 . . . . 0.0 109.534 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.462 ' C ' ' H ' ' C' ' 52' ' ' SER . 2.7 m-70 -59.48 160.87 6.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.375 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.71 -18.14 1.91 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 30.6 p -48.66 -25.9 2.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -1.158 . . . . 0.0 109.395 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 66.97 -40.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.748 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' C' ' 52' ' ' SER . 20.4 mt-30 -69.73 -23.79 63.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.295 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.45 HG23 ' OG ' ' C' ' 52' ' ' SER . 56.6 t -69.64 -40.51 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.915 . . . . 0.0 109.133 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -65.7 -54.42 27.69 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.307 -0.87 . . . . 0.0 108.656 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.17 -36.12 21.08 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.505 ' ND1' HD11 ' C' ' 29' ' ' LEU . 6.1 t-80 -60.54 -36.5 78.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.957 -1.319 . . . . 0.0 109.874 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.36 -29.33 37.91 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 56.8 mttm -65.07 -23.67 67.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.148 -1.207 . . . . 0.0 110.268 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.531 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 0.5 OUTLIER -69.18 -58.18 4.39 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.999 -1.063 . . . . 0.0 108.591 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 72.8 t -56.49 -44.71 81.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.579 -0.7 . . . . 0.0 109.299 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.93 -41.6 74.38 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.24 -0.912 . . . . 0.0 109.21 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 7.9 t70 -65.88 -38.1 87.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.13 -0.981 . . . . 0.0 108.493 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.793 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -67.5 -53.43 28.7 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.415 ' O ' HG23 ' C' ' 70' ' ' VAL . 1.0 OUTLIER -58.49 -42.25 87.14 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.425 ' O ' ' N ' ' C' ' 71' ' ' ALA . 15.7 m -69.64 -51.67 32.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.28 -0.888 . . . . 0.0 108.731 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -62.22 -25.95 68.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 108.537 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' C' ' 65' ' ' ALA . . . -85.11 -46.4 11.17 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.415 HG23 ' O ' ' C' ' 66' ' ' LEU . 38.2 t -66.56 -22.85 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -69.56 -36.3 76.2 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.587 ' O ' ' N ' ' C' ' 74' ' ' ASP . 26.1 m80 -103.32 -66.69 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.609 -0.682 . . . . 0.0 109.443 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.547 HG22 ' O ' ' C' ' 73' ' ' VAL . 14.8 p 44.42 14.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.954 0.883 . . . . 0.0 109.323 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' C' ' 72' ' ' HIS . 5.5 m-20 -137.99 12.07 2.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.412 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 0.2 OUTLIER 171.78 31.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.139 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 3.5 ptt? -78.27 -23.66 0.42 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 111.849 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' C' ' 76' ' ' MET . 50.8 Cg_exo -53.6 -19.35 13.76 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.705 1.604 . . . . 0.0 112.5 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -94.25 -40.44 9.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.08 -1.012 . . . . 0.0 109.741 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.73 -48.88 67.81 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.248 -0.908 . . . . 0.0 109.36 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.58 6.03 6.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 109.298 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 34.1 t -54.48 -19.59 6.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 0.0 109.602 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -83.16 -58.52 2.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 109.891 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.613 HD22 HBA1 ' C' ' 142' ' ' HEC . 3.8 mt -45.32 -44.69 11.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.424 -0.797 . . . . 0.0 109.068 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.496 ' CB ' ' HG ' ' C' ' 138' ' ' SER . 23.3 t -59.96 -18.93 49.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -0.775 . . . . 0.0 109.536 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' C' ' 89' ' ' HIS . 36.7 t70 -81.11 -50.9 9.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.95 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.451 ' CD1' HBD2 ' C' ' 142' ' ' HEC . 4.6 tt -64.15 -26.71 68.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.89 . . . . 0.0 110.068 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.79 -21.78 26.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.312 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.47 -11.26 11.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.141 -0.975 . . . . 0.0 110.172 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . 0.56 ' N ' ' O ' ' C' ' 85' ' ' ASP . 42.4 t60 -106.51 -74.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.166 -0.958 . . . . 0.0 109.996 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' C' ' 92' ' ' ARG . 79.7 mttt -63.74 -110.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 0.0 110.077 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . . . . . . . . . 14.1 mt -44.45 -17.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.346 -0.846 . . . . 0.0 110.009 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' C' ' 90' ' ' LYS . 31.8 ttm-85 46.84 41.47 10.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.138 -0.977 . . . . 0.0 109.492 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 70.1 t -45.91 144.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.694 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' C' ' 97' ' ' ASN . 10.7 m-20 -80.68 150.29 69.43 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.71 -19.49 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.384 2.056 . . . . 0.0 112.22 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.31 -7.71 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.357 -0.84 . . . . 0.0 109.752 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' C' ' 94' ' ' ASP . 12.8 m120 -79.71 -36.25 37.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.475 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -46.35 -41.56 13.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.896 -1.127 . . . . 0.0 109.569 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.48 ' NZ ' ' CB ' ' C' ' 99' ' ' LYS . 8.0 mtmp? -51.39 -28.25 12.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.238 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.565 HD22 ' CZ ' ' C' ' 36' ' ' PHE . 15.4 mt -84.31 -61.8 1.72 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.719 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.79 HD22 ' CHC' ' C' ' 142' ' ' HEC . 5.4 tp -49.92 -23.65 2.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.796 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -73.28 -49.47 27.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.906 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -80.68 -26.41 37.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.862 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 65.3 m -64.95 -60.37 3.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 110.167 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.717 ' C ' HD12 ' C' ' 105' ' ' LEU . 0.9 OUTLIER -57.51 -22.38 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 109.827 -179.402 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 58.7 tp -80.08 -31.47 39.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.879 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . 0.469 HG11 ' OE1' ' D' ' 127' ' ' GLN . 57.0 t -83.32 -24.91 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.042 -1.036 . . . . 0.0 110.094 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' C' ' 109' ' ' LEU . 1.5 t -79.79 -47.68 14.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.06 -1.025 . . . . 0.0 109.919 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.732 HD12 ' O ' ' C' ' 109' ' ' LEU . 0.8 OUTLIER -69.77 -18.51 63.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 109.762 -179.583 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.95 -22.2 46.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 110.287 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.51 -56.16 25.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -0.995 . . . . 0.0 110.162 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . 0.681 ' CG ' ' H ' ' C' ' 113' ' ' LEU . 9.4 p80 -72.42 -61.85 1.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.016 . . . . 0.0 109.563 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.909 HD23 ' O ' ' C' ' 113' ' ' LEU . 0.0 OUTLIER -119.81 121.46 29.76 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.37 175.61 7.56 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.476 2.117 . . . . 0.0 112.932 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.649 ' O ' ' CB ' ' C' ' 116' ' ' GLU . . . -45.22 -55.08 6.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.604 -0.685 . . . . 0.0 109.374 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.649 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 26.0 mt-10 122.98 -2.84 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.472 ' CG ' ' C ' ' C' ' 116' ' ' GLU . 1.8 m-85 72.23 32.86 1.64 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.708 -0.62 . . . . 0.0 111.259 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.772 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.3 p -97.54 121.26 58.76 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.927 -1.108 . . . . 0.0 108.231 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.55 24.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.059 1.839 . . . . 0.0 112.531 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -150.46 -32.31 0.18 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.928 -1.108 . . . . 0.0 110.46 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.657 HG13 ' N ' ' C' ' 122' ' ' HIS . 11.9 p -54.03 -50.11 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 110.292 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.657 ' N ' HG13 ' C' ' 121' ' ' VAL . 23.1 m-70 -54.71 -45.07 73.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.577 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.37 -20.02 32.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 110.267 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.549 ' N ' ' O ' ' C' ' 120' ' ' ALA . 93.6 p -52.22 -52.93 49.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.931 . . . . 0.0 110.615 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.448 HD11 ' HZ3' ' C' ' 14' ' ' TRP . 5.5 mt -84.11 -19.24 34.58 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.081 -1.012 . . . . 0.0 110.047 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -78.76 -51.82 9.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.092 . . . . 0.0 110.333 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -78.68 -43.02 26.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.057 -1.027 . . . . 0.0 110.188 -179.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.482 ' CD2' ' CD1' ' C' ' 2' ' ' LEU . 33.7 t80 -50.5 -21.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 0.0 108.992 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.723 ' CD2' HBB1 ' C' ' 142' ' ' HEC . 17.4 mt -73.77 -18.26 60.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -60.14 -35.48 75.38 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.44 ' O ' HG23 ' C' ' 135' ' ' VAL . 97.3 p -80.74 -27.09 36.94 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -84.71 -30.06 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.492 ' N ' ' O ' ' C' ' 129' ' ' LEU . 50.3 m -79.31 -40.78 29.54 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 53.3 m -69.31 -26.35 64.68 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.289 -0.882 . . . . 0.0 108.644 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 131' ' ' SER . 23.6 t -81.56 -30.19 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -23.21 61.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.349 -0.844 . . . . 0.0 109.071 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . 0.433 ' O ' ' O ' ' C' ' 138' ' ' SER . 38.3 p -87.28 -18.43 30.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.21 -0.931 . . . . 0.0 109.552 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . 0.496 ' HG ' ' CB ' ' C' ' 84' ' ' SER . 21.7 m 51.72 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.433 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -61.92 -160.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.928 . . . . 0.0 109.548 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -76.75 -45.0 30.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.571 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.507 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.848 HG13 ' H ' ' D' ' 2' ' ' HIS . 13.0 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . 0.848 ' H ' HG13 ' D' ' 1' ' ' VAL . 82.1 t60 47.72 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.987 -1.071 . . . . 0.0 109.724 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.85 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -135.94 179.73 6.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 108.982 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.466 ' O ' ' N ' ' D' ' 7' ' ' GLU . 7.3 p -76.16 132.42 73.61 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.112 -0.993 . . . . 0.0 109.153 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -41.19 -24.75 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.369 2.046 . . . . 0.0 112.446 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -87.14 -21.84 25.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.927 . . . . 0.0 109.874 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' D' ' 4' ' ' THR . 32.2 tt0 -80.36 -63.09 1.49 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.097 -1.002 . . . . 0.0 109.938 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.59 ' HB3' HD13 ' D' ' 3' ' ' LEU . 24.1 pttt -62.38 -31.63 72.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 0.0 110.008 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 1.2 t -44.55 -23.44 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -81.57 -57.34 3.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.019 -1.051 . . . . 0.0 110.11 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.434 HG23 ' CE2' ' D' ' 130' ' ' TYR . 14.9 p -68.76 -24.64 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.055 -1.028 . . . . 0.0 108.256 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 12.6 m -71.91 -42.15 67.06 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.347 0.594 . . . . 0.0 109.852 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.77 -30.38 69.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 109.868 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -50.32 -18.79 0.67 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.95 . . . . 0.0 109.33 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . 0.412 ' CZ2' HD13 ' D' ' 75' ' ' LEU . 0.7 OUTLIER -53.18 -51.39 62.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 0.0 109.158 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.09 -32.47 35.47 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 -46.68 14.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.333 -1.098 . . . . 0.0 109.214 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 69.6 t -59.02 114.91 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.546 -0.721 . . . . 0.0 109.842 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' D' ' 21' ' ' ASP . 19.0 m120 -79.43 71.58 6.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 108.742 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.443 HG12 ' O ' ' D' ' 20' ' ' VAL . 57.2 t -46.99 -11.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.89 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' D' ' 19' ' ' ASN . 16.5 m-20 -73.51 -5.35 39.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 109.847 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -156.31 -40.35 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 0.0 109.577 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -46.4 -55.54 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.0 109.66 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.72 -29.85 50.42 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.53 -29.93 69.34 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.94 -31.46 59.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -1.11 . . . . 0.0 109.467 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.11 -54.32 48.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . 0.535 HD22 ' N ' ' D' ' 28' ' ' LEU . 3.8 mm? -61.9 -40.06 94.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.935 . . . . 0.0 109.26 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.98 -42.78 76.31 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 60.2 mmt-85 -72.74 -36.97 67.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -1.098 . . . . 0.0 109.481 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 65.2 tp -50.12 -31.72 14.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.32 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.18 -22.59 38.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.625 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.97 -64.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.578 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.444 ' H ' HG23 ' D' ' 34' ' ' VAL . 0.2 OUTLIER -64.11 -22.69 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -0.828 . . . . 0.0 109.644 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -140.31 79.22 21.56 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.218 -0.926 . . . . 0.0 109.526 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -83.49 -12.42 8.98 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.865 2.377 . . . . 0.0 112.36 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . 0.524 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 3.3 p-90 -48.62 -33.95 10.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.586 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.524 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 3.2 m -78.96 2.59 19.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.509 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' D' ' 39' ' ' GLN . 1.4 tm0? -65.48 -19.08 65.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . 1.455 ' NH2' ' CG ' ' A' ' 92' ' ' ARG . 32.9 mtp85 -68.49 -40.94 80.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.746 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -93.03 -18.98 22.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' D' ' 45' ' ' PHE . 1.3 t80 -89.86 28.56 1.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 109.44 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -84.39 -13.99 50.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.351 -0.843 . . . . 0.0 109.608 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -80.12 -7.59 58.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.602 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.656 ' HZ ' ' CMD' ' D' ' 147' ' ' HEC . 33.5 m-85 -83.68 -3.44 57.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 109.483 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.03 -172.78 25.07 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -84.81 98.39 10.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -1.125 . . . . 0.0 109.339 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . 0.708 HD12 ' N ' ' D' ' 48' ' ' LEU . 7.2 mp -88.0 30.85 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.0 108.956 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -45.0 -30.96 1.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.444 -0.785 . . . . 0.0 109.89 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 6.7 p -142.35 138.2 16.29 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -41.2 -28.45 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.423 2.082 . . . . 0.0 112.362 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . 0.4 ' C ' ' N ' ' D' ' 54' ' ' VAL . 12.0 t70 -76.96 -39.81 49.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.0 109.578 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.8 -19.79 0.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.355 -0.84 . . . . 0.0 109.653 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . 0.4 ' N ' ' C ' ' D' ' 52' ' ' ASP . 45.8 t -67.06 -63.87 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.656 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 9.8 mmt -51.48 -19.92 1.63 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.757 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.0 -31.75 38.23 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . 0.408 ' N ' HD22 ' D' ' 57' ' ' ASN . 2.7 m120 -63.18 132.74 95.19 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.232 -1.157 . . . . 0.0 109.318 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.26 -50.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.447 2.098 . . . . 0.0 112.523 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.05 -34.93 72.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 109.967 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -55.34 -49.88 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.032 . . . . 0.0 109.193 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . 0.431 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 26.2 mtmt -73.6 -29.34 62.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.169 -0.957 . . . . 0.0 109.277 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.31 68.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.449 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 1.257 ' NE2' ' CHA' ' D' ' 147' ' ' HEC . 2.5 t60 -54.39 -25.36 24.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.81 -32.25 83.1 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 0.4 OUTLIER -62.88 -36.79 84.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.183 -1.186 . . . . 0.0 109.274 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -75.76 -35.1 60.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 109.344 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.687 HG22 ' CHB' ' D' ' 147' ' ' HEC . 47.7 t -69.03 -63.12 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.285 -0.885 . . . . 0.0 109.324 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.551 ' O ' HD23 ' D' ' 68' ' ' LEU . 1.8 tt -53.75 -32.81 53.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 108.898 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.93 -56.98 21.07 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.81 -42.25 79.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -1.085 . . . . 0.0 109.455 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . 0.405 ' O ' ' CD1' ' D' ' 71' ' ' PHE . 3.0 t80 -67.24 -35.12 78.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . 0.404 ' HB2' ' HE1' ' D' ' 15' ' ' TRP . 62.2 p -73.78 -35.61 64.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.63 -21.16 0.54 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.908 . . . . 0.0 109.361 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.13 -60.12 4.65 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.642 ' H ' HD12 ' D' ' 75' ' ' LEU . 5.1 mp -53.46 -28.9 32.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -1.161 . . . . 0.0 109.25 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.78 3.5 41.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' D' ' 79' ' ' ASP . 23.5 t-80 -170.41 61.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.692 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . 0.659 HD22 HG21 ' D' ' 1' ' ' VAL . 59.2 mt -73.69 15.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.257 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' D' ' 77' ' ' HIS . 16.8 t70 -76.38 -36.02 58.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.216 -0.927 . . . . 0.0 109.522 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -161.61 100.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 109.401 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 33.2 mt -79.21 -50.23 11.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . 0.431 ' NZ ' ' ND1' ' D' ' 143' ' ' HIS . 24.6 mmtp -48.41 -23.92 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.929 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.08 -63.27 3.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.3 t -63.94 -48.11 77.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.262 -1.14 . . . . 0.0 109.397 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' D' ' 84' ' ' THR . 46.6 m-85 -63.61 -8.5 10.11 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.435 -0.79 . . . . 0.0 109.374 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.25 -34.86 34.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.394 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 27.9 p -83.96 -50.97 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 0.0 109.535 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 35.8 mt -56.11 -55.56 31.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 109.161 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . 0.491 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 1.5 m -51.55 -38.91 56.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.323 -0.861 . . . . 0.0 109.44 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' D' ' 94' ' ' ASP . 29.1 tt0 -74.24 -54.64 7.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 tt -62.49 -29.3 70.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.687 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' D' ' 97' ' ' HIS . 1.3 m80 -79.31 -48.35 14.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.97 . . . . 0.0 110.043 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' D' ' 89' ' ' SER . 6.6 m -82.97 -31.14 27.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.028 -1.045 . . . . 0.0 110.301 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' D' ' 90' ' ' GLU . 6.4 t70 -86.66 -43.52 12.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.065 -1.022 . . . . 0.0 110.901 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -52.25 5.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 0.0 110.732 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.63 ' O ' ' ND1' ' D' ' 97' ' ' HIS . 4.1 mm? -82.98 -43.48 16.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.0 109.486 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 1.137 ' CD2' HG21 ' A' ' 41' ' ' THR . 0.0 OUTLIER 74.81 19.77 2.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.427 -0.796 . . . . 0.0 109.727 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . 0.403 HG23 ' H ' ' D' ' 98' ' ' VAL . 8.6 t -45.11 122.24 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 109.471 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . 0.512 ' O ' ' ND2' ' D' ' 102' ' ' ASN . 15.6 m-20 -69.18 151.46 97.05 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.41 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' D' ' 99' ' ' ASP . 75.7 Cg_exo -42.9 178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.631 2.22 . . . . 0.0 112.414 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 57.52 64.76 1.5 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 109.569 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' D' ' 99' ' ' ASP . 73.1 m-20 -161.92 -52.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.41 -0.806 . . . . 0.0 109.263 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . 0.702 ' HA ' HBB2 ' D' ' 147' ' ' HEC . 4.2 p90 -66.96 -25.96 66.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.44 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . 0.417 ' O ' ' OD1' ' D' ' 108' ' ' ASN . 39.3 ttt-85 -78.53 -25.76 45.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.91 -45.7 49.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.915 . . . . 0.0 109.605 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.963 HD13 ' C3B' ' D' ' 147' ' ' HEC . 4.6 tt -49.39 -46.07 46.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.4 -48.83 64.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' D' ' 104' ' ' ARG . 30.1 m120 -50.22 -44.26 53.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -1.172 . . . . 0.0 109.739 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.04 -35.27 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.757 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tp -63.41 -38.8 92.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.662 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . 0.435 HG21 HE21 ' D' ' 131' ' ' GLN . 66.8 t -51.37 -30.52 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.676 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.22 -59.38 2.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.615 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . 0.403 HG23 ' H ' ' D' ' 113' ' ' VAL . 29.3 t -46.17 -27.91 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.833 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . 0.451 HD13 ' OH ' ' D' ' 130' ' ' TYR . 17.0 mt -82.66 -53.12 6.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.527 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.454 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -65.38 -19.43 65.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.639 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.08 -62.84 1.25 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.689 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -77.26 -48.3 17.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.823 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -92.8 30.21 1.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.751 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' D' ' 121' ' ' GLU . . . -55.05 -27.73 46.51 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -64.65 7.09 0.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -1.136 . . . . 0.0 109.598 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' D' ' 119' ' ' GLY . 61.0 mm-40 -133.14 6.87 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 109.434 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.538 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -73.32 34.8 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.427 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.493 ' H ' ' C ' ' D' ' 121' ' ' GLU . 2.9 p -44.87 148.96 0.88 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.339 -0.85 . . . . 0.0 109.504 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.514 ' HA ' HH22 ' C' ' 31' ' ' ARG . 5.4 Cg_exo -44.36 -54.04 4.34 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.437 2.091 . . . . 0.0 112.78 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 21.2 Cg_endo -61.35 -48.25 10.11 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.934 1.756 . . . . 0.0 112.0 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.426 ' O ' HG12 ' D' ' 126' ' ' VAL . 72.8 t -55.48 -13.02 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.357 -0.839 . . . . 0.0 109.518 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . 1.063 ' CG ' ' NH1' ' C' ' 31' ' ' ARG . 0.7 OUTLIER -82.47 -59.87 2.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.646 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.805 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -66.56 -26.52 67.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.435 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.78 26.44 0.83 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.451 ' OH ' HD13 ' D' ' 114' ' ' LEU . 0.1 OUTLIER -123.47 -61.36 1.41 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.295 -0.878 . . . . 0.0 109.303 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 0.711 ' OE1' ' OG ' ' C' ' 35' ' ' SER . 26.1 mp0 -53.56 -36.37 61.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.671 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -69.47 -25.13 63.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 64.4 t -77.27 -43.66 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.581 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.61 -17.1 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.603 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.36 -28.95 70.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.541 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -36.43 59.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . 0.492 HG13 ' CZ ' ' D' ' 85' ' ' PHE . 76.4 t -75.24 -36.47 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -1.153 . . . . 0.0 109.456 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.22 -38.91 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' D' ' 143' ' ' HIS . 9.9 m120 -85.21 -21.3 29.18 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.21 -0.931 . . . . 0.0 109.758 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.69 -55.52 33.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.514 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 41.4 mt -61.52 -24.77 66.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.277 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' D' ' 145' ' ' TYR . . . -100.29 1.79 42.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 109.378 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . 0.527 ' N ' ' O ' ' D' ' 139' ' ' ASN . 71.2 t60 -80.91 -1.68 44.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.453 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' D' ' 146' ' ' HIS . 5.4 tppt? -120.75 -32.04 4.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' D' ' 142' ' ' ALA . 0.1 OUTLIER -49.12 -10.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.233 -0.917 . . . . 0.0 109.888 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' D' ' 144' ' ' LYS . 4.9 m-70 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.656 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.916 HMB1 HBB2 ' A' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 1.23 ' CHA' ' NE2' ' B' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.917 HMB1 HBB2 ' C' ' 142' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 1.257 ' CHA' ' NE2' ' D' ' 63' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 131' ' ' SER . 12.4 tp -171.74 145.51 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 109.634 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.6 168.29 20.94 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 109.319 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 5' ' ' ALA . 55.7 Cg_endo -73.13 -61.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.618 2.212 . . . . 0.0 112.666 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 4' ' ' PRO . . . -45.26 -38.27 5.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.934 . . . . 0.0 109.673 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 5' ' ' ALA . 4.8 m-20 -44.52 -28.36 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 108.977 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 10' ' ' VAL . 76.8 mttt -83.06 -60.33 2.19 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.437 -0.789 . . . . 0.0 109.093 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.1 m -46.37 -31.61 2.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.471 -0.768 . . . . 0.0 109.657 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -76.72 -35.85 57.55 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.492 HG21 ' CG ' ' A' ' 128' ' ' PHE . 4.4 t -73.58 -50.25 31.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -49.15 -42.79 40.75 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.4 -63.57 1.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.257 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.706 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -55.37 -39.05 69.63 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 109.178 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.43 ' NE1' ' OG1' ' A' ' 67' ' ' THR . 0.1 OUTLIER -71.31 -17.19 62.47 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.044 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.26 -46.23 7.66 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -70.67 -34.61 72.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.146 . . . . 0.0 108.742 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 13' ' ' ALA . 70.1 t -63.02 -66.03 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 20' ' ' HIS . . . 60.84 -140.82 48.08 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 20' ' ' HIS . . . -66.7 49.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.434 -1.039 . . . . 0.0 110.194 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 18' ' ' GLY . 80.0 m-70 -153.75 19.64 0.53 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -83.8 -62.87 1.46 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.701 -0.624 . . . . 0.0 109.781 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.2 -14.45 0.16 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 21' ' ' ALA . 3.4 mm-40 -86.71 -56.47 3.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -1.132 . . . . 0.0 109.744 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 3.9 m-30 -55.38 -52.23 64.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 109.159 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.14 -22.79 14.58 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB1' HG12 ' A' ' 55' ' ' VAL . . . -73.67 -45.4 52.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -1.129 . . . . 0.0 109.702 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.518 ' OE1' ' NE2' ' A' ' 112' ' ' HIS . 94.9 mt-10 -65.69 -19.83 66.05 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.509 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.58 -24.5 60.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.381 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.3 mt -65.81 -41.23 92.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.735 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -75.68 -12.54 60.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.09 -1.006 . . . . 0.0 109.739 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 31' ' ' ARG . 3.1 tpm_? -78.93 -47.36 16.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 0.0 110.155 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.551 ' HE1' HBC3 ' A' ' 142' ' ' HEC . 1.1 ptm -65.74 -26.35 67.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.007 -1.058 . . . . 0.0 109.683 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.37 -36.45 82.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.101 -0.999 . . . . 0.0 109.436 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 12.1 mt -85.66 -44.88 12.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.708 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 40.2 t -51.5 -19.61 1.52 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.824 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.529 ' CG ' ' O ' ' A' ' 35' ' ' SER . 60.1 m-85 -160.92 90.23 1.61 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.098 -1.001 . . . . 0.0 109.733 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 39' ' ' THR . 52.4 Cg_exo -50.28 -26.15 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.594 2.196 . . . . 0.0 112.158 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.764 ' O ' HG22 ' A' ' 41' ' ' THR . 10.8 p -47.54 -18.51 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 37' ' ' PRO . 22.1 p -76.47 -22.89 53.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.273 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 43' ' ' PHE . 28.8 ttmt -74.22 -31.74 62.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.88 . . . . 0.0 109.84 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 1.413 HG21 ' ND1' ' D' ' 97' ' ' HIS . 14.3 t -47.13 -25.74 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.333 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.474 ' C ' ' CG ' ' A' ' 43' ' ' PHE . 97.5 m-85 -87.86 30.95 0.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.474 ' CG ' ' C ' ' A' ' 42' ' ' TYR . 0.9 OUTLIER 70.26 149.55 0.12 Allowed Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.16 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 46' ' ' PHE . 40.0 Cg_endo -68.73 -42.92 4.17 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.058 1.838 . . . . 0.0 112.337 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.546 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 21.7 p80 34.38 34.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.549 -0.72 . . . . 0.0 109.248 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.714 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -166.63 75.49 0.18 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.621 ' C ' ' O ' ' A' ' 46' ' ' PHE . 20.8 m-20 -8.8 -54.67 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.028 -0.42 . . . . 0.0 111.522 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.714 ' N ' ' O ' ' A' ' 46' ' ' PHE . 5.7 mt 56.71 4.81 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.244 -0.91 . . . . 0.0 109.386 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 47' ' ' ASP . 33.3 t -73.24 19.0 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.242 -0.911 . . . . 0.0 109.362 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' A' ' 48' ' ' LEU . 6.6 t-80 58.86 156.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.06 15.33 1.46 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 10.7 t -72.59 -21.27 61.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -1.116 . . . . 0.0 109.403 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.5 -50.62 0.5 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.709 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 52' ' ' SER . 15.8 pt20 -45.37 -17.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.684 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.55 HG12 ' HB1' ' A' ' 26' ' ' ALA . 77.9 t -73.84 -32.85 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.83 -24.82 67.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.641 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.15 -51.1 40.94 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 24.7 t-80 -67.82 -27.81 67.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.13 -1.217 . . . . 0.0 110.282 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 26' ' ' ALA . . . -63.22 -31.05 79.39 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 16.9 mtpp -71.79 -23.63 61.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -1.157 . . . . 0.0 110.146 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.817 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 0.4 OUTLIER -66.8 -58.1 5.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.124 -0.985 . . . . 0.0 108.644 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.8 t -55.2 -48.94 75.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.544 -0.723 . . . . 0.0 109.238 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -64.23 -42.57 96.5 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.23 -0.919 . . . . 0.0 108.959 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 7.5 t70 -72.02 -25.63 61.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.806 . . . . 0.0 109.056 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.094 ' HB2' HMA1 ' A' ' 142' ' ' HEC . . . -80.65 -44.74 18.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.94 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -76.57 -27.35 55.83 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.568 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 63' ' ' ALA . 52.8 m -75.92 -44.62 39.37 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 36.3 t30 -57.41 -20.81 32.32 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.631 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.24 -45.88 12.42 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.46 ' CG2' HG11 ' A' ' 10' ' ' VAL . 6.0 t -59.62 -22.63 23.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -65.39 -15.25 62.39 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.568 ' O ' ' N ' ' A' ' 74' ' ' ASP . 31.6 m80 -153.04 -51.75 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.403 -0.811 . . . . 0.0 109.353 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.631 ' N ' ' O ' ' A' ' 69' ' ' ALA . 13.9 p 44.56 15.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.977 0.894 . . . . 0.0 109.32 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 72' ' ' HIS . 95.9 m-20 -134.3 10.57 3.81 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 78' ' ' ASN . 31.1 t70 -175.23 27.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.14 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.69 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 2.1 ptt? -78.59 -24.19 0.43 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.47 -0.769 . . . . 0.0 111.829 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.3 Cg_exo -52.9 -19.8 11.91 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.701 1.601 . . . . 0.0 112.634 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.448 ' ND2' ' N ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -94.21 -33.12 13.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.114 -0.991 . . . . 0.0 109.822 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.448 ' N ' ' ND2' ' A' ' 78' ' ' ASN . . . -74.6 -40.79 61.37 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.27 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.64 12.12 13.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.024 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 66.5 p -70.6 -16.21 62.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.655 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 83' ' ' LEU . . . -82.07 -51.71 7.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.693 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 83' ' ' LEU . 3.4 mt -44.89 -43.0 8.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.382 -0.824 . . . . 0.0 109.043 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.1 p -57.14 -22.07 37.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.428 -0.795 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -72.54 -32.75 66.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.686 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 90' ' ' LYS . 7.0 tt -81.4 -29.18 34.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.417 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -89.9 -28.42 19.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 109.529 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 90' ' ' LYS . . . -83.9 -80.41 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.665 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.539 ' O ' ' ND1' ' A' ' 89' ' ' HIS . 30.4 t-80 -61.09 2.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.841 . . . . 0.0 109.61 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 88' ' ' ALA . 6.1 mtmm -156.15 152.29 27.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.289 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' A' ' 93' ' ' VAL . 10.9 mp 56.95 63.89 1.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 108.983 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.287 ' HB3' ' NH1' ' D' ' 40' ' ' ARG . 8.4 ptp180 -62.77 14.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.578 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.636 ' H ' ' C ' ' A' ' 91' ' ' LEU . 73.7 t -41.43 121.69 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -0.812 . . . . 0.0 109.631 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.11 147.81 2.29 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.533 ' C ' ' H ' ' A' ' 97' ' ' ASN . 37.9 Cg_endo -68.23 -10.66 29.63 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.486 2.124 . . . . 0.0 112.069 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 96' ' ' VAL . 2.8 t -55.25 -1.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.716 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 1.045 ' HB3' HMC1 ' A' ' 142' ' ' HEC . 5.0 m120 -74.66 -42.34 58.65 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.084 -1.01 . . . . 0.0 109.808 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 2.2 m-85 -46.38 -42.05 14.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 0.0 109.275 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -58.1 -32.91 68.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.244 -0.91 . . . . 0.0 109.316 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.1 mt -84.08 -62.28 1.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.105 HD22 HBB3 ' A' ' 142' ' ' HEC . 6.3 tt -50.22 -41.84 50.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 0.0 109.291 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.4 m -63.26 -51.03 67.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -66.1 -26.82 67.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.513 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 96.6 m -63.51 -50.59 69.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 109.75 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.31 -43.02 22.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 106' ' ' LEU . 8.6 mp -64.17 -59.24 4.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.423 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.563 ' CG1' ' NE2' ' B' ' 127' ' ' GLN . 76.7 t -56.48 -30.99 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -75.7 -63.03 1.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.459 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 113' ' ' LEU . 13.1 mt -51.34 -30.65 19.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.326 -0.859 . . . . 0.0 109.495 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -47.43 -42.29 22.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.885 . . . . 0.0 109.679 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.11 -49.25 11.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.829 . . . . 0.0 109.787 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 27' ' ' GLU . 11.4 m170 -76.24 -69.98 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 109.868 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -110.96 97.05 32.57 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 109.054 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 113' ' ' LEU . 71.2 Cg_exo -47.31 -174.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.372 2.048 . . . . 0.0 112.879 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 122' ' ' HIS . . . -86.67 -35.09 19.53 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.664 0.745 . . . . 0.0 109.574 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 3.8 mt-10 78.4 0.86 2.63 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.943 ' HD1' ' NH2' ' B' ' 30' ' ' ARG . 21.7 t80 65.3 37.56 6.32 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.639 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.749 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -93.97 115.07 64.69 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.82 -1.175 . . . . 0.0 107.953 178.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.755 ' HA ' ' CG1' ' B' ' 33' ' ' VAL . 50.4 Cg_exo -50.36 21.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.021 1.814 . . . . 0.0 112.553 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.749 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -147.07 -21.7 0.4 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.003 -1.061 . . . . 0.0 110.961 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.77 HG13 ' N ' ' A' ' 122' ' ' HIS . 10.5 p -58.13 -58.75 5.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.976 -1.078 . . . . 0.0 110.48 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.77 ' N ' HG13 ' A' ' 121' ' ' VAL . 1.1 m-70 -71.03 -24.89 62.45 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.3 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' B' ' 33' ' ' VAL . . . -84.08 -20.74 32.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 128' ' ' PHE . 62.7 p -77.41 -63.19 1.43 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.248 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 mt -60.46 -19.84 57.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.057 -1.027 . . . . 0.0 109.102 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.494 ' OD2' ' OH ' ' B' ' 35' ' ' TYR . 7.4 t70 -77.77 -51.18 10.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.482 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -90.28 -41.82 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.845 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 124' ' ' SER . 29.8 t80 -50.23 -22.88 1.92 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.008 -1.057 . . . . 0.0 109.037 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 133' ' ' SER . 15.0 mt -73.99 -24.76 59.64 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -56.77 -31.87 65.05 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.463 ' HB3' HD13 ' A' ' 2' ' ' LEU . 89.6 p -73.97 -32.56 63.51 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.37 -29.79 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 129' ' ' LEU . 9.9 p -81.92 -25.26 35.08 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.843 . . . . 0.0 108.913 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.8 m -74.91 -40.13 61.06 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.305 -0.872 . . . . 0.0 109.102 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.13 -21.79 17.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 108.782 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.75 -35.96 72.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.472 -0.767 . . . . 0.0 109.103 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.435 ' O ' ' O ' ' A' ' 138' ' ' SER . 57.8 p -88.13 -2.3 58.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.333 -0.854 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' THR . 28.3 m 51.79 98.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 109.471 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 138' ' ' SER . 5.9 mtpm? -55.11 -170.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.537 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -61.34 -67.76 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.483 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.832 HH12 HH12 ' C' ' 141' ' ' ARG . 43.3 mtp180 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.479 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.942 HG22 ' H ' ' B' ' 2' ' ' HIS . 8.2 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 0.942 ' H ' HG22 ' B' ' 1' ' ' VAL . 86.7 m-70 52.13 98.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 109.34 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.906 HD12 ' N ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -136.41 -163.11 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 109.265 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.412 ' O ' ' N ' ' B' ' 6' ' ' GLU . 11.9 p -88.98 130.64 43.87 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 109.19 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -42.05 -23.04 0.23 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.362 2.041 . . . . 0.0 112.271 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' B' ' 4' ' ' THR . 51.9 mt-10 -80.11 -54.26 5.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.812 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.42 -41.09 85.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.746 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.721 ' HB2' HD13 ' B' ' 3' ' ' LEU . 0.3 OUTLIER -68.54 -35.1 76.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.5 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 4.9 m -60.68 -23.58 64.95 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.885 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.49 -57.58 3.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.11 -0.994 . . . . 0.0 109.809 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.76 -24.39 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 85.6 m -83.85 -35.2 24.37 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.345 0.593 . . . . 0.0 109.606 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' B' ' 9' ' ' SER . . . -69.05 -29.27 67.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.386 -0.821 . . . . 0.0 109.791 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.1 -21.07 0.65 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.244 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . 0.463 ' HE1' ' HB2' ' B' ' 72' ' ' SER . 0.8 OUTLIER -53.54 -17.88 2.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.175 -0.953 . . . . 0.0 109.084 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.8 -33.31 46.97 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' B' ' 17' ' ' LYS . 4.3 mmtt -89.82 -41.46 11.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -1.178 . . . . 0.0 109.361 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -57.22 114.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 109.833 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' B' ' 21' ' ' ASP . 7.4 m120 -84.3 68.41 10.18 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 71.3 t -43.88 -18.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.392 -0.817 . . . . 0.0 109.73 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' B' ' 19' ' ' ASN . 1.1 m-20 -62.39 -10.79 12.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.709 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -154.42 -35.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -0.995 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 72.3 t -48.74 -34.89 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.3 -25.9 68.87 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.97 -36.3 25.37 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -67.67 -30.7 70.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -1.114 . . . . 0.0 109.472 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.68 -54.53 45.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.548 HD12 ' N ' ' B' ' 28' ' ' LEU . 9.9 mp -64.3 -55.76 19.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.399 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.03 -41.32 29.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.943 ' NH2' ' HD1' ' A' ' 117' ' ' PHE . 73.5 mtt-85 -80.01 -34.64 38.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -1.144 . . . . 0.0 109.499 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . 0.443 HD12 HG21 ' B' ' 109' ' ' VAL . 65.4 tp -47.11 -37.21 9.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 109.499 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' B' ' 36' ' ' PRO . 15.0 mt -81.32 -39.29 25.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.817 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.755 ' CG1' ' HA ' ' A' ' 119' ' ' PRO . 72.4 t -58.13 -61.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.12 -0.988 . . . . 0.0 109.442 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.686 HG13 ' HB3' ' A' ' 122' ' ' HIS . 1.7 t -68.69 -22.56 26.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.396 -0.815 . . . . 0.0 109.83 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.494 ' OH ' ' OD2' ' A' ' 126' ' ' ASP . 64.0 m-85 -146.75 76.47 11.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.776 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . 0.423 ' N ' ' O ' ' B' ' 32' ' ' LEU . 72.1 Cg_endo -82.95 28.98 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.95 2.433 . . . . 0.0 112.382 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.532 ' CD1' HG23 ' B' ' 38' ' ' THR . 3.8 p-90 -81.08 -19.85 42.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.167 -0.958 . . . . 0.0 109.654 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.532 HG23 ' CD1' ' B' ' 37' ' ' TRP . 44.8 p -78.39 -104.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.523 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . 0.521 ' N ' ' OG1' ' B' ' 38' ' ' THR . 13.9 mt-30 54.94 10.65 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.654 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 1.321 ' NH1' ' HB3' ' C' ' 92' ' ' ARG . 15.9 mmt180 -88.55 -58.98 2.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -71.44 -8.19 52.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 1.418 ' CZ ' ' CBC' ' B' ' 147' ' ' HEC . 50.4 m-85 -87.75 28.16 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.361 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.66 -27.3 65.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.355 -0.841 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 93.9 p -84.15 -27.19 28.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 109.465 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -49.65 -24.39 2.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.331 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.87 173.05 0.19 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.97 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -1.142 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 12.6 mt -138.92 19.68 2.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -58.93 -33.9 71.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . 0.487 ' HG1' ' CG ' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -140.61 154.34 69.06 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.49 -24.26 74.15 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.212 1.941 . . . . 0.0 111.756 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.487 ' CG ' ' HG1' ' B' ' 50' ' ' THR . 2.8 p30 -85.2 -21.02 29.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 109.608 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.96 -19.95 65.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 109.736 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.449 ' O ' HG21 ' B' ' 60' ' ' VAL . 4.4 t -67.05 -64.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.94 . . . . 0.0 109.473 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.09 8.13 1.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' B' ' 54' ' ' VAL . . . -74.57 -29.99 60.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -84.42 147.72 50.57 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.195 -1.179 . . . . 0.0 109.34 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.72 -7.08 19.66 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.564 2.176 . . . . 0.0 112.175 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -85.77 -28.45 24.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.162 -0.961 . . . . 0.0 109.659 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.449 HG21 ' O ' ' B' ' 54' ' ' VAL . 83.5 t -70.31 -53.0 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.174 -0.954 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -57.8 -26.38 61.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.0 -46.5 43.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.619 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 58.0 t-80 -61.87 -23.82 66.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.376 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.06 -19.97 77.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -69.52 -37.31 77.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -1.197 . . . . 0.0 109.124 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . 0.599 ' CB ' HBA2 ' B' ' 147' ' ' HEC . 62.1 mmtt -68.06 -40.78 82.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.337 -0.852 . . . . 0.0 109.539 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 0.591 HG13 ' C2B' ' B' ' 147' ' ' HEC . 42.1 t -61.14 -59.15 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.285 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.521 ' O ' HD23 ' B' ' 68' ' ' LEU . 4.8 tt -58.56 -52.66 64.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.001 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.08 -45.02 26.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.429 ' HB2' HMA1 ' B' ' 147' ' ' HEC . . . -60.62 -44.45 96.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -1.129 . . . . 0.0 109.386 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.526 ' CD1' ' O ' ' B' ' 71' ' ' PHE . 2.5 t80 -69.63 -27.3 64.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.378 -0.826 . . . . 0.0 109.332 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.463 ' HB2' ' HE1' ' B' ' 15' ' ' TRP . 88.1 p -76.77 -27.91 55.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.938 . . . . 0.0 109.557 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' B' ' 77' ' ' HIS . 10.6 t70 -47.34 -37.08 10.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.584 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.05 -60.63 6.6 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.56 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.7 mp -56.71 -24.67 50.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -1.217 . . . . 0.0 109.176 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.542 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -93.91 -11.06 31.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.314 -0.866 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.542 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 80.3 m-70 -161.31 65.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 0.0 109.648 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.568 HD21 HG21 ' B' ' 1' ' ' VAL . 2.0 mt -71.69 10.27 0.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 0.0 109.04 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' B' ' 77' ' ' HIS . 2.8 p30 -64.42 -30.24 71.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.286 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' B' ' 79' ' ' ASP . 34.5 t-20 -171.05 105.13 0.23 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.371 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.21 -58.79 2.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.521 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -48.24 -23.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.447 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -68.72 -54.77 13.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.9 t -75.19 -47.17 29.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -1.18 . . . . 0.0 109.427 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' B' ' 84' ' ' THR . 48.8 m-85 -62.72 -5.42 2.72 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.428 -0.795 . . . . 0.0 109.459 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.7 -34.59 62.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.329 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 37.3 p -79.82 -51.15 9.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.456 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 27.8 mt -59.69 -42.08 92.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.88 . . . . 0.0 109.333 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 5.1 m -65.08 -42.46 94.07 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -73.04 -40.19 65.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' B' ' 95' ' ' LYS . 4.6 tt -66.97 -34.98 78.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' B' ' 97' ' ' HIS . 60.1 m80 -84.35 -20.29 32.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.004 -1.06 . . . . 0.0 109.703 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 39.3 t -84.02 -60.04 2.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.915 . . . . 0.0 110.987 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -86.91 -29.86 21.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.991 -1.068 . . . . 0.0 111.601 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' B' ' 91' ' ' LEU . 0.0 OUTLIER -85.8 -51.81 6.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.695 -1.253 . . . . 0.0 110.69 -178.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.613 ' C ' ' CG ' ' B' ' 97' ' ' HIS . 0.1 OUTLIER -102.77 -24.21 13.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.021 -1.049 . . . . 0.0 109.853 -179.269 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 1.371 ' ND1' HG21 ' C' ' 41' ' ' THR . 0.5 OUTLIER 44.64 47.23 8.62 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.146 -0.971 . . . . 0.0 109.822 179.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.426 ' H ' HG23 ' B' ' 98' ' ' VAL . 4.0 t -60.73 121.48 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -0.995 . . . . 0.0 108.987 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' B' ' 100' ' ' PRO . 13.9 m-20 -59.08 143.99 83.41 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 0.0 109.236 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' B' ' 99' ' ' ASP . 76.1 Cg_exo -45.85 -174.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.356 2.038 . . . . 0.0 112.317 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 57.45 76.58 0.31 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.218 -0.926 . . . . 0.0 109.52 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.448 ' C ' ' N ' ' B' ' 104' ' ' ARG . 40.5 t-20 -171.57 -67.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.41 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -49.05 -15.78 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.93 . . . . 0.0 109.319 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . 0.448 ' N ' ' C ' ' B' ' 102' ' ' ASN . 10.3 mmt180 -76.27 -31.06 58.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 mt -77.83 -52.03 9.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.917 HD13 ' CHC' ' B' ' 147' ' ' HEC . 5.4 tt -51.03 -49.16 61.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.155 -0.966 . . . . 0.0 109.308 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.78 -21.32 65.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -85.62 -27.76 25.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -1.18 . . . . 0.0 109.731 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.443 HG21 HD12 ' B' ' 31' ' ' LEU . 76.4 t -69.15 -47.48 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 0.0 109.647 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 16.1 mt -48.39 -39.74 23.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.553 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 65.2 t -51.08 -36.41 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.657 ' SG ' ' CD2' ' A' ' 122' ' ' HIS . 14.4 t -78.19 -22.99 47.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.554 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.17 -27.2 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.603 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 28.6 mt -81.36 -22.39 38.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.144 -0.972 . . . . 0.0 109.502 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' B' ' 119' ' ' GLY . . . -83.48 -37.0 23.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.468 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 9.1 t-80 -68.97 -49.04 61.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.496 ' O ' ' CD1' ' B' ' 118' ' ' PHE . 0.3 OUTLIER -74.32 -17.68 60.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.475 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' B' ' 117' ' ' HIS . 6.1 m-85 -152.38 61.94 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.439 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.54 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -62.08 -25.52 66.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -74.1 -31.03 62.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -1.139 . . . . 0.0 109.544 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -82.25 11.73 5.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.321 -0.862 . . . . 0.0 109.626 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -85.0 35.05 0.56 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.557 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.465 ' OG1' HG23 ' B' ' 126' ' ' VAL . 63.4 p -54.53 147.31 30.04 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.373 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.512 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 4.0 Cg_exo -45.13 -54.53 4.22 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.541 2.16 . . . . 0.0 113.173 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 18.4 Cg_endo -59.41 -11.56 14.05 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.119 1.88 . . . . 0.0 112.236 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.465 HG23 ' OG1' ' B' ' 123' ' ' THR . 72.5 t -97.72 -20.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.222 -0.924 . . . . 0.0 109.626 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . 0.563 ' NE2' ' CG1' ' A' ' 107' ' ' VAL . 5.4 tp-100 -83.37 -59.99 2.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.159 -0.963 . . . . 0.0 109.886 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.602 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -61.67 -34.81 76.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.21 -0.931 . . . . 0.0 109.623 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.02 23.93 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' B' ' 128' ' ' ALA . 23.4 t80 -118.9 -59.17 1.89 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.837 . . . . 0.0 109.68 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -47.07 -23.33 0.47 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.861 . . . . 0.0 109.955 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -82.52 -38.28 24.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 109.892 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . 0.587 ' HA ' HG23 ' B' ' 1' ' ' VAL . 45.0 t -61.6 -41.04 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.885 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.443 HG22 ' H ' ' B' ' 134' ' ' VAL . 1.6 m -81.97 -40.72 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.77 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 1.06 ' O ' ' CD2' ' D' ' 146' ' ' HIS . . . -47.51 -20.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.008 . . . . 0.0 109.523 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 134' ' ' VAL . . . -75.63 -41.63 28.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.21 -21.96 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -1.13 . . . . 0.0 109.483 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.55 -44.36 80.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.463 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.864 HD21 ' HB2' ' D' ' 146' ' ' HIS . 0.9 OUTLIER -79.71 -35.35 39.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.2 -43.95 42.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.905 . . . . 0.0 109.53 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.1 17.79 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.415 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' B' ' 146' ' ' HIS . . . -141.07 8.18 2.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -67.03 -38.19 85.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.307 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.32 -13.42 62.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' B' ' 145' ' ' TYR . 23.1 p90 -160.55 55.36 0.32 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 1.035 ' CD2' ' O ' ' D' ' 135' ' ' ALA . 2.2 p-80 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' C' ' 131' ' ' SER . 12.4 tp -171.71 145.52 1.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -0.953 . . . . 0.0 109.661 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.59 168.39 20.17 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.309 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' C' ' 5' ' ' ALA . 55.7 Cg_endo -73.22 -61.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.656 2.237 . . . . 0.0 112.662 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -45.2 -38.26 5.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.145 -0.972 . . . . 0.0 109.717 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' C' ' 5' ' ' ALA . 4.8 m-20 -44.63 -28.23 0.58 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.05 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' C' ' 10' ' ' VAL . 77.0 mttt -83.19 -60.24 2.21 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.443 -0.786 . . . . 0.0 109.033 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 46.1 m -46.46 -31.56 2.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.519 -0.738 . . . . 0.0 109.639 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -76.73 -35.93 57.48 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.492 HG21 ' CG ' ' C' ' 128' ' ' PHE . 4.5 t -73.53 -50.24 31.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -49.08 -42.98 40.61 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.32 -63.59 1.14 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.494 -0.754 . . . . 0.0 109.3 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.696 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -55.33 -39.12 69.59 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.428 -0.795 . . . . 0.0 109.191 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . 0.428 ' NE1' ' OG1' ' C' ' 67' ' ' THR . 0.1 OUTLIER -71.21 -17.31 62.52 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.285 -0.885 . . . . 0.0 109.088 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.19 -46.18 7.73 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 12.9 mmmt -70.6 -34.78 72.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -1.156 . . . . 0.0 108.806 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.696 HG23 ' O ' ' C' ' 13' ' ' ALA . 69.0 t -62.8 -66.19 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' C' ' 20' ' ' HIS . . . 60.9 -140.83 48.09 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . 0.405 ' O ' ' CG ' ' C' ' 20' ' ' HIS . . . -66.63 49.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.458 -1.025 . . . . 0.0 110.169 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' C' ' 18' ' ' GLY . 79.7 m-70 -153.79 19.66 0.52 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -83.87 -62.83 1.47 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.693 -0.63 . . . . 0.0 109.743 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.25 -14.37 0.16 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 21' ' ' ALA . 3.4 mm-40 -86.75 -56.5 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 109.703 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 3.8 m-30 -55.27 -52.35 63.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.175 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.05 -22.88 14.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . 0.548 ' HB1' HG12 ' C' ' 55' ' ' VAL . . . -73.57 -45.42 53.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -1.145 . . . . 0.0 109.762 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . 0.512 ' OE1' ' NE2' ' C' ' 112' ' ' HIS . 94.9 mt-10 -65.65 -19.87 66.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.482 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.49 60.04 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.905 . . . . 0.0 109.377 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.463 HD11 ' HD1' ' C' ' 58' ' ' HIS . 21.4 mt -65.88 -41.2 91.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.711 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -75.64 -12.55 60.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.858 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.401 ' HA ' ' NE ' ' C' ' 31' ' ' ARG . 3.1 tpm_? -78.94 -47.34 16.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.154 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 0.491 ' HE1' HBC3 ' C' ' 142' ' ' HEC . 1.1 ptm -65.76 -26.24 67.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 0.0 109.733 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.41 -36.52 83.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 0.0 109.373 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 12.1 mt -85.66 -44.88 12.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.678 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.52 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 40.3 t -51.51 -19.63 1.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.852 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' C' ' 35' ' ' SER . 59.9 m-85 -160.92 90.4 1.61 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 0.0 109.65 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' C' ' 39' ' ' THR . 52.2 Cg_exo -50.4 -26.17 15.52 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.488 2.125 . . . . 0.0 112.137 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.784 ' O ' HG22 ' C' ' 41' ' ' THR . 10.8 p -47.32 -18.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.439 ' N ' ' O ' ' C' ' 37' ' ' PRO . 21.8 p -76.6 -22.76 53.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.238 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' C' ' 43' ' ' PHE . 28.8 ttmt -74.29 -31.77 62.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.777 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 1.371 HG21 ' ND1' ' B' ' 97' ' ' HIS . 14.2 t -47.03 -25.75 0.89 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 109.354 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.474 ' C ' ' CG ' ' C' ' 43' ' ' PHE . 97.4 m-85 -87.92 31.02 0.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.474 ' CG ' ' C ' ' C' ' 42' ' ' TYR . 0.9 OUTLIER 70.2 149.64 0.12 Allowed Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.531 ' O ' ' C ' ' C' ' 45' ' ' HIS . 39.9 Cg_endo -68.86 -42.88 3.99 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.036 1.824 . . . . 0.0 112.261 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.534 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 21.6 p80 34.42 34.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.586 -0.696 . . . . 0.0 109.244 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.705 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.9 OUTLIER -166.6 75.47 0.18 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.609 ' C ' ' O ' ' C' ' 46' ' ' PHE . 20.7 m-20 -8.76 -54.69 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 120.985 0.422 . . . . 0.0 111.493 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.705 ' N ' ' O ' ' C' ' 46' ' ' PHE . 5.7 mt 56.71 4.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.198 -0.939 . . . . 0.0 109.408 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.485 ' H ' ' C ' ' C' ' 47' ' ' ASP . 33.4 t -73.34 19.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.351 -0.843 . . . . 0.0 109.348 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' C' ' 48' ' ' LEU . 6.6 t-80 58.81 156.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.42 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.06 15.23 1.43 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 10.7 t -72.49 -21.33 61.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -1.127 . . . . 0.0 109.422 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 67.54 -50.69 0.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.463 -0.773 . . . . 0.0 109.717 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' C' ' 52' ' ' SER . 15.8 pt20 -45.39 -17.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.667 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.548 HG12 ' HB1' ' C' ' 26' ' ' ALA . 77.4 t -73.87 -32.94 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 109.545 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -62.75 -24.77 67.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.673 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.16 -51.07 41.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 24.9 t-80 -67.8 -27.92 67.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -1.202 . . . . 0.0 110.221 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' C' ' 26' ' ' ALA . . . -63.13 -31.05 79.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.419 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 16.9 mtpp -71.92 -23.48 61.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -1.152 . . . . 0.0 110.118 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.817 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 0.4 OUTLIER -66.91 -58.15 5.56 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.044 -1.035 . . . . 0.0 108.574 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -55.08 -48.98 75.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.536 -0.728 . . . . 0.0 109.245 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' C' ' 67' ' ' THR . . . -64.33 -42.55 96.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.299 -0.875 . . . . 0.0 108.854 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 7.4 t70 -72.0 -25.69 61.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.065 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 1.076 ' HB2' HMA1 ' C' ' 142' ' ' HEC . . . -80.61 -44.75 18.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.375 -0.828 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . 0.936 ' O ' HD12 ' C' ' 66' ' ' LEU . 0.1 OUTLIER -76.5 -27.38 56.01 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.428 ' OG1' ' NE1' ' C' ' 14' ' ' TRP . 52.0 m -75.89 -44.66 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' C' ' 71' ' ' ALA . 36.5 t30 -57.45 -20.72 32.34 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' C' ' 73' ' ' VAL . . . -84.33 -45.68 12.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.458 ' CG2' HG11 ' C' ' 10' ' ' VAL . 6.0 t -59.75 -22.57 24.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.521 ' O ' ' CD2' ' C' ' 72' ' ' HIS . . . -65.48 -15.17 62.38 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.092 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.577 ' O ' ' N ' ' C' ' 74' ' ' ASP . 32.0 m80 -153.03 -51.87 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.434 -0.791 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.1 p 44.59 15.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.85 0.833 . . . . 0.0 109.214 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' C' ' 72' ' ' HIS . 95.8 m-20 -134.36 10.43 3.78 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' C' ' 78' ' ' ASN . 31.2 t70 -175.1 27.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.248 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.693 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 2.1 ptt? -78.52 -24.29 0.43 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.433 -0.792 . . . . 0.0 111.839 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.693 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.4 Cg_exo -52.81 -19.79 11.62 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.711 1.607 . . . . 0.0 112.629 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . 0.452 ' ND2' ' N ' ' C' ' 79' ' ' ALA . 0.8 OUTLIER -94.25 -33.09 13.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.823 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . 0.452 ' N ' ' ND2' ' C' ' 78' ' ' ASN . . . -74.6 -40.81 61.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.204 -0.935 . . . . 0.0 109.287 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.62 12.13 13.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 108.983 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . 0.417 ' O ' ' OD1' ' C' ' 85' ' ' ASP . 66.3 p -70.63 -16.19 62.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.632 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -82.1 -51.59 7.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.16 -0.963 . . . . 0.0 109.719 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.438 ' N ' HD23 ' C' ' 83' ' ' LEU . 3.5 mt -45.2 -42.82 9.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.413 -0.804 . . . . 0.0 109.028 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 29.7 p -57.1 -22.15 37.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.493 -0.755 . . . . 0.0 109.574 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' C' ' 82' ' ' ALA . 0.8 OUTLIER -72.6 -32.7 66.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.94 . . . . 0.0 109.592 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' C' ' 90' ' ' LYS . 7.0 tt -81.37 -29.13 34.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 109.516 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -89.87 -28.47 19.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.58 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' C' ' 90' ' ' LYS . . . -83.84 -80.44 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.89 . . . . 0.0 109.661 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' C' ' 89' ' ' HIS . 30.6 t-80 -61.2 2.49 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.57 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' C' ' 88' ' ' ALA . 6.1 mtmm -156.07 152.38 27.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.281 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' C' ' 93' ' ' VAL . 10.9 mp 56.97 63.81 1.82 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -0.865 . . . . 0.0 109.033 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . 1.321 ' HB3' ' NH1' ' B' ' 40' ' ' ARG . 8.4 ptp180 -62.73 14.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.47 -0.769 . . . . 0.0 109.501 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.636 ' H ' ' C ' ' C' ' 91' ' ' LEU . 74.1 t -41.38 121.66 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.384 -0.823 . . . . 0.0 109.64 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.06 147.87 2.2 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.465 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' C' ' 97' ' ' ASN . 38.0 Cg_endo -68.25 -10.7 29.74 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.512 2.141 . . . . 0.0 112.126 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 0.419 ' H ' HG23 ' C' ' 96' ' ' VAL . 2.8 t -55.27 -1.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.329 -0.857 . . . . 0.0 109.744 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 1.047 ' HB3' HMC1 ' C' ' 142' ' ' HEC . 5.1 m120 -74.69 -42.27 58.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.857 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' C' ' 98' ' ' PHE . 2.2 m-85 -46.37 -42.1 14.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 0.0 109.337 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -57.95 -33.07 68.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.302 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' C' ' 97' ' ' ASN . 11.1 mt -84.09 -62.12 1.64 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 1.102 HD22 HBB3 ' C' ' 142' ' ' HEC . 6.3 tt -50.35 -41.91 52.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 109.199 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 39.0 m -63.17 -51.01 68.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.528 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -66.1 -26.76 67.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.544 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.55 -50.5 69.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.0 109.753 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.38 -43.02 23.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -0.931 . . . . 0.0 109.384 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.551 ' N ' HD12 ' C' ' 106' ' ' LEU . 8.6 mp -64.15 -59.39 4.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.356 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . 0.554 ' CG1' ' NE2' ' D' ' 127' ' ' GLN . 77.0 t -56.33 -30.93 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.379 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 26.6 m -75.75 -63.09 1.38 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.318 -0.864 . . . . 0.0 109.388 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' C' ' 113' ' ' LEU . 13.1 mt -51.32 -30.66 19.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 109.486 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -47.42 -42.29 21.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.717 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.12 -49.21 11.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.422 -0.799 . . . . 0.0 109.763 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . 0.512 ' NE2' ' OE1' ' C' ' 27' ' ' GLU . 11.4 m170 -76.3 -70.0 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.871 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' C' ' 114' ' ' PRO . 0.3 OUTLIER -110.88 97.07 32.27 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.433 -0.792 . . . . 0.0 109.132 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' C' ' 113' ' ' LEU . 73.0 Cg_exo -47.46 -174.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.399 2.066 . . . . 0.0 112.883 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.482 ' HB2' ' CE1' ' C' ' 122' ' ' HIS . . . -86.59 -35.18 19.6 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.696 0.76 . . . . 0.0 109.517 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.459 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 3.8 mt-10 78.45 0.84 2.61 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.94 ' HD1' HH21 ' D' ' 30' ' ' ARG . 22.0 t80 65.27 37.64 6.33 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.602 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.764 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.6 OUTLIER -94.01 115.15 64.81 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.749 -1.22 . . . . 0.0 107.907 178.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . 0.76 ' HA ' ' CG1' ' D' ' 33' ' ' VAL . 50.5 Cg_exo -50.38 21.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.974 1.782 . . . . 0.0 112.571 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -147.08 -21.66 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.037 -1.039 . . . . 0.0 110.966 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.76 HG13 ' N ' ' C' ' 122' ' ' HIS . 10.4 p -58.23 -58.76 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.95 -1.094 . . . . 0.0 110.385 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.76 ' N ' HG13 ' C' ' 121' ' ' VAL . 1.1 m-70 -70.98 -24.97 62.51 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 109.266 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' D' ' 33' ' ' VAL . . . -84.1 -20.68 32.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.508 ' N ' ' O ' ' C' ' 120' ' ' ALA . 62.5 p -77.38 -63.15 1.44 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.267 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' C' ' 125' ' ' LEU . 4.6 mt -60.5 -19.95 58.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.075 -1.016 . . . . 0.0 109.084 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . 0.487 ' OD2' ' OH ' ' D' ' 35' ' ' TYR . 7.4 t70 -77.71 -51.21 10.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.455 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -90.26 -41.75 11.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.817 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' C' ' 124' ' ' SER . 29.8 t80 -50.25 -22.94 1.96 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.985 -1.072 . . . . 0.0 108.991 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.495 HD22 HBB1 ' C' ' 142' ' ' HEC . 14.9 mt -74.05 -24.69 59.56 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -56.67 -31.99 64.97 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.481 ' HB3' HD13 ' C' ' 2' ' ' LEU . 89.4 p -73.99 -32.42 63.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.48 -29.74 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.45 ' N ' ' O ' ' C' ' 129' ' ' LEU . 9.8 p -81.86 -25.33 35.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.329 -0.857 . . . . 0.0 108.881 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 36.8 m -74.96 -40.08 60.95 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.361 -0.837 . . . . 0.0 109.1 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.08 -21.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.344 -0.847 . . . . 0.0 108.779 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.77 -35.99 72.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.434 -0.792 . . . . 0.0 109.072 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . 0.434 ' O ' ' O ' ' C' ' 138' ' ' SER . 57.5 p -88.04 -2.44 58.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 109.571 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . 0.434 ' O ' ' O ' ' C' ' 137' ' ' THR . 28.3 m 51.89 98.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 109.555 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' C' ' 138' ' ' SER . 5.9 mtpm? -55.04 -170.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 109.532 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -61.42 -67.75 0.38 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.435 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . 0.832 HH12 HH12 ' A' ' 141' ' ' ARG . 43.4 mtp180 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.441 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.935 HG22 ' H ' ' D' ' 2' ' ' HIS . 8.3 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . 0.935 ' H ' HG22 ' D' ' 1' ' ' VAL . 86.8 m-70 52.03 98.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.384 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.892 HD12 ' N ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -136.45 -163.14 1.36 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.356 -0.84 . . . . 0.0 109.254 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.403 ' O ' ' N ' ' D' ' 6' ' ' GLU . 11.9 p -89.02 130.64 43.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.132 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -42.05 -23.06 0.23 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.292 1.995 . . . . 0.0 112.24 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' D' ' 4' ' ' THR . 51.9 mt-10 -80.05 -54.34 5.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.925 . . . . 0.0 109.877 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.39 -40.98 85.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.946 . . . . 0.0 109.87 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.729 ' HB2' HD13 ' D' ' 3' ' ' LEU . 0.3 OUTLIER -68.64 -35.08 76.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.473 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' D' ' 13' ' ' ALA . 4.9 m -60.66 -23.64 64.96 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 109.879 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.38 -57.64 3.39 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.067 -1.02 . . . . 0.0 109.859 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.436 ' H ' HG12 ' D' ' 11' ' ' VAL . 1.3 p -62.69 -24.41 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 82.0 m -83.9 -35.1 24.35 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.349 0.595 . . . . 0.0 109.695 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' D' ' 9' ' ' SER . . . -69.11 -29.37 67.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.83 . . . . 0.0 109.668 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.1 -20.98 0.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.312 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . 0.46 ' HE1' ' HB2' ' D' ' 72' ' ' SER . 0.8 OUTLIER -53.61 -17.93 2.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 109.067 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.7 -33.35 47.3 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -89.72 -41.63 11.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -1.178 . . . . 0.0 109.35 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -57.17 114.83 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.84 . . . . 0.0 109.847 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' D' ' 21' ' ' ASP . 7.4 m120 -84.1 68.41 10.07 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.296 -0.877 . . . . 0.0 108.686 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' D' ' 19' ' ' ASN . 72.3 t -43.94 -18.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.453 -0.779 . . . . 0.0 109.673 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' D' ' 19' ' ' ASN . 1.1 m-20 -62.39 -10.77 12.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.764 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -154.37 -35.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.125 -0.984 . . . . 0.0 109.517 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 72.8 t -48.72 -34.97 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.17 -25.99 68.8 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.04 -36.22 25.37 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -67.66 -30.67 70.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -1.125 . . . . 0.0 109.487 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.43 46.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . 0.55 HD12 ' N ' ' D' ' 28' ' ' LEU . 10.0 mp -64.32 -55.71 19.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.377 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -49.1 -41.35 29.86 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . 0.94 HH21 ' HD1' ' C' ' 117' ' ' PHE . 73.3 mtt-85 -80.0 -34.57 38.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -1.117 . . . . 0.0 109.502 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . 0.438 HD12 HG21 ' D' ' 109' ' ' VAL . 65.3 tp -47.19 -37.11 9.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' D' ' 36' ' ' PRO . 14.7 mt -81.31 -39.24 25.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.923 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.76 ' CG1' ' HA ' ' C' ' 119' ' ' PRO . 73.1 t -58.11 -61.48 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.385 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' C' ' 122' ' ' HIS . 1.7 t -68.69 -22.55 26.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.397 -0.814 . . . . 0.0 109.828 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . 0.487 ' OH ' ' OD2' ' C' ' 126' ' ' ASP . 63.9 m-85 -146.77 76.43 11.65 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.153 -0.967 . . . . 0.0 109.767 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' D' ' 32' ' ' LEU . 72.2 Cg_endo -82.86 28.9 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.912 2.408 . . . . 0.0 112.323 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . 0.534 ' CD1' HG23 ' D' ' 38' ' ' THR . 3.8 p-90 -80.95 -20.0 42.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.095 -1.003 . . . . 0.0 109.717 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.534 HG23 ' CD1' ' D' ' 37' ' ' TRP . 44.8 p -78.37 -103.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.554 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . 0.524 ' N ' ' OG1' ' D' ' 38' ' ' THR . 13.9 mt-30 55.03 10.67 0.42 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.37 -0.831 . . . . 0.0 109.645 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . 1.287 ' NH1' ' HB3' ' A' ' 92' ' ' ARG . 15.8 mmt180 -88.7 -58.86 2.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -71.45 -8.28 52.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 1.399 ' CZ ' ' CBC' ' D' ' 147' ' ' HEC . 49.4 m-85 -87.72 28.22 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.7 -27.31 65.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.462 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 94.0 p -84.11 -27.22 28.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -49.55 -24.43 2.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.299 -0.876 . . . . 0.0 109.241 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.82 173.11 0.19 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 51.89 91.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.345 -1.091 . . . . 0.0 109.572 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 12.6 mt -139.01 19.71 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 109.31 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -58.85 -34.02 71.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.15 -0.969 . . . . 0.0 109.434 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . 0.479 ' HG1' ' CG ' ' D' ' 52' ' ' ASP . 0.1 OUTLIER -140.6 154.23 68.97 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.32 -24.34 73.94 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.253 1.969 . . . . 0.0 111.765 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . 0.479 ' CG ' ' HG1' ' D' ' 50' ' ' THR . 2.8 p30 -85.22 -21.0 29.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.608 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.98 -19.9 65.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 109.735 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . 0.445 ' O ' HG21 ' D' ' 60' ' ' VAL . 4.4 t -67.07 -64.03 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 0.0 109.465 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.05 8.13 1.38 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.537 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.68 -29.83 60.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -84.42 147.65 50.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.212 -1.169 . . . . 0.0 109.377 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.65 -7.14 19.79 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.584 2.19 . . . . 0.0 112.193 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -85.69 -28.56 24.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.666 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . 0.445 HG21 ' O ' ' D' ' 54' ' ' VAL . 83.9 t -70.24 -52.95 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.611 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -57.82 -26.42 61.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.543 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.89 -46.68 43.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 109.398 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.625 ' CE1' ' CHA' ' D' ' 147' ' ' HEC . 58.2 t-80 -61.72 -23.84 66.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.887 . . . . 0.0 109.443 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.07 -20.0 77.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -69.51 -37.3 77.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 109.084 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . 0.599 ' CB ' HBA2 ' D' ' 147' ' ' HEC . 62.1 mmtt -68.13 -40.69 82.42 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.444 -0.785 . . . . 0.0 109.498 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.581 HG13 ' C2B' ' D' ' 147' ' ' HEC . 41.9 t -61.29 -59.1 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.203 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.518 ' O ' HD23 ' D' ' 68' ' ' LEU . 4.8 tt -58.59 -52.61 64.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 108.983 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.15 -44.98 27.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . 0.437 ' HB2' HMA1 ' D' ' 147' ' ' HEC . . . -60.7 -44.46 96.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -1.128 . . . . 0.0 109.379 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' D' ' 71' ' ' PHE . 2.5 t80 -69.59 -27.22 64.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.853 . . . . 0.0 109.336 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . 0.46 ' HB2' ' HE1' ' D' ' 15' ' ' TRP . 88.5 p -76.93 -27.85 55.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' D' ' 77' ' ' HIS . 10.6 t70 -47.42 -37.11 10.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 109.55 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.09 -60.6 6.62 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.544 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.7 mp -56.61 -24.79 50.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -1.159 . . . . 0.0 109.156 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . 0.544 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -93.86 -11.11 31.86 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 109.583 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 80.0 m-70 -161.19 65.15 0.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.903 . . . . 0.0 109.59 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . 0.574 HD21 HG21 ' D' ' 1' ' ' VAL . 2.0 mt -71.73 10.29 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.082 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' D' ' 77' ' ' HIS . 2.8 p30 -64.35 -30.23 71.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.378 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.433 ' N ' ' OD1' ' D' ' 79' ' ' ASP . 34.5 t-20 -171.09 105.08 0.23 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -80.14 -58.87 2.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -48.23 -23.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.0 109.449 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . 0.417 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -68.73 -54.82 13.23 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.54 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.9 t -75.2 -47.17 29.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -1.164 . . . . 0.0 109.417 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.54 ' N ' ' CG2' ' D' ' 84' ' ' THR . 48.6 m-85 -62.7 -5.41 2.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.67 62.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.273 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 37.1 p -79.75 -51.22 9.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.379 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.431 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 27.1 mt -59.68 -42.07 92.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 5.1 m -65.09 -42.41 94.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -73.1 -40.15 65.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.44 ' O ' ' CB ' ' D' ' 95' ' ' LYS . 4.6 tt -67.02 -35.03 79.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.607 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.561 ' O ' ' N ' ' D' ' 97' ' ' HIS . 60.0 m80 -84.28 -20.28 32.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.926 -1.109 . . . . 0.0 109.722 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 39.4 t -84.01 -60.07 2.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 111.01 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -86.96 -29.8 21.77 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.001 -1.062 . . . . 0.0 111.59 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' D' ' 91' ' ' LEU . 0.0 OUTLIER -85.77 -51.92 6.11 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.772 -1.205 . . . . 0.0 110.649 -178.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.607 ' C ' ' CG ' ' D' ' 97' ' ' HIS . 0.1 OUTLIER -102.75 -24.12 13.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.06 -1.025 . . . . 0.0 109.856 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 1.413 ' ND1' HG21 ' A' ' 41' ' ' THR . 0.5 OUTLIER 44.64 47.08 8.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.104 -0.998 . . . . 0.0 109.892 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 t -60.6 121.51 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.119 -0.988 . . . . 0.0 109.033 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' D' ' 100' ' ' PRO . 13.9 m-20 -59.09 143.97 83.47 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.225 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' D' ' 99' ' ' ASP . 75.4 Cg_exo -45.85 -174.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.423 2.082 . . . . 0.0 112.342 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 57.44 76.61 0.31 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' D' ' 104' ' ' ARG . 40.5 t-20 -171.6 -67.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 109.432 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -49.0 -15.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' D' ' 102' ' ' ASN . 10.3 mmt180 -76.2 -31.15 58.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.336 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 mt -77.78 -51.99 9.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.859 . . . . 0.0 109.645 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.914 HD13 ' CHC' ' D' ' 147' ' ' HEC . 5.4 tt -51.09 -49.18 61.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.107 -0.996 . . . . 0.0 109.23 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -63.77 -21.24 65.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -85.75 -27.64 25.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -1.162 . . . . 0.0 109.715 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . 0.438 HG21 HD12 ' D' ' 31' ' ' LEU . 77.0 t -69.15 -47.48 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.646 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 16.2 mt -48.48 -39.7 23.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.0 109.503 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 65.4 t -51.11 -36.45 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . 0.649 ' SG ' ' CD2' ' C' ' 122' ' ' HIS . 14.4 t -78.09 -23.02 48.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 109.553 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 t -79.14 -27.18 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.644 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 29.0 mt -81.47 -22.31 38.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.903 . . . . 0.0 109.507 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' D' ' 119' ' ' GLY . . . -83.45 -36.93 23.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 109.635 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.456 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 9.2 t-80 -68.96 -49.08 61.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . 0.502 ' O ' ' CD1' ' D' ' 118' ' ' PHE . 0.3 OUTLIER -74.32 -17.7 60.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.486 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' D' ' 117' ' ' HIS . 6.2 m-85 -152.37 62.07 0.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -62.07 -25.55 66.38 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 38.7 mttp -74.16 -31.0 62.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.535 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -82.27 11.75 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' D' ' 119' ' ' GLY . 0.1 OUTLIER -84.98 34.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.961 . . . . 0.0 109.536 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.479 ' OG1' HG23 ' D' ' 126' ' ' VAL . 65.1 p -54.42 147.34 28.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.516 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 3.9 Cg_exo -45.11 -54.58 4.16 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.411 2.074 . . . . 0.0 113.16 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 18.3 Cg_endo -59.39 -11.5 13.81 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.113 1.875 . . . . 0.0 112.298 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.479 HG23 ' OG1' ' D' ' 123' ' ' THR . 72.1 t -97.86 -20.44 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 109.59 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . 0.554 ' NE2' ' CG1' ' C' ' 107' ' ' VAL . 5.4 tp-100 -83.34 -60.1 2.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 109.859 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -61.67 -34.78 76.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.96 23.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' D' ' 128' ' ' ALA . 23.5 t80 -118.96 -59.19 1.88 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.44 -0.788 . . . . 0.0 109.591 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -47.03 -23.35 0.46 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.983 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -82.56 -38.22 24.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -0.972 . . . . 0.0 109.932 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . 0.585 ' HA ' HG23 ' D' ' 1' ' ' VAL . 45.2 t -61.59 -41.05 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.179 -0.95 . . . . 0.0 109.881 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.43 ' H ' HG22 ' D' ' 134' ' ' VAL . 1.6 m -82.04 -40.71 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -0.98 . . . . 0.0 109.771 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 1.035 ' O ' ' CD2' ' B' ' 146' ' ' HIS . . . -47.5 -20.99 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.119 -0.988 . . . . 0.0 109.58 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -75.63 -41.51 29.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.31 -21.86 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.282 -1.128 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.63 -44.29 81.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.88 HD21 ' HB2' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -79.67 -35.4 39.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.539 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.23 -43.94 43.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.496 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 40.2 mt -84.07 17.72 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' D' ' 146' ' ' HIS . . . -140.99 8.15 2.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.264 -0.898 . . . . 0.0 109.467 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -67.02 -38.13 85.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.888 . . . . 0.0 109.31 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.38 -13.47 62.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.862 . . . . 0.0 109.355 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' D' ' 145' ' ' TYR . 23.2 p90 -160.51 55.4 0.33 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 1.06 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 2.2 p-80 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 1.105 HBB3 HD22 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 1.418 ' CBC' ' CZ ' ' B' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 1.102 HBB3 HD22 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 1.399 ' CBC' ' CZ ' ' D' ' 42' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.416 ' C ' ' OG ' ' A' ' 3' ' ' SER . 14.7 mt -139.09 -178.34 5.3 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.375 -0.828 . . . . 0.0 109.18 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.497 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER 178.77 -50.9 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.993 . . . . 0.0 110.065 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 6' ' ' ASP . 83.0 Cg_exo -43.63 155.64 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.43 2.087 . . . . 0.0 112.538 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -46.21 -16.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 109.803 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' PRO . 12.5 t70 -39.45 -44.86 1.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 109.816 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 8' ' ' THR . 6.5 ptmt -58.01 -50.41 73.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.125 -0.985 . . . . 0.0 108.992 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.415 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 22.7 m -54.73 -31.41 58.3 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 108.652 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -77.23 -34.84 55.87 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.85 -51.81 41.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -47.78 46.96 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.47 -61.14 2.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.645 -0.659 . . . . 0.0 109.458 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.596 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -50.27 -41.91 51.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.403 -0.811 . . . . 0.0 109.066 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -17.54 64.93 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.4 -0.813 . . . . 0.0 109.178 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.18 -45.48 10.11 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.438 ' H ' ' HG2' ' A' ' 16' ' ' LYS . 39.5 mmtt -68.62 -39.59 80.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -1.174 . . . . 0.0 108.763 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 13' ' ' ALA . 58.1 t -61.88 -64.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 54.76 -132.77 47.83 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.73 27.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -1.063 . . . . 0.0 110.376 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.551 ' H ' ' C ' ' A' ' 18' ' ' GLY . 91.8 m-70 -131.83 25.2 4.67 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.232 -0.918 . . . . 0.0 108.538 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -89.41 -59.55 2.18 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.566 -0.709 . . . . 0.0 109.789 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.71 -13.89 0.2 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' ALA . 11.6 mt-10 -87.58 -56.48 3.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 109.912 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.526 ' CD1' ' ND1' ' A' ' 112' ' ' HIS . 3.0 m-30 -60.11 -29.22 68.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.99 -34.5 87.19 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.16 -39.13 29.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -1.165 . . . . 0.0 109.75 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -63.88 -25.54 68.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.261 -0.899 . . . . 0.0 109.318 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.35 -23.06 66.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.572 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.669 HD11 ' ND1' ' A' ' 58' ' ' HIS . 10.7 mt -76.65 -58.49 3.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.55 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -62.39 -12.42 21.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.947 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -69.65 -49.92 49.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 110.329 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.6 ptt? -84.11 -36.45 22.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.046 -1.034 . . . . 0.0 110.404 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -43.78 -23.84 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.171 -0.955 . . . . 0.0 110.107 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.548 ' CD1' ' HB2' ' B' ' 128' ' ' ALA . 2.3 pp -92.16 -28.8 16.84 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.125 -0.984 . . . . 0.0 109.951 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 36' ' ' PHE . 81.2 p -89.21 -18.44 27.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.087 -1.008 . . . . 0.0 110.022 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 35' ' ' SER . 84.7 m-85 -157.95 75.82 3.81 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.104 -0.997 . . . . 0.0 109.719 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.34 -19.98 60.77 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.889 2.393 . . . . 0.0 112.247 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.442 ' O ' HG22 ' A' ' 41' ' ' THR . 24.4 p -48.61 -18.78 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.943 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.1 p -85.92 -52.98 5.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.957 . . . . 0.0 109.803 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 42' ' ' TYR . 0.5 OUTLIER -80.01 -17.57 52.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 109.644 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 40' ' ' LYS . 10.7 t -37.55 -28.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.453 -0.78 . . . . 0.0 109.894 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 40' ' ' LYS . 23.6 m-85 -51.31 -36.5 42.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.101 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 43' ' ' PHE . 77.8 t80 45.54 56.6 15.49 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.44 -0.787 . . . . 0.0 110.099 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 43' ' ' PHE . 80.8 Cg_endo -79.6 -41.69 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.637 2.225 . . . . 0.0 111.901 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -176.58 56.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -139.35 63.78 1.49 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 49' ' ' SER . 33.7 m-20 -37.94 -22.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 46' ' ' PHE . 1.2 mt 52.6 6.33 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.218 -0.926 . . . . 0.0 109.583 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 47' ' ' ASP . 34.5 t -81.3 153.3 27.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 28.3 m170 -47.79 128.64 13.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.53 22.04 13.45 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 54' ' ' GLN . 36.9 m -95.03 66.02 2.95 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -1.155 . . . . 0.0 108.964 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 52' ' ' SER . . . -37.85 -25.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.818 -0.551 . . . . 0.0 110.237 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' A' ' 52' ' ' SER . 14.1 mt-30 -60.8 -46.22 91.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.476 HG22 ' CE2' ' A' ' 46' ' ' PHE . 15.9 t -55.99 -47.62 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 109.087 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -66.55 -54.19 26.45 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.12 -26.77 29.07 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.669 ' ND1' HD11 ' A' ' 29' ' ' LEU . 6.8 t-80 -69.85 -33.48 72.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.985 -1.303 . . . . 0.0 109.798 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.6 -48.61 83.68 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' ASP . 51.3 mttp -51.0 -23.82 3.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.402 -1.057 . . . . 0.0 109.811 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.678 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 0.5 OUTLIER -71.43 -50.68 29.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.208 -0.933 . . . . 0.0 108.891 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.63 -43.61 90.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.603 -0.686 . . . . 0.0 109.327 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.04 -28.88 64.7 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.234 -0.916 . . . . 0.0 109.432 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 15.1 t70 -72.26 -40.12 67.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.075 -1.016 . . . . 0.0 108.782 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.33 82.03 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.372 -0.83 . . . . 0.0 108.875 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.15 -40.31 95.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.5 m -70.62 -51.03 30.87 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -59.39 -22.96 62.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.684 ' HB1' ' SD ' ' A' ' 76' ' ' MET . . . -83.58 -47.31 11.42 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.08 -22.63 31.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.44 -15.09 63.43 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.596 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.1 m80 -143.78 -59.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.509 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 73' ' ' VAL . 14.5 p 44.57 13.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.713 0.768 . . . . 0.0 109.492 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.596 ' N ' ' O ' ' A' ' 72' ' ' HIS . 12.8 t70 -133.38 9.66 4.04 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 2.1 m-20 -179.58 27.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.942 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.684 ' SD ' ' HB1' ' A' ' 69' ' ' ALA . 17.7 ptt? -78.74 -22.75 0.39 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 112.006 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 76' ' ' MET . 52.3 Cg_exo -52.63 -22.01 15.99 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.578 1.519 . . . . 0.0 112.592 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.13 -24.03 17.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.728 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.47 -54.29 6.92 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.151 -0.968 . . . . 0.0 109.183 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.664 ' N ' HD12 ' A' ' 80' ' ' LEU . 7.0 mp -77.15 8.89 3.46 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.433 -0.792 . . . . 0.0 109.046 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.6 t -65.18 -15.83 62.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 109.886 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.79 -46.08 14.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 0.0 109.854 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 83' ' ' LEU . 4.2 mt -46.43 -45.93 18.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.314 -0.866 . . . . 0.0 108.94 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 135' ' ' VAL . 37.6 m -54.04 -29.15 42.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.552 -0.717 . . . . 0.0 109.45 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' ALA . 25.9 t0 -65.68 -33.93 77.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 109.499 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.543 ' CD1' ' CBD' ' A' ' 142' ' ' HEC . 3.0 tt -82.99 -63.65 1.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 109.537 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -50.09 -21.97 1.48 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.313 -0.867 . . . . 0.0 109.954 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . -97.76 -48.11 5.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.168 -0.957 . . . . 0.0 109.955 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -76.73 -70.95 0.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 86' ' ' LEU . 30.1 mttm -86.43 140.65 29.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.808 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.6 mp 53.88 57.91 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.07 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.565 ' HD3' ' CD ' ' D' ' 40' ' ' ARG . 72.5 ttt180 -47.89 -47.58 31.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.829 . . . . 0.0 109.288 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 94' ' ' ASP . 62.1 t 49.67 179.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.353 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.738 ' H ' HG12 ' A' ' 93' ' ' VAL . 34.7 m-20 -133.09 151.87 78.64 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.151 -0.968 . . . . 0.0 109.12 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 98' ' ' PHE . 82.3 Cg_exo -39.28 -19.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.571 2.181 . . . . 0.0 112.282 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 1.317 HG21 ' CB ' ' D' ' 99' ' ' ASP . 64.6 t -47.07 -32.91 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.697 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 1.5 m120 -79.23 -25.15 42.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.509 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 95' ' ' PRO . 77.4 t80 -67.88 -56.38 9.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.506 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.83 -28.8 2.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 109.545 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.407 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 17.0 mt -84.04 -52.37 6.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.803 HD22 ' CHC' ' A' ' 142' ' ' HEC . 57.7 tp -47.2 -39.75 14.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.948 . . . . 0.0 109.76 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.2 p -65.04 -59.22 4.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.69 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -52.97 -26.79 16.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.811 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 60.4 m -66.46 -58.44 5.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -45.98 -22.99 0.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.175 -0.953 . . . . 0.0 109.91 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 106' ' ' LEU . 4.1 mm? -82.19 -32.33 29.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.029 -1.044 . . . . 0.0 109.808 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.92 -27.5 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.686 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.8 p -69.01 -60.45 2.35 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.156 -0.965 . . . . 0.0 109.549 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 113' ' ' LEU . 37.1 mt -55.88 -42.1 75.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 109.291 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.31 11.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.798 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.27 -55.79 4.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 109.901 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.526 ' ND1' ' CD1' ' A' ' 24' ' ' TYR . 22.3 m170 -59.59 -62.66 1.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.083 -1.011 . . . . 0.0 109.128 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.808 HD12 ' O ' ' A' ' 114' ' ' PRO . 2.4 pp -137.69 118.94 10.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.808 ' O ' HD12 ' A' ' 113' ' ' LEU . 88.2 Cg_exo -40.78 -178.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.551 2.167 . . . . 0.0 113.292 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.791 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -57.42 -55.19 37.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.43 -0.794 . . . . 0.0 109.157 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.647 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 4.8 mm-40 120.48 -2.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 20.2 t80 64.52 52.19 1.83 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.962 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -133.04 111.5 13.17 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.838 ' HA ' HG13 ' B' ' 33' ' ' VAL . 76.7 Cg_exo -47.48 10.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.139 1.893 . . . . 0.0 112.582 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -132.65 -19.37 2.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.289 -0.882 . . . . 0.0 110.197 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.791 HG21 ' O ' ' A' ' 115' ' ' ALA . 11.6 p -60.36 -55.4 24.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.154 -0.966 . . . . 0.0 110.299 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 1.004 ' HB3' HG13 ' B' ' 34' ' ' VAL . 6.4 m170 -71.93 -33.35 68.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 0.0 108.947 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.99 -20.16 49.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.348 -0.845 . . . . 0.0 109.16 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 120' ' ' ALA . 3.2 m -64.86 -62.71 1.4 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 110.003 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.54 -19.56 65.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.191 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.91 -50.11 11.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.718 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.433 ' CD ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -85.55 -43.19 13.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.114 -0.991 . . . . 0.0 109.857 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' N ' ' CD ' ' A' ' 127' ' ' LYS . 53.6 t80 -49.44 -21.0 0.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.962 -1.086 . . . . 0.0 108.668 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.622 ' O ' ' N ' ' A' ' 133' ' ' SER . 12.8 mt -71.94 -17.48 62.08 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.98 -31.65 72.02 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.446 ' O ' HG23 ' A' ' 135' ' ' VAL . 57.4 p -83.29 -34.02 25.83 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.418 -0.801 . . . . 0.0 108.86 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.31 -28.01 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 108.654 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 129' ' ' LEU . 36.8 m -80.08 -28.85 39.05 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.495 -0.753 . . . . 0.0 109.236 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.9 m -71.31 -33.59 69.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.245 -0.909 . . . . 0.0 109.044 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 131' ' ' SER . 30.0 t -79.93 -28.19 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -35.81 73.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.468 -0.77 . . . . 0.0 109.106 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 133' ' ' SER . 14.9 t -101.86 -14.57 17.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 0.0 109.588 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.5 t 55.73 -173.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.329 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 141' ' ' ARG . 56.5 mttp -49.61 -59.86 3.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.561 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.511 ' CD2' ' O ' ' A' ' 140' ' ' TYR . 67.9 t80 52.38 9.33 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.525 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 139' ' ' LYS . 26.0 mtm180 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.944 -1.027 . . . . 0.0 109.475 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.988 HG13 ' H ' ' B' ' 2' ' ' HIS . 2.7 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . 0.988 ' H ' HG13 ' B' ' 1' ' ' VAL . 0.5 OUTLIER 53.89 105.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.121 -0.987 . . . . 0.0 109.826 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.449 HD12 ' O ' ' B' ' 3' ' ' LEU . 0.3 OUTLIER -158.92 179.06 9.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.422 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 2.2 p -73.39 151.64 89.79 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.413 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.54 -28.61 21.28 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.558 2.172 . . . . 0.0 112.049 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -78.73 -41.23 31.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.573 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.77 -46.08 83.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.559 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.475 ' O ' ' OG1' ' B' ' 12' ' ' THR . 0.0 OUTLIER -72.63 -37.44 68.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 109.624 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.403 ' C ' ' O ' ' B' ' 8' ' ' LYS . 3.3 t -45.63 -23.62 0.26 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.688 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -83.32 -56.51 3.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.159 -0.963 . . . . 0.0 109.949 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 p -65.21 -24.62 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 5.8 m -77.53 -45.73 24.52 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.398 0.618 . . . . 0.0 109.53 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.21 -34.54 72.3 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.396 -0.815 . . . . 0.0 109.573 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.43 ' C ' ' N ' ' B' ' 16' ' ' GLY . 0.8 OUTLIER -51.8 -32.12 30.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.922 . . . . 0.0 109.122 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -48.68 -17.99 0.22 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.343 -0.848 . . . . 0.0 109.267 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' B' ' 14' ' ' LEU . . . -76.78 -56.7 4.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.416 ' N ' ' CD ' ' B' ' 17' ' ' LYS . 0.0 OUTLIER -64.78 -27.48 68.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -1.203 . . . . 0.0 109.15 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.9 114.69 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' B' ' 21' ' ' ASP . 25.4 m-80 -80.42 69.15 6.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.231 -0.918 . . . . 0.0 109.048 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 74.2 t -44.32 -21.32 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.419 -0.801 . . . . 0.0 109.651 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' B' ' 19' ' ' ASN . 68.1 m-20 -74.08 3.87 6.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' B' ' 19' ' ' ASN . 35.1 mt-10 -153.01 -41.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.177 -0.952 . . . . 0.0 109.313 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.54 -46.63 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.288 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.32 -42.94 64.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.88 -44.02 63.75 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -68.01 -25.06 65.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.27 -49.44 66.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.551 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.613 HD12 ' N ' ' B' ' 28' ' ' LEU . 9.4 mp -79.12 -54.51 5.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 109.426 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.45 -33.4 8.3 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -82.08 -39.33 23.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -1.119 . . . . 0.0 109.337 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -49.2 -35.79 18.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 27.3 mt -79.88 -31.95 40.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.0 109.56 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.838 HG13 ' HA ' ' A' ' 119' ' ' PRO . 61.7 t -66.43 -64.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.423 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 1.004 HG13 ' HB3' ' A' ' 122' ' ' HIS . 1.3 t -64.43 -22.74 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.355 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -146.17 80.73 10.05 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.342 -0.849 . . . . 0.0 109.382 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.36 -5.6 14.33 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.672 2.248 . . . . 0.0 112.439 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.535 ' NE1' ' OG1' ' B' ' 38' ' ' THR . 1.3 p-90 -58.86 -24.43 62.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.535 ' OG1' ' NE1' ' B' ' 37' ' ' TRP . 3.1 m -95.91 38.22 1.19 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.891 . . . . 0.0 109.39 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . 0.422 ' H ' ' HG3' ' B' ' 39' ' ' GLN . 5.3 pp0? -90.98 9.52 30.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 109.624 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 1.665 ' CD ' ' HD3' ' C' ' 92' ' ' ARG . 55.1 ttt85 -81.56 -29.83 33.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.198 -0.939 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' B' ' 42' ' ' PHE . 66.2 m-85 -90.91 30.08 1.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.948 . . . . 0.0 109.405 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 1.023 ' HE1' ' CBC' ' B' ' 147' ' ' HEC . 70.5 m-85 -145.66 22.61 1.45 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.48 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -78.93 -16.51 56.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.255 -0.903 . . . . 0.0 109.51 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.463 ' O ' ' N ' ' B' ' 46' ' ' GLY . 27.8 p -67.47 -43.23 81.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.598 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' B' ' 47' ' ' ASP . 88.4 m-85 -48.89 -14.49 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.506 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 66.89 -65.42 0.19 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' B' ' 45' ' ' PHE . 4.6 m-20 -46.18 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -1.163 . . . . 0.0 109.576 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 tp -159.47 22.62 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 12.9 p -70.45 -33.83 71.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.533 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . 0.442 ' O ' ' N ' ' B' ' 53' ' ' ALA . 3.4 p -145.7 151.52 46.5 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 0.0 109.111 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -39.96 -42.09 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.373 2.049 . . . . 0.0 112.238 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.2 -31.05 72.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -61.93 -19.79 63.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.475 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 78.6 t -67.96 -63.83 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 109.657 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 22.4 ptp -83.18 4.49 26.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.723 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.88 -17.23 70.64 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -82.19 138.18 45.67 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.0 109.024 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -71.18 -12.88 30.7 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.247 1.964 . . . . 0.0 112.14 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -80.17 -57.47 3.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.332 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 43.0 t -48.02 -31.58 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.341 -0.85 . . . . 0.0 109.56 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.401 ' HB3' ' HZ2' ' B' ' 61' ' ' LYS . 16.2 mtpp -78.99 -32.94 45.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.508 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.62 -45.79 16.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.69 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.999 ' NE2' HAD2 ' B' ' 147' ' ' HEC . 0.9 OUTLIER -62.72 -23.64 67.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.22 -0.925 . . . . 0.0 109.671 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.57 -36.34 83.15 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -60.15 -25.46 65.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -1.2 . . . . 0.0 109.58 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.69 -50.17 39.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.317 -0.865 . . . . 0.0 109.62 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 1.159 HG13 ' C2B' ' B' ' 147' ' ' HEC . 42.3 t -57.72 -36.73 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 109.343 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.445 HD23 ' C ' ' B' ' 68' ' ' LEU . 5.6 tt -71.58 -48.03 51.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.288 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.46 -44.91 16.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.62 -51.85 56.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -1.131 . . . . 0.0 109.44 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -49.5 -35.29 19.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.403 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -76.01 -24.49 55.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.4 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -52.37 -43.58 64.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.86 -60.12 8.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.495 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.2 mp -57.98 -28.08 64.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.117 . . . . 0.0 109.277 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -80.45 -9.28 59.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.29 -0.881 . . . . 0.0 109.556 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 57.2 m80 -160.27 65.94 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.389 -0.819 . . . . 0.0 109.539 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 9.0 mt -68.4 11.62 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' B' ' 77' ' ' HIS . 81.5 m-20 -72.4 -31.07 65.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.124 -0.985 . . . . 0.0 109.553 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' B' ' 83' ' ' GLY . 16.4 t-20 -171.02 108.89 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.558 ' N ' HD12 ' B' ' 81' ' ' LEU . 9.5 mp -80.26 -54.75 5.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.5 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.446 ' HD3' ' H ' ' B' ' 82' ' ' LYS . 0.6 OUTLIER -49.92 -24.0 2.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.486 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . 0.448 ' N ' ' OD1' ' B' ' 80' ' ' ASN . . . -73.12 -52.44 8.89 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.1 t -76.48 -47.58 22.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -1.189 . . . . 0.0 109.528 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.547 ' N ' ' CG2' ' B' ' 84' ' ' THR . 50.2 m-85 -66.04 4.76 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.461 -0.775 . . . . 0.0 109.566 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -63.73 -33.4 75.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.423 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.1 p -79.36 -51.3 9.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.418 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.572 ' O ' ' N ' ' B' ' 92' ' ' HIS . 8.7 mp -53.33 -51.17 63.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.158 -0.964 . . . . 0.0 109.345 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 36.4 p -54.7 -45.4 73.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.927 . . . . 0.0 109.632 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.428 ' O ' ' OD2' ' B' ' 94' ' ' ASP . 32.9 tt0 -66.3 -41.58 89.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.663 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.53 -20.14 40.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.599 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' B' ' 88' ' ' LEU . 1.5 m80 -87.65 -41.21 13.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 110.239 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -82.99 -39.64 21.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.048 -1.032 . . . . 0.0 110.795 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' B' ' 90' ' ' GLU . 12.1 m-20 -86.18 -36.38 19.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.921 -1.112 . . . . 0.0 111.181 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -52.18 5.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.928 -1.108 . . . . 0.0 110.594 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.583 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 10.0 mp -86.29 -31.81 21.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.92 -1.112 . . . . 0.0 109.68 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 13.5 p80 41.89 29.39 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.382 -0.824 . . . . 0.0 109.858 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.09 124.65 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.178 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 1.284 ' CB ' HG21 ' C' ' 96' ' ' VAL . 0.4 OUTLIER -47.67 154.24 0.94 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.09 -160.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.628 2.219 . . . . 0.0 111.959 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.447 ' O ' ' OD1' ' B' ' 102' ' ' ASN . 29.6 mm-40 57.64 26.3 12.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' B' ' 101' ' ' GLU . 39.1 m-20 -137.53 -32.76 0.75 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.35 -0.844 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.48 -37.01 85.65 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.497 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -70.14 -23.74 63.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.191 -0.943 . . . . 0.0 109.589 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.583 HD12 ' N ' ' B' ' 105' ' ' LEU . 7.8 mp -79.74 -17.68 52.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.48 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 1.657 ' CD1' ' HAB' ' B' ' 147' ' ' HEC . 2.6 tm? -78.92 -46.72 17.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.318 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.99 -20.46 77.67 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -70.52 -55.66 8.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.083 -1.245 . . . . 0.0 109.797 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -53.72 -24.06 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.634 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.517 ' O ' HD23 ' B' ' 110' ' ' LEU . 1.6 tt -64.44 -50.85 65.91 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.472 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.563 ' CG2' ' CE1' ' B' ' 130' ' ' TYR . 46.7 t -49.44 -45.21 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.716 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 56.5 m -51.55 -35.92 42.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.876 . . . . 0.0 109.631 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.91 -28.58 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 41.6 mt -72.73 -40.68 65.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.178 -0.951 . . . . 0.0 109.431 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.21 -20.85 59.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 109.297 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.54 ' C ' ' ND1' ' B' ' 116' ' ' HIS . 3.0 t-80 -84.75 -54.62 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.297 -0.877 . . . . 0.0 109.301 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.428 ' N ' ' HD1' ' B' ' 117' ' ' HIS . 0.5 OUTLIER -70.97 -17.54 62.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 0.0 109.671 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.41 ' CG ' ' O ' ' B' ' 117' ' ' HIS . 68.3 m-85 -152.71 62.3 0.8 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.573 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.542 ' O ' ' CD1' ' B' ' 122' ' ' PHE . . . -58.86 -26.99 61.3 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -68.37 -34.97 77.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -82.78 14.23 3.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.638 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.551 ' CG ' ' O ' ' B' ' 122' ' ' PHE . 0.1 OUTLIER -82.91 36.32 0.5 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.196 -0.94 . . . . 0.0 109.627 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.605 ' OG1' HG23 ' B' ' 126' ' ' VAL . 7.4 p -46.42 154.15 0.67 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.454 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.453 ' O ' HD13 ' A' ' 34' ' ' LEU . 24.5 Cg_exo -55.49 -44.81 44.85 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.358 2.039 . . . . 0.0 113.749 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' B' ' 124' ' ' PRO . 67.1 Cg_endo -78.17 -8.16 16.35 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.021 1.814 . . . . 0.0 112.615 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.605 HG23 ' OG1' ' B' ' 123' ' ' THR . 10.6 t -83.76 -31.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 109.198 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -83.26 -59.73 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 109.629 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 1.548 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . . . -48.49 -41.96 31.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.18 -36.46 83.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.831 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.563 ' CE1' ' CG2' ' B' ' 111' ' ' VAL . 30.0 t80 -61.23 -60.9 3.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.067 -1.021 . . . . 0.0 109.402 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -47.77 -25.81 1.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.873 . . . . 0.0 109.563 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.442 ' NZ ' ' CB ' ' B' ' 132' ' ' LYS . 5.0 ttpm? -85.53 -31.52 22.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 109.739 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.49 -65.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.54 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.418 ' H ' HG22 ' B' ' 134' ' ' VAL . 5.9 m -55.48 -15.67 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.597 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.648 ' CB ' ' OXT' ' D' ' 146' ' ' HIS . . . -56.22 -33.73 65.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.341 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.83 -30.52 57.62 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.15 -32.86 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.428 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.94 76.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.332 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -78.73 -21.26 48.32 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.299 -0.875 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.64 -60.73 2.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.942 . . . . 0.0 109.676 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 63.9 mt -54.22 -20.32 6.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.135 -0.978 . . . . 0.0 109.256 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' B' ' 145' ' ' TYR . . . -88.98 -4.6 58.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 109.116 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' B' ' 146' ' ' HIS . 71.4 t60 -49.45 -39.08 31.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.498 ' O ' ' ND1' ' B' ' 146' ' ' HIS . 0.9 OUTLIER -86.94 -55.15 3.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.133 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' B' ' 145' ' ' TYR . 0.0 OUTLIER -52.8 -10.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.514 -0.741 . . . . 0.0 109.36 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.62 ' OXT' ' CB ' ' D' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.469 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.429 ' C ' ' OG ' ' C' ' 3' ' ' SER . 14.6 mt -139.05 -178.3 5.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.361 -0.837 . . . . 0.0 109.218 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.494 ' H ' ' HD2' ' C' ' 4' ' ' PRO . 0.0 OUTLIER 178.76 -50.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' C' ' 6' ' ' ASP . 83.1 Cg_exo -43.64 155.71 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.309 2.006 . . . . 0.0 112.576 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -46.27 -16.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.841 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' C' ' 4' ' ' PRO . 12.5 t70 -39.43 -44.91 1.43 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.39 -0.819 . . . . 0.0 109.792 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.411 ' CG ' ' N ' ' C' ' 8' ' ' THR . 6.5 ptmt -57.95 -50.48 73.23 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.117 -0.989 . . . . 0.0 109.01 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.411 ' N ' ' CG ' ' C' ' 7' ' ' LYS . 22.6 m -54.67 -31.51 57.85 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 108.61 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -77.16 -34.85 56.38 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.79 -51.82 41.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.37 -47.74 47.33 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.45 -61.18 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.494 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.599 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -50.18 -42.0 50.44 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.392 -0.817 . . . . 0.0 109.06 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -17.57 64.93 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.437 -0.789 . . . . 0.0 109.156 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.2 -45.38 10.17 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 39.6 mmtt -68.72 -39.54 80.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 108.798 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.599 HG23 ' O ' ' C' ' 13' ' ' ALA . 58.1 t -61.86 -65.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 54.78 -132.82 47.94 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.75 27.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.456 -1.026 . . . . 0.0 110.383 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.556 ' H ' ' C ' ' C' ' 18' ' ' GLY . 91.7 m-70 -131.77 25.12 4.69 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -89.32 -59.6 2.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.679 -0.638 . . . . 0.0 109.827 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.73 -13.85 0.2 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' C' ' 21' ' ' ALA . 11.5 mt-10 -87.59 -56.45 3.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.39 -1.065 . . . . 0.0 109.897 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.526 ' CD1' ' ND1' ' C' ' 112' ' ' HIS . 3.0 m-30 -60.18 -29.15 68.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 0.0 109.467 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.06 -34.49 86.82 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.12 -39.13 30.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -1.159 . . . . 0.0 109.754 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.94 -25.55 68.19 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 109.271 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.4 -22.95 66.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.594 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.671 HD11 ' ND1' ' C' ' 58' ' ' HIS . 10.7 mt -76.65 -58.47 3.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -62.38 -12.57 22.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 109.923 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.458 ' HA ' ' HE ' ' C' ' 31' ' ' ARG . 0.3 OUTLIER -69.64 -49.79 50.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 110.327 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 0.432 ' O ' ' N ' ' C' ' 34' ' ' LEU . 2.6 ptt? -84.22 -36.53 22.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.136 -0.977 . . . . 0.0 110.335 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' C' ' 32' ' ' MET . 13.9 t80 -43.63 -23.93 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 110.175 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 1.56 ' CD1' ' HB2' ' D' ' 128' ' ' ALA . 2.3 pp -92.05 -28.85 16.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.001 -1.062 . . . . 0.0 110.03 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.516 ' O ' ' CG ' ' C' ' 36' ' ' PHE . 81.5 p -89.25 -18.45 27.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 0.0 109.928 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.516 ' CG ' ' O ' ' C' ' 35' ' ' SER . 85.0 m-85 -157.89 75.78 3.84 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.127 -0.983 . . . . 0.0 109.797 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' C' ' 39' ' ' THR . 26.2 Cg_exo -60.36 -19.99 60.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.906 2.404 . . . . 0.0 112.166 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.436 ' O ' HG22 ' C' ' 41' ' ' THR . 24.4 p -48.63 -18.76 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 109.926 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.4 ' N ' ' C ' ' C' ' 37' ' ' PRO . 38.0 p -85.93 -53.07 5.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.712 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' C' ' 42' ' ' TYR . 0.5 OUTLIER -79.93 -17.56 52.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.666 -179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.483 ' C ' ' O ' ' C' ' 40' ' ' LYS . 10.9 t -37.45 -28.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.484 -0.76 . . . . 0.0 109.992 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.544 ' N ' ' O ' ' C' ' 40' ' ' LYS . 23.6 m-85 -51.32 -36.54 43.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.018 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.53 ' CD2' ' O ' ' C' ' 43' ' ' PHE . 77.6 t80 45.56 56.6 15.51 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.461 -0.774 . . . . 0.0 110.076 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' C' ' 43' ' ' PHE . 82.5 Cg_endo -79.56 -41.62 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.551 2.167 . . . . 0.0 111.964 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.403 ' ND1' ' C ' ' C' ' 45' ' ' HIS . 0.0 OUTLIER -176.52 56.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.568 -0.708 . . . . 0.0 109.117 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -139.26 63.69 1.49 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' C' ' 49' ' ' SER . 33.9 m-20 -37.9 -22.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.365 -0.834 . . . . 0.0 110.226 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' C' ' 46' ' ' PHE . 1.2 mt 52.64 6.34 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.127 -0.983 . . . . 0.0 109.608 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.515 ' H ' ' C ' ' C' ' 47' ' ' ASP . 34.6 t -81.3 153.32 27.14 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.95 . . . . 0.0 109.351 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.403 ' CD2' ' N ' ' C' ' 50' ' ' HIS . 28.6 m170 -47.92 128.71 13.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.372 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.48 22.06 13.48 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.554 ' O ' ' N ' ' C' ' 54' ' ' GLN . 37.9 m -95.15 66.15 2.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.288 -1.124 . . . . 0.0 108.936 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' C' ' 52' ' ' SER . . . -37.92 -25.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.809 -0.557 . . . . 0.0 110.264 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' C' ' 52' ' ' SER . 14.2 mt-30 -60.64 -46.28 90.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.964 . . . . 0.0 109.529 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.478 HG22 ' CE2' ' C' ' 46' ' ' PHE . 15.9 t -56.05 -47.51 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.139 -0.976 . . . . 0.0 109.128 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -66.52 -54.22 26.25 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . 0.433 ' O ' ' NZ ' ' C' ' 61' ' ' LYS . . . -53.21 -26.64 29.33 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.671 ' ND1' HD11 ' C' ' 29' ' ' LEU . 6.8 t-80 -69.92 -33.55 72.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.08 -1.247 . . . . 0.0 109.736 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.48 -48.68 82.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.448 ' O ' ' CB ' ' C' ' 64' ' ' ASP . 51.4 mttp -51.07 -23.81 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -1.095 . . . . 0.0 109.705 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.691 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 0.5 OUTLIER -71.49 -50.5 30.86 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 108.966 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.72 -43.61 89.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 O-C-N 121.601 -0.687 . . . . 0.0 109.303 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.12 -28.71 64.5 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.306 -0.872 . . . . 0.0 109.44 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' C' ' 60' ' ' LYS . 15.1 t70 -72.35 -40.09 67.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.034 . . . . 0.0 108.753 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.57 -47.38 81.75 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.01 -40.29 95.15 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -70.63 -51.01 30.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.264 -0.898 . . . . 0.0 108.604 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -59.35 -23.03 62.18 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.671 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -83.56 -47.27 11.48 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.96 -22.79 32.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.47 -14.99 63.38 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.602 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.2 m80 -143.75 -59.56 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.38 -0.825 . . . . 0.0 109.581 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.542 HG22 ' O ' ' C' ' 73' ' ' VAL . 14.5 p 44.68 13.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.711 0.767 . . . . 0.0 109.507 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' C' ' 72' ' ' HIS . 12.8 t70 -133.37 9.58 4.04 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 178.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 2.1 m-20 -179.43 27.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.883 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 17.7 ptt? -78.82 -22.69 0.39 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.365 -0.834 . . . . 0.0 112.004 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.1 Cg_exo -52.54 -22.07 15.79 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.63 1.553 . . . . 0.0 112.522 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.16 -24.08 17.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.643 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.51 -54.27 6.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.15 -0.968 . . . . 0.0 109.142 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . 0.668 ' N ' HD12 ' C' ' 80' ' ' LEU . 7.0 mp -77.21 8.94 3.46 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.384 -0.823 . . . . 0.0 109.058 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t -65.21 -15.82 62.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.843 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.75 -46.13 14.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.183 -0.948 . . . . 0.0 109.846 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.417 HD23 ' N ' ' C' ' 83' ' ' LEU . 4.1 mt -46.26 -46.0 17.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.835 . . . . 0.0 109.044 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' C' ' 135' ' ' VAL . 37.6 m -54.02 -29.13 42.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.547 -0.721 . . . . 0.0 109.428 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' C' ' 82' ' ' ALA . 25.9 t0 -65.81 -33.85 76.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.109 -0.994 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.537 ' CD1' ' CBD' ' C' ' 142' ' ' HEC . 3.0 tt -83.02 -63.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -49.97 -22.02 1.41 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.877 . . . . 0.0 110.028 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' C' ' 84' ' ' SER . . . -97.69 -48.14 5.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 110.007 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -76.72 -71.05 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 109.956 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' C' ' 86' ' ' LEU . 30.1 mttm -86.29 140.58 29.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.736 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.56 ' N ' HD12 ' C' ' 91' ' ' LEU . 10.6 mp 54.0 57.82 5.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.021 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . 1.665 ' HD3' ' CD ' ' B' ' 40' ' ' ARG . 72.5 ttt180 -47.86 -47.52 31.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 0.0 109.374 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.74 HG12 ' H ' ' C' ' 94' ' ' ASP . 61.9 t 49.67 179.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 109.314 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.74 ' H ' HG12 ' C' ' 93' ' ' VAL . 34.8 m-20 -133.12 151.81 78.49 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.266 -0.896 . . . . 0.0 109.119 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' C' ' 98' ' ' PHE . 81.7 Cg_exo -39.19 -19.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.612 2.208 . . . . 0.0 112.302 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . 1.284 HG21 ' CB ' ' B' ' 99' ' ' ASP . 63.9 t -46.98 -32.92 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.74 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' C' ' 97' ' ' ASN . 1.5 m120 -79.31 -25.07 42.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.942 . . . . 0.0 109.507 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' C' ' 95' ' ' PRO . 77.2 t80 -67.95 -56.37 9.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.8 -28.83 2.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.566 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.477 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 17.0 mt -83.98 -52.36 6.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.165 -0.959 . . . . 0.0 109.565 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.798 HD22 ' CHC' ' C' ' 142' ' ' HEC . 58.0 tp -47.27 -39.55 14.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.777 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 99.3 p -65.13 -59.25 4.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.687 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -53.01 -26.72 16.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.197 -0.939 . . . . 0.0 109.83 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 60.4 m -66.42 -58.48 5.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 109.825 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -45.93 -23.13 0.26 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -0.924 . . . . 0.0 109.849 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.424 ' N ' HD22 ' C' ' 106' ' ' LEU . 4.1 mm? -82.12 -32.34 30.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.046 -1.034 . . . . 0.0 109.819 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 38.4 t -82.86 -27.61 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.173 -0.954 . . . . 0.0 109.689 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 6.8 p -68.92 -60.52 2.31 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.184 -0.948 . . . . 0.0 109.572 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' C' ' 113' ' ' LEU . 36.7 mt -55.79 -42.08 75.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.346 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.88 -41.33 11.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.773 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.24 -55.79 4.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.941 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . 0.526 ' ND1' ' CD1' ' C' ' 24' ' ' TYR . 22.6 m170 -59.67 -62.64 1.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.983 -1.073 . . . . 0.0 109.062 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.806 HD12 ' O ' ' C' ' 114' ' ' PRO . 2.4 pp -137.71 118.91 10.63 Favored Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . 0.806 ' O ' HD12 ' C' ' 113' ' ' LEU . 89.4 Cg_exo -40.74 -178.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.561 2.174 . . . . 0.0 113.318 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.779 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -57.46 -55.07 39.52 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.422 -0.799 . . . . 0.0 109.164 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.649 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 4.8 mm-40 120.32 -2.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . . . . . . . . . 20.0 t80 64.34 52.32 1.91 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.161 0.505 . . . . 0.0 110.989 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.746 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.0 OUTLIER -133.13 111.5 13.07 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . 0.85 ' HA ' HG13 ' D' ' 33' ' ' VAL . 78.1 Cg_exo -47.41 10.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.171 1.914 . . . . 0.0 112.561 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -132.72 -19.4 2.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.882 . . . . 0.0 110.279 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.779 HG21 ' O ' ' C' ' 115' ' ' ALA . 11.7 p -60.42 -55.33 25.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.119 -0.988 . . . . 0.0 110.302 -178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 1.03 ' HB3' HG13 ' D' ' 34' ' ' VAL . 6.4 m170 -72.05 -33.25 67.82 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.129 -0.982 . . . . 0.0 108.883 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.08 -20.18 49.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.485 -0.759 . . . . 0.0 109.137 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.581 ' N ' ' O ' ' C' ' 120' ' ' ALA . 3.1 m -64.86 -62.7 1.41 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.351 -0.843 . . . . 0.0 109.998 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.55 -19.5 65.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 109.203 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.99 -50.09 11.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.75 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -85.66 -43.12 13.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.117 -0.989 . . . . 0.0 109.795 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.434 ' N ' ' CD ' ' C' ' 127' ' ' LYS . 53.5 t80 -49.45 -20.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.898 -1.126 . . . . 0.0 108.672 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' C' ' 133' ' ' SER . 12.8 mt -71.9 -17.62 62.09 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -61.9 -31.72 72.04 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.434 ' O ' HG23 ' C' ' 135' ' ' VAL . 57.0 p -83.22 -34.01 25.98 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.325 -0.859 . . . . 0.0 108.947 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -85.31 -27.96 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 108.655 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.626 ' N ' ' O ' ' C' ' 129' ' ' LEU . 37.2 m -80.14 -28.92 38.83 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.408 -0.808 . . . . 0.0 109.159 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 41.8 m -71.24 -33.67 70.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 109.035 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 131' ' ' SER . 30.0 t -79.9 -28.13 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.26 -0.9 . . . . 0.0 108.623 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.63 -35.76 73.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.037 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . 0.447 HG22 ' O ' ' C' ' 133' ' ' SER . 14.9 t -101.93 -14.55 17.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.371 -0.83 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 8.5 t 55.66 -173.39 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.146 -0.971 . . . . 0.0 109.401 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' C' ' 141' ' ' ARG . 56.5 mttp -49.6 -59.83 3.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.937 . . . . 0.0 109.56 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.509 ' CD2' ' O ' ' C' ' 140' ' ' TYR . 68.0 t80 52.35 9.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . 0.467 ' H ' ' C ' ' C' ' 139' ' ' LYS . 26.0 mtm180 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.923 -1.036 . . . . 0.0 109.464 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 1.028 HG13 ' H ' ' D' ' 2' ' ' HIS . 2.6 p . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . 1.028 ' H ' HG13 ' D' ' 1' ' ' VAL . 0.5 OUTLIER 53.87 106.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.085 -1.009 . . . . 0.0 109.782 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.443 HD12 ' O ' ' D' ' 3' ' ' LEU . 0.3 OUTLIER -159.05 179.04 9.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.365 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.419 ' OG1' ' OE2' ' D' ' 7' ' ' GLU . 2.2 p -73.36 151.57 89.84 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.46 -28.54 21.77 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.552 2.168 . . . . 0.0 112.107 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -78.83 -41.25 30.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.939 . . . . 0.0 109.534 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.419 ' OE2' ' OG1' ' D' ' 4' ' ' THR . 46.2 mt-10 -64.76 -46.03 83.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.467 ' O ' ' OG1' ' D' ' 12' ' ' THR . 0.0 OUTLIER -72.63 -37.53 68.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.605 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 3.4 t -45.52 -23.7 0.25 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.788 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -83.23 -56.51 3.73 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.147 -0.971 . . . . 0.0 109.999 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 6.7 p -65.24 -24.62 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 5.8 m -77.51 -45.66 24.83 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.395 0.616 . . . . 0.0 109.575 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.45 72.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.385 -0.822 . . . . 0.0 109.592 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.43 ' C ' ' N ' ' D' ' 16' ' ' GLY . 0.8 OUTLIER -51.9 -32.12 31.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.072 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -48.66 -17.96 0.22 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.275 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' D' ' 14' ' ' LEU . . . -76.8 -56.81 3.99 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.432 ' CD ' ' N ' ' D' ' 17' ' ' LYS . 0.0 OUTLIER -64.77 -27.39 68.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 109.217 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -54.91 114.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' D' ' 21' ' ' ASP . 25.3 m-80 -80.45 69.15 6.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.244 -0.91 . . . . 0.0 109.009 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -44.39 -21.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.748 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' D' ' 19' ' ' ASN . 68.0 m-20 -74.16 3.92 6.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.489 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' D' ' 19' ' ' ASN . 35.1 mt-10 -153.0 -41.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.316 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.52 -46.59 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -0.858 . . . . 0.0 109.327 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.36 -42.9 65.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.87 -44.05 63.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.1 -24.94 65.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -1.163 . . . . 0.0 109.528 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.32 -49.46 67.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . 0.594 HD12 ' N ' ' D' ' 28' ' ' LEU . 9.4 mp -79.12 -54.38 6.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -47.57 -33.38 8.68 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -81.99 -39.33 23.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -1.142 . . . . 0.0 109.419 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -49.27 -35.76 18.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 109.556 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 27.0 mt -79.9 -31.83 40.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.618 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . 0.85 HG13 ' HA ' ' C' ' 119' ' ' PRO . 61.6 t -66.51 -64.41 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 109.38 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 1.03 HG13 ' HB3' ' C' ' 122' ' ' HIS . 1.3 t -64.47 -22.64 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -146.21 80.85 9.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.397 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.45 -5.56 14.23 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.692 2.261 . . . . 0.0 112.386 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . 0.546 ' NE1' ' OG1' ' D' ' 38' ' ' THR . 1.3 p-90 -58.87 -24.37 62.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.965 . . . . 0.0 109.51 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.546 ' OG1' ' NE1' ' D' ' 37' ' ' TRP . 3.0 m -96.01 38.29 1.19 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.285 -0.884 . . . . 0.0 109.39 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -91.16 9.63 30.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 109.496 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . 1.565 ' CD ' ' HD3' ' A' ' 92' ' ' ARG . 55.0 ttt85 -81.6 -29.82 33.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.543 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' D' ' 42' ' ' PHE . 66.1 m-85 -90.9 30.12 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 0.0 109.384 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 1.045 ' HE1' ' CBC' ' D' ' 147' ' ' HEC . 70.4 m-85 -145.66 22.65 1.45 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 109.381 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -79.11 -16.45 56.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.407 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . 0.468 ' O ' ' N ' ' D' ' 46' ' ' GLY . 27.6 p -67.48 -43.32 81.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.503 ' O ' ' N ' ' D' ' 47' ' ' ASP . 88.3 m-85 -48.73 -14.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' D' ' 44' ' ' SER . . . 66.9 -65.38 0.19 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' D' ' 45' ' ' PHE . 4.6 m-20 -46.18 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -1.16 . . . . 0.0 109.555 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 tp -159.46 22.59 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 12.8 p -70.54 -33.8 71.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . 0.427 ' O ' ' N ' ' D' ' 53' ' ' ALA . 3.4 p -145.64 151.56 46.82 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.325 -0.859 . . . . 0.0 109.031 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -39.97 -42.01 3.12 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.302 2.001 . . . . 0.0 112.256 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.32 -31.01 72.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.488 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -61.92 -19.81 63.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.98 -63.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 109.615 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . 0.41 ' H ' ' HG2' ' D' ' 55' ' ' MET . 22.4 ptp -83.2 4.5 26.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.364 -0.835 . . . . 0.0 109.648 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.92 -17.25 70.49 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -82.1 138.05 46.03 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.276 -1.132 . . . . 0.0 109.071 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.11 -12.84 30.81 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.232 1.955 . . . . 0.0 112.162 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -80.15 -57.45 3.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -48.0 -31.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.484 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . 0.418 ' HB3' ' HZ2' ' D' ' 61' ' ' LYS . 16.2 mtpp -79.03 -32.81 45.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.76 -45.64 16.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.679 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.991 ' NE2' HAD2 ' D' ' 147' ' ' HEC . 0.9 OUTLIER -62.79 -23.67 67.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.722 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.49 -36.32 83.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -60.17 -25.44 65.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.108 -1.23 . . . . 0.0 109.591 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.71 -50.13 39.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 1.157 HG13 ' C2B' ' D' ' 147' ' ' HEC . 42.3 t -57.81 -36.67 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.35 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.447 ' O ' HD23 ' D' ' 68' ' ' LEU . 5.6 tt -71.56 -48.09 50.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.42 -44.95 16.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.55 -51.94 56.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -1.102 . . . . 0.0 109.414 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -49.53 -35.32 19.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.269 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 8.3 t -75.98 -24.49 55.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -52.3 -43.64 64.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.281 -0.887 . . . . 0.0 109.381 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.84 -60.13 8.57 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.502 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.2 mp -57.98 -27.99 63.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -1.118 . . . . 0.0 109.317 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -80.62 -9.24 59.79 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.214 -0.929 . . . . 0.0 109.427 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 56.8 m80 -160.34 66.02 0.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.42 11.58 0.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.309 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' D' ' 77' ' ' HIS . 81.4 m-20 -72.38 -30.97 65.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.614 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' D' ' 83' ' ' GLY . 16.5 t-20 -171.07 108.91 0.3 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.605 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . 0.563 ' N ' HD12 ' D' ' 81' ' ' LEU . 9.5 mp -80.31 -54.68 5.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.92 . . . . 0.0 109.502 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' D' ' 82' ' ' LYS . 0.6 OUTLIER -49.97 -24.03 2.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.181 -0.949 . . . . 0.0 109.421 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . 0.44 ' N ' ' OD1' ' D' ' 80' ' ' ASN . . . -73.15 -52.37 8.94 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.55 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.1 t -76.51 -47.63 22.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -1.179 . . . . 0.0 109.484 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' D' ' 84' ' ' THR . 50.1 m-85 -66.0 4.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.448 -0.783 . . . . 0.0 109.505 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -63.63 -33.49 75.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 10.0 p -79.27 -51.43 9.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.411 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' D' ' 92' ' ' HIS . 8.7 mp -53.24 -51.19 63.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.352 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 34.8 p -54.57 -45.47 73.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.69 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.432 ' O ' ' OD2' ' D' ' 94' ' ' ASP . 32.9 tt0 -66.24 -41.64 89.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.155 -0.966 . . . . 0.0 109.624 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 tt -81.43 -20.2 40.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.643 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.581 ' N ' ' O ' ' D' ' 88' ' ' LEU . 1.5 m80 -87.62 -41.16 13.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 110.267 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . . . . . . . . . 35.6 t -83.11 -39.57 20.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.043 -1.035 . . . . 0.0 110.739 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' D' ' 90' ' ' GLU . 12.2 m-20 -86.27 -36.41 19.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.009 -1.057 . . . . 0.0 111.093 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -52.26 5.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.9 -1.125 . . . . 0.0 110.531 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.571 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 10.0 mp -86.28 -31.89 21.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.912 -1.117 . . . . 0.0 109.603 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 13.5 p80 42.04 29.32 0.13 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.426 -0.796 . . . . 0.0 109.818 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.16 124.61 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.862 . . . . 0.0 109.168 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . 1.317 ' CB ' HG21 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -47.55 154.21 0.92 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.18 -160.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.651 2.234 . . . . 0.0 112.001 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . 0.446 ' O ' ' OD1' ' D' ' 102' ' ' ASN . 29.8 mm-40 57.64 26.31 12.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.872 . . . . 0.0 109.499 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' D' ' 101' ' ' GLU . 39.1 m-20 -137.47 -32.88 0.75 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.369 -0.832 . . . . 0.0 109.341 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -63.39 -37.13 86.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -70.14 -23.6 63.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.122 -0.987 . . . . 0.0 109.548 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . 0.589 HD12 ' N ' ' D' ' 105' ' ' LEU . 7.8 mp -79.85 -17.7 52.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.175 -0.953 . . . . 0.0 109.463 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 1.599 ' CD1' ' HAB' ' D' ' 147' ' ' HEC . 2.6 tm? -78.87 -46.76 17.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.302 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.02 -20.41 77.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -70.45 -55.7 8.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -1.216 . . . . 0.0 109.787 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 p -53.66 -24.05 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.962 . . . . 0.0 109.71 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . 0.512 ' O ' HD23 ' D' ' 110' ' ' LEU . 1.6 tt -64.48 -50.8 66.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.913 . . . . 0.0 109.501 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . 0.556 ' CG2' ' CE1' ' D' ' 130' ' ' TYR . 46.9 t -49.53 -45.19 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 56.4 m -51.6 -35.84 43.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.61 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.96 -28.59 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . . . . . . . . . 41.6 mt -72.74 -40.73 65.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.353 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.0 59.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.28 -0.888 . . . . 0.0 109.259 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.535 ' C ' ' ND1' ' D' ' 116' ' ' HIS . 3.0 t-80 -84.58 -54.69 4.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.322 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . 0.437 ' N ' ' HD1' ' D' ' 117' ' ' HIS . 0.5 OUTLIER -70.97 -17.45 62.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.704 -179.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.402 ' CG ' ' O ' ' D' ' 117' ' ' HIS . 68.3 m-85 -152.75 62.24 0.8 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 109.601 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' D' ' 122' ' ' PHE . . . -58.84 -27.0 61.26 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -68.42 -34.95 76.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -1.225 . . . . 0.0 109.559 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.84 14.35 3.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.624 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.558 ' CG ' ' O ' ' D' ' 122' ' ' PHE . 0.1 OUTLIER -83.01 36.4 0.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.592 ' OG1' HG23 ' D' ' 126' ' ' VAL . 7.4 p -46.45 154.14 0.68 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.115 -0.991 . . . . 0.0 109.445 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.453 ' O ' HD13 ' C' ' 34' ' ' LEU . 24.4 Cg_exo -55.4 -44.89 44.3 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.334 2.022 . . . . 0.0 113.786 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' D' ' 124' ' ' PRO . 67.1 Cg_endo -78.21 -8.06 16.28 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.994 1.796 . . . . 0.0 112.598 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.592 HG23 ' OG1' ' D' ' 123' ' ' THR . 10.6 t -83.79 -31.04 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 109.276 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.28 -59.67 2.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 109.637 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 1.56 ' HB2' ' CD1' ' C' ' 34' ' ' LEU . . . -48.55 -41.97 31.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 0.0 109.42 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.55 83.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.89 . . . . 0.0 109.881 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.556 ' CE1' ' CG2' ' D' ' 111' ' ' VAL . 29.7 t80 -61.11 -60.87 3.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.0 109.398 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -47.83 -25.8 1.42 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.584 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . 0.441 ' NZ ' ' CB ' ' D' ' 132' ' ' LYS . 5.0 ttpm? -85.5 -31.56 22.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.728 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.39 -65.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.527 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 5.9 m -55.53 -15.64 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.639 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.62 ' CB ' ' OXT' ' B' ' 146' ' ' HIS . . . -56.22 -33.68 65.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.214 -0.929 . . . . 0.0 109.335 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.9 -30.52 57.5 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.14 -32.85 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -1.117 . . . . 0.0 109.433 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.97 76.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.345 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -78.7 -21.11 48.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 109.428 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.77 -60.63 2.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.657 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 63.6 mt -54.33 -20.25 6.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.315 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' D' ' 145' ' ' TYR . . . -89.01 -4.57 58.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 109.126 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . 0.538 ' O ' ' CG ' ' D' ' 146' ' ' HIS . 71.4 t60 -49.48 -39.13 32.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.484 ' O ' ' ND1' ' D' ' 146' ' ' HIS . 0.8 OUTLIER -86.83 -55.13 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.944 . . . . 0.0 109.217 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . 0.494 ' CD1' ' C ' ' D' ' 145' ' ' TYR . 0.0 OUTLIER -52.82 -10.41 0.16 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.56 -0.713 . . . . 0.0 109.387 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.648 ' OXT' ' CB ' ' B' ' 135' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.484 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.803 ' CHC' HD22 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 1.657 ' HAB' ' CD1' ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.798 ' CHC' HD22 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 1.599 ' HAB' ' CD1' ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.429 ' C ' HD22 ' A' ' 2' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.576 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.9 mm? -95.01 -169.27 1.96 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.182 -0.949 . . . . 0.0 109.697 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.45 ' CB ' ' CD ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -116.24 179.54 0.78 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.504 -0.747 . . . . 0.0 109.228 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 21.7 Cg_exo -62.81 -69.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.722 2.281 . . . . 0.0 112.752 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -83.09 -16.63 46.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.897 . . . . 0.0 110.391 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.55 ' OD2' HD12 ' A' ' 2' ' ' LEU . 7.8 t70 -40.1 -41.17 1.21 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.215 -0.928 . . . . 0.0 109.778 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 10' ' ' VAL . 68.8 mttt -69.44 -55.97 8.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.872 . . . . 0.0 109.639 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.0 m -45.03 -30.78 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.428 -0.795 . . . . 0.0 109.674 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -78.48 -36.4 45.24 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 7' ' ' LYS . 48.9 t -72.09 -48.84 47.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -53.05 -44.39 67.39 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 0.0 108.78 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.74 -57.4 12.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.434 -0.791 . . . . 0.0 109.32 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -56.41 -36.2 68.67 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.431 -0.793 . . . . 0.0 109.27 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.92 -17.22 60.6 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.248 -0.908 . . . . 0.0 108.936 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.76 -42.0 22.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -71.43 -42.12 68.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -1.178 . . . . 0.0 108.84 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 13' ' ' ALA . 61.2 t -60.71 -63.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 47.73 -127.2 14.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.3 24.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.457 -1.025 . . . . 0.0 110.446 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.537 ' H ' ' C ' ' A' ' 18' ' ' GLY . 88.3 m-70 -128.84 22.13 5.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.887 . . . . 0.0 108.609 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.73 -55.93 3.5 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.577 -0.702 . . . . 0.0 109.443 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.49 -14.43 0.61 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 21' ' ' ALA . 12.7 mm-40 -87.49 -56.52 3.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.396 -1.061 . . . . 0.0 109.744 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 2.9 m-30 -60.87 -22.84 64.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 0.0 109.246 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.19 -23.54 63.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.93 -40.04 22.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -1.132 . . . . 0.0 109.619 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -69.43 -19.62 63.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.819 . . . . 0.0 109.25 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.3 -20.44 57.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 0.0 109.641 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.3 mt -78.15 -46.9 19.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 0.0 109.786 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.02 -38.13 75.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 109.738 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.4 mtt85 -63.18 -39.13 93.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.54 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.734 ' HE1' HBC2 ' A' ' 142' ' ' HEC . 51.0 ttp -64.6 -50.44 67.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.203 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 1.8 t80 -44.07 -33.87 1.6 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.427 -0.796 . . . . 0.0 109.697 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 10.3 mt -84.95 -40.02 17.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.76 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.543 ' O ' ' CD2' ' A' ' 36' ' ' PHE . 74.4 m -53.42 -38.4 63.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 109.665 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 35' ' ' SER . 30.5 m-85 -164.29 87.11 1.14 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 109.506 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 39' ' ' THR . 76.5 Cg_exo -48.18 -19.98 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.612 2.208 . . . . 0.0 112.141 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.818 ' HB ' ' HB3' ' D' ' 97' ' ' HIS . 9.1 p -46.82 -18.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.88 . . . . 0.0 109.738 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 37' ' ' PRO . 53.2 p -80.89 -63.11 1.48 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.13 -0.981 . . . . 0.0 109.989 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' TYR . 8.6 mmpt? -59.09 -18.57 36.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.94 . . . . 0.0 109.955 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 38' ' ' THR . 5.8 t -44.37 -19.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.143 -0.973 . . . . 0.0 109.835 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 40' ' ' LYS . 38.6 m-85 -73.3 4.05 5.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.55 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 43' ' ' PHE . 83.2 t80 47.57 74.18 0.86 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.179 -0.951 . . . . 0.0 109.471 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.685 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 69.8 Cg_endo -78.1 -14.9 14.87 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.742 2.295 . . . . 0.0 112.23 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.685 ' ND1' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER 81.33 26.19 0.22 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.473 0.654 . . . . 0.0 109.612 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.771 ' O ' ' N ' ' A' ' 48' ' ' LEU . 3.3 m-85 -82.89 14.2 3.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.315 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 49' ' ' SER . 4.7 m-20 60.42 -51.35 0.09 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.771 ' N ' ' O ' ' A' ' 46' ' ' PHE . 19.5 mt 41.59 20.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.677 -0.639 . . . . 0.0 109.961 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 47' ' ' ASP . 6.2 m -93.35 42.33 1.1 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.493 ' CG ' ' C ' ' A' ' 49' ' ' SER . 0.7 OUTLIER 71.88 129.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.434 -0.792 . . . . 0.0 109.351 -179.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.54 29.33 73.22 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.626 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 8.1 p -52.36 -36.68 54.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -1.064 . . . . 0.0 109.54 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 73.27 -64.45 0.4 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.466 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 53' ' ' ALA . 18.9 mt-30 -43.59 -35.72 1.83 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 109.48 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.3 t -55.32 -28.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.407 -0.808 . . . . 0.0 110.017 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 57' ' ' GLY . 2.5 ptpt -61.53 -38.89 89.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 0.0 109.453 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' N ' ' CG ' ' A' ' 56' ' ' LYS . . . -52.43 -35.83 45.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' A' ' 58' ' ' HIS . 8.7 t-80 -76.6 -27.91 55.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -1.167 . . . . 0.0 109.913 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.59 -37.26 94.17 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 46.6 mtpt -62.68 -24.34 67.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -1.186 . . . . 0.0 110.268 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.893 ' HB3' ' C3A' ' A' ' 142' ' ' HEC . 0.2 OUTLIER -65.01 -58.7 5.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.041 -1.037 . . . . 0.0 109.356 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 62' ' ' VAL . 11.5 t -54.0 -43.83 59.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.469 -0.77 . . . . 0.0 109.289 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.78 -46.88 62.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 0.0 108.924 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 62.4 m-20 -64.48 -34.4 78.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 108.661 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 61' ' ' LYS . . . -67.13 -50.36 61.64 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -55.69 -44.62 77.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 71' ' ' ALA . 19.3 m -65.5 -54.21 31.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.258 -0.901 . . . . 0.0 108.786 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.461 HD22 HD21 ' A' ' 80' ' ' LEU . 49.1 t30 -55.86 -27.35 51.27 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.446 ' HB1' ' SD ' ' A' ' 76' ' ' MET . . . -81.12 -47.68 13.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.32 -22.74 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 67' ' ' THR . . . -70.28 -13.01 61.98 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.598 ' O ' ' N ' ' A' ' 74' ' ' ASP . 34.0 m170 -136.3 -67.17 0.52 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.457 -0.777 . . . . 0.0 109.251 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 72' ' ' HIS . 13.2 p 44.77 14.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.952 0.882 . . . . 0.0 109.439 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 72' ' ' HIS . 35.0 m-20 -139.24 12.57 2.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 74' ' ' ASP . 1.1 m-20 172.79 30.98 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.692 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 6.9 ptt? -78.31 -22.82 0.4 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 111.928 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 76' ' ' MET . 51.6 Cg_exo -53.84 -20.75 18.41 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.577 1.518 . . . . 0.0 112.387 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -94.11 -35.54 12.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 109.844 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.03 -46.89 61.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.097 -1.002 . . . . 0.0 109.257 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.461 HD21 HD22 ' A' ' 68' ' ' ASN . 11.8 mt -80.3 8.27 7.8 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.345 -0.847 . . . . 0.0 109.024 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.2 p -56.05 -21.92 24.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.907 . . . . 0.0 109.731 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -70.8 -53.79 14.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.788 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' ALA . 6.0 mt -44.78 -47.1 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 20.0 m -50.2 -39.61 44.62 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 82' ' ' ALA . 28.8 t70 -82.82 -17.33 44.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.817 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.745 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.3 tm? -71.41 -58.19 3.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -83.11 -21.72 33.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.938 -1.102 . . . . 0.0 110.736 -178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 84' ' ' SER . . . -67.04 -79.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.888 -1.132 . . . . 0.0 109.788 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -59.53 5.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.811 . . . . 0.0 109.475 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 86' ' ' LEU . 41.2 mttm -88.02 135.7 33.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' A' ' 93' ' ' VAL . 14.9 mt 61.16 66.43 0.89 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.833 . . . . 0.0 109.153 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 1.453 ' NE ' ' HB2' ' D' ' 40' ' ' ARG . 39.1 ttt-85 -66.33 18.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.504 -0.748 . . . . 0.0 109.347 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.59 ' H ' ' C ' ' A' ' 91' ' ' LEU . 11.9 p -42.61 129.52 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.895 . . . . 0.0 109.767 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.85 148.74 75.45 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.28 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ASN . 37.5 Cg_endo -67.56 -10.9 30.28 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.476 2.117 . . . . 0.0 112.046 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 95' ' ' PRO . 47.7 t -44.55 -19.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.715 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' PRO . 17.8 m120 -79.16 -24.77 43.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.545 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.534 ' CG ' ' N ' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -53.71 -45.01 70.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.372 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.534 ' N ' ' CG ' ' A' ' 98' ' ' PHE . 65.2 mttm -49.28 -41.02 36.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.498 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 12.4 mt -71.55 -43.24 66.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.892 . . . . 0.0 109.403 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.085 ' CD1' ' CHC' ' A' ' 142' ' ' HEC . 3.5 tt -57.99 -57.09 14.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.317 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.5 p -61.86 -34.9 76.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.857 . . . . 0.0 109.687 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 103' ' ' HIS . 22.8 t-160 -77.68 -26.69 50.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.462 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 55.6 m -69.68 -41.52 75.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 0.0 109.686 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mt -52.35 -50.17 62.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.36 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 106' ' ' LEU . 3.8 mm? -58.83 -59.12 5.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 65.1 t -51.71 -49.68 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.197 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 110' ' ' ALA . 17.6 m -62.15 -60.27 3.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.394 -0.816 . . . . 0.0 109.3 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 113' ' ' LEU . 24.9 mt -47.13 -18.92 0.1 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 109.522 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -73.41 -36.24 65.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.01 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.13 -3.18 24.87 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.708 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -141.28 -83.9 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -0.967 . . . . 0.0 109.908 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -106.06 83.37 1.07 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.085 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.32 -174.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.148 1.899 . . . . 0.0 112.356 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.84 ' O ' HG21 ' A' ' 121' ' ' VAL . . . -46.19 -55.43 7.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.557 -0.715 . . . . 0.0 109.26 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.65 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 31.7 mt-10 118.87 -7.01 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.479 ' CB ' ' O ' ' A' ' 116' ' ' GLU . 4.8 t80 79.08 34.48 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.969 -0.457 . . . . 0.0 111.2 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.722 ' O ' ' N ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -109.47 122.7 38.67 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.39 18.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.32 2.013 . . . . 0.0 112.925 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.722 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -146.34 -33.17 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.886 -1.134 . . . . 0.0 110.404 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.84 HG21 ' O ' ' A' ' 115' ' ' ALA . 7.2 p -51.68 -47.26 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.111 -0.993 . . . . 0.0 110.117 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.615 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.0 t-160 -59.8 -37.27 78.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.955 . . . . 0.0 109.365 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.19 -19.71 33.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.711 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 125' ' ' LEU . 14.8 p -64.86 -62.5 1.53 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 110.625 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.497 ' N ' ' OG ' ' A' ' 124' ' ' SER . 1.6 mt -72.24 -19.77 61.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 0.0 109.978 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -82.38 -44.46 16.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.974 -1.079 . . . . 0.0 109.594 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.48 ' HG3' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -84.88 -41.02 16.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 109.52 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.48 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 27.8 t80 -51.72 -21.1 2.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.897 -1.127 . . . . 0.0 108.446 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 133' ' ' SER . 20.2 mt -76.6 -26.55 55.13 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 127' ' ' LYS . . . -54.52 -33.46 59.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.527 ' O ' HG23 ' A' ' 135' ' ' VAL . 1.6 m -77.65 -41.74 37.25 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 t -75.05 -33.13 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.224 -0.923 . . . . 0.0 108.578 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 129' ' ' LEU . 31.3 m -77.12 -42.21 38.9 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.399 -0.813 . . . . 0.0 109.172 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 92.3 m -70.39 -26.07 63.53 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.214 -0.929 . . . . 0.0 108.557 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 131' ' ' SER . 8.4 t -77.14 -37.78 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.06 -38.48 86.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 108.834 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 m -90.39 -14.6 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 53.8 p 49.02 -150.6 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.474 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -150.92 -79.81 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 0.0 109.433 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.434 ' OH ' HG22 ' C' ' 1' ' ' VAL . 77.4 m-85 -74.51 -60.08 2.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 109.381 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.417 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.781 ' H2 ' HD11 ' B' ' 3' ' ' LEU . 14.4 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 8.5 t60 55.32 62.21 2.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.913 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -127.76 177.82 6.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.391 -0.818 . . . . 0.0 109.186 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.44 ' OG1' ' OE2' ' B' ' 7' ' ' GLU . 0.6 OUTLIER -68.65 125.32 91.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 108.983 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -42.07 -35.55 3.32 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.349 2.032 . . . . 0.0 112.537 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' B' ' 6' ' ' GLU . 14.3 mp0 -76.16 -23.89 54.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.228 -0.92 . . . . 0.0 109.7 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' B' ' 7' ' ' GLU . 0.2 OUTLIER -84.17 -39.53 19.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 109.767 -179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.7 ' HB3' HD13 ' B' ' 3' ' ' LEU . 22.9 pttt -83.87 -39.18 20.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 110.114 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' B' ' 8' ' ' LYS . 19.5 m -43.9 -23.33 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.315 -0.865 . . . . 0.0 110.192 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' B' ' 8' ' ' LYS . . . -82.25 -57.06 3.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.139 -0.976 . . . . 0.0 109.997 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.09 -24.63 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 5.1 m -75.02 -45.71 39.9 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.367 0.603 . . . . 0.0 109.565 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.52 94.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.53 -0.731 . . . . 0.0 109.626 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' B' ' 16' ' ' GLY . 0.5 OUTLIER -48.0 -34.47 9.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -45.84 -17.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.344 -0.847 . . . . 0.0 109.413 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' B' ' 14' ' ' LEU . . . -76.56 -43.06 20.34 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' B' ' 17' ' ' LYS . 1.6 mmtt -79.76 -30.55 40.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.175 -1.191 . . . . 0.0 109.254 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -47.82 114.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 109.552 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' B' ' 22' ' ' GLU . 5.8 m-20 -77.84 66.13 3.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.198 -0.939 . . . . 0.0 108.998 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' B' ' 22' ' ' GLU . 73.8 t -43.81 -26.87 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 109.754 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.76 7.21 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 109.504 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' B' ' 20' ' ' VAL . 36.6 mt-10 -155.24 -50.25 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.332 -0.855 . . . . 0.0 109.563 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 69.3 t -47.03 -33.75 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.627 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.57 -50.72 59.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.39 -36.87 78.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -73.74 -38.64 64.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -1.133 . . . . 0.0 109.449 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.85 -34.05 72.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.405 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -84.99 -34.53 22.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 109.53 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.36 -50.36 60.16 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -58.21 -30.55 66.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -1.204 . . . . 0.0 109.425 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . 0.476 ' CD2' HBC2 ' B' ' 147' ' ' HEC . 9.3 tp -50.44 -39.21 46.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 109.469 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -81.01 -21.97 39.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.69 -64.13 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.724 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.52 HG13 ' CD2' ' A' ' 122' ' ' HIS . 2.3 t -64.46 -22.94 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.876 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.442 ' HB3' ' HE1' ' B' ' 37' ' ' TRP . 53.9 m-85 -139.71 78.61 25.5 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.271 -0.893 . . . . 0.0 109.392 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -82.82 -17.87 6.84 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.817 2.345 . . . . 0.0 112.381 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.536 ' O ' ' NH2' ' C' ' 92' ' ' ARG . 5.2 p-90 -49.64 -19.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.5 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.514 HG23 ' CE2' ' B' ' 37' ' ' TRP . 1.4 p -92.15 -11.34 35.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.241 -0.912 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -45.05 -34.24 2.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.711 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 1.379 ' HB2' ' NE ' ' C' ' 92' ' ' ARG . 37.6 mtp85 -61.08 -26.03 67.36 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.478 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' B' ' 38' ' ' THR . 32.1 t80 -100.88 30.64 3.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.315 -0.866 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -146.25 31.22 1.01 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 109.327 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' B' ' 43' ' ' GLU . 13.8 pt-20 -79.75 -14.04 59.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.402 ' O ' ' N ' ' B' ' 46' ' ' GLY . 28.5 t -65.47 -43.85 89.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.538 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' B' ' 47' ' ' ASP . 44.8 m-85 -48.87 -18.58 0.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 48' ' ' LEU . . . 65.77 -66.56 0.12 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' B' ' 45' ' ' PHE . 79.6 m-20 -54.05 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -1.136 . . . . 0.0 109.674 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 46' ' ' GLY . 0.8 OUTLIER -164.47 21.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.115 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 56.0 m -57.97 -41.1 82.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.413 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . 0.431 ' O ' ' N ' ' B' ' 53' ' ' ALA . 1.3 p -146.25 152.4 46.56 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.424 -0.797 . . . . 0.0 109.045 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -40.63 -30.04 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.402 2.068 . . . . 0.0 112.345 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -75.05 -29.2 60.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.641 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 50' ' ' THR . . . -63.9 -20.5 65.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 109.557 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.55 -24.01 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . 0.413 ' O ' ' OD1' ' B' ' 57' ' ' ASN . 16.3 mmt -90.01 -6.2 55.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 109.611 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.587 ' O ' ' CB ' ' B' ' 57' ' ' ASN . . . -47.93 -35.83 13.43 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . 0.71 ' N ' ' CD ' ' B' ' 58' ' ' PRO . 21.0 m-20 91.7 23.56 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 122.245 -0.562 . . . . 0.0 111.623 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.71 ' CD ' ' N ' ' B' ' 57' ' ' ASN . 77.4 Cg_endo -81.34 -157.52 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.965 1.776 . . . . 0.0 112.125 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -47.66 -24.39 0.91 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.71 -50.05 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.566 -0.709 . . . . 0.0 109.294 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' B' ' 62' ' ' ALA . 0.0 OUTLIER -79.48 -32.49 42.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.363 -0.836 . . . . 0.0 109.637 -179.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.416 ' N ' ' HG2' ' B' ' 61' ' ' LYS . . . -56.99 -49.72 74.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 109.565 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 1.179 ' NE2' HAD2 ' B' ' 147' ' ' HEC . 46.3 t-80 -59.42 -26.3 65.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.589 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.56 -19.4 74.64 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -76.04 -24.98 55.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 109.122 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -74.29 -59.29 2.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 109.568 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 1.537 HG13 ' C1B' ' B' ' 147' ' ' HEC . 40.4 t -47.0 -34.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 109.473 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.33 -42.75 96.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -0.914 . . . . 0.0 109.16 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.73 -49.82 52.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.75 -33.44 66.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -1.127 . . . . 0.0 109.51 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -76.25 -37.66 57.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.386 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -80.49 -28.13 37.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.341 -0.849 . . . . 0.0 109.436 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -51.17 -38.89 54.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.21 -60.13 7.99 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.577 ' H ' HD12 ' B' ' 75' ' ' LEU . 4.9 mp -56.83 -18.65 13.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -1.106 . . . . 0.0 109.407 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -83.22 -19.31 36.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 71.5 m-70 -159.42 62.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.11 -0.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 109.315 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' B' ' 77' ' ' HIS . 45.7 t0 -57.62 -25.87 60.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' B' ' 80' ' ' ASN . 9.1 p-10 -170.58 105.85 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.56 ' N ' HD12 ' B' ' 81' ' ' LEU . 10.2 mp -79.98 -57.26 3.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.469 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -45.79 -24.06 0.34 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -0.973 . . . . 0.0 109.61 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.76 -63.21 2.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 3.0 t -61.01 -47.49 86.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -1.168 . . . . 0.0 109.516 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.547 ' N ' ' CG2' ' B' ' 84' ' ' THR . 64.2 m-85 -67.86 4.77 1.04 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.504 -0.747 . . . . 0.0 109.597 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -55.82 -46.57 78.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.544 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -75.12 -52.59 10.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.526 ' O ' ' ND1' ' B' ' 92' ' ' HIS . 55.6 mt -50.73 -47.36 59.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . 0.483 ' O ' ' SG ' ' B' ' 93' ' ' CYS . 14.7 m -57.52 -36.26 71.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.356 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.87 -22.28 43.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.91 -18.06 26.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.972 . . . . 0.0 109.815 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' B' ' 88' ' ' LEU . 9.9 m80 -87.89 -60.76 1.88 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.916 -1.115 . . . . 0.0 110.484 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' B' ' 89' ' ' SER . 12.8 p -83.82 -59.77 2.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.955 -1.091 . . . . 0.0 111.469 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.473 ' N ' ' SG ' ' B' ' 93' ' ' CYS . 14.2 m-20 -59.2 -26.76 65.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.071 -1.018 . . . . 0.0 111.724 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' B' ' 97' ' ' HIS . 3.1 tppp? -107.51 -51.97 2.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.737 -1.227 . . . . 0.0 110.795 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.447 ' C ' ' CD2' ' B' ' 97' ' ' HIS . 5.7 mp -87.19 -30.48 20.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.926 -1.109 . . . . 0.0 109.931 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.738 ' HB3' ' CG2' ' C' ' 38' ' ' THR . 9.6 m-70 66.47 49.16 1.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.117 -0.989 . . . . 0.0 110.013 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 33.1 t -96.62 114.18 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.198 -0.939 . . . . 0.0 109.031 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' B' ' 100' ' ' PRO . 0.9 OUTLIER -62.59 153.66 76.84 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 109.605 -179.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' B' ' 99' ' ' ASP . 51.0 Cg_exo -51.98 -156.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.442 2.095 . . . . 0.0 112.452 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 52.95 46.74 26.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.522 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' B' ' 100' ' ' PRO . 35.3 m120 -158.08 -35.74 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.526 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.0 -39.22 93.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.152 -0.968 . . . . 0.0 109.526 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -65.47 -31.24 72.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 109.658 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.582 HD12 ' N ' ' B' ' 105' ' ' LEU . 9.8 mp -62.35 -57.95 9.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.118 -0.989 . . . . 0.0 109.462 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 1.558 ' CD2' HBB3 ' B' ' 147' ' ' HEC . 6.4 tt -48.23 -22.75 0.71 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.928 . . . . 0.0 109.605 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' B' ' 109' ' ' VAL . . . -79.29 -45.35 8.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -46.61 -16.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -1.122 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' B' ' 107' ' ' GLY . 97.6 t -85.15 -62.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.41 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 14.6 mt -47.41 -26.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.92 -47.65 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.792 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . . . . . . . . . 20.2 p -79.28 -41.32 28.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.018 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . . . . . . . . . 77.7 t -47.4 -41.15 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.974 . . . . 0.0 109.747 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' B' ' 118' ' ' PHE . 46.1 mt -79.47 -40.49 29.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 109.526 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.438 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.14 -30.41 2.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.526 ' C ' ' HD1' ' B' ' 116' ' ' HIS . 0.2 OUTLIER -84.64 -56.98 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.265 -0.897 . . . . 0.0 109.288 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . 0.411 ' C ' ' CG ' ' B' ' 118' ' ' PHE . 85.7 m-70 -63.53 -17.72 63.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 0.0 109.57 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.452 ' N ' ' O ' ' B' ' 114' ' ' LEU . 65.2 m-85 -153.29 62.35 0.76 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.938 . . . . 0.0 109.543 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' B' ' 122' ' ' PHE . . . -68.92 -50.48 34.78 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -47.86 -31.05 4.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 109.38 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -82.7 -19.07 38.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.555 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' B' ' 119' ' ' GLY . 6.3 t80 -76.09 66.61 2.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.29 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.439 ' OG1' HG23 ' B' ' 126' ' ' VAL . 1.3 p -79.14 149.8 73.53 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.276 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.508 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 5.5 Cg_exo -45.36 -53.58 5.3 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.466 2.111 . . . . 0.0 112.968 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 26.0 Cg_endo -62.45 1.11 1.08 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.01 1.806 . . . . 0.0 112.192 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.455 HG12 ' O ' ' B' ' 126' ' ' VAL . 87.9 t -112.45 -8.23 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.316 -0.865 . . . . 0.0 109.306 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.3 -53.97 5.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.517 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -54.69 -33.81 61.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.886 . . . . 0.0 109.537 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.2 2.6 17.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.675 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.17 -29.6 13.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.218 -0.926 . . . . 0.0 109.374 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' B' ' 135' ' ' ALA . 88.9 mm-40 -84.4 -23.3 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 109.916 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.723 ' HG3' ' HB3' ' D' ' 146' ' ' HIS . 14.4 ttmt -85.56 -36.08 20.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.13 -0.981 . . . . 0.0 110.121 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . 0.737 HG13 ' N ' ' B' ' 134' ' ' VAL . 11.8 p -65.38 -58.91 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.081 -1.012 . . . . 0.0 110.037 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.737 ' N ' HG13 ' B' ' 133' ' ' VAL . 11.3 t -62.1 -33.43 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.02 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' B' ' 131' ' ' GLN . . . -45.89 -21.47 0.13 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 0.0 109.684 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 134' ' ' VAL . . . -82.7 -26.83 44.59 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' B' ' 134' ' ' VAL . 97.7 t -78.88 -21.2 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -1.133 . . . . 0.0 109.585 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.02 -38.37 32.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.629 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.8 -21.09 30.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.785 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.21 -48.46 70.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.115 -0.991 . . . . 0.0 109.713 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' B' ' 92' ' ' HIS . 28.4 mt -58.26 -22.04 50.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.574 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.531 ' O ' ' CD1' ' B' ' 145' ' ' TYR . . . -89.71 26.1 1.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -80.53 -6.98 59.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.162 -0.962 . . . . 0.0 109.13 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' B' ' 146' ' ' HIS . 11.6 mptt -122.14 -27.84 4.47 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.52 -0.737 . . . . 0.0 109.696 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 142' ' ' ALA . 0.1 OUTLIER -50.26 -7.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.11 -0.993 . . . . 0.0 110.034 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.72 ' HB3' ' HG3' ' D' ' 132' ' ' LYS . 12.0 m-70 . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.736 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . 0.434 HG22 ' OH ' ' A' ' 140' ' ' TYR . 40.2 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.289 0.566 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . 0.575 HD22 ' N ' ' C' ' 2' ' ' LEU . 3.9 mm? -94.95 -169.37 1.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.213 -0.929 . . . . 0.0 109.691 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.452 ' CB ' ' CD ' ' C' ' 4' ' ' PRO . 0.1 OUTLIER -116.13 179.55 0.78 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.491 -0.756 . . . . 0.0 109.233 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 21.8 Cg_exo -62.85 -69.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.69 2.26 . . . . 0.0 112.781 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -83.13 -16.69 45.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.931 . . . . 0.0 110.308 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.561 ' OD2' HD12 ' C' ' 2' ' ' LEU . 7.8 t70 -40.05 -41.18 1.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.173 -0.955 . . . . 0.0 109.773 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' C' ' 10' ' ' VAL . 68.7 mttt -69.45 -56.04 8.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 109.57 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 53.5 m -45.04 -30.75 1.12 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.32 -0.863 . . . . 0.0 109.707 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -78.39 -36.41 45.92 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' C' ' 7' ' ' LYS . 49.2 t -72.01 -48.93 47.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -53.02 -44.45 67.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 108.783 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.77 -57.34 12.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.361 -0.837 . . . . 0.0 109.338 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.625 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -56.45 -36.27 68.85 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.377 -0.827 . . . . 0.0 109.24 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.79 -17.2 60.66 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.278 -0.889 . . . . 0.0 109.029 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.83 -41.98 21.93 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . 0.42 ' HG2' ' H ' ' C' ' 16' ' ' LYS . 12.9 mmmt -71.43 -42.08 68.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -1.153 . . . . 0.0 108.837 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.625 HG23 ' O ' ' C' ' 13' ' ' ALA . 61.5 t -60.71 -63.79 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 47.8 -127.32 14.62 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 24.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.414 -1.05 . . . . 0.0 110.447 -178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.539 ' H ' ' C ' ' C' ' 18' ' ' GLY . 88.3 m-70 -128.85 22.05 5.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.905 . . . . 0.0 108.612 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.46 ' C ' ' N ' ' C' ' 23' ' ' GLU . . . -88.75 -55.85 3.53 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.585 -0.697 . . . . 0.0 109.464 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.59 -14.4 0.64 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.46 ' N ' ' C ' ' C' ' 21' ' ' ALA . 12.8 mm-40 -87.48 -56.56 3.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -1.079 . . . . 0.0 109.714 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' C' ' 24' ' ' TYR . 2.9 m-30 -60.78 -22.9 64.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.2 -23.49 63.22 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.96 -40.1 22.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -1.128 . . . . 0.0 109.604 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -69.35 -19.59 63.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.284 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.31 -20.39 57.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.684 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mt -78.3 -46.84 19.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 109.752 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -58.04 -38.1 75.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.74 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -63.2 -39.19 93.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -0.972 . . . . 0.0 109.526 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 0.685 ' HE1' HBC2 ' C' ' 142' ' ' HEC . 50.9 ttp -64.52 -50.54 66.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.196 -0.94 . . . . 0.0 109.176 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . 0.469 ' O ' ' CD1' ' C' ' 33' ' ' PHE . 1.8 t80 -43.95 -33.99 1.55 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.682 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.774 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 10.4 mt -85.0 -39.87 17.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.793 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD2' ' C' ' 36' ' ' PHE . 74.5 m -53.44 -38.44 63.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.96 . . . . 0.0 109.749 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' C' ' 35' ' ' SER . 30.8 m-85 -164.22 87.12 1.15 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.877 . . . . 0.0 109.521 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' C' ' 39' ' ' THR . 76.6 Cg_exo -48.21 -19.92 2.0 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.551 2.167 . . . . 0.0 112.135 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.738 ' CG2' ' HB3' ' B' ' 97' ' ' HIS . 9.0 p -46.84 -18.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.889 . . . . 0.0 109.757 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.444 ' N ' ' O ' ' C' ' 37' ' ' PRO . 53.2 p -80.91 -63.1 1.48 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.981 . . . . 0.0 109.992 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' C' ' 42' ' ' TYR . 8.6 mmpt? -59.05 -18.59 36.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.165 -0.96 . . . . 0.0 109.935 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.532 HG22 ' O ' ' C' ' 38' ' ' THR . 5.8 t -44.46 -19.11 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.144 -0.972 . . . . 0.0 109.828 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' C' ' 40' ' ' LYS . 38.5 m-85 -73.34 4.04 5.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 109.582 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' C' ' 43' ' ' PHE . 83.1 t80 47.58 74.16 0.86 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 109.452 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.688 ' O ' ' ND1' ' C' ' 45' ' ' HIS . 70.5 Cg_endo -78.03 -14.87 15.01 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.772 2.314 . . . . 0.0 112.308 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.688 ' ND1' ' O ' ' C' ' 44' ' ' PRO . 0.0 OUTLIER 81.25 26.12 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.621 -0.675 . . . . 0.0 109.648 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.778 ' O ' ' N ' ' C' ' 48' ' ' LEU . 3.3 m-85 -82.87 14.33 3.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.399 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' C' ' 49' ' ' SER . 4.6 m-20 60.39 -51.33 0.09 Allowed 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.778 ' N ' ' O ' ' C' ' 46' ' ' PHE . 19.4 mt 41.53 20.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.661 -0.649 . . . . 0.0 110.004 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.538 ' N ' ' O ' ' C' ' 47' ' ' ASP . 6.2 m -93.35 42.27 1.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . 0.49 ' CG ' ' C ' ' C' ' 49' ' ' SER . 0.7 OUTLIER 71.98 129.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.516 -0.74 . . . . 0.0 109.295 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.42 29.4 73.24 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.65 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 8.1 p -52.34 -36.7 54.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -1.111 . . . . 0.0 109.595 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 73.26 -64.41 0.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.862 . . . . 0.0 109.549 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' C' ' 53' ' ' ALA . 18.9 mt-30 -43.57 -35.78 1.85 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.0 109.482 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -55.35 -28.15 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.433 -0.792 . . . . 0.0 109.986 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' C' ' 57' ' ' GLY . 2.5 ptpt -61.47 -38.97 89.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.031 -1.043 . . . . 0.0 109.461 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . 0.434 ' N ' ' CG ' ' C' ' 56' ' ' LYS . . . -52.41 -35.75 44.73 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.557 ' ND1' ' O ' ' C' ' 58' ' ' HIS . 8.7 t-80 -76.65 -27.84 55.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -1.165 . . . . 0.0 109.922 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.61 -37.27 94.18 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -62.64 -24.3 67.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.24 -1.153 . . . . 0.0 110.362 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.905 ' HB3' ' C3A' ' C' ' 142' ' ' HEC . 0.2 OUTLIER -65.04 -58.78 5.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.011 -1.056 . . . . 0.0 109.319 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.422 ' H ' HG23 ' C' ' 62' ' ' VAL . 11.6 t -54.02 -43.85 60.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.434 -0.791 . . . . 0.0 109.246 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.7 -46.9 62.26 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 108.921 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -64.44 -34.51 78.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 108.655 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.06 -50.31 62.26 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -55.75 -44.6 77.77 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.305 -0.872 . . . . 0.0 108.704 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.421 ' O ' ' N ' ' C' ' 71' ' ' ALA . 19.2 m -65.43 -54.22 31.65 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -0.847 . . . . 0.0 108.794 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.463 HD22 HD21 ' C' ' 80' ' ' LEU . 48.9 t30 -55.9 -27.39 51.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.46 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -81.02 -47.78 13.13 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.26 -22.69 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' C' ' 67' ' ' THR . . . -70.36 -13.04 61.98 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' C' ' 74' ' ' ASP . 34.0 m170 -136.31 -67.12 0.52 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.548 -0.72 . . . . 0.0 109.206 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.554 HG12 ' O ' ' C' ' 72' ' ' HIS . 13.2 p 44.64 14.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.946 0.879 . . . . 0.0 109.37 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' C' ' 72' ' ' HIS . 35.2 m-20 -139.26 12.52 2.59 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' C' ' 74' ' ' ASP . 1.1 m-20 172.72 30.92 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.688 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 6.9 ptt? -78.29 -22.87 0.4 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.174 -0.954 . . . . 0.0 111.889 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' C' ' 76' ' ' MET . 51.4 Cg_exo -53.82 -20.69 18.17 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 121.596 1.531 . . . . 0.0 112.405 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -94.15 -35.55 12.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.825 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.04 -46.91 61.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.157 -0.965 . . . . 0.0 109.303 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . 0.463 HD21 HD22 ' C' ' 68' ' ' ASN . 11.7 mt -80.21 8.17 7.9 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.387 -0.821 . . . . 0.0 109.047 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 45.0 p -56.01 -21.87 23.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.953 . . . . 0.0 109.797 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -70.88 -53.82 13.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.746 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' C' ' 83' ' ' LEU . 6.0 mt -44.82 -46.93 10.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . . . . . . . . . 20.0 m -50.24 -39.62 45.24 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' C' ' 82' ' ' ALA . 28.7 t70 -82.79 -17.39 44.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 109.807 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.74 HD13 ' C ' ' C' ' 86' ' ' LEU . 3.3 tm? -71.4 -58.16 3.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 110.426 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -83.12 -21.79 33.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.956 -1.09 . . . . 0.0 110.697 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.11 -79.3 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 109.72 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.18 -59.53 5.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.491 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' C' ' 86' ' ' LEU . 41.2 mttm -87.99 135.77 33.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.6 ' C ' ' H ' ' C' ' 93' ' ' VAL . 14.9 mt 61.09 66.44 0.89 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 109.141 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . 1.379 ' NE ' ' HB2' ' B' ' 40' ' ' ARG . 38.9 ttt-85 -66.34 18.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.6 ' H ' ' C ' ' C' ' 91' ' ' LEU . 11.8 p -42.57 129.55 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -0.872 . . . . 0.0 109.709 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.86 148.81 75.36 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.213 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' C' ' 97' ' ' ASN . 37.6 Cg_endo -67.57 -10.95 30.46 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.48 2.12 . . . . 0.0 112.059 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -44.56 -19.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.358 -0.839 . . . . 0.0 109.669 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' C' ' 95' ' ' PRO . 17.7 m120 -79.1 -24.71 43.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.653 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . 0.541 ' CG ' ' N ' ' C' ' 99' ' ' LYS . 0.1 OUTLIER -53.75 -44.96 70.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -0.941 . . . . 0.0 109.426 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.541 ' N ' ' CG ' ' C' ' 98' ' ' PHE . 65.3 mttm -49.33 -41.05 37.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.5 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 12.4 mt -71.61 -43.16 66.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 1.106 ' CD1' ' CHC' ' C' ' 142' ' ' HEC . 3.6 tt -58.0 -57.03 14.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 109.341 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . . . . . . . . . 84.3 p -61.87 -34.95 76.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.371 -0.831 . . . . 0.0 109.69 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.421 ' CD2' ' O ' ' C' ' 103' ' ' HIS . 22.8 t-160 -77.65 -26.62 50.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.508 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 55.3 m -69.84 -41.45 74.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.86 . . . . 0.0 109.64 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 mt -52.33 -50.19 62.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.962 . . . . 0.0 109.324 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.54 ' N ' HD22 ' C' ' 106' ' ' LEU . 3.8 mm? -58.87 -59.11 5.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.635 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 65.0 t -51.73 -49.64 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.324 -0.86 . . . . 0.0 109.197 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.44 ' O ' ' N ' ' C' ' 110' ' ' ALA . 17.6 m -62.06 -60.35 3.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.29 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' C' ' 113' ' ' LEU . 25.5 mt -47.18 -18.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.872 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -73.46 -36.14 65.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 110.069 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.11 -3.27 25.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.747 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -141.2 -83.95 0.21 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 109.904 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' C' ' 113' ' ' LEU . 0.3 OUTLIER -106.0 83.35 1.05 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.344 -0.848 . . . . 0.0 109.068 -179.629 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.28 -174.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.087 1.858 . . . . 0.0 112.399 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.828 ' O ' HG21 ' C' ' 121' ' ' VAL . . . -46.18 -55.51 6.99 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.558 -0.714 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.653 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 31.7 mt-10 118.93 -6.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.489 ' CB ' ' O ' ' C' ' 116' ' ' GLU . 4.8 t80 79.01 34.54 0.21 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.968 -0.458 . . . . 0.0 111.228 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.732 ' O ' ' N ' ' C' ' 120' ' ' ALA . 0.8 OUTLIER -109.52 122.7 38.63 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.037 -1.04 . . . . 0.0 108.271 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.36 18.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.3 2.0 . . . . 0.0 112.915 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -146.32 -33.22 0.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.89 -1.131 . . . . 0.0 110.403 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.828 HG21 ' O ' ' C' ' 115' ' ' ALA . 7.2 p -51.66 -47.13 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 110.177 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.625 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.0 t-160 -59.8 -37.32 78.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.357 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.25 -19.72 33.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.646 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' C' ' 125' ' ' LEU . 14.8 p -64.79 -62.54 1.5 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 110.593 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.517 ' N ' ' OG ' ' C' ' 124' ' ' SER . 1.6 mt -72.34 -19.73 61.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.11 -0.993 . . . . 0.0 109.932 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.26 -44.5 16.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.981 -1.075 . . . . 0.0 109.64 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' C' ' 130' ' ' ALA . 0.0 OUTLIER -84.94 -41.03 16.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.13 -0.981 . . . . 0.0 109.567 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.483 ' N ' ' HG3' ' C' ' 127' ' ' LYS . 28.0 t80 -51.67 -21.01 2.34 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.937 -1.102 . . . . 0.0 108.559 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' C' ' 133' ' ' SER . 20.3 mt -76.66 -26.5 54.89 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' C' ' 127' ' ' LYS . . . -54.55 -33.41 60.09 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.54 ' OG ' HD21 ' C' ' 2' ' ' LEU . 1.6 m -77.57 -41.87 37.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . . . . . . . . . 4.9 t -75.03 -33.14 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . 0.513 ' N ' ' O ' ' C' ' 129' ' ' LEU . 31.5 m -77.11 -42.21 38.96 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.485 -0.759 . . . . 0.0 109.146 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . . . . . . . . . 92.2 m -70.26 -26.1 63.66 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.174 -0.954 . . . . 0.0 108.569 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.538 HG23 ' O ' ' C' ' 131' ' ' SER . 8.6 t -77.17 -37.84 26.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.17 -38.45 86.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 108.846 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 24.9 m -90.34 -14.57 32.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.239 -0.913 . . . . 0.0 109.477 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 53.7 p 48.95 -150.56 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.461 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -150.94 -79.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 109.43 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.403 ' OH ' HG22 ' A' ' 1' ' ' VAL . 77.7 m-85 -74.43 -60.09 2.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.913 -1.041 . . . . 0.0 109.414 179.935 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.817 ' H2 ' HD11 ' D' ' 3' ' ' LEU . 14.4 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 t60 55.29 62.27 2.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.935 . . . . 0.0 109.512 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.904 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -127.74 177.74 6.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.343 -0.848 . . . . 0.0 109.138 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' D' ' 7' ' ' GLU . 0.6 OUTLIER -68.65 125.3 91.64 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.044 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -42.11 -35.47 3.32 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.325 2.017 . . . . 0.0 112.488 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' D' ' 6' ' ' GLU . 14.2 mp0 -76.2 -23.93 54.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 109.731 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' D' ' 7' ' ' GLU . 0.2 OUTLIER -84.09 -39.6 19.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.797 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.678 ' HB3' HD13 ' D' ' 3' ' ' LEU . 22.9 pttt -83.78 -39.27 20.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.0 110.074 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' D' ' 8' ' ' LYS . 19.7 m -43.78 -23.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 110.163 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' D' ' 8' ' ' LYS . . . -82.25 -57.05 3.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.114 -0.991 . . . . 0.0 109.979 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.08 -24.73 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 5.0 m -74.9 -45.83 40.06 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.387 0.613 . . . . 0.0 109.597 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.24 -39.51 94.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.427 -0.796 . . . . 0.0 109.688 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' D' ' 16' ' ' GLY . 0.5 OUTLIER -48.06 -34.49 9.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.368 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -45.77 -17.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.827 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' D' ' 14' ' ' LEU . . . -76.44 -43.11 20.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' D' ' 17' ' ' LYS . 1.5 mmtt -79.72 -30.6 40.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.127 -1.219 . . . . 0.0 109.247 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -47.86 114.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.882 . . . . 0.0 109.569 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' D' ' 22' ' ' GLU . 5.8 m-20 -77.87 66.04 3.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 108.988 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' D' ' 22' ' ' GLU . 73.7 t -43.66 -26.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.446 -0.784 . . . . 0.0 109.786 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.72 7.22 0.92 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' D' ' 19' ' ' ASN . 36.6 mt-10 -155.28 -50.25 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.567 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 69.7 t -46.98 -33.86 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.47 -50.78 59.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.35 -36.81 79.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -73.68 -38.76 64.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -1.158 . . . . 0.0 109.45 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.82 -34.07 72.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 109.436 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -84.94 -34.56 22.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.45 -50.2 60.81 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -58.22 -30.6 66.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -1.117 . . . . 0.0 109.398 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . 0.468 ' CD2' HBC2 ' D' ' 147' ' ' HEC . 9.3 tp -50.41 -39.17 46.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.967 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 mt -81.03 -22.0 39.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.163 -0.961 . . . . 0.0 109.597 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 21.1 t -82.7 -64.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 109.772 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.529 HG13 ' CD2' ' C' ' 122' ' ' HIS . 2.3 t -64.57 -22.9 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.875 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . 0.43 ' HB3' ' HE1' ' D' ' 37' ' ' TRP . 53.7 m-85 -139.77 78.63 25.16 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.285 -0.884 . . . . 0.0 109.399 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.81 -17.81 6.9 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.814 2.342 . . . . 0.0 112.417 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . 0.57 ' O ' ' NH2' ' A' ' 92' ' ' ARG . 5.2 p-90 -49.7 -19.89 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.514 HG23 ' CE2' ' D' ' 37' ' ' TRP . 1.4 p -92.1 -11.39 35.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.264 -0.897 . . . . 0.0 109.332 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -45.03 -34.17 2.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.337 -0.852 . . . . 0.0 109.736 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . 1.453 ' HB2' ' NE ' ' A' ' 92' ' ' ARG . 37.7 mtp85 -61.12 -26.08 67.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.441 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' D' ' 38' ' ' THR . 32.3 t80 -100.85 30.75 3.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -0.865 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -146.26 31.24 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 109.343 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.75 -14.08 58.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . 0.406 ' C ' ' N ' ' D' ' 46' ' ' GLY . 28.5 t -65.52 -43.79 88.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.541 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.501 ' O ' ' N ' ' D' ' 47' ' ' ASP . 44.5 m-85 -48.99 -18.49 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.425 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' D' ' 48' ' ' LEU . . . 65.82 -66.58 0.12 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' D' ' 45' ' ' PHE . 79.6 m-20 -54.07 86.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -1.123 . . . . 0.0 109.632 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' D' ' 46' ' ' GLY . 0.8 OUTLIER -164.46 21.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.167 179.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.0 m -57.98 -41.04 82.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.419 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . 0.434 ' O ' ' N ' ' D' ' 53' ' ' ALA . 1.3 p -146.28 152.29 46.16 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.0 109.092 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -40.49 -30.12 0.46 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.449 2.1 . . . . 0.0 112.361 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -75.13 -29.14 60.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.615 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' D' ' 50' ' ' THR . . . -63.93 -20.39 65.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.63 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.58 -24.04 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . 0.418 ' O ' ' OD1' ' D' ' 57' ' ' ASN . 16.3 mmt -90.0 -6.14 55.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.605 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.602 ' O ' ' CB ' ' D' ' 57' ' ' ASN . . . -47.94 -35.82 13.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . 0.725 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 21.3 m-20 91.7 23.55 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 122.137 -0.625 . . . . 0.0 111.568 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.725 ' CD ' ' N ' ' D' ' 57' ' ' ASN . 75.3 Cg_endo -81.36 -157.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.948 1.765 . . . . 0.0 112.122 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -47.61 -24.52 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' D' ' 58' ' ' PRO . 54.7 t -51.56 -50.18 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.494 -0.754 . . . . 0.0 109.279 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' D' ' 62' ' ' ALA . 0.0 OUTLIER -79.37 -32.62 43.19 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.38 -0.825 . . . . 0.0 109.631 -179.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' D' ' 61' ' ' LYS . . . -57.02 -49.74 74.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.979 . . . . 0.0 109.532 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 1.197 ' NE2' HAD2 ' D' ' 147' ' ' HEC . 46.5 t-80 -59.42 -26.28 65.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.905 . . . . 0.0 109.557 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.47 -19.46 74.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -76.09 -24.91 55.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -1.176 . . . . 0.0 109.082 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -74.36 -59.18 2.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.84 . . . . 0.0 109.564 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 1.565 HG13 ' C1B' ' D' ' 147' ' ' HEC . 40.5 t -47.15 -34.16 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.194 -0.941 . . . . 0.0 109.465 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.47 -42.61 95.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.142 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.71 -49.92 51.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.7 -33.5 66.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -1.144 . . . . 0.0 109.52 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -76.2 -37.66 57.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 60.4 p -80.42 -28.28 37.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 109.385 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -51.11 -38.86 54.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.915 . . . . 0.0 109.415 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.22 -60.15 7.96 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.599 ' H ' HD12 ' D' ' 75' ' ' LEU . 4.9 mp -56.87 -18.63 13.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -1.131 . . . . 0.0 109.345 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -83.22 -19.32 36.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.883 . . . . 0.0 109.615 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 72.0 m-70 -159.37 62.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.689 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . . . . . . . . . 64.7 mt -62.1 -0.43 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -0.945 . . . . 0.0 109.409 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' D' ' 77' ' ' HIS . 45.8 t0 -57.66 -25.85 60.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.917 . . . . 0.0 109.503 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' D' ' 80' ' ' ASN . 9.0 p-10 -170.64 105.9 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.487 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . 0.548 ' N ' HD12 ' D' ' 81' ' ' LEU . 10.2 mp -79.97 -57.3 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -45.83 -23.97 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 109.566 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.82 -63.27 2.75 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.553 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 3.0 t -61.02 -47.46 86.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -1.181 . . . . 0.0 109.557 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.553 ' N ' ' CG2' ' D' ' 84' ' ' THR . 64.4 m-85 -67.82 4.68 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.574 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -55.68 -46.68 77.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.0 109.544 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -75.08 -52.46 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.522 ' O ' ' ND1' ' D' ' 92' ' ' HIS . 55.6 mt -50.74 -47.46 59.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . 0.5 ' O ' ' SG ' ' D' ' 93' ' ' CYS . 14.7 m -57.5 -36.19 71.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 109.36 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -79.88 -22.25 43.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 0.0 109.457 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tt -89.98 -18.01 26.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.766 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' D' ' 88' ' ' LEU . 10.0 m80 -87.88 -60.67 1.9 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.96 -1.088 . . . . 0.0 110.486 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' D' ' 89' ' ' SER . 12.5 p -83.94 -59.78 2.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.969 -1.082 . . . . 0.0 111.438 -178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.477 ' N ' ' SG ' ' D' ' 93' ' ' CYS . 14.2 m-20 -59.14 -26.76 65.02 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.095 -1.003 . . . . 0.0 111.709 -177.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . 0.526 ' O ' ' NE2' ' D' ' 97' ' ' HIS . 3.2 tppp? -107.55 -51.93 2.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.658 -1.276 . . . . 0.0 110.796 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.451 ' C ' ' CD2' ' D' ' 97' ' ' HIS . 5.7 mp -87.22 -30.55 20.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.915 -1.115 . . . . 0.0 109.918 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.818 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 9.6 m-70 66.47 49.19 1.41 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.16 -0.962 . . . . 0.0 110.039 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 33.0 t -96.63 114.2 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.27 -0.894 . . . . 0.0 108.987 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' D' ' 100' ' ' PRO . 0.9 OUTLIER -62.65 153.59 77.63 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 109.553 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' D' ' 99' ' ' ASP . 50.6 Cg_exo -51.86 -156.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.504 2.136 . . . . 0.0 112.409 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 52.93 46.66 26.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.578 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' D' ' 100' ' ' PRO . 35.3 m120 -158.03 -35.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -65.0 -39.16 93.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.494 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -65.55 -31.2 72.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 109.666 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . 0.575 HD12 ' N ' ' D' ' 105' ' ' LEU . 9.8 mp -62.4 -57.98 9.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.437 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 1.613 ' CD2' HBB3 ' D' ' 147' ' ' HEC . 6.4 tt -48.2 -22.73 0.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.627 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' D' ' 109' ' ' VAL . . . -79.3 -45.51 8.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -46.53 -16.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.201 -1.176 . . . . 0.0 109.623 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' D' ' 107' ' ' GLY . 98.2 t -85.07 -62.62 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.503 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . . . . . . . . . 14.7 mt -47.39 -26.18 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.661 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 70.8 t -68.96 -47.52 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.084 -1.01 . . . . 0.0 109.906 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . . . . . . . . . 20.0 p -79.41 -41.22 28.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.138 -0.976 . . . . 0.0 110.037 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . . . . . . . . . 78.2 t -47.57 -41.07 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.721 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' D' ' 118' ' ' PHE . 46.6 mt -79.52 -40.37 29.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.567 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.429 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.2 -30.38 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.399 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.535 ' C ' ' HD1' ' D' ' 116' ' ' HIS . 0.2 OUTLIER -84.75 -56.96 3.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 109.235 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' D' ' 118' ' ' PHE . 85.8 m-70 -63.48 -17.66 62.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.574 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.418 ' N ' ' O ' ' D' ' 114' ' ' LEU . 65.6 m-85 -153.33 62.32 0.76 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.943 . . . . 0.0 109.544 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' D' ' 122' ' ' PHE . . . -68.84 -50.51 35.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -47.95 -30.93 4.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -1.191 . . . . 0.0 109.404 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -82.81 -18.98 38.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.557 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' D' ' 119' ' ' GLY . 6.3 t80 -76.17 66.6 2.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.129 -0.982 . . . . 0.0 109.293 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.429 ' OG1' HG23 ' D' ' 126' ' ' VAL . 1.3 p -79.1 149.68 73.51 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.288 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.508 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 5.4 Cg_exo -45.3 -53.6 5.24 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.488 2.125 . . . . 0.0 112.972 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 25.7 Cg_endo -62.52 1.18 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.012 1.808 . . . . 0.0 112.21 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.453 ' O ' HG12 ' D' ' 126' ' ' VAL . 86.9 t -112.44 -8.31 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.298 -0.876 . . . . 0.0 109.352 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.21 -54.08 5.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 109.556 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.774 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -54.62 -33.84 61.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.14 2.52 17.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.21 -29.5 13.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 109.444 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' D' ' 135' ' ' ALA . 88.7 mm-40 -84.34 -23.49 30.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 109.901 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' B' ' 146' ' ' HIS . 14.4 ttmt -85.46 -36.06 20.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.141 -0.974 . . . . 0.0 110.183 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . 0.758 HG13 ' N ' ' D' ' 134' ' ' VAL . 11.9 p -65.44 -58.78 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.094 -1.004 . . . . 0.0 110.041 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.758 ' N ' HG13 ' D' ' 133' ' ' VAL . 11.5 t -62.23 -33.38 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.264 -0.897 . . . . 0.0 109.959 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' D' ' 131' ' ' GLN . . . -45.92 -21.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 0.0 109.743 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' D' ' 134' ' ' VAL . . . -82.79 -26.75 44.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' D' ' 134' ' ' VAL . 97.5 t -78.89 -21.15 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -1.148 . . . . 0.0 109.644 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -80.11 -38.3 31.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 109.644 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.66 -21.21 30.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.755 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.26 -48.44 70.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 0.0 109.697 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.414 HD22 ' CD2' ' D' ' 92' ' ' HIS . 28.3 mt -58.15 -22.08 49.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.925 . . . . 0.0 109.669 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . 0.533 ' O ' ' CD1' ' D' ' 145' ' ' TYR . . . -89.65 26.07 1.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 0.0 109.568 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -80.53 -6.91 58.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.108 -0.995 . . . . 0.0 109.128 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' D' ' 146' ' ' HIS . 11.6 mptt -122.15 -27.96 4.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.457 -0.777 . . . . 0.0 109.671 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' D' ' 142' ' ' ALA . 0.1 OUTLIER -50.21 -7.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 110.066 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.723 ' HB3' ' HG3' ' B' ' 132' ' ' LYS . 12.0 m-70 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.669 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 1.085 ' CHC' ' CD1' ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 1.558 HBB3 ' CD2' ' B' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 1.106 ' CHC' ' CD1' ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 1.613 HBB3 ' CD2' ' D' ' 106' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.28 -169.92 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -0.907 . . . . 0.0 109.903 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.594 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 0.1 OUTLIER -100.01 -179.2 0.78 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.35 -0.844 . . . . 0.0 109.566 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' A' ' 3' ' ' SER . 23.0 Cg_exo -62.83 -58.51 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.893 2.395 . . . . 0.0 113.049 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 6' ' ' ASP . . . -78.65 -16.44 57.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.03 -1.044 . . . . 0.0 110.204 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.594 ' CG ' ' H ' ' A' ' 3' ' ' SER . 33.5 m-20 -39.79 -30.69 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 0.0 109.72 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.638 ' CD ' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -83.7 -39.47 20.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.531 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' ALA . 37.2 m -44.82 -42.87 8.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.326 -0.859 . . . . 0.0 109.461 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.24 -25.33 62.44 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.578 ' N ' ' O ' ' A' ' 7' ' ' LYS . 53.2 t -78.82 -55.19 10.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -53.48 -37.19 62.47 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.459 -1.296 . . . . 0.0 107.875 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.78 -63.18 1.22 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.238 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.787 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -60.24 -36.17 77.15 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -0.843 . . . . 0.0 108.768 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -17.51 62.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 109.088 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -78.79 -46.43 8.54 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HG2' ' H ' ' A' ' 16' ' ' LYS . 13.2 mmmt -70.14 -36.62 74.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -1.098 . . . . 0.0 108.817 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 13' ' ' ALA . 95.4 t -60.65 -65.93 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 20' ' ' HIS . . . 58.71 -134.9 52.32 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.41 27.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.429 -1.042 . . . . 0.0 110.437 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.541 ' H ' ' C ' ' A' ' 18' ' ' GLY . 92.4 m-70 -131.58 25.68 4.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.199 -0.938 . . . . 0.0 108.481 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -88.57 -61.66 1.66 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.613 -0.679 . . . . 0.0 109.754 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.68 -14.38 0.23 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 21' ' ' ALA . 1.2 mm-40 -84.33 -56.33 3.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.345 -1.091 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.605 ' CE1' ' CG ' ' A' ' 112' ' ' HIS . 2.8 m-30 -60.64 -27.78 68.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.458 -0.776 . . . . 0.0 109.172 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.82 -22.92 75.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.65 -42.2 18.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -1.138 . . . . 0.0 109.795 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -64.29 -19.88 65.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 109.511 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.11 -19.68 60.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.937 . . . . 0.0 109.313 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.491 HD11 ' ND1' ' A' ' 58' ' ' HIS . 12.8 mt -78.43 -54.1 6.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 109.6 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.26 -37.6 64.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.447 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -43.87 98.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.502 ' HE2' ' HB3' ' A' ' 32' ' ' MET . 53.5 ttp -67.26 -49.92 62.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.425 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -51.54 -46.32 63.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 12.8 mt -64.09 -60.21 3.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 109.793 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 18.8 p -55.46 -18.98 8.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.646 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 35' ' ' SER . 79.6 m-85 -156.05 113.36 2.13 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.54 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 39' ' ' THR . 73.0 Cg_endo -79.56 -20.14 9.62 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.32 2.013 . . . . 0.0 111.945 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.85 ' O ' HG22 ' A' ' 41' ' ' THR . 41.0 p -47.12 -18.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.373 -0.829 . . . . 0.0 109.735 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 37' ' ' PRO . 42.6 p -74.68 -22.72 58.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 109.876 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -70.13 -20.05 63.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 0.0 110.0 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.85 HG22 ' O ' ' A' ' 38' ' ' THR . 12.2 t -73.69 -18.9 60.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.818 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.441 ' CZ ' HG23 ' A' ' 93' ' ' VAL . 33.3 m-85 -80.1 19.38 0.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.969 . . . . 0.0 109.576 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 51.5 94.04 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.996 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.665 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 71.5 Cg_endo -81.58 -34.56 0.51 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.653 2.236 . . . . 0.0 111.791 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.665 ' CG ' ' O ' ' A' ' 44' ' ' PRO . 15.1 p80 51.56 30.65 6.7 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.744 -0.597 . . . . 0.0 111.297 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.605 ' CD2' ' O ' ' A' ' 44' ' ' PRO . 4.9 p90 -145.42 23.2 1.47 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.891 -1.131 . . . . 0.0 109.526 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' SER . 57.2 m-20 42.52 84.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.551 -0.718 . . . . 0.0 109.829 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.62 HD12 ' H ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -50.22 -11.17 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 47' ' ' ASP . 14.7 m -58.88 147.36 34.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.383 -0.823 . . . . 0.0 109.491 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -64.54 148.46 50.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.596 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.03 83.81 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 5.4 p -69.07 -23.72 64.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -1.221 . . . . 0.0 109.337 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 52' ' ' SER . . . 67.57 -56.15 0.46 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.837 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 52' ' ' SER . 43.1 mt-30 -43.89 -22.44 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.356 -0.84 . . . . 0.0 109.812 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 53' ' ' ALA . 41.0 t -74.35 -26.74 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.32 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' ALA . 5.7 ptmt -65.7 -27.41 68.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.87 . . . . 0.0 109.552 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.08 -50.44 40.12 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.491 ' ND1' HD11 ' A' ' 29' ' ' LEU . 20.4 t-80 -53.85 -32.42 52.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -1.156 . . . . 0.0 109.476 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.22 -47.27 91.92 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -58.35 -23.43 56.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.362 -1.081 . . . . 0.0 109.592 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.686 ' HB3' ' C2A' ' A' ' 142' ' ' HEC . 0.7 OUTLIER -74.29 -39.49 62.9 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.228 -0.92 . . . . 0.0 108.88 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.7 -49.07 48.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.97 71.17 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.299 -0.876 . . . . 0.0 109.052 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -67.18 -38.73 85.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.299 -0.876 . . . . 0.0 108.759 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.562 ' HB3' HMB3 ' A' ' 142' ' ' HEC . . . -64.07 -52.1 60.96 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -57.24 -44.6 83.98 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.243 -0.91 . . . . 0.0 108.731 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.4 m -68.74 -50.65 48.97 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.44 HD22 HD21 ' A' ' 80' ' ' LEU . 61.0 t30 -60.36 -24.28 64.95 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 73' ' ' VAL . . . -84.96 -45.64 12.0 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.65 -23.38 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.66 -18.7 64.23 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 74' ' ' ASP . 27.7 m80 -144.08 -58.89 0.39 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.404 -0.81 . . . . 0.0 109.339 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 69' ' ' ALA . 14.3 p 44.19 13.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 121.879 0.847 . . . . 0.0 109.561 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.612 ' N ' ' O ' ' A' ' 72' ' ' HIS . 46.0 t0 -133.8 11.08 3.99 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.408 ' C ' ' HD2' ' A' ' 77' ' ' PRO . 1.9 p-10 179.03 29.39 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.973 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.695 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 17.4 ptt? -78.62 -22.61 0.39 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.426 -0.796 . . . . 0.0 111.805 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.695 ' CD ' ' N ' ' A' ' 76' ' ' MET . 52.4 Cg_exo -54.12 -22.27 24.84 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.497 1.465 . . . . 0.0 112.347 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -94.16 -33.86 13.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.8 59.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.146 -0.971 . . . . 0.0 109.353 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 68' ' ' ASN . 12.8 mt -80.36 8.5 7.42 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.372 -0.83 . . . . 0.0 109.123 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.0 p -55.89 -17.11 5.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.929 . . . . 0.0 109.666 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . -81.09 -55.97 4.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 83' ' ' LEU . 3.5 mt -45.4 -44.02 11.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 108.935 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 136' ' ' LEU . 29.7 t -57.23 -22.63 42.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.503 -0.748 . . . . 0.0 109.448 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 89' ' ' HIS . 23.1 t70 -82.01 -58.3 3.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.854 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.63 -27.45 17.17 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.279 -0.888 . . . . 0.0 109.757 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.448 ' ND1' ' O ' ' A' ' 83' ' ' LEU . 38.6 m80 -91.84 -21.76 20.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.129 -0.982 . . . . 0.0 109.858 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.47 -11.35 15.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.214 -0.929 . . . . 0.0 109.902 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.581 ' N ' ' O ' ' A' ' 85' ' ' ASP . 14.4 m80 -113.94 -77.81 0.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 89' ' ' HIS . 9.9 mptt -45.79 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.481 ' C ' ' N ' ' A' ' 93' ' ' VAL . 19.6 mt -65.69 -17.33 64.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.838 . . . . 0.0 110.16 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.518 ' NH1' ' OE2' ' D' ' 43' ' ' GLU . 25.0 ttm180 48.93 15.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.058 -1.026 . . . . 0.0 109.003 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.481 ' N ' ' C ' ' A' ' 91' ' ' LEU . 10.8 p -46.01 156.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.0 109.878 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 93' ' ' VAL . 3.5 m-20 -100.23 153.03 37.98 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.39 -0.818 . . . . 0.0 109.046 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 98' ' ' PHE . 32.7 Cg_endo -65.79 -10.64 27.48 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.539 2.159 . . . . 0.0 111.954 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 95' ' ' PRO . 83.4 t -44.05 -29.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.343 -0.848 . . . . 0.0 109.767 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -79.32 -32.92 43.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 109.577 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' A' ' 95' ' ' PRO . 0.0 OUTLIER -50.18 -34.9 24.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.347 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -49.99 -34.91 22.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.493 ' O ' ' SG ' ' A' ' 104' ' ' CYS . 9.8 mt -82.12 -50.52 8.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.812 HD21 HBB3 ' A' ' 142' ' ' HEC . 53.1 tp -45.77 -20.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.627 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' LEU . 93.3 p -73.3 -59.33 2.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 109.945 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.822 ' CG ' HD21 ' B' ' 108' ' ' ASN . 40.7 m80 -71.81 -26.48 62.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.922 . . . . 0.0 109.769 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 100' ' ' LEU . 62.4 m -58.11 -42.23 85.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.89 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.64 -22.74 62.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.221 -0.924 . . . . 0.0 110.186 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.594 ' N ' HD22 ' A' ' 106' ' ' LEU . 3.7 mm? -79.01 -35.96 41.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.0 -1.062 . . . . 0.0 110.137 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 45.3 t -62.89 -39.46 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.058 -1.026 . . . . 0.0 109.499 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.486 ' OG1' ' N ' ' A' ' 109' ' ' LEU . 12.2 p -65.23 -62.97 1.22 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.176 -0.952 . . . . 0.0 109.644 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.486 ' N ' ' OG1' ' A' ' 108' ' ' THR . 14.7 mt -48.2 -22.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 107' ' ' VAL . . . -63.35 -36.47 83.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 109.896 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.16 -42.59 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.158 -0.964 . . . . 0.0 109.893 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.605 ' CG ' ' CE1' ' A' ' 24' ' ' TYR . 93.3 m-70 -81.8 -75.36 0.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.011 . . . . 0.0 109.519 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 113' ' ' LEU . 1.5 pp -137.14 94.44 12.48 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.19 -171.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.248 1.965 . . . . 0.0 112.931 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.524 ' O ' HG11 ' A' ' 121' ' ' VAL . . . -47.23 -38.55 12.44 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.52 0.676 . . . . 0.0 109.539 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 6.7 mt-10 85.37 9.52 0.33 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.805 ' CE1' ' NE2' ' B' ' 116' ' ' HIS . 6.9 m-85 65.04 34.86 8.48 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.83 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.713 ' O ' ' N ' ' A' ' 120' ' ' ALA . 1.2 p -94.42 121.3 63.76 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.745 -1.222 . . . . 0.0 107.971 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -51.31 23.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.039 1.826 . . . . 0.0 112.914 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 118' ' ' THR . . . -154.97 -30.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.778 -1.201 . . . . 0.0 110.851 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.731 HG13 ' N ' ' A' ' 122' ' ' HIS . 11.8 p -47.83 -50.38 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.086 -1.008 . . . . 0.0 110.375 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.731 ' N ' HG13 ' A' ' 121' ' ' VAL . 2.4 t-80 -65.38 -43.5 90.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.453 -0.779 . . . . 0.0 109.999 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' B' ' 34' ' ' VAL . . . -79.07 -19.36 51.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.243 -0.911 . . . . 0.0 109.921 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 120' ' ' ALA . 64.3 m -72.45 -63.95 1.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 111.08 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.01 -18.25 64.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.947 -1.096 . . . . 0.0 109.48 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.26 -49.41 10.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.961 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -90.83 -57.77 2.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.906 -1.122 . . . . 0.0 111.441 -178.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.456 ' CD2' ' HA ' ' A' ' 124' ' ' SER . 21.9 m-85 -46.55 -21.53 0.19 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.776 -1.202 . . . . 0.0 110.239 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.768 ' O ' HD12 ' A' ' 129' ' ' LEU . 0.7 OUTLIER -66.58 -18.87 65.6 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 134' ' ' THR . . . -55.96 -33.21 64.55 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.489 ' OG ' ' CE ' ' A' ' 76' ' ' MET . 7.9 t -66.77 -36.73 83.11 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.217 -0.927 . . . . 0.0 108.762 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.504 ' O ' HD13 ' A' ' 136' ' ' LEU . 1.8 t -78.34 -40.0 24.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 34.8 t -73.41 -37.8 65.8 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.324 -0.86 . . . . 0.0 108.905 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 130' ' ' ALA . 88.9 m -71.55 -31.08 66.62 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.234 -0.916 . . . . 0.0 108.555 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 131' ' ' SER . 2.9 t -70.44 -36.58 67.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 132' ' ' VAL . 3.3 mp -56.71 -32.93 65.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 109.008 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.9 m -89.34 -27.25 20.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.59 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.2 p -66.59 132.09 47.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.528 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.459 ' C ' ' CG ' ' A' ' 140' ' ' TYR . 18.9 pttp -169.28 172.09 7.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.403 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.459 ' CG ' ' C ' ' A' ' 139' ' ' LYS . 28.1 m-85 -154.43 -44.49 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.534 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.469 ' CA ' ' HE ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.447 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.685 ' H1 ' ' HA ' ' B' ' 133' ' ' VAL . 13.2 p . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' HIS . . . . . . . . . . . . . 19.0 m170 50.79 35.57 12.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.285 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.904 HD12 ' H ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -86.47 178.11 7.21 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.188 -0.945 . . . . 0.0 109.25 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.415 ' O ' ' N ' ' B' ' 6' ' ' GLU . 7.5 p -92.09 145.42 30.81 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 109.368 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -39.96 -26.03 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.544 2.162 . . . . 0.0 112.17 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' B' ' 4' ' ' THR . 39.4 mt-10 -81.69 -51.91 7.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.565 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' B' ' 7' ' ' GLU . 0.7 OUTLIER -75.38 -22.6 57.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.913 . . . . 0.0 109.504 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.477 ' HB2' HD13 ' B' ' 3' ' ' LEU . 6.7 tttm -78.47 -37.1 44.21 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.33 -0.856 . . . . 0.0 109.121 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -63.12 -23.31 67.38 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.557 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.12 -57.64 3.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.148 -0.97 . . . . 0.0 110.166 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.46 -24.92 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.055 . . . . 0.0 108.574 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' B' ' 8' ' ' LYS . 96.4 m -78.26 -31.58 49.17 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.749 -0.594 . . . . 0.0 109.823 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' B' ' 15' ' ' TRP . . . -67.23 -63.79 0.99 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.767 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.563 HD12 ' N ' ' B' ' 14' ' ' LEU . 10.6 mp -45.83 -19.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.388 -0.82 . . . . 0.0 109.901 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' TRP . . . . . 0.463 ' N ' ' O ' ' B' ' 13' ' ' ALA . 4.0 t90 -78.78 -40.82 32.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.064 -1.023 . . . . 0.0 108.82 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.43 -24.07 59.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -79.87 -32.65 40.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -1.014 . . . . 0.0 109.286 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.56 HG23 ' O ' ' B' ' 14' ' ' LEU . 3.7 t -62.6 132.08 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.318 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' B' ' 21' ' ' ASP . 71.8 m-20 -81.26 78.28 8.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.858 . . . . 0.0 109.246 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.465 HG12 ' O ' ' B' ' 20' ' ' VAL . 77.9 t -49.82 -10.54 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' B' ' 19' ' ' ASN . 21.4 m-20 -55.31 -29.95 59.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.895 . . . . 0.0 109.729 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.511 ' O ' ' N ' ' B' ' 25' ' ' GLY . 18.3 pt-20 -152.5 -32.16 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.147 -0.971 . . . . 0.0 109.96 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' B' ' 22' ' ' GLU . 92.8 t -44.71 -26.32 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 109.638 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.51 -26.27 47.57 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' B' ' 22' ' ' GLU . . . -66.85 -45.12 86.62 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.415 ' N ' ' OE2' ' B' ' 26' ' ' GLU . 1.2 mp0 -63.91 -47.75 79.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.255 -1.144 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.41 -30.8 42.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.161 -0.962 . . . . 0.0 109.372 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.2 -54.27 5.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.37 -35.23 91.78 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -67.01 -32.38 73.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.12 . . . . 0.0 109.466 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 tp -47.24 -41.31 18.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 109.638 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.68 -23.91 39.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 109.712 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.17 -64.03 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.983 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.702 ' HA ' ' HB2' ' A' ' 123' ' ' ALA . 2.5 t -46.76 -43.9 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.322 -0.861 . . . . 0.0 109.373 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -171.79 130.0 0.69 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.336 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.59 62.32 7.71 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.302 2.002 . . . . 0.0 112.088 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' TRP . . . . . 0.493 ' CD1' ' N ' ' B' ' 37' ' ' TRP . 0.0 OUTLIER -57.65 -43.75 85.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.151 -0.968 . . . . 0.0 109.276 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.992 ' CG2' HBC1 ' B' ' 147' ' ' HEC . 1.7 p -49.78 -64.42 0.81 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.902 . . . . 0.0 109.373 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . 0.533 ' N ' ' OG1' ' B' ' 38' ' ' THR . 31.8 tt0 48.16 43.94 18.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.483 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 ttt85 -163.44 -36.67 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.554 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -119.28 16.11 13.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 109.193 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' B' ' 43' ' ' GLU . 30.7 p90 -87.54 -35.15 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.534 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.489 ' OE2' ' NH1' ' C' ' 92' ' ' ARG . 12.1 pt-20 -81.98 -13.92 56.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.683 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 86.4 p -57.68 -29.05 64.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 109.6 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -85.23 19.23 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.514 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.62 1.87 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' B' ' 48' ' ' LEU . 35.7 t0 49.79 -145.96 0.41 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -1.196 . . . . 0.0 109.488 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.539 ' CB ' ' O ' ' B' ' 47' ' ' ASP . 2.4 tp 82.73 24.29 0.16 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.787 -0.571 . . . . 0.0 109.64 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 49.7 m -57.59 -35.16 70.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.935 . . . . 0.0 109.202 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . 0.402 ' O ' ' N ' ' B' ' 52' ' ' ASP . 1.2 p -146.93 153.64 46.09 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 108.923 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -42.44 -22.74 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.258 1.972 . . . . 0.0 112.257 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' B' ' 50' ' ' THR . 26.2 t70 -85.13 -38.58 18.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.586 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.92 -19.52 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.34 -0.85 . . . . 0.0 109.53 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' B' ' 52' ' ' ASP . 14.4 t -60.63 -59.34 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' MET . . . . . . . . . . . . . 17.2 ptp -90.33 14.13 13.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.267 -0.895 . . . . 0.0 109.572 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.85 -18.98 58.77 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -89.08 146.95 37.45 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.133 -1.216 . . . . 0.0 109.486 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.87 -20.44 17.18 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.565 2.177 . . . . 0.0 112.388 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.61 -32.37 25.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 109.796 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -60.65 -41.15 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.969 . . . . 0.0 109.654 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.493 ' O ' ' NZ ' ' B' ' 65' ' ' LYS . 11.9 ptpt -79.03 -35.87 42.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -0.989 . . . . 0.0 109.38 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.25 69.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' HIS . . . . . 0.798 ' CE1' ' CHA' ' B' ' 147' ' ' HEC . 0.8 OUTLIER -72.87 -24.05 60.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.91 . . . . 0.0 109.594 -179.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.72 -19.08 80.04 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -68.5 -32.2 72.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -1.139 . . . . 0.0 109.323 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -75.95 -34.46 59.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.403 -0.811 . . . . 0.0 109.631 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' VAL . . . . . 0.84 HG22 ' CHB' ' B' ' 147' ' ' HEC . 53.9 t -68.9 -62.87 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.5 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.766 ' O ' HD23 ' B' ' 68' ' ' LEU . 2.6 tt -50.21 -29.01 8.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.934 . . . . 0.0 109.315 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.73 -38.93 96.74 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.47 93.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -1.135 . . . . 0.0 109.822 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.433 ' CE2' HD23 ' B' ' 110' ' ' LEU . 25.3 m-85 -46.98 -30.25 2.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.772 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 3.9 p -57.56 -49.7 75.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -60.38 -16.91 39.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.399 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.17 -31.04 79.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.861 ' H ' HD23 ' B' ' 75' ' ' LEU . 1.4 pt? -136.58 -22.38 1.27 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.268 -1.136 . . . . 0.0 110.031 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG ' ' B' ' 77' ' ' HIS . . . -77.59 5.11 9.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.03 -1.044 . . . . 0.0 109.733 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' B' ' 76' ' ' ALA . 46.5 m-70 -161.03 66.22 0.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.418 HD21 ' HA ' ' B' ' 75' ' ' LEU . 87.1 mt -72.96 10.82 0.8 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.498 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' B' ' 77' ' ' HIS . 13.7 t70 -66.74 -45.68 77.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.422 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -162.21 96.2 0.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.805 . . . . 0.0 109.414 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 24.7 mt -76.16 -58.79 3.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.579 ' NZ ' ' CD2' ' B' ' 143' ' ' HIS . 11.0 ttmm -54.72 -23.94 19.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.486 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.13 -47.54 9.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' B' ' 85' ' ' PHE . 2.8 t -78.25 -48.28 16.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -1.158 . . . . 0.0 109.628 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' PHE . . . . . 0.563 ' N ' ' CG2' ' B' ' 84' ' ' THR . 27.9 m-85 -59.62 -1.71 0.28 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.5 -0.75 . . . . 0.0 109.425 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' B' ' 84' ' ' THR . . . -56.3 -35.25 67.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 109.371 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 34.8 p -73.09 -57.77 3.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' B' ' 88' ' ' LEU . 32.5 mt -56.43 -29.5 61.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.949 . . . . 0.0 109.312 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' SER . . . . . . . . . . . . . 69.6 m -81.14 -32.56 33.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -82.6 -22.28 34.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.869 . . . . 0.0 109.546 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' LEU . . . . . 0.493 ' C ' HD23 ' B' ' 91' ' ' LEU . 9.8 tt -78.78 -68.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.759 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' B' ' 97' ' ' HIS . 0.4 OUTLIER -55.31 -20.12 10.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.075 -179.198 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' CYS . . . . . 0.532 ' N ' ' ND1' ' B' ' 92' ' ' HIS . 36.4 t -83.53 -60.68 2.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 110.642 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' B' ' 94' ' ' ASP . 0.8 OUTLIER -87.78 -25.75 23.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.084 -1.01 . . . . 0.0 111.446 -178.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.96 -52.24 5.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.717 -1.239 . . . . 0.0 110.96 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.607 ' O ' ' CG ' ' B' ' 97' ' ' HIS . 2.3 mm? -112.56 -11.63 13.56 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.941 -1.1 . . . . 0.0 109.828 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' HIS . . . . . 0.607 ' CG ' ' O ' ' B' ' 96' ' ' LEU . 49.2 p-80 41.84 41.51 1.87 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.351 -0.843 . . . . 0.0 109.761 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 59.6 t -51.41 132.32 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.389 -0.819 . . . . 0.0 109.457 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.07 153.0 90.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.171 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.47 -164.76 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.544 2.162 . . . . 0.0 112.229 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 56.91 48.38 15.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.203 -0.936 . . . . 0.0 109.36 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -160.62 -33.53 0.05 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.315 -0.865 . . . . 0.0 109.46 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -63.42 -60.94 2.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.37 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -57.53 -20.3 30.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.357 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.509 HD23 ' O ' ' B' ' 105' ' ' LEU . 1.6 tt -77.34 -49.79 14.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.383 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.871 HD13 ' CHC' ' B' ' 147' ' ' HEC . 6.7 tt -49.38 -46.3 47.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.274 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.35 -45.82 95.45 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . 0.822 HD21 ' CG ' ' A' ' 103' ' ' HIS . 11.8 t-20 -53.8 -34.7 59.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.151 -1.205 . . . . 0.0 109.565 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' VAL . . . . . 0.465 ' O ' ' SG ' ' B' ' 112' ' ' CYS . 89.7 t -80.28 -24.06 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.433 HD23 ' CE2' ' B' ' 71' ' ' PHE . 34.6 tp -78.06 -32.37 50.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.29 -49.59 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 109.754 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' B' ' 113' ' ' VAL . 18.7 p -53.08 -37.21 61.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.692 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' VAL . . . . . 0.468 ' N ' ' SG ' ' B' ' 112' ' ' CYS . 96.5 t -60.64 -21.37 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.661 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' B' ' 130' ' ' TYR . 23.6 mt -77.63 -57.02 4.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' ALA . . . . . 0.462 ' O ' ' CA ' ' B' ' 119' ' ' GLY . . . -47.1 -19.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.372 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' HIS . . . . . 0.805 ' NE2' ' CE1' ' A' ' 117' ' ' PHE . 1.5 t-80 -79.33 -56.78 4.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -69.24 -17.72 63.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 109.71 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -151.22 60.96 0.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 0.0 109.588 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' B' ' 115' ' ' ALA . . . -77.76 -23.23 67.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.53 8.71 4.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -1.1 . . . . 0.0 109.447 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -134.63 12.88 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.18 43.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.0 109.119 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . 0.488 ' OG1' HG23 ' B' ' 126' ' ' VAL . 1.0 OUTLIER -48.64 151.1 2.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.147 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.502 ' N ' ' HD2' ' B' ' 125' ' ' PRO . 6.0 Cg_exo -45.98 -52.32 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.281 1.987 . . . . 0.0 113.029 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' B' ' 124' ' ' PRO . 46.8 Cg_endo -68.34 15.24 0.16 Allowed 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.173 1.916 . . . . 0.0 112.973 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.488 HG23 ' OG1' ' B' ' 123' ' ' THR . 53.2 t -108.53 -42.69 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.988 -1.07 . . . . 0.0 109.878 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' B' ' 127' ' ' GLN . 0.0 OUTLIER -70.7 -59.87 2.57 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.086 -1.009 . . . . 0.0 109.798 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.684 ' HB2' ' HB3' ' A' ' 34' ' ' LEU . . . -49.48 -34.79 17.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.099 -1.001 . . . . 0.0 109.358 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.34 27.75 1.04 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.29 -0.881 . . . . 0.0 109.641 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' TYR . . . . . 0.516 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 1.6 t80 -126.69 -34.68 2.39 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.356 -0.84 . . . . 0.0 109.637 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -71.22 -62.86 1.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.743 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -48.7 -21.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.774 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . 0.685 ' HA ' ' H1 ' ' B' ' 1' ' ' VAL . 33.8 t -69.13 -65.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.741 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 9.2 m -74.15 -16.38 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.607 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' D' ' 146' ' ' HIS . . . -49.41 -30.26 7.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.331 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.59 -26.3 70.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.79 -39.81 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -1.11 . . . . 0.0 109.367 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.57 -44.88 95.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.873 ' ND2' ' CE1' ' D' ' 146' ' ' HIS . 1.2 m-20 -73.72 -44.14 57.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.422 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.09 -37.68 47.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.331 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.529 ' O ' ' NE2' ' B' ' 92' ' ' HIS . 18.1 mt -82.35 11.27 5.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' B' ' 144' ' ' LYS . . . -123.7 -30.97 3.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.382 -0.823 . . . . 0.0 109.514 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . 0.579 ' CD2' ' NZ ' ' B' ' 82' ' ' LYS . 1.5 m80 -49.68 -13.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.355 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' B' ' 142' ' ' ALA . 3.2 tptp -77.88 -43.07 31.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.21 -0.931 . . . . 0.0 109.511 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -50.1 -25.25 3.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' HIS . . . . . 0.837 ' CE1' ' ND2' ' D' ' 139' ' ' ASN . 25.8 m170 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.495 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.36 -169.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.897 . . . . 0.0 109.862 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' SER . . . . . 0.604 ' H ' ' CG ' ' C' ' 6' ' ' ASP . 0.1 OUTLIER -99.93 -179.11 0.77 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.404 -0.81 . . . . 0.0 109.644 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.474 ' CD ' ' CB ' ' C' ' 3' ' ' SER . 22.8 Cg_exo -62.92 -58.46 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.908 2.405 . . . . 0.0 113.091 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' C' ' 6' ' ' ASP . . . -78.7 -16.4 57.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.1 -1.0 . . . . 0.0 110.215 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' C' ' 3' ' ' SER . 33.5 m-20 -39.86 -30.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.701 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' LYS . . . . . 0.622 ' CD ' ' H ' ' C' ' 7' ' ' LYS . 0.0 OUTLIER -83.65 -39.52 20.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.39 -0.819 . . . . 0.0 109.493 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.45 ' N ' ' O ' ' C' ' 5' ' ' ALA . 36.4 m -44.85 -42.87 8.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.369 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -71.23 -25.37 62.47 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' C' ' 7' ' ' LYS . 52.9 t -78.83 -55.24 10.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' C' ' 15' ' ' GLY . 0.0 OUTLIER -53.41 -37.18 62.27 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.526 -1.27 . . . . 0.0 107.89 178.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.79 -63.16 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.332 -0.855 . . . . 0.0 109.241 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.766 ' O ' HG23 ' C' ' 17' ' ' VAL . . . -60.29 -36.2 77.31 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -17.49 62.37 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.487 -0.758 . . . . 0.0 109.067 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' C' ' 11' ' ' LYS . . . -78.86 -46.42 8.48 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -70.04 -36.65 75.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -1.118 . . . . 0.0 108.869 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.766 HG23 ' O ' ' C' ' 13' ' ' ALA . 94.9 t -60.65 -66.02 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.56 ' C ' ' H ' ' C' ' 20' ' ' HIS . . . 58.77 -134.78 52.36 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.55 27.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -1.025 . . . . 0.0 110.427 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' HIS . . . . . 0.56 ' H ' ' C ' ' C' ' 18' ' ' GLY . 92.2 m-70 -131.59 25.72 4.74 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' C' ' 23' ' ' GLU . . . -88.65 -61.55 1.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.61 -0.681 . . . . 0.0 109.755 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.7 -14.42 0.23 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 21' ' ' ALA . 1.2 mm-40 -84.28 -56.4 3.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -1.059 . . . . 0.0 109.526 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . 0.606 ' CE1' ' CG ' ' C' ' 112' ' ' HIS . 2.8 m-30 -60.6 -27.83 68.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 109.176 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.75 -22.94 75.66 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.72 -41.98 18.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.249 -1.147 . . . . 0.0 109.832 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -64.37 -19.99 65.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.405 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.05 -19.71 60.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.262 -0.899 . . . . 0.0 109.347 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.481 HD11 ' ND1' ' C' ' 58' ' ' HIS . 12.8 mt -78.41 -53.98 6.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.688 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -54.31 -37.64 65.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -43.84 98.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' MET . . . . . 0.523 ' HB3' ' HE2' ' C' ' 32' ' ' MET . 53.4 ttp -67.29 -49.96 62.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 0.0 109.407 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -51.49 -46.32 63.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.673 ' HB3' ' HB2' ' D' ' 128' ' ' ALA . 12.8 mt -64.08 -60.22 3.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.927 . . . . 0.0 109.865 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' C' ' 36' ' ' PHE . 18.7 p -55.36 -19.05 7.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' C' ' 35' ' ' SER . 79.6 m-85 -156.16 113.27 2.11 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.578 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' C' ' 39' ' ' THR . 73.0 Cg_endo -79.47 -20.12 9.74 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.259 1.973 . . . . 0.0 111.982 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . 0.844 ' O ' HG22 ' C' ' 41' ' ' THR . 40.9 p -47.17 -18.41 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 109.65 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.443 ' N ' ' O ' ' C' ' 37' ' ' PRO . 42.4 p -74.71 -22.79 58.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 109.854 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -69.96 -20.15 63.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 110.082 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.844 HG22 ' O ' ' C' ' 38' ' ' THR . 12.2 t -73.69 -18.85 60.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.075 -1.016 . . . . 0.0 109.83 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.437 ' CZ ' HG23 ' C' ' 93' ' ' VAL . 33.0 m-85 -80.2 19.48 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 51.48 94.02 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.999 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.668 ' O ' ' CG ' ' C' ' 45' ' ' HIS . 71.2 Cg_endo -81.59 -34.49 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.556 2.171 . . . . 0.0 111.763 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' HIS . . . . . 0.668 ' CG ' ' O ' ' C' ' 44' ' ' PRO . 15.1 p80 51.67 30.51 6.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.589 -0.694 . . . . 0.0 111.279 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' PHE . . . . . 0.608 ' CD2' ' O ' ' C' ' 44' ' ' PRO . 5.0 p90 -145.36 23.2 1.48 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.9 -1.125 . . . . 0.0 109.541 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' C' ' 49' ' ' SER . 56.9 m-20 42.51 84.14 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.533 -0.73 . . . . 0.0 109.772 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.611 HD12 ' H ' ' C' ' 48' ' ' LEU . 0.1 OUTLIER -50.27 -11.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.421 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.482 ' N ' ' O ' ' C' ' 47' ' ' ASP . 14.7 m -58.97 147.38 34.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -64.57 148.37 50.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.528 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.63 -4.15 83.65 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' SER . . . . . 0.536 ' O ' ' HB3' ' C' ' 53' ' ' ALA . 5.4 p -69.03 -23.66 64.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -1.167 . . . . 0.0 109.328 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' C' ' 52' ' ' SER . . . 67.5 -56.14 0.46 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.795 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' C' ' 52' ' ' SER . 43.0 mt-30 -43.95 -22.5 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.372 -0.83 . . . . 0.0 109.798 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' C' ' 53' ' ' ALA . 40.9 t -74.23 -26.72 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.323 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' C' ' 53' ' ' ALA . 5.7 ptmt -65.75 -27.41 68.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.18 -50.51 39.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' HIS . . . . . 0.481 ' ND1' HD11 ' C' ' 29' ' ' LEU . 20.6 t-80 -53.73 -32.44 52.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -1.136 . . . . 0.0 109.567 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.23 -47.3 91.76 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -58.2 -23.46 55.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.385 -1.068 . . . . 0.0 109.694 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' LYS . . . . . 0.674 ' HB3' ' C2A' ' C' ' 142' ' ' HEC . 0.7 OUTLIER -74.26 -39.44 63.0 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.229 -0.919 . . . . 0.0 108.927 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.76 -49.05 48.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.48 -30.02 71.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.315 -0.866 . . . . 0.0 109.017 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -67.14 -38.66 85.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.898 . . . . 0.0 108.819 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' ALA . . . . . 0.547 ' HB3' HMB3 ' C' ' 142' ' ' HEC . . . -64.09 -52.13 60.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' LEU . . . . . . . . . . . . . 14.6 mt -57.08 -44.71 83.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.227 -0.92 . . . . 0.0 108.764 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 17.5 m -68.74 -50.61 49.28 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.294 -0.879 . . . . 0.0 108.703 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . 0.432 HD22 HD21 ' C' ' 80' ' ' LEU . 61.0 t30 -60.38 -24.27 64.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.563 ' HB1' ' SD ' ' C' ' 76' ' ' MET . . . -84.95 -45.64 12.0 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.56 -23.48 33.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.65 -18.74 64.27 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' HIS . . . . . 0.614 ' O ' ' N ' ' C' ' 74' ' ' ASP . 27.7 m80 -144.06 -58.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.446 -0.783 . . . . 0.0 109.337 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' C' ' 69' ' ' ALA . 14.3 p 44.28 13.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.796 0.808 . . . . 0.0 109.475 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' ASP . . . . . 0.614 ' N ' ' O ' ' C' ' 72' ' ' HIS . 46.0 t0 -133.86 11.11 3.97 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.416 ' C ' ' HD2' ' C' ' 77' ' ' PRO . 2.0 p-10 179.0 29.25 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.003 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' MET . . . . . 0.691 ' N ' ' CD ' ' C' ' 77' ' ' PRO . 17.4 ptt? -78.57 -22.63 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 111.796 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.691 ' CD ' ' N ' ' C' ' 76' ' ' MET . 52.4 Cg_exo -54.0 -22.36 24.45 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.559 1.506 . . . . 0.0 112.334 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -94.2 -33.86 13.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.13 -0.981 . . . . 0.0 109.775 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.29 -46.74 60.12 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -0.948 . . . . 0.0 109.427 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' LEU . . . . . 0.432 HD21 HD22 ' C' ' 68' ' ' ASN . 12.9 mt -80.39 8.43 7.62 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 109.07 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 38.5 p -55.78 -17.14 5.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.742 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' C' ' 85' ' ' ASP . . . -81.16 -55.89 4.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 109.752 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.486 ' O ' ' ND1' ' C' ' 87' ' ' HIS . 3.5 mt -45.41 -43.97 11.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 108.967 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' C' ' 136' ' ' LEU . 29.7 t -57.32 -22.55 42.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.464 -0.772 . . . . 0.0 109.44 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' C' ' 89' ' ' HIS . 23.0 t70 -82.01 -58.37 3.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.14 -0.975 . . . . 0.0 109.926 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.49 -27.42 16.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 109.77 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' C' ' 83' ' ' LEU . 38.8 m80 -91.97 -21.7 20.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.795 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.41 -11.41 15.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 109.914 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' C' ' 85' ' ' ASP . 14.3 m80 -113.94 -77.86 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.034 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' C' ' 89' ' ' HIS . 9.9 mptt -45.78 -97.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.868 . . . . 0.0 110.213 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' C' ' 93' ' ' VAL . 19.6 mt -65.67 -17.32 64.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 110.178 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' ARG . . . . . 0.489 ' NH1' ' OE2' ' B' ' 43' ' ' GLU . 25.1 ttm180 48.86 15.34 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.986 -1.071 . . . . 0.0 108.938 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' C' ' 91' ' ' LEU . 10.8 p -46.05 156.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.395 -0.816 . . . . 0.0 109.886 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . 0.432 ' N ' HG22 ' C' ' 93' ' ' VAL . 3.5 m-20 -100.21 153.0 37.99 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.079 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' C' ' 98' ' ' PHE . 32.7 Cg_endo -65.87 -10.58 27.37 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.535 2.157 . . . . 0.0 111.947 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' VAL . . . . . . . . . . . . . 84.0 t -44.01 -29.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -0.839 . . . . 0.0 109.852 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -79.42 -32.86 42.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.621 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' PHE . . . . . 0.448 ' N ' ' O ' ' C' ' 95' ' ' PRO . 0.0 OUTLIER -50.18 -34.91 24.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.345 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -50.02 -34.91 22.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.486 ' O ' ' SG ' ' C' ' 104' ' ' CYS . 9.9 mt -82.11 -50.53 8.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.792 HD21 HBB3 ' C' ' 142' ' ' HEC . 53.2 tp -45.75 -20.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.396 -0.815 . . . . 0.0 109.64 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' SER . . . . . 0.445 ' N ' ' O ' ' C' ' 100' ' ' LEU . 93.1 p -73.4 -59.15 2.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.932 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.834 ' CG ' HD21 ' D' ' 108' ' ' ASN . 40.7 m80 -71.92 -26.52 62.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.173 -0.954 . . . . 0.0 109.753 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 104' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' C' ' 100' ' ' LEU . 62.1 m -58.07 -42.13 84.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.042 -1.036 . . . . 0.0 109.942 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.68 -22.85 62.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.123 -0.986 . . . . 0.0 110.123 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.598 ' N ' HD22 ' C' ' 106' ' ' LEU . 3.7 mm? -79.01 -35.98 41.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.021 -1.049 . . . . 0.0 110.146 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' C' ' 110' ' ' ALA . 45.7 t -62.8 -39.47 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.054 -1.029 . . . . 0.0 109.536 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' C' ' 109' ' ' LEU . 12.5 p -65.31 -62.86 1.28 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.171 -0.956 . . . . 0.0 109.639 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 109' ' ' LEU . . . . . 0.492 ' N ' ' OG1' ' C' ' 108' ' ' THR . 14.8 mt -48.3 -22.42 0.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.355 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' C' ' 107' ' ' VAL . . . -63.37 -36.5 83.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.932 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.54 20.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.961 . . . . 0.0 109.863 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 112' ' ' HIS . . . . . 0.606 ' CG ' ' CE1' ' C' ' 24' ' ' TYR . 93.3 m-70 -81.78 -75.43 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.115 -0.991 . . . . 0.0 109.54 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.638 ' O ' HD12 ' C' ' 113' ' ' LEU . 1.5 pp -137.05 94.42 12.62 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 114' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.2 -171.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.26 1.973 . . . . 0.0 112.899 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 115' ' ' ALA . . . . . 0.536 ' O ' HG11 ' C' ' 121' ' ' VAL . . . -47.3 -38.53 12.79 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.622 0.725 . . . . 0.0 109.598 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 116' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' C' ' 115' ' ' ALA . 6.7 mt-10 85.34 9.57 0.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 117' ' ' PHE . . . . . 0.812 ' CE1' ' NE2' ' D' ' 116' ' ' HIS . 6.9 m-85 65.11 34.93 8.28 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.779 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 118' ' ' THR . . . . . 0.727 ' O ' ' N ' ' C' ' 120' ' ' ALA . 1.2 p -94.58 121.33 63.43 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.783 -1.198 . . . . 0.0 107.942 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 119' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -51.35 23.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.124 1.883 . . . . 0.0 112.849 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 120' ' ' ALA . . . . . 0.727 ' N ' ' O ' ' C' ' 118' ' ' THR . . . -155.06 -30.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.742 -1.223 . . . . 0.0 110.773 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 121' ' ' VAL . . . . . 0.718 HG13 ' N ' ' C' ' 122' ' ' HIS . 11.9 p -47.8 -50.35 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 122' ' ' HIS . . . . . 0.718 ' N ' HG13 ' C' ' 121' ' ' VAL . 2.4 t-80 -65.41 -43.56 90.17 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.41 -0.806 . . . . 0.0 109.976 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 123' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' D' ' 34' ' ' VAL . . . -79.06 -19.38 51.5 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 109.914 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 124' ' ' SER . . . . . 0.58 ' N ' ' O ' ' C' ' 120' ' ' ALA . 63.7 m -72.42 -63.85 1.07 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 111.128 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.05 -18.18 64.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.06 -1.025 . . . . 0.0 109.562 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 126' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -82.24 -49.55 9.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.899 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' C' ' 128' ' ' PHE . 0.0 OUTLIER -90.86 -57.64 2.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.903 -1.123 . . . . 0.0 111.476 -178.187 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 128' ' ' PHE . . . . . 0.47 ' CD2' ' HA ' ' C' ' 124' ' ' SER . 21.9 m-85 -46.57 -21.53 0.19 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.731 -1.231 . . . . 0.0 110.189 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 129' ' ' LEU . . . . . 0.768 ' O ' HD12 ' C' ' 129' ' ' LEU . 0.7 OUTLIER -66.6 -18.86 65.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' C' ' 134' ' ' THR . . . -56.01 -33.18 64.64 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.506 ' O ' HG23 ' C' ' 135' ' ' VAL . 7.9 t -66.67 -36.83 83.47 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.168 -0.958 . . . . 0.0 108.767 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 132' ' ' VAL . . . . . 0.498 ' O ' HD13 ' C' ' 136' ' ' LEU . 1.8 t -78.3 -39.98 24.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 133' ' ' SER . . . . . . . . . . . . . 34.9 t -73.52 -37.66 65.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.466 -0.771 . . . . 0.0 108.95 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 134' ' ' THR . . . . . 0.448 ' N ' ' O ' ' C' ' 130' ' ' ALA . 88.8 m -71.62 -31.1 66.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 135' ' ' VAL . . . . . 0.506 HG23 ' O ' ' C' ' 131' ' ' SER . 2.9 t -70.35 -36.58 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.498 HD13 ' O ' ' C' ' 132' ' ' VAL . 3.2 mp -56.73 -32.85 65.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.361 -0.837 . . . . 0.0 108.998 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 137' ' ' THR . . . . . . . . . . . . . 51.4 m -89.36 -27.46 20.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.477 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 138' ' ' SER . . . . . . . . . . . . . 25.1 p -66.47 132.03 47.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.977 . . . . 0.0 109.501 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.46 ' C ' ' CG ' ' C' ' 140' ' ' TYR . 18.9 pttp -169.24 172.1 7.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.46 ' CG ' ' C ' ' C' ' 139' ' ' LYS . 27.8 m-85 -154.4 -44.54 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.971 . . . . 0.0 109.521 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 141' ' ' ARG . . . . . 0.462 ' HE ' ' CA ' ' C' ' 141' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.438 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 1' ' ' VAL . . . . . 0.675 ' H1 ' ' HA ' ' D' ' 133' ' ' VAL . 13.5 p . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 2' ' ' HIS . . . . . . . . . . . . . 18.9 m170 50.84 35.5 12.42 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.32 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 3' ' ' LEU . . . . . 0.923 HD12 ' H ' ' D' ' 3' ' ' LEU . 0.0 OUTLIER -86.4 178.15 7.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.903 . . . . 0.0 109.338 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.412 ' O ' ' N ' ' D' ' 6' ' ' GLU . 7.3 p -92.2 145.54 30.95 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 109.285 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -40.09 -25.96 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.534 2.156 . . . . 0.0 112.177 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 6' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' D' ' 4' ' ' THR . 39.5 mt-10 -81.72 -51.91 7.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' D' ' 7' ' ' GLU . 0.7 OUTLIER -75.3 -22.75 57.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.47 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 8' ' ' LYS . . . . . 0.468 ' HB2' HD13 ' D' ' 3' ' ' LEU . 6.7 tttm -78.39 -37.17 44.73 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.299 -0.876 . . . . 0.0 109.131 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 37.5 t -63.07 -23.28 67.37 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.612 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.23 -57.5 3.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.16 -0.962 . . . . 0.0 110.082 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.52 -24.88 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.977 -1.077 . . . . 0.0 108.54 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' D' ' 8' ' ' LYS . 96.7 m -78.35 -31.59 48.64 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.729 -0.607 . . . . 0.0 109.724 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' D' ' 15' ' ' TRP . . . -67.25 -63.82 0.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.747 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.576 HD12 ' N ' ' D' ' 14' ' ' LEU . 10.6 mp -45.79 -19.29 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.377 -0.827 . . . . 0.0 109.898 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 15' ' ' TRP . . . . . 0.472 ' N ' ' O ' ' D' ' 13' ' ' ALA . 4.1 t90 -78.95 -40.8 30.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.986 -1.071 . . . . 0.0 108.751 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.31 -24.19 59.57 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -79.77 -32.71 40.97 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.456 -1.026 . . . . 0.0 109.353 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.568 HG23 ' O ' ' D' ' 14' ' ' LEU . 3.7 t -62.62 132.13 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.4 -0.812 . . . . 0.0 109.399 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 19' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' D' ' 21' ' ' ASP . 71.7 m-20 -81.21 78.17 8.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.291 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 20' ' ' VAL . . . . . 0.455 HG12 ' O ' ' D' ' 20' ' ' VAL . 78.4 t -49.78 -10.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.498 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' D' ' 19' ' ' ASN . 21.4 m-20 -55.33 -29.89 59.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 22' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' D' ' 25' ' ' GLY . 18.3 pt-20 -152.57 -32.15 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.095 -1.003 . . . . 0.0 110.045 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' D' ' 22' ' ' GLU . 93.0 t -44.72 -26.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.113 -0.992 . . . . 0.0 109.597 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.5 -26.31 47.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 25' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' D' ' 22' ' ' GLU . . . -66.71 -45.22 86.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 26' ' ' GLU . . . . . 0.423 ' N ' ' OE2' ' D' ' 26' ' ' GLU . 1.2 mp0 -63.9 -47.82 79.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -1.125 . . . . 0.0 109.318 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.3 -30.86 41.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.339 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.22 -54.32 5.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.24 -35.29 91.88 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -66.98 -32.36 73.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -1.091 . . . . 0.0 109.495 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 31' ' ' LEU . . . . . . . . . . . . . 64.5 tp -47.35 -41.24 19.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.599 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 mt -80.73 -23.88 39.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.699 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.09 -64.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.474 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 34' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' C' ' 123' ' ' ALA . 2.4 t -46.65 -43.89 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 35' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -171.88 130.05 0.68 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.325 -0.859 . . . . 0.0 109.304 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.51 62.17 7.63 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.366 2.044 . . . . 0.0 112.126 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 37' ' ' TRP . . . . . 0.487 ' CZ3' HD11 ' D' ' 105' ' ' LEU . 0.0 OUTLIER -57.6 -43.72 84.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.143 -0.973 . . . . 0.0 109.272 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 38' ' ' THR . . . . . 0.99 HG21 HBC1 ' D' ' 147' ' ' HEC . 1.8 p -49.86 -64.41 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.371 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 39' ' ' GLN . . . . . 0.553 ' N ' ' OG1' ' D' ' 38' ' ' THR . 31.9 tt0 48.09 44.09 18.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 109.429 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 40' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -163.55 -36.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -119.3 16.14 13.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.309 -0.869 . . . . 0.0 109.216 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 42' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' D' ' 43' ' ' GLU . 30.8 p90 -87.61 -35.07 18.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.542 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . 0.518 ' OE2' ' NH1' ' A' ' 92' ' ' ARG . 12.1 pt-20 -81.97 -13.89 56.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.696 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 86.2 p -57.63 -29.09 64.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.607 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -85.27 19.24 2.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.262 -0.899 . . . . 0.0 109.44 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.63 1.87 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' D' ' 48' ' ' LEU . 35.7 t0 49.98 -146.01 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -1.186 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 48' ' ' LEU . . . . . 0.531 ' CB ' ' O ' ' D' ' 47' ' ' ASP . 2.4 tp 82.77 24.19 0.16 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.807 -0.558 . . . . 0.0 109.622 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -57.56 -35.12 69.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.273 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 50' ' ' THR . . . . . . . . . . . . . 1.2 p -146.93 153.69 46.13 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.402 -0.811 . . . . 0.0 108.887 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 51' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -42.47 -22.7 0.25 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.249 1.966 . . . . 0.0 112.251 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -85.15 -38.6 18.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.562 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 53' ' ' ALA . . . . . . . . . . . . . . . -47.82 -19.58 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.362 -0.836 . . . . 0.0 109.573 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 t -60.66 -59.45 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.514 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 55' ' ' MET . . . . . . . . . . . . . 17.1 ptp -90.25 14.19 13.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.0 109.493 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.03 -18.91 58.61 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 57' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -89.07 146.99 37.55 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 109.443 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.76 -20.56 17.34 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.609 2.206 . . . . 0.0 112.4 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.55 -32.39 25.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.902 . . . . 0.0 109.785 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 60' ' ' VAL . . . . . . . . . . . . . 67.0 t -60.72 -41.18 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.672 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 61' ' ' LYS . . . . . 0.462 ' O ' ' NZ ' ' D' ' 65' ' ' LYS . 12.0 ptpt -78.94 -35.79 42.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.34 -30.12 69.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 63' ' ' HIS . . . . . 0.792 ' CE1' ' CHA' ' D' ' 147' ' ' HEC . 0.8 OUTLIER -72.93 -24.08 60.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.71 -19.12 80.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 65' ' ' LYS . . . . . 0.462 ' NZ ' ' O ' ' D' ' 61' ' ' LYS . 0.3 OUTLIER -68.44 -32.32 72.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -1.128 . . . . 0.0 109.326 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -75.78 -34.55 60.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.313 -0.867 . . . . 0.0 109.738 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 67' ' ' VAL . . . . . 0.832 HG22 ' CHB' ' D' ' 147' ' ' HEC . 53.9 t -68.85 -62.94 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.755 ' O ' HD23 ' D' ' 68' ' ' LEU . 2.5 tt -50.14 -29.07 8.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.373 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.02 96.84 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.56 93.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -1.165 . . . . 0.0 109.804 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 71' ' ' PHE . . . . . 0.436 ' CE2' HD23 ' D' ' 110' ' ' LEU . 25.1 m-85 -47.0 -30.29 2.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.173 -0.954 . . . . 0.0 109.634 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 72' ' ' SER . . . . . . . . . . . . . 3.8 p -57.6 -49.68 75.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.461 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -60.32 -17.01 39.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.09 79.79 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.855 ' H ' HD23 ' D' ' 75' ' ' LEU . 1.4 pt? -136.62 -22.34 1.27 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.317 -1.108 . . . . 0.0 109.973 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 76' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' D' ' 77' ' ' HIS . . . -77.61 5.09 9.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.072 -1.017 . . . . 0.0 109.679 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 77' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' D' ' 76' ' ' ALA . 46.8 m-70 -160.99 66.27 0.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.531 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 78' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' D' ' 75' ' ' LEU . 87.3 mt -73.08 11.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.533 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' D' ' 77' ' ' HIS . 13.7 t70 -66.73 -45.72 77.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.399 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -162.21 96.19 0.97 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.44 -0.787 . . . . 0.0 109.417 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 81' ' ' LEU . . . . . . . . . . . . . 24.9 mt -76.19 -58.77 3.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.418 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 82' ' ' LYS . . . . . 0.584 ' NZ ' ' CD2' ' D' ' 143' ' ' HIS . 11.0 ttmm -54.76 -23.87 19.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.534 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.14 -47.51 9.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 84' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' D' ' 85' ' ' PHE . 2.8 t -78.28 -48.21 16.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -1.193 . . . . 0.0 109.67 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 85' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' D' ' 84' ' ' THR . 27.9 m-85 -59.72 -1.76 0.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.41 -0.806 . . . . 0.0 109.387 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 86' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' D' ' 84' ' ' THR . . . -56.21 -35.24 67.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.158 -0.964 . . . . 0.0 109.423 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 87' ' ' THR . . . . . . . . . . . . . 34.5 p -73.2 -57.6 3.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 31.9 mt -56.49 -29.49 61.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.31 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 89' ' ' SER . . . . . . . . . . . . . 69.2 m -81.12 -32.64 33.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.439 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -82.62 -22.41 34.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.862 . . . . 0.0 109.482 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 91' ' ' LEU . . . . . 0.489 ' C ' HD23 ' D' ' 91' ' ' LEU . 9.8 tt -78.69 -68.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.853 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 92' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' D' ' 97' ' ' HIS . 0.4 OUTLIER -55.17 -20.28 10.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 0.0 110.092 -179.304 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 93' ' ' CYS . . . . . 0.526 ' N ' ' ND1' ' D' ' 92' ' ' HIS . 36.4 t -83.45 -60.66 2.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.1 -1.0 . . . . 0.0 110.706 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' D' ' 94' ' ' ASP . 0.8 OUTLIER -87.78 -25.64 23.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.087 -1.008 . . . . 0.0 111.45 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.02 -52.28 5.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.84 -1.163 . . . . 0.0 110.895 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 96' ' ' LEU . . . . . 0.609 ' O ' ' CG ' ' D' ' 97' ' ' HIS . 2.3 mm? -112.5 -11.67 13.58 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.995 -1.065 . . . . 0.0 109.857 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 97' ' ' HIS . . . . . 0.609 ' CG ' ' O ' ' D' ' 96' ' ' LEU . 49.3 p-80 41.89 41.48 1.89 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.31 -0.869 . . . . 0.0 109.786 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.42 132.32 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 0.0 109.472 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.01 152.96 90.0 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.245 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 100' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.54 -164.81 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.595 2.197 . . . . 0.0 112.162 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 101' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 57.01 48.34 15.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.32 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 102' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -160.61 -33.61 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -63.3 -60.91 2.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.445 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 104' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -57.63 -20.24 31.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 109.333 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 105' ' ' LEU . . . . . 0.51 HD23 ' O ' ' D' ' 105' ' ' LEU . 1.6 tt -77.37 -49.72 14.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.355 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.877 HD13 ' CHC' ' D' ' 147' ' ' HEC . 6.7 tt -49.41 -46.29 47.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.859 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.36 -45.78 95.53 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 108' ' ' ASN . . . . . 0.834 HD21 ' CG ' ' C' ' 103' ' ' HIS . 11.8 t-20 -53.76 -34.7 59.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -1.176 . . . . 0.0 109.583 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 109' ' ' VAL . . . . . 0.452 ' O ' ' SG ' ' D' ' 112' ' ' CYS . 90.7 t -80.25 -24.12 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.548 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 110' ' ' LEU . . . . . 0.436 HD23 ' CE2' ' D' ' 71' ' ' PHE . 34.2 tp -78.05 -32.43 50.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 109.412 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 94.3 t -65.15 -49.77 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.685 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 112' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' D' ' 113' ' ' VAL . 18.6 p -52.95 -37.23 60.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.939 . . . . 0.0 109.747 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 113' ' ' VAL . . . . . 0.462 ' N ' ' SG ' ' D' ' 112' ' ' CYS . 96.5 t -60.66 -21.38 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.675 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 114' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' D' ' 130' ' ' TYR . 23.6 mt -77.64 -57.07 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 109.571 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 115' ' ' ALA . . . . . 0.459 ' O ' ' CA ' ' D' ' 119' ' ' GLY . . . -47.03 -19.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.088 -1.007 . . . . 0.0 109.386 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 116' ' ' HIS . . . . . 0.812 ' NE2' ' CE1' ' C' ' 117' ' ' PHE . 1.5 t-80 -79.45 -56.69 4.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.147 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 117' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -69.27 -17.61 63.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.683 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -151.31 60.98 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 119' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' D' ' 115' ' ' ALA . . . -77.78 -23.32 67.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -78.41 8.63 4.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.363 -1.08 . . . . 0.0 109.477 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -134.57 12.81 3.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.404 -0.81 . . . . 0.0 109.52 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.15 43.86 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.116 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . 0.475 ' OG1' HG23 ' D' ' 126' ' ' VAL . 1.0 OUTLIER -48.61 151.1 2.15 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 109.161 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.501 ' N ' ' HD2' ' D' ' 125' ' ' PRO . 6.0 Cg_exo -46.0 -52.3 7.25 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.307 2.005 . . . . 0.0 113.034 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 125' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' D' ' 124' ' ' PRO . 46.7 Cg_endo -68.29 15.16 0.16 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.157 1.905 . . . . 0.0 113.091 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.475 HG23 ' OG1' ' D' ' 123' ' ' THR . 53.1 t -108.4 -42.76 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.056 -1.027 . . . . 0.0 109.914 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 127' ' ' GLN . . . . . 0.616 ' CD ' ' H ' ' D' ' 127' ' ' GLN . 0.0 OUTLIER -70.66 -60.01 2.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.997 -1.064 . . . . 0.0 109.734 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 128' ' ' ALA . . . . . 0.673 ' HB2' ' HB3' ' C' ' 34' ' ' LEU . . . -49.37 -34.77 16.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.11 -0.993 . . . . 0.0 109.461 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.39 27.76 1.04 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.306 -0.871 . . . . 0.0 109.686 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 130' ' ' TYR . . . . . 0.516 ' CZ ' ' CD1' ' D' ' 114' ' ' LEU . 1.6 t80 -126.65 -34.73 2.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.345 -0.847 . . . . 0.0 109.592 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 131' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -71.32 -62.86 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.159 -0.963 . . . . 0.0 109.642 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -48.77 -21.7 0.67 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 109.709 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 133' ' ' VAL . . . . . 0.675 ' HA ' ' H1 ' ' D' ' 1' ' ' VAL . 34.2 t -69.17 -65.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.715 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.415 ' H ' HG22 ' D' ' 134' ' ' VAL . 9.0 m -74.22 -16.44 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.228 -0.92 . . . . 0.0 109.569 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' B' ' 146' ' ' HIS . . . -49.32 -30.28 7.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.372 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.68 -26.22 70.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 137' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' D' ' 134' ' ' VAL . 89.1 t -68.84 -39.75 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -1.132 . . . . 0.0 109.336 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.01 94.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.837 ' ND2' ' CE1' ' B' ' 146' ' ' HIS . 1.2 m-20 -73.7 -44.03 57.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.13 -37.67 47.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.219 -0.926 . . . . 0.0 109.351 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.52 ' O ' ' NE2' ' D' ' 92' ' ' HIS . 18.0 mt -82.31 11.2 5.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' D' ' 144' ' ' LYS . . . -123.66 -30.94 3.53 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.414 -0.804 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 143' ' ' HIS . . . . . 0.584 ' CD2' ' NZ ' ' D' ' 82' ' ' LYS . 1.5 m80 -49.69 -13.53 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 109.401 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 144' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' D' ' 142' ' ' ALA . 3.2 tptp -77.76 -43.0 32.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 145' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.25 -25.24 3.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.263 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 146' ' ' HIS . . . . . 0.873 ' CE1' ' ND2' ' B' ' 139' ' ' ASN . 25.9 m170 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.449 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' HEC . . . . . 0.812 HBB3 HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' HEC . . . . . 0.992 HBC1 ' CG2' ' B' ' 38' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 142' ' ' HEC . . . . . 0.792 HBB3 HD21 ' C' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 147' ' ' HEC . . . . . 0.99 HBC1 HG21 ' D' ' 38' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_